,Word,T,P
0,Pre-operative,1,0
1,short-term,1,0
2,pulmonary,1,0
3,rehabilitation,1,0
4,for,1,0
5,patients,0,0
6,of,0,0
7,chronic,0,0
8,obstructive,0,0
9,pulmonary,0,1
10,disease,0,1
11,undergoing,0,1
12,coronary,1,1
13,artery,1,1
14,bypass,1,1
15,graft,1,0
16,surgery,1,0
17,.,1,0
18,The,0,0
19,role,0,0
20,of,0,0
21,pre-operative,1,0
22,short-term,1,0
23,pulmonary,1,0
24,rehabilitation,1,0
25,in,0,0
26,patients,0,0
27,with,0,0
28,chronic,0,0
29,obstructive,0,0
30,pulmonary,0,1
31,disease,0,0
32,who,0,0
33,undergo,0,0
34,coronary,0,0
35,artery,0,0
36,bypass,0,1
37,graft,0,0
38,surgery,0,0
39,has,0,0
40,been,0,0
41,assessed,0,0
42,for,0,0
43,the,0,0
44,first,0,0
45,time,0,0
46,prospectively,0,0
47,.,0,0
48,Forty-five,0,0
49,patients,0,0
50,posted,0,0
51,for,0,0
52,coronary,1,0
53,artery,1,0
54,bypass,0,1
55,graft,0,0
56,surgery,0,0
57,were,0,0
58,randomised,0,0
59,to,0,0
60,receive,0,0
61,either,0,0
62,short-term,1,0
63,pulmonary,1,1
64,rehabilitation,1,1
65,(,0,1
66,group,0,0
67,I,0,0
68,),0,0
69,or,1,0
70,no,1,0
71,such,1,0
72,programme,1,0
73,(,0,1
74,group,0,1
75,II,0,1
76,),0,0
77,.,0,0
78,Patients,0,0
79,of,0,0
80,both,0,0
81,the,0,0
82,groups,0,0
83,were,0,0
84,evenly,0,0
85,matched,0,0
86,with,0,0
87,respect,0,0
88,to,0,0
89,age,0,0
90,",",0,0
91,sex,0,0
92,",",0,0
93,body,0,0
94,surface,0,0
95,area,0,0
96,",",0,0
97,duration,0,0
98,and,0,0
99,severity,0,0
100,of,0,0
101,chronic,0,0
102,obstructive,0,0
103,pulmonary,0,0
104,disease,0,0
105,and,0,0
106,coronary,0,0
107,artery,0,0
108,disease,0,0
109,.,0,0
110,Normal,0,0
111,individuals,0,0
112,who,0,0
113,evenly,0,0
114,matched,0,0
115,with,0,0
116,the,0,0
117,study,0,0
118,group,0,0
119,were,0,0
120,assessed,0,0
121,for,0,0
122,normal,0,0
123,respiratory,0,0
124,function,0,0
125,parameters,0,0
126,.,0,0
127,Pre-operative,0,0
128,and,0,0
129,post-operative,0,0
130,peak,0,0
131,expiratory,0,0
132,flow,0,0
133,rate,0,0
134,",",0,0
135,inspiratory,0,0
136,capacity,0,0
137,",",0,0
138,post-operative,0,0
139,ventilation,0,0
140,time,0,0
141,",",0,0
142,post-operative,0,0
143,pulmonary,0,0
144,complication,0,0
145,and,0,0
146,hospital,0,0
147,stay,0,0
148,were,0,0
149,determined,0,0
150,in,0,0
151,both,0,0
152,the,0,0
153,groups,0,0
154,.,0,0
155,Peak,0,0
156,expiratory,0,0
157,flow,0,0
158,rate,0,0
159,(,0,0
160,220.0,0,0
161,+/-,0,0
162,12.9,0,0
163,and,0,0
164,324.3,0,0
165,+/-,0,0
166,84.3,0,0
167,in,0,0
168,group,0,0
169,I,0,0
170,",",0,0
171,218.0,0,0
172,+/-,0,0
173,16.4,0,0
174,and,0,0
175,260.5,0,0
176,+/-,0,0
177,35.2,0,0
178,in,0,0
179,group,0,0
180,II,0,1
181,),0,1
182,and,0,0
183,inspiratory,0,1
184,capacity,0,0
185,(,0,0
186,844.0,0,0
187,+/-,0,0
188,147.4,0,0
189,and,0,0
190,1100.0,0,0
191,+/-,0,0
192,158.1,0,0
193,in,0,0
194,group,0,0
195,I,0,0
196,",",0,0
197,830.0,0,0
198,+/-,0,0
199,117.4,0,0
200,and,0,0
201,1090,0,0
202,+/-,0,0
203,137,0,0
204,in,0,0
205,group,0,0
206,II,0,0
207,),0,0
208,were,0,0
209,significantly,0,0
210,lower,0,0
211,before,0,0
212,and,0,0
213,after,0,0
214,surgery,0,0
215,respectively,0,0
216,in,0,0
217,both,0,0
218,groups,0,0
219,compared,0,0
220,to,0,0
221,normal,0,0
222,values,0,0
223,.,0,0
224,Even,0,0
225,though,0,0
226,both,0,0
227,groups,0,0
228,showed,0,0
229,a,0,0
230,significant,0,0
231,rise,0,0
232,in,0,0
233,post-operative,0,0
234,peak,0,0
235,expiratory,0,0
236,flow,0,0
237,rate,0,0
238,and,0,0
239,inspiratory,0,0
240,capacity,0,0
241,after,0,0
242,surgery,0,0
243,",",0,0
244,the,0,0
245,post-operative,0,0
246,peak,0,0
247,expiratory,0,0
248,flow,0,0
249,rate,0,0
250,and,0,0
251,inspiratory,0,0
252,capacity,0,0
253,in,0,0
254,group,0,0
255,I,0,0
256,was,0,0
257,significantly,0,0
258,higher,0,0
259,than,0,0
260,in,0,0
261,group,0,0
262,II,0,0
263,.,0,0
264,In,0,0
265,group,0,0
266,I,0,0
267,",",0,0
268,the,0,0
269,post-operative,0,0
270,ventilation,0,0
271,time,0,0
272,(,0,0
273,24.5,0,0
274,+/-,0,0
275,6.00,0,0
276,hours,0,0
277,),0,0
278,",",0,1
279,post-operative,0,1
280,complications,0,1
281,(,0,0
282,n,0,0
283,=,0,0
284,4,0,0
285,),0,0
286,and,0,0
287,hospital,0,1
288,stay,0,1
289,(,0,0
290,12.4,0,0
291,+/-,0,0
292,3.6,0,0
293,days,0,0
294,),0,0
295,were,0,0
296,significantly,0,0
297,lower,0,0
298,than,0,0
299,in,0,0
300,group,0,0
301,II,0,0
302,(,0,0
303,35.2,0,0
304,+/-,0,0
305,22.3,0,0
306,hours,0,0
307,",",0,0
308,n,0,0
309,=,0,0
310,11,0,0
311,",",0,0
312,18.8,0,0
313,+/-,0,0
314,6.6,0,0
315,days,0,0
316,respectively,0,0
317,),0,0
318,.,0,0
319,These,0,0
320,data,0,0
321,suggest,0,0
322,that,0,0
323,short-term,0,0
324,pulmonary,0,0
325,rehabilitation,0,0
326,is,0,0
327,feasible,0,0
328,and,0,0
329,effective,0,0
330,in,0,0
331,improving,0,0
332,pulmonary,0,0
333,functions,0,0
334,before,0,0
335,and,0,0
336,after,0,0
337,surgery,0,0
338,and,0,0
339,in,0,0
340,reducing,0,0
341,surgical,0,0
342,morbidity,0,0
343,and,0,0
344,cost,0,0
345,of,0,0
346,medical,0,0
347,care,0,0
348,significantly,0,0
349,.,0,0
350,Effects,0,0
351,of,0,0
352,insufficient,1,0
353,sleep,1,0
354,on,0,0
355,blood,0,0
356,pressure,0,0
357,in,0,0
358,hypertensive,0,0
359,patients,0,0
360,:,0,0
361,a,0,0
362,24-h,0,1
363,study,0,0
364,.,0,0
365,The,0,0
366,influence,0,0
367,of,0,0
368,acute,0,0
369,sleep,0,0
370,deprivation,0,0
371,during,0,0
372,the,0,0
373,first,0,0
374,part,0,0
375,of,0,0
376,the,0,0
377,night,0,0
378,on,0,0
379,24-h,1,1
380,blood,1,1
381,pressure,1,1
382,monitoring,1,0
383,(,0,1
384,ABPM,0,1
385,),0,0
386,was,0,0
387,studied,0,0
388,in,0,0
389,36,0,0
390,never-treated,0,0
391,mild,0,0
392,to,0,0
393,moderate,0,0
394,hypertensive,0,0
395,patients,0,0
396,.,0,0
397,According,0,0
398,to,0,0
399,a,0,0
400,crossover,0,1
401,design,0,1
402,",",0,0
403,they,0,0
404,were,0,0
405,randomized,0,0
406,to,0,0
407,have,0,0
408,either,0,0
409,sleep,1,0
410,deprivation,1,0
411,or,0,0
412,a,0,0
413,full,1,0
414,night,1,0
415,'s,1,1
416,sleep,1,0
417,1,0,0
418,week,0,0
419,apart,0,0
420,",",0,0
421,during,0,0
422,which,0,0
423,they,0,0
424,were,0,0
425,monitored,0,0
426,with,0,0
427,ABPM,0,0
428,.,0,0
429,Urine,0,0
430,samples,0,0
431,for,0,0
432,analysis,0,0
433,of,0,0
434,nocturnal,0,0
435,urinary,0,1
436,excretion,0,1
437,of,0,1
438,norepinephrine,0,1
439,were,0,0
440,collected,0,0
441,.,0,0
442,During,0,0
443,the,0,0
444,sleep-deprivation,1,0
445,day,0,0
446,",",0,0
447,both,0,0
448,mean,0,0
449,24-h,0,1
450,blood,0,0
451,pressure,0,0
452,and,0,0
453,mean,0,0
454,24-h,0,1
455,heart,0,0
456,rate,0,0
457,were,0,0
458,higher,0,0
459,in,0,0
460,comparison,0,0
461,with,0,0
462,those,0,0
463,recorded,0,0
464,during,0,0
465,the,0,0
466,routine,0,0
467,workday,0,0
468,",",0,0
469,the,0,0
470,difference,0,0
471,being,0,0
472,more,0,0
473,pronounced,0,0
474,during,0,0
475,the,0,0
476,nighttime,0,0
477,(,0,0
478,P,0,0
479,<,0,0
480,.01,0,0
481,),0,0
482,.,0,0
483,Urinary,0,0
484,excretion,0,1
485,of,0,1
486,norepinephrine,0,1
487,showed,0,0
488,a,0,0
489,significant,0,0
490,increase,0,0
491,at,0,0
492,night,0,0
493,during,0,0
494,sleep,1,0
495,deprivation,1,0
496,(,0,0
497,P,0,0
498,<,0,0
499,.05,0,0
500,),0,0
501,.,0,0
502,Blood,0,0
503,pressure,0,0
504,and,0,0
505,heart,0,0
506,rate,0,0
507,significantly,0,0
508,increased,0,0
509,in,0,0
510,the,0,0
511,morning,0,0
512,after,0,0
513,a,0,0
514,sleep-insufficient,1,0
515,night,0,0
516,(,0,0
517,P,0,0
518,<,0,0
519,.05,0,0
520,),0,0
521,.,0,0
522,These,0,0
523,data,0,0
524,suggest,0,0
525,that,0,0
526,lack,0,0
527,of,0,0
528,sleep,0,0
529,in,0,0
530,hypertensive,0,0
531,patients,0,0
532,may,0,0
533,increase,0,0
534,sympathetic,0,0
535,nervous,0,0
536,activity,0,0
537,during,0,0
538,the,0,0
539,night,0,0
540,and,0,0
541,the,0,0
542,following,0,0
543,morning,0,0
544,",",0,0
545,leading,0,0
546,to,0,0
547,increased,0,0
548,blood,0,0
549,pressure,0,0
550,and,0,0
551,heart,0,0
552,rate,0,0
553,.,0,0
554,This,0,0
555,situation,0,0
556,might,0,0
557,represent,0,0
558,an,0,0
559,increased,0,0
560,risk,0,0
561,for,0,0
562,both,0,0
563,target,0,0
564,organ,0,0
565,damage,0,0
566,and,0,0
567,acute,0,0
568,cardiovascular,0,0
569,diseases,0,0
570,.,0,0
571,Masticatory,0,0
572,performance,0,0
573,and,0,0
574,chewing,0,0
575,experience,0,0
576,with,0,0
577,implant-retained,0,0
578,mandibular,0,0
579,overdentures,0,0
580,.,0,0
581,The,0,0
582,relationship,0,0
583,between,0,0
584,masticatory,0,0
585,performance,0,0
586,and,0,0
587,chewing,0,0
588,experience,0,0
589,has,0,0
590,not,0,0
591,yet,0,0
592,been,0,0
593,explored,0,0
594,for,0,0
595,patients,0,0
596,with,0,0
597,implant-retained,1,0
598,overdentures,1,0
599,.,1,0
600,Although,0,0
601,many,0,0
602,relationships,0,0
603,have,0,0
604,been,0,0
605,found,0,0
606,between,0,0
607,parameters,0,0
608,of,0,0
609,objective,0,0
610,and,0,0
611,subjective,0,1
612,oral,0,1
613,function,0,0
614,",",0,0
615,the,0,0
616,structure,0,0
617,of,0,0
618,these,0,0
619,relationships,0,0
620,remain,0,0
621,unclear,0,0
622,.,0,0
623,Therefore,0,0
624,",",0,0
625,we,0,0
626,studied,0,0
627,in,0,0
628,a,0,0
629,randomized,0,0
630,clinical,0,0
631,trial,0,0
632,the,0,0
633,relationship,0,0
634,between,0,0
635,the,0,0
636,comminution,0,0
637,of,0,0
638,an,0,0
639,artificial,0,0
640,test,0,0
641,food,0,0
642,",",0,0
643,i.e,1,0
644,.,1,0
645,masticatory,1,0
646,performance,1,0
647,",",1,0
648,and,1,0
649,the,1,0
650,subjective,1,0
651,chewing,1,0
652,experience,1,0
653,.,1,0
654,The,0,0
655,trial,0,0
656,involved,0,0
657,a,0,0
658,comparison,0,0
659,between,0,0
660,two,0,0
661,groups,0,0
662,receiving,0,0
663,implant,1,0
664,treatment,1,0
665,and,1,0
666,one,1,0
667,group,1,0
668,receiving,1,0
669,conventional,1,0
670,complete,1,0
671,dentures,1,0
672,(,1,1
673,CD,1,1
674,),1,1
675,.,1,0
676,The,0,0
677,implant,0,0
678,treatment,0,0
679,involved,0,0
680,either,0,0
681,a,0,0
682,mainly,0,0
683,implant-supported,1,0
684,mandibular,1,0
685,overdenture,1,0
686,on,0,0
687,a,0,0
688,transmandibular,1,0
689,implant,1,1
690,(,1,1
691,TMI,1,1
692,),1,1
693,or,0,0
694,an,0,0
695,implant-tissue-supported,1,0
696,mandibular,1,0
697,overdenture,1,0
698,on,0,0
699,two,0,0
700,IMZ,1,1
701,implants,1,1
702,(,1,1
703,IMZ,1,1
704,),1,1
705,.,1,0
706,Masticatory,0,0
707,performance,0,0
708,as,0,0
709,well,0,0
710,as,0,0
711,chewing,0,0
712,experience,0,0
713,were,0,0
714,substantially,0,0
715,better,0,0
716,for,0,0
717,the,0,0
718,implant-retained,0,0
719,overdentures,0,0
720,compared,0,0
721,with,0,0
722,the,0,0
723,complete,0,0
724,denture,0,0
725,group,0,0
726,.,0,0
727,No,0,1
728,significant,0,0
729,differences,0,0
730,emerged,0,0
731,between,0,0
732,the,0,0
733,TMI,1,0
734,and,0,0
735,the,0,0
736,IMZ,1,1
737,group,0,0
738,.,0,0
739,A,0,0
740,multiple,0,0
741,regression,0,0
742,analysis,0,0
743,did,0,0
744,not,0,0
745,provide,0,0
746,any,0,0
747,comprehensibility,0,0
748,in,0,0
749,the,0,0
750,relationship,0,0
751,between,0,0
752,masticatory,0,0
753,performance,0,0
754,and,0,0
755,the,0,0
756,variables,0,0
757,of,0,0
758,chewing,0,0
759,experience,0,0
760,.,0,0
761,In,0,0
762,the,0,0
763,linear,0,0
764,structural,0,0
765,relation,0,0
766,analysis,0,0
767,(,0,0
768,LISREL,0,1
769,),0,1
770,no,0,0
771,direct,0,0
772,relationship,0,0
773,was,0,0
774,found,0,0
775,between,0,0
776,masticatory,0,0
777,performance,0,0
778,and,0,0
779,functional,0,0
780,complaints,0,0
781,mandibular,0,0
782,denture,0,0
783,.,0,0
784,The,0,0
785,results,0,0
786,show,0,0
787,that,0,0
788,an,0,0
789,improvement,0,0
790,in,0,0
791,masticatory,0,0
792,performance,0,0
793,does,0,0
794,not,0,0
795,imply,0,0
796,the,0,0
797,same,0,0
798,improvement,0,0
799,in,0,0
800,chewing,0,0
801,experience,0,0
802,and,0,0
803,vice,0,0
804,versa,0,0
805,.,0,0
806,Comparison,0,0
807,of,0,0
808,patient-controlled,1,1
809,and,1,1
810,nurse-administered,1,1
811,analgesia,1,1
812,using,0,1
813,intravenous,0,1
814,fentanyl,0,1
815,during,0,1
816,labor,0,0
817,.,0,0
818,Preliminary,0,0
819,observations,0,0
820,have,0,0
821,shown,0,0
822,that,0,0
823,fentanyl,1,1
824,citrate,1,1
825,",",0,1
826,a,0,1
827,potent,0,1
828,narcotic,0,1
829,",",0,1
830,is,0,0
831,helpful,0,0
832,during,0,0
833,labor,0,0
834,without,0,0
835,undue,0,0
836,side,0,0
837,effects,0,0
838,.,0,0
839,This,0,0
840,randomized,0,0
841,prospective,0,0
842,investigation,0,0
843,compared,0,0
844,the,0,0
845,patient-controlled,1,1
846,administration,1,1
847,of,1,1
848,fentanyl,1,1
849,with,0,0
850,that,0,0
851,of,0,0
852,administration,1,1
853,by,1,0
854,nurses,1,1
855,on,1,0
856,request,1,0
857,.,1,0
858,Eighty,0,0
859,healthy,0,0
860,women,0,0
861,beginning,0,0
862,active,0,0
863,labor,0,1
864,(,0,0
865,cervical,0,1
866,dilation,0,1
867,4,0,1
868,cm,0,0
869,),0,0
870,at,0,0
871,term,0,0
872,were,0,0
873,assigned,0,0
874,to,0,0
875,receive,0,1
876,fentanyl,1,1
877,intravenously,1,1
878,by,1,1
879,either,1,1
880,patient-controlled,1,1
881,administration,1,1
882,(,1,1
883,n=37,1,0
884,),1,0
885,or,1,0
886,nurse,1,1
887,administration,1,1
888,on,1,1
889,demand,1,0
890,(,0,0
891,n=43,0,0
892,),0,0
893,.,0,0
894,Pain,0,0
895,intensity,0,0
896,measurements,0,0
897,during,0,0
898,early,0,0
899,and,0,0
900,late,0,0
901,labor,0,0
902,revealed,0,0
903,the,0,0
904,degree,0,0
905,of,0,0
906,analgesia,0,1
907,to,0,0
908,be,0,0
909,the,0,0
910,same,0,0
911,in,0,0
912,both,0,0
913,groups,0,0
914,.,0,0
915,The,0,0
916,delay,0,0
917,in,0,0
918,setting,0,0
919,up,0,0
920,the,0,0
921,infusion,0,1
922,system,0,0
923,and,0,0
924,the,0,0
925,short,0,0
926,time,0,0
927,between,0,0
928,requesting,0,1
929,analgesia,0,1
930,and,0,1
931,vaginal,0,0
932,delivery,0,0
933,were,0,0
934,limitations,0,0
935,with,0,0
936,self-administration,0,1
937,.,0,0
938,Maternal,0,0
939,oversedation,0,0
940,and,0,0
941,vomiting,0,0
942,did,0,0
943,not,0,0
944,occur,0,0
945,.,0,0
946,Neonatal,0,0
947,naloxone,0,1
948,therapy,0,1
949,was,0,0
950,used,0,0
951,infrequently,0,0
952,",",0,0
953,umbilical,0,1
954,serum,0,1
955,levels,0,0
956,of,0,0
957,fentanyl,0,1
958,were,0,0
959,the,0,0
960,same,0,0
961,in,0,0
962,both,0,0
963,groups,0,0
964,",",0,0
965,and,0,0
966,postnatal,0,0
967,neuroadaptive,0,0
968,testing,0,0
969,revealed,0,0
970,comparable,0,0
971,results,0,0
972,in,0,0
973,both,0,0
974,groups,0,0
975,.,0,0
976,Despite,0,0
977,the,0,0
978,usefulness,0,0
979,of,0,0
980,fentanyl,0,1
981,during,0,0
982,labor,0,1
983,",",0,0
984,administration,1,1
985,by,1,0
986,the,1,0
987,patient,1,0
988,had,0,0
989,no,0,0
990,advantages,0,0
991,over,0,0
992,administration,1,1
993,by,1,0
994,the,1,0
995,nurses,1,0
996,in,0,0
997,significantly,0,0
998,reducing,0,0
999,drug,0,1
1000,use,0,0
1001,",",0,0
1002,improving,0,0
1003,pain,0,0
1004,relief,0,0
1005,",",0,0
1006,or,0,0
1007,avoiding,0,0
1008,drowsiness,0,0
1009,.,0,0
1010,Protocol,0,0
1011,for,0,0
1012,the,0,0
1013,Multicenter,0,0
1014,Acute,0,0
1015,Stroke,0,0
1016,Trial,0,0
1017,--,0,0
1018,thrombolysis,0,0
1019,study,0,0
1020,.,0,0
1021,The,0,0
1022,rationale,0,0
1023,for,0,0
1024,the,0,0
1025,Multicenter,0,0
1026,Acute,0,0
1027,Stroke,0,0
1028,Trial,0,0
1029,(,0,1
1030,MAST,0,1
1031,),0,0
1032,is,0,0
1033,presented,0,0
1034,in,0,0
1035,a,0,0
1036,companion,0,0
1037,article,0,0
1038,appearing,0,0
1039,in,0,0
1040,this,0,0
1041,issue,0,0
1042,.,0,0
1043,Acute,0,0
1044,ischaemic,0,0
1045,stroke,0,0
1046,is,0,0
1047,the,0,0
1048,third,0,0
1049,major,0,0
1050,cause,0,0
1051,of,0,0
1052,death,0,0
1053,in,0,0
1054,developed,0,0
1055,countries,0,0
1056,",",0,0
1057,and,0,0
1058,a,0,0
1059,major,0,0
1060,cause,0,0
1061,of,0,0
1062,disability,0,0
1063,.,0,0
1064,Despite,0,0
1065,a,0,0
1066,very,0,0
1067,poor,0,0
1068,prognosis,0,0
1069,",",0,0
1070,no,0,0
1071,treatment,0,0
1072,has,0,0
1073,demonstrated,0,0
1074,an,0,0
1075,efficacy,0,0
1076,in,0,0
1077,lowering,0,0
1078,the,0,0
1079,mortality,0,0
1080,and,0,0
1081,disability,0,0
1082,resulting,0,0
1083,from,0,0
1084,stroke,0,0
1085,events,0,0
1086,.,0,0
1087,Thrombolysis,1,0
1088,has,0,0
1089,been,0,0
1090,proven,0,0
1091,to,0,0
1092,reduce,0,0
1093,mortality,0,0
1094,in,0,0
1095,myocardial,0,0
1096,infarction,0,0
1097,",",0,0
1098,and,0,0
1099,it,0,0
1100,has,0,0
1101,been,0,0
1102,shown,0,0
1103,able,0,0
1104,to,0,0
1105,induce,0,0
1106,recanalisation,0,0
1107,when,0,0
1108,administered,0,1
1109,to,0,0
1110,acute,0,0
1111,stroke,0,0
1112,patients,0,0
1113,.,0,0
1114,A,0,0
1115,recent,0,0
1116,meta,0,0
1117,analysis,0,0
1118,of,0,0
1119,small-sized,0,0
1120,studies,0,0
1121,suggests,0,0
1122,that,0,0
1123,thrombolysis,1,0
1124,could,0,0
1125,offer,0,0
1126,some,0,0
1127,benefit,0,0
1128,to,0,0
1129,stroke,0,0
1130,patients,0,0
1131,",",0,0
1132,by,0,0
1133,reducing,0,0
1134,the,0,0
1135,mortality,0,0
1136,and,0,0
1137,severe,0,0
1138,invalidity,0,0
1139,by,0,0
1140,56,0,0
1141,%,0,0
1142,;,0,0
1143,these,0,0
1144,results,0,0
1145,need,0,0
1146,to,0,0
1147,be,0,0
1148,confirmed,0,0
1149,in,0,0
1150,adequately,0,0
1151,designed,0,0
1152,and,0,0
1153,sized,0,0
1154,studies,0,0
1155,.,0,0
1156,Isradipine,1,1
1157,",",0,1
1158,raised,0,1
1159,glycosylated,0,1
1160,haemoglobin,0,1
1161,",",0,1
1162,and,0,0
1163,risk,0,0
1164,of,0,0
1165,cardiovascular,0,0
1166,events,0,0
1167,.,0,0
1168,Long,0,0
1169,term,0,0
1170,response,0,0
1171,to,0,0
1172,therapy,0,0
1173,of,0,0
1174,chronic,0,0
1175,anti-HBe-positive,0,0
1176,hepatitis,0,0
1177,B,0,0
1178,is,0,0
1179,poor,0,0
1180,independent,0,0
1181,of,0,0
1182,type,0,0
1183,and,0,0
1184,schedule,0,0
1185,of,0,0
1186,interferon,0,1
1187,.,0,0
1188,OBJECTIVE,0,0
1189,The,0,0
1190,response,0,0
1191,rate,0,0
1192,to,0,0
1193,alpha,1,0
1194,interferon,1,1
1195,(,1,1
1196,IFN,1,1
1197,),1,1
1198,of,0,0
1199,chronic,0,0
1200,anti-HBe-positive,0,0
1201,hepatitis,0,0
1202,B,0,0
1203,is,0,0
1204,variable,0,0
1205,.,0,0
1206,We,0,0
1207,studied,0,0
1208,whether,0,0
1209,type,0,0
1210,",",0,0
1211,dose,0,1
1212,",",0,1
1213,and,0,0
1214,schedule,0,0
1215,of,0,0
1216,IFN,1,0
1217,",",0,0
1218,and,0,0
1219,type,0,0
1220,and,0,0
1221,frequency,0,0
1222,of,0,0
1223,posttreatment,0,0
1224,monitoring,0,0
1225,",",0,0
1226,influence,0,0
1227,the,0,0
1228,response,0,0
1229,rate,0,0
1230,.,0,0
1231,METHODS,0,0
1232,Seventy-two,0,0
1233,consecutive,0,0
1234,anti-HBe-positive,0,0
1235,chronic,0,0
1236,hepatitis,0,0
1237,B,0,1
1238,patients,0,0
1239,(,0,0
1240,59,0,0
1241,male,0,0
1242,and,0,0
1243,13,0,0
1244,female,0,0
1245,",",0,0
1246,median,0,0
1247,age,0,0
1248,41,0,0
1249,yr,0,0
1250,),0,0
1251,stratified,0,0
1252,by,0,0
1253,sex,0,0
1254,and,0,0
1255,histology,0,0
1256,were,0,0
1257,randomly,0,0
1258,allocated,0,0
1259,to,0,0
1260,three,0,0
1261,treatment,0,0
1262,arms,0,0
1263,.,0,0
1264,Twenty-seven,0,0
1265,patients,0,0
1266,(,0,0
1267,A,0,1
1268,),0,1
1269,received,0,0
1270,10,0,0
1271,million,0,0
1272,units,0,0
1273,alpha-N1,1,0
1274,IFN,1,1
1275,i.m,1,1
1276,.,1,1
1277,t.w,0,0
1278,.,0,0
1279,for,0,0
1280,24,0,0
1281,wk,0,0
1282,(,0,1
1283,total,0,1
1284,dose,0,1
1285,:,0,0
1286,720,0,0
1287,million,0,0
1288,units,0,0
1289,),0,1
1290,;,0,1
1291,21,0,1
1292,(,0,1
1293,B,0,1
1294,),0,1
1295,received,0,0
1296,9,0,0
1297,million,0,0
1298,units,0,1
1299,alpha-2a,1,1
1300,IFN,1,1
1301,i.m,1,1
1302,.,1,1
1303,t.w,0,0
1304,.,0,0
1305,for,0,0
1306,4,0,0
1307,wk,0,0
1308,",",0,0
1309,followed,0,0
1310,by,0,0
1311,18,0,0
1312,million,0,0
1313,units,0,0
1314,for,0,0
1315,12,0,0
1316,wk,0,0
1317,and,0,0
1318,9,0,0
1319,million,0,0
1320,units,0,0
1321,for,0,0
1322,8,0,0
1323,wk,0,0
1324,(,0,0
1325,972,0,0
1326,million,0,0
1327,units,0,0
1328,),0,1
1329,;,0,1
1330,24,0,1
1331,(,0,1
1332,C,0,1
1333,),0,1
1334,received,0,0
1335,2,1,1
1336,alpha-2a,1,1
1337,IFN,1,1
1338,courses,1,1
1339,(,0,0
1340,9,0,0
1341,million,0,0
1342,units,0,0
1343,i.m,0,1
1344,.,0,1
1345,t.w,0,0
1346,.,0,0
1347,for,0,0
1348,16,0,0
1349,and,0,0
1350,12,0,0
1351,wk,0,0
1352,separated,0,0
1353,by,0,0
1354,a,0,0
1355,6-month,0,0
1356,interval,0,0
1357,[,0,0
1358,756,0,0
1359,million,0,0
1360,units,0,0
1361,],0,1
1362,),0,0
1363,.,0,0
1364,Primary,0,0
1365,response,0,0
1366,was,0,0
1367,defined,0,0
1368,by,0,0
1369,normal,0,0
1370,ALT,0,0
1371,and,0,0
1372,serum,0,1
1373,HBV-DNA,0,1
1374,levels,0,0
1375,below,0,0
1376,10,0,0
1377,pg/ml,0,0
1378,at,0,0
1379,the,0,0
1380,end,0,0
1381,of,0,0
1382,therapy,0,0
1383,and,0,0
1384,sustained,0,0
1385,response,0,0
1386,by,0,0
1387,normal,0,0
1388,ALT,0,0
1389,(,0,0
1390,tested,0,0
1391,monthly,0,1
1392,),0,0
1393,",",0,0
1394,undetectable,0,0
1395,HBV-DNA,0,0
1396,and,0,0
1397,IgM,0,1
1398,anti-HBc,0,1
1399,(,0,0
1400,<,0,0
1401,7,0,0
1402,I.U,0,0
1403,.,0,0
1404,Paul,0,0
1405,Ehrlich,0,1
1406,Institute,0,1
1407,),0,1
1408,(,0,1
1409,tested,0,0
1410,every,0,0
1411,3,0,0
1412,months,0,0
1413,),0,0
1414,during,0,0
1415,the,0,0
1416,posttreatment,0,0
1417,follow-up,0,0
1418,.,0,0
1419,RESULTS,0,0
1420,At,0,0
1421,the,0,0
1422,end,0,0
1423,of,0,0
1424,treatment,0,0
1425,",",0,0
1426,12,0,0
1427,",",0,0
1428,8,0,0
1429,",",0,0
1430,and,0,0
1431,13,0,0
1432,patients,0,0
1433,from,0,0
1434,groups,0,0
1435,A,0,0
1436,",",0,0
1437,B,0,0
1438,",",0,0
1439,and,0,0
1440,C,0,0
1441,",",0,0
1442,respectively,0,0
1443,",",0,0
1444,were,0,0
1445,responders,0,0
1446,.,0,0
1447,At,0,0
1448,the,0,0
1449,18-month,0,0
1450,follow-up,0,0
1451,",",0,0
1452,two,0,0
1453,patients,0,0
1454,in,0,0
1455,group,0,0
1456,A,0,0
1457,and,0,0
1458,only,0,0
1459,one,0,0
1460,in,0,0
1461,groups,0,0
1462,B,0,0
1463,and,0,0
1464,C,0,0
1465,maintained,0,0
1466,the,0,0
1467,response,0,0
1468,.,0,0
1469,Overall,0,0
1470,",",0,0
1471,after,0,0
1472,34,0,0
1473,months,0,0
1474,(,0,0
1475,median,0,0
1476,posttreatment,0,0
1477,follow-up,0,0
1478,),0,0
1479,",",0,0
1480,three,0,0
1481,patients,0,0
1482,were,0,0
1483,long,0,0
1484,term,0,0
1485,responders,0,0
1486,",",0,0
1487,whereas,0,0
1488,three,0,0
1489,showed,0,0
1490,a,0,0
1491,sustained,0,0
1492,remission,0,0
1493,after,0,0
1494,relapse,0,0
1495,.,0,0
1496,CONCLUSIONS,0,0
1497,The,0,0
1498,rate,0,0
1499,of,0,0
1500,long,0,0
1501,term,0,0
1502,response,0,0
1503,to,0,0
1504,interferon,0,1
1505,of,0,0
1506,anti-HBe-positive,0,0
1507,chronic,0,0
1508,hepatitis,0,0
1509,B,0,0
1510,is,0,0
1511,poor,0,0
1512,",",0,0
1513,independent,0,0
1514,of,0,0
1515,IFN,0,0
1516,type,0,0
1517,",",0,0
1518,dose,0,1
1519,",",0,1
1520,or,0,1
1521,schedule,0,1
1522,;,0,0
1523,the,0,0
1524,more,0,0
1525,stringent,0,0
1526,the,0,0
1527,monitoring,0,0
1528,",",0,0
1529,the,0,0
1530,higher,0,0
1531,the,0,0
1532,relapse,0,0
1533,rate,0,0
1534,.,0,0
1535,Comparative,0,0
1536,evaluation,0,0
1537,of,0,0
1538,olopatadine,1,1
1539,ophthalmic,1,1
1540,solution,1,0
1541,(,0,0
1542,0.1,0,0
1543,%,0,0
1544,),0,0
1545,versus,0,0
1546,ketorolac,1,1
1547,ophthalmic,1,1
1548,solution,1,1
1549,(,0,0
1550,0.5,0,0
1551,%,0,0
1552,),0,0
1553,using,0,0
1554,the,0,0
1555,provocative,0,0
1556,antigen,0,0
1557,challenge,0,0
1558,model,0,0
1559,.,0,0
1560,OBJECTIVE,0,0
1561,This,0,0
1562,study,0,0
1563,was,0,0
1564,conducted,0,0
1565,to,0,0
1566,compare,0,0
1567,the,0,0
1568,efficacy,0,0
1569,and,0,0
1570,safety,0,0
1571,of,0,0
1572,olopatadine,1,1
1573,ophthalmic,1,1
1574,solution,1,0
1575,(,0,0
1576,0.1,0,0
1577,%,0,0
1578,),0,0
1579,with,0,0
1580,ketorolac,1,1
1581,ophthalmic,1,1
1582,solution,1,1
1583,(,0,0
1584,0.5,0,0
1585,%,0,0
1586,),0,0
1587,in,0,0
1588,a,0,0
1589,clinical,0,0
1590,model,0,0
1591,of,0,0
1592,acute,0,0
1593,allergic,0,0
1594,conjunctivitis,0,1
1595,.,0,0
1596,Olopatadine,1,1
1597,is,0,0
1598,a,0,0
1599,dual,0,0
1600,acting,0,0
1601,H1,0,1
1602,histamine,0,1
1603,receptor,0,1
1604,antagonist,0,1
1605,and,0,0
1606,a,0,0
1607,mast,0,0
1608,cell,0,0
1609,stabilizer,0,1
1610,",",0,0
1611,shown,0,0
1612,to,0,0
1613,be,0,0
1614,effective,0,0
1615,in,0,0
1616,treating,0,0
1617,allergic,0,0
1618,conjunctivitis,0,1
1619,.,0,0
1620,Ketorolac,1,1
1621,is,0,0
1622,a,0,1
1623,non-steroidal,0,1
1624,anti-inflammatory,0,1
1625,drug,0,1
1626,approved,0,1
1627,in,0,0
1628,the,0,0
1629,United,0,0
1630,States,0,0
1631,for,0,0
1632,the,0,0
1633,relief,0,0
1634,of,0,0
1635,ocular,0,0
1636,itching,0,0
1637,associated,0,0
1638,with,0,0
1639,seasonal,0,0
1640,allergic,0,0
1641,conjunctivitis,0,0
1642,.,0,0
1643,METHODS,0,0
1644,The,0,0
1645,provocative,0,0
1646,antigen,0,0
1647,challenge,0,0
1648,model,0,0
1649,was,0,0
1650,used,0,0
1651,in,0,0
1652,this,0,0
1653,randomized,0,0
1654,",",0,0
1655,double-blind,0,1
1656,",",0,1
1657,single-center,0,1
1658,",",0,0
1659,crossover,0,1
1660,study,0,0
1661,.,0,0
1662,The,0,0
1663,allergen,0,1
1664,and,0,0
1665,concentration,0,0
1666,that,0,0
1667,consistently,0,0
1668,elicited,0,0
1669,a,0,0
1670,positive,0,0
1671,allergic,0,0
1672,reaction,0,0
1673,was,0,0
1674,used,0,0
1675,for,0,0
1676,challenge,0,0
1677,.,0,0
1678,After,0,0
1679,at,0,0
1680,least,0,0
1681,14,0,0
1682,days,0,0
1683,",",0,0
1684,subjects,0,0
1685,were,0,0
1686,randomized,0,0
1687,to,0,0
1688,receive,0,0
1689,either,0,0
1690,olopatadine,1,1
1691,in,0,0
1692,one,0,0
1693,eye,0,0
1694,and,0,0
1695,placebo,1,1
1696,in,0,0
1697,the,0,0
1698,contralateral,0,0
1699,eye,0,0
1700,",",0,0
1701,or,0,0
1702,ketorolac,1,1
1703,in,0,0
1704,one,0,0
1705,eye,0,0
1706,and,0,0
1707,placebo,1,1
1708,in,0,0
1709,the,0,0
1710,contralateral,0,0
1711,eye,0,0
1712,.,0,0
1713,Twenty-seven,0,0
1714,minutes,0,0
1715,after,0,0
1716,drug,0,1
1717,instillation,0,1
1718,subjects,0,0
1719,were,0,0
1720,challenged,0,0
1721,with,0,0
1722,allergen,0,1
1723,.,0,1
1724,At,0,1
1725,3,0,0
1726,",",0,0
1727,10,0,0
1728,",",0,0
1729,and,0,0
1730,20,0,0
1731,minutes,0,0
1732,following,0,0
1733,allergen,0,1
1734,challenge,0,0
1735,",",0,0
1736,subjects,0,0
1737,graded,0,0
1738,ocular,0,0
1739,itching,0,0
1740,and,0,0
1741,were,0,0
1742,assessed,0,0
1743,for,0,0
1744,hyperemia,0,0
1745,in,0,0
1746,conjunctival,0,0
1747,",",0,0
1748,ciliary,0,0
1749,",",0,0
1750,and,0,0
1751,episcleral,0,0
1752,vessel,0,0
1753,beds,0,0
1754,.,0,0
1755,Approximately,0,0
1756,14,0,0
1757,days,0,0
1758,later,0,0
1759,",",0,0
1760,subjects,0,0
1761,received,0,0
1762,the,0,0
1763,alternate,1,0
1764,treatment,1,0
1765,in,0,0
1766,one,0,0
1767,eye,0,0
1768,and,0,0
1769,placebo,1,1
1770,in,0,0
1771,the,0,0
1772,contralateral,0,0
1773,eye,0,0
1774,.,0,0
1775,They,0,0
1776,were,0,0
1777,again,0,0
1778,challenged,0,0
1779,with,0,0
1780,allergen,0,1
1781,and,0,0
1782,their,0,0
1783,responses,0,0
1784,were,0,0
1785,rated,0,0
1786,in,0,0
1787,the,0,0
1788,same,0,0
1789,manner,0,0
1790,.,0,0
1791,RESULTS,0,0
1792,Olopatadine,1,1
1793,significantly,0,0
1794,(,0,0
1795,p,0,0
1796,<,0,0
1797,0.0001,0,0
1798,),0,0
1799,reduced,0,0
1800,both,0,0
1801,ocular,0,0
1802,itching,0,0
1803,and,0,0
1804,hyperemia,0,0
1805,in,0,0
1806,all,0,0
1807,three,0,0
1808,vessel,0,0
1809,beds,0,0
1810,compared,0,0
1811,to,0,0
1812,placebo,1,1
1813,at,0,0
1814,all,0,0
1815,time,0,0
1816,points,0,0
1817,tested,0,0
1818,following,0,0
1819,allergen,0,1
1820,challenge,0,0
1821,.,0,1
1822,Ketorolac,1,1
1823,did,0,0
1824,not,0,0
1825,significantly,0,0
1826,reduce,0,0
1827,itching,0,0
1828,and,0,0
1829,showed,0,0
1830,a,0,0
1831,trend,0,0
1832,of,0,0
1833,increased,0,0
1834,hyperemia,0,0
1835,compared,0,0
1836,to,0,0
1837,placebo,1,1
1838,.,1,1
1839,Olopatadine,1,1
1840,was,0,0
1841,significantly,0,0
1842,(,0,0
1843,p,0,0
1844,<,0,0
1845,0.001,0,0
1846,),0,0
1847,more,0,0
1848,effective,0,0
1849,than,0,0
1850,ketorolac,1,1
1851,in,0,0
1852,reducing,0,0
1853,hyperemia,0,0
1854,and,0,0
1855,ocular,0,0
1856,itching,0,0
1857,at,0,0
1858,all,0,0
1859,time,0,0
1860,points,0,0
1861,and,0,0
1862,was,0,0
1863,also,0,0
1864,significantly,0,0
1865,(,0,0
1866,p,0,0
1867,<,0,0
1868,0.05,0,0
1869,),0,0
1870,more,0,0
1871,comfortable,0,1
1872,than,0,0
1873,ketorolac,1,1
1874,as,0,0
1875,reported,0,0
1876,by,0,0
1877,subjects,0,0
1878,immediately,0,0
1879,following,0,0
1880,drug,0,1
1881,instillation,0,1
1882,.,0,1
1883,CONCLUSION,0,0
1884,The,0,0
1885,study,0,0
1886,demonstrated,0,0
1887,that,0,0
1888,olopatadine,1,1
1889,is,0,0
1890,effective,0,0
1891,and,0,0
1892,safe,0,0
1893,in,0,0
1894,preventing,0,0
1895,and,0,0
1896,treating,0,0
1897,ocular,0,0
1898,itching,0,0
1899,and,0,0
1900,hyperemia,0,0
1901,associated,0,0
1902,with,0,0
1903,acute,0,0
1904,allergic,0,0
1905,conjunctivitis,0,0
1906,and,0,0
1907,is,0,0
1908,more,0,0
1909,effective,0,0
1910,and,0,0
1911,more,0,0
1912,comfortable,0,1
1913,than,0,0
1914,ketorolac,1,1
1915,.,1,1
1916,Problem-solving,1,0
1917,counseling,1,0
1918,for,0,0
1919,caregivers,0,0
1920,of,0,0
1921,the,0,0
1922,cognitively,0,0
1923,impaired,0,0
1924,:,0,0
1925,effective,0,0
1926,for,0,0
1927,whom,0,0
1928,?,0,0
1929,BACKGROUND,0,1
1930,Individualized,0,1
1931,problem-solving,1,0
1932,counseling,1,0
1933,for,0,0
1934,caregivers,0,0
1935,of,0,0
1936,cognitively,0,0
1937,impaired,0,0
1938,relatives,0,0
1939,is,0,0
1940,thought,0,0
1941,to,0,0
1942,help,0,0
1943,caregivers,0,0
1944,cope,0,0
1945,with,0,0
1946,the,0,0
1947,stress,0,0
1948,and,0,0
1949,burden,0,0
1950,of,0,0
1951,caregiving,0,0
1952,.,0,0
1953,Few,0,0
1954,studies,0,0
1955,have,0,0
1956,shown,0,0
1957,the,0,0
1958,effectiveness,0,0
1959,of,0,0
1960,counseling,0,0
1961,for,0,0
1962,these,0,0
1963,caregivers,0,0
1964,.,0,0
1965,OBJECTIVES,0,0
1966,To,0,0
1967,determine,0,0
1968,the,0,0
1969,effectiveness,0,0
1970,of,0,0
1971,individualized,1,0
1972,problem-solving,1,0
1973,counseling,1,0
1974,by,1,0
1975,nurses,1,0
1976,for,0,0
1977,caregivers,0,0
1978,and,0,0
1979,the,0,0
1980,expenditures,0,0
1981,of,0,0
1982,health,0,0
1983,care,0,0
1984,utilization,0,0
1985,.,0,0
1986,METHOD,0,1
1987,Caregivers,0,1
1988,(,0,0
1989,n,0,0
1990,=,0,0
1991,77,0,0
1992,),0,0
1993,of,0,0
1994,the,0,0
1995,cognitively,0,0
1996,impaired,0,0
1997,living,0,0
1998,at,0,0
1999,home,0,0
2000,were,0,0
2001,randomized,0,0
2002,to,0,0
2003,receive,0,0
2004,nurse,1,0
2005,counseling,1,0
2006,or,1,0
2007,not,1,0
2008,.,1,0
2009,Psychosocial,0,0
2010,adjustment,0,0
2011,to,0,0
2012,their,0,0
2013,relative,0,0
2014,'s,0,0
2015,illness,0,0
2016,",",0,0
2017,psychological,0,0
2018,distress,0,0
2019,",",0,0
2020,burden,0,0
2021,",",0,0
2022,coping,0,0
2023,skills,0,0
2024,",",0,0
2025,and,0,0
2026,expenditures,0,0
2027,were,0,0
2028,measured,0,0
2029,after,0,0
2030,6,0,0
2031,months,0,0
2032,and,0,0
2033,1,0,0
2034,year,0,0
2035,.,0,0
2036,RESULTS,0,0
2037,Although,0,0
2038,on,0,0
2039,average,0,0
2040,",",0,0
2041,all,0,0
2042,caregivers,0,0
2043,receiving,0,0
2044,nurse,1,0
2045,counseling,1,0
2046,indicated,0,0
2047,no,0,0
2048,improvement,0,0
2049,in,0,0
2050,psychosocial,0,0
2051,adjustment,0,0
2052,to,0,0
2053,their,0,0
2054,relative,0,0
2055,'s,0,0
2056,illness,0,0
2057,",",0,0
2058,psychological,0,0
2059,distress,0,0
2060,",",0,0
2061,or,0,0
2062,caregiver,0,0
2063,burden,0,0
2064,",",0,0
2065,they,0,0
2066,found,0,0
2067,counseling,0,0
2068,very,0,0
2069,helpful,0,0
2070,and,0,0
2071,it,0,0
2072,was,0,0
2073,effective,0,0
2074,for,0,0
2075,a,0,0
2076,subgroup,0,0
2077,of,0,0
2078,caregivers,0,0
2079,.,0,0
2080,Those,0,0
2081,with,0,0
2082,poor,0,0
2083,logical,0,0
2084,analysis,0,0
2085,coping,0,0
2086,skills,0,0
2087,at,0,0
2088,baseline,0,0
2089,had,0,0
2090,decreased,0,0
2091,psychological,0,0
2092,distress,0,1
2093,(,0,1
2094,F,0,1
2095,(,0,0
2096,"1,53",0,0
2097,),0,0
2098,=,0,0
2099,9.7,0,0
2100,",",0,0
2101,p,0,0
2102,=,0,0
2103,.003,0,0
2104,),0,0
2105,and,0,0
2106,improved,0,0
2107,psychosocial,0,1
2108,adjustment,0,1
2109,(,0,1
2110,F,0,1
2111,(,0,0
2112,"1,53",0,0
2113,),0,0
2114,=,0,0
2115,4.7,0,0
2116,",",0,0
2117,p,0,0
2118,=,0,0
2119,.035,0,0
2120,),0,0
2121,after,0,0
2122,1,0,0
2123,year,0,0
2124,.,0,0
2125,Caregivers,0,0
2126,in,0,0
2127,control,1,0
2128,and,0,0
2129,counseling,1,0
2130,groups,0,0
2131,whose,0,0
2132,relatives,0,0
2133,entered,0,0
2134,a,0,0
2135,nursing,0,0
2136,home,0,0
2137,improved,0,0
2138,their,0,0
2139,psychosocial,0,0
2140,adjustment,0,0
2141,23,0,0
2142,%,0,0
2143,on,0,0
2144,average,0,0
2145,whereas,0,0
2146,those,0,0
2147,continuing,0,0
2148,to,0,0
2149,live,0,0
2150,in,0,0
2151,the,0,0
2152,community,0,0
2153,decreased,0,0
2154,by,0,0
2155,8,0,0
2156,%,0,0
2157,.,0,0
2158,Almost,0,0
2159,half,0,0
2160,as,0,0
2161,many,0,0
2162,relatives,0,0
2163,entered,0,0
2164,nursing,0,0
2165,homes,0,0
2166,in,0,0
2167,the,0,0
2168,counseling,1,1
2169,group,0,0
2170,(,0,0
2171,n,0,0
2172,=,0,0
2173,9,0,0
2174,vs.,0,0
2175,n,0,0
2176,=,0,0
2177,5,0,0
2178,),0,0
2179,but,0,0
2180,these,0,0
2181,compared,0,0
2182,to,0,0
2183,control,1,0
2184,group,0,0
2185,relatives,0,0
2186,had,0,0
2187,greater,0,0
2188,annualized,0,0
2189,per,0,0
2190,person,0,0
2191,expenditures,0,0
2192,for,0,0
2193,health,0,0
2194,and,0,0
2195,social,0,1
2196,services,0,1
2197,(,0,0
2198,Cdn,0,0
2199,$,0,0
2200,"23,437",0,0
2201,vs.,0,0
2202,Cdn,0,0
2203,$,0,0
2204,"15,151",0,0
2205,),0,0
2206,.,0,0
2207,CONCLUSIONS,0,0
2208,Caregivers,0,0
2209,found,0,0
2210,nurse,1,0
2211,counseling,1,0
2212,most,0,0
2213,helpful,0,0
2214,.,0,0
2215,Those,0,0
2216,indicating,0,0
2217,infrequent,0,0
2218,use,0,0
2219,of,0,0
2220,logical,0,0
2221,analysis,0,0
2222,coping,0,0
2223,skills,0,0
2224,showed,0,0
2225,benefits,0,0
2226,.,0,0
2227,A,0,1
2228,prospective,0,1
2229,randomized,0,0
2230,trial,0,0
2231,of,0,0
2232,Duraflo,1,1
2233,II,1,1
2234,heparin-coated,1,1
2235,circuits,1,1
2236,in,0,0
2237,cardiac,0,0
2238,reoperations,0,0
2239,.,0,0
2240,BACKGROUND,0,1
2241,Heparin-coated,1,1
2242,circuits,1,1
2243,in,0,0
2244,cardiopulmonary,0,0
2245,bypass,0,0
2246,have,0,0
2247,been,0,0
2248,shown,0,0
2249,to,0,0
2250,decrease,0,0
2251,the,0,0
2252,systemic,0,0
2253,inflammatory,0,0
2254,responses,0,0
2255,associated,0,0
2256,with,0,0
2257,cardiopulmonary,0,0
2258,bypass,0,0
2259,.,0,0
2260,Previous,0,0
2261,clinical,0,0
2262,studies,0,0
2263,on,0,0
2264,low-risk,0,0
2265,patients,0,0
2266,who,0,0
2267,had,0,0
2268,coronary,1,0
2269,artery,1,0
2270,bypass,1,1
2271,grafting,1,1
2272,(,0,1
2273,CABG,0,1
2274,),0,1
2275,and,0,0
2276,received,0,0
2277,full-dose,0,1
2278,systemic,0,1
2279,heparin,1,1
2280,did,0,0
2281,not,0,0
2282,have,0,0
2283,clearly,0,0
2284,improved,0,0
2285,clinical,0,0
2286,outcomes,0,0
2287,.,0,0
2288,We,0,0
2289,hypothesized,0,0
2290,that,0,0
2291,the,0,0
2292,beneficial,0,0
2293,effects,0,0
2294,of,0,0
2295,heparin-coated,1,1
2296,circuits,1,1
2297,might,0,0
2298,be,0,0
2299,seen,0,0
2300,in,0,0
2301,patients,0,0
2302,who,0,0
2303,had,0,0
2304,cardiac,0,0
2305,reoperations,0,0
2306,.,0,0
2307,METHODS,0,0
2308,Three,0,0
2309,hundred,0,0
2310,fifty,0,0
2311,patients,0,0
2312,who,0,0
2313,had,0,0
2314,reoperation,0,0
2315,with,0,0
2316,CABG,0,0
2317,only,0,0
2318,(,0,0
2319,58,0,0
2320,%,0,0
2321,),0,0
2322,",",0,0
2323,or,0,0
2324,with,0,0
2325,valve,0,0
2326,operations,0,0
2327,(,0,0
2328,42,0,0
2329,%,0,0
2330,),0,0
2331,were,0,0
2332,randomly,0,0
2333,assigned,0,0
2334,to,0,0
2335,receive,0,0
2336,either,0,0
2337,a,0,0
2338,heparin-coated,1,1
2339,(,1,1
2340,Duraflo,1,1
2341,II,1,1
2342,;,1,0
2343,study,1,0
2344,group,1,0
2345,),1,0
2346,or,1,1
2347,uncoated,1,1
2348,(,1,1
2349,control,1,1
2350,group,1,0
2351,),1,0
2352,circuit,1,0
2353,.,1,0
2354,Clinical,0,0
2355,outcomes,0,0
2356,were,0,0
2357,compared,0,0
2358,and,0,0
2359,the,0,0
2360,variables,0,0
2361,were,0,0
2362,analyzed,0,0
2363,using,0,0
2364,the,0,0
2365,following,0,0
2366,three,0,0
2367,groups,0,0
2368,:,0,0
2369,entire,0,0
2370,populations,0,0
2371,of,0,0
2372,study,0,0
2373,group,0,0
2374,and,0,0
2375,control,0,0
2376,group,0,0
2377,",",0,0
2378,subgroup,0,0
2379,of,0,0
2380,patients,0,0
2381,who,0,0
2382,had,0,0
2383,CABG,0,0
2384,reoperation,0,0
2385,only,0,0
2386,",",0,0
2387,and,0,0
2388,a,0,0
2389,subgroup,0,0
2390,who,0,0
2391,had,0,0
2392,valve,0,0
2393,reoperation,0,0
2394,or,0,0
2395,combined,0,0
2396,valve,0,0
2397,and,0,0
2398,CABG,0,0
2399,reoperation,0,0
2400,.,0,0
2401,RESULTS,0,0
2402,Preoperative,0,0
2403,variables,0,0
2404,were,0,0
2405,the,0,0
2406,same,0,0
2407,in,0,0
2408,both,0,0
2409,groups,0,0
2410,.,0,0
2411,No,0,1
2412,difference,0,0
2413,in,0,0
2414,clinical,0,0
2415,outcomes,0,0
2416,could,0,0
2417,be,0,0
2418,demonstrated,0,0
2419,except,0,0
2420,that,0,0
2421,the,0,0
2422,percentage,0,0
2423,of,0,0
2424,patients,0,0
2425,with,0,0
2426,major,0,0
2427,bleeding,0,0
2428,episodes,0,0
2429,was,0,0
2430,significantly,0,0
2431,lower,0,0
2432,in,0,0
2433,the,0,0
2434,study,0,0
2435,group,0,0
2436,(,0,0
2437,1.2,0,0
2438,%,0,0
2439,versus,0,0
2440,5.4,0,0
2441,%,0,0
2442,",",0,0
2443,p,0,0
2444,=,0,0
2445,0.035,0,0
2446,),0,0
2447,.,0,0
2448,In,0,0
2449,the,0,0
2450,subgroup,0,0
2451,analysis,0,0
2452,of,0,0
2453,patients,0,0
2454,who,0,0
2455,had,0,0
2456,valve,0,0
2457,reoperations,0,0
2458,",",0,0
2459,lower,0,0
2460,blood,0,0
2461,transfusion,0,0
2462,requirements,0,0
2463,in,0,0
2464,the,0,0
2465,intensive,0,0
2466,care,0,0
2467,unit,0,0
2468,(,0,0
2469,p,0,0
2470,=,0,0
2471,0.013,0,0
2472,),0,0
2473,were,0,0
2474,found,0,0
2475,in,0,0
2476,the,0,0
2477,study,0,0
2478,group,0,0
2479,.,0,0
2480,When,0,0
2481,the,0,0
2482,subgroup,0,0
2483,of,0,0
2484,patients,0,0
2485,who,0,0
2486,had,0,0
2487,CABG,0,0
2488,reoperations,0,0
2489,was,0,0
2490,analyzed,0,0
2491,separately,0,0
2492,",",0,0
2493,there,0,0
2494,was,0,0
2495,a,0,0
2496,trend,0,0
2497,toward,0,0
2498,less,0,0
2499,reoperation,0,0
2500,for,0,0
2501,bleeding,0,0
2502,in,0,0
2503,the,0,0
2504,study,0,0
2505,group,0,0
2506,(,0,0
2507,0,0,0
2508,%,0,0
2509,versus,0,0
2510,4.0,0,0
2511,%,0,0
2512,",",0,0
2513,p,0,0
2514,=,0,0
2515,0.058,0,0
2516,),0,0
2517,.,0,0
2518,CONCLUSIONS,0,0
2519,We,0,0
2520,conclude,0,0
2521,that,0,0
2522,the,0,0
2523,use,0,0
2524,of,0,0
2525,heparin-coated,0,1
2526,circuits,0,1
2527,was,0,0
2528,safe,0,0
2529,and,0,0
2530,imparted,0,0
2531,protection,0,0
2532,from,0,0
2533,reoperations,0,0
2534,for,0,0
2535,bleeding,0,0
2536,and,0,0
2537,major,0,0
2538,bleeding,0,0
2539,episodes,0,0
2540,.,0,0
2541,Material-independent,0,0
2542,blood,0,0
2543,activation,0,0
2544,(,0,0
2545,eg,0,0
2546,",",0,0
2547,blood-air,0,0
2548,interface,0,0
2549,and,0,0
2550,cardiotomy,0,1
2551,suction,0,1
2552,),0,0
2553,blunted,0,0
2554,the,0,0
2555,total,0,0
2556,effect,0,0
2557,of,0,0
2558,the,0,0
2559,heparin-coated,0,1
2560,surface,0,0
2561,.,0,0
2562,A,0,1
2563,randomized,0,0
2564,phase,0,0
2565,II,0,0
2566,trial,0,0
2567,of,0,0
2568,5-fluorouracil,1,1
2569,",",0,0
2570,with,0,0
2571,or,0,0
2572,without,0,0
2573,human,1,0
2574,interferon-beta,1,1
2575,",",0,0
2576,for,0,0
2577,advanced,0,0
2578,colorectal,0,0
2579,cancer,0,0
2580,.,0,0
2581,This,0,0
2582,study,0,0
2583,compared,0,0
2584,the,0,0
2585,efficacy,0,0
2586,and,0,0
2587,safety,0,0
2588,of,0,1
2589,5-fluorouracil,1,1
2590,(,1,1
2591,5-FU,1,1
2592,),1,1
2593,monotherapy,1,1
2594,to,0,0
2595,that,0,0
2596,of,0,0
2597,5-FU,1,0
2598,combined,1,0
2599,with,1,0
2600,natural,1,0
2601,human,1,0
2602,interferon-beta,1,1
2603,(,1,1
2604,IFN-beta,1,1
2605,),1,0
2606,in,0,0
2607,patients,0,0
2608,with,0,0
2609,unresectable,0,0
2610,",",0,0
2611,advanced,0,0
2612,colorectal,0,0
2613,carcinoma,0,0
2614,.,0,0
2615,Forty-nine,0,0
2616,chemotherapy-naive,0,0
2617,patients,0,0
2618,were,0,0
2619,randomized,0,0
2620,to,0,0
2621,5-FU,0,0
2622,alone,0,0
2623,or,0,0
2624,to,0,0
2625,the,0,0
2626,combination,0,0
2627,.,0,0
2628,All,0,0
2629,patients,0,0
2630,received,0,0
2631,750,0,0
2632,mg,0,1
2633,m,0,1
2634,(,0,1
2635,-2,0,1
2636,),0,1
2637,day,0,1
2638,(,0,1
2639,-1,0,1
2640,),0,0
2641,5-FU,0,1
2642,for,0,0
2643,5,0,0
2644,days,0,0
2645,by,0,0
2646,continuous,0,1
2647,intravenous,0,1
2648,(,0,1
2649,i.v,0,1
2650,.,0,1
2651,),0,1
2652,infusion,0,1
2653,",",0,1
2654,followed,0,0
2655,after,0,0
2656,day,0,0
2657,15,0,0
2658,by,0,0
2659,a,0,0
2660,weekly,0,1
2661,i.v,0,1
2662,.,0,1
2663,bolus,0,1
2664,of,0,0
2665,750,0,1
2666,mg,0,1
2667,m,0,1
2668,(,0,1
2669,-2,0,0
2670,),0,0
2671,.,0,0
2672,IFN-beta,1,0
2673,was,0,0
2674,injected,0,0
2675,intramuscularly,0,1
2676,three,0,1
2677,times,0,1
2678,weekly,0,0
2679,at,0,0
2680,9,0,0
2681,M,0,0
2682,IU,0,1
2683,.,0,0
2684,Treatment,0,0
2685,continued,0,0
2686,for,0,0
2687,52,0,0
2688,weeks,0,0
2689,",",0,0
2690,or,0,0
2691,until,0,0
2692,disease,0,0
2693,progression,0,0
2694,or,0,0
2695,intolerable,0,0
2696,toxicity,0,0
2697,.,0,0
2698,Clinical,0,0
2699,endpoints,0,0
2700,were,0,0
2701,tumor,0,0
2702,response,0,0
2703,",",0,0
2704,time,0,0
2705,to,0,0
2706,progression,0,0
2707,",",0,0
2708,survival,0,0
2709,and,0,0
2710,toxicity,0,0
2711,.,0,0
2712,The,0,0
2713,addition,0,0
2714,of,0,0
2715,IFN-3,1,0
2716,to,1,0
2717,5-FU,1,0
2718,significantly,0,0
2719,improved,0,0
2720,response,0,0
2721,rate,0,0
2722,(,0,0
2723,33.3,0,0
2724,%,0,0
2725,vs,0,0
2726,4.5,0,0
2727,%,0,0
2728,for,0,0
2729,evaluable,0,0
2730,patients,0,0
2731,;,0,0
2732,P,0,0
2733,=,0,0
2734,0.021,0,0
2735,),0,0
2736,",",0,0
2737,time,0,0
2738,to,0,0
2739,progression,0,0
2740,(,0,0
2741,median,0,0
2742,7.2,0,0
2743,vs,0,0
2744,4.2,0,0
2745,months,0,0
2746,;,0,0
2747,P,0,0
2748,=,0,0
2749,0.0435,0,0
2750,),0,0
2751,",",0,0
2752,and,0,0
2753,survival,0,0
2754,time,0,0
2755,(,0,0
2756,median,0,0
2757,15.9,0,0
2758,vs,0,0
2759,7.2,0,0
2760,months,0,0
2761,;,0,0
2762,P,0,0
2763,=,0,0
2764,0.038,0,0
2765,),0,0
2766,without,0,0
2767,significantly,0,0
2768,increasing,0,0
2769,toxicity,0,0
2770,compared,0,0
2771,to,0,0
2772,5-FU,0,0
2773,alone,0,0
2774,.,0,0
2775,Cumulative,0,0
2776,5-FU,1,1
2777,dose,0,1
2778,was,0,0
2779,higher,0,0
2780,with,0,0
2781,combined,0,0
2782,therapy,0,0
2783,(,0,0
2784,P,0,0
2785,<,0,0
2786,0.001,0,0
2787,),0,0
2788,:,0,0
2789,more,0,0
2790,patients,0,0
2791,receiving,0,0
2792,monotherapy,0,1
2793,discontinued,0,1
2794,treatment,0,1
2795,because,0,0
2796,of,0,0
2797,disease,0,0
2798,progression,0,0
2799,.,0,0
2800,Fever,0,0
2801,was,0,0
2802,more,0,0
2803,frequent,0,0
2804,with,0,0
2805,combined,0,0
2806,therapy,0,0
2807,(,0,0
2808,P,0,0
2809,=,0,0
2810,0.008,0,0
2811,),0,0
2812,;,0,0
2813,there,0,0
2814,were,0,0
2815,no,0,0
2816,other,0,0
2817,differences,0,0
2818,in,0,0
2819,toxicity,0,0
2820,.,0,0
2821,The,0,0
2822,only,0,0
2823,grade,0,0
2824,IV,0,0
2825,toxicity,0,0
2826,observed,0,0
2827,was,0,0
2828,neutropenia,0,0
2829,(,0,0
2830,two,0,0
2831,patients,0,0
2832,per,0,0
2833,group,0,0
2834,),0,0
2835,.,0,0
2836,A,0,0
2837,randomized,0,0
2838,phase,0,0
2839,III,0,0
2840,trial,0,0
2841,has,0,0
2842,been,0,0
2843,initiated,0,0
2844,to,0,0
2845,confirm,0,0
2846,the,0,0
2847,synergy,0,0
2848,between,0,0
2849,5-FU,1,0
2850,and,0,0
2851,IFN-beta,1,0
2852,.,1,0
2853,Effects,0,0
2854,of,0,0
2855,a,0,0
2856,videotape,1,0
2857,information,1,0
2858,intervention,1,0
2859,at,0,0
2860,discharge,0,0
2861,on,0,0
2862,diet,0,1
2863,and,0,0
2864,exercise,0,1
2865,compliance,0,0
2866,after,0,0
2867,coronary,0,0
2868,bypass,0,0
2869,surgery,0,0
2870,.,0,0
2871,BACKGROUND,0,0
2872,This,0,0
2873,study,0,0
2874,evaluated,0,0
2875,the,0,0
2876,relative,0,0
2877,effects,0,0
2878,on,0,0
2879,compliance,0,0
2880,with,0,0
2881,recommended,0,0
2882,lifestyle,0,0
2883,changes,0,0
2884,of,0,0
2885,two,0,0
2886,experimental,1,0
2887,videotapes,1,0
2888,that,0,0
2889,involved,0,0
2890,different,0,0
2891,approaches,0,0
2892,for,0,0
2893,preparing,0,0
2894,coronary,0,0
2895,artery,0,0
2896,bypass,0,1
2897,graft,0,1
2898,(,0,1
2899,CABG,0,1
2900,),0,1
2901,patients,0,0
2902,for,0,0
2903,the,0,0
2904,posthospital,0,0
2905,recovery,0,0
2906,period,0,0
2907,.,0,0
2908,The,0,0
2909,tapes,0,0
2910,differed,0,0
2911,in,0,0
2912,the,0,0
2913,extent,0,0
2914,to,0,0
2915,which,0,0
2916,they,0,0
2917,portrayed,0,0
2918,the,0,0
2919,recovery,0,0
2920,period,0,0
2921,as,0,0
2922,a,0,0
2923,steady,0,0
2924,",",0,0
2925,forward,0,0
2926,progression,0,0
2927,versus,0,0
2928,a,0,0
2929,series,0,0
2930,of,0,0
2931,ups,0,0
2932,and,0,0
2933,downs,0,0
2934,.,0,0
2935,METHODS,0,0
2936,Two,0,0
2937,hundred,0,0
2938,sixteen,0,0
2939,male,0,0
2940,and,0,0
2941,female,0,0
2942,CABG,0,0
2943,patients,0,0
2944,were,0,0
2945,assigned,0,0
2946,randomly,0,0
2947,either,0,0
2948,to,0,0
2949,view,0,0
2950,one,1,0
2951,of,1,0
2952,the,1,0
2953,two,1,0
2954,videotapes,1,0
2955,before,1,0
2956,discharge,1,0
2957,from,1,0
2958,the,1,0
2959,hospital,1,0
2960,or,1,0
2961,to,1,0
2962,receive,1,0
2963,only,1,0
2964,the,1,0
2965,standard,1,0
2966,discharge,1,0
2967,preparation,1,0
2968,provided,0,0
2969,by,0,0
2970,the,0,0
2971,hospital,0,0
2972,.,0,0
2973,All,0,0
2974,patients,0,0
2975,completed,0,0
2976,measures,0,0
2977,of,0,0
2978,anxiety,0,0
2979,and,0,0
2980,self-efficacy,0,0
2981,at,0,0
2982,discharge,0,0
2983,",",0,0
2984,1,0,0
2985,month,0,0
2986,and,0,0
2987,3,0,0
2988,months,0,0
2989,after,0,0
2990,discharge,0,0
2991,from,0,0
2992,the,0,0
2993,hospital,0,0
2994,.,0,0
2995,Patients,0,0
2996,also,0,0
2997,completed,0,0
2998,measures,0,0
2999,of,0,0
3000,dietary,0,1
3001,fat,0,1
3002,consumption,0,1
3003,and,0,0
3004,activity,0,0
3005,level,0,0
3006,1,0,0
3007,and,0,0
3008,3,0,0
3009,months,0,0
3010,after,0,0
3011,discharge,0,0
3012,.,0,0
3013,RESULTS,0,0
3014,Relative,0,0
3015,to,0,0
3016,controls,0,0
3017,",",0,0
3018,patients,0,0
3019,who,0,0
3020,viewed,0,0
3021,either,0,0
3022,of,0,0
3023,the,0,0
3024,videotapes,1,0
3025,before,0,0
3026,hospital,0,0
3027,release,0,0
3028,reported,0,0
3029,higher,0,0
3030,self-efficacy,0,0
3031,for,0,0
3032,adhering,0,0
3033,to,0,0
3034,the,0,0
3035,recommended,0,1
3036,low-fat,0,1
3037,diet,0,1
3038,both,0,1
3039,at,0,0
3040,discharge,0,0
3041,and,0,0
3042,1,0,0
3043,month,0,0
3044,after,0,0
3045,surgery,0,0
3046,.,0,0
3047,Viewing,0,0
3048,either,0,0
3049,of,0,0
3050,the,0,0
3051,videotapes,0,0
3052,also,0,0
3053,resulted,0,0
3054,in,0,0
3055,significantly,0,0
3056,less,0,0
3057,dietary,0,1
3058,fat,0,1
3059,intake,0,1
3060,1,0,1
3061,month,0,0
3062,after,0,0
3063,hospital,0,0
3064,release,0,0
3065,compared,0,0
3066,with,0,0
3067,controls,0,0
3068,.,0,0
3069,Patients,0,0
3070,who,0,0
3071,viewed,0,0
3072,the,0,0
3073,tape,0,0
3074,that,0,0
3075,portrayed,0,0
3076,the,0,0
3077,recovery,0,0
3078,period,0,0
3079,as,0,0
3080,consisting,0,0
3081,of,0,0
3082,ups,0,0
3083,and,0,0
3084,downs,0,0
3085,also,0,0
3086,reported,0,0
3087,significantly,0,0
3088,more,0,0
3089,frequent,0,0
3090,moderate,0,0
3091,exercise,0,0
3092,at,0,0
3093,1,0,0
3094,month,0,0
3095,and,0,0
3096,more,0,0
3097,frequent,0,0
3098,strenuous,0,0
3099,exercise,0,0
3100,3,0,0
3101,months,0,0
3102,after,0,0
3103,discharge,0,0
3104,.,0,0
3105,CONCLUSIONS,0,0
3106,The,0,0
3107,experimental,0,0
3108,videotapes,1,0
3109,proved,0,0
3110,to,0,0
3111,be,0,0
3112,an,0,0
3113,effective,0,0
3114,method,0,0
3115,for,0,0
3116,increasing,0,0
3117,dietary,0,1
3118,and,0,1
3119,exercise,0,1
3120,compliance,0,0
3121,during,0,0
3122,the,0,0
3123,first,0,0
3124,3,0,0
3125,months,0,0
3126,after,0,0
3127,CABG,0,0
3128,.,0,0
3129,Cycle,0,0
3130,control,0,0
3131,with,0,0
3132,oral,1,1
3133,contraceptives,1,1
3134,containing,1,1
3135,20,1,1
3136,micrograms,1,1
3137,of,1,1
3138,ethinyl,1,1
3139,estradiol,1,1
3140,.,1,1
3141,A,0,1
3142,multicenter,0,0
3143,",",0,0
3144,randomized,0,0
3145,comparison,0,0
3146,of,0,0
3147,levonorgestrel/ethinyl,1,1
3148,estradiol,1,1
3149,(,0,1
3150,100,0,1
3151,micrograms/20,0,1
3152,micrograms,0,1
3153,),0,1
3154,and,0,1
3155,norethindrone/ethinyl,1,1
3156,estradiol,1,1
3157,(,0,1
3158,1000,0,1
3159,micrograms/20,0,1
3160,micrograms,0,1
3161,),0,1
3162,.,0,1
3163,A,0,0
3164,randomized,0,1
3165,",",0,0
3166,open-label,0,1
3167,",",0,1
3168,multicenter,0,0
3169,study,0,0
3170,was,0,0
3171,undertaken,0,0
3172,to,0,0
3173,compare,0,0
3174,the,0,0
3175,effects,0,0
3176,of,0,0
3177,oral,1,1
3178,contraceptives,1,1
3179,(,1,1
3180,OC,1,1
3181,),1,1
3182,containing,1,0
3183,100,1,1
3184,micrograms,1,1
3185,levonorgestrel,1,1
3186,(,1,1
3187,LNG,1,1
3188,),1,0
3189,/20,1,0
3190,micrograms,1,1
3191,ethinyl,1,1
3192,estradiol,1,1
3193,(,1,1
3194,EE,1,1
3195,),1,1
3196,(,1,1
3197,Aless/Loette,1,1
3198,),1,1
3199,and,0,0
3200,1000,1,1
3201,micrograms,1,1
3202,norethindrone,1,1
3203,acetate,1,1
3204,(,1,1
3205,NETA,1,1
3206,),1,0
3207,/20,1,0
3208,micrograms,1,1
3209,EE,1,1
3210,(,1,1
3211,Loestrin,1,1
3212,Fe,1,1
3213,1/20,1,0
3214,),1,0
3215,on,0,0
3216,menstrual,0,0
3217,cycle,0,0
3218,control,0,0
3219,over,0,0
3220,four,0,0
3221,cycles,0,0
3222,of,0,0
3223,use,0,0
3224,.,0,0
3225,A,0,0
3226,total,0,0
3227,of,0,0
3228,84,0,0
3229,evaluable,0,0
3230,women,0,0
3231,provided,0,0
3232,274,0,0
3233,cycles,0,0
3234,of,0,0
3235,exposure,0,0
3236,in,0,0
3237,the,0,0
3238,LNG/EE,0,0
3239,group,0,0
3240,",",0,0
3241,and,0,0
3242,89,0,0
3243,women,0,0
3244,provided,0,0
3245,289,0,0
3246,cycles,0,0
3247,of,0,0
3248,exposure,0,0
3249,in,0,0
3250,the,0,0
3251,NETA/EE,0,0
3252,group,0,0
3253,.,0,0
3254,Overall,0,0
3255,",",0,0
3256,the,0,0
3257,LNG/EE,0,1
3258,group,0,0
3259,achieved,0,0
3260,a,0,0
3261,consistently,0,0
3262,higher,0,0
3263,percentage,0,0
3264,of,0,0
3265,normal,0,0
3266,menstrual,0,0
3267,cycles,0,0
3268,as,0,0
3269,well,0,0
3270,as,0,0
3271,a,0,0
3272,lower,0,0
3273,rate,0,0
3274,of,0,0
3275,intermenstrual,0,0
3276,bleeding,0,0
3277,and,0,0
3278,amenorrhea,0,0
3279,than,0,0
3280,the,0,0
3281,NETA/EE,0,1
3282,group,0,0
3283,.,0,0
3284,In,0,0
3285,cycle,0,0
3286,4,0,0
3287,",",0,0
3288,63.8,0,0
3289,%,0,0
3290,of,0,0
3291,cycles,0,0
3292,were,0,0
3293,normal,0,0
3294,in,0,0
3295,the,0,0
3296,LNG/EE,0,0
3297,group,0,0
3298,compared,0,0
3299,with,0,0
3300,41.9,0,0
3301,%,0,0
3302,in,0,0
3303,the,0,0
3304,NETA/EE,0,1
3305,group,0,0
3306,(,0,0
3307,p,0,0
3308,<,0,0
3309,0.005,0,0
3310,),0,0
3311,.,0,0
3312,Of,0,0
3313,the,0,0
3314,total,0,0
3315,cycles,0,0
3316,in,0,0
3317,the,0,0
3318,NETA/EE,0,0
3319,group,0,0
3320,",",0,0
3321,10,0,0
3322,%,0,0
3323,were,0,0
3324,amenorrheic,0,0
3325,",",0,0
3326,compared,0,0
3327,with,0,0
3328,1.1,0,0
3329,%,0,0
3330,in,0,0
3331,the,0,0
3332,LNG/EE,0,0
3333,group,0,0
3334,.,0,0
3335,The,0,0
3336,occurrence,0,0
3337,of,0,0
3338,bleeding,0,0
3339,and/or,0,0
3340,spotting,0,0
3341,was,0,0
3342,significantly,0,0
3343,lower,0,0
3344,in,0,0
3345,cycles,0,0
3346,2,0,0
3347,and,0,0
3348,3,0,0
3349,in,0,0
3350,the,0,0
3351,LNG/EE,0,1
3352,group,0,0
3353,(,0,0
3354,41.7,0,0
3355,%,0,0
3356,and,0,0
3357,34.8,0,0
3358,%,0,0
3359,",",0,0
3360,respectively,0,0
3361,),0,0
3362,compared,0,0
3363,with,0,0
3364,the,0,0
3365,NETA/EE,0,1
3366,group,0,0
3367,(,0,0
3368,62.3,0,0
3369,%,0,0
3370,and,0,0
3371,56.3,0,0
3372,%,0,0
3373,;,0,0
3374,p,0,0
3375,<,0,0
3376,0.05,0,0
3377,),0,0
3378,.,0,0
3379,Other,0,0
3380,cycle,0,0
3381,variables,0,0
3382,were,0,0
3383,generally,0,0
3384,similar,0,0
3385,between,0,0
3386,groups,0,0
3387,",",0,0
3388,as,0,0
3389,was,0,0
3390,the,0,0
3391,incidence,0,0
3392,of,0,0
3393,adverse,0,0
3394,events,0,0
3395,.,0,0
3396,These,0,0
3397,results,0,0
3398,demonstrate,0,0
3399,that,0,0
3400,good,0,0
3401,cycle,0,0
3402,control,0,0
3403,was,0,0
3404,achieved,0,0
3405,with,0,0
3406,an,0,0
3407,OC,0,0
3408,containing,0,0
3409,20,0,0
3410,micrograms,0,1
3411,EE,1,1
3412,and,0,0
3413,that,0,0
3414,100,0,0
3415,micrograms,0,1
3416,LNG/20,1,1
3417,micrograms,0,1
3418,EE,1,1
3419,produces,0,0
3420,better,0,0
3421,cycle,0,0
3422,control,0,0
3423,than,0,0
3424,1000,0,0
3425,micrograms,0,1
3426,NETA/20,1,1
3427,micrograms,0,1
3428,EE,1,1
3429,.,1,0
3430,Calcitriol,1,1
3431,for,0,1
3432,bone,0,1
3433,disease,0,0
3434,in,0,0
3435,patients,0,0
3436,with,0,0
3437,cirrhosis,0,0
3438,of,0,0
3439,the,0,0
3440,liver,0,0
3441,.,0,0
3442,BACKGROUND,0,0
3443,Osteoporosis,0,0
3444,is,0,0
3445,associated,0,0
3446,with,0,0
3447,cirrhosis,0,0
3448,of,0,0
3449,the,0,0
3450,liver,0,0
3451,",",0,0
3452,but,0,0
3453,the,0,0
3454,effects,0,0
3455,of,0,0
3456,therapy,0,0
3457,for,0,0
3458,osteoporosis,0,0
3459,associated,0,0
3460,with,0,0
3461,cirrhosis,0,0
3462,are,0,0
3463,still,0,0
3464,controversial,0,0
3465,.,0,0
3466,METHODS,0,0
3467,We,0,0
3468,evaluated,0,0
3469,the,0,0
3470,effects,0,0
3471,of,0,0
3472,calcitriol,1,1
3473,(,1,1
3474,"1alpha,25-dihydroxyvitamin",1,1
3475,D3,1,1
3476,),1,1
3477,on,0,0
3478,bone,0,0
3479,mineral,0,0
3480,density,0,0
3481,(,0,1
3482,BMD,0,1
3483,),0,0
3484,in,0,0
3485,76,0,0
3486,patients,0,0
3487,(,0,0
3488,26,0,0
3489,men,0,0
3490,and,0,0
3491,50,0,0
3492,women,0,1
3493,),0,0
3494,with,0,0
3495,cirrhosis,0,0
3496,who,0,0
3497,were,0,0
3498,assigned,0,0
3499,randomly,1,0
3500,to,1,0
3501,receive,1,1
3502,calcitriol,1,1
3503,(,1,1
3504,0.5,1,1
3505,mg,1,1
3506,twice,1,1
3507,per,1,1
3508,day,1,1
3509,),1,1
3510,or,1,0
3511,not,1,0
3512,.,1,0
3513,The,0,0
3514,BMD,0,0
3515,of,0,0
3516,the,0,0
3517,lumbar,0,0
3518,vertebrae,0,0
3519,was,0,0
3520,measured,1,0
3521,by,1,0
3522,dual-energy,1,0
3523,X-ray,1,0
3524,absorptiometry,1,0
3525,at,1,0
3526,least,1,0
3527,twice,1,0
3528,",",1,0
3529,12-57,1,0
3530,months,1,0
3531,apart,1,0
3532,.,1,0
3533,RESULTS,0,0
3534,For,0,0
3535,men,0,0
3536,",",0,0
3537,the,0,0
3538,mean,0,0
3539,annual,0,0
3540,change,0,0
3541,in,0,0
3542,BMD,0,0
3543,was,0,0
3544,1.1,0,0
3545,%,0,0
3546,in,0,0
3547,the,0,0
3548,treated,0,0
3549,group,0,0
3550,and,0,0
3551,-0.4,0,0
3552,%,0,0
3553,in,0,0
3554,the,0,0
3555,control,0,0
3556,group,0,0
3557,.,0,0
3558,The,0,0
3559,median,0,0
3560,(,0,0
3561,25th,0,0
3562,and,0,0
3563,75th,0,0
3564,percentiles,0,0
3565,),0,0
3566,annual,0,0
3567,change,0,0
3568,in,0,0
3569,BMD,0,0
3570,was,0,0
3571,0.6,0,0
3572,(,0,0
3573,-0.1,0,0
3574,",",0,0
3575,2.1,0,0
3576,%,0,0
3577,),0,0
3578,in,0,0
3579,the,0,0
3580,treated,0,0
3581,group,0,0
3582,and,0,0
3583,-1.4,0,0
3584,(,0,0
3585,-1.9,0,0
3586,",",0,0
3587,1.6,0,0
3588,%,0,0
3589,),0,0
3590,in,0,0
3591,the,0,0
3592,control,0,0
3593,group,0,0
3594,.,0,0
3595,The,0,0
3596,difference,0,0
3597,in,0,0
3598,the,0,0
3599,median,0,0
3600,annual,0,0
3601,change,0,0
3602,between,0,0
3603,the,0,0
3604,two,0,0
3605,groups,0,0
3606,was,0,0
3607,significant,0,0
3608,(,0,0
3609,P,0,0
3610,=,0,0
3611,0.013,0,0
3612,),0,0
3613,.,0,0
3614,For,0,0
3615,women,0,0
3616,",",0,0
3617,the,0,0
3618,mean,0,0
3619,annual,0,0
3620,change,0,0
3621,in,0,0
3622,BMD,0,0
3623,was,0,0
3624,-0.5,0,0
3625,%,0,0
3626,in,0,0
3627,the,0,0
3628,treated,0,0
3629,group,0,0
3630,and,0,0
3631,-2.3,0,0
3632,%,0,0
3633,in,0,0
3634,the,0,0
3635,control,0,0
3636,group,0,0
3637,.,0,0
3638,The,0,0
3639,median,0,0
3640,(,0,0
3641,25th,0,0
3642,and,0,0
3643,75th,0,0
3644,percentiles,0,0
3645,),0,0
3646,annual,0,0
3647,change,0,0
3648,in,0,0
3649,BMD,0,0
3650,was,0,0
3651,-0.5,0,0
3652,(,0,0
3653,-1.8,0,0
3654,",",0,0
3655,1.3,0,0
3656,%,0,0
3657,),0,0
3658,in,0,0
3659,the,0,0
3660,treated,0,0
3661,group,0,0
3662,and,0,0
3663,-1.5,0,0
3664,(,0,0
3665,-3.8,0,0
3666,",",0,0
3667,-0.7,0,0
3668,%,0,0
3669,),0,0
3670,in,0,0
3671,the,0,0
3672,control,0,0
3673,group,0,0
3674,.,0,0
3675,This,0,0
3676,difference,0,0
3677,was,0,0
3678,significant,0,0
3679,(,0,0
3680,P,0,0
3681,=,0,0
3682,0.011,0,0
3683,),0,0
3684,.,0,0
3685,CONCLUSIONS,0,0
3686,Our,0,0
3687,results,0,0
3688,suggest,0,0
3689,that,0,0
3690,calcitriol,0,1
3691,can,0,0
3692,prevent,0,0
3693,bone,0,0
3694,loss,0,0
3695,and,0,0
3696,",",0,0
3697,therefore,0,0
3698,",",0,0
3699,may,0,0
3700,be,0,0
3701,useful,0,0
3702,for,0,0
3703,the,0,0
3704,treatment,0,0
3705,of,0,0
3706,bone,0,0
3707,disease,0,0
3708,in,0,0
3709,patients,0,0
3710,with,0,0
3711,cirrhosis,0,0
3712,of,0,0
3713,the,0,0
3714,liver,0,0
3715,.,0,0
3716,Effects,0,0
3717,of,0,0
3718,captopril,1,1
3719,and,0,1
3720,enalapril,1,1
3721,on,0,0
3722,electroencephalogram,0,0
3723,and,0,0
3724,cognitive,0,0
3725,performance,0,0
3726,in,0,0
3727,healthy,0,0
3728,volunteers,0,0
3729,.,0,0
3730,OBJECTIVE,0,1
3731,Captopril,1,1
3732,and,0,1
3733,enalapril,1,1
3734,have,0,0
3735,been,0,0
3736,reported,0,0
3737,to,0,0
3738,influence,0,0
3739,cognitive,0,0
3740,functions,0,0
3741,and,0,0
3742,quality,0,0
3743,of,0,0
3744,life,0,0
3745,in,0,0
3746,hypertensive,0,0
3747,patients,0,0
3748,.,0,0
3749,METHODS,0,0
3750,The,0,0
3751,effects,0,0
3752,of,0,0
3753,captopril,1,1
3754,(,0,1
3755,12.5,0,1
3756,mg,0,1
3757,and,0,0
3758,25,0,1
3759,mg,0,1
3760,),0,1
3761,and,0,1
3762,enalapril,1,1
3763,(,0,1
3764,5,0,1
3765,mg,0,1
3766,and,0,1
3767,10,0,1
3768,mg,0,1
3769,),0,1
3770,administered,0,1
3771,during,0,1
3772,7-day,0,1
3773,periods,0,1
3774,on,0,1
3775,electroencephalogram,1,0
3776,(,0,1
3777,EEG,0,1
3778,),0,1
3779,",",0,0
3780,cognitive,0,0
3781,functions,0,0
3782,",",0,0
3783,and,0,0
3784,subjective,0,0
3785,assessments,0,0
3786,were,0,0
3787,investigated,0,0
3788,in,0,0
3789,healthy,0,0
3790,males,0,0
3791,.,0,0
3792,RESULTS,0,0
3793,Neither,0,0
3794,captopril,0,1
3795,nor,0,1
3796,enalapril,0,1
3797,influenced,0,0
3798,EEG,0,1
3799,and,0,0
3800,cognitive,0,0
3801,functions,0,0
3802,compared,0,0
3803,with,0,0
3804,placebo,0,1
3805,.,0,1
3806,Captopril,1,1
3807,12.5,0,0
3808,mg,0,1
3809,decreased,0,0
3810,subjective,0,0
3811,activity,0,0
3812,compared,0,0
3813,with,0,0
3814,placebo,1,1
3815,.,1,1
3816,Enalapril,1,1
3817,did,0,0
3818,not,0,0
3819,alter,0,0
3820,subjective,0,0
3821,ratings,0,0
3822,.,0,0
3823,Both,0,0
3824,systolic,0,0
3825,and,0,0
3826,diastolic,0,0
3827,blood,0,0
3828,pressure,0,0
3829,were,0,0
3830,significantly,0,0
3831,lower,0,0
3832,after,0,0
3833,administration,0,1
3834,of,0,1
3835,captopril,1,1
3836,25,0,1
3837,mg,0,1
3838,",",0,0
3839,whereas,0,0
3840,blood,0,0
3841,pressure,0,0
3842,was,0,0
3843,unaffected,0,0
3844,by,0,0
3845,enalapril,1,1
3846,compared,0,0
3847,with,0,0
3848,placebo,0,1
3849,.,0,0
3850,CONCLUSION,0,0
3851,Our,0,0
3852,results,0,0
3853,suggest,0,0
3854,that,0,0
3855,central,0,0
3856,effects,0,0
3857,of,0,0
3858,captopril,1,1
3859,and,0,1
3860,enalapril,1,1
3861,were,0,0
3862,minor,0,0
3863,and,0,0
3864,not,0,0
3865,constant,0,0
3866,in,0,0
3867,young,0,0
3868,healthy,0,0
3869,men,0,0
3870,.,0,0
3871,Why,0,0
3872,the,0,0
3873,prone,1,0
3874,position,1,0
3875,is,0,0
3876,a,0,0
3877,risk,0,0
3878,factor,0,0
3879,for,0,0
3880,sudden,0,0
3881,infant,0,0
3882,death,0,0
3883,syndrome,0,0
3884,.,0,0
3885,INTRODUCTION,0,0
3886,The,0,0
3887,laryngeal,0,0
3888,chemoreflex,0,0
3889,may,0,0
3890,explain,0,0
3891,why,0,0
3892,prone,0,0
3893,sleeping,0,0
3894,increases,0,0
3895,the,0,0
3896,risk,0,0
3897,of,0,0
3898,sudden,0,0
3899,infant,0,0
3900,death,0,1
3901,syndrome,0,1
3902,(,0,1
3903,SIDS,0,1
3904,),0,1
3905,.,0,0
3906,Swallowing,0,0
3907,and,0,0
3908,arousal,0,0
3909,are,0,0
3910,crucial,0,0
3911,to,0,0
3912,prevent,0,0
3913,laryngeal,0,0
3914,chemoreflex,0,0
3915,stimulation,0,0
3916,.,0,0
3917,Our,0,0
3918,aim,0,0
3919,was,0,0
3920,to,0,0
3921,examine,0,0
3922,these,0,0
3923,reflexes,0,0
3924,and,0,0
3925,breathing,0,0
3926,responses,0,0
3927,in,0,0
3928,healthy,0,0
3929,neonates,0,0
3930,after,0,0
3931,pharyngeal,0,0
3932,infusion,0,1
3933,of,0,0
3934,water,0,0
3935,in,0,0
3936,the,0,0
3937,supine,0,0
3938,versus,0,0
3939,the,0,0
3940,prone,0,0
3941,position,0,0
3942,",",0,0
3943,controlling,0,0
3944,for,0,0
3945,sleep,0,0
3946,state,0,0
3947,.,0,0
3948,METHODS,0,0
3949,A,0,0
3950,total,0,0
3951,of,0,0
3952,10,0,0
3953,term,0,0
3954,infants,0,0
3955,were,0,0
3956,recruited,0,0
3957,after,0,0
3958,parental,0,0
3959,consent,0,0
3960,and,0,0
3961,ethics,0,0
3962,approval,0,0
3963,.,0,0
3964,Polygraphic,0,0
3965,recordings,0,0
3966,included,0,0
3967,sleep,0,0
3968,state,0,0
3969,(,0,0
3970,active,0,0
3971,and,0,0
3972,quiet,0,0
3973,sleep,0,0
3974,by,0,0
3975,electroencephalogram,0,0
3976,",",0,0
3977,eye,0,0
3978,movements,0,0
3979,",",0,0
3980,breathing,0,0
3981,",",0,0
3982,and,0,0
3983,behavior,0,0
3984,),0,0
3985,",",0,0
3986,cardiorespiratory,0,1
3987,measurements,0,0
3988,(,0,0
3989,nasal,0,0
3990,airflow,0,1
3991,",",0,0
3992,chest,0,0
3993,wall,0,0
3994,movements,0,0
3995,",",0,0
3996,heart,0,0
3997,rate,0,0
3998,",",0,0
3999,and,0,0
4000,oxygen,0,0
4001,saturation,0,0
4002,),0,0
4003,",",0,0
4004,swallowing,0,0
4005,",",0,0
4006,and,0,0
4007,esophageal,0,0
4008,activity,0,0
4009,(,0,0
4010,solid,0,0
4011,state,0,0
4012,pressure,0,0
4013,catheter,0,1
4014,),0,0
4015,.,0,0
4016,Initial,1,0
4017,sleeping,1,0
4018,position,1,0
4019,was,1,0
4020,assigned,1,0
4021,randomly,1,0
4022,.,1,0
4023,Measurements,0,0
4024,were,0,0
4025,made,0,0
4026,for,0,0
4027,1,1,0
4028,minute,1,0
4029,before,1,0
4030,and,1,0
4031,after,1,0
4032,0.4,1,0
4033,mL,1,0
4034,of,1,0
4035,water,1,0
4036,was,1,0
4037,instilled,1,1
4038,into,1,0
4039,the,1,0
4040,oropharynx,1,0
4041,.,1,0
4042,To,0,0
4043,detect,0,0
4044,a,0,0
4045,30,0,0
4046,%,0,0
4047,decrease,0,0
4048,in,0,0
4049,swallowing,0,0
4050,",",0,0
4051,power,0,0
4052,analysis,0,0
4053,indicated,0,0
4054,that,0,0
4055,>,0,0
4056,/=10,0,0
4057,babies,0,0
4058,were,0,0
4059,required,0,0
4060,.,0,0
4061,Analysis,0,0
4062,",",0,0
4063,blinded,0,0
4064,to,0,0
4065,position,0,0
4066,",",0,0
4067,was,0,0
4068,made,0,0
4069,using,0,0
4070,nonparametric,0,0
4071,statistics,0,0
4072,.,0,0
4073,RESULTS,0,0
4074,Of,0,0
4075,the,0,0
4076,164,0,0
4077,infusions,0,0
4078,",",0,0
4079,the,0,0
4080,most,0,0
4081,commonly,0,0
4082,evoked,0,0
4083,airway,0,0
4084,protective,0,0
4085,responses,0,0
4086,to,0,0
4087,pharyngeal,0,0
4088,infusion,0,1
4089,were,0,1
4090,swallowing,0,0
4091,(,0,0
4092,95,0,0
4093,%,0,0
4094,),0,0
4095,and,0,0
4096,arousal,0,0
4097,(,0,0
4098,54,0,0
4099,%,0,0
4100,),0,0
4101,.,0,0
4102,After,0,1
4103,infusion,0,1
4104,in,0,0
4105,active,0,0
4106,sleep,0,0
4107,",",0,0
4108,there,0,0
4109,was,0,0
4110,a,0,0
4111,significant,0,0
4112,reduction,0,0
4113,in,0,0
4114,swallowing,0,0
4115,and,0,0
4116,breathing,0,0
4117,when,0,0
4118,the,0,0
4119,prone,0,0
4120,position,0,0
4121,was,0,0
4122,compared,0,0
4123,with,0,0
4124,the,0,0
4125,supine,0,0
4126,position,0,0
4127,(,0,0
4128,prone,0,0
4129,:,0,0
4130,21.3,0,0
4131,[,0,0
4132,1.0,0,0
4133,],0,1
4134,swallows/min,0,1
4135,and,0,0
4136,-9.6,0,0
4137,[,0,0
4138,2.1,0,0
4139,],0,0
4140,breaths/min,0,1
4141,;,0,1
4142,and,0,0
4143,supine,0,0
4144,:,0,0
4145,32,0,0
4146,(,0,0
4147,2.2,0,0
4148,),0,0
4149,and,0,0
4150,-2,0,0
4151,.,0,0
4152,9,0,0
4153,(,0,0
4154,1.5,0,0
4155,),0,0
4156,",",0,0
4157,respectively,0,0
4158,),0,0
4159,.,0,0
4160,However,0,0
4161,",",0,0
4162,there,0,0
4163,was,0,0
4164,no,0,0
4165,difference,0,0
4166,in,0,0
4167,the,0,0
4168,occurrence,0,0
4169,of,0,0
4170,arousal,0,0
4171,after,0,0
4172,water,0,0
4173,infusion,0,1
4174,.,0,1
4175,CONCLUSION,0,1
4176,These,0,0
4177,data,0,0
4178,suggest,0,0
4179,that,0,0
4180,airway,0,0
4181,protection,0,0
4182,is,0,0
4183,compromised,0,0
4184,in,0,0
4185,the,0,0
4186,prone,0,0
4187,sleeping,0,0
4188,position,0,0
4189,during,0,0
4190,active,0,0
4191,sleep,0,0
4192,",",0,0
4193,even,0,0
4194,in,0,0
4195,healthy,0,0
4196,infants,0,0
4197,exposed,0,0
4198,to,0,0
4199,minute,0,0
4200,pharyngeal,0,0
4201,fluid,0,1
4202,volumes,0,0
4203,of,0,0
4204,0.4,0,0
4205,mL,0,0
4206,.,0,0
4207,This,0,0
4208,is,0,0
4209,because,0,0
4210,swallowing,0,0
4211,rate,0,0
4212,is,0,0
4213,reduced,0,0
4214,significantly,0,0
4215,",",0,0
4216,and,0,0
4217,there,0,0
4218,is,0,0
4219,no,0,0
4220,compensatory,0,0
4221,increase,0,0
4222,in,0,0
4223,arousal,0,0
4224,.,0,0
4225,The,0,0
4226,reduction,0,0
4227,in,0,0
4228,airway,0,0
4229,protective,0,0
4230,reflexes,0,0
4231,when,0,0
4232,in,0,0
4233,the,0,0
4234,prone,0,0
4235,position,0,0
4236,and,0,0
4237,in,0,0
4238,active,0,0
4239,sleep,0,0
4240,may,0,0
4241,be,0,0
4242,the,0,0
4243,mechanism,0,0
4244,for,0,0
4245,the,0,0
4246,increased,0,0
4247,risk,0,0
4248,of,0,0
4249,SIDS,0,0
4250,in,0,0
4251,the,0,0
4252,prone,0,0
4253,position,0,0
4254,.,0,0
4255,Effects,0,0
4256,of,0,0
4257,amlodipine,1,1
4258,and,1,1
4259,enalapril,1,1
4260,on,0,1
4261,platelet,0,1
4262,function,0,0
4263,in,0,0
4264,patients,0,0
4265,with,0,0
4266,mild,0,0
4267,to,0,0
4268,moderate,0,0
4269,hypertension,0,0
4270,.,0,0
4271,OBJECTIVE,0,0
4272,The,0,0
4273,aim,0,0
4274,of,0,0
4275,this,0,0
4276,study,0,0
4277,was,0,0
4278,to,0,0
4279,compare,0,0
4280,the,0,0
4281,effect,0,0
4282,of,0,0
4283,amlodipine,1,1
4284,and,1,1
4285,enalapril,1,1
4286,on,0,1
4287,platelet,0,1
4288,aggregation,0,0
4289,",",0,0
4290,and,0,0
4291,platelet,0,1
4292,production,0,0
4293,of,0,0
4294,malondialdehyde,0,1
4295,in,0,0
4296,patients,0,0
4297,with,0,0
4298,mild,0,0
4299,to,0,0
4300,moderate,0,0
4301,arterial,0,0
4302,hypertension,0,0
4303,.,0,0
4304,PATIENTS,0,0
4305,AND,0,1
4306,METHODS,0,1
4307,A,0,0
4308,parallel,0,0
4309,",",0,0
4310,double-blind,0,1
4311,",",0,1
4312,placebo-controlled,1,1
4313,study,0,0
4314,was,0,0
4315,carried,0,0
4316,out,0,0
4317,in,0,0
4318,24,0,0
4319,patients,0,0
4320,(,0,0
4321,2,0,0
4322,groups,0,0
4323,of,0,0
4324,12,0,0
4325,patients,0,0
4326,each,0,0
4327,),0,0
4328,.,0,0
4329,Initially,0,0
4330,all,0,0
4331,patients,0,0
4332,received,0,0
4333,placebo,1,1
4334,for,0,0
4335,four,0,0
4336,weeks,0,0
4337,;,0,0
4338,then,0,0
4339,amlodipine,1,1
4340,",",0,1
4341,5,0,1
4342,mg,0,1
4343,daily,0,1
4344,or,1,1
4345,enalapril,1,1
4346,20,0,1
4347,mg,0,1
4348,daily,0,1
4349,taken,0,1
4350,once,0,1
4351,a,0,0
4352,day,0,1
4353,at,0,0
4354,7,0,0
4355,am,0,0
4356,.,0,0
4357,Dosage,0,0
4358,was,0,0
4359,doubled,0,0
4360,after,0,0
4361,4,0,0
4362,weeks,0,0
4363,when,0,0
4364,diastolic,0,0
4365,blood,0,0
4366,pressure,0,0
4367,was,0,0
4368,>,0,0
4369,90,0,0
4370,mmHg,0,0
4371,in,0,0
4372,sitting,0,0
4373,position,0,0
4374,",",0,0
4375,the,0,0
4376,treatment,0,0
4377,was,0,0
4378,continued,0,0
4379,for,0,0
4380,12,0,0
4381,weeks,0,0
4382,.,0,0
4383,At,0,0
4384,the,0,0
4385,end,0,0
4386,of,0,0
4387,placebo,1,1
4388,and,0,0
4389,active,0,0
4390,phases,0,0
4391,a,0,0
4392,platelet,0,1
4393,aggregation,0,0
4394,test,0,0
4395,",",0,0
4396,using,0,0
4397,adenosine,0,1
4398,diphosphate,0,1
4399,",",0,1
4400,collagen,0,0
4401,and,0,0
4402,adrenaline,0,1
4403,",",0,1
4404,and,0,0
4405,a,0,0
4406,platelet,0,1
4407,malondialdehyde,0,1
4408,production,0,1
4409,test,0,0
4410,",",0,0
4411,either,0,0
4412,in,0,0
4413,basal,0,0
4414,conditions,0,0
4415,(,0,0
4416,MDA-basal,0,1
4417,),0,1
4418,and,0,0
4419,after,0,0
4420,the,0,0
4421,stimulation,0,0
4422,of,0,0
4423,arachidonic,0,1
4424,acid,0,1
4425,pathway,0,0
4426,by,0,0
4427,adding,0,0
4428,ethylmaleimide,0,1
4429,(,0,1
4430,MDA-activated,0,0
4431,),0,0
4432,were,0,0
4433,carried,0,0
4434,out,0,0
4435,.,0,0
4436,RESULTS,0,0
4437,Blood,0,0
4438,pressure,0,0
4439,was,0,0
4440,reduced,0,0
4441,by,0,0
4442,both,0,0
4443,agents,0,0
4444,",",0,0
4445,enalapril,1,1
4446,and,1,1
4447,amlodipine,1,1
4448,.,1,1
4449,Enalapril,1,1
4450,controlled,0,0
4451,58.3,0,0
4452,%,0,0
4453,of,0,0
4454,hypertensive,0,0
4455,patients,0,0
4456,with,0,0
4457,an,0,0
4458,average,0,0
4459,dosage,0,0
4460,of,0,0
4461,31.7,0,0
4462,mg/daily,0,1
4463,.,0,0
4464,Amlodipine,1,1
4465,controlled,0,0
4466,75,0,0
4467,%,0,0
4468,of,0,0
4469,patients,0,0
4470,with,0,0
4471,a,0,0
4472,dosage,0,1
4473,of,0,0
4474,7.1,0,0
4475,mg/daily,0,1
4476,.,0,1
4477,Platelet,0,1
4478,aggregation,0,0
4479,was,0,0
4480,reduced,0,0
4481,by,0,0
4482,amlodipine,1,0
4483,in,0,0
4484,15.9,0,0
4485,%,0,0
4486,for,0,0
4487,ADP,0,0
4488,(,0,0
4489,10,0,0
4490,microM,0,0
4491,),0,0
4492,;,0,0
4493,17.4,0,0
4494,%,0,0
4495,for,0,0
4496,collagen,0,0
4497,(,0,0
4498,2,0,1
4499,microg/ml,0,1
4500,),0,0
4501,and,0,0
4502,19.9,0,0
4503,%,0,0
4504,for,0,0
4505,adrenaline,0,1
4506,(,0,1
4507,2,0,1
4508,microM,0,0
4509,),0,0
4510,(,0,0
4511,p,0,0
4512,<,0,0
4513,0.025,0,0
4514,),0,0
4515,.,0,0
4516,Meanwhile,0,1
4517,enalapril,1,1
4518,slightly,0,0
4519,increased,0,0
4520,platelet,0,1
4521,aggregation,0,0
4522,by,0,0
4523,6.7,0,0
4524,%,0,0
4525,",",0,0
4526,1.3,0,0
4527,%,0,0
4528,and,0,0
4529,5.6,0,0
4530,%,0,0
4531,for,0,0
4532,the,0,0
4533,three,0,0
4534,agents,0,0
4535,",",0,0
4536,respectively,0,0
4537,(,0,0
4538,p,0,0
4539,>,0,0
4540,0.05,0,0
4541,",",0,0
4542,ns,0,0
4543,),0,1
4544,.,0,1
4545,Malondialdehyde,0,1
4546,was,0,0
4547,reduced,0,0
4548,by,0,0
4549,amlodipine,1,0
4550,in,0,0
4551,45.33,0,0
4552,%,0,0
4553,(,0,0
4554,p,0,0
4555,<,0,0
4556,0.05,0,0
4557,),0,0
4558,for,0,0
4559,MDA-basal,0,1
4560,;,0,0
4561,3.76,0,0
4562,%,0,0
4563,(,0,0
4564,p,0,0
4565,>,0,0
4566,0.05,0,0
4567,),0,0
4568,for,0,0
4569,MDA-activated,0,0
4570,;,0,0
4571,and,0,0
4572,the,0,0
4573,ratio,0,0
4574,MDA-basal,0,0
4575,:,0,0
4576,MDA-activated,0,0
4577,in,0,0
4578,36.79,0,0
4579,%,0,0
4580,(,0,0
4581,p,0,0
4582,<,0,0
4583,0.005,0,0
4584,),0,0
4585,.,0,0
4586,Meanwhile,0,1
4587,enalapril,1,1
4588,increased,0,0
4589,MDA-basal,0,0
4590,in,0,0
4591,2.89,0,0
4592,%,0,0
4593,;,0,0
4594,MDA-activated,0,0
4595,in,0,0
4596,3.58,0,0
4597,%,0,0
4598,and,0,0
4599,reduced,0,0
4600,the,0,0
4601,ratio,0,0
4602,MDA-basal,0,0
4603,:,0,0
4604,MDA-activated,0,0
4605,",",0,0
4606,in,0,0
4607,10.34,0,0
4608,%,0,0
4609,(,0,0
4610,p,0,0
4611,>,0,0
4612,0.05,0,0
4613,),0,0
4614,.,0,0
4615,CONCLUSION,0,0
4616,Both,0,0
4617,agents,0,0
4618,",",0,0
4619,enalapril,1,1
4620,and,0,1
4621,amlodipine,1,1
4622,",",0,0
4623,reduced,0,0
4624,blood,0,0
4625,pressure,0,0
4626,",",0,0
4627,but,0,0
4628,only,0,0
4629,amlodipine,1,1
4630,reduced,0,1
4631,platelet,0,1
4632,aggregation,0,1
4633,and,0,1
4634,platelet,0,1
4635,production,0,0
4636,of,0,0
4637,malondialdehyde,0,1
4638,",",0,0
4639,indicating,0,0
4640,its,0,0
4641,action,0,0
4642,on,0,0
4643,the,0,0
4644,arachidonic,0,1
4645,acid,0,1
4646,metabolic,0,0
4647,pathway,0,0
4648,.,0,0
4649,Inhibition,0,0
4650,of,0,0
4651,the,0,0
4652,seasonal,0,0
4653,IgE,0,0
4654,increase,0,0
4655,to,0,0
4656,Dactylis,0,1
4657,glomerata,0,1
4658,by,0,1
4659,daily,1,1
4660,sodium,1,1
4661,chloride,1,1
4662,nasal-sinus,1,1
4663,irrigation,1,0
4664,during,0,0
4665,the,0,0
4666,grass,0,1
4667,pollen,0,1
4668,season,0,1
4669,.,0,0
4670,Intra-luminal,0,1
4671,nicotine,0,1
4672,reduces,0,0
4673,smooth,0,0
4674,muscle,0,0
4675,tone,0,0
4676,and,0,0
4677,contractile,0,0
4678,activity,0,0
4679,in,0,0
4680,the,0,0
4681,distal,0,0
4682,large,0,0
4683,bowel,0,0
4684,.,0,0
4685,BACKGROUND,0,1
4686,Nicotine,0,1
4687,may,0,0
4688,be,0,0
4689,of,0,0
4690,therapeutic,0,0
4691,value,0,0
4692,in,0,0
4693,ulcerative,0,0
4694,colitis,0,1
4695,(,0,1
4696,UC,0,0
4697,),0,0
4698,",",0,0
4699,although,0,0
4700,its,0,0
4701,mechanism,0,0
4702,of,0,0
4703,action,0,0
4704,has,0,0
4705,not,0,0
4706,been,0,0
4707,established,0,0
4708,.,0,0
4709,OBJECTIVE,0,0
4710,To,0,0
4711,examine,0,0
4712,the,0,0
4713,effect,0,0
4714,of,0,0
4715,a,0,0
4716,solution,0,0
4717,of,0,0
4718,nicotine,0,1
4719,on,0,0
4720,sustained,0,0
4721,resting,0,0
4722,pressure,0,1
4723,(,0,1
4724,tone,0,1
4725,),0,1
4726,and,0,0
4727,contractile,0,0
4728,activity,0,0
4729,in,0,0
4730,the,0,0
4731,human,0,0
4732,colon,0,0
4733,.,0,0
4734,METHODS,0,0
4735,Ten,0,0
4736,healthy,0,0
4737,volunteers,0,0
4738,",",0,0
4739,and,0,0
4740,seven,0,0
4741,with,0,0
4742,UC,0,0
4743,in,0,0
4744,symptomatic,0,0
4745,remission,0,0
4746,took,0,0
4747,part,0,0
4748,;,0,0
4749,all,0,0
4750,were,0,0
4751,non-smokers,0,0
4752,.,0,0
4753,All,0,0
4754,17,0,0
4755,subjects,0,0
4756,were,0,0
4757,given,1,0
4758,nicotine,1,1
4759,or,1,1
4760,placebo,1,1
4761,solution,1,0
4762,on,1,0
4763,two,1,0
4764,separate,1,0
4765,occasions,1,0
4766,in,1,0
4767,a,1,0
4768,randomized,1,0
4769,sequence,1,0
4770,.,1,0
4771,A,0,0
4772,water-perfused,1,0
4773,manometry,1,0
4774,catheter,1,0
4775,",",1,0
4776,with,1,0
4777,openings,1,0
4778,at,1,0
4779,5,1,0
4780,",",1,0
4781,10,1,0
4782,and,1,0
4783,15,1,0
4784,cm,1,0
4785,from,1,0
4786,the,1,0
4787,tip,1,0
4788,",",1,0
4789,was,1,0
4790,placed,1,0
4791,by,1,0
4792,rigid,1,0
4793,sigmoidoscopy,1,0
4794,in,1,0
4795,the,1,0
4796,recto-sigmoid,1,0
4797,region,1,0
4798,.,1,0
4799,Baseline,1,0
4800,tone,1,0
4801,and,1,0
4802,activity,1,0
4803,were,1,0
4804,measured,1,0
4805,for,1,0
4806,15,1,0
4807,min,1,0
4808,prior,1,0
4809,to,1,0
4810,instillation,1,1
4811,of,1,0
4812,20,1,0
4813,ml,1,0
4814,of,1,0
4815,saline,1,1
4816,alone,1,0
4817,or,1,0
4818,with,1,0
4819,nicotine,1,1
4820,",",1,1
4821,1.2,1,1
4822,mg,1,1
4823,",",1,0
4824,at,1,0
4825,pH,1,0
4826,4.5,1,0
4827,.,1,0
4828,Observations,0,0
4829,were,0,0
4830,made,0,0
4831,over,0,0
4832,the,0,0
4833,subsequent,0,0
4834,15-20,0,0
4835,min,0,0
4836,.,0,0
4837,RESULTS,0,0
4838,Baseline,0,0
4839,spontaneous,0,0
4840,activity,0,0
4841,in,0,0
4842,all,0,0
4843,subjects,0,0
4844,showed,0,0
4845,both,0,0
4846,high-,0,0
4847,and,0,0
4848,low-frequency,0,1
4849,components,0,0
4850,;,0,0
4851,in,0,0
4852,three,0,0
4853,patients,0,0
4854,with,0,0
4855,UC,0,0
4856,",",0,0
4857,the,0,0
4858,low-frequency,0,0
4859,activity,0,0
4860,was,0,0
4861,of,0,0
4862,high,0,0
4863,amplitude,0,0
4864,.,0,0
4865,The,0,0
4866,nicotine,0,1
4867,reduced,0,0
4868,both,0,0
4869,tone,0,0
4870,and,0,0
4871,activity,0,0
4872,in,0,0
4873,all,0,0
4874,subjects,0,0
4875,",",0,0
4876,with,0,0
4877,reduction,0,0
4878,or,0,0
4879,abolition,0,0
4880,of,0,0
4881,the,0,0
4882,large,0,0
4883,contractions,0,0
4884,in,0,0
4885,UC,0,0
4886,.,0,0
4887,Tone,0,1
4888,in,0,0
4889,all,0,0
4890,17,0,0
4891,subjects,0,0
4892,was,0,0
4893,reduced,0,0
4894,significantly,0,0
4895,at,0,0
4896,3,0,0
4897,min,0,0
4898,after,0,0
4899,nicotine,0,1
4900,(,0,0
4901,P,0,0
4902,=,0,0
4903,0.000015,0,0
4904,",",0,0
4905,sign,0,0
4906,test,0,1
4907,),0,1
4908,;,0,0
4909,the,0,0
4910,rate,0,0
4911,of,0,0
4912,recovery,0,0
4913,varied,0,0
4914,in,0,0
4915,individuals,0,0
4916,.,0,0
4917,Results,0,0
4918,from,0,0
4919,normals,0,0
4920,and,0,0
4921,UC,0,0
4922,did,0,0
4923,not,0,0
4924,differ,0,0
4925,significantly,0,0
4926,from,0,0
4927,each,0,0
4928,other,0,0
4929,.,0,0
4930,No,0,0
4931,significant,0,0
4932,change,0,0
4933,in,0,0
4934,tone,0,0
4935,or,0,0
4936,activity,0,0
4937,was,0,0
4938,observed,0,0
4939,with,0,0
4940,the,0,0
4941,saline,0,1
4942,solution,0,0
4943,.,0,0
4944,CONCLUSION,0,1
4945,Intra-luminal,0,1
4946,nicotine,0,1
4947,significantly,0,0
4948,reduces,0,0
4949,both,0,0
4950,smooth,0,0
4951,muscle,0,0
4952,tone,0,0
4953,and,0,0
4954,contractile,0,0
4955,activity,0,0
4956,in,0,0
4957,the,0,0
4958,recto-sigmoid,0,0
4959,colon,0,0
4960,in,0,0
4961,both,0,0
4962,normal,0,0
4963,subjects,0,0
4964,and,0,0
4965,patients,0,0
4966,with,0,0
4967,UC,0,0
4968,.,0,0
4969,Comparison,0,0
4970,of,0,0
4971,antiresorptive,0,1
4972,activities,0,0
4973,of,0,0
4974,ipriflavone,1,1
4975,",",0,1
4976,an,0,1
4977,isoflavone,1,1
4978,derivative,1,1
4979,",",0,1
4980,and,0,1
4981,elcatonin,1,1
4982,",",0,0
4983,an,0,0
4984,eel,1,1
4985,carbocalcitonin,1,1
4986,.,1,1
4987,Thirty,0,0
4988,postmenopausal,0,0
4989,women,0,0
4990,with,0,0
4991,reduced,0,0
4992,bone,0,0
4993,mineral,0,0
4994,density,0,0
4995,were,0,0
4996,divided,0,0
4997,randomly,0,0
4998,into,0,0
4999,two,0,0
5000,groups,0,0
5001,based,0,0
5002,on,0,0
5003,the,0,0
5004,chronological,0,0
5005,sequence,0,0
5006,of,0,0
5007,their,0,0
5008,first,0,0
5009,visit,0,0
5010,to,0,0
5011,the,0,0
5012,Osteoporosis,0,0
5013,Clinic,0,1
5014,of,0,0
5015,Katsuragi,0,1
5016,Hospital,0,0
5017,.,0,0
5018,Group,0,0
5019,I,0,0
5020,was,0,0
5021,given,0,0
5022,600,0,1
5023,mg,0,1
5024,ipriflavone,1,1
5025,orally,0,1
5026,daily,0,1
5027,and,0,1
5028,group,0,0
5029,II,0,0
5030,was,0,0
5031,weekly,0,1
5032,injected,0,0
5033,intramuscularly,0,1
5034,with,0,1
5035,20,0,0
5036,units,0,0
5037,elcatonin,1,1
5038,",",1,1
5039,Asu1-7,1,1
5040,eel,1,1
5041,calcitonin,1,1
5042,(,1,1
5043,carbocalcitonin,1,1
5044,),1,1
5045,.,1,1
5046,Lumbar,0,0
5047,spine,0,0
5048,BMD,0,0
5049,was,0,0
5050,measured,0,0
5051,by,0,0
5052,dual-energy,1,0
5053,X-ray,1,0
5054,absorptiometry,1,0
5055,",",0,0
5056,and,0,0
5057,trabecular,0,1
5058,bone,0,1
5059,mineral,0,0
5060,density,0,0
5061,at,0,0
5062,the,0,0
5063,distal,0,0
5064,radius,0,0
5065,",",0,0
5066,cortical,0,0
5067,bone,0,0
5068,density,0,0
5069,",",0,0
5070,and,0,0
5071,relative,0,0
5072,cortical,0,0
5073,volume,0,0
5074,at,0,0
5075,the,0,0
5076,radial,0,0
5077,diaphysis,0,0
5078,by,0,0
5079,peripheral,0,0
5080,computed,0,0
5081,tomography,0,0
5082,before,0,0
5083,the,0,0
5084,beginning,0,0
5085,of,0,0
5086,the,0,0
5087,study,0,0
5088,and,0,0
5089,at,0,0
5090,the,0,0
5091,4th,0,0
5092,",",0,0
5093,8th,0,0
5094,",",0,0
5095,and,0,0
5096,12th,0,0
5097,month,0,0
5098,.,0,0
5099,Markers,0,0
5100,of,0,0
5101,bone,0,0
5102,metabolism,0,0
5103,--,0,0
5104,serum,0,1
5105,total,0,0
5106,alkaline,0,0
5107,phosphatase,0,1
5108,",",0,0
5109,bone-specific,0,0
5110,alkaline,0,0
5111,phosphatase,0,1
5112,",",0,1
5113,tartrate-resistant,0,1
5114,acid,0,1
5115,phosphatase,0,1
5116,",",0,1
5117,osteocalcin,0,1
5118,",",0,1
5119,intact,0,0
5120,osteocalcin,0,1
5121,",",0,0
5122,PICP,0,1
5123,and,0,0
5124,ICTP,0,0
5125,",",0,0
5126,and,0,0
5127,urinary,0,1
5128,pyridinoline,0,1
5129,",",0,1
5130,deoxypyridinoline,0,1
5131,",",0,1
5132,and,0,1
5133,calcium/creatinine,0,1
5134,(,0,1
5135,Ca/Cr,0,1
5136,),0,0
5137,--,0,0
5138,were,0,0
5139,also,0,0
5140,measured,0,0
5141,at,0,0
5142,the,0,0
5143,same,0,0
5144,interval,0,0
5145,.,0,0
5146,Plasma,0,1
5147,parathyroid,0,1
5148,hormone,0,1
5149,(,0,1
5150,PTH,0,1
5151,),0,1
5152,and,0,1
5153,calcitonin,0,1
5154,(,0,1
5155,CT,0,1
5156,),0,0
5157,were,0,0
5158,measured,0,0
5159,at,0,0
5160,the,0,0
5161,same,0,0
5162,time,0,0
5163,.,0,0
5164,Radial,0,0
5165,trabecular,0,0
5166,bone,0,0
5167,density,0,0
5168,showed,0,0
5169,a,0,0
5170,significantly,0,0
5171,higher,0,0
5172,rate,0,0
5173,of,0,0
5174,increase,0,0
5175,in,0,0
5176,group,0,0
5177,I,0,0
5178,(,1,1
5179,ipriflavone,1,1
5180,group,0,1
5181,),0,1
5182,than,0,0
5183,in,0,0
5184,group,0,0
5185,II,0,1
5186,(,0,1
5187,elcatonin,0,1
5188,group,0,1
5189,),0,0
5190,at,0,0
5191,the,0,0
5192,4th,0,0
5193,month,0,0
5194,",",0,0
5195,whereas,0,0
5196,lumbar,0,0
5197,spine,0,0
5198,BMD,0,0
5199,showed,0,0
5200,more,0,0
5201,pronounced,0,0
5202,increase,0,0
5203,in,0,0
5204,the,0,0
5205,elcatonin,0,1
5206,group,0,1
5207,than,0,0
5208,in,0,0
5209,the,0,0
5210,ipriflavone,1,1
5211,group,0,0
5212,throughout,0,0
5213,the,0,0
5214,study,0,0
5215,period,0,0
5216,.,0,1
5217,Bone,0,1
5218,metabolism,0,0
5219,markers,0,0
5220,tended,0,0
5221,to,0,0
5222,decline,0,0
5223,in,0,0
5224,both,0,0
5225,groups,0,0
5226,.,0,0
5227,Total,0,0
5228,and,0,0
5229,intact,0,0
5230,osteocalcin,0,1
5231,showed,0,0
5232,a,0,0
5233,significant,0,0
5234,fall,0,0
5235,from,0,0
5236,the,0,0
5237,baseline,0,0
5238,throughout,0,0
5239,the,0,0
5240,study,0,0
5241,period,0,0
5242,only,0,0
5243,in,0,0
5244,the,0,0
5245,ipriflavone,0,1
5246,group,0,1
5247,.,0,1
5248,Urine,0,1
5249,pyridinoline,0,1
5250,and,0,1
5251,deoxypyridinoline,0,1
5252,showed,0,0
5253,a,0,0
5254,significant,0,0
5255,fall,0,0
5256,from,0,0
5257,the,0,0
5258,baseline,0,0
5259,at,0,0
5260,the,0,0
5261,12th,0,0
5262,month,0,0
5263,only,0,0
5264,in,0,0
5265,the,0,0
5266,ipriflavone,0,1
5267,group,0,1
5268,.,0,0
5269,On,0,0
5270,comparing,0,0
5271,bone,0,0
5272,gainers,0,0
5273,with,0,0
5274,increase,0,0
5275,of,0,0
5276,lumbar,0,0
5277,spine,0,0
5278,BMD,0,1
5279,by,0,0
5280,2,0,0
5281,%,0,0
5282,or,0,0
5283,more,0,0
5284,with,0,0
5285,bone,0,0
5286,losers,0,0
5287,with,0,0
5288,a,0,0
5289,decrease,0,0
5290,by,0,0
5291,2,0,0
5292,%,0,0
5293,or,0,0
5294,more,0,0
5295,",",0,0
5296,only,0,0
5297,urine,0,1
5298,Ca/Cr,0,1
5299,was,0,0
5300,significantly,0,0
5301,different,0,0
5302,",",0,0
5303,lower,0,0
5304,in,0,0
5305,the,0,0
5306,former,0,0
5307,than,0,0
5308,in,0,0
5309,the,0,0
5310,latter,0,0
5311,",",0,0
5312,despite,0,0
5313,the,0,0
5314,general,0,0
5315,tendency,0,0
5316,for,0,0
5317,bone,0,0
5318,resorption,0,0
5319,markers,0,0
5320,to,0,0
5321,decrease,0,0
5322,in,0,0
5323,bone,0,0
5324,gainers,0,0
5325,and,0,0
5326,to,0,0
5327,increase,0,0
5328,in,0,0
5329,bone,0,0
5330,losers,0,0
5331,.,0,0
5332,Clinical,0,0
5333,effects,0,0
5334,of,0,0
5335,root,0,0
5336,instrumentation,0,0
5337,using,0,0
5338,conventional,0,0
5339,steel,0,0
5340,or,0,0
5341,non-tooth,0,0
5342,substance,0,0
5343,removing,0,0
5344,plastic,0,0
5345,curettes,0,0
5346,during,0,0
5347,supportive,0,0
5348,periodontal,0,1
5349,therapy,0,1
5350,(,0,1
5351,SPT,0,1
5352,),0,1
5353,.,0,0
5354,Although,0,0
5355,root,0,0
5356,instrumentation,0,0
5357,has,0,0
5358,been,0,0
5359,accepted,0,0
5360,as,0,0
5361,the,0,0
5362,most,0,0
5363,important,0,0
5364,cause-related,0,0
5365,treatment,0,0
5366,of,0,0
5367,periodontal,0,0
5368,diseases,0,0
5369,",",0,0
5370,repeated,0,0
5371,scaling,0,0
5372,and,0,0
5373,root,0,0
5374,planing,0,0
5375,may,0,0
5376,over,0,0
5377,time,0,0
5378,result,0,0
5379,in,0,0
5380,substantive,0,0
5381,loss,0,0
5382,of,0,0
5383,tooth,0,0
5384,substance,0,0
5385,and,0,0
5386,increased,0,0
5387,sensitivity,0,0
5388,of,0,0
5389,the,0,0
5390,teeth,0,0
5391,.,0,0
5392,In,0,0
5393,an,0,0
5394,effort,0,0
5395,to,0,0
5396,minimize,0,0
5397,these,0,0
5398,side,0,0
5399,effects,0,0
5400,of,0,0
5401,therapy,0,0
5402,",",0,0
5403,non-root,0,0
5404,substance,0,0
5405,removing,0,0
5406,curettes,0,0
5407,have,0,0
5408,been,0,0
5409,developed,0,0
5410,.,0,0
5411,However,0,0
5412,",",0,0
5413,the,0,0
5414,clinical,0,0
5415,effects,0,0
5416,of,0,0
5417,such,0,0
5418,plastic,0,0
5419,curettes,0,0
5420,with,0,0
5421,regard,0,0
5422,to,0,0
5423,the,0,0
5424,control,0,0
5425,of,0,0
5426,the,0,0
5427,periodontal,0,0
5428,infection,0,0
5429,has,0,0
5430,not,0,0
5431,yet,0,0
5432,been,0,0
5433,established,0,0
5434,.,0,0
5435,The,0,0
5436,aims,0,0
5437,of,0,0
5438,this,0,0
5439,study,0,0
5440,were,0,0
5441,",",0,0
5442,therefore,0,0
5443,",",0,0
5444,to,0,0
5445,compare,0,0
5446,the,0,0
5447,effects,0,0
5448,of,0,0
5449,root,0,0
5450,instrumentation,0,0
5451,using,0,0
5452,plastic,1,0
5453,curettes,1,0
5454,(,0,0
5455,Universal,0,0
5456,Perio,0,1
5457,Soft,0,0
5458,Scaler,0,0
5459,",",0,0
5460,Hawe-Neos,0,1
5461,Dental,0,1
5462,",",0,0
5463,Bioggio,0,1
5464,",",0,1
5465,TI,0,1
5466,",",0,1
5467,Switzerland,0,1
5468,),0,0
5469,versus,0,0
5470,conventional,1,0
5471,steel,1,0
5472,curettes,1,0
5473,on,0,0
5474,the,0,0
5475,periodontal,0,0
5476,conditions,0,0
5477,during,0,0
5478,supportive,0,0
5479,periodontal,0,0
5480,therapy,0,0
5481,.,0,0
5482,40,0,0
5483,subjects,0,0
5484,participated,0,0
5485,in,0,0
5486,this,0,0
5487,parallel,0,0
5488,",",0,0
5489,randomized,0,0
5490,",",0,0
5491,double,0,0
5492,blind,0,0
5493,",",0,0
5494,prospective,0,0
5495,longitudinal,0,0
5496,clinical,0,0
5497,study,0,0
5498,following,0,0
5499,active,0,0
5500,peridontal,0,0
5501,therapy,0,0
5502,.,0,0
5503,20,0,0
5504,subjects,0,0
5505,served,0,0
5506,as,0,0
5507,a,0,0
5508,control,1,0
5509,group,1,0
5510,and,0,0
5511,were,0,0
5512,treated,1,0
5513,with,1,0
5514,conventional,1,0
5515,steel,1,0
5516,curettes,1,0
5517,during,0,0
5518,a,0,0
5519,supportive,0,0
5520,periodontal,0,0
5521,care,0,1
5522,visit,0,1
5523,(,0,1
5524,SPT,0,1
5525,),0,1
5526,.,0,0
5527,The,0,0
5528,other,0,0
5529,20,0,0
5530,subjects,0,0
5531,",",0,0
5532,the,0,0
5533,experimental,0,0
5534,group,0,0
5535,",",0,0
5536,were,0,0
5537,treated,0,0
5538,using,0,0
5539,plastic,1,0
5540,curettes,1,0
5541,during,0,0
5542,a,0,0
5543,similar,0,0
5544,SPT,0,0
5545,visit,0,0
5546,.,0,0
5547,Clinical,0,0
5548,parameters,0,0
5549,",",0,0
5550,such,0,0
5551,as,0,0
5552,bleeding,0,0
5553,on,0,0
5554,probing,0,0
5555,(,0,0
5556,BOP,0,1
5557,),0,1
5558,and,0,0
5559,probing,0,0
5560,pocket,0,0
5561,depth,0,0
5562,(,0,1
5563,PPD,0,1
5564,),0,0
5565,",",0,0
5566,were,0,0
5567,assessed,0,0
5568,at,0,0
5569,baseline,0,0
5570,and,0,0
5571,3-6,0,0
5572,months,0,0
5573,later,0,0
5574,at,0,0
5575,the,0,0
5576,next,0,0
5577,regular,0,0
5578,SPT,0,0
5579,visit,0,0
5580,.,0,0
5581,In,0,0
5582,addition,0,0
5583,",",0,0
5584,the,0,0
5585,BOP,0,0
5586,percentage,0,0
5587,was,0,0
5588,determined,0,0
5589,10,0,0
5590,days,0,0
5591,following,0,0
5592,baseline,0,0
5593,.,0,0
5594,The,0,0
5595,results,0,0
5596,showed,0,0
5597,that,0,0
5598,there,0,0
5599,were,0,0
5600,no,0,0
5601,statistically,0,0
5602,significant,0,0
5603,differences,0,0
5604,between,0,0
5605,the,0,0
5606,2,0,0
5607,treatment,0,0
5608,modalities,0,0
5609,regarding,0,0
5610,BOP,0,0
5611,and,0,0
5612,PPD,0,0
5613,at,0,0
5614,any,0,0
5615,observation,0,0
5616,time,0,0
5617,.,0,0
5618,Both,0,0
5619,treatments,0,0
5620,were,0,0
5621,effective,0,0
5622,in,0,0
5623,reducing,0,0
5624,the,0,0
5625,BOP,0,0
5626,percentage,0,0
5627,which,0,0
5628,ranged,0,0
5629,from,0,0
5630,17-42,0,0
5631,%,0,0
5632,at,0,0
5633,baseline,0,0
5634,by,0,0
5635,about,0,0
5636,40,0,0
5637,%,0,0
5638,after,0,0
5639,10,0,0
5640,days,0,0
5641,(,0,0
5642,mean,0,0
5643,BOP,0,0
5644,baseline,0,0
5645,:,0,0
5646,26,0,0
5647,%,0,0
5648,",",0,0
5649,mean,0,0
5650,BOP,0,0
5651,after,0,0
5652,10,0,0
5653,days,0,0
5654,:,0,0
5655,16,0,0
5656,%,0,0
5657,),0,0
5658,.,0,0
5659,This,0,0
5660,clinical,0,0
5661,study,0,0
5662,suggests,0,0
5663,that,0,0
5664,non-root,1,0
5665,substance,1,0
5666,removing,1,0
5667,curettes,1,0
5668,may,0,0
5669,be,0,0
5670,valuable,0,0
5671,instruments,0,0
5672,for,0,0
5673,periodontally,0,0
5674,treated,0,0
5675,patients,0,0
5676,during,0,0
5677,maintenance,0,0
5678,care,0,0
5679,",",0,0
5680,thus,0,0
5681,minimizing,0,0
5682,trauma,0,0
5683,on,0,0
5684,the,0,0
5685,hard,0,0
5686,structures,0,0
5687,of,0,0
5688,the,0,0
5689,teeth,0,0
5690,.,0,0
5691,A,0,0
5692,comparative,0,0
5693,study,0,0
5694,of,0,0
5695,the,0,0
5696,safety,0,0
5697,and,0,0
5698,efficacy,0,0
5699,of,0,0
5700,FemCap,1,0
5701,",",1,0
5702,a,1,0
5703,new,1,0
5704,vaginal,1,0
5705,barrier,1,0
5706,contraceptive,1,0
5707,",",0,0
5708,and,0,0
5709,the,0,0
5710,Ortho,1,0
5711,All-Flex,1,0
5712,diaphragm,1,0
5713,.,1,0
5714,The,0,0
5715,FemCap,0,0
5716,Investigators,0,0
5717,',0,0
5718,Group,0,0
5719,.,0,0
5720,The,0,0
5721,FemCap,1,0
5722,is,0,0
5723,a,0,0
5724,new,0,0
5725,silicone,0,0
5726,rubber,0,0
5727,barrier,0,0
5728,contraceptive,0,0
5729,shaped,0,0
5730,like,0,0
5731,a,0,0
5732,sailor,0,0
5733,'s,0,0
5734,hat,0,0
5735,",",0,0
5736,with,0,0
5737,a,0,0
5738,dome,0,0
5739,that,0,0
5740,covers,0,0
5741,the,0,0
5742,cervix,0,0
5743,",",0,0
5744,a,0,0
5745,rim,0,0
5746,that,0,0
5747,fits,0,0
5748,into,0,0
5749,the,0,0
5750,fornices,0,0
5751,",",0,0
5752,and,0,0
5753,a,0,0
5754,brim,0,0
5755,that,0,0
5756,conforms,0,0
5757,to,0,0
5758,the,0,0
5759,vaginal,0,0
5760,walls,0,0
5761,around,0,0
5762,the,0,0
5763,cervix,0,0
5764,.,0,0
5765,It,0,0
5766,was,0,0
5767,designed,0,0
5768,to,0,0
5769,result,0,0
5770,in,0,0
5771,fewer,0,0
5772,dislodgments,0,0
5773,and,0,0
5774,less,0,0
5775,pressure,0,0
5776,on,0,0
5777,the,0,0
5778,urethra,0,0
5779,than,0,0
5780,the,0,0
5781,cervical,0,0
5782,cap,0,0
5783,and,0,0
5784,diaphragm,0,0
5785,",",0,0
5786,respectively,0,0
5787,",",0,0
5788,and,0,0
5789,to,0,0
5790,require,0,0
5791,less,0,0
5792,clinician,0,0
5793,time,0,0
5794,for,0,0
5795,fitting,0,0
5796,.,0,0
5797,This,0,0
5798,was,0,0
5799,a,0,0
5800,phase,0,0
5801,II/III,0,0
5802,",",0,0
5803,multicenter,0,0
5804,",",0,0
5805,randomized,0,1
5806,",",0,1
5807,open-label,0,1
5808,",",0,1
5809,parallel,0,0
5810,group,0,0
5811,study,0,0
5812,of,0,0
5813,841,0,0
5814,women,0,0
5815,at,0,0
5816,risk,0,0
5817,for,0,0
5818,pregnancy,0,0
5819,.,0,0
5820,A,0,0
5821,subset,0,0
5822,of,0,0
5823,42,0,0
5824,women,0,0
5825,at,0,0
5826,one,0,0
5827,site,0,0
5828,underwent,0,0
5829,colposcopy,0,0
5830,.,0,0
5831,Women,0,0
5832,were,0,0
5833,randomized,0,0
5834,to,0,0
5835,use,0,0
5836,the,0,0
5837,FemCap,1,0
5838,or,1,0
5839,Ortho,1,0
5840,All-Flex,1,1
5841,contraceptive,1,0
5842,diaphragm,1,0
5843,",",1,0
5844,both,1,0
5845,with,1,0
5846,2,1,0
5847,%,1,0
5848,nonoxynol-9,1,1
5849,spermicide,1,1
5850,",",0,0
5851,for,0,0
5852,28,0,0
5853,weeks,0,0
5854,.,0,0
5855,The,0,0
5856,objectives,0,0
5857,were,0,0
5858,to,0,0
5859,compare,0,0
5860,the,0,0
5861,two,0,0
5862,devices,0,0
5863,with,0,0
5864,regard,0,0
5865,to,0,0
5866,their,0,0
5867,safety,0,0
5868,and,0,0
5869,acceptability,0,0
5870,and,0,0
5871,to,0,0
5872,determine,0,0
5873,whether,0,0
5874,the,0,0
5875,probability,0,0
5876,of,0,0
5877,pregnancy,0,0
5878,among,0,0
5879,FemCap,1,0
5880,users,0,0
5881,was,0,0
5882,no,0,0
5883,worse,0,0
5884,than,0,0
5885,that,0,0
5886,of,0,0
5887,the,0,0
5888,diaphragm,1,0
5889,(,0,0
5890,meaning,0,0
5891,not,0,0
5892,more,0,0
5893,than,0,0
5894,6,0,0
5895,percentage,0,0
5896,points,0,0
5897,higher,0,0
5898,),0,0
5899,.,0,0
5900,The,0,0
5901,6-month,0,0
5902,Kaplan-Meier,0,0
5903,cumulative,0,0
5904,unadjusted,0,0
5905,typical,0,0
5906,use,0,0
5907,pregnancy,0,0
5908,probabilities,0,0
5909,were,0,0
5910,13.5,0,0
5911,%,0,0
5912,among,0,0
5913,FemCap,1,0
5914,users,0,0
5915,and,0,0
5916,7.9,0,0
5917,%,0,0
5918,among,0,0
5919,diaphragm,1,0
5920,users,0,0
5921,.,0,0
5922,The,0,0
5923,adjusted,0,0
5924,risk,0,0
5925,of,0,0
5926,pregnancy,0,0
5927,among,0,0
5928,FemCap,1,0
5929,users,0,0
5930,was,0,0
5931,1.96,0,0
5932,times,0,0
5933,that,0,0
5934,among,0,0
5935,diaphragm,1,0
5936,users,0,0
5937,",",0,0
5938,with,0,0
5939,an,0,0
5940,upper,0,0
5941,95,0,0
5942,%,0,0
5943,confidence,0,0
5944,limit,0,0
5945,of,0,0
5946,3.01,0,0
5947,.,0,0
5948,Clinical,0,0
5949,equivalence,0,1
5950,(,0,1
5951,noninferiority,0,1
5952,),0,0
5953,of,0,0
5954,the,0,0
5955,FemCap,1,0
5956,compared,0,0
5957,with,0,0
5958,the,0,0
5959,diaphragm,0,0
5960,",",0,0
5961,as,0,0
5962,defined,0,0
5963,in,0,0
5964,this,0,0
5965,study,0,0
5966,",",0,0
5967,would,0,0
5968,mean,0,0
5969,that,0,0
5970,the,0,0
5971,true,0,0
5972,risk,0,0
5973,of,0,0
5974,pregnancy,0,0
5975,among,0,0
5976,FemCap,1,0
5977,users,0,0
5978,was,0,0
5979,no,0,0
5980,more,0,0
5981,than,0,0
5982,1.73,0,0
5983,times,0,0
5984,the,0,0
5985,pregnancy,0,0
5986,risk,0,0
5987,of,0,0
5988,diaphragm,1,0
5989,users,0,0
5990,.,0,0
5991,Because,0,0
5992,the,0,0
5993,observed,0,0
5994,upper,0,0
5995,95,0,0
5996,%,0,0
5997,confidence,0,0
5998,limit,0,0
5999,(,0,0
6000,and,0,0
6001,even,0,0
6002,the,0,0
6003,point,0,0
6004,estimate,0,0
6005,),0,0
6006,exceeded,0,0
6007,1.73,0,0
6008,",",0,0
6009,the,0,0
6010,probability,0,0
6011,of,0,0
6012,pregnancy,0,0
6013,among,0,0
6014,FemCap,1,0
6015,users,0,0
6016,",",0,0
6017,compared,0,0
6018,with,0,0
6019,that,0,0
6020,among,0,0
6021,diaphragm,1,0
6022,users,0,0
6023,",",0,0
6024,did,0,0
6025,not,0,0
6026,meet,0,0
6027,the,0,0
6028,definition,0,0
6029,of,0,0
6030,clinical,0,0
6031,equivalence,0,0
6032,used,0,0
6033,in,0,0
6034,this,0,0
6035,study,0,0
6036,.,0,0
6037,The,0,0
6038,FemCap,1,0
6039,was,0,0
6040,believed,0,0
6041,to,0,0
6042,be,0,0
6043,safe,0,0
6044,and,0,0
6045,was,0,0
6046,associated,0,0
6047,with,0,0
6048,significantly,0,0
6049,fewer,0,0
6050,urinary,0,0
6051,tract,0,0
6052,infections,0,0
6053,.,0,0
6054,More,0,0
6055,women,0,0
6056,reported,0,0
6057,problems,0,0
6058,with,0,0
6059,the,0,0
6060,FemCap,1,0
6061,with,0,0
6062,regard,0,0
6063,to,0,0
6064,insertion,0,0
6065,",",0,0
6066,dislodgement,0,0
6067,",",0,0
6068,and,0,0
6069,especially,0,0
6070,removal,0,0
6071,",",0,0
6072,although,0,0
6073,their,0,0
6074,general,0,0
6075,assessments,0,0
6076,were,0,0
6077,positive,0,0
6078,.,0,0
6079,The,0,0
6080,two,0,0
6081,devices,0,0
6082,were,0,0
6083,comparable,0,0
6084,with,0,0
6085,regard,0,0
6086,to,0,0
6087,safety,0,0
6088,and,0,0
6089,acceptability,0,0
6090,",",0,0
6091,but,0,0
6092,a,0,0
6093,6-point,0,0
6094,difference,0,0
6095,in,0,0
6096,the,0,0
6097,true,0,0
6098,6-month,0,0
6099,pregnancy,0,0
6100,probabilities,0,0
6101,of,0,0
6102,the,0,0
6103,two,0,0
6104,devices,0,0
6105,could,0,0
6106,not,0,0
6107,be,0,0
6108,ruled,0,0
6109,out,0,0
6110,.,0,0
6111,Further,0,0
6112,studies,0,0
6113,are,0,0
6114,needed,0,0
6115,to,0,0
6116,determine,0,0
6117,whether,0,0
6118,design,0,0
6119,modifications,0,0
6120,can,0,0
6121,simplify,0,0
6122,insertion,0,0
6123,and,0,0
6124,removal,0,0
6125,.,0,0
6126,Ursodeoxycholic,1,1
6127,acid,1,1
6128,has,0,0
6129,no,0,0
6130,influence,0,0
6131,on,0,0
6132,function,0,0
6133,after,0,0
6134,restorative,0,0
6135,proctocolectomy,0,0
6136,in,0,0
6137,ulcerative,0,0
6138,colitis,0,0
6139,.,0,0
6140,BACKGROUND,0,0
6141,Poor,0,0
6142,pouch,0,0
6143,function,0,0
6144,is,0,0
6145,associated,0,0
6146,with,0,0
6147,impaired,0,0
6148,bile,0,1
6149,acid,0,1
6150,absorption,0,1
6151,and,0,0
6152,increased,0,0
6153,faecal,0,0
6154,loss,0,0
6155,of,0,0
6156,bile,0,1
6157,acids,0,1
6158,.,0,1
6159,Bile,1,1
6160,acid,1,1
6161,replacement,1,0
6162,therapy,1,0
6163,might,0,0
6164,therefore,0,0
6165,be,0,0
6166,of,0,0
6167,clinical,0,0
6168,benefit,0,0
6169,",",0,0
6170,provided,0,0
6171,that,0,0
6172,diarrhoea,0,0
6173,is,0,0
6174,not,0,0
6175,aggravated,0,0
6176,by,0,0
6177,therapy,0,0
6178,.,0,0
6179,AIM,0,0
6180,To,0,0
6181,investigate,0,0
6182,the,0,0
6183,role,0,0
6184,of,0,0
6185,exogenous,1,0
6186,bile,1,1
6187,acid,1,1
6188,therapy,1,1
6189,in,0,0
6190,patients,0,0
6191,with,0,0
6192,poor,0,0
6193,pouch,0,0
6194,function,0,0
6195,after,0,0
6196,restorative,0,0
6197,proctocolectomy,0,0
6198,for,0,0
6199,ulcerative,0,0
6200,colitis,0,0
6201,.,0,0
6202,PATIENTS,0,0
6203,AND,0,1
6204,METHODS,0,1
6205,Twenty,0,1
6206,ulcerative,0,0
6207,colitis,0,0
6208,patients,0,0
6209,with,0,0
6210,poor,0,0
6211,pouch,0,0
6212,function,0,0
6213,(,0,0
6214,score,0,0
6215,>,0,0
6216,4,0,0
6217,on,0,0
6218,a,0,0
6219,12-point,0,0
6220,score,0,0
6221,),0,0
6222,were,0,0
6223,recruited,0,0
6224,for,0,0
6225,inclusion,0,0
6226,to,0,0
6227,a,0,0
6228,prospective,0,0
6229,",",0,0
6230,randomized,0,1
6231,",",0,1
6232,double-blind,0,1
6233,crossover,0,1
6234,",",0,1
6235,placebo-controlled,1,1
6236,trial,0,1
6237,of,0,1
6238,ursodeoxycholic,1,1
6239,acid,1,1
6240,(,0,1
6241,10,0,1
6242,mg/kg,0,1
6243,per,0,1
6244,day,0,0
6245,in,0,0
6246,two,0,0
6247,divided,0,0
6248,doses,0,1
6249,for,0,0
6250,1,0,0
6251,month,0,0
6252,),0,0
6253,.,0,0
6254,RESULTS,0,0
6255,A,0,0
6256,total,0,0
6257,of,0,0
6258,16,0,0
6259,patients,0,0
6260,completed,0,0
6261,the,0,0
6262,study,0,0
6263,.,0,0
6264,There,0,0
6265,was,0,0
6266,no,0,0
6267,significant,0,0
6268,difference,0,0
6269,in,0,0
6270,the,0,0
6271,functional,0,0
6272,score,0,0
6273,or,0,0
6274,bowel,0,0
6275,frequency,0,0
6276,following,0,0
6277,treatment,0,0
6278,irrespective,0,0
6279,of,0,0
6280,whether,0,0
6281,the,0,0
6282,active,0,0
6283,treatment,0,0
6284,was,0,0
6285,given,0,0
6286,before,0,0
6287,or,0,0
6288,after,0,0
6289,placebo,0,1
6290,.,0,0
6291,CONCLUSIONS,0,1
6292,We,0,0
6293,conclude,0,0
6294,that,0,0
6295,ursodeoxycholic,1,1
6296,acid,1,1
6297,given,0,1
6298,over,0,0
6299,4,0,0
6300,weeks,0,0
6301,had,0,0
6302,no,0,0
6303,influence,0,0
6304,on,0,0
6305,functional,0,0
6306,score,0,0
6307,or,0,0
6308,bowel,0,0
6309,frequency,0,0
6310,after,0,0
6311,restorative,0,0
6312,proctocolectomy,0,0
6313,for,0,0
6314,U.C,0,0
6315,.,0,0
6316,Early,0,0
6317,immunisation,0,0
6318,with,0,0
6319,hepatitis,1,0
6320,B,1,1
6321,vaccine,1,1
6322,:,1,0
6323,a,0,0
6324,five-year,0,0
6325,study,0,0
6326,.,0,0
6327,We,0,0
6328,evaluated,0,0
6329,the,0,0
6330,response,0,0
6331,to,0,0
6332,the,0,0
6333,recombinant,1,1
6334,Hepatitis,1,1
6335,B,1,1
6336,vaccine,1,1
6337,using,0,0
6338,an,0,0
6339,accelerated,0,0
6340,schedule,0,0
6341,versus,0,0
6342,the,0,0
6343,traditional,0,0
6344,schedule,0,0
6345,by,0,0
6346,studying,0,0
6347,the,0,0
6348,immunologic,0,0
6349,memory,0,0
6350,induced,0,0
6351,in,0,0
6352,200,0,0
6353,children,0,0
6354,with,0,0
6355,HBs-Ag,0,0
6356,negative,0,0
6357,mothers,0,0
6358,.,0,0
6359,At,0,0
6360,seroconversion,0,0
6361,",",0,0
6362,the,0,0
6363,traditional,0,0
6364,schedule,0,0
6365,presented,0,0
6366,a,0,0
6367,higher,0,0
6368,percentage,0,0
6369,of,0,0
6370,children,0,0
6371,with,0,0
6372,serum,0,1
6373,HBs-Ag,0,1
6374,concentrations,0,1
6375,over,0,0
6376,100,0,0
6377,mIU/ml,0,0
6378,than,0,0
6379,the,0,0
6380,accelerated,0,0
6381,schedule,0,0
6382,.,0,0
6383,After,0,0
6384,five,0,0
6385,years,0,0
6386,this,0,0
6387,difference,0,0
6388,was,0,0
6389,no,0,0
6390,longer,0,0
6391,statistically,0,0
6392,significant,0,0
6393,and,0,0
6394,children,0,0
6395,who,0,0
6396,presented,0,0
6397,anti-HBsAg,0,1
6398,concentrations,0,1
6399,below,0,0
6400,10,0,0
6401,mUI/ml,0,0
6402,received,0,0
6403,an,0,0
6404,additional,0,0
6405,booster,0,0
6406,dose,0,1
6407,which,0,0
6408,stimulated,0,0
6409,the,0,0
6410,antibody,0,0
6411,concentration,0,0
6412,to,0,0
6413,exceed,0,0
6414,100,0,0
6415,mIU/ml,0,0
6416,in,0,0
6417,all,0,0
6418,cases,0,0
6419,.,0,0
6420,Recombinant,1,0
6421,HBV,1,1
6422,vaccine,1,1
6423,induced,0,0
6424,better,0,0
6425,long,0,0
6426,term,0,0
6427,immunologic,0,0
6428,memory,0,0
6429,when,0,0
6430,it,0,0
6431,was,0,0
6432,administered,0,1
6433,earlier,0,0
6434,.,0,0
6435,Comparison,0,0
6436,of,0,0
6437,chemotherapy,1,0
6438,with,1,0
6439,chemohormonal,1,0
6440,therapy,1,0
6441,as,0,0
6442,first-line,0,0
6443,therapy,0,0
6444,for,0,0
6445,metastatic,0,0
6446,",",0,0
6447,hormone-sensitive,0,0
6448,breast,0,0
6449,cancer,0,1
6450,:,0,1
6451,An,0,1
6452,Eastern,0,1
6453,Cooperative,0,1
6454,Oncology,0,0
6455,Group,0,0
6456,study,0,0
6457,.,0,0
6458,PURPOSE,0,0
6459,Although,0,0
6460,hormonal,0,0
6461,therapy,0,0
6462,represents,0,0
6463,standard,0,0
6464,therapy,0,0
6465,for,0,0
6466,metastatic,0,0
6467,hormone-sensitive,0,0
6468,disease,0,0
6469,",",0,0
6470,many,0,0
6471,patients,0,0
6472,receive,0,0
6473,initial,0,0
6474,chemotherapy,1,0
6475,because,0,0
6476,of,0,0
6477,the,0,0
6478,location,0,0
6479,",",0,0
6480,bulk,0,0
6481,",",0,0
6482,or,0,0
6483,aggressiveness,0,0
6484,of,0,0
6485,their,0,0
6486,disease,0,0
6487,.,0,0
6488,It,0,0
6489,is,0,0
6490,uncertain,0,0
6491,whether,0,0
6492,simultaneous,1,0
6493,hormonal,1,0
6494,therapy,1,0
6495,provides,0,0
6496,additional,0,0
6497,benefit,0,0
6498,compared,0,0
6499,with,0,0
6500,chemotherapy,0,0
6501,alone,0,0
6502,.,0,0
6503,Eastern,0,0
6504,Cooperative,0,0
6505,Oncology,0,0
6506,Group,0,0
6507,trial,0,0
6508,E3186,0,0
6509,was,0,0
6510,initiated,0,0
6511,to,0,0
6512,explore,0,0
6513,this,0,0
6514,question,0,0
6515,.,0,0
6516,PATIENTS,0,0
6517,AND,0,1
6518,METHODS,0,1
6519,Between,0,1
6520,January,0,0
6521,1988,0,0
6522,and,0,0
6523,December,0,0
6524,1992,0,0
6525,",",0,0
6526,231,0,0
6527,patients,0,0
6528,with,0,0
6529,estrogen,0,1
6530,receptor,0,1
6531,(,0,1
6532,ER,0,1
6533,),0,1
6534,-positive,0,0
6535,or,0,0
6536,ER-unknown,0,1
6537,metastatic,0,1
6538,breast,0,0
6539,cancer,0,0
6540,were,0,0
6541,randomized,0,0
6542,to,0,0
6543,receive,0,0
6544,either,0,0
6545,chemotherapy,1,1
6546,(,1,1
6547,cyclophosphamide,1,1
6548,",",1,1
6549,doxorubicin,1,1
6550,",",1,1
6551,and,1,1
6552,fluorouracil,1,1
6553,?CAF,1,1
6554,),1,1
6555,or,1,0
6556,chemohormonal,1,1
6557,therapy,1,1
6558,(,1,0
6559,CAF,1,1
6560,plus,1,0
6561,tamoxifen,1,1
6562,and,1,1
6563,Halotestin,1,1
6564,?fluoxymesterone,1,1
6565,;,1,1
6566,Pharmacia-Upjohn,1,1
6567,",",1,0
6568,Kalamazoo,1,0
6569,",",1,0
6570,MI,1,1
6571,?CAFTH,1,1
6572,),1,0
6573,as,1,0
6574,front-line,1,0
6575,therapy,1,0
6576,for,1,0
6577,metastatic,0,0
6578,breast,0,0
6579,cancer,0,0
6580,.,0,0
6581,Patients,0,0
6582,who,0,0
6583,experienced,0,0
6584,a,0,0
6585,complete,0,0
6586,response,0,0
6587,to,0,0
6588,induction,0,0
6589,therapy,0,0
6590,either,0,0
6591,received,0,0
6592,or,0,0
6593,did,0,0
6594,not,0,0
6595,receive,0,0
6596,maintenance,0,0
6597,cyclophosphamide,0,1
6598,",",0,1
6599,methotrexate,0,1
6600,",",0,1
6601,fluorouracil,0,1
6602,",",0,1
6603,prednisone,0,1
6604,",",0,1
6605,and,0,0
6606,TH,0,0
6607,as,0,0
6608,a,0,0
6609,secondary,0,0
6610,randomization,0,0
6611,.,0,0
6612,RESULTS,0,0
6613,The,0,0
6614,response,0,0
6615,rates,0,0
6616,(,0,0
6617,complete,0,0
6618,response,0,0
6619,and,0,0
6620,partial,0,0
6621,response,0,0
6622,),0,0
6623,of,0,0
6624,patients,0,0
6625,who,0,0
6626,received,0,0
6627,CAF,0,0
6628,and,0,0
6629,CAFTH,0,0
6630,were,0,0
6631,similar,0,0
6632,(,0,0
6633,69.2,0,0
6634,%,0,0
6635,v,0,0
6636,68.9,0,0
6637,%,0,0
6638,",",0,0
6639,respectively,0,0
6640,;,0,0
6641,P,0,0
6642,=.99,0,0
6643,),0,0
6644,.,0,0
6645,Time,0,0
6646,to,0,0
6647,treatment,0,0
6648,failure,0,1
6649,(,0,1
6650,TTF,0,1
6651,),0,0
6652,was,0,0
6653,slightly,0,0
6654,longer,0,0
6655,for,0,0
6656,patients,0,0
6657,who,0,0
6658,received,0,0
6659,chemohormonal,0,0
6660,therapy,0,0
6661,compared,0,0
6662,with,0,0
6663,chemotherapy,0,0
6664,alone,0,0
6665,patients,0,0
6666,(,0,0
6667,13.4,0,0
6668,months,0,0
6669,v,0,0
6670,10.3,0,0
6671,months,0,0
6672,",",0,0
6673,respectively,0,0
6674,;,0,0
6675,P,0,0
6676,=.087,0,0
6677,),0,0
6678,",",0,0
6679,and,0,0
6680,TTF,0,0
6681,was,0,0
6682,significantly,0,0
6683,longer,0,0
6684,in,0,0
6685,ER-positive,0,0
6686,compared,0,0
6687,with,0,0
6688,ER-negative,0,0
6689,patients,0,0
6690,(,0,0
6691,17.4,0,0
6692,months,0,0
6693,v,0,0
6694,10.3,0,0
6695,months,0,0
6696,",",0,0
6697,respectively,0,0
6698,;,0,0
6699,P,0,0
6700,=.048,0,0
6701,),0,0
6702,.,0,0
6703,However,0,0
6704,",",0,0
6705,ER,0,0
6706,status,0,0
6707,had,0,0
6708,no,0,0
6709,effect,0,0
6710,on,0,0
6711,overall,0,0
6712,survival,0,0
6713,(,0,0
6714,30.0,0,0
6715,months,0,0
6716,for,0,0
6717,CAF,0,0
6718,v,0,0
6719,29.3,0,0
6720,months,0,0
6721,for,0,0
6722,CAFTH,0,1
6723,),0,0
6724,.,0,0
6725,CONCLUSION,0,0
6726,In,0,0
6727,patients,0,0
6728,with,0,0
6729,potentially,0,0
6730,hormone-sensitive,0,0
6731,metastatic,0,0
6732,breast,0,0
6733,cancer,1,0
6734,",",1,0
6735,chemohormonal,1,0
6736,therapy,1,0
6737,prolongs,1,0
6738,TTF,0,0
6739,for,0,0
6740,ER-positive,0,0
6741,patients,0,0
6742,without,0,0
6743,improving,0,0
6744,overall,0,0
6745,survival,0,0
6746,.,0,0
6747,Effectiveness,0,0
6748,of,0,0
6749,manual,1,0
6750,physical,1,0
6751,therapy,1,0
6752,and,1,0
6753,exercise,1,0
6754,in,0,0
6755,osteoarthritis,0,0
6756,of,0,0
6757,the,0,0
6758,knee,0,0
6759,.,0,0
6760,A,0,0
6761,randomized,0,0
6762,",",0,0
6763,controlled,0,0
6764,trial,0,0
6765,.,0,0
6766,BACKGROUND,0,0
6767,Few,0,0
6768,investigations,0,0
6769,include,0,0
6770,both,0,0
6771,subjective,0,0
6772,and,0,0
6773,objective,0,0
6774,measurements,0,0
6775,of,0,0
6776,the,0,0
6777,effectiveness,0,0
6778,of,0,0
6779,treatments,0,0
6780,for,0,0
6781,osteoarthritis,0,0
6782,of,0,0
6783,the,0,0
6784,knee,0,0
6785,.,0,0
6786,Beneficial,0,0
6787,interventions,0,0
6788,may,0,0
6789,decrease,0,0
6790,the,0,0
6791,disability,0,0
6792,associated,0,0
6793,with,0,0
6794,osteoarthritis,0,0
6795,and,0,0
6796,the,0,0
6797,need,0,0
6798,for,0,0
6799,more,0,0
6800,invasive,0,0
6801,treatments,0,0
6802,.,0,0
6803,OBJECTIVE,0,0
6804,To,0,0
6805,evaluate,0,0
6806,the,0,0
6807,effectiveness,0,0
6808,of,0,0
6809,physical,1,0
6810,therapy,1,0
6811,for,0,0
6812,osteoarthritis,0,0
6813,of,0,0
6814,the,0,0
6815,knee,0,0
6816,",",0,0
6817,applied,0,0
6818,by,0,0
6819,experienced,0,0
6820,physical,0,0
6821,therapists,0,0
6822,with,0,0
6823,formal,0,0
6824,training,0,0
6825,in,0,0
6826,manual,0,0
6827,therapy,0,0
6828,.,0,0
6829,DESIGN,0,0
6830,Randomized,0,0
6831,",",0,0
6832,controlled,0,0
6833,clinical,0,0
6834,trial,0,0
6835,.,0,0
6836,SETTING,0,0
6837,Outpatient,0,0
6838,physical,0,1
6839,therapy,0,0
6840,department,0,0
6841,of,0,0
6842,a,0,0
6843,large,0,0
6844,military,0,0
6845,medical,0,0
6846,center,0,0
6847,.,0,0
6848,PATIENTS,0,0
6849,83,0,0
6850,patients,0,0
6851,with,0,0
6852,osteoarthritis,0,0
6853,of,0,0
6854,the,0,0
6855,knee,0,0
6856,who,0,0
6857,were,0,0
6858,randomly,0,0
6859,assigned,0,0
6860,to,0,0
6861,receive,0,0
6862,treatment,1,0
6863,(,0,0
6864,n,0,0
6865,=,0,0
6866,42,0,0
6867,;,0,0
6868,15,0,0
6869,men,0,0
6870,and,0,0
6871,27,0,0
6872,women,0,0
6873,[,0,0
6874,mean,0,0
6875,age,0,0
6876,",",0,0
6877,60,0,0
6878,+/-,0,0
6879,11,0,0
6880,years,0,0
6881,],0,1
6882,),0,1
6883,or,0,1
6884,placebo,1,1
6885,(,0,0
6886,n,0,0
6887,=,0,0
6888,41,0,0
6889,;,0,0
6890,19,0,0
6891,men,0,0
6892,and,0,0
6893,22,0,0
6894,women,0,0
6895,[,0,0
6896,mean,0,0
6897,age,0,0
6898,",",0,0
6899,62,0,0
6900,+/-,0,0
6901,10,0,0
6902,years,0,0
6903,],0,1
6904,),0,0
6905,.,0,0
6906,INTERVENTION,0,0
6907,The,0,0
6908,treatment,0,0
6909,group,0,0
6910,received,0,0
6911,manual,1,0
6912,therapy,1,0
6913,",",0,0
6914,applied,0,0
6915,to,0,0
6916,the,0,0
6917,knee,0,0
6918,as,0,0
6919,well,0,0
6920,as,0,0
6921,to,0,0
6922,the,0,0
6923,lumbar,0,0
6924,spine,0,0
6925,",",0,0
6926,hip,0,0
6927,",",0,0
6928,and,0,0
6929,ankle,0,0
6930,as,0,0
6931,required,0,0
6932,",",0,0
6933,and,0,0
6934,performed,0,0
6935,a,0,0
6936,standardized,1,0
6937,knee,1,0
6938,exercise,1,0
6939,program,1,0
6940,in,0,0
6941,the,0,0
6942,clinic,0,0
6943,and,0,0
6944,at,0,0
6945,home,0,0
6946,.,0,0
6947,The,0,0
6948,placebo,1,1
6949,group,0,0
6950,had,0,0
6951,subtherapeutic,1,1
6952,ultrasound,1,1
6953,to,0,0
6954,the,0,0
6955,knee,0,0
6956,at,0,0
6957,an,0,0
6958,intensity,0,0
6959,of,0,0
6960,0.1,0,0
6961,W/cm2,0,0
6962,with,0,0
6963,a,0,0
6964,10,0,0
6965,%,0,0
6966,pulsed,0,0
6967,mode,0,0
6968,.,0,0
6969,Both,0,0
6970,groups,0,0
6971,were,0,0
6972,treated,0,0
6973,at,0,0
6974,the,0,0
6975,clinic,0,1
6976,twice,0,1
6977,weekly,0,1
6978,for,0,0
6979,4,0,0
6980,weeks,0,0
6981,.,0,0
6982,MEASUREMENTS,0,0
6983,Distance,0,0
6984,walked,0,0
6985,in,0,0
6986,6,0,0
6987,minutes,0,0
6988,and,0,0
6989,sum,0,0
6990,of,0,0
6991,the,0,0
6992,function,0,0
6993,",",0,0
6994,pain,0,0
6995,",",0,0
6996,and,0,0
6997,stiffness,0,0
6998,subscores,0,0
6999,of,0,0
7000,the,0,0
7001,Western,0,0
7002,Ontario,0,0
7003,and,0,0
7004,McMaster,0,1
7005,Universities,0,1
7006,Osteoarthritis,0,1
7007,Index,0,1
7008,(,0,1
7009,WOMAC,0,1
7010,),0,1
7011,.,0,0
7012,A,0,0
7013,tester,0,0
7014,who,0,0
7015,was,0,0
7016,blinded,0,0
7017,to,0,0
7018,group,0,0
7019,assignment,0,0
7020,made,0,0
7021,group,0,0
7022,comparisons,0,0
7023,at,0,0
7024,the,0,0
7025,initial,0,0
7026,visit,0,0
7027,(,0,0
7028,before,0,0
7029,initiation,0,0
7030,of,0,0
7031,treatment,0,0
7032,),0,0
7033,",",0,0
7034,4,0,0
7035,weeks,0,0
7036,",",0,0
7037,8,0,0
7038,weeks,0,0
7039,",",0,0
7040,and,0,0
7041,1,0,0
7042,year,0,0
7043,.,0,0
7044,RESULTS,0,0
7045,Clinically,0,0
7046,and,0,0
7047,statistically,0,0
7048,significant,0,0
7049,improvements,0,0
7050,in,0,0
7051,6-minute,0,0
7052,walk,0,0
7053,distance,0,0
7054,and,0,0
7055,WOMAC,0,0
7056,score,0,1
7057,at,0,0
7058,4,0,0
7059,weeks,0,0
7060,and,0,0
7061,8,0,0
7062,weeks,0,0
7063,were,0,0
7064,seen,0,0
7065,in,0,0
7066,the,0,0
7067,treatment,1,0
7068,group,0,0
7069,but,0,0
7070,not,0,0
7071,the,0,0
7072,placebo,1,1
7073,group,0,1
7074,.,0,0
7075,By,0,0
7076,8,0,0
7077,weeks,0,0
7078,",",0,0
7079,average,0,0
7080,6-minute,0,0
7081,walk,0,0
7082,distances,0,0
7083,had,0,0
7084,improved,0,0
7085,by,0,0
7086,13.1,0,0
7087,%,0,0
7088,and,0,0
7089,WOMAC,0,0
7090,scores,0,0
7091,had,0,0
7092,improved,0,0
7093,by,0,0
7094,55.8,0,0
7095,%,0,0
7096,over,0,0
7097,baseline,0,0
7098,values,0,0
7099,in,0,0
7100,the,0,0
7101,treatment,1,0
7102,group,0,0
7103,(,0,0
7104,P,0,0
7105,<,0,0
7106,0.05,0,0
7107,),0,0
7108,.,0,0
7109,After,0,0
7110,controlling,0,0
7111,for,0,0
7112,potential,0,0
7113,confounding,0,0
7114,variables,0,0
7115,",",0,0
7116,the,0,0
7117,average,0,0
7118,distance,0,0
7119,walked,0,0
7120,in,0,0
7121,6,0,0
7122,minutes,0,0
7123,at,0,0
7124,8,0,0
7125,weeks,0,0
7126,among,0,0
7127,patients,0,0
7128,in,0,0
7129,the,0,0
7130,treatment,1,0
7131,group,0,0
7132,was,0,0
7133,170,0,0
7134,m,0,0
7135,(,0,0
7136,95,0,0
7137,%,0,0
7138,CI,0,0
7139,",",0,0
7140,71,0,0
7141,to,0,0
7142,270,0,0
7143,m,0,0
7144,),0,0
7145,more,0,0
7146,than,0,0
7147,that,0,0
7148,in,0,0
7149,the,0,0
7150,placebo,1,1
7151,group,0,0
7152,and,0,0
7153,the,0,0
7154,average,0,0
7155,WOMAC,0,0
7156,scores,0,0
7157,were,0,0
7158,599,0,0
7159,mm,0,0
7160,higher,0,0
7161,(,0,0
7162,95,0,0
7163,%,0,0
7164,CI,0,0
7165,",",0,0
7166,197,0,0
7167,to,0,0
7168,1002,0,0
7169,mm,0,0
7170,),0,0
7171,.,0,0
7172,At,0,0
7173,1,0,0
7174,year,0,0
7175,",",0,0
7176,patients,0,0
7177,in,0,0
7178,the,0,0
7179,treatment,1,0
7180,group,0,0
7181,had,0,0
7182,clinically,0,0
7183,and,0,0
7184,statistically,0,0
7185,significant,0,0
7186,gains,0,0
7187,over,0,0
7188,baseline,0,0
7189,WOMAC,0,0
7190,scores,0,1
7191,and,0,0
7192,walking,0,1
7193,distance,0,1
7194,;,0,0
7195,20,0,0
7196,%,0,0
7197,of,0,0
7198,patients,0,0
7199,in,0,0
7200,the,0,0
7201,placebo,1,1
7202,group,0,1
7203,and,0,0
7204,5,0,0
7205,%,0,0
7206,of,0,0
7207,patients,0,0
7208,in,0,0
7209,the,0,0
7210,treatment,1,0
7211,group,0,0
7212,had,0,0
7213,undergone,0,0
7214,knee,1,0
7215,arthroplasty,1,0
7216,.,1,0
7217,CONCLUSIONS,0,0
7218,A,0,0
7219,combination,0,0
7220,of,0,0
7221,manual,1,0
7222,physical,1,0
7223,therapy,1,0
7224,and,1,0
7225,supervised,1,0
7226,exercise,1,0
7227,yields,0,0
7228,functional,0,0
7229,benefits,0,0
7230,for,0,0
7231,patients,0,0
7232,with,0,0
7233,osteoarthritis,0,0
7234,of,0,0
7235,the,0,0
7236,knee,0,0
7237,and,0,0
7238,may,0,0
7239,delay,0,0
7240,or,0,0
7241,prevent,0,0
7242,the,0,0
7243,need,0,0
7244,for,0,0
7245,surgical,0,0
7246,intervention,0,0
7247,.,0,0
7248,Regression,0,0
7249,of,0,0
7250,left,0,0
7251,ventricular,0,0
7252,hypertrophy,0,0
7253,after,0,0
7254,stentless,1,0
7255,versus,0,0
7256,conventional,1,0
7257,aortic,1,0
7258,valve,1,0
7259,replacement,1,0
7260,.,1,0
7261,The,0,0
7262,goal,0,0
7263,of,0,0
7264,this,0,0
7265,study,0,0
7266,was,0,0
7267,to,0,0
7268,analyze,0,0
7269,regression,0,0
7270,of,0,0
7271,left,0,0
7272,ventricular,0,0
7273,hypertrophy,0,0
7274,after,0,0
7275,randomization,0,0
7276,to,0,0
7277,conventional,1,0
7278,biological,1,0
7279,versus,1,0
7280,stentless,1,0
7281,aortic,1,0
7282,valve,1,0
7283,replacement,1,0
7284,.,1,0
7285,Stentless,1,0
7286,(,0,0
7287,Freestyle,0,0
7288,",",0,0
7289,Toronto,0,0
7290,",",0,0
7291,n,0,0
7292,=,0,0
7293,106,0,0
7294,),0,0
7295,or,0,0
7296,conventional,1,0
7297,biological,1,0
7298,aortic,1,0
7299,valves,1,1
7300,(,0,0
7301,Carpentier-Edwards,0,1
7302,",",0,0
7303,n,0,0
7304,=,0,0
7305,74,0,0
7306,),0,0
7307,were,0,0
7308,evaluated,0,0
7309,prospectively,0,0
7310,.,0,0
7311,Preoperatively,0,0
7312,there,0,0
7313,were,0,0
7314,no,0,0
7315,differences,0,0
7316,with,0,0
7317,regard,0,0
7318,to,0,0
7319,aortic,0,0
7320,valve,0,0
7321,pathology,0,0
7322,",",0,0
7323,left,0,0
7324,ventricular,0,0
7325,function,0,0
7326,",",0,0
7327,and,0,0
7328,pressure,0,0
7329,gradients,0,0
7330,between,0,0
7331,the,0,0
7332,two,0,0
7333,patient,0,0
7334,groups,0,0
7335,.,0,0
7336,The,0,0
7337,patient,0,0
7338,annulus,0,0
7339,index,0,0
7340,(,0,0
7341,13.55,0,0
7342,vs.,0,0
7343,13.46,0,0
7344,mm,0,0
7345,;,0,0
7346,NS,0,1
7347,),0,1
7348,measured,0,0
7349,intraoperatively,0,0
7350,was,0,0
7351,used,0,0
7352,as,0,0
7353,baseline,0,0
7354,for,0,0
7355,further,0,0
7356,comparison,0,0
7357,.,0,0
7358,Postoperatively,0,0
7359,",",0,0
7360,left,0,0
7361,ventricular,0,0
7362,mass,0,0
7363,index,0,0
7364,was,0,0
7365,213+/-77,0,0
7366,g/m2,0,1
7367,(,0,1
7368,stentless,0,1
7369,),0,0
7370,compared,0,0
7371,with,0,0
7372,202+/-72,0,0
7373,(,0,0
7374,conventional,0,0
7375,group,0,1
7376,),0,1
7377,g/m2,0,1
7378,(,0,1
7379,NS,0,1
7380,),0,1
7381,",",0,0
7382,whereas,0,0
7383,after,0,0
7384,6,0,0
7385,months,0,0
7386,it,0,0
7387,was,0,0
7388,141+/-41,0,0
7389,g/m2,0,0
7390,in,0,0
7391,the,0,0
7392,stentless,0,0
7393,and,0,0
7394,170+/-43,0,0
7395,g/m2,0,0
7396,in,0,0
7397,the,0,0
7398,conventional,0,0
7399,group,0,0
7400,(,0,0
7401,P,0,0
7402,<,0,0
7403,.05,0,0
7404,),0,0
7405,.,0,0
7406,Regression,0,0
7407,of,0,0
7408,left,0,0
7409,ventricular,0,0
7410,hypertrophy,0,0
7411,occurs,0,0
7412,in,0,0
7413,all,0,0
7414,patients,0,0
7415,after,0,0
7416,aortic,0,0
7417,valve,0,0
7418,replacement,0,0
7419,.,0,0
7420,Nevertheless,0,0
7421,",",0,0
7422,the,0,0
7423,use,0,0
7424,of,0,0
7425,stentless,1,0
7426,bioprostheses,1,0
7427,leads,0,0
7428,to,0,0
7429,a,0,0
7430,significant,0,0
7431,enhancement,0,0
7432,",",0,0
7433,which,0,0
7434,may,0,0
7435,result,0,0
7436,in,0,0
7437,a,0,0
7438,reduction,0,0
7439,of,0,0
7440,the,0,0
7441,cardiac,0,0
7442,risk,0,0
7443,profile,0,0
7444,for,0,0
7445,the,0,0
7446,patient,0,0
7447,.,0,0
7448,Differential,0,0
7449,effects,0,0
7450,of,0,0
7451,amino,0,0
7452,acid,0,1
7453,and,0,1
7454,ketoacid,0,1
7455,on,0,0
7456,protein,0,0
7457,metabolism,0,0
7458,in,0,0
7459,humans,0,0
7460,.,0,0
7461,We,0,0
7462,examined,0,0
7463,the,0,0
7464,effects,0,0
7465,of,0,0
7466,insulin,0,1
7467,",",0,0
7468,amino,0,1
7469,acid,0,1
7470,(,0,1
7471,AA,0,1
7472,),0,1
7473,",",0,0
7474,and,0,1
7475,branched-chain,0,1
7476,ketoacid,0,1
7477,(,0,1
7478,KA,0,1
7479,),0,1
7480,availability,0,0
7481,on,0,0
7482,leucine,0,0
7483,kinetics,0,0
7484,in,0,0
7485,eight,0,0
7486,healthy,0,0
7487,volunteers,0,0
7488,(,0,0
7489,age,0,0
7490,=,0,0
7491,22,0,0
7492,+/-,0,0
7493,2,0,0
7494,y,0,0
7495,",",0,0
7496,body,0,0
7497,mass,0,0
7498,index,0,0
7499,=,0,0
7500,24,0,0
7501,+/-,0,0
7502,1,0,0
7503,kg,0,0
7504,),0,0
7505,by,0,0
7506,using,0,0
7507,the,0,0
7508,euglycemic,1,1
7509,insulin,1,1
7510,clamp,1,1
7511,and,1,1
7512,[,1,1
7513,1-14C,1,1
7514,],1,1
7515,leucine,1,1
7516,turnover,1,0
7517,techniques,1,0
7518,.,1,0
7519,Four,0,0
7520,experimental,0,0
7521,conditions,0,0
7522,were,0,0
7523,studied,0,0
7524,:,0,0
7525,study,0,0
7526,I,0,0
7527,",",0,1
7528,hyperinsulinemia,0,1
7529,;,0,1
7530,study,0,0
7531,II,0,1
7532,",",0,0
7533,hyperinsulinemia,0,1
7534,with,0,0
7535,maintenance,0,0
7536,of,0,0
7537,basal,0,0
7538,plasma,0,1
7539,AA,0,1
7540,and,0,1
7541,branched-chain,0,1
7542,KA,0,1
7543,concentrations,0,1
7544,;,0,1
7545,study,0,0
7546,III,0,1
7547,",",0,0
7548,hyperinsulinemia,0,1
7549,with,0,1
7550,hyperaminoacidemia,0,1
7551,and,0,0
7552,basal,0,1
7553,plasma,0,1
7554,branched-chain,0,1
7555,KA,0,1
7556,concentrations,0,1
7557,;,0,1
7558,and,0,0
7559,study,0,0
7560,IV,0,1
7561,",",0,0
7562,hyperinsulinemia,0,1
7563,plus,0,0
7564,basal,0,0
7565,plasma,0,1
7566,AA,0,1
7567,concentrations,0,1
7568,and,0,0
7569,elevated,0,0
7570,branched-chain,0,1
7571,KA,0,1
7572,levels,0,0
7573,.,0,0
7574,Basal,0,0
7575,endogenous,0,0
7576,leucine,0,1
7577,flux,0,0
7578,(,0,1
7579,ELF,0,1
7580,),0,0
7581,averaged,0,0
7582,1.20,0,0
7583,+/-,0,0
7584,0.05,0,0
7585,(,0,0
7586,mumol.kg-1.min-1,0,1
7587,",",0,0
7588,mean,0,0
7589,+/-,0,0
7590,SE,0,0
7591,),0,0
7592,;,0,0
7593,basal,0,0
7594,leucine,0,1
7595,oxidation,0,0
7596,(,0,1
7597,LOX,0,1
7598,),0,1
7599,was,0,0
7600,0.25,0,0
7601,+/-,0,0
7602,0.01,0,0
7603,;,0,0
7604,and,0,0
7605,basal,0,0
7606,non-oxidative,0,0
7607,leucine,0,1
7608,disposal,0,1
7609,(,0,1
7610,NOLD,0,1
7611,),0,0
7612,was,0,0
7613,0.95,0,0
7614,+/-,0,0
7615,0.04,0,0
7616,.,0,0
7617,ELF,0,0
7618,significantly,0,0
7619,decreased,0,0
7620,in,0,0
7621,study,0,0
7622,I,0,0
7623,(,0,0
7624,0.77,0,0
7625,+/-,0,0
7626,0.06,0,0
7627,mumol.kg-1.min-1,0,0
7628,",",0,0
7629,P,0,0
7630,<,0,0
7631,0.01,0,0
7632,versus,0,0
7633,basal,0,0
7634,),0,0
7635,.,0,0
7636,When,0,1
7637,plasma,0,1
7638,AA,0,1
7639,and,0,1
7640,branched-chain,0,1
7641,KA,0,1
7642,were,0,0
7643,either,0,0
7644,maintained,0,0
7645,at,0,0
7646,their,0,0
7647,basal,0,0
7648,levels,0,0
7649,(,0,0
7650,study,0,0
7651,II,0,1
7652,),0,0
7653,or,0,0
7654,increased,0,0
7655,above,0,0
7656,baseline,0,0
7657,values,0,0
7658,(,0,0
7659,studies,0,0
7660,III,0,1
7661,and,0,0
7662,IV,0,1
7663,),0,1
7664,",",0,0
7665,ELF,0,0
7666,declined,0,0
7667,further,0,0
7668,(,0,0
7669,0.64,0,0
7670,+/-,0,0
7671,0.05,0,0
7672,",",0,0
7673,0.66,0,0
7674,+/-,0,0
7675,0.02,0,0
7676,",",0,0
7677,and,0,0
7678,0.66,0,0
7679,+/-,0,0
7680,0.03,0,0
7681,mumol.kg-1.min-1,0,0
7682,",",0,0
7683,respectively,0,0
7684,;,0,0
7685,all,0,0
7686,Ps,0,0
7687,<,0,0
7688,0.01,0,0
7689,versus,0,0
7690,basal,0,0
7691,and,0,0
7692,P,0,0
7693,<,0,0
7694,0.01,0,0
7695,versus,0,0
7696,study,0,0
7697,I,0,0
7698,),0,0
7699,.,0,0
7700,LOX,0,0
7701,declined,0,0
7702,in,0,0
7703,study,0,0
7704,I,0,0
7705,(,0,0
7706,0.12,0,0
7707,+/-,0,0
7708,0.02,0,0
7709,mumol.kg-1.min-1,0,0
7710,",",0,0
7711,P,0,0
7712,<,0,0
7713,0.01,0,0
7714,versus,0,0
7715,basal,0,0
7716,),0,0
7717,but,0,0
7718,increased,0,0
7719,significantly,0,0
7720,in,0,0
7721,studies,0,0
7722,II,0,0
7723,",",0,0
7724,III,0,0
7725,",",0,0
7726,and,0,0
7727,IV,0,0
7728,(,0,0
7729,0.31,0,0
7730,+/-,0,0
7731,0.04,0,0
7732,",",0,0
7733,0.37,0,0
7734,+/-,0,0
7735,0.03,0,0
7736,",",0,0
7737,and,0,0
7738,0.40,0,0
7739,+/-,0,0
7740,0.03,0,0
7741,mumol.kg-1.min-1,0,0
7742,",",0,0
7743,respectively,0,0
7744,",",0,0
7745,all,0,0
7746,Ps,0,0
7747,<,0,0
7748,0.01,0,0
7749,versus,0,0
7750,basal,0,0
7751,",",0,0
7752,P,0,0
7753,<,0,0
7754,0.05,0,0
7755,study,0,0
7756,IV,0,0
7757,versus,0,0
7758,study,0,0
7759,II,0,0
7760,",",0,0
7761,and,0,0
7762,P,0,0
7763,<,0,0
7764,0.05,0,0
7765,study,0,0
7766,III,0,0
7767,versus,0,0
7768,study,0,0
7769,II,0,1
7770,),0,0
7771,.,0,0
7772,NOLD,0,0
7773,declined,0,0
7774,in,0,0
7775,study,0,0
7776,I,0,0
7777,(,0,0
7778,0.65,0,0
7779,+/-,0,0
7780,0.05,0,0
7781,mumol/kg.min,0,0
7782,",",0,0
7783,P,0,0
7784,<,0,0
7785,0.01,0,0
7786,versus,0,0
7787,basal,0,0
7788,),0,0
7789,",",0,0
7790,whereas,0,0
7791,neither,0,0
7792,the,0,0
7793,maintenance,0,0
7794,of,0,0
7795,basal,0,0
7796,plasma,0,1
7797,AA/branched-chain,0,1
7798,KA,0,1
7799,levels,0,0
7800,(,0,0
7801,study,0,0
7802,II,0,0
7803,;,0,0
7804,0.89,0,0
7805,+/-,0,0
7806,0.2,0,0
7807,mumol.kg-1.min-1,0,0
7808,),0,0
7809,nor,0,0
7810,the,0,0
7811,elevation,0,0
7812,of,0,0
7813,plasma,0,1
7814,branched-chain,0,1
7815,KA,0,1
7816,concentration,0,0
7817,(,0,0
7818,study,0,0
7819,IV,0,0
7820,;,0,0
7821,0.96,0,0
7822,+/-,0,0
7823,0.1,0,0
7824,mumol.kg-1.min-1,0,0
7825,),0,0
7826,increased,0,0
7827,NOLD,0,0
7828,above,0,0
7829,baseline,0,0
7830,level,0,0
7831,.,0,0
7832,A,0,0
7833,stimulation,0,0
7834,of,0,0
7835,NOLD,0,0
7836,was,0,0
7837,observed,0,0
7838,only,0,0
7839,when,0,0
7840,plasma,0,1
7841,AA,0,0
7842,levels,0,0
7843,were,0,0
7844,increased,0,0
7845,(,0,0
7846,study,0,0
7847,III,0,1
7848,;,0,0
7849,1.23,0,0
7850,+/-,0,0
7851,0.03,0,0
7852,mumol/kg.min,0,0
7853,",",0,0
7854,P,0,0
7855,<,0,0
7856,0.01,0,0
7857,versus,0,0
7858,basal,0,0
7859,),0,0
7860,.,0,0
7861,In,0,0
7862,conclusion,0,0
7863,",",0,0
7864,the,0,0
7865,present,0,0
7866,data,0,0
7867,do,0,0
7868,not,0,0
7869,support,0,0
7870,the,0,0
7871,concept,0,0
7872,of,0,0
7873,a,0,0
7874,direct,0,0
7875,anabolic,0,1
7876,action,0,0
7877,of,0,0
7878,ketoanalogs,0,1
7879,but,0,0
7880,do,0,0
7881,provide,0,0
7882,additional,0,0
7883,evidence,0,0
7884,for,0,0
7885,the,0,0
7886,pivotal,0,0
7887,role,0,0
7888,of,0,0
7889,AA,0,0
7890,availability,0,0
7891,in,0,0
7892,the,0,0
7893,stimulation,0,0
7894,of,0,0
7895,whole-body,0,0
7896,protein,0,0
7897,synthesis,0,0
7898,.,0,0
7899,Efficacy,0,0
7900,of,0,1
7901,primaquine,1,1
7902,regimens,1,1
7903,for,0,1
7904,primaquine-resistant,0,1
7905,Plasmodium,0,1
7906,vivax,0,1
7907,malaria,0,0
7908,in,0,0
7909,Thailand,0,0
7910,.,0,0
7911,To,0,0
7912,define,0,0
7913,the,0,0
7914,current,0,0
7915,efficacy,0,0
7916,of,0,0
7917,Fansidar,1,1
7918,(,1,0
7919,F.,1,1
7920,Hoffmann-La,1,1
7921,Roche,1,1
7922,Ltd.,1,1
7923,",",0,0
7924,Basel,1,1
7925,Switzerland,1,1
7926,),1,1
7927,(,1,1
7928,pyrimethamine,1,1
7929,and,1,1
7930,sulfadoxine,1,1
7931,),1,1
7932,",",1,1
7933,primaquine,1,1
7934,in,0,0
7935,a,0,0
7936,high,0,0
7937,dose,0,1
7938,",",0,1
7939,and,0,1
7940,artesunate,1,1
7941,for,0,0
7942,treating,0,0
7943,acute,0,0
7944,Plasmodium,0,0
7945,vivax,0,0
7946,malaria,0,0
7947,",",0,0
7948,we,0,0
7949,conducted,0,0
7950,a,0,0
7951,comparative,0,0
7952,clinical,0,0
7953,trial,0,0
7954,of,0,0
7955,these,0,0
7956,3,0,0
7957,drugs,0,1
7958,in,0,1
7959,an,0,0
7960,open-label,0,1
7961,study,0,0
7962,.,0,0
7963,Patients,0,0
7964,(,0,0
7965,15-65,0,0
7966,years,0,0
7967,old,0,0
7968,),0,0
7969,were,0,0
7970,assigned,0,0
7971,to,0,0
7972,1,0,0
7973,of,0,0
7974,4,0,1
7975,treatments,0,0
7976,regimens,0,1
7977,in,0,0
7978,a,0,0
7979,serial,0,0
7980,order,0,0
7981,.,0,0
7982,Ninety,0,0
7983,percent,0,0
7984,of,0,0
7985,the,0,0
7986,patients,0,0
7987,were,0,0
7988,infected,0,0
7989,at,0,0
7990,Thailand-Myanmar,0,0
7991,border,0,0
7992,.,0,0
7993,Patients,0,0
7994,in,0,0
7995,group,0,0
7996,I,0,0
7997,(,0,0
7998,n,0,0
7999,=,0,0
8000,23,0,0
8001,),0,0
8002,received,0,0
8003,Fansidar,1,1
8004,(,0,1
8005,3,0,1
8006,tablets,0,1
8007,",",0,1
8008,75,0,0
8009,mg,0,1
8010,of,0,0
8011,pyrimethamine,1,1
8012,and,1,1
8013,"1,500",1,1
8014,mg,1,1
8015,of,1,1
8016,sulfadoxine,1,1
8017,",",0,0
8018,a,0,0
8019,single,0,0
8020,dose,0,1
8021,on,0,0
8022,the,0,0
8023,first,0,0
8024,day,0,0
8025,),0,1
8026,",",0,1
8027,group,0,1
8028,II,0,1
8029,(,0,0
8030,n,0,0
8031,=,0,0
8032,23,0,0
8033,),0,0
8034,received,0,0
8035,Fansidar,1,1
8036,(,1,1
8037,3,1,1
8038,tablets,1,1
8039,",",1,1
8040,75,1,0
8041,mg,1,1
8042,of,1,0
8043,pyrimethamine,1,1
8044,and,1,1
8045,"1,500",1,1
8046,mg,1,1
8047,of,1,1
8048,sulfadoxine,1,1
8049,",",0,0
8050,a,0,0
8051,single,0,0
8052,dose,0,1
8053,on,0,0
8054,the,0,0
8055,first,0,0
8056,day,0,0
8057,),0,0
8058,and,0,0
8059,then,0,0
8060,received,0,0
8061,primaquine,1,1
8062,(,1,1
8063,30,1,1
8064,mg,1,1
8065,a,1,0
8066,day,1,0
8067,for,1,0
8068,14,1,1
8069,days,1,0
8070,),1,1
8071,",",0,1
8072,group,0,1
8073,III,0,1
8074,(,0,0
8075,n,0,0
8076,=,0,0
8077,23,0,0
8078,),0,0
8079,received,1,0
8080,primaquine,1,1
8081,(,1,1
8082,30,1,1
8083,mg,1,1
8084,a,1,0
8085,day,1,0
8086,for,1,0
8087,14,1,1
8088,days,1,0
8089,),1,1
8090,",",0,0
8091,and,0,0
8092,group,0,0
8093,IV,0,1
8094,(,0,0
8095,n,0,0
8096,=,0,0
8097,23,0,0
8098,),0,0
8099,received,1,0
8100,artesunate,1,1
8101,(,0,1
8102,200,0,1
8103,mg,0,1
8104,once,0,1
8105,a,0,1
8106,day,0,0
8107,for,0,0
8108,3,0,1
8109,days,0,0
8110,),0,1
8111,and,0,1
8112,then,0,1
8113,primaquine,1,1
8114,(,0,1
8115,30,0,1
8116,mg,0,1
8117,a,0,0
8118,day,0,0
8119,for,0,0
8120,14,0,1
8121,days,0,0
8122,),0,0
8123,.,0,0
8124,Cure,0,0
8125,rates,0,0
8126,on,0,0
8127,day,0,0
8128,28,0,0
8129,of,0,0
8130,follow-up,0,0
8131,were,0,0
8132,40,0,0
8133,%,0,0
8134,",",0,0
8135,100,0,0
8136,%,0,0
8137,",",0,0
8138,100,0,0
8139,%,0,0
8140,",",0,0
8141,and,0,0
8142,100,0,0
8143,%,0,0
8144,in,0,0
8145,groups,0,0
8146,I,0,0
8147,",",0,0
8148,II,0,0
8149,",",0,0
8150,II,0,0
8151,",",0,0
8152,and,0,0
8153,IV,0,0
8154,",",0,0
8155,respectively,0,0
8156,.,0,0
8157,There,0,0
8158,were,0,0
8159,4,0,0
8160,and,0,0
8161,5,0,0
8162,patients,0,0
8163,in,0,0
8164,group,0,0
8165,I,0,0
8166,showing,0,0
8167,post-treatment,0,0
8168,reappearance,0,0
8169,of,0,0
8170,parasitemia,0,0
8171,at,0,0
8172,<,0,0
8173,or,0,0
8174,=,0,0
8175,16,0,0
8176,days,0,0
8177,and,0,0
8178,between,0,0
8179,17,0,0
8180,and,0,0
8181,28,0,0
8182,days,0,0
8183,",",0,0
8184,respectively,0,0
8185,.,0,0
8186,Patients,0,0
8187,in,0,0
8188,the,0,0
8189,other,0,0
8190,3,0,0
8191,groups,0,0
8192,showed,0,0
8193,negative,0,0
8194,parasitemias,0,0
8195,within,0,0
8196,7,0,0
8197,days,0,0
8198,after,0,0
8199,treatment,0,0
8200,.,0,0
8201,Artesunate,0,1
8202,plus,0,1
8203,primaquine,0,1
8204,(,0,1
8205,group,0,1
8206,IV,0,1
8207,),0,1
8208,cleared,0,0
8209,parasitemia,0,1
8210,faster,0,0
8211,than,0,0
8212,the,0,0
8213,other,0,0
8214,3,0,0
8215,regimens,0,1
8216,.,0,1
8217,There,0,0
8218,is,0,0
8219,a,0,0
8220,high,0,0
8221,proportion,0,0
8222,of,0,0
8223,ineffectiveness,0,0
8224,of,0,0
8225,Fansidar,0,0
8226,for,0,0
8227,treatment,0,0
8228,of,0,0
8229,P.,0,1
8230,vivax,0,0
8231,malaria,0,0
8232,and,0,0
8233,it,0,0
8234,should,0,0
8235,be,0,0
8236,no,0,0
8237,longer,0,0
8238,used,0,0
8239,for,0,0
8240,treatment,0,0
8241,of,0,0
8242,P.,0,1
8243,vivax,0,0
8244,malaria,0,0
8245,acquired,0,0
8246,at,0,0
8247,the,0,0
8248,Thailand-Myanmar,0,0
8249,border,0,0
8250,.,0,0
8251,A,0,0
8252,high,0,0
8253,dose,0,1
8254,of,0,1
8255,primaquine,0,1
8256,is,0,0
8257,safe,0,0
8258,and,0,0
8259,effective,0,0
8260,in,0,0
8261,the,0,0
8262,treatment,0,0
8263,of,0,0
8264,P.,0,1
8265,vivax,0,0
8266,malaria,0,0
8267,during,0,0
8268,the,0,0
8269,28-day,0,1
8270,follow-up,0,1
8271,period,0,1
8272,.,0,0
8273,Safety,0,0
8274,of,0,0
8275,the,0,0
8276,combination,1,0
8277,of,1,0
8278,valsartan,1,1
8279,and,1,1
8280,benazepril,1,1
8281,in,0,0
8282,patients,0,0
8283,with,0,0
8284,chronic,0,0
8285,renal,0,0
8286,disease,0,0
8287,.,0,0
8288,European,0,0
8289,Group,0,0
8290,for,0,0
8291,the,0,0
8292,Investigation,0,0
8293,of,0,0
8294,Valsartan,1,1
8295,in,0,0
8296,Chronic,0,0
8297,Renal,0,0
8298,Disease,0,0
8299,.,0,0
8300,OBJECTIVE,0,0
8301,Several,0,0
8302,experimental,0,0
8303,and,0,0
8304,clinical,0,0
8305,studies,0,0
8306,indicate,0,0
8307,that,0,0
8308,the,0,0
8309,renin,0,1
8310,system,0,0
8311,may,0,0
8312,play,0,0
8313,a,0,0
8314,pivotal,0,0
8315,role,0,0
8316,in,0,0
8317,progressing,0,0
8318,renal,0,0
8319,disease,0,0
8320,.,0,0
8321,The,0,0
8322,combination,0,0
8323,of,0,0
8324,an,0,0
8325,angiotensin-converting,0,1
8326,enzyme,0,1
8327,inhibitor,0,1
8328,and,0,0
8329,an,0,0
8330,angiotensin,0,1
8331,receptor,0,1
8332,blocker,0,1
8333,could,0,0
8334,provide,0,0
8335,a,0,0
8336,higher,0,0
8337,degree,0,0
8338,of,0,0
8339,blockade,0,1
8340,of,0,0
8341,the,0,0
8342,renin-angiotensin,0,1
8343,system,0,0
8344,than,0,0
8345,either,0,0
8346,agent,0,0
8347,alone,0,0
8348,.,0,0
8349,Such,0,0
8350,enhanced,0,0
8351,suppression,0,0
8352,might,0,0
8353,be,0,0
8354,of,0,0
8355,benefit,0,0
8356,for,0,0
8357,patients,0,0
8358,exhibiting,0,0
8359,a,0,0
8360,progressive,0,0
8361,decline,0,0
8362,in,0,0
8363,renal,0,0
8364,function,0,0
8365,because,0,0
8366,of,0,0
8367,chronic,0,0
8368,renal,0,0
8369,disease,0,0
8370,.,0,0
8371,METHODS,0,0
8372,A,0,1
8373,pilot,0,1
8374,multinational,0,0
8375,",",0,0
8376,multicentre,0,0
8377,",",0,0
8378,randomized,0,1
8379,",",0,1
8380,active-controlled,0,1
8381,",",0,1
8382,parallel,0,0
8383,group,0,0
8384,open-label,0,1
8385,study,0,0
8386,has,0,0
8387,been,0,0
8388,conducted,0,0
8389,in,0,0
8390,a,0,0
8391,group,0,0
8392,of,0,0
8393,patients,0,0
8394,with,0,0
8395,progressive,0,0
8396,chronic,0,0
8397,renal,0,1
8398,failure,0,1
8399,(,0,1
8400,creatinine,0,1
8401,clearance,0,1
8402,20-45,0,0
8403,ml/min,0,0
8404,),0,0
8405,either,0,0
8406,with,0,0
8407,or,0,0
8408,without,0,0
8409,proteinuria,0,1
8410,and,0,0
8411,hypertension,0,0
8412,.,0,0
8413,The,0,0
8414,primary,0,0
8415,aim,0,0
8416,of,0,0
8417,the,0,0
8418,study,0,0
8419,was,0,0
8420,to,0,0
8421,investigate,0,0
8422,the,0,0
8423,safety,0,0
8424,and,0,0
8425,tolerability,0,1
8426,of,0,0
8427,the,0,0
8428,combination,1,0
8429,of,1,0
8430,valsartan,1,1
8431,and,1,1
8432,benazepril,1,1
8433,.,1,0
8434,Patients,0,0
8435,were,0,0
8436,randomly,0,0
8437,assigned,0,0
8438,to,0,0
8439,one,0,0
8440,of,0,0
8441,three,0,0
8442,groups,0,0
8443,:,0,0
8444,group,0,0
8445,1,0,0
8446,received,0,0
8447,valsartan,1,1
8448,160,1,1
8449,mg,1,1
8450,once,0,1
8451,daily,0,1
8452,(,0,1
8453,n,0,0
8454,=,0,0
8455,22,0,0
8456,),0,0
8457,;,0,0
8458,group,0,0
8459,2,0,0
8460,received,0,0
8461,valsartan,1,1
8462,80,1,1
8463,mg,1,1
8464,once,1,1
8465,daily,1,1
8466,plus,1,1
8467,benazepril,1,1
8468,5,1,1
8469,or,1,1
8470,10,1,1
8471,mg,1,1
8472,once,1,1
8473,daily,1,1
8474,(,0,1
8475,n,0,0
8476,=,0,0
8477,42,0,0
8478,),0,0
8479,;,0,0
8480,group,0,0
8481,3,0,0
8482,received,0,0
8483,valsartan,1,1
8484,160,1,1
8485,mg,1,1
8486,once,0,1
8487,daily,0,1
8488,plus,1,1
8489,benazepril,1,1
8490,5,1,1
8491,or,1,1
8492,10,1,1
8493,mg,1,1
8494,once,0,1
8495,daily,0,1
8496,(,0,1
8497,n,0,0
8498,=,0,0
8499,44,0,0
8500,),0,0
8501,.,0,0
8502,The,0,0
8503,study,0,0
8504,lasted,0,0
8505,for,0,0
8506,5,0,0
8507,weeks,0,0
8508,",",0,0
8509,and,0,0
8510,in,0,0
8511,groups,0,0
8512,2,0,0
8513,and,0,0
8514,3,0,1
8515,benazepril,0,1
8516,was,0,0
8517,added,0,0
8518,on,0,0
8519,top,0,0
8520,of,0,0
8521,valsartan,0,1
8522,after,0,0
8523,the,0,0
8524,first,0,0
8525,week,0,0
8526,of,0,0
8527,therapy,0,0
8528,with,0,0
8529,the,0,0
8530,angiotensin,0,1
8531,receptor,0,1
8532,blocker,0,1
8533,.,0,1
8534,RESULTS,0,1
8535,Serum,0,1
8536,creatinine,0,1
8537,increased,0,0
8538,in,0,0
8539,all,0,0
8540,three,0,0
8541,groups,0,0
8542,(,0,0
8543,mean,0,0
8544,change,0,0
8545,within,0,0
8546,a,0,0
8547,group,0,0
8548,:,0,0
8549,11,0,0
8550,micromol/l,0,1
8551,in,0,0
8552,group,0,0
8553,1,0,0
8554,",",0,0
8555,P=,0,0
8556,0.045,0,0
8557,;,0,0
8558,9,0,0
8559,micromol/l,0,1
8560,in,0,0
8561,group,0,0
8562,2,0,0
8563,",",0,0
8564,P=,0,0
8565,0.030,0,0
8566,;,0,0
8567,15,0,0
8568,micromol/l,0,1
8569,in,0,0
8570,group,0,0
8571,3,0,0
8572,",",0,0
8573,P=,0,0
8574,0.0006,0,0
8575,),0,0
8576,.,0,0
8577,Serum,0,1
8578,potassium,0,1
8579,also,0,0
8580,increased,0,0
8581,in,0,0
8582,all,0,0
8583,three,0,0
8584,groups,0,0
8585,of,0,0
8586,patients,0,0
8587,(,0,0
8588,mean,0,0
8589,change,0,0
8590,within,0,0
8591,a,0,0
8592,group,0,0
8593,:,0,0
8594,0.28,0,0
8595,mmol/l,0,0
8596,in,0,0
8597,group,0,0
8598,1,0,0
8599,",",0,0
8600,P=,0,0
8601,0.28,0,0
8602,;,0,0
8603,0.48,0,0
8604,mmol/l,0,0
8605,in,0,0
8606,group,0,0
8607,2,0,0
8608,",",0,0
8609,P=,0,0
8610,0.0008,0,0
8611,;,0,0
8612,0.36,0,0
8613,mmol/l,0,0
8614,in,0,0
8615,group,0,0
8616,3,0,0
8617,",",0,0
8618,P=,0,0
8619,0.02,0,0
8620,),0,0
8621,.,0,0
8622,After,0,0
8623,5,0,0
8624,weeks,0,0
8625,of,0,0
8626,treatment,0,0
8627,",",0,0
8628,the,0,0
8629,largest,0,0
8630,decrease,0,0
8631,in,0,0
8632,blood,0,0
8633,pressure,0,0
8634,was,0,0
8635,observed,0,0
8636,in,0,0
8637,group,0,0
8638,3,0,0
8639,(,0,0
8640,the,0,0
8641,mean,0,0
8642,change,0,0
8643,from,0,0
8644,baseline,0,0
8645,in,0,0
8646,seated,0,0
8647,diastolic,0,0
8648,blood,0,1
8649,pressure,0,1
8650,(,0,1
8651,SDBP,0,1
8652,),0,1
8653,and,0,0
8654,seated,0,1
8655,systolic,0,1
8656,blood,0,1
8657,pressure,0,1
8658,(,0,1
8659,SSBP,0,1
8660,),0,0
8661,",",0,0
8662,respectively,0,0
8663,",",0,0
8664,were,0,0
8665,:,0,0
8666,-2.0,0,0
8667,and,0,0
8668,-11.5,0,0
8669,mmHg,0,0
8670,in,0,0
8671,group,0,0
8672,1,0,0
8673,;,0,0
8674,-7.6,0,0
8675,and,0,0
8676,-15.4,0,0
8677,mmHg,0,0
8678,in,0,0
8679,group,0,0
8680,2,0,0
8681,;,0,0
8682,-12.6,0,0
8683,and,0,0
8684,-21.6,0,0
8685,mmHg,0,0
8686,in,0,0
8687,group,0,0
8688,3,0,0
8689,),0,0
8690,.,0,0
8691,In,0,0
8692,addition,0,0
8693,",",0,0
8694,both,0,0
8695,combination,0,0
8696,treatments,0,0
8697,resulted,0,0
8698,in,0,0
8699,the,0,0
8700,reduction,0,0
8701,of,0,0
8702,proteinuria,0,0
8703,.,0,0
8704,The,0,0
8705,total,0,0
8706,number,0,0
8707,of,0,0
8708,patients,0,0
8709,with,0,0
8710,adverse,0,0
8711,experiences,0,0
8712,were,0,0
8713,10,0,0
8714,(,0,0
8715,45.5,0,0
8716,%,0,0
8717,),0,0
8718,",",0,0
8719,14,0,0
8720,(,0,0
8721,33.3,0,0
8722,%,0,0
8723,),0,0
8724,and,0,0
8725,11,0,1
8726,(,0,0
8727,25,0,0
8728,%,0,0
8729,),0,0
8730,in,0,0
8731,groups,0,0
8732,"1,2",0,0
8733,and,0,0
8734,3,0,0
8735,",",0,0
8736,respectively,0,0
8737,.,0,0
8738,In,0,0
8739,six,0,0
8740,patients,0,0
8741,(,0,0
8742,5.6,0,0
8743,%,0,0
8744,),0,0
8745,therapy,0,0
8746,was,0,0
8747,discontinued,0,1
8748,as,0,0
8749,a,0,0
8750,result,0,0
8751,of,0,0
8752,adverse,0,0
8753,experiences,0,0
8754,.,0,0
8755,Only,0,0
8756,one,0,0
8757,patient,0,0
8758,in,0,0
8759,each,0,0
8760,of,0,0
8761,the,0,0
8762,combined,0,0
8763,therapy,0,0
8764,groups,0,0
8765,withdrew,0,0
8766,from,0,0
8767,the,0,0
8768,study,0,0
8769,because,0,0
8770,of,0,0
8771,hyperkalaemia,0,0
8772,and,0,0
8773,no,0,0
8774,patients,0,0
8775,were,0,0
8776,forced,0,0
8777,to,0,0
8778,withdraw,0,0
8779,because,0,0
8780,of,0,0
8781,an,0,0
8782,increase,0,0
8783,in,0,0
8784,serum,0,1
8785,creatinine,0,1
8786,",",0,1
8787,acute,0,1
8788,renal,0,0
8789,failure,0,0
8790,or,0,0
8791,hospitalization,0,0
8792,.,0,0
8793,CONCLUSIONS,0,0
8794,These,0,0
8795,results,0,0
8796,indicate,0,0
8797,that,0,0
8798,short-term,0,0
8799,combination,0,0
8800,of,0,0
8801,an,0,0
8802,angiotensin-converting,0,1
8803,enzyme,0,1
8804,inhibitor,0,1
8805,and,0,0
8806,an,0,0
8807,angiotensin,0,1
8808,receptor,0,1
8809,blocker,0,1
8810,is,0,0
8811,safe,0,1
8812,and,0,0
8813,well,0,0
8814,tolerated,0,1
8815,in,0,0
8816,patients,0,0
8817,with,0,0
8818,moderate,0,0
8819,chronic,0,0
8820,renal,0,0
8821,failure,0,0
8822,.,0,0
8823,Sun,1,1
8824,protection,1,0
8825,counseling,1,0
8826,for,1,0
8827,children,1,0
8828,:,1,0
8829,primary,0,0
8830,care,0,0
8831,practice,0,0
8832,patterns,0,0
8833,and,0,0
8834,effect,0,0
8835,of,0,0
8836,an,0,0
8837,intervention,0,0
8838,on,0,0
8839,clinicians,0,0
8840,.,0,0
8841,OBJECTIVES,0,0
8842,To,0,0
8843,describe,0,0
8844,current,0,0
8845,primary,1,0
8846,care,1,0
8847,sun,1,0
8848,protection,1,0
8849,advice,0,0
8850,for,0,0
8851,children,0,0
8852,and,0,0
8853,assess,0,0
8854,the,0,0
8855,effect,0,0
8856,on,0,0
8857,clinicians,0,0
8858,of,0,0
8859,an,0,0
8860,intervention,0,0
8861,to,0,0
8862,enhance,0,0
8863,their,0,0
8864,sun,0,0
8865,protection,0,0
8866,advocacy,0,0
8867,.,0,0
8868,SETTING,0,0
8869,Primary,0,0
8870,care,0,1
8871,practices,0,0
8872,caring,0,0
8873,for,0,0
8874,children,0,0
8875,in,0,0
8876,New,0,0
8877,Hampshire,0,0
8878,with,0,0
8879,special,0,0
8880,attention,0,0
8881,to,0,0
8882,clinicians,0,0
8883,serving,0,0
8884,10,0,0
8885,towns,0,0
8886,that,0,0
8887,were,0,0
8888,involved,0,0
8889,in,0,0
8890,a,0,0
8891,randomized,0,0
8892,controlled,0,0
8893,trial,0,0
8894,of,0,0
8895,the,0,0
8896,multicomponent,0,0
8897,SunSafe,1,0
8898,intervention,0,0
8899,involving,0,0
8900,schools,0,0
8901,",",0,0
8902,recreation,0,0
8903,areas,0,0
8904,",",0,0
8905,and,0,0
8906,primary,0,0
8907,care,0,0
8908,practices,0,0
8909,.,0,0
8910,DESIGN/INTERVENTION,0,0
8911,A,0,1
8912,statewide,0,0
8913,survey,0,0
8914,of,0,0
8915,all,0,0
8916,primary,0,0
8917,care,0,0
8918,clinicians,0,0
8919,serving,0,0
8920,children,0,0
8921,addressed,0,0
8922,their,0,0
8923,self-reported,0,0
8924,sun,0,0
8925,protection,0,0
8926,advocacy,0,0
8927,practices,0,0
8928,.,0,0
8929,Clinicians,0,0
8930,in,0,0
8931,10,0,0
8932,systematically,0,0
8933,selected,0,0
8934,rural,0,0
8935,towns,0,0
8936,were,0,0
8937,involved,0,0
8938,in,0,0
8939,the,0,0
8940,subsequent,0,0
8941,intervention,0,0
8942,study,0,0
8943,.,0,0
8944,The,0,0
8945,primary,1,0
8946,care,1,0
8947,intervention,1,0
8948,provided,1,0
8949,assistance,1,0
8950,to,1,0
8951,practices,1,0
8952,in,1,0
8953,establishing,1,0
8954,an,1,0
8955,office,1,0
8956,system,1,0
8957,that,1,0
8958,promoted,1,0
8959,sun,1,0
8960,protection,1,0
8961,advice,1,0
8962,to,1,0
8963,children,1,0
8964,and,1,0
8965,their,1,0
8966,parents,1,0
8967,during,1,0
8968,office,1,0
8969,visits,1,0
8970,.,1,0
8971,MAIN,0,0
8972,OUTCOME,0,1
8973,MEASURES,0,1
8974,Sun,0,0
8975,protection,0,0
8976,promotion,0,0
8977,activities,0,0
8978,of,0,0
8979,primary,0,0
8980,care,0,0
8981,clinicians,0,0
8982,as,0,0
8983,determined,0,0
8984,by,0,0
8985,their,0,0
8986,self,0,0
8987,report,0,0
8988,",",0,0
8989,research,0,0
8990,assistant,0,0
8991,observation,0,0
8992,",",0,0
8993,and,0,0
8994,parent,0,0
8995,interviews,0,0
8996,.,0,0
8997,RESULTS,0,0
8998,Of,0,0
8999,261,0,0
9000,eligible,0,0
9001,clinicians,0,0
9002,responding,0,0
9003,to,0,0
9004,the,0,0
9005,statewide,0,0
9006,survey,0,0
9007,",",0,0
9008,about,0,0
9009,half,0,0
9010,provide,0,0
9011,sun,0,0
9012,protection,0,0
9013,counseling,0,0
9014,most,0,0
9015,of,0,0
9016,the,0,0
9017,time,0,0
9018,or,0,0
9019,almost,0,0
9020,always,0,0
9021,during,0,0
9022,summer,0,0
9023,well,0,0
9024,care,0,0
9025,visits,0,0
9026,.,0,0
9027,Pediatricians,0,0
9028,do,0,0
9029,so,0,0
9030,more,0,0
9031,often,0,0
9032,than,0,0
9033,family,0,0
9034,physicians,0,0
9035,.,0,0
9036,Clinicians,0,0
9037,involved,0,0
9038,in,0,0
9039,the,0,0
9040,intervention,0,0
9041,increased,0,0
9042,their,0,0
9043,use,0,0
9044,of,0,0
9045,handouts,0,0
9046,",",0,0
9047,waiting,0,0
9048,room,0,0
9049,educational,0,0
9050,materials,0,0
9051,",",0,0
9052,and,0,0
9053,sunscreen,0,1
9054,samples,0,0
9055,.,0,0
9056,Compared,0,0
9057,with,0,0
9058,control,0,0
9059,town,0,0
9060,parents,0,0
9061,",",0,0
9062,parents,0,0
9063,in,0,0
9064,intervention,0,0
9065,towns,0,0
9066,reported,0,0
9067,an,0,0
9068,increase,0,0
9069,in,0,0
9070,clinician,0,0
9071,sun,0,0
9072,protection,0,0
9073,advice,0,0
9074,.,0,0
9075,CONCLUSIONS,0,0
9076,The,0,0
9077,SunSafe,0,0
9078,primary,0,0
9079,care,0,0
9080,intervention,0,0
9081,increased,0,0
9082,sun,0,0
9083,protection,0,0
9084,counseling,0,0
9085,activities,0,0
9086,of,0,0
9087,participating,0,0
9088,clinicians,0,0
9089,.,0,0
9090,A,0,0
9091,single-focus,0,0
9092,preventive,0,1
9093,service,0,0
9094,office,0,0
9095,system,0,0
9096,is,0,0
9097,feasible,0,0
9098,to,0,0
9099,include,0,0
9100,in,0,0
9101,community,0,0
9102,interventions,0,0
9103,to,0,0
9104,promote,0,0
9105,sun,0,0
9106,protection,0,0
9107,.,0,0
9108,Treatment,0,1
9109,with,0,0
9110,metformin,1,1
9111,of,0,0
9112,non-diabetic,0,0
9113,men,0,0
9114,with,0,0
9115,hypertension,0,0
9116,",",0,0
9117,hypertriglyceridaemia,0,1
9118,and,0,0
9119,central,0,0
9120,fat,0,0
9121,distribution,0,0
9122,:,0,0
9123,the,0,0
9124,BIGPRO,0,0
9125,1.2,0,0
9126,trial,0,0
9127,.,0,0
9128,BACKGROUND,0,0
9129,In,0,0
9130,the,0,0
9131,BIGPRO,0,0
9132,1,0,0
9133,trial,0,0
9134,",",0,0
9135,one,0,0
9136,year,0,0
9137,of,0,0
9138,treatment,0,0
9139,with,0,0
9140,metformin,1,1
9141,in,0,0
9142,non-diabetic,0,0
9143,obese,0,0
9144,subjects,0,0
9145,with,0,0
9146,a,0,0
9147,central,0,0
9148,fat,0,0
9149,distribution,0,0
9150,had,0,0
9151,no,0,0
9152,significant,0,0
9153,effect,0,0
9154,on,0,0
9155,fasting,0,1
9156,plasma,0,1
9157,triglyceride,0,1
9158,concentration,0,1
9159,or,0,0
9160,on,0,0
9161,blood,0,0
9162,pressure,0,0
9163,despite,0,0
9164,a,0,0
9165,decrease,0,0
9166,in,0,0
9167,weight,0,0
9168,",",0,1
9169,fasting,0,1
9170,plasma,0,1
9171,insulin,0,1
9172,and,0,1
9173,glucose,0,1
9174,concentrations,0,1
9175,.,0,1
9176,To,0,0
9177,re-evaluate,0,0
9178,the,0,0
9179,effect,0,0
9180,of,0,0
9181,metformin,1,1
9182,on,0,1
9183,fasting,0,1
9184,triglyceride,0,1
9185,concentration,0,1
9186,and,0,0
9187,on,0,0
9188,blood,0,0
9189,pressure,0,0
9190,",",0,0
9191,the,0,0
9192,BIGPRO,0,0
9193,1.2,0,0
9194,trial,0,0
9195,included,0,0
9196,non-diabetic,0,0
9197,men,0,0
9198,(,0,0
9199,n=168,0,0
9200,),0,0
9201,with,0,0
9202,a,0,0
9203,fasting,0,1
9204,plasma,0,1
9205,triglyceride,0,1
9206,concentration,0,0
9207,>,0,0
9208,or,0,0
9209,=1.7,0,0
9210,and,0,0
9211,<,0,0
9212,or,0,0
9213,=6.5,0,0
9214,mmol/l,0,0
9215,",",0,0
9216,high,0,0
9217,blood,0,1
9218,pressure,0,1
9219,(,0,1
9220,systolic,0,0
9221,>,0,0
9222,or,0,0
9223,=140,0,0
9224,and,0,0
9225,<,0,0
9226,or,0,0
9227,=180,0,0
9228,and/or,0,0
9229,diastolic,0,0
9230,>,0,0
9231,or,0,0
9232,=90,0,0
9233,and,0,0
9234,<,0,0
9235,or,0,0
9236,=105,0,0
9237,mmHg,0,0
9238,",",0,0
9239,or,0,0
9240,treatment,0,0
9241,for,0,0
9242,hypertension,0,1
9243,),0,0
9244,and,0,0
9245,a,0,0
9246,waist-to-hip,0,1
9247,ratio,0,0
9248,>,0,0
9249,or,0,0
9250,=0.95,0,0
9251,.,0,0
9252,METHODS,0,0
9253,A,0,1
9254,randomised,0,1
9255,double-blind,0,1
9256,trial,0,1
9257,comparing,0,0
9258,metformin,1,1
9259,treatment,1,0
9260,(,1,0
9261,850,1,0
9262,mg,1,1
9263,bid,1,1
9264,),1,1
9265,with,1,1
9266,placebo,1,1
9267,.,1,1
9268,RESULTS,0,1
9269,Metformin,1,1
9270,had,0,0
9271,no,0,0
9272,significant,0,0
9273,effect,0,0
9274,either,0,0
9275,on,0,0
9276,blood,0,0
9277,pressure,0,0
9278,or,0,1
9279,plasma,0,1
9280,triglyceride,0,1
9281,concentration,0,0
9282,.,0,0
9283,In,0,0
9284,comparison,0,0
9285,with,0,0
9286,the,0,0
9287,placebo,1,1
9288,group,0,1
9289,",",0,1
9290,fasting,0,1
9291,plasma,0,1
9292,insulin,0,1
9293,(,0,0
9294,p,0,0
9295,<,0,0
9296,0.04,0,0
9297,),0,0
9298,",",0,0
9299,total,0,1
9300,cholesterol,0,1
9301,(,0,0
9302,p,0,0
9303,<,0,0
9304,0.05,0,0
9305,),0,0
9306,and,0,0
9307,Apo,0,1
9308,B,0,1
9309,(,0,0
9310,p,0,0
9311,<,0,0
9312,0.008,0,0
9313,),0,0
9314,concentrations,0,0
9315,decreased,0,0
9316,more,0,0
9317,in,0,0
9318,the,0,0
9319,metformin,0,1
9320,group,0,0
9321,in,0,0
9322,the,0,0
9323,BIGPRO,0,0
9324,1,0,0
9325,.,0,0
9326,2,0,0
9327,trial,0,0
9328,",",0,0
9329,confirming,0,0
9330,most,0,0
9331,of,0,0
9332,the,0,0
9333,previous,0,0
9334,results,0,0
9335,of,0,0
9336,the,0,0
9337,BIGPRO,0,0
9338,1,0,0
9339,trial,0,0
9340,.,0,0
9341,Tissue,0,0
9342,plasminogen,0,1
9343,activator,0,1
9344,antigen,0,0
9345,concentration,0,0
9346,decreased,0,0
9347,significantly,0,0
9348,(,0,0
9349,p,0,0
9350,<,0,0
9351,0.01,0,0
9352,),0,0
9353,only,0,0
9354,in,0,0
9355,the,0,0
9356,metformin,1,1
9357,group,0,0
9358,",",0,0
9359,but,0,0
9360,this,0,0
9361,was,0,0
9362,not,0,0
9363,significantly,0,0
9364,different,0,0
9365,from,0,0
9366,the,0,0
9367,placebo,1,1
9368,group,0,0
9369,(,0,0
9370,p,0,0
9371,<,0,0
9372,0.12,0,0
9373,),0,0
9374,;,0,0
9375,further,0,0
9376,",",0,0
9377,there,0,0
9378,were,0,0
9379,no,0,0
9380,significant,0,0
9381,differences,0,0
9382,in,0,0
9383,the,0,0
9384,change,0,0
9385,in,0,0
9386,plasminogen,0,1
9387,activator,0,1
9388,inhibitor,0,1
9389,1,0,1
9390,.,0,0
9391,CONCLUSIONS,0,0
9392,The,0,0
9393,consistency,0,0
9394,of,0,0
9395,the,0,0
9396,two,0,0
9397,BIGPRO,0,0
9398,trials,0,0
9399,supports,0,0
9400,the,0,0
9401,conclusion,0,0
9402,that,0,0
9403,metformin,1,1
9404,affects,0,0
9405,several,0,0
9406,cardiovascular,0,0
9407,risk,0,0
9408,factors,0,0
9409,favourably,0,0
9410,in,0,0
9411,non-diabetic,0,0
9412,subjects,0,0
9413,with,0,0
9414,a,0,0
9415,central,0,0
9416,fat,0,0
9417,distribution,0,0
9418,.,0,0
9419,Study,0,0
9420,of,0,0
9421,the,0,0
9422,vaginal,0,0
9423,tolerance,0,0
9424,to,0,0
9425,Acidform,1,0
9426,",",1,0
9427,an,1,0
9428,acid-buffering,1,1
9429,",",1,1
9430,bioadhesive,1,1
9431,gel,1,1
9432,.,1,1
9433,Vaginal,0,0
9434,tolerance,0,0
9435,tests,0,0
9436,were,0,0
9437,performed,0,0
9438,with,0,0
9439,a,0,0
9440,new,0,0
9441,potential,0,0
9442,microbicidal,0,1
9443,and,0,1
9444,spermicidal,0,1
9445,product,0,0
9446,",",0,0
9447,an,0,0
9448,acid-buffering,1,1
9449,vaginal,1,1
9450,gel,1,1
9451,(,1,1
9452,Acidform,1,1
9453,),1,1
9454,without,1,0
9455,or,1,0
9456,with,1,0
9457,nonoxynol-9,1,1
9458,(,1,1
9459,N-9,1,1
9460,),1,1
9461,.,1,0
9462,The,0,0
9463,potential,0,0
9464,advantages,0,0
9465,over,0,0
9466,other,0,0
9467,vaginal,0,0
9468,products,0,0
9469,include,0,0
9470,keeping,0,0
9471,a,0,0
9472,low,0,0
9473,pH,0,0
9474,",",0,0
9475,decrease,0,0
9476,of,0,0
9477,the,0,0
9478,irritating,0,0
9479,effect,0,0
9480,of,0,0
9481,N-9,1,0
9482,on,0,0
9483,the,0,0
9484,cervix,0,0
9485,or,0,0
9486,vaginal,0,0
9487,mucosa,0,0
9488,associated,0,0
9489,with,0,0
9490,greater,0,0
9491,retention,0,0
9492,of,0,0
9493,the,0,0
9494,product,0,0
9495,after,0,0
9496,application,0,0
9497,",",0,0
9498,and,0,0
9499,decreasing,0,0
9500,messiness,0,0
9501,as,0,0
9502,compared,0,0
9503,to,0,0
9504,other,0,0
9505,vaginal,0,0
9506,products,0,0
9507,.,0,0
9508,Three,0,0
9509,groups,0,0
9510,of,0,0
9511,six,0,0
9512,women,0,0
9513,were,0,0
9514,admitted,0,0
9515,and,0,0
9516,randomly,0,0
9517,assigned,0,0
9518,to,0,0
9519,use,0,0
9520,Acidform,1,0
9521,with,0,0
9522,0,0,0
9523,%,0,0
9524,",",0,0
9525,2.5,0,0
9526,%,0,0
9527,",",0,0
9528,and,0,0
9529,5,0,0
9530,%,0,0
9531,N-9,1,0
9532,.,1,0
9533,Colposcopic,0,0
9534,evaluation,0,0
9535,for,0,0
9536,vulvar,0,0
9537,",",0,0
9538,vaginal,0,0
9539,",",0,0
9540,and,0,0
9541,cervical,0,0
9542,signs,0,0
9543,of,0,0
9544,irritation,0,0
9545,was,0,0
9546,performed,0,0
9547,and,0,0
9548,photographs,0,0
9549,were,0,0
9550,taken,0,0
9551,",",0,0
9552,following,0,0
9553,a,0,0
9554,specific,0,0
9555,World,0,0
9556,Health,0,1
9557,Organization,0,0
9558,protocol,0,0
9559,",",0,0
9560,at,0,0
9561,time,0,0
9562,0,0,0
9563,",",0,0
9564,and,0,0
9565,after,0,0
9566,24,0,0
9567,h,0,0
9568,and,0,0
9569,6,0,0
9570,days,0,0
9571,of,0,0
9572,application,0,0
9573,of,0,0
9574,the,0,0
9575,gel,0,1
9576,.,0,1
9577,No,0,1
9578,irritation,0,1
9579,or,0,0
9580,symptom,0,0
9581,was,0,0
9582,reported,0,0
9583,by,0,0
9584,users,0,0
9585,of,0,0
9586,Acidform,1,0
9587,without,1,0
9588,N-9,1,0
9589,.,1,0
9590,A,0,0
9591,generalized,0,0
9592,and,0,0
9593,intense,0,0
9594,erythema,0,0
9595,in,0,0
9596,cervix,0,0
9597,was,0,0
9598,observed,0,0
9599,in,0,0
9600,10,0,0
9601,of,0,0
9602,12,0,0
9603,Acidform/N-9,1,0
9604,users,0,1
9605,and,0,0
9606,abrasion,0,0
9607,occurred,0,0
9608,in,0,0
9609,nine,0,0
9610,of,0,0
9611,them,0,0
9612,.,0,0
9613,Vulvar,0,0
9614,irritation,0,0
9615,was,0,0
9616,seen,0,0
9617,in,0,0
9618,seven,0,0
9619,of,0,0
9620,these,0,0
9621,10,0,0
9622,volunteers,0,0
9623,.,0,0
9624,N-9,0,0
9625,concentration,0,0
9626,in,0,0
9627,the,0,0
9628,gel,0,1
9629,(,0,0
9630,2.5,0,0
9631,%,0,0
9632,or,0,0
9633,5.0,0,0
9634,%,0,0
9635,),0,0
9636,was,0,0
9637,not,0,0
9638,related,0,0
9639,to,0,0
9640,the,0,0
9641,findings,0,0
9642,.,0,0
9643,No,0,1
9644,ulcer,0,1
9645,",",0,0
9646,exulceration,0,0
9647,",",0,0
9648,or,0,0
9649,de-epithelialization,0,0
9650,was,0,0
9651,observed,0,0
9652,.,0,0
9653,Acidform,1,0
9654,without,1,0
9655,N-9,1,0
9656,was,0,0
9657,well,0,0
9658,tolerated,0,1
9659,by,0,0
9660,volunteers,0,0
9661,",",0,0
9662,but,0,0
9663,it,0,0
9664,was,0,0
9665,unable,0,0
9666,to,0,0
9667,protect,0,0
9668,the,0,0
9669,cervix,0,0
9670,",",0,0
9671,vagina,0,0
9672,",",0,0
9673,and,0,0
9674,vulva,0,0
9675,from,0,0
9676,the,0,0
9677,N-9,0,0
9678,effects,0,0
9679,.,0,0
9680,Growth,0,1
9681,hormone,0,1
9682,(,0,1
9683,GH,0,1
9684,),0,0
9685,responses,0,0
9686,to,0,1
9687,GH-releasing,1,1
9688,hormone,1,1
9689,alone,1,0
9690,or,0,0
9691,combined,1,0
9692,with,1,0
9693,arginine,1,0
9694,in,0,0
9695,patients,0,0
9696,with,0,0
9697,adrenal,0,1
9698,incidentaloma,0,1
9699,:,0,0
9700,evidence,0,0
9701,for,0,0
9702,enhanced,0,0
9703,somatostatinergic,0,1
9704,tone,0,1
9705,.,0,0
9706,Spontaneous,0,0
9707,and,0,0
9708,stimulated,0,0
9709,GH,0,0
9710,secretion,0,0
9711,is,0,0
9712,blunted,0,0
9713,in,0,0
9714,hypercortisolemic,0,1
9715,states,0,0
9716,due,0,0
9717,to,0,0
9718,increased,0,0
9719,hypothalamic,0,1
9720,somatostatinergic,0,1
9721,tone,0,1
9722,.,0,0
9723,However,0,0
9724,",",0,0
9725,no,0,0
9726,data,0,0
9727,are,0,0
9728,available,0,0
9729,on,0,0
9730,the,0,0
9731,characteristics,0,0
9732,of,0,0
9733,GH,0,0
9734,secretion,0,0
9735,in,0,0
9736,patients,0,0
9737,with,0,0
9738,incidentally,0,0
9739,discovered,0,0
9740,adrenal,0,1
9741,adenomas,0,1
9742,.,0,0
9743,They,0,0
9744,represent,0,0
9745,an,0,0
9746,interesting,0,0
9747,model,0,0
9748,for,0,0
9749,studying,0,0
9750,GH,0,0
9751,secretion,0,0
9752,",",0,0
9753,as,0,0
9754,a,0,0
9755,slight,0,0
9756,degree,0,0
9757,of,0,0
9758,cortisol,0,1
9759,excess,0,0
9760,may,0,0
9761,frequently,0,0
9762,be,0,0
9763,observed,0,0
9764,in,0,0
9765,such,0,0
9766,patients,0,0
9767,who,0,0
9768,do,0,0
9769,not,0,0
9770,present,0,0
9771,with,0,0
9772,any,0,0
9773,clear,0,0
9774,Cushingoid,0,0
9775,sign,0,0
9776,.,0,0
9777,In,0,0
9778,the,0,0
9779,present,0,0
9780,study,0,0
9781,",",0,0
9782,10,0,0
9783,patients,0,0
9784,(,0,0
9785,3,0,0
9786,men,0,0
9787,and,0,0
9788,7,0,0
9789,women,0,0
9790,",",0,0
9791,aged,0,0
9792,48-63,0,0
9793,yr,0,0
9794,),0,0
9795,with,0,0
9796,an,0,0
9797,adrenal,0,0
9798,mass,0,0
9799,discovered,0,0
9800,serendipitously,0,0
9801,underwent,0,0
9802,",",0,0
9803,on,0,0
9804,separate,0,0
9805,occasions,0,0
9806,",",0,0
9807,a,0,0
9808,GHRH,1,1
9809,injection,1,1
9810,alone,1,0
9811,or,0,0
9812,combined,1,0
9813,with,1,0
9814,an,1,0
9815,infusion,1,1
9816,of,1,0
9817,the,1,0
9818,functional,1,0
9819,somatostatin,1,1
9820,antagonist,1,1
9821,",",1,1
9822,arginine,1,1
9823,.,1,0
9824,Thirteen,0,0
9825,age-matched,0,0
9826,healthy,0,0
9827,volunteers,0,0
9828,served,0,0
9829,as,0,0
9830,controls,1,0
9831,.,1,0
9832,Briefly,0,0
9833,",",0,0
9834,arginine,1,1
9835,(,1,1
9836,30,1,1
9837,g,1,0
9838,),1,1
9839,was,1,0
9840,infused,1,1
9841,from,1,0
9842,-30,1,0
9843,to,1,0
9844,0,1,0
9845,min,1,0
9846,",",1,0
9847,and,1,0
9848,GHRH,1,1
9849,(,1,1
9850,100,1,1
9851,microg,1,1
9852,),1,1
9853,was,1,0
9854,injected,1,0
9855,as,1,0
9856,a,1,0
9857,bolus,1,1
9858,at,1,1
9859,0,1,0
9860,min,1,0
9861,",",0,0
9862,with,0,0
9863,measurement,0,0
9864,of,0,0
9865,serum,1,1
9866,GH,1,1
9867,[,1,1
9868,immunoradiometric,1,1
9869,assay,1,1
9870,(,1,1
9871,IRMA,1,1
9872,),1,1
9873,],1,1
9874,every,0,1
9875,15,0,0
9876,min,0,0
9877,for,0,0
9878,150,0,0
9879,min,0,0
9880,.,0,0
9881,Plasma,1,1
9882,IGF-I,1,1
9883,(,1,1
9884,RIA,1,1
9885,after,1,0
9886,acid-ethanol,1,1
9887,extraction,1,0
9888,),1,0
9889,was,0,0
9890,measured,0,0
9891,in,0,0
9892,a,0,0
9893,morning,0,0
9894,sample,0,0
9895,.,0,0
9896,The,0,0
9897,diagnosis,0,0
9898,of,0,0
9899,cortical,0,0
9900,adenoma,0,0
9901,was,0,0
9902,based,0,0
9903,on,0,0
9904,computed,0,0
9905,tomography,0,0
9906,features,0,0
9907,and,0,0
9908,pattern,0,0
9909,of,0,0
9910,uptake,0,0
9911,on,0,0
9912,adrenal,0,0
9913,scintigraphy,0,0
9914,.,0,0
9915,Patients,0,0
9916,with,0,0
9917,obesity,0,0
9918,and/or,0,0
9919,diabetes,0,0
9920,were,0,0
9921,excluded,0,0
9922,.,0,0
9923,The,0,0
9924,study,0,0
9925,design,0,0
9926,included,0,0
9927,also,0,0
9928,an,0,0
9929,endocrine,0,0
9930,work-up,0,0
9931,aimed,0,0
9932,to,0,0
9933,study,0,0
9934,the,0,0
9935,hypothalamic-pituitary-adrenal,0,0
9936,axis,0,1
9937,[,0,0
9938,urinary,0,1
9939,free,0,1
9940,cortisol,0,1
9941,(,0,1
9942,UFC,0,1
9943,),0,1
9944,excretion,0,1
9945,",",0,1
9946,serum,0,1
9947,cortisol,0,1
9948,at,0,1
9949,0800,0,1
9950,h,0,1
9951,",",0,0
9952,plasma,0,1
9953,ACTH,0,1
9954,at,0,1
9955,0800,0,1
9956,h,0,1
9957,",",0,0
9958,morning,0,1
9959,cortisol,0,1
9960,after,0,1
9961,overnight,0,1
9962,1,0,1
9963,mg,0,1
9964,dexamethasone,0,1
9965,],0,1
9966,.,0,0
9967,Five,0,0
9968,of,0,0
9969,10,0,0
9970,patients,0,0
9971,showed,0,0
9972,abnormalities,0,0
9973,of,0,0
9974,the,0,0
9975,hypothalamic-pituitary-adrenal,0,0
9976,axis,0,0
9977,",",0,0
9978,including,0,0
9979,borderline,0,0
9980,or,0,0
9981,increased,0,0
9982,UFC,0,1
9983,excretion,0,1
9984,in,0,0
9985,4,0,0
9986,of,0,0
9987,them,0,0
9988,accompanied,0,0
9989,by,0,0
9990,blunted,0,0
9991,ACTH,0,0
9992,in,0,0
9993,2,0,0
9994,cases,0,0
9995,and,0,0
9996,failure,0,0
9997,of,0,0
9998,cortisol,0,1
9999,to,0,0
10000,suppress,0,0
10001,after,0,0
10002,dexamethasone,0,1
10003,in,0,0
10004,1,0,1
10005,;,0,0
10006,the,0,0
10007,fifth,0,0
10008,patient,0,0
10009,displayed,0,0
10010,low,0,0
10011,ACTH,0,0
10012,and,0,0
10013,resistance,0,0
10014,to,0,0
10015,dexamethasone,0,1
10016,suppression,0,0
10017,.,0,0
10018,However,0,0
10019,",",0,0
10020,all,0,0
10021,patients,0,0
10022,had,0,0
10023,a,0,0
10024,unilateral,0,0
10025,uptake,0,0
10026,of,0,0
10027,the,0,0
10028,tracer,0,0
10029,on,0,0
10030,the,0,0
10031,side,0,0
10032,of,0,0
10033,the,0,0
10034,mass,0,0
10035,with,0,0
10036,suppression,0,0
10037,of,0,0
10038,the,0,0
10039,contralateral,0,0
10040,normal,0,0
10041,adrenal,0,0
10042,gland,0,0
10043,.,0,0
10044,As,0,0
10045,a,0,0
10046,group,0,0
10047,",",0,0
10048,the,0,0
10049,patients,0,0
10050,displayed,0,0
10051,greater,0,0
10052,UFC,0,1
10053,excretion,0,1
10054,and,0,0
10055,lower,0,0
10056,ACTH,0,1
10057,concentrations,0,1
10058,than,0,0
10059,the,0,0
10060,controls,0,0
10061,.,0,0
10062,GH,0,1
10063,release,0,0
10064,after,0,0
10065,GHRH,1,0
10066,treatment,1,0
10067,was,0,0
10068,blunted,0,0
10069,in,0,0
10070,patients,0,0
10071,bearing,0,0
10072,adrenal,0,1
10073,incidentaloma,0,0
10074,compared,0,0
10075,with,0,0
10076,controls,0,0
10077,(,0,0
10078,GH,0,1
10079,peak,0,0
10080,",",0,0
10081,5.7,0,0
10082,+/-,0,0
10083,5.2,0,0
10084,vs.,0,0
10085,18.0,0,0
10086,+/-,0,0
10087,7.0,0,0
10088,microg/L,0,0
10089,;,0,0
10090,P,0,0
10091,<,0,0
10092,0.0001,0,0
10093,),0,0
10094,",",0,0
10095,whereas,0,0
10096,GHRH,1,0
10097,plus,1,0
10098,arginine,1,0
10099,was,0,0
10100,able,0,0
10101,to,0,0
10102,elicit,0,0
10103,a,0,0
10104,comparable,0,0
10105,response,0,0
10106,in,0,0
10107,the,0,0
10108,2,0,0
10109,groups,0,0
10110,(,0,0
10111,GH,0,1
10112,peak,0,0
10113,",",0,0
10114,33.5,0,0
10115,+/-,0,0
10116,20.3,0,0
10117,vs.,0,0
10118,33.7,0,0
10119,+/-,0,0
10120,17.5,0,0
10121,microg/L,0,0
10122,;,0,0
10123,P,0,0
10124,=,0,0
10125,NS,0,0
10126,),0,0
10127,.,0,0
10128,The,0,0
10129,ratio,0,0
10130,between,0,0
10131,GH,0,0
10132,peaks,0,0
10133,after,0,0
10134,GHRH,1,0
10135,plus,1,0
10136,arginine,1,0
10137,and,0,0
10138,after,0,0
10139,GHRH,1,0
10140,plus,1,0
10141,saline,1,1
10142,was,0,0
10143,significantly,0,0
10144,greater,0,0
10145,in,0,0
10146,patients,0,0
10147,than,0,0
10148,in,0,0
10149,controls,0,0
10150,(,0,0
10151,751,0,0
10152,+/-,0,0
10153,531,0,0
10154,%,0,0
10155,vs.,0,0
10156,81,0,0
10157,+/-,0,0
10158,45,0,0
10159,%,0,0
10160,;,0,0
10161,P,0,0
10162,=,0,0
10163,0.0001,0,0
10164,),0,0
10165,.,0,0
10166,Similar,0,0
10167,data,0,0
10168,were,0,0
10169,obtained,0,0
10170,when,0,0
10171,comparing,0,0
10172,GH,0,0
10173,area,0,0
10174,under,0,0
10175,the,0,0
10176,curve,0,0
10177,after,0,0
10178,GHRH,0,0
10179,plus,0,0
10180,saline,0,1
10181,or,0,0
10182,GHRH,0,1
10183,plus,0,0
10184,arginine,0,0
10185,between,0,0
10186,the,0,0
10187,2,0,0
10188,groups,0,0
10189,.,0,0
10190,In,0,0
10191,summary,0,0
10192,",",0,0
10193,the,0,0
10194,present,0,0
10195,data,0,0
10196,suggest,0,0
10197,that,0,0
10198,in,0,0
10199,patients,0,0
10200,with,0,0
10201,incidental,0,1
10202,adrenal,0,1
10203,adenomas,0,1
10204,the,0,0
10205,GH,0,0
10206,response,0,0
10207,to,0,0
10208,GHRH,0,0
10209,is,0,0
10210,blunted,0,0
10211,due,0,0
10212,to,0,0
10213,increased,0,0
10214,somatostatinergic,0,1
10215,tone,0,1
10216,",",0,0
10217,as,0,0
10218,it,0,0
10219,can,0,0
10220,be,0,0
10221,restored,0,0
10222,to,0,0
10223,normal,0,0
10224,by,0,0
10225,pretreatment,0,0
10226,with,0,0
10227,the,0,0
10228,functional,0,0
10229,somatostatin,0,1
10230,antagonist,0,1
10231,arginine,0,1
10232,.,0,1
10233,The,0,0
10234,blunted,0,0
10235,GH,0,0
10236,release,0,0
10237,to,0,0
10238,GHRH,0,0
10239,may,0,0
10240,be,0,0
10241,an,0,0
10242,early,0,0
10243,and,0,0
10244,long,0,0
10245,lasting,0,0
10246,sign,0,0
10247,of,0,0
10248,autonomous,0,0
10249,cortisol,0,1
10250,secretion,0,0
10251,by,0,0
10252,the,0,0
10253,adrenal,0,1
10254,adenoma,0,1
10255,.,0,0
10256,Comparison,0,0
10257,of,0,0
10258,different,0,0
10259,long-term,0,0
10260,asthma,0,0
10261,treatments,0,0
10262,in,0,0
10263,subjects,0,0
10264,with,0,0
10265,mild-to-moderate,0,0
10266,asthma,0,0
10267,.,0,0
10268,In,0,0
10269,order,0,0
10270,to,0,0
10271,compare,0,0
10272,the,0,0
10273,efficacy,0,0
10274,of,0,0
10275,different,0,0
10276,asthma,0,0
10277,treatment,0,0
10278,in,0,0
10279,subjects,0,0
10280,with,0,0
10281,mild-to-moderate,0,0
10282,asthma,0,0
10283,",",0,0
10284,three,0,0
10285,groups,0,0
10286,of,0,0
10287,11,0,0
10288,patients,0,0
10289,were,0,0
10290,treated,0,0
10291,with,0,0
10292,nedocromil,1,1
10293,sodium,1,1
10294,(,1,1
10295,NS,1,1
10296,),1,1
10297,",",1,1
10298,beclomethasone,1,1
10299,dipropionate,1,1
10300,(,1,1
10301,BDP,1,1
10302,),1,1
10303,and,1,1
10304,beclomethasone,1,1
10305,dipropionate,1,1
10306,plus,1,1
10307,salmeterol,1,1
10308,(,1,1
10309,BDP,1,1
10310,+,1,1
10311,S,1,1
10312,),1,0
10313,in,0,0
10314,an,0,0
10315,open,0,0
10316,",",0,0
10317,randomized,0,0
10318,study,0,0
10319,.,0,0
10320,Symptom,0,0
10321,score,0,0
10322,",",0,0
10323,peak,0,0
10324,expiratory,0,0
10325,flow,0,0
10326,(,0,1
10327,PEF,0,1
10328,),0,0
10329,maximal,0,0
10330,amplitude,0,0
10331,",",0,0
10332,forced,0,0
10333,expiratory,0,0
10334,volume,0,0
10335,in,0,0
10336,one,0,0
10337,second,0,0
10338,(,0,0
10339,FEV1,0,1
10340,),0,1
10341,",",0,0
10342,and,0,1
10343,methacholine,0,1
10344,reactivity,0,0
10345,were,0,0
10346,measured,0,0
10347,at,0,0
10348,the,0,0
10349,baseline,0,0
10350,and,0,0
10351,at,0,0
10352,intervals,0,0
10353,of,0,0
10354,3,0,0
10355,months,0,0
10356,up,0,0
10357,to,0,0
10358,12,0,0
10359,months,0,0
10360,.,0,0
10361,After,0,0
10362,3,0,0
10363,months,0,0
10364,",",0,0
10365,symptoms,0,0
10366,reduced,0,0
10367,significantly,0,0
10368,in,0,0
10369,all,0,0
10370,treatment,0,0
10371,groups,0,0
10372,",",0,0
10373,while,0,0
10374,PEF,0,0
10375,variability,0,0
10376,improved,0,0
10377,in,0,0
10378,BDP,0,0
10379,and,0,0
10380,BDP,0,1
10381,+,0,1
10382,S,0,1
10383,groups,0,1
10384,;,0,0
10385,FEV1,0,1
10386,and,0,0
10387,bronchial,0,0
10388,responsiveness,0,0
10389,to,0,0
10390,methacholine,0,1
10391,were,0,0
10392,significantly,0,0
10393,improved,0,0
10394,in,0,0
10395,comparison,0,0
10396,with,0,0
10397,baseline,0,0
10398,value,0,0
10399,in,0,0
10400,the,0,0
10401,BDP,0,1
10402,+,0,1
10403,S,0,1
10404,group,0,0
10405,only,0,0
10406,.,0,0
10407,No,0,0
10408,significant,0,0
10409,difference,0,0
10410,was,0,0
10411,observed,0,0
10412,after,0,0
10413,6,0,0
10414,and,0,0
10415,12,0,0
10416,months,0,0
10417,of,0,0
10418,treatment,0,0
10419,in,0,0
10420,PEF,0,0
10421,variability,0,0
10422,",",0,0
10423,FEV1,0,0
10424,or,0,0
10425,bronchial,0,0
10426,hyperreactivity,0,0
10427,in,0,0
10428,the,0,0
10429,NS,0,0
10430,group,0,0
10431,compared,0,0
10432,with,0,0
10433,baseline,0,0
10434,values,0,0
10435,",",0,0
10436,while,0,0
10437,a,0,0
10438,significant,0,0
10439,difference,0,0
10440,was,0,0
10441,observed,0,0
10442,in,0,0
10443,symptom,0,0
10444,score,0,0
10445,.,0,0
10446,BDP,0,0
10447,group,0,0
10448,showed,0,0
10449,a,0,0
10450,significant,0,0
10451,improvement,0,0
10452,in,0,0
10453,FEV1,0,0
10454,and,0,0
10455,bronchial,0,0
10456,reactivity,0,0
10457,to,0,0
10458,methacholine,0,1
10459,after,0,0
10460,6,0,0
10461,and,0,0
10462,12,0,0
10463,months,0,0
10464,of,0,0
10465,treatment,0,0
10466,.,0,0
10467,In,0,0
10468,the,0,0
10469,BDP,0,1
10470,+,0,1
10471,S,0,1
10472,group,0,0
10473,",",0,0
10474,the,0,0
10475,improvement,0,0
10476,in,0,0
10477,symptoms,0,0
10478,and,0,0
10479,pulmonary,0,0
10480,function,0,0
10481,persisted,0,0
10482,until,0,0
10483,the,0,0
10484,end,0,0
10485,of,0,0
10486,the,0,0
10487,study,0,0
10488,.,0,0
10489,In,0,0
10490,conclusion,0,0
10491,",",0,0
10492,the,0,0
10493,combination,0,0
10494,of,0,0
10495,beclomethasone,0,1
10496,dipropionate,0,1
10497,and,0,1
10498,salmeterol,0,1
10499,improved,0,0
10500,pulmonary,0,0
10501,function,0,0
10502,and,0,0
10503,bronchial,0,0
10504,reactivity,0,0
10505,earlier,0,0
10506,than,0,1
10507,beclomethasone,0,1
10508,dipropionate,0,1
10509,alone,0,0
10510,",",0,0
10511,while,0,0
10512,nedocromil,0,1
10513,sodium,0,1
10514,improved,0,1
10515,symptoms,0,0
10516,but,0,0
10517,not,0,0
10518,pulmonary,0,0
10519,function,0,0
10520,.,0,0
10521,Assuming,0,0
10522,that,0,0
10523,bronchial,0,0
10524,reactivity,0,0
10525,could,0,0
10526,be,0,0
10527,an,0,0
10528,indirect,0,0
10529,measurement,0,0
10530,of,0,0
10531,airway,0,0
10532,inflammation,0,0
10533,",",0,0
10534,overtreatment,0,0
10535,of,0,0
10536,asthma,0,0
10537,in,0,0
10538,relationship,0,0
10539,with,0,0
10540,the,0,0
10541,classification,0,0
10542,of,0,0
10543,asthma,0,0
10544,severity,0,0
10545,of,0,0
10546,the,0,0
10547,International,0,0
10548,Guidelines,0,0
10549,could,0,0
10550,improve,0,0
10551,both,0,0
10552,airway,0,0
10553,inflammation,0,0
10554,and,0,0
10555,the,0,0
10556,prognosis,0,0
10557,of,0,0
10558,airway,0,0
10559,obstruction,0,0
10560,.,0,0
10561,Antisaccade,0,0
10562,and,0,0
10563,smooth,0,0
10564,pursuit,0,0
10565,eye,0,0
10566,movements,0,0
10567,in,0,0
10568,healthy,0,0
10569,subjects,0,0
10570,receiving,0,0
10571,sertraline,1,1
10572,and,0,1
10573,lorazepam,1,1
10574,.,1,1
10575,Patients,0,0
10576,suffering,0,0
10577,from,0,0
10578,some,0,0
10579,psychiatric,0,0
10580,and,0,0
10581,neurological,0,0
10582,disorders,0,0
10583,demonstrate,0,0
10584,abnormally,0,0
10585,high,0,0
10586,levels,0,0
10587,of,0,0
10588,saccadic,0,0
10589,distractibility,0,0
10590,when,0,0
10591,carrying,0,0
10592,out,0,0
10593,the,0,0
10594,antisaccade,0,0
10595,task,0,0
10596,.,0,0
10597,This,0,0
10598,has,0,0
10599,been,0,0
10600,particularly,0,0
10601,thoroughly,0,0
10602,demonstrated,0,0
10603,in,0,0
10604,patients,0,0
10605,with,0,0
10606,schizophrenia,0,0
10607,.,0,0
10608,A,0,0
10609,large,0,0
10610,body,0,0
10611,of,0,0
10612,evidence,0,0
10613,has,0,0
10614,been,0,0
10615,accumulated,0,0
10616,from,0,0
10617,studies,0,0
10618,of,0,0
10619,patients,0,0
10620,which,0,0
10621,suggests,0,0
10622,that,0,0
10623,such,0,0
10624,eye,0,0
10625,movement,0,0
10626,abnormalities,0,0
10627,may,0,0
10628,arise,0,0
10629,from,0,0
10630,frontal,0,0
10631,lobe,0,0
10632,dysfunction,0,0
10633,.,0,0
10634,The,0,0
10635,psychopharmacology,0,0
10636,of,0,0
10637,saccadic,0,0
10638,distractibility,0,0
10639,is,0,0
10640,less,0,0
10641,well,0,0
10642,understood,0,0
10643,",",0,0
10644,but,0,0
10645,is,0,0
10646,relevant,0,0
10647,both,0,0
10648,to,0,0
10649,interpreting,0,0
10650,patient,0,0
10651,studies,0,0
10652,and,0,0
10653,to,0,0
10654,establishing,0,0
10655,the,0,0
10656,neurological,0,0
10657,basis,0,0
10658,of,0,0
10659,their,0,0
10660,findings,0,0
10661,.,0,0
10662,Twenty,0,0
10663,healthy,0,0
10664,subjects,0,0
10665,received,0,0
10666,lorazepam,1,1
10667,0.5,1,1
10668,mg,1,1
10669,",",1,1
10670,1,1,1
10671,mg,1,1
10672,and,1,1
10673,2,1,1
10674,mg,1,1
10675,",",1,1
10676,sertraline,1,1
10677,50,1,1
10678,mg,1,1
10679,and,1,1
10680,placebo,1,1
10681,in,0,0
10682,a,0,0
10683,balanced,0,0
10684,",",0,0
10685,repeated,0,0
10686,measures,0,0
10687,study,0,0
10688,design,0,0
10689,.,0,0
10690,Antisaccade,0,0
10691,",",0,0
10692,no-saccade,0,0
10693,",",0,0
10694,visually,0,0
10695,guided,0,0
10696,saccade,0,0
10697,and,0,0
10698,smooth,0,0
10699,pursuit,0,0
10700,tasks,0,0
10701,were,0,0
10702,carried,0,0
10703,out,0,0
10704,and,0,0
10705,the,0,0
10706,effects,0,0
10707,of,0,0
10708,practice,0,0
10709,and,0,0
10710,drugs,0,1
10711,measured,0,1
10712,.,0,1
10713,Lorazepam,1,1
10714,increased,0,0
10715,direction,0,0
10716,errors,0,0
10717,in,0,0
10718,the,0,0
10719,antisaccade,0,0
10720,and,0,0
10721,no-saccade,0,0
10722,tasks,0,0
10723,in,0,0
10724,a,0,0
10725,dose-dependent,0,0
10726,manner,0,0
10727,.,0,0
10728,Sertraline,1,1
10729,had,0,0
10730,no,0,0
10731,effect,0,0
10732,on,0,0
10733,these,0,0
10734,measures,0,0
10735,.,0,0
10736,Correlation,0,0
10737,showed,0,0
10738,a,0,0
10739,statistically,0,0
10740,significant,0,0
10741,",",0,0
10742,but,0,0
10743,rather,0,0
10744,weak,0,0
10745,",",0,0
10746,association,0,0
10747,between,0,0
10748,direction,0,0
10749,errors,0,0
10750,and,0,0
10751,smooth,0,0
10752,pursuit,0,0
10753,measures,0,0
10754,.,0,0
10755,Practice,0,0
10756,was,0,0
10757,shown,0,0
10758,to,0,0
10759,have,0,0
10760,a,0,0
10761,powerful,0,0
10762,effect,0,0
10763,on,0,0
10764,antisaccade,0,0
10765,direction,0,0
10766,errors,0,0
10767,.,0,0
10768,This,0,0
10769,study,0,0
10770,supports,0,0
10771,our,0,0
10772,previous,0,0
10773,work,0,0
10774,by,0,0
10775,confirming,0,0
10776,that,0,0
10777,lorazepam,1,1
10778,reliably,0,0
10779,worsens,0,1
10780,saccadic,0,0
10781,distractibility,0,0
10782,",",0,0
10783,in,0,0
10784,contrast,0,0
10785,to,0,0
10786,other,0,0
10787,psychotropic,0,1
10788,drugs,0,1
10789,such,0,1
10790,as,0,0
10791,sertraline,1,1
10792,and,0,1
10793,chlorpromazine,0,1
10794,.,0,1
10795,Our,0,0
10796,results,0,0
10797,also,0,0
10798,suggest,0,0
10799,that,0,0
10800,other,0,0
10801,studies,0,0
10802,in,0,0
10803,this,0,0
10804,field,0,0
10805,",",0,0
10806,particularly,0,0
10807,those,0,0
10808,using,0,0
10809,parallel,0,0
10810,groups,0,0
10811,design,0,0
10812,",",0,0
10813,should,0,0
10814,take,0,0
10815,account,0,0
10816,of,0,0
10817,practice,0,0
10818,effects,0,0
10819,.,0,0
10820,Ropivacaine-clonidine,1,1
10821,combination,1,1
10822,for,0,0
10823,caudal,0,1
10824,blockade,0,1
10825,in,0,0
10826,children,0,0
10827,.,0,0
10828,BACKGROUND,0,0
10829,Adding,0,0
10830,clonidine,1,1
10831,to,0,0
10832,weak,1,0
10833,ropivacaine,1,1
10834,solutions,1,0
10835,(,0,0
10836,<,0,0
10837,0.2,0,0
10838,%,0,0
10839,),0,0
10840,could,0,0
10841,potentially,0,0
10842,enhance,0,0
10843,analgesia,0,1
10844,as,0,0
10845,well,0,0
10846,as,0,0
10847,further,0,0
10848,reduce,0,0
10849,the,0,0
10850,risk,0,0
10851,for,0,0
10852,unwanted,0,0
10853,motor,0,0
10854,blockade,0,1
10855,.,0,1
10856,The,0,0
10857,aim,0,0
10858,of,0,0
10859,the,0,0
10860,present,0,0
10861,study,0,0
10862,was,0,0
10863,to,0,0
10864,compare,0,0
10865,the,0,0
10866,postoperative,0,1
10867,pain-relieving,0,1
10868,quality,0,1
10869,of,0,0
10870,a,0,0
10871,ropivacaine,1,0
10872,0.1,1,0
10873,%,1,0
10874,-clonidine,1,0
10875,mixture,1,0
10876,to,0,0
10877,that,0,0
10878,of,0,0
10879,plain,1,0
10880,ropivacaine,1,0
10881,0.2,0,0
10882,%,0,0
10883,following,0,0
10884,caudal,0,0
10885,administration,0,1
10886,in,0,0
10887,children,0,0
10888,.,0,0
10889,METHODS,0,0
10890,In,0,0
10891,a,0,0
10892,prospective,0,0
10893,",",0,0
10894,observer-blinded,0,0
10895,fashion,0,0
10896,",",0,0
10897,40,0,0
10898,ASA,0,0
10899,1,0,0
10900,paediatric,0,0
10901,patients,0,0
10902,undergoing,0,0
10903,subumbilical,0,0
10904,surgery,0,0
10905,were,0,0
10906,randomly,1,0
10907,allocated,1,0
10908,to,1,0
10909,receive,1,0
10910,a,1,0
10911,caudal,1,1
10912,injection,1,1
10913,of,1,0
10914,either,1,0
10915,plain,1,0
10916,ropivacaine,1,0
10917,0.2,1,0
10918,%,1,0
10919,(,1,0
10920,1,1,0
10921,ml/kg,1,1
10922,),1,1
10923,(,1,1
10924,R0.2,1,0
10925,),1,0
10926,or,1,0
10927,a,1,0
10928,mixture,1,0
10929,of,1,0
10930,ropivacaine,1,0
10931,0.1,1,0
10932,%,1,0
10933,with,1,0
10934,clonidine,1,1
10935,2,1,1
10936,microg/kg,1,1
10937,(,1,1
10938,1,1,1
10939,ml/kg,1,1
10940,),1,1
10941,(,1,1
10942,R0.1C,1,1
10943,),1,1
10944,.,0,0
10945,Objective,1,0
10946,pain,1,0
10947,scale,1,0
10948,score,1,0
10949,and,1,0
10950,need,1,0
10951,for,1,0
10952,supplemental,1,0
10953,analgesia,1,1
10954,were,1,0
10955,used,1,0
10956,to,1,0
10957,evaluate,1,0
10958,analgesia,1,1
10959,during,1,0
10960,the,1,0
10961,first,1,0
10962,24,1,0
10963,h,1,0
10964,postoperatively,1,0
10965,.,1,0
10966,Residual,1,0
10967,postoperative,1,0
10968,sedation,1,0
10969,was,1,0
10970,also,1,0
10971,assessed,1,0
10972,.,1,0
10973,RESULTS,0,0
10974,A,0,0
10975,significantly,0,0
10976,higher,0,0
10977,number,0,0
10978,of,0,0
10979,patients,0,0
10980,in,0,0
10981,the,0,0
10982,R0.1C,0,1
10983,group,0,0
10984,(,0,0
10985,18/20,0,0
10986,),0,0
10987,could,0,0
10988,be,0,0
10989,managed,0,0
10990,without,0,0
10991,supplemental,0,0
10992,analgesia,0,1
10993,during,0,0
10994,the,0,0
10995,first,0,0
10996,24,0,0
10997,h,0,0
10998,postoperatively,0,0
10999,compared,0,0
11000,to,0,0
11001,the,0,0
11002,R0.2,0,0
11003,group,0,0
11004,(,0,0
11005,11/20,0,0
11006,),0,0
11007,(,0,0
11008,P=0.034,0,0
11009,),0,0
11010,.,0,0
11011,Both,0,0
11012,the,0,0
11013,degree,0,0
11014,and,0,0
11015,the,0,0
11016,duration,0,0
11017,of,0,0
11018,postoperative,0,0
11019,sedation,0,0
11020,was,0,0
11021,similar,0,0
11022,in,0,0
11023,both,0,0
11024,groups,0,0
11025,.,0,0
11026,No,0,1
11027,signs,0,0
11028,of,0,0
11029,postoperative,0,1
11030,motor,0,1
11031,blockade,0,1
11032,were,0,0
11033,observed,0,0
11034,.,0,0
11035,CONCLUSIONS,0,0
11036,The,0,0
11037,combination,0,0
11038,of,0,0
11039,clonidine,1,1
11040,(,1,1
11041,2,1,1
11042,microg/kg,1,1
11043,),1,1
11044,and,1,0
11045,ropivacaine,1,1
11046,0.1,1,0
11047,%,1,0
11048,is,0,0
11049,associated,0,0
11050,with,0,0
11051,an,0,0
11052,improved,0,0
11053,quality,0,0
11054,of,0,0
11055,postoperative,0,0
11056,analgesia,0,1
11057,compared,0,0
11058,to,0,0
11059,plain,1,0
11060,0.2,1,0
11061,%,1,0
11062,ropivacaine,1,0
11063,.,1,0
11064,The,0,0
11065,improved,0,0
11066,analgesic,0,1
11067,quality,0,1
11068,of,0,0
11069,the,0,0
11070,clonidine-ropivacaine,0,1
11071,mixture,0,0
11072,is,0,0
11073,achieved,0,0
11074,without,0,0
11075,causing,0,0
11076,any,0,0
11077,significant,0,0
11078,degree,0,0
11079,of,0,0
11080,postoperative,0,0
11081,sedation,0,0
11082,.,0,0
11083,Low,1,1
11084,molecular-weight,1,0
11085,heparin,1,1
11086,versus,1,1
11087,aspirin,1,1
11088,in,0,0
11089,patients,0,0
11090,with,0,0
11091,acute,0,0
11092,ischaemic,0,0
11093,stroke,0,0
11094,and,0,0
11095,atrial,0,0
11096,fibrillation,0,0
11097,:,0,0
11098,a,0,0
11099,double-blind,0,1
11100,randomised,0,1
11101,study,0,0
11102,.,0,0
11103,HAEST,0,0
11104,Study,0,0
11105,Group,0,0
11106,.,0,0
11107,Heparin,0,1
11108,in,0,0
11109,Acute,0,0
11110,Embolic,0,0
11111,Stroke,0,0
11112,Trial,0,0
11113,.,0,0
11114,BACKGROUND,0,0
11115,Patients,0,0
11116,with,0,0
11117,acute,0,0
11118,ischaemic,0,0
11119,stroke,0,0
11120,and,0,0
11121,atrial,0,0
11122,fibrillation,0,0
11123,have,0,0
11124,an,0,0
11125,increased,0,0
11126,risk,0,0
11127,of,0,0
11128,early,0,0
11129,stroke,0,0
11130,recurrence,0,0
11131,",",0,0
11132,and,0,0
11133,anticoagulant,0,1
11134,treatment,0,1
11135,with,0,1
11136,heparins,1,1
11137,has,0,0
11138,been,0,0
11139,widely,0,0
11140,advocated,0,0
11141,",",0,0
11142,despite,0,0
11143,missing,0,0
11144,data,0,0
11145,on,0,0
11146,the,0,0
11147,balance,0,0
11148,of,0,0
11149,risk,0,0
11150,and,0,0
11151,benefit,0,0
11152,.,0,0
11153,METHODS,0,1
11154,Heparin,1,1
11155,in,0,0
11156,Acute,0,0
11157,Embolic,0,0
11158,Stroke,0,0
11159,Trial,0,0
11160,(,0,1
11161,HAEST,0,1
11162,),0,0
11163,was,0,0
11164,a,0,0
11165,multicentre,0,0
11166,",",0,0
11167,randomised,0,1
11168,",",0,1
11169,double-blind,0,1
11170,",",0,1
11171,and,0,1
11172,double-dummy,0,1
11173,trial,0,1
11174,on,0,0
11175,the,0,0
11176,effect,0,0
11177,of,0,0
11178,low-molecular-weight,1,1
11179,heparin,1,1
11180,(,1,1
11181,LMWH,1,1
11182,",",1,1
11183,dalteparin,1,1
11184,100,1,1
11185,IU/kg,1,1
11186,subcutaneously,1,1
11187,twice,1,1
11188,a,1,1
11189,day,1,1
11190,),1,1
11191,or,1,1
11192,aspirin,1,1
11193,(,1,1
11194,160,1,1
11195,mg,1,1
11196,every,1,1
11197,day,1,1
11198,),1,1
11199,for,0,0
11200,the,0,0
11201,treatment,0,0
11202,of,0,0
11203,449,0,0
11204,patients,0,0
11205,with,0,0
11206,acute,0,0
11207,ischaemic,0,0
11208,stroke,0,0
11209,and,0,0
11210,atrial,0,0
11211,fibrillation,0,0
11212,.,0,0
11213,The,0,0
11214,primary,0,0
11215,aim,0,0
11216,was,0,0
11217,to,0,0
11218,test,0,0
11219,whether,0,0
11220,treatment,0,0
11221,with,0,0
11222,LMWH,1,0
11223,",",0,0
11224,started,0,0
11225,within,0,0
11226,30,0,0
11227,h,0,0
11228,of,0,0
11229,stroke,0,0
11230,onset,0,0
11231,",",0,0
11232,is,0,0
11233,superior,0,0
11234,to,0,0
11235,aspirin,1,1
11236,for,0,0
11237,the,0,0
11238,prevention,0,0
11239,of,0,0
11240,recurrent,0,0
11241,stroke,0,0
11242,during,0,0
11243,the,0,0
11244,first,0,0
11245,14,0,0
11246,days,0,0
11247,.,0,0
11248,FINDINGS,0,0
11249,The,0,0
11250,frequency,0,0
11251,of,0,0
11252,recurrent,0,0
11253,ischaemic,0,0
11254,stroke,0,0
11255,during,0,0
11256,the,0,0
11257,first,0,0
11258,14,0,0
11259,days,0,0
11260,was,0,0
11261,19/244,0,0
11262,(,0,0
11263,8.5,0,0
11264,%,0,0
11265,),0,0
11266,in,0,0
11267,dalteparin-allocated,0,0
11268,patients,0,0
11269,versus,0,0
11270,17/225,0,0
11271,(,0,0
11272,7.5,0,0
11273,%,0,0
11274,),0,0
11275,in,0,0
11276,aspirin-allocated,0,1
11277,patients,0,1
11278,(,0,0
11279,odds,0,0
11280,ratio=1.13,0,0
11281,",",0,0
11282,95,0,0
11283,%,0,0
11284,CI,0,0
11285,0.57-2.24,0,0
11286,),0,0
11287,.,0,0
11288,The,0,0
11289,secondary,0,0
11290,events,0,0
11291,during,0,0
11292,the,0,0
11293,first,0,0
11294,14,0,0
11295,days,0,0
11296,also,0,0
11297,revealed,0,0
11298,no,0,0
11299,benefit,0,0
11300,of,0,0
11301,dalteparin,1,1
11302,compared,0,0
11303,with,0,0
11304,aspirin,1,1
11305,:,1,1
11306,symptomatic,0,0
11307,cerebral,0,0
11308,haemorrhage,0,0
11309,6/224,0,0
11310,versus,0,0
11311,4/225,0,0
11312,;,0,0
11313,symptomatic,0,0
11314,and,0,0
11315,asymptomatic,0,0
11316,cerebral,0,0
11317,haemorrhage,0,0
11318,26/224,0,0
11319,versus,0,0
11320,32/225,0,0
11321,;,0,0
11322,progression,0,0
11323,of,0,0
11324,symptoms,0,0
11325,within,0,0
11326,the,0,0
11327,first,0,0
11328,48,0,0
11329,hours,0,0
11330,24/224,0,0
11331,versus,0,0
11332,17/225,0,0
11333,;,0,0
11334,and,0,0
11335,death,0,0
11336,21/224,0,0
11337,versus,0,0
11338,16/225,0,0
11339,.,0,0
11340,There,0,0
11341,were,0,0
11342,no,0,0
11343,significant,0,0
11344,differences,0,0
11345,in,0,0
11346,functional,0,0
11347,outcome,0,0
11348,or,0,0
11349,death,0,0
11350,at,0,0
11351,14,0,0
11352,days,0,0
11353,or,0,0
11354,3,0,0
11355,months,0,0
11356,.,0,0
11357,INTERPRETATION,0,0
11358,The,0,0
11359,present,0,0
11360,data,0,0
11361,do,0,0
11362,not,0,0
11363,provide,0,0
11364,any,0,0
11365,evidence,0,0
11366,that,0,0
11367,LMWH,1,0
11368,is,0,0
11369,superior,0,0
11370,to,0,0
11371,aspirin,0,1
11372,for,0,0
11373,the,0,0
11374,treatment,0,0
11375,of,0,0
11376,acute,0,0
11377,ischaemic,0,0
11378,stroke,0,0
11379,in,0,0
11380,patients,0,0
11381,with,0,0
11382,atrial,0,0
11383,fibrillation,0,0
11384,.,0,0
11385,However,0,0
11386,",",0,0
11387,the,0,0
11388,study,0,0
11389,could,0,0
11390,not,0,0
11391,exclude,0,0
11392,the,0,0
11393,possibility,0,0
11394,of,0,0
11395,smaller,0,0
11396,",",0,0
11397,but,0,0
11398,still,0,0
11399,worthwhile,0,0
11400,",",0,0
11401,effects,0,0
11402,of,0,0
11403,either,0,0
11404,of,0,0
11405,the,0,0
11406,trial,0,0
11407,drugs,0,1
11408,.,0,0
11409,Increased,0,0
11410,growth,0,0
11411,hormone,0,1
11412,response,0,0
11413,to,0,0
11414,sumatriptan,1,1
11415,challenge,0,0
11416,in,0,0
11417,adult,0,0
11418,autistic,0,0
11419,disorders,0,1
11420,.,0,1
11421,Serotonergic,0,1
11422,(,0,1
11423,5-HT,0,1
11424,),0,1
11425,abnormalities,0,0
11426,have,0,0
11427,been,0,0
11428,documented,0,0
11429,in,0,0
11430,autism,0,0
11431,.,0,0
11432,To,0,0
11433,assess,0,0
11434,sensitivity,0,0
11435,of,0,0
11436,the,0,0
11437,5-HT1d,0,0
11438,receptor,0,0
11439,",",0,0
11440,growth,0,0
11441,hormone,0,1
11442,response,0,0
11443,to,0,0
11444,the,0,0
11445,5-HT1d,1,0
11446,receptor,1,1
11447,agonist,1,1
11448,sumatriptan,1,1
11449,was,0,0
11450,studied,0,0
11451,in,0,0
11452,adult,0,0
11453,autistic,0,0
11454,patients,0,0
11455,and,0,0
11456,matched,0,0
11457,normal,0,0
11458,controls,0,0
11459,.,0,0
11460,In,0,0
11461,this,0,0
11462,study,0,0
11463,",",0,0
11464,11,0,0
11465,adult,0,0
11466,patients,0,0
11467,with,0,0
11468,autism,0,0
11469,or,0,0
11470,Asperger,0,0
11471,'s,0,0
11472,disorder,0,0
11473,were,0,0
11474,compared,0,0
11475,with,0,0
11476,nine,0,0
11477,matched,0,0
11478,controls,0,0
11479,.,0,0
11480,All,0,0
11481,subjects,0,0
11482,were,0,0
11483,randomized,0,0
11484,to,0,0
11485,single,1,0
11486,dose,1,1
11487,sumatriptan,1,1
11488,(,1,1
11489,6,1,1
11490,mg,1,1
11491,SQ,1,1
11492,),1,1
11493,and,1,1
11494,placebo,1,1
11495,challenges,1,1
11496,",",1,0
11497,separated,1,0
11498,by,1,0
11499,a,1,0
11500,1-week,1,0
11501,interval,1,0
11502,",",1,0
11503,and,1,0
11504,growth,1,0
11505,hormone,1,1
11506,was,1,0
11507,measured,1,0
11508,before,1,0
11509,and,1,0
11510,during,1,0
11511,the,1,0
11512,challenges,1,0
11513,.,1,0
11514,The,0,0
11515,results,0,0
11516,showed,0,0
11517,a,0,0
11518,highly,0,0
11519,significant,0,0
11520,diagnosisxdrugxtime,0,0
11521,interaction,0,0
11522,on,0,0
11523,repeated,0,0
11524,measure,0,0
11525,analysis,0,0
11526,covaried,0,0
11527,for,0,0
11528,baseline,0,0
11529,.,0,0
11530,This,0,0
11531,suggests,0,0
11532,that,0,0
11533,autistic,0,0
11534,patients,0,0
11535,had,0,0
11536,significantly,0,0
11537,greater,0,0
11538,growth,0,0
11539,hormone,0,1
11540,response,0,0
11541,to,0,0
11542,sumatriptan,1,1
11543,than,0,1
11544,normal,0,0
11545,controls,0,0
11546,",",0,0
11547,independent,0,0
11548,of,0,0
11549,placebo,0,1
11550,effects,0,0
11551,.,0,0
11552,Therefore,0,0
11553,",",0,0
11554,abnormalities,0,0
11555,in,0,0
11556,5-HT,0,0
11557,regulation,0,0
11558,in,0,0
11559,autism,0,0
11560,may,0,0
11561,be,0,0
11562,related,0,0
11563,to,0,0
11564,increased,0,0
11565,sensitivity,0,0
11566,of,0,0
11567,the,0,0
11568,5-HT1d,0,0
11569,inhibitory,0,0
11570,receptor,0,0
11571,in,0,0
11572,autism,0,0
11573,.,0,0
11574,Plasma,0,1
11575,antioxidant,0,1
11576,status,0,1
11577,after,0,1
11578,high-dose,1,1
11579,chemotherapy,1,1
11580,:,1,0
11581,a,0,0
11582,randomized,0,0
11583,trial,0,0
11584,of,0,0
11585,parenteral,0,1
11586,nutrition,0,1
11587,in,0,0
11588,bone,0,0
11589,marrow,0,0
11590,transplantation,0,0
11591,patients,0,0
11592,.,0,0
11593,BACKGROUND,0,0
11594,Chemotherapy,1,0
11595,and,1,0
11596,radiation,1,0
11597,therapy,1,0
11598,result,0,0
11599,in,0,0
11600,increased,0,0
11601,free,0,0
11602,radical,0,0
11603,formation,0,0
11604,and,0,0
11605,depletion,0,0
11606,of,0,0
11607,tissue,0,0
11608,antioxidants,0,1
11609,.,0,0
11610,It,0,0
11611,is,0,0
11612,not,0,0
11613,known,0,0
11614,whether,0,0
11615,parenteral,1,1
11616,nutrition,1,1
11617,(,1,1
11618,PN,1,1
11619,),1,1
11620,administered,0,1
11621,during,0,1
11622,bone,1,1
11623,marrow,1,1
11624,transplantation,1,1
11625,(,1,1
11626,BMT,1,1
11627,),1,0
11628,supports,0,0
11629,systemic,0,1
11630,antioxidant,0,1
11631,status,0,1
11632,.,0,0
11633,OBJECTIVE,0,0
11634,The,0,0
11635,aims,0,0
11636,of,0,0
11637,the,0,0
11638,study,0,0
11639,were,0,0
11640,to,0,0
11641,determine,0,0
11642,1,0,0
11643,),0,0
11644,whether,0,0
11645,high-dose,1,1
11646,chemotherapy,1,1
11647,decreases,0,0
11648,concentrations,0,0
11649,of,0,0
11650,major,0,0
11651,circulating,0,0
11652,antioxidants,0,1
11653,in,0,0
11654,patients,0,0
11655,undergoing,0,0
11656,BMT,1,1
11657,and,0,0
11658,2,0,0
11659,),0,0
11660,whether,0,0
11661,administration,0,1
11662,of,0,0
11663,standard,0,1
11664,PN,1,0
11665,maintains,0,0
11666,systemic,0,0
11667,antioxidant,0,1
11668,concentrations,0,1
11669,compared,0,0
11670,with,0,0
11671,PN,1,0
11672,containing,0,0
11673,micronutrients,0,1
11674,and,0,0
11675,minimal,0,0
11676,lipids,0,0
11677,alone,0,0
11678,.,0,0
11679,DESIGN,0,0
11680,Twenty-four,0,0
11681,BMT,1,0
11682,patients,0,0
11683,were,0,0
11684,randomly,0,0
11685,assigned,0,0
11686,to,0,0
11687,receive,0,0
11688,either,0,0
11689,standard,1,0
11690,PN,1,0
11691,containing,1,0
11692,conventional,1,0
11693,amounts,1,0
11694,of,1,0
11695,dextrose,1,1
11696,",",1,0
11697,amino,1,0
11698,acids,1,1
11699,",",1,1
11700,micronutrients,1,1
11701,",",1,1
11702,and,1,0
11703,lipid,1,0
11704,(,0,0
11705,120,0,1
11706,kJ/d,0,1
11707,),0,1
11708,or,0,0
11709,a,0,0
11710,solution,1,0
11711,containing,1,0
11712,only,1,0
11713,micronutrients,1,1
11714,(,0,1
11715,identical,0,0
11716,to,0,0
11717,those,0,0
11718,in,0,0
11719,standard,0,1
11720,PN,0,1
11721,),0,0
11722,and,0,0
11723,a,0,0
11724,small,0,0
11725,amount,0,0
11726,of,0,0
11727,lipid,0,0
11728,(,0,0
11729,12,0,1
11730,kJ/d,0,1
11731,),0,1
11732,.,0,1
11733,Plasma,0,1
11734,antioxidant,0,1
11735,status,0,1
11736,was,0,0
11737,measured,0,0
11738,before,0,0
11739,conditioning,0,0
11740,therapy,0,0
11741,and,0,0
11742,serially,0,0
11743,at,0,0
11744,days,0,0
11745,1,0,0
11746,",",0,0
11747,3,0,0
11748,",",0,0
11749,7,0,0
11750,",",0,0
11751,10,0,0
11752,",",0,0
11753,and,0,0
11754,14,0,0
11755,after,0,0
11756,BMT,0,0
11757,.,0,0
11758,RESULTS,0,1
11759,Plasma,0,1
11760,glutathione,0,1
11761,(,0,1
11762,GSH,0,1
11763,),0,1
11764,and,0,0
11765,alpha-,0,1
11766,and,0,1
11767,gamma-tocopherol,0,1
11768,concentrations,0,1
11769,decreased,0,0
11770,and,0,0
11771,the,0,0
11772,GSH,0,0
11773,redox,0,0
11774,state,0,0
11775,became,0,0
11776,more,0,0
11777,oxidized,0,0
11778,after,0,0
11779,conditioning,0,0
11780,chemotherapy,0,0
11781,.,0,1
11782,Plasma,0,1
11783,cysteine,0,1
11784,concentrations,0,1
11785,were,0,0
11786,unchanged,0,0
11787,",",0,0
11788,whereas,0,0
11789,cystine,0,1
11790,concentrations,0,1
11791,increased,0,0
11792,.,0,1
11793,Plasma,0,1
11794,vitamin,0,1
11795,C,0,1
11796,and,0,1
11797,zinc,0,1
11798,concentrations,0,1
11799,and,0,1
11800,GSH,0,1
11801,peroxidase,0,1
11802,activity,0,0
11803,increased,0,0
11804,over,0,0
11805,time,0,0
11806,.,0,0
11807,Plasma,0,1
11808,alpha-tocopherol,0,1
11809,concentrations,0,1
11810,were,0,0
11811,lower,0,0
11812,in,0,0
11813,patients,0,0
11814,given,0,0
11815,standard,0,0
11816,PN,0,0
11817,.,0,0
11818,There,0,0
11819,were,0,0
11820,no,0,0
11821,differences,0,0
11822,in,0,0
11823,other,0,0
11824,plasma,0,1
11825,antioxidants,0,1
11826,between,0,1
11827,groups,0,0
11828,.,0,0
11829,CONCLUSIONS,0,0
11830,A,0,0
11831,significant,0,0
11832,decline,0,0
11833,in,0,0
11834,GSH-glutathione,0,1
11835,disulfide,0,1
11836,",",0,1
11837,cysteine-cystine,0,1
11838,",",0,1
11839,and,0,1
11840,vitamin,0,1
11841,E,0,0
11842,status,0,0
11843,occurs,0,0
11844,after,0,0
11845,chemotherapy,1,0
11846,and,1,0
11847,BMT,1,0
11848,.,1,0
11849,Standard,0,0
11850,PN,0,0
11851,does,0,0
11852,not,0,0
11853,improve,0,0
11854,antioxidant,0,1
11855,status,0,1
11856,compared,0,0
11857,with,0,0
11858,administration,0,1
11859,of,0,0
11860,micronutrients,0,1
11861,alone,0,0
11862,.,0,0
11863,Further,0,0
11864,evaluation,0,0
11865,of,0,0
11866,PN,0,1
11867,formulations,0,1
11868,to,0,0
11869,support,0,0
11870,patients,0,0
11871,undergoing,0,1
11872,high-dose,1,1
11873,chemotherapy,1,1
11874,and,0,0
11875,BMT,1,0
11876,are,0,0
11877,needed,0,0
11878,.,0,0
11879,Atrophy,0,0
11880,and,0,0
11881,intestinal,0,0
11882,metaplasia,0,0
11883,one,0,0
11884,year,0,0
11885,after,0,0
11886,cure,0,0
11887,of,0,0
11888,H.,0,1
11889,pylori,0,0
11890,infection,0,0
11891,:,0,0
11892,a,0,0
11893,prospective,0,0
11894,",",0,0
11895,randomized,0,0
11896,study,0,0
11897,.,0,0
11898,BACKGROUND,0,0
11899,&,0,1
11900,AIMS,0,1
11901,Helicobacter,0,1
11902,pylori-infected,0,1
11903,gastric,0,1
11904,mucosa,0,0
11905,evolves,0,0
11906,through,0,0
11907,stages,0,0
11908,of,0,0
11909,chronic,0,0
11910,gastritis,0,0
11911,",",0,0
11912,intestinal,0,0
11913,metaplasia,0,1
11914,(,0,1
11915,IM,0,1
11916,),0,1
11917,",",0,0
11918,glandular,0,0
11919,atrophy,0,1
11920,(,0,1
11921,GA,0,1
11922,),0,1
11923,",",0,0
11924,and,0,0
11925,dysplasia,0,0
11926,before,0,0
11927,carcinoma,0,0
11928,develops,0,0
11929,.,0,0
11930,We,0,0
11931,studied,0,0
11932,if,0,0
11933,H.,0,0
11934,pylori,0,0
11935,eradication,0,0
11936,would,0,0
11937,alter,0,0
11938,the,0,0
11939,course,0,0
11940,of,0,0
11941,premalignant,0,0
11942,histologic,0,0
11943,changes,0,0
11944,in,0,0
11945,the,0,0
11946,stomach,0,0
11947,.,0,0
11948,METHODS,0,0
11949,Volunteers,0,0
11950,from,0,0
11951,the,0,0
11952,Yantai,0,0
11953,County,0,0
11954,in,0,0
11955,China,0,0
11956,underwent,0,0
11957,upper,1,0
11958,endoscopy,1,0
11959,with,1,0
11960,biopsy,1,0
11961,specimens,0,0
11962,obtained,0,0
11963,from,0,0
11964,the,0,0
11965,antrum,0,0
11966,and,0,0
11967,corpus,0,0
11968,.,0,0
11969,H.,0,1
11970,pylori-infected,0,1
11971,subjects,0,0
11972,were,0,0
11973,randomized,0,0
11974,to,0,0
11975,receive,0,0
11976,either,0,0
11977,a,0,0
11978,1-week,1,0
11979,course,1,0
11980,of,1,0
11981,omeprazole,1,1
11982,",",1,1
11983,amoxicillin,1,1
11984,",",1,1
11985,and,1,1
11986,clarithromycin,1,1
11987,(,1,1
11988,OAC,1,1
11989,),1,1
11990,or,1,0
11991,placebo,1,1
11992,.,1,1
11993,At,0,1
11994,1,0,0
11995,year,0,0
11996,",",0,0
11997,endoscopies,0,0
11998,with,0,0
11999,biopsies,0,0
12000,were,0,0
12001,repeated,0,0
12002,.,0,0
12003,RESULTS,0,0
12004,A,0,0
12005,total,0,0
12006,of,0,0
12007,587,0,0
12008,H.,0,0
12009,pylori-infected,0,1
12010,subjects,0,0
12011,were,0,0
12012,randomized,0,0
12013,to,0,0
12014,OAC,1,1
12015,(,0,0
12016,n,0,0
12017,=,0,0
12018,295,0,0
12019,),0,0
12020,and,0,0
12021,placebo,0,1
12022,(,0,0
12023,n,0,0
12024,=,0,0
12025,292,0,0
12026,),0,0
12027,.,0,0
12028,At,0,0
12029,1,0,0
12030,year,0,0
12031,",",0,0
12032,H.,0,0
12033,pylori,0,0
12034,was,0,0
12035,eradicated,0,0
12036,in,0,0
12037,226,0,0
12038,subjects,0,0
12039,assigned,0,0
12040,to,0,0
12041,OAC,1,0
12042,.,0,0
12043,In,0,0
12044,the,0,0
12045,placebo,1,1
12046,group,0,0
12047,",",0,0
12048,245,0,0
12049,patients,0,0
12050,remained,0,0
12051,H.,0,0
12052,pylori,0,0
12053,infected,0,0
12054,.,0,0
12055,Analysis,0,0
12056,of,0,0
12057,paired,0,0
12058,samples,0,0
12059,obtained,0,0
12060,from,0,0
12061,the,0,0
12062,same,0,0
12063,patients,0,0
12064,showed,0,0
12065,that,0,0
12066,acute,0,0
12067,and,0,0
12068,chronic,0,0
12069,gastritis,0,0
12070,decreased,0,0
12071,in,0,0
12072,both,0,0
12073,the,0,0
12074,antrum,0,0
12075,and,0,0
12076,corpus,0,0
12077,after,0,0
12078,H.,0,0
12079,pylori,0,1
12080,eradication,0,0
12081,(,0,0
12082,P,0,0
12083,<,0,0
12084,0.001,0,0
12085,),0,0
12086,and,0,0
12087,activity,0,0
12088,of,0,0
12089,IM,0,0
12090,decreased,0,0
12091,in,0,0
12092,antrum,0,0
12093,(,0,0
12094,P,0,0
12095,=,0,0
12096,0.014,0,0
12097,),0,0
12098,.,0,0
12099,In,0,0
12100,the,0,0
12101,H.,0,1
12102,pylori-infected,0,1
12103,group,0,1
12104,",",0,0
12105,antral,0,0
12106,biopsy,0,0
12107,specimens,0,0
12108,had,0,0
12109,more,0,0
12110,pronounced,0,0
12111,acute,0,0
12112,gastritis,0,0
12113,(,0,0
12114,P,0,0
12115,=,0,0
12116,0.01,0,0
12117,),0,0
12118,",",0,0
12119,whereas,0,0
12120,corpus,0,0
12121,specimens,0,0
12122,showed,0,0
12123,increased,0,0
12124,acute,0,0
12125,and,0,0
12126,chronic,0,1
12127,gastritis,0,0
12128,(,0,0
12129,P,0,0
12130,<,0,0
12131,0.001,0,0
12132,),0,0
12133,and,0,0
12134,a,0,0
12135,marginal,0,0
12136,increase,0,0
12137,in,0,0
12138,GA,0,1
12139,(,0,0
12140,P,0,0
12141,=,0,0
12142,0.052,0,0
12143,),0,0
12144,.,0,0
12145,When,0,0
12146,histologic,0,0
12147,changes,0,0
12148,were,0,0
12149,compared,0,0
12150,between,0,0
12151,the,0,0
12152,2,0,0
12153,groups,0,0
12154,",",0,0
12155,decrease,0,0
12156,in,0,0
12157,acute,0,0
12158,and,0,0
12159,chronic,0,0
12160,gastritis,0,0
12161,was,0,0
12162,more,0,0
12163,frequent,0,0
12164,after,0,0
12165,H.,0,0
12166,pylori,0,1
12167,eradication,0,0
12168,(,0,0
12169,P,0,0
12170,<,0,0
12171,0.001,0,0
12172,),0,0
12173,but,0,0
12174,changes,0,0
12175,in,0,0
12176,IM,0,0
12177,were,0,0
12178,similar,0,0
12179,.,0,0
12180,In,0,0
12181,the,0,0
12182,H.,0,1
12183,pylori-infected,0,1
12184,group,0,1
12185,",",0,0
12186,increase,0,0
12187,in,0,0
12188,GA,0,1
12189,was,0,0
12190,seen,0,0
12191,in,0,0
12192,the,0,0
12193,corpus,0,0
12194,(,0,0
12195,P,0,0
12196,=,0,0
12197,0.01,0,0
12198,),0,0
12199,.,0,0
12200,CONCLUSIONS,0,1
12201,At,0,1
12202,1,0,0
12203,year,0,0
12204,",",0,0
12205,H.,0,1
12206,pylori,0,1
12207,eradication,0,0
12208,is,0,0
12209,beneficial,0,0
12210,in,0,0
12211,preventing,0,0
12212,progression,0,0
12213,of,0,0
12214,pathologic,0,0
12215,changes,0,0
12216,of,0,0
12217,the,0,0
12218,gastric,0,0
12219,mucosa,0,0
12220,.,0,0
12221,Is,0,0
12222,a,0,0
12223,calculated,0,0
12224,total,0,0
12225,hip,0,0
12226,BMD,0,0
12227,of,0,0
12228,clinical,0,0
12229,use,0,0
12230,?,0,0
12231,The,0,0
12232,diagnosis,0,0
12233,of,0,0
12234,osteoporosis,0,0
12235,is,0,0
12236,based,0,0
12237,on,0,0
12238,bone,0,0
12239,mass,0,0
12240,measurement,0,0
12241,.,0,0
12242,To,0,0
12243,avoid,0,0
12244,the,0,0
12245,errors,0,0
12246,associated,0,0
12247,with,0,0
12248,the,0,0
12249,measurement,0,0
12250,of,0,0
12251,spinal,0,0
12252,bone,0,0
12253,density,0,0
12254,the,0,0
12255,total,0,0
12256,hip,0,0
12257,has,0,0
12258,been,0,0
12259,accepted,0,0
12260,as,0,0
12261,the,0,0
12262,standard,0,0
12263,measurement,0,0
12264,site,0,0
12265,.,0,0
12266,This,0,0
12267,information,0,0
12268,is,0,0
12269,not,0,0
12270,available,0,0
12271,for,0,0
12272,many,0,0
12273,early,0,0
12274,measurements,0,0
12275,.,0,0
12276,We,0,0
12277,have,0,0
12278,assessed,0,0
12279,whether,0,0
12280,it,0,0
12281,is,0,0
12282,possible,0,0
12283,to,0,0
12284,derive,0,0
12285,clinically,0,0
12286,useful,0,0
12287,information,0,0
12288,about,0,0
12289,total,1,0
12290,hip,1,0
12291,bone,1,0
12292,mineral,1,1
12293,density,1,0
12294,(,0,1
12295,BMD,0,1
12296,),0,0
12297,from,0,0
12298,measurements,0,0
12299,at,0,0
12300,other,0,0
12301,hip,0,0
12302,sites,0,0
12303,.,0,0
12304,The,0,0
12305,bone,0,0
12306,mass,0,0
12307,measurements,0,0
12308,of,0,0
12309,46,0,0
12310,patients,0,0
12311,participating,0,0
12312,in,0,0
12313,a,0,0
12314,current,0,0
12315,trial,0,0
12316,of,0,0
12317,therapy,0,0
12318,for,0,0
12319,osteoporosis,0,0
12320,were,0,0
12321,reviewed,0,0
12322,.,0,0
12323,The,0,0
12324,total,0,0
12325,hip,0,0
12326,BMD,0,0
12327,as,0,0
12328,directly,0,0
12329,measured,0,0
12330,was,0,0
12331,compared,0,0
12332,with,0,0
12333,that,0,0
12334,obtained,0,0
12335,from,0,0
12336,the,0,0
12337,formula,0,1
12338,:,0,1
12339,Total,0,0
12340,hip,0,0
12341,BMD,0,0
12342,=,0,0
12343,0.48,0,0
12344,x,0,0
12345,Neck,0,0
12346,BMD,0,1
12347,+,0,0
12348,0.62,0,0
12349,x,0,0
12350,Trochanteric,0,0
12351,BMD,0,1
12352,+,0,0
12353,0.03,0,0
12354,.,0,0
12355,In,0,0
12356,30,0,0
12357,patients,0,0
12358,with,0,0
12359,follow-up,0,0
12360,data,0,0
12361,the,0,0
12362,rate,0,0
12363,of,0,0
12364,change,0,0
12365,in,0,0
12366,hip,0,0
12367,BMD,0,0
12368,over,0,0
12369,a,0,0
12370,year,0,0
12371,was,0,0
12372,also,0,0
12373,determined,0,0
12374,by,0,0
12375,both,0,0
12376,methods,0,0
12377,.,0,0
12378,In,0,0
12379,the,0,0
12380,pretreatment,0,0
12381,state,0,0
12382,there,0,0
12383,was,0,0
12384,good,0,0
12385,agreement,0,0
12386,between,0,0
12387,the,0,0
12388,two,0,0
12389,measures,0,0
12390,(,0,0
12391,r2,0,0
12392,=,0,0
12393,0.96,0,0
12394,",",0,0
12395,SEE,0,0
12396,0.012,0,0
12397,g/cm2,0,0
12398,),0,0
12399,.,0,0
12400,If,0,1
12401,the,0,0
12402,formula,0,0
12403,was,0,0
12404,used,0,0
12405,to,0,0
12406,compute,0,0
12407,a,0,0
12408,change,0,0
12409,in,0,0
12410,total,0,0
12411,hip,0,0
12412,BMD,0,0
12413,",",0,0
12414,the,0,0
12415,agreement,0,0
12416,between,0,0
12417,both,0,0
12418,methods,0,0
12419,remained,0,0
12420,good,0,0
12421,.,0,0
12422,However,0,0
12423,",",0,0
12424,the,0,0
12425,standard,0,0
12426,error,0,0
12427,of,0,0
12428,the,0,0
12429,estimate,0,0
12430,of,0,0
12431,the,0,0
12432,change,0,0
12433,represented,0,0
12434,59,0,0
12435,%,0,0
12436,of,0,0
12437,the,0,0
12438,observed,0,0
12439,change,0,0
12440,.,0,0
12441,This,0,0
12442,indicates,0,0
12443,that,0,0
12444,the,0,0
12445,error,0,0
12446,associated,0,0
12447,with,0,0
12448,this,0,0
12449,estimate,0,0
12450,is,0,0
12451,too,0,0
12452,great,0,0
12453,to,0,0
12454,allow,0,0
12455,clinically,0,0
12456,meaningful,0,0
12457,conclusions,0,0
12458,to,0,0
12459,be,0,0
12460,drawn,0,0
12461,from,0,0
12462,calculated,0,0
12463,total,0,0
12464,hip,0,0
12465,BMD,0,0
12466,.,0,0
12467,We,0,0
12468,conclude,0,0
12469,that,0,0
12470,",",0,0
12471,whilst,0,0
12472,it,0,0
12473,may,0,0
12474,be,0,0
12475,possible,0,0
12476,to,0,0
12477,obtain,0,0
12478,reasonable,0,0
12479,point,0,0
12480,estimates,0,0
12481,of,0,0
12482,total,0,0
12483,hip,0,0
12484,BMD,0,0
12485,from,0,0
12486,other,0,0
12487,measures,0,0
12488,in,0,0
12489,the,0,0
12490,hip,0,0
12491,",",0,0
12492,these,0,0
12493,estimates,0,0
12494,are,0,0
12495,too,0,0
12496,imprecise,0,0
12497,to,0,0
12498,allow,0,0
12499,conclusions,0,0
12500,about,0,0
12501,change,0,0
12502,in,0,0
12503,BMD,0,0
12504,to,0,0
12505,be,0,0
12506,made,0,0
12507,.,0,0
12508,Randomized,0,0
12509,trial,0,0
12510,of,0,0
12511,intensive,1,0
12512,early,1,0
12513,intervention,1,0
12514,for,0,0
12515,children,0,0
12516,with,0,0
12517,pervasive,0,0
12518,developmental,0,0
12519,disorder,0,0
12520,.,0,0
12521,Young,0,0
12522,children,0,0
12523,with,0,0
12524,pervasive,0,0
12525,developmental,0,0
12526,disorder,0,0
12527,were,0,0
12528,randomly,0,0
12529,assigned,0,0
12530,to,0,0
12531,intensive,1,0
12532,treatment,1,0
12533,or,0,0
12534,parent,1,0
12535,training,1,0
12536,.,1,0
12537,The,0,0
12538,intensive,1,0
12539,treatment,1,0
12540,group,0,1
12541,(,0,0
12542,7,0,0
12543,with,0,0
12544,autism,0,0
12545,",",0,0
12546,8,0,0
12547,with,0,0
12548,pervasive,0,0
12549,developmental,0,0
12550,disorder,0,0
12551,not,0,0
12552,otherwise,0,0
12553,specified,0,0
12554,--,0,0
12555,NOS,0,0
12556,),0,0
12557,averaged,0,0
12558,24.52,0,0
12559,hours,0,0
12560,per,0,0
12561,week,0,0
12562,of,0,0
12563,individual,1,0
12564,treatment,1,0
12565,for,0,0
12566,one,0,0
12567,year,0,0
12568,",",0,0
12569,gradually,0,0
12570,reducing,0,0
12571,hours,0,0
12572,over,0,0
12573,the,0,0
12574,next,0,0
12575,1,0,0
12576,to,0,0
12577,2,0,0
12578,years,0,0
12579,.,0,0
12580,The,0,0
12581,parent,1,0
12582,training,1,0
12583,group,0,0
12584,(,0,0
12585,7,0,0
12586,with,0,0
12587,autism,0,0
12588,",",0,0
12589,6,0,0
12590,with,0,0
12591,pervasive,0,0
12592,developmental,0,0
12593,disorder,0,1
12594,NOS,0,1
12595,),0,1
12596,received,0,0
12597,3,0,0
12598,to,0,0
12599,9,0,0
12600,months,0,0
12601,of,0,0
12602,parent,1,0
12603,training,1,0
12604,.,1,0
12605,The,0,0
12606,groups,0,0
12607,appeared,0,0
12608,similar,0,0
12609,at,0,0
12610,intake,0,1
12611,on,0,0
12612,all,0,0
12613,measures,0,0
12614,;,0,0
12615,however,0,0
12616,",",0,0
12617,at,0,0
12618,follow-up,0,0
12619,the,0,0
12620,intensive,1,0
12621,treatment,1,0
12622,group,0,0
12623,outperformed,0,0
12624,the,0,0
12625,parent,1,0
12626,training,1,0
12627,group,0,0
12628,on,0,0
12629,measures,0,0
12630,of,0,0
12631,intelligence,0,0
12632,",",0,0
12633,visual-spatial,0,0
12634,skills,0,0
12635,",",0,0
12636,language,0,0
12637,",",0,0
12638,and,0,0
12639,academics,0,0
12640,",",0,0
12641,though,0,0
12642,not,0,0
12643,adaptive,0,0
12644,functioning,0,0
12645,or,0,0
12646,behavior,0,0
12647,problems,0,0
12648,.,0,0
12649,Children,0,0
12650,with,0,0
12651,pervasive,0,0
12652,developmental,0,0
12653,disorder,0,0
12654,NOS,0,0
12655,may,0,0
12656,have,0,0
12657,gained,0,0
12658,more,0,0
12659,than,0,0
12660,those,0,0
12661,with,0,0
12662,autism,0,0
12663,.,0,0
12664,5-fluorouracil,1,1
12665,plus,1,1
12666,folinic,1,1
12667,acid,1,1
12668,with,0,1
12669,or,0,0
12670,without,0,0
12671,ifosfamide,1,1
12672,in,0,0
12673,advanced,0,1
12674,colorectal,0,0
12675,cancer,0,0
12676,:,0,0
12677,a,0,0
12678,phase,0,0
12679,II,0,0
12680,randomized,0,0
12681,trial,0,0
12682,.,0,0
12683,AIM,0,0
12684,This,0,0
12685,phase,0,0
12686,II,0,0
12687,trial,0,0
12688,evaluated,0,0
12689,the,0,0
12690,biomodulation,0,0
12691,of,0,0
12692,5-fluorouracil,1,1
12693,(,1,1
12694,5-FU,1,1
12695,),1,1
12696,plus,1,0
12697,folinic,1,1
12698,acid,1,1
12699,(,1,1
12700,FA,1,1
12701,),1,1
12702,with,1,0
12703,or,1,0
12704,without,1,0
12705,ifosfamide,1,1
12706,(,1,1
12707,IFO,1,1
12708,),1,0
12709,in,0,0
12710,chemotherapy-naive,0,1
12711,patients,0,0
12712,with,0,0
12713,colorectal,0,0
12714,cancer,0,0
12715,.,0,0
12716,PATIENTS,0,0
12717,AND,0,0
12718,METHODS,0,0
12719,Forty-eight,0,0
12720,patients,0,0
12721,were,0,0
12722,randomized,0,0
12723,to,0,0
12724,receive,0,0
12725,:,0,0
12726,FA,1,1
12727,(,0,1
12728,25,0,1
12729,mg/m2,0,1
12730,iv,0,1
12731,bolus,0,1
12732,days,0,1
12733,1,0,1
12734,to,0,0
12735,3,0,1
12736,),0,0
12737,",",0,0
12738,followed,0,0
12739,by,0,0
12740,5-FU,1,1
12741,(,0,1
12742,750,0,1
12743,mg/m2,0,1
12744,iv,0,1
12745,bolus,0,1
12746,days,0,1
12747,1,0,1
12748,to,0,0
12749,3,0,1
12750,),0,0
12751,",",0,0
12752,arm,0,1
12753,A,0,1
12754,;,0,1
12755,or,0,0
12756,FA,1,1
12757,(,0,1
12758,25,0,1
12759,mg/m2,0,1
12760,iv,0,1
12761,bolus,0,1
12762,days,0,1
12763,1,0,1
12764,to,0,0
12765,3,0,1
12766,),0,0
12767,",",0,0
12768,followed,0,0
12769,by,0,0
12770,5-FU,1,1
12771,(,0,1
12772,750,0,1
12773,mg/m2,0,1
12774,iv,0,1
12775,bolus,0,1
12776,days,0,1
12777,1,0,1
12778,to,0,0
12779,3,0,0
12780,),0,0
12781,plus,0,0
12782,IFO,1,1
12783,(,0,1
12784,"2,000",0,1
12785,mg/m2,0,1
12786,in,0,1
12787,1000,0,0
12788,mL,0,0
12789,5,0,0
12790,%,0,0
12791,dextrose,0,1
12792,in,0,0
12793,a,0,1
12794,2-hr,0,1
12795,infusion,0,1
12796,",",0,1
12797,days,0,1
12798,1,0,0
12799,to,0,0
12800,3,0,1
12801,),0,0
12802,",",0,0
12803,arm,0,1
12804,B.,0,1
12805,Mesna,0,0
12806,was,0,0
12807,added,0,0
12808,during,0,0
12809,and,0,0
12810,after,0,0
12811,IFO,0,0
12812,to,0,0
12813,prevent,0,0
12814,hemorrhagic,0,0
12815,cystitis,0,0
12816,.,0,0
12817,Treatment,0,0
12818,was,0,0
12819,repeated,0,0
12820,every,0,0
12821,21,0,0
12822,days,0,0
12823,in,0,0
12824,both,0,0
12825,arms,0,0
12826,.,0,0
12827,RESULTS,0,0
12828,Forty-five,0,0
12829,patients,0,0
12830,were,0,0
12831,assessable,0,0
12832,for,0,0
12833,response,0,0
12834,:,0,0
12835,in,0,0
12836,arm,0,0
12837,A,0,1
12838,",",0,0
12839,5,0,0
12840,patients,0,0
12841,achieved,0,0
12842,a,0,0
12843,partial,0,0
12844,response,0,0
12845,(,0,0
12846,overall,0,0
12847,response,0,0
12848,",",0,0
12849,25,0,0
12850,%,0,0
12851,),0,0
12852,",",0,0
12853,and,0,0
12854,in,0,0
12855,arm,0,0
12856,B,0,1
12857,",",0,0
12858,2,0,0
12859,patients,0,0
12860,achieved,0,0
12861,a,0,0
12862,complete,0,0
12863,and,0,0
12864,1,0,0
12865,a,0,0
12866,partial,0,0
12867,response,0,0
12868,(,0,0
12869,overall,0,0
12870,response,0,0
12871,",",0,0
12872,12,0,0
12873,%,0,0
12874,),0,0
12875,.,0,0
12876,Time,0,0
12877,to,0,0
12878,failure,0,0
12879,was,0,0
12880,3.5,0,0
12881,months,0,0
12882,(,0,0
12883,range,0,0
12884,",",0,0
12885,1-38,0,0
12886,),0,0
12887,in,0,0
12888,patients,0,0
12889,treated,0,0
12890,with,0,0
12891,5-FU,0,0
12892,plus,0,0
12893,FA,0,0
12894,",",0,0
12895,and,0,0
12896,3,0,0
12897,months,0,0
12898,(,0,0
12899,range,0,0
12900,",",0,0
12901,1-21,0,0
12902,),0,0
12903,in,0,0
12904,patients,0,0
12905,treated,0,0
12906,with,0,0
12907,the,0,0
12908,IFO,0,0
12909,combination,0,0
12910,.,0,0
12911,The,0,0
12912,median,0,0
12913,survival,0,0
12914,time,0,0
12915,was,0,0
12916,13.5,0,0
12917,months,0,0
12918,(,0,0
12919,range,0,0
12920,",",0,0
12921,1-49,0,0
12922,months,0,0
12923,),0,0
12924,in,0,0
12925,arm,0,0
12926,A,0,1
12927,and,0,0
12928,16,0,0
12929,months,0,0
12930,(,0,0
12931,range,0,0
12932,",",0,0
12933,1-43,0,0
12934,months,0,0
12935,),0,0
12936,in,0,0
12937,arm,0,0
12938,B,0,0
12939,.,0,0
12940,Diarrhea,0,0
12941,",",0,0
12942,stomatitis,0,0
12943,and,0,0
12944,vomiting,0,0
12945,were,0,0
12946,the,0,0
12947,most,0,0
12948,common,0,0
12949,nonhematologic,0,0
12950,toxicities,0,1
12951,in,0,0
12952,both,0,0
12953,arms,0,0
12954,.,0,0
12955,The,0,0
12956,most,0,0
12957,notable,0,0
12958,hematologic,0,0
12959,toxicity,0,0
12960,was,0,0
12961,leukopenia,0,1
12962,;,0,0
12963,15,0,0
12964,%,0,0
12965,and,0,0
12966,20,0,0
12967,%,0,0
12968,of,0,0
12969,patients,0,0
12970,experienced,0,0
12971,grade,0,0
12972,4,0,0
12973,in,0,0
12974,arm,0,0
12975,A,0,1
12976,and,0,0
12977,arm,0,0
12978,B,0,0
12979,",",0,0
12980,respectively,0,0
12981,.,0,0
12982,CONCLUSIONS,0,0
12983,IFO,0,0
12984,does,0,0
12985,not,0,0
12986,increase,0,0
12987,the,0,0
12988,activity,0,0
12989,of,0,0
12990,the,0,0
12991,5-FU,0,0
12992,plus,0,0
12993,FA,0,0
12994,combination,0,0
12995,in,0,0
12996,advanced,0,0
12997,colorectal,0,0
12998,cancer,0,0
12999,.,0,0
13000,Effect,0,0
13001,of,0,0
13002,L-ornithine-L-aspartate,1,0
13003,on,0,0
13004,patients,0,0
13005,with,0,0
13006,and,0,0
13007,without,0,0
13008,TIPS,0,0
13009,undergoing,0,0
13010,glutamine,0,1
13011,challenge,0,0
13012,:,0,0
13013,a,0,0
13014,double,0,0
13015,blind,0,0
13016,",",0,0
13017,placebo,0,1
13018,controlled,0,0
13019,trial,0,0
13020,.,0,0
13021,BACKGROUND,0,0
13022,AND,0,1
13023,AIM,0,1
13024,An,0,1
13025,oral,0,1
13026,glutamine,0,1
13027,load,0,1
13028,in,0,0
13029,cirrhotic,0,0
13030,patients,0,0
13031,awaiting,0,0
13032,liver,0,0
13033,transplantation,0,0
13034,was,0,0
13035,shown,0,0
13036,to,0,0
13037,cause,0,0
13038,a,0,0
13039,rise,0,0
13040,in,0,0
13041,blood,0,0
13042,ammonia,0,1
13043,and,0,0
13044,psychometric,0,0
13045,abnormalities,0,0
13046,which,0,0
13047,were,0,0
13048,reversed,0,0
13049,by,0,0
13050,hepatic,0,0
13051,transplantation,0,0
13052,.,0,0
13053,L-Ornithine-L-aspartate,1,1
13054,(,1,1
13055,LOLA,1,1
13056,),1,0
13057,has,0,0
13058,been,0,0
13059,shown,0,0
13060,to,0,0
13061,reduce,0,0
13062,ammonia,0,1
13063,and,0,0
13064,improve,0,0
13065,psychometric,0,0
13066,function,0,0
13067,in,0,0
13068,patients,0,0
13069,with,0,0
13070,hepatic,0,0
13071,encephalopathy,0,0
13072,.,0,0
13073,The,0,0
13074,aim,0,0
13075,of,0,0
13076,the,0,0
13077,present,0,0
13078,study,0,0
13079,was,0,0
13080,to,0,0
13081,assess,0,0
13082,the,0,0
13083,effect,0,0
13084,of,0,0
13085,LOLA,1,0
13086,in,0,0
13087,healthy,0,0
13088,patients,0,0
13089,with,0,0
13090,cirrhosis,0,0
13091,and,0,0
13092,no,0,0
13093,evidence,0,0
13094,of,0,0
13095,clinical,0,0
13096,encephalopathy,0,0
13097,after,0,0
13098,challenging,0,0
13099,the,0,0
13100,central,0,0
13101,nervous,0,0
13102,system,0,0
13103,by,0,0
13104,administration,0,1
13105,of,0,1
13106,oral,0,1
13107,glutamine,0,1
13108,.,0,1
13109,PATIENTS,0,0
13110,AND,0,0
13111,METHODS,0,1
13112,Eight,0,0
13113,cirrhotics,0,1
13114,(,0,0
13115,Child,0,0
13116,'s,0,0
13117,B,0,1
13118,or,0,1
13119,C,0,1
13120,),0,1
13121,without,0,0
13122,transjugular,0,0
13123,intrahepatic,0,0
13124,portosystemic,0,1
13125,shunts,0,1
13126,(,0,1
13127,TIPS,0,1
13128,),0,1
13129,and,0,0
13130,seven,0,0
13131,with,0,0
13132,TIPS,0,0
13133,underwent,0,0
13134,two,0,0
13135,oral,1,1
13136,glutamine,1,1
13137,(,1,1
13138,20,1,1
13139,g,1,1
13140,),1,1
13141,challenges,1,1
13142,",",1,0
13143,receiving,1,0
13144,LOLA,1,1
13145,(,1,1
13146,5,1,1
13147,g,1,1
13148,intravenously,1,1
13149,),1,1
13150,on,0,0
13151,one,0,0
13152,occasion,0,0
13153,and,0,0
13154,placebo,1,1
13155,on,0,0
13156,the,0,0
13157,other,0,0
13158,in,0,0
13159,random,0,0
13160,order,0,0
13161,.,0,0
13162,Psychometric,0,0
13163,tests,0,0
13164,",",0,0
13165,including,0,0
13166,choice,0,0
13167,reaction,0,0
13168,time,0,0
13169,(,0,0
13170,CRT,0,1
13171,),0,1
13172,and,0,0
13173,number,0,0
13174,connection,0,0
13175,test,0,0
13176,",",0,0
13177,were,0,0
13178,performed,0,0
13179,before,0,0
13180,and,0,0
13181,after,0,0
13182,glutamine,0,0
13183,",",0,0
13184,together,0,0
13185,with,0,0
13186,electroencephalography,0,0
13187,and,0,0
13188,blood,0,1
13189,ammonia,0,1
13190,.,0,1
13191,RESULTS,0,0
13192,Mean,0,0
13193,basal,0,0
13194,ammonia,0,0
13195,was,0,0
13196,27,0,0
13197,(,0,0
13198,SEM,0,0
13199,5,0,1
13200,),0,0
13201,micromol/l,0,1
13202,in,0,0
13203,non-TIPS,0,0
13204,and,0,0
13205,76,0,0
13206,(,0,0
13207,10,0,0
13208,),0,1
13209,micromol/l,0,1
13210,in,0,0
13211,TIPS,0,1
13212,patients,0,0
13213,(,0,0
13214,p,0,0
13215,<,0,0
13216,0.05,0,0
13217,),0,0
13218,.,0,0
13219,Basal,0,0
13220,CRT,0,0
13221,2,0,0
13222,was,0,0
13223,0.643,0,0
13224,(,0,0
13225,0.033,0,0
13226,),0,0
13227,s,0,0
13228,in,0,0
13229,non-TIPS,0,0
13230,and,0,0
13231,0.825,0,0
13232,(,0,0
13233,0.076,0,0
13234,),0,0
13235,s,0,0
13236,in,0,0
13237,TIPS,0,1
13238,patients,0,0
13239,(,0,0
13240,p,0,0
13241,<,0,0
13242,0.02,0,0
13243,),0,0
13244,.,0,0
13245,In,0,0
13246,non-TIPS,0,0
13247,patients,0,0
13248,",",0,0
13249,ammonia,0,1
13250,increased,0,0
13251,to,0,0
13252,36,0,0
13253,(,0,0
13254,10,0,0
13255,),0,1
13256,micromol/l,0,1
13257,when,0,0
13258,LOLA,1,1
13259,was,0,0
13260,administered,0,1
13261,and,0,0
13262,to,0,0
13263,62,0,0
13264,(,0,0
13265,13,0,0
13266,),0,1
13267,micromol/l,0,1
13268,with,0,1
13269,placebo,0,1
13270,(,0,0
13271,p,0,0
13272,<,0,0
13273,0.02,0,0
13274,),0,0
13275,.,0,0
13276,There,0,0
13277,was,0,0
13278,no,0,0
13279,alteration,0,0
13280,in,0,0
13281,psychometric,0,0
13282,function,0,0
13283,in,0,0
13284,non-TIPS,0,0
13285,patients,0,0
13286,after,0,0
13287,glutamine,0,0
13288,when,0,0
13289,LOLA,1,1
13290,was,0,0
13291,given,0,0
13292,but,0,0
13293,when,0,0
13294,placebo,1,1
13295,was,0,0
13296,given,0,0
13297,",",0,0
13298,glutamine,0,0
13299,caused,0,0
13300,prolongation,0,0
13301,of,0,0
13302,CRT,0,0
13303,(,0,0
13304,p=0.02,0,0
13305,),0,0
13306,.,0,0
13307,Glutamine,0,1
13308,did,0,0
13309,not,0,0
13310,affect,0,0
13311,psychometric,0,0
13312,function,0,0
13313,in,0,0
13314,TIPS,0,0
13315,patients,0,0
13316,with,0,0
13317,or,0,0
13318,without,0,0
13319,LOLA,0,0
13320,.,0,0
13321,CONCLUSION,0,0
13322,This,0,0
13323,study,0,0
13324,showed,0,0
13325,that,0,0
13326,LOLA,1,0
13327,ameliorated,0,0
13328,the,0,0
13329,deleterious,0,0
13330,psychometric,0,0
13331,effects,0,0
13332,of,0,0
13333,glutamine,0,0
13334,in,0,0
13335,Child,0,0
13336,'s,0,0
13337,grade,0,0
13338,B,0,1
13339,and,0,0
13340,C,0,0
13341,patients,0,0
13342,with,0,0
13343,cirrhosis,0,0
13344,without,0,0
13345,TIPS,0,0
13346,and,0,0
13347,supports,0,0
13348,its,0,0
13349,use,0,0
13350,in,0,0
13351,clinical,0,0
13352,practice,0,0
13353,in,0,0
13354,hepatic,0,0
13355,encephalopathy,0,0
13356,.,0,0
13357,Outcomes,0,0
13358,of,0,0
13359,early,0,0
13360,endovascular,0,0
13361,versus,0,0
13362,surgical,1,0
13363,treatment,1,0
13364,of,0,0
13365,ruptured,0,0
13366,cerebral,0,0
13367,aneurysms,0,0
13368,.,0,0
13369,A,0,0
13370,prospective,0,0
13371,randomized,0,0
13372,study,0,0
13373,.,0,0
13374,BACKGROUND,0,0
13375,AND,0,1
13376,PURPOSE,0,1
13377,This,0,0
13378,prospective,0,0
13379,study,0,0
13380,was,0,0
13381,conducted,0,0
13382,to,0,0
13383,compare,0,0
13384,the,0,0
13385,outcomes,0,0
13386,of,0,0
13387,surgical,1,0
13388,clipping,1,0
13389,and,1,0
13390,endovascular,1,0
13391,treatment,1,0
13392,in,0,0
13393,acute,0,0
13394,(,0,0
13395,<,0,0
13396,72,0,0
13397,hours,0,0
13398,),0,0
13399,aneurysmal,0,1
13400,subarachnoid,0,1
13401,hemorrhage,0,1
13402,(,0,1
13403,SAH,0,1
13404,),0,1
13405,.,0,0
13406,METHODS,0,0
13407,One,0,0
13408,hundred,0,0
13409,nine,0,0
13410,consecutive,0,0
13411,patients,0,0
13412,were,0,0
13413,randomly,0,0
13414,assigned,0,0
13415,to,0,0
13416,either,0,0
13417,surgical,1,0
13418,(,0,0
13419,n=57,0,0
13420,),0,0
13421,or,1,0
13422,endovascular,1,0
13423,(,0,0
13424,n=52,0,0
13425,),0,0
13426,treatment,0,0
13427,.,0,0
13428,Clinical,0,0
13429,and,0,0
13430,neuropsychological,0,0
13431,outcome,0,0
13432,was,0,0
13433,assessed,0,0
13434,at,0,0
13435,3,0,0
13436,and,0,0
13437,12,0,0
13438,months,0,0
13439,after,0,0
13440,treatment,0,0
13441,;,0,0
13442,MRI,0,0
13443,of,0,0
13444,the,0,0
13445,brain,0,0
13446,was,0,0
13447,performed,0,0
13448,at,0,0
13449,12,0,0
13450,months,0,0
13451,.,0,0
13452,Follow-up,1,0
13453,angiography,1,0
13454,was,0,0
13455,scheduled,0,0
13456,after,0,0
13457,clipping,0,0
13458,and,0,0
13459,3,0,0
13460,and,0,0
13461,12,0,0
13462,months,0,0
13463,after,0,0
13464,endovascular,0,0
13465,treatment,0,0
13466,.,0,0
13467,RESULTS,0,0
13468,One,0,0
13469,year,0,0
13470,postoperatively,0,0
13471,",",0,0
13472,43/41,0,0
13473,(,0,0
13474,surgical/endovascular,0,0
13475,),0,0
13476,patients,0,0
13477,had,0,0
13478,good,0,0
13479,or,0,0
13480,moderate,0,0
13481,recovery,0,0
13482,",",0,0
13483,5/4,0,0
13484,had,0,0
13485,severe,0,0
13486,disability,0,0
13487,or,0,0
13488,were,0,0
13489,in,0,0
13490,a,0,0
13491,vegetative,0,0
13492,state,0,0
13493,",",0,0
13494,and,0,0
13495,9/7,0,0
13496,had,0,0
13497,died,0,0
13498,(,0,0
13499,NS,0,1
13500,),0,1
13501,according,0,0
13502,to,0,0
13503,intention,0,0
13504,to,0,0
13505,treat,0,0
13506,.,0,0
13507,Patients,0,0
13508,with,0,0
13509,good,0,0
13510,clinical,0,0
13511,recovery,0,0
13512,did,0,0
13513,not,0,0
13514,differ,0,0
13515,in,0,0
13516,their,0,0
13517,neuropsychological,0,0
13518,test,0,0
13519,scores,0,0
13520,.,0,0
13521,Symptomatic,0,0
13522,vasospasm,0,1
13523,(,0,0
13524,OR,0,0
13525,2.47,0,0
13526,;,0,0
13527,95,0,0
13528,%,0,0
13529,CI,0,0
13530,1.45,0,0
13531,to,0,0
13532,4.19,0,0
13533,;,0,0
13534,P,0,0
13535,<,0,0
13536,0.001,0,0
13537,),0,0
13538,",",0,0
13539,poorer,0,1
13540,Hunt,0,1
13541,and,0,0
13542,Hess,0,1
13543,grade,0,1
13544,(,0,0
13545,OR,0,0
13546,2.50,0,0
13547,;,0,0
13548,95,0,0
13549,%,0,0
13550,CI,0,0
13551,1.31,0,0
13552,to,0,0
13553,4.75,0,0
13554,;,0,0
13555,P=0.005,0,0
13556,),0,0
13557,",",0,0
13558,need,0,0
13559,for,0,0
13560,permanent,0,0
13561,shunt,0,0
13562,(,0,0
13563,OR,0,0
13564,8.90,0,0
13565,;,0,0
13566,95,0,0
13567,%,0,0
13568,CI,0,0
13569,1.80,0,0
13570,to,0,0
13571,44.15,0,0
13572,;,0,0
13573,P=0.008,0,0
13574,),0,0
13575,",",0,0
13576,and,0,0
13577,larger,0,0
13578,size,0,0
13579,of,0,0
13580,the,0,0
13581,aneurysm,0,0
13582,(,0,1
13583,OR,0,1
13584,1,0,0
13585,.,0,0
13586,22,0,0
13587,;,0,0
13588,95,0,0
13589,%,0,0
13590,CI,0,0
13591,1.02,0,0
13592,to,0,0
13593,1.45,0,0
13594,;,0,0
13595,P=0.032,0,0
13596,),0,0
13597,independently,0,0
13598,predicted,0,0
13599,worsened,0,0
13600,clinical,0,0
13601,outcome,0,0
13602,regardless,0,0
13603,of,0,0
13604,the,0,0
13605,treatment,0,0
13606,modality,0,0
13607,.,0,0
13608,In,0,0
13609,MRI,1,0
13610,",",0,0
13611,superficial,0,0
13612,brain,0,0
13613,retraction,0,0
13614,deficits,0,0
13615,(,0,0
13616,P,0,0
13617,<,0,0
13618,0.001,0,0
13619,),0,0
13620,and,0,0
13621,ischemic,0,0
13622,lesions,0,0
13623,in,0,0
13624,the,0,0
13625,territory,0,0
13626,of,0,0
13627,the,0,0
13628,ruptured,0,0
13629,aneurysm,0,0
13630,(,0,0
13631,P=0.025,0,0
13632,),0,0
13633,were,0,0
13634,more,0,0
13635,frequent,0,0
13636,in,0,0
13637,the,0,0
13638,surgical,0,0
13639,group,0,0
13640,.,0,0
13641,Kaplan-Meier,0,0
13642,analysis,0,0
13643,(,0,0
13644,mean+/-SD,0,0
13645,follow-up,0,0
13646,39+/-18,0,0
13647,months,0,0
13648,),0,0
13649,revealed,0,0
13650,equal,0,0
13651,survival,0,0
13652,in,0,0
13653,both,0,0
13654,treatment,0,0
13655,groups,0,0
13656,.,0,0
13657,No,0,1
13658,late,0,0
13659,rebleedings,0,0
13660,have,0,0
13661,occurred,0,0
13662,.,0,0
13663,CONCLUSIONS,0,0
13664,One-year,0,0
13665,clinical,0,0
13666,and,0,0
13667,neuropsychological,0,0
13668,outcomes,0,0
13669,seem,0,0
13670,comparable,0,0
13671,after,0,0
13672,early,0,0
13673,surgical,0,0
13674,and,0,0
13675,endovascular,0,0
13676,treatment,0,0
13677,of,0,0
13678,ruptured,0,0
13679,intracranial,0,0
13680,aneurysms,0,0
13681,.,0,0
13682,The,0,0
13683,long-term,0,0
13684,efficacy,0,0
13685,of,0,0
13686,endovascular,0,0
13687,treatment,0,0
13688,in,0,0
13689,preventing,0,0
13690,rebleeding,0,0
13691,remains,0,0
13692,open,0,0
13693,.,0,0
13694,Commentary,0,0
13695,on,0,0
13696,cytoreduction,1,0
13697,nephrectomy,1,0
13698,in,0,0
13699,metastatic,0,0
13700,renal,0,0
13701,cancer,0,0
13702,:,0,0
13703,the,0,0
13704,results,0,0
13705,of,0,0
13706,Southwest,0,0
13707,Oncology,0,0
13708,Group,0,0
13709,Trial,0,0
13710,8949,0,0
13711,.,0,0
13712,Effects,0,0
13713,of,0,0
13714,nicotine,1,1
13715,on,0,0
13716,regional,0,0
13717,cerebral,0,0
13718,glucose,0,1
13719,metabolism,0,0
13720,in,0,0
13721,awake,0,0
13722,resting,0,0
13723,tobacco,0,0
13724,smokers,0,0
13725,.,0,0
13726,Eleven,0,0
13727,healthy,0,0
13728,tobacco,0,0
13729,smoking,0,0
13730,adult,0,0
13731,male,0,0
13732,volunteers,0,0
13733,of,0,0
13734,mixed,0,0
13735,race,0,0
13736,were,0,0
13737,tobacco,1,0
13738,abstinent,1,0
13739,overnight,0,0
13740,for,0,0
13741,this,0,0
13742,study,0,0
13743,.,0,0
13744,In,0,0
13745,each,0,0
13746,subject,0,0
13747,",",0,0
13748,positron,0,0
13749,emission,0,0
13750,tomographic,0,0
13751,images,0,0
13752,of,0,0
13753,regional,0,0
13754,cerebral,0,0
13755,metabolism,0,0
13756,of,0,0
13757,glucose,0,1
13758,with,0,0
13759,[,0,0
13760,18F,0,0
13761,],0,0
13762,fluorodeoxyglucose,0,1
13763,were,0,0
13764,obtained,0,0
13765,in,0,0
13766,two,0,0
13767,conditions,0,0
13768,in,0,0
13769,the,0,0
13770,morning,0,0
13771,on,0,0
13772,different,0,0
13773,days,0,0
13774,:,0,0
13775,about,0,0
13776,3min,0,0
13777,after,0,0
13778,approximately,1,0
13779,1-2mg,1,1
13780,of,1,1
13781,nasal,1,1
13782,nicotine,1,1
13783,spray,1,1
13784,and,1,1
13785,after,1,0
13786,an,1,0
13787,equivalent,1,0
13788,volume,1,0
13789,of,1,0
13790,an,1,0
13791,active,1,0
13792,placebo,1,1
13793,spray,1,1
13794,of,1,1
13795,oleoresin,1,1
13796,of,1,0
13797,pepper,1,0
13798,in,0,0
13799,a,0,0
13800,random,0,0
13801,counterbalanced,0,0
13802,design,0,0
13803,.,0,0
13804,A,0,0
13805,Siemens/CTI,0,1
13806,931/08-12,0,1
13807,scanner,0,0
13808,with,0,0
13809,the,0,0
13810,capability,0,0
13811,of,0,0
13812,15,0,0
13813,horizontal,0,0
13814,brain,0,0
13815,slices,0,0
13816,was,0,0
13817,used,0,0
13818,.,0,0
13819,The,0,0
13820,images,0,0
13821,were,0,0
13822,further,0,0
13823,converted,0,0
13824,into,0,0
13825,a,0,0
13826,standard,0,0
13827,uniform,0,0
13828,brain,0,0
13829,format,0,0
13830,in,0,0
13831,which,0,0
13832,the,0,0
13833,mean,0,0
13834,data,0,0
13835,of,0,0
13836,all,0,0
13837,11,0,0
13838,subjects,0,0
13839,were,0,0
13840,obtained,0,0
13841,.,0,0
13842,Images,0,0
13843,were,0,0
13844,analysed,0,0
13845,in,0,0
13846,stereotactic,0,0
13847,coordinates,0,0
13848,using,0,0
13849,pixel-wise,0,1
13850,t,0,0
13851,statistics,0,0
13852,and,0,0
13853,a,0,0
13854,smoothed,0,0
13855,Gaussian,0,0
13856,model,0,0
13857,.,0,0
13858,Peak,0,1
13859,plasma,0,1
13860,nicotine,1,1
13861,levels,0,0
13862,varied,0,0
13863,three-fold,0,0
13864,and,0,0
13865,the,0,0
13866,areas,0,0
13867,under,0,0
13868,the,0,0
13869,curve,0,1
13870,(,0,1
13871,0-30min,0,1
13872,),0,1
13873,varied,0,0
13874,seven-fold,0,0
13875,among,0,0
13876,the,0,0
13877,individual,0,0
13878,subjects,0,0
13879,.,0,0
13880,Nicotine,1,1
13881,caused,0,0
13882,a,0,0
13883,small,0,0
13884,overall,0,0
13885,reduction,0,0
13886,in,0,0
13887,global,0,0
13888,cerebral,0,0
13889,metabolism,0,0
13890,of,0,0
13891,glucose,0,1
13892,but,0,0
13893,",",0,0
13894,when,0,0
13895,the,0,0
13896,data,0,0
13897,were,0,0
13898,normalized,0,0
13899,",",0,0
13900,several,0,0
13901,brain,0,0
13902,regions,0,0
13903,showed,0,0
13904,relative,0,0
13905,increases,0,0
13906,in,0,0
13907,activity,0,0
13908,.,0,0
13909,Cerebral,0,0
13910,structures,0,0
13911,specifically,0,0
13912,activated,0,0
13913,by,0,0
13914,nicotine,1,1
13915,(,0,1
13916,nicotine,0,1
13917,minus,0,1
13918,pepper,0,1
13919,",",0,0
13920,Z,0,0
13921,score,0,0
13922,>,0,0
13923,4.0,0,0
13924,),0,0
13925,included,0,0
13926,:,0,0
13927,left,0,0
13928,inferior,0,0
13929,frontal,0,0
13930,gyrus,0,0
13931,",",0,0
13932,left,0,0
13933,posterior,0,1
13934,cingulate,0,0
13935,gyrus,0,0
13936,and,0,0
13937,right,0,0
13938,thalamus,0,0
13939,.,0,0
13940,The,0,0
13941,visual,0,0
13942,cortex,0,0
13943,",",0,0
13944,including,0,0
13945,the,0,0
13946,right,0,0
13947,and,0,0
13948,left,0,0
13949,cuneus,0,0
13950,and,0,0
13951,left,0,0
13952,lateral,0,0
13953,occipito-temporal,0,0
13954,gyrus,0,0
13955,fusiformis,0,1
13956,",",0,0
13957,also,0,0
13958,showed,0,0
13959,an,0,0
13960,increase,0,0
13961,in,0,0
13962,regional,0,0
13963,cerebral,0,0
13964,metabolism,0,0
13965,of,0,0
13966,glucose,0,1
13967,with,0,0
13968,Z,0,0
13969,scores,0,0
13970,>,0,0
13971,3,0,0
13972,.,0,0
13973,6,0,0
13974,.,0,0
13975,Structures,0,0
13976,with,0,0
13977,a,0,0
13978,decrease,0,0
13979,in,0,0
13980,regional,0,0
13981,cerebral,0,0
13982,metabolism,0,0
13983,of,0,0
13984,glucose,0,1
13985,(,0,1
13986,pepper,0,1
13987,minus,0,1
13988,nicotine,0,1
13989,),0,1
13990,were,0,0
13991,the,0,0
13992,left,0,0
13993,insula,0,0
13994,and,0,0
13995,right,0,0
13996,inferior,0,1
13997,occipital,0,0
13998,gyrus,0,0
13999,",",0,0
14000,with,0,0
14001,Z,0,0
14002,scores,0,0
14003,>,0,0
14004,3.5,0,0
14005,.,0,0
14006,Especially,0,0
14007,important,0,0
14008,is,0,0
14009,the,0,0
14010,fact,0,0
14011,that,0,0
14012,the,0,0
14013,thalamus,0,0
14014,is,0,0
14015,activated,0,0
14016,by,0,0
14017,nicotine,1,1
14018,.,1,1
14019,This,0,0
14020,is,0,0
14021,consistent,0,0
14022,with,0,0
14023,the,0,0
14024,high,0,0
14025,density,0,0
14026,of,0,0
14027,nicotinic,0,1
14028,cholinoceptors,0,1
14029,in,0,0
14030,that,0,0
14031,brain,0,0
14032,region,0,0
14033,.,0,0
14034,However,0,0
14035,",",0,0
14036,not,0,0
14037,all,0,0
14038,brain,0,0
14039,regions,0,0
14040,affected,0,0
14041,by,0,0
14042,nicotine,0,1
14043,are,0,0
14044,known,0,0
14045,to,0,0
14046,have,0,0
14047,many,0,0
14048,nicotinic,0,1
14049,cholinoceptors,0,1
14050,.,0,1
14051,The,0,0
14052,results,0,0
14053,are,0,0
14054,discussed,0,0
14055,in,0,0
14056,relation,0,0
14057,to,0,0
14058,the,0,0
14059,cognitive,0,0
14060,effects,0,0
14061,of,0,0
14062,nicotine,1,1
14063,.,1,0
14064,Effect,0,0
14065,of,0,0
14066,secretin,1,1
14067,on,0,0
14068,children,0,0
14069,with,0,0
14070,autism,0,0
14071,:,0,0
14072,a,0,0
14073,randomized,0,0
14074,controlled,0,0
14075,trial,0,0
14076,.,0,0
14077,To,0,0
14078,determine,0,0
14079,the,0,0
14080,effect,0,0
14081,of,0,0
14082,intravenous,1,1
14083,porcine,1,1
14084,secretin,1,1
14085,on,0,0
14086,autistic,0,0
14087,behaviours,0,0
14088,in,0,0
14089,children,0,0
14090,aged,0,0
14091,2,0,0
14092,to,0,0
14093,7,0,0
14094,years,0,0
14095,",",0,0
14096,the,0,0
14097,effects,0,0
14098,of,0,0
14099,secretin,0,1
14100,on,0,1
14101,(,0,1
14102,1,0,0
14103,),0,0
14104,performance,0,0
14105,on,0,0
14106,a,0,0
14107,standardized,0,0
14108,language,0,0
14109,measure,0,0
14110,",",0,0
14111,and,0,0
14112,(,0,1
14113,2,0,1
14114,),0,0
14115,autistic,0,1
14116,behaviours,0,0
14117,",",0,0
14118,as,0,0
14119,rated,0,0
14120,by,0,0
14121,parents,0,0
14122,and,0,0
14123,child,0,0
14124,development,0,0
14125,professionals,0,0
14126,was,0,0
14127,examined,0,0
14128,.,0,0
14129,Employing,0,0
14130,a,0,0
14131,randomized,0,0
14132,",",0,0
14133,double-blind,0,1
14134,",",0,1
14135,placebo-controlled,0,1
14136,design,0,0
14137,",",0,0
14138,95,0,0
14139,participants,0,0
14140,were,0,0
14141,assigned,0,0
14142,to,0,0
14143,one,0,0
14144,of,0,0
14145,two,0,0
14146,groups,0,0
14147,and,0,0
14148,administered,0,1
14149,a,0,0
14150,single,0,0
14151,dose,0,1
14152,of,0,0
14153,either,0,0
14154,secretin,1,1
14155,or,1,1
14156,placebo,1,1
14157,.,1,1
14158,A,0,1
14159,follow-up,0,0
14160,assessment,0,0
14161,was,0,0
14162,conducted,0,0
14163,3,0,0
14164,weeks,0,0
14165,after,0,0
14166,the,0,0
14167,injection,0,1
14168,.,0,1
14169,No,0,1
14170,significant,0,0
14171,differences,0,0
14172,in,0,0
14173,language,0,0
14174,or,0,0
14175,autistic,0,0
14176,behaviour,0,0
14177,measures,0,0
14178,were,0,0
14179,observed,0,0
14180,at,0,0
14181,the,0,0
14182,3-week,0,1
14183,follow-up,0,1
14184,between,0,0
14185,the,0,0
14186,groups,0,0
14187,.,0,0
14188,Also,0,0
14189,",",0,0
14190,there,0,0
14191,was,0,0
14192,no,0,0
14193,significant,0,0
14194,difference,0,0
14195,in,0,0
14196,the,0,0
14197,proportion,0,0
14198,of,0,0
14199,individuals,0,0
14200,who,0,0
14201,improved,0,0
14202,by,0,0
14203,>,0,0
14204,or,0,0
14205,=,0,0
14206,6,0,0
14207,points,0,0
14208,on,0,0
14209,the,0,0
14210,language,0,0
14211,measure,0,0
14212,at,0,0
14213,follow-up,0,0
14214,.,0,0
14215,This,0,0
14216,study,0,0
14217,showed,0,0
14218,no,0,0
14219,significant,0,0
14220,effects,0,0
14221,of,0,0
14222,secretin,0,1
14223,on,0,0
14224,children,0,0
14225,with,0,0
14226,autism,0,0
14227,.,0,0
14228,Our,0,0
14229,results,0,0
14230,are,0,0
14231,consistent,0,0
14232,with,0,0
14233,a,0,0
14234,systematic,0,0
14235,review,0,0
14236,of,0,0
14237,randomized,0,0
14238,controlled,0,0
14239,trials,0,0
14240,evaluating,0,0
14241,the,0,0
14242,effect,0,0
14243,of,0,0
14244,secretin,0,1
14245,in,0,0
14246,children,0,0
14247,with,0,0
14248,autism,0,0
14249,.,0,0
14250,Spatial,1,0
14251,orientation,1,0
14252,adjustments,1,0
14253,in,0,0
14254,children,0,0
14255,with,0,0
14256,autism,0,0
14257,in,0,0
14258,Hong,0,0
14259,Kong,0,0
14260,.,0,0
14261,Abnormal,0,0
14262,spatial,0,0
14263,orientation,0,0
14264,and,0,0
14265,body,0,0
14266,postures,0,0
14267,in,0,0
14268,children,0,0
14269,with,0,0
14270,autism,0,0
14271,often,0,0
14272,interfere,0,0
14273,with,0,0
14274,visual,0,0
14275,abilities,0,0
14276,to,0,0
14277,attend,0,0
14278,tasks,0,0
14279,and,0,0
14280,social,0,0
14281,interactions,0,0
14282,.,0,0
14283,Twenty-four,0,0
14284,children,0,0
14285,diagnosed,0,0
14286,with,0,0
14287,autism,0,0
14288,from,0,0
14289,Kowloon,0,0
14290,",",0,0
14291,Hong,0,0
14292,Kong,0,0
14293,were,0,0
14294,assessed,0,0
14295,for,0,0
14296,spatial,0,0
14297,orientation,0,0
14298,and,0,0
14299,spatial,0,0
14300,management,0,0
14301,abilities,0,0
14302,.,0,0
14303,Positive,0,0
14304,changes,0,0
14305,in,0,0
14306,spatial,0,0
14307,orientation,0,0
14308,were,0,0
14309,evident,0,0
14310,when,0,0
14311,the,0,0
14312,children,0,0
14313,wore,1,0
14314,ambient,1,0
14315,prism,1,0
14316,lenses,1,0
14317,and,0,0
14318,included,0,0
14319,changes,0,0
14320,in,0,0
14321,posture,0,0
14322,from,0,0
14323,slanted,0,0
14324,to,0,0
14325,erect,0,0
14326,.,0,0
14327,Adjustments,0,0
14328,in,0,0
14329,spatial,0,0
14330,management,0,0
14331,were,0,0
14332,evident,0,0
14333,in,0,0
14334,improved,0,0
14335,ball,0,0
14336,catching,0,0
14337,ability,0,0
14338,",",0,0
14339,a,0,0
14340,task,0,0
14341,requiring,0,0
14342,visual,0,0
14343,tracking,0,0
14344,and,0,0
14345,eye-hand,0,0
14346,coordination,0,0
14347,.,0,0
14348,The,0,0
14349,findings,0,0
14350,suggest,0,0
14351,that,0,0
14352,alterations,1,0
14353,to,1,0
14354,the,1,0
14355,sensory,1,0
14356,systems,1,0
14357,may,0,0
14358,lead,0,0
14359,to,0,0
14360,behavioral,0,0
14361,change,0,0
14362,in,0,0
14363,some,0,0
14364,children,0,0
14365,.,0,0
14366,Comparison,0,0
14367,of,0,0
14368,the,0,0
14369,efficacy,0,0
14370,of,0,0
14371,fluoxetine,1,1
14372,alone,1,0
14373,vs.,1,0
14374,fluoxetine,1,0
14375,plus,1,0
14376,local,1,1
14377,lidocaine,1,1
14378,ointment,1,1
14379,in,0,0
14380,the,0,0
14381,treatment,0,0
14382,of,0,0
14383,premature,0,0
14384,ejaculation,0,0
14385,.,0,0
14386,OBJECTIVE,0,0
14387,The,0,0
14388,present,0,0
14389,study,0,0
14390,compares,0,0
14391,the,0,0
14392,efficacy,0,0
14393,and,0,0
14394,side,0,0
14395,effects,0,0
14396,of,0,0
14397,fluoxetine,1,0
14398,alone,1,0
14399,vs.,1,0
14400,fluoxetine,1,0
14401,plus,1,0
14402,local,1,1
14403,lidocaine,1,1
14404,ointment,1,1
14405,in,0,0
14406,the,0,0
14407,treatment,0,0
14408,of,0,0
14409,premature,0,0
14410,ejaculation,0,0
14411,.,0,0
14412,METHODS,0,0
14413,Forty-three,0,0
14414,patients,0,0
14415,suffering,0,0
14416,from,0,0
14417,premature,0,0
14418,ejaculation,0,0
14419,were,0,0
14420,studied,0,0
14421,.,0,0
14422,The,0,0
14423,exclusion,0,0
14424,criteria,0,0
14425,were,0,0
14426,erectile,0,0
14427,dysfunction,0,0
14428,",",0,0
14429,loss,0,0
14430,of,0,0
14431,libido,0,0
14432,",",0,1
14433,alcohol,0,1
14434,and,0,1
14435,substance,0,1
14436,abuse,0,0
14437,",",0,0
14438,mental,0,0
14439,retardation,0,0
14440,",",0,0
14441,diabetes,0,0
14442,mellitus,0,0
14443,",",0,0
14444,thyroid,0,0
14445,disease,0,0
14446,",",0,0
14447,hypotension,0,0
14448,",",0,0
14449,previous,0,0
14450,use,0,0
14451,of,0,0
14452,these,0,0
14453,drugs,0,1
14454,and,0,1
14455,urogenital,0,1
14456,infections,0,0
14457,.,0,0
14458,The,0,0
14459,patients,0,0
14460,',0,0
14461,ages,0,0
14462,ranged,0,0
14463,from,0,0
14464,19,0,0
14465,to,0,0
14466,48,0,0
14467,years,0,0
14468,(,0,0
14469,mean,0,0
14470,age,0,0
14471,28,0,0
14472,+/-,0,0
14473,1.6,0,0
14474,),0,0
14475,.,0,0
14476,They,0,0
14477,had,0,0
14478,regular,0,0
14479,sexual,0,0
14480,lives,0,0
14481,.,0,0
14482,They,0,0
14483,had,0,0
14484,normal,0,0
14485,psychiatric,0,0
14486,consultation,0,0
14487,and,0,0
14488,the,0,0
14489,Glombock,0,1
14490,Rast,0,1
14491,Sexual,0,1
14492,Satisfactory,0,1
14493,Test,0,1
14494,(,0,1
14495,GRISS,0,1
14496,),0,1
14497,psychiatric,0,0
14498,test,0,0
14499,were,0,0
14500,in,0,0
14501,accordance,0,0
14502,with,0,0
14503,premature,0,0
14504,ejaculation,0,0
14505,.,0,0
14506,RESULTS,0,0
14507,The,0,0
14508,patients,0,0
14509,were,0,0
14510,assigned,0,0
14511,to,0,0
14512,two,0,0
14513,groups,0,0
14514,.,0,0
14515,Twenty-six,0,0
14516,patients,0,0
14517,",",0,0
14518,aged,0,0
14519,21,0,0
14520,to,0,0
14521,36,0,0
14522,years,0,0
14523,(,0,0
14524,mean,0,0
14525,age,0,0
14526,27,0,0
14527,),0,0
14528,",",0,0
14529,received,0,0
14530,only,0,0
14531,fluoxetine,1,1
14532,20,0,1
14533,mg/day,0,1
14534,(,0,1
14535,1,0,1
14536,capsule,0,1
14537,),0,1
14538,for,0,0
14539,a,0,0
14540,week,0,0
14541,which,0,0
14542,was,0,0
14543,later,0,0
14544,increased,0,0
14545,to,0,0
14546,40,0,1
14547,mg/day,0,1
14548,(,0,1
14549,2,0,1
14550,capsules,0,1
14551,),0,1
14552,.,0,0
14553,Seventeen,0,0
14554,patients,0,0
14555,",",0,0
14556,aged,0,0
14557,19,0,0
14558,to,0,0
14559,48,0,0
14560,years,0,0
14561,(,0,0
14562,mean,0,0
14563,age,0,0
14564,31,0,0
14565,),0,0
14566,",",0,0
14567,were,0,0
14568,given,0,1
14569,fluoxetine,1,1
14570,20,0,1
14571,mg/day,0,1
14572,plus,0,0
14573,local,0,0
14574,application,0,0
14575,of,0,0
14576,lidocaine,1,1
14577,ointment,1,1
14578,.,1,1
14579,The,0,0
14580,patients,0,0
14581,and,0,0
14582,partners,0,0
14583,were,0,0
14584,re-evaluated,0,0
14585,8,0,0
14586,weeks,0,0
14587,after,0,0
14588,the,0,0
14589,treatment,0,0
14590,.,0,0
14591,The,0,0
14592,results,0,0
14593,were,0,0
14594,classified,0,0
14595,as,0,0
14596,unsuccessful,0,0
14597,",",0,0
14598,improvement,0,0
14599,and,0,0
14600,cure,0,0
14601,.,0,0
14602,The,0,0
14603,chi-square,0,0
14604,test,0,0
14605,was,0,0
14606,used,0,0
14607,for,0,0
14608,statistical,0,0
14609,analysis,0,0
14610,.,0,0
14611,In,0,0
14612,the,0,0
14613,fluoxetine,0,1
14614,group,0,1
14615,",",0,0
14616,8,0,0
14617,(,0,0
14618,30.8,0,0
14619,%,0,0
14620,),0,0
14621,patients,0,0
14622,cured,0,0
14623,",",0,0
14624,11,0,0
14625,(,0,0
14626,42.2,0,0
14627,%,0,0
14628,),0,0
14629,showed,0,0
14630,improvement,0,0
14631,and,0,0
14632,there,0,0
14633,were,0,0
14634,7,0,0
14635,failures,0,0
14636,(,0,0
14637,26.9,0,0
14638,%,0,0
14639,),0,0
14640,.,0,0
14641,In,0,0
14642,the,0,0
14643,combination,0,0
14644,treatment,0,0
14645,group,0,0
14646,",",0,0
14647,9,0,0
14648,(,0,0
14649,52.9,0,0
14650,%,0,0
14651,),0,0
14652,patients,0,0
14653,cured,0,0
14654,",",0,0
14655,improvement,0,0
14656,was,0,0
14657,observed,0,0
14658,in,0,0
14659,5,0,0
14660,(,0,0
14661,29.4,0,0
14662,%,0,0
14663,),0,0
14664,and,0,0
14665,failure,0,0
14666,in,0,0
14667,3,0,0
14668,(,0,0
14669,17.6,0,0
14670,%,0,0
14671,),0,0
14672,.,0,0
14673,Side,0,0
14674,effects,0,0
14675,in,0,0
14676,group,0,0
14677,I,0,0
14678,were,0,0
14679,observed,0,0
14680,in,0,0
14681,6,0,0
14682,patients,0,0
14683,(,0,0
14684,23,0,0
14685,%,0,0
14686,),0,0
14687,and,0,0
14688,in,0,0
14689,5,0,0
14690,(,0,0
14691,29.4,0,0
14692,%,0,0
14693,),0,0
14694,in,0,0
14695,group,0,0
14696,II,0,0
14697,.,0,0
14698,There,0,0
14699,were,0,0
14700,no,0,0
14701,statistical,0,0
14702,differences,0,0
14703,between,0,0
14704,the,0,0
14705,two,0,0
14706,groups,0,0
14707,according,0,0
14708,to,0,0
14709,the,0,0
14710,side,0,0
14711,effects,0,0
14712,(,0,0
14713,p,0,0
14714,>,0,0
14715,0.01,0,0
14716,),0,0
14717,.,0,0
14718,No,0,1
14719,patients,0,0
14720,were,0,0
14721,excluded,0,0
14722,from,0,0
14723,the,0,0
14724,study,0,0
14725,due,0,0
14726,to,0,0
14727,side,0,0
14728,effects,0,0
14729,.,0,0
14730,CONCLUSION,0,0
14731,The,0,0
14732,combination,0,0
14733,of,0,0
14734,fluoxetine,1,1
14735,plus,0,0
14736,local,0,0
14737,application,0,0
14738,of,0,0
14739,lidocaine,1,1
14740,ointment,0,1
14741,was,0,0
14742,found,0,0
14743,to,0,0
14744,be,0,0
14745,more,0,0
14746,effective,0,0
14747,than,0,0
14748,fluoxetine,1,1
14749,alone,0,0
14750,in,0,0
14751,the,0,0
14752,treatment,0,0
14753,of,0,0
14754,premature,0,0
14755,ejaculation,0,0
14756,.,0,0
14757,However,0,0
14758,",",0,0
14759,the,0,0
14760,results,0,0
14761,should,0,0
14762,be,0,0
14763,confirmed,0,0
14764,in,0,0
14765,further,0,0
14766,studies,0,0
14767,with,0,0
14768,a,0,0
14769,placebo,0,1
14770,group,0,0
14771,to,0,0
14772,rule,0,0
14773,out,0,0
14774,the,0,0
14775,placebo,0,1
14776,effect,0,0
14777,.,0,0
14778,Beneficial,0,0
14779,effects,0,0
14780,of,0,0
14781,a,0,0
14782,soy-based,1,1
14783,dietary,1,1
14784,supplement,1,1
14785,on,0,0
14786,lipid,0,0
14787,levels,0,0
14788,and,0,0
14789,cardiovascular,0,0
14790,risk,0,0
14791,markers,0,0
14792,in,0,0
14793,type,0,0
14794,2,0,0
14795,diabetic,0,0
14796,subjects,0,0
14797,.,0,0
14798,OBJECTIVE,0,0
14799,Consumption,0,0
14800,of,0,0
14801,soy,0,1
14802,protein,0,0
14803,has,0,0
14804,recently,0,0
14805,been,0,0
14806,shown,0,0
14807,to,0,0
14808,improve,0,0
14809,the,0,0
14810,blood,0,0
14811,lipid,0,0
14812,levels,0,0
14813,in,0,0
14814,nondiabetic,0,0
14815,subjects,0,0
14816,.,0,0
14817,The,0,0
14818,purpose,0,0
14819,of,0,0
14820,this,0,0
14821,study,0,0
14822,was,0,0
14823,to,0,0
14824,evaluate,0,0
14825,if,0,0
14826,a,0,0
14827,dietary,0,1
14828,supplement,0,1
14829,of,0,1
14830,soy,1,1
14831,protein,1,1
14832,",",1,1
14833,isoflavones,1,1
14834,",",1,1
14835,and,1,0
14836,cotyledon,1,0
14837,fiber,1,0
14838,(,1,1
14839,Abalon,1,1
14840,),1,1
14841,affects,0,0
14842,cardiovascular,0,0
14843,risk,0,0
14844,markers,0,0
14845,",",0,0
14846,blood,0,1
14847,glucose,0,1
14848,",",0,1
14849,and,0,1
14850,insulin,0,1
14851,levels,0,0
14852,in,0,0
14853,type,0,0
14854,2,0,0
14855,diabetic,0,0
14856,subjects,0,0
14857,.,0,0
14858,RESEARCH,0,0
14859,DESIGN,0,1
14860,AND,0,1
14861,METHODS,0,1
14862,Twenty,0,0
14863,type,0,0
14864,2,0,0
14865,diabetic,0,0
14866,subjects,0,0
14867,participated,0,0
14868,in,0,0
14869,a,0,0
14870,crossover,0,1
14871,trial,0,1
14872,.,0,0
14873,They,0,0
14874,were,0,0
14875,randomized,0,0
14876,to,0,1
14877,double-blind,0,1
14878,supplementation,0,1
14879,for,0,1
14880,6,1,0
14881,weeks,1,0
14882,with,1,1
14883,Abalon,1,1
14884,(,1,1
14885,soy,1,1
14886,protein,1,1
14887,[,0,1
14888,50,0,1
14889,g/day,0,1
14890,],0,1
14891,with,0,0
14892,high,0,0
14893,levels,0,0
14894,of,0,0
14895,isoflavones,1,1
14896,[,0,0
14897,minimum,0,0
14898,165,0,0
14899,mg/day,0,1
14900,],0,0
14901,and,0,0
14902,cotyledon,1,0
14903,fiber,1,0
14904,[,0,0
14905,20,0,1
14906,g/day,0,1
14907,],0,1
14908,),0,1
14909,or,0,1
14910,placebo,1,1
14911,(,0,1
14912,casein,0,1
14913,[,0,1
14914,50,0,1
14915,g/day,0,1
14916,],0,1
14917,and,0,1
14918,cellulose,0,1
14919,[,0,1
14920,20,0,1
14921,g/day,0,1
14922,],0,1
14923,),0,1
14924,",",0,0
14925,separated,0,0
14926,by,0,0
14927,a,0,0
14928,3-week,0,1
14929,wash-out,0,1
14930,period,0,1
14931,.,0,0
14932,RESULTS,0,0
14933,The,0,0
14934,results,0,0
14935,are,0,0
14936,expressed,0,0
14937,as,0,0
14938,means,0,0
14939,+/-,0,0
14940,SD,0,0
14941,.,0,0
14942,The,0,0
14943,percentage,0,0
14944,mean,0,0
14945,treatment,0,0
14946,difference,0,0
14947,between,0,0
14948,Abalon,1,1
14949,and,0,1
14950,placebo,1,1
14951,demonstrated,0,0
14952,significantly,0,0
14953,lower,0,0
14954,mean,0,0
14955,values,0,0
14956,after,0,0
14957,Abalon,1,0
14958,for,0,0
14959,LDL,0,1
14960,cholesterol,0,1
14961,(,0,0
14962,10,0,0
14963,+/-,0,0
14964,15,0,0
14965,%,0,0
14966,",",0,0
14967,P,0,0
14968,<,0,0
14969,0.05,0,0
14970,),0,0
14971,",",0,0
14972,LDL/UHDL,0,1
14973,ratio,0,1
14974,(,0,0
14975,12,0,0
14976,+/-,0,0
14977,18,0,0
14978,%,0,0
14979,",",0,0
14980,P,0,0
14981,<,0,0
14982,0.05,0,0
14983,),0,0
14984,",",0,0
14985,apolipoprotein,0,1
14986,(,0,1
14987,apo,0,1
14988,),0,1
14989,B100,0,1
14990,(,0,0
14991,30,0,0
14992,+/-,0,0
14993,38,0,0
14994,%,0,0
14995,",",0,0
14996,P,0,0
14997,<,0,0
14998,0.01,0,0
14999,),0,0
15000,",",0,0
15001,triglycerides,0,1
15002,(,0,0
15003,22,0,0
15004,+/-,0,0
15005,10,0,0
15006,%,0,0
15007,",",0,0
15008,P,0,0
15009,<,0,0
15010,0.05,0,0
15011,),0,0
15012,",",0,0
15013,and,0,1
15014,homocysteine,0,1
15015,(,0,0
15016,14,0,0
15017,+/-,0,0
15018,21,0,0
15019,%,0,0
15020,",",0,0
15021,P,0,0
15022,<,0,0
15023,0.01,0,0
15024,),0,0
15025,",",0,0
15026,whereas,0,0
15027,the,0,0
15028,total,0,0
15029,cholesterol,0,1
15030,value,0,0
15031,tended,0,0
15032,to,0,0
15033,be,0,0
15034,less,0,0
15035,significant,0,0
15036,but,0,0
15037,still,0,0
15038,lower,0,0
15039,(,0,0
15040,8,0,0
15041,+/-,0,0
15042,15,0,0
15043,%,0,0
15044,",",0,0
15045,P,0,0
15046,<,0,0
15047,0.08,0,0
15048,),0,0
15049,.,0,0
15050,No,0,1
15051,change,0,0
15052,occurred,0,0
15053,in,0,0
15054,HDL,0,1
15055,cholesterol,0,1
15056,",",0,1
15057,apo,0,1
15058,B100/apo,0,1
15059,A1,0,1
15060,ratio,0,0
15061,",",0,0
15062,plasminogen,0,1
15063,activator,0,1
15064,inhibitor,0,1
15065,1,0,1
15066,",",0,0
15067,factor,0,0
15068,VIIc,0,0
15069,",",0,0
15070,von,0,0
15071,Willebrand,0,0
15072,factor,0,0
15073,",",0,0
15074,fibrinogen,0,1
15075,",",0,1
15076,lipoprotein,0,1
15077,(,0,1
15078,a,0,1
15079,),0,1
15080,",",0,0
15081,glucose,0,1
15082,",",0,1
15083,HbA1c,0,1
15084,",",0,0
15085,or,0,0
15086,24-h,0,1
15087,blood,0,1
15088,pressure,0,1
15089,.,0,0
15090,CONCLUSIONS,0,0
15091,These,0,0
15092,results,0,0
15093,indicate,0,0
15094,beneficial,0,0
15095,effects,0,0
15096,of,0,0
15097,dietary,0,1
15098,supplementation,0,1
15099,with,0,1
15100,Abalon,1,1
15101,on,0,0
15102,cardiovascular,0,0
15103,risk,0,0
15104,markers,0,0
15105,in,0,0
15106,type,0,0
15107,2,0,0
15108,diabetic,0,0
15109,subjects,0,0
15110,.,0,0
15111,This,0,0
15112,improvement,0,0
15113,is,0,0
15114,seen,0,0
15115,even,0,0
15116,in,0,0
15117,individuals,0,0
15118,with,0,0
15119,near-normal,0,0
15120,lipid,0,0
15121,values,0,0
15122,.,0,0
15123,Effect,0,0
15124,of,0,0
15125,protein,1,0
15126,ingestion,1,1
15127,on,0,0
15128,the,0,0
15129,glucose,0,1
15130,appearance,0,0
15131,rate,0,0
15132,in,0,0
15133,people,0,0
15134,with,0,0
15135,type,0,0
15136,2,0,0
15137,diabetes,0,0
15138,.,0,1
15139,Amino,0,1
15140,acids,0,1
15141,derived,0,0
15142,from,0,0
15143,ingested,0,0
15144,protein,0,0
15145,are,0,0
15146,potential,0,0
15147,substrates,0,0
15148,for,0,0
15149,gluconeogenesis,0,1
15150,.,0,0
15151,However,0,0
15152,",",0,0
15153,several,0,0
15154,laboratories,0,0
15155,have,0,0
15156,reported,0,0
15157,that,0,0
15158,protein,0,0
15159,ingestion,0,1
15160,does,0,0
15161,not,0,0
15162,result,0,0
15163,in,0,0
15164,an,0,0
15165,increase,0,0
15166,in,0,0
15167,the,0,0
15168,circulating,0,0
15169,glucose,0,1
15170,concentration,0,0
15171,in,0,0
15172,people,0,0
15173,with,0,0
15174,or,0,0
15175,without,0,0
15176,type,0,0
15177,2,0,0
15178,diabetes,0,0
15179,.,0,0
15180,The,0,0
15181,reason,0,0
15182,for,0,0
15183,this,0,0
15184,has,0,0
15185,remained,0,0
15186,unclear,0,0
15187,.,0,0
15188,In,0,0
15189,people,0,0
15190,without,0,0
15191,diabetes,0,0
15192,it,0,0
15193,seems,0,0
15194,to,0,0
15195,be,0,0
15196,due,0,0
15197,to,0,0
15198,less,0,0
15199,glucose,0,1
15200,being,0,0
15201,produced,0,0
15202,and,0,0
15203,entering,0,0
15204,the,0,0
15205,circulation,0,0
15206,than,0,0
15207,the,0,0
15208,calculated,0,0
15209,theoretical,0,0
15210,amount,0,0
15211,.,0,0
15212,Therefore,0,0
15213,",",0,0
15214,we,0,0
15215,were,0,0
15216,interested,0,0
15217,in,0,0
15218,determining,0,0
15219,whether,0,0
15220,this,0,0
15221,also,0,0
15222,was,0,0
15223,the,0,0
15224,case,0,0
15225,in,0,0
15226,people,0,0
15227,with,0,0
15228,type,0,0
15229,2,0,0
15230,diabetes,0,0
15231,.,0,0
15232,Ten,0,0
15233,male,0,0
15234,subjects,0,0
15235,with,0,0
15236,untreated,0,0
15237,type,0,0
15238,2,0,0
15239,diabetes,0,0
15240,were,0,0
15241,given,0,0
15242,",",0,0
15243,in,0,0
15244,random,0,0
15245,sequence,0,0
15246,",",0,0
15247,50,1,0
15248,g,1,0
15249,protein,1,0
15250,in,1,0
15251,the,1,0
15252,form,1,0
15253,of,1,0
15254,very,1,0
15255,lean,1,0
15256,beef,1,1
15257,or,1,0
15258,only,1,0
15259,water,1,0
15260,at,1,0
15261,0800,1,1
15262,h,1,1
15263,and,1,0
15264,studied,1,0
15265,over,1,0
15266,the,1,0
15267,subsequent,1,0
15268,8,1,0
15269,h.,1,1
15270,Protein,1,1
15271,ingestion,0,1
15272,resulted,0,0
15273,in,0,0
15274,an,0,0
15275,increase,0,0
15276,in,0,0
15277,circulating,0,0
15278,insulin,0,1
15279,",",0,1
15280,C-peptide,0,1
15281,",",0,1
15282,glucagon,0,1
15283,",",0,0
15284,alpha,0,0
15285,amino,0,0
15286,and,0,0
15287,urea,0,1
15288,nitrogen,0,0
15289,",",0,0
15290,and,0,1
15291,triglycerides,0,1
15292,;,0,1
15293,a,0,0
15294,decrease,0,0
15295,in,0,0
15296,nonesterified,0,1
15297,fatty,0,1
15298,acids,0,1
15299,;,0,1
15300,and,0,0
15301,a,0,0
15302,modest,0,0
15303,increase,0,0
15304,in,0,0
15305,respiratory,0,0
15306,quotient,0,0
15307,.,0,0
15308,The,0,0
15309,total,0,0
15310,amount,0,0
15311,of,0,0
15312,protein,0,0
15313,deaminated,0,0
15314,and,0,0
15315,the,0,0
15316,amino,0,0
15317,groups,0,0
15318,incorporated,0,0
15319,into,0,0
15320,urea,0,1
15321,was,0,0
15322,calculated,0,0
15323,to,0,0
15324,be,0,0
15325,approximately,0,0
15326,20-23,0,0
15327,g.,0,0
15328,The,0,0
15329,net,0,0
15330,amount,0,0
15331,of,0,0
15332,glucose,0,1
15333,estimated,0,0
15334,to,0,0
15335,be,0,0
15336,produced,0,0
15337,",",0,0
15338,based,0,0
15339,on,0,0
15340,the,0,0
15341,quantity,0,0
15342,of,0,0
15343,amino,0,0
15344,acids,0,0
15345,deaminated,0,0
15346,",",0,0
15347,was,0,0
15348,approximately,0,0
15349,11-13,0,0
15350,g.,0,0
15351,However,0,0
15352,",",0,0
15353,the,0,0
15354,amount,0,0
15355,of,0,0
15356,glucose,0,1
15357,appearing,0,0
15358,in,0,0
15359,the,0,0
15360,circulation,0,0
15361,was,0,0
15362,only,0,0
15363,approximately,0,0
15364,2,0,0
15365,g.,0,0
15366,The,0,0
15367,peripheral,0,0
15368,plasma,0,1
15369,glucose,0,1
15370,concentration,0,0
15371,decreased,0,0
15372,by,0,0
15373,approximately,0,0
15374,1,0,0
15375,mM,0,0
15376,after,0,0
15377,ingestion,0,1
15378,of,0,0
15379,either,0,0
15380,protein,0,0
15381,or,0,0
15382,water,0,0
15383,",",0,0
15384,confirming,0,0
15385,that,0,0
15386,ingested,0,0
15387,protein,0,0
15388,does,0,0
15389,not,0,0
15390,result,0,0
15391,in,0,0
15392,a,0,0
15393,net,0,0
15394,increase,0,0
15395,in,0,0
15396,glucose,0,1
15397,concentration,0,0
15398,",",0,0
15399,and,0,0
15400,results,0,0
15401,in,0,0
15402,only,0,0
15403,a,0,0
15404,modest,0,0
15405,increase,0,0
15406,in,0,0
15407,the,0,0
15408,rate,0,0
15409,of,0,0
15410,glucose,0,1
15411,disappearance,0,0
15412,.,0,0
15413,Effectiveness,0,0
15414,of,0,0
15415,N,0,1
15416,",",0,0
15417,N-dimethylglycine,0,1
15418,in,0,0
15419,autism,0,0
15420,and,0,0
15421,pervasive,0,0
15422,developmental,0,0
15423,disorder,0,0
15424,.,0,0
15425,N,1,0
15426,",",1,0
15427,N-dimethylglycine,1,1
15428,",",0,1
15429,a,0,1
15430,dietary,0,1
15431,supplement,0,1
15432,",",0,1
15433,has,0,0
15434,been,0,0
15435,reported,0,0
15436,to,0,0
15437,be,0,0
15438,beneficial,0,0
15439,in,0,0
15440,children,0,0
15441,with,0,0
15442,autism,0,0
15443,and,0,0
15444,pervasive,0,0
15445,developmental,0,0
15446,disorder,0,0
15447,.,0,0
15448,We,0,0
15449,examined,0,0
15450,the,0,0
15451,effectiveness,0,0
15452,of,0,0
15453,dimethylglycine,0,1
15454,in,0,0
15455,children,0,0
15456,with,0,0
15457,autism,0,0
15458,and,0,0
15459,pervasive,0,0
15460,developmental,0,0
15461,disorder,0,0
15462,in,0,0
15463,a,0,0
15464,double-blind,0,1
15465,",",0,1
15466,placebo-controlled,0,1
15467,study,0,0
15468,.,0,0
15469,Thirty-seven,0,0
15470,children,0,0
15471,between,0,0
15472,3,0,0
15473,and,0,0
15474,11,0,0
15475,years,0,0
15476,of,0,0
15477,age,0,0
15478,with,0,0
15479,a,0,0
15480,diagnosis,0,0
15481,of,0,0
15482,autism,0,0
15483,and/or,0,0
15484,pervasive,0,0
15485,developmental,0,0
15486,disorder,0,0
15487,were,0,0
15488,gender,0,0
15489,and,0,0
15490,age,0,0
15491,matched,0,0
15492,and,0,0
15493,randomly,0,0
15494,assigned,0,0
15495,to,0,0
15496,receive,1,0
15497,either,1,0
15498,placebo,1,1
15499,or,1,1
15500,dimethylglycine,1,1
15501,for,1,0
15502,4,1,0
15503,weeks,1,0
15504,.,1,0
15505,All,0,0
15506,children,0,0
15507,were,0,0
15508,assessed,0,0
15509,before,0,0
15510,and,0,0
15511,after,0,0
15512,treatment,0,0
15513,on,0,0
15514,two,1,0
15515,behavioral,1,0
15516,measures,1,0
15517,",",1,0
15518,the,1,0
15519,Vineland,1,0
15520,Maladaptive,1,0
15521,Behavior,1,0
15522,Domain,1,0
15523,and,1,0
15524,the,1,0
15525,Aberrant,1,0
15526,Behavior,1,0
15527,Checklist,1,0
15528,.,1,0
15529,Standardized,0,0
15530,neurologic,0,0
15531,examinations,0,0
15532,before,0,0
15533,and,0,0
15534,after,0,0
15535,treatment,0,0
15536,on,0,0
15537,33,0,0
15538,children,0,0
15539,showed,0,0
15540,no,0,0
15541,change,0,0
15542,.,0,0
15543,An,0,1
15544,overall,0,0
15545,improvement,0,0
15546,on,0,0
15547,all,0,0
15548,behavioral,0,0
15549,measures,0,0
15550,was,0,0
15551,observed,0,0
15552,for,0,0
15553,both,0,0
15554,the,0,0
15555,placebo,0,1
15556,and,0,1
15557,the,0,1
15558,dimethylglycine,0,1
15559,groups,0,0
15560,.,0,0
15561,However,0,0
15562,",",0,0
15563,the,0,0
15564,improvement,0,0
15565,among,0,0
15566,the,0,0
15567,children,0,0
15568,who,0,0
15569,received,0,0
15570,dimethylglycine,0,1
15571,was,0,0
15572,not,0,0
15573,statistically,0,0
15574,different,0,0
15575,from,0,0
15576,the,0,0
15577,improvement,0,0
15578,observed,0,0
15579,among,0,0
15580,the,0,0
15581,children,0,0
15582,who,0,0
15583,received,0,0
15584,the,0,0
15585,placebo,0,1
15586,.,0,0
15587,The,0,0
15588,children,0,0
15589,who,0,0
15590,participated,0,0
15591,in,0,0
15592,this,0,0
15593,study,0,0
15594,were,0,0
15595,a,0,0
15596,heterogeneous,0,0
15597,group,0,0
15598,",",0,0
15599,and,0,0
15600,their,0,0
15601,apparent,0,0
15602,responses,0,0
15603,to,0,0
15604,the,0,0
15605,dimethylglycine,0,1
15606,varied,0,0
15607,.,0,0
15608,Some,0,0
15609,children,0,0
15610,appeared,0,0
15611,to,0,0
15612,respond,0,0
15613,positively,0,0
15614,to,0,0
15615,the,0,0
15616,dimethylglycine,0,1
15617,",",0,0
15618,and,0,0
15619,there,0,0
15620,was,0,0
15621,a,0,0
15622,smaller,0,0
15623,proportion,0,0
15624,of,0,0
15625,negative,0,0
15626,changes,0,0
15627,in,0,0
15628,the,0,0
15629,dimethylglycine,0,1
15630,group,0,0
15631,",",0,0
15632,but,0,0
15633,the,0,0
15634,quantitative,0,0
15635,changes,0,0
15636,in,0,0
15637,the,0,0
15638,dimethylglycine,0,1
15639,behavioral,0,1
15640,assessments,0,0
15641,were,0,0
15642,not,0,0
15643,significantly,0,0
15644,different,0,0
15645,from,0,0
15646,what,0,0
15647,was,0,0
15648,observed,0,0
15649,among,0,0
15650,children,0,0
15651,who,0,0
15652,received,0,0
15653,placebo,0,1
15654,.,0,0
15655,Clinical,0,0
15656,and,0,0
15657,microbial,0,0
15658,evaluation,0,0
15659,of,0,0
15660,a,0,0
15661,histatin-containing,1,0
15662,mouthrinse,1,1
15663,in,0,0
15664,humans,0,0
15665,with,0,0
15666,experimental,0,0
15667,gingivitis,0,0
15668,.,0,0
15669,OBJECTIVE,0,0
15670,P-113,1,0
15671,",",1,0
15672,a,1,0
15673,12,1,0
15674,amino,1,0
15675,acid,1,1
15676,histatin-based,1,1
15677,peptide,1,0
15678,",",0,0
15679,was,0,0
15680,evaluated,0,0
15681,in,0,0
15682,a,0,0
15683,mouthrinse,1,1
15684,formulation,1,1
15685,for,0,1
15686,safety,0,1
15687,",",0,0
15688,prevention,0,0
15689,of,0,0
15690,the,0,0
15691,development,0,0
15692,of,0,0
15693,experimental,0,0
15694,gingivitis,0,0
15695,",",0,0
15696,and,0,0
15697,for,0,0
15698,its,0,0
15699,effects,0,0
15700,on,0,0
15701,periodontal,0,0
15702,flora,0,0
15703,.,0,0
15704,METHOD,0,0
15705,159,0,0
15706,periodontally,0,0
15707,healthy,0,0
15708,subjects,0,0
15709,abstained,0,0
15710,from,0,0
15711,oral,0,1
15712,hygiene,0,1
15713,procedures,0,1
15714,and,0,0
15715,self-administered,1,0
15716,either,1,0
15717,0.005,1,0
15718,%,1,0
15719,",",1,0
15720,0.01,1,0
15721,%,1,0
15722,",",1,0
15723,0.05,1,0
15724,%,1,0
15725,P-113,1,0
15726,or,1,0
15727,placebo,1,1
15728,mouthrinse,1,1
15729,formulations,1,1
15730,twice,1,1
15731,daily,1,1
15732,over,1,0
15733,a,1,0
15734,four,1,0
15735,week,1,0
15736,treatment,1,0
15737,period,1,0
15738,.,1,0
15739,During,0,0
15740,this,0,0
15741,time,0,0
15742,",",0,0
15743,the,0,0
15744,safety,0,0
15745,",",0,0
15746,anti-plaque,0,1
15747,",",0,1
15748,and,0,1
15749,anti-gingivitis,0,1
15750,effects,0,0
15751,of,0,0
15752,P-113,0,0
15753,were,0,0
15754,evaluated,0,0
15755,.,0,0
15756,RESULTS,0,0
15757,There,0,0
15758,was,0,0
15759,a,0,0
15760,significant,0,0
15761,reduction,0,0
15762,in,0,0
15763,plaque,0,0
15764,(,0,0
15765,p=0.046,0,0
15766,),0,0
15767,and,0,0
15768,a,0,0
15769,reduction,0,0
15770,in,0,0
15771,gingivitis,0,0
15772,(,0,0
15773,p=0.086,0,0
15774,),0,0
15775,for,0,0
15776,subjects,0,0
15777,using,0,0
15778,0.01,0,0
15779,%,0,0
15780,P-113,1,0
15781,mouthrinse,1,1
15782,.,1,0
15783,Significantly,0,0
15784,more,0,0
15785,subjects,0,0
15786,in,0,0
15787,the,0,0
15788,0.01,0,0
15789,%,0,0
15790,and,0,0
15791,0.05,0,0
15792,%,0,0
15793,treatment,0,0
15794,groups,0,0
15795,showed,0,0
15796,a,0,0
15797,small,0,0
15798,increase,0,0
15799,in,0,0
15800,plaque,0,0
15801,index,0,0
15802,of,0,0
15803,<,0,0
15804,0.25,0,0
15805,as,0,0
15806,compared,0,0
15807,to,0,0
15808,the,0,0
15809,placebo,0,1
15810,group,0,0
15811,(,0,0
15812,p,0,0
15813,<,0,0
15814,0.05,0,0
15815,),0,0
15816,.,0,0
15817,Similar,0,0
15818,trends,0,0
15819,were,0,0
15820,noted,0,0
15821,for,0,0
15822,changes,0,0
15823,in,0,0
15824,the,0,0
15825,%,0,0
15826,of,0,0
15827,sites,0,0
15828,with,0,0
15829,bleeding,0,0
15830,on,0,0
15831,probing,0,0
15832,in,0,0
15833,the,0,0
15834,0.01,0,0
15835,%,0,0
15836,P-113,1,0
15837,group,0,0
15838,.,0,0
15839,There,0,0
15840,were,0,0
15841,no,0,0
15842,treatment-related,0,0
15843,adverse,0,0
15844,events,0,0
15845,",",0,0
15846,and,0,0
15847,there,0,0
15848,were,0,0
15849,no,0,0
15850,adverse,0,0
15851,shifts,0,0
15852,in,0,0
15853,supragingival,0,0
15854,microflora,0,0
15855,during,0,0
15856,the,0,0
15857,study,0,0
15858,.,0,0
15859,CONCLUSION,0,0
15860,These,0,0
15861,data,0,0
15862,suggest,0,0
15863,that,0,0
15864,P-113,1,1
15865,mouthrinse,1,1
15866,is,0,0
15867,safe,0,0
15868,and,0,0
15869,reduces,0,0
15870,plaque,0,0
15871,",",0,0
15872,gingivitis,0,0
15873,and,0,0
15874,gingival,0,0
15875,bleeding,0,0
15876,in,0,0
15877,the,0,0
15878,human,0,0
15879,experimental,0,0
15880,gingivitis,0,0
15881,model,0,0
15882,.,0,0
15883,Dose,0,0
15884,response,0,0
15885,effect,0,0
15886,of,0,0
15887,cyclical,1,0
15888,medroxyprogesterone,1,1
15889,on,0,0
15890,blood,0,0
15891,pressure,0,0
15892,in,0,0
15893,postmenopausal,0,0
15894,women,0,0
15895,.,0,0
15896,OBJECTIVE,0,0
15897,This,0,0
15898,study,0,0
15899,was,0,0
15900,designed,0,0
15901,to,0,0
15902,compare,0,0
15903,with,0,0
15904,placebo,1,1
15905,the,0,1
15906,dose-response,0,1
15907,effect,0,0
15908,of,0,0
15909,cyclical,0,0
15910,doses,0,1
15911,of,0,0
15912,the,0,0
15913,C21,1,1
15914,progestogen,1,1
15915,",",1,1
15916,medroxyprogesterone,1,1
15917,acetate,1,1
15918,(,0,1
15919,MPA,0,1
15920,),0,1
15921,on,0,0
15922,blood,0,1
15923,pressure,0,1
15924,(,0,1
15925,BP,0,1
15926,),0,1
15927,when,0,0
15928,administered,0,1
15929,to,0,1
15930,normotensive,0,1
15931,postmenopausal,0,1
15932,women,0,1
15933,receiving,0,0
15934,a,0,0
15935,fixed,0,0
15936,mid-range,0,1
15937,daily,0,1
15938,dose,0,1
15939,of,0,1
15940,conjugated,1,1
15941,equine,1,1
15942,oestrogen,1,1
15943,(,1,1
15944,CEE,1,1
15945,),1,1
15946,.,1,0
15947,MATERIALS,0,0
15948,AND,0,1
15949,METHODS,0,1
15950,Twenty,0,1
15951,normotensive,0,1
15952,postmenopausal,0,1
15953,women,0,1
15954,(,0,0
15955,median,0,0
15956,age,0,0
15957,53,0,0
15958,years,0,0
15959,),0,0
15960,participated,0,0
15961,in,0,0
15962,the,0,0
15963,study,0,0
15964,which,0,0
15965,used,0,0
15966,a,0,0
15967,double-blind,0,1
15968,crossover,0,1
15969,design,0,1
15970,.,0,0
15971,There,0,0
15972,were,0,0
15973,four,1,0
15974,randomised,1,0
15975,treatment,1,0
15976,phases,1,0
15977,",",0,0
15978,each,0,0
15979,of,0,0
15980,4,0,0
15981,weeks,0,0
15982,duration,0,0
15983,.,0,0
15984,The,0,0
15985,four,0,0
15986,blinded,0,0
15987,treatments,0,0
15988,were,0,0
15989,MPA,1,1
15990,2.5,1,1
15991,mg,1,1
15992,",",1,1
15993,MPA,1,1
15994,5,1,1
15995,mg,1,1
15996,",",1,1
15997,MPA,1,1
15998,10,1,1
15999,mg,1,1
16000,and,1,1
16001,matching,1,0
16002,placebo,1,1
16003,",",1,0
16004,taken,1,0
16005,for,1,0
16006,the,1,0
16007,last,1,0
16008,14,1,0
16009,days,1,0
16010,of,1,0
16011,each,1,0
16012,28,1,0
16013,day,1,0
16014,treatment,1,0
16015,cycle,1,0
16016,.,1,0
16017,CEE,0,1
16018,0.625,0,1
16019,mg,0,1
16020,was,0,0
16021,also,0,0
16022,administered,0,1
16023,once,0,1
16024,daily,0,1
16025,as,0,1
16026,open,0,1
16027,labelled,0,0
16028,tablets,0,1
16029,to,0,0
16030,all,0,0
16031,subjects,0,0
16032,throughout,0,0
16033,the,0,0
16034,study,0,0
16035,.,0,0
16036,Clinic,0,1
16037,BP,0,1
16038,was,0,0
16039,measured,0,0
16040,weekly,0,0
16041,with,0,0
16042,the,0,0
16043,mean,0,0
16044,values,0,0
16045,of,0,0
16046,weeks,0,0
16047,3,0,0
16048,and,0,0
16049,4,0,0
16050,of,0,0
16051,each,0,0
16052,phase,0,0
16053,used,0,0
16054,for,0,0
16055,analysis,0,0
16056,.,0,0
16057,Ambulatory,0,0
16058,BP,0,0
16059,was,0,0
16060,performed,0,0
16061,in,0,0
16062,the,0,0
16063,final,0,0
16064,week,0,0
16065,of,0,0
16066,each,0,0
16067,phase,0,0
16068,.,0,0
16069,RESULTS,0,0
16070,Compared,0,0
16071,with,0,0
16072,the,0,0
16073,placebo,0,1
16074,phase,0,0
16075,",",0,0
16076,end,0,0
16077,of,0,0
16078,phase,0,0
16079,clinic,0,0
16080,BP,0,0
16081,was,0,0
16082,unchanged,0,0
16083,by,0,0
16084,any,0,0
16085,of,0,0
16086,the,0,0
16087,progestogen,0,1
16088,treatments,0,1
16089,.,0,0
16090,There,0,0
16091,was,0,0
16092,a,0,0
16093,dose-dependent,0,0
16094,decrease,0,0
16095,in,0,0
16096,ambulatory,0,0
16097,daytime,0,0
16098,diastolic,0,0
16099,and,0,0
16100,mean,0,0
16101,arterial,0,0
16102,BP,0,0
16103,with,0,0
16104,the,0,0
16105,progestogen,0,1
16106,treatments,0,1
16107,compared,0,0
16108,with,0,0
16109,placebo,0,0
16110,(,0,0
16111,P,0,0
16112,<,0,0
16113,0.05,0,0
16114,),0,0
16115,.,0,0
16116,CONCLUSION,0,0
16117,In,0,0
16118,a,0,0
16119,regimen,0,1
16120,of,0,1
16121,postmenopausal,0,1
16122,hormone,0,1
16123,replacement,0,0
16124,therapy,0,0
16125,with,0,0
16126,a,0,0
16127,fixed,0,0
16128,mid-range,0,1
16129,daily,0,1
16130,dose,0,1
16131,of,0,1
16132,CEE,1,0
16133,combined,0,0
16134,with,0,0
16135,a,0,0
16136,cyclical,0,0
16137,regimen,0,1
16138,of,0,0
16139,a,0,0
16140,C21,0,1
16141,progestogen,0,1
16142,spanning,0,0
16143,the,0,0
16144,current,0,0
16145,clinical,0,1
16146,dose,0,1
16147,range,0,0
16148,",",0,0
16149,the,0,0
16150,progestogen,1,1
16151,has,0,0
16152,either,0,0
16153,no,0,0
16154,effect,0,0
16155,or,0,0
16156,a,0,0
16157,small,0,0
16158,dose-dependent,0,0
16159,reduction,0,0
16160,in,0,0
16161,clinic,0,0
16162,and,0,0
16163,ambulatory,0,0
16164,BPs,0,1
16165,over,0,0
16166,one,0,0
16167,treatment,0,0
16168,cycle,0,0
16169,.,0,0
16170,Why,0,0
16171,were,0,0
16172,the,0,0
16173,results,0,0
16174,of,0,0
16175,the,0,0
16176,Heart,0,0
16177,Outcomes,0,0
16178,Prevention,0,1
16179,Evaluation,0,1
16180,(,0,1
16181,HOPE,0,1
16182,),0,1
16183,trial,0,0
16184,so,0,0
16185,astounding,0,0
16186,?,0,0
16187,The,0,0
16188,Heart,0,0
16189,Outcomes,0,0
16190,Prevention,0,1
16191,Evaluation,0,1
16192,(,0,1
16193,HOPE,0,1
16194,),0,0
16195,study,0,0
16196,was,0,0
16197,important,0,0
16198,because,0,0
16199,it,0,0
16200,showed,0,0
16201,the,0,0
16202,benefits,0,0
16203,of,0,0
16204,ramipril,1,1
16205,-,0,1
16206,an,0,1
16207,angiotensin-converting,1,1
16208,enzyme,1,1
16209,(,1,1
16210,ACE,1,1
16211,),1,1
16212,inhibitor,1,1
16213,-,0,1
16214,in,0,0
16215,patients,0,0
16216,at,0,0
16217,high,0,0
16218,risk,0,0
16219,for,0,0
16220,cardiovascular,0,0
16221,events,0,0
16222,.,0,0
16223,Treatment,0,0
16224,with,0,0
16225,ramipril,1,1
16226,significantly,0,0
16227,reduced,0,0
16228,the,0,0
16229,rates,0,0
16230,of,0,0
16231,death,0,0
16232,",",0,0
16233,myocardial,0,0
16234,infarction,0,0
16235,",",0,0
16236,stroke,0,0
16237,",",0,0
16238,coronary,0,0
16239,revascularization,0,0
16240,",",0,0
16241,cardiac,0,0
16242,arrest,0,0
16243,and,0,0
16244,heart,0,0
16245,failure,0,0
16246,",",0,0
16247,as,0,0
16248,well,0,0
16249,as,0,0
16250,the,0,0
16251,risk,0,0
16252,of,0,0
16253,diabetes-related,0,0
16254,complications,0,0
16255,and,0,0
16256,of,0,0
16257,diabetes,0,0
16258,itself,0,0
16259,.,0,0
16260,The,0,0
16261,effects,0,0
16262,of,0,0
16263,therapy,0,0
16264,with,0,0
16265,vitamin,1,1
16266,E,1,0
16267,were,0,0
16268,also,0,0
16269,evaluated,0,0
16270,",",0,0
16271,but,0,0
16272,no,0,0
16273,statistical,0,0
16274,benefits,0,0
16275,were,0,0
16276,shown,0,0
16277,.,0,0
16278,The,0,0
16279,benefits,0,0
16280,of,0,0
16281,ACE,1,1
16282,inhibitor,1,1
16283,therapy,1,0
16284,that,0,0
16285,were,0,0
16286,observed,0,0
16287,were,0,0
16288,likely,0,0
16289,due,0,0
16290,to,0,0
16291,a,0,0
16292,variety,0,0
16293,of,0,0
16294,mechanisms,0,0
16295,",",0,0
16296,not,0,0
16297,just,0,0
16298,a,0,0
16299,reduction,0,0
16300,in,0,0
16301,blood,0,0
16302,pressure,0,0
16303,.,0,0
16304,Double-blind,0,1
16305,",",0,1
16306,placebo-controlled,1,1
16307,study,0,0
16308,of,0,1
16309,amantadine,1,1
16310,hydrochloride,1,1
16311,in,0,0
16312,the,0,0
16313,treatment,0,0
16314,of,0,0
16315,children,0,0
16316,with,0,0
16317,autistic,0,0
16318,disorder,0,0
16319,.,0,0
16320,OBJECTIVE,0,0
16321,To,0,0
16322,test,0,0
16323,the,0,0
16324,hypothesis,0,0
16325,that,0,0
16326,amantadine,1,1
16327,hydrochloride,0,1
16328,is,0,1
16329,a,0,0
16330,safe,0,0
16331,and,0,0
16332,effective,0,0
16333,treatment,0,0
16334,for,0,0
16335,behavioral,0,0
16336,disturbances,0,0
16337,--,0,0
16338,for,0,0
16339,example,0,0
16340,",",0,0
16341,hyperactivity,0,0
16342,and,0,0
16343,irritability,0,0
16344,--,0,0
16345,in,0,0
16346,children,0,0
16347,with,0,0
16348,autism,0,0
16349,.,0,0
16350,METHOD,0,0
16351,Thirty-nine,0,0
16352,subjects,0,0
16353,(,0,0
16354,intent,0,0
16355,to,0,0
16356,treat,0,0
16357,;,0,0
16358,5-19,0,0
16359,years,0,0
16360,old,0,0
16361,;,0,0
16362,IQ,0,0
16363,>,0,0
16364,35,0,0
16365,),0,0
16366,had,0,0
16367,autism,0,0
16368,diagnosed,0,0
16369,according,0,0
16370,to,0,0
16371,DSM-IV,0,0
16372,and,0,0
16373,ICD-10,0,0
16374,criteria,0,0
16375,using,0,0
16376,the,0,0
16377,Autism,0,0
16378,Diagnostic,0,0
16379,Interview-Revised,0,0
16380,and,0,0
16381,the,0,0
16382,Autism,0,0
16383,Diagnostic,0,0
16384,Observation,0,0
16385,Schedule-Generic,0,0
16386,.,0,0
16387,The,0,0
16388,Aberrant,0,0
16389,Behavior,0,0
16390,Checklist-Community,0,1
16391,Version,0,1
16392,(,0,1
16393,ABC-CV,0,1
16394,),0,1
16395,and,0,0
16396,Clinical,0,0
16397,Global,0,0
16398,Impressions,0,0
16399,(,0,0
16400,CGI,0,1
16401,),0,0
16402,scale,0,0
16403,were,0,0
16404,used,0,0
16405,as,0,0
16406,outcome,0,0
16407,variables,0,0
16408,.,0,0
16409,After,0,0
16410,a,0,0
16411,1-week,0,0
16412,",",0,1
16413,single-blind,0,1
16414,placebo,0,1
16415,run-in,0,1
16416,",",0,1
16417,patients,0,0
16418,received,0,0
16419,a,0,0
16420,single,1,0
16421,daily,1,1
16422,dose,1,1
16423,of,1,1
16424,amantadine,1,1
16425,(,1,1
16426,2.5,1,1
16427,mg/kg,1,1
16428,per,1,1
16429,day,1,1
16430,),1,1
16431,or,1,1
16432,placebo,1,1
16433,for,1,0
16434,the,1,0
16435,next,1,0
16436,week,1,0
16437,",",1,0
16438,and,1,0
16439,then,1,0
16440,bid,1,1
16441,dosing,1,1
16442,(,1,1
16443,5.0,1,1
16444,mg/kg,1,1
16445,per,1,1
16446,day,1,1
16447,),1,0
16448,for,1,0
16449,the,1,0
16450,subsequent,1,0
16451,3,1,0
16452,weeks,1,0
16453,.,1,0
16454,RESULTS,0,0
16455,When,0,0
16456,assessed,0,0
16457,on,0,0
16458,the,0,0
16459,basis,0,0
16460,of,0,0
16461,parent-rated,0,0
16462,ABC-CV,0,0
16463,ratings,0,0
16464,of,0,0
16465,irritability,0,0
16466,and,0,0
16467,hyperactivity,0,0
16468,",",0,0
16469,the,0,0
16470,mean,0,0
16471,placebo,0,0
16472,response,0,0
16473,rate,0,0
16474,was,0,0
16475,37,0,0
16476,%,0,0
16477,versus,0,0
16478,amantadine,0,0
16479,at,0,0
16480,47,0,0
16481,%,0,0
16482,(,0,0
16483,not,0,0
16484,significant,0,0
16485,),0,0
16486,.,0,0
16487,However,0,0
16488,",",0,0
16489,in,0,0
16490,the,0,0
16491,amantadine-treated,1,0
16492,group,0,0
16493,there,0,0
16494,were,0,0
16495,statistically,0,0
16496,significant,0,0
16497,improvements,0,0
16498,in,0,0
16499,absolute,0,0
16500,changes,0,0
16501,in,0,0
16502,clinician-rated,0,0
16503,ABC-CVs,0,0
16504,for,0,0
16505,hyperactivity,0,1
16506,(,0,0
16507,amantadine,0,1
16508,-6.4,0,1
16509,versus,0,0
16510,placebo,0,0
16511,-2.1,0,0
16512,;,0,0
16513,p,0,0
16514,=,0,0
16515,.046,0,0
16516,),0,0
16517,and,0,0
16518,inappropriate,0,1
16519,speech,0,0
16520,(,0,0
16521,-1.9,0,0
16522,versus,0,0
16523,0.4,0,0
16524,;,0,0
16525,p,0,0
16526,=,0,0
16527,.008,0,0
16528,),0,0
16529,.,0,0
16530,CGI,0,0
16531,scale,0,0
16532,ratings,0,0
16533,were,0,0
16534,higher,0,0
16535,in,0,0
16536,the,0,0
16537,amantadine,0,1
16538,group,0,0
16539,:,0,0
16540,53,0,0
16541,%,0,0
16542,improved,0,0
16543,versus,0,0
16544,25,0,0
16545,%,0,0
16546,(,0,0
16547,p,0,0
16548,=,0,0
16549,.076,0,0
16550,),0,0
16551,.,0,0
16552,Amantadine,1,1
16553,was,0,0
16554,well,0,0
16555,tolerated,0,1
16556,.,0,0
16557,CONCLUSIONS,0,0
16558,Parents,0,0
16559,did,0,0
16560,not,0,0
16561,report,0,0
16562,statistically,0,0
16563,significant,0,0
16564,behavioral,0,0
16565,change,0,0
16566,with,0,0
16567,amantadine,0,1
16568,.,0,0
16569,However,0,0
16570,",",0,0
16571,clinician-rated,0,0
16572,improvements,0,0
16573,in,0,0
16574,behavioral,0,0
16575,ratings,0,0
16576,following,0,0
16577,treatment,0,0
16578,with,0,0
16579,amantadine,1,1
16580,suggest,0,0
16581,that,0,0
16582,further,0,0
16583,studies,0,0
16584,with,0,0
16585,this,0,0
16586,or,0,0
16587,other,0,0
16588,drugs,0,1
16589,acting,0,0
16590,on,0,0
16591,the,0,0
16592,glutamatergic,0,0
16593,system,0,0
16594,are,0,0
16595,warranted,0,0
16596,.,0,0
16597,The,0,0
16598,design,0,0
16599,of,0,0
16600,these,0,0
16601,and,0,0
16602,similar,0,0
16603,drug,0,1
16604,trials,0,1
16605,in,0,0
16606,children,0,0
16607,with,0,0
16608,autistic,0,0
16609,disorder,0,0
16610,must,0,0
16611,take,0,0
16612,into,0,0
16613,account,0,0
16614,the,0,0
16615,possibility,0,0
16616,of,0,0
16617,a,0,0
16618,large,0,0
16619,placebo,0,1
16620,response,0,0
16621,.,0,0
16622,Nicotine,1,1
16623,infusion,0,1
16624,acutely,0,1
16625,impairs,0,0
16626,insulin,0,1
16627,sensitivity,0,0
16628,in,0,0
16629,type,0,0
16630,2,0,0
16631,diabetic,0,0
16632,patients,0,0
16633,but,0,0
16634,not,0,0
16635,in,0,0
16636,healthy,0,0
16637,subjects,0,0
16638,.,0,0
16639,OBJECTIVES,0,0
16640,The,0,0
16641,aim,0,0
16642,of,0,0
16643,this,0,0
16644,study,0,0
16645,was,0,0
16646,to,0,0
16647,examine,0,0
16648,if,0,0
16649,an,0,0
16650,acute,0,1
16651,nicotine,1,1
16652,infusion,0,1
16653,alters,0,1
16654,insulin,0,1
16655,sensitivity,0,0
16656,to,0,0
16657,a,0,0
16658,similar,0,0
16659,degree,0,0
16660,in,0,0
16661,type,0,0
16662,2,0,0
16663,diabetic,0,0
16664,patients,0,0
16665,as,0,0
16666,in,0,0
16667,healthy,0,0
16668,control,0,0
16669,subjects,0,0
16670,.,0,0
16671,DESIGN,0,0
16672,.,0,0
16673,Double-blind,0,1
16674,",",0,1
16675,cross-over,0,1
16676,",",0,1
16677,placebo-controlled,1,1
16678,",",0,1
16679,randomized,0,0
16680,experimental,0,0
16681,study,0,0
16682,.,0,0
16683,Nicotine,1,1
16684,0.3,0,1
16685,microg,0,1
16686,kg-1,0,1
16687,min,0,1
16688,(,0,1
16689,-1,0,0
16690,),0,0
16691,or,1,0
16692,NaCl,1,1
16693,was,1,0
16694,infused,1,1
16695,(,0,1
16696,2,0,1
16697,h,0,1
16698,),0,0
16699,during,0,0
16700,a,0,1
16701,euglycaemic,0,1
16702,hyperinsulinaemic,0,1
16703,clamp,0,1
16704,(,0,1
16705,4,0,1
16706,h,0,1
16707,),0,0
16708,to,0,0
16709,assess,0,0
16710,insulin,0,1
16711,sensitivity,0,0
16712,.,0,0
16713,SETTING,0,0
16714,University,0,0
16715,research,0,0
16716,laboratory,0,0
16717,.,0,0
16718,SUBJECTS,0,1
16719,Six,0,1
16720,male,0,0
16721,and,0,0
16722,female,0,0
16723,type,0,0
16724,2,0,0
16725,diabetic,0,0
16726,patients,0,0
16727,[,0,1
16728,DM2,0,1
16729,;,0,0
16730,age,0,0
16731,54,0,0
16732,+/-,0,0
16733,10,0,0
16734,(,0,0
16735,mean,0,0
16736,+/-,0,0
16737,SD,0,0
16738,),0,0
16739,years,0,1
16740,;,0,1
16741,body,0,0
16742,mass,0,0
16743,index,0,1
16744,(,0,1
16745,BMI,0,1
16746,),0,0
16747,25.6,0,0
16748,+/-,0,0
16749,2.9,0,0
16750,kg,0,0
16751,m,0,0
16752,(,0,1
16753,-2,0,1
16754,),0,1
16755,],0,0
16756,treated,0,0
16757,with,0,0
16758,diet,0,1
16759,or,0,0
16760,one,0,1
16761,oral,0,1
16762,hypoglycaemic,0,1
16763,agent,0,1
16764,and,0,0
16765,six,0,0
16766,age-,0,0
16767,and,0,0
16768,BMI-matched,0,0
16769,control,0,0
16770,subjects,0,0
16771,(,0,1
16772,Ctr,0,1
16773,),0,1
16774,.,0,0
16775,MAIN,0,0
16776,OUTCOME,0,1
16777,MEASURE,0,1
16778,Insulin,0,1
16779,sensitivity,0,1
16780,(,0,0
16781,rate,0,0
16782,of,0,1
16783,glucose,0,1
16784,infusion,0,1
16785,per,0,1
16786,kg,0,0
16787,fat,0,0
16788,free,0,0
16789,body,0,0
16790,mass,0,0
16791,and,0,0
16792,minute,0,0
16793,),0,1
16794,",",0,1
16795,nicotine,0,1
16796,and,0,1
16797,free,0,1
16798,fatty,0,1
16799,acid,0,1
16800,(,0,1
16801,FFA,0,1
16802,),0,0
16803,levels,0,0
16804,",",0,0
16805,pulse,0,0
16806,rate,0,0
16807,and,0,0
16808,blood,0,0
16809,pressure,0,0
16810,.,0,0
16811,RESULTS,0,0
16812,The,0,0
16813,infusions,0,1
16814,produced,0,0
16815,similar,0,0
16816,nicotine,0,1
16817,levels,0,0
16818,in,0,0
16819,both,0,0
16820,groups,0,0
16821,.,0,0
16822,In,0,0
16823,the,0,0
16824,absence,0,0
16825,of,0,0
16826,nicotine,1,1
16827,",",0,0
16828,DM2,0,1
16829,were,0,0
16830,more,0,0
16831,insulin,0,1
16832,resistant,0,0
16833,than,0,1
16834,Ctr,0,0
16835,(,0,0
16836,6.7,0,0
16837,+/-,0,0
16838,0.4,0,0
16839,vs.,0,0
16840,10.9,0,0
16841,+/-,0,0
16842,0.3,0,0
16843,mg,0,1
16844,kg-1,0,1
16845,LBM,0,1
16846,min,0,1
16847,(,0,1
16848,-1,0,0
16849,),0,0
16850,",",0,0
16851,respectively,0,0
16852,;,0,0
16853,P,0,0
16854,<,0,0
16855,0.0001,0,0
16856,),0,0
16857,.,0,0
16858,This,0,1
16859,insulin,0,1
16860,resistance,0,0
16861,was,0,0
16862,further,0,0
16863,aggravated,0,0
16864,by,0,0
16865,the,0,0
16866,nicotine,0,1
16867,infusion,0,1
16868,in,0,1
16869,DM2,0,0
16870,but,0,0
16871,not,0,0
16872,in,0,0
16873,Ctr,0,0
16874,(,0,0
16875,4.6,0,0
16876,+/-,0,0
16877,0.3,0,0
16878,vs.,0,0
16879,10.9,0,0
16880,+/-,0,0
16881,0.3,0,0
16882,mg,0,0
16883,kg,0,0
16884,(,0,1
16885,-1,0,1
16886,),0,1
16887,LBM,0,1
16888,min,0,1
16889,(,0,1
16890,-1,0,1
16891,),0,0
16892,;,0,0
16893,P,0,0
16894,<,0,0
16895,0.0001,0,0
16896,),0,0
16897,.,0,0
16898,Only,0,0
16899,minor,0,0
16900,differences,0,0
16901,were,0,0
16902,seen,0,0
16903,in,0,0
16904,FFA,0,0
16905,levels,0,0
16906,",",0,0
16907,pulse,0,0
16908,rates,0,0
16909,and,0,0
16910,blood,0,0
16911,pressure,0,0
16912,.,0,0
16913,CONCLUSIONS,0,0
16914,At,0,0
16915,this,0,0
16916,low,0,0
16917,infusion,0,1
16918,rate,0,1
16919,",",0,1
16920,nicotine,1,1
16921,aggravated,0,0
16922,the,0,0
16923,insulin,0,1
16924,resistance,0,0
16925,in,0,0
16926,DM2,0,0
16927,but,0,0
16928,not,0,0
16929,in,0,0
16930,Ctr,0,0
16931,.,0,0
16932,This,0,0
16933,finding,0,0
16934,may,0,0
16935,be,0,0
16936,because,0,0
16937,of,0,0
16938,the,0,0
16939,(,0,1
16940,dysmetabolic,0,1
16941,),0,1
16942,diabetic,0,0
16943,state,0,0
16944,per,0,0
16945,se,0,0
16946,or,0,0
16947,to,0,0
16948,an,0,0
16949,increased,0,0
16950,sensitivity,0,0
16951,to,0,0
16952,environmental,0,0
16953,factors,0,0
16954,associated,0,0
16955,with,0,0
16956,a,0,0
16957,genetic,0,0
16958,predisposition,0,0
16959,for,0,0
16960,type,0,0
16961,2,0,0
16962,diabetes,0,0
16963,.,0,0
16964,These,0,0
16965,results,0,0
16966,show,0,0
16967,that,0,0
16968,diabetic,0,0
16969,subjects,0,0
16970,are,0,0
16971,particularly,0,0
16972,susceptible,0,0
16973,to,0,0
16974,the,0,0
16975,detrimental,0,0
16976,effects,0,0
16977,of,0,0
16978,nicotine,1,1
16979,.,0,0
16980,Comparison,0,0
16981,of,0,0
16982,enoxaparin,1,1
16983,and,1,1
16984,standard,1,1
16985,heparin,1,1
16986,in,0,0
16987,gynaecologic,0,1
16988,oncologic,0,0
16989,surgery,0,0
16990,:,0,0
16991,a,0,0
16992,randomised,0,0
16993,prospective,0,1
16994,double-blind,0,1
16995,clinical,0,1
16996,study,0,0
16997,.,0,0
16998,OBJECTIVE,0,0
16999,This,0,0
17000,study,0,0
17001,aimed,0,0
17002,to,0,0
17003,compare,0,0
17004,the,0,0
17005,haemorrhagic,0,0
17006,complications,0,0
17007,and,0,0
17008,efficacy,0,0
17009,of,0,0
17010,enoxaparin,1,1
17011,",",0,0
17012,a,0,0
17013,low,0,0
17014,molecular,0,0
17015,weight,0,1
17016,heparin,0,1
17017,(,0,1
17018,LMWH,0,1
17019,),0,1
17020,",",0,0
17021,and,0,0
17022,conventional,0,0
17023,standard,1,1
17024,heparin,1,1
17025,(,1,1
17026,SH,1,1
17027,),1,1
17028,in,0,0
17029,gynaecological,0,0
17030,oncologic,0,0
17031,surgery,0,0
17032,.,0,0
17033,MATERIALS,0,0
17034,METHODS,0,0
17035,A,0,1
17036,double,0,0
17037,blind,0,0
17038,",",0,0
17039,randomised,0,0
17040,trial,0,0
17041,was,0,0
17042,performed,0,0
17043,on,0,0
17044,102,0,0
17045,consecutive,0,0
17046,women,0,0
17047,undergoing,0,1
17048,gynaecologic,0,1
17049,cancer,0,0
17050,surgery,0,0
17051,with,0,0
17052,pelvic,0,0
17053,and,0,0
17054,paraaortic,0,0
17055,lymphadenectomy,0,0
17056,.,0,0
17057,The,0,0
17058,women,0,0
17059,were,0,0
17060,separated,0,0
17061,into,0,0
17062,those,0,0
17063,who,0,0
17064,were,0,0
17065,given,0,0
17066,"2,500",1,0
17067,IU,1,0
17068,enoxaparin,1,1
17069,once,1,1
17070,daily,1,1
17071,and,1,1
17072,SH,1,1
17073,in,1,0
17074,a,1,0
17075,dose,1,1
17076,of,1,0
17077,"5,000",1,0
17078,IU,1,0
17079,three,1,0
17080,times,1,1
17081,daily,1,1
17082,.,1,1
17083,The,0,0
17084,groups,0,0
17085,were,0,0
17086,analysed,0,0
17087,for,0,0
17088,intraoperative,0,0
17089,blood,0,0
17090,loss,0,0
17091,",",0,0
17092,drainage,0,0
17093,",",0,0
17094,transfusion,0,0
17095,requirements,0,0
17096,",",0,0
17097,perioperative,0,1
17098,haemoglobin,0,1
17099,decrease,0,0
17100,",",0,0
17101,wound,0,0
17102,haematoma,0,0
17103,",",0,0
17104,and,0,0
17105,clinical,0,0
17106,deep,0,1
17107,venous,0,0
17108,thrombosis,0,0
17109,.,0,0
17110,RESULTS,0,0
17111,The,0,0
17112,two,0,0
17113,groups,0,0
17114,were,0,0
17115,well,0,0
17116,matched,0,0
17117,for,0,0
17118,age,0,0
17119,",",0,0
17120,weight,0,0
17121,",",0,0
17122,and,0,0
17123,other,0,0
17124,factors,0,0
17125,",",0,0
17126,which,0,0
17127,could,0,0
17128,predispose,0,0
17129,to,0,0
17130,the,0,0
17131,development,0,0
17132,of,0,0
17133,deep,0,0
17134,venous,0,1
17135,thrombosis,0,1
17136,(,0,1
17137,DVT,0,1
17138,),0,1
17139,and,0,0
17140,haemorrhage,0,1
17141,.,0,1
17142,No,0,1
17143,patient,0,0
17144,developed,0,0
17145,clinical,0,0
17146,significant,0,0
17147,DVT,0,0
17148,",",0,0
17149,wound,0,0
17150,haematoma,0,0
17151,or,0,0
17152,intra-abdominal,0,0
17153,bleeding,0,0
17154,.,0,0
17155,There,0,0
17156,was,0,0
17157,no,0,0
17158,significant,0,0
17159,difference,0,0
17160,in,0,0
17161,bleeding,0,0
17162,complications,0,0
17163,between,0,0
17164,the,0,0
17165,two,0,0
17166,regimens,0,1
17167,.,0,0
17168,The,0,0
17169,antiFXa,0,0
17170,level,0,0
17171,in,0,0
17172,the,0,0
17173,plasma,0,0
17174,was,0,0
17175,correlated,0,0
17176,strongly,0,0
17177,with,0,0
17178,patient,0,0
17179,weight,0,0
17180,.,0,0
17181,CONCLUSIONS,0,1
17182,A,0,1
17183,dose,0,1
17184,of,0,0
17185,"2,500",0,0
17186,IU,0,0
17187,enoxaparin/day,1,1
17188,does,0,0
17189,not,0,0
17190,cause,0,0
17191,more,0,0
17192,bleeding,0,0
17193,complications,0,1
17194,than,0,0
17195,SH,0,0
17196,"5,000",0,0
17197,IU,0,0
17198,three,0,0
17199,times,0,1
17200,daily,0,1
17201,when,0,0
17202,used,0,0
17203,to,0,0
17204,prevent,0,0
17205,thrombosis,0,0
17206,.,0,0
17207,However,0,0
17208,",",0,0
17209,the,0,0
17210,dose,0,1
17211,of,0,1
17212,enoxaparin,0,1
17213,must,0,0
17214,be,0,0
17215,adjusted,0,0
17216,to,0,0
17217,the,0,0
17218,patient,0,0
17219,'s,0,0
17220,weight,0,0
17221,.,0,0
17222,Children,0,1
17223,'s,0,0
17224,attitudes,0,0
17225,and,0,0
17226,behavioral,0,0
17227,intentions,0,0
17228,toward,0,0
17229,a,0,0
17230,peer,0,0
17231,with,0,0
17232,autistic,0,0
17233,behaviors,0,0
17234,:,0,0
17235,does,0,0
17236,a,0,0
17237,brief,0,0
17238,educational,1,0
17239,intervention,1,0
17240,have,0,0
17241,an,0,0
17242,effect,0,0
17243,?,0,0
17244,This,0,0
17245,study,0,0
17246,examined,0,0
17247,children,0,0
17248,'s,0,0
17249,ratings,0,0
17250,of,0,0
17251,attitudes,0,0
17252,and,0,0
17253,behavioral,0,0
17254,intentions,0,0
17255,toward,0,0
17256,a,0,0
17257,peer,0,0
17258,presented,0,0
17259,with,0,0
17260,or,0,0
17261,without,0,0
17262,autistic,0,0
17263,behaviors,0,0
17264,.,0,0
17265,The,0,0
17266,impact,0,0
17267,of,0,0
17268,information,0,0
17269,about,0,0
17270,autism,0,0
17271,on,0,0
17272,these,0,0
17273,ratings,0,0
17274,was,0,0
17275,investigated,0,0
17276,as,0,0
17277,well,0,0
17278,as,0,0
17279,age,0,0
17280,and,0,0
17281,gender,0,0
17282,effects,0,0
17283,.,0,0
17284,Third-,0,0
17285,and,0,0
17286,sixth-grade,0,1
17287,children,0,1
17288,(,0,0
17289,N,0,0
17290,=,0,0
17291,233,0,0
17292,),0,0
17293,were,0,0
17294,randomly,0,0
17295,assigned,0,0
17296,to,0,0
17297,view,1,0
17298,a,1,0
17299,video,1,0
17300,of,1,0
17301,the,1,0
17302,same,1,0
17303,boy,1,0
17304,in,1,0
17305,one,1,0
17306,of,1,0
17307,three,1,0
17308,conditions,1,0
17309,:,1,0
17310,No,1,1
17311,Autism,1,1
17312,",",1,0
17313,Autism,1,0
17314,",",1,0
17315,or,1,0
17316,Autism/Information,1,0
17317,.,1,0
17318,Children,0,0
17319,at,0,0
17320,both,0,0
17321,grade,0,0
17322,levels,0,0
17323,showed,0,0
17324,less,0,0
17325,positive,0,0
17326,attitudes,0,0
17327,toward,0,0
17328,the,0,0
17329,child,0,0
17330,in,0,0
17331,the,0,0
17332,two,0,0
17333,autism,0,0
17334,conditions,0,0
17335,.,0,0
17336,In,0,0
17337,rating,0,0
17338,their,0,0
17339,own,0,0
17340,behavioral,0,0
17341,intentions,0,0
17342,",",0,0
17343,children,0,0
17344,showed,0,0
17345,no,0,0
17346,differences,0,0
17347,between,0,0
17348,conditions,0,0
17349,.,0,0
17350,However,0,0
17351,",",0,0
17352,in,0,0
17353,attributing,0,0
17354,intentions,0,0
17355,to,0,0
17356,their,0,0
17357,classmates,0,0
17358,",",0,0
17359,older,0,0
17360,children,0,0
17361,and,0,0
17362,girls,0,0
17363,gave,0,0
17364,lower,0,0
17365,ratings,0,0
17366,to,0,0
17367,the,0,0
17368,child,0,0
17369,in,0,0
17370,the,0,0
17371,autism,0,0
17372,conditions,0,0
17373,.,0,0
17374,Information,0,0
17375,about,0,0
17376,autism,0,0
17377,did,0,0
17378,not,0,0
17379,affect,0,0
17380,ratings,0,0
17381,of,0,0
17382,either,0,0
17383,attitudes,0,0
17384,or,0,0
17385,behavioral,0,0
17386,intentions,0,0
17387,as,0,0
17388,ascribed,0,0
17389,to,0,0
17390,self,0,0
17391,or,0,0
17392,others,0,0
17393,.,0,0
17394,Uncomplicated,0,0
17395,moderate,0,0
17396,coronary,0,0
17397,artery,0,0
17398,dissections,0,0
17399,after,0,0
17400,balloon,0,0
17401,angioplasty,0,0
17402,:,0,0
17403,good,0,0
17404,outcome,0,0
17405,without,0,0
17406,stenting,1,0
17407,.,1,0
17408,OBJECTIVE,0,0
17409,To,0,0
17410,study,0,0
17411,the,0,0
17412,relation,0,0
17413,between,0,0
17414,moderate,0,0
17415,coronary,0,0
17416,dissections,0,0
17417,",",0,0
17418,coronary,0,0
17419,flow,0,0
17420,velocity,0,1
17421,reserve,0,1
17422,(,0,1
17423,CFVR,0,1
17424,),0,1
17425,",",0,0
17426,and,0,0
17427,long,0,0
17428,term,0,0
17429,outcome,0,0
17430,.,0,0
17431,METHODS,0,0
17432,523,0,0
17433,patients,0,0
17434,undergoing,0,0
17435,balloon,1,0
17436,angioplasty,1,0
17437,and,0,0
17438,sequential,0,0
17439,intracoronary,0,1
17440,Doppler,0,0
17441,measurements,0,0
17442,were,0,0
17443,examined,0,0
17444,as,0,0
17445,part,0,0
17446,of,0,0
17447,the,0,0
17448,DEBATE,0,0
17449,II,0,1
17450,trial,0,1
17451,(,0,1
17452,Doppler,0,1
17453,endpoints,0,1
17454,balloon,0,1
17455,angioplasty,0,1
17456,trial,0,1
17457,Europe,0,1
17458,),0,0
17459,.,0,0
17460,After,0,0
17461,successful,0,0
17462,balloon,1,0
17463,angioplasty,1,0
17464,",",0,0
17465,patients,0,0
17466,were,0,0
17467,randomised,0,0
17468,to,0,0
17469,stenting,1,0
17470,or,1,0
17471,no,1,0
17472,further,1,0
17473,treatment,1,0
17474,.,1,0
17475,Dissections,0,0
17476,were,0,0
17477,graded,0,0
17478,at,0,0
17479,the,0,0
17480,core,0,0
17481,laboratory,0,0
17482,by,0,0
17483,two,0,0
17484,observers,0,0
17485,and,0,0
17486,divided,0,0
17487,into,0,0
17488,four,0,0
17489,categories,0,0
17490,:,0,0
17491,none,0,0
17492,",",0,0
17493,mild,0,0
17494,(,0,0
17495,type,0,0
17496,A-B,0,1
17497,),0,0
17498,",",0,0
17499,moderate,0,0
17500,(,0,0
17501,type,0,0
17502,C,0,1
17503,),0,0
17504,",",0,0
17505,severe,0,1
17506,(,0,0
17507,types,0,0
17508,D,0,0
17509,to,0,0
17510,F,0,1
17511,),0,0
17512,.,0,0
17513,Patients,0,0
17514,with,0,0
17515,severe,0,0
17516,dissections,0,1
17517,(,0,0
17518,n,0,0
17519,=,0,0
17520,128,0,0
17521,),0,0
17522,or,0,0
17523,without,0,0
17524,available,0,0
17525,reference,0,0
17526,vessel,0,0
17527,CFVR,0,1
17528,(,0,0
17529,n,0,0
17530,=,0,0
17531,139,0,0
17532,),0,0
17533,were,0,0
17534,excluded,0,0
17535,.,0,0
17536,The,0,0
17537,remaining,0,0
17538,256,0,0
17539,patients,0,0
17540,were,0,0
17541,divided,0,0
17542,into,0,0
17543,two,0,0
17544,groups,0,0
17545,according,0,0
17546,to,0,0
17547,the,0,0
17548,presence,0,0
17549,(,0,0
17550,group,0,0
17551,A,0,1
17552,",",0,0
17553,n,0,0
17554,=,0,0
17555,45,0,0
17556,),0,0
17557,or,0,0
17558,absence,0,0
17559,(,0,0
17560,group,0,0
17561,B,0,1
17562,",",0,0
17563,n,0,0
17564,=,0,0
17565,211,0,0
17566,),0,0
17567,of,0,0
17568,moderate,0,0
17569,dissection,0,0
17570,.,0,0
17571,RESULTS,0,0
17572,Following,0,0
17573,balloon,0,0
17574,angioplasty,0,0
17575,",",0,0
17576,there,0,0
17577,was,0,0
17578,no,0,0
17579,difference,0,0
17580,in,0,0
17581,CFVR,0,0
17582,between,0,0
17583,the,0,0
17584,two,0,0
17585,groups,0,0
17586,.,0,0
17587,At,0,0
17588,12,0,0
17589,months,0,0
17590,follow,0,0
17591,up,0,0
17592,",",0,0
17593,a,0,0
17594,higher,0,0
17595,rate,0,0
17596,of,0,0
17597,major,0,0
17598,adverse,0,0
17599,cardiac,0,0
17600,events,0,0
17601,was,0,0
17602,observed,0,0
17603,overall,0,0
17604,in,0,0
17605,group,0,0
17606,A,0,0
17607,than,0,0
17608,in,0,0
17609,group,0,0
17610,B,0,1
17611,(,0,1
17612,10,0,0
17613,(,0,0
17614,22,0,0
17615,%,0,0
17616,),0,0
17617,v,0,0
17618,23,0,0
17619,(,0,0
17620,11,0,0
17621,%,0,0
17622,),0,0
17623,",",0,0
17624,p,0,0
17625,=,0,0
17626,0.041,0,0
17627,),0,0
17628,.,0,0
17629,However,0,0
17630,",",0,0
17631,the,0,0
17632,risk,0,0
17633,of,0,0
17634,major,0,0
17635,adverse,0,0
17636,events,0,0
17637,was,0,0
17638,similar,0,0
17639,in,0,0
17640,the,0,0
17641,subgroups,0,0
17642,receiving,0,0
17643,balloon,0,1
17644,angioplasty,0,1
17645,(,0,1
17646,group,0,0
17647,A,0,1
17648,",",0,1
17649,6,0,0
17650,(,0,0
17651,19,0,0
17652,%,0,0
17653,),0,0
17654,v,0,0
17655,group,0,0
17656,B,0,0
17657,",",0,1
17658,16,0,0
17659,(,0,0
17660,16,0,0
17661,%,0,0
17662,),0,0
17663,",",0,0
17664,NS,0,1
17665,),0,1
17666,.,0,0
17667,Among,0,0
17668,group,0,0
17669,A,0,0
17670,patients,0,0
17671,",",0,0
17672,the,0,0
17673,adverse,0,0
17674,events,0,0
17675,risk,0,0
17676,was,0,0
17677,greater,0,0
17678,in,0,0
17679,those,0,0
17680,randomised,0,0
17681,to,0,0
17682,stenting,0,1
17683,(,0,0
17684,odds,0,0
17685,ratios,0,0
17686,6.603,0,0
17687,v,0,0
17688,1.197,0,0
17689,",",0,0
17690,p,0,0
17691,=,0,0
17692,0.046,0,0
17693,),0,0
17694,",",0,0
17695,whereas,0,0
17696,there,0,0
17697,was,0,0
17698,no,0,0
17699,difference,0,0
17700,in,0,0
17701,risk,0,0
17702,if,0,0
17703,the,0,0
17704,group,0,0
17705,was,0,0
17706,analysed,0,0
17707,according,0,0
17708,to,0,0
17709,whether,0,0
17710,the,0,0
17711,CFVR,0,0
17712,was,0,0
17713,<,0,0
17714,2.5,0,0
17715,or,0,0
17716,>,0,0
17717,/=,0,0
17718,2.5,0,0
17719,after,0,0
17720,balloon,0,0
17721,angioplasty,0,0
17722,.,0,0
17723,CONCLUSIONS,0,0
17724,Moderate,0,0
17725,dissections,0,0
17726,left,0,0
17727,untreated,0,0
17728,result,0,0
17729,in,0,0
17730,no,0,0
17731,increased,0,0
17732,risk,0,0
17733,of,0,0
17734,major,0,0
17735,adverse,0,0
17736,cardiac,0,0
17737,events,0,0
17738,.,0,0
17739,Additional,0,0
17740,stenting,0,0
17741,does,0,0
17742,not,0,0
17743,improve,0,0
17744,the,0,0
17745,long,0,0
17746,term,0,0
17747,outcome,0,0
17748,.,0,0
17749,There,0,0
17750,are,0,0
17751,some,0,0
17752,benefits,0,0
17753,for,0,0
17754,eradicating,0,1
17755,Helicobacter,0,1
17756,pylori,0,1
17757,in,0,0
17758,patients,0,0
17759,with,0,0
17760,non-ulcer,0,0
17761,dyspepsia,0,0
17762,.,0,0
17763,BACKGROUND,0,0
17764,The,0,0
17765,relationship,0,0
17766,between,0,0
17767,Helicobacter,0,1
17768,pylori,0,1
17769,infection,0,1
17770,and,0,0
17771,non-ulcer,0,0
17772,dyspepsia,0,0
17773,is,0,0
17774,not,0,0
17775,established,0,0
17776,.,0,0
17777,AIM,0,0
17778,To,0,0
17779,determine,0,0
17780,whether,0,0
17781,eradication,0,0
17782,of,0,0
17783,H.,0,0
17784,pylori,0,0
17785,might,0,0
17786,be,0,0
17787,of,0,0
17788,benefit,0,0
17789,in,0,0
17790,non-ulcer,0,0
17791,dyspepsia,0,0
17792,patients,0,0
17793,.,0,0
17794,METHODS,0,0
17795,We,0,0
17796,randomly,0,0
17797,assigned,0,0
17798,129,0,0
17799,H.,0,0
17800,pylori,0,0
17801,infected,0,0
17802,patients,0,0
17803,with,0,0
17804,severe,0,0
17805,epigastric,0,0
17806,pain,0,0
17807,",",0,0
17808,without,0,0
17809,gastro-oesophageal,0,0
17810,reflux,0,0
17811,symptoms,0,0
17812,",",0,0
17813,to,0,0
17814,receive,0,1
17815,twice,0,1
17816,daily,0,1
17817,treatment,0,1
17818,with,0,1
17819,300,0,0
17820,mg,0,1
17821,of,0,1
17822,ranitidine,1,1
17823,",",0,1
17824,1000,0,1
17825,mg,0,1
17826,of,0,1
17827,amoxicillin,1,1
17828,",",0,1
17829,and,0,1
17830,500,0,1
17831,mg,0,1
17832,of,0,1
17833,clarithromycin,1,1
17834,for,0,0
17835,7,0,0
17836,days,0,0
17837,and,0,0
17838,124,0,0
17839,such,0,0
17840,patients,0,0
17841,to,0,0
17842,receive,0,1
17843,identical-appearing,0,1
17844,placebos,1,1
17845,.,1,1
17846,RESULTS,0,0
17847,Treatment,0,0
17848,was,0,0
17849,successful,0,0
17850,(,0,0
17851,decrease,0,0
17852,of,0,0
17853,symptoms,0,0
17854,at,0,0
17855,12,0,0
17856,months,0,0
17857,),0,0
17858,in,0,0
17859,62,0,0
17860,%,0,0
17861,of,0,0
17862,patients,0,0
17863,in,0,0
17864,the,0,0
17865,active-treatment,0,0
17866,group,0,0
17867,and,0,0
17868,in,0,0
17869,60,0,0
17870,%,0,0
17871,of,0,0
17872,the,0,0
17873,placebo,0,1
17874,group,0,1
17875,(,0,1
17876,N.S.,0,1
17877,),0,1
17878,.,0,0
17879,At,0,0
17880,12,0,0
17881,months,0,0
17882,",",0,0
17883,the,0,0
17884,rate,0,0
17885,of,0,0
17886,eradication,0,0
17887,of,0,0
17888,H.,0,0
17889,pylori,0,0
17890,was,0,0
17891,69,0,0
17892,%,0,0
17893,in,0,0
17894,the,0,0
17895,active-treatment,0,0
17896,group,0,0
17897,and,0,0
17898,18,0,0
17899,%,0,0
17900,in,0,0
17901,the,0,0
17902,placebo,1,1
17903,group,0,0
17904,(,0,0
17905,P,0,0
17906,<,0,0
17907,0.001,0,0
17908,),0,0
17909,.,0,0
17910,Complete,0,0
17911,relief,0,0
17912,of,0,0
17913,symptoms,0,0
17914,occurred,0,0
17915,significantly,0,0
17916,more,0,0
17917,frequently,0,0
17918,in,0,0
17919,patients,0,0
17920,on,0,0
17921,the,0,0
17922,active,0,0
17923,treatment,0,0
17924,(,0,0
17925,43,0,0
17926,%,0,0
17927,),0,0
17928,than,0,0
17929,in,0,0
17930,placebo-treated,1,0
17931,patients,0,0
17932,(,0,0
17933,31,0,0
17934,%,0,0
17935,",",0,0
17936,P=0.048,0,0
17937,),0,0
17938,.,0,0
17939,Within,0,0
17940,the,0,0
17941,active-treatment,0,0
17942,group,0,0
17943,",",0,0
17944,therapeutic,0,0
17945,success,0,0
17946,was,0,0
17947,significantly,0,0
17948,more,0,0
17949,frequent,0,0
17950,in,0,0
17951,the,0,0
17952,non-infected,0,0
17953,patients,0,0
17954,(,0,0
17955,84,0,0
17956,%,0,0
17957,vs.,0,0
17958,64,0,0
17959,%,0,0
17960,",",0,0
17961,P=0.04,0,0
17962,),0,0
17963,.,0,0
17964,CONCLUSIONS,0,0
17965,Although,0,0
17966,eradicating,0,0
17967,H.,0,0
17968,pylori,0,0
17969,is,0,0
17970,not,0,0
17971,likely,0,0
17972,to,0,0
17973,relieve,0,0
17974,symptoms,0,0
17975,in,0,0
17976,the,0,0
17977,majority,0,0
17978,of,0,0
17979,patients,0,0
17980,with,0,0
17981,non-ulcer,0,0
17982,dyspepsia,0,0
17983,",",0,0
17984,a,0,0
17985,small,0,0
17986,proportion,0,0
17987,of,0,0
17988,H.,0,1
17989,pylori-infected,0,1
17990,patients,0,0
17991,may,0,0
17992,benefit,0,0
17993,from,0,0
17994,eradication,0,0
17995,treatment,0,0
17996,.,0,0
17997,Clomipramine,1,1
17998,versus,1,1
17999,haloperidol,1,1
18000,in,0,0
18001,the,0,0
18002,treatment,0,0
18003,of,0,0
18004,autistic,0,0
18005,disorder,0,0
18006,:,0,0
18007,a,0,0
18008,double-blind,0,1
18009,",",0,1
18010,placebo-controlled,1,1
18011,",",0,1
18012,crossover,0,1
18013,study,0,1
18014,.,0,1
18015,Clomipramine,1,1
18016,",",1,1
18017,haloperidol,1,1
18018,",",1,1
18019,and,1,0
18020,placebo,1,1
18021,were,0,0
18022,compared,0,0
18023,with,0,0
18024,baseline,0,0
18025,in,0,0
18026,the,0,0
18027,treatment,0,0
18028,of,0,0
18029,autism,0,0
18030,",",0,0
18031,and,0,0
18032,overall,0,0
18033,outcome,0,0
18034,",",0,0
18035,specific,0,0
18036,symptoms,0,0
18037,",",0,0
18038,and,0,0
18039,side,0,0
18040,effects,0,0
18041,were,0,0
18042,examined,0,0
18043,.,0,0
18044,It,0,0
18045,was,0,0
18046,hypothesized,0,0
18047,that,0,0
18048,clomipramine,1,1
18049,would,0,0
18050,be,0,0
18051,better,0,0
18052,tolerated,0,1
18053,than,0,1
18054,haloperidol,1,1
18055,and,0,0
18056,prove,0,0
18057,superior,0,0
18058,on,0,0
18059,a,0,0
18060,measure,0,0
18061,of,0,0
18062,stereotypy,0,0
18063,.,0,0
18064,Individuals,0,0
18065,with,0,0
18066,a,0,0
18067,DSM-IV,0,0
18068,diagnosis,0,0
18069,of,0,0
18070,autistic,0,1
18071,disorder,0,0
18072,(,0,0
18073,mean,0,0
18074,age,0,0
18075,",",0,0
18076,16.3,0,0
18077,years,0,0
18078,;,0,0
18079,range,0,0
18080,",",0,0
18081,10-36,0,0
18082,years,0,0
18083,),0,0
18084,were,0,0
18085,randomly,0,0
18086,assigned,0,0
18087,",",0,0
18088,by,0,0
18089,using,0,0
18090,a,0,0
18091,Latin,0,1
18092,square,0,0
18093,design,0,0
18094,",",0,0
18095,to,0,0
18096,the,0,0
18097,following,0,0
18098,7-week,0,0
18099,trials,0,1
18100,:,0,1
18101,placebo,1,1
18102,",",1,1
18103,clomipramine,1,1
18104,(,0,1
18105,mean,0,1
18106,daily,0,1
18107,dose,0,1
18108,",",0,1
18109,128.4,0,1
18110,mg,0,1
18111,;,0,0
18112,range,0,1
18113,",",0,1
18114,100-150,0,1
18115,mg,0,1
18116,),0,1
18117,",",0,1
18118,or,0,1
18119,haloperidol,1,1
18120,(,0,1
18121,mean,0,1
18122,daily,0,1
18123,dose,0,1
18124,",",0,1
18125,1.3,0,1
18126,mg,0,1
18127,;,0,1
18128,range,0,1
18129,",",0,1
18130,1-1.5,0,1
18131,mg,0,1
18132,),0,1
18133,.,0,1
18134,Data,0,0
18135,on,0,0
18136,36,0,0
18137,subjects,0,0
18138,were,0,0
18139,analyzed,0,0
18140,and,0,0
18141,taken,0,0
18142,together,0,0
18143,;,0,0
18144,the,0,0
18145,results,0,0
18146,favored,0,0
18147,haloperidol,1,1
18148,.,1,0
18149,In,0,0
18150,those,0,0
18151,patients,0,0
18152,who,0,0
18153,were,0,0
18154,able,0,0
18155,to,0,0
18156,complete,0,0
18157,a,0,0
18158,full,0,0
18159,therapeutic,0,0
18160,trial,0,1
18161,",",0,0
18162,clomipramine,1,1
18163,proved,0,0
18164,comparable,0,0
18165,to,0,0
18166,haloperidol,1,1
18167,in,0,0
18168,terms,0,0
18169,of,0,0
18170,improvement,0,0
18171,compared,0,0
18172,with,0,0
18173,baseline,0,0
18174,.,0,0
18175,However,0,0
18176,",",0,0
18177,significantly,0,0
18178,fewer,0,0
18179,individuals,0,0
18180,receiving,0,0
18181,clomipramine,1,1
18182,versus,0,1
18183,haloperidol,1,1
18184,were,0,0
18185,able,0,0
18186,to,0,0
18187,complete,0,0
18188,the,0,0
18189,trial,0,0
18190,(,0,0
18191,37.5,0,0
18192,%,0,0
18193,vs.,0,0
18194,69.7,0,0
18195,%,0,0
18196,",",0,0
18197,respectively,0,0
18198,),0,0
18199,for,0,0
18200,reasons,0,0
18201,related,0,0
18202,to,0,0
18203,both,0,0
18204,side,0,0
18205,effects,0,0
18206,and,0,0
18207,efficacy,0,0
18208,or,0,0
18209,behavior,0,0
18210,problems,0,0
18211,.,0,0
18212,In,0,0
18213,the,0,0
18214,intent-to-treat,0,0
18215,sample,0,0
18216,",",0,0
18217,which,0,0
18218,is,0,0
18219,perhaps,0,0
18220,more,0,0
18221,clinically,0,0
18222,relevant,0,0
18223,",",0,0
18224,only,0,0
18225,haloperidol,1,1
18226,proved,0,0
18227,superior,0,0
18228,to,0,0
18229,baseline,0,0
18230,on,0,0
18231,a,0,0
18232,global,0,0
18233,measure,0,0
18234,of,0,0
18235,autistic,0,0
18236,symptom,0,0
18237,severity,0,0
18238,",",0,0
18239,as,0,0
18240,well,0,0
18241,as,0,0
18242,specific,0,0
18243,measures,0,0
18244,for,0,0
18245,irritability,0,0
18246,and,0,0
18247,hyperactivity,0,0
18248,.,0,0
18249,Clomipramine,1,1
18250,did,0,0
18251,not,0,0
18252,seem,0,0
18253,more,0,0
18254,effective,0,0
18255,on,0,0
18256,a,0,0
18257,measure,0,0
18258,of,0,0
18259,stereotypy,0,0
18260,",",0,0
18261,nor,0,0
18262,was,0,0
18263,it,0,0
18264,better,0,0
18265,tolerated,0,1
18266,.,0,0
18267,Relationships,0,0
18268,between,0,0
18269,age,0,0
18270,at,0,0
18271,diagnosis,0,0
18272,",",0,0
18273,clinical,0,0
18274,features,0,0
18275,",",0,0
18276,and,0,0
18277,outcome,0,0
18278,of,0,0
18279,therapy,0,0
18280,in,0,0
18281,children,0,0
18282,treated,0,0
18283,in,0,0
18284,the,0,0
18285,Medical,0,0
18286,Research,0,0
18287,Council,0,0
18288,AML,0,0
18289,10,0,0
18290,and,0,0
18291,12,0,0
18292,trials,0,0
18293,for,0,0
18294,acute,0,0
18295,myeloid,0,0
18296,leukemia,0,0
18297,.,0,0
18298,Between,0,0
18299,May,0,0
18300,1988,0,0
18301,and,0,0
18302,June,0,0
18303,2000,0,0
18304,",",0,0
18305,698,0,0
18306,children,0,0
18307,were,0,0
18308,treated,0,0
18309,in,0,0
18310,the,0,0
18311,Medical,0,0
18312,Research,0,0
18313,Council,0,0
18314,acute,0,0
18315,myeloid,0,1
18316,leukemia,0,0
18317,10,0,0
18318,and,0,0
18319,12,0,0
18320,trials,0,0
18321,.,0,0
18322,The,0,0
18323,presenting,0,0
18324,features,1,0
18325,and,1,0
18326,outcomes,1,0
18327,of,1,0
18328,therapy,1,0
18329,in,1,0
18330,these,1,0
18331,children,1,0
18332,were,1,0
18333,compared,1,0
18334,by,1,0
18335,age,1,0
18336,.,1,0
18337,Although,0,0
18338,there,0,0
18339,was,0,0
18340,no,0,0
18341,single,0,0
18342,cutoff,0,0
18343,in,0,0
18344,age,0,0
18345,",",0,0
18346,younger,0,0
18347,children,0,0
18348,were,0,0
18349,more,0,0
18350,likely,0,0
18351,to,0,0
18352,have,0,0
18353,intermediate,0,0
18354,risk,0,0
18355,and,0,0
18356,less,0,0
18357,likely,0,0
18358,to,0,0
18359,have,0,0
18360,favorable,0,0
18361,cytogenetics,0,0
18362,(,0,0
18363,P,0,0
18364,<,0,0
18365,.001,0,0
18366,),0,0
18367,",",0,0
18368,and,0,0
18369,they,0,0
18370,had,0,0
18371,a,0,0
18372,higher,0,0
18373,incidence,0,0
18374,of,0,0
18375,translocations,0,0
18376,involving,0,0
18377,chromosome,0,1
18378,11q23,0,0
18379,(,0,0
18380,P,0,0
18381,<,0,0
18382,.001,0,0
18383,),0,0
18384,.,0,0
18385,The,0,0
18386,distribution,0,0
18387,of,0,0
18388,French-American-British,0,0
18389,(,0,1
18390,FAB,0,1
18391,),0,0
18392,types,0,0
18393,also,0,0
18394,varied,0,0
18395,with,0,0
18396,age,0,0
18397,;,0,0
18398,FAB,0,0
18399,types,0,0
18400,M5,0,0
18401,(,0,0
18402,P,0,0
18403,<,0,0
18404,.001,0,0
18405,),0,0
18406,and,0,0
18407,M7,0,0
18408,(,0,0
18409,P,0,0
18410,<,0,0
18411,.001,0,0
18412,),0,0
18413,were,0,0
18414,more,0,0
18415,common,0,0
18416,in,0,0
18417,early,0,0
18418,childhood,0,0
18419,",",0,0
18420,whereas,0,0
18421,older,0,0
18422,children,0,0
18423,were,0,0
18424,more,0,0
18425,likely,0,0
18426,to,0,0
18427,have,0,0
18428,FAB,0,0
18429,types,0,0
18430,M0,0,0
18431,(,0,0
18432,P,0,0
18433,=.03,0,0
18434,),0,0
18435,",",0,0
18436,M1,0,0
18437,(,0,0
18438,P,0,0
18439,=.04,0,0
18440,),0,0
18441,",",0,0
18442,M2,0,0
18443,(,0,0
18444,P,0,0
18445,=.005,0,0
18446,),0,0
18447,",",0,0
18448,and,0,0
18449,M3,0,0
18450,(,0,0
18451,P,0,0
18452,<,0,0
18453,.001,0,0
18454,),0,0
18455,.,0,0
18456,Involvement,0,0
18457,of,0,0
18458,the,0,0
18459,central,0,0
18460,nervous,0,0
18461,system,0,0
18462,at,0,0
18463,diagnosis,0,0
18464,was,0,0
18465,also,0,0
18466,more,0,0
18467,common,0,0
18468,in,0,0
18469,the,0,0
18470,youngest,0,0
18471,children,0,0
18472,(,0,0
18473,P,0,0
18474,=.01,0,0
18475,),0,0
18476,.,0,0
18477,Younger,0,0
18478,children,0,0
18479,had,0,0
18480,more,0,0
18481,severe,0,0
18482,diarrhea,0,0
18483,(,0,0
18484,P,0,0
18485,=.002,0,0
18486,),0,0
18487,",",0,0
18488,whereas,0,0
18489,older,0,0
18490,children,0,0
18491,had,0,0
18492,worse,0,0
18493,nausea,0,1
18494,and,0,1
18495,vomiting,0,0
18496,(,0,0
18497,P,0,0
18498,=.01,0,0
18499,),0,0
18500,after,0,0
18501,chemotherapy,0,0
18502,.,0,0
18503,When,0,0
18504,adjusted,0,0
18505,for,0,0
18506,other,0,0
18507,important,0,0
18508,factors,0,0
18509,",",0,0
18510,complete,0,0
18511,remission,0,0
18512,rates,0,0
18513,were,0,0
18514,similar,0,0
18515,(,0,0
18516,P,0,0
18517,=.5,0,0
18518,),0,0
18519,and,0,0
18520,although,0,0
18521,there,0,0
18522,was,0,0
18523,less,0,0
18524,resistant,0,0
18525,disease,0,0
18526,in,0,0
18527,younger,0,1
18528,children,0,0
18529,(,0,0
18530,P,0,0
18531,=.003,0,0
18532,),0,0
18533,",",0,0
18534,this,0,0
18535,was,0,0
18536,partially,0,0
18537,balanced,0,0
18538,by,0,0
18539,a,0,0
18540,slight,0,0
18541,increase,0,0
18542,in,0,0
18543,deaths,0,0
18544,during,0,0
18545,induction,0,0
18546,therapy,0,0
18547,in,0,0
18548,younger,0,0
18549,patients,0,0
18550,(,0,0
18551,P,0,0
18552,=.06,0,0
18553,),0,0
18554,.,0,0
18555,On,0,0
18556,multivariate,0,0
18557,analysis,0,0
18558,overall,0,0
18559,survival,0,0
18560,(,0,0
18561,P,0,0
18562,=.02,0,0
18563,),0,0
18564,",",0,0
18565,event-free,0,1
18566,survival,0,0
18567,(,0,0
18568,P,0,0
18569,=.02,0,0
18570,),0,0
18571,",",0,0
18572,and,0,0
18573,disease-free,0,0
18574,survival,0,0
18575,were,0,0
18576,better,0,0
18577,(,0,0
18578,P,0,0
18579,=.06,0,0
18580,),0,0
18581,in,0,0
18582,younger,0,0
18583,children,0,0
18584,due,0,0
18585,to,0,0
18586,a,0,0
18587,lower,0,0
18588,relapse,0,0
18589,rate,0,0
18590,(,0,0
18591,P,0,0
18592,=.02,0,0
18593,),0,0
18594,especially,0,0
18595,in,0,0
18596,the,0,0
18597,bone,0,0
18598,marrow,0,0
18599,(,0,0
18600,P,0,0
18601,=.02,0,0
18602,),0,0
18603,.,0,0
18604,A,0,1
18605,randomized,0,1
18606,effectiveness,0,0
18607,trial,0,0
18608,of,0,0
18609,collaborative,1,0
18610,care,1,0
18611,for,0,0
18612,patients,0,0
18613,with,0,0
18614,panic,0,0
18615,disorder,0,0
18616,in,0,0
18617,primary,0,0
18618,care,0,0
18619,.,0,0
18620,BACKGROUND,0,0
18621,Effectiveness,0,0
18622,studies,0,0
18623,have,0,0
18624,tested,0,0
18625,interventions,0,0
18626,to,0,0
18627,improve,0,0
18628,quality,0,0
18629,of,0,0
18630,care,0,0
18631,for,0,0
18632,depression,0,0
18633,in,0,0
18634,primary,0,0
18635,care,0,0
18636,",",0,0
18637,but,0,0
18638,none,0,0
18639,",",0,0
18640,to,0,0
18641,our,0,0
18642,knowledge,0,0
18643,",",0,0
18644,have,0,0
18645,been,0,0
18646,completed,0,0
18647,for,0,0
18648,panic,0,1
18649,disorder,0,1
18650,(,0,1
18651,PD,0,1
18652,),0,0
18653,in,0,0
18654,this,0,0
18655,setting,0,0
18656,.,0,0
18657,This,0,0
18658,study,0,0
18659,sought,0,0
18660,to,0,0
18661,test,0,0
18662,the,0,0
18663,clinical,0,0
18664,effectiveness,0,0
18665,of,0,0
18666,PD,1,0
18667,pharmacotherapy,1,0
18668,embedded,1,0
18669,in,1,0
18670,a,1,0
18671,disease,1,0
18672,management,1,0
18673,framework,1,0
18674,of,1,0
18675,collaborative,1,1
18676,care,1,1
18677,(,1,1
18678,CC,1,1
18679,),1,1
18680,.,1,0
18681,METHODS,0,0
18682,One,0,0
18683,hundred,0,0
18684,fifteen,0,0
18685,patients,0,0
18686,with,0,0
18687,PD,0,0
18688,from,0,0
18689,3,0,0
18690,primary,0,0
18691,care,0,0
18692,clinics,0,0
18693,were,0,0
18694,randomized,0,0
18695,to,0,0
18696,CC,1,0
18697,or,0,0
18698,usual,1,1
18699,care,1,1
18700,(,1,1
18701,UC,1,0
18702,),1,0
18703,.,1,0
18704,Patients,0,0
18705,in,0,0
18706,CC,0,1
18707,(,0,0
18708,n,0,0
18709,=,0,0
18710,57,0,0
18711,),0,0
18712,received,0,0
18713,educational,1,0
18714,videotapes,1,0
18715,and,1,0
18716,pamphlets,1,1
18717,;,1,0
18718,pharmacotherapy,1,0
18719,with,1,0
18720,the,1,0
18721,selective,1,0
18722,serotonin,1,1
18723,reuptake,1,1
18724,inhibitor,1,1
18725,paroxetine,1,1
18726,;,1,1
18727,2,1,1
18728,psychiatrist,1,0
18729,visits,1,1
18730,and,1,0
18731,2,1,0
18732,telephone,1,0
18733,calls,1,0
18734,in,0,0
18735,the,0,0
18736,first,0,0
18737,8,0,0
18738,weeks,0,0
18739,;,0,0
18740,and,0,0
18741,up,0,0
18742,to,0,0
18743,5,0,0
18744,telephone,1,0
18745,calls,1,0
18746,between,0,0
18747,3,0,0
18748,and,0,0
18749,12,0,0
18750,months,0,0
18751,',0,0
18752,follow-up,0,0
18753,.,0,0
18754,Usual,0,0
18755,care,0,0
18756,patients,0,0
18757,(,0,0
18758,n,0,0
18759,=,0,0
18760,58,0,0
18761,),0,0
18762,were,0,0
18763,treated,0,0
18764,by,0,0
18765,their,0,0
18766,primary,0,0
18767,care,0,0
18768,physician,0,0
18769,.,0,0
18770,Telephone,0,0
18771,assessments,0,0
18772,of,0,0
18773,panic,0,0
18774,",",0,0
18775,anxiety,0,0
18776,sensitivity,0,0
18777,",",0,0
18778,depression,0,0
18779,",",0,0
18780,and,0,0
18781,disability,0,0
18782,variables,0,0
18783,were,0,0
18784,performed,0,0
18785,at,0,0
18786,3,0,0
18787,",",0,0
18788,6,0,0
18789,",",0,0
18790,9,0,0
18791,",",0,0
18792,and,0,0
18793,12,0,0
18794,months,0,0
18795,',0,0
18796,follow-up,0,0
18797,.,0,0
18798,Adequacy,0,0
18799,of,0,0
18800,pharmacotherapy,0,0
18801,was,0,0
18802,assessed,0,0
18803,with,0,0
18804,an,0,0
18805,algorithm,0,0
18806,based,0,0
18807,on,0,0
18808,a,0,0
18809,review,0,0
18810,of,0,0
18811,efficacy,0,0
18812,studies,0,0
18813,.,0,0
18814,RESULTS,0,0
18815,Patients,0,0
18816,in,0,0
18817,CC,0,0
18818,were,0,0
18819,more,0,0
18820,likely,0,0
18821,to,0,0
18822,receive,0,0
18823,adequate,0,1
18824,(,0,0
18825,type,0,0
18826,",",0,0
18827,dose,0,1
18828,",",0,1
18829,duration,0,1
18830,),0,1
18831,medication,0,0
18832,and,0,0
18833,more,0,0
18834,likely,0,0
18835,to,0,0
18836,adhere,0,0
18837,to,0,0
18838,this,0,0
18839,medication,0,0
18840,at,0,0
18841,3,0,0
18842,and,0,0
18843,6,0,0
18844,months,0,0
18845,.,0,0
18846,Random,0,0
18847,regression,0,0
18848,analyses,0,0
18849,showed,0,0
18850,that,0,0
18851,CC,0,0
18852,patients,0,0
18853,improved,0,0
18854,significantly,0,0
18855,more,0,0
18856,over,0,0
18857,time,0,0
18858,compared,0,0
18859,with,0,0
18860,UC,0,0
18861,patients,0,0
18862,on,0,0
18863,anxiety,0,0
18864,",",0,0
18865,depression,0,0
18866,",",0,0
18867,and,0,0
18868,disability,0,0
18869,measures,0,0
18870,",",0,0
18871,with,0,0
18872,the,0,0
18873,greatest,0,0
18874,effects,0,0
18875,at,0,0
18876,3,0,0
18877,and,0,0
18878,6,0,0
18879,months,0,0
18880,.,0,0
18881,CONCLUSIONS,0,0
18882,Compared,0,0
18883,with,0,0
18884,UC,0,0
18885,",",0,0
18886,CC,0,0
18887,interventions,0,0
18888,significantly,0,0
18889,improved,0,0
18890,both,0,0
18891,quality,0,0
18892,of,0,0
18893,care,0,0
18894,and,0,0
18895,clinical,0,0
18896,and,0,0
18897,functional,0,0
18898,outcomes,0,0
18899,in,0,0
18900,primary,0,0
18901,care,0,0
18902,PD,0,0
18903,patients,0,0
18904,.,0,0
18905,Clinical,0,0
18906,differences,0,0
18907,were,0,0
18908,greatest,0,0
18909,in,0,0
18910,the,0,0
18911,first,0,0
18912,6,0,0
18913,months,0,0
18914,",",0,0
18915,corresponding,0,0
18916,to,0,0
18917,the,0,0
18918,greater,0,0
18919,quality,0,0
18920,of,0,0
18921,care,0,0
18922,and,0,0
18923,the,0,0
18924,greater,0,0
18925,intensity,0,0
18926,of,0,0
18927,intervention,0,0
18928,.,0,0
18929,Is,0,1
18930,psychotherapy,1,0
18931,more,0,0
18932,effective,0,0
18933,when,0,0
18934,therapists,0,0
18935,disclose,0,0
18936,information,0,0
18937,about,0,0
18938,themselves,0,0
18939,?,0,0
18940,Theorists,0,0
18941,have,0,0
18942,long,0,0
18943,debated,0,0
18944,the,0,0
18945,wisdom,0,0
18946,of,0,0
18947,therapists,0,0
18948,disclosing,0,0
18949,personal,0,0
18950,information,0,0
18951,during,0,0
18952,psychotherapy,1,0
18953,.,1,0
18954,Some,0,0
18955,observers,0,0
18956,have,0,0
18957,argued,0,0
18958,that,0,0
18959,such,0,0
18960,therapist,0,0
18961,self-disclosure,0,0
18962,impedes,0,0
18963,treatment,0,0
18964,",",0,0
18965,whereas,0,0
18966,others,0,0
18967,have,0,0
18968,suggested,0,0
18969,that,0,0
18970,it,0,0
18971,enhances,0,0
18972,the,0,0
18973,effectiveness,0,0
18974,of,0,0
18975,therapy,0,0
18976,.,0,0
18977,To,0,0
18978,test,0,0
18979,these,0,0
18980,competing,0,0
18981,positions,0,0
18982,",",0,0
18983,therapists,0,0
18984,at,0,0
18985,a,0,0
18986,university,0,0
18987,counseling,0,0
18988,center,0,0
18989,were,0,0
18990,instructed,0,0
18991,to,0,0
18992,increase,1,0
18993,the,1,0
18994,number,1,0
18995,of,1,0
18996,self-disclosures,1,0
18997,they,0,0
18998,made,0,0
18999,during,0,0
19000,treatment,1,0
19001,of,0,0
19002,one,0,0
19003,client,0,0
19004,and,0,0
19005,refrain,1,0
19006,from,1,0
19007,making,1,0
19008,self-disclosures,1,0
19009,during,1,0
19010,treatment,1,0
19011,of,0,0
19012,another,0,0
19013,client,0,0
19014,.,0,0
19015,Analyses,0,0
19016,revealed,0,0
19017,that,0,0
19018,clients,0,0
19019,receiving,0,0
19020,psychotherapy,1,0
19021,under,0,0
19022,conditions,0,0
19023,of,0,0
19024,heightened,0,0
19025,therapist,1,0
19026,disclosure,1,0
19027,not,0,0
19028,only,0,0
19029,reported,0,0
19030,lower,0,0
19031,levels,0,0
19032,of,0,0
19033,symptom,0,0
19034,distress,0,0
19035,but,0,0
19036,also,0,0
19037,liked,0,0
19038,their,0,0
19039,therapist,0,0
19040,more,0,0
19041,.,0,0
19042,Such,0,0
19043,findings,0,0
19044,suggest,0,0
19045,that,0,0
19046,self-disclosure,0,0
19047,by,0,0
19048,the,0,0
19049,therapist,0,0
19050,may,0,0
19051,improve,0,0
19052,both,0,0
19053,the,0,0
19054,quality,0,0
19055,of,0,0
19056,the,0,0
19057,therapeutic,0,0
19058,relationship,0,0
19059,and,0,0
19060,the,0,0
19061,outcome,0,0
19062,of,0,0
19063,treatment,0,0
19064,.,0,0
19065,A,0,1
19066,randomized,0,0
19067,intervention,0,0
19068,to,0,0
19069,improve,0,0
19070,ongoing,0,0
19071,participation,0,0
19072,in,0,0
19073,mammography,0,0
19074,.,0,0
19075,OBJECTIVE,0,0
19076,To,0,0
19077,test,0,0
19078,the,0,0
19079,effectiveness,0,0
19080,of,0,0
19081,interventions,1,0
19082,intended,1,0
19083,to,0,0
19084,increase,0,0
19085,rates,0,0
19086,of,0,0
19087,regular,0,0
19088,breast,0,0
19089,cancer,0,0
19090,screening,0,0
19091,",",0,0
19092,according,0,0
19093,to,0,0
19094,recommended,0,0
19095,guidelines,0,0
19096,.,0,0
19097,STUDY,0,0
19098,DESIGN,0,1
19099,A,0,1
19100,randomized,0,0
19101,controlled,0,0
19102,trial,0,0
19103,of,0,0
19104,2,0,0
19105,outreach,1,0
19106,interventions,1,1
19107,(,1,0
19108,a,1,0
19109,mail,1,0
19110,reminder,1,0
19111,and,1,0
19112,a,1,0
19113,telephone,1,0
19114,reminder,1,0
19115,plus,1,0
19116,appointment,1,0
19117,scheduling,1,1
19118,),1,0
19119,compared,0,0
19120,with,0,0
19121,a,0,0
19122,routine,1,0
19123,publicity,1,0
19124,campaign,1,0
19125,to,0,0
19126,encourage,0,0
19127,continued,0,0
19128,participation,0,0
19129,in,0,0
19130,mammography,1,0
19131,screening,0,0
19132,.,0,0
19133,PARTICIPANTS,0,0
19134,AND,0,1
19135,METHODS,0,1
19136,Participants,0,0
19137,were,0,0
19138,1908,0,0
19139,women,0,0
19140,aged,0,0
19141,50,0,0
19142,to,0,0
19143,75,0,0
19144,years,0,0
19145,continuously,0,0
19146,enrolled,0,0
19147,in,0,0
19148,a,0,0
19149,large,0,0
19150,group-model,0,0
19151,HMO,0,0
19152,during,0,0
19153,the,0,0
19154,study,0,0
19155,who,0,0
19156,underwent,0,0
19157,a,0,0
19158,bilateral,0,0
19159,mammogram,0,0
19160,during,0,0
19161,the,0,0
19162,first,0,0
19163,quarter,0,0
19164,of,0,0
19165,1994,0,0
19166,and,0,0
19167,no,0,0
19168,subsequent,0,0
19169,mammogram,0,0
19170,during,0,0
19171,the,0,0
19172,next,0,0
19173,18,0,0
19174,to,0,0
19175,21,0,0
19176,months,0,0
19177,.,0,0
19178,Data,0,0
19179,were,0,0
19180,obtained,0,0
19181,from,0,0
19182,health,0,0
19183,plan,0,0
19184,administrative,0,0
19185,data,0,0
19186,files,0,0
19187,supplemented,0,0
19188,by,0,0
19189,medical,0,1
19190,chart,0,0
19191,review,0,0
19192,.,0,0
19193,Women,0,0
19194,were,0,0
19195,randomly,0,0
19196,assigned,0,0
19197,to,0,0
19198,receive,0,1
19199,(,0,1
19200,1,0,1
19201,),0,0
19202,a,1,0
19203,mail,1,0
19204,reminder,1,1
19205,",",1,1
19206,(,1,1
19207,2,1,1
19208,),1,0
19209,a,1,0
19210,telephone,1,0
19211,reminder,1,0
19212,",",1,0
19213,or,1,0
19214,(,1,1
19215,3,1,1
19216,),1,0
19217,routine,1,1
19218,publicity,1,1
19219,on,1,0
19220,mammography,1,0
19221,for,1,0
19222,all,1,0
19223,women,1,0
19224,.,1,0
19225,The,0,0
19226,outcome,0,0
19227,measure,0,0
19228,was,0,0
19229,a,0,0
19230,mammogram,0,0
19231,received,0,0
19232,after,0,0
19233,the,0,0
19234,intervention,0,0
19235,period,0,0
19236,and,0,0
19237,within,0,0
19238,2,0,0
19239,years,0,0
19240,of,0,0
19241,the,0,0
19242,initial,0,0
19243,mammogram,0,0
19244,date,0,0
19245,.,0,0
19246,RESULTS,0,0
19247,Bivariate,0,0
19248,and,0,0
19249,multivariate,0,0
19250,statistical,0,0
19251,analyses,0,0
19252,showed,0,0
19253,that,0,0
19254,participation,0,0
19255,was,0,0
19256,significantly,0,0
19257,higher,0,0
19258,for,0,0
19259,women,0,0
19260,contacted,0,0
19261,by,0,0
19262,telephone,0,0
19263,than,0,0
19264,through,0,0
19265,routine,0,0
19266,publicity,0,0
19267,.,0,0
19268,Mail,0,0
19269,reminders,0,0
19270,were,0,0
19271,no,0,0
19272,more,0,0
19273,effective,0,0
19274,than,0,0
19275,a,0,0
19276,routine,1,0
19277,publicity,1,0
19278,campaign,1,0
19279,.,1,0
19280,Primary,0,0
19281,care,0,0
19282,physician,0,0
19283,and,0,0
19284,gynecologist,0,0
19285,visits,0,0
19286,increased,0,0
19287,the,0,0
19288,likelihood,0,0
19289,of,0,0
19290,a,0,0
19291,subsequent,0,0
19292,mammogram,0,0
19293,for,0,0
19294,women,0,0
19295,in,0,0
19296,all,0,0
19297,intervention,0,0
19298,groups,0,0
19299,.,0,0
19300,CONCLUSIONS,0,0
19301,Telephone,1,0
19302,contact,1,0
19303,by,0,0
19304,regular,0,0
19305,health,0,0
19306,plan,0,0
19307,staff,0,0
19308,was,0,0
19309,more,0,0
19310,successful,0,0
19311,than,0,0
19312,publicity,0,0
19313,in,0,0
19314,encouraging,0,0
19315,continued,0,0
19316,participation,0,0
19317,in,0,0
19318,mammography,0,0
19319,screening,0,0
19320,in,0,0
19321,women,0,0
19322,enrolled,0,0
19323,in,0,0
19324,a,0,0
19325,group-model,0,0
19326,managed,0,0
19327,health,0,1
19328,care,0,0
19329,plan,0,0
19330,.,0,0
19331,Because,0,0
19332,mailings,0,0
19333,did,0,0
19334,not,0,0
19335,influence,0,0
19336,participation,0,0
19337,in,0,0
19338,mammography,0,0
19339,screening,0,0
19340,",",0,0
19341,health,0,0
19342,plans,0,0
19343,should,0,0
19344,be,0,0
19345,cautious,0,0
19346,about,0,0
19347,investing,0,0
19348,in,0,0
19349,member,0,0
19350,mailings,0,0
19351,without,0,0
19352,first,0,0
19353,evaluating,0,0
19354,their,0,0
19355,effectiveness,0,0
19356,in,0,0
19357,the,0,0
19358,context,0,0
19359,of,0,0
19360,existing,0,0
19361,outreach,0,0
19362,efforts,0,0
19363,.,0,0
19364,[,1,1
19365,Neoton,1,1
19366,and,1,0
19367,thrombolytic,1,0
19368,therapy,1,0
19369,of,0,0
19370,myocardial,0,1
19371,infarction,0,1
19372,],0,0
19373,.,0,0
19374,AIM,0,0
19375,To,0,1
19376,evaluate,0,0
19377,neoton,1,1
19378,therapy,1,1
19379,effects,0,0
19380,in,0,0
19381,acute,0,0
19382,myocardial,0,1
19383,infarction,0,1
19384,(,0,1
19385,MI,0,1
19386,),0,1
19387,on,0,0
19388,systolic,0,0
19389,function,0,0
19390,of,0,0
19391,the,0,0
19392,left,0,0
19393,ventricle,0,0
19394,",",0,0
19395,arrhythmia,0,0
19396,and,0,0
19397,clinical,0,0
19398,symptoms,0,0
19399,in,0,0
19400,patients,0,0
19401,on,0,0
19402,thrombolytic,1,0
19403,therapy,1,1
19404,(,1,1
19405,TLT,1,1
19406,),1,1
19407,.,1,0
19408,MATERIAL,0,0
19409,AND,0,0
19410,METHODS,0,0
19411,106,0,0
19412,males,0,0
19413,with,0,0
19414,Q-MI,0,0
19415,entered,0,0
19416,the,0,0
19417,study,0,0
19418,.,0,0
19419,47,0,0
19420,received,0,0
19421,treatment,1,0
19422,without,1,0
19423,TLT,1,1
19424,and,1,0
19425,neoton,1,1
19426,",",0,0
19427,30,0,0
19428,patients,0,0
19429,received,0,0
19430,TLT,1,1
19431,with,1,1
19432,streptokinase,1,1
19433,preparations,1,0
19434,",",0,0
19435,29,0,0
19436,patients,0,0
19437,were,0,0
19438,given,0,0
19439,streptokinase,1,1
19440,preparations,1,0
19441,and,1,1
19442,neoton,1,1
19443,.,1,1
19444,Left,0,0
19445,ventricular,0,0
19446,systolic,0,0
19447,function,0,0
19448,was,0,0
19449,measured,0,0
19450,by,0,0
19451,echocardiography,0,0
19452,on,0,0
19453,day,0,0
19454,1,0,0
19455,",",0,0
19456,3,0,0
19457,",",0,0
19458,7,0,0
19459,",",0,0
19460,14,0,0
19461,",",0,0
19462,21,0,0
19463,and,0,0
19464,28,0,0
19465,;,0,0
19466,arrhythmia,0,0
19467,was,0,0
19468,analysed,0,0
19469,at,0,0
19470,Holter,0,0
19471,monitoring,0,0
19472,in,0,0
19473,day,0,0
19474,1,0,1
19475,and,0,0
19476,2,0,0
19477,of,0,0
19478,MI,0,0
19479,.,0,0
19480,RESULTS,0,0
19481,TLT,0,0
19482,failed,0,0
19483,to,0,0
19484,arrest,0,0
19485,progression,0,0
19486,of,0,0
19487,left,0,0
19488,ventricular,0,0
19489,dilation,0,0
19490,by,0,0
19491,the,0,0
19492,end,0,0
19493,of,0,0
19494,the,0,0
19495,hospital,0,0
19496,stay,0,0
19497,.,0,0
19498,Patients,0,0
19499,given,0,0
19500,neoton,1,1
19501,in,0,0
19502,acute,0,1
19503,period,0,0
19504,of,0,0
19505,MI,0,0
19506,had,0,0
19507,no,0,0
19508,increase,0,0
19509,in,0,0
19510,the,0,0
19511,end,0,0
19512,systolic,0,0
19513,and,0,0
19514,diastolic,0,0
19515,volumes,0,0
19516,of,0,0
19517,the,0,0
19518,left,0,0
19519,ventricle,0,0
19520,in,0,0
19521,the,0,0
19522,course,0,0
19523,of,0,0
19524,the,0,0
19525,first,0,0
19526,months,0,0
19527,after,0,0
19528,MI,0,0
19529,onset,0,0
19530,.,0,0
19531,Antiarrhythmic,0,0
19532,action,0,0
19533,of,0,0
19534,neoton,1,1
19535,manifested,0,0
19536,on,0,0
19537,MI,0,1
19538,day,0,0
19539,2,0,0
19540,.,0,0
19541,CONCLUSION,0,1
19542,Neoton,1,1
19543,given,0,0
19544,to,0,0
19545,MI,0,0
19546,patients,0,0
19547,receiving,0,0
19548,TLT,0,0
19549,prevents,0,0
19550,progression,0,0
19551,of,0,0
19552,left,0,0
19553,ventricular,0,0
19554,systolic,0,0
19555,dysfunction,0,0
19556,and,0,0
19557,establishment,0,0
19558,of,0,0
19559,predictors,0,0
19560,of,0,0
19561,unfavourable,0,0
19562,outcome,0,0
19563,.,0,0
19564,Multisite,0,0
19565,",",0,0
19566,double-blind,0,1
19567,",",0,1
19568,placebo-controlled,1,1
19569,trial,0,1
19570,of,0,0
19571,porcine,1,0
19572,secretin,1,1
19573,in,0,0
19574,autism,0,0
19575,.,0,0
19576,OBJECTIVE,0,0
19577,To,0,0
19578,examine,0,0
19579,the,0,0
19580,efficacy,0,0
19581,of,0,0
19582,intravenous,0,1
19583,porcine,1,1
19584,secretin,1,1
19585,for,0,0
19586,the,0,0
19587,treatment,0,0
19588,of,0,0
19589,autistic,0,0
19590,disorder,0,0
19591,.,0,0
19592,METHOD,0,0
19593,Randomized,0,1
19594,",",0,0
19595,double-blind,0,1
19596,",",0,1
19597,placebo-controlled,1,1
19598,",",0,1
19599,crossover,0,1
19600,design,0,0
19601,.,0,0
19602,Fifty-six,0,0
19603,subjects,0,0
19604,with,0,0
19605,autistic,0,0
19606,disorder,0,0
19607,received,0,0
19608,either,0,0
19609,a,0,0
19610,secretin,1,1
19611,or,1,1
19612,placebo,1,1
19613,infusion,1,1
19614,at,0,1
19615,baseline,0,0
19616,and,0,0
19617,the,0,0
19618,other,0,0
19619,substance,0,0
19620,at,0,0
19621,week,0,0
19622,4,0,0
19623,.,0,0
19624,Subjects,0,0
19625,were,0,0
19626,given,0,0
19627,the,0,0
19628,Autism,0,0
19629,Diagnostic,0,1
19630,Observation,0,1
19631,Schedule,0,1
19632,(,0,1
19633,ADOS,0,1
19634,),0,1
19635,and,0,0
19636,other,0,0
19637,pertinent,0,0
19638,developmental,0,0
19639,measures,0,0
19640,at,0,0
19641,baseline,0,0
19642,and,0,0
19643,at,0,0
19644,weeks,0,0
19645,4,0,0
19646,and,0,0
19647,8,0,0
19648,to,0,0
19649,assess,0,0
19650,drug,0,1
19651,effects,0,0
19652,.,0,0
19653,RESULTS,0,0
19654,For,0,0
19655,the,0,0
19656,primary,0,0
19657,efficacy,0,0
19658,analysis,0,0
19659,",",0,0
19660,change,0,0
19661,of,0,0
19662,ADOS,0,0
19663,social-communication,0,0
19664,total,0,0
19665,score,0,0
19666,from,0,0
19667,week,0,0
19668,0,0,0
19669,to,0,0
19670,week,0,0
19671,4,0,0
19672,",",0,0
19673,no,0,0
19674,statistically,0,0
19675,significant,0,0
19676,difference,0,0
19677,was,0,0
19678,obtained,0,0
19679,between,0,0
19680,placebo,1,1
19681,(,0,0
19682,-0.8,0,0
19683,+/-,0,0
19684,2.9,0,0
19685,),0,0
19686,and,0,0
19687,secretin,1,1
19688,groups,0,1
19689,(,0,0
19690,-0.6,0,0
19691,+/-,0,0
19692,1.4,0,0
19693,;,0,0
19694,t54,0,0
19695,=,0,0
19696,0.346,0,0
19697,",",0,0
19698,p,0,0
19699,<,0,0
19700,.73,0,0
19701,),0,0
19702,.,0,0
19703,The,0,0
19704,other,0,0
19705,measures,0,0
19706,showed,0,0
19707,no,0,0
19708,treatment,0,0
19709,effect,0,0
19710,for,0,0
19711,secretin,1,1
19712,compared,0,0
19713,with,0,0
19714,placebo,1,1
19715,.,1,0
19716,CONCLUSION,0,0
19717,There,0,0
19718,was,0,0
19719,no,0,0
19720,evidence,0,0
19721,for,0,0
19722,efficacy,0,0
19723,of,0,0
19724,secretin,0,1
19725,in,0,0
19726,this,0,0
19727,randomized,0,0
19728,",",0,0
19729,placebo-controlled,0,1
19730,",",0,1
19731,double-blind,0,1
19732,trial,0,1
19733,.,0,0
19734,Oral,1,1
19735,estrogen,1,1
19736,antagonizes,0,1
19737,the,0,0
19738,metabolic,0,0
19739,actions,0,0
19740,of,0,0
19741,growth,0,0
19742,hormone,0,1
19743,in,0,0
19744,growth,0,0
19745,hormone-deficient,0,1
19746,women,0,1
19747,.,0,0
19748,We,0,0
19749,have,0,0
19750,determined,0,0
19751,whether,0,0
19752,oral,1,1
19753,estrogen,1,1
19754,reduces,0,0
19755,the,0,0
19756,biological,0,0
19757,effects,0,0
19758,of,0,0
19759,growth,0,0
19760,hormone,0,1
19761,(,0,1
19762,GH,0,1
19763,),0,0
19764,in,0,0
19765,GH-deficient,0,0
19766,(,0,0
19767,GHD,0,1
19768,),0,1
19769,women,0,0
19770,compared,0,0
19771,with,0,0
19772,transdermal,1,1
19773,estrogen,1,1
19774,treatment,0,1
19775,.,0,0
19776,In,0,0
19777,two,0,0
19778,separate,0,0
19779,studies,0,0
19780,",",0,0
19781,eight,0,0
19782,GHD,0,0
19783,women,0,0
19784,randomly,0,0
19785,received,0,0
19786,either,0,0
19787,oral,1,1
19788,or,1,1
19789,transdermal,1,1
19790,estrogen,1,1
19791,for,0,1
19792,8,0,0
19793,wk,0,0
19794,before,0,0
19795,crossing,0,0
19796,over,0,0
19797,to,0,0
19798,the,0,0
19799,alternate,0,0
19800,route,0,0
19801,of,0,0
19802,administration,0,1
19803,.,0,0
19804,The,0,0
19805,first,0,0
19806,study,0,0
19807,assessed,0,0
19808,the,0,0
19809,effects,0,0
19810,of,0,0
19811,incremental,0,0
19812,doses,0,1
19813,of,0,1
19814,GH,0,1
19815,(,0,0
19816,0.5,0,0
19817,",",0,0
19818,1.0,0,0
19819,",",0,0
19820,2.0,0,0
19821,IU/day,0,1
19822,for,0,1
19823,1,0,1
19824,wk,0,0
19825,each,0,1
19826,),0,1
19827,on,0,0
19828,insulin-like,0,1
19829,growth,0,0
19830,factor,0,0
19831,I,0,0
19832,(,0,1
19833,IGF-I,0,1
19834,),0,0
19835,levels,0,0
19836,during,0,0
19837,each,0,0
19838,estrogen,1,1
19839,treatment,1,0
19840,phase,0,0
19841,.,0,0
19842,The,0,0
19843,second,0,0
19844,study,0,0
19845,assessed,0,0
19846,the,0,0
19847,effects,0,0
19848,of,0,0
19849,GH,0,1
19850,(,0,1
19851,2,0,1
19852,IU/day,0,1
19853,),0,1
19854,on,0,0
19855,lipid,0,0
19856,oxidation,0,0
19857,and,0,0
19858,on,0,0
19859,protein,0,0
19860,metabolism,0,0
19861,using,0,0
19862,the,0,0
19863,whole,0,0
19864,body,0,0
19865,leucine,0,1
19866,turnover,0,0
19867,technique,0,0
19868,.,0,0
19869,Mean,0,0
19870,IGF-I,0,0
19871,level,0,0
19872,was,0,0
19873,significantly,0,0
19874,lower,0,0
19875,during,0,0
19876,oral,1,1
19877,estrogen,1,1
19878,treatment,0,0
19879,(,0,0
19880,P,0,0
19881,<,0,0
19882,0.05,0,0
19883,),0,0
19884,and,0,0
19885,rose,0,0
19886,dose,0,1
19887,dependently,0,1
19888,during,0,1
19889,GH,0,1
19890,administration,0,1
19891,by,0,0
19892,a,0,0
19893,lesser,0,0
19894,magnitude,0,0
19895,(,0,0
19896,P,0,0
19897,<,0,0
19898,0.05,0,0
19899,),0,0
19900,compared,0,0
19901,with,0,0
19902,transdermal,1,1
19903,treatment,1,1
19904,.,1,1
19905,Postprandial,0,1
19906,lipid,0,0
19907,oxidation,0,0
19908,was,0,0
19909,significantly,0,0
19910,lower,0,0
19911,with,0,0
19912,oral,1,1
19913,estrogen,1,1
19914,treatment,0,1
19915,",",0,0
19916,both,0,0
19917,before,0,0
19918,(,0,0
19919,P,0,0
19920,<,0,0
19921,0.05,0,0
19922,),0,0
19923,and,0,0
19924,during,0,0
19925,(,0,0
19926,P,0,0
19927,<,0,0
19928,0.05,0,0
19929,),0,0
19930,GH,0,0
19931,administration,0,1
19932,",",0,0
19933,compared,0,0
19934,with,0,0
19935,transdermal,0,1
19936,treatment,0,0
19937,.,0,0
19938,Protein,0,0
19939,synthesis,0,0
19940,was,0,0
19941,lower,0,0
19942,during,0,0
19943,oral,0,1
19944,estrogen,1,1
19945,both,0,0
19946,before,0,0
19947,and,0,0
19948,during,0,0
19949,GH,1,1
19950,administration,0,1
19951,(,0,0
19952,P,0,0
19953,<,0,0
19954,0.05,0,0
19955,),0,0
19956,.,0,0
19957,Oral,1,1
19958,estrogen,1,1
19959,antagonizes,0,1
19960,several,0,0
19961,of,0,0
19962,the,0,0
19963,metabolic,0,0
19964,actions,0,0
19965,of,0,0
19966,GH,0,0
19967,.,0,0
19968,It,0,0
19969,may,0,0
19970,aggravate,0,0
19971,body,0,0
19972,composition,0,0
19973,abnormalities,0,0
19974,already,0,0
19975,present,0,0
19976,in,0,0
19977,GHD,0,0
19978,women,0,0
19979,and,0,0
19980,attenuate,0,0
19981,the,0,0
19982,beneficial,0,0
19983,effects,0,0
19984,of,0,0
19985,GH,1,0
19986,therapy,1,0
19987,.,1,0
19988,Estrogen,1,0
19989,replacement,1,0
19990,in,0,0
19991,GHD,0,0
19992,women,0,0
19993,should,0,0
19994,be,0,0
19995,administered,0,1
19996,by,0,0
19997,a,0,0
19998,nonoral,0,0
19999,route,0,0
20000,.,0,0
20001,Acute,0,0
20002,effect,0,0
20003,of,0,0
20004,pegvisomant,1,1
20005,on,0,0
20006,cardiovascular,0,0
20007,risk,0,0
20008,markers,0,0
20009,in,0,0
20010,healthy,0,0
20011,men,0,0
20012,:,0,0
20013,implications,0,0
20014,for,0,0
20015,the,0,0
20016,pathogenesis,0,0
20017,of,0,0
20018,atherosclerosis,0,0
20019,in,0,0
20020,GH,0,0
20021,deficiency,0,0
20022,.,0,0
20023,Cardiovascular,0,0
20024,risk,0,0
20025,is,0,0
20026,increased,0,0
20027,in,0,0
20028,GH,0,0
20029,deficiency,0,0
20030,(,0,1
20031,GHD,0,1
20032,),0,1
20033,.,0,0
20034,GHD,0,0
20035,adults,0,0
20036,are,0,0
20037,frequently,0,0
20038,abdominally,0,0
20039,obese,0,0
20040,and,0,0
20041,display,0,0
20042,features,0,0
20043,of,0,0
20044,the,0,0
20045,metabolic,0,0
20046,syndrome,0,0
20047,.,0,0
20048,Otherwise,0,0
20049,healthy,0,0
20050,abdominally,0,0
20051,obese,0,0
20052,subjects,0,0
20053,have,0,0
20054,low,0,0
20055,GH,0,0
20056,levels,0,0
20057,and,0,0
20058,show,0,0
20059,features,0,0
20060,of,0,0
20061,the,0,0
20062,metabolic,0,0
20063,syndrome,0,0
20064,as,0,0
20065,well,0,0
20066,.,0,0
20067,We,0,0
20068,investigated,0,0
20069,in,0,0
20070,healthy,0,0
20071,nonobese,0,0
20072,males,0,0
20073,the,0,0
20074,effect,0,0
20075,of,0,0
20076,the,0,0
20077,GH,0,0
20078,receptor,0,1
20079,antagonist,0,1
20080,pegvisomant,1,1
20081,in,0,0
20082,different,0,0
20083,metabolic,0,0
20084,conditions,0,0
20085,.,0,0
20086,This,0,0
20087,is,0,0
20088,a,0,0
20089,model,0,0
20090,for,0,0
20091,acute,0,0
20092,GHD,0,0
20093,without,0,0
20094,the,0,0
20095,alterations,0,0
20096,in,0,0
20097,body,0,0
20098,composition,0,0
20099,associated,0,0
20100,with,0,0
20101,GHD,0,0
20102,.,0,0
20103,We,0,0
20104,compared,0,0
20105,the,0,0
20106,effect,0,0
20107,of,0,0
20108,pegvisomant,1,1
20109,with,0,0
20110,that,0,0
20111,of,0,0
20112,placebo,1,1
20113,before,0,0
20114,and,0,0
20115,after,0,0
20116,3,0,0
20117,d,0,0
20118,of,0,0
20119,fasting,0,1
20120,.,0,0
20121,In,0,0
20122,addition,0,0
20123,",",0,0
20124,we,0,0
20125,investigated,0,0
20126,the,0,0
20127,effect,0,0
20128,of,0,0
20129,pegvisomant,1,1
20130,under,0,0
20131,normal,0,0
20132,",",0,0
20133,i.e,0,0
20134,.,0,0
20135,fed,0,0
20136,",",0,0
20137,conditions,0,0
20138,.,0,0
20139,Three,0,0
20140,days,0,0
20141,of,0,0
20142,fasting,0,1
20143,as,0,0
20144,well,0,0
20145,as,0,0
20146,pegvisomant,0,1
20147,alone,0,0
20148,decreased,0,0
20149,serum,0,1
20150,free,0,0
20151,IGF-I,0,1
20152,levels,0,0
20153,(,0,0
20154,1.0,0,0
20155,+/-,0,0
20156,0.15,0,0
20157,vs.,0,0
20158,0.31,0,0
20159,+/-,0,0
20160,0.05,0,0
20161,ng/ml,0,0
20162,and,0,0
20163,0.86,0,0
20164,+/-,0,0
20165,0.23,0,0
20166,vs.,0,0
20167,0.46,0,0
20168,+/-,0,0
20169,0.23,0,0
20170,ng/ml,0,0
20171,",",0,0
20172,respectively,0,0
20173,),0,0
20174,.,0,0
20175,Fasting,0,0
20176,in,0,0
20177,combination,0,0
20178,with,0,0
20179,pegvisomant,0,1
20180,also,0,0
20181,decreased,0,0
20182,serum,0,1
20183,free,0,0
20184,IGF-I,0,1
20185,levels,0,0
20186,(,0,0
20187,1.0,0,0
20188,+/-,0,0
20189,0.15,0,0
20190,vs.,0,0
20191,0.31,0,0
20192,+/-,0,0
20193,0.07,0,0
20194,ng/ml,0,0
20195,),0,0
20196,.,0,0
20197,Treatment,0,0
20198,with,0,0
20199,pegvisomant,1,1
20200,had,0,0
20201,no,0,0
20202,additional,0,0
20203,influence,0,0
20204,on,0,0
20205,the,0,0
20206,decline,0,0
20207,of,0,0
20208,free,0,0
20209,IGF-I,0,0
20210,induced,0,0
20211,by,0,0
20212,fasting,0,1
20213,.,0,1
20214,Pegvisomant,0,1
20215,alone,0,0
20216,had,0,0
20217,no,0,0
20218,influence,0,0
20219,on,0,0
20220,insulin,0,1
20221,sensitivity,0,0
20222,.,0,0
20223,The,0,0
20224,increase,0,0
20225,in,0,0
20226,insulin,0,1
20227,sensitivity,0,0
20228,induced,0,0
20229,by,0,0
20230,fasting,0,1
20231,was,0,0
20232,comparable,0,0
20233,to,0,0
20234,the,0,0
20235,increase,0,0
20236,in,0,0
20237,insulin,0,1
20238,sensitivity,0,0
20239,induced,0,0
20240,by,0,0
20241,fasting,0,1
20242,combined,0,0
20243,with,0,1
20244,pegvisomant,0,1
20245,.,0,1
20246,Among,0,1
20247,serum,0,1
20248,lipid,0,1
20249,concentrations,0,1
20250,",",0,0
20251,only,0,1
20252,serum,0,1
20253,triglycerides,0,1
20254,increased,0,0
20255,significantly,0,0
20256,as,0,0
20257,a,0,0
20258,result,0,0
20259,of,0,0
20260,pegvisomant,0,1
20261,alone,0,0
20262,(,0,0
20263,1.0,0,0
20264,+/-,0,0
20265,0.2,0,0
20266,vs.,0,0
20267,1.6,0,0
20268,+/-,0,0
20269,0.4,0,0
20270,mmol/liter,0,0
20271,),0,0
20272,.,0,0
20273,The,0,0
20274,changes,0,0
20275,in,0,0
20276,lipid,0,0
20277,concentrations,0,0
20278,induced,0,0
20279,by,0,0
20280,fasting,0,1
20281,alone,0,0
20282,or,0,0
20283,pegvisomant,0,1
20284,were,0,0
20285,not,0,0
20286,different,0,0
20287,from,0,0
20288,those,0,0
20289,induced,0,0
20290,by,0,0
20291,pegvisomant,0,1
20292,alone,0,0
20293,.,0,0
20294,von,0,0
20295,Willebrand,0,0
20296,factor,0,0
20297,antigen,0,0
20298,levels,0,0
20299,declined,0,0
20300,significantly,0,0
20301,under,0,0
20302,the,0,0
20303,influence,0,0
20304,of,0,0
20305,pegvisomant,0,1
20306,alone,0,0
20307,(,0,0
20308,1.1,0,0
20309,+/-,0,0
20310,0.07,0,0
20311,vs.,0,0
20312,0.8,0,0
20313,+/-,0,0
20314,0.06,0,0
20315,U/ml,0,0
20316,),0,0
20317,.,0,0
20318,In,0,0
20319,conclusion,0,0
20320,",",0,0
20321,in,0,0
20322,different,0,0
20323,metabolic,0,0
20324,conditions,0,0
20325,the,0,0
20326,GH,0,0
20327,receptor,0,1
20328,antagonist,0,1
20329,pegvisomant,0,1
20330,induces,0,1
20331,no,0,0
20332,significant,0,0
20333,acute,0,0
20334,changes,0,0
20335,in,0,0
20336,the,0,0
20337,major,0,0
20338,risk,0,0
20339,markers,0,0
20340,for,0,0
20341,cardiovascular,0,0
20342,disease,0,0
20343,.,0,0
20344,These,0,0
20345,data,0,0
20346,suggest,0,0
20347,that,0,0
20348,the,0,0
20349,secondary,0,0
20350,metabolic,0,0
20351,changes,0,0
20352,",",0,0
20353,e.g,0,0
20354,.,0,0
20355,abdominal,0,0
20356,obesity,0,0
20357,or,0,0
20358,inflammatory,0,0
20359,factors,0,0
20360,",",0,0
20361,that,0,0
20362,develop,0,0
20363,as,0,0
20364,a,0,0
20365,result,0,0
20366,of,0,0
20367,long-standing,0,0
20368,GHD,0,0
20369,are,0,0
20370,of,0,0
20371,primary,0,0
20372,importance,0,0
20373,in,0,0
20374,the,0,0
20375,pathogenesis,0,0
20376,of,0,0
20377,atherosclerosis,0,0
20378,in,0,0
20379,patients,0,0
20380,with,0,0
20381,GHD,0,0
20382,.,0,0
20383,Social,1,0
20384,support,1,0
20385,and,0,0
20386,abstinence,1,0
20387,from,0,0
20388,opiates,0,1
20389,and,0,1
20390,cocaine,0,1
20391,during,0,1
20392,opioid,1,1
20393,maintenance,1,0
20394,treatment,1,0
20395,.,1,0
20396,Social,1,0
20397,support,1,0
20398,may,0,0
20399,play,0,0
20400,an,0,0
20401,important,0,0
20402,role,0,0
20403,in,0,0
20404,helping,0,0
20405,drug,0,1
20406,users,0,1
20407,achieve,0,1
20408,abstinence,0,0
20409,;,0,0
20410,however,0,0
20411,these,0,0
20412,benefits,0,0
20413,may,0,0
20414,depend,0,0
20415,on,0,0
20416,the,0,0
20417,type,0,0
20418,of,0,0
20419,support,0,0
20420,experienced,0,0
20421,.,0,0
20422,In,0,0
20423,this,0,0
20424,prospective,0,0
20425,observational,0,0
20426,study,0,0
20427,",",0,0
20428,we,0,0
20429,examined,0,0
20430,the,0,0
20431,extent,0,0
20432,to,0,0
20433,which,0,0
20434,general,1,0
20435,and,1,0
20436,abstinence-specific,1,0
20437,support,1,0
20438,",",1,0
20439,both,1,0
20440,structural,1,0
20441,and,1,0
20442,functional,1,0
20443,",",0,0
20444,predicted,0,0
20445,opiate,0,1
20446,and,0,1
20447,cocaine,0,1
20448,abstinence,0,0
20449,in,0,0
20450,128,0,0
20451,opioid,0,0
20452,maintenance,0,0
20453,patients,0,0
20454,receiving,0,0
20455,either,0,0
20456,methadone,1,1
20457,or,1,0
20458,LAAM,1,1
20459,.,1,0
20460,A,0,0
20461,new,0,0
20462,multidimensional,0,0
20463,self-report,0,0
20464,instrument,0,0
20465,assessing,0,0
20466,abstinence-specific,1,0
20467,functional,0,0
20468,support,0,0
20469,was,0,0
20470,developed,0,0
20471,for,0,0
20472,the,0,0
20473,study,0,0
20474,.,0,0
20475,Previously,0,0
20476,validated,0,0
20477,measures,0,0
20478,were,0,0
20479,used,0,0
20480,to,0,0
20481,assess,0,0
20482,the,0,0
20483,remaining,0,0
20484,types,0,0
20485,of,0,0
20486,support,0,0
20487,.,0,0
20488,With,0,0
20489,baseline,0,0
20490,abstinence,0,0
20491,and,0,0
20492,other,0,0
20493,statistically,0,0
20494,important,0,0
20495,covariates,0,0
20496,adjusted,0,0
20497,",",0,0
20498,hierarchical,0,0
20499,logistic,0,0
20500,regression,0,0
20501,analyses,0,0
20502,demonstrated,0,0
20503,that,0,0
20504,the,0,0
20505,associations,0,0
20506,between,0,0
20507,social,0,0
20508,support,0,0
20509,at,0,0
20510,study,0,0
20511,baseline,0,0
20512,and,0,0
20513,biochemically,0,0
20514,confirmed,0,0
20515,abstinence,0,0
20516,3,0,0
20517,months,0,0
20518,later,0,0
20519,varied,0,0
20520,by,0,0
20521,type,0,0
20522,of,0,0
20523,support,0,0
20524,and,0,0
20525,by,0,0
20526,drug,0,1
20527,.,0,1
20528,Greater,0,0
20529,abstinence-specific,1,0
20530,structural,0,0
20531,support,0,1
20532,(,0,0
20533,operationalized,0,0
20534,as,0,0
20535,fewer,0,0
20536,drug,0,1
20537,users,0,1
20538,in,0,0
20539,the,0,0
20540,social,0,0
20541,network,0,0
20542,),0,0
20543,and,0,0
20544,decreases,0,0
20545,in,0,0
20546,three,0,0
20547,types,0,0
20548,of,0,0
20549,negative,0,0
20550,abstinence-specific,1,0
20551,functional,0,0
20552,support,0,1
20553,(,0,0
20554,Complaints,0,0
20555,about,0,0
20556,Drug,0,0
20557,Use,0,1
20558,",",0,0
20559,Drug,0,0
20560,Exposure,0,0
20561,",",0,0
20562,and,0,0
20563,Demoralization,0,1
20564,),0,1
20565,predicted,0,0
20566,cocaine,0,1
20567,",",0,0
20568,but,0,0
20569,not,0,0
20570,opiate,0,1
20571,abstinence,0,1
20572,.,0,0
20573,There,0,0
20574,were,0,0
20575,no,0,0
20576,effects,0,0
20577,for,0,0
20578,general,0,0
20579,support,0,0
20580,",",0,0
20581,whether,0,0
20582,structural,0,0
20583,or,0,0
20584,functional,0,0
20585,",",0,0
20586,on,0,0
20587,abstinence,0,0
20588,from,0,0
20589,either,0,0
20590,drug,0,1
20591,.,0,0
20592,Interventions,0,0
20593,that,0,0
20594,focus,0,0
20595,on,0,0
20596,modifying,0,0
20597,patients,0,0
20598,',0,0
20599,abstinence-specific,1,0
20600,support,0,0
20601,may,0,0
20602,be,0,0
20603,helpful,0,0
20604,in,0,0
20605,reducing,0,0
20606,the,0,0
20607,high,0,0
20608,rates,0,0
20609,of,0,0
20610,cocaine,0,1
20611,use,0,0
20612,disorders,0,0
20613,in,0,0
20614,this,0,0
20615,population,0,0
20616,.,0,0
20617,Antioxidant,1,1
20618,supplementation,1,1
20619,and,0,1
20620,exercise-induced,0,0
20621,oxidative,0,0
20622,stress,0,0
20623,in,0,0
20624,the,0,0
20625,60-year-old,0,0
20626,as,0,0
20627,measured,0,0
20628,by,0,0
20629,antipyrine,1,1
20630,hydroxylates,0,1
20631,.,0,1
20632,The,0,0
20633,effects,0,0
20634,of,0,0
20635,12,0,0
20636,weeks,0,0
20637,of,0,0
20638,antioxidant,1,1
20639,supplementation,1,1
20640,on,0,1
20641,exercise-induced,0,0
20642,oxidative,0,0
20643,stress,0,0
20644,were,0,0
20645,investigated,0,0
20646,in,0,0
20647,older,0,0
20648,adults,0,1
20649,(,0,1
20650,60,0,0
20651,(,0,1
20652,SE,0,1
20653,1,0,1
20654,),0,1
20655,years,0,1
20656,;,0,0
20657,BMI,0,0
20658,26,0,0
20659,(,0,0
20660,SE,0,0
20661,1,0,1
20662,),0,0
20663,kg/m,0,0
20664,(,0,0
20665,2,0,0
20666,),0,1
20667,),0,1
20668,.,0,0
20669,Subjects,0,0
20670,were,0,0
20671,randomly,0,0
20672,divided,0,0
20673,in,0,0
20674,two,0,0
20675,groups,0,0
20676,:,0,1
20677,supplementation,1,1
20678,(,0,1
20679,n,0,1
20680,11,0,0
20681,),0,0
20682,with,0,1
20683,100,0,1
20684,mg,0,1
20685,dl-alpha-tocopheryl,1,1
20686,acetate,1,1
20687,",",0,1
20688,200,0,1
20689,mg,0,1
20690,ascorbic,1,1
20691,acid,1,1
20692,",",0,1
20693,and,0,1
20694,2,0,1
20695,mg,0,1
20696,beta-carotene,1,1
20697,",",1,1
20698,and,1,1
20699,placebo,1,1
20700,(,0,1
20701,n,0,1
20702,9,0,0
20703,),0,0
20704,.,0,0
20705,Before,0,0
20706,and,0,0
20707,after,0,0
20708,the,0,0
20709,12,0,0
20710,week,0,0
20711,supplementation,0,1
20712,period,0,1
20713,",",0,0
20714,subjects,0,0
20715,cycled,0,0
20716,for,0,0
20717,45,0,0
20718,min,0,0
20719,at,0,0
20720,submaximal,0,1
20721,intensity,0,1
20722,(,0,0
20723,50,0,0
20724,%,0,0
20725,maximal,0,0
20726,workload,0,0
20727,capacity,0,0
20728,),0,0
20729,.,0,0
20730,Antipyrine,1,1
20731,was,0,0
20732,used,0,0
20733,as,0,0
20734,marker,0,0
20735,for,0,0
20736,oxidative,0,0
20737,stress,0,0
20738,.,0,0
20739,Antipyrine,0,1
20740,reacts,0,0
20741,quickly,0,0
20742,with,0,0
20743,hydroxyl,0,1
20744,radicals,0,0
20745,to,0,0
20746,form,0,0
20747,para-,0,0
20748,and,0,0
20749,ortho-hydroxyantipyrine,0,1
20750,.,0,0
20751,The,0,0
20752,latter,0,0
20753,metabolite,0,0
20754,is,0,0
20755,not,0,0
20756,formed,0,0
20757,in,0,0
20758,man,0,0
20759,through,0,0
20760,the,0,0
20761,mono-oxygenase,0,1
20762,pathway,0,0
20763,of,0,0
20764,cytochrome,0,1
20765,P450,0,1
20766,.,0,1
20767,Daily,0,0
20768,supplementation,1,1
20769,significantly,0,0
20770,increased,0,0
20771,plasma,0,1
20772,concentrations,0,1
20773,of,0,1
20774,alpha-tocopherol,0,1
20775,and,0,1
20776,beta-carotene,0,1
20777,in,0,0
20778,the,0,0
20779,supplemented,0,0
20780,group,0,0
20781,(,0,0
20782,Delta,0,1
20783,14.4,0,0
20784,(,0,0
20785,SE,0,0
20786,3.2,0,0
20787,),0,0
20788,and,0,0
20789,0.4,0,0
20790,(,0,0
20791,se,0,0
20792,0.1,0,0
20793,),0,0
20794,micromol/l,0,0
20795,;,0,0
20796,P,0,0
20797,<,0,0
20798,0.001,0,0
20799,and,0,0
20800,P,0,0
20801,<,0,0
20802,0.01,0,0
20803,),0,0
20804,.,0,0
20805,No,0,1
20806,significant,0,0
20807,differences,0,0
20808,",",0,0
20809,within,0,0
20810,and,0,0
20811,between,0,0
20812,groups,0,0
20813,",",0,0
20814,were,0,0
20815,observed,0,0
20816,in,0,0
20817,the,0,0
20818,exercise-induced,0,0
20819,increase,0,0
20820,in,0,0
20821,the,0,0
20822,ratios,0,0
20823,para-,0,0
20824,and,0,0
20825,ortho-hydroxyantipyrine,0,1
20826,to,0,1
20827,antipyrine,0,1
20828,.,0,0
20829,In,0,0
20830,addition,0,0
20831,",",0,0
20832,supplementation,1,1
20833,did,0,0
20834,not,0,0
20835,affect,0,0
20836,the,0,0
20837,exercise-induced,0,0
20838,increase,0,0
20839,in,0,0
20840,thiobarbituric,0,1
20841,acid,0,1
20842,reactive,0,0
20843,substances,0,0
20844,in,0,0
20845,plasma,0,0
20846,.,0,0
20847,In,0,0
20848,conclusion,0,0
20849,",",0,0
20850,in,0,0
20851,60-year-old,0,0
20852,subjects,0,0
20853,antioxidant,1,1
20854,supplementation,1,1
20855,had,0,0
20856,no,0,0
20857,effect,0,0
20858,on,0,0
20859,the,0,0
20860,exercise-induced,0,0
20861,increase,0,0
20862,in,0,0
20863,oxidative,0,0
20864,stress,0,0
20865,as,0,0
20866,measured,0,0
20867,by,0,0
20868,free,0,0
20869,radical,0,0
20870,products,0,0
20871,of,0,0
20872,antipyrine,0,1
20873,.,0,0
20874,Prognostic,0,0
20875,significance,0,0
20876,of,0,0
20877,the,0,0
20878,dobutamine,0,1
20879,echocardiography,0,1
20880,test,0,0
20881,in,0,0
20882,idiopathic,0,0
20883,dilated,0,0
20884,cardiomyopathy,0,1
20885,.,0,0
20886,Dobutamine,1,1
20887,stress,1,0
20888,echo,1,0
20889,provides,0,0
20890,potentially,0,0
20891,useful,0,0
20892,information,0,0
20893,on,0,0
20894,idiopathic,1,0
20895,dilated,1,1
20896,cardiomyopathy,1,1
20897,(,0,1
20898,IDC,0,1
20899,),0,1
20900,.,0,0
20901,From,0,1
20902,February,0,0
20903,1,0,0
20904,",",0,0
20905,1997,0,0
20906,",",0,0
20907,to,0,0
20908,October,0,0
20909,1,0,0
20910,",",0,0
20911,1999,0,0
20912,",",0,0
20913,186,0,0
20914,patients,0,0
20915,(,0,0
20916,131,0,0
20917,men,0,0
20918,and,0,0
20919,55,0,0
20920,women,0,0
20921,",",0,0
20922,mean,0,0
20923,age,0,0
20924,56,0,0
20925,+/-,0,0
20926,12,0,0
20927,years,0,0
20928,),0,0
20929,with,0,0
20930,IDC,0,0
20931,",",0,0
20932,ejection,0,0
20933,fraction,0,0
20934,<,0,0
20935,35,0,0
20936,%,0,0
20937,",",0,0
20938,and,0,0
20939,angiographically,0,0
20940,normal,0,0
20941,coronary,0,0
20942,arteries,0,0
20943,were,0,0
20944,studied,0,0
20945,by,0,0
20946,high-dose,1,1
20947,(,0,0
20948,up,0,0
20949,to,0,0
20950,40,0,0
20951,micro/kg/min,0,1
20952,),0,1
20953,dobutamine,1,1
20954,echo,1,1
20955,in,0,0
20956,6,0,0
20957,centers,0,0
20958,",",0,0
20959,all,0,0
20960,quality,0,0
20961,controlled,0,0
20962,for,0,0
20963,stress,0,0
20964,echo,0,0
20965,reading,0,0
20966,.,0,0
20967,In,0,0
20968,all,0,0
20969,patients,0,0
20970,",",0,0
20971,wall,0,0
20972,motion,0,0
20973,score,0,1
20974,index,0,1
20975,(,0,1
20976,WMSI,0,1
20977,),0,1
20978,(,0,0
20979,from,0,0
20980,1,0,0
20981,=,0,0
20982,normal,0,0
20983,to,0,0
20984,4,0,0
20985,=,0,0
20986,dyskinetic,0,0
20987,in,0,0
20988,a,0,0
20989,16-,0,0
20990,segment,0,0
20991,model,0,0
20992,of,0,0
20993,the,0,0
20994,left,0,0
20995,ventricle,0,1
20996,),0,0
20997,was,0,0
20998,evaluated,0,0
20999,by,0,0
21000,echo,0,0
21001,at,0,0
21002,baseline,0,0
21003,and,0,0
21004,peak,0,0
21005,dobutamine,0,1
21006,.,0,0
21007,One,0,0
21008,hundred,0,0
21009,eighty-four,0,0
21010,patients,0,0
21011,were,0,0
21012,followed,0,0
21013,up,0,0
21014,(,0,0
21015,mean,0,0
21016,15,0,0
21017,+/-,0,0
21018,13,0,0
21019,months,0,0
21020,),0,0
21021,and,0,0
21022,only,0,0
21023,cardiac,0,0
21024,death,0,0
21025,was,0,0
21026,considered,0,0
21027,as,0,0
21028,an,0,0
21029,end,0,0
21030,point,0,0
21031,.,0,0
21032,There,0,0
21033,were,0,0
21034,29,0,0
21035,cardiac,0,0
21036,deaths,0,0
21037,.,0,0
21038,Significant,0,0
21039,parameters,0,0
21040,for,0,0
21041,survival,0,0
21042,prediction,0,0
21043,at,0,0
21044,univariate,0,0
21045,analysis,0,0
21046,are,0,0
21047,:,0,0
21048,DeltaWMSI,0,1
21049,(,0,0
21050,chi-square,0,0
21051,20.1,0,0
21052,;,0,0
21053,p,0,0
21054,<,0,0
21055,0.0000,0,0
21056,),0,0
21057,",",0,0
21058,New,0,1
21059,York,0,1
21060,Heart,0,1
21061,Association,0,0
21062,(,0,1
21063,NYHA,0,1
21064,),0,1
21065,class,0,0
21066,(,0,0
21067,chi-square,0,0
21068,17.57,0,0
21069,;,0,0
21070,p,0,0
21071,<,0,0
21072,0.0000,0,0
21073,),0,0
21074,",",0,0
21075,rest,0,0
21076,ejection,0,0
21077,fraction,0,0
21078,(,0,0
21079,chi-square,0,0
21080,10.41,0,0
21081,;,0,0
21082,p,0,0
21083,=,0,0
21084,0.0013,0,0
21085,),0,0
21086,",",0,0
21087,angiotensin-converting,0,1
21088,enzyme,0,1
21089,inhibitors,0,1
21090,(,0,0
21091,chi-square,0,0
21092,8.23,0,0
21093,;,0,0
21094,p,0,0
21095,=,0,0
21096,0.0041,0,0
21097,),0,0
21098,",",0,0
21099,and,0,1
21100,hypertension,0,1
21101,(,0,0
21102,chi-square,0,0
21103,8.08,0,0
21104,",",0,0
21105,p,0,0
21106,=,0,0
21107,0.0045,0,0
21108,),0,0
21109,.,0,0
21110,In,0,0
21111,the,0,0
21112,multivariate,0,0
21113,stepwise,0,0
21114,analysis,0,0
21115,only,0,0
21116,DeltaWMSI,0,0
21117,and,0,0
21118,NYHA,0,0
21119,were,0,0
21120,independent,0,0
21121,predictors,0,0
21122,of,0,0
21123,outcome,0,1
21124,(,0,0
21125,DeltaWMSI,0,0
21126,=,0,0
21127,hazard,0,0
21128,ratio,0,0
21129,0.02,0,0
21130,",",0,0
21131,p,0,0
21132,<,0,0
21133,0.0000,0,0
21134,;,0,0
21135,NYHA,0,0
21136,class,0,0
21137,=,0,0
21138,hazard,0,0
21139,ratio,0,0
21140,3.83,0,0
21141,",",0,0
21142,p,0,0
21143,<,0,0
21144,0.0000,0,0
21145,),0,0
21146,.,0,0
21147,Kaplan-Meier,0,0
21148,survival,0,0
21149,estimates,0,0
21150,showed,0,0
21151,a,0,0
21152,better,0,0
21153,outcome,0,0
21154,for,0,0
21155,patients,0,0
21156,with,0,0
21157,a,0,0
21158,large,0,0
21159,inotropic,0,1
21160,response,0,1
21161,(,0,1
21162,DeltaWMSI,0,1
21163,>,0,0
21164,or,0,0
21165,=0.44,0,0
21166,",",0,0
21167,a,0,0
21168,cutoff,0,0
21169,identified,0,0
21170,by,0,0
21171,receiver-operating,0,0
21172,characteristic,0,0
21173,curves,0,0
21174,analysis,0,0
21175,),0,0
21176,than,0,0
21177,for,0,0
21178,those,0,0
21179,with,0,0
21180,a,0,0
21181,small,0,0
21182,or,0,0
21183,no,0,0
21184,myocardial,0,0
21185,inotropic,0,1
21186,response,0,0
21187,to,0,1
21188,dobutamine,0,1
21189,(,0,0
21190,93.6,0,0
21191,%,0,0
21192,vs,0,0
21193,69.4,0,0
21194,%,0,0
21195,",",0,0
21196,p,0,0
21197,=,0,0
21198,0.00033,0,0
21199,),0,0
21200,.,0,0
21201,Thus,0,0
21202,",",0,0
21203,in,0,0
21204,patients,0,0
21205,with,0,0
21206,IDC,0,0
21207,",",0,0
21208,an,0,0
21209,extensive,0,0
21210,contractile,0,0
21211,reserve,0,0
21212,identified,0,0
21213,by,0,0
21214,high-dose,0,1
21215,dobutamine,0,1
21216,stress,0,1
21217,echocardiography,0,0
21218,is,0,0
21219,associated,0,0
21220,with,0,0
21221,a,0,0
21222,better,0,0
21223,survival,0,0
21224,.,0,0
21225,A,0,1
21226,randomized,0,1
21227,",",0,0
21228,double-blind,0,1
21229,",",0,1
21230,placebo-controlled,0,1
21231,MRI,0,1
21232,study,0,0
21233,of,0,0
21234,anti-herpes,1,1
21235,virus,1,1
21236,therapy,1,1
21237,in,0,0
21238,MS,0,0
21239,.,0,0
21240,OBJECTIVE,0,0
21241,To,0,0
21242,evaluate,0,0
21243,the,0,0
21244,effect,0,0
21245,of,0,0
21246,treatment,0,0
21247,with,0,0
21248,the,0,0
21249,antiherpes,1,1
21250,drug,1,1
21251,valacyclovir,1,1
21252,on,0,1
21253,MRI-evident,0,0
21254,lesions,0,0
21255,in,0,0
21256,patients,0,0
21257,with,0,0
21258,relapsing-remitting,0,0
21259,MS,0,0
21260,in,0,0
21261,a,0,0
21262,phase,0,0
21263,2,0,0
21264,",",0,0
21265,randomized,0,1
21266,",",0,1
21267,double-blind,0,1
21268,",",0,1
21269,placebo-controlled,1,1
21270,study,0,0
21271,.,0,0
21272,BACKGROUND,0,0
21273,It,0,0
21274,has,0,0
21275,been,0,0
21276,postulated,0,0
21277,from,0,0
21278,virologic,0,0
21279,studies,0,0
21280,that,0,0
21281,herpesvirus,0,0
21282,infection,0,0
21283,could,0,0
21284,play,0,0
21285,a,0,0
21286,role,0,0
21287,in,0,0
21288,the,0,0
21289,progression,0,0
21290,of,0,0
21291,MS.,0,0
21292,METHODS,0,0
21293,Patients,0,0
21294,were,0,0
21295,eligible,0,0
21296,for,0,0
21297,the,0,0
21298,study,0,0
21299,if,0,0
21300,they,0,0
21301,had,0,0
21302,had,0,0
21303,two,0,0
21304,or,0,0
21305,more,0,0
21306,MS,0,0
21307,relapses,0,0
21308,in,0,0
21309,the,0,0
21310,2-year,0,0
21311,period,0,0
21312,before,0,0
21313,enrollment,0,0
21314,.,0,0
21315,Seventy,0,0
21316,patients,0,0
21317,with,0,0
21318,Expanded,0,0
21319,Disability,0,0
21320,Status,0,1
21321,Scale,0,0
21322,scores,0,0
21323,of,0,0
21324,0,0,0
21325,to,0,0
21326,5.5,0,0
21327,were,0,0
21328,randomly,0,0
21329,assigned,0,0
21330,to,0,0
21331,receive,0,1
21332,1,0,1
21333,gram,0,1
21334,of,0,1
21335,valacyclovir,1,1
21336,(,0,0
21337,n,0,0
21338,=,0,0
21339,36,0,0
21340,),0,0
21341,or,0,0
21342,placebo,1,1
21343,(,0,0
21344,n,0,0
21345,=,0,0
21346,34,0,0
21347,),0,0
21348,three,0,0
21349,times,0,1
21350,daily,0,1
21351,for,0,0
21352,24,0,0
21353,weeks,0,0
21354,.,0,0
21355,Patients,0,0
21356,underwent,0,0
21357,MRI,0,1
21358,every,0,0
21359,fourth,0,0
21360,week,0,0
21361,for,0,0
21362,32,0,0
21363,weeks,0,0
21364,:,0,0
21365,twice,0,0
21366,during,0,0
21367,pretreatment,0,1
21368,",",0,0
21369,six,0,0
21370,times,0,0
21371,during,0,0
21372,treatment,0,0
21373,",",0,0
21374,and,0,0
21375,once,0,0
21376,after,0,0
21377,treatment,0,0
21378,.,0,0
21379,Scoring,0,0
21380,of,0,0
21381,neurologic,0,0
21382,disability,0,0
21383,was,0,0
21384,performed,0,0
21385,at,0,0
21386,the,0,0
21387,start,0,0
21388,and,0,0
21389,end,0,0
21390,of,0,0
21391,the,0,0
21392,treatment,0,0
21393,period,0,0
21394,.,0,0
21395,The,0,0
21396,primary,0,0
21397,endpoint,0,0
21398,was,0,0
21399,the,0,0
21400,number,0,0
21401,of,0,0
21402,new,0,0
21403,active,0,0
21404,MRI-evident,0,0
21405,lesions,0,0
21406,over,0,0
21407,24,0,0
21408,weeks,0,0
21409,of,0,0
21410,treatment,0,0
21411,.,0,0
21412,Secondary,0,0
21413,endpoints,0,0
21414,included,0,0
21415,other,0,0
21416,MRI,0,0
21417,measures,0,0
21418,and,0,0
21419,clinical,0,0
21420,endpoints,0,0
21421,.,0,0
21422,RESULTS,0,0
21423,The,0,0
21424,mean,0,0
21425,number,0,0
21426,of,0,0
21427,new,0,0
21428,active,0,0
21429,lesions,0,0
21430,+/-,0,0
21431,SD,0,0
21432,per,0,0
21433,patient,0,0
21434,during,0,0
21435,24,0,0
21436,weeks,0,0
21437,of,0,0
21438,treatment,0,0
21439,with,0,0
21440,valacyclovir,1,1
21441,was,0,0
21442,11.9,0,0
21443,+/-,0,0
21444,17.6,0,0
21445,and,0,0
21446,that,0,0
21447,during,0,0
21448,placebo,1,1
21449,treatment,0,0
21450,was,0,0
21451,14.5,0,0
21452,+/-,0,0
21453,21.4,0,0
21454,.,0,0
21455,A,0,0
21456,protocol-planned,0,0
21457,exploratory,0,0
21458,analysis,0,0
21459,stratified,0,0
21460,patients,0,0
21461,according,0,0
21462,to,0,0
21463,baseline,0,0
21464,activity,0,0
21465,;,0,0
21466,this,0,0
21467,analysis,0,0
21468,showed,0,0
21469,that,0,0
21470,patients,0,0
21471,with,0,0
21472,high,0,0
21473,levels,0,0
21474,of,0,0
21475,disease,0,0
21476,activity,0,0
21477,in,0,0
21478,the,0,0
21479,valacyclovir,1,1
21480,treatment,0,1
21481,group,0,1
21482,(,0,0
21483,n,0,0
21484,=,0,0
21485,17,0,0
21486,),0,0
21487,developed,0,0
21488,fewer,0,0
21489,new,0,0
21490,active,0,0
21491,lesions,0,0
21492,per,0,0
21493,scan,0,0
21494,than,0,0
21495,did,0,0
21496,those,0,0
21497,in,0,0
21498,the,0,0
21499,placebo,0,1
21500,treatment,0,1
21501,group,0,1
21502,(,0,0
21503,n,0,0
21504,=,0,0
21505,11,0,0
21506,),0,0
21507,.,0,0
21508,The,0,0
21509,median,0,0
21510,number,0,0
21511,(,0,0
21512,Q,0,1
21513,(,0,1
21514,1,0,1
21515,),0,0
21516,",",0,1
21517,Q,0,1
21518,(,0,1
21519,3,0,1
21520,),0,1
21521,range,0,0
21522,),0,0
21523,of,0,0
21524,active,0,0
21525,lesions,0,0
21526,was,0,0
21527,2.0,0,0
21528,(,0,0
21529,1.38,0,0
21530,",",0,0
21531,3.96,0,0
21532,),0,0
21533,in,0,0
21534,the,0,0
21535,valacyclovir,0,1
21536,treatment,0,1
21537,group,0,0
21538,and,0,0
21539,6.5,0,0
21540,(,0,0
21541,2.63,0,0
21542,",",0,0
21543,9.0,0,0
21544,),0,0
21545,in,0,0
21546,the,0,0
21547,placebo,0,1
21548,treatment,0,1
21549,group,0,0
21550,.,0,0
21551,CONCLUSIONS,0,1
21552,Valacyclovir,1,1
21553,treatment,0,0
21554,did,0,0
21555,not,0,0
21556,reduce,0,0
21557,the,0,0
21558,formation,0,0
21559,of,0,0
21560,active,0,0
21561,lesions,0,0
21562,in,0,0
21563,patients,0,0
21564,with,0,0
21565,relapsing-remitting,0,0
21566,MS,0,0
21567,who,0,0
21568,had,0,0
21569,two,0,0
21570,or,0,0
21571,more,0,0
21572,relapses,0,0
21573,during,0,0
21574,the,0,0
21575,previous,0,0
21576,2-year,0,0
21577,period,0,0
21578,.,0,0
21579,In,0,0
21580,a,0,0
21581,subgroup,0,0
21582,of,0,0
21583,patients,0,0
21584,with,0,0
21585,high,0,0
21586,levels,0,0
21587,of,0,0
21588,disease,0,0
21589,activity,0,0
21590,who,0,0
21591,had,0,0
21592,more,0,0
21593,than,0,0
21594,one,0,0
21595,active,0,0
21596,MRI-evident,0,0
21597,lesion,0,0
21598,during,0,0
21599,4,0,0
21600,weeks,0,0
21601,",",0,0
21602,valacyclovir,1,1
21603,treatment,0,0
21604,was,0,0
21605,associated,0,0
21606,with,0,0
21607,a,0,0
21608,reduced,0,0
21609,number,0,0
21610,of,0,0
21611,new,0,0
21612,active,0,0
21613,MRI-evident,0,0
21614,lesions,0,0
21615,and,0,0
21616,with,0,0
21617,an,0,0
21618,increase,0,0
21619,in,0,0
21620,the,0,0
21621,number,0,0
21622,of,0,0
21623,scans,0,0
21624,free,0,0
21625,of,0,0
21626,new,0,0
21627,active,0,0
21628,lesions,0,0
21629,.,0,0
21630,The,0,0
21631,results,0,0
21632,of,0,0
21633,the,0,0
21634,exploratory,0,0
21635,subgroup,0,0
21636,analysis,0,0
21637,provide,0,0
21638,support,0,0
21639,for,0,0
21640,further,0,0
21641,studies,0,0
21642,of,0,0
21643,antiherpes,1,1
21644,therapy,1,1
21645,for,0,0
21646,patients,0,0
21647,with,0,0
21648,MS,0,0
21649,and,0,0
21650,high,0,0
21651,levels,0,0
21652,of,0,0
21653,MRI-evident,0,0
21654,disease,0,0
21655,activity,0,0
21656,.,0,0
21657,A,0,1
21658,double-blind,0,1
21659,",",0,1
21660,placebo-controlled,1,1
21661,crossover,0,1
21662,study,0,0
21663,investigating,0,0
21664,the,0,0
21665,effect,0,0
21666,of,0,0
21667,porcine,1,0
21668,secretin,1,1
21669,in,0,0
21670,children,0,0
21671,with,0,0
21672,autism,0,0
21673,.,0,0
21674,OBJECTIVES,0,0
21675,A,0,0
21676,recent,0,0
21677,patient,0,0
21678,series,0,0
21679,reported,0,0
21680,the,0,0
21681,incidental,0,0
21682,findings,0,0
21683,of,0,0
21684,improved,0,0
21685,social,0,0
21686,and,0,0
21687,language,0,0
21688,skills,0,0
21689,in,0,0
21690,3,0,0
21691,children,0,0
21692,with,0,0
21693,autistic,0,0
21694,spectrum,0,0
21695,disorders,0,0
21696,after,0,0
21697,the,0,0
21698,administration,0,1
21699,of,0,1
21700,secretin,1,1
21701,",",0,0
21702,a,0,0
21703,peptide,0,0
21704,hormone,0,1
21705,.,0,0
21706,However,0,0
21707,",",0,0
21708,a,0,0
21709,subsequent,0,0
21710,study,0,0
21711,did,0,0
21712,not,0,0
21713,find,0,0
21714,evidence,0,0
21715,for,0,0
21716,a,0,0
21717,drug,0,1
21718,effect,0,0
21719,.,0,0
21720,Parents,0,0
21721,are,0,0
21722,seeking,0,0
21723,treatment,0,0
21724,with,0,0
21725,secretin,1,1
21726,despite,0,0
21727,the,0,0
21728,absence,0,0
21729,of,0,0
21730,empirical,0,0
21731,investigations,0,0
21732,demonstrating,0,0
21733,amelioration,0,0
21734,in,0,0
21735,autism,0,0
21736,symptomology,0,0
21737,.,0,0
21738,In,0,0
21739,order,0,0
21740,to,0,0
21741,more,0,0
21742,precisely,0,0
21743,measure,0,0
21744,the,0,0
21745,effects,0,0
21746,of,0,0
21747,secretin,1,1
21748,",",0,0
21749,this,0,0
21750,study,0,0
21751,investigated,0,0
21752,the,0,0
21753,effect,0,0
21754,of,0,0
21755,a,0,0
21756,single,0,0
21757,intravenous,1,1
21758,dose,1,1
21759,of,1,1
21760,porcine,1,0
21761,secretin,1,1
21762,on,0,0
21763,12,0,0
21764,autistic,0,0
21765,children,0,0
21766,through,0,0
21767,a,0,0
21768,randomized,0,0
21769,",",0,0
21770,double-blind,0,1
21771,",",0,1
21772,placebo-controlled,1,1
21773,",",0,1
21774,crossover,0,1
21775,study,0,0
21776,.,0,0
21777,Children,0,0
21778,were,0,0
21779,assessed,0,0
21780,on,0,0
21781,objective,0,0
21782,language,0,0
21783,and,0,0
21784,on,0,0
21785,social,0,0
21786,",",0,0
21787,neuropsychological,0,0
21788,",",0,0
21789,and,0,0
21790,gastrointestinal,0,0
21791,measures,0,0
21792,to,0,0
21793,evaluate,0,0
21794,drug,0,1
21795,effects,0,0
21796,.,0,0
21797,The,0,0
21798,study,0,0
21799,was,0,0
21800,conducted,0,0
21801,over,0,0
21802,a,0,0
21803,16-week,0,0
21804,trial,0,0
21805,.,0,0
21806,The,0,0
21807,results,0,0
21808,indicated,0,0
21809,that,0,0
21810,significant,0,0
21811,differences,0,0
21812,were,0,0
21813,not,0,0
21814,observed,0,0
21815,on,0,0
21816,the,0,0
21817,majority,0,0
21818,of,0,0
21819,the,0,0
21820,dependent,0,0
21821,variables,0,0
21822,.,0,0
21823,Statistically,0,0
21824,significant,0,0
21825,differences,0,0
21826,were,0,0
21827,observed,0,0
21828,on,0,0
21829,measures,0,0
21830,of,0,0
21831,positive,0,0
21832,affect,0,0
21833,and,0,0
21834,activity,0,0
21835,level,0,0
21836,following,0,0
21837,secretin,1,1
21838,infusion,0,1
21839,.,0,1
21840,In,0,0
21841,general,0,0
21842,",",0,0
21843,the,0,0
21844,autistic,0,0
21845,children,0,0
21846,did,0,0
21847,not,0,0
21848,demonstrate,0,0
21849,the,0,0
21850,improvements,0,0
21851,described,0,0
21852,in,0,0
21853,the,0,0
21854,initial,0,0
21855,retrospective,0,0
21856,report,0,0
21857,.,0,0
21858,Pacifier,1,0
21859,as,0,0
21860,a,0,0
21861,risk,0,0
21862,factor,0,0
21863,for,0,0
21864,acute,0,0
21865,otitis,0,0
21866,media,0,0
21867,.,0,0
21868,Glibenclamide,1,1
21869,vs,1,1
21870,gliclazide,1,1
21871,in,0,0
21872,reducing,0,0
21873,oxidative,0,0
21874,stress,0,0
21875,in,0,0
21876,patients,0,0
21877,of,0,0
21878,noninsulin,0,1
21879,dependent,0,0
21880,diabetes,0,1
21881,mellitus,0,0
21882,--,0,0
21883,a,0,0
21884,double,0,0
21885,blind,0,0
21886,randomized,0,0
21887,study,0,0
21888,.,0,0
21889,OBJECTIVE,0,0
21890,Parameters,0,0
21891,of,0,0
21892,oxidative,0,0
21893,stress,0,0
21894,were,0,0
21895,quantitated,0,0
21896,in,0,0
21897,50,0,0
21898,patients,0,0
21899,with,0,0
21900,type,0,0
21901,2,0,0
21902,diabetes,0,0
21903,mellitus,0,0
21904,in,0,0
21905,uncontrolled,0,0
21906,state,0,0
21907,and,0,0
21908,after,0,0
21909,control,0,0
21910,using,0,0
21911,oral,0,1
21912,glibenclamide,1,1
21913,or,1,1
21914,gliclazide,1,1
21915,.,1,1
21916,The,0,0
21917,estimates,0,0
21918,were,0,0
21919,further,0,0
21920,compared,0,0
21921,between,0,0
21922,the,0,0
21923,two,0,0
21924,groups,0,0
21925,irrespective,0,0
21926,of,0,0
21927,drug,0,1
21928,used,0,0
21929,to,0,0
21930,evaluate,0,0
21931,the,0,0
21932,difference,0,0
21933,",",0,0
21934,if,0,0
21935,any,0,0
21936,.,0,0
21937,METHODS,0,0
21938,The,0,0
21939,study,0,0
21940,was,0,0
21941,a,0,0
21942,double,0,0
21943,blind,0,0
21944,",",0,0
21945,uncontrolled,0,0
21946,",",0,0
21947,noncrossover,0,0
21948,and,0,0
21949,randomized,0,0
21950,trial,0,0
21951,.,0,0
21952,Fifty,0,0
21953,patients,0,0
21954,of,0,0
21955,uncontrolled,0,0
21956,type,0,0
21957,2,0,0
21958,diabetes,0,0
21959,were,0,0
21960,divided,0,0
21961,in,0,0
21962,to,0,0
21963,two,0,0
21964,groups,0,0
21965,.,0,0
21966,Group,0,0
21967,I,0,0
21968,(,0,0
21969,25,0,0
21970,patients,0,0
21971,),0,0
21972,received,0,0
21973,capsule,1,1
21974,A,1,1
21975,(,1,1
21976,glibenclamide,1,1
21977,),1,1
21978,while,0,0
21979,Group,0,0
21980,II,0,1
21981,(,0,0
21982,25,0,0
21983,patients,0,0
21984,),0,0
21985,received,0,0
21986,capsule,1,1
21987,B,1,1
21988,(,1,1
21989,gliclazide,1,1
21990,),1,1
21991,.,1,0
21992,The,0,0
21993,parameters,0,0
21994,studied,0,0
21995,were,0,0
21996,Superoxide,0,1
21997,dismutase,0,1
21998,(,0,1
21999,SOD,0,1
22000,),0,1
22001,",",0,1
22002,malonyl-dialdehyde,0,1
22003,(,0,1
22004,MDA,0,1
22005,),0,1
22006,and,0,0
22007,reduced,0,1
22008,glutathione,0,1
22009,(,0,1
22010,GSH,0,1
22011,),0,1
22012,.,0,0
22013,They,0,0
22014,were,0,0
22015,done,0,0
22016,at,0,0
22017,(,0,0
22018,a,0,0
22019,),0,0
22020,uncontrolled,0,1
22021,stage,0,0
22022,(,0,0
22023,FBS,0,0
22024,--,0,0
22025,165,0,0
22026,+/-,0,0
22027,16.7,0,0
22028,mg/dl,0,0
22029,",",0,0
22030,PP,0,0
22031,--,0,0
22032,240,0,0
22033,+/-,0,0
22034,30.1,0,0
22035,mg/dl,0,0
22036,and,0,0
22037,HbA1,0,0
22038,--,0,0
22039,10.5,0,0
22040,+/-,0,0
22041,0.9,0,0
22042,%,0,0
22043,in,0,0
22044,group,0,0
22045,I,0,0
22046,and,0,0
22047,FBS,0,0
22048,--,0,0
22049,150,0,0
22050,+/-,0,0
22051,15.8,0,0
22052,mg/dl,0,0
22053,",",0,0
22054,PP,0,0
22055,--,0,0
22056,246,0,0
22057,+/-,0,0
22058,29.1,0,0
22059,mg/dl,0,0
22060,HbA1,0,0
22061,10.6,0,0
22062,+/-,0,0
22063,0.8,0,0
22064,%,0,0
22065,in,0,0
22066,group,0,0
22067,II,0,1
22068,),0,1
22069,and,0,0
22070,during,0,0
22071,controlled,0,0
22072,stage,0,0
22073,at,0,0
22074,12,0,0
22075,weeks,0,0
22076,(,0,0
22077,FBS,0,1
22078,--,0,0
22079,120,0,0
22080,+/-,0,0
22081,18.5,0,0
22082,mg/dl,0,0
22083,",",0,0
22084,PP,0,0
22085,--,0,0
22086,180,0,0
22087,+/-,0,0
22088,19.1,0,0
22089,mg/dl,0,0
22090,and,0,0
22091,HbA1,0,0
22092,--,0,0
22093,8.4,0,0
22094,+/-,0,0
22095,0.29,0,0
22096,%,0,0
22097,in,0,0
22098,group,0,0
22099,I,0,0
22100,and,0,0
22101,FBS,0,0
22102,--,0,0
22103,118,0,0
22104,+/-,0,0
22105,17.6,0,0
22106,mg/dl,0,0
22107,",",0,0
22108,PP,0,0
22109,--,0,0
22110,176,0,0
22111,+/-,0,0
22112,20.1,0,0
22113,mg/dl,0,0
22114,and,0,0
22115,HbA1,0,0
22116,--,0,0
22117,8.5,0,0
22118,+/-,0,0
22119,0.39,0,0
22120,%,0,0
22121,in,0,0
22122,group,0,0
22123,II,0,0
22124,patients,0,0
22125,),0,0
22126,.,0,0
22127,RESULTS,0,0
22128,The,0,0
22129,significantly,0,0
22130,raised,0,0
22131,levels,0,0
22132,of,0,0
22133,MDA,0,0
22134,and,0,0
22135,SOD,0,0
22136,",",0,0
22137,and,0,0
22138,decreased,0,0
22139,levels,0,0
22140,of,0,0
22141,reduced,0,0
22142,glutathione,0,1
22143,(,0,1
22144,GSH,0,1
22145,),0,1
22146,during,0,0
22147,uncontrolled,0,0
22148,stage,0,0
22149,of,0,0
22150,diabetes,0,0
22151,indicated,0,0
22152,free,0,0
22153,radical,0,0
22154,stress,0,0
22155,induced,0,0
22156,lipid,0,0
22157,peroxidation,0,1
22158,.,0,0
22159,The,0,0
22160,significant,0,0
22161,fall,0,0
22162,of,0,0
22163,MDA,0,0
22164,and,0,0
22165,SOD,0,0
22166,and,0,0
22167,increased,0,0
22168,levels,0,0
22169,of,0,0
22170,GSH,0,0
22171,in,0,0
22172,blood,0,0
22173,in,0,0
22174,both,0,0
22175,groups,0,0
22176,after,0,0
22177,control,0,0
22178,revealed,0,0
22179,beneficial,0,0
22180,effects,0,0
22181,of,0,0
22182,glycemic,0,0
22183,control,0,0
22184,on,0,0
22185,oxidative,0,0
22186,stress,0,0
22187,.,0,0
22188,The,0,0
22189,levels,0,0
22190,were,0,0
22191,not,0,0
22192,normalized,0,0
22193,and,0,0
22194,stayed,0,0
22195,higher,0,0
22196,than,0,0
22197,those,0,0
22198,in,0,0
22199,controls,0,0
22200,.,0,0
22201,On,0,0
22202,intergroup,0,0
22203,comparison,0,0
22204,;,0,0
22205,the,0,0
22206,control,0,0
22207,of,0,0
22208,diabetes,0,0
22209,with,0,1
22210,gliclazide,1,1
22211,(,0,1
22212,group,0,1
22213,II,0,1
22214,),0,1
22215,showed,0,0
22216,improvement,0,0
22217,in,0,0
22218,oxidative,0,0
22219,stress,0,0
22220,(,0,0
22221,MDA,0,1
22222,",",0,1
22223,GSH,0,1
22224,),0,1
22225,better,0,0
22226,(,0,0
22227,p,0,0
22228,<,0,0
22229,0.001,0,0
22230,),0,0
22231,than,0,0
22232,glibenclamide,1,1
22233,(,0,1
22234,group,0,1
22235,I,0,0
22236,),0,0
22237,.,0,0
22238,CONCLUSION,0,0
22239,Oxidative,0,0
22240,stress,0,0
22241,in,0,0
22242,uncontrolled,0,0
22243,diabetes,0,0
22244,is,0,0
22245,decreased,0,0
22246,with,0,0
22247,glycemic,0,0
22248,control,0,0
22249,.,0,0
22250,The,0,0
22251,control,0,0
22252,of,0,0
22253,diabetes,0,0
22254,with,0,0
22255,gliclazide,1,1
22256,reduced,0,0
22257,oxidative,0,0
22258,stress,0,0
22259,more,0,0
22260,than,0,0
22261,glibenclamide,1,1
22262,",",0,0
22263,indicating,0,0
22264,higher,0,0
22265,antioxidant,0,1
22266,properties,0,0
22267,of,0,0
22268,gliclazide,0,1
22269,.,0,0
22270,Normalization,0,0
22271,of,0,0
22272,oxidative,0,0
22273,stress,0,0
22274,was,0,0
22275,not,0,0
22276,achieved,0,0
22277,.,0,0
22278,Further,0,0
22279,studies,0,0
22280,are,0,0
22281,required,0,0
22282,to,0,0
22283,see,0,0
22284,long-term,0,0
22285,effect,0,0
22286,of,0,0
22287,drug,0,1
22288,therapy,0,1
22289,in,0,0
22290,combating,0,0
22291,oxidative,0,0
22292,stress,0,0
22293,after,0,0
22294,achieving,0,0
22295,acceptable,0,0
22296,control,0,0
22297,of,0,0
22298,diabetes,0,0
22299,.,0,0
22300,Effectiveness,0,0
22301,of,0,0
22302,two,0,0
22303,quadruple,0,0
22304,",",0,0
22305,tetracycline-,1,1
22306,or,0,1
22307,clarithromycin-containing,1,1
22308,",",0,1
22309,second-line,0,1
22310,",",0,1
22311,Helicobacter,1,1
22312,pylori,1,1
22313,eradication,1,1
22314,therapies,1,0
22315,.,1,0
22316,BACKGROUND,0,0
22317,There,0,0
22318,are,0,0
22319,no,0,0
22320,guidelines,0,0
22321,on,0,0
22322,second-line,0,1
22323,therapies,0,0
22324,for,0,0
22325,Helicobacter,0,1
22326,pylori,0,1
22327,eradication,0,1
22328,failures,0,0
22329,of,0,0
22330,omeprazole-clarithromycin-amoxicillin,0,1
22331,triple,0,0
22332,therapy,0,0
22333,.,0,0
22334,AIM,0,0
22335,To,0,0
22336,compare,0,0
22337,the,0,0
22338,efficacy,0,0
22339,of,0,0
22340,two,0,0
22341,second-line,0,1
22342,therapies,0,0
22343,for,0,0
22344,persistent,0,0
22345,H.,0,0
22346,pylori,0,0
22347,infection,0,0
22348,.,0,0
22349,METHODS,0,0
22350,Over,0,0
22351,a,0,0
22352,6-year,0,0
22353,period,0,0
22354,",",0,0
22355,patients,0,0
22356,with,0,0
22357,persistent,0,0
22358,H.,0,0
22359,pylori,0,0
22360,infection,0,0
22361,following,0,0
22362,omeprazole-clarithromycin-amoxicillin,1,1
22363,eradication,0,1
22364,therapy,0,1
22365,were,0,0
22366,randomized,0,0
22367,to,0,0
22368,receive,0,1
22369,omeprazole,1,1
22370,",",1,1
22371,20,1,1
22372,mg,1,1
22373,twice,1,1
22374,daily,1,1
22375,",",1,1
22376,bismuth,1,1
22377,",",1,1
22378,120,1,1
22379,mg,1,1
22380,four,1,0
22381,times,1,1
22382,daily,1,1
22383,",",1,1
22384,metronidazole,1,1
22385,",",1,1
22386,500,1,1
22387,mg,1,1
22388,twice,1,1
22389,daily,1,1
22390,",",1,1
22391,and,1,0
22392,either,1,0
22393,tetracycline,1,1
22394,",",1,1
22395,500,1,1
22396,mg,1,1
22397,four,1,0
22398,times,1,1
22399,daily,1,1
22400,",",1,1
22401,or,1,1
22402,clarithromycin,1,1
22403,",",1,1
22404,500,1,1
22405,mg,1,1
22406,twice,1,1
22407,daily,1,1
22408,",",0,1
22409,given,0,0
22410,for,0,0
22411,7,0,0
22412,days,0,0
22413,.,0,0
22414,Before,0,0
22415,therapy,0,0
22416,",",0,0
22417,patients,0,0
22418,underwent,0,0
22419,endoscopy,0,0
22420,with,0,0
22421,biopsies,0,0
22422,for,0,0
22423,histology,0,0
22424,",",0,0
22425,culture,0,0
22426,and,0,0
22427,antibiotic,0,1
22428,susceptibility,0,0
22429,tests,0,0
22430,.,0,0
22431,H.,0,0
22432,pylori,0,0
22433,infection,0,0
22434,was,0,0
22435,confirmed,0,0
22436,by,0,0
22437,histology,0,0
22438,.,0,0
22439,RESULTS,0,0
22440,Of,0,0
22441,the,0,0
22442,95,0,0
22443,randomized,0,0
22444,patients,0,0
22445,",",0,0
22446,88,0,0
22447,(,0,0
22448,93,0,0
22449,%,0,0
22450,),0,0
22451,completed,0,0
22452,the,0,0
22453,study,0,0
22454,.,0,0
22455,Age,0,0
22456,",",0,0
22457,sex,0,1
22458,",",0,0
22459,smoking,0,0
22460,",",0,0
22461,ulcer/non-ulcer,0,0
22462,dyspepsia,0,1
22463,ratio,0,0
22464,and,0,0
22465,antibiotic,0,1
22466,resistance,0,0
22467,were,0,0
22468,not,0,0
22469,significantly,0,0
22470,different,0,0
22471,between,0,0
22472,the,0,0
22473,treatment,0,0
22474,groups,0,0
22475,.,0,0
22476,On,0,0
22477,intention-to-treat,0,0
22478,analysis,0,0
22479,",",0,0
22480,eradication,0,0
22481,was,0,0
22482,achieved,0,0
22483,in,0,0
22484,41,0,0
22485,of,0,0
22486,the,0,0
22487,49,0,0
22488,patients,0,0
22489,(,0,0
22490,84,0,0
22491,%,0,0
22492,;,0,0
22493,95,0,0
22494,%,0,0
22495,confidence,0,0
22496,interval,0,0
22497,",",0,0
22498,70.4-92.7,0,0
22499,%,0,0
22500,),0,0
22501,and,0,0
22502,27,0,0
22503,of,0,0
22504,the,0,0
22505,46,0,0
22506,patients,0,0
22507,(,0,0
22508,59,0,0
22509,%,0,0
22510,;,0,0
22511,95,0,0
22512,%,0,0
22513,confidence,0,0
22514,interval,0,0
22515,",",0,0
22516,43.3-73.0,0,0
22517,%,0,0
22518,),0,0
22519,of,0,0
22520,the,0,0
22521,tetracycline-,0,1
22522,and,0,1
22523,clarithromycin-containing,0,1
22524,groups,0,0
22525,",",0,0
22526,respectively,0,0
22527,(,0,0
22528,P=0.007,0,0
22529,),0,0
22530,.,0,0
22531,On,0,1
22532,multivariate,0,0
22533,regression,0,0
22534,analysis,0,0
22535,",",0,0
22536,the,0,0
22537,sensitivity,0,0
22538,of,0,0
22539,H.,0,0
22540,pylori,0,0
22541,to,0,0
22542,metronidazole,0,1
22543,had,0,0
22544,a,0,0
22545,likelihood,0,0
22546,ratio,0,0
22547,of,0,0
22548,5.2,0,0
22549,(,0,0
22550,P=0.022,0,0
22551,),0,0
22552,",",0,0
22553,followed,0,0
22554,by,0,0
22555,the,0,0
22556,type,0,0
22557,of,0,0
22558,quadruple,0,0
22559,therapy,0,1
22560,(,0,1
22561,likelihood,0,1
22562,ratio,0,0
22563,",",0,0
22564,4.4,0,0
22565,;,0,0
22566,P=0.036,0,0
22567,),0,0
22568,.,0,0
22569,CONCLUSIONS,0,0
22570,Tetracycline-containing,1,0
22571,quadruple,1,0
22572,rescue,1,0
22573,therapy,1,0
22574,is,0,0
22575,highly,0,0
22576,effective,0,0
22577,in,0,0
22578,treating,0,0
22579,H.,0,0
22580,pylori,0,1
22581,eradication,0,0
22582,failures,0,0
22583,of,0,0
22584,the,0,0
22585,omeprazole-amoxicillin-clarithromycin,0,1
22586,regimen,0,1
22587,.,0,1
22588,The,0,0
22589,impact,0,0
22590,of,0,0
22591,different,0,0
22592,doses,0,1
22593,of,0,1
22594,medroxyprogesterone,1,1
22595,acetate,1,1
22596,on,0,1
22597,mood,0,0
22598,symptoms,0,0
22599,in,0,0
22600,sequential,1,0
22601,hormonal,1,0
22602,therapy,1,0
22603,.,1,0
22604,The,0,0
22605,aim,0,0
22606,of,0,0
22607,this,0,0
22608,study,0,0
22609,was,0,0
22610,to,0,0
22611,compare,0,0
22612,adverse,0,0
22613,mood,0,0
22614,effects,0,0
22615,of,0,0
22616,two,0,0
22617,different,0,0
22618,doses,0,1
22619,of,0,1
22620,medroxyprogesterone,1,1
22621,acetate,1,1
22622,(,1,1
22623,MPA,1,1
22624,),1,1
22625,during,0,0
22626,postmenopausal,0,1
22627,hormone,0,1
22628,replacement,0,1
22629,therapy,0,1
22630,(,0,1
22631,HRT,0,1
22632,),0,1
22633,in,0,0
22634,women,0,0
22635,with,0,0
22636,and,0,0
22637,without,0,0
22638,a,0,0
22639,history,0,0
22640,of,0,0
22641,premenstrual,0,1
22642,syndrome,0,1
22643,(,0,1
22644,PMS,0,1
22645,),0,1
22646,.,0,0
22647,The,0,0
22648,study,0,0
22649,was,0,0
22650,designed,0,0
22651,as,0,0
22652,a,0,0
22653,randomized,0,1
22654,double-blind,0,1
22655,cross-over,0,1
22656,study,0,0
22657,and,0,0
22658,included,0,0
22659,36,0,0
22660,postmenopausal,0,0
22661,women,0,0
22662,at,0,0
22663,three,0,0
22664,health,0,0
22665,care,0,0
22666,areas,0,0
22667,in,0,0
22668,northern,0,0
22669,Sweden,0,0
22670,.,0,0
22671,The,0,0
22672,women,0,0
22673,received,0,0
22674,2,1,1
22675,mg,1,1
22676,estradiol,1,1
22677,continuously,0,0
22678,during,0,0
22679,five,0,0
22680,28-day,0,1
22681,cycles,0,0
22682,and,0,1
22683,10,0,1
22684,mg,0,1
22685,or,0,1
22686,20,0,1
22687,mg,0,1
22688,MPA,0,1
22689,sequentially,0,0
22690,for,0,0
22691,12,0,0
22692,days,0,0
22693,during,0,0
22694,each,0,0
22695,cycle,0,0
22696,.,0,0
22697,The,0,0
22698,main,0,0
22699,outcome,0,0
22700,measures,0,0
22701,were,0,0
22702,mood,0,0
22703,and,0,0
22704,physical,0,0
22705,symptoms,0,0
22706,noted,0,0
22707,on,0,0
22708,a,0,0
22709,daily,0,1
22710,rating,0,1
22711,scale,0,1
22712,.,0,0
22713,We,0,0
22714,found,0,0
22715,that,0,0
22716,physical,0,0
22717,symptoms,0,0
22718,did,0,0
22719,not,0,0
22720,differ,0,0
22721,between,0,0
22722,10,0,0
22723,and,0,0
22724,20,0,1
22725,mg,0,1
22726,MPA,0,1
22727,.,0,1
22728,Both,0,0
22729,women,0,0
22730,with,0,0
22731,a,0,0
22732,history,0,0
22733,of,0,0
22734,PMS,0,0
22735,and,0,0
22736,women,0,0
22737,without,0,0
22738,responded,0,0
22739,with,0,0
22740,more,0,0
22741,negative,0,0
22742,mood,0,0
22743,symptoms,0,0
22744,with,0,0
22745,the,0,0
22746,lower,0,0
22747,dose,0,1
22748,of,0,0
22749,MPA,0,1
22750,.,0,0
22751,In,0,0
22752,women,0,0
22753,with,0,0
22754,previous,0,0
22755,PMS,0,0
22756,the,0,0
22757,higher,0,0
22758,dose,0,1
22759,of,0,0
22760,MPA,0,0
22761,enhanced,0,0
22762,positive,0,0
22763,mood,0,0
22764,symptoms,0,0
22765,.,0,0
22766,With,0,0
22767,respect,0,0
22768,to,0,0
22769,mood,0,0
22770,and,0,0
22771,physical,0,0
22772,symptoms,0,0
22773,",",0,0
22774,the,0,0
22775,aim,0,0
22776,to,0,0
22777,lower,0,0
22778,MPA,0,1
22779,doses,0,1
22780,in,0,0
22781,HRT,0,1
22782,is,0,0
22783,unwarranted,0,0
22784,.,0,0
22785,Prolonged,1,0
22786,GnRH,1,1
22787,agonist,1,1
22788,and,1,1
22789,add-back,1,1
22790,therapy,1,1
22791,for,0,0
22792,symptomatic,0,0
22793,endometriosis,0,0
22794,:,0,0
22795,long-term,0,0
22796,follow-up,0,0
22797,.,0,0
22798,OBJECTIVE,0,0
22799,To,0,0
22800,assess,0,0
22801,post-treatment,0,0
22802,effects,0,0
22803,in,0,0
22804,endometriosis,0,0
22805,patients,0,0
22806,of,0,0
22807,a,0,0
22808,12-month,0,0
22809,course,0,0
22810,of,0,0
22811,GnRH,1,1
22812,agonist,1,1
22813,alone,0,0
22814,or,0,0
22815,with,0,0
22816,one,0,0
22817,of,0,0
22818,three,1,0
22819,add-back,1,1
22820,regimens,1,1
22821,.,1,1
22822,METHODS,0,1
22823,This,0,0
22824,is,0,0
22825,a,0,0
22826,post-treatment,0,0
22827,follow-up,0,0
22828,analysis,0,0
22829,of,0,0
22830,a,0,0
22831,randomized,0,0
22832,",",0,0
22833,double-masked,0,1
22834,",",0,1
22835,placebo-controlled,1,1
22836,52-week,0,1
22837,trial,0,1
22838,.,0,0
22839,All,0,0
22840,patients,0,0
22841,had,0,0
22842,received,0,0
22843,monthly,0,1
22844,leuprolide,1,1
22845,acetate,1,1
22846,and,0,1
22847,were,0,0
22848,randomized,0,0
22849,to,0,0
22850,one,0,0
22851,of,0,0
22852,four,0,0
22853,groups,0,0
22854,:,0,0
22855,A-daily,0,1
22856,placebo,1,1
22857,;,1,1
22858,B-daily,0,1
22859,norethindrone,1,1
22860,acetate,1,1
22861,5,0,1
22862,mg,0,1
22863,;,0,1
22864,C-daily,1,1
22865,norethindrone,1,1
22866,acetate,1,1
22867,5,0,1
22868,mg,0,1
22869,and,0,1
22870,conjugated,1,1
22871,equine,1,1
22872,estrogens,1,1
22873,0.625,0,1
22874,mg,0,1
22875,;,0,1
22876,and,0,1
22877,D-daily,0,1
22878,norethindrone,1,1
22879,acetate,1,1
22880,5,0,1
22881,mg,0,1
22882,and,0,1
22883,conjugated,1,1
22884,equine,1,1
22885,estrogens,1,1
22886,1.25,0,1
22887,mg.,0,1
22888,Of,0,1
22889,201,0,0
22890,patients,0,0
22891,enrolled,0,0
22892,in,0,0
22893,the,0,0
22894,initial,0,0
22895,trial,0,0
22896,",",0,0
22897,123,0,0
22898,completed,0,0
22899,at,0,0
22900,least,0,0
22901,280,0,0
22902,days,0,0
22903,of,0,0
22904,therapy,0,0
22905,and,0,0
22906,entered,0,0
22907,the,0,0
22908,follow-up,0,0
22909,period,0,0
22910,.,0,0
22911,Physical,0,0
22912,findings,0,0
22913,and,0,0
22914,symptoms,0,0
22915,were,0,0
22916,quantified,0,0
22917,",",0,0
22918,and,0,0
22919,lumbar,0,0
22920,spine,0,1
22921,bone,0,1
22922,mineral,0,0
22923,density,0,0
22924,was,0,0
22925,determined,0,0
22926,at,0,0
22927,intervals,0,0
22928,for,0,0
22929,up,0,0
22930,to,0,0
22931,12,0,0
22932,and,0,0
22933,24,0,0
22934,months,0,0
22935,post-therapy,0,0
22936,.,0,0
22937,RESULTS,0,0
22938,Symptom,0,0
22939,and,0,0
22940,pelvic,0,0
22941,examination,0,0
22942,scores,0,0
22943,remained,0,0
22944,significantly,0,0
22945,below,0,0
22946,baseline,0,0
22947,for,0,0
22948,at,0,0
22949,least,0,0
22950,8,0,0
22951,months,0,0
22952,after,0,0
22953,completion,0,0
22954,of,0,0
22955,therapy,0,0
22956,for,0,0
22957,all,0,0
22958,four,0,0
22959,groups,0,0
22960,(,0,0
22961,P,0,0
22962,<,0,0
22963,.05,0,0
22964,),0,0
22965,.,0,0
22966,Findings,0,0
22967,were,0,0
22968,not,0,0
22969,affected,0,0
22970,by,0,0
22971,endometriosis,0,0
22972,scores,0,0
22973,noted,0,0
22974,on,0,0
22975,screening,0,0
22976,laparoscopy,0,0
22977,.,0,0
22978,Mean,0,0
22979,bone,0,0
22980,mineral,0,0
22981,density,0,0
22982,values,0,0
22983,remained,0,0
22984,at,0,0
22985,or,0,0
22986,above,0,0
22987,baseline,0,0
22988,in,0,0
22989,all,0,0
22990,add-back,0,1
22991,groups,0,0
22992,.,0,0
22993,The,0,0
22994,significant,0,0
22995,mean,0,0
22996,loss,0,0
22997,in,0,0
22998,bone,0,0
22999,density,0,0
23000,in,0,0
23001,group,0,0
23002,A,0,0
23003,during,0,0
23004,therapy,0,0
23005,reversed,0,0
23006,slowly,0,0
23007,and,0,0
23008,had,0,0
23009,not,0,0
23010,returned,0,0
23011,to,0,0
23012,baseline,0,0
23013,at,0,0
23014,the,0,0
23015,final,0,0
23016,follow-up,0,0
23017,visit,0,0
23018,(,0,0
23019,P,0,0
23020,<,0,0
23021,.001,0,0
23022,),0,0
23023,.,0,0
23024,CONCLUSION,0,1
23025,GnRH,1,1
23026,agonist,1,1
23027,and,0,1
23028,norethindrone,1,1
23029,acetate,1,1
23030,alone,1,0
23031,or,0,0
23032,combined,0,0
23033,with,0,0
23034,low-dose,1,1
23035,conjugated,1,1
23036,equine,1,1
23037,estrogens,1,1
23038,administered,0,1
23039,to,0,1
23040,symptomatic,0,0
23041,endometriosis,0,0
23042,patients,0,0
23043,for,0,0
23044,12,0,0
23045,months,0,0
23046,provides,0,0
23047,extended,0,0
23048,pain,0,0
23049,relief,0,0
23050,and,0,0
23051,bone,0,0
23052,mineral,0,0
23053,density,0,0
23054,preservation,0,0
23055,after,0,0
23056,completion,0,0
23057,of,0,0
23058,therapy,0,0
23059,.,0,0
23060,Thiabendazole,1,1
23061,for,0,1
23062,the,0,0
23063,prophylaxis,0,0
23064,of,0,0
23065,strongyloidiasis,0,0
23066,in,0,0
23067,immunosuppressed,0,0
23068,patients,0,0
23069,with,0,0
23070,hematological,0,0
23071,diseases,0,0
23072,:,0,0
23073,a,0,0
23074,randomized,0,1
23075,double-blind,0,1
23076,placebo-controlled,1,1
23077,study,0,1
23078,.,0,0
23079,Clinical,0,0
23080,evaluation,0,0
23081,of,0,0
23082,the,0,0
23083,WOMAC,0,0
23084,3.0,0,0
23085,OA,0,0
23086,Index,0,0
23087,in,0,0
23088,numeric,0,0
23089,rating,0,0
23090,scale,0,0
23091,format,0,0
23092,using,0,0
23093,a,0,0
23094,computerized,1,0
23095,touch,1,0
23096,screen,1,0
23097,version,1,0
23098,.,1,0
23099,BACKGROUND,0,0
23100,The,0,0
23101,Western,0,0
23102,Ontario,0,0
23103,and,0,0
23104,McMaster,0,1
23105,Universities,0,1
23106,(,0,1
23107,WOMAC,0,1
23108,),0,1
23109,Osteoarthritis,0,0
23110,Index,0,0
23111,is,0,0
23112,a,0,0
23113,previously,0,0
23114,described,0,0
23115,self-administered,0,0
23116,questionnaire,0,0
23117,covering,0,0
23118,three,0,0
23119,domains,0,0
23120,:,0,0
23121,pain,0,0
23122,",",0,0
23123,stiffness,0,0
23124,and,0,0
23125,function,0,0
23126,.,0,0
23127,It,0,0
23128,has,0,0
23129,been,0,0
23130,validated,0,0
23131,in,0,0
23132,patients,0,0
23133,with,0,0
23134,osteoarthritis,0,0
23135,(,0,1
23136,OA,0,1
23137,),0,0
23138,of,0,0
23139,the,0,0
23140,hip,0,0
23141,or,0,0
23142,knee,0,0
23143,in,0,0
23144,a,0,0
23145,paper-based,0,0
23146,format,0,0
23147,.,0,0
23148,AIM,0,0
23149,To,0,0
23150,validate,0,0
23151,the,0,0
23152,WOMAC,0,0
23153,3.0,0,0
23154,using,0,0
23155,a,0,0
23156,numerical,0,0
23157,rating,0,0
23158,scale,0,0
23159,in,0,0
23160,a,0,0
23161,computerized,0,0
23162,touch,0,0
23163,screen,0,0
23164,format,0,0
23165,allowing,0,0
23166,immediate,0,0
23167,evaluation,0,0
23168,of,0,0
23169,the,0,0
23170,questionnaire,0,0
23171,.,0,0
23172,In,0,0
23173,the,0,0
23174,computed,0,0
23175,version,0,0
23176,cartoons,0,0
23177,",",0,0
23178,written,0,0
23179,and,0,0
23180,audio,0,0
23181,instruments,0,0
23182,were,0,0
23183,included,0,0
23184,in,0,0
23185,order,0,0
23186,facilitate,0,0
23187,application,0,0
23188,.,0,0
23189,METHODS,0,0
23190,Fifty,0,0
23191,patients,0,0
23192,",",0,0
23193,demographically,0,0
23194,balanced,0,0
23195,",",0,0
23196,with,0,0
23197,radiographically,0,0
23198,proven,0,0
23199,primary,0,0
23200,hip,0,0
23201,or,0,0
23202,knee,0,0
23203,OA,0,1
23204,completed,0,0
23205,the,0,0
23206,classical,1,0
23207,paper,1,0
23208,and,1,0
23209,the,1,0
23210,new,1,0
23211,computerized,1,0
23212,WOMAC,1,0
23213,version,1,0
23214,.,1,0
23215,Subjects,0,0
23216,were,0,0
23217,randomized,0,0
23218,either,0,0
23219,to,0,0
23220,paper,0,0
23221,format,0,0
23222,or,0,0
23223,computerized,0,0
23224,format,0,0
23225,first,0,0
23226,to,0,0
23227,balance,0,0
23228,possible,0,0
23229,order,0,0
23230,effects,0,0
23231,.,0,0
23232,RESULTS,0,0
23233,The,0,0
23234,intra-class,0,0
23235,correlation,0,0
23236,coefficients,0,0
23237,for,0,0
23238,pain,0,0
23239,",",0,0
23240,stiffness,0,0
23241,and,0,0
23242,function,0,0
23243,values,0,0
23244,were,0,0
23245,0.915,0,0
23246,",",0,0
23247,0.745,0,0
23248,and,0,0
23249,0.940,0,0
23250,",",0,0
23251,respectively,0,0
23252,.,0,0
23253,The,0,0
23254,Spearman,0,0
23255,correlation,0,0
23256,coefficients,0,0
23257,for,0,0
23258,pain,0,0
23259,",",0,0
23260,stiffness,0,0
23261,and,0,0
23262,function,0,0
23263,were,0,0
23264,0.88,0,0
23265,",",0,0
23266,0.77,0,0
23267,and,0,0
23268,0.87,0,0
23269,",",0,0
23270,respectively,0,0
23271,.,0,0
23272,CONCLUSION,0,0
23273,These,0,0
23274,data,0,0
23275,indicate,0,0
23276,that,0,0
23277,the,0,0
23278,computerized,0,0
23279,WOMAC,0,1
23280,OA,0,1
23281,index,0,0
23282,3.0,0,0
23283,is,0,0
23284,comparable,0,0
23285,to,0,0
23286,the,0,0
23287,paper,0,0
23288,WOMAC,0,0
23289,in,0,0
23290,all,0,0
23291,three,0,0
23292,dimensions,0,0
23293,.,0,0
23294,The,1,0
23295,computerized,1,0
23296,version,1,0
23297,would,0,0
23298,allow,0,0
23299,physicians,0,0
23300,to,0,0
23301,get,0,0
23302,an,0,0
23303,immediate,0,0
23304,result,0,0
23305,and,0,0
23306,if,0,0
23307,present,0,0
23308,a,0,0
23309,direct,0,0
23310,comparison,0,0
23311,with,0,0
23312,a,0,0
23313,previous,0,0
23314,exam,0,0
23315,.,0,0
23316,Use,0,1
23317,of,0,1
23318,high-dose,0,1
23319,cytarabine,1,1
23320,to,0,1
23321,enhance,0,0
23322,cisplatin,1,1
23323,cytotoxicity-effects,0,0
23324,on,0,0
23325,the,0,0
23326,response,0,0
23327,and,0,0
23328,overall,0,0
23329,survival,0,0
23330,rates,0,0
23331,of,0,0
23332,advanced,0,0
23333,head,0,0
23334,and,0,0
23335,neck,0,0
23336,cancer,0,0
23337,patients,0,0
23338,.,0,0
23339,UNLABELLED,0,0
23340,It,0,0
23341,has,0,0
23342,been,0,0
23343,reported,0,0
23344,that,0,0
23345,cytarabine,1,1
23346,",",0,0
23347,acting,0,0
23348,by,0,0
23349,at,0,0
23350,least,0,0
23351,two,0,0
23352,different,0,0
23353,mechanisms,0,0
23354,",",0,0
23355,enhances,0,0
23356,the,0,0
23357,cytotoxic,0,0
23358,effect,0,0
23359,of,0,0
23360,cisplatin,1,1
23361,in,0,0
23362,in,0,0
23363,vitro,0,0
23364,systems,0,0
23365,.,0,0
23366,The,0,0
23367,aim,0,0
23368,of,0,0
23369,this,0,0
23370,open,0,0
23371,",",0,0
23372,prospective,0,0
23373,",",0,0
23374,randomised,0,0
23375,study,0,0
23376,was,0,0
23377,to,0,0
23378,estimate,0,0
23379,the,0,0
23380,eventual,0,0
23381,benefits,0,0
23382,from,0,0
23383,the,0,0
23384,inclusion,0,0
23385,of,0,0
23386,high-dose,0,1
23387,cytarabine,1,1
23388,in,0,1
23389,the,0,1
23390,cisplatin-5-fluorouracil,1,1
23391,(,1,1
23392,5-FU,1,1
23393,),1,1
23394,regimen,0,1
23395,as,0,1
23396,first-line,0,0
23397,treatment,0,0
23398,of,0,0
23399,patients,0,0
23400,with,0,0
23401,advanced,0,0
23402,head,0,0
23403,and,0,0
23404,neck,0,0
23405,cancer,0,0
23406,.,0,0
23407,The,0,0
23408,study,0,0
23409,recruited,0,0
23410,successive,0,0
23411,patients,0,0
23412,with,0,0
23413,unresectable,0,0
23414,grade,0,0
23415,I/II,0,1
23416,head,0,1
23417,and,0,0
23418,neck,0,0
23419,cancer,0,0
23420,who,0,0
23421,were,0,0
23422,not,0,0
23423,suitable,0,0
23424,for,0,0
23425,irradiation,1,0
23426,treatment,1,0
23427,(,0,0
23428,T,0,1
23429,any,0,0
23430,N3,0,0
23431,or,0,0
23432,T4,0,0
23433,N2C,0,0
23434,),0,0
23435,",",0,0
23436,metastatic,0,0
23437,or,0,0
23438,previously,0,0
23439,irradiated,0,0
23440,.,0,0
23441,All,0,0
23442,patients,0,0
23443,gave,0,0
23444,their,0,0
23445,informed,0,0
23446,consent,0,0
23447,.,0,0
23448,A,0,0
23449,joint,0,0
23450,ear,0,0
23451,",",0,0
23452,nose,0,0
23453,and,0,0
23454,throat,0,1
23455,(,0,1
23456,ENT,0,1
23457,),0,1
23458,oncological,0,0
23459,committee,0,0
23460,performed,0,0
23461,the,0,0
23462,selection,0,0
23463,.,0,0
23464,A,0,0
23465,total,0,0
23466,of,0,0
23467,170,0,0
23468,patients,0,0
23469,were,0,0
23470,included,0,0
23471,in,0,0
23472,the,0,0
23473,study,0,0
23474,.,0,0
23475,Patients,0,0
23476,randomised,0,0
23477,to,0,0
23478,arm,0,0
23479,A,0,0
23480,were,0,0
23481,given,0,0
23482,1000,1,1
23483,mg/m,1,1
23484,(,1,1
23485,2,1,1
23486,),1,1
23487,cytarabine,1,1
23488,on,0,1
23489,day,0,0
23490,1,0,0
23491,preceding,0,0
23492,for,0,0
23493,6,0,0
23494,h,0,1
23495,cisplatin,1,1
23496,infusion,1,1
23497,",",0,1
23498,30,0,1
23499,mg/m,0,1
23500,(,0,1
23501,2,0,1
23502,),0,0
23503,/24,0,0
23504,h,0,0
23505,cisplatin,1,1
23506,intravenous,0,1
23507,(,0,1
23508,i.v,0,1
23509,.,0,1
23510,),0,1
23511,bolus,0,1
23512,days,0,1
23513,1-4,0,1
23514,and,0,0
23515,1000,0,1
23516,mg/m,0,1
23517,(,0,1
23518,2,0,1
23519,),0,0
23520,/24,0,0
23521,h,0,0
23522,5-FU,0,0
23523,in,0,0
23524,a,0,0
23525,4-h,0,1
23526,infusion,0,1
23527,on,0,1
23528,days,0,0
23529,1-4,0,0
23530,.,0,0
23531,Patients,0,0
23532,in,0,0
23533,arm,0,0
23534,B,0,0
23535,were,0,0
23536,given,0,0
23537,cisplatin,1,1
23538,and,1,0
23539,5-FU,1,1
23540,in,0,0
23541,the,0,0
23542,same,0,0
23543,dosage,0,1
23544,and,0,0
23545,schedule,0,0
23546,as,0,0
23547,in,0,0
23548,arm,0,0
23549,A,0,0
23550,.,0,0
23551,Additional,0,0
23552,irradiation+/-surgery,1,0
23553,was,0,0
23554,performed,0,0
23555,if,0,0
23556,and,0,0
23557,when,0,0
23558,feasible,0,0
23559,.,0,0
23560,Patients,0,0
23561,in,0,0
23562,both,0,0
23563,arms,0,0
23564,were,0,0
23565,well,0,0
23566,balanced,0,0
23567,with,0,0
23568,regard,0,0
23569,to,0,0
23570,clinical,0,0
23571,variables,0,0
23572,.,0,0
23573,The,0,0
23574,following,0,0
23575,results,0,0
23576,were,0,0
23577,obtained,0,0
23578,:,0,0
23579,Arm,0,0
23580,A,0,0
23581,:,0,0
23582,84,0,0
23583,patients,0,0
23584,were,0,0
23585,included,0,0
23586,",",0,0
23587,74,0,0
23588,were,0,0
23589,evaluable,0,0
23590,for,0,0
23591,activity,0,0
23592,;,0,0
23593,RESPONSE,0,0
23594,complete,0,0
23595,response,0,0
23596,(,0,0
23597,CR,0,1
23598,),0,1
23599,8,0,1
23600,(,0,0
23601,11,0,0
23602,%,0,0
23603,),0,0
23604,",",0,0
23605,partial,0,0
23606,response,0,0
23607,(,0,0
23608,PR,0,1
23609,),0,1
23610,40,0,0
23611,(,0,0
23612,54,0,0
23613,%,0,0
23614,),0,0
23615,",",0,0
23616,stable,0,1
23617,disease,0,0
23618,(,0,1
23619,SD,0,1
23620,),0,1
23621,11,0,1
23622,(,0,0
23623,15,0,0
23624,%,0,0
23625,),0,0
23626,",",0,0
23627,progressive,0,0
23628,disease,0,1
23629,(,0,1
23630,PD,0,1
23631,),0,1
23632,15,0,1
23633,(,0,0
23634,20,0,0
23635,%,0,0
23636,),0,0
23637,.,0,0
23638,The,0,0
23639,overall,0,0
23640,response,0,0
23641,rate,0,0
23642,(,0,0
23643,RR,0,1
23644,),0,1
23645,based,0,0
23646,on,0,0
23647,the,0,0
23648,evaluable,0,0
23649,patients,0,0
23650,was,0,0
23651,48/74,0,0
23652,(,0,0
23653,65,0,0
23654,%,0,0
23655,",",0,0
23656,95,0,0
23657,%,0,0
23658,confidence,0,0
23659,interval,0,0
23660,(,0,0
23661,CI,0,0
23662,),0,0
23663,54-75,0,0
23664,%,0,0
23665,),0,0
23666,;,0,0
23667,The,0,0
23668,RR,0,0
23669,based,0,0
23670,on,0,0
23671,an,0,0
23672,intent-to-treat,0,0
23673,analysis,0,0
23674,was,0,0
23675,57,0,0
23676,%,0,0
23677,",",0,0
23678,95,0,0
23679,%,0,0
23680,CI,0,0
23681,47-67,0,0
23682,%,0,0
23683,;,0,0
23684,Median,0,0
23685,survival,0,0
23686,was,0,0
23687,13,0,0
23688,months,0,0
23689,;,0,0
23690,There,0,0
23691,were,0,0
23692,50,0,0
23693,episodes,0,0
23694,of,0,0
23695,granulocytopenia,0,1
23696,grade,0,1
23697,IV,0,1
23698,and,0,0
23699,15,0,0
23700,of,0,0
23701,febrile,0,0
23702,neutropenia,0,0
23703,per,0,0
23704,316,0,0
23705,cycles,0,0
23706,.,0,0
23707,Arm,0,0
23708,B,0,0
23709,:,0,0
23710,86,0,0
23711,patients,0,0
23712,were,0,0
23713,included,0,0
23714,",",0,0
23715,80,0,0
23716,were,0,0
23717,evaluable,0,0
23718,for,0,0
23719,activity,0,0
23720,;,0,0
23721,RESPONSE,0,1
23722,CR,0,1
23723,7,0,1
23724,(,0,0
23725,9,0,0
23726,%,0,0
23727,),0,0
23728,",",0,0
23729,PR,0,0
23730,29,0,0
23731,(,0,0
23732,36,0,0
23733,%,0,0
23734,),0,0
23735,",",0,0
23736,SD,0,1
23737,10,0,0
23738,(,0,0
23739,12.5,0,0
23740,%,0,0
23741,),0,0
23742,",",0,0
23743,PD,0,1
23744,34,0,0
23745,(,0,0
23746,42.5,0,0
23747,%,0,0
23748,),0,0
23749,;,0,0
23750,The,0,0
23751,overall,0,0
23752,RR,0,0
23753,based,0,0
23754,on,0,0
23755,the,0,0
23756,evaluable,0,0
23757,patients,0,0
23758,was,0,0
23759,36/80,0,0
23760,(,0,0
23761,45,0,0
23762,%,0,0
23763,",",0,0
23764,95,0,0
23765,%,0,0
23766,CI,0,0
23767,35-56,0,0
23768,%,0,0
23769,),0,0
23770,;,0,0
23771,The,0,0
23772,RR,0,0
23773,based,0,0
23774,on,0,0
23775,an,0,0
23776,intent-to-treat,0,0
23777,analysis,0,0
23778,was,0,0
23779,42,0,0
23780,%,0,0
23781,",",0,0
23782,95,0,0
23783,%,0,0
23784,CI,0,0
23785,32-52,0,0
23786,%,0,0
23787,;,0,0
23788,Median,0,0
23789,survival,0,0
23790,was,0,0
23791,8,0,0
23792,months,0,0
23793,;,0,0
23794,There,0,0
23795,were,0,0
23796,14,0,0
23797,episodes,0,0
23798,of,0,0
23799,granulocytopenia,0,1
23800,grade,0,1
23801,IV,0,1
23802,and,0,0
23803,7,0,0
23804,febrile,0,0
23805,neutropenias,0,0
23806,per,0,0
23807,324,0,0
23808,cycles,0,0
23809,.,0,0
23810,The,0,0
23811,RR,0,0
23812,was,0,0
23813,significantly,0,0
23814,higher,0,0
23815,in,0,0
23816,arm,0,0
23817,A,0,0
23818,(,0,0
23819,P=0.013,0,0
23820,),0,0
23821,",",0,0
23822,power,0,1
23823,(,0,1
23824,one-sided,0,1
23825,),0,0
23826,80,0,0
23827,%,0,0
23828,.,0,0
23829,The,0,0
23830,proportion,0,0
23831,of,0,0
23832,patients,0,0
23833,from,0,0
23834,the,0,0
23835,appropriate,0,0
23836,subset,0,0
23837,who,0,0
23838,achieved,0,0
23839,a,0,0
23840,clinical,0,0
23841,response,0,0
23842,making,0,0
23843,additional,0,0
23844,treatment,0,0
23845,feasible,0,0
23846,was,0,0
23847,higher,0,0
23848,in,0,0
23849,arm,0,0
23850,A,0,0
23851,(,0,0
23852,P=0.00015,0,0
23853,),0,0
23854,",",0,0
23855,as,0,0
23856,well,0,0
23857,as,0,0
23858,the,0,0
23859,proportion,0,0
23860,of,0,0
23861,patients,0,0
23862,with,0,0
23863,a,0,0
23864,performance,0,0
23865,status,0,0
23866,2+3,0,0
23867,achieving,0,0
23868,a,0,0
23869,response,0,0
23870,(,0,0
23871,P,0,0
23872,<,0,0
23873,0.0001,0,0
23874,),0,0
23875,.,0,0
23876,Using,0,0
23877,the,0,0
23878,Log-rank,0,0
23879,test,0,0
23880,",",0,0
23881,patients,0,0
23882,from,0,0
23883,arm,0,0
23884,A,0,0
23885,achieved,0,0
23886,a,0,0
23887,significantly,0,0
23888,longer,0,0
23889,survival,0,0
23890,(,0,0
23891,P=0.009,0,0
23892,),0,0
23893,",",0,0
23894,with,0,0
23895,the,0,0
23896,probability,0,0
23897,of,0,0
23898,survival,0,0
23899,at,0,0
23900,12,0,0
23901,months,0,0
23902,of,0,0
23903,0.58,0,0
23904,for,0,0
23905,patients,0,0
23906,in,0,0
23907,arm,0,0
23908,A,0,0
23909,and,0,0
23910,0.28,0,0
23911,for,0,0
23912,patients,0,0
23913,in,0,0
23914,arm,0,0
23915,B.,0,0
23916,Grade,0,1
23917,IV,0,1
23918,granulocytopenia,0,1
23919,and,0,0
23920,thrombocytopenia,0,0
23921,were,0,0
23922,more,0,0
23923,frequent,0,0
23924,in,0,0
23925,arm,0,0
23926,A,0,0
23927,.,0,0
23928,Due,0,0
23929,to,0,0
23930,its,0,0
23931,haematological,0,0
23932,side-effects,0,1
23933,",",0,0
23934,cytarabine,1,1
23935,might,0,0
23936,not,0,0
23937,be,0,0
23938,the,0,0
23939,ideal,0,0
23940,drug,0,1
23941,to,0,0
23942,modulate,0,0
23943,the,0,0
23944,cytotoxicity,0,0
23945,of,0,0
23946,cisplatin,1,1
23947,.,1,0
23948,However,0,0
23949,",",0,0
23950,other,0,0
23951,modulators,0,0
23952,of,0,0
23953,its,0,0
23954,activity,0,0
23955,could,0,0
23956,be,0,0
23957,of,0,0
23958,interest,0,0
23959,for,0,0
23960,further,0,0
23961,studies,0,0
23962,in,0,0
23963,head,0,0
23964,and,0,0
23965,neck,0,0
23966,cancer,0,0
23967,patients,0,0
23968,.,0,0
23969,Monitoring,0,0
23970,tumour,0,0
23971,cells,0,0
23972,in,0,0
23973,the,0,0
23974,peripheral,0,0
23975,blood,0,0
23976,of,0,0
23977,small,0,0
23978,cell,0,0
23979,lung,0,0
23980,cancer,0,0
23981,patients,0,0
23982,.,0,0
23983,BACKGROUND,0,0
23984,Flow,1,0
23985,cytometry,1,0
23986,was,0,0
23987,used,0,0
23988,to,0,0
23989,enumerate,0,0
23990,tumour,0,0
23991,cells,0,0
23992,in,0,0
23993,longitudinal,0,0
23994,studies,0,0
23995,of,0,0
23996,peripheral,0,0
23997,blood,0,0
23998,from,0,0
23999,small,0,0
24000,cell,0,0
24001,lung,0,0
24002,cancer,0,1
24003,(,0,1
24004,SCLC,0,1
24005,),0,1
24006,patients,0,0
24007,",",0,0
24008,together,0,0
24009,with,0,0
24010,magnetic,0,0
24011,bead,0,0
24012,selection,0,0
24013,to,0,0
24014,isolate,0,0
24015,and,0,0
24016,identify,0,0
24017,these,0,0
24018,cells,0,0
24019,.,0,0
24020,As,0,0
24021,part,0,0
24022,of,0,0
24023,a,0,0
24024,trial,0,0
24025,",",0,0
24026,11,0,0
24027,patients,0,0
24028,received,0,0
24029,either,0,0
24030,standard,0,1
24031,(,0,0
24032,four,0,0
24033,weekly,0,1
24034,),0,1
24035,chemotherapy,1,1
24036,with,1,1
24037,ifosfamide,1,1
24038,",",1,1
24039,carboplatin,1,1
24040,",",1,1
24041,and,1,1
24042,etoposide,1,1
24043,(,1,1
24044,ICE,1,1
24045,),1,1
24046,or,1,0
24047,accelerated,1,0
24048,(,1,0
24049,two,1,0
24050,weekly,1,1
24051,),1,1
24052,ICE,1,1
24053,with,1,1
24054,filgrastim,1,1
24055,(,1,1
24056,granulocyte,1,1
24057,colony-stimulating,1,1
24058,factor,1,1
24059,[,1,1
24060,G-CSF,1,1
24061,],1,1
24062,),1,0
24063,and,1,0
24064,autologous,1,0
24065,stem,1,0
24066,cell,1,0
24067,support,1,0
24068,.,1,0
24069,METHODS,0,0
24070,Fresh,0,1
24071,venous,0,0
24072,blood,0,0
24073,was,0,0
24074,taken,0,0
24075,throughout,0,0
24076,treatment,0,0
24077,and,0,0
24078,follow-up,0,1
24079,.,0,0
24080,Aliquots,0,1
24081,were,0,0
24082,stained,0,0
24083,with,0,0
24084,a,0,0
24085,tumour-specific,0,0
24086,antibody,0,0
24087,against,0,0
24088,epithelial,0,0
24089,tissue,0,0
24090,(,0,0
24091,Ber,0,0
24092,EP4,0,1
24093,),0,0
24094,",",0,0
24095,verified,0,0
24096,as,0,0
24097,a,0,0
24098,good,0,0
24099,marker,0,0
24100,of,0,0
24101,SCLC,0,0
24102,cells,0,0
24103,by,0,0
24104,immunohistochemistry,0,0
24105,.,0,0
24106,Matched,0,0
24107,samples,0,0
24108,labelled,0,0
24109,with,0,0
24110,Ber,0,0
24111,EP4,0,0
24112,were,0,0
24113,separated,0,0
24114,magnetically,0,0
24115,by,0,0
24116,adding,0,0
24117,a,0,0
24118,secondary,0,0
24119,bead-antibody,0,0
24120,conjugate,0,0
24121,for,0,0
24122,confirmation,0,0
24123,of,0,0
24124,tumour,0,0
24125,cell,0,0
24126,identity,0,0
24127,.,0,0
24128,RESULTS,0,0
24129,Circulating,0,0
24130,tumour,0,0
24131,cells,0,0
24132,were,0,0
24133,detected,0,0
24134,and,0,0
24135,monitored,0,0
24136,throughout,0,0
24137,treatment,0,0
24138,periods,0,0
24139,.,0,0
24140,An,0,1
24141,initial,0,0
24142,rise,0,0
24143,in,0,0
24144,circulating,0,0
24145,cells,0,0
24146,after,0,0
24147,the,0,0
24148,first,0,0
24149,cycle,0,0
24150,was,0,0
24151,followed,0,0
24152,by,0,0
24153,a,0,0
24154,fall,0,0
24155,in,0,0
24156,both,0,0
24157,treatment,0,0
24158,arms,0,0
24159,to,0,0
24160,baseline,0,0
24161,levels,0,0
24162,set,0,0
24163,by,0,0
24164,normal,0,0
24165,controls,0,0
24166,.,0,0
24167,This,0,0
24168,was,0,0
24169,achieved,0,0
24170,by,0,0
24171,week,0,0
24172,12,0,0
24173,in,0,0
24174,the,0,0
24175,accelerated,0,0
24176,treatment,0,0
24177,arm,0,0
24178,and,0,0
24179,by,0,0
24180,week,0,0
24181,24,0,0
24182,in,0,0
24183,the,0,0
24184,standard,0,0
24185,arm,0,0
24186,.,0,0
24187,CONCLUSIONS,0,0
24188,Flow,0,0
24189,cytometry,0,0
24190,and,0,0
24191,magnetic,0,0
24192,bead,0,0
24193,isolation,0,0
24194,can,0,0
24195,be,0,0
24196,used,0,0
24197,to,0,0
24198,identify,0,0
24199,changes,0,0
24200,in,0,0
24201,numbers,0,0
24202,of,0,0
24203,circulating,0,0
24204,tumour,0,0
24205,cells,0,0
24206,in,0,0
24207,patients,0,0
24208,undergoing,0,0
24209,chemotherapy,1,0
24210,for,0,0
24211,SCLC,0,0
24212,and,0,0
24213,thereafter,0,0
24214,during,0,0
24215,follow-up,0,0
24216,periods,0,0
24217,.,0,0
24218,Absence,0,0
24219,of,0,0
24220,tumour,0,0
24221,cells,0,0
24222,may,0,0
24223,indicate,0,0
24224,a,0,0
24225,more,0,0
24226,favourable,0,0
24227,patient,0,1
24228,group,0,0
24229,who,0,0
24230,would,0,0
24231,benefit,0,0
24232,from,0,0
24233,a,0,0
24234,more,0,0
24235,intense,0,0
24236,course,0,0
24237,of,0,0
24238,treatment,0,0
24239,.,0,0
24240,A,0,0
24241,scanning,0,0
24242,electron,0,0
24243,microscopic,0,0
24244,study,0,0
24245,of,0,0
24246,different,0,0
24247,caries,0,0
24248,removal,0,0
24249,techniques,0,0
24250,on,0,0
24251,human,0,0
24252,dentin,0,0
24253,.,0,0
24254,Scanning,0,0
24255,electron,0,0
24256,microscopy,0,0
24257,(,0,0
24258,SEM,0,1
24259,),0,0
24260,evaluated,0,0
24261,the,0,0
24262,effect,0,0
24263,of,0,0
24264,different,0,0
24265,caries,0,0
24266,removal,0,0
24267,techniques,0,0
24268,on,0,0
24269,human,0,0
24270,dentin,0,0
24271,topography,0,0
24272,.,0,0
24273,Thirty-six,0,0
24274,extracted,0,0
24275,human,0,0
24276,carious,0,0
24277,mandibular,0,0
24278,molars,0,0
24279,were,0,0
24280,randomly,0,0
24281,assigned,0,0
24282,to,0,0
24283,six,0,0
24284,groups,0,0
24285,according,0,0
24286,to,0,0
24287,caries,0,0
24288,removal,0,0
24289,technique,0,0
24290,.,0,0
24291,Carious,0,0
24292,tissue,0,0
24293,was,0,0
24294,removed,0,0
24295,by,0,0
24296,hand,1,0
24297,excavation,1,0
24298,",",1,0
24299,bur,1,0
24300,excavation,1,1
24301,",",1,1
24302,air-abrasion,1,1
24303,",",1,1
24304,laser,1,1
24305,ablation,1,0
24306,",",1,0
24307,chemomechanical,1,0
24308,methods,1,0
24309,and,1,0
24310,sono-abrasion,1,0
24311,.,1,0
24312,The,0,0
24313,remaining,0,0
24314,dentin,0,0
24315,surfaces,0,0
24316,were,0,0
24317,replicated,1,0
24318,and,1,0
24319,gold-coated,1,0
24320,.,1,0
24321,The,0,0
24322,surfaces,0,0
24323,were,0,0
24324,examined,0,0
24325,using,0,0
24326,SEM,0,0
24327,and,0,0
24328,distinct,0,0
24329,differences,0,0
24330,in,0,0
24331,appearance,0,0
24332,were,0,0
24333,observed,0,0
24334,among,0,0
24335,specimens,0,0
24336,treated,0,0
24337,with,0,0
24338,different,0,0
24339,caries,0,0
24340,removal,0,0
24341,techniques,0,0
24342,.,0,0
24343,While,0,0
24344,hand-excavated,0,0
24345,",",0,0
24346,bur-excavated,0,1
24347,and,0,1
24348,air-abraded,0,1
24349,carious,0,1
24350,dentin,0,0
24351,surfaces,0,0
24352,were,0,0
24353,covered,0,0
24354,with,0,0
24355,a,0,0
24356,residual,0,0
24357,smear,0,0
24358,layer,0,0
24359,",",0,0
24360,sono-abrasion,0,0
24361,with,0,0
24362,patent,0,0
24363,dentinal,0,0
24364,tubules,0,0
24365,completely,0,0
24366,removed,0,0
24367,the,0,0
24368,smear,0,0
24369,layer,0,0
24370,.,0,0
24371,A,0,0
24372,few,0,0
24373,patent,0,0
24374,orifices,0,0
24375,of,0,0
24376,dentinal,0,0
24377,tubules,0,0
24378,were,0,0
24379,observed,0,0
24380,in,0,0
24381,dentin,0,0
24382,subjected,0,0
24383,to,0,0
24384,laser,0,0
24385,ablation,0,0
24386,and,0,0
24387,chemo-mechanical,0,0
24388,caries,0,0
24389,removal,0,0
24390,.,0,0
24391,[,1,0
24392,Limbal,1,0
24393,epithelial,1,0
24394,autograft,1,0
24395,transplantation,1,0
24396,in,0,0
24397,treatment,0,0
24398,of,0,0
24399,pterygium,0,1
24400,],0,0
24401,.,0,0
24402,OBJECTIVE,0,0
24403,To,0,0
24404,observe,0,0
24405,the,0,0
24406,therapeutic,0,0
24407,effects,0,0
24408,of,0,0
24409,limbal,1,0
24410,epithelial,1,0
24411,autograft,1,0
24412,transplantation,1,0
24413,and,0,0
24414,pterygium,1,0
24415,excision,1,0
24416,in,0,0
24417,the,0,0
24418,treatment,0,0
24419,of,0,0
24420,pterygium,0,0
24421,.,0,0
24422,METHODS,0,0
24423,A,0,1
24424,prospective,0,1
24425,randomized,0,1
24426,paired-eye,0,0
24427,trial,0,0
24428,was,0,0
24429,studied,0,0
24430,.,0,0
24431,There,0,0
24432,were,0,0
24433,208,0,0
24434,patients,0,0
24435,(,0,0
24436,229,0,0
24437,eyes,0,0
24438,),0,0
24439,with,0,0
24440,initial,0,0
24441,pterygium,0,0
24442,",",0,0
24443,and,0,0
24444,they,0,0
24445,were,0,0
24446,allocated,0,0
24447,to,0,0
24448,two,0,0
24449,groups,0,0
24450,:,0,0
24451,excision,1,0
24452,of,1,0
24453,pterygium,1,0
24454,with,1,0
24455,limbal,1,0
24456,epithelial,1,0
24457,autograft,1,0
24458,transplantation,1,1
24459,surgery,1,1
24460,(,0,1
24461,A,0,1
24462,group,0,0
24463,",",0,0
24464,106,0,0
24465,cases,0,0
24466,and,0,0
24467,124,0,0
24468,eyes,0,0
24469,),0,0
24470,and,0,0
24471,simple,1,0
24472,pterygium,1,1
24473,excision,1,1
24474,(,0,1
24475,B,0,1
24476,group,0,0
24477,",",0,0
24478,102,0,0
24479,cases,0,0
24480,and,0,0
24481,105,0,0
24482,eyes,0,0
24483,),0,0
24484,.,0,0
24485,The,0,0
24486,criteria,0,0
24487,for,0,0
24488,recovery,0,0
24489,were,0,0
24490,corneal,0,0
24491,transparency,0,0
24492,with,0,0
24493,stable,0,0
24494,epithelial,0,0
24495,healing,0,0
24496,and,0,0
24497,no,0,0
24498,abnormal,0,0
24499,proliferation,0,0
24500,of,0,0
24501,pterygium-like,0,0
24502,tissue,0,0
24503,.,0,0
24504,The,0,0
24505,post-operative,0,0
24506,follow-up,0,0
24507,periods,0,0
24508,ranged,0,0
24509,from,0,0
24510,18,0,0
24511,approximately,0,0
24512,28,0,0
24513,(,0,0
24514,22.4,0,0
24515,+/-,0,0
24516,4.9,0,0
24517,),0,0
24518,months,0,0
24519,.,0,0
24520,RESULTS,0,0
24521,Some,0,0
24522,of,0,0
24523,the,0,0
24524,patients,0,0
24525,lost,0,0
24526,follow-up,0,0
24527,.,0,0
24528,In,0,0
24529,the,0,0
24530,eyes,0,0
24531,followed,0,0
24532,up,0,0
24533,",",0,0
24534,5,0,0
24535,of,0,0
24536,11,0,0
24537,2,0,0
24538,eyes,0,0
24539,(,0,0
24540,4.5,0,0
24541,%,0,0
24542,),0,0
24543,in,0,0
24544,A,0,1
24545,group,0,0
24546,and,0,0
24547,41,0,0
24548,of,0,0
24549,96,0,0
24550,eyes,0,0
24551,(,0,0
24552,42.7,0,0
24553,%,0,0
24554,),0,0
24555,in,0,0
24556,B,0,1
24557,group,0,0
24558,were,0,0
24559,recurred,0,0
24560,",",0,0
24561,the,0,0
24562,difference,0,0
24563,being,0,0
24564,very,0,0
24565,significant,0,0
24566,(,0,0
24567,P,0,0
24568,<,0,0
24569,0.001,0,0
24570,),0,0
24571,.,0,0
24572,CONCLUSION,0,0
24573,To,0,0
24574,provide,0,0
24575,a,0,0
24576,new,0,0
24577,stem,0,0
24578,cell,0,0
24579,source,0,0
24580,",",0,0
24581,limbal,1,0
24582,epithelial,1,0
24583,autograft,1,0
24584,transplantation,1,0
24585,",",0,0
24586,for,0,0
24587,an,0,0
24588,injured,0,0
24589,limb,0,0
24590,us,0,0
24591,is,0,0
24592,a,0,0
24593,reasonable,0,0
24594,therapeutic,0,0
24595,method,0,0
24596,for,0,0
24597,the,0,0
24598,treatment,0,0
24599,of,0,0
24600,pterygium,0,0
24601,.,0,0
24602,Effect,0,0
24603,of,0,0
24604,clinical,1,0
24605,pharmacy,1,0
24606,services,1,0
24607,on,0,0
24608,the,0,0
24609,blood,0,0
24610,pressure,0,0
24611,of,0,0
24612,African-American,0,1
24613,renal,0,0
24614,transplant,0,0
24615,patients,0,0
24616,.,0,0
24617,OBJECTIVE,0,0
24618,The,0,0
24619,objective,0,0
24620,of,0,0
24621,this,0,0
24622,study,0,0
24623,was,0,0
24624,to,0,0
24625,determine,0,0
24626,if,0,0
24627,African-American,0,0
24628,renal,0,0
24629,transplant,0,0
24630,patients,0,0
24631,who,0,0
24632,received,0,0
24633,direct,0,0
24634,patient,0,0
24635,care,0,0
24636,from,0,0
24637,a,0,0
24638,clinical,1,0
24639,pharmacist,1,0
24640,had,0,0
24641,better,0,0
24642,blood,0,0
24643,pressure,0,0
24644,control,0,0
24645,compared,0,0
24646,to,0,0
24647,African-American,0,0
24648,renal,0,0
24649,transplant,0,0
24650,patients,0,0
24651,who,0,0
24652,did,0,0
24653,not,0,0
24654,have,0,0
24655,clinical,0,0
24656,pharmacy,0,0
24657,services,0,0
24658,.,0,0
24659,METHODS,0,0
24660,Renal,0,0
24661,transplant,0,0
24662,patients,0,0
24663,were,0,0
24664,prospectively,0,0
24665,randomized,0,0
24666,into,0,0
24667,an,0,0
24668,intervention,0,0
24669,group,0,0
24670,or,0,0
24671,a,0,0
24672,control,0,0
24673,group,0,0
24674,.,0,0
24675,Patients,0,0
24676,in,0,0
24677,the,0,0
24678,intervention,0,0
24679,group,0,0
24680,received,1,0
24681,clinical,1,0
24682,pharmacy,1,0
24683,services,1,0
24684,that,1,0
24685,included,1,0
24686,a,1,0
24687,clinical,1,0
24688,pharmacist,1,0
24689,performing,1,0
24690,patient,1,0
24691,medication,1,0
24692,reviews,1,0
24693,",",1,0
24694,with,1,0
24695,emphasis,1,0
24696,on,1,0
24697,preventing,1,0
24698,or,1,0
24699,resolving,1,0
24700,medication-related,1,0
24701,problems,1,0
24702,and,1,0
24703,providing,1,0
24704,medication,1,0
24705,recommendations,1,0
24706,.,1,0
24707,Patients,0,0
24708,in,0,0
24709,the,0,0
24710,control,0,0
24711,group,0,0
24712,received,1,0
24713,routine,1,0
24714,clinic,1,0
24715,services,1,0
24716,",",1,0
24717,but,1,0
24718,had,1,0
24719,no,1,0
24720,clinical,1,0
24721,pharmacist,1,0
24722,interaction,1,0
24723,.,1,0
24724,Analysis,0,0
24725,was,0,0
24726,performed,0,0
24727,to,0,0
24728,detect,0,0
24729,differences,0,0
24730,between,0,0
24731,the,0,0
24732,intervention,0,0
24733,and,0,0
24734,control,0,0
24735,groups,0,0
24736,in,0,0
24737,baseline,0,0
24738,and,0,0
24739,quarterly,0,0
24740,systolic,0,1
24741,blood,0,1
24742,pressure,0,1
24743,(,0,1
24744,SBP,0,1
24745,),0,1
24746,and,0,0
24747,diastolic,0,1
24748,blood,0,1
24749,pressure,0,1
24750,(,0,1
24751,DBP,0,1
24752,),0,0
24753,for,0,0
24754,one,0,0
24755,year,0,0
24756,post-study,0,0
24757,enrollment,0,0
24758,.,0,0
24759,RESULTS,0,0
24760,There,0,0
24761,were,0,0
24762,no,0,0
24763,differences,0,0
24764,between,0,0
24765,the,0,0
24766,intervention,0,0
24767,(,0,0
24768,N,0,0
24769,=,0,0
24770,13,0,0
24771,),0,0
24772,and,0,0
24773,control,0,0
24774,(,0,0
24775,N,0,0
24776,=,0,0
24777,10,0,0
24778,),0,0
24779,groups,0,0
24780,in,0,0
24781,baseline,0,0
24782,blood,0,0
24783,pressures,0,0
24784,or,0,0
24785,in,0,0
24786,the,0,0
24787,percentage,0,0
24788,of,0,0
24789,hypertensive,0,0
24790,patients,0,0
24791,.,0,0
24792,Significant,0,0
24793,differences,0,0
24794,in,0,0
24795,the,0,0
24796,change,0,0
24797,in,0,0
24798,SBP,0,0
24799,and,0,0
24800,DBP,0,0
24801,from,0,0
24802,baseline,0,0
24803,between,0,0
24804,the,0,0
24805,intervention,0,0
24806,and,0,0
24807,control,0,0
24808,groups,0,0
24809,were,0,0
24810,observed,0,0
24811,at,0,0
24812,the,0,0
24813,second,0,0
24814,",",0,0
24815,third,0,0
24816,",",0,0
24817,and,0,0
24818,fourth,0,0
24819,quarters,0,0
24820,of,0,0
24821,the,0,0
24822,study,0,0
24823,",",0,0
24824,favoring,0,0
24825,the,0,0
24826,intervention,0,1
24827,group,0,0
24828,(,0,0
24829,P,0,0
24830,<,0,0
24831,.01,0,0
24832,),0,0
24833,.,0,0
24834,Mean,0,0
24835,SBP,0,0
24836,was,0,0
24837,significantly,0,0
24838,lower,0,0
24839,in,0,0
24840,the,0,0
24841,intervention,0,0
24842,group,0,0
24843,at,0,0
24844,the,0,0
24845,second,0,0
24846,(,0,0
24847,137.8,0,0
24848,+/-,0,0
24849,15.0,0,0
24850,vs,0,0
24851,168.9,0,0
24852,+/-,0,0
24853,15.3,0,0
24854,),0,0
24855,",",0,0
24856,third,0,0
24857,(,0,0
24858,135.9,0,0
24859,+/-,0,0
24860,11.7,0,0
24861,vs,0,0
24862,164.6,0,0
24863,+/-,0,0
24864,20.1,0,0
24865,),0,0
24866,",",0,0
24867,and,0,0
24868,fourth,0,0
24869,(,0,0
24870,145.3,0,0
24871,+/-,0,0
24872,16.8,0,0
24873,vs,0,0
24874,175.8,0,0
24875,+/-,0,0
24876,33.9,0,0
24877,),0,0
24878,quarters,0,0
24879,of,0,0
24880,the,0,0
24881,study,0,0
24882,(,0,0
24883,P,0,0
24884,<,0,0
24885,.05,0,0
24886,),0,0
24887,.,0,0
24888,Mean,0,0
24889,DBP,0,0
24890,was,0,0
24891,significantly,0,0
24892,lower,0,0
24893,in,0,0
24894,the,0,0
24895,intervention,0,0
24896,group,0,0
24897,at,0,0
24898,the,0,0
24899,second,0,0
24900,(,0,0
24901,76.0,0,0
24902,+/-,0,0
24903,11.8,0,0
24904,vs,0,0
24905,84.9,0,0
24906,+/-,0,0
24907,6.1,0,0
24908,),0,0
24909,and,0,0
24910,fourth,0,0
24911,(,0,0
24912,77.0,0,0
24913,+/-,0,0
24914,10.2,0,0
24915,vs,0,0
24916,91.8,0,0
24917,+/-,0,0
24918,12.0,0,0
24919,),0,0
24920,quarters,0,0
24921,(,0,0
24922,P,0,0
24923,<,0,0
24924,.05,0,0
24925,),0,0
24926,.,0,0
24927,CONCLUSION,0,0
24928,Direct,0,0
24929,patient,0,0
24930,care,0,0
24931,services,0,0
24932,provided,0,0
24933,by,0,0
24934,a,0,0
24935,clinical,0,0
24936,pharmacist,0,0
24937,",",0,0
24938,in,0,0
24939,addition,0,0
24940,to,0,0
24941,routine,0,0
24942,clinical,0,0
24943,services,0,0
24944,",",0,0
24945,have,0,0
24946,a,0,0
24947,positive,0,0
24948,effect,0,0
24949,on,0,0
24950,the,0,0
24951,blood,0,0
24952,pressure,0,0
24953,of,0,0
24954,African-American,0,1
24955,renal,0,0
24956,transplant,0,0
24957,patients,0,0
24958,.,0,0
24959,A,0,0
24960,multidisciplinary,0,0
24961,team,0,0
24962,that,0,0
24963,includes,0,0
24964,a,0,0
24965,clinical,0,0
24966,pharmacist,0,0
24967,is,0,0
24968,beneficial,0,0
24969,to,0,0
24970,patient,0,0
24971,care,0,0
24972,.,0,0
24973,A,0,1
24974,randomised,0,0
24975,",",0,0
24976,controlled,0,0
24977,study,0,0
24978,of,0,0
24979,dietary,1,1
24980,intervention,1,1
24981,in,0,0
24982,autistic,0,0
24983,syndromes,0,0
24984,.,0,0
24985,Impaired,0,0
24986,social,0,0
24987,interaction,0,0
24988,",",0,0
24989,communication,0,0
24990,and,0,0
24991,imaginative,0,0
24992,skills,0,0
24993,characterize,0,0
24994,autistic,0,0
24995,syndromes,0,0
24996,.,0,0
24997,In,0,0
24998,these,0,0
24999,syndromes,0,0
25000,urinary,0,0
25001,peptide,0,0
25002,abnormalities,0,0
25003,",",0,0
25004,derived,0,0
25005,from,0,0
25006,gluten,0,1
25007,",",0,1
25008,gliadin,0,1
25009,",",0,1
25010,and,0,1
25011,casein,0,1
25012,",",0,0
25013,are,0,0
25014,reported,0,0
25015,.,0,0
25016,They,0,0
25017,reflect,0,0
25018,processes,0,0
25019,with,0,0
25020,opioid,0,1
25021,effect,0,0
25022,.,0,0
25023,The,0,0
25024,aim,0,0
25025,of,0,0
25026,this,0,0
25027,single,0,0
25028,blind,0,0
25029,study,0,0
25030,was,0,0
25031,to,0,0
25032,evaluate,0,0
25033,effect,0,0
25034,of,0,0
25035,gluten,1,1
25036,and,1,1
25037,casein-free,1,1
25038,diet,1,1
25039,for,0,1
25040,children,0,0
25041,with,0,0
25042,autistic,0,0
25043,syndromes,0,0
25044,and,0,0
25045,urinary,0,0
25046,peptide,0,0
25047,abnormalities,0,0
25048,.,0,0
25049,A,0,0
25050,randomly,0,0
25051,selected,0,0
25052,diet,0,1
25053,and,0,0
25054,control,0,0
25055,group,0,0
25056,with,0,0
25057,10,0,0
25058,children,0,0
25059,in,0,0
25060,each,0,0
25061,group,0,0
25062,participated,0,0
25063,.,0,0
25064,Observations,0,0
25065,and,0,0
25066,tests,0,0
25067,were,0,0
25068,done,0,0
25069,before,0,0
25070,and,0,0
25071,after,0,0
25072,a,0,0
25073,period,0,0
25074,of,0,0
25075,1,0,0
25076,year,0,0
25077,.,0,0
25078,The,0,0
25079,development,0,0
25080,for,0,0
25081,the,0,0
25082,group,0,0
25083,of,0,0
25084,children,0,1
25085,on,0,0
25086,diet,0,1
25087,was,0,0
25088,significantly,0,0
25089,better,0,0
25090,than,0,0
25091,for,0,0
25092,the,0,0
25093,controls,1,0
25094,.,1,0
25095,Effect,0,0
25096,of,0,0
25097,macronutrient,1,1
25098,composition,0,0
25099,of,0,0
25100,the,0,0
25101,diet,0,1
25102,on,0,0
25103,the,0,0
25104,regulation,0,0
25105,of,0,0
25106,lipolysis,0,1
25107,in,0,0
25108,adipose,0,0
25109,tissue,0,0
25110,at,0,0
25111,rest,0,0
25112,and,0,0
25113,during,0,0
25114,exercise,0,0
25115,:,0,0
25116,microdialysis,0,1
25117,study,0,0
25118,.,0,0
25119,The,0,0
25120,aim,0,0
25121,of,0,0
25122,the,0,0
25123,present,0,0
25124,study,0,0
25125,was,0,0
25126,to,0,0
25127,elucidate,0,0
25128,",",0,0
25129,using,0,0
25130,a,0,0
25131,microdialysis,0,1
25132,technique,0,1
25133,",",0,0
25134,whether,0,0
25135,modifications,0,0
25136,in,0,0
25137,the,0,0
25138,proportion,0,0
25139,of,0,0
25140,fat,1,0
25141,in,1,0
25142,the,1,0
25143,diet,1,1
25144,influence,0,0
25145,lipid,0,0
25146,mobilization,0,0
25147,from,0,0
25148,adipose,0,0
25149,tissue,0,0
25150,in,0,0
25151,situ,0,0
25152,.,0,0
25153,Nine,0,1
25154,healthy,0,0
25155,volunteers,0,0
25156,(,0,0
25157,age,0,0
25158,",",0,0
25159,23.4,0,0
25160,+/-,0,0
25161,0.2,0,0
25162,years,0,0
25163,;,0,0
25164,body,0,0
25165,mas,0,0
25166,index,0,1
25167,[,0,1
25168,BMI,0,1
25169,],0,0
25170,",",0,0
25171,23.5,0,0
25172,+/-,0,0
25173,1.6,0,0
25174,kg/m,0,0
25175,(,0,0
25176,2,0,0
25177,),0,1
25178,),0,0
25179,were,0,0
25180,fed,0,0
25181,",",0,0
25182,in,0,0
25183,random,0,0
25184,order,0,0
25185,",",0,0
25186,with,0,0
25187,a,0,0
25188,high-fat,1,1
25189,diet,1,1
25190,(,1,1
25191,HFD,1,1
25192,),1,1
25193,(,1,0
25194,65,1,0
25195,%,1,0
25196,of,1,0
25197,energy,1,0
25198,content,1,0
25199,fat,1,0
25200,",",1,0
25201,15,1,0
25202,%,1,0
25203,protein,1,0
25204,",",1,0
25205,20,1,0
25206,%,1,0
25207,carbohydrate,1,1
25208,),1,0
25209,or,1,0
25210,a,1,1
25211,high-carbohydrate,1,1
25212,diet,1,1
25213,(,1,1
25214,HCD,1,1
25215,),1,1
25216,(,1,0
25217,70,1,0
25218,%,1,0
25219,carbohydrate,1,0
25220,",",1,0
25221,15,1,0
25222,%,1,0
25223,protein,1,0
25224,",",1,0
25225,15,1,0
25226,%,1,0
25227,fat,1,0
25228,),1,0
25229,for,1,0
25230,5,1,0
25231,days,1,0
25232,",",1,0
25233,with,1,0
25234,a,1,0
25235,washout,1,1
25236,period,1,1
25237,of,1,0
25238,10,1,0
25239,days,1,0
25240,between,1,0
25241,the,1,0
25242,diets,1,1
25243,.,1,0
25244,Subjects,0,0
25245,were,0,0
25246,studied,0,0
25247,in,0,0
25248,the,0,0
25249,fasting,0,1
25250,state,0,0
25251,on,0,0
25252,the,0,0
25253,morning,0,0
25254,following,0,0
25255,days,0,0
25256,4,0,0
25257,and,0,0
25258,5,0,0
25259,of,0,0
25260,each,0,0
25261,diet,0,1
25262,.,0,0
25263,We,0,0
25264,measured,0,0
25265,the,0,0
25266,concentration,0,0
25267,of,0,0
25268,extracellular,0,0
25269,glycerol,0,1
25270,(,0,1
25271,EGC,0,1
25272,),0,1
25273,in,0,0
25274,adipose,0,0
25275,tissue,0,0
25276,in,0,0
25277,response,0,0
25278,to,0,0
25279,(,0,0
25280,1,0,1
25281,),0,0
25282,pharmacologic,0,1
25283,stimulation,0,0
25284,with,0,1
25285,isoprenaline,1,1
25286,(,0,1
25287,1,0,1
25288,and,0,0
25289,10,0,1
25290,micromol/L,0,1
25291,),0,1
25292,in,0,0
25293,situ,0,0
25294,",",0,0
25295,(,0,1
25296,2,0,1
25297,),0,0
25298,stimulation,0,0
25299,with,0,1
25300,intravenous,0,1
25301,infusion,0,1
25302,of,0,1
25303,epinephrine,1,1
25304,(,0,1
25305,0.0375,0,1
25306,microg/min/kg,0,1
25307,body,0,1
25308,weight,0,1
25309,),0,0
25310,",",0,0
25311,and,0,1
25312,(,0,1
25313,3,0,1
25314,),0,1
25315,submaximal,0,1
25316,aerobic,1,1
25317,exercise,1,1
25318,(,0,0
25319,50,0,0
25320,%,0,0
25321,V*O2max,0,0
25322,",",0,0
25323,60-minute,0,1
25324,duration,0,1
25325,),0,1
25326,.,0,0
25327,No,0,1
25328,effect,0,0
25329,of,0,0
25330,the,0,0
25331,diet,0,1
25332,composition,0,0
25333,was,0,0
25334,found,0,0
25335,in,0,0
25336,the,0,0
25337,increases,0,0
25338,of,0,0
25339,EGC,0,0
25340,in,0,0
25341,response,0,0
25342,to,0,0
25343,isoprenaline,0,1
25344,(,0,1
25345,area,0,0
25346,under,0,0
25347,the,0,0
25348,curve,0,1
25349,[,0,1
25350,AUC,0,1
25351,],0,1
25352,:,0,0
25353,HFD,0,0
25354,",",0,0
25355,"1,534",0,0
25356,+/-,0,0
25357,370,0,0
25358,micromol/90,0,0
25359,min,0,0
25360,;,0,1
25361,HCD,0,0
25362,",",0,0
25363,"1,108",0,0
25364,+/-,0,0
25365,465,0,0
25366,micromol/90,0,0
25367,min,0,0
25368,;,0,0
25369,not,0,0
25370,significant,0,0
25371,[,0,0
25372,NS,0,1
25373,],0,1
25374,),0,1
25375,or,0,1
25376,epinephrine,0,1
25377,stimulations,0,1
25378,(,0,1
25379,AUC,0,1
25380,:,0,0
25381,HFD,0,0
25382,",",0,0
25383,190,0,0
25384,+/-,0,0
25385,92,0,0
25386,micromol/30,0,0
25387,min,0,0
25388,;,0,0
25389,HCD,0,0
25390,",",0,0
25391,251,0,0
25392,+/-,0,0
25393,298,0,0
25394,micromol/30,0,0
25395,min,0,0
25396,;,0,1
25397,NS,0,1
25398,),0,1
25399,.,0,0
25400,The,0,0
25401,exercise-induced,0,0
25402,increase,0,0
25403,in,0,0
25404,EGC,0,0
25405,was,0,0
25406,higher,0,0
25407,during,0,0
25408,the,0,0
25409,HFD,0,1
25410,(,0,0
25411,AUC,0,1
25412,:,0,0
25413,HFD,0,0
25414,",",0,0
25415,"1,641",0,0
25416,+/-,0,0
25417,181,0,0
25418,micromol/60,0,0
25419,min,0,0
25420,;,0,0
25421,HCD,0,0
25422,",",0,0
25423,963,0,0
25424,+/-,0,0
25425,156,0,0
25426,micromol/60,0,0
25427,min,0,0
25428,;,0,0
25429,P,0,0
25430,<,0,0
25431,.05,0,0
25432,),0,0
25433,and,0,0
25434,was,0,0
25435,associated,0,0
25436,with,0,0
25437,a,0,0
25438,higher,0,0
25439,exercise-induced,0,0
25440,response,0,0
25441,of,0,0
25442,norepinephrine,0,1
25443,(,0,0
25444,P,0,0
25445,<,0,0
25446,.05,0,0
25447,),0,0
25448,and,0,0
25449,epinephrine,0,1
25450,(,0,0
25451,P,0,0
25452,=.056,0,0
25453,),0,0
25454,and,0,0
25455,lower,0,0
25456,insulinemia,0,1
25457,during,0,0
25458,exercise,0,0
25459,.,0,0
25460,The,0,0
25461,results,0,0
25462,suggest,0,0
25463,that,0,0
25464,macronutrient,0,1
25465,composition,0,0
25466,of,0,0
25467,diet,0,1
25468,does,0,0
25469,not,0,0
25470,affect,0,0
25471,the,0,0
25472,beta-adrenergic,0,1
25473,responsiveness,0,0
25474,of,0,0
25475,adipose,0,0
25476,tissue,0,0
25477,to,0,0
25478,catecholamine,0,1
25479,action,0,0
25480,at,0,0
25481,rest,0,0
25482,.,0,0
25483,During,0,0
25484,exercise,0,0
25485,",",0,0
25486,the,0,0
25487,HFD,1,0
25488,promotes,0,0
25489,higher,0,0
25490,lipolysis,0,1
25491,in,0,0
25492,adipose,0,0
25493,tissue,0,0
25494,and,0,0
25495,this,0,0
25496,is,0,0
25497,associated,0,0
25498,with,0,0
25499,a,0,0
25500,higher,0,0
25501,catecholamine,0,1
25502,response,0,0
25503,and,0,0
25504,lower,0,0
25505,insulinemia,0,1
25506,.,0,0
25507,Randomized,0,0
25508,trial,0,0
25509,of,0,0
25510,adoptive,0,0
25511,transfer,0,0
25512,of,0,0
25513,melanoma,0,0
25514,tumor-infiltrating,1,0
25515,lymphocytes,1,0
25516,as,0,0
25517,adjuvant,0,1
25518,therapy,0,1
25519,for,0,0
25520,stage,0,0
25521,III,0,0
25522,melanoma,0,0
25523,.,0,0
25524,The,0,0
25525,aim,0,0
25526,of,0,0
25527,this,0,0
25528,study,0,0
25529,was,0,0
25530,to,0,0
25531,demonstrate,0,0
25532,the,0,0
25533,interest,0,0
25534,of,0,0
25535,using,0,0
25536,tumor-infiltrating,1,0
25537,lymphocytes,1,1
25538,(,1,1
25539,TIL,1,1
25540,),1,1
25541,as,0,0
25542,adjuvant,0,1
25543,therapy,0,1
25544,for,0,0
25545,stage,0,0
25546,III,0,1
25547,(,0,0
25548,regional,0,0
25549,lymph,0,1
25550,nodes,0,1
25551,),0,0
25552,melanoma,0,0
25553,.,0,0
25554,After,0,0
25555,lymph,0,0
25556,node,0,0
25557,excision,0,0
25558,",",0,0
25559,patients,0,0
25560,without,0,0
25561,any,0,0
25562,detectable,0,0
25563,metastases,0,0
25564,were,0,0
25565,randomly,0,0
25566,assigned,0,0
25567,to,0,0
25568,receive,0,0
25569,either,0,0
25570,TIL,1,0
25571,plus,1,1
25572,interleukin-2,1,1
25573,(,1,1
25574,IL-2,1,1
25575,),1,1
25576,for,0,0
25577,2,0,0
25578,months,0,0
25579,",",0,0
25580,or,0,0
25581,IL-2,1,0
25582,only,1,0
25583,.,1,0
25584,The,0,0
25585,primary,0,0
25586,endpoint,0,0
25587,was,0,0
25588,determination,0,0
25589,of,0,0
25590,the,0,0
25591,duration,0,0
25592,of,0,0
25593,the,0,0
25594,relapse-free,0,0
25595,interval,0,0
25596,.,0,0
25597,Eighty-eight,0,0
25598,patients,0,0
25599,determined,0,0
25600,as,0,0
25601,eligible,0,0
25602,for,0,0
25603,treatment,0,0
25604,were,0,0
25605,enrolled,0,0
25606,in,0,0
25607,the,0,0
25608,study,0,0
25609,.,0,0
25610,After,0,0
25611,a,0,0
25612,median,0,0
25613,follow-up,0,0
25614,of,0,0
25615,46.9,0,0
25616,months,0,0
25617,",",0,0
25618,for,0,0
25619,the,0,0
25620,study,0,0
25621,population,0,0
25622,the,0,0
25623,analysis,0,0
25624,did,0,0
25625,not,0,0
25626,show,0,0
25627,a,0,0
25628,significant,0,0
25629,extension,0,0
25630,of,0,0
25631,the,0,0
25632,relapse-free,0,0
25633,interval,0,0
25634,or,0,0
25635,overall,0,0
25636,survival,0,0
25637,.,0,0
25638,However,0,0
25639,",",0,0
25640,a,0,0
25641,significant,0,0
25642,interaction,0,0
25643,(,0,0
25644,P,0,0
25645,<,0,0
25646,0.001,0,0
25647,),0,0
25648,was,0,0
25649,found,0,0
25650,between,0,0
25651,the,0,0
25652,treatment,0,0
25653,and,0,0
25654,the,0,0
25655,number,0,0
25656,of,0,0
25657,invaded,0,0
25658,lymph,0,0
25659,nodes,0,0
25660,.,0,0
25661,In,0,0
25662,the,0,0
25663,group,0,0
25664,with,0,0
25665,only,0,0
25666,one,0,0
25667,invaded,0,0
25668,lymph,0,0
25669,node,0,0
25670,",",0,0
25671,the,0,0
25672,estimated,0,0
25673,relapse,0,0
25674,rate,0,0
25675,was,0,0
25676,significantly,0,0
25677,lower,0,0
25678,(,0,0
25679,P,0,0
25680,(,0,0
25681,adjusted,0,0
25682,),0,0
25683,=0.0285,0,0
25684,),0,0
25685,and,0,0
25686,the,0,0
25687,overall,0,0
25688,survival,0,0
25689,was,0,0
25690,increased,0,0
25691,(,0,0
25692,P,0,0
25693,(,0,0
25694,adjusted,0,0
25695,),0,0
25696,=0.039,0,0
25697,),0,0
25698,in,0,0
25699,the,0,0
25700,TIL+IL-2,1,0
25701,arm,0,0
25702,compared,0,0
25703,with,0,0
25704,the,0,0
25705,IL-2,1,0
25706,only,0,0
25707,arm,0,0
25708,.,0,0
25709,No,0,0
25710,differences,0,0
25711,between,0,0
25712,the,0,0
25713,two,0,0
25714,arms,0,0
25715,",",0,0
25716,either,0,0
25717,as,0,0
25718,regards,0,0
25719,the,0,0
25720,duration,0,0
25721,of,0,0
25722,disease-free,0,0
25723,survival,0,0
25724,or,0,0
25725,overall,0,0
25726,survival,0,0
25727,",",0,0
25728,were,0,0
25729,noted,0,0
25730,in,0,0
25731,the,0,0
25732,group,0,0
25733,with,0,0
25734,more,0,0
25735,than,0,0
25736,one,0,0
25737,invaded,0,0
25738,lymph,0,0
25739,node,0,0
25740,whatever,0,0
25741,the,0,0
25742,number,0,0
25743,of,0,0
25744,invaded,0,0
25745,lymph,0,0
25746,nodes,0,0
25747,.,0,0
25748,Treatment,0,0
25749,was,0,0
25750,compatible,0,0
25751,with,0,0
25752,normal,0,0
25753,daily,0,1
25754,activity,0,0
25755,.,0,0
25756,This,0,0
25757,study,0,0
25758,demonstrates,0,0
25759,for,0,0
25760,the,0,0
25761,first,0,0
25762,time,0,0
25763,that,0,0
25764,the,0,0
25765,efficiency,0,0
25766,of,0,0
25767,TIL,1,0
25768,in,0,0
25769,stage,0,0
25770,III,0,1
25771,melanoma,0,1
25772,(,0,1
25773,AJCC,0,1
25774,),0,1
25775,is,0,0
25776,directly,0,0
25777,related,0,0
25778,to,0,0
25779,the,0,0
25780,number,0,0
25781,of,0,0
25782,invaded,0,0
25783,lymph,0,0
25784,nodes,0,0
25785,",",0,0
25786,indicating,0,0
25787,that,0,0
25788,tumor,0,0
25789,burden,0,0
25790,might,0,0
25791,be,0,0
25792,a,0,0
25793,crucial,0,0
25794,factor,0,0
25795,in,0,0
25796,the,0,0
25797,efficacy,0,0
25798,and/or,0,0
25799,in,0,0
25800,vitro,0,0
25801,expansion,0,0
25802,of,0,0
25803,T,0,0
25804,cells,0,0
25805,specific,0,0
25806,for,0,0
25807,autologous,0,0
25808,tumor,0,0
25809,antigen,0,0
25810,",",0,0
25811,a,0,0
25812,finding,0,0
25813,which,0,0
25814,could,0,0
25815,be,0,0
25816,of,0,0
25817,value,0,0
25818,in,0,0
25819,future,0,1
25820,vaccine,0,1
25821,development,0,0
25822,for,0,0
25823,the,0,0
25824,treatment,0,0
25825,of,0,0
25826,melanoma,0,0
25827,.,0,0
25828,Adherence,0,0
25829,to,0,0
25830,moderate-intensity,1,0
25831,exercise,1,0
25832,during,0,0
25833,breast,1,0
25834,cancer,1,0
25835,therapy,1,0
25836,.,1,0
25837,PURPOSE,0,0
25838,The,0,0
25839,aims,0,0
25840,of,0,0
25841,this,0,0
25842,pilot,0,0
25843,study,0,0
25844,were,0,0
25845,the,0,0
25846,following,0,0
25847,:,0,0
25848,1,0,0
25849,),0,0
25850,to,0,0
25851,examine,0,0
25852,patterns,0,0
25853,of,0,0
25854,adherence,0,0
25855,to,0,0
25856,a,0,0
25857,brisk,1,0
25858,walking,1,0
25859,program,1,0
25860,in,0,0
25861,women,0,0
25862,receiving,0,0
25863,adjuvant,1,1
25864,chemotherapy,1,1
25865,or,1,0
25866,radiation,1,0
25867,therapy,1,0
25868,for,0,0
25869,newly,0,0
25870,diagnosed,0,0
25871,breast,0,0
25872,cancer,0,0
25873,using,0,0
25874,a,0,0
25875,prospective,0,0
25876,",",0,0
25877,randomized,0,0
25878,",",0,0
25879,controlled,0,0
25880,experimental,0,0
25881,design,0,1
25882,;,0,1
25883,2,0,1
25884,),0,0
25885,to,0,0
25886,examine,0,0
25887,the,0,0
25888,influence,0,0
25889,of,0,0
25890,disease,0,0
25891,symptoms,0,0
25892,and,0,0
25893,treatment,0,0
25894,side,0,0
25895,effects,0,0
25896,on,0,0
25897,exercise,1,0
25898,levels,0,0
25899,;,0,0
25900,and,0,0
25901,3,0,1
25902,),0,0
25903,to,0,0
25904,suggest,0,0
25905,methods,0,0
25906,that,0,0
25907,may,0,0
25908,improve,0,0
25909,future,0,0
25910,clinical,0,0
25911,trials,0,0
25912,of,0,0
25913,moderate-intensity,0,0
25914,exercise,0,0
25915,in,0,0
25916,similar,0,0
25917,populations,0,0
25918,.,0,0
25919,DESCRIPTION,0,0
25920,OF,0,0
25921,STUDY,0,0
25922,Fifty-two,0,0
25923,patients,0,0
25924,with,0,0
25925,newly,0,0
25926,diagnosed,0,0
25927,breast,0,0
25928,cancer,0,0
25929,were,0,0
25930,randomly,0,0
25931,assigned,0,0
25932,to,0,0
25933,one,0,0
25934,of,0,0
25935,two,0,0
25936,treatment,0,0
25937,arms,0,0
25938,:,0,0
25939,usual,1,0
25940,care,1,0
25941,or,0,0
25942,usual,1,0
25943,care,1,0
25944,plus,1,0
25945,exercise,1,0
25946,.,1,0
25947,Those,0,0
25948,assigned,0,0
25949,to,0,0
25950,the,0,0
25951,exercise,1,0
25952,group,0,0
25953,received,0,0
25954,a,0,0
25955,standardized,1,0
25956,",",1,0
25957,self-administered,1,0
25958,",",1,0
25959,home-based,1,0
25960,brisk,1,1
25961,walking,1,0
25962,intervention,1,0
25963,in,0,0
25964,addition,0,0
25965,to,0,0
25966,usual,0,0
25967,care,0,0
25968,.,0,0
25969,Each,0,0
25970,day,0,0
25971,subjects,0,0
25972,completed,0,1
25973,self-report,0,0
25974,diary,0,0
25975,forms,0,0
25976,that,0,0
25977,elicited,0,0
25978,information,0,0
25979,about,0,0
25980,activity,0,0
25981,levels,0,0
25982,",",0,0
25983,and,0,0
25984,the,0,0
25985,occurrence,0,0
25986,of,0,0
25987,symptoms,0,0
25988,and,0,0
25989,side,0,0
25990,effects,0,0
25991,during,0,0
25992,cancer,0,0
25993,treatment,0,0
25994,.,0,0
25995,RESULTS,0,0
25996,Analyses,0,0
25997,of,0,0
25998,self-reported,0,1
25999,daily,0,1
26000,activity,0,0
26001,levels,0,0
26002,revealed,0,0
26003,a,0,0
26004,diffusion,0,0
26005,of,0,0
26006,treatment,0,0
26007,effect,0,0
26008,.,0,0
26009,Fifty,0,0
26010,percent,0,0
26011,of,0,0
26012,the,0,0
26013,usual-care,0,0
26014,group,0,0
26015,reported,0,0
26016,maintaining,0,0
26017,or,0,0
26018,increasing,0,0
26019,their,0,0
26020,physical,0,0
26021,activity,0,0
26022,to,0,0
26023,a,0,0
26024,moderate-intensity,0,0
26025,level,0,0
26026,",",0,0
26027,while,0,0
26028,33,0,0
26029,%,0,0
26030,of,0,0
26031,the,0,0
26032,exercise,0,0
26033,group,0,0
26034,did,0,0
26035,not,0,0
26036,exercise,0,0
26037,at,0,0
26038,the,0,0
26039,prescribed,0,0
26040,levels,0,0
26041,.,0,0
26042,Analyses,0,0
26043,of,0,0
26044,self-reported,0,0
26045,disease,0,0
26046,symptoms,0,0
26047,and,0,0
26048,treatment,0,0
26049,side,0,0
26050,effects,0,0
26051,did,0,0
26052,not,0,0
26053,reveal,0,0
26054,clinically,0,0
26055,meaningful,0,0
26056,differences,0,0
26057,between,0,0
26058,the,0,0
26059,two,0,0
26060,groups,0,0
26061,.,0,0
26062,CLINICAL,0,0
26063,IMPLICATIONS,0,0
26064,The,0,0
26065,results,0,0
26066,of,0,0
26067,this,0,0
26068,study,0,0
26069,suggest,0,0
26070,that,0,0
26071,women,0,0
26072,who,0,0
26073,exercised,0,0
26074,regularly,0,0
26075,before,0,0
26076,receiving,0,0
26077,a,0,0
26078,breast,0,0
26079,cancer,0,0
26080,diagnosis,0,0
26081,attempted,0,0
26082,to,0,0
26083,maintain,0,0
26084,their,0,0
26085,exercise,1,0
26086,programs,1,0
26087,.,1,0
26088,Women,0,0
26089,who,0,0
26090,lead,0,0
26091,sedentary,0,0
26092,lifestyles,0,0
26093,may,0,0
26094,benefit,0,0
26095,from,0,0
26096,a,0,0
26097,structured,1,0
26098,exercise,1,0
26099,program,1,0
26100,that,0,0
26101,includes,0,0
26102,information,0,0
26103,and,0,0
26104,support,0,0
26105,related,0,0
26106,to,0,0
26107,exercise,0,0
26108,adherence,0,0
26109,strategies,0,0
26110,.,0,0
26111,A,0,0
26112,comparison,0,0
26113,of,0,0
26114,the,0,0
26115,upper,1,0
26116,lip,1,0
26117,bite,1,1
26118,test,1,0
26119,(,1,0
26120,a,1,0
26121,simple,1,0
26122,new,1,0
26123,technique,1,0
26124,),1,0
26125,with,1,0
26126,modified,1,0
26127,Mallampati,1,0
26128,classification,1,0
26129,in,0,0
26130,predicting,0,0
26131,difficulty,0,0
26132,in,0,0
26133,endotracheal,0,0
26134,intubation,0,0
26135,:,0,0
26136,a,0,0
26137,prospective,0,0
26138,blinded,0,0
26139,study,0,0
26140,.,0,0
26141,We,0,0
26142,explored,0,0
26143,the,0,0
26144,possibility,0,0
26145,that,0,0
26146,a,0,0
26147,simple,0,0
26148,and,0,0
26149,single,0,0
26150,test,0,0
26151,could,0,0
26152,replace,0,0
26153,the,0,0
26154,modified,0,0
26155,Mallampati,0,0
26156,score,0,0
26157,for,0,0
26158,either,0,0
26159,a,0,0
26160,difficult,0,0
26161,or,0,0
26162,an,0,0
26163,unaccomplished,0,0
26164,tracheal,0,0
26165,intubation,0,0
26166,in,0,0
26167,an,0,0
26168,impending,0,0
26169,hypoxic,0,0
26170,patient,0,0
26171,.,0,0
26172,Three,0,0
26173,hundred,0,0
26174,adult,0,0
26175,patients,0,0
26176,were,0,0
26177,enrolled,0,0
26178,in,0,0
26179,this,0,0
26180,study,0,0
26181,.,0,0
26182,They,0,0
26183,were,0,0
26184,subjected,0,0
26185,to,0,0
26186,the,0,0
26187,following,0,0
26188,assessments,0,0
26189,:,0,0
26190,1,0,0
26191,),0,0
26192,oropharyngeal,1,0
26193,class,1,0
26194,according,1,0
26195,to,1,0
26196,the,1,0
26197,modified,1,0
26198,Mallampati,1,0
26199,criteria,1,1
26200,;,1,1
26201,2,0,1
26202,),0,0
26203,the,1,0
26204,new,1,0
26205,",",1,0
26206,upper,1,0
26207,lip,1,1
26208,bite,1,0
26209,criteria-class,1,0
26210,I,1,0
26211,=,1,0
26212,lower,1,0
26213,incisors,1,0
26214,can,1,0
26215,bite,1,0
26216,the,1,0
26217,upper,1,0
26218,lip,1,0
26219,above,1,0
26220,the,1,0
26221,vermilion,1,0
26222,line,1,0
26223,",",1,0
26224,class,1,0
26225,II,1,0
26226,=,1,0
26227,lower,1,0
26228,incisors,1,0
26229,can,1,0
26230,bite,1,0
26231,the,1,0
26232,upper,1,0
26233,lip,1,0
26234,below,1,0
26235,the,1,0
26236,vermilion,1,0
26237,line,1,0
26238,",",1,0
26239,and,1,0
26240,class,1,0
26241,III,1,0
26242,=,1,0
26243,lower,1,0
26244,incisors,1,0
26245,can,1,0
26246,not,1,0
26247,bite,1,0
26248,the,1,0
26249,upper,1,1
26250,lip,1,1
26251,;,1,1
26252,and,1,0
26253,3,0,1
26254,),0,0
26255,laryngeal,1,0
26256,view,1,0
26257,grading,1,0
26258,according,1,0
26259,to,1,0
26260,Cormack,1,0
26261,'s,1,0
26262,criteria,1,0
26263,.,1,0
26264,The,0,0
26265,incidence,0,0
26266,of,0,0
26267,difficult,0,0
26268,intubation,0,0
26269,was,0,0
26270,5.7,0,0
26271,%,0,0
26272,.,0,0
26273,The,1,0
26274,upper,1,0
26275,lip,1,0
26276,bite,1,0
26277,test,1,0
26278,showed,0,0
26279,significantly,0,0
26280,higher,0,0
26281,specificity,0,0
26282,and,0,0
26283,accuracy,0,0
26284,than,0,0
26285,the,0,0
26286,modified,1,0
26287,Mallampati,1,0
26288,test,1,0
26289,(,0,0
26290,P,0,0
26291,<,0,0
26292,0.001,0,0
26293,),0,0
26294,.,0,0
26295,Comparisons,0,0
26296,of,0,0
26297,sensitivity,0,0
26298,",",0,0
26299,positive,0,0
26300,and,0,0
26301,negative,0,0
26302,predictive,0,0
26303,values,0,0
26304,",",0,0
26305,between,0,0
26306,the,0,0
26307,two,0,0
26308,tests,0,0
26309,",",0,0
26310,however,0,0
26311,",",0,0
26312,did,0,0
26313,not,0,0
26314,reveal,0,0
26315,any,0,0
26316,significant,0,0
26317,differences,0,0
26318,(,0,0
26319,P,0,0
26320,>,0,0
26321,0.05,0,0
26322,),0,0
26323,.,0,0
26324,In,0,0
26325,conclusion,0,0
26326,",",0,0
26327,the,0,0
26328,upper,0,0
26329,lip,0,0
26330,bite,0,0
26331,test,0,0
26332,is,0,0
26333,an,0,0
26334,acceptable,0,0
26335,option,0,0
26336,for,0,0
26337,predicting,0,0
26338,difficult,0,0
26339,intubation,0,0
26340,as,0,0
26341,a,0,0
26342,simple,0,0
26343,",",0,0
26344,single,0,0
26345,test,0,0
26346,.,0,0
26347,A,0,1
26348,pilot,0,0
26349,randomised,0,0
26350,control,0,0
26351,trial,0,0
26352,of,0,0
26353,a,0,0
26354,parent,1,0
26355,training,1,0
26356,intervention,1,0
26357,for,0,0
26358,pre-school,0,0
26359,children,0,0
26360,with,0,0
26361,autism,0,0
26362,.,0,0
26363,Preliminary,0,0
26364,findings,0,0
26365,and,0,0
26366,methodological,0,0
26367,challenges,0,0
26368,.,0,0
26369,Few,0,0
26370,attempts,0,0
26371,have,0,0
26372,been,0,0
26373,made,0,0
26374,to,0,0
26375,conduct,0,0
26376,randomised,0,0
26377,control,0,0
26378,trials,0,0
26379,(,0,1
26380,RCTs,0,1
26381,),0,1
26382,of,0,0
26383,interventions,0,0
26384,for,0,0
26385,pre-school,0,0
26386,children,0,0
26387,with,0,0
26388,autism,0,0
26389,.,0,0
26390,We,0,0
26391,report,0,0
26392,findings,0,0
26393,of,0,0
26394,a,0,0
26395,pilot,0,0
26396,RCT,0,0
26397,for,0,0
26398,a,0,0
26399,parent,1,0
26400,training,1,0
26401,intervention,1,0
26402,with,0,0
26403,a,0,0
26404,focus,0,0
26405,on,0,0
26406,the,0,0
26407,development,0,0
26408,of,0,0
26409,joint,0,0
26410,attention,0,0
26411,skills,0,0
26412,and,0,0
26413,joint,0,0
26414,action,0,0
26415,routines,0,0
26416,.,0,0
26417,Twenty-four,0,0
26418,children,0,0
26419,meeting,0,0
26420,ICD-10,0,1
26421,criteria,0,0
26422,for,0,0
26423,childhood,0,1
26424,autism,0,0
26425,(,0,0
26426,mean,0,0
26427,age,0,0
26428,=,0,0
26429,23,0,0
26430,months,0,0
26431,),0,0
26432,were,0,0
26433,identified,0,0
26434,using,0,0
26435,the,0,0
26436,CHAT,1,0
26437,screen,1,0
26438,and,1,0
26439,randomised,1,0
26440,to,1,0
26441,the,1,0
26442,parent,1,0
26443,training,1,0
26444,group,1,0
26445,or,1,0
26446,to,1,0
26447,local,1,0
26448,services,1,0
26449,only,1,0
26450,.,1,0
26451,A,0,0
26452,follow-up,0,0
26453,was,0,0
26454,conducted,0,0
26455,12,0,0
26456,months,0,0
26457,later,0,0
26458,(,0,0
26459,mean,0,0
26460,age,0,0
26461,=,0,0
26462,35,0,0
26463,months,0,0
26464,),0,0
26465,.,0,0
26466,There,0,0
26467,was,0,0
26468,some,0,0
26469,evidence,0,0
26470,that,0,0
26471,the,0,0
26472,parent,0,0
26473,training,0,0
26474,group,0,0
26475,made,0,0
26476,more,0,0
26477,progress,0,0
26478,in,0,0
26479,language,0,0
26480,development,0,0
26481,than,0,0
26482,the,0,0
26483,local,0,0
26484,services,0,0
26485,group,0,0
26486,.,0,0
26487,However,0,0
26488,",",0,0
26489,the,0,0
26490,present,0,0
26491,pilot,0,0
26492,study,0,0
26493,was,0,0
26494,compromised,0,0
26495,by,0,0
26496,several,0,0
26497,factors,0,0
26498,:,0,0
26499,a,0,0
26500,reliance,0,0
26501,on,0,0
26502,parental,0,0
26503,report,0,0
26504,to,0,0
26505,measure,0,0
26506,language,0,0
26507,",",0,0
26508,non-matching,0,0
26509,of,0,0
26510,the,0,0
26511,groups,0,0
26512,on,0,0
26513,initial,0,0
26514,IQ,0,0
26515,",",0,0
26516,and,0,0
26517,a,0,0
26518,lack,0,0
26519,of,0,0
26520,systematic,0,0
26521,checking,0,0
26522,regarding,0,0
26523,the,0,0
26524,implementation,0,0
26525,of,0,0
26526,the,0,0
26527,parent,0,0
26528,training,0,0
26529,intervention,0,0
26530,.,0,0
26531,Furthermore,0,0
26532,",",0,0
26533,three,0,0
26534,parents,0,0
26535,in,0,0
26536,the,0,0
26537,local,0,0
26538,services,0,0
26539,group,0,0
26540,commenced,0,0
26541,intensive,0,0
26542,",",0,0
26543,home-based,1,0
26544,behavioural,1,0
26545,intervention,1,0
26546,during,0,0
26547,the,0,0
26548,course,0,0
26549,of,0,0
26550,the,0,0
26551,study,0,0
26552,.,0,0
26553,The,0,0
26554,difficulties,0,0
26555,encountered,0,0
26556,in,0,0
26557,the,0,0
26558,conduct,0,0
26559,of,0,0
26560,RCTs,0,0
26561,for,0,0
26562,pre-school,0,0
26563,children,0,0
26564,with,0,0
26565,autism,0,0
26566,are,0,0
26567,discussed,0,0
26568,.,0,0
26569,Methodological,0,0
26570,challenges,0,0
26571,and,0,0
26572,strategies,0,0
26573,for,0,0
26574,future,0,0
26575,well-designed,0,0
26576,RCTs,0,0
26577,for,0,0
26578,autism,0,0
26579,interventions,0,0
26580,are,0,0
26581,highlighted,0,0
26582,.,0,0
26583,Lack,0,0
26584,of,0,0
26585,benefit,0,0
26586,of,0,0
26587,intravenous,1,1
26588,synthetic,1,0
26589,human,1,0
26590,secretin,1,1
26591,in,0,0
26592,the,0,0
26593,treatment,0,0
26594,of,0,0
26595,autism,0,0
26596,.,0,0
26597,The,0,0
26598,objective,0,0
26599,of,0,0
26600,this,0,0
26601,study,0,0
26602,was,0,0
26603,to,0,0
26604,determine,0,0
26605,if,0,0
26606,an,0,0
26607,intravenous,1,1
26608,infusion,1,1
26609,of,1,0
26610,synthetic,1,0
26611,human,1,0
26612,secretin,1,1
26613,improves,0,0
26614,language,0,1
26615,and,0,0
26616,behavioral,0,0
26617,symptoms,0,0
26618,in,0,0
26619,children,0,0
26620,with,0,0
26621,autism,0,0
26622,.,0,0
26623,Forty-two,0,0
26624,children,0,0
26625,with,0,0
26626,the,0,0
26627,diagnosis,0,0
26628,of,0,0
26629,autism,0,0
26630,were,0,0
26631,randomized,0,0
26632,to,0,0
26633,one,0,0
26634,of,0,0
26635,two,0,0
26636,groups,0,0
26637,in,0,0
26638,this,0,0
26639,double-blind,0,1
26640,cross-over,0,1
26641,trial,0,1
26642,.,0,0
26643,One,0,0
26644,group,0,0
26645,received,0,0
26646,2,1,0
26647,IU/kg,1,1
26648,of,1,1
26649,intravenous,1,1
26650,synthetic,1,0
26651,human,1,0
26652,secretin,1,1
26653,at,0,0
26654,the,0,0
26655,first,0,0
26656,visit,0,0
26657,",",0,0
26658,followed,0,0
26659,by,0,0
26660,an,0,0
26661,equal,0,0
26662,volume,0,0
26663,of,0,0
26664,intravenous,1,1
26665,saline,1,1
26666,placebo,1,1
26667,at,0,1
26668,week,0,0
26669,6,0,0
26670,.,0,0
26671,The,0,0
26672,other,0,0
26673,group,0,0
26674,received,0,0
26675,treatments,0,0
26676,in,0,0
26677,the,0,0
26678,reverse,0,0
26679,order,0,0
26680,.,0,0
26681,All,0,0
26682,children,0,0
26683,were,0,0
26684,evaluated,0,0
26685,at,0,0
26686,weeks,0,0
26687,1,0,0
26688,",",0,0
26689,3,0,0
26690,",",0,0
26691,6,0,0
26692,",",0,0
26693,9,0,0
26694,",",0,0
26695,and,0,0
26696,12,0,0
26697,with,0,0
26698,standardized,0,0
26699,assessments,0,0
26700,of,0,0
26701,language,0,0
26702,",",0,0
26703,behavior,0,0
26704,",",0,0
26705,and,0,0
26706,autism,0,0
26707,symptomatology,0,0
26708,.,0,0
26709,There,0,0
26710,were,0,0
26711,no,0,0
26712,significant,0,0
26713,differences,0,0
26714,in,0,0
26715,the,0,0
26716,mean,0,0
26717,scores,0,0
26718,on,0,0
26719,any,0,0
26720,measure,0,0
26721,of,0,0
26722,language,0,0
26723,",",0,0
26724,behavior,0,0
26725,",",0,0
26726,or,0,0
26727,autism,0,0
26728,symptom,0,1
26729,severity,0,0
26730,after,0,0
26731,treatment,0,0
26732,with,0,0
26733,secretin,0,1
26734,compared,0,0
26735,to,0,0
26736,treatment,0,0
26737,with,0,0
26738,placebo,0,1
26739,.,0,0
26740,The,0,0
26741,results,0,0
26742,of,0,0
26743,this,0,0
26744,study,0,0
26745,do,0,0
26746,not,0,0
26747,support,0,0
26748,secretin,0,1
26749,as,0,0
26750,a,0,0
26751,treatment,0,0
26752,for,0,0
26753,autism,0,0
26754,.,0,0
26755,Topical,0,0
26756,imiquimod,1,1
26757,5,1,0
26758,%,1,0
26759,cream,1,1
26760,as,0,0
26761,an,0,0
26762,effective,0,0
26763,treatment,0,0
26764,for,0,0
26765,external,0,0
26766,genital,0,0
26767,and,0,0
26768,perianal,0,0
26769,warts,0,0
26770,in,0,0
26771,different,0,0
26772,patient,0,0
26773,populations,0,0
26774,.,0,0
26775,BACKGROUND,0,0
26776,Genital,0,0
26777,infection,0,0
26778,with,0,0
26779,human,0,0
26780,papillomavirus,0,0
26781,",",0,0
26782,the,0,0
26783,cause,0,0
26784,of,0,0
26785,genital,0,0
26786,warts,0,0
26787,",",0,0
26788,is,0,0
26789,one,0,0
26790,of,0,0
26791,the,0,0
26792,most,0,0
26793,common,0,0
26794,sexually,0,0
26795,transmitted,0,0
26796,diseases,0,0
26797,.,0,0
26798,GOAL,0,0
26799,The,0,0
26800,aim,0,0
26801,of,0,0
26802,this,0,0
26803,analysis,0,0
26804,was,0,0
26805,to,0,0
26806,determine,0,0
26807,whether,0,0
26808,patients,0,0
26809,',0,0
26810,demographic,0,0
26811,variables,0,0
26812,affect,0,0
26813,the,0,0
26814,efficacy,0,0
26815,of,0,0
26816,imiquimod,1,1
26817,5,1,0
26818,%,1,0
26819,cream,1,1
26820,versus,0,1
26821,vehicle,1,1
26822,cream,1,1
26823,for,0,0
26824,the,0,0
26825,treatment,0,0
26826,of,0,0
26827,external,0,0
26828,genital,0,0
26829,and,0,0
26830,perianal,0,0
26831,warts,0,0
26832,.,0,0
26833,STUDY,0,0
26834,DESIGN,0,1
26835,Male,0,1
26836,and,0,0
26837,female,0,0
26838,immunocompetent,0,0
26839,patients,0,0
26840,applied,0,0
26841,imiquimod,1,1
26842,5,1,0
26843,%,1,1
26844,cream,1,1
26845,topically,1,1
26846,to,0,1
26847,external,0,0
26848,genital,0,0
26849,warts,0,0
26850,3,0,0
26851,times,0,0
26852,a,0,0
26853,week,0,0
26854,until,0,0
26855,wart,0,1
26856,clearance,0,1
26857,or,0,0
26858,for,0,0
26859,up,0,0
26860,to,0,0
26861,16,0,0
26862,weeks,0,0
26863,.,0,0
26864,RESULTS,0,0
26865,As,0,0
26866,previously,0,0
26867,published,0,0
26868,",",0,0
26869,the,0,0
26870,intent-to-treat,0,1
26871,(,0,1
26872,ITT,0,1
26873,),0,1
26874,clearance,0,1
26875,rate,0,0
26876,was,0,0
26877,50,0,0
26878,%,0,0
26879,(,0,0
26880,54/109,0,0
26881,),0,0
26882,in,0,0
26883,the,0,0
26884,imiquimod-treated,1,0
26885,group,0,0
26886,and,0,0
26887,11,0,0
26888,%,0,0
26889,(,0,0
26890,11/100,0,0
26891,),0,0
26892,in,0,0
26893,the,0,0
26894,vehicle-treated,1,1
26895,group,0,0
26896,(,0,0
26897,P,0,0
26898,<,0,0
26899,0.0001,0,0
26900,),0,0
26901,.,0,0
26902,The,0,0
26903,ITT,0,0
26904,clearance,0,1
26905,rate,0,0
26906,in,0,0
26907,the,0,0
26908,imiquimod-treated,1,0
26909,group,0,0
26910,was,0,0
26911,higher,0,0
26912,in,0,0
26913,females,0,0
26914,(,0,0
26915,72,0,0
26916,%,0,0
26917,),0,0
26918,than,0,0
26919,in,0,0
26920,males,0,0
26921,(,0,0
26922,33,0,0
26923,%,0,0
26924,),0,0
26925,.,0,0
26926,We,0,0
26927,have,0,0
26928,examined,0,0
26929,the,0,0
26930,clearance,0,1
26931,rates,0,0
26932,for,0,0
26933,subgroups,0,0
26934,based,0,0
26935,on,0,0
26936,variables,0,0
26937,of,0,0
26938,gender,0,0
26939,",",0,0
26940,baseline,0,0
26941,wart,0,0
26942,area,0,0
26943,",",0,0
26944,duration,0,0
26945,of,0,0
26946,current,0,0
26947,outbreak,0,0
26948,of,0,0
26949,warts,0,0
26950,",",0,0
26951,previous,0,0
26952,wart,0,0
26953,treatment,0,0
26954,",",0,0
26955,and,0,0
26956,tobacco,0,0
26957,use,0,0
26958,.,0,0
26959,For,0,0
26960,each,0,0
26961,of,0,0
26962,these,0,0
26963,subgroups,0,0
26964,",",0,0
26965,imiquimod,1,1
26966,was,0,0
26967,statistically,0,0
26968,more,0,0
26969,effective,0,0
26970,than,0,0
26971,vehicle,1,1
26972,in,0,0
26973,eradicating,0,0
26974,external,0,0
26975,genital,0,0
26976,and,0,0
26977,perianal,0,0
26978,warts,0,0
26979,.,0,0
26980,CONCLUSION,0,1
26981,Imiquimod,1,1
26982,5,1,0
26983,%,1,0
26984,cream,1,1
26985,is,0,0
26986,an,0,0
26987,effective,0,0
26988,treatment,0,0
26989,for,0,0
26990,external,0,0
26991,genital,0,0
26992,and,0,0
26993,perianal,0,0
26994,warts,0,0
26995,and,0,0
26996,provides,0,0
26997,a,0,0
26998,significant,0,0
26999,benefit,0,0
27000,in,0,0
27001,comparison,0,0
27002,with,0,0
27003,vehicle,1,1
27004,cream,1,1
27005,",",0,1
27006,independent,0,0
27007,of,0,0
27008,gender,0,0
27009,",",0,0
27010,initial,0,0
27011,wart,0,0
27012,size,0,0
27013,",",0,0
27014,duration,0,0
27015,of,0,0
27016,current,0,0
27017,outbreak,0,0
27018,of,0,0
27019,warts,0,0
27020,",",0,0
27021,previous,0,0
27022,wart,0,0
27023,treatment,0,0
27024,",",0,0
27025,or,0,0
27026,tobacco,0,0
27027,use,0,0
27028,.,0,0
27029,Double-blind,0,1
27030,",",0,1
27031,placebo-controlled,1,1
27032,study,0,0
27033,of,0,1
27034,L-carnosine,1,1
27035,supplementation,1,1
27036,in,0,1
27037,children,0,0
27038,with,0,0
27039,autistic,0,0
27040,spectrum,0,0
27041,disorders,0,0
27042,.,0,0
27043,L-Carnosine,1,0
27044,",",1,0
27045,a,1,0
27046,dipeptide,1,1
27047,",",0,0
27048,can,0,0
27049,enhance,0,0
27050,frontal,0,0
27051,lobe,0,0
27052,function,0,0
27053,or,0,0
27054,be,0,0
27055,neuroprotective,0,1
27056,.,0,0
27057,It,0,0
27058,can,0,0
27059,also,0,0
27060,correlate,0,0
27061,with,0,0
27062,gamma-aminobutyric,0,1
27063,acid,0,1
27064,(,0,1
27065,GABA,0,1
27066,),0,1
27067,-homocarnosine,0,1
27068,interaction,0,0
27069,",",0,0
27070,with,0,0
27071,possible,0,0
27072,anticonvulsive,0,1
27073,effects,0,0
27074,.,0,0
27075,We,0,0
27076,investigated,0,0
27077,31,0,0
27078,children,0,0
27079,with,0,0
27080,autistic,0,0
27081,spectrum,0,0
27082,disorders,0,0
27083,in,0,0
27084,an,0,0
27085,8-week,0,0
27086,",",0,0
27087,double-blinded,0,1
27088,study,0,0
27089,to,0,0
27090,determine,0,0
27091,if,0,0
27092,800,0,1
27093,mg,0,1
27094,L-carnosine,1,1
27095,daily,0,1
27096,would,0,0
27097,result,0,0
27098,in,0,0
27099,observable,0,0
27100,changes,0,0
27101,versus,0,0
27102,placebo,1,1
27103,.,1,1
27104,Outcome,0,0
27105,measures,0,0
27106,were,0,0
27107,the,0,0
27108,Childhood,0,0
27109,Autism,0,0
27110,Rating,0,0
27111,Scale,0,0
27112,",",0,0
27113,the,0,0
27114,Gilliam,0,0
27115,Autism,0,0
27116,Rating,0,0
27117,Scale,0,0
27118,",",0,0
27119,the,0,0
27120,Expressive,0,0
27121,and,0,0
27122,Receptive,0,0
27123,One-Word,0,1
27124,Picture,0,1
27125,Vocabulary,0,0
27126,tests,0,0
27127,",",0,0
27128,and,0,0
27129,Clinical,0,0
27130,Global,0,0
27131,Impressions,0,0
27132,of,0,0
27133,Change,0,0
27134,.,0,0
27135,Children,0,0
27136,on,0,0
27137,placebo,1,1
27138,did,0,0
27139,not,0,0
27140,show,0,0
27141,statistically,0,0
27142,significant,0,0
27143,changes,0,0
27144,.,0,0
27145,After,0,0
27146,8,0,0
27147,weeks,0,0
27148,on,0,0
27149,L-carnosine,1,1
27150,",",0,0
27151,children,0,0
27152,showed,0,0
27153,statistically,0,0
27154,significant,0,0
27155,improvements,0,0
27156,on,0,0
27157,the,0,0
27158,Gilliam,0,0
27159,Autism,0,0
27160,Rating,0,0
27161,Scale,0,0
27162,(,0,0
27163,total,0,0
27164,score,0,0
27165,and,0,0
27166,the,0,0
27167,Behavior,0,0
27168,",",0,0
27169,Socialization,0,0
27170,",",0,0
27171,and,0,0
27172,Communication,0,1
27173,subscales,0,1
27174,),0,0
27175,and,0,0
27176,the,0,0
27177,Receptive,0,0
27178,One-Word,0,1
27179,Picture,0,1
27180,Vocabulary,0,1
27181,test,0,0
27182,(,0,0
27183,all,0,0
27184,P,0,0
27185,<,0,0
27186,.05,0,0
27187,),0,0
27188,.,0,0
27189,Improved,0,0
27190,trends,0,0
27191,were,0,0
27192,noted,0,0
27193,on,0,0
27194,other,0,0
27195,outcome,0,0
27196,measures,0,0
27197,.,0,0
27198,Although,0,0
27199,the,0,0
27200,mechanism,0,0
27201,of,0,0
27202,action,0,0
27203,of,0,0
27204,L-carnosine,1,1
27205,is,0,0
27206,not,0,0
27207,well,0,0
27208,understood,0,0
27209,",",0,0
27210,it,0,0
27211,may,0,0
27212,enhance,0,0
27213,neurologic,0,0
27214,function,0,0
27215,",",0,0
27216,perhaps,0,0
27217,in,0,0
27218,the,0,0
27219,enterorhinal,0,0
27220,or,0,0
27221,temporal,0,0
27222,cortex,0,0
27223,.,0,0
27224,Iontophoretic,1,1
27225,administration,0,1
27226,of,0,1
27227,dexamethasone,1,1
27228,sodium,1,1
27229,phosphate,1,1
27230,for,0,1
27231,acute,0,0
27232,epicondylitis,0,0
27233,.,0,0
27234,A,0,0
27235,randomized,0,1
27236,",",0,0
27237,double-blinded,0,1
27238,",",0,1
27239,placebo-controlled,1,1
27240,study,0,0
27241,.,0,0
27242,BACKGROUND,0,0
27243,A,0,0
27244,better,0,0
27245,treatment,0,0
27246,modality,0,0
27247,is,0,0
27248,needed,0,0
27249,to,0,0
27250,control,0,0
27251,the,0,0
27252,pain,0,0
27253,of,0,0
27254,medial,0,0
27255,or,0,0
27256,lateral,0,0
27257,epicondylitis,0,1
27258,(,0,0
27259,tennis,0,1
27260,elbow,0,1
27261,),0,0
27262,.,0,0
27263,HYPOTHESIS,0,1
27264,Dermal,0,0
27265,iontophoretic,1,1
27266,administration,0,1
27267,of,0,1
27268,dexamethasone,1,1
27269,sodium,0,1
27270,phosphate,0,1
27271,will,0,0
27272,be,0,0
27273,significantly,0,0
27274,more,0,0
27275,effective,0,0
27276,in,0,0
27277,controlling,0,0
27278,pain,0,0
27279,than,0,0
27280,a,0,0
27281,placebo,0,1
27282,in,0,0
27283,patients,0,0
27284,with,0,0
27285,medial,0,0
27286,or,0,0
27287,lateral,0,0
27288,elbow,0,0
27289,epicondylitis,0,0
27290,.,0,0
27291,STUDY,0,0
27292,DESIGN,0,1
27293,Randomized,0,1
27294,",",0,0
27295,double-blinded,0,1
27296,",",0,1
27297,placebo-controlled,1,1
27298,study,0,0
27299,.,0,0
27300,METHODS,0,0
27301,On,0,0
27302,six,0,0
27303,occasions,0,0
27304,",",0,0
27305,1,0,0
27306,to,0,0
27307,3,0,0
27308,days,0,0
27309,apart,0,0
27310,within,0,0
27311,15,0,0
27312,days,0,0
27313,",",0,0
27314,199,0,0
27315,patients,0,0
27316,with,0,0
27317,elbow,0,0
27318,epicondylitis,0,0
27319,received,0,0
27320,40,0,0
27321,mA-minutes,0,0
27322,of,0,0
27323,either,0,0
27324,active,0,0
27325,or,0,0
27326,placebo,1,1
27327,treatment,0,1
27328,.,0,1
27329,RESULTS,0,1
27330,Dexamethasone,1,1
27331,produced,0,0
27332,a,0,0
27333,significant,0,0
27334,23-mm,0,0
27335,improvement,0,0
27336,on,0,0
27337,the,0,0
27338,100-mm,0,0
27339,patient,0,0
27340,visual,0,1
27341,analog,0,1
27342,scale,0,1
27343,ratings,0,0
27344,",",0,0
27345,compared,0,0
27346,with,0,0
27347,14,0,0
27348,mm,0,0
27349,for,0,0
27350,placebo,1,1
27351,at,0,1
27352,2,0,0
27353,days,0,0
27354,and,0,0
27355,24,0,0
27356,mm,0,0
27357,compared,0,0
27358,with,0,0
27359,19,0,0
27360,mm,0,0
27361,at,0,0
27362,1,0,0
27363,month,0,0
27364,.,0,0
27365,More,0,0
27366,patients,0,0
27367,treated,0,0
27368,with,0,0
27369,dexamethasone,1,1
27370,than,0,0
27371,those,0,0
27372,treated,0,0
27373,with,0,0
27374,placebo,1,1
27375,scored,0,0
27376,moderate,0,0
27377,or,0,0
27378,better,0,0
27379,on,0,0
27380,the,0,0
27381,investigator,0,0
27382,'s,0,0
27383,global,0,0
27384,improvement,0,1
27385,scale,0,0
27386,(,0,0
27387,52,0,0
27388,%,0,0
27389,versus,0,0
27390,33,0,0
27391,%,0,0
27392,),0,0
27393,at,0,0
27394,2,0,0
27395,days,0,0
27396,",",0,0
27397,but,0,0
27398,the,0,0
27399,difference,0,0
27400,was,0,0
27401,not,0,0
27402,significant,0,0
27403,at,0,0
27404,1,0,0
27405,month,0,0
27406,(,0,0
27407,54,0,0
27408,%,0,0
27409,versus,0,0
27410,49,0,0
27411,%,0,0
27412,),0,0
27413,.,0,0
27414,Investigator-rated,0,0
27415,pain,0,0
27416,and,0,0
27417,tenderness,0,0
27418,scores,0,1
27419,favored,0,0
27420,dexamethasone,0,1
27421,over,0,1
27422,placebo,0,1
27423,at,0,1
27424,2,0,0
27425,days,0,0
27426,.,0,0
27427,Patients,0,0
27428,completing,0,0
27429,six,0,0
27430,treatments,0,0
27431,in,0,0
27432,10,0,0
27433,days,0,0
27434,or,0,0
27435,less,0,0
27436,had,0,0
27437,better,0,0
27438,results,0,0
27439,than,0,0
27440,those,0,0
27441,treated,0,0
27442,over,0,0
27443,a,0,0
27444,longer,0,0
27445,period,0,0
27446,.,0,0
27447,CONCLUSIONS,0,1
27448,Iontophoresis,1,1
27449,treatment,0,0
27450,was,0,0
27451,well,0,0
27452,tolerated,0,1
27453,by,0,0
27454,most,0,0
27455,patients,0,0
27456,and,0,0
27457,was,0,0
27458,effective,0,0
27459,in,0,0
27460,reducing,0,0
27461,symptoms,0,0
27462,of,0,0
27463,epicondylitis,0,0
27464,at,0,0
27465,short-term,0,0
27466,follow-up,0,0
27467,.,0,0
27468,Acute,0,0
27469,and,0,0
27470,subchronic,0,1
27471,effects,0,0
27472,of,0,0
27473,levocetirizine,1,1
27474,and,1,1
27475,diphenhydramine,1,1
27476,on,0,0
27477,memory,0,0
27478,functioning,0,0
27479,",",0,0
27480,psychomotor,0,0
27481,performance,0,0
27482,",",0,0
27483,and,0,0
27484,mood,0,0
27485,.,0,0
27486,BACKGROUND,0,0
27487,Central,0,0
27488,nervous,0,0
27489,system,0,0
27490,adverse,0,0
27491,effects,0,0
27492,",",0,0
27493,such,0,0
27494,as,0,0
27495,sedation,0,0
27496,",",0,0
27497,often,0,0
27498,accompany,0,0
27499,the,0,0
27500,use,0,0
27501,of,0,0
27502,first-generation,0,0
27503,antihistamines,0,1
27504,.,0,0
27505,These,0,0
27506,effects,0,0
27507,might,0,0
27508,interfere,0,0
27509,with,0,0
27510,memory,0,0
27511,functioning,0,0
27512,and,0,0
27513,psychomotor,0,0
27514,performance,0,0
27515,.,0,0
27516,Levocetirizine,1,1
27517,was,0,0
27518,recently,0,0
27519,introduced,0,0
27520,as,0,0
27521,a,0,0
27522,new,0,0
27523,antihistamine,0,1
27524,said,0,1
27525,to,0,0
27526,be,0,0
27527,free,0,0
27528,from,0,0
27529,sedative,0,1
27530,effects,0,0
27531,.,0,0
27532,OBJECTIVE,0,0
27533,We,0,0
27534,sought,0,0
27535,to,0,0
27536,investigate,0,0
27537,the,0,0
27538,effects,0,0
27539,of,0,0
27540,levocetirizine,1,1
27541,(,0,1
27542,5,0,1
27543,mg,0,1
27544,),0,1
27545,",",0,1
27546,diphenhydramine,1,1
27547,(,0,1
27548,50,0,1
27549,mg,0,1
27550,),0,1
27551,",",0,1
27552,and,1,1
27553,placebo,1,1
27554,on,0,0
27555,memory,0,0
27556,and,0,0
27557,psychomotor,0,0
27558,performance,0,0
27559,after,0,0
27560,acute,0,0
27561,(,0,1
27562,day,0,1
27563,1,0,1
27564,),0,1
27565,and,0,1
27566,subchronic,0,1
27567,(,0,1
27568,day,0,1
27569,4,0,1
27570,),0,1
27571,daily,0,1
27572,administration,0,1
27573,in,0,1
27574,48,0,0
27575,healthy,0,0
27576,volunteers,0,0
27577,(,0,0
27578,24,0,0
27579,men,0,0
27580,and,0,0
27581,24,0,0
27582,women,0,1
27583,),0,0
27584,.,0,0
27585,METHODS,0,0
27586,This,0,0
27587,study,0,0
27588,was,0,0
27589,a,0,0
27590,double-blind,0,1
27591,",",0,1
27592,placebo-controlled,1,1
27593,",",0,1
27594,randomized,0,1
27595,clinical,0,0
27596,trial,0,0
27597,.,0,0
27598,Treatments,0,0
27599,were,0,0
27600,administrated,0,1
27601,on,0,1
27602,days,0,0
27603,1,0,0
27604,",",0,0
27605,2,0,0
27606,",",0,0
27607,3,0,0
27608,",",0,0
27609,and,0,0
27610,4,0,0
27611,",",0,0
27612,3,0,0
27613,hours,0,0
27614,before,0,0
27615,the,0,0
27616,start,0,0
27617,of,0,0
27618,the,0,0
27619,laboratory,0,0
27620,test,0,0
27621,battery,0,1
27622,(,0,0
27623,performed,0,0
27624,on,0,0
27625,days,0,0
27626,1,0,0
27627,and,0,0
27628,4,0,1
27629,),0,0
27630,",",0,0
27631,comprising,0,0
27632,a,0,0
27633,word-learning,0,0
27634,test,0,0
27635,",",0,0
27636,the,0,0
27637,Sternberg,0,0
27638,Memory,0,0
27639,Scanning,0,0
27640,Test,0,0
27641,",",0,0
27642,a,0,0
27643,tracking,0,0
27644,test,0,0
27645,(,0,0
27646,easy,0,0
27647,and,0,0
27648,hard,0,0
27649,version,0,1
27650,),0,0
27651,",",0,0
27652,and,0,0
27653,a,0,0
27654,divided,0,0
27655,attention,0,0
27656,test,0,0
27657,(,0,0
27658,tracking,0,0
27659,and,0,0
27660,memory,0,0
27661,scanning,0,0
27662,simultaneously,0,0
27663,),0,0
27664,.,0,0
27665,Statistical,0,0
27666,analyses,0,0
27667,were,0,0
27668,performed,0,0
27669,separately,0,0
27670,for,0,0
27671,days,0,0
27672,1,0,1
27673,and,0,0
27674,4,0,0
27675,by,0,0
27676,using,0,0
27677,analysis,0,0
27678,of,0,0
27679,variance,0,0
27680,.,0,0
27681,RESULTS,0,1
27682,On,0,1
27683,day,0,0
27684,1,0,1
27685,",",0,0
27686,diphenhydramine,1,1
27687,significantly,0,0
27688,impaired,0,0
27689,tracking,0,0
27690,performance,0,0
27691,(,0,0
27692,easy,0,0
27693,:,0,1
27694,F,0,0
27695,(,0,0
27696,"1,90",0,0
27697,),0,0
27698,=,0,0
27699,25.9,0,0
27700,",",0,0
27701,P,0,0
27702,<,0,0
27703,.0001,0,0
27704,;,0,0
27705,hard,0,0
27706,:,0,0
27707,F,0,0
27708,(,0,0
27709,"1,90",0,0
27710,),0,0
27711,=,0,0
27712,20.5,0,0
27713,",",0,0
27714,P,0,0
27715,<,0,0
27716,.0001,0,0
27717,),0,0
27718,and,0,0
27719,divided,0,0
27720,attention,0,0
27721,(,0,0
27722,tracking,0,0
27723,:,0,0
27724,F,0,0
27725,(,0,0
27726,"1,90",0,0
27727,),0,0
27728,=,0,0
27729,23.8,0,0
27730,",",0,0
27731,P,0,0
27732,<,0,0
27733,.0001,0,0
27734,;,0,0
27735,memory,0,0
27736,scanning,0,0
27737,:,0,0
27738,F,0,0
27739,(,0,0
27740,"1,90",0,0
27741,),0,0
27742,=,0,0
27743,22.0,0,0
27744,",",0,0
27745,P,0,0
27746,<,0,0
27747,.0001,0,0
27748,),0,0
27749,.,0,0
27750,Results,0,0
27751,on,0,0
27752,word-learning,0,0
27753,tests,0,0
27754,and,0,0
27755,Sternberg,0,0
27756,Memory,0,0
27757,Scanning,0,0
27758,Tests,0,0
27759,were,0,0
27760,not,0,0
27761,significantly,0,0
27762,impaired,0,0
27763,.,0,0
27764,On,0,1
27765,day,0,0
27766,4,0,0
27767,",",0,0
27768,the,0,0
27769,effects,0,0
27770,of,0,0
27771,diphenhydramine,1,1
27772,did,0,0
27773,not,0,0
27774,reach,0,0
27775,significance,0,0
27776,.,0,0
27777,In,0,0
27778,contrast,0,0
27779,",",0,0
27780,on,0,0
27781,both,0,0
27782,days,0,0
27783,1,0,1
27784,and,0,0
27785,4,0,1
27786,",",0,0
27787,levocetirizine,1,1
27788,did,0,0
27789,not,0,0
27790,significantly,0,0
27791,impair,0,0
27792,laboratory,0,0
27793,test,0,0
27794,performance,0,0
27795,.,0,0
27796,CONCLUSION,0,0
27797,The,0,0
27798,results,0,0
27799,show,0,0
27800,that,0,0
27801,memory,0,0
27802,",",0,0
27803,attention,0,0
27804,",",0,0
27805,and,0,0
27806,tracking,0,0
27807,performance,0,0
27808,are,0,0
27809,unaffected,0,0
27810,after,0,0
27811,acute,0,0
27812,and,0,1
27813,subchronic,0,1
27814,administration,0,1
27815,of,0,1
27816,levocetirizine,1,1
27817,(,0,1
27818,5,0,1
27819,mg,0,1
27820,),0,1
27821,",",0,1
27822,whereas,0,0
27823,diphenhydramine,1,1
27824,(,0,1
27825,50,0,1
27826,mg,0,1
27827,),0,1
27828,significantly,0,0
27829,affected,0,0
27830,divided,0,0
27831,attention,0,0
27832,and,0,0
27833,tracking,0,0
27834,after,0,0
27835,acute,0,0
27836,administration,0,1
27837,.,0,0
27838,Clonidine,1,1
27839,premedication,0,1
27840,improves,0,0
27841,metabolic,0,0
27842,control,0,0
27843,in,0,0
27844,type,0,0
27845,2,0,0
27846,diabetic,0,0
27847,patients,0,0
27848,during,0,0
27849,ophthalmic,0,0
27850,surgery,0,0
27851,.,0,0
27852,BACKGROUND,0,0
27853,In,0,0
27854,stressful,0,0
27855,conditions,0,0
27856,",",0,0
27857,increasing,0,0
27858,blood,0,1
27859,glucose,0,1
27860,concentrations,0,1
27861,are,0,0
27862,closely,0,0
27863,related,0,0
27864,to,0,0
27865,an,0,0
27866,increase,0,0
27867,in,0,0
27868,catecholamines,0,1
27869,and,0,1
27870,cortisol,0,1
27871,release,0,1
27872,.,0,1
27873,Clonidine,0,1
27874,",",0,0
27875,a,0,0
27876,centrally,0,0
27877,acting,0,0
27878,alpha,0,0
27879,(,0,0
27880,2,0,1
27881,),0,1
27882,-adrenoceptor,0,1
27883,agonist,0,1
27884,",",0,1
27885,has,0,0
27886,neuroendocrine,0,0
27887,effects,0,0
27888,",",0,0
27889,including,0,0
27890,inhibition,0,0
27891,of,0,0
27892,sympathoadrenal,0,0
27893,activity,0,0
27894,.,0,0
27895,We,0,0
27896,therefore,0,0
27897,evaluated,0,0
27898,the,0,0
27899,effect,0,0
27900,of,0,0
27901,clonidine,1,1
27902,on,0,1
27903,blood,0,1
27904,glucose,0,1
27905,control,0,1
27906,and,0,0
27907,insulin,0,1
27908,requirements,0,0
27909,during,0,0
27910,ophthalmic,0,0
27911,surgery,0,0
27912,when,0,0
27913,given,0,0
27914,as,0,0
27915,premedication,0,1
27916,in,0,0
27917,type,0,0
27918,2,0,0
27919,diabetic,0,0
27920,patients,0,0
27921,.,0,0
27922,METHODS,0,0
27923,After,0,0
27924,randomization,0,0
27925,",",0,0
27926,patients,0,0
27927,were,0,0
27928,premedicated,0,1
27929,with,0,1
27930,clonidine,1,1
27931,or,1,1
27932,flunitrazepam,1,1
27933,(,0,1
27934,control,0,0
27935,),0,0
27936,.,0,0
27937,Patients,0,0
27938,were,0,0
27939,given,0,0
27940,insulin,1,1
27941,by,0,0
27942,continuous,0,0
27943,i.v,0,1
27944,.,0,1
27945,infusion,0,1
27946,to,0,0
27947,maintain,0,0
27948,blood,0,0
27949,glucose,0,1
27950,in,0,0
27951,the,0,0
27952,range,0,0
27953,5.5-11.1,0,0
27954,mmol,0,1
27955,litre,0,1
27956,(,0,1
27957,-1,0,1
27958,),0,0
27959,.,0,0
27960,Blood,0,1
27961,glucose,0,1
27962,concentrations,0,1
27963,were,0,0
27964,measured,0,0
27965,every,0,0
27966,15,0,0
27967,min,0,0
27968,during,0,0
27969,surgery,0,0
27970,",",0,0
27971,and,0,0
27972,hourly,0,0
27973,for,0,0
27974,6,0,0
27975,h,0,0
27976,after,0,0
27977,surgery,0,0
27978,.,0,0
27979,Plasma,0,1
27980,C-peptide,0,1
27981,and,0,1
27982,counter-regulatory,0,1
27983,hormones,0,0
27984,were,0,0
27985,also,0,0
27986,measured,0,0
27987,.,0,0
27988,RESULTS,0,0
27989,Glycaemia,0,0
27990,was,0,0
27991,significantly,0,0
27992,lower,0,0
27993,in,0,0
27994,the,0,0
27995,clonidine,0,1
27996,group,0,0
27997,(,0,0
27998,P,0,0
27999,<,0,0
28000,0.01,0,0
28001,),0,0
28002,and,0,0
28003,the,0,0
28004,median,0,0
28005,amount,0,0
28006,of,0,0
28007,insulin,0,1
28008,administered,0,1
28009,was,0,0
28010,significantly,0,0
28011,reduced,0,0
28012,:,0,0
28013,clonidine,0,1
28014,group,0,0
28015,9.0,0,0
28016,(,0,0
28017,interquartile,0,0
28018,range,0,0
28019,5.1,0,0
28020,),0,0
28021,units,0,0
28022,;,0,0
28023,control,0,0
28024,18.6,0,0
28025,(,0,0
28026,10.2,0,0
28027,),0,0
28028,units,0,0
28029,;,0,0
28030,P,0,0
28031,<,0,0
28032,0.01,0,0
28033,),0,0
28034,.,0,0
28035,Plasma,0,1
28036,catecholamine,0,1
28037,concentrations,0,1
28038,were,0,0
28039,lower,0,0
28040,in,0,0
28041,patients,0,0
28042,given,0,1
28043,clonidine,1,1
28044,(,0,0
28045,P,0,0
28046,<,0,0
28047,0.05,0,0
28048,),0,0
28049,but,0,0
28050,there,0,0
28051,was,0,0
28052,no,0,0
28053,difference,0,0
28054,in,0,0
28055,cortisol,0,1
28056,concentrations,0,1
28057,.,0,1
28058,CONCLUSION,0,1
28059,Premedication,0,1
28060,of,0,0
28061,type,0,0
28062,2,0,0
28063,diabetic,0,0
28064,patients,0,0
28065,with,0,0
28066,clonidine,1,1
28067,90,0,0
28068,min,0,0
28069,before,0,0
28070,surgery,0,0
28071,improves,0,0
28072,blood,0,0
28073,glucose,0,1
28074,control,0,0
28075,and,0,0
28076,decreases,0,0
28077,insulin,0,1
28078,requirements,0,0
28079,during,0,0
28080,ophthalmic,0,0
28081,surgery,0,0
28082,.,0,0
28083,A,0,1
28084,randomized,0,0
28085,trial,0,1
28086,comparing,0,0
28087,intravesical,1,1
28088,instillations,1,1
28089,of,0,1
28090,mitoxantrone,1,1
28091,and,1,1
28092,doxorubicin,1,1
28093,in,0,0
28094,patients,0,0
28095,with,0,0
28096,superficial,0,0
28097,bladder,0,0
28098,cancer,0,0
28099,.,0,0
28100,BACKGROUND,0,0
28101,This,0,0
28102,randomized,0,0
28103,trial,0,0
28104,was,0,0
28105,conducted,0,0
28106,to,0,0
28107,compare,0,0
28108,the,0,0
28109,efficacy,0,0
28110,and,0,0
28111,side,0,0
28112,effects,0,0
28113,of,0,0
28114,intravesical,1,1
28115,mitoxantrone,1,1
28116,instillation,1,1
28117,with,0,1
28118,those,0,0
28119,of,0,0
28120,doxorubicin,1,1
28121,in,0,0
28122,superficial,0,1
28123,bladder,0,0
28124,cancer,0,0
28125,following,0,0
28126,transurethral,0,0
28127,resection,0,0
28128,.,0,0
28129,METHODS,0,0
28130,Sixty-three,0,0
28131,patients,0,0
28132,were,0,0
28133,randomized,0,0
28134,into,0,0
28135,mitoxantrone,1,1
28136,and,1,1
28137,doxorubicin,1,1
28138,groups,0,1
28139,.,0,0
28140,Most,0,0
28141,of,0,0
28142,the,0,0
28143,patients,0,0
28144,enrolled,0,0
28145,were,0,0
28146,elderly,0,0
28147,people,0,1
28148,(,0,0
28149,mean,0,0
28150,age,0,0
28151,",",0,0
28152,71,0,0
28153,years,0,0
28154,),0,0
28155,.,0,0
28156,The,0,0
28157,instilled,0,1
28158,doses,0,1
28159,of,0,1
28160,doxorubicin,1,1
28161,and,1,1
28162,mitoxantrone,1,1
28163,were,0,0
28164,30,0,0
28165,and,0,0
28166,14,0,1
28167,mg,0,1
28168,",",0,0
28169,respectively,0,0
28170,.,0,0
28171,Disease,0,0
28172,recurrence,0,0
28173,and,0,0
28174,side,0,0
28175,effects,0,0
28176,were,0,0
28177,compared,0,0
28178,using,0,0
28179,Fisher,0,0
28180,'s,0,0
28181,exact,0,0
28182,test,0,0
28183,.,0,0
28184,The,0,0
28185,interval,0,0
28186,to,0,0
28187,recurrence,0,0
28188,was,0,0
28189,shown,0,0
28190,by,0,0
28191,Kaplan-Meier,0,0
28192,survivorship,0,0
28193,curves,0,0
28194,",",0,0
28195,and,0,0
28196,the,0,0
28197,log-rank,0,0
28198,test,0,0
28199,was,0,0
28200,used,0,0
28201,to,0,0
28202,compare,0,0
28203,the,0,0
28204,time,0,0
28205,to,0,0
28206,recurrence,0,0
28207,.,0,0
28208,RESULTS,0,0
28209,The,0,0
28210,median,0,0
28211,follow-up,0,0
28212,period,0,0
28213,was,0,0
28214,36,0,0
28215,months,0,0
28216,.,0,0
28217,Thirty-three,0,0
28218,patients,0,0
28219,received,0,0
28220,mitoxantrone,1,1
28221,",",0,1
28222,whereas,0,0
28223,30,0,0
28224,patients,0,0
28225,used,0,0
28226,doxorubicin,1,1
28227,.,1,0
28228,The,0,0
28229,recurrence,0,0
28230,rate,0,0
28231,in,0,0
28232,the,0,0
28233,doxorubicin,1,1
28234,group,0,1
28235,was,0,0
28236,30,0,0
28237,%,0,0
28238,(,0,0
28239,95,0,0
28240,%,0,0
28241,CI,0,0
28242,:,0,0
28243,19.8,0,0
28244,%,0,0
28245,-38.8,0,0
28246,%,0,0
28247,),0,0
28248,",",0,0
28249,while,0,0
28250,it,0,0
28251,was,0,0
28252,27.3,0,0
28253,%,0,0
28254,(,0,0
28255,95,0,0
28256,%,0,0
28257,CI,0,0
28258,:,0,0
28259,17.5,0,0
28260,%,0,0
28261,-36.8,0,0
28262,%,0,0
28263,),0,0
28264,in,0,0
28265,the,0,0
28266,mitoxantrone,1,1
28267,group,0,0
28268,.,0,0
28269,The,0,0
28270,median,0,0
28271,recurrence-free,0,0
28272,survival,0,0
28273,in,0,0
28274,the,0,0
28275,mitoxantrone,1,1
28276,group,0,0
28277,and,0,0
28278,in,0,0
28279,the,0,0
28280,doxorubicin,1,1
28281,group,0,0
28282,was,0,0
28283,22,0,0
28284,and,0,0
28285,20,0,0
28286,months,0,0
28287,",",0,0
28288,respectively,0,0
28289,(,0,0
28290,p=0.580,0,0
28291,),0,0
28292,.,0,0
28293,Higher,0,0
28294,recurrence,0,0
28295,rates,0,0
28296,were,0,0
28297,found,0,0
28298,for,0,0
28299,Grade,0,0
28300,III,0,0
28301,and,0,0
28302,multiple,0,0
28303,primary,0,0
28304,tumors,0,0
28305,.,0,0
28306,There,0,0
28307,was,0,0
28308,no,0,0
28309,significant,0,0
28310,difference,0,0
28311,in,0,0
28312,response,0,0
28313,rates,0,0
28314,(,0,0
28315,p=0.784,0,0
28316,),0,0
28317,.,0,0
28318,The,0,0
28319,incidence,0,0
28320,of,0,0
28321,side,0,0
28322,effects,0,0
28323,was,0,0
28324,20,0,0
28325,%,0,0
28326,in,0,0
28327,the,0,0
28328,doxorubicin,1,1
28329,group,0,0
28330,and,0,0
28331,21.2,0,0
28332,%,0,0
28333,in,0,0
28334,the,0,0
28335,mitoxantrone,1,1
28336,group,0,0
28337,.,0,0
28338,However,0,0
28339,",",0,0
28340,the,0,0
28341,difference,0,0
28342,was,0,0
28343,not,0,0
28344,significant,0,0
28345,(,0,0
28346,p,0,0
28347,>,0,0
28348,0.99,0,0
28349,),0,0
28350,.,0,0
28351,CONCLUSIONS,0,0
28352,The,0,0
28353,results,0,0
28354,revealed,0,0
28355,that,0,0
28356,the,0,0
28357,efficacy,0,0
28358,and,0,0
28359,side,0,0
28360,effects,0,0
28361,of,0,0
28362,mitoxantrone,1,1
28363,were,0,0
28364,similar,0,0
28365,to,0,0
28366,those,0,0
28367,of,0,0
28368,doxorubicin,1,1
28369,.,1,0
28370,Especially,0,0
28371,for,0,0
28372,patients,0,0
28373,with,0,0
28374,pulmonary,0,0
28375,tuberculosis,0,0
28376,or,0,0
28377,aged,0,0
28378,patients,0,0
28379,with,0,0
28380,primary,0,0
28381,bladder,0,0
28382,tumors,0,1
28383,",",0,0
28384,mitoxantrone,1,1
28385,and,0,1
28386,doxorubicin,1,1
28387,may,0,0
28388,be,0,0
28389,the,0,0
28390,tolerable,0,1
28391,and,0,1
28392,effective,0,0
28393,intravesical,0,1
28394,agents,0,0
28395,.,0,0
28396,The,0,0
28397,utility,0,0
28398,of,0,0
28399,laparoscopy,0,0
28400,in,0,0
28401,the,0,0
28402,diagnosis,0,0
28403,of,0,0
28404,acute,0,0
28405,appendicitis,0,0
28406,in,0,0
28407,women,0,0
28408,of,0,0
28409,reproductive,0,0
28410,age,0,0
28411,.,0,0
28412,AIM,0,0
28413,To,0,1
28414,see,0,0
28415,whether,0,0
28416,laparoscopy,1,0
28417,improves,0,0
28418,the,0,0
28419,accuracy,0,0
28420,of,0,0
28421,a,0,0
28422,clinical,0,0
28423,diagnosis,0,0
28424,of,0,0
28425,acute,0,0
28426,appendicitis,0,0
28427,in,0,0
28428,women,0,0
28429,of,0,0
28430,reproductive,0,0
28431,age,0,0
28432,",",0,0
28433,and,0,0
28434,to,0,0
28435,determine,0,0
28436,what,0,0
28437,the,0,0
28438,long-term,0,0
28439,sequelae,0,0
28440,are,0,0
28441,of,0,0
28442,not,0,0
28443,removing,0,0
28444,an,0,0
28445,appendix,0,0
28446,deemed,0,0
28447,at,0,0
28448,laparoscopy,0,0
28449,to,0,0
28450,be,0,0
28451,normal,0,0
28452,.,0,0
28453,METHOD,0,0
28454,The,0,0
28455,initial,0,0
28456,part,0,0
28457,of,0,0
28458,the,0,0
28459,study,0,0
28460,was,0,0
28461,undertaken,0,0
28462,during,0,0
28463,1991-1992,0,0
28464,.,0,0
28465,Female,0,0
28466,patients,0,0
28467,between,0,0
28468,16,0,0
28469,and,0,0
28470,45,0,0
28471,years,0,0
28472,were,0,0
28473,eligible,0,0
28474,for,0,0
28475,inclusion,0,0
28476,once,0,0
28477,a,0,0
28478,clinical,0,0
28479,decision,0,0
28480,had,0,0
28481,been,0,0
28482,made,0,0
28483,to,0,0
28484,perform,0,0
28485,an,0,0
28486,appendicectomy,0,0
28487,for,0,0
28488,suspected,0,0
28489,acute,0,0
28490,appendicitis,0,0
28491,.,0,0
28492,Following,0,0
28493,consent,0,0
28494,",",0,0
28495,patients,0,0
28496,were,0,0
28497,randomized,0,0
28498,into,0,0
28499,two,0,0
28500,groups,0,0
28501,.,0,0
28502,One,0,0
28503,group,0,0
28504,had,0,0
28505,open,1,0
28506,appendicectomy,1,0
28507,",",0,0
28508,as,0,0
28509,planned,0,0
28510,.,0,0
28511,The,0,0
28512,other,0,0
28513,group,0,0
28514,had,0,0
28515,laparoscopy,1,0
28516,",",1,0
28517,followed,1,0
28518,by,1,0
28519,open,1,0
28520,appendicectomy,1,0
28521,only,0,0
28522,if,0,0
28523,the,0,0
28524,appendix,0,0
28525,was,0,0
28526,seen,0,0
28527,to,0,0
28528,be,0,0
28529,inflamed,0,0
28530,or,0,0
28531,was,0,0
28532,not,0,0
28533,visualized,0,0
28534,.,0,0
28535,The,0,0
28536,end,0,0
28537,points,0,0
28538,for,0,0
28539,the,0,0
28540,study,0,0
28541,were,0,0
28542,the,0,0
28543,clinical,0,0
28544,outcomes,0,0
28545,of,0,0
28546,all,0,0
28547,patients,0,0
28548,",",0,0
28549,and,0,0
28550,the,0,0
28551,results,0,0
28552,of,0,0
28553,histology,0,0
28554,",",0,0
28555,where,0,0
28556,appropriate,0,0
28557,.,0,0
28558,An,0,1
28559,attempt,0,1
28560,was,0,0
28561,made,0,0
28562,to,0,0
28563,contact,0,0
28564,all,0,0
28565,patients,0,0
28566,at,0,0
28567,10,0,0
28568,years,0,0
28569,to,0,0
28570,determine,0,0
28571,whether,0,0
28572,they,0,0
28573,had,0,0
28574,had,0,0
28575,a,0,0
28576,subsequent,0,0
28577,appendicectomy,0,0
28578,",",0,0
28579,or,0,0
28580,had,0,0
28581,been,0,0
28582,diagnosed,0,0
28583,with,0,0
28584,another,0,0
28585,abdominal,0,0
28586,condition,0,0
28587,that,0,0
28588,might,0,0
28589,be,0,0
28590,relevant,0,0
28591,to,0,0
28592,the,0,0
28593,initial,0,0
28594,presentation,0,0
28595,in,0,0
28596,1991-1992,0,0
28597,.,0,0
28598,RESULTS,0,0
28599,Laparoscopic,0,0
28600,assessment,0,0
28601,was,0,0
28602,correct,0,0
28603,in,0,0
28604,all,0,0
28605,cases,0,0
28606,in,0,0
28607,which,0,0
28608,the,0,0
28609,appendix,0,0
28610,was,0,0
28611,visualized,0,0
28612,.,0,0
28613,Diagnostic,0,0
28614,accuracy,0,0
28615,was,0,0
28616,improved,0,0
28617,from,0,0
28618,75,0,0
28619,%,0,0
28620,to,0,0
28621,97,0,0
28622,%,0,0
28623,.,0,0
28624,Laparoscopy,0,0
28625,was,0,0
28626,associated,0,0
28627,with,0,0
28628,no,0,0
28629,added,0,0
28630,complications,0,0
28631,",",0,0
28632,no,0,0
28633,increase,0,0
28634,in,0,0
28635,hospital,0,0
28636,stay,0,0
28637,in,0,0
28638,patients,0,0
28639,who,0,0
28640,went,0,0
28641,on,0,0
28642,to,0,0
28643,appendicectomy,0,0
28644,",",0,0
28645,and,0,0
28646,a,0,0
28647,reduction,0,0
28648,in,0,0
28649,hospital,0,0
28650,stay,0,0
28651,for,0,0
28652,those,0,0
28653,who,0,0
28654,underwent,0,0
28655,laparoscopy,0,0
28656,alone,0,0
28657,.,0,0
28658,No,0,0
28659,patients,0,0
28660,developed,0,0
28661,a,0,0
28662,problem,0,0
28663,over,0,0
28664,the,0,0
28665,10-year,0,0
28666,follow-up,0,0
28667,period,0,0
28668,from,0,0
28669,having,0,0
28670,a,0,0
28671,normal-looking,0,0
28672,appendix,0,0
28673,not,0,0
28674,removed,0,0
28675,at,0,0
28676,laparoscopy,0,0
28677,.,0,0
28678,CONCLUSION,0,0
28679,Laparoscopic,0,0
28680,assessment,0,0
28681,of,0,0
28682,the,0,0
28683,appendix,0,0
28684,is,0,0
28685,reliable,0,0
28686,",",0,0
28687,and,0,0
28688,to,0,0
28689,leave,0,0
28690,a,0,0
28691,normal-looking,0,0
28692,appendix,0,0
28693,at,0,0
28694,laparoscopy,0,0
28695,does,0,0
28696,not,0,0
28697,appear,0,0
28698,to,0,0
28699,cause,0,0
28700,any,0,0
28701,long-term,0,0
28702,problems,0,0
28703,.,0,0
28704,Efficacy,0,0
28705,of,0,0
28706,second,1,0
28707,versus,0,0
28708,third,1,0
28709,generation,1,0
28710,oral,1,1
28711,contraceptives,1,1
28712,in,0,0
28713,the,0,0
28714,treatment,0,0
28715,of,0,0
28716,hirsutism,0,0
28717,.,0,0
28718,OBJECTIVE,0,0
28719,To,0,0
28720,compare,0,0
28721,second,1,0
28722,versus,0,0
28723,third,1,0
28724,generation,1,0
28725,combination,1,0
28726,oral,1,1
28727,contraceptives,1,1
28728,(,1,1
28729,OCs,1,1
28730,),1,0
28731,in,0,0
28732,the,0,0
28733,treatment,0,0
28734,of,0,0
28735,hirsutism,0,0
28736,.,0,0
28737,METHODS,0,0
28738,Women,0,0
28739,with,0,0
28740,hirsutism,0,0
28741,",",0,0
28742,as,0,0
28743,defined,0,0
28744,by,0,0
28745,a,0,0
28746,minimum,0,0
28747,Ferriman-Gallwey,0,0
28748,score,0,0
28749,of,0,0
28750,10,0,0
28751,",",0,0
28752,were,0,0
28753,randomized,0,0
28754,in,0,0
28755,a,0,0
28756,double-blind,0,1
28757,fashion,0,0
28758,to,0,0
28759,receive,0,0
28760,an,0,0
28761,OC,0,0
28762,containing,0,0
28763,either,0,0
28764,ethinyl,1,1
28765,estradiol/desogestrel,1,1
28766,or,0,1
28767,ethinyl,1,1
28768,estradiol/levonorgestrel,1,1
28769,for,0,1
28770,9,0,0
28771,months,0,0
28772,of,0,0
28773,treatment,0,0
28774,.,0,0
28775,Ferriman-Gallwey,0,0
28776,scores,0,1
28777,",",0,0
28778,androgen,0,1
28779,levels,0,0
28780,and,0,1
28781,sex,0,1
28782,hormone-binding,0,1
28783,globulin,0,1
28784,were,0,0
28785,measured,0,0
28786,at,0,0
28787,baseline,0,0
28788,and,0,0
28789,every,0,0
28790,3,0,0
28791,months,0,0
28792,for,0,0
28793,the,0,0
28794,duration,0,0
28795,of,0,0
28796,the,0,0
28797,study,0,0
28798,.,0,0
28799,Hormones,0,1
28800,were,0,0
28801,measured,0,0
28802,in,0,0
28803,duplicate,0,0
28804,by,0,0
28805,radioimmunoassay,0,1
28806,.,0,1
28807,RESULTS,0,1
28808,Of,0,0
28809,the,0,0
28810,47,0,0
28811,women,0,0
28812,enrolled,0,0
28813,",",0,0
28814,24,0,0
28815,were,0,0
28816,randomized,0,0
28817,to,0,1
28818,ethinyl,1,1
28819,estradiol/desogestrel,1,1
28820,and,0,0
28821,23,0,0
28822,were,0,0
28823,randomized,0,0
28824,to,0,1
28825,ethinyl,1,1
28826,estradiol/levonorgestrel,1,1
28827,.,1,1
28828,Mean,0,0
28829,sex,0,1
28830,hormone-binding,0,1
28831,globulin,0,1
28832,increased,0,0
28833,significantly,0,0
28834,in,0,0
28835,subjects,0,0
28836,using,0,0
28837,the,0,0
28838,desogestrel-containing,1,1
28839,contraceptive,1,1
28840,compared,0,0
28841,with,0,0
28842,the,0,0
28843,levonorgestrel-containing,1,1
28844,contraceptive,1,1
28845,.,1,0
28846,Ten,0,0
28847,subjects,0,0
28848,completed,0,0
28849,the,0,0
28850,9,0,0
28851,months,0,0
28852,of,0,0
28853,treatment,0,0
28854,in,0,0
28855,the,0,0
28856,levonorgestrel,1,1
28857,group,0,1
28858,and,0,0
28859,11,0,0
28860,completed,0,0
28861,the,0,0
28862,study,0,0
28863,in,0,0
28864,the,0,0
28865,desogestrel,1,1
28866,group,0,0
28867,.,0,0
28868,Mean,0,0
28869,free,0,0
28870,testosterone,0,1
28871,and,0,1
28872,3alpha-androstanediol,0,1
28873,glucuronide,0,1
28874,decreased,0,0
28875,significantly,0,0
28876,in,0,0
28877,the,0,0
28878,group,0,0
28879,receiving,0,0
28880,ethinyl,1,1
28881,estradiol/desogestrel,1,1
28882,but,0,0
28883,not,0,0
28884,in,0,0
28885,the,0,0
28886,ethinyl,1,1
28887,estradiol/levonorgestrel,1,1
28888,group,0,1
28889,.,0,0
28890,Mean,0,0
28891,Ferriman-Gallwey,0,0
28892,scores,0,0
28893,decreased,0,0
28894,significantly,0,0
28895,in,0,0
28896,both,0,0
28897,treatment,0,0
28898,groups,0,0
28899,.,0,0
28900,Improvement,0,0
28901,in,0,0
28902,mean,0,0
28903,Ferriman-Gallwey,0,0
28904,score,0,0
28905,was,0,0
28906,35.7,0,0
28907,+/-,0,0
28908,38.1,0,0
28909,%,0,0
28910,(,0,0
28911,p,0,0
28912,<,0,0
28913,0.001,0,0
28914,),0,0
28915,for,0,0
28916,the,0,1
28917,ethinyl,1,1
28918,estradiol/desogestrel,1,1
28919,arm,0,1
28920,and,0,0
28921,33.4,0,0
28922,+/-,0,0
28923,27.3,0,0
28924,%,0,0
28925,(,0,0
28926,p,0,0
28927,<,0,0
28928,0.001,0,0
28929,),0,0
28930,for,0,0
28931,the,0,1
28932,ethinyl,1,1
28933,estradiol/levonorgestrel,1,1
28934,arm,0,1
28935,.,0,0
28936,There,0,0
28937,were,0,0
28938,no,0,0
28939,statistically,0,0
28940,significant,0,0
28941,differences,0,0
28942,found,0,0
28943,in,0,0
28944,the,0,0
28945,improvement,0,0
28946,of,0,0
28947,Ferriman-Gallwey,0,0
28948,scores,0,0
28949,between,0,0
28950,the,0,0
28951,two,0,0
28952,treatment,0,0
28953,arms,0,0
28954,",",0,0
28955,although,0,0
28956,the,0,0
28957,power,0,0
28958,to,0,0
28959,detect,0,0
28960,a,0,0
28961,difference,0,0
28962,was,0,0
28963,limited,0,0
28964,by,0,0
28965,the,0,0
28966,small,0,0
28967,sample,0,0
28968,size,0,0
28969,.,0,0
28970,CONCLUSIONS,0,0
28971,Treatment,0,0
28972,of,0,0
28973,hirsute,0,1
28974,women,0,1
28975,with,0,0
28976,third,1,0
28977,generation,1,0
28978,OCs,1,0
28979,containing,0,0
28980,desogestrel,1,1
28981,results,0,0
28982,in,0,0
28983,a,0,0
28984,significant,0,0
28985,increase,0,0
28986,in,0,0
28987,sex,0,1
28988,hormone-binding,0,1
28989,globulin,0,1
28990,and,0,1
28991,decrease,0,0
28992,in,0,0
28993,free,0,0
28994,testosterone,0,1
28995,and,0,1
28996,3alpha-androstanediol,0,1
28997,glucuronide,0,1
28998,.,0,1
28999,Both,0,0
29000,second,1,0
29001,and,1,0
29002,third,1,0
29003,generation,1,0
29004,OCs,1,0
29005,were,0,0
29006,clinically,0,0
29007,effective,0,0
29008,in,0,0
29009,treating,0,0
29010,hirsutism,0,0
29011,.,0,0
29012,Preservative-free,1,1
29013,ocular,1,1
29014,hydrating,1,1
29015,agents,1,0
29016,in,0,0
29017,symptomatic,0,0
29018,contact,0,0
29019,lens,0,0
29020,wearers,0,0
29021,:,0,0
29022,saline,1,1
29023,versus,1,0
29024,PVP,1,0
29025,solution,1,0
29026,.,1,0
29027,PURPOSE,0,0
29028,To,0,0
29029,compare,0,0
29030,two,0,0
29031,preservative-free,1,1
29032,hydrating,1,1
29033,agents,1,0
29034,",",0,0
29035,in,0,0
29036,multidose,0,1
29037,(,0,1
29038,ABAK,0,1
29039,),0,1
29040,bottles,0,1
29041,",",0,0
29042,in,0,0
29043,contact,0,0
29044,lens,0,0
29045,wearers,0,0
29046,experiencing,0,0
29047,symptoms,0,0
29048,of,0,0
29049,ocular,0,0
29050,dryness,0,0
29051,.,0,0
29052,METHODS,0,0
29053,The,0,0
29054,endpoint,0,0
29055,of,0,0
29056,this,0,0
29057,4-week,0,1
29058,multicenter,0,1
29059,",",0,0
29060,randomized,0,1
29061,",",0,1
29062,double-blind,0,1
29063,",",0,1
29064,parallel-group,0,1
29065,study,0,0
29066,comparing,0,0
29067,a,0,0
29068,2,1,0
29069,%,1,0
29070,polyvinylpyrrolidone,1,1
29071,(,1,1
29072,PVP,1,1
29073,),1,0
29074,solution,1,0
29075,with,1,0
29076,a,1,0
29077,0.9,1,0
29078,%,1,0
29079,NaCl,1,0
29080,solution,1,0
29081,was,0,0
29082,to,0,0
29083,assess,0,0
29084,ocular,0,0
29085,discomfort,0,0
29086,using,0,0
29087,a,0,0
29088,visual,0,0
29089,analog,0,1
29090,scale,0,1
29091,.,0,0
29092,A,0,0
29093,biomicroscopic,0,0
29094,examination,0,0
29095,and,0,0
29096,a,0,0
29097,test,0,0
29098,of,0,0
29099,tolerability,0,1
29100,on,0,0
29101,instillation,0,1
29102,were,0,0
29103,also,0,0
29104,performed,0,0
29105,",",0,0
29106,and,0,0
29107,adverse,0,0
29108,events,0,0
29109,were,0,0
29110,recorded,0,0
29111,.,0,0
29112,RESULTS,0,0
29113,Thirty-nine,0,0
29114,subjects,0,0
29115,were,0,0
29116,enrolled,0,0
29117,(,0,0
29118,23,0,0
29119,PVP,0,0
29120,;,0,0
29121,16,0,0
29122,NaCl,0,1
29123,),0,0
29124,.,0,0
29125,The,0,0
29126,average,0,0
29127,age,0,0
29128,was,0,0
29129,30,0,0
29130,;,0,0
29131,subjects,0,0
29132,were,0,0
29133,predominantly,0,0
29134,female,0,0
29135,",",0,0
29136,and,0,0
29137,mostly,0,0
29138,wore,0,0
29139,frequent-replacement,0,0
29140,contact,0,0
29141,lenses,0,0
29142,.,0,0
29143,They,0,0
29144,were,0,0
29145,all,0,0
29146,exposed,0,0
29147,to,0,0
29148,environmental,0,0
29149,factors,0,0
29150,such,0,0
29151,as,0,0
29152,routine,0,0
29153,use,0,0
29154,of,0,0
29155,video,0,0
29156,monitors,0,0
29157,or,0,0
29158,air,0,0
29159,conditioning,0,0
29160,.,0,0
29161,The,0,0
29162,two,0,0
29163,groups,0,0
29164,were,0,0
29165,similar,0,0
29166,at,0,0
29167,baseline,0,0
29168,(,0,1
29169,D0,0,1
29170,),0,1
29171,.,0,0
29172,Both,0,0
29173,PVP,1,0
29174,and,0,0
29175,NaCl,1,0
29176,improved,0,0
29177,the,0,0
29178,comfort,0,0
29179,of,0,0
29180,contact,0,0
29181,lens,0,0
29182,wear,0,0
29183,(,0,0
29184,P,0,0
29185,=,0,0
29186,0.0003,0,0
29187,),0,0
29188,",",0,0
29189,with,0,0
29190,no,0,0
29191,difference,0,0
29192,between,0,0
29193,them,0,0
29194,(,0,0
29195,P,0,0
29196,=,0,0
29197,0.25,0,0
29198,),0,0
29199,.,0,0
29200,The,0,0
29201,mean,0,0
29202,daily,0,0
29203,duration,0,0
29204,of,0,0
29205,lens,0,0
29206,wear,0,0
29207,and,0,0
29208,the,0,0
29209,daily,0,1
29210,number,0,0
29211,of,0,0
29212,instillations,0,1
29213,to,0,0
29214,relieve,0,1
29215,discomfort,0,0
29216,(,0,0
29217,4.2,0,0
29218,+/-,0,0
29219,2.0,0,0
29220,for,0,0
29221,PVP,1,0
29222,ABAK,0,0
29223,;,0,0
29224,4.6,0,0
29225,+/-,0,0
29226,1.9,0,0
29227,for,0,0
29228,NaCl,1,0
29229,ABAK,0,1
29230,),0,0
29231,were,0,0
29232,comparable,0,0
29233,.,0,0
29234,However,0,0
29235,",",0,0
29236,PVP,1,0
29237,use,0,0
29238,led,0,0
29239,to,0,0
29240,more,0,0
29241,favorable,0,0
29242,evolution,0,0
29243,of,0,0
29244,fluorescein-staining,0,0
29245,corneal,0,0
29246,punctuations,0,0
29247,(,0,0
29248,P,0,0
29249,=,0,0
29250,0.028,0,0
29251,),0,0
29252,.,0,0
29253,Safety,0,0
29254,was,0,0
29255,good,0,0
29256,",",0,0
29257,with,0,0
29258,minimal,0,0
29259,adverse,0,0
29260,events,0,0
29261,considered,0,0
29262,unrelated,0,0
29263,to,0,0
29264,the,0,0
29265,products,0,0
29266,.,0,0
29267,Lens,0,0
29268,wettability,0,0
29269,was,0,0
29270,excellent,0,0
29271,",",0,0
29272,and,0,0
29273,there,0,0
29274,were,0,0
29275,no,0,0
29276,clinically,0,0
29277,relevant,0,0
29278,deposits,0,0
29279,.,0,0
29280,Most,0,0
29281,subjects,0,0
29282,also,0,0
29283,found,0,0
29284,the,0,0
29285,ABAK,0,1
29286,bottles,0,1
29287,convenient,0,0
29288,.,0,0
29289,CONCLUSIONS,0,0
29290,Ocular,0,0
29291,hydration,0,0
29292,improves,0,0
29293,comfort,0,0
29294,in,0,0
29295,contact,0,0
29296,lens,0,0
29297,wearers,0,0
29298,.,0,0
29299,NaCl,1,0
29300,is,0,0
29301,an,0,0
29302,appropriate,0,0
29303,first-line,0,0
29304,treatment,0,0
29305,",",0,0
29306,but,0,0
29307,for,0,0
29308,subjects,0,0
29309,with,0,0
29310,fluorescein-staining,0,0
29311,punctuations,0,0
29312,",",0,0
29313,lubrication,0,0
29314,with,0,0
29315,PVP,1,0
29316,is,0,0
29317,preferable,0,0
29318,.,0,0
29319,Changing,0,0
29320,Childbirth,0,0
29321,:,0,0
29322,a,0,0
29323,pilot,0,0
29324,project,0,0
29325,.,0,0
29326,OBJECTIVE,0,0
29327,To,0,0
29328,compare,0,0
29329,the,0,0
29330,outcomes,0,0
29331,of,0,0
29332,an,0,0
29333,adapted,0,0
29334,pilot,0,0
29335,Changing,1,0
29336,Childbirth,1,0
29337,initiative,1,0
29338,providing,1,0
29339,continuity,1,0
29340,of,1,0
29341,care,1,0
29342,by,1,0
29343,a,1,0
29344,group,1,0
29345,of,1,0
29346,known,1,0
29347,midwives,1,0
29348,with,1,0
29349,traditional,1,0
29350,maternity,1,0
29351,care,1,0
29352,.,1,0
29353,DESIGN,0,0
29354,Between-groups,0,0
29355,trial,0,0
29356,to,0,0
29357,compare,0,0
29358,levels,0,0
29359,of,0,0
29360,satisfaction,0,0
29361,and,0,0
29362,clinical,0,0
29363,outcomes,0,0
29364,for,0,0
29365,two,0,0
29366,groups,0,0
29367,of,0,0
29368,women,0,0
29369,",",0,0
29370,cared,0,0
29371,for,0,0
29372,either,0,0
29373,under,0,0
29374,this,0,0
29375,Changing,1,0
29376,Childbirth,1,0
29377,scheme,1,0
29378,or,1,0
29379,the,1,0
29380,traditional,1,0
29381,model,1,0
29382,of,1,0
29383,care,1,0
29384,.,1,0
29385,METHOD,0,0
29386,Of,0,0
29387,the,0,0
29388,200,0,0
29389,women,0,0
29390,who,0,0
29391,agreed,0,0
29392,to,0,0
29393,participate,0,0
29394,in,0,0
29395,the,0,0
29396,project,0,0
29397,",",0,0
29398,100,0,0
29399,were,0,0
29400,randomly,0,0
29401,allocated,0,0
29402,to,0,0
29403,the,0,0
29404,pilot,1,0
29405,scheme,1,0
29406,and,0,0
29407,100,0,0
29408,to,0,0
29409,the,0,0
29410,traditional,1,0
29411,care,1,0
29412,package,1,0
29413,.,1,0
29414,During,0,0
29415,the,0,0
29416,postpartum,0,0
29417,period,0,0
29418,",",0,0
29419,information,0,0
29420,was,0,0
29421,collected,0,0
29422,via,0,0
29423,a,0,0
29424,questionnaire,0,0
29425,about,0,0
29426,participants,0,0
29427,',0,0
29428,levels,0,0
29429,of,0,0
29430,satisfaction,0,0
29431,with,0,0
29432,a,0,0
29433,variety,0,0
29434,of,0,0
29435,aspects,0,0
29436,of,0,0
29437,care,0,0
29438,provided,0,0
29439,during,0,0
29440,the,0,0
29441,antenatal,0,0
29442,",",0,0
29443,delivery,0,0
29444,and,0,0
29445,postpartum,0,0
29446,periods,0,0
29447,.,0,0
29448,Data,0,0
29449,about,0,0
29450,clinical,0,0
29451,outcomes,0,0
29452,for,0,0
29453,the,0,0
29454,two,0,0
29455,groups,0,0
29456,were,0,0
29457,also,0,0
29458,obtained,0,0
29459,.,0,0
29460,RESULTS,0,0
29461,Women,0,0
29462,in,0,0
29463,the,0,0
29464,pilot,0,0
29465,group,0,0
29466,had,0,0
29467,significantly,0,0
29468,more,0,0
29469,continuity,0,0
29470,of,0,0
29471,care,0,0
29472,throughout,0,0
29473,each,0,0
29474,of,0,0
29475,the,0,0
29476,three,0,0
29477,periods,0,0
29478,",",0,0
29479,were,0,0
29480,generally,0,0
29481,more,0,0
29482,satisfied,0,0
29483,with,0,0
29484,their,0,0
29485,care,0,0
29486,",",0,0
29487,felt,0,0
29488,that,0,0
29489,they,0,0
29490,had,0,0
29491,more,0,0
29492,choice,0,0
29493,over,0,0
29494,a,0,0
29495,variety,0,0
29496,of,0,0
29497,aspects,0,0
29498,of,0,0
29499,care,0,0
29500,and,0,0
29501,experienced,0,0
29502,no,0,0
29503,compromise,0,0
29504,in,0,0
29505,clinical,0,0
29506,outcomes,0,0
29507,(,0,0
29508,P,0,0
29509,=,0,0
29510,0.05,0,0
29511,or,0,0
29512,less,0,0
29513,in,0,0
29514,each,0,0
29515,case,0,0
29516,),0,0
29517,.,0,0
29518,IMPLICATIONS,0,0
29519,FOR,0,1
29520,PRACTICE,0,1
29521,Many,0,0
29522,previous,0,0
29523,attempts,0,0
29524,to,0,0
29525,introduce,0,0
29526,the,0,0
29527,Changing,0,0
29528,Childbirth,0,0
29529,initiative,0,0
29530,have,0,0
29531,revealed,0,0
29532,significant,0,0
29533,problems,0,0
29534,",",0,0
29535,particularly,0,0
29536,with,0,0
29537,regard,0,0
29538,to,0,0
29539,the,0,0
29540,continuity,0,0
29541,of,0,0
29542,carer,0,0
29543,requirement,0,0
29544,.,0,0
29545,Taking,0,0
29546,account,0,0
29547,of,0,0
29548,local,0,0
29549,health,0,0
29550,care,0,0
29551,needs,0,0
29552,and,0,0
29553,existing,0,0
29554,provision,0,0
29555,",",0,0
29556,the,0,0
29557,present,0,0
29558,study,0,0
29559,adapted,0,0
29560,this,0,0
29561,concept,0,0
29562,to,0,0
29563,continuity,0,0
29564,of,0,0
29565,care,0,0
29566,.,0,0
29567,This,0,0
29568,did,0,0
29569,not,0,0
29570,apparently,0,0
29571,affect,0,0
29572,any,0,0
29573,of,0,0
29574,the,0,0
29575,guiding,0,0
29576,principles,0,0
29577,contained,0,0
29578,in,0,0
29579,the,0,0
29580,original,0,0
29581,document,0,0
29582,",",0,0
29583,and,0,0
29584,yet,0,0
29585,enhanced,0,0
29586,satisfaction,0,0
29587,.,0,0
29588,It,0,0
29589,would,0,0
29590,appear,0,0
29591,that,0,0
29592,the,0,0
29593,Changing,0,0
29594,Childbirth,0,0
29595,agenda,0,0
29596,can,0,0
29597,be,0,0
29598,adapted,0,0
29599,and,0,0
29600,integrated,0,0
29601,with,0,0
29602,local,0,0
29603,health,0,0
29604,care,0,0
29605,situations,0,0
29606,without,0,0
29607,sacrificing,0,0
29608,any,0,0
29609,of,0,0
29610,the,0,0
29611,overarching,0,0
29612,principles,0,0
29613,.,0,0
29614,Recombinant,1,0
29615,human,1,0
29616,thrombopoietin,1,1
29617,augments,0,0
29618,mobilization,0,0
29619,of,0,0
29620,peripheral,0,0
29621,blood,0,0
29622,progenitor,0,0
29623,cells,0,0
29624,for,0,0
29625,autologous,0,0
29626,transplantation,0,0
29627,.,0,0
29628,This,0,0
29629,study,0,0
29630,assessed,0,0
29631,the,0,0
29632,ability,0,0
29633,of,0,0
29634,various,0,0
29635,schedules,0,0
29636,of,0,0
29637,recombinant,1,1
29638,human,1,1
29639,thrombopoietin,1,1
29640,(,1,1
29641,rhTPO,1,1
29642,),1,0
29643,to,0,0
29644,enhance,0,0
29645,mobilization,0,0
29646,of,0,0
29647,peripheral,0,0
29648,blood,0,0
29649,progenitor,0,0
29650,cells,0,0
29651,(,0,1
29652,PBPCs,0,1
29653,),0,0
29654,in,0,0
29655,134,0,0
29656,patients,0,0
29657,with,0,0
29658,cancer,0,0
29659,undergoing,0,1
29660,high-dose,0,1
29661,chemotherapy,0,1
29662,and,0,0
29663,autologous,0,0
29664,PBPC,0,1
29665,transplantation,0,0
29666,.,0,0
29667,Patients,0,0
29668,received,0,0
29669,the,0,0
29670,study,0,0
29671,drug,0,1
29672,on,0,1
29673,days,0,0
29674,1,0,0
29675,",",0,0
29676,3,0,0
29677,",",0,0
29678,and,0,0
29679,5,0,0
29680,before,0,0
29681,initiation,0,0
29682,of,0,0
29683,granulocyte,0,1
29684,colony-stimulating,0,1
29685,factor,0,1
29686,(,0,1
29687,G-CSF,0,1
29688,),0,1
29689,10,0,1
29690,microg/kg/day,0,1
29691,on,0,1
29692,day,0,0
29693,5,0,0
29694,and,0,1
29695,pheresis,0,1
29696,starting,0,1
29697,on,0,0
29698,day,0,0
29699,9,0,0
29700,.,0,0
29701,Randomly,0,0
29702,assigned,0,0
29703,treatments,0,0
29704,on,0,0
29705,days,0,0
29706,1,0,0
29707,",",0,0
29708,3,0,0
29709,",",0,0
29710,and,0,0
29711,5,0,0
29712,were,0,0
29713,:,0,0
29714,group,0,0
29715,1,0,0
29716,(,0,0
29717,n=27,0,0
29718,),0,0
29719,placebo,1,1
29720,",",1,1
29721,placebo,1,1
29722,",",1,1
29723,rhTPO,1,1
29724,1.5,0,1
29725,microg/kg,0,1
29726,;,0,1
29727,group,0,1
29728,2,0,0
29729,(,0,0
29730,n=27,0,0
29731,),0,0
29732,rhTPO,0,0
29733,1.5,0,1
29734,microg/kg,0,1
29735,",",0,1
29736,placebo,0,1
29737,",",0,1
29738,placebo,0,1
29739,;,0,1
29740,groups,0,1
29741,3,0,0
29742,(,0,0
29743,n=28,0,0
29744,),0,0
29745,and,0,0
29746,4,0,0
29747,(,0,0
29748,n=22,0,0
29749,),0,0
29750,rhTPO,0,0
29751,0.5,0,1
29752,microg/kg,0,1
29753,on,0,0
29754,all,0,0
29755,3,0,0
29756,treatment,0,0
29757,days,0,1
29758,;,0,1
29759,and,0,1
29760,group,0,1
29761,5,0,0
29762,(,0,0
29763,n=30,0,0
29764,),0,0
29765,placebo,0,1
29766,on,0,0
29767,all,0,0
29768,3,0,0
29769,treatment,0,0
29770,days,0,0
29771,.,0,1
29772,After,0,1
29773,high-dose,1,1
29774,chemotherapy,1,1
29775,and,1,0
29776,PBPC,1,1
29777,transplantation,1,1
29778,",",0,0
29779,groups,0,0
29780,1,0,0
29781,through,0,0
29782,4,0,0
29783,received,0,0
29784,rhTPO,0,1
29785,1.5,0,1
29786,microg/kg,0,1
29787,days,0,1
29788,0,0,1
29789,",",0,0
29790,+2,0,1
29791,",",0,0
29792,+4,0,0
29793,",",0,0
29794,and,0,0
29795,+6,0,0
29796,with,0,0
29797,either,0,0
29798,G-CSF,0,0
29799,5,0,1
29800,microg/kg/day,0,1
29801,(,0,1
29802,groups,0,1
29803,1-3,0,0
29804,),0,1
29805,or,0,1
29806,granulocyte-macrophage,0,1
29807,colony-stimulating,0,1
29808,factor,0,1
29809,250,0,1
29810,microg/m,0,1
29811,(,0,1
29812,2,0,1
29813,),0,1
29814,/day,0,1
29815,(,0,1
29816,group,0,1
29817,4,0,1
29818,),0,0
29819,.,0,0
29820,Group,0,0
29821,5,0,0
29822,received,0,0
29823,placebo,1,1
29824,plus,0,0
29825,G-CSF,0,1
29826,5,0,1
29827,microg/kg/day,0,1
29828,.,0,0
29829,The,0,0
29830,addition,0,0
29831,of,0,0
29832,rhTPO,1,0
29833,to,0,0
29834,G-CSF,0,0
29835,increased,0,0
29836,median,0,0
29837,CD34+,0,0
29838,cell,0,0
29839,yield/pheresis,0,0
29840,in,0,0
29841,cohorts,0,0
29842,in,0,0
29843,which,0,0
29844,rhTPO,1,0
29845,was,0,0
29846,started,0,0
29847,before,0,0
29848,day,0,1
29849,5,0,0
29850,",",0,0
29851,with,0,0
29852,higher,0,0
29853,yields,0,0
29854,in,0,0
29855,groups,0,0
29856,2,0,0
29857,(,0,0
29858,2.67,0,0
29859,x,0,0
29860,10,0,0
29861,(,0,1
29862,6,0,1
29863,),0,1
29864,/kg,0,1
29865,),0,1
29866,and,0,1
29867,groups,0,0
29868,3,0,0
29869,and,0,0
29870,4,0,0
29871,(,0,0
29872,3.10,0,0
29873,x,0,0
29874,10,0,0
29875,(,0,1
29876,6,0,1
29877,),0,1
29878,/kg,0,1
29879,),0,1
29880,than,0,0
29881,in,0,0
29882,group,0,0
29883,1,0,0
29884,(,0,0
29885,1.86,0,0
29886,x,0,0
29887,10,0,0
29888,(,0,1
29889,6,0,1
29890,),0,1
29891,/kg,0,1
29892,),0,1
29893,or,0,1
29894,group,0,1
29895,5,0,0
29896,(,0,0
29897,1.65,0,0
29898,x,0,0
29899,10,0,0
29900,(,0,1
29901,6,0,1
29902,),0,1
29903,/kg,0,1
29904,),0,1
29905,(,0,1
29906,P=.006,0,1
29907,across,0,1
29908,groups,0,0
29909,),0,0
29910,.,0,0
29911,Comparing,0,0
29912,rhTPO,1,0
29913,to,0,0
29914,placebo,1,1
29915,",",0,0
29916,higher,0,0
29917,percentages,0,0
29918,of,0,0
29919,patients,0,0
29920,achieved,0,0
29921,the,0,0
29922,minimum,0,0
29923,yield,0,0
29924,of,0,0
29925,CD34+,0,0
29926,>,0,0
29927,or,0,0
29928,=2,0,0
29929,x,0,0
29930,10,0,0
29931,(,0,1
29932,6,0,1
29933,),0,1
29934,/kg,0,1
29935,(,0,0
29936,92,0,0
29937,%,0,0
29938,v,0,0
29939,75,0,0
29940,%,0,0
29941,;,0,0
29942,P=.050,0,0
29943,),0,0
29944,as,0,0
29945,well,0,0
29946,as,0,0
29947,the,0,0
29948,target,0,0
29949,yield,0,0
29950,of,0,0
29951,CD34+,0,0
29952,>,0,0
29953,or,0,0
29954,=5,0,0
29955,x,0,0
29956,10,0,0
29957,(,0,1
29958,6,0,1
29959,),0,1
29960,/kg,0,1
29961,(,0,0
29962,73,0,0
29963,%,0,0
29964,v,0,0
29965,46,0,0
29966,%,0,0
29967,;,0,0
29968,P=,0,0
29969,.041,0,0
29970,),0,0
29971,.,0,0
29972,rhTPO-treated,1,0
29973,patients,0,0
29974,required,0,0
29975,fewer,0,0
29976,phereses,0,0
29977,to,0,0
29978,achieve,0,0
29979,minimum,0,0
29980,(,0,0
29981,P=,0,0
29982,.011,0,0
29983,),0,0
29984,and,0,0
29985,target,0,0
29986,(,0,0
29987,P=,0,0
29988,.015,0,0
29989,),0,0
29990,CD34+,0,0
29991,cell,0,0
29992,values,0,0
29993,.,0,0
29994,rhTPO,1,0
29995,given,0,0
29996,after,0,0
29997,transplantation,0,0
29998,did,0,0
29999,not,0,0
30000,speed,0,0
30001,platelet,0,1
30002,recovery,0,0
30003,.,0,1
30004,No,0,1
30005,neutralizing,0,1
30006,antibodies,0,0
30007,were,0,0
30008,observed,0,0
30009,.,0,0
30010,We,0,0
30011,conclude,0,0
30012,that,0,0
30013,rhTPO,1,0
30014,can,0,0
30015,safely,0,0
30016,enhance,0,0
30017,mobilization,0,0
30018,of,0,0
30019,PBPC,0,0
30020,",",0,0
30021,reduce,0,0
30022,the,0,0
30023,number,0,0
30024,of,0,0
30025,leukapheresis,0,1
30026,",",0,0
30027,and,0,0
30028,allow,0,0
30029,more,0,0
30030,patients,0,0
30031,to,0,0
30032,meet,0,0
30033,minimal,0,0
30034,cell,0,0
30035,yield,0,0
30036,requirements,0,0
30037,to,0,0
30038,receive,0,1
30039,high-dose,0,1
30040,chemotherapy,1,1
30041,with,0,0
30042,PBPC,1,0
30043,transplantation,1,0
30044,.,1,0
30045,Pethidine,1,1
30046,versus,1,1
30047,tramadol,1,1
30048,for,0,1
30049,pain,0,1
30050,relief,0,0
30051,during,0,0
30052,labor,0,0
30053,.,0,0
30054,OBJECTIVE,0,0
30055,To,0,0
30056,evaluate,0,0
30057,and,0,0
30058,compare,0,0
30059,the,0,0
30060,analgesic,0,1
30061,efficacy,0,1
30062,and,0,0
30063,adverse,0,0
30064,effects,0,0
30065,of,0,0
30066,tramadol,1,1
30067,and,0,1
30068,pethidine,1,1
30069,in,0,0
30070,labor,0,0
30071,.,0,0
30072,METHOD,0,0
30073,Fifty-nine,0,0
30074,full,0,0
30075,term,0,0
30076,parturients,0,0
30077,were,0,0
30078,randomly,0,0
30079,assigned,0,0
30080,to,0,0
30081,one,0,0
30082,of,0,0
30083,two,0,0
30084,groups,0,0
30085,in,0,0
30086,active,0,0
30087,labor,0,0
30088,.,0,0
30089,Group,0,0
30090,1,0,0
30091,received,0,0
30092,100,0,1
30093,mg,0,1
30094,pethidine,1,1
30095,;,1,1
30096,group,0,0
30097,2,0,0
30098,",",0,0
30099,100,0,1
30100,mg,0,1
30101,tramadol,1,1
30102,",",0,1
30103,intramuscularly,0,1
30104,.,0,1
30105,Analgesic,0,1
30106,efficacy,0,1
30107,",",0,0
30108,maternal,0,0
30109,side,0,0
30110,effects,0,0
30111,",",0,0
30112,changes,0,0
30113,in,0,0
30114,the,0,0
30115,blood,0,0
30116,pressure,0,0
30117,",",0,0
30118,heart,0,0
30119,rate,0,0
30120,",",0,0
30121,and,0,0
30122,duration,0,0
30123,of,0,0
30124,labor,0,0
30125,were,0,0
30126,assessed,0,0
30127,.,0,0
30128,RESULT,0,0
30129,At,0,0
30130,30,0,0
30131,and,0,0
30132,60,0,0
30133,min,0,0
30134,after,0,0
30135,drug,0,1
30136,administration,0,1
30137,",",0,1
30138,pain,0,1
30139,relief,0,0
30140,was,0,0
30141,greater,0,0
30142,in,0,0
30143,the,0,0
30144,pethidine,1,1
30145,group,0,1
30146,than,0,0
30147,in,0,0
30148,tramadol,1,1
30149,group,0,0
30150,.,0,0
30151,The,0,0
30152,incidence,0,0
30153,of,0,0
30154,nausea,0,1
30155,and,0,0
30156,fatigue,0,0
30157,was,0,0
30158,higher,0,0
30159,in,0,0
30160,the,0,0
30161,tramadol,1,1
30162,group,0,0
30163,.,0,0
30164,Following,0,0
30165,drug,0,1
30166,administration,0,1
30167,the,0,0
30168,decrease,0,0
30169,in,0,0
30170,systolic,0,0
30171,and,0,0
30172,diastolic,0,0
30173,blood,0,0
30174,pressure,0,0
30175,and,0,0
30176,the,0,0
30177,increase,0,0
30178,in,0,0
30179,heart,0,0
30180,rate,0,0
30181,were,0,0
30182,statistically,0,0
30183,significant,0,0
30184,in,0,0
30185,both,0,0
30186,groups,0,0
30187,.,0,0
30188,No,0,1
30189,significant,0,0
30190,difference,0,0
30191,was,0,0
30192,found,0,0
30193,between,0,0
30194,the,0,0
30195,groups,0,0
30196,when,0,0
30197,compared,0,0
30198,for,0,0
30199,duration,0,0
30200,of,0,0
30201,labor,0,0
30202,and,0,0
30203,Apgar,0,0
30204,scores,0,1
30205,.,0,0
30206,None,0,1
30207,of,0,0
30208,the,0,0
30209,neonates,0,0
30210,developed,0,0
30211,respiratory,0,0
30212,depression,0,0
30213,.,0,0
30214,CONCLUSION,0,1
30215,Pethidine,1,1
30216,seems,0,0
30217,to,0,0
30218,be,0,0
30219,a,0,0
30220,better,0,0
30221,alternative,0,0
30222,than,0,0
30223,tramadol,1,1
30224,in,0,1
30225,obstetric,0,1
30226,analgesia,0,1
30227,because,0,0
30228,of,0,0
30229,its,0,0
30230,superiority,0,0
30231,in,0,0
30232,analgesic,0,1
30233,efficacy,0,1
30234,and,0,0
30235,low,0,0
30236,incidence,0,0
30237,of,0,0
30238,maternal,0,0
30239,side,0,0
30240,effects,0,0
30241,.,0,0
30242,A,0,0
30243,comparative,0,0
30244,study,0,0
30245,of,0,0
30246,a,0,0
30247,new,0,0
30248,food,0,1
30249,supplement,0,1
30250,",",0,1
30251,ViviScal,1,1
30252,",",1,0
30253,with,1,0
30254,fish,1,0
30255,extract,1,0
30256,for,0,0
30257,the,0,0
30258,treatment,0,0
30259,of,0,0
30260,hereditary,0,1
30261,androgenic,0,1
30262,alopecia,0,1
30263,in,0,0
30264,young,0,0
30265,males,0,0
30266,.,0,0
30267,A,0,0
30268,controlled,0,0
30269,",",0,0
30270,randomized,0,0
30271,",",0,1
30272,double-blind,0,1
30273,",",0,1
30274,parallel-group,0,1
30275,study,0,0
30276,compared,0,0
30277,the,0,0
30278,effects,0,0
30279,of,0,0
30280,ViviScal,1,1
30281,(,1,0
30282,a,1,0
30283,new,1,0
30284,food,1,0
30285,supplement,1,1
30286,incorporating,1,0
30287,special,1,0
30288,marine,1,0
30289,extracts,1,0
30290,and,1,0
30291,a,1,0
30292,silica,1,1
30293,compound,1,0
30294,),1,0
30295,with,1,0
30296,those,1,0
30297,of,1,0
30298,a,1,0
30299,fish,1,0
30300,extract,1,0
30301,in,0,0
30302,the,0,0
30303,treatment,0,0
30304,of,0,0
30305,young,0,0
30306,males,0,0
30307,with,0,0
30308,hereditary,0,1
30309,androgenic,0,1
30310,alopecia,0,1
30311,.,0,0
30312,The,0,0
30313,pretreatment,0,0
30314,histological,0,0
30315,diagnosis,0,0
30316,was,0,0
30317,alopecia,0,0
30318,with,0,0
30319,a,0,0
30320,mild,0,0
30321,to,0,0
30322,moderate,0,0
30323,perifollicular,0,0
30324,inflammation,0,0
30325,zone,0,0
30326,.,0,0
30327,The,0,0
30328,study,0,0
30329,consisted,0,0
30330,of,0,0
30331,20,0,0
30332,subjects,0,0
30333,who,0,0
30334,received,0,0
30335,two,1,0
30336,tablets,1,1
30337,of,1,1
30338,ViviScal,1,1
30339,once,1,1
30340,daily,1,1
30341,and,1,1
30342,20,1,0
30343,who,1,0
30344,received,1,0
30345,two,1,0
30346,tablets,1,1
30347,of,1,0
30348,fish,1,0
30349,extract,1,1
30350,once,1,1
30351,daily,1,1
30352,for,1,1
30353,6,1,0
30354,months,1,0
30355,.,1,0
30356,The,0,0
30357,mean,0,0
30358,patient,0,0
30359,age,0,0
30360,and,0,0
30361,mean,0,0
30362,duration,0,0
30363,and,0,0
30364,severity,0,0
30365,of,0,0
30366,baldness,0,0
30367,compared,0,0
30368,well,0,0
30369,between,0,0
30370,the,0,0
30371,two,0,0
30372,groups,0,0
30373,.,0,0
30374,Most,0,0
30375,patients,0,0
30376,had,0,0
30377,been,0,0
30378,treated,0,0
30379,with,0,0
30380,long-term,0,1
30381,topical,0,1
30382,2,0,1
30383,%,0,0
30384,minoxidil,1,1
30385,for,0,0
30386,1,0,0
30387,year,0,0
30388,or,0,0
30389,more,0,0
30390,prior,0,0
30391,to,0,0
30392,the,0,0
30393,study,0,0
30394,.,0,0
30395,At,0,0
30396,baseline,0,0
30397,and,0,0
30398,after,0,0
30399,6,0,0
30400,months,0,0
30401,',0,0
30402,treatment,0,0
30403,",",0,0
30404,a,0,0
30405,biopsy,0,0
30406,was,0,0
30407,taken,0,0
30408,for,0,0
30409,histological,0,0
30410,examination,0,0
30411,.,0,0
30412,A,0,0
30413,non-vellus,0,0
30414,hair,0,0
30415,count,0,0
30416,was,0,0
30417,performed,0,0
30418,at,0,0
30419,baseline,0,0
30420,and,0,0
30421,after,0,0
30422,2,0,0
30423,",",0,0
30424,4,0,0
30425,and,0,0
30426,6,0,0
30427,months,0,0
30428,.,0,0
30429,In,0,0
30430,the,0,0
30431,fish,1,0
30432,extract,1,1
30433,treatment,0,0
30434,group,0,0
30435,three,0,0
30436,patients,0,0
30437,withdrew,0,0
30438,from,0,0
30439,the,0,0
30440,study,0,0
30441,before,0,0
30442,the,0,0
30443,fourth,0,0
30444,month,0,0
30445,due,0,0
30446,to,0,0
30447,lack,0,0
30448,of,0,0
30449,therapeutic,0,0
30450,effect,0,0
30451,.,0,0
30452,After,0,0
30453,6,0,0
30454,months,0,0
30455,',0,0
30456,treatment,0,0
30457,",",0,0
30458,patients,0,0
30459,receiving,0,0
30460,ViviScal,1,0
30461,showed,0,0
30462,a,0,0
30463,mean,0,0
30464,increase,0,0
30465,in,0,0
30466,non-vellus,0,0
30467,hair,0,0
30468,of,0,0
30469,38,0,0
30470,%,0,0
30471,compared,0,0
30472,with,0,0
30473,a,0,0
30474,2,0,0
30475,%,0,0
30476,increase,0,0
30477,in,0,0
30478,the,0,0
30479,fish,1,0
30480,extract,1,1
30481,treatment,0,1
30482,group,0,0
30483,(,0,0
30484,P,0,0
30485,<,0,0
30486,0.0001,0,0
30487,),0,0
30488,.,0,0
30489,In,0,0
30490,the,0,0
30491,ViviScal,1,0
30492,group,0,0
30493,",",0,0
30494,19,0,0
30495,(,0,0
30496,95,0,0
30497,%,0,0
30498,),0,0
30499,subjects,0,0
30500,showed,0,0
30501,both,0,0
30502,clinical,0,0
30503,and,0,0
30504,histological,0,0
30505,cure,0,0
30506,",",0,0
30507,whereas,0,0
30508,none,0,0
30509,treated,0,0
30510,with,0,0
30511,fish,0,0
30512,extract,0,0
30513,showed,0,0
30514,any,0,0
30515,clinical,0,0
30516,or,0,0
30517,histological,0,0
30518,difference,0,0
30519,after,0,0
30520,6,0,0
30521,months,0,0
30522,',0,0
30523,treatment,0,0
30524,(,0,0
30525,P,0,0
30526,<,0,0
30527,0.0001,0,0
30528,),0,0
30529,.,0,0
30530,In,0,0
30531,both,0,0
30532,groups,0,0
30533,",",0,0
30534,a,0,0
30535,minimal,0,0
30536,decrease,0,0
30537,in,0,0
30538,the,0,0
30539,erythemal,0,0
30540,index,0,0
30541,was,0,0
30542,observed,0,0
30543,.,0,0
30544,In,0,0
30545,conclusion,0,0
30546,",",0,0
30547,ViviScal,1,0
30548,appears,0,0
30549,to,0,0
30550,be,0,0
30551,the,0,0
30552,first,0,0
30553,highly,0,0
30554,active,0,0
30555,treatment,0,0
30556,for,0,0
30557,androgenic,0,1
30558,alopecia,0,1
30559,in,0,0
30560,young,0,0
30561,males,0,0
30562,.,0,0
30563,Children,0,0
30564,with,0,0
30565,autistic,0,0
30566,spectrum,0,0
30567,disorders,0,0
30568,.,0,0
30569,I,0,0
30570,:,0,0
30571,comparison,0,0
30572,of,0,0
30573,placebo,1,1
30574,and,0,1
30575,single,0,0
30576,dose,0,1
30577,of,0,0
30578,human,1,0
30579,synthetic,1,0
30580,secretin,1,1
30581,.,1,1
30582,AIMS,0,1
30583,To,0,0
30584,examine,0,0
30585,the,0,0
30586,effect,0,0
30587,of,0,0
30588,a,0,0
30589,single,0,0
30590,dose,0,1
30591,of,0,0
30592,human,1,0
30593,synthetic,1,0
30594,secretin,1,1
30595,(,1,1
30596,HSS,1,1
30597,),1,1
30598,on,0,0
30599,behaviour,0,0
30600,and,0,0
30601,communication,0,0
30602,in,0,0
30603,children,0,0
30604,with,0,0
30605,autism,0,0
30606,spectrum,0,0
30607,disorder,0,1
30608,(,0,1
30609,ASD,0,1
30610,),0,0
30611,using,0,0
30612,an,0,0
30613,objective,0,0
30614,measure,0,0
30615,of,0,0
30616,communication,0,0
30617,and,0,0
30618,social,0,0
30619,reciprocity,0,0
30620,and,0,0
30621,standardised,0,0
30622,rating,0,0
30623,scales,0,0
30624,.,0,0
30625,METHODS,0,0
30626,Randomised,0,1
30627,",",0,0
30628,crossover,0,1
30629,",",0,0
30630,double,0,0
30631,blind,0,0
30632,",",0,0
30633,and,0,0
30634,placebo,1,1
30635,controlled,0,0
30636,trial,0,0
30637,of,0,0
30638,a,0,0
30639,single,0,0
30640,intravenous,0,1
30641,dose,0,1
30642,of,0,0
30643,human,1,0
30644,synthetic,1,0
30645,secretin,1,1
30646,(,1,1
30647,HSS,1,1
30648,),1,1
30649,2,0,1
30650,CU/kg,0,1
30651,.,0,0
30652,The,0,0
30653,62,0,0
30654,subjects,0,0
30655,(,0,0
30656,3-8,0,0
30657,years,0,0
30658,),0,0
30659,were,0,0
30660,assigned,0,0
30661,to,0,0
30662,group,0,0
30663,1,0,1
30664,(,1,1
30665,saline,1,1
30666,placebo/HSS,1,1
30667,),1,1
30668,or,0,1
30669,group,0,1
30670,2,0,1
30671,(,1,1
30672,HSS/saline,1,1
30673,placebo,1,1
30674,),1,1
30675,.,1,0
30676,Diagnosis,0,0
30677,was,0,0
30678,confirmed,0,0
30679,by,0,0
30680,ADI-R,0,1
30681,(,0,1
30682,Autism,0,1
30683,Diagnostic,0,1
30684,Interview-Revised,0,1
30685,),0,0
30686,algorithm,0,0
30687,.,0,0
30688,Severity,0,0
30689,of,0,0
30690,symptoms,0,0
30691,was,0,0
30692,rated,0,0
30693,using,0,0
30694,the,0,0
30695,CARS,0,1
30696,(,0,1
30697,Childhood,0,0
30698,Autism,0,0
30699,Rating,0,0
30700,Scale,0,0
30701,),0,0
30702,.,0,0
30703,Outcome,0,0
30704,measures,0,0
30705,included,0,0
30706,Communication,0,0
30707,and,0,0
30708,Symbolic,0,0
30709,Behavior,0,1
30710,Scale,0,1
30711,(,0,1
30712,CSBS,0,1
30713,),0,1
30714,",",0,0
30715,Ritvo,0,1
30716,Real-life,0,0
30717,Rating,0,0
30718,Scale,0,0
30719,",",0,0
30720,weekly,0,0
30721,Global,0,0
30722,Rating,0,0
30723,Scale,0,0
30724,(,0,1
30725,GBRS,0,1
30726,),0,1
30727,by,0,0
30728,parents,0,0
30729,and,0,0
30730,teachers,0,0
30731,",",0,0
30732,and,0,0
30733,daily,0,1
30734,log,0,0
30735,of,0,0
30736,gastrointestinal,0,0
30737,symptoms,0,0
30738,.,0,0
30739,The,0,0
30740,communication,0,0
30741,subscale,0,0
30742,of,0,0
30743,the,0,0
30744,CSBS,0,0
30745,",",0,0
30746,specifying,0,0
30747,communication,0,0
30748,function,0,0
30749,",",0,0
30750,reciprocity,0,0
30751,",",0,0
30752,and,0,0
30753,social-affective,0,0
30754,signalling,0,0
30755,was,0,0
30756,videotaped,0,0
30757,and,0,0
30758,scored,0,0
30759,by,0,0
30760,a,0,0
30761,blinded,0,0
30762,",",0,0
30763,trained,0,0
30764,observer,0,0
30765,.,0,0
30766,RESULTS,0,0
30767,Sixty,0,0
30768,one,0,0
30769,children,0,0
30770,completed,0,0
30771,the,0,0
30772,study,0,0
30773,.,0,0
30774,After,0,0
30775,randomisation,0,0
30776,",",0,0
30777,there,0,0
30778,were,0,0
30779,no,0,0
30780,significant,0,0
30781,differences,0,0
30782,in,0,0
30783,gender,0,0
30784,",",0,0
30785,race,0,0
30786,",",0,0
30787,age,0,0
30788,",",0,0
30789,and,0,0
30790,parent,0,0
30791,and,0,0
30792,teacher,0,0
30793,GBRS,0,1
30794,and,0,0
30795,Ritvo,0,0
30796,Scale,0,0
30797,between,0,0
30798,the,0,0
30799,two,0,0
30800,groups,0,0
30801,.,0,0
30802,Compared,0,0
30803,with,0,0
30804,placebo,1,1
30805,",",1,1
30806,secretin,1,1
30807,treatment,1,0
30808,was,0,0
30809,not,0,0
30810,associated,0,0
30811,with,0,0
30812,significant,0,0
30813,improvement,0,0
30814,of,0,0
30815,CSBS,0,1
30816,standard,0,0
30817,scores,0,0
30818,from,0,0
30819,baseline,0,0
30820,to,0,0
30821,2,0,0
30822,or,0,0
30823,4,0,0
30824,weeks,0,0
30825,post-infusion,0,1
30826,.,0,1
30827,Five,0,0
30828,children,0,0
30829,showed,0,0
30830,clinical,0,0
30831,improvement,0,0
30832,in,0,0
30833,standard,0,0
30834,scores,0,0
30835,:,0,0
30836,two,0,0
30837,after,0,0
30838,HSS,1,0
30839,and,0,0
30840,three,0,0
30841,after,0,0
30842,placebo,1,1
30843,.,1,0
30844,There,0,0
30845,were,0,0
30846,no,0,0
30847,significant,0,0
30848,changes,0,0
30849,in,0,0
30850,gastrointestinal,0,0
30851,symptoms,0,0
30852,after,0,0
30853,HSS,1,0
30854,or,0,1
30855,saline,1,1
30856,placebo,1,1
30857,.,1,1
30858,CONCLUSIONS,0,1
30859,A,0,1
30860,single,0,0
30861,dose,0,1
30862,of,0,1
30863,intravenous,0,1
30864,human,1,1
30865,secretin,1,1
30866,is,0,0
30867,not,0,0
30868,effective,0,0
30869,in,0,0
30870,changing,0,0
30871,behaviour,0,0
30872,and,0,0
30873,communication,0,0
30874,in,0,0
30875,children,0,0
30876,with,0,0
30877,ASD,0,0
30878,when,0,0
30879,compared,0,0
30880,to,0,0
30881,placebo,1,1
30882,.,1,0
30883,Children,0,0
30884,with,0,0
30885,autistic,0,0
30886,spectrum,0,0
30887,disorders,0,0
30888,.,0,0
30889,II,0,0
30890,:,0,0
30891,parents,0,0
30892,are,0,0
30893,unable,0,0
30894,to,0,0
30895,distinguish,0,0
30896,secretin,0,1
30897,from,0,1
30898,placebo,0,1
30899,under,0,1
30900,double-blind,0,1
30901,conditions,0,0
30902,.,0,0
30903,BACKGROUND,0,0
30904,Standardised,0,0
30905,measures,0,0
30906,of,0,0
30907,behaviour,0,0
30908,have,0,0
30909,failed,0,0
30910,to,0,0
30911,detect,0,0
30912,short,0,0
30913,term,0,0
30914,improvement,0,0
30915,in,0,0
30916,children,0,0
30917,with,0,0
30918,autism,0,0
30919,following,0,0
30920,treatment,0,0
30921,with,0,0
30922,secretin,1,1
30923,.,1,0
30924,However,0,0
30925,",",0,0
30926,it,0,0
30927,is,0,0
30928,possible,0,0
30929,that,0,0
30930,standardised,0,0
30931,measures,0,0
30932,are,0,0
30933,insensitive,0,0
30934,to,0,0
30935,dimensions,0,0
30936,of,0,0
30937,child,0,0
30938,behaviour,0,0
30939,that,0,0
30940,are,0,0
30941,nonetheless,0,0
30942,detectable,0,0
30943,by,0,0
30944,parents,0,0
30945,.,0,0
30946,AIM,0,0
30947,To,0,0
30948,determine,0,0
30949,the,0,0
30950,ability,0,0
30951,of,0,0
30952,parents,0,0
30953,of,0,0
30954,children,0,0
30955,with,0,0
30956,autism,0,0
30957,to,0,0
30958,guess,0,0
30959,",",0,0
30960,under,0,0
30961,double,0,0
30962,blind,0,0
30963,conditions,0,0
30964,",",0,0
30965,whether,0,0
30966,their,0,0
30967,child,0,0
30968,had,0,0
30969,received,0,0
30970,secretin,1,1
30971,or,0,1
30972,placebo,1,1
30973,.,1,1
30974,METHODS,0,1
30975,2x2,0,1
30976,crossover,0,1
30977,randomised,0,1
30978,blinded,0,1
30979,study,0,0
30980,",",0,0
30981,comparing,0,0
30982,the,0,0
30983,effect,0,0
30984,of,0,0
30985,synthetic,1,0
30986,human,1,0
30987,secretin,1,1
30988,2,0,1
30989,U/kg,0,1
30990,to,0,1
30991,placebo,1,1
30992,(,1,1
30993,saline,1,1
30994,),1,1
30995,.,1,0
30996,Sixty,0,0
30997,two,0,0
30998,children,0,0
30999,with,0,0
31000,autism,0,0
31001,(,0,0
31002,aged,0,0
31003,43-103,0,0
31004,months,0,0
31005,),0,0
31006,were,0,0
31007,randomly,0,0
31008,allocated,0,0
31009,to,0,0
31010,two,0,0
31011,groups,0,0
31012,:,0,0
31013,group,0,0
31014,1,0,0
31015,received,0,0
31016,placebo,1,1
31017,",",1,0
31018,followed,1,0
31019,six,1,0
31020,weeks,1,0
31021,later,1,0
31022,by,1,0
31023,secretin,1,1
31024,",",0,1
31025,and,0,1
31026,group,0,0
31027,2,0,0
31028,received,0,0
31029,secretin,1,1
31030,followed,1,1
31031,by,1,0
31032,placebo,1,1
31033,.,1,0
31034,At,0,0
31035,the,0,0
31036,conclusion,0,0
31037,of,0,0
31038,the,0,0
31039,study,0,0
31040,",",0,0
31041,parents,0,0
31042,were,0,0
31043,asked,0,0
31044,to,0,0
31045,guess,0,0
31046,their,0,0
31047,child,0,0
31048,'s,0,0
31049,group,0,0
31050,assignment,0,0
31051,.,0,0
31052,RESULTS,0,0
31053,Twenty,0,0
31054,seven,0,0
31055,families,0,0
31056,guessed,0,0
31057,their,0,0
31058,child,0,0
31059,'s,0,0
31060,group,0,0
31061,assignment,0,0
31062,correctly,0,0
31063,and,0,0
31064,27,0,0
31065,guessed,0,0
31066,incorrectly,0,0
31067,.,0,0
31068,In,0,0
31069,48,0,0
31070,instances,0,0
31071,",",0,0
31072,parents,0,0
31073,based,0,0
31074,their,0,0
31075,guess,0,0
31076,on,0,0
31077,perceived,0,0
31078,improvement,0,0
31079,;,0,0
31080,in,0,0
31081,six,0,0
31082,cases,0,0
31083,",",0,0
31084,parents,0,0
31085,based,0,0
31086,their,0,0
31087,guess,0,0
31088,on,0,0
31089,perceived,0,0
31090,deterioration,0,0
31091,.,0,0
31092,Six,0,0
31093,families,0,0
31094,saw,0,0
31095,no,0,0
31096,difference,0,0
31097,after,0,0
31098,either,0,0
31099,infusion,0,1
31100,",",0,0
31101,and,0,0
31102,offered,0,0
31103,no,0,0
31104,guess,0,0
31105,.,0,0
31106,One,0,0
31107,family,0,0
31108,dropped,0,0
31109,out,0,0
31110,after,0,0
31111,the,0,0
31112,first,0,0
31113,infusion,0,1
31114,",",0,0
31115,and,0,0
31116,one,0,0
31117,family,0,0
31118,was,0,0
31119,lost,0,0
31120,to,0,0
31121,follow,0,0
31122,up,0,0
31123,after,0,0
31124,the,0,0
31125,second,0,0
31126,infusion,0,1
31127,.,0,1
31128,CONCLUSION,0,0
31129,In,0,0
31130,a,0,0
31131,controlled,0,0
31132,setting,0,0
31133,",",0,0
31134,parents,0,0
31135,of,0,0
31136,young,0,0
31137,children,0,0
31138,with,0,0
31139,autism,0,0
31140,are,0,0
31141,unable,0,0
31142,to,0,0
31143,distinguish,0,0
31144,the,0,0
31145,short,0,0
31146,term,0,0
31147,behavioural,0,0
31148,effects,0,0
31149,of,0,0
31150,secretin,1,1
31151,from,0,1
31152,placebo,1,1
31153,.,1,0
31154,Left,1,0
31155,ventricular,1,0
31156,mass,1,0
31157,regression,1,0
31158,in,0,0
31159,elderly,0,0
31160,hypertensives,0,0
31161,.,0,0
31162,It,0,0
31163,is,0,0
31164,now,0,0
31165,recognized,0,0
31166,that,0,0
31167,left,0,0
31168,ventricular,0,1
31169,hypertrophy,0,1
31170,(,0,1
31171,LVH,0,1
31172,),0,1
31173,",",0,0
31174,often,0,0
31175,associated,0,0
31176,with,0,0
31177,hypertension,0,0
31178,",",0,0
31179,is,0,0
31180,itself,0,0
31181,a,0,0
31182,risk,0,0
31183,factor,0,0
31184,for,0,0
31185,coronary,0,0
31186,disease,0,0
31187,in,0,0
31188,the,0,0
31189,elderly,0,0
31190,.,0,0
31191,Although,0,0
31192,many,0,0
31193,agents,0,0
31194,are,0,0
31195,capable,0,0
31196,of,0,0
31197,controlling,0,0
31198,blood,0,0
31199,pressure,0,0
31200,",",0,0
31201,the,0,0
31202,ability,0,0
31203,of,0,0
31204,these,0,0
31205,agents,0,0
31206,to,0,0
31207,induce,0,0
31208,regression,0,0
31209,of,0,0
31210,left,0,1
31211,ventricular,0,1
31212,(,0,1
31213,LV,0,1
31214,),0,0
31215,mass,0,0
31216,",",0,0
31217,and,0,0
31218,the,0,0
31219,effect,0,0
31220,of,0,0
31221,regression,0,0
31222,on,0,0
31223,diastolic,0,0
31224,relaxation,0,0
31225,and,0,0
31226,contractile,0,0
31227,indices,0,0
31228,in,0,0
31229,the,0,0
31230,elderly,0,0
31231,are,0,0
31232,less,0,0
31233,well,0,0
31234,known,0,0
31235,.,0,0
31236,Our,0,0
31237,study,0,0
31238,compared,0,0
31239,the,0,0
31240,ability,0,0
31241,of,0,0
31242,the,0,0
31243,calcium,1,1
31244,blocker,1,1
31245,",",1,1
31246,verapamil,1,1
31247,",",1,1
31248,and,1,0
31249,the,1,0
31250,beta-blocker,1,1
31251,",",1,1
31252,atenolol,1,1
31253,",",0,0
31254,to,0,0
31255,both,0,0
31256,control,0,0
31257,blood,0,0
31258,pressure,0,1
31259,(,0,1
31260,BP,0,1
31261,),0,1
31262,and,0,0
31263,to,0,0
31264,induce,0,0
31265,regression,0,0
31266,of,0,0
31267,LV,0,0
31268,mass,0,0
31269,in,0,0
31270,older,0,0
31271,hypertensives,0,0
31272,.,0,0
31273,In,0,0
31274,addition,0,0
31275,",",0,0
31276,the,0,0
31277,influence,0,0
31278,of,0,0
31279,regression,0,0
31280,on,0,0
31281,resting,0,0
31282,diastolic,0,0
31283,filling,0,0
31284,and,0,0
31285,on,0,0
31286,cardiac,0,0
31287,output,0,0
31288,and,0,0
31289,ejection,0,0
31290,fraction,0,0
31291,during,0,0
31292,rest,0,0
31293,and,0,0
31294,mild,0,0
31295,upright,0,0
31296,bicycle,0,0
31297,exercise,0,0
31298,were,0,0
31299,determined,0,0
31300,.,0,0
31301,Forty-two,0,0
31302,hypertensives,0,0
31303,60,0,0
31304,years,0,0
31305,of,0,0
31306,age,0,0
31307,or,0,0
31308,above,0,0
31309,",",0,0
31310,without,0,0
31311,evidence,0,0
31312,of,0,0
31313,ischemic,0,0
31314,disease,0,0
31315,underwent,0,0
31316,2-D,1,0
31317,echocardiographic,1,0
31318,evaluation,1,0
31319,of,0,0
31320,LV,0,0
31321,mass,0,0
31322,and,0,0
31323,gated,0,0
31324,blood,0,0
31325,pool,0,0
31326,scan,0,0
31327,determination,0,0
31328,of,0,0
31329,early,0,0
31330,diastolic,0,0
31331,filling,0,0
31332,",",0,0
31333,cardiac,0,0
31334,output,0,0
31335,and,0,0
31336,ejection,0,0
31337,fraction,0,0
31338,.,0,0
31339,They,0,0
31340,were,0,0
31341,then,0,0
31342,randomized,0,0
31343,to,0,0
31344,receive,0,1
31345,verapamil,1,1
31346,or,0,1
31347,atenolol,1,1
31348,during,0,0
31349,a,0,0
31350,four-week,0,1
31351,titration,0,1
31352,period,0,1
31353,so,0,0
31354,as,0,0
31355,to,0,0
31356,achieve,0,0
31357,a,0,0
31358,BP,0,0
31359,of,0,0
31360,less,0,0
31361,than,0,0
31362,160/90,0,0
31363,mm,0,0
31364,Hg,0,0
31365,.,0,0
31366,If,0,0
31367,BP,0,0
31368,was,0,0
31369,not,0,0
31370,controlled,0,0
31371,with,0,0
31372,either,0,0
31373,agent,0,0
31374,",",0,0
31375,chlorthalidone,0,1
31376,was,0,0
31377,added,0,0
31378,.,0,0
31379,Individuals,0,0
31380,whose,0,0
31381,BP,0,0
31382,was,0,0
31383,controlled,0,0
31384,continued,0,0
31385,on,0,0
31386,the,0,0
31387,protocol,0,0
31388,for,0,0
31389,six,0,0
31390,months,0,0
31391,.,0,0
31392,At,0,0
31393,that,0,0
31394,time,0,0
31395,",",0,0
31396,the,0,0
31397,echocardiographic,0,0
31398,and,0,0
31399,gated,0,0
31400,blood,0,0
31401,pool,0,0
31402,studies,0,0
31403,were,0,0
31404,repeated,0,0
31405,both,0,0
31406,on,0,0
31407,and,0,0
31408,after,0,0
31409,subsequent,0,0
31410,withdrawal,0,0
31411,of,0,0
31412,the,0,0
31413,study,0,0
31414,medications,0,1
31415,.,0,0
31416,Twenty-one,0,0
31417,patients,0,0
31418,were,0,0
31419,randomized,0,0
31420,to,0,0
31421,receive,0,1
31422,verapamil,1,1
31423,and,0,0
31424,21,0,0
31425,patients,0,0
31426,to,0,0
31427,receive,0,1
31428,atenolol,1,1
31429,.,1,1
31430,Blood,0,0
31431,pressure,0,0
31432,control,0,0
31433,was,0,0
31434,achieved,0,0
31435,with,0,0
31436,verapamil,0,1
31437,alone,0,0
31438,in,0,0
31439,18,0,0
31440,patients,0,0
31441,",",0,0
31442,but,0,0
31443,with,0,0
31444,atenolol,0,1
31445,alone,0,0
31446,in,0,0
31447,only,0,0
31448,8,0,0
31449,patients,0,0
31450,(,0,0
31451,p,0,0
31452,<,0,0
31453,0.01,0,0
31454,),0,0
31455,.,0,0
31456,(,0,0
31457,ABSTRACT,0,1
31458,TRUNCATED,0,1
31459,AT,0,1
31460,250,0,1
31461,WORDS,0,1
31462,),0,1
31463,Effects,0,0
31464,of,0,0
31465,pentoxifylline,1,1
31466,administration,0,1
31467,on,0,1
31468,urinary,0,1
31469,N-acetyl-beta-glucosaminidase,0,1
31470,excretion,0,1
31471,in,0,1
31472,type,0,0
31473,2,0,0
31474,diabetic,0,0
31475,patients,0,0
31476,:,0,0
31477,a,0,0
31478,short-term,0,0
31479,",",0,0
31480,prospective,0,0
31481,",",0,0
31482,randomized,0,0
31483,study,0,0
31484,.,0,0
31485,BACKGROUND,0,0
31486,Tubulointerstitial,0,0
31487,injury,0,0
31488,is,0,0
31489,a,0,0
31490,major,0,0
31491,feature,0,0
31492,of,0,0
31493,diabetic,0,0
31494,nephropathy,0,0
31495,and,0,0
31496,an,0,0
31497,important,0,0
31498,predictor,0,0
31499,of,0,0
31500,renal,0,0
31501,dysfunction,0,0
31502,.,0,0
31503,In,0,0
31504,45,0,0
31505,patients,0,0
31506,with,0,0
31507,type,0,0
31508,2,0,0
31509,diabetes,0,0
31510,mellitus,0,1
31511,(,0,1
31512,DM,0,1
31513,),0,1
31514,",",0,0
31515,we,0,0
31516,prospectively,0,0
31517,analyzed,0,0
31518,urinary,0,1
31519,excretion,0,1
31520,of,0,1
31521,N-acetyl-beta-glucosaminidase,0,1
31522,(,0,1
31523,NAG,0,1
31524,),0,1
31525,",",0,0
31526,a,0,0
31527,marker,0,0
31528,of,0,0
31529,tubular,0,0
31530,renal,0,0
31531,damage,0,0
31532,;,0,0
31533,the,0,0
31534,potential,0,0
31535,relationship,0,0
31536,with,0,0
31537,urinary,0,0
31538,protein,0,0
31539,excretion,0,1
31540,;,0,1
31541,and,0,0
31542,effects,0,0
31543,of,0,0
31544,pentoxifylline,1,1
31545,(,1,1
31546,PTF,1,1
31547,),1,1
31548,administration,0,1
31549,.,0,0
31550,METHODS,0,0
31551,Forty-five,0,0
31552,patients,0,0
31553,with,0,0
31554,type,0,0
31555,2,0,0
31556,DM,0,0
31557,initially,0,0
31558,were,0,0
31559,compared,0,0
31560,with,0,0
31561,15,0,0
31562,healthy,0,0
31563,controls,0,0
31564,matched,0,0
31565,for,0,0
31566,age,0,0
31567,and,0,0
31568,sex,0,0
31569,.,0,0
31570,After,0,0
31571,randomization,0,0
31572,",",0,0
31573,PTF,1,1
31574,(,0,1
31575,"1,200",0,1
31576,mg/d,0,1
31577,),0,1
31578,was,0,0
31579,administered,0,1
31580,for,0,0
31581,4,0,0
31582,months,0,0
31583,to,0,0
31584,30,0,0
31585,patients,0,0
31586,and,0,0
31587,results,0,0
31588,were,0,0
31589,compared,0,0
31590,with,0,0
31591,data,0,0
31592,from,0,0
31593,a,0,0
31594,control,0,0
31595,group,0,0
31596,(,0,0
31597,n,0,0
31598,=,0,0
31599,15,0,0
31600,),0,0
31601,.,0,0
31602,RESULTS,0,0
31603,Proteinuria,0,1
31604,and,0,0
31605,urinary,0,1
31606,NAG,0,1
31607,excretion,0,1
31608,were,0,0
31609,significantly,0,0
31610,greater,0,0
31611,in,0,0
31612,patients,0,0
31613,with,0,0
31614,DM,0,0
31615,with,0,0
31616,respect,0,0
31617,to,0,0
31618,healthy,0,0
31619,controls,0,0
31620,.,0,0
31621,Before,0,0
31622,PTF,0,1
31623,administration,0,1
31624,",",0,1
31625,baseline,0,0
31626,parameters,0,0
31627,were,0,0
31628,similar,0,0
31629,in,0,0
31630,both,0,0
31631,groups,0,0
31632,of,0,0
31633,patients,0,0
31634,with,0,0
31635,DM,0,0
31636,.,0,0
31637,At,0,0
31638,the,0,0
31639,end,0,0
31640,of,0,0
31641,the,0,0
31642,study,0,0
31643,",",0,0
31644,urinary,0,0
31645,protein,0,0
31646,excretion,0,1
31647,and,0,1
31648,NAG-creatinine,0,1
31649,ratios,0,0
31650,decreased,0,0
31651,in,0,0
31652,the,0,0
31653,active,0,0
31654,group,0,0
31655,from,0,0
31656,920,0,0
31657,+/-,0,0
31658,522,0,0
31659,mg/d,0,0
31660,and,0,0
31661,14.3,0,0
31662,+/-,0,0
31663,16.9,0,0
31664,U/g,0,0
31665,to,0,0
31666,803,0,0
31667,+/-,0,0
31668,523,0,0
31669,mg/d,0,0
31670,(,0,0
31671,P,0,0
31672,<,0,0
31673,0.001,0,0
31674,),0,0
31675,and,0,0
31676,10.5,0,0
31677,+/-,0,0
31678,9.3,0,0
31679,U/g,0,0
31680,(,0,0
31681,P,0,0
31682,<,0,0
31683,0.05,0,0
31684,),0,0
31685,",",0,0
31686,respectively,0,0
31687,.,0,0
31688,Conversely,0,0
31689,",",0,0
31690,proteinuria,0,1
31691,and,0,1
31692,urinary,0,1
31693,NAG,0,1
31694,excretion,0,1
31695,did,0,0
31696,not,0,0
31697,change,0,0
31698,in,0,0
31699,the,0,0
31700,control,1,0
31701,group,0,0
31702,.,0,0
31703,Regression,0,0
31704,analysis,0,0
31705,showed,0,0
31706,that,0,0
31707,urinary,0,0
31708,NAG,0,1
31709,excretion,0,1
31710,was,0,0
31711,significantly,0,0
31712,associated,0,0
31713,with,0,0
31714,duration,0,0
31715,of,0,0
31716,DM,0,1
31717,(,0,0
31718,r,0,0
31719,=,0,0
31720,0.61,0,0
31721,;,0,0
31722,P,0,0
31723,<,0,0
31724,0.001,0,0
31725,),0,0
31726,and,0,0
31727,proteinuria,0,1
31728,(,0,1
31729,r,0,0
31730,=,0,0
31731,0.51,0,0
31732,;,0,0
31733,P,0,0
31734,<,0,0
31735,0.001,0,0
31736,),0,0
31737,.,0,0
31738,CONCLUSION,0,0
31739,Urinary,0,0
31740,NAG,0,1
31741,excretion,0,1
31742,is,0,0
31743,elevated,0,0
31744,in,0,0
31745,patients,0,0
31746,with,0,0
31747,type,0,0
31748,2,0,0
31749,DM,0,0
31750,compared,0,0
31751,with,0,0
31752,healthy,0,0
31753,individuals,0,0
31754,and,0,0
31755,increases,0,0
31756,as,0,0
31757,nephropathy,0,0
31758,progresses,0,0
31759,.,0,0
31760,PTF,1,1
31761,administration,0,1
31762,is,0,0
31763,effective,0,0
31764,in,0,0
31765,reducing,0,0
31766,proteinuria,0,1
31767,and,0,1
31768,urinary,0,1
31769,NAG,0,1
31770,excretion,0,1
31771,in,0,0
31772,these,0,0
31773,patients,0,0
31774,.,0,0
31775,These,0,0
31776,findings,0,0
31777,suggest,0,0
31778,that,0,0
31779,PTF,1,0
31780,may,0,0
31781,have,0,0
31782,beneficial,0,0
31783,effects,0,0
31784,on,0,0
31785,tubulointerstitial,0,0
31786,damage,0,0
31787,in,0,0
31788,diabetic,0,0
31789,kidney,0,0
31790,disease,0,0
31791,.,0,0
31792,Gastric,0,0
31793,dysrhythmia,0,0
31794,in,0,0
31795,infants,0,0
31796,with,0,0
31797,gastrointestinal,0,0
31798,diseases,0,0
31799,measured,0,0
31800,by,0,0
31801,epigastric,1,0
31802,impedance,1,0
31803,.,1,0
31804,BACKGROUND,0,0
31805,Gastrointestinal,0,0
31806,symptoms,0,0
31807,have,0,0
31808,been,0,0
31809,reported,0,0
31810,in,0,0
31811,association,0,0
31812,with,0,0
31813,myoelectrical,0,0
31814,dysrhythmia,0,0
31815,",",0,0
31816,where,0,0
31817,different,0,0
31818,types,0,0
31819,of,0,0
31820,gastric,0,0
31821,electrical,0,0
31822,activity,0,0
31823,have,0,0
31824,been,0,0
31825,described,0,0
31826,.,0,0
31827,These,0,0
31828,types,0,0
31829,of,0,0
31830,gastric,0,0
31831,myoelectrical,0,0
31832,activity,0,0
31833,and,0,0
31834,dysrhythmia,0,0
31835,can,0,0
31836,be,0,0
31837,measured,0,0
31838,by,0,0
31839,electrogastrography,1,0
31840,using,0,0
31841,cutaneous,0,0
31842,electrodes,0,0
31843,.,0,0
31844,Epigastric,1,0
31845,impedance,1,0
31846,is,0,0
31847,a,0,0
31848,non-invasive,0,0
31849,method,0,0
31850,used,0,0
31851,to,0,0
31852,study,0,0
31853,gastric,0,0
31854,emptying,0,1
31855,time,0,0
31856,and,0,0
31857,gastric,0,0
31858,phasic,0,0
31859,activity,0,0
31860,.,0,0
31861,At,0,0
31862,present,0,0
31863,no,0,0
31864,study,0,0
31865,of,0,0
31866,gastric,0,0
31867,dysrhythmia,0,0
31868,",",0,0
31869,measured,0,0
31870,with,0,0
31871,epigastric,1,0
31872,impedance,1,0
31873,",",0,0
31874,has,0,0
31875,been,0,0
31876,presented,0,0
31877,",",0,0
31878,and,0,0
31879,the,0,0
31880,purpose,0,0
31881,of,0,0
31882,the,0,0
31883,present,0,0
31884,study,0,0
31885,was,0,0
31886,to,0,0
31887,investigate,0,0
31888,gastric,0,0
31889,rhythms,0,0
31890,by,0,0
31891,means,0,0
31892,of,0,0
31893,impedance,1,0
31894,gastrography,1,0
31895,in,0,0
31896,control,0,0
31897,infants,0,0
31898,",",0,0
31899,compared,0,0
31900,to,0,0
31901,infants,0,0
31902,with,0,0
31903,different,0,0
31904,gastrointestinal,0,0
31905,diseases,0,0
31906,",",0,0
31907,before,0,0
31908,and,0,0
31909,after,0,0
31910,treatment,0,0
31911,of,0,0
31912,their,0,0
31913,disease,0,0
31914,.,0,0
31915,METHOD,0,0
31916,21,0,0
31917,patients,0,0
31918,(,0,0
31919,age,0,0
31920,0-2,0,0
31921,months,0,0
31922,),0,0
31923,and,0,0
31924,40,0,0
31925,healthy,0,0
31926,infants,0,1
31927,(,0,0
31928,age,0,0
31929,0-2,0,0
31930,months,0,0
31931,),0,0
31932,were,0,0
31933,investigated,0,0
31934,.,0,0
31935,The,0,0
31936,patients,0,0
31937,suffered,0,0
31938,from,0,0
31939,partial,0,0
31940,or,0,0
31941,total,0,0
31942,intestinal,0,0
31943,obstruction,0,0
31944,",",0,0
31945,necrotizing,0,0
31946,enterocolitis,0,0
31947,or,0,0
31948,pyloric,0,0
31949,stenosis.All,0,0
31950,infants,0,0
31951,were,0,0
31952,fasting,0,1
31953,and,0,0
31954,studied,0,0
31955,during,0,0
31956,periods,0,0
31957,of,0,0
31958,at,0,0
31959,least,0,0
31960,one,0,0
31961,hour,0,0
31962,.,0,0
31963,The,0,0
31964,patients,0,0
31965,were,0,0
31966,examined,0,0
31967,in,0,0
31968,the,0,0
31969,acute,0,0
31970,state,0,0
31971,and,0,0
31972,after,0,0
31973,treatment,0,0
31974,when,0,0
31975,possible,0,0
31976,.,0,0
31977,RESULTS,0,0
31978,A,0,1
31979,pathologic,0,0
31980,result,0,0
31981,was,0,0
31982,found,0,0
31983,in,0,0
31984,90,0,0
31985,%,0,0
31986,of,0,0
31987,the,0,0
31988,patients,0,0
31989,.,0,0
31990,A,0,0
31991,persistent,0,0
31992,phasic,0,0
31993,activity,0,0
31994,pattern,0,0
31995,was,0,0
31996,found,0,0
31997,in,0,0
31998,19,0,0
31999,of,0,0
32000,the,0,0
32001,21,0,0
32002,patients,0,0
32003,",",0,0
32004,high,0,0
32005,frequency,0,0
32006,phasic,0,0
32007,activity,0,0
32008,in,0,0
32009,11,0,0
32010,of,0,0
32011,the,0,0
32012,21,0,0
32013,patients,0,0
32014,.,0,0
32015,Short-term,0,0
32016,phasic,0,0
32017,activity,0,0
32018,was,0,0
32019,only,0,0
32020,found,0,0
32021,in,0,0
32022,13,0,0
32023,out,0,0
32024,of,0,0
32025,40,0,0
32026,of,0,0
32027,the,0,0
32028,normal,0,0
32029,infants,0,0
32030,(,0,0
32031,32.5,0,0
32032,%,0,0
32033,),0,0
32034,.,0,0
32035,CONCLUSION,0,0
32036,Using,0,0
32037,epigastric,1,0
32038,impedance,1,0
32039,we,0,0
32040,found,0,0
32041,that,0,0
32042,infants,0,0
32043,with,0,0
32044,partial,0,0
32045,or,0,0
32046,total,0,0
32047,intestinal,0,0
32048,obstruction,0,0
32049,had,0,0
32050,gastric,0,0
32051,phasic,0,0
32052,activity,0,0
32053,",",0,0
32054,which,0,0
32055,was,0,0
32056,not,0,0
32057,found,0,0
32058,in,0,0
32059,the,0,0
32060,control,0,0
32061,infants,0,0
32062,.,0,0
32063,The,0,0
32064,origin,0,0
32065,of,0,0
32066,the,0,0
32067,gastric,0,0
32068,phasic,0,0
32069,activity,0,0
32070,patterns,0,0
32071,is,0,0
32072,unknown,0,0
32073,",",0,0
32074,but,0,0
32075,they,0,0
32076,may,0,0
32077,be,0,0
32078,related,0,0
32079,to,0,0
32080,electrical,0,0
32081,control,0,0
32082,activity,0,0
32083,.,0,0
32084,Long-term,0,1
32085,anticoagulant,1,1
32086,treatment,1,1
32087,after,0,0
32088,acute,0,0
32089,myocardial,0,0
32090,infarction,0,0
32091,.,0,0
32092,The,0,0
32093,Warfarin,0,1
32094,Re-Infarction,0,1
32095,Study,0,1
32096,.,0,0
32097,High,0,0
32098,levels,0,0
32099,of,0,0
32100,fibrinogen,0,1
32101,and,0,0
32102,clotting,0,0
32103,factor,0,0
32104,VII,0,0
32105,are,0,0
32106,associated,0,0
32107,with,0,0
32108,an,0,0
32109,increased,0,0
32110,risk,0,0
32111,for,0,0
32112,subsequent,0,0
32113,death,0,0
32114,and,0,0
32115,cardiovascular,0,0
32116,disease,0,0
32117,in,0,0
32118,apparently,0,0
32119,healthy,0,0
32120,individuals,0,0
32121,.,0,0
32122,Furthermore,0,0
32123,",",0,0
32124,pathoanatomic,0,0
32125,studies,0,0
32126,and,0,0
32127,coronary,0,0
32128,angiography,0,0
32129,have,0,0
32130,confirmed,0,0
32131,a,0,0
32132,relationship,0,0
32133,between,0,0
32134,coronary,0,0
32135,thrombus,0,0
32136,formation,0,0
32137,and,0,0
32138,acute,0,0
32139,Q-wave,0,0
32140,infarction,0,0
32141,.,0,0
32142,Effective,0,0
32143,antithrombotic,0,1
32144,agents,0,0
32145,may,0,0
32146,prevent,0,0
32147,or,0,0
32148,limit,0,0
32149,thrombus,0,0
32150,formation,0,0
32151,and,0,0
32152,events,0,0
32153,related,0,0
32154,to,0,0
32155,thrombosis,0,0
32156,.,0,0
32157,The,0,0
32158,Warfarin,0,1
32159,Re-Infarction,0,1
32160,Study,0,1
32161,(,0,1
32162,WARIS,0,1
32163,),0,0
32164,studied,0,0
32165,the,0,0
32166,effect,0,0
32167,of,0,0
32168,warfarin,1,1
32169,in,0,0
32170,survivors,0,0
32171,of,0,0
32172,acute,0,0
32173,myocardial,0,0
32174,infarction,0,0
32175,.,0,0
32176,Patients,0,0
32177,aged,0,0
32178,75,0,0
32179,years,0,0
32180,or,0,0
32181,less,0,0
32182,were,0,0
32183,randomized,0,0
32184,in,0,0
32185,a,0,0
32186,double-blind,0,1
32187,",",0,1
32188,placebo-controlled,1,1
32189,study,0,0
32190,to,0,0
32191,test,0,0
32192,whether,0,0
32193,long-term,0,0
32194,treatment,0,0
32195,with,0,0
32196,warfarin,1,1
32197,reduces,0,0
32198,the,0,0
32199,risk,0,0
32200,of,0,0
32201,death,0,0
32202,",",0,0
32203,reinfarction,0,0
32204,",",0,0
32205,and,0,0
32206,thromboembolic,0,0
32207,morbidity,0,0
32208,.,0,0
32209,A,0,0
32210,total,0,0
32211,of,0,0
32212,1918,0,0
32213,patients,0,0
32214,were,0,0
32215,screened,0,0
32216,for,0,0
32217,participation,0,0
32218,;,0,0
32219,1214,0,0
32220,were,0,0
32221,recruited,0,0
32222,.,0,0
32223,The,0,0
32224,mean,0,0
32225,follow-up,0,0
32226,was,0,0
32227,37,0,0
32228,months,0,0
32229,.,0,0
32230,Analyzed,0,0
32231,on,0,0
32232,an,0,0
32233,intention-to-treat,0,0
32234,basis,0,0
32235,",",0,0
32236,123,0,0
32237,(,0,0
32238,20,0,0
32239,%,0,0
32240,),0,0
32241,in,0,0
32242,the,0,0
32243,placebo,1,1
32244,group,0,0
32245,died,0,0
32246,",",0,0
32247,versus,0,0
32248,94,0,0
32249,(,0,0
32250,15,0,0
32251,%,0,0
32252,),0,0
32253,in,0,0
32254,the,0,0
32255,warfarin,1,1
32256,group,0,0
32257,",",0,0
32258,a,0,0
32259,risk,0,0
32260,reduction,0,0
32261,of,0,0
32262,24,0,0
32263,%,0,0
32264,(,0,0
32265,P,0,0
32266,=,0,0
32267,0.026,0,0
32268,),0,0
32269,.,0,0
32270,Considering,0,0
32271,patients,0,0
32272,on,0,0
32273,treatment,0,0
32274,or,0,0
32275,within,0,0
32276,28,0,0
32277,days,0,0
32278,after,0,0
32279,discontinuing,0,0
32280,the,0,0
32281,test,0,0
32282,medication,0,0
32283,",",0,0
32284,92,0,0
32285,in,0,0
32286,the,0,0
32287,placebo,0,1
32288,group,0,0
32289,died,0,0
32290,",",0,0
32291,as,0,0
32292,compared,0,0
32293,with,0,0
32294,60,0,0
32295,of,0,0
32296,the,0,0
32297,warfarin-treated,1,0
32298,patients,0,0
32299,",",0,0
32300,a,0,0
32301,risk,0,0
32302,reduction,0,0
32303,of,0,0
32304,35,0,0
32305,%,0,0
32306,(,0,0
32307,P,0,0
32308,=,0,0
32309,0.005,0,0
32310,),0,0
32311,.,0,0
32312,Relapsing,0,0
32313,myocardial,0,1
32314,infarction,0,1
32315,(,0,0
32316,fatal,0,0
32317,and,0,1
32318,nonfatal,0,1
32319,),0,0
32320,was,0,0
32321,reduced,0,0
32322,by,0,0
32323,43,0,0
32324,%,0,0
32325,(,0,0
32326,P,0,0
32327,=,0,0
32328,0.0001,0,0
32329,),0,0
32330,.,0,0
32331,The,0,0
32332,incidence,0,0
32333,of,0,0
32334,cerebrovascular,0,0
32335,attacks,0,0
32336,was,0,0
32337,lower,0,0
32338,in,0,0
32339,the,0,0
32340,warfarin,1,1
32341,group,0,1
32342,(,0,0
32343,16,0,0
32344,patients,0,0
32345,),0,0
32346,than,0,0
32347,the,0,0
32348,placebo,1,1
32349,group,0,1
32350,(,0,0
32351,41,0,0
32352,patients,0,0
32353,),0,0
32354,",",0,0
32355,a,0,0
32356,highly,0,0
32357,significant,0,0
32358,reduction,0,0
32359,of,0,0
32360,61,0,0
32361,%,0,0
32362,(,0,0
32363,P,0,0
32364,=,0,0
32365,0.0003,0,0
32366,),0,0
32367,.,0,0
32368,Serious,0,0
32369,bleeding,0,0
32370,occurred,0,0
32371,in,0,0
32372,11,0,0
32373,patients,0,0
32374,taking,0,0
32375,warfarin,1,1
32376,",",0,0
32377,an,0,0
32378,incidence,0,0
32379,of,0,0
32380,0.6,0,0
32381,%,0,0
32382,per,0,0
32383,year,0,0
32384,.,0,0
32385,In,0,0
32386,conclusion,0,0
32387,",",0,0
32388,long-term,0,1
32389,anticoagulant,1,1
32390,therapy,1,1
32391,may,0,0
32392,be,0,0
32393,recommended,0,0
32394,after,0,0
32395,acute,0,0
32396,myocardial,0,0
32397,infarction,0,0
32398,.,0,0
32399,Induction,1,0
32400,chemotherapy,1,0
32401,in,0,0
32402,head,0,0
32403,and,0,0
32404,neck,0,0
32405,cancer,0,0
32406,:,0,0
32407,results,0,0
32408,of,0,0
32409,a,0,0
32410,phase,0,0
32411,III,0,0
32412,trial,0,0
32413,.,0,0
32414,Between,0,0
32415,December,0,0
32416,1982,0,0
32417,and,0,0
32418,October,0,0
32419,1986,0,0
32420,",",0,0
32421,131,0,0
32422,patients,0,0
32423,with,0,0
32424,stage,0,0
32425,II-III-IV,0,0
32426,squamous,0,0
32427,cell,0,0
32428,carcinoma,0,0
32429,of,0,0
32430,the,0,0
32431,oropharynx,0,0
32432,or,0,0
32433,oral,0,1
32434,cavity,0,0
32435,were,0,0
32436,randomized,0,0
32437,to,0,0
32438,induction,1,0
32439,chemotherapy,1,0
32440,",",1,0
32441,consisting,1,0
32442,of,1,0
32443,bleomycin,1,1
32444,(,1,1
32445,10,1,1
32446,mg/m2/day,1,1
32447,in,1,0
32448,continuous,1,0
32449,infusion,1,1
32450,from,1,1
32451,day,1,0
32452,1,1,0
32453,to,1,0
32454,day,1,1
32455,5,1,1
32456,),1,1
32457,",",1,1
32458,methotrexate,1,1
32459,(,1,1
32460,120,1,1
32461,mg/m2,1,1
32462,on,1,1
32463,day,1,1
32464,2,1,0
32465,),1,0
32466,followed,1,0
32467,by,1,0
32468,folinic,1,1
32469,acid,1,1
32470,",",1,1
32471,5-fluorouracil,1,1
32472,(,1,1
32473,5,1,1
32474,FU,1,1
32475,),1,1
32476,(,1,1
32477,600,1,1
32478,mg/m2,1,1
32479,on,1,1
32480,day,1,1
32481,2,1,1
32482,),1,0
32483,",",1,0
32484,and,1,1
32485,cisplatin,1,1
32486,(,1,1
32487,120,1,1
32488,mg/m2,1,1
32489,on,1,1
32490,day,1,1
32491,4,1,1
32492,),1,1
32493,every,1,0
32494,4,1,0
32495,weeks,1,0
32496,for,1,0
32497,a,1,0
32498,total,1,0
32499,of,1,0
32500,three,1,0
32501,cycles,1,0
32502,followed,1,0
32503,by,1,0
32504,definitive,1,0
32505,locoregional,1,0
32506,treatment,1,0
32507,versus,1,0
32508,locoregional,1,0
32509,treatment,1,0
32510,alone,1,0
32511,.,1,0
32512,The,0,0
32513,modalities,0,0
32514,of,0,0
32515,definitive,0,0
32516,treatment,0,0
32517,(,1,0
32518,radiotherapy,1,0
32519,+/-,1,0
32520,surgery,1,0
32521,),1,0
32522,were,0,0
32523,chosen,0,0
32524,prior,0,0
32525,to,0,0
32526,randomization,0,0
32527,.,0,0
32528,A,0,0
32529,total,0,0
32530,of,0,0
32531,116,0,0
32532,patients,0,0
32533,were,0,0
32534,evaluable,0,0
32535,.,0,0
32536,Of,0,0
32537,55,0,0
32538,patients,0,0
32539,in,0,0
32540,the,0,0
32541,chemotherapy,1,0
32542,arm,0,0
32543,",",0,0
32544,four,0,0
32545,(,0,0
32546,7,0,0
32547,%,0,0
32548,),0,0
32549,had,0,0
32550,a,0,0
32551,complete,0,0
32552,response,0,0
32553,(,0,0
32554,CR,0,1
32555,),0,0
32556,and,0,0
32557,23,0,0
32558,(,0,0
32559,42,0,0
32560,%,0,0
32561,),0,0
32562,a,0,0
32563,partial,0,0
32564,response,0,0
32565,(,0,0
32566,PR,0,1
32567,),0,0
32568,following,0,0
32569,the,0,0
32570,induction,0,0
32571,regimen,0,1
32572,.,0,0
32573,At,0,0
32574,the,0,0
32575,completion,0,0
32576,of,0,0
32577,locoregional,0,0
32578,treatment,0,0
32579,",",0,0
32580,76,0,0
32581,%,0,0
32582,(,0,0
32583,42,0,0
32584,of,0,0
32585,55,0,0
32586,),0,0
32587,of,0,0
32588,patients,0,0
32589,in,0,0
32590,the,0,0
32591,experimental,0,0
32592,group,0,0
32593,were,0,0
32594,in,0,0
32595,CR,0,0
32596,compared,0,0
32597,to,0,0
32598,89,0,0
32599,%,0,0
32600,(,0,0
32601,54,0,0
32602,of,0,0
32603,61,0,0
32604,),0,0
32605,in,0,0
32606,the,0,0
32607,control,0,0
32608,group,0,0
32609,.,0,0
32610,There,0,0
32611,was,0,0
32612,no,0,0
32613,difference,0,0
32614,in,0,0
32615,survival,0,0
32616,",",0,0
32617,cause-specific,0,0
32618,survival,0,0
32619,",",0,0
32620,and,0,0
32621,pattern,0,0
32622,of,0,0
32623,relapse,0,0
32624,between,0,0
32625,both,0,0
32626,groups,0,0
32627,.,0,0
32628,The,0,0
32629,median,0,0
32630,survival,0,0
32631,was,0,0
32632,22,0,0
32633,months,0,0
32634,in,0,0
32635,the,0,0
32636,chemotherapy,0,0
32637,group,0,0
32638,and,0,0
32639,29,0,0
32640,months,0,0
32641,in,0,0
32642,the,0,0
32643,control,0,0
32644,group,0,0
32645,.,0,0
32646,Responders,0,0
32647,to,0,0
32648,chemotherapy,0,0
32649,did,0,0
32650,not,0,0
32651,fare,0,0
32652,better,0,0
32653,than,0,0
32654,nonresponders,0,0
32655,.,0,0
32656,Chemotherapy-related,0,0
32657,toxicities,0,1
32658,were,0,0
32659,few,0,0
32660,and,0,0
32661,most,0,0
32662,of,0,0
32663,them,0,0
32664,related,0,0
32665,to,0,0
32666,cisplatin,0,1
32667,which,0,0
32668,was,0,0
32669,reduced,0,0
32670,to,0,0
32671,100,0,0
32672,mg/m2,0,1
32673,for,0,0
32674,35,0,0
32675,patients,0,0
32676,.,0,0
32677,There,0,0
32678,were,0,0
32679,no,0,0
32680,treatment-related,0,0
32681,deaths,0,0
32682,and,0,0
32683,",",0,0
32684,in,0,0
32685,the,0,0
32686,experimental,0,0
32687,arm,0,0
32688,of,0,0
32689,the,0,0
32690,trial,0,0
32691,",",0,0
32692,no,0,0
32693,increased,0,0
32694,morbidity,0,0
32695,from,0,0
32696,locoregional,0,0
32697,treatment,0,0
32698,.,0,0
32699,This,0,0
32700,induction,0,0
32701,regimen,0,1
32702,does,0,0
32703,not,0,0
32704,offer,0,0
32705,any,0,0
32706,advantages,0,0
32707,over,0,0
32708,standard,0,0
32709,treatment,0,0
32710,.,0,0
32711,Treatment,0,0
32712,of,0,0
32713,peptic,0,0
32714,ulcer,0,0
32715,disease,0,1
32716,with,0,0
32717,furazolidone,1,1
32718,.,1,1
32719,Furazolidone,1,1
32720,(,0,1
32721,FZ,0,1
32722,),0,0
32723,has,0,0
32724,been,0,0
32725,used,0,0
32726,in,0,0
32727,China,0,0
32728,as,0,0
32729,a,0,0
32730,treatment,0,0
32731,of,0,0
32732,peptic,0,0
32733,ulcer,0,0
32734,disease,0,0
32735,for,0,0
32736,about,0,0
32737,20,0,0
32738,years,0,0
32739,.,0,0
32740,Clinical,0,0
32741,and,0,0
32742,experimental,0,0
32743,studies,0,0
32744,suggest,0,0
32745,that,0,0
32746,it,0,0
32747,has,0,0
32748,good,0,0
32749,short-term,0,0
32750,and,0,0
32751,long-term,0,0
32752,effects,0,0
32753,on,0,0
32754,both,0,0
32755,human,0,0
32756,and,0,0
32757,animal,0,0
32758,ulcers,0,0
32759,.,0,0
32760,The,0,0
32761,ulcer,0,0
32762,healing,0,0
32763,rate,0,0
32764,is,0,0
32765,related,0,0
32766,to,0,0
32767,the,0,0
32768,dosage,0,1
32769,and,0,0
32770,course,0,0
32771,of,0,0
32772,treatment,0,0
32773,.,0,0
32774,The,0,0
32775,healing,0,0
32776,rate,0,0
32777,of,0,0
32778,a,0,0
32779,high,0,0
32780,dose,0,1
32781,",",0,0
32782,2,0,0
32783,week,0,0
32784,course,0,0
32785,is,0,0
32786,about,0,0
32787,70-75,0,0
32788,%,0,0
32789,and,0,0
32790,the,0,0
32791,relapse,0,0
32792,rate,0,0
32793,after,0,0
32794,3,0,0
32795,years,0,0
32796,is,0,0
32797,9.5,0,0
32798,%,0,0
32799,.,0,0
32800,The,0,0
32801,adverse,0,0
32802,reactions,0,0
32803,to,0,0
32804,FZ,0,0
32805,are,0,0
32806,not,0,0
32807,severe,0,0
32808,",",0,0
32809,and,0,0
32810,are,0,0
32811,well,0,0
32812,tolerated,0,1
32813,in,0,0
32814,most,0,0
32815,patients,0,0
32816,.,0,0
32817,However,0,0
32818,the,0,0
32819,mutagenic,0,0
32820,studies,0,0
32821,of,0,0
32822,several,0,0
32823,biological,0,0
32824,systems,0,0
32825,indicate,0,0
32826,that,0,0
32827,it,0,0
32828,has,0,0
32829,a,0,0
32830,mutagenic,0,0
32831,effect,0,0
32832,",",0,0
32833,but,0,0
32834,the,0,0
32835,mutagenic,0,0
32836,and,0,0
32837,carcinogenic,0,1
32838,effects,0,0
32839,on,0,0
32840,humans,0,0
32841,and,0,0
32842,animals,0,0
32843,remain,0,0
32844,questionable,0,0
32845,",",0,0
32846,because,0,0
32847,FZ,0,0
32848,has,0,0
32849,been,0,0
32850,biotransformed,0,0
32851,into,0,0
32852,other,0,0
32853,metabolites,0,0
32854,.,0,0
32855,The,0,0
32856,mechanisms,0,0
32857,of,0,0
32858,FZ,0,0
32859,in,0,0
32860,the,0,0
32861,treatment,0,0
32862,of,0,0
32863,peptic,0,0
32864,ulcer,0,0
32865,disease,0,0
32866,are,0,0
32867,not,0,0
32868,fully,0,0
32869,understood,0,0
32870,",",0,0
32871,perhaps,0,0
32872,partly,0,0
32873,due,0,0
32874,to,0,0
32875,the,0,0
32876,monoamine,0,1
32877,oxidase,0,1
32878,(,0,1
32879,MAO,0,1
32880,),0,0
32881,inhibitory,0,0
32882,reaction,0,0
32883,and,0,0
32884,partly,0,0
32885,to,0,0
32886,the,0,0
32887,antibacterial,0,1
32888,activity,0,0
32889,to,0,0
32890,Helicobacter,0,1
32891,pylori,0,1
32892,(,0,1
32893,HP,0,1
32894,),0,1
32895,.,0,0
32896,The,0,0
32897,long-term,0,0
32898,effects,0,0
32899,of,0,0
32900,FZ,0,0
32901,are,0,0
32902,still,0,0
32903,not,0,0
32904,clear,0,0
32905,.,0,0
32906,Buprenorphine,1,1
32907,alone,0,0
32908,and,0,0
32909,in,0,0
32910,combination,0,0
32911,with,0,0
32912,naloxone,1,1
32913,in,0,0
32914,non-dependent,0,0
32915,humans,0,0
32916,.,0,0
32917,This,0,0
32918,study,0,0
32919,evaluated,0,0
32920,the,0,0
32921,effects,0,0
32922,of,0,0
32923,concurrent,0,0
32924,naloxone,1,1
32925,on,0,0
32926,the,0,1
32927,opioid,0,1
32928,agonist,0,1
32929,effects,0,1
32930,of,0,0
32931,buprenorphine,1,1
32932,",",0,0
32933,a,0,0
32934,mixed,0,0
32935,agonist-antagonist,0,1
32936,marketed,0,1
32937,as,0,1
32938,an,0,0
32939,analgesic,0,1
32940,and,0,0
32941,under,0,0
32942,development,0,0
32943,as,0,0
32944,a,0,0
32945,treatment,0,0
32946,for,0,0
32947,drug,0,1
32948,abuse,0,1
32949,.,0,0
32950,In,0,0
32951,a,0,0
32952,residential,0,0
32953,laboratory,0,0
32954,seven,0,0
32955,non-physically-dependent,0,0
32956,opioid,0,1
32957,abuser,0,1
32958,volunteers,0,0
32959,received,0,0
32960,intramuscular,0,1
32961,buprenorphine,1,1
32962,(,0,1
32963,0.4,0,1
32964,mg,0,0
32965,or,0,0
32966,0.8,0,0
32967,mg/70,0,1
32968,kg,0,0
32969,),0,0
32970,alone,0,0
32971,and,0,0
32972,in,0,0
32973,combination,0,0
32974,with,0,1
32975,naloxone,1,1
32976,(,0,1
32977,0.4,0,1
32978,mg,0,0
32979,or,0,0
32980,0.8,0,0
32981,mg/70,0,1
32982,kg,0,0
32983,),0,1
32984,versus,0,0
32985,placebo,1,1
32986,.,1,1
32987,Buprenorphine,1,1
32988,produced,0,1
32989,dose-related,0,1
32990,opioid,0,1
32991,agonist,0,1
32992,effects,0,1
32993,on,0,0
32994,physiological,0,0
32995,and,0,0
32996,subjective,0,0
32997,measures,0,0
32998,.,0,0
32999,Concurrent,0,0
33000,naloxone,1,1
33001,attenuated,0,0
33002,the,0,1
33003,opioid,0,1
33004,agonist,0,1
33005,effects,0,1
33006,of,0,0
33007,buprenorphine,1,1
33008,.,1,1
33009,Thus,0,0
33010,",",0,0
33011,a,0,0
33012,combination,0,0
33013,product,0,0
33014,of,0,0
33015,buprenorphine,1,1
33016,and,0,1
33017,naloxone,0,1
33018,may,0,0
33019,have,0,0
33020,lower,0,0
33021,abuse,0,0
33022,liability,0,1
33023,than,0,0
33024,buprenorphine,1,1
33025,alone,0,0
33026,.,0,0
33027,A,0,1
33028,randomized,0,0
33029,trial,0,0
33030,of,0,0
33031,a,0,0
33032,health,1,0
33033,care,1,0
33034,program,1,0
33035,for,1,0
33036,first-time,1,0
33037,adolescent,1,0
33038,mothers,1,0
33039,and,1,0
33040,their,1,0
33041,infants,1,0
33042,.,1,0
33043,To,0,0
33044,test,0,0
33045,the,0,0
33046,effectiveness,0,0
33047,of,0,0
33048,a,0,0
33049,special,1,0
33050,health,1,0
33051,care,1,0
33052,program,1,0
33053,for,0,0
33054,adolescent,0,1
33055,mothers,0,1
33056,(,0,0
33057,17,0,0
33058,years,0,0
33059,old,0,0
33060,or,0,0
33061,younger,0,1
33062,),0,0
33063,and,0,0
33064,their,0,0
33065,infants,0,0
33066,",",0,0
33067,243,0,0
33068,mother-infant,0,0
33069,pairs,0,0
33070,were,0,0
33071,randomly,0,0
33072,assigned,0,0
33073,to,0,0
33074,one,0,0
33075,of,0,0
33076,two,0,0
33077,groups,0,0
33078,.,0,0
33079,All,0,0
33080,of,0,0
33081,the,0,0
33082,mothers,0,0
33083,were,0,0
33084,unwed,0,0
33085,",",0,0
33086,on,0,0
33087,Medicaid,0,0
33088,",",0,0
33089,and,0,0
33090,black,0,0
33091,.,0,0
33092,The,0,0
33093,control,1,0
33094,group,1,0
33095,received,1,0
33096,routine,1,0
33097,well-baby,1,0
33098,care,1,0
33099,.,1,0
33100,The,0,0
33101,experimental,0,0
33102,group,0,0
33103,received,0,0
33104,routine,1,0
33105,care,1,0
33106,and,1,0
33107,services,1,0
33108,that,1,0
33109,included,1,0
33110,rigorous,1,0
33111,follow-up,1,0
33112,",",1,0
33113,discussions,1,0
33114,with,1,0
33115,the,1,0
33116,mother,1,0
33117,about,1,0
33118,her,1,0
33119,plans,1,0
33120,for,1,0
33121,return,1,0
33122,to,1,0
33123,school,1,0
33124,and,1,0
33125,use,1,0
33126,of,1,0
33127,family,1,0
33128,planning,1,0
33129,methods,1,0
33130,",",1,0
33131,and,1,0
33132,extra,1,0
33133,health,1,0
33134,teaching,1,0
33135,.,1,0
33136,The,0,0
33137,dropout,0,0
33138,rate,0,0
33139,in,0,0
33140,the,0,0
33141,experimental,0,0
33142,group,0,0
33143,(,0,0
33144,60,0,0
33145,%,0,0
33146,),0,0
33147,was,0,0
33148,significantly,0,0
33149,less,0,0
33150,after,0,0
33151,18,0,0
33152,months,0,0
33153,than,0,0
33154,the,0,0
33155,control,0,0
33156,group,0,0
33157,(,0,0
33158,82,0,0
33159,%,0,0
33160,),0,0
33161,.,0,0
33162,In,0,0
33163,spite,0,0
33164,of,0,0
33165,the,0,0
33166,high,0,0
33167,dropout,0,0
33168,rate,0,0
33169,",",0,0
33170,91,0,0
33171,%,0,0
33172,of,0,0
33173,the,0,0
33174,mothers,0,0
33175,were,0,0
33176,located,0,0
33177,for,0,0
33178,the,0,0
33179,18,0,0
33180,month,0,0
33181,follow-up,0,0
33182,interview,0,0
33183,.,0,0
33184,The,0,0
33185,repeat,0,0
33186,pregnancy,0,0
33187,rate,0,0
33188,in,0,0
33189,the,0,0
33190,experimental,0,0
33191,group,0,0
33192,was,0,0
33193,12,0,0
33194,%,0,0
33195,after,0,0
33196,18,0,0
33197,months,0,0
33198,",",0,0
33199,and,0,0
33200,28,0,0
33201,%,0,0
33202,in,0,0
33203,the,0,0
33204,control,0,0
33205,group,0,0
33206,.,0,0
33207,There,0,0
33208,was,0,0
33209,no,0,0
33210,significant,0,0
33211,difference,0,0
33212,in,0,0
33213,the,0,0
33214,percentage,0,0
33215,returning,0,0
33216,to,0,0
33217,school,0,0
33218,.,0,0
33219,After,0,0
33220,12,0,0
33221,months,0,0
33222,",",0,0
33223,the,0,0
33224,infants,0,0
33225,in,0,0
33226,the,0,0
33227,experimental,0,0
33228,group,0,0
33229,were,0,0
33230,more,0,0
33231,likely,0,0
33232,to,0,0
33233,be,0,0
33234,fully,0,0
33235,immunized,0,1
33236,(,0,0
33237,33,0,0
33238,%,0,0
33239,),0,0
33240,than,0,0
33241,the,0,0
33242,infants,0,0
33243,in,0,0
33244,the,0,0
33245,control,0,0
33246,group,0,0
33247,(,0,0
33248,18,0,0
33249,%,0,0
33250,),0,0
33251,.,0,0
33252,Mothers,0,0
33253,in,0,0
33254,the,0,0
33255,special,1,0
33256,care,1,0
33257,program,1,0
33258,who,0,0
33259,continued,0,0
33260,to,0,0
33261,attend,0,0
33262,clinic,0,0
33263,used,0,0
33264,the,0,0
33265,emergency,0,0
33266,room,0,0
33267,less,0,0
33268,than,0,0
33269,the,0,0
33270,mothers,0,0
33271,who,0,0
33272,continued,0,0
33273,to,0,0
33274,attend,0,0
33275,in,0,0
33276,the,0,0
33277,control,0,0
33278,group,0,0
33279,.,0,0
33280,These,0,0
33281,results,0,0
33282,suggest,0,0
33283,that,0,0
33284,a,0,0
33285,comprehensive,1,0
33286,health,1,0
33287,care,1,0
33288,program,1,0
33289,is,0,0
33290,one,0,0
33291,way,0,0
33292,to,0,0
33293,bring,0,0
33294,about,0,0
33295,better,0,0
33296,outcomes,0,0
33297,for,0,0
33298,both,0,0
33299,adolescent,0,0
33300,mothers,0,0
33301,and,0,0
33302,their,0,0
33303,infants,0,0
33304,.,0,0
33305,[,0,1
33306,Physical,0,1
33307,performance,0,0
33308,and,0,0
33309,sedation,0,0
33310,:,0,0
33311,comparative,0,0
33312,study,0,0
33313,of,0,0
33314,the,0,0
33315,effects,0,0
33316,of,0,0
33317,a,0,0
33318,benzodiazepine,1,1
33319,(,1,1
33320,temazepam,1,1
33321,),1,1
33322,and,0,0
33323,of,0,0
33324,a,1,0
33325,non-benzodiazepine,1,1
33326,hypnotic,1,1
33327,(,1,1
33328,zolpidem,1,1
33329,),1,1
33330,],1,1
33331,.,0,0
33332,It,0,0
33333,is,0,0
33334,well-known,0,0
33335,that,0,0
33336,many,0,0
33337,athletes,0,0
33338,experience,0,0
33339,some,0,0
33340,form,0,0
33341,of,0,0
33342,precompetition,0,0
33343,stress,0,0
33344,that,0,0
33345,may,0,0
33346,result,0,0
33347,in,0,0
33348,insomnia,0,0
33349,during,0,0
33350,the,0,0
33351,night,0,0
33352,before,0,0
33353,their,0,0
33354,competition,0,0
33355,.,0,0
33356,Yet,0,0
33357,",",0,0
33358,sleep,0,0
33359,withdrawal,0,0
33360,even,0,0
33361,if,0,0
33362,only,0,0
33363,partial,0,0
33364,",",0,0
33365,has,0,0
33366,a,0,0
33367,negative,0,0
33368,influence,0,0
33369,on,0,0
33370,performance,0,0
33371,",",0,0
33372,particularly,0,0
33373,when,0,0
33374,the,0,0
33375,type,0,0
33376,of,0,0
33377,exercise,0,0
33378,requires,0,0
33379,good,0,0
33380,psychomotor,0,0
33381,performance,0,0
33382,The,0,0
33383,purpose,0,0
33384,of,0,0
33385,the,0,0
33386,present,0,0
33387,study,0,0
33388,was,0,0
33389,to,0,0
33390,investigate,0,0
33391,whether,0,0
33392,the,0,0
33393,intake,0,1
33394,of,0,0
33395,a,0,1
33396,hypnotic,0,1
33397,drug,0,1
33398,would,0,0
33399,have,0,0
33400,negative,0,0
33401,effects,0,0
33402,on,0,0
33403,physical,0,0
33404,performance,0,0
33405,capacity,0,0
33406,.,0,0
33407,The,0,0
33408,authors,0,0
33409,have,0,0
33410,compared,0,0
33411,the,0,0
33412,effects,0,0
33413,of,0,0
33414,oral,1,1
33415,temazepam,1,1
33416,",",0,1
33417,a,0,0
33418,medium,1,0
33419,half-life,1,1
33420,benzodiazepine,1,1
33421,vs,1,1
33422,oral,1,1
33423,zolpidem,1,1
33424,",",1,1
33425,a,1,0
33426,short,1,0
33427,half-life,1,1
33428,non-benzodiazepine,1,1
33429,drug,1,1
33430,",",0,1
33431,vs,0,0
33432,placebo,1,1
33433,.,1,0
33434,A,0,1
33435,randomized,0,1
33436,double-blind,0,1
33437,trial,0,1
33438,was,0,0
33439,used,0,0
33440,to,0,0
33441,assess,0,0
33442,endurance,0,0
33443,",",0,0
33444,resistance,0,0
33445,",",0,0
33446,strength,0,0
33447,and,0,0
33448,coordination,0,0
33449,in,0,0
33450,26,0,0
33451,athletes,0,0
33452,.,0,0
33453,The,0,0
33454,results,0,0
33455,did,0,0
33456,not,0,0
33457,show,0,0
33458,any,0,0
33459,differences,0,0
33460,between,0,0
33461,the,0,0
33462,three,0,0
33463,groups,0,0
33464,",",0,0
33465,neither,0,0
33466,in,0,0
33467,physical,0,0
33468,performance,0,0
33469,characteristic,0,0
33470,nor,0,0
33471,in,0,0
33472,coordination,0,0
33473,.,0,0
33474,It,0,0
33475,is,0,0
33476,concluded,0,0
33477,that,0,0
33478,as,0,0
33479,regards,0,0
33480,the,0,0
33481,performance,0,0
33482,capacity,0,0
33483,",",0,0
33484,there,0,0
33485,is,0,0
33486,no,0,0
33487,risk,0,0
33488,for,0,0
33489,stressed,0,0
33490,athletes,0,0
33491,to,0,0
33492,use,0,0
33493,sleep,0,0
33494,inducers,0,0
33495,the,0,0
33496,night,0,0
33497,before,0,0
33498,their,0,0
33499,competition,0,0
33500,.,0,0
33501,GnRH,1,1
33502,agonist,1,1
33503,treatment,1,0
33504,before,0,0
33505,total,0,0
33506,laparoscopic,0,0
33507,hysterectomy,0,0
33508,for,0,0
33509,large,0,0
33510,uteri,0,0
33511,.,0,0
33512,STUDY,0,0
33513,OBJECTIVE,0,0
33514,To,0,0
33515,evaluate,0,0
33516,whether,0,0
33517,uterine,0,0
33518,shrinkage,0,0
33519,induced,0,0
33520,by,0,0
33521,gonadotropin-releasing,1,1
33522,hormone,1,1
33523,(,1,1
33524,GnRH,1,1
33525,),1,1
33526,agonists,1,1
33527,in,0,1
33528,women,0,0
33529,with,0,0
33530,a,0,0
33531,large,0,0
33532,uterus,0,1
33533,(,0,0
33534,>,0,0
33535,14,0,0
33536,wks,0,0
33537,),0,0
33538,may,0,0
33539,facilitate,0,0
33540,total,0,0
33541,laparoscopic,0,0
33542,hysterectomy,0,0
33543,.,0,0
33544,DESIGN,0,0
33545,Randomized,0,0
33546,",",0,0
33547,prospective,0,0
33548,study,0,0
33549,(,0,0
33550,Canadian,0,0
33551,Task,0,1
33552,Force,0,1
33553,classification,0,1
33554,I,0,0
33555,),0,0
33556,.,0,0
33557,SETTING,0,1
33558,University-affiliated,0,0
33559,hospital,0,0
33560,.,0,0
33561,PATIENTS,0,0
33562,Sixty-two,0,0
33563,women,0,0
33564,with,0,0
33565,symptomatic,0,0
33566,uterine,0,1
33567,myomas,0,1
33568,(,0,0
33569,size,0,0
33570,16-20,0,0
33571,wks,0,0
33572,),0,0
33573,.,0,0
33574,INTERVENTIONS,0,1
33575,Total,1,0
33576,laparoscopic,1,0
33577,hysterectomy,1,0
33578,for,1,0
33579,benign,1,0
33580,pathology,1,0
33581,.,1,0
33582,MEASUREMENTS,0,0
33583,AND,0,1
33584,MAIN,0,1
33585,RESULTS,0,1
33586,Before,0,0
33587,surgery,0,0
33588,",",0,0
33589,women,0,0
33590,were,0,0
33591,assigned,0,0
33592,",",0,0
33593,at,0,0
33594,a,0,0
33595,ratio,0,0
33596,of,0,0
33597,1:1,0,1
33598,by,0,0
33599,random,0,0
33600,selection,0,0
33601,",",0,0
33602,to,0,0
33603,receive,0,1
33604,injections,0,1
33605,of,0,1
33606,triptorelin,1,1
33607,depot,1,1
33608,11.25,0,1
33609,mg,0,1
33610,3,0,0
33611,months,0,0
33612,before,0,0
33613,surgery,0,1
33614,(,0,1
33615,group,0,1
33616,A,0,1
33617,),0,1
33618,or,0,0
33619,no,0,0
33620,treatment,0,0
33621,(,0,0
33622,group,0,1
33623,B,0,1
33624,),0,1
33625,.,0,1
33626,Uterine,0,1
33627,volume,0,1
33628,",",0,0
33629,mean,0,0
33630,operating,0,0
33631,time,0,0
33632,",",0,0
33633,uterine,0,0
33634,weight,0,1
33635,",",0,0
33636,drop,0,1
33637,in,0,0
33638,hemoglobin,0,1
33639,",",0,1
33640,intraoperative,0,1
33641,complications,0,0
33642,",",0,0
33643,conversions,0,0
33644,to,0,0
33645,laparotomy,0,0
33646,",",0,0
33647,and,0,0
33648,hospital,0,0
33649,stay,0,0
33650,were,0,0
33651,recorded,0,0
33652,.,0,0
33653,Triptorelin,0,1
33654,decreased,0,0
33655,uterine,0,0
33656,volume,0,0
33657,",",0,0
33658,calculated,0,0
33659,by,0,0
33660,ultrasonography,0,0
33661,",",0,0
33662,by,0,0
33663,26.5,0,0
33664,%,0,0
33665,in,0,0
33666,group,0,0
33667,A,0,0
33668,",",0,0
33669,whereas,0,0
33670,the,0,0
33671,volume,0,0
33672,remained,0,0
33673,unchanged,0,0
33674,in,0,0
33675,group,0,0
33676,B,0,0
33677,.,0,0
33678,Statistical,0,0
33679,differences,0,0
33680,were,0,0
33681,found,0,0
33682,between,0,0
33683,groups,0,0
33684,concerning,0,0
33685,uterine,0,0
33686,weight,0,0
33687,",",0,0
33688,operating,0,0
33689,time,0,0
33690,",",0,0
33691,and,0,0
33692,drop,0,1
33693,in,0,0
33694,hemoglobin,0,1
33695,level,0,0
33696,.,0,0
33697,Three,0,0
33698,patients,0,0
33699,in,0,0
33700,group,0,0
33701,B,0,0
33702,were,0,0
33703,converted,0,0
33704,to,0,0
33705,laparotomy,0,0
33706,because,0,0
33707,of,0,0
33708,uterine,0,0
33709,size,0,0
33710,.,0,0
33711,CONCLUSION,0,0
33712,In,0,0
33713,women,0,0
33714,with,0,0
33715,a,0,0
33716,large,0,0
33717,uterus,0,0
33718,",",0,0
33719,a,0,0
33720,3-month,0,0
33721,preoperative,0,0
33722,course,0,0
33723,of,0,0
33724,GnRH,1,0
33725,may,0,0
33726,facilitate,0,0
33727,laparoscopic,0,0
33728,hysterectomy,0,0
33729,",",0,0
33730,decreasing,0,0
33731,uterine,0,0
33732,size,0,0
33733,",",0,0
33734,operating,0,0
33735,time,0,0
33736,",",0,0
33737,and,0,0
33738,blood,0,0
33739,loss,0,0
33740,.,0,0
33741,Remifentanil,0,1
33742,with,0,1
33743,morphine,0,1
33744,transitional,0,1
33745,analgesia,0,1
33746,shortens,0,0
33747,neurological,0,0
33748,recovery,0,0
33749,compared,0,0
33750,to,0,0
33751,fentanyl,0,1
33752,for,0,0
33753,supratentorial,0,1
33754,craniotomy,0,0
33755,.,0,0
33756,PURPOSE,0,0
33757,To,0,0
33758,compare,0,0
33759,the,0,0
33760,recovery,0,0
33761,profiles,0,0
33762,",",0,0
33763,efficacy,0,0
33764,and,0,0
33765,safety,0,0
33766,of,0,0
33767,remifentanil,0,1
33768,and,0,1
33769,morphine,0,1
33770,for,0,0
33771,transitional,0,0
33772,analgesia,0,1
33773,with,0,1
33774,fentanyl,0,1
33775,in,0,0
33776,patients,0,0
33777,undergoing,0,0
33778,elective,0,0
33779,craniotomy,0,0
33780,for,0,0
33781,supratentorial,0,0
33782,mass,0,0
33783,lesions,0,0
33784,.,0,0
33785,METHODS,0,0
33786,Ninety-one,0,0
33787,patients,0,0
33788,were,0,0
33789,enrolled,0,0
33790,in,0,0
33791,this,0,0
33792,prospective,0,0
33793,",",0,0
33794,randomized,0,0
33795,",",0,0
33796,multicentre,0,0
33797,study,0,0
33798,.,0,0
33799,Anesthesia,1,0
33800,was,1,0
33801,induced,1,0
33802,with,1,0
33803,thiopental,1,1
33804,and,1,1
33805,remifentanil,1,1
33806,(,1,1
33807,1.0,1,1
33808,micro,1,1
33809,g,1,0
33810,x,1,1
33811,kg,1,1
33812,(,1,1
33813,-1,1,1
33814,),1,1
33815,bolus,1,1
33816,and,1,1
33817,a,1,0
33818,1,1,0
33819,micro,1,0
33820,g,1,0
33821,x,1,1
33822,kg,1,1
33823,(,1,1
33824,-1,1,1
33825,),1,0
33826,x,1,0
33827,min,1,0
33828,(,1,1
33829,-1,1,1
33830,),1,1
33831,infusion,1,1
33832,),1,1
33833,or,1,1
33834,fentanyl,1,1
33835,(,1,1
33836,1,1,1
33837,micro,1,1
33838,g,1,0
33839,x,1,1
33840,kg,1,1
33841,(,1,1
33842,-1,1,1
33843,),1,1
33844,bolus,1,1
33845,and,1,1
33846,a,1,0
33847,1.0,1,0
33848,micro,1,1
33849,g,1,0
33850,x,1,1
33851,kg,1,1
33852,(,1,1
33853,-1,1,1
33854,),1,0
33855,x,1,0
33856,min,1,0
33857,(,1,1
33858,-1,1,1
33859,),1,1
33860,infusion,1,1
33861,),1,1
33862,.,1,1
33863,The,1,0
33864,opioid,1,1
33865,infusion,1,1
33866,continued,1,1
33867,until,1,0
33868,the,1,0
33869,level,1,0
33870,of,1,0
33871,anesthesia,1,0
33872,was,1,0
33873,deemed,1,0
33874,appropriate,1,0
33875,for,1,0
33876,intubation,1,0
33877,.,1,0
33878,Anesthesia,1,0
33879,was,1,0
33880,maintained,1,0
33881,with,1,0
33882,N,1,0
33883,(,1,1
33884,2,1,1
33885,),1,1
33886,O/O,1,1
33887,(,1,1
33888,2,1,1
33889,),1,1
33890,",",1,1
33891,isoflurane,1,1
33892,0.5,1,1
33893,MAC,1,1
33894,and,1,0
33895,remifentanil,1,1
33896,0.2,1,1
33897,micro,1,1
33898,g,1,0
33899,x,1,1
33900,kg,1,1
33901,(,1,1
33902,-1,1,1
33903,),1,0
33904,x,1,0
33905,min,1,0
33906,(,1,1
33907,-1,1,0
33908,),1,1
33909,or,1,0
33910,fentanyl,1,1
33911,0.04,1,1
33912,micro,1,1
33913,g,1,0
33914,x,1,1
33915,kg,1,1
33916,(,1,1
33917,-1,1,1
33918,),1,0
33919,x,1,0
33920,min,1,0
33921,(,1,1
33922,-1,1,0
33923,),1,0
33924,.,1,0
33925,At,1,1
33926,bone,1,0
33927,flap,1,0
33928,replacement,1,0
33929,",",1,0
33930,either,1,0
33931,morphine,1,1
33932,0.08,1,1
33933,mg,1,1
33934,x,1,0
33935,kg,1,1
33936,(,1,1
33937,-1,1,1
33938,),1,1
33939,(,1,1
33940,remifentanil,1,1
33941,group,1,1
33942,),1,1
33943,or,1,1
33944,saline,1,1
33945,(,1,1
33946,fentanyl,1,1
33947,group,1,1
33948,),1,1
33949,was,1,0
33950,given,1,0
33951,.,1,0
33952,RESULTS,0,0
33953,Systolic,0,0
33954,blood,0,0
33955,pressure,0,0
33956,was,0,0
33957,greater,0,0
33958,in,0,0
33959,those,0,0
33960,receiving,0,0
33961,fentanyl,0,1
33962,during,0,0
33963,induction,0,0
33964,(,0,0
33965,145.6,0,0
33966,+/-17.5,0,0
33967,mmHg,0,0
33968,vs,0,0
33969,128.8,0,0
33970,+/-18.3,0,0
33971,mmHg,0,0
33972,;,0,0
33973,P,0,0
33974,=,0,0
33975,0.006,0,0
33976,),0,0
33977,and,0,0
33978,intubation,0,0
33979,(,0,0
33980,126.9,0,0
33981,+/-17.1,0,0
33982,vs,0,0
33983,110.9,0,0
33984,+/-16.5,0,0
33985,mmHg,0,0
33986,;,0,0
33987,P,0,0
33988,<,0,0
33989,0.001,0,0
33990,),0,0
33991,.,0,0
33992,Median,0,0
33993,time,0,0
33994,to,0,0
33995,tracheal,0,0
33996,extubation,0,0
33997,was,0,0
33998,similar,0,0
33999,but,0,0
34000,less,0,0
34001,variable,0,0
34002,in,0,0
34003,the,0,0
34004,remifentanil,0,1
34005,group,0,1
34006,(,0,0
34007,remifentanil,0,1
34008,=,0,0
34009,8,0,0
34010,min,0,0
34011,:,0,0
34012,range,0,0
34013,=,0,0
34014,2-44,0,0
34015,min,0,0
34016,;,0,0
34017,fentanyl,0,1
34018,=,0,0
34019,8,0,0
34020,min,0,0
34021,:,0,0
34022,range,0,0
34023,=,0,0
34024,1-732,0,0
34025,min,0,0
34026,),0,0
34027,.,0,0
34028,The,0,0
34029,fentanyl,0,1
34030,patients,0,0
34031,required,0,0
34032,a,0,0
34033,longer,0,0
34034,time,0,0
34035,to,0,0
34036,achieve,0,0
34037,the,0,0
34038,first,0,0
34039,normal,0,0
34040,neurological,0,0
34041,score,0,1
34042,(,0,0
34043,fentanyl,0,1
34044,=,0,0
34045,38.0,0,0
34046,min,0,0
34047,;,0,0
34048,remifentanil,0,1
34049,=,0,0
34050,26.0,0,0
34051,min,0,0
34052,;,0,0
34053,P,0,0
34054,=,0,0
34055,0.035,0,0
34056,),0,0
34057,.,0,0
34058,Both,0,0
34059,the,0,0
34060,anesthesiologists,0,0
34061,and,0,0
34062,the,0,0
34063,recovery,0,0
34064,room,0,0
34065,nurses,0,1
34066,rated,0,1
34067,remifentanil,0,1
34068,better,0,0
34069,with,0,0
34070,respect,0,0
34071,to,0,0
34072,level,0,0
34073,of,0,0
34074,consciousness,0,0
34075,.,0,0
34076,Analgesics,0,1
34077,were,0,0
34078,required,0,0
34079,earlier,0,0
34080,in,0,0
34081,patients,0,0
34082,receiving,0,0
34083,remifentanil,0,1
34084,;,0,0
34085,median,0,0
34086,time,0,0
34087,0.5,0,0
34088,vs,0,0
34089,1.08,0,0
34090,hr,0,0
34091,",",0,0
34092,P,0,0
34093,<,0,0
34094,0.001,0,0
34095,.,0,0
34096,CONCLUSIONS,0,0
34097,Remifentanil,0,1
34098,is,0,0
34099,a,0,0
34100,suitable,0,0
34101,alternative,0,0
34102,to,0,0
34103,fentanyl,0,1
34104,in,0,0
34105,supratentorial,0,1
34106,craniotomy,0,0
34107,.,0,0
34108,Time,0,0
34109,to,0,0
34110,preoperative,0,0
34111,neurological,0,0
34112,recovery,0,0
34113,is,0,0
34114,faster,0,0
34115,and,0,0
34116,morphine,0,1
34117,provides,0,0
34118,some,0,0
34119,transitional,0,0
34120,analgesia,0,1
34121,without,0,0
34122,compromising,0,0
34123,the,0,0
34124,quality,0,0
34125,of,0,0
34126,recovery,0,0
34127,.,0,0
34128,Intraperitoneal,0,1
34129,application,0,1
34130,of,0,0
34131,bupivacaine,1,1
34132,plus,0,1
34133,morphine,1,1
34134,for,0,0
34135,pain,0,1
34136,relief,0,0
34137,after,0,0
34138,laparoscopic,0,0
34139,cholecystectomy,0,0
34140,.,0,0
34141,BACKGROUND,0,0
34142,AND,0,1
34143,OBJECTIVE,0,1
34144,Intraperitoneal,0,1
34145,administration,0,1
34146,of,0,0
34147,a,0,0
34148,local,0,0
34149,anaesthetic,0,0
34150,in,0,0
34151,combination,0,0
34152,with,0,0
34153,an,0,0
34154,opioid,1,1
34155,",",0,0
34156,for,0,0
34157,the,0,0
34158,relief,0,0
34159,of,0,0
34160,postoperative,0,0
34161,pain,0,0
34162,",",0,0
34163,has,0,0
34164,already,0,0
34165,been,0,0
34166,reported,0,0
34167,except,0,0
34168,after,0,0
34169,laparoscopic,0,0
34170,cholecystectomy,0,0
34171,.,0,0
34172,This,0,0
34173,study,0,0
34174,was,0,0
34175,aimed,0,0
34176,at,0,0
34177,assessing,0,0
34178,the,0,0
34179,analgesic,0,1
34180,effect,0,0
34181,of,0,0
34182,the,0,0
34183,intraperitoneal,0,1
34184,administration,0,1
34185,of,0,1
34186,bupivacaine,1,1
34187,and,1,1
34188,morphine,1,1
34189,in,0,0
34190,patients,0,0
34191,undergoing,0,0
34192,laparoscopic,0,0
34193,cholecystectomy,0,0
34194,.,0,0
34195,METHODS,0,0
34196,At,0,0
34197,the,0,0
34198,end,0,0
34199,of,0,0
34200,laparoscopic,0,0
34201,cholecystectomy,0,0
34202,",",0,0
34203,in,0,0
34204,a,0,0
34205,double-blind,0,1
34206,",",0,0
34207,randomized,0,0
34208,manner,0,0
34209,",",0,0
34210,one,0,0
34211,of,0,0
34212,the,0,0
34213,following,0,0
34214,injections,0,1
34215,was,0,0
34216,given,0,1
34217,intraperitoneally,0,1
34218,.,0,0
34219,There,0,0
34220,were,0,0
34221,30,0,0
34222,patients,0,0
34223,in,0,0
34224,each,0,0
34225,group,0,0
34226,:,0,0
34227,Group,0,0
34228,1,0,0
34229,",",0,0
34230,physiological,1,0
34231,saline,1,1
34232,30,0,1
34233,mL,0,1
34234,;,0,1
34235,Group,0,0
34236,2,0,0
34237,",",0,0
34238,bupivacaine,1,1
34239,0.25,0,0
34240,%,0,0
34241,30,0,0
34242,mL,0,0
34243,;,0,1
34244,Group,0,0
34245,3,0,0
34246,",",0,0
34247,bupivacaine,1,1
34248,0.25,0,0
34249,%,0,0
34250,30,0,0
34251,mL,0,0
34252,plus,1,0
34253,morphine,1,1
34254,2,0,1
34255,mg,0,1
34256,.,0,1
34257,In,0,0
34258,addition,0,0
34259,",",0,0
34260,Group,0,0
34261,2,0,0
34262,received,0,0
34263,2,0,1
34264,mg,0,1
34265,intravenous,0,1
34266,(,0,1
34267,i.v,0,1
34268,.,0,1
34269,),0,1
34270,morphine,1,1
34271,in,0,1
34272,2,0,1
34273,mL,0,1
34274,saline,1,1
34275,",",0,0
34276,and,0,0
34277,Groups,0,0
34278,1,0,0
34279,and,0,0
34280,3,0,0
34281,",",0,0
34282,2,0,1
34283,mL,0,1
34284,saline,1,1
34285,intravenously,0,1
34286,.,0,1
34287,Patients,0,0
34288,',0,0
34289,postoperative,0,0
34290,pain,0,0
34291,was,0,0
34292,evaluated,0,0
34293,using,0,0
34294,a,0,0
34295,visual,0,1
34296,analogue,0,1
34297,scale,0,1
34298,and,0,0
34299,a,0,0
34300,verbal,0,0
34301,rating,0,0
34302,score,0,0
34303,.,0,0
34304,The,0,0
34305,postoperative,0,0
34306,analgesic,0,1
34307,requirement,0,0
34308,was,0,0
34309,assessed,0,0
34310,by,0,0
34311,the,0,0
34312,total,0,0
34313,dose,0,1
34314,of,0,1
34315,metamizol,0,1
34316,administered,0,1
34317,by,0,1
34318,an,0,0
34319,i.v,0,1
34320,.,0,1
34321,patient-controlled,0,1
34322,analgesia,0,1
34323,(,0,1
34324,PCA,0,1
34325,),0,1
34326,device,0,0
34327,.,0,0
34328,Pain,0,0
34329,",",0,0
34330,vital,0,0
34331,signs,0,0
34332,",",0,0
34333,supplemental,0,1
34334,analgesic,0,1
34335,consumption,0,1
34336,and,0,0
34337,side-effects,0,0
34338,were,0,0
34339,recorded,0,0
34340,for,0,0
34341,all,0,0
34342,patients,0,0
34343,for,0,0
34344,24,0,0
34345,h.,0,0
34346,RESULTS,0,0
34347,There,0,0
34348,were,0,0
34349,no,0,0
34350,differences,0,0
34351,between,0,0
34352,the,0,0
34353,three,0,0
34354,groups,0,0
34355,regarding,0,0
34356,pain,0,1
34357,scores,0,1
34358,(,0,0
34359,at,0,0
34360,rest,0,0
34361,and,0,0
34362,coughing,0,0
34363,),0,0
34364,during,0,0
34365,the,0,0
34366,study,0,0
34367,except,0,0
34368,in,0,0
34369,the,0,0
34370,first,0,0
34371,2,0,0
34372,h,0,0
34373,",",0,0
34374,when,0,0
34375,scores,0,0
34376,were,0,0
34377,lower,0,0
34378,for,0,0
34379,patients,0,0
34380,receiving,0,0
34381,intraperitoneal,0,1
34382,bupivacaine,1,1
34383,plus,0,1
34384,i.v,0,1
34385,.,0,1
34386,morphine,1,1
34387,(,0,0
34388,P,0,0
34389,<,0,0
34390,0.05,0,0
34391,),0,0
34392,.,0,0
34393,Supplemental,0,0
34394,consumption,0,1
34395,of,0,0
34396,metamizol,0,1
34397,was,0,0
34398,significantly,0,0
34399,lower,0,0
34400,(,0,0
34401,P,0,0
34402,<,0,0
34403,0.05,0,0
34404,),0,0
34405,in,0,0
34406,Group,0,0
34407,3,0,0
34408,than,0,0
34409,in,0,0
34410,Group,0,0
34411,1,0,0
34412,during,0,0
34413,the,0,0
34414,first,0,0
34415,6,0,0
34416,h,0,0
34417,after,0,0
34418,surgery,0,0
34419,.,0,0
34420,However,0,0
34421,",",0,0
34422,the,0,0
34423,cumulative,0,1
34424,doses,0,1
34425,of,0,1
34426,metamizol,0,1
34427,were,0,0
34428,also,0,0
34429,lower,0,0
34430,in,0,0
34431,Group,0,0
34432,2,0,0
34433,than,0,0
34434,in,0,0
34435,Groups,0,0
34436,1,0,0
34437,and,0,0
34438,3,0,0
34439,over,0,0
34440,the,0,0
34441,entire,0,0
34442,study,0,0
34443,(,0,0
34444,2025,0,0
34445,+/-,0,0
34446,1044,0,0
34447,mg,0,0
34448,vs.,0,0
34449,4925,0,0
34450,+/-,0,0
34451,1238,0,0
34452,and,0,0
34453,4125,0,0
34454,+/-,0,0
34455,1276mg,0,0
34456,;,0,0
34457,P,0,0
34458,<,0,0
34459,0.05,0,0
34460,),0,0
34461,.,0,0
34462,CONCLUSIONS,0,0
34463,In,0,0
34464,patients,0,0
34465,undergoing,0,0
34466,laparoscopic,0,0
34467,cholecystectomy,0,0
34468,",",0,0
34469,the,0,0
34470,intraperitoneal,0,1
34471,administration,0,1
34472,of,0,1
34473,morphine,1,1
34474,plus,0,1
34475,bupivacaine,1,1
34476,0.25,0,0
34477,%,0,0
34478,reduced,0,0
34479,the,0,0
34480,analgesic,0,1
34481,requirements,0,0
34482,during,0,0
34483,the,0,0
34484,first,0,0
34485,6,0,0
34486,postoperative,0,0
34487,hours,0,0
34488,compared,0,0
34489,with,0,0
34490,the,0,0
34491,control,0,0
34492,group,0,0
34493,.,0,0
34494,However,0,0
34495,",",0,0
34496,the,0,0
34497,combination,0,0
34498,of,0,0
34499,intraperitoneal,0,1
34500,bupivacaine,1,1
34501,0.25,0,0
34502,%,0,0
34503,and,0,0
34504,i.v,0,1
34505,.,0,1
34506,morphine,1,1
34507,was,0,0
34508,more,0,0
34509,effective,0,0
34510,for,0,0
34511,treatment,0,0
34512,of,0,0
34513,pain,0,0
34514,after,0,0
34515,laparoscopic,0,0
34516,cholecystectomy,0,0
34517,.,0,0
34518,Future,0,0
34519,therapeutic,0,0
34520,directions,0,0
34521,for,0,0
34522,factor,0,0
34523,Xa,0,0
34524,inhibition,0,0
34525,in,0,0
34526,the,0,0
34527,prophylaxis,0,0
34528,and,0,0
34529,treatment,0,0
34530,of,0,0
34531,thrombotic,0,0
34532,disorders,0,0
34533,.,0,0
34534,The,0,0
34535,targeted,0,0
34536,mechanism,0,0
34537,of,0,0
34538,factor,0,0
34539,Xa,0,0
34540,inhibition,0,0
34541,has,0,0
34542,been,0,0
34543,studied,0,0
34544,extensively,0,0
34545,",",0,0
34546,initially,0,0
34547,as,0,0
34548,prophylaxis,0,0
34549,for,0,0
34550,venous,0,1
34551,thromboembolism,0,1
34552,(,0,1
34553,VTE,0,1
34554,),0,0
34555,in,0,0
34556,the,0,0
34557,orthopedic,0,0
34558,surgical,0,0
34559,setting,0,0
34560,.,0,0
34561,Future,0,0
34562,therapeutic,0,0
34563,directions,0,0
34564,for,0,0
34565,selective,0,0
34566,factor,0,0
34567,Xa,0,0
34568,inhibition,0,0
34569,in,0,0
34570,the,0,0
34571,management,0,0
34572,of,0,0
34573,other,0,0
34574,thrombotic,0,0
34575,diseases,0,0
34576,are,0,0
34577,discussed,0,0
34578,.,0,0
34579,Thromboembolic,0,0
34580,diseases,0,0
34581,can,0,0
34582,occur,0,0
34583,in,0,0
34584,the,0,0
34585,venous,0,0
34586,or,0,0
34587,arterial,0,0
34588,sides,0,0
34589,of,0,0
34590,the,0,0
34591,circulatory,0,0
34592,system,0,0
34593,.,0,0
34594,Factor,0,0
34595,Xa,0,0
34596,inhibition,0,0
34597,is,0,0
34598,a,0,0
34599,targeted,0,0
34600,approach,0,0
34601,to,0,0
34602,anticoagulation,0,0
34603,that,0,0
34604,resulted,0,0
34605,from,0,0
34606,significant,0,0
34607,advances,0,0
34608,in,0,0
34609,our,0,0
34610,understanding,0,0
34611,of,0,0
34612,the,0,0
34613,coagulation,0,0
34614,cascade,0,0
34615,.,0,0
34616,The,0,0
34617,factor,1,0
34618,Xa,1,1
34619,inhibitor,1,1
34620,fondaparinux,1,1
34621,has,0,0
34622,been,0,0
34623,studied,0,0
34624,extensively,0,0
34625,in,0,0
34626,the,0,0
34627,orthopedic,0,0
34628,surgical,0,0
34629,setting,0,0
34630,for,0,0
34631,the,0,0
34632,prophylaxis,0,0
34633,of,0,0
34634,VTE,0,0
34635,.,0,0
34636,Current,0,0
34637,investigations,0,0
34638,that,0,0
34639,are,0,0
34640,under,0,0
34641,way,0,0
34642,or,0,0
34643,completed,0,0
34644,evaluate,0,0
34645,the,0,0
34646,efficacy,0,0
34647,and,0,0
34648,safety,0,0
34649,of,0,0
34650,fondaparinux,0,1
34651,for,0,0
34652,the,0,0
34653,management,0,0
34654,of,0,0
34655,various,0,0
34656,thrombotic,0,0
34657,diseases,0,0
34658,.,0,0
34659,The,0,0
34660,future,0,0
34661,development,0,0
34662,of,0,0
34663,fondaparinux,0,1
34664,resides,0,0
34665,primarily,0,0
34666,in,0,0
34667,three,0,0
34668,therapeutic,0,0
34669,areas,0,0
34670,:,0,0
34671,prevention,0,0
34672,of,0,0
34673,VTE,0,0
34674,",",0,0
34675,treatment,0,0
34676,of,0,0
34677,VTE,0,0
34678,",",0,0
34679,and,0,0
34680,treatment,0,0
34681,of,0,0
34682,acute,0,0
34683,coronary,0,0
34684,syndromes,0,0
34685,.,0,0
34686,For,0,0
34687,the,0,0
34688,prevention,0,0
34689,of,0,0
34690,VTE,0,1
34691,",",0,0
34692,fondaparinux,1,1
34693,has,0,0
34694,been,0,0
34695,studied,0,0
34696,as,0,0
34697,extended,0,0
34698,prophylaxis,0,0
34699,following,0,0
34700,hip,0,0
34701,fracture,0,1
34702,surgery,0,1
34703,(,0,1
34704,PENTHIFRA,0,1
34705,Plus,0,1
34706,),0,0
34707,",",0,0
34708,for,0,0
34709,use,0,0
34710,in,0,0
34711,high-risk,0,0
34712,abdominal,0,0
34713,surgical,0,1
34714,patients,0,0
34715,(,0,0
34716,PEGASUS,0,1
34717,and,0,1
34718,APOLLO,0,1
34719,),0,1
34720,",",0,0
34721,and,0,0
34722,for,0,0
34723,use,0,0
34724,in,0,0
34725,medical,0,0
34726,patients,0,0
34727,(,0,1
34728,ARTEMIS,0,1
34729,),0,1
34730,.,0,0
34731,Studies,0,0
34732,evaluating,0,0
34733,fondaparinux,1,1
34734,for,0,0
34735,the,0,0
34736,treatment,0,0
34737,of,0,0
34738,VTE,0,0
34739,are,0,0
34740,part,0,0
34741,of,0,0
34742,the,0,0
34743,large,0,0
34744,MATISSE,0,0
34745,clinical,0,1
34746,program,0,1
34747,(,0,0
34748,MATISSE,0,1
34749,DVT,0,1
34750,and,0,0
34751,MATISSE,0,1
34752,PE,0,1
34753,),0,1
34754,.,0,0
34755,Fondaparinux,1,1
34756,was,0,0
34757,investigated,0,0
34758,in,0,0
34759,phase,0,0
34760,2,0,0
34761,studies,0,0
34762,for,0,0
34763,the,0,0
34764,treatment,0,0
34765,of,0,0
34766,acute,0,0
34767,coronary,0,0
34768,syndromes,0,0
34769,",",0,0
34770,including,0,0
34771,acute,0,0
34772,ST-segment,0,0
34773,myocardial,0,1
34774,infarction,0,1
34775,(,0,1
34776,PENTALYSE,0,1
34777,),0,1
34778,and,0,0
34779,unstable,0,0
34780,angina,0,1
34781,(,0,1
34782,PENTUA,0,1
34783,),0,1
34784,.,0,0
34785,Encouraging,0,0
34786,data,0,0
34787,from,0,0
34788,these,0,0
34789,trials,0,0
34790,are,0,0
34791,the,0,0
34792,basis,0,0
34793,for,0,0
34794,phase,0,0
34795,3,0,0
34796,programs,0,0
34797,in,0,0
34798,this,0,0
34799,area,0,0
34800,(,0,0
34801,MICHELANGELO,0,1
34802,),0,1
34803,.,0,0
34804,The,0,0
34805,orthopedic,0,0
34806,prophylactic,0,0
34807,and,0,0
34808,nonorthopedic,0,0
34809,clinical,0,0
34810,programs,0,0
34811,for,0,0
34812,fondaparinux,0,1
34813,in,0,0
34814,the,0,0
34815,management,0,0
34816,of,0,0
34817,thrombosis,0,0
34818,support,0,0
34819,the,0,0
34820,concept,0,0
34821,that,0,0
34822,targeted,0,0
34823,inhibition,0,0
34824,of,0,0
34825,coagulation,0,0
34826,is,0,0
34827,an,0,0
34828,effective,0,0
34829,advance,0,0
34830,in,0,0
34831,antithrombotic,0,1
34832,therapy,0,1
34833,.,0,0
34834,Intraperitoneal,1,1
34835,cisplatin,1,1
34836,versus,0,1
34837,no,0,0
34838,further,0,0
34839,treatment,0,0
34840,:,0,0
34841,8-year,0,0
34842,results,0,0
34843,of,0,0
34844,EORTC,0,0
34845,55875,0,1
34846,",",0,0
34847,a,0,0
34848,randomized,0,0
34849,phase,0,0
34850,III,0,0
34851,study,0,0
34852,in,0,0
34853,ovarian,0,0
34854,cancer,0,0
34855,patients,0,0
34856,with,0,0
34857,a,0,0
34858,pathologically,0,0
34859,complete,0,0
34860,remission,0,0
34861,after,0,0
34862,platinum-based,1,1
34863,intravenous,1,1
34864,chemotherapy,1,1
34865,.,1,1
34866,First-line,1,1
34867,intravenous,1,1
34868,chemotherapy,1,1
34869,(,0,1
34870,CT,0,0
34871,),0,0
34872,following,0,0
34873,debulking,0,0
34874,surgery,0,0
34875,is,0,0
34876,associated,0,0
34877,with,0,0
34878,prolonged,0,0
34879,survival,0,0
34880,",",0,0
34881,in,0,0
34882,particular,0,0
34883,in,0,0
34884,patients,0,0
34885,who,0,0
34886,achieve,0,0
34887,a,0,0
34888,pathological,0,0
34889,complete,0,0
34890,remission,0,1
34891,(,0,1
34892,pCR,0,1
34893,),0,1
34894,at,0,0
34895,second-look,0,0
34896,surgery,0,0
34897,but,0,0
34898,in,0,0
34899,whom,0,0
34900,a,0,0
34901,high,0,0
34902,rate,0,0
34903,of,0,0
34904,relapses,0,0
34905,still,0,0
34906,occurs,0,0
34907,.,0,0
34908,Between,0,0
34909,1988,0,0
34910,and,0,0
34911,1997,0,0
34912,",",0,0
34913,153,0,0
34914,patients,0,0
34915,in,0,0
34916,pCR,0,0
34917,following,0,0
34918,platinum-based,1,1
34919,intravenous,1,1
34920,CT,1,1
34921,were,0,0
34922,randomized,0,0
34923,between,0,0
34924,four,1,0
34925,courses,1,0
34926,of,1,0
34927,intraperitoneal,1,1
34928,cisplatin,1,1
34929,(,1,1
34930,P,1,1
34931,),1,0
34932,(,1,0
34933,90,1,1
34934,mg/m2,1,1
34935,every,1,1
34936,3,1,1
34937,weeks,1,0
34938,),1,0
34939,or,1,0
34940,observation,1,0
34941,.,1,0
34942,Overall,0,0
34943,survival,0,1
34944,(,0,1
34945,OS,0,1
34946,),0,0
34947,was,0,0
34948,the,0,0
34949,primary,0,0
34950,endpoint,0,0
34951,",",0,0
34952,while,0,0
34953,progression-free,0,1
34954,survival,0,1
34955,(,0,1
34956,PFS,0,1
34957,),0,0
34958,was,0,0
34959,a,0,0
34960,secondary,0,0
34961,endpoint,0,0
34962,.,0,0
34963,This,0,0
34964,intent-to-treat,0,0
34965,analysis,0,0
34966,includes,0,0
34967,16,0,0
34968,patients,0,0
34969,who,0,0
34970,were,0,0
34971,not,0,0
34972,eligible,0,0
34973,and,0,0
34974,17,0,0
34975,patients,0,0
34976,who,0,0
34977,had,0,0
34978,protocol,0,0
34979,violations,0,0
34980,.,0,0
34981,The,0,0
34982,two,0,0
34983,groups,0,0
34984,were,0,0
34985,well,0,0
34986,balanced,0,0
34987,in,0,0
34988,terms,0,0
34989,of,0,0
34990,age,0,0
34991,(,0,0
34992,median,0,0
34993,=,0,0
34994,55,0,0
34995,years,0,0
34996,),0,0
34997,",",0,0
34998,performance,0,1
34999,status,0,0
35000,(,0,0
35001,78,0,0
35002,%,0,0
35003,P.S,0,0
35004,.,0,0
35005,O,0,1
35006,),0,0
35007,",",0,0
35008,FIGO,0,1
35009,stage,0,0
35010,(,0,0
35011,96,0,0
35012,%,0,0
35013,stage,0,0
35014,III,0,0
35015,),0,0
35016,",",0,0
35017,histology,0,1
35018,(,0,0
35019,serous,0,0
35020,in,0,0
35021,66,0,0
35022,%,0,0
35023,),0,0
35024,",",0,0
35025,grade,0,1
35026,(,0,0
35027,2,0,0
35028,or,0,0
35029,3,0,0
35030,in,0,0
35031,80,0,0
35032,%,0,0
35033,),0,0
35034,",",0,0
35035,and,0,0
35036,residuum,0,0
35037,before,0,0
35038,intravenous,0,1
35039,CT,0,1
35040,(,0,1
35041,>,0,0
35042,1,0,0
35043,cm,0,0
35044,in,0,0
35045,40,0,0
35046,%,0,0
35047,),0,0
35048,.,0,0
35049,Intraperitoneal,1,1
35050,CT,1,0
35051,was,0,0
35052,delivered,0,0
35053,mainly,0,0
35054,through,0,0
35055,intraperitoneal,0,1
35056,catheters,0,1
35057,(,0,0
35058,Port-a-Cath,0,0
35059,61,0,0
35060,%,0,0
35061,and,0,0
35062,Tenckhoff,0,0
35063,25,0,0
35064,%,0,0
35065,),0,0
35066,.,0,0
35067,Side,0,0
35068,effects,0,0
35069,of,0,1
35070,intraperitoneal,1,1
35071,cisplatin,1,1
35072,included,0,1
35073,vomiting,0,1
35074,[,0,0
35075,>,0,0
35076,or,0,0
35077,=grade,0,1
35078,2,0,0
35079,(,0,0
35080,82,0,0
35081,%,0,0
35082,),0,0
35083,],0,0
35084,",",0,0
35085,rise,0,0
35086,in,0,0
35087,serum,0,1
35088,creatinine,0,1
35089,[,0,1
35090,>,0,0
35091,or,0,0
35092,=grade,0,1
35093,2,0,1
35094,(,0,0
35095,14,0,0
35096,%,0,0
35097,),0,0
35098,],0,0
35099,",",0,0
35100,abdominal,0,1
35101,pain,0,1
35102,[,0,1
35103,grade,0,1
35104,1-2,0,1
35105,(,0,0
35106,38,0,0
35107,%,0,0
35108,),0,0
35109,],0,0
35110,",",0,1
35111,and,0,1
35112,neurotoxicity,0,1
35113,[,0,1
35114,grade,0,1
35115,2-3,0,1
35116,(,0,0
35117,15,0,0
35118,%,0,0
35119,),0,0
35120,],0,0
35121,.,0,0
35122,After,0,0
35123,a,0,0
35124,median,0,0
35125,follow-up,0,0
35126,of,0,0
35127,8,0,0
35128,years,0,0
35129,",",0,0
35130,80,0,0
35131,patients,0,0
35132,(,0,0
35133,52,0,0
35134,%,0,0
35135,),0,0
35136,have,0,0
35137,progressed,0,0
35138,with,0,0
35139,no,0,0
35140,difference,0,0
35141,in,0,0
35142,the,0,0
35143,pattern,0,0
35144,of,0,0
35145,relapse,0,0
35146,between,0,0
35147,the,0,0
35148,two,0,0
35149,groups,0,0
35150,and,0,0
35151,75,0,0
35152,patients,0,0
35153,(,0,0
35154,49,0,0
35155,%,0,0
35156,),0,0
35157,have,0,0
35158,died,0,0
35159,;,0,0
35160,the,0,0
35161,respective,0,0
35162,hazard,0,0
35163,ratios,0,0
35164,for,0,0
35165,PFS,0,0
35166,and,0,0
35167,OS,0,0
35168,with,0,0
35169,95,0,0
35170,%,0,0
35171,CI,0,0
35172,are,0,0
35173,0.89,0,0
35174,(,0,0
35175,0.59-1.33,0,0
35176,),0,0
35177,and,0,0
35178,0.82,0,0
35179,(,0,0
35180,0.52-1.29,0,0
35181,),0,0
35182,.,0,0
35183,These,0,0
35184,results,0,0
35185,are,0,0
35186,suggestive,0,0
35187,of,0,0
35188,a,0,0
35189,treatment,0,0
35190,benefit,0,0
35191,but,0,0
35192,do,0,0
35193,not,0,0
35194,support,0,0
35195,a,0,0
35196,change,0,0
35197,in,0,0
35198,clinical,0,0
35199,practice,0,0
35200,.,0,0
35201,Other,0,0
35202,randomized,0,0
35203,clinical,0,0
35204,trials,0,0
35205,of,0,0
35206,intraperitoneal,1,1
35207,CT,1,0
35208,are,0,0
35209,reviewed,0,0
35210,and,0,0
35211,briefly,0,0
35212,discussed,0,0
35213,.,0,0
35214,The,0,0
35215,effect,0,0
35216,of,0,0
35217,use,0,0
35218,of,0,0
35219,pyridostigmine,1,1
35220,and,0,0
35221,requirement,0,0
35222,of,0,0
35223,vecuronium,1,1
35224,in,0,0
35225,patients,0,0
35226,with,0,0
35227,myasthenia,0,0
35228,gravis,0,0
35229,.,0,0
35230,CONTEXT,0,0
35231,Patients,0,0
35232,with,0,0
35233,myasthenia,0,0
35234,gravis,0,1
35235,receive,0,1
35236,pyridostigmine,1,1
35237,",",0,1
35238,an,0,0
35239,anticholinesterase,1,1
35240,agent,1,0
35241,",",0,0
35242,as,0,0
35243,a,0,0
35244,part,0,0
35245,of,0,0
35246,therapy,0,0
35247,.,0,0
35248,These,0,0
35249,patients,0,0
35250,demonstrate,0,0
35251,a,0,0
35252,heightened,0,0
35253,sensitivity,0,0
35254,towards,0,0
35255,non-depolarising,0,1
35256,muscle,0,1
35257,relaxants,0,1
35258,.,0,1
35259,Continuing,0,1
35260,pyridostigmine,1,1
35261,till,0,1
35262,the,0,0
35263,day,0,0
35264,of,0,0
35265,the,0,0
35266,surgery,0,0
35267,or,0,0
35268,omitting,0,0
35269,it,0,0
35270,on,0,0
35271,the,0,0
35272,night,0,0
35273,before,0,0
35274,surgery,0,0
35275,could,0,0
35276,provide,0,0
35277,variable,0,0
35278,results,0,0
35279,with,0,0
35280,regards,0,0
35281,to,0,0
35282,the,0,0
35283,effect,0,0
35284,of,0,0
35285,vecuronium,1,1
35286,.,1,1
35287,AIMS,0,1
35288,Myographic,0,0
35289,evaluation,0,0
35290,of,0,0
35291,a,0,0
35292,dose,0,1
35293,of,0,1
35294,vecuronium,0,1
35295,in,0,0
35296,patients,0,0
35297,with,0,0
35298,myasthenia,0,0
35299,gravis,0,0
35300,on,0,0
35301,pyridostigmine,0,1
35302,therapy,0,1
35303,.,0,0
35304,SETTING,0,0
35305,AND,0,1
35306,DESIGN,0,1
35307,A,0,1
35308,randomised,0,1
35309,",",0,0
35310,double-blind,0,1
35311,",",0,1
35312,clinical,0,0
35313,study,0,0
35314,conducted,0,0
35315,in,0,0
35316,a,0,0
35317,teaching,0,0
35318,hospital,0,0
35319,.,0,0
35320,SUBJECTS,0,0
35321,AND,0,0
35322,METHODS,0,1
35323,Medically,0,1
35324,(,1,1
35325,oral,1,1
35326,pyridostigmine,1,1
35327,),1,1
35328,well-controlled,0,1
35329,adult,0,0
35330,patients,0,0
35331,with,0,0
35332,myasthenia,0,0
35333,gravis,0,0
35334,who,0,0
35335,were,0,0
35336,posted,0,0
35337,for,0,0
35338,thymectomy,1,0
35339,",",0,0
35340,were,0,0
35341,randomly,0,0
35342,divided,0,0
35343,into,0,0
35344,two,0,0
35345,groups,0,0
35346,.,0,0
35347,Patients,0,0
35348,in,0,0
35349,Group,0,0
35350,1,0,0
35351,received,0,0
35352,their,0,0
35353,last,0,0
35354,dose,0,1
35355,of,0,1
35356,pyridostigmine,1,1
35357,on,1,0
35358,the,1,0
35359,night,1,0
35360,before,1,0
35361,surgery,1,0
35362,while,0,0
35363,those,0,0
35364,in,0,0
35365,Group,0,0
35366,2,0,0
35367,received,0,0
35368,even,0,0
35369,the,0,0
35370,morning,1,0
35371,dose,1,1
35372,of,1,0
35373,the,1,0
35374,drug,1,1
35375,on,1,0
35376,the,1,0
35377,day,1,0
35378,of,1,0
35379,surgery,1,1
35380,.,1,1
35381,Neostigmine,1,1
35382,(,0,1
35383,1-2,0,1
35384,mg,0,1
35385,),0,1
35386,intravenously,0,1
35387,was,0,0
35388,used,0,0
35389,as,0,0
35390,rescue,0,0
35391,medication,0,0
35392,.,0,1
35393,Vecuronium,1,1
35394,(,0,1
35395,0.01,0,1
35396,mg/kg,0,1
35397,),0,0
35398,was,0,0
35399,used,0,0
35400,for,0,0
35401,intubation,0,0
35402,and,0,0
35403,muscle,0,0
35404,relaxation,0,0
35405,during,0,0
35406,trans-sternal,1,0
35407,thymectomy,1,0
35408,and,0,0
35409,its,0,0
35410,effect,0,0
35411,was,0,0
35412,reversed,0,0
35413,using,0,0
35414,neostigmine,0,1
35415,and,0,1
35416,atropine,0,1
35417,.,0,1
35418,RESULTS,0,0
35419,Fourteen,0,0
35420,patients,0,0
35421,(,0,0
35422,7,0,0
35423,in,0,0
35424,each,0,0
35425,group,0,0
35426,),0,0
35427,belonging,0,0
35428,to,0,0
35429,both,0,0
35430,sexes,0,0
35431,were,0,0
35432,enrolled,0,0
35433,in,0,0
35434,the,0,0
35435,study,0,0
35436,.,0,0
35437,The,0,0
35438,intubating,0,0
35439,dose,0,1
35440,of,0,1
35441,vecuronium,0,1
35442,showed,0,0
35443,quicker,0,0
35444,onset,0,0
35445,time,0,0
35446,(,0,0
35447,155,0,0
35448,sec,0,0
35449,or,0,0
35450,2.7,0,0
35451,min,0,0
35452,approx,0,0
35453,.,0,0
35454,),0,0
35455,and,0,0
35456,peak,0,0
35457,effect,0,0
35458,(,0,0
35459,99,0,0
35460,%,0,0
35461,T1,0,0
35462,suppression,0,0
35463,),0,0
35464,in,0,0
35465,patients,0,0
35466,belonging,0,0
35467,to,0,0
35468,Group,0,0
35469,1,0,0
35470,",",0,0
35471,and,0,0
35472,3/7,0,0
35473,(,0,0
35474,43,0,0
35475,%,0,0
35476,),0,0
35477,complained,0,0
35478,of,0,0
35479,respiratory,0,0
35480,discomfort,0,0
35481,while,0,0
35482,waiting,0,0
35483,for,0,0
35484,surgery,0,0
35485,.,0,0
35486,By,0,0
35487,giving,0,0
35488,the,0,0
35489,morning,0,0
35490,dose,0,1
35491,of,0,1
35492,pyridostigmine,1,1
35493,(,0,1
35494,Group,0,0
35495,2,0,1
35496,),0,0
35497,",",0,0
35498,an,0,0
35499,identical,0,0
35500,intubating,0,0
35501,dose,0,1
35502,of,0,1
35503,vecuronium,1,1
35504,showed,0,0
35505,relative,0,0
35506,resistance,0,0
35507,(,0,0
35508,peak,0,0
35509,effect-97,0,1
35510,%,0,0
35511,T1,0,0
35512,suppression,0,0
35513,),0,0
35514,and,0,0
35515,delayed,0,0
35516,onset,0,1
35517,time,0,0
35518,(,0,0
35519,198,0,0
35520,sec,0,0
35521,approx.,0,0
35522,),0,0
35523,.,0,0
35524,However,0,0
35525,",",0,0
35526,the,0,0
35527,reversal,0,0
35528,was,0,0
35529,complete,0,0
35530,at,0,0
35531,the,0,0
35532,end,0,0
35533,of,0,0
35534,surgery,0,0
35535,in,0,0
35536,both,0,0
35537,the,0,0
35538,regimens,0,1
35539,.,0,1
35540,CONCLUSIONS,0,1
35541,Omission,0,0
35542,of,0,0
35543,the,0,0
35544,pyridostigmine,1,1
35545,dose,0,1
35546,on,0,1
35547,the,0,0
35548,day,0,0
35549,of,0,0
35550,surgery,0,0
35551,predisposed,0,0
35552,patients,0,0
35553,with,0,0
35554,myasthenia,0,0
35555,gravis,0,0
35556,to,0,0
35557,the,0,0
35558,possibility,0,0
35559,of,0,0
35560,respiratory,0,0
35561,discomfort,0,0
35562,and,0,0
35563,sensitivity,0,0
35564,to,0,0
35565,vecuronium,1,1
35566,.,1,1
35567,Continued,0,1
35568,administration,0,1
35569,significantly,0,0
35570,prolonged,0,0
35571,the,0,0
35572,onset,0,0
35573,time,0,0
35574,of,0,0
35575,vecuronium,1,1
35576,and,0,0
35577,the,0,0
35578,patients,0,0
35579,required,0,0
35580,a,0,0
35581,higher,0,0
35582,dose,0,1
35583,of,0,1
35584,vecuronium,1,1
35585,.,1,0
35586,Intervention,0,0
35587,in,0,0
35588,children,0,0
35589,with,0,0
35590,Developmental,0,0
35591,Coordination,0,0
35592,Disorder,0,0
35593,:,0,0
35594,the,0,0
35595,role,0,0
35596,of,0,0
35597,parents,1,0
35598,and,1,0
35599,teachers,1,0
35600,.,1,0
35601,BACKGROUND,0,0
35602,Children,0,0
35603,with,0,0
35604,Developmental,0,0
35605,Coordination,0,0
35606,Disorder,0,0
35607,(,0,0
35608,DCD,0,1
35609,),0,0
35610,are,0,0
35611,a,0,0
35612,heterogeneous,0,0
35613,group,0,0
35614,who,0,0
35615,have,0,0
35616,a,0,0
35617,marked,0,0
35618,impairment,0,0
35619,in,0,0
35620,the,0,0
35621,performance,0,0
35622,of,0,0
35623,functional,0,0
35624,skills,0,0
35625,.,0,0
35626,Provision,0,0
35627,for,0,0
35628,these,0,0
35629,children,0,0
35630,is,0,0
35631,usually,0,0
35632,made,0,0
35633,via,0,0
35634,a,0,0
35635,paediatrician,0,0
35636,through,0,0
35637,occupational,1,0
35638,or,0,0
35639,physiotherapy,1,0
35640,though,0,0
35641,",",0,0
35642,with,0,0
35643,a,0,0
35644,prevalence,0,0
35645,rate,0,0
35646,of,0,0
35647,5,0,0
35648,%,0,0
35649,",",0,0
35650,regular,0,0
35651,provision,0,0
35652,is,0,0
35653,not,0,0
35654,possible,0,0
35655,due,0,0
35656,to,0,0
35657,limited,0,0
35658,professional,0,0
35659,resources,0,0
35660,.,0,0
35661,AIMS,0,0
35662,The,0,0
35663,study,0,0
35664,aimed,0,0
35665,to,0,0
35666,determine,0,0
35667,the,0,0
35668,extent,0,0
35669,to,0,0
35670,which,0,0
35671,parents,1,0
35672,and,1,0
35673,teachers,1,0
35674,",",0,0
35675,with,0,0
35676,guidance,0,0
35677,",",0,0
35678,can,0,0
35679,assist,0,0
35680,in,0,0
35681,the,0,0
35682,management,0,0
35683,of,0,0
35684,children,0,0
35685,with,0,0
35686,DCD,0,1
35687,;,0,0
35688,whether,0,0
35689,children,0,0
35690,with,0,0
35691,DCD,0,0
35692,are,0,0
35693,helped,0,0
35694,in,0,0
35695,this,0,0
35696,way,0,0
35697,and,0,0
35698,how,0,0
35699,this,0,0
35700,may,0,0
35701,contribute,0,0
35702,to,0,0
35703,our,0,0
35704,understanding,0,0
35705,of,0,0
35706,the,0,0
35707,condition,0,0
35708,.,0,0
35709,SAMPLE,0,0
35710,Thirty-one,0,0
35711,children,0,0
35712,with,0,0
35713,DCD,0,0
35714,aged,0,0
35715,7,0,0
35716,to,0,0
35717,9,0,0
35718,years,0,0
35719,participated,0,0
35720,in,0,0
35721,the,0,0
35722,study,0,0
35723,.,0,0
35724,METHODS,0,0
35725,Following,0,0
35726,assessment,0,0
35727,",",0,0
35728,individual,0,0
35729,profiles,0,0
35730,were,0,0
35731,developed,0,0
35732,and,0,0
35733,each,0,0
35734,week,0,0
35735,teachers,1,0
35736,and,1,0
35737,parents,1,0
35738,were,0,0
35739,given,0,0
35740,guidelines,0,0
35741,for,0,0
35742,working,0,0
35743,with,0,0
35744,the,0,0
35745,children,0,0
35746,and,0,0
35747,each,0,0
35748,child,0,0
35749,had,0,0
35750,three,0,0
35751,to,0,0
35752,four,0,0
35753,sessions,0,0
35754,a,0,0
35755,week,0,0
35756,lasting,0,0
35757,approximately,0,0
35758,for,0,0
35759,20,0,0
35760,minutes,0,0
35761,.,0,0
35762,In,0,0
35763,Phase,0,0
35764,1,0,0
35765,",",0,0
35766,one,0,0
35767,group,0,0
35768,of,0,0
35769,children,0,0
35770,worked,0,0
35771,with,0,0
35772,teachers,0,0
35773,and,0,0
35774,the,0,0
35775,other,0,0
35776,group,0,0
35777,worked,0,0
35778,with,0,0
35779,parents,0,0
35780,.,0,0
35781,In,0,0
35782,Phase,0,0
35783,2,0,0
35784,",",0,0
35785,the,0,0
35786,two,0,0
35787,groups,0,0
35788,of,0,0
35789,children,0,0
35790,swapped,0,0
35791,over,0,0
35792,.,0,0
35793,The,0,0
35794,children,0,0
35795,were,0,0
35796,assessed,0,0
35797,regularly,0,0
35798,throughout,0,0
35799,the,0,0
35800,project,0,0
35801,using,0,0
35802,the,0,0
35803,Movement,0,0
35804,ABC,0,0
35805,",",0,0
35806,together,0,0
35807,with,0,0
35808,diaries,0,0
35809,and,0,0
35810,comments,0,0
35811,from,0,0
35812,teachers,0,0
35813,and,0,0
35814,parents,0,0
35815,.,0,0
35816,RESULTS,0,0
35817,At,0,0
35818,the,0,0
35819,end,0,0
35820,of,0,0
35821,the,0,0
35822,40-week,0,0
35823,study,0,0
35824,",",0,0
35825,27,0,0
35826,children,0,0
35827,showed,0,0
35828,significant,0,0
35829,improvement,0,0
35830,in,0,0
35831,their,0,0
35832,motor,0,0
35833,skills,0,0
35834,.,0,0
35835,CONCLUSIONS,0,0
35836,Both,0,1
35837,teachers,1,1
35838,and,1,0
35839,parents,1,0
35840,were,0,0
35841,able,0,0
35842,to,0,0
35843,provide,0,0
35844,effective,0,0
35845,intervention,0,0
35846,for,0,0
35847,the,0,0
35848,majority,0,0
35849,of,0,0
35850,the,0,0
35851,children,0,0
35852,.,0,0
35853,It,0,0
35854,is,0,0
35855,possible,0,0
35856,that,0,0
35857,the,0,0
35858,children,0,0
35859,who,0,0
35860,did,0,0
35861,not,0,0
35862,improve,0,0
35863,have,0,0
35864,difficulties,0,0
35865,that,0,0
35866,are,0,0
35867,of,0,0
35868,a,0,0
35869,more,0,0
35870,complex,0,0
35871,type,0,0
35872,which,0,0
35873,require,0,0
35874,more,0,0
35875,specialist,1,0
35876,therapy,1,0
35877,to,0,0
35878,meet,0,0
35879,their,0,0
35880,need,0,0
35881,.,0,0
35882,Skin,0,1
35883,concentrations,0,1
35884,of,0,1
35885,thromboxane,0,1
35886,synthetase,0,1
35887,inhibitor,0,1
35888,after,0,1
35889,topical,0,1
35890,application,0,0
35891,with,0,0
35892,bioelastic,0,0
35893,membrane,0,0
35894,.,0,0
35895,Elevated,0,0
35896,thromboxane,0,1
35897,levels,0,0
35898,are,0,0
35899,associated,0,0
35900,with,0,0
35901,a,0,0
35902,number,0,0
35903,of,0,0
35904,disease,0,0
35905,states,0,0
35906,",",0,0
35907,including,0,0
35908,dermal,0,0
35909,pressure,0,0
35910,ulcers,0,0
35911,.,0,0
35912,When,0,0
35913,dazmegrel,1,1
35914,was,1,1
35915,orally,1,1
35916,administered,1,1
35917,to,1,1
35918,greyhound,1,0
35919,dogs,1,0
35920,wearing,1,0
35921,leg,1,0
35922,casts,1,0
35923,",",0,0
35924,it,0,0
35925,resulted,0,0
35926,in,0,0
35927,a,0,0
35928,sparring,0,0
35929,effect,0,0
35930,on,0,0
35931,the,0,0
35932,skin,0,0
35933,areas,0,0
35934,of,0,0
35935,potential,0,0
35936,pressure,0,0
35937,ulcer,0,0
35938,development,0,0
35939,.,0,0
35940,The,0,0
35941,objective,0,0
35942,of,0,0
35943,this,0,0
35944,research,0,0
35945,was,0,0
35946,to,0,0
35947,determine,0,0
35948,if,0,0
35949,bioelastic,0,0
35950,matrices,0,0
35951,could,0,0
35952,provide,0,0
35953,controlled,0,0
35954,release,0,0
35955,of,0,0
35956,thromboxane,0,1
35957,A2,0,1
35958,synthetase,0,1
35959,inhibitor,0,1
35960,(,0,1
35961,dazmegrel,0,1
35962,),0,1
35963,at,0,0
35964,tissue,0,0
35965,concentrations,0,0
35966,sufficient,0,0
35967,for,0,0
35968,inhibition,0,0
35969,of,0,0
35970,thromboxane,0,1
35971,synthesis,0,0
35972,.,0,0
35973,The,0,0
35974,animal,0,0
35975,used,0,0
35976,for,0,0
35977,these,0,0
35978,studies,0,0
35979,was,0,0
35980,the,0,0
35981,greyhound,0,0
35982,",",0,0
35983,which,0,0
35984,has,0,0
35985,thin,0,0
35986,skin,0,0
35987,",",0,0
35988,angular,0,0
35989,conformation,0,0
35990,",",0,0
35991,limited,0,0
35992,body,0,0
35993,fat,0,0
35994,and,0,0
35995,is,0,0
35996,predisposed,0,0
35997,to,0,0
35998,pressure,0,0
35999,ulcers,0,0
36000,similar,0,0
36001,to,0,0
36002,those,0,0
36003,occurring,0,0
36004,in,0,0
36005,humans,0,0
36006,.,0,0
36007,In,0,0
36008,vivo,0,0
36009,skin,0,0
36010,penetration,0,0
36011,studies,0,0
36012,showed,0,0
36013,that,0,0
36014,epidermal,0,0
36015,exposure,0,0
36016,to,0,0
36017,bioelastic,0,1
36018,thromboxane,0,1
36019,synthetase,0,1
36020,inhibitor,0,1
36021,(,0,1
36022,TSI,0,1
36023,),0,0
36024,matrix,0,0
36025,resulted,0,0
36026,in,0,0
36027,local,0,0
36028,tissue,0,0
36029,concentrations,0,0
36030,of,0,0
36031,TSI,0,0
36032,sufficient,0,0
36033,for,0,0
36034,thromboxane,0,1
36035,synthetase,0,1
36036,inhibition,0,0
36037,.,0,0
36038,There,0,0
36039,were,0,0
36040,no,0,0
36041,significant,0,0
36042,differences,0,0
36043,between,0,0
36044,dazmegrel,0,1
36045,in,0,0
36046,the,0,0
36047,skin,0,0
36048,layers,0,0
36049,(,0,0
36050,epidermis,0,0
36051,",",0,0
36052,dermis,0,0
36053,and,0,0
36054,subcutaneous,0,1
36055,layers,0,1
36056,),0,1
36057,on,0,0
36058,1,0,0
36059,",",0,0
36060,7,0,0
36061,and,0,0
36062,14-day,0,1
36063,exposures,0,1
36064,.,0,0
36065,A,0,1
36066,randomised,0,0
36067,controlled,0,0
36068,trial,0,0
36069,comparing,0,0
36070,Drawtex,1,0
36071,with,1,0
36072,standard,1,0
36073,dressings,1,0
36074,for,0,0
36075,exuding,0,0
36076,wounds,0,0
36077,.,0,0
36078,OBJECTIVE,0,0
36079,This,0,0
36080,randomised,0,0
36081,controlled,0,0
36082,clinical,0,0
36083,trial,0,0
36084,compared,0,0
36085,a,0,0
36086,capillary,1,0
36087,dressing,1,0
36088,(,1,0
36089,Drawtex,1,1
36090,",",1,0
36091,now,1,0
36092,rebranded,1,0
36093,as,1,0
36094,Vibriant,1,0
36095,RCD,1,1
36096,[,1,0
36097,Vibriant,1,0
36098,Technology,1,1
36099,Services,1,1
36100,],1,1
36101,),1,0
36102,with,1,0
36103,routine,1,0
36104,practice,1,0
36105,for,1,0
36106,exuding,1,0
36107,wounds,1,0
36108,greater,0,0
36109,than,0,0
36110,2.5,0,0
36111,x,0,0
36112,2.5,0,0
36113,cm,0,0
36114,.,0,0
36115,METHOD,0,0
36116,The,0,0
36117,target,0,0
36118,population,0,0
36119,was,0,0
36120,300,0,0
36121,control,0,0
36122,and,0,0
36123,300,0,0
36124,test,0,0
36125,subjects,0,0
36126,across,0,0
36127,three,0,0
36128,sites,0,0
36129,in,0,0
36130,the,0,0
36131,UK,0,0
36132,",",0,0
36133,but,0,0
36134,recruitment,0,0
36135,difficulties,0,0
36136,resulted,0,0
36137,in,0,0
36138,only,0,0
36139,125,0,0
36140,patients,0,0
36141,being,0,0
36142,evaluable,0,0
36143,.,0,0
36144,Wound,0,0
36145,progress,0,0
36146,was,0,0
36147,recorded,0,0
36148,by,0,0
36149,nurses,0,0
36150,',0,0
36151,perception,0,0
36152,of,0,0
36153,the,0,0
36154,progress,0,0
36155,of,0,0
36156,wound,0,0
36157,healing,0,0
36158,and,0,0
36159,by,0,0
36160,objective,0,0
36161,digital,0,0
36162,imaging,0,0
36163,.,0,0
36164,In,0,0
36165,the,0,0
36166,final,0,0
36167,analysis,0,0
36168,digital,0,0
36169,images,0,0
36170,were,0,0
36171,randomised,0,0
36172,(,0,0
36173,in,0,0
36174,time,0,0
36175,order,0,0
36176,),0,0
36177,and,0,0
36178,a,0,0
36179,panel,0,0
36180,of,0,0
36181,nurses,0,0
36182,who,0,0
36183,were,0,0
36184,not,0,0
36185,otherwise,0,0
36186,involved,0,0
36187,in,0,0
36188,the,0,0
36189,research,0,0
36190,project,0,0
36191,graded,0,0
36192,the,0,0
36193,wound,0,0
36194,'s,0,0
36195,progress,0,0
36196,.,0,0
36197,RESULTS,0,0
36198,After,0,0
36199,deconvolution,0,0
36200,of,0,0
36201,the,0,0
36202,data,0,0
36203,",",0,0
36204,the,0,0
36205,subjective,0,1
36206,(,0,0
36207,nurse,0,1
36208,perception,0,1
36209,),0,0
36210,method,0,0
36211,of,0,0
36212,evaluation,0,0
36213,determined,0,0
36214,that,0,0
36215,the,0,0
36216,new,0,0
36217,dressing,0,0
36218,resulted,0,0
36219,in,0,0
36220,wound,0,0
36221,improvement,0,0
36222,in,0,0
36223,12.7,0,0
36224,%,0,0
36225,more,0,0
36226,patients,0,0
36227,than,0,0
36228,did,0,0
36229,routine,0,0
36230,practice,0,0
36231,",",0,0
36232,but,0,0
36233,the,0,0
36234,blinded,0,0
36235,assessment,0,0
36236,method,0,0
36237,(,0,0
36238,based,0,0
36239,on,0,0
36240,the,0,0
36241,digital,0,0
36242,images,0,1
36243,),0,0
36244,showed,0,0
36245,that,0,0
36246,routine,0,0
36247,practice,0,0
36248,was,0,0
36249,better,0,0
36250,by,0,0
36251,6.6,0,0
36252,%,0,0
36253,.,0,0
36254,CONCLUSION,0,0
36255,Evaluation,0,0
36256,of,0,0
36257,wound,0,0
36258,progress,0,0
36259,is,0,0
36260,clearly,0,0
36261,difficult,0,0
36262,.,0,0
36263,Human,0,0
36264,nature,0,0
36265,makes,0,0
36266,us,0,0
36267,favour,0,0
36268,novelty,0,0
36269,if,0,0
36270,we,0,0
36271,believe,0,0
36272,it,0,0
36273,is,0,0
36274,going,0,0
36275,to,0,0
36276,be,0,0
36277,better,0,0
36278,.,0,0
36279,Making,0,0
36280,interpretation,0,0
36281,more,0,0
36282,objective,0,0
36283,removed,0,0
36284,that,0,0
36285,bias,0,0
36286,and,0,0
36287,did,0,0
36288,not,0,0
36289,demonstrate,0,0
36290,a,0,0
36291,significant,0,0
36292,advantage,0,0
36293,for,0,0
36294,the,0,0
36295,test,0,0
36296,dressing,0,0
36297,.,0,0
36298,The,0,0
36299,findings,0,0
36300,suggest,0,0
36301,that,0,0
36302,unblinded,0,0
36303,assessment,0,0
36304,by,0,0
36305,trial,0,0
36306,nurses,0,0
36307,is,0,0
36308,unacceptable,0,0
36309,on,0,0
36310,its,0,0
36311,own,0,0
36312,.,0,0
36313,Blinded,0,0
36314,assessments,0,0
36315,may,0,0
36316,miss,0,0
36317,finer,0,0
36318,nuances,0,0
36319,of,0,0
36320,wound,0,0
36321,progression,0,0
36322,",",0,0
36323,but,0,0
36324,are,0,0
36325,likely,0,0
36326,to,0,0
36327,be,0,0
36328,more,0,0
36329,accurate,0,0
36330,.,0,0
36331,The,0,0
36332,authors,0,0
36333,suggest,0,0
36334,that,0,0
36335,the,0,0
36336,true,0,0
36337,result,0,0
36338,lies,0,0
36339,somewhere,0,0
36340,in,0,0
36341,the,0,0
36342,middle,0,0
36343,",",0,0
36344,with,0,0
36345,the,0,0
36346,trial,0,0
36347,dressing,0,0
36348,likely,0,0
36349,to,0,0
36350,be,0,0
36351,as,0,0
36352,effective,0,0
36353,as,0,0
36354,",",0,0
36355,but,0,0
36356,not,0,0
36357,more,0,0
36358,effective,0,0
36359,than,0,0
36360,",",0,0
36361,a,0,0
36362,standard,0,0
36363,dressing,0,0
36364,.,0,0
36365,Does,0,1
36366,aerobic,1,0
36367,training,1,0
36368,lead,0,0
36369,to,0,0
36370,a,0,0
36371,more,0,0
36372,active,0,0
36373,lifestyle,0,0
36374,and,0,0
36375,improved,0,0
36376,quality,0,0
36377,of,0,0
36378,life,0,0
36379,in,0,0
36380,patients,0,0
36381,with,0,0
36382,chronic,0,0
36383,heart,0,0
36384,failure,0,0
36385,?,0,0
36386,BACKGROUND,0,1
36387,Due,0,1
36388,to,0,0
36389,dyspnea,0,0
36390,and,0,0
36391,fatigue,0,0
36392,",",0,0
36393,patients,0,0
36394,with,0,0
36395,chronic,0,0
36396,heart,0,1
36397,failure,0,1
36398,(,0,1
36399,CHF,0,1
36400,),0,1
36401,are,0,0
36402,often,0,0
36403,restricted,0,0
36404,in,0,0
36405,the,0,0
36406,performance,0,0
36407,of,0,0
36408,everyday,0,0
36409,activities,0,0
36410,",",0,0
36411,which,0,0
36412,gradually,0,0
36413,may,0,0
36414,lead,0,0
36415,to,0,0
36416,hypoactivity,0,0
36417,.,0,0
36418,AIMS,0,0
36419,To,0,0
36420,assess,0,0
36421,whether,0,0
36422,aerobic,1,0
36423,training,1,0
36424,leads,0,0
36425,to,0,0
36426,a,0,0
36427,more,0,0
36428,active,0,0
36429,lifestyle,0,0
36430,and,0,0
36431,improved,0,0
36432,quality,0,0
36433,of,0,0
36434,life,0,1
36435,(,0,1
36436,QoL,0,1
36437,),0,0
36438,in,0,0
36439,patients,0,0
36440,with,0,0
36441,CHF,0,1
36442,.,0,0
36443,METHODS,0,0
36444,Patients,0,0
36445,with,0,0
36446,stable,0,1
36447,CHF,0,1
36448,(,0,1
36449,NYHA,0,1
36450,II/III,0,1
36451,;,0,0
36452,59,0,0
36453,(,0,0
36454,11,0,0
36455,),0,1
36456,years,0,1
36457,),0,0
36458,were,0,0
36459,randomly,0,0
36460,assigned,0,0
36461,to,0,0
36462,a,0,0
36463,training,1,1
36464,group,0,0
36465,(,0,0
36466,n=18,0,0
36467,;,0,0
36468,3-month,0,0
36469,aerobic,1,1
36470,program,1,0
36471,above,1,0
36472,standard,1,0
36473,treatment,1,0
36474,),1,0
36475,or,0,0
36476,control,1,0
36477,group,1,0
36478,(,0,0
36479,n=16,0,0
36480,;,0,0
36481,standard,1,0
36482,treatment,1,0
36483,without,1,0
36484,special,1,0
36485,advice,1,0
36486,for,1,0
36487,exercise,1,0
36488,),1,0
36489,.,0,0
36490,Measurements,0,0
36491,were,0,0
36492,performed,0,0
36493,on,0,0
36494,level,0,0
36495,of,0,0
36496,everyday,0,0
36497,physical,0,0
36498,activity,0,0
36499,(,0,0
36500,PA,0,0
36501,",",0,0
36502,novel,0,0
36503,accelerometry-based,0,0
36504,activity,0,0
36505,monitor,0,1
36506,),0,0
36507,and,0,0
36508,QoL,0,1
36509,",",0,0
36510,and,0,0
36511,on,0,0
36512,several,0,0
36513,related,0,0
36514,parameters,0,0
36515,.,0,0
36516,RESULTS,0,0
36517,Training,0,0
36518,did,0,0
36519,not,0,0
36520,result,0,0
36521,in,0,0
36522,a,0,0
36523,more,0,0
36524,active,0,0
36525,lifestyle,0,0
36526,or,0,0
36527,improved,0,0
36528,QoL,0,0
36529,",",0,0
36530,but,0,0
36531,improved,0,0
36532,(,0,0
36533,P,0,0
36534,<,0,0
36535,0.05,0,0
36536,),0,0
36537,peak,0,0
36538,power,0,1
36539,(,0,0
36540,17,0,0
36541,%,0,0
36542,),0,0
36543,",",0,0
36544,6-min,0,1
36545,walk,0,1
36546,distance,0,1
36547,(,0,0
36548,10,0,0
36549,%,0,0
36550,),0,0
36551,",",0,0
36552,muscle,0,0
36553,strength,0,0
36554,(,0,0
36555,13-15,0,0
36556,%,0,0
36557,),0,0
36558,and,0,0
36559,depression,0,0
36560,(,0,0
36561,-1.3,0,0
36562,unit,0,0
36563,),0,0
36564,.,0,0
36565,Changes,0,0
36566,in,0,0
36567,level,0,0
36568,of,0,0
36569,everyday,0,0
36570,PA,0,0
36571,were,0,0
36572,related,0,0
36573,to,0,0
36574,changes,0,0
36575,in,0,0
36576,peak,0,0
36577,Vo,0,1
36578,(,0,1
36579,2,0,1
36580,),0,0
36581,(,0,0
36582,r=0.58,0,0
36583,",",0,0
36584,P=0.01,0,0
36585,),0,0
36586,and,0,0
36587,knee,0,0
36588,extension,0,0
36589,strength,0,0
36590,(,0,0
36591,r=0.48,0,0
36592,",",0,0
36593,P=0.05,0,0
36594,),0,0
36595,.,0,0
36596,CONCLUSIONS,0,1
36597,At,0,1
36598,group,0,0
36599,level,0,0
36600,training,0,0
36601,did,0,0
36602,not,0,0
36603,result,0,0
36604,in,0,0
36605,a,0,0
36606,more,0,0
36607,active,0,0
36608,lifestyle,0,0
36609,or,0,0
36610,improved,0,0
36611,QoL,0,0
36612,.,0,0
36613,However,0,0
36614,",",0,0
36615,correlations,0,0
36616,between,0,0
36617,training-related,0,0
36618,changes,0,0
36619,in,0,0
36620,parameters,0,0
36621,suggest,0,0
36622,that,0,0
36623,aerobic,0,0
36624,training,0,0
36625,has,0,0
36626,the,0,0
36627,potential,0,0
36628,to,0,0
36629,increase,0,0
36630,levels,0,0
36631,of,0,0
36632,everyday,0,0
36633,PA,0,1
36634,in,0,0
36635,CHF,0,1
36636,.,0,0
36637,Correlates,0,0
36638,of,0,0
36639,cognitive,0,0
36640,deficits,0,0
36641,in,0,0
36642,first,0,0
36643,episode,0,0
36644,schizophrenia,0,0
36645,.,0,0
36646,OBJECTIVE,0,0
36647,The,0,0
36648,presence,0,0
36649,of,0,0
36650,cognitive,0,0
36651,dysfunction,0,0
36652,in,0,0
36653,schizophrenia,0,0
36654,has,0,0
36655,been,0,0
36656,well,0,0
36657,documented,0,0
36658,",",0,0
36659,but,0,0
36660,questions,0,0
36661,remain,0,0
36662,about,0,0
36663,whether,0,0
36664,there,0,0
36665,are,0,0
36666,relationships,0,0
36667,between,0,0
36668,this,0,0
36669,dysfunction,0,0
36670,and,0,0
36671,clinical,0,0
36672,symptomatology,0,0
36673,.,0,0
36674,If,0,0
36675,present,0,0
36676,",",0,0
36677,such,0,0
36678,relationships,0,0
36679,should,0,0
36680,be,0,0
36681,most,0,0
36682,clearly,0,0
36683,observable,0,0
36684,in,0,0
36685,patients,0,0
36686,with,0,0
36687,first,0,0
36688,episode,0,0
36689,schizophrenia,0,1
36690,;,0,0
36691,that,0,0
36692,is,0,0
36693,",",0,0
36694,before,0,0
36695,the,0,0
36696,effects,0,0
36697,of,0,0
36698,chronic,0,0
36699,illness,0,0
36700,",",0,0
36701,institutionalization,0,0
36702,",",0,0
36703,or,0,0
36704,treatment,0,0
36705,might,0,0
36706,confound,0,0
36707,them,0,0
36708,.,0,0
36709,METHOD,0,0
36710,307,0,0
36711,schizophrenia,0,0
36712,subjects,0,0
36713,in,0,0
36714,their,0,0
36715,first,0,0
36716,episode,0,0
36717,of,0,0
36718,illness,0,0
36719,were,0,0
36720,recruited,0,0
36721,to,0,0
36722,participate,0,0
36723,in,0,0
36724,a,0,0
36725,clinical,0,0
36726,trial,0,0
36727,comparing,0,0
36728,the,0,0
36729,long-term,0,0
36730,efficacy,0,0
36731,of,0,0
36732,haloperidol,1,1
36733,and,1,1
36734,risperidone,1,1
36735,.,1,1
36736,The,0,0
36737,psychopathology,0,0
36738,",",0,0
36739,cognitive,0,0
36740,functioning,0,0
36741,",",0,0
36742,early,0,0
36743,treatment,0,0
36744,history,0,0
36745,",",0,0
36746,and,0,0
36747,duration,0,0
36748,of,0,0
36749,untreated,0,0
36750,psychosis,0,0
36751,of,0,0
36752,these,0,0
36753,subjects,0,0
36754,were,0,0
36755,assessed,0,0
36756,prior,0,0
36757,to,0,0
36758,their,0,0
36759,assignment,0,0
36760,to,0,0
36761,randomized,0,0
36762,",",0,0
36763,double-blind,0,1
36764,treatment,0,1
36765,.,0,0
36766,Approximately,0,0
36767,two-thirds,0,0
36768,of,0,0
36769,the,0,0
36770,subjects,0,0
36771,were,0,0
36772,receiving,0,0
36773,antipsychotic,1,1
36774,treatment,1,1
36775,at,0,0
36776,the,0,0
36777,time,0,0
36778,of,0,0
36779,assessment,0,0
36780,;,0,0
36781,however,0,0
36782,",",0,0
36783,the,0,0
36784,duration,0,0
36785,of,0,0
36786,treatment,0,0
36787,was,0,0
36788,limited,0,0
36789,to,0,0
36790,12,0,0
36791,weeks,0,0
36792,or,0,0
36793,less,0,0
36794,.,0,0
36795,RESULTS,0,0
36796,The,0,0
36797,severity,0,0
36798,of,0,0
36799,negative,0,0
36800,symptoms,0,0
36801,at,0,0
36802,the,0,0
36803,time,0,0
36804,of,0,0
36805,assessment,0,0
36806,was,0,0
36807,associated,0,0
36808,with,0,0
36809,deficits,0,0
36810,in,0,0
36811,memory,0,0
36812,",",0,0
36813,verbal,0,0
36814,fluency,0,0
36815,",",0,0
36816,psychomotor,0,0
36817,speed,0,0
36818,and,0,0
36819,executive,0,0
36820,function,0,0
36821,.,0,0
36822,Positive,0,0
36823,symptoms,0,0
36824,were,0,0
36825,not,0,0
36826,associated,0,0
36827,with,0,0
36828,cognitive,0,0
36829,deficits,0,0
36830,.,0,0
36831,Also,0,0
36832,",",0,0
36833,the,0,0
36834,duration,0,0
36835,of,0,0
36836,untreated,0,0
36837,illness,0,0
36838,(,0,1
36839,DUI,0,1
36840,),0,1
36841,prior,0,0
36842,to,0,0
36843,assessment,0,0
36844,was,0,0
36845,not,0,0
36846,significantly,0,0
36847,associated,0,0
36848,with,0,0
36849,cognitive,0,0
36850,impairment,0,0
36851,.,0,0
36852,CONCLUSIONS,0,0
36853,The,0,0
36854,results,0,0
36855,of,0,0
36856,this,0,0
36857,study,0,0
36858,of,0,0
36859,first,0,0
36860,episode,0,0
36861,schizophrenia,0,0
36862,patients,0,0
36863,suggest,0,0
36864,that,0,0
36865,a,0,0
36866,relationship,0,0
36867,exists,0,0
36868,between,0,0
36869,negative,0,0
36870,symptoms,0,0
36871,and,0,0
36872,cognitive,0,0
36873,dysfunction,0,0
36874,.,0,0
36875,However,0,0
36876,",",0,0
36877,that,0,0
36878,relationship,0,0
36879,accounts,0,0
36880,for,0,0
36881,only,0,0
36882,a,0,0
36883,minor,0,0
36884,portion,0,0
36885,of,0,0
36886,the,0,0
36887,variance,0,0
36888,(,0,0
36889,i.e.,0,0
36890,",",0,0
36891,10-15,0,0
36892,%,0,0
36893,),0,0
36894,in,0,0
36895,the,0,0
36896,severity,0,0
36897,of,0,0
36898,cognitive,0,0
36899,dysfunction,0,0
36900,after,0,0
36901,controlling,0,0
36902,for,0,0
36903,a,0,0
36904,number,0,0
36905,of,0,0
36906,potentially,0,0
36907,confounding,0,0
36908,factors,0,0
36909,.,0,0
36910,This,0,0
36911,finding,0,0
36912,provides,0,0
36913,support,0,0
36914,for,0,0
36915,the,0,0
36916,theory,0,0
36917,that,0,0
36918,the,0,0
36919,neurobiological,0,0
36920,processes,0,0
36921,that,0,0
36922,give,0,0
36923,rise,0,0
36924,to,0,0
36925,symptomatology,0,0
36926,and,0,0
36927,cognitive,0,0
36928,dysfunction,0,0
36929,in,0,0
36930,schizophrenia,0,0
36931,are,0,0
36932,partially,0,0
36933,overlapping,0,0
36934,.,0,0
36935,Perispinal,0,1
36936,analgesia,0,1
36937,for,0,0
36938,labour,0,0
36939,followed,0,0
36940,by,0,0
36941,patient-controlled,0,1
36942,infusion,0,1
36943,with,0,1
36944,bupivacaine,1,1
36945,and,0,1
36946,sufentanil,1,1
36947,:,1,0
36948,combined,1,0
36949,spinal-epidural,1,0
36950,vs.,1,0
36951,epidural,1,0
36952,analgesia,0,1
36953,alone,0,0
36954,.,0,0
36955,BACKGROUND,0,0
36956,AND,0,0
36957,OBJECTIVE,0,1
36958,Combined,0,0
36959,spinal-epidural,0,0
36960,is,0,0
36961,an,0,0
36962,alternative,0,0
36963,technique,0,0
36964,to,0,0
36965,epidural,0,1
36966,analgesia,0,1
36967,for,0,0
36968,labour,0,0
36969,",",0,0
36970,but,0,0
36971,its,0,0
36972,benefits,0,0
36973,are,0,0
36974,not,0,0
36975,clearly,0,0
36976,identified,0,0
36977,.,0,0
36978,METHODS,0,0
36979,A,0,1
36980,prospective,0,1
36981,",",0,0
36982,blinded,0,0
36983,",",0,0
36984,randomized,0,0
36985,study,0,0
36986,was,0,0
36987,undertaken,0,0
36988,involving,0,0
36989,113,0,0
36990,women,0,0
36991,attending,0,0
36992,a,0,0
36993,university,0,0
36994,hospital,0,0
36995,obstetric,0,0
36996,department,0,1
36997,.,0,0
36998,Analgesia,0,1
36999,was,0,0
37000,initiated,1,0
37001,with,1,1
37002,intrathecal,1,1
37003,bupivacaine,1,1
37004,0.25,1,1
37005,%,1,0
37006,1,1,0
37007,mL,1,0
37008,+,1,1
37009,sufentanil,1,1
37010,5,1,1
37011,microg,1,1
37012,in,1,0
37013,the,1,0
37014,combined,1,0
37015,spinal-epidural,1,1
37016,group,1,0
37017,(,1,0
37018,n,1,0
37019,=,1,0
37020,54,1,0
37021,),1,0
37022,",",1,0
37023,and,1,0
37024,with,1,1
37025,bupivacaine,1,1
37026,0.125,1,1
37027,%,1,1
37028,+,1,0
37029,epinephrine,1,1
37030,2.5,1,1
37031,microg,1,1
37032,mL,1,1
37033,(,1,1
37034,-1,1,1
37035,),1,1
37036,+,1,1
37037,sufentanil,1,1
37038,7.5,1,1
37039,microg,1,1
37040,in,1,0
37041,the,1,0
37042,epidural,1,1
37043,group,1,0
37044,(,1,0
37045,n,1,0
37046,=,1,0
37047,59,1,0
37048,),1,0
37049,.,1,0
37050,In,1,0
37051,both,1,0
37052,cases,1,0
37053,this,1,0
37054,was,1,0
37055,followed,1,0
37056,by,1,0
37057,patient-controlled,1,1
37058,epidural,1,1
37059,analgesia,1,1
37060,with,1,1
37061,bupivacaine,1,1
37062,0.125,1,1
37063,%,1,1
37064,(,1,0
37065,+,1,0
37066,sufentanil,1,1
37067,0.25,1,1
37068,microg,1,1
37069,mL,1,1
37070,(,1,1
37071,-1,1,1
37072,),1,1
37073,),1,0
37074,.,1,0
37075,Duration,0,0
37076,of,0,0
37077,labour,0,0
37078,",",0,0
37079,quality,0,0
37080,of,0,0
37081,analgesia,0,1
37082,and,0,0
37083,side-effects,0,1
37084,were,0,0
37085,compared,0,0
37086,between,0,0
37087,groups,0,0
37088,.,0,0
37089,RESULTS,0,0
37090,In,0,0
37091,the,0,0
37092,combined,0,0
37093,spinal-epidural,0,0
37094,group,0,0
37095,",",0,0
37096,the,0,0
37097,onset,0,0
37098,of,0,0
37099,analgesia,0,1
37100,was,0,0
37101,faster,0,0
37102,(,0,0
37103,5,0,0
37104,vs.,0,0
37105,15,0,0
37106,min,0,0
37107,",",0,0
37108,P,0,0
37109,<,0,0
37110,0.001,0,0
37111,),0,0
37112,",",0,0
37113,the,0,0
37114,consumption,0,1
37115,of,0,0
37116,bupivacaine,1,1
37117,was,0,0
37118,lower,0,0
37119,(,0,0
37120,7.5,0,0
37121,vs.,0,0
37122,11.3,0,0
37123,mg,0,0
37124,h,0,1
37125,(,0,1
37126,-1,0,1
37127,),0,0
37128,",",0,0
37129,P,0,0
37130,=,0,0
37131,0.003,0,0
37132,),0,0
37133,and,0,0
37134,there,0,0
37135,was,0,0
37136,less,0,0
37137,unilateral,0,1
37138,analgesia,0,1
37139,(,0,0
37140,14.8,0,0
37141,%,0,0
37142,vs.,0,0
37143,40.7,0,0
37144,%,0,0
37145,",",0,0
37146,P,0,0
37147,=,0,0
37148,0.002,0,0
37149,),0,0
37150,than,0,0
37151,in,0,0
37152,the,0,0
37153,epidural,0,0
37154,group,0,0
37155,.,0,0
37156,The,0,0
37157,characteristics,0,0
37158,of,0,0
37159,labour,0,0
37160,were,0,0
37161,similar,0,0
37162,in,0,0
37163,both,0,0
37164,groups,0,0
37165,.,0,0
37166,However,0,0
37167,",",0,0
37168,in,0,0
37169,the,0,0
37170,combined,0,0
37171,spinal-epidural,0,0
37172,group,0,0
37173,",",0,0
37174,there,0,0
37175,was,0,0
37176,a,0,0
37177,higher,0,0
37178,incidence,0,0
37179,of,0,0
37180,posterior,0,1
37181,presentation,0,0
37182,(,0,0
37183,25.9,0,0
37184,%,0,0
37185,vs.,0,0
37186,10,0,0
37187,%,0,0
37188,",",0,0
37189,P,0,0
37190,=,0,0
37191,0.03,0,0
37192,),0,0
37193,",",0,0
37194,pruritus,0,0
37195,(,0,0
37196,P,0,0
37197,<,0,0
37198,0.001,0,0
37199,),0,0
37200,",",0,0
37201,hypotension,0,0
37202,(,0,0
37203,P,0,0
37204,=,0,0
37205,0.002,0,0
37206,),0,0
37207,",",0,0
37208,somnolence,0,0
37209,(,0,0
37210,P,0,0
37211,=,0,0
37212,0.01,0,0
37213,),0,0
37214,",",0,0
37215,nausea,0,1
37216,(,0,0
37217,P,0,0
37218,=,0,0
37219,0.02,0,0
37220,),0,0
37221,and,0,0
37222,one,0,0
37223,case,0,0
37224,of,0,0
37225,meningitis,0,0
37226,.,0,0
37227,CONCLUSIONS,0,0
37228,The,0,0
37229,combined,0,0
37230,spinal-epidural,0,0
37231,technique,0,0
37232,provided,0,0
37233,more,0,0
37234,effective,0,0
37235,analgesia,0,1
37236,during,0,0
37237,labour,0,1
37238,than,0,0
37239,epidural,0,0
37240,analgesia,0,1
37241,alone,0,0
37242,but,0,0
37243,offered,0,0
37244,no,0,0
37245,other,0,0
37246,advantage,0,0
37247,.,0,0
37248,It,0,0
37249,induced,0,0
37250,more,0,0
37251,adverse,0,0
37252,effects,0,0
37253,and,0,0
37254,this,0,0
37255,should,0,0
37256,be,0,0
37257,considered,0,0
37258,before,0,0
37259,routinely,0,0
37260,using,0,0
37261,the,0,0
37262,combined,0,0
37263,spinal-epidural,0,0
37264,technique,0,0
37265,.,0,0
37266,Calcium,1,1
37267,chloride,1,1
37268,before,1,1
37269,i.v,1,1
37270,.,1,1
37271,diltiazem,1,1
37272,in,0,0
37273,the,0,0
37274,management,0,0
37275,of,0,0
37276,atrial,0,0
37277,fibrillation,0,1
37278,.,0,0
37279,Diltiazem,1,1
37280,is,0,0
37281,commonly,0,0
37282,used,0,0
37283,to,0,0
37284,treat,0,0
37285,atrial,0,0
37286,fibrillation,0,0
37287,or,0,0
37288,flutter,0,1
37289,(,0,1
37290,AFF,0,1
37291,),0,1
37292,with,0,0
37293,rapid,0,0
37294,ventricular,0,0
37295,response,0,0
37296,(,0,1
37297,RVR,0,1
37298,),0,1
37299,.,0,0
37300,Although,0,0
37301,it,0,0
37302,is,0,0
37303,very,0,0
37304,effective,0,0
37305,for,0,0
37306,rate,0,0
37307,control,0,0
37308,",",0,0
37309,up,0,0
37310,to,0,0
37311,an,0,0
37312,18,0,0
37313,%,0,0
37314,prevalence,0,0
37315,of,0,0
37316,reported,0,0
37317,diltiazem-induced,1,1
37318,hypotension,0,1
37319,[,0,0
37320,defined,0,0
37321,by,0,0
37322,systolic,0,0
37323,blood,0,1
37324,pressure,0,1
37325,(,0,1
37326,SBP,0,1
37327,),0,0
37328,<,0,0
37329,90,0,0
37330,mm,0,0
37331,Hg,0,1
37332,],0,1
37333,",",0,0
37334,and,0,0
37335,a,0,0
37336,mean,0,0
37337,of,0,0
37338,9.7,0,0
37339,%,0,0
37340,hypotension,0,0
37341,have,0,0
37342,been,0,0
37343,reported,0,0
37344,from,0,0
37345,several,0,0
37346,studies,0,0
37347,totaling,0,0
37348,over,0,0
37349,450,0,0
37350,patients,0,0
37351,.,0,0
37352,This,0,0
37353,hypotension,0,0
37354,may,0,0
37355,complicate,0,0
37356,therapy,0,0
37357,.,0,0
37358,Our,0,0
37359,objective,0,0
37360,was,0,0
37361,to,0,0
37362,determine,0,0
37363,if,0,0
37364,calcium,1,1
37365,chloride,1,1
37366,(,1,1
37367,CaCl,1,1
37368,(,1,1
37369,2,1,1
37370,),1,1
37371,),1,0
37372,pre-treatment,0,0
37373,would,0,0
37374,blunt,0,0
37375,a,0,0
37376,SBP,0,1
37377,drop,0,1
37378,after,0,0
37379,i.v,0,1
37380,.,0,1
37381,diltiazem,0,1
37382,",",0,0
37383,while,0,0
37384,allowing,0,0
37385,diltiazem,1,1
37386,to,0,0
37387,maintain,0,0
37388,its,0,0
37389,efficacy,0,0
37390,.,0,0
37391,A,0,0
37392,prospective,0,0
37393,",",0,0
37394,randomized,0,1
37395,",",0,1
37396,double-blind,0,1
37397,",",0,1
37398,placebo-controlled,0,1
37399,study,0,0
37400,was,0,0
37401,conducted,0,0
37402,.,0,0
37403,Seventy-eight,0,0
37404,patients,0,0
37405,with,0,0
37406,AFF,0,0
37407,and,0,0
37408,a,0,0
37409,ventricular,0,0
37410,rate,0,0
37411,of,0,0
37412,>,0,0
37413,/=,0,0
37414,120,0,0
37415,beats,0,0
37416,per,0,0
37417,minute,0,0
37418,were,0,0
37419,enrolled,0,0
37420,.,0,0
37421,Half,0,0
37422,received,0,0
37423,i.v,0,1
37424,.,0,1
37425,CaCl,1,1
37426,(,1,1
37427,2,1,1
37428,),1,1
37429,pre-treatment,0,0
37430,;,0,0
37431,the,0,0
37432,other,0,0
37433,half,0,0
37434,received,0,0
37435,placebo,1,1
37436,.,1,1
37437,All,0,0
37438,patients,0,0
37439,then,0,0
37440,received,0,0
37441,i.v,0,1
37442,.,0,1
37443,diltiazem,1,1
37444,in,0,0
37445,a,0,0
37446,standard,0,0
37447,",",0,0
37448,weight-based,0,1
37449,dose,0,1
37450,.,0,1
37451,A,0,1
37452,second,0,0
37453,dose,0,1
37454,of,0,1
37455,CaCl,0,1
37456,(,0,1
37457,2,0,1
37458,),0,0
37459,pre-treatment,0,0
37460,or,0,0
37461,placebo,1,1
37462,and,0,1
37463,diltiazem,1,1
37464,was,0,0
37465,given,0,0
37466,if,0,0
37467,clinically,0,0
37468,indicated,0,0
37469,for,0,0
37470,additional,0,0
37471,rate,0,0
37472,control,0,0
37473,.,0,0
37474,Both,0,1
37475,CaCl,0,1
37476,(,0,1
37477,2,0,1
37478,),0,1
37479,and,0,1
37480,placebo,1,1
37481,pre-treatment,0,0
37482,groups,0,0
37483,had,0,0
37484,equal,0,0
37485,lowering,0,0
37486,of,0,0
37487,heart,0,0
37488,rate,0,0
37489,(,0,0
37490,p,0,0
37491,<,0,0
37492,0.001,0,0
37493,),0,0
37494,.,0,0
37495,There,0,0
37496,were,0,0
37497,no,0,0
37498,adverse,0,0
37499,events,0,0
37500,in,0,0
37501,the,0,0
37502,calcium,0,1
37503,pre-treatment,0,0
37504,study,0,0
37505,arm,0,0
37506,.,0,0
37507,One,0,0
37508,patient,0,0
37509,in,0,0
37510,the,0,0
37511,placebo,0,1
37512,group,0,0
37513,became,0,0
37514,paradoxically,0,0
37515,more,0,0
37516,tachycardic,0,1
37517,and,0,1
37518,apneic,0,1
37519,after,0,0
37520,the,0,0
37521,diltiazem,0,1
37522,infusion,0,1
37523,.,0,1
37524,Although,0,0
37525,i.v,0,1
37526,.,0,1
37527,CaCl,0,1
37528,(,0,1
37529,2,0,1
37530,),0,0
37531,seems,0,0
37532,to,0,0
37533,be,0,0
37534,equally,0,0
37535,safe,0,0
37536,compared,0,0
37537,to,0,0
37538,placebo,0,1
37539,as,0,0
37540,a,0,0
37541,pre-treatment,0,0
37542,in,0,0
37543,the,0,0
37544,management,0,0
37545,of,0,0
37546,AFF,0,0
37547,with,0,0
37548,RVR,0,0
37549,",",0,0
37550,we,0,0
37551,were,0,0
37552,unable,0,0
37553,to,0,0
37554,find,0,0
37555,a,0,0
37556,statistically,0,0
37557,significant,0,0
37558,blunting,0,0
37559,of,0,0
37560,SBP,0,1
37561,drop,0,1
37562,with,0,1
37563,CaCl,0,1
37564,(,0,1
37565,2,0,1
37566,),0,1
37567,i.v,0,1
37568,.,0,1
37569,pre-treatment,0,0
37570,.,0,0
37571,Until,0,1
37572,further,0,0
37573,research,0,0
37574,determines,0,0
37575,a,0,0
37576,benefit,0,0
37577,exists,0,0
37578,",",0,0
37579,we,0,0
37580,can,0,0
37581,not,0,0
37582,recommend,0,0
37583,i.v,0,1
37584,.,0,1
37585,CaCl,1,1
37586,(,1,1
37587,2,1,1
37588,),1,0
37589,pre-treatment,0,0
37590,before,0,0
37591,diltiazem,1,1
37592,in,0,0
37593,the,0,0
37594,treatment,0,0
37595,of,0,0
37596,AFF,0,0
37597,with,0,0
37598,RVR,0,0
37599,.,0,0
37600,Bitewing,0,1
37601,film,0,1
37602,quality,0,0
37603,:,0,0
37604,a,0,0
37605,clinical,0,0
37606,comparison,0,0
37607,of,0,0
37608,the,0,0
37609,loop,1,0
37610,vs.,1,0
37611,holder,1,0
37612,techniques,1,0
37613,.,1,0
37614,OBJECTIVE,0,0
37615,To,0,0
37616,compare,0,0
37617,in,0,0
37618,vivo,0,0
37619,bitewing,0,0
37620,film,0,1
37621,quality,0,0
37622,using,0,0
37623,the,0,0
37624,holder,1,0
37625,versus,1,0
37626,the,1,0
37627,paper,1,0
37628,loop,1,0
37629,technique,1,0
37630,.,1,0
37631,METHOD,0,0
37632,AND,0,1
37633,MATERIALS,0,1
37634,Four,0,1
37635,bitewing,0,0
37636,films,0,0
37637,were,0,0
37638,taken,0,0
37639,from,0,0
37640,the,0,0
37641,right,0,0
37642,and,0,0
37643,left,0,0
37644,premolar,0,0
37645,and,0,0
37646,molar,0,0
37647,regions,0,0
37648,of,0,0
37649,45,0,0
37650,dental,0,0
37651,students,0,0
37652,using,0,0
37653,both,0,0
37654,the,0,0
37655,bitewing,1,0
37656,holder,1,0
37657,and,1,0
37658,paper,1,0
37659,loop,1,0
37660,techniques,1,0
37661,.,1,0
37662,A,0,0
37663,total,0,0
37664,of,0,0
37665,360,0,0
37666,films,0,0
37667,were,0,0
37668,taken,0,0
37669,and,0,0
37670,assessed,0,0
37671,by,0,0
37672,an,0,0
37673,experienced,0,0
37674,practitioner,0,0
37675,not,0,0
37676,apprised,0,0
37677,of,0,0
37678,the,0,0
37679,bitewing,1,0
37680,technique,1,0
37681,used,0,0
37682,.,0,0
37683,Of,0,0
37684,interest,0,0
37685,were,0,0
37686,:,0,0
37687,(,0,0
37688,1,0,0
37689,),0,0
37690,the,0,0
37691,number,0,0
37692,of,0,0
37693,overlaps,0,0
37694,and,0,0
37695,the,0,0
37696,percentage,0,0
37697,of,0,0
37698,teeth,0,0
37699,showing,0,0
37700,the,0,0
37701,alveolar,0,0
37702,crest,0,1
37703,;,0,1
37704,(,0,1
37705,2,0,1
37706,),0,0
37707,proper,0,0
37708,film,0,1
37709,positioning,0,0
37710,;,0,1
37711,and,0,0
37712,(,0,1
37713,3,0,1
37714,),0,0
37715,the,0,0
37716,percentage,0,0
37717,of,0,0
37718,cone,0,0
37719,cutting,0,0
37720,.,0,0
37721,A,0,0
37722,Poisson,0,0
37723,regression,0,0
37724,using,0,0
37725,generalized,0,0
37726,estimating,0,0
37727,equations,0,0
37728,(,0,1
37729,GEEs,0,1
37730,),0,0
37731,was,0,0
37732,used,0,0
37733,to,0,0
37734,estimate,0,0
37735,the,0,0
37736,difference,0,0
37737,in,0,0
37738,overlap,0,0
37739,between,0,0
37740,the,0,0
37741,two,0,0
37742,techniques,0,0
37743,.,0,0
37744,For,0,0
37745,proper,0,0
37746,positioning,0,0
37747,and,0,0
37748,cone,0,0
37749,cutting,0,0
37750,",",0,0
37751,logistic,0,0
37752,regressions,0,0
37753,using,0,0
37754,GEEs,0,0
37755,were,0,0
37756,used,0,0
37757,.,0,0
37758,RESULTS,0,0
37759,The,0,0
37760,average,0,0
37761,number,0,0
37762,of,0,0
37763,horizontal,0,0
37764,overlaps,0,0
37765,for,0,0
37766,the,0,0
37767,loop,1,0
37768,and,0,0
37769,holder,1,0
37770,techniques,1,0
37771,at,0,0
37772,the,0,0
37773,right,0,0
37774,premolar,0,0
37775,",",0,0
37776,right,0,0
37777,molar,0,0
37778,",",0,0
37779,left,0,0
37780,premolar,0,0
37781,",",0,0
37782,and,0,0
37783,left,0,0
37784,molar,0,0
37785,were,0,0
37786,1.64,0,0
37787,",",0,0
37788,2.11,0,0
37789,",",0,0
37790,2.16,0,0
37791,",",0,0
37792,2.78,0,0
37793,",",0,0
37794,and,0,0
37795,1.64,0,0
37796,",",0,0
37797,2.00,0,0
37798,",",0,0
37799,2.00,0,0
37800,",",0,0
37801,2.18,0,0
37802,",",0,0
37803,respectively,0,0
37804,.,0,0
37805,The,0,0
37806,loop,1,0
37807,technique,1,0
37808,was,0,0
37809,1.11,0,0
37810,times,0,0
37811,more,0,0
37812,likely,0,0
37813,to,0,0
37814,cause,0,0
37815,overlapping,0,0
37816,than,0,0
37817,the,0,0
37818,holder,1,0
37819,technique,1,0
37820,.,1,0
37821,The,0,0
37822,highest,0,0
37823,percentage,0,0
37824,of,0,0
37825,teeth,0,0
37826,showing,0,0
37827,the,0,0
37828,alveolar,0,0
37829,crest,0,0
37830,by,0,0
37831,the,0,0
37832,loop,1,0
37833,technique,1,0
37834,was,0,0
37835,97.8,0,0
37836,%,0,0
37837,in,0,0
37838,the,0,0
37839,mandibular,0,0
37840,second,0,0
37841,premolar,0,0
37842,and,0,0
37843,first,0,0
37844,molar,0,0
37845,.,0,0
37846,With,0,0
37847,respect,0,0
37848,to,0,0
37849,film,0,0
37850,positioning,0,0
37851,",",0,0
37852,the,0,0
37853,loop,1,0
37854,technique,1,0
37855,was,0,0
37856,1.12,0,0
37857,times,0,0
37858,more,0,0
37859,likely,0,0
37860,to,0,0
37861,cause,0,0
37862,improper,0,0
37863,positioning,0,0
37864,than,0,0
37865,the,0,0
37866,holder,1,0
37867,technique,1,0
37868,.,1,0
37869,Both,0,0
37870,techniques,0,0
37871,demonstrated,0,0
37872,minimal,0,0
37873,cone,0,0
37874,cutting,0,0
37875,(,0,0
37876,1,0,0
37877,in,0,0
37878,the,0,0
37879,loop,0,0
37880,versus,0,0
37881,0,0,0
37882,in,0,0
37883,the,0,0
37884,holder,0,0
37885,),0,0
37886,.,0,0
37887,CONCLUSION,0,0
37888,The,0,0
37889,quality,0,0
37890,of,0,0
37891,bitewing,0,0
37892,films,0,0
37893,taken,0,0
37894,by,0,0
37895,the,0,0
37896,loop,1,0
37897,and,1,0
37898,holder,1,0
37899,techniques,1,0
37900,was,0,0
37901,not,0,0
37902,significantly,0,0
37903,different,0,0
37904,.,0,0
37905,A,0,0
37906,comparison,0,0
37907,of,0,0
37908,laparoscopically,1,0
37909,assisted,1,0
37910,and,1,0
37911,open,1,0
37912,colectomy,1,0
37913,for,0,0
37914,colon,0,0
37915,cancer,0,0
37916,.,0,0
37917,BACKGROUND,0,0
37918,Minimally,0,0
37919,invasive,0,0
37920,",",0,0
37921,laparoscopically,1,0
37922,assisted,1,0
37923,surgery,1,0
37924,was,0,0
37925,first,0,0
37926,considered,0,0
37927,in,0,0
37928,1990,0,0
37929,for,0,0
37930,patients,0,0
37931,undergoing,0,0
37932,colectomy,0,0
37933,for,0,0
37934,cancer,0,0
37935,.,0,0
37936,Concern,0,0
37937,that,0,0
37938,this,0,0
37939,approach,0,0
37940,would,0,0
37941,compromise,0,0
37942,survival,0,0
37943,by,0,0
37944,failing,0,0
37945,to,0,0
37946,achieve,0,0
37947,a,0,0
37948,proper,0,0
37949,oncologic,0,0
37950,resection,0,0
37951,or,0,0
37952,adequate,0,0
37953,staging,0,0
37954,or,0,0
37955,by,0,0
37956,altering,0,0
37957,patterns,0,0
37958,of,0,0
37959,recurrence,0,0
37960,(,0,0
37961,based,0,0
37962,on,0,0
37963,frequent,0,0
37964,reports,0,0
37965,of,0,0
37966,tumor,0,0
37967,recurrences,0,0
37968,within,0,0
37969,surgical,0,1
37970,wounds,0,1
37971,),0,0
37972,prompted,0,0
37973,a,0,0
37974,controlled,0,0
37975,trial,0,0
37976,evaluation,0,0
37977,.,0,0
37978,METHODS,0,0
37979,We,0,0
37980,conducted,0,0
37981,a,0,0
37982,noninferiority,0,0
37983,trial,0,0
37984,at,0,0
37985,48,0,0
37986,institutions,0,0
37987,and,0,0
37988,randomly,0,0
37989,assigned,0,0
37990,872,0,0
37991,patients,0,0
37992,with,0,0
37993,adenocarcinoma,0,0
37994,of,0,0
37995,the,0,0
37996,colon,0,0
37997,to,0,0
37998,undergo,0,0
37999,open,1,0
38000,or,1,0
38001,laparoscopically,1,0
38002,assisted,1,0
38003,colectomy,1,0
38004,performed,0,0
38005,by,0,0
38006,credentialed,0,0
38007,surgeons,0,0
38008,.,0,0
38009,The,0,0
38010,median,0,0
38011,follow-up,0,0
38012,was,0,0
38013,4.4,0,0
38014,years,0,0
38015,.,0,0
38016,The,0,0
38017,primary,0,0
38018,end,0,0
38019,point,0,0
38020,was,0,0
38021,the,0,0
38022,time,0,0
38023,to,0,0
38024,tumor,0,0
38025,recurrence,0,0
38026,.,0,0
38027,RESULTS,0,0
38028,At,0,0
38029,three,0,0
38030,years,0,0
38031,",",0,0
38032,the,0,0
38033,rates,0,0
38034,of,0,0
38035,recurrence,0,0
38036,were,0,0
38037,similar,0,0
38038,in,0,0
38039,the,0,0
38040,two,0,0
38041,groups,0,0
38042,--,0,0
38043,16,0,0
38044,percent,0,0
38045,among,0,0
38046,patients,0,0
38047,in,0,0
38048,the,0,0
38049,group,0,0
38050,that,0,0
38051,underwent,0,0
38052,laparoscopically,0,0
38053,assisted,0,0
38054,surgery,0,0
38055,and,0,0
38056,18,0,0
38057,percent,0,0
38058,among,0,0
38059,patients,0,0
38060,in,0,0
38061,the,0,0
38062,open-colectomy,0,1
38063,group,0,0
38064,(,0,0
38065,two-sided,0,0
38066,P=0.32,0,0
38067,;,0,0
38068,hazard,0,0
38069,ratio,0,0
38070,for,0,0
38071,recurrence,0,0
38072,",",0,0
38073,0.86,0,0
38074,;,0,0
38075,95,0,0
38076,percent,0,0
38077,confidence,0,0
38078,interval,0,0
38079,",",0,0
38080,0.63,0,0
38081,to,0,0
38082,1.17,0,0
38083,),0,0
38084,.,0,0
38085,Recurrence,0,0
38086,rates,0,0
38087,in,0,0
38088,surgical,0,0
38089,wounds,0,0
38090,were,0,0
38091,less,0,0
38092,than,0,0
38093,1,0,0
38094,percent,0,0
38095,in,0,0
38096,both,0,0
38097,groups,0,0
38098,(,0,0
38099,P=0.50,0,0
38100,),0,0
38101,.,0,0
38102,The,0,0
38103,overall,0,0
38104,survival,0,0
38105,rate,0,0
38106,at,0,0
38107,three,0,0
38108,years,0,0
38109,was,0,0
38110,also,0,0
38111,very,0,0
38112,similar,0,0
38113,in,0,0
38114,the,0,0
38115,two,0,0
38116,groups,0,0
38117,(,0,0
38118,86,0,0
38119,percent,0,0
38120,in,0,0
38121,the,0,0
38122,laparoscopic-surgery,0,0
38123,group,0,0
38124,and,0,0
38125,85,0,0
38126,percent,0,0
38127,in,0,0
38128,the,0,0
38129,open-colectomy,0,1
38130,group,0,0
38131,;,0,0
38132,P=0.51,0,0
38133,;,0,0
38134,hazard,0,0
38135,ratio,0,0
38136,for,0,0
38137,death,0,0
38138,in,0,0
38139,the,0,0
38140,laparoscopic-surgery,0,0
38141,group,0,0
38142,",",0,0
38143,0.91,0,0
38144,;,0,0
38145,95,0,0
38146,percent,0,0
38147,confidence,0,0
38148,interval,0,0
38149,",",0,0
38150,0.68,0,0
38151,to,0,0
38152,1.21,0,0
38153,),0,0
38154,",",0,0
38155,with,0,0
38156,no,0,0
38157,significant,0,0
38158,difference,0,0
38159,between,0,0
38160,groups,0,0
38161,in,0,0
38162,the,0,0
38163,time,0,0
38164,to,0,0
38165,recurrence,0,0
38166,or,0,0
38167,overall,0,0
38168,survival,0,0
38169,for,0,0
38170,patients,0,0
38171,with,0,0
38172,any,0,0
38173,stage,0,0
38174,of,0,0
38175,cancer,0,0
38176,.,0,0
38177,Perioperative,0,0
38178,recovery,0,0
38179,was,0,0
38180,faster,0,0
38181,in,0,0
38182,the,0,0
38183,laparoscopic-surgery,0,0
38184,group,0,0
38185,than,0,0
38186,in,0,0
38187,the,0,0
38188,open-colectomy,0,0
38189,group,0,0
38190,",",0,0
38191,as,0,0
38192,reflected,0,0
38193,by,0,0
38194,a,0,0
38195,shorter,0,0
38196,median,0,0
38197,hospital,0,0
38198,stay,0,0
38199,(,0,0
38200,five,0,0
38201,days,0,0
38202,vs.,0,0
38203,six,0,0
38204,days,0,0
38205,",",0,0
38206,P,0,0
38207,<,0,0
38208,0.001,0,0
38209,),0,0
38210,and,0,0
38211,briefer,0,0
38212,use,0,0
38213,of,0,0
38214,parenteral,0,1
38215,narcotics,0,1
38216,(,0,1
38217,three,0,0
38218,days,0,0
38219,vs.,0,0
38220,four,0,0
38221,days,0,0
38222,",",0,0
38223,P,0,0
38224,<,0,0
38225,0.001,0,0
38226,),0,0
38227,and,0,0
38228,oral,0,1
38229,analgesics,0,1
38230,(,0,1
38231,one,0,0
38232,day,0,0
38233,vs.,0,0
38234,two,0,0
38235,days,0,0
38236,",",0,0
38237,P=0.02,0,0
38238,),0,0
38239,.,0,0
38240,The,0,0
38241,rates,0,0
38242,of,0,0
38243,intraoperative,0,0
38244,complications,0,0
38245,",",0,0
38246,30-day,0,0
38247,postoperative,0,0
38248,mortality,0,0
38249,",",0,0
38250,complications,0,0
38251,at,0,0
38252,discharge,0,0
38253,and,0,0
38254,60,0,0
38255,days,0,0
38256,",",0,0
38257,hospital,0,1
38258,readmission,0,0
38259,",",0,0
38260,and,0,0
38261,reoperation,0,0
38262,were,0,0
38263,very,0,0
38264,similar,0,0
38265,between,0,0
38266,groups,0,0
38267,.,0,0
38268,CONCLUSIONS,0,0
38269,In,0,0
38270,this,0,0
38271,multi-institutional,0,0
38272,study,0,0
38273,",",0,0
38274,the,0,0
38275,rates,0,0
38276,of,0,0
38277,recurrent,0,0
38278,cancer,0,0
38279,were,0,0
38280,similar,0,0
38281,after,0,0
38282,laparoscopically,1,0
38283,assisted,1,0
38284,colectomy,1,0
38285,and,0,0
38286,open,1,0
38287,colectomy,1,0
38288,",",0,0
38289,suggesting,0,0
38290,that,0,0
38291,the,0,0
38292,laparoscopic,0,0
38293,approach,0,0
38294,is,0,0
38295,an,0,0
38296,acceptable,0,0
38297,alternative,0,0
38298,to,0,0
38299,open,0,0
38300,surgery,0,0
38301,for,0,0
38302,colon,0,0
38303,cancer,0,0
38304,.,0,0
38305,Weight,0,0
38306,and,0,0
38307,leptin,0,1
38308,changes,0,0
38309,among,0,0
38310,risperidone-treated,1,1
38311,youths,0,1
38312,with,0,0
38313,autism,0,0
38314,:,0,0
38315,6-month,0,0
38316,prospective,0,0
38317,data,0,0
38318,.,0,0
38319,OBJECTIVE,0,0
38320,The,0,0
38321,authors,0,0
38322,examined,0,0
38323,the,0,0
38324,developmental,0,0
38325,impact,0,0
38326,and,0,0
38327,temporal,0,0
38328,characteristics,0,0
38329,of,0,0
38330,risperidone-associated,1,1
38331,weight,0,1
38332,change,0,0
38333,.,0,0
38334,METHOD,0,0
38335,Weight,0,0
38336,change,0,0
38337,was,0,0
38338,measured,0,0
38339,for,0,0
38340,63,0,0
38341,children,0,0
38342,and,0,0
38343,adolescents,0,0
38344,with,0,0
38345,autism,0,0
38346,treated,0,0
38347,with,0,0
38348,risperidone,1,1
38349,for,0,0
38350,6,0,0
38351,months,0,0
38352,.,0,0
38353,Change,0,0
38354,in,0,0
38355,serum,0,1
38356,leptin,0,1
38357,levels,0,1
38358,after,0,0
38359,2,0,0
38360,months,0,0
38361,was,0,0
38362,examined,0,0
38363,as,0,0
38364,a,0,0
38365,predictor,0,0
38366,of,0,0
38367,final,0,0
38368,weight,0,0
38369,gain,0,0
38370,in,0,0
38371,mixed,0,0
38372,regression,0,0
38373,models,0,0
38374,that,0,0
38375,controlled,0,0
38376,for,0,0
38377,site,0,0
38378,",",0,0
38379,gender,0,0
38380,",",0,0
38381,age,0,0
38382,",",0,0
38383,and,0,1
38384,risperidone,1,1
38385,dose,0,1
38386,.,0,1
38387,RESULTS,0,1
38388,Age-,0,1
38389,and,0,0
38390,gender-standardized,0,0
38391,weight,0,0
38392,increased,0,0
38393,after,0,0
38394,6,0,0
38395,months,0,0
38396,of,0,0
38397,treatment,0,0
38398,(,0,0
38399,gross,0,0
38400,:,0,0
38401,mean=5.6,0,0
38402,kg,0,0
38403,[,0,0
38404,SD=3.9,0,1
38405,],0,1
38406,;,0,0
38407,standardized,0,0
38408,:,0,0
38409,mean=0.6,0,0
38410,z,0,0
38411,[,0,0
38412,SD=0.5,0,1
38413,],0,1
38414,),0,0
38415,and,0,0
38416,was,0,0
38417,positively,0,0
38418,correlated,0,0
38419,with,0,0
38420,weight,0,0
38421,gained,0,0
38422,after,0,0
38423,1,0,0
38424,month,0,0
38425,.,0,0
38426,Change,0,0
38427,in,0,0
38428,leptin,0,1
38429,levels,0,0
38430,after,0,0
38431,2,0,0
38432,months,0,0
38433,of,0,0
38434,treatment,0,0
38435,(,0,0
38436,mean=-0.3,0,0
38437,ng/ml,0,0
38438,",",0,0
38439,SD=6.2,0,0
38440,),0,0
38441,(,0,0
38442,N=48,0,1
38443,),0,0
38444,did,0,0
38445,not,0,0
38446,predict,0,0
38447,final,0,0
38448,weight,0,0
38449,gain,0,0
38450,.,0,0
38451,CONCLUSIONS,0,0
38452,Chronic,0,1
38453,risperidone,1,1
38454,exposure,0,0
38455,in,0,0
38456,children,0,0
38457,with,0,0
38458,autism,0,0
38459,causes,0,0
38460,weight,0,0
38461,gain,0,0
38462,in,0,0
38463,excess,0,0
38464,of,0,0
38465,developmentally,0,0
38466,expected,0,0
38467,norms,0,0
38468,that,0,0
38469,follows,0,0
38470,a,0,0
38471,curvilinear,0,0
38472,trajectory,0,0
38473,and,0,0
38474,decelerates,0,0
38475,over,0,0
38476,time,0,0
38477,.,0,0
38478,Serum,0,1
38479,leptin,0,1
38480,change,0,0
38481,does,0,0
38482,not,0,0
38483,reliably,0,0
38484,predict,0,0
38485,risperidone-associated,0,1
38486,weight,0,1
38487,gain,0,0
38488,.,0,0
38489,Comparative,0,0
38490,effects,0,0
38491,of,0,0
38492,valsartan,1,1
38493,versus,0,1
38494,amlodipine,1,1
38495,on,0,1
38496,left,0,0
38497,ventricular,0,0
38498,mass,0,0
38499,and,0,0
38500,reactive,0,0
38501,oxygen,0,0
38502,species,0,0
38503,formation,0,0
38504,by,0,0
38505,monocytes,0,0
38506,in,0,0
38507,hypertensive,0,0
38508,patients,0,0
38509,with,0,0
38510,left,0,0
38511,ventricular,0,0
38512,hypertrophy,0,0
38513,.,0,0
38514,OBJECTIVES,0,0
38515,To,0,0
38516,compare,0,0
38517,the,0,0
38518,effects,0,0
38519,of,0,0
38520,the,0,0
38521,angiotensin,1,1
38522,receptor,1,1
38523,blocker,1,1
38524,(,1,1
38525,ARB,1,1
38526,),1,1
38527,valsartan,1,1
38528,versus,0,1
38529,the,0,0
38530,calcium,1,1
38531,channel,1,1
38532,blocker,1,1
38533,amlodipine,1,1
38534,",",0,1
38535,reactive,0,0
38536,oxygen,0,0
38537,species,0,0
38538,(,0,0
38539,ROS,0,1
38540,),0,0
38541,formation,0,0
38542,by,0,0
38543,monocytes,0,0
38544,",",0,0
38545,C-reactive,0,0
38546,protein,0,0
38547,(,0,0
38548,CRP,0,1
38549,),0,1
38550,",",0,0
38551,and,0,0
38552,left,0,1
38553,ventricular,0,1
38554,(,0,1
38555,LV,0,1
38556,),0,0
38557,mass,0,0
38558,were,0,0
38559,studied,0,0
38560,in,0,0
38561,104,0,0
38562,hypertensive,0,0
38563,patients,0,0
38564,with,0,0
38565,left,0,0
38566,ventricular,0,1
38567,hypertrophy,0,1
38568,(,0,1
38569,LVH,0,1
38570,),0,1
38571,.,0,0
38572,BACKGROUND,0,0
38573,There,0,0
38574,is,0,0
38575,evidence,0,0
38576,that,0,0
38577,ARBs,1,0
38578,have,0,0
38579,blood,0,1
38580,pressure,0,1
38581,(,0,1
38582,BP,0,1
38583,),0,0
38584,-independent,0,0
38585,effects,0,0
38586,on,0,0
38587,LV,0,0
38588,mass,0,0
38589,.,0,0
38590,Whether,0,0
38591,regression,0,0
38592,of,0,0
38593,LV,0,0
38594,mass,0,0
38595,by,0,0
38596,ARBs,1,0
38597,is,0,0
38598,correlated,0,0
38599,to,0,0
38600,ROS,0,0
38601,formation,0,0
38602,by,0,0
38603,monocytes,0,0
38604,and,0,0
38605,CRP,0,1
38606,is,0,0
38607,not,0,0
38608,fully,0,0
38609,understood,0,0
38610,yet,0,0
38611,.,0,0
38612,METHODS,0,0
38613,A,0,1
38614,cross-sectional,0,1
38615,and,0,0
38616,prospective,0,0
38617,study,0,0
38618,was,0,0
38619,performed,0,0
38620,.,0,0
38621,Participants,0,0
38622,were,0,0
38623,randomly,0,0
38624,assigned,0,0
38625,to,0,0
38626,either,0,0
38627,the,0,0
38628,80-mg,1,1
38629,valsartan,1,1
38630,(,0,1
38631,n,0,0
38632,=,0,0
38633,52,0,0
38634,),0,0
38635,or,0,0
38636,5-mg,1,1
38637,amlodipine,1,1
38638,(,0,1
38639,n,0,0
38640,=,0,0
38641,52,0,0
38642,),0,0
38643,group,0,0
38644,and,0,0
38645,were,0,0
38646,treated,0,0
38647,for,0,0
38648,eight,0,0
38649,months,0,0
38650,.,0,0
38651,The,0,0
38652,left,0,0
38653,ventricular,0,0
38654,mass,0,0
38655,index,0,1
38656,(,0,1
38657,LVMI,0,1
38658,),0,0
38659,was,0,0
38660,calculated,0,0
38661,from,0,0
38662,two-dimensional,0,0
38663,M-mode,0,0
38664,echocardiography,0,0
38665,.,0,0
38666,Formation,0,0
38667,of,0,0
38668,ROS,0,0
38669,by,0,0
38670,monocytes,0,0
38671,was,0,0
38672,measured,0,0
38673,by,0,0
38674,gated,0,0
38675,flow,0,0
38676,cytometry,0,0
38677,.,0,0
38678,In,0,0
38679,addition,0,0
38680,",",0,0
38681,CRP,0,1
38682,",",0,1
38683,plasma,0,1
38684,renin,0,1
38685,activity,0,1
38686,",",0,1
38687,plasma,0,1
38688,aldosterone,0,1
38689,",",0,1
38690,and,0,0
38691,traditional,0,0
38692,risk,0,0
38693,factors,0,0
38694,were,0,0
38695,assessed,0,0
38696,.,0,0
38697,RESULTS,0,0
38698,Multiple,0,0
38699,regression,0,0
38700,analysis,0,0
38701,showed,0,0
38702,a,0,0
38703,significant,0,0
38704,correlation,0,0
38705,between,0,0
38706,LVMI,0,0
38707,and,0,0
38708,ROS,0,0
38709,formation,0,0
38710,by,0,0
38711,monocytes,0,0
38712,and,0,0
38713,between,0,0
38714,LVMI,0,0
38715,and,0,0
38716,CRP,0,0
38717,.,0,0
38718,Treatment,0,0
38719,reduced,0,0
38720,BP,0,0
38721,to,0,0
38722,a,0,0
38723,similar,0,0
38724,extent,0,0
38725,in,0,0
38726,both,0,0
38727,groups,0,0
38728,.,0,0
38729,Valsartan,1,1
38730,significantly,0,0
38731,reduced,0,0
38732,LVMI,0,0
38733,after,0,0
38734,eight,0,0
38735,months,0,0
38736,",",0,0
38737,but,0,0
38738,amlodipine,1,1
38739,had,0,0
38740,less,0,0
38741,effect,0,0
38742,(,0,0
38743,16,0,0
38744,%,0,0
38745,vs.,0,0
38746,1.2,0,0
38747,%,0,0
38748,",",0,0
38749,n,0,0
38750,=,0,0
38751,50,0,0
38752,",",0,0
38753,p,0,0
38754,<,0,0
38755,0.01,0,0
38756,),0,0
38757,.,0,0
38758,Formation,0,0
38759,of,0,0
38760,ROS,0,0
38761,by,0,0
38762,monocytes,0,0
38763,was,0,0
38764,reduced,0,0
38765,to,0,0
38766,a,0,0
38767,greater,0,0
38768,extent,0,0
38769,with,0,0
38770,valsartan,1,1
38771,than,0,1
38772,with,0,1
38773,amlodipine,1,1
38774,(,0,0
38775,28,0,0
38776,%,0,0
38777,vs.,0,0
38778,2,0,0
38779,%,0,0
38780,",",0,0
38781,n,0,0
38782,=,0,0
38783,50,0,0
38784,",",0,0
38785,p,0,0
38786,<,0,0
38787,0.01,0,0
38788,),0,0
38789,.,0,0
38790,Valsartan,1,1
38791,but,0,0
38792,not,0,0
38793,amlodipine,1,1
38794,reduced,0,0
38795,CRP,0,0
38796,levels,0,0
38797,.,0,0
38798,A,0,0
38799,significant,0,0
38800,correlation,0,0
38801,between,0,0
38802,changes,0,0
38803,in,0,0
38804,ROS,0,0
38805,formation,0,0
38806,by,0,0
38807,monocytes,0,0
38808,and,0,0
38809,LVMI,0,1
38810,or,0,0
38811,between,0,0
38812,CRP,0,0
38813,and,0,0
38814,LVMI,0,0
38815,was,0,0
38816,observed,0,0
38817,.,0,0
38818,CONCLUSIONS,0,0
38819,The,0,0
38820,ARB,1,1
38821,valsartan,1,1
38822,has,0,0
38823,BP-independent,0,0
38824,effects,0,0
38825,on,0,0
38826,LVH,0,0
38827,",",0,0
38828,ROS,0,0
38829,formation,0,0
38830,by,0,0
38831,monocytes,0,0
38832,",",0,0
38833,and,0,0
38834,CRP,0,0
38835,in,0,0
38836,hypertensive,0,0
38837,patients,0,0
38838,with,0,0
38839,LVH,0,0
38840,.,0,0
38841,Chronic,0,1
38842,fatigue,0,1
38843,syndrome,0,1
38844,versus,0,0
38845,neuroendocrineimmune,0,0
38846,dysfunction,0,0
38847,syndrome,1,0
38848,:,1,0
38849,differential,1,0
38850,attributions,1,0
38851,.,1,0
38852,Since,0,0
38853,1988,0,0
38854,",",0,0
38855,when,0,0
38856,the,0,0
38857,term,0,0
38858,chronic,0,0
38859,fatigue,0,1
38860,syndrome,0,1
38861,(,0,1
38862,CFS,0,1
38863,),0,0
38864,was,0,0
38865,coined,0,0
38866,",",0,0
38867,considerable,0,0
38868,discussion,0,0
38869,has,0,0
38870,occurred,0,0
38871,about,0,0
38872,stigma,0,0
38873,associated,0,0
38874,with,0,0
38875,this,0,0
38876,diagnostic,0,0
38877,term,0,0
38878,.,0,0
38879,In,0,0
38880,particular,0,0
38881,",",0,0
38882,patients,0,0
38883,with,0,0
38884,CFS,0,0
38885,have,0,0
38886,felt,0,0
38887,that,0,0
38888,this,0,0
38889,term,0,0
38890,trivializes,0,0
38891,the,0,0
38892,serious,0,0
38893,nature,0,0
38894,of,0,0
38895,this,0,0
38896,disorder,0,0
38897,.,0,0
38898,A,0,0
38899,Name,0,1
38900,Change,0,1
38901,Work,0,1
38902,group,0,0
38903,",",0,0
38904,appointed,0,0
38905,by,0,0
38906,the,0,0
38907,CFS,0,0
38908,Coordinating,0,0
38909,Committee,0,0
38910,",",0,0
38911,developed,0,0
38912,an,0,0
38913,umbrella,0,0
38914,term,0,0
38915,:,0,0
38916,chronic,0,0
38917,neuroendocrineimmune,0,0
38918,dysfunction,0,1
38919,syndrome,0,1
38920,(,0,1
38921,CNDS,0,1
38922,),0,1
38923,",",0,0
38924,and,0,0
38925,proposed,0,0
38926,that,0,0
38927,there,0,0
38928,would,0,0
38929,be,0,0
38930,sub-types,0,0
38931,under,0,0
38932,this,0,0
38933,term,0,0
38934,",",0,0
38935,one,0,0
38936,being,0,0
38937,CFS,0,0
38938,.,0,0
38939,The,0,0
38940,present,0,0
38941,study,0,0
38942,examined,0,0
38943,attributions,0,0
38944,of,0,0
38945,this,0,0
38946,new,0,0
38947,umbrella,0,0
38948,term,0,0
38949,when,0,0
38950,compared,0,0
38951,with,0,0
38952,CFS,0,0
38953,.,0,0
38954,Nurses,1,0
38955,and,1,0
38956,physician,1,1
38957,assistants,1,1
38958,(,1,1
38959,PAs,1,1
38960,),1,0
38961,were,1,0
38962,presented,1,0
38963,a,1,0
38964,case,1,0
38965,study,1,0
38966,of,1,0
38967,a,1,0
38968,patient,1,0
38969,with,1,0
38970,symptoms,1,0
38971,of,1,0
38972,CFS,1,0
38973,.,1,0
38974,They,0,0
38975,were,0,0
38976,told,0,0
38977,that,0,0
38978,the,0,0
38979,patient,0,0
38980,had,0,0
38981,either,0,0
38982,chronic,0,0
38983,fatigue,0,0
38984,syndrome,0,0
38985,",",0,0
38986,chronic,0,0
38987,neuroendocrineimmune,0,1
38988,dysfunction,0,0
38989,syndrome,0,0
38990,",",0,0
38991,or,0,0
38992,chronic,0,0
38993,neuroendocrineimmune,0,1
38994,dysfunction,0,0
38995,syndrome,0,0
38996,",",0,0
38997,which,0,0
38998,had,0,0
38999,formerly,0,0
39000,been,0,0
39001,called,0,0
39002,chronic,0,0
39003,fatigue,0,0
39004,syndrome,0,0
39005,.,0,0
39006,The,0,0
39007,different,0,0
39008,terms,0,0
39009,led,0,0
39010,to,0,0
39011,different,0,0
39012,attributions,0,0
39013,",",0,0
39014,with,0,0
39015,PA,0,0
39016,respondents,0,0
39017,rating,0,0
39018,the,0,0
39019,CNDS,0,0
39020,label,0,0
39021,as,0,0
39022,more,0,0
39023,severe,0,0
39024,.,0,0
39025,Results,0,0
39026,suggest,0,0
39027,that,0,0
39028,a,0,0
39029,more,0,0
39030,medical,1,0
39031,sounding,1,1
39032,term,1,1
39033,(,1,1
39034,CNDS,1,1
39035,),1,0
39036,may,0,0
39037,lead,0,0
39038,to,0,0
39039,attributions,0,0
39040,that,0,0
39041,this,0,0
39042,syndrome,0,0
39043,is,0,0
39044,a,0,0
39045,more,0,0
39046,serious,0,0
39047,",",0,0
39048,disabling,0,0
39049,illness,0,0
39050,.,0,0
39051,The,0,0
39052,policy,0,0
39053,implications,0,0
39054,of,0,0
39055,these,0,0
39056,findings,0,0
39057,are,0,0
39058,discussed,0,0
39059,.,0,0
39060,Why,0,0
39061,distinctive,1,0
39062,information,1,0
39063,reduces,0,0
39064,false,0,0
39065,memories,0,0
39066,:,0,0
39067,evidence,0,0
39068,for,0,0
39069,both,0,0
39070,impoverished,0,0
39071,relational-encoding,0,0
39072,and,0,0
39073,distinctiveness,0,0
39074,heuristic,0,0
39075,accounts,0,0
39076,.,0,0
39077,Two,0,0
39078,accounts,0,0
39079,explain,0,0
39080,why,0,0
39081,studying,1,0
39082,pictures,1,0
39083,reduces,0,0
39084,false,0,0
39085,memories,0,0
39086,within,0,0
39087,the,0,0
39088,Deese-Roediger-McDermott,0,1
39089,paradigm,0,1
39090,(,0,0
39091,J.,0,1
39092,Deese,0,1
39093,",",0,0
39094,1959,0,0
39095,;,0,0
39096,H.,0,1
39097,L.,0,1
39098,Roediger,0,1
39099,&,0,1
39100,K.,0,0
39101,B.,0,1
39102,McDermott,0,1
39103,",",0,1
39104,1995,0,1
39105,),0,0
39106,.,0,0
39107,The,0,0
39108,impoverished,0,0
39109,relational-encoding,0,0
39110,account,0,0
39111,suggests,0,0
39112,that,0,0
39113,studying,1,0
39114,pictures,1,0
39115,interferes,0,0
39116,with,0,0
39117,the,0,0
39118,encoding,0,0
39119,of,0,0
39120,relational,0,0
39121,information,0,0
39122,",",0,0
39123,which,0,0
39124,is,0,0
39125,the,0,0
39126,primary,0,0
39127,basis,0,0
39128,for,0,0
39129,false,0,0
39130,memories,0,0
39131,in,0,0
39132,this,0,0
39133,paradigm,0,0
39134,.,0,0
39135,Alternatively,0,0
39136,",",0,0
39137,the,0,0
39138,distinctiveness,0,0
39139,heuristic,0,0
39140,assumes,0,0
39141,that,0,0
39142,critical,0,0
39143,lures,0,0
39144,are,0,0
39145,actively,0,0
39146,withheld,0,0
39147,by,0,0
39148,the,0,0
39149,use,0,0
39150,of,0,0
39151,a,0,0
39152,retrieval,1,0
39153,strategy,1,0
39154,.,1,0
39155,When,0,0
39156,participants,0,0
39157,were,0,0
39158,given,0,0
39159,inclusion,1,0
39160,recall,1,0
39161,instructions,1,0
39162,to,1,0
39163,report,1,0
39164,studied,1,0
39165,items,1,0
39166,as,1,0
39167,well,1,0
39168,as,1,0
39169,related,1,0
39170,items,1,0
39171,",",0,0
39172,they,0,0
39173,still,0,0
39174,reported,0,0
39175,critical,0,0
39176,lures,0,0
39177,less,0,0
39178,often,0,0
39179,after,0,0
39180,picture,0,0
39181,encoding,0,0
39182,than,0,0
39183,they,0,0
39184,did,0,0
39185,after,0,0
39186,word,0,0
39187,encoding,0,0
39188,.,0,0
39189,As,0,0
39190,the,0,0
39191,impoverished,0,0
39192,relational-encoding,0,0
39193,account,0,0
39194,suggests,0,0
39195,",",0,0
39196,critical,0,0
39197,lures,0,0
39198,appear,0,0
39199,less,0,0
39200,likely,0,0
39201,to,0,0
39202,come,0,0
39203,to,0,0
39204,mind,0,0
39205,after,0,0
39206,picture,1,0
39207,encoding,1,0
39208,than,0,0
39209,they,0,0
39210,do,0,0
39211,after,0,0
39212,word,1,0
39213,encoding,1,0
39214,.,1,0
39215,However,0,0
39216,",",0,0
39217,the,0,0
39218,results,0,0
39219,from,0,0
39220,a,0,0
39221,postrecall,1,0
39222,recognition,1,0
39223,test,1,0
39224,provide,0,0
39225,evidence,0,0
39226,in,0,0
39227,favor,0,0
39228,of,0,0
39229,the,0,0
39230,distinctiveness,0,0
39231,heuristic,0,0
39232,.,0,0
39233,The,0,0
39234,A-V,1,0
39235,Impulse,1,0
39236,System,1,0
39237,reduces,0,0
39238,deep-vein,0,0
39239,thrombosis,0,0
39240,and,0,0
39241,swelling,0,0
39242,after,0,0
39243,hemiarthroplasty,0,0
39244,for,0,0
39245,hip,0,0
39246,fracture,0,0
39247,.,0,0
39248,We,0,0
39249,performed,0,0
39250,a,0,0
39251,prospective,0,0
39252,randomised,0,0
39253,controlled,0,0
39254,trial,0,0
39255,of,0,0
39256,the,0,0
39257,A-V,1,0
39258,Impulse,1,0
39259,System,1,0
39260,in,0,0
39261,82,0,0
39262,patients,0,0
39263,treated,0,0
39264,by,0,0
39265,hemiarthroplasty,0,0
39266,for,0,0
39267,subcapital,0,0
39268,fracture,0,0
39269,of,0,0
39270,the,0,0
39271,femoral,0,0
39272,neck,0,0
39273,.,0,0
39274,The,0,0
39275,incidence,0,0
39276,of,0,0
39277,proximal,0,0
39278,deep-vein,0,0
39279,thrombosis,0,0
39280,as,0,0
39281,assessed,0,0
39282,by,0,0
39283,Doppler,1,0
39284,ultrasonography,1,0
39285,was,0,0
39286,23,0,0
39287,%,0,0
39288,in,0,0
39289,the,0,0
39290,control,0,0
39291,group,0,0
39292,and,0,0
39293,0,0,0
39294,%,0,0
39295,in,0,0
39296,those,0,0
39297,using,0,0
39298,the,0,0
39299,device,0,0
39300,(,0,0
39301,p,0,0
39302,less,0,0
39303,than,0,0
39304,0.01,0,0
39305,),0,0
39306,.,0,0
39307,Calf,0,0
39308,and,0,0
39309,thigh,0,0
39310,circumferences,0,0
39311,were,0,0
39312,measured,0,0
39313,in,0,0
39314,both,0,0
39315,groups,0,0
39316,at,0,0
39317,seven,0,0
39318,to,0,0
39319,ten,0,0
39320,days,0,0
39321,after,0,0
39322,operation,0,0
39323,.,0,0
39324,In,0,0
39325,the,0,0
39326,treatment,0,0
39327,group,0,0
39328,there,0,0
39329,was,0,0
39330,a,0,0
39331,mean,0,0
39332,relative,0,0
39333,reduction,0,0
39334,of,0,0
39335,postoperative,0,0
39336,swelling,0,0
39337,of,0,0
39338,the,0,0
39339,thigh,0,0
39340,by,0,0
39341,3.27,0,0
39342,cm,0,0
39343,(,0,0
39344,p,0,0
39345,less,0,0
39346,than,0,0
39347,0.001,0,0
39348,),0,0
39349,and,0,0
39350,of,0,0
39351,the,0,0
39352,calf,0,0
39353,by,0,0
39354,1.55,0,0
39355,cm,0,0
39356,(,0,0
39357,p,0,0
39358,less,0,0
39359,than,0,0
39360,0.001,0,0
39361,),0,0
39362,.,0,0
39363,The,0,0
39364,A-V,0,0
39365,Impulse,0,0
39366,System,0,0
39367,appears,0,0
39368,to,0,0
39369,be,0,0
39370,a,0,0
39371,safe,0,0
39372,and,0,0
39373,effective,0,0
39374,method,0,0
39375,of,0,0
39376,reducing,0,0
39377,the,0,0
39378,incidence,0,0
39379,of,0,0
39380,proximal,0,0
39381,deep-vein,0,0
39382,thrombosis,0,0
39383,",",0,0
39384,and,0,0
39385,of,0,0
39386,postoperative,0,0
39387,swelling,0,0
39388,.,0,0
39389,Gonadotropin-releasing,1,1
39390,hormone,1,1
39391,agonist,1,1
39392,with,0,1
39393,or,0,0
39394,without,0,0
39395,raloxifene,1,1
39396,:,1,0
39397,effects,0,0
39398,on,0,0
39399,cognition,0,0
39400,",",0,0
39401,mood,0,0
39402,",",0,0
39403,and,0,0
39404,quality,0,0
39405,of,0,0
39406,life,0,0
39407,.,0,0
39408,Randomized,0,1
39409,",",0,0
39410,double-blind,0,1
39411,",",0,1
39412,placebo-controlled,1,1
39413,trial,0,1
39414,of,0,1
39415,oral,0,1
39416,sirolimus,0,1
39417,for,0,1
39418,restenosis,0,1
39419,prevention,0,0
39420,in,0,0
39421,patients,0,0
39422,with,0,0
39423,in-stent,0,0
39424,restenosis,0,0
39425,:,0,0
39426,the,0,0
39427,Oral,0,0
39428,Sirolimus,1,1
39429,to,0,0
39430,Inhibit,0,0
39431,Recurrent,0,0
39432,In-stent,0,1
39433,Stenosis,0,1
39434,(,0,1
39435,OSIRIS,0,1
39436,),0,1
39437,trial,0,0
39438,.,0,0
39439,BACKGROUND,0,0
39440,Despite,0,0
39441,recent,0,0
39442,advances,0,0
39443,in,0,0
39444,interventional,0,0
39445,cardiology,0,0
39446,",",0,0
39447,including,0,0
39448,the,0,0
39449,introduction,0,0
39450,of,0,0
39451,drug-eluting,0,0
39452,stents,0,0
39453,for,0,0
39454,de,0,0
39455,novo,0,0
39456,coronary,0,0
39457,lesions,0,0
39458,",",0,0
39459,the,0,0
39460,treatment,0,0
39461,of,0,0
39462,in-stent,0,1
39463,restenosis,0,1
39464,(,0,1
39465,ISR,0,1
39466,),0,1
39467,remains,0,0
39468,a,0,0
39469,challenging,0,0
39470,clinical,0,0
39471,issue,0,0
39472,.,0,0
39473,Given,0,0
39474,the,0,0
39475,efficacy,0,0
39476,of,0,0
39477,systemic,0,1
39478,sirolimus,0,1
39479,administration,0,1
39480,to,0,1
39481,prevent,0,0
39482,neointimal,0,0
39483,hyperplasia,0,0
39484,in,0,0
39485,animal,0,0
39486,models,0,0
39487,and,0,0
39488,to,0,0
39489,halt,0,0
39490,and,0,0
39491,even,0,0
39492,reverse,0,0
39493,the,0,0
39494,progression,0,0
39495,of,0,0
39496,allograft,0,0
39497,vasculopathy,0,0
39498,",",0,0
39499,the,0,0
39500,aim,0,0
39501,of,0,0
39502,the,0,0
39503,present,0,0
39504,double-blind,0,1
39505,",",0,1
39506,placebo-controlled,0,1
39507,study,0,0
39508,was,0,0
39509,to,0,0
39510,evaluate,0,0
39511,the,0,0
39512,efficacy,0,0
39513,of,0,0
39514,a,0,0
39515,10-day,0,1
39516,oral,0,1
39517,sirolimus,0,1
39518,treatment,0,1
39519,with,0,0
39520,2,0,0
39521,different,0,0
39522,loading,0,0
39523,regimens,0,1
39524,for,0,0
39525,the,0,0
39526,prevention,0,0
39527,of,0,0
39528,recurrent,0,0
39529,restenosis,0,0
39530,in,0,0
39531,patients,0,0
39532,with,0,0
39533,ISR,0,0
39534,.,0,0
39535,METHODS,0,0
39536,AND,0,1
39537,RESULTS,0,0
39538,Three,0,0
39539,hundred,0,0
39540,symptomatic,0,0
39541,patients,0,0
39542,with,0,0
39543,ISR,0,0
39544,were,0,0
39545,randomly,0,0
39546,assigned,0,0
39547,to,0,0
39548,1,0,0
39549,of,0,0
39550,3,0,0
39551,treatment,0,0
39552,arms,0,1
39553,:,0,1
39554,placebo,1,1
39555,or,1,1
39556,usual-dose,1,1
39557,or,1,1
39558,high-dose,1,1
39559,sirolimus,1,1
39560,.,1,1
39561,Patients,0,0
39562,received,0,0
39563,a,0,0
39564,cumulative,0,0
39565,loading,0,0
39566,dose,0,1
39567,of,0,0
39568,0,0,0
39569,",",0,0
39570,8,0,0
39571,",",0,0
39572,or,0,0
39573,24,0,1
39574,mg,0,1
39575,of,0,1
39576,sirolimus,0,1
39577,2,0,1
39578,days,0,0
39579,before,0,0
39580,and,0,0
39581,the,0,0
39582,day,0,0
39583,of,0,0
39584,repeat,0,0
39585,intervention,0,0
39586,followed,0,0
39587,by,0,0
39588,maintenance,0,0
39589,therapy,0,0
39590,of,0,0
39591,2,0,0
39592,mg/d,0,1
39593,for,0,1
39594,7,0,0
39595,days,0,0
39596,.,0,0
39597,Angiographic,0,0
39598,restenosis,0,0
39599,at,0,0
39600,6-month,1,0
39601,angiography,1,0
39602,was,0,0
39603,the,0,0
39604,primary,0,0
39605,end,0,0
39606,point,0,0
39607,of,0,0
39608,the,0,0
39609,study,0,0
39610,.,0,0
39611,Restenosis,0,0
39612,was,0,0
39613,significantly,0,0
39614,reduced,0,0
39615,from,0,0
39616,42.2,0,0
39617,%,0,0
39618,to,0,0
39619,38.6,0,0
39620,%,0,0
39621,and,0,0
39622,to,0,0
39623,22.1,0,0
39624,%,0,0
39625,in,0,0
39626,the,0,0
39627,placebo,0,1
39628,",",0,1
39629,usual-dose,0,1
39630,",",0,1
39631,and,0,1
39632,high-dose,0,1
39633,sirolimus,0,1
39634,groups,0,0
39635,",",0,0
39636,respectively,0,0
39637,(,0,0
39638,P=0.005,0,0
39639,),0,0
39640,.,0,0
39641,Similarly,0,0
39642,",",0,0
39643,the,0,0
39644,need,0,0
39645,for,0,0
39646,target,0,0
39647,vessel,0,0
39648,revascularization,0,0
39649,was,0,0
39650,reduced,0,0
39651,from,0,0
39652,25.5,0,0
39653,%,0,0
39654,to,0,0
39655,24.2,0,0
39656,%,0,0
39657,and,0,0
39658,to,0,0
39659,15.2,0,0
39660,%,0,0
39661,in,0,0
39662,the,0,0
39663,placebo,0,1
39664,",",0,1
39665,usual-dose,0,1
39666,",",0,1
39667,and,0,1
39668,high-dose,0,1
39669,groups,0,0
39670,",",0,0
39671,respectively,0,0
39672,(,0,0
39673,P=0.08,0,0
39674,),0,0
39675,.,0,0
39676,The,0,0
39677,sirolimus,0,1
39678,blood,0,0
39679,concentration,0,0
39680,on,0,0
39681,the,0,0
39682,day,0,0
39683,of,0,0
39684,the,0,0
39685,procedure,0,0
39686,correlated,0,0
39687,significantly,0,0
39688,with,0,0
39689,the,0,0
39690,late,0,0
39691,lumen,0,0
39692,loss,0,0
39693,at,0,0
39694,follow-up,0,0
39695,(,0,0
39696,P,0,0
39697,<,0,0
39698,0.001,0,0
39699,),0,0
39700,.,0,0
39701,CONCLUSIONS,0,0
39702,In,0,0
39703,patients,0,0
39704,with,0,0
39705,ISR,0,0
39706,",",0,0
39707,an,0,0
39708,oral,0,1
39709,adjunctive,0,1
39710,sirolimus,0,1
39711,treatment,0,0
39712,with,0,0
39713,an,0,0
39714,intensified,0,0
39715,loading,0,0
39716,regimen,0,1
39717,before,0,0
39718,coronary,0,1
39719,intervention,0,0
39720,resulted,0,0
39721,in,0,0
39722,a,0,0
39723,significant,0,0
39724,improvement,0,0
39725,in,0,0
39726,the,0,0
39727,angiographic,0,0
39728,parameters,0,0
39729,of,0,0
39730,restenosis,0,0
39731,.,0,0
39732,Flutamide-metformin,0,1
39733,plus,0,1
39734,ethinylestradiol-drospirenone,0,1
39735,for,0,1
39736,lipolysis,0,1
39737,and,0,1
39738,antiatherogenesis,0,1
39739,in,0,0
39740,young,0,1
39741,women,0,0
39742,with,0,0
39743,ovarian,0,0
39744,hyperandrogenism,0,0
39745,:,0,0
39746,the,0,0
39747,key,0,0
39748,role,0,0
39749,of,0,0
39750,early,0,0
39751,",",0,0
39752,low-dose,0,1
39753,flutamide,0,1
39754,.,0,1
39755,A,0,1
39756,low-dose,0,1
39757,combination,0,0
39758,of,0,0
39759,flutamide-metformin,1,1
39760,and,1,1
39761,ethinylestradiol-drospirenone,1,1
39762,was,0,0
39763,recently,0,0
39764,found,0,0
39765,to,0,0
39766,reduce,0,0
39767,the,0,0
39768,excess,0,0
39769,of,0,0
39770,total,0,0
39771,and,0,0
39772,abdominal,0,0
39773,fat,0,0
39774,",",0,0
39775,to,0,0
39776,diminish,0,0
39777,the,0,0
39778,deficit,0,0
39779,in,0,0
39780,lean,0,0
39781,mass,0,0
39782,",",0,0
39783,and,0,0
39784,to,0,0
39785,attenuate,0,0
39786,the,0,0
39787,dysadipocytokinemia,0,0
39788,of,0,0
39789,young,0,0
39790,women,0,0
39791,with,0,0
39792,ovarian,0,0
39793,hyperandrogenism,0,0
39794,",",0,0
39795,a,0,0
39796,variant,0,0
39797,of,0,0
39798,polycystic,0,0
39799,ovary,0,0
39800,syndrome,0,0
39801,.,0,0
39802,We,0,0
39803,questioned,0,0
39804,the,0,0
39805,need,0,0
39806,to,0,0
39807,give,0,0
39808,flutamide,0,1
39809,",",0,1
39810,an,0,0
39811,androgen,0,1
39812,receptor,0,1
39813,blocker,0,1
39814,",",0,0
39815,together,0,0
39816,with,0,0
39817,an,0,0
39818,oral,0,1
39819,contraceptive,0,1
39820,that,0,0
39821,contains,0,0
39822,drospirenone,1,1
39823,",",0,1
39824,a,0,0
39825,progestin,0,1
39826,claimed,0,0
39827,to,0,0
39828,have,0,0
39829,antiandrogen,0,1
39830,properties,0,0
39831,.,0,0
39832,The,0,0
39833,additive,0,0
39834,effects,0,0
39835,of,0,0
39836,low-dose,1,1
39837,flutamide,1,1
39838,(,0,1
39839,62.5,0,1
39840,mg/d,0,1
39841,),0,0
39842,were,0,0
39843,assessed,0,0
39844,over,0,0
39845,3,0,0
39846,months,0,0
39847,in,0,0
39848,young,0,0
39849,patients,0,0
39850,with,0,0
39851,hyperinsulinemic,0,1
39852,ovarian,0,1
39853,hyperandrogenism,0,1
39854,(,0,0
39855,n,0,0
39856,=,0,0
39857,40,0,0
39858,;,0,0
39859,age,0,0
39860,",",0,0
39861,approximately,0,0
39862,17,0,0
39863,yr,0,0
39864,;,0,0
39865,body,0,0
39866,mass,0,0
39867,index,0,0
39868,",",0,0
39869,approximately,0,0
39870,22,0,0
39871,kg/m,0,0
39872,(,0,0
39873,2,0,0
39874,),0,1
39875,),0,1
39876,;,0,0
39877,all,0,1
39878,participants,0,1
39879,started,0,1
39880,on,0,1
39881,metformin,1,1
39882,(,0,0
39883,850,0,1
39884,mg/d,0,1
39885,),0,0
39886,and,0,0
39887,a,0,0
39888,fourth-generation,0,0
39889,contraceptive,0,1
39890,(,1,1
39891,ethinylestradiol,1,1
39892,30,1,1
39893,microg,1,1
39894,plus,1,1
39895,drospirenone,1,1
39896,3,1,1
39897,mg,1,1
39898,",",1,1
39899,21,1,1
39900,d/month,1,1
39901,),1,1
39902,",",0,0
39903,and,0,0
39904,they,0,0
39905,were,0,0
39906,randomized,0,0
39907,to,0,0
39908,receive,0,1
39909,flutamide,1,1
39910,in,0,0
39911,addition,0,0
39912,(,0,0
39913,n,0,0
39914,=,0,0
39915,20,0,0
39916,),0,0
39917,or,0,0
39918,not,0,0
39919,(,0,0
39920,n,0,0
39921,=,0,0
39922,20,0,0
39923,),0,0
39924,.,0,0
39925,Fasting,0,0
39926,blood,0,0
39927,glucose,0,1
39928,",",0,1
39929,serum,0,1
39930,insulin,0,1
39931,",",0,1
39932,lipid,0,0
39933,profile,0,0
39934,",",0,0
39935,testosterone,0,1
39936,",",0,1
39937,adiponectin,0,1
39938,",",0,1
39939,and,0,0
39940,IL-6,0,0
39941,were,0,0
39942,determined,0,0
39943,at,0,0
39944,baseline,0,0
39945,and,0,0
39946,after,0,0
39947,3,0,0
39948,months,0,0
39949,",",0,0
39950,together,0,0
39951,with,0,0
39952,body,0,0
39953,composition,0,0
39954,(,0,0
39955,by,0,0
39956,dual,0,0
39957,x-ray,0,0
39958,absorptiometry,0,1
39959,),0,0
39960,and,0,0
39961,with,0,0
39962,Doppler,0,0
39963,assessment,0,0
39964,of,0,0
39965,ovarian,0,0
39966,arterial,0,0
39967,resistance,0,0
39968,.,0,0
39969,At,0,0
39970,start,0,0
39971,",",0,0
39972,the,0,0
39973,pulsatility,0,0
39974,and,0,0
39975,resistance,0,0
39976,indices,0,0
39977,of,0,0
39978,ovarian,0,0
39979,arteries,0,0
39980,were,0,0
39981,elevated,0,0
39982,.,0,0
39983,By,0,0
39984,comparison,0,0
39985,of,0,0
39986,3-month,0,0
39987,changes,0,0
39988,between,0,0
39989,randomized,0,0
39990,subgroups,0,0
39991,",",0,0
39992,the,0,0
39993,addition,0,0
39994,of,0,0
39995,low-dose,0,1
39996,flutamide,1,1
39997,was,0,0
39998,found,0,0
39999,to,0,0
40000,have,0,0
40001,consistently,0,0
40002,(,0,0
40003,more,0,0
40004,),0,0
40005,normalizing,0,0
40006,effects,0,0
40007,on,0,0
40008,low-density,0,1
40009,lipoprotein,0,1
40010,cholesterol,0,1
40011,",",0,1
40012,IL-6,0,1
40013,",",0,0
40014,and,0,0
40015,adiponectin,0,1
40016,",",0,1
40017,lean,0,1
40018,body,0,0
40019,mass,0,0
40020,",",0,0
40021,total,0,0
40022,and,0,0
40023,abdominal,0,0
40024,fat,0,0
40025,mass,0,0
40026,",",0,0
40027,and,0,0
40028,arterial,0,0
40029,flow,0,0
40030,in,0,0
40031,the,0,0
40032,ovaries,0,0
40033,.,0,0
40034,In,0,0
40035,conclusion,0,0
40036,",",0,1
40037,low-dose,0,1
40038,flutamide,0,1
40039,is,0,0
40040,herewith,0,0
40041,identified,0,0
40042,as,0,0
40043,a,0,0
40044,pivotal,0,0
40045,component,0,0
40046,within,0,0
40047,a,0,0
40048,first,0,0
40049,contraceptive,0,0
40050,combination,0,0
40051,therapy,0,0
40052,that,0,0
40053,has,0,0
40054,been,0,0
40055,shown,0,0
40056,to,0,0
40057,attenuate,0,0
40058,the,0,0
40059,hypoadiponectinemia,0,0
40060,",",0,0
40061,ovarian,0,0
40062,vascular,0,0
40063,hyperresistance,0,0
40064,",",0,0
40065,lean,0,0
40066,mass,0,0
40067,deficit,0,0
40068,",",0,0
40069,and,0,0
40070,central,0,0
40071,adiposity,0,0
40072,of,0,0
40073,young,0,0
40074,women,0,0
40075,with,0,0
40076,polycystic,0,0
40077,ovary,0,0
40078,syndrome,0,0
40079,.,0,0
40080,Finally,0,0
40081,",",0,0
40082,these,0,0
40083,data,0,0
40084,challenge,0,0
40085,any,0,0
40086,claim,0,0
40087,that,0,0
40088,drospirenone,1,1
40089,",",0,0
40090,as,0,0
40091,currently,0,0
40092,used,0,0
40093,in,0,0
40094,a,0,0
40095,contraceptive,0,0
40096,",",0,0
40097,is,0,0
40098,a,0,0
40099,clinically,0,0
40100,significant,0,0
40101,antiandrogen,0,1
40102,.,0,0
40103,Low-dose,1,1
40104,oral,1,1
40105,etoposide-based,1,1
40106,induction,0,1
40107,regimen,0,1
40108,for,0,0
40109,children,0,0
40110,with,0,0
40111,acute,0,0
40112,lymphoblastic,0,0
40113,leukemia,0,0
40114,in,0,0
40115,first,0,0
40116,bone,0,0
40117,marrow,0,0
40118,relapse,0,0
40119,.,0,0
40120,We,0,0
40121,evaluated,0,0
40122,the,0,0
40123,clinical,0,0
40124,response,0,0
40125,to,0,0
40126,low-dose,1,1
40127,etoposide,1,1
40128,in,0,1
40129,relapsed,0,1
40130,acute,0,0
40131,lymphoblastic,0,1
40132,leukemia,0,1
40133,(,0,1
40134,ALL,0,1
40135,),0,1
40136,.,0,0
40137,Of,0,0
40138,the,0,0
40139,45,0,0
40140,patients,0,0
40141,with,0,0
40142,ALL,0,0
40143,in,0,0
40144,first,0,0
40145,bone,0,0
40146,marrow,0,0
40147,relapse,0,0
40148,enrolled,0,0
40149,on,0,0
40150,the,0,0
40151,ALL,0,0
40152,R15,0,1
40153,protocol,0,0
40154,",",0,0
40155,44,0,0
40156,had,0,0
40157,received,0,0
40158,epipodophyllotoxins,1,1
40159,during,1,0
40160,frontline,1,1
40161,therapy,1,0
40162,.,1,0
40163,In,0,0
40164,the,0,0
40165,first,0,0
40166,week,0,0
40167,of,0,0
40168,remission,0,0
40169,induction,0,0
40170,therapy,0,0
40171,",",0,0
40172,patients,1,0
40173,received,1,0
40174,etoposide,1,1
40175,(,1,1
40176,50,1,1
40177,mg/m,1,1
40178,(,1,1
40179,2,1,1
40180,),1,1
40181,per,1,1
40182,day,1,1
40183,),1,1
40184,administered,1,1
40185,orally,1,1
40186,as,1,0
40187,a,1,0
40188,single,1,0
40189,agent,1,0
40190,once,1,0
40191,or,1,1
40192,twice,1,1
40193,daily,1,1
40194,.,1,1
40195,On,0,1
40196,Day,0,0
40197,8,0,0
40198,",",0,0
40199,patients,0,0
40200,started,0,0
40201,to,0,0
40202,receive,0,1
40203,dexamethasone,1,1
40204,",",1,1
40205,vincristine,1,1
40206,",",1,1
40207,and,1,1
40208,L-asparaginase,1,1
40209,.,1,1
40210,Etoposide,1,1
40211,was,1,0
40212,administered,1,1
40213,until,1,1
40214,Day,1,0
40215,22,1,0
40216,.,1,0
40217,Two,1,0
40218,courses,1,0
40219,of,1,0
40220,consolidation,1,0
40221,therapy,1,0
40222,were,1,0
40223,followed,1,0
40224,by,1,0
40225,continuation,1,0
40226,therapy,1,0
40227,or,1,0
40228,hematopoietic,1,0
40229,stem,1,0
40230,cell,1,0
40231,transplantation,1,0
40232,.,1,0
40233,After,0,0
40234,7,0,0
40235,days,0,0
40236,of,0,1
40237,single-agent,0,1
40238,etoposide,0,1
40239,treatment,0,1
40240,",",0,0
40241,peripheral,0,0
40242,blast,0,0
40243,cell,0,0
40244,counts,0,0
40245,(,0,0
40246,P=0.013,0,0
40247,),0,0
40248,and,0,0
40249,percentages,0,0
40250,of,0,0
40251,bone,0,0
40252,marrow,0,1
40253,blasts,0,0
40254,(,0,0
40255,P=0.016,0,0
40256,),0,0
40257,were,0,0
40258,significantly,0,0
40259,reduced,0,0
40260,.,0,0
40261,In,0,0
40262,all,0,0
40263,",",0,0
40264,38,0,0
40265,(,0,0
40266,84.4,0,0
40267,%,0,0
40268,),0,0
40269,attained,0,0
40270,second,0,0
40271,remission,0,0
40272,.,0,0
40273,Only,0,0
40274,time,0,0
40275,to,0,0
40276,relapse,0,0
40277,was,0,0
40278,significantly,0,0
40279,associated,0,0
40280,with,0,0
40281,outcome,0,0
40282,(,0,0
40283,P=0.025,0,0
40284,),0,0
40285,:,0,0
40286,the,0,0
40287,5-year,0,0
40288,event-free,0,0
40289,survival,0,1
40290,estimates,0,0
40291,(,0,0
40292,+/-se,0,0
40293,),0,0
40294,were,0,0
40295,52.0+/-9.6,0,0
40296,%,0,0
40297,for,0,0
40298,those,0,0
40299,with,0,0
40300,late,0,0
40301,relapse,0,0
40302,and,0,0
40303,20.0+/-8.0,0,0
40304,%,0,0
40305,for,0,0
40306,those,0,0
40307,with,0,0
40308,early,0,0
40309,relapse,0,0
40310,.,0,0
40311,We,0,0
40312,conclude,0,0
40313,that,0,0
40314,low-dose,1,1
40315,etoposide,1,1
40316,administered,0,1
40317,orally,0,1
40318,has,0,1
40319,a,0,0
40320,cytoreductive,0,0
40321,effect,0,0
40322,in,0,0
40323,relapsed,0,0
40324,ALL,0,0
40325,.,0,0
40326,Superior,0,1
40327,visual,0,0
40328,search,0,0
40329,in,0,0
40330,adults,0,0
40331,with,0,0
40332,autism,0,0
40333,.,0,0
40334,Recent,0,0
40335,studies,0,0
40336,have,0,0
40337,suggested,0,0
40338,that,0,0
40339,children,0,0
40340,with,0,0
40341,autism,0,0
40342,perform,0,0
40343,better,0,0
40344,than,0,0
40345,matched,0,0
40346,controls,0,0
40347,on,0,0
40348,visual,0,0
40349,search,0,0
40350,tasks,0,0
40351,and,0,0
40352,that,0,0
40353,this,0,0
40354,stems,0,0
40355,from,0,0
40356,a,0,0
40357,superior,0,0
40358,visual,0,0
40359,discrimination,0,0
40360,ability,0,0
40361,.,0,0
40362,This,0,0
40363,study,0,0
40364,assessed,0,0
40365,whether,0,0
40366,these,0,0
40367,findings,0,0
40368,generalize,0,0
40369,from,0,0
40370,children,0,0
40371,to,0,0
40372,adults,0,0
40373,with,0,0
40374,autism,0,0
40375,.,0,0
40376,Experiments,0,0
40377,1,0,0
40378,and,0,0
40379,2,0,0
40380,showed,0,0
40381,that,0,0
40382,",",0,0
40383,like,0,0
40384,children,0,0
40385,",",0,0
40386,adults,0,0
40387,with,0,0
40388,autism,0,0
40389,were,0,0
40390,superior,0,0
40391,to,0,0
40392,controls,0,0
40393,at,0,0
40394,searching,0,0
40395,for,0,0
40396,targets,0,0
40397,.,0,0
40398,Experiment,0,0
40399,3,0,0
40400,showed,0,0
40401,that,0,0
40402,increases,0,0
40403,in,0,0
40404,target-distractor,1,0
40405,similarity,1,0
40406,slowed,0,0
40407,the,0,0
40408,visual,0,0
40409,search,0,0
40410,performance,0,0
40411,of,0,0
40412,the,0,0
40413,control,0,0
40414,group,0,0
40415,significantly,0,0
40416,more,0,0
40417,than,0,0
40418,that,0,0
40419,of,0,0
40420,the,0,0
40421,autism,0,0
40422,group,0,0
40423,",",0,0
40424,suggesting,0,0
40425,that,0,0
40426,the,0,0
40427,adults,0,0
40428,with,0,0
40429,autism,0,0
40430,have,0,0
40431,a,0,0
40432,superior,0,0
40433,visual,0,0
40434,discrimination,0,0
40435,ability,0,0
40436,.,0,0
40437,Thus,0,0
40438,",",0,0
40439,these,0,0
40440,experiments,0,0
40441,replicate,0,0
40442,in,0,0
40443,adults,0,0
40444,previous,0,0
40445,findings,0,0
40446,in,0,0
40447,children,0,0
40448,with,0,0
40449,autism,0,0
40450,.,0,0
40451,Superior,0,0
40452,unique,0,0
40453,item,0,0
40454,detection,0,0
40455,in,0,0
40456,adults,0,0
40457,with,0,0
40458,autism,0,0
40459,",",0,0
40460,stemming,0,0
40461,from,0,0
40462,enhanced,0,0
40463,discrimination,0,0
40464,",",0,0
40465,is,0,0
40466,discussed,0,0
40467,in,0,0
40468,the,0,0
40469,light,0,0
40470,of,0,0
40471,the,0,0
40472,possible,0,0
40473,role,0,0
40474,of,0,0
40475,stimulus,0,0
40476,processing,0,0
40477,disturbances,0,0
40478,in,0,0
40479,the,0,0
40480,disorder,0,0
40481,in,0,0
40482,general,0,0
40483,.,0,0
40484,Differential,0,0
40485,response,0,0
40486,of,0,0
40487,seven,0,0
40488,subjects,0,0
40489,with,0,0
40490,autistic,0,0
40491,disorder,0,0
40492,to,0,0
40493,clomipramine,1,1
40494,and,0,1
40495,desipramine,1,1
40496,.,1,1
40497,OBJECTIVE,0,1
40498,Clomipramine,0,1
40499,",",0,1
40500,a,0,1
40501,serotonin,0,1
40502,reuptake,0,1
40503,blocker,0,1
40504,that,0,0
40505,has,0,0
40506,unique,0,0
40507,antiobsessional,0,0
40508,properties,0,0
40509,",",0,0
40510,was,0,0
40511,hypothesized,0,0
40512,to,0,0
40513,have,0,0
40514,a,0,0
40515,different,0,0
40516,effect,0,0
40517,from,0,0
40518,that,0,0
40519,of,0,0
40520,desipramine,0,1
40521,",",0,1
40522,a,0,1
40523,tricyclic,0,1
40524,antidepressant,0,1
40525,with,0,1
40526,selective,0,0
40527,adrenergic,0,1
40528,effects,0,0
40529,",",0,0
40530,for,0,0
40531,the,0,0
40532,stereotyped,0,0
40533,",",0,0
40534,repetitive,0,0
40535,behaviors,0,0
40536,in,0,0
40537,autism,0,0
40538,.,0,0
40539,METHOD,0,0
40540,Seven,0,0
40541,subjects,0,0
40542,",",0,0
40543,ages,0,0
40544,6-18,0,0
40545,years,0,0
40546,",",0,0
40547,with,0,0
40548,autistic,0,0
40549,disorder,0,0
40550,completed,0,0
40551,a,0,0
40552,10-week,0,1
40553,double-blind,0,1
40554,",",0,1
40555,crossover,0,1
40556,trial,0,1
40557,of,0,1
40558,clomipramine,1,1
40559,and,1,1
40560,desipramine,1,1
40561,following,0,0
40562,a,0,1
40563,2-week,0,1
40564,single-blind,0,1
40565,",",0,1
40566,placebo,1,1
40567,phase,0,0
40568,.,0,1
40569,RESULTS,0,0
40570,Clomipramine,0,1
40571,was,0,0
40572,superior,0,0
40573,to,0,0
40574,desipramine,0,1
40575,and,0,1
40576,placebo,0,1
40577,",",0,0
40578,as,0,0
40579,indicated,0,0
40580,by,0,0
40581,standardized,0,0
40582,ratings,0,0
40583,of,0,0
40584,autism,0,0
40585,and,0,0
40586,anger,0,0
40587,as,0,0
40588,well,0,0
40589,as,0,0
40590,ratings,0,0
40591,of,0,0
40592,repetitive,0,0
40593,and,0,0
40594,compulsive,0,0
40595,behaviors,0,1
40596,.,0,1
40597,Clomipramine,0,1
40598,and,0,1
40599,desipramine,0,1
40600,were,0,0
40601,equally,0,0
40602,superior,0,0
40603,to,0,0
40604,placebo,0,1
40605,for,0,0
40606,ratings,0,0
40607,of,0,0
40608,hyperactivity,0,0
40609,.,0,0
40610,Parents,0,0
40611,of,0,0
40612,all,0,0
40613,seven,0,0
40614,subjects,0,0
40615,elected,0,0
40616,to,0,0
40617,have,0,0
40618,their,0,0
40619,children,0,0
40620,continue,0,0
40621,to,0,0
40622,take,0,1
40623,clomipramine,0,1
40624,after,0,0
40625,the,0,0
40626,study,0,0
40627,.,0,0
40628,CONCLUSIONS,0,1
40629,Clomipramine,0,1
40630,and,0,1
40631,desipramine,0,1
40632,are,0,0
40633,differentially,0,0
40634,effective,0,0
40635,in,0,0
40636,treating,0,0
40637,the,0,0
40638,obsessive-compulsive,0,0
40639,and,0,0
40640,core,0,0
40641,symptoms,0,0
40642,in,0,0
40643,autistic,0,0
40644,disorder,0,0
40645,.,0,0
40646,Biological,0,0
40647,links,0,0
40648,between,0,0
40649,compulsions,0,0
40650,and,0,0
40651,stereotyped,0,0
40652,",",0,0
40653,repetitive,0,0
40654,behaviors,0,0
40655,in,0,0
40656,autistic,0,0
40657,disorder,0,0
40658,should,0,0
40659,be,0,0
40660,explored,0,0
40661,.,0,0
40662,Further,0,0
40663,evaluation,0,0
40664,of,0,0
40665,docosahexaenoic,1,1
40666,acid,1,1
40667,in,0,0
40668,patients,0,0
40669,with,0,0
40670,retinitis,0,0
40671,pigmentosa,0,0
40672,receiving,0,0
40673,vitamin,1,1
40674,A,1,1
40675,treatment,0,0
40676,:,0,0
40677,subgroup,0,0
40678,analyses,0,0
40679,.,0,0
40680,OBJECTIVE,0,0
40681,To,0,0
40682,determine,0,0
40683,whether,0,0
40684,docosahexaenoic,1,1
40685,acid,1,1
40686,will,0,0
40687,slow,0,0
40688,the,0,0
40689,course,0,0
40690,of,0,0
40691,retinal,0,0
40692,degeneration,0,0
40693,in,0,0
40694,subgroups,0,0
40695,of,0,0
40696,patients,0,0
40697,with,0,0
40698,retinitis,0,0
40699,pigmentosa,0,0
40700,who,0,0
40701,are,0,0
40702,receiving,0,0
40703,vitamin,1,1
40704,A,1,1
40705,.,1,1
40706,DESIGN,0,0
40707,A,0,1
40708,cohort,0,0
40709,of,0,0
40710,208,0,0
40711,patients,0,0
40712,with,0,0
40713,retinitis,0,0
40714,pigmentosa,0,0
40715,",",0,0
40716,aged,0,0
40717,18,0,0
40718,to,0,0
40719,55,0,0
40720,years,0,0
40721,",",0,0
40722,were,0,0
40723,randomly,0,0
40724,assigned,0,0
40725,to,0,0
40726,1200,0,1
40727,mg,0,1
40728,of,0,1
40729,docosahexaenoic,1,1
40730,acid,1,1
40731,plus,1,0
40732,15,1,0
40733,000,1,0
40734,IU/d,1,1
40735,of,1,0
40736,vitamin,1,1
40737,A,1,1
40738,given,1,1
40739,as,1,0
40740,retinyl,1,1
40741,palmitate,1,1
40742,(,1,1
40743,DHA,1,1
40744,+,1,1
40745,A,1,1
40746,group,1,1
40747,),1,0
40748,or,1,0
40749,control,1,0
40750,fatty,1,1
40751,acid,1,1
40752,plus,1,0
40753,15,1,0
40754,000,1,0
40755,IU/d,1,1
40756,of,1,0
40757,vitamin,1,1
40758,A,1,1
40759,(,1,1
40760,control,1,0
40761,+,1,0
40762,A,1,1
40763,group,1,1
40764,),1,0
40765,and,0,0
40766,followed,0,0
40767,up,0,0
40768,over,0,0
40769,4,0,0
40770,years,0,0
40771,.,0,0
40772,Seventy,0,0
40773,percent,0,0
40774,of,0,0
40775,the,0,0
40776,patients,0,0
40777,in,0,0
40778,each,0,0
40779,group,0,0
40780,were,0,0
40781,taking,0,0
40782,vitamin,1,1
40783,A,1,1
40784,",",0,1
40785,15,0,0
40786,000,0,0
40787,IU/d,0,0
40788,",",0,0
40789,prior,0,0
40790,to,0,0
40791,entry,0,0
40792,.,0,0
40793,We,0,0
40794,compared,0,0
40795,rates,0,0
40796,of,0,0
40797,decline,0,0
40798,in,0,0
40799,ocular,0,0
40800,function,0,0
40801,in,0,0
40802,the,0,0
40803,DHA,1,1
40804,+,1,0
40805,A,1,0
40806,vs,0,0
40807,control,1,0
40808,+,1,0
40809,A,1,1
40810,groups,0,0
40811,among,0,0
40812,the,0,0
40813,subgroups,0,0
40814,defined,0,0
40815,by,0,0
40816,use,0,0
40817,or,0,0
40818,nonuse,0,0
40819,of,0,0
40820,vitamin,1,1
40821,A,1,1
40822,prior,0,0
40823,to,0,0
40824,entry,0,0
40825,.,0,0
40826,We,0,0
40827,also,0,0
40828,determined,0,0
40829,whether,0,0
40830,decline,0,0
40831,in,0,0
40832,ocular,0,0
40833,function,0,0
40834,was,0,0
40835,related,0,0
40836,to,0,0
40837,red,0,0
40838,blood,0,0
40839,cell,0,1
40840,phosphatidylethanolamine,0,1
40841,docosahexaenoic,0,1
40842,acid,0,1
40843,level,0,1
40844,",",0,1
40845,dietary,0,1
40846,omega-3,0,1
40847,fatty,0,1
40848,acid,0,1
40849,intake,0,1
40850,",",0,1
40851,or,0,0
40852,duration,0,0
40853,of,0,0
40854,vitamin,0,1
40855,A,0,1
40856,use,0,0
40857,.,0,0
40858,Main,0,1
40859,outcome,0,1
40860,measures,0,1
40861,were,0,0
40862,Humphrey,0,0
40863,Field,0,1
40864,Analyzer,0,0
40865,visual,0,0
40866,field,0,0
40867,sensitivity,0,0
40868,",",0,0
40869,30-Hz,0,1
40870,electroretinogram,0,1
40871,amplitude,0,0
40872,",",0,0
40873,and,0,0
40874,visual,0,0
40875,acuity,0,0
40876,.,0,0
40877,RESULTS,0,0
40878,Among,0,0
40879,patients,0,0
40880,not,1,0
40881,taking,1,0
40882,vitamin,1,1
40883,A,1,1
40884,prior,0,0
40885,to,0,0
40886,entry,0,0
40887,",",0,0
40888,those,0,0
40889,in,0,0
40890,the,0,0
40891,DHA,1,1
40892,+,1,1
40893,A,1,1
40894,group,0,0
40895,had,0,0
40896,a,0,0
40897,slower,0,0
40898,decline,0,0
40899,in,0,0
40900,field,0,0
40901,sensitivity,0,0
40902,and,0,0
40903,electroretinogram,0,0
40904,amplitude,0,0
40905,than,0,0
40906,those,0,0
40907,in,0,0
40908,the,0,0
40909,control,1,0
40910,+,1,0
40911,A,1,1
40912,group,0,0
40913,over,0,0
40914,the,0,0
40915,first,0,0
40916,2,0,0
40917,years,0,0
40918,(,0,0
40919,P,0,0
40920,=.01,0,0
40921,and,0,0
40922,P,0,0
40923,=.03,0,0
40924,",",0,0
40925,respectively,0,0
40926,),0,0
40927,;,0,0
40928,these,0,0
40929,differences,0,0
40930,were,0,0
40931,not,0,0
40932,observed,0,0
40933,in,0,0
40934,years,0,0
40935,3,0,0
40936,and,0,0
40937,4,0,0
40938,of,0,0
40939,follow-up,0,0
40940,or,0,0
40941,among,0,0
40942,patients,0,0
40943,taking,0,0
40944,vitamin,1,1
40945,A,1,1
40946,prior,0,0
40947,to,0,0
40948,entry,0,0
40949,.,0,0
40950,In,0,0
40951,the,0,0
40952,entire,0,0
40953,cohort,0,0
40954,",",0,0
40955,red,0,0
40956,blood,0,0
40957,cell,0,1
40958,phosphatidylethanolamine,0,1
40959,docosahexaenoic,1,1
40960,acid,1,1
40961,level,0,0
40962,was,0,0
40963,inversely,0,0
40964,related,0,0
40965,to,0,0
40966,rate,0,0
40967,of,0,0
40968,decline,0,0
40969,in,0,0
40970,total,0,0
40971,field,0,0
40972,sensitivity,0,0
40973,over,0,0
40974,4,0,0
40975,years,0,0
40976,(,0,0
40977,test,0,0
40978,for,0,0
40979,trend,0,0
40980,",",0,0
40981,P,0,0
40982,=.05,0,0
40983,),0,0
40984,.,0,0
40985,This,0,0
40986,was,0,0
40987,particularly,0,0
40988,evident,0,0
40989,over,0,0
40990,the,0,0
40991,first,0,0
40992,2,0,0
40993,years,0,0
40994,among,0,0
40995,those,0,0
40996,not,1,0
40997,on,1,0
40998,vitamin,1,1
40999,A,1,1
41000,prior,0,0
41001,to,0,0
41002,entry,0,0
41003,(,0,0
41004,test,0,0
41005,for,0,0
41006,trend,0,0
41007,",",0,0
41008,P,0,0
41009,=.003,0,0
41010,),0,0
41011,.,0,0
41012,In,0,0
41013,the,0,0
41014,entire,0,0
41015,control,1,0
41016,+,1,0
41017,A,1,1
41018,group,0,1
41019,",",0,1
41020,dietary,1,1
41021,omega-3,1,1
41022,fatty,1,1
41023,acid,1,1
41024,intake,0,1
41025,was,0,0
41026,inversely,0,0
41027,related,0,0
41028,to,0,0
41029,loss,0,0
41030,of,0,0
41031,total,0,0
41032,field,0,0
41033,sensitivity,0,0
41034,over,0,0
41035,4,0,0
41036,years,0,1
41037,(,0,1
41038,intake,0,1
41039,",",0,0
41040,<,0,0
41041,0.20,0,0
41042,vs,0,0
41043,>,0,0
41044,or,0,0
41045,=0.20,0,0
41046,g/d,0,0
41047,;,0,0
41048,P,0,0
41049,=.02,0,0
41050,),0,0
41051,.,0,0
41052,The,0,0
41053,duration,0,0
41054,of,0,0
41055,vitamin,1,1
41056,A,1,1
41057,supplementation,1,1
41058,prior,0,0
41059,to,0,0
41060,entry,0,0
41061,was,0,0
41062,inversely,0,0
41063,related,0,0
41064,to,0,0
41065,rate,0,0
41066,of,0,0
41067,decline,0,0
41068,in,0,0
41069,electroretinogram,0,0
41070,amplitude,0,0
41071,(,0,0
41072,P,0,0
41073,=.008,0,0
41074,),0,0
41075,.,0,0
41076,CONCLUSIONS,0,0
41077,For,0,0
41078,patients,0,0
41079,with,0,0
41080,retinitis,0,0
41081,pigmentosa,0,0
41082,beginning,0,0
41083,vitamin,1,1
41084,A,1,1
41085,therapy,1,1
41086,",",0,0
41087,addition,0,0
41088,of,0,0
41089,docosahexaenoic,1,1
41090,acid,1,1
41091,",",0,1
41092,1200,0,1
41093,mg/d,0,1
41094,",",0,1
41095,slowed,0,0
41096,the,0,0
41097,course,0,0
41098,of,0,0
41099,disease,0,0
41100,for,0,0
41101,2,0,0
41102,years,0,0
41103,.,0,0
41104,Among,0,0
41105,patients,0,0
41106,on,0,0
41107,vitamin,1,1
41108,A,1,1
41109,for,0,0
41110,at,0,0
41111,least,0,0
41112,2,0,0
41113,years,0,0
41114,",",0,0
41115,a,0,0
41116,diet,0,1
41117,rich,0,0
41118,in,0,1
41119,omega-3,1,1
41120,fatty,1,1
41121,acids,1,1
41122,(,0,1
41123,>,0,0
41124,or,0,0
41125,=0.20,0,0
41126,g/d,0,1
41127,),0,0
41128,slowed,0,0
41129,the,0,0
41130,decline,0,0
41131,in,0,0
41132,visual,0,0
41133,field,0,0
41134,sensitivity,0,0
41135,.,0,0
41136,Association,0,0
41137,of,0,0
41138,race,1,0
41139,with,0,0
41140,complications,0,0
41141,and,0,0
41142,prognosis,0,0
41143,following,0,0
41144,acute,0,0
41145,coronary,0,0
41146,syndromes,0,0
41147,.,0,0
41148,The,0,0
41149,baseline,0,0
41150,characteristics,0,0
41151,",",0,0
41152,complications,0,0
41153,",",0,0
41154,and,0,0
41155,survival,0,0
41156,of,0,0
41157,489,0,0
41158,black,0,0
41159,and,0,0
41160,"6,890",0,0
41161,non-black,0,0
41162,patients,0,0
41163,with,0,0
41164,acute,0,0
41165,coronary,0,0
41166,syndromes,0,0
41167,were,0,0
41168,studied,0,0
41169,.,0,0
41170,Important,0,0
41171,racial,0,0
41172,differences,0,0
41173,were,0,0
41174,observed,0,0
41175,in,0,0
41176,demographic,0,0
41177,features,0,0
41178,",",0,0
41179,atherosclerosis,0,0
41180,risk,0,0
41181,factors,0,0
41182,",",0,0
41183,and,0,0
41184,treatment,1,0
41185,strategies,1,1
41186,;,1,0
41187,however,0,0
41188,",",0,0
41189,despite,0,0
41190,these,0,0
41191,differences,0,0
41192,",",0,0
41193,no,0,0
41194,independent,0,0
41195,difference,0,0
41196,was,0,0
41197,observed,0,0
41198,in,0,0
41199,clinical,0,0
41200,outcomes,0,0
41201,according,0,0
41202,to,0,0
41203,race,0,0
41204,.,0,0
41205,The,0,0
41206,1-year,0,0
41207,mortality,0,0
41208,rate,0,0
41209,was,0,0
41210,2.9,0,0
41211,%,0,0
41212,for,0,0
41213,black,0,0
41214,patients,0,0
41215,and,0,0
41216,2.5,0,0
41217,%,0,0
41218,for,0,0
41219,non-black,0,0
41220,patients,0,0
41221,(,0,0
41222,p,0,0
41223,=,0,0
41224,0.93,0,0
41225,),0,0
41226,.,0,0
41227,Atrial,1,0
41228,remodeling,1,0
41229,after,0,0
41230,mitral,1,0
41231,valve,1,0
41232,surgery,1,0
41233,in,0,0
41234,patients,0,0
41235,with,0,0
41236,permanent,0,0
41237,atrial,0,0
41238,fibrillation,0,0
41239,.,0,0
41240,BACKGROUND,0,0
41241,Mitral,0,0
41242,valve,0,0
41243,pathology,0,0
41244,is,0,0
41245,frequently,0,0
41246,associated,0,0
41247,with,0,0
41248,auricular,0,0
41249,dilatation,0,0
41250,and,0,0
41251,atrial,0,0
41252,fibrillation,0,0
41253,.,0,0
41254,Mitral,1,0
41255,surgery,1,0
41256,allows,0,0
41257,an,0,0
41258,immediate,0,0
41259,surgical,0,0
41260,auricular,0,0
41261,remodeling,0,0
41262,and,0,0
41263,besides,0,0
41264,in,0,0
41265,those,0,0
41266,cases,0,0
41267,in,0,0
41268,which,0,0
41269,sinus,0,0
41270,rhythm,0,0
41271,is,0,0
41272,reached,0,0
41273,",",0,0
41274,it,0,0
41275,is,0,0
41276,followed,0,0
41277,by,0,0
41278,a,0,0
41279,late,0,0
41280,remodeling,0,0
41281,.,0,0
41282,The,0,0
41283,aim,0,0
41284,of,0,0
41285,this,0,0
41286,study,0,0
41287,is,0,0
41288,to,0,0
41289,investigate,0,0
41290,the,0,0
41291,process,0,0
41292,of,0,0
41293,postoperative,0,0
41294,auricular,0,0
41295,remodeling,0,0
41296,in,0,0
41297,patients,0,0
41298,with,0,0
41299,permanent,0,0
41300,atrial,0,0
41301,fibrillation,0,0
41302,undergoing,0,1
41303,mitral,1,0
41304,surgery,1,0
41305,.,1,0
41306,METHODS,0,0
41307,In,0,0
41308,a,0,0
41309,prospective,0,0
41310,randomized,0,0
41311,trial,0,0
41312,",",0,0
41313,50,0,0
41314,patients,0,0
41315,with,0,0
41316,permanent,0,0
41317,atrial,0,0
41318,fibrillation,0,0
41319,and,0,0
41320,dilated,0,0
41321,left,0,0
41322,atrium,0,0
41323,",",0,0
41324,submitted,0,0
41325,to,0,0
41326,surgical,0,0
41327,mitral,0,0
41328,repair,0,0
41329,",",0,0
41330,were,0,0
41331,divided,0,0
41332,into,0,0
41333,two,0,0
41334,groups,0,0
41335,:,0,0
41336,Group,1,0
41337,I,1,0
41338,contained,1,0
41339,25,1,0
41340,patients,1,0
41341,with,1,0
41342,left,1,0
41343,auricular,1,0
41344,reduction,1,0
41345,and,1,0
41346,mitral,1,0
41347,surgery,1,0
41348,",",1,0
41349,and,1,0
41350,Group,1,0
41351,II,1,0
41352,contained,1,0
41353,25,1,0
41354,patients,1,0
41355,with,1,0
41356,isolated,1,0
41357,valve,1,0
41358,surgery,1,0
41359,.,1,0
41360,Both,0,0
41361,groups,0,0
41362,were,0,0
41363,considered,0,0
41364,homogeneous,0,0
41365,in,0,0
41366,the,0,0
41367,preoperative,0,0
41368,assessment,0,0
41369,.,0,0
41370,RESULTS,0,0
41371,After,0,0
41372,a,0,0
41373,mean,0,0
41374,follow-up,0,0
41375,of,0,0
41376,31,0,0
41377,months,0,0
41378,",",0,0
41379,46,0,0
41380,%,0,0
41381,of,0,0
41382,patients,0,0
41383,included,0,0
41384,in,0,0
41385,Group,0,0
41386,I,0,0
41387,versus,0,0
41388,18,0,0
41389,%,0,0
41390,of,0,0
41391,patients,0,0
41392,included,0,0
41393,in,0,0
41394,Group,0,0
41395,II,0,1
41396,restarted,0,1
41397,sinus,0,1
41398,rhythm,0,1
41399,(,0,0
41400,p,0,0
41401,=,0,0
41402,0.06,0,0
41403,),0,0
41404,.,0,0
41405,An,0,1
41406,auricular,0,0
41407,remodeling,0,0
41408,with,0,0
41409,size,0,0
41410,regression,0,0
41411,occurred,0,0
41412,in,0,0
41413,those,0,0
41414,patients,0,0
41415,who,0,0
41416,recovered,0,0
41417,from,0,0
41418,sinus,0,0
41419,rhythm,0,0
41420,",",0,0
41421,worthy,0,0
41422,of,0,0
41423,remark,0,0
41424,in,0,0
41425,Group,0,0
41426,II,0,0
41427,(,0,0
41428,-10.8,0,0
41429,%,0,0
41430,of,0,0
41431,left,0,0
41432,auricular,0,0
41433,volume,0,0
41434,reduction,0,0
41435,in,0,0
41436,Group,0,0
41437,I,0,0
41438,compared,0,0
41439,to,0,0
41440,-21.5,0,0
41441,%,0,0
41442,in,0,0
41443,Group,0,0
41444,II,0,0
41445,;,0,0
41446,p,0,0
41447,<,0,0
41448,0.05,0,0
41449,),0,0
41450,.,0,0
41451,A,0,0
41452,new,0,0
41453,atrial,0,0
41454,enlargement,0,0
41455,took,0,0
41456,place,0,0
41457,in,0,0
41458,those,0,0
41459,patients,0,0
41460,who,0,0
41461,remained,0,0
41462,with,0,0
41463,atrial,0,0
41464,fibrillation,0,0
41465,(,0,0
41466,+16.8,0,0
41467,%,0,0
41468,left,0,0
41469,auricular,0,0
41470,volume,0,0
41471,in,0,0
41472,Group,0,0
41473,I,0,0
41474,vs.,0,0
41475,+8.4,0,0
41476,%,0,0
41477,in,0,0
41478,Group,0,0
41479,II,0,0
41480,;,0,0
41481,p,0,0
41482,<,0,0
41483,0.05,0,0
41484,),0,0
41485,.,0,0
41486,CONCLUSIONS,0,1
41487,Mitral,0,0
41488,surgery,0,0
41489,produces,0,0
41490,an,0,0
41491,atrial,0,0
41492,postoperative,0,0
41493,volume,0,0
41494,that,0,0
41495,decrease,0,0
41496,especially,0,0
41497,when,0,0
41498,reduction,0,0
41499,techniques,0,0
41500,are,0,0
41501,employed,0,0
41502,.,0,0
41503,Late,0,0
41504,left,0,0
41505,atrial,0,0
41506,remodeling,0,0
41507,depended,0,0
41508,on,0,0
41509,the,0,0
41510,type,0,0
41511,of,0,0
41512,atrial,0,0
41513,rhythm,0,0
41514,and,0,0
41515,postoperative,0,0
41516,surgical,0,0
41517,volume,0,0
41518,.,0,0
41519,Transitions,0,0
41520,during,0,0
41521,effective,0,0
41522,treatment,0,0
41523,for,0,0
41524,cocaine-abusing,0,0
41525,homeless,0,0
41526,persons,0,0
41527,:,0,0
41528,establishing,0,0
41529,abstinence,0,0
41530,",",0,0
41531,lapse,0,0
41532,",",0,0
41533,and,0,0
41534,relapse,0,0
41535,",",0,0
41536,and,0,0
41537,reestablishing,0,0
41538,abstinence,0,0
41539,.,0,0
41540,Data,0,0
41541,are,0,0
41542,reported,0,0
41543,on,0,0
41544,drug,0,1
41545,use,0,0
41546,among,0,0
41547,cocaine-dependent,0,0
41548,homeless,0,0
41549,persons,0,1
41550,who,0,0
41551,participated,0,0
41552,in,0,0
41553,a,0,0
41554,clinical,0,0
41555,trial,0,0
41556,that,0,0
41557,compared,0,0
41558,day,1,0
41559,treatment,1,0
41560,only,1,0
41561,(,0,0
41562,DT,0,1
41563,",",0,0
41564,n,0,0
41565,=,0,0
41566,69,0,0
41567,),0,0
41568,with,0,0
41569,day,1,0
41570,treatment,1,0
41571,plus,1,0
41572,abstinent-contingent,1,0
41573,housing,1,0
41574,and,1,0
41575,work,1,0
41576,(,0,0
41577,DT+,0,1
41578,",",0,0
41579,n,0,0
41580,=,0,0
41581,72,0,0
41582,),0,0
41583,.,0,0
41584,Drug,0,0
41585,use,0,0
41586,was,0,0
41587,measured,0,0
41588,with,0,0
41589,multiple,0,0
41590,weekly,0,1
41591,urine,0,1
41592,toxicologies,0,1
41593,.,0,0
41594,Compared,0,0
41595,with,0,0
41596,DT,0,0
41597,participants,0,0
41598,",",0,0
41599,more,0,0
41600,DT+,0,0
41601,participants,0,0
41602,established,0,0
41603,abstinence,1,0
41604,",",0,0
41605,maintained,0,0
41606,abstinence,0,0
41607,for,0,0
41608,longer,0,0
41609,durations,0,0
41610,",",0,0
41611,were,0,0
41612,marginally,0,0
41613,significantly,0,0
41614,more,0,0
41615,likely,0,0
41616,to,0,0
41617,lapse,0,0
41618,",",0,0
41619,and,0,0
41620,significantly,0,0
41621,less,0,0
41622,likely,0,0
41623,to,0,0
41624,relapse,0,0
41625,.,0,0
41626,Of,0,0
41627,all,0,0
41628,participants,0,0
41629,who,0,0
41630,established,0,0
41631,abstinence,0,0
41632,and,0,0
41633,then,0,0
41634,relapsed,0,0
41635,",",0,0
41636,DT+,0,1
41637,participants,0,1
41638,relapsed,0,0
41639,later,0,0
41640,and,0,0
41641,were,0,0
41642,more,0,0
41643,likely,0,0
41644,to,0,0
41645,reestablish,0,0
41646,abstinence,0,0
41647,.,0,0
41648,These,0,0
41649,analyses,0,0
41650,yield,0,0
41651,information,0,0
41652,on,0,0
41653,the,0,0
41654,processes,0,0
41655,involved,0,0
41656,in,0,0
41657,the,0,0
41658,manner,0,0
41659,in,0,0
41660,which,0,0
41661,drug,0,1
41662,use,0,0
41663,changes,0,0
41664,as,0,0
41665,a,0,0
41666,result,0,0
41667,of,0,0
41668,abstinent-contingent,1,0
41669,housing,1,0
41670,and,1,0
41671,work,1,0
41672,.,1,0
41673,A,0,1
41674,new,0,0
41675,social,1,0
41676,communication,1,0
41677,intervention,1,0
41678,for,0,0
41679,children,0,0
41680,with,0,0
41681,autism,0,0
41682,:,0,0
41683,pilot,0,0
41684,randomised,0,0
41685,controlled,0,0
41686,treatment,0,0
41687,study,0,0
41688,suggesting,0,0
41689,effectiveness,0,0
41690,.,0,0
41691,BACKGROUND,0,0
41692,Psychosocial,0,0
41693,treatments,0,0
41694,are,0,0
41695,the,0,0
41696,mainstay,0,0
41697,of,0,0
41698,management,0,0
41699,of,0,0
41700,autism,0,0
41701,in,0,0
41702,the,0,0
41703,UK,0,0
41704,but,0,0
41705,there,0,0
41706,is,0,0
41707,a,0,0
41708,notable,0,0
41709,lack,0,0
41710,of,0,0
41711,a,0,0
41712,systematic,0,0
41713,evidence,0,0
41714,base,0,0
41715,for,0,0
41716,their,0,0
41717,effectiveness,0,0
41718,.,0,0
41719,Randomised,0,0
41720,controlled,0,0
41721,trial,0,1
41722,(,0,1
41723,RCT,0,1
41724,),0,0
41725,studies,0,0
41726,in,0,0
41727,this,0,0
41728,area,0,0
41729,have,0,0
41730,been,0,0
41731,rare,0,0
41732,but,0,0
41733,are,0,0
41734,essential,0,0
41735,because,0,0
41736,of,0,0
41737,the,0,0
41738,developmental,0,0
41739,heterogeneity,0,0
41740,of,0,0
41741,the,0,0
41742,disorder,0,0
41743,.,0,0
41744,We,0,0
41745,aimed,0,0
41746,to,0,0
41747,test,0,0
41748,a,0,0
41749,new,1,0
41750,theoretically,1,0
41751,based,1,0
41752,social,1,0
41753,communication,1,0
41754,intervention,1,0
41755,targeting,1,0
41756,parental,1,0
41757,communication,1,0
41758,in,0,0
41759,a,0,0
41760,randomised,0,0
41761,design,0,0
41762,against,0,0
41763,routine,1,0
41764,care,1,0
41765,alone,1,0
41766,.,1,0
41767,METHODS,0,0
41768,The,0,0
41769,intervention,1,0
41770,was,1,0
41771,given,1,0
41772,in,1,0
41773,addition,1,0
41774,to,1,0
41775,existing,1,0
41776,care,1,0
41777,and,0,0
41778,involved,0,0
41779,regular,1,0
41780,monthly,1,0
41781,therapist,1,0
41782,contact,1,0
41783,for,0,0
41784,6,0,0
41785,months,0,0
41786,with,0,0
41787,a,0,0
41788,further,0,0
41789,6,0,0
41790,months,0,0
41791,of,0,0
41792,2-monthly,0,0
41793,consolidation,0,0
41794,sessions,0,0
41795,.,0,0
41796,It,0,0
41797,aimed,0,0
41798,to,0,0
41799,educate,0,0
41800,parents,0,0
41801,and,0,0
41802,train,0,0
41803,them,0,0
41804,in,0,0
41805,adapted,0,0
41806,communication,0,0
41807,tailored,0,0
41808,to,0,0
41809,their,0,0
41810,child,0,0
41811,'s,0,0
41812,individual,0,0
41813,competencies,0,0
41814,.,0,0
41815,Twenty-eight,0,0
41816,children,0,0
41817,with,0,0
41818,autism,0,0
41819,were,0,0
41820,randomised,0,0
41821,between,0,0
41822,this,0,0
41823,treatment,1,0
41824,and,1,0
41825,routine,1,0
41826,care,1,0
41827,alone,1,0
41828,",",0,0
41829,stratified,0,0
41830,for,0,0
41831,age,0,0
41832,and,0,0
41833,baseline,0,0
41834,severity,0,0
41835,.,0,0
41836,Outcome,0,0
41837,was,0,0
41838,measured,0,0
41839,at,0,0
41840,12,0,0
41841,months,0,0
41842,from,0,0
41843,commencement,0,0
41844,of,0,0
41845,intervention,0,0
41846,",",0,0
41847,using,0,0
41848,standardised,0,0
41849,instruments,0,0
41850,.,0,0
41851,RESULTS,0,0
41852,All,0,0
41853,cases,0,0
41854,studied,0,0
41855,met,0,0
41856,full,0,0
41857,Autism,0,0
41858,Diagnostic,0,1
41859,Interview,0,1
41860,(,0,1
41861,ADI,0,1
41862,),0,1
41863,criteria,0,0
41864,for,0,0
41865,classical,0,0
41866,autism,0,0
41867,.,0,0
41868,Treatment,0,0
41869,and,0,0
41870,controls,0,0
41871,had,0,0
41872,similar,0,0
41873,routine,0,0
41874,care,0,0
41875,during,0,0
41876,the,0,0
41877,study,0,0
41878,period,0,0
41879,and,0,0
41880,there,0,0
41881,were,0,0
41882,no,0,0
41883,study,0,0
41884,dropouts,0,0
41885,after,0,0
41886,treatment,0,0
41887,had,0,0
41888,started,0,0
41889,.,0,0
41890,The,0,0
41891,active,0,0
41892,treatment,0,0
41893,group,0,0
41894,showed,0,0
41895,significant,0,0
41896,improvement,0,0
41897,compared,0,0
41898,with,0,0
41899,controls,0,0
41900,on,0,0
41901,the,0,0
41902,primary,0,0
41903,outcome,0,0
41904,measure,0,0
41905,--,0,0
41906,Autism,0,0
41907,Diagnostic,0,1
41908,Observation,0,1
41909,Schedule,0,1
41910,(,0,1
41911,ADOS,0,1
41912,),0,1
41913,total,0,0
41914,score,0,0
41915,",",0,0
41916,particularly,0,0
41917,in,0,0
41918,reciprocal,0,0
41919,social,0,0
41920,interaction,0,0
41921,--,0,0
41922,and,0,0
41923,on,0,0
41924,secondary,0,0
41925,measures,0,0
41926,of,0,0
41927,expressive,0,0
41928,language,0,0
41929,",",0,0
41930,communicative,0,0
41931,initiation,0,0
41932,and,0,0
41933,parent-child,0,0
41934,interaction,0,0
41935,.,0,0
41936,Suggestive,0,0
41937,but,0,0
41938,non-significant,0,0
41939,results,0,0
41940,were,0,0
41941,found,0,0
41942,in,0,0
41943,Vineland,0,0
41944,Adaptive,0,0
41945,Behaviour,0,1
41946,Scales,0,1
41947,(,0,0
41948,Communication,0,1
41949,Sub-domain,0,0
41950,),0,0
41951,and,0,0
41952,ADOS,0,1
41953,stereotyped,0,0
41954,and,0,0
41955,restricted,0,0
41956,behaviour,0,0
41957,domain,0,0
41958,.,0,0
41959,CONCLUSIONS,0,0
41960,A,0,1
41961,Randomised,0,0
41962,Treatment,0,0
41963,Trial,0,0
41964,design,0,0
41965,of,0,0
41966,this,0,0
41967,kind,0,0
41968,in,0,0
41969,classical,0,0
41970,autism,0,0
41971,is,0,0
41972,feasible,0,0
41973,and,0,0
41974,acceptable,0,0
41975,to,0,0
41976,patients,0,0
41977,.,0,0
41978,This,0,0
41979,pilot,0,0
41980,study,0,0
41981,suggests,0,0
41982,significant,0,0
41983,additional,0,0
41984,treatment,0,0
41985,benefits,0,0
41986,following,0,0
41987,a,0,0
41988,targeted,0,0
41989,(,0,0
41990,but,0,0
41991,relatively,0,0
41992,non-intensive,0,1
41993,),0,0
41994,dyadic,0,1
41995,social,0,1
41996,communication,0,0
41997,treatment,0,0
41998,",",0,0
41999,when,0,0
42000,compared,0,0
42001,with,0,0
42002,routine,0,0
42003,care,0,0
42004,.,0,0
42005,The,0,0
42006,study,0,0
42007,needs,0,0
42008,replication,0,0
42009,on,0,0
42010,larger,0,0
42011,and,0,0
42012,independent,0,0
42013,samples,0,0
42014,.,0,0
42015,It,0,0
42016,should,0,0
42017,encourage,0,0
42018,further,0,0
42019,RCT,0,0
42020,designs,0,0
42021,in,0,0
42022,this,0,0
42023,area,0,0
42024,.,0,0
42025,[,0,1
42026,Long-term,0,0
42027,effects,0,0
42028,of,0,0
42029,7-year,0,0
42030,growth,1,0
42031,hormone,1,1
42032,substitution,1,0
42033,on,0,0
42034,bone,0,0
42035,metabolism,0,0
42036,",",0,0
42037,bone,0,0
42038,density,0,0
42039,",",0,0
42040,and,0,0
42041,bone,0,0
42042,quality,0,0
42043,in,0,0
42044,growth,0,0
42045,hormone-deficient,0,1
42046,adults,0,1
42047,],0,1
42048,.,0,0
42049,BACKGROUND,0,0
42050,AND,0,1
42051,PURPOSE,0,1
42052,Subnormal,0,1
42053,bone,0,1
42054,mineral,0,1
42055,density,0,0
42056,(,0,1
42057,BMD,0,1
42058,),0,1
42059,and,0,0
42060,increased,0,0
42061,fracture,0,0
42062,risk,0,0
42063,are,0,0
42064,described,0,0
42065,in,0,0
42066,patients,0,0
42067,with,0,0
42068,growth,0,0
42069,hormone,0,1
42070,deficiency,0,1
42071,(,0,1
42072,GHD,0,1
42073,),0,1
42074,.,0,0
42075,Growth,1,1
42076,hormone,1,1
42077,(,1,1
42078,GH,1,1
42079,),1,0
42080,has,0,0
42081,been,0,0
42082,reported,0,0
42083,to,0,0
42084,have,0,0
42085,beneficial,0,0
42086,effects,0,0
42087,on,0,0
42088,bone,0,0
42089,in,0,0
42090,GHD,0,0
42091,.,0,0
42092,The,0,0
42093,aim,0,0
42094,of,0,0
42095,this,0,0
42096,study,0,0
42097,was,0,0
42098,to,0,0
42099,investigate,0,0
42100,the,0,0
42101,long-term,0,0
42102,effects,0,0
42103,of,0,0
42104,GH,1,0
42105,replacement,1,0
42106,therapy,1,0
42107,on,0,0
42108,bone,0,0
42109,metabolism,0,0
42110,",",0,0
42111,BMD,0,0
42112,",",0,0
42113,and,0,0
42114,bone,0,0
42115,quality,0,0
42116,in,0,0
42117,patients,0,0
42118,with,0,0
42119,GHD,0,0
42120,.,0,0
42121,PATIENTS,0,0
42122,AND,0,1
42123,METHODS,0,1
42124,20,0,0
42125,adult,0,0
42126,patients,0,0
42127,with,0,0
42128,GHD,1,1
42129,(,0,0
42130,eleven,0,0
42131,male,0,0
42132,",",0,0
42133,nine,0,0
42134,female,0,0
42135,",",0,0
42136,mean,0,0
42137,age,0,0
42138,42.5,0,0
42139,years,0,0
42140,),0,0
42141,were,0,0
42142,included,0,0
42143,in,0,0
42144,the,0,0
42145,study,0,0
42146,and,0,0
42147,randomized,0,0
42148,to,0,0
42149,either,0,0
42150,GH,1,1
42151,or,1,0
42152,placebo,1,1
42153,in,1,0
42154,a,1,0
42155,dose,1,1
42156,of,1,0
42157,0.25,1,1
42158,U/kg,1,1
42159,body,0,1
42160,weight/week,0,1
42161,.,0,1
42162,After,0,0
42163,6,0,0
42164,months,0,0
42165,all,0,0
42166,patients,0,0
42167,received,0,0
42168,GH,1,0
42169,.,1,0
42170,After,0,0
42171,a,0,0
42172,1-year,0,1
42173,double-blind,0,1
42174,",",0,1
42175,placebo-controlled,1,1
42176,study,0,0
42177,the,0,0
42178,patients,0,0
42179,were,0,0
42180,followed,0,0
42181,for,0,0
42182,another,0,0
42183,72,0,0
42184,months,0,0
42185,in,0,0
42186,an,0,0
42187,open,0,0
42188,study,0,0
42189,.,0,0
42190,The,0,0
42191,patients,0,0
42192,were,0,0
42193,compared,0,0
42194,to,0,0
42195,20,0,0
42196,age-,0,0
42197,und,0,0
42198,sex-matched,0,0
42199,healthy,0,0
42200,controls,0,0
42201,.,0,0
42202,Bone,0,1
42203,turnover,0,0
42204,was,0,0
42205,determined,0,0
42206,by,0,0
42207,ICTP,0,1
42208,(,0,0
42209,type,0,0
42210,I,0,0
42211,collagen,0,0
42212,carboxyterminal,0,1
42213,cross-linked,0,1
42214,telopeptide,0,1
42215,),0,1
42216,as,0,0
42217,parameter,0,0
42218,of,0,0
42219,bone,0,0
42220,resorption,0,0
42221,and,0,0
42222,PICP,0,1
42223,(,0,1
42224,carboxyterminal,0,1
42225,propeptide,0,1
42226,of,0,0
42227,type,0,0
42228,I,0,1
42229,procollagen,0,1
42230,),0,1
42231,as,0,0
42232,marker,0,0
42233,of,0,0
42234,bone,0,0
42235,formation,0,0
42236,.,0,0
42237,BMD,0,0
42238,was,0,0
42239,measured,0,0
42240,at,0,0
42241,the,0,0
42242,lumbar,0,0
42243,spine,0,0
42244,by,0,0
42245,dual-photon,0,1
42246,absorptiometry,0,1
42247,(,0,1
42248,DPA,0,1
42249,),0,1
42250,and,0,0
42251,at,0,0
42252,the,0,0
42253,forearm,0,0
42254,by,0,0
42255,single-photon,0,1
42256,absorptiometry,0,1
42257,(,0,1
42258,SPA,0,1
42259,),0,1
42260,.,0,0
42261,Apparent,0,0
42262,phalangeal,0,0
42263,ultrasound,0,0
42264,transmission,0,0
42265,velocity,0,1
42266,(,0,1
42267,APU,0,1
42268,),0,0
42269,was,0,0
42270,assessed,0,0
42271,as,0,0
42272,parameter,0,0
42273,of,0,0
42274,bone,0,0
42275,quality,0,0
42276,independent,0,0
42277,of,0,0
42278,BMD,0,0
42279,.,0,0
42280,RESULTS,0,0
42281,At,0,0
42282,the,0,0
42283,beginning,0,0
42284,of,0,0
42285,the,0,0
42286,study,0,0
42287,BMD,0,0
42288,at,0,0
42289,both,0,0
42290,measuring,0,0
42291,sites,0,0
42292,was,0,0
42293,lower,0,0
42294,in,0,0
42295,patients,0,0
42296,with,0,0
42297,GHD,1,0
42298,than,0,0
42299,in,0,0
42300,healthy,0,0
42301,controls,0,0
42302,.,0,0
42303,During,0,0
42304,the,0,0
42305,1st,0,0
42306,year,0,0
42307,of,0,0
42308,GH,0,0
42309,replacement,0,0
42310,therapy,0,0
42311,BMD,0,0
42312,decreased,0,0
42313,",",0,0
42314,followed,0,0
42315,by,0,0
42316,a,0,0
42317,continuous,0,0
42318,increase,0,0
42319,in,0,0
42320,BMD,0,1
42321,(,0,0
42322,about,0,0
42323,12,0,0
42324,%,0,0
42325,),0,0
42326,up,0,0
42327,to,0,0
42328,60,0,0
42329,months,0,0
42330,which,0,0
42331,remained,0,0
42332,unchanged,0,0
42333,thereafter,0,0
42334,",",0,0
42335,building,0,0
42336,up,0,0
42337,a,0,0
42338,plateau,0,0
42339,.,0,0
42340,After,0,0
42341,72,0,0
42342,months,0,0
42343,no,0,0
42344,significant,0,0
42345,difference,0,0
42346,between,0,0
42347,the,0,0
42348,patients,0,0
42349,and,0,0
42350,the,0,0
42351,healthy,0,0
42352,controls,0,0
42353,could,0,0
42354,be,0,0
42355,detected,0,0
42356,.,0,0
42357,Concerning,0,0
42358,parameters,0,0
42359,of,0,0
42360,bone,0,0
42361,turnover,0,0
42362,",",0,0
42363,first,0,0
42364,ICTP,0,0
42365,as,0,0
42366,marker,0,0
42367,of,0,0
42368,bone,0,0
42369,resorption,0,0
42370,showed,0,0
42371,a,0,0
42372,significant,0,0
42373,increase,0,0
42374,",",0,0
42375,later,0,0
42376,on,0,0
42377,the,0,0
42378,marker,0,0
42379,of,0,0
42380,bone,0,0
42381,formation,0,0
42382,increased,0,0
42383,as,0,0
42384,well,0,0
42385,.,0,0
42386,APU,0,0
42387,decreased,0,0
42388,during,0,0
42389,the,0,0
42390,first,0,0
42391,6,0,0
42392,months,0,0
42393,of,0,0
42394,treatment,0,0
42395,",",0,0
42396,but,0,0
42397,had,0,0
42398,returned,0,0
42399,to,0,0
42400,its,0,0
42401,baseline,0,0
42402,value,0,0
42403,after,0,0
42404,24,0,0
42405,months,0,0
42406,and,0,0
42407,remained,0,0
42408,unchanged,0,0
42409,throughout,0,0
42410,the,0,0
42411,rest,0,0
42412,of,0,0
42413,the,0,0
42414,study,0,0
42415,.,0,0
42416,CONCLUSION,0,0
42417,BMD,0,0
42418,is,0,0
42419,subnormal,0,0
42420,in,0,0
42421,adults,0,0
42422,with,0,0
42423,GHD,1,0
42424,.,1,0
42425,GH,1,0
42426,replacement,0,0
42427,therapy,0,0
42428,stimulates,0,0
42429,bone,0,0
42430,turnover,0,0
42431,in,0,0
42432,patients,0,0
42433,with,0,0
42434,GHD,0,0
42435,and,0,0
42436,in,0,0
42437,the,0,0
42438,long,0,0
42439,term,0,0
42440,such,0,0
42441,stimulation,0,0
42442,results,0,0
42443,in,0,0
42444,an,0,0
42445,increased,0,0
42446,BMD,0,0
42447,.,0,0
42448,Thereby,0,0
42449,",",0,0
42450,GH,1,0
42451,shows,0,0
42452,a,0,0
42453,triphasic,0,1
42454,action,0,0
42455,on,0,0
42456,BMD,0,0
42457,:,0,0
42458,an,0,0
42459,initial,0,0
42460,decrease,0,0
42461,in,0,0
42462,BMD,0,0
42463,during,0,0
42464,the,0,0
42465,1st,0,0
42466,year,0,0
42467,",",0,0
42468,followed,0,0
42469,by,0,0
42470,a,0,0
42471,continuous,0,0
42472,increase,0,0
42473,in,0,0
42474,BMD,0,0
42475,with,0,0
42476,buildup,0,0
42477,of,0,0
42478,a,0,0
42479,stable,0,0
42480,plateau,0,0
42481,after,0,0
42482,60,0,0
42483,months,0,0
42484,.,0,0
42485,The,0,0
42486,newly,0,0
42487,formed,0,0
42488,bone,0,0
42489,seems,0,0
42490,to,0,0
42491,have,0,0
42492,normal,0,0
42493,bone,0,0
42494,elasticity,0,0
42495,.,0,0
42496,[,1,1
42497,Rilmenidine,1,1
42498,sympatholytic,0,1
42499,activity,0,1
42500,preserves,0,0
42501,mental,0,0
42502,and,0,0
42503,orthostatic,0,0
42504,sympathetic,0,0
42505,response,0,0
42506,and,0,0
42507,epinephrine,0,1
42508,secretion,0,1
42509,],0,0
42510,.,0,0
42511,BACKGROUND,0,0
42512,Heightened,0,0
42513,central,0,0
42514,sympathetic,0,0
42515,nervous,0,0
42516,outflow,0,0
42517,is,0,0
42518,common,0,0
42519,in,0,0
42520,essential,0,0
42521,hypertension,0,0
42522,",",0,0
42523,contributing,0,0
42524,to,0,0
42525,hypertension,0,0
42526,development,0,0
42527,and,0,0
42528,perhaps,0,0
42529,also,0,0
42530,to,0,0
42531,complications,0,0
42532,.,0,0
42533,Acute,0,0
42534,sympathetic,0,0
42535,nervous,0,0
42536,activation,0,0
42537,is,0,0
42538,a,0,0
42539,proven,0,0
42540,trigger,0,0
42541,for,0,0
42542,adverse,0,0
42543,cardiovascular,0,0
42544,events,0,0
42545,.,0,0
42546,Accordingly,0,0
42547,",",0,0
42548,antihypertensive,0,1
42549,drugs,0,1
42550,inhibiting,0,1
42551,sympathetic,0,1
42552,outflow,0,0
42553,represent,0,0
42554,a,0,0
42555,theoretically,0,0
42556,attractive,0,0
42557,therapeutic,0,0
42558,option,0,0
42559,.,0,0
42560,OBJECTIVES,0,0
42561,To,0,0
42562,study,0,0
42563,the,0,0
42564,sympatholytic,0,1
42565,and,0,1
42566,blood,0,1
42567,pressure,0,0
42568,lowering,0,0
42569,activity,0,0
42570,of,0,0
42571,the,0,0
42572,imidazoline,0,1
42573,binding,0,0
42574,agent,0,0
42575,rilmenidine,1,1
42576,at,0,0
42577,rest,0,0
42578,and,0,0
42579,during,0,0
42580,reflex,0,0
42581,sympathetic,0,0
42582,activation,0,0
42583,.,0,0
42584,DESIGN,0,0
42585,AND,0,0
42586,METHODS,0,1
42587,The,0,0
42588,HERA,0,0
42589,study,0,0
42590,(,0,0
42591,Hyperium,0,0
42592,Effect,0,0
42593,on,0,0
42594,the,0,0
42595,sympathetic,0,0
42596,Reflex,0,0
42597,activation,0,0
42598,and,0,1
42599,Adrenaline,0,1
42600,),0,1
42601,is,0,0
42602,a,0,0
42603,randomised,0,0
42604,",",0,0
42605,double-blind,0,1
42606,",",0,1
42607,6-week,0,1
42608,cross-over,0,1
42609,trial,0,1
42610,",",0,0
42611,with,0,0
42612,a,0,0
42613,1-week,0,1
42614,placebo,1,1
42615,run-in,0,1
42616,period,0,1
42617,",",0,0
42618,two,0,0
42619,2-week,0,1
42620,active,0,0
42621,treatment,0,0
42622,intervals,0,1
42623,(,1,1
42624,rilmenidine,1,1
42625,1,1,1
42626,mg,1,1
42627,bid,1,1
42628,",",1,1
42629,placebo,1,1
42630,),1,1
42631,and,0,0
42632,intervening,0,0
42633,one,0,0
42634,week,0,0
42635,placebo,1,1
42636,wash-out,0,1
42637,.,0,1
42638,In,0,0
42639,15,0,0
42640,hypertensive,0,0
42641,patients,0,0
42642,",",0,0
42643,noradrenaline,0,1
42644,and,0,1
42645,adrenaline,0,1
42646,plasma,0,1
42647,kinetics,0,1
42648,and,0,1
42649,intra-arterial,0,1
42650,blood,0,1
42651,pressure,0,0
42652,measurements,0,0
42653,were,0,0
42654,performed,0,0
42655,at,0,0
42656,rest,0,0
42657,",",0,0
42658,after,0,0
42659,mental,0,0
42660,stress,0,0
42661,(,0,0
42662,difficult,0,0
42663,mental,0,1
42664,arithmetic,0,1
42665,),0,0
42666,and,0,0
42667,during,0,0
42668,head-up,0,0
42669,tilting,0,0
42670,",",0,0
42671,at,0,0
42672,the,0,0
42673,end,0,0
42674,of,0,0
42675,the,0,0
42676,2-week,0,1
42677,dosing,0,1
42678,periods,0,1
42679,.,0,0
42680,RESULTS,0,0
42681,The,0,0
42682,noradrenaline,0,1
42683,spillover,0,0
42684,rate,0,0
42685,",",0,0
42686,indicative,0,0
42687,of,0,0
42688,whole,0,0
42689,body,0,0
42690,sympathetic,0,0
42691,activity,0,0
42692,",",0,0
42693,was,0,0
42694,reduced,0,0
42695,35,0,0
42696,%,0,0
42697,by,0,0
42698,rilmenidine,0,0
42699,at,0,1
42700,rest,0,0
42701,(,0,0
42702,p,0,0
42703,<,0,0
42704,0.01,0,0
42705,),0,0
42706,and,0,0
42707,remained,0,0
42708,significantly,0,0
42709,lower,0,0
42710,during,0,0
42711,mental,0,0
42712,stress,0,0
42713,and,0,0
42714,tilting,0,0
42715,",",0,0
42716,although,0,0
42717,the,0,0
42718,increases,0,0
42719,in,0,0
42720,noradrenaline,0,1
42721,spillover,0,0
42722,with,0,0
42723,both,0,0
42724,stimuli,0,0
42725,were,0,0
42726,preserved,0,0
42727,.,0,0
42728,The,0,0
42729,effects,0,0
42730,on,0,0
42731,intraarterial,0,1
42732,blood,0,1
42733,pressure,0,0
42734,ran,0,0
42735,in,0,0
42736,parallel,0,0
42737,",",0,0
42738,a,0,0
42739,fall,0,0
42740,in,0,0
42741,supine,0,0
42742,resting,0,0
42743,pressure,0,0
42744,",",0,0
42745,but,0,0
42746,no,0,0
42747,reduction,0,0
42748,in,0,0
42749,BP,0,0
42750,rise,0,0
42751,during,0,0
42752,mental,0,0
42753,stress,0,0
42754,and,0,0
42755,a,0,0
42756,lack,0,0
42757,of,0,0
42758,fall,0,0
42759,in,0,0
42760,BP,0,0
42761,with,0,0
42762,tilting,0,0
42763,.,0,0
42764,On,0,1
42765,placebo,0,1
42766,",",0,1
42767,adrenaline,0,1
42768,secretion,0,0
42769,was,0,0
42770,162,0,0
42771,+/-,0,0
42772,27,0,0
42773,ng/min,0,0
42774,(,0,0
42775,mean,0,0
42776,",",0,0
42777,SE,0,0
42778,),0,0
42779,at,0,0
42780,rest,0,0
42781,",",0,0
42782,increased,0,0
42783,by,0,0
42784,77,0,0
42785,+/-,0,0
42786,42,0,0
42787,ng/min,0,0
42788,with,0,0
42789,mental,0,0
42790,stress,0,0
42791,(,0,0
42792,p=0.019,0,0
42793,),0,0
42794,and,0,0
42795,was,0,0
42796,unchanged,0,0
42797,with,0,0
42798,tilting,0,0
42799,.,0,0
42800,Rilmenidine,0,1
42801,left,0,1
42802,adrenaline,0,1
42803,secretion,0,0
42804,untouched,0,0
42805,under,0,0
42806,all,0,0
42807,conditions,0,0
42808,.,0,0
42809,CONCLUSIONS,0,0
42810,This,0,0
42811,study,0,0
42812,confirms,0,0
42813,a,0,0
42814,sympatholytic,0,1
42815,effect,0,0
42816,of,0,0
42817,rilmenidine,0,1
42818,during,0,0
42819,supine,0,0
42820,rest,0,0
42821,but,0,0
42822,demonstrates,0,0
42823,that,0,0
42824,sympathetic,0,0
42825,responses,0,0
42826,during,0,0
42827,mental,0,0
42828,stress,0,0
42829,and,0,0
42830,tilting,0,0
42831,are,0,0
42832,preserved,0,0
42833,",",0,0
42834,the,0,0
42835,latter,0,0
42836,underlying,0,0
42837,a,0,0
42838,perhaps,0,0
42839,surprising,0,0
42840,absence,0,0
42841,of,0,0
42842,postural,0,0
42843,hypotension,0,0
42844,on,0,0
42845,the,0,0
42846,drug,0,1
42847,.,0,0
42848,The,0,0
42849,absence,0,0
42850,of,0,0
42851,suppression,0,0
42852,of,0,0
42853,reflexive,0,0
42854,sympathetic,0,0
42855,responses,0,0
42856,contrasts,0,0
42857,with,0,0
42858,the,0,0
42859,effects,0,0
42860,of,0,0
42861,rilmenidine,0,1
42862,in,0,0
42863,experimental,0,0
42864,animals,0,0
42865,",",0,0
42866,and,0,0
42867,emphasises,0,0
42868,the,0,0
42869,previously,0,0
42870,demonstrated,0,0
42871,unique,0,0
42872,importance,0,0
42873,in,0,0
42874,humans,0,0
42875,of,0,0
42876,suprabulbar,0,0
42877,noradrenergic,0,1
42878,neuronal,0,0
42879,projections,0,0
42880,from,0,0
42881,the,0,0
42882,brainstem,0,0
42883,",",0,0
42884,which,0,0
42885,are,0,0
42886,inhibited,0,0
42887,by,0,0
42888,imidazoline,0,1
42889,binding,0,0
42890,agents,0,0
42891,",",0,0
42892,in,0,0
42893,regulating,0,0
42894,tonic,0,0
42895,sympathetic,0,0
42896,activity,0,0
42897,in,0,0
42898,essential,0,0
42899,hypertension,0,0
42900,.,0,0
42901,Sympathetic,0,0
42902,nervous,0,0
42903,inhibition,0,0
42904,with,0,0
42905,rilmenidine,0,1
42906,contrasted,0,0
42907,with,0,0
42908,an,0,0
42909,absence,0,0
42910,of,0,0
42911,suppression,0,0
42912,of,0,0
42913,the,0,0
42914,secretion,0,0
42915,of,0,0
42916,adrenaline,0,1
42917,affirming,0,0
42918,that,0,0
42919,here,0,0
42920,",",0,0
42921,as,0,0
42922,elsewhere,0,0
42923,",",0,0
42924,sympathetic,0,0
42925,nervous,0,1
42926,and,0,1
42927,adrenal,0,1
42928,medullary,0,1
42929,function,0,0
42930,can,0,0
42931,be,0,0
42932,disconnected,0,0
42933,.,0,0
42934,Low-intensity,1,0
42935,exercise,1,0
42936,and,0,0
42937,reduction,0,0
42938,of,0,0
42939,the,0,0
42940,risk,0,0
42941,for,0,0
42942,falls,0,0
42943,among,0,0
42944,at-risk,0,0
42945,elders,0,0
42946,.,0,0
42947,BACKGROUND,0,0
42948,Among,0,0
42949,elderly,0,0
42950,persons,0,0
42951,",",0,0
42952,falls,0,0
42953,account,0,0
42954,for,0,0
42955,87,0,0
42956,%,0,0
42957,of,0,0
42958,all,0,0
42959,fractures,0,0
42960,and,0,0
42961,are,0,0
42962,contributing,0,0
42963,factors,0,0
42964,in,0,0
42965,many,0,0
42966,nursing,0,0
42967,home,0,0
42968,admissions,0,0
42969,.,0,0
42970,This,0,0
42971,study,0,0
42972,evaluated,0,0
42973,the,0,0
42974,effect,0,0
42975,of,0,0
42976,an,0,0
42977,easily,0,0
42978,implemented,0,0
42979,",",0,0
42980,low-intensity,1,0
42981,exercise,1,1
42982,program,1,0
42983,on,0,0
42984,the,0,0
42985,incidence,0,0
42986,of,0,0
42987,falls,0,0
42988,and,0,0
42989,the,0,0
42990,time,0,0
42991,to,0,0
42992,first,0,0
42993,fall,0,0
42994,among,0,0
42995,a,0,0
42996,clinically,0,0
42997,defined,0,0
42998,population,0,0
42999,of,0,0
43000,elderly,0,0
43001,men,0,0
43002,and,0,0
43003,women,0,0
43004,.,0,0
43005,METHODS,0,0
43006,This,0,0
43007,community-based,0,0
43008,",",0,0
43009,randomized,0,0
43010,trial,0,0
43011,compared,0,0
43012,the,0,0
43013,exercise,1,0
43014,intervention,1,0
43015,with,0,0
43016,a,0,0
43017,no-intervention,1,0
43018,control,1,0
43019,.,1,0
43020,The,0,0
43021,participants,0,0
43022,were,0,0
43023,294,0,0
43024,men,0,0
43025,and,0,0
43026,women,0,0
43027,",",0,0
43028,aged,0,0
43029,60,0,0
43030,years,0,0
43031,or,0,0
43032,older,0,0
43033,",",0,0
43034,who,0,0
43035,had,0,0
43036,either,0,0
43037,a,0,0
43038,hospital,0,0
43039,admission,0,0
43040,or,0,0
43041,bed,0,0
43042,rest,0,0
43043,for,0,0
43044,2,0,0
43045,days,0,0
43046,or,0,0
43047,more,0,0
43048,within,0,0
43049,the,0,0
43050,previous,0,0
43051,month,0,0
43052,.,0,0
43053,Exercise,1,0
43054,participants,0,0
43055,were,0,0
43056,scheduled,0,0
43057,to,0,0
43058,attend,0,0
43059,exercise,1,0
43060,sessions,1,0
43061,lasting,0,0
43062,45,0,0
43063,minutes,0,0
43064,",",0,0
43065,including,0,0
43066,warm-up,0,0
43067,and,0,0
43068,cool-down,0,0
43069,",",0,0
43070,3,0,0
43071,times,0,0
43072,a,0,0
43073,week,0,0
43074,for,0,0
43075,8,0,0
43076,weeks,0,0
43077,(,0,0
43078,24,0,0
43079,sessions,0,1
43080,),0,0
43081,.,0,0
43082,Assessments,0,0
43083,included,0,0
43084,gait,0,0
43085,and,0,0
43086,balance,0,0
43087,measures,0,0
43088,",",0,0
43089,self-reported,0,0
43090,physical,0,0
43091,function,0,0
43092,",",0,0
43093,the,0,0
43094,number,0,0
43095,of,0,0
43096,medications,0,1
43097,being,0,0
43098,taking,0,0
43099,at,0,0
43100,baseline,0,0
43101,",",0,0
43102,participant,0,0
43103,age,0,0
43104,",",0,0
43105,sex,0,0
43106,",",0,0
43107,and,0,0
43108,history,0,0
43109,of,0,0
43110,falling,0,0
43111,.,0,0
43112,Falls,0,0
43113,were,0,0
43114,tracked,0,0
43115,for,0,0
43116,1,0,0
43117,year,0,0
43118,after,0,0
43119,each,0,0
43120,participant,0,0
43121,'s,0,0
43122,baseline,0,0
43123,assessment,0,0
43124,.,0,0
43125,RESULTS,0,0
43126,29,0,0
43127,%,0,0
43128,of,0,0
43129,the,0,0
43130,study,0,0
43131,participants,0,0
43132,reported,0,0
43133,a,0,0
43134,fall,0,0
43135,during,0,0
43136,the,0,0
43137,study,0,0
43138,period,0,0
43139,.,0,0
43140,The,0,0
43141,effect,0,0
43142,of,0,0
43143,exercise,1,0
43144,in,0,0
43145,preventing,0,0
43146,falls,0,0
43147,varied,0,0
43148,significantly,0,0
43149,by,0,0
43150,baseline,0,0
43151,physical,0,0
43152,function,0,0
43153,level,0,0
43154,(,0,0
43155,p,0,0
43156,<,0,0
43157,or,0,0
43158,=.002,0,0
43159,),0,0
43160,.,0,0
43161,The,0,0
43162,risk,0,0
43163,for,0,0
43164,falls,0,0
43165,decreased,0,0
43166,for,0,0
43167,exercise,0,0
43168,participants,0,0
43169,with,0,0
43170,low,0,0
43171,baseline,0,0
43172,physical,0,0
43173,functioning,0,0
43174,(,0,0
43175,hazard,0,0
43176,ratio,0,0
43177,",",0,0
43178,.51,0,0
43179,),0,0
43180,but,0,0
43181,increased,0,0
43182,for,0,0
43183,exercise,0,0
43184,participants,0,0
43185,with,0,0
43186,high,0,0
43187,baseline,0,0
43188,physical,0,0
43189,functioning,0,0
43190,(,0,0
43191,hazard,0,0
43192,ratio,0,0
43193,",",0,0
43194,3.51,0,0
43195,),0,0
43196,.,0,0
43197,CONCLUSIONS,0,0
43198,This,0,0
43199,easily,0,0
43200,implemented,0,0
43201,",",0,0
43202,low-intensity,1,0
43203,exercise,1,0
43204,program,1,0
43205,appears,0,0
43206,to,0,0
43207,reduce,0,0
43208,the,0,0
43209,risk,0,0
43210,for,0,0
43211,falls,0,0
43212,among,0,0
43213,elderly,0,0
43214,men,0,0
43215,and,0,0
43216,women,0,0
43217,recovering,0,0
43218,from,0,0
43219,recent,0,0
43220,hospitalizations,0,0
43221,",",0,0
43222,bed,0,0
43223,rest,0,0
43224,",",0,0
43225,or,0,0
43226,both,0,0
43227,who,0,0
43228,have,0,0
43229,low,0,0
43230,levels,0,0
43231,of,0,0
43232,physical,0,0
43233,functioning,0,0
43234,.,0,0
43235,Influenza,0,0
43236,and,0,0
43237,pneumococcal,0,0
43238,vaccination,1,0
43239,as,0,0
43240,a,0,0
43241,model,0,0
43242,to,0,0
43243,assess,0,0
43244,C-reactive,0,0
43245,protein,0,0
43246,response,0,0
43247,to,0,0
43248,mild,0,0
43249,inflammation,0,0
43250,.,0,0
43251,This,0,0
43252,study,0,0
43253,was,0,0
43254,set,0,0
43255,up,0,0
43256,to,0,0
43257,examine,0,0
43258,whether,0,0
43259,an,0,0
43260,influenza,1,1
43261,vaccine,1,1
43262,or,1,0
43263,an,1,0
43264,influenza,1,1
43265,vaccine,1,1
43266,in,1,0
43267,combination,1,0
43268,with,1,0
43269,pneumococcal,1,0
43270,vaccine,1,0
43271,can,0,0
43272,be,0,0
43273,used,0,0
43274,as,0,0
43275,a,0,0
43276,model,0,0
43277,to,0,0
43278,study,0,0
43279,responses,0,0
43280,to,0,0
43281,mild,0,0
43282,stimulation,0,0
43283,of,0,0
43284,the,0,0
43285,inflammatory,0,0
43286,system,0,0
43287,.,0,0
43288,In,0,0
43289,this,0,0
43290,study,0,0
43291,",",0,0
43292,19,0,0
43293,subjects,0,0
43294,received,0,0
43295,the,0,0
43296,influenza,1,1
43297,vaccine,1,1
43298,",",0,0
43299,20,0,0
43300,subjects,0,0
43301,the,0,0
43302,combination,0,0
43303,of,0,0
43304,influenza,1,0
43305,and,1,0
43306,pneumococcal,1,1
43307,vaccine,1,1
43308,.,1,1
43309,CRP,0,1
43310,and,0,0
43311,prothrombin,0,1
43312,fragment,0,0
43313,1,0,1
43314,and,0,0
43315,2,0,1
43316,(,0,1
43317,F1+2,0,1
43318,),0,0
43319,were,0,0
43320,measured,0,0
43321,at,0,0
43322,baseline,0,0
43323,",",0,0
43324,and,0,0
43325,two,0,0
43326,times,0,0
43327,after,0,0
43328,vaccination,0,0
43329,.,0,0
43330,Influenza,1,0
43331,vaccination,1,0
43332,increased,0,0
43333,CRP,0,0
43334,by,0,0
43335,0.20,0,0
43336,mg/L,0,0
43337,",",0,0
43338,and,0,0
43339,influenza,0,0
43340,in,0,0
43341,combination,0,0
43342,with,0,0
43343,pneumococcal,1,0
43344,vaccine,1,1
43345,increased,0,0
43346,CRP,0,0
43347,by,0,0
43348,0.60,0,0
43349,mg/L,0,0
43350,.,0,0
43351,F1+2,0,0
43352,increased,0,0
43353,0.15,0,0
43354,nmol/L,0,0
43355,after,0,0
43356,the,0,0
43357,combined,0,0
43358,vaccination,0,0
43359,;,0,0
43360,an,0,0
43361,increase,0,0
43362,in,0,0
43363,response,0,0
43364,to,0,0
43365,the,0,0
43366,influenza,1,0
43367,vaccination,1,0
43368,was,0,0
43369,not,0,0
43370,statistically,0,0
43371,significant,0,0
43372,.,0,0
43373,Our,0,0
43374,findings,0,0
43375,show,0,0
43376,that,0,0
43377,the,0,0
43378,influenza,1,1
43379,vaccine,1,1
43380,alone,0,0
43381,as,0,0
43382,well,0,0
43383,as,0,0
43384,the,0,0
43385,combination,0,0
43386,of,0,0
43387,the,0,0
43388,influenza,1,0
43389,and,1,0
43390,pneumococcal,1,1
43391,vaccine,1,1
43392,increases,0,0
43393,CRP-levels,0,0
43394,with,0,0
43395,a,0,0
43396,peak,0,0
43397,2,0,0
43398,days,0,0
43399,after,0,0
43400,vaccination,0,0
43401,.,0,0
43402,Intranasal,0,1
43403,nicotine,1,1
43404,for,0,1
43405,postoperative,0,1
43406,pain,0,0
43407,treatment,0,0
43408,.,0,0
43409,BACKGROUND,0,0
43410,Despite,0,0
43411,pharmacological,0,0
43412,treatment,0,0
43413,",",0,0
43414,70-80,0,0
43415,%,0,0
43416,of,0,0
43417,patients,0,0
43418,report,0,0
43419,moderate,0,0
43420,to,0,0
43421,severe,0,0
43422,pain,0,0
43423,after,0,0
43424,surgery,0,0
43425,.,0,0
43426,Because,0,0
43427,nicotine,0,1
43428,has,0,0
43429,been,0,0
43430,reported,0,0
43431,to,0,0
43432,have,0,0
43433,analgesic,0,1
43434,properties,0,0
43435,in,0,0
43436,animal,0,0
43437,and,0,0
43438,human,0,0
43439,volunteer,0,0
43440,studies,0,0
43441,",",0,0
43442,the,0,0
43443,authors,0,0
43444,assessed,0,0
43445,the,0,0
43446,analgesic,0,1
43447,efficacy,0,1
43448,of,0,0
43449,a,0,0
43450,single,0,0
43451,3,0,1
43452,mg,0,1
43453,dose,0,1
43454,of,0,1
43455,nicotine,1,1
43456,nasal,0,1
43457,spray,0,1
43458,administered,0,1
43459,before,0,0
43460,emergence,0,0
43461,from,0,0
43462,general,0,0
43463,anesthesia,0,0
43464,.,0,0
43465,METHODS,0,0
43466,The,0,0
43467,authors,0,0
43468,conducted,0,0
43469,a,0,0
43470,randomized,0,0
43471,",",0,0
43472,double,0,0
43473,blind,0,0
43474,",",0,0
43475,placebo,1,1
43476,controlled,0,0
43477,trial,0,0
43478,of,0,0
43479,20,0,0
43480,healthy,0,0
43481,women,0,0
43482,(,0,0
43483,mean,0,0
43484,age,0,0
43485,45,0,0
43486,(,0,0
43487,SD,0,0
43488,8,0,0
43489,),0,0
43490,yr,0,0
43491,),0,0
43492,who,0,0
43493,were,0,0
43494,to,0,0
43495,undergo,0,0
43496,uterine,1,0
43497,surgery,1,0
43498,through,0,0
43499,a,0,0
43500,low,1,0
43501,transverse,1,0
43502,incision,1,0
43503,.,1,0
43504,After,0,0
43505,the,0,0
43506,conclusion,0,0
43507,of,0,0
43508,surgery,0,0
43509,but,0,0
43510,before,0,0
43511,emergence,0,0
43512,from,0,0
43513,general,0,0
43514,anesthesia,0,0
43515,",",0,0
43516,the,0,0
43517,anesthesiologist,0,1
43518,administered,0,1
43519,either,0,1
43520,nicotine,1,1
43521,nasal,1,1
43522,spray,1,1
43523,or,1,1
43524,a,1,0
43525,placebo,1,1
43526,.,1,1
43527,Numerical,0,1
43528,analog,0,1
43529,pain,0,1
43530,score,0,1
43531,and,0,0
43532,morphine,0,1
43533,utilization,0,0
43534,and,0,0
43535,hemodynamic,0,0
43536,values,0,0
43537,were,0,0
43538,measured,0,0
43539,for,0,0
43540,24,0,0
43541,h.,0,0
43542,RESULTS,0,1
43543,The,0,0
43544,patients,0,0
43545,treated,0,0
43546,with,0,0
43547,nicotine,0,1
43548,reported,0,0
43549,lower,0,0
43550,pain,0,0
43551,scores,0,0
43552,during,0,0
43553,the,0,0
43554,first,0,0
43555,hour,0,0
43556,after,0,0
43557,surgery,0,1
43558,(,0,0
43559,peak,0,0
43560,numerical,0,1
43561,analog,0,1
43562,score,0,0
43563,",",0,0
43564,7.6,0,0
43565,(,0,0
43566,SD,0,0
43567,1.4,0,1
43568,),0,0
43569,versus,0,0
43570,5.3,0,0
43571,(,0,0
43572,SD,0,0
43573,1.6,0,1
43574,),0,0
43575,;,0,0
43576,P,0,0
43577,<,0,0
43578,0.001,0,0
43579,),0,0
43580,and,0,0
43581,used,0,0
43582,half,0,0
43583,the,0,0
43584,amount,0,0
43585,of,0,0
43586,morphine,0,1
43587,as,0,0
43588,the,0,0
43589,control,0,0
43590,group,0,0
43591,(,0,0
43592,12,0,1
43593,(,0,1
43594,SD,0,1
43595,6,0,1
43596,),0,0
43597,versus,0,0
43598,6,0,0
43599,(,0,0
43600,SD,0,1
43601,5,0,1
43602,),0,1
43603,mg,0,1
43604,;,0,0
43605,P,0,0
43606,<,0,0
43607,0.05,0,0
43608,),0,0
43609,.,0,0
43610,Patients,0,0
43611,who,0,0
43612,received,0,0
43613,nicotine,0,1
43614,still,0,0
43615,reported,0,0
43616,less,0,0
43617,pain,0,0
43618,than,0,0
43619,those,0,0
43620,in,0,0
43621,the,0,0
43622,control,0,0
43623,group,0,0
43624,24,0,0
43625,h,0,0
43626,after,0,0
43627,surgery,0,1
43628,(,0,0
43629,1.5,0,0
43630,(,0,1
43631,SD,0,1
43632,0.5,0,1
43633,),0,0
43634,versus,0,0
43635,4.9,0,0
43636,(,0,0
43637,SD,0,0
43638,1.4,0,1
43639,),0,0
43640,;,0,0
43641,P,0,0
43642,<,0,0
43643,0.01,0,0
43644,),0,0
43645,.,0,0
43646,Systolic,0,0
43647,blood,0,0
43648,pressure,0,0
43649,was,0,0
43650,lower,0,0
43651,in,0,0
43652,the,0,0
43653,group,0,0
43654,that,0,0
43655,received,0,1
43656,nicotine,0,1
43657,(,0,1
43658,105,0,0
43659,(,0,0
43660,SD,0,0
43661,3,0,1
43662,),0,0
43663,versus,0,0
43664,122,0,0
43665,(,0,0
43666,SD,0,0
43667,3,0,1
43668,),0,0
43669,;,0,0
43670,P,0,0
43671,<,0,0
43672,0.001,0,0
43673,),0,0
43674,",",0,0
43675,but,0,0
43676,there,0,0
43677,was,0,0
43678,no,0,0
43679,difference,0,0
43680,in,0,0
43681,diastolic,0,0
43682,blood,0,0
43683,pressure,0,0
43684,or,0,0
43685,heart,0,0
43686,rate,0,0
43687,.,0,0
43688,CONCLUSIONS,0,0
43689,Treatment,0,0
43690,with,0,0
43691,a,0,0
43692,single,0,0
43693,dose,0,1
43694,of,0,1
43695,nicotine,0,1
43696,immediately,0,0
43697,before,0,0
43698,emergence,0,0
43699,from,0,0
43700,anesthesia,0,0
43701,was,0,0
43702,associated,0,0
43703,with,0,0
43704,significantly,0,0
43705,lower,0,0
43706,reported,0,0
43707,pain,0,0
43708,scores,0,0
43709,during,0,0
43710,the,0,0
43711,first,0,0
43712,day,0,0
43713,after,0,0
43714,surgery,0,0
43715,.,0,0
43716,The,0,0
43717,decreased,0,0
43718,pain,0,0
43719,was,0,0
43720,associated,0,0
43721,with,0,0
43722,a,0,0
43723,reduction,0,0
43724,in,0,0
43725,morphine,0,1
43726,utilization,0,0
43727,and,0,0
43728,the,0,0
43729,analgesic,0,1
43730,effect,0,0
43731,of,0,0
43732,nicotine,0,1
43733,was,0,0
43734,not,0,0
43735,associated,0,0
43736,with,0,0
43737,hypertension,0,0
43738,or,0,0
43739,tachycardia,0,0
43740,.,0,0
43741,Use,0,1
43742,of,0,0
43743,abciximab,1,1
43744,prior,0,0
43745,to,0,0
43746,primary,1,0
43747,angioplasty,1,0
43748,in,0,0
43749,STEMI,0,0
43750,results,0,0
43751,in,0,0
43752,early,0,0
43753,recanalization,0,0
43754,of,0,0
43755,the,0,0
43756,infarct-related,0,0
43757,artery,0,0
43758,and,0,0
43759,improved,0,0
43760,myocardial,0,0
43761,tissue,0,0
43762,reperfusion,0,1
43763,-,0,1
43764,results,0,0
43765,of,0,0
43766,the,0,0
43767,Austrian,0,0
43768,multi-centre,0,0
43769,randomized,0,0
43770,ReoPro-BRIDGING,0,1
43771,Study,0,0
43772,.,0,0
43773,AIMS,0,0
43774,The,0,0
43775,aim,0,0
43776,of,0,0
43777,the,0,0
43778,ReoPro-BRIDGING,0,0
43779,Austrian,0,0
43780,multi-centre,0,0
43781,study,0,0
43782,was,0,0
43783,to,0,0
43784,investigate,0,0
43785,the,0,0
43786,effects,0,0
43787,of,0,0
43788,abciximab,1,1
43789,(,1,1
43790,ReoPro,1,1
43791,),1,1
43792,on,0,0
43793,early,0,0
43794,reperfusion,0,1
43795,in,0,0
43796,ST-elevation,0,0
43797,myocardial,0,0
43798,infarction,0,0
43799,prior,0,0
43800,to,0,0
43801,or,0,0
43802,during,0,0
43803,primary,0,0
43804,percutaneous,1,0
43805,coronary,1,1
43806,angioplasty,1,1
43807,(,1,1
43808,pPCI,1,1
43809,),1,1
43810,.,1,0
43811,METHODS,0,0
43812,AND,0,0
43813,RESULTS,0,0
43814,Fifty-five,0,0
43815,patients,0,0
43816,with,0,0
43817,STEMI,0,0
43818,were,0,0
43819,randomized,0,0
43820,either,0,0
43821,to,0,0
43822,start,0,1
43823,abciximab,1,1
43824,(,0,1
43825,0.25,0,1
43826,mg/kg,0,1
43827,bolus,0,1
43828,followed,0,1
43829,by,0,0
43830,10,0,1
43831,microg/min,0,1
43832,infusion,0,1
43833,),0,1
43834,during,0,0
43835,the,0,0
43836,organization,0,0
43837,phase,0,0
43838,for,0,0
43839,pPCI,0,1
43840,(,0,0
43841,Group,0,0
43842,1,0,0
43843,",",0,0
43844,n=28,0,0
43845,),0,0
43846,or,0,0
43847,immediately,0,0
43848,before,0,0
43849,pPCI,0,1
43850,(,0,0
43851,Group,0,0
43852,2,0,0
43853,",",0,0
43854,n=27,0,0
43855,),0,0
43856,.,0,0
43857,The,0,0
43858,time,0,0
43859,between,0,0
43860,first,0,0
43861,bolus,0,1
43862,of,0,1
43863,abciximab,1,1
43864,and,0,0
43865,first,0,0
43866,balloon,0,0
43867,inflation,0,0
43868,of,0,0
43869,pPCI,0,0
43870,was,0,0
43871,83+/-18,0,0
43872,vs,0,0
43873,21+/-13,0,0
43874,min,0,0
43875,in,0,0
43876,Group,0,0
43877,1,0,0
43878,vs,0,0
43879,2,0,0
43880,.,0,0
43881,The,0,0
43882,pre-pPCI,0,0
43883,ST-segment,0,0
43884,resolution,0,0
43885,(,0,0
43886,55+/-21.4,0,0
43887,%,0,0
43888,vs,0,0
43889,42.4+/-18.2,0,0
43890,%,0,0
43891,",",0,0
43892,p=0.005,0,0
43893,),0,0
43894,",",0,0
43895,TIMI,0,1
43896,flow,0,0
43897,grade,0,0
43898,3,0,0
43899,(,0,0
43900,29,0,0
43901,%,0,0
43902,vs,0,0
43903,7,0,0
43904,%,0,0
43905,",",0,0
43906,p=0.042,0,0
43907,),0,0
43908,",",0,0
43909,corrected,0,0
43910,TIMI,0,0
43911,frame,0,1
43912,count,0,0
43913,(,0,0
43914,58.4+/-32.7,0,0
43915,vs,0,0
43916,78.9+/-28.4,0,0
43917,frame,0,0
43918,",",0,0
43919,p=0.018,0,0
43920,),0,0
43921,%,0,0
43922,diameter,0,0
43923,stenosis,0,0
43924,(,0,0
43925,76.3,0,0
43926,/63.5-100/,0,0
43927,vs,0,0
43928,100,0,0
43929,/73.5-100/,0,0
43930,;,0,0
43931,median,0,0
43932,/interquartile,0,0
43933,range/,0,0
43934,",",0,0
43935,p=0.023,0,0
43936,),0,0
43937,",",0,0
43938,were,0,0
43939,significantly,0,0
43940,higher,0,0
43941,in,0,0
43942,Group,0,0
43943,1,0,0
43944,vs,0,0
43945,Group,0,0
43946,2,0,0
43947,.,0,0
43948,Quantitative,0,0
43949,myocardial,0,0
43950,dye,0,1
43951,intensity,0,0
43952,measurement,0,0
43953,revealed,0,0
43954,a,0,0
43955,significantly,0,0
43956,higher,0,0
43957,grade,0,0
43958,of,0,0
43959,myocardial,0,0
43960,tissue,0,0
43961,perfusion,0,1
43962,(,0,0
43963,1,0,0
43964,/0-9.25/,0,0
43965,vs,0,0
43966,0,0,0
43967,/0-3.0/,0,0
43968,grey,0,0
43969,pixel,0,0
43970,unit,0,0
43971,",",0,0
43972,p=0.048,0,0
43973,),0,0
43974,in,0,0
43975,Group,0,0
43976,1,0,0
43977,before,0,0
43978,pPCI,0,0
43979,.,0,0
43980,Rapid,0,0
43981,release,0,0
43982,of,0,0
43983,cardiac,0,0
43984,enzymes,0,0
43985,was,0,0
43986,observed,0,0
43987,in,0,0
43988,Group,0,0
43989,1,0,0
43990,as,0,0
43991,compared,0,0
43992,with,0,0
43993,Group,0,0
43994,2,0,0
43995,:,0,0
43996,rate,0,0
43997,of,0,0
43998,rise,0,0
43999,of,0,0
44000,CK,0,0
44001,was,0,0
44002,210+/-209,0,0
44003,vs,0,0
44004,97+/-95,0,0
44005,U/l/h,0,0
44006,(,0,0
44007,p=0.015,0,0
44008,),0,0
44009,.,0,0
44010,QRS,0,0
44011,score,0,0
44012,indicated,0,0
44013,a,0,0
44014,smaller,0,0
44015,infarct,0,0
44016,size,0,0
44017,in,0,0
44018,Group,0,0
44019,1,0,0
44020,(,0,0
44021,4.8+/-3.8,0,0
44022,vs,0,0
44023,7.6+/-3.5,0,0
44024,",",0,0
44025,p=0.011,0,0
44026,),0,0
44027,on,0,0
44028,day,0,0
44029,7,0,0
44030,.,0,0
44031,CONCLUSION,0,0
44032,The,0,0
44033,use,0,0
44034,of,0,0
44035,abciximab,0,1
44036,in,0,0
44037,the,0,0
44038,organization,0,0
44039,phase,0,0
44040,for,0,0
44041,pPCI,0,0
44042,results,0,0
44043,in,0,0
44044,signs,0,0
44045,of,0,0
44046,early,0,0
44047,recanalization,0,0
44048,of,0,0
44049,the,0,0
44050,infarct-related,0,0
44051,artery,0,0
44052,and,0,0
44053,a,0,0
44054,subsequent,0,0
44055,improved,0,0
44056,myocardial,0,0
44057,tissue,0,0
44058,reperfusion,0,1
44059,.,0,0
44060,Randomized,0,1
44061,",",0,0
44062,double-blind,0,1
44063,",",0,0
44064,phase,0,0
44065,III,0,0
44066,",",0,0
44067,controlled,0,0
44068,trial,0,0
44069,comparing,0,0
44070,levobupivacaine,1,1
44071,0.25,0,0
44072,%,0,0
44073,",",0,0
44074,ropivacaine,1,0
44075,0.25,0,0
44076,%,0,0
44077,and,0,0
44078,bupivacaine,1,0
44079,0.25,0,0
44080,%,0,0
44081,by,0,0
44082,the,0,0
44083,caudal,0,0
44084,route,0,0
44085,in,0,0
44086,children,0,0
44087,.,0,0
44088,BACKGROUND,0,0
44089,The,0,0
44090,rationale,0,0
44091,for,0,0
44092,replacing,0,0
44093,racemic,1,1
44094,bupivacaine,1,1
44095,with,0,1
44096,the,0,1
44097,s-enantiomers,1,1
44098,levobupivacaine,1,1
44099,and,0,1
44100,ropivacaine,1,1
44101,is,0,0
44102,to,0,0
44103,provide,0,0
44104,a,0,0
44105,wider,0,0
44106,margin,0,0
44107,of,0,0
44108,safety,0,0
44109,with,0,0
44110,the,0,0
44111,same,0,0
44112,analgesic,0,1
44113,efficacy,0,1
44114,and,0,0
44115,less,0,0
44116,postoperative,0,0
44117,motor,0,0
44118,block,0,0
44119,.,0,0
44120,In,0,0
44121,a,0,0
44122,randomized,0,0
44123,",",0,0
44124,double-blind,0,1
44125,",",0,0
44126,phase,0,0
44127,III,0,0
44128,",",0,0
44129,controlled,0,0
44130,trial,0,0
44131,we,0,0
44132,compared,0,0
44133,the,0,0
44134,caudal,0,1
44135,administration,0,1
44136,of,0,1
44137,levobupivacaine,1,1
44138,0.25,0,0
44139,%,0,0
44140,and,0,0
44141,ropivacaine,1,0
44142,0.25,0,0
44143,%,0,0
44144,with,0,0
44145,bupivacaine,1,0
44146,0.25,0,0
44147,%,0,0
44148,in,0,0
44149,children,0,0
44150,.,0,0
44151,METHODS,0,0
44152,Ninety-nine,0,0
44153,ASA,0,0
44154,I-II,0,0
44155,children,0,0
44156,less,0,0
44157,than,0,0
44158,10,0,0
44159,yr,0,0
44160,old,0,0
44161,scheduled,0,0
44162,for,0,0
44163,elective,0,0
44164,sub-umbilical,0,0
44165,surgery,0,0
44166,were,0,0
44167,randomized,0,0
44168,to,0,0
44169,receive,0,0
44170,caudal,0,0
44171,block,0,0
44172,with,0,0
44173,bupivacaine,1,0
44174,0.25,0,0
44175,%,0,0
44176,",",0,0
44177,ropivacaine,1,0
44178,0.25,0,0
44179,%,0,0
44180,or,0,0
44181,levobupivacaine,1,0
44182,0.25,0,0
44183,%,0,0
44184,.,0,0
44185,The,0,0
44186,primary,0,0
44187,outcome,0,0
44188,of,0,0
44189,the,0,0
44190,study,0,0
44191,was,0,0
44192,the,0,0
44193,clinical,0,0
44194,efficacy,0,0
44195,of,0,0
44196,the,0,0
44197,caudal,0,0
44198,block,0,0
44199,during,0,0
44200,the,0,0
44201,operation,0,0
44202,.,0,0
44203,Secondary,0,0
44204,outcome,0,0
44205,measures,0,0
44206,were,0,0
44207,analgesic,0,1
44208,onset,0,1
44209,time,0,0
44210,",",0,0
44211,pain,0,0
44212,relief,0,0
44213,after,0,0
44214,the,0,0
44215,operation,0,0
44216,and,0,0
44217,residual,0,0
44218,motor,0,1
44219,blockade,0,1
44220,.,0,1
44221,RESULTS,0,0
44222,The,0,0
44223,proportion,0,0
44224,of,0,0
44225,children,0,0
44226,with,0,0
44227,effective,0,0
44228,analgesia,0,1
44229,during,0,0
44230,the,0,0
44231,operation,0,0
44232,was,0,0
44233,similar,0,0
44234,among,0,0
44235,groups,0,0
44236,.,0,0
44237,There,0,0
44238,were,0,0
44239,no,0,0
44240,significant,0,0
44241,differences,0,0
44242,in,0,0
44243,the,0,0
44244,analgesic,0,1
44245,onset,0,1
44246,time,0,0
44247,of,0,0
44248,the,0,0
44249,caudal,0,0
44250,block,0,0
44251,.,0,0
44252,Bupivacaine,0,1
44253,produced,0,0
44254,a,0,0
44255,significant,0,0
44256,incidence,0,0
44257,of,0,0
44258,residual,0,0
44259,motor,0,0
44260,block,0,0
44261,compared,0,0
44262,with,0,0
44263,levobupivacaine,0,1
44264,or,0,1
44265,ropivacaine,0,1
44266,at,0,1
44267,wake-up,0,0
44268,(,0,0
44269,P,0,0
44270,<,0,0
44271,0.01,0,0
44272,),0,0
44273,.,0,0
44274,There,0,0
44275,were,0,0
44276,no,0,0
44277,significant,0,0
44278,differences,0,0
44279,in,0,0
44280,the,0,0
44281,number,0,0
44282,of,0,0
44283,patients,0,0
44284,receiving,0,0
44285,rescue,0,0
44286,analgesia,0,1
44287,after,0,0
44288,surgery,0,0
44289,.,0,0
44290,However,0,0
44291,",",0,0
44292,analgesic,0,1
44293,block,0,0
44294,lasted,0,0
44295,significantly,0,0
44296,longer,0,0
44297,in,0,0
44298,patients,0,0
44299,receiving,0,0
44300,bupivacaine,0,1
44301,(,0,1
44302,P=0.03,0,0
44303,),0,0
44304,.,0,0
44305,CONCLUSION,0,0
44306,During,0,0
44307,sub-umbilical,0,0
44308,surgery,0,0
44309,",",0,1
44310,caudal,0,1
44311,levobupivacaine,0,1
44312,",",0,1
44313,ropivacaine,0,1
44314,and,0,1
44315,bupivacaine,0,1
44316,provided,0,0
44317,comparable,0,0
44318,analgesic,0,1
44319,efficacy,0,1
44320,.,0,1
44321,Bupivacaine,0,1
44322,produced,0,0
44323,a,0,0
44324,higher,0,0
44325,incidence,0,0
44326,of,0,0
44327,residual,0,0
44328,motor,0,1
44329,blockade,0,1
44330,and,0,0
44331,a,0,0
44332,longer,0,0
44333,analgesic,0,1
44334,block,0,1
44335,than,0,1
44336,ropivacaine,0,1
44337,and,0,1
44338,levobupivacaine,0,1
44339,.,0,0
44340,Efficiency,1,0
44341,of,1,0
44342,adjuvant,1,1
44343,immunochemotherapy,1,1
44344,following,0,0
44345,curative,0,0
44346,resection,0,0
44347,in,0,0
44348,patients,0,0
44349,with,0,0
44350,locally,0,0
44351,advanced,0,0
44352,gastric,0,0
44353,cancer,0,0
44354,.,0,0
44355,BACKGROUND,0,0
44356,Despite,0,0
44357,curative,0,0
44358,resection,0,0
44359,",",0,0
44360,50,0,0
44361,%,0,0
44362,-90,0,0
44363,%,0,0
44364,of,0,0
44365,gastric,0,0
44366,cancer,0,0
44367,patients,0,0
44368,die,0,0
44369,of,0,0
44370,disease,0,0
44371,relapse,0,0
44372,.,0,0
44373,Although,0,0
44374,some,0,0
44375,clinical,0,0
44376,trials,0,0
44377,have,0,0
44378,indicated,0,0
44379,that,0,0
44380,chemotherapy,0,0
44381,and,0,0
44382,immunochemotherapy,0,1
44383,may,0,0
44384,be,0,0
44385,effective,0,0
44386,modalities,0,0
44387,",",0,0
44388,more,0,0
44389,recent,0,0
44390,studies,0,0
44391,have,0,0
44392,not,0,0
44393,been,0,0
44394,able,0,0
44395,to,0,0
44396,define,0,0
44397,the,0,0
44398,standard,0,0
44399,treatment,0,0
44400,for,0,0
44401,advanced,0,0
44402,gastric,0,0
44403,cancer,0,0
44404,.,0,0
44405,The,0,0
44406,present,0,0
44407,study,0,0
44408,evaluated,0,0
44409,the,0,0
44410,effect,0,0
44411,of,0,0
44412,adjuvant,1,1
44413,immunochemotherapy,1,1
44414,with,1,0
44415,the,1,0
44416,use,1,0
44417,of,1,0
44418,BCG,1,1
44419,(,1,1
44420,bacille,1,1
44421,Calmette-Guerin,1,1
44422,),1,1
44423,and,1,0
44424,FAM,1,1
44425,(,1,1
44426,5-fluorouracil,1,1
44427,",",1,1
44428,adriamycin,1,1
44429,",",1,1
44430,mitomycin,1,1
44431,C,1,1
44432,),1,1
44433,chemotherapy,1,0
44434,on,0,0
44435,the,0,0
44436,survival,0,0
44437,of,0,0
44438,patients,0,0
44439,with,0,0
44440,locally,0,0
44441,advanced,0,0
44442,resectable,0,0
44443,gastric,0,0
44444,cancer,0,0
44445,.,0,0
44446,METHODS,0,0
44447,A,0,0
44448,total,0,0
44449,of,0,0
44450,156,0,0
44451,patients,0,0
44452,with,0,0
44453,stage,0,0
44454,III,0,0
44455,or,0,0
44456,IV,0,1
44457,gastric,0,1
44458,cancer,0,0
44459,who,0,0
44460,had,0,0
44461,undergone,0,0
44462,curative,0,0
44463,resection,0,0
44464,were,0,0
44465,randomly,1,0
44466,assigned,1,0
44467,to,1,0
44468,three,1,0
44469,treatment,1,0
44470,groups,1,0
44471,:,1,0
44472,BCG,1,1
44473,+,1,1
44474,FAM,1,1
44475,(,1,1
44476,immunochemotherapy,1,1
44477,),1,1
44478,",",1,0
44479,FAM,1,1
44480,(,1,1
44481,chemotherapy,1,1
44482,),1,1
44483,",",1,0
44484,and,1,0
44485,control,1,0
44486,(,1,0
44487,surgery,1,1
44488,only,1,0
44489,),1,0
44490,.,1,0
44491,Treatment,1,0
44492,was,1,0
44493,continued,1,0
44494,for,1,0
44495,2,1,0
44496,years,1,0
44497,or,1,0
44498,until,1,0
44499,death,1,0
44500,.,1,0
44501,Further,1,0
44502,postsurgical,1,0
44503,follow,1,0
44504,up,1,0
44505,was,1,0
44506,carried,1,0
44507,on,1,0
44508,for,1,0
44509,up,1,0
44510,to,1,0
44511,10,1,0
44512,years,1,0
44513,.,1,0
44514,RESULTS,0,0
44515,Overall,0,0
44516,10-year,0,0
44517,survival,0,0
44518,was,0,0
44519,47.1,0,0
44520,%,0,0
44521,for,0,0
44522,the,0,0
44523,immunochemotherapy,0,1
44524,group,0,0
44525,(,0,0
44526,P,0,0
44527,<,0,0
44528,0.037,0,0
44529,vs,0,0
44530,FAM,1,0
44531,and,0,0
44532,P,0,0
44533,<,0,0
44534,0.0006,0,0
44535,vs,0,0
44536,control,0,0
44537,),0,0
44538,",",0,0
44539,30,0,0
44540,%,0,0
44541,for,0,0
44542,the,0,0
44543,chemotherapy,1,1
44544,group,0,0
44545,(,0,0
44546,vs,0,0
44547,control,0,0
44548,",",0,0
44549,NS,0,1
44550,),0,1
44551,",",0,0
44552,and,0,0
44553,15.2,0,0
44554,%,0,0
44555,for,0,0
44556,the,0,0
44557,control,0,0
44558,group,0,0
44559,.,0,0
44560,In,0,0
44561,patients,0,0
44562,with,0,0
44563,pT2/T3,0,0
44564,primary,0,0
44565,tumors,0,0
44566,",",0,0
44567,10-year,0,0
44568,survival,0,0
44569,was,0,0
44570,55.3,0,0
44571,%,0,0
44572,for,0,0
44573,BCG,1,0
44574,+,1,0
44575,FAM,1,0
44576,vs,0,0
44577,28.2,0,0
44578,%,0,0
44579,for,0,0
44580,FAM,0,0
44581,(,0,0
44582,P,0,0
44583,<,0,0
44584,0.01,0,0
44585,),0,0
44586,and,0,0
44587,14.6,0,0
44588,%,0,0
44589,for,0,0
44590,the,0,0
44591,control,0,0
44592,group,0,0
44593,(,0,0
44594,P,0,0
44595,<,0,0
44596,0.00018,0,0
44597,),0,0
44598,.,0,0
44599,BCG,1,1
44600,+,1,0
44601,FAM,1,0
44602,significantly,0,0
44603,improved,0,0
44604,the,0,0
44605,survival,0,0
44606,of,0,0
44607,patients,0,0
44608,with,0,0
44609,intestinal-type,0,0
44610,but,0,0
44611,not,0,0
44612,diffuse-type,0,0
44613,cancer,0,0
44614,.,0,0
44615,Immunochemotherapy,1,0
44616,was,0,0
44617,well,0,0
44618,tolerated,0,1
44619,.,0,0
44620,CONCLUSION,0,1
44621,This,0,0
44622,study,0,0
44623,",",0,0
44624,based,0,0
44625,on,0,0
44626,a,0,0
44627,limited,0,0
44628,number,0,0
44629,of,0,0
44630,patients,0,0
44631,",",0,0
44632,indicates,0,0
44633,that,0,0
44634,adjuvant,0,1
44635,immunochemotherapy,0,1
44636,(,0,1
44637,BCG,0,1
44638,+,0,1
44639,FAM,0,1
44640,),0,1
44641,may,0,0
44642,prolong,0,0
44643,the,0,0
44644,survival,0,0
44645,of,0,0
44646,gastric,0,0
44647,cancer,0,0
44648,patients,0,0
44649,after,0,0
44650,curative,0,0
44651,gastrectomy,0,0
44652,;,0,0
44653,in,0,0
44654,particular,0,0
44655,",",0,0
44656,in,0,0
44657,patients,0,0
44658,with,0,0
44659,pT2/T3,0,0
44660,tumors,0,0
44661,and,0,0
44662,intestinal-type,0,0
44663,primary,0,0
44664,tumors,0,0
44665,.,0,0
44666,There,0,0
44667,was,0,0
44668,no,0,0
44669,survival,0,0
44670,benefit,0,0
44671,from,0,0
44672,FAM,1,1
44673,adjuvant,1,1
44674,chemotherapy,1,1
44675,.,1,0
44676,A,0,1
44677,home,1,1
44678,visiting,1,1
44679,asthma,1,1
44680,education,1,0
44681,program,1,0
44682,:,1,0
44683,challenges,0,0
44684,to,0,0
44685,program,0,0
44686,implementation,0,0
44687,.,0,0
44688,This,0,0
44689,study,0,0
44690,describes,0,0
44691,the,0,0
44692,implementation,0,0
44693,of,0,0
44694,a,0,0
44695,nurse,1,0
44696,home,1,0
44697,visiting,1,1
44698,asthma,1,1
44699,education,1,0
44700,program,1,0
44701,for,0,0
44702,low-income,0,0
44703,African,0,0
44704,American,0,0
44705,families,0,0
44706,of,0,0
44707,young,0,0
44708,children,0,0
44709,with,0,0
44710,asthma,0,0
44711,.,0,0
44712,Of,0,0
44713,55,0,0
44714,families,0,0
44715,",",0,0
44716,71,0,0
44717,%,0,0
44718,completed,0,0
44719,the,0,0
44720,program,0,0
44721,consisting,0,0
44722,of,0,0
44723,eight,0,0
44724,lessons,0,0
44725,.,0,0
44726,The,0,0
44727,achievement,0,0
44728,of,0,0
44729,learning,0,0
44730,objectives,0,0
44731,was,0,0
44732,predicted,0,0
44733,by,0,0
44734,caregiver,0,0
44735,factors,0,0
44736,",",0,0
44737,such,0,0
44738,as,0,0
44739,education,0,0
44740,",",0,0
44741,presence,0,0
44742,of,0,0
44743,father,0,0
44744,or,0,0
44745,surrogate,0,0
44746,father,0,0
44747,in,0,0
44748,the,0,0
44749,household,0,0
44750,",",0,0
44751,and,0,0
44752,safety,0,0
44753,of,0,0
44754,the,0,0
44755,neighborhood,0,0
44756,",",0,0
44757,but,0,0
44758,not,0,0
44759,by,0,0
44760,child,0,0
44761,factors,0,0
44762,",",0,0
44763,such,0,0
44764,as,0,0
44765,age,0,0
44766,or,0,0
44767,severity,0,0
44768,of,0,0
44769,asthma,0,0
44770,as,0,0
44771,implied,0,0
44772,by,0,0
44773,the,0,0
44774,prescribed,0,0
44775,asthma,0,1
44776,medication,0,1
44777,regimen,0,1
44778,.,0,0
44779,Incompatibility,0,0
44780,between,0,0
44781,the,0,0
44782,scheduling,0,0
44783,needs,0,0
44784,of,0,0
44785,the,0,0
44786,families,0,0
44787,and,0,0
44788,the,0,0
44789,nurse,0,0
44790,home,0,0
44791,visitors,0,0
44792,was,0,0
44793,a,0,0
44794,major,0,0
44795,obstacle,0,0
44796,in,0,0
44797,delivering,0,0
44798,the,0,0
44799,program,0,0
44800,on,0,0
44801,time,0,0
44802,",",0,0
44803,despite,0,0
44804,the,0,0
44805,flexibility,0,0
44806,of,0,0
44807,the,0,0
44808,nurse,0,0
44809,home,0,0
44810,visitors,0,0
44811,.,0,0
44812,The,0,0
44813,authors,0,0
44814,suggest,0,0
44815,that,0,0
44816,future,0,0
44817,home-based,1,0
44818,asthma,1,1
44819,education,1,0
44820,programs,1,0
44821,contain,0,0
44822,a,0,0
44823,more,0,0
44824,limited,0,0
44825,number,0,0
44826,of,0,0
44827,home,0,0
44828,visits,0,0
44829,but,0,0
44830,add,0,0
44831,telephone,0,0
44832,follow-ups,0,0
44833,and,0,0
44834,address,0,0
44835,the,0,0
44836,broader,0,0
44837,needs,0,0
44838,of,0,0
44839,low-income,0,0
44840,families,0,0
44841,that,0,0
44842,most,0,0
44843,likely,0,0
44844,function,0,0
44845,as,0,0
44846,barriers,0,0
44847,to,0,0
44848,program,0,0
44849,success,0,0
44850,.,0,0
44851,Primary,1,0
44852,vitrectomy,1,0
44853,for,0,0
44854,combined,0,0
44855,rhegmatogenous,0,0
44856,retinal,0,0
44857,detachment,0,0
44858,and,0,0
44859,choroidal,0,0
44860,detachment,0,0
44861,with,1,0
44862,or,1,0
44863,without,1,0
44864,oral,1,1
44865,corticosteroids,1,1
44866,:,1,1
44867,a,0,0
44868,pilot,0,0
44869,study,0,0
44870,.,0,0
44871,PURPOSE,0,0
44872,The,0,0
44873,occurrence,0,0
44874,of,0,0
44875,choroidal,0,0
44876,detachment,0,0
44877,(,0,1
44878,CD,0,1
44879,),0,1
44880,in,0,0
44881,eyes,0,0
44882,with,0,0
44883,primary,0,0
44884,rhegmatogenous,0,0
44885,retinal,0,0
44886,detachment,0,0
44887,(,0,0
44888,RRD,0,1
44889,),0,0
44890,is,0,0
44891,relatively,0,0
44892,uncommon,0,1
44893,(,0,0
44894,2,0,0
44895,%,0,0
44896,-4.5,0,0
44897,%,0,0
44898,),0,0
44899,.,0,0
44900,Recent,0,0
44901,reports,0,0
44902,suggest,0,0
44903,that,0,0
44904,primary,0,0
44905,vitrectomy,0,0
44906,yields,0,0
44907,better,0,0
44908,anatomic,0,0
44909,success,0,1
44910,than,0,0
44911,scleral,0,0
44912,buckling,0,0
44913,.,0,0
44914,However,0,0
44915,",",0,0
44916,for,0,0
44917,these,0,0
44918,inflamed,0,0
44919,eyes,0,0
44920,with,0,0
44921,low,0,0
44922,intraocular,0,0
44923,pressure,0,0
44924,",",0,0
44925,the,0,0
44926,influence,0,0
44927,of,0,0
44928,preoperative,0,1
44929,oral,0,1
44930,steroids,0,1
44931,on,0,1
44932,reattachment,0,0
44933,rates,0,0
44934,has,0,0
44935,not,0,0
44936,been,0,0
44937,elucidated,0,0
44938,yet,0,0
44939,.,0,0
44940,METHODS,0,0
44941,Twenty,0,0
44942,eyes,0,0
44943,with,0,0
44944,combined,0,0
44945,RRD,0,0
44946,and,0,0
44947,CD,0,0
44948,that,0,0
44949,underwent,1,0
44950,primary,1,0
44951,vitrectomy,1,0
44952,were,0,0
44953,randomized,0,0
44954,to,0,0
44955,receive,1,1
44956,oral,1,1
44957,steroids,1,1
44958,(,1,1
44959,for,1,0
44960,1,1,0
44961,week,1,0
44962,),1,0
44963,or,1,0
44964,no,1,1
44965,oral,1,1
44966,steroids,1,1
44967,before,1,1
44968,surgery,1,0
44969,.,1,0
44970,RESULTS,0,0
44971,Preoperative,0,0
44972,clinical,0,0
44973,data,0,0
44974,such,0,0
44975,as,0,0
44976,mean,0,0
44977,age,0,0
44978,",",0,0
44979,lens,0,0
44980,status,0,0
44981,",",0,0
44982,Snellen,0,0
44983,visual,0,0
44984,acuity,0,0
44985,",",0,0
44986,duration,0,0
44987,of,0,0
44988,macular,0,0
44989,detachment,0,0
44990,",",0,0
44991,CD,0,1
44992,(,0,0
44993,size,0,0
44994,and,0,0
44995,extent,0,0
44996,),0,0
44997,",",0,0
44998,and,0,0
44999,retinal,0,0
45000,detachment,0,0
45001,characteristics,0,0
45002,(,0,0
45003,e.g.,0,0
45004,",",0,0
45005,extent,0,0
45006,",",0,0
45007,number,0,0
45008,of,0,0
45009,retinal,0,0
45010,breaks,0,0
45011,",",0,0
45012,atrophic,0,0
45013,or,0,0
45014,tractional,0,0
45015,retinal,0,0
45016,break,0,0
45017,",",0,0
45018,size,0,0
45019,of,0,0
45020,retinal,0,0
45021,break,0,0
45022,",",0,0
45023,and,0,0
45024,location,0,0
45025,of,0,0
45026,retinal,0,0
45027,break,0,0
45028,),0,0
45029,were,0,0
45030,similarly,0,0
45031,distributed,0,0
45032,in,0,0
45033,both,0,0
45034,groups,0,0
45035,.,0,0
45036,Single-operation,0,0
45037,anatomic,0,0
45038,success,0,0
45039,was,0,0
45040,81.8,0,0
45041,%,0,0
45042,(,0,0
45043,9/11,0,0
45044,),0,0
45045,among,0,0
45046,those,0,0
45047,patients,0,0
45048,who,0,0
45049,received,0,0
45050,preoperative,0,1
45051,oral,0,1
45052,steroids,1,1
45053,and,0,0
45054,was,0,0
45055,66.7,0,0
45056,%,0,0
45057,(,0,0
45058,6/9,0,0
45059,),0,0
45060,among,0,0
45061,those,0,0
45062,who,0,0
45063,did,0,0
45064,not,0,0
45065,receive,0,0
45066,preoperative,0,1
45067,oral,0,1
45068,steroids,1,1
45069,.,1,1
45070,After,0,0
45071,reoperation,0,0
45072,",",0,0
45073,anatomic,0,0
45074,success,0,0
45075,was,0,0
45076,100,0,0
45077,%,0,0
45078,in,0,0
45079,both,0,0
45080,groups,0,0
45081,.,0,0
45082,The,0,0
45083,mean,0,0
45084,follow-up,0,0
45085,was,0,0
45086,20.1,0,0
45087,months,0,0
45088,.,0,0
45089,CONCLUSION,0,0
45090,The,0,0
45091,results,0,0
45092,suggest,0,0
45093,that,0,0
45094,administration,0,1
45095,of,0,1
45096,oral,0,1
45097,steroids,1,1
45098,before,0,1
45099,primary,0,0
45100,vitrectomy,0,0
45101,in,0,0
45102,eyes,0,0
45103,with,0,0
45104,combined,0,0
45105,RRD,0,0
45106,and,0,0
45107,CD,0,0
45108,improves,0,0
45109,reattachment,0,0
45110,rates,0,0
45111,.,0,0
45112,The,0,0
45113,effect,0,0
45114,of,0,0
45115,vitamin,1,1
45116,A-fortified,1,1
45117,coconut,1,1
45118,cooking,1,1
45119,oil,1,1
45120,on,0,0
45121,the,0,1
45122,serum,0,1
45123,retinol,0,1
45124,concentration,0,1
45125,of,0,0
45126,Filipino,0,0
45127,children,0,0
45128,4-7,0,0
45129,years,0,0
45130,old,0,0
45131,.,0,0
45132,A,0,0
45133,6-month,0,0
45134,intervention,0,0
45135,trial,0,0
45136,was,0,0
45137,conducted,0,0
45138,among,0,0
45139,542,0,0
45140,Filipino,0,0
45141,children,0,0
45142,aged,0,0
45143,4,0,0
45144,to,0,0
45145,7,0,0
45146,years,0,0
45147,to,0,0
45148,determine,0,0
45149,the,0,0
45150,effect,0,0
45151,of,0,0
45152,vitamin,1,1
45153,A-fortified,1,1
45154,coconut,1,1
45155,cooking,1,1
45156,oil,1,1
45157,intake,0,1
45158,on,0,1
45159,their,0,0
45160,vitamin,0,1
45161,A,0,1
45162,status,0,1
45163,and,0,0
45164,to,0,0
45165,identify,0,0
45166,factors,0,0
45167,that,0,0
45168,influence,0,0
45169,this,0,0
45170,.,0,0
45171,Children,0,0
45172,were,0,0
45173,randomly,0,0
45174,assigned,0,0
45175,to,0,0
45176,the,0,0
45177,Experimental,0,0
45178,group,0,0
45179,",",0,0
45180,with,0,1
45181,vitamin,1,1
45182,A-fortified,1,1
45183,cooking,1,1
45184,oil,1,1
45185,ration,0,0
45186,;,0,0
45187,to,0,0
45188,Control-1,0,1
45189,group,0,0
45190,with,0,0
45191,unfortified,1,1
45192,cooking,1,1
45193,oil,1,1
45194,ration,1,0
45195,;,1,0
45196,and,0,0
45197,to,0,0
45198,Control-2,0,1
45199,group,0,0
45200,without,1,0
45201,cooking,1,0
45202,oil,1,1
45203,ration,1,0
45204,.,1,0
45205,In,0,0
45206,all,0,0
45207,groups,0,0
45208,",",0,0
45209,children,0,1
45210,'s,0,1
45211,serum,0,1
45212,retinol,0,1
45213,concentration,0,0
45214,improved,0,0
45215,.,0,0
45216,Relative,0,0
45217,change,0,0
45218,in,0,0
45219,serum,0,1
45220,retinol,0,1
45221,concentration,0,0
45222,was,0,0
45223,significantly,0,0
45224,higher,0,0
45225,among,0,0
45226,the,0,0
45227,Experimental,0,0
45228,group,0,0
45229,",",0,0
45230,with,0,0
45231,one-third,0,0
45232,of,0,0
45233,total,0,0
45234,vitamin,0,1
45235,A,0,1
45236,intake,0,1
45237,coming,0,0
45238,from,0,1
45239,vitamin,1,1
45240,A-fortified,1,1
45241,cooking,1,1
45242,oil,1,1
45243,intake,0,1
45244,",",0,1
45245,than,0,0
45246,in,0,0
45247,the,0,0
45248,Control,0,0
45249,groups,0,0
45250,",",0,0
45251,with,0,0
45252,more,0,0
45253,than,0,0
45254,half,0,0
45255,of,0,0
45256,intake,0,1
45257,from,0,0
45258,other,0,0
45259,vitamin,0,1
45260,A-rich,0,0
45261,foods,0,0
45262,.,0,0
45263,Determinants,0,0
45264,of,0,0
45265,post-intervention,0,1
45266,serum,0,1
45267,retinol,0,1
45268,concentration,0,0
45269,included,0,0
45270,baseline,0,1
45271,serum,0,1
45272,retinol,0,1
45273,concentration,0,1
45274,",",0,0
45275,caregiver,0,0
45276,'s,0,0
45277,education,0,0
45278,",",0,0
45279,receipt,0,0
45280,of,0,1
45281,high-dose,0,1
45282,vitamin,0,1
45283,A,0,1
45284,capsule,0,1
45285,",",0,0
45286,interaction,0,0
45287,between,0,0
45288,consumption,0,0
45289,of,0,1
45290,vitamin,0,1
45291,A-fortified,0,1
45292,cooking,0,1
45293,oil,0,1
45294,and,0,0
45295,of,0,0
45296,other,0,0
45297,vitamin,0,1
45298,A-rich,0,0
45299,foods,0,0
45300,",",0,0
45301,and,0,0
45302,between,0,0
45303,households,0,0
45304,purchasing,0,1
45305,cooking,0,1
45306,oil,0,1
45307,and,0,1
45308,food,0,1
45309,expenditure,0,0
45310,.,0,0
45311,Intake,0,0
45312,of,0,0
45313,vitamin,1,1
45314,A-fortified,1,1
45315,cooking,1,1
45316,oil,1,1
45317,combined,0,1
45318,with,0,1
45319,vitamin,0,1
45320,A-rich,0,0
45321,foods,0,0
45322,was,0,0
45323,necessary,0,0
45324,to,0,0
45325,increase,0,0
45326,serum,0,1
45327,retinol,0,1
45328,concentration,0,1
45329,.,0,0
45330,It,0,0
45331,is,0,0
45332,recommended,0,0
45333,to,0,0
45334,vigorously,0,0
45335,promote,0,0
45336,the,0,0
45337,consumption,0,0
45338,of,0,1
45339,vitamin,1,1
45340,A-fortified,1,1
45341,cooking,1,1
45342,oil,1,1
45343,together,0,0
45344,with,0,0
45345,other,0,0
45346,vitamin,0,1
45347,A-rich,0,0
45348,sources,0,0
45349,to,0,0
45350,sustain,0,0
45351,the,0,0
45352,prevention,0,0
45353,and,0,0
45354,control,0,0
45355,of,0,0
45356,vitamin,0,1
45357,A,0,1
45358,deficiency,0,0
45359,.,0,0
45360,Zoledronic,1,1
45361,acid,1,1
45362,significantly,0,0
45363,reduces,0,0
45364,skeletal,0,0
45365,complications,0,0
45366,compared,0,0
45367,with,0,0
45368,placebo,1,1
45369,in,0,0
45370,Japanese,0,1
45371,women,0,0
45372,with,0,0
45373,bone,0,0
45374,metastases,0,0
45375,from,0,0
45376,breast,0,0
45377,cancer,0,0
45378,:,0,0
45379,a,0,0
45380,randomized,0,0
45381,",",0,0
45382,placebo-controlled,0,1
45383,trial,0,1
45384,.,0,0
45385,PURPOSE,0,0
45386,To,0,0
45387,investigate,0,0
45388,the,0,0
45389,efficacy,0,0
45390,and,0,0
45391,safety,0,0
45392,of,0,0
45393,zoledronic,1,1
45394,acid,1,1
45395,for,0,0
45396,the,0,0
45397,treatment,0,0
45398,of,0,0
45399,bone,0,0
45400,metastases,0,0
45401,from,0,0
45402,breast,0,0
45403,cancer,0,0
45404,.,0,0
45405,PATIENTS,0,0
45406,AND,0,1
45407,METHODS,0,1
45408,Women,0,0
45409,with,0,0
45410,bone,0,0
45411,metastases,0,1
45412,(,0,0
45413,N,0,0
45414,=,0,0
45415,228,0,0
45416,),0,0
45417,were,0,0
45418,randomly,0,0
45419,assigned,0,0
45420,to,0,0
45421,receive,0,1
45422,4,1,1
45423,mg,1,1
45424,zoledronic,1,1
45425,acid,1,1
45426,(,0,1
45427,n,0,0
45428,=,0,0
45429,114,0,0
45430,),0,0
45431,or,0,0
45432,placebo,1,1
45433,(,0,0
45434,n,0,0
45435,=,0,0
45436,114,0,0
45437,),0,0
45438,via,0,0
45439,15-minute,0,1
45440,infusions,0,1
45441,every,0,1
45442,4,0,0
45443,weeks,0,0
45444,for,0,0
45445,1,0,0
45446,year,0,0
45447,.,0,0
45448,The,0,0
45449,primary,0,0
45450,efficacy,0,0
45451,end,0,0
45452,point,0,0
45453,was,0,0
45454,the,0,0
45455,skeletal-related,0,0
45456,event,0,0
45457,(,0,1
45458,SRE,0,1
45459,),0,1
45460,rate,0,0
45461,ratio,0,0
45462,between,0,0
45463,treatment,0,0
45464,groups,0,0
45465,.,0,0
45466,An,0,1
45467,SRE,0,1
45468,was,0,0
45469,defined,0,0
45470,as,0,0
45471,pathologic,0,0
45472,fracture,0,0
45473,",",0,0
45474,spinal,0,0
45475,cord,0,0
45476,compression,0,0
45477,",",0,0
45478,and,0,0
45479,radiation,0,0
45480,or,0,0
45481,surgery,0,0
45482,to,0,0
45483,bone,0,0
45484,.,0,0
45485,Secondary,0,0
45486,end,0,0
45487,points,0,0
45488,included,0,0
45489,percentage,0,0
45490,of,0,0
45491,patients,0,0
45492,with,0,0
45493,at,0,0
45494,least,0,0
45495,one,0,0
45496,SRE,0,0
45497,",",0,0
45498,time-to-first,0,0
45499,SRE,0,1
45500,",",0,0
45501,and,0,0
45502,Andersen-Gill,0,0
45503,multiple-event,0,0
45504,analysis,0,0
45505,.,0,0
45506,RESULTS,0,0
45507,The,0,0
45508,SRE,0,0
45509,rate,0,0
45510,ratio,0,0
45511,at,0,0
45512,1,0,0
45513,year,0,0
45514,(,0,0
45515,excluding,0,0
45516,HCM,0,1
45517,and,0,0
45518,adjusted,0,0
45519,for,0,0
45520,prior,0,0
45521,fracture,0,0
45522,),0,0
45523,was,0,0
45524,0.61,0,0
45525,(,0,0
45526,permutation,0,0
45527,test,0,0
45528,;,0,0
45529,P,0,0
45530,=,0,0
45531,.027,0,0
45532,),0,0
45533,",",0,0
45534,indicating,0,0
45535,that,0,0
45536,zoledronic,1,1
45537,acid,1,1
45538,reduced,0,0
45539,the,0,0
45540,rate,0,0
45541,of,0,0
45542,SRE,0,0
45543,by,0,0
45544,39,0,0
45545,%,0,0
45546,compared,0,0
45547,with,0,0
45548,placebo,1,1
45549,.,1,0
45550,The,0,0
45551,percentage,0,0
45552,of,0,0
45553,patients,0,0
45554,with,0,0
45555,at,0,0
45556,least,0,0
45557,one,0,0
45558,SRE,0,1
45559,(,0,0
45560,excluding,0,0
45561,HCM,0,1
45562,),0,0
45563,was,0,0
45564,significantly,0,0
45565,reduced,0,0
45566,by,0,0
45567,20,0,0
45568,%,0,0
45569,by,0,0
45570,zoledronic,0,1
45571,acid,0,1
45572,(,0,0
45573,29.8,0,0
45574,%,0,0
45575,v,0,0
45576,49.6,0,0
45577,%,0,0
45578,for,0,0
45579,placebo,0,0
45580,;,0,0
45581,P,0,0
45582,=,0,0
45583,.003,0,0
45584,),0,0
45585,.,0,0
45586,Zoledronic,1,1
45587,acid,1,1
45588,significantly,0,0
45589,delayed,0,0
45590,time-to-first,0,1
45591,SRE,0,1
45592,(,0,0
45593,median,0,0
45594,not,0,0
45595,reached,0,0
45596,v,0,0
45597,364,0,0
45598,days,0,0
45599,;,0,0
45600,Cox,0,1
45601,regression,0,0
45602,;,0,0
45603,P,0,0
45604,=,0,0
45605,.007,0,0
45606,),0,0
45607,and,0,0
45608,reduced,0,0
45609,the,0,0
45610,risk,0,0
45611,of,0,0
45612,SREs,0,0
45613,by,0,0
45614,41,0,0
45615,%,0,0
45616,in,0,0
45617,multiple,0,0
45618,event,0,0
45619,analysis,0,0
45620,(,0,0
45621,risk,0,0
45622,ratio,0,0
45623,=,0,0
45624,0.59,0,0
45625,;,0,0
45626,P,0,0
45627,=,0,0
45628,.019,0,0
45629,),0,0
45630,compared,0,0
45631,with,0,0
45632,placebo,1,1
45633,.,1,1
45634,Zoledronic,1,1
45635,acid,1,1
45636,was,0,0
45637,well,0,0
45638,tolerated,0,1
45639,with,0,0
45640,a,0,0
45641,safety,0,0
45642,profile,0,0
45643,similar,0,0
45644,to,0,0
45645,placebo,0,1
45646,.,0,1
45647,No,0,1
45648,patient,0,0
45649,treated,0,0
45650,with,0,0
45651,zoledronic,0,1
45652,acid,0,1
45653,had,0,0
45654,grade,0,0
45655,3,0,0
45656,or,0,0
45657,4,0,1
45658,serum,0,1
45659,creatinine,0,1
45660,increase,0,1
45661,.,0,1
45662,CONCLUSION,0,1
45663,Zoledronic,1,1
45664,acid,1,1
45665,significantly,0,0
45666,reduced,0,0
45667,skeletal,0,0
45668,complications,0,0
45669,compared,0,0
45670,with,0,0
45671,placebo,1,1
45672,across,0,0
45673,multiple,0,0
45674,end,0,0
45675,points,0,0
45676,in,0,0
45677,Japanese,0,0
45678,women,0,0
45679,with,0,0
45680,bone,0,0
45681,metastases,0,0
45682,from,0,0
45683,breast,0,0
45684,cancer,0,0
45685,.,0,0
45686,Prospective,0,1
45687,randomised,0,0
45688,trial,0,0
45689,of,0,1
45690,amifostine,1,1
45691,cytoprotection,1,1
45692,in,0,1
45693,myeloma,0,0
45694,patients,0,0
45695,undergoing,0,1
45696,high-dose,1,1
45697,melphalan,1,1
45698,conditioned,0,1
45699,autologous,0,0
45700,stem,0,0
45701,cell,0,0
45702,transplantation,0,0
45703,.,0,0
45704,In,0,0
45705,this,0,0
45706,prospective,0,0
45707,multicentre,0,0
45708,trial,0,0
45709,",",0,0
45710,90,0,0
45711,patients,0,0
45712,undergoing,0,0
45713,autologous,0,0
45714,stem,0,0
45715,cell,0,0
45716,transplantation,0,0
45717,(,0,1
45718,ASCT,0,1
45719,),0,1
45720,were,0,0
45721,randomised,0,0
45722,to,0,0
45723,receive,0,0
45724,(,0,0
45725,n=43,0,0
45726,),0,0
45727,or,0,0
45728,not,0,0
45729,receive,0,0
45730,(,0,0
45731,n=47,0,0
45732,),0,0
45733,amifostine,1,0
45734,910,1,1
45735,mg/m,1,1
45736,(,1,1
45737,2,1,1
45738,),1,0
45739,prior,1,0
45740,to,1,0
45741,melphalan,1,1
45742,200,1,1
45743,mg/m,1,1
45744,(,1,1
45745,2,1,1
45746,),1,0
45747,.,0,0
45748,Patients,0,0
45749,were,0,0
45750,monitored,0,0
45751,for,0,0
45752,regimen-related,0,0
45753,toxicity,0,0
45754,",",0,0
45755,engraftment,0,0
45756,",",0,0
45757,supportive,0,0
45758,care,0,0
45759,",",0,0
45760,response,0,0
45761,and,0,0
45762,survival,0,0
45763,.,0,0
45764,Both,0,0
45765,groups,0,0
45766,underwent,0,0
45767,ASCT,1,0
45768,at,0,0
45769,a,0,0
45770,median,0,0
45771,of,0,0
45772,8,0,0
45773,months,0,0
45774,from,0,0
45775,diagnosis,0,0
45776,and,0,0
45777,were,0,0
45778,matched,0,0
45779,for,0,0
45780,disease,0,0
45781,characteristics,0,0
45782,",",0,0
45783,prior,0,0
45784,therapy,0,0
45785,and,0,0
45786,pre-ASCT,0,0
45787,disease,0,0
45788,responsiveness,0,0
45789,.,0,1
45790,Amifostine,1,1
45791,infusional,0,1
45792,side-effects,0,1
45793,were,0,0
45794,frequent,0,0
45795,",",0,0
45796,occurring,0,0
45797,in,0,0
45798,65,0,0
45799,%,0,0
45800,of,0,0
45801,patients,0,0
45802,",",0,0
45803,but,0,0
45804,of,0,0
45805,mild,0,0
45806,severity,0,0
45807,.,0,0
45808,Amifostine,1,1
45809,use,0,0
45810,was,0,0
45811,associated,0,0
45812,with,0,0
45813,a,0,0
45814,reduction,0,0
45815,in,0,0
45816,the,0,0
45817,median,0,0
45818,grade,0,0
45819,of,0,0
45820,oral,0,1
45821,mucositis,0,1
45822,(,0,0
45823,1,0,0
45824,vs,0,0
45825,2,0,0
45826,",",0,0
45827,P=0.01,0,0
45828,),0,0
45829,and,0,0
45830,the,0,0
45831,frequency,0,0
45832,of,0,0
45833,severe,0,0
45834,(,0,0
45835,WHO,0,1
45836,grades,0,1
45837,3,0,0
45838,or,0,0
45839,4,0,1
45840,),0,1
45841,mucositis,0,1
45842,(,0,0
45843,12,0,0
45844,vs,0,0
45845,33,0,0
45846,%,0,0
45847,",",0,0
45848,P=0.02,0,0
45849,),0,0
45850,",",0,0
45851,but,0,0
45852,no,0,0
45853,reduction,0,0
45854,in,0,0
45855,the,0,0
45856,requirement,0,0
45857,for,0,0
45858,parenteral,0,1
45859,nutrition,0,1
45860,or,0,1
45861,analgesic,0,1
45862,use,0,0
45863,.,0,0
45864,Conversion,0,0
45865,to,0,0
45866,complete,0,0
45867,remission,0,0
45868,post-ASCT,0,0
45869,occurred,0,0
45870,in,0,0
45871,30,0,0
45872,and,0,0
45873,14,0,0
45874,%,0,0
45875,of,0,0
45876,the,0,0
45877,amifostine,1,1
45878,and,0,0
45879,control,0,0
45880,groups,0,0
45881,",",0,0
45882,respectively,0,0
45883,(,0,0
45884,P=0.09,0,0
45885,),0,0
45886,.,0,0
45887,With,0,0
45888,a,0,0
45889,median,0,0
45890,follow-up,0,0
45891,of,0,0
45892,35,0,0
45893,months,0,0
45894,",",0,0
45895,there,0,0
45896,was,0,0
45897,no,0,0
45898,statistically,0,0
45899,significant,0,0
45900,difference,0,0
45901,between,0,0
45902,the,0,0
45903,median,0,0
45904,progression-free,0,0
45905,or,0,0
45906,overall,0,0
45907,survival,0,0
45908,times,0,0
45909,for,0,0
45910,the,0,0
45911,two,0,0
45912,groups,0,0
45913,.,0,0
45914,We,0,0
45915,conclude,0,0
45916,that,0,0
45917,amifostine,1,1
45918,can,0,0
45919,be,0,0
45920,safely,0,1
45921,administered,0,1
45922,prior,0,0
45923,to,0,1
45924,high-dose,0,1
45925,melphalan,0,1
45926,and,0,1
45927,significantly,0,0
45928,reduces,0,0
45929,the,0,0
45930,frequency,0,0
45931,and,0,0
45932,severity,0,0
45933,of,0,0
45934,therapy-induced,0,1
45935,oral,0,1
45936,mucositis,0,1
45937,.,0,0
45938,Simvastatin,1,1
45939,blunts,0,1
45940,endotoxin-induced,0,1
45941,tissue,0,0
45942,factor,0,0
45943,in,0,0
45944,vivo,0,0
45945,.,0,0
45946,BACKGROUND,0,0
45947,Beyond,0,0
45948,lipid,0,0
45949,lowering,0,0
45950,",",0,0
45951,various,0,0
45952,antiinflammatory,0,1
45953,properties,0,0
45954,have,0,0
45955,been,0,0
45956,ascribed,0,0
45957,to,0,0
45958,statins,0,1
45959,.,0,0
45960,Moreover,0,0
45961,",",0,0
45962,in,0,0
45963,vitro,0,0
45964,studies,0,0
45965,have,0,0
45966,suggested,0,0
45967,the,0,0
45968,presence,0,0
45969,of,0,0
45970,anticoagulant,0,1
45971,effects,0,0
45972,of,0,1
45973,3-hydroxy-3-methylglutaryl,0,1
45974,coenzyme,0,1
45975,A,0,1
45976,reductase,0,1
45977,inhibitors,0,1
45978,",",0,1
45979,as,0,1
45980,lipopolysaccharide,0,1
45981,(,0,1
45982,LPS,0,1
45983,),0,1
45984,-induced,0,1
45985,monocyte,0,1
45986,tissue,0,1
45987,factor,0,0
45988,(,0,0
45989,TF,0,1
45990,),0,0
45991,was,0,0
45992,suppressed,0,0
45993,.,0,0
45994,In,0,0
45995,this,0,0
45996,study,0,0
45997,",",0,0
45998,we,0,0
45999,examined,0,0
46000,the,0,0
46001,role,0,0
46002,of,0,0
46003,statins,1,1
46004,in,0,0
46005,experimental,0,0
46006,endotoxemia,0,1
46007,on,0,0
46008,inflammatory,0,1
46009,and,0,0
46010,procoagulant,0,1
46011,responses,0,0
46012,in,0,0
46013,vivo,0,0
46014,.,0,0
46015,METHODS,0,0
46016,AND,0,1
46017,RESULTS,0,1
46018,In,0,0
46019,this,0,0
46020,double-blind,0,1
46021,",",0,1
46022,placebo-controlled,1,1
46023,",",0,1
46024,parallel-group,0,1
46025,study,0,0
46026,",",0,0
46027,20,0,0
46028,healthy,0,0
46029,",",0,0
46030,male,0,0
46031,subjects,0,0
46032,were,0,0
46033,randomized,0,0
46034,to,0,0
46035,receive,0,0
46036,either,0,0
46037,simvastatin,1,1
46038,(,0,1
46039,80,0,1
46040,mg/d,0,1
46041,),0,1
46042,or,1,1
46043,placebo,1,1
46044,for,0,1
46045,4,0,1
46046,days,0,0
46047,before,0,1
46048,intravenous,0,1
46049,administration,0,1
46050,of,0,1
46051,LPS,0,1
46052,(,0,1
46053,20,0,1
46054,IU/kg,0,1
46055,IV,0,1
46056,),0,1
46057,.,0,0
46058,Plasma,0,1
46059,high-sensitive,0,0
46060,C-reactive,0,0
46061,protein,0,0
46062,(,0,0
46063,hsCRP,0,1
46064,),0,1
46065,",",0,1
46066,monocyte,0,1
46067,chemoattractant,0,1
46068,protein,0,1
46069,(,0,1
46070,MCP-1,0,1
46071,),0,1
46072,",",0,0
46073,sCD40L,0,1
46074,",",0,0
46075,sCD40,0,0
46076,",",0,0
46077,and,0,0
46078,prothrombin,0,1
46079,fragment,0,1
46080,F1+2,0,1
46081,(,0,0
46082,F1.2,0,0
46083,),0,0
46084,were,0,0
46085,determined,0,0
46086,by,0,0
46087,ELISAs,0,0
46088,at,0,0
46089,baseline,0,0
46090,and,0,0
46091,at,0,0
46092,4,0,0
46093,and,0,0
46094,8,0,0
46095,hours,0,0
46096,after,0,0
46097,LPS,0,1
46098,administration,0,1
46099,.,0,1
46100,Monocyte,0,0
46101,TF,0,0
46102,expression,0,0
46103,and,0,0
46104,monocyte-platelet,0,1
46105,aggregates,0,0
46106,were,0,0
46107,measured,0,0
46108,by,0,0
46109,whole-blood,0,1
46110,flow,0,0
46111,cytometry,0,0
46112,over,0,0
46113,the,0,0
46114,same,0,0
46115,time,0,0
46116,course,0,0
46117,.,0,0
46118,The,0,0
46119,increases,0,0
46120,in,0,0
46121,hsCRP,0,0
46122,and,0,0
46123,MCP-1,0,0
46124,",",0,0
46125,both,0,0
46126,known,0,0
46127,inducers,0,0
46128,of,0,0
46129,TF,0,0
46130,",",0,0
46131,were,0,0
46132,significantly,0,0
46133,suppressed,0,0
46134,by,0,0
46135,statin,0,1
46136,treatment,0,1
46137,after,0,0
46138,LPS,0,0
46139,challenge,0,0
46140,.,0,0
46141,Statin,1,1
46142,premedication,0,1
46143,blunted,0,0
46144,the,0,0
46145,increase,0,0
46146,of,0,0
46147,monocyte,0,1
46148,TF,0,1
46149,expression,0,0
46150,in,0,0
46151,response,0,0
46152,to,0,0
46153,LPS,0,0
46154,.,0,0
46155,In,0,0
46156,parallel,0,0
46157,",",0,0
46158,endotoxin-induced,0,1
46159,formation,0,0
46160,of,0,0
46161,F1.2,0,0
46162,was,0,0
46163,significantly,0,0
46164,reduced,0,0
46165,by,0,0
46166,simvastatin,1,1
46167,after,0,0
46168,4,0,0
46169,and,0,0
46170,8,0,0
46171,hours,0,0
46172,.,0,1
46173,LPS,0,1
46174,infusion,0,1
46175,affected,0,0
46176,neither,0,0
46177,the,0,0
46178,formation,0,0
46179,and,0,0
46180,activation,0,0
46181,of,0,0
46182,monocyte-platelet,0,1
46183,aggregates,0,0
46184,nor,0,0
46185,plasma,0,0
46186,levels,0,0
46187,of,0,0
46188,sCD40,0,0
46189,and,0,0
46190,sCD40L,0,0
46191,.,0,1
46192,CONCLUSIONS,0,1
46193,Simvastatin,1,1
46194,suppresses,0,0
46195,the,0,0
46196,inflammatory,0,0
46197,response,0,0
46198,to,0,0
46199,endotoxin,0,1
46200,and,0,1
46201,blunts,0,1
46202,monocyte,0,1
46203,TF,0,1
46204,expression,0,0
46205,but,0,0
46206,does,0,0
46207,not,0,0
46208,affect,0,0
46209,platelet,0,1
46210,activation,0,0
46211,.,0,0
46212,Use,0,0
46213,of,0,0
46214,an,0,0
46215,inspiratory,1,0
46216,impedance,1,1
46217,threshold,1,1
46218,device,1,0
46219,on,1,0
46220,a,1,0
46221,facemask,1,0
46222,and,1,0
46223,endotracheal,1,0
46224,tube,1,0
46225,to,0,0
46226,reduce,0,0
46227,intrathoracic,0,0
46228,pressures,0,0
46229,during,0,0
46230,the,0,0
46231,decompression,0,0
46232,phase,0,0
46233,of,0,0
46234,active,0,0
46235,compression-decompression,0,0
46236,cardiopulmonary,0,0
46237,resuscitation,0,0
46238,.,0,0
46239,INTRODUCTION,0,0
46240,Use,0,0
46241,of,0,0
46242,an,0,0
46243,inspiratory,1,0
46244,impedance,1,1
46245,threshold,1,1
46246,device,1,1
46247,(,1,1
46248,ITD,1,1
46249,),1,0
46250,significantly,0,0
46251,increases,0,0
46252,coronary,0,0
46253,perfusion,0,0
46254,pressures,0,0
46255,and,0,0
46256,survival,0,0
46257,in,0,0
46258,patients,0,0
46259,ventilated,0,0
46260,with,0,0
46261,an,0,0
46262,endotracheal,1,0
46263,tube,1,1
46264,(,1,1
46265,ETT,1,1
46266,),1,0
46267,during,0,0
46268,active,1,0
46269,compression-decompression,1,0
46270,cardiopulmonary,1,0
46271,resuscitation,1,0
46272,.,1,0
46273,We,0,0
46274,tested,0,0
46275,the,0,0
46276,hypothesis,0,0
46277,that,0,0
46278,the,0,0
46279,ITD,1,0
46280,could,0,0
46281,lower,0,0
46282,intratracheal,0,1
46283,pressures,0,1
46284,when,0,0
46285,attached,0,0
46286,to,0,0
46287,either,0,0
46288,a,0,0
46289,facemask,1,0
46290,or,1,0
46291,ETT,1,0
46292,.,1,1
46293,METHODS,0,1
46294,An,1,1
46295,active,1,1
46296,and,1,1
46297,sham,1,0
46298,ITD,1,1
46299,were,0,0
46300,randomly,0,0
46301,applied,0,0
46302,first,0,0
46303,to,0,0
46304,a,0,0
46305,facemask,1,0
46306,and,0,0
46307,then,0,0
46308,to,0,0
46309,an,0,0
46310,ETT,1,0
46311,during,0,0
46312,active,1,0
46313,compression-decompression,1,0
46314,cardiopulmonary,1,0
46315,resuscitation,1,0
46316,in,0,0
46317,13,0,0
46318,out-of-hospital,0,0
46319,cardiac,0,0
46320,arrest,0,0
46321,patients,0,0
46322,in,0,0
46323,a,0,0
46324,randomized,0,0
46325,",",0,0
46326,double-blinded,0,1
46327,",",0,1
46328,prospective,0,1
46329,clinical,0,0
46330,trial,0,0
46331,.,0,0
46332,The,0,0
46333,compression-to-bag-valve,0,0
46334,ventilation,0,0
46335,ratio,0,0
46336,was,0,0
46337,15:2,0,0
46338,.,0,0
46339,Airway,0,0
46340,pressures,0,0
46341,(,0,0
46342,surrogate,0,0
46343,for,0,0
46344,intrathoracic,0,0
46345,pressure,0,0
46346,),0,0
46347,were,0,0
46348,measured,0,0
46349,with,0,0
46350,a,0,0
46351,pressure,0,0
46352,transducer,0,0
46353,.,0,0
46354,A,1,1
46355,sham,1,0
46356,and,1,0
46357,an,1,0
46358,active,1,0
46359,ITD,1,0
46360,were,0,0
46361,used,0,0
46362,for,0,0
46363,1,0,0
46364,min,0,0
46365,each,0,0
46366,in,0,0
46367,a,0,0
46368,randomized,0,0
46369,order,0,0
46370,",",0,0
46371,first,0,0
46372,on,0,0
46373,a,0,0
46374,facemask,1,0
46375,and,0,0
46376,then,0,0
46377,on,0,0
46378,an,0,0
46379,ETT,1,0
46380,.,1,0
46381,Statistical,0,0
46382,analyses,0,0
46383,were,0,0
46384,made,0,0
46385,using,0,0
46386,Friedman,0,0
46387,'s,0,0
46388,and,0,0
46389,Wilcoxon,0,0
46390,'s,0,0
46391,rank-sum,0,0
46392,tests,0,0
46393,.,0,0
46394,RESULTS,0,0
46395,For,0,0
46396,the,0,0
46397,primary,0,0
46398,end,0,0
46399,point,0,0
46400,",",0,0
46401,mean,0,0
46402,+/-,0,0
46403,sd,0,0
46404,maximum,0,0
46405,negative,0,0
46406,intrathoracic,0,0
46407,pressures,0,1
46408,(,0,0
46409,mm,0,0
46410,Hg,0,1
46411,),0,0
46412,during,0,0
46413,the,0,0
46414,decompression,0,0
46415,phase,0,0
46416,of,0,0
46417,cardiopulmonary,0,0
46418,resuscitation,0,0
46419,were,0,0
46420,-1.0,0,0
46421,+/-,0,0
46422,0.73,0,0
46423,mm,0,0
46424,Hg,0,0
46425,with,0,0
46426,a,0,0
46427,sham,1,0
46428,vs.,0,0
46429,-4.6,0,0
46430,+/-,0,0
46431,3.7,0,0
46432,mm,0,0
46433,Hg,0,0
46434,with,0,0
46435,an,0,0
46436,active,1,0
46437,ITD,1,0
46438,on,0,0
46439,the,0,0
46440,facemask,0,0
46441,(,0,0
46442,p,0,0
46443,=,0,0
46444,.003,0,0
46445,),0,0
46446,and,0,0
46447,-1.3,0,0
46448,+/-,0,0
46449,1.3,0,0
46450,mm,0,0
46451,Hg,0,0
46452,with,0,0
46453,a,0,0
46454,sham,0,0
46455,ITD,0,0
46456,vs.,0,0
46457,-7.3,0,0
46458,+/-,0,0
46459,4.5,0,0
46460,mm,0,0
46461,Hg,0,0
46462,with,0,0
46463,an,0,0
46464,active,0,0
46465,ITD,0,0
46466,on,0,0
46467,an,0,0
46468,ETT,0,0
46469,(,0,0
46470,p,0,0
46471,=,0,0
46472,.0009,0,0
46473,),0,0
46474,.,0,0
46475,Decompression,0,0
46476,phase,0,0
46477,airway,0,0
46478,pressures,0,0
46479,with,0,0
46480,the,0,0
46481,facemask,1,0
46482,and,1,0
46483,ETT,1,0
46484,were,0,0
46485,not,0,0
46486,statistically,0,0
46487,different,0,0
46488,.,0,0
46489,CONCLUSIONS,0,0
46490,Use,0,0
46491,of,0,0
46492,an,0,0
46493,active,1,0
46494,ITD,1,0
46495,attached,1,0
46496,to,1,0
46497,a,1,0
46498,facemask,1,0
46499,or,1,0
46500,an,1,0
46501,ETT,1,0
46502,resulted,0,0
46503,in,0,0
46504,a,0,0
46505,significantly,0,0
46506,lower,0,0
46507,negative,0,0
46508,intratracheal,0,1
46509,pressure,0,1
46510,during,0,0
46511,the,0,0
46512,decompression,0,0
46513,phase,0,0
46514,of,0,0
46515,active,0,0
46516,compression-decompression,0,0
46517,cardiopulmonary,0,0
46518,resuscitation,0,0
46519,when,0,0
46520,compared,0,0
46521,with,0,0
46522,controls,0,0
46523,.,0,0
46524,Airway,0,0
46525,pressures,0,0
46526,with,0,0
46527,an,0,0
46528,ITD,1,0
46529,on,0,0
46530,either,0,0
46531,a,1,0
46532,facemask,1,0
46533,or,0,0
46534,ETT,1,0
46535,were,0,0
46536,similar,0,0
46537,.,0,0
46538,The,0,0
46539,ITD-facemask,1,0
46540,combination,1,0
46541,was,0,0
46542,practical,0,0
46543,and,0,0
46544,enables,0,0
46545,rapid,0,0
46546,deployment,0,0
46547,of,0,0
46548,this,0,0
46549,life-saving,0,0
46550,technology,0,0
46551,.,0,0
46552,Cost-effectiveness,0,0
46553,of,0,0
46554,combined,1,0
46555,manipulation,1,0
46556,",",1,0
46557,stabilizing,1,0
46558,exercises,1,0
46559,",",1,0
46560,and,1,0
46561,physician,1,0
46562,consultation,1,0
46563,compared,0,0
46564,to,0,0
46565,physician,1,0
46566,consultation,1,0
46567,alone,1,0
46568,for,0,0
46569,chronic,0,0
46570,low,0,0
46571,back,0,0
46572,pain,0,0
46573,:,0,0
46574,a,0,0
46575,prospective,0,0
46576,randomized,0,0
46577,trial,0,0
46578,with,0,0
46579,2-year,0,0
46580,follow-up,0,0
46581,.,0,0
46582,STUDY,0,0
46583,DESIGN,0,1
46584,A,0,1
46585,prospective,0,1
46586,",",0,0
46587,randomized,0,0
46588,controlled,0,0
46589,trial,0,0
46590,.,0,0
46591,OBJECTIVE,0,0
46592,To,0,0
46593,examine,0,0
46594,long-term,0,0
46595,effects,0,0
46596,and,0,0
46597,costs,0,0
46598,of,0,0
46599,combined,1,0
46600,manipulative,1,0
46601,treatment,1,0
46602,",",1,0
46603,stabilizing,1,0
46604,exercises,1,0
46605,",",1,0
46606,and,1,0
46607,physician,1,0
46608,consultation,1,0
46609,compared,1,0
46610,with,1,0
46611,physician,1,0
46612,consultation,1,0
46613,alone,1,0
46614,for,0,0
46615,chronic,0,0
46616,low,0,0
46617,back,0,1
46618,pain,0,1
46619,(,0,1
46620,cLBP,0,1
46621,),0,1
46622,.,0,0
46623,SUMMARY,0,0
46624,OF,0,1
46625,BACKGROUND,0,1
46626,DATA,0,1
46627,An,0,1
46628,obvious,0,0
46629,gap,0,0
46630,exists,0,0
46631,in,0,0
46632,knowledge,0,0
46633,concerning,0,0
46634,long-term,0,0
46635,efficacy,0,0
46636,and,0,0
46637,cost-effectiveness,0,0
46638,of,0,0
46639,manipulative,0,0
46640,treatment,0,0
46641,methods,0,0
46642,.,0,0
46643,METHODS,0,0
46644,Of,0,0
46645,204,0,0
46646,patients,0,0
46647,with,0,0
46648,cLBP,0,0
46649,whose,0,0
46650,Oswestry,0,0
46651,Disability,0,1
46652,Index,0,1
46653,(,0,1
46654,ODI,0,1
46655,),0,0
46656,was,0,0
46657,at,0,0
46658,least,0,0
46659,16,0,0
46660,%,0,0
46661,",",0,0
46662,102,0,0
46663,were,0,0
46664,randomized,0,0
46665,into,0,0
46666,a,0,0
46667,combined,1,0
46668,manipulative,1,0
46669,treatment,1,0
46670,",",1,0
46671,exercise,1,0
46672,",",1,0
46673,and,1,0
46674,physician,1,0
46675,consultation,1,1
46676,group,1,0
46677,(,0,0
46678,i.e.,0,0
46679,",",0,0
46680,a,0,0
46681,combination,0,0
46682,group,0,0
46683,),0,0
46684,",",0,0
46685,and,0,0
46686,102,0,0
46687,to,0,0
46688,a,0,0
46689,consultation,1,0
46690,alone,1,0
46691,group,0,0
46692,.,0,0
46693,All,0,0
46694,patients,0,0
46695,were,0,0
46696,clinically,0,0
46697,examined,0,0
46698,",",0,0
46699,informed,0,0
46700,about,0,0
46701,their,0,0
46702,back,0,0
46703,pain,0,0
46704,",",0,0
46705,and,0,0
46706,encouraged,0,0
46707,to,0,0
46708,stay,0,0
46709,active,0,0
46710,and,0,0
46711,exercise,0,0
46712,according,0,0
46713,to,0,0
46714,specific,0,0
46715,instructions,0,0
46716,based,0,0
46717,on,0,0
46718,clinical,0,0
46719,evaluation,0,0
46720,.,0,0
46721,Treatment,0,0
46722,included,0,0
46723,4,0,0
46724,sessions,0,0
46725,of,0,0
46726,manual,1,0
46727,therapy,1,0
46728,and,1,0
46729,stabilizing,1,0
46730,exercises,1,0
46731,aimed,0,0
46732,at,0,0
46733,correcting,0,0
46734,the,0,0
46735,lumbopelvic,0,0
46736,rhythm,0,0
46737,.,0,0
46738,Questionnaires,0,0
46739,inquired,0,0
46740,about,0,0
46741,pain,0,1
46742,(,0,1
46743,visual,0,1
46744,analog,0,1
46745,scale,0,1
46746,(,0,1
46747,VAS,0,1
46748,),0,1
46749,),0,0
46750,",",0,1
46751,disability,0,1
46752,(,0,1
46753,ODI,0,1
46754,),0,1
46755,",",0,0
46756,health-related,0,0
46757,quality,0,0
46758,of,0,0
46759,life,0,0
46760,(,0,0
46761,15D,0,0
46762,Quality,0,0
46763,of,0,0
46764,Life,0,1
46765,Instrument,0,1
46766,),0,1
46767,",",0,0
46768,satisfaction,0,0
46769,with,0,0
46770,care,0,0
46771,",",0,0
46772,and,0,0
46773,costs,0,0
46774,.,0,0
46775,RESULTS,0,0
46776,Significant,0,0
46777,improvement,0,0
46778,occurred,0,0
46779,in,0,0
46780,both,0,0
46781,groups,0,0
46782,on,0,0
46783,every,0,0
46784,self-rated,0,0
46785,outcome,0,0
46786,measurement,0,0
46787,.,0,0
46788,Within,0,0
46789,2,0,0
46790,years,0,0
46791,",",0,0
46792,the,0,0
46793,combination,0,0
46794,group,0,0
46795,showed,0,0
46796,only,0,0
46797,a,0,0
46798,slightly,0,0
46799,more,0,0
46800,significant,0,0
46801,reduction,0,0
46802,in,0,0
46803,VAS,0,0
46804,(,0,0
46805,P,0,0
46806,=,0,0
46807,0.01,0,0
46808,",",0,0
46809,analysis,0,0
46810,of,0,0
46811,variance,0,0
46812,),0,0
46813,but,0,0
46814,clearly,0,0
46815,higher,0,0
46816,patient,0,0
46817,satisfaction,0,0
46818,(,0,0
46819,P,0,0
46820,=,0,0
46821,0.001,0,0
46822,",",0,0
46823,Pearson,0,0
46824,chi2,0,0
46825,),0,0
46826,as,0,0
46827,compared,0,0
46828,to,0,0
46829,the,0,0
46830,consultation,0,0
46831,group,0,0
46832,.,0,0
46833,Incremental,0,0
46834,analysis,0,0
46835,showed,0,0
46836,that,0,0
46837,for,0,0
46838,combined,0,0
46839,group,0,0
46840,compared,0,0
46841,to,0,0
46842,consultation,0,0
46843,group,0,0
46844,",",0,0
46845,a,0,0
46846,one-point,0,0
46847,change,0,0
46848,in,0,0
46849,VAS,0,0
46850,scale,0,0
46851,cost,0,0
46852,$,0,0
46853,512,0,0
46854,.,0,0
46855,CONCLUSIONS,0,0
46856,Physician,1,0
46857,consultation,1,0
46858,alone,1,0
46859,was,0,0
46860,more,0,0
46861,cost-effective,0,0
46862,for,0,0
46863,both,0,0
46864,health,0,0
46865,care,0,0
46866,use,0,0
46867,and,0,0
46868,work,0,0
46869,absenteeism,0,0
46870,",",0,0
46871,and,0,0
46872,led,0,0
46873,to,0,0
46874,equal,0,0
46875,improvement,0,0
46876,in,0,0
46877,disability,0,0
46878,and,0,0
46879,health-related,0,0
46880,quality,0,0
46881,of,0,0
46882,life,0,0
46883,.,0,0
46884,It,0,0
46885,seems,0,0
46886,obvious,0,0
46887,that,0,0
46888,encouraging,0,0
46889,information,0,0
46890,and,0,0
46891,advice,0,0
46892,are,0,0
46893,major,0,0
46894,elements,0,0
46895,for,0,0
46896,the,0,0
46897,treatment,0,0
46898,of,0,0
46899,patients,0,0
46900,with,0,0
46901,cLBP,0,0
46902,.,0,0
46903,[,0,0
46904,Final,0,0
46905,evaluation,0,0
46906,of,0,0
46907,the,0,0
46908,randomized,0,0
46909,multicenter,0,0
46910,study,0,0
46911,SAKK,0,0
46912,40/81,0,0
46913,:,0,0
46914,adjuvant,1,1
46915,portal,1,1
46916,chemotherapy,1,1
46917,of,0,0
46918,curatively,0,0
46919,resected,0,0
46920,colorectal,0,1
46921,cancer,0,1
46922,],0,0
46923,.,0,0
46924,Between,0,0
46925,1981,0,0
46926,and,0,0
46927,1987,0,0
46928,",",0,0
46929,533,0,0
46930,patients,0,0
46931,from,0,0
46932,9,0,0
46933,institutions,0,0
46934,have,0,0
46935,been,0,0
46936,entered,0,0
46937,in,0,0
46938,a,0,0
46939,randomized,0,0
46940,trial,0,0
46941,to,0,0
46942,assess,0,0
46943,the,0,0
46944,value,0,0
46945,of,0,0
46946,adjuvant,1,1
46947,portal,1,1
46948,infusion,1,1
46949,(,1,1
46950,5-Fluorouracil,1,1
46951,",",1,1
46952,Mitomycin,1,1
46953,C,1,1
46954,),1,0
46955,compared,1,0
46956,to,1,0
46957,radical,1,0
46958,surgery,1,0
46959,alone,1,0
46960,.,1,0
46961,Analysis,0,0
46962,of,0,0
46963,469,0,0
46964,evaluable,0,0
46965,patients,0,0
46966,at,0,0
46967,a,0,0
46968,median,0,0
46969,follow-up,0,0
46970,of,0,0
46971,5.8,0,0
46972,years,0,0
46973,revealed,0,0
46974,110,0,0
46975,recurrences,0,0
46976,in,0,0
46977,the,0,0
46978,control,0,0
46979,and,0,0
46980,94,0,0
46981,recurrences,0,0
46982,in,0,0
46983,the,0,0
46984,infusion,0,1
46985,group,0,0
46986,.,0,0
46987,Estimated,0,0
46988,5-year,0,0
46989,disease-free,0,0
46990,survival,0,0
46991,was,0,0
46992,52,0,0
46993,%,0,0
46994,and,0,0
46995,61,0,0
46996,%,0,0
46997,respectively,0,0
46998,(,0,0
46999,hazard,0,0
47000,ratio,0,0
47001,1:0.75,0,0
47002,;,0,0
47003,95,0,0
47004,%,0,0
47005,confidence,0,0
47006,interval,0,0
47007,0.57-0.99,0,0
47008,;,0,0
47009,p,0,0
47010,=,0,0
47011,0.046,0,0
47012,),0,0
47013,.,0,0
47014,Overall,0,0
47015,survival,0,0
47016,was,0,0
47017,59,0,0
47018,%,0,0
47019,in,0,0
47020,the,0,0
47021,control,0,0
47022,and,0,0
47023,69,0,0
47024,in,0,0
47025,the,0,0
47026,infusion,0,1
47027,group,0,0
47028,(,0,0
47029,p,0,0
47030,=,0,0
47031,0.048,0,0
47032,),0,0
47033,.,0,0
47034,Adjuvant,0,1
47035,portal,0,1
47036,infusion,0,1
47037,did,0,0
47038,not,0,0
47039,influence,0,0
47040,the,0,0
47041,occurrence,0,0
47042,of,0,0
47043,liver,0,0
47044,metastases,0,0
47045,but,0,0
47046,reduced,0,0
47047,the,0,0
47048,overall,0,0
47049,recurrence,0,0
47050,rate,0,0
47051,.,0,0
47052,Efficacy,0,0
47053,of,0,0
47054,rofecoxib,1,1
47055,",",1,1
47056,celecoxib,1,1
47057,",",0,1
47058,and,0,1
47059,acetaminophen,1,1
47060,in,0,0
47061,patients,0,0
47062,with,0,0
47063,osteoarthritis,0,0
47064,of,0,0
47065,the,0,0
47066,knee,0,0
47067,.,0,0
47068,A,0,0
47069,combined,0,0
47070,analysis,0,0
47071,of,0,0
47072,the,0,0
47073,VACT,0,0
47074,studies,0,0
47075,.,0,0
47076,OBJECTIVE,0,0
47077,To,0,0
47078,compare,0,0
47079,efficacy,0,0
47080,among,0,0
47081,1578,0,0
47082,patients,0,0
47083,with,0,0
47084,osteoarthritis,0,0
47085,randomized,0,0
47086,to,0,0
47087,take,0,1
47088,acetaminophen,1,1
47089,4000,0,1
47090,mg,0,1
47091,(,0,0
47092,n=269,0,0
47093,),0,0
47094,",",0,0
47095,celecoxib,1,1
47096,200,0,1
47097,mg,0,1
47098,(,0,0
47099,n=523,0,0
47100,),0,0
47101,",",0,0
47102,rofecoxib,1,1
47103,12.5,0,1
47104,mg,0,1
47105,(,0,0
47106,n=259,0,0
47107,),0,0
47108,",",0,0
47109,or,0,1
47110,rofecoxib,1,1
47111,25,0,1
47112,mg,0,1
47113,(,0,0
47114,n=527,0,0
47115,),0,0
47116,in,0,0
47117,a,0,0
47118,double,0,0
47119,blind,0,0
47120,trial,0,1
47121,[,1,0
47122,Vioxx,1,1
47123,",",1,1
47124,Acetaminophen,1,1
47125,",",1,1
47126,Celecoxib,1,1
47127,Trial,0,1
47128,(,0,1
47129,VACT2,0,1
47130,),0,1
47131,],0,0
47132,.,0,0
47133,Results,0,0
47134,were,0,0
47135,also,0,0
47136,pooled,0,0
47137,with,0,0
47138,the,0,0
47139,similarly,0,0
47140,designed,0,0
47141,VACT1,0,0
47142,trial,0,0
47143,.,0,0
47144,METHODS,0,0
47145,Patients,0,0
47146,evaluated,0,0
47147,over,0,0
47148,Days,0,0
47149,1,0,0
47150,to,0,0
47151,6,0,0
47152,and,0,0
47153,6,0,0
47154,weeks,0,0
47155,with,0,0
47156,Patient,0,0
47157,Global,0,0
47158,Assessment,0,0
47159,of,0,0
47160,Response,0,0
47161,to,0,0
47162,Therapy,0,0
47163,(,0,1
47164,PGART,0,1
47165,),0,1
47166,and,0,0
47167,Western,0,0
47168,Ontario,0,0
47169,and,0,0
47170,McMaster,0,1
47171,Universities,0,1
47172,(,0,1
47173,WOMAC,0,1
47174,),0,1
47175,Osteoarthritis,0,0
47176,Index,0,1
47177,.,0,0
47178,RESULTS,0,0
47179,For,0,0
47180,VACT2,0,0
47181,",",0,0
47182,median,0,0
47183,time,0,0
47184,to,0,0
47185,good,0,0
47186,or,0,0
47187,excellent,0,0
47188,PGART,0,0
47189,response,0,0
47190,was,0,0
47191,6,0,0
47192,",",0,0
47193,5,0,0
47194,",",0,0
47195,4,0,0
47196,",",0,0
47197,and,0,0
47198,3,0,0
47199,days,0,0
47200,for,0,1
47201,acetaminophen,1,1
47202,",",1,1
47203,celecoxib,1,1
47204,",",1,1
47205,rofecoxib,1,1
47206,12.5,0,1
47207,mg,0,1
47208,",",0,0
47209,and,0,1
47210,rofecoxib,1,1
47211,25,0,1
47212,mg,0,1
47213,(,0,1
47214,COX-2,0,1
47215,inhibitors,0,1
47216,vs,0,0
47217,acetaminophen,1,0
47218,",",0,0
47219,p,0,0
47220,<,0,0
47221,or=0.035,0,0
47222,;,0,0
47223,rofecoxib,1,1
47224,25,0,1
47225,mg,0,1
47226,vs,0,1
47227,celecoxib,1,1
47228,",",0,0
47229,p=0.01,0,0
47230,),0,0
47231,.,0,0
47232,WOMAC,0,0
47233,response,0,0
47234,over,0,0
47235,the,0,0
47236,first,0,0
47237,6,0,0
47238,days,0,0
47239,was,0,0
47240,greater,0,0
47241,(,0,0
47242,p,0,0
47243,<,0,0
47244,0.05,0,0
47245,),0,0
47246,with,0,0
47247,both,0,0
47248,rofecoxib,1,1
47249,doses,0,1
47250,than,0,1
47251,acetaminophen,0,1
47252,and,0,1
47253,celecoxib,0,1
47254,.,0,1
47255,At,0,1
47256,Week,0,0
47257,6,0,0
47258,",",0,0
47259,all,0,0
47260,COX-2,0,1
47261,inhibitors,0,1
47262,provided,0,0
47263,significantly,0,0
47264,greater,0,0
47265,efficacy,0,0
47266,than,0,0
47267,acetaminophen,0,1
47268,.,0,1
47269,Good,0,0
47270,or,0,0
47271,excellent,0,0
47272,PGART,0,0
47273,was,0,0
47274,numerically,0,0
47275,",",0,0
47276,but,0,0
47277,not,0,0
47278,significantly,0,0
47279,",",0,0
47280,greater,0,0
47281,with,0,0
47282,rofecoxib,1,1
47283,25,0,1
47284,mg,0,1
47285,(,0,0
47286,55.4,0,0
47287,%,0,0
47288,),0,0
47289,than,0,0
47290,celecoxib,1,1
47291,(,0,0
47292,50.6,0,0
47293,%,0,0
47294,),0,0
47295,at,0,0
47296,Week,0,0
47297,6,0,0
47298,;,0,0
47299,a,0,0
47300,significant,0,0
47301,difference,0,0
47302,was,0,0
47303,seen,0,0
47304,at,0,0
47305,Weeks,0,0
47306,2,0,0
47307,(,0,0
47308,6.9,0,0
47309,",",0,0
47310,p=0.022,0,0
47311,),0,0
47312,and,0,0
47313,4,0,0
47314,(,0,0
47315,6.7,0,0
47316,",",0,0
47317,p=0.027,0,0
47318,),0,0
47319,and,0,0
47320,over,0,0
47321,6,0,0
47322,weeks,0,0
47323,with,0,0
47324,analysis,0,0
47325,of,0,0
47326,all,0,0
47327,5,0,0
47328,PGART,0,0
47329,categories,0,0
47330,of,0,0
47331,response,0,0
47332,(,0,0
47333,p=0.035,0,0
47334,),0,0
47335,.,0,0
47336,Rofecoxib,1,1
47337,25,0,1
47338,mg,0,1
47339,provided,0,0
47340,greater,0,0
47341,response,0,0
47342,(,0,0
47343,p,0,0
47344,<,0,0
47345,0.05,0,0
47346,),0,0
47347,than,0,0
47348,celecoxib,1,1
47349,on,0,1
47350,WOMAC,0,1
47351,subscales,0,0
47352,.,0,0
47353,Pooled,0,0
47354,analysis,0,0
47355,of,0,0
47356,VACT1/VACT2,0,0
47357,demonstrated,0,0
47358,greater,0,0
47359,PGART,0,0
47360,(,0,0
47361,p=0.023,0,0
47362,),0,0
47363,with,0,0
47364,rofecoxib,1,1
47365,25,0,1
47366,mg,0,1
47367,(,0,0
47368,56.1,0,0
47369,%,0,0
47370,),0,0
47371,than,0,0
47372,celecoxib,1,1
47373,(,0,0
47374,49.8,0,0
47375,%,0,0
47376,),0,0
47377,at,0,0
47378,6,0,0
47379,weeks,0,0
47380,and,0,0
47381,greater,0,0
47382,response,0,0
47383,to,0,0
47384,all,0,0
47385,other,0,0
47386,PGART,0,0
47387,and,0,0
47388,WOMAC,0,1
47389,endpoints,0,0
47390,",",0,0
47391,and,0,0
47392,confirmed,0,0
47393,superiority,0,0
47394,of,0,0
47395,COX-2,0,1
47396,inhibitors,0,1
47397,to,0,1
47398,acetaminophen,1,1
47399,.,1,0
47400,Overall,0,0
47401,",",0,0
47402,tolerability,0,1
47403,of,0,0
47404,the,0,0
47405,study,0,0
47406,medications,0,1
47407,was,0,0
47408,generally,0,0
47409,good,0,0
47410,and,0,0
47411,similar,0,0
47412,.,0,0
47413,There,0,0
47414,was,0,0
47415,no,0,0
47416,significant,0,0
47417,difference,0,0
47418,between,0,0
47419,treatment,0,0
47420,groups,0,0
47421,in,0,0
47422,the,0,0
47423,percentage,0,0
47424,of,0,0
47425,patients,0,0
47426,who,0,0
47427,experienced,0,0
47428,a,0,0
47429,clinical,0,0
47430,adverse,0,1
47431,experience,0,1
47432,(,0,1
47433,AE,0,1
47434,),0,1
47435,.,0,0
47436,The,0,0
47437,incidence,0,0
47438,of,0,0
47439,discontinuations,0,0
47440,due,0,0
47441,to,0,0
47442,an,0,0
47443,AE,0,0
47444,was,0,0
47445,significantly,0,0
47446,lower,0,0
47447,with,0,0
47448,celecoxib,1,1
47449,(,0,0
47450,2.5,0,0
47451,%,0,0
47452,),0,0
47453,compared,0,0
47454,to,0,0
47455,rofecoxib,1,1
47456,25,0,1
47457,mg,0,1
47458,(,0,0
47459,6.3,0,0
47460,%,0,0
47461,",",0,0
47462,p=0.004,0,0
47463,),0,0
47464,or,0,0
47465,acetaminophen,1,1
47466,(,0,0
47467,7.8,0,0
47468,%,0,0
47469,",",0,0
47470,p,0,0
47471,<,0,0
47472,0.001,0,0
47473,),0,0
47474,",",0,0
47475,and,0,0
47476,did,0,0
47477,not,0,0
47478,differ,0,0
47479,significantly,0,0
47480,from,0,0
47481,rofecoxib,0,1
47482,12.5,0,1
47483,mg,0,1
47484,(,0,0
47485,4.6,0,0
47486,%,0,0
47487,),0,0
47488,.,0,0
47489,Discontinuation,0,0
47490,rates,0,0
47491,due,0,0
47492,to,0,0
47493,edema,0,0
47494,and,0,0
47495,hypertension,0,0
47496,related,0,0
47497,AE,0,0
47498,were,0,0
47499,similar,0,0
47500,among,0,0
47501,all,0,0
47502,COX-2,0,0
47503,inhibitors,0,1
47504,.,0,1
47505,CONCLUSION,0,1
47506,Rofecoxib,1,1
47507,and,0,1
47508,celecoxib,1,1
47509,provided,0,0
47510,superior,0,0
47511,efficacy,0,0
47512,to,0,0
47513,acetaminophen,1,1
47514,.,1,0
47515,There,0,0
47516,was,0,0
47517,a,0,0
47518,more,0,0
47519,rapid,0,0
47520,and,0,0
47521,greater,0,0
47522,response,0,0
47523,with,0,0
47524,rofecoxib,0,1
47525,25,0,1
47526,mg,0,1
47527,than,0,1
47528,celecoxib,1,1
47529,200,0,1
47530,mg.,0,1
47531,Rofecoxib,1,1
47532,12.5,0,1
47533,mg,0,0
47534,demonstrated,0,0
47535,greater,0,0
47536,efficacy,0,0
47537,than,0,1
47538,celecoxib,1,1
47539,200,0,1
47540,mg,0,1
47541,over,0,0
47542,the,0,0
47543,first,0,0
47544,6,0,0
47545,days,0,0
47546,",",0,0
47547,and,0,0
47548,was,0,0
47549,similar,0,0
47550,over,0,0
47551,6,0,0
47552,weeks,0,0
47553,.,0,0
47554,All,0,0
47555,study,0,0
47556,medications,0,1
47557,were,0,0
47558,generally,0,0
47559,well,0,0
47560,tolerated,0,1
47561,.,0,0
47562,TENS,1,0
47563,for,0,0
47564,the,0,0
47565,treatment,0,0
47566,of,0,0
47567,writer,0,0
47568,'s,0,0
47569,cramp,0,0
47570,dystonia,0,0
47571,:,0,0
47572,a,0,0
47573,randomized,0,0
47574,",",0,0
47575,placebo-controlled,1,1
47576,study,0,0
47577,.,0,0
47578,Manipulation,0,0
47579,of,0,0
47580,afferent,0,0
47581,inputs,0,0
47582,may,0,0
47583,temporarily,0,0
47584,modulate,0,0
47585,dystonic,0,0
47586,spasms,0,0
47587,.,0,0
47588,Ten,0,0
47589,patients,0,0
47590,with,0,0
47591,writer,0,0
47592,'s,0,0
47593,cramp,0,0
47594,were,0,0
47595,enrolled,0,0
47596,in,0,0
47597,a,0,0
47598,double-blind,0,1
47599,",",0,1
47600,randomized,0,1
47601,",",0,0
47602,crossover,0,1
47603,study,0,0
47604,in,0,0
47605,which,0,0
47606,the,0,0
47607,effects,0,0
47608,of,0,0
47609,transcutaneous,1,0
47610,electrical,1,0
47611,stimulation,1,0
47612,(,1,1
47613,TENS,1,1
47614,),1,1
47615,and,1,0
47616,placebo,1,1
47617,treatment,0,0
47618,were,0,0
47619,compared,0,0
47620,.,0,0
47621,Patients,0,0
47622,were,0,0
47623,evaluated,0,0
47624,using,0,0
47625,four,0,0
47626,measures,0,0
47627,of,0,0
47628,dystonic,0,0
47629,impairment,0,0
47630,.,0,0
47631,The,0,0
47632,TENS,1,0
47633,group,0,0
47634,showed,0,0
47635,a,0,0
47636,significant,0,0
47637,improvement,0,0
47638,that,0,0
47639,persisted,0,0
47640,for,0,0
47641,3,0,0
47642,weeks,0,0
47643,in,0,0
47644,three,0,0
47645,of,0,0
47646,the,0,0
47647,four,0,0
47648,measures,0,0
47649,.,0,0
47650,Montelukast,1,1
47651,treatment,1,1
47652,of,0,0
47653,moderate,0,0
47654,to,0,0
47655,severe,0,0
47656,atopic,0,0
47657,dermatitis,0,0
47658,in,0,0
47659,adults,0,0
47660,:,0,0
47661,a,0,0
47662,randomized,0,0
47663,",",0,0
47664,double-blind,0,1
47665,",",0,1
47666,placebo-controlled,1,1
47667,trial,0,1
47668,.,0,0
47669,In,0,0
47670,a,0,0
47671,randomized,0,0
47672,",",0,0
47673,double-blind,0,1
47674,",",0,1
47675,placebo-controlled,1,1
47676,4-week,0,1
47677,trial,0,1
47678,",",0,0
47679,59,0,0
47680,patients,0,0
47681,with,0,0
47682,moderate,0,0
47683,to,0,0
47684,severe,0,0
47685,atopic,0,0
47686,dermatitis,0,0
47687,were,0,0
47688,treated,0,0
47689,orally,0,1
47690,with,0,1
47691,10,0,1
47692,mg,0,1
47693,of,0,0
47694,the,0,1
47695,leukotriene,1,1
47696,antagonist,1,1
47697,montelukast,1,1
47698,.,1,0
47699,Forty-seven,0,0
47700,patients,0,0
47701,completed,0,0
47702,the,0,0
47703,study,0,0
47704,.,0,0
47705,No,0,0
47706,difference,0,0
47707,in,0,0
47708,efficacy,0,0
47709,was,0,0
47710,seen,0,0
47711,among,0,0
47712,patients,0,0
47713,who,0,0
47714,received,0,0
47715,montelukast,1,1
47716,and,0,1
47717,the,0,0
47718,group,0,0
47719,given,0,0
47720,a,0,0
47721,placebo,1,1
47722,.,1,0
47723,Long,0,0
47724,term,0,0
47725,follow,0,0
47726,up,0,0
47727,of,0,0
47728,patients,0,0
47729,treated,0,0
47730,for,0,0
47731,Helicobacter,0,1
47732,pylori,0,1
47733,infection,0,1
47734,.,0,0
47735,BACKGROUND,0,1
47736,Helicobacter,0,1
47737,pylori,0,1
47738,infection,0,0
47739,induces,0,0
47740,progressive,0,0
47741,inflammatory,0,0
47742,changes,0,0
47743,in,0,0
47744,the,0,0
47745,gastric,0,0
47746,mucosa,0,0
47747,that,0,0
47748,may,0,0
47749,lead,0,0
47750,to,0,0
47751,gastric,0,0
47752,cancer,0,0
47753,.,0,0
47754,Understanding,0,0
47755,long,0,0
47756,term,0,0
47757,effects,0,0
47758,resulting,0,0
47759,from,0,0
47760,the,0,0
47761,cure,0,0
47762,of,0,0
47763,this,0,0
47764,infection,0,0
47765,is,0,0
47766,needed,0,0
47767,to,0,0
47768,design,0,0
47769,cancer,0,0
47770,prevention,0,0
47771,strategies,0,0
47772,.,0,0
47773,METHODS,0,0
47774,A,0,1
47775,cohort,0,0
47776,of,0,0
47777,795,0,0
47778,adults,0,0
47779,with,0,0
47780,preneoplastic,0,0
47781,gastric,0,0
47782,lesions,0,0
47783,was,0,0
47784,randomised,0,0
47785,to,0,0
47786,receive,1,1
47787,anti-H,1,1
47788,pylori,1,1
47789,treatment,1,1
47790,and/or,1,0
47791,antioxidants,1,1
47792,.,1,0
47793,At,0,0
47794,the,0,0
47795,end,0,0
47796,of,0,0
47797,six,0,0
47798,years,0,0
47799,of,0,0
47800,intervention,0,0
47801,",",0,0
47802,those,0,0
47803,who,0,0
47804,did,0,0
47805,not,0,0
47806,receive,0,1
47807,anti-H,0,1
47808,pylori,0,1
47809,treatment,0,0
47810,were,0,0
47811,offered,0,0
47812,it,0,0
47813,.,0,0
47814,Gastric,0,0
47815,biopsies,0,0
47816,were,0,0
47817,obtained,0,0
47818,at,0,0
47819,baseline,0,0
47820,",",0,0
47821,and,0,0
47822,at,0,0
47823,3,0,0
47824,",",0,0
47825,6,0,0
47826,",",0,0
47827,and,0,0
47828,12,0,0
47829,years,0,0
47830,.,0,0
47831,A,0,0
47832,histopathology,0,0
47833,score,0,0
47834,was,0,0
47835,utilised,0,0
47836,to,0,0
47837,document,0,0
47838,changes,0,0
47839,in,0,0
47840,gastric,0,0
47841,lesions,0,0
47842,.,0,0
47843,Non-linear,0,0
47844,mixed,0,0
47845,models,0,0
47846,were,0,0
47847,used,0,0
47848,to,0,0
47849,estimate,0,0
47850,the,0,0
47851,cumulative,0,0
47852,effect,0,0
47853,of,0,0
47854,H,0,1
47855,pylori,0,1
47856,clearance,0,1
47857,on,0,0
47858,histopathology,0,0
47859,scores,0,0
47860,adjusted,0,0
47861,for,0,0
47862,follow,0,0
47863,up,0,0
47864,time,0,0
47865,",",0,0
47866,interventions,0,0
47867,",",0,0
47868,and,0,0
47869,confounders,0,0
47870,.,0,0
47871,RESULTS,0,0
47872,Ninety,0,0
47873,seven,0,0
47874,per,0,0
47875,cent,0,0
47876,of,0,0
47877,subjects,0,0
47878,were,0,0
47879,H,0,0
47880,pylori,0,0
47881,positive,0,0
47882,at,0,0
47883,baseline,0,0
47884,",",0,0
47885,and,0,0
47886,53,0,0
47887,%,0,0
47888,were,0,0
47889,positive,0,0
47890,at,0,0
47891,12,0,0
47892,years,0,0
47893,.,0,0
47894,Subjects,0,0
47895,accumulated,0,0
47896,1703,0,0
47897,person,0,0
47898,years,0,0
47899,free,0,0
47900,of,0,0
47901,infection,0,0
47902,.,0,0
47903,A,0,0
47904,multivariate,0,0
47905,model,0,0
47906,showed,0,0
47907,a,0,0
47908,significant,0,0
47909,regression,0,0
47910,in,0,0
47911,histopathology,0,0
47912,score,0,0
47913,as,0,0
47914,a,0,0
47915,function,0,0
47916,of,0,0
47917,the,0,0
47918,square,0,0
47919,of,0,0
47920,H,0,0
47921,pylori,0,0
47922,negative,0,0
47923,time,0,0
47924,.,0,0
47925,Subjects,0,0
47926,who,0,0
47927,were,0,0
47928,H,0,0
47929,pylori,0,0
47930,negative,0,0
47931,had,0,0
47932,14.8,0,0
47933,%,0,0
47934,more,0,0
47935,regression,0,0
47936,and,0,0
47937,13.7,0,0
47938,%,0,0
47939,less,0,0
47940,progression,0,0
47941,than,0,0
47942,patients,0,0
47943,who,0,0
47944,were,0,0
47945,positive,0,0
47946,at,0,0
47947,12,0,0
47948,years,0,0
47949,(,0,0
47950,p,0,0
47951,=,0,0
47952,0.001,0,0
47953,),0,0
47954,.,0,0
47955,The,0,0
47956,rate,0,0
47957,of,0,0
47958,healing,0,0
47959,of,0,0
47960,gastric,0,0
47961,lesions,0,0
47962,occurred,0,0
47963,more,0,0
47964,rapidly,0,0
47965,as,0,0
47966,years,0,0
47967,free,0,0
47968,of,0,0
47969,infection,0,0
47970,accumulated,0,0
47971,",",0,0
47972,and,0,0
47973,was,0,0
47974,more,0,0
47975,pronounced,0,0
47976,in,0,0
47977,less,0,0
47978,advanced,0,0
47979,lesions,0,0
47980,.,0,0
47981,CONCLUSIONS,0,0
47982,Preneoplastic,0,0
47983,gastric,0,1
47984,lesions,0,0
47985,regress,0,0
47986,at,0,0
47987,a,0,0
47988,rate,0,0
47989,equal,0,0
47990,to,0,0
47991,the,0,0
47992,square,0,0
47993,of,0,0
47994,time,0,0
47995,in,0,0
47996,patients,0,0
47997,rendered,0,0
47998,free,0,0
47999,of,0,0
48000,H,0,0
48001,pylori,0,0
48002,infection,0,0
48003,.,0,0
48004,Our,0,0
48005,findings,0,0
48006,suggest,0,0
48007,that,0,0
48008,patients,0,0
48009,with,0,0
48010,preneoplastic,0,0
48011,gastric,0,0
48012,lesions,0,0
48013,should,0,0
48014,be,0,0
48015,treated,0,0
48016,and,0,0
48017,cured,0,0
48018,of,0,0
48019,their,0,0
48020,H,0,0
48021,pylori,0,0
48022,infection,0,0
48023,.,0,0
48024,The,0,0
48025,assessment,0,0
48026,of,0,0
48027,erythema,0,0
48028,and,0,0
48029,thickness,0,0
48030,on,0,0
48031,burn,0,0
48032,related,0,0
48033,scars,0,0
48034,during,0,0
48035,pressure,1,0
48036,garment,1,0
48037,therapy,1,0
48038,as,0,0
48039,a,0,0
48040,preventive,0,0
48041,measure,0,0
48042,for,0,0
48043,hypertrophic,0,0
48044,scarring,0,0
48045,.,0,0
48046,The,0,0
48047,aim,0,0
48048,of,0,0
48049,this,0,0
48050,study,0,0
48051,was,0,0
48052,threefold,0,0
48053,:,0,0
48054,(,0,0
48055,1,0,1
48056,),0,0
48057,Assess,0,0
48058,the,0,0
48059,pressure,0,0
48060,loss,0,0
48061,of,0,0
48062,two,1,0
48063,types,1,0
48064,of,1,0
48065,pressure,1,0
48066,garments,1,0
48067,that,0,0
48068,are,0,0
48069,used,0,0
48070,in,0,0
48071,the,0,0
48072,treatment,0,0
48073,of,0,0
48074,hypertrophic,0,0
48075,scars,0,0
48076,after,0,0
48077,burn,0,0
48078,injury,0,0
48079,",",0,1
48080,(,0,1
48081,2,0,1
48082,),0,0
48083,investigate,0,0
48084,the,0,0
48085,influence,0,0
48086,of,0,0
48087,two,1,0
48088,different,1,0
48089,levels,1,0
48090,of,1,0
48091,compression,1,0
48092,on,0,0
48093,erythema,0,0
48094,and,0,0
48095,thickness,0,0
48096,of,0,0
48097,burn,0,0
48098,scars,0,1
48099,and,0,1
48100,(,0,1
48101,3,0,1
48102,),0,0
48103,examine,0,0
48104,the,0,0
48105,association,0,0
48106,between,0,0
48107,erythema,0,0
48108,and,0,0
48109,thickness,0,0
48110,.,0,0
48111,The,0,0
48112,study,0,0
48113,was,0,0
48114,a,0,0
48115,prospective,0,0
48116,trial,0,0
48117,in,0,0
48118,which,0,0
48119,76,0,0
48120,burn,0,0
48121,scars,0,0
48122,in,0,0
48123,60,0,0
48124,patients,0,0
48125,were,0,0
48126,objectively,0,0
48127,assessed,1,0
48128,with,1,0
48129,the,1,0
48130,Minolta,1,1
48131,Chromameter,1,0
48132,CR-300,1,0
48133,for,1,0
48134,erythema,1,0
48135,and,1,0
48136,with,1,0
48137,the,1,0
48138,Dermascan,1,0
48139,C,1,0
48140,for,1,0
48141,thickness,1,0
48142,of,1,0
48143,the,1,0
48144,scar,1,0
48145,over,1,0
48146,a,1,0
48147,period,1,0
48148,of,1,0
48149,3,1,0
48150,months,1,0
48151,.,1,0
48152,Each,0,0
48153,patient,0,0
48154,was,0,0
48155,randomly,0,0
48156,assigned,0,0
48157,to,0,0
48158,a,0,0
48159,normal,1,0
48160,or,1,0
48161,lower,1,0
48162,compression,1,0
48163,class,1,0
48164,treatment,1,0
48165,",",1,0
48166,with,1,0
48167,respectively,1,0
48168,mean,1,0
48169,values,1,0
48170,of,1,0
48171,15,1,0
48172,and,1,0
48173,10,1,0
48174,mmHg,1,1
48175,pressure,1,1
48176,after,1,0
48177,wearing,1,0
48178,the,1,0
48179,garment,1,0
48180,for,1,0
48181,1,1,0
48182,month,1,0
48183,.,1,0
48184,Measurements,1,0
48185,for,1,0
48186,both,1,0
48187,parameters,1,0
48188,were,1,0
48189,taken,1,0
48190,at,1,0
48191,0,1,0
48192,",",1,0
48193,1,1,0
48194,",",1,0
48195,2,1,0
48196,and,1,0
48197,3,1,0
48198,months,1,0
48199,of,1,0
48200,treatment,1,0
48201,.,1,0
48202,Pressure,0,0
48203,garments,0,0
48204,with,0,0
48205,normal,0,0
48206,compression,0,0
48207,did,0,0
48208,lose,0,0
48209,significantly,0,0
48210,more,0,0
48211,compression,0,0
48212,over,0,0
48213,1,0,0
48214,month,0,0
48215,(,0,0
48216,4.82,0,0
48217,mmHg,0,0
48218,),0,0
48219,than,0,0
48220,did,0,0
48221,the,0,0
48222,garments,0,0
48223,from,0,0
48224,the,0,0
48225,low,0,0
48226,compression,0,0
48227,class,0,0
48228,(,0,0
48229,2.57,0,0
48230,mmHg,0,0
48231,),0,0
48232,.,0,0
48233,Scars,0,0
48234,that,0,0
48235,were,0,0
48236,treated,0,0
48237,with,0,0
48238,garments,0,0
48239,from,0,0
48240,a,0,0
48241,normal,0,0
48242,compression,0,0
48243,class,0,0
48244,did,0,0
48245,score,0,0
48246,significantly,0,0
48247,better,0,0
48248,for,0,0
48249,thickness,0,0
48250,compared,0,0
48251,to,0,0
48252,the,0,0
48253,low,0,0
48254,compression,0,0
48255,class,0,0
48256,.,0,0
48257,The,0,0
48258,difference,0,0
48259,in,0,0
48260,thickness,0,0
48261,was,0,0
48262,most,0,0
48263,evident,0,0
48264,at,0,0
48265,1,0,0
48266,month,0,0
48267,.,0,0
48268,Thereafter,0,0
48269,no,0,0
48270,further,0,0
48271,significant,0,0
48272,improvement,0,0
48273,between,0,0
48274,the,0,0
48275,two,0,0
48276,different,0,0
48277,treatments,0,0
48278,over,0,0
48279,time,0,0
48280,could,0,0
48281,be,0,0
48282,obtained,0,0
48283,.,0,0
48284,This,0,0
48285,difference,0,0
48286,was,0,0
48287,not,0,0
48288,found,0,0
48289,for,0,0
48290,erythema,0,0
48291,.,0,0
48292,Positive,0,0
48293,correlations,0,0
48294,could,0,0
48295,be,0,0
48296,found,0,0
48297,between,0,0
48298,erythema,0,0
48299,and,0,0
48300,thickness,0,0
48301,values,0,0
48302,at,0,0
48303,all,0,0
48304,of,0,0
48305,the,0,0
48306,three,0,0
48307,test,0,0
48308,points,0,0
48309,while,0,0
48310,changes,0,0
48311,in,0,0
48312,erythema,0,0
48313,and,0,0
48314,thickness,0,0
48315,only,0,0
48316,correlated,0,0
48317,significantly,0,0
48318,after,0,0
48319,the,0,0
48320,first,0,0
48321,month,0,0
48322,.,0,0
48323,The,0,0
48324,pattern,0,0
48325,of,0,0
48326,change,0,0
48327,of,0,0
48328,both,0,0
48329,parameters,0,0
48330,correlated,0,0
48331,at,0,0
48332,a,0,0
48333,high,0,0
48334,level,0,0
48335,of,0,0
48336,significance,0,0
48337,after,0,0
48338,3,0,0
48339,months,0,0
48340,of,0,0
48341,treatment,0,0
48342,.,0,0
48343,These,0,0
48344,data,0,0
48345,suggest,0,0
48346,that,0,0
48347,pressure,0,0
48348,garments,0,0
48349,that,0,0
48350,deliver,0,0
48351,a,0,0
48352,pressure,0,0
48353,of,0,0
48354,at,0,0
48355,least,0,0
48356,15,0,0
48357,mmHg,0,0
48358,pressure,0,0
48359,tend,0,0
48360,to,0,0
48361,accelerate,0,0
48362,scar,0,0
48363,maturation,0,0
48364,and,0,0
48365,that,0,0
48366,measurements,0,0
48367,of,0,0
48368,the,0,0
48369,pattern,0,0
48370,of,0,0
48371,change,0,0
48372,of,0,0
48373,the,0,0
48374,erythema,0,0
48375,can,0,0
48376,be,0,0
48377,used,0,0
48378,to,0,0
48379,predict,0,0
48380,changes,0,0
48381,in,0,0
48382,scar,0,0
48383,thickness,0,0
48384,and,0,0
48385,vice,0,0
48386,versa,0,0
48387,.,0,0
48388,Tolerance,0,0
48389,and,0,0
48390,efficacy,0,0
48391,of,0,0
48392,combined,1,0
48393,diethylcarbamazine,1,1
48394,and,1,1
48395,albendazole,1,1
48396,for,0,0
48397,treatment,0,0
48398,of,0,0
48399,Wuchereria,0,0
48400,bancrofti,0,0
48401,and,0,0
48402,intestinal,0,0
48403,helminth,0,0
48404,infections,0,0
48405,in,0,0
48406,Haitian,0,0
48407,children,0,0
48408,.,0,0
48409,This,0,0
48410,randomized,0,0
48411,",",0,1
48412,placebo-controlled,1,1
48413,trial,0,1
48414,investigated,0,0
48415,the,0,0
48416,tolerance,0,0
48417,",",0,0
48418,efficacy,0,0
48419,",",0,0
48420,and,0,0
48421,nutritional,0,0
48422,benefit,0,0
48423,of,0,0
48424,combining,0,0
48425,chemotherapeutic,1,1
48426,treatment,1,0
48427,of,0,0
48428,intestinal,0,0
48429,helminths,0,0
48430,and,0,0
48431,lymphatic,0,0
48432,filariasis,0,0
48433,.,0,0
48434,Children,0,0
48435,were,0,0
48436,infected,0,0
48437,with,0,0
48438,Ascaris,0,0
48439,(,0,0
48440,30.7,0,0
48441,%,0,0
48442,),0,0
48443,",",0,0
48444,Trichuris,0,1
48445,(,0,0
48446,53.4,0,0
48447,%,0,0
48448,),0,0
48449,",",0,0
48450,and,0,1
48451,hookworm,0,0
48452,(,0,0
48453,9.7,0,0
48454,%,0,0
48455,),0,0
48456,with,0,0
48457,69.9,0,0
48458,%,0,0
48459,having,0,0
48460,more,0,0
48461,than,0,0
48462,one,0,0
48463,of,0,0
48464,these,0,0
48465,parasites,0,0
48466,.,0,0
48467,A,0,0
48468,total,0,0
48469,of,0,0
48470,15.8,0,0
48471,%,0,0
48472,of,0,0
48473,the,0,0
48474,children,0,0
48475,had,0,0
48476,Wuchereria,0,0
48477,bancrofti,0,1
48478,microfilariae,0,1
48479,.,0,0
48480,Children,0,0
48481,were,0,0
48482,randomly,0,0
48483,assigned,0,0
48484,treatment,0,0
48485,with,0,0
48486,placebo,1,1
48487,",",1,1
48488,albendazole,1,1
48489,(,1,1
48490,ALB,1,1
48491,),1,1
48492,",",1,1
48493,diethylcarbamazine,1,1
48494,(,1,1
48495,DEC,1,1
48496,),1,1
48497,",",1,0
48498,or,1,0
48499,combined,1,0
48500,therapy,1,0
48501,.,1,0
48502,The,0,0
48503,combination,0,0
48504,of,0,0
48505,DEC/ALB,0,0
48506,reduced,0,0
48507,microfilarial,0,0
48508,density,0,0
48509,compared,0,0
48510,with,0,0
48511,placebo,0,1
48512,",",0,0
48513,ALB,0,1
48514,",",0,0
48515,or,0,0
48516,DEC,0,0
48517,(,0,0
48518,P,0,0
48519,<,0,0
48520,or,0,0
48521,=,0,0
48522,0.03,0,0
48523,),0,0
48524,.,0,0
48525,Albendazole,1,1
48526,and,0,0
48527,DEC/ALB,1,1
48528,reduced,0,0
48529,the,0,0
48530,prevalence,0,0
48531,of,0,0
48532,Ascaris,0,0
48533,",",0,0
48534,Trichuris,0,0
48535,",",0,0
48536,and,0,0
48537,hookworm,0,0
48538,more,0,0
48539,than,0,0
48540,placebo,0,1
48541,or,0,1
48542,DEC,0,0
48543,(,0,0
48544,P,0,0
48545,<,0,0
48546,or,0,0
48547,=,0,0
48548,0.03,0,0
48549,),0,0
48550,.,0,0
48551,Among,0,0
48552,Trichuris-infected,0,0
48553,children,0,0
48554,",",0,0
48555,those,0,0
48556,receiving,0,0
48557,ALB,1,0
48558,and,0,0
48559,DEC/ALB,1,0
48560,demonstrated,0,0
48561,greater,0,0
48562,gains,0,0
48563,in,0,0
48564,weight,0,0
48565,compared,0,0
48566,with,0,0
48567,placebo,1,0
48568,(,0,0
48569,P,0,0
48570,<,0,0
48571,or,0,0
48572,=,0,0
48573,0.05,0,0
48574,),0,0
48575,.,0,0
48576,Albendazole,1,1
48577,and,0,0
48578,DEC/ALB,1,1
48579,were,0,0
48580,equally,0,0
48581,efficacious,0,0
48582,in,0,0
48583,treating,0,0
48584,intestinal,0,0
48585,helminths,0,0
48586,and,0,0
48587,for,0,0
48588,children,0,0
48589,with,0,0
48590,W.,0,0
48591,bancrofti,0,0
48592,microfilaremia,0,0
48593,",",0,0
48594,DEC/ALB,1,0
48595,was,0,0
48596,more,0,0
48597,effective,0,0
48598,than,0,0
48599,DEC,1,0
48600,",",0,0
48601,with,0,0
48602,no,0,0
48603,increase,0,0
48604,in,0,0
48605,severity,0,0
48606,of,0,0
48607,adverse,0,0
48608,reactions,0,0
48609,.,0,0
48610,Autism-Spectrum,1,1
48611,Quotient-Japanese,1,0
48612,version,0,0
48613,and,0,0
48614,its,0,0
48615,short,0,0
48616,forms,0,0
48617,for,0,0
48618,screening,0,0
48619,normally,0,0
48620,intelligent,0,0
48621,persons,0,0
48622,with,0,0
48623,pervasive,0,0
48624,developmental,0,0
48625,disorders,0,0
48626,.,0,0
48627,A,0,0
48628,Japanese,1,0
48629,version,1,0
48630,of,1,0
48631,the,1,0
48632,Autism,1,0
48633,Spectrum,1,0
48634,Quotient,1,0
48635,(,1,1
48636,AQ,1,1
48637,),1,1
48638,",",1,0
48639,AQ-J,1,1
48640,was,0,0
48641,administered,0,1
48642,to,0,0
48643,25,0,0
48644,normally,0,0
48645,intelligent,0,0
48646,high-functioning,0,0
48647,pervasive,0,0
48648,developmental,0,0
48649,disorder,0,1
48650,(,0,1
48651,HPDD,0,1
48652,),0,1
48653,patients,0,0
48654,(,0,0
48655,mean,0,0
48656,age,0,0
48657,",",0,0
48658,24.2,0,0
48659,years,0,0
48660,;,0,0
48661,24,0,0
48662,male,0,0
48663,",",0,0
48664,one,0,0
48665,female,0,1
48666,),0,0
48667,and,0,0
48668,215,0,0
48669,controls,0,0
48670,(,0,0
48671,mean,0,0
48672,age,0,0
48673,",",0,0
48674,30.4,0,0
48675,years,0,0
48676,;,0,0
48677,86,0,0
48678,male,0,0
48679,",",0,0
48680,129,0,0
48681,female,0,0
48682,),0,0
48683,randomly,0,0
48684,selected,0,0
48685,from,0,0
48686,the,0,0
48687,general,0,0
48688,population,0,0
48689,.,0,0
48690,The,0,0
48691,AQ-J,1,0
48692,had,0,0
48693,satisfactory,0,0
48694,internal,0,0
48695,consistency,0,1
48696,reliability,0,1
48697,(,0,1
48698,Cronbach,0,0
48699,'s,0,0
48700,alpha,0,0
48701,>,0,0
48702,0.70,0,0
48703,in,0,0
48704,the,0,0
48705,two,0,0
48706,groups,0,0
48707,),0,0
48708,",",0,0
48709,test-retest,0,1
48710,reliability,0,0
48711,",",0,0
48712,and,0,0
48713,discriminant,0,1
48714,validity,0,1
48715,[,0,0
48716,i.e,0,0
48717,.,0,0
48718,the,0,0
48719,AQ-J,0,0
48720,score,0,0
48721,was,0,0
48722,significantly,0,0
48723,higher,0,0
48724,in,0,0
48725,the,0,0
48726,HPDD,0,0
48727,(,0,0
48728,mean,0,0
48729,",",0,0
48730,29.6,0,0
48731,),0,0
48732,than,0,0
48733,controls,0,0
48734,(,0,0
48735,mean,0,0
48736,",",0,0
48737,22.2,0,0
48738,),0,0
48739,],0,0
48740,.,0,0
48741,At,0,0
48742,a,0,0
48743,cut-off,0,0
48744,of,0,0
48745,26,0,0
48746,",",0,0
48747,the,0,0
48748,AQ-J,1,0
48749,had,0,0
48750,satisfactory,0,0
48751,sensitivity,0,0
48752,",",0,0
48753,specificity,0,0
48754,",",0,0
48755,and,0,0
48756,negative,0,0
48757,predictive,0,0
48758,value,0,0
48759,",",0,0
48760,but,0,0
48761,it,0,0
48762,had,0,0
48763,low,0,0
48764,positive,0,0
48765,predictive,0,0
48766,value,0,0
48767,(,0,0
48768,0.24,0,0
48769,),0,0
48770,possibly,0,0
48771,due,0,0
48772,to,0,0
48773,the,0,0
48774,facts,0,0
48775,that,0,0
48776,the,0,0
48777,25,0,0
48778,mild,0,0
48779,HPDD,0,0
48780,patients,0,0
48781,scored,0,0
48782,lower,0,0
48783,and,0,0
48784,the,0,0
48785,controls,0,0
48786,scored,0,0
48787,higher,0,0
48788,on,0,0
48789,the,0,0
48790,AQ-J,1,0
48791,than,0,0
48792,British,0,0
48793,counterparts,0,0
48794,on,0,0
48795,the,0,0
48796,AQ,0,0
48797,.,0,0
48798,The,0,0
48799,AQ-J-21,1,0
48800,(,0,0
48801,consisting,0,0
48802,of,0,0
48803,21,0,0
48804,items,0,0
48805,significantly,0,0
48806,associated,0,0
48807,with,0,0
48808,HPDD,0,1
48809,diagnosis,0,1
48810,),0,0
48811,and,0,0
48812,the,0,0
48813,AQ-J-10,1,1
48814,(,0,0
48815,consisting,0,0
48816,of,0,0
48817,10,0,0
48818,of,0,0
48819,the,0,0
48820,21,0,0
48821,items,0,0
48822,with,0,0
48823,an,0,0
48824,effect,0,0
48825,size,0,0
48826,>,0,0
48827,0.17,0,0
48828,),0,0
48829,had,0,0
48830,higher,0,0
48831,",",0,0
48832,although,0,0
48833,not,0,0
48834,satisfactory,0,0
48835,",",0,0
48836,positive,0,0
48837,predictive,0,0
48838,values,0,0
48839,of,0,0
48840,0.35,0,0
48841,and,0,0
48842,0.46,0,0
48843,at,0,0
48844,cut-offs,0,0
48845,of,0,0
48846,12,0,0
48847,and,0,0
48848,7,0,0
48849,",",0,0
48850,respectively,0,0
48851,",",0,0
48852,than,0,0
48853,the,0,0
48854,AQ-J,1,0
48855,.,1,0
48856,The,0,0
48857,AQ-J,1,0
48858,and,0,0
48859,two,0,0
48860,short,0,0
48861,forms,0,0
48862,are,0,0
48863,useful,0,0
48864,not,0,0
48865,to,0,0
48866,predict,0,0
48867,but,0,0
48868,to,0,0
48869,rule,0,0
48870,out,0,0
48871,mild,0,0
48872,HPDD,0,0
48873,",",0,0
48874,the,0,0
48875,most,0,0
48876,difficult,0,0
48877,part,0,0
48878,of,0,0
48879,HPDD,0,0
48880,to,0,0
48881,be,0,0
48882,distinguished,0,0
48883,from,0,0
48884,non-PDD,0,0
48885,conditions,0,0
48886,",",0,0
48887,in,0,0
48888,persons,0,0
48889,scoring,0,0
48890,under,0,0
48891,the,0,0
48892,cut-offs,0,0
48893,and,0,0
48894,to,0,0
48895,consider,0,0
48896,professionals,0,0
48897,',0,0
48898,examination,0,0
48899,of,0,0
48900,HPDD,0,0
48901,in,0,0
48902,persons,0,0
48903,scoring,0,0
48904,over,0,0
48905,them,0,0
48906,",",0,0
48907,because,0,0
48908,their,0,0
48909,negative,0,0
48910,predictive,0,0
48911,values,0,0
48912,were,0,0
48913,satisfactory,0,0
48914,.,0,0
48915,Hydrogen,1,1
48916,peroxide,1,1
48917,mouth,1,1
48918,rinse,1,1
48919,:,1,1
48920,an,0,0
48921,analgesic,0,1
48922,post-tonsillectomy,0,1
48923,.,0,0
48924,OBJECTIVE,0,0
48925,To,0,0
48926,compare,0,0
48927,the,0,0
48928,analgesic,0,1
48929,efficacy,0,1
48930,of,0,0
48931,hydrogen,1,0
48932,peroxide,1,1
48933,(,1,1
48934,H2O2,1,1
48935,),1,1
48936,mouth,1,1
48937,rinse,1,1
48938,with,0,1
48939,control,1,0
48940,for,0,0
48941,post-tonsillectomy,0,0
48942,pain,0,0
48943,management,0,0
48944,.,0,0
48945,DESIGN,0,1
48946,Double-blinded,0,1
48947,",",0,1
48948,prospective,0,1
48949,",",0,0
48950,randomized,0,0
48951,",",0,0
48952,controlled,0,0
48953,clinical,0,0
48954,trial,0,0
48955,.,0,0
48956,PATIENTS,0,0
48957,AND,0,0
48958,METHODS,0,0
48959,Thirty-seven,0,0
48960,patients,0,0
48961,from,0,0
48962,5,0,0
48963,to,0,0
48964,14,0,0
48965,years,0,0
48966,old,0,1
48967,undergoing,0,1
48968,electrocautery,1,0
48969,tonsillectomy,1,0
48970,were,0,0
48971,randomized,0,0
48972,to,0,0
48973,either,0,0
48974,the,0,0
48975,H2O2,1,1
48976,mouth,1,1
48977,rinse,1,1
48978,or,1,1
48979,the,1,0
48980,water,1,0
48981,rinse,1,1
48982,(,1,1
48983,control,1,1
48984,),1,0
48985,group,1,0
48986,.,1,0
48987,For,0,0
48988,14,0,0
48989,days,0,0
48990,",",0,0
48991,patients,0,0
48992,recorded,0,0
48993,pain,0,0
48994,levels,0,0
48995,twice,0,1
48996,daily,0,1
48997,using,0,1
48998,a,0,0
48999,visual,0,1
49000,analogue,0,1
49001,scale,0,1
49002,.,0,1
49003,Analgesic,0,1
49004,uses,0,0
49005,",",0,0
49006,as,0,0
49007,well,0,0
49008,as,0,0
49009,any,0,0
49010,complications,0,0
49011,",",0,0
49012,were,0,0
49013,also,0,0
49014,noted,0,0
49015,by,0,0
49016,the,0,0
49017,patients,0,0
49018,.,0,0
49019,RESULTS,0,0
49020,Thirty-seven,0,0
49021,patients,0,0
49022,completed,0,0
49023,the,0,0
49024,study,0,0
49025,",",0,0
49026,21,0,0
49027,in,0,0
49028,the,0,0
49029,treatment,0,0
49030,group,0,0
49031,and,0,0
49032,16,0,0
49033,in,0,0
49034,the,0,0
49035,control,0,0
49036,group,0,0
49037,.,0,0
49038,Mean,0,0
49039,postoperative,0,0
49040,days,0,0
49041,of,0,0
49042,pain,0,0
49043,were,0,0
49044,10.3,0,0
49045,and,0,0
49046,8.3,0,0
49047,",",0,0
49048,respectively,0,0
49049,",",0,0
49050,and,0,0
49051,differed,0,0
49052,significantly,0,0
49053,(,0,0
49054,p,0,0
49055,=,0,0
49056,.008,0,0
49057,),0,0
49058,.,0,0
49059,Mean,0,0
49060,postoperative,0,0
49061,days,0,0
49062,of,0,0
49063,analgesic,0,1
49064,use,0,0
49065,were,0,0
49066,9.0,0,0
49067,and,0,0
49068,6.7,0,0
49069,",",0,0
49070,respectively,0,0
49071,",",0,0
49072,and,0,0
49073,differed,0,0
49074,significantly,0,0
49075,(,0,0
49076,p,0,0
49077,=,0,0
49078,.005,0,0
49079,),0,0
49080,.,0,0
49081,Only,0,0
49082,one,0,0
49083,incidence,0,0
49084,of,0,0
49085,postoperative,0,0
49086,hemorrhage,0,0
49087,occurred,0,0
49088,in,0,0
49089,the,0,0
49090,study,0,0
49091,group,0,0
49092,.,0,0
49093,CONCLUSION,0,0
49094,In,0,0
49095,our,0,0
49096,study,0,0
49097,",",0,0
49098,the,0,0
49099,H2O2,1,1
49100,mouth,1,1
49101,rinse,1,1
49102,does,0,0
49103,not,0,0
49104,provide,0,0
49105,a,0,0
49106,better,0,0
49107,analgesic,0,1
49108,effect,0,0
49109,than,0,0
49110,the,0,0
49111,water,0,0
49112,rinse,0,1
49113,for,0,0
49114,post-tonsillectomy,0,1
49115,pain,0,0
49116,relief,0,0
49117,.,0,0
49118,Effect,0,0
49119,of,0,0
49120,soy,1,1
49121,protein,1,0
49122,containing,1,0
49123,isoflavones,1,1
49124,on,0,0
49125,blood,0,0
49126,lipids,0,0
49127,in,0,0
49128,moderately,0,0
49129,hypercholesterolemic,0,1
49130,adults,0,1
49131,:,0,0
49132,a,0,0
49133,randomized,0,0
49134,controlled,0,0
49135,trial,0,0
49136,.,0,0
49137,BACKGROUND,0,1
49138,Dietary,1,1
49139,intake,1,1
49140,of,1,1
49141,soy,1,1
49142,protein,1,0
49143,with,1,1
49144,isoflavones,1,1
49145,may,0,0
49146,be,0,0
49147,associated,0,0
49148,with,0,0
49149,reductions,0,0
49150,in,0,0
49151,serum,0,1
49152,cholesterol,0,1
49153,.,0,1
49154,OBJECTIVES,0,1
49155,To,0,0
49156,compare,0,0
49157,the,0,0
49158,effects,0,0
49159,of,0,0
49160,a,0,0
49161,water-washed,1,0
49162,soy,1,1
49163,protein,1,0
49164,concentrate,1,0
49165,with,0,0
49166,a,0,0
49167,milk-protein,1,0
49168,based,1,0
49169,control,1,0
49170,on,0,0
49171,blood,0,0
49172,lipid,0,0
49173,levels,0,0
49174,in,0,0
49175,hyperlipidemic,0,1
49176,men,0,1
49177,and,0,0
49178,women,0,0
49179,.,0,0
49180,METHODS,0,0
49181,A,0,1
49182,randomized,0,1
49183,",",0,0
49184,double-blind,0,1
49185,",",0,0
49186,controlled,0,0
49187,clinical,0,0
49188,trial,0,0
49189,including,0,0
49190,159,0,0
49191,subjects,0,0
49192,.,0,0
49193,After,0,0
49194,a,0,0
49195,3-week,0,1
49196,run-in,0,1
49197,period,0,1
49198,during,0,0
49199,which,0,0
49200,all,0,0
49201,subjects,0,0
49202,consumed,0,1
49203,a,0,1
49204,milk,1,1
49205,protein-based,1,1
49206,supplement,1,1
49207,",",0,0
49208,participants,0,0
49209,were,0,0
49210,randomized,0,0
49211,into,0,0
49212,one,0,0
49213,of,0,0
49214,two,0,0
49215,groups,0,0
49216,:,0,0
49217,a,0,0
49218,control,0,0
49219,group,0,0
49220,(,1,1
49221,continued,1,1
49222,milk,1,1
49223,protein,1,1
49224,),1,0
49225,and,0,0
49226,an,0,0
49227,intervention,0,1
49228,group,0,1
49229,(,1,1
49230,soy,1,1
49231,protein,1,1
49232,),1,0
49233,for,0,0
49234,a,0,0
49235,five-week,0,0
49236,period,0,0
49237,.,0,0
49238,Fasting,0,0
49239,venous,0,0
49240,blood,0,0
49241,draws,0,0
49242,for,0,0
49243,lipid,0,0
49244,measurement,0,0
49245,were,0,0
49246,obtained,0,0
49247,at,0,0
49248,baseline,0,0
49249,",",0,0
49250,towards,0,0
49251,the,0,0
49252,end,0,0
49253,of,0,0
49254,the,0,0
49255,run-in,0,1
49256,period,0,1
49257,and,0,0
49258,at,0,0
49259,the,0,0
49260,end,0,0
49261,of,0,0
49262,the,0,0
49263,intervention,0,0
49264,.,0,0
49265,Blood,0,1
49266,isoflavone,1,1
49267,concentrations,0,1
49268,were,0,0
49269,measured,0,0
49270,at,0,0
49271,the,0,0
49272,end,0,0
49273,of,0,0
49274,the,0,0
49275,study,0,0
49276,.,0,0
49277,RESULTS,0,0
49278,Blood,0,0
49279,lipid,0,0
49280,levels,0,0
49281,were,0,0
49282,not,0,0
49283,significantly,0,0
49284,different,0,0
49285,between,0,0
49286,groups,0,0
49287,at,0,0
49288,any,0,0
49289,point,0,0
49290,in,0,0
49291,time,0,0
49292,;,0,0
49293,and,0,0
49294,there,0,0
49295,were,0,0
49296,no,0,0
49297,significant,0,0
49298,associations,0,0
49299,between,0,0
49300,blood,0,1
49301,isoflavones,1,1
49302,and,0,0
49303,lipid,0,0
49304,levels,0,0
49305,.,0,0
49306,Significant,0,0
49307,decreases,0,0
49308,in,0,0
49309,total,0,0
49310,cholesterol,0,1
49311,(,0,1
49312,19,0,1
49313,mg/dL,0,1
49314,),0,1
49315,",",0,1
49316,and,0,1
49317,LDL-cholesterol,0,1
49318,(,0,1
49319,11,0,1
49320,mg/dL,0,1
49321,),0,1
49322,",",0,0
49323,were,0,0
49324,observed,0,0
49325,during,0,0
49326,the,0,0
49327,run-in,0,1
49328,period,0,1
49329,",",0,0
49330,with,0,0
49331,no,0,0
49332,further,0,0
49333,decreases,0,0
49334,in,0,0
49335,lipids,0,0
49336,during,0,0
49337,the,0,0
49338,intervention,0,0
49339,period,0,0
49340,in,0,0
49341,either,0,0
49342,group,0,0
49343,.,0,0
49344,CONCLUSIONS,0,0
49345,These,0,0
49346,results,0,0
49347,do,0,0
49348,not,0,0
49349,support,0,0
49350,the,0,0
49351,hypothesis,0,0
49352,that,0,0
49353,water-washed,0,0
49354,soy,1,1
49355,protein,1,0
49356,has,0,0
49357,an,0,0
49358,effect,0,0
49359,on,0,0
49360,blood,0,0
49361,lipids,0,0
49362,.,0,0
49363,Several,0,0
49364,hypotheses,0,0
49365,are,0,0
49366,discussed,0,0
49367,",",0,0
49368,highlighting,0,0
49369,the,0,0
49370,selective,0,0
49371,nature,0,0
49372,of,0,0
49373,the,0,0
49374,effect,0,0
49375,of,0,0
49376,soy,0,1
49377,consumption,0,1
49378,in,0,0
49379,the,0,0
49380,population,0,0
49381,.,0,0
49382,The,0,0
49383,cholesterol-lowering,0,1
49384,effect,0,0
49385,during,0,0
49386,the,0,0
49387,run-in,0,1
49388,period,0,1
49389,may,0,0
49390,be,0,0
49391,explained,0,0
49392,by,0,0
49393,the,0,0
49394,regression,0,0
49395,to,0,0
49396,the,0,0
49397,mean,0,0
49398,effect,0,0
49399,and,0,0
49400,by,0,0
49401,other,0,0
49402,factors,0,0
49403,related,0,0
49404,to,0,0
49405,study,0,0
49406,participation,0,0
49407,",",0,0
49408,mainly,0,0
49409,nutrient,0,0
49410,displacement,0,0
49411,induced,0,0
49412,by,0,0
49413,the,0,0
49414,protein,1,0
49415,supplement,1,1
49416,.,1,0
49417,Safety,0,1
49418,and,0,0
49419,immunogenicity,0,1
49420,of,0,0
49421,an,0,0
49422,oral,1,1
49423,",",1,0
49424,inactivated,1,0
49425,",",1,0
49426,whole-cell,1,0
49427,vaccine,1,1
49428,for,1,1
49429,Shigella,1,1
49430,sonnei,1,1
49431,:,1,0
49432,preclinical,0,0
49433,studies,0,0
49434,and,0,0
49435,a,0,0
49436,Phase,0,0
49437,I,0,0
49438,trial,0,0
49439,.,0,0
49440,Orally,0,0
49441,delivered,0,0
49442,",",0,0
49443,inactivated,0,0
49444,whole-cell,0,0
49445,vaccines,1,0
49446,are,0,0
49447,safe,0,0
49448,methods,0,0
49449,of,0,0
49450,inducing,0,0
49451,local,0,0
49452,and,0,0
49453,systemic,0,0
49454,immunity,0,0
49455,.,0,0
49456,To,0,0
49457,increase,0,0
49458,surface,0,0
49459,proteins,0,0
49460,associated,0,0
49461,with,0,0
49462,adherence,0,0
49463,and,0,0
49464,invasion,0,0
49465,",",0,0
49466,Shigella,0,1
49467,sonnei,0,1
49468,were,0,0
49469,grown,0,0
49470,in,0,0
49471,BHI,0,1
49472,broth,0,1
49473,containing,0,1
49474,deoxycholate,0,1
49475,.,0,0
49476,A,0,1
49477,whole-cell,1,1
49478,vaccine,1,1
49479,(,1,1
49480,SsWC,1,1
49481,),1,0
49482,was,0,0
49483,then,0,0
49484,produced,0,0
49485,by,0,0
49486,formalin,0,1
49487,inactivation,0,0
49488,.,0,0
49489,In,0,0
49490,pre-clinical,0,0
49491,studies,0,0
49492,",",0,0
49493,the,0,0
49494,SsWC,1,1
49495,vaccine,1,1
49496,was,0,0
49497,immunogenic,0,0
49498,and,0,0
49499,protected,0,0
49500,against,0,0
49501,S.,0,0
49502,sonnei-induced,0,0
49503,keratoconjunctivitis,0,0
49504,in,0,0
49505,the,0,0
49506,guinea,0,1
49507,pig,0,0
49508,model,0,0
49509,.,0,0
49510,In,0,0
49511,a,0,0
49512,randomized,0,0
49513,",",0,0
49514,double-blind,0,1
49515,",",0,1
49516,placebo-controlled,1,1
49517,",",0,0
49518,Phase,0,0
49519,I,0,0
49520,study,0,0
49521,",",0,0
49522,10,0,0
49523,evaluable,0,0
49524,subjects,0,0
49525,received,0,0
49526,either,0,0
49527,three,0,0
49528,doses,0,1
49529,of,0,0
49530,SsWC,1,1
49531,on,0,0
49532,Days,0,0
49533,0,0,0
49534,",",0,0
49535,14,0,0
49536,",",0,0
49537,and,0,0
49538,28,0,0
49539,(,0,0
49540,N,0,0
49541,=,0,0
49542,3,0,0
49543,),0,0
49544,;,0,1
49545,five,0,0
49546,doses,0,1
49547,of,0,0
49548,SsWC,1,1
49549,on,0,0
49550,Days,0,0
49551,0,0,0
49552,",",0,0
49553,2,0,0
49554,",",0,0
49555,4,0,0
49556,",",0,0
49557,6,0,0
49558,",",0,0
49559,and,0,0
49560,28,0,0
49561,(,0,0
49562,N,0,0
49563,=,0,0
49564,4,0,0
49565,),0,0
49566,;,0,1
49567,or,1,1
49568,placebo,1,1
49569,(,0,1
49570,N,0,1
49571,=,0,0
49572,3,0,0
49573,),0,0
49574,.,0,1
49575,Each,0,1
49576,dose,0,1
49577,contained,0,0
49578,2.0,0,0
49579,x,0,0
49580,10,0,0
49581,(,0,1
49582,10,0,0
49583,),0,0
49584,inactivated,0,0
49585,cells,0,0
49586,.,0,0
49587,Serum,0,0
49588,and,0,0
49589,fecal,0,0
49590,antibodies,0,0
49591,against,0,0
49592,SsWC,0,0
49593,",",0,0
49594,LPS,0,0
49595,",",0,0
49596,and,0,0
49597,IpaC,0,0
49598,were,0,0
49599,measured,0,0
49600,by,0,0
49601,ELISA,0,0
49602,.,0,0
49603,A,0,0
49604,>,0,0
49605,or,0,0
49606,=,0,0
49607,4-fold,0,0
49608,increase,0,0
49609,in,0,0
49610,titer,0,0
49611,was,0,0
49612,considered,0,0
49613,significant,0,0
49614,.,0,0
49615,Both,0,0
49616,SsWC,1,1
49617,dosing,0,1
49618,regimens,0,1
49619,were,0,1
49620,well,0,0
49621,tolerated,0,1
49622,.,0,1
49623,No,0,1
49624,fever,0,1
49625,or,0,0
49626,severe,0,0
49627,gastrointestinal,0,0
49628,symptoms,0,0
49629,were,0,0
49630,noted,0,0
49631,by,0,0
49632,any,0,0
49633,of,0,0
49634,the,0,0
49635,vaccinated,0,0
49636,subjects,0,0
49637,.,0,0
49638,Antibody,0,0
49639,responses,0,0
49640,were,0,0
49641,similar,0,0
49642,in,0,0
49643,the,0,0
49644,two,0,0
49645,dosing,0,1
49646,groups,0,1
49647,.,0,0
49648,Serum,0,0
49649,IgG,0,1
49650,or,0,0
49651,IgA,0,0
49652,responses,0,0
49653,to,0,0
49654,SsWC,1,0
49655,were,0,0
49656,seen,0,0
49657,in,0,0
49658,six,0,0
49659,of,0,0
49660,seven,0,0
49661,vaccinees,0,0
49662,(,0,0
49663,86,0,0
49664,%,0,0
49665,),0,0
49666,",",0,0
49667,to,0,0
49668,LPS,0,0
49669,in,0,0
49670,four,0,0
49671,of,0,0
49672,seven,0,0
49673,(,0,0
49674,57,0,0
49675,%,0,0
49676,),0,0
49677,",",0,0
49678,and,0,0
49679,to,0,0
49680,IpaC,0,0
49681,in,0,0
49682,five,0,0
49683,of,0,0
49684,seven,0,0
49685,(,0,0
49686,61,0,0
49687,%,0,0
49688,),0,0
49689,.,0,0
49690,Fecal,0,0
49691,IgA,0,0
49692,responses,0,0
49693,to,0,0
49694,these,0,0
49695,three,0,0
49696,antigens,0,0
49697,developed,0,0
49698,in,0,0
49699,five,0,0
49700,of,0,0
49701,five,0,0
49702,",",0,0
49703,three,0,0
49704,of,0,0
49705,five,0,0
49706,",",0,0
49707,and,0,0
49708,three,0,0
49709,of,0,0
49710,five,0,0
49711,subjects,0,0
49712,",",0,0
49713,respectively,0,0
49714,.,0,0
49715,Among,0,0
49716,the,0,0
49717,seven,0,0
49718,vaccinees,0,0
49719,",",0,0
49720,geometric,0,0
49721,mean,0,0
49722,rises,0,0
49723,in,0,0
49724,serum,0,1
49725,IgA,0,1
49726,levels,0,0
49727,to,0,0
49728,all,0,0
49729,three,0,0
49730,immunogens,0,1
49731,were,0,0
49732,significant,0,0
49733,;,0,0
49734,IgG,0,0
49735,increases,0,0
49736,trended,0,0
49737,toward,0,0
49738,significance,0,0
49739,(,0,0
49740,paired,0,0
49741,one-tailed,0,1
49742,t-test,0,1
49743,),0,0
49744,.,0,0
49745,We,0,0
49746,conclude,0,0
49747,that,0,0
49748,SsWC,1,0
49749,was,0,0
49750,immunogenic,0,0
49751,and,0,0
49752,protective,0,0
49753,in,0,0
49754,animal,0,0
49755,studies,0,0
49756,and,0,0
49757,well,0,0
49758,tolerated,0,1
49759,and,0,0
49760,immunogenic,0,0
49761,in,0,0
49762,a,0,0
49763,Phase,0,0
49764,I,0,0
49765,trial,0,0
49766,.,0,0
49767,Impact,0,0
49768,of,0,0
49769,a,0,0
49770,single,0,0
49771,intravenous,0,1
49772,administration,0,1
49773,of,0,1
49774,nicorandil,1,1
49775,before,0,1
49776,reperfusion,0,1
49777,in,0,0
49778,patients,0,0
49779,with,0,0
49780,ST-segment-elevation,0,0
49781,myocardial,0,0
49782,infarction,0,0
49783,.,0,0
49784,BACKGROUND,0,1
49785,Intravenous,0,1
49786,nicorandil,1,1
49787,",",0,1
49788,a,0,0
49789,hybrid,0,0
49790,compound,0,0
49791,of,0,0
49792,ATP-sensitive,0,0
49793,potassium,0,1
49794,channel,0,1
49795,opener,0,1
49796,and,0,1
49797,nitric,0,1
49798,oxide,0,1
49799,donor,0,0
49800,",",0,0
49801,has,0,0
49802,been,0,0
49803,reported,0,0
49804,to,0,0
49805,ameliorate,0,0
49806,early,0,0
49807,functional,0,0
49808,and,0,0
49809,clinical,0,0
49810,problems,0,0
49811,in,0,0
49812,patients,0,0
49813,with,0,0
49814,acute,0,0
49815,myocardial,0,0
49816,infarction,0,0
49817,.,0,0
49818,However,0,0
49819,",",0,0
49820,its,0,0
49821,effects,0,0
49822,on,0,0
49823,the,0,0
49824,late,0,0
49825,phase,0,0
49826,remain,0,0
49827,unclear,0,0
49828,.,0,0
49829,METHODS,0,0
49830,AND,0,1
49831,RESULTS,0,1
49832,This,0,0
49833,follow-up,0,0
49834,study,0,0
49835,to,0,0
49836,5,0,0
49837,years,0,0
49838,of,0,0
49839,a,0,0
49840,randomized,0,0
49841,",",0,0
49842,double-blinded,0,1
49843,trial,0,1
49844,was,0,0
49845,conducted,0,0
49846,among,0,0
49847,368,0,0
49848,patients,0,0
49849,with,0,0
49850,first,0,0
49851,ST-segment-elevation,0,0
49852,myocardial,0,0
49853,infarction,0,1
49854,undergoing,0,1
49855,percutaneous,0,1
49856,coronary,0,1
49857,intervention,0,1
49858,(,0,1
49859,PCI,0,1
49860,),0,1
49861,.,0,0
49862,They,0,0
49863,were,0,0
49864,randomly,0,0
49865,assigned,0,0
49866,to,0,0
49867,receive,0,1
49868,12,0,1
49869,mg,0,1
49870,of,0,1
49871,nicorandil,1,1
49872,or,1,1
49873,a,1,1
49874,placebo,1,1
49875,intravenously,0,1
49876,just,0,1
49877,before,0,0
49878,reperfusion,0,1
49879,.,0,0
49880,We,0,0
49881,analyzed,0,0
49882,incidence,0,0
49883,of,0,0
49884,cardiovascular,0,0
49885,death,0,0
49886,or,0,0
49887,rehospitalization,0,0
49888,for,0,0
49889,congestive,0,0
49890,heart,0,0
49891,failure,0,0
49892,after,0,0
49893,PCI,0,0
49894,as,0,0
49895,well,0,0
49896,as,0,0
49897,various,0,0
49898,aspects,0,0
49899,of,0,0
49900,epicardial,0,0
49901,flow,0,0
49902,and,0,0
49903,microvascular,0,0
49904,function,0,0
49905,.,0,0
49906,Mean,0,0
49907,follow-up,0,0
49908,was,0,0
49909,2.4,0,0
49910,years,0,0
49911,(,0,0
49912,SD,0,1
49913,",",0,1
49914,1.4,0,0
49915,),0,0
49916,.,0,0
49917,A,0,0
49918,total,0,0
49919,of,0,0
49920,12,0,0
49921,(,0,0
49922,6.5,0,0
49923,%,0,0
49924,),0,0
49925,patients,0,0
49926,receiving,0,0
49927,nicorandil,1,1
49928,and,0,1
49929,30,0,0
49930,(,0,0
49931,16.4,0,0
49932,%,0,0
49933,),0,0
49934,receiving,0,0
49935,placebo,1,1
49936,had,0,0
49937,cardiovascular,0,0
49938,death,0,0
49939,or,0,0
49940,hospital,0,0
49941,admission,0,0
49942,for,0,0
49943,congestive,0,0
49944,heart,0,1
49945,failure,0,1
49946,(,0,1
49947,hazard,0,1
49948,ratio,0,0
49949,",",0,0
49950,0.39,0,0
49951,;,0,0
49952,95,0,0
49953,%,0,0
49954,CI,0,0
49955,",",0,0
49956,0.20,0,0
49957,to,0,0
49958,0.76,0,0
49959,;,0,0
49960,P=0.0058,0,0
49961,),0,0
49962,.,0,0
49963,Postprocedural,0,0
49964,TIMI,0,0
49965,3,0,0
49966,flow,0,0
49967,was,0,0
49968,obtained,0,0
49969,in,0,0
49970,89.7,0,0
49971,%,0,0
49972,of,0,0
49973,the,0,0
49974,nicorandil,1,1
49975,group,0,0
49976,and,0,0
49977,in,0,0
49978,81.4,0,0
49979,%,0,0
49980,of,0,0
49981,the,0,0
49982,placebo,1,1
49983,(,0,1
49984,hazard,0,1
49985,ratio,0,0
49986,",",0,0
49987,1.99,0,0
49988,;,0,0
49989,95,0,0
49990,%,0,0
49991,CI,0,0
49992,",",0,0
49993,1.09,0,0
49994,to,0,0
49995,3.65,0,0
49996,;,0,0
49997,P=0.025,0,0
49998,),0,0
49999,.,0,0
50000,Corrected,0,0
50001,TIMI,0,0
50002,frame,0,0
50003,count,0,0
50004,was,0,0
50005,furthermore,0,0
50006,lower,0,0
50007,in,0,0
50008,the,0,0
50009,nicorandil,1,1
50010,group,0,1
50011,(,0,0
50012,21.0+/-9.1,0,0
50013,versus,0,0
50014,25.1+/-14.1,0,0
50015,;,0,0
50016,P=0.0009,0,0
50017,),0,0
50018,.,0,0
50019,ST-segment,0,0
50020,resolution,0,0
50021,>,0,0
50022,50,0,0
50023,%,0,0
50024,was,0,0
50025,observed,0,0
50026,in,0,0
50027,79.5,0,0
50028,%,0,0
50029,and,0,0
50030,61.2,0,0
50031,%,0,0
50032,of,0,0
50033,the,0,0
50034,nicorandil,1,1
50035,and,0,1
50036,placebo,1,1
50037,groups,0,0
50038,",",0,0
50039,respectively,0,0
50040,(,0,0
50041,hazard,0,0
50042,ratio,0,0
50043,",",0,0
50044,2.45,0,0
50045,;,0,0
50046,95,0,0
50047,%,0,0
50048,CI,0,0
50049,",",0,0
50050,1.54,0,0
50051,to,0,0
50052,3.90,0,0
50053,;,0,0
50054,P=0.0002,0,0
50055,),0,0
50056,.,0,0
50057,CONCLUSIONS,0,0
50058,The,0,0
50059,addition,0,0
50060,of,0,0
50061,intravenous,0,1
50062,nicorandil,1,1
50063,to,0,1
50064,PCI,0,0
50065,leads,0,0
50066,to,0,0
50067,beneficial,0,0
50068,clinical,0,0
50069,outcomes,0,0
50070,and,0,0
50071,prevents,0,0
50072,cardiovascular,0,0
50073,events,0,0
50074,of,0,0
50075,long,0,0
50076,duration,0,0
50077,and,0,0
50078,death,0,0
50079,in,0,0
50080,patients,0,0
50081,with,0,0
50082,ST-segment-elevation,0,0
50083,myocardial,0,0
50084,infarction,0,0
50085,.,0,0
50086,Clinical,0,0
50087,efficacy,0,0
50088,of,0,0
50089,fluvoxamine,1,1
50090,and,0,0
50091,functional,0,0
50092,polymorphism,0,0
50093,in,0,0
50094,a,0,0
50095,serotonin,0,1
50096,transporter,0,0
50097,gene,0,0
50098,on,0,0
50099,childhood,0,0
50100,autism,0,0
50101,.,0,0
50102,We,0,0
50103,studied,0,0
50104,the,0,0
50105,correlation,0,0
50106,between,0,0
50107,response,0,0
50108,to,0,0
50109,fluvoxamine,1,1
50110,and,0,1
50111,serotonin,0,1
50112,transporter,0,0
50113,gene,0,0
50114,promoter,0,0
50115,region,0,0
50116,polymorphism,0,0
50117,(,0,1
50118,5-HTTLPR,0,1
50119,),0,1
50120,.,0,0
50121,Eighteen,0,0
50122,children,0,0
50123,with,0,0
50124,autistic,0,0
50125,disorder,0,0
50126,completed,0,0
50127,a,0,0
50128,12-week,0,1
50129,double-blind,0,1
50130,",",0,1
50131,placebo-controlled,1,1
50132,",",0,1
50133,randomized,0,1
50134,crossover,0,1
50135,study,0,0
50136,of,0,0
50137,fluvoxamine,1,1
50138,.,1,1
50139,Behavioral,0,0
50140,assessments,0,0
50141,were,0,0
50142,obtained,0,0
50143,before,0,0
50144,and,0,0
50145,at,0,0
50146,12,0,0
50147,weeks,0,0
50148,of,0,0
50149,treatment,0,0
50150,.,0,0
50151,5-HTTLPR,0,1
50152,(,0,0
50153,long,0,0
50154,(,0,1
50155,l,0,1
50156,),0,0
50157,or,0,0
50158,short,0,0
50159,(,0,1
50160,s,0,1
50161,),0,1
50162,),0,0
50163,",",0,0
50164,was,0,0
50165,analyzed,0,0
50166,by,0,0
50167,the,0,0
50168,PCR,1,0
50169,method,1,0
50170,.,1,0
50171,Ten,0,0
50172,out,0,0
50173,of,0,0
50174,18,0,0
50175,patients,0,0
50176,responded,0,0
50177,to,0,0
50178,fluvoxamine,1,1
50179,treatment,0,1
50180,;,0,1
50181,allele,0,0
50182,type,0,0
50183,analysis,0,0
50184,revealed,0,0
50185,that,0,0
50186,clinical,0,0
50187,global,0,0
50188,effectiveness,0,0
50189,was,0,0
50190,noted,0,0
50191,significantly,0,0
50192,more,0,0
50193,in,0,0
50194,the,0,0
50195,l,0,0
50196,allele,0,0
50197,than,0,0
50198,in,0,0
50199,the,0,0
50200,s,0,0
50201,allele,0,0
50202,.,0,0
50203,However,0,0
50204,",",0,0
50205,with,0,0
50206,respect,0,0
50207,to,0,0
50208,language,0,0
50209,use,0,0
50210,",",0,0
50211,a,0,0
50212,significant,0,0
50213,effectiveness,0,0
50214,was,0,0
50215,noted,0,0
50216,in,0,0
50217,the,0,0
50218,s,0,0
50219,allele,0,0
50220,.,0,0
50221,5-HTTLPR,0,0
50222,may,0,0
50223,influence,0,0
50224,the,0,0
50225,individual,0,0
50226,responses,0,0
50227,to,0,0
50228,fluvoxamine,1,1
50229,administration,0,1
50230,.,0,1
50231,Efficacy,0,0
50232,and,0,0
50233,safety,0,0
50234,of,0,0
50235,zidovudine,1,1
50236,and,1,1
50237,zalcitabine,1,1
50238,combined,0,0
50239,with,0,0
50240,a,0,0
50241,combination,0,0
50242,of,0,0
50243,herbs,0,1
50244,in,0,0
50245,the,0,0
50246,treatment,0,0
50247,of,0,0
50248,HIV-infected,0,0
50249,Thai,0,0
50250,patients,0,0
50251,.,0,0
50252,A,0,0
50253,randomized,0,0
50254,double,0,0
50255,blind,0,1
50256,placebo,1,1
50257,controlled,0,0
50258,trial,0,0
50259,to,0,0
50260,determine,0,0
50261,the,0,0
50262,efficacy,0,0
50263,and,0,0
50264,safety,0,0
50265,of,0,0
50266,combined-herbs,0,1
50267,(,0,1
50268,SH,0,1
50269,),0,1
50270,given,0,1
50271,with,0,1
50272,zidovudine,1,1
50273,(,0,1
50274,ZDV,0,1
50275,),0,1
50276,and,0,1
50277,zalcitabine,1,1
50278,(,0,1
50279,ddC,0,1
50280,),0,0
50281,for,0,0
50282,the,0,0
50283,treatment,0,0
50284,of,0,0
50285,HIV,0,0
50286,infection,0,0
50287,in,0,0
50288,Thai,0,0
50289,adults,0,0
50290,was,0,0
50291,conducted,0,0
50292,in,0,0
50293,3,0,0
50294,hospitals,0,0
50295,in,0,0
50296,northern,0,0
50297,Thailand,0,0
50298,during,0,0
50299,2002,0,0
50300,to,0,0
50301,2003,0,0
50302,.,0,0
50303,The,0,0
50304,eligible,0,0
50305,subjects,0,0
50306,were,0,0
50307,HIV-infected,0,0
50308,Thai,0,0
50309,adults,0,0
50310,who,0,0
50311,had,0,0
50312,never,0,0
50313,received,0,0
50314,anti-retrovirals,1,1
50315,",",0,0
50316,had,0,0
50317,a,0,0
50318,Karnofski,0,0
50319,Performance,0,0
50320,Score,0,0
50321,(,0,1
50322,KPS,0,1
50323,),0,1
50324,of,0,0
50325,>,0,0
50326,or,0,0
50327,=,0,0
50328,70,0,0
50329,",",0,0
50330,and,0,0
50331,had,0,0
50332,no,0,0
50333,opportunistic,0,0
50334,infections,0,0
50335,.,0,0
50336,The,0,0
50337,subjects,0,0
50338,were,0,0
50339,randomized,0,0
50340,to,0,0
50341,receive,0,0
50342,either,0,0
50343,a,0,0
50344,combination,0,0
50345,of,0,0
50346,ZDV,1,1
50347,200,0,1
50348,mg,0,1
50349,three,0,0
50350,times,0,1
50351,per,0,0
50352,day,0,0
50353,",",0,0
50354,ddC,1,1
50355,0.75,0,0
50356,mg,0,0
50357,three,0,0
50358,times,0,1
50359,per,0,0
50360,day,0,0
50361,",",0,0
50362,and,0,0
50363,SH,1,1
50364,2.5,0,1
50365,g,0,0
50366,three,0,0
50367,times,0,1
50368,per,0,0
50369,day,0,0
50370,or,0,0
50371,a,1,0
50372,combination,1,0
50373,of,1,0
50374,ZDV,1,1
50375,200,1,1
50376,mg,1,1
50377,three,1,0
50378,times,1,1
50379,per,1,0
50380,day,1,0
50381,",",1,0
50382,ddC,1,1
50383,0.75,1,0
50384,mg,1,0
50385,three,1,0
50386,times,1,1
50387,per,1,0
50388,day,1,0
50389,",",1,1
50390,and,1,1
50391,placebo,1,1
50392,2.5,0,1
50393,g,0,0
50394,three,0,0
50395,times,0,1
50396,per,0,0
50397,day,0,0
50398,for,0,0
50399,24,0,0
50400,weeks,0,0
50401,.,0,0
50402,The,0,0
50403,main,0,0
50404,outcome,0,0
50405,measures,0,0
50406,were,0,0
50407,HIV-RNA,0,0
50408,",",0,0
50409,CD4,0,0
50410,cells,0,0
50411,",",0,0
50412,and,0,0
50413,blood,0,0
50414,chemistry,0,0
50415,profiles,0,0
50416,prior,0,0
50417,to,0,0
50418,the,0,0
50419,treatment,0,0
50420,and,0,0
50421,then,0,0
50422,every,0,0
50423,4,0,0
50424,weeks,0,0
50425,for,0,0
50426,24,0,0
50427,weeks,0,0
50428,.,0,0
50429,The,0,0
50430,baseline,0,0
50431,characteristics,0,0
50432,of,0,0
50433,60,0,0
50434,evaluable,0,0
50435,subjects,0,0
50436,",",0,0
50437,40,0,0
50438,in,0,0
50439,the,0,0
50440,SH,1,0
50441,group,0,0
50442,and,0,0
50443,20,0,0
50444,in,0,0
50445,the,0,0
50446,placebo,1,1
50447,group,0,0
50448,",",0,0
50449,were,0,0
50450,not,0,0
50451,significantly,0,0
50452,different,0,0
50453,.,0,0
50454,HIV,0,0
50455,RNA,0,0
50456,at,0,0
50457,week,0,0
50458,4,0,0
50459,and,0,0
50460,thereafter,0,0
50461,was,0,0
50462,significantly,0,0
50463,decreased,0,0
50464,from,0,0
50465,the,0,0
50466,baseline,0,0
50467,value,0,0
50468,in,0,0
50469,both,0,0
50470,groups,0,0
50471,(,0,0
50472,p,0,0
50473,<,0,0
50474,0.001,0,0
50475,),0,0
50476,.,0,0
50477,However,0,0
50478,",",0,0
50479,the,0,0
50480,decline,0,0
50481,in,0,0
50482,HIV,0,0
50483,RNA,0,0
50484,in,0,0
50485,the,0,0
50486,SH,1,0
50487,group,0,0
50488,was,0,0
50489,significantly,0,0
50490,more,0,0
50491,than,0,0
50492,that,0,0
50493,in,0,0
50494,the,0,0
50495,placebo,0,1
50496,group,0,0
50497,.,0,0
50498,The,0,0
50499,CD4,0,0
50500,cells,0,0
50501,in,0,0
50502,the,0,0
50503,SH,0,0
50504,group,0,0
50505,at,0,0
50506,week,0,0
50507,12,0,0
50508,and,0,0
50509,thereafter,0,0
50510,were,0,0
50511,significantly,0,0
50512,increased,0,0
50513,from,0,0
50514,the,0,0
50515,baseline,0,0
50516,value,0,0
50517,.,0,0
50518,Serious,0,0
50519,adverse,0,0
50520,events,0,0
50521,in,0,0
50522,the,0,0
50523,two,0,0
50524,groups,0,0
50525,were,0,0
50526,not,0,0
50527,observed,0,0
50528,.,0,0
50529,It,0,0
50530,is,0,0
50531,concluded,0,0
50532,that,0,0
50533,an,0,0
50534,addition,0,0
50535,of,0,0
50536,SH,0,1
50537,herbs,0,1
50538,to,0,0
50539,two,0,0
50540,nucleoside,0,1
50541,reverse,0,1
50542,transcriptase,0,1
50543,inhibitors,0,1
50544,has,0,1
50545,greater,0,0
50546,antiviral,0,1
50547,activity,0,1
50548,than,0,1
50549,antiretrovirals,0,1
50550,only,0,0
50551,.,0,0
50552,The,0,0
50553,SH,1,0
50554,herbs,0,1
50555,may,0,0
50556,be,0,0
50557,an,0,0
50558,alternative,0,0
50559,for,0,0
50560,the,0,0
50561,third,0,0
50562,anti-retroviral,0,0
50563,agent,0,0
50564,in,0,0
50565,the,0,0
50566,triple,0,0
50567,drug,0,1
50568,regimen,0,1
50569,for,0,0
50570,the,0,0
50571,treatment,0,0
50572,of,0,0
50573,HIV,0,0
50574,infected,0,0
50575,patients,0,0
50576,in,0,0
50577,countries,0,0
50578,with,0,0
50579,limited,0,0
50580,resources,0,0
50581,.,0,0
50582,Drug,0,1
50583,therapy,0,0
50584,of,0,0
50585,ventricular,0,0
50586,tachycardia,0,0
50587,:,0,0
50588,a,0,0
50589,cost,0,0
50590,comparison,0,0
50591,of,0,0
50592,randomized,0,0
50593,noninvasive,1,0
50594,and,1,0
50595,invasive,1,0
50596,approaches,1,0
50597,.,1,0
50598,OBJECTIVE,0,0
50599,Economic,0,0
50600,evaluation,0,0
50601,of,0,0
50602,noninvasive,1,0
50603,(,1,0
50604,suppression,1,0
50605,of,1,0
50606,ventricular,1,0
50607,arrhythmias,1,0
50608,detected,1,0
50609,by,1,0
50610,ambulatory,1,0
50611,monitoring,1,0
50612,),1,0
50613,and,0,0
50614,invasive,1,1
50615,(,1,0
50616,suppression,1,0
50617,of,1,0
50618,arrhythmias,1,0
50619,induced,1,0
50620,by,1,0
50621,programmed,1,0
50622,stimulation,1,0
50623,),1,0
50624,approaches,0,0
50625,to,0,1
50626,antiarrhythmic,0,1
50627,drug,0,1
50628,selection,0,1
50629,for,0,0
50630,ventricular,0,0
50631,tachyarrhythmias,0,0
50632,.,0,0
50633,DESIGN/SETTING,0,0
50634,Randomized,0,0
50635,clinical,0,1
50636,trial/tertiary-care,0,0
50637,hospital,0,0
50638,.,0,0
50639,PATIENTS,0,0
50640,Of,0,0
50641,124,0,0
50642,consecutive,0,0
50643,patients,0,0
50644,referred,0,0
50645,for,0,0
50646,treatment,0,0
50647,of,0,0
50648,symptomatic,0,0
50649,ventricular,0,0
50650,tachyarrhythmias,0,0
50651,",",0,0
50652,57,0,0
50653,consenting,0,0
50654,patients,0,0
50655,were,0,0
50656,eligible,0,0
50657,to,0,0
50658,have,0,0
50659,drug,0,1
50660,therapy,0,1
50661,selected,0,0
50662,by,0,0
50663,either,0,0
50664,noninvasive,1,0
50665,or,1,0
50666,invasive,1,0
50667,approaches,1,0
50668,.,1,0
50669,MEASUREMENTS,0,0
50670,Costs,0,0
50671,of,0,0
50672,initial,0,0
50673,and,0,0
50674,follow-up,0,0
50675,(,0,0
50676,26,0,0
50677,+/-,0,0
50678,15,0,0
50679,months,0,0
50680,),0,0
50681,admissions,0,0
50682,for,0,0
50683,the,0,0
50684,two,0,0
50685,groups,0,0
50686,were,0,0
50687,compared,0,0
50688,.,0,0
50689,This,0,0
50690,economic,0,0
50691,evaluation,0,0
50692,also,0,0
50693,considered,0,0
50694,relative,0,0
50695,efficacies,0,0
50696,of,0,0
50697,the,0,0
50698,approaches,0,0
50699,using,0,0
50700,the,0,0
50701,primary,0,0
50702,outcome,0,0
50703,variable,0,0
50704,of,0,0
50705,symptomatic,0,0
50706,",",0,0
50707,sustained,0,0
50708,ventricular,0,0
50709,tachyarrhythmia,0,1
50710,recurrence,0,1
50711,(,0,0
50712,including,0,0
50713,sudden,0,1
50714,death,0,1
50715,),0,0
50716,.,0,0
50717,RESULTS,0,1
50718,Initial,0,0
50719,hospitalization,0,0
50720,for,0,0
50721,therapy,0,0
50722,selection,0,0
50723,was,0,0
50724,less,0,0
50725,costly,0,0
50726,by,0,0
50727,the,0,0
50728,noninvasive,0,0
50729,approach,0,0
50730,(,0,0
50731,$,0,0
50732,"6,869",0,0
50733,+/-,0,0
50734,"4,019",0,0
50735,),0,0
50736,than,0,0
50737,by,0,0
50738,the,0,0
50739,invasive,1,0
50740,approach,1,0
50741,(,0,0
50742,$,0,0
50743,"13,164",0,0
50744,+/-,0,0
50745,"6,740",0,0
50746,),0,0
50747,(,0,0
50748,P,0,0
50749,less,0,0
50750,than,0,0
50751,0.001,0,0
50752,),0,0
50753,.,0,0
50754,However,0,0
50755,",",0,0
50756,the,0,0
50757,noninvasive,1,0
50758,approach,1,0
50759,generated,0,0
50760,higher,0,0
50761,follow-up,0,0
50762,hospital,0,1
50763,costs,0,0
50764,(,0,0
50765,$,0,0
50766,"9,204",0,0
50767,+/-,0,0
50768,"9,217",0,0
50769,),0,0
50770,than,0,0
50771,the,0,0
50772,invasive,0,0
50773,approach,0,0
50774,(,0,0
50775,$,0,0
50776,"3,784",0,0
50777,+/-,0,0
50778,"4,944",0,0
50779,),0,0
50780,(,0,0
50781,P,0,0
50782,=,0,0
50783,0.01,0,0
50784,),0,0
50785,.,0,0
50786,Thus,0,0
50787,",",0,0
50788,total,0,0
50789,hospital,0,0
50790,costs,0,0
50791,of,0,0
50792,the,0,0
50793,noninvasive,0,0
50794,(,0,0
50795,$,0,0
50796,"16,073",0,0
50797,+/-,0,0
50798,"9,423",0,0
50799,),0,0
50800,and,0,0
50801,invasive,0,1
50802,approaches,0,0
50803,(,0,0
50804,$,0,0
50805,"16,949",0,0
50806,+/-,0,0
50807,"7,174",0,0
50808,),0,0
50809,were,0,0
50810,equivalent,0,0
50811,.,0,0
50812,The,0,0
50813,two-year,0,0
50814,actuarial,0,0
50815,probability,0,0
50816,of,0,0
50817,a,0,0
50818,recurrent,0,0
50819,",",0,0
50820,sustained,0,0
50821,",",0,0
50822,symptomatic,0,0
50823,ventricular,0,0
50824,tachyarrhythmia,0,0
50825,was,0,0
50826,greater,0,0
50827,in,0,0
50828,noninvasive,1,0
50829,(,0,0
50830,0.50,0,0
50831,+/-,0,0
50832,0.10,0,0
50833,),0,0
50834,than,0,0
50835,in,0,0
50836,invasive,1,0
50837,(,0,0
50838,0.20,0,0
50839,+/-,0,0
50840,0.08,0,0
50841,),0,0
50842,approach,0,0
50843,patients,0,0
50844,(,0,0
50845,P,0,0
50846,=,0,0
50847,0.02,0,0
50848,),0,0
50849,.,0,0
50850,CONCLUSIONS,0,0
50851,The,0,0
50852,lower,0,0
50853,initial,0,0
50854,hospital,0,0
50855,costs,0,0
50856,of,0,0
50857,the,0,0
50858,noninvasive,0,0
50859,approach,0,0
50860,are,0,0
50861,offset,0,0
50862,by,0,0
50863,greater,0,0
50864,follow-up,0,0
50865,costs,0,0
50866,.,0,0
50867,Within,0,0
50868,two,0,0
50869,years,0,0
50870,the,0,0
50871,costs,0,0
50872,of,0,0
50873,the,0,0
50874,two,0,0
50875,approaches,0,0
50876,are,0,0
50877,equivalent,0,0
50878,.,0,0
50879,Thus,0,0
50880,",",0,0
50881,greater,0,0
50882,antiarrhythmic,0,1
50883,efficacy,0,1
50884,can,0,0
50885,be,0,0
50886,achieved,0,0
50887,by,0,0
50888,the,0,0
50889,invasive,1,0
50890,approach,1,0
50891,to,0,0
50892,drug,0,1
50893,selection,0,0
50894,without,0,0
50895,increasing,0,0
50896,total,0,0
50897,hospital,0,0
50898,costs,0,0
50899,.,0,0
50900,[,0,1
50901,A,0,1
50902,clinical,0,1
50903,study,0,0
50904,on,0,0
50905,the,0,0
50906,effect,0,0
50907,of,0,0
50908,Yinxing,1,0
50909,Damo,1,0
50910,combined,1,0
50911,with,1,1
50912,betahistine,1,1
50913,hydrochloride,1,1
50914,injection,0,1
50915,on,0,1
50916,vertebral,0,0
50917,basilar,0,0
50918,artery,0,1
50919,ischemic,0,1
50920,vertigo,0,1
50921,],0,0
50922,.,0,0
50923,OBJECTIVE,0,0
50924,To,0,0
50925,evaluate,0,0
50926,the,0,0
50927,therapeutic,0,0
50928,efficacy,0,0
50929,of,0,0
50930,Yinxing,1,1
50931,Damo,1,1
50932,(,1,1
50933,YXDM,1,1
50934,),1,0
50935,combined,1,0
50936,with,1,1
50937,Betahistine,1,1
50938,Hydrochloride,1,1
50939,Injection,1,1
50940,(,0,1
50941,BHI,0,1
50942,),0,1
50943,on,0,0
50944,vertebra,0,0
50945,basilar,0,0
50946,artery,0,1
50947,ischemic,0,1
50948,vertigo,0,1
50949,(,0,1
50950,VBIV,0,1
50951,),0,1
50952,.,0,0
50953,METHODS,0,0
50954,Ninety,0,0
50955,patients,0,0
50956,with,0,0
50957,VBIV,0,0
50958,were,0,0
50959,randomly,0,0
50960,divided,0,0
50961,into,0,0
50962,two,0,0
50963,groups,0,0
50964,;,0,0
50965,45,0,0
50966,patients,0,0
50967,(,0,0
50968,the,0,0
50969,treated,0,0
50970,group,0,0
50971,),0,0
50972,were,0,0
50973,treated,0,0
50974,with,0,0
50975,YXDM,1,0
50976,and,0,0
50977,BHI,1,1
50978,intravenous,0,1
50979,dripping,0,1
50980,",",0,1
50981,once,0,1
50982,a,0,0
50983,day,0,0
50984,for,0,0
50985,14,0,0
50986,days,0,0
50987,.,0,0
50988,Another,0,0
50989,45,0,0
50990,patients,0,0
50991,(,0,0
50992,control,0,0
50993,group,0,0
50994,),0,0
50995,were,0,0
50996,treated,0,0
50997,with,0,0
50998,Xueshuantong,0,1
50999,and,0,1
51000,BHI,0,1
51001,intravenous,0,1
51002,dripping,0,1
51003,",",0,1
51004,once,0,1
51005,daily,0,1
51006,for,0,1
51007,14,0,0
51008,days,0,0
51009,.,0,0
51010,The,0,0
51011,clinical,0,0
51012,syndromes,0,0
51013,and,0,0
51014,the,0,0
51015,index,0,0
51016,of,0,0
51017,the,0,0
51018,transcranial,0,0
51019,Doppler,0,1
51020,(,0,1
51021,TCD,0,1
51022,),0,1
51023,and,0,0
51024,hemorheology,0,0
51025,were,0,0
51026,observed,0,0
51027,.,0,0
51028,RESULTS,0,0
51029,The,0,0
51030,total,0,0
51031,effective,0,0
51032,rate,0,0
51033,was,0,0
51034,100,0,0
51035,%,0,0
51036,in,0,0
51037,the,0,0
51038,treated,0,0
51039,group,0,0
51040,",",0,0
51041,which,0,0
51042,was,0,0
51043,better,0,0
51044,than,0,0
51045,that,0,0
51046,in,0,0
51047,the,0,0
51048,control,0,0
51049,group,0,0
51050,90.5,0,0
51051,%,0,0
51052,",",0,0
51053,(,0,0
51054,P,0,0
51055,<,0,0
51056,0.05,0,0
51057,),0,0
51058,.,0,0
51059,The,0,0
51060,indexes,0,0
51061,of,0,0
51062,TCD,0,0
51063,and,0,0
51064,hemorheology,0,0
51065,in,0,0
51066,the,0,0
51067,treated,0,0
51068,group,0,0
51069,were,0,0
51070,obviously,0,0
51071,improved,0,0
51072,after,0,0
51073,treatment,0,0
51074,",",0,0
51075,(,0,0
51076,P,0,0
51077,<,0,0
51078,0.01,0,0
51079,),0,0
51080,.,0,0
51081,CONCLUSION,0,0
51082,YXDM,0,0
51083,combined,0,0
51084,with,0,0
51085,BHT,0,0
51086,injection,0,1
51087,had,0,0
51088,better,0,0
51089,effect,0,0
51090,in,0,0
51091,treating,0,0
51092,patients,0,0
51093,with,0,0
51094,VBIV,0,0
51095,is,0,0
51096,an,0,0
51097,ideal,0,0
51098,drug,0,1
51099,for,0,0
51100,VBIV,0,1
51101,.,0,0
51102,Intensive,1,0
51103,behavioral,1,0
51104,treatment,1,0
51105,for,0,0
51106,children,0,0
51107,with,0,0
51108,autism,0,0
51109,:,0,0
51110,four-year,0,0
51111,outcome,0,0
51112,and,0,0
51113,predictors,0,0
51114,.,0,0
51115,Twenty-four,0,0
51116,children,0,0
51117,with,0,0
51118,autism,0,0
51119,were,0,0
51120,randomly,0,0
51121,assigned,0,0
51122,to,0,0
51123,a,0,0
51124,clinic-directed,1,0
51125,group,1,0
51126,",",0,0
51127,replicating,0,0
51128,the,0,0
51129,parameters,0,0
51130,of,0,0
51131,the,0,0
51132,early,1,0
51133,intensive,1,0
51134,behavioral,1,0
51135,treatment,1,0
51136,developed,1,0
51137,at,1,0
51138,UCLA,1,0
51139,",",1,0
51140,or,1,0
51141,to,1,0
51142,a,1,0
51143,parent-directed,1,0
51144,group,1,0
51145,that,1,0
51146,received,1,0
51147,intensive,1,0
51148,hours,1,0
51149,but,1,0
51150,less,1,0
51151,supervision,1,0
51152,by,1,0
51153,equally,1,0
51154,well-trained,1,0
51155,supervisors,1,0
51156,.,1,0
51157,Outcome,0,0
51158,after,0,0
51159,4,0,0
51160,years,0,0
51161,of,0,0
51162,treatment,0,0
51163,",",0,0
51164,including,0,0
51165,cognitive,0,0
51166,",",0,0
51167,language,0,0
51168,",",0,0
51169,adaptive,0,0
51170,",",0,0
51171,social,0,0
51172,",",0,0
51173,and,0,0
51174,academic,0,0
51175,measures,0,0
51176,",",0,0
51177,was,0,0
51178,similar,0,0
51179,for,0,0
51180,both,0,0
51181,groups,0,0
51182,.,0,0
51183,After,0,0
51184,combining,0,0
51185,groups,0,0
51186,",",0,0
51187,we,0,0
51188,found,0,0
51189,that,0,0
51190,48,0,0
51191,%,0,0
51192,of,0,0
51193,all,0,0
51194,children,0,0
51195,showed,0,0
51196,rapid,0,0
51197,learning,0,0
51198,",",0,0
51199,achieved,0,0
51200,average,0,0
51201,posttreatment,0,0
51202,scores,0,0
51203,",",0,0
51204,and,0,0
51205,at,0,0
51206,age,0,0
51207,7,0,0
51208,",",0,0
51209,were,0,0
51210,succeeding,0,0
51211,in,0,0
51212,regular,0,0
51213,education,0,0
51214,classrooms,0,0
51215,.,0,0
51216,Treatment,0,0
51217,outcome,0,0
51218,was,0,0
51219,best,0,0
51220,predicted,0,0
51221,by,0,0
51222,pretreatment,0,1
51223,imitation,0,1
51224,",",0,0
51225,language,0,0
51226,",",0,0
51227,and,0,0
51228,social,0,0
51229,responsiveness,0,0
51230,.,0,0
51231,These,0,0
51232,results,0,0
51233,are,0,0
51234,consistent,0,0
51235,with,0,0
51236,those,0,0
51237,reported,0,0
51238,by,0,0
51239,Lovaas,0,0
51240,and,0,0
51241,colleagues,0,1
51242,(,0,1
51243,Lovaas,0,0
51244,",",0,1
51245,1987,0,1
51246,;,0,0
51247,McEachin,0,1
51248,",",0,0
51249,Smith,0,1
51250,",",0,0
51251,&,0,1
51252,Lovaas,0,0
51253,",",0,0
51254,1993,0,1
51255,),0,0
51256,.,0,0
51257,Minimal,0,0
51258,tolerance,0,0
51259,to,0,0
51260,the,0,0
51261,bronchoprotective,0,1
51262,effect,0,0
51263,of,0,1
51264,inhaled,0,1
51265,salmeterol/fluticasone,1,1
51266,combination,0,1
51267,on,0,0
51268,allergene,0,1
51269,challenge,0,0
51270,.,0,0
51271,In,0,0
51272,order,0,0
51273,to,0,0
51274,assess,0,0
51275,whether,0,0
51276,the,0,0
51277,administration,0,1
51278,of,1,1
51279,salmeterol/fluticasone,1,1
51280,propionate,1,1
51281,combination,0,1
51282,(,0,1
51283,50/250,0,1
51284,mcg,0,1
51285,by,0,1
51286,Diskus,0,1
51287,),0,0
51288,for,0,0
51289,1,0,0
51290,week,0,0
51291,induces,0,0
51292,tolerance,0,0
51293,to,0,0
51294,the,0,0
51295,bronchoprotective,0,1
51296,effect,0,0
51297,of,0,0
51298,salmeterol,1,1
51299,on,0,1
51300,allergen,0,1
51301,challenge,0,0
51302,",",0,0
51303,a,0,0
51304,single-blind,0,1
51305,",",0,1
51306,cross-over,0,1
51307,study,0,0
51308,was,0,0
51309,carried,0,0
51310,out,0,0
51311,.,0,0
51312,We,0,0
51313,studied,0,0
51314,nine,0,0
51315,subjects,0,0
51316,(,0,0
51317,eight,0,0
51318,men,0,0
51319,and,0,0
51320,one,0,0
51321,woman,0,0
51322,;,0,0
51323,mean,0,0
51324,age+/-SD,0,0
51325,:,0,0
51326,31.3+/-11.0,0,0
51327,yr,0,0
51328,),0,0
51329,with,0,0
51330,mild,0,0
51331,intermittent,0,0
51332,allergic,0,0
51333,asthma,0,0
51334,",",0,0
51335,never,0,0
51336,treated,0,0
51337,with,0,0
51338,regular,0,0
51339,beta2-agonists,0,1
51340,or,0,1
51341,inhaled,0,1
51342,corticosteroids,0,1
51343,.,0,1
51344,In,0,0
51345,a,0,0
51346,previous,0,0
51347,allergen,0,1
51348,challenge,0,0
51349,all,0,0
51350,subjects,0,0
51351,had,0,0
51352,shown,0,0
51353,a,0,0
51354,positive,0,0
51355,early,0,0
51356,airway,0,0
51357,response,0,0
51358,(,0,1
51359,EAR,0,1
51360,),0,1
51361,to,0,0
51362,allergen,0,1
51363,.,0,0
51364,They,0,1
51365,underwent,0,0
51366,allergen,0,1
51367,challenge,0,0
51368,after,0,0
51369,1-week,0,0
51370,treatment,0,0
51371,with,0,0
51372,placebo,1,1
51373,and,0,0
51374,a,0,0
51375,single,0,0
51376,dose,0,1
51377,of,0,1
51378,placebo,1,1
51379,immediately,0,0
51380,before,0,0
51381,allergen,1,1
51382,challenge,1,1
51383,(,1,1
51384,T1,1,1
51385,),1,1
51386,",",0,0
51387,or,0,0
51388,1-week,0,0
51389,treatment,0,0
51390,with,0,0
51391,placebo,1,1
51392,and,1,0
51393,a,1,0
51394,single,1,0
51395,dose,1,1
51396,of,1,1
51397,salmeterol/fluticasone,1,1
51398,immediately,0,0
51399,before,0,0
51400,allergen,1,1
51401,challenge,1,1
51402,(,1,1
51403,T2,1,1
51404,),1,1
51405,",",0,0
51406,or,0,0
51407,1-week,1,0
51408,treatment,1,0
51409,with,1,0
51410,salmeterol/fluticasone,1,1
51411,combination,1,1
51412,bid,0,1
51413,and,0,0
51414,a,0,0
51415,single,0,0
51416,dose,0,1
51417,of,0,1
51418,salmeterol/fluticasone,1,1
51419,immediately,0,0
51420,before,0,0
51421,allergen,1,1
51422,challenge,1,1
51423,(,1,1
51424,T3,1,1
51425,),1,1
51426,.,1,0
51427,EAR,0,0
51428,was,0,0
51429,evaluated,0,0
51430,both,0,0
51431,as,0,0
51432,maximum,0,0
51433,decrease,0,0
51434,in,0,0
51435,FEV1,0,1
51436,(,0,0
51437,MaxDeltaFEV1,0,0
51438,%,0,0
51439,),0,0
51440,after,0,0
51441,allergen,0,1
51442,challenge,0,0
51443,and,0,0
51444,as,0,0
51445,area,0,0
51446,under,0,0
51447,FEV1,0,1
51448,-time,0,1
51449,curve,0,1
51450,.,0,0
51451,MaxDeltaFEV1,0,0
51452,%,0,0
51453,during,0,0
51454,allergen,0,0
51455,challenge,0,0
51456,protected,0,0
51457,by,0,0
51458,placebo,0,1
51459,(,0,1
51460,T1,0,1
51461,),0,0
51462,was,0,0
51463,significantly,0,0
51464,greater,0,0
51465,than,0,0
51466,MaxDeltaFEV1,0,0
51467,%,0,0
51468,during,0,0
51469,allergen,0,1
51470,challenges,0,1
51471,protected,0,0
51472,by,0,0
51473,single,0,0
51474,dose,0,1
51475,of,0,1
51476,salmeterol/fluticasone,0,1
51477,(,0,1
51478,T2,0,1
51479,),0,1
51480,and,0,0
51481,by,0,0
51482,salmeterol/fluticasone,0,1
51483,1-week,0,1
51484,treatment,0,1
51485,(,0,1
51486,T3,0,1
51487,),0,1
51488,.,0,0
51489,No,0,1
51490,difference,0,0
51491,was,0,0
51492,found,0,0
51493,in,0,0
51494,MaxDeltaFEV1,0,0
51495,%,0,0
51496,between,0,0
51497,T2,0,0
51498,and,0,0
51499,T3,0,0
51500,.,0,0
51501,The,0,0
51502,same,0,0
51503,results,0,0
51504,were,0,0
51505,observed,0,0
51506,also,0,0
51507,after,0,0
51508,computing,0,0
51509,the,0,0
51510,area,0,0
51511,under,0,0
51512,the,0,0
51513,curve,0,0
51514,for,0,0
51515,each,0,0
51516,challenge,0,0
51517,.,0,0
51518,When,0,0
51519,individually,0,0
51520,considered,0,0
51521,",",0,0
51522,all,0,0
51523,subjects,0,0
51524,were,0,0
51525,protected,0,0
51526,against,0,0
51527,EAR,0,0
51528,(,0,0
51529,protection,0,0
51530,index,0,0
51531,>,0,0
51532,or,0,0
51533,=,0,0
51534,80,0,0
51535,%,0,0
51536,),0,0
51537,at,0,0
51538,T2,0,0
51539,",",0,0
51540,while,0,0
51541,at,0,0
51542,3,0,0
51543,seven,0,0
51544,out,0,0
51545,of,0,0
51546,nine,0,0
51547,subjects,0,0
51548,were,0,0
51549,still,0,0
51550,protected,0,0
51551,against,0,0
51552,EAR,0,0
51553,.,0,0
51554,In,0,0
51555,conclusion,0,0
51556,",",0,0
51557,the,0,0
51558,simultaneous,0,0
51559,administration,0,1
51560,of,0,1
51561,salmeterol,0,1
51562,and,0,1
51563,fluticasone,0,1
51564,in,0,0
51565,the,0,0
51566,same,0,0
51567,device,0,0
51568,prevents,0,0
51569,in,0,0
51570,almost,0,0
51571,80,0,0
51572,%,0,0
51573,of,0,0
51574,examined,0,0
51575,subjects,0,0
51576,the,0,0
51577,development,0,0
51578,of,0,0
51579,tolerance,0,0
51580,to,0,0
51581,the,0,0
51582,protective,0,0
51583,effect,0,0
51584,of,0,0
51585,salmeterol,0,1
51586,on,0,1
51587,allergen,0,1
51588,challenge,0,0
51589,.,0,0
51590,This,0,0
51591,observation,0,0
51592,may,0,0
51593,contribute,0,0
51594,to,0,0
51595,explain,0,0
51596,the,0,0
51597,positive,0,0
51598,interaction,0,0
51599,between,0,0
51600,inhaled,0,1
51601,beta2-agonists,0,1
51602,and,0,1
51603,corticosteroids,0,1
51604,in,0,0
51605,the,0,0
51606,long-term,0,0
51607,treatment,0,0
51608,of,0,0
51609,asthma,0,0
51610,.,0,0
51611,Safety,0,1
51612,and,0,0
51613,immunogenicity,0,1
51614,of,0,0
51615,IMVAMUNE,1,1
51616,",",0,0
51617,a,0,0
51618,promising,0,0
51619,candidate,0,0
51620,as,0,0
51621,a,0,0
51622,third,0,0
51623,generation,0,0
51624,smallpox,0,1
51625,vaccine,0,1
51626,.,0,1
51627,A,0,0
51628,Phase,0,0
51629,I,0,0
51630,trial,0,0
51631,was,0,0
51632,performed,0,0
51633,to,0,0
51634,investigate,0,0
51635,the,0,0
51636,safety,0,0
51637,and,0,0
51638,immunogenicity,0,1
51639,of,0,0
51640,the,0,0
51641,third,1,0
51642,generation,1,0
51643,smallpox,1,1
51644,vaccine,1,1
51645,MVA-BN,1,1
51646,(,1,1
51647,IMVAMUNE,1,1
51648,),1,1
51649,",",0,0
51650,a,0,0
51651,highly,0,0
51652,attenuated,0,0
51653,clone,0,0
51654,derived,0,0
51655,from,0,0
51656,the,0,0
51657,Modified,0,0
51658,Vaccinia,0,0
51659,Virus,0,0
51660,Ankara,0,0
51661,strain,0,0
51662,571,0,0
51663,",",0,0
51664,in,0,0
51665,naive,0,0
51666,and,0,0
51667,pre-immunized,0,0
51668,subjects,0,0
51669,.,0,0
51670,A,0,0
51671,total,0,0
51672,of,0,0
51673,86,0,0
51674,healthy,0,0
51675,subjects,0,0
51676,received,0,0
51677,the,0,0
51678,vaccine,1,0
51679,in,0,0
51680,five,0,0
51681,groups,0,0
51682,using,0,0
51683,different,0,0
51684,doses,0,1
51685,and,0,0
51686,routes,0,0
51687,of,0,0
51688,administration,0,1
51689,.,0,0
51690,All,0,0
51691,38,0,0
51692,subjects,0,0
51693,seroconverted,0,0
51694,in,0,0
51695,the,0,0
51696,groups,0,0
51697,receiving,0,0
51698,the,0,0
51699,highest,0,0
51700,dose,0,1
51701,(,0,1
51702,10,0,1
51703,(,0,1
51704,8,0,1
51705,),0,1
51706,TCID50,0,1
51707,),0,1
51708,.,0,0
51709,All,0,0
51710,vaccinations,0,0
51711,were,0,0
51712,well,0,0
51713,tolerated,0,1
51714,with,0,0
51715,mainly,0,0
51716,mild,0,0
51717,or,0,0
51718,moderate,0,0
51719,pain,0,0
51720,at,0,0
51721,the,0,0
51722,injection,0,1
51723,site,0,0
51724,being,0,0
51725,the,0,0
51726,most,0,0
51727,frequent,0,0
51728,symptom,0,0
51729,.,0,0
51730,The,0,0
51731,results,0,0
51732,indicate,0,0
51733,that,0,0
51734,MVA-BN,0,0
51735,has,0,0
51736,the,0,0
51737,potential,0,0
51738,to,0,0
51739,be,0,0
51740,developed,0,0
51741,as,0,0
51742,an,0,0
51743,efficient,0,0
51744,and,0,0
51745,safe,0,0
51746,alternative,0,0
51747,to,0,0
51748,the,0,0
51749,conventional,0,0
51750,smallpox,0,0
51751,vaccines,0,0
51752,such,0,0
51753,as,0,0
51754,Lister-Elstree,1,0
51755,or,1,0
51756,Dryvax,1,1
51757,.,1,0
51758,Unique,0,0
51759,attributes,0,0
51760,render,0,0
51761,it,0,0
51762,a,0,0
51763,promising,0,0
51764,candidate,0,0
51765,for,0,0
51766,prophylactic,0,0
51767,mass,0,0
51768,immunization,0,0
51769,",",0,0
51770,even,0,0
51771,in,0,0
51772,subjects,0,0
51773,for,0,0
51774,whom,0,0
51775,conventional,0,0
51776,smallpox,0,0
51777,vaccines,0,0
51778,are,0,0
51779,contraindicated,0,0
51780,.,0,0
51781,Combined,1,0
51782,typhoid,1,0
51783,fever,1,0
51784,and,1,0
51785,hepatitis,1,1
51786,A,1,1
51787,vaccine,1,1
51788,:,1,0
51789,comparison,0,0
51790,of,0,0
51791,immunogenicity,0,1
51792,and,0,0
51793,safety,0,0
51794,to,0,0
51795,concomitant,0,0
51796,monovalent,0,1
51797,vaccine,0,1
51798,over,0,1
51799,3,0,0
51800,years,0,0
51801,.,0,0
51802,BACKGROUND,0,0
51803,The,0,0
51804,safety,0,0
51805,and,0,0
51806,immunogenicity,0,1
51807,of,0,0
51808,Viatim,1,1
51809,",",0,0
51810,a,0,0
51811,combined,1,0
51812,hepatitis,1,0
51813,A,1,1
51814,(,1,1
51815,HA,1,1
51816,),1,1
51817,and,1,0
51818,typhoid,1,1
51819,fever,1,1
51820,(,1,1
51821,Vi,1,1
51822,),1,1
51823,vaccine,1,1
51824,",",0,0
51825,were,0,0
51826,compared,0,0
51827,with,0,0
51828,the,0,0
51829,monovalent,1,0
51830,component,1,0
51831,vaccines,1,0
51832,up,0,0
51833,to,0,0
51834,and,0,0
51835,1,0,0
51836,month,0,0
51837,after,0,0
51838,a,0,0
51839,booster,0,0
51840,dose,0,1
51841,at,0,1
51842,3,0,0
51843,years,0,0
51844,.,0,0
51845,METHODS,0,0
51846,Healthy,0,0
51847,",",0,0
51848,adult,0,0
51849,volunteers,0,0
51850,were,0,0
51851,randomized,0,0
51852,to,0,0
51853,receive,0,1
51854,Viatim,1,1
51855,(,0,1
51856,group,0,0
51857,A,0,1
51858,",",0,0
51859,n,0,0
51860,=,0,0
51861,179,0,0
51862,),0,0
51863,or,0,0
51864,separate,1,0
51865,HA,1,0
51866,and,1,0
51867,Vi,1,1
51868,vaccines,1,1
51869,(,0,1
51870,group,0,0
51871,B,0,1
51872,",",0,0
51873,n,0,0
51874,=,0,0
51875,181,0,0
51876,),0,0
51877,;,0,0
51878,subgroups,0,0
51879,were,0,0
51880,boosted,0,0
51881,after,0,0
51882,3,0,0
51883,years,0,0
51884,with,0,1
51885,Viatim,1,1
51886,(,0,1
51887,groups,0,0
51888,C,0,1
51889,and,0,0
51890,D,0,1
51891,",",0,0
51892,n,0,0
51893,=,0,0
51894,56,0,0
51895,and,0,0
51896,46,0,0
51897,",",0,0
51898,respectively,0,0
51899,),0,0
51900,.,0,0
51901,Local,0,0
51902,and,0,0
51903,systemic,0,0
51904,reactions,0,0
51905,were,0,0
51906,recorded,0,0
51907,for,0,0
51908,28,0,0
51909,days,0,0
51910,postvaccination,0,0
51911,.,0,0
51912,Seroconversion,0,0
51913,and,0,0
51914,seroprotection,0,1
51915,rates,0,0
51916,and,0,0
51917,geometric,0,0
51918,mean,0,0
51919,antibody,0,0
51920,concentrations,0,0
51921,were,0,0
51922,measured,0,0
51923,at,0,0
51924,14,0,0
51925,and,0,0
51926,28,0,0
51927,days,0,0
51928,",",0,0
51929,1,0,1
51930,",",0,0
51931,2,0,0
51932,",",0,0
51933,and,0,0
51934,3,0,0
51935,years,0,0
51936,postvaccination,0,0
51937,",",0,0
51938,and,0,0
51939,28,0,0
51940,days,0,0
51941,after,0,0
51942,the,0,0
51943,booster,0,0
51944,dose,0,1
51945,.,0,1
51946,RESULTS,0,1
51947,Local,0,0
51948,and,0,0
51949,systemic,0,0
51950,safety,0,0
51951,profiles,0,0
51952,were,0,0
51953,equivalent,0,0
51954,between,0,0
51955,the,0,0
51956,two,0,0
51957,groups,0,0
51958,.,0,0
51959,Immediate,0,0
51960,local,0,0
51961,reactions,0,0
51962,were,0,0
51963,infrequent,0,0
51964,(,0,0
51965,1,0,0
51966,in,0,0
51967,group,0,0
51968,A,0,0
51969,and,0,0
51970,2,0,0
51971,in,0,0
51972,group,0,0
51973,B,0,1
51974,),0,1
51975,.,0,0
51976,Local,0,0
51977,reactions,0,0
51978,",",0,0
51979,consisting,0,0
51980,mostly,0,0
51981,of,0,0
51982,mild,0,0
51983,or,0,0
51984,moderate,0,0
51985,pain,0,0
51986,",",0,0
51987,were,0,0
51988,least,0,0
51989,frequent,0,0
51990,with,0,0
51991,monovalent,0,0
51992,HA,0,1
51993,.,0,0
51994,Antibody,0,0
51995,concentrations,0,0
51996,to,0,0
51997,both,0,0
51998,antigens,0,0
51999,were,0,0
52000,similar,0,0
52001,in,0,0
52002,groups,0,0
52003,A,0,0
52004,and,0,0
52005,B,0,0
52006,",",0,0
52007,in,0,0
52008,which,0,0
52009,HA,0,1
52010,seroprotection,0,1
52011,rates,0,1
52012,(,0,1
52013,>,0,0
52014,or,0,0
52015,=,0,0
52016,20,0,0
52017,mIU/mL,0,0
52018,),0,0
52019,were,0,0
52020,respectively,0,0
52021,",",0,0
52022,98.7,0,0
52023,%,0,0
52024,and,0,0
52025,100,0,0
52026,%,0,0
52027,at,0,0
52028,day,0,0
52029,28,0,0
52030,",",0,0
52031,and,0,0
52032,99.1,0,0
52033,%,0,0
52034,and,0,0
52035,99.0,0,0
52036,%,0,0
52037,after,0,0
52038,3,0,0
52039,years,0,0
52040,",",0,0
52041,achieving,0,0
52042,100,0,0
52043,%,0,0
52044,after,0,0
52045,the,0,0
52046,booster,0,0
52047,.,0,0
52048,Vi,0,1
52049,seroprotection,0,1
52050,rates,0,1
52051,(,0,1
52052,>,0,0
52053,or,0,0
52054,=,0,0
52055,1,0,1
52056,microg/mL,0,1
52057,),0,0
52058,of,0,0
52059,85.2,0,0
52060,%,0,0
52061,and,0,0
52062,84.9,0,0
52063,%,0,0
52064,after,0,0
52065,28,0,0
52066,days,0,0
52067,fell,0,0
52068,to,0,0
52069,32.1,0,0
52070,%,0,0
52071,and,0,0
52072,35.6,0,0
52073,%,0,0
52074,after,0,0
52075,3,0,0
52076,years,0,0
52077,",",0,0
52078,increasing,0,0
52079,to,0,0
52080,67.3,0,0
52081,%,0,0
52082,and,0,0
52083,69.8,0,0
52084,%,0,0
52085,after,0,0
52086,the,0,0
52087,booster,0,0
52088,dose,0,1
52089,.,0,1
52090,CONCLUSIONS,0,0
52091,The,0,0
52092,combined,1,0
52093,HA/Vi,1,1
52094,vaccine,1,1
52095,",",1,1
52096,Viatim,1,1
52097,",",0,0
52098,had,0,0
52099,equivalent,0,0
52100,tolerability,0,1
52101,and,0,1
52102,safety,0,0
52103,and,0,0
52104,was,0,0
52105,as,0,0
52106,rapidly,0,0
52107,immunogenic,0,0
52108,as,0,0
52109,its,0,0
52110,component,0,0
52111,monovalent,0,1
52112,vaccines,0,1
52113,when,0,0
52114,given,0,0
52115,concurrently,0,0
52116,.,0,0
52117,A,0,0
52118,booster,0,1
52119,dose,0,1
52120,after,0,0
52121,3,0,0
52122,years,0,0
52123,significantly,0,0
52124,increased,0,0
52125,antibody,0,0
52126,levels,0,0
52127,with,0,0
52128,some,0,0
52129,evidence,0,0
52130,of,0,0
52131,relative,0,0
52132,hyporesponsiveness,0,0
52133,of,0,0
52134,the,0,0
52135,typhoid,0,0
52136,response,0,0
52137,.,0,0
52138,Performance,0,0
52139,of,0,0
52140,a,0,0
52141,modified,1,0
52142,starch,1,1
52143,hydrophilic,1,0
52144,matrix,1,0
52145,for,1,0
52146,the,1,0
52147,sustained,1,0
52148,release,1,0
52149,of,1,0
52150,theophylline,1,1
52151,in,0,0
52152,healthy,0,0
52153,volunteers,0,0
52154,.,0,0
52155,Two,0,1
52156,experimental,0,0
52157,formulations,0,1
52158,of,0,1
52159,theophylline,1,1
52160,with,1,0
52161,a,1,0
52162,hydrophilic,1,0
52163,starch,1,1
52164,matrix,1,0
52165,were,0,0
52166,evaluated,0,0
52167,for,0,0
52168,their,0,0
52169,sustained-release,0,1
52170,characteristics,0,0
52171,after,0,0
52172,single,0,0
52173,administration,0,1
52174,in,0,0
52175,healthy,0,0
52176,human,0,0
52177,volunteers,0,0
52178,.,0,0
52179,Theo-dur,1,1
52180,was,0,0
52181,chosen,0,0
52182,as,0,0
52183,a,0,0
52184,reference,0,0
52185,sustained-release,0,1
52186,formulation,0,1
52187,.,0,1
52188,In,0,0
52189,a,0,0
52190,first,0,0
52191,study,0,0
52192,",",0,0
52193,the,0,0
52194,extent,0,0
52195,of,0,0
52196,absorption,0,0
52197,was,0,0
52198,similar,0,0
52199,for,0,0
52200,a,0,0
52201,syrup,0,1
52202,",",0,1
52203,for,0,0
52204,Theo-dur,1,1
52205,",",0,0
52206,and,0,0
52207,for,0,0
52208,the,0,0
52209,experimental,0,0
52210,formulation,0,1
52211,of,0,1
52212,theophylline,1,1
52213,with,1,0
52214,70,1,0
52215,%,1,0
52216,drum-dried,1,1
52217,corn,1,1
52218,starch,1,1
52219,as,1,1
52220,the,1,0
52221,sustained-release,1,1
52222,agent,1,1
52223,(,1,1
52224,DDCS-70,1,1
52225,),1,1
52226,.,0,0
52227,The,0,0
52228,maximal,0,0
52229,plasma,0,0
52230,concentration,0,0
52231,(,0,1
52232,Cmax,0,1
52233,),0,0
52234,was,0,0
52235,significantly,0,0
52236,lower,0,0
52237,",",0,0
52238,and,0,0
52239,the,0,0
52240,time,0,0
52241,to,0,0
52242,reach,0,0
52243,Cmax,0,0
52244,as,0,0
52245,well,0,0
52246,as,0,0
52247,the,0,0
52248,time,0,0
52249,span,0,0
52250,during,0,0
52251,which,0,0
52252,the,0,0
52253,plasma,0,0
52254,concentration,0,0
52255,was,0,0
52256,at,0,0
52257,least,0,0
52258,75,0,0
52259,%,0,0
52260,of,0,0
52261,the,0,0
52262,Cmax,0,0
52263,were,0,0
52264,significantly,0,0
52265,higher,0,0
52266,for,0,0
52267,Theo-dur,0,1
52268,than,0,0
52269,for,0,0
52270,the,0,0
52271,DDCS-70,0,1
52272,formulation,0,1
52273,.,0,1
52274,A,0,1
52275,sustained-release,0,1
52276,profile,0,0
52277,",",0,0
52278,as,0,0
52279,for,0,0
52280,Theo-dur,1,1
52281,",",0,0
52282,was,0,0
52283,not,0,0
52284,reached,0,0
52285,for,0,0
52286,DDCS-70,0,0
52287,.,0,0
52288,In,0,0
52289,a,0,0
52290,second,0,0
52291,study,0,0
52292,the,0,0
52293,influence,0,0
52294,of,0,0
52295,the,0,0
52296,starch,0,1
52297,:,0,1
52298,drug,0,1
52299,ratio,0,0
52300,on,0,0
52301,the,0,0
52302,bioavailability,0,1
52303,was,0,0
52304,investigated,0,0
52305,.,0,0
52306,The,0,0
52307,decrease,0,0
52308,in,0,0
52309,starch,0,1
52310,content,0,0
52311,from,0,0
52312,70,0,0
52313,to,0,0
52314,50,0,0
52315,%,0,0
52316,of,0,0
52317,the,0,0
52318,formulation,0,1
52319,did,0,0
52320,not,0,0
52321,improve,0,0
52322,the,0,0
52323,plasma,0,1
52324,concentration-time,0,1
52325,profile,0,0
52326,towards,0,0
52327,a,0,0
52328,sustained-release,0,1
52329,profile,0,0
52330,.,0,0
52331,Does,0,0
52332,a,0,0
52333,first,0,0
52334,trimester,0,0
52335,dating,0,0
52336,scan,0,0
52337,using,0,0
52338,crown,0,0
52339,rump,0,0
52340,length,0,0
52341,measurement,0,0
52342,reduce,0,0
52343,the,0,0
52344,rate,0,0
52345,of,0,0
52346,induction,0,0
52347,of,0,0
52348,labour,0,0
52349,for,0,0
52350,prolonged,0,0
52351,pregnancy,0,0
52352,?,0,1
52353,An,0,1
52354,uncompleted,0,1
52355,randomised,0,1
52356,controlled,0,0
52357,trial,0,0
52358,of,0,0
52359,463,0,0
52360,women,0,0
52361,.,0,0
52362,OBJECTIVE,0,0
52363,To,0,0
52364,evaluate,0,0
52365,the,0,0
52366,effect,0,0
52367,of,0,0
52368,a,0,0
52369,first,0,0
52370,trimester,0,0
52371,ultrasound,1,0
52372,dating,1,0
52373,scan,1,0
52374,on,0,0
52375,the,0,0
52376,rate,0,0
52377,of,0,0
52378,induction,0,0
52379,of,0,0
52380,labour,0,0
52381,for,0,0
52382,prolonged,0,0
52383,pregnancy,0,0
52384,.,0,0
52385,DESIGN,0,0
52386,Randomised,0,0
52387,controlled,0,0
52388,trial,0,0
52389,to,0,0
52390,include,0,0
52391,400,0,0
52392,women,0,0
52393,in,0,0
52394,each,0,0
52395,arm,0,0
52396,of,0,0
52397,the,0,0
52398,trial,0,0
52399,.,0,0
52400,SETTING,0,0
52401,Participating,0,0
52402,general,0,0
52403,practices,0,0
52404,and,0,0
52405,a,0,0
52406,district,0,0
52407,general,0,0
52408,teaching,0,0
52409,hospital,0,0
52410,.,0,0
52411,POPULATION,0,0
52412,Women,0,0
52413,attending,0,0
52414,their,0,0
52415,general,0,0
52416,practitioner,0,0
52417,in,0,0
52418,the,0,0
52419,first,0,0
52420,trimester,0,0
52421,to,0,0
52422,confirm,0,0
52423,pregnancy,0,0
52424,",",0,0
52425,in,0,0
52426,whom,0,0
52427,a,0,0
52428,first,0,0
52429,trimester,0,0
52430,ultrasound,1,0
52431,scan,1,0
52432,was,0,0
52433,not,0,0
52434,indicated,0,0
52435,.,0,0
52436,METHODS,0,0
52437,Women,0,0
52438,randomised,0,0
52439,to,0,0
52440,the,0,0
52441,study,0,0
52442,group,0,0
52443,(,0,0
52444,scan,0,1
52445,group,0,1
52446,),0,0
52447,underwent,0,0
52448,an,0,0
52449,ultrasound,1,0
52450,dating,1,0
52451,scan,1,0
52452,between,1,0
52453,8,1,0
52454,and,1,0
52455,12,1,0
52456,weeks,1,0
52457,",",1,0
52458,measuring,1,0
52459,crown-rump,1,0
52460,length,1,0
52461,.,1,0
52462,The,0,0
52463,estimated,0,0
52464,date,0,0
52465,of,0,0
52466,delivery,0,1
52467,(,0,1
52468,EDD,0,1
52469,),0,1
52470,was,0,0
52471,changed,0,0
52472,if,0,0
52473,there,0,0
52474,was,0,0
52475,a,0,0
52476,discrepancy,0,0
52477,of,0,0
52478,more,0,0
52479,than,0,0
52480,5,0,0
52481,days,0,0
52482,from,0,0
52483,the,0,0
52484,gestation,0,0
52485,",",0,0
52486,calculated,0,0
52487,from,0,0
52488,the,0,0
52489,last,0,0
52490,menstrual,0,0
52491,period,0,1
52492,(,0,1
52493,LMP,0,1
52494,),0,1
52495,.,0,0
52496,For,0,0
52497,the,0,0
52498,remaining,0,0
52499,women,0,1
52500,(,0,0
52501,no-scan,0,1
52502,group,0,1
52503,),0,0
52504,",",0,0
52505,gestation,0,0
52506,was,0,0
52507,determined,0,0
52508,using,0,0
52509,the,0,0
52510,LMP,0,0
52511,.,0,0
52512,MAIN,0,0
52513,OUTCOME,0,0
52514,MEASURES,0,1
52515,The,0,0
52516,rate,0,0
52517,of,0,0
52518,induction,0,0
52519,of,0,0
52520,labour,0,0
52521,for,0,0
52522,prolonged,0,0
52523,pregnancy,0,0
52524,.,0,0
52525,RESULTS,0,0
52526,Due,0,0
52527,to,0,0
52528,circumstances,0,0
52529,beyond,0,0
52530,the,0,0
52531,researchers,0,0
52532,',0,0
52533,control,0,0
52534,",",0,0
52535,recruitment,0,0
52536,was,0,0
52537,abandoned,0,0
52538,when,0,0
52539,463,0,0
52540,women,0,0
52541,had,0,0
52542,been,0,0
52543,enrolled,0,0
52544,.,0,0
52545,The,0,0
52546,EDD,0,0
52547,was,0,0
52548,adjusted,0,0
52549,in,0,0
52550,13,0,0
52551,(,0,0
52552,5.7,0,0
52553,%,0,0
52554,),0,0
52555,women,0,0
52556,in,0,0
52557,the,0,0
52558,scan,0,0
52559,group,0,0
52560,and,0,0
52561,in,0,0
52562,2,0,0
52563,(,0,0
52564,0.9,0,0
52565,%,0,0
52566,),0,0
52567,in,0,0
52568,the,0,0
52569,no-scan,0,0
52570,group,0,0
52571,.,0,0
52572,There,0,0
52573,was,0,0
52574,no,0,0
52575,difference,0,0
52576,in,0,0
52577,the,0,0
52578,rate,0,0
52579,of,0,0
52580,induction,0,0
52581,for,0,0
52582,prolonged,0,0
52583,pregnancy,0,0
52584,between,0,0
52585,the,0,0
52586,scan,0,1
52587,(,0,1
52588,19,0,0
52589,[,0,0
52590,8.2,0,0
52591,%,0,0
52592,],0,0
52593,),0,0
52594,and,0,0
52595,the,0,0
52596,no-scan,0,1
52597,(,0,1
52598,17,0,0
52599,[,0,0
52600,7.4,0,0
52601,%,0,0
52602,],0,0
52603,),0,0
52604,groups,0,1
52605,(,0,0
52606,relative,0,0
52607,risk,0,0
52608,1.10,0,0
52609,;,0,0
52610,95,0,0
52611,%,0,0
52612,CI,0,0
52613,0.59-2.07,0,0
52614,),0,0
52615,.,0,0
52616,CONCLUSIONS,0,0
52617,Acknowledging,0,0
52618,the,0,0
52619,reduced,0,0
52620,numbers,0,0
52621,recruited,0,0
52622,for,0,0
52623,study,0,0
52624,",",0,0
52625,it,0,0
52626,is,0,0
52627,concluded,0,0
52628,that,0,0
52629,there,0,0
52630,is,0,0
52631,no,0,0
52632,evidence,0,0
52633,that,0,0
52634,a,0,0
52635,first,0,0
52636,trimester,0,0
52637,ultrasound,1,0
52638,dating,1,0
52639,scan,1,0
52640,reduces,0,0
52641,the,0,0
52642,rate,0,0
52643,of,0,0
52644,induction,0,0
52645,of,0,0
52646,labour,0,0
52647,for,0,0
52648,prolonged,0,0
52649,pregnancy,0,0
52650,and,0,0
52651,may,0,0
52652,result,0,0
52653,in,0,0
52654,a,0,0
52655,more,0,0
52656,expensive,0,0
52657,healthcare,0,0
52658,strategy,0,0
52659,.,0,0
52660,Effect,0,0
52661,of,0,0
52662,micronutrient,1,1
52663,supplement,1,1
52664,on,0,1
52665,health,0,0
52666,and,0,0
52667,nutritional,0,0
52668,status,0,0
52669,of,0,0
52670,schoolchildren,0,0
52671,:,0,0
52672,study,0,0
52673,design,0,0
52674,.,0,0
52675,OBJECTIVE,0,0
52676,We,0,0
52677,tested,0,0
52678,the,0,0
52679,hypothesis,0,0
52680,that,0,0
52681,supplementation,1,1
52682,with,1,1
52683,a,1,1
52684,micronutrient-fortified,1,1
52685,beverage,1,1
52686,improves,0,1
52687,micronutrient,0,1
52688,status,0,1
52689,and,0,0
52690,physical,0,0
52691,and,0,0
52692,mental,0,0
52693,development,0,0
52694,in,0,0
52695,apparently,0,0
52696,healthy,0,0
52697,schoolchildren,0,0
52698,.,0,0
52699,METHODS,0,0
52700,The,0,0
52701,study,0,0
52702,was,0,0
52703,carried,0,0
52704,out,0,0
52705,in,0,0
52706,middle-income,0,0
52707,students,0,0
52708,in,0,0
52709,two,0,0
52710,residential,0,0
52711,schools,0,0
52712,that,0,0
52713,catered,0,0
52714,to,0,0
52715,children,0,0
52716,from,0,0
52717,a,0,0
52718,semi-urban,0,0
52719,population,0,0
52720,near,0,0
52721,Hyderabad,0,0
52722,",",0,0
52723,India,0,0
52724,.,0,0
52725,Included,0,0
52726,were,0,0
52727,869,0,0
52728,children,0,0
52729,who,0,0
52730,were,0,0
52731,6,0,0
52732,to,0,0
52733,16,0,0
52734,y,0,0
52735,of,0,0
52736,age,0,0
52737,in,0,0
52738,grades,0,0
52739,1,0,0
52740,to,0,0
52741,10,0,0
52742,.,0,0
52743,Because,0,0
52744,children,0,0
52745,at,0,0
52746,each,0,0
52747,grade,0,0
52748,were,0,0
52749,distributed,0,0
52750,across,0,0
52751,two,0,0
52752,classrooms,0,0
52753,(,0,0
52754,clusters,0,0
52755,),0,0
52756,and,0,0
52757,were,0,0
52758,homogeneous,0,0
52759,",",0,0
52760,each,0,0
52761,grade,0,0
52762,was,0,0
52763,considered,0,0
52764,to,0,0
52765,consist,0,0
52766,of,0,0
52767,a,0,0
52768,matched,0,0
52769,pair,0,0
52770,.,0,0
52771,There,0,0
52772,were,0,0
52773,thus,0,0
52774,10,0,0
52775,pairs,0,0
52776,available,0,0
52777,for,0,0
52778,the,0,0
52779,study,0,0
52780,.,0,0
52781,Classes,0,0
52782,in,0,0
52783,each,0,0
52784,grade,0,0
52785,were,0,0
52786,randomized,0,0
52787,to,0,0
52788,receive,0,0
52789,a,0,0
52790,micronutrient-enriched,1,1
52791,beverage,1,1
52792,or,1,1
52793,a,1,1
52794,placebo,1,1
52795,without,1,0
52796,added,1,0
52797,micronutrients,1,1
52798,.,1,0
52799,The,0,0
52800,study,0,0
52801,was,0,0
52802,double,0,0
52803,blinded,0,0
52804,and,0,0
52805,the,0,0
52806,duration,0,0
52807,was,0,0
52808,14,0,0
52809,mo,0,0
52810,",",0,0
52811,with,0,0
52812,supervised,0,0
52813,feeding,0,0
52814,of,0,0
52815,the,0,0
52816,micronutrient-enriched,1,1
52817,beverage,1,1
52818,.,1,1
52819,The,0,0
52820,effect,0,0
52821,of,0,0
52822,the,0,0
52823,micronutrients,1,1
52824,on,0,0
52825,the,0,0
52826,outcome,0,0
52827,variables,0,0
52828,growth,0,0
52829,",",0,0
52830,biochemical,0,0
52831,status,0,0
52832,",",0,0
52833,mental,0,0
52834,function,0,0
52835,",",0,0
52836,and,0,0
52837,bone,0,0
52838,health,0,0
52839,were,0,0
52840,assessed,0,0
52841,.,0,0
52842,RESULTS,0,0
52843,The,0,0
52844,number,0,0
52845,of,0,0
52846,matched,0,0
52847,pairs,0,0
52848,varied,0,0
52849,between,0,0
52850,seven,0,0
52851,and,0,0
52852,eight,0,0
52853,",",0,0
52854,and,0,0
52855,the,0,0
52856,required,0,0
52857,number,0,0
52858,of,0,0
52859,children,0,0
52860,per,0,0
52861,treatment,0,0
52862,group,0,0
52863,ranged,0,0
52864,from,0,0
52865,32,0,0
52866,in,0,0
52867,the,0,0
52868,case,0,0
52869,of,0,0
52870,bone,0,0
52871,heath,0,0
52872,to,0,0
52873,177,0,0
52874,for,0,0
52875,body,0,0
52876,weight,0,0
52877,.,0,0
52878,The,0,0
52879,power,0,0
52880,of,0,0
52881,the,0,0
52882,outcome,0,0
52883,variables,0,0
52884,ranged,0,0
52885,from,0,0
52886,74,0,0
52887,%,0,0
52888,to,0,0
52889,100,0,0
52890,%,0,0
52891,and,0,0
52892,was,0,0
52893,adequate,0,0
52894,for,0,0
52895,successful,0,0
52896,pairing,0,0
52897,.,0,0
52898,The,0,0
52899,effect,0,0
52900,assessed,0,0
52901,at,0,0
52902,the,0,0
52903,end,0,0
52904,of,0,0
52905,supplementation,1,1
52906,showed,0,0
52907,that,0,0
52908,the,0,0
52909,intervention,0,0
52910,was,0,0
52911,beneficial,0,0
52912,.,0,0
52913,CONCLUSIONS,0,0
52914,Designing,0,0
52915,an,0,0
52916,intervention,0,0
52917,",",0,0
52918,choosing,0,0
52919,outcome,0,0
52920,variables,0,0
52921,",",0,0
52922,and,0,0
52923,implementing,0,0
52924,the,0,0
52925,protocol,0,0
52926,in,0,0
52927,a,0,0
52928,typical,0,0
52929,Indian,0,0
52930,school,0,0
52931,setting,0,0
52932,were,0,0
52933,achieved,0,0
52934,.,0,0
52935,Brain,0,0
52936,mechanisms,0,0
52937,of,0,0
52938,expectation,0,0
52939,associated,0,0
52940,with,0,0
52941,insula,0,0
52942,and,0,0
52943,amygdala,0,0
52944,response,0,0
52945,to,0,0
52946,aversive,0,1
52947,taste,0,1
52948,:,0,0
52949,implications,0,0
52950,for,0,0
52951,placebo,1,1
52952,.,1,0
52953,The,0,0
52954,experience,0,0
52955,of,0,0
52956,aversion,0,0
52957,is,0,0
52958,shaped,0,0
52959,by,0,0
52960,multiple,0,0
52961,physiological,0,0
52962,and,0,0
52963,psychological,0,0
52964,factors,0,0
52965,including,0,0
52966,one,0,0
52967,'s,0,0
52968,expectations,0,0
52969,.,0,0
52970,Recent,0,0
52971,work,0,0
52972,has,0,0
52973,shown,0,0
52974,that,0,0
52975,expectancy,0,0
52976,manipulation,0,0
52977,can,0,0
52978,alter,0,0
52979,perceptions,0,0
52980,of,0,0
52981,aversive,0,0
52982,events,0,0
52983,and,0,0
52984,concomitant,0,0
52985,brain,0,0
52986,activation,0,0
52987,.,0,0
52988,Accruing,0,0
52989,evidence,0,0
52990,indicates,0,0
52991,a,0,0
52992,primary,0,0
52993,role,0,0
52994,of,0,0
52995,altered,0,0
52996,expectancies,0,0
52997,in,0,0
52998,the,0,0
52999,placebo,1,1
53000,effect,0,0
53001,.,0,0
53002,Here,0,0
53003,",",0,0
53004,we,0,0
53005,probed,0,0
53006,the,0,0
53007,mechanism,0,0
53008,by,0,0
53009,which,0,0
53010,expectation,0,0
53011,attenuates,0,0
53012,sensory,0,1
53013,taste,0,1
53014,transmission,0,0
53015,by,0,0
53016,examining,0,0
53017,how,0,0
53018,brain,0,0
53019,areas,0,0
53020,activated,0,0
53021,by,0,0
53022,misleading,1,0
53023,information,1,0
53024,during,0,0
53025,an,0,0
53026,expectancy,0,0
53027,period,0,0
53028,modulate,0,0
53029,insula,0,0
53030,and,0,0
53031,amygdala,0,0
53032,activation,0,0
53033,to,0,0
53034,a,0,0
53035,highly,1,0
53036,aversive,1,1
53037,bitter,1,1
53038,taste,1,1
53039,.,1,1
53040,In,0,0
53041,a,0,0
53042,rapid,0,0
53043,event-related,0,0
53044,fMRI,1,1
53045,design,1,0
53046,",",0,0
53047,we,0,0
53048,showed,0,0
53049,that,0,0
53050,activations,0,0
53051,in,0,0
53052,the,0,0
53053,rostral,0,0
53054,anterior,0,0
53055,cingulate,0,1
53056,cortex,0,1
53057,(,0,1
53058,rACC,0,1
53059,),0,1
53060,",",0,0
53061,orbitofrontal,0,1
53062,cortex,0,1
53063,(,0,1
53064,OFC,0,1
53065,),0,1
53066,",",0,0
53067,and,0,0
53068,dorsolateral,0,0
53069,prefrontal,0,0
53070,cortex,0,0
53071,to,0,0
53072,a,0,0
53073,misleading,0,0
53074,cue,0,0
53075,that,0,0
53076,the,0,0
53077,taste,0,0
53078,would,0,0
53079,be,0,0
53080,mildly,0,0
53081,aversive,0,0
53082,predicted,0,0
53083,decreases,0,0
53084,in,0,0
53085,insula,0,0
53086,and,0,0
53087,amygdala,0,0
53088,activation,0,0
53089,to,0,0
53090,the,0,0
53091,highly,0,0
53092,aversive,0,1
53093,taste,0,1
53094,.,0,1
53095,OFC,0,1
53096,and,0,0
53097,rACC,0,0
53098,activation,0,0
53099,to,0,0
53100,the,0,0
53101,misleading,1,0
53102,cue,1,0
53103,were,0,0
53104,also,0,0
53105,associated,0,0
53106,with,0,0
53107,less,0,0
53108,aversive,0,0
53109,ratings,0,0
53110,of,0,0
53111,that,0,0
53112,taste,0,0
53113,.,0,0
53114,Additional,0,0
53115,analyses,0,0
53116,revealed,0,0
53117,consistent,0,0
53118,results,0,0
53119,demonstrating,0,0
53120,functional,0,0
53121,connectivity,0,0
53122,among,0,0
53123,the,0,0
53124,OFC,0,0
53125,",",0,0
53126,rACC,0,0
53127,",",0,0
53128,and,0,0
53129,insula,0,0
53130,.,0,0
53131,Altering,0,0
53132,expectancies,0,0
53133,of,0,0
53134,upcoming,0,0
53135,aversive,0,0
53136,events,0,0
53137,are,0,0
53138,shown,0,0
53139,here,0,0
53140,to,0,0
53141,depend,0,0
53142,on,0,0
53143,robust,0,0
53144,functional,0,0
53145,associations,0,0
53146,among,0,0
53147,brain,0,0
53148,regions,0,0
53149,implicated,0,0
53150,in,0,0
53151,prior,0,0
53152,work,0,0
53153,on,0,0
53154,the,0,0
53155,placebo,0,1
53156,effect,0,0
53157,.,0,0
53158,Pharmacokinetic,0,1
53159,and,0,1
53160,safety,0,0
53161,evaluation,0,0
53162,of,0,0
53163,high-dose,0,1
53164,combinations,0,0
53165,of,0,0
53166,fosamprenavir,0,1
53167,and,0,1
53168,ritonavir,0,1
53169,.,0,1
53170,High-dose,0,1
53171,combinations,0,0
53172,of,0,1
53173,fosamprenavir,1,1
53174,(,1,1
53175,FPV,1,1
53176,),1,1
53177,and,1,1
53178,ritonavir,1,1
53179,(,1,1
53180,RTV,1,1
53181,),1,0
53182,were,0,0
53183,evaluated,0,0
53184,in,0,0
53185,healthy,0,0
53186,adult,0,0
53187,subjects,0,0
53188,in,0,0
53189,order,0,0
53190,to,0,0
53191,select,0,0
53192,doses,0,1
53193,for,0,0
53194,further,0,0
53195,study,0,0
53196,in,0,0
53197,multiple,0,0
53198,protease,0,0
53199,inhibitor,0,1
53200,(,0,1
53201,PI,0,1
53202,),0,1
53203,-experienced,0,0
53204,patients,0,0
53205,infected,0,0
53206,with,0,0
53207,human,0,0
53208,immunodeficiency,0,0
53209,virus,0,0
53210,type,0,0
53211,1,0,0
53212,.,0,0
53213,Two,0,1
53214,high-dose,0,1
53215,regimens,0,1
53216,",",0,1
53217,FPV,1,1
53218,"1,400",0,1
53219,mg,0,1
53220,twice,0,0
53221,a,0,1
53222,day,0,1
53223,(,0,1
53224,BID,0,1
53225,),0,1
53226,plus,0,0
53227,RTV,1,1
53228,100,0,1
53229,mg,0,1
53230,BID,0,1
53231,and,0,0
53232,FPV,1,0
53233,"1,400",0,0
53234,mg,0,0
53235,BID,0,0
53236,plus,0,0
53237,RTV,1,1
53238,200,0,1
53239,mg,0,1
53240,BID,0,1
53241,",",0,0
53242,were,0,0
53243,planned,0,0
53244,to,0,0
53245,be,0,0
53246,compared,0,0
53247,to,0,0
53248,the,0,0
53249,approved,0,1
53250,regimen,0,1
53251,",",0,1
53252,FPV,1,1
53253,700,0,1
53254,mg,0,1
53255,BID,0,1
53256,plus,0,0
53257,RTV,1,1
53258,100,0,1
53259,mg,0,1
53260,BID,0,1
53261,",",0,0
53262,in,0,0
53263,a,0,0
53264,randomized,0,1
53265,three-period,0,1
53266,crossover,0,1
53267,study,0,0
53268,.,0,0
53269,Forty-two,0,0
53270,healthy,0,0
53271,adult,0,0
53272,subjects,0,0
53273,were,0,0
53274,enrolled,0,0
53275,",",0,0
53276,and,0,0
53277,39,0,0
53278,subjects,0,0
53279,completed,0,0
53280,period,0,0
53281,1,0,0
53282,.,0,0
53283,Due,0,0
53284,to,0,0
53285,marked,0,0
53286,hepatic,0,0
53287,transaminase,0,1
53288,elevations,0,0
53289,",",0,0
53290,predominantly,0,0
53291,with,0,0
53292,FPV,1,0
53293,"1,400",0,0
53294,mg,0,0
53295,BID,0,0
53296,plus,0,0
53297,RTV,1,1
53298,200,0,1
53299,mg,0,1
53300,BID,0,1
53301,",",0,0
53302,the,0,0
53303,study,0,0
53304,was,0,0
53305,terminated,0,0
53306,prematurely,0,0
53307,.,0,0
53308,For,0,0
53309,FPV,1,0
53310,"1,400",0,0
53311,mg,0,0
53312,BID,0,0
53313,plus,0,0
53314,RTV,1,1
53315,100,0,1
53316,mg,0,1
53317,BID,0,1
53318,",",0,0
53319,the,0,0
53320,values,0,0
53321,for,0,0
53322,plasma,0,1
53323,amprenavir,0,1
53324,(,0,1
53325,APV,0,1
53326,),0,0
53327,area,0,0
53328,under,0,0
53329,the,0,0
53330,concentration-time,0,1
53331,profile,0,0
53332,over,0,0
53333,the,0,0
53334,dosing,0,1
53335,interval,0,0
53336,(,0,0
53337,tau,0,0
53338,),0,0
53339,at,0,0
53340,steady,0,0
53341,state,0,0
53342,[,0,0
53343,AUC,0,1
53344,(,0,1
53345,0-tau,0,1
53346,),0,1
53347,],0,1
53348,",",0,0
53349,maximum,0,0
53350,concentration,0,0
53351,of,0,0
53352,drug,0,1
53353,in,0,1
53354,plasma,0,1
53355,(,0,1
53356,C,0,1
53357,(,0,1
53358,max,0,1
53359,),0,1
53360,),0,0
53361,",",0,0
53362,and,0,0
53363,plasma,0,1
53364,concentration,0,0
53365,at,0,0
53366,the,0,0
53367,end,0,0
53368,of,0,0
53369,tau,0,0
53370,at,0,0
53371,steady,0,0
53372,state,0,0
53373,(,0,0
53374,C,0,1
53375,(,0,1
53376,tau,0,1
53377,),0,1
53378,),0,0
53379,were,0,0
53380,54,0,0
53381,",",0,0
53382,81,0,0
53383,",",0,0
53384,and,0,0
53385,26,0,0
53386,%,0,0
53387,higher,0,0
53388,",",0,0
53389,respectively,0,0
53390,",",0,0
53391,and,0,0
53392,the,0,0
53393,values,0,0
53394,for,0,0
53395,plasma,0,1
53396,RTV,0,1
53397,AUC,0,1
53398,(,0,1
53399,0-tau,0,1
53400,),0,1
53401,",",0,1
53402,C,0,1
53403,(,0,1
53404,max,0,0
53405,),0,0
53406,",",0,0
53407,and,0,0
53408,C,0,1
53409,(,0,1
53410,tau,0,0
53411,),0,0
53412,were,0,0
53413,49,0,0
53414,%,0,0
53415,higher,0,0
53416,",",0,0
53417,71,0,0
53418,%,0,0
53419,higher,0,0
53420,",",0,0
53421,and,0,0
53422,11,0,0
53423,%,0,0
53424,lower,0,0
53425,",",0,0
53426,respectively,0,0
53427,",",0,0
53428,than,0,0
53429,those,0,0
53430,for,0,0
53431,FPV,1,1
53432,700,0,1
53433,mg,0,1
53434,BID,0,1
53435,plus,0,0
53436,RTV,0,1
53437,100,0,1
53438,mg,0,1
53439,BID,0,1
53440,.,0,0
53441,For,0,0
53442,FPV,1,0
53443,"1,400",0,0
53444,mg,0,0
53445,BID,0,0
53446,plus,0,0
53447,RTV,0,1
53448,200,0,1
53449,mg,0,1
53450,BID,0,1
53451,",",0,0
53452,the,0,0
53453,values,0,0
53454,for,0,0
53455,plasma,0,1
53456,APV,0,1
53457,AUC,0,1
53458,(,0,1
53459,0-tau,0,1
53460,),0,1
53461,",",0,1
53462,C,0,1
53463,(,0,1
53464,max,0,0
53465,),0,0
53466,",",0,0
53467,and,0,0
53468,C,0,1
53469,(,0,1
53470,tau,0,0
53471,),0,0
53472,were,0,0
53473,26,0,0
53474,",",0,0
53475,48,0,0
53476,",",0,0
53477,and,0,0
53478,32,0,0
53479,%,0,0
53480,higher,0,0
53481,",",0,0
53482,respectively,0,0
53483,",",0,0
53484,and,0,0
53485,the,0,0
53486,values,0,0
53487,for,0,0
53488,plasma,0,1
53489,RTV,0,1
53490,AUC,0,1
53491,(,0,1
53492,0-tau,0,1
53493,),0,1
53494,",",0,1
53495,C,0,1
53496,(,0,1
53497,max,0,0
53498,),0,0
53499,",",0,0
53500,and,0,0
53501,C,0,1
53502,(,0,1
53503,tau,0,0
53504,),0,0
53505,increased,0,0
53506,4.15-fold,0,0
53507,",",0,0
53508,4.17-fold,0,0
53509,",",0,0
53510,and,0,0
53511,3.99-fold,0,0
53512,",",0,0
53513,respectively,0,0
53514,",",0,0
53515,compared,0,0
53516,to,0,0
53517,those,0,0
53518,for,0,0
53519,FPV,1,1
53520,700,0,1
53521,mg,0,1
53522,BID,0,1
53523,plus,0,0
53524,RTV,1,1
53525,100,0,1
53526,mg,0,1
53527,BID,0,1
53528,.,0,0
53529,FPV,1,0
53530,"1,400",0,0
53531,mg,0,0
53532,BID,0,0
53533,plus,0,0
53534,RTV,1,1
53535,200,0,1
53536,mg,0,1
53537,BID,0,1
53538,is,0,0
53539,not,0,0
53540,recommended,0,0
53541,due,0,0
53542,to,0,0
53543,an,0,0
53544,increased,0,0
53545,rate,0,0
53546,of,0,0
53547,marked,0,0
53548,hepatic,0,0
53549,transaminase,0,1
53550,elevations,0,0
53551,and,0,0
53552,lack,0,0
53553,of,0,0
53554,pharmacokinetic,0,1
53555,advantage,0,0
53556,.,0,0
53557,FPV,1,0
53558,"1,400",0,0
53559,mg,0,0
53560,BID,0,0
53561,plus,0,0
53562,RTV,1,1
53563,100,0,1
53564,mg,0,1
53565,BID,0,1
53566,is,0,0
53567,currently,0,0
53568,under,0,0
53569,clinical,0,0
53570,evaluation,0,0
53571,in,0,0
53572,multiple,0,0
53573,PI-experienced,0,0
53574,patients,0,0
53575,.,0,0
53576,Nasotracheal,1,0
53577,intubation,1,0
53578,under,1,0
53579,curve-tipped,1,0
53580,suction,1,0
53581,catheter,1,0
53582,guidance,0,0
53583,reduces,0,0
53584,epistaxis,0,0
53585,.,0,0
53586,BACKGROUND,0,0
53587,Nasotracheal,1,1
53588,intubation,1,1
53589,(,1,1
53590,NTI,1,1
53591,),1,0
53592,has,0,0
53593,greater,0,0
53594,potential,0,0
53595,for,0,0
53596,trauma,0,0
53597,of,0,0
53598,nasopharyngeal,0,0
53599,mucosa,0,0
53600,than,0,0
53601,orotracheal,0,0
53602,intubation,0,0
53603,.,0,0
53604,The,0,0
53605,present,0,0
53606,study,0,0
53607,investigated,0,0
53608,the,0,0
53609,success,0,0
53610,rate,0,0
53611,of,0,0
53612,NTI,0,0
53613,and,0,0
53614,frequency,0,0
53615,of,0,0
53616,nasal,0,0
53617,bleeding,0,0
53618,using,0,0
53619,a,0,0
53620,curve-tipped,1,0
53621,suction,1,1
53622,catheter,1,1
53623,(,1,1
53624,CTSC,1,1
53625,),1,1
53626,to,1,0
53627,guide,0,0
53628,nasotracheal,0,0
53629,tube,0,0
53630,advancement,0,0
53631,.,0,0
53632,METHODS,0,0
53633,Subjects,0,0
53634,comprised,0,0
53635,131,0,0
53636,adult,0,0
53637,patients,0,0
53638,who,0,0
53639,under-went,0,0
53640,NTI,1,1
53641,.,1,0
53642,Subjects,0,0
53643,were,0,0
53644,randomly,0,0
53645,divided,0,0
53646,into,0,0
53647,two,0,0
53648,groups,0,0
53649,:,0,0
53650,a,0,0
53651,),0,0
53652,NTI,1,0
53653,under,1,0
53654,CTSC,1,1
53655,guidance,1,1
53656,(,1,1
53657,G,1,1
53658,[,1,1
53659,+,1,1
53660,],1,1
53661,group,1,1
53662,),1,0
53663,.,0,0
53664,The,0,0
53665,CTSC,0,1
53666,(,0,0
53667,14,0,0
53668,Fr,0,1
53669,),0,0
53670,was,0,0
53671,first,0,0
53672,inserted,0,0
53673,through,0,0
53674,the,0,0
53675,tracheal,0,0
53676,tube,0,0
53677,",",0,0
53678,with,0,0
53679,the,0,0
53680,tip,0,0
53681,of,0,0
53682,the,0,0
53683,CTSC,0,0
53684,emerging,0,0
53685,from,0,0
53686,the,0,0
53687,distal,0,0
53688,end,0,0
53689,of,0,0
53690,the,0,0
53691,tube,0,0
53692,.,0,0
53693,The,0,0
53694,curved,0,0
53695,tip,0,0
53696,was,0,0
53697,directed,0,0
53698,ventrally,0,0
53699,.,0,0
53700,Both,0,0
53701,tracheal,0,0
53702,tube,0,0
53703,and,0,0
53704,CTSC,0,0
53705,were,0,0
53706,advanced,0,0
53707,together,0,0
53708,through,0,0
53709,the,0,0
53710,nasopharynx,0,1
53711,;,0,1
53712,b,0,1
53713,),0,1
53714,NTI,1,1
53715,without,1,0
53716,CTSC,1,1
53717,guidance,1,1
53718,(,0,1
53719,G,0,1
53720,[,0,1
53721,-,0,1
53722,],0,1
53723,group,0,1
53724,),0,0
53725,.,0,0
53726,The,0,0
53727,tracheal,0,0
53728,tube,0,0
53729,was,0,0
53730,advanced,0,0
53731,into,0,0
53732,the,0,0
53733,nasal,0,0
53734,cavity,0,0
53735,and,0,0
53736,passed,0,0
53737,into,0,0
53738,the,0,0
53739,pharynx,0,0
53740,without,0,0
53741,CTSC,0,0
53742,guidance,0,0
53743,.,0,0
53744,The,0,0
53745,time,0,0
53746,required,0,0
53747,to,0,0
53748,pass,0,0
53749,the,0,0
53750,endotracheal,0,0
53751,tube,0,0
53752,through,0,0
53753,the,0,0
53754,nasal,0,0
53755,cavity,0,0
53756,(,0,0
53757,nasal,0,0
53758,passage,0,0
53759,time,0,0
53760,),0,0
53761,",",0,0
53762,success,0,0
53763,rate,0,0
53764,of,0,0
53765,nasal,0,0
53766,passage,0,0
53767,with,0,0
53768,nasotracheal,0,0
53769,tube,0,0
53770,",",0,0
53771,and,0,0
53772,the,0,0
53773,incidence,0,0
53774,and,0,0
53775,severity,0,0
53776,of,0,0
53777,nasal,0,0
53778,bleeding,0,0
53779,were,0,0
53780,compared,0,0
53781,.,0,0
53782,RESULTS,0,0
53783,Success,0,0
53784,rate,0,0
53785,for,0,0
53786,nasal,0,0
53787,passage,0,0
53788,was,0,0
53789,100,0,0
53790,%,0,0
53791,in,0,0
53792,the,0,0
53793,G,0,1
53794,(,0,1
53795,+,0,1
53796,),0,1
53797,group,0,0
53798,(,0,0
53799,62/62,0,0
53800,),0,0
53801,and,0,0
53802,82.6,0,0
53803,%,0,0
53804,in,0,0
53805,the,0,0
53806,G,0,1
53807,(,0,1
53808,-,0,1
53809,),0,1
53810,group,0,0
53811,(,0,0
53812,57/69,0,0
53813,;,0,0
53814,P,0,0
53815,=,0,0
53816,0.0006,0,0
53817,),0,0
53818,.,0,0
53819,Frequency,0,0
53820,of,0,0
53821,nasal,0,0
53822,bleeding,0,0
53823,was,0,0
53824,significantly,0,0
53825,lower,0,0
53826,in,0,0
53827,the,0,0
53828,G,0,1
53829,(,0,1
53830,+,0,1
53831,),0,1
53832,group,0,0
53833,(,0,0
53834,21/62,0,0
53835,",",0,0
53836,33.9,0,0
53837,%,0,0
53838,),0,0
53839,than,0,0
53840,in,0,0
53841,the,0,0
53842,G,0,1
53843,(,0,1
53844,-,0,1
53845,),0,1
53846,group,0,0
53847,(,0,0
53848,37/69,0,0
53849,",",0,0
53850,53.6,0,0
53851,%,0,0
53852,;,0,0
53853,P,0,0
53854,=,0,0
53855,0.023,0,0
53856,),0,0
53857,.,0,0
53858,Severity,0,0
53859,of,0,0
53860,nasal,0,0
53861,bleeding,0,0
53862,was,0,0
53863,also,0,0
53864,significantly,0,0
53865,lower,0,0
53866,in,0,0
53867,the,0,0
53868,G,0,1
53869,(,0,1
53870,+,0,1
53871,),0,1
53872,group,0,0
53873,than,0,0
53874,in,0,0
53875,the,0,0
53876,G,0,1
53877,(,0,1
53878,-,0,1
53879,),0,1
53880,group,0,0
53881,(,0,0
53882,P,0,0
53883,=,0,0
53884,0.030,0,0
53885,),0,0
53886,.,0,0
53887,CONCLUSIONS,0,1
53888,Nasotracheal,1,0
53889,intubation,1,0
53890,under,1,0
53891,CTSC,1,0
53892,guidance,1,0
53893,increases,0,0
53894,the,0,0
53895,success,0,0
53896,rate,0,0
53897,of,0,0
53898,airway,0,0
53899,instrumentation,0,0
53900,",",0,0
53901,and,0,0
53902,also,0,0
53903,reduces,0,0
53904,the,0,0
53905,incidence,0,0
53906,and,0,0
53907,severity,0,0
53908,of,0,0
53909,epistaxis,0,0
53910,.,0,0
53911,Web-based,1,1
53912,weight,1,1
53913,management,1,0
53914,programs,1,0
53915,in,0,0
53916,an,0,0
53917,integrated,0,0
53918,health,0,0
53919,care,0,0
53920,setting,0,0
53921,:,0,0
53922,a,0,0
53923,randomized,0,0
53924,",",0,0
53925,controlled,0,0
53926,trial,0,0
53927,.,0,0
53928,OBJECTIVE,0,0
53929,To,0,0
53930,assess,0,0
53931,the,0,0
53932,efficacy,0,0
53933,of,0,0
53934,a,0,0
53935,Web-based,1,0
53936,tailored,1,0
53937,behavioral,1,1
53938,weight,1,1
53939,management,1,0
53940,program,1,0
53941,compared,0,0
53942,with,0,0
53943,Web-based,0,0
53944,information-only,0,0
53945,weight,0,0
53946,management,0,0
53947,materials,0,0
53948,.,0,0
53949,RESEARCH,0,0
53950,METHODS,0,1
53951,AND,0,1
53952,PROCEDURES,0,1
53953,Participants,0,0
53954,",",0,0
53955,2862,0,0
53956,eligible,0,0
53957,overweight,0,0
53958,and,0,0
53959,obese,0,1
53960,(,0,0
53961,BMI,0,0
53962,=,0,0
53963,27,0,0
53964,to,0,0
53965,40,0,0
53966,kg/m2,0,0
53967,),0,0
53968,members,0,0
53969,from,0,0
53970,four,0,0
53971,regions,0,0
53972,of,0,0
53973,Kaiser,0,0
53974,Permanente,0,0
53975,'s,0,0
53976,integrated,0,0
53977,health,0,0
53978,care,0,0
53979,delivery,0,0
53980,system,0,0
53981,",",0,0
53982,were,0,0
53983,randomized,0,0
53984,to,0,0
53985,receive,0,0
53986,either,0,0
53987,a,0,0
53988,tailored,1,0
53989,expert,1,0
53990,system,1,0
53991,or,1,0
53992,information-only,1,0
53993,Web-based,1,1
53994,weight,1,0
53995,management,1,0
53996,materials,1,0
53997,.,1,0
53998,Weight,0,0
53999,change,0,0
54000,and,0,0
54001,program,0,0
54002,satisfaction,0,0
54003,were,0,0
54004,assessed,0,0
54005,by,0,0
54006,self-report,0,0
54007,through,0,0
54008,an,0,0
54009,Internet-based,0,0
54010,survey,0,0
54011,at,0,0
54012,3-,0,0
54013,and,0,0
54014,6-month,0,1
54015,follow-up,0,0
54016,periods,0,0
54017,.,0,0
54018,RESULTS,0,0
54019,Significantly,0,0
54020,greater,0,0
54021,weight,0,0
54022,loss,0,0
54023,at,0,0
54024,follow-up,0,0
54025,was,0,0
54026,found,0,0
54027,among,0,0
54028,participants,0,0
54029,assigned,0,0
54030,to,0,0
54031,the,0,0
54032,tailored,1,0
54033,expert,1,0
54034,system,1,0
54035,than,0,0
54036,among,0,0
54037,those,0,0
54038,assigned,0,0
54039,to,0,0
54040,the,0,0
54041,information-only,0,0
54042,condition,0,0
54043,.,0,0
54044,Subjects,0,0
54045,in,0,0
54046,the,0,0
54047,tailored,1,0
54048,expert,1,0
54049,system,1,0
54050,lost,0,0
54051,a,0,0
54052,mean,0,0
54053,of,0,0
54054,3,0,0
54055,+/-,0,0
54056,0.3,0,0
54057,%,0,0
54058,of,0,0
54059,their,0,0
54060,baseline,0,0
54061,weight,0,0
54062,",",0,0
54063,whereas,0,0
54064,subjects,0,0
54065,in,0,0
54066,the,0,0
54067,information-only,0,0
54068,condition,0,0
54069,lost,0,0
54070,a,0,0
54071,mean,0,0
54072,of,0,0
54073,1.2,0,0
54074,+/-,0,0
54075,0.4,0,0
54076,%,0,0
54077,(,0,0
54078,p,0,0
54079,<,0,0
54080,0.0004,0,0
54081,),0,0
54082,.,0,0
54083,Participants,0,0
54084,were,0,0
54085,also,0,0
54086,more,0,0
54087,likely,0,0
54088,to,0,0
54089,report,0,0
54090,that,0,0
54091,the,0,0
54092,tailored,1,0
54093,expert,1,0
54094,system,1,0
54095,was,0,0
54096,personally,0,0
54097,relevant,0,0
54098,",",0,0
54099,helpful,0,0
54100,",",0,0
54101,and,0,0
54102,easy,0,0
54103,to,0,0
54104,understand,0,0
54105,.,0,0
54106,Notably,0,0
54107,",",0,0
54108,36,0,0
54109,%,0,0
54110,of,0,0
54111,enrollees,0,0
54112,were,0,0
54113,African-American,0,0
54114,",",0,0
54115,with,0,0
54116,enrollment,0,0
54117,rates,0,0
54118,higher,0,0
54119,than,0,0
54120,the,0,0
54121,general,0,0
54122,proportion,0,0
54123,of,0,0
54124,African,0,0
54125,Americans,0,0
54126,in,0,0
54127,any,0,0
54128,of,0,0
54129,the,0,0
54130,study,0,0
54131,regions,0,0
54132,.,0,0
54133,DISCUSSION,0,0
54134,The,0,0
54135,results,0,0
54136,of,0,0
54137,this,0,0
54138,large,0,0
54139,",",0,0
54140,randomized,0,0
54141,control,0,0
54142,trial,0,0
54143,show,0,0
54144,the,0,0
54145,potential,0,0
54146,benefit,0,0
54147,of,0,0
54148,the,0,0
54149,Web-based,1,0
54150,tailored,1,0
54151,expert,1,0
54152,system,1,0
54153,for,1,0
54154,weight,1,0
54155,management,1,0
54156,compared,0,0
54157,with,0,0
54158,a,0,0
54159,Web-based,1,0
54160,information-only,1,0
54161,weight,1,1
54162,management,1,0
54163,program,1,0
54164,.,1,0
54165,Evaluation,0,0
54166,of,0,0
54167,nonpharmacologic,1,0
54168,methods,1,0
54169,of,1,0
54170,pain,1,0
54171,and,1,0
54172,anxiety,1,0
54173,management,1,0
54174,for,0,0
54175,laceration,0,0
54176,repair,0,0
54177,in,0,0
54178,the,0,0
54179,pediatric,0,0
54180,emergency,0,0
54181,department,0,0
54182,.,0,0
54183,BACKGROUND,0,0
54184,Nonpharmacologic,1,0
54185,interventions,1,0
54186,",",1,0
54187,such,1,0
54188,as,1,0
54189,distraction,1,0
54190,",",0,0
54191,have,0,0
54192,been,0,0
54193,shown,0,0
54194,to,0,0
54195,be,0,0
54196,powerful,0,0
54197,adjuncts,0,0
54198,in,0,0
54199,reducing,0,0
54200,pain,0,0
54201,and,0,0
54202,anxiety,0,0
54203,in,0,0
54204,children,0,0
54205,with,0,0
54206,both,0,0
54207,acute,0,0
54208,and,0,0
54209,chronic,0,0
54210,painful,0,0
54211,conditions,0,0
54212,.,0,0
54213,There,0,0
54214,are,0,0
54215,no,0,0
54216,controlled,0,0
54217,studies,0,0
54218,evaluating,0,0
54219,these,0,0
54220,interventions,0,0
54221,as,0,0
54222,adjuncts,0,0
54223,to,0,0
54224,facilitate,0,0
54225,completion,0,0
54226,of,0,0
54227,painful,0,0
54228,procedures,0,0
54229,in,0,0
54230,the,0,0
54231,pediatric,0,0
54232,emergency,0,1
54233,department,0,1
54234,(,0,1
54235,ED,0,1
54236,),0,1
54237,.,0,0
54238,OBJECTIVE,0,0
54239,We,0,0
54240,assessed,0,0
54241,the,0,0
54242,effectiveness,0,0
54243,of,0,0
54244,distraction,1,0
54245,techniques,1,0
54246,in,0,0
54247,reducing,0,0
54248,the,0,0
54249,sensory,0,0
54250,and,0,0
54251,affective,0,0
54252,components,0,0
54253,of,0,0
54254,pain,0,0
54255,among,0,0
54256,pediatric,0,0
54257,patients,0,0
54258,undergoing,0,0
54259,laceration,0,0
54260,repair,0,0
54261,in,0,0
54262,the,0,0
54263,ED,0,0
54264,.,0,0
54265,METHODS,0,0
54266,Eligible,0,0
54267,children,0,0
54268,between,0,0
54269,6,0,0
54270,and,0,0
54271,18,0,0
54272,years,0,0
54273,of,0,0
54274,age,0,1
54275,(,0,0
54276,N,0,0
54277,=,0,0
54278,240,0,0
54279,),0,0
54280,presenting,0,0
54281,to,0,0
54282,the,0,0
54283,ED,0,0
54284,for,0,0
54285,laceration,0,0
54286,repair,0,0
54287,were,0,0
54288,randomly,0,0
54289,assigned,0,0
54290,to,0,0
54291,an,0,0
54292,intervention,0,0
54293,or,0,0
54294,control,0,0
54295,arm,0,0
54296,.,0,0
54297,Those,0,0
54298,assigned,0,0
54299,to,0,0
54300,the,0,0
54301,intervention,0,0
54302,arm,0,0
54303,were,0,0
54304,given,0,0
54305,a,0,0
54306,choice,0,0
54307,of,0,0
54308,age-appropriate,1,0
54309,distracters,1,0
54310,during,0,0
54311,laceration,0,0
54312,repair,0,0
54313,.,0,0
54314,Quantitative,0,0
54315,measures,0,0
54316,of,0,0
54317,pain,0,0
54318,intensity,0,0
54319,",",0,0
54320,situational,0,0
54321,anxiety,0,0
54322,",",0,0
54323,and,0,0
54324,pain,0,1
54325,distress,0,1
54326,(,0,0
54327,as,0,0
54328,perceived,0,0
54329,by,0,0
54330,the,0,0
54331,parent,0,0
54332,),0,0
54333,were,0,0
54334,assessed,0,0
54335,by,0,0
54336,using,0,0
54337,the,0,0
54338,7-point,0,0
54339,Facial,0,0
54340,Pain,0,0
54341,Scale,0,0
54342,",",0,0
54343,State,0,0
54344,Trait,0,0
54345,Anxiety,0,0
54346,Inventory,0,0
54347,for,0,0
54348,Children,0,0
54349,",",0,0
54350,and,0,0
54351,a,0,0
54352,visual,0,1
54353,analog,0,1
54354,scale,0,0
54355,",",0,0
54356,respectively,0,0
54357,",",0,0
54358,before,0,0
54359,and,0,0
54360,after,0,0
54361,laceration,0,0
54362,repair,0,0
54363,.,0,0
54364,The,0,0
54365,State,0,0
54366,Trait,0,0
54367,Anxiety,0,0
54368,Inventory,0,0
54369,for,0,0
54370,Children,0,0
54371,was,0,0
54372,performed,0,0
54373,in,0,0
54374,children,0,0
54375,>,0,0
54376,or,0,0
54377,=,0,0
54378,10,0,0
54379,years,0,0
54380,of,0,0
54381,age,0,0
54382,.,0,0
54383,RESULTS,0,0
54384,There,0,0
54385,was,0,0
54386,no,0,0
54387,difference,0,0
54388,in,0,0
54389,mean,0,0
54390,change,0,0
54391,in,0,0
54392,Facial,0,0
54393,Pain,0,0
54394,Scale,0,0
54395,scores,0,0
54396,between,0,0
54397,the,0,0
54398,control,0,0
54399,and,0,0
54400,the,0,0
54401,intervention,0,0
54402,groups,0,0
54403,in,0,0
54404,children,0,0
54405,<,0,0
54406,10,0,0
54407,years,0,0
54408,of,0,0
54409,age,0,0
54410,.,0,0
54411,Multivariate,0,0
54412,analysis,0,0
54413,in,0,0
54414,this,0,0
54415,same,0,0
54416,age,0,0
54417,group,0,0
54418,showed,0,0
54419,that,0,0
54420,the,0,0
54421,intervention,0,0
54422,was,0,0
54423,independently,0,0
54424,associated,0,0
54425,with,0,0
54426,a,0,0
54427,reduction,0,0
54428,in,0,0
54429,pain,0,0
54430,distress,0,0
54431,as,0,0
54432,perceived,0,0
54433,by,0,0
54434,parents,0,0
54435,based,0,0
54436,on,0,0
54437,the,0,0
54438,mean,0,0
54439,change,0,0
54440,in,0,0
54441,visual,0,0
54442,analog,0,1
54443,scale,0,1
54444,scores,0,1
54445,.,0,0
54446,In,0,0
54447,older,0,0
54448,children,0,0
54449,",",0,0
54450,the,0,0
54451,intervention,0,0
54452,was,0,0
54453,independently,0,0
54454,associated,0,0
54455,with,0,0
54456,reduction,0,0
54457,in,0,0
54458,situational,0,0
54459,anxiety,0,0
54460,but,0,0
54461,not,0,0
54462,in,0,0
54463,pain,0,0
54464,intensity,0,0
54465,or,0,0
54466,in,0,0
54467,parental,0,0
54468,perception,0,0
54469,of,0,0
54470,pain,0,0
54471,distress,0,0
54472,.,0,0
54473,CONCLUSIONS,0,0
54474,The,0,0
54475,use,0,0
54476,of,0,0
54477,distraction,1,0
54478,techniques,1,0
54479,is,0,0
54480,effective,0,0
54481,in,0,0
54482,reducing,0,0
54483,situational,0,0
54484,anxiety,0,0
54485,in,0,0
54486,older,0,0
54487,children,0,0
54488,and,0,0
54489,lowering,0,0
54490,parental,0,0
54491,perception,0,0
54492,of,0,0
54493,pain,0,0
54494,distress,0,0
54495,in,0,0
54496,younger,0,0
54497,children,0,0
54498,.,0,0
54499,This,0,0
54500,technique,0,0
54501,may,0,0
54502,have,0,0
54503,a,0,0
54504,role,0,0
54505,in,0,0
54506,improving,0,0
54507,the,0,0
54508,quality,0,0
54509,of,0,0
54510,management,0,0
54511,of,0,0
54512,procedural,0,0
54513,pain,0,0
54514,in,0,0
54515,a,0,0
54516,pediatric,0,0
54517,ED,0,0
54518,setting,0,0
54519,.,0,0
54520,A,0,1
54521,randomized,0,0
54522,trial,0,0
54523,of,0,0
54524,an,0,0
54525,interim,0,0
54526,methadone,1,1
54527,maintenance,0,0
54528,clinic,0,0
54529,.,0,0
54530,BACKGROUND,0,1
54531,Interim,0,1
54532,methadone,1,1
54533,maintenance,0,0
54534,has,0,0
54535,been,0,0
54536,proposed,0,0
54537,as,0,0
54538,a,0,0
54539,method,0,0
54540,of,0,0
54541,providing,0,0
54542,clinically,0,0
54543,effective,0,0
54544,services,0,0
54545,to,0,0
54546,heroin,0,1
54547,addicts,0,1
54548,waiting,0,0
54549,for,0,0
54550,treatment,0,0
54551,in,0,0
54552,standard,0,0
54553,comprehensive,0,0
54554,methadone,0,1
54555,maintenance,0,0
54556,programs,0,0
54557,.,0,0
54558,METHODS,0,0
54559,A,0,1
54560,clinic,0,0
54561,that,0,0
54562,provided,0,0
54563,initial,0,0
54564,medical,0,0
54565,evaluation,0,0
54566,",",0,0
54567,methadone,0,1
54568,medication,0,1
54569,",",0,0
54570,and,0,0
54571,AIDS,0,1
54572,education,0,0
54573,",",0,0
54574,but,0,0
54575,did,0,0
54576,not,0,0
54577,include,0,0
54578,formal,0,1
54579,drug,0,1
54580,abuse,0,1
54581,counseling,0,1
54582,or,0,0
54583,other,0,0
54584,social,0,0
54585,support,0,0
54586,services,0,0
54587,was,0,0
54588,established,0,0
54589,in,0,0
54590,New,0,0
54591,York,0,1
54592,City,0,0
54593,.,0,0
54594,A,0,0
54595,sample,0,0
54596,of,0,0
54597,301,0,0
54598,volunteer,0,0
54599,subjects,0,0
54600,recruited,0,0
54601,from,0,0
54602,the,0,0
54603,waiting,0,0
54604,list,0,0
54605,for,0,0
54606,treatment,0,0
54607,in,0,0
54608,the,0,0
54609,Beth,0,0
54610,Israel,0,1
54611,methadone,1,1
54612,program,0,1
54613,were,0,0
54614,randomly,0,0
54615,assigned,0,0
54616,to,0,0
54617,immediate,0,0
54618,entry,0,0
54619,into,0,0
54620,the,0,0
54621,interim,1,0
54622,clinic,1,0
54623,or,1,0
54624,a,1,0
54625,control,1,0
54626,group,1,0
54627,.,1,0
54628,RESULTS,0,0
54629,There,0,0
54630,were,0,0
54631,no,0,0
54632,differences,0,0
54633,in,0,0
54634,initial,0,0
54635,levels,0,0
54636,of,0,0
54637,illicit,0,0
54638,drug,0,1
54639,use,0,0
54640,across,0,0
54641,the,0,0
54642,experimental,0,0
54643,and,0,0
54644,control,0,0
54645,groups,0,0
54646,.,0,0
54647,One-month,0,0
54648,urinalysis,0,0
54649,follow-up,0,0
54650,data,0,0
54651,showed,0,0
54652,a,0,0
54653,significant,0,0
54654,reduction,0,0
54655,in,0,0
54656,heroin,0,1
54657,use,0,0
54658,in,0,0
54659,the,0,0
54660,experimental,0,0
54661,group,0,0
54662,(,0,0
54663,from,0,0
54664,63,0,0
54665,%,0,0
54666,positive,0,0
54667,at,0,0
54668,intake,0,0
54669,to,0,0
54670,29,0,0
54671,%,0,0
54672,positive,0,0
54673,),0,0
54674,with,0,0
54675,no,0,0
54676,change,0,0
54677,in,0,0
54678,the,0,0
54679,control,0,0
54680,group,0,0
54681,(,0,0
54682,62,0,0
54683,%,0,0
54684,to,0,0
54685,60,0,0
54686,%,0,0
54687,positive,0,0
54688,),0,0
54689,.,0,0
54690,No,0,1
54691,significant,0,0
54692,change,0,0
54693,was,0,0
54694,observed,0,0
54695,in,0,0
54696,cocaine,0,1
54697,urinalyses,0,1
54698,(,0,0
54699,approximately,0,0
54700,70,0,0
54701,%,0,0
54702,positive,0,0
54703,for,0,0
54704,both,0,0
54705,groups,0,0
54706,at,0,0
54707,intake,0,1
54708,and,0,1
54709,follow-up,0,1
54710,),0,0
54711,.,0,0
54712,A,0,0
54713,higher,0,0
54714,percentage,0,0
54715,of,0,0
54716,the,0,0
54717,experimental,0,0
54718,group,0,0
54719,were,0,0
54720,in,0,0
54721,treatment,0,0
54722,at,0,0
54723,16-month,0,0
54724,follow-up,0,0
54725,(,0,0
54726,72,0,0
54727,%,0,0
54728,vs,0,0
54729,56,0,0
54730,%,0,0
54731,),0,0
54732,.,0,0
54733,CONCLUSIONS,0,0
54734,Limited,0,0
54735,services,0,1
54736,interim,0,1
54737,methadone,0,1
54738,maintenance,0,0
54739,can,0,0
54740,reduce,0,0
54741,heroin,0,1
54742,use,0,0
54743,among,0,0
54744,persons,0,0
54745,awaiting,0,0
54746,entry,0,0
54747,into,0,0
54748,comprehensive,0,0
54749,treatment,0,0
54750,and,0,0
54751,increase,0,0
54752,the,0,0
54753,percentage,0,0
54754,entering,0,0
54755,treatment,0,0
54756,.,0,0
54757,A,0,1
54758,crossover,0,1
54759,study,0,0
54760,of,0,0
54761,risperidone,1,1
54762,in,0,0
54763,children,0,1
54764,",",0,0
54765,adolescents,0,0
54766,and,0,0
54767,adults,0,0
54768,with,0,0
54769,mental,0,0
54770,retardation,0,0
54771,.,0,0
54772,Risperidone,1,1
54773,has,0,0
54774,shown,0,0
54775,safety,0,0
54776,and,0,0
54777,efficacy,0,0
54778,for,0,0
54779,aggressive,0,0
54780,and,0,0
54781,destructive,0,0
54782,behaviors,0,0
54783,in,0,0
54784,short-term,0,0
54785,studies,0,0
54786,.,0,0
54787,This,0,0
54788,longer-duration,0,0
54789,study,0,0
54790,includes,0,0
54791,a,0,0
54792,broad,0,0
54793,sample,0,0
54794,.,0,0
54795,Forty,0,0
54796,subjects,0,0
54797,",",0,0
54798,aged,0,0
54799,8-56,0,0
54800,years,0,0
54801,(,0,0
54802,mean=22,0,0
54803,),0,0
54804,",",0,0
54805,all,0,0
54806,with,0,0
54807,mental,0,0
54808,retardation,0,0
54809,and,0,0
54810,36,0,0
54811,with,0,0
54812,autism,0,0
54813,spectrum,0,0
54814,disorders,0,0
54815,participated,0,0
54816,in,0,0
54817,this,0,0
54818,22-week,0,0
54819,crossover,0,1
54820,study,0,0
54821,",",0,0
54822,with,0,0
54823,24,0,0
54824,weeks,0,0
54825,of,0,0
54826,open,0,0
54827,maintenance,0,0
54828,thereafter,0,0
54829,.,0,0
54830,Of,0,0
54831,40,0,0
54832,subjects,0,0
54833,",",0,0
54834,23,0,0
54835,(,0,0
54836,57.5,0,0
54837,%,0,0
54838,),0,0
54839,responded,0,0
54840,fully,0,0
54841,(,0,0
54842,50,0,0
54843,%,0,0
54844,decrease,0,0
54845,in,0,0
54846,Aberrant,0,0
54847,Behavior,0,0
54848,Checklist-Community,0,0
54849,Irritability,0,0
54850,subscale,0,1
54851,score,0,1
54852,),0,0
54853,",",0,0
54854,while,0,0
54855,35,0,0
54856,subjects,0,0
54857,(,0,0
54858,87.5,0,0
54859,%,0,0
54860,),0,0
54861,showed,0,0
54862,a,0,0
54863,25,0,0
54864,%,0,0
54865,decrease,0,0
54866,.,0,0
54867,Gender,0,0
54868,",",0,0
54869,mood,0,0
54870,disorder,0,0
54871,",",0,0
54872,and,0,1
54873,antiseizure,0,1
54874,medications,0,1
54875,did,0,0
54876,not,0,0
54877,alter,0,0
54878,response,0,0
54879,.,0,0
54880,Increased,0,0
54881,appetite,0,1
54882,and,0,0
54883,weight,0,0
54884,gain,0,0
54885,were,0,0
54886,common,0,0
54887,.,0,0
54888,Low,0,1
54889,dose,0,1
54890,risperidone,0,1
54891,was,0,0
54892,effective,0,0
54893,for,0,0
54894,aggressive,0,0
54895,behavior,0,0
54896,in,0,0
54897,persons,0,0
54898,with,0,0
54899,MR.,0,0
54900,More,0,0
54901,long-term,0,0
54902,studies,0,0
54903,are,0,0
54904,needed,0,0
54905,",",0,0
54906,incorporating,0,0
54907,weight,0,0
54908,control,0,0
54909,interventions,0,0
54910,.,0,0
54911,The,0,0
54912,effect,0,0
54913,of,0,0
54914,a,0,0
54915,parent-implemented,1,0
54916,imitation,1,0
54917,intervention,1,0
54918,on,0,0
54919,spontaneous,0,0
54920,imitation,0,0
54921,skills,0,0
54922,in,0,0
54923,young,0,0
54924,children,0,0
54925,with,0,0
54926,autism,0,0
54927,.,0,0
54928,Children,0,0
54929,with,0,0
54930,autism,0,0
54931,exhibit,0,0
54932,significant,0,0
54933,deficits,0,0
54934,in,0,0
54935,their,0,0
54936,ability,0,0
54937,to,0,0
54938,spontaneously,0,0
54939,imitate,0,0
54940,the,0,0
54941,play,0,0
54942,actions,0,0
54943,and,0,0
54944,descriptive,0,0
54945,gestures,0,0
54946,of,0,0
54947,others,0,0
54948,.,0,0
54949,Reciprocal,1,0
54950,imitation,1,0
54951,training,1,1
54952,(,1,1
54953,RIT,1,1
54954,),1,0
54955,is,1,0
54956,a,1,0
54957,naturalistic,1,0
54958,imitation,1,0
54959,intervention,1,0
54960,designed,0,0
54961,to,0,0
54962,teach,0,0
54963,spontaneous,0,0
54964,imitation,0,0
54965,skills,0,0
54966,during,0,0
54967,play,0,0
54968,.,0,0
54969,This,0,0
54970,study,0,0
54971,assessed,0,0
54972,the,0,0
54973,effectiveness,0,0
54974,of,0,0
54975,parent-implemented,0,0
54976,RIT,1,0
54977,using,0,0
54978,a,0,0
54979,multiple-baseline,0,0
54980,design,0,0
54981,across,0,0
54982,three,0,0
54983,young,0,0
54984,children,0,0
54985,with,0,0
54986,autism,0,0
54987,and,0,0
54988,their,0,0
54989,mothers,0,0
54990,.,0,0
54991,After,0,0
54992,an,0,0
54993,initial,0,0
54994,baseline,0,0
54995,",",0,0
54996,mothers,0,0
54997,were,0,0
54998,taught,0,0
54999,to,0,0
55000,implement,0,0
55001,RIT,1,0
55002,techniques,0,0
55003,with,0,0
55004,their,0,0
55005,child,0,0
55006,twice,0,0
55007,a,0,0
55008,week,0,0
55009,for,0,0
55010,10,0,0
55011,weeks,0,0
55012,in,0,0
55013,a,0,0
55014,clinic,0,0
55015,setting,0,0
55016,.,0,0
55017,Two,0,0
55018,mothers,0,0
55019,were,0,0
55020,taught,0,0
55021,to,0,0
55022,use,0,0
55023,RIT,1,0
55024,to,0,0
55025,teach,0,0
55026,object,0,0
55027,imitation,0,0
55028,.,0,0
55029,The,0,0
55030,third,0,0
55031,mother,0,0
55032,was,0,0
55033,taught,0,0
55034,to,0,0
55035,use,0,0
55036,RIT,1,0
55037,to,0,0
55038,target,0,0
55039,both,0,0
55040,object,0,0
55041,and,0,0
55042,gesture,0,0
55043,imitation,0,0
55044,in,0,0
55045,a,0,0
55046,multiple-baseline,0,0
55047,design,0,0
55048,across,0,0
55049,behaviors,0,0
55050,.,0,0
55051,Generalization,0,0
55052,was,0,0
55053,assessed,0,0
55054,in,0,0
55055,the,0,0
55056,families,0,0
55057,',0,0
55058,homes,0,0
55059,at,0,0
55060,the,0,0
55061,end,0,0
55062,of,0,0
55063,treatment,0,0
55064,and,0,0
55065,a,0,0
55066,1-month,0,0
55067,follow-up,0,0
55068,.,0,0
55069,Parents,0,0
55070,learned,0,0
55071,to,0,0
55072,use,0,0
55073,the,0,0
55074,intervention,0,0
55075,strategies,0,0
55076,and,0,0
55077,their,0,0
55078,children,0,0
55079,exhibited,0,0
55080,increases,0,0
55081,in,0,0
55082,spontaneous,0,0
55083,imitation,0,0
55084,.,0,0
55085,These,0,0
55086,findings,0,0
55087,replicate,0,0
55088,the,0,0
55089,results,0,0
55090,from,0,0
55091,previous,0,0
55092,studies,0,0
55093,",",0,0
55094,indicating,0,0
55095,that,0,0
55096,RIT,0,0
55097,is,0,0
55098,effective,0,0
55099,for,0,0
55100,teaching,0,0
55101,imitation,0,0
55102,skills,0,0
55103,to,0,0
55104,young,0,0
55105,children,0,0
55106,with,0,0
55107,autism,0,0
55108,in,0,0
55109,a,0,0
55110,naturalistic,0,0
55111,setting,0,0
55112,and,0,0
55113,extend,0,0
55114,the,0,0
55115,findings,0,0
55116,to,0,0
55117,parents,0,0
55118,.,0,0
55119,Evaluation,0,0
55120,of,0,0
55121,prostaglandin,1,1
55122,E1,1,1
55123,for,0,0
55124,prevention,0,0
55125,of,0,0
55126,respiratory,0,0
55127,failure,0,0
55128,in,0,0
55129,high,0,0
55130,risk,0,0
55131,trauma,0,0
55132,patients,0,0
55133,:,0,0
55134,a,0,0
55135,prospective,0,0
55136,clinical,0,0
55137,trial,0,0
55138,and,0,0
55139,correlation,0,0
55140,with,0,0
55141,plasma,0,0
55142,suppressive,0,0
55143,factors,0,0
55144,for,0,0
55145,neutrophil,0,1
55146,activation,0,0
55147,.,0,0
55148,A,0,0
55149,group,0,0
55150,of,0,0
55151,48,0,0
55152,critically,0,0
55153,injured,0,0
55154,patients,0,0
55155,were,0,0
55156,entered,0,0
55157,into,0,0
55158,a,0,0
55159,prospective,0,0
55160,",",0,0
55161,double-blind,0,1
55162,",",0,1
55163,placebo-controlled,1,1
55164,trial,0,1
55165,to,0,0
55166,evaluate,0,0
55167,the,0,0
55168,efficacy,0,0
55169,of,0,0
55170,early,1,0
55171,infusion,1,1
55172,of,1,0
55173,PGE1,1,0
55174,for,0,0
55175,reducing,0,0
55176,the,0,0
55177,incidence,0,0
55178,of,0,0
55179,severe,0,0
55180,respiratory,0,0
55181,failure,0,0
55182,and,0,0
55183,mortality,0,0
55184,.,0,0
55185,Secondary,0,0
55186,assessments,0,0
55187,examined,0,0
55188,the,0,0
55189,effects,0,0
55190,of,0,0
55191,the,0,0
55192,PGE1,0,1
55193,infusion,0,1
55194,on,0,1
55195,plasma,0,1
55196,mediated,0,0
55197,suppression,0,0
55198,of,0,0
55199,PMN,0,1
55200,superoxide,0,1
55201,production,0,0
55202,and,0,0
55203,loss,0,0
55204,of,0,0
55205,PMN,0,0
55206,granule,0,0
55207,enzyme,0,0
55208,content,0,0
55209,.,0,0
55210,The,0,0
55211,incidence,0,0
55212,of,0,0
55213,severe,0,0
55214,respiratory,0,0
55215,failure,0,0
55216,was,0,0
55217,lower,0,0
55218,in,0,0
55219,the,0,0
55220,PGE1,0,0
55221,group,0,0
55222,--,0,0
55223,13,0,0
55224,%,0,0
55225,versus,0,0
55226,32,0,0
55227,%,0,0
55228,",",0,0
55229,but,0,0
55230,this,0,0
55231,did,0,0
55232,not,0,0
55233,reach,0,0
55234,significance,0,0
55235,.,0,0
55236,The,0,0
55237,overall,0,0
55238,morality,0,0
55239,was,0,0
55240,equivalent,0,0
55241,between,0,0
55242,the,0,0
55243,two,0,0
55244,groups,0,0
55245,--,0,0
55246,26,0,0
55247,%,0,0
55248,(,1,0
55249,PGE1,1,0
55250,),1,1
55251,versus,0,0
55252,28,0,0
55253,%,0,0
55254,(,1,0
55255,placebo,1,1
55256,),1,1
55257,.,0,0
55258,The,0,0
55259,suppressive,0,0
55260,activity,0,0
55261,of,0,0
55262,the,0,0
55263,patient,0,0
55264,plasma,0,1
55265,was,0,0
55266,assayed,0,0
55267,by,0,0
55268,measurement,0,0
55269,of,0,0
55270,normal,0,0
55271,PMN,0,0
55272,superoxide,0,1
55273,production,0,0
55274,relative,0,0
55275,to,0,0
55276,normal,0,0
55277,control,0,0
55278,plasma,0,1
55279,(,0,0
55280,ratio,0,0
55281,P,0,0
55282,:,0,0
55283,C,0,0
55284,),0,0
55285,.,0,0
55286,The,0,0
55287,baseline,0,0
55288,ratio,0,0
55289,P,0,0
55290,:,0,0
55291,C,0,0
55292,was,0,0
55293,62,0,0
55294,+/-,0,0
55295,5,0,0
55296,%,0,0
55297,in,0,0
55298,the,0,0
55299,PGE1,0,1
55300,group,0,0
55301,versus,0,0
55302,60,0,0
55303,+/-,0,0
55304,5,0,0
55305,%,0,0
55306,in,0,0
55307,the,0,0
55308,placebo,0,1
55309,group,0,0
55310,.,0,0
55311,The,0,0
55312,day,0,0
55313,1,0,0
55314,plasma,0,1
55315,samples,0,0
55316,showed,0,0
55317,significant,0,0
55318,reversal,0,0
55319,of,0,0
55320,plasma,0,0
55321,suppressive,0,0
55322,activity,0,0
55323,in,0,0
55324,the,0,0
55325,PGE1,0,0
55326,group,0,0
55327,--,0,0
55328,ratio,0,0
55329,P,0,0
55330,:,0,0
55331,C,0,0
55332,88,0,0
55333,+/-,0,0
55334,5,0,0
55335,%,0,0
55336,versus,0,0
55337,67,0,0
55338,+/-,0,0
55339,5,0,0
55340,%,0,0
55341,in,0,0
55342,the,0,0
55343,placebo,0,1
55344,group,0,0
55345,(,0,0
55346,P,0,0
55347,less,0,0
55348,than,0,0
55349,0.02,0,0
55350,),0,0
55351,.,0,0
55352,In,0,0
55353,patients,0,0
55354,who,0,0
55355,received,0,0
55356,the,0,0
55357,full,0,0
55358,7,0,0
55359,days,0,0
55360,of,0,1
55361,infusion,0,1
55362,",",0,0
55363,the,0,0
55364,plasma,0,0
55365,suppressive,0,0
55366,activity,0,0
55367,remained,0,0
55368,significantly,0,0
55369,diminished,0,0
55370,in,0,0
55371,the,0,0
55372,PGE1,0,0
55373,group,0,0
55374,--,0,0
55375,ratio,0,0
55376,P,0,0
55377,:,0,0
55378,C,0,0
55379,77,0,0
55380,+/-,0,0
55381,4,0,0
55382,%,0,0
55383,versus,0,0
55384,61,0,0
55385,+/-,0,0
55386,5,0,0
55387,%,0,0
55388,(,0,0
55389,P,0,0
55390,less,0,0
55391,than,0,0
55392,0.04,0,0
55393,),0,0
55394,.,0,0
55395,The,0,0
55396,baseline,0,0
55397,lysozyme,0,0
55398,content,0,0
55399,of,0,0
55400,patient,0,0
55401,PMN,0,0
55402,'s,0,0
55403,relative,0,0
55404,to,0,0
55405,that,0,0
55406,of,0,0
55407,normal,0,0
55408,control,0,0
55409,PMNs,0,0
55410,(,0,0
55411,ratio,0,0
55412,P,0,0
55413,:,0,0
55414,C,0,0
55415,),0,0
55416,was,0,0
55417,119,0,0
55418,+/-,0,0
55419,14,0,0
55420,%,0,0
55421,in,0,0
55422,the,0,0
55423,PGE1,0,0
55424,group,0,0
55425,.,0,0
55426,A,0,0
55427,significant,0,0
55428,loss,0,0
55429,of,0,0
55430,lysozyme,0,0
55431,content,0,0
55432,was,0,0
55433,observed,0,0
55434,in,0,0
55435,the,0,0
55436,PGE1,0,1
55437,group,0,0
55438,on,0,0
55439,day,0,0
55440,1,0,0
55441,of,0,0
55442,the,0,0
55443,infusion,0,1
55444,--,0,0
55445,ratio,0,0
55446,P,0,0
55447,:,0,0
55448,C,0,0
55449,79,0,0
55450,+/-,0,0
55451,8,0,0
55452,%,0,0
55453,(,0,0
55454,P,0,0
55455,less,0,0
55456,than,0,0
55457,0.03,0,0
55458,),0,0
55459,",",0,0
55460,and,0,0
55461,was,0,0
55462,associated,0,0
55463,with,0,0
55464,a,0,0
55465,reduction,0,0
55466,in,0,0
55467,the,0,0
55468,plasma,0,0
55469,suppressive,0,0
55470,activity,0,0
55471,.,0,0
55472,(,0,0
55473,ABSTRACT,0,1
55474,TRUNCATED,0,1
55475,AT,0,1
55476,250,0,1
55477,WORDS,0,1
55478,),0,1
55479,Effect,0,0
55480,of,0,0
55481,step,1,0
55482,aerobics,1,0
55483,training,1,0
55484,on,0,0
55485,anaerobic,0,0
55486,performance,0,0
55487,of,0,0
55488,men,0,0
55489,and,0,0
55490,women,0,0
55491,.,0,0
55492,The,0,0
55493,purpose,0,0
55494,of,0,0
55495,this,0,0
55496,study,0,0
55497,was,0,0
55498,to,0,0
55499,investigate,0,0
55500,the,0,0
55501,effects,0,0
55502,of,0,0
55503,10,0,0
55504,weeks,0,0
55505,of,0,0
55506,step,1,0
55507,aerobics,1,0
55508,training,1,0
55509,on,0,0
55510,anaerobic,0,0
55511,performance,0,0
55512,of,0,0
55513,men,0,0
55514,and,0,0
55515,women,0,0
55516,.,0,0
55517,College-age,0,0
55518,volunteers,0,0
55519,(,0,0
55520,64,0,0
55521,women,0,0
55522,and,0,0
55523,54,0,0
55524,men,0,0
55525,),0,0
55526,were,0,0
55527,divided,0,0
55528,into,0,0
55529,step,1,0
55530,aerobics,1,0
55531,(,0,0
55532,33,0,0
55533,women,0,0
55534,",",0,0
55535,27,0,0
55536,men,0,0
55537,),0,0
55538,and,0,0
55539,control,1,0
55540,(,0,0
55541,31,0,0
55542,women,0,0
55543,",",0,0
55544,27,0,0
55545,men,0,0
55546,),0,0
55547,groups,0,0
55548,.,0,0
55549,Before,0,0
55550,and,0,0
55551,after,0,0
55552,the,0,0
55553,10-week,0,0
55554,period,0,0
55555,",",0,0
55556,the,0,0
55557,subjects,0,0
55558,',0,0
55559,body,0,0
55560,composition,0,0
55561,",",0,0
55562,muscular,0,0
55563,strength,0,1
55564,",",0,0
55565,Wingate,0,0
55566,anaerobic,0,1
55567,performance,0,0
55568,",",0,0
55569,and,0,0
55570,vertical,0,0
55571,jump,0,0
55572,anaerobic,0,0
55573,performance,0,0
55574,were,0,0
55575,determined,0,0
55576,.,0,0
55577,The,0,0
55578,step,1,0
55579,aerobics,1,0
55580,group,0,0
55581,participated,0,0
55582,in,0,0
55583,step,1,0
55584,aerobics,1,0
55585,sessions,0,0
55586,of,0,0
55587,50,0,0
55588,minutes,0,0
55589,per,0,0
55590,day,0,0
55591,",",0,1
55592,3,0,1
55593,days,0,0
55594,per,0,0
55595,week,0,0
55596,for,0,0
55597,10,0,0
55598,weeks,0,0
55599,",",0,0
55600,at,0,0
55601,60-80,0,0
55602,%,0,0
55603,of,0,0
55604,their,0,0
55605,heart,0,0
55606,rate,0,0
55607,reserve,0,0
55608,.,0,0
55609,Results,0,0
55610,of,0,0
55611,2,0,0
55612,x,0,0
55613,2,0,0
55614,analysis,0,0
55615,of,0,0
55616,covariance,0,0
55617,with,0,0
55618,repeated,0,0
55619,measures,0,0
55620,indicated,0,0
55621,significant,0,0
55622,sex,0,0
55623,differences,0,0
55624,in,0,0
55625,percentage,0,0
55626,body,0,0
55627,fat,0,0
55628,",",0,0
55629,lean,0,0
55630,body,0,0
55631,mass,0,0
55632,",",0,0
55633,muscular,0,0
55634,strength,0,1
55635,",",0,0
55636,and,0,0
55637,in,0,0
55638,all,0,0
55639,of,0,0
55640,the,0,0
55641,measured,0,0
55642,indices,0,0
55643,of,0,0
55644,the,0,0
55645,Wingate,0,0
55646,Anaerobic,0,0
55647,Test,0,0
55648,.,0,0
55649,The,0,0
55650,step,0,0
55651,aerobics,1,0
55652,group,0,0
55653,showed,0,0
55654,significant,0,0
55655,improvement,0,0
55656,only,0,0
55657,in,0,0
55658,mean,0,0
55659,power,0,0
55660,relative,0,0
55661,to,0,0
55662,body,0,0
55663,weight,0,0
55664,compared,0,0
55665,with,0,0
55666,the,0,0
55667,control,0,0
55668,group,0,0
55669,and,0,0
55670,women,0,0
55671,showed,0,0
55672,significant,0,0
55673,improvement,0,0
55674,only,0,0
55675,in,0,0
55676,anaerobic,0,0
55677,power,0,0
55678,of,0,0
55679,vertical,0,0
55680,jump,0,0
55681,when,0,0
55682,compared,0,0
55683,with,0,0
55684,men,0,0
55685,.,0,0
55686,It,0,0
55687,can,0,0
55688,be,0,0
55689,concluded,0,0
55690,that,0,0
55691,10,0,0
55692,weeks,0,0
55693,of,0,0
55694,step,0,0
55695,aerobics,0,0
55696,was,0,0
55697,not,0,0
55698,effective,0,0
55699,in,0,0
55700,improving,0,0
55701,all,0,0
55702,of,0,0
55703,the,0,0
55704,measured,0,0
55705,anaerobic,0,0
55706,indices,0,0
55707,in,0,0
55708,men,0,0
55709,and,0,0
55710,women,0,0
55711,.,0,0
55712,Thromboprophylaxis,0,0
55713,by,0,1
55714,low-molecular-weight,1,1
55715,heparin,1,1
55716,in,0,1
55717,elective,0,1
55718,hip,0,0
55719,surgery,0,0
55720,.,0,0
55721,A,0,1
55722,placebo,1,1
55723,controlled,0,0
55724,study,0,0
55725,.,0,0
55726,In,0,0
55727,a,0,0
55728,double-blind,0,1
55729,",",0,0
55730,randomised,0,0
55731,study,0,0
55732,of,0,0
55733,thromboprophylaxis,0,0
55734,in,0,0
55735,patients,0,0
55736,undergoing,0,0
55737,total,0,0
55738,hip,0,0
55739,replacement,0,0
55740,",",0,0
55741,we,0,0
55742,compared,0,0
55743,a,0,0
55744,low-molecular-weight,1,1
55745,heparin,1,1
55746,with,1,1
55747,a,1,0
55748,placebo,1,1
55749,.,1,0
55750,Of,0,0
55751,the,0,0
55752,120,0,0
55753,patients,0,0
55754,enrolled,0,0
55755,",",0,0
55756,112,0,0
55757,completed,0,0
55758,the,0,0
55759,trial,0,0
55760,;,0,0
55761,58,0,0
55762,in,0,0
55763,the,0,0
55764,treatment,0,0
55765,group,0,0
55766,and,0,0
55767,54,0,0
55768,in,0,0
55769,the,0,0
55770,placebo,0,1
55771,group,0,1
55772,.,0,1
55773,Nine,0,1
55774,(,0,0
55775,16,0,0
55776,%,0,0
55777,),0,0
55778,patients,0,0
55779,in,0,0
55780,the,0,0
55781,treatment,0,0
55782,group,0,0
55783,and,0,0
55784,19,0,0
55785,(,0,0
55786,35,0,0
55787,%,0,0
55788,),0,0
55789,in,0,0
55790,the,0,0
55791,placebo,1,1
55792,group,0,0
55793,developed,0,0
55794,deep,0,0
55795,venous,0,0
55796,thrombosis,0,0
55797,",",0,0
55798,diagnosed,0,0
55799,by,0,0
55800,the,0,0
55801,125I-fibrinogen,0,0
55802,uptake,0,0
55803,test,0,0
55804,(,0,0
55805,p,0,0
55806,<,0,0
55807,0.02,0,0
55808,),0,0
55809,.,0,0
55810,Verification,0,0
55811,was,0,0
55812,obtained,0,0
55813,by,0,0
55814,phlebography,0,0
55815,in,0,0
55816,86,0,0
55817,%,0,0
55818,of,0,0
55819,the,0,0
55820,patients,0,0
55821,.,0,0
55822,Prolonged,0,0
55823,surgery,0,0
55824,increased,0,0
55825,the,0,0
55826,risk,0,0
55827,of,0,0
55828,thrombosis,0,0
55829,in,0,0
55830,the,0,0
55831,placebo,0,1
55832,group,0,0
55833,but,0,0
55834,not,0,0
55835,in,0,0
55836,the,0,0
55837,treatment,0,0
55838,group,0,0
55839,(,0,0
55840,p,0,0
55841,<,0,0
55842,0.05,0,0
55843,),0,0
55844,.,0,0
55845,There,0,0
55846,were,0,0
55847,significantly,0,0
55848,more,0,0
55849,cases,0,0
55850,of,0,0
55851,deep,0,0
55852,venous,0,0
55853,thrombosis,0,0
55854,in,0,0
55855,the,0,0
55856,placebo,0,1
55857,group,0,0
55858,during,0,0
55859,the,0,0
55860,first,0,0
55861,four,0,0
55862,postoperative,0,1
55863,days,0,0
55864,(,0,0
55865,p,0,0
55866,<,0,0
55867,0.02,0,0
55868,),0,0
55869,.,0,0
55870,The,0,0
55871,groups,0,0
55872,did,0,0
55873,not,0,0
55874,differ,0,0
55875,with,0,0
55876,respect,0,0
55877,to,0,0
55878,peroperative,0,0
55879,and,0,0
55880,postoperative,0,0
55881,bleeding,0,0
55882,.,0,1
55883,Low-molecular-weight,1,1
55884,heparin,1,1
55885,offers,0,1
55886,safe,0,0
55887,and,0,0
55888,easily,0,0
55889,administered,0,1
55890,thromboprophylaxis,0,1
55891,in,0,0
55892,total,0,0
55893,hip,0,0
55894,replacement,0,0
55895,.,0,0
55896,A,0,1
55897,randomised,0,0
55898,trial,0,0
55899,comparing,0,0
55900,holmium,1,0
55901,laser,1,0
55902,enucleation,1,1
55903,versus,0,0
55904,transurethral,1,0
55905,resection,1,0
55906,in,0,0
55907,the,0,0
55908,treatment,0,0
55909,of,0,0
55910,prostates,0,0
55911,larger,0,0
55912,than,0,0
55913,40,0,0
55914,grams,0,1
55915,:,0,0
55916,results,0,0
55917,at,0,0
55918,2,0,0
55919,years,0,0
55920,.,0,0
55921,OBJECTIVE,0,0
55922,To,0,0
55923,compare,0,0
55924,holmium,1,0
55925,laser,1,0
55926,enucleation,1,0
55927,of,1,0
55928,the,1,0
55929,prostate,1,0
55930,(,1,1
55931,HoLEP,1,1
55932,),1,1
55933,with,0,0
55934,transurethral,1,0
55935,resection,1,0
55936,of,1,0
55937,the,1,0
55938,prostate,1,0
55939,(,1,1
55940,TURP,1,1
55941,),1,0
55942,for,0,0
55943,treatment,0,0
55944,of,0,0
55945,men,0,0
55946,with,0,0
55947,bladder,0,0
55948,outflow,0,1
55949,obstruction,0,1
55950,(,0,1
55951,BOO,0,1
55952,),0,0
55953,secondary,0,0
55954,to,0,0
55955,benign,0,0
55956,prostatic,0,0
55957,hyperplasia,0,0
55958,with,0,0
55959,a,0,0
55960,minimum,0,0
55961,of,0,0
55962,24-month,0,0
55963,follow-up,0,0
55964,.,0,0
55965,PATIENTS,0,0
55966,AND,0,0
55967,METHODS,0,0
55968,Sixty-one,0,0
55969,patients,0,0
55970,were,0,0
55971,randomised,0,0
55972,to,0,0
55973,either,0,0
55974,HoLEP,1,0
55975,or,0,0
55976,TURP,1,0
55977,.,1,0
55978,All,0,0
55979,patients,0,0
55980,had,0,0
55981,BOO,0,0
55982,proven,0,0
55983,on,0,0
55984,urodynamic,0,0
55985,studies,0,0
55986,pre-operatively,0,1
55987,(,0,0
55988,prostate,0,0
55989,size,0,0
55990,40-200,0,0
55991,g,0,0
55992,),0,0
55993,.,0,0
55994,One,0,0
55995,patient,0,0
55996,died,0,0
55997,before,0,0
55998,treatment,0,0
55999,",",0,0
56000,which,0,0
56001,left,0,0
56002,30,0,0
56003,patients,0,0
56004,in,0,0
56005,each,0,0
56006,group,0,0
56007,.,0,0
56008,Perioperative,0,0
56009,data,0,0
56010,",",0,0
56011,as,0,0
56012,well,0,0
56013,as,0,0
56014,symptom,0,0
56015,scores,0,0
56016,",",0,0
56017,Quality,0,0
56018,of,0,1
56019,Life,0,1
56020,(,0,1
56021,QoL,0,1
56022,),0,1
56023,scores,0,0
56024,",",0,0
56025,and,0,0
56026,maximum,0,0
56027,urinary,0,0
56028,flow,0,0
56029,rates,0,0
56030,(,0,0
56031,Qmax,0,0
56032,),0,0
56033,were,0,0
56034,obtained,0,0
56035,at,0,0
56036,one,0,0
56037,",",0,0
56038,three,0,0
56039,",",0,0
56040,"six,12",0,0
56041,",",0,0
56042,and,0,0
56043,24,0,0
56044,months,0,0
56045,.,0,0
56046,Post-void,0,0
56047,residual,0,0
56048,volumes,0,0
56049,",",0,0
56050,transrectal,0,1
56051,ultrasound,0,1
56052,(,0,1
56053,TRUS,0,1
56054,),0,1
56055,volumes,0,0
56056,",",0,0
56057,and,0,0
56058,pressure,0,0
56059,flow,0,0
56060,studies,0,0
56061,were,0,0
56062,obtained,0,0
56063,six,0,0
56064,months,0,0
56065,post-operatively,0,0
56066,.,0,0
56067,Continence,0,0
56068,and,0,0
56069,potency,0,0
56070,data,0,0
56071,were,0,0
56072,also,0,0
56073,recorded,0,0
56074,.,0,0
56075,RESULTS,0,0
56076,There,0,0
56077,were,0,0
56078,no,0,0
56079,significant,0,0
56080,differences,0,0
56081,between,0,0
56082,the,0,0
56083,two,0,0
56084,surgical,0,0
56085,groups,0,0
56086,pre-operatively,0,0
56087,.,0,0
56088,Mean,0,0
56089,pre-operative,0,0
56090,TRUS,0,0
56091,volume,0,0
56092,was,0,0
56093,77.8+/-5.6,0,0
56094,g,0,0
56095,(,0,0
56096,42-152,0,0
56097,),0,0
56098,in,0,0
56099,the,0,0
56100,HoLEP,0,0
56101,group,0,0
56102,and,0,0
56103,70.0+/-5.0,0,0
56104,g,0,0
56105,(,0,0
56106,46-156,0,0
56107,),0,0
56108,in,0,0
56109,the,0,0
56110,TURP,1,0
56111,group,0,0
56112,.,0,0
56113,Patients,0,0
56114,in,0,0
56115,the,0,0
56116,HoLEP,1,0
56117,group,0,0
56118,had,0,0
56119,shorter,0,0
56120,catheter,0,0
56121,times,0,0
56122,and,0,0
56123,hospital,0,0
56124,stays,0,0
56125,.,0,0
56126,More,0,0
56127,prostate,0,0
56128,tissue,0,0
56129,was,0,0
56130,retrieved,0,0
56131,in,0,0
56132,the,0,0
56133,HoLEP,1,0
56134,group,0,0
56135,.,0,0
56136,At,0,0
56137,six,0,0
56138,months,0,0
56139,",",0,0
56140,HoLEP,1,0
56141,was,0,0
56142,urodynamically,0,0
56143,superior,0,0
56144,to,0,0
56145,TURP,1,0
56146,in,0,0
56147,relieving,0,0
56148,BOO,0,0
56149,.,0,0
56150,At,0,0
56151,24,0,0
56152,months,0,0
56153,",",0,0
56154,there,0,0
56155,was,0,0
56156,no,0,0
56157,significant,0,0
56158,difference,0,0
56159,between,0,0
56160,the,0,0
56161,two,0,0
56162,surgical,0,0
56163,groups,0,0
56164,with,0,0
56165,respect,0,0
56166,to,0,0
56167,American,0,0
56168,Urology,0,0
56169,Association,0,0
56170,scores,0,0
56171,",",0,0
56172,QoL,0,1
56173,scores,0,0
56174,",",0,0
56175,or,0,0
56176,Qmax,0,0
56177,values,0,0
56178,;,0,0
56179,however,0,0
56180,",",0,0
56181,two,0,0
56182,patients,0,0
56183,in,0,0
56184,the,0,0
56185,TURP,0,0
56186,group,0,0
56187,required,0,0
56188,re-operation,0,0
56189,.,0,0
56190,CONCLUSIONS,0,0
56191,HoLEP,1,0
56192,has,0,0
56193,less,0,0
56194,perioperative,0,0
56195,morbidity,0,0
56196,and,0,0
56197,produces,0,0
56198,superior,0,0
56199,urodynamic,0,0
56200,outcomes,0,1
56201,than,0,0
56202,TURP,1,0
56203,",",0,0
56204,when,0,0
56205,treating,0,0
56206,prostates,0,0
56207,>,0,0
56208,40,0,0
56209,g.,0,1
56210,At,0,1
56211,24,0,0
56212,months,0,0
56213,of,0,0
56214,follow-up,0,0
56215,",",0,0
56216,HoLEP,1,0
56217,is,0,0
56218,equivalent,0,0
56219,to,0,0
56220,TURP,1,0
56221,.,1,0
56222,Outcomes,0,0
56223,in,0,0
56224,a,0,0
56225,nursing,0,0
56226,home,0,0
56227,transition,0,0
56228,case-management,0,0
56229,program,0,0
56230,targeting,0,0
56231,new,0,0
56232,admissions,0,0
56233,.,0,0
56234,PURPOSE,0,0
56235,The,0,0
56236,Providing,1,0
56237,Assistance,1,0
56238,to,1,0
56239,Caregivers,1,0
56240,in,1,0
56241,Transition,1,0
56242,(,1,0
56243,PACT,1,1
56244,),1,1
56245,program,1,0
56246,offers,0,0
56247,nursing,0,0
56248,home,0,0
56249,discharge,0,0
56250,planning,0,0
56251,and,0,0
56252,case,0,0
56253,management,0,0
56254,for,0,0
56255,individuals,0,0
56256,in,0,0
56257,the,0,0
56258,transitional,0,0
56259,period,0,0
56260,following,0,0
56261,a,0,0
56262,return,0,0
56263,to,0,0
56264,the,0,0
56265,community,0,0
56266,.,0,0
56267,The,0,0
56268,PACT,1,0
56269,program,1,0
56270,targeted,0,0
56271,individuals,0,0
56272,newly,0,0
56273,admitted,0,0
56274,to,0,0
56275,nursing,0,0
56276,homes,0,0
56277,and,0,0
56278,worked,0,0
56279,with,0,0
56280,a,0,0
56281,family,0,0
56282,caregiver,0,0
56283,to,0,0
56284,develop,0,0
56285,and,0,0
56286,implement,0,0
56287,a,0,0
56288,nursing,0,0
56289,home,0,0
56290,discharge,0,0
56291,plan,0,0
56292,.,0,0
56293,DESIGN,0,0
56294,AND,0,0
56295,METHOD,0,0
56296,Reported,0,0
56297,are,0,0
56298,the,0,0
56299,results,0,0
56300,of,0,0
56301,a,0,0
56302,randomized,0,0
56303,control,0,0
56304,design,0,0
56305,evaluating,0,0
56306,the,0,0
56307,program,0,0
56308,'s,0,0
56309,effectiveness,0,0
56310,.,0,0
56311,Those,0,0
56312,individuals,0,0
56313,randomly,0,0
56314,assigned,0,0
56315,to,0,0
56316,the,0,0
56317,intervention,0,1
56318,group,0,0
56319,(,0,0
56320,n,0,0
56321,=,0,0
56322,33,0,0
56323,),0,0
56324,received,0,0
56325,PACT,1,0
56326,case,1,0
56327,management,1,0
56328,in,1,0
56329,addition,1,0
56330,to,1,0
56331,their,1,0
56332,usual,1,0
56333,medical,1,0
56334,and,1,0
56335,nursing,1,0
56336,home,1,0
56337,care,1,0
56338,.,1,0
56339,The,0,0
56340,individuals,0,0
56341,in,0,0
56342,the,0,0
56343,control,0,0
56344,group,0,0
56345,(,0,0
56346,n,0,0
56347,=,0,0
56348,29,0,0
56349,),0,0
56350,continued,0,0
56351,their,0,0
56352,usual,1,0
56353,care,1,0
56354,.,1,0
56355,RESULT,0,0
56356,There,0,0
56357,were,0,0
56358,no,0,0
56359,statistical,0,0
56360,differences,0,0
56361,in,0,0
56362,the,0,0
56363,discharge,0,0
56364,rate,0,0
56365,(,0,0
56366,84,0,0
56367,%,0,0
56368,treatment,0,0
56369,vs,0,0
56370,76,0,0
56371,%,0,0
56372,controls,0,0
56373,),0,0
56374,or,0,0
56375,in,0,0
56376,the,0,0
56377,median,0,0
56378,length,0,0
56379,of,0,0
56380,stay,0,0
56381,(,0,0
56382,42,0,0
56383,days,0,0
56384,vs,0,0
56385,55,0,0
56386,days,0,0
56387,),0,0
56388,between,0,0
56389,the,0,0
56390,two,0,0
56391,groups,0,0
56392,of,0,0
56393,individuals,0,0
56394,.,0,0
56395,IMPLICATIONS,0,0
56396,Replications,0,0
56397,or,0,0
56398,extensions,0,0
56399,of,0,0
56400,a,0,0
56401,PACT-type,1,0
56402,intervention,1,0
56403,might,0,0
56404,consider,0,0
56405,a,0,0
56406,broader,0,0
56407,mix,0,0
56408,of,0,0
56409,nursing,0,0
56410,homes,0,0
56411,",",0,0
56412,working,0,0
56413,directly,0,0
56414,with,0,0
56415,the,0,0
56416,nursing,0,0
56417,home,0,0
56418,'s,0,0
56419,admission,0,0
56420,Minimum,0,1
56421,Data,0,1
56422,Set,0,0
56423,coordinator,0,0
56424,in,0,0
56425,patient,0,0
56426,selection,0,0
56427,",",0,0
56428,or,0,0
56429,working,0,0
56430,with,0,0
56431,Medicare,0,0
56432,or,0,0
56433,Medicaid,0,0
56434,HMO,0,1
56435,plans,0,0
56436,.,0,0
56437,Different,0,0
56438,loss,0,0
56439,of,0,0
56440,BMD,0,0
56441,using,0,0
56442,uncemented,1,0
56443,press-fit,1,0
56444,and,1,0
56445,whole,1,0
56446,polyethylene,1,1
56447,cups,1,1
56448,fixed,1,0
56449,with,1,0
56450,cement,1,0
56451,:,1,0
56452,repeated,0,0
56453,DXA,0,0
56454,studies,0,0
56455,in,0,0
56456,96,0,0
56457,hips,0,0
56458,randomized,0,0
56459,to,0,0
56460,3,0,0
56461,types,0,0
56462,of,0,0
56463,fixation,0,0
56464,.,0,0
56465,BACKGROUND,0,0
56466,In,0,0
56467,cemented,0,0
56468,THA,0,1
56469,",",0,0
56470,aseptic,0,0
56471,loosening,0,0
56472,of,0,0
56473,the,0,0
56474,cup,0,0
56475,is,0,0
56476,more,0,0
56477,common,0,0
56478,than,0,0
56479,loosening,0,0
56480,of,0,0
56481,the,0,0
56482,stem,0,0
56483,",",0,0
56484,while,0,0
56485,periprosthetic,0,0
56486,osteolysis,0,0
56487,of,0,0
56488,the,0,0
56489,socket,0,0
56490,resulting,0,0
56491,in,0,0
56492,difficult,0,0
56493,reconstruction,0,0
56494,problems,0,0
56495,has,0,0
56496,emerged,0,0
56497,as,0,0
56498,the,0,0
56499,most,0,0
56500,significant,0,0
56501,problem,0,0
56502,with,0,0
56503,cementless,0,0
56504,cup,0,0
56505,fixation,0,0
56506,.,0,0
56507,PATIENTS,0,0
56508,AND,0,1
56509,METHODS,0,1
56510,90,0,0
56511,patients,0,0
56512,(,0,0
56513,96,0,0
56514,hips,0,0
56515,),0,0
56516,scheduled,0,0
56517,for,0,0
56518,THA,0,0
56519,were,0,0
56520,stratified,0,0
56521,in,0,0
56522,three,0,0
56523,groups,0,0
56524,according,0,0
56525,to,0,0
56526,the,0,0
56527,method,0,0
56528,of,0,0
56529,fixation,0,0
56530,of,0,0
56531,the,0,0
56532,acetabular,0,0
56533,component,0,0
56534,:,0,0
56535,acrylic,1,1
56536,bone,1,1
56537,cement,1,1
56538,with,1,1
56539,fluoride,1,1
56540,(,1,1
56541,Cemex-F,1,1
56542,),1,1
56543,",",1,0
56544,porous-coated,1,1
56545,press-fit,1,0
56546,cup,1,0
56547,with,1,0
56548,ceramic,1,0
56549,coating,1,0
56550,(,1,0
56551,Trilogy,1,1
56552,",",1,1
56553,uncemented,1,1
56554,),1,1
56555,and,1,1
56556,acrylic,1,1
56557,cement,1,1
56558,with,1,1
56559,gentamicin,1,1
56560,(,1,1
56561,Palacos,1,1
56562,),1,1
56563,.,1,0
56564,All,0,0
56565,patients,0,0
56566,received,0,0
56567,the,0,0
56568,Spectron,1,0
56569,EF,1,0
56570,stem,1,0
56571,.,1,0
56572,Acetabular,0,0
56573,bone,0,0
56574,mineral,0,0
56575,density,0,0
56576,was,0,0
56577,measured,0,0
56578,with,0,0
56579,dual-energy,0,0
56580,X-ray,0,1
56581,absorptiometry,0,1
56582,(,0,1
56583,DXA,0,1
56584,),0,1
56585,1,0,0
56586,week,0,0
56587,postoperatively,0,0
56588,",",0,0
56589,and,0,0
56590,after,0,0
56591,12,0,0
56592,and,0,0
56593,24,0,0
56594,months,0,0
56595,.,0,0
56596,The,0,0
56597,periprosthetic,0,0
56598,BMD,0,0
56599,was,0,0
56600,evaluated,0,0
56601,in,0,0
56602,5,0,0
56603,ROIs,0,0
56604,positioned,0,0
56605,around,0,0
56606,the,0,0
56607,acetabular,0,0
56608,component,0,0
56609,.,0,0
56610,RESULTS,0,0
56611,In,0,0
56612,the,0,0
56613,uncemented,0,0
56614,sockets,0,0
56615,",",0,0
56616,the,0,0
56617,BMD,0,0
56618,had,0,0
56619,decreased,0,0
56620,proximally,0,0
56621,and,0,0
56622,medially,0,0
56623,to,0,0
56624,the,0,0
56625,cup,0,0
56626,after,0,0
56627,2,0,0
56628,years,0,0
56629,.,0,0
56630,The,0,0
56631,difference,0,0
56632,was,0,0
56633,significant,0,0
56634,in,0,0
56635,the,0,0
56636,proximal,0,0
56637,region,0,0
56638,as,0,0
56639,compared,0,0
56640,to,0,0
56641,the,0,0
56642,control,1,0
56643,group,1,0
56644,(,1,1
56645,Palacos,1,1
56646,),1,1
56647,.,1,0
56648,No,0,1
56649,difference,0,0
56650,was,0,0
56651,noted,0,0
56652,between,0,0
56653,the,0,0
56654,2,0,0
56655,groups,0,0
56656,with,0,0
56657,cemented,0,0
56658,components,0,0
56659,after,0,0
56660,2,0,0
56661,years,0,0
56662,.,0,0
56663,Stepwise,0,0
56664,linear,0,0
56665,regression,0,0
56666,analysis,0,0
56667,showed,0,0
56668,that,0,0
56669,loss,0,0
56670,of,0,0
56671,periprosthetic,0,0
56672,BMD,0,0
56673,in,0,0
56674,the,0,0
56675,proximal,0,0
56676,high-pressure,0,0
56677,region,0,0
56678,after,0,0
56679,2,0,0
56680,years,0,0
56681,increased,0,0
56682,with,0,0
56683,higher,0,0
56684,postoperative,0,0
56685,BMD,0,0
56686,and,0,0
56687,when,0,0
56688,the,0,0
56689,uncemented,0,0
56690,design,0,0
56691,had,0,0
56692,been,0,0
56693,used,0,0
56694,.,0,0
56695,INTERPRETATION,0,0
56696,Contrary,0,0
56697,to,0,0
56698,previous,0,0
56699,studies,0,0
56700,of,0,0
56701,cemented,0,0
56702,stems,0,0
56703,",",0,0
56704,the,0,0
56705,use,0,0
56706,of,0,0
56707,fluoride,1,1
56708,cement,1,1
56709,did,0,0
56710,not,0,0
56711,influence,0,0
56712,the,0,0
56713,periprosthetic,0,0
56714,BMD,0,1
56715,2,0,0
56716,years,0,0
56717,after,0,0
56718,the,0,0
56719,examination,0,0
56720,.,0,0
56721,Increased,0,0
56722,loss,0,0
56723,of,0,0
56724,BMD,0,0
56725,with,0,0
56726,use,0,0
56727,of,0,0
56728,uncemented,0,0
56729,press-fit,0,0
56730,cups,0,0
56731,in,0,0
56732,the,0,0
56733,region,0,0
56734,in,0,0
56735,which,0,0
56736,osteolytic,0,0
56737,lesions,0,0
56738,are,0,0
56739,commonly,0,0
56740,found,0,0
56741,suggests,0,0
56742,that,0,0
56743,stress,0,0
56744,shielding,0,0
56745,may,0,0
56746,initiate,0,0
56747,the,0,0
56748,development,0,0
56749,of,0,0
56750,this,0,0
56751,complication,0,0
56752,.,0,0
56753,Longer,0,0
56754,follow-up,0,0
56755,will,0,0
56756,",",0,0
56757,however,0,0
56758,",",0,0
56759,be,0,0
56760,necessary,0,0
56761,to,0,0
56762,substantiate,0,0
56763,this,0,0
56764,hypothesis,0,0
56765,.,0,0
56766,Paraesthesia,0,0
56767,during,0,0
56768,the,0,0
56769,needle-through-needle,1,0
56770,and,0,0
56771,the,0,0
56772,double,1,0
56773,segment,1,0
56774,technique,1,0
56775,for,0,0
56776,combined,0,0
56777,spinal,0,0
56778,epidural,0,0
56779,anaesthesia,0,0
56780,.,0,0
56781,Paraesthesia,0,0
56782,during,0,0
56783,regional,0,0
56784,anaesthesia,0,0
56785,is,0,0
56786,an,0,0
56787,unpleasant,0,0
56788,sensation,0,0
56789,for,0,0
56790,patients,0,0
56791,and,0,0
56792,",",0,0
56793,more,0,0
56794,importantly,0,0
56795,",",0,0
56796,in,0,0
56797,some,0,0
56798,cases,0,0
56799,it,0,0
56800,is,0,0
56801,related,0,0
56802,to,0,0
56803,neurological,0,0
56804,injury,0,0
56805,.,0,0
56806,Relatively,0,0
56807,few,0,0
56808,studies,0,0
56809,have,0,0
56810,been,0,0
56811,conducted,0,0
56812,on,0,0
56813,the,0,0
56814,frequency,0,0
56815,of,0,0
56816,paraesthesia,0,0
56817,during,0,0
56818,combined,0,0
56819,spinal,0,0
56820,epidural,0,0
56821,anaesthesia,0,0
56822,.,0,0
56823,We,0,0
56824,compared,0,0
56825,two,0,0
56826,combined,0,0
56827,spinal,1,0
56828,epidural,1,0
56829,anaesthesia,1,0
56830,techniques,0,0
56831,:,0,0
56832,the,1,0
56833,needle-through-needle,1,0
56834,technique,1,0
56835,and,1,0
56836,the,1,0
56837,double,1,0
56838,segment,1,0
56839,technique,1,0
56840,in,0,0
56841,this,0,0
56842,respect,0,0
56843,.,0,0
56844,We,0,0
56845,randomly,0,0
56846,allocated,0,0
56847,116,0,0
56848,parturients,0,0
56849,undergoing,0,0
56850,elective,0,0
56851,Caesarean,0,0
56852,section,0,0
56853,to,0,0
56854,receive,0,0
56855,anaesthesia,1,0
56856,using,0,0
56857,one,0,0
56858,of,0,0
56859,these,0,0
56860,techniques,0,0
56861,.,0,0
56862,Both,0,0
56863,techniques,0,0
56864,were,0,0
56865,performed,0,0
56866,using,0,0
56867,a,0,0
56868,27G,1,0
56869,pencil,1,0
56870,point,1,0
56871,needle,1,0
56872,",",1,0
56873,an,1,0
56874,18G,1,0
56875,Tuohy,1,1
56876,needle,1,0
56877,",",1,0
56878,and,1,0
56879,a,1,0
56880,20G,1,0
56881,multiport,1,0
56882,epidural,1,0
56883,catheter,1,0
56884,from,0,0
56885,the,0,0
56886,same,0,0
56887,manufacturer,0,0
56888,.,0,0
56889,The,0,0
56890,overall,0,0
56891,frequency,0,0
56892,of,0,0
56893,paraesthesia,0,0
56894,was,0,0
56895,higher,0,0
56896,in,0,0
56897,the,0,0
56898,needle-through-needle,1,0
56899,technique,1,1
56900,group,0,0
56901,(,0,0
56902,56.9,0,0
56903,%,0,0
56904,vs.,0,0
56905,31.6,0,0
56906,%,0,0
56907,",",0,0
56908,p,0,0
56909,=,0,0
56910,0.011,0,0
56911,),0,0
56912,.,0,0
56913,The,0,0
56914,frequency,0,0
56915,of,0,0
56916,paraesthesia,0,0
56917,at,0,0
56918,spinal,0,0
56919,needle,0,0
56920,insertion,0,0
56921,was,0,0
56922,20.7,0,0
56923,%,0,0
56924,in,0,0
56925,the,0,0
56926,needle-through-needle,1,0
56927,technique,0,0
56928,group,0,0
56929,and,0,0
56930,8.8,0,0
56931,%,0,0
56932,in,0,0
56933,the,0,0
56934,double,1,0
56935,segment,1,0
56936,technique,0,1
56937,group,0,0
56938,;,0,0
56939,whereas,0,0
56940,the,0,0
56941,frequency,0,0
56942,of,0,0
56943,paraesthesia,0,0
56944,at,0,0
56945,epidural,0,0
56946,catheter,0,0
56947,insertion,0,0
56948,was,0,0
56949,46.6,0,0
56950,%,0,0
56951,in,0,0
56952,the,0,0
56953,needle-through-needle,1,0
56954,technique,1,0
56955,group,0,0
56956,and,0,0
56957,24.6,0,0
56958,%,0,0
56959,in,0,0
56960,the,0,0
56961,double,1,0
56962,segment,1,0
56963,technique,0,0
56964,group,0,0
56965,.,0,0
56966,Modulation,0,0
56967,of,0,0
56968,human,0,0
56969,motor,0,0
56970,cortex,0,0
56971,excitability,0,0
56972,by,0,0
56973,single,0,0
56974,doses,0,1
56975,of,0,1
56976,amantadine,1,1
56977,.,1,1
56978,Amantadine-sulfate,1,1
56979,has,0,0
56980,been,0,0
56981,used,0,0
56982,for,0,0
56983,several,0,0
56984,decades,0,0
56985,to,0,0
56986,treat,0,0
56987,acute,0,0
56988,influenza,0,0
56989,A,0,1
56990,",",0,0
56991,Parkinson,0,0
56992,'s,0,1
56993,disease,0,1
56994,(,0,1
56995,PD,0,1
56996,),0,1
56997,",",0,0
56998,and,0,0
56999,acute,0,0
57000,or,0,0
57001,chronic,0,0
57002,drug-induced,0,0
57003,dyskinesia,0,0
57004,.,0,0
57005,Several,0,0
57006,mechanisms,0,0
57007,of,0,0
57008,actions,0,0
57009,detected,0,0
57010,in,0,0
57011,vivo/in,0,0
57012,vitro,0,0
57013,including,0,0
57014,N-methyl-D-aspartate,0,1
57015,(,0,1
57016,NMDA,0,1
57017,),0,1
57018,-receptor,0,1
57019,antagonism,0,1
57020,",",0,1
57021,blockage,0,0
57022,of,0,0
57023,potassium,0,1
57024,channels,0,1
57025,",",0,1
57026,dopamine,0,1
57027,receptor,0,1
57028,agonism,0,1
57029,",",0,0
57030,enhancement,0,0
57031,of,0,0
57032,noradrenergic,0,1
57033,release,0,0
57034,",",0,1
57035,and,0,1
57036,anticholinergic,0,1
57037,effects,0,0
57038,have,0,0
57039,been,0,0
57040,described,0,0
57041,.,0,0
57042,We,0,0
57043,used,0,0
57044,transcranial,1,0
57045,magnetic,1,0
57046,stimulation,1,0
57047,(,1,1
57048,TMS,1,1
57049,),1,0
57050,to,0,0
57051,evaluate,0,0
57052,the,0,0
57053,effect,0,0
57054,of,0,0
57055,single,0,0
57056,doses,0,1
57057,of,0,1
57058,amantadine,1,1
57059,on,0,0
57060,human,0,0
57061,motor,0,0
57062,cortex,0,0
57063,excitability,0,0
57064,in,0,0
57065,normal,0,0
57066,subjects,0,0
57067,.,0,0
57068,Using,0,0
57069,a,0,0
57070,double-blind,0,1
57071,",",0,1
57072,placebo-controlled,1,1
57073,",",0,1
57074,crossover,0,1
57075,study,0,0
57076,design,0,1
57077,",",0,0
57078,motor,0,0
57079,thresholds,0,0
57080,",",0,0
57081,recruitment,0,0
57082,curves,0,0
57083,",",0,0
57084,cortical,0,0
57085,stimulation-induced,0,0
57086,silent,0,0
57087,period,0,0
57088,(,0,1
57089,CSP,0,1
57090,),0,1
57091,",",0,0
57092,short,0,0
57093,intracortical,0,0
57094,inhibition,0,0
57095,(,0,1
57096,ICI,0,1
57097,),0,1
57098,",",0,0
57099,intracortical,0,1
57100,facilitation,0,0
57101,(,0,1
57102,ICF,0,1
57103,),0,1
57104,",",0,0
57105,and,0,0
57106,late,0,0
57107,inhibition,0,0
57108,(,0,0
57109,L-ICI,0,1
57110,),0,1
57111,in,0,0
57112,14,0,0
57113,healthy,0,0
57114,subjects,0,0
57115,were,0,0
57116,investigated,0,0
57117,after,0,0
57118,oral,1,1
57119,doses,1,1
57120,of,1,1
57121,50,1,0
57122,and,1,0
57123,100,1,1
57124,mg,1,1
57125,amantadine,1,1
57126,with,1,1
57127,single,1,0
57128,and,1,0
57129,paired,1,0
57130,pulse,1,0
57131,TMS,1,0
57132,paradigms,1,0
57133,.,1,0
57134,Spinal,0,0
57135,cord,0,0
57136,excitability,0,0
57137,was,0,0
57138,investigated,0,0
57139,by,0,0
57140,distal,0,0
57141,latencies,0,0
57142,and,0,0
57143,M-amplitudes,0,0
57144,of,0,0
57145,the,0,0
57146,abductor,0,0
57147,digiti,0,0
57148,minimi,0,0
57149,muscle,0,0
57150,.,0,0
57151,After,0,0
57152,intake,0,1
57153,of,0,1
57154,amantadine,1,1
57155,",",0,0
57156,a,0,0
57157,significant,0,0
57158,dose-dependent,0,0
57159,decrease,0,0
57160,of,0,0
57161,ICF,0,0
57162,was,0,0
57163,noticed,0,0
57164,as,0,0
57165,well,0,0
57166,as,0,0
57167,a,0,0
57168,significant,0,0
57169,increase,0,0
57170,of,0,0
57171,L-ICI,0,0
57172,as,0,0
57173,compared,0,0
57174,to,0,0
57175,placebo,0,1
57176,.,0,0
57177,The,0,0
57178,effect,0,0
57179,on,0,0
57180,ICF,0,0
57181,and,0,0
57182,L-ICI,0,0
57183,significantly,0,0
57184,correlated,0,0
57185,with,0,1
57186,amantadine,1,1
57187,serum,0,1
57188,levels,0,1
57189,.,0,0
57190,ICI,0,0
57191,was,0,0
57192,slightly,0,0
57193,increased,0,0
57194,after,0,0
57195,amantadine,1,1
57196,intake,0,1
57197,",",0,1
57198,but,0,0
57199,the,0,0
57200,effect,0,0
57201,failed,0,0
57202,to,0,0
57203,be,0,0
57204,significant,0,0
57205,.,0,0
57206,Furthermore,0,0
57207,",",0,0
57208,amantadine,1,1
57209,had,0,0
57210,no,0,0
57211,significant,0,0
57212,effects,0,0
57213,on,0,0
57214,motor,0,0
57215,thresholds,0,0
57216,",",0,0
57217,MEP,0,0
57218,recruitment,0,0
57219,curves,0,0
57220,",",0,0
57221,CSP,0,0
57222,",",0,0
57223,or,0,0
57224,peripheral,0,0
57225,excitability,0,0
57226,.,0,0
57227,In,0,0
57228,conclusion,0,0
57229,",",0,0
57230,a,0,0
57231,low,0,0
57232,dose,0,1
57233,of,0,1
57234,amantadine,1,1
57235,is,0,0
57236,sufficient,0,0
57237,in,0,0
57238,modulating,0,0
57239,human,0,0
57240,motor,0,0
57241,cortex,0,0
57242,excitability,0,0
57243,.,0,0
57244,The,0,0
57245,decrease,0,0
57246,of,0,0
57247,ICF,0,0
57248,and,0,0
57249,increase,0,0
57250,of,0,0
57251,L-ICI,0,0
57252,may,0,0
57253,reflect,0,0
57254,glutamatergic,0,0
57255,modulation,0,0
57256,or,0,0
57257,a,0,0
57258,polysynaptic,0,0
57259,interaction,0,0
57260,of,0,0
57261,glutamatergic,0,0
57262,and,0,0
57263,GABA-ergic,0,0
57264,circuits,0,0
57265,.,0,0
57266,Although,0,0
57267,amantadine,1,1
57268,has,0,0
57269,several,0,0
57270,mechanisms,0,0
57271,of,0,0
57272,action,0,0
57273,",",0,0
57274,the,0,0
57275,NMDA-receptor,0,0
57276,antagonism,0,1
57277,seems,0,0
57278,to,0,0
57279,be,0,0
57280,the,0,0
57281,most,0,0
57282,relevant,0,0
57283,effect,0,0
57284,on,0,0
57285,cortical,0,0
57286,excitability,0,0
57287,.,0,0
57288,As,0,0
57289,L-ICI,0,0
57290,can,0,0
57291,be,0,0
57292,influenced,0,0
57293,by,0,0
57294,this,0,0
57295,type,0,0
57296,of,0,0
57297,drug,0,1
57298,",",0,0
57299,it,0,0
57300,may,0,0
57301,be,0,0
57302,an,0,0
57303,interesting,0,0
57304,parameter,0,0
57305,for,0,0
57306,studies,0,0
57307,of,0,0
57308,motor,0,0
57309,learning,0,1
57310,and,0,0
57311,use-dependent,0,1
57312,plasticity,0,0
57313,.,0,0
57314,Analysis,0,0
57315,of,0,0
57316,face,1,0
57317,gaze,1,0
57318,in,0,0
57319,autism,0,0
57320,using,0,0
57321,Bubbles,0,0
57322,.,0,0
57323,One,0,0
57324,of,0,0
57325,the,0,0
57326,components,0,0
57327,of,0,0
57328,abnormal,0,0
57329,social,0,0
57330,functioning,0,0
57331,in,0,0
57332,autism,0,0
57333,is,0,0
57334,an,0,0
57335,impaired,0,0
57336,ability,0,0
57337,to,0,0
57338,direct,0,0
57339,eye,0,0
57340,gaze,0,0
57341,onto,0,0
57342,other,0,0
57343,people,0,0
57344,'s,0,0
57345,faces,0,0
57346,in,0,0
57347,social,0,0
57348,situations,0,0
57349,.,0,0
57350,Here,0,0
57351,",",0,0
57352,we,0,0
57353,investigated,0,0
57354,the,0,0
57355,relationship,0,0
57356,between,0,0
57357,gaze,0,0
57358,onto,0,0
57359,the,0,0
57360,eye,0,0
57361,and,0,1
57362,mouth,0,1
57363,regions,0,0
57364,of,0,0
57365,faces,0,0
57366,",",0,0
57367,and,0,0
57368,the,0,0
57369,visual,0,0
57370,information,0,0
57371,that,0,0
57372,was,0,0
57373,present,0,0
57374,within,0,0
57375,those,0,0
57376,regions,0,0
57377,.,0,0
57378,We,0,0
57379,used,0,0
57380,the,0,0
57381,Bubbles,1,0
57382,method,1,0
57383,to,0,0
57384,vary,0,0
57385,the,0,0
57386,facial,0,0
57387,information,0,0
57388,available,0,0
57389,on,0,0
57390,any,0,0
57391,given,0,0
57392,trial,0,0
57393,by,0,0
57394,revealing,0,0
57395,only,0,0
57396,small,0,0
57397,parts,0,0
57398,of,0,0
57399,the,0,0
57400,face,0,0
57401,",",0,0
57402,and,0,0
57403,measured,0,0
57404,the,0,0
57405,eye,0,0
57406,movements,0,0
57407,made,0,0
57408,as,0,0
57409,participants,0,0
57410,viewed,0,0
57411,these,0,0
57412,stimuli,0,0
57413,.,0,0
57414,Compared,0,0
57415,to,0,0
57416,ten,0,0
57417,IQ-,0,0
57418,and,0,0
57419,age-matched,0,0
57420,healthy,0,0
57421,controls,0,0
57422,",",0,0
57423,eight,0,0
57424,participants,0,0
57425,with,0,0
57426,autism,0,0
57427,showed,0,0
57428,less,0,0
57429,fixation,0,0
57430,specificity,0,0
57431,to,0,0
57432,the,0,0
57433,eyes,0,0
57434,and,0,1
57435,mouth,0,1
57436,",",0,0
57437,a,0,0
57438,greater,0,0
57439,tendency,0,0
57440,to,0,0
57441,saccade,0,0
57442,away,0,0
57443,from,0,0
57444,the,0,0
57445,eyes,0,0
57446,when,0,0
57447,information,0,0
57448,was,0,0
57449,present,0,0
57450,in,0,0
57451,those,0,0
57452,regions,0,0
57453,",",0,0
57454,and,0,0
57455,abnormal,0,0
57456,directionality,0,0
57457,of,0,0
57458,saccades,0,0
57459,.,0,0
57460,The,0,0
57461,findings,0,0
57462,provide,0,0
57463,novel,0,0
57464,detail,0,0
57465,to,0,0
57466,the,0,0
57467,abnormal,0,0
57468,way,0,0
57469,in,0,0
57470,which,0,0
57471,people,0,0
57472,with,0,0
57473,autism,0,0
57474,look,0,0
57475,at,0,0
57476,faces,0,0
57477,",",0,0
57478,an,0,0
57479,impairment,0,0
57480,that,0,0
57481,likely,0,0
57482,influences,0,0
57483,all,0,0
57484,subsequent,0,0
57485,face,0,0
57486,processing,0,0
57487,.,0,0
57488,Effects,0,0
57489,of,0,0
57490,two,0,0
57491,different,0,0
57492,short-term,1,0
57493,training,1,0
57494,programs,1,0
57495,on,0,0
57496,the,0,0
57497,physical,0,0
57498,and,0,0
57499,technical,0,0
57500,abilities,0,0
57501,of,0,0
57502,adolescent,0,0
57503,basketball,0,0
57504,players,0,0
57505,.,0,0
57506,This,0,0
57507,study,0,0
57508,evaluated,0,0
57509,and,0,0
57510,compared,0,0
57511,the,0,0
57512,effectiveness,0,0
57513,of,0,0
57514,two,0,0
57515,different,0,0
57516,off-season,1,0
57517,",",1,0
57518,short-term,1,0
57519,basketball,1,1
57520,training,1,1
57521,programs,1,0
57522,on,0,0
57523,physical,0,0
57524,and,0,0
57525,technical,0,0
57526,abilities,0,0
57527,of,0,0
57528,young,0,0
57529,basketball,0,0
57530,players,0,0
57531,.,0,0
57532,Twenty-seven,0,0
57533,adolescent,0,0
57534,basketball,0,0
57535,players,0,0
57536,(,0,0
57537,14.7+/-0.5,0,0
57538,years,0,0
57539,;,0,0
57540,Tanner,0,0
57541,stage,0,0
57542,:,0,0
57543,3.5+/-0.5,0,0
57544,),0,0
57545,were,0,0
57546,randomly,0,0
57547,divided,0,0
57548,into,0,0
57549,a,0,0
57550,specialized,1,0
57551,basketball,1,0
57552,training,1,1
57553,group,1,1
57554,(,0,0
57555,SP,0,0
57556,",",0,0
57557,n=10,0,0
57558,),0,0
57559,",",0,0
57560,a,1,0
57561,mixed,1,0
57562,basketball,1,0
57563,plus,1,0
57564,conditioning,1,0
57565,training,1,1
57566,group,1,1
57567,(,0,0
57568,MX,0,0
57569,",",0,0
57570,n=10,0,0
57571,),0,0
57572,and,1,0
57573,a,1,0
57574,control,1,0
57575,group,1,0
57576,(,0,0
57577,n=7,0,0
57578,),0,0
57579,.,0,0
57580,Training,1,0
57581,included,0,0
57582,five,0,0
57583,sessions,0,0
57584,per,0,0
57585,week,0,0
57586,(,0,0
57587,100-120,0,0
57588,min,0,0
57589,each,0,0
57590,),0,0
57591,and,0,0
57592,was,0,0
57593,performed,0,0
57594,for,0,0
57595,4,0,0
57596,weeks,0,0
57597,.,0,0
57598,Maximal,0,1
57599,oxygen,0,0
57600,uptake,0,0
57601,was,0,0
57602,similarly,0,0
57603,improved,0,0
57604,after,0,0
57605,SP,0,0
57606,(,0,0
57607,4.9+/-1.8,0,0
57608,%,0,0
57609,),0,0
57610,and,0,0
57611,MX,0,1
57612,(,0,0
57613,4.9+/-1.4,0,0
57614,%,0,0
57615,),0,0
57616,",",0,0
57617,but,0,0
57618,there,0,0
57619,was,0,0
57620,no,0,0
57621,effect,0,0
57622,on,0,0
57623,ventilatory,0,0
57624,threshold,0,0
57625,.,0,0
57626,Peak,0,0
57627,and,0,0
57628,mean,0,0
57629,power,0,0
57630,output,0,0
57631,measured,0,0
57632,during,0,0
57633,the,0,0
57634,Wingate,0,0
57635,test,0,0
57636,were,0,0
57637,also,0,0
57638,improved,0,0
57639,by,0,0
57640,a,0,0
57641,similar,0,0
57642,magnitude,0,0
57643,after,0,0
57644,SP,0,0
57645,(,0,0
57646,21+/-5,0,0
57647,%,0,0
57648,),0,0
57649,and,0,0
57650,MX,0,1
57651,(,0,0
57652,15+/-6,0,0
57653,%,0,0
57654,),0,0
57655,.,0,0
57656,Trunk,0,0
57657,muscle,0,0
57658,endurance,0,0
57659,was,0,0
57660,equally,0,0
57661,increased,0,0
57662,(,0,0
57663,SP,0,0
57664,:,0,0
57665,23+/-4,0,0
57666,%,0,0
57667,",",0,0
57668,MX,0,0
57669,:,0,0
57670,25+/-5,0,0
57671,%,0,0
57672,),0,0
57673,",",0,0
57674,but,0,0
57675,arms,0,0
57676,endurance,0,0
57677,was,0,0
57678,improved,0,0
57679,significantly,0,0
57680,more,0,0
57681,after,0,0
57682,MX,0,0
57683,(,0,0
57684,50+/-11,0,0
57685,%,0,0
57686,),0,0
57687,compared,0,0
57688,to,0,0
57689,SP,0,0
57690,(,0,0
57691,11+/-14,0,0
57692,%,0,0
57693,",",0,0
57694,p,0,0
57695,<,0,0
57696,0.05,0,0
57697,),0,0
57698,.,0,0
57699,Performance,0,0
57700,in,0,0
57701,four,0,0
57702,basketball,0,0
57703,technical,0,0
57704,skills,0,0
57705,was,0,0
57706,similarly,0,0
57707,increased,0,0
57708,(,0,0
57709,by,0,0
57710,17-27,0,0
57711,%,0,0
57712,),0,0
57713,in,0,0
57714,both,0,0
57715,groups,0,0
57716,",",0,0
57717,with,0,0
57718,a,0,0
57719,tendency,0,0
57720,for,0,0
57721,greater,0,0
57722,improvement,0,0
57723,of,0,0
57724,the,0,0
57725,SP,0,0
57726,groups,0,0
57727,in,0,0
57728,the,0,0
57729,technical,0,0
57730,skills,0,0
57731,of,0,0
57732,shooting,0,0
57733,and,0,0
57734,passing,0,0
57735,.,0,0
57736,These,0,0
57737,results,0,0
57738,indicate,0,0
57739,that,0,0
57740,a,0,0
57741,SP,0,0
57742,basketball,0,1
57743,training,0,0
57744,program,0,0
57745,",",0,0
57746,performed,0,0
57747,exclusively,0,0
57748,on-court,0,0
57749,was,0,0
57750,as,0,0
57751,effective,0,0
57752,as,0,0
57753,a,0,0
57754,MX,0,0
57755,training,0,0
57756,program,0,0
57757,in,0,0
57758,terms,0,0
57759,of,0,0
57760,aerobic,0,0
57761,and,0,0
57762,anaerobic,0,1
57763,fitness,0,1
57764,improvement,0,0
57765,.,0,0
57766,Furthermore,0,0
57767,",",0,0
57768,the,0,0
57769,decrease,0,0
57770,of,0,0
57771,the,0,0
57772,total,0,0
57773,on-court,0,0
57774,training,0,0
57775,time,0,0
57776,in,0,0
57777,the,0,0
57778,MX,0,0
57779,group,0,0
57780,resulted,0,0
57781,in,0,0
57782,a,0,0
57783,tendency,0,0
57784,for,0,0
57785,a,0,0
57786,smaller,0,0
57787,improvement,0,0
57788,of,0,0
57789,basketball,0,0
57790,technical,0,0
57791,skills,0,0
57792,.,0,0
57793,In,0,0
57794,conclusion,0,0
57795,",",0,0
57796,both,0,0
57797,SP,0,0
57798,and,0,0
57799,MX,0,0
57800,training,0,0
57801,are,0,0
57802,equally,0,0
57803,effective,0,0
57804,in,0,0
57805,order,0,0
57806,to,0,0
57807,limit,0,0
57808,and/or,0,0
57809,reverse,0,0
57810,the,0,0
57811,detraining,0,0
57812,effects,0,0
57813,that,0,0
57814,occur,0,0
57815,during,0,0
57816,the,0,0
57817,off-season,0,0
57818,in,0,0
57819,basketball,0,0
57820,.,0,0
57821,Teaching,0,1
57822,young,0,1
57823,nonverbal,0,0
57824,children,0,0
57825,with,0,0
57826,autism,0,0
57827,useful,0,0
57828,speech,0,0
57829,:,0,0
57830,a,0,0
57831,pilot,0,0
57832,study,0,0
57833,of,0,0
57834,the,0,0
57835,Denver,1,0
57836,Model,1,0
57837,and,1,0
57838,PROMPT,1,0
57839,interventions,1,0
57840,.,1,0
57841,This,0,0
57842,single,0,0
57843,subject,0,0
57844,design,0,0
57845,study,0,0
57846,examined,0,0
57847,two,0,0
57848,models,0,0
57849,of,0,0
57850,intervention,0,0
57851,:,0,0
57852,Denver,1,0
57853,Model,1,1
57854,(,1,0
57855,which,1,0
57856,merges,1,0
57857,behavioral,1,0
57858,",",1,0
57859,developmental,1,0
57860,",",1,0
57861,and,1,0
57862,relationship-oriented,1,1
57863,intervention,1,1
57864,),1,0
57865,",",1,0
57866,and,1,0
57867,PROMPT,1,1
57868,(,1,0
57869,a,1,0
57870,neuro-developmental,1,0
57871,approach,1,0
57872,for,1,0
57873,speech,1,0
57874,production,1,0
57875,disorders,1,0
57876,),1,0
57877,.,1,0
57878,Ten,0,0
57879,young,0,0
57880,",",0,0
57881,nonverbal,0,0
57882,children,0,0
57883,with,0,0
57884,autism,0,0
57885,were,0,0
57886,matched,0,0
57887,in,0,0
57888,pairs,0,0
57889,and,0,0
57890,randomized,0,0
57891,to,0,0
57892,treatment,0,0
57893,.,0,0
57894,They,0,0
57895,received,0,0
57896,12,0,0
57897,1-h,0,1
57898,weekly,0,1
57899,sessions,0,1
57900,of,0,0
57901,therapy,0,0
57902,and,0,1
57903,daily,0,1
57904,1-h,0,1
57905,home,0,1
57906,intervention,0,0
57907,delivered,0,0
57908,by,0,0
57909,parents,0,0
57910,.,0,0
57911,Fidelity,0,0
57912,criteria,0,0
57913,were,0,0
57914,maintained,0,0
57915,throughout,0,0
57916,.,0,0
57917,Eight,0,0
57918,of,0,0
57919,the,0,0
57920,ten,0,0
57921,children,0,0
57922,used,0,0
57923,five,0,0
57924,or,0,0
57925,more,0,0
57926,novel,0,0
57927,",",0,0
57928,functional,0,0
57929,words,0,0
57930,spontaneously,0,0
57931,and,0,0
57932,spoke,0,0
57933,multiple,0,0
57934,times,0,0
57935,per,0,0
57936,hour,0,0
57937,by,0,0
57938,the,0,0
57939,conclusion,0,0
57940,of,0,0
57941,treatment,0,0
57942,.,0,0
57943,There,0,0
57944,were,0,0
57945,no,0,0
57946,differences,0,0
57947,in,0,0
57948,acquired,0,0
57949,language,0,0
57950,skills,0,0
57951,by,0,0
57952,intervention,0,0
57953,group,0,0
57954,.,0,0
57955,Initial,0,0
57956,characteristics,0,0
57957,of,0,0
57958,the,0,0
57959,best,0,0
57960,responders,0,0
57961,were,0,0
57962,mild,0,0
57963,to,0,0
57964,moderate,0,0
57965,symptoms,0,0
57966,of,0,0
57967,autism,0,0
57968,",",0,0
57969,better,0,0
57970,motor,0,0
57971,imitation,0,0
57972,skills,0,0
57973,",",0,0
57974,and,0,0
57975,emerging,0,0
57976,joint,0,0
57977,attention,0,0
57978,skills,0,0
57979,.,0,0
57980,[,0,1
57981,Pilot,0,0
57982,results,0,0
57983,of,0,0
57984,using,0,0
57985,tamsulone-FS,1,1
57986,in,0,0
57987,patients,0,0
57988,with,0,0
57989,prostatic,0,0
57990,adenoma,0,0
57991,according,0,0
57992,to,0,0
57993,the,0,0
57994,results,0,0
57995,of,0,0
57996,a,0,0
57997,randomized,0,0
57998,multicenter,0,0
57999,comparative,0,0
58000,trial,0,0
58001,],0,0
58002,.,0,0
58003,Tamsulone-FS,1,1
58004,--,1,0
58005,a,1,0
58006,novel,1,0
58007,Russian,1,1
58008,alpha1A/D-adrenoblocker,1,1
58009,(,1,1
58010,Farm-Syntez,1,1
58011,),1,0
58012,--,1,0
58013,was,1,0
58014,studied,0,0
58015,in,0,0
58016,a,0,0
58017,randomized,0,0
58018,multicenter,0,0
58019,comparative,0,0
58020,trial,0,0
58021,in,0,0
58022,patients,0,0
58023,with,0,0
58024,prostatic,0,0
58025,adenoma,0,0
58026,.,0,0
58027,Pilot,0,0
58028,results,0,0
58029,agreed,0,0
58030,with,0,0
58031,other,0,0
58032,trials,0,0
58033,published,0,0
58034,in,0,0
58035,the,0,0
58036,literature,0,0
58037,and,0,0
58038,demonstrated,0,0
58039,tamsulone-FS,1,1
58040,efficacy,0,1
58041,and,0,0
58042,safety,0,0
58043,for,0,0
58044,management,0,0
58045,of,0,0
58046,lower,0,0
58047,urinary,0,0
58048,tract,0,0
58049,symptoms,0,0
58050,caused,0,0
58051,by,0,0
58052,prostatic,0,0
58053,adenoma,0,0
58054,.,0,0
58055,The,0,0
58056,efficacy,0,0
58057,and,0,0
58058,safety,0,0
58059,of,0,0
58060,tamsulone-FS,1,1
58061,was,0,0
58062,comparable,0,0
58063,to,0,0
58064,those,0,0
58065,of,0,0
58066,omnik,0,0
58067,.,0,0
58068,This,0,0
58069,drug,0,1
58070,can,0,0
58071,be,0,0
58072,recommended,0,0
58073,for,0,0
58074,wide,0,0
58075,clinical,0,0
58076,practice,0,0
58077,in,0,0
58078,prostatic,0,0
58079,adenoma,0,0
58080,.,0,0
58081,It,0,0
58082,is,0,0
58083,registered,0,0
58084,by,0,0
58085,Roszdravnadzor,0,1
58086,(,0,1
58087,certificate,0,1
58088,N,0,1
58089,LC-000859,0,0
58090,of,0,0
58091,03.11.2005,0,0
58092,),0,0
58093,and,0,0
58094,allowed,0,0
58095,for,0,0
58096,production,0,0
58097,and,0,0
58098,sale,0,0
58099,.,0,0
58100,Patient-reported,0,0
58101,outcomes,0,0
58102,after,0,0
58103,inguinal,1,0
58104,herniorrhaphy,1,0
58105,.,1,0
58106,BACKGROUND,0,0
58107,Patient-reported,0,1
58108,outcomes,0,1
58109,(,0,1
58110,PRO,0,1
58111,),0,0
58112,reflect,0,0
58113,the,0,0
58114,functional,0,0
58115,outcomes,0,0
58116,of,0,0
58117,inguinal,1,0
58118,herniorrhaphy,1,0
58119,.,1,0
58120,We,0,0
58121,studied,0,0
58122,the,0,0
58123,effect,0,0
58124,of,0,0
58125,hernia,0,0
58126,recurrence,0,0
58127,and,0,0
58128,complications,0,0
58129,on,0,0
58130,PRO,0,0
58131,for,0,0
58132,participants,0,0
58133,in,0,0
58134,the,0,0
58135,Veterans,0,0
58136,Affairs,0,0
58137,trial,0,0
58138,of,0,0
58139,Open,0,0
58140,or,0,0
58141,Laparoscopic,0,0
58142,Repair,0,0
58143,of,0,0
58144,Inguinal,0,0
58145,Hernia,0,0
58146,.,0,0
58147,METHODS,0,0
58148,Analyzed,0,0
58149,PRO,0,0
58150,included,0,0
58151,(,0,0
58152,1,0,0
58153,),0,0
58154,the,0,0
58155,Medical,0,0
58156,Outcomes,0,0
58157,Study,0,0
58158,Short,0,0
58159,Form,0,0
58160,36,0,0
58161,",",0,0
58162,version,0,0
58163,2,0,1
58164,",",0,0
58165,(,0,1
58166,2,0,1
58167,),0,0
58168,the,0,0
58169,Surgical,0,0
58170,Pain,0,0
58171,Scale,0,0
58172,",",0,0
58173,(,0,1
58174,3,0,1
58175,),0,0
58176,the,0,0
58177,Activities,0,0
58178,Assessment,0,0
58179,Scale,0,0
58180,",",0,0
58181,and,0,0
58182,(,0,1
58183,4,0,1
58184,),0,0
58185,patient,0,1
58186,satisfaction,0,1
58187,.,0,0
58188,Recurrences,0,0
58189,and,0,0
58190,complications,0,0
58191,were,0,0
58192,recorded,0,0
58193,at,0,0
58194,follow-up,0,0
58195,visits,0,0
58196,.,0,0
58197,Complications,0,0
58198,were,0,0
58199,categorized,0,0
58200,by,0,0
58201,(,0,1
58202,1,0,1
58203,),0,0
58204,hematoma/seroma,0,1
58205,",",0,1
58206,(,0,1
58207,2,0,1
58208,),0,0
58209,orchitis,0,1
58210,",",0,1
58211,(,0,1
58212,3,0,1
58213,),0,0
58214,neuralgia,0,1
58215,",",0,1
58216,and,0,0
58217,(,0,1
58218,4,0,1
58219,),0,0
58220,other,0,0
58221,.,0,0
58222,Univariate,0,0
58223,and,0,0
58224,multivariable,0,0
58225,regression,0,0
58226,analyses,0,0
58227,identified,0,0
58228,variables,0,0
58229,significantly,0,0
58230,associated,0,0
58231,with,0,0
58232,postoperative,0,0
58233,PRO,0,0
58234,.,0,0
58235,RESULTS,0,0
58236,Of,0,0
58237,the,0,0
58238,1603,0,0
58239,patients,0,0
58240,with,0,0
58241,PRO,0,0
58242,data,0,0
58243,",",0,0
58244,105,0,0
58245,had,0,0
58246,a,0,0
58247,recurrence,0,0
58248,and,0,0
58249,342,0,0
58250,had,0,0
58251,a,0,0
58252,complication,0,0
58253,at,0,0
58254,2,0,0
58255,years,0,0
58256,.,0,0
58257,Multivariable,0,0
58258,analyses,0,0
58259,showed,0,0
58260,neuralgia,0,0
58261,(,0,0
58262,P,0,0
58263,<,0,0
58264,.0005,0,0
58265,),0,0
58266,adversely,0,0
58267,affected,0,0
58268,all,0,0
58269,PRO,0,0
58270,",",0,0
58271,and,0,0
58272,recurrence,0,0
58273,(,0,0
58274,P,0,0
58275,<,0,0
58276,.05,0,0
58277,),0,0
58278,affected,0,0
58279,patient-reported,0,0
58280,pain,0,0
58281,",",0,0
58282,activity,0,0
58283,",",0,0
58284,and,0,0
58285,satisfaction,0,0
58286,",",0,0
58287,but,0,0
58288,not,0,0
58289,the,0,0
58290,score,0,0
58291,for,0,0
58292,the,0,0
58293,Medical,0,0
58294,Outcomes,0,0
58295,Study,0,0
58296,Short,0,1
58297,Form,0,0
58298,3,0,0
58299,.,0,0
58300,Patients,0,0
58301,with,0,0
58302,a,0,0
58303,recurrence,0,0
58304,after,0,0
58305,open,0,0
58306,repair,0,0
58307,had,0,0
58308,more,0,0
58309,pain,0,0
58310,than,0,0
58311,those,0,0
58312,with,0,0
58313,a,0,0
58314,recurrence,0,0
58315,after,0,0
58316,laparoscopic,0,0
58317,repair,0,0
58318,(,0,0
58319,P,0,0
58320,=,0,0
58321,.0001,0,0
58322,),0,0
58323,.,0,0
58324,Patients,0,0
58325,with,0,0
58326,other,0,0
58327,complications,0,0
58328,after,0,0
58329,laparoscopic,0,0
58330,repair,0,0
58331,reported,0,0
58332,more,0,0
58333,pain,0,0
58334,and,0,0
58335,less,0,0
58336,activity,0,0
58337,than,0,0
58338,those,0,0
58339,with,0,0
58340,other,0,0
58341,complications,0,0
58342,after,0,0
58343,open,0,0
58344,repair,0,0
58345,(,0,0
58346,P,0,0
58347,=,0,0
58348,.003,0,0
58349,and,0,0
58350,P,0,0
58351,=,0,0
58352,.009,0,0
58353,",",0,0
58354,respectively,0,0
58355,),0,0
58356,.,0,0
58357,CONCLUSIONS,0,0
58358,The,0,0
58359,effectiveness,0,0
58360,of,0,0
58361,inguinal,0,0
58362,herniorrhaphy,0,0
58363,should,0,0
58364,be,0,0
58365,measured,0,0
58366,by,0,0
58367,the,0,0
58368,rate,0,0
58369,of,0,0
58370,recurrence,0,0
58371,and,0,0
58372,neuralgia,0,0
58373,.,0,0
58374,Postoperative,0,0
58375,neuralgias,0,0
58376,have,0,0
58377,a,0,0
58378,deleterious,0,0
58379,effect,0,0
58380,on,0,0
58381,all,0,0
58382,patient-reported,0,0
58383,outcomes,0,0
58384,.,0,0
58385,A,0,1
58386,randomized,0,0
58387,comparison,0,0
58388,of,0,0
58389,the,0,0
58390,effect,0,0
58391,of,0,0
58392,two,0,0
58393,prelinguistic,1,0
58394,communication,1,0
58395,interventions,1,0
58396,on,0,0
58397,the,0,0
58398,acquisition,0,0
58399,of,0,0
58400,spoken,0,0
58401,communication,0,0
58402,in,0,0
58403,preschoolers,0,0
58404,with,0,0
58405,ASD,0,0
58406,.,0,0
58407,PURPOSE,0,0
58408,This,0,0
58409,randomized,0,0
58410,group,0,0
58411,experiment,0,0
58412,compared,0,0
58413,the,0,0
58414,efficacy,0,0
58415,of,0,0
58416,2,0,0
58417,communication,1,0
58418,interventions,1,1
58419,(,1,0
58420,Responsive,1,0
58421,Education,1,0
58422,and,1,0
58423,Prelinguistic,1,0
58424,Milieu,1,1
58425,Teaching,1,1
58426,[,1,1
58427,RPMT,1,1
58428,],1,1
58429,and,1,0
58430,the,1,0
58431,Picture,1,0
58432,Exchange,1,0
58433,Communication,1,0
58434,System,1,0
58435,[,1,1
58436,PECS,1,1
58437,],1,1
58438,),1,0
58439,on,0,0
58440,spoken,0,0
58441,communication,0,0
58442,in,0,0
58443,36,0,0
58444,preschoolers,0,0
58445,with,0,0
58446,autism,0,0
58447,spectrum,0,0
58448,disorders,0,1
58449,(,0,1
58450,ASD,0,1
58451,),0,1
58452,.,0,0
58453,METHOD,0,0
58454,Each,0,0
58455,treatment,0,0
58456,was,0,0
58457,delivered,0,0
58458,to,0,0
58459,children,0,0
58460,for,0,0
58461,a,0,0
58462,maximum,0,0
58463,total,0,0
58464,of,0,0
58465,24,0,0
58466,hr,0,0
58467,over,0,0
58468,a,0,0
58469,6-month,0,0
58470,period,0,0
58471,.,0,0
58472,Spoken,0,0
58473,communication,0,0
58474,was,0,0
58475,assessed,0,0
58476,in,0,0
58477,a,0,0
58478,rigorous,0,0
58479,test,0,0
58480,of,0,0
58481,generalization,0,0
58482,at,0,0
58483,pretreatment,0,0
58484,",",0,0
58485,posttreatment,0,0
58486,",",0,0
58487,and,0,0
58488,6-month,0,0
58489,follow-up,0,0
58490,periods,0,0
58491,.,0,0
58492,RESULTS,0,0
58493,PECS,0,0
58494,was,0,0
58495,more,0,0
58496,successful,0,0
58497,than,0,0
58498,RPMT,0,0
58499,in,0,0
58500,increasing,0,0
58501,the,0,0
58502,number,0,0
58503,of,0,0
58504,nonimitative,0,0
58505,spoken,0,0
58506,communication,0,0
58507,acts,0,0
58508,and,0,0
58509,the,0,0
58510,number,0,0
58511,of,0,0
58512,different,0,0
58513,nonimitative,0,0
58514,words,0,0
58515,used,0,0
58516,at,0,0
58517,the,0,0
58518,posttreatment,0,0
58519,period,0,0
58520,.,0,0
58521,Considering,0,0
58522,growth,0,0
58523,over,0,0
58524,all,0,0
58525,3,0,0
58526,measurement,0,0
58527,periods,0,0
58528,",",0,0
58529,an,0,0
58530,exploratory,0,0
58531,analysis,0,0
58532,showed,0,0
58533,that,0,0
58534,growth,0,0
58535,rate,0,0
58536,of,0,0
58537,the,0,0
58538,number,0,0
58539,of,0,0
58540,different,0,0
58541,nonimitative,0,0
58542,words,0,0
58543,was,0,0
58544,faster,0,0
58545,in,0,0
58546,the,0,0
58547,PECS,0,1
58548,group,0,0
58549,than,0,0
58550,in,0,0
58551,the,0,0
58552,RPMT,0,0
58553,group,0,0
58554,for,0,0
58555,children,0,0
58556,who,0,0
58557,began,0,0
58558,treatment,0,0
58559,with,0,0
58560,relatively,0,0
58561,high,0,0
58562,object,0,0
58563,exploration,0,0
58564,.,0,0
58565,In,0,0
58566,contrast,0,0
58567,",",0,0
58568,analogous,0,0
58569,slopes,0,0
58570,were,0,0
58571,steeper,0,0
58572,in,0,0
58573,the,0,0
58574,RPMT,0,1
58575,group,0,0
58576,than,0,0
58577,in,0,0
58578,the,0,0
58579,PECS,0,0
58580,group,0,0
58581,for,0,0
58582,children,0,0
58583,who,0,0
58584,began,0,0
58585,treatment,0,0
58586,with,0,0
58587,relatively,0,0
58588,low,0,0
58589,object,0,0
58590,exploration,0,0
58591,.,0,0
58592,Effects,0,0
58593,of,0,0
58594,monotherapy,1,1
58595,and,1,0
58596,combination,1,0
58597,therapy,1,0
58598,on,0,0
58599,blood,0,0
58600,pressure,0,0
58601,control,0,0
58602,and,0,0
58603,target,0,0
58604,organ,0,0
58605,damage,0,0
58606,:,0,0
58607,a,0,0
58608,randomized,0,0
58609,prospective,0,0
58610,intervention,0,0
58611,study,0,0
58612,in,0,0
58613,a,0,0
58614,large,0,0
58615,population,0,0
58616,of,0,0
58617,hypertensive,0,0
58618,patients,0,0
58619,.,0,0
58620,This,0,0
58621,prospective,0,0
58622,",",0,0
58623,randomized,0,0
58624,trial,0,0
58625,evaluated,0,0
58626,the,0,0
58627,effect,0,0
58628,of,0,0
58629,monotherapy,1,1
58630,and,1,0
58631,different,1,0
58632,combination,1,0
58633,therapies,1,0
58634,on,0,0
58635,cardiovascular,0,0
58636,target,0,0
58637,organ,0,0
58638,damage,0,0
58639,and,0,0
58640,metabolic,0,0
58641,profile,0,0
58642,in,0,0
58643,520,0,0
58644,hypertensive,0,0
58645,patients,0,0
58646,.,0,0
58647,Patients,0,0
58648,were,0,0
58649,allocated,0,0
58650,to,0,0
58651,a,0,0
58652,single,0,0
58653,agent,0,0
58654,:,0,0
58655,carvedilol,1,1
58656,25,1,1
58657,mg,1,1
58658,",",1,1
58659,amlodipine,1,1
58660,10,1,1
58661,mg,1,1
58662,",",1,1
58663,enalapril,1,1
58664,20,1,1
58665,mg,1,1
58666,",",1,1
58667,or,1,1
58668,losartan,1,1
58669,50,1,1
58670,mg,1,1
58671,(,0,1
58672,groups,0,1
58673,C,0,1
58674,",",0,0
58675,A,0,0
58676,",",0,0
58677,E,0,0
58678,",",0,0
58679,and,0,0
58680,L,0,0
58681,",",0,0
58682,respectively,0,0
58683,),0,0
58684,.,0,0
58685,After,0,0
58686,2,0,0
58687,months,0,0
58688,(,0,0
58689,level,0,0
58690,2,0,1
58691,),0,0
58692,",",0,0
58693,nonresponders,0,0
58694,received,0,0
58695,a,0,0
58696,low-dose,1,1
58697,thiazide,1,1
58698,diuretic,1,1
58699,",",0,1
58700,and,0,0
58701,after,0,0
58702,4,0,0
58703,months,0,0
58704,(,0,0
58705,level,0,0
58706,3,0,1
58707,),0,0
58708,",",0,1
58709,amlodipine,1,1
58710,(,0,1
58711,groups,0,0
58712,E,0,0
58713,",",0,0
58714,C,0,0
58715,",",0,0
58716,and,0,0
58717,L,0,0
58718,),0,1
58719,and,0,1
58720,carvedilol,1,1
58721,(,0,1
58722,group,0,1
58723,A,0,1
58724,),0,1
58725,.,0,0
58726,Twenty-four-hour,0,0
58727,blood,0,0
58728,pressure,0,0
58729,was,0,0
58730,significantly,0,0
58731,lowered,0,0
58732,in,0,0
58733,all,0,0
58734,treatment,0,0
58735,groups,0,0
58736,.,0,0
58737,Blood,0,0
58738,pressure,0,0
58739,control,0,0
58740,was,0,0
58741,more,0,0
58742,pronounced,0,0
58743,in,0,0
58744,patients,0,0
58745,receiving,0,0
58746,two,0,0
58747,or,0,0
58748,three,0,0
58749,drugs,0,1
58750,.,0,0
58751,At,0,0
58752,the,0,0
58753,end,0,0
58754,of,0,0
58755,the,0,0
58756,study,0,0
58757,",",0,0
58758,the,0,0
58759,carotid,0,0
58760,intima-media,0,0
58761,thickness,0,0
58762,decreased,0,0
58763,in,0,0
58764,group,0,0
58765,L,0,0
58766,(,0,0
58767,P,0,0
58768,<,0,0
58769,.01,0,0
58770,),0,0
58771,",",0,0
58772,left,0,0
58773,ventricular,0,0
58774,mass,0,0
58775,index,0,0
58776,in,0,0
58777,groups,0,0
58778,E,0,0
58779,and,0,0
58780,L,0,0
58781,(,0,0
58782,P,0,0
58783,<,0,0
58784,.05,0,0
58785,and,0,0
58786,P,0,0
58787,<,0,0
58788,.001,0,0
58789,",",0,0
58790,respectively,0,0
58791,),0,0
58792,",",0,0
58793,with,0,0
58794,a,0,0
58795,concomitant,0,0
58796,reduction,0,0
58797,in,0,0
58798,cholesterol,0,1
58799,in,0,0
58800,group,0,0
58801,L,0,0
58802,(,0,0
58803,P,0,0
58804,<,0,0
58805,.03,0,0
58806,),0,0
58807,.,0,0
58808,Diastolic,0,0
58809,function,0,0
58810,improved,0,0
58811,significantly,0,0
58812,in,0,0
58813,group,0,0
58814,L,0,0
58815,(,0,0
58816,P,0,0
58817,<,0,0
58818,.05,0,0
58819,),0,0
58820,.,0,0
58821,This,0,0
58822,study,0,0
58823,describes,0,0
58824,the,0,0
58825,need,0,0
58826,to,0,0
58827,control,0,0
58828,blood,0,0
58829,pressure,0,0
58830,with,0,0
58831,two,0,0
58832,or,0,0
58833,more,0,0
58834,drugs,0,1
58835,in,0,0
58836,most,0,0
58837,hypertensive,0,0
58838,patients,0,0
58839,and,0,0
58840,illustrates,0,0
58841,good,0,0
58842,clinical,0,0
58843,outcomes,0,0
58844,",",0,0
58845,independent,0,0
58846,of,0,0
58847,blood,0,0
58848,pressure,0,0
58849,lowering,0,0
58850,",",0,0
58851,using,0,0
58852,combination,0,0
58853,therapy,0,0
58854,with,0,0
58855,losartan,1,1
58856,",",1,1
58857,low-dose,1,1
58858,thiazide,1,1
58859,",",1,1
58860,and,1,1
58861,amlodipine,1,1
58862,.,1,0
58863,Effectiveness,0,0
58864,of,0,0
58865,written,0,0
58866,guidelines,0,0
58867,on,0,0
58868,the,0,0
58869,appropriateness,0,0
58870,of,0,0
58871,thromboprophylaxis,1,0
58872,prescriptions,1,0
58873,for,0,0
58874,medical,0,0
58875,patients,0,0
58876,:,0,0
58877,a,0,0
58878,prospective,0,0
58879,randomized,0,0
58880,study,0,0
58881,.,0,0
58882,OBJECTIVE,0,0
58883,To,0,0
58884,assess,0,0
58885,the,0,0
58886,effectiveness,0,0
58887,of,0,0
58888,providing,0,0
58889,doctors,0,0
58890,with,0,0
58891,written,0,0
58892,thromboprophylaxis,1,0
58893,prescription,1,0
58894,aids,1,0
58895,based,0,0
58896,on,0,0
58897,current,0,0
58898,recommendations,0,0
58899,.,0,0
58900,DESIGN,0,0
58901,A,0,1
58902,prospective,0,0
58903,trial,0,0
58904,of,0,0
58905,specific,0,0
58906,anticoagulant,0,1
58907,prescription,0,1
58908,forms,0,0
58909,:,0,0
58910,a,0,0
58911,1-day,0,0
58912,survey,0,0
58913,before,0,0
58914,and,0,0
58915,after,0,0
58916,the,0,0
58917,intervention,0,0
58918,in,0,0
58919,each,0,0
58920,centre,0,0
58921,.,0,0
58922,SETTING,0,0
58923,30,0,0
58924,Internal,0,0
58925,Medicine,0,0
58926,departments,0,0
58927,of,0,0
58928,Assistance,0,0
58929,Publique-H?pitaux,0,1
58930,de,0,0
58931,Paris,0,0
58932,.,0,0
58933,SUBJECTS,0,0
58934,All,0,0
58935,inpatients,0,0
58936,were,0,0
58937,included,0,0
58938,",",0,0
58939,except,0,0
58940,those,0,0
58941,who,0,0
58942,were,0,0
58943,either,0,0
58944,admitted,0,0
58945,or,0,0
58946,discharged,0,0
58947,on,0,0
58948,the,0,0
58949,day,0,0
58950,of,0,0
58951,the,0,0
58952,survey,0,0
58953,",",0,0
58954,and,0,0
58955,those,0,0
58956,receiving,0,0
58957,curative,1,1
58958,anticoagulant,1,1
58959,treatment,0,1
58960,.,0,0
58961,INTERVENTIONS,0,0
58962,The,0,0
58963,study,0,0
58964,included,0,0
58965,three,0,0
58966,parts,0,0
58967,:,0,0
58968,(,0,0
58969,i,0,0
58970,),0,0
58971,a,0,0
58972,1-day,0,0
58973,baseline,0,1
58974,survey,0,1
58975,;,0,1
58976,(,0,1
58977,ii,0,1
58978,),0,0
58979,over,0,0
58980,the,0,0
58981,following,0,0
58982,3-month,0,0
58983,period,0,0
58984,",",0,0
58985,departments,0,0
58986,were,0,0
58987,randomized,0,0
58988,into,0,0
58989,two,0,0
58990,groups,0,0
58991,:,0,0
58992,all,0,0
58993,practitioners,0,0
58994,in,0,0
58995,wards,0,0
58996,allocated,0,0
58997,to,0,0
58998,the,0,0
58999,intervention,0,0
59000,group,0,0
59001,were,0,0
59002,required,0,0
59003,to,0,0
59004,systematically,0,0
59005,use,0,0
59006,specific,1,0
59007,anticoagulant,1,1
59008,prescription,0,1
59009,forms,0,0
59010,",",0,0
59011,whilst,0,0
59012,doctors,0,0
59013,in,0,0
59014,the,0,0
59015,control,0,0
59016,group,0,0
59017,continued,0,0
59018,prescribing,0,0
59019,according,0,0
59020,to,0,0
59021,their,1,0
59022,usual,1,0
59023,practices,1,1
59024,and,0,0
59025,(,0,0
59026,iii,0,0
59027,),0,0
59028,a,0,0
59029,1-day,0,0
59030,postintervention,0,0
59031,survey,0,0
59032,.,0,0
59033,MAIN,0,0
59034,OUTCOME,0,0
59035,MEASURE,0,0
59036,The,0,0
59037,proportion,0,0
59038,of,0,0
59039,prescriptions,0,0
59040,in,0,0
59041,accordance,0,0
59042,with,0,0
59043,the,0,0
59044,recommendations,0,0
59045,.,0,0
59046,RESULTS,0,0
59047,"1,469",0,0
59048,patients,0,0
59049,were,0,0
59050,included,0,0
59051,.,0,0
59052,The,0,0
59053,intervention,0,0
59054,produced,0,0
59055,a,0,0
59056,significant,0,0
59057,reduction,0,0
59058,in,0,0
59059,the,0,0
59060,frequency,0,0
59061,of,0,0
59062,over-prescriptions,0,0
59063,",",0,0
59064,from,0,0
59065,25,0,0
59066,%,0,0
59067,to,0,0
59068,14,0,0
59069,%,0,0
59070,of,0,0
59071,the,0,0
59072,patients,0,0
59073,who,0,0
59074,did,0,0
59075,not,0,0
59076,meet,0,0
59077,the,0,0
59078,guideline,0,1
59079,criteria,0,1
59080,(,0,1
59081,adjusted,0,0
59082,OR,0,0
59083,:,0,0
59084,0.3,0,0
59085,;,0,0
59086,95,0,0
59087,%,0,0
59088,CI,0,0
59089,:,0,0
59090,0.1-0.8,0,0
59091,),0,0
59092,.,0,0
59093,Using,0,0
59094,specific,0,0
59095,forms,0,0
59096,did,0,0
59097,not,0,0
59098,improve,0,0
59099,under-prescription,0,0
59100,of,1,0
59101,anticoagulants,1,1
59102,.,1,0
59103,A,0,0
59104,little,0,0
59105,over,0,0
59106,60,0,0
59107,%,0,0
59108,of,0,0
59109,the,0,0
59110,patients,0,0
59111,who,0,0
59112,met,0,1
59113,guideline,0,0
59114,criteria,0,0
59115,for,0,0
59116,thromboprophylaxis,0,0
59117,were,0,0
59118,prescribed,1,0
59119,anticoagulants,1,1
59120,in,0,0
59121,both,0,0
59122,intervention,0,0
59123,and,0,0
59124,control,0,0
59125,wards,0,0
59126,",",0,0
59127,either,0,0
59128,at,0,0
59129,baseline,0,0
59130,or,0,0
59131,after,0,0
59132,intervention,0,0
59133,.,0,0
59134,CONCLUSIONS,1,1
59135,Multitargeted,1,1
59136,interventions,1,1
59137,using,0,0
59138,a,0,0
59139,variety,0,0
59140,of,0,0
59141,means,0,0
59142,and,0,0
59143,strategies,0,0
59144,should,0,0
59145,still,0,0
59146,be,0,0
59147,considered,0,0
59148,to,0,0
59149,improve,0,0
59150,prescriptions,0,0
59151,that,0,0
59152,may,0,0
59153,have,0,0
59154,a,0,0
59155,significant,0,0
59156,impact,0,0
59157,on,0,0
59158,health,0,0
59159,expenses,0,0
59160,and,0,0
59161,",",0,0
59162,most,0,0
59163,importantly,0,0
59164,",",0,0
59165,on,0,0
59166,patients,0,0
59167,outcomes,0,0
59168,.,0,0
59169,Use,0,0
59170,of,0,0
59171,an,0,0
59172,alpha,1,0
59173,1-blocker,1,1
59174,",",1,1
59175,YM617,1,1
59176,",",0,0
59177,in,0,0
59178,the,0,0
59179,treatment,0,0
59180,of,0,0
59181,benign,0,0
59182,prostatic,0,0
59183,hypertrophy,0,0
59184,.,0,0
59185,YM617,0,0
59186,Clinical,0,0
59187,Study,0,0
59188,Group,0,0
59189,.,0,0
59190,A,0,0
59191,recently,0,0
59192,synthesized,0,0
59193,alpha,1,0
59194,1-blocker,1,1
59195,",",1,1
59196,(,1,1
59197,R,1,1
59198,),1,1
59199,(,1,1
59200,-,1,1
59201,),1,1
59202,-5-,1,1
59203,[,1,1
59204,2-,1,1
59205,[,1,1
59206,[,1,1
59207,2-,1,1
59208,(,1,1
59209,o-ethoxyphenoxy,1,1
59210,),1,1
59211,ethyl,1,1
59212,],1,1
59213,amino,1,1
59214,],1,1
59215,propyl,1,1
59216,],1,1
59217,-2-,1,1
59218,methoxybenzenesulfonamide,1,1
59219,hydrochloride,1,1
59220,(,1,1
59221,YM617,1,1
59222,),1,1
59223,",",0,0
59224,was,0,0
59225,evaluated,0,0
59226,in,0,0
59227,270,0,0
59228,patients,0,0
59229,with,0,0
59230,benign,0,0
59231,prostatic,0,0
59232,hypertrophy,0,0
59233,in,0,0
59234,a,0,0
59235,double-blind,0,1
59236,study,0,0
59237,.,0,0
59238,After,0,0
59239,2,0,0
59240,weeks,0,0
59241,on,0,0
59242,placebo,1,1
59243,the,0,0
59244,patients,0,0
59245,were,0,0
59246,assigned,0,0
59247,at,0,0
59248,random,0,0
59249,to,0,0
59250,4,0,0
59251,groups,0,0
59252,:,0,0
59253,group,0,0
59254,P,1,0
59255,--,1,0
59256,placebo,1,0
59257,",",0,1
59258,group,0,0
59259,L,0,0
59260,--,0,0
59261,0.1,0,0
59262,mg.,0,1
59263,",",0,0
59264,group,0,0
59265,M,0,0
59266,--,0,0
59267,0.2,0,0
59268,mg.,0,1
59269,and,0,0
59270,group,0,0
59271,H,0,0
59272,--,0,0
59273,0.4,0,0
59274,mg.,0,0
59275,of,0,0
59276,YM617,1,1
59277,.,1,0
59278,Comparing,0,0
59279,the,0,0
59280,placebo,1,1
59281,to,0,0
59282,the,0,0
59283,treatment,0,0
59284,period,0,0
59285,",",0,0
59286,subjective,0,0
59287,symptoms,0,0
59288,",",0,0
59289,such,0,0
59290,as,0,0
59291,nocturia,0,0
59292,and,0,0
59293,urgency,0,0
59294,",",0,0
59295,were,0,0
59296,significantly,0,0
59297,decreased,0,0
59298,in,0,0
59299,group,0,0
59300,H,0,0
59301,(,0,0
59302,p,0,0
59303,less,0,0
59304,than,0,0
59305,0.01,0,0
59306,),0,0
59307,.,0,0
59308,The,0,0
59309,sensation,0,0
59310,of,0,0
59311,incomplete,0,0
59312,voiding,0,0
59313,was,0,0
59314,significantly,0,0
59315,improved,0,0
59316,in,0,0
59317,groups,0,0
59318,M,0,0
59319,and,0,1
59320,H,0,0
59321,(,0,0
59322,p,0,0
59323,less,0,0
59324,than,0,0
59325,0.01,0,0
59326,),0,0
59327,.,0,0
59328,However,0,0
59329,",",0,0
59330,the,0,0
59331,differences,0,0
59332,among,0,0
59333,the,0,0
59334,groups,0,0
59335,were,0,0
59336,statistically,0,0
59337,insignificant,0,0
59338,.,0,0
59339,Residual,0,0
59340,urine,0,1
59341,volume,0,1
59342,was,0,0
59343,significantly,0,0
59344,decreased,0,0
59345,in,0,0
59346,groups,0,0
59347,L,0,0
59348,",",0,0
59349,M,0,1
59350,and,0,0
59351,H,0,1
59352,after,0,0
59353,instillation,0,1
59354,of,0,0
59355,saline,0,1
59356,into,0,0
59357,the,0,0
59358,bladder,0,0
59359,(,0,0
59360,p,0,0
59361,less,0,0
59362,than,0,0
59363,0.01,0,0
59364,),0,0
59365,but,0,0
59366,not,0,0
59367,in,0,0
59368,group,0,0
59369,P.,0,0
59370,The,0,0
59371,maximum,0,0
59372,and,0,0
59373,average,0,0
59374,flow,0,0
59375,rates,0,0
59376,were,0,0
59377,significantly,0,0
59378,increased,0,0
59379,in,0,0
59380,groups,0,0
59381,L,0,0
59382,",",0,0
59383,M,0,1
59384,and,0,1
59385,H,0,0
59386,(,0,0
59387,p,0,0
59388,less,0,0
59389,than,0,0
59390,0.01,0,0
59391,),0,0
59392,but,0,0
59393,not,0,0
59394,in,0,0
59395,group,0,0
59396,P.,0,0
59397,Average,0,0
59398,flow,0,0
59399,rate,0,0
59400,showed,0,0
59401,significant,0,0
59402,differences,0,0
59403,between,0,0
59404,groups,0,0
59405,M,0,0
59406,or,0,0
59407,H,0,1
59408,versus,0,0
59409,group,0,0
59410,P.,0,0
59411,Neither,0,0
59412,orthostatic,0,0
59413,hypotension,0,0
59414,nor,0,0
59415,a,0,0
59416,decrease,0,0
59417,in,0,0
59418,blood,0,0
59419,pressure,0,0
59420,was,0,0
59421,noted,0,0
59422,.,0,0
59423,Adverse,0,0
59424,side,0,0
59425,effects,0,0
59426,and,0,0
59427,changes,0,0
59428,in,0,0
59429,laboratory,0,0
59430,data,0,0
59431,were,0,0
59432,all,0,0
59433,slight,0,0
59434,and,0,0
59435,disappeared,0,0
59436,when,0,0
59437,the,0,0
59438,second,0,0
59439,tests,0,0
59440,were,0,0
59441,performed,0,0
59442,.,0,0
59443,In,0,0
59444,summary,0,0
59445,",",0,0
59446,the,0,0
59447,irritative,0,0
59448,and,0,0
59449,obstructive,0,0
59450,symptoms,0,0
59451,caused,0,0
59452,by,0,0
59453,benign,0,0
59454,prostatic,0,0
59455,hypertrophy,0,0
59456,were,0,0
59457,decreased,0,0
59458,and,0,0
59459,urodynamic,0,0
59460,studies,0,0
59461,were,0,0
59462,markedly,0,0
59463,improved,0,0
59464,by,0,0
59465,the,0,0
59466,alpha,1,0
59467,1-blocker,1,1
59468,",",1,0
59469,YM617,1,1
59470,.,1,0
59471,The,0,0
59472,drug,0,1
59473,seems,0,0
59474,to,0,0
59475,be,0,0
59476,useful,0,0
59477,in,0,0
59478,the,0,0
59479,treatment,0,0
59480,of,0,0
59481,patients,0,0
59482,with,0,0
59483,benign,0,0
59484,prostatic,0,0
59485,hypertrophy,0,0
59486,.,0,0
59487,Thrombus,0,0
59488,aspiration,0,0
59489,reduces,0,0
59490,microvascular,0,0
59491,obstruction,0,0
59492,after,0,0
59493,primary,0,0
59494,coronary,0,0
59495,intervention,0,0
59496,:,0,0
59497,a,0,0
59498,myocardial,0,0
59499,contrast,0,0
59500,echocardiography,0,0
59501,substudy,0,0
59502,of,0,0
59503,the,0,0
59504,REMEDIA,0,0
59505,Trial,0,0
59506,.,0,0
59507,OBJECTIVES,0,0
59508,The,0,0
59509,aim,0,0
59510,of,0,0
59511,this,0,0
59512,study,0,0
59513,was,0,0
59514,to,0,0
59515,clarify,0,0
59516,the,0,0
59517,role,0,0
59518,of,0,0
59519,microembolization,0,0
59520,in,0,0
59521,the,0,0
59522,genesis,0,0
59523,of,0,0
59524,microvascular,0,0
59525,obstruction,0,1
59526,(,0,1
59527,MO,0,1
59528,),0,1
59529,after,0,0
59530,percutaneous,0,0
59531,coronary,0,1
59532,intervention,0,1
59533,(,0,1
59534,PCI,0,1
59535,),0,1
59536,.,0,0
59537,BACKGROUND,0,0
59538,Fifty,0,0
59539,consecutive,0,0
59540,patients,0,0
59541,entered,0,0
59542,the,0,0
59543,myocardial,0,0
59544,contrast,0,0
59545,echocardiography,0,1
59546,(,0,1
59547,MCE,0,1
59548,),0,1
59549,substudy,0,0
59550,of,0,0
59551,the,0,0
59552,REMEDIA,0,1
59553,(,0,1
59554,Randomized,0,0
59555,Evaluation,0,0
59556,of,0,0
59557,the,0,0
59558,Effect,0,0
59559,of,0,0
59560,Mechanical,0,0
59561,Reduction,0,0
59562,of,0,0
59563,Distal,0,0
59564,Embolization,0,0
59565,by,0,0
59566,Thrombus,0,0
59567,Aspiration,0,0
59568,in,0,0
59569,Primary,0,0
59570,and,0,0
59571,Rescue,0,1
59572,Angioplasty,0,1
59573,),0,0
59574,trial,0,0
59575,",",0,0
59576,which,0,0
59577,defined,0,0
59578,the,0,0
59579,role,0,0
59580,of,0,0
59581,a,0,0
59582,new,0,0
59583,thrombus-aspirating,0,0
59584,device,0,0
59585,in,0,0
59586,preventing,0,0
59587,distal,0,0
59588,microembolization,0,0
59589,after,0,0
59590,PCI,0,0
59591,.,0,0
59592,METHODS,0,0
59593,A,0,0
59594,total,0,0
59595,of,0,0
59596,25,0,0
59597,patients,0,0
59598,were,0,0
59599,randomized,0,0
59600,to,0,0
59601,be,0,0
59602,pretreated,0,0
59603,with,0,0
59604,thrombus,1,0
59605,aspiration,1,0
59606,before,1,0
59607,PCI,1,0
59608,of,1,0
59609,the,1,0
59610,culprit,1,0
59611,lesion,1,0
59612,and,1,0
59613,25,0,0
59614,received,0,0
59615,standard,1,0
59616,PCI,1,1
59617,.,1,0
59618,At,0,0
59619,24,0,0
59620,h,0,0
59621,",",0,0
59622,1,0,0
59623,week,0,0
59624,",",0,0
59625,and,0,0
59626,6,0,0
59627,months,0,0
59628,after,0,0
59629,PCI,0,0
59630,",",0,0
59631,MCE,0,0
59632,was,0,0
59633,performed,0,0
59634,by,0,0
59635,Sonovue,0,1
59636,",",0,0
59637,and,0,0
59638,real-time,0,0
59639,imaging,0,0
59640,was,0,0
59641,performed,0,0
59642,by,0,0
59643,contrast,0,0
59644,pulse,0,0
59645,sequencing,0,0
59646,technology,0,0
59647,.,0,0
59648,Regional,0,0
59649,wall,0,0
59650,motion,0,0
59651,score,0,1
59652,index,0,1
59653,(,0,1
59654,WMSI,0,1
59655,),0,1
59656,",",0,0
59657,contrast,0,0
59658,score,0,1
59659,index,0,1
59660,(,0,1
59661,CSI,0,1
59662,),0,1
59663,",",0,0
59664,endocardial,0,0
59665,length,0,0
59666,of,0,0
59667,wall,0,0
59668,motion,0,0
59669,abnormality,0,0
59670,(,0,0
59671,WML,0,0
59672,),0,0
59673,and,0,0
59674,contrast,0,0
59675,defect,0,0
59676,(,0,0
59677,CDL,0,1
59678,),0,1
59679,",",0,0
59680,end-diastolic,0,1
59681,and,0,0
59682,end-systolic,0,0
59683,left,0,1
59684,ventricular,0,1
59685,(,0,1
59686,LV,0,1
59687,),0,1
59688,volumes,0,0
59689,",",0,0
59690,and,0,0
59691,ejection,0,0
59692,fraction,0,0
59693,were,0,0
59694,calculated,0,0
59695,.,0,0
59696,RESULTS,0,0
59697,At,0,0
59698,each,0,0
59699,time,0,0
59700,point,0,0
59701,",",0,0
59702,in,0,0
59703,patients,0,0
59704,treated,0,0
59705,with,0,0
59706,a,0,0
59707,thrombus-aspiration,0,0
59708,filter,0,0
59709,device,0,0
59710,",",0,0
59711,WMSI,0,1
59712,",",0,0
59713,CSI,0,0
59714,",",0,0
59715,WML,0,0
59716,",",0,0
59717,and,0,0
59718,CDL,0,0
59719,were,0,0
59720,significantly,0,0
59721,lower,0,0
59722,and,0,0
59723,ejection,0,0
59724,fraction,0,0
59725,higher,0,0
59726,(,0,0
59727,p,0,0
59728,<,0,0
59729,0.05,0,0
59730,vs.,0,0
59731,control,0,0
59732,patients,0,0
59733,),0,0
59734,",",0,0
59735,whereas,0,0
59736,LV,0,0
59737,volumes,0,0
59738,were,0,0
59739,slightly,0,0
59740,but,0,0
59741,not,0,0
59742,significantly,0,0
59743,smaller,0,0
59744,compared,0,0
59745,with,0,0
59746,control,0,0
59747,patients,0,0
59748,.,0,0
59749,In,0,0
59750,the,0,0
59751,overall,0,0
59752,study,0,0
59753,population,0,0
59754,",",0,0
59755,the,0,0
59756,extent,0,0
59757,of,0,0
59758,MO,0,0
59759,significantly,0,0
59760,correlated,0,0
59761,with,0,0
59762,temporal,0,0
59763,changes,0,0
59764,in,0,0
59765,LV,0,0
59766,volumes,0,0
59767,.,0,0
59768,CONCLUSIONS,0,0
59769,Thrombus,0,0
59770,aspiration,0,0
59771,used,0,0
59772,at,0,0
59773,the,0,0
59774,time,0,0
59775,of,0,0
59776,PCI,0,0
59777,significantly,0,0
59778,reduces,0,0
59779,the,0,0
59780,extent,0,0
59781,of,0,0
59782,MO,0,0
59783,and,0,0
59784,myocardial,0,0
59785,dysfunction,0,0
59786,",",0,0
59787,although,0,0
59788,it,0,0
59789,does,0,0
59790,not,0,0
59791,have,0,0
59792,a,0,0
59793,significant,0,0
59794,favorable,0,0
59795,effect,0,0
59796,in,0,0
59797,preventing,0,0
59798,LV,0,0
59799,remodeling,0,0
59800,.,0,0
59801,Thus,0,0
59802,",",0,0
59803,the,0,0
59804,beneficial,0,0
59805,effect,0,0
59806,of,0,0
59807,thrombus,0,0
59808,aspiration,0,0
59809,occurs,0,0
59810,at,0,0
59811,the,0,0
59812,microvascular,0,0
59813,level,0,0
59814,",",0,0
59815,but,0,0
59816,additional,0,0
59817,mechanisms,0,0
59818,may,0,0
59819,play,0,0
59820,a,0,0
59821,role,0,0
59822,in,0,0
59823,influencing,0,0
59824,the,0,0
59825,final,0,0
59826,extent,0,0
59827,of,0,0
59828,MO,0,0
59829,",",0,0
59830,which,0,0
59831,strictly,0,0
59832,correlates,0,0
59833,with,0,0
59834,post-infarct,0,0
59835,LV,0,0
59836,remodeling,0,0
59837,.,0,0
59838,Endocrine,0,1
59839,response,0,0
59840,to,0,0
59841,cataract,1,0
59842,surgery,1,0
59843,under,1,0
59844,total,1,0
59845,intravenous,1,1
59846,anaesthesia,1,1
59847,",",1,0
59848,local,1,0
59849,anaesthesia,1,0
59850,under,1,0
59851,sedation,1,0
59852,or,1,0
59853,local,1,0
59854,anaesthesia,1,0
59855,alone,1,0
59856,:,1,0
59857,a,0,0
59858,comparative,0,0
59859,study,0,0
59860,.,0,0
59861,Effect,0,0
59862,of,0,0
59863,patient,0,0
59864,withdrawal,0,0
59865,on,0,0
59866,a,0,0
59867,study,0,0
59868,evaluating,0,0
59869,pharmacist,1,0
59870,management,1,0
59871,of,1,0
59872,hypertension,1,0
59873,.,1,0
59874,STUDY,0,0
59875,OBJECTIVES,0,0
59876,To,0,0
59877,examine,0,0
59878,potential,0,0
59879,threats,0,0
59880,to,0,0
59881,internal,0,0
59882,and,0,0
59883,external,0,0
59884,study,0,0
59885,validity,0,0
59886,caused,0,0
59887,by,0,0
59888,differential,0,0
59889,patient,0,0
59890,withdrawal,0,0
59891,from,0,0
59892,a,0,0
59893,randomized,0,0
59894,controlled,0,0
59895,trial,0,0
59896,evaluating,0,0
59897,pharmacist,0,0
59898,management,0,0
59899,of,0,0
59900,hypertension,0,0
59901,",",0,0
59902,to,0,0
59903,compare,0,0
59904,the,0,0
59905,characteristics,0,0
59906,of,0,0
59907,patients,0,0
59908,who,0,0
59909,withdrew,0,0
59910,with,0,0
59911,those,0,0
59912,of,0,0
59913,patients,0,0
59914,who,0,0
59915,completed,0,0
59916,the,0,0
59917,study,0,0
59918,",",0,0
59919,and,0,0
59920,to,0,0
59921,identify,0,0
59922,characteristics,0,0
59923,that,0,0
59924,predispose,0,0
59925,patients,0,0
59926,to,0,0
59927,withdraw,0,0
59928,from,0,0
59929,hypertension,0,0
59930,management,0,0
59931,.,0,0
59932,DESIGN,0,0
59933,Prospective,0,0
59934,",",0,0
59935,randomized,0,0
59936,",",0,0
59937,comparative,0,0
59938,study,0,0
59939,.,0,0
59940,SETTING,0,0
59941,Network,0,0
59942,of,0,0
59943,primary,0,0
59944,care,0,0
59945,clinics,0,0
59946,.,0,0
59947,PATIENTS,0,0
59948,Four,0,0
59949,hundred,0,0
59950,sixty-three,0,0
59951,patients,0,0
59952,with,0,0
59953,a,0,0
59954,diagnosis,0,0
59955,of,0,0
59956,hypertension,0,0
59957,and,0,0
59958,a,0,0
59959,last,0,0
59960,documented,0,0
59961,systolic,0,0
59962,blood,0,0
59963,pressure,0,0
59964,of,0,0
59965,160,0,0
59966,mm,0,0
59967,Hg,0,0
59968,or,0,0
59969,greater,0,0
59970,and/or,0,0
59971,diastolic,0,0
59972,blood,0,0
59973,pressure,0,0
59974,of,0,0
59975,100,0,0
59976,mm,0,0
59977,Hg,0,0
59978,or,0,0
59979,greater,0,0
59980,.,0,0
59981,INTERVENTION,0,0
59982,Patients,0,0
59983,were,0,0
59984,randomly,0,0
59985,allocated,0,0
59986,to,0,0
59987,the,0,0
59988,pharmacist,1,0
59989,intervention,1,0
59990,or,1,0
59991,usual-care,1,0
59992,(,1,1
59993,control,1,0
59994,),1,0
59995,group,1,0
59996,.,1,0
59997,Those,0,0
59998,in,0,0
59999,the,0,0
60000,pharmacist,0,0
60001,intervention,0,0
60002,group,0,0
60003,were,0,0
60004,collaboratively,1,0
60005,managed,1,0
60006,by,1,0
60007,a,1,0
60008,primary,1,0
60009,care,1,0
60010,clinical,1,0
60011,pharmacy,1,0
60012,specialist,1,0
60013,and,1,0
60014,their,1,0
60015,primary,1,0
60016,care,1,0
60017,provider,1,0
60018,.,1,0
60019,Patients,0,0
60020,in,0,0
60021,the,0,0
60022,control,0,0
60023,group,0,0
60024,received,1,0
60025,usual,1,0
60026,care,1,0
60027,from,1,0
60028,only,1,0
60029,their,1,0
60030,primary,1,0
60031,care,1,0
60032,provider,1,0
60033,.,1,0
60034,MEASUREMENTS,0,0
60035,AND,0,1
60036,MAIN,0,1
60037,RESULTS,0,1
60038,Of,0,0
60039,the,0,0
60040,463,0,0
60041,patients,0,0
60042,",",0,0
60043,191,0,0
60044,(,0,0
60045,41,0,0
60046,%,0,0
60047,),0,0
60048,withdrew,0,0
60049,from,0,0
60050,the,0,0
60051,study,0,0
60052,after,0,0
60053,randomization,0,0
60054,and,0,0
60055,272,0,0
60056,(,0,0
60057,59,0,0
60058,%,0,0
60059,),0,0
60060,completed,0,0
60061,the,0,0
60062,study,0,0
60063,.,0,0
60064,Patients,0,0
60065,who,0,0
60066,withdrew,0,0
60067,from,0,0
60068,the,0,0
60069,pharmacist,1,0
60070,intervention,1,0
60071,group,0,0
60072,were,0,0
60073,similar,0,0
60074,to,0,0
60075,patients,0,0
60076,who,0,0
60077,withdrew,0,0
60078,from,0,0
60079,the,0,0
60080,usual-care,0,0
60081,group,0,0
60082,with,0,0
60083,respect,0,0
60084,to,0,0
60085,age,0,0
60086,",",0,0
60087,sex,0,0
60088,",",0,0
60089,insurance,0,0
60090,status,0,0
60091,",",0,0
60092,and,0,0
60093,chronic,0,0
60094,conditions,0,0
60095,.,0,0
60096,Patients,0,0
60097,who,0,0
60098,smoked,0,0
60099,or,0,0
60100,had,0,0
60101,commercial,0,0
60102,insurance,0,0
60103,were,0,0
60104,more,0,0
60105,likely,0,0
60106,to,0,0
60107,withdraw,0,0
60108,from,0,0
60109,the,0,0
60110,study,0,0
60111,than,0,0
60112,the,0,0
60113,other,0,0
60114,participants,0,0
60115,.,0,0
60116,However,0,0
60117,",",0,0
60118,multivariate,0,0
60119,analysis,0,0
60120,of,0,0
60121,all,0,0
60122,variables,0,0
60123,",",0,0
60124,when,0,0
60125,adjusted,0,0
60126,for,0,0
60127,the,0,0
60128,effect,0,0
60129,of,0,0
60130,the,0,0
60131,intervention,0,0
60132,",",0,0
60133,revealed,0,0
60134,that,0,0
60135,insurance,0,0
60136,status,0,0
60137,was,0,0
60138,the,0,0
60139,only,0,0
60140,variable,0,0
60141,associated,0,0
60142,with,0,0
60143,a,0,0
60144,heightened,0,0
60145,probability,0,0
60146,of,0,0
60147,withdrawal,0,0
60148,(,0,0
60149,p=0.002,0,0
60150,),0,0
60151,.,0,0
60152,CONCLUSION,0,0
60153,Although,0,0
60154,this,0,0
60155,study,0,0
60156,had,0,0
60157,a,0,0
60158,high,0,0
60159,withdrawal,0,0
60160,rate,0,0
60161,",",0,0
60162,between-group,0,0
60163,patient,0,0
60164,characteristics,0,0
60165,remained,0,0
60166,balanced,0,0
60167,.,0,0
60168,Therefore,0,0
60169,",",0,0
60170,internal,0,0
60171,validity,0,0
60172,was,0,0
60173,preserved,0,0
60174,",",0,0
60175,and,0,0
60176,outcomes,0,0
60177,from,0,0
60178,the,0,0
60179,study,0,0
60180,groups,0,0
60181,could,0,0
60182,be,0,0
60183,reliably,0,0
60184,compared,0,0
60185,.,0,0
60186,A,0,0
60187,lack,0,0
60188,of,0,0
60189,significant,0,0
60190,differences,0,0
60191,between,0,0
60192,patients,0,0
60193,who,0,0
60194,withdrew,0,0
60195,versus,0,0
60196,those,0,0
60197,who,0,0
60198,completed,0,0
60199,",",0,0
60200,with,0,0
60201,the,0,0
60202,exception,0,0
60203,of,0,0
60204,insurance,0,0
60205,status,0,0
60206,",",0,0
60207,suggests,0,0
60208,that,0,0
60209,external,0,0
60210,validity,0,0
60211,was,0,0
60212,not,0,0
60213,jeopardized,0,0
60214,.,0,0
60215,Evolution,0,0
60216,of,0,0
60217,neuropathy,0,0
60218,and,0,0
60219,myopathy,0,0
60220,during,0,0
60221,intensive,0,1
60222,vincristine/corticosteroid,1,1
60223,chemotherapy,1,1
60224,for,0,0
60225,non-Hodgkin,0,0
60226,'s,0,0
60227,lymphoma,0,0
60228,.,0,0
60229,Neuropathy,0,0
60230,and,0,0
60231,myopathy,0,0
60232,are,0,0
60233,common,0,0
60234,sequelae,0,0
60235,of,0,0
60236,intensive,1,0
60237,chemotherapy,1,0
60238,protocols,1,0
60239,that,1,0
60240,contain,1,0
60241,vincristine,1,1
60242,and,1,1
60243,corticosteroids,1,1
60244,.,1,1
60245,The,0,0
60246,authors,0,0
60247,prospectively,0,0
60248,monitored,0,0
60249,the,0,0
60250,evolution,0,0
60251,of,0,0
60252,neuropathy,0,0
60253,and,0,0
60254,myopathy,0,0
60255,during,0,0
60256,an,0,0
60257,intensive,0,0
60258,12-week,0,0
60259,chemotherapy,1,0
60260,program,0,0
60261,for,0,0
60262,patients,0,0
60263,with,0,0
60264,intermediate,0,0
60265,and,0,0
60266,high-grade,0,0
60267,non-Hodgkin,0,1
60268,'s,0,0
60269,lymphoma,0,0
60270,.,0,0
60271,In,0,0
60272,this,0,0
60273,study,0,0
60274,",",0,0
60275,vincristine,1,1
60276,was,0,0
60277,administered,0,1
60278,by,0,1
60279,bolus,1,1
60280,injection,0,1
60281,followed,0,1
60282,by,0,0
60283,a,0,0
60284,3-day,0,1
60285,continuous,0,1
60286,intravenous,0,1
60287,(,0,1
60288,IV,0,1
60289,),0,1
60290,infusion,0,1
60291,(,0,1
60292,total,0,1
60293,dose,0,1
60294,of,0,1
60295,2.0,0,1
60296,mg/m2,0,1
60297,every,0,1
60298,other,0,0
60299,week,0,1
60300,),0,0
60301,;,0,0
60302,the,0,0
60303,maximum,0,0
60304,dose,0,1
60305,of,0,1
60306,vincristine,1,1
60307,was,0,0
60308,not,0,0
60309,arbitrarily,0,0
60310,limited,0,0
60311,.,0,0
60312,Cronassial,1,0
60313,",",1,0
60314,a,1,0
60315,mixture,1,0
60316,of,1,0
60317,four,1,0
60318,naturally,1,0
60319,occurring,1,0
60320,gangliosides,1,1
60321,",",0,1
60322,was,0,0
60323,administered,0,1
60324,in,0,0
60325,a,0,0
60326,randomized,0,1
60327,double-blind,0,1
60328,test,0,0
60329,to,0,0
60330,evaluate,0,0
60331,whether,0,0
60332,this,0,0
60333,agent,0,0
60334,could,0,0
60335,prevent,0,0
60336,vincristine-induced,1,1
60337,neuropathy,0,1
60338,.,0,1
60339,High,0,0
60340,doses,0,1
60341,of,0,1
60342,dexamethasone,1,1
60343,(,0,1
60344,50,0,1
60345,mg/d,0,1
60346,for,0,1
60347,3,0,1
60348,days,0,0
60349,weekly,0,1
60350,or,0,1
60351,every,0,0
60352,other,0,0
60353,week,0,0
60354,),0,0
60355,were,0,0
60356,also,0,0
60357,prescribed,0,0
60358,.,0,0
60359,Patients,0,0
60360,were,0,0
60361,monitored,0,0
60362,every,0,0
60363,4,0,0
60364,weeks,0,0
60365,with,0,0
60366,comprehensive,0,0
60367,physical,0,0
60368,and,0,0
60369,neurologic,0,0
60370,examinations,0,0
60371,and,0,0
60372,electrophysiologic,0,0
60373,studies,0,0
60374,of,0,0
60375,peripheral,0,0
60376,nerve,0,0
60377,function,0,0
60378,.,0,0
60379,Twenty-seven,0,0
60380,patients,0,0
60381,were,0,0
60382,fully,0,0
60383,evaluable,0,0
60384,.,0,0
60385,Weakness,0,0
60386,was,0,0
60387,a,0,0
60388,prominent,0,0
60389,adverse,0,0
60390,reaction,0,0
60391,in,0,0
60392,this,0,0
60393,study,0,0
60394,",",0,0
60395,and,0,0
60396,all,0,0
60397,patients,0,0
60398,had,0,0
60399,moderate,0,0
60400,to,0,0
60401,severe,0,0
60402,signs,0,0
60403,and,0,0
60404,symptoms,0,0
60405,of,0,0
60406,neuropathy,0,0
60407,and,0,0
60408,myopathy,0,0
60409,.,0,0
60410,Cronassial,1,1
60411,(,0,1
60412,100,0,1
60413,mg,0,1
60414,),0,1
60415,administered,0,1
60416,by,0,1
60417,intramuscular,0,1
60418,(,0,1
60419,IM,0,1
60420,),0,1
60421,injection,0,1
60422,daily,0,1
60423,provided,0,1
60424,no,0,0
60425,protection,0,0
60426,against,0,0
60427,the,0,0
60428,development,0,0
60429,of,0,0
60430,neuropathic,0,0
60431,symptoms,0,1
60432,.,0,0
60433,Vincristine,1,1
60434,typically,0,0
60435,impaired,0,0
60436,fine-motor,0,0
60437,coordination,0,0
60438,initially,0,0
60439,",",0,0
60440,whereas,0,0
60441,corticosteroids,1,1
60442,were,0,0
60443,associated,0,0
60444,with,0,0
60445,delayed,0,0
60446,development,0,0
60447,of,0,0
60448,proximal,0,0
60449,muscle,0,0
60450,weakness,0,0
60451,.,0,0
60452,Results,0,0
60453,of,0,0
60454,electrodiagnostic,0,0
60455,studies,0,0
60456,did,0,0
60457,not,0,0
60458,add,0,0
60459,to,0,0
60460,the,0,0
60461,clinical,0,0
60462,examination,0,0
60463,results,0,0
60464,.,0,0
60465,The,0,0
60466,authors,0,0
60467,conclude,0,0
60468,that,0,0
60469,symptomatic,0,0
60470,weakness,0,0
60471,due,0,0
60472,to,0,0
60473,neuropathy,0,0
60474,or,0,0
60475,myopathy,0,0
60476,appears,0,0
60477,in,0,0
60478,a,0,0
60479,predictable,0,0
60480,manner,0,0
60481,during,0,0
60482,intensive,0,1
60483,vincristine/corticosteroid-based,1,1
60484,treatment,1,1
60485,protocols,0,1
60486,.,0,0
60487,Simple,0,0
60488,clinical,0,0
60489,tests,0,0
60490,can,0,0
60491,be,0,0
60492,used,0,0
60493,to,0,0
60494,rapidly,0,0
60495,distinguish,0,0
60496,between,0,0
60497,toxic,0,0
60498,effects,0,0
60499,due,0,0
60500,either,0,0
60501,to,0,0
60502,vincristine,1,1
60503,or,1,1
60504,corticosteroids,1,1
60505,",",0,1
60506,and,0,0
60507,routine,0,0
60508,implementation,0,0
60509,of,0,0
60510,these,0,0
60511,tests,0,0
60512,can,0,0
60513,prevent,0,0
60514,inappropriate,0,0
60515,dose,0,1
60516,attenuation,0,0
60517,of,0,0
60518,these,0,0
60519,agents,0,0
60520,.,0,0
60521,The,0,0
60522,instruction,0,0
60523,to,0,0
60524,refrain,1,0
60525,from,1,0
60526,blinking,1,0
60527,affects,0,0
60528,auditory,0,0
60529,P3,0,1
60530,and,0,0
60531,N1,0,0
60532,amplitudes,0,0
60533,.,0,0
60534,Often,0,0
60535,subjects,0,0
60536,have,0,0
60537,been,0,0
60538,instructed,0,0
60539,to,0,0
60540,refrain,1,0
60541,from,1,0
60542,blinking,1,0
60543,lest,0,0
60544,their,0,0
60545,evoked,0,0
60546,EEG,0,0
60547,potentials,0,0
60548,should,0,0
60549,be,0,0
60550,distorted,0,0
60551,.,0,0
60552,We,0,0
60553,studied,0,0
60554,whether,0,0
60555,these,0,0
60556,very,0,0
60557,instructions,0,0
60558,have,0,0
60559,any,0,0
60560,impact,0,0
60561,on,0,0
60562,P3,0,0
60563,amplitude,0,0
60564,.,0,0
60565,Two,0,0
60566,tones,0,0
60567,were,0,0
60568,presented,0,0
60569,in,0,0
60570,random,0,0
60571,order,0,0
60572,",",0,0
60573,and,0,0
60574,subjects,0,0
60575,had,0,0
60576,to,0,0
60577,count,0,0
60578,the,0,0
60579,high-pitched,0,0
60580,tones,0,0
60581,.,0,0
60582,Half,0,0
60583,the,0,0
60584,subjects,0,0
60585,were,0,0
60586,instructed,1,0
60587,not,1,0
60588,to,1,0
60589,blink,1,0
60590,",",0,0
60591,whereas,0,0
60592,this,0,0
60593,instruction,0,0
60594,was,0,0
60595,omitted,0,0
60596,for,0,0
60597,the,0,0
60598,other,0,0
60599,subjects,0,0
60600,.,0,0
60601,Target,0,0
60602,tones,0,0
60603,evoked,0,0
60604,larger,0,0
60605,P3s,0,1
60606,than,0,0
60607,non-targets,0,0
60608,in,0,0
60609,the,0,0
60610,latter,0,0
60611,group,0,0
60612,but,0,0
60613,not,0,0
60614,in,0,0
60615,the,0,0
60616,former,0,0
60617,",",0,0
60618,in,0,0
60619,particular,0,0
60620,not,0,0
60621,in,0,0
60622,those,0,0
60623,subjects,0,0
60624,that,0,0
60625,actually,0,0
60626,blinked,0,0
60627,rarely,0,0
60628,.,0,0
60629,The,0,0
60630,groups,0,0
60631,also,0,0
60632,differed,0,0
60633,in,0,0
60634,their,0,0
60635,N1,0,0
60636,amplitudes,0,0
60637,.,0,0
60638,These,0,0
60639,findings,0,0
60640,might,0,0
60641,be,0,0
60642,relevant,0,0
60643,to,0,0
60644,P3,0,0
60645,studies,0,0
60646,working,0,0
60647,with,0,0
60648,patients,0,0
60649,and,0,0
60650,controls,0,0
60651,:,0,0
60652,the,0,0
60653,harder,0,0
60654,some,0,0
60655,frequently,0,0
60656,blinking,0,0
60657,subjects,0,0
60658,try,0,0
60659,to,0,0
60660,refrain,0,0
60661,from,0,0
60662,blinking,0,0
60663,",",0,0
60664,the,0,0
60665,smaller,0,0
60666,might,0,0
60667,become,0,0
60668,their,0,0
60669,P3,0,0
60670,amplitudes,0,0
60671,.,0,0
60672,Omitting,0,0
60673,the,0,0
60674,instruction,0,0
60675,and,0,0
60676,using,0,0
60677,off-line,0,0
60678,blink,0,0
60679,subtraction,0,0
60680,procedures,0,0
60681,seems,0,0
60682,a,0,0
60683,viable,0,0
60684,alternative,0,0
60685,.,0,0
60686,This,0,0
60687,study,0,0
60688,was,0,0
60689,actually,0,0
60690,motivated,0,0
60691,by,0,0
60692,discrepant,0,0
60693,findings,0,0
60694,on,0,0
60695,the,0,0
60696,effects,0,0
60697,of,0,0
60698,the,0,0
60699,preceding,0,0
60700,tone,0,0
60701,sequence,0,0
60702,on,0,0
60703,P3,0,0
60704,.,0,0
60705,These,0,0
60706,discrepancies,0,0
60707,could,0,0
60708,be,0,0
60709,largely,0,0
60710,resolved,0,0
60711,by,0,0
60712,the,0,0
60713,instructional,0,0
60714,variable,0,0
60715,",",0,0
60716,in,0,0
60717,conjunction,0,0
60718,with,0,0
60719,different,0,0
60720,tone,0,0
60721,intensities,0,0
60722,.,0,0
60723,It,0,0
60724,is,0,0
60725,suggested,0,0
60726,that,0,0
60727,subjects,1,0
60728,who,1,0
60729,are,1,0
60730,discouraged,1,0
60731,from,1,0
60732,blinking,1,0
60733,try,0,0
60734,to,0,0
60735,protect,0,0
60736,themselves,0,0
60737,against,0,0
60738,the,0,0
60739,arousing,0,0
60740,effects,0,0
60741,of,0,0
60742,stimuli,0,0
60743,.,0,0
60744,Predictors,0,0
60745,of,0,0
60746,mental,0,0
60747,health,0,0
60748,problems,0,0
60749,and,0,0
60750,negative,0,0
60751,caregiving,0,0
60752,experiences,0,0
60753,in,0,0
60754,carers,0,0
60755,of,0,0
60756,adolescents,0,0
60757,with,0,0
60758,bulimia,0,0
60759,nervosa,0,0
60760,.,0,0
60761,OBJECTIVE,0,0
60762,This,0,0
60763,exploratory,0,0
60764,study,0,0
60765,focuses,0,0
60766,on,0,0
60767,the,0,0
60768,mental,1,0
60769,health,1,1
60770,(,1,1
60771,MH,1,1
60772,),1,1
60773,and,1,0
60774,caregiving,1,0
60775,experience,1,0
60776,of,1,0
60777,carers,1,0
60778,of,1,0
60779,adolescents,1,0
60780,with,0,0
60781,Bulimia,0,0
60782,Nervosa,0,1
60783,(,0,1
60784,BN,0,1
60785,),0,0
60786,/Eating,0,0
60787,Disorder,0,0
60788,not,0,0
60789,otherwise,0,0
60790,specified,0,0
60791,(,0,0
60792,EDNOS,0,1
60793,),0,1
60794,",",0,0
60795,aiming,0,0
60796,to,0,0
60797,determine,0,0
60798,:,0,0
60799,levels,0,0
60800,of,0,0
60801,MH,0,0
60802,problems,0,0
60803,in,0,0
60804,carers,0,0
60805,and,0,0
60806,if,0,0
60807,a,0,0
60808,negative,0,0
60809,experience,0,0
60810,of,0,0
60811,caregiving,0,0
60812,predicts,0,0
60813,carer,0,0
60814,MH,0,0
60815,status,0,0
60816,and,0,0
60817,which,0,0
60818,factors,0,0
60819,predict,0,0
60820,a,0,0
60821,negative,0,0
60822,experience,0,0
60823,of,0,0
60824,caregiving,0,0
60825,.,0,0
60826,METHOD,0,0
60827,Hundred,0,0
60828,and,0,0
60829,twelve,0,0
60830,carers,0,0
60831,and,0,0
60832,68,0,0
60833,adolescents,0,0
60834,with,0,0
60835,BN/EDNOS,0,0
60836,completed,0,0
60837,self-report,1,1
60838,measures,1,1
60839,(,1,1
60840,General,1,1
60841,Health,1,1
60842,Questionnaire,1,0
60843,",",1,0
60844,Experience,1,0
60845,of,1,0
60846,Caregiving,1,0
60847,Inventory,1,0
60848,",",1,0
60849,Level,1,0
60850,of,1,0
60851,Expressed,1,0
60852,Emotion,1,0
60853,",",1,0
60854,Self-report,1,0
60855,Family,1,0
60856,Inventory,1,0
60857,",",1,0
60858,Inventory,1,0
60859,of,1,0
60860,Interpersonal,1,1
60861,Problems,1,1
60862,),1,0
60863,.,1,0
60864,RESULTS,0,0
60865,Over,0,0
60866,half,0,0
60867,of,0,0
60868,the,0,0
60869,carers,0,0
60870,reported,0,0
60871,some,0,0
60872,MH,0,0
60873,problems,0,0
60874,and,0,0
60875,a,0,0
60876,minority,0,0
60877,(,0,0
60878,5.4,0,0
60879,%,0,0
60880,),0,0
60881,were,0,0
60882,experiencing,0,0
60883,considerable,0,0
60884,difficulties,0,0
60885,.,0,0
60886,A,0,0
60887,negative,0,0
60888,experience,0,0
60889,of,0,0
60890,caregiving,0,0
60891,predicted,0,0
60892,carer,0,0
60893,MH,0,0
60894,status,0,0
60895,.,0,0
60896,Higher,0,0
60897,weekly,0,0
60898,contact,0,0
60899,hours,0,1
60900,and,0,0
60901,patient,0,1
60902,ratings,0,0
60903,of,0,0
60904,expressed,0,0
60905,emotion,0,0
60906,(,0,1
60907,EE,0,1
60908,),0,0
60909,predicted,0,0
60910,a,0,0
60911,negative,0,0
60912,experience,0,0
60913,of,0,0
60914,caregiving,0,0
60915,.,0,0
60916,CONCLUSIONS,0,0
60917,Interventions,1,0
60918,focusing,1,0
60919,on,1,0
60920,reducing,1,0
60921,EE,1,0
60922,and,1,0
60923,contact,1,0
60924,hours,1,0
60925,could,0,0
60926,prove,0,0
60927,beneficial,0,0
60928,for,0,0
60929,both,0,0
60930,patient,0,0
60931,and,0,0
60932,caregiver,0,0
60933,outcomes,0,0
60934,.,0,0
60935,The,0,0
60936,use,0,0
60937,of,0,0
60938,the,0,0
60939,Antenatal,1,0
60940,Psychosocial,1,0
60941,Health,1,1
60942,Assessment,1,1
60943,(,1,1
60944,ALPHA,1,1
60945,),1,0
60946,tool,1,0
60947,in,0,0
60948,the,0,0
60949,detection,0,0
60950,of,0,0
60951,psychosocial,0,0
60952,risk,0,0
60953,factors,0,0
60954,for,0,0
60955,postpartum,0,0
60956,depression,0,0
60957,:,0,0
60958,a,0,0
60959,randomized,0,0
60960,controlled,0,0
60961,trial,0,0
60962,.,0,0
60963,OBJECTIVE,0,0
60964,Eliciting,0,0
60965,known,0,0
60966,risk,0,0
60967,factors,0,0
60968,for,0,0
60969,postpartum,0,0
60970,depression,0,1
60971,(,0,1
60972,PPD,0,1
60973,),0,1
60974,during,0,0
60975,pregnancy,0,0
60976,may,0,0
60977,enable,0,0
60978,primary,0,0
60979,health,0,0
60980,care,0,0
60981,providers,0,0
60982,to,0,0
60983,identify,0,0
60984,women,0,0
60985,at,0,0
60986,increased,0,0
60987,risk,0,0
60988,of,0,0
60989,becoming,0,0
60990,depressed,0,0
60991,.,0,0
60992,The,0,0
60993,purpose,0,0
60994,of,0,0
60995,this,0,0
60996,study,0,0
60997,was,0,0
60998,to,0,0
60999,examine,0,0
61000,how,0,0
61001,well,0,0
61002,the,0,0
61003,Antenatal,1,0
61004,Psychosocial,1,0
61005,Health,1,1
61006,Assessment,1,1
61007,(,1,1
61008,ALPHA,1,1
61009,),1,0
61010,form,0,0
61011,identified,0,0
61012,antenatal,0,0
61013,risk,0,0
61014,factors,0,0
61015,for,0,0
61016,PPD,0,0
61017,",",0,0
61018,compared,0,0
61019,with,0,0
61020,routine,0,0
61021,care,0,0
61022,",",0,0
61023,in,0,0
61024,a,0,0
61025,sample,0,0
61026,of,0,0
61027,pregnant,0,0
61028,women,0,0
61029,.,0,0
61030,METHODS,0,0
61031,A,0,1
61032,randomized,0,0
61033,controlled,0,0
61034,trial,0,0
61035,was,0,0
61036,conducted,0,0
61037,to,0,0
61038,assess,0,0
61039,the,0,0
61040,effectiveness,0,0
61041,of,0,0
61042,the,0,0
61043,ALPHA,1,0
61044,form,0,0
61045,in,0,0
61046,detecting,0,0
61047,antenatal,0,0
61048,risk,0,0
61049,factors,0,0
61050,associated,0,0
61051,with,0,0
61052,the,0,0
61053,adverse,0,0
61054,postpartum,0,0
61055,outcomes,0,0
61056,of,0,0
61057,postpartum,0,0
61058,depression,0,0
61059,",",0,0
61060,intimate,0,0
61061,partner,0,0
61062,violence,0,0
61063,",",0,0
61064,child,0,0
61065,abuse,0,0
61066,",",0,0
61067,and,0,0
61068,couple,0,0
61069,dysfunction,0,0
61070,.,0,0
61071,The,0,0
61072,participants,0,0
61073,were,0,0
61074,primary,0,0
61075,antenatal,0,0
61076,care,0,0
61077,providers,0,0
61078,--,0,0
61079,family,0,0
61080,physicians,0,0
61081,",",0,0
61082,obstetricians,0,0
61083,",",0,0
61084,and,0,0
61085,midwives,0,0
61086,--,0,0
61087,from,0,0
61088,four,0,0
61089,diverse,0,0
61090,communities,0,0
61091,in,0,0
61092,Ontario,0,0
61093,.,0,0
61094,These,0,0
61095,providers,0,0
61096,were,0,0
61097,matched,1,0
61098,and,1,0
61099,then,1,0
61100,randomly,1,0
61101,allocated,1,0
61102,into,1,0
61103,the,1,0
61104,intervention,1,0
61105,group,1,0
61106,",",1,0
61107,who,1,0
61108,used,1,0
61109,the,1,0
61110,ALPHA,1,0
61111,form,1,0
61112,",",1,0
61113,or,1,0
61114,into,1,0
61115,the,1,0
61116,control,1,0
61117,group,1,0
61118,",",1,0
61119,who,1,1
61120,administered,1,1
61121,usual,1,1
61122,care,1,1
61123,.,1,0
61124,In,0,0
61125,total,0,0
61126,",",0,0
61127,227,0,0
61128,pregnant,0,0
61129,women,0,0
61130,were,0,0
61131,recruited,0,0
61132,:,0,0
61133,98,0,0
61134,in,0,0
61135,the,0,0
61136,ALPHA,1,0
61137,group,0,0
61138,and,0,0
61139,129,0,0
61140,in,0,0
61141,the,0,0
61142,control,0,0
61143,group,0,0
61144,.,0,0
61145,The,0,0
61146,data,0,0
61147,presented,0,0
61148,in,0,0
61149,this,0,0
61150,paper,0,0
61151,are,0,0
61152,from,0,0
61153,a,0,0
61154,secondary,0,0
61155,analysis,0,0
61156,focusing,0,0
61157,on,0,0
61158,PPD,0,0
61159,as,0,0
61160,the,0,0
61161,outcome,0,0
61162,.,0,0
61163,RESULTS,0,0
61164,Providers,0,0
61165,randomized,0,0
61166,to,0,0
61167,the,0,0
61168,ALPHA,0,0
61169,group,0,0
61170,identified,0,0
61171,a,0,0
61172,statistically,0,0
61173,significantly,0,0
61174,higher,0,0
61175,proportion,0,0
61176,of,0,0
61177,women,0,0
61178,with,0,0
61179,antenatal,0,0
61180,psychosocial,0,0
61181,risk,0,0
61182,factors,0,0
61183,for,0,0
61184,PPD,0,0
61185,(,0,0
61186,36,0,0
61187,%,0,0
61188,vs.,0,0
61189,26,0,0
61190,%,0,0
61191,),0,0
61192,and,0,0
61193,a,0,0
61194,significantly,0,0
61195,higher,0,0
61196,number,0,0
61197,of,0,0
61198,risk,0,0
61199,factors,0,0
61200,per,0,0
61201,woman,0,0
61202,compared,0,0
61203,with,0,0
61204,the,0,0
61205,control,0,0
61206,group,0,0
61207,(,0,0
61208,mean,0,0
61209,2.1,0,0
61210,vs.1.8,0,0
61211,),0,0
61212,(,0,0
61213,z,0,0
61214,=,0,0
61215,-1.96,0,0
61216,",",0,0
61217,P,0,0
61218,=,0,0
61219,0.05,0,0
61220,),0,0
61221,.,0,0
61222,Providers,0,0
61223,in,0,0
61224,the,0,0
61225,ALPHA,0,0
61226,group,0,0
61227,also,0,0
61228,identified,0,0
61229,significantly,0,0
61230,more,0,0
61231,women,0,0
61232,having,0,0
61233,a,0,0
61234,previous,0,0
61235,history,0,0
61236,of,0,0
61237,depression,0,1
61238,(,0,0
61239,16,0,0
61240,%,0,0
61241,vs.,0,0
61242,6,0,0
61243,%,0,0
61244,),0,0
61245,(,0,0
61246,chi2,0,0
61247,=,0,0
61248,5.243,0,0
61249,",",0,0
61250,df,0,0
61251,=,0,0
61252,1,0,0
61253,",",0,0
61254,P,0,0
61255,=,0,0
61256,0.03,0,0
61257,),0,0
61258,and,0,0
61259,[,0,1
61260,having,0,0
61261,],0,0
61262,witnessed,0,0
61263,or,0,0
61264,experienced,0,0
61265,abuse,0,0
61266,as,0,0
61267,a,0,0
61268,child,0,1
61269,(,0,0
61270,17,0,0
61271,%,0,0
61272,vs.,0,0
61273,3,0,0
61274,%,0,0
61275,),0,0
61276,(,0,0
61277,chi2,0,0
61278,=,0,0
61279,12.488,0,0
61280,",",0,0
61281,df,0,0
61282,=,0,0
61283,1,0,0
61284,",",0,0
61285,P,0,0
61286,=,0,0
61287,0.0005,0,0
61288,),0,0
61289,",",0,0
61290,which,0,0
61291,are,0,0
61292,both,0,0
61293,established,0,0
61294,risk,0,0
61295,factors,0,0
61296,for,0,0
61297,PPD,0,0
61298,.,0,0
61299,CONCLUSION,0,0
61300,The,0,0
61301,ALPHA,1,0
61302,provides,0,0
61303,a,0,0
61304,systematic,0,0
61305,means,0,0
61306,of,0,0
61307,eliciting,0,0
61308,antenatal,0,0
61309,psychosocial,0,0
61310,risk,0,0
61311,factors,0,0
61312,for,0,0
61313,PPD,0,0
61314,for,0,0
61315,primary,0,0
61316,care,0,0
61317,providers,0,0
61318,",",0,0
61319,and,0,0
61320,it,0,0
61321,may,0,0
61322,be,0,0
61323,particularly,0,0
61324,useful,0,0
61325,for,0,0
61326,raising,0,0
61327,and,0,0
61328,discussing,0,0
61329,sensitive,0,0
61330,issues,0,0
61331,.,0,0
61332,The,0,0
61333,detection,0,0
61334,of,0,0
61335,depressive,0,0
61336,symptomatology,0,0
61337,during,0,0
61338,pregnancy,0,0
61339,remains,0,0
61340,problematic,0,0
61341,",",0,0
61342,however,0,0
61343,",",0,0
61344,and,0,0
61345,detection,0,0
61346,may,0,0
61347,be,0,0
61348,improved,0,0
61349,by,0,0
61350,administering,0,1
61351,a,0,0
61352,simple,0,0
61353,standardized,0,0
61354,measure,0,0
61355,of,0,0
61356,depressive,0,0
61357,symptomatology,0,0
61358,during,0,0
61359,routine,0,0
61360,antenatal,0,0
61361,care,0,0
61362,.,0,0
61363,Cognitive-behavioural,1,0
61364,stress,1,0
61365,management,1,0
61366,with,0,0
61367,HIV-positive,0,0
61368,homosexual,0,0
61369,men,0,0
61370,:,0,0
61371,mechanisms,0,0
61372,of,0,0
61373,sustained,0,0
61374,reductions,0,0
61375,in,0,0
61376,depressive,0,0
61377,symptoms,0,0
61378,.,0,0
61379,BACKGROUND,0,0
61380,We,0,0
61381,examined,0,0
61382,the,0,0
61383,sustained,0,0
61384,efficacy,0,0
61385,of,0,0
61386,a,0,0
61387,group-based,1,0
61388,cognitive-behavioural,1,0
61389,stress,1,0
61390,management,1,1
61391,(,1,1
61392,CBSM,1,1
61393,),1,1
61394,intervention,1,0
61395,in,0,0
61396,comparison,0,0
61397,to,0,0
61398,a,0,0
61399,modified,0,0
61400,wait-list,1,0
61401,control,1,0
61402,condition,1,0
61403,on,0,0
61404,measures,0,0
61405,of,0,0
61406,mood,0,0
61407,",",0,0
61408,coping,0,0
61409,and,0,0
61410,social,0,0
61411,support,0,0
61412,in,0,0
61413,mildly,0,0
61414,symptomatic,0,0
61415,HIV-positive,0,0
61416,homosexual,0,0
61417,and,0,0
61418,bisexual,0,0
61419,men,0,0
61420,.,0,0
61421,Participants,0,0
61422,were,0,0
61423,recruited,0,0
61424,largely,0,0
61425,during,0,0
61426,the,0,0
61427,era,0,0
61428,prior,0,0
61429,to,0,0
61430,highly,0,0
61431,active,0,0
61432,antiretroviral,0,1
61433,therapy,0,1
61434,(,0,1
61435,HAART,0,1
61436,;,0,1
61437,1992-1997,0,1
61438,),0,1
61439,.,0,0
61440,METHODS,0,0
61441,Men,0,0
61442,were,0,0
61443,randomized,0,0
61444,to,0,0
61445,either,0,0
61446,a,0,0
61447,10-week,0,0
61448,",",0,0
61449,group-based,0,0
61450,CBSM,1,1
61451,intervention,1,1
61452,(,0,0
61453,n,0,0
61454,=,0,0
61455,83,0,0
61456,),0,0
61457,or,0,0
61458,a,0,0
61459,psychoeducational,1,0
61460,seminar,1,1
61461,group,1,1
61462,(,0,0
61463,n,0,0
61464,=,0,0
61465,46,0,0
61466,),0,0
61467,.,0,0
61468,All,0,1
61469,participants,0,0
61470,completed,0,0
61471,a,0,0
61472,battery,1,0
61473,of,1,0
61474,psychosocial,1,1
61475,questionnaires,1,1
61476,administered,1,1
61477,by,1,0
61478,a,1,0
61479,research,1,0
61480,assistant,1,0
61481,at,1,0
61482,baseline,1,0
61483,",",1,0
61484,immediately,1,0
61485,following,1,0
61486,the,1,0
61487,10-week,1,0
61488,CBSM,1,1
61489,intervention,1,1
61490,period,1,0
61491,",",1,0
61492,and,1,0
61493,at,1,0
61494,a,1,0
61495,6-month,1,0
61496,follow-up,1,0
61497,.,1,0
61498,RESULTS,0,0
61499,Men,0,0
61500,in,0,0
61501,the,0,0
61502,CBSM,0,1
61503,group,0,0
61504,maintained,0,0
61505,previously,0,0
61506,observed,0,0
61507,effects,0,0
61508,on,0,0
61509,depressive,0,0
61510,symptoms,0,0
61511,and,0,0
61512,perceived,0,0
61513,social,0,0
61514,support,0,0
61515,.,0,0
61516,These,0,0
61517,sustained,0,0
61518,effects,0,0
61519,of,0,0
61520,CBSM,0,0
61521,on,0,0
61522,depressive,0,0
61523,symptoms,0,0
61524,were,0,0
61525,mediated,0,0
61526,by,0,0
61527,10-week,0,0
61528,increases,0,0
61529,in,0,0
61530,cognitive,0,0
61531,coping,0,1
61532,(,0,0
61533,i.e,0,0
61534,.,0,0
61535,positive,0,0
61536,reframing,0,0
61537,),0,0
61538,.,0,0
61539,DISCUSSION,0,0
61540,CBSM,0,0
61541,appears,0,0
61542,to,0,0
61543,be,0,0
61544,a,0,0
61545,potentially,0,0
61546,efficacious,0,0
61547,treatment,0,0
61548,that,0,0
61549,reduces,0,0
61550,and,0,0
61551,maintains,0,0
61552,lower,0,0
61553,levels,0,0
61554,of,0,0
61555,depressive,0,0
61556,symptoms,0,0
61557,and,0,0
61558,enhances,0,0
61559,social,0,0
61560,support,0,0
61561,in,0,0
61562,HIV-positive,0,0
61563,homosexual,0,0
61564,and,0,0
61565,bisexual,0,0
61566,men,0,0
61567,.,0,0
61568,In,0,0
61569,particular,0,0
61570,",",0,0
61571,changes,0,0
61572,in,0,0
61573,positive,0,0
61574,reframing,0,0
61575,during,0,0
61576,the,0,0
61577,10-week,0,0
61578,intervention,0,0
61579,period,0,0
61580,remain,0,0
61581,a,0,0
61582,crucial,0,0
61583,factor,0,0
61584,contributing,0,0
61585,to,0,0
61586,sustained,0,0
61587,reductions,0,0
61588,in,0,0
61589,depressive,0,0
61590,symptoms,0,0
61591,.,0,0
61592,[,0,1
61593,A,0,1
61594,randomized,0,1
61595,trial,0,0
61596,of,0,0
61597,PVB,1,0
61598,",",1,0
61599,VAB-6,1,1
61600,",",1,1
61601,BVP,1,1
61602,regimen,1,1
61603,versus,1,1
61604,PEB,1,1
61605,chemotherapy,1,0
61606,in,0,0
61607,patients,0,0
61608,with,0,0
61609,disseminated,0,0
61610,testicular,0,1
61611,tumors,0,1
61612,],0,0
61613,.,0,0
61614,During,0,0
61615,2,0,0
61616,years,0,0
61617,and,0,0
61618,7,0,0
61619,months,0,0
61620,from,0,0
61621,June,0,0
61622,",",0,0
61623,1985,0,0
61624,to,0,0
61625,December,0,0
61626,",",0,0
61627,1987,0,0
61628,",",0,0
61629,a,0,0
61630,randomized,0,0
61631,multi-center,0,0
61632,trial,0,0
61633,of,0,0
61634,PVB,1,0
61635,",",1,0
61636,VAB-6,1,1
61637,",",1,1
61638,BVP,1,1
61639,regimen,1,1
61640,(,0,1
61641,group,0,1
61642,A,0,1
61643,),0,1
61644,without,1,0
61645,etoposide,1,1
61646,versus,1,0
61647,PEB,1,1
61648,chemotherapy,1,1
61649,(,1,1
61650,bleomycin,1,1
61651,",",1,1
61652,etoposide,1,1
61653,and,1,1
61654,cisplatinum,1,1
61655,),1,1
61656,(,0,1
61657,group,0,1
61658,B,0,1
61659,),0,1
61660,was,0,0
61661,given,0,0
61662,to,0,0
61663,patients,0,0
61664,with,0,0
61665,disseminated,0,0
61666,testicular,0,0
61667,tumors,0,0
61668,.,0,0
61669,Of,0,0
61670,34,0,0
61671,patients,0,0
61672,registered,0,0
61673,",",0,0
61674,10,0,0
61675,patients,0,0
61676,were,0,0
61677,with,0,0
61678,minimal,0,0
61679,disease,0,0
61680,in,0,0
61681,stages,0,0
61682,IIA,0,0
61683,",",0,0
61684,IIIO,0,1
61685,and,0,0
61686,IIIA,0,1
61687,and,0,0
61688,24,0,0
61689,with,0,0
61690,extensive,0,0
61691,disease,0,0
61692,in,0,0
61693,IIB,0,0
61694,",",0,0
61695,IIIB2,0,1
61696,and,0,0
61697,IIIC,0,0
61698,.,0,0
61699,Seminomas,0,0
61700,were,0,0
61701,found,0,0
61702,in,0,0
61703,10,0,0
61704,patients,0,0
61705,",",0,0
61706,while,0,0
61707,non-seminomatous,0,0
61708,tumors,0,0
61709,in,0,0
61710,24,0,0
61711,.,0,0
61712,Among,0,0
61713,groups,0,0
61714,A,0,0
61715,and,0,0
61716,B,0,0
61717,",",0,0
61718,there,0,0
61719,was,0,0
61720,no,0,0
61721,statistical,0,0
61722,difference,0,0
61723,in,0,0
61724,clinicopathological,0,0
61725,profiles,0,0
61726,.,0,0
61727,A,0,0
61728,group,0,0
61729,patients,0,0
61730,were,0,0
61731,given,0,0
61732,either,0,0
61733,PVB,0,0
61734,",",0,0
61735,VAB-6,0,1
61736,or,0,0
61737,BVP,0,0
61738,according,0,0
61739,to,0,0
61740,the,0,0
61741,physician,0,0
61742,'s,0,0
61743,discretion,0,0
61744,.,0,0
61745,In,0,0
61746,groups,0,0
61747,A,0,0
61748,and,0,0
61749,B,0,0
61750,",",0,0
61751,35,0,0
61752,%,0,0
61753,and,0,0
61754,43,0,0
61755,%,0,0
61756,of,0,0
61757,the,0,0
61758,patients,0,0
61759,achieved,0,0
61760,complete,0,0
61761,response,0,0
61762,",",0,0
61763,and,0,0
61764,45,0,0
61765,%,0,0
61766,and,0,0
61767,50,0,0
61768,%,0,0
61769,achieved,0,0
61770,partial,0,0
61771,response,0,0
61772,",",0,0
61773,respectively,0,0
61774,.,0,0
61775,The,0,0
61776,difference,0,0
61777,in,0,0
61778,CR,0,0
61779,rates,0,0
61780,among,0,0
61781,both,0,0
61782,groups,0,0
61783,was,0,0
61784,not,0,0
61785,statistically,0,0
61786,significant,0,0
61787,even,0,0
61788,when,0,0
61789,calculated,0,0
61790,according,0,0
61791,to,0,0
61792,the,0,0
61793,stage,0,0
61794,or,0,0
61795,histologic,0,0
61796,grouping,0,0
61797,.,0,0
61798,Salvage,0,0
61799,treatments,0,0
61800,mainly,0,0
61801,with,0,0
61802,surgical,0,0
61803,resection,0,0
61804,of,0,0
61805,residual,0,0
61806,tumors,0,0
61807,after,0,0
61808,the,0,0
61809,chemotherapy,0,0
61810,",",0,0
61811,however,0,0
61812,",",0,0
61813,were,0,0
61814,more,0,0
61815,successful,0,0
61816,in,0,0
61817,group,0,0
61818,B,0,0
61819,(,0,0
61820,88,0,0
61821,%,0,0
61822,),0,0
61823,than,0,0
61824,group,0,0
61825,A,0,0
61826,(,0,0
61827,61,0,0
61828,%,0,0
61829,),0,0
61830,.,0,0
61831,It,0,0
61832,appears,0,0
61833,likely,0,0
61834,that,0,0
61835,the,0,0
61836,higher,0,0
61837,response,0,0
61838,of,0,0
61839,induction,0,0
61840,chemotherapy,1,0
61841,in,0,0
61842,patients,0,0
61843,with,0,0
61844,extensive,0,0
61845,disease,0,0
61846,made,0,0
61847,the,0,0
61848,salvage,0,0
61849,surgery,1,0
61850,more,0,0
61851,successful,0,0
61852,in,0,0
61853,group,0,0
61854,B,0,0
61855,than,0,0
61856,in,0,0
61857,group,0,0
61858,A,0,0
61859,.,0,0
61860,The,0,0
61861,3,0,0
61862,year,0,0
61863,survival,0,0
61864,rate,0,0
61865,was,0,0
61866,100,0,0
61867,%,0,0
61868,in,0,0
61869,group,0,0
61870,B,0,0
61871,",",0,0
61872,whereas,0,0
61873,it,0,0
61874,was,0,0
61875,76,0,0
61876,%,0,0
61877,in,0,0
61878,group,0,0
61879,A,0,0
61880,.,0,0
61881,Although,0,0
61882,the,0,0
61883,incidence,0,0
61884,of,0,0
61885,myelosuppression,0,1
61886,and,0,0
61887,alopecia,0,0
61888,was,0,0
61889,significantly,0,0
61890,higher,0,0
61891,in,0,0
61892,group,0,0
61893,B,0,0
61894,",",0,0
61895,neuropathy,0,0
61896,was,0,0
61897,significantly,0,0
61898,more,0,0
61899,frequent,0,0
61900,in,0,0
61901,group,0,0
61902,A,0,0
61903,.,0,0
61904,From,0,0
61905,the,0,0
61906,above,0,0
61907,results,0,0
61908,",",0,0
61909,PEB,0,0
61910,seems,0,0
61911,to,0,0
61912,be,0,0
61913,a,0,0
61914,better,0,0
61915,induction,0,0
61916,chemotherapy,0,0
61917,than,0,0
61918,the,0,0
61919,conventional,0,0
61920,one,0,0
61921,for,0,0
61922,advanced,0,0
61923,testicular,0,0
61924,tumors,0,0
61925,.,0,0
61926,Midazolam,1,1
61927,vs,1,1
61928,ondansetron,1,1
61929,for,0,0
61930,preventing,0,0
61931,postoperative,0,1
61932,nausea,0,1
61933,and,0,1
61934,vomiting,0,0
61935,:,0,0
61936,a,0,0
61937,randomised,0,0
61938,controlled,0,0
61939,trial,0,0
61940,.,0,0
61941,We,0,0
61942,compared,0,0
61943,the,0,0
61944,prophylactic,0,1
61945,anti-emetic,0,1
61946,efficacy,0,1
61947,of,0,1
61948,midazolam,1,1
61949,and,0,1
61950,ondansetron,1,1
61951,in,0,0
61952,90,0,0
61953,patients,0,0
61954,scheduled,0,0
61955,for,0,0
61956,minor,0,0
61957,gynaecological,0,1
61958,(,0,1
61959,hysteroscopy,0,1
61960,),0,1
61961,or,0,0
61962,urological,0,1
61963,(,0,1
61964,ureteroscopy,0,1
61965,),0,1
61966,procedures,0,0
61967,planned,0,0
61968,to,0,0
61969,last,0,0
61970,1-2,0,0
61971,h,0,1
61972,under,0,0
61973,sevoflurane,0,1
61974,anaesthesia,0,1
61975,with,0,0
61976,spontaneous,0,0
61977,ventilation,0,0
61978,of,0,0
61979,the,0,0
61980,lungs,0,0
61981,via,0,0
61982,a,0,0
61983,laryngeal,0,0
61984,mask,0,0
61985,airway,0,1
61986,.,0,1
61987,Midazolam,1,1
61988,2,1,1
61989,mg,1,1
61990,or,1,1
61991,ondansetron,1,1
61992,4,1,1
61993,mg,1,1
61994,were,0,1
61995,administered,0,1
61996,intravenously,0,1
61997,30,0,1
61998,min,0,0
61999,before,0,0
62000,the,0,0
62001,end,0,0
62002,of,0,0
62003,surgery,0,0
62004,.,0,0
62005,The,0,0
62006,proportions,0,0
62007,of,0,0
62008,patients,0,0
62009,who,0,0
62010,experienced,0,1
62011,postoperative,0,1
62012,nausea,0,1
62013,and,0,1
62014,vomiting,0,0
62015,in,0,0
62016,the,0,0
62017,first,0,0
62018,24,0,0
62019,h,0,0
62020,(,0,0
62021,30,0,0
62022,%,0,0
62023,and,0,0
62024,27,0,0
62025,%,0,0
62026,for,0,0
62027,the,0,0
62028,midazolam,1,1
62029,and,0,1
62030,ondansetron,1,1
62031,groups,0,0
62032,",",0,0
62033,respectively,0,0
62034,),0,0
62035,were,0,0
62036,similar,0,0
62037,in,0,0
62038,the,0,0
62039,two,0,0
62040,groups,0,0
62041,.,0,0
62042,The,0,0
62043,incidence,0,0
62044,of,0,0
62045,postoperative,0,1
62046,nausea,0,1
62047,and,0,1
62048,vomiting,0,0
62049,was,0,0
62050,significantly,0,0
62051,smaller,0,0
62052,in,0,0
62053,both,0,0
62054,groups,0,0
62055,than,0,0
62056,predicted,0,0
62057,according,0,0
62058,to,0,0
62059,the,0,0
62060,patients,0,0
62061,',0,0
62062,underlying,0,0
62063,risks,0,1
62064,(,1,1
62065,midazolam,1,1
62066,group,0,0
62067,:,0,0
62068,p,0,0
62069,=,0,0
62070,0.018,0,0
62071,;,0,0
62072,ondansetron,1,1
62073,group,0,0
62074,:,0,0
62075,p,0,0
62076,=,0,0
62077,0.017,0,0
62078,),0,0
62079,.,0,0
62080,There,0,0
62081,were,0,0
62082,no,0,0
62083,significant,0,0
62084,differences,0,0
62085,in,0,0
62086,average,0,0
62087,sedation,0,0
62088,scores,0,0
62089,or,0,0
62090,pain,0,0
62091,scores,0,0
62092,.,0,0
62093,Treatment,0,0
62094,using,0,0
62095,ondansetron,1,1
62096,for,0,1
62097,anti-emetic,0,1
62098,prophylaxis,0,1
62099,did,0,0
62100,not,0,0
62101,provide,0,0
62102,a,0,0
62103,superior,0,0
62104,benefit,0,0
62105,compared,0,0
62106,to,0,0
62107,midazolam,1,1
62108,in,0,0
62109,the,0,0
62110,present,0,0
62111,study,0,0
62112,.,0,0
62113,Assisted,1,0
62114,exercise,1,0
62115,and,0,0
62116,bone,0,0
62117,strength,0,1
62118,in,0,0
62119,preterm,0,0
62120,infants,0,0
62121,.,0,0
62122,Studies,0,0
62123,have,0,0
62124,previously,0,0
62125,demonstrated,0,0
62126,that,0,0
62127,brief,0,1
62128,(,0,0
62129,4,0,0
62130,weeks,0,0
62131,),0,0
62132,passive,0,0
62133,range-of-motion,0,0
62134,exercise,1,0
62135,is,0,0
62136,beneficial,0,0
62137,for,0,0
62138,bone,0,0
62139,development,0,0
62140,in,0,0
62141,very,0,0
62142,low,0,0
62143,birth,0,0
62144,weight,0,1
62145,(,0,1
62146,VLBW,0,1
62147,),0,1
62148,preterm,0,0
62149,infants,0,0
62150,.,0,0
62151,However,0,0
62152,",",0,0
62153,the,0,0
62154,optimal,0,0
62155,duration,0,0
62156,of,0,0
62157,exercise,0,0
62158,for,0,0
62159,bone,0,0
62160,development,0,0
62161,in,0,0
62162,preterm,0,0
62163,infants,0,0
62164,is,0,0
62165,yet,0,0
62166,unknown,0,0
62167,.,0,0
62168,The,0,0
62169,aim,0,0
62170,of,0,0
62171,the,0,0
62172,present,0,0
62173,study,0,0
62174,was,0,0
62175,to,0,0
62176,examine,0,0
62177,the,0,0
62178,effect,0,0
62179,of,0,0
62180,8,0,0
62181,weeks,0,0
62182,of,0,0
62183,assisted,1,0
62184,exercise,1,0
62185,on,0,0
62186,bone,0,0
62187,strength,0,0
62188,and,0,0
62189,metabolism,0,0
62190,in,0,0
62191,VLBW,0,0
62192,premature,0,0
62193,infants,0,0
62194,.,0,0
62195,Sixteen,0,0
62196,infants,0,0
62197,(,0,0
62198,mean,0,0
62199,+/-,0,0
62200,standard,0,0
62201,error,0,0
62202,of,0,0
62203,the,0,0
62204,mean,0,0
62205,birth,0,0
62206,weight,0,0
62207,"1,009",0,0
62208,+/-,0,0
62209,55,0,0
62210,g,0,0
62211,and,0,0
62212,gestational,0,0
62213,age,0,0
62214,27.3,0,0
62215,+/-,0,0
62216,0.3,0,0
62217,weeks,0,0
62218,),0,0
62219,were,0,0
62220,randomly,0,0
62221,assigned,0,0
62222,into,0,0
62223,exercise,0,1
62224,(,0,0
62225,n,0,0
62226,=,0,0
62227,8,0,0
62228,),0,0
62229,and,0,0
62230,control,1,0
62231,(,0,0
62232,n,0,0
62233,=,0,0
62234,8,0,0
62235,),0,0
62236,groups,0,0
62237,.,0,0
62238,The,0,0
62239,intervention,0,0
62240,started,0,0
62241,at,0,0
62242,the,0,0
62243,first,0,0
62244,week,0,0
62245,of,0,0
62246,life,0,0
62247,and,0,0
62248,involved,0,0
62249,8,0,0
62250,weeks,0,0
62251,of,0,0
62252,daily,1,1
62253,passive,1,0
62254,extension,1,0
62255,and,1,0
62256,flexion,1,0
62257,range-of-motion,1,0
62258,exercise,1,0
62259,of,0,0
62260,the,0,0
62261,upper,0,0
62262,and,0,0
62263,lower,0,0
62264,extremities,0,0
62265,.,0,0
62266,Biochemical,0,0
62267,markers,0,0
62268,of,0,0
62269,bone,0,0
62270,turnover,0,0
62271,were,0,0
62272,measured,0,0
62273,at,0,0
62274,enrollment,0,0
62275,and,0,0
62276,after,0,0
62277,8,0,0
62278,weeks,0,0
62279,.,0,1
62280,Bone,0,1
62281,strength,0,1
62282,was,0,0
62283,measured,0,0
62284,weekly,0,0
62285,by,0,0
62286,quantitative,0,0
62287,ultrasound,0,0
62288,measurement,0,0
62289,of,0,0
62290,tibial,0,0
62291,bone,0,0
62292,speed,0,0
62293,of,0,0
62294,sound,0,1
62295,(,0,1
62296,SOS,0,1
62297,),0,1
62298,.,0,1
62299,Bone,0,1
62300,SOS,0,1
62301,decreased,0,0
62302,significantly,0,0
62303,in,0,0
62304,the,0,0
62305,control,0,0
62306,group,0,0
62307,(,0,0
62308,-108.1,0,0
62309,+/-,0,0
62310,33.7,0,0
62311,m/second,0,0
62312,",",0,0
62313,P,0,0
62314,<,0,0
62315,0.0001,0,0
62316,),0,0
62317,during,0,0
62318,the,0,0
62319,study,0,0
62320,period,0,0
62321,",",0,0
62322,while,0,0
62323,remaining,0,0
62324,stable,0,0
62325,in,0,0
62326,the,0,0
62327,exercise,0,1
62328,group,0,0
62329,(,0,0
62330,11.3,0,0
62331,+/-,0,0
62332,22.8,0,0
62333,m/second,0,0
62334,),0,0
62335,.,0,0
62336,The,0,0
62337,main,0,0
62338,beneficial,0,0
62339,effect,0,0
62340,of,0,0
62341,exercise,0,0
62342,occurred,0,0
62343,in,0,0
62344,the,0,0
62345,first,0,0
62346,4,0,0
62347,weeks,0,0
62348,of,0,0
62349,the,0,0
62350,intervention,0,0
62351,.,0,0
62352,There,0,0
62353,were,0,0
62354,no,0,0
62355,significant,0,0
62356,differences,0,0
62357,in,0,0
62358,the,0,0
62359,bone,0,0
62360,turnover,0,0
62361,marker,0,0
62362,changes,0,0
62363,between,0,0
62364,the,0,0
62365,groups,0,0
62366,.,0,0
62367,There,0,0
62368,is,0,0
62369,a,0,0
62370,significant,0,0
62371,postnatal,0,0
62372,decrease,0,0
62373,in,0,0
62374,bone,0,0
62375,SOS,0,0
62376,in,0,0
62377,VLBW,0,1
62378,preterm,0,0
62379,infants,0,0
62380,.,0,0
62381,Eight,0,0
62382,weeks,0,0
62383,of,0,0
62384,assisted,0,0
62385,range-of-motion,0,0
62386,exercise,1,0
62387,attenuates,0,0
62388,the,0,0
62389,decrease,0,0
62390,in,0,0
62391,bone,0,0
62392,strength,0,0
62393,and,0,0
62394,may,0,0
62395,decrease,0,0
62396,the,0,0
62397,risk,0,0
62398,of,0,0
62399,osteopenia,0,0
62400,in,0,0
62401,premature,0,0
62402,infants,0,0
62403,.,0,0
62404,A,0,0
62405,comparison,0,0
62406,of,0,0
62407,three,0,0
62408,highly,0,0
62409,active,0,0
62410,antiretroviral,0,1
62411,treatment,0,1
62412,strategies,0,0
62413,consisting,0,0
62414,of,0,0
62415,non-nucleoside,1,1
62416,reverse,1,1
62417,transcriptase,1,1
62418,inhibitors,1,1
62419,",",1,1
62420,protease,1,0
62421,inhibitors,1,1
62422,",",1,0
62423,or,1,0
62424,both,1,0
62425,in,1,0
62426,the,1,0
62427,presence,1,0
62428,of,1,0
62429,nucleoside,1,1
62430,reverse,1,1
62431,transcriptase,1,1
62432,inhibitors,1,1
62433,as,0,0
62434,initial,0,0
62435,therapy,0,0
62436,(,0,0
62437,CPCRA,0,0
62438,058,0,0
62439,FIRST,0,0
62440,Study,0,0
62441,),0,0
62442,:,0,0
62443,a,0,0
62444,long-term,0,0
62445,randomised,0,0
62446,trial,0,0
62447,.,0,0
62448,BACKGROUND,0,0
62449,Long-term,0,0
62450,data,0,0
62451,from,0,0
62452,randomised,0,0
62453,trials,0,0
62454,on,0,0
62455,the,0,0
62456,consequences,0,0
62457,of,0,0
62458,treatment,0,0
62459,with,0,0
62460,a,0,0
62461,protease,1,0
62462,inhibitor,1,1
62463,(,1,1
62464,PI,1,1
62465,),1,1
62466,",",1,0
62467,non-nucleoside,1,1
62468,reverse,1,1
62469,transcriptase,1,1
62470,inhibitor,1,1
62471,(,1,1
62472,NNRTI,1,1
62473,),1,1
62474,",",1,0
62475,or,1,0
62476,both,1,0
62477,are,1,0
62478,lacking,1,0
62479,.,1,0
62480,Here,0,0
62481,",",0,0
62482,we,0,0
62483,report,0,0
62484,results,0,0
62485,from,0,0
62486,the,0,0
62487,FIRST,0,0
62488,trial,0,0
62489,",",0,0
62490,which,0,0
62491,compared,0,0
62492,initial,0,0
62493,treatment,0,0
62494,strategies,0,0
62495,for,0,0
62496,clinical,0,0
62497,",",0,0
62498,immunological,0,0
62499,",",0,0
62500,and,0,0
62501,virological,0,0
62502,outcomes,0,0
62503,.,0,0
62504,METHODS,0,0
62505,Between,0,0
62506,1999,0,0
62507,and,0,0
62508,2002,0,0
62509,",",0,0
62510,1397,0,0
62511,antiretroviral-treatment-naive,0,0
62512,patients,0,0
62513,",",0,0
62514,presenting,0,0
62515,at,0,0
62516,18,0,0
62517,clinical,0,0
62518,trial,0,0
62519,units,0,0
62520,with,0,0
62521,80,0,0
62522,research,0,0
62523,sites,0,0
62524,in,0,0
62525,the,0,0
62526,USA,0,0
62527,",",0,0
62528,were,0,0
62529,randomly,0,0
62530,assigned,0,0
62531,in,0,0
62532,a,0,0
62533,ratio,0,0
62534,of,0,0
62535,1:1:1,0,1
62536,to,0,0
62537,a,0,0
62538,protease,1,0
62539,inhibitor,1,1
62540,(,1,1
62541,PI,1,1
62542,),1,1
62543,strategy,1,0
62544,(,1,0
62545,PI,1,1
62546,plus,1,0
62547,nucleoside,1,1
62548,reverse,1,1
62549,transcriptase,1,1
62550,inhibitor,1,1
62551,[,1,1
62552,NRTI,1,1
62553,],1,1
62554,;,1,0
62555,n=470,0,0
62556,),0,0
62557,",",0,0
62558,a,1,0
62559,non-nucleoside,1,1
62560,reverse,1,1
62561,transcriptase,1,1
62562,inhibitor,1,1
62563,(,1,1
62564,NNRTI,1,1
62565,),1,1
62566,strategy,1,0
62567,(,1,0
62568,NNRTI,1,0
62569,plus,1,0
62570,NRTI,1,0
62571,;,1,0
62572,n=463,0,0
62573,),0,0
62574,",",0,0
62575,or,1,0
62576,a,1,0
62577,three-class,1,0
62578,strategy,1,0
62579,(,1,0
62580,PI,1,0
62581,plus,1,0
62582,NNRTI,1,0
62583,plus,1,0
62584,NRTI,1,0
62585,;,1,0
62586,n=464,0,0
62587,),0,0
62588,.,0,0
62589,Primary,0,0
62590,endpoints,0,0
62591,were,0,0
62592,a,0,0
62593,composite,0,0
62594,of,0,0
62595,an,0,0
62596,AIDS-defining,0,0
62597,event,0,0
62598,",",0,0
62599,death,0,0
62600,",",0,0
62601,or,0,0
62602,CD4,0,0
62603,cell,0,0
62604,count,0,0
62605,decline,0,0
62606,to,0,0
62607,less,0,0
62608,than,0,0
62609,200,0,0
62610,cells,0,0
62611,per,0,0
62612,mm3,0,0
62613,for,0,0
62614,the,0,0
62615,PI,0,1
62616,versus,0,0
62617,NNRTI,0,0
62618,comparison,0,0
62619,",",0,0
62620,and,0,0
62621,average,0,0
62622,change,0,0
62623,in,0,0
62624,CD4,0,0
62625,cell,0,0
62626,count,0,0
62627,at,0,0
62628,or,0,0
62629,after,0,0
62630,32,0,0
62631,months,0,0
62632,for,0,0
62633,the,0,0
62634,three-class,0,0
62635,versus,0,0
62636,combined,0,0
62637,two-class,0,0
62638,comparison,0,0
62639,.,0,0
62640,Analyses,0,0
62641,were,0,0
62642,by,0,0
62643,intention-to-treat,0,0
62644,.,0,0
62645,This,0,0
62646,study,0,0
62647,is,0,0
62648,registered,0,0
62649,ClinicalTrials.gov,0,0
62650,",",0,0
62651,number,0,0
62652,NCT00000922,0,0
62653,.,0,0
62654,FINDINGS,0,0
62655,1397,0,0
62656,patients,0,0
62657,were,0,0
62658,assessed,0,0
62659,for,0,0
62660,the,0,0
62661,composite,0,0
62662,endpoint,0,0
62663,.,0,0
62664,A,0,0
62665,total,0,0
62666,of,0,0
62667,388,0,0
62668,participants,0,0
62669,developed,0,0
62670,the,0,0
62671,composite,0,0
62672,endpoint,0,0
62673,",",0,0
62674,302,0,0
62675,developed,0,0
62676,AIDS,0,0
62677,or,0,0
62678,died,0,0
62679,",",0,0
62680,and,0,0
62681,188,0,0
62682,died,0,0
62683,.,0,0
62684,NNRTI,0,0
62685,versus,0,0
62686,PI,0,0
62687,hazard,0,1
62688,ratios,0,0
62689,(,0,0
62690,HRs,0,1
62691,),0,0
62692,for,0,0
62693,the,0,0
62694,composite,0,0
62695,endpoint,0,0
62696,",",0,0
62697,for,0,0
62698,AIDS,0,0
62699,or,0,0
62700,death,0,0
62701,",",0,0
62702,for,0,0
62703,death,0,0
62704,",",0,0
62705,and,0,0
62706,for,0,0
62707,virological,0,0
62708,failure,0,0
62709,were,0,0
62710,1.02,0,0
62711,(,0,0
62712,95,0,0
62713,%,0,0
62714,CI,0,0
62715,0.79-1.31,0,0
62716,),0,0
62717,",",0,0
62718,1.07,0,0
62719,(,0,0
62720,0.80-1.41,0,0
62721,),0,0
62722,",",0,0
62723,0.95,0,0
62724,(,0,0
62725,0.66-1.37,0,0
62726,),0,0
62727,",",0,0
62728,and,0,0
62729,0.66,0,0
62730,(,0,0
62731,0.56-0.78,0,0
62732,),0,0
62733,",",0,0
62734,respectively,0,0
62735,.,0,0
62736,1196,0,0
62737,patients,0,0
62738,were,0,0
62739,assessed,0,0
62740,for,0,0
62741,the,0,0
62742,three-class,0,0
62743,versus,0,0
62744,combined,0,0
62745,two-class,0,0
62746,primary,0,0
62747,endpoint,0,0
62748,.,0,0
62749,Mean,0,0
62750,change,0,0
62751,in,0,0
62752,CD4,0,0
62753,cell,0,0
62754,count,0,0
62755,at,0,0
62756,or,0,0
62757,after,0,0
62758,32,0,0
62759,months,0,0
62760,was,0,0
62761,+234,0,0
62762,cells,0,0
62763,per,0,0
62764,mm3,0,0
62765,and,0,0
62766,+227,0,0
62767,cells,0,0
62768,per,0,0
62769,mm3,0,0
62770,for,0,0
62771,the,0,0
62772,three-class,0,0
62773,and,0,0
62774,the,0,0
62775,combined,0,0
62776,two-class,0,0
62777,strategies,0,0
62778,(,0,0
62779,p=0.62,0,0
62780,),0,0
62781,",",0,0
62782,respectively,0,0
62783,.,0,0
62784,HRs,0,0
62785,(,0,0
62786,three-class,0,0
62787,vs,0,0
62788,combined,0,0
62789,two-class,0,0
62790,),0,0
62791,for,0,0
62792,AIDS,0,1
62793,or,0,0
62794,death,0,0
62795,and,0,0
62796,virological,0,0
62797,failure,0,0
62798,were,0,0
62799,1.15,0,0
62800,(,0,0
62801,0.91-1.45,0,0
62802,),0,0
62803,and,0,0
62804,0.87,0,0
62805,(,0,0
62806,0.75-1.00,0,0
62807,),0,0
62808,",",0,0
62809,respectively,0,0
62810,.,0,0
62811,HRs,0,0
62812,(,0,0
62813,three-class,0,0
62814,vs,0,0
62815,combined,0,0
62816,two-class,0,0
62817,),0,0
62818,for,0,0
62819,AIDS,0,1
62820,or,0,0
62821,death,0,0
62822,were,0,0
62823,similar,0,0
62824,for,0,0
62825,participants,0,0
62826,with,0,0
62827,baseline,0,0
62828,CD4,0,0
62829,cell,0,0
62830,counts,0,0
62831,of,0,0
62832,200,0,0
62833,cells,0,0
62834,per,0,0
62835,mm3,0,0
62836,or,0,0
62837,less,0,0
62838,and,0,0
62839,of,0,0
62840,more,0,0
62841,than,0,0
62842,200,0,0
62843,cells,0,0
62844,per,0,0
62845,mm3,0,0
62846,(,0,0
62847,p=0.38,0,0
62848,for,0,0
62849,interaction,0,0
62850,),0,0
62851,",",0,0
62852,and,0,0
62853,for,0,0
62854,participants,0,0
62855,with,0,0
62856,baseline,0,0
62857,HIV,0,0
62858,RNA,0,1
62859,concentrations,0,1
62860,less,0,0
62861,than,0,0
62862,100,0,0
62863,000,0,0
62864,copies,0,0
62865,per,0,0
62866,mL,0,0
62867,and,0,0
62868,"100,000",0,0
62869,copies,0,0
62870,per,0,0
62871,mL,0,0
62872,or,0,0
62873,more,0,0
62874,(,0,0
62875,p=0.26,0,0
62876,for,0,0
62877,interaction,0,0
62878,),0,0
62879,.,0,0
62880,Participants,0,0
62881,assigned,0,0
62882,the,0,0
62883,three-class,0,0
62884,strategy,0,0
62885,were,0,0
62886,significantly,0,0
62887,more,0,0
62888,likely,0,0
62889,to,0,0
62890,discontinue,0,0
62891,treatment,0,0
62892,because,0,0
62893,of,0,0
62894,toxic,0,0
62895,effects,0,0
62896,than,0,0
62897,were,0,0
62898,those,0,0
62899,assigned,0,0
62900,to,0,0
62901,the,0,0
62902,two-class,0,0
62903,strategies,0,1
62904,(,0,0
62905,HR,0,0
62906,1.58,0,0
62907,;,0,0
62908,p,0,0
62909,<,0,0
62910,0.0001,0,0
62911,),0,0
62912,.,0,0
62913,INTERPRETATION,0,0
62914,Initial,0,0
62915,treatment,0,0
62916,with,0,0
62917,either,0,0
62918,an,0,0
62919,NNRTI-based,1,1
62920,regimen,1,1
62921,or,0,0
62922,a,0,0
62923,PI-based,1,0
62924,regimen,1,1
62925,",",0,0
62926,but,0,0
62927,not,0,0
62928,both,0,0
62929,together,0,0
62930,",",0,0
62931,is,0,0
62932,a,0,0
62933,good,0,0
62934,strategy,0,0
62935,for,0,0
62936,long-term,0,1
62937,antiretroviral,0,1
62938,management,0,1
62939,in,0,0
62940,treatment-naive,0,0
62941,patients,0,0
62942,with,0,0
62943,HIV,0,0
62944,.,0,0
62945,Comparison,0,0
62946,of,0,0
62947,7-day,1,1
62948,and,1,1
62949,14-day,1,1
62950,proton,1,1
62951,pump,1,1
62952,inhibitor-containing,1,0
62953,triple,1,0
62954,therapy,1,0
62955,for,0,0
62956,Helicobacter,0,1
62957,pylori,0,1
62958,eradication,0,1
62959,:,0,0
62960,neither,0,0
62961,treatment,0,0
62962,duration,0,0
62963,provides,0,0
62964,acceptable,0,0
62965,eradication,0,0
62966,rate,0,0
62967,in,0,0
62968,Korea,0,0
62969,.,0,0
62970,BACKGROUND,0,0
62971,AND,0,0
62972,AIMS,0,0
62973,Although,0,0
62974,triple,1,0
62975,combination,1,0
62976,therapy,1,0
62977,containing,0,0
62978,a,1,0
62979,proton,1,0
62980,pump,1,1
62981,inhibitor,1,1
62982,(,1,1
62983,PPI,1,1
62984,),1,1
62985,and,0,0
62986,two,1,0
62987,antibiotics,1,1
62988,is,0,0
62989,considered,0,0
62990,as,0,0
62991,a,0,0
62992,standard,0,0
62993,regimen,0,1
62994,for,0,0
62995,the,0,0
62996,first-line,0,1
62997,anti-Helicobacter,0,1
62998,pylori,0,1
62999,treatment,0,0
63000,",",0,0
63001,there,0,0
63002,are,0,0
63003,still,0,0
63004,debates,0,0
63005,on,0,0
63006,the,0,0
63007,ideal,0,0
63008,duration,0,0
63009,of,0,0
63010,treatment,0,0
63011,.,0,0
63012,The,0,0
63013,aim,0,0
63014,of,0,0
63015,this,0,0
63016,study,0,0
63017,was,0,0
63018,to,0,0
63019,compare,0,0
63020,the,0,0
63021,efficacies,0,0
63022,of,0,0
63023,7-day,1,1
63024,and,1,1
63025,14-day,1,1
63026,PPI-containing,1,0
63027,triple,1,0
63028,therapy,1,0
63029,.,1,0
63030,MATERIALS,0,0
63031,AND,0,1
63032,METHODS,0,1
63033,This,0,0
63034,study,0,0
63035,was,0,0
63036,performed,0,0
63037,in,0,0
63038,a,0,0
63039,randomized,0,0
63040,",",0,0
63041,multicenter,0,0
63042,",",0,0
63043,prospective,0,0
63044,manner,0,0
63045,.,0,0
63046,After,0,0
63047,upper,1,0
63048,gastrointestinal,1,0
63049,endoscopy,1,0
63050,",",0,0
63051,H.,0,1
63052,pylori-infected,0,1
63053,patients,0,0
63054,with,0,0
63055,a,0,0
63056,gastric,0,0
63057,ulcer,0,0
63058,and/or,0,0
63059,a,0,0
63060,duodenal,0,0
63061,ulcer,0,0
63062,were,0,0
63063,randomly,0,0
63064,assigned,0,0
63065,to,0,0
63066,a,0,0
63067,PAC7,1,1
63068,group,0,1
63069,(,1,1
63070,omeprazole,1,1
63071,20,1,1
63072,mg,1,1
63073,or,1,1
63074,equivalent,1,0
63075,dose,1,1
63076,of,1,0
63077,other,1,0
63078,PPIs,1,1
63079,",",1,1
63080,amoxicillin,1,1
63081,1000,1,1
63082,mg,1,1
63083,",",1,1
63084,and,1,1
63085,clarithromycin,1,1
63086,500,1,1
63087,mg,1,1
63088,twice,1,1
63089,daily,1,1
63090,for,1,1
63091,7,1,1
63092,days,1,0
63093,),1,1
63094,or,0,0
63095,to,0,0
63096,a,0,0
63097,PAC14,1,1
63098,group,0,0
63099,(,1,0
63100,the,1,0
63101,same,1,0
63102,regimen,1,1
63103,as,1,0
63104,the,1,0
63105,PAC7,1,0
63106,group,1,0
63107,but,1,0
63108,for,1,0
63109,14,1,0
63110,days,1,0
63111,),1,1
63112,.,0,1
63113,H.,0,1
63114,pylori,0,0
63115,status,0,0
63116,was,0,0
63117,evaluated,0,0
63118,by,0,0
63119,(,0,0
63120,13,0,0
63121,),0,1
63122,C,0,1
63123,urea,0,1
63124,breath,0,1
63125,test,0,0
63126,5,0,0
63127,weeks,0,0
63128,after,0,0
63129,anti-ulcer,0,1
63130,treatment,0,0
63131,completion,0,1
63132,.,0,0
63133,RESULTS,0,0
63134,A,0,0
63135,total,0,0
63136,of,0,0
63137,598,0,0
63138,patients,0,0
63139,were,0,0
63140,enrolled,0,0
63141,;,0,0
63142,337,0,0
63143,were,0,0
63144,randomized,0,0
63145,to,0,0
63146,the,0,0
63147,PAC7,1,0
63148,group,0,0
63149,and,0,0
63150,261,0,0
63151,to,0,0
63152,the,0,0
63153,PAC14,1,0
63154,group,0,0
63155,.,0,0
63156,The,0,0
63157,two,0,0
63158,groups,0,0
63159,were,0,0
63160,comparable,0,0
63161,in,0,0
63162,terms,0,0
63163,of,0,0
63164,baseline,0,0
63165,characteristics,0,0
63166,.,0,0
63167,The,0,0
63168,eradication,0,0
63169,rates,0,0
63170,of,0,0
63171,the,0,0
63172,PAC7,1,0
63173,group,0,0
63174,were,0,0
63175,not,0,0
63176,inferior,0,0
63177,to,0,0
63178,those,0,0
63179,of,0,0
63180,the,0,0
63181,PAC14,1,0
63182,group,0,0
63183,in,0,0
63184,both,0,0
63185,intention-to-treat,0,0
63186,analysis,0,0
63187,(,0,0
63188,71.2,0,0
63189,%,0,0
63190,vs.,0,0
63191,75.5,0,0
63192,%,0,0
63193,),0,0
63194,and,0,0
63195,per-protocol,0,1
63196,analysis,0,0
63197,(,0,0
63198,83.6,0,0
63199,%,0,0
63200,vs.,0,0
63201,86.6,0,0
63202,%,0,0
63203,),0,0
63204,.,0,0
63205,Incidences,0,0
63206,of,0,0
63207,adverse,0,0
63208,events,0,0
63209,were,0,0
63210,comparable,0,0
63211,.,0,0
63212,CONCLUSIONS,0,0
63213,Although,0,0
63214,the,0,0
63215,7-day,1,1
63216,PPI-containing,1,0
63217,triple,1,0
63218,anti-H.,1,1
63219,pylori,1,1
63220,therapy,1,0
63221,is,0,0
63222,not,0,0
63223,inferior,0,0
63224,to,0,0
63225,the,0,0
63226,14-day,1,1
63227,therapy,0,1
63228,",",0,0
63229,neither,0,0
63230,treatment,0,0
63231,duration,0,0
63232,provides,0,0
63233,acceptable,0,0
63234,eradication,0,0
63235,rate,0,0
63236,reaching,0,0
63237,90,0,0
63238,%,0,0
63239,in,0,0
63240,per-protocol,0,0
63241,analysis,0,0
63242,.,0,0
63243,New,0,0
63244,combination,0,0
63245,regimen,0,1
63246,with,0,0
63247,higher,0,0
63248,efficacy,0,0
63249,should,0,0
63250,be,0,0
63251,developed,0,0
63252,as,0,0
63253,a,0,0
63254,first-line,0,0
63255,eradication,0,0
63256,therapy,0,0
63257,for,0,0
63258,H.,0,0
63259,pylori,0,0
63260,in,0,0
63261,Korea,0,0
63262,.,0,0
63263,Developmental,0,0
63264,disabilities,0,0
63265,modification,0,0
63266,of,0,0
63267,the,0,0
63268,Children,0,0
63269,'s,0,0
63270,Global,0,0
63271,Assessment,0,0
63272,Scale,0,0
63273,.,0,0
63274,BACKGROUND,0,0
63275,Interventions,1,0
63276,for,0,0
63277,pervasive,0,0
63278,developmental,0,0
63279,disorders,0,1
63280,(,0,1
63281,PDD,0,1
63282,),0,1
63283,aim,0,0
63284,to,0,0
63285,alleviate,0,0
63286,symptoms,0,0
63287,and,0,0
63288,improve,0,0
63289,functioning,0,0
63290,.,0,0
63291,To,0,0
63292,measure,0,0
63293,global,0,0
63294,functioning,0,0
63295,in,0,0
63296,treatment,0,0
63297,studies,0,0
63298,",",0,0
63299,the,0,0
63300,Children,0,0
63301,'s,0,0
63302,Global,0,0
63303,Assessment,0,0
63304,Scale,0,0
63305,was,0,0
63306,modified,0,0
63307,and,0,0
63308,psychometric,1,0
63309,properties,1,0
63310,of,1,0
63311,the,1,0
63312,revised,1,0
63313,version,1,0
63314,(,1,1
63315,DD-CGAS,1,1
63316,),1,0
63317,were,0,0
63318,assessed,0,0
63319,in,0,0
63320,children,0,0
63321,with,0,0
63322,PDD,0,0
63323,.,0,0
63324,METHODS,0,0
63325,Developmental,0,0
63326,disabilities-relevant,0,0
63327,descriptors,0,0
63328,were,0,0
63329,developed,0,0
63330,for,0,0
63331,the,0,0
63332,DD-CGAS,0,0
63333,",",0,0
63334,and,0,0
63335,administration,0,1
63336,procedures,0,1
63337,were,0,0
63338,established,0,0
63339,to,0,0
63340,enhance,0,0
63341,rater,0,0
63342,consistency,0,0
63343,.,0,0
63344,Ratings,0,0
63345,of,0,0
63346,clinical,0,0
63347,case,0,0
63348,vignettes,0,0
63349,were,0,0
63350,used,0,0
63351,to,0,0
63352,assess,0,0
63353,inter-rater,0,0
63354,reliability,0,0
63355,and,0,0
63356,temporal,0,0
63357,stability,0,0
63358,.,0,0
63359,Validity,0,0
63360,was,0,0
63361,assessed,0,0
63362,by,0,0
63363,correlating,0,0
63364,the,0,0
63365,DD-CGAS,0,0
63366,with,0,0
63367,measures,0,0
63368,of,0,0
63369,functioning,0,0
63370,and,0,0
63371,symptoms,0,0
63372,in,0,0
63373,83,0,0
63374,youngsters,0,0
63375,with,0,0
63376,PDD,0,0
63377,.,0,0
63378,Sensitivity,0,0
63379,to,0,0
63380,change,0,0
63381,was,0,0
63382,assessed,0,0
63383,by,0,0
63384,comparing,0,0
63385,change,0,0
63386,from,0,0
63387,baseline,0,0
63388,to,0,0
63389,post-treatment,0,0
63390,with,0,0
63391,change,0,0
63392,on,0,0
63393,the,0,0
63394,Aberrant,0,0
63395,Behavior,0,0
63396,Checklist-Irritability,0,0
63397,and,0,0
63398,Clinical,0,0
63399,Global,0,0
63400,Impressions-Improvement,0,0
63401,subscale,0,0
63402,scores,0,0
63403,in,0,0
63404,a,0,0
63405,subset,0,0
63406,of,0,0
63407,14,0,0
63408,children,0,0
63409,.,0,0
63410,RESULTS,0,0
63411,Inter-rater,0,1
63412,reliability,0,1
63413,(,0,0
63414,intraclass,0,0
63415,correlation,0,0
63416,coefficient,0,1
63417,[,0,1
63418,ICC,0,1
63419,],0,0
63420,=,0,0
63421,.79,0,0
63422,),0,0
63423,and,0,0
63424,temporal,0,0
63425,stability,0,0
63426,(,0,0
63427,average,0,0
63428,ICC,0,0
63429,=,0,0
63430,.86,0,0
63431,),0,0
63432,were,0,0
63433,excellent,0,0
63434,.,0,0
63435,The,0,0
63436,DD-CGAS,0,0
63437,scores,0,0
63438,correlated,0,0
63439,with,0,0
63440,measures,0,0
63441,of,0,0
63442,functioning,0,0
63443,and,0,0
63444,symptoms,0,0
63445,with,0,0
63446,moderate,0,0
63447,to,0,0
63448,large,0,0
63449,effect,0,0
63450,sizes,0,0
63451,.,0,0
63452,Changes,0,0
63453,on,0,0
63454,the,0,0
63455,DD-CGAS,0,0
63456,correlated,0,0
63457,with,0,0
63458,changes,0,0
63459,on,0,0
63460,the,0,0
63461,Aberrant,0,0
63462,Behavior,0,0
63463,Checklist-I,0,1
63464,(,0,0
63465,r,0,0
63466,=,0,0
63467,-.71,0,0
63468,),0,0
63469,and,0,0
63470,Global,0,0
63471,Impressions,0,1
63472,Scale-I,0,1
63473,(,0,0
63474,r,0,0
63475,=,0,0
63476,-.52,0,0
63477,),0,0
63478,.,0,0
63479,The,0,0
63480,pre-post,0,0
63481,DD-CGAS,0,0
63482,change,0,0
63483,had,0,0
63484,an,0,0
63485,effect,0,0
63486,size,0,0
63487,of,0,0
63488,.72,0,0
63489,.,0,0
63490,CONCLUSIONS,0,0
63491,The,0,0
63492,DD-CGAS,0,0
63493,is,0,0
63494,a,0,0
63495,reliable,0,0
63496,instrument,0,0
63497,with,0,0
63498,apparent,0,0
63499,convergent,0,0
63500,validity,0,0
63501,for,0,0
63502,measuring,0,0
63503,global,0,0
63504,functioning,0,0
63505,of,0,0
63506,children,0,0
63507,with,0,0
63508,PDD,0,0
63509,in,0,0
63510,treatment,0,0
63511,studies,0,0
63512,.,0,0
63513,Stage,0,0
63514,II,0,0
63515,carcinoma,0,0
63516,of,0,0
63517,the,0,0
63518,ovary,0,0
63519,:,0,0
63520,an,0,0
63521,analysis,0,0
63522,of,0,0
63523,survival,0,0
63524,after,0,0
63525,comprehensive,0,0
63526,surgical,1,0
63527,staging,1,1
63528,and,0,1
63529,adjuvant,1,1
63530,therapy,1,1
63531,.,1,0
63532,Ninety-three,0,0
63533,women,0,0
63534,with,0,0
63535,FIGO,0,0
63536,stage,0,0
63537,II,0,0
63538,epithelial,0,0
63539,ovarian,0,0
63540,carcinoma,0,0
63541,underwent,0,0
63542,comprehensive,0,0
63543,surgical,0,0
63544,staging,0,0
63545,and,0,0
63546,were,0,0
63547,randomized,0,0
63548,prospectively,0,0
63549,to,0,0
63550,therapy,0,0
63551,consisting,0,0
63552,of,0,0
63553,either,0,0
63554,intraperitoneal,1,1
63555,radioactive,1,1
63556,phosphorus,1,1
63557,or,1,1
63558,oral,1,1
63559,melphalan,1,1
63560,.,1,1
63561,No,0,1
63562,patient,0,0
63563,had,0,0
63564,gross,0,0
63565,residual,0,0
63566,disease,0,0
63567,at,0,0
63568,the,0,0
63569,time,0,0
63570,of,0,0
63571,randomization,0,0
63572,.,0,0
63573,Ten,0,0
63574,of,0,0
63575,the,0,0
63576,forty-five,0,0
63577,women,0,0
63578,treated,0,0
63579,with,0,0
63580,melphalan,1,1
63581,experienced,0,1
63582,severe,0,1
63583,bone,0,1
63584,marrow,0,0
63585,depression,0,0
63586,at,0,0
63587,some,0,0
63588,time,0,0
63589,during,0,0
63590,therapy,0,0
63591,and,0,0
63592,two,0,0
63593,women,0,0
63594,expired,0,0
63595,from,0,0
63596,leukemia,0,0
63597,.,0,0
63598,Four,0,0
63599,of,0,0
63600,the,0,0
63601,forty-eight,0,0
63602,women,0,0
63603,treated,0,0
63604,with,0,0
63605,intraperitoneal,1,1
63606,phosphorus,1,1
63607,required,0,1
63608,surgical,0,1
63609,reexploration,0,0
63610,for,0,0
63611,intestinal,0,0
63612,obstruction,0,0
63613,or,0,0
63614,bowel,0,0
63615,injury,0,0
63616,.,0,0
63617,Twenty-one,0,0
63618,women,0,0
63619,died,0,0
63620,of,0,0
63621,their,0,0
63622,disease,0,0
63623,.,0,0
63624,Survival,0,0
63625,was,0,0
63626,not,0,0
63627,statistically,0,0
63628,different,0,0
63629,between,0,0
63630,the,0,0
63631,two,0,0
63632,treatment,0,0
63633,arms,0,0
63634,.,0,0
63635,The,0,0
63636,5-year,0,0
63637,actuarial,0,0
63638,survival,0,0
63639,was,0,0
63640,78,0,0
63641,%,0,0
63642,.,0,0
63643,Injection,1,0
63644,sclerotherapy,1,0
63645,versus,1,0
63646,electrocoagulation,1,0
63647,in,0,0
63648,the,0,0
63649,management,0,0
63650,outcome,0,0
63651,of,0,0
63652,early,0,0
63653,haemorrhoids,0,0
63654,.,0,0
63655,OBJECTIVE,0,0
63656,To,0,0
63657,study,0,0
63658,the,0,0
63659,symptomatology,0,0
63660,of,0,0
63661,early,0,0
63662,hemorrhoids,0,0
63663,and,0,0
63664,to,0,0
63665,compare,0,0
63666,injection,1,1
63667,sclerotherapy,1,1
63668,(,1,1
63669,IS,1,1
63670,),1,1
63671,with,1,0
63672,electrocoagulation,1,1
63673,(,1,1
63674,EC,1,1
63675,),1,0
63676,in,0,0
63677,the,0,0
63678,management,0,0
63679,outcome,0,0
63680,of,0,0
63681,early,0,0
63682,haemorrhoids,0,0
63683,with,0,0
63684,respect,0,0
63685,to,0,0
63686,pain,0,0
63687,during,0,0
63688,the,0,0
63689,procedure,0,0
63690,",",0,0
63691,reduction,0,0
63692,in,0,0
63693,bleeding,0,0
63694,per,0,0
63695,rectum,0,0
63696,",",0,0
63697,and,0,0
63698,overall,0,0
63699,patient,0,0
63700,satisfaction,0,0
63701,score,0,0
63702,.,0,0
63703,METHODS,0,0
63704,A,0,0
63705,total,0,0
63706,of,0,0
63707,102,0,0
63708,patients,0,0
63709,were,0,0
63710,included,0,0
63711,in,0,0
63712,this,0,0
63713,experimental,0,0
63714,study,0,0
63715,at,0,0
63716,the,0,0
63717,POF,0,0
63718,Hospital,0,0
63719,",",0,0
63720,Wah,0,0
63721,Cantt,0,1
63722,from,0,0
63723,October,0,0
63724,2004,0,0
63725,to,0,0
63726,June,0,0
63727,2005,0,0
63728,.,0,0
63729,A,0,0
63730,detailed,0,0
63731,history,0,0
63732,was,0,0
63733,taken,0,0
63734,and,0,0
63735,proctoscopic,0,0
63736,examination,0,0
63737,was,0,0
63738,performed,0,0
63739,.,0,0
63740,Patients,0,0
63741,were,0,0
63742,then,0,0
63743,randomly,0,0
63744,divided,0,0
63745,into,0,0
63746,two,0,0
63747,groups,0,0
63748,(,0,0
63749,Lottery,0,0
63750,method,0,0
63751,),0,0
63752,.,0,0
63753,One,0,0
63754,group,0,0
63755,was,0,0
63756,subjected,0,0
63757,to,0,0
63758,EC,0,0
63759,and,0,0
63760,the,0,0
63761,other,0,0
63762,to,0,0
63763,IS,0,0
63764,.,0,0
63765,In,0,0
63766,the,0,0
63767,EC,0,0
63768,",",0,0
63769,using,0,0
63770,the,0,0
63771,EC,0,1
63772,machine,0,1
63773,(,0,0
63774,Wieda,0,1
63775,",",0,1
63776,China,0,1
63777,),0,0
63778,",",0,0
63779,direct,0,0
63780,current,0,0
63781,of,0,0
63782,10-20,0,0
63783,mA,0,0
63784,was,0,0
63785,applied,0,0
63786,in,0,0
63787,the,0,0
63788,submucosal,0,0
63789,plane,0,0
63790,of,0,0
63791,each,0,0
63792,pile,0,0
63793,core,0,0
63794,for,0,0
63795,5-7,0,0
63796,minutes,0,0
63797,.,0,0
63798,In,0,0
63799,the,0,0
63800,IS,0,1
63801,1-2,0,0
63802,ml,0,0
63803,of,0,0
63804,5,0,0
63805,%,0,0
63806,phenol,1,0
63807,in,1,0
63808,almond,1,1
63809,oil,1,1
63810,was,0,1
63811,injected,0,0
63812,in,0,0
63813,the,0,0
63814,same,0,0
63815,plane,0,0
63816,in,0,0
63817,each,0,0
63818,pile,0,0
63819,core,0,0
63820,.,0,0
63821,Pain,0,0
63822,during,0,0
63823,the,0,0
63824,procedure,0,0
63825,",",0,0
63826,reduction,0,0
63827,in,0,0
63828,bleeding,0,0
63829,per,0,0
63830,rectum,0,0
63831,and,0,0
63832,overall,0,0
63833,patient,0,0
63834,satisfaction,0,0
63835,",",0,0
63836,were,0,0
63837,studied,0,0
63838,as,0,0
63839,outcome,0,0
63840,measures,0,0
63841,.,0,0
63842,RESULTS,0,0
63843,The,0,0
63844,mean,0,0
63845,age,0,0
63846,of,0,0
63847,the,0,0
63848,patients,0,0
63849,was,0,0
63850,44,0,0
63851,years,0,0
63852,",",0,0
63853,86,0,0
63854,were,0,0
63855,males,0,0
63856,and,0,0
63857,16,0,0
63858,were,0,0
63859,females,0,0
63860,.,0,0
63861,Two,0,0
63862,thirds,0,0
63863,of,0,0
63864,the,0,0
63865,patients,0,0
63866,were,0,0
63867,having,0,0
63868,symptoms,0,0
63869,for,0,0
63870,more,0,0
63871,than,0,0
63872,6,0,0
63873,months,0,0
63874,.,0,0
63875,A,0,0
63876,third,0,0
63877,of,0,0
63878,patients,0,0
63879,had,0,0
63880,associated,0,0
63881,local,0,0
63882,pain,0,0
63883,while,0,0
63884,another,0,0
63885,third,0,0
63886,had,0,0
63887,associated,0,0
63888,mucous,0,0
63889,discharge,0,0
63890,.,0,0
63891,Chronic,0,0
63892,constipation,0,0
63893,was,0,0
63894,present,0,0
63895,in,0,0
63896,81,0,0
63897,%,0,0
63898,patients,0,0
63899,.,0,0
63900,Only,0,0
63901,24.5,0,0
63902,%,0,0
63903,of,0,0
63904,the,0,0
63905,patients,0,0
63906,had,0,0
63907,a,0,0
63908,positive,0,0
63909,family,0,0
63910,history,0,0
63911,of,0,0
63912,haemorrhoids,0,0
63913,.,0,0
63914,Patients,0,0
63915,in,0,0
63916,the,0,0
63917,electrocoagulation,0,0
63918,(,0,1
63919,EC,0,1
63920,),0,1
63921,group,0,0
63922,experienced,0,0
63923,more,0,0
63924,pain,0,0
63925,during,0,0
63926,the,0,0
63927,procedure,0,0
63928,than,0,0
63929,the,0,0
63930,injection,0,1
63931,sclerotherapy,1,1
63932,(,1,1
63933,IS,1,1
63934,),1,1
63935,group,0,0
63936,(,0,0
63937,P,0,0
63938,<,0,0
63939,0.000,0,0
63940,),0,0
63941,",",0,0
63942,but,0,0
63943,EC,0,0
63944,was,0,0
63945,significantly,0,0
63946,more,0,0
63947,effective,0,0
63948,than,0,0
63949,IS,0,0
63950,in,0,0
63951,terms,0,0
63952,of,0,0
63953,reducing,0,0
63954,the,0,0
63955,bleeding,0,0
63956,per,0,0
63957,rectum,0,0
63958,(,0,0
63959,P,0,0
63960,=,0,0
63961,0.039,0,0
63962,),0,0
63963,",",0,0
63964,and,0,0
63965,also,0,0
63966,significantly,0,0
63967,higher,0,0
63968,number,0,0
63969,of,0,0
63970,patients,0,0
63971,were,0,0
63972,fully,0,0
63973,satisfied,0,0
63974,with,0,0
63975,EC,0,0
63976,than,0,0
63977,with,0,0
63978,IS,0,0
63979,(,0,0
63980,P,0,0
63981,<,0,0
63982,0.04,0,0
63983,),0,0
63984,.,0,0
63985,CONCLUSION,0,0
63986,EC,0,0
63987,",",0,0
63988,although,0,0
63989,more,0,0
63990,painful,0,0
63991,",",0,0
63992,is,0,0
63993,a,0,0
63994,safe,0,0
63995,",",0,0
63996,more,0,0
63997,effective,0,0
63998,and,0,0
63999,a,0,0
64000,highly,0,0
64001,satisfying,0,0
64002,procedure,0,0
64003,for,0,0
64004,treating,0,0
64005,early,0,0
64006,hemorrhoids,0,0
64007,.,0,0
64008,Pathological,0,0
64009,features,0,0
64010,and,0,1
64011,inhaled,0,1
64012,corticosteroid,0,1
64013,response,0,1
64014,of,0,0
64015,eosinophilic,0,0
64016,and,0,0
64017,non-eosinophilic,0,0
64018,asthma,0,0
64019,.,0,0
64020,BACKGROUND,0,0
64021,Non-eosinophilic,0,0
64022,asthma,0,0
64023,is,0,0
64024,a,0,0
64025,potentially,0,0
64026,important,0,0
64027,clinicopathological,0,0
64028,phenotype,0,0
64029,since,0,0
64030,there,0,0
64031,is,0,0
64032,evidence,0,0
64033,that,0,0
64034,it,0,0
64035,responds,0,0
64036,poorly,0,0
64037,to,0,0
64038,inhaled,0,1
64039,corticosteroid,0,1
64040,therapy,0,1
64041,.,0,0
64042,However,0,0
64043,",",0,0
64044,little,0,0
64045,is,0,0
64046,known,0,0
64047,about,0,0
64048,the,0,0
64049,underlying,0,0
64050,airway,0,0
64051,immunopathology,0,0
64052,and,0,0
64053,there,0,0
64054,are,0,0
64055,no,0,0
64056,data,0,0
64057,from,0,0
64058,placebo-controlled,0,1
64059,studies,0,0
64060,examining,0,0
64061,the,0,0
64062,effect,0,0
64063,of,0,0
64064,inhaled,0,1
64065,corticosteroids,0,1
64066,.,0,1
64067,METHODS,0,1
64068,Airway,0,0
64069,immunopathology,0,0
64070,was,0,0
64071,investigated,0,0
64072,using,0,0
64073,induced,0,0
64074,sputum,0,0
64075,",",0,0
64076,bronchial,0,0
64077,biopsies,0,0
64078,",",0,0
64079,bronchial,0,0
64080,wash,0,0
64081,and,0,0
64082,bronchoalveolar,0,0
64083,lavage,0,0
64084,in,0,0
64085,12,0,0
64086,patients,0,0
64087,with,0,0
64088,symptomatic,0,0
64089,eosinophilic,0,0
64090,asthma,0,0
64091,",",0,0
64092,11,0,0
64093,patients,0,0
64094,with,0,0
64095,non-eosinophilic,0,0
64096,asthma,0,0
64097,and,0,0
64098,10,0,0
64099,healthy,0,0
64100,controls,0,0
64101,.,0,0
64102,The,0,0
64103,patients,0,0
64104,with,0,0
64105,non-eosinophilic,0,0
64106,asthma,0,0
64107,and,0,0
64108,6,0,0
64109,different,0,0
64110,patients,0,0
64111,with,0,0
64112,eosinophilic,0,0
64113,asthma,0,0
64114,entered,0,0
64115,a,0,0
64116,randomised,0,0
64117,",",0,0
64118,double-blind,0,1
64119,",",0,1
64120,placebo-controlled,1,1
64121,crossover,0,1
64122,study,0,0
64123,in,0,0
64124,which,0,0
64125,the,0,0
64126,effects,0,0
64127,of,0,0
64128,inhaled,1,1
64129,mometasone,1,1
64130,400,1,1
64131,microg,1,1
64132,once,0,1
64133,daily,0,1
64134,for,0,1
64135,8,0,0
64136,weeks,0,0
64137,on,0,0
64138,airway,0,0
64139,responsiveness,0,0
64140,and,0,0
64141,asthma,0,0
64142,quality,0,0
64143,of,0,0
64144,life,0,0
64145,were,0,0
64146,investigated,0,0
64147,.,0,0
64148,RESULTS,0,0
64149,Patients,0,0
64150,with,0,0
64151,non-eosinophilic,0,0
64152,asthma,0,0
64153,had,0,0
64154,absence,0,0
64155,of,0,0
64156,eosinophils,0,1
64157,in,0,0
64158,the,0,0
64159,mucosa,0,0
64160,(,0,0
64161,median,0,0
64162,4.4,0,0
64163,cells/mm,0,0
64164,(,0,0
64165,2,0,0
64166,),0,0
64167,vs,0,0
64168,23,0,0
64169,cells/mm,0,0
64170,(,0,0
64171,2,0,0
64172,),0,0
64173,in,0,0
64174,eosinophilic,0,0
64175,asthma,0,0
64176,and,0,0
64177,0,0,0
64178,cells/mm,0,0
64179,(,0,0
64180,2,0,0
64181,),0,0
64182,in,0,0
64183,normal,0,1
64184,controls,0,0
64185,;,0,0
64186,p,0,0
64187,=,0,0
64188,0.03,0,0
64189,),0,0
64190,and,0,0
64191,normal,0,0
64192,subepithelial,0,0
64193,layer,0,0
64194,thickness,0,0
64195,(,0,0
64196,5.8,0,0
64197,microm,0,0
64198,vs,0,0
64199,10.3,0,0
64200,microm,0,0
64201,in,0,0
64202,eosinophilic,0,0
64203,asthma,0,0
64204,and,0,0
64205,5.1,0,0
64206,microm,0,0
64207,in,0,0
64208,controls,0,0
64209,",",0,0
64210,p,0,0
64211,=,0,0
64212,0.002,0,0
64213,),0,0
64214,.,0,0
64215,Non-eosinophilic,0,0
64216,and,0,0
64217,eosinophilic,0,0
64218,asthma,0,0
64219,groups,0,0
64220,had,0,0
64221,increased,0,0
64222,mast,0,0
64223,cell,0,0
64224,numbers,0,0
64225,in,0,0
64226,the,0,0
64227,airway,0,0
64228,smooth,0,0
64229,muscle,0,0
64230,compared,0,0
64231,with,0,0
64232,normal,0,0
64233,controls,0,0
64234,(,0,0
64235,9,0,0
64236,vs,0,0
64237,8,0,0
64238,vs,0,0
64239,0,0,0
64240,cells/mm,0,0
64241,(,0,0
64242,2,0,0
64243,),0,0
64244,",",0,0
64245,p,0,0
64246,=,0,0
64247,0.016,0,0
64248,),0,0
64249,.,0,0
64250,Compared,0,0
64251,with,0,0
64252,placebo,0,1
64253,",",0,0
64254,8,0,0
64255,weeks,0,0
64256,of,0,0
64257,treatment,0,0
64258,with,0,1
64259,inhaled,0,1
64260,mometasone,0,1
64261,led,0,0
64262,to,0,0
64263,less,0,0
64264,improvement,0,0
64265,in,0,0
64266,methacholine,0,1
64267,PC,0,1
64268,(,0,1
64269,20,0,1
64270,),0,1
64271,(,0,0
64272,0.5,0,0
64273,vs,0,0
64274,5.5,0,0
64275,doubling,0,0
64276,concentrations,0,0
64277,",",0,0
64278,95,0,0
64279,%,0,0
64280,CI,0,0
64281,of,0,0
64282,difference,0,0
64283,1.1,0,0
64284,to,0,0
64285,9.1,0,0
64286,;,0,0
64287,p,0,0
64288,=,0,0
64289,0.018,0,0
64290,),0,0
64291,and,0,0
64292,asthma,0,0
64293,quality,0,0
64294,of,0,0
64295,life,0,0
64296,(,0,0
64297,0.2,0,0
64298,vs,0,0
64299,1.0,0,0
64300,points,0,0
64301,",",0,0
64302,95,0,0
64303,%,0,0
64304,CI,0,0
64305,of,0,0
64306,difference,0,0
64307,0.27,0,0
64308,to,0,0
64309,1.43,0,0
64310,;,0,0
64311,p,0,0
64312,=,0,0
64313,0.008,0,0
64314,),0,0
64315,.,0,0
64316,CONCLUSIONS,0,1
64317,Non-eosinophilic,0,0
64318,asthma,0,0
64319,represents,0,0
64320,a,0,0
64321,pathologically,0,0
64322,distinct,0,0
64323,disease,0,0
64324,phenotype,0,0
64325,which,0,0
64326,is,0,0
64327,characterised,0,0
64328,by,0,0
64329,the,0,0
64330,absence,0,0
64331,of,0,0
64332,airway,0,0
64333,eosinophilia,0,0
64334,",",0,0
64335,normal,0,0
64336,subepithelial,0,0
64337,layer,0,0
64338,thickness,0,0
64339,and,0,0
64340,a,0,0
64341,poor,0,0
64342,short-term,0,0
64343,response,0,0
64344,to,0,0
64345,treatment,0,0
64346,with,0,1
64347,inhaled,0,1
64348,corticosteroids,0,1
64349,.,0,1
64350,p16,1,1
64351,(,1,1
64352,INK4a,1,1
64353,),1,1
64354,Expression,1,0
64355,does,0,0
64356,not,0,0
64357,predict,0,0
64358,the,0,0
64359,outcome,0,0
64360,of,0,0
64361,cervical,0,0
64362,intraepithelial,0,0
64363,neoplasia,0,1
64364,grade,0,0
64365,2,0,0
64366,.,0,0
64367,Spontaneous,0,0
64368,regression,0,0
64369,of,0,0
64370,cervical,0,0
64371,intraepithelial,0,0
64372,neoplasia,0,1
64373,grade,0,1
64374,2,0,1
64375,(,0,1
64376,CIN2,0,1
64377,),0,1
64378,lesions,0,0
64379,has,0,0
64380,been,0,0
64381,recognized,0,0
64382,since,0,0
64383,1955,0,0
64384,",",0,0
64385,but,0,0
64386,predictors,0,0
64387,of,0,0
64388,this,0,0
64389,are,0,0
64390,poorly,0,0
64391,understood,0,0
64392,.,0,0
64393,Among,0,0
64394,the,0,0
64395,predictive,0,0
64396,markers,0,0
64397,studied,0,0
64398,",",0,0
64399,p16,1,1
64400,(,1,1
64401,INK4a,1,1
64402,),1,0
64403,has,0,0
64404,been,0,0
64405,suggested,0,0
64406,to,0,0
64407,be,0,0
64408,of,0,0
64409,some,0,0
64410,value,0,0
64411,in,0,0
64412,monitoring,0,0
64413,the,0,0
64414,diagnosis,0,0
64415,of,0,0
64416,CIN2,0,0
64417,.,0,0
64418,In,0,0
64419,this,0,0
64420,clinical,0,0
64421,trial,0,0
64422,",",0,0
64423,90,0,0
64424,Brazilian,0,0
64425,women,0,0
64426,",",0,0
64427,diagnosed,0,0
64428,to,0,0
64429,CIN2,0,0
64430,and,0,0
64431,high-risk,0,0
64432,human,0,0
64433,papillomavirus,0,0
64434,infection,0,0
64435,",",0,0
64436,were,0,0
64437,randomized,0,0
64438,into,0,0
64439,two,0,0
64440,groups,0,0
64441,of,0,0
64442,equal,0,0
64443,size,0,0
64444,:,0,0
64445,45,0,0
64446,women,0,0
64447,whose,0,0
64448,lesions,1,0
64449,were,1,0
64450,excised,1,0
64451,and,0,0
64452,45,0,0
64453,women,0,0
64454,subjected,0,0
64455,to,0,0
64456,prospective,1,0
64457,follow-up,1,0
64458,at,0,0
64459,3-month,0,0
64460,intervals,0,0
64461,at,0,0
64462,least,0,0
64463,for,0,0
64464,1,0,0
64465,year,0,0
64466,(,0,0
64467,mean,0,0
64468,6.8,0,0
64469,months,0,0
64470,),0,0
64471,.,0,1
64472,p16,1,1
64473,(,1,1
64474,INK4a,1,1
64475,),1,0
64476,expression,0,0
64477,was,0,0
64478,analyzed,0,0
64479,in,0,0
64480,paraffin-embedded,0,0
64481,sections,0,0
64482,using,0,0
64483,immunohistochemical,1,0
64484,staining,1,0
64485,.,1,0
64486,Among,0,0
64487,the,0,0
64488,45,0,0
64489,women,0,0
64490,in,0,0
64491,the,0,0
64492,follow-up,0,0
64493,group,0,0
64494,",",0,0
64495,42,0,0
64496,%,0,0
64497,experienced,0,0
64498,spontaneous,0,0
64499,regression,0,0
64500,",",0,0
64501,11,0,0
64502,%,0,0
64503,showed,0,0
64504,persistence,0,0
64505,",",0,0
64506,22,0,0
64507,%,0,0
64508,progressed,0,0
64509,to,0,0
64510,CIN3,0,0
64511,",",0,0
64512,and,0,0
64513,20,0,0
64514,%,0,0
64515,had,0,0
64516,partial,0,0
64517,regression,0,0
64518,to,0,0
64519,CIN1,0,0
64520,or,0,0
64521,ASCUS,0,1
64522,(,0,0
64523,atypical,0,0
64524,squamous,0,0
64525,cell,0,0
64526,undetermined,0,0
64527,signifiance,0,0
64528,),0,0
64529,.,0,0
64530,p16,1,1
64531,(,1,1
64532,INK4a,1,1
64533,),1,0
64534,expression,0,0
64535,was,0,0
64536,detected,0,0
64537,in,0,0
64538,68.9,0,0
64539,%,0,0
64540,of,0,0
64541,the,0,0
64542,patients,0,0
64543,.,0,0
64544,In,0,0
64545,univariate,0,0
64546,survival,0,1
64547,(,0,1
64548,Cox,0,1
64549,),0,0
64550,analysis,0,0
64551,",",0,0
64552,no,0,0
64553,significant,0,0
64554,difference,0,0
64555,in,0,0
64556,regression,0,0
64557,was,0,0
64558,obtained,0,0
64559,between,0,0
64560,p16,1,1
64561,(,1,1
64562,INK4a,1,1
64563,),1,1
64564,-negative,1,0
64565,and,1,0
64566,-positive,1,0
64567,CIN2,0,1
64568,lesions,0,1
64569,(,0,1
64570,adjusted,0,0
64571,HR,0,0
64572,=,0,0
64573,1.1,0,0
64574,;,0,0
64575,95,0,0
64576,%,0,0
64577,CI,0,0
64578,0.6-2.0,0,0
64579,),0,0
64580,.,0,0
64581,In,0,0
64582,conclusion,0,0
64583,",",0,0
64584,p16,1,1
64585,(,1,1
64586,INK4a,1,1
64587,),1,0
64588,expression,0,0
64589,could,0,0
64590,be,0,0
64591,useful,0,0
64592,in,0,0
64593,the,0,0
64594,diagnosis,0,0
64595,of,0,0
64596,CIN2,0,0
64597,.,0,0
64598,However,0,0
64599,",",0,0
64600,it,0,0
64601,failed,0,0
64602,to,0,0
64603,predict,0,0
64604,the,0,0
64605,outcome,0,0
64606,of,0,0
64607,CIN2,0,0
64608,.,0,0
64609,Because,0,0
64610,of,0,0
64611,its,0,0
64612,high,0,0
64613,spontaneous,0,0
64614,regression,0,0
64615,rate,0,0
64616,",",0,0
64617,follow-up,0,0
64618,could,0,0
64619,be,0,0
64620,considered,0,0
64621,as,0,0
64622,a,0,0
64623,management,0,0
64624,option,0,0
64625,of,0,0
64626,CIN2,0,0
64627,in,0,0
64628,young,0,0
64629,and,0,0
64630,compliant,0,0
64631,women,0,0
64632,.,0,0
64633,A,0,0
64634,comparison,0,0
64635,of,0,0
64636,laser-assisted,1,1
64637,drug,1,1
64638,delivery,1,1
64639,at,0,0
64640,two,0,0
64641,output,0,0
64642,energies,0,0
64643,for,0,0
64644,enhancing,0,0
64645,the,0,0
64646,delivery,0,0
64647,of,0,0
64648,topically,1,1
64649,applied,1,1
64650,LMX-4,1,1
64651,cream,1,1
64652,prior,0,0
64653,to,0,0
64654,venipuncture,1,0
64655,.,1,0
64656,BACKGROUND,0,1
64657,Laser-assisted,1,1
64658,drug,1,1
64659,delivery,1,1
64660,(,1,1
64661,LAD,1,1
64662,),1,0
64663,has,0,0
64664,the,0,0
64665,potential,0,0
64666,for,0,0
64667,facilitating,0,0
64668,topical,0,1
64669,anesthesia,0,1
64670,with,0,0
64671,reduced,0,0
64672,onset,0,0
64673,time,0,0
64674,.,0,0
64675,METHODS,0,0
64676,In,0,0
64677,this,0,0
64678,randomized,0,0
64679,",",0,0
64680,double-blind,0,1
64681,",",0,1
64682,crossover,0,1
64683,study,0,0
64684,we,0,0
64685,compared,0,0
64686,the,0,0
64687,efficacy,0,0
64688,and,0,0
64689,adverse,0,0
64690,event,0,0
64691,profile,0,0
64692,of,0,0
64693,LAD,1,0
64694,for,1,0
64695,topical,1,1
64696,anesthesia,1,1
64697,before,0,0
64698,venipuncture,1,0
64699,using,0,0
64700,two,0,0
64701,output,0,1
64702,energies,0,1
64703,(,0,0
64704,2.0,0,0
64705,and,0,0
64706,3.5,0,0
64707,J/cm2,0,1
64708,),0,0
64709,.,0,0
64710,RESULTS,0,0
64711,Mean,0,0
64712,Visual,0,0
64713,Analog,0,1
64714,Scale,0,1
64715,pain,0,1
64716,scores,0,0
64717,were,0,0
64718,not,0,0
64719,statistically,0,0
64720,different,0,0
64721,(,0,0
64722,P,0,0
64723,=,0,0
64724,0.57,0,0
64725,),0,0
64726,between,0,0
64727,the,0,0
64728,low-energy,0,0
64729,(,0,0
64730,mean,0,0
64731,=,0,0
64732,6.7,0,0
64733,),0,0
64734,and,0,0
64735,high-energy,0,0
64736,(,0,0
64737,mean,0,0
64738,=,0,0
64739,8.1,0,0
64740,),0,0
64741,lasers,0,0
64742,.,0,0
64743,CONCLUSIONS,0,0
64744,LAD,1,0
64745,at,0,0
64746,an,0,0
64747,energy,0,0
64748,of,0,0
64749,2.0,0,0
64750,J/cm2,0,0
64751,(,0,0
64752,570,0,0
64753,mJ,0,0
64754,),0,0
64755,is,0,0
64756,as,0,0
64757,effective,0,0
64758,",",0,0
64759,with,0,0
64760,similar,0,0
64761,adverse,0,0
64762,events,0,0
64763,",",0,0
64764,as,0,0
64765,an,0,0
64766,energy,0,0
64767,of,0,0
64768,3.5,0,0
64769,J/cm2,0,1
64770,(,0,1
64771,1000,0,0
64772,mJ,0,1
64773,),0,0
64774,in,0,0
64775,facilitating,0,0
64776,topical,0,1
64777,anesthesia,0,1
64778,.,0,0
64779,[,0,1
64780,Evaluation,0,1
64781,on,0,0
64782,the,0,0
64783,effect,0,0
64784,of,0,0
64785,intervention,0,0
64786,regarding,0,0
64787,breast,0,0
64788,self-examination,0,0
64789,for,0,0
64790,decreasing,0,0
64791,breast,0,0
64792,cancer,0,1
64793,mortality,0,1
64794,],0,0
64795,.,0,0
64796,OBJECTIVE,0,1
64797,A,0,1
64798,randomized,0,0
64799,trial,0,0
64800,of,0,0
64801,breast,1,1
64802,self-examination,1,1
64803,(,1,1
64804,BSE,1,1
64805,),1,1
64806,Program,1,0
64807,was,0,0
64808,carried,0,0
64809,out,0,0
64810,to,0,0
64811,evaluate,0,0
64812,whether,0,0
64813,the,0,0
64814,intensive,0,0
64815,BSE,1,0
64816,could,0,0
64817,reduce,0,0
64818,the,0,0
64819,number,0,0
64820,of,0,0
64821,deaths,0,0
64822,among,0,0
64823,women,0,0
64824,from,0,0
64825,breast,0,0
64826,cancer,0,0
64827,.,0,0
64828,METHODS,0,0
64829,This,0,0
64830,study,0,0
64831,was,0,0
64832,a,0,0
64833,randomized,0,0
64834,controlled,0,0
64835,trial,0,1
64836,(,0,1
64837,RCT,0,1
64838,),0,1
64839,.,0,0
64840,A,0,0
64841,total,0,0
64842,of,0,0
64843,266,0,0
64844,064,0,0
64845,women,0,0
64846,(,0,0
64847,age,0,0
64848,of,0,0
64849,30,0,0
64850,to,0,0
64851,64,0,0
64852,years,0,0
64853,),0,0
64854,associated,0,0
64855,with,0,0
64856,519,0,0
64857,textile,0,0
64858,factories,0,0
64859,in,0,0
64860,Shanghai,0,0
64861,had,0,0
64862,been,0,0
64863,randomly,0,0
64864,assigned,0,0
64865,to,0,0
64866,a,0,0
64867,BSE,1,1
64868,group,0,0
64869,(,0,0
64870,132,0,0
64871,979,0,0
64872,women,0,0
64873,),0,0
64874,or,0,0
64875,a,0,0
64876,control,1,0
64877,group,1,0
64878,(,0,0
64879,133,0,0
64880,085,0,0
64881,women,0,0
64882,),0,0
64883,since,0,0
64884,1989,0,0
64885,.,0,0
64886,Initial,0,0
64887,instruction,0,0
64888,in,0,0
64889,BSE,0,0
64890,group,0,0
64891,would,0,0
64892,include,0,0
64893,demonstration,0,0
64894,of,0,0
64895,proper,0,0
64896,palpation,0,0
64897,techniques,0,0
64898,and,0,0
64899,was,0,0
64900,followed,0,0
64901,by,0,0
64902,2,0,0
64903,reinforcement,0,0
64904,sessions,0,0
64905,during,0,0
64906,the,0,0
64907,subsequent,0,0
64908,4,0,0
64909,years,0,0
64910,including,0,0
64911,video,0,0
64912,shows,0,0
64913,",",0,0
64914,BSE,0,1
64915,instruction,0,1
64916,sessions,0,0
64917,and,0,0
64918,BSE,1,0
64919,practice,0,0
64920,under,0,0
64921,medical,0,0
64922,supervision,0,0
64923,.,0,0
64924,These,0,0
64925,activities,0,0
64926,were,0,0
64927,continued,0,0
64928,for,0,0
64929,5,0,0
64930,years,0,0
64931,.,0,0
64932,Attendance,0,0
64933,at,0,0
64934,all,0,0
64935,events,0,0
64936,was,0,0
64937,recorded,0,0
64938,.,0,0
64939,The,0,0
64940,cohort,0,0
64941,was,0,0
64942,followed,0,0
64943,through,0,0
64944,July,0,0
64945,2000,0,0
64946,for,0,0
64947,development,0,0
64948,of,0,0
64949,breast,0,0
64950,diseases,0,0
64951,",",0,0
64952,and,0,0
64953,the,0,0
64954,breast,0,0
64955,cancer,0,0
64956,cases,0,0
64957,were,0,0
64958,followed,0,0
64959,through,0,0
64960,2001,0,0
64961,for,0,0
64962,vital,0,0
64963,status,0,0
64964,.,0,0
64965,Data,0,0
64966,analysis,0,0
64967,methods,0,0
64968,used,0,0
64969,would,0,0
64970,include,0,0
64971,Kaplan-Meier,0,0
64972,plots,0,0
64973,",",0,0
64974,log-rank,0,0
64975,test,0,0
64976,and,0,0
64977,Cox,0,0
64978,modeling,0,0
64979,.,0,0
64980,RESULTS,0,0
64981,Among,0,0
64982,women,0,0
64983,under,0,0
64984,instruction,0,0
64985,",",0,0
64986,864,0,0
64987,breast,0,0
64988,cancers,0,0
64989,detected,0,0
64990,and,0,0
64991,133,0,0
64992,breast,0,0
64993,cancer,0,0
64994,deaths,0,0
64995,occurred,0,0
64996,while,0,0
64997,896,0,0
64998,breast,0,0
64999,cancers,0,0
65000,were,0,0
65001,detected,0,0
65002,and,0,0
65003,130,0,0
65004,deaths,0,0
65005,recorded,0,0
65006,in,0,0
65007,the,0,0
65008,control,0,0
65009,group,0,0
65010,.,0,0
65011,The,0,0
65012,tumor,0,0
65013,size,0,0
65014,(,0,0
65015,P,0,0
65016,=,0,0
65017,0.07,0,0
65018,),0,0
65019,",",0,0
65020,TNM,0,1
65021,stage,0,0
65022,(,0,0
65023,P,0,0
65024,=,0,0
65025,0.39,0,0
65026,),0,0
65027,and,0,0
65028,cumulative,0,1
65029,breast,0,1
65030,cancer,0,0
65031,mortality,0,1
65032,rate,0,0
65033,(,0,0
65034,P,0,0
65035,=,0,0
65036,0.72,0,0
65037,),0,0
65038,were,0,0
65039,not,0,0
65040,significantly,0,0
65041,different,0,0
65042,between,0,0
65043,the,0,0
65044,2,0,0
65045,groups,0,0
65046,.,0,0
65047,However,0,0
65048,",",0,0
65049,more,0,0
65050,and,0,0
65051,smaller,0,0
65052,fibroadenomas,0,0
65053,were,0,0
65054,detected,0,0
65055,in,0,0
65056,the,0,0
65057,instruction,0,0
65058,group,0,0
65059,than,0,0
65060,in,0,0
65061,the,0,0
65062,control,0,0
65063,group,0,0
65064,(,0,0
65065,P,0,0
65066,<,0,0
65067,0.01,0,0
65068,),0,0
65069,.,0,0
65070,CONCLUSION,0,0
65071,Intensive,0,0
65072,instruction,0,0
65073,in,0,0
65074,BSE,1,0
65075,did,0,0
65076,not,0,0
65077,seem,0,0
65078,to,0,0
65079,have,0,0
65080,reduced,0,0
65081,the,0,0
65082,mortality,0,0
65083,rate,0,0
65084,of,0,0
65085,breast,0,0
65086,cancer,0,0
65087,",",0,0
65088,but,0,0
65089,more,0,0
65090,and,0,0
65091,smaller,0,0
65092,benign,0,0
65093,breast,0,0
65094,lumps,0,0
65095,could,0,0
65096,be,0,0
65097,detected,0,0
65098,.,0,0
65099,Women,0,0
65100,'s,0,0
65101,responses,0,0
65102,to,0,0
65103,information,0,0
65104,on,0,0
65105,mammographic,0,0
65106,breast,0,0
65107,density,0,0
65108,.,0,0
65109,The,0,0
65110,objective,0,0
65111,of,0,0
65112,this,0,0
65113,study,0,0
65114,was,0,0
65115,to,0,0
65116,determine,0,0
65117,the,0,0
65118,negative,0,0
65119,and,0,0
65120,positive,0,0
65121,outcomes,0,0
65122,of,0,0
65123,providing,0,0
65124,mammographic,0,0
65125,breast,0,0
65126,density,0,0
65127,(,0,1
65128,MBD,0,1
65129,),0,0
65130,information,0,0
65131,to,0,0
65132,participants,0,0
65133,of,0,0
65134,a,0,0
65135,screening,1,0
65136,program,1,0
65137,.,1,0
65138,A,0,0
65139,randomized,0,0
65140,experiment,0,0
65141,was,0,0
65142,conducted,0,0
65143,with,0,0
65144,a,0,0
65145,sample,0,0
65146,of,0,0
65147,618,0,0
65148,women,0,0
65149,50,0,0
65150,years,0,0
65151,or,0,0
65152,older,0,0
65153,with,0,0
65154,MBD,0,0
65155,greater,0,0
65156,than,0,0
65157,50,0,0
65158,%,0,0
65159,of,0,0
65160,breast,0,0
65161,volume,0,0
65162,.,0,0
65163,The,0,0
65164,intervention,0,0
65165,consisted,0,0
65166,of,0,0
65167,reporting,1,0
65168,the,1,0
65169,presence,1,0
65170,of,1,0
65171,MBD,1,0
65172,in,1,0
65173,the,1,0
65174,screening,1,0
65175,mammography,1,0
65176,results,1,0
65177,letter,1,0
65178,that,1,0
65179,was,1,0
65180,sent,1,0
65181,along,1,0
65182,with,1,0
65183,an,1,0
65184,information,1,0
65185,pamphlet,1,0
65186,.,1,0
65187,Compared,0,0
65188,to,0,0
65189,the,0,0
65190,controls,1,0
65191,",",0,0
65192,more,0,0
65193,women,0,0
65194,in,0,0
65195,the,0,0
65196,intervention,0,0
65197,group,0,0
65198,described,0,0
65199,the,0,0
65200,term,0,0
65201,breast,0,0
65202,density,0,0
65203,correctly,0,0
65204,and,0,0
65205,recognized,0,0
65206,it,0,0
65207,as,0,0
65208,a,0,0
65209,risk,0,0
65210,factor,0,0
65211,for,0,0
65212,breast,0,0
65213,cancer,0,0
65214,.,0,0
65215,Although,0,0
65216,at,0,0
65217,the,0,0
65218,4-week,0,1
65219,follow-up,0,1
65220,the,0,0
65221,intervention,0,0
65222,group,0,0
65223,indicated,0,0
65224,that,0,0
65225,they,0,0
65226,were,0,0
65227,very,0,0
65228,likely,0,0
65229,to,0,0
65230,have,0,0
65231,an,0,0
65232,annual,1,0
65233,clinical,1,0
65234,breast,1,0
65235,examination,1,0
65236,more,0,0
65237,frequently,0,0
65238,than,0,0
65239,controls,0,0
65240,",",0,0
65241,no,0,0
65242,differences,0,0
65243,were,0,0
65244,detected,0,0
65245,at,0,0
65246,6,0,0
65247,months,0,0
65248,.,0,0
65249,There,0,0
65250,were,0,0
65251,no,0,0
65252,significant,0,0
65253,differences,0,0
65254,on,0,0
65255,other,0,0
65256,behavioural,0,0
65257,or,0,0
65258,psychological,0,0
65259,measures,0,0
65260,",",0,0
65261,although,0,0
65262,at,0,0
65263,the,0,0
65264,4-week,0,1
65265,follow-up,0,0
65266,the,0,0
65267,control,0,0
65268,group,0,0
65269,perceived,0,0
65270,their,0,0
65271,risk,0,0
65272,for,0,0
65273,breast,0,0
65274,cancer,0,0
65275,",",0,0
65276,relative,0,0
65277,to,0,0
65278,other,0,0
65279,women,0,0
65280,their,0,0
65281,age,0,0
65282,",",0,0
65283,as,0,0
65284,a,0,0
65285,lot,0,0
65286,lower,0,0
65287,than,0,0
65288,did,0,0
65289,women,0,0
65290,in,0,0
65291,the,0,0
65292,intervention,0,0
65293,group,0,0
65294,.,0,0
65295,The,0,0
65296,results,0,0
65297,demonstrate,0,0
65298,a,0,0
65299,feasible,0,0
65300,and,0,0
65301,non-threatening,0,0
65302,way,0,0
65303,to,0,0
65304,provide,0,0
65305,women,0,0
65306,with,0,0
65307,important,0,0
65308,personalized,0,0
65309,information,0,0
65310,about,0,0
65311,breast,0,0
65312,cancer,0,0
65313,risk,0,0
65314,.,0,0
65315,Use,0,0
65316,of,0,0
65317,the,0,0
65318,electrothermal,1,0
65319,bipolar,1,0
65320,vessel,1,1
65321,system,1,0
65322,(,1,1
65323,EBVS,1,1
65324,),1,1
65325,in,0,0
65326,laparoscopic,0,1
65327,adrenalectomy,0,1
65328,:,0,0
65329,a,0,0
65330,prospective,0,0
65331,study,0,0
65332,.,0,0
65333,BACKGROUND,0,0
65334,Since,0,1
65335,laparoscopic,0,1
65336,adrenalectomy,0,1
65337,(,0,1
65338,LA,0,1
65339,),0,0
65340,has,0,0
65341,been,0,0
65342,adopted,0,0
65343,as,0,0
65344,the,0,0
65345,gold,0,0
65346,standard,0,0
65347,for,0,0
65348,the,0,0
65349,treatment,0,0
65350,of,0,0
65351,adrenal,0,1
65352,diseases,0,1
65353,",",0,0
65354,the,0,0
65355,development,0,0
65356,of,0,0
65357,technology,0,0
65358,for,0,0
65359,vascular,0,0
65360,control,0,0
65361,and,0,0
65362,dissection,0,0
65363,manoeuvres,0,0
65364,",",0,0
65365,amongst,0,0
65366,other,0,0
65367,things,0,0
65368,",",0,0
65369,may,0,0
65370,play,0,0
65371,a,0,0
65372,pivotal,0,0
65373,role,0,0
65374,in,0,0
65375,its,0,0
65376,further,0,0
65377,improvement,0,0
65378,.,0,0
65379,We,0,0
65380,report,0,0
65381,our,0,0
65382,experience,0,0
65383,with,0,0
65384,the,0,0
65385,electrothermal,1,0
65386,bipolar,1,0
65387,vessel,1,1
65388,sealing,1,1
65389,(,1,1
65390,EBVS,1,1
65391,),1,1
65392,device,0,0
65393,for,0,0
65394,LA,0,0
65395,.,0,0
65396,METHODS,0,0
65397,From,0,1
65398,January,0,0
65399,2004,0,0
65400,to,0,0
65401,January,0,0
65402,2006,0,0
65403,",",0,0
65404,50,0,0
65405,patients,0,0
65406,(,0,1
65407,pts,0,1
65408,),0,1
65409,undergoing,0,0
65410,LA,0,1
65411,were,0,0
65412,selected,0,0
65413,and,0,0
65414,randomized,0,0
65415,for,0,0
65416,use,0,0
65417,of,0,0
65418,the,0,0
65419,EBVS,1,1
65420,(,1,0
65421,25,1,0
65422,pts,1,0
65423,",",1,0
65424,group,1,0
65425,A,1,1
65426,),1,1
65427,versus,1,0
65428,the,1,0
65429,UltraSonic,1,1
65430,Shears,1,1
65431,(,1,1
65432,USS,1,1
65433,),1,1
65434,device,1,1
65435,(,0,1
65436,25,0,0
65437,pts,0,0
65438,",",0,0
65439,group,0,0
65440,B,0,1
65441,),0,1
65442,.,0,1
65443,Age,0,1
65444,",",0,0
65445,sex,0,1
65446,",",0,0
65447,body,0,0
65448,mass,0,0
65449,index,0,1
65450,(,0,1
65451,BMI,0,1
65452,),0,1
65453,",",0,0
65454,previous,0,0
65455,surgery,0,0
65456,and,0,0
65457,associated,0,0
65458,diseases,0,0
65459,were,0,0
65460,similar,0,0
65461,between,0,0
65462,the,0,0
65463,two,0,0
65464,groups,0,0
65465,.,0,0
65466,The,0,0
65467,main,0,0
65468,surgical,0,0
65469,parameters,0,0
65470,collected,0,0
65471,for,0,0
65472,each,0,0
65473,patient,0,1
65474,(,0,1
65475,pt,0,1
65476,),0,0
65477,concerned,0,0
65478,operative,0,0
65479,time,0,0
65480,",",0,0
65481,major,0,0
65482,and,0,0
65483,minor,0,0
65484,complications,0,0
65485,",",0,0
65486,conversion,0,0
65487,rate,0,0
65488,",",0,0
65489,blood,0,0
65490,loss,0,0
65491,",",0,0
65492,hospital,0,0
65493,stay,0,0
65494,and,0,0
65495,histology,0,0
65496,.,0,0
65497,RESULTS,0,0
65498,There,0,0
65499,was,0,0
65500,no,0,0
65501,mortality,0,0
65502,in,0,0
65503,either,0,0
65504,group,0,0
65505,.,0,0
65506,The,0,0
65507,right,0,0
65508,adrenalectomy,0,1
65509,mean,0,0
65510,operative,0,0
65511,time,0,0
65512,(,0,1
65513,OpT,0,1
65514,),0,0
65515,was,0,0
65516,51.8,0,0
65517,mins,0,0
65518,(,0,0
65519,range,0,0
65520,40-90,0,0
65521,mins,0,0
65522,),0,0
65523,and,0,0
65524,68.6,0,0
65525,mins,0,0
65526,(,0,0
65527,range,0,0
65528,50-130,0,0
65529,mins,0,0
65530,),0,0
65531,in,0,0
65532,group,0,0
65533,A,0,0
65534,and,0,0
65535,B,0,0
65536,",",0,0
65537,respectively,0,0
65538,(,0,0
65539,P,0,0
65540,not,0,0
65541,significant,0,0
65542,),0,0
65543,.,0,0
65544,The,0,0
65545,left,0,0
65546,adrenalectomy,0,1
65547,mean,0,0
65548,OpT,0,0
65549,was,0,0
65550,72.2,0,0
65551,mins,0,0
65552,(,0,0
65553,range,0,0
65554,55-100,0,0
65555,mins,0,0
65556,),0,0
65557,and,0,0
65558,94,0,0
65559,mins,0,0
65560,(,0,0
65561,range,0,0
65562,65-140,0,0
65563,mins,0,0
65564,),0,0
65565,for,0,0
65566,group,0,0
65567,A,0,0
65568,and,0,0
65569,B,0,0
65570,",",0,0
65571,respectively,0,0
65572,(,0,0
65573,P,0,0
65574,<,0,0
65575,0.05,0,0
65576,),0,0
65577,.,0,0
65578,The,0,0
65579,mean,0,0
65580,blood,0,0
65581,loss,0,0
65582,was,0,0
65583,83,0,0
65584,ml,0,0
65585,(,0,0
65586,group,0,1
65587,A,0,1
65588,),0,0
65589,and,0,0
65590,210,0,0
65591,ml,0,0
65592,(,0,0
65593,group,0,1
65594,B,0,1
65595,),0,1
65596,(,0,0
65597,p,0,0
65598,<,0,0
65599,0.05,0,0
65600,),0,0
65601,.,0,0
65602,Complications,0,0
65603,were,0,0
65604,not,0,0
65605,different,0,0
65606,for,0,0
65607,the,0,0
65608,two,0,0
65609,groups,0,0
65610,.,0,0
65611,The,0,0
65612,mean,0,0
65613,hospital,0,0
65614,stay,0,0
65615,was,0,0
65616,2.9,0,0
65617,and,0,0
65618,3.1,0,0
65619,days,0,0
65620,in,0,0
65621,group,0,0
65622,A,0,0
65623,and,0,0
65624,B,0,0
65625,",",0,0
65626,respectively,0,0
65627,(,0,0
65628,P,0,0
65629,not,0,0
65630,significant,0,0
65631,),0,0
65632,.,0,0
65633,CONCLUSIONS,0,0
65634,EBVS,0,0
65635,in,0,0
65636,LA,0,0
65637,may,0,0
65638,provide,0,0
65639,a,0,0
65640,significantly,0,0
65641,short,0,0
65642,operating,0,0
65643,time,0,0
65644,and,0,0
65645,blood,0,0
65646,loss,0,0
65647,.,0,0
65648,The,0,0
65649,effectiveness,0,0
65650,of,0,0
65651,Picture,1,0
65652,Exchange,1,0
65653,Communication,1,0
65654,System,1,0
65655,(,1,1
65656,PECS,1,1
65657,),1,1
65658,training,1,0
65659,for,0,0
65660,teachers,0,0
65661,of,0,0
65662,children,0,0
65663,with,0,0
65664,autism,0,0
65665,:,0,0
65666,a,0,0
65667,pragmatic,0,0
65668,",",0,0
65669,group,0,0
65670,randomised,0,0
65671,controlled,0,0
65672,trial,0,0
65673,.,0,0
65674,OBJECTIVE,0,0
65675,To,0,0
65676,assess,0,0
65677,the,0,0
65678,effectiveness,0,0
65679,of,0,0
65680,expert,0,0
65681,training,0,0
65682,and,0,0
65683,consultancy,0,0
65684,for,0,0
65685,teachers,0,0
65686,of,0,0
65687,children,0,0
65688,with,0,0
65689,autism,0,0
65690,spectrum,0,0
65691,disorder,0,0
65692,in,0,0
65693,the,0,0
65694,use,0,0
65695,of,0,0
65696,the,0,0
65697,Picture,1,0
65698,Exchange,1,0
65699,Communication,1,0
65700,System,1,0
65701,(,1,1
65702,PECS,1,1
65703,),1,1
65704,.,1,0
65705,METHOD,0,0
65706,DESIGN,0,0
65707,Group,0,0
65708,randomised,0,0
65709,",",0,0
65710,controlled,0,0
65711,trial,0,1
65712,(,0,0
65713,3,0,0
65714,groups,0,0
65715,:,0,0
65716,immediate,0,0
65717,treatment,0,0
65718,",",0,0
65719,delayed,0,0
65720,treatment,0,0
65721,",",0,0
65722,no,0,0
65723,treatment,0,0
65724,),0,0
65725,.,0,0
65726,PARTICIPANTS,0,0
65727,84,0,0
65728,elementary,0,0
65729,school,0,0
65730,children,0,0
65731,",",0,0
65732,mean,0,0
65733,age,0,0
65734,6.8,0,0
65735,years,0,0
65736,.,0,0
65737,TREATMENT,0,0
65738,A,1,1
65739,2-day,1,1
65740,PECS,1,1
65741,workshop,1,0
65742,for,1,0
65743,teachers,1,0
65744,plus,1,0
65745,6,1,0
65746,half-day,1,0
65747,",",1,0
65748,school-based,1,0
65749,training,1,0
65750,sessions,1,0
65751,with,1,0
65752,expert,1,0
65753,consultants,1,0
65754,over,1,0
65755,5,1,0
65756,months,1,0
65757,.,1,0
65758,OUTCOME,0,0
65759,MEASURES,0,0
65760,Rates,0,0
65761,of,0,0
65762,:,0,0
65763,communicative,0,0
65764,initiations,0,0
65765,",",0,0
65766,use,0,0
65767,of,0,0
65768,PECS,1,0
65769,",",0,0
65770,and,0,0
65771,speech,0,0
65772,in,0,0
65773,the,0,0
65774,classroom,0,1
65775,;,0,0
65776,Autism,0,1
65777,Diagnostic,0,1
65778,Observation,0,1
65779,Schedule-Generic,0,1
65780,(,0,1
65781,ADOS-G,0,1
65782,),0,1
65783,domain,0,0
65784,scores,0,0
65785,for,0,0
65786,Communication,0,0
65787,and,0,0
65788,Reciprocal,0,0
65789,Social,0,0
65790,Interaction,0,0
65791,;,0,0
65792,scores,0,0
65793,on,0,0
65794,formal,0,0
65795,language,0,0
65796,tests,0,0
65797,.,0,0
65798,RESULTS,0,0
65799,Controlling,0,0
65800,for,0,0
65801,baseline,0,0
65802,age,0,0
65803,",",0,0
65804,developmental,0,0
65805,quotient,0,1
65806,(,0,1
65807,DQ,0,1
65808,),0,1
65809,and,0,0
65810,language,0,1
65811,;,0,0
65812,rates,0,0
65813,of,0,0
65814,initiations,0,0
65815,and,0,0
65816,PECS,0,0
65817,usage,0,0
65818,increased,0,0
65819,significantly,0,0
65820,immediately,0,0
65821,post-treatment,0,0
65822,(,0,0
65823,Odds,0,1
65824,Ratio,0,1
65825,(,0,1
65826,OR,0,1
65827,),0,0
65828,of,0,0
65829,being,0,0
65830,in,0,0
65831,a,0,0
65832,higher,0,0
65833,ordinal,0,0
65834,rate,0,0
65835,category,0,0
65836,2.72,0,0
65837,",",0,0
65838,95,0,0
65839,%,0,0
65840,confidence,0,0
65841,interval,0,0
65842,1.22-6.09,0,0
65843,",",0,0
65844,p,0,0
65845,<,0,0
65846,.05,0,0
65847,and,0,0
65848,OR,0,0
65849,3.90,0,0
65850,(,0,0
65851,95,0,0
65852,%,0,0
65853,CI,0,0
65854,1.75-8.68,0,0
65855,),0,0
65856,",",0,0
65857,p,0,0
65858,<,0,0
65859,.001,0,0
65860,",",0,0
65861,respectively,0,0
65862,),0,0
65863,.,0,0
65864,There,0,0
65865,were,0,0
65866,no,0,0
65867,increases,0,0
65868,in,0,0
65869,frequency,0,0
65870,of,0,0
65871,speech,0,0
65872,",",0,0
65873,or,0,0
65874,improvements,0,0
65875,in,0,0
65876,ADOS-G,0,0
65877,ratings,0,0
65878,or,0,0
65879,language,0,0
65880,test,0,0
65881,scores,0,0
65882,.,0,0
65883,CONCLUSIONS,0,0
65884,The,0,0
65885,results,0,0
65886,indicate,0,0
65887,modest,0,0
65888,effectiveness,0,0
65889,of,0,0
65890,PECS,1,1
65891,teacher,1,0
65892,training/consultancy,1,0
65893,.,1,0
65894,Rates,0,0
65895,of,0,0
65896,pupils,0,0
65897,',0,0
65898,initiations,0,0
65899,and,0,0
65900,use,0,0
65901,of,0,0
65902,symbols,0,0
65903,in,0,0
65904,the,0,0
65905,classroom,0,0
65906,increased,0,0
65907,",",0,0
65908,although,0,0
65909,there,0,0
65910,was,0,0
65911,no,0,0
65912,evidence,0,0
65913,of,0,0
65914,improvement,0,0
65915,in,0,0
65916,other,0,0
65917,areas,0,0
65918,of,0,0
65919,communication,0,0
65920,.,0,0
65921,TREATMENT,0,0
65922,effects,0,0
65923,were,0,0
65924,not,0,0
65925,maintained,0,0
65926,once,0,0
65927,active,0,0
65928,intervention,0,0
65929,ceased,0,0
65930,.,0,0
65931,Tacrolimus,1,1
65932,monotherapy,0,1
65933,without,0,1
65934,steroids,0,1
65935,after,0,0
65936,liver,0,0
65937,transplantation,0,0
65938,--,0,0
65939,a,0,0
65940,prospective,0,0
65941,randomized,0,1
65942,double-blinded,0,1
65943,placebo-controlled,0,1
65944,trial,0,1
65945,.,0,1
65946,Early,0,1
65947,steroid,0,1
65948,withdrawal,0,1
65949,after,0,0
65950,liver,0,0
65951,transplantation,0,0
65952,(,0,1
65953,LT,0,1
65954,),0,0
65955,is,0,0
65956,desirable,0,0
65957,in,0,0
65958,order,0,0
65959,to,0,0
65960,reduce,0,0
65961,steroid,0,1
65962,side,0,0
65963,effects,0,0
65964,.,0,0
65965,Between,0,0
65966,February,0,0
65967,2000,0,0
65968,and,0,0
65969,August,0,0
65970,2004,0,0
65971,",",0,0
65972,110,0,0
65973,patients,0,0
65974,after,0,0
65975,LT,0,0
65976,were,0,0
65977,included,0,0
65978,in,0,0
65979,this,0,0
65980,prospective,0,0
65981,",",0,0
65982,randomized,0,1
65983,",",0,1
65984,double-blind,0,1
65985,",",0,1
65986,placebo-controlled,1,1
65987,trial,0,1
65988,.,0,0
65989,Randomization,0,0
65990,was,0,0
65991,performed,0,0
65992,before,0,0
65993,LT,0,0
65994,.,0,0
65995,In,0,0
65996,all,0,0
65997,patients,0,0
65998,",",0,0
65999,tacrolimus,1,1
66000,was,1,0
66001,used,1,0
66002,without,1,0
66003,induction,1,0
66004,therapy,1,0
66005,.,1,0
66006,All,0,0
66007,patients,0,0
66008,received,0,0
66009,methylprednisolon,1,1
66010,for,0,1
66011,14,0,0
66012,days,0,0
66013,",",0,0
66014,thereafter,0,0
66015,a,0,0
66016,double-blinded,0,1
66017,medication,0,1
66018,containing,0,0
66019,either,0,0
66020,placebo,1,1
66021,(,0,0
66022,n,0,0
66023,=,0,0
66024,56,0,0
66025,),0,0
66026,or,0,0
66027,methylprednisolon,1,1
66028,(,0,0
66029,n,0,0
66030,=,0,0
66031,54,0,0
66032,),0,0
66033,for,0,0
66034,6,0,0
66035,months,0,0
66036,",",0,0
66037,which,0,0
66038,was,0,0
66039,completely,0,0
66040,stopped,0,1
66041,thereafter,0,0
66042,.,0,0
66043,End,0,0
66044,points,0,0
66045,were,0,0
66046,patient,0,0
66047,and,0,0
66048,graft,0,0
66049,survival,0,0
66050,",",0,0
66051,acute,0,0
66052,and,0,0
66053,chronic,0,0
66054,rejection,0,0
66055,",",0,0
66056,and,0,0
66057,incidence,0,0
66058,of,0,0
66059,steroid,0,1
66060,side,0,0
66061,effects,0,0
66062,during,0,0
66063,the,0,0
66064,first,0,0
66065,year,0,0
66066,after,0,0
66067,LT,0,0
66068,.,0,0
66069,One-year,0,0
66070,patient,0,0
66071,survival,0,0
66072,was,0,0
66073,85.7,0,0
66074,%,0,0
66075,(,0,0
66076,placebo,0,1
66077,),0,1
66078,and,0,0
66079,88.8,0,0
66080,%,0,0
66081,(,0,0
66082,steroid,0,1
66083,),0,1
66084,(,0,0
66085,p,0,0
66086,=,0,0
66087,0.572,0,0
66088,),0,0
66089,.,0,0
66090,Twenty-seven,0,0
66091,(,0,0
66092,48.2,0,0
66093,%,0,0
66094,),0,0
66095,and,0,0
66096,19,0,0
66097,(,0,0
66098,35.2,0,0
66099,%,0,0
66100,),0,0
66101,patients,0,0
66102,experienced,0,0
66103,acute,0,1
66104,rejection,0,1
66105,(,0,1
66106,placebo,0,1
66107,versus,0,1
66108,steroid,0,1
66109,",",0,0
66110,respectively,0,0
66111,;,0,0
66112,p,0,0
66113,=,0,0
66114,0.116,0,0
66115,),0,0
66116,.,0,0
66117,Two,0,1
66118,patients,0,0
66119,in,0,0
66120,the,0,0
66121,placebo,0,1
66122,group,0,0
66123,but,0,0
66124,none,0,0
66125,in,0,0
66126,the,0,0
66127,steroid,0,1
66128,group,0,1
66129,experienced,0,1
66130,chronic,0,1
66131,rejection,0,0
66132,(,0,0
66133,p,0,0
66134,=,0,0
66135,0.257,0,0
66136,),0,0
66137,.,0,0
66138,The,0,0
66139,rates,0,0
66140,of,0,0
66141,side,0,0
66142,effects,0,0
66143,were,0,0
66144,(,1,0
66145,placebo,1,1
66146,versus,0,1
66147,steroid,1,1
66148,",",0,0
66149,respectively,0,0
66150,),0,0
66151,:,0,0
66152,CMV,0,1
66153,infection,0,0
66154,25,0,0
66155,%,0,0
66156,versus,0,0
66157,33,0,0
66158,%,0,0
66159,(,0,0
66160,p,0,0
66161,=,0,0
66162,0.336,0,0
66163,),0,0
66164,",",0,0
66165,post-transplant,0,1
66166,diabetes,0,0
66167,30,0,0
66168,%,0,0
66169,versus,0,0
66170,53,0,0
66171,%,0,0
66172,(,0,0
66173,p,0,0
66174,=,0,0
66175,0.024,0,0
66176,),0,0
66177,",",0,0
66178,hypertension,0,0
66179,39,0,0
66180,%,0,0
66181,versus,0,0
66182,52,0,0
66183,%,0,0
66184,(,0,0
66185,p,0,0
66186,=,0,0
66187,0.248,0,0
66188,),0,0
66189,",",0,0
66190,hypercholesterolemia,0,0
66191,10,0,0
66192,%,0,0
66193,versus,0,0
66194,41,0,0
66195,%,0,0
66196,(,0,0
66197,p,0,0
66198,=,0,0
66199,0.002,0,0
66200,),0,0
66201,and,0,0
66202,hypertriglyceridemia,0,1
66203,32,0,0
66204,%,0,0
66205,versus,0,0
66206,54,0,0
66207,%,0,0
66208,(,0,0
66209,p,0,0
66210,=,0,0
66211,0.046,0,0
66212,),0,0
66213,.,0,0
66214,In,0,0
66215,conclusion,0,0
66216,",",0,0
66217,early,0,0
66218,steroid,0,1
66219,withdrawal,0,1
66220,after,0,0
66221,LT,0,0
66222,is,0,0
66223,feasible,0,0
66224,under,0,0
66225,tacrolimus,1,1
66226,monotherapy,0,1
66227,without,0,1
66228,increased,0,0
66229,rejection,0,0
66230,rates,0,0
66231,and,0,0
66232,with,0,0
66233,a,0,0
66234,lower,0,0
66235,rate,0,0
66236,of,0,0
66237,side,0,0
66238,effects,0,0
66239,.,0,0
66240,Propofol,1,1
66241,and,1,1
66242,midazolam,1,1
66243,act,0,0
66244,synergistically,0,0
66245,in,0,0
66246,combination,0,0
66247,.,0,0
66248,We,0,0
66249,have,0,0
66250,studied,0,0
66251,interactions,0,0
66252,between,0,0
66253,i.v,1,1
66254,.,1,1
66255,propofol,1,1
66256,and,1,1
66257,midazolam,1,1
66258,for,0,0
66259,induction,0,0
66260,of,0,0
66261,anaesthesia,0,0
66262,in,0,0
66263,200,0,0
66264,unpremedicated,0,1
66265,female,0,1
66266,patients,0,0
66267,undergoing,0,0
66268,elective,0,1
66269,gynaecological,0,0
66270,surgery,0,0
66271,.,0,0
66272,Using,0,0
66273,end-points,0,0
66274,of,0,0
66275,hypnosis,0,0
66276,(,0,0
66277,loss,0,0
66278,of,0,0
66279,response,0,0
66280,to,0,0
66281,verbal,0,0
66282,command,0,1
66283,),0,0
66284,and,0,0
66285,anaesthesia,0,1
66286,(,0,0
66287,loss,0,0
66288,of,0,0
66289,response,0,0
66290,to,0,0
66291,a,0,0
66292,5-s,0,1
66293,transcutaneous,0,1
66294,tetanic,0,1
66295,stimulus,0,1
66296,),0,1
66297,",",0,0
66298,we,0,0
66299,determined,0,0
66300,dose-response,0,1
66301,curves,0,0
66302,for,0,0
66303,propofol,1,1
66304,and,1,1
66305,midazolam,1,1
66306,alone,1,0
66307,and,1,0
66308,in,1,0
66309,combination,1,0
66310,.,1,0
66311,For,0,0
66312,hypnosis,0,0
66313,",",0,0
66314,synergistic,0,0
66315,interaction,0,0
66316,was,0,0
66317,found,0,0
66318,(,0,0
66319,P,0,0
66320,less,0,0
66321,than,0,0
66322,0.01,0,0
66323,),0,0
66324,",",0,0
66325,the,0,0
66326,combination,0,0
66327,having,0,0
66328,1.44,0,0
66329,times,0,0
66330,the,0,0
66331,potency,0,0
66332,of,0,0
66333,the,0,0
66334,individual,0,0
66335,agents,0,0
66336,.,0,0
66337,Although,0,0
66338,midazolam,1,1
66339,failed,0,0
66340,to,0,0
66341,produce,0,0
66342,anaesthesia,0,0
66343,in,0,0
66344,the,0,0
66345,dose,0,1
66346,range,0,0
66347,used,0,0
66348,",",0,0
66349,the,0,0
66350,dose,0,1
66351,of,0,1
66352,propofol,1,1
66353,required,0,0
66354,to,0,0
66355,produce,0,0
66356,anaesthesia,0,0
66357,was,0,0
66358,reduced,0,0
66359,by,0,0
66360,52,0,0
66361,%,0,0
66362,in,0,0
66363,the,0,0
66364,presence,0,0
66365,of,0,0
66366,midazolam,1,1
66367,(,0,0
66368,P,0,0
66369,less,0,0
66370,than,0,0
66371,0.01,0,0
66372,),0,0
66373,.,0,0
66374,The,0,0
66375,reduction,0,0
66376,in,0,0
66377,arterial,0,0
66378,pressure,0,0
66379,at,0,0
66380,induction,0,0
66381,was,0,0
66382,the,0,0
66383,same,0,0
66384,for,0,0
66385,the,0,0
66386,combination,0,0
66387,as,0,0
66388,for,0,0
66389,the,0,0
66390,individual,0,0
66391,agents,0,0
66392,.,0,0
66393,The,0,0
66394,cause,0,0
66395,of,0,0
66396,the,0,0
66397,synergism,0,0
66398,was,0,0
66399,not,0,0
66400,clear,0,0
66401,",",0,0
66402,but,0,0
66403,may,0,0
66404,have,0,0
66405,been,0,0
66406,interaction,0,0
66407,at,0,0
66408,CNS,0,0
66409,GABAA,0,0
66410,receptors,0,0
66411,.,0,0
66412,Randomized,0,0
66413,trial,0,0
66414,of,0,0
66415,an,0,0
66416,allogeneic,1,0
66417,melanoma,1,1
66418,lysate,1,1
66419,vaccine,1,1
66420,with,1,1
66421,low-dose,1,1
66422,interferon,1,1
66423,Alfa-2b,1,1
66424,compared,0,1
66425,with,0,1
66426,high-dose,1,1
66427,interferon,1,1
66428,Alfa-2b,1,1
66429,for,0,0
66430,Resected,0,0
66431,stage,0,0
66432,III,0,0
66433,cutaneous,0,0
66434,melanoma,0,0
66435,.,0,0
66436,PURPOSE,0,0
66437,To,0,0
66438,compare,0,0
66439,the,0,0
66440,overall,0,0
66441,survival,0,1
66442,(,0,1
66443,OS,0,1
66444,),0,0
66445,of,0,0
66446,patients,0,0
66447,with,0,0
66448,resected,0,0
66449,stage,0,0
66450,III,0,1
66451,melanoma,0,1
66452,administered,0,1
66453,active,0,0
66454,specific,1,0
66455,immunotherapy,1,0
66456,and,1,1
66457,low-dose,1,1
66458,interferon,1,1
66459,alfa-2b,1,1
66460,(,1,1
66461,IFN-alpha-2b,1,1
66462,),1,1
66463,with,0,0
66464,the,0,0
66465,OS,0,0
66466,achieved,0,0
66467,using,0,0
66468,high-dose,1,1
66469,IFN-alpha-2b,1,1
66470,.,1,1
66471,PATIENTS,0,1
66472,AND,0,1
66473,METHODS,0,1
66474,An,0,1
66475,Ad,0,1
66476,Hoc,0,1
66477,Melanoma,0,0
66478,Working,0,0
66479,Group,0,0
66480,of,0,0
66481,25,0,0
66482,investigators,0,0
66483,treated,0,0
66484,604,0,0
66485,patients,0,0
66486,from,0,0
66487,April,0,1
66488,1997,0,1
66489,to,0,0
66490,January,0,0
66491,2003,0,0
66492,.,0,0
66493,Patients,0,0
66494,were,0,0
66495,stratified,0,0
66496,by,0,0
66497,sex,0,0
66498,and,0,0
66499,number,0,0
66500,of,0,0
66501,nodes,0,0
66502,and,0,0
66503,were,0,0
66504,randomly,0,0
66505,assigned,0,0
66506,to,0,0
66507,receive,0,0
66508,either,0,0
66509,2,0,0
66510,years,0,0
66511,of,0,0
66512,treatment,0,0
66513,with,0,0
66514,active,1,0
66515,specific,1,0
66516,immunotherapy,1,0
66517,with,1,0
66518,allogeneic,1,0
66519,melanoma,1,0
66520,lysates,1,0
66521,and,1,1
66522,low-dose,1,1
66523,IFN-alpha-2b,1,1
66524,(,1,1
66525,arm,1,1
66526,1,1,1
66527,),1,0
66528,or,0,1
66529,high-dose,1,1
66530,IFN-alpha-2b,1,1
66531,alone,1,0
66532,for,0,0
66533,1,0,0
66534,year,0,0
66535,(,0,1
66536,arm,0,1
66537,2,0,1
66538,),0,0
66539,.,0,0
66540,Active,0,0
66541,specific,0,0
66542,immunotherapy,0,0
66543,was,0,0
66544,injected,0,0
66545,subcutaneously,0,1
66546,(,0,1
66547,SC,0,1
66548,),0,1
66549,weekly,0,0
66550,for,0,0
66551,4,0,0
66552,weeks,0,0
66553,",",0,0
66554,at,0,0
66555,week,0,0
66556,8,0,0
66557,",",0,0
66558,and,0,0
66559,bimonthly,0,0
66560,thereafter,0,0
66561,.,0,0
66562,IFN-alpha-2b,1,1
66563,SC,1,1
66564,was,0,0
66565,begun,0,0
66566,on,0,0
66567,week,0,0
66568,4,0,0
66569,and,0,0
66570,continued,0,1
66571,thrice,0,1
66572,weekly,0,1
66573,at,0,1
66574,5,0,0
66575,MU/m2,0,0
66576,for,0,0
66577,2,0,0
66578,years,0,0
66579,.,0,0
66580,IFN-alpha-2b,1,1
66581,in,0,0
66582,arm,0,0
66583,2,0,0
66584,was,0,0
66585,administered,0,1
66586,according,0,0
66587,to,0,0
66588,the,0,0
66589,Eastern,0,0
66590,Cooperative,0,0
66591,Oncology,0,0
66592,Group,0,0
66593,1684,0,0
66594,study,0,0
66595,regimen,0,1
66596,.,0,1
66597,RESULTS,0,1
66598,Median,0,0
66599,follow-up,0,0
66600,time,0,0
66601,was,0,0
66602,32,0,0
66603,months,0,0
66604,for,0,0
66605,all,0,0
66606,patients,0,0
66607,and,0,0
66608,42,0,0
66609,months,0,0
66610,for,0,0
66611,surviving,0,0
66612,patients,0,0
66613,.,0,0
66614,Median,0,0
66615,OS,0,0
66616,time,0,0
66617,exceeds,0,0
66618,84,0,0
66619,months,0,0
66620,in,0,0
66621,arm,0,0
66622,1,0,0
66623,and,0,0
66624,is,0,0
66625,83,0,0
66626,months,0,0
66627,in,0,0
66628,arm,0,0
66629,2,0,0
66630,(,0,0
66631,P,0,0
66632,=,0,0
66633,.56,0,0
66634,),0,0
66635,.,0,0
66636,Five-year,0,0
66637,OS,0,0
66638,rate,0,0
66639,is,0,0
66640,61,0,0
66641,%,0,0
66642,in,0,0
66643,arm,0,0
66644,1,0,0
66645,and,0,0
66646,57,0,0
66647,%,0,0
66648,in,0,0
66649,arm,0,0
66650,2,0,0
66651,.,0,0
66652,Estimated,0,0
66653,5-year,0,0
66654,relapse-free,0,1
66655,survival,0,1
66656,(,0,1
66657,RFS,0,1
66658,),0,0
66659,rate,0,0
66660,is,0,0
66661,50,0,0
66662,%,0,0
66663,in,0,0
66664,arm,0,0
66665,1,0,0
66666,and,0,0
66667,48,0,0
66668,%,0,0
66669,in,0,0
66670,arm,0,0
66671,2,0,0
66672,",",0,0
66673,with,0,0
66674,median,0,0
66675,RFS,0,0
66676,times,0,0
66677,of,0,0
66678,58,0,0
66679,and,0,0
66680,50,0,0
66681,months,0,0
66682,",",0,0
66683,respectively,0,0
66684,.,0,0
66685,The,0,0
66686,incidence,0,0
66687,of,0,0
66688,serious,0,0
66689,adverse,0,0
66690,events,0,0
66691,as,0,0
66692,a,0,0
66693,result,0,0
66694,of,0,0
66695,treatment,0,0
66696,was,0,0
66697,the,0,0
66698,same,0,0
66699,in,0,0
66700,both,0,0
66701,arms,0,0
66702,",",0,0
66703,but,0,0
66704,more,0,0
66705,severe,0,0
66706,neuropsychiatric,0,0
66707,toxicity,0,0
66708,was,0,0
66709,seen,0,0
66710,in,0,0
66711,arm,0,0
66712,2,0,0
66713,.,0,0
66714,CONCLUSION,0,0
66715,OS,0,0
66716,and,0,0
66717,RFS,0,0
66718,achieved,0,0
66719,by,0,0
66720,active,1,0
66721,specific,1,0
66722,immunotherapy,1,0
66723,and,1,1
66724,low-dose,1,1
66725,IFN-alpha-2b,1,1
66726,were,0,0
66727,indistinguishable,0,0
66728,from,0,0
66729,those,0,0
66730,achieved,0,0
66731,by,0,0
66732,high-dose,1,1
66733,IFN-alpha-2b,1,1
66734,.,1,1
66735,Long,0,0
66736,RFS,0,0
66737,and,0,0
66738,OS,0,0
66739,times,0,0
66740,were,0,0
66741,observed,0,0
66742,in,0,0
66743,both,0,0
66744,treatment,0,0
66745,arms,0,0
66746,.,0,0
66747,Bright,1,0
66748,light,1,0
66749,therapy,1,0
66750,in,0,0
66751,Parkinson,0,0
66752,'s,0,0
66753,disease,0,0
66754,:,0,0
66755,a,0,0
66756,pilot,0,0
66757,study,0,0
66758,.,0,0
66759,Several,0,0
66760,observations,0,0
66761,suggest,0,0
66762,a,0,0
66763,beneficial,0,0
66764,effect,0,0
66765,of,0,0
66766,melatonin,1,1
66767,antagonism,1,1
66768,for,0,1
66769,Parkinson,0,0
66770,'s,0,1
66771,disease,0,1
66772,(,0,1
66773,PD,0,1
66774,),0,1
66775,.,0,0
66776,Although,0,0
66777,bright,1,0
66778,light,1,0
66779,therapy,1,0
66780,(,1,1
66781,BLT,1,1
66782,),1,1
66783,suppresses,0,0
66784,melatonin,0,1
66785,release,0,0
66786,and,0,0
66787,is,0,0
66788,an,0,0
66789,established,0,0
66790,treatment,0,0
66791,for,0,0
66792,depression,0,0
66793,and,0,0
66794,sleep,0,0
66795,disturbances,0,0
66796,",",0,0
66797,it,0,0
66798,has,0,0
66799,not,0,0
66800,been,0,0
66801,evaluated,0,0
66802,in,0,0
66803,PD,0,0
66804,.,0,0
66805,We,0,0
66806,examined,0,0
66807,effects,0,0
66808,of,0,0
66809,BLT,1,0
66810,on,0,0
66811,motor,0,0
66812,symptoms,0,0
66813,",",0,0
66814,depression,0,0
66815,",",0,0
66816,and,0,0
66817,sleep,0,0
66818,in,0,0
66819,PD,0,0
66820,in,0,0
66821,a,0,0
66822,randomized,0,1
66823,placebo-controlled,1,1
66824,double-blind,0,1
66825,study,0,0
66826,in,0,0
66827,36,0,0
66828,PD,0,0
66829,patients,0,0
66830,",",0,0
66831,using,0,0
66832,Parkinson,0,0
66833,'s,0,0
66834,Disease,0,0
66835,Rating,0,0
66836,Scale,0,1
66837,(,0,1
66838,UPDRS,0,1
66839,),0,1
66840,I-IV,0,1
66841,",",0,0
66842,Beck,0,1
66843,'s,0,1
66844,Depression,0,0
66845,Inventory,0,0
66846,",",0,0
66847,and,0,0
66848,Epworth,0,0
66849,Sleepiness,0,0
66850,Scale,0,0
66851,.,0,0
66852,All,0,0
66853,patients,0,0
66854,received,0,0
66855,BLT,1,0
66856,for,0,0
66857,15,0,0
66858,days,0,0
66859,in,0,0
66860,the,0,0
66861,morning,0,0
66862,",",0,0
66863,30,0,0
66864,min,0,0
66865,daily,0,1
66866,.,0,1
66867,Illuminance,0,0
66868,was,0,0
66869,7.500,0,0
66870,lux,0,0
66871,in,0,0
66872,the,0,0
66873,active,0,0
66874,treatment,0,0
66875,group,0,0
66876,and,0,0
66877,950,0,0
66878,lux,0,0
66879,in,0,0
66880,the,0,0
66881,placebo,1,1
66882,group,0,0
66883,.,0,0
66884,Although,0,0
66885,group,0,0
66886,differences,0,0
66887,were,0,0
66888,small,0,0
66889,",",0,0
66890,BLT,1,0
66891,led,0,0
66892,to,0,0
66893,significant,0,0
66894,improvement,0,0
66895,of,0,0
66896,tremor,0,0
66897,",",0,0
66898,UPDRS,0,0
66899,I,0,0
66900,",",0,0
66901,II,0,0
66902,",",0,0
66903,and,0,0
66904,IV,0,0
66905,",",0,0
66906,and,0,0
66907,depression,0,0
66908,in,0,0
66909,the,0,0
66910,active,0,0
66911,treatment,0,0
66912,group,0,0
66913,but,0,0
66914,not,0,0
66915,in,0,0
66916,the,0,0
66917,placebo,1,1
66918,group,0,1
66919,.,0,0
66920,It,0,0
66921,was,0,0
66922,very,0,0
66923,well,0,0
66924,tolerated,0,1
66925,.,0,0
66926,Follow,0,0
66927,up,0,0
66928,studies,0,0
66929,in,0,0
66930,more,0,0
66931,advanced,0,0
66932,patient,0,0
66933,populations,0,0
66934,employing,0,0
66935,longer,0,0
66936,treatment,0,0
66937,durations,0,0
66938,are,0,0
66939,warranted,0,0
66940,.,0,0
66941,Long-term,0,0
66942,growth,0,0
66943,hormone,0,1
66944,treatment,0,0
66945,in,0,0
66946,growth,0,0
66947,hormone,0,1
66948,deficient,0,0
66949,adults,0,0
66950,.,0,0
66951,Growth,1,1
66952,hormone,1,1
66953,treatment,1,0
66954,in,0,0
66955,GH-deficient,0,0
66956,adults,0,0
66957,has,0,0
66958,proved,0,0
66959,beneficial,0,0
66960,in,0,0
66961,recent,0,0
66962,short-term,0,0
66963,trials,0,0
66964,",",0,0
66965,but,0,0
66966,long-term,0,0
66967,results,0,0
66968,have,0,0
66969,not,0,0
66970,yet,0,0
66971,been,0,0
66972,reported,0,0
66973,.,0,0
66974,Thirteen,0,0
66975,GH-deficient,0,0
66976,adults,0,1
66977,(,0,0
66978,4,0,0
66979,females,0,0
66980,",",0,0
66981,9,0,0
66982,males,0,0
66983,;,0,0
66984,mean,0,0
66985,(,0,0
66986,SEM,0,1
66987,),0,0
66988,age,0,0
66989,26.4,0,0
66990,(,0,0
66991,1.7,0,0
66992,),0,0
66993,years,0,0
66994,),0,1
66995,",",0,0
66996,who,0,0
66997,had,0,0
66998,completed,0,0
66999,4,0,0
67000,months,0,0
67001,of,0,0
67002,GH,1,0
67003,therapy,1,0
67004,in,0,0
67005,a,0,0
67006,double-blind,0,1
67007,placebo-controlled,1,1
67008,cross-over,0,1
67009,study,0,0
67010,were,0,0
67011,followed,0,0
67012,",",0,0
67013,for,0,0
67014,further,0,0
67015,16.1,0,0
67016,(,0,0
67017,0.8,0,0
67018,),0,0
67019,months,0,0
67020,of,0,0
67021,uninterrupted,0,0
67022,GH,1,0
67023,therapy,1,0
67024,in,0,0
67025,an,0,0
67026,open,0,0
67027,design,0,0
67028,.,0,0
67029,A,0,0
67030,significant,0,0
67031,mean,0,0
67032,increase,0,0
67033,of,0,0
67034,1.3,0,0
67035,cm,0,0
67036,in,0,0
67037,linear,0,0
67038,height,0,0
67039,was,0,0
67040,recorded,0,0
67041,",",0,0
67042,whereas,0,0
67043,body,0,0
67044,mass,0,0
67045,index,0,0
67046,remained,0,0
67047,unchanged,0,0
67048,.,0,0
67049,Mean,0,0
67050,muscle,0,0
67051,volume,0,0
67052,of,0,0
67053,the,0,0
67054,thigh,0,0
67055,",",0,0
67056,estimated,0,0
67057,by,0,0
67058,computerised,0,0
67059,tomography,0,0
67060,",",0,0
67061,increased,0,0
67062,significantly,0,0
67063,compared,0,0
67064,with,0,0
67065,that,0,0
67066,of,0,0
67067,the,0,0
67068,initial,0,0
67069,placebo,1,1
67070,period,0,1
67071,(,0,0
67072,p,0,0
67073,=,0,0
67074,0.01,0,0
67075,),0,0
67076,",",0,0
67077,and,0,0
67078,a,0,0
67079,slight,0,0
67080,decrease,0,0
67081,was,0,0
67082,recorded,0,0
67083,in,0,0
67084,adipose,0,0
67085,tissue,0,0
67086,volume,0,0
67087,of,0,0
67088,the,0,0
67089,thigh,0,0
67090,(,0,0
67091,p,0,0
67092,=,0,0
67093,0.10,0,0
67094,),0,0
67095,and,0,0
67096,subscapular,0,1
67097,skinfold,0,1
67098,thickness,0,0
67099,(,0,0
67100,p,0,0
67101,=,0,0
67102,0.10,0,0
67103,),0,0
67104,.,0,0
67105,Still,0,0
67106,",",0,0
67107,the,0,0
67108,muscle,0,0
67109,to,0,0
67110,fat,0,0
67111,ratio,0,0
67112,of,0,0
67113,the,0,0
67114,thigh,0,0
67115,was,0,0
67116,significantly,0,0
67117,lower,0,0
67118,compared,0,0
67119,with,0,0
67120,that,0,0
67121,of,0,0
67122,normal,0,0
67123,subjects,0,0
67124,(,0,0
67125,72.6/27.4,0,0
67126,vs,0,0
67127,77.9/22.1,0,0
67128,),0,0
67129,(,0,0
67130,p,0,0
67131,less,0,0
67132,than,0,0
67133,0.01,0,0
67134,),0,0
67135,.,0,0
67136,The,0,0
67137,mean,0,0
67138,isometric,0,0
67139,strength,0,0
67140,of,0,0
67141,the,0,0
67142,quadriceps,0,0
67143,muscles,0,0
67144,increased,0,0
67145,significantly,0,0
67146,during,0,0
67147,long-term,0,0
67148,GH,0,1
67149,therapy,0,0
67150,(,0,0
67151,p,0,0
67152,less,0,0
67153,than,0,0
67154,0.01,0,0
67155,),0,0
67156,",",0,0
67157,but,0,0
67158,remained,0,0
67159,lower,0,0
67160,compared,0,0
67161,with,0,0
67162,that,0,0
67163,of,0,0
67164,normal,0,0
67165,subjects,0,0
67166,(,0,0
67167,1.66,0,0
67168,(,0,0
67169,0.10,0,0
67170,),0,0
67171,vs,0,0
67172,2.13,0,0
67173,(,0,0
67174,0.11,0,0
67175,),0,0
67176,Nm/kg,0,1
67177,body,0,1
67178,weight,0,1
67179,),0,0
67180,.,0,0
67181,Exercise,0,0
67182,capacity,0,0
67183,performed,0,0
67184,on,0,0
67185,a,0,0
67186,bicycle,0,0
67187,ergometer,0,0
67188,increased,0,0
67189,significantly,0,0
67190,after,0,0
67191,long-term,0,0
67192,therapy,0,0
67193,(,0,0
67194,p,0,0
67195,less,0,0
67196,than,0,0
67197,0.05,0,0
67198,),0,0
67199,",",0,0
67200,but,0,0
67201,still,0,0
67202,did,0,0
67203,not,0,0
67204,reach,0,0
67205,the,0,0
67206,values,0,0
67207,seen,0,0
67208,in,0,0
67209,normal,0,0
67210,subjects,0,0
67211,(,0,0
67212,22.5,0,0
67213,(,0,0
67214,3.4,0,0
67215,),0,0
67216,vs,0,0
67217,37.4,0,0
67218,(,0,0
67219,4.2,0,0
67220,),0,0
67221,watt.min.kg-1,0,1
67222,.,0,1
67223,No,0,1
67224,adverse,0,0
67225,reactions,0,0
67226,were,0,0
67227,recorded,0,0
67228,during,0,0
67229,long-term,0,0
67230,therapy,0,1
67231,and,0,1
67232,hemoglobin,0,1
67233,A1c,0,1
67234,remained,0,0
67235,unchanged,0,0
67236,.,0,0
67237,These,0,0
67238,data,0,0
67239,suggest,0,0
67240,that,0,0
67241,long-term,0,0
67242,GH,0,0
67243,replacement,0,0
67244,therapy,0,0
67245,in,0,0
67246,GH-deficient,0,0
67247,adults,0,0
67248,has,0,0
67249,beneficial,0,0
67250,effects,0,0
67251,on,0,0
67252,several,0,0
67253,physiological,0,0
67254,features,0,0
67255,which,0,0
67256,are,0,0
67257,subnormal,0,0
67258,in,0,0
67259,these,0,0
67260,patients,0,0
67261,.,0,0
67262,Parenteral,1,1
67263,amino,1,1
67264,acid,1,1
67265,and,0,0
67266,metabolic,0,0
67267,acidosis,0,0
67268,in,0,0
67269,premature,0,0
67270,infants,0,0
67271,.,0,0
67272,BACKGROUND,0,1
67273,Aggressive,1,1
67274,parenteral,1,1
67275,nutrition,1,1
67276,(,1,1
67277,PN,1,1
67278,),1,0
67279,including,1,0
67280,amino,1,0
67281,acids,1,0
67282,is,0,0
67283,recommended,0,0
67284,for,0,0
67285,low-birth-weight,0,0
67286,infants,0,0
67287,to,0,0
67288,prevent,0,0
67289,energy,0,0
67290,and,0,0
67291,protein,0,0
67292,deficit,0,0
67293,.,0,0
67294,Their,0,0
67295,impact,0,0
67296,on,0,0
67297,acid-base,0,0
67298,homeostasis,0,0
67299,has,0,0
67300,not,0,0
67301,been,0,0
67302,examined,0,0
67303,.,0,0
67304,METHODS,0,0
67305,We,0,0
67306,investigated,0,0
67307,the,0,0
67308,impact,0,0
67309,of,0,0
67310,dose,0,1
67311,and,0,0
67312,duration,0,1
67313,of,0,0
67314,parenteral,1,1
67315,amino,1,1
67316,acids,1,1
67317,",",1,0
67318,with,1,0
67319,cysteine,1,1
67320,",",0,0
67321,on,0,0
67322,acid-base,0,0
67323,parameters,0,0
67324,in,0,0
67325,122,0,0
67326,low-birth-weight,0,0
67327,infants,0,0
67328,.,0,0
67329,Premature,0,0
67330,infants,0,0
67331,<,0,0
67332,or=32,0,0
67333,weeks,0,0
67334,",",0,0
67335,<,0,0
67336,or=1850,0,0
67337,g,0,0
67338,",",0,0
67339,and,0,0
67340,receiving,0,0
67341,parenteral,1,1
67342,amino,1,1
67343,acids,1,1
67344,at,0,1
67345,1.5,0,0
67346,g/kg/d,0,1
67347,for,0,0
67348,an,0,0
67349,extended,0,0
67350,period,0,1
67351,(,0,0
67352,>,0,0
67353,24,0,1
67354,hours,0,1
67355,),0,1
67356,",",0,1
67357,or,0,0
67358,3,0,1
67359,g/kg/d,0,1
67360,for,0,0
67361,a,0,0
67362,short,0,0
67363,(,0,0
67364,5,0,1
67365,hour,0,1
67366,),0,1
67367,",",0,1
67368,extended,0,0
67369,(,0,0
67370,24,0,1
67371,hour,0,1
67372,),0,1
67373,",",0,0
67374,or,0,0
67375,prolonged,0,0
67376,(,0,0
67377,3-5,0,0
67378,days,0,1
67379,),0,0
67380,duration,0,0
67381,were,0,0
67382,included,0,0
67383,in,0,0
67384,the,0,0
67385,study,0,0
67386,.,0,0
67387,Data,0,0
67388,were,0,0
67389,obtained,0,0
67390,at,0,0
67391,age,0,0
67392,0-3,0,0
67393,days,0,0
67394,(,0,0
67395,n,0,0
67396,=,0,0
67397,43,0,0
67398,),0,0
67399,or,0,0
67400,",",0,0
67401,when,0,0
67402,clinically,0,0
67403,stable,0,0
67404,",",0,0
67405,age,0,0
67406,3-5,0,1
67407,days,0,1
67408,(,0,0
67409,n,0,0
67410,=,0,0
67411,49,0,0
67412,),0,0
67413,.,0,0
67414,Data,0,0
67415,from,0,0
67416,30,0,0
67417,infants,0,0
67418,",",0,0
67419,matched,0,0
67420,for,0,0
67421,birth,0,0
67422,weight,0,0
67423,and,0,0
67424,gestational,0,0
67425,age,0,0
67426,",",0,0
67427,receiving,0,0
67428,PN,1,0
67429,during,0,0
67430,the,0,0
67431,first,0,0
67432,5,0,0
67433,days,0,0
67434,after,0,0
67435,birth,0,0
67436,were,0,0
67437,also,0,0
67438,obtained,0,0
67439,.,0,0
67440,Acidosis,0,0
67441,was,0,0
67442,defined,0,0
67443,as,0,0
67444,pH,0,0
67445,<,0,0
67446,7.25,0,0
67447,.,0,0
67448,RESULTS,0,0
67449,Acidosis,0,0
67450,was,0,0
67451,evident,0,0
67452,in,0,0
67453,all,0,0
67454,infants,0,0
67455,between,0,0
67456,2,0,0
67457,and,0,0
67458,5,0,0
67459,days,0,0
67460,after,0,0
67461,birth,0,0
67462,.,0,0
67463,Infants,0,0
67464,with,0,0
67465,large,0,0
67466,patent,0,0
67467,ductus,0,1
67468,arteriosus,0,1
67469,(,0,1
67470,PDA,0,1
67471,),0,0
67472,exhibited,0,0
67473,significantly,0,0
67474,(,0,0
67475,p,0,0
67476,<,0,0
67477,.05,0,0
67478,),0,0
67479,lower,0,0
67480,pH,0,0
67481,early,0,0
67482,",",0,0
67483,had,0,0
67484,higher,0,0
67485,blood,0,0
67486,urea,0,1
67487,nitrogen,0,0
67488,levels,0,0
67489,(,0,0
67490,26,0,0
67491,+/-,0,0
67492,9,0,0
67493,vs,0,0
67494,18,0,0
67495,+,0,0
67496,8,0,1
67497,mg/dL,0,1
67498,;,0,0
67499,p,0,0
67500,<,0,0
67501,.05,0,0
67502,),0,0
67503,",",0,0
67504,and,0,0
67505,had,0,0
67506,greater,0,0
67507,weight,0,0
67508,loss,0,0
67509,(,0,0
67510,approximately,0,0
67511,17,0,0
67512,%,0,0
67513,of,0,0
67514,birth,0,0
67515,weight,0,1
67516,),0,0
67517,when,0,0
67518,compared,0,0
67519,with,0,0
67520,infants,0,0
67521,without,0,0
67522,PDA,0,0
67523,.,0,0
67524,Gestational,0,0
67525,age,0,0
67526,",",0,0
67527,weight,0,0
67528,loss,0,0
67529,",",0,0
67530,and,0,0
67531,patent,0,0
67532,ductus,0,0
67533,arteriosus,0,0
67534,accounted,0,0
67535,for,0,0
67536,65,0,0
67537,%,0,0
67538,of,0,0
67539,variance,0,0
67540,in,0,0
67541,acidosis,0,0
67542,.,0,0
67543,CONCLUSIONS,0,0
67544,Low-birth-weight,0,0
67545,infants,0,0
67546,develop,0,0
67547,metabolic,0,0
67548,acidosis,0,0
67549,between,0,0
67550,2,0,0
67551,and,0,0
67552,5,0,0
67553,days,0,0
67554,after,0,0
67555,birth,0,0
67556,",",0,0
67557,irrespective,0,0
67558,of,0,0
67559,dose,0,1
67560,and,0,0
67561,duration,0,1
67562,of,0,0
67563,parenteral,1,1
67564,amino,1,1
67565,acid,1,1
67566,administration,1,1
67567,.,1,1
67568,Careful,0,0
67569,management,0,0
67570,of,0,1
67571,parenteral,1,1
67572,fluids,1,1
67573,and,0,1
67574,comorbidities,0,0
67575,may,0,0
67576,lower,0,0
67577,the,0,0
67578,incidence,0,0
67579,of,0,0
67580,acidosis,0,0
67581,and,0,0
67582,promote,0,0
67583,protein,0,0
67584,accretion,0,0
67585,.,0,0
67586,A,0,1
67587,prospective,0,1
67588,",",0,0
67589,randomized,0,0
67590,trial,0,0
67591,of,0,0
67592,clear,0,1
67593,liquids,0,1
67594,versus,0,1
67595,low-fat,0,1
67596,solid,0,1
67597,diet,0,1
67598,as,0,0
67599,the,0,0
67600,initial,0,0
67601,meal,0,1
67602,in,0,0
67603,mild,0,0
67604,acute,0,0
67605,pancreatitis,0,0
67606,.,0,0
67607,BACKGROUND,0,0
67608,&,0,0
67609,AIMS,0,0
67610,Patients,0,0
67611,recovering,0,0
67612,from,0,0
67613,mild,0,0
67614,acute,0,0
67615,pancreatitis,0,0
67616,typically,0,0
67617,receive,0,0
67618,a,0,0
67619,clear,1,1
67620,liquid,1,1
67621,diet,1,1
67622,(,1,1
67623,CLD,1,1
67624,),1,0
67625,when,0,0
67626,ready,0,0
67627,to,0,0
67628,initiate,0,0
67629,oral,0,1
67630,nutrition,0,1
67631,.,0,0
67632,Patient,0,0
67633,discharge,0,0
67634,then,0,0
67635,depends,0,0
67636,on,0,0
67637,their,0,0
67638,successful,0,0
67639,advancement,0,0
67640,to,0,0
67641,solid,0,0
67642,food,0,0
67643,.,0,0
67644,We,0,0
67645,hypothesized,0,0
67646,that,0,0
67647,initiating,0,0
67648,oral,1,1
67649,nutrition,1,1
67650,with,1,0
67651,a,1,0
67652,low-fat,1,1
67653,solid,1,1
67654,diet,1,1
67655,(,1,1
67656,LFSD,1,1
67657,),1,1
67658,after,0,0
67659,mild,0,0
67660,pancreatitis,0,0
67661,would,0,0
67662,be,0,0
67663,well,0,0
67664,tolerated,0,1
67665,and,0,0
67666,would,0,0
67667,result,0,0
67668,in,0,0
67669,a,0,0
67670,shorter,0,0
67671,length,0,0
67672,of,0,0
67673,hospitalization,0,0
67674,(,0,1
67675,LOH,0,1
67676,),0,1
67677,.,0,0
67678,METHODS,0,0
67679,Patients,0,0
67680,with,0,0
67681,mild,0,0
67682,pancreatitis,0,0
67683,were,0,0
67684,randomized,0,0
67685,to,0,0
67686,a,0,0
67687,CLD,1,0
67688,or,1,0
67689,LFSD,1,0
67690,when,0,0
67691,they,0,0
67692,were,0,0
67693,ready,0,0
67694,to,0,0
67695,resume,0,1
67696,oral,0,1
67697,nutrition,0,1
67698,.,0,0
67699,Decisions,0,0
67700,about,0,0
67701,diet,0,1
67702,advancement,0,1
67703,and,0,0
67704,hospital,0,0
67705,discharge,0,0
67706,were,0,0
67707,at,0,0
67708,the,0,0
67709,discretion,0,0
67710,of,0,0
67711,the,0,0
67712,medical,0,0
67713,team,0,0
67714,",",0,0
67715,without,0,0
67716,input,0,0
67717,from,0,0
67718,study,0,0
67719,team,0,0
67720,members,0,0
67721,.,0,0
67722,Patients,0,0
67723,were,0,0
67724,monitored,0,0
67725,daily,0,1
67726,for,0,0
67727,recurrence,0,0
67728,of,0,0
67729,pain,0,0
67730,",",0,0
67731,need,0,0
67732,to,0,0
67733,stop,0,0
67734,feeding,0,0
67735,",",0,0
67736,post-refeeding,0,1
67737,LOH,0,1
67738,(,0,0
67739,primary,0,0
67740,end,0,0
67741,point,0,0
67742,),0,0
67743,",",0,0
67744,and,0,0
67745,for,0,0
67746,28,0,0
67747,days,0,0
67748,post-refeeding,0,0
67749,to,0,0
67750,capture,0,0
67751,re-admission,0,0
67752,rates,0,0
67753,.,0,0
67754,RESULTS,0,0
67755,We,0,0
67756,randomized,0,0
67757,121,0,0
67758,patients,0,0
67759,:,0,0
67760,66,0,0
67761,to,0,0
67762,CLD,0,0
67763,and,0,0
67764,55,0,0
67765,to,0,0
67766,LFSD,0,0
67767,.,0,0
67768,The,0,0
67769,number,0,0
67770,of,0,0
67771,patients,0,0
67772,requiring,0,0
67773,cessation,0,0
67774,of,0,0
67775,feeding,0,0
67776,because,0,0
67777,of,0,0
67778,pain,0,0
67779,or,0,0
67780,nausea,0,1
67781,was,0,0
67782,similar,0,0
67783,in,0,0
67784,both,0,0
67785,groups,0,0
67786,(,0,0
67787,6,0,0
67788,%,0,0
67789,for,0,0
67790,CLD,0,0
67791,",",0,0
67792,11,0,0
67793,%,0,0
67794,for,0,0
67795,LFSD,0,0
67796,;,0,0
67797,P,0,0
67798,=,0,0
67799,.51,0,0
67800,),0,0
67801,.,0,0
67802,The,0,0
67803,median,0,0
67804,LOH,0,0
67805,after,0,0
67806,refeeding,0,1
67807,was,0,0
67808,identical,0,0
67809,in,0,0
67810,both,0,0
67811,groups,0,0
67812,(,0,0
67813,1-day,0,0
67814,interquartile,0,0
67815,range,0,0
67816,",",0,0
67817,1-2,0,0
67818,;,0,0
67819,P,0,0
67820,=,0,0
67821,.77,0,0
67822,),0,0
67823,.,0,0
67824,Patients,0,0
67825,in,0,0
67826,the,0,0
67827,LFSD,0,1
67828,arm,0,1
67829,consumed,0,1
67830,significantly,0,0
67831,more,0,0
67832,calories,0,1
67833,and,0,1
67834,grams,0,1
67835,of,0,1
67836,fat,0,0
67837,than,0,0
67838,those,0,0
67839,in,0,0
67840,the,0,0
67841,CLD,0,0
67842,arm,0,0
67843,during,0,0
67844,their,0,0
67845,first,0,0
67846,meal,0,1
67847,and,0,0
67848,on,0,0
67849,study,0,0
67850,day,0,0
67851,1,0,0
67852,.,0,0
67853,There,0,0
67854,was,0,0
67855,no,0,0
67856,difference,0,0
67857,in,0,0
67858,the,0,0
67859,28-day,0,1
67860,re-admission,0,1
67861,rates,0,0
67862,between,0,0
67863,the,0,0
67864,2,0,0
67865,arms,0,0
67866,.,0,0
67867,CONCLUSIONS,0,0
67868,Initiating,0,0
67869,oral,0,1
67870,nutrition,0,1
67871,after,0,0
67872,mild,0,0
67873,acute,0,0
67874,pancreatitis,0,0
67875,with,0,0
67876,an,0,0
67877,LFSD,0,0
67878,appeared,0,0
67879,safe,0,0
67880,and,0,0
67881,provided,0,0
67882,more,0,0
67883,calories,0,1
67884,than,0,0
67885,a,0,0
67886,CLD,0,0
67887,",",0,0
67888,but,0,0
67889,did,0,0
67890,not,0,0
67891,result,0,0
67892,in,0,0
67893,a,0,0
67894,shorter,0,0
67895,LOH,0,0
67896,.,0,0
67897,[,0,0
67898,Application,0,0
67899,of,0,0
67900,tacrolimus,1,1
67901,and,1,1
67902,cyclosporine,1,1
67903,A,1,1
67904,in,0,0
67905,HBV-carrying,0,0
67906,renal,0,0
67907,transplant,0,1
67908,recipients,0,0
67909,],0,0
67910,.,0,0
67911,OBJECTIVE,0,0
67912,To,0,0
67913,compare,0,0
67914,the,0,0
67915,long-term,0,0
67916,effect,0,0
67917,and,0,0
67918,safety,0,0
67919,of,0,1
67920,tacrolimus,1,1
67921,(,1,1
67922,FK506,1,1
67923,),1,1
67924,and,1,1
67925,cyclosporine,1,1
67926,(,1,1
67927,CsA,1,1
67928,),1,1
67929,in,0,0
67930,kidney,0,1
67931,transplant,0,1
67932,(,0,1
67933,KT,0,1
67934,),0,1
67935,recipients,0,0
67936,carrying,0,0
67937,hepatitis,0,0
67938,B,0,1
67939,Virus,0,1
67940,(,0,1
67941,HBV,0,1
67942,),0,1
67943,.,0,0
67944,METHODS,0,0
67945,A,0,0
67946,total,0,0
67947,of,0,0
67948,109,0,0
67949,patients,0,0
67950,with,0,0
67951,HBV,0,0
67952,were,0,0
67953,randomized,0,0
67954,into,0,0
67955,FK506,1,1
67956,group,0,0
67957,(,0,0
67958,52,0,0
67959,cases,0,0
67960,),0,0
67961,and,0,0
67962,CsA,1,1
67963,group,0,0
67964,(,0,0
67965,57,0,0
67966,cases,0,0
67967,),0,0
67968,after,0,0
67969,KT,0,0
67970,",",0,0
67971,and,0,0
67972,a,0,0
67973,2-year-long,0,0
67974,follow-up,0,0
67975,of,0,0
67976,the,0,0
67977,patients,0,0
67978,was,0,0
67979,conducted,0,0
67980,to,0,0
67981,record,0,0
67982,the,0,0
67983,patient,0,0
67984,and,0,0
67985,graft,0,0
67986,survival,0,0
67987,",",0,0
67988,incidence,0,0
67989,of,0,0
67990,acute,0,0
67991,graft,0,0
67992,rejection,0,0
67993,and,0,0
67994,postoperative,0,0
67995,liver,0,0
67996,function,0,0
67997,.,0,0
67998,RESULTS,0,0
67999,The,0,0
68000,2-year,0,0
68001,patient/graft,0,0
68002,survival,0,0
68003,was,0,0
68004,86.0,0,0
68005,%,0,0
68006,/73.7,0,0
68007,%,0,0
68008,and,0,0
68009,94.2,0,0
68010,%,0,0
68011,/90.3,0,0
68012,%,0,0
68013,in,0,0
68014,CsA,0,0
68015,and,0,0
68016,FK506,0,1
68017,groups,0,0
68018,",",0,0
68019,respectively,0,0
68020,(,0,0
68021,P,0,0
68022,<,0,0
68023,0.05,0,0
68024,),0,0
68025,",",0,0
68026,with,0,0
68027,incidence,0,0
68028,of,0,0
68029,acute,0,0
68030,rejection,0,0
68031,of,0,0
68032,10.5,0,0
68033,%,0,0
68034,and,0,0
68035,9.6,0,0
68036,%,0,0
68037,(,0,0
68038,P,0,0
68039,>,0,0
68040,0.05,0,0
68041,),0,0
68042,",",0,0
68043,and,0,0
68044,rate,0,0
68045,of,0,0
68046,abnormal,0,0
68047,liver,0,0
68048,function,0,0
68049,of,0,0
68050,26.3,0,0
68051,%,0,0
68052,and,0,0
68053,15.4,0,0
68054,%,0,0
68055,(,0,0
68056,P,0,0
68057,<,0,0
68058,0.05,0,0
68059,),0,0
68060,",",0,0
68061,respectively,0,0
68062,.,0,0
68063,Eight,0,0
68064,patients,0,0
68065,(,0,0
68066,14.4,0,0
68067,%,0,0
68068,),0,0
68069,in,0,0
68070,CsA,0,1
68071,group,0,0
68072,required,0,0
68073,a,0,0
68074,drug,0,1
68075,conversion,0,0
68076,but,0,0
68077,none,0,0
68078,in,0,0
68079,FK506,0,0
68080,group,0,0
68081,.,0,0
68082,The,0,0
68083,drug,0,1
68084,conversion,0,0
68085,resulted,0,0
68086,in,0,0
68087,significant,0,0
68088,reduction,0,0
68089,of,0,0
68090,ALT/AST,0,0
68091,level,0,0
68092,from,0,0
68093,255.13+/-31.38/201.88+/-21.25,0,0
68094,U/L,0,0
68095,to,0,0
68096,31.25+/-11.50/25.13+/-9.68,0,0
68097,U/L,0,0
68098,(,0,0
68099,P,0,0
68100,<,0,0
68101,0.01,0,0
68102,),0,0
68103,.,0,0
68104,CONCLUSION,0,0
68105,For,0,0
68106,HBV-carrying,0,0
68107,renal,0,0
68108,transplant,0,0
68109,recipients,0,0
68110,",",0,0
68111,FK506,1,0
68112,as,0,0
68113,the,0,0
68114,primary,0,0
68115,choice,0,0
68116,of,0,0
68117,immunosuppressant,0,1
68118,can,0,0
68119,be,0,0
68120,more,0,0
68121,effective,0,0
68122,and,0,0
68123,safer,0,0
68124,than,0,0
68125,CsA,0,0
68126,.,0,0
68127,[,0,0
68128,Effect,0,0
68129,of,0,0
68130,electroacununcture,1,0
68131,on,0,0
68132,sex,0,0
68133,hormone,0,1
68134,levels,0,0
68135,in,0,0
68136,patients,0,0
68137,with,0,0
68138,Sj?gren,0,0
68139,'s,0,1
68140,syndrome,0,1
68141,],0,0
68142,.,0,0
68143,OBJECTIVE,0,0
68144,To,0,0
68145,observe,0,0
68146,the,0,0
68147,effect,0,0
68148,of,1,0
68149,electroacupuncture,1,1
68150,(,1,1
68151,EA,1,1
68152,),1,1
68153,on,0,1
68154,serum,0,1
68155,testosterone,0,1
68156,(,0,1
68157,T,0,1
68158,),0,1
68159,",",0,1
68160,estradiol,0,1
68161,(,0,1
68162,F2,0,1
68163,),0,1
68164,",",0,1
68165,luteotropic,0,1
68166,hormone,0,1
68167,(,0,1
68168,LH,0,1
68169,),0,1
68170,",",0,1
68171,follicle-stimulating,0,1
68172,hormone,0,1
68173,(,0,1
68174,FSH,0,1
68175,),0,1
68176,",",0,1
68177,progesterone,0,1
68178,(,0,0
68179,P,0,0
68180,),0,0
68181,",",0,0
68182,and,0,1
68183,prolactin,0,1
68184,(,0,1
68185,PRL,0,1
68186,),0,0
68187,in,0,0
68188,patients,0,0
68189,with,0,0
68190,Sj?gren,0,0
68191,'s,0,1
68192,Syndrome,0,1
68193,(,0,1
68194,SS,0,1
68195,),0,0
68196,in,0,0
68197,order,0,0
68198,to,0,0
68199,analyze,0,0
68200,the,0,0
68201,correlation,0,0
68202,between,0,0
68203,the,0,0
68204,adjustment,0,0
68205,effect,0,0
68206,of,0,0
68207,EA,1,0
68208,and,1,0
68209,changes,0,0
68210,of,0,0
68211,hormone,0,1
68212,levels,0,0
68213,.,0,0
68214,METHODS,0,0
68215,Fifty-seven,0,0
68216,middle-aged,0,0
68217,and,0,0
68218,old,0,0
68219,women,0,0
68220,with,0,0
68221,SS,0,0
68222,were,0,0
68223,divided,0,0
68224,into,1,0
68225,medication,1,1
68226,group,1,0
68227,(,0,0
68228,n=27,0,0
68229,),0,0
68230,and,1,0
68231,acupuncture,1,1
68232,group,1,0
68233,(,0,0
68234,n=30,0,0
68235,),0,0
68236,.,0,0
68237,Patients,0,0
68238,in,0,0
68239,acupuncture,1,0
68240,group,1,0
68241,were,1,0
68242,treated,1,0
68243,with,1,0
68244,EA,1,1
68245,(,1,0
68246,80,1,0
68247,Hz,1,1
68248,",",1,0
68249,2.5,1,0
68250,mA,1,1
68251,),1,0
68252,of,1,0
68253,Shenshu,1,1
68254,(,1,0
68255,BL,1,0
68256,23,1,0
68257,),1,0
68258,",",1,0
68259,Taixi,1,1
68260,(,1,1
68261,KI,1,1
68262,3,1,1
68263,),1,0
68264,",",1,1
68265,Hegu,1,1
68266,(,1,1
68267,LI,1,1
68268,4,1,1
68269,),1,0
68270,",",1,0
68271,etc,1,0
68272,.,1,0
68273,for,1,0
68274,30,1,0
68275,min,1,0
68276,",",1,0
68277,once,1,1
68278,every,1,1
68279,other,1,1
68280,day,1,1
68281,",",1,0
68282,and,1,0
68283,those,1,0
68284,of,1,0
68285,medication,1,0
68286,group,1,0
68287,were,1,0
68288,treated,1,0
68289,with,1,0
68290,oral,1,1
68291,administration,1,1
68292,of,1,1
68293,hydroxyl-chloroquine,1,1
68294,(,1,1
68295,6,1,1
68296,mg/kg,1,1
68297,per,1,1
68298,day,1,1
68299,),1,1
68300,",",1,1
68301,oral,1,1
68302,transfer,1,0
68303,agent,1,0
68304,liquid,1,1
68305,",",1,0
68306,Vit,1,1
68307,B1,1,1
68308,",",1,0
68309,Vit,1,1
68310,B2,1,1
68311,",",1,0
68312,Vit,1,1
68313,C,1,1
68314,",",1,0
68315,fish-liver,1,0
68316,oil,1,1
68317,",",1,1
68318,one,1,0
68319,tablet/time,1,1
68320,",",1,1
68321,t.i.d.,1,1
68322,",",1,1
68323,and,1,1
68324,pilocarpine,1,1
68325,(,1,1
68326,20,1,1
68327,mg/d,1,1
68328,),1,1
68329,",",1,0
68330,continuously,1,0
68331,for,1,0
68332,2,1,0
68333,months,1,0
68334,.,1,0
68335,Venous,0,0
68336,blood,0,0
68337,samples,0,0
68338,were,0,0
68339,collected,0,0
68340,before,0,0
68341,and,0,0
68342,after,0,0
68343,the,0,0
68344,treatment,0,0
68345,to,0,0
68346,examine,0,0
68347,contents,0,0
68348,of,0,0
68349,the,0,0
68350,abovementioned,0,0
68351,sex,0,0
68352,hormones,0,0
68353,by,0,0
68354,using,1,0
68355,electro-chemiluminescent,1,1
68356,immunoassay,1,1
68357,(,1,1
68358,CLIA,1,1
68359,),1,1
68360,.,1,0
68361,RESULTS,0,1
68362,(,0,1
68363,1,0,1
68364,),0,0
68365,Before,0,0
68366,the,0,0
68367,treatment,0,0
68368,",",0,0
68369,no,0,0
68370,significant,0,0
68371,differences,0,0
68372,were,0,0
68373,found,0,0
68374,between,0,0
68375,two,0,0
68376,groups,0,0
68377,in,0,0
68378,the,0,0
68379,levels,0,0
68380,of,0,0
68381,serum,0,1
68382,T,0,1
68383,",",0,1
68384,E2,0,1
68385,",",0,0
68386,LH,0,1
68387,",",0,0
68388,FSH,0,0
68389,",",0,0
68390,P,0,0
68391,and,0,0
68392,PRL,0,0
68393,(,0,0
68394,P,0,0
68395,>,0,0
68396,0.05,0,0
68397,),0,0
68398,.,0,0
68399,After,0,0
68400,the,0,0
68401,treatment,0,0
68402,",",0,0
68403,self-comparison,0,0
68404,of,0,0
68405,each,0,0
68406,group,0,0
68407,showed,0,0
68408,that,0,0
68409,serum,0,1
68410,EF,0,1
68411,and,0,0
68412,T,0,0
68413,contents,0,0
68414,in,0,0
68415,acupuncture,0,0
68416,group,0,0
68417,increased,0,0
68418,significantly,0,0
68419,(,0,0
68420,P,0,0
68421,<,0,0
68422,0.01,0,0
68423,),0,0
68424,and,0,0
68425,serum,0,1
68426,LH,0,1
68427,content,0,0
68428,decreased,0,0
68429,significantly,0,0
68430,(,0,0
68431,P,0,0
68432,<,0,0
68433,0.01,0,0
68434,),0,0
68435,;,0,0
68436,while,0,0
68437,in,0,0
68438,medication,0,0
68439,group,0,0
68440,",",0,0
68441,only,0,0
68442,serum,0,1
68443,LH,0,1
68444,decreased,0,0
68445,markedly,0,0
68446,(,0,0
68447,P,0,0
68448,<,0,0
68449,0.05,0,0
68450,),0,0
68451,in,0,0
68452,comparison,0,0
68453,with,0,0
68454,its,0,0
68455,basic,0,0
68456,value,0,0
68457,of,0,0
68458,pretreatment,0,1
68459,.,0,1
68460,No,0,1
68461,significant,0,0
68462,changes,0,0
68463,were,0,0
68464,found,0,0
68465,in,0,0
68466,serum,0,0
68467,P,0,0
68468,",",0,0
68469,FSH,0,0
68470,and,0,0
68471,PRL,0,0
68472,levels,0,0
68473,in,0,0
68474,both,0,0
68475,groups,0,0
68476,after,0,0
68477,the,0,0
68478,treatment,0,0
68479,(,0,0
68480,P,0,0
68481,>,0,0
68482,0.05,0,0
68483,),0,0
68484,.,0,0
68485,The,0,0
68486,results,0,0
68487,suggested,0,0
68488,that,0,0
68489,the,0,0
68490,therapeutic,0,0
68491,effect,0,0
68492,of,0,0
68493,acupuncture,0,0
68494,group,0,0
68495,was,0,0
68496,better,0,0
68497,than,0,0
68498,that,0,0
68499,of,0,0
68500,medication,0,0
68501,group,0,0
68502,in,0,0
68503,regulating,0,0
68504,multiple,0,0
68505,sex,0,0
68506,hormones,0,0
68507,.,0,1
68508,CONCLUSION,1,1
68509,EA,1,0
68510,can,1,0
68511,effectively,0,0
68512,adjust,0,0
68513,E2,0,1
68514,",",0,0
68515,T,0,1
68516,and,0,0
68517,LH,0,0
68518,levels,0,0
68519,in,0,0
68520,Sj?gren,0,0
68521,'s,0,0
68522,Syndrome,0,0
68523,patients,0,0
68524,and,0,0
68525,improve,0,0
68526,most,0,0
68527,patients,0,0
68528,',0,0
68529,clinical,0,0
68530,symptoms,0,0
68531,",",0,0
68532,and,0,0
68533,the,0,0
68534,therapeutic,0,0
68535,effect,0,0
68536,of,0,0
68537,EA,1,0
68538,is,0,0
68539,better,0,0
68540,than,0,0
68541,that,0,0
68542,of,0,0
68543,medication,1,0
68544,.,1,0
68545,Predictors,0,0
68546,of,0,0
68547,incident,0,0
68548,depression,0,0
68549,after,0,0
68550,hip,0,0
68551,fracture,0,0
68552,surgery,0,0
68553,.,0,0
68554,OBJECTIVE,0,0
68555,Depression,0,0
68556,after,0,0
68557,hip,1,0
68558,fracture,1,0
68559,surgery,1,0
68560,is,0,0
68561,prevalent,0,0
68562,and,0,0
68563,associated,0,0
68564,with,0,0
68565,increased,0,0
68566,mortality,0,0
68567,rates,0,0
68568,and,0,0
68569,impaired,0,0
68570,functional,0,0
68571,recovery,0,0
68572,.,0,0
68573,The,0,0
68574,incidence,0,0
68575,of,0,0
68576,new-onset,0,0
68577,depressive,0,0
68578,symptoms,0,0
68579,in,0,0
68580,patients,0,0
68581,initially,0,0
68582,not,0,0
68583,depressed,0,0
68584,after,0,0
68585,hip,1,0
68586,fracture,1,0
68587,surgery,1,0
68588,and,0,0
68589,their,0,0
68590,relationship,0,0
68591,with,0,0
68592,functional,0,0
68593,recovery,0,0
68594,is,0,0
68595,unknown,0,0
68596,.,0,0
68597,METHODS,0,0
68598,A,0,1
68599,cohort,0,0
68600,of,0,0
68601,139,0,0
68602,nondepressed,0,0
68603,elderly,0,0
68604,patients,0,0
68605,(,0,0
68606,>,0,0
68607,60,0,0
68608,years,0,1
68609,),0,0
68610,hospitalized,0,0
68611,for,0,0
68612,hip,1,0
68613,fracture,1,0
68614,surgery,1,0
68615,were,0,0
68616,followed,0,0
68617,up,0,0
68618,for,0,0
68619,six,0,0
68620,months,0,0
68621,.,0,0
68622,Clinically,0,0
68623,significant,0,0
68624,depressive,0,0
68625,symptoms,0,0
68626,were,0,0
68627,defined,0,0
68628,as,0,0
68629,a,0,0
68630,score,0,0
68631,of,0,0
68632,7,0,0
68633,or,0,0
68634,more,0,0
68635,on,0,0
68636,the,0,0
68637,15-item,0,0
68638,Geriatric,0,0
68639,Depression,0,0
68640,Scale,0,0
68641,.,0,0
68642,RESULTS,0,0
68643,The,0,0
68644,authors,0,0
68645,found,0,0
68646,a,0,0
68647,cumulative,0,0
68648,incidence,0,0
68649,rate,0,0
68650,of,0,0
68651,20.5,0,0
68652,%,0,0
68653,adjusted,0,0
68654,for,0,0
68655,dropouts,0,0
68656,.,0,0
68657,Multiple,0,0
68658,Cox-regression,0,0
68659,analyses,0,0
68660,yielded,0,0
68661,the,0,0
68662,presence,0,0
68663,of,0,0
68664,subthreshold,0,0
68665,symptoms,0,0
68666,of,0,0
68667,depression,0,0
68668,",",0,0
68669,anxiety,0,0
68670,",",0,0
68671,pain,0,0
68672,",",0,0
68673,and,0,0
68674,cognitive,0,0
68675,impairment,0,0
68676,at,0,0
68677,baseline,0,0
68678,",",0,0
68679,the,0,0
68680,premorbid,0,0
68681,level,0,0
68682,of,0,0
68683,mobility,0,0
68684,",",0,0
68685,and,0,0
68686,a,0,0
68687,history,0,0
68688,of,0,0
68689,(,0,0
68690,treated,0,0
68691,),0,0
68692,depression,0,0
68693,as,0,0
68694,risk,0,0
68695,factors,0,0
68696,for,0,0
68697,incident,0,0
68698,depression,0,0
68699,(,0,0
68700,p,0,0
68701,<,0,0
68702,0.05,0,0
68703,),0,0
68704,.,0,0
68705,A,0,0
68706,forward,0,0
68707,",",0,0
68708,conditional,0,0
68709,procedure,0,0
68710,identified,0,0
68711,postoperative,0,1
68712,pain,0,1
68713,(,0,1
68714,hazard,0,1
68715,ratio,0,1
68716,[,0,1
68717,HR,0,1
68718,],0,0
68719,=,0,0
68720,1.32,0,0
68721,",",0,0
68722,95,0,0
68723,%,0,0
68724,confidence,0,0
68725,interval,0,0
68726,[,0,0
68727,CI,0,0
68728,],0,0
68729,:,0,0
68730,1.14-1.53,0,0
68731,",",0,0
68732,Wald,0,1
68733,chi,0,1
68734,(,0,1
68735,2,0,0
68736,),0,0
68737,=,0,0
68738,13.57,0,0
68739,",",0,0
68740,df,0,0
68741,=,0,0
68742,1,0,0
68743,",",0,0
68744,p,0,0
68745,<,0,0
68746,0.001,0,0
68747,),0,0
68748,and,0,0
68749,baseline,0,1
68750,anxiety,0,1
68751,(,0,0
68752,HR,0,0
68753,=,0,0
68754,1.25,0,0
68755,",",0,0
68756,95,0,0
68757,%,0,0
68758,CI,0,0
68759,:,0,0
68760,1.08-1.44,0,0
68761,",",0,0
68762,Wald,0,1
68763,chi,0,1
68764,(,0,1
68765,2,0,0
68766,),0,0
68767,=,0,0
68768,8.86,0,0
68769,",",0,0
68770,df,0,0
68771,=,0,0
68772,1,0,0
68773,",",0,0
68774,p,0,0
68775,=,0,0
68776,0.003,0,0
68777,),0,0
68778,as,0,0
68779,the,0,0
68780,strongest,0,0
68781,independent,0,0
68782,risk,0,0
68783,factors,0,0
68784,.,0,0
68785,Incident,0,0
68786,depression,0,0
68787,was,0,0
68788,associated,0,0
68789,with,0,0
68790,a,0,0
68791,less,0,0
68792,favorable,0,0
68793,outcome,0,0
68794,at,0,0
68795,3,0,0
68796,months,0,0
68797,follow-up,0,0
68798,.,0,0
68799,CONCLUSION,0,0
68800,This,0,0
68801,exploratory,0,0
68802,study,0,0
68803,identified,0,0
68804,two,0,0
68805,treatable,0,0
68806,baseline,0,0
68807,characteristics,0,0
68808,that,0,0
68809,predicted,0,0
68810,incident,0,0
68811,depression,0,0
68812,in,0,0
68813,nondepressed,0,0
68814,patients,0,0
68815,after,0,0
68816,hip-fracture,0,0
68817,surgery,0,0
68818,.,0,0
68819,Anti-inflammatory,0,1
68820,effects,0,1
68821,of,0,0
68822,inhaled,1,1
68823,carbon,1,1
68824,monoxide,1,1
68825,in,0,0
68826,patients,0,0
68827,with,0,0
68828,COPD,0,0
68829,:,0,0
68830,a,0,0
68831,pilot,0,0
68832,study,0,0
68833,.,0,0
68834,In,0,0
68835,vitro,0,0
68836,and,0,0
68837,in,0,0
68838,vivo,0,0
68839,studies,0,0
68840,have,0,0
68841,shown,0,0
68842,that,0,0
68843,carbon,1,0
68844,monoxide,1,1
68845,(,0,1
68846,CO,0,1
68847,),0,0
68848,has,0,0
68849,both,0,0
68850,anti-inflammatory,0,1
68851,and,0,1
68852,anti-oxidant,0,1
68853,capacities,0,0
68854,.,0,0
68855,Since,0,0
68856,chronic,0,0
68857,obstructive,0,1
68858,pulmonary,0,1
68859,disease,0,1
68860,(,0,1
68861,COPD,0,1
68862,),0,0
68863,is,0,0
68864,characterised,0,0
68865,by,0,0
68866,inflammation,0,0
68867,and,0,0
68868,oxidative,0,0
68869,stress,0,0
68870,",",0,0
68871,low-dose,1,1
68872,CO,1,1
68873,could,0,0
68874,be,0,0
68875,of,0,0
68876,therapeutic,0,0
68877,use,0,0
68878,.,0,0
68879,The,0,0
68880,aim,0,0
68881,of,0,0
68882,the,0,0
68883,present,0,0
68884,study,0,0
68885,was,0,0
68886,to,0,0
68887,investigate,0,0
68888,the,0,0
68889,feasibility,0,0
68890,and,0,0
68891,anti-inflammatory,0,1
68892,effects,0,0
68893,of,0,0
68894,100-125,0,0
68895,ppm,0,1
68896,CO,1,1
68897,inhalation,1,1
68898,in,0,0
68899,patients,0,0
68900,with,0,0
68901,stable,0,0
68902,COPD,0,0
68903,.,0,0
68904,In,0,0
68905,total,0,0
68906,",",0,0
68907,20,0,0
68908,ex-smoking,0,0
68909,COPD,0,0
68910,patients,0,0
68911,with,0,0
68912,post-bronchodilator,0,0
68913,forced,0,0
68914,expiratory,0,0
68915,volume,0,0
68916,in,0,0
68917,one,0,0
68918,second,0,0
68919,(,0,0
68920,FEV,0,1
68921,(,0,1
68922,1,0,1
68923,),0,1
68924,),0,0
68925,>,0,0
68926,1.20,0,0
68927,L,0,0
68928,and,0,0
68929,FEV,0,1
68930,(,0,1
68931,1,0,1
68932,),0,0
68933,/forced,0,0
68934,vital,0,0
68935,capacity,0,0
68936,<,0,0
68937,70,0,0
68938,%,0,0
68939,were,0,0
68940,enrolled,0,0
68941,in,0,0
68942,a,0,0
68943,randomised,0,0
68944,",",0,0
68945,placebo-controlled,1,1
68946,",",0,1
68947,crossover,0,1
68948,study,0,0
68949,.,0,0
68950,Effects,0,0
68951,on,0,0
68952,inflammation,0,0
68953,were,0,0
68954,measured,0,0
68955,in,0,0
68956,induced,0,0
68957,sputum,0,0
68958,and,0,0
68959,blood,0,0
68960,.,0,0
68961,CO,0,1
68962,inhalation,0,1
68963,was,0,0
68964,feasible,0,0
68965,and,0,0
68966,patients,0,0
68967,',0,0
68968,vital,0,0
68969,signs,0,0
68970,were,0,0
68971,unaffected,0,0
68972,;,0,0
68973,2,0,1
68974,h.day,0,1
68975,(,0,1
68976,-1,0,1
68977,),0,1
68978,inhalation,0,1
68979,of,0,1
68980,low-dose,0,1
68981,CO,0,1
68982,on,0,0
68983,4,0,0
68984,consecutive,0,0
68985,days,0,0
68986,led,0,0
68987,to,0,0
68988,a,0,0
68989,maximal,0,0
68990,individual,0,0
68991,carboxyhaemoglobin,0,1
68992,level,0,0
68993,of,0,0
68994,4.5,0,0
68995,%,0,0
68996,.,0,0
68997,Two,0,0
68998,exacerbations,0,0
68999,occurred,0,0
69000,in,0,0
69001,the,0,0
69002,CO,0,0
69003,period,0,0
69004,.,0,0
69005,CO,0,1
69006,inhalation,0,1
69007,led,0,0
69008,to,0,0
69009,trends,0,0
69010,in,0,0
69011,reduced,0,0
69012,sputum,0,1
69013,eosinophils,0,1
69014,(,0,0
69015,median,0,0
69016,reduction,0,0
69017,0.25,0,0
69018,%,0,0
69019,point,0,0
69020,),0,0
69021,and,0,0
69022,improved,0,0
69023,responsiveness,0,0
69024,to,0,0
69025,methacholine,0,1
69026,(,0,0
69027,median,0,0
69028,provocative,0,0
69029,concentration,0,0
69030,causing,0,0
69031,a,0,0
69032,20,0,0
69033,%,0,0
69034,fall,0,0
69035,in,0,0
69036,FEV,0,1
69037,(,0,1
69038,1,0,0
69039,),0,0
69040,0.85,0,0
69041,versus,0,0
69042,0.63,0,0
69043,mg.mL,0,1
69044,(,0,1
69045,-1,0,1
69046,),0,1
69047,),0,1
69048,.,0,1
69049,Inhalation,0,1
69050,of,0,0
69051,100-125,0,0
69052,ppm,0,1
69053,carbon,1,0
69054,monoxide,1,1
69055,by,0,0
69056,patients,0,0
69057,with,0,0
69058,chronic,0,0
69059,obstructive,0,0
69060,pulmonary,0,0
69061,disease,0,0
69062,in,0,0
69063,a,0,0
69064,stable,0,0
69065,phase,0,0
69066,was,0,0
69067,feasible,0,0
69068,and,0,0
69069,led,0,0
69070,to,0,0
69071,trends,0,0
69072,in,0,0
69073,reduction,0,0
69074,of,0,0
69075,sputum,0,1
69076,eosinophils,0,1
69077,and,0,1
69078,improvement,0,0
69079,of,0,0
69080,responsiveness,0,0
69081,to,0,0
69082,methacholine,0,1
69083,.,0,0
69084,Further,0,0
69085,studies,0,0
69086,need,0,0
69087,to,0,0
69088,confirm,0,0
69089,the,0,0
69090,safety,0,0
69091,and,0,0
69092,efficacy,0,0
69093,in,0,0
69094,inflammatory,0,0
69095,lung,0,0
69096,diseases,0,0
69097,.,0,0
69098,[,0,0
69099,Effects,0,0
69100,of,0,0
69101,electroacupuncture,1,1
69102,combined,1,0
69103,with,1,0
69104,behavior,1,0
69105,therapy,1,0
69106,on,0,0
69107,intelligence,0,0
69108,and,0,0
69109,behavior,0,0
69110,of,0,0
69111,children,0,0
69112,of,0,0
69113,autism,0,0
69114,],0,0
69115,.,0,0
69116,OBJECTIVE,0,0
69117,To,0,0
69118,find,0,0
69119,out,0,0
69120,an,0,0
69121,effective,0,0
69122,therapy,0,0
69123,for,0,0
69124,autism,0,0
69125,.,0,0
69126,METHODS,0,0
69127,Sixty,0,0
69128,children,0,0
69129,of,0,0
69130,autism,0,0
69131,were,0,0
69132,randomly,0,0
69133,divided,0,0
69134,into,0,0
69135,an,0,0
69136,electroacupuncture,1,1
69137,(,1,1
69138,EA,1,1
69139,),1,0
69140,plus,1,0
69141,behavior,1,0
69142,therapy,1,0
69143,group,1,0
69144,and,1,0
69145,a,1,0
69146,behavior,1,0
69147,therapy,1,0
69148,group,1,0
69149,",",0,0
69150,30,0,0
69151,cases,0,0
69152,in,0,0
69153,each,0,0
69154,group,0,0
69155,.,0,0
69156,The,0,0
69157,patients,0,0
69158,in,0,0
69159,the,0,0
69160,two,0,0
69161,groups,0,0
69162,were,0,0
69163,treated,0,0
69164,with,0,0
69165,routine,1,0
69166,behavior,1,0
69167,",",0,0
69168,with,0,0
69169,EA,1,0
69170,at,0,0
69171,Baihui,0,0
69172,(,0,0
69173,GV,0,1
69174,20,0,1
69175,),0,0
69176,",",0,0
69177,Sishencong,0,1
69178,(,0,1
69179,EX-HN,0,1
69180,1,0,1
69181,),0,0
69182,",",0,0
69183,Shenting,0,0
69184,(,0,0
69185,GV,0,1
69186,24,0,1
69187,),0,0
69188,",",0,0
69189,Benshen,0,1
69190,(,0,1
69191,GB,0,1
69192,13,0,1
69193,),0,0
69194,",",0,1
69195,Yintang,0,1
69196,(,0,1
69197,EX-HN,0,1
69198,3,0,1
69199,),0,0
69200,",",0,1
69201,Naohu,0,1
69202,(,0,1
69203,GV,0,1
69204,17,0,1
69205,),0,0
69206,",",0,0
69207,Naokong,0,1
69208,(,0,1
69209,GB,0,1
69210,19,0,1
69211,),0,0
69212,",",0,0
69213,Neiguan,0,1
69214,(,0,1
69215,PC,0,1
69216,6,0,1
69217,),0,0
69218,and,0,0
69219,scalp,1,0
69220,acupuncture,1,0
69221,at,0,0
69222,Speech,0,0
69223,Areas,0,0
69224,I,0,0
69225,",",0,0
69226,II,0,0
69227,",",0,0
69228,III,0,0
69229,added,0,0
69230,for,0,0
69231,the,0,0
69232,EA,1,0
69233,plus,1,0
69234,behavior,1,0
69235,therapy,1,0
69236,group,0,0
69237,.,0,0
69238,Their,0,0
69239,therapeutic,0,0
69240,effects,0,0
69241,were,0,0
69242,observed,0,0
69243,",",0,0
69244,and,0,0
69245,the,0,0
69246,picture,0,0
69247,and,0,0
69248,vocabulary,0,1
69249,scale,0,1
69250,(,0,1
69251,PPVT,0,1
69252,),0,1
69253,and,0,0
69254,behavior,0,0
69255,ability,0,0
69256,were,0,0
69257,detected,0,0
69258,.,0,0
69259,RESULTS,0,0
69260,The,0,0
69261,total,0,0
69262,effective,0,0
69263,rate,0,0
69264,was,0,0
69265,86.7,0,0
69266,%,0,0
69267,in,0,0
69268,the,0,0
69269,EA,1,0
69270,plus,1,0
69271,behavior,1,0
69272,therapy,1,0
69273,group,0,0
69274,which,0,0
69275,was,0,0
69276,better,0,0
69277,than,0,0
69278,56.7,0,0
69279,%,0,0
69280,of,0,0
69281,the,0,0
69282,behavior,0,0
69283,therapy,0,0
69284,group,0,0
69285,",",0,0
69286,and,0,0
69287,had,0,0
69288,significant,0,0
69289,enhancement,0,0
69290,in,0,0
69291,sensation,0,0
69292,",",0,0
69293,association,0,0
69294,",",0,0
69295,body,0,0
69296,",",0,0
69297,and,0,0
69298,ability,0,0
69299,of,0,0
69300,self-care,0,0
69301,(,0,0
69302,P,0,0
69303,<,0,0
69304,0.05,0,0
69305,),0,0
69306,and,0,0
69307,was,0,0
69308,better,0,0
69309,than,0,0
69310,the,0,0
69311,behavior,0,0
69312,therapy,0,0
69313,group,0,0
69314,in,0,0
69315,sensation,0,0
69316,",",0,0
69317,body,0,0
69318,and,0,0
69319,self-care,0,0
69320,factors,0,0
69321,",",0,0
69322,with,0,0
69323,no,0,0
69324,significantly,0,0
69325,improvement,0,0
69326,in,0,0
69327,the,0,0
69328,scores,0,0
69329,of,0,0
69330,PPVT,0,0
69331,in,0,0
69332,the,0,0
69333,two,0,0
69334,groups,0,0
69335,(,0,0
69336,P,0,0
69337,>,0,0
69338,0.05,0,0
69339,),0,0
69340,.,0,0
69341,CONCLUSION,0,0
69342,EA,1,0
69343,combined,1,0
69344,with,1,0
69345,behavior,1,0
69346,therapy,1,0
69347,can,0,0
69348,significantly,0,0
69349,improve,0,0
69350,clinical,0,0
69351,symptoms,0,0
69352,of,0,0
69353,autism,0,0
69354,",",0,0
69355,but,0,0
69356,does,0,0
69357,not,0,0
69358,improve,0,0
69359,intelligence,0,0
69360,.,0,0
69361,A,0,1
69362,double-blind,0,1
69363,placebo,1,1
69364,controlled,0,1
69365,trial,0,1
69366,of,0,0
69367,piracetam,1,1
69368,added,0,0
69369,to,0,0
69370,risperidone,1,1
69371,in,0,0
69372,patients,0,0
69373,with,0,0
69374,autistic,0,0
69375,disorder,0,0
69376,.,0,0
69377,It,0,0
69378,has,0,0
69379,been,0,0
69380,reported,0,0
69381,that,0,0
69382,autism,0,0
69383,is,0,0
69384,a,0,0
69385,hypoglutamatergic,0,1
69386,disorder,0,1
69387,.,0,0
69388,Therefore,0,0
69389,",",0,0
69390,it,0,0
69391,was,0,0
69392,of,0,0
69393,interest,0,0
69394,to,0,0
69395,assess,0,0
69396,the,0,0
69397,efficacy,0,0
69398,of,0,0
69399,piracetam,1,1
69400,",",0,0
69401,a,0,0
69402,positive,0,0
69403,modulator,0,0
69404,of,0,0
69405,AMPA-sensitive,0,0
69406,glutamate,0,0
69407,receptors,0,0
69408,in,0,0
69409,autistic,0,0
69410,disorder,0,0
69411,.,0,0
69412,About,0,0
69413,40,0,0
69414,children,0,0
69415,between,0,0
69416,the,0,0
69417,ages,0,0
69418,three,0,0
69419,and,0,0
69420,11,0,0
69421,years,0,1
69422,(,0,1
69423,inclusive,0,1
69424,),0,0
69425,with,0,0
69426,a,0,0
69427,DSM,0,0
69428,IV,0,1
69429,clinical,0,0
69430,diagnosis,0,0
69431,of,0,0
69432,autism,0,0
69433,and,0,0
69434,who,0,0
69435,were,0,0
69436,outpatients,0,0
69437,from,0,0
69438,a,0,0
69439,specialty,0,0
69440,clinic,0,0
69441,for,0,0
69442,children,0,0
69443,were,0,0
69444,recruited,0,0
69445,.,0,0
69446,The,0,0
69447,children,0,0
69448,presented,0,0
69449,with,0,0
69450,a,0,0
69451,chief,0,0
69452,complaint,0,0
69453,of,0,0
69454,severely,0,0
69455,disruptive,0,0
69456,symptoms,0,0
69457,related,0,0
69458,to,0,0
69459,autistic,0,0
69460,disorder,0,0
69461,.,0,0
69462,Patients,0,0
69463,were,0,0
69464,randomly,0,0
69465,allocated,0,0
69466,to,0,0
69467,piracetam,1,1
69468,+,1,1
69469,risperidone,1,1
69470,(,1,1
69471,Group,1,1
69472,A,1,1
69473,),1,1
69474,or,1,1
69475,placebo,1,1
69476,+,1,1
69477,risperidone,1,1
69478,(,0,1
69479,Group,0,1
69480,B,0,1
69481,),0,0
69482,for,0,0
69483,a,0,0
69484,10-week,0,0
69485,",",0,0
69486,double-blind,0,1
69487,",",0,1
69488,placebo-controlled,0,1
69489,study,0,0
69490,.,0,0
69491,The,0,0
69492,dose,0,1
69493,of,0,0
69494,risperidone,1,1
69495,was,0,0
69496,titrated,0,1
69497,up,0,0
69498,to,0,0
69499,2,0,0
69500,mg/day,0,1
69501,for,0,0
69502,children,0,0
69503,between,0,0
69504,10,0,0
69505,and,0,0
69506,40,0,0
69507,kg,0,0
69508,and,0,0
69509,3,0,1
69510,mg/day,0,1
69511,for,0,1
69512,children,0,1
69513,weighting,0,0
69514,above,0,0
69515,40,0,0
69516,kg,0,0
69517,.,0,0
69518,The,0,0
69519,dose,0,1
69520,of,0,0
69521,piracetam,1,1
69522,was,0,0
69523,titrated,0,1
69524,up,0,0
69525,to,0,0
69526,800,0,0
69527,mg/day,0,1
69528,.,0,1
69529,Patients,0,0
69530,were,0,0
69531,assessed,0,0
69532,at,0,0
69533,baseline,0,0
69534,and,0,0
69535,after,0,0
69536,2,0,0
69537,",",0,0
69538,4,0,0
69539,",",0,0
69540,6,0,0
69541,",",0,0
69542,8,0,0
69543,and,0,0
69544,10,0,0
69545,weeks,0,0
69546,of,0,0
69547,starting,0,0
69548,medication,0,0
69549,.,0,0
69550,The,0,0
69551,measure,0,0
69552,of,0,0
69553,the,0,0
69554,outcome,0,0
69555,was,0,0
69556,the,0,0
69557,Aberrant,0,0
69558,Behavior,0,0
69559,Checklist-Community,0,1
69560,(,0,1
69561,ABC-C,0,1
69562,),0,1
69563,Rating,0,0
69564,Scale,0,1
69565,(,0,0
69566,total,0,0
69567,score,0,1
69568,),0,0
69569,.,0,0
69570,The,0,0
69571,ABC-C,0,0
69572,Rating,0,0
69573,Scale,0,0
69574,scores,0,0
69575,improved,0,0
69576,with,0,0
69577,piracetam,0,1
69578,.,0,0
69579,The,0,0
69580,difference,0,0
69581,between,0,0
69582,the,0,0
69583,two,0,0
69584,protocols,0,0
69585,was,0,0
69586,significant,0,0
69587,as,0,0
69588,indicated,0,0
69589,by,0,0
69590,the,0,0
69591,effect,0,0
69592,of,0,0
69593,group,0,0
69594,",",0,0
69595,the,0,0
69596,between,0,0
69597,subjects,0,0
69598,factor,0,0
69599,(,0,0
69600,F,0,0
69601,=,0,0
69602,5.85,0,0
69603,",",0,0
69604,d.f,0,0
69605,.,0,0
69606,=,0,0
69607,1,0,0
69608,",",0,0
69609,P,0,0
69610,=,0,0
69611,0.02,0,0
69612,),0,0
69613,.,0,0
69614,The,0,0
69615,changes,0,0
69616,at,0,0
69617,the,0,0
69618,endpoint,0,0
69619,compared,0,0
69620,with,0,0
69621,baseline,0,0
69622,were,0,0
69623,:,0,0
69624,-11.90,0,0
69625,+/-,0,0
69626,3.79,0,0
69627,(,0,0
69628,mean,0,0
69629,+/-,0,0
69630,SD,0,0
69631,),0,0
69632,and,0,0
69633,-5.15,0,0
69634,+/-,0,0
69635,3.04,0,0
69636,for,0,0
69637,group,0,0
69638,A,0,0
69639,and,0,0
69640,B,0,0
69641,respectively,0,0
69642,.,0,0
69643,A,0,0
69644,significant,0,0
69645,difference,0,0
69646,was,0,0
69647,observed,0,0
69648,on,0,0
69649,the,0,0
69650,change,0,0
69651,in,0,0
69652,scores,0,0
69653,in,0,0
69654,the,0,0
69655,ABC-C,0,0
69656,Rating,0,0
69657,Scale,0,0
69658,in,0,0
69659,week,0,0
69660,10,0,0
69661,compared,0,0
69662,with,0,0
69663,baseline,0,0
69664,in,0,0
69665,the,0,0
69666,two,0,0
69667,groups,0,1
69668,(,0,0
69669,t,0,0
69670,=,0,0
69671,6.017,0,0
69672,",",0,0
69673,d.f,0,0
69674,.,0,0
69675,=,0,0
69676,38,0,0
69677,",",0,0
69678,P,0,0
69679,<,0,0
69680,0.0001,0,0
69681,),0,0
69682,.,0,0
69683,The,0,0
69684,results,0,0
69685,suggest,0,0
69686,that,0,0
69687,a,0,0
69688,combination,0,0
69689,of,0,0
69690,atypical,0,0
69691,antipsychotic,0,1
69692,medications,0,1
69693,and,0,1
69694,a,0,0
69695,glutamate,0,0
69696,agent,0,0
69697,such,0,0
69698,as,0,0
69699,piracetam,0,1
69700,",",0,0
69701,might,0,0
69702,have,0,0
69703,increase,0,0
69704,synergistic,0,0
69705,effects,0,0
69706,in,0,0
69707,the,0,0
69708,treatment,0,0
69709,of,0,0
69710,autism,0,0
69711,.,0,0
69712,Maternal,0,0
69713,breast-milk,0,1
69714,and,0,1
69715,intestinal,0,1
69716,bifidobacteria,0,1
69717,guide,0,0
69718,the,0,0
69719,compositional,0,0
69720,development,0,0
69721,of,0,0
69722,the,0,0
69723,Bifidobacterium,0,1
69724,microbiota,0,1
69725,in,0,0
69726,infants,0,0
69727,at,0,0
69728,risk,0,0
69729,of,0,0
69730,allergic,0,0
69731,disease,0,0
69732,.,0,0
69733,BACKGROUND,0,0
69734,The,0,0
69735,sources,0,0
69736,and,0,0
69737,the,0,0
69738,impact,0,0
69739,of,0,0
69740,maternal,0,0
69741,bacteria,0,0
69742,on,0,0
69743,the,0,0
69744,initial,0,0
69745,inoculum,0,1
69746,of,0,0
69747,the,0,0
69748,intestinal,0,0
69749,microflora,0,0
69750,of,0,0
69751,newborn,0,0
69752,infants,0,0
69753,remain,0,0
69754,elusive,0,0
69755,.,0,0
69756,OBJECTIVE,0,0
69757,To,0,0
69758,assess,0,0
69759,the,0,0
69760,association,0,0
69761,between,0,0
69762,maternal,0,1
69763,breast-milk,0,1
69764,and,0,1
69765,fecal,0,1
69766,bifidobacteria,0,1
69767,and,0,1
69768,infants,0,0
69769,',0,0
69770,fecal,0,1
69771,bifidobacteria,0,1
69772,.,0,0
69773,METHODS,0,0
69774,Sixty-one,0,0
69775,mother-infant,0,0
69776,pairs,0,0
69777,were,0,0
69778,included,0,0
69779,",",0,0
69780,special,0,0
69781,emphasis,0,0
69782,being,0,0
69783,placed,0,0
69784,on,0,0
69785,the,0,0
69786,maternal,0,0
69787,allergic,0,0
69788,status,0,1
69789,.,0,0
69790,Bifidobacteria,1,1
69791,were,1,0
69792,analysed,1,0
69793,by,1,0
69794,a,1,0
69795,direct,1,0
69796,PCR,1,0
69797,method,1,0
69798,in,1,0
69799,fecal,1,0
69800,samples,1,0
69801,from,1,0
69802,mothers,1,0
69803,at,0,0
69804,30-35,0,0
69805,weeks,0,0
69806,of,0,0
69807,gestation,0,0
69808,and,0,0
69809,from,0,0
69810,infants,0,0
69811,at,0,0
69812,1,0,0
69813,month,0,0
69814,of,0,0
69815,age,0,0
69816,and,0,0
69817,from,0,0
69818,breast-milk,1,1
69819,samples,1,0
69820,1,1,0
69821,month,1,0
69822,post-partum,1,0
69823,.,1,0
69824,RESULTS,0,1
69825,Fecal,0,1
69826,Bifidobacterium,0,1
69827,adolescentis,0,1
69828,and,0,1
69829,Bifidobacterium,0,1
69830,bifidum,0,1
69831,colonization,0,0
69832,frequencies,0,0
69833,and,0,0
69834,counts,0,0
69835,among,0,0
69836,mother-infant,0,0
69837,pairs,0,0
69838,correlated,0,0
69839,significantly,0,0
69840,(,0,0
69841,P=0.005,0,0
69842,and,0,0
69843,0.02,0,0
69844,for,0,0
69845,frequencies,0,0
69846,",",0,0
69847,respectively,0,0
69848,",",0,0
69849,and,0,0
69850,P=0.002,0,0
69851,and,0,0
69852,0.01,0,0
69853,for,0,0
69854,counts,0,0
69855,",",0,0
69856,respectively,0,0
69857,),0,0
69858,.,0,0
69859,Only,0,0
69860,infants,0,0
69861,of,0,0
69862,allergic,0,0
69863,",",0,0
69864,atopic,0,0
69865,mothers,0,0
69866,were,0,0
69867,colonized,0,0
69868,with,0,0
69869,B.,0,0
69870,adolescentis,0,1
69871,.,0,0
69872,Each,0,0
69873,of,0,0
69874,the,0,0
69875,breast-milk,0,0
69876,samples,0,0
69877,contained,0,0
69878,bifidobacteria,0,1
69879,[,0,0
69880,median,0,0
69881,1.4,0,0
69882,x,0,0
69883,10,0,0
69884,(,0,1
69885,3,0,1
69886,),0,0
69887,bacterial,0,0
69888,cells/mL,0,1
69889,;,0,0
69890,interquartile,0,0
69891,range,0,0
69892,(,0,0
69893,IQR,0,1
69894,),0,0
69895,48.7-3.8,0,0
69896,x,0,0
69897,10,0,0
69898,(,0,1
69899,3,0,1
69900,),0,1
69901,],0,1
69902,.,0,1
69903,Bifidobacterium,0,1
69904,longum,0,1
69905,was,0,0
69906,the,0,0
69907,most,0,0
69908,frequently,0,0
69909,detected,0,0
69910,species,0,0
69911,in,0,0
69912,breast-milk,0,1
69913,.,0,1
69914,Allergic,0,0
69915,mothers,0,0
69916,had,0,0
69917,significantly,0,0
69918,lower,0,0
69919,amounts,0,0
69920,of,0,0
69921,bifidobacteria,0,1
69922,in,0,1
69923,breast-milk,0,1
69924,compared,0,0
69925,with,0,0
69926,non-allergic,0,0
69927,mothers,0,0
69928,[,0,0
69929,median,0,0
69930,1.3,0,0
69931,x,0,0
69932,10,0,0
69933,(,0,1
69934,3,0,1
69935,),0,0
69936,bacterial,0,0
69937,cells/mL,0,1
69938,(,0,0
69939,IQR,0,0
69940,22.4-3.0,0,0
69941,x,0,0
69942,10,0,0
69943,(,0,1
69944,3,0,1
69945,),0,0
69946,),0,0
69947,vs.,0,0
69948,5.6,0,0
69949,x,0,0
69950,10,0,0
69951,(,0,1
69952,3,0,1
69953,),0,0
69954,bacterial,0,0
69955,cells/mL,0,1
69956,(,0,0
69957,1.8,0,0
69958,x,0,0
69959,10,0,0
69960,(,0,1
69961,3,0,0
69962,),0,0
69963,-1.8,0,0
69964,x,0,0
69965,10,0,0
69966,(,0,1
69967,4,0,1
69968,),0,1
69969,),0,0
69970,",",0,0
69971,respectively,0,0
69972,",",0,0
69973,(,0,0
69974,P=0.004,0,0
69975,),0,0
69976,],0,0
69977,",",0,0
69978,and,0,0
69979,their,0,0
69980,infants,0,0
69981,had,0,0
69982,concurrently,0,0
69983,lower,0,0
69984,counts,0,0
69985,of,0,0
69986,bifidobacteria,0,1
69987,in,0,1
69988,feces,0,1
69989,[,0,0
69990,3.9,0,0
69991,x,0,0
69992,10,0,0
69993,(,0,1
69994,8,0,0
69995,),0,0
69996,bacterial,0,0
69997,cells/g,0,0
69998,(,0,0
69999,IQR,0,0
70000,6.5,0,0
70001,x,0,0
70002,10,0,0
70003,(,0,1
70004,6,0,0
70005,),0,0
70006,-1.5,0,0
70007,x,0,0
70008,10,0,0
70009,(,0,1
70010,9,0,1
70011,),0,1
70012,),0,0
70013,in,0,0
70014,infants,0,0
70015,of,0,0
70016,allergic,0,0
70017,mothers,0,0
70018,",",0,0
70019,vs.,0,0
70020,2.5,0,0
70021,x,0,0
70022,10,0,0
70023,(,0,1
70024,9,0,0
70025,),0,0
70026,bacterial,0,0
70027,cells/g,0,0
70028,(,0,0
70029,6.5,0,0
70030,x,0,0
70031,10,0,0
70032,(,0,1
70033,8,0,0
70034,),0,0
70035,-3.2,0,0
70036,x,0,0
70037,10,0,0
70038,(,0,1
70039,10,0,1
70040,),0,1
70041,),0,0
70042,in,0,0
70043,infants,0,0
70044,of,0,0
70045,non-allergic,0,0
70046,mothers,0,0
70047,",",0,0
70048,P=0.013,0,0
70049,],0,0
70050,.,0,0
70051,CONCLUSIONS,0,1
70052,Breast-milk,0,1
70053,contains,0,0
70054,significant,0,0
70055,numbers,0,0
70056,of,0,0
70057,bifidobacteria,0,1
70058,and,0,0
70059,the,0,0
70060,maternal,0,0
70061,allergic,0,0
70062,status,0,0
70063,further,0,0
70064,deranges,0,0
70065,the,0,0
70066,counts,0,0
70067,of,0,0
70068,bifidobacteria,0,1
70069,in,0,1
70070,breast-milk,0,1
70071,.,0,0
70072,Maternal,0,0
70073,fecal,0,0
70074,and,0,1
70075,breast-milk,0,1
70076,bifidobacterial,0,1
70077,counts,0,0
70078,impacted,0,0
70079,on,0,0
70080,the,0,0
70081,infants,0,0
70082,',0,0
70083,fecal,0,1
70084,Bifidobacterium,0,1
70085,levels,0,1
70086,.,0,1
70087,Breast-milk,0,1
70088,bacteria,0,0
70089,should,0,0
70090,thus,0,0
70091,be,0,0
70092,considered,0,0
70093,an,0,0
70094,important,0,0
70095,source,0,0
70096,of,0,0
70097,bacteria,0,0
70098,in,0,0
70099,the,0,0
70100,establishment,0,0
70101,of,0,0
70102,infantile,0,0
70103,intestinal,0,0
70104,microbiota,0,0
70105,.,0,0
70106,Human,1,1
70107,papillomavirus,1,1
70108,and,0,0
70109,Papanicolaou,1,0
70110,tests,1,0
70111,to,0,0
70112,screen,0,0
70113,for,0,0
70114,cervical,0,0
70115,cancer,0,0
70116,.,0,0
70117,BACKGROUND,0,0
70118,Screening,0,0
70119,for,0,0
70120,cervical,0,0
70121,cancer,0,0
70122,based,0,0
70123,on,0,0
70124,testing,0,0
70125,for,0,0
70126,human,0,0
70127,papillomavirus,0,0
70128,(,0,1
70129,HPV,0,1
70130,),0,0
70131,increases,0,0
70132,the,0,0
70133,sensitivity,0,0
70134,of,0,0
70135,detection,0,0
70136,of,0,0
70137,high-grade,0,1
70138,(,0,1
70139,grade,0,0
70140,2,0,1
70141,or,0,0
70142,3,0,1
70143,),0,0
70144,cervical,0,1
70145,intraepithelial,0,1
70146,neoplasia,0,0
70147,",",0,0
70148,but,0,0
70149,whether,0,0
70150,this,0,0
70151,gain,0,0
70152,represents,0,0
70153,overdiagnosis,0,0
70154,or,0,0
70155,protection,0,0
70156,against,0,0
70157,future,0,0
70158,high-grade,0,0
70159,cervical,0,0
70160,epithelial,0,0
70161,neoplasia,0,0
70162,or,0,0
70163,cervical,0,0
70164,cancer,0,0
70165,is,0,0
70166,unknown,0,0
70167,.,0,0
70168,METHODS,0,0
70169,In,0,0
70170,a,0,0
70171,population-based,0,0
70172,screening,0,0
70173,program,0,0
70174,in,0,0
70175,Sweden,0,0
70176,",",0,0
70177,"12,527",0,0
70178,women,0,0
70179,32,0,0
70180,to,0,0
70181,38,0,0
70182,years,0,0
70183,of,0,0
70184,age,0,0
70185,were,0,0
70186,randomly,0,0
70187,assigned,0,0
70188,at,0,0
70189,a,0,0
70190,1:1,0,1
70191,ratio,0,0
70192,to,0,0
70193,have,0,0
70194,an,0,0
70195,HPV,1,0
70196,test,1,0
70197,plus,1,0
70198,a,1,0
70199,Papanicolaou,1,1
70200,(,1,1
70201,Pap,1,1
70202,),1,1
70203,test,1,1
70204,(,1,1
70205,intervention,1,1
70206,group,1,1
70207,),1,0
70208,or,0,0
70209,a,1,0
70210,Pap,1,0
70211,test,1,0
70212,alone,1,0
70213,(,1,0
70214,control,1,0
70215,group,1,0
70216,),1,0
70217,.,1,0
70218,Women,0,0
70219,with,0,0
70220,a,0,0
70221,positive,0,0
70222,HPV,1,0
70223,test,1,0
70224,and,0,0
70225,a,0,0
70226,normal,0,0
70227,Pap,1,0
70228,test,1,0
70229,result,0,0
70230,were,0,0
70231,offered,0,0
70232,a,0,0
70233,second,0,0
70234,HPV,1,0
70235,test,1,0
70236,at,0,0
70237,least,0,0
70238,1,0,0
70239,year,0,0
70240,later,0,0
70241,",",0,0
70242,and,0,0
70243,those,0,0
70244,who,0,0
70245,were,0,0
70246,found,0,0
70247,to,0,0
70248,be,0,0
70249,persistently,0,0
70250,infected,0,0
70251,with,0,0
70252,the,0,0
70253,same,0,0
70254,high-risk,0,0
70255,type,0,0
70256,of,0,0
70257,HPV,0,0
70258,were,0,0
70259,then,0,0
70260,offered,0,0
70261,colposcopy,0,0
70262,with,0,0
70263,cervical,0,0
70264,biopsy,0,0
70265,.,0,0
70266,A,0,0
70267,similar,0,0
70268,number,0,0
70269,of,0,0
70270,double-blinded,0,1
70271,Pap,1,1
70272,smears,1,1
70273,and,1,0
70274,colposcopies,1,0
70275,with,1,0
70276,biopsy,1,0
70277,were,0,0
70278,performed,0,0
70279,in,0,0
70280,randomly,0,0
70281,selected,0,0
70282,women,0,0
70283,in,0,0
70284,the,0,0
70285,control,0,0
70286,group,0,0
70287,.,0,0
70288,Comprehensive,0,0
70289,registry,0,0
70290,data,0,0
70291,were,0,0
70292,used,0,0
70293,to,0,0
70294,follow,0,0
70295,the,0,0
70296,women,0,0
70297,for,0,0
70298,a,0,0
70299,mean,0,0
70300,of,0,0
70301,4.1,0,0
70302,years,0,0
70303,.,0,0
70304,The,0,0
70305,relative,0,0
70306,rates,0,0
70307,of,0,0
70308,grade,0,0
70309,2,0,0
70310,or,0,0
70311,3,0,0
70312,cervical,0,0
70313,intraepithelial,0,1
70314,neoplasia,0,0
70315,or,0,0
70316,cancer,0,0
70317,detected,0,0
70318,at,0,0
70319,enrollment,0,0
70320,and,0,0
70321,at,0,0
70322,subsequent,0,0
70323,screening,0,0
70324,examinations,0,0
70325,were,0,0
70326,calculated,0,0
70327,.,0,0
70328,RESULTS,0,0
70329,At,0,1
70330,enrollment,0,0
70331,",",0,0
70332,the,0,0
70333,proportion,0,0
70334,of,0,0
70335,women,0,0
70336,in,0,0
70337,the,0,0
70338,intervention,1,0
70339,group,0,0
70340,who,0,0
70341,were,0,0
70342,found,0,0
70343,to,0,0
70344,have,0,0
70345,lesions,0,0
70346,of,0,0
70347,grade,0,0
70348,2,0,0
70349,or,0,0
70350,3,0,0
70351,cervical,0,0
70352,intraepithelial,0,1
70353,neoplasia,0,0
70354,or,0,0
70355,cancer,0,0
70356,was,0,0
70357,51,0,0
70358,%,0,0
70359,greater,0,0
70360,(,0,0
70361,95,0,0
70362,%,0,0
70363,confidence,0,0
70364,interval,0,0
70365,[,0,0
70366,CI,0,0
70367,],0,1
70368,",",0,0
70369,13,0,0
70370,to,0,0
70371,102,0,0
70372,),0,0
70373,than,0,0
70374,the,0,0
70375,proportion,0,0
70376,of,0,0
70377,women,0,0
70378,in,0,0
70379,the,0,0
70380,control,1,0
70381,group,0,0
70382,who,0,0
70383,were,0,0
70384,found,0,0
70385,to,0,0
70386,have,0,0
70387,such,0,0
70388,lesions,0,0
70389,.,0,0
70390,At,0,0
70391,subsequent,0,0
70392,screening,0,0
70393,examinations,0,0
70394,",",0,0
70395,the,0,0
70396,proportion,0,0
70397,of,0,0
70398,women,0,0
70399,in,0,0
70400,the,0,0
70401,intervention,1,0
70402,group,0,0
70403,who,0,0
70404,were,0,0
70405,found,0,0
70406,to,0,0
70407,have,0,0
70408,grade,0,0
70409,2,0,0
70410,or,0,0
70411,3,0,0
70412,lesions,0,0
70413,or,0,0
70414,cancer,0,0
70415,was,0,0
70416,42,0,0
70417,%,0,0
70418,less,0,0
70419,(,0,0
70420,95,0,0
70421,%,0,0
70422,CI,0,0
70423,",",0,0
70424,4,0,0
70425,to,0,0
70426,64,0,0
70427,),0,0
70428,and,0,0
70429,the,0,0
70430,proportion,0,0
70431,with,0,0
70432,grade,0,0
70433,3,0,0
70434,lesions,0,0
70435,or,0,0
70436,cancer,0,0
70437,was,0,0
70438,47,0,0
70439,%,0,0
70440,less,0,0
70441,(,0,0
70442,95,0,0
70443,%,0,0
70444,CI,0,0
70445,",",0,0
70446,2,0,0
70447,to,0,0
70448,71,0,0
70449,),0,0
70450,than,0,0
70451,the,0,0
70452,proportions,0,0
70453,of,0,0
70454,control,1,0
70455,women,0,0
70456,who,0,0
70457,were,0,0
70458,found,0,0
70459,to,0,0
70460,have,0,0
70461,such,0,0
70462,lesions,0,0
70463,.,0,0
70464,Women,0,0
70465,with,0,0
70466,persistent,0,0
70467,HPV,0,0
70468,infection,0,0
70469,remained,0,0
70470,at,0,0
70471,high,0,0
70472,risk,0,0
70473,for,0,0
70474,grade,0,0
70475,2,0,0
70476,or,0,0
70477,3,0,0
70478,lesions,0,0
70479,or,0,0
70480,cancer,0,0
70481,after,0,0
70482,referral,0,0
70483,for,0,0
70484,colposcopy,0,0
70485,.,0,0
70486,CONCLUSIONS,0,0
70487,The,0,0
70488,addition,0,0
70489,of,0,0
70490,an,0,0
70491,HPV,1,0
70492,test,1,0
70493,to,0,0
70494,the,0,0
70495,Pap,1,0
70496,test,1,0
70497,to,0,0
70498,screen,0,0
70499,women,0,0
70500,in,0,0
70501,their,0,0
70502,mid-30s,0,0
70503,for,0,0
70504,cervical,0,0
70505,cancer,0,0
70506,reduces,0,0
70507,the,0,0
70508,incidence,0,0
70509,of,0,0
70510,grade,0,0
70511,2,0,0
70512,or,0,0
70513,3,0,0
70514,cervical,0,0
70515,intraepithelial,0,1
70516,neoplasia,0,0
70517,or,0,0
70518,cancer,0,0
70519,detected,0,0
70520,by,0,0
70521,subsequent,0,0
70522,screening,0,0
70523,examinations,0,0
70524,.,0,0
70525,(,0,0
70526,ClinicalTrials.gov,0,0
70527,number,0,0
70528,",",0,0
70529,NCT00479375,0,1
70530,[,0,1
70531,ClinicalTrials.gov,0,1
70532,],0,1
70533,.,0,0
70534,),0,0
70535,.,0,0
70536,Efficacy,0,0
70537,of,0,1
70538,intravenous,0,1
70539,acetaminophen,1,1
70540,and,0,1
70541,lidocaine,1,1
70542,on,0,1
70543,propofol,0,1
70544,injection,0,1
70545,pain,0,1
70546,.,0,0
70547,BACKGROUND,0,0
70548,Different,0,0
70549,methods,0,0
70550,and,0,0
70551,propofol,0,1
70552,formulations,0,1
70553,have,0,0
70554,been,0,0
70555,used,0,0
70556,to,0,0
70557,decrease,0,0
70558,propofol,0,1
70559,injection,0,1
70560,pain,0,1
70561,",",0,0
70562,but,0,0
70563,it,0,0
70564,remains,0,0
70565,an,0,0
70566,unresolved,0,0
70567,problem,0,0
70568,.,0,0
70569,We,0,0
70570,aimed,0,0
70571,to,0,0
70572,investigate,0,0
70573,the,0,0
70574,effect,0,0
70575,of,0,0
70576,i.v,0,1
70577,.,0,1
70578,acetaminophen,0,1
70579,pretreatment,0,1
70580,on,0,1
70581,the,0,0
70582,propofol,0,1
70583,injection,0,1
70584,pain,0,1
70585,.,0,0
70586,METHODS,0,0
70587,One,0,0
70588,hundred,0,0
70589,and,0,0
70590,fifty,0,0
70591,ASA,0,0
70592,I-II,0,0
70593,patients,0,0
70594,undergoing,0,0
70595,general,0,0
70596,anaesthesia,0,0
70597,were,0,0
70598,randomly,0,0
70599,allocated,0,0
70600,into,0,0
70601,three,0,0
70602,groups,0,0
70603,.,0,0
70604,A,0,0
70605,20-gauge,1,0
70606,catheter,1,0
70607,was,0,0
70608,inserted,0,0
70609,into,0,0
70610,a,0,0
70611,superficial,0,0
70612,radial,0,0
70613,vein,0,0
70614,of,0,0
70615,the,0,0
70616,left,0,0
70617,hand,0,0
70618,",",0,0
70619,and,0,0
70620,after,0,0
70621,the,0,0
70622,occlusion,0,0
70623,of,0,0
70624,venous,0,0
70625,drainage,0,0
70626,",",0,0
70627,Groups,0,0
70628,I,0,0
70629,",",0,0
70630,II,0,0
70631,",",0,0
70632,and,0,0
70633,III,0,0
70634,were,0,0
70635,pretreated,0,0
70636,with,0,0
70637,40,1,0
70638,mg,1,1
70639,of,1,1
70640,lidocaine,1,1
70641,in,1,1
70642,saline,1,1
70643,",",1,1
70644,50,1,1
70645,mg,1,1
70646,of,1,1
70647,i.v,1,1
70648,.,1,1
70649,acetaminophen,1,1
70650,",",1,0
70651,and,1,0
70652,5,1,0
70653,ml,1,0
70654,of,1,0
70655,saline,1,1
70656,",",0,0
70657,respectively,0,0
70658,.,0,0
70659,The,0,0
70660,occlusion,0,0
70661,was,0,0
70662,released,0,0
70663,after,0,0
70664,2,0,0
70665,min,0,0
70666,and,0,0
70667,one-fourth,0,0
70668,of,0,0
70669,the,0,0
70670,total,0,0
70671,propofol,1,1
70672,dose,0,1
70673,was,0,1
70674,injected,0,0
70675,into,0,0
70676,the,0,0
70677,vein,0,0
70678,over,0,0
70679,a,0,0
70680,period,0,0
70681,of,0,0
70682,5,0,0
70683,s.,0,0
70684,During,0,0
70685,the,0,0
70686,injection,0,1
70687,of,0,0
70688,both,0,0
70689,pretreatment,0,0
70690,solution,0,0
70691,and,0,0
70692,propofol,0,1
70693,",",0,0
70694,patients,0,0
70695,',0,0
70696,pain,0,0
70697,was,0,0
70698,assessed,0,0
70699,and,0,0
70700,recorded,0,0
70701,as,0,0
70702,0-3,0,0
70703,",",0,0
70704,corresponding,0,0
70705,to,0,0
70706,no,0,0
70707,",",0,0
70708,mild,0,0
70709,",",0,0
70710,moderate,0,0
70711,or,0,0
70712,severe,0,0
70713,pain,0,0
70714,",",0,0
70715,respectively,0,0
70716,.,0,0
70717,Chi2,0,0
70718,and,0,0
70719,Kruskal-Wallis,0,0
70720,tests,0,0
70721,were,0,0
70722,used,0,0
70723,for,0,0
70724,the,0,0
70725,statistical,0,0
70726,analysis,0,0
70727,.,0,0
70728,For,0,0
70729,all,0,0
70730,analyses,0,0
70731,",",0,0
70732,differences,0,0
70733,were,0,0
70734,considered,0,0
70735,to,0,0
70736,be,0,0
70737,significant,0,0
70738,at,0,0
70739,P,0,0
70740,<,0,0
70741,0.05,0,0
70742,.,0,0
70743,RESULTS,0,0
70744,Patient,0,0
70745,characteristics,0,0
70746,were,0,0
70747,similar,0,0
70748,among,0,0
70749,the,0,0
70750,groups,0,0
70751,.,0,0
70752,Incidence,0,0
70753,of,0,0
70754,pain,0,0
70755,on,0,0
70756,injection,0,1
70757,of,0,0
70758,propofol,1,1
70759,in,0,0
70760,control,0,0
70761,",",0,0
70762,i.v,0,1
70763,.,0,1
70764,acetaminophen,1,1
70765,",",0,1
70766,and,0,1
70767,lidocaine,1,1
70768,groups,0,0
70769,was,0,0
70770,64,0,0
70771,%,0,0
70772,",",0,0
70773,22,0,0
70774,%,0,0
70775,and,0,0
70776,8,0,0
70777,%,0,0
70778,",",0,0
70779,respectively,0,0
70780,(,0,0
70781,P,0,0
70782,<,0,0
70783,0.05,0,0
70784,),0,0
70785,.,0,0
70786,CONCLUSIONS,0,0
70787,Pretreatment,0,1
70788,with,0,0
70789,i.v,0,1
70790,.,0,1
70791,acetaminophen,1,1
70792,seems,0,0
70793,to,0,0
70794,be,0,0
70795,effective,0,0
70796,in,0,0
70797,attenuating,0,0
70798,pain,0,0
70799,during,0,0
70800,i.v,0,1
70801,.,0,1
70802,injection,0,1
70803,of,0,1
70804,propofol,1,1
70805,.,1,0
70806,How,0,1
70807,well,0,0
70808,do,0,0
70809,blood,1,1
70810,folate,1,1
70811,concentrations,0,1
70812,predict,0,1
70813,dietary,1,1
70814,folate,1,1
70815,intakes,1,1
70816,in,0,0
70817,a,0,0
70818,sample,0,0
70819,of,0,0
70820,Canadian,0,1
70821,lactating,0,1
70822,women,0,1
70823,exposed,0,0
70824,to,0,0
70825,high,0,0
70826,levels,0,0
70827,of,0,0
70828,folate,0,1
70829,?,0,1
70830,An,0,1
70831,observational,0,1
70832,study,0,0
70833,.,0,0
70834,BACKGROUND,0,0
70835,In,0,0
70836,1998,0,0
70837,",",0,0
70838,mandatory,0,1
70839,folic,0,1
70840,acid,0,1
70841,fortification,0,1
70842,of,0,1
70843,white,1,1
70844,flour,1,1
70845,and,1,1
70846,select,1,1
70847,cereal,1,0
70848,grain,1,0
70849,products,1,0
70850,was,0,0
70851,implemented,0,0
70852,in,0,0
70853,Canada,0,0
70854,with,0,0
70855,the,0,0
70856,intention,0,0
70857,to,0,0
70858,increase,0,0
70859,dietary,1,1
70860,folate,1,1
70861,intakes,1,1
70862,of,0,1
70863,reproducing,0,0
70864,women,0,0
70865,.,0,0
70866,Folic,0,1
70867,acid,0,1
70868,fortification,0,1
70869,has,0,0
70870,produced,0,0
70871,a,0,0
70872,dramatic,0,0
70873,increase,0,0
70874,in,0,0
70875,blood,0,1
70876,folate,0,1
70877,concentrations,0,1
70878,among,0,0
70879,reproductive,0,0
70880,age,0,0
70881,women,0,0
70882,",",0,0
70883,and,0,0
70884,a,0,0
70885,reduction,0,0
70886,in,0,0
70887,neural,0,0
70888,tube,0,0
70889,defect,0,0
70890,(,0,1
70891,NTD,0,1
70892,),0,1
70893,-affected,0,0
70894,pregnancies,0,0
70895,.,0,0
70896,In,0,0
70897,response,0,0
70898,to,0,0
70899,improved,0,0
70900,blood,0,1
70901,folate,0,1
70902,concentrations,0,1
70903,",",0,1
70904,many,0,0
70905,health,0,0
70906,care,0,0
70907,professionals,0,0
70908,are,0,0
70909,asking,0,0
70910,whether,0,0
70911,a,0,0
70912,folic,1,1
70913,acid,1,1
70914,supplement,1,1
70915,is,0,0
70916,necessary,0,0
70917,for,0,0
70918,NTD,0,0
70919,prevention,0,0
70920,among,0,0
70921,women,0,0
70922,with,0,0
70923,high,0,0
70924,blood,0,0
70925,folate,0,1
70926,values,0,0
70927,",",0,0
70928,and,0,0
70929,how,0,0
70930,reliably,0,0
70931,high,0,0
70932,RBC,0,1
70933,folate,0,1
70934,concentrations,0,1
70935,predict,0,1
70936,folate,0,1
70937,intakes,0,1
70938,shown,0,1
70939,in,0,0
70940,randomized,0,0
70941,controlled,0,0
70942,trials,0,0
70943,to,0,0
70944,be,0,0
70945,protective,0,0
70946,against,0,0
70947,NTDs,0,0
70948,.,0,0
70949,The,0,0
70950,objective,0,0
70951,of,0,0
70952,this,0,0
70953,study,0,0
70954,was,0,0
70955,to,0,0
70956,determine,0,0
70957,how,0,0
70958,predictive,0,0
70959,blood,1,1
70960,folate,1,1
70961,concentrations,0,1
70962,and,0,1
70963,folate,0,1
70964,intakes,0,1
70965,are,0,0
70966,of,0,0
70967,each,0,0
70968,other,0,0
70969,in,0,0
70970,a,0,0
70971,sample,0,0
70972,of,0,0
70973,well-educated,0,1
70974,lactating,0,1
70975,Canadian,0,1
70976,women,0,0
70977,exposed,0,0
70978,to,0,0
70979,high,0,0
70980,levels,0,0
70981,of,0,0
70982,synthetic,0,0
70983,folate,0,1
70984,.,0,0
70985,METHODS,0,0
70986,The,0,0
70987,relationship,0,0
70988,between,0,0
70989,blood,1,1
70990,folate,1,1
70991,concentrations,0,1
70992,and,0,1
70993,dietary,0,1
70994,folate,0,1
70995,intakes,0,1
70996,",",0,1
70997,determined,0,0
70998,by,0,0
70999,weighed,1,0
71000,food,1,0
71001,records,1,0
71002,",",0,0
71003,were,0,0
71004,assessed,0,0
71005,in,0,0
71006,a,0,0
71007,sample,0,0
71008,of,0,0
71009,predominantly,0,0
71010,university-educated,0,1
71011,lactating,0,1
71012,women,0,1
71013,(,0,0
71014,32,0,0
71015,+/-,0,0
71016,4,0,0
71017,yr,0,0
71018,),0,0
71019,at,0,0
71020,4-,0,1
71021,(,0,0
71022,n,0,0
71023,=,0,0
71024,53,0,0
71025,),0,0
71026,and,0,0
71027,16-wk,0,1
71028,postpartum,0,1
71029,(,0,0
71030,n,0,0
71031,=,0,0
71032,55,0,0
71033,),0,0
71034,.,0,0
71035,RESULTS,0,0
71036,Median,0,0
71037,blood,1,1
71038,folate,1,1
71039,concentrations,0,1
71040,of,0,0
71041,all,0,0
71042,participants,0,0
71043,were,0,0
71044,well,0,0
71045,above,0,0
71046,plasma,0,0
71047,and,0,1
71048,RBC,0,1
71049,folate,0,1
71050,cut-off,0,1
71051,levels,0,0
71052,indicative,0,0
71053,of,0,0
71054,deficiency,0,0
71055,(,0,0
71056,6.7,0,0
71057,and,0,0
71058,317,0,0
71059,nmol/L,0,0
71060,",",0,0
71061,respectively,0,0
71062,),0,0
71063,and,0,0
71064,all,0,0
71065,",",0,0
71066,except,0,0
71067,for,0,0
71068,2,0,0
71069,subjects,0,0
71070,",",0,0
71071,were,0,0
71072,above,0,0
71073,the,0,0
71074,cut-off,0,0
71075,for,0,0
71076,NTD-risk,0,0
71077,reduction,0,0
71078,(,0,0
71079,>,0,0
71080,906,0,0
71081,nmol/L,0,1
71082,),0,0
71083,.,0,0
71084,Only,0,0
71085,modest,0,0
71086,associations,0,0
71087,existed,0,0
71088,between,0,0
71089,total,1,0
71090,folate,1,1
71091,intakes,1,1
71092,and,0,1
71093,plasma,0,1
71094,(,0,1
71095,r,0,0
71096,=,0,0
71097,0.46,0,0
71098,",",0,0
71099,P,0,0
71100,<,0,0
71101,0.001,0,0
71102,),0,0
71103,and,0,0
71104,RBC,0,1
71105,(,0,0
71106,r,0,0
71107,=,0,0
71108,0.36,0,0
71109,",",0,0
71110,P,0,0
71111,<,0,0
71112,0.01,0,0
71113,),0,0
71114,folate,0,1
71115,concentrations,0,1
71116,at,0,1
71117,16-wk,0,1
71118,postpartum,0,1
71119,.,0,1
71120,Plasma,0,1
71121,and,0,1
71122,RBC,0,1
71123,folate,0,1
71124,values,0,0
71125,at,0,1
71126,16-wk,0,0
71127,postpartum,0,0
71128,correctly,0,0
71129,identified,0,0
71130,the,0,0
71131,quartile,0,0
71132,of,0,0
71133,folate,0,1
71134,intake,0,1
71135,of,0,0
71136,only,0,0
71137,26,0,0
71138,of,0,0
71139,55,0,0
71140,(,0,0
71141,47,0,0
71142,%,0,0
71143,),0,0
71144,and,0,0
71145,18,0,0
71146,of,0,0
71147,55,0,0
71148,(,0,0
71149,33,0,0
71150,%,0,0
71151,),0,0
71152,of,0,0
71153,subjects,0,0
71154,",",0,0
71155,respectively,0,0
71156,.,0,0
71157,The,0,0
71158,mean,0,0
71159,RBC,0,0
71160,folate,0,1
71161,concentration,0,0
71162,of,0,0
71163,women,0,0
71164,consuming,0,0
71165,151-410,0,0
71166,microg/d,0,0
71167,of,0,0
71168,synthetic,0,1
71169,folate,0,1
71170,(,0,1
71171,2nd,0,0
71172,quartile,0,0
71173,of,0,0
71174,intake,0,1
71175,),0,1
71176,did,0,0
71177,not,0,0
71178,differ,0,0
71179,from,0,0
71180,that,0,0
71181,of,0,0
71182,women,0,0
71183,consuming,0,0
71184,>,0,0
71185,410,0,0
71186,microg/d,0,1
71187,(,0,0
71188,3rd,0,0
71189,and,0,0
71190,4th,0,0
71191,quartile,0,0
71192,),0,0
71193,.,0,0
71194,CONCLUSION,0,1
71195,Folate,1,0
71196,intakes,1,1
71197,",",0,0
71198,estimated,0,0
71199,by,0,0
71200,food,0,0
71201,composition,0,0
71202,tables,0,0
71203,",",0,0
71204,and,0,0
71205,blood,0,1
71206,folate,0,1
71207,concentrations,0,1
71208,are,0,0
71209,not,0,0
71210,predictive,0,0
71211,of,0,0
71212,each,0,0
71213,other,0,0
71214,in,0,0
71215,Canadian,0,1
71216,lactating,0,1
71217,women,0,1
71218,exposed,0,0
71219,to,0,0
71220,high,0,0
71221,levels,0,0
71222,of,0,0
71223,folate,0,1
71224,.,0,1
71225,Synthetic,0,0
71226,intakes,0,1
71227,>,0,0
71228,151-410,0,0
71229,microg/d,0,0
71230,in,0,0
71231,these,0,0
71232,women,0,0
71233,produced,0,0
71234,little,0,0
71235,additional,0,0
71236,benefit,0,0
71237,in,0,0
71238,terms,0,0
71239,of,0,0
71240,maximizing,0,0
71241,RBC,0,0
71242,content,0,0
71243,.,0,0
71244,More,0,0
71245,studies,0,0
71246,are,0,0
71247,needed,0,0
71248,to,0,0
71249,examine,0,0
71250,the,0,0
71251,relationship,0,0
71252,between,0,0
71253,blood,1,0
71254,folate,1,1
71255,concentration,0,0
71256,and,0,0
71257,NTD,0,0
71258,risk,0,1
71259,.,0,0
71260,Until,0,1
71261,data,0,0
71262,from,0,0
71263,such,0,0
71264,studies,0,0
71265,are,0,0
71266,available,0,0
71267,",",0,0
71268,women,0,0
71269,planning,0,0
71270,a,0,0
71271,pregnancy,0,0
71272,should,0,0
71273,continue,0,0
71274,to,0,0
71275,consume,0,1
71276,a,0,1
71277,daily,0,1
71278,folic,1,1
71279,acid,1,1
71280,supplement,1,1
71281,of,0,1
71282,400,0,1
71283,microg,0,1
71284,.,0,0
71285,Robotic,1,0
71286,therapy,1,0
71287,:,1,0
71288,a,0,0
71289,novel,0,0
71290,approach,0,0
71291,in,0,0
71292,upper-limb,0,0
71293,neurorehabilitation,0,0
71294,after,0,0
71295,stroke,0,0
71296,.,0,0
71297,Cost-effectiveness,0,0
71298,of,0,0
71299,clopidogrel,1,1
71300,in,0,0
71301,acute,0,1
71302,coronary,0,0
71303,syndromes,0,0
71304,in,0,0
71305,Canada,0,0
71306,:,0,0
71307,a,0,0
71308,long-term,0,0
71309,analysis,0,0
71310,based,0,0
71311,on,0,0
71312,the,0,0
71313,CURE,0,0
71314,trial,0,0
71315,.,0,0
71316,BACKGROUND,0,0
71317,Cardiovascular,0,0
71318,diseases,0,0
71319,account,0,0
71320,for,0,0
71321,nearly,0,0
71322,20,0,0
71323,%,0,0
71324,of,0,0
71325,all,0,0
71326,hospitalizations,0,0
71327,in,0,0
71328,Canada,0,1
71329,and,0,1
71330,consume,0,0
71331,12,0,0
71332,%,0,0
71333,of,0,0
71334,the,0,0
71335,total,0,0
71336,cost,0,0
71337,of,0,0
71338,all,0,0
71339,illnesses,0,0
71340,.,0,0
71341,With,0,0
71342,increasing,0,0
71343,trends,0,0
71344,of,0,0
71345,cardiovascular,0,0
71346,disease,0,0
71347,and,0,0
71348,increasing,0,0
71349,costs,0,0
71350,of,0,0
71351,care,0,0
71352,",",0,0
71353,development,0,0
71354,of,0,0
71355,cost-effective,0,0
71356,strategies,0,0
71357,is,0,0
71358,vital,0,0
71359,.,0,0
71360,The,0,0
71361,Clopidogrel,1,1
71362,in,0,0
71363,Unstable,0,0
71364,angina,0,0
71365,to,0,0
71366,prevent,0,0
71367,Recurrent,0,0
71368,Events,0,0
71369,(,0,1
71370,CURE,0,1
71371,),0,1
71372,trial,0,0
71373,demonstrated,0,0
71374,the,0,0
71375,effectiveness,0,0
71376,of,0,0
71377,clopidogrel,1,1
71378,plus,1,1
71379,acetylsalicylic,1,1
71380,acid,1,1
71381,(,1,1
71382,ASA,1,1
71383,),1,0
71384,compared,0,0
71385,with,0,0
71386,ASA,1,0
71387,alone,1,0
71388,in,0,0
71389,reducing,0,0
71390,cardiovascular,0,0
71391,events,0,0
71392,in,0,0
71393,patients,0,0
71394,with,0,0
71395,acute,0,0
71396,coronary,0,0
71397,syndromes,0,0
71398,and,0,0
71399,",",0,0
71400,in,0,0
71401,addition,0,0
71402,",",0,0
71403,patients,0,0
71404,undergoing,0,0
71405,percutaneous,0,1
71406,coronary,0,0
71407,intervention,0,0
71408,in,0,0
71409,the,0,0
71410,Percutaneous,0,0
71411,Coronary,0,0
71412,Intervention,0,0
71413,in,0,0
71414,CURE,0,1
71415,(,0,1
71416,PCI-CURE,0,1
71417,),0,1
71418,trial,0,0
71419,.,0,0
71420,OBJECTIVE,0,0
71421,To,0,0
71422,assess,0,0
71423,the,0,0
71424,cost-effectiveness,0,0
71425,of,0,0
71426,clopidogrel,1,1
71427,in,0,0
71428,the,0,0
71429,Canadian,0,0
71430,health,0,0
71431,care,0,0
71432,system,0,0
71433,.,0,0
71434,METHODS,0,0
71435,Estimates,0,0
71436,of,0,0
71437,hospitalization,0,0
71438,costs,0,0
71439,were,0,0
71440,based,0,0
71441,on,0,0
71442,the,0,0
71443,2003,0,0
71444,cost,0,0
71445,schedules,0,0
71446,released,0,0
71447,by,0,0
71448,the,0,0
71449,Health,0,0
71450,Funding,0,0
71451,and,0,0
71452,Costing,0,0
71453,Branch,0,0
71454,of,0,0
71455,the,0,0
71456,Alberta,0,0
71457,Health,0,0
71458,and,0,0
71459,Wellness,0,0
71460,",",0,0
71461,as,0,0
71462,well,0,0
71463,as,0,0
71464,on,0,0
71465,the,0,0
71466,Case,0,1
71467,Mix,0,1
71468,Group,0,0
71469,classification,0,0
71470,system,0,0
71471,.,0,0
71472,Life,0,1
71473,expectancy,0,0
71474,beyond,0,0
71475,the,0,0
71476,trial,0,0
71477,was,0,0
71478,estimated,0,0
71479,from,0,0
71480,the,0,0
71481,Saskatchewan,0,0
71482,Health,0,0
71483,Database,0,0
71484,.,0,0
71485,Cost-effectiveness,0,0
71486,was,0,0
71487,expressed,0,0
71488,as,0,0
71489,the,0,0
71490,incremental,0,0
71491,cost-effectiveness,0,0
71492,ratio,0,0
71493,",",0,0
71494,and,0,0
71495,bootstrap,0,0
71496,methods,0,0
71497,were,0,0
71498,used,0,0
71499,to,0,0
71500,estimate,0,0
71501,the,0,0
71502,joint,0,0
71503,distribution,0,0
71504,of,0,0
71505,costs,0,0
71506,and,0,0
71507,effectiveness,0,0
71508,.,0,0
71509,RESULTS,0,1
71510,Clopidogrel,1,1
71511,was,0,0
71512,shown,0,0
71513,to,0,0
71514,be,0,0
71515,cost-effective,0,0
71516,",",0,0
71517,with,0,0
71518,incremental,0,0
71519,cost-effectiveness,0,0
71520,ratios,0,0
71521,less,0,0
71522,than,0,0
71523,$,0,0
71524,"10,000",0,0
71525,per,0,0
71526,event,0,0
71527,prevented,0,0
71528,and,0,0
71529,less,0,0
71530,than,0,0
71531,$,0,0
71532,"4,000",0,0
71533,per,0,0
71534,life-year,0,0
71535,gained,0,0
71536,.,0,0
71537,The,0,0
71538,probability,0,0
71539,of,0,0
71540,clopidogrel,1,1
71541,resulting,0,0
71542,in,0,0
71543,cost,0,0
71544,per,0,0
71545,life-year,0,0
71546,gained,0,0
71547,of,0,0
71548,less,0,0
71549,than,0,0
71550,$,0,0
71551,"20,000",0,0
71552,was,0,0
71553,0.975,0,0
71554,for,0,0
71555,CURE,0,0
71556,patients,0,0
71557,and,0,0
71558,0.904,0,0
71559,for,0,0
71560,PCI-CURE,0,0
71561,patients,0,0
71562,.,0,0
71563,CONCLUSIONS,0,0
71564,The,0,0
71565,economic,0,0
71566,analysis,0,0
71567,demonstrated,0,0
71568,that,0,0
71569,clopidogrel,1,1
71570,combination,1,0
71571,therapy,1,0
71572,is,0,0
71573,not,0,0
71574,only,0,0
71575,cost-effective,0,0
71576,as,0,0
71577,antiplatelet,0,1
71578,therapy,0,1
71579,compared,0,0
71580,with,0,0
71581,ASA,1,0
71582,alone,0,0
71583,",",0,0
71584,but,0,0
71585,it,0,0
71586,is,0,0
71587,also,0,0
71588,cost-effective,0,0
71589,compared,0,0
71590,with,0,0
71591,other,0,0
71592,commonly,0,0
71593,used,0,0
71594,and,0,0
71595,openly,0,0
71596,reimbursed,0,1
71597,cardiovascular,0,0
71598,therapies,0,0
71599,in,0,0
71600,the,0,0
71601,Canadian,0,0
71602,health,0,0
71603,care,0,0
71604,system,0,0
71605,.,0,0
71606,Short-course,0,1
71607,nitrofurantoin,1,1
71608,for,0,0
71609,the,0,0
71610,treatment,0,0
71611,of,0,0
71612,acute,0,0
71613,uncomplicated,0,0
71614,cystitis,0,0
71615,in,0,0
71616,women,0,0
71617,.,0,0
71618,BACKGROUND,0,0
71619,There,0,0
71620,is,0,0
71621,a,0,0
71622,paucity,0,0
71623,of,0,0
71624,data,0,0
71625,on,0,0
71626,the,0,0
71627,efficacy,0,0
71628,of,0,0
71629,nitrofurantoin,1,1
71630,for,0,0
71631,the,0,0
71632,treatment,0,0
71633,of,0,0
71634,acute,0,0
71635,uncomplicated,0,0
71636,cystitis,0,0
71637,in,0,0
71638,regimens,0,1
71639,shorter,0,0
71640,than,0,0
71641,7,0,0
71642,days,0,0
71643,.,0,0
71644,Evidence-based,0,0
71645,use,0,0
71646,of,0,0
71647,this,0,0
71648,drug,0,1
71649,is,0,0
71650,increasingly,0,0
71651,important,0,0
71652,as,0,0
71653,trimethoprim-sulfamethoxazole,1,1
71654,resistance,0,0
71655,among,0,0
71656,uropathogens,0,0
71657,increases,0,0
71658,.,0,0
71659,METHODS,0,0
71660,To,0,0
71661,assess,0,0
71662,the,0,0
71663,efficacy,0,0
71664,of,0,0
71665,nitrofurantoin,1,1
71666,vs,0,1
71667,trimethoprim-sulfamethoxazole,1,1
71668,",",0,0
71669,338,0,0
71670,women,0,0
71671,aged,0,0
71672,18,0,0
71673,to,0,0
71674,45,0,0
71675,years,0,0
71676,with,0,0
71677,acute,0,0
71678,uncomplicated,0,0
71679,cystitis,0,0
71680,were,0,0
71681,randomized,0,0
71682,to,0,0
71683,open-label,0,1
71684,treatment,0,0
71685,with,0,0
71686,either,0,0
71687,trimethoprim-sulfamethoxazole,1,1
71688,",",1,1
71689,1,1,1
71690,double-strength,1,1
71691,tablet,1,1
71692,twice,1,1
71693,daily,1,1
71694,for,1,1
71695,3,1,1
71696,days,1,0
71697,",",1,1
71698,or,1,1
71699,nitrofurantoin,1,1
71700,",",1,1
71701,100,1,1
71702,mg,1,1
71703,twice,1,1
71704,daily,1,1
71705,for,1,1
71706,5,1,0
71707,days,1,0
71708,.,1,0
71709,Clinical,0,1
71710,cure,0,0
71711,30,0,0
71712,days,0,0
71713,after,0,0
71714,therapy,0,0
71715,was,0,0
71716,the,0,0
71717,main,0,0
71718,outcome,0,0
71719,measure,0,0
71720,.,0,0
71721,Secondary,0,0
71722,outcomes,0,0
71723,included,0,0
71724,clinical,0,0
71725,and,0,0
71726,microbiological,0,0
71727,cure,0,0
71728,rates,0,0
71729,5,0,0
71730,to,0,0
71731,9,0,0
71732,days,0,0
71733,after,0,0
71734,therapy,0,0
71735,and,0,0
71736,",",0,0
71737,for,0,0
71738,trimethoprim-sulfamethoxazole-treated,1,1
71739,women,0,1
71740,",",0,0
71741,clinical,0,0
71742,cure,0,0
71743,stratified,0,0
71744,by,0,0
71745,the,0,0
71746,trimethoprim-sulfamethoxazole,1,1
71747,susceptibility,0,0
71748,of,0,0
71749,the,0,0
71750,uropathogen,0,0
71751,.,0,0
71752,RESULTS,0,0
71753,Clinical,0,0
71754,cure,0,0
71755,was,0,0
71756,achieved,0,0
71757,in,0,0
71758,79,0,0
71759,%,0,0
71760,of,0,0
71761,the,0,0
71762,trimethoprim-sulfamethoxazole,0,1
71763,group,0,0
71764,and,0,0
71765,in,0,0
71766,84,0,0
71767,%,0,0
71768,of,0,0
71769,the,0,0
71770,nitrofurantoin,0,1
71771,group,0,0
71772,",",0,0
71773,for,0,0
71774,a,0,0
71775,difference,0,0
71776,of,0,0
71777,-5,0,0
71778,%,0,0
71779,(,0,0
71780,95,0,0
71781,%,0,0
71782,confidence,0,0
71783,interval,0,0
71784,",",0,0
71785,-13,0,0
71786,%,0,0
71787,to,0,0
71788,4,0,0
71789,%,0,0
71790,),0,0
71791,.,0,0
71792,Clinical,0,0
71793,and,0,0
71794,microbiological,0,0
71795,cure,0,0
71796,rates,0,0
71797,at,0,0
71798,the,0,0
71799,first,0,0
71800,follow-up,0,0
71801,visit,0,0
71802,were,0,0
71803,also,0,0
71804,equivalent,0,0
71805,between,0,0
71806,the,0,0
71807,2,0,0
71808,groups,0,0
71809,.,0,0
71810,In,0,0
71811,the,0,0
71812,trimethoprim-sulfamethoxazole,1,1
71813,arm,0,1
71814,",",0,0
71815,7,0,0
71816,of,0,0
71817,17,0,0
71818,women,0,0
71819,(,0,0
71820,41,0,0
71821,%,0,0
71822,),0,0
71823,with,0,0
71824,a,0,0
71825,trimethoprim-sulfamethoxazole-nonsusceptible,0,1
71826,isolate,0,0
71827,had,0,0
71828,a,0,0
71829,clinical,0,0
71830,cure,0,0
71831,compared,0,0
71832,with,0,0
71833,84,0,0
71834,%,0,0
71835,of,0,0
71836,women,0,0
71837,with,0,0
71838,a,0,0
71839,trimethoprim-sulfamethoxazole-susceptible,0,1
71840,isolate,0,0
71841,(,0,0
71842,P,0,0
71843,<,0,0
71844,.001,0,0
71845,),0,0
71846,.,0,0
71847,CONCLUSION,0,1
71848,A,0,1
71849,5-day,0,1
71850,course,0,1
71851,of,0,1
71852,nitrofurantoin,0,1
71853,is,0,0
71854,equivalent,0,0
71855,clinically,0,0
71856,and,0,0
71857,microbiologically,0,0
71858,to,0,0
71859,a,0,0
71860,3-day,0,1
71861,course,0,1
71862,of,0,1
71863,trimethoprim-sulfamethoxazole,0,1
71864,and,0,0
71865,should,0,0
71866,be,0,0
71867,considered,0,0
71868,an,0,0
71869,effective,0,0
71870,fluoroquinolone-sparing,0,1
71871,alternative,0,0
71872,for,0,0
71873,the,0,0
71874,treatment,0,0
71875,of,0,0
71876,acute,0,0
71877,cystitis,0,0
71878,in,0,0
71879,women,0,0
71880,.,0,0
71881,Leucine-enriched,0,1
71882,essential,0,0
71883,amino,0,0
71884,acid,0,1
71885,and,0,1
71886,carbohydrate,0,1
71887,ingestion,0,1
71888,following,0,0
71889,resistance,0,0
71890,exercise,0,0
71891,enhances,0,0
71892,mTOR,0,0
71893,signaling,0,0
71894,and,0,0
71895,protein,0,0
71896,synthesis,0,0
71897,in,0,0
71898,human,0,0
71899,muscle,0,0
71900,.,0,0
71901,We,0,0
71902,recently,0,0
71903,showed,0,0
71904,that,0,0
71905,resistance,0,0
71906,exercise,0,0
71907,and,0,0
71908,ingestion,0,1
71909,of,0,0
71910,essential,1,0
71911,amino,1,0
71912,acids,1,1
71913,with,1,1
71914,carbohydrate,1,1
71915,(,1,1
71916,EAA+CHO,1,1
71917,),1,0
71918,can,0,0
71919,independently,0,0
71920,stimulate,0,0
71921,mammalian,0,0
71922,target,0,0
71923,of,0,0
71924,rapamycin,0,1
71925,(,0,1
71926,mTOR,0,1
71927,),0,0
71928,signaling,0,0
71929,and,0,0
71930,muscle,0,0
71931,protein,0,0
71932,synthesis,0,0
71933,in,0,0
71934,humans,0,0
71935,.,0,0
71936,Providing,0,0
71937,an,0,0
71938,EAA+CHO,0,0
71939,solution,0,0
71940,postexercise,0,0
71941,can,0,0
71942,further,0,0
71943,increase,0,0
71944,muscle,0,0
71945,protein,0,0
71946,synthesis,0,0
71947,.,0,0
71948,Therefore,0,0
71949,",",0,0
71950,we,0,0
71951,hypothesized,0,0
71952,that,0,0
71953,enhanced,0,0
71954,mTOR,0,0
71955,signaling,0,0
71956,might,0,0
71957,be,0,0
71958,responsible,0,0
71959,for,0,0
71960,the,0,0
71961,greater,0,0
71962,muscle,0,0
71963,protein,0,0
71964,synthesis,0,0
71965,when,0,0
71966,leucine-enriched,0,1
71967,EAA+CHOs,0,1
71968,are,0,0
71969,ingested,0,1
71970,during,0,0
71971,postexercise,0,0
71972,recovery,0,0
71973,.,0,0
71974,Sixteen,0,0
71975,male,0,0
71976,subjects,0,0
71977,were,0,0
71978,randomized,0,0
71979,to,0,0
71980,one,0,0
71981,of,0,0
71982,two,0,0
71983,groups,0,0
71984,(,1,0
71985,control,1,0
71986,or,1,0
71987,EAA+CHO,1,1
71988,),1,0
71989,.,0,0
71990,The,1,0
71991,EAA+CHO,1,0
71992,group,1,0
71993,ingested,1,0
71994,the,1,0
71995,nutrient,1,0
71996,solution,1,0
71997,1,1,0
71998,h,1,0
71999,after,1,0
72000,resistance,1,0
72001,exercise,1,0
72002,.,1,0
72003,mTOR,0,0
72004,signaling,0,0
72005,was,0,0
72006,assessed,0,0
72007,by,0,0
72008,immunoblotting,1,0
72009,from,1,0
72010,repeated,1,0
72011,muscle,1,0
72012,biopsy,1,0
72013,samples,1,0
72014,.,1,0
72015,Mixed,0,0
72016,muscle,0,0
72017,fractional,0,0
72018,synthetic,0,0
72019,rate,0,0
72020,(,0,0
72021,FSR,0,1
72022,),0,0
72023,was,0,0
72024,measured,0,0
72025,using,0,0
72026,stable,0,0
72027,isotope,0,0
72028,techniques,0,0
72029,.,0,0
72030,Muscle,0,0
72031,protein,0,0
72032,synthesis,0,0
72033,and,0,0
72034,4E-BP1,0,0
72035,phosphorylation,0,0
72036,during,0,0
72037,exercise,0,0
72038,were,0,0
72039,significantly,0,0
72040,reduced,0,0
72041,(,0,0
72042,P,0,0
72043,<,0,0
72044,0.05,0,0
72045,),0,0
72046,.,0,0
72047,Postexercise,0,1
72048,FSR,0,1
72049,was,0,0
72050,elevated,0,0
72051,above,0,0
72052,baseline,0,0
72053,in,0,0
72054,both,0,0
72055,groups,0,0
72056,at,0,0
72057,1,0,0
72058,h,0,0
72059,but,0,0
72060,was,0,0
72061,even,0,0
72062,further,0,0
72063,elevated,0,0
72064,in,0,0
72065,the,0,0
72066,EAA+CHO,0,0
72067,group,0,0
72068,at,0,0
72069,2,0,0
72070,h,0,0
72071,postexercise,0,0
72072,(,0,0
72073,P,0,0
72074,<,0,0
72075,0.05,0,0
72076,),0,0
72077,.,0,0
72078,Increased,0,0
72079,FSR,0,0
72080,was,0,0
72081,associated,0,0
72082,with,0,0
72083,enhanced,0,0
72084,phosphorylation,0,0
72085,of,0,0
72086,mTOR,0,0
72087,and,0,0
72088,S6K1,0,0
72089,(,0,0
72090,P,0,0
72091,<,0,0
72092,0.05,0,0
72093,),0,0
72094,.,0,0
72095,Akt,0,0
72096,phosphorylation,0,0
72097,was,0,0
72098,elevated,0,0
72099,at,0,0
72100,1,0,0
72101,h,0,0
72102,and,0,0
72103,returned,0,0
72104,to,0,0
72105,baseline,0,0
72106,by,0,0
72107,2,0,0
72108,h,0,0
72109,in,0,0
72110,the,0,0
72111,control,0,0
72112,group,0,0
72113,",",0,0
72114,but,0,0
72115,it,0,0
72116,remained,0,0
72117,elevated,0,0
72118,in,0,0
72119,the,0,0
72120,EAA+CHO,0,1
72121,group,0,0
72122,(,0,0
72123,P,0,0
72124,<,0,0
72125,0.05,0,0
72126,),0,0
72127,.,0,0
72128,4E-BP1,0,0
72129,phosphorylation,0,0
72130,returned,0,0
72131,to,0,0
72132,baseline,0,0
72133,during,0,0
72134,recovery,0,0
72135,in,0,0
72136,control,0,0
72137,but,0,0
72138,became,0,0
72139,elevated,0,0
72140,when,0,0
72141,EAA+CHO,0,0
72142,was,0,0
72143,ingested,0,0
72144,(,0,0
72145,P,0,0
72146,<,0,0
72147,0.05,0,0
72148,),0,0
72149,.,0,0
72150,eEF2,0,0
72151,phosphorylation,0,0
72152,decreased,0,0
72153,at,0,0
72154,1,0,0
72155,and,0,0
72156,2,0,0
72157,h,0,0
72158,postexercise,0,0
72159,to,0,0
72160,a,0,0
72161,similar,0,0
72162,extent,0,0
72163,in,0,0
72164,both,0,0
72165,groups,0,0
72166,(,0,0
72167,P,0,0
72168,<,0,0
72169,0.05,0,0
72170,),0,0
72171,.,0,0
72172,Our,0,0
72173,data,0,0
72174,suggest,0,0
72175,that,0,0
72176,enhanced,0,0
72177,activation,0,0
72178,of,0,0
72179,the,0,0
72180,mTOR,0,0
72181,signaling,0,0
72182,pathway,0,0
72183,is,0,0
72184,playing,0,0
72185,a,0,0
72186,role,0,0
72187,in,0,0
72188,the,0,0
72189,greater,0,0
72190,synthesis,0,0
72191,of,0,0
72192,muscle,0,0
72193,proteins,0,0
72194,when,0,0
72195,resistance,0,0
72196,exercise,0,0
72197,is,0,0
72198,followed,0,0
72199,by,0,0
72200,EAA+CHO,0,1
72201,ingestion,0,1
72202,.,0,0
72203,Comparison,0,0
72204,of,0,0
72205,two,0,0
72206,sedation,1,0
72207,techniques,1,0
72208,in,0,0
72209,patients,0,0
72210,undergoing,0,0
72211,surgical,0,0
72212,procedures,0,0
72213,under,0,0
72214,regional,0,0
72215,anaesthesia,0,0
72216,.,0,0
72217,OBJECTIVE,0,0
72218,Intraoperative,0,0
72219,comfort,0,0
72220,and,0,0
72221,patient,0,0
72222,satisfaction,0,0
72223,during,0,0
72224,surgical,0,0
72225,procedures,0,0
72226,under,0,0
72227,regional,0,0
72228,anaesthesia,0,0
72229,can,0,0
72230,be,0,0
72231,improved,0,0
72232,with,0,0
72233,the,0,0
72234,use,0,0
72235,of,0,0
72236,supplemental,0,1
72237,intravenous,0,1
72238,sedation,0,1
72239,.,0,0
72240,The,0,0
72241,authors,0,0
72242,conducted,0,0
72243,a,0,0
72244,study,0,0
72245,to,0,0
72246,compare,0,0
72247,two,0,0
72248,sedation,0,0
72249,techniques,0,0
72250,for,0,0
72251,surgical,0,0
72252,procedures,0,0
72253,performed,0,0
72254,under,0,0
72255,regional,0,0
72256,anaesthesia,0,0
72257,",",0,0
72258,i.e.,0,0
72259,",",0,0
72260,midazolam,1,1
72261,and,1,1
72262,pethidine,1,1
72263,combination,1,0
72264,compared,0,0
72265,with,0,0
72266,midazolam,1,1
72267,and,1,1
72268,tramadol,1,1
72269,combination,1,0
72270,.,1,0
72271,METHODS,0,0
72272,Forty,0,0
72273,adult,0,0
72274,American,0,0
72275,Society,0,0
72276,of,0,0
72277,Anaesthesiologists,0,1
72278,(,0,1
72279,ASA,0,1
72280,),0,0
72281,grade,0,0
72282,1-111,0,0
72283,patients,0,0
72284,",",0,0
72285,aged,0,0
72286,between,0,0
72287,40-65,0,0
72288,years,0,0
72289,undergoing,0,0
72290,surgery,0,0
72291,under,0,0
72292,regional,0,0
72293,anaesthesia,0,1
72294,(,0,0
72295,sub-arachnoid,0,1
72296,block,0,0
72297,),0,0
72298,were,0,0
72299,included,0,0
72300,.,0,0
72301,The,0,0
72302,patients,0,0
72303,were,0,0
72304,randomly,0,0
72305,divided,0,0
72306,into,0,0
72307,two,0,0
72308,groups,0,0
72309,.,0,0
72310,All,0,0
72311,patients,0,0
72312,received,0,0
72313,standardized,0,1
72314,premedication,0,1
72315,",",0,1
72316,intraoperative,0,0
72317,monitoring,0,0
72318,and,0,0
72319,oxygen,0,0
72320,therapy,0,0
72321,.,0,0
72322,Group,0,0
72323,A,0,0
72324,patients,0,0
72325,received,0,0
72326,midazolam,1,1
72327,0.03,1,1
72328,mg/kg,1,1
72329,followed,1,0
72330,by,1,0
72331,pethidine,1,1
72332,20,1,1
72333,mg,1,1
72334,intravenously,1,1
72335,",",0,1
72336,and,0,0
72337,group,0,0
72338,B,0,0
72339,patients,0,0
72340,received,0,0
72341,midazolam,1,1
72342,0.03,1,1
72343,mg/kg,1,1
72344,followed,1,0
72345,by,1,0
72346,tramadol,1,1
72347,20,1,1
72348,mg,1,1
72349,intravenously,0,1
72350,after,0,1
72351,the,0,0
72352,institution,0,0
72353,of,0,0
72354,regional,0,0
72355,anaesthesia,0,0
72356,.,0,0
72357,Monitoring,0,0
72358,included,0,0
72359,ECG,0,0
72360,",",0,0
72361,blood,0,0
72362,pressure,0,0
72363,",",0,0
72364,respiratory,0,0
72365,rate,0,0
72366,",",0,0
72367,oxygen,0,0
72368,saturation,0,0
72369,and,0,0
72370,sedation,0,0
72371,score,0,0
72372,.,0,0
72373,Complications,0,0
72374,",",0,0
72375,if,0,0
72376,any,0,0
72377,",",0,0
72378,were,0,0
72379,recorded,0,0
72380,.,0,0
72381,Monitoring,0,0
72382,was,0,0
72383,continued,0,0
72384,during,0,0
72385,the,0,0
72386,recovery,0,0
72387,room,0,0
72388,stay,0,0
72389,.,0,0
72390,All,0,0
72391,patients,0,0
72392,were,0,0
72393,interviewed,0,0
72394,in,0,0
72395,the,0,0
72396,evening,0,0
72397,and,0,0
72398,time,0,0
72399,of,0,0
72400,ambulation,0,0
72401,and,0,0
72402,rating,0,0
72403,of,0,0
72404,OR,0,0
72405,experience,0,0
72406,was,0,0
72407,noted,0,0
72408,.,0,0
72409,RESULTS,0,0
72410,Data,0,0
72411,analysis,0,0
72412,showed,0,0
72413,no,0,0
72414,significant,0,0
72415,difference,0,0
72416,between,0,0
72417,pethidine,1,1
72418,and,0,1
72419,tramadol,1,1
72420,for,0,0
72421,all,0,0
72422,the,0,0
72423,haemodynamic,0,1
72424,variables,0,0
72425,(,0,0
72426,p,0,0
72427,=,0,0
72428,>,0,0
72429,0.05,0,0
72430,),0,0
72431,.,0,0
72432,There,0,0
72433,was,0,0
72434,also,0,0
72435,no,0,0
72436,significant,0,0
72437,difference,0,0
72438,in,0,0
72439,patient,0,0
72440,'s,0,0
72441,and,0,0
72442,surgeon,0,0
72443,'s,0,0
72444,assessment,0,0
72445,of,0,0
72446,their,0,0
72447,experience,0,0
72448,.,0,0
72449,Complications,0,0
72450,and,0,0
72451,recovery,0,0
72452,characteristics,0,0
72453,also,0,0
72454,did,0,0
72455,not,0,0
72456,show,0,0
72457,any,0,0
72458,significant,0,0
72459,difference,0,0
72460,.,0,0
72461,CONCLUSION,0,1
72462,Midazolam-tramadol,1,1
72463,combination,1,0
72464,may,0,0
72465,be,0,0
72466,used,0,0
72467,as,0,0
72468,an,0,0
72469,alternative,0,0
72470,to,0,0
72471,midazolam-pethidine,1,1
72472,combination,1,0
72473,for,0,0
72474,sedation,0,0
72475,during,0,0
72476,surgical,0,0
72477,procedures,0,0
72478,performed,0,0
72479,under,0,0
72480,regional,0,0
72481,anaesthesia,0,0
72482,.,0,0
72483,A,0,1
72484,randomized,0,1
72485,",",0,1
72486,placebo-controlled,1,1
72487,trial,0,1
72488,of,0,0
72489,controlled,0,0
72490,release,0,0
72491,melatonin,1,1
72492,treatment,1,1
72493,of,0,0
72494,delayed,0,0
72495,sleep,0,0
72496,phase,0,0
72497,syndrome,0,0
72498,and,0,0
72499,impaired,0,0
72500,sleep,0,0
72501,maintenance,0,0
72502,in,0,0
72503,children,0,0
72504,with,0,0
72505,neurodevelopmental,0,0
72506,disabilities,0,0
72507,.,0,0
72508,The,0,0
72509,purpose,0,0
72510,of,0,0
72511,this,0,0
72512,study,0,0
72513,was,0,0
72514,to,0,0
72515,determine,0,0
72516,the,0,0
72517,efficacy,0,0
72518,of,0,0
72519,controlled-release,0,1
72520,(,0,1
72521,CR,0,1
72522,),0,1
72523,melatonin,1,1
72524,in,0,0
72525,the,0,0
72526,treatment,0,0
72527,of,0,0
72528,delayed,0,0
72529,sleep,0,0
72530,phase,0,0
72531,syndrome,0,0
72532,and,0,0
72533,impaired,0,0
72534,sleep,0,0
72535,maintenance,0,0
72536,of,0,0
72537,children,0,0
72538,with,0,0
72539,neurodevelopmental,0,0
72540,disabilities,0,0
72541,including,0,0
72542,autistic,0,0
72543,spectrum,0,0
72544,disorders,0,0
72545,.,0,0
72546,A,0,1
72547,randomized,0,1
72548,double-blind,0,1
72549,",",0,1
72550,placebo-controlled,1,1
72551,crossover,0,1
72552,trial,0,1
72553,of,0,0
72554,CR,1,1
72555,melatonin,1,1
72556,(,0,1
72557,5,0,1
72558,mg,0,1
72559,),0,1
72560,followed,0,0
72561,by,0,0
72562,a,0,0
72563,3-month,0,0
72564,open-label,0,1
72565,study,0,0
72566,was,0,0
72567,conducted,0,0
72568,during,0,0
72569,which,0,0
72570,the,0,0
72571,dose,0,1
72572,was,0,0
72573,gradually,0,0
72574,increased,0,0
72575,until,0,0
72576,the,0,0
72577,therapy,0,0
72578,showed,0,0
72579,optimal,0,0
72580,beneficial,0,0
72581,effects,0,0
72582,.,0,0
72583,Sleep,0,0
72584,characteristics,0,0
72585,were,0,0
72586,measured,0,0
72587,by,0,0
72588,caregiver,0,0
72589,who,0,0
72590,completed,0,0
72591,somnologs,0,0
72592,and,0,0
72593,wrist,0,0
72594,actigraphs,0,0
72595,.,0,0
72596,Clinician,0,0
72597,rating,0,0
72598,of,0,0
72599,severity,0,0
72600,of,0,0
72601,the,0,0
72602,sleep,0,0
72603,disorder,0,0
72604,and,0,0
72605,improvement,0,0
72606,from,0,0
72607,baseline,0,0
72608,",",0,0
72609,along,0,0
72610,with,0,0
72611,caregiver,0,0
72612,ratings,0,0
72613,of,0,0
72614,global,0,0
72615,functioning,0,0
72616,and,0,0
72617,family,0,0
72618,stress,0,0
72619,were,0,0
72620,also,0,0
72621,obtained,0,0
72622,.,0,0
72623,Fifty-one,0,0
72624,children,0,0
72625,(,0,0
72626,age,0,0
72627,range,0,0
72628,2-18,0,0
72629,years,0,0
72630,),0,0
72631,who,0,0
72632,did,0,0
72633,not,0,0
72634,respond,0,0
72635,to,0,0
72636,sleep,0,0
72637,hygiene,0,0
72638,intervention,0,0
72639,were,0,0
72640,enrolled,0,0
72641,.,0,0
72642,Fifty,0,0
72643,patients,0,0
72644,completed,0,0
72645,the,0,0
72646,crossover,0,1
72647,trial,0,0
72648,and,0,0
72649,47,0,0
72650,completed,0,0
72651,the,0,0
72652,open-label,0,1
72653,phase,0,0
72654,.,0,0
72655,Recordings,0,0
72656,of,0,0
72657,total,0,0
72658,night-time,0,0
72659,sleep,0,0
72660,and,0,0
72661,sleep,0,0
72662,latency,0,0
72663,showed,0,0
72664,significant,0,0
72665,improvement,0,0
72666,of,0,0
72667,approximately,0,0
72668,30,0,0
72669,min,0,0
72670,.,0,0
72671,Similarly,0,0
72672,",",0,0
72673,significant,0,0
72674,improvement,0,0
72675,was,0,0
72676,observed,0,0
72677,in,0,0
72678,clinician,0,0
72679,and,0,0
72680,parent,0,0
72681,ratings,0,0
72682,.,0,0
72683,There,0,0
72684,was,0,0
72685,additional,0,0
72686,improvement,0,0
72687,in,0,0
72688,the,0,0
72689,open-label,0,1
72690,somnolog,0,1
72691,measures,0,1
72692,of,0,0
72693,sleep,0,0
72694,efficiency,0,0
72695,and,0,0
72696,the,0,0
72697,longest,0,0
72698,sleep,0,0
72699,episode,0,0
72700,in,0,0
72701,the,0,0
72702,open-label,0,1
72703,phase,0,0
72704,.,0,0
72705,Overall,0,0
72706,",",0,0
72707,the,0,0
72708,therapy,0,0
72709,improved,0,0
72710,the,0,0
72711,sleep,0,0
72712,of,0,0
72713,47,0,0
72714,children,0,0
72715,and,0,0
72716,was,0,0
72717,effective,0,0
72718,in,0,0
72719,reducing,0,0
72720,family,0,0
72721,stress,0,0
72722,.,0,0
72723,Children,0,0
72724,with,0,0
72725,neurodevelopmental,0,0
72726,disabilities,0,0
72727,",",0,0
72728,who,0,0
72729,had,0,0
72730,treatment,0,0
72731,resistant,0,0
72732,chronic,0,0
72733,delayed,0,0
72734,sleep,0,0
72735,phase,0,0
72736,syndrome,0,0
72737,and,0,0
72738,impaired,0,0
72739,sleep,0,0
72740,maintenance,0,0
72741,",",0,0
72742,showed,0,0
72743,improvement,0,0
72744,in,0,0
72745,melatonin,1,1
72746,therapy,1,1
72747,.,1,0
72748,Effect,0,0
72749,of,0,0
72750,upper,0,0
72751,arm,0,0
72752,brachial,0,0
72753,basilic,0,0
72754,and,0,0
72755,prosthetic,0,0
72756,forearm,0,1
72757,arteriovenous,0,0
72758,fistula,0,0
72759,on,0,0
72760,left,0,0
72761,ventricular,0,0
72762,hypertrophy,0,0
72763,.,0,0
72764,BACKGROUND,0,0
72765,Creation,0,0
72766,of,0,0
72767,an,0,0
72768,arteriovenous,0,0
72769,fistula,0,1
72770,(,0,1
72771,AVF,0,1
72772,),0,0
72773,may,0,0
72774,increase,0,0
72775,left,0,0
72776,ventricular,0,0
72777,hypertrophy,0,0
72778,in,0,0
72779,the,0,0
72780,hemodialysis,0,0
72781,population,0,0
72782,.,0,0
72783,Aim,0,0
72784,of,0,0
72785,this,0,0
72786,study,0,0
72787,was,0,0
72788,to,0,0
72789,compare,0,0
72790,the,0,0
72791,effects,0,0
72792,of,0,0
72793,a,0,0
72794,brachial-basilic,1,0
72795,(,1,1
72796,BB,1,1
72797,),1,1
72798,AVF,1,1
72799,and,0,0
72800,the,0,0
72801,prosthetic,1,0
72802,brachial-antecubital,1,0
72803,forearm,1,0
72804,loop,1,0
72805,access,1,1
72806,(,0,1
72807,PTFE,0,1
72808,),0,1
72809,on,0,0
72810,cardiac,0,0
72811,performance,0,0
72812,.,0,0
72813,METHODS,0,0
72814,Patients,0,0
72815,were,0,0
72816,randomized,0,0
72817,to,0,0
72818,receive,0,0
72819,BB-AVF,1,1
72820,or,1,0
72821,prosthetic,1,0
72822,brachial-antecubital,1,0
72823,forearm,1,0
72824,loop,1,0
72825,access,1,0
72826,.,1,0
72827,Before,0,0
72828,and,0,0
72829,three,0,0
72830,months,0,0
72831,after,0,0
72832,AVF,0,0
72833,creation,0,0
72834,patients,0,0
72835,underwent,0,0
72836,an,0,0
72837,echocardiographic,0,0
72838,examination,0,0
72839,.,0,0
72840,Mann-Whitney,0,0
72841,U-test,0,0
72842,was,0,0
72843,used,0,0
72844,to,0,0
72845,compare,0,0
72846,relative,0,0
72847,increase,0,0
72848,between,0,0
72849,the,0,0
72850,measured,0,0
72851,cardiac,0,0
72852,parameters,0,0
72853,for,0,0
72854,the,0,0
72855,two,0,0
72856,groups,0,0
72857,.,0,0
72858,RESULTS,0,0
72859,Twenty-seven,0,0
72860,patients,0,0
72861,participated,0,0
72862,in,0,0
72863,the,0,0
72864,study,0,0
72865,.,0,0
72866,The,0,0
72867,relative,0,0
72868,increase,0,0
72869,in,0,0
72870,left,0,0
72871,ventricular,0,0
72872,parameters,0,0
72873,was,0,0
72874,not,0,0
72875,significantly,0,0
72876,different,0,0
72877,between,0,0
72878,the,0,0
72879,two,0,0
72880,groups,0,0
72881,.,0,0
72882,Only,0,0
72883,left,0,0
72884,ventricular,0,0
72885,end-diastolic,0,0
72886,diameter,0,0
72887,tended,0,0
72888,to,0,0
72889,be,0,0
72890,of,0,0
72891,significance,0,0
72892,.,0,0
72893,Mean,0,0
72894,blood,0,0
72895,flow,0,0
72896,through,0,0
72897,the,0,0
72898,brachial,0,0
72899,artery,0,0
72900,was,0,0
72901,1680+/-156,0,0
72902,and,0,0
72903,1450+/-221,0,0
72904,mL/min,0,0
72905,three,0,0
72906,months,0,0
72907,after,0,0
72908,surgery,0,0
72909,for,0,0
72910,the,0,0
72911,PTFE,0,0
72912,and,0,0
72913,the,0,0
72914,BB-AVF,0,1
72915,group,0,0
72916,",",0,0
72917,respectively,0,0
72918,.,0,0
72919,CONCLUSION,0,0
72920,After,0,0
72921,three,0,0
72922,months,0,0
72923,of,0,0
72924,follow-up,0,0
72925,",",0,0
72926,changes,0,0
72927,in,0,0
72928,cardiac,0,0
72929,structure,0,0
72930,were,0,0
72931,comparable,0,0
72932,between,0,0
72933,patients,0,0
72934,with,0,0
72935,BB,0,0
72936,and,0,0
72937,PTFE,0,0
72938,AVFs,0,1
72939,.,0,0
72940,Also,0,0
72941,access,0,0
72942,flow,0,0
72943,was,0,0
72944,comparable,0,0
72945,at,0,0
72946,this,0,0
72947,time,0,0
72948,.,0,0
72949,In,0,0
72950,general,0,0
72951,",",0,0
72952,the,0,0
72953,effects,0,0
72954,of,0,0
72955,creation,0,0
72956,of,0,0
72957,a,0,0
72958,fistula,0,0
72959,on,0,0
72960,LV,0,0
72961,structure,0,0
72962,were,0,0
72963,limited,0,0
72964,.,0,0
72965,Longer,0,0
72966,follow,0,0
72967,up,0,0
72968,time,0,0
72969,may,0,0
72970,be,0,0
72971,needed,0,0
72972,to,0,0
72973,explore,0,0
72974,the,0,0
72975,long,0,0
72976,term,0,0
72977,effects,0,0
72978,of,0,0
72979,different,0,0
72980,vascular,0,0
72981,accesses,0,0
72982,on,0,0
72983,cardiac,0,0
72984,function,0,0
72985,.,0,0
72986,The,0,0
72987,cost-effectiveness,0,0
72988,of,0,0
72989,parasitologic,0,0
72990,diagnosis,0,0
72991,for,0,0
72992,malaria-suspected,0,0
72993,patients,0,0
72994,in,0,0
72995,an,0,0
72996,era,0,0
72997,of,0,0
72998,combination,0,0
72999,therapy,0,0
73000,.,0,0
73001,The,0,0
73002,introduction,0,0
73003,of,0,0
73004,artemisinin-based,1,1
73005,combination,1,0
73006,therapy,1,0
73007,in,0,0
73008,sub-Saharan,0,0
73009,Africa,0,0
73010,has,0,0
73011,prompted,0,0
73012,calls,0,0
73013,for,0,0
73014,increased,0,0
73015,use,0,0
73016,of,0,0
73017,parasitologic,0,0
73018,diagnosis,0,0
73019,for,0,0
73020,malaria,0,0
73021,.,0,0
73022,We,0,0
73023,evaluated,0,0
73024,the,0,0
73025,cost-effectiveness,0,0
73026,of,0,0
73027,rapid,1,0
73028,diagnostic,1,0
73029,tests,1,1
73030,(,1,1
73031,RDTs,1,1
73032,),1,0
73033,in,0,0
73034,comparison,0,0
73035,to,0,0
73036,microscopy,1,0
73037,in,0,0
73038,guiding,0,0
73039,treatment,0,0
73040,of,0,0
73041,non-severe,0,0
73042,febrile,0,0
73043,illness,0,0
73044,at,0,0
73045,varying,0,0
73046,levels,0,0
73047,of,0,0
73048,malaria,0,0
73049,endemicity,0,0
73050,using,0,0
73051,data,0,0
73052,on,0,0
73053,test,0,0
73054,accuracy,0,0
73055,and,0,0
73056,costs,0,0
73057,collected,0,0
73058,as,0,0
73059,part,0,0
73060,of,0,0
73061,a,0,0
73062,Tanzanian,0,0
73063,trial,0,0
73064,.,0,0
73065,If,0,0
73066,prescribers,0,0
73067,complied,0,0
73068,with,0,0
73069,current,0,0
73070,guidelines,0,0
73071,",",0,0
73072,microscopy,0,0
73073,would,0,0
73074,give,0,0
73075,rise,0,0
73076,to,0,0
73077,lower,0,0
73078,average,0,0
73079,costs,0,0
73080,per,0,0
73081,patient,0,0
73082,correctly,0,0
73083,treated,0,0
73084,than,0,0
73085,RDTs,1,0
73086,in,0,0
73087,areas,0,0
73088,of,0,0
73089,both,0,0
73090,high,0,0
73091,and,0,0
73092,low,0,0
73093,transmission,0,0
73094,.,0,0
73095,RDT,0,0
73096,introduction,0,0
73097,would,0,0
73098,result,0,0
73099,in,0,0
73100,an,0,0
73101,additional,0,0
73102,2.3,0,0
73103,%,0,0
73104,and,0,0
73105,9.4,0,0
73106,%,0,0
73107,of,0,0
73108,patients,0,0
73109,correctly,0,0
73110,treated,0,0
73111,",",0,0
73112,at,0,0
73113,an,0,0
73114,incremental,0,0
73115,cost,0,0
73116,of,0,0
73117,$,0,0
73118,25,0,0
73119,and,0,0
73120,$,0,0
73121,7,0,0
73122,in,0,0
73123,the,0,0
73124,low,0,0
73125,and,0,0
73126,high,0,0
73127,transmission,0,0
73128,settings,0,0
73129,",",0,0
73130,respectively,0,0
73131,.,0,0
73132,Cost-effectiveness,0,0
73133,would,0,0
73134,be,0,0
73135,worse,0,0
73136,if,0,0
73137,prescribers,0,0
73138,do,0,0
73139,not,0,0
73140,comply,0,0
73141,with,0,0
73142,test,0,0
73143,results,0,0
73144,.,0,0
73145,The,0,0
73146,cost,0,0
73147,of,0,0
73148,this,0,0
73149,additional,0,0
73150,benefit,0,0
73151,may,0,0
73152,be,0,0
73153,higher,0,0
73154,than,0,0
73155,many,0,0
73156,countries,0,0
73157,can,0,0
73158,afford,0,0
73159,without,0,0
73160,external,0,0
73161,assistance,0,0
73162,or,0,0
73163,lower,0,0
73164,RDT,0,0
73165,prices,0,0
73166,.,0,0
73167,A,0,1
73168,randomised,0,1
73169,double-blind,0,1
73170,trial,0,1
73171,of,0,1
73172,cyclosporin,1,1
73173,and,1,1
73174,azathioprine,1,1
73175,in,0,0
73176,refractory,0,1
73177,rheumatoid,0,0
73178,arthritis,0,0
73179,.,0,0
73180,Fifty-two,0,0
73181,patients,0,0
73182,with,0,0
73183,severe,0,0
73184,rheumatoid,0,1
73185,arthritis,0,1
73186,(,0,1
73187,RA,0,1
73188,),0,0
73189,from,0,0
73190,four,0,0
73191,Australian,0,0
73192,centres,0,0
73193,were,0,0
73194,randomised,0,0
73195,to,0,0
73196,receive,1,1
73197,cyclosporin,1,1
73198,A,1,1
73199,(,1,1
73200,CSA,1,1
73201,),1,1
73202,(,1,0
73203,n,1,0
73204,=,1,0
73205,25,1,0
73206,),1,0
73207,or,1,1
73208,azathioprine,1,1
73209,(,1,1
73210,AZA,1,1
73211,),1,1
73212,(,1,0
73213,n,1,0
73214,=,1,0
73215,27,1,0
73216,),1,0
73217,for,1,0
73218,six,1,0
73219,months,1,0
73220,.,1,0
73221,Initial,0,0
73222,mean,0,0
73223,doses,0,0
73224,of,0,0
73225,CSA,1,0
73226,and,0,0
73227,AZA,1,0
73228,were,0,0
73229,4.2,0,0
73230,mg/kg,0,0
73231,and,0,0
73232,1.7,0,0
73233,mg/kg,0,0
73234,respectively,0,0
73235,.,0,0
73236,The,0,0
73237,mean,0,0
73238,doses,0,0
73239,of,0,0
73240,CSA,1,0
73241,and,0,0
73242,AZA,1,0
73243,at,0,0
73244,six,0,0
73245,months,0,0
73246,were,0,0
73247,3.4,0,0
73248,mg/kg,0,0
73249,and,0,0
73250,1.9,0,0
73251,mg/kg,0,0
73252,.,0,0
73253,Assessments,0,0
73254,of,0,0
73255,side-effects,0,1
73256,and,0,0
73257,outcomes,0,0
73258,of,0,0
73259,benefit,0,0
73260,were,0,0
73261,made,0,0
73262,monthly,0,0
73263,by,0,0
73264,independent,0,0
73265,",",0,0
73266,blinded,0,0
73267,observers,0,0
73268,.,0,0
73269,Both,0,0
73270,treatment,0,0
73271,groups,0,0
73272,exhibited,0,0
73273,statistically,0,0
73274,significant,0,0
73275,improvement,0,0
73276,in,0,0
73277,standard,0,0
73278,outcome,0,0
73279,parameters,0,0
73280,when,0,0
73281,compared,0,0
73282,with,0,0
73283,baseline,0,0
73284,values,0,0
73285,.,0,0
73286,However,0,0
73287,",",0,0
73288,there,0,0
73289,were,0,0
73290,no,0,0
73291,statistically,0,0
73292,significant,0,0
73293,differences,0,0
73294,in,0,0
73295,these,0,0
73296,parameters,0,0
73297,between,0,0
73298,the,0,0
73299,two,0,0
73300,groups,0,0
73301,.,0,0
73302,There,0,0
73303,was,0,0
73304,a,0,0
73305,mean,0,0
73306,increase,0,0
73307,in,0,0
73308,serum,0,1
73309,creatinine,0,1
73310,concentration,0,0
73311,associated,0,0
73312,with,0,0
73313,CSA,0,0
73314,;,0,0
73315,no,0,0
73316,persons,0,0
73317,were,0,0
73318,withdrawn,0,0
73319,from,0,0
73320,the,0,0
73321,study,0,0
73322,for,0,0
73323,this,0,0
73324,reason,0,0
73325,.,0,0
73326,Seven,0,0
73327,CSA,1,0
73328,recipients,0,0
73329,(,0,0
73330,three,0,0
73331,gastrointestinal,0,0
73332,symptoms,0,0
73333,",",0,0
73334,two,0,0
73335,neurological,0,0
73336,symptoms,0,0
73337,",",0,0
73338,two,0,0
73339,other,0,0
73340,),0,0
73341,and,0,0
73342,12,0,0
73343,AZA,1,1
73344,recipients,0,0
73345,(,0,0
73346,six,0,0
73347,gastrointestinal,0,0
73348,symptoms,0,0
73349,",",0,0
73350,four,0,0
73351,inefficacy,0,0
73352,",",0,0
73353,two,0,0
73354,other,0,0
73355,),0,0
73356,withdrew,0,0
73357,from,0,0
73358,treatment,0,0
73359,prematurely,0,0
73360,.,0,0
73361,Seven,0,0
73362,CSA,1,0
73363,recipients,0,0
73364,became,0,0
73365,hypertensive,0,0
73366,and,0,0
73367,four,0,0
73368,required,0,0
73369,anti-hypertensive,0,1
73370,therapy,0,1
73371,.,0,0
73372,Adverse,0,0
73373,events,0,0
73374,not,0,0
73375,requiring,0,0
73376,cessation,0,0
73377,of,0,0
73378,therapy,0,0
73379,were,0,0
73380,more,0,0
73381,commonly,0,0
73382,seen,0,0
73383,among,0,0
73384,CSA,1,0
73385,patients,0,0
73386,.,0,0
73387,In,0,0
73388,this,0,0
73389,group,0,0
73390,of,0,0
73391,severely,0,0
73392,affected,0,0
73393,patients,0,0
73394,with,0,0
73395,RA,0,0
73396,both,0,0
73397,cyclosporin,1,1
73398,and,0,1
73399,azathioprine,1,1
73400,were,0,0
73401,effective,0,0
73402,therapies,0,0
73403,.,0,0
73404,CSA,1,0
73405,toxicities,0,1
73406,were,0,0
73407,predictable,0,0
73408,and,0,0
73409,manageable,0,0
73410,but,0,0
73411,required,0,0
73412,close,0,0
73413,monitoring,0,0
73414,.,0,0
73415,The,0,0
73416,impact,0,0
73417,of,0,0
73418,fasting,1,1
73419,and,1,0
73420,treatment,1,0
73421,omission,1,0
73422,on,0,0
73423,susceptibility,0,0
73424,to,0,0
73425,hypoglycaemia,0,0
73426,in,0,0
73427,children,0,0
73428,and,0,0
73429,adolescents,0,0
73430,with,0,0
73431,GH,0,0
73432,and,0,0
73433,cortisol,0,1
73434,insufficiency,0,1
73435,.,0,1
73436,OBJECTIVE,0,1
73437,Hypoglycaemia,0,1
73438,may,0,0
73439,be,0,0
73440,a,0,0
73441,frequent,0,0
73442,occurrence,0,0
73443,in,0,0
73444,young,0,0
73445,GH,0,0
73446,deficient,0,0
73447,patients,0,0
73448,and,0,0
73449,so,0,0
73450,we,0,0
73451,studied,0,0
73452,the,0,0
73453,response,0,0
73454,to,0,0
73455,fasting,0,1
73456,in,0,0
73457,children,0,1
73458,and,0,0
73459,adolescents,0,0
73460,with,0,0
73461,GH,0,0
73462,and/or,0,0
73463,cortisol,0,1
73464,deficiency,0,0
73465,.,0,0
73466,METHODS,0,0
73467,A,0,0
73468,total,0,0
73469,of,0,0
73470,20,0,0
73471,patients,0,0
73472,(,0,0
73473,2-18,0,0
73474,years,0,0
73475,),0,0
73476,fasted,1,1
73477,for,0,1
73478,14,0,0
73479,h,0,0
73480,(,0,0
73481,22.00-12.00,0,0
73482,h,0,0
73483,),0,0
73484,on,0,0
73485,two,0,0
73486,occasions,0,0
73487,as,0,0
73488,part,0,0
73489,of,0,0
73490,a,0,0
73491,randomized,0,0
73492,cross-over,0,1
73493,study,0,0
73494,.,0,0
73495,Fourteen,0,0
73496,had,0,0
73497,pituitary,0,0
73498,hormone,0,1
73499,deficiency,0,1
73500,(,0,1
73501,PHD,0,1
73502,),0,1
73503,including,0,0
73504,GH,0,1
73505,deficiency,0,0
73506,(,0,1
73507,GHD,0,1
73508,),0,1
73509,.,0,0
73510,Of,0,0
73511,the,0,0
73512,14,0,0
73513,patients,0,0
73514,",",0,0
73515,seven,0,0
73516,were,0,0
73517,ACTH,0,0
73518,sufficient,0,0
73519,(,0,1
73520,PHDC+,0,1
73521,),0,1
73522,and,0,0
73523,seven,0,0
73524,ACTH,0,0
73525,deficient,0,0
73526,(,0,1
73527,PHDC-,0,1
73528,),0,1
73529,.,0,0
73530,Six,0,1
73531,had,0,0
73532,primary,0,0
73533,adrenal,0,1
73534,failure,0,1
73535,(,0,1
73536,PAF,0,1
73537,),0,1
73538,.,0,0
73539,Subjects,0,1
73540,administered,0,1
73541,or,0,0
73542,omitted,1,0
73543,their,0,0
73544,normal,1,0
73545,dose,1,1
73546,of,1,0
73547,evening,1,1
73548,GH,1,0
73549,and/or,1,0
73550,morning,1,1
73551,hydrocortisone,1,1
73552,.,1,1
73553,Glucose,0,1
73554,",",0,1
73555,insulin,0,1
73556,",",0,1
73557,GH,0,1
73558,",",0,1
73559,cortisol,0,1
73560,",",0,1
73561,ketones,0,1
73562,and,0,1
73563,catecholamines,0,1
73564,were,0,0
73565,measured,0,0
73566,at,0,0
73567,04.00,0,0
73568,h,0,0
73569,and,0,0
73570,regularly,0,0
73571,from,0,0
73572,07.00,0,0
73573,to,0,0
73574,12.00,0,0
73575,h.,0,0
73576,Insulin,0,1
73577,sensitivity,0,0
73578,was,0,0
73579,assessed,0,0
73580,by,0,0
73581,HOMA,0,0
73582,and,0,0
73583,hypoglycaemia,0,0
73584,defined,0,0
73585,as,0,0
73586,a,0,0
73587,blood,0,1
73588,glucose,0,1
73589,(,0,1
73590,BG,0,1
73591,),0,0
73592,<,0,0
73593,/=,0,0
73594,3.3,0,0
73595,mmol/l,0,0
73596,.,0,0
73597,RESULTS,0,0
73598,BG,0,0
73599,was,0,0
73600,related,0,0
73601,to,0,0
73602,age,0,0
73603,and,0,0
73604,body,0,0
73605,mass,0,0
73606,index,0,0
73607,on,0,0
73608,treatment,0,0
73609,but,0,0
73610,no,0,0
73611,subject,0,0
73612,became,0,0
73613,hypoglycaemic,0,1
73614,on,0,0
73615,or,0,0
73616,off,0,0
73617,therapy,0,0
73618,prior,0,0
73619,to,0,0
73620,07.00,0,0
73621,h.,0,1
73622,Five,0,1
73623,children,0,1
73624,(,0,0
73625,aged,0,0
73626,3,0,0
73627,",",0,0
73628,4,0,0
73629,",",0,0
73630,7,0,0
73631,",",0,0
73632,8,0,0
73633,and,0,0
73634,11,0,0
73635,years,0,0
73636,),0,1
73637,were,0,0
73638,hypoglycaemic,0,1
73639,between,0,1
73640,07.00,0,0
73641,and,0,0
73642,12.00,0,0
73643,h,0,0
73644,off,0,0
73645,treatment,0,0
73646,.,0,0
73647,There,0,0
73648,was,0,0
73649,a,0,0
73650,positive,0,0
73651,relationship,0,0
73652,between,0,0
73653,GH,0,0
73654,AUC,0,1
73655,and,0,0
73656,minimum,0,0
73657,BG,0,0
73658,in,0,0
73659,patients,0,0
73660,with,0,0
73661,PHD,0,0
73662,on,0,0
73663,treatment,0,0
73664,(,0,1
73665,r,0,1
73666,(,0,1
73667,2,0,0
73668,),0,0
73669,=,0,0
73670,0.45,0,0
73671,",",0,0
73672,P,0,0
73673,=,0,0
73674,0.012,0,0
73675,),0,0
73676,with,0,0
73677,increased,0,0
73678,insulin,0,1
73679,sensitivity,0,0
73680,off,0,0
73681,treatment,0,0
73682,.,0,0
73683,Increased,0,0
73684,cortisol,0,0
73685,levels,0,0
73686,were,0,0
73687,seen,0,0
73688,in,0,0
73689,PHDC+,0,0
73690,patients,0,0
73691,off,0,0
73692,GH,0,0
73693,(,0,0
73694,P,0,0
73695,<,0,0
73696,0.001,0,0
73697,),0,0
73698,.,0,0
73699,A,0,0
73700,negative,0,0
73701,relationship,0,0
73702,was,0,0
73703,observed,0,0
73704,between,0,0
73705,minimum,0,0
73706,BG,0,1
73707,and,0,1
73708,adrenaline,0,1
73709,(,0,1
73710,r,0,1
73711,(,0,1
73712,2,0,0
73713,),0,0
73714,=,0,0
73715,0.37,0,0
73716,",",0,0
73717,P,0,0
73718,=,0,0
73719,0.01,0,0
73720,),0,0
73721,",",0,0
73722,ketone,0,1
73723,bodies,0,1
73724,(,0,1
73725,r,0,1
73726,(,0,1
73727,2,0,0
73728,),0,0
73729,=,0,0
73730,-0.20,0,0
73731,",",0,0
73732,P,0,0
73733,=,0,0
73734,0.05,0,0
73735,),0,0
73736,and,0,0
73737,NEFA,0,1
73738,(,0,1
73739,r,0,1
73740,(,0,1
73741,2,0,0
73742,),0,0
73743,=,0,0
73744,-0.35,0,0
73745,",",0,0
73746,P,0,0
73747,=,0,0
73748,0.02,0,0
73749,),0,0
73750,.,0,0
73751,Noradrenaline,0,1
73752,levels,0,0
73753,were,0,0
73754,reduced,0,0
73755,in,0,0
73756,patients,0,0
73757,with,0,0
73758,PHDC-,0,0
73759,.,0,0
73760,Low,0,1
73761,BMI,0,1
73762,(,0,0
73763,on,0,0
73764,treatment,0,0
73765,),0,0
73766,and,0,0
73767,young,0,1
73768,age,0,1
73769,(,0,0
73770,off,0,1
73771,treatment,0,0
73772,),0,0
73773,were,0,0
73774,determinants,0,0
73775,of,0,0
73776,low,0,0
73777,BG,0,0
73778,levels,0,0
73779,in,0,0
73780,a,0,0
73781,multiple,0,0
73782,regression,0,0
73783,model,0,0
73784,.,0,0
73785,CONCLUSIONS,0,0
73786,Unrecognized,0,0
73787,overnight,0,0
73788,hypoglycaemia,0,0
73789,in,0,0
73790,children,0,0
73791,and,0,0
73792,adolescents,0,0
73793,on,0,0
73794,pituitary,0,0
73795,hormone,0,1
73796,replacement,0,0
73797,is,0,0
73798,uncommon,0,0
73799,but,0,0
73800,BG,0,0
73801,levels,0,0
73802,quickly,0,0
73803,become,0,0
73804,abnormal,0,0
73805,when,0,0
73806,treatment,0,0
73807,and,0,0
73808,meals,0,1
73809,are,0,0
73810,omitted,1,0
73811,.,1,0
73812,The,0,0
73813,insulin,0,1
73814,antagonistic,0,0
73815,actions,0,0
73816,of,0,0
73817,GH,0,0
73818,are,0,0
73819,important,0,0
73820,in,0,0
73821,preventing,0,0
73822,hypoglycaemia,0,0
73823,.,0,0
73824,Patients,0,0
73825,with,0,0
73826,PHD,0,0
73827,have,0,0
73828,altered,0,0
73829,sympathetic,0,0
73830,nerve,0,0
73831,activity,0,0
73832,.,0,0
73833,Microtensile,0,1
73834,bond,0,1
73835,strength,0,1
73836,of,0,0
73837,a,0,0
73838,repair,0,0
73839,composite,0,0
73840,to,0,0
73841,leucite-reinforced,0,0
73842,feldspathic,0,0
73843,ceramic,0,0
73844,.,0,0
73845,The,0,0
73846,purpose,0,0
73847,of,0,0
73848,this,0,0
73849,study,0,0
73850,was,0,0
73851,to,0,0
73852,evaluate,0,0
73853,the,0,0
73854,microtensile,0,1
73855,bond,0,1
73856,strength,0,1
73857,of,0,0
73858,a,0,0
73859,repair,0,0
73860,composite,0,0
73861,resin,0,1
73862,to,0,0
73863,a,0,0
73864,leucite-reinforced,0,0
73865,feldspathic,0,0
73866,ceramic,0,1
73867,(,0,0
73868,Omega,0,1
73869,900,0,0
73870,",",0,0
73871,VITA,0,1
73872,),0,0
73873,submitted,0,0
73874,to,0,0
73875,two,0,0
73876,surface,0,0
73877,conditionings,0,0
73878,methods,0,0
73879,:,0,0
73880,1,0,0
73881,),0,1
73882,etching,1,1
73883,with,1,1
73884,hydrofluoric,1,1
73885,acid,1,1
73886,+,1,1
73887,silane,1,1
73888,application,1,1
73889,or,1,0
73890,2,1,1
73891,),1,1
73892,tribochemical,1,1
73893,silica,1,1
73894,coating,1,0
73895,.,1,0
73896,The,0,0
73897,null,0,0
73898,hypothesis,0,0
73899,is,0,0
73900,that,0,0
73901,both,0,0
73902,surface,0,0
73903,treatments,0,0
73904,can,0,0
73905,generate,0,0
73906,similar,0,0
73907,bond,0,0
73908,strengths,0,0
73909,.,0,0
73910,Ten,0,0
73911,ceramic,0,0
73912,blocks,0,0
73913,(,0,0
73914,6x6x6,0,1
73915,mm,0,0
73916,),0,0
73917,were,0,0
73918,fabricated,0,0
73919,and,0,0
73920,randomly,0,0
73921,assigned,0,0
73922,to,0,0
73923,2,0,1
73924,groups,0,0
73925,(,0,0
73926,n=5,0,0
73927,),0,0
73928,",",0,0
73929,according,0,0
73930,to,0,0
73931,the,0,0
73932,conditioning,0,0
73933,method,0,0
73934,:,0,0
73935,G1-,0,0
73936,10,0,0
73937,%,0,0
73938,hydrofluoric,1,1
73939,acid,1,1
73940,application,0,0
73941,for,0,0
73942,2,0,0
73943,min,0,0
73944,plus,0,0
73945,rinsing,0,1
73946,and,0,1
73947,drying,0,0
73948,",",0,0
73949,followed,0,0
73950,by,0,0
73951,silane,1,1
73952,application,0,0
73953,for,0,0
73954,30,0,0
73955,s,0,0
73956,;,0,0
73957,G2-,0,1
73958,airborne,0,0
73959,particle,0,0
73960,abrasion,0,0
73961,with,0,0
73962,30,0,0
73963,microm,0,0
73964,silica,0,1
73965,oxide,0,1
73966,particles,0,1
73967,(,0,1
73968,CoJet-Sand,0,1
73969,),0,1
73970,for,0,0
73971,20,0,0
73972,s,0,0
73973,using,0,0
73974,a,0,0
73975,chairside,0,1
73976,air-abrasion,0,1
73977,device,0,1
73978,(,0,1
73979,CoJet,0,1
73980,System,0,0
73981,),0,0
73982,",",0,0
73983,followed,0,0
73984,by,0,0
73985,silane,0,1
73986,application,0,0
73987,for,0,0
73988,5,0,0
73989,min,0,0
73990,.,0,0
73991,Single,0,1
73992,Bond,0,1
73993,adhesive,0,0
73994,system,0,0
73995,was,0,0
73996,applied,0,0
73997,to,0,0
73998,the,0,0
73999,surfaces,0,0
74000,and,0,0
74001,light,0,0
74002,cured,0,0
74003,(,0,0
74004,40,0,0
74005,s,0,1
74006,),0,0
74007,.,0,0
74008,Z-250,0,1
74009,composite,0,0
74010,resin,0,1
74011,was,0,0
74012,placed,0,0
74013,incrementally,0,0
74014,on,0,0
74015,the,0,0
74016,treated,0,0
74017,ceramic,0,0
74018,surface,0,0
74019,to,0,0
74020,build,0,0
74021,a,0,0
74022,6x6x6,0,0
74023,mm,0,0
74024,block,0,0
74025,.,0,0
74026,Bar,0,0
74027,specimens,0,0
74028,with,0,0
74029,an,0,0
74030,adhesive,0,0
74031,area,0,0
74032,of,0,0
74033,approximately,0,0
74034,1,0,0
74035,+/-,0,0
74036,0.1,0,0
74037,mm,0,0
74038,(,0,0
74039,2,0,0
74040,),0,0
74041,were,0,0
74042,obtained,0,0
74043,from,0,0
74044,the,0,0
74045,composite-ceramic,0,0
74046,blocks,0,0
74047,(,0,0
74048,6,0,0
74049,per,0,0
74050,block,0,0
74051,and,0,0
74052,30,0,0
74053,per,0,0
74054,group,0,0
74055,),0,0
74056,for,0,1
74057,microtensile,0,1
74058,testing,0,1
74059,.,0,1
74060,No,0,0
74061,statistically,0,0
74062,significant,0,0
74063,difference,0,0
74064,was,0,0
74065,observed,0,0
74066,between,0,0
74067,G1,0,0
74068,(,0,0
74069,10.19,0,0
74070,+/-,0,0
74071,3.1,0,0
74072,MPa,0,0
74073,),0,0
74074,and,0,0
74075,G2,0,1
74076,(,0,0
74077,10.17,0,0
74078,+/-,0,0
74079,3.1,0,0
74080,MPa,0,0
74081,),0,0
74082,(,0,0
74083,p=0.982,0,1
74084,),0,0
74085,(,0,0
74086,Student,0,1
74087,'s,0,1
74088,t,0,1
74089,test,0,1
74090,;,0,0
74091,?,0,0
74092,=,0,0
74093,0.05,0,0
74094,),0,0
74095,.,0,0
74096,The,0,0
74097,null,0,0
74098,hypothesis,0,0
74099,was,0,0
74100,",",0,0
74101,therefore,0,0
74102,",",0,0
74103,accepted,0,0
74104,.,0,0
74105,In,0,0
74106,conclusion,0,0
74107,",",0,0
74108,both,0,0
74109,surface,0,0
74110,conditioning,0,0
74111,methods,0,0
74112,provided,0,0
74113,similar,0,0
74114,microtensile,0,1
74115,bond,0,0
74116,strengths,0,0
74117,between,0,0
74118,the,0,0
74119,repair,0,0
74120,composite,0,0
74121,resin,0,1
74122,and,0,0
74123,the,0,0
74124,ceramic,0,0
74125,.,0,0
74126,Further,0,0
74127,studies,0,0
74128,using,0,0
74129,long-term,0,0
74130,aging,0,0
74131,procedures,0,0
74132,should,0,0
74133,be,0,0
74134,conducted,0,0
74135,.,0,0
74136,Safety,0,1
74137,and,0,0
74138,tolerability,0,1
74139,of,0,0
74140,cold-adapted,0,1
74141,influenza,1,1
74142,vaccine,1,1
74143,",",1,1
74144,trivalent,1,1
74145,",",0,0
74146,in,0,0
74147,infants,0,0
74148,younger,0,1
74149,than,0,0
74150,6,0,0
74151,months,0,0
74152,of,0,0
74153,age,0,0
74154,.,0,0
74155,OBJECTIVE,0,0
74156,Young,0,0
74157,children,0,0
74158,are,0,0
74159,at,0,0
74160,high,0,0
74161,risk,0,0
74162,for,0,0
74163,influenza-related,0,0
74164,complications,0,0
74165,.,0,0
74166,Vaccination,0,0
74167,of,0,0
74168,close,0,0
74169,household,0,0
74170,contacts,0,0
74171,is,0,0
74172,recommended,0,0
74173,to,0,0
74174,provide,0,0
74175,indirect,0,0
74176,protection,0,0
74177,to,0,0
74178,children,0,0
74179,<,0,0
74180,6,0,0
74181,months,0,0
74182,of,0,0
74183,age,0,0
74184,.,0,0
74185,Studies,0,0
74186,have,0,0
74187,shown,0,0
74188,that,0,0
74189,live,0,0
74190,",",0,0
74191,cold-adapted,0,0
74192,influenza,1,1
74193,vaccine,1,1
74194,",",0,1
74195,trivalent,0,1
74196,",",0,0
74197,is,0,0
74198,efficacious,0,1
74199,in,0,0
74200,children,0,0
74201,.,0,0
74202,To,0,0
74203,assess,0,0
74204,the,0,0
74205,risks,0,0
74206,associated,0,0
74207,with,0,0
74208,inadvertent,0,0
74209,exposure,0,0
74210,of,0,0
74211,infants,0,0
74212,to,0,1
74213,vaccine,0,1
74214,viruses,0,1
74215,from,0,0
74216,vaccinated,0,0
74217,contacts,0,0
74218,",",0,0
74219,this,0,0
74220,study,0,0
74221,was,0,0
74222,designed,0,0
74223,to,0,0
74224,evaluate,0,0
74225,the,0,0
74226,safety,0,0
74227,and,0,0
74228,tolerability,0,1
74229,of,0,0
74230,cold-adapted,0,1
74231,influenza,1,1
74232,vaccine,1,1
74233,",",0,1
74234,trivalent,0,1
74235,",",0,1
74236,administered,0,1
74237,intranasally,0,1
74238,to,0,1
74239,healthy,0,0
74240,children,0,0
74241,6,0,0
74242,to,0,0
74243,<,0,0
74244,24,0,0
74245,weeks,0,0
74246,of,0,0
74247,age,0,0
74248,.,0,0
74249,METHODS,0,0
74250,Healthy,0,0
74251,infants,0,0
74252,aged,0,0
74253,6,0,0
74254,to,0,0
74255,<,0,0
74256,16,0,0
74257,weeks,0,0
74258,and,0,0
74259,16,0,0
74260,to,0,0
74261,<,0,0
74262,24,0,0
74263,weeks,0,0
74264,",",0,0
74265,respectively,0,0
74266,",",0,0
74267,were,0,0
74268,randomly,0,0
74269,assigned,0,0
74270,to,0,0
74271,receive,0,1
74272,2,1,1
74273,doses,1,1
74274,of,1,1
74275,influenza,1,1
74276,vaccine,1,1
74277,",",1,1
74278,or,1,1
74279,placebo,1,1
74280,intranasally,0,1
74281,35,0,0
74282,+/-,0,0
74283,7,0,0
74284,days,0,0
74285,apart,0,0
74286,.,0,1
74287,Reactogenicity,0,0
74288,events,0,0
74289,were,0,0
74290,monitored,0,0
74291,for,0,0
74292,11,0,0
74293,days,0,0
74294,after,0,0
74295,each,0,0
74296,dose,0,1
74297,.,0,0
74298,Other,0,0
74299,adverse,0,0
74300,events,0,0
74301,were,0,0
74302,monitored,0,0
74303,through,0,0
74304,28,0,0
74305,to,0,0
74306,35,0,0
74307,days,0,0
74308,after,0,0
74309,dose,0,1
74310,2,0,0
74311,.,0,0
74312,RESULTS,0,0
74313,Of,0,0
74314,the,0,0
74315,infants,0,0
74316,aged,0,0
74317,6,0,0
74318,to,0,0
74319,<,0,0
74320,16,0,0
74321,weeks,0,0
74322,",",0,0
74323,31,0,0
74324,received,0,0
74325,influenza,1,0
74326,vaccine,1,1
74327,and,0,0
74328,28,0,0
74329,received,0,0
74330,placebo,1,1
74331,",",0,1
74332,and,0,0
74333,of,0,0
74334,those,0,0
74335,aged,0,0
74336,16,0,0
74337,to,0,0
74338,<,0,0
74339,24,0,0
74340,weeks,0,0
74341,",",0,0
74342,30,0,0
74343,received,0,0
74344,influenza,1,1
74345,vaccine,1,1
74346,and,0,0
74347,31,0,0
74348,received,0,0
74349,placebo,1,1
74350,.,1,1
74351,In,0,0
74352,the,0,0
74353,6-,0,0
74354,to,0,0
74355,<,0,0
74356,16-week,0,0
74357,cohort,0,0
74358,",",0,0
74359,more,0,0
74360,influenza,0,1
74361,vaccine,0,1
74362,",",0,0
74363,recipients,0,0
74364,experienced,0,1
74365,irritability,0,0
74366,(,0,0
74367,66.7,0,0
74368,%,0,0
74369,vs,0,0
74370,35.7,0,0
74371,%,0,0
74372,),0,0
74373,and,0,0
74374,runny,0,1
74375,nose,0,1
74376,or,0,0
74377,nasal,0,1
74378,congestion,0,0
74379,(,0,0
74380,63.3,0,0
74381,%,0,0
74382,vs,0,0
74383,33.3,0,0
74384,%,0,0
74385,),0,0
74386,after,0,0
74387,dose,0,1
74388,1,0,0
74389,but,0,0
74390,not,0,0
74391,dose,0,1
74392,2,0,1
74393,.,0,0
74394,There,0,0
74395,were,0,0
74396,no,0,0
74397,significant,0,0
74398,increases,0,0
74399,in,0,0
74400,any,0,0
74401,other,0,0
74402,reactogenicity,0,1
74403,events,0,0
74404,or,0,0
74405,adverse,0,0
74406,events,0,0
74407,in,0,0
74408,the,0,0
74409,vaccine,0,0
74410,recipients,0,0
74411,compared,0,0
74412,with,0,0
74413,the,0,0
74414,placebo,1,1
74415,group,0,1
74416,.,0,0
74417,CONCLUSIONS,0,0
74418,Although,0,0
74419,there,0,0
74420,was,0,0
74421,an,0,0
74422,increase,0,0
74423,in,0,0
74424,mild,0,0
74425,reactogenicity,0,1
74426,events,0,0
74427,in,0,0
74428,children,0,0
74429,6,0,0
74430,to,0,0
74431,<,0,0
74432,16,0,0
74433,weeks,0,0
74434,of,0,0
74435,age,0,0
74436,",",0,0
74437,cold-adapted,0,0
74438,influenza,1,1
74439,vaccine,1,1
74440,",",0,1
74441,trivalent,0,1
74442,",",0,0
74443,was,0,0
74444,generally,0,0
74445,well,0,0
74446,tolerated,0,1
74447,in,0,0
74448,infants,0,0
74449,6,0,0
74450,to,0,0
74451,<,0,0
74452,24,0,0
74453,weeks,0,0
74454,of,0,0
74455,age,0,0
74456,.,0,0
74457,These,0,0
74458,findings,0,0
74459,support,0,0
74460,further,0,0
74461,evaluation,0,0
74462,of,0,0
74463,cold-adapted,0,0
74464,influenza,1,1
74465,vaccine,1,1
74466,",",0,1
74467,trivalent,0,1
74468,",",0,0
74469,in,0,0
74470,infants,0,0
74471,<,0,0
74472,6,0,0
74473,months,0,0
74474,of,0,0
74475,age,0,0
74476,.,0,0
74477,Prognosis,0,0
74478,of,0,0
74479,advanced,0,0
74480,hepatocellular,0,0
74481,carcinoma,0,0
74482,:,0,0
74483,comparison,0,0
74484,of,0,0
74485,three,0,0
74486,staging,0,0
74487,systems,0,0
74488,in,0,0
74489,two,0,0
74490,French,0,0
74491,clinical,0,0
74492,trials,0,0
74493,.,0,0
74494,OBJECTIVE,0,0
74495,The,0,0
74496,objective,0,0
74497,of,0,0
74498,this,0,0
74499,study,0,0
74500,was,0,0
74501,to,0,0
74502,assess,0,0
74503,the,0,0
74504,performance,0,0
74505,of,0,0
74506,three,1,0
74507,staging,1,0
74508,systems,1,0
74509,[,1,0
74510,Okuda,1,1
74511,",",1,0
74512,Cancer,1,0
74513,of,1,0
74514,the,1,0
74515,Liver,1,0
74516,Italian,1,1
74517,Program,1,0
74518,(,1,1
74519,CLIP,1,1
74520,),1,1
74521,and,1,0
74522,Barcelona,1,1
74523,Clinic,1,1
74524,Liver,1,1
74525,Cancer,1,1
74526,group,1,0
74527,(,1,1
74528,BCLC,1,1
74529,),1,1
74530,],1,0
74531,",",0,0
74532,for,0,0
74533,predicting,0,0
74534,survival,0,0
74535,in,0,0
74536,patients,0,0
74537,with,0,0
74538,hepatocellular,0,0
74539,carcinoma,0,1
74540,(,0,1
74541,HCC,0,1
74542,),0,1
74543,and,0,0
74544,to,0,0
74545,explore,0,0
74546,how,0,0
74547,to,0,0
74548,improve,0,0
74549,prognostic,0,0
74550,classification,0,0
74551,among,0,0
74552,French,0,0
74553,patients,0,0
74554,with,0,0
74555,HCC,0,0
74556,whose,0,0
74557,main,0,0
74558,etiology,0,0
74559,is,0,0
74560,alcoholic,0,0
74561,cirrhosis,0,0
74562,.,0,0
74563,METHODS,0,0
74564,We,0,0
74565,have,0,0
74566,pooled,0,0
74567,two,0,0
74568,randomized,0,0
74569,clinical,0,0
74570,trials,0,0
74571,in,0,0
74572,palliative,0,0
74573,condition,0,0
74574,from,0,0
74575,the,0,0
74576,F?d?ration,0,0
74577,Francophone,0,0
74578,de,0,0
74579,Cancerologie,0,0
74580,Digestive,0,0
74581,.,0,0
74582,They,0,0
74583,had,0,0
74584,included,0,0
74585,416,0,0
74586,and,0,0
74587,122,0,0
74588,patients,0,0
74589,.,0,0
74590,Performances,0,0
74591,of,0,0
74592,Okuda,0,0
74593,",",0,0
74594,CLIP,0,1
74595,and,0,0
74596,BCLC,0,0
74597,scores,0,0
74598,have,0,0
74599,been,0,0
74600,compared,0,0
74601,using,0,0
74602,Akaike,0,0
74603,information,0,0
74604,criterion,0,0
74605,",",0,0
74606,discriminatory,0,0
74607,ability,0,0
74608,(,0,0
74609,Harrell,0,0
74610,'s,0,0
74611,C,0,0
74612,and,0,0
74613,the,0,0
74614,Royston,0,0
74615,'s,0,0
74616,D,0,1
74617,statistics,0,1
74618,),0,0
74619,",",0,0
74620,monotonicity,0,0
74621,of,0,0
74622,gradients,0,0
74623,and,0,0
74624,predictive,0,1
74625,accuracy,0,1
74626,(,0,1
74627,Schemper,0,1
74628,statistics,0,1
74629,Vs,0,1
74630,),0,0
74631,.,0,0
74632,To,0,0
74633,explore,0,0
74634,how,0,0
74635,to,0,0
74636,improve,0,0
74637,classifications,0,0
74638,",",0,0
74639,univariate,0,0
74640,and,0,0
74641,multivariate,0,0
74642,Cox,0,0
74643,model,0,0
74644,analyses,0,0
74645,were,0,0
74646,carried,0,0
74647,out,0,0
74648,.,0,0
74649,RESULTS,0,0
74650,The,0,0
74651,pooled,0,0
74652,database,0,0
74653,included,0,0
74654,538,0,0
74655,patients,0,0
74656,.,0,0
74657,The,0,0
74658,median,0,0
74659,survival,0,0
74660,was,0,0
74661,5.3,0,0
74662,months,0,0
74663,(,0,0
74664,95,0,0
74665,%,0,0
74666,confidence,0,0
74667,interval,0,0
74668,4.6-6.2,0,0
74669,),0,0
74670,.,0,0
74671,For,0,0
74672,all,0,0
74673,statistics,1,0
74674,CLIP,1,1
74675,staging,1,0
74676,system,1,0
74677,had,0,0
74678,a,0,0
74679,better,0,0
74680,prognostic,0,0
74681,ability,0,0
74682,.,0,0
74683,Performances,0,0
74684,of,0,0
74685,all,0,0
74686,staging,0,0
74687,systems,0,0
74688,were,0,0
74689,rather,0,0
74690,disappointing,0,0
74691,.,0,0
74692,World,0,0
74693,Health,0,0
74694,Organization,0,0
74695,performance,0,0
74696,status,0,1
74697,(,0,0
74698,WHO,0,1
74699,PS,0,1
74700,),0,0
74701,for,1,0
74702,CLIP,1,1
74703,or,1,0
74704,alpha-fetoprotein,1,1
74705,for,1,0
74706,BCLC,0,0
74707,allowed,0,0
74708,a,0,0
74709,significant,0,0
74710,improvement,0,0
74711,of,0,0
74712,prognostic,0,0
74713,information,0,0
74714,.,0,0
74715,CONCLUSION,0,0
74716,Our,0,0
74717,results,0,0
74718,indicate,0,0
74719,that,1,0
74720,CLIP,1,0
74721,staging,1,0
74722,seems,1,0
74723,to,0,0
74724,be,0,0
74725,most,0,0
74726,adapted,0,0
74727,to,0,0
74728,palliative,0,0
74729,setting,0,0
74730,and,0,0
74731,that,0,0
74732,it,0,0
74733,could,0,0
74734,be,0,0
74735,better,0,0
74736,by,0,0
74737,associating,0,0
74738,WHO,0,0
74739,PS,0,0
74740,.,0,0
74741,Once-daily,0,1
74742,amoxicillin,1,1
74743,versus,0,1
74744,twice-daily,0,1
74745,penicillin,1,1
74746,V,1,1
74747,in,0,0
74748,group,0,0
74749,A,0,1
74750,beta-haemolytic,0,1
74751,streptococcal,0,1
74752,pharyngitis,0,1
74753,.,0,0
74754,BACKGROUND,0,0
74755,Rheumatic,0,0
74756,fever,0,0
74757,is,0,0
74758,a,0,0
74759,preventable,0,0
74760,chronic,0,0
74761,disease,0,0
74762,preceded,0,0
74763,by,0,0
74764,group,0,0
74765,A,0,1
74766,beta-haemolytic,0,1
74767,streptococcal,0,1
74768,(,0,1
74769,GABHS,0,1
74770,),0,1
74771,pharyngitis,0,0
74772,.,0,0
74773,OBJECTIVE,0,0
74774,To,0,0
74775,test,0,0
74776,the,0,0
74777,non-inferiority,0,0
74778,of,0,0
74779,once-daily,0,1
74780,(,0,1
74781,QD,0,1
74782,),0,1
74783,oral,0,1
74784,amoxicillin,1,1
74785,to,0,1
74786,the,0,0
74787,recommended,0,1
74788,twice-daily,0,1
74789,(,0,1
74790,BID,0,1
74791,),0,1
74792,oral,0,1
74793,penicillin,1,1
74794,V,1,1
74795,in,0,0
74796,GABHS,0,0
74797,pharyngitis,0,0
74798,.,0,0
74799,METHODS,0,0
74800,This,0,0
74801,was,0,0
74802,a,0,0
74803,randomised,0,0
74804,non-inferiority,0,0
74805,trial,0,0
74806,carried,0,0
74807,out,0,0
74808,in,0,0
74809,a,0,0
74810,school-based,0,0
74811,clinic,0,0
74812,in,0,0
74813,New,0,0
74814,Zealand,0,0
74815,.,0,0
74816,Children,0,0
74817,presenting,0,0
74818,with,0,0
74819,GABHS,0,0
74820,pharyngitis,0,0
74821,were,0,0
74822,randomised,0,0
74823,to,0,1
74824,oral,1,1
74825,amoxicillin,1,1
74826,1500,1,1
74827,mg,1,1
74828,QD,0,1
74829,(,0,1
74830,or,0,0
74831,750,0,1
74832,mg,0,1
74833,if,0,0
74834,bodyweight,0,1
74835,was,0,0
74836,<,0,0
74837,or=30,0,0
74838,kg,0,0
74839,),0,0
74840,or,0,0
74841,to,0,1
74842,oral,1,1
74843,penicillin,1,1
74844,V,1,1
74845,500,1,1
74846,mg,1,1
74847,BID,0,1
74848,(,0,1
74849,or,0,1
74850,250,0,1
74851,mg,0,1
74852,if,0,1
74853,bodyweight,0,1
74854,was,0,0
74855,<,0,0
74856,or=20,0,0
74857,kg,0,0
74858,),0,0
74859,for,0,0
74860,10,0,0
74861,days,0,0
74862,.,0,0
74863,Observed,0,0
74864,medication,0,0
74865,and,0,0
74866,weekend,0,0
74867,diary,0,0
74868,cards,0,0
74869,were,0,0
74870,used,0,0
74871,to,0,0
74872,monitor,0,0
74873,adherence,0,0
74874,.,0,0
74875,OUTCOME,0,0
74876,Eradication,0,0
74877,of,0,0
74878,GABHS,0,0
74879,",",0,0
74880,determined,0,0
74881,with,0,0
74882,follow-up,0,0
74883,throat,0,0
74884,cultures,0,0
74885,on,0,0
74886,days,0,0
74887,3-6,0,0
74888,",",0,0
74889,12-16,0,0
74890,and,0,0
74891,26-36,0,0
74892,.,0,0
74893,GABHS,0,0
74894,isolates,0,0
74895,were,0,0
74896,serotyped,0,0
74897,to,0,0
74898,distinguish,0,0
74899,bacteriological,0,0
74900,treatment,0,0
74901,failures,0,1
74902,(,0,0
74903,and,0,0
74904,relapses,0,1
74905,),0,0
74906,from,0,0
74907,new,0,0
74908,acquisitions,0,0
74909,.,0,0
74910,Non-inferiority,0,0
74911,was,0,0
74912,defined,0,0
74913,as,0,0
74914,an,0,0
74915,upper,0,0
74916,95,0,0
74917,%,0,0
74918,confidence,0,0
74919,limit,0,0
74920,(,0,0
74921,CL,0,1
74922,),0,0
74923,for,0,0
74924,the,0,0
74925,difference,0,0
74926,in,0,0
74927,success,0,0
74928,of,0,0
74929,eradication,0,0
74930,in,0,0
74931,the,0,0
74932,amoxicillin,1,1
74933,and,0,1
74934,penicillin,1,1
74935,V,1,1
74936,treatment,0,1
74937,groups,0,0
74938,of,0,0
74939,<,0,0
74940,or=10,0,0
74941,%,0,0
74942,.,0,0
74943,RESULTS,0,0
74944,353,0,0
74945,children,0,0
74946,with,0,0
74947,positive,0,0
74948,throat,0,0
74949,swabs,0,0
74950,for,0,0
74951,GABHS,0,0
74952,were,0,0
74953,randomised,0,0
74954,to,0,1
74955,amoxicillin,1,1
74956,(,0,0
74957,n,0,0
74958,=,0,0
74959,177,0,0
74960,),0,0
74961,or,0,0
74962,penicillin,1,1
74963,V,1,1
74964,(,0,0
74965,n,0,0
74966,=,0,0
74967,176,0,0
74968,),0,0
74969,.,0,0
74970,The,0,0
74971,upper,0,0
74972,95,0,0
74973,%,0,0
74974,CL,0,0
74975,for,0,0
74976,the,0,0
74977,differences,0,0
74978,in,0,0
74979,positive,0,0
74980,cultures,0,0
74981,between,0,0
74982,the,0,0
74983,antibiotics,0,1
74984,was,0,0
74985,4.9,0,0
74986,%,0,0
74987,at,0,0
74988,days,0,0
74989,3-6,0,0
74990,",",0,0
74991,6.5,0,0
74992,%,0,0
74993,at,0,0
74994,days,0,0
74995,12-16,0,0
74996,and,0,0
74997,8.5,0,0
74998,%,0,0
74999,at,0,0
75000,days,0,0
75001,26-36,0,0
75002,.,0,0
75003,Treatment,0,0
75004,failures,0,1
75005,(,0,0
75006,including,0,0
75007,relapses,0,1
75008,),0,0
75009,occurred,0,0
75010,at,0,0
75011,each,0,0
75012,visit,0,0
75013,in,0,0
75014,5.8,0,0
75015,%,0,0
75016,",",0,0
75017,12.7,0,0
75018,%,0,0
75019,and,0,0
75020,10.7,0,0
75021,%,0,0
75022,of,0,0
75023,amoxicillin,1,0
75024,recipients,0,0
75025,and,0,0
75026,6.2,0,0
75027,%,0,0
75028,",",0,0
75029,11.9,0,0
75030,%,0,0
75031,and,0,0
75032,11.3,0,0
75033,%,0,0
75034,of,0,0
75035,penicillin,1,1
75036,V,1,1
75037,recipients,0,0
75038,",",0,0
75039,respectively,0,0
75040,.,0,0
75041,No,0,0
75042,significant,0,0
75043,differences,0,0
75044,in,0,0
75045,resolution,0,0
75046,of,0,0
75047,symptoms,0,0
75048,were,0,0
75049,noted,0,0
75050,between,0,0
75051,treatment,0,0
75052,groups,0,0
75053,.,0,0
75054,One,0,0
75055,case,0,0
75056,of,0,0
75057,unsubstantiated,0,0
75058,acute,0,1
75059,rheumatic,0,0
75060,fever,0,0
75061,occurred,0,0
75062,after,0,0
75063,7,0,0
75064,days,0,0
75065,of,0,0
75066,amoxicillin,1,1
75067,.,1,1
75068,CONCLUSION,0,0
75069,In,0,0
75070,this,0,0
75071,adequately,0,0
75072,powered,0,0
75073,study,0,0
75074,",",0,1
75075,once-daily,0,1
75076,oral,0,1
75077,amoxicillin,1,1
75078,is,0,1
75079,not,0,0
75080,inferior,0,0
75081,to,0,0
75082,twice-daily,0,1
75083,penicillin,1,1
75084,V,1,1
75085,for,0,0
75086,the,0,0
75087,treatment,0,0
75088,and,0,0
75089,eradication,0,0
75090,of,0,0
75091,GABHS,0,0
75092,in,0,0
75093,children,0,0
75094,with,0,0
75095,pharyngitis,0,0
75096,.,0,0
75097,Determinants,0,0
75098,of,0,0
75099,improvement,0,0
75100,in,0,0
75101,walking,0,0
75102,capacity,0,0
75103,among,0,0
75104,individuals,0,0
75105,with,0,0
75106,chronic,0,0
75107,stroke,0,0
75108,following,0,0
75109,a,0,0
75110,multi-dimensional,1,0
75111,exercise,1,0
75112,program,1,0
75113,.,1,0
75114,OBJECTIVE,0,0
75115,To,0,0
75116,identify,0,0
75117,the,0,0
75118,determinants,0,0
75119,of,0,0
75120,improvement,0,0
75121,in,0,0
75122,walking,0,0
75123,capacity,0,0
75124,following,0,0
75125,therapeutic,1,0
75126,exercise,1,0
75127,in,0,0
75128,chronic,0,0
75129,stroke,0,0
75130,survivors,0,0
75131,.,0,0
75132,DESIGN,0,0
75133,A,0,0
75134,secondary,0,0
75135,analysis,0,0
75136,of,0,0
75137,data,0,0
75138,obtained,0,0
75139,from,0,0
75140,a,0,0
75141,prospective,0,0
75142,",",0,0
75143,single-blind,0,1
75144,",",0,1
75145,randomized,0,0
75146,controlled,0,0
75147,intervention,0,0
75148,trial,0,0
75149,.,0,0
75150,SUBJECTS,0,0
75151,Sixty-three,0,0
75152,community-dwelling,0,0
75153,individuals,0,0
75154,(,0,0
75155,mean,0,0
75156,age,0,0
75157,=,0,0
75158,65,0,0
75159,years,0,0
75160,",",0,0
75161,age,0,0
75162,range,0,0
75163,=,0,0
75164,50-87,0,0
75165,years,0,0
75166,),0,0
75167,with,0,0
75168,a,0,0
75169,chronic,0,0
75170,stroke,0,1
75171,(,0,1
75172,post-stroke,0,0
75173,duration,0,0
75174,:,0,0
75175,mean,0,0
75176,=,0,0
75177,5.5,0,0
75178,years,0,0
75179,",",0,0
75180,range,0,0
75181,=,0,0
75182,1-28,0,0
75183,years,0,0
75184,),0,0
75185,.,0,0
75186,METHODS,0,0
75187,Subjects,0,0
75188,were,0,0
75189,randomized,0,0
75190,into,0,0
75191,a,0,0
75192,leg,1,0
75193,exercise,1,1
75194,group,0,1
75195,(,0,0
75196,n,0,0
75197,=,0,0
75198,32,0,0
75199,),0,0
75200,or,0,0
75201,an,0,0
75202,arm,1,0
75203,exercise,1,1
75204,group,0,1
75205,(,0,0
75206,n,0,0
75207,=,0,0
75208,31,0,0
75209,),0,0
75210,.,0,0
75211,Subjects,0,0
75212,in,0,0
75213,each,0,0
75214,group,0,0
75215,underwent,0,0
75216,3,0,1
75217,1-hour,0,1
75218,exercise,1,1
75219,sessions,1,1
75220,per,0,0
75221,week,0,0
75222,for,0,0
75223,19,0,0
75224,weeks,0,0
75225,.,0,0
75226,Walking,0,0
75227,capacity,0,0
75228,",",0,0
75229,cardiorespiratory,0,0
75230,fitness,0,0
75231,",",0,0
75232,isometric,0,0
75233,knee,0,0
75234,extensor,0,0
75235,muscle,0,0
75236,strength,0,0
75237,",",0,0
75238,balance,0,0
75239,ability,0,0
75240,",",0,0
75241,and,0,0
75242,balance,0,0
75243,confidence,0,0
75244,were,0,0
75245,evaluated,0,0
75246,before,0,0
75247,and,0,0
75248,after,0,0
75249,the,0,0
75250,interventions,0,0
75251,.,0,0
75252,Multiple,0,0
75253,regression,0,0
75254,analysis,0,0
75255,was,0,0
75256,performed,0,0
75257,to,0,0
75258,identify,0,0
75259,the,0,0
75260,determinants,0,0
75261,of,0,0
75262,improvement,0,0
75263,in,0,0
75264,walking,0,0
75265,capacity,0,0
75266,.,0,0
75267,RESULTS,0,0
75268,After,0,0
75269,controlling,0,0
75270,for,0,0
75271,age,0,0
75272,",",0,0
75273,gender,0,0
75274,",",0,0
75275,post-stroke,0,0
75276,duration,0,0
75277,",",0,0
75278,and,0,0
75279,baseline,0,0
75280,walking,0,0
75281,capacity,0,0
75282,",",0,0
75283,gain,0,0
75284,in,0,0
75285,paretic,0,0
75286,leg,0,0
75287,muscle,0,0
75288,strength,0,0
75289,and,0,0
75290,peak,0,0
75291,oxygen,0,0
75292,consumption,0,0
75293,remained,0,0
75294,independently,0,0
75295,associated,0,0
75296,with,0,0
75297,gain,0,0
75298,in,0,0
75299,walking,0,0
75300,capacity,0,0
75301,(,0,0
75302,R2,0,0
75303,=,0,0
75304,0.229,0,0
75305,),0,0
75306,.,0,0
75307,CONCLUSION,0,0
75308,Enhancement,0,0
75309,of,0,0
75310,cardiorespiratory,0,0
75311,fitness,0,0
75312,and,0,0
75313,paretic,0,0
75314,leg,0,0
75315,muscle,0,0
75316,strength,0,0
75317,are,0,0
75318,both,0,0
75319,significant,0,0
75320,determinants,0,0
75321,in,0,0
75322,improving,0,0
75323,walking,0,0
75324,capacity,0,0
75325,among,0,0
75326,chronic,0,0
75327,stroke,0,0
75328,survivors,0,0
75329,.,0,0
75330,However,0,0
75331,",",0,0
75332,the,0,0
75333,rather,0,0
75334,weak,0,0
75335,relationship,0,0
75336,(,0,0
75337,R2,0,0
75338,=,0,0
75339,0.229,0,0
75340,),0,0
75341,indicates,0,0
75342,that,0,0
75343,other,0,0
75344,factors,0,0
75345,not,0,0
75346,measured,0,0
75347,in,0,0
75348,this,0,0
75349,study,0,0
75350,may,0,0
75351,also,0,0
75352,contribute,0,0
75353,to,0,0
75354,the,0,0
75355,improvement,0,0
75356,in,0,0
75357,walking,0,0
75358,capacity,0,0
75359,.,0,0
75360,Enrollment,0,0
75361,of,0,0
75362,racial,0,0
75363,and,0,0
75364,ethnic,0,0
75365,minorities,0,0
75366,in,0,0
75367,the,0,0
75368,Prostate,0,0
75369,",",0,0
75370,Lung,0,1
75371,",",0,0
75372,Colorectal,0,0
75373,and,0,0
75374,Ovarian,0,0
75375,Cancer,0,0
75376,Screening,0,0
75377,Trial,0,0
75378,.,0,0
75379,BACKGROUND,0,0
75380,Minority,0,0
75381,populations,0,0
75382,in,0,0
75383,the,0,0
75384,United,0,0
75385,States,0,0
75386,",",0,0
75387,especially,0,0
75388,blacks,0,0
75389,and,0,0
75390,Hispanics,0,0
75391,",",0,0
75392,are,0,0
75393,generally,0,0
75394,underrepresented,0,0
75395,among,0,0
75396,participants,0,0
75397,in,0,0
75398,clinical,0,0
75399,trials,0,0
75400,.,0,0
75401,Here,0,0
75402,",",0,0
75403,we,0,0
75404,report,0,0
75405,the,0,0
75406,experience,0,0
75407,of,0,0
75408,enrolling,0,0
75409,ethnic,0,0
75410,minorities,0,0
75411,in,0,0
75412,a,0,0
75413,large,0,0
75414,cancer,0,0
75415,screening,0,0
75416,trial,0,0
75417,.,0,0
75418,METHODS,0,0
75419,The,0,0
75420,Prostate,1,0
75421,",",1,0
75422,Colorectal,1,0
75423,",",1,0
75424,Lung,1,0
75425,and,1,0
75426,Ovarian,1,0
75427,(,1,1
75428,PLCO,1,1
75429,),1,1
75430,Cancer,1,0
75431,Screening,1,0
75432,Trial,0,0
75433,is,0,0
75434,a,0,0
75435,multicenter,0,0
75436,randomized,0,0
75437,trial,0,0
75438,designed,0,0
75439,to,0,0
75440,evaluate,0,0
75441,the,0,0
75442,effectiveness,0,0
75443,of,0,0
75444,screening,1,0
75445,for,1,0
75446,the,1,0
75447,PLCO,1,0
75448,cancers,1,0
75449,.,1,0
75450,Subjects,0,0
75451,were,0,0
75452,recruited,0,0
75453,at,0,0
75454,10,0,0
75455,U.S.,0,0
75456,centers,0,0
75457,between,0,0
75458,1993,0,0
75459,and,0,0
75460,2001,0,0
75461,.,0,0
75462,One,0,0
75463,screening,0,0
75464,center,0,0
75465,had,0,0
75466,a,0,0
75467,major,0,0
75468,special,1,0
75469,recruitment,1,0
75470,effort,1,0
75471,for,1,0
75472,blacks,1,0
75473,and,0,0
75474,another,0,0
75475,center,0,0
75476,had,0,0
75477,a,0,0
75478,major,0,0
75479,special,1,0
75480,recruitment,1,0
75481,effort,1,0
75482,for,1,0
75483,Hispanics,1,0
75484,.,1,0
75485,RESULTS,0,0
75486,Among,0,0
75487,almost,0,0
75488,"155,000",0,0
75489,subjects,0,0
75490,enrolled,0,0
75491,in,0,0
75492,PLCO,0,0
75493,",",0,0
75494,minority,0,0
75495,enrollment,0,0
75496,was,0,0
75497,as,0,0
75498,follows,0,0
75499,:,0,0
75500,black,0,0
75501,(,0,0
75502,5.0,0,0
75503,%,0,0
75504,),0,0
75505,",",0,0
75506,Hispanic,0,1
75507,(,0,0
75508,1.8,0,0
75509,%,0,0
75510,),0,0
75511,and,0,0
75512,Asian,0,0
75513,(,0,0
75514,3.6,0,0
75515,%,0,0
75516,),0,0
75517,.,0,0
75518,This,0,0
75519,compares,0,0
75520,to,0,0
75521,an,0,0
75522,age-eligible,0,0
75523,population,0,0
75524,in,0,0
75525,the,0,0
75526,combined,0,0
75527,catchment,0,0
75528,areas,0,0
75529,of,0,0
75530,the,0,0
75531,PLCO,0,0
75532,centers,0,0
75533,that,0,0
75534,was,0,0
75535,14.0,0,0
75536,%,0,0
75537,black,0,0
75538,",",0,0
75539,2.9,0,0
75540,%,0,0
75541,Hispanic,0,0
75542,and,0,0
75543,5.4,0,0
75544,%,0,0
75545,Asian,0,0
75546,",",0,0
75547,and,0,0
75548,an,0,0
75549,age-eligible,0,0
75550,population,0,0
75551,across,0,0
75552,the,0,0
75553,U.S.,0,0
75554,that,0,0
75555,was,0,0
75556,9.5,0,0
75557,%,0,0
75558,black,0,0
75559,",",0,0
75560,6.5,0,0
75561,%,0,0
75562,Hispanic,0,0
75563,and,0,0
75564,3.0,0,0
75565,%,0,0
75566,Asian,0,0
75567,.,0,0
75568,About,0,0
75569,half,0,0
75570,(,0,0
75571,45,0,0
75572,%,0,0
75573,),0,0
75574,of,0,0
75575,Hispanics,0,0
75576,were,0,0
75577,recruited,0,0
75578,at,0,0
75579,the,0,0
75580,center,0,0
75581,with,0,0
75582,the,0,0
75583,special,0,0
75584,Hispanic,0,0
75585,recruitment,0,0
75586,effort,0,0
75587,.,0,0
75588,Seventy,0,0
75589,percent,0,0
75590,of,0,0
75591,blacks,0,0
75592,were,0,0
75593,recruited,0,0
75594,at,0,0
75595,two,0,0
75596,centers,0,0
75597,;,0,0
75598,the,0,0
75599,one,0,0
75600,with,0,0
75601,the,0,0
75602,major,0,0
75603,special,0,0
75604,recruitment,0,0
75605,effort,0,0
75606,and,0,0
75607,a,0,0
75608,center,0,0
75609,in,0,0
75610,Detroit,0,0
75611,whose,0,0
75612,catchment,0,0
75613,area,0,0
75614,was,0,0
75615,20,0,0
75616,%,0,0
75617,black,0,0
75618,among,0,0
75619,age-eligibles,0,0
75620,.,0,0
75621,Blacks,0,0
75622,",",0,0
75623,Hispanics,0,1
75624,and,0,0
75625,(,0,1
75626,non-Hispanic,0,1
75627,),0,0
75628,whites,0,0
75629,were,0,0
75630,all,0,0
75631,more,0,0
75632,highly,0,0
75633,educated,0,0
75634,",",0,0
75635,less,0,0
75636,likely,0,0
75637,to,0,0
75638,currently,0,0
75639,smoke,0,0
75640,and,0,0
75641,more,0,0
75642,likely,0,0
75643,to,0,0
75644,get,0,0
75645,regular,0,0
75646,exercise,0,0
75647,than,0,0
75648,their,0,0
75649,counterparts,0,0
75650,in,0,0
75651,the,0,0
75652,general,0,0
75653,population,0,0
75654,.,0,0
75655,CONCLUSION,0,0
75656,Significant,0,0
75657,efforts,0,0
75658,were,0,0
75659,made,0,0
75660,to,0,0
75661,recruit,0,0
75662,racial/,0,0
75663,ethnic,0,0
75664,minorities,0,0
75665,into,0,0
75666,PLCO,0,0
75667,",",0,0
75668,and,0,0
75669,these,0,0
75670,efforts,0,0
75671,resulted,0,0
75672,in,0,0
75673,enrollment,0,0
75674,levels,0,0
75675,that,0,0
75676,were,0,0
75677,comparable,0,0
75678,to,0,0
75679,those,0,0
75680,seen,0,0
75681,in,0,0
75682,many,0,0
75683,recent,0,0
75684,cancer,0,0
75685,screening,0,0
75686,or,0,0
75687,prevention,0,0
75688,trials,0,0
75689,.,0,0
75690,Blacks,0,0
75691,and,0,0
75692,Hispanics,0,0
75693,were,0,0
75694,nonetheless,0,0
75695,underrepresented,0,0
75696,in,0,0
75697,PLCO,0,0
75698,compared,0,0
75699,to,0,0
75700,their,0,0
75701,levels,0,0
75702,among,0,0
75703,age-eligibles,0,0
75704,in,0,0
75705,the,0,0
75706,overall,0,0
75707,U.S.,0,0
75708,population,0,0
75709,or,0,0
75710,in,0,0
75711,the,0,0
75712,aggregate,0,0
75713,PLCO,0,0
75714,catchment,0,0
75715,areas,0,0
75716,.,0,0
75717,Effect,0,0
75718,of,0,0
75719,intestinal,0,0
75720,production,0,0
75721,of,0,0
75722,equol,0,1
75723,on,0,0
75724,menopausal,0,0
75725,symptoms,0,0
75726,in,0,0
75727,women,0,0
75728,treated,0,0
75729,with,0,0
75730,soy,1,1
75731,isoflavones,1,1
75732,.,1,1
75733,OBJECTIVE,0,1
75734,To,0,0
75735,evaluate,0,0
75736,the,0,0
75737,effect,0,0
75738,of,0,0
75739,soy,1,1
75740,isoflavones,1,1
75741,on,0,1
75742,menopausal,0,0
75743,symptoms,0,0
75744,in,0,0
75745,women,0,0
75746,who,0,0
75747,do,0,0
75748,and,0,0
75749,who,0,0
75750,do,0,0
75751,not,0,0
75752,produce,0,0
75753,equol,0,1
75754,",",0,1
75755,a,0,1
75756,daidzein,0,1
75757,metabolite,0,1
75758,.,0,1
75759,METHOD,0,1
75760,A,0,1
75761,randomized,0,1
75762,",",0,0
75763,double-blind,0,1
75764,",",0,1
75765,placebo-controlled,1,1
75766,clinical,0,1
75767,trial,0,0
75768,was,0,0
75769,conducted,0,0
75770,over,0,0
75771,6,0,0
75772,months,0,0
75773,with,0,0
75774,96,0,0
75775,healthy,0,0
75776,menopausal,0,0
75777,women,0,0
75778,.,0,0
75779,After,0,0
75780,taking,0,0
75781,take,0,0
75782,135,0,0
75783,mg,0,1
75784,of,0,0
75785,isoflavones,1,1
75786,daily,0,1
75787,for,0,1
75788,1,0,0
75789,week,0,0
75790,",",0,0
75791,the,0,0
75792,women,0,0
75793,in,0,0
75794,the,0,0
75795,study,0,0
75796,group,0,0
75797,were,0,0
75798,assigned,0,0
75799,to,0,0
75800,the,0,0
75801,equol-producing,0,0
75802,(,0,1
75803,EP,0,1
75804,),0,1
75805,or,0,0
75806,the,0,0
75807,non-EP,0,0
75808,group,0,0
75809,according,0,0
75810,to,0,0
75811,the,0,0
75812,presence,0,0
75813,or,0,0
75814,absence,0,0
75815,of,0,0
75816,equol,0,1
75817,in,0,0
75818,their,0,0
75819,urine,0,1
75820,.,0,1
75821,Menopausal,0,0
75822,symptoms,0,0
75823,were,0,0
75824,evaluated,0,0
75825,using,0,0
75826,a,0,0
75827,modified,0,0
75828,Kupperman,0,0
75829,Index,0,0
75830,.,0,0
75831,RESULT,0,0
75832,Compared,0,0
75833,with,0,0
75834,the,0,0
75835,placebo,1,1
75836,group,0,0
75837,",",0,0
75838,the,0,0
75839,scores,0,0
75840,for,0,0
75841,hot,0,0
75842,flashes,0,0
75843,and,0,0
75844,excessive,0,0
75845,sweating,0,0
75846,were,0,0
75847,significantly,0,0
75848,reduced,0,0
75849,after,0,0
75850,3,0,0
75851,months,0,0
75852,",",0,0
75853,and,0,0
75854,the,0,0
75855,scores,0,0
75856,for,0,0
75857,weakness,0,0
75858,",",0,0
75859,palpitations,0,0
75860,",",0,0
75861,limb,0,0
75862,paresthesia,0,0
75863,",",0,0
75864,and,0,0
75865,total,0,0
75866,symptoms,0,0
75867,after,0,0
75868,6,0,0
75869,months,0,0
75870,",",0,0
75871,in,0,0
75872,the,0,0
75873,EP,0,0
75874,group,0,0
75875,only,0,0
75876,.,0,0
75877,CONCLUSIONS,0,1
75878,Isoflavone,1,1
75879,supplementation,1,1
75880,improves,0,1
75881,menopausal,0,1
75882,symptoms,0,0
75883,only,0,0
75884,in,0,0
75885,women,0,0
75886,with,0,0
75887,the,0,0
75888,ability,0,0
75889,to,0,0
75890,produce,0,0
75891,equol,0,1
75892,.,0,0
75893,Effect,0,0
75894,of,0,0
75895,radiotherapy,1,0
75896,on,0,0
75897,blood,0,0
75898,lymphocyte,0,0
75899,population,0,0
75900,in,0,0
75901,mammary,0,0
75902,carcinoma,0,0
75903,.,0,0
75904,A,0,1
75905,multi-component,1,0
75906,social,1,0
75907,skills,1,0
75908,intervention,1,0
75909,for,0,0
75910,children,0,0
75911,with,0,0
75912,Asperger,0,0
75913,syndrome,0,0
75914,:,0,0
75915,the,0,0
75916,Junior,1,0
75917,Detective,1,0
75918,Training,1,0
75919,Program,1,0
75920,.,1,0
75921,BACKGROUND,0,0
75922,The,0,0
75923,study,0,0
75924,aimed,0,0
75925,to,0,0
75926,investigate,0,0
75927,the,0,0
75928,effectiveness,0,0
75929,of,0,0
75930,a,0,0
75931,new,0,0
75932,multi-component,1,0
75933,social,1,0
75934,skills,1,0
75935,intervention,1,0
75936,for,0,0
75937,children,0,0
75938,with,0,0
75939,Asperger,0,0
75940,syndrome,0,1
75941,(,0,1
75942,AS,0,1
75943,),0,1
75944,:,0,0
75945,The,1,0
75946,Junior,1,0
75947,Detective,1,0
75948,Training,1,0
75949,Program,1,0
75950,.,1,0
75951,This,0,0
75952,7-week,0,0
75953,program,0,0
75954,included,0,0
75955,a,0,0
75956,computer,0,0
75957,game,0,0
75958,",",0,0
75959,small,0,0
75960,group,0,0
75961,sessions,0,0
75962,",",0,0
75963,parent,0,0
75964,training,0,0
75965,sessions,0,0
75966,and,0,0
75967,teacher,0,0
75968,handouts,0,0
75969,.,0,0
75970,METHOD,0,0
75971,Forty-nine,0,0
75972,children,0,0
75973,with,0,0
75974,AS,0,0
75975,were,0,0
75976,recruited,0,0
75977,to,0,0
75978,participate,0,0
75979,and,0,0
75980,randomly,0,0
75981,assigned,0,0
75982,to,0,0
75983,intervention,1,1
75984,(,0,0
75985,n,0,0
75986,=,0,0
75987,26,0,0
75988,),0,0
75989,or,0,0
75990,wait-list,1,1
75991,control,1,0
75992,(,0,0
75993,n,0,0
75994,=,0,0
75995,23,0,0
75996,),0,0
75997,conditions,0,0
75998,.,0,0
75999,RESULTS,0,0
76000,Relative,0,0
76001,to,0,0
76002,children,0,0
76003,in,0,0
76004,the,0,0
76005,wait-list,0,0
76006,group,0,0
76007,",",0,0
76008,program,0,0
76009,participants,0,0
76010,showed,0,0
76011,greater,0,0
76012,improvements,0,0
76013,in,0,0
76014,social,0,0
76015,skills,0,0
76016,over,0,0
76017,the,0,0
76018,course,0,0
76019,of,0,0
76020,the,0,0
76021,intervention,0,0
76022,",",0,0
76023,as,0,0
76024,indicated,0,0
76025,by,0,0
76026,parent-report,0,0
76027,measures,0,0
76028,.,0,0
76029,Teacher-report,0,0
76030,data,0,0
76031,also,0,0
76032,confirmed,0,0
76033,that,0,0
76034,children,0,0
76035,receiving,0,0
76036,the,0,0
76037,intervention,0,0
76038,made,0,0
76039,significant,0,0
76040,improvements,0,0
76041,in,0,0
76042,social,0,0
76043,functioning,0,0
76044,from,0,0
76045,pre-,0,0
76046,to,0,0
76047,post-treatment,0,0
76048,.,0,0
76049,Treatment,0,0
76050,group,0,0
76051,participants,0,0
76052,were,0,0
76053,better,0,0
76054,able,0,0
76055,to,0,0
76056,suggest,0,0
76057,appropriate,0,0
76058,emotion-management,0,0
76059,strategies,0,0
76060,for,0,0
76061,story,0,0
76062,characters,0,0
76063,at,0,0
76064,post-intervention,0,0
76065,than,0,0
76066,at,0,0
76067,pre-intervention,0,0
76068,",",0,0
76069,whereas,0,0
76070,control,0,0
76071,participants,0,0
76072,were,0,0
76073,not,0,0
76074,.,0,0
76075,However,0,0
76076,",",0,0
76077,there,0,0
76078,was,0,0
76079,no,0,0
76080,difference,0,0
76081,in,0,0
76082,the,0,0
76083,improvements,0,0
76084,made,0,0
76085,by,0,0
76086,children,0,0
76087,in,0,0
76088,the,0,0
76089,intervention,0,0
76090,and,0,0
76091,control,0,0
76092,conditions,0,0
76093,on,0,0
76094,facial,0,0
76095,expression,0,0
76096,and,0,0
76097,body-posture,0,0
76098,recognition,0,0
76099,measures,0,0
76100,.,0,0
76101,Follow-up,0,0
76102,data,0,0
76103,suggested,0,0
76104,that,0,0
76105,treatment,0,0
76106,gains,0,0
76107,were,0,0
76108,maintained,0,0
76109,by,0,0
76110,children,0,0
76111,at,0,0
76112,5-months,0,0
76113,post-intervention,0,0
76114,.,0,0
76115,CONCLUSIONS,0,0
76116,The,1,0
76117,Junior,1,0
76118,Detective,1,0
76119,Training,1,0
76120,Program,1,0
76121,appeared,0,0
76122,to,0,0
76123,be,0,0
76124,effective,0,0
76125,in,0,0
76126,enhancing,0,0
76127,the,0,0
76128,social,0,0
76129,skills,0,0
76130,and,0,0
76131,emotional,0,0
76132,understanding,0,0
76133,of,0,0
76134,children,0,0
76135,with,0,0
76136,AS,0,0
76137,.,0,0
76138,Limitations,0,0
76139,and,0,0
76140,suggestions,0,0
76141,for,0,0
76142,future,0,0
76143,research,0,0
76144,are,0,0
76145,discussed,0,0
76146,.,0,0
76147,Effect,0,0
76148,of,0,0
76149,adhesive,0,0
76150,system,0,0
76151,type,0,0
76152,and,0,0
76153,tooth,0,0
76154,region,0,0
76155,on,0,0
76156,the,0,0
76157,bond,0,0
76158,strength,0,0
76159,to,0,0
76160,dentin,0,0
76161,.,0,0
76162,PURPOSE,0,0
76163,This,0,0
76164,study,0,0
76165,evaluated,0,0
76166,the,0,0
76167,bond,0,0
76168,strength,0,0
76169,of,0,0
76170,two,0,0
76171,etch-and-rinse,1,1
76172,adhesive,1,1
76173,systems,1,0
76174,(,0,0
76175,two-,0,0
76176,and,0,0
76177,three-step,0,0
76178,),0,0
76179,and,1,0
76180,a,1,0
76181,self-etching,1,0
76182,system,1,0
76183,to,0,0
76184,coronal,0,0
76185,and,0,0
76186,root,0,0
76187,canal,0,0
76188,dentin,0,0
76189,.,0,0
76190,MATERIALS,0,0
76191,AND,0,0
76192,METHODS,0,1
76193,The,0,0
76194,root,0,0
76195,canals,0,0
76196,of,0,0
76197,30,0,0
76198,human,0,0
76199,incisors,0,0
76200,and,0,0
76201,canines,0,0
76202,were,0,0
76203,instrumented,0,0
76204,and,0,0
76205,prepared,0,0
76206,with,0,0
76207,burs,0,0
76208,.,0,0
76209,The,0,0
76210,posts,1,0
76211,used,1,0
76212,for,1,0
76213,luting,1,0
76214,were,1,0
76215,duplicated,1,0
76216,with,1,0
76217,dual,1,0
76218,resin,1,1
76219,cement,1,1
76220,(,1,1
76221,Duo-link,1,1
76222,),1,1
76223,inside,1,0
76224,Aestheti,1,0
76225,Plus,1,0
76226,#,1,0
76227,2,1,0
76228,molds,1,0
76229,.,1,0
76230,Thus,0,0
76231,",",0,0
76232,three,0,0
76233,groups,0,0
76234,were,0,0
76235,formed,0,0
76236,(,0,0
76237,n,0,0
76238,=,0,0
76239,10,0,0
76240,),0,0
76241,according,0,0
76242,to,0,0
76243,the,0,0
76244,adhesive,0,0
76245,system,0,0
76246,employed,0,0
76247,:,0,0
76248,All-Bond,1,0
76249,2,1,1
76250,(,1,1
76251,TE3,1,1
76252,),1,1
76253,+,1,1
76254,resin,1,1
76255,cement,1,1
76256,post,1,1
76257,(,1,1
76258,rcp,1,1
76259,),1,1
76260,+,1,1
76261,Duo-link,1,1
76262,(,1,1
76263,Dl,1,1
76264,),1,1
76265,;,1,1
76266,One-Step,1,1
76267,Plus,1,1
76268,(,1,1
76269,TE2,1,1
76270,),1,1
76271,+,1,1
76272,rcp,1,1
76273,+,1,1
76274,Dl,1,1
76275,;,1,1
76276,Tyrian/One-Step,1,1
76277,Plus,1,1
76278,(,1,1
76279,SE,1,1
76280,),1,1
76281,+,1,1
76282,rcp,1,1
76283,+,1,1
76284,Dl,1,1
76285,.,1,0
76286,Afterwards,0,0
76287,",",0,0
76288,8,0,0
76289,transverse,0,0
76290,sections,0,0
76291,(,0,0
76292,1.5,0,0
76293,mm,0,0
76294,),0,0
76295,were,0,0
76296,cut,0,0
76297,from,0,0
76298,4,0,0
76299,mm,0,0
76300,above,0,0
76301,the,0,0
76302,CEJ,0,0
76303,up,0,0
76304,to,0,0
76305,4,0,0
76306,mm,0,0
76307,short,0,0
76308,of,0,0
76309,the,0,0
76310,root,0,0
76311,canal,0,0
76312,apex,0,0
76313,",",0,0
76314,comprising,0,0
76315,coronal,0,0
76316,and,0,0
76317,root,0,0
76318,canal,0,0
76319,dentin,0,0
76320,.,0,0
76321,The,0,0
76322,sections,0,0
76323,were,0,0
76324,submitted,0,0
76325,to,0,0
76326,push-out,0,0
76327,testing,0,0
76328,in,0,0
76329,a,0,0
76330,universal,0,0
76331,testing,0,0
76332,machine,0,1
76333,EMIC,0,1
76334,(,0,0
76335,1,0,0
76336,mm/min,0,0
76337,),0,0
76338,.,0,0
76339,Bond,0,1
76340,strength,0,0
76341,data,0,0
76342,were,0,0
76343,analyzed,0,0
76344,with,0,0
76345,two-way,0,0
76346,repeated,0,0
76347,measures,0,0
76348,ANOVA,0,1
76349,and,0,0
76350,Tukey,0,0
76351,'s,0,1
76352,test,0,0
76353,(,0,0
76354,p,0,0
76355,<,0,0
76356,0.05,0,0
76357,),0,0
76358,.,0,0
76359,RESULTS,0,0
76360,The,0,0
76361,relationship,0,0
76362,between,0,0
76363,the,0,0
76364,adhesives,0,0
76365,was,0,0
76366,not,0,0
76367,the,0,0
76368,same,0,0
76369,in,0,0
76370,the,0,0
76371,different,0,0
76372,regions,0,0
76373,(,0,0
76374,p,0,0
76375,<,0,0
76376,0.05,0,0
76377,),0,0
76378,.,0,0
76379,Comparison,0,0
76380,of,0,0
76381,the,0,0
76382,means,0,0
76383,achieved,0,0
76384,with,0,0
76385,the,0,0
76386,adhesives,0,0
76387,in,0,0
76388,each,0,0
76389,region,0,0
76390,(,0,1
76391,Tukey,0,0
76392,;,0,0
76393,p,0,0
76394,<,0,0
76395,0.05,0,0
76396,),0,0
76397,revealed,0,0
76398,that,0,0
76399,TE3,0,0
76400,(,0,0
76401,mean,0,0
76402,+/-,0,0
76403,standard,0,0
76404,deviation,0,0
76405,:,0,0
76406,5.22,0,0
76407,+/-,0,0
76408,1.70,0,0
76409,),0,0
76410,was,0,0
76411,higher,0,0
76412,than,0,0
76413,TE2,0,0
76414,(,0,0
76415,2.60,0,0
76416,+/-,0,0
76417,1.74,0,0
76418,),0,0
76419,and,0,0
76420,SE,0,1
76421,(,0,0
76422,1.68,0,0
76423,+/-,0,0
76424,1.85,0,0
76425,),0,0
76426,.,0,0
76427,CONCLUSION,0,0
76428,Under,0,0
76429,the,0,0
76430,experimental,0,0
76431,conditions,0,0
76432,",",0,0
76433,better,0,0
76434,bonding,0,0
76435,to,0,0
76436,dentin,0,0
76437,was,0,0
76438,achieved,0,0
76439,using,0,0
76440,the,0,0
76441,three-step,0,0
76442,etch-and-rinse,0,1
76443,system,0,0
76444,",",0,0
76445,especially,0,0
76446,in,0,0
76447,the,0,0
76448,coronal,0,0
76449,region,0,0
76450,.,0,0
76451,Therefore,0,0
76452,",",0,0
76453,the,0,0
76454,traditional,0,0
76455,etch-and-rinse,0,1
76456,three-step,0,0
76457,adhesive,0,0
76458,system,0,0
76459,seems,0,0
76460,to,0,0
76461,be,0,0
76462,the,0,0
76463,best,0,0
76464,choice,0,0
76465,for,0,0
76466,teeth,0,0
76467,needing,0,1
76468,adhesive,0,1
76469,endodontic,0,0
76470,restorations,0,0
76471,.,0,0
76472,Effects,0,0
76473,of,0,0
76474,20,0,1
76475,mg,0,1
76476,rosuvastatin,1,1
76477,on,0,1
76478,VLDL1-,0,1
76479,",",0,0
76480,VLDL2-,0,0
76481,",",0,0
76482,IDL-,0,0
76483,and,0,0
76484,LDL-ApoB,0,0
76485,kinetics,0,0
76486,in,0,0
76487,type,0,0
76488,2,0,0
76489,diabetes,0,0
76490,.,0,0
76491,AIMS/HYPOTHESIS,0,0
76492,In,0,0
76493,addition,0,0
76494,to,0,0
76495,its,0,0
76496,efficacy,0,0
76497,in,0,0
76498,reducing,0,0
76499,LDL-cholesterol,0,1
76500,",",0,1
76501,rosuvastatin,1,1
76502,has,0,0
76503,been,0,0
76504,shown,0,0
76505,to,0,0
76506,significantly,0,0
76507,decrease,0,0
76508,plasma,0,1
76509,triacylglycerol,0,1
76510,.,0,1
76511,The,0,0
76512,use,0,0
76513,of,0,0
76514,rosuvastatin,1,1
76515,may,0,0
76516,be,0,0
76517,beneficial,0,0
76518,in,0,0
76519,patients,0,0
76520,with,0,0
76521,type,0,0
76522,2,0,0
76523,diabetes,0,0
76524,",",0,0
76525,who,0,0
76526,usually,0,0
76527,have,0,0
76528,increased,0,0
76529,triacylglycerol,0,1
76530,levels,0,0
76531,.,0,0
76532,However,0,0
76533,",",0,0
76534,its,0,0
76535,effects,0,0
76536,on,0,0
76537,the,0,0
76538,metabolism,0,0
76539,of,0,0
76540,triacylglycerol-rich,0,1
76541,lipoproteins,0,1
76542,in,0,1
76543,type,0,0
76544,2,0,0
76545,diabetic,0,0
76546,patients,0,0
76547,remains,0,0
76548,unknown,0,0
76549,.,0,0
76550,METHODS,0,0
76551,We,0,0
76552,performed,0,0
76553,a,0,0
76554,randomised,0,1
76555,double-blind,0,1
76556,crossover,0,1
76557,trial,0,1
76558,of,0,0
76559,6-week,0,0
76560,treatment,0,0
76561,with,0,0
76562,placebo,1,1
76563,or,1,1
76564,rosuvastatin,1,1
76565,20,1,1
76566,mg,1,1
76567,in,0,0
76568,eight,0,0
76569,patients,0,0
76570,with,0,0
76571,type,0,0
76572,2,0,0
76573,diabetes,0,0
76574,who,0,0
76575,were,0,0
76576,being,0,0
76577,treated,0,0
76578,with,0,0
76579,oral,0,1
76580,glucose-lowering,0,1
76581,agents,0,1
76582,.,0,0
76583,In,0,0
76584,each,0,0
76585,patient,0,0
76586,",",0,0
76587,an,0,0
76588,in,0,0
76589,vivo,0,0
76590,kinetic,0,0
76591,study,0,0
76592,of,0,0
76593,apolipoprotein,0,1
76594,B,0,1
76595,(,0,1
76596,ApoB,0,1
76597,),0,1
76598,-containing,0,0
76599,lipoproteins,0,1
76600,with,0,0
76601,[,0,0
76602,13C,0,0
76603,],0,0
76604,leucine,0,0
76605,was,0,0
76606,performed,0,0
76607,at,0,0
76608,the,0,0
76609,end,0,0
76610,of,0,0
76611,each,0,0
76612,treatment,0,0
76613,period,0,0
76614,.,0,0
76615,A,0,0
76616,central,0,0
76617,randomisation,0,0
76618,centre,0,0
76619,used,0,0
76620,computer-generated,0,0
76621,tables,0,0
76622,to,0,0
76623,allocate,0,0
76624,treatments,0,0
76625,.,0,0
76626,Participants,0,0
76627,",",0,0
76628,caregivers,0,0
76629,and,0,0
76630,those,0,0
76631,assessing,0,0
76632,the,0,0
76633,outcomes,0,0
76634,were,0,0
76635,blinded,0,0
76636,to,0,0
76637,group,0,0
76638,assignment,0,0
76639,.,0,0
76640,RESULTS,0,1
76641,Rosuvastatin,1,1
76642,20,0,1
76643,mg,0,1
76644,significantly,0,0
76645,reduced,0,0
76646,plasma,0,1
76647,LDL-cholesterol,0,1
76648,",",0,1
76649,triacylglycerol,0,1
76650,and,0,0
76651,total,0,0
76652,ApoB,0,0
76653,.,0,0
76654,It,0,0
76655,also,0,0
76656,significantly,0,0
76657,reduced,0,0
76658,ApoB,0,0
76659,pool,0,0
76660,sizes,0,0
76661,of,0,0
76662,larger,0,0
76663,triacylglycerol-rich,0,1
76664,VLDL,0,1
76665,particles,0,0
76666,(,0,1
76667,VLDL1,0,0
76668,;,0,0
76669,p,0,0
76670,=,0,0
76671,0.011,0,0
76672,),0,0
76673,",",0,0
76674,smaller,0,0
76675,VLDL,0,0
76676,particles,0,0
76677,(,0,1
76678,VLDL2,0,0
76679,;,0,0
76680,p,0,0
76681,=,0,0
76682,0.011,0,0
76683,),0,0
76684,",",0,0
76685,intermediate,0,0
76686,density,0,0
76687,lipoprotein,0,1
76688,(,0,1
76689,IDL,0,1
76690,;,0,0
76691,p,0,0
76692,=,0,0
76693,0.011,0,0
76694,),0,0
76695,and,0,0
76696,LDL,0,1
76697,(,0,0
76698,p,0,0
76699,=,0,0
76700,0.011,0,0
76701,),0,0
76702,.,0,0
76703,This,0,0
76704,reduction,0,0
76705,was,0,0
76706,associated,0,0
76707,with,0,0
76708,a,0,0
76709,significant,0,0
76710,increase,0,0
76711,in,0,0
76712,the,0,0
76713,total,0,0
76714,fractional,0,0
76715,catabolic,0,0
76716,rate,0,0
76717,of,0,0
76718,VLDL1-ApoB,0,0
76719,(,0,0
76720,6.70,0,0
76721,+/-,0,0
76722,3.24,0,0
76723,vs,0,0
76724,4.52,0,0
76725,+/-,0,0
76726,2.34,0,0
76727,pool/day,0,0
76728,",",0,0
76729,p,0,0
76730,=,0,0
76731,0.049,0,0
76732,),0,0
76733,",",0,0
76734,VLDL2-ApoB,0,1
76735,(,0,0
76736,8.72,0,0
76737,+/-,0,0
76738,3.37,0,0
76739,vs,0,0
76740,5.36,0,0
76741,+/-,0,0
76742,2.64,0,0
76743,",",0,0
76744,p,0,0
76745,=,0,0
76746,0.011,0,0
76747,),0,0
76748,",",0,0
76749,IDL-ApoB,0,1
76750,(,0,0
76751,7.06,0,0
76752,+/-,0,0
76753,1.68,0,0
76754,vs,0,0
76755,4.21,0,0
76756,+/-,0,0
76757,1.51,0,0
76758,",",0,0
76759,p,0,0
76760,=,0,0
76761,0.011,0,0
76762,),0,0
76763,and,0,0
76764,LDL-ApoB,0,1
76765,(,0,0
76766,1.02,0,0
76767,+/-,0,0
76768,0.27,0,0
76769,vs,0,0
76770,0.59,0,0
76771,+/-,0,0
76772,0.13,0,0
76773,",",0,0
76774,p,0,0
76775,=,0,0
76776,0.011,0,0
76777,),0,0
76778,.,0,0
76779,Rosuvastatin,1,1
76780,did,0,0
76781,not,0,0
76782,change,0,0
76783,the,0,0
76784,production,0,0
76785,rates,0,0
76786,of,0,0
76787,VLDL2-,0,0
76788,",",0,0
76789,IDL-,0,0
76790,or,0,0
76791,LDL-,0,0
76792,",",0,0
76793,but,0,0
76794,did,0,0
76795,reduce,0,0
76796,VLDL1-ApoB,0,0
76797,production,0,0
76798,rate,0,0
76799,(,0,0
76800,12.4,0,0
76801,+/-,0,0
76802,4.5,0,0
76803,vs,0,0
76804,19.5,0,0
76805,+/-,0,0
76806,8.4,0,0
76807,mg,0,0
76808,kg,0,0
76809,(,0,1
76810,-1,0,1
76811,),0,1
76812,day,0,1
76813,(,0,1
76814,-1,0,1
76815,),0,0
76816,",",0,0
76817,p,0,0
76818,=,0,0
76819,0.035,0,0
76820,),0,0
76821,.,0,0
76822,No,0,1
76823,side,0,0
76824,effects,0,0
76825,of,0,0
76826,rosuvastatin,0,1
76827,were,0,0
76828,observed,0,0
76829,during,0,0
76830,the,0,0
76831,study,0,0
76832,.,0,0
76833,CONCLUSIONS/INTERPRETATION,0,0
76834,In,0,0
76835,type,0,0
76836,2,0,0
76837,diabetic,0,0
76838,patients,0,0
76839,rosuvastatin,1,1
76840,20,0,1
76841,mg,0,1
76842,not,0,0
76843,only,0,0
76844,induces,0,0
76845,a,0,0
76846,significant,0,0
76847,increase,0,0
76848,of,0,0
76849,LDL-ApoB,0,0
76850,catabolism,0,0
76851,(,0,0
76852,73,0,0
76853,%,0,0
76854,),0,0
76855,",",0,0
76856,but,0,0
76857,also,0,0
76858,has,0,0
76859,favourable,0,0
76860,effects,0,0
76861,on,0,0
76862,the,0,0
76863,catabolism,0,0
76864,of,0,0
76865,triacylglycerol-rich,0,1
76866,lipoproteins,0,1
76867,",",0,1
76868,e.g,0,0
76869,.,0,0
76870,a,0,0
76871,significant,0,0
76872,increase,0,0
76873,in,0,0
76874,the,0,0
76875,catabolism,0,0
76876,of,0,0
76877,VLDL1-ApoB,0,1
76878,(,0,0
76879,48,0,0
76880,%,0,0
76881,),0,0
76882,",",0,0
76883,VLDL2-ApoB,0,1
76884,(,0,0
76885,63,0,0
76886,%,0,0
76887,),0,0
76888,and,0,0
76889,IDL-ApoB,0,1
76890,(,0,0
76891,68,0,0
76892,%,0,0
76893,),0,0
76894,",",0,0
76895,and,0,0
76896,a,0,0
76897,reduction,0,0
76898,in,0,0
76899,the,0,0
76900,production,0,0
76901,rate,0,0
76902,of,0,0
76903,VLDL1-ApoB,0,0
76904,(,0,0
76905,-36,0,0
76906,%,0,0
76907,),0,0
76908,.,0,0
76909,The,0,0
76910,effects,0,0
76911,of,0,0
76912,rosuvastatin,1,1
76913,on,0,0
76914,the,0,0
76915,metabolism,0,0
76916,of,0,0
76917,triacylglycerol-rich,0,1
76918,lipoproteins,0,1
76919,may,0,0
76920,be,0,0
76921,beneficial,0,0
76922,for,0,0
76923,prevention,0,0
76924,of,0,0
76925,atherosclerosis,0,0
76926,in,0,0
76927,type,0,0
76928,2,0,0
76929,diabetic,0,0
76930,patients,0,0
76931,.,0,0
76932,A,0,0
76933,comparison,0,0
76934,of,0,0
76935,single-dose,1,1
76936,versus,0,1
76937,conventional-dose,1,1
76938,antibiotic,1,1
76939,treatment,1,1
76940,of,0,0
76941,bacteriuria,0,0
76942,in,0,0
76943,elderly,0,0
76944,women,0,0
76945,.,0,0
76946,The,0,0
76947,efficacy,0,0
76948,of,0,0
76949,single-dose,1,1
76950,antibiotic,1,1
76951,therapy,1,1
76952,for,0,0
76953,the,0,0
76954,treatment,0,0
76955,of,0,0
76956,bacteriuria,0,0
76957,in,0,0
76958,a,0,0
76959,group,0,0
76960,of,0,0
76961,non-catheterized,0,0
76962,elderly,0,0
76963,women,0,0
76964,was,0,0
76965,compared,0,0
76966,with,0,0
76967,that,0,0
76968,of,0,0
76969,conventional,1,0
76970,7-10,1,0
76971,day,1,0
76972,courses,1,1
76973,of,1,1
76974,antibiotic,1,1
76975,therapy,1,0
76976,.,1,0
76977,Thirty-one,0,0
76978,women,0,0
76979,received,0,0
76980,single-dose,1,1
76981,treatment,1,0
76982,and,0,0
76983,22,0,0
76984,conventional-dose,1,0
76985,treatment,1,0
76986,.,1,0
76987,The,0,0
76988,cure,0,0
76989,rates,0,0
76990,at,0,0
76991,1,0,0
76992,and,0,0
76993,6,0,0
76994,weeks,0,0
76995,for,0,0
76996,the,0,0
76997,single-dose,0,1
76998,treatments,0,0
76999,were,0,0
77000,52,0,0
77001,%,0,0
77002,and,0,0
77003,38,0,0
77004,%,0,0
77005,",",0,0
77006,respectively,0,0
77007,",",0,0
77008,and,0,0
77009,the,0,0
77010,cure,0,0
77011,rates,0,0
77012,for,0,0
77013,the,0,0
77014,conventional-dose,0,1
77015,treatments,0,1
77016,at,0,0
77017,1,0,0
77018,and,0,0
77019,6,0,0
77020,weeks,0,0
77021,were,0,0
77022,59,0,0
77023,%,0,0
77024,and,0,0
77025,52,0,0
77026,%,0,0
77027,",",0,0
77028,respectively,0,0
77029,.,0,0
77030,It,0,0
77031,is,0,0
77032,concluded,0,0
77033,that,0,0
77034,there,0,0
77035,may,0,0
77036,be,0,0
77037,a,0,0
77038,place,0,0
77039,for,0,0
77040,the,0,0
77041,use,0,0
77042,of,0,0
77043,single-dose,1,1
77044,antibiotic,1,1
77045,therapy,1,1
77046,for,0,0
77047,the,0,0
77048,treatment,0,0
77049,of,0,0
77050,selected,0,0
77051,elderly,0,0
77052,women,0,0
77053,with,0,0
77054,bacteriuria,0,0
77055,",",0,0
77056,but,0,0
77057,larger,0,0
77058,studies,0,0
77059,are,0,0
77060,needed,0,0
77061,.,0,0
77062,Multiple,0,0
77063,sclerosis,0,0
77064,risk,0,0
77065,after,0,0
77066,optic,0,0
77067,neuritis,0,0
77068,:,0,0
77069,final,0,0
77070,optic,0,0
77071,neuritis,0,0
77072,treatment,0,0
77073,trial,0,0
77074,follow-up,0,0
77075,.,0,0
77076,OBJECTIVE,0,0
77077,To,0,0
77078,assess,0,0
77079,the,0,0
77080,risk,0,0
77081,of,0,0
77082,developing,0,0
77083,multiple,0,0
77084,sclerosis,0,0
77085,(,0,1
77086,MS,0,1
77087,),0,1
77088,after,0,0
77089,optic,0,0
77090,neuritis,0,0
77091,and,0,0
77092,the,0,0
77093,factors,0,0
77094,predictive,0,0
77095,of,0,0
77096,high,0,0
77097,and,0,0
77098,low,0,0
77099,risk,0,0
77100,.,0,0
77101,DESIGN,0,0
77102,Subjects,0,0
77103,in,0,0
77104,the,0,0
77105,Optic,1,0
77106,Neuritis,1,0
77107,Treatment,1,0
77108,Trial,0,0
77109,",",0,0
77110,who,0,0
77111,were,0,0
77112,enrolled,0,0
77113,between,0,0
77114,July,0,0
77115,1,0,0
77116,",",0,0
77117,1988,0,0
77118,",",0,0
77119,and,0,0
77120,June,0,0
77121,30,0,0
77122,",",0,0
77123,1991,0,0
77124,",",0,0
77125,were,0,0
77126,followed,0,0
77127,up,0,0
77128,prospectively,0,0
77129,for,0,0
77130,15,0,0
77131,years,0,0
77132,",",0,0
77133,with,0,0
77134,the,0,0
77135,final,0,0
77136,examination,0,0
77137,in,0,0
77138,2006,0,0
77139,.,0,0
77140,SETTING,0,0
77141,Neurologic,0,0
77142,and,0,0
77143,ophthalmologic,0,0
77144,examinations,0,0
77145,at,0,0
77146,13,0,0
77147,clinical,0,0
77148,sites,0,0
77149,.,0,0
77150,PARTICIPANTS,0,0
77151,Three,0,0
77152,hundred,0,0
77153,eighty-nine,0,0
77154,subjects,0,0
77155,with,0,0
77156,acute,0,0
77157,optic,0,0
77158,neuritis,0,0
77159,.,0,0
77160,MAIN,0,0
77161,OUTCOME,0,0
77162,MEASURES,0,0
77163,Development,0,0
77164,of,0,0
77165,MS,0,0
77166,and,0,0
77167,neurologic,0,0
77168,disability,0,0
77169,assessment,0,0
77170,.,0,0
77171,RESULTS,0,0
77172,The,0,0
77173,cumulative,0,0
77174,probability,0,0
77175,of,0,0
77176,developing,0,0
77177,MS,0,0
77178,by,0,0
77179,15,0,0
77180,years,0,0
77181,after,0,0
77182,onset,0,0
77183,of,0,0
77184,optic,0,0
77185,neuritis,0,0
77186,was,0,0
77187,50,0,0
77188,%,0,0
77189,(,0,0
77190,95,0,0
77191,%,0,0
77192,confidence,0,0
77193,interval,0,0
77194,",",0,0
77195,44,0,0
77196,%,0,0
77197,-56,0,0
77198,%,0,0
77199,),0,0
77200,and,0,0
77201,strongly,0,0
77202,related,0,0
77203,to,0,0
77204,presence,0,0
77205,of,0,0
77206,lesions,0,0
77207,on,0,0
77208,a,0,0
77209,baseline,0,0
77210,non-contrast-enhanced,0,0
77211,magnetic,0,1
77212,resonance,0,1
77213,imaging,0,1
77214,(,0,1
77215,MRI,0,1
77216,),0,0
77217,of,0,0
77218,the,0,0
77219,brain,0,0
77220,.,0,0
77221,Twenty-five,0,0
77222,percent,0,0
77223,of,0,0
77224,patients,0,0
77225,with,0,0
77226,no,0,0
77227,lesions,0,0
77228,on,0,0
77229,baseline,0,0
77230,brain,1,0
77231,MRI,1,0
77232,developed,0,0
77233,MS,0,0
77234,during,0,0
77235,follow-up,0,0
77236,compared,0,0
77237,with,0,0
77238,72,0,0
77239,%,0,0
77240,of,0,0
77241,patients,0,0
77242,with,0,0
77243,1,0,0
77244,or,0,0
77245,more,0,0
77246,lesions,0,0
77247,.,0,0
77248,After,0,0
77249,10,0,0
77250,years,0,0
77251,",",0,0
77252,the,0,0
77253,risk,0,0
77254,of,0,0
77255,developing,0,0
77256,MS,0,0
77257,was,0,0
77258,very,0,0
77259,low,0,0
77260,for,0,0
77261,patients,0,0
77262,without,0,0
77263,baseline,0,0
77264,lesions,0,0
77265,but,0,0
77266,remained,0,0
77267,substantial,0,0
77268,for,0,0
77269,those,0,0
77270,with,0,0
77271,lesions,0,0
77272,.,0,0
77273,Among,0,0
77274,patients,0,0
77275,without,0,0
77276,lesions,0,0
77277,on,0,0
77278,MRI,0,0
77279,",",0,0
77280,baseline,0,0
77281,factors,0,0
77282,associated,0,0
77283,with,0,0
77284,a,0,0
77285,substantially,0,0
77286,lower,0,0
77287,risk,0,0
77288,for,0,0
77289,MS,0,0
77290,included,0,0
77291,male,0,0
77292,sex,0,0
77293,",",0,0
77294,optic,0,0
77295,disc,0,0
77296,swelling,0,0
77297,",",0,0
77298,and,0,0
77299,certain,0,0
77300,atypical,0,0
77301,features,0,0
77302,of,0,0
77303,optic,0,0
77304,neuritis,0,0
77305,.,0,0
77306,CONCLUSIONS,0,0
77307,The,0,0
77308,presence,0,0
77309,of,0,0
77310,brain,0,0
77311,MRI,0,0
77312,abnormalities,0,0
77313,at,0,0
77314,the,0,0
77315,time,0,0
77316,of,0,0
77317,an,0,0
77318,optic,0,0
77319,neuritis,0,0
77320,attack,0,0
77321,is,0,0
77322,a,0,0
77323,strong,0,0
77324,predictor,0,0
77325,of,0,0
77326,the,0,0
77327,15-year,0,0
77328,risk,0,0
77329,of,0,0
77330,MS,0,0
77331,.,0,0
77332,In,0,0
77333,the,0,0
77334,absence,0,0
77335,of,0,0
77336,MRI-detected,0,0
77337,lesions,0,0
77338,",",0,0
77339,male,0,0
77340,sex,0,0
77341,",",0,0
77342,optic,0,0
77343,disc,0,0
77344,swelling,0,0
77345,",",0,0
77346,and,0,0
77347,atypical,0,0
77348,clinical,0,0
77349,features,0,0
77350,of,0,0
77351,optic,0,0
77352,neuritis,0,0
77353,are,0,0
77354,associated,0,0
77355,with,0,0
77356,a,0,0
77357,low,0,0
77358,likelihood,0,0
77359,of,0,0
77360,developing,0,0
77361,MS,0,0
77362,.,0,0
77363,This,0,0
77364,natural,0,0
77365,history,0,0
77366,information,0,0
77367,is,0,0
77368,important,0,0
77369,when,0,0
77370,considering,0,0
77371,prophylactic,0,0
77372,treatment,0,0
77373,for,0,0
77374,MS,0,0
77375,at,0,0
77376,the,0,0
77377,time,0,0
77378,of,0,0
77379,a,0,0
77380,first,0,0
77381,acute,0,0
77382,onset,0,0
77383,of,0,0
77384,optic,0,0
77385,neuritis,0,0
77386,.,0,0
77387,In,0,0
77388,school-aged,0,0
77389,children,0,0
77390,a,0,0
77391,combination,0,0
77392,of,0,0
77393,galacto-oligosaccharides,1,1
77394,and,1,1
77395,Lactobacillus,1,1
77396,GG,1,1
77397,increases,0,1
77398,bifidobacteria,0,1
77399,more,0,1
77400,than,0,1
77401,Lactobacillus,1,1
77402,GG,1,1
77403,on,0,0
77404,its,0,0
77405,own,0,0
77406,.,0,0
77407,The,0,0
77408,aim,0,0
77409,of,0,0
77410,this,0,0
77411,study,0,0
77412,was,0,0
77413,to,0,0
77414,compare,0,0
77415,a,0,0
77416,combination,0,0
77417,of,0,0
77418,Lactobacillus,1,1
77419,GG,1,1
77420,(,1,1
77421,LGG,1,1
77422,),1,1
77423,and,1,1
77424,galacto-oligosaccharides,1,1
77425,(,1,1
77426,GOS,1,1
77427,),1,1
77428,with,1,0
77429,LGG,1,0
77430,on,1,0
77431,its,1,0
77432,own,1,0
77433,",",0,0
77434,and,0,0
77435,their,0,0
77436,effects,0,0
77437,on,0,0
77438,the,0,0
77439,intestinal,0,0
77440,microbiota,0,0
77441,in,0,0
77442,school-aged,0,0
77443,children,0,0
77444,.,0,0
77445,The,0,0
77446,randomized,0,0
77447,",",0,0
77448,double-blinded,0,1
77449,",",0,1
77450,crossover,0,1
77451,study,0,0
77452,comprised,0,0
77453,30,0,0
77454,healthy,0,0
77455,children,0,0
77456,.,0,0
77457,There,0,0
77458,were,0,0
77459,two,0,0
77460,3-week,0,1
77461,study,0,0
77462,periods,0,0
77463,with,0,0
77464,a,0,0
77465,4-week,0,1
77466,wash-out,0,1
77467,period,0,1
77468,in,0,0
77469,between,0,0
77470,.,0,0
77471,The,0,0
77472,children,0,0
77473,ingested,0,1
77474,daily,0,1
77475,65,0,0
77476,ml,0,0
77477,of,0,0
77478,milk-based,1,1
77479,fruit,1,1
77480,juice,1,1
77481,containing,1,0
77482,either,1,0
77483,LGG,1,0
77484,alone,1,0
77485,(,0,0
77486,6.5,0,0
77487,x,0,0
77488,10,0,0
77489,(,0,1
77490,9,0,1
77491,),0,1
77492,CFU,0,1
77493,),0,1
77494,or,0,0
77495,LGG,1,1
77496,plus,1,0
77497,2,1,0
77498,g,1,0
77499,of,1,0
77500,GOS,1,1
77501,.,1,0
77502,Symptom,0,0
77503,diaries,0,0
77504,were,0,0
77505,filled,0,0
77506,during,0,0
77507,the,0,0
77508,study,0,0
77509,periods,0,0
77510,.,0,0
77511,Fecal,0,0
77512,samples,0,0
77513,were,0,0
77514,collected,0,0
77515,at,0,0
77516,the,0,0
77517,beginning,0,0
77518,and,0,0
77519,end,0,0
77520,of,0,0
77521,both,0,0
77522,study,0,0
77523,periods,0,0
77524,.,0,0
77525,At,0,0
77526,the,0,0
77527,end,0,0
77528,of,0,0
77529,both,0,0
77530,study,0,0
77531,periods,0,0
77532,",",0,0
77533,the,0,0
77534,amount,0,0
77535,of,0,0
77536,bifidobacteria,0,1
77537,was,0,0
77538,significantly,0,0
77539,greater,0,0
77540,after,0,0
77541,the,0,0
77542,ingestion,0,1
77543,of,0,1
77544,LGG,1,1
77545,+,1,0
77546,GOS,1,0
77547,compared,0,0
77548,with,0,0
77549,LGG,1,0
77550,alone,1,0
77551,(,0,0
77552,geometric,0,0
77553,mean,0,0
77554,9.33,0,0
77555,x,0,0
77556,10,0,0
77557,(,0,1
77558,9,0,0
77559,),0,0
77560,vs.,0,0
77561,4.28,0,0
77562,x,0,0
77563,10,0,0
77564,(,0,1
77565,9,0,1
77566,),0,0
77567,CFU/g,0,0
77568,",",0,0
77569,p,0,0
77570,<,0,0
77571,0.001,0,0
77572,),0,0
77573,.,0,0
77574,No,0,1
77575,significant,0,0
77576,differences,0,0
77577,were,0,0
77578,seen,0,0
77579,in,0,0
77580,the,0,0
77581,amount,0,0
77582,of,0,0
77583,lactobacilli,0,1
77584,or,0,1
77585,LGG,1,1
77586,",",0,0
77587,nor,0,0
77588,did,0,0
77589,gastrointestinal,0,0
77590,symptoms,0,0
77591,",",0,0
77592,defecation,0,0
77593,frequency,0,0
77594,",",0,0
77595,consistency,0,0
77596,of,0,0
77597,stools,0,0
77598,or,0,0
77599,ease,0,0
77600,of,0,0
77601,defecation,0,0
77602,differ,0,0
77603,between,0,0
77604,the,0,0
77605,two,0,0
77606,study,0,0
77607,periods,0,0
77608,.,0,0
77609,Ingestion,0,0
77610,of,0,0
77611,LGG,1,0
77612,combined,1,0
77613,with,1,0
77614,2,1,0
77615,g,1,0
77616,of,1,0
77617,GOS,1,0
77618,increased,0,0
77619,the,0,0
77620,bifidobacteria,0,1
77621,more,0,0
77622,than,0,0
77623,LGG,1,0
77624,on,1,0
77625,its,1,0
77626,own,1,0
77627,and,0,0
77628,thus,0,0
77629,GOS,1,0
77630,clearly,0,0
77631,has,0,0
77632,a,0,0
77633,prebiotic,0,1
77634,effect,0,0
77635,in,0,0
77636,children,0,0
77637,.,0,0
77638,The,0,0
77639,children,0,0
77640,tolerated,0,1
77641,well,0,0
77642,a,0,1
77643,daily,0,1
77644,intake,0,1
77645,of,0,1
77646,2,0,1
77647,g,0,0
77648,of,0,0
77649,GOS,1,1
77650,.,1,0
77651,Anxiety,0,0
77652,sensitivity,0,0
77653,as,0,0
77654,an,0,0
77655,incremental,0,0
77656,predictor,0,0
77657,of,0,0
77658,later,0,0
77659,anxiety,0,0
77660,symptoms,0,0
77661,and,0,0
77662,syndromes,0,0
77663,.,0,0
77664,Although,0,0
77665,anxiety,0,0
77666,sensitivity,0,0
77667,(,0,1
77668,AS,0,1
77669,),0,0
77670,has,0,0
77671,been,0,0
77672,shown,0,0
77673,to,0,0
77674,predict,0,0
77675,anxiety,0,0
77676,symptoms,0,0
77677,and,0,0
77678,panic,0,0
77679,",",0,0
77680,this,0,0
77681,literature,0,0
77682,is,0,0
77683,limited,0,0
77684,in,0,0
77685,regard,0,0
77686,to,0,0
77687,evaluating,0,0
77688,AS,0,0
77689,as,0,0
77690,an,0,0
77691,incremental,0,0
77692,predictor,0,0
77693,of,0,0
77694,anxiety,1,0
77695,psychopathology,1,0
77696,relative,0,0
77697,to,0,0
77698,other,0,0
77699,established,0,0
77700,risk,0,0
77701,factors,0,0
77702,including,0,0
77703,sex,0,0
77704,and,0,0
77705,negative,0,0
77706,affect,0,0
77707,.,0,0
77708,The,0,0
77709,present,0,0
77710,report,0,0
77711,prospectively,0,0
77712,evaluated,0,0
77713,whether,0,0
77714,AS,0,0
77715,was,0,0
77716,predictive,0,0
77717,of,0,0
77718,later,0,0
77719,changes,0,0
77720,in,0,0
77721,anxiety,0,0
77722,symptoms,0,0
77723,after,0,0
77724,controlling,1,0
77725,for,1,0
77726,potential,1,0
77727,confounding,1,0
77728,factors,1,0
77729,.,1,0
77730,Consistent,0,0
77731,with,0,0
77732,hypothesis,0,0
77733,",",0,0
77734,AS,0,0
77735,was,0,0
77736,found,0,0
77737,to,0,0
77738,be,0,0
77739,a,0,0
77740,significant,0,0
77741,",",0,0
77742,incremental,0,0
77743,predictor,0,0
77744,of,0,0
77745,anxiety,0,0
77746,symptoms,0,0
77747,over,0,0
77748,time,0,0
77749,",",0,0
77750,even,0,0
77751,after,0,0
77752,controlling,0,0
77753,for,0,0
77754,sex,0,0
77755,and,0,0
77756,negative,0,0
77757,affectivity,0,0
77758,.,0,0
77759,These,0,0
77760,data,0,0
77761,provide,0,0
77762,novel,0,0
77763,evidence,0,0
77764,for,0,0
77765,the,0,0
77766,unique,0,0
77767,association,0,0
77768,between,0,0
77769,AS,0,0
77770,of,0,0
77771,the,0,0
77772,development,0,0
77773,of,0,0
77774,anxiety,0,0
77775,symptoms,0,0
77776,.,0,0
77777,Intra-articular,0,1
77778,hyaluronic,1,1
77779,acid,1,1
77780,compared,0,0
77781,to,0,0
77782,exercise,1,0
77783,therapy,1,0
77784,in,0,0
77785,osteoarthritis,0,0
77786,of,0,0
77787,the,0,0
77788,ankle,0,0
77789,.,0,0
77790,A,0,0
77791,prospective,0,0
77792,randomized,0,0
77793,trial,0,0
77794,with,0,0
77795,long-term,0,0
77796,follow-up,0,0
77797,.,0,0
77798,OBJECTIVE,0,0
77799,The,0,0
77800,goal,0,0
77801,of,0,0
77802,this,0,0
77803,study,0,0
77804,has,0,0
77805,been,0,0
77806,to,0,0
77807,determine,0,0
77808,whether,0,0
77809,hyaluronic,1,1
77810,acid,1,1
77811,(,1,1
77812,HA,1,1
77813,),1,1
77814,or,0,0
77815,exercise,1,0
77816,therapy,1,0
77817,can,0,0
77818,improve,0,0
77819,functional,0,0
77820,parameters,0,0
77821,in,0,0
77822,patients,0,0
77823,with,0,0
77824,osteoarthritis,0,0
77825,(,0,1
77826,OA,0,1
77827,),0,0
77828,of,0,0
77829,the,0,0
77830,ankle,0,0
77831,.,0,0
77832,METHODS,0,0
77833,In,0,0
77834,a,0,0
77835,prospective,0,0
77836,clinical,0,0
77837,trial,0,0
77838,",",0,0
77839,43,0,0
77840,ankles,0,0
77841,(,0,0
77842,30,0,0
77843,patients,0,0
77844,),0,0
77845,with,0,0
77846,radiographic,0,0
77847,Kellgren,0,0
77848,Lawrence,0,0
77849,grade,0,0
77850,III,0,0
77851,OA,0,1
77852,were,0,0
77853,randomized,0,0
77854,to,0,0
77855,receive,0,0
77856,three,1,0
77857,intra-articular,1,1
77858,HA,1,1
77859,injections,1,1
77860,",",0,1
77861,with,0,0
77862,one-week,0,0
77863,interval,0,0
77864,of,0,0
77865,or,0,0
77866,exercise,1,0
77867,therapy,1,0
77868,for,0,0
77869,six,0,0
77870,weeks,0,0
77871,.,0,0
77872,Patients,0,0
77873,were,0,0
77874,evaluated,0,0
77875,by,0,0
77876,the,0,0
77877,American,0,0
77878,Orthopaedic,0,0
77879,Foot,0,1
77880,and,0,0
77881,Ankle,0,1
77882,Society,0,1
77883,(,0,1
77884,AOFAS,0,1
77885,),0,1
77886,Ankle-Hindfoot,0,1
77887,Scale,0,1
77888,and,0,0
77889,followed-up,0,0
77890,after,0,0
77891,12,0,0
77892,months,0,0
77893,.,0,0
77894,RESULTS,0,0
77895,Total,0,0
77896,AOFAS,0,1
77897,Ankle-Hindfoot,0,0
77898,score,0,0
77899,of,0,0
77900,OA,0,0
77901,patients,0,0
77902,has,0,0
77903,improved,0,0
77904,in,0,0
77905,both,0,0
77906,groups,0,0
77907,",",0,0
77908,varying,0,0
77909,from,0,0
77910,61.6+/-16.8,0,0
77911,to,0,0
77912,90.1+/-9.7,0,0
77913,with,0,0
77914,HA,1,0
77915,treatment,0,0
77916,and,0,0
77917,from,0,0
77918,72.1+/-16.6,0,0
77919,to,0,0
77920,87.5+/-17.5,0,0
77921,using,0,0
77922,exercise,1,0
77923,therapy,1,0
77924,at,0,0
77925,the,0,0
77926,end,0,0
77927,of,0,0
77928,the,0,0
77929,trial,0,0
77930,(,0,0
77931,p,0,0
77932,<,0,0
77933,0.01,0,0
77934,),0,0
77935,.,0,0
77936,There,0,0
77937,were,0,0
77938,no,0,0
77939,statistically,0,0
77940,significant,0,0
77941,differences,0,0
77942,between,0,0
77943,the,0,0
77944,groups,0,0
77945,.,0,0
77946,CONCLUSION,0,0
77947,This,0,0
77948,prospective,0,0
77949,randomized,0,0
77950,trial,0,0
77951,confirmed,0,0
77952,that,0,0
77953,",",0,0
77954,both,0,0
77955,HA,1,1
77956,injections,0,1
77957,and,0,1
77958,exercise,1,1
77959,therapy,1,0
77960,provide,0,0
77961,functional,0,0
77962,improvement,0,0
77963,.,0,0
77964,However,0,0
77965,",",0,0
77966,larger,0,0
77967,trials,0,0
77968,with,0,0
77969,longer,0,0
77970,follow-up,0,0
77971,are,0,0
77972,necessary,0,0
77973,for,0,0
77974,more,0,0
77975,definite,0,0
77976,conclusions,0,0
77977,.,0,0
77978,Influence,0,0
77979,of,0,0
77980,infusion,0,1
77981,time,0,0
77982,on,0,0
77983,the,0,0
77984,acute,0,0
77985,toxicity,0,0
77986,of,0,0
77987,amphotericin,1,1
77988,B,1,1
77989,:,1,0
77990,results,0,0
77991,of,0,0
77992,a,0,0
77993,randomized,0,0
77994,double-blind,0,1
77995,study,0,0
77996,.,0,0
77997,Cardiopulmonary,1,1
77998,exercise,1,0
77999,variables,0,0
78000,in,0,0
78001,diastolic,0,0
78002,versus,0,0
78003,systolic,0,0
78004,heart,0,0
78005,failure,0,0
78006,.,0,0
78007,The,0,0
78008,response,0,0
78009,to,0,0
78010,cardiopulmonary,1,0
78011,exercise,1,1
78012,(,1,1
78013,CPX,1,1
78014,),1,0
78015,in,0,0
78016,patients,0,0
78017,with,0,0
78018,heart,0,0
78019,failure,0,1
78020,(,0,1
78021,HF,0,1
78022,),0,0
78023,with,0,0
78024,normal,0,0
78025,left,0,0
78026,ventricular,0,1
78027,(,0,1
78028,LV,0,1
78029,),0,1
78030,ejection,0,1
78031,fractions,0,0
78032,(,0,1
78033,EFs,0,1
78034,),0,0
78035,is,0,0
78036,not,0,0
78037,well,0,0
78038,characterized,0,0
78039,.,0,0
78040,To,0,0
78041,determine,0,0
78042,if,0,0
78043,CPX,1,0
78044,testing,0,0
78045,could,0,0
78046,distinguish,0,0
78047,between,0,0
78048,patients,0,0
78049,with,0,0
78050,HF,0,0
78051,with,0,0
78052,normal,0,0
78053,EFs,0,1
78054,(,0,0
78055,>,0,0
78056,50,0,0
78057,%,0,0
78058,;,0,0
78059,i.e.,0,0
78060,",",0,0
78061,diastolic,0,1
78062,HF,0,1
78063,),0,0
78064,and,0,0
78065,those,0,0
78066,with,0,0
78067,decreased,0,0
78068,EFs,0,1
78069,(,0,0
78070,>,0,0
78071,or,0,0
78072,=50,0,0
78073,%,0,0
78074,;,0,0
78075,i.e.,0,0
78076,",",0,0
78077,systolic,0,1
78078,HF,0,1
78079,),0,0
78080,",",0,0
78081,CPX,1,0
78082,responses,0,0
78083,were,0,0
78084,compared,0,0
78085,between,0,0
78086,185,0,0
78087,patients,0,0
78088,with,0,0
78089,systolic,0,0
78090,HF,0,0
78091,(,0,0
78092,79,0,0
78093,%,0,0
78094,men,0,0
78095,",",0,0
78096,mean,0,0
78097,age,0,0
78098,62.6,0,0
78099,+/-,0,0
78100,10.9,0,0
78101,years,0,0
78102,),0,0
78103,and,0,0
78104,43,0,0
78105,with,0,0
78106,diastolic,0,0
78107,HF,0,0
78108,(,0,0
78109,54,0,0
78110,%,0,0
78111,men,0,0
78112,",",0,0
78113,mean,0,0
78114,age,0,0
78115,67.4,0,0
78116,+/-,0,0
78117,9.8,0,0
78118,years,0,0
78119,),0,0
78120,enrolled,0,0
78121,in,0,0
78122,a,0,0
78123,phase,0,0
78124,II,0,0
78125,multicenter,0,1
78126,clinical,0,0
78127,trial,0,0
78128,.,0,0
78129,All,0,0
78130,patients,0,0
78131,were,0,0
78132,evaluated,0,0
78133,with,0,0
78134,echocardiography,1,0
78135,and,0,0
78136,a,0,0
78137,standardized,1,0
78138,CPX,1,0
78139,test,1,0
78140,as,0,0
78141,part,0,0
78142,of,0,0
78143,the,0,0
78144,trial,0,0
78145,.,0,0
78146,CPX,1,0
78147,variables,0,0
78148,",",0,0
78149,including,0,0
78150,oxygen,0,0
78151,uptake,0,0
78152,at,0,0
78153,peak,0,0
78154,exercise,0,0
78155,(,0,0
78156,peak,0,0
78157,VO,0,0
78158,(,0,0
78159,2,0,0
78160,),0,1
78161,),0,0
78162,and,0,0
78163,the,0,0
78164,slope,0,0
78165,of,0,0
78166,the,0,0
78167,ventilation/carbon,0,0
78168,dioxide,0,1
78169,production,0,1
78170,ratio,0,0
78171,(,0,0
78172,VE/VCO,0,1
78173,(,0,1
78174,2,0,1
78175,),0,1
78176,),0,0
78177,",",0,0
78178,were,0,0
78179,determined,0,0
78180,and,0,0
78181,analyzed,0,0
78182,by,0,0
78183,core,0,0
78184,laboratory,0,0
78185,personnel,0,0
78186,.,0,0
78187,Echocardiographic,0,0
78188,measurements,0,0
78189,included,0,0
78190,the,0,0
78191,LV,0,0
78192,EF,0,0
78193,",",0,0
78194,the,0,0
78195,E/A,0,1
78196,ratio,0,0
78197,",",0,0
78198,filling,0,0
78199,time,0,0
78200,",",0,0
78201,cavity,0,0
78202,volumes,0,0
78203,",",0,0
78204,right,0,0
78205,ventricular,0,0
78206,function,0,0
78207,",",0,0
78208,and,0,0
78209,mitral,0,0
78210,regurgitation,0,0
78211,.,0,0
78212,Patients,0,0
78213,in,0,0
78214,the,0,0
78215,diastolic,0,0
78216,HF,0,0
78217,group,0,0
78218,tended,0,0
78219,to,0,0
78220,be,0,0
78221,older,0,0
78222,(,0,0
78223,p,0,0
78224,<,0,0
78225,0.08,0,0
78226,),0,0
78227,",",0,0
78228,with,0,0
78229,more,0,0
78230,women,0,0
78231,(,0,0
78232,p,0,0
78233,<,0,0
78234,0.006,0,0
78235,),0,0
78236,and,0,0
78237,with,0,0
78238,greater,0,0
78239,body,0,0
78240,mass,0,0
78241,indexes,0,0
78242,(,0,0
78243,p,0,0
78244,<,0,0
78245,0.02,0,0
78246,),0,0
78247,",",0,0
78248,than,0,0
78249,those,0,0
78250,in,0,0
78251,the,0,0
78252,systolic,0,0
78253,HF,0,0
78254,group,0,0
78255,.,0,0
78256,There,0,0
78257,was,0,0
78258,no,0,0
78259,significant,0,0
78260,difference,0,0
78261,in,0,0
78262,the,0,0
78263,use,0,0
78264,of,0,0
78265,beta,0,1
78266,blockers,0,1
78267,or,0,1
78268,the,0,0
78269,incidence,0,0
78270,of,0,0
78271,coronary,0,0
78272,artery,0,0
78273,disease,0,0
78274,.,0,0
78275,Patients,0,0
78276,with,0,0
78277,diastolic,0,0
78278,HF,0,0
78279,had,0,0
78280,decreased,0,0
78281,E/A,0,0
78282,ratios,0,0
78283,(,0,0
78284,0.9,0,0
78285,+/-,0,0
78286,0.4,0,0
78287,vs,0,0
78288,1.4,0,0
78289,+/-,0,0
78290,1.1,0,0
78291,",",0,0
78292,p,0,0
78293,<,0,0
78294,0.02,0,0
78295,",",0,0
78296,diastolic,0,0
78297,HF,0,0
78298,vs,0,0
78299,systolic,0,0
78300,HF,0,0
78301,),0,0
78302,and,0,0
78303,increased,0,0
78304,filling,0,0
78305,times,0,0
78306,(,0,0
78307,30.4,0,0
78308,+/-,0,0
78309,3.2,0,0
78310,vs,0,0
78311,26.5,0,0
78312,+/-,0,0
78313,4.7,0,0
78314,ms,0,0
78315,",",0,0
78316,p,0,0
78317,<,0,0
78318,0.01,0,0
78319,",",0,0
78320,diastolic,0,0
78321,HF,0,0
78322,vs,0,0
78323,systolic,0,0
78324,HF,0,0
78325,),0,1
78326,.,0,0
78327,No,0,1
78328,significant,0,0
78329,differences,0,0
78330,in,0,0
78331,peak,0,0
78332,VO,0,0
78333,(,0,0
78334,2,0,0
78335,),0,1
78336,(,0,0
78337,14.4,0,0
78338,+/-,0,0
78339,1.9,0,0
78340,vs,0,0
78341,15.6,0,0
78342,+/-,0,0
78343,3.2,0,0
78344,ml/kg/min,0,0
78345,",",0,0
78346,p,0,0
78347,=,0,0
78348,0.06,0,0
78349,",",0,0
78350,diastolic,0,0
78351,HF,0,0
78352,vs,0,0
78353,systolic,0,0
78354,HF,0,0
78355,),0,0
78356,were,0,0
78357,observed,0,0
78358,.,0,0
78359,The,0,0
78360,VE/VCO,0,1
78361,(,0,0
78362,2,0,1
78363,),0,0
78364,ratios,0,0
78365,for,0,0
78366,the,0,0
78367,2,0,0
78368,groups,0,0
78369,were,0,0
78370,abnormal,0,0
78371,and,0,0
78372,comparable,0,0
78373,(,0,0
78374,32,0,0
78375,2,0,0
78376,+/-,0,0
78377,7.5,0,0
78378,vs,0,0
78379,34.0,0,0
78380,+/-,0,0
78381,8.3,0,0
78382,",",0,0
78383,p,0,0
78384,=,0,0
78385,0.3,0,0
78386,",",0,0
78387,diastolic,0,0
78388,HF,0,0
78389,vs,0,0
78390,systolic,0,0
78391,HF,0,0
78392,),0,0
78393,.,0,0
78394,In,0,0
78395,conclusion,0,0
78396,",",0,0
78397,the,0,0
78398,CPX,1,0
78399,response,0,0
78400,in,0,0
78401,patients,0,0
78402,with,0,0
78403,diastolic,0,0
78404,HF,0,0
78405,and,0,0
78406,systolic,0,0
78407,HF,0,0
78408,is,0,0
78409,markedly,0,0
78410,abnormal,0,0
78411,and,0,0
78412,indistinguishable,0,0
78413,with,0,0
78414,regard,0,0
78415,to,0,0
78416,peak,0,0
78417,VO,0,0
78418,(,0,0
78419,2,0,0
78420,),0,0
78421,and,0,0
78422,ventilation,0,0
78423,despite,0,0
78424,marked,0,0
78425,differences,0,0
78426,in,0,0
78427,the,0,0
78428,LV,0,0
78429,EF,0,0
78430,.,0,0
78431,Comparison,0,0
78432,of,0,0
78433,amantadine,1,1
78434,and,1,1
78435,desipramine,1,1
78436,combined,0,0
78437,with,0,0
78438,psychotherapy,1,0
78439,for,0,0
78440,treatment,0,0
78441,of,0,0
78442,cocaine,0,1
78443,dependence,0,0
78444,.,0,0
78445,We,0,0
78446,conducted,0,0
78447,a,0,0
78448,single-blind,0,1
78449,",",0,0
78450,random,0,0
78451,assignment,0,0
78452,",",0,0
78453,placebo-controlled,1,1
78454,",",0,1
78455,12-week,0,0
78456,comparison,0,0
78457,of,0,0
78458,desipramine,1,1
78459,hydrochloride,1,1
78460,and,1,1
78461,amantadine,1,1
78462,hydrochloride,1,1
78463,as,0,1
78464,adjunctive,0,1
78465,treatments,0,0
78466,to,0,0
78467,counseling,0,0
78468,for,0,0
78469,cocaine,0,1
78470,dependence,0,0
78471,.,0,0
78472,Subjects,0,0
78473,were,0,0
78474,54,0,0
78475,outpatients,0,0
78476,who,0,0
78477,met,0,0
78478,DSM,0,0
78479,III-R,0,1
78480,criteria,0,0
78481,for,0,0
78482,active,0,0
78483,cocaine,0,1
78484,dependence,0,0
78485,and,0,0
78486,who,0,0
78487,completed,0,0
78488,a,0,0
78489,minimum,0,0
78490,of,0,0
78491,2,0,0
78492,weeks,0,0
78493,of,0,0
78494,treatment,0,0
78495,.,0,0
78496,Subjects,0,0
78497,treated,0,0
78498,with,0,0
78499,fixed,0,0
78500,doses,0,1
78501,of,0,1
78502,200,0,1
78503,mg/day,0,1
78504,desipramine,1,1
78505,(,0,1
78506,N,0,1
78507,=,0,0
78508,17,0,0
78509,),0,0
78510,",",0,0
78511,400,0,1
78512,mg/day,0,1
78513,amantadine-placebo,1,1
78514,(,0,1
78515,N,0,1
78516,=,0,0
78517,16,0,0
78518,),0,0
78519,",",0,0
78520,and,0,1
78521,placebo,1,1
78522,(,0,1
78523,N,0,1
78524,=,0,0
78525,21,0,0
78526,),0,0
78527,did,0,0
78528,not,0,0
78529,differ,0,0
78530,for,0,0
78531,lifetime,0,0
78532,cocaine,0,1
78533,use,0,0
78534,",",0,0
78535,lifetime,0,0
78536,histories,0,0
78537,of,0,0
78538,psychopathology,0,0
78539,",",0,0
78540,admission,0,0
78541,scores,0,0
78542,on,0,0
78543,psychometric,0,0
78544,assessments,0,0
78545,",",0,0
78546,and,0,0
78547,sociodemographics,0,0
78548,.,0,0
78549,All,0,0
78550,treatment,0,0
78551,groups,0,0
78552,demonstrated,0,0
78553,dramatic,0,0
78554,and,0,0
78555,persistent,0,0
78556,decreases,0,0
78557,in,0,0
78558,cocaine,0,1
78559,use,0,0
78560,",",0,0
78561,craving,0,0
78562,for,0,0
78563,cocaine,0,1
78564,",",0,1
78565,and,0,0
78566,psychiatric,0,0
78567,symptoms,0,0
78568,consequent,0,0
78569,to,0,0
78570,treatment,0,0
78571,.,0,0
78572,Although,0,0
78573,there,0,0
78574,was,0,0
78575,a,0,0
78576,trend,0,0
78577,for,0,0
78578,more,0,0
78579,dropouts,0,0
78580,by,0,0
78581,subjects,0,0
78582,taking,0,0
78583,desipramine,1,1
78584,",",0,0
78585,there,0,0
78586,were,0,0
78587,no,0,0
78588,significant,0,0
78589,differences,0,0
78590,among,0,0
78591,treatment,0,0
78592,groups,0,0
78593,regarding,0,0
78594,retention,0,0
78595,in,0,0
78596,treatment,0,0
78597,",",0,0
78598,craving,0,0
78599,for,0,0
78600,cocaine,0,1
78601,",",0,0
78602,and,0,0
78603,decreased,0,0
78604,cocaine,0,1
78605,use,0,0
78606,confirmed,0,0
78607,by,0,0
78608,urine,0,1
78609,toxicology,0,1
78610,.,0,0
78611,There,0,0
78612,was,0,0
78613,a,0,0
78614,trend,0,0
78615,for,0,0
78616,subjects,0,0
78617,treated,0,0
78618,with,0,0
78619,desipramine,1,1
78620,to,0,0
78621,maintain,0,0
78622,longer,0,0
78623,periods,0,0
78624,of,0,0
78625,cocaine,0,1
78626,abstinence,0,1
78627,.,0,1
78628,Mean,0,0
78629,plasma,0,0
78630,concentration,0,0
78631,of,0,0
78632,desipramine,1,1
78633,in,0,0
78634,a,0,0
78635,subsample,0,0
78636,of,0,0
78637,our,0,0
78638,subjects,0,0
78639,was,0,0
78640,less,0,0
78641,than,0,0
78642,that,0,0
78643,recommended,0,0
78644,for,0,0
78645,treatment,0,0
78646,of,0,0
78647,depression,0,0
78648,",",0,0
78649,thus,0,0
78650,the,0,0
78651,dosage,0,1
78652,of,0,1
78653,desipramine,1,1
78654,may,0,0
78655,have,0,0
78656,been,0,0
78657,subtherapeutic,0,1
78658,.,0,0
78659,Effects,0,0
78660,of,0,0
78661,fatty,1,1
78662,and,1,0
78663,lean,1,1
78664,fish,1,0
78665,intake,1,1
78666,on,0,0
78667,blood,0,0
78668,pressure,0,0
78669,in,0,0
78670,subjects,0,0
78671,with,0,0
78672,coronary,0,0
78673,heart,0,0
78674,disease,0,0
78675,using,0,0
78676,multiple,0,0
78677,medications,0,1
78678,.,0,1
78679,BACKGROUND,0,1
78680,Intake,0,0
78681,of,0,0
78682,fish,0,0
78683,and,0,0
78684,long-chain,0,1
78685,n-3,0,1
78686,fatty,0,1
78687,acids,0,1
78688,has,0,0
78689,been,0,0
78690,of,0,0
78691,wide,0,0
78692,interest,0,0
78693,due,0,0
78694,to,0,0
78695,their,0,0
78696,beneficial,0,0
78697,effects,0,0
78698,on,0,0
78699,cardiovascular,0,0
78700,risk,0,0
78701,factors,0,0
78702,and,0,0
78703,lower,0,0
78704,coronary,0,0
78705,heart,0,1
78706,disease,0,1
78707,(,0,1
78708,CHD,0,1
78709,),0,1
78710,risk,0,0
78711,.,0,0
78712,AIM,0,0
78713,OF,0,1
78714,THE,0,1
78715,STUDY,0,1
78716,The,0,0
78717,aim,0,0
78718,of,0,0
78719,this,0,0
78720,pilot,0,0
78721,study,0,0
78722,was,0,0
78723,to,0,0
78724,examine,0,0
78725,the,0,0
78726,effects,0,0
78727,of,0,0
78728,fatty,1,1
78729,fish,1,0
78730,and,0,1
78731,lean,1,1
78732,(,1,1
78733,white,1,1
78734,),1,0
78735,fish,1,0
78736,on,0,0
78737,fatty,0,1
78738,acid,0,1
78739,composition,0,1
78740,of,0,0
78741,serum,0,1
78742,lipids,0,0
78743,and,0,0
78744,cardiovascular,0,0
78745,risk,0,0
78746,factors,0,0
78747,in,0,0
78748,subjects,0,0
78749,with,0,0
78750,CHD,0,0
78751,using,0,0
78752,multiple,0,0
78753,drugs,0,1
78754,for,0,0
78755,this,0,0
78756,condition,0,0
78757,.,0,0
78758,METHODS,0,0
78759,The,0,0
78760,study,0,0
78761,was,0,0
78762,an,0,0
78763,8-week,0,0
78764,controlled,0,0
78765,",",0,0
78766,parallel,0,0
78767,intervention,0,0
78768,.,0,0
78769,Inclusion,0,0
78770,criteria,0,0
78771,were,0,0
78772,myocardial,0,0
78773,infarction,0,0
78774,or,0,0
78775,unstable,0,0
78776,ischemic,0,0
78777,attack,0,0
78778,",",0,0
78779,age,0,0
78780,under,0,0
78781,70,0,0
78782,years,0,0
78783,",",0,0
78784,use,0,0
78785,of,0,0
78786,betablockers,0,1
78787,and,0,0
78788,presence,0,0
78789,of,0,0
78790,sinus,0,0
78791,rhythm,0,0
78792,.,0,0
78793,The,0,0
78794,subjects,0,0
78795,were,0,0
78796,randomized,0,0
78797,to,0,0
78798,one,0,0
78799,of,0,0
78800,the,0,0
78801,following,0,0
78802,groups,0,0
78803,:,0,0
78804,4,1,1
78805,meals/week,1,1
78806,fatty,1,1
78807,fish,1,1
78808,(,1,0
78809,n,1,0
78810,=,1,0
78811,11,1,0
78812,),1,0
78813,",",1,0
78814,4,1,1
78815,meals/week,1,1
78816,lean,1,1
78817,fish,1,1
78818,(,1,0
78819,n,1,0
78820,=,1,0
78821,12,1,0
78822,),1,0
78823,and,1,0
78824,control,1,0
78825,diet,1,1
78826,including,1,0
78827,lean,1,1
78828,meat,1,1
78829,(,1,0
78830,n,1,0
78831,=,1,0
78832,10,1,0
78833,),1,0
78834,.,1,0
78835,RESULTS,0,0
78836,The,0,0
78837,mean,0,0
78838,(,0,0
78839,+/-SD,0,0
78840,),0,0
78841,of,0,0
78842,reported,0,0
78843,fish,0,0
78844,meals,0,1
78845,per,0,0
78846,week,0,0
78847,was,0,0
78848,4.3,0,0
78849,+/-,0,0
78850,0.4,0,0
78851,",",0,0
78852,4.7,0,0
78853,+/-,0,0
78854,1.1,0,0
78855,and,0,0
78856,0.6,0,0
78857,+/-,0,0
78858,0.4,0,0
78859,in,0,0
78860,the,0,0
78861,groups,0,0
78862,",",0,0
78863,respectively,0,0
78864,.,0,0
78865,The,0,0
78866,proportions,0,0
78867,of,0,0
78868,eicosapentaenoic,0,1
78869,and,0,1
78870,docosahexaenoic,0,1
78871,acids,0,1
78872,in,0,1
78873,serum,0,1
78874,lipids,0,0
78875,increased,0,0
78876,in,0,0
78877,the,0,0
78878,fatty,0,1
78879,fish,0,0
78880,group,0,0
78881,only,0,0
78882,(,0,0
78883,P,0,0
78884,<,0,0
78885,0.05,0,0
78886,),0,0
78887,.,0,0
78888,Systolic,0,0
78889,and,0,0
78890,diastolic,0,0
78891,blood,0,0
78892,pressure,0,0
78893,levels,0,0
78894,decreased,0,0
78895,in,0,0
78896,the,0,0
78897,lean,0,0
78898,fish,0,0
78899,group,0,0
78900,(,0,0
78901,0,0,0
78902,vs.,0,0
78903,8,0,0
78904,week,0,0
78905,:,0,0
78906,3.5,0,0
78907,+/-,0,0
78908,3.2,0,0
78909,and,0,0
78910,4.6,0,0
78911,+/-,0,0
78912,3.6,0,0
78913,%,0,0
78914,",",0,0
78915,respectively,0,0
78916,",",0,0
78917,P,0,0
78918,<,0,0
78919,0.05,0,0
78920,),0,0
78921,.,0,0
78922,Serum,0,1
78923,total,0,0
78924,triglyceride,0,1
78925,concentration,0,0
78926,did,0,0
78927,not,0,0
78928,significantly,0,0
78929,change,0,0
78930,.,0,0
78931,HDL,0,1
78932,cholesterol,0,1
78933,concentration,0,0
78934,change,0,0
78935,differed,0,0
78936,among,0,0
78937,groups,0,0
78938,but,0,0
78939,without,0,0
78940,significant,0,0
78941,post,0,0
78942,hoc,0,0
78943,differences,0,0
78944,.,0,0
78945,Apolipoprotein,0,1
78946,A-1,0,1
78947,concentration,0,0
78948,decreased,0,0
78949,in,0,0
78950,the,0,0
78951,control,0,0
78952,group,0,0
78953,(,0,0
78954,0,0,0
78955,vs.,0,0
78956,8,0,0
78957,week,0,0
78958,",",0,0
78959,P,0,0
78960,<,0,0
78961,0.05,0,0
78962,),0,0
78963,.,0,0
78964,Coagulation,0,0
78965,factors,0,0
78966,",",0,1
78967,25-hydroxy,0,1
78968,vitamin,0,1
78969,D,0,1
78970,",",0,0
78971,and,0,0
78972,heart,0,0
78973,rate,0,0
78974,variability,0,0
78975,(,0,0
78976,24,0,0
78977,h,0,1
78978,Holter,0,0
78979,),0,0
78980,did,0,0
78981,not,0,0
78982,change,0,0
78983,among,0,0
78984,the,0,0
78985,groups,0,0
78986,.,0,0
78987,CONCLUSIONS,0,0
78988,Our,0,0
78989,results,0,0
78990,suggest,0,0
78991,that,0,0
78992,intake,0,1
78993,of,0,0
78994,lean,1,0
78995,fish,1,0
78996,at,0,0
78997,least,0,0
78998,four,0,0
78999,times,0,0
79000,per,0,0
79001,week,0,0
79002,could,0,0
79003,reduce,0,0
79004,blood,0,0
79005,pressure,0,0
79006,levels,0,0
79007,in,0,0
79008,CHD,0,0
79009,patients,0,0
79010,.,0,0
79011,Combination,1,0
79012,chemotherapy,1,0
79013,and,0,0
79014,ALVAC-CEA/B7.1,1,1
79015,vaccine,1,1
79016,in,0,0
79017,patients,0,0
79018,with,0,0
79019,metastatic,0,0
79020,colorectal,0,0
79021,cancer,0,0
79022,.,0,0
79023,PURPOSE,0,0
79024,The,0,0
79025,combination,0,0
79026,of,0,0
79027,vaccines,1,0
79028,and,0,0
79029,chemotherapy,1,0
79030,holds,0,0
79031,promise,0,0
79032,for,0,0
79033,cancer,0,0
79034,therapy,0,0
79035,",",0,0
79036,but,0,0
79037,the,0,0
79038,effect,0,0
79039,of,0,0
79040,cytotoxic,0,1
79041,chemotherapy,0,1
79042,on,0,0
79043,vaccine-induced,0,1
79044,antitumor,0,1
79045,immunity,0,1
79046,is,0,0
79047,unknown,0,0
79048,.,0,0
79049,This,0,0
79050,study,0,0
79051,was,0,0
79052,conducted,0,0
79053,to,0,0
79054,assess,0,0
79055,the,0,0
79056,effects,0,0
79057,of,0,0
79058,systemic,0,0
79059,chemotherapy,0,0
79060,on,0,0
79061,ALVAC-CEA/B7.1-induced,0,0
79062,T-cell,0,0
79063,immunity,0,0
79064,in,0,0
79065,patients,0,0
79066,with,0,0
79067,metastatic,0,0
79068,colorectal,0,0
79069,cancer,0,0
79070,.,0,0
79071,EXPERIMENTAL,0,0
79072,DESIGN,0,0
79073,Patients,0,0
79074,with,0,0
79075,metastatic,0,0
79076,colorectal,0,0
79077,cancer,0,0
79078,were,0,0
79079,treated,0,0
79080,with,0,0
79081,fluorouracil,1,1
79082,",",1,1
79083,leucovorin,1,1
79084,",",1,1
79085,and,1,1
79086,irinotecan,1,1
79087,and,0,0
79088,were,0,0
79089,also,0,0
79090,given,0,1
79091,ALVAC-CEA/B7.1,1,1
79092,vaccine,1,1
79093,with,1,1
79094,or,1,0
79095,without,1,0
79096,tetanus,1,1
79097,toxoid,1,1
79098,adjuvant,1,1
79099,.,1,1
79100,Eligible,0,0
79101,patients,0,0
79102,were,0,0
79103,randomized,0,0
79104,to,0,0
79105,ALVAC,1,0
79106,followed,1,0
79107,by,1,0
79108,chemotherapy,1,0
79109,and,1,0
79110,booster,1,1
79111,vaccination,1,1
79112,(,1,1
79113,group,1,0
79114,1,1,1
79115,),1,0
79116,",",1,0
79117,ALVAC,1,1
79118,and,1,1
79119,tetanus,1,1
79120,toxoid,1,1
79121,followed,1,1
79122,by,1,0
79123,chemotherapy,1,1
79124,(,1,1
79125,group,1,0
79126,2,1,1
79127,),1,0
79128,",",1,0
79129,or,1,0
79130,chemotherapy,1,0
79131,alone,1,0
79132,followed,1,0
79133,by,1,0
79134,ALVAC,1,0
79135,in,1,0
79136,patients,1,0
79137,without,1,0
79138,disease,1,0
79139,progression,1,0
79140,(,1,1
79141,group,1,1
79142,3,0,1
79143,),0,0
79144,.,0,0
79145,Humoral,0,0
79146,immune,0,0
79147,responses,0,0
79148,were,0,0
79149,measured,0,0
79150,by,0,0
79151,standard,0,0
79152,ELISA,1,0
79153,assay,1,0
79154,",",0,0
79155,and,0,0
79156,carcinoembryonic,0,1
79157,antigen,0,1
79158,(,0,1
79159,CEA,0,1
79160,),0,0
79161,-specific,0,0
79162,T-cell,0,0
79163,responses,0,0
79164,were,0,0
79165,measured,0,0
79166,by,0,0
79167,IFN-gamma,1,1
79168,enzyme-linked,1,1
79169,immunospot,1,1
79170,assay,1,1
79171,.,1,0
79172,RESULTS,0,0
79173,One,0,0
79174,hundred,0,0
79175,eighteen,0,0
79176,patients,0,0
79177,were,0,0
79178,randomized,0,0
79179,to,0,0
79180,receive,0,0
79181,either,0,0
79182,ALVAC,1,0
79183,before,0,0
79184,and,0,0
79185,concomitantly,0,0
79186,with,0,0
79187,chemotherapy,1,0
79188,(,0,0
79189,n,0,0
79190,=,0,0
79191,39,0,0
79192,),0,0
79193,",",0,0
79194,ALVAC,1,1
79195,with,0,1
79196,tetanus,1,1
79197,adjuvant,1,1
79198,before,0,1
79199,and,0,0
79200,concomitantly,0,0
79201,with,0,0
79202,chemotherapy,1,0
79203,(,0,0
79204,n,0,0
79205,=,0,0
79206,40,0,0
79207,),0,0
79208,",",0,0
79209,or,0,0
79210,chemotherapy,1,0
79211,followed,0,0
79212,by,0,0
79213,ALVAC,1,1
79214,(,0,0
79215,n,0,0
79216,=,0,0
79217,39,0,0
79218,),0,0
79219,.,0,0
79220,Serious,0,0
79221,adverse,0,0
79222,events,0,0
79223,were,0,0
79224,largely,0,0
79225,gastrointestinal,0,1
79226,(,0,0
79227,n,0,0
79228,=,0,0
79229,30,0,0
79230,),0,0
79231,and,0,0
79232,hematologic,0,1
79233,(,0,0
79234,n,0,0
79235,=,0,0
79236,24,0,0
79237,),0,0
79238,.,0,0
79239,Overall,0,0
79240,",",0,0
79241,42,0,0
79242,patients,0,0
79243,(,0,0
79244,40.4,0,0
79245,%,0,0
79246,),0,0
79247,showed,0,0
79248,objective,0,0
79249,clinical,0,0
79250,responses,0,0
79251,.,0,0
79252,All,0,0
79253,patients,0,0
79254,developed,0,0
79255,antibody,0,0
79256,responses,0,0
79257,against,0,0
79258,ALVAC,0,0
79259,",",0,0
79260,but,0,0
79261,increased,0,0
79262,anti-CEA,0,0
79263,antibody,0,0
79264,titers,0,0
79265,were,0,0
79266,detected,0,0
79267,in,0,0
79268,only,0,0
79269,three,0,0
79270,patients,0,0
79271,.,0,0
79272,Increases,0,0
79273,in,0,0
79274,CEA-specific,0,0
79275,T,0,0
79276,cells,0,0
79277,were,0,0
79278,detected,0,0
79279,in,0,0
79280,50,0,0
79281,%,0,0
79282,",",0,0
79283,37,0,0
79284,%,0,0
79285,",",0,0
79286,and,0,0
79287,30,0,0
79288,%,0,0
79289,of,0,0
79290,patients,0,0
79291,in,0,0
79292,groups,0,0
79293,1,0,0
79294,",",0,0
79295,2,0,0
79296,",",0,0
79297,and,0,0
79298,3,0,0
79299,",",0,0
79300,respectively,0,0
79301,.,0,0
79302,There,0,0
79303,were,0,0
79304,no,0,0
79305,differences,0,0
79306,in,0,0
79307,clinical,0,0
79308,or,0,0
79309,immune,0,0
79310,responses,0,0
79311,between,0,0
79312,the,0,0
79313,treatment,0,0
79314,groups,0,0
79315,.,0,0
79316,CONCLUSION,0,0
79317,The,0,0
79318,combination,0,0
79319,of,0,0
79320,ALVAC-CEA/B7.1,1,1
79321,vaccine,1,1
79322,and,0,0
79323,systemic,0,0
79324,chemotherapy,1,0
79325,has,0,0
79326,an,0,0
79327,acceptable,0,0
79328,safety,0,0
79329,profile,0,0
79330,in,0,0
79331,patients,0,0
79332,with,0,0
79333,metastatic,0,0
79334,colorectal,0,0
79335,cancer,0,0
79336,.,0,0
79337,Systemic,0,0
79338,chemotherapy,0,0
79339,did,0,0
79340,not,0,0
79341,affect,0,0
79342,the,0,0
79343,generation,0,0
79344,of,0,0
79345,CEA-specific,0,0
79346,T-cell,0,0
79347,responses,0,0
79348,following,0,0
79349,vaccination,0,0
79350,.,0,0
79351,Concurrent,1,1
79352,doxorubicin,1,1
79353,plus,1,1
79354,docetaxel,1,1
79355,is,0,0
79356,not,0,0
79357,more,0,0
79358,effective,0,0
79359,than,0,0
79360,concurrent,1,0
79361,doxorubicin,1,1
79362,plus,1,1
79363,cyclophosphamide,1,1
79364,in,0,0
79365,operable,0,1
79366,breast,0,0
79367,cancer,0,0
79368,with,0,0
79369,0,0,0
79370,to,0,0
79371,3,0,0
79372,positive,0,0
79373,axillary,0,0
79374,nodes,0,0
79375,:,0,0
79376,North,0,0
79377,American,0,0
79378,Breast,0,0
79379,Cancer,0,0
79380,Intergroup,0,0
79381,Trial,0,0
79382,E,0,0
79383,2197,0,0
79384,.,0,0
79385,PURPOSE,0,0
79386,The,0,0
79387,combination,0,0
79388,of,0,0
79389,doxorubicin,1,1
79390,and,1,1
79391,cyclophosphamide,1,1
79392,(,1,1
79393,AC,1,1
79394,),1,0
79395,is,0,0
79396,a,0,0
79397,standard,0,1
79398,adjuvant,0,1
79399,regimen,0,1
79400,.,0,1
79401,Doxorubicin,1,1
79402,and,1,1
79403,docetaxel,1,1
79404,(,1,1
79405,AT,1,1
79406,),1,0
79407,is,0,0
79408,one,0,0
79409,of,0,0
79410,the,0,0
79411,most,0,0
79412,active,0,0
79413,cytotoxic,0,1
79414,regimens,0,1
79415,for,0,1
79416,metastatic,0,1
79417,breast,0,0
79418,cancer,0,0
79419,.,0,0
79420,The,0,0
79421,purpose,0,0
79422,of,0,0
79423,this,0,0
79424,trial,0,0
79425,was,0,0
79426,to,0,0
79427,determine,0,0
79428,whether,0,0
79429,adjuvant,0,1
79430,AT,0,1
79431,improved,0,0
79432,disease-free,0,0
79433,survival,0,0
79434,compared,0,0
79435,with,0,0
79436,AC,0,0
79437,in,0,0
79438,operable,0,0
79439,breast,0,0
79440,cancer,0,0
79441,.,0,0
79442,PATIENTS,0,0
79443,AND,0,1
79444,METHODS,0,1
79445,Women,0,0
79446,with,0,0
79447,invasive,0,0
79448,breast,0,0
79449,cancer,0,0
79450,were,0,0
79451,eligible,0,0
79452,if,0,0
79453,there,0,0
79454,were,0,0
79455,one,0,0
79456,to,0,0
79457,three,0,0
79458,positive,0,0
79459,lymph,0,0
79460,nodes,0,0
79461,or,0,0
79462,if,0,0
79463,the,0,0
79464,node-negative,0,0
79465,tumor,0,0
79466,was,0,0
79467,greater,0,0
79468,than,0,0
79469,1,0,0
79470,cm,0,0
79471,.,0,0
79472,Patients,0,0
79473,were,0,0
79474,randomly,0,0
79475,assigned,0,0
79476,after,0,0
79477,surgery,0,0
79478,to,0,0
79479,receive,0,1
79480,doxorubicin,1,1
79481,(,0,1
79482,60,0,1
79483,mg/m,0,1
79484,(,0,1
79485,2,0,1
79486,),0,1
79487,),0,0
79488,plus,1,0
79489,either,1,0
79490,cyclophosphamide,1,1
79491,(,0,1
79492,600,0,1
79493,mg/m,0,1
79494,(,0,1
79495,2,0,1
79496,),0,1
79497,;,0,1
79498,AC,0,1
79499,),0,1
79500,or,1,1
79501,docetaxel,1,1
79502,(,0,1
79503,60,0,1
79504,mg/m,0,1
79505,(,0,1
79506,2,0,1
79507,),0,1
79508,;,0,1
79509,AT,0,1
79510,),0,1
79511,given,0,1
79512,every,0,0
79513,3,0,0
79514,weeks,0,0
79515,for,0,0
79516,four,0,0
79517,cycles,0,0
79518,",",0,0
79519,followed,0,0
79520,by,0,0
79521,hormone,0,1
79522,therapy,0,1
79523,for,0,0
79524,patients,0,0
79525,with,0,0
79526,estrogen,0,1
79527,receptor,0,1
79528,(,0,1
79529,ER,0,1
79530,),0,1
79531,and/or,0,0
79532,progesterone,0,1
79533,receptor,0,1
79534,(,0,1
79535,PR,0,1
79536,),0,1
79537,-positive,0,0
79538,tumors,0,0
79539,.,0,0
79540,RESULTS,0,0
79541,There,0,0
79542,were,0,0
79543,"2,882",0,0
79544,eligible,0,0
79545,patients,0,0
79546,enrolled,0,0
79547,.,0,0
79548,After,0,0
79549,a,0,0
79550,median,0,0
79551,follow-up,0,0
79552,of,0,0
79553,79.5,0,0
79554,months,0,0
79555,",",0,0
79556,there,0,0
79557,was,0,0
79558,no,0,0
79559,significant,0,0
79560,difference,0,0
79561,in,0,0
79562,disease-free,0,0
79563,survival,0,1
79564,(,0,1
79565,DFS,0,1
79566,;,0,0
79567,85,0,0
79568,%,0,0
79569,in,0,0
79570,both,0,0
79571,arms,0,0
79572,),0,0
79573,or,0,0
79574,overall,0,0
79575,survival,0,0
79576,(,0,0
79577,91,0,0
79578,%,0,0
79579,v,0,0
79580,92,0,0
79581,%,0,0
79582,),0,0
79583,at,0,0
79584,5,0,0
79585,years,0,0
79586,.,0,0
79587,The,0,0
79588,hazard,0,0
79589,ratio,0,0
79590,for,0,0
79591,AC,1,1
79592,versus,0,0
79593,AT,0,0
79594,was,0,0
79595,1.02,0,0
79596,(,0,0
79597,95,0,0
79598,%,0,0
79599,CI,0,0
79600,for,0,0
79601,DFS,0,0
79602,",",0,0
79603,0.86,0,0
79604,to,0,0
79605,1.22,0,0
79606,;,0,0
79607,P,0,0
79608,=,0,0
79609,.78,0,0
79610,),0,0
79611,.,0,0
79612,In,0,0
79613,an,0,0
79614,exploratory,0,0
79615,analysis,0,0
79616,of,0,0
79617,prespecified,0,0
79618,stratification,0,0
79619,factors,0,0
79620,by,0,0
79621,ER,0,0
79622,and,0,0
79623,PR,0,0
79624,expression,0,0
79625,there,0,0
79626,were,0,0
79627,trends,0,0
79628,toward,0,0
79629,improved,0,0
79630,DFS,0,0
79631,for,0,0
79632,AT,0,0
79633,in,0,0
79634,ER/PR-negative,0,0
79635,disease,0,0
79636,.,0,0
79637,Grade,0,0
79638,3,0,0
79639,neutropenia,0,0
79640,associated,0,0
79641,with,0,0
79642,fever,0,0
79643,or,0,0
79644,infection,0,0
79645,occurred,0,0
79646,more,0,0
79647,often,0,0
79648,with,0,0
79649,AT,0,0
79650,(,0,0
79651,26,0,0
79652,%,0,0
79653,v,0,0
79654,10,0,0
79655,%,0,0
79656,;,0,0
79657,P,0,0
79658,<,0,0
79659,.05,0,0
79660,),0,0
79661,.,0,0
79662,CONCLUSION,0,0
79663,AT,1,0
79664,did,0,0
79665,not,0,0
79666,improve,0,0
79667,DFS,0,0
79668,or,0,0
79669,overall,0,0
79670,survival,0,0
79671,in,0,0
79672,this,0,0
79673,population,0,0
79674,",",0,0
79675,and,0,0
79676,was,0,0
79677,associated,0,0
79678,with,0,0
79679,more,0,0
79680,toxicity,0,0
79681,.,0,0
79682,Genetic,1,0
79683,testing,1,0
79684,for,1,0
79685,BRCA1,0,0
79686,:,0,0
79687,effects,0,0
79688,of,0,0
79689,a,0,0
79690,randomised,0,0
79691,study,0,0
79692,of,0,0
79693,knowledge,0,0
79694,provision,0,0
79695,on,0,0
79696,interest,0,0
79697,in,0,0
79698,testing,0,0
79699,and,0,0
79700,long,0,0
79701,term,0,0
79702,test,0,0
79703,uptake,0,0
79704,;,0,0
79705,implications,0,0
79706,for,0,0
79707,the,0,0
79708,NICE,0,0
79709,guidelines,0,0
79710,.,0,0
79711,INTRODUCTION,0,0
79712,Interest,0,0
79713,in,0,0
79714,searching,0,0
79715,for,0,0
79716,mutations,0,0
79717,in,0,0
79718,BRCA1,0,0
79719,and,0,0
79720,BRCA2,0,0
79721,is,0,0
79722,high,0,0
79723,.,0,0
79724,Knowledge,0,0
79725,regarding,0,0
79726,these,0,0
79727,genes,0,0
79728,and,0,0
79729,the,0,0
79730,advantages,0,0
79731,and,0,0
79732,limitations,0,0
79733,of,0,0
79734,genetic,0,0
79735,testing,0,0
79736,is,0,0
79737,limited,0,0
79738,.,0,0
79739,It,0,0
79740,is,0,0
79741,unknown,0,0
79742,whether,0,0
79743,increasing,0,0
79744,knowledge,0,0
79745,about,0,0
79746,breast,0,0
79747,cancer,0,0
79748,genetic,0,0
79749,testing,0,0
79750,alters,0,0
79751,interest,0,0
79752,in,0,0
79753,testing,0,0
79754,.,0,0
79755,METHODS,0,0
79756,Three,0,0
79757,hundred,0,0
79758,and,0,0
79759,seventy,0,0
79760,nine,0,0
79761,women,0,0
79762,(,0,0
79763,260,0,0
79764,with,0,0
79765,a,0,0
79766,family,0,0
79767,history,0,0
79768,of,0,0
79769,breast,0,1
79770,cancer,0,0
79771,;,0,0
79772,119,0,0
79773,with,0,0
79774,breast,0,0
79775,cancer,0,1
79776,),0,0
79777,from,0,0
79778,The,0,0
79779,Royal,0,0
79780,Marsden,0,0
79781,NHS,0,0
79782,Foundation,0,0
79783,Trust,0,0
79784,were,0,0
79785,randomised,0,0
79786,to,0,0
79787,receive,1,0
79788,or,1,0
79789,not,1,0
79790,receive,1,0
79791,written,1,0
79792,educational,1,0
79793,information,1,0
79794,on,0,0
79795,cancer,0,0
79796,genetics,0,0
79797,.,0,0
79798,A,0,0
79799,questionnaire,1,0
79800,was,0,0
79801,completed,0,0
79802,assessing,0,0
79803,interest,0,0
79804,in,0,0
79805,BRCA1,0,0
79806,testing,0,0
79807,and,0,0
79808,knowledge,0,0
79809,on,0,0
79810,breast,0,0
79811,cancer,0,0
79812,genetics,0,0
79813,and,0,0
79814,screening,0,0
79815,.,0,0
79816,Actual,0,0
79817,uptake,0,0
79818,of,0,0
79819,BRCA1,0,0
79820,testing,1,0
79821,is,0,0
79822,reported,0,0
79823,with,0,0
79824,a,0,0
79825,six,0,0
79826,year,0,0
79827,follow-up,0,0
79828,.,0,0
79829,RESULTS,0,0
79830,Eighty,0,0
79831,nine,0,0
79832,percent,0,0
79833,of,0,0
79834,women,0,0
79835,at,0,0
79836,risk,0,0
79837,of,0,0
79838,breast,0,0
79839,cancer,0,0
79840,and,0,0
79841,76,0,0
79842,%,0,0
79843,of,0,0
79844,women,0,0
79845,with,0,0
79846,breast,0,0
79847,cancer,0,0
79848,were,0,0
79849,interested,0,0
79850,in,0,0
79851,BRCA1,0,1
79852,testing,0,0
79853,(,0,0
79854,P,0,0
79855,<,0,0
79856,0.0001,0,0
79857,),0,0
79858,.,0,0
79859,Provision,0,0
79860,of,0,0
79861,educational,0,0
79862,information,0,0
79863,did,0,0
79864,not,0,0
79865,affect,0,0
79866,level,0,0
79867,of,0,0
79868,interest,0,0
79869,.,0,0
79870,Knowledge,0,0
79871,about,0,0
79872,breast,0,0
79873,cancer,0,0
79874,susceptibility,0,0
79875,genes,0,0
79876,was,0,0
79877,poor,0,0
79878,.,0,0
79879,According,0,0
79880,to,0,0
79881,the,0,0
79882,NICE,0,0
79883,guidelines,0,0
79884,regarding,0,0
79885,eligibility,0,0
79886,for,0,0
79887,BRCA1,0,0
79888,and,0,0
79889,BRCA2,0,0
79890,testing,0,0
79891,",",0,0
79892,the,0,0
79893,families,0,0
79894,of,0,0
79895,66,0,0
79896,%,0,0
79897,of,0,0
79898,the,0,0
79899,at,0,0
79900,risk,0,0
79901,group,0,0
79902,and,0,0
79903,13,0,0
79904,%,0,0
79905,of,0,0
79906,the,0,0
79907,women,0,0
79908,with,0,0
79909,breast,0,0
79910,cancer,0,0
79911,would,0,0
79912,be,0,0
79913,eligible,0,0
79914,for,0,0
79915,testing,0,0
79916,(,0,0
79917,probability,0,0
79918,of,0,0
79919,BRCA1,0,0
79920,mutation,0,0
79921,>,0,0
79922,or=20,0,0
79923,%,0,0
79924,),0,0
79925,.,0,0
79926,Within,0,0
79927,six,0,0
79928,years,0,0
79929,of,0,0
79930,randomisation,0,0
79931,",",0,0
79932,genetic,0,0
79933,testing,0,0
79934,was,0,0
79935,actually,0,0
79936,undertaken,0,0
79937,on,0,0
79938,12,0,0
79939,women,0,0
79940,",",0,0
79941,only,0,0
79942,10,0,0
79943,of,0,0
79944,whom,0,0
79945,would,0,0
79946,now,0,0
79947,be,0,0
79948,eligible,0,0
79949,",",0,0
79950,on,0,0
79951,the,0,0
79952,NICE,0,0
79953,guidelines,0,0
79954,.,0,0
79955,CONCLUSIONS,0,0
79956,There,0,0
79957,is,0,0
79958,strong,0,0
79959,interest,0,0
79960,in,0,0
79961,BRCA1,0,0
79962,testing,0,0
79963,.,0,0
79964,Despite,0,0
79965,considerable,0,0
79966,ignorance,0,0
79967,of,0,0
79968,factors,0,0
79969,affecting,0,0
79970,the,0,0
79971,inheritance,0,0
79972,of,0,0
79973,breast,0,0
79974,cancer,0,0
79975,",",0,0
79976,education,0,0
79977,neither,0,0
79978,reduced,0,0
79979,nor,0,0
79980,increased,0,0
79981,interest,0,0
79982,to,0,0
79983,undergo,0,0
79984,testing,0,0
79985,.,0,0
79986,The,0,0
79987,NICE,0,0
79988,guidelines,0,0
79989,successfully,0,0
79990,triage,0,0
79991,those,0,0
79992,with,0,0
79993,a,0,0
79994,high,0,0
79995,breast,0,0
79996,cancer,0,0
79997,risk,0,0
79998,to,0,0
79999,be,0,0
80000,managed,0,0
80001,in,0,0
80002,cancer,0,0
80003,genetics,0,0
80004,clinics,0,0
80005,.,0,0
80006,[,1,1
80007,Intra-uterine,1,1
80008,insemination,1,0
80009,with,1,0
80010,controlled,1,0
80011,ovarian,1,0
80012,hyperstimulation,1,0
80013,compared,1,0
80014,to,1,0
80015,an,1,0
80016,expectant,1,0
80017,management,1,0
80018,in,0,0
80019,couples,0,0
80020,with,0,0
80021,unexplained,0,0
80022,subfertility,0,0
80023,and,0,0
80024,an,0,0
80025,intermediate,0,0
80026,prognosis,0,0
80027,:,0,0
80028,a,0,0
80029,randomised,0,0
80030,study,0,0
80031,],0,0
80032,.,0,0
80033,OBJECTIVE,0,1
80034,Intrauterine,1,1
80035,insemination,1,1
80036,(,1,1
80037,IUI,1,1
80038,),1,1
80039,with,1,0
80040,controlled,1,0
80041,ovarian,1,0
80042,hyperstimulation,1,1
80043,(,1,1
80044,COH,1,1
80045,),1,0
80046,is,0,0
80047,commonly,0,0
80048,used,0,0
80049,as,0,0
80050,treatment,0,0
80051,of,0,0
80052,first,0,0
80053,choice,0,0
80054,in,0,0
80055,couples,0,0
80056,with,0,0
80057,unexplained,0,0
80058,subfertility,0,0
80059,.,0,0
80060,This,0,0
80061,treatment,0,0
80062,should,0,0
80063,only,0,0
80064,be,0,0
80065,applied,0,0
80066,when,0,0
80067,there,0,0
80068,is,0,0
80069,a,0,0
80070,realistic,0,0
80071,increase,0,0
80072,in,0,0
80073,chance,0,0
80074,of,0,0
80075,pregnancy,0,0
80076,",",0,0
80077,particularly,0,0
80078,because,0,0
80079,it,0,0
80080,carries,0,0
80081,the,0,0
80082,increased,0,0
80083,risk,0,0
80084,of,0,0
80085,multiple,0,0
80086,pregnancies,0,0
80087,.,0,0
80088,We,0,0
80089,evaluated,0,0
80090,the,0,0
80091,effectiveness,0,0
80092,of,0,0
80093,IUI,1,0
80094,with,1,0
80095,COH,1,0
80096,relative,0,0
80097,to,0,0
80098,expectant,1,0
80099,management,1,0
80100,in,0,0
80101,couples,0,0
80102,with,0,0
80103,unexplained,0,0
80104,subfertility,0,0
80105,and,0,0
80106,an,0,0
80107,intermediate,0,0
80108,prognosis,0,0
80109,of,0,0
80110,a,0,0
80111,spontaneous,0,0
80112,ongoing,0,0
80113,pregnancy,0,0
80114,.,0,0
80115,DESIGN,0,0
80116,Multicentre,0,0
80117,randomised,0,0
80118,clinical,0,0
80119,study,0,0
80120,.,0,0
80121,METHOD,0,0
80122,253,0,0
80123,couples,0,0
80124,with,0,0
80125,unexplained,0,0
80126,subfertility,0,0
80127,and,0,0
80128,a,0,0
80129,probability,0,0
80130,of,0,0
80131,a,0,0
80132,spontaneous,0,0
80133,ongoing,0,0
80134,pregnancy,0,0
80135,of,0,0
80136,30,0,0
80137,%,0,0
80138,to,0,0
80139,40,0,0
80140,%,0,0
80141,within,0,0
80142,12,0,0
80143,months,0,0
80144,",",0,0
80145,were,0,0
80146,randomly,0,0
80147,assigned,0,0
80148,to,0,0
80149,IUI,1,0
80150,with,1,0
80151,COH,1,0
80152,for,0,0
80153,6,0,0
80154,months,0,0
80155,or,0,0
80156,expectant,1,0
80157,management,1,0
80158,for,0,0
80159,6,0,0
80160,months,0,0
80161,.,0,0
80162,The,0,0
80163,primary,0,0
80164,endpoint,0,0
80165,of,0,0
80166,our,0,0
80167,study,0,0
80168,was,0,0
80169,ongoing,0,0
80170,pregnancy,0,0
80171,within,0,0
80172,6,0,0
80173,months,0,0
80174,.,0,0
80175,Analysis,0,0
80176,was,0,0
80177,carried,0,0
80178,out,0,0
80179,according,0,0
80180,to,0,0
80181,the,0,0
80182,intention,0,0
80183,to,0,0
80184,treat,0,0
80185,principle,0,0
80186,.,0,0
80187,This,0,0
80188,study,0,0
80189,was,0,0
80190,registered,0,0
80191,with,0,0
80192,the,0,0
80193,Dutch,0,0
80194,Trial,0,0
80195,Register,0,0
80196,and,0,0
80197,has,0,0
80198,the,0,0
80199,International,0,0
80200,Standard,0,0
80201,Randomised,0,0
80202,Clinical,0,0
80203,Trial,0,0
80204,number,0,0
80205,ISRCTN72675518,0,0
80206,.,0,0
80207,RESULTS,0,0
80208,Of,0,0
80209,the,0,0
80210,253,0,0
80211,couples,0,0
80212,included,0,0
80213,",",0,0
80214,127,0,0
80215,couples,0,0
80216,were,0,0
80217,allocated,0,0
80218,to,0,0
80219,IUI,1,0
80220,with,1,0
80221,COH,1,0
80222,and,0,0
80223,126,0,0
80224,to,0,0
80225,expectant,1,0
80226,management,1,0
80227,.,1,0
80228,In,0,0
80229,the,0,0
80230,intervention,0,0
80231,group,0,0
80232,",",0,0
80233,42,0,0
80234,women,0,0
80235,(,0,0
80236,33,0,0
80237,%,0,0
80238,),0,0
80239,conceived,0,0
80240,",",0,0
80241,of,0,0
80242,which,0,0
80243,29,0,0
80244,pregnancies,0,0
80245,were,0,0
80246,ongoing,0,0
80247,(,0,0
80248,23,0,0
80249,%,0,0
80250,),0,0
80251,.,0,0
80252,In,0,0
80253,the,0,0
80254,expectant,0,0
80255,management,0,0
80256,group,0,0
80257,",",0,0
80258,40,0,0
80259,women,0,0
80260,(,0,0
80261,32,0,0
80262,%,0,0
80263,),0,0
80264,conceived,0,0
80265,",",0,0
80266,of,0,0
80267,which,0,0
80268,34,0,0
80269,pregnancies,0,0
80270,were,0,0
80271,ongoing,0,0
80272,(,0,0
80273,27,0,0
80274,%,0,0
80275,),0,0
80276,(,0,0
80277,relative,0,0
80278,risk,0,0
80279,:,0,0
80280,0.85,0,0
80281,;,0,0
80282,95,0,0
80283,%,0,0
80284,CI,0,0
80285,:,0,0
80286,0.63-1.1,0,0
80287,),0,0
80288,.,0,0
80289,In,0,0
80290,the,0,0
80291,expectant,1,0
80292,management,1,0
80293,group,0,0
80294,one,0,0
80295,twin,0,0
80296,pregnancy,0,0
80297,occurred,0,0
80298,and,0,0
80299,in,0,0
80300,the,0,0
80301,intervention,0,0
80302,group,0,0
80303,one,0,0
80304,woman,0,0
80305,conceived,0,0
80306,twins,0,0
80307,and,0,0
80308,one,0,0
80309,a,0,0
80310,triplet,0,0
80311,.,0,0
80312,CONCLUSION,0,0
80313,A,0,0
80314,substantial,0,0
80315,beneficial,0,0
80316,effect,0,0
80317,of,0,0
80318,IUI,1,0
80319,with,1,0
80320,COH,1,0
80321,in,0,0
80322,couples,0,0
80323,with,0,0
80324,unexplained,0,0
80325,subfertility,0,0
80326,and,0,0
80327,an,0,0
80328,intermediate,0,0
80329,prognosis,0,0
80330,can,0,0
80331,be,0,0
80332,excluded,0,0
80333,.,0,0
80334,Expectant,0,0
80335,management,0,0
80336,for,0,0
80337,a,0,0
80338,period,0,0
80339,of,0,0
80340,6,0,0
80341,months,0,0
80342,therefore,0,0
80343,appears,0,0
80344,justified,0,0
80345,in,0,0
80346,these,0,0
80347,couples,0,0
80348,.,0,0
80349,Long,1,0
80350,pediatric,1,0
80351,colonoscope,1,0
80352,versus,0,0
80353,intermediate,1,0
80354,length,1,0
80355,adult,1,0
80356,colonoscope,1,0
80357,for,0,0
80358,colonoscopy,0,0
80359,.,0,0
80360,BACKGROUND,0,0
80361,Controversy,0,0
80362,exists,0,0
80363,on,0,0
80364,how,0,0
80365,the,0,0
80366,length,0,0
80367,and,0,0
80368,diameter,0,0
80369,of,0,0
80370,colonoscopes,0,0
80371,affect,0,0
80372,the,0,0
80373,quality,0,0
80374,of,0,0
80375,colonoscopy,0,0
80376,.,0,0
80377,The,0,0
80378,aim,0,0
80379,of,0,0
80380,this,0,0
80381,study,0,0
80382,was,0,0
80383,to,0,0
80384,compare,0,0
80385,a,0,0
80386,long,1,0
80387,pediatric,1,0
80388,colonoscope,1,0
80389,with,0,0
80390,an,0,0
80391,intermediate,1,0
80392,length,1,0
80393,adult,1,0
80394,colonoscope,1,0
80395,with,0,0
80396,regards,0,0
80397,to,0,0
80398,completion,0,0
80399,rate,0,0
80400,and,0,0
80401,cecal,0,0
80402,intubation,0,0
80403,time,0,0
80404,.,0,0
80405,Whether,0,0
80406,either,0,0
80407,scope,0,0
80408,may,0,0
80409,be,0,0
80410,more,0,0
80411,efficient,0,0
80412,in,0,0
80413,any,0,0
80414,subgroups,0,0
80415,was,0,0
80416,also,0,0
80417,investigated,0,0
80418,.,0,0
80419,METHODS,0,0
80420,Asymptomatic,0,0
80421,patients,0,0
80422,admitted,0,0
80423,to,0,0
80424,the,0,0
80425,physical,0,0
80426,check-up,0,0
80427,department,0,0
80428,of,0,0
80429,Buddhist,0,0
80430,Dalin,0,1
80431,Tzu,0,1
80432,Chi,0,1
80433,General,0,0
80434,Hospital,0,0
80435,were,0,0
80436,included,0,0
80437,.,0,0
80438,A,0,0
80439,single,0,0
80440,endoscopist,0,0
80441,performed,0,0
80442,all,0,0
80443,of,0,0
80444,the,0,0
80445,colonoscopic,1,0
80446,examinations,1,0
80447,under,0,0
80448,sedation,0,0
80449,.,0,0
80450,Consecutive,0,0
80451,patients,0,0
80452,were,0,0
80453,randomized,0,0
80454,to,0,0
80455,undergo,0,0
80456,colonoscopy,1,0
80457,with,1,0
80458,either,1,0
80459,intermediate,1,0
80460,length,1,0
80461,adult,1,0
80462,colonoscope,1,1
80463,(,1,1
80464,CF-240I,1,1
80465,),1,1
80466,or,1,0
80467,long,1,0
80468,pediatric,1,1
80469,colonoscope,1,1
80470,(,1,1
80471,PCF-240L,1,1
80472,),1,1
80473,.,1,0
80474,The,0,0
80475,success,0,0
80476,rate,0,0
80477,and,0,0
80478,time,0,0
80479,required,0,0
80480,to,0,0
80481,reach,0,0
80482,cecum,0,0
80483,were,0,0
80484,compared,0,0
80485,between,0,0
80486,the,0,0
80487,two,0,0
80488,groups,0,0
80489,.,0,0
80490,RESULTS,0,1
80491,Between,0,1
80492,April,0,1
80493,2005,0,1
80494,and,0,0
80495,February,0,0
80496,2006,0,0
80497,",",0,0
80498,a,0,0
80499,total,0,0
80500,of,0,0
80501,918,0,0
80502,patients,0,0
80503,were,0,0
80504,enrolled,0,0
80505,.,0,0
80506,Incomplete,0,0
80507,colonoscopy,0,0
80508,occurred,0,0
80509,in,0,0
80510,21,0,0
80511,(,0,0
80512,2.3,0,0
80513,%,0,0
80514,),0,0
80515,cases,0,0
80516,(,0,0
80517,14,0,0
80518,in,0,0
80519,the,0,0
80520,CF-240I,0,0
80521,group,0,0
80522,and,0,0
80523,seven,0,0
80524,in,0,0
80525,the,0,0
80526,PCF-240L,0,0
80527,group,0,0
80528,",",0,0
80529,P,0,0
80530,>,0,0
80531,0.1,0,0
80532,),0,0
80533,.,0,0
80534,The,0,0
80535,overall,0,0
80536,cecal,0,0
80537,mean,0,0
80538,insertion,0,0
80539,time,0,0
80540,was,0,0
80541,6.00,0,0
80542,+/-,0,0
80543,3.66,0,0
80544,min,0,0
80545,.,0,0
80546,There,0,0
80547,was,0,0
80548,no,0,0
80549,significant,0,0
80550,difference,0,0
80551,between,0,0
80552,the,0,0
80553,CF-240I,1,0
80554,and,0,0
80555,PCF,1,1
80556,240L,1,1
80557,groups,0,0
80558,with,0,0
80559,regard,0,0
80560,to,0,0
80561,the,0,0
80562,cecal,0,0
80563,intubation,0,0
80564,rate,0,0
80565,(,0,0
80566,96.9,0,0
80567,%,0,0
80568,vs,0,0
80569,98.5,0,0
80570,%,0,0
80571,",",0,0
80572,P,0,0
80573,=,0,0
80574,0.18,0,0
80575,),0,0
80576,",",0,0
80577,the,0,0
80578,need,0,0
80579,for,0,0
80580,abdominal,0,0
80581,pressure,0,0
80582,(,0,0
80583,71.7,0,0
80584,%,0,0
80585,vs,0,0
80586,73.4,0,0
80587,%,0,0
80588,",",0,0
80589,P,0,0
80590,=,0,0
80591,0.55,0,0
80592,),0,0
80593,and,0,0
80594,change,0,0
80595,of,0,0
80596,position,0,0
80597,(,0,0
80598,13.5,0,0
80599,%,0,0
80600,vs,0,0
80601,11.5,0,0
80602,%,0,0
80603,",",0,0
80604,P,0,0
80605,=,0,0
80606,0.37,0,0
80607,),0,0
80608,.,0,0
80609,However,0,0
80610,",",0,0
80611,the,0,0
80612,cecal,0,0
80613,intubation,0,0
80614,time,0,0
80615,was,0,0
80616,shorter,0,0
80617,in,0,0
80618,the,0,0
80619,CF-240I,0,1
80620,group,0,0
80621,(,0,0
80622,5.75,0,0
80623,+/-,0,0
80624,3.18,0,0
80625,vs,0,0
80626,6.26,0,0
80627,+/-,0,0
80628,3.30,0,0
80629,min,0,0
80630,",",0,0
80631,P,0,0
80632,=,0,0
80633,0.02,0,0
80634,),0,0
80635,.,0,0
80636,Subgroup,0,0
80637,analysis,0,0
80638,by,0,0
80639,sex,0,0
80640,",",0,0
80641,age,0,0
80642,",",0,0
80643,and,0,0
80644,body,0,0
80645,mass,0,0
80646,index,0,0
80647,showed,0,0
80648,comparable,0,0
80649,outcomes,0,0
80650,between,0,0
80651,the,0,0
80652,two,0,0
80653,groups,0,0
80654,except,0,0
80655,that,0,0
80656,the,0,0
80657,cecal,0,0
80658,intubation,0,0
80659,times,0,0
80660,were,0,0
80661,significantly,0,0
80662,shorter,0,0
80663,in,0,0
80664,the,0,0
80665,CF-240I,0,0
80666,group,0,0
80667,when,0,0
80668,only,0,0
80669,men,0,0
80670,(,0,0
80671,4.78,0,0
80672,+/-,0,0
80673,2.57,0,0
80674,vs,0,0
80675,5.50,0,0
80676,+/-,0,0
80677,2.93,0,0
80678,min,0,0
80679,",",0,0
80680,P,0,0
80681,<,0,0
80682,0.01,0,0
80683,),0,0
80684,or,0,0
80685,those,0,0
80686,younger,0,0
80687,than,0,0
80688,50,0,0
80689,years,0,0
80690,(,0,0
80691,5.50,0,0
80692,+/-,0,0
80693,2.90,0,0
80694,vs,0,0
80695,6.25,0,0
80696,+/-,0,0
80697,3.68,0,0
80698,min,0,0
80699,",",0,0
80700,P,0,0
80701,=,0,0
80702,0.02,0,0
80703,),0,0
80704,were,0,0
80705,considered,0,0
80706,.,0,0
80707,CONCLUSION,0,0
80708,Cecal,0,0
80709,intubation,0,0
80710,time,0,0
80711,is,0,0
80712,shorter,0,0
80713,in,0,0
80714,patients,0,0
80715,examined,0,0
80716,with,0,0
80717,an,0,0
80718,intermediate,1,0
80719,length,1,0
80720,adult,1,0
80721,colonoscope,1,0
80722,",",0,0
80723,mainly,0,0
80724,in,0,0
80725,the,0,0
80726,subgroups,0,0
80727,of,0,0
80728,men,0,0
80729,and,0,0
80730,those,0,0
80731,younger,0,0
80732,than,0,0
80733,50,0,0
80734,years,0,0
80735,of,0,0
80736,age,0,0
80737,.,0,0
80738,Association,0,0
80739,of,0,0
80740,chronic,1,0
80741,kidney,1,0
80742,disease,1,0
80743,with,0,0
80744,outcomes,0,0
80745,in,0,0
80746,chronic,0,0
80747,heart,0,0
80748,failure,0,0
80749,:,0,0
80750,a,0,0
80751,propensity-matched,0,0
80752,study,0,0
80753,.,0,0
80754,BACKGROUND,0,0
80755,Chronic,1,0
80756,kidney,1,1
80757,disease,1,1
80758,(,1,1
80759,CKD,1,1
80760,),1,0
80761,is,0,0
80762,associated,0,0
80763,with,0,0
80764,increased,0,0
80765,mortality,0,0
80766,in,0,0
80767,patients,0,0
80768,with,0,0
80769,heart,1,0
80770,failure,1,1
80771,(,1,1
80772,HF,1,1
80773,),1,0
80774,.,1,0
80775,However,0,0
80776,",",0,0
80777,its,0,0
80778,association,0,0
80779,with,0,0
80780,hospitalization,0,0
80781,in,0,0
80782,HF,0,0
80783,patients,0,0
80784,has,0,0
80785,not,0,0
80786,been,0,0
80787,well,0,0
80788,studied,0,0
80789,.,0,0
80790,METHODS,0,0
80791,Of,0,0
80792,7788,0,0
80793,patients,0,0
80794,in,0,0
80795,the,0,0
80796,Digitalis,0,1
80797,Investigation,0,0
80798,Group,0,0
80799,trial,0,0
80800,",",0,0
80801,3527,0,0
80802,had,0,0
80803,CKD,0,0
80804,",",0,0
80805,defined,0,0
80806,by,0,0
80807,an,0,0
80808,estimated,0,0
80809,glomerular,0,0
80810,filtration,0,0
80811,rate,0,0
80812,(,0,1
80813,GFR,0,0
80814,),0,0
80815,<,0,0
80816,60,0,0
80817,ml/min/1.73,0,0
80818,m,0,0
80819,(,0,0
80820,2,0,1
80821,),0,0
80822,body,0,0
80823,surface,0,0
80824,area,0,0
80825,(,0,0
80826,BSA,0,1
80827,),0,1
80828,.,0,0
80829,Propensity,0,0
80830,scores,0,0
80831,for,0,0
80832,CKD,1,0
80833,were,0,0
80834,calculated,0,0
80835,using,0,0
80836,a,0,0
80837,multivariable,1,0
80838,logistic,1,0
80839,regression,1,0
80840,model,1,0
80841,and,0,0
80842,used,0,0
80843,to,0,0
80844,match,0,0
80845,2399,0,0
80846,pairs,0,0
80847,of,0,0
80848,patients,1,0
80849,with,1,0
80850,and,1,0
80851,without,1,0
80852,CKD,1,0
80853,.,1,0
80854,Matched,1,0
80855,Cox,1,0
80856,regression,1,0
80857,analyses,1,0
80858,were,0,0
80859,used,0,0
80860,to,0,0
80861,estimate,0,0
80862,association,0,0
80863,of,0,0
80864,CKD,1,0
80865,with,0,0
80866,outcomes,0,0
80867,.,0,0
80868,RESULTS,0,0
80869,All-cause,0,0
80870,hospitalization,0,0
80871,occurred,0,0
80872,in,0,0
80873,1636,0,0
80874,(,0,0
80875,rate,0,0
80876,",",0,0
80877,"4233/10,000",0,0
80878,person-years,0,0
80879,),0,0
80880,and,0,0
80881,1587,0,0
80882,(,0,0
80883,rate,0,0
80884,",",0,0
80885,"3733/10,000",0,0
80886,person-years,0,0
80887,),0,0
80888,patients,0,0
80889,respectively,0,0
80890,",",0,0
80891,with,1,0
80892,and,1,0
80893,without,1,0
80894,CKD,1,1
80895,(,0,0
80896,matched,0,0
80897,hazard,0,1
80898,ratio,0,0
80899,[,0,1
80900,HR,0,1
80901,],0,1
80902,for,0,0
80903,CKD,0,0
80904,",",0,0
80905,1.18,0,0
80906,",",0,0
80907,95,0,0
80908,%,0,0
80909,confidence,0,0
80910,interval,0,0
80911,[,0,0
80912,CI,0,0
80913,],0,0
80914,",",0,0
80915,1.08-1.29,0,0
80916,;,0,0
80917,P,0,0
80918,<,0,0
80919,0.0001,0,0
80920,),0,0
80921,.,0,0
80922,Matched,0,0
80923,HR,0,0
80924,for,0,0
80925,cardiovascular,0,0
80926,and,0,0
80927,HF,0,0
80928,hospitalization,0,0
80929,were,0,0
80930,respectively,0,0
80931,1.17,0,0
80932,(,0,0
80933,95,0,0
80934,%,0,0
80935,CI,0,0
80936,",",0,0
80937,1.06-1.28,0,0
80938,",",0,0
80939,P,0,0
80940,=,0,0
80941,0.002,0,0
80942,),0,0
80943,and,0,0
80944,1.28,0,0
80945,(,0,0
80946,95,0,0
80947,%,0,0
80948,CI,0,0
80949,",",0,0
80950,1.13-1.45,0,0
80951,",",0,0
80952,P,0,0
80953,<,0,0
80954,0.0001,0,0
80955,),0,0
80956,.,0,0
80957,Compared,0,0
80958,to,0,0
80959,GFR,0,0
80960,>,0,0
80961,or=60,0,0
80962,ml/min/1.73,0,0
80963,m,0,0
80964,(,0,0
80965,2,0,1
80966,),0,0
80967,BSA,0,1
80968,",",0,0
80969,HR,0,0
80970,for,0,0
80971,all-cause,0,0
80972,hospitalization,0,0
80973,for,0,0
80974,GFR,0,0
80975,45-59,0,0
80976,and,0,0
80977,<,0,0
80978,45,0,0
80979,ml/min/1.73,0,0
80980,m,0,0
80981,(,0,0
80982,2,0,1
80983,),0,0
80984,BSA,0,0
80985,were,0,0
80986,respectively,0,0
80987,1.04,0,0
80988,(,0,0
80989,95,0,0
80990,%,0,0
80991,CI,0,0
80992,",",0,0
80993,0.94-1.16,0,0
80994,;,0,0
80995,P,0,0
80996,=,0,0
80997,0.422,0,0
80998,),0,0
80999,and,0,0
81000,1.58,0,0
81001,(,0,0
81002,95,0,0
81003,%,0,0
81004,CI,0,0
81005,",",0,0
81006,1.34-1.87,0,0
81007,;,0,0
81008,P,0,0
81009,<,0,0
81010,0.0001,0,0
81011,),0,0
81012,.,0,0
81013,Similarly,0,0
81014,",",0,0
81015,HR,0,0
81016,for,0,0
81017,all-cause,0,0
81018,death,0,0
81019,for,0,0
81020,GFR,0,0
81021,45-59,0,0
81022,and,0,0
81023,<,0,0
81024,45,0,0
81025,ml/min/1.73,0,0
81026,m,0,0
81027,(,0,0
81028,2,0,1
81029,),0,0
81030,BSA,0,0
81031,were,0,0
81032,respectively,0,0
81033,1.03,0,0
81034,(,0,0
81035,95,0,0
81036,%,0,0
81037,CI,0,0
81038,",",0,0
81039,0.90-1.18,0,0
81040,;,0,0
81041,P,0,0
81042,=,0,0
81043,0.651,0,0
81044,),0,0
81045,and,0,0
81046,1.70,0,0
81047,(,0,0
81048,95,0,0
81049,%,0,0
81050,CI,0,0
81051,",",0,0
81052,1.40-2.07,0,0
81053,;,0,0
81054,P,0,0
81055,<,0,0
81056,0.0001,0,0
81057,),0,0
81058,.,0,0
81059,Matched,0,0
81060,HR,0,0
81061,for,0,0
81062,death,0,0
81063,due,0,0
81064,to,0,0
81065,cardiovascular,0,0
81066,causes,0,0
81067,and,0,0
81068,progressive,0,0
81069,HF,0,0
81070,were,0,0
81071,respectively,0,0
81072,1.24,0,0
81073,(,0,0
81074,95,0,0
81075,%,0,0
81076,CI,0,0
81077,",",0,0
81078,1.09-1.40,0,0
81079,;,0,0
81080,P,0,0
81081,=,0,0
81082,0.001,0,0
81083,),0,0
81084,and,0,0
81085,1.42,0,0
81086,(,0,0
81087,95,0,0
81088,%,0,0
81089,CI,0,0
81090,",",0,0
81091,1.16-1.72,0,0
81092,;,0,0
81093,P,0,0
81094,=,0,0
81095,0.001,0,0
81096,),0,0
81097,.,0,0
81098,CONCLUSION,0,0
81099,CKD,1,0
81100,was,0,0
81101,associated,0,0
81102,with,0,0
81103,increased,0,0
81104,mortality,0,0
81105,and,0,0
81106,hospitalization,0,0
81107,in,0,0
81108,ambulatory,0,0
81109,patients,0,0
81110,with,0,0
81111,chronic,0,0
81112,HF,0,0
81113,",",0,0
81114,which,0,0
81115,increased,0,0
81116,progressively,0,0
81117,with,0,0
81118,worsening,0,0
81119,kidney,0,0
81120,function,0,0
81121,.,0,0
81122,Short-term,0,0
81123,metabolic,0,0
81124,and,0,0
81125,cardiovascular,0,0
81126,effects,0,0
81127,of,0,0
81128,metformin,1,1
81129,in,0,0
81130,markedly,0,0
81131,obese,0,0
81132,adolescents,0,0
81133,with,0,0
81134,normal,0,0
81135,glucose,0,1
81136,tolerance,0,0
81137,.,0,0
81138,OBJECTIVE,0,0
81139,Although,0,0
81140,metformin,1,1
81141,(,0,1
81142,MET,0,1
81143,),0,0
81144,is,0,0
81145,an,0,1
81146,insulin,0,1
81147,sensitizer,0,1
81148,currently,0,0
81149,used,0,0
81150,as,0,0
81151,an,0,0
81152,adjunct,0,0
81153,to,0,0
81154,the,0,0
81155,treatment,0,0
81156,of,0,0
81157,some,0,0
81158,of,0,0
81159,the,0,0
81160,complications,0,0
81161,of,0,0
81162,childhood,0,0
81163,obesity,0,0
81164,besides,0,0
81165,type,0,0
81166,2,0,0
81167,diabetes,0,0
81168,mellitus,0,0
81169,",",0,0
81170,few,0,0
81171,studies,0,0
81172,have,0,0
81173,comprehensively,0,0
81174,examined,0,0
81175,its,0,0
81176,metabolic,0,0
81177,and,0,0
81178,clinical,0,0
81179,effects,0,0
81180,in,0,0
81181,obese,0,0
81182,children,0,0
81183,with,0,0
81184,normal,0,0
81185,glucose,0,1
81186,tolerance,0,1
81187,(,0,1
81188,NGT,0,1
81189,),0,1
81190,.,0,0
81191,METHODS,0,0
81192,We,0,0
81193,therefore,0,0
81194,conducted,0,0
81195,a,0,0
81196,4-month,0,1
81197,double-blind,0,1
81198,clinical,0,1
81199,trial,0,0
81200,in,0,0
81201,28,0,0
81202,obese,0,0
81203,[,0,0
81204,mean,0,0
81205,body,0,0
81206,mass,0,0
81207,index,0,1
81208,(,0,1
81209,BMI,0,1
81210,),0,0
81211,:,0,0
81212,40.3,0,0
81213,+/-,0,0
81214,5.7,0,0
81215,kg/m,0,0
81216,(,0,0
81217,2,0,0
81218,),0,1
81219,],0,1
81220,",",0,1
81221,insulin-resistant,0,1
81222,[,0,1
81223,homeostasis,0,0
81224,model,0,0
81225,assessment,0,1
81226,-,0,1
81227,insulin,0,1
81228,resistance,0,0
81229,:,0,0
81230,7.6,0,0
81231,+/-,0,0
81232,2.8,0,0
81233,and,0,0
81234,whole,0,0
81235,body,0,1
81236,insulin,0,1
81237,sensitivity,0,1
81238,index,0,1
81239,(,0,1
81240,WBISI,0,1
81241,),0,1
81242,:,0,0
81243,1.5,0,0
81244,+/-,0,0
81245,0.7,0,0
81246,],0,0
81247,adolescents,0,0
81248,(,0,0
81249,age,0,0
81250,15.0,0,0
81251,+/-,0,0
81252,1.3,0,0
81253,yr,0,0
81254,),0,0
81255,randomized,0,0
81256,to,0,0
81257,MET,0,1
81258,(,0,0
81259,n,0,0
81260,=,0,0
81261,15,0,0
81262,",",0,0
81263,dose,0,1
81264,1500,0,1
81265,mg,0,1
81266,daily,0,1
81267,),0,1
81268,or,0,1
81269,placebo,1,1
81270,(,0,0
81271,n,0,0
81272,=,0,0
81273,13,0,0
81274,),0,0
81275,.,0,0
81276,RESULTS,0,0
81277,The,0,0
81278,treatment,0,0
81279,with,0,0
81280,MET,0,0
81281,was,0,0
81282,well,0,0
81283,tolerated,0,1
81284,.,0,0
81285,MET,0,0
81286,treatment,0,0
81287,was,0,0
81288,associated,0,0
81289,with,0,0
81290,a,0,0
81291,decreased,0,0
81292,BMI,0,0
81293,(,0,0
81294,p,0,0
81295,=,0,0
81296,0.02,0,0
81297,),0,0
81298,as,0,0
81299,well,0,0
81300,as,0,0
81301,with,0,0
81302,a,0,0
81303,reduction,0,0
81304,in,0,0
81305,subcutaneous,0,1
81306,fat,0,1
81307,(,0,0
81308,p,0,0
81309,=,0,0
81310,0.03,0,0
81311,),0,0
81312,",",0,0
81313,particularly,0,0
81314,the,0,0
81315,deep,0,1
81316,subcutaneous,0,1
81317,fat,0,1
81318,(,0,0
81319,p,0,0
81320,=,0,0
81321,0.04,0,0
81322,),0,0
81323,as,0,0
81324,assessed,0,0
81325,by,0,0
81326,magnetic,0,0
81327,resonance,0,0
81328,imaging,0,0
81329,.,0,0
81330,Postintervention,0,0
81331,",",0,0
81332,the,0,0
81333,MET,0,0
81334,group,0,0
81335,had,0,0
81336,a,0,0
81337,35,0,0
81338,%,0,0
81339,improvement,0,0
81340,in,0,0
81341,insulin,0,1
81342,sensitivity,0,1
81343,(,0,1
81344,WBISI,0,1
81345,),0,0
81346,compared,0,0
81347,with,0,0
81348,the,0,0
81349,placebo,1,1
81350,group,0,0
81351,(,0,0
81352,p,0,0
81353,=,0,0
81354,0.008,0,0
81355,),0,0
81356,.,0,0
81357,However,0,0
81358,",",0,0
81359,significance,0,0
81360,was,0,0
81361,lost,0,0
81362,with,0,0
81363,adjustments,0,0
81364,for,0,0
81365,differences,0,0
81366,in,0,0
81367,baseline,0,0
81368,insulin,0,1
81369,sensitivity,0,0
81370,(,0,0
81371,p,0,0
81372,=,0,0
81373,0.09,0,0
81374,),0,0
81375,.,0,0
81376,While,0,0
81377,there,0,0
81378,was,0,0
81379,no,0,0
81380,change,0,0
81381,in,0,0
81382,inflammatory,0,0
81383,cytokines,0,0
81384,or,0,0
81385,lipid,0,0
81386,parameters,0,0
81387,",",0,0
81388,cardiovascular,0,0
81389,function,0,0
81390,as,0,0
81391,assessed,0,0
81392,by,0,0
81393,heart,0,0
81394,rate,0,0
81395,recovery,0,0
81396,after,0,0
81397,exercise,0,0
81398,improved,0,0
81399,with,0,0
81400,MET,0,0
81401,and,0,0
81402,worsened,0,0
81403,in,0,1
81404,placebo,0,1
81405,(,0,0
81406,p,0,0
81407,=,0,0
81408,0.03,0,0
81409,),0,0
81410,.,0,0
81411,CONCLUSION,0,0
81412,Short-term,0,0
81413,use,0,0
81414,of,0,0
81415,MET,0,0
81416,is,0,0
81417,well,0,0
81418,tolerated,0,1
81419,by,0,0
81420,obese,0,1
81421,children,0,0
81422,with,0,0
81423,NGT,0,0
81424,and,0,0
81425,has,0,0
81426,a,0,0
81427,beneficial,0,0
81428,effect,0,0
81429,on,0,0
81430,BMI,0,0
81431,and,0,0
81432,autonomic,0,0
81433,control,0,0
81434,of,0,0
81435,the,0,0
81436,heart,0,0
81437,as,0,0
81438,well,0,0
81439,as,0,0
81440,a,0,0
81441,trend,0,0
81442,toward,0,0
81443,improved,0,0
81444,insulin,0,1
81445,sensitivity,0,0
81446,.,0,0
81447,Thus,0,0
81448,",",0,0
81449,long-term,0,0
81450,treatment,0,0
81451,with,0,0
81452,MET,0,0
81453,may,0,0
81454,provide,0,0
81455,a,0,0
81456,means,0,0
81457,to,0,0
81458,ameliorate,0,0
81459,the,0,0
81460,cardio-metabolic,0,0
81461,consequences,0,0
81462,of,0,0
81463,adolescent,0,0
81464,obesity,0,0
81465,.,0,0
81466,Psychological,0,0
81467,mediators,0,0
81468,of,0,0
81469,bupropion,1,1
81470,sustained-release,1,1
81471,treatment,0,1
81472,for,0,0
81473,smoking,0,0
81474,cessation,0,0
81475,.,0,0
81476,AIM,0,0
81477,The,0,0
81478,study,0,0
81479,aimed,0,0
81480,to,0,0
81481,test,0,0
81482,simultaneously,0,0
81483,our,0,0
81484,understanding,0,0
81485,of,0,0
81486,the,0,0
81487,effects,0,0
81488,of,0,0
81489,bupropion,1,1
81490,sustained-release,1,1
81491,(,1,1
81492,SR,1,1
81493,),1,1
81494,treatment,0,0
81495,on,0,0
81496,putative,0,0
81497,mediators,0,0
81498,and,0,0
81499,our,0,0
81500,understanding,0,0
81501,of,0,0
81502,determinants,0,0
81503,of,0,0
81504,post-quit,0,0
81505,abstinence,0,0
81506,",",0,0
81507,including,0,0
81508,withdrawal,0,0
81509,distress,0,0
81510,",",0,0
81511,cigarette,0,0
81512,craving,0,0
81513,",",0,0
81514,positive,0,0
81515,affect,0,0
81516,and,0,0
81517,subjective,0,0
81518,reactions,0,0
81519,to,0,0
81520,cigarettes,0,0
81521,smoked,0,0
81522,during,0,0
81523,a,0,0
81524,lapse,0,0
81525,.,0,0
81526,The,0,0
81527,specificity,0,0
81528,of,0,0
81529,bupropion,1,1
81530,SR,1,1
81531,effects,0,0
81532,was,0,0
81533,also,0,0
81534,tested,0,0
81535,in,0,0
81536,exploratory,0,0
81537,analyses,0,0
81538,.,0,0
81539,DESIGN,0,0
81540,Data,0,0
81541,from,0,0
81542,a,0,0
81543,randomized,0,0
81544,",",0,0
81545,placebo-controlled,1,1
81546,clinical,0,1
81547,trial,0,1
81548,of,0,0
81549,bupropion,1,1
81550,SR,1,1
81551,were,0,0
81552,submitted,0,0
81553,to,0,0
81554,mediation,0,0
81555,analyses,0,0
81556,.,0,0
81557,SETTING,0,0
81558,Center,0,0
81559,for,0,0
81560,Tobacco,0,0
81561,Research,0,0
81562,and,0,0
81563,Intervention,0,0
81564,",",0,0
81565,Madison,0,1
81566,",",0,0
81567,WI,0,1
81568,",",0,0
81569,USA,0,0
81570,.,0,0
81571,PARTICIPANTS,0,0
81572,A,0,0
81573,total,0,0
81574,of,0,0
81575,403,0,0
81576,adult,0,0
81577,",",0,0
81578,daily,0,1
81579,smokers,0,1
81580,without,0,0
81581,contraindications,0,0
81582,to,0,0
81583,bupropion,1,1
81584,SR,1,1
81585,use,0,0
81586,.,0,0
81587,INTERVENTION,0,0
81588,Participants,0,0
81589,were,0,0
81590,assigned,0,0
81591,randomly,0,0
81592,to,0,0
81593,receive,0,0
81594,a,0,0
81595,9-week,0,0
81596,course,0,0
81597,of,0,0
81598,bupropion,1,1
81599,SR,1,1
81600,or,1,1
81601,placebo,1,1
81602,pill,1,1
81603,and,0,1
81604,to,0,0
81605,receive,0,0
81606,eight,1,0
81607,brief,1,0
81608,individual,1,0
81609,counseling,1,0
81610,sessions,1,0
81611,or,1,0
81612,no,1,0
81613,counseling,1,0
81614,.,1,0
81615,MEASUREMENTS,0,0
81616,Ecological,0,0
81617,momentary,0,1
81618,assessment,0,0
81619,ratings,0,0
81620,of,0,0
81621,smoking,0,0
81622,behavior,0,0
81623,and,0,0
81624,putative,0,0
81625,mediators,0,0
81626,were,0,0
81627,collected,0,0
81628,pre-,0,0
81629,and,0,0
81630,post-quit,0,0
81631,.,0,0
81632,FINDINGS,0,0
81633,Results,0,0
81634,of,0,0
81635,structural,0,0
81636,equation,0,0
81637,and,0,0
81638,hierarchical,0,0
81639,linear,0,0
81640,models,0,0
81641,did,0,0
81642,not,0,0
81643,support,0,0
81644,the,0,0
81645,hypothesis,0,0
81646,that,0,0
81647,bupropion,0,1
81648,SR,0,1
81649,treatment,0,0
81650,improves,0,0
81651,short-term,0,0
81652,abstinence,0,0
81653,by,0,0
81654,reducing,0,0
81655,withdrawal,0,0
81656,distress,0,0
81657,or,0,0
81658,affecting,0,0
81659,the,0,0
81660,subjective,0,0
81661,effects,0,0
81662,of,0,0
81663,a,0,0
81664,lapse,0,0
81665,cigarette,0,0
81666,",",0,0
81667,but,0,0
81668,provided,0,0
81669,partial,0,0
81670,support,0,0
81671,for,0,0
81672,mediation,0,0
81673,by,0,0
81674,cigarette,0,0
81675,craving,0,0
81676,reduction,0,0
81677,and,0,0
81678,enhanced,0,0
81679,positive,0,0
81680,affect,0,0
81681,.,0,0
81682,Bupropion,1,1
81683,SR,1,1
81684,effects,0,0
81685,on,0,0
81686,point-prevalence,0,0
81687,abstinence,0,0
81688,at,0,0
81689,1,0,0
81690,month,0,0
81691,post-quit,0,0
81692,were,0,0
81693,also,0,0
81694,mediated,0,0
81695,partially,0,0
81696,by,0,0
81697,enhanced,0,0
81698,motivation,0,0
81699,to,0,0
81700,quit,0,0
81701,and,0,0
81702,self-efficacy,0,0
81703,.,0,0
81704,CONCLUSIONS,0,0
81705,Results,0,0
81706,provided,0,0
81707,some,0,0
81708,support,0,0
81709,for,0,0
81710,models,0,0
81711,of,0,0
81712,bupropion,1,1
81713,SR,1,1
81714,treatment,0,1
81715,and,0,0
81716,relapse,0,0
81717,and,0,0
81718,suggested,0,0
81719,that,0,0
81720,motivational,0,0
81721,processes,0,0
81722,may,0,0
81723,partially,0,0
81724,account,0,0
81725,for,0,0
81726,bupropion,0,1
81727,SR,0,1
81728,efficacy,0,1
81729,.,0,0
81730,CASTLE,1,0
81731,data,1,0
81732,show,0,0
81733,no,0,0
81734,gender,0,0
81735,differences,0,0
81736,.,0,0
81737,Bacterial,1,0
81738,ribosomal,1,0
81739,immunostimulants,1,1
81740,prime,0,0
81741,alveolar,0,0
81742,macrophages,0,0
81743,in,0,0
81744,vivo,0,0
81745,to,0,0
81746,produce,0,0
81747,interleukin,0,1
81748,1,0,0
81749,in,0,0
81750,vitro,0,0
81751,.,0,0
81752,Alveolar,0,0
81753,macrophages,0,0
81754,(,0,1
81755,AMs,0,1
81756,),0,0
81757,may,0,0
81758,play,0,0
81759,a,0,0
81760,key,0,0
81761,role,0,0
81762,in,0,0
81763,human,0,0
81764,respiratory,0,0
81765,immune,0,0
81766,defenses,0,0
81767,",",0,0
81768,partially,0,0
81769,by,0,0
81770,synthesizing,0,0
81771,and,0,0
81772,releasing,0,0
81773,interleukin,0,1
81774,1,0,1
81775,(,0,0
81776,IL,0,0
81777,=,0,0
81778,1,0,0
81779,),0,0
81780,.,0,1
81781,D53,1,1
81782,(,1,1
81783,Ribomunyl,1,1
81784,),1,1
81785,",",1,0
81786,a,1,0
81787,composite,1,0
81788,bacterial,1,0
81789,ribosomal,1,0
81790,immunostimulant,1,1
81791,",",0,0
81792,has,0,0
81793,been,0,0
81794,recognized,0,0
81795,as,0,0
81796,an,0,0
81797,efficient,0,0
81798,prevention,0,0
81799,of,0,0
81800,respiratory,0,0
81801,tract,0,0
81802,infections,0,0
81803,.,0,0
81804,In,0,0
81805,vitro,0,0
81806,",",0,0
81807,D53,1,0
81808,enhances,0,0
81809,the,0,0
81810,IL-1,0,0
81811,production,0,0
81812,by,0,0
81813,mouse,0,0
81814,spleen,0,0
81815,adherent,0,0
81816,cells,0,0
81817,.,0,0
81818,A,0,0
81819,thymocyte,0,0
81820,proliferative,0,0
81821,response,0,0
81822,assay,0,0
81823,was,0,0
81824,used,0,0
81825,to,0,0
81826,evaluate,0,0
81827,the,0,0
81828,in,0,0
81829,vitro,0,0
81830,IL-1,0,0
81831,production,0,0
81832,by,0,0
81833,AMs,0,0
81834,in,0,0
81835,healthy,0,0
81836,subjects,0,0
81837,who,0,0
81838,received,0,0
81839,D53,1,1
81840,immunostimulant,1,1
81841,.,1,1
81842,Twelve,0,0
81843,nonsmoking,0,0
81844,healthy,0,0
81845,subjects,0,0
81846,took,0,0
81847,part,0,0
81848,in,0,0
81849,a,0,0
81850,prospective,0,1
81851,double-blind,0,1
81852,placebo,0,1
81853,control,0,0
81854,study,0,0
81855,.,0,0
81856,On,0,1
81857,day,0,0
81858,1,0,0
81859,",",0,0
81860,a,0,0
81861,first,0,0
81862,bronchoalveolar,0,0
81863,lavage,0,1
81864,(,0,1
81865,BAL,0,1
81866,),0,0
81867,was,0,0
81868,performed,0,0
81869,to,0,0
81870,assess,0,0
81871,IL-1,0,0
81872,production,0,0
81873,by,0,0
81874,unstimulated,0,0
81875,and,0,0
81876,lipopolysaccharide,0,1
81877,(,0,1
81878,LPS,0,1
81879,),0,1
81880,stimulated,0,0
81881,AM,0,0
81882,.,0,0
81883,Then,0,0
81884,",",0,0
81885,subjects,0,0
81886,were,0,0
81887,randomized,0,0
81888,to,0,0
81889,receive,0,1
81890,D53,1,1
81891,(,0,0
81892,n,0,0
81893,=,0,0
81894,6,0,0
81895,),0,0
81896,or,0,0
81897,its,0,1
81898,placebo,1,1
81899,(,0,0
81900,n,0,0
81901,=,0,0
81902,6,0,0
81903,),0,0
81904,by,0,0
81905,both,0,0
81906,oral,0,1
81907,and,0,1
81908,subcutaneous,0,1
81909,injection,0,1
81910,routes,0,1
81911,from,0,0
81912,day,0,0
81913,1,0,0
81914,to,0,0
81915,day,0,0
81916,15,0,0
81917,.,0,0
81918,On,0,1
81919,day,0,0
81920,15,0,0
81921,",",0,0
81922,a,0,0
81923,second,0,0
81924,BAL,0,0
81925,was,0,0
81926,done,0,0
81927,and,0,0
81928,AM,0,0
81929,IL-1,0,0
81930,production,0,0
81931,was,0,0
81932,again,0,0
81933,tested,0,0
81934,.,0,0
81935,IL-1,0,0
81936,production,0,0
81937,on,0,0
81938,day,0,0
81939,15,0,0
81940,did,0,0
81941,not,0,0
81942,significantly,0,0
81943,differ,0,0
81944,from,0,0
81945,day,0,0
81946,1,0,0
81947,in,0,0
81948,both,0,0
81949,D53-treated,1,0
81950,and,0,0
81951,placebo,0,1
81952,groups,0,0
81953,either,0,0
81954,when,0,0
81955,AMs,0,0
81956,were,0,0
81957,unstimulated,0,0
81958,or,0,0
81959,were,0,0
81960,stimulated,0,0
81961,with,0,0
81962,concentrations,0,0
81963,of,0,0
81964,LPS,0,0
81965,resulting,0,0
81966,in,0,0
81967,maximal,0,0
81968,IL-1,0,0
81969,production,0,0
81970,.,0,0
81971,However,0,0
81972,",",0,0
81973,in,0,0
81974,the,0,0
81975,D53-treated,1,0
81976,group,0,0
81977,",",0,0
81978,but,0,0
81979,not,0,0
81980,in,0,0
81981,the,0,0
81982,placebo,1,1
81983,group,0,1
81984,",",0,0
81985,IL-1,0,0
81986,production,0,0
81987,induced,0,0
81988,by,0,0
81989,low,0,0
81990,LPS,0,0
81991,concentration,0,0
81992,(,0,1
81993,5,0,1
81994,mg/L,0,1
81995,),0,1
81996,was,0,0
81997,significantly,0,0
81998,higher,0,0
81999,(,0,0
82000,mean,0,0
82001,+/-,0,0
82002,SEM,0,0
82003,:,0,0
82004,"1,238",0,0
82005,+/-,0,0
82006,287,0,0
82007,U/10,0,0
82008,(,0,0
82009,6,0,0
82010,),0,1
82011,AM,0,1
82012,),0,1
82013,on,0,0
82014,day,0,0
82015,15,0,0
82016,in,0,0
82017,comparison,0,0
82018,with,0,0
82019,day,0,0
82020,1,0,0
82021,(,0,0
82022,577,0,0
82023,+/-,0,0
82024,113,0,0
82025,U/10,0,0
82026,(,0,0
82027,6,0,0
82028,),0,1
82029,AM,0,1
82030,;,0,0
82031,p,0,0
82032,less,0,0
82033,than,0,0
82034,0.05,0,0
82035,",",0,0
82036,Wilcoxon,0,0
82037,W,0,1
82038,test,0,0
82039,),0,0
82040,and,0,0
82041,in,0,0
82042,comparison,0,0
82043,with,0,0
82044,the,0,0
82045,control,0,0
82046,group,0,0
82047,(,0,1
82048,day,0,1
82049,15,0,0
82050,IL-1,0,0
82051,production,0,0
82052,induced,0,0
82053,by,0,0
82054,5,0,0
82055,mg/L,0,1
82056,LPS,0,1
82057,",",0,0
82058,758,0,0
82059,+/-,0,0
82060,175,0,0
82061,U/10,0,0
82062,(,0,0
82063,6,0,0
82064,),0,1
82065,AM,0,1
82066,;,0,0
82067,p,0,0
82068,less,0,0
82069,than,0,0
82070,0.05,0,0
82071,",",0,0
82072,Mann-Whitney,0,0
82073,U,0,1
82074,test,0,1
82075,),0,0
82076,.,0,0
82077,Moreover,0,0
82078,",",0,0
82079,in,0,0
82080,the,0,0
82081,D53-treated,1,0
82082,group,0,0
82083,",",0,0
82084,the,0,0
82085,optimal,0,0
82086,LPS,0,0
82087,concentration,0,0
82088,(,0,0
82089,ie,0,0
82090,",",0,0
82091,LPS,0,0
82092,concentration,0,0
82093,that,0,0
82094,induced,0,0
82095,maximal,0,0
82096,IL-1,0,0
82097,production,0,0
82098,),0,0
82099,was,0,0
82100,significantly,0,0
82101,lower,0,0
82102,on,0,0
82103,day,0,0
82104,15,0,0
82105,(,0,0
82106,mean,0,0
82107,+/-,0,0
82108,SD,0,0
82109,:,0,0
82110,11,0,0
82111,+/-,0,0
82112,7,0,0
82113,mg/L,0,1
82114,),0,1
82115,than,0,1
82116,on,0,0
82117,day,0,0
82118,1,0,1
82119,(,0,0
82120,16,0,0
82121,+/-,0,0
82122,7,0,0
82123,mg/L,0,0
82124,;,0,0
82125,p,0,0
82126,less,0,0
82127,than,0,0
82128,0.05,0,0
82129,Wilcoxon,0,0
82130,W,0,0
82131,test,0,0
82132,),0,0
82133,.,0,0
82134,We,0,0
82135,conclude,0,0
82136,that,0,0
82137,D53,1,1
82138,immunostimulant,1,1
82139,in,0,0
82140,vivo,0,0
82141,primes,0,0
82142,AM,0,0
82143,to,0,0
82144,produce,0,0
82145,IL-1,0,0
82146,following,0,0
82147,low,0,0
82148,LPS,0,0
82149,concentration,0,0
82150,stimulation,0,0
82151,.,0,0
82152,This,0,0
82153,may,0,0
82154,partially,0,0
82155,explain,0,0
82156,the,0,0
82157,protective,0,0
82158,effect,0,0
82159,of,0,0
82160,D53,1,1
82161,immunostimulant,1,1
82162,against,0,0
82163,respiratory,0,1
82164,tract,0,0
82165,infection,0,0
82166,.,0,0
82167,Impact,0,0
82168,of,0,0
82169,isotonic,1,1
82170,and,1,1
82171,hypertonic,1,1
82172,saline,1,1
82173,solutions,1,1
82174,on,0,0
82175,mucociliary,0,0
82176,activity,0,0
82177,in,0,0
82178,various,0,0
82179,nasal,0,0
82180,pathologies,0,0
82181,:,0,0
82182,clinical,0,0
82183,study,0,0
82184,.,0,0
82185,OBJECTIVE,0,0
82186,To,0,0
82187,investigate,0,0
82188,the,0,0
82189,impact,0,0
82190,of,0,0
82191,nasal,0,0
82192,irrigation,0,1
82193,with,0,1
82194,isotonic,1,1
82195,or,1,1
82196,hypertonic,1,1
82197,sodium,1,1
82198,chloride,1,1
82199,solution,1,0
82200,on,0,0
82201,mucociliary,0,0
82202,clearance,0,1
82203,time,0,0
82204,in,0,0
82205,patients,0,0
82206,with,0,0
82207,allergic,0,0
82208,rhinitis,0,0
82209,",",0,0
82210,acute,0,0
82211,sinusitis,0,0
82212,and,0,0
82213,chronic,0,0
82214,sinusitis,0,0
82215,.,0,0
82216,PATIENTS,0,0
82217,AND,0,1
82218,METHODS,0,1
82219,Mucociliary,0,1
82220,clearance,0,1
82221,time,0,0
82222,was,0,0
82223,measured,0,0
82224,using,0,0
82225,the,0,0
82226,saccharine,0,1
82227,clearance,0,1
82228,test,0,0
82229,on,0,0
82230,132,0,0
82231,adults,0,0
82232,before,0,0
82233,and,0,0
82234,after,0,0
82235,10,0,0
82236,days,0,0
82237,',0,0
82238,application,1,0
82239,of,1,0
82240,intranasal,1,1
82241,isotonic,1,1
82242,or,1,1
82243,hypertonic,1,1
82244,saline,1,1
82245,.,1,1
82246,Patient,0,0
82247,numbers,0,0
82248,were,0,0
82249,as,0,0
82250,follows,0,0
82251,:,0,0
82252,controls,0,0
82253,",",0,0
82254,45,0,0
82255,;,0,0
82256,allergic,0,0
82257,rhinitis,0,1
82258,",",0,0
82259,21,0,0
82260,;,0,0
82261,acute,0,1
82262,sinusitis,0,1
82263,",",0,0
82264,24,0,0
82265,;,0,0
82266,and,0,0
82267,chronic,0,1
82268,sinusitis,0,0
82269,",",0,0
82270,42,0,0
82271,.,0,0
82272,The,0,0
82273,results,0,0
82274,before,0,0
82275,and,0,0
82276,after,0,0
82277,irrigation,0,0
82278,were,0,0
82279,compared,0,0
82280,using,0,0
82281,the,0,0
82282,Wilcoxon,0,0
82283,t-test,0,0
82284,.,0,0
82285,RESULTS,0,0
82286,Before,0,0
82287,application,0,0
82288,of,0,0
82289,saline,1,1
82290,solutions,1,0
82291,",",0,1
82292,mucociliary,0,1
82293,clearance,0,1
82294,times,0,1
82295,in,0,0
82296,the,0,0
82297,three,0,0
82298,patient,0,0
82299,treatment,0,0
82300,groups,0,0
82301,were,0,0
82302,found,0,0
82303,to,0,0
82304,be,0,0
82305,significantly,0,0
82306,delayed,0,0
82307,",",0,0
82308,compared,0,0
82309,with,0,0
82310,the,0,0
82311,control,0,0
82312,group,0,0
82313,.,0,0
82314,Irrigation,0,0
82315,with,0,1
82316,hypertonic,1,1
82317,saline,1,1
82318,restored,0,1
82319,impaired,0,0
82320,mucociliary,0,0
82321,clearance,0,1
82322,in,0,0
82323,chronic,0,0
82324,sinusitis,0,1
82325,patients,0,0
82326,(,0,0
82327,p,0,0
82328,<,0,0
82329,0.05,0,0
82330,),0,0
82331,",",0,0
82332,while,0,1
82333,isotonic,1,1
82334,saline,1,1
82335,improved,0,1
82336,mucociliary,0,1
82337,clearance,0,1
82338,times,0,1
82339,significantly,0,0
82340,in,0,0
82341,allergic,0,0
82342,rhinitis,0,0
82343,and,0,0
82344,acute,0,0
82345,sinusitis,0,1
82346,patients,0,0
82347,(,0,0
82348,p,0,0
82349,<,0,0
82350,0.05,0,0
82351,),0,0
82352,.,0,0
82353,CONCLUSION,0,1
82354,Nasal,0,1
82355,irrigation,0,1
82356,with,0,1
82357,isotonic,1,1
82358,or,1,1
82359,hypertonic,1,1
82360,saline,1,1
82361,can,0,1
82362,improve,0,0
82363,mucociliary,0,0
82364,clearance,0,1
82365,time,0,0
82366,in,0,0
82367,various,0,0
82368,nasal,0,0
82369,pathologies,0,0
82370,.,0,0
82371,However,0,0
82372,",",0,0
82373,these,0,0
82374,solutions,0,0
82375,should,0,0
82376,be,0,0
82377,selectively,0,0
82378,prescribed,0,0
82379,rather,0,0
82380,than,0,0
82381,used,0,0
82382,based,0,0
82383,on,0,0
82384,anecdotal,0,0
82385,evidence,0,0
82386,.,0,0
82387,Further,0,0
82388,studies,0,0
82389,should,0,0
82390,be,0,0
82391,conducted,0,0
82392,to,0,0
82393,develop,0,0
82394,a,0,0
82395,protocol,0,0
82396,for,0,0
82397,standardised,0,0
82398,use,0,0
82399,of,0,0
82400,saline,1,1
82401,solution,1,0
82402,irrigation,1,0
82403,in,0,0
82404,various,0,0
82405,nasal,0,0
82406,pathologies,0,0
82407,.,0,0
82408,Hyperinsulinemia,0,1
82409,fails,0,0
82410,to,0,0
82411,augment,0,0
82412,ET-1,0,0
82413,action,0,0
82414,in,0,0
82415,the,0,0
82416,skeletal,0,0
82417,muscle,0,0
82418,vascular,0,0
82419,bed,0,0
82420,in,0,0
82421,vivo,0,0
82422,in,0,0
82423,humans,0,0
82424,.,0,0
82425,Endogenous,0,0
82426,endothelin,0,1
82427,action,0,0
82428,is,0,0
82429,augmented,0,0
82430,in,0,0
82431,human,0,0
82432,obesity,0,0
82433,and,0,0
82434,type,0,0
82435,2,0,0
82436,diabetes,0,0
82437,and,0,0
82438,contributes,0,0
82439,to,0,0
82440,endothelial,0,0
82441,dysfunction,0,0
82442,and,0,0
82443,impairs,0,0
82444,insulin-mediated,0,1
82445,vasodilation,0,1
82446,in,0,0
82447,humans,0,0
82448,.,0,0
82449,We,0,0
82450,hypothesized,0,0
82451,that,0,0
82452,insulin,0,1
82453,resistance-associated,0,1
82454,hyperinsulinemia,0,1
82455,could,0,0
82456,preferentially,0,0
82457,drive,0,0
82458,endothelin-mediated,0,0
82459,vasoconstriction,0,1
82460,.,0,0
82461,We,0,1
82462,applied,0,0
82463,hyperinsulinemic-euglycemic,1,1
82464,clamps,1,1
82465,with,0,1
82466,higher,0,0
82467,insulin,1,1
82468,dosing,0,1
82469,in,0,1
82470,obese,0,1
82471,subjects,0,0
82472,than,0,0
82473,lean,0,0
82474,subjects,0,0
82475,(,0,0
82476,30,0,0
82477,vs.,0,0
82478,10,0,0
82479,mU.m,0,0
82480,(,0,1
82481,-2,0,1
82482,),0,1
82483,.min,0,1
82484,(,0,1
82485,-1,0,1
82486,),0,0
82487,",",0,0
82488,respectively,0,0
82489,),0,0
82490,",",0,0
82491,with,0,0
82492,the,0,0
82493,goal,0,0
82494,of,0,0
82495,matching,0,0
82496,insulin,0,1
82497,'s,0,1
82498,nitric,0,1
82499,oxide,0,1
82500,(,0,1
82501,NO,0,1
82502,),0,1
82503,-mediated,0,0
82504,vascular,0,0
82505,effects,0,0
82506,.,0,0
82507,We,0,0
82508,predicted,0,0
82509,that,0,0
82510,",",0,0
82511,under,0,0
82512,these,0,0
82513,circumstances,0,0
82514,",",0,1
82515,insulin-stimulated,0,1
82516,endothelin-1,0,1
82517,(,0,1
82518,ET-1,0,1
82519,),0,1
82520,action,0,0
82521,(,0,0
82522,assessed,0,0
82523,with,0,0
82524,the,0,0
82525,type,0,0
82526,A,0,1
82527,endothelin,0,1
82528,receptor,0,1
82529,antagonist,0,1
82530,BQ-123,0,1
82531,),0,1
82532,would,0,0
82533,be,0,0
82534,augmented,0,0
82535,in,0,0
82536,proportion,0,0
82537,to,0,0
82538,hyperinsulinemia,0,1
82539,.,0,0
82540,NO,0,0
82541,bioactivity,0,0
82542,was,0,0
82543,assessed,0,0
82544,using,0,0
82545,the,0,0
82546,nitric,0,1
82547,oxide,0,1
82548,synthase,0,1
82549,inhibitor,0,1
82550,N,0,1
82551,(,0,1
82552,G,0,1
82553,),0,1
82554,-monomethyl-l-arginine,0,1
82555,.,0,1
82556,Insulin-mediated,1,1
82557,vasodilation,0,1
82558,and,0,1
82559,insulin-stimulated,0,1
82560,NO,0,1
82561,bioavailability,0,1
82562,were,0,0
82563,well,0,0
82564,matched,0,0
82565,across,0,0
82566,groups,0,0
82567,by,0,0
82568,this,0,0
82569,approach,0,0
82570,.,0,0
82571,As,0,0
82572,expected,0,0
82573,",",0,0
82574,steady-state,0,0
82575,insulin,0,1
82576,levels,0,0
82577,were,0,0
82578,approximately,0,0
82579,threefold,0,0
82580,higher,0,0
82581,in,0,0
82582,obese,0,0
82583,than,0,0
82584,lean,0,0
82585,subjects,0,0
82586,(,0,0
82587,109.2,0,0
82588,+/-,0,0
82589,10.2,0,0
82590,pmol/l,0,0
82591,vs.,0,0
82592,518.4,0,0
82593,+/-,0,0
82594,84.0,0,0
82595,",",0,0
82596,P,0,0
82597,=,0,0
82598,0.03,0,0
82599,),0,0
82600,.,0,0
82601,Despite,0,0
82602,this,0,0
82603,",",0,0
82604,the,0,0
82605,augmentation,0,0
82606,of,0,0
82607,insulin-mediated,0,1
82608,vasodilation,0,1
82609,by,0,1
82610,BQ-123,0,0
82611,was,0,0
82612,not,0,0
82613,different,0,0
82614,between,0,0
82615,groups,0,0
82616,.,0,0
82617,ET-1,0,0
82618,flux,0,0
82619,across,0,0
82620,the,0,0
82621,leg,0,0
82622,was,0,0
82623,not,0,0
82624,augmented,0,0
82625,by,0,0
82626,insulin,0,1
82627,alone,0,0
82628,but,0,0
82629,was,0,0
82630,increased,0,0
82631,with,0,0
82632,the,0,0
82633,addition,0,0
82634,of,0,0
82635,BQ-123,0,0
82636,to,0,1
82637,insulin,0,1
82638,(,0,0
82639,P,0,0
82640,=,0,0
82641,0.01,0,0
82642,BQ-123,0,0
82643,effect,0,0
82644,",",0,0
82645,P,0,0
82646,=,0,0
82647,not,0,0
82648,significant,0,0
82649,comparing,0,0
82650,groups,0,0
82651,),0,0
82652,.,0,1
82653,Endothelin,0,1
82654,antagonism,0,1
82655,augmented,0,1
82656,insulin-stimulated,0,1
82657,NO,0,1
82658,bioavailability,0,1
82659,and,0,1
82660,NOx,0,1
82661,flux,0,0
82662,",",0,0
82663,but,0,0
82664,not,0,0
82665,differently,0,0
82666,between,0,0
82667,groups,0,0
82668,and,0,0
82669,not,0,0
82670,proportional,0,0
82671,to,0,0
82672,hyperinsulinemia,0,1
82673,.,0,0
82674,These,0,0
82675,findings,0,0
82676,do,0,0
82677,not,0,0
82678,support,0,0
82679,the,0,0
82680,hypothesis,0,0
82681,that,0,0
82682,insulin,0,1
82683,resistance-associated,0,1
82684,hyperinsulinemia,0,1
82685,preferentially,0,0
82686,drives,0,0
82687,endothelin-mediated,0,0
82688,vasoconstriction,0,1
82689,.,0,0
82690,Phosphate,1,0
82691,binder,1,0
82692,impact,0,0
82693,on,0,0
82694,bone,0,0
82695,remodeling,0,0
82696,and,0,0
82697,coronary,0,0
82698,calcification,0,0
82699,--,0,0
82700,results,0,0
82701,from,0,0
82702,the,0,0
82703,BRiC,0,0
82704,study,0,0
82705,.,0,0
82706,BACKGROUND,0,0
82707,AND,0,1
82708,AIMS,0,1
82709,Calcium-containing,1,1
82710,phosphate,1,1
82711,binders,1,0
82712,have,0,0
82713,been,0,0
82714,shown,0,0
82715,to,0,0
82716,increase,0,0
82717,the,0,0
82718,progression,0,0
82719,of,0,0
82720,vascular,0,0
82721,calcification,0,0
82722,in,0,0
82723,hemodialysis,0,0
82724,patients,0,0
82725,.,0,0
82726,This,0,0
82727,is,0,0
82728,a,0,0
82729,prospective,0,0
82730,study,0,0
82731,that,0,0
82732,compares,0,0
82733,the,0,0
82734,effects,0,0
82735,of,0,0
82736,calcium,1,1
82737,acetate,1,1
82738,and,1,1
82739,sevelamer,1,1
82740,on,0,0
82741,coronary,0,1
82742,calcification,0,0
82743,(,0,1
82744,CAC,0,1
82745,),0,1
82746,and,0,0
82747,bone,0,0
82748,histology,0,0
82749,.,0,0
82750,METHODS,0,0
82751,101,0,0
82752,hemodialysis,0,0
82753,patients,0,0
82754,were,0,0
82755,randomized,0,0
82756,for,0,0
82757,each,0,0
82758,phosphate,1,1
82759,binder,1,1
82760,and,0,0
82761,submitted,0,0
82762,to,0,0
82763,multislice,1,0
82764,coronary,1,0
82765,tomographies,1,0
82766,and,1,0
82767,bone,1,0
82768,biopsies,1,0
82769,at,0,0
82770,entry,0,0
82771,and,0,0
82772,12,0,0
82773,months,0,0
82774,.,0,0
82775,RESULTS,0,0
82776,The,0,0
82777,71,0,0
82778,patients,0,0
82779,who,0,0
82780,concluded,0,0
82781,the,0,0
82782,study,0,0
82783,had,0,0
82784,similar,0,0
82785,baseline,0,0
82786,characteristics,0,0
82787,.,0,0
82788,On,0,0
82789,follow-up,0,0
82790,",",0,0
82791,the,0,0
82792,sevelamer,0,1
82793,group,0,0
82794,had,0,0
82795,higher,0,0
82796,levels,0,0
82797,of,0,0
82798,intact,0,0
82799,parathyroid,0,1
82800,hormone,0,1
82801,(,0,0
82802,498,0,0
82803,+/-,0,0
82804,352,0,0
82805,vs.,0,0
82806,326,0,0
82807,+/-,0,0
82808,236,0,0
82809,pg/ml,0,0
82810,",",0,0
82811,p,0,0
82812,=,0,0
82813,0.017,0,0
82814,),0,0
82815,",",0,0
82816,bone,0,0
82817,alkaline,0,0
82818,phosphatase,0,1
82819,(,0,0
82820,38,0,0
82821,+/-,0,0
82822,24,0,0
82823,vs.,0,0
82824,28,0,0
82825,+/-,0,0
82826,15,0,0
82827,U/l,0,0
82828,",",0,0
82829,p,0,0
82830,=,0,0
82831,0.03,0,0
82832,),0,0
82833,and,0,0
82834,deoxypyridinoline,0,1
82835,(,0,0
82836,135,0,0
82837,+/-,0,0
82838,107,0,0
82839,vs.,0,0
82840,89,0,0
82841,+/-,0,0
82842,71,0,0
82843,nmol/l,0,0
82844,",",0,0
82845,p,0,0
82846,=,0,0
82847,0.03,0,0
82848,),0,0
82849,and,0,0
82850,lower,0,0
82851,LDL,0,1
82852,cholesterol,0,1
82853,(,0,0
82854,74,0,0
82855,+/-,0,0
82856,21,0,0
82857,vs.,0,0
82858,91,0,0
82859,+/-,0,0
82860,28,0,0
82861,mg/dl,0,0
82862,",",0,0
82863,p,0,0
82864,=,0,0
82865,0.015,0,0
82866,),0,0
82867,.,0,0
82868,Phosphorus,0,1
82869,(,0,0
82870,5.8,0,0
82871,+/-,0,0
82872,1.0,0,0
82873,vs.,0,0
82874,6,0,0
82875,+/-,0,0
82876,1.0,0,0
82877,mg/dl,0,0
82878,",",0,0
82879,p,0,0
82880,=,0,0
82881,0.47,0,0
82882,),0,0
82883,and,0,0
82884,calcium,0,1
82885,(,0,0
82886,1.27,0,0
82887,+/-,0,0
82888,0.07,0,0
82889,vs.,0,0
82890,1.23,0,0
82891,+/-,0,0
82892,0.08,0,0
82893,mmol/l,0,0
82894,",",0,0
82895,p,0,0
82896,=,0,0
82897,0.68,0,0
82898,),0,0
82899,levels,0,0
82900,did,0,0
82901,not,0,0
82902,differ,0,0
82903,between,0,0
82904,groups,0,0
82905,.,0,0
82906,CAC,0,1
82907,progression,0,0
82908,(,0,0
82909,35,0,0
82910,vs.,0,0
82911,24,0,0
82912,%,0,0
82913,",",0,0
82914,p,0,0
82915,=,0,0
82916,0.94,0,0
82917,),0,0
82918,and,0,0
82919,bone,0,1
82920,histological,0,0
82921,diagnosis,0,0
82922,at,0,0
82923,baseline,0,0
82924,and,0,0
82925,12,0,0
82926,months,0,0
82927,were,0,0
82928,similar,0,0
82929,in,0,0
82930,both,0,0
82931,groups,0,0
82932,.,0,0
82933,Patients,0,0
82934,of,0,0
82935,the,0,0
82936,sevelamer,0,1
82937,group,0,0
82938,with,0,0
82939,a,0,0
82940,high,0,0
82941,turnover,0,0
82942,at,0,0
82943,baseline,0,0
82944,had,0,0
82945,an,0,0
82946,increase,0,0
82947,in,0,0
82948,bone,0,0
82949,resorption,0,1
82950,(,0,0
82951,eroded,0,0
82952,surface,0,0
82953,",",0,0
82954,ES/BS,0,0
82955,=,0,0
82956,9.0,0,0
82957,+/-,0,0
82958,5.9,0,0
82959,vs.,0,0
82960,13.1,0,0
82961,+/-,0,0
82962,9.5,0,0
82963,%,0,0
82964,",",0,0
82965,p,0,0
82966,=,0,0
82967,0.05,0,0
82968,),0,0
82969,",",0,0
82970,whereas,0,0
82971,patients,0,0
82972,of,0,0
82973,both,0,0
82974,groups,0,0
82975,with,0,0
82976,low,0,0
82977,turnover,0,0
82978,at,0,0
82979,baseline,0,0
82980,had,0,0
82981,an,0,0
82982,improvement,0,0
82983,in,0,0
82984,bone,0,0
82985,formation,0,0
82986,rate,0,0
82987,(,0,0
82988,BFR/BS,0,0
82989,=,0,0
82990,0.015,0,0
82991,+/-,0,0
82992,0.016,0,0
82993,vs.,0,0
82994,0.062,0,0
82995,+/-,0,0
82996,0.078,0,0
82997,",",0,0
82998,p,0,0
82999,=,0,0
83000,0.003,0,0
83001,for,0,0
83002,calcium,0,0
83003,and,0,0
83004,0.017,0,0
83005,+/-,0,0
83006,0.016,0,0
83007,vs.,0,0
83008,0.071,0,0
83009,+/-,0,0
83010,0.084,0,0
83011,microm,0,0
83012,(,0,0
83013,3,0,0
83014,),0,0
83015,/microm,0,0
83016,(,0,0
83017,2,0,0
83018,),0,1
83019,/day,0,1
83020,",",0,0
83021,p,0,0
83022,=,0,0
83023,0.010,0,0
83024,for,0,0
83025,sevelamer,0,1
83026,),0,1
83027,.,0,0
83028,CONCLUSIONS,0,0
83029,There,0,0
83030,was,0,0
83031,no,0,0
83032,difference,0,0
83033,in,0,0
83034,CAC,0,0
83035,progression,0,0
83036,or,0,0
83037,changes,0,0
83038,in,0,0
83039,bone,0,0
83040,remodeling,0,0
83041,between,0,0
83042,the,0,0
83043,calcium,0,1
83044,and,0,1
83045,the,0,1
83046,sevelamer,0,1
83047,groups,0,0
83048,.,0,0
83049,Impacts,0,0
83050,of,0,0
83051,a,0,0
83052,disease,1,0
83053,management,1,0
83054,program,1,0
83055,for,0,0
83056,dually,0,0
83057,eligible,0,0
83058,beneficiaries,0,0
83059,.,0,0
83060,The,0,0
83061,LifeMasters,1,0
83062,Supported,1,0
83063,SelfCare,1,0
83064,demonstration,1,0
83065,program,1,0
83066,provides,0,0
83067,disease,1,1
83068,management,1,1
83069,(,1,1
83070,DM,1,1
83071,),1,1
83072,services,1,0
83073,to,0,0
83074,Florida,0,0
83075,Medicare,0,0
83076,beneficiaries,0,0
83077,who,0,0
83078,are,0,0
83079,also,0,0
83080,enrolled,0,0
83081,in,0,0
83082,Medicaid,0,0
83083,and,0,0
83084,have,0,0
83085,congestive,0,0
83086,heart,0,1
83087,failure,0,1
83088,(,0,1
83089,CHF,0,1
83090,),0,1
83091,",",0,0
83092,diabetes,0,0
83093,",",0,0
83094,or,0,0
83095,coronary,0,0
83096,artery,0,1
83097,disease,0,1
83098,(,0,1
83099,CAD,0,1
83100,),0,1
83101,.,0,0
83102,The,0,0
83103,population-based,0,0
83104,program,0,0
83105,provides,0,0
83106,primarily,1,0
83107,telephonic,1,0
83108,patient,1,0
83109,education,1,0
83110,and,1,0
83111,monitoring,1,0
83112,services,1,0
83113,.,1,0
83114,Findings,0,0
83115,from,0,0
83116,the,0,0
83117,randomized,0,0
83118,",",0,0
83119,intent-to-treat,0,0
83120,design,0,0
83121,over,0,0
83122,the,0,0
83123,first,0,0
83124,18,0,0
83125,months,0,0
83126,of,0,0
83127,operations,0,0
83128,show,0,0
83129,virtually,0,0
83130,no,0,0
83131,overall,0,0
83132,impacts,0,0
83133,on,0,0
83134,hospital,0,0
83135,or,0,0
83136,emergency,0,1
83137,room,0,1
83138,(,0,1
83139,ER,0,1
83140,),0,0
83141,use,0,0
83142,",",0,0
83143,Medicare,0,0
83144,expenditures,0,0
83145,",",0,0
83146,quality,0,0
83147,of,0,0
83148,care,0,0
83149,",",0,0
83150,or,0,0
83151,prescription,0,1
83152,drug,0,1
83153,use,0,0
83154,for,0,0
83155,the,0,0
83156,"33,000",0,0
83157,enrollees,0,0
83158,.,0,0
83159,However,0,0
83160,",",0,0
83161,for,0,0
83162,beneficiaries,0,0
83163,with,0,1
83164,CHF,0,0
83165,who,0,0
83166,resided,0,0
83167,in,0,0
83168,high-cost,0,0
83169,South,0,0
83170,Florida,0,0
83171,counties,0,0
83172,",",0,0
83173,the,0,0
83174,program,0,0
83175,reduced,0,0
83176,Medicare,0,0
83177,expenditures,0,0
83178,by,0,0
83179,9.6,0,0
83180,percent,0,0
83181,.,0,0
83182,Acceptability,0,0
83183,of,0,0
83184,an,0,0
83185,Electronic,1,0
83186,Self-Report,1,0
83187,Assessment,1,0
83188,Program,1,0
83189,for,0,0
83190,patients,0,0
83191,with,0,0
83192,cancer,0,0
83193,.,0,0
83194,Eliciting,0,0
83195,symptom,0,0
83196,and,0,0
83197,quality,0,0
83198,of,0,0
83199,life,0,0
83200,information,0,0
83201,from,0,0
83202,patients,0,0
83203,is,0,0
83204,an,0,0
83205,important,0,0
83206,component,0,0
83207,of,0,0
83208,medical,0,0
83209,and,0,0
83210,nursing,0,0
83211,care,0,0
83212,processes,0,0
83213,.,0,0
83214,Traditionally,0,0
83215,",",0,0
83216,this,0,0
83217,information,0,0
83218,has,0,0
83219,been,0,0
83220,collected,0,0
83221,with,0,0
83222,paper,0,0
83223,and,0,0
83224,pencil,0,0
83225,.,0,0
83226,However,0,0
83227,",",0,0
83228,this,0,0
83229,approach,0,0
83230,presents,0,0
83231,several,0,0
83232,barriers,0,0
83233,",",0,0
83234,including,0,0
83235,delays,0,0
83236,in,0,0
83237,receiving,0,0
83238,information,0,0
83239,",",0,0
83240,difficulty,0,0
83241,in,0,0
83242,integrating,0,0
83243,responses,0,0
83244,with,0,0
83245,electronic,0,0
83246,records,0,0
83247,",",0,0
83248,and,0,0
83249,the,0,0
83250,time,0,0
83251,required,0,0
83252,to,0,0
83253,manually,0,0
83254,score,0,0
83255,questionnaires,0,0
83256,for,0,0
83257,measurement,0,0
83258,purposes,0,0
83259,.,0,0
83260,One,0,0
83261,solution,0,0
83262,that,0,0
83263,addresses,0,0
83264,many,0,0
83265,of,0,0
83266,these,0,0
83267,barriers,0,0
83268,is,0,0
83269,the,0,0
83270,adoption,1,0
83271,of,1,0
83272,computerized,1,0
83273,screening,1,0
83274,for,1,0
83275,symptom,1,0
83276,and,1,0
83277,quality-of-life,1,0
83278,information,1,0
83279,.,1,0
83280,This,0,0
83281,research,0,0
83282,explored,0,0
83283,the,0,0
83284,acceptability,0,0
83285,of,0,0
83286,asking,0,0
83287,symptom,0,0
83288,and,0,0
83289,quality-of-life,0,0
83290,questions,0,0
83291,using,1,0
83292,the,1,0
83293,Electronic,1,0
83294,Self,1,1
83295,Report,1,1
83296,Assessment-Cancer,1,0
83297,program,1,0
83298,on,1,0
83299,wireless,1,0
83300,laptops,1,0
83301,equipped,1,0
83302,with,1,0
83303,touch-screen,1,0
83304,format,1,0
83305,.,1,0
83306,Acceptability,0,0
83307,data,0,0
83308,were,0,0
83309,explored,0,0
83310,with,0,0
83311,respect,0,0
83312,to,0,0
83313,whether,0,0
83314,any,0,0
83315,differences,0,0
83316,may,0,0
83317,be,0,0
83318,attributed,0,0
83319,to,0,0
83320,demographics,0,0
83321,and,0,0
83322,symptom,0,0
83323,and,0,0
83324,quality-of-life,0,0
83325,levels,0,0
83326,",",0,0
83327,such,0,0
83328,as,0,0
83329,depression,0,0
83330,and,0,0
83331,cognitive,0,0
83332,and,0,0
83333,emotional,0,0
83334,functioning,0,0
83335,.,0,0
83336,This,0,0
83337,evaluation,0,0
83338,used,0,0
83339,descriptive,0,0
83340,and,0,0
83341,univariate,0,0
83342,statistics,0,0
83343,to,0,0
83344,examine,0,0
83345,data,0,0
83346,from,0,0
83347,342,0,0
83348,participants,0,0
83349,from,0,0
83350,the,0,0
83351,ongoing,0,0
83352,ESRA-C,1,1
83353,randomized,0,1
83354,clinical,0,0
83355,trial,0,0
83356,.,0,0
83357,Research,0,0
83358,participants,0,0
83359,for,0,0
83360,the,0,0
83361,ESRA-C,1,0
83362,study,0,0
83363,were,0,0
83364,recruited,0,0
83365,from,0,0
83366,the,0,0
83367,Seattle,0,0
83368,Cancer,0,0
83369,Care,0,0
83370,Alliance,0,0
83371,",",0,0
83372,a,0,0
83373,consortium,0,0
83374,among,0,0
83375,the,0,0
83376,University,0,0
83377,of,0,0
83378,Washington,0,0
83379,Medical,0,0
83380,Center,0,0
83381,",",0,0
83382,Fred,0,0
83383,Hutchinson,0,0
83384,Cancer,0,0
83385,Research,0,0
83386,Center,0,0
83387,",",0,0
83388,and,0,0
83389,Children,0,0
83390,'s,0,0
83391,Hospital,0,0
83392,and,0,0
83393,Regional,0,0
83394,Medical,0,0
83395,Center,0,0
83396,in,0,0
83397,Seattle,0,0
83398,",",0,0
83399,WA,0,0
83400,.,0,0
83401,The,0,0
83402,sample,0,0
83403,consisted,0,0
83404,of,0,0
83405,342,0,0
83406,adult,0,0
83407,participants,0,0
83408,who,0,0
83409,completed,0,0
83410,both,0,0
83411,baseline,0,0
83412,and,0,0
83413,follow-up,0,0
83414,survey,0,0
83415,sessions,0,0
83416,.,0,0
83417,Medical,0,0
83418,oncology,0,0
83419,represented,0,0
83420,the,0,0
83421,largest,0,0
83422,recruitment,0,0
83423,group,0,0
83424,(,0,0
83425,45.3,0,0
83426,%,0,0
83427,),0,0
83428,",",0,0
83429,followed,0,0
83430,by,0,0
83431,stem,0,0
83432,cell,0,0
83433,transplant,0,0
83434,(,0,0
83435,34.5,0,0
83436,%,0,0
83437,),0,0
83438,and,0,0
83439,radiation,0,0
83440,oncology,0,0
83441,(,0,0
83442,20.2,0,0
83443,%,0,0
83444,),0,0
83445,.,0,0
83446,The,0,0
83447,primary,0,0
83448,finding,0,0
83449,was,0,0
83450,that,0,0
83451,patients,0,0
83452,were,0,0
83453,generally,0,0
83454,able,0,0
83455,to,0,0
83456,use,0,0
83457,ESRA-C,1,0
83458,quickly,0,0
83459,and,0,0
83460,without,0,0
83461,difficulty,0,0
83462,in,0,0
83463,a,0,0
83464,real-world,0,0
83465,clinical,0,0
83466,setting,0,0
83467,and,0,0
83468,that,0,0
83469,they,0,0
83470,were,0,0
83471,overall,0,0
83472,quite,0,0
83473,satisfied,0,0
83474,with,0,0
83475,the,0,0
83476,ESRA-C,1,0
83477,program,1,0
83478,.,1,0
83479,Significant,0,0
83480,differences,0,0
83481,were,0,0
83482,found,0,0
83483,in,0,0
83484,several,0,0
83485,acceptability,0,0
83486,areas,0,0
83487,with,0,0
83488,respect,0,0
83489,to,0,0
83490,demographics,0,0
83491,and,0,0
83492,quality,0,0
83493,of,0,0
83494,life,0,0
83495,measures,0,0
83496,such,0,0
83497,as,0,0
83498,age,0,0
83499,",",0,0
83500,sex,0,0
83501,",",0,0
83502,and,0,0
83503,severe,0,0
83504,distress,0,0
83505,.,0,0
83506,This,0,0
83507,analysis,0,0
83508,confirms,0,0
83509,that,0,0
83510,the,0,0
83511,ESRA-C,1,0
83512,application,1,0
83513,for,1,0
83514,collecting,1,0
83515,symptom,1,0
83516,and,1,0
83517,quality,1,0
83518,of,1,0
83519,life,1,0
83520,information,1,0
83521,is,0,0
83522,easy,0,0
83523,for,0,0
83524,patients,0,0
83525,to,0,0
83526,use,0,0
83527,and,0,0
83528,acceptable,0,0
83529,across,0,0
83530,a,0,0
83531,range,0,0
83532,of,0,0
83533,user,0,0
83534,characteristics,0,0
83535,.,0,0
83536,We,0,0
83537,intend,0,0
83538,to,0,0
83539,build,0,0
83540,on,0,0
83541,our,0,0
83542,work,0,0
83543,by,0,0
83544,using,0,0
83545,the,0,0
83546,survey,0,0
83547,platform,0,0
83548,in,0,0
83549,other,0,0
83550,modalities,0,0
83551,while,0,0
83552,ensuring,0,0
83553,that,0,0
83554,the,0,0
83555,patient,0,0
83556,'s,0,0
83557,preferences,0,0
83558,are,0,0
83559,considered,0,0
83560,at,0,0
83561,all,0,0
83562,times,0,0
83563,.,0,0
83564,Pre-operative,1,0
83565,radiochemotherapy,1,0
83566,for,0,0
83567,rectal,0,0
83568,cancer,0,0
83569,.,0,0
83570,A,0,0
83571,prospective,0,0
83572,randomized,0,0
83573,trial,0,0
83574,comparing,0,0
83575,pre-operative,1,0
83576,vs.,1,0
83577,postoperative,1,0
83578,radiochemotherapy,1,0
83579,in,0,0
83580,rectal,0,0
83581,cancer,0,0
83582,patients,0,0
83583,.,0,0
83584,PURPOSE,0,0
83585,The,0,0
83586,aim,0,0
83587,of,0,0
83588,the,0,0
83589,study,0,0
83590,was,0,0
83591,to,0,0
83592,find,0,0
83593,out,0,0
83594,whether,0,0
83595,pre-operative,1,0
83596,radiochemotherapy,1,0
83597,had,0,0
83598,any,0,0
83599,survival,0,0
83600,advantage,0,0
83601,over,0,0
83602,postoperative,1,0
83603,radiochemotherapy,1,0
83604,for,0,0
83605,rectal,0,0
83606,carcinoma,0,0
83607,patients,0,0
83608,without,0,0
83609,distant,0,0
83610,metastasis,0,0
83611,or,0,0
83612,peritoneal,0,0
83613,carcinomatosis,0,0
83614,.,0,0
83615,MATERIAL,0,0
83616,AND,0,1
83617,METHODS,0,1
83618,Between,0,1
83619,January,0,0
83620,1998,0,0
83621,and,0,0
83622,December,0,0
83623,2003,0,0
83624,",",0,0
83625,51,0,0
83626,rectal,0,0
83627,carcinoma,0,0
83628,patients,0,0
83629,without,0,0
83630,distant,0,0
83631,metastasis,0,0
83632,or,0,0
83633,peritoneal,0,0
83634,carcinomatosis,0,0
83635,were,0,0
83636,randomly,0,0
83637,divided,0,0
83638,into,0,0
83639,pre-operative,1,1
83640,(,1,1
83641,PRE,1,1
83642,),1,1
83643,and,0,0
83644,postoperative,1,1
83645,(,1,1
83646,POST,1,1
83647,),1,1
83648,radiochemotherapy,1,1
83649,groups,0,0
83650,.,0,0
83651,Twenty-six,0,0
83652,were,0,0
83653,assigned,0,0
83654,to,0,0
83655,the,0,0
83656,PRE,0,0
83657,group,0,0
83658,and,0,0
83659,were,0,0
83660,operated,0,0
83661,on,0,0
83662,5,0,0
83663,to,0,0
83664,8,0,0
83665,weeks,0,0
83666,after,0,0
83667,the,0,0
83668,completion,0,0
83669,of,0,0
83670,radiotherapy,1,0
83671,.,1,0
83672,The,0,0
83673,other,0,0
83674,25,0,0
83675,patients,0,0
83676,were,0,0
83677,operated,0,0
83678,on,0,0
83679,immediately,0,0
83680,and,0,0
83681,received,0,0
83682,radiotherapy,0,0
83683,postoperatively,0,0
83684,2,0,0
83685,to,0,0
83686,4,0,0
83687,weeks,0,0
83688,after,0,0
83689,surgery,0,0
83690,.,0,0
83691,The,0,0
83692,patients,0,0
83693,were,0,0
83694,followed,0,0
83695,up,0,0
83696,for,0,0
83697,between,0,0
83698,4,0,0
83699,to,0,0
83700,51,0,0
83701,months,0,0
83702,.,0,0
83703,RESULTS,0,0
83704,In,0,0
83705,the,0,0
83706,PRE,0,0
83707,group,0,0
83708,the,0,0
83709,rates,0,0
83710,of,0,0
83711,disease-free,0,0
83712,survival,0,0
83713,were,0,0
83714,92,0,0
83715,%,0,0
83716,",",0,0
83717,70,0,0
83718,%,0,0
83719,",",0,0
83720,56,0,0
83721,%,0,0
83722,and,0,0
83723,56,0,0
83724,%,0,0
83725,at,0,0
83726,the,0,0
83727,end,0,0
83728,of,0,0
83729,the,0,0
83730,1st,0,0
83731,",",0,0
83732,2nd,0,0
83733,",",0,0
83734,3rd,0,0
83735,and,0,0
83736,4th,0,0
83737,years,0,0
83738,",",0,0
83739,respectively,0,0
83740,.,0,0
83741,In,0,0
83742,the,0,0
83743,POST,0,0
83744,group,0,0
83745,those,0,0
83746,percentages,0,0
83747,were,0,0
83748,83,0,0
83749,%,0,0
83750,",",0,0
83751,68,0,0
83752,%,0,0
83753,",",0,0
83754,51,0,0
83755,%,0,0
83756,and,0,0
83757,51,0,0
83758,%,0,0
83759,at,0,0
83760,the,0,0
83761,1st,0,0
83762,",",0,0
83763,2nd,0,0
83764,",",0,0
83765,3rd,0,0
83766,and,0,0
83767,4th,0,0
83768,years,0,0
83769,",",0,0
83770,respectively,0,0
83771,(,0,0
83772,p,0,0
83773,=,0,0
83774,0.707,0,0
83775,),0,0
83776,.,0,0
83777,One-year,0,0
83778,and,0,0
83779,4-year,0,0
83780,overall,0,0
83781,survival,0,0
83782,rates,0,0
83783,in,0,0
83784,the,0,0
83785,PRE,0,0
83786,group,0,0
83787,were,0,0
83788,100,0,0
83789,%,0,0
83790,and,0,0
83791,86,0,0
83792,%,0,0
83793,respectively,0,0
83794,and,0,0
83795,100,0,0
83796,%,0,0
83797,and,0,0
83798,60,0,0
83799,%,0,0
83800,in,0,0
83801,the,0,0
83802,POST,0,1
83803,group,0,0
83804,(,0,0
83805,p,0,0
83806,=,0,0
83807,0.520,0,0
83808,),0,0
83809,.,0,0
83810,CONCLUSION,0,1
83811,No,0,1
83812,statistical,0,1
83813,difference,0,0
83814,was,0,0
83815,found,0,0
83816,between,0,0
83817,the,0,0
83818,survival,0,0
83819,rates,0,0
83820,of,0,0
83821,the,0,0
83822,rectal,0,0
83823,carcinoma,0,0
83824,patients,0,0
83825,receiving,0,0
83826,radiotherapy,0,0
83827,either,0,0
83828,pre-operatively,0,0
83829,or,0,0
83830,postoperatively,0,0
83831,.,0,0
83832,However,0,0
83833,",",0,0
83834,the,0,0
83835,disease-free,0,0
83836,survival,0,0
83837,rates,0,0
83838,of,0,0
83839,the,0,0
83840,PRE,1,0
83841,group,0,0
83842,were,0,0
83843,higher,0,0
83844,than,0,0
83845,the,0,0
83846,POST,1,1
83847,group,0,0
83848,'s,0,0
83849,during,0,0
83850,each,0,0
83851,year,0,0
83852,and,0,0
83853,overall,0,0
83854,survival,0,0
83855,rates,0,0
83856,were,0,0
83857,higher,0,0
83858,after,0,0
83859,the,0,0
83860,third,0,0
83861,and,0,0
83862,fourth,0,0
83863,years,0,0
83864,.,0,0
83865,We,0,0
83866,conclude,0,0
83867,that,0,0
83868,pre-operative,1,0
83869,radiotherapy,1,0
83870,is,0,0
83871,at,0,0
83872,least,0,0
83873,as,0,0
83874,effective,0,0
83875,as,0,0
83876,postoperative,1,0
83877,radiotherapy,1,0
83878,.,1,0
83879,Effect,0,0
83880,of,0,0
83881,diltiazem,1,1
83882,on,0,0
83883,symptomatic,0,0
83884,and,0,0
83885,asymptomatic,0,0
83886,episodes,0,0
83887,of,0,0
83888,ST,0,0
83889,segment,0,0
83890,depression,0,0
83891,occurring,0,0
83892,during,0,0
83893,daily,0,1
83894,life,0,1
83895,and,0,0
83896,during,0,0
83897,exercise,0,0
83898,.,0,0
83899,BACKGROUND,0,0
83900,Silent,0,0
83901,myocardial,0,0
83902,ischemia,0,0
83903,is,0,0
83904,an,0,0
83905,adverse,0,0
83906,prognostic,0,0
83907,marker,0,0
83908,in,0,0
83909,patients,0,0
83910,with,0,0
83911,coronary,0,0
83912,disease,0,1
83913,;,0,0
83914,however,0,0
83915,",",0,0
83916,controlled,0,0
83917,data,0,0
83918,on,0,0
83919,the,0,0
83920,effect,0,0
83921,of,0,0
83922,treatment,0,0
83923,are,0,0
83924,sparse,0,0
83925,and,0,0
83926,contradictory,0,0
83927,",",0,0
83928,and,0,0
83929,the,0,0
83930,relations,0,0
83931,among,0,0
83932,the,0,0
83933,occurrence,0,0
83934,of,0,0
83935,ST,0,0
83936,segment,0,0
83937,depression,0,0
83938,",",0,0
83939,drug,0,1
83940,efficacy,0,1
83941,",",0,0
83942,and,0,0
83943,heart,0,0
83944,rate,0,0
83945,are,0,0
83946,unclear,0,0
83947,.,0,0
83948,METHODS,0,0
83949,AND,0,1
83950,RESULTS,0,1
83951,Sixty,0,0
83952,patients,0,0
83953,with,0,0
83954,stable,0,0
83955,coronary,0,0
83956,artery,0,0
83957,disease,0,0
83958,",",0,0
83959,a,0,0
83960,positive,0,0
83961,treadmill,0,0
83962,exercise,0,0
83963,test,0,0
83964,and,0,0
83965,asymptomatic,0,0
83966,ST,0,0
83967,segment,0,0
83968,depression,0,0
83969,on,0,0
83970,ambulatory,0,0
83971,electrocardiographic,0,0
83972,recording,0,0
83973,were,0,0
83974,assessed,0,0
83975,in,0,0
83976,a,0,0
83977,multicenter,0,0
83978,",",0,0
83979,double-blind,0,1
83980,",",0,1
83981,placebo-controlled,1,1
83982,",",0,1
83983,cross-over,0,1
83984,trial,0,1
83985,.,0,0
83986,Treadmill,1,0
83987,exercise,1,0
83988,tests,0,1
83989,and,0,1
83990,72-hour,0,1
83991,electrocardiographic,0,1
83992,recordings,0,0
83993,were,0,0
83994,obtained,0,0
83995,at,0,0
83996,the,0,0
83997,end,0,0
83998,of,0,0
83999,two,0,0
84000,2-week,0,1
84001,treatment,0,1
84002,periods,0,1
84003,with,0,1
84004,sustained-release,1,1
84005,diltiazem,1,1
84006,180,0,1
84007,mg,0,1
84008,b.i.d,0,1
84009,.,0,1
84010,or,0,0
84011,equivalent,0,0
84012,placebo,1,1
84013,.,1,0
84014,Episodes,0,0
84015,of,0,0
84016,asymptomatic,0,0
84017,ST,0,0
84018,depression,0,0
84019,decreased,0,0
84020,by,0,0
84021,50,0,0
84022,%,0,0
84023,or,0,0
84024,more,0,0
84025,in,0,0
84026,70,0,0
84027,%,0,0
84028,of,0,0
84029,the,0,0
84030,patients,0,0
84031,from,0,0
84032,a,0,0
84033,median,0,0
84034,number,0,0
84035,of,0,0
84036,4.5,0,0
84037,(,0,0
84038,range,0,0
84039,",",0,0
84040,0-19,0,0
84041,),0,0
84042,to,0,0
84043,1.5,0,0
84044,(,0,0
84045,range,0,0
84046,",",0,0
84047,0-13,0,0
84048,),0,0
84049,(,0,0
84050,p,0,0
84051,=,0,0
84052,0.0001,0,0
84053,),0,0
84054,;,0,0
84055,their,0,0
84056,cumulative,0,0
84057,duration,0,0
84058,also,0,0
84059,decreased,0,0
84060,from,0,0
84061,78.5,0,0
84062,(,0,0
84063,range,0,0
84064,",",0,0
84065,0-60,0,0
84066,),0,0
84067,to,0,0
84068,24.5,0,0
84069,(,0,0
84070,range,0,0
84071,",",0,0
84072,0-411,0,0
84073,),0,0
84074,minutes,0,0
84075,(,0,0
84076,p,0,0
84077,=,0,0
84078,0.001,0,0
84079,),0,0
84080,.,0,0
84081,No,0,1
84082,circadian,0,0
84083,variation,0,0
84084,was,0,0
84085,found,0,0
84086,in,0,0
84087,the,0,0
84088,efficacy,0,0
84089,of,0,0
84090,diltiazem,1,1
84091,.,1,0
84092,The,0,0
84093,occurrence,0,0
84094,of,0,0
84095,ischemic,0,0
84096,type,0,0
84097,ST,0,0
84098,segment,0,0
84099,depression,0,0
84100,was,0,0
84101,modulated,0,0
84102,by,0,0
84103,changes,0,0
84104,in,0,0
84105,heart,0,0
84106,rate,0,0
84107,rather,0,0
84108,than,0,0
84109,by,0,0
84110,absolute,0,0
84111,heart,0,0
84112,rate,0,0
84113,.,0,0
84114,Diltiazem,1,1
84115,also,0,0
84116,improved,0,0
84117,exercise,0,0
84118,test,0,0
84119,end,0,0
84120,points,0,0
84121,but,0,0
84122,to,0,0
84123,a,0,0
84124,lesser,0,0
84125,extent,0,0
84126,.,0,0
84127,Time,0,0
84128,to,0,0
84129,ST,0,0
84130,segment,0,0
84131,depression,0,0
84132,increased,0,0
84133,to,0,0
84134,341,0,0
84135,+/-,0,0
84136,148,0,0
84137,from,0,0
84138,296,0,0
84139,+/-,0,0
84140,154,0,0
84141,seconds,0,0
84142,(,0,0
84143,p,0,0
84144,=,0,0
84145,0.005,0,0
84146,),0,0
84147,.,0,0
84148,Although,0,0
84149,less,0,0
84150,frequent,0,0
84151,with,0,1
84152,diltiazem,1,1
84153,administration,0,1
84154,(,0,1
84155,45,0,0
84156,versus,0,0
84157,54,0,0
84158,patients,0,0
84159,",",0,0
84160,p,0,0
84161,less,0,0
84162,than,0,0
84163,0.03,0,0
84164,),0,0
84165,",",0,0
84166,exercise-induced,0,1
84167,ST,0,1
84168,depression,0,0
84169,was,0,0
84170,more,0,0
84171,often,0,0
84172,asymptomatic,0,0
84173,(,0,0
84174,98,0,0
84175,%,0,0
84176,versus,0,0
84177,72,0,0
84178,%,0,0
84179,of,0,0
84180,patients,0,0
84181,",",0,0
84182,p,0,0
84183,less,0,0
84184,than,0,0
84185,0.0001,0,0
84186,),0,0
84187,.,0,0
84188,CONCLUSIONS,0,1
84189,Diltiazem,1,1
84190,reduces,0,0
84191,the,0,0
84192,frequency,0,0
84193,and,0,0
84194,severity,0,0
84195,of,0,0
84196,ischemic,0,0
84197,type,0,0
84198,ST,0,0
84199,depression,0,0
84200,in,0,0
84201,patients,0,0
84202,with,0,0
84203,stable,0,0
84204,coronary,0,0
84205,artery,0,0
84206,disease,0,0
84207,.,0,0
84208,Recombinant,1,0
84209,human,1,0
84210,granulocyte-macrophage,1,1
84211,colony,1,0
84212,stimulating,1,0
84213,factor,1,0
84214,(,1,0
84215,rhGM-CSF,1,1
84216,),1,1
84217,reduces,0,0
84218,infection-related,0,0
84219,mortality,0,0
84220,after,0,0
84221,allogeneic,0,0
84222,T-cell,0,0
84223,depleted,0,0
84224,BMT,0,0
84225,.,0,0
84226,Two,0,1
84227,different,0,0
84228,methods,0,0
84229,for,0,0
84230,donor,0,0
84231,hepatic,0,0
84232,transection,0,0
84233,:,0,0
84234,cavitron,1,0
84235,ultrasonic,1,0
84236,surgical,1,0
84237,aspirator,1,0
84238,with,1,0
84239,bipolar,1,0
84240,cautery,1,0
84241,versus,0,0
84242,cavitron,1,0
84243,ultrasonic,1,1
84244,surgical,1,0
84245,aspirator,1,0
84246,with,1,0
84247,radiofrequency,1,0
84248,coagulator-A,1,0
84249,randomized,0,0
84250,controlled,0,0
84251,trial,0,0
84252,.,0,0
84253,The,0,0
84254,aim,0,0
84255,of,0,0
84256,this,0,0
84257,study,0,0
84258,was,0,0
84259,to,0,0
84260,compare,0,0
84261,the,0,0
84262,Cavitron,1,0
84263,ultrasonic,1,0
84264,surgical,1,1
84265,aspirator,1,1
84266,(,1,1
84267,CUSA,1,1
84268,),1,1
84269,with,1,0
84270,bipolar,1,1
84271,cautery,1,1
84272,(,1,1
84273,BP,1,1
84274,),1,1
84275,to,1,0
84276,CUSA,1,0
84277,with,1,0
84278,a,1,0
84279,radiofrequency,1,0
84280,coagulator,1,1
84281,[,0,1
84282,TissueLink,0,1
84283,(,0,1
84284,TL,0,1
84285,),0,1
84286,],0,0
84287,in,0,0
84288,terms,0,0
84289,of,0,0
84290,efficacy,0,0
84291,and,0,0
84292,safety,0,0
84293,for,0,0
84294,hepatic,0,0
84295,transection,0,0
84296,in,0,0
84297,living,0,0
84298,donor,0,0
84299,liver,0,0
84300,transplantation,0,0
84301,.,0,0
84302,Twenty-four,0,0
84303,living,0,0
84304,liver,0,0
84305,donors,0,0
84306,(,0,0
84307,n,0,0
84308,=,0,0
84309,12,0,0
84310,for,0,0
84311,each,0,0
84312,group,0,0
84313,),0,0
84314,were,0,0
84315,randomized,0,0
84316,to,0,0
84317,undergo,0,0
84318,hepatic,0,0
84319,transection,0,0
84320,using,0,0
84321,CUSA,1,0
84322,with,1,0
84323,BP,1,0
84324,or,0,0
84325,CUSA,1,0
84326,with,1,0
84327,TL,1,0
84328,.,1,0
84329,Blood,0,0
84330,loss,0,0
84331,during,0,0
84332,parenchymal,0,0
84333,transection,0,0
84334,and,0,0
84335,speed,0,0
84336,of,0,0
84337,transection,0,0
84338,were,0,0
84339,the,0,0
84340,primary,0,0
84341,endpoints,0,0
84342,",",0,0
84343,whereas,0,0
84344,the,0,0
84345,degree,0,0
84346,of,0,0
84347,postoperative,0,0
84348,liver,0,0
84349,injury,0,0
84350,and,0,0
84351,morbidity,0,0
84352,were,0,0
84353,secondary,0,0
84354,endpoints,0,0
84355,.,0,0
84356,Median,0,0
84357,blood,0,0
84358,loss,0,0
84359,during,0,0
84360,liver,0,0
84361,transection,0,0
84362,was,0,0
84363,significantly,0,0
84364,lower,0,0
84365,in,0,0
84366,the,0,0
84367,TL,0,1
84368,group,0,0
84369,than,0,0
84370,in,0,0
84371,the,0,0
84372,BP,0,1
84373,group,0,0
84374,(,0,0
84375,195.2,0,0
84376,+/-,0,0
84377,84.5,0,0
84378,versus,0,0
84379,343.3,0,0
84380,+/-,0,0
84381,198.4,0,0
84382,mL,0,0
84383,;,0,0
84384,P,0,0
84385,=,0,0
84386,0.023,0,0
84387,),0,0
84388,",",0,0
84389,and,0,0
84390,liver,0,0
84391,transection,0,0
84392,was,0,0
84393,significantly,0,0
84394,faster,0,0
84395,in,0,0
84396,the,0,0
84397,TL,0,1
84398,group,0,0
84399,than,0,0
84400,in,0,0
84401,the,0,0
84402,BP,0,1
84403,group,0,0
84404,(,0,0
84405,0.7,0,0
84406,+/-,0,0
84407,0.2,0,0
84408,versus,0,0
84409,0.5,0,0
84410,+/-,0,0
84411,0.2,0,0
84412,cm,0,0
84413,(,0,0
84414,2,0,1
84415,),0,0
84416,/minute,0,0
84417,;,0,0
84418,P,0,0
84419,=,0,0
84420,0.048,0,0
84421,),0,0
84422,.,0,0
84423,Significantly,0,0
84424,fewer,0,0
84425,ties,0,0
84426,were,0,0
84427,required,0,0
84428,during,0,0
84429,liver,0,0
84430,transection,0,0
84431,in,0,0
84432,the,0,0
84433,TL,0,1
84434,group,0,0
84435,than,0,0
84436,in,0,0
84437,the,0,0
84438,BP,0,1
84439,group,0,0
84440,(,0,0
84441,15.8,0,0
84442,+/-,0,0
84443,4.8,0,0
84444,versus,0,0
84445,22.8,0,0
84446,+/-,0,0
84447,7.9,0,0
84448,ties,0,0
84449,;,0,0
84450,P,0,0
84451,=,0,0
84452,0.023,0,0
84453,),0,0
84454,.,0,0
84455,The,0,0
84456,morbidity,0,0
84457,rates,0,0
84458,were,0,0
84459,similar,0,0
84460,for,0,0
84461,the,0,0
84462,2,0,0
84463,groups,0,0
84464,.,0,0
84465,In,0,0
84466,conclusion,0,0
84467,",",0,0
84468,CUSA,0,0
84469,with,0,0
84470,TL,0,0
84471,is,0,0
84472,superior,0,0
84473,to,0,0
84474,CUSA,0,0
84475,with,0,0
84476,BP,0,0
84477,for,0,0
84478,donor,0,0
84479,hepatectomy,0,0
84480,in,0,0
84481,terms,0,0
84482,of,0,0
84483,blood,0,0
84484,loss,0,0
84485,and,0,0
84486,speed,0,0
84487,of,0,0
84488,transection,0,0
84489,with,0,0
84490,no,0,0
84491,increase,0,0
84492,in,0,0
84493,morbidity,0,0
84494,.,0,0
84495,Recommendations,0,0
84496,for,0,0
84497,implementing,0,0
84498,stereotactic,1,0
84499,radiotherapy,1,0
84500,in,0,0
84501,peripheral,0,0
84502,stage,0,0
84503,IA,0,0
84504,non-small,0,0
84505,cell,0,0
84506,lung,0,0
84507,cancer,0,0
84508,:,0,0
84509,report,0,0
84510,from,0,0
84511,the,0,0
84512,Quality,0,0
84513,Assurance,0,0
84514,Working,0,0
84515,Party,0,0
84516,of,0,0
84517,the,0,0
84518,randomised,0,0
84519,phase,0,0
84520,III,0,0
84521,ROSEL,0,0
84522,study,0,0
84523,.,0,0
84524,BACKGROUND,0,0
84525,A,0,0
84526,phase,0,0
84527,III,0,1
84528,multi-centre,0,1
84529,randomised,0,1
84530,trial,0,1
84531,(,0,1
84532,ROSEL,0,1
84533,),0,0
84534,has,0,0
84535,been,0,0
84536,initiated,0,0
84537,to,0,0
84538,establish,0,0
84539,the,0,0
84540,role,0,0
84541,of,0,0
84542,stereotactic,1,0
84543,radiotherapy,1,0
84544,in,0,0
84545,patients,0,0
84546,with,0,0
84547,operable,0,0
84548,stage,0,0
84549,IA,0,0
84550,lung,0,0
84551,cancer,0,0
84552,.,0,0
84553,Due,0,0
84554,to,0,0
84555,rapid,0,0
84556,changes,0,0
84557,in,0,0
84558,radiotherapy,0,0
84559,technology,0,0
84560,and,0,0
84561,evolving,0,0
84562,techniques,0,0
84563,for,0,0
84564,image-guided,0,0
84565,delivery,0,0
84566,",",0,0
84567,guidelines,0,0
84568,had,0,0
84569,to,0,0
84570,be,0,0
84571,developed,0,0
84572,in,0,0
84573,order,0,0
84574,to,0,0
84575,ensure,0,0
84576,uniformity,0,0
84577,in,0,0
84578,implementation,0,0
84579,of,0,0
84580,stereotactic,1,0
84581,radiotherapy,1,0
84582,in,0,0
84583,this,0,0
84584,multi-centre,0,0
84585,study,0,0
84586,.,0,0
84587,METHODS/DESIGN,0,0
84588,A,0,1
84589,Quality,0,1
84590,Assurance,0,0
84591,Working,0,0
84592,Party,0,0
84593,was,0,0
84594,formed,0,0
84595,by,0,0
84596,radiation,0,0
84597,oncologists,0,0
84598,and,0,0
84599,clinical,0,0
84600,physicists,0,0
84601,from,0,0
84602,both,0,0
84603,academic,0,0
84604,as,0,0
84605,well,0,0
84606,as,0,0
84607,non-academic,0,0
84608,hospitals,0,0
84609,that,0,0
84610,had,0,0
84611,already,0,0
84612,implemented,0,0
84613,stereotactic,1,0
84614,radiotherapy,1,0
84615,for,0,0
84616,lung,0,0
84617,cancer,0,0
84618,.,0,0
84619,A,0,0
84620,literature,1,0
84621,survey,1,0
84622,was,0,0
84623,conducted,0,0
84624,and,0,0
84625,consensus,0,0
84626,meetings,0,0
84627,were,0,0
84628,held,0,0
84629,in,0,0
84630,which,0,0
84631,both,0,0
84632,the,0,0
84633,knowledge,0,0
84634,from,0,0
84635,the,0,0
84636,literature,0,0
84637,and,0,0
84638,clinical,0,0
84639,experience,0,0
84640,were,0,0
84641,pooled,0,0
84642,.,0,0
84643,In,0,0
84644,addition,0,0
84645,",",0,0
84646,a,0,0
84647,planning,0,0
84648,study,0,0
84649,was,0,0
84650,performed,0,0
84651,in,0,0
84652,26,0,0
84653,stage,0,0
84654,I,0,0
84655,patients,0,0
84656,",",0,0
84657,of,0,0
84658,which,0,0
84659,22,0,0
84660,were,0,0
84661,stage,0,0
84662,1A,0,0
84663,",",0,0
84664,in,0,0
84665,order,0,0
84666,to,0,0
84667,develop,0,0
84668,and,0,0
84669,evaluate,0,0
84670,the,0,0
84671,planning,0,0
84672,guidelines,0,0
84673,.,0,0
84674,Plans,0,0
84675,were,0,0
84676,optimised,0,0
84677,according,0,0
84678,to,0,0
84679,parameters,0,0
84680,adopted,0,0
84681,from,0,0
84682,RTOG,0,0
84683,trials,0,0
84684,using,0,0
84685,both,0,0
84686,an,0,0
84687,algorithm,0,0
84688,with,0,0
84689,a,0,0
84690,simple,0,0
84691,homogeneity,0,0
84692,correction,0,0
84693,(,0,0
84694,Type,0,1
84695,A,0,1
84696,),0,0
84697,and,0,0
84698,a,0,0
84699,more,0,0
84700,advanced,1,0
84701,algorithm,1,1
84702,(,0,1
84703,Type,0,1
84704,B,0,1
84705,),0,0
84706,.,0,0
84707,Dose,0,0
84708,conformity,0,0
84709,requirements,0,0
84710,were,0,0
84711,then,0,0
84712,formulated,0,0
84713,based,0,0
84714,on,0,0
84715,these,0,0
84716,results,0,0
84717,.,0,0
84718,CONCLUSION,0,0
84719,Based,0,0
84720,on,0,0
84721,current,0,0
84722,literature,0,0
84723,and,0,0
84724,expert,0,0
84725,experience,0,0
84726,",",0,0
84727,guidelines,0,0
84728,were,0,0
84729,formulated,0,0
84730,for,0,0
84731,this,0,0
84732,phase,0,0
84733,III,0,0
84734,study,0,0
84735,of,0,0
84736,stereotactic,1,0
84737,radiotherapy,1,1
84738,versus,1,0
84739,surgery,1,0
84740,.,1,0
84741,These,0,0
84742,guidelines,0,0
84743,can,0,0
84744,serve,0,0
84745,to,0,0
84746,facilitate,0,0
84747,the,0,0
84748,design,0,0
84749,of,0,0
84750,future,0,0
84751,multi-centre,0,0
84752,clinical,0,0
84753,trials,0,0
84754,of,0,0
84755,stereotactic,1,0
84756,radiotherapy,1,0
84757,in,0,0
84758,other,0,0
84759,patient,0,0
84760,groups,0,0
84761,and,0,0
84762,aid,0,0
84763,a,0,0
84764,more,0,0
84765,uniform,0,0
84766,implementation,0,0
84767,of,0,0
84768,this,0,0
84769,technique,0,0
84770,outside,0,0
84771,clinical,0,0
84772,trials,0,0
84773,.,0,0
84774,Adjuvant,0,1
84775,goserelin,0,1
84776,and,0,1
84777,ovarian,0,0
84778,preservation,0,0
84779,in,0,0
84780,chemotherapy,0,0
84781,treated,0,0
84782,patients,0,0
84783,with,0,0
84784,early,0,0
84785,breast,0,0
84786,cancer,0,0
84787,:,0,0
84788,results,0,0
84789,from,0,0
84790,a,0,0
84791,randomized,0,0
84792,trial,0,0
84793,.,0,0
84794,The,0,0
84795,purpose,0,0
84796,of,0,0
84797,this,0,0
84798,randomized,0,0
84799,study,0,0
84800,was,0,0
84801,to,0,0
84802,examine,0,0
84803,if,0,0
84804,goserelin,0,1
84805,concomitant,0,0
84806,to,0,0
84807,CMF-chemotherapy,0,0
84808,as,0,0
84809,adjuvant,0,1
84810,treatment,0,0
84811,for,0,0
84812,premenopausal,0,0
84813,breast,0,0
84814,cancer,0,0
84815,",",0,0
84816,protects,0,0
84817,the,0,0
84818,ovaries,0,0
84819,from,0,0
84820,premature,0,0
84821,failure,0,0
84822,.,0,0
84823,A,0,0
84824,total,0,0
84825,of,0,0
84826,285,0,0
84827,premenopausal,0,0
84828,breast,0,0
84829,cancer,0,0
84830,patients,0,0
84831,",",0,0
84832,in,0,0
84833,a,0,0
84834,randomized,0,1
84835,adjuvant,0,1
84836,trial,0,1
84837,(,1,1
84838,Zoladex,1,1
84839,in,0,0
84840,premenopausal,0,1
84841,patients,0,0
84842,(,0,1
84843,ZIPP,0,1
84844,),0,1
84845,),0,0
84846,",",0,0
84847,were,0,0
84848,assigned,0,0
84849,to,0,0
84850,a,0,0
84851,study,0,0
84852,on,0,0
84853,ovarian,0,0
84854,function,0,0
84855,.,0,0
84856,Node,0,0
84857,positive,0,0
84858,patients,0,0
84859,were,0,0
84860,assigned,0,0
84861,to,0,0
84862,CMF-,1,1
84863,(,1,1
84864,cyclophosphamide,1,1
84865,",",1,1
84866,methotrexate,1,1
84867,and,1,1
84868,5-fluorouracil,1,1
84869,),1,1
84870,chemotherapy,1,0
84871,in,1,0
84872,addition,1,0
84873,to,1,0
84874,endocrine,1,0
84875,therapy,1,0
84876,.,1,0
84877,All,0,0
84878,patients,0,0
84879,were,0,0
84880,randomly,0,0
84881,assigned,0,0
84882,to,0,0
84883,receive,0,0
84884,2,0,0
84885,years,0,0
84886,of,0,0
84887,goserelin,1,1
84888,",",1,1
84889,goserelin,1,1
84890,plus,1,1
84891,tamoxifen,1,1
84892,",",1,1
84893,tamoxifen,1,1
84894,alone,1,0
84895,or,1,0
84896,no,1,0
84897,endocrine,1,0
84898,treatment,1,0
84899,.,1,0
84900,We,0,0
84901,studied,0,0
84902,",",0,0
84903,if,0,0
84904,menses,0,0
84905,were,0,0
84906,affected,0,0
84907,in,0,0
84908,the,0,0
84909,treatment,0,0
84910,groups,0,0
84911,",",0,0
84912,up,0,0
84913,to,0,0
84914,36,0,0
84915,months,0,0
84916,after,0,0
84917,randomization,0,0
84918,.,0,0
84919,One,0,0
84920,year,0,0
84921,after,0,0
84922,completed,0,0
84923,CMF-,0,0
84924,and,0,0
84925,endocrine,0,0
84926,therapy,0,0
84927,",",0,0
84928,36,0,0
84929,%,0,0
84930,of,0,0
84931,the,0,0
84932,women,0,0
84933,in,0,0
84934,the,0,0
84935,goserelin,0,1
84936,group,0,0
84937,reported,0,0
84938,menses,0,0
84939,",",0,0
84940,compared,0,0
84941,to,0,0
84942,7,0,0
84943,%,0,0
84944,in,0,0
84945,the,0,0
84946,goserelin,0,1
84947,plus,0,1
84948,tamoxifen,0,1
84949,group,0,1
84950,",",0,0
84951,13,0,0
84952,%,0,0
84953,in,0,0
84954,the,0,0
84955,tamoxifen,0,1
84956,group,0,1
84957,and,0,0
84958,10,0,0
84959,%,0,0
84960,of,0,0
84961,the,0,0
84962,controls,0,0
84963,.,0,0
84964,Among,0,0
84965,women,0,0
84966,treated,0,0
84967,with,0,0
84968,goserelin,0,1
84969,",",0,0
84970,there,0,0
84971,was,0,0
84972,a,0,0
84973,statistically,0,0
84974,significant,0,0
84975,increase,0,0
84976,in,0,0
84977,the,0,0
84978,proportion,0,0
84979,of,0,0
84980,menstruating,0,0
84981,women,0,0
84982,",",0,0
84983,1,0,0
84984,year,0,0
84985,after,0,0
84986,completed,0,0
84987,treatment,0,0
84988,compared,0,0
84989,to,0,0
84990,at,0,0
84991,24,0,0
84992,months,0,0
84993,of,0,0
84994,treatment,0,0
84995,(,0,0
84996,P,0,0
84997,=,0,0
84998,0.006,0,0
84999,),0,0
85000,",",0,0
85001,in,0,0
85002,contrast,0,0
85003,to,0,0
85004,all,0,0
85005,other,0,0
85006,treatment,0,0
85007,groups,0,0
85008,",",0,0
85009,who,0,0
85010,were,0,0
85011,unchanged,0,0
85012,or,0,0
85013,more,0,0
85014,often,0,0
85015,amenorrheic,0,0
85016,.,0,0
85017,In,0,0
85018,our,0,0
85019,study,0,0
85020,",",0,0
85021,there,0,0
85022,is,0,0
85023,some,0,0
85024,evidence,0,0
85025,of,0,0
85026,protective,0,0
85027,effect,0,0
85028,of,0,0
85029,goserelin,0,1
85030,on,0,0
85031,ovarian,0,0
85032,function,0,0
85033,in,0,0
85034,CMF,0,0
85035,treated,0,0
85036,women,0,0
85037,.,0,0
85038,This,0,0
85039,effect,0,0
85040,was,0,0
85041,not,0,0
85042,observed,0,0
85043,in,0,0
85044,the,0,0
85045,combined,0,0
85046,tamoxifen,0,1
85047,and,0,1
85048,goserelin,0,1
85049,treatment,0,1
85050,.,0,0
85051,Bevacizumab,1,1
85052,compared,0,1
85053,with,0,0
85054,macular,1,0
85055,laser,1,0
85056,grid,1,0
85057,photocoagulation,1,0
85058,for,0,0
85059,cystoid,0,0
85060,macular,0,0
85061,edema,0,0
85062,in,0,0
85063,branch,0,0
85064,retinal,0,0
85065,vein,0,0
85066,occlusion,0,0
85067,.,0,0
85068,INTRODUCTION,0,0
85069,To,0,0
85070,evaluate,0,0
85071,the,0,0
85072,outcome,0,0
85073,of,0,0
85074,cystoid,0,0
85075,macular,0,0
85076,edema,0,0
85077,treated,0,0
85078,with,0,0
85079,intravitreal,1,1
85080,injections,1,1
85081,of,1,1
85082,bevacizumab,1,1
85083,and,1,1
85084,macular,1,1
85085,grid,1,1
85086,laser,1,1
85087,photocoagulation,1,1
85088,(,1,1
85089,GLP,1,1
85090,),1,1
85091,",",0,0
85092,in,0,0
85093,patients,0,0
85094,with,0,0
85095,perfused,0,1
85096,branch,0,0
85097,retinal,0,0
85098,vein,0,0
85099,occlusion,0,0
85100,.,0,0
85101,METHODS,0,0
85102,Thirty,0,0
85103,eyes,0,0
85104,of,0,0
85105,30,0,0
85106,consecutive,0,0
85107,patients,0,0
85108,with,0,0
85109,cystoid,0,0
85110,macular,0,0
85111,edema,0,0
85112,secondary,0,0
85113,to,0,0
85114,nonischemic,0,0
85115,branch,0,0
85116,retinal,0,0
85117,vein,0,0
85118,occlusion,0,0
85119,were,0,0
85120,assigned,0,0
85121,to,0,0
85122,either,0,0
85123,GLP,1,0
85124,group,1,0
85125,or,0,0
85126,to,0,1
85127,intravitreal,1,1
85128,bevacizumab,1,1
85129,(,1,1
85130,IB,1,1
85131,),1,1
85132,group,0,0
85133,.,0,0
85134,Complete,0,0
85135,ophthalmologic,0,0
85136,examinations,0,0
85137,were,0,0
85138,performed,0,0
85139,just,0,0
85140,before,0,0
85141,GLP,1,0
85142,and,0,0
85143,IB,1,1
85144,injection,0,1
85145,at,0,1
85146,1,0,0
85147,",",0,0
85148,3,0,0
85149,",",0,0
85150,6,0,0
85151,",",0,0
85152,and,0,0
85153,12,0,0
85154,months,0,0
85155,after,0,0
85156,treatment,0,0
85157,.,0,0
85158,Changes,0,0
85159,in,0,0
85160,logarithm,0,0
85161,of,0,0
85162,minimum,0,0
85163,angle,0,0
85164,of,0,0
85165,resolution,0,0
85166,(,0,0
85167,logMAR,0,1
85168,),0,1
85169,best-corrected,0,1
85170,visual,0,1
85171,acuity,0,1
85172,(,0,1
85173,BCVA,0,1
85174,),0,1
85175,",",0,0
85176,central,0,0
85177,macular,0,1
85178,thickness,0,1
85179,(,0,1
85180,CMT,0,1
85181,),0,0
85182,shown,0,0
85183,by,0,0
85184,optical,0,0
85185,coherence,0,0
85186,tomography-3,0,0
85187,were,0,0
85188,evaluated,0,0
85189,.,0,0
85190,RESULTS,0,0
85191,Baseline,0,1
85192,BCVA,0,1
85193,(,0,1
85194,logMAR,0,1
85195,),0,1
85196,and,0,0
85197,CMT,0,0
85198,were,0,0
85199,",",0,0
85200,respectively,0,0
85201,",",0,0
85202,0.89,0,0
85203,+/-,0,0
85204,0.13,0,0
85205,and,0,0
85206,650,0,0
85207,+/-,0,0
85208,140,0,0
85209,microm,0,0
85210,for,0,0
85211,the,0,0
85212,GLP,1,0
85213,group,0,0
85214,",",0,0
85215,0.87,0,0
85216,+/-,0,0
85217,0.16,0,0
85218,and,0,0
85219,690,0,0
85220,+/-,0,0
85221,120,0,0
85222,microm,0,0
85223,for,0,0
85224,the,0,0
85225,IB,1,0
85226,group,0,0
85227,.,0,0
85228,After,0,0
85229,the,0,0
85230,treatment,0,0
85231,",",0,0
85232,at,0,0
85233,1,0,0
85234,",",0,0
85235,3,0,0
85236,",",0,0
85237,6,0,0
85238,",",0,0
85239,and,0,0
85240,12,0,0
85241,months,0,0
85242,in,0,0
85243,the,0,0
85244,GLP,1,0
85245,group,0,0
85246,",",0,0
85247,BCVA,0,0
85248,had,0,0
85249,improved,0,0
85250,by,0,0
85251,0.19,0,0
85252,",",0,0
85253,0.22,0,0
85254,",",0,0
85255,0.21,0,0
85256,",",0,0
85257,and,0,0
85258,0.20,0,0
85259,logMAR,0,0
85260,",",0,0
85261,CMT,0,0
85262,had,0,0
85263,decreased,0,0
85264,by,0,0
85265,40,0,0
85266,%,0,0
85267,",",0,0
85268,41.3,0,0
85269,%,0,0
85270,",",0,0
85271,40.5,0,0
85272,%,0,0
85273,",",0,0
85274,and,0,0
85275,42,0,0
85276,%,0,0
85277,.,0,0
85278,In,0,0
85279,the,0,0
85280,IB,1,0
85281,group,0,0
85282,",",0,0
85283,BCVA,0,0
85284,had,0,0
85285,improved,0,0
85286,by,0,0
85287,0.31,0,0
85288,",",0,0
85289,0.32,0,0
85290,",",0,0
85291,0.30,0,0
85292,",",0,0
85293,and,0,0
85294,0.31,0,0
85295,logMAR,0,0
85296,and,0,0
85297,CMT,0,0
85298,had,0,0
85299,decreased,0,0
85300,by,0,0
85301,59.5,0,0
85302,%,0,0
85303,",",0,0
85304,59,0,0
85305,%,0,0
85306,",",0,0
85307,60,0,0
85308,%,0,0
85309,",",0,0
85310,and,0,0
85311,60.3,0,0
85312,%,0,0
85313,.,0,0
85314,The,0,0
85315,group,0,0
85316,receiving,0,0
85317,bevacizumab,1,1
85318,had,0,0
85319,better,0,0
85320,BCVA,0,0
85321,and,0,0
85322,lower,0,0
85323,CMT,0,0
85324,values,0,0
85325,at,0,0
85326,all,0,0
85327,time,0,0
85328,points,0,0
85329,(,0,0
85330,P,0,0
85331,<,0,0
85332,0.05,0,0
85333,),0,0
85334,.,0,0
85335,CONCLUSION,0,1
85336,Intravitreal,0,1
85337,bevacizumab,1,1
85338,injection,0,1
85339,improves,0,1
85340,BCVA,0,1
85341,and,0,0
85342,reduces,0,0
85343,CMT,0,0
85344,more,0,0
85345,than,0,0
85346,GLP,0,0
85347,.,0,1
85348,Intravitreal,0,1
85349,bevacizumab,1,1
85350,injection,0,1
85351,was,0,1
85352,well,0,0
85353,tolerated,0,1
85354,and,0,0
85355,could,0,0
85356,be,0,0
85357,used,0,0
85358,as,0,0
85359,primary,0,0
85360,treatment,0,0
85361,in,0,0
85362,patients,0,0
85363,with,0,0
85364,cystoid,0,0
85365,macular,0,0
85366,edema,0,0
85367,secondary,0,0
85368,to,0,0
85369,perfused,0,1
85370,branch,0,0
85371,retinal,0,0
85372,vein,0,0
85373,occlusion,0,0
85374,.,0,0
85375,Evaluation,0,0
85376,of,0,0
85377,mood,0,0
85378,profiles,0,0
85379,during,0,0
85380,malaria,1,0
85381,chemoprophylaxis,1,0
85382,:,1,0
85383,a,0,0
85384,randomized,0,0
85385,",",0,0
85386,double-blind,0,1
85387,",",0,1
85388,four-arm,0,0
85389,study,0,0
85390,.,0,0
85391,BACKGROUND,0,0
85392,To,0,1
85393,objectively,0,0
85394,compare,0,0
85395,the,0,0
85396,mood,0,0
85397,profiles,0,0
85398,of,0,0
85399,users,0,0
85400,of,0,0
85401,malaria,1,1
85402,chemoprophylaxis,1,1
85403,regimens,0,1
85404,(,1,1
85405,atovaquone-proguanil,1,1
85406,",",1,1
85407,chloroquine-proguanil,1,1
85408,",",1,1
85409,doxycycline,1,1
85410,",",1,1
85411,or,1,1
85412,mefloquine,1,1
85413,),1,1
85414,in,0,0
85415,a,0,0
85416,group,0,0
85417,of,0,0
85418,nonimmune,0,0
85419,tourists,0,0
85420,to,0,0
85421,sub-Saharan,0,0
85422,Africa,0,0
85423,.,0,0
85424,METHODS,0,0
85425,In,0,0
85426,a,0,0
85427,randomized,0,0
85428,",",0,0
85429,double-blind,0,1
85430,",",0,1
85431,four-arm,0,0
85432,study,0,0
85433,with,0,1
85434,placebo,0,1
85435,run-in,0,1
85436,phase,0,0
85437,conducted,0,0
85438,at,0,0
85439,travel,0,0
85440,clinics,0,0
85441,in,0,0
85442,Switzerland,0,0
85443,",",0,0
85444,Germany,0,0
85445,",",0,0
85446,and,0,0
85447,Israel,0,0
85448,",",0,0
85449,we,0,0
85450,compared,0,0
85451,moods,0,0
85452,and,0,0
85453,feelings,0,0
85454,in,0,0
85455,chemoprophylaxis,0,1
85456,users,0,0
85457,(,0,0
85458,n=,0,0
85459,547,0,0
85460,),0,0
85461,by,0,0
85462,administering,0,1
85463,the,0,0
85464,standardized,0,0
85465,Profile,1,0
85466,of,1,0
85467,Mood,1,0
85468,States,1,0
85469,(,1,1
85470,POMS,1,1
85471,),1,1
85472,questionnaire,1,0
85473,.,1,0
85474,This,0,0
85475,is,0,0
85476,designed,0,0
85477,to,0,0
85478,provide,0,0
85479,data,0,0
85480,on,0,0
85481,six,0,0
85482,categories,0,0
85483,of,0,0
85484,feelings,0,0
85485,:,0,0
85486,tension,0,0
85487,",",0,0
85488,depression,0,0
85489,",",0,0
85490,anger,0,0
85491,",",0,0
85492,vigor,0,0
85493,",",0,0
85494,fatigue,0,0
85495,",",0,0
85496,and,0,0
85497,confusion,0,0
85498,.,0,0
85499,The,0,0
85500,questionnaire,0,0
85501,was,0,0
85502,administered,0,1
85503,at,0,0
85504,four,0,0
85505,time,0,0
85506,points,0,0
85507,:,0,0
85508,recruitment,0,0
85509,(,0,0
85510,T1,0,1
85511,),0,1
85512,",",0,0
85513,13,0,0
85514,to,0,0
85515,11,0,0
85516,days,0,0
85517,before,0,0
85518,departure,0,0
85519,(,0,0
85520,T2,0,1
85521,),0,1
85522,",",0,0
85523,6,0,0
85524,to,0,0
85525,4,0,0
85526,days,0,0
85527,before,0,0
85528,departure,0,0
85529,(,0,1
85530,T3,0,1
85531,),0,1
85532,",",0,0
85533,and,0,0
85534,7,0,0
85535,to,0,0
85536,14,0,0
85537,days,0,0
85538,after,0,0
85539,return,0,0
85540,from,0,0
85541,Africa,0,0
85542,(,0,0
85543,T4,0,0
85544,),0,0
85545,.,0,0
85546,RESULTS,0,0
85547,There,0,0
85548,were,0,0
85549,no,0,0
85550,significant,0,0
85551,differences,0,0
85552,with,0,0
85553,respect,0,0
85554,to,0,0
85555,overall,0,0
85556,mood,0,0
85557,impact,0,0
85558,between,0,0
85559,the,0,0
85560,medication,0,0
85561,arms,0,0
85562,.,0,0
85563,All,0,0
85564,scores,0,0
85565,were,0,0
85566,in,0,0
85567,the,0,0
85568,normal,0,0
85569,range,0,0
85570,",",0,0
85571,and,0,0
85572,no,0,0
85573,means,0,0
85574,were,0,0
85575,more,0,0
85576,than,0,0
85577,1,0,0
85578,SD,0,0
85579,from,0,0
85580,the,0,0
85581,norm,0,0
85582,.,0,0
85583,The,0,0
85584,POMS,0,0
85585,data,0,0
85586,were,0,0
85587,reanalyzed,0,0
85588,with,0,0
85589,respect,0,0
85590,to,0,0
85591,sex,0,0
85592,",",0,0
85593,age,0,0
85594,",",0,0
85595,medication,0,0
85596,group,0,0
85597,",",0,0
85598,and,0,0
85599,control,0,0
85600,time,0,0
85601,points,0,1
85602,(,0,1
85603,T1-T4,0,1
85604,),0,1
85605,.,0,0
85606,There,0,0
85607,were,0,0
85608,significant,0,0
85609,interaction,0,0
85610,effects,0,0
85611,between,0,0
85612,sex,0,0
85613,and,0,0
85614,medication,0,0
85615,group,0,0
85616,--,0,0
85617,women,0,0
85618,in,0,0
85619,the,0,0
85620,mefloquine,0,1
85621,group,0,0
85622,showed,0,0
85623,more,0,0
85624,fatigue,0,0
85625,(,0,0
85626,p=,0,0
85627,.011,0,0
85628,),0,0
85629,and,0,0
85630,confusion,0,0
85631,(,0,0
85632,p=,0,0
85633,.011,0,0
85634,),0,0
85635,than,0,0
85636,men,0,0
85637,.,0,0
85638,Significant,0,0
85639,effects,0,0
85640,of,0,0
85641,age,0,1
85642,group,0,0
85643,(,0,0
85644,below,0,0
85645,median,0,0
85646,age,0,0
85647,34,0,0
85648,y,0,0
85649,vs,0,0
85650,median,0,0
85651,age,0,0
85652,and,0,0
85653,above,0,0
85654,),0,0
85655,were,0,0
85656,noted,0,0
85657,on,0,0
85658,the,0,0
85659,tension,0,0
85660,and,0,0
85661,fatigue,0,0
85662,scales,0,0
85663,in,0,0
85664,that,0,0
85665,less,0,0
85666,tension,0,0
85667,(,0,0
85668,p=,0,0
85669,.045,0,0
85670,),0,0
85671,and,0,0
85672,less,0,0
85673,fatigue,0,0
85674,(,0,0
85675,p=,0,0
85676,.000,0,0
85677,),0,0
85678,were,0,0
85679,noted,0,0
85680,in,0,0
85681,those,0,0
85682,aged,0,0
85683,34,0,0
85684,years,0,0
85685,and,0,0
85686,older,0,0
85687,.,0,0
85688,Younger,0,0
85689,participants,0,0
85690,",",0,0
85691,aged,0,0
85692,<,0,0
85693,34,0,0
85694,years,0,0
85695,",",0,0
85696,reported,0,0
85697,more,0,0
85698,confusion,0,0
85699,(,0,0
85700,p=,0,0
85701,.013,0,0
85702,),0,0
85703,at,0,0
85704,T2,0,1
85705,than,0,0
85706,at,0,0
85707,T1,0,0
85708,and,0,0
85709,T4,0,0
85710,.,0,0
85711,CONCLUSIONS,0,0
85712,Although,0,0
85713,the,0,0
85714,overall,0,0
85715,mood,0,0
85716,profiles,0,0
85717,were,0,0
85718,similar,0,0
85719,for,0,0
85720,the,0,0
85721,users,0,0
85722,of,0,0
85723,any,0,0
85724,of,0,0
85725,the,0,0
85726,standard,1,0
85727,malaria,1,1
85728,chemoprophylaxis,1,1
85729,regimens,1,1
85730,",",0,0
85731,we,0,0
85732,found,0,0
85733,that,0,0
85734,women,0,0
85735,using,0,0
85736,mefloquine,0,1
85737,showed,0,0
85738,more,0,0
85739,fatigue,0,0
85740,and,0,0
85741,confusion,0,1
85742,than,0,0
85743,men,0,0
85744,and,0,0
85745,that,0,0
85746,younger,0,0
85747,persons,0,0
85748,aged,0,0
85749,less,0,0
85750,than,0,0
85751,34,0,0
85752,years,0,0
85753,",",0,0
85754,regardless,0,0
85755,of,0,0
85756,chemoprophylaxis,0,0
85757,used,0,0
85758,",",0,0
85759,reported,0,0
85760,more,0,0
85761,tension,0,0
85762,and,0,0
85763,fatigue,0,0
85764,than,0,0
85765,their,0,0
85766,older,0,0
85767,counterparts,0,0
85768,.,0,0
85769,Effects,0,0
85770,of,0,0
85771,propranolol,1,1
85772,on,0,0
85773,bone,0,0
85774,metabolism,0,0
85775,in,0,0
85776,the,0,0
85777,rat,0,0
85778,.,0,0
85779,Propranolol,1,1
85780,",",0,0
85781,a,0,0
85782,nonspecific,0,0
85783,beta-blocker,0,1
85784,has,0,0
85785,many,0,0
85786,physiologic,0,0
85787,effects,0,0
85788,.,0,0
85789,Its,0,0
85790,effects,0,0
85791,on,0,0
85792,bone,0,0
85793,in,0,0
85794,vivo,0,0
85795,are,0,0
85796,unknown,0,0
85797,",",0,0
85798,although,0,0
85799,beta,0,0
85800,receptor,0,0
85801,sites,0,0
85802,have,0,0
85803,been,0,0
85804,found,0,0
85805,on,0,0
85806,osteoblasts,0,0
85807,.,0,0
85808,In,0,0
85809,this,0,0
85810,study,0,0
85811,",",0,0
85812,the,0,0
85813,hypothesis,0,0
85814,tested,0,0
85815,was,0,0
85816,that,0,0
85817,low,0,0
85818,doses,0,1
85819,of,0,1
85820,propranolol,1,1
85821,could,0,0
85822,alter,0,0
85823,bone,0,0
85824,properties,0,0
85825,and,0,0
85826,enhance,0,0
85827,orthotopic,0,0
85828,endochondral,0,0
85829,bone,0,0
85830,formation,0,0
85831,.,0,0
85832,In,0,0
85833,a,0,0
85834,group,0,0
85835,of,0,0
85836,nonsurgical,0,1
85837,rats,0,0
85838,",",0,1
85839,propranolol,1,1
85840,treatment,0,1
85841,increased,0,0
85842,femoral,0,0
85843,torsional,0,0
85844,strength,0,1
85845,on,0,0
85846,biomechanical,0,0
85847,testing,0,0
85848,.,0,0
85849,In,0,0
85850,the,0,0
85851,rat,0,0
85852,surgical,0,0
85853,model,0,0
85854,used,0,0
85855,",",0,0
85856,right,0,0
85857,femora,0,0
85858,were,0,0
85859,fixed,0,0
85860,to,0,0
85861,a,0,0
85862,polyethylene,0,1
85863,plate,0,0
85864,and,0,0
85865,then,0,0
85866,defects,0,0
85867,were,0,0
85868,created,0,0
85869,mid-diaphysis,0,0
85870,and,0,0
85871,subsequently,0,0
85872,filled,0,0
85873,with,0,0
85874,demineralized,0,1
85875,bone,0,0
85876,matrix,0,0
85877,.,0,0
85878,These,0,1
85879,rats,0,1
85880,(,0,1
85881,defect,0,1
85882,rats,0,0
85883,),0,0
85884,were,0,0
85885,randomly,0,0
85886,divided,0,0
85887,into,0,0
85888,groups,0,0
85889,that,0,0
85890,were,0,0
85891,given,0,0
85892,propranolol,1,1
85893,or,0,1
85894,a,0,0
85895,saline,1,1
85896,carrier,0,0
85897,for,0,0
85898,19,0,0
85899,consecutive,0,0
85900,days,0,0
85901,.,0,0
85902,In,0,0
85903,the,0,0
85904,defect,0,0
85905,rats,0,0
85906,",",0,0
85907,increased,0,0
85908,trabecular,0,0
85909,femoral,0,1
85910,metaphyseal,0,1
85911,mineral,0,0
85912,apposition,0,0
85913,rates,0,0
85914,were,0,0
85915,observed,0,0
85916,in,0,0
85917,propranolol-treated,0,1
85918,groups,0,1
85919,.,0,0
85920,Densitometry,0,0
85921,and,0,0
85922,roentgenographic,0,0
85923,scoring,0,0
85924,of,0,0
85925,callus,0,0
85926,formation,0,0
85927,after,0,0
85928,12,0,0
85929,weeks,0,0
85930,in,0,0
85931,propranolol-treated,0,1
85932,rats,0,0
85933,revealed,0,0
85934,increased,0,0
85935,callus,0,0
85936,and,0,0
85937,bone,0,0
85938,union,0,0
85939,.,0,0
85940,The,0,0
85941,results,0,0
85942,of,0,0
85943,this,0,0
85944,study,0,0
85945,indicate,0,0
85946,that,0,0
85947,propranolol,1,1
85948,treatment,0,0
85949,can,0,0
85950,significantly,0,0
85951,affect,0,0
85952,bone,0,0
85953,properties,0,0
85954,.,0,0
85955,Using,0,0
85956,a,0,0
85957,laryngeal,1,0
85958,tube,1,1
85959,suction-device,1,1
85960,(,1,1
85961,LTS-D,1,1
85962,),1,0
85963,reduces,0,0
85964,the,0,0
85965,no,0,0
85966,flow,0,0
85967,time,0,0
85968,in,0,0
85969,a,0,0
85970,single,0,0
85971,rescuer,0,0
85972,manikin,0,0
85973,study,0,0
85974,.,0,0
85975,BACKGROUND,0,0
85976,In,0,0
85977,2005,0,0
85978,",",0,0
85979,the,0,0
85980,European,0,0
85981,Resuscitation,0,0
85982,Council,0,0
85983,and,0,0
85984,the,0,0
85985,American,0,0
85986,Heart,0,0
85987,Association,0,0
85988,published,0,0
85989,new,0,0
85990,guidelines,0,0
85991,for,0,0
85992,Advanced,0,1
85993,Life,0,1
85994,Support,0,1
85995,.,0,0
85996,One,0,0
85997,of,0,0
85998,the,0,0
85999,points,0,0
86000,was,0,0
86001,to,0,0
86002,reduce,0,0
86003,the,0,0
86004,time,0,0
86005,without,0,0
86006,chest,0,0
86007,compressions,0,0
86008,in,0,0
86009,the,0,0
86010,first,0,0
86011,phase,0,0
86012,of,0,0
86013,cardiac,0,0
86014,arrest,0,0
86015,.,0,0
86016,OBJECTIVE,0,0
86017,We,0,0
86018,evaluated,0,0
86019,in,0,0
86020,a,0,0
86021,manikin,0,0
86022,model,0,0
86023,whether,0,0
86024,using,0,0
86025,the,0,0
86026,single-use,1,0
86027,laryngeal,1,0
86028,tube,1,0
86029,with,1,0
86030,suction,1,0
86031,option,1,1
86032,(,1,1
86033,LTS-D,1,1
86034,),1,0
86035,instead,1,0
86036,of,0,0
86037,endotracheal,1,0
86038,intubation,1,1
86039,(,1,1
86040,ET,1,1
86041,),1,1
86042,and,1,0
86043,bag-mask-valve,1,1
86044,ventilation,1,1
86045,(,1,1
86046,BMV,1,1
86047,),1,1
86048,for,1,0
86049,emergency,1,0
86050,airway,1,0
86051,management,1,0
86052,could,1,0
86053,reduce,0,0
86054,the,0,0
86055,no-flow,0,0
86056,time,0,0
86057,(,0,1
86058,NFT,0,1
86059,),0,1
86060,.,0,0
86061,The,0,0
86062,NFT,0,0
86063,is,0,0
86064,defined,0,0
86065,as,0,0
86066,the,0,0
86067,time,0,0
86068,during,0,0
86069,resuscitation,0,0
86070,when,0,0
86071,no,0,0
86072,chest,0,0
86073,compressions,0,0
86074,take,0,0
86075,place,0,0
86076,.,0,0
86077,METHODS,0,0
86078,A,0,1
86079,randomized,0,1
86080,",",0,0
86081,prospective,0,0
86082,study,0,0
86083,was,0,0
86084,undertaken,0,0
86085,with,0,0
86086,150,0,0
86087,volunteers,0,0
86088,who,0,0
86089,performed,0,0
86090,management,0,0
86091,of,0,0
86092,a,0,0
86093,standardized,0,0
86094,simulated,0,0
86095,cardiac,0,0
86096,arrest,0,0
86097,in,0,0
86098,a,0,0
86099,manikin,0,0
86100,.,0,0
86101,Every,0,0
86102,participant,0,0
86103,was,0,0
86104,randomized,0,0
86105,to,0,0
86106,one,0,0
86107,of,0,0
86108,three,0,0
86109,different,0,0
86110,airway,0,0
86111,management,0,1
86112,groups,0,1
86113,(,0,0
86114,LTS-D,0,0
86115,vs,0,0
86116,.,0,0
86117,ET,0,0
86118,vs.,0,0
86119,BMV,0,0
86120,),0,0
86121,.,0,0
86122,RESULTS,0,0
86123,The,0,0
86124,LTS-D,1,0
86125,was,0,0
86126,inserted,0,0
86127,significantly,0,0
86128,faster,0,0
86129,than,0,0
86130,the,0,0
86131,ET,0,1
86132,tube,0,1
86133,(,0,1
86134,15,0,0
86135,s,0,0
86136,vs.,0,0
86137,44,0,0
86138,s,0,0
86139,",",0,0
86140,respectively,0,0
86141,",",0,0
86142,p,0,0
86143,<,0,0
86144,0.01,0,0
86145,),0,0
86146,.,0,0
86147,During,0,0
86148,the,0,0
86149,cardiac,0,0
86150,arrest,0,0
86151,simulation,0,0
86152,",",0,0
86153,establishing,0,0
86154,and,0,0
86155,performing,0,0
86156,ventilation,0,0
86157,took,0,0
86158,an,0,0
86159,average,0,0
86160,of,0,0
86161,57,0,0
86162,s,0,0
86163,with,0,0
86164,the,0,0
86165,LTS-D,1,0
86166,compared,0,0
86167,to,0,0
86168,116,0,0
86169,s,0,0
86170,with,0,0
86171,ET,1,0
86172,and,0,0
86173,111,0,0
86174,s,0,0
86175,with,0,0
86176,the,0,0
86177,BMV,1,0
86178,.,1,0
86179,Using,0,0
86180,the,0,0
86181,LTS-D,1,0
86182,significantly,0,0
86183,reduced,0,0
86184,NFT,1,0
86185,compared,0,0
86186,to,0,0
86187,ET,1,0
86188,and,0,0
86189,the,0,0
86190,BMV,1,1
86191,(,0,0
86192,125,0,0
86193,s,0,0
86194,vs.,0,0
86195,207,0,0
86196,s,0,0
86197,vs.,0,0
86198,160,0,0
86199,s,0,0
86200,;,0,0
86201,p,0,0
86202,<,0,0
86203,0.01,0,0
86204,),0,0
86205,.,0,0
86206,CONCLUSIONS,0,0
86207,In,0,0
86208,our,0,0
86209,manikin,0,0
86210,study,0,0
86211,",",0,0
86212,NFT,1,0
86213,was,0,0
86214,reduced,0,0
86215,significantly,0,0
86216,when,0,0
86217,the,0,0
86218,LTS-D,1,0
86219,was,0,0
86220,used,0,0
86221,when,0,0
86222,compared,0,0
86223,to,0,0
86224,ET,1,0
86225,and,1,0
86226,BMV,1,0
86227,.,1,0
86228,The,0,0
86229,results,0,0
86230,of,0,0
86231,our,0,0
86232,manikin,0,0
86233,study,0,0
86234,suggest,0,0
86235,that,0,0
86236,for,0,0
86237,personnel,0,0
86238,not,0,0
86239,experienced,0,0
86240,in,0,0
86241,tracheal,0,0
86242,intubation,0,0
86243,",",0,0
86244,the,0,0
86245,LTS-D,1,0
86246,offers,0,0
86247,a,0,0
86248,good,0,0
86249,alternative,0,0
86250,to,0,0
86251,ET,1,0
86252,and,0,0
86253,BMV,1,0
86254,to,0,0
86255,manage,0,0
86256,the,0,0
86257,airway,0,0
86258,during,0,0
86259,resuscitation,0,0
86260,",",0,0
86261,and,0,0
86262,to,0,0
86263,avoid,0,0
86264,the,0,0
86265,failure,0,0
86266,to,0,0
86267,achieve,0,0
86268,tracheal,0,0
86269,intubation,0,0
86270,with,0,0
86271,the,0,0
86272,ET,1,0
86273,",",0,0
86274,and,0,0
86275,the,0,0
86276,failure,0,0
86277,to,0,0
86278,achieve,0,0
86279,adequate,0,0
86280,ventilation,0,0
86281,with,0,0
86282,the,0,0
86283,BMV,1,0
86284,.,1,0
86285,Cardiovascular,0,0
86286,safety,0,0
86287,and,0,0
86288,gastrointestinal,0,1
86289,tolerability,0,1
86290,of,0,0
86291,etoricoxib,1,1
86292,vs,1,0
86293,diclofenac,1,1
86294,in,0,0
86295,a,0,0
86296,randomized,0,0
86297,controlled,0,0
86298,clinical,0,1
86299,trial,0,1
86300,(,0,0
86301,The,0,0
86302,MEDAL,0,1
86303,study,0,0
86304,),0,0
86305,.,0,0
86306,OBJECTIVE,0,0
86307,To,0,0
86308,compare,0,0
86309,cardiovascular,0,1
86310,(,0,1
86311,CV,0,1
86312,),0,1
86313,and,0,0
86314,other,0,0
86315,safety,0,0
86316,and,0,0
86317,efficacy,0,0
86318,parameters,0,0
86319,of,0,0
86320,etoricoxib,1,1
86321,60,0,1
86322,and,0,1
86323,90,0,1
86324,mg,0,1
86325,",",0,1
86326,and,0,1
86327,diclofenac,1,1
86328,150,0,1
86329,mg.,0,1
86330,METHODS,0,1
86331,This,0,1
86332,double-blind,0,1
86333,study,0,0
86334,randomized,0,0
86335,OA,0,0
86336,patients,0,0
86337,to,0,0
86338,etoricoxib,1,1
86339,90,0,1
86340,mg,0,1
86341,",",0,0
86342,then,0,0
86343,to,0,0
86344,60,0,1
86345,mg,0,1
86346,once,0,1
86347,daily,0,1
86348,vs,0,1
86349,diclofenac,1,1
86350,75,0,0
86351,mg,0,1
86352,twice,0,1
86353,daily,0,1
86354,;,0,1
86355,RA,0,1
86356,patients,0,0
86357,were,0,0
86358,randomized,0,0
86359,to,0,0
86360,etoricoxib,1,1
86361,90,0,1
86362,mg,0,1
86363,once,0,1
86364,daily,0,1
86365,or,0,1
86366,diclofenac,1,1
86367,75,0,1
86368,mg,0,1
86369,twice,0,1
86370,daily,0,1
86371,.,0,1
86372,The,0,0
86373,primary,0,0
86374,endpoint,0,0
86375,was,0,0
86376,non-inferiority,0,0
86377,of,0,0
86378,etoricoxib,1,1
86379,vs,0,0
86380,diclofenac,1,1
86381,for,0,0
86382,thrombotic,0,1
86383,CV,0,1
86384,events,0,0
86385,(,0,0
86386,95,0,0
86387,%,0,0
86388,CI,0,0
86389,upper,0,0
86390,bound,0,0
86391,of,0,0
86392,hazard,0,0
86393,ratio,0,0
86394,<,0,0
86395,1.30,0,0
86396,),0,0
86397,.,0,0
86398,Other,0,0
86399,safety,0,0
86400,and,0,0
86401,efficacy,0,0
86402,parameters,0,0
86403,were,0,0
86404,evaluated,0,0
86405,in,0,0
86406,cohorts,0,0
86407,of,0,0
86408,patients,0,0
86409,based,0,0
86410,on,0,0
86411,etoricoxib,1,1
86412,dose,0,1
86413,and,0,1
86414,disease,0,1
86415,.,0,0
86416,RESULTS,0,0
86417,A,0,0
86418,total,0,0
86419,of,0,0
86420,23,0,0
86421,504,0,0
86422,patients,0,0
86423,were,0,0
86424,randomized,0,0
86425,with,0,0
86426,mean,0,0
86427,treatment,0,0
86428,duration,0,0
86429,from,0,0
86430,19.4,0,0
86431,to,0,0
86432,20.8,0,0
86433,months,0,0
86434,.,0,0
86435,The,0,0
86436,thrombotic,0,0
86437,CV,0,0
86438,risk,0,1
86439,hazard,0,1
86440,ratio,0,0
86441,(,0,1
86442,HR,0,1
86443,),0,1
86444,(,1,1
86445,etoricoxib,1,1
86446,to,0,1
86447,diclofenac,0,1
86448,),0,0
86449,was,0,0
86450,0.96,0,0
86451,(,0,0
86452,95,0,0
86453,%,0,0
86454,CI,0,0
86455,0.81,0,0
86456,",",0,0
86457,1.15,0,0
86458,),0,0
86459,",",0,0
86460,consistent,0,0
86461,with,0,0
86462,non-inferiority,0,0
86463,of,0,0
86464,etoricoxib,1,1
86465,to,0,1
86466,diclofenac,1,1
86467,.,1,0
86468,The,0,0
86469,cumulative,0,0
86470,gastrointestinal,0,0
86471,(,0,1
86472,GI,0,1
86473,),0,1
86474,/liver,0,1
86475,adverse,0,1
86476,events,0,0
86477,(,0,1
86478,AEs,0,1
86479,),0,1
86480,discontinuation,0,0
86481,rate,0,0
86482,was,0,0
86483,significantly,0,0
86484,lower,0,0
86485,for,0,0
86486,etoricoxib,1,1
86487,than,0,1
86488,diclofenac,1,1
86489,in,0,0
86490,each,0,0
86491,patient,0,0
86492,cohort,0,1
86493,;,0,1
86494,HR,0,1
86495,(,0,0
86496,95,0,0
86497,%,0,0
86498,CI,0,0
86499,),0,0
86500,of,0,0
86501,0.46,0,0
86502,(,0,0
86503,0.39,0,0
86504,",",0,0
86505,0.54,0,0
86506,),0,0
86507,",",0,0
86508,0.52,0,0
86509,(,0,0
86510,0.42,0,0
86511,",",0,0
86512,0.63,0,0
86513,),0,0
86514,and,0,0
86515,0.49,0,0
86516,(,0,0
86517,0.39,0,0
86518,",",0,0
86519,0.62,0,0
86520,),0,0
86521,for,0,0
86522,the,0,0
86523,60,0,0
86524,mg,0,1
86525,OA,0,1
86526,",",0,1
86527,90,0,1
86528,mg,0,1
86529,OA,0,1
86530,and,0,1
86531,RA,0,0
86532,cohorts,0,0
86533,.,0,0
86534,The,0,0
86535,maximum,0,0
86536,average,0,0
86537,change,0,0
86538,in,0,0
86539,systolic,0,0
86540,blood,0,1
86541,pressure,0,1
86542,(,0,1
86543,BP,0,1
86544,),0,1
86545,with,0,0
86546,etoricoxib,1,1
86547,was,0,0
86548,3.4-3.6,0,0
86549,mmHg,0,0
86550,(,0,0
86551,diastolic,0,0
86552,BP,0,0
86553,:,0,0
86554,1.0-1.5,0,0
86555,mmHg,0,0
86556,),0,0
86557,",",0,0
86558,while,0,0
86559,diclofenac,0,1
86560,produced,0,0
86561,a,0,0
86562,maximum,0,0
86563,average,0,0
86564,change,0,0
86565,of,0,0
86566,0.9-1.9,0,0
86567,mmHg,0,0
86568,(,0,0
86569,diastolic,0,0
86570,BP,0,0
86571,:,0,0
86572,0.0-0.5,0,0
86573,mmHg,0,0
86574,),0,0
86575,.,0,0
86576,Both,0,0
86577,agents,0,0
86578,resulted,0,0
86579,in,0,0
86580,similar,0,0
86581,efficacy,0,0
86582,regardless,0,0
86583,of,0,0
86584,etoricoxib,0,1
86585,dose,0,1
86586,.,0,1
86587,CONCLUSION,0,1
86588,Long-term,0,1
86589,etoricoxib,1,1
86590,use,0,0
86591,is,0,0
86592,associated,0,0
86593,with,0,0
86594,a,0,0
86595,risk,0,0
86596,of,0,0
86597,thrombotic,0,0
86598,CV,0,0
86599,events,0,0
86600,comparable,0,0
86601,with,0,0
86602,that,0,0
86603,of,0,0
86604,diclofenac,1,1
86605,.,1,0
86606,Compared,0,0
86607,with,0,0
86608,diclofenac,1,1
86609,",",1,1
86610,etoricoxib,1,1
86611,demonstrated,0,0
86612,a,0,0
86613,greater,0,0
86614,risk,0,0
86615,of,0,0
86616,renovascular,0,0
86617,AEs,0,0
86618,",",0,0
86619,but,0,0
86620,a,0,0
86621,more,0,0
86622,favourable,0,0
86623,GI/liver,0,1
86624,tolerability,0,1
86625,profile,0,0
86626,.,0,0
86627,[,0,1
86628,Efficacy,0,1
86629,of,0,0
86630,immunomodulating,1,1
86631,treatment,1,0
86632,in,0,0
86633,patients,0,0
86634,with,0,0
86635,different,0,0
86636,degrees,0,0
86637,of,0,0
86638,immunosuppression,0,1
86639,],0,0
86640,.,0,0
86641,Immunodepression,0,0
86642,is,0,0
86643,a,0,0
86644,common,0,0
86645,condition,0,0
86646,in,0,0
86647,patients,0,0
86648,undergoing,0,0
86649,elective,0,0
86650,operations,0,0
86651,and,0,0
86652,it,0,0
86653,constitutes,0,0
86654,a,0,0
86655,high,0,0
86656,risk,0,0
86657,for,0,0
86658,the,0,0
86659,onset,0,0
86660,of,0,0
86661,postoperative,0,0
86662,infective,0,0
86663,complications,0,0
86664,.,0,0
86665,The,0,0
86666,use,0,0
86667,of,0,0
86668,immunomodulatory,1,1
86669,drugs,1,1
86670,has,0,0
86671,proved,0,0
86672,useful,0,0
86673,in,0,0
86674,the,0,0
86675,prophylaxis,0,0
86676,of,0,0
86677,these,0,0
86678,complications,0,0
86679,",",0,0
86680,although,0,0
86681,the,0,0
86682,precise,0,0
86683,indications,0,0
86684,for,0,0
86685,each,0,0
86686,drug,0,1
86687,have,0,0
86688,not,0,0
86689,yet,0,0
86690,been,0,0
86691,clearly,0,0
86692,codified,0,0
86693,.,0,0
86694,The,0,0
86695,present,0,0
86696,study,0,0
86697,aimed,0,0
86698,to,0,0
86699,assess,0,0
86700,the,0,0
86701,effects,0,0
86702,of,0,0
86703,thymostimulin,1,1
86704,in,0,0
86705,patients,0,0
86706,with,0,0
86707,different,0,0
86708,degrees,0,0
86709,of,0,0
86710,immunodepression,0,0
86711,",",0,0
86712,by,0,0
86713,evaluating,0,0
86714,both,0,0
86715,the,0,0
86716,incidence,0,0
86717,of,0,0
86718,postoperative,0,0
86719,infections,0,0
86720,and,0,0
86721,the,0,0
86722,changes,0,0
86723,induced,0,0
86724,in,0,0
86725,various,0,0
86726,immunological,0,0
86727,parameters,0,0
86728,.,0,0
86729,The,0,0
86730,results,0,0
86731,obtained,0,0
86732,indicated,0,0
86733,that,0,0
86734,those,0,0
86735,subjects,0,0
86736,with,0,0
86737,the,0,0
86738,highest,0,0
86739,degree,0,0
86740,of,0,0
86741,immunodepression,0,1
86742,(,0,1
86743,hypo-anergic,0,1
86744,),0,0
86745,benefited,0,0
86746,most,0,0
86747,from,0,0
86748,drug,1,1
86749,therapy,1,1
86750,in,0,0
86751,comparison,0,0
86752,to,0,0
86753,those,0,0
86754,with,0,0
86755,a,0,0
86756,lesser,0,0
86757,degree,0,0
86758,of,0,0
86759,immunodepression,0,0
86760,(,0,0
86761,relatively,0,0
86762,hypo-ergic,0,1
86763,),0,0
86764,.,0,0
86765,The,0,0
86766,advantages,0,0
86767,were,0,0
86768,evident,0,0
86769,in,0,0
86770,hypo-anergic,0,0
86771,subjects,0,0
86772,both,0,0
86773,with,0,0
86774,regard,0,0
86775,to,0,0
86776,the,0,0
86777,frequency,0,0
86778,of,0,0
86779,early,0,0
86780,postoperative,0,0
86781,infections,0,0
86782,",",0,0
86783,and,0,0
86784,with,0,0
86785,regard,0,0
86786,to,0,0
86787,immunological,0,0
86788,parameters,0,0
86789,.,0,0
86790,On,0,0
86791,the,0,0
86792,other,0,0
86793,hand,0,0
86794,",",0,0
86795,in,0,0
86796,relatively,0,0
86797,hypo-ergic,0,0
86798,subjects,0,0
86799,",",0,0
86800,benefits,0,0
86801,were,0,0
86802,limited,0,0
86803,to,0,0
86804,the,0,0
86805,improvement,0,0
86806,of,0,0
86807,some,0,0
86808,immunological,0,0
86809,parameters,0,0
86810,.,0,0
86811,In,0,0
86812,our,0,0
86813,opinion,0,0
86814,",",0,0
86815,the,0,0
86816,use,0,0
86817,of,0,0
86818,thymostimulin,1,1
86819,is,0,0
86820,of,0,0
86821,particular,0,0
86822,use,0,0
86823,only,0,0
86824,in,0,0
86825,those,0,0
86826,subjects,0,0
86827,with,0,0
86828,marked,0,0
86829,immunodepression,0,0
86830,since,0,0
86831,the,0,0
86832,incidence,0,0
86833,of,0,0
86834,post-operative,0,0
86835,sepsis,0,0
86836,is,0,0
86837,highest,0,0
86838,in,0,0
86839,this,0,0
86840,group,0,0
86841,.,0,0
86842,Neuromuscular,0,0
86843,excitability,0,0
86844,changes,0,0
86845,in,0,0
86846,the,0,0
86847,vastus,0,0
86848,medialis,0,0
86849,following,0,0
86850,anterior,1,0
86851,cruciate,1,0
86852,ligament,1,0
86853,reconstruction,1,0
86854,.,1,0
86855,PURPOSE,0,0
86856,Quadriceps,0,0
86857,weakness,0,0
86858,following,0,0
86859,anterior,0,0
86860,cruciate,1,0
86861,ligament,1,1
86862,reconstruction,1,1
86863,(,1,1
86864,ACLR,1,1
86865,),1,0
86866,is,0,0
86867,prevalent,0,0
86868,despite,0,0
86869,intensive,0,0
86870,rehabilitation,0,0
86871,.,0,0
86872,Diminished,0,0
86873,neuromuscular,0,0
86874,excitability,0,0
86875,is,0,0
86876,one,0,0
86877,potential,0,0
86878,factor,0,0
86879,that,0,0
86880,may,0,0
86881,limit,0,0
86882,muscular,0,0
86883,recovery,0,0
86884,following,0,0
86885,injury,0,0
86886,or,0,0
86887,surgery,0,0
86888,.,0,0
86889,The,0,0
86890,H-reflex,0,0
86891,provides,0,0
86892,a,0,0
86893,measure,0,0
86894,of,0,0
86895,alpha,0,0
86896,motorneuron,0,1
86897,(,0,1
86898,neuromuscular,0,1
86899,),0,1
86900,excitability,0,0
86901,in,0,0
86902,the,0,0
86903,sensory-motor,0,0
86904,pathway,0,0
86905,of,0,0
86906,the,0,0
86907,respective,0,0
86908,muscle,0,0
86909,and,0,0
86910,nerve,0,0
86911,.,0,0
86912,To,0,0
86913,date,0,0
86914,the,0,0
86915,vastus,0,1
86916,medialis,0,1
86917,(,0,1
86918,VM,0,1
86919,),0,1
86920,and,0,0
86921,soleus,0,1
86922,(,0,1
86923,SOL,0,1
86924,),0,1
86925,H-reflexes,0,0
86926,have,0,0
86927,been,0,0
86928,examined,0,0
86929,primarily,0,0
86930,in,0,0
86931,control,0,0
86932,subjects,0,0
86933,with,0,0
86934,induced,0,0
86935,knee,0,0
86936,joint,0,0
86937,effusion,0,0
86938,.,0,0
86939,This,0,0
86940,prospective,0,0
86941,",",0,0
86942,randomized,0,0
86943,clinical,0,0
86944,trial,0,0
86945,evaluated,0,0
86946,the,0,0
86947,affect,0,0
86948,of,0,0
86949,ACLR,1,0
86950,",",0,0
86951,utilizing,0,0
86952,hamsting,1,1
86953,(,1,1
86954,HS,1,1
86955,),1,1
86956,or,1,0
86957,bone-patellar,1,1
86958,tendon-bone,1,1
86959,(,1,1
86960,BTB,1,1
86961,),1,1
86962,autograft,1,0
86963,",",0,0
86964,on,0,0
86965,VM,0,0
86966,and,0,0
86967,SOL,0,1
86968,H-reflex,0,1
86969,latency,0,0
86970,and,0,0
86971,amplitude,0,0
86972,in,0,0
86973,twenty,0,0
86974,subjects,0,0
86975,.,0,0
86976,METHODS,0,0
86977,Preoperatively,0,0
86978,bilateral,0,0
86979,VM,0,1
86980,and,0,0
86981,SOL,0,1
86982,H-reflex,0,0
86983,tests,0,0
86984,were,0,0
86985,conducted,0,0
86986,.,0,0
86987,VM,0,0
86988,and,0,0
86989,SOL,0,0
86990,H-reflexes,0,0
86991,were,0,0
86992,subsequently,0,0
86993,conducted,0,0
86994,on,0,0
86995,the,0,0
86996,involved,0,0
86997,lower,0,0
86998,extremity,0,0
86999,at,0,0
87000,1,0,0
87001,and,0,0
87002,3,0,0
87003,months,0,0
87004,post,0,0
87005,surgery,0,0
87006,.,0,0
87007,At,0,0
87008,each,0,0
87009,test,0,0
87010,session,0,0
87011,subjects,0,0
87012,completed,0,0
87013,visual,0,1
87014,analog,0,1
87015,scales,0,1
87016,and,0,0
87017,knee,0,0
87018,girth,0,0
87019,was,0,0
87020,measured,0,0
87021,.,0,0
87022,RESULTS,0,0
87023,The,0,0
87024,VM,0,0
87025,H-reflex,0,0
87026,amplitude,0,0
87027,increased,0,0
87028,in,0,0
87029,the,0,0
87030,HS,0,0
87031,group,0,0
87032,at,0,0
87033,3,0,0
87034,months,0,0
87035,compared,0,0
87036,to,0,0
87037,1-month,0,0
87038,post,0,0
87039,surgery,0,0
87040,(,0,0
87041,p,0,0
87042,<,0,0
87043,.05,0,0
87044,),0,0
87045,.,0,0
87046,Significant,0,0
87047,changes,0,0
87048,over,0,0
87049,time,0,0
87050,were,0,0
87051,also,0,0
87052,noted,0,0
87053,in,0,0
87054,the,0,0
87055,visual,0,0
87056,analog,0,1
87057,pain,0,1
87058,and,0,0
87059,functional,0,0
87060,scales,0,0
87061,and,0,0
87062,the,0,0
87063,mid-patella,0,0
87064,girth,0,0
87065,.,0,0
87066,CONCLUSIONS,0,0
87067,The,0,0
87068,increased,0,0
87069,VM,0,0
87070,H-reflex,0,0
87071,amplitude,0,0
87072,at,0,0
87073,3,0,0
87074,months,0,0
87075,following,0,0
87076,HS,0,0
87077,autograft,0,0
87078,ACLR,1,0
87079,demonstrates,0,0
87080,an,0,0
87081,increase,0,0
87082,in,0,0
87083,VM,0,0
87084,neuromuscular,0,0
87085,excitability,0,0
87086,.,0,0
87087,Increased,0,0
87088,VM,0,0
87089,neuromuscular,0,0
87090,excitability,0,0
87091,was,0,0
87092,not,0,0
87093,evident,0,0
87094,in,0,0
87095,patients,0,0
87096,following,0,0
87097,BTB,0,0
87098,reconstruction,0,0
87099,.,0,0
87100,The,0,0
87101,increased,0,0
87102,neuromuscular,0,0
87103,excitability,0,0
87104,",",0,0
87105,observed,0,0
87106,only,0,0
87107,in,0,0
87108,the,0,0
87109,HS,0,0
87110,group,0,0
87111,",",0,0
87112,warrants,0,0
87113,consideration,0,0
87114,when,0,0
87115,selecting,0,0
87116,graft,0,0
87117,type,0,0
87118,for,0,0
87119,patients,0,0
87120,with,0,0
87121,extensive,0,0
87122,preoperative,0,0
87123,quadriceps,0,0
87124,dysfunction,0,0
87125,.,0,0
87126,Cognitive,1,1
87127,behavioral,1,0
87128,therapy,1,0
87129,for,0,0
87130,anxiety,0,0
87131,in,0,0
87132,children,0,0
87133,with,0,0
87134,autism,0,0
87135,spectrum,0,0
87136,disorders,0,0
87137,:,0,0
87138,a,0,0
87139,randomized,0,0
87140,",",0,0
87141,controlled,0,0
87142,trial,0,0
87143,.,0,0
87144,BACKGROUND,0,0
87145,Children,0,0
87146,with,0,0
87147,autism,0,0
87148,spectrum,0,0
87149,disorders,0,0
87150,often,0,0
87151,present,0,0
87152,with,0,0
87153,comorbid,0,0
87154,anxiety,0,0
87155,disorders,0,0
87156,that,0,0
87157,cause,0,0
87158,significant,0,0
87159,functional,0,0
87160,impairment,0,0
87161,.,0,0
87162,This,0,0
87163,study,0,0
87164,tested,0,0
87165,a,0,0
87166,modular,1,0
87167,cognitive,1,0
87168,behavioral,1,1
87169,therapy,1,1
87170,(,1,1
87171,CBT,1,1
87172,),1,1
87173,program,0,0
87174,for,0,0
87175,children,0,0
87176,with,0,0
87177,this,0,0
87178,profile,0,0
87179,.,0,0
87180,A,0,0
87181,standard,0,0
87182,CBT,1,1
87183,program,0,0
87184,was,0,0
87185,augmented,0,0
87186,with,0,0
87187,multiple,0,0
87188,treatment,0,0
87189,components,0,0
87190,designed,0,0
87191,to,0,0
87192,accommodate,0,0
87193,or,0,0
87194,remediate,0,0
87195,the,0,0
87196,social,0,0
87197,and,0,0
87198,adaptive,0,0
87199,skill,0,0
87200,deficits,0,0
87201,of,0,0
87202,children,0,0
87203,with,0,0
87204,ASD,0,0
87205,that,0,0
87206,could,0,0
87207,pose,0,0
87208,barriers,0,0
87209,to,0,0
87210,anxiety,0,0
87211,reduction,0,0
87212,.,0,0
87213,METHOD,0,0
87214,Forty,0,1
87215,children,0,0
87216,(,0,0
87217,7-11,0,0
87218,years,0,0
87219,old,0,0
87220,),0,0
87221,were,0,0
87222,randomly,0,0
87223,assigned,0,0
87224,to,0,0
87225,16,0,0
87226,sessions,0,0
87227,of,0,0
87228,CBT,1,0
87229,or,0,0
87230,a,0,0
87231,3-month,1,1
87232,waitlist,1,0
87233,(,0,0
87234,36,0,0
87235,completed,0,0
87236,treatment,0,0
87237,or,0,0
87238,waitlist,0,1
87239,),0,0
87240,.,0,0
87241,Therapists,0,0
87242,worked,0,0
87243,with,0,0
87244,individual,0,0
87245,families,0,0
87246,.,0,0
87247,The,0,0
87248,CBT,1,0
87249,model,0,0
87250,emphasized,0,0
87251,behavioral,0,0
87252,experimentation,0,1
87253,",",0,0
87254,parent-training,0,0
87255,",",0,0
87256,and,0,0
87257,school,0,0
87258,consultation,0,0
87259,.,0,0
87260,Independent,0,0
87261,evaluators,0,0
87262,blind,0,0
87263,to,0,0
87264,treatment,0,0
87265,condition,0,0
87266,conducted,0,0
87267,structured,0,0
87268,diagnostic,0,0
87269,interviews,0,0
87270,and,0,0
87271,parents,0,0
87272,and,0,0
87273,children,0,0
87274,completed,0,1
87275,anxiety,0,1
87276,symptom,0,0
87277,checklists,0,0
87278,at,0,0
87279,baseline,0,0
87280,and,0,0
87281,posttreatment/postwaitlist,0,0
87282,.,0,0
87283,RESULTS,0,0
87284,In,0,0
87285,intent-to-treat,0,0
87286,analyses,0,0
87287,",",0,0
87288,78.5,0,0
87289,%,0,0
87290,of,0,0
87291,the,0,0
87292,CBT,1,1
87293,group,0,0
87294,met,0,0
87295,Clinical,0,0
87296,Global,0,0
87297,Impressions-Improvement,0,0
87298,scale,0,0
87299,criteria,0,0
87300,for,0,0
87301,positive,0,0
87302,treatment,0,0
87303,response,0,0
87304,at,0,0
87305,posttreatment,0,0
87306,",",0,0
87307,as,0,0
87308,compared,0,0
87309,to,0,0
87310,only,0,0
87311,8.7,0,0
87312,%,0,0
87313,of,0,0
87314,the,0,0
87315,waitlist,1,0
87316,group,0,0
87317,.,0,0
87318,CBT,1,0
87319,also,0,0
87320,outperformed,0,0
87321,the,0,0
87322,waitlist,1,0
87323,on,0,0
87324,diagnostic,0,0
87325,outcomes,0,0
87326,and,0,0
87327,parent,0,0
87328,reports,0,0
87329,of,0,0
87330,child,0,0
87331,anxiety,0,0
87332,",",0,0
87333,but,0,0
87334,not,0,0
87335,children,0,0
87336,'s,0,0
87337,self-reports,0,0
87338,.,0,0
87339,Treatment,0,0
87340,gains,0,0
87341,were,0,0
87342,maintained,0,0
87343,at,0,0
87344,3-month,0,0
87345,follow-up,0,0
87346,.,0,0
87347,CONCLUSIONS,0,0
87348,The,0,0
87349,CBT,1,0
87350,manual,0,0
87351,employed,0,0
87352,in,0,0
87353,this,0,0
87354,study,0,0
87355,is,0,0
87356,one,0,0
87357,of,0,0
87358,the,0,0
87359,first,0,0
87360,adaptations,0,0
87361,of,0,0
87362,an,0,0
87363,evidence-based,0,0
87364,treatment,0,0
87365,for,0,0
87366,children,0,0
87367,with,0,0
87368,autism,0,0
87369,spectrum,0,0
87370,disorders,0,0
87371,.,0,0
87372,Remission,0,0
87373,of,0,0
87374,anxiety,0,0
87375,disorders,0,0
87376,appears,0,0
87377,to,0,0
87378,be,0,0
87379,an,0,0
87380,achievable,0,0
87381,goal,0,0
87382,among,0,0
87383,high-functioning,0,0
87384,children,0,0
87385,with,0,0
87386,autism,0,0
87387,.,0,0
87388,The,0,0
87389,SNRI,1,0
87390,venlafaxine,1,1
87391,improves,0,0
87392,emotional,0,1
87393,unawareness,0,0
87394,in,0,0
87395,patients,0,0
87396,with,0,0
87397,post-stroke,0,0
87398,depression,0,0
87399,.,0,0
87400,OBJECTIVE,0,0
87401,Patients,0,0
87402,with,0,0
87403,stroke,0,0
87404,have,0,0
87405,a,0,0
87406,high,0,0
87407,prevalence,0,0
87408,of,0,0
87409,depression,0,0
87410,and,0,0
87411,unawareness,0,0
87412,of,0,0
87413,emotions,0,0
87414,or,0,0
87415,alexithymia,0,0
87416,.,0,0
87417,Here,0,0
87418,we,0,0
87419,investigated,0,0
87420,the,0,0
87421,effects,0,0
87422,of,0,0
87423,the,0,0
87424,serotoninergic,1,1
87425,and,1,1
87426,noradrenergic,1,1
87427,reuptake,1,1
87428,inhibitor,1,1
87429,(,1,1
87430,SNRI,1,1
87431,),1,1
87432,venlafaxine,1,1
87433,in,0,0
87434,comparison,0,0
87435,with,0,0
87436,the,0,0
87437,SSRI,1,1
87438,fluoxetine,1,1
87439,on,0,0
87440,alexithymia,0,0
87441,severity,0,0
87442,in,0,0
87443,patients,0,0
87444,with,0,0
87445,DSM-IV,0,0
87446,post-stroke,0,0
87447,major,0,0
87448,depressive-like,0,1
87449,episode,0,1
87450,(,0,1
87451,PSD,0,1
87452,),0,1
87453,.,0,0
87454,METHODS,0,0
87455,Fifty,0,0
87456,inpatients,0,0
87457,with,0,0
87458,first-ever,0,0
87459,stroke,0,0
87460,and,0,0
87461,PSD,0,0
87462,were,0,0
87463,consecutively,0,0
87464,enrolled,0,0
87465,in,0,0
87466,this,0,0
87467,randomized,0,0
87468,open-label,0,1
87469,study,0,0
87470,.,0,0
87471,Twenty-five,0,0
87472,were,0,0
87473,treated,0,0
87474,with,0,0
87475,the,0,0
87476,SNRI,1,1
87477,venlafaxine,1,1
87478,SR,0,1
87479,(,0,1
87480,75-150,0,1
87481,mg/die,0,1
87482,),0,1
87483,",",0,0
87484,and,0,0
87485,25,0,0
87486,with,0,0
87487,the,0,0
87488,SSRI,1,1
87489,fluoxetine,1,1
87490,(,0,1
87491,20-40,0,1
87492,mg/die,0,1
87493,),0,1
87494,.,0,0
87495,All,0,0
87496,patients,0,0
87497,were,0,0
87498,assessed,0,0
87499,at,0,0
87500,day,0,0
87501,0,0,0
87502,",",0,0
87503,and,0,0
87504,after,0,0
87505,1,0,0
87506,",",0,0
87507,2,0,0
87508,",",0,0
87509,4,0,0
87510,",",0,0
87511,6,0,0
87512,",",0,0
87513,and,0,0
87514,8,0,0
87515,weeks,0,0
87516,",",0,0
87517,using,0,0
87518,the,0,0
87519,Mini-Mental,0,0
87520,State,0,0
87521,Examination,0,0
87522,",",0,0
87523,the,0,0
87524,Hamilton,0,0
87525,Depression,0,0
87526,Rating,0,0
87527,Scale,0,0
87528,",",0,0
87529,and,0,0
87530,the,0,0
87531,Toronto,0,0
87532,Alexithymia,0,1
87533,Scale,0,1
87534,(,0,1
87535,TAS-20,0,1
87536,),0,1
87537,.,0,0
87538,RESULTS,0,0
87539,Patients,0,0
87540,treated,0,0
87541,with,0,0
87542,fluoxetine,0,1
87543,and,0,0
87544,those,0,0
87545,treated,0,0
87546,with,0,0
87547,venlafaxine,0,1
87548,showed,0,0
87549,similar,0,0
87550,improvement,0,0
87551,in,0,0
87552,depressive,0,0
87553,symptoms,0,0
87554,.,0,0
87555,However,0,0
87556,",",0,0
87557,patients,0,0
87558,treated,0,0
87559,with,0,0
87560,venlafaxine,0,1
87561,had,0,0
87562,a,0,0
87563,greater,0,0
87564,improvement,0,0
87565,on,0,0
87566,alexithymia,0,0
87567,severity,0,0
87568,than,0,0
87569,those,0,0
87570,treated,0,0
87571,with,0,0
87572,fluoxetine,0,1
87573,.,0,0
87574,The,0,0
87575,effect,0,0
87576,of,0,0
87577,venlafaxine,0,1
87578,on,0,0
87579,unawareness,0,0
87580,of,0,0
87581,emotions,0,0
87582,was,0,0
87583,evident,0,0
87584,in,0,0
87585,patients,0,0
87586,with,0,0
87587,alexithymia,0,0
87588,(,0,0
87589,TAS-20,0,0
87590,>,0,0
87591,or=,0,0
87592,61,0,0
87593,),0,0
87594,at,0,0
87595,the,0,0
87596,baseline,0,0
87597,and,0,0
87598,in,0,0
87599,those,0,0
87600,without,0,0
87601,alexithymia,0,0
87602,(,0,0
87603,TAS-20,0,0
87604,<,0,0
87605,61,0,0
87606,),0,0
87607,.,0,0
87608,CONCLUSIONS,0,1
87609,Antidepressants,0,1
87610,acting,0,0
87611,on,0,0
87612,both,0,0
87613,the,0,0
87614,serotoninergic,0,1
87615,and,0,1
87616,noradrenergic,0,1
87617,systems,0,0
87618,might,0,0
87619,represent,0,0
87620,a,0,0
87621,valid,0,0
87622,resource,0,0
87623,not,0,0
87624,only,0,0
87625,for,0,0
87626,the,0,0
87627,treatment,0,0
87628,of,0,0
87629,depression,0,0
87630,but,0,0
87631,also,0,0
87632,for,0,0
87633,improving,0,0
87634,emotional,0,0
87635,unawareness,0,0
87636,in,0,0
87637,stroke,0,0
87638,patients,0,0
87639,.,0,0
87640,Bridge,1,0
87641,plate,1,0
87642,osteosynthesis,1,0
87643,using,1,0
87644,dynamic,1,0
87645,condylar,1,0
87646,screw,1,1
87647,(,1,1
87648,DCS,1,1
87649,),1,1
87650,or,1,0
87651,retrograde,1,1
87652,intramedullary,1,1
87653,supracondylar,1,1
87654,nail,1,1
87655,(,1,1
87656,RIMSN,1,1
87657,),1,0
87658,in,0,0
87659,the,0,0
87660,treatment,0,0
87661,of,0,0
87662,distal,0,0
87663,femoral,0,0
87664,fractures,0,0
87665,:,0,0
87666,comparison,0,0
87667,of,0,0
87668,two,0,0
87669,methods,0,0
87670,in,0,0
87671,a,0,0
87672,prospective,0,0
87673,randomized,0,0
87674,study,0,0
87675,.,0,0
87676,BACKGROUND,0,0
87677,The,0,0
87678,treatment,0,0
87679,of,0,0
87680,distal,0,0
87681,femoral,0,0
87682,fractures,0,0
87683,remains,0,0
87684,a,0,0
87685,significant,0,0
87686,surgical,0,0
87687,challenge,0,0
87688,.,0,0
87689,With,0,0
87690,the,0,0
87691,rigid,0,0
87692,fixation,0,0
87693,of,0,0
87694,the,0,0
87695,distal,0,0
87696,femoral,0,0
87697,fractures,0,0
87698,",",0,0
87699,bone,0,0
87700,grafting,0,0
87701,is,0,0
87702,frequently,0,0
87703,needed,0,0
87704,.,0,0
87705,Biological,0,0
87706,osteosynthesis,0,0
87707,using,0,0
87708,dynamic,0,0
87709,condylar,0,0
87710,screw,0,1
87711,(,0,1
87712,DCS,0,1
87713,),0,1
87714,and,0,0
87715,retrograde,0,1
87716,intramedullary,0,1
87717,supracondylar,0,1
87718,nail,0,1
87719,(,0,1
87720,RIMSN,0,1
87721,),0,0
87722,preserve,0,0
87723,the,0,0
87724,blood,0,0
87725,supply,0,0
87726,and,0,0
87727,limit,0,0
87728,the,0,0
87729,need,0,0
87730,for,0,0
87731,bone,0,0
87732,grafting,0,0
87733,.,0,0
87734,METHODS,0,0
87735,From,0,1
87736,September,0,0
87737,2002,0,0
87738,to,0,0
87739,December,0,0
87740,2004,0,0
87741,",",0,0
87742,68,0,0
87743,closed,0,0
87744,fractures,0,0
87745,of,0,0
87746,the,0,0
87747,distal,0,0
87748,femur,0,0
87749,were,0,0
87750,treated,0,0
87751,by,0,0
87752,bridge,1,0
87753,plate,1,0
87754,osteosynthesis,1,0
87755,using,1,0
87756,DCS,1,0
87757,in,1,0
87758,31,1,0
87759,and,1,0
87760,RIMSN,1,0
87761,in,1,0
87762,37,1,0
87763,.,1,0
87764,The,0,0
87765,patients,0,0
87766,were,0,0
87767,allocated,0,0
87768,to,0,0
87769,one,0,0
87770,of,0,0
87771,the,0,0
87772,two,0,0
87773,groups,0,0
87774,randomly,0,0
87775,and,0,0
87776,followed,0,0
87777,for,0,0
87778,24-36,0,0
87779,months,0,0
87780,(,0,0
87781,average,0,0
87782,:,0,0
87783,30,0,0
87784,months,0,0
87785,),0,0
87786,.,0,0
87787,RESULTS,0,0
87788,With,0,0
87789,respect,0,0
87790,to,0,0
87791,operation,0,0
87792,time,0,0
87793,",",0,0
87794,the,0,0
87795,DCS,0,1
87796,group,0,0
87797,presented,0,0
87798,significantly,0,0
87799,better,0,0
87800,results,0,0
87801,than,0,0
87802,the,0,0
87803,RIMSN,0,1
87804,group,0,0
87805,(,0,0
87806,p=0.000,0,0
87807,),0,0
87808,.,0,0
87809,However,0,0
87810,",",0,0
87811,the,0,0
87812,blood,0,0
87813,loss,0,0
87814,was,0,0
87815,significantly,0,0
87816,more,0,0
87817,in,0,0
87818,the,0,0
87819,DCS,0,1
87820,group,0,0
87821,(,0,0
87822,p=0.000,0,0
87823,),0,0
87824,.,0,0
87825,There,0,0
87826,were,0,0
87827,no,0,0
87828,significant,0,0
87829,differences,0,0
87830,in,0,0
87831,terms,0,0
87832,of,0,0
87833,cumulative,0,0
87834,rate,0,0
87835,of,0,0
87836,union,0,0
87837,(,0,0
87838,p=0.855,0,0
87839,),0,0
87840,",",0,0
87841,range,0,0
87842,of,0,0
87843,motion,0,0
87844,of,0,0
87845,the,0,0
87846,knee,0,0
87847,(,0,0
87848,p=0.727,0,0
87849,),0,0
87850,",",0,0
87851,overall,0,0
87852,results,0,0
87853,(,0,0
87854,p=0.925,0,0
87855,),0,0
87856,and,0,0
87857,complications,0,0
87858,(,0,0
87859,p=0.927,0,0
87860,),0,0
87861,between,0,0
87862,the,0,0
87863,two,0,0
87864,groups,0,0
87865,.,0,0
87866,CONCLUSION,0,1
87867,No,0,1
87868,implant,0,1
87869,or,0,0
87870,surgical,0,0
87871,technique,0,0
87872,is,0,0
87873,superior,0,0
87874,to,0,0
87875,any,0,0
87876,other,0,0
87877,under,0,0
87878,all,0,0
87879,circumstances,0,0
87880,for,0,0
87881,distal,0,0
87882,femoral,0,0
87883,fracture,0,0
87884,.,0,0
87885,RIMSN,0,0
87886,is,0,0
87887,standard,0,0
87888,care,0,0
87889,",",0,0
87890,yet,0,0
87891,the,0,0
87892,biological,0,0
87893,osteosynthesis,0,0
87894,using,0,0
87895,DCS,0,0
87896,is,0,0
87897,a,0,0
87898,very,0,0
87899,good,0,0
87900,alternative,0,0
87901,for,0,0
87902,the,0,0
87903,treatment,0,0
87904,of,0,0
87905,distal,0,0
87906,femoral,0,0
87907,fractures,0,0
87908,.,0,0
87909,MDM2,0,1
87910,and,0,0
87911,Ki-67,0,0
87912,predict,0,0
87913,for,0,0
87914,distant,0,0
87915,metastasis,0,0
87916,and,0,0
87917,mortality,0,0
87918,in,0,0
87919,men,0,0
87920,treated,0,0
87921,with,0,0
87922,radiotherapy,1,0
87923,and,0,0
87924,androgen,1,1
87925,deprivation,1,1
87926,for,0,0
87927,prostate,0,0
87928,cancer,0,0
87929,:,0,0
87930,RTOG,0,0
87931,92-02,0,0
87932,.,0,0
87933,PURPOSE,0,0
87934,MDM2,0,0
87935,regulates,0,0
87936,p53,0,0
87937,",",0,0
87938,which,0,0
87939,controls,0,0
87940,cell,0,0
87941,cycle,0,0
87942,arrest,0,0
87943,and,0,0
87944,apoptosis,0,0
87945,.,0,0
87946,Both,0,0
87947,proteins,0,0
87948,",",0,0
87949,along,0,0
87950,with,0,0
87951,Ki-67,0,0
87952,",",0,0
87953,which,0,0
87954,is,0,0
87955,an,0,0
87956,established,0,0
87957,strong,0,0
87958,determinant,0,0
87959,of,0,0
87960,metastasis,0,0
87961,",",0,0
87962,have,0,0
87963,shown,0,0
87964,promise,0,0
87965,in,0,0
87966,predicting,0,0
87967,the,0,0
87968,outcome,0,0
87969,of,0,0
87970,men,0,0
87971,treated,0,0
87972,with,0,0
87973,radiation,1,0
87974,therapy,1,0
87975,(,1,1
87976,RT,1,1
87977,),1,1
87978,with,1,0
87979,or,1,0
87980,without,1,0
87981,short-term,1,1
87982,androgen,1,1
87983,deprivation,1,1
87984,(,1,1
87985,STAD,1,1
87986,),1,1
87987,.,1,0
87988,This,0,0
87989,report,0,0
87990,compares,0,0
87991,the,0,0
87992,utility,0,0
87993,of,0,0
87994,abnormal,0,0
87995,expression,0,0
87996,of,0,0
87997,these,0,0
87998,biomarkers,0,0
87999,in,0,0
88000,estimating,0,0
88001,progression,0,0
88002,in,0,0
88003,a,0,0
88004,cohort,0,0
88005,of,0,0
88006,men,0,0
88007,treated,0,0
88008,on,0,0
88009,RTOG,0,0
88010,92-02,0,0
88011,.,0,0
88012,PATIENTS,0,0
88013,AND,0,0
88014,METHODS,0,0
88015,Adequate,0,0
88016,tissue,0,0
88017,for,0,0
88018,immunohistochemistry,0,0
88019,was,0,0
88020,available,0,0
88021,for,0,0
88022,p53,0,0
88023,",",0,0
88024,Ki-67,0,1
88025,",",0,0
88026,and,0,0
88027,MDM2,0,0
88028,analyses,0,0
88029,in,0,0
88030,478,0,0
88031,patient,0,0
88032,cases,0,0
88033,.,0,0
88034,The,0,0
88035,percentage,0,0
88036,of,0,0
88037,tumor,0,0
88038,nuclei,0,0
88039,staining,0,0
88040,positive,0,0
88041,(,0,0
88042,PSP,0,1
88043,),0,0
88044,was,0,0
88045,quantified,0,0
88046,manually,0,0
88047,or,0,0
88048,by,0,0
88049,image,0,0
88050,analysis,0,0
88051,",",0,0
88052,and,0,0
88053,the,0,0
88054,per-sample,0,0
88055,mean,0,0
88056,intensity,0,0
88057,score,0,0
88058,(,0,1
88059,MIS,0,1
88060,),0,0
88061,was,0,0
88062,quantified,0,0
88063,by,0,0
88064,image,0,0
88065,analysis,0,0
88066,.,0,0
88067,Cox,0,0
88068,regression,0,0
88069,models,0,0
88070,were,0,0
88071,used,0,0
88072,to,0,0
88073,estimate,0,0
88074,overall,0,0
88075,mortality,0,0
88076,(,0,1
88077,OM,0,1
88078,),0,1
88079,",",0,0
88080,and,0,0
88081,Fine,0,1
88082,and,0,1
88083,Gray,0,1
88084,'s,0,0
88085,regressions,0,0
88086,were,0,0
88087,applied,0,0
88088,to,0,0
88089,the,0,0
88090,end,0,0
88091,points,0,0
88092,of,0,0
88093,distant,0,0
88094,metastasis,0,0
88095,(,0,1
88096,DM,0,1
88097,),0,1
88098,and,0,0
88099,cause-specific,0,1
88100,mortality,0,1
88101,(,0,1
88102,CSM,0,1
88103,),0,1
88104,.,0,0
88105,Results,0,0
88106,In,0,0
88107,multivariate,0,0
88108,analyses,0,0
88109,that,0,0
88110,adjusted,0,0
88111,for,0,0
88112,all,0,0
88113,markers,0,0
88114,and,0,0
88115,treatment,0,0
88116,covariates,0,0
88117,",",0,0
88118,MDM2,0,0
88119,overexpression,0,0
88120,was,0,0
88121,significantly,0,0
88122,related,0,0
88123,to,0,0
88124,DM,0,0
88125,(,0,0
88126,P,0,0
88127,=,0,0
88128,.02,0,0
88129,),0,0
88130,and,0,0
88131,OM,0,0
88132,(,0,0
88133,P,0,0
88134,=,0,0
88135,.003,0,0
88136,),0,0
88137,",",0,0
88138,and,0,0
88139,Ki-67,0,0
88140,overexpression,0,0
88141,was,0,0
88142,significantly,0,0
88143,related,0,0
88144,to,0,0
88145,DM,0,0
88146,(,0,0
88147,P,0,0
88148,<,0,0
88149,.0001,0,0
88150,),0,0
88151,",",0,0
88152,CSM,0,0
88153,(,0,0
88154,P,0,0
88155,=,0,0
88156,.0007,0,0
88157,),0,0
88158,",",0,0
88159,and,0,0
88160,OM,0,0
88161,(,0,0
88162,P,0,0
88163,=,0,0
88164,.01,0,0
88165,),0,0
88166,.,0,0
88167,P53,0,0
88168,overexpression,0,0
88169,was,0,0
88170,significantly,0,0
88171,related,0,0
88172,to,0,0
88173,OM,0,0
88174,(,0,0
88175,P,0,0
88176,=,0,0
88177,.02,0,0
88178,),0,0
88179,.,0,0
88180,When,0,0
88181,considered,0,0
88182,in,0,0
88183,combination,0,0
88184,",",0,0
88185,the,0,0
88186,overexpression,0,0
88187,of,0,0
88188,both,0,0
88189,Ki-67,0,0
88190,and,0,0
88191,MDM2,0,0
88192,at,0,0
88193,high,0,0
88194,levels,0,0
88195,was,0,0
88196,associated,0,0
88197,with,0,0
88198,significantly,0,0
88199,increased,0,0
88200,failure,0,0
88201,rates,0,0
88202,for,0,0
88203,all,0,0
88204,end,0,0
88205,points,0,0
88206,(,0,0
88207,P,0,0
88208,<,0,0
88209,.001,0,0
88210,for,0,0
88211,DM,0,0
88212,",",0,0
88213,CSM,0,0
88214,",",0,0
88215,and,0,0
88216,OM,0,1
88217,),0,0
88218,.,0,0
88219,CONCLUSION,0,0
88220,Combined,0,0
88221,MDM2,0,0
88222,and,0,0
88223,Ki-67,0,0
88224,expression,0,0
88225,levels,0,0
88226,were,0,0
88227,independently,0,0
88228,related,0,0
88229,to,0,0
88230,distant,0,0
88231,metastasis,0,0
88232,and,0,0
88233,mortality,0,0
88234,and,0,0
88235,",",0,0
88236,if,0,0
88237,validated,0,0
88238,",",0,0
88239,could,0,0
88240,be,0,0
88241,considered,0,0
88242,for,0,0
88243,risk,0,0
88244,stratification,0,0
88245,of,0,0
88246,patients,0,0
88247,with,0,0
88248,prostate,0,0
88249,cancer,0,0
88250,in,0,0
88251,clinical,0,0
88252,trials,0,0
88253,.,0,0
88254,One-year,0,0
88255,follow-up,0,0
88256,of,0,0
88257,the,0,0
88258,outcome,0,0
88259,of,0,0
88260,a,0,0
88261,randomized,0,0
88262,controlled,0,0
88263,trial,0,0
88264,of,0,0
88265,a,0,0
88266,home-based,1,0
88267,intervention,1,0
88268,programme,1,0
88269,for,0,0
88270,children,0,0
88271,with,0,0
88272,autism,0,0
88273,and,0,0
88274,developmental,0,0
88275,delay,0,0
88276,and,0,0
88277,their,0,0
88278,families,0,0
88279,.,0,0
88280,INTRODUCTION,0,0
88281,There,0,0
88282,is,0,0
88283,debate,0,0
88284,about,0,0
88285,the,0,0
88286,type,0,0
88287,and,0,0
88288,intensity,0,0
88289,of,0,0
88290,early,1,0
88291,childhood,1,0
88292,intervention,1,0
88293,that,0,0
88294,is,0,0
88295,most,0,0
88296,helpful,0,0
88297,for,0,0
88298,children,0,0
88299,with,0,0
88300,developmental,0,0
88301,problems,0,0
88302,.,0,0
88303,The,0,0
88304,aim,0,0
88305,of,0,0
88306,the,0,0
88307,study,0,0
88308,was,0,0
88309,to,0,0
88310,determine,0,0
88311,whether,0,0
88312,a,0,0
88313,home-based,0,0
88314,programme,0,0
88315,provided,0,0
88316,over,0,0
88317,12,0,0
88318,months,0,0
88319,resulted,0,0
88320,in,0,0
88321,sustained,0,0
88322,improvement,0,0
88323,in,0,0
88324,development,0,0
88325,and,0,0
88326,behaviour,0,0
88327,12,0,0
88328,months,0,0
88329,after,0,0
88330,the,0,0
88331,intervention,0,0
88332,ceased,0,0
88333,.,0,0
88334,The,0,0
88335,characteristics,0,0
88336,of,0,0
88337,the,0,0
88338,children,0,0
88339,and,0,0
88340,families,0,0
88341,who,0,0
88342,benefited,0,0
88343,most,0,0
88344,from,0,0
88345,the,0,0
88346,intervention,0,0
88347,were,0,0
88348,also,0,0
88349,studied,0,0
88350,.,0,0
88351,METHOD,0,0
88352,Randomized,0,0
88353,controlled,0,0
88354,trial,0,0
88355,.,0,0
88356,Participants,0,0
88357,A,0,0
88358,total,0,0
88359,of,0,0
88360,59,0,0
88361,children,0,0
88362,",",0,0
88363,aged,0,0
88364,3-5,0,0
88365,years,0,0
88366,",",0,0
88367,attending,0,0
88368,two,0,0
88369,early,0,0
88370,childhood,0,0
88371,intervention,0,0
88372,centres,0,0
88373,in,0,0
88374,Melbourne,0,0
88375,",",0,0
88376,Australia,0,0
88377,.,0,0
88378,Intervention,1,0
88379,Half,1,0
88380,of,1,0
88381,the,1,0
88382,subjects,1,0
88383,received,1,0
88384,an,1,0
88385,additional,1,0
88386,home-based,1,0
88387,programme,1,0
88388,consisting,1,0
88389,of,1,0
88390,40,1,0
88391,weekly,1,0
88392,visits,1,1
88393,.,1,0
88394,MAIN,0,0
88395,OUTCOME,0,1
88396,MEASURES,0,1
88397,Bayley,0,0
88398,Scales,0,0
88399,of,0,0
88400,Infant,0,0
88401,Development,0,0
88402,and,0,0
88403,Wechsler,0,0
88404,Preschool,0,0
88405,and,0,0
88406,Primary,0,0
88407,Scale,0,0
88408,of,0,0
88409,Intelligence,0,0
88410,Revised,0,0
88411,",",0,0
88412,Preschool,0,0
88413,Behaviour,0,0
88414,Checklist,0,0
88415,",",0,0
88416,Bayley,0,0
88417,Behaviour,0,0
88418,Rating,0,0
88419,Scale,0,0
88420,and,0,0
88421,Behaviour,0,0
88422,Screening,0,0
88423,Questionnaire,0,0
88424,.,0,0
88425,All,0,1
88426,tests,0,1
88427,administered,0,1
88428,pre-intervention,0,1
88429,",",0,0
88430,following,0,0
88431,the,0,0
88432,intervention,0,0
88433,and,0,0
88434,12,0,0
88435,months,0,0
88436,later,0,0
88437,.,0,0
88438,Secondary,0,0
88439,outcome,0,0
88440,measures,0,0
88441,Family,0,0
88442,stress,0,0
88443,",",0,0
88444,support,0,0
88445,and,0,0
88446,empowerment,0,0
88447,.,0,0
88448,RESULTS,0,0
88449,Fifty-four,0,0
88450,children,0,0
88451,completed,0,0
88452,the,0,0
88453,assessments,0,0
88454,12,0,0
88455,months,0,0
88456,after,0,0
88457,conclusion,0,0
88458,of,0,0
88459,the,0,0
88460,intervention,0,0
88461,.,0,0
88462,Compared,0,0
88463,with,0,0
88464,the,0,0
88465,control,0,0
88466,group,0,0
88467,",",0,0
88468,improvement,0,0
88469,in,0,0
88470,aspects,0,0
88471,of,0,0
88472,cognitive,0,0
88473,development,0,0
88474,in,0,0
88475,the,0,0
88476,children,0,0
88477,who,0,0
88478,received,0,0
88479,the,0,0
88480,extra,0,0
88481,intervention,0,0
88482,was,0,0
88483,sustained,0,0
88484,1,0,0
88485,year,0,0
88486,later,0,0
88487,(,0,0
88488,P=,0,0
88489,0.007,0,0
88490,),0,0
88491,while,0,0
88492,significant,0,0
88493,behavioural,0,0
88494,differences,0,0
88495,post,0,0
88496,intervention,0,0
88497,were,0,0
88498,not,0,0
88499,.,0,0
88500,Analyses,0,0
88501,of,0,0
88502,the,0,0
88503,data,0,0
88504,by,0,0
88505,the,0,0
88506,Reliable,0,0
88507,Change,0,0
88508,Index,0,0
88509,indicated,0,0
88510,improvement,0,0
88511,of,0,0
88512,clinical,0,0
88513,significance,0,0
88514,occurred,0,0
88515,in,0,0
88516,non-verbal,0,0
88517,areas,0,0
88518,.,0,0
88519,In,0,0
88520,contrast,0,0
88521,to,0,0
88522,the,0,0
88523,control,0,0
88524,group,0,0
88525,who,0,0
88526,deteriorated,0,0
88527,",",0,0
88528,language,0,0
88529,skills,0,0
88530,in,0,0
88531,the,0,0
88532,intervention,0,0
88533,group,0,0
88534,remained,0,0
88535,stable,0,0
88536,.,0,0
88537,Improvements,0,0
88538,were,0,0
88539,significantly,0,0
88540,associated,0,0
88541,with,0,0
88542,higher,0,0
88543,stress,0,0
88544,in,0,0
88545,the,0,0
88546,families,0,0
88547,.,0,0
88548,CONCLUSION,0,0
88549,Improvements,0,0
88550,following,0,0
88551,the,0,0
88552,provision,0,0
88553,of,0,0
88554,a,0,0
88555,home-based,0,0
88556,programme,0,0
88557,to,0,0
88558,preschool,0,0
88559,children,0,0
88560,with,0,0
88561,developmental,0,0
88562,disabilities,0,0
88563,were,0,0
88564,sustained,0,0
88565,1,0,0
88566,year,0,0
88567,later,0,0
88568,.,0,0
88569,Children,0,0
88570,from,0,0
88571,highly,0,0
88572,stressed,0,0
88573,families,0,0
88574,appeared,0,0
88575,to,0,0
88576,benefit,0,0
88577,most,0,0
88578,",",0,0
88579,reinforcing,0,0
88580,the,0,0
88581,importance,0,0
88582,of,0,0
88583,involving,0,0
88584,families,0,0
88585,in,0,0
88586,early,0,0
88587,childhood,0,0
88588,intervention,0,0
88589,programmes,0,0
88590,.,0,0
88591,Folic,1,1
88592,acid-based,1,0
88593,intervention,1,0
88594,in,0,0
88595,non-ST,0,0
88596,elevation,0,0
88597,acute,0,0
88598,coronary,0,0
88599,syndromes,0,0
88600,.,0,0
88601,Homocysteinemia,0,0
88602,is,0,0
88603,a,0,0
88604,risk,0,0
88605,factor,0,0
88606,for,0,0
88607,cardiovascular,0,0
88608,diseases,0,0
88609,.,0,0
88610,Folic,1,1
88611,acid,1,1
88612,combined,1,1
88613,with,1,1
88614,vitamins,1,1
88615,B,1,1
88616,(,1,1
88617,6,1,0
88618,),1,0
88619,and,1,0
88620,B,1,1
88621,(,1,1
88622,12,1,0
88623,),1,0
88624,is,0,0
88625,effective,0,0
88626,in,0,0
88627,lowering,0,0
88628,homocysteine,0,1
88629,levels,0,0
88630,.,0,0
88631,This,0,0
88632,randomized,0,1
88633,placebo-controlled,1,1
88634,study,0,0
88635,was,0,0
88636,designed,0,0
88637,to,0,0
88638,determine,0,0
88639,the,0,0
88640,effect,0,0
88641,of,0,0
88642,a,0,0
88643,folic,1,1
88644,acid-based,1,1
88645,supplement,1,1
88646,on,0,0
88647,secondary,0,0
88648,prevention,0,0
88649,of,0,0
88650,clinical,0,0
88651,events,0,0
88652,in,0,0
88653,non-ST-segment,0,0
88654,elevation,0,0
88655,acute,0,0
88656,coronary,0,0
88657,syndromes,0,0
88658,.,0,0
88659,The,0,0
88660,study,0,0
88661,comprised,0,0
88662,240,0,0
88663,patients,0,0
88664,with,0,0
88665,either,0,0
88666,unstable,0,0
88667,angina,0,0
88668,or,0,0
88669,non-ST-elevation,0,0
88670,myocardial,0,0
88671,infarction,0,0
88672,in,0,0
88673,the,0,0
88674,previous,0,0
88675,2,0,0
88676,weeks,0,0
88677,who,0,0
88678,were,0,0
88679,randomized,0,0
88680,to,0,0
88681,a,0,0
88682,folate,1,1
88683,group,0,1
88684,(,0,0
88685,n,0,0
88686,=116,0,0
88687,),0,0
88688,or,0,0
88689,a,0,0
88690,placebo,1,1
88691,group,1,1
88692,(,0,0
88693,n,0,0
88694,=124,0,0
88695,),0,0
88696,.,0,0
88697,The,0,0
88698,folate,0,1
88699,group,0,0
88700,received,0,0
88701,1,0,1
88702,mg,0,1
88703,folic,1,1
88704,acid,1,1
88705,",",0,1
88706,400,0,1
88707,microg,0,1
88708,vitamin,1,1
88709,B,1,1
88710,(,1,1
88711,12,1,0
88712,),1,0
88713,",",0,0
88714,and,0,1
88715,10,0,1
88716,mg,0,1
88717,vitamin,1,1
88718,B,1,1
88719,(,1,1
88720,6,1,1
88721,),1,1
88722,daily,0,1
88723,.,0,1
88724,Clinical,0,0
88725,outcomes,0,0
88726,within,0,0
88727,6,0,0
88728,months,0,0
88729,were,0,0
88730,assessed,0,0
88731,.,0,0
88732,The,0,0
88733,composite,0,0
88734,endpoint,0,0
88735,of,0,0
88736,death,0,0
88737,",",0,0
88738,nonfatal,0,0
88739,acute,0,1
88740,coronary,0,0
88741,syndrome,0,0
88742,",",0,0
88743,and,0,0
88744,serious,0,0
88745,re-hospitalization,0,0
88746,was,0,0
88747,significantly,0,0
88748,higher,0,0
88749,in,0,0
88750,the,0,0
88751,folate,0,1
88752,group,0,1
88753,;,0,1
88754,serious,0,1
88755,re-hospitalization,0,0
88756,alone,0,0
88757,was,0,0
88758,significantly,0,0
88759,higher,0,0
88760,in,0,0
88761,this,0,0
88762,group,0,0
88763,.,0,0
88764,Advanced,0,0
88765,age,0,0
88766,and,0,0
88767,diabetes,0,0
88768,increased,0,0
88769,susceptibility,0,0
88770,to,0,0
88771,the,0,0
88772,composite,0,0
88773,outcome,0,0
88774,.,0,0
88775,Folic,1,1
88776,acid-based,1,0
88777,supplementation,1,1
88778,is,0,0
88779,not,0,0
88780,beneficial,0,0
88781,and,0,0
88782,may,0,0
88783,even,0,0
88784,be,0,0
88785,harmful,0,0
88786,in,0,0
88787,the,0,0
88788,secondary,0,0
88789,prevention,0,0
88790,of,0,0
88791,cardiovascular,0,0
88792,events,0,0
88793,in,0,0
88794,patients,0,0
88795,with,0,0
88796,unstable,0,0
88797,angina,0,0
88798,and,0,0
88799,non-ST-elevation,0,0
88800,myocardial,0,0
88801,infarction,0,0
88802,.,0,0
88803,Further,0,0
88804,studies,0,0
88805,on,0,0
88806,the,0,0
88807,safety,0,0
88808,of,0,0
88809,such,0,0
88810,supplements,0,1
88811,are,0,0
88812,suggested,0,0
88813,.,0,0
88814,Controlled,0,0
88815,Clinical,0,0
88816,Trials,0,0
88817,Registry,0,0
88818,no,0,0
88819,.,0,0
88820,ISRCTN30249553,0,0
88821,.,0,0
88822,Leucocyte,0,0
88823,depletion,0,0
88824,of,0,0
88825,perioperative,1,0
88826,blood,1,0
88827,transfusion,1,0
88828,does,0,0
88829,not,0,0
88830,affect,0,0
88831,long-term,0,0
88832,survival,0,0
88833,and,0,0
88834,recurrence,0,0
88835,in,0,0
88836,patients,0,0
88837,with,0,0
88838,gastrointestinal,0,0
88839,cancer,0,0
88840,.,0,0
88841,BACKGROUND,0,0
88842,Perioperative,1,0
88843,red,1,0
88844,blood,1,0
88845,cell,1,0
88846,(,1,1
88847,RBC,1,1
88848,),1,1
88849,transfusion,1,0
88850,may,0,0
88851,be,0,0
88852,associated,0,0
88853,with,0,0
88854,a,0,0
88855,poor,0,0
88856,prognosis,0,0
88857,in,0,0
88858,cancer,0,0
88859,surgery,0,0
88860,.,0,0
88861,Allogeneic,0,0
88862,leucocytes,0,0
88863,are,0,0
88864,assumed,0,0
88865,to,0,0
88866,play,0,0
88867,a,0,0
88868,causal,0,0
88869,role,0,0
88870,.,0,0
88871,This,0,0
88872,study,0,0
88873,evaluated,0,0
88874,the,0,0
88875,long-term,0,0
88876,effect,0,0
88877,of,0,0
88878,transfusion,1,0
88879,with,1,1
88880,leucocyte-depleted,1,1
88881,(,0,1
88882,LD,0,1
88883,),0,1
88884,blood,0,0
88885,in,0,0
88886,patients,0,0
88887,with,0,0
88888,gastrointestinal,0,0
88889,cancer,0,0
88890,.,0,0
88891,METHODS,0,0
88892,The,0,0
88893,Transfusion,0,0
88894,Associated,0,0
88895,Complications,0,0
88896,=,0,0
88897,Transfusion,0,0
88898,Induced,0,0
88899,Complications,0,1
88900,?,0,1
88901,(,0,1
88902,TACTIC,0,1
88903,),0,0
88904,study,0,0
88905,is,0,0
88906,a,0,0
88907,multicentre,0,0
88908,randomized,0,0
88909,controlled,0,0
88910,trial,0,0
88911,evaluating,0,0
88912,the,0,0
88913,short-term,0,0
88914,benefits,0,0
88915,of,0,0
88916,LD,1,0
88917,versus,1,0
88918,non-LD,1,0
88919,RBC,1,0
88920,transfusions,1,0
88921,.,1,0
88922,The,0,0
88923,present,0,0
88924,study,0,0
88925,evaluated,0,0
88926,5-year,0,0
88927,survival,0,0
88928,and,0,0
88929,cancer,0,0
88930,recurrence,0,0
88931,among,0,0
88932,512,0,0
88933,patients,0,0
88934,with,0,0
88935,gastrointestinal,0,0
88936,cancer,0,0
88937,included,0,0
88938,in,0,0
88939,the,0,0
88940,TACTIC,0,0
88941,study,0,0
88942,.,0,0
88943,RESULTS,0,0
88944,Some,0,0
88945,89.2,0,0
88946,per,0,0
88947,cent,0,0
88948,of,0,0
88949,patients,0,0
88950,had,0,0
88951,a,0,0
88952,primary,0,0
88953,tumour,0,0
88954,and,0,0
88955,79.7,0,0
88956,per,0,0
88957,cent,0,0
88958,underwent,0,0
88959,surgery,1,0
88960,with,0,0
88961,curative,0,0
88962,intent,0,0
88963,;,0,0
88964,243,0,0
88965,patients,0,0
88966,received,0,0
88967,perioperative,1,0
88968,RBC,1,1
88969,transfusion,1,0
88970,(,0,0
88971,median,0,0
88972,3,0,0
88973,units,0,0
88974,),0,0
88975,.,0,0
88976,The,0,0
88977,5-year,0,0
88978,overall,0,0
88979,survival,0,0
88980,rate,0,0
88981,of,0,0
88982,patients,0,0
88983,with,0,0
88984,any,0,0
88985,type,0,0
88986,of,0,0
88987,gastrointestinal,0,0
88988,cancer,0,0
88989,was,0,0
88990,50.8,0,0
88991,per,0,0
88992,cent,0,0
88993,in,0,0
88994,the,0,0
88995,LD,0,0
88996,group,0,0
88997,and,0,0
88998,45.8,0,0
88999,per,0,0
89000,cent,0,0
89001,in,0,0
89002,the,0,0
89003,non-LD,0,0
89004,group,0,0
89005,(,0,0
89006,P,0,0
89007,=,0,0
89008,0.191,0,0
89009,),0,0
89010,.,0,0
89011,Corresponding,0,0
89012,5-year,0,0
89013,disease-free,0,0
89014,survival,0,0
89015,rates,0,0
89016,were,0,0
89017,60.0,0,0
89018,and,0,0
89019,56.6,0,0
89020,per,0,0
89021,cent,0,0
89022,(,0,0
89023,P,0,0
89024,=,0,0
89025,0.482,0,0
89026,),0,0
89027,",",0,0
89028,and,0,0
89029,recurrence,0,0
89030,rates,0,0
89031,32.9,0,0
89032,and,0,0
89033,34.3,0,0
89034,per,0,0
89035,cent,0,0
89036,(,0,0
89037,P,0,0
89038,=,0,0
89039,0.864,0,0
89040,),0,0
89041,.,0,0
89042,CONCLUSION,0,0
89043,Leucocyte,0,0
89044,depletion,0,0
89045,is,0,0
89046,not,0,0
89047,associated,0,0
89048,with,0,0
89049,better,0,0
89050,long-term,0,0
89051,survival,0,0
89052,and,0,0
89053,lower,0,0
89054,recurrence,0,0
89055,rates,0,0
89056,in,0,0
89057,patients,0,0
89058,with,0,0
89059,gastrointestinal,0,0
89060,cancer,0,0
89061,.,0,0
89062,Gemcitabine,1,1
89063,combined,1,1
89064,with,1,0
89065,either,1,0
89066,pemetrexed,1,1
89067,or,1,1
89068,paclitaxel,1,1
89069,in,1,0
89070,the,0,0
89071,treatment,0,0
89072,of,0,0
89073,advanced,0,0
89074,non-small,0,0
89075,cell,0,0
89076,lung,0,0
89077,cancer,0,0
89078,:,0,0
89079,a,0,0
89080,randomized,0,0
89081,phase,0,0
89082,II,0,0
89083,SICOG,0,1
89084,trial,0,0
89085,.,0,0
89086,PURPOSE,0,0
89087,To,0,0
89088,estimate,0,0
89089,the,0,0
89090,safety,0,0
89091,",",0,0
89092,activity,0,0
89093,",",0,0
89094,and,0,0
89095,impact,0,0
89096,on,0,0
89097,quality,0,0
89098,of,0,0
89099,life,0,0
89100,of,0,0
89101,a,0,0
89102,combination,1,0
89103,of,1,0
89104,gemcitabine,1,1
89105,and,1,1
89106,pemetrexed,1,1
89107,in,0,0
89108,patients,0,0
89109,with,0,0
89110,locally,0,0
89111,advanced,0,0
89112,or,0,0
89113,metastatic,0,0
89114,non-small,0,0
89115,cell,0,0
89116,lung,0,1
89117,cancer,0,1
89118,(,0,1
89119,NSCLC,0,1
89120,),0,0
89121,in,0,0
89122,the,0,0
89123,context,0,0
89124,of,0,0
89125,a,0,0
89126,randomized,0,0
89127,two-stage,0,0
89128,phase,0,0
89129,II,0,0
89130,study,0,0
89131,.,0,0
89132,PATIENTS,0,0
89133,AND,0,0
89134,METHODS,0,1
89135,Patients,0,0
89136,in,0,0
89137,stage,0,0
89138,IIIB,0,0
89139,or,0,0
89140,IV,0,0
89141,NSCLC,0,0
89142,were,0,0
89143,randomly,0,0
89144,allocated,0,0
89145,to,0,0
89146,receive,0,0
89147,either,1,0
89148,gemcitabine,1,1
89149,1250,0,1
89150,mg/m,0,1
89151,(,0,1
89152,2,0,1
89153,),0,1
89154,on,0,0
89155,day,0,0
89156,1,0,0
89157,",",0,0
89158,and,1,1
89159,pemetrexed,1,1
89160,(,0,1
89161,Alimta,0,1
89162,),0,1
89163,500,0,1
89164,mg/m,0,1
89165,(,0,1
89166,2,0,1
89167,),0,0
89168,followed,1,0
89169,by,1,0
89170,gemcitabine,1,1
89171,1250,0,1
89172,mg/m,0,1
89173,(,0,1
89174,2,0,1
89175,),0,1
89176,on,0,0
89177,day,0,0
89178,8,0,0
89179,of,0,0
89180,a,0,0
89181,3-weekly,0,1
89182,cycle,0,1
89183,(,1,1
89184,GA,1,1
89185,arm,0,1
89186,),0,1
89187,",",0,0
89188,or,0,1
89189,paclitaxel,1,1
89190,120,0,1
89191,mg/m,0,1
89192,(,0,1
89193,2,0,1
89194,),0,0
89195,followed,1,0
89196,by,1,0
89197,gemcitabine,1,1
89198,1000,0,1
89199,mg/m,0,1
89200,(,0,1
89201,2,0,1
89202,),0,0
89203,",",0,0
89204,both,0,0
89205,given,0,0
89206,on,0,0
89207,days,0,0
89208,1,0,0
89209,and,0,0
89210,8,0,0
89211,of,0,0
89212,a,0,0
89213,3-weekly,0,1
89214,cycle,0,1
89215,(,1,1
89216,PG,1,1
89217,arm,0,1
89218,),0,0
89219,.,0,0
89220,RESULTS,0,0
89221,105,0,0
89222,(,0,0
89223,GA,0,1
89224,arm,0,1
89225,",",0,0
89226,51,0,0
89227,;,0,0
89228,PG,0,0
89229,arm,0,0
89230,",",0,0
89231,54,0,0
89232,),0,0
89233,eligible,0,0
89234,patients,0,0
89235,(,0,0
89236,stage,0,0
89237,IV,0,0
89238,",",0,0
89239,32,0,0
89240,and,0,0
89241,30,0,0
89242,",",0,0
89243,respectively,0,0
89244,),0,0
89245,were,0,0
89246,enrolled,0,0
89247,into,0,0
89248,this,0,0
89249,study,0,0
89250,;,0,0
89251,thereafter,0,0
89252,",",0,0
89253,accrual,0,0
89254,was,0,0
89255,stopped,0,1
89256,due,0,0
89257,to,0,0
89258,first-stage,0,0
89259,analysis,0,0
89260,.,0,0
89261,The,0,0
89262,response,0,0
89263,rate,0,0
89264,was,0,0
89265,20,0,0
89266,%,0,0
89267,(,0,0
89268,95,0,0
89269,%,0,0
89270,confidence,0,0
89271,interval,0,0
89272,[,0,0
89273,CI,0,0
89274,],0,0
89275,",",0,0
89276,10-33,0,0
89277,%,0,0
89278,),0,0
89279,in,0,0
89280,the,0,0
89281,GA,0,1
89282,arm,0,1
89283,",",0,0
89284,and,0,0
89285,32,0,0
89286,%,0,0
89287,(,0,0
89288,95,0,0
89289,%,0,0
89290,CI,0,0
89291,",",0,0
89292,20-46,0,0
89293,%,0,0
89294,),0,0
89295,in,0,0
89296,the,0,0
89297,PG,0,0
89298,arm,0,0
89299,.,0,0
89300,Median,0,0
89301,progression-free,0,0
89302,survival,0,0
89303,was,0,0
89304,5.1,0,0
89305,(,0,0
89306,95,0,0
89307,%,0,0
89308,CI,0,0
89309,",",0,0
89310,3.7-6.5,0,0
89311,),0,0
89312,months,0,0
89313,in,0,0
89314,the,0,0
89315,GA,0,1
89316,arm,0,1
89317,",",0,0
89318,and,0,0
89319,8.3,0,0
89320,(,0,0
89321,95,0,0
89322,%,0,0
89323,CI,0,0
89324,",",0,0
89325,5.9-10.7,0,0
89326,),0,0
89327,months,0,0
89328,in,0,0
89329,the,0,0
89330,PG,0,0
89331,arm,0,0
89332,",",0,0
89333,while,0,0
89334,median,0,0
89335,overall,0,0
89336,survival,0,0
89337,was,0,0
89338,10.5,0,0
89339,(,0,0
89340,95,0,0
89341,%,0,0
89342,CI,0,0
89343,7.1-13.9,0,0
89344,),0,0
89345,",",0,0
89346,and,0,0
89347,13.3,0,0
89348,(,0,0
89349,95,0,0
89350,%,0,0
89351,CI,0,0
89352,11.7-14.9,0,0
89353,),0,0
89354,months,0,0
89355,",",0,0
89356,respectively,0,0
89357,.,0,0
89358,Severe,0,0
89359,neutropenia,0,0
89360,(,0,0
89361,36,0,0
89362,%,0,0
89363,vs,0,0
89364,22,0,0
89365,%,0,0
89366,),0,0
89367,",",0,0
89368,and,0,0
89369,febrile,0,1
89370,neutropenia,0,1
89371,(,0,0
89372,14,0,0
89373,%,0,0
89374,vs,0,0
89375,7,0,0
89376,%,0,0
89377,),0,0
89378,were,0,0
89379,more,0,0
89380,common,0,0
89381,with,0,0
89382,the,0,0
89383,GA,0,1
89384,regimen,0,1
89385,",",0,1
89386,while,0,0
89387,hair,0,0
89388,loss,0,0
89389,(,0,0
89390,52,0,0
89391,%,0,0
89392,vs,0,0
89393,16,0,0
89394,%,0,0
89395,),0,0
89396,and,0,0
89397,any,0,0
89398,grade,0,0
89399,peripheral,0,0
89400,neuropathy,0,0
89401,(,0,0
89402,31,0,0
89403,%,0,0
89404,vs,0,0
89405,2,0,0
89406,%,0,0
89407,),0,0
89408,occurred,0,0
89409,more,0,0
89410,frequently,0,0
89411,with,0,0
89412,PG,1,1
89413,regimen,1,1
89414,.,1,0
89415,Other,0,0
89416,severe,0,0
89417,side,0,0
89418,effects,0,0
89419,of,0,0
89420,GA,1,1
89421,regimen,1,1
89422,were,0,1
89423,diarrhoea,0,1
89424,(,0,0
89425,10,0,0
89426,%,0,0
89427,),0,0
89428,",",0,0
89429,liver,0,0
89430,enzyme,0,0
89431,derangement,0,0
89432,(,0,0
89433,10,0,0
89434,%,0,0
89435,),0,0
89436,",",0,0
89437,and,0,1
89438,fatigue,0,1
89439,(,0,0
89440,8,0,0
89441,%,0,0
89442,),0,0
89443,.,0,0
89444,CONCLUSION,0,1
89445,The,0,0
89446,GA,0,1
89447,regimen,0,1
89448,was,0,1
89449,tolerated,0,1
89450,and,0,0
89451,moderately,0,0
89452,active,0,0
89453,in,0,0
89454,advanced,0,0
89455,or,0,0
89456,metastatic,0,0
89457,NSCLC,0,0
89458,.,0,0
89459,However,0,0
89460,",",0,0
89461,this,0,0
89462,combination,0,0
89463,did,0,0
89464,not,0,0
89465,yield,0,0
89466,any,0,0
89467,advantage,0,0
89468,in,0,0
89469,comparison,0,0
89470,with,0,0
89471,the,0,0
89472,PG,0,1
89473,regimen,0,1
89474,",",0,0
89475,and,0,0
89476,does,0,0
89477,not,0,0
89478,deserve,0,0
89479,further,0,0
89480,evaluation,0,0
89481,.,0,0
89482,Pharmacokinetic-,0,1
89483,pharmacodynamic,0,1
89484,analysis,0,0
89485,of,0,0
89486,the,0,0
89487,role,0,0
89488,of,0,0
89489,CYP2C19,0,0
89490,genotypes,0,0
89491,in,0,0
89492,short-term,0,1
89493,rabeprazole-based,1,1
89494,triple,1,0
89495,therapy,1,1
89496,against,0,0
89497,Helicobacter,0,1
89498,pylori,0,1
89499,.,0,0
89500,AIMS,0,0
89501,The,0,0
89502,aim,0,0
89503,was,0,0
89504,to,0,0
89505,explore,0,0
89506,the,0,0
89507,role,0,0
89508,of,0,0
89509,CYP2C19,0,0
89510,polymorphism,0,0
89511,in,0,0
89512,short-term,0,1
89513,rabeprazole-based,1,1
89514,triple,1,0
89515,therapy,1,1
89516,against,0,0
89517,Helicobacter,0,1
89518,pylori,0,1
89519,infection,0,1
89520,.,0,0
89521,METHODS,0,0
89522,Patients,0,0
89523,with,0,0
89524,H.,0,0
89525,pylori,0,0
89526,infection,0,0
89527,were,0,0
89528,tested,0,0
89529,for,0,0
89530,CYP2C19,0,0
89531,genotype,0,0
89532,as,0,0
89533,poor,0,0
89534,metabolizers,0,1
89535,(,0,1
89536,PMs,0,1
89537,),0,1
89538,or,0,0
89539,extensive,0,1
89540,metabolizers,0,1
89541,(,0,1
89542,EMs,0,1
89543,",",0,0
89544,homozygous,0,0
89545,EM,0,1
89546,or,0,0
89547,heterozygous,0,1
89548,EM,0,1
89549,),0,1
89550,and,0,1
89551,given,0,1
89552,rabeprazole,1,1
89553,for,0,0
89554,7,0,0
89555,days,0,0
89556,.,0,1
89557,Antibiotics,1,1
89558,(,1,1
89559,clarithromycin,1,1
89560,and,1,1
89561,amoxicillin,1,1
89562,),1,1
89563,were,0,0
89564,given,0,0
89565,on,0,0
89566,days,0,0
89567,1-4,0,0
89568,",",0,0
89569,days,0,0
89570,4-7,0,0
89571,",",0,0
89572,or,0,0
89573,days,0,1
89574,1-7,0,1
89575,.,0,1
89576,A,0,0
89577,direct,0,0
89578,link,0,0
89579,model,0,0
89580,with,0,0
89581,an,0,0
89582,effect,0,0
89583,compartment,0,0
89584,was,0,0
89585,used,0,0
89586,in,0,0
89587,the,0,0
89588,population,0,0
89589,pharmacokinetic-pharmacodynamic,0,1
89590,analysis,0,0
89591,.,0,0
89592,The,0,0
89593,status,0,0
89594,of,0,0
89595,H.,0,1
89596,pylori,0,0
89597,infection,0,0
89598,was,0,0
89599,evaluated,0,0
89600,.,0,0
89601,RESULTS,0,1
89602,Rabeprazole,1,1
89603,clearance,0,1
89604,was,0,0
89605,lower,0,0
89606,in,0,0
89607,CYP2C19,0,0
89608,PMs,0,1
89609,than,0,0
89610,in,0,0
89611,EMs,0,1
89612,(,0,0
89613,with,0,0
89614,average,0,0
89615,values,0,0
89616,of,0,0
89617,10.7,0,0
89618,vs.,0,0
89619,16.8,0,0
89620,l,0,0
89621,h,0,0
89622,(,0,1
89623,-1,0,0
89624,),0,0
89625,in,0,0
89626,PMs,0,1
89627,and,0,0
89628,EMs,0,0
89629,",",0,0
89630,respectively,0,0
89631,),0,0
89632,",",0,0
89633,resulting,0,0
89634,in,0,0
89635,higher,0,0
89636,plasma,0,0
89637,levels,0,0
89638,in,0,0
89639,the,0,0
89640,former,0,0
89641,group,0,0
89642,.,0,0
89643,The,0,0
89644,values,0,0
89645,of,0,0
89646,EC,0,1
89647,(,0,1
89648,50,0,0
89649,),0,1
89650,and,0,1
89651,k,0,1
89652,(,0,1
89653,eo,0,1
89654,),0,1
89655,of,0,0
89656,gastrin,0,1
89657,response,0,0
89658,increased,0,0
89659,with,0,0
89660,multiple,0,0
89661,doses,0,1
89662,of,0,1
89663,rabeprazole,1,1
89664,.,1,1
89665,The,0,0
89666,k,0,1
89667,(,0,1
89668,eo,0,1
89669,),0,0
89670,values,0,0
89671,were,0,0
89672,lower,0,0
89673,in,0,0
89674,CYP2C19,0,0
89675,PMs,0,1
89676,than,0,0
89677,in,0,0
89678,EMs,0,1
89679,on,0,0
89680,day,0,0
89681,1,0,0
89682,(,0,0
89683,0.012,0,0
89684,vs.,0,0
89685,0.017,0,0
89686,x,0,0
89687,10,0,0
89688,(,0,0
89689,-4,0,0
89690,),0,0
89691,l,0,0
89692,min,0,0
89693,(,0,1
89694,-1,0,1
89695,),0,1
89696,),0,0
89697,",",0,0
89698,and,0,0
89699,higher,0,0
89700,than,0,0
89701,in,0,0
89702,EMs,0,1
89703,on,0,0
89704,day,0,0
89705,4,0,0
89706,(,0,0
89707,0.804,0,0
89708,vs.,0,0
89709,0.169,0,0
89710,x,0,0
89711,10,0,0
89712,(,0,0
89713,-4,0,0
89714,),0,0
89715,l,0,0
89716,min,0,0
89717,(,0,1
89718,-1,0,1
89719,),0,1
89720,),0,1
89721,of,0,0
89722,rabeprazole,1,1
89723,treatment,0,0
89724,.,0,0
89725,The,0,0
89726,predicted,0,0
89727,gastrin-time,0,0
89728,profile,0,0
89729,showed,0,0
89730,a,0,0
89731,higher,0,0
89732,response,0,0
89733,in,0,0
89734,CYP2C19,0,0
89735,PMs,0,1
89736,than,0,0
89737,in,0,0
89738,EMs,0,1
89739,on,0,0
89740,days,0,0
89741,4,0,0
89742,and,0,0
89743,7,0,0
89744,.,0,0
89745,Helicobacter,0,1
89746,pylori,0,0
89747,was,0,0
89748,eradicated,0,0
89749,in,0,0
89750,all,0,0
89751,CYP2C19,0,0
89752,PMs,0,0
89753,except,0,0
89754,in,0,0
89755,one,0,0
89756,patient,0,0
89757,infected,0,0
89758,by,0,0
89759,a,0,0
89760,resistant,0,0
89761,strain,0,0
89762,.,0,0
89763,In,0,0
89764,contrast,0,0
89765,",",0,0
89766,in,0,0
89767,CYP2C19,0,0
89768,EMs,0,0
89769,the,0,0
89770,eradication,0,0
89771,rates,0,0
89772,ranged,0,0
89773,from,0,0
89774,58,0,0
89775,to,0,0
89776,85,0,0
89777,%,0,0
89778,.,0,0
89779,CONCLUSIONS,0,0
89780,CYP2C19,0,0
89781,genotypes,0,0
89782,play,0,0
89783,a,0,0
89784,role,0,0
89785,in,0,0
89786,H.,0,0
89787,pylori,0,1
89788,eradication,0,0
89789,therapy,0,1
89790,.,0,1
89791,Rabeprazole-based,1,1
89792,short-term,1,1
89793,triple,1,0
89794,therapy,1,0
89795,may,0,0
89796,be,0,0
89797,applicable,0,0
89798,in,0,0
89799,CYP2C19,0,0
89800,PMs,0,0
89801,for,0,0
89802,H.,0,1
89803,pylori,0,0
89804,eradication,0,0
89805,.,0,0
89806,Excimer,1,1
89807,laser,1,1
89808,trabeculotomy,1,0
89809,vs,0,0
89810,180,1,0
89811,degrees,1,0
89812,selective,1,0
89813,laser,1,0
89814,trabeculoplasty,1,0
89815,in,0,0
89816,primary,0,0
89817,open-angle,0,0
89818,glaucoma,0,0
89819,.,0,0
89820,A,0,0
89821,2-year,0,0
89822,randomized,0,0
89823,",",0,0
89824,controlled,0,0
89825,trial,0,0
89826,.,0,0
89827,PURPOSE,0,0
89828,To,0,0
89829,compare,0,0
89830,the,0,0
89831,effectiveness,0,0
89832,and,0,0
89833,safety,0,0
89834,of,0,0
89835,excimer,1,0
89836,laser,1,1
89837,trabeculotomy,1,1
89838,(,1,1
89839,ELT,1,1
89840,),1,1
89841,ab,0,0
89842,interno,0,0
89843,vs,0,0
89844,selective,1,0
89845,laser,1,0
89846,trabeculoplasty,1,1
89847,(,1,1
89848,SLT,1,1
89849,),1,1
89850,over,0,0
89851,24,0,0
89852,months,0,0
89853,of,0,0
89854,follow-up,0,0
89855,in,0,0
89856,patients,0,0
89857,with,0,0
89858,primary,0,0
89859,open-angle,0,0
89860,glaucoma,0,1
89861,(,0,1
89862,POAG,0,1
89863,),0,1
89864,refractory,0,0
89865,to,0,0
89866,medical,0,0
89867,therapy,0,0
89868,.,0,0
89869,PATIENTS,0,0
89870,AND,0,1
89871,METHODS,0,1
89872,This,0,1
89873,prospective,0,0
89874,",",0,0
89875,randomized,0,0
89876,study,0,0
89877,included,0,0
89878,30,0,0
89879,consecutive,0,0
89880,eyes,0,0
89881,assigned,0,0
89882,randomly,0,0
89883,to,0,0
89884,either,0,0
89885,ELT,1,0
89886,or,0,0
89887,SLT,1,1
89888,group,0,0
89889,.,0,0
89890,ELT,1,0
89891,was,1,0
89892,carried,1,0
89893,out,1,0
89894,using,1,0
89895,a,1,0
89896,XeCl,1,1
89897,Excimer,1,1
89898,Laser,1,1
89899,with,1,0
89900,an,1,0
89901,emission,1,0
89902,wavelength,1,0
89903,of,1,0
89904,308,1,0
89905,nm,1,0
89906,.,1,0
89907,Eight,1,0
89908,spots,1,0
89909,were,1,0
89910,equally,1,0
89911,distributed,1,0
89912,at,1,0
89913,a,1,0
89914,distance,1,0
89915,of,1,0
89916,500,1,0
89917,microm,1,0
89918,from,1,0
89919,one,1,0
89920,another,1,0
89921,over,1,0
89922,the,1,0
89923,anterior,1,0
89924,trabeculum,1,0
89925,.,1,0
89926,The,0,0
89927,SLT,0,0
89928,patients,0,0
89929,were,0,0
89930,treated,1,0
89931,with,1,0
89932,a,1,0
89933,frequency-doubled,1,0
89934,q-switched,1,1
89935,neodymium,1,1
89936,:,1,1
89937,yytrium-aluminum-garnet,1,1
89938,laser,1,1
89939,(,1,0
89940,wavelength,1,0
89941,532,1,0
89942,nm,1,0
89943,),1,0
89944,.,1,0
89945,Approximately,1,0
89946,50,1,0
89947,adjacent,1,0
89948,",",1,0
89949,but,1,0
89950,not,1,0
89951,overlapping,1,0
89952,",",1,0
89953,laser,1,0
89954,spots,1,0
89955,were,1,0
89956,distributed,1,0
89957,over,1,0
89958,180,1,0
89959,degrees,1,0
89960,of,1,0
89961,the,1,0
89962,trabecular,1,0
89963,meshwork,1,0
89964,",",1,0
89965,using,1,0
89966,an,1,0
89967,energy,1,0
89968,level,1,0
89969,ranging,1,0
89970,from,1,0
89971,0.7,1,0
89972,to,1,0
89973,1.0,1,0
89974,mJ,1,0
89975,per,1,0
89976,pulse,1,0
89977,.,1,0
89978,The,0,0
89979,main,0,0
89980,outcome,0,0
89981,measure,0,0
89982,was,0,0
89983,intraocular,0,0
89984,pressure,0,1
89985,(,0,1
89986,IOP,0,1
89987,),0,1
89988,lowering,0,0
89989,after,0,0
89990,ELT,0,0
89991,and,0,0
89992,SLT,0,0
89993,.,0,0
89994,Success,0,0
89995,was,0,0
89996,defined,0,0
89997,as,0,0
89998,>,0,0
89999,or=20,0,0
90000,%,0,0
90001,reduction,0,0
90002,in,0,0
90003,IOP,0,0
90004,without,0,0
90005,further,0,0
90006,glaucoma,0,0
90007,intervention,0,0
90008,.,0,0
90009,RESULTS,0,0
90010,At,0,0
90011,24,0,0
90012,months,0,0
90013,",",0,0
90014,complete,0,0
90015,success,0,0
90016,rates,0,0
90017,were,0,0
90018,53.3,0,0
90019,%,0,0
90020,for,0,0
90021,the,0,0
90022,ELT,0,0
90023,group,0,0
90024,and,0,0
90025,40,0,0
90026,%,0,0
90027,for,0,0
90028,the,0,0
90029,SLT,0,1
90030,group,0,0
90031,(,0,0
90032,P=0.35,0,0
90033,",",0,0
90034,Fisher,0,0
90035,'s,0,0
90036,exact,0,0
90037,test,0,1
90038,),0,1
90039,;,0,0
90040,qualified,0,1
90041,success,0,0
90042,rates,0,0
90043,were,0,0
90044,33.3,0,0
90045,%,0,0
90046,for,0,0
90047,the,0,0
90048,ELT,0,0
90049,and,0,0
90050,26.6,0,0
90051,%,0,0
90052,for,0,0
90053,the,0,0
90054,SLT,0,1
90055,group,0,0
90056,(,0,0
90057,P=0.5,0,0
90058,",",0,0
90059,Fisher,0,0
90060,'s,0,0
90061,exact,0,0
90062,test,0,0
90063,),0,0
90064,.Mean,0,0
90065,IOP,0,1
90066,decreased,0,0
90067,from,0,0
90068,25.0+/-1.9,0,0
90069,to,0,0
90070,17.6+/-2.2,0,0
90071,mmHg,0,0
90072,(,0,0
90073,-29.6,0,0
90074,%,0,0
90075,;,0,0
90076,P,0,0
90077,<,0,0
90078,0.0001,0,0
90079,),0,0
90080,in,0,0
90081,the,0,0
90082,ELT,0,0
90083,group,0,0
90084,and,0,0
90085,from,0,0
90086,23.9+/-0.9,0,0
90087,to,0,0
90088,19.1+/-1.8,0,0
90089,mmHg,0,0
90090,(,0,0
90091,-21,0,0
90092,%,0,0
90093,;,0,0
90094,P,0,0
90095,<,0,0
90096,0.0001,0,0
90097,),0,0
90098,in,0,0
90099,the,0,0
90100,SLT,0,0
90101,group,0,0
90102,.,0,0
90103,CONCLUSIONS,0,0
90104,Both,0,1
90105,ELT,0,1
90106,and,0,0
90107,SLT,0,0
90108,proved,0,0
90109,to,0,0
90110,be,0,0
90111,effective,0,0
90112,techniques,0,0
90113,in,0,0
90114,the,0,0
90115,treatment,0,0
90116,of,0,0
90117,POAG,0,0
90118,refractory,0,0
90119,to,0,0
90120,medical,0,0
90121,therapy,0,0
90122,.,0,0
90123,Treatment,0,0
90124,of,0,0
90125,hepatitis,0,0
90126,B,0,1
90127,virus,0,0
90128,infection,0,1
90129,with,0,0
90130,interferon,1,1
90131,.,1,0
90132,Factors,0,0
90133,predicting,0,0
90134,response,0,0
90135,to,0,0
90136,interferon,1,1
90137,.,1,0
90138,Several,0,0
90139,randomised,0,0
90140,controlled,0,0
90141,trials,0,0
90142,have,0,0
90143,been,0,0
90144,undertaken,0,0
90145,to,0,0
90146,evaluate,0,0
90147,the,0,0
90148,efficacy,0,0
90149,of,0,0
90150,alpha-interferon,1,1
90151,in,0,0
90152,the,0,0
90153,therapy,0,0
90154,of,0,0
90155,chronic,0,0
90156,hepatitis,0,0
90157,B,0,1
90158,.,0,0
90159,In,0,0
90160,patients,0,0
90161,with,0,0
90162,HBe,0,0
90163,antigen-positive,0,0
90164,disease,0,0
90165,acquired,0,0
90166,in,0,0
90167,adult,0,0
90168,life,0,0
90169,the,0,0
90170,response,0,0
90171,rates,0,0
90172,vary,0,0
90173,from,0,0
90174,25-50,0,0
90175,%,0,0
90176,.,0,0
90177,In,0,0
90178,those,0,0
90179,infected,0,0
90180,at,0,0
90181,birth,0,0
90182,",",0,0
90183,response,0,0
90184,rates,0,0
90185,are,0,0
90186,lower,0,0
90187,.,0,0
90188,Twenty-one,0,0
90189,pretreatment,0,0
90190,variables,0,0
90191,were,0,0
90192,assessed,0,0
90193,for,0,0
90194,their,0,0
90195,significance,0,0
90196,in,0,0
90197,response,0,0
90198,prediction,0,0
90199,using,0,0
90200,data,0,0
90201,from,0,0
90202,114,0,0
90203,patients,0,0
90204,given,0,0
90205,alpha-interferon,1,1
90206,for,0,0
90207,chronic,0,1
90208,hepatitis,0,0
90209,B,0,1
90210,virus,0,0
90211,infection,0,0
90212,.,0,0
90213,In,0,0
90214,those,0,0
90215,patients,0,0
90216,who,0,0
90217,had,0,0
90218,received,0,0
90219,a,0,0
90220,minimum,0,0
90221,of,0,0
90222,90,0,0
90223,million,0,0
90224,units,0,0
90225,per,0,0
90226,m2,0,0
90227,total,0,0
90228,dose,0,1
90229,over,0,0
90230,12,0,0
90231,weeks,0,0
90232,",",0,0
90233,a,0,0
90234,negative,0,0
90235,anti-human,0,1
90236,immunodeficiency,0,1
90237,virus,0,0
90238,antibody,0,0
90239,status,0,0
90240,(,0,0
90241,p,0,0
90242,less,0,0
90243,than,0,0
90244,0.001,0,0
90245,),0,0
90246,",",0,0
90247,chronic,0,0
90248,active,0,0
90249,hepatitis,0,0
90250,on,0,0
90251,liver,0,0
90252,biopsy,0,0
90253,(,0,0
90254,p,0,0
90255,less,0,0
90256,than,0,0
90257,0.005,0,0
90258,),0,0
90259,",",0,0
90260,high,0,0
90261,AST,0,1
90262,level,0,0
90263,(,0,0
90264,p,0,0
90265,less,0,0
90266,than,0,0
90267,0.001,0,0
90268,),0,0
90269,",",0,0
90270,low,0,0
90271,hepatitis,0,0
90272,B,0,1
90273,virus,0,0
90274,DNA,0,1
90275,level,0,0
90276,(,0,0
90277,p,0,0
90278,less,0,0
90279,than,0,0
90280,0.001,0,0
90281,),0,0
90282,and,0,0
90283,a,0,0
90284,history,0,0
90285,of,0,0
90286,acute,0,1
90287,hepatitis,0,0
90288,(,0,0
90289,p,0,0
90290,less,0,0
90291,than,0,0
90292,0.005,0,0
90293,),0,0
90294,were,0,0
90295,all,0,0
90296,associated,0,0
90297,with,0,0
90298,an,0,0
90299,increased,0,0
90300,likelihood,0,0
90301,of,0,0
90302,response,0,0
90303,on,0,0
90304,univariate,0,0
90305,analysis,0,0
90306,.,0,0
90307,On,0,0
90308,stepwise,0,0
90309,logistic,0,0
90310,regression,0,0
90311,analysis,0,0
90312,",",0,0
90313,hepatitis,0,0
90314,B,0,1
90315,virus,0,0
90316,DNA,0,1
90317,",",0,0
90318,AST,0,0
90319,and,0,0
90320,a,0,0
90321,history,0,0
90322,of,0,0
90323,acute,0,0
90324,hepatitis,0,0
90325,predicted,0,0
90326,response,0,0
90327,independently,0,0
90328,(,0,0
90329,p,0,0
90330,less,0,0
90331,than,0,0
90332,0.05,0,0
90333,),0,0
90334,.,0,0
90335,The,0,0
90336,most,0,0
90337,reliable,0,0
90338,combination,0,0
90339,of,0,0
90340,predictive,0,0
90341,factors,0,0
90342,was,0,0
90343,a,0,0
90344,negative,0,0
90345,anti-human,0,1
90346,immunodeficiency,0,1
90347,virus,0,0
90348,antibody,0,0
90349,status,0,0
90350,",",0,0
90351,with,0,0
90352,either,0,0
90353,a,0,0
90354,positive,0,0
90355,history,0,0
90356,of,0,0
90357,acute,0,0
90358,icteric,0,0
90359,hepatitis,0,0
90360,and,0,0
90361,AST,0,0
90362,greater,0,0
90363,than,0,0
90364,45,0,0
90365,IU,0,0
90366,per,0,0
90367,liter,0,0
90368,or,0,0
90369,no,0,0
90370,history,0,0
90371,of,0,0
90372,acute,0,0
90373,icteric,0,0
90374,hepatitis,0,0
90375,and,0,0
90376,AST,0,0
90377,greater,0,0
90378,than,0,0
90379,85,0,0
90380,IU,0,0
90381,per,0,0
90382,liter,0,0
90383,",",0,0
90384,which,0,0
90385,predicted,0,0
90386,response,0,0
90387,in,0,0
90388,77,0,0
90389,%,0,0
90390,with,0,0
90391,a,0,0
90392,specificity,0,0
90393,of,0,0
90394,79,0,0
90395,%,0,0
90396,(,0,0
90397,p,0,0
90398,less,0,0
90399,than,0,0
90400,0.001,0,0
90401,),0,0
90402,.,0,0
90403,The,0,0
90404,loss,0,0
90405,of,0,0
90406,HBsAg,0,0
90407,in,0,0
90408,addition,0,0
90409,to,0,0
90410,HBeAg,0,0
90411,and,0,0
90412,hepatitis,0,0
90413,B,0,1
90414,virus,0,0
90415,DNA,0,0
90416,was,0,0
90417,more,0,0
90418,likely,0,0
90419,to,0,0
90420,occur,0,0
90421,in,0,0
90422,patients,0,0
90423,with,0,0
90424,chronic,0,0
90425,infection,0,0
90426,of,0,0
90427,less,0,0
90428,than,0,0
90429,2,0,0
90430,years,0,1
90431,duration,0,0
90432,(,0,0
90433,p,0,0
90434,less,0,0
90435,than,0,0
90436,0.001,0,0
90437,),0,0
90438,.,0,0
90439,Seven-star,1,1
90440,needle,1,0
90441,stimulation,1,0
90442,improves,0,0
90443,language,0,0
90444,and,0,0
90445,social,0,0
90446,interaction,0,0
90447,of,0,0
90448,children,0,0
90449,with,0,0
90450,autistic,0,0
90451,spectrum,0,0
90452,disorders,0,0
90453,.,0,0
90454,This,0,0
90455,is,0,0
90456,a,0,0
90457,randomized,0,0
90458,controlled,0,0
90459,trial,0,0
90460,that,0,0
90461,aimed,0,0
90462,to,0,0
90463,evaluate,0,0
90464,the,0,0
90465,effect,0,0
90466,of,0,0
90467,the,0,0
90468,Seven-star,1,0
90469,Needle,1,0
90470,Stimulation,1,0
90471,treatment,0,0
90472,on,0,0
90473,children,0,0
90474,with,0,0
90475,Autistic,0,0
90476,Spectrum,0,0
90477,Disorders,0,1
90478,(,0,1
90479,ASD,0,1
90480,),0,0
90481,.,0,0
90482,Thirty-two,0,0
90483,children,0,0
90484,with,0,0
90485,ASD,0,0
90486,were,0,0
90487,assigned,0,0
90488,randomly,0,0
90489,into,0,0
90490,the,0,0
90491,treatment,0,0
90492,and,0,0
90493,control,0,0
90494,groups,0,0
90495,.,0,0
90496,Children,0,0
90497,in,0,0
90498,the,0,0
90499,treatment,0,0
90500,group,0,0
90501,underwent,0,0
90502,30,0,0
90503,sessions,0,0
90504,of,0,0
90505,stimulation,0,0
90506,over,0,0
90507,6,0,0
90508,weeks,0,0
90509,",",0,0
90510,while,0,0
90511,children,0,0
90512,in,0,0
90513,the,0,0
90514,control,0,0
90515,group,0,0
90516,were,0,0
90517,on,0,0
90518,a,0,0
90519,waiting,0,0
90520,list,0,0
90521,and,0,0
90522,did,0,0
90523,not,0,0
90524,receive,0,0
90525,treatment,0,0
90526,during,0,0
90527,this,0,0
90528,period,0,0
90529,of,0,0
90530,time,0,0
90531,.,0,0
90532,Intervention,0,0
90533,consisted,0,0
90534,of,0,0
90535,a,0,0
90536,treatment,0,0
90537,regime,0,0
90538,comprising,0,0
90539,of,0,0
90540,30,1,0
90541,sessions,1,0
90542,of,1,0
90543,Seven-star,1,0
90544,Needle,1,0
90545,Stimulation,1,0
90546,",",0,0
90547,delivered,0,0
90548,over,0,0
90549,6,0,0
90550,weeks,0,0
90551,.,0,0
90552,Each,0,0
90553,session,0,0
90554,lasted,0,0
90555,5,0,0
90556,to,0,0
90557,10,0,0
90558,min,0,0
90559,",",0,0
90560,children,0,0
90561,in,0,0
90562,the,0,0
90563,treatment,0,0
90564,group,0,0
90565,were,0,0
90566,stimulated,0,0
90567,at,0,0
90568,the,0,0
90569,front,0,0
90570,and,0,0
90571,back,0,0
90572,sides,0,0
90573,of,0,0
90574,their,0,0
90575,body,0,0
90576,and,0,0
90577,the,0,0
90578,head,0,0
90579,by,0,0
90580,using,0,0
90581,Seven-star,1,0
90582,Needles,1,0
90583,.,1,0
90584,The,0,0
90585,change,0,0
90586,in,0,0
90587,the,0,0
90588,children,0,0
90589,'s,0,0
90590,behavior,0,0
90591,was,0,0
90592,evaluated,0,0
90593,using,0,0
90594,parents,0,0
90595,',0,0
90596,report,0,0
90597,and,0,0
90598,neurophysiological,0,0
90599,changes,0,0
90600,were,0,0
90601,measured,0,0
90602,by,0,0
90603,quantitative,0,0
90604,EEG,0,1
90605,(,0,1
90606,qEEG,0,1
90607,),0,1
90608,.,0,0
90609,Results,0,0
90610,showed,0,0
90611,that,0,0
90612,the,0,0
90613,treatment,0,0
90614,group,0,0
90615,demonstrated,0,0
90616,significant,0,0
90617,improvement,0,0
90618,in,0,0
90619,language,0,0
90620,and,0,0
90621,social,0,0
90622,interaction,0,0
90623,",",0,0
90624,but,0,0
90625,not,0,0
90626,in,0,0
90627,stereotyped,0,0
90628,behavior,0,0
90629,or,0,0
90630,motor,0,0
90631,function,0,0
90632,",",0,0
90633,compared,0,0
90634,to,0,0
90635,the,0,0
90636,control,0,0
90637,group,0,0
90638,.,0,0
90639,qEEG,0,0
90640,spectral,0,0
90641,amplitudes,0,0
90642,in,0,0
90643,the,0,0
90644,treatment,0,0
90645,",",0,0
90646,but,0,0
90647,not,0,0
90648,in,0,0
90649,the,0,0
90650,control,0,0
90651,group,0,0
90652,",",0,0
90653,were,0,0
90654,also,0,0
90655,reduced,0,0
90656,significantly,0,0
90657,.,0,0
90658,The,0,0
90659,results,0,0
90660,suggested,0,0
90661,that,0,0
90662,Seven-star,1,0
90663,Needle,1,0
90664,Stimulation,1,0
90665,might,0,0
90666,be,0,0
90667,an,0,0
90668,effective,0,0
90669,intervention,0,0
90670,to,0,0
90671,improve,0,0
90672,language,0,0
90673,and,0,0
90674,social,0,0
90675,functioning,0,0
90676,of,0,0
90677,children,0,0
90678,with,0,0
90679,ASD,0,0
90680,.,0,0
90681,[,0,0
90682,Effect,0,0
90683,of,0,0
90684,liu,1,0
90685,wei,1,0
90686,di,1,0
90687,huang,1,0
90688,or,1,0
90689,jin,1,0
90690,gui,1,0
90691,shen,1,1
90692,qi,1,1
90693,decoction,1,1
90694,as,0,1
90695,on,0,0
90696,adjuvant,0,1
90697,treatment,0,0
90698,in,0,0
90699,small,0,0
90700,cell,0,0
90701,lung,0,0
90702,cancer,0,1
90703,],0,0
90704,.,0,0
90705,Eighty-three,0,0
90706,patients,0,0
90707,with,0,0
90708,small,0,0
90709,cell,0,0
90710,lung,0,0
90711,cancer,0,0
90712,were,0,0
90713,randomized,0,0
90714,with,1,0
90715,or,1,0
90716,without,1,0
90717,using,1,0
90718,a,1,0
90719,traditional,1,0
90720,Chinese,1,0
90721,Kidney-tonifying,1,1
90722,decoction,1,1
90723,(,1,1
90724,Liu,1,1
90725,Wei,1,1
90726,Di,1,1
90727,Huang,1,0
90728,or,1,0
90729,Jin,1,0
90730,Gui,1,0
90731,Shen,1,1
90732,Qi,1,1
90733,medicinal,1,1
90734,decoction,1,1
90735,),1,1
90736,in,1,0
90737,chemotherapy,1,0
90738,or,1,0
90739,radiotherapy,1,0
90740,courses,1,0
90741,.,1,0
90742,74,0,0
90743,patients,0,0
90744,were,0,0
90745,availble,0,0
90746,to,0,0
90747,be,0,0
90748,analysis,0,0
90749,.,0,0
90750,The,0,0
90751,two,0,0
90752,treatment,0,0
90753,groups,0,0
90754,were,0,0
90755,well-matched,0,0
90756,in,0,0
90757,age,0,0
90758,",",0,0
90759,sex,0,0
90760,",",0,0
90761,stage,0,0
90762,and,0,0
90763,performance,0,0
90764,status,0,0
90765,.,0,0
90766,There,0,0
90767,was,0,0
90768,a,0,0
90769,statistically,0,0
90770,significant,0,0
90771,difference,0,0
90772,in,0,0
90773,response,0,0
90774,rate,0,0
90775,and,0,0
90776,the,0,0
90777,median,0,0
90778,survival,0,0
90779,between,0,0
90780,two,0,0
90781,groups,0,0
90782,.,0,0
90783,The,0,0
90784,overall,0,0
90785,response,0,0
90786,rate,0,0
90787,(,0,0
90788,CR+PR,0,1
90789,),0,0
90790,was,0,0
90791,91.5,0,0
90792,%,0,0
90793,for,0,0
90794,Chinese,1,0
90795,herb,1,1
90796,group,0,0
90797,and,0,0
90798,46.9,0,0
90799,%,0,0
90800,for,0,0
90801,control,0,0
90802,group,0,0
90803,(,0,0
90804,P,0,0
90805,less,0,0
90806,than,0,0
90807,0.001,0,0
90808,),0,0
90809,.,0,0
90810,The,0,0
90811,median,0,0
90812,survival,0,0
90813,was,0,0
90814,16,0,0
90815,months,0,0
90816,for,0,0
90817,the,0,0
90818,traditional,0,0
90819,Chinese,1,0
90820,Kidney-tonifying,1,1
90821,decoction,1,1
90822,group,0,1
90823,",",0,0
90824,and,0,0
90825,10,0,0
90826,months,0,0
90827,for,0,0
90828,the,0,0
90829,control,0,0
90830,group,0,0
90831,(,0,0
90832,P,0,0
90833,less,0,0
90834,than,0,0
90835,0.05,0,0
90836,),0,0
90837,.,0,0
90838,Survival,0,1
90839,curve,0,1
90840,(,0,1
90841,Kaplan-meire,0,1
90842,'s,0,1
90843,),0,0
90844,of,0,0
90845,the,0,0
90846,Chinese,0,1
90847,herb,0,1
90848,group,0,0
90849,was,0,0
90850,better,0,0
90851,than,0,0
90852,that,0,0
90853,of,0,0
90854,the,0,0
90855,control,0,0
90856,group,0,0
90857,.,0,0
90858,10,0,0
90859,patients,0,0
90860,of,0,0
90861,Chinese,1,1
90862,herb,1,1
90863,group,0,0
90864,was,0,0
90865,alive,0,0
90866,beyond,0,0
90867,more,0,0
90868,than,0,0
90869,2,0,0
90870,years,0,1
90871,.,0,1
90872,Until,0,1
90873,now,0,0
90874,",",0,0
90875,4,0,0
90876,patients,0,0
90877,in,0,0
90878,the,0,0
90879,Chinese,1,1
90880,herb,1,1
90881,group,0,0
90882,",",0,0
90883,one,0,0
90884,in,0,0
90885,the,0,0
90886,control,0,0
90887,group,0,0
90888,are,0,0
90889,still,0,0
90890,enjoying,0,0
90891,their,0,0
90892,disease-free,0,0
90893,life,0,0
90894,for,0,0
90895,more,0,0
90896,than,0,0
90897,7,0,0
90898,years,0,0
90899,.,0,0
90900,Hematologic,0,0
90901,toxicities,0,1
90902,were,0,0
90903,observed,0,0
90904,much,0,0
90905,frequently,0,0
90906,in,0,0
90907,the,0,0
90908,patients,0,0
90909,of,0,0
90910,the,0,0
90911,control,0,0
90912,group,0,0
90913,(,0,0
90914,P,0,0
90915,less,0,0
90916,than,0,0
90917,0.005,0,0
90918,and,0,0
90919,0.01/WBC,0,0
90920,and,0,0
90921,BPC,0,0
90922,),0,1
90923,.,0,0
90924,Results,0,0
90925,of,0,0
90926,animal,0,0
90927,experiments,0,0
90928,with,0,0
90929,the,0,0
90930,same,0,0
90931,traditional,0,0
90932,medicinal,0,0
90933,decoctions,0,1
90934,as,0,0
90935,used,0,0
90936,in,0,0
90937,clinic,0,0
90938,have,0,0
90939,showed,0,0
90940,immuno-enhancement,0,0
90941,activities,0,0
90942,.,0,0
90943,These,0,0
90944,results,0,0
90945,have,0,0
90946,showed,0,0
90947,that,0,0
90948,the,0,0
90949,traditional,1,0
90950,Chinese,1,0
90951,Kidney-tonifying,1,1
90952,decoction,1,1
90953,may,0,0
90954,enhance,0,0
90955,non-specific,0,0
90956,immunology,0,0
90957,activities,0,0
90958,and,0,0
90959,may,0,0
90960,be,0,0
90961,much,0,0
90962,useful,0,0
90963,for,0,0
90964,solid,0,0
90965,cancer,0,0
90966,patients,0,0
90967,as,0,0
90968,an,0,0
90969,adjuvant,0,1
90970,treatment,0,0
90971,.,0,0
90972,Assessment,0,0
90973,of,0,0
90974,elementary,0,0
90975,school,0,0
90976,students,0,0
90977,',0,0
90978,sun,0,0
90979,protection,0,0
90980,behaviors,0,0
90981,.,0,0
90982,BACKGROUND/OBJECTIVES,0,0
90983,Studies,0,0
90984,suggest,0,0
90985,that,0,0
90986,excessive,0,0
90987,sun,0,0
90988,exposure,0,0
90989,in,0,0
90990,childhood,0,0
90991,contributes,0,0
90992,to,0,0
90993,the,0,0
90994,development,0,0
90995,of,0,0
90996,skin,0,0
90997,cancer,0,0
90998,later,0,0
90999,in,0,0
91000,life,0,0
91001,.,0,0
91002,METHODS,0,0
91003,This,0,0
91004,study,0,0
91005,explores,0,0
91006,4th,0,0
91007,grade,0,0
91008,student,0,0
91009,assessment,0,0
91010,of,0,0
91011,their,0,0
91012,sun,0,0
91013,protection,0,0
91014,behaviors,0,0
91015,.,0,0
91016,This,0,0
91017,study,0,0
91018,used,0,0
91019,baseline,0,0
91020,data,0,0
91021,collected,0,0
91022,in,0,0
91023,the,0,0
91024,Fall,0,0
91025,of,0,0
91026,2006,0,0
91027,for,0,0
91028,the,0,0
91029,Sun,0,0
91030,Protection,0,0
91031,for,0,0
91032,Florida,0,0
91033,'s,0,1
91034,Children,0,1
91035,(,0,1
91036,SPF,0,1
91037,),0,1
91038,project,0,0
91039,.,0,0
91040,In,0,0
91041,brief,0,0
91042,",",0,0
91043,the,0,0
91044,SPF,0,0
91045,project,0,0
91046,is,0,0
91047,a,0,0
91048,group,0,0
91049,randomized,0,0
91050,trial,0,0
91051,to,0,0
91052,test,0,0
91053,the,0,0
91054,effectiveness,0,0
91055,of,0,0
91056,a,0,0
91057,school,1,0
91058,based,1,0
91059,intervention,1,0
91060,promoting,1,0
91061,sun,1,0
91062,protection,1,0
91063,in,1,0
91064,general,1,0
91065,",",1,0
91066,and,1,0
91067,hat,1,0
91068,use,1,0
91069,in,1,0
91070,particular,1,0
91071,",",0,0
91072,in,0,0
91073,Hillsborough,0,0
91074,County,0,0
91075,Schools,0,0
91076,",",0,0
91077,Florida,0,0
91078,.,0,0
91079,The,0,0
91080,data,0,0
91081,reported,0,0
91082,in,0,0
91083,this,0,0
91084,study,0,0
91085,were,0,0
91086,collected,0,0
91087,at,0,0
91088,baseline,0,0
91089,before,0,0
91090,any,0,0
91091,intervention,0,0
91092,activities,0,0
91093,was,0,0
91094,initiated,0,0
91095,.,0,0
91096,RESULTS,0,0
91097,The,0,0
91098,self-reported,0,0
91099,use,0,0
91100,of,0,0
91101,various,0,0
91102,methods,0,0
91103,of,0,0
91104,sun,1,0
91105,protection,1,0
91106,was,0,0
91107,low,0,0
91108,.,0,0
91109,Only,0,0
91110,a,0,0
91111,small,0,0
91112,percentage,0,0
91113,of,0,0
91114,students,0,0
91115,wore,0,0
91116,long,1,0
91117,sleeves,1,0
91118,or,0,0
91119,a,0,0
91120,hat,1,0
91121,with,1,0
91122,a,1,0
91123,brim,1,0
91124,before,0,0
91125,leaving,0,0
91126,for,0,0
91127,school,0,0
91128,.,0,0
91129,In,0,0
91130,addition,0,0
91131,",",0,0
91132,few,0,0
91133,students,0,0
91134,wore,0,0
91135,a,0,0
91136,hat,1,0
91137,with,1,0
91138,a,1,0
91139,wide,1,0
91140,brim,1,0
91141,when,0,0
91142,outside,0,0
91143,but,0,0
91144,not,0,0
91145,at,0,0
91146,school,0,0
91147,.,0,0
91148,Students,0,0
91149,spent,0,0
91150,an,0,0
91151,average,0,0
91152,of,0,0
91153,59.1,0,0
91154,minutes,0,0
91155,per,0,0
91156,week,0,0
91157,outdoors,0,0
91158,while,0,0
91159,attending,0,0
91160,school,0,0
91161,and,0,0
91162,35.5,0,0
91163,minutes,0,0
91164,during,0,0
91165,peak,0,0
91166,sun,0,0
91167,exposure,0,0
91168,.,0,0
91169,CONCLUSION,0,0
91170,Sun,0,0
91171,exposure,0,0
91172,at,0,0
91173,school,0,0
91174,poses,0,0
91175,a,0,0
91176,significant,0,0
91177,risk,0,0
91178,to,0,0
91179,student,0,0
91180,health,0,0
91181,and,0,0
91182,more,0,0
91183,needs,0,0
91184,to,0,0
91185,be,0,0
91186,carried,0,0
91187,out,0,0
91188,to,0,0
91189,promote,0,0
91190,the,0,0
91191,use,0,0
91192,of,0,0
91193,a,0,0
91194,wide-brimmed,1,0
91195,hat,1,0
91196,and,0,0
91197,limiting,0,0
91198,student,0,0
91199,sun,0,0
91200,exposure,0,0
91201,.,0,0
91202,[,0,0
91203,Effect,0,0
91204,of,0,0
91205,transcranial,1,0
91206,electrostimulation,1,0
91207,on,0,0
91208,clinical,0,0
91209,and,0,0
91210,laboratory,0,0
91211,characteristics,0,0
91212,in,0,0
91213,patients,0,0
91214,with,0,0
91215,gastric,0,0
91216,ulcer,0,1
91217,],0,0
91218,.,0,0
91219,The,0,0
91220,study,0,0
91221,included,0,0
91222,100,0,0
91223,patients,0,0
91224,with,0,0
91225,gastric,0,0
91226,ulcer,0,0
91227,aged,0,0
91228,from,0,0
91229,16,0,0
91230,to,0,0
91231,60,0,0
91232,years,0,0
91233,.,0,0
91234,In,0,0
91235,58,0,0
91236,patients,0,0
91237,",",0,0
91238,traditional,1,0
91239,treatment,1,0
91240,was,1,0
91241,supplemented,1,0
91242,by,1,0
91243,transcranial,1,0
91244,electrotherapy,1,0
91245,using,1,0
91246,a,1,0
91247,TRANSAIR-02,1,0
91248,apparatus,1,0
91249,.,1,0
91250,Laboratory,0,0
91251,studies,0,0
91252,included,0,0
91253,measurements,0,0
91254,of,0,0
91255,lactoferrin,0,1
91256,(,0,1
91257,LF,0,1
91258,),0,1
91259,and,0,0
91260,tumour,0,1
91261,necrosis,0,1
91262,factor-alpha,0,1
91263,(,0,1
91264,TNF-alpha,0,1
91265,),0,0
91266,",",0,0
91267,besides,0,0
91268,standard,0,0
91269,analyses,0,0
91270,.,0,0
91271,Combined,1,0
91272,treatment,1,0
91273,(,1,0
91274,traditional,1,0
91275,therapy,1,0
91276,plus,1,0
91277,electrostimulation,1,0
91278,),1,0
91279,resulted,0,0
91280,in,0,0
91281,a,0,0
91282,significant,0,0
91283,reduction,0,0
91284,in,0,0
91285,duration,0,0
91286,of,0,0
91287,the,0,0
91288,main,0,0
91289,symptoms,0,0
91290,of,0,0
91291,the,0,0
91292,gastric,0,0
91293,ulcer,0,0
91294,depending,0,0
91295,on,0,0
91296,the,0,0
91297,severity,0,0
91298,of,0,0
91299,ulceration,0,0
91300,process,0,0
91301,",",0,0
91302,patients,0,0
91303,',0,0
91304,age,0,0
91305,and,0,0
91306,sex,0,0
91307,.,0,0
91308,Moreover,0,0
91309,",",0,0
91310,it,0,0
91311,facilitated,0,0
91312,ulcer,0,0
91313,scarring,0,0
91314,and,0,0
91315,had,0,0
91316,beneficial,0,0
91317,effect,0,0
91318,on,0,0
91319,dynamics,0,0
91320,of,0,0
91321,serum,0,1
91322,LF,0,1
91323,and,0,0
91324,TNF-alpha,0,0
91325,levels,0,0
91326,.,0,0
91327,Arterial,0,1
91328,cardiovascular,0,0
91329,risk,0,0
91330,factors,0,0
91331,and,0,0
91332,venous,0,0
91333,thrombosis,0,0
91334,:,0,0
91335,results,0,0
91336,from,0,0
91337,a,0,0
91338,population-based,0,0
91339,",",0,0
91340,prospective,0,0
91341,study,0,0
91342,(,0,0
91343,the,0,0
91344,HUNT,0,1
91345,2,0,1
91346,),0,0
91347,.,0,1
91348,BACKGROUND,0,1
91349,An,0,1
91350,explanation,0,0
91351,for,0,0
91352,the,0,0
91353,increased,0,0
91354,risk,0,0
91355,of,0,0
91356,myocardial,0,0
91357,infarction,0,0
91358,and,0,0
91359,stroke,0,0
91360,in,0,0
91361,patients,0,0
91362,with,0,0
91363,venous,0,0
91364,thrombosis,0,0
91365,is,0,0
91366,lacking,0,0
91367,.,0,0
91368,The,0,0
91369,objective,0,0
91370,of,0,0
91371,this,0,0
91372,study,0,0
91373,was,0,0
91374,to,0,0
91375,investigate,0,0
91376,whether,0,0
91377,risk,0,0
91378,factors,0,0
91379,for,0,0
91380,arterial,0,0
91381,cardiovascular,0,0
91382,disease,0,0
91383,also,0,0
91384,increase,0,0
91385,the,0,0
91386,risk,0,0
91387,of,0,0
91388,venous,0,0
91389,thrombosis,0,0
91390,.,0,0
91391,DESIGN,0,0
91392,AND,0,1
91393,METHODS,0,1
91394,Cases,0,0
91395,who,0,0
91396,had,0,0
91397,a,0,0
91398,first,0,0
91399,venous,0,0
91400,thrombosis,0,0
91401,(,0,0
91402,n=515,0,0
91403,),0,0
91404,and,0,0
91405,matched,0,0
91406,controls,0,0
91407,(,0,0
91408,"n=1,505",0,0
91409,),0,0
91410,were,0,0
91411,identified,0,0
91412,from,0,0
91413,a,0,0
91414,population-based,0,0
91415,",",0,0
91416,nested,0,0
91417,",",0,0
91418,case-cohort,0,0
91419,study,0,0
91420,(,0,0
91421,the,0,0
91422,HUNT,0,0
91423,2,0,0
91424,study,0,0
91425,),0,0
91426,comprising,0,0
91427,71,0,0
91428,%,0,0
91429,(,0,0
91430,"n=66,140",0,0
91431,),0,0
91432,of,0,0
91433,the,0,0
91434,adult,0,0
91435,residents,0,0
91436,of,0,0
91437,Nord-Tr?ndelag,0,0
91438,County,0,0
91439,in,0,0
91440,Norway,0,0
91441,.,0,0
91442,RESULTS,0,0
91443,The,0,0
91444,age-,0,0
91445,and,0,0
91446,sex-adjusted,0,0
91447,odds,0,1
91448,ratio,0,0
91449,of,0,0
91450,venous,0,0
91451,thrombosis,0,0
91452,for,0,0
91453,subjects,0,0
91454,with,0,0
91455,concentrations,0,0
91456,of,0,0
91457,C-reactive,0,0
91458,protein,0,0
91459,in,0,0
91460,the,0,0
91461,highest,0,0
91462,quintile,0,0
91463,was,0,0
91464,1.6,0,0
91465,(,0,0
91466,95,0,0
91467,%,0,0
91468,confidence,0,0
91469,interval,0,0
91470,:,0,0
91471,1.2-2.2,0,0
91472,),0,0
91473,compared,0,0
91474,to,0,0
91475,subjects,0,0
91476,with,0,0
91477,C-reactive,0,0
91478,protein,0,0
91479,in,0,0
91480,the,0,0
91481,lowest,0,0
91482,quintile,0,0
91483,.,0,0
91484,This,0,0
91485,association,0,0
91486,was,0,0
91487,strongest,0,0
91488,in,0,0
91489,subjects,0,0
91490,who,0,0
91491,experienced,0,1
91492,venous,0,0
91493,thrombosis,0,0
91494,within,0,0
91495,a,0,0
91496,year,0,0
91497,after,0,0
91498,blood,0,0
91499,sampling,0,0
91500,with,0,0
91501,a,0,0
91502,three-fold,0,0
91503,increased,0,0
91504,risk,0,0
91505,of,0,0
91506,participants,0,0
91507,in,0,0
91508,the,0,0
91509,highest,0,0
91510,versus,0,0
91511,the,0,0
91512,lowest,0,0
91513,quintile,0,0
91514,.,0,0
91515,Having,0,0
91516,first,0,0
91517,degree,0,0
91518,relatives,0,0
91519,who,0,0
91520,had,0,0
91521,a,0,0
91522,myocardial,0,0
91523,infarction,0,0
91524,before,0,0
91525,the,0,0
91526,age,0,0
91527,of,0,0
91528,60,0,0
91529,years,0,0
91530,was,0,0
91531,positively,0,0
91532,associated,0,0
91533,with,0,0
91534,venous,0,0
91535,thrombosis,0,0
91536,compared,0,0
91537,to,0,0
91538,not,0,0
91539,having,0,0
91540,a,0,0
91541,positive,0,0
91542,family,0,0
91543,history,0,1
91544,[,0,0
91545,odds,0,1
91546,ratio,0,1
91547,1.3,0,0
91548,(,0,0
91549,95,0,0
91550,%,0,0
91551,confidence,0,0
91552,interval,0,0
91553,:,0,0
91554,1.1-1.6,0,0
91555,),0,0
91556,],0,0
91557,.,0,0
91558,Subjects,0,0
91559,with,0,0
91560,blood,0,0
91561,pressure,0,0
91562,in,0,0
91563,the,0,0
91564,highest,0,0
91565,quintile,0,0
91566,had,0,0
91567,half,0,0
91568,the,0,0
91569,risk,0,0
91570,of,0,0
91571,developing,0,0
91572,venous,0,0
91573,thrombosis,0,0
91574,compared,0,0
91575,to,0,0
91576,subjects,0,0
91577,whose,0,0
91578,blood,0,0
91579,pressure,0,0
91580,was,0,0
91581,in,0,0
91582,the,0,0
91583,lowest,0,0
91584,quintile,0,0
91585,.,0,0
91586,There,0,0
91587,were,0,0
91588,no,0,0
91589,associations,0,0
91590,between,0,0
91591,the,0,0
91592,risk,0,0
91593,of,0,0
91594,venous,0,0
91595,thrombosis,0,0
91596,and,0,0
91597,total,0,0
91598,cholesterol,0,1
91599,",",0,0
91600,low,0,0
91601,density,0,0
91602,lipoprotein-cholesterol,0,1
91603,",",0,0
91604,high,0,0
91605,density,0,0
91606,lipoprotein-cholesterol,0,1
91607,",",0,1
91608,triglycerides,0,1
91609,",",0,1
91610,glucose,0,1
91611,or,0,1
91612,smoking,0,1
91613,.,0,0
91614,We,0,0
91615,confirmed,0,0
91616,the,0,0
91617,positive,0,0
91618,association,0,0
91619,between,0,0
91620,obesity,0,0
91621,and,0,0
91622,venous,0,0
91623,thrombosis,0,0
91624,.,0,0
91625,CONCLUSIONS,0,0
91626,C-reactive,0,0
91627,protein,0,0
91628,and,0,0
91629,a,0,0
91630,family,0,0
91631,history,0,0
91632,of,0,0
91633,myocardial,0,0
91634,infarction,0,0
91635,were,0,0
91636,positively,0,0
91637,associated,0,0
91638,with,0,0
91639,subsequent,0,0
91640,venous,0,0
91641,thrombosis,0,0
91642,.,0,0
91643,Blood,0,0
91644,pressure,0,0
91645,was,0,0
91646,inversely,0,0
91647,correlated,0,0
91648,to,0,0
91649,venous,0,0
91650,thrombosis,0,0
91651,.,0,0
91652,These,0,0
91653,findings,0,0
91654,should,0,0
91655,be,0,0
91656,confirmed,0,0
91657,by,0,0
91658,further,0,0
91659,investigations,0,0
91660,.,0,0
91661,Treatment,0,0
91662,of,0,0
91663,sperm,0,0
91664,with,0,0
91665,platelet-activating,1,1
91666,factor,1,0
91667,does,0,0
91668,not,0,0
91669,improve,0,0
91670,intrauterine,1,0
91671,insemination,1,0
91672,outcome,0,0
91673,in,0,0
91674,unselected,0,0
91675,cases,0,0
91676,of,0,0
91677,mild,0,0
91678,male,0,0
91679,factor,0,0
91680,infertility,0,0
91681,:,0,0
91682,a,0,0
91683,prospective,0,1
91684,double-blind,0,1
91685,randomized,0,1
91686,crossover,0,1
91687,study,0,0
91688,.,0,0
91689,OBJECTIVES,0,0
91690,To,0,0
91691,evaluate,0,0
91692,the,0,0
91693,effect,0,0
91694,of,0,0
91695,sperm,0,0
91696,treatment,0,0
91697,with,0,0
91698,exogenous,1,0
91699,platelet-activating,1,1
91700,factor,1,1
91701,(,1,1
91702,PAF,1,1
91703,),1,1
91704,on,0,0
91705,intrauterine,1,1
91706,insemination,1,1
91707,(,1,1
91708,IUI,1,1
91709,),1,1
91710,clinical,0,0
91711,pregnancy,0,0
91712,rate,0,0
91713,in,0,0
91714,cases,0,0
91715,of,0,0
91716,mild,0,0
91717,male,0,0
91718,factor,0,0
91719,infertility,0,0
91720,.,0,0
91721,PAF,0,0
91722,is,0,0
91723,a,0,0
91724,phospholipid,0,0
91725,mediator,0,0
91726,",",0,0
91727,which,0,0
91728,is,0,0
91729,present,0,0
91730,in,0,0
91731,human,0,0
91732,sperm,0,0
91733,.,0,0
91734,METHODS,0,0
91735,The,0,0
91736,study,0,0
91737,was,0,0
91738,performed,0,0
91739,in,0,0
91740,the,0,0
91741,Assisted,0,0
91742,Reproduction,0,0
91743,Unit,0,0
91744,of,0,0
91745,the,0,0
91746,2nd,0,0
91747,Department,0,0
91748,of,0,0
91749,Obstetrics,0,0
91750,and,0,0
91751,Gynecology,0,0
91752,",",0,0
91753,University,0,0
91754,of,0,0
91755,Athens,0,0
91756,",",0,0
91757,Aretaieion,0,0
91758,Hospital,0,0
91759,",",0,0
91760,Athens,0,0
91761,",",0,0
91762,Greece,0,0
91763,",",0,0
91764,and,0,0
91765,included,0,0
91766,92,0,0
91767,couples,0,0
91768,who,0,0
91769,presented,0,0
91770,with,0,0
91771,mild,0,0
91772,male,0,0
91773,factor,0,0
91774,infertility-all,0,0
91775,candidates,0,0
91776,for,0,0
91777,IUI,0,0
91778,.,0,0
91779,A,0,0
91780,maximum,0,0
91781,of,0,0
91782,4,0,0
91783,IUI,1,0
91784,cycles,0,0
91785,per,0,0
91786,couple,0,0
91787,with,1,0
91788,or,1,0
91789,without,1,0
91790,exogenous,1,0
91791,PAF,1,0
91792,treatment,1,0
91793,were,0,0
91794,performed,0,0
91795,and,0,0
91796,the,0,0
91797,main,0,0
91798,outcome,0,0
91799,measure,0,0
91800,was,0,0
91801,the,0,0
91802,clinical,0,0
91803,pregnancy,0,0
91804,rate,0,0
91805,(,0,0
91806,pregnancies,0,0
91807,confirmed,0,0
91808,by,0,0
91809,ultrasonography,0,0
91810,per,0,0
91811,100,0,0
91812,cycles,0,0
91813,),0,0
91814,.,0,0
91815,RESULTS,0,0
91816,The,0,0
91817,overall,0,0
91818,clinical,0,0
91819,pregnancy,0,0
91820,rate,0,0
91821,after,0,0
91822,a,0,0
91823,maximum,0,0
91824,of,0,0
91825,4,0,0
91826,IUI,1,0
91827,cycles,0,0
91828,was,0,0
91829,comparable,0,0
91830,in,0,0
91831,cases,0,0
91832,with,0,0
91833,and,0,0
91834,without,0,0
91835,sperm,1,0
91836,treatment,1,0
91837,with,1,0
91838,PAF,1,0
91839,(,0,0
91840,12.24,0,0
91841,%,0,0
91842,vs,0,0
91843,11.11,0,0
91844,%,0,0
91845,),0,0
91846,.,0,0
91847,Addition,0,0
91848,or,0,0
91849,exclusion,0,0
91850,of,0,0
91851,PAF,1,0
91852,sperm,1,0
91853,treatment,1,0
91854,in,0,0
91855,the,0,0
91856,same,0,0
91857,patients,0,0
91858,did,0,0
91859,not,0,0
91860,significantly,0,0
91861,alter,0,0
91862,the,0,0
91863,outcome,0,0
91864,.,0,0
91865,CONCLUSIONS,0,0
91866,The,0,0
91867,generalized,0,0
91868,use,0,0
91869,of,0,0
91870,exogenous,1,0
91871,PAF,1,0
91872,for,0,0
91873,the,0,0
91874,preparation,0,0
91875,of,0,0
91876,sperm,0,0
91877,in,0,0
91878,unselected,0,0
91879,cases,0,0
91880,of,0,0
91881,mild,0,0
91882,male,0,0
91883,infertility,0,0
91884,does,0,0
91885,not,0,0
91886,improve,0,0
91887,the,0,0
91888,clinical,0,0
91889,outcome,0,0
91890,of,0,0
91891,IUI,0,0
91892,.,0,0
91893,Prospective,0,1
91894,randomised,0,1
91895,multicentre,0,0
91896,trial,0,0
91897,with,0,0
91898,the,0,0
91899,birth,1,0
91900,trainer,1,0
91901,EPI-NO,1,0
91902,for,0,0
91903,the,0,0
91904,prevention,0,0
91905,of,0,0
91906,perineal,0,0
91907,trauma,0,0
91908,.,0,0
91909,BACKGROUND,0,0
91910,In,0,0
91911,several,0,0
91912,non-randomised,0,0
91913,trials,0,0
91914,training,0,0
91915,with,0,0
91916,EPI-NO,1,0
91917,increased,0,0
91918,the,0,0
91919,rate,0,0
91920,of,0,0
91921,intact,0,0
91922,perineum,0,0
91923,and,0,0
91924,decreased,0,0
91925,episiotomy,0,0
91926,rates,0,0
91927,",",0,0
91928,shortened,0,0
91929,the,0,0
91930,second,0,0
91931,stage,0,0
91932,of,0,0
91933,labour,0,0
91934,and,0,0
91935,lowered,0,0
91936,use,0,0
91937,of,0,0
91938,pain,0,0
91939,killers,0,0
91940,.,0,0
91941,AIMS,0,0
91942,To,0,0
91943,verify,0,0
91944,the,0,0
91945,preliminary,0,0
91946,results,0,0
91947,with,0,0
91948,EPI-NO,1,0
91949,in,0,0
91950,a,0,0
91951,prospective,0,0
91952,randomised,0,0
91953,trial,0,0
91954,.,0,0
91955,METHODS,0,0
91956,Randomised,0,1
91957,",",0,1
91958,single-blind,0,1
91959,multicentre,0,1
91960,trial,0,0
91961,in,0,0
91962,four,0,0
91963,university,0,0
91964,hospitals,0,0
91965,in,0,0
91966,Germany,0,0
91967,including,0,0
91968,276,0,0
91969,primigravidae,0,0
91970,.,0,0
91971,RESULTS,0,0
91972,After,0,0
91973,training,0,0
91974,with,0,0
91975,EPI-NO,1,0
91976,we,0,0
91977,observed,0,0
91978,a,0,0
91979,significant,0,0
91980,increase,0,0
91981,in,0,0
91982,the,0,0
91983,incidence,0,0
91984,of,0,0
91985,intact,0,0
91986,perineum,0,0
91987,(,0,0
91988,37.4,0,0
91989,%,0,0
91990,vs,0,0
91991,25.7,0,0
91992,%,0,0
91993,;,0,0
91994,P,0,0
91995,=,0,0
91996,0.05,0,0
91997,),0,0
91998,and,0,0
91999,a,0,0
92000,tendency,0,0
92001,towards,0,0
92002,lower,0,0
92003,episiotomy,0,0
92004,rates,0,0
92005,(,0,0
92006,41.9,0,0
92007,%,0,0
92008,vs,0,0
92009,50.5,0,0
92010,%,0,0
92011,;,0,0
92012,P,0,0
92013,=,0,0
92014,0.11,0,0
92015,),0,0
92016,.,0,0
92017,We,0,0
92018,found,0,0
92019,no,0,0
92020,significant,0,0
92021,differences,0,0
92022,between,0,0
92023,the,0,0
92024,two,0,0
92025,groups,0,0
92026,regarding,0,0
92027,incidence,0,0
92028,of,0,0
92029,perineal,0,0
92030,tears,0,0
92031,",",0,0
92032,duration,0,0
92033,of,0,0
92034,second,0,0
92035,stage,0,0
92036,of,0,0
92037,labour,0,0
92038,",",0,0
92039,use,0,0
92040,of,0,0
92041,pain,0,0
92042,relief,0,0
92043,and,0,0
92044,rate,0,0
92045,of,0,0
92046,vaginal,0,0
92047,infection,0,0
92048,.,0,0
92049,CONCLUSIONS,0,0
92050,Training,0,0
92051,with,0,0
92052,EPI-NO,1,0
92053,increases,0,0
92054,significantly,0,0
92055,the,0,0
92056,likelihood,0,0
92057,of,0,0
92058,having,0,0
92059,an,0,0
92060,intact,0,0
92061,perineum,0,0
92062,and,0,0
92063,reduces,0,0
92064,the,0,0
92065,episiotomy,0,0
92066,rate,0,0
92067,.,0,0
92068,Design,0,0
92069,of,0,0
92070,the,0,0
92071,DEFINE,0,0
92072,trial,0,0
92073,:,0,0
92074,determining,0,0
92075,the,0,0
92076,EFficacy,0,0
92077,and,0,0
92078,tolerability,0,1
92079,of,0,0
92080,CETP,0,0
92081,INhibition,0,0
92082,with,0,0
92083,AnacEtrapib,1,1
92084,.,1,0
92085,BACKGROUND,0,0
92086,Residual,0,0
92087,cardiovascular,0,1
92088,(,0,1
92089,CV,0,1
92090,),0,1
92091,risk,0,0
92092,often,0,0
92093,remains,0,0
92094,high,0,0
92095,despite,0,0
92096,statin,0,1
92097,therapy,0,1
92098,to,0,0
92099,lower,0,0
92100,low-density,0,1
92101,lipoprotein,0,1
92102,cholesterol,0,1
92103,(,0,1
92104,LDL-C,0,1
92105,),0,1
92106,.,0,0
92107,New,0,0
92108,therapies,0,0
92109,to,0,0
92110,raise,0,0
92111,high-density,0,0
92112,lipoprotein,0,1
92113,cholesterol,0,1
92114,(,0,1
92115,HDL-C,0,1
92116,),0,0
92117,are,0,0
92118,currently,0,0
92119,being,0,0
92120,investigated,0,0
92121,.,0,0
92122,Anacetrapib,1,1
92123,is,0,0
92124,a,0,1
92125,cholesteryl,0,1
92126,ester,0,1
92127,transfer,0,1
92128,protein,0,0
92129,(,0,0
92130,CETP,0,1
92131,),0,1
92132,inhibitor,0,1
92133,that,0,0
92134,raises,0,0
92135,HDL-C,0,0
92136,and,0,0
92137,reduces,0,0
92138,LDL-C,0,1
92139,when,0,0
92140,administered,0,1
92141,alone,0,0
92142,or,0,0
92143,with,0,0
92144,a,0,0
92145,statin,0,1
92146,.,0,0
92147,Adverse,0,0
92148,effects,0,0
92149,on,0,0
92150,blood,0,0
92151,pressure,0,0
92152,",",0,0
92153,electrolytes,0,1
92154,",",0,1
92155,and,0,1
92156,aldosterone,0,1
92157,levels,0,0
92158,",",0,0
92159,seen,0,0
92160,with,0,0
92161,another,0,0
92162,drug,0,1
92163,in,0,0
92164,this,0,0
92165,class,0,0
92166,",",0,0
92167,have,0,0
92168,not,0,0
92169,been,0,0
92170,noted,0,0
92171,in,0,0
92172,studies,0,0
92173,of,0,0
92174,anacetrapib,1,1
92175,to,0,0
92176,date,0,0
92177,.,0,0
92178,METHODS,0,0
92179,Determining,0,0
92180,the,0,0
92181,EFficacy,0,0
92182,and,0,0
92183,Tolerability,0,1
92184,of,0,0
92185,CETP,0,0
92186,INhibition,0,0
92187,with,0,1
92188,AnacEtrapib,1,1
92189,(,0,1
92190,DEFINE,0,1
92191,),0,0
92192,is,0,0
92193,a,0,0
92194,randomized,0,0
92195,",",0,0
92196,double-blind,0,1
92197,",",0,1
92198,placebo-controlled,1,1
92199,trial,0,1
92200,to,0,0
92201,assess,0,0
92202,the,0,0
92203,efficacy,0,0
92204,and,0,0
92205,safety,0,0
92206,profile,0,0
92207,of,0,0
92208,anacetrapib,1,1
92209,in,0,0
92210,patients,0,0
92211,with,0,0
92212,coronary,0,0
92213,heart,0,1
92214,disease,0,1
92215,(,0,1
92216,CHD,0,1
92217,),0,1
92218,or,0,0
92219,CHD,0,1
92220,risk,0,1
92221,equivalents,0,0
92222,(,0,0
92223,clinical,0,0
92224,trials.gov,0,1
92225,NCT00685776,0,1
92226,),0,0
92227,.,0,0
92228,Eligible,0,0
92229,patients,0,0
92230,at,0,0
92231,National,0,0
92232,Cholesterol,0,1
92233,Education,0,1
92234,Program-Adult,0,1
92235,Treatment,0,0
92236,Panel,0,0
92237,III,0,1
92238,LDL-C,0,1
92239,treatment,0,0
92240,goal,0,0
92241,on,0,0
92242,a,0,0
92243,statin,0,1
92244,",",0,0
92245,with,0,0
92246,or,0,0
92247,without,0,0
92248,other,0,0
92249,lipid-modifying,0,1
92250,medications,0,1
92251,",",0,0
92252,are,0,0
92253,treated,0,0
92254,with,0,0
92255,anacetrapib,1,1
92256,",",0,1
92257,100,0,1
92258,mg,0,1
92259,",",0,1
92260,or,0,1
92261,placebo,1,1
92262,for,0,0
92263,18,0,0
92264,months,0,0
92265,",",0,0
92266,followed,0,0
92267,by,0,0
92268,a,0,0
92269,3-month,0,0
92270,",",0,0
92271,poststudy,0,0
92272,follow-up,0,0
92273,.,0,0
92274,The,0,0
92275,primary,0,0
92276,end,0,0
92277,points,0,0
92278,are,0,0
92279,percent,0,0
92280,change,0,0
92281,from,0,0
92282,baseline,0,0
92283,in,0,0
92284,LDL-C,0,0
92285,and,0,0
92286,the,0,0
92287,safety,0,0
92288,and,0,0
92289,tolerability,0,1
92290,of,0,1
92291,anacetrapib,1,1
92292,.,1,1
92293,Comprehensive,0,0
92294,preplanned,0,0
92295,interim,0,0
92296,safety,0,0
92297,analyses,0,0
92298,will,0,0
92299,be,0,0
92300,performed,0,0
92301,at,0,0
92302,the,0,0
92303,6-,0,0
92304,and,0,0
92305,12-month,0,0
92306,time,0,0
92307,points,0,0
92308,to,0,0
92309,examine,0,0
92310,treatment,0,0
92311,effects,0,0
92312,on,0,0
92313,key,0,0
92314,safety,0,0
92315,end,0,0
92316,points,0,0
92317,",",0,0
92318,including,0,0
92319,blood,0,0
92320,pressure,0,1
92321,and,0,0
92322,electrolytes,0,1
92323,.,0,1
92324,A,0,1
92325,preplanned,0,0
92326,Bayesian,0,0
92327,analysis,0,0
92328,will,0,0
92329,be,0,0
92330,performed,0,0
92331,to,0,0
92332,interpret,0,0
92333,the,0,0
92334,CV,0,0
92335,event,0,0
92336,distribution,0,0
92337,",",0,0
92338,given,0,0
92339,the,0,0
92340,limited,0,0
92341,number,0,0
92342,of,0,0
92343,events,0,0
92344,expected,0,0
92345,in,0,0
92346,this,0,0
92347,study,0,0
92348,.,0,0
92349,RESULTS,0,0
92350,A,0,0
92351,total,0,0
92352,of,0,0
92353,"2,757",0,0
92354,patients,0,0
92355,were,0,0
92356,screened,0,0
92357,at,0,0
92358,153,0,0
92359,centers,0,0
92360,in,0,0
92361,20,0,0
92362,countries,0,0
92363,",",0,0
92364,and,0,0
92365,"1,623",0,0
92366,patients,0,0
92367,were,0,0
92368,randomized,0,0
92369,into,0,0
92370,the,0,0
92371,trial,0,0
92372,.,0,0
92373,Lipid,0,0
92374,results,0,0
92375,",",0,0
92376,clinical,0,0
92377,CV,0,0
92378,events,0,0
92379,",",0,0
92380,and,0,0
92381,safety,0,0
92382,outcomes,0,0
92383,from,0,0
92384,this,0,0
92385,trial,0,0
92386,are,0,0
92387,anticipated,0,0
92388,in,0,0
92389,2010,0,0
92390,.,0,0
92391,A,0,1
92392,good,0,0
92393,response,0,0
92394,to,0,0
92395,oil,1,1
92396,with,1,0
92397,medium-,1,0
92398,and,1,0
92399,long-chain,1,1
92400,fatty,1,1
92401,acids,1,1
92402,in,0,1
92403,body,0,0
92404,fat,0,0
92405,and,0,0
92406,blood,0,0
92407,lipid,0,0
92408,profiles,0,0
92409,of,0,0
92410,male,0,0
92411,hypertriglyceridemic,0,1
92412,subjects,0,0
92413,.,0,0
92414,A,0,0
92415,double,0,0
92416,blind,0,0
92417,clinical,0,0
92418,trial,0,0
92419,was,0,0
92420,carried,0,0
92421,out,0,0
92422,to,0,0
92423,clarify,0,0
92424,the,0,0
92425,effects,0,0
92426,of,0,0
92427,oil,1,1
92428,with,1,0
92429,medium-,1,0
92430,and,1,0
92431,long-chain,1,1
92432,triglyceride,1,1
92433,(,1,1
92434,MLCT,1,1
92435,),1,1
92436,on,0,0
92437,body,0,0
92438,fat,0,0
92439,and,0,0
92440,blood,0,0
92441,lipid,0,0
92442,profiles,0,0
92443,in,0,0
92444,hypertriglyceridemic,0,1
92445,subjects,0,0
92446,.,0,0
92447,One-hundred-and-twelve,0,0
92448,subjects,0,0
92449,were,0,0
92450,enrolled,0,0
92451,and,0,0
92452,divided,0,0
92453,into,0,0
92454,two,0,0
92455,groups,0,0
92456,;,0,0
92457,those,1,0
92458,that,1,0
92459,consumed,1,1
92460,MLCT,1,1
92461,oil,1,1
92462,and,1,0
92463,those,1,0
92464,that,1,0
92465,consumed,1,1
92466,long-chain,1,1
92467,triglyceride,1,1
92468,(,1,1
92469,LCT,1,1
92470,),1,1
92471,oil,1,1
92472,for,0,0
92473,8,0,0
92474,weeks,0,0
92475,.,0,0
92476,All,0,0
92477,subjects,0,0
92478,were,0,0
92479,requested,0,0
92480,to,0,0
92481,consume,0,0
92482,25-30,0,0
92483,g,0,0
92484,of,0,0
92485,the,0,1
92486,oils,0,1
92487,daily,0,1
92488,and,0,1
92489,maintain,0,0
92490,a,0,0
92491,fixed,0,0
92492,level,0,0
92493,of,0,0
92494,energy,0,0
92495,intake,0,1
92496,and,0,0
92497,exercise,0,1
92498,.,0,0
92499,Anthropometric,0,0
92500,and,0,0
92501,blood,0,0
92502,biochemical,0,0
92503,parameters,0,0
92504,were,0,0
92505,measured,0,0
92506,when,0,0
92507,the,0,0
92508,study,0,0
92509,was,0,0
92510,initiated,0,0
92511,and,0,0
92512,completed,0,0
92513,.,0,0
92514,The,0,0
92515,LCT,1,0
92516,group,0,0
92517,consisted,0,0
92518,of,0,0
92519,50,0,0
92520,subjects,0,0
92521,(,0,0
92522,34,0,0
92523,men,0,0
92524,and,0,0
92525,16,0,0
92526,women,0,1
92527,),0,0
92528,",",0,0
92529,while,0,0
92530,the,0,0
92531,MLCT,1,0
92532,group,0,0
92533,consisted,0,0
92534,of,0,0
92535,51,0,0
92536,subjects,0,0
92537,(,0,0
92538,33,0,0
92539,men,0,0
92540,and,0,0
92541,18,0,0
92542,women,0,1
92543,),0,1
92544,who,0,0
92545,completed,0,0
92546,the,0,0
92547,study,0,0
92548,.,0,0
92549,Larger,0,0
92550,decreases,0,0
92551,in,0,0
92552,body,0,0
92553,weight,0,0
92554,",",0,0
92555,body,0,0
92556,mass,0,0
92557,index,0,0
92558,",",0,0
92559,waist,0,0
92560,circumference,0,0
92561,",",0,0
92562,body,0,0
92563,fat,0,0
92564,",",0,0
92565,total,0,0
92566,fat,0,0
92567,area,0,0
92568,and,0,0
92569,subcutaneous,0,1
92570,fat,0,1
92571,area,0,0
92572,in,0,0
92573,the,0,0
92574,abdomen,0,0
92575,and,0,1
92576,serum,0,1
92577,triglycerides,0,1
92578,",",0,1
92579,low-density,0,1
92580,lipoprotein,0,1
92581,cholesterol,0,1
92582,",",0,1
92583,apolipoprotein,0,1
92584,B,0,1
92585,",",0,1
92586,C2,0,1
92587,",",0,0
92588,C3,0,0
92589,and,0,0
92590,E,0,0
92591,were,0,0
92592,observed,0,0
92593,in,0,0
92594,male,0,0
92595,subjects,0,0
92596,in,0,0
92597,the,0,0
92598,MLCT,1,1
92599,group,0,0
92600,than,0,0
92601,those,0,0
92602,in,0,0
92603,the,0,0
92604,LCT,1,0
92605,group,0,0
92606,.,0,0
92607,However,0,0
92608,",",0,0
92609,no,0,0
92610,significant,0,0
92611,differences,0,0
92612,in,0,0
92613,these,0,0
92614,parameters,0,0
92615,between,0,0
92616,the,0,0
92617,female,0,0
92618,subjects,0,0
92619,in,0,0
92620,the,0,0
92621,two,0,0
92622,groups,0,0
92623,were,0,0
92624,observed,0,0
92625,.,0,0
92626,Data,0,0
92627,from,0,0
92628,this,0,0
92629,study,0,0
92630,indicate,0,0
92631,that,0,0
92632,consumption,0,0
92633,of,0,0
92634,medium-and,0,1
92635,long-chain,0,1
92636,triglycerides,0,1
92637,can,0,0
92638,reduce,0,0
92639,body,0,0
92640,weight,0,0
92641,and,0,0
92642,body,0,0
92643,fat,0,0
92644,and,0,0
92645,improve,0,0
92646,blood,0,0
92647,lipid,0,0
92648,profiles,0,0
92649,in,0,0
92650,male,0,0
92651,hypertriglyceridemic,0,1
92652,subjects,0,0
92653,.,0,0
92654,Comparison,0,0
92655,of,0,0
92656,fluid,0,0
92657,types,0,0
92658,for,0,0
92659,resuscitation,0,0
92660,after,0,0
92661,acute,0,0
92662,blood,0,0
92663,loss,0,0
92664,in,0,0
92665,mallard,0,0
92666,ducks,0,0
92667,(,0,0
92668,Anas,0,1
92669,platyrhynchos,0,1
92670,),0,0
92671,.,0,0
92672,OBJECTIVE,0,0
92673,The,0,0
92674,purpose,0,0
92675,of,0,0
92676,this,0,0
92677,study,0,0
92678,was,0,0
92679,to,0,0
92680,determine,0,0
92681,the,0,0
92682,LD,0,1
92683,(,0,1
92684,50,0,0
92685,),0,0
92686,for,0,0
92687,acute,0,0
92688,blood,0,0
92689,loss,0,0
92690,in,0,0
92691,mallard,0,0
92692,ducks,0,0
92693,(,0,0
92694,Anas,0,1
92695,platyrhynchos,0,1
92696,),0,0
92697,",",0,0
92698,compare,0,0
92699,the,0,0
92700,mortality,0,0
92701,rate,0,0
92702,among,0,0
92703,3,0,0
92704,fluid,0,0
92705,resuscitation,0,1
92706,groups,0,0
92707,",",0,0
92708,and,0,0
92709,determine,0,0
92710,the,0,0
92711,time,0,0
92712,required,0,0
92713,for,0,0
92714,a,0,0
92715,regenerative,0,0
92716,RBC,0,0
92717,response,0,0
92718,.,0,0
92719,DESIGN,0,0
92720,Prospective,0,0
92721,study,0,0
92722,.,0,0
92723,SETTING,0,0
92724,Medical,0,0
92725,College,0,0
92726,of,0,0
92727,Wisconsin,0,0
92728,Research,0,0
92729,facility,0,0
92730,.,0,0
92731,ANIMALS,0,0
92732,Eighteen,0,0
92733,mallard,0,0
92734,ducks,0,0
92735,were,0,0
92736,included,0,0
92737,for,0,0
92738,the,0,0
92739,LD,0,1
92740,(,0,1
92741,50,0,0
92742,),0,0
92743,study,0,0
92744,and,0,0
92745,28,0,0
92746,for,0,0
92747,the,0,0
92748,fluid,1,0
92749,resuscitation,1,0
92750,study,0,0
92751,.,0,0
92752,INTERVENTIONS,0,0
92753,Phlebotomy,1,0
92754,was,0,0
92755,performed,0,0
92756,during,0,0
92757,both,0,0
92758,the,0,0
92759,LD,0,1
92760,(,0,1
92761,50,0,0
92762,),0,1
92763,and,0,0
92764,fluid,1,1
92765,resuscitation,1,0
92766,studies,0,0
92767,.,0,0
92768,Ducks,0,0
92769,in,0,0
92770,the,0,0
92771,fluid,0,0
92772,resuscitation,0,0
92773,study,0,0
92774,received,0,0
92775,a,0,0
92776,5,1,1
92777,mL/kg,1,1
92778,intravenous,1,1
92779,bolus,1,1
92780,of,1,1
92781,crystalloids,1,1
92782,",",1,1
92783,hetastarch,1,1
92784,(,1,1
92785,HES,1,1
92786,),1,1
92787,",",1,0
92788,or,1,0
92789,a,1,0
92790,hemoglobin-based,1,1
92791,oxygen-carrying,1,1
92792,solution,1,1
92793,(,1,1
92794,HBOCS,1,1
92795,),1,1
92796,.,0,0
92797,MEASUREMENTS,0,0
92798,AND,0,1
92799,MAIN,0,1
92800,RESULTS,0,1
92801,The,0,0
92802,LD,0,0
92803,(,0,0
92804,50,0,0
92805,),0,0
92806,for,0,0
92807,acute,0,0
92808,blood,0,0
92809,loss,0,0
92810,was,0,0
92811,60,0,0
92812,%,0,0
92813,of,0,0
92814,total,0,0
92815,blood,0,0
92816,volume,0,0
92817,.,0,0
92818,This,0,0
92819,blood,0,0
92820,volume,0,0
92821,was,0,0
92822,removed,0,0
92823,in,0,0
92824,the,0,0
92825,fluid,0,0
92826,resuscitation,0,0
92827,study,0,0
92828,to,0,0
92829,create,0,0
92830,a,0,0
92831,model,0,0
92832,of,0,0
92833,acute,0,0
92834,blood,0,0
92835,loss,0,0
92836,.,0,0
92837,Following,0,0
92838,fluid,0,1
92839,administration,0,1
92840,",",0,1
92841,6,0,0
92842,birds,0,0
92843,in,0,0
92844,the,0,0
92845,crystalloid,0,1
92846,group,0,1
92847,(,0,0
92848,66,0,0
92849,%,0,0
92850,),0,0
92851,",",0,0
92852,4,0,0
92853,birds,0,0
92854,in,0,0
92855,the,0,0
92856,HES,0,1
92857,group,0,1
92858,(,0,0
92859,40,0,0
92860,%,0,0
92861,),0,0
92862,",",0,0
92863,and,0,0
92864,2,0,0
92865,birds,0,0
92866,in,0,0
92867,the,0,0
92868,HBOCS,0,1
92869,group,0,1
92870,(,0,0
92871,20,0,0
92872,%,0,0
92873,),0,0
92874,died,0,0
92875,.,0,0
92876,No,0,1
92877,statistical,0,0
92878,difference,0,0
92879,in,0,0
92880,mortality,0,0
92881,rate,0,0
92882,was,0,0
92883,seen,0,0
92884,among,0,0
92885,the,0,0
92886,3,0,0
92887,fluid,0,0
92888,resuscitation,0,1
92889,groups,0,0
92890,.,0,0
92891,Relative,0,0
92892,polychromasia,0,0
92893,evaluated,0,0
92894,post-phlebotomy,0,0
92895,demonstrated,0,0
92896,regeneration,0,0
92897,starting,0,0
92898,at,0,0
92899,24,0,0
92900,hours,0,0
92901,and,0,0
92902,continuing,0,1
92903,through,0,0
92904,48,0,0
92905,hours,0,0
92906,.,0,0
92907,CONCLUSIONS,0,1
92908,The,0,0
92909,LD,0,0
92910,(,0,0
92911,50,0,0
92912,),0,0
92913,for,0,0
92914,acute,0,0
92915,blood,0,0
92916,loss,0,0
92917,in,0,0
92918,mallard,0,0
92919,ducks,0,0
92920,was,0,0
92921,60,0,0
92922,%,0,0
92923,of,0,0
92924,their,0,0
92925,total,0,0
92926,blood,0,0
92927,volume,0,0
92928,.,0,0
92929,Although,0,0
92930,no,0,0
92931,statistical,0,0
92932,difference,0,0
92933,in,0,0
92934,mortality,0,0
92935,rate,0,0
92936,was,0,0
92937,appreciated,0,0
92938,among,0,0
92939,the,0,0
92940,3,0,0
92941,fluid,0,0
92942,resuscitation,0,1
92943,groups,0,0
92944,",",0,0
92945,a,0,0
92946,trend,0,0
92947,of,0,0
92948,decreased,0,0
92949,mortality,0,0
92950,rate,0,0
92951,was,0,0
92952,observed,0,0
92953,in,0,0
92954,the,0,0
92955,HBOCS,0,0
92956,group,0,0
92957,.,0,0
92958,An,0,1
92959,early,0,0
92960,regenerative,0,0
92961,response,0,0
92962,was,0,0
92963,apparent,0,0
92964,following,0,0
92965,acute,0,0
92966,blood,0,0
92967,loss,0,0
92968,.,0,0
92969,Long-term,0,0
92970,results,0,0
92971,after,0,0
92972,intracoronary,1,1
92973,injection,1,1
92974,of,1,1
92975,autologous,1,1
92976,mononuclear,1,0
92977,bone,1,0
92978,marrow,1,0
92979,cells,1,0
92980,in,0,0
92981,acute,0,0
92982,myocardial,0,0
92983,infarction,0,0
92984,:,0,0
92985,the,0,0
92986,ASTAMI,0,0
92987,randomised,0,0
92988,",",0,0
92989,controlled,0,0
92990,study,0,0
92991,.,0,0
92992,OBJECTIVE,0,0
92993,To,0,0
92994,investigate,0,0
92995,long-term,0,0
92996,safety,0,0
92997,and,0,0
92998,efficacy,0,1
92999,after,0,1
93000,intracoronary,1,1
93001,injection,1,1
93002,of,1,1
93003,autologous,1,1
93004,mononuclear,1,0
93005,bone,1,0
93006,marrow,1,1
93007,cells,1,0
93008,(,1,1
93009,mBMCs,1,1
93010,),1,1
93011,in,1,0
93012,acute,0,0
93013,myocardial,0,1
93014,infarction,0,1
93015,(,0,1
93016,AMI,0,1
93017,),0,1
93018,.,0,0
93019,DESIGN,0,0
93020,Randomised,0,0
93021,",",0,0
93022,controlled,0,0
93023,trial,0,0
93024,.,0,0
93025,SETTING,0,0
93026,Two,0,1
93027,university,0,0
93028,hospitals,0,0
93029,in,0,0
93030,Oslo,0,0
93031,",",0,0
93032,Norway,0,0
93033,.,0,0
93034,PATIENTS,0,0
93035,Patients,0,0
93036,from,0,0
93037,the,0,0
93038,Autologous,0,1
93039,Stem,0,1
93040,cell,0,0
93041,Transplantation,0,0
93042,in,0,0
93043,Acute,0,0
93044,Myocardial,0,0
93045,Infarction,0,1
93046,(,0,1
93047,ASTAMI,0,1
93048,),0,0
93049,study,0,0
93050,were,0,0
93051,re-assessed,0,0
93052,3,0,0
93053,years,0,0
93054,after,0,0
93055,inclusion,0,0
93056,.,0,0
93057,INTERVENTIONS,0,0
93058,100,0,0
93059,patients,0,0
93060,with,0,0
93061,anterior,0,0
93062,wall,0,0
93063,ST-elevation,0,0
93064,myocardial,0,0
93065,infarction,0,0
93066,treated,0,0
93067,with,0,0
93068,acute,1,0
93069,percutaneous,1,0
93070,coronary,1,1
93071,intervention,1,1
93072,(,1,1
93073,PCI,1,1
93074,),1,1
93075,were,0,0
93076,randomised,0,0
93077,to,0,0
93078,receive,0,1
93079,intracoronary,1,1
93080,injection,1,1
93081,of,1,1
93082,mBMCs,1,1
93083,(,1,0
93084,n,1,0
93085,=,1,0
93086,50,1,0
93087,),1,0
93088,or,1,0
93089,not,1,0
93090,(,0,0
93091,n,0,0
93092,=,0,0
93093,50,0,0
93094,),0,0
93095,.,0,0
93096,MAIN,0,0
93097,OUTCOME,0,1
93098,MEASURES,0,1
93099,Change,0,0
93100,in,0,0
93101,left,0,1
93102,ventricular,0,1
93103,(,0,1
93104,LV,0,1
93105,),0,1
93106,ejection,0,1
93107,fraction,0,0
93108,(,0,0
93109,primary,0,0
93110,),0,0
93111,.,0,0
93112,Change,0,0
93113,in,0,0
93114,exercise,0,0
93115,capacity,0,0
93116,(,0,0
93117,peak,0,0
93118,VO,0,0
93119,(,0,0
93120,2,0,0
93121,),0,1
93122,),0,1
93123,and,0,0
93124,quality,0,0
93125,of,0,0
93126,life,0,0
93127,(,0,0
93128,secondary,0,0
93129,),0,0
93130,.,0,0
93131,Infarct,0,0
93132,size,0,0
93133,(,0,0
93134,additional,0,0
93135,aim,0,1
93136,),0,0
93137,",",0,0
93138,and,0,0
93139,safety,0,0
93140,.,0,0
93141,RESULTS,0,0
93142,The,0,0
93143,rates,0,0
93144,of,0,0
93145,adverse,0,0
93146,clinical,0,0
93147,events,0,0
93148,in,0,0
93149,the,0,0
93150,groups,0,0
93151,were,0,0
93152,low,0,0
93153,and,0,0
93154,equal,0,0
93155,.,0,0
93156,There,0,0
93157,were,0,0
93158,no,0,0
93159,significant,0,0
93160,differences,0,0
93161,between,0,0
93162,groups,0,0
93163,in,0,0
93164,change,0,0
93165,of,0,0
93166,global,0,0
93167,LV,0,0
93168,systolic,0,0
93169,function,0,0
93170,by,0,0
93171,echocardiography,0,0
93172,or,0,0
93173,magnetic,0,0
93174,resonance,0,1
93175,imaging,0,1
93176,(,0,1
93177,MRI,0,1
93178,),0,0
93179,during,0,0
93180,the,0,0
93181,follow-up,0,0
93182,.,0,0
93183,On,0,0
93184,exercise,0,0
93185,testing,0,0
93186,",",0,0
93187,the,0,0
93188,mBMC-treated,1,0
93189,patients,0,0
93190,had,0,0
93191,larger,0,0
93192,improvement,0,0
93193,in,0,0
93194,exercise,0,0
93195,time,0,0
93196,from,0,0
93197,2-3,0,0
93198,weeks,0,0
93199,to,0,0
93200,3,0,0
93201,years,0,1
93202,(,0,0
93203,1.5,0,0
93204,minutes,0,0
93205,vs,0,0
93206,0.6,0,0
93207,minutes,0,0
93208,",",0,0
93209,p,0,0
93210,=,0,0
93211,0.05,0,0
93212,),0,0
93213,",",0,0
93214,but,0,0
93215,the,0,0
93216,change,0,0
93217,in,0,0
93218,peak,0,0
93219,oxygen,0,0
93220,consumption,0,0
93221,did,0,0
93222,not,0,0
93223,differ,0,0
93224,(,0,0
93225,3.0,0,0
93226,ml/kg/min,0,0
93227,vs,0,0
93228,3.1,0,0
93229,ml/kg/min,0,0
93230,",",0,0
93231,p,0,0
93232,=,0,0
93233,0.75,0,0
93234,),0,0
93235,.,0,0
93236,CONCLUSION,0,0
93237,The,0,0
93238,results,0,0
93239,indicate,0,0
93240,that,0,0
93241,intracoronary,0,1
93242,mBMC,0,1
93243,treatment,0,0
93244,in,0,0
93245,AMI,0,0
93246,is,0,0
93247,safe,0,0
93248,in,0,0
93249,the,0,0
93250,long,0,0
93251,term,0,0
93252,.,0,0
93253,A,0,0
93254,small,0,0
93255,improvement,0,0
93256,in,0,0
93257,exercise,0,0
93258,time,0,0
93259,in,0,0
93260,the,0,0
93261,mBMC,1,0
93262,group,0,0
93263,was,0,0
93264,found,0,0
93265,",",0,0
93266,but,0,0
93267,no,0,0
93268,other,0,0
93269,effects,0,0
93270,of,0,0
93271,treatment,0,0
93272,could,0,0
93273,be,0,0
93274,identified,0,0
93275,3,0,0
93276,years,0,0
93277,after,0,0
93278,cell,1,0
93279,therapy,1,0
93280,.,1,0
93281,Direct,0,0
93282,evidence,0,0
93283,for,0,0
93284,spinal,0,0
93285,cord,0,0
93286,involvement,0,0
93287,in,0,0
93288,placebo,0,1
93289,analgesia,0,1
93290,.,0,1
93291,Placebo,0,1
93292,analgesia,0,1
93293,is,0,0
93294,a,0,0
93295,prime,0,0
93296,example,0,0
93297,of,0,0
93298,the,0,0
93299,impact,0,0
93300,that,0,0
93301,psychological,0,0
93302,factors,0,0
93303,have,0,0
93304,on,0,0
93305,pain,0,0
93306,perception,0,0
93307,.,0,0
93308,We,0,0
93309,used,0,0
93310,functional,1,0
93311,magnetic,1,0
93312,resonance,1,0
93313,imaging,1,0
93314,of,0,0
93315,the,0,0
93316,human,0,0
93317,spinal,0,0
93318,cord,0,0
93319,to,0,0
93320,test,0,0
93321,the,0,0
93322,hypothesis,0,0
93323,that,0,0
93324,placebo,0,1
93325,analgesia,0,1
93326,results,0,0
93327,in,0,0
93328,a,0,0
93329,reduction,0,0
93330,of,0,0
93331,nociceptive,0,0
93332,processing,0,0
93333,in,0,0
93334,the,0,0
93335,spinal,0,0
93336,cord,0,0
93337,.,0,0
93338,In,0,0
93339,line,0,0
93340,with,0,0
93341,behavioral,0,0
93342,data,0,0
93343,that,0,0
93344,show,0,0
93345,decreased,0,0
93346,pain,0,0
93347,responses,0,0
93348,under,0,0
93349,placebo,0,1
93350,",",0,0
93351,pain-related,0,0
93352,activity,0,0
93353,in,0,0
93354,the,0,0
93355,spinal,0,0
93356,cord,0,0
93357,is,0,0
93358,strongly,0,0
93359,reduced,0,0
93360,under,0,0
93361,placebo,0,1
93362,.,0,0
93363,These,0,0
93364,results,0,0
93365,provide,0,0
93366,direct,0,0
93367,evidence,0,0
93368,for,0,0
93369,spinal,0,0
93370,inhibition,0,0
93371,as,0,0
93372,one,0,0
93373,mechanism,0,0
93374,of,0,0
93375,placebo,0,1
93376,analgesia,0,1
93377,and,0,1
93378,highlight,0,0
93379,that,0,0
93380,psychological,0,0
93381,factors,0,0
93382,can,0,0
93383,act,0,0
93384,on,0,0
93385,the,0,0
93386,earliest,0,0
93387,stages,0,0
93388,of,0,0
93389,pain,0,0
93390,processing,0,0
93391,in,0,0
93392,the,0,0
93393,central,0,0
93394,nervous,0,0
93395,system,0,0
93396,.,0,0
93397,Screening,1,0
93398,",",1,0
93399,brief,1,0
93400,intervention,1,0
93401,",",1,0
93402,and,1,0
93403,referral,1,0
93404,to,1,0
93405,treatment,1,0
93406,(,1,1
93407,SBIRT,1,1
93408,),1,0
93409,in,0,0
93410,a,0,0
93411,Polish,0,0
93412,emergency,0,0
93413,department,0,0
93414,:,0,0
93415,three-month,0,0
93416,outcomes,0,0
93417,of,0,0
93418,a,0,0
93419,randomized,0,0
93420,",",0,0
93421,controlled,0,0
93422,clinical,0,0
93423,trial,0,0
93424,.,0,0
93425,OBJECTIVE,0,0
93426,A,0,1
93427,randomized,0,0
93428,",",0,0
93429,controlled,0,0
93430,trial,0,0
93431,of,0,0
93432,screening,1,0
93433,",",1,0
93434,brief,1,0
93435,intervention,1,0
93436,",",1,0
93437,and,1,0
93438,referral,1,0
93439,to,1,0
93440,treatment,1,0
93441,(,1,1
93442,SBIRT,1,1
93443,),1,1
93444,for,0,0
93445,drinking,0,0
93446,and,0,0
93447,related,0,0
93448,problems,0,0
93449,among,0,0
93450,at-risk,0,0
93451,and,0,0
93452,dependent,0,0
93453,drinkers,0,0
93454,was,0,0
93455,conducted,0,0
93456,in,0,0
93457,an,0,0
93458,emergency,0,0
93459,department,0,1
93460,(,0,1
93461,ED,0,1
93462,),0,1
93463,in,0,0
93464,Sosnowiec,0,1
93465,",",0,0
93466,Poland,0,0
93467,",",0,0
93468,among,0,0
93469,patients,0,0
93470,ages,0,0
93471,18,0,0
93472,years,0,0
93473,and,0,0
93474,older,0,0
93475,.,0,0
93476,METHOD,0,0
93477,Data,0,0
93478,were,0,0
93479,collected,0,0
93480,over,0,0
93481,a,0,0
93482,23-week,0,0
93483,period,0,0
93484,",",0,0
93485,from,0,0
93486,4:00,0,0
93487,PM,0,0
93488,to,0,1
93489,midnight,0,1
93490,",",0,0
93491,and,0,0
93492,resulted,0,0
93493,in,0,0
93494,446,0,0
93495,patients,0,0
93496,being,0,0
93497,recruited,0,0
93498,into,0,0
93499,the,0,0
93500,study,0,0
93501,(,0,0
93502,90,0,0
93503,%,0,0
93504,of,0,0
93505,those,0,0
93506,who,0,0
93507,screened,0,0
93508,positive,0,0
93509,),0,0
93510,and,0,0
93511,randomized,0,0
93512,to,0,0
93513,three,0,0
93514,conditions,0,0
93515,following,0,0
93516,a,0,0
93517,two-stage,0,0
93518,process,0,0
93519,:,0,0
93520,screened,1,0
93521,only,1,0
93522,(,0,0
93523,n,0,0
93524,=,0,0
93525,147,0,0
93526,),0,0
93527,",",0,0
93528,assessed,1,0
93529,(,0,0
93530,n,0,0
93531,=,0,0
93532,152,0,0
93533,),0,0
93534,",",0,0
93535,and,0,0
93536,received,1,0
93537,intervention,1,1
93538,(,0,0
93539,n,0,0
93540,=,0,0
93541,147,0,0
93542,),0,0
93543,.,0,0
93544,Patients,0,0
93545,in,0,0
93546,the,0,0
93547,assessment,1,0
93548,(,0,0
93549,85,0,0
93550,%,0,0
93551,),0,0
93552,and,0,0
93553,intervention,1,0
93554,(,0,0
93555,83,0,0
93556,%,0,0
93557,),0,0
93558,conditions,0,0
93559,were,0,0
93560,blindly,0,0
93561,reassessed,0,0
93562,at,0,0
93563,3,0,0
93564,months,0,0
93565,via,0,0
93566,a,0,0
93567,telephone,0,0
93568,interview,0,0
93569,.,0,0
93570,RESULTS,0,0
93571,At,0,1
93572,3-month,0,1
93573,follow-up,0,0
93574,",",0,0
93575,both,0,0
93576,groups,0,0
93577,showed,0,0
93578,significant,0,0
93579,decreases,0,0
93580,in,0,0
93581,the,0,0
93582,proportion,0,0
93583,who,0,0
93584,were,0,0
93585,positive,0,0
93586,for,0,0
93587,at-risk,0,0
93588,drinking,0,0
93589,",",0,0
93590,the,0,0
93591,primary,0,0
93592,outcome,0,0
93593,variable,0,0
93594,.,0,0
93595,Both,0,0
93596,groups,0,0
93597,also,0,0
93598,showed,0,0
93599,significant,0,0
93600,decreases,0,0
93601,in,0,0
93602,drinking,0,0
93603,days,0,0
93604,per,0,0
93605,week,0,0
93606,",",0,0
93607,drinks,0,1
93608,per,0,1
93609,drinking,0,1
93610,day,0,0
93611,",",0,0
93612,maximum,0,1
93613,drinks,0,1
93614,per,0,1
93615,occasion,0,0
93616,",",0,0
93617,and,0,0
93618,negative,0,0
93619,consequences,0,0
93620,of,0,0
93621,drinking,0,0
93622,.,0,0
93623,Using,0,0
93624,analysis,0,0
93625,of,0,0
93626,covariance,0,0
93627,to,0,0
93628,control,0,0
93629,for,0,0
93630,baseline,0,0
93631,measures,0,0
93632,and,0,0
93633,demographic,0,0
93634,characteristics,0,0
93635,",",0,0
93636,no,0,0
93637,difference,0,0
93638,in,0,0
93639,outcome,0,0
93640,measures,0,0
93641,was,0,0
93642,found,0,0
93643,between,0,0
93644,intervention,1,0
93645,and,0,0
93646,assessment,1,0
93647,conditions,0,0
93648,.,0,0
93649,Subgroup,0,0
93650,analysis,0,0
93651,found,0,0
93652,some,0,0
93653,significant,0,0
93654,interactions,0,0
93655,between,0,0
93656,intervention,1,0
93657,and,0,0
93658,secondary,0,0
93659,outcomes,0,0
93660,.,0,0
93661,CONCLUSIONS,0,0
93662,Although,0,0
93663,the,0,0
93664,main,0,0
93665,findings,0,0
93666,were,0,0
93667,similar,0,0
93668,to,0,0
93669,those,0,0
93670,from,0,0
93671,other,0,0
93672,brief-intervention,0,0
93673,studies,0,0
93674,in,0,0
93675,Western,0,0
93676,cultures,0,0
93677,",",0,0
93678,findings,0,0
93679,here,0,0
93680,also,0,0
93681,suggest,0,0
93682,that,0,0
93683,intervention,0,0
93684,may,0,0
93685,have,0,0
93686,differential,0,0
93687,benefits,0,0
93688,for,0,0
93689,specific,0,0
93690,subgroups,0,0
93691,of,0,0
93692,patients,0,0
93693,in,0,0
93694,the,0,0
93695,ED,0,0
93696,",",0,0
93697,an,0,0
93698,area,0,0
93699,of,0,0
93700,research,0,0
93701,that,0,0
93702,may,0,0
93703,warrant,0,0
93704,additional,0,0
93705,study,0,0
93706,of,0,0
93707,brief,0,0
93708,intervention,0,0
93709,in,0,0
93710,the,0,0
93711,ED,0,0
93712,setting,0,0
93713,.,0,0
93714,Brief,0,0
93715,Report,0,0
93716,:,0,0
93717,Randomized,0,0
93718,test,0,0
93719,of,0,0
93720,the,0,0
93721,efficacy,0,0
93722,of,0,0
93723,picture,1,0
93724,exchange,1,0
93725,communication,1,0
93726,system,1,0
93727,on,0,0
93728,highly,0,0
93729,generalized,0,0
93730,picture,0,0
93731,exchanges,0,0
93732,in,0,0
93733,children,0,0
93734,with,0,0
93735,ASD,0,0
93736,.,0,0
93737,A,0,0
93738,randomized,0,0
93739,control,0,0
93740,trial,0,0
93741,comparing,0,0
93742,two,0,0
93743,social-communication,1,0
93744,interventions,1,0
93745,in,0,0
93746,young,0,0
93747,children,0,0
93748,with,0,0
93749,autism,0,0
93750,examined,0,0
93751,far-transfer,0,0
93752,of,0,0
93753,the,0,0
93754,use,0,0
93755,of,0,0
93756,picture,1,0
93757,exchange,1,0
93758,to,0,0
93759,communicate,0,0
93760,.,0,0
93761,Thirty-six,0,0
93762,children,0,0
93763,were,0,0
93764,randomly,0,0
93765,assigned,0,0
93766,to,0,0
93767,one,0,0
93768,of,0,0
93769,two,0,0
93770,treatment,0,0
93771,conditions,0,0
93772,",",0,0
93773,one,1,0
93774,of,1,0
93775,which,1,0
93776,was,1,0
93777,the,1,0
93778,Picture,1,0
93779,Exchange,1,0
93780,Communication,1,0
93781,System,1,0
93782,(,1,1
93783,PECS,1,1
93784,),1,1
93785,.,1,0
93786,All,0,0
93787,children,0,0
93788,had,0,0
93789,access,0,0
93790,to,0,0
93791,picture,1,0
93792,symbols,1,0
93793,during,1,0
93794,assessments,1,0
93795,.,1,0
93796,Post-treatment,0,0
93797,measurement,0,0
93798,of,0,0
93799,the,0,0
93800,number,0,0
93801,of,0,0
93802,picture,0,0
93803,exchanges,0,0
93804,in,0,0
93805,a,0,0
93806,far-transfer,0,0
93807,",",0,0
93808,assessment,0,0
93809,context,0,0
93810,favored,0,0
93811,the,0,0
93812,PECS,1,0
93813,intervention,0,0
93814,.,0,0
93815,These,0,0
93816,findings,0,0
93817,were,0,0
93818,interpreted,0,0
93819,as,0,0
93820,support,0,0
93821,for,0,0
93822,the,0,0
93823,hypothesis,0,0
93824,that,0,0
93825,the,0,0
93826,PECS,1,0
93827,curriculum,0,0
93828,can,0,0
93829,successfully,0,0
93830,teach,0,0
93831,a,0,0
93832,generalized,0,0
93833,means,0,0
93834,of,0,0
93835,showing,0,0
93836,coordinated,0,0
93837,attention,0,0
93838,to,0,0
93839,object,0,0
93840,and,0,0
93841,person,0,0
93842,without,0,0
93843,requiring,0,0
93844,eye,0,0
93845,contact,0,0
93846,to,0,0
93847,children,0,0
93848,with,0,0
93849,ASD,0,0
93850,.,0,0
93851,Effects,0,0
93852,of,0,0
93853,fluoride,1,1
93854,and,1,1
93855,chlorhexidine,1,1
93856,on,0,0
93857,the,0,0
93858,microflora,0,0
93859,of,0,0
93860,dental,0,0
93861,root,0,0
93862,surfaces,0,0
93863,and,0,0
93864,progression,0,0
93865,of,0,0
93866,root-surface,0,0
93867,caries,0,0
93868,.,0,0
93869,The,0,0
93870,effects,0,0
93871,of,0,0
93872,fluoride,1,1
93873,and,1,1
93874,chlorhexidine,1,1
93875,varnishes,0,1
93876,on,0,1
93877,the,0,0
93878,microflora,0,0
93879,of,0,0
93880,dental,0,0
93881,root,0,0
93882,surfaces,0,0
93883,and,0,0
93884,on,0,0
93885,the,0,0
93886,progression,0,0
93887,of,0,0
93888,root-surface,0,0
93889,caries,0,0
93890,were,0,0
93891,studied,0,0
93892,.,0,0
93893,Forty-four,0,0
93894,patients,0,0
93895,",",0,0
93896,surgically,0,0
93897,treated,0,0
93898,for,0,0
93899,advanced,0,0
93900,periodontal,0,0
93901,disease,0,0
93902,",",0,0
93903,were,0,0
93904,distributed,0,0
93905,at,0,0
93906,random,0,0
93907,among,0,0
93908,three,0,0
93909,groups,0,0
93910,.,0,0
93911,All,0,0
93912,patients,0,0
93913,received,0,0
93914,a,0,0
93915,standardized,0,0
93916,preventive,0,0
93917,treatment,0,0
93918,.,0,0
93919,Furthermore,0,0
93920,",",0,0
93921,the,0,0
93922,dentition,0,0
93923,of,0,0
93924,the,0,0
93925,patients,0,0
93926,in,0,0
93927,the,0,0
93928,two,0,0
93929,experimental,0,0
93930,groups,0,0
93931,was,0,0
93932,treated,0,0
93933,",",0,0
93934,at,0,0
93935,three-month,0,0
93936,intervals,0,0
93937,",",0,0
93938,with,0,0
93939,chlorhexidine,1,1
93940,and,1,1
93941,fluoride,1,1
93942,varnish,1,1
93943,",",0,0
93944,respectively,0,0
93945,.,0,0
93946,Patients,0,0
93947,in,0,0
93948,the,0,0
93949,control,1,0
93950,group,1,0
93951,received,0,0
93952,no,0,0
93953,additional,0,0
93954,treatment,0,0
93955,.,0,0
93956,In,0,0
93957,the,0,0
93958,experimental,0,0
93959,groups,0,0
93960,",",0,0
93961,plaque,0,0
93962,samples,0,0
93963,were,0,0
93964,collected,0,0
93965,from,0,0
93966,selected,0,0
93967,sound,0,0
93968,and,0,0
93969,carious,0,0
93970,root,0,0
93971,surfaces,0,0
93972,at,0,0
93973,baseline,0,0
93974,and,0,0
93975,at,0,0
93976,three,0,0
93977,",",0,0
93978,six,0,0
93979,",",0,0
93980,and,0,0
93981,nine,0,0
93982,months,0,0
93983,after,0,0
93984,the,0,0
93985,onset,0,0
93986,of,0,0
93987,the,0,0
93988,study,0,0
93989,.,0,0
93990,The,0,0
93991,presence,0,0
93992,of,0,0
93993,root-surface,0,0
93994,caries,0,0
93995,was,0,0
93996,scored,0,0
93997,at,0,0
93998,baseline,0,0
93999,and,0,0
94000,after,0,0
94001,one,0,0
94002,year,0,0
94003,.,0,0
94004,In,0,0
94005,addition,0,0
94006,",",0,0
94007,the,0,0
94008,texture,0,0
94009,",",0,0
94010,depth,0,0
94011,",",0,0
94012,and,0,0
94013,color,0,0
94014,of,0,0
94015,the,0,0
94016,root-surface,0,0
94017,lesions,0,0
94018,were,0,0
94019,monitored,0,0
94020,.,0,0
94021,Mutans,0,0
94022,streptococci,0,1
94023,on,0,0
94024,root,0,0
94025,surfaces,0,0
94026,were,0,0
94027,suppressed,0,0
94028,significantly,0,0
94029,(,0,0
94030,p,0,0
94031,less,0,0
94032,than,0,0
94033,0.05,0,0
94034,),0,0
94035,during,0,0
94036,the,0,0
94037,whole,0,0
94038,experimental,0,0
94039,period,0,0
94040,in,0,0
94041,the,0,0
94042,chlorhexidine,1,1
94043,varnish,0,1
94044,group,0,1
94045,",",0,0
94046,but,0,0
94047,not,0,0
94048,in,0,0
94049,the,0,0
94050,fluoride,1,1
94051,varnish,0,1
94052,group,0,1
94053,.,0,0
94054,A,0,0
94055,non-significant,0,0
94056,increase,0,0
94057,in,0,0
94058,the,0,0
94059,number,0,0
94060,of,0,0
94061,Actinomyces,0,0
94062,viscosus/naeslundii,0,0
94063,was,0,0
94064,noted,0,0
94065,after,0,0
94066,treatment,0,0
94067,with,0,0
94068,chlorhexidine,1,1
94069,and,0,1
94070,fluoride,1,1
94071,varnish,0,1
94072,.,0,1
94073,The,0,0
94074,increase,0,0
94075,in,0,0
94076,the,0,0
94077,number,0,0
94078,of,0,0
94079,decayed,0,0
94080,and,0,0
94081,filled,0,0
94082,root,0,0
94083,surfaces,0,0
94084,after,0,0
94085,one,0,0
94086,year,0,0
94087,was,0,0
94088,significantly,0,0
94089,lower,0,0
94090,in,0,0
94091,the,0,0
94092,experimental,0,0
94093,groups,0,0
94094,than,0,0
94095,in,0,0
94096,the,0,0
94097,control,0,0
94098,group,0,0
94099,.,0,0
94100,After,0,0
94101,treatment,0,0
94102,with,0,1
94103,chlorhexidine,1,1
94104,varnish,0,1
94105,",",0,1
94106,significantly,0,0
94107,more,0,0
94108,initial,0,0
94109,root-surface,0,0
94110,lesions,0,0
94111,had,0,0
94112,hardened,0,0
94113,than,0,0
94114,in,0,0
94115,the,0,0
94116,other,0,0
94117,groups,0,0
94118,.,0,0
94119,Tetracaine,1,1
94120,(,1,1
94121,ametop,1,1
94122,),1,1
94123,compared,0,0
94124,to,0,0
94125,placebo,0,1
94126,for,0,0
94127,reducing,0,0
94128,pain,0,0
94129,associated,0,0
94130,with,0,1
94131,intramuscular,0,1
94132,injection,0,1
94133,of,0,1
94134,palivizumab,0,1
94135,(,0,1
94136,synagis,0,1
94137,),0,1
94138,.,0,1
94139,Infants,0,0
94140,receive,0,0
94141,many,0,0
94142,painful,0,0
94143,immunizations,0,0
94144,before,0,0
94145,they,0,0
94146,are,0,0
94147,2,0,0
94148,years,0,0
94149,old,0,0
94150,.,0,0
94151,The,0,0
94152,purpose,0,0
94153,of,0,0
94154,this,0,0
94155,study,0,0
94156,was,0,0
94157,to,0,0
94158,evaluate,0,0
94159,if,0,0
94160,topical,1,1
94161,tetracaine,1,1
94162,reduces,0,1
94163,the,0,0
94164,pain,0,0
94165,of,0,0
94166,intramuscular,0,1
94167,palivizumab,1,1
94168,compared,0,1
94169,to,0,0
94170,placebo,1,1
94171,.,1,0
94172,There,0,0
94173,were,0,0
94174,two,0,0
94175,study,0,0
94176,injections,0,1
94177,",",0,0
94178,one,0,0
94179,with,0,0
94180,tetracaine,1,1
94181,and,0,0
94182,one,0,0
94183,with,0,0
94184,placebo,1,1
94185,.,1,0
94186,Pain,0,0
94187,was,0,0
94188,scored,0,0
94189,by,0,0
94190,their,0,0
94191,parents,0,0
94192,and,0,0
94193,a,0,0
94194,pediatric,0,0
94195,nurse,0,0
94196,.,0,0
94197,Topical,0,0
94198,tetracaine,1,1
94199,was,0,0
94200,not,0,0
94201,associated,0,0
94202,with,0,0
94203,a,0,0
94204,significant,0,0
94205,reduction,0,0
94206,in,0,0
94207,pain,0,0
94208,score,0,0
94209,",",0,0
94210,although,0,0
94211,it,0,0
94212,did,0,0
94213,lead,0,0
94214,to,0,0
94215,faster,0,0
94216,recovery,0,0
94217,times,0,0
94218,.,0,0
94219,Additional,0,0
94220,pain-reduction,0,0
94221,strategies,0,0
94222,are,0,0
94223,required,0,0
94224,.,0,0
94225,Low-frequency,1,1
94226,repetitive,1,0
94227,transcranial,1,0
94228,magnetic,1,0
94229,stimulation,1,0
94230,(,1,1
94231,rTMS,1,1
94232,),1,1
94233,affects,0,0
94234,event-related,0,0
94235,potential,0,0
94236,measures,0,0
94237,of,0,0
94238,novelty,0,0
94239,processing,0,0
94240,in,0,0
94241,autism,0,0
94242,.,0,0
94243,In,0,0
94244,our,0,0
94245,previous,0,0
94246,study,0,0
94247,on,0,0
94248,individuals,0,0
94249,with,0,0
94250,autism,0,0
94251,spectrum,0,0
94252,disorder,0,1
94253,(,0,1
94254,ASD,0,1
94255,),0,1
94256,(,0,1
94257,Sokhadze,0,1
94258,et,0,1
94259,al.,0,0
94260,",",0,0
94261,Appl,0,1
94262,Psychophysiol,0,1
94263,Biofeedback,0,0
94264,34:37-51,0,1
94265,",",0,1
94266,2009a,0,1
94267,),0,0
94268,we,0,0
94269,reported,0,0
94270,abnormalities,0,0
94271,in,0,0
94272,the,0,0
94273,attention-orienting,0,0
94274,frontal,0,0
94275,event-related,0,1
94276,potentials,0,0
94277,(,0,1
94278,ERP,0,1
94279,),0,1
94280,and,0,0
94281,the,0,0
94282,sustained-attention,0,0
94283,centro-parietal,0,0
94284,ERPs,0,0
94285,in,0,0
94286,a,0,0
94287,visual,0,0
94288,oddball,0,0
94289,experiment,0,0
94290,.,0,0
94291,These,0,0
94292,results,0,0
94293,suggest,0,0
94294,that,0,0
94295,individuals,0,0
94296,with,0,0
94297,autism,0,0
94298,over-process,0,0
94299,information,0,0
94300,needed,0,0
94301,for,0,0
94302,the,0,0
94303,successful,0,0
94304,differentiation,0,0
94305,of,0,0
94306,target,0,0
94307,and,0,0
94308,novel,0,0
94309,stimuli,0,0
94310,.,0,0
94311,In,0,0
94312,the,0,0
94313,present,0,0
94314,study,0,0
94315,we,0,0
94316,examine,0,0
94317,the,0,0
94318,effects,0,0
94319,of,0,0
94320,low-frequency,1,0
94321,",",1,0
94322,repetitive,1,0
94323,Transcranial,1,0
94324,Magnetic,1,0
94325,Stimulation,1,0
94326,(,1,1
94327,rTMS,1,1
94328,),1,1
94329,on,0,0
94330,novelty,0,0
94331,processing,0,0
94332,as,0,0
94333,well,0,0
94334,as,0,0
94335,behavior,0,0
94336,and,0,0
94337,social,0,0
94338,functioning,0,0
94339,in,0,0
94340,13,0,0
94341,individuals,0,0
94342,with,0,0
94343,ASD,0,0
94344,.,0,0
94345,Our,0,0
94346,hypothesis,0,0
94347,was,0,0
94348,that,0,0
94349,low-frequency,1,0
94350,rTMS,1,0
94351,application,0,0
94352,to,0,0
94353,dorsolateral,0,0
94354,prefrontal,0,1
94355,cortex,0,1
94356,(,0,1
94357,DLFPC,0,1
94358,),0,0
94359,would,0,0
94360,result,0,0
94361,in,0,0
94362,an,0,0
94363,alteration,0,0
94364,of,0,0
94365,the,0,0
94366,cortical,0,0
94367,excitatory/inhibitory,0,0
94368,balance,0,0
94369,through,0,0
94370,the,0,0
94371,activation,0,0
94372,of,0,0
94373,inhibitory,0,0
94374,GABAergic,0,0
94375,double,0,0
94376,bouquet,0,0
94377,interneurons,0,0
94378,.,0,0
94379,We,0,0
94380,expected,0,0
94381,to,0,0
94382,find,0,0
94383,post-TMS,0,0
94384,differences,0,0
94385,in,0,0
94386,amplitude,0,0
94387,and,0,0
94388,latency,0,0
94389,of,0,0
94390,early,0,0
94391,and,0,0
94392,late,0,0
94393,ERP,0,0
94394,components,0,0
94395,.,0,0
94396,The,0,0
94397,results,0,0
94398,of,0,0
94399,our,0,0
94400,current,0,0
94401,study,0,0
94402,validate,0,0
94403,the,0,0
94404,use,0,0
94405,of,0,0
94406,low-frequency,0,0
94407,rTMS,0,0
94408,as,0,0
94409,a,0,0
94410,modulatory,0,0
94411,tool,0,0
94412,that,0,0
94413,altered,0,0
94414,the,0,0
94415,disrupted,0,0
94416,ratio,0,0
94417,of,0,0
94418,cortical,0,0
94419,excitation,0,0
94420,to,0,0
94421,inhibition,0,0
94422,in,0,0
94423,autism,0,0
94424,.,0,0
94425,After,0,0
94426,rTMS,0,0
94427,the,0,0
94428,parieto-occipital,0,0
94429,P50,0,0
94430,amplitude,0,0
94431,decreased,0,0
94432,to,0,0
94433,novel,0,0
94434,distracters,0,0
94435,but,0,0
94436,not,0,0
94437,to,0,0
94438,targets,0,0
94439,;,0,0
94440,also,0,0
94441,the,0,0
94442,amplitude,0,0
94443,and,0,0
94444,latency,0,0
94445,to,0,0
94446,targets,0,0
94447,increased,0,0
94448,for,0,0
94449,the,0,0
94450,frontal,0,0
94451,P50,0,0
94452,while,0,0
94453,decreasing,0,0
94454,to,0,0
94455,non-target,0,0
94456,stimuli,0,0
94457,.,0,0
94458,Low-frequency,0,0
94459,rTMS,0,0
94460,minimized,0,0
94461,early,0,0
94462,cortical,0,0
94463,responses,0,0
94464,to,0,0
94465,irrelevant,0,0
94466,stimuli,0,0
94467,and,0,0
94468,increased,0,0
94469,responses,0,0
94470,to,0,0
94471,relevant,0,0
94472,stimuli,0,0
94473,.,0,0
94474,Improved,0,0
94475,selectivity,0,0
94476,in,0,0
94477,early,0,0
94478,cortical,0,0
94479,responses,0,0
94480,lead,0,0
94481,to,0,0
94482,better,0,0
94483,stimulus,0,0
94484,differentiation,0,0
94485,at,0,0
94486,later-stage,0,0
94487,responses,0,0
94488,as,0,0
94489,was,0,0
94490,made,0,0
94491,evident,0,0
94492,by,0,0
94493,our,0,0
94494,P3b,0,0
94495,and,0,0
94496,P3a,0,0
94497,component,0,0
94498,findings,0,0
94499,.,0,0
94500,These,0,0
94501,results,0,0
94502,indicate,0,0
94503,a,0,0
94504,significant,0,0
94505,change,0,0
94506,in,0,0
94507,early,0,0
94508,",",0,0
94509,middle-latency,0,0
94510,and,0,0
94511,late,0,0
94512,ERP,0,0
94513,components,0,0
94514,at,0,0
94515,the,0,0
94516,frontal,0,0
94517,",",0,0
94518,centro-parietal,0,0
94519,",",0,0
94520,and,0,0
94521,parieto-occipital,0,0
94522,regions,0,0
94523,of,0,0
94524,interest,0,0
94525,in,0,0
94526,response,0,0
94527,to,0,0
94528,target,0,0
94529,and,0,0
94530,distracter,0,0
94531,stimuli,0,0
94532,as,0,0
94533,a,0,0
94534,result,0,0
94535,of,0,0
94536,rTMS,0,0
94537,treatment,0,0
94538,.,0,0
94539,Overall,0,0
94540,",",0,0
94541,our,0,0
94542,preliminary,0,0
94543,results,0,0
94544,show,0,0
94545,that,0,0
94546,rTMS,0,0
94547,may,0,0
94548,prove,0,0
94549,to,0,0
94550,be,0,0
94551,an,0,0
94552,important,0,0
94553,research,0,0
94554,tool,0,0
94555,or,0,0
94556,treatment,0,0
94557,modality,0,0
94558,in,0,0
94559,addressing,0,0
94560,the,0,0
94561,stimulus,0,0
94562,hypersensitivity,0,0
94563,characteristic,0,0
94564,of,0,0
94565,autism,0,0
94566,spectrum,0,0
94567,disorders,0,0
94568,.,0,0
94569,Randomized,0,0
94570,",",0,0
94571,controlled,0,0
94572,trial,0,0
94573,of,0,0
94574,an,0,0
94575,intervention,1,0
94576,for,0,0
94577,toddlers,0,0
94578,with,0,0
94579,autism,0,0
94580,:,0,0
94581,the,0,0
94582,Early,0,0
94583,Start,0,0
94584,Denver,0,0
94585,Model,0,0
94586,.,0,0
94587,OBJECTIVE,0,0
94588,To,0,1
94589,conduct,0,0
94590,a,0,0
94591,randomized,0,0
94592,",",0,0
94593,controlled,0,0
94594,trial,0,0
94595,to,0,0
94596,evaluate,0,0
94597,the,0,0
94598,efficacy,0,0
94599,of,0,0
94600,the,0,0
94601,Early,1,0
94602,Start,1,0
94603,Denver,1,0
94604,Model,1,1
94605,(,1,1
94606,ESDM,1,1
94607,),1,1
94608,",",0,0
94609,a,0,0
94610,comprehensive,0,0
94611,developmental,0,0
94612,behavioral,0,0
94613,intervention,0,0
94614,",",0,0
94615,for,0,0
94616,improving,0,0
94617,outcomes,0,0
94618,of,0,0
94619,toddlers,0,0
94620,diagnosed,0,0
94621,with,0,0
94622,autism,0,0
94623,spectrum,0,0
94624,disorder,0,1
94625,(,0,1
94626,ASD,0,1
94627,),0,1
94628,.,0,0
94629,METHODS,0,0
94630,Forty-eight,0,0
94631,children,0,0
94632,diagnosed,0,0
94633,with,0,0
94634,ASD,0,0
94635,between,0,0
94636,18,0,0
94637,and,0,0
94638,30,0,0
94639,months,0,0
94640,of,0,0
94641,age,0,0
94642,were,0,0
94643,randomly,0,0
94644,assigned,0,0
94645,to,0,0
94646,1,0,0
94647,of,0,0
94648,2,0,0
94649,groups,0,0
94650,:,0,0
94651,(,0,0
94652,1,0,1
94653,),0,0
94654,ESDM,1,1
94655,intervention,1,1
94656,",",0,0
94657,which,0,0
94658,is,0,0
94659,based,0,0
94660,on,0,0
94661,developmental,0,0
94662,and,0,0
94663,applied,0,0
94664,behavioral,0,0
94665,analytic,0,0
94666,principles,0,0
94667,and,0,0
94668,delivered,0,0
94669,by,0,0
94670,trained,0,0
94671,therapists,0,0
94672,and,0,0
94673,parents,0,0
94674,for,0,0
94675,2,0,0
94676,years,0,0
94677,;,0,1
94678,or,0,1
94679,(,0,1
94680,2,0,1
94681,),0,0
94682,referral,1,0
94683,to,1,0
94684,community,1,0
94685,providers,1,0
94686,for,1,0
94687,intervention,1,0
94688,commonly,1,0
94689,available,1,0
94690,in,1,0
94691,the,1,0
94692,community,1,0
94693,.,1,0
94694,RESULTS,0,0
94695,Compared,0,0
94696,with,0,0
94697,children,0,0
94698,who,0,0
94699,received,0,0
94700,community-intervention,0,0
94701,",",0,0
94702,children,0,0
94703,who,0,0
94704,received,0,0
94705,ESDM,0,0
94706,showed,0,0
94707,significant,0,0
94708,improvements,0,0
94709,in,0,0
94710,IQ,0,0
94711,",",0,0
94712,adaptive,0,0
94713,behavior,0,0
94714,",",0,0
94715,and,0,0
94716,autism,0,0
94717,diagnosis,0,0
94718,.,0,0
94719,Two,0,1
94720,years,0,0
94721,after,0,0
94722,entering,0,0
94723,intervention,0,0
94724,",",0,0
94725,the,0,0
94726,ESDM,0,1
94727,group,0,0
94728,on,0,0
94729,average,0,0
94730,improved,0,0
94731,17.6,0,0
94732,standard,0,0
94733,score,0,0
94734,points,0,1
94735,(,0,0
94736,1,0,0
94737,SD,0,1
94738,:,0,0
94739,15,0,0
94740,points,0,0
94741,),0,0
94742,compared,0,0
94743,with,0,0
94744,7.0,0,0
94745,points,0,0
94746,in,0,0
94747,the,0,0
94748,comparison,0,0
94749,group,0,0
94750,relative,0,0
94751,to,0,0
94752,baseline,0,0
94753,scores,0,0
94754,.,0,0
94755,The,0,0
94756,ESDM,0,0
94757,group,0,0
94758,maintained,0,0
94759,its,0,0
94760,rate,0,0
94761,of,0,0
94762,growth,0,0
94763,in,0,0
94764,adaptive,0,0
94765,behavior,0,0
94766,compared,0,0
94767,with,0,0
94768,a,0,0
94769,normative,0,0
94770,sample,0,0
94771,of,0,0
94772,typically,0,0
94773,developing,0,0
94774,children,0,0
94775,.,0,0
94776,In,0,0
94777,contrast,0,0
94778,",",0,0
94779,over,0,0
94780,the,0,0
94781,2-year,0,0
94782,span,0,0
94783,",",0,0
94784,the,0,0
94785,comparison,0,0
94786,group,0,0
94787,showed,0,0
94788,greater,0,0
94789,delays,0,0
94790,in,0,0
94791,adaptive,0,0
94792,behavior,0,0
94793,.,0,0
94794,Children,0,0
94795,who,0,0
94796,received,0,0
94797,ESDM,1,0
94798,also,0,0
94799,were,0,0
94800,more,0,0
94801,likely,0,0
94802,to,0,0
94803,experience,0,0
94804,a,0,0
94805,change,0,0
94806,in,0,0
94807,diagnosis,0,0
94808,from,0,0
94809,autism,0,0
94810,to,0,0
94811,pervasive,0,0
94812,developmental,0,0
94813,disorder,0,0
94814,",",0,0
94815,not,0,0
94816,otherwise,0,0
94817,specified,0,0
94818,",",0,0
94819,than,0,0
94820,the,0,0
94821,comparison,0,0
94822,group,0,0
94823,.,0,0
94824,CONCLUSIONS,0,0
94825,This,0,0
94826,is,0,0
94827,the,0,0
94828,first,0,0
94829,randomized,0,0
94830,",",0,0
94831,controlled,0,0
94832,trial,0,0
94833,to,0,0
94834,demonstrate,0,0
94835,the,0,0
94836,efficacy,0,0
94837,of,0,0
94838,a,0,0
94839,comprehensive,0,0
94840,developmental,0,0
94841,behavioral,0,0
94842,intervention,0,0
94843,for,0,0
94844,toddlers,0,0
94845,with,0,0
94846,ASD,0,0
94847,for,0,0
94848,improving,0,0
94849,cognitive,0,0
94850,and,0,0
94851,adaptive,0,0
94852,behavior,0,0
94853,and,0,0
94854,reducing,0,0
94855,severity,0,0
94856,of,0,0
94857,ASD,0,0
94858,diagnosis,0,0
94859,.,0,0
94860,Results,0,0
94861,of,0,0
94862,this,0,0
94863,study,0,0
94864,underscore,0,0
94865,the,0,0
94866,importance,0,0
94867,of,0,0
94868,early,0,0
94869,detection,0,0
94870,of,0,0
94871,and,0,0
94872,intervention,0,0
94873,in,0,0
94874,autism,0,0
94875,.,0,0
94876,Aripiprazole,1,1
94877,in,0,0
94878,the,0,0
94879,treatment,0,0
94880,of,0,0
94881,irritability,0,0
94882,in,0,0
94883,children,0,0
94884,and,0,0
94885,adolescents,0,0
94886,with,0,0
94887,autistic,0,0
94888,disorder,0,0
94889,.,0,0
94890,OBJECTIVE,0,0
94891,The,0,0
94892,objective,0,0
94893,of,0,0
94894,this,0,0
94895,study,0,0
94896,was,0,0
94897,to,0,0
94898,evaluate,0,0
94899,short-term,0,0
94900,efficacy,0,0
94901,and,0,0
94902,safety,0,0
94903,of,0,0
94904,aripiprazole,1,1
94905,in,0,0
94906,the,0,0
94907,treatment,0,0
94908,of,0,0
94909,irritability,0,0
94910,in,0,0
94911,children,0,0
94912,and,0,0
94913,adolescents,0,0
94914,with,0,0
94915,autistic,0,0
94916,disorder,0,0
94917,who,0,0
94918,were,0,0
94919,manifesting,0,0
94920,behaviors,0,0
94921,such,0,0
94922,as,0,0
94923,tantrums,0,0
94924,",",0,0
94925,aggression,0,0
94926,",",0,0
94927,self-injurious,0,0
94928,behavior,0,0
94929,",",0,0
94930,or,0,0
94931,a,0,0
94932,combination,0,0
94933,of,0,0
94934,these,0,0
94935,.,0,0
94936,METHODS,0,0
94937,This,0,0
94938,8-week,0,1
94939,",",0,0
94940,double-blind,0,1
94941,",",0,1
94942,randomized,0,1
94943,",",0,1
94944,placebo-controlled,0,1
94945,",",0,1
94946,parallel-group,0,1
94947,study,0,0
94948,was,0,0
94949,conducted,0,0
94950,of,0,0
94951,children,0,0
94952,and,0,0
94953,adolescents,0,1
94954,(,0,0
94955,aged,0,0
94956,6-17,0,0
94957,years,0,0
94958,),0,0
94959,with,0,0
94960,autistic,0,0
94961,disorder,0,0
94962,.,0,0
94963,Patients,1,0
94964,were,1,0
94965,randomly,1,0
94966,assigned,1,0
94967,(,1,1
94968,1:1,1,1
94969,),1,1
94970,to,1,0
94971,flexibly,1,1
94972,dosed,1,1
94973,aripiprazole,1,1
94974,(,1,1
94975,target,1,1
94976,dosage,1,1
94977,:,1,0
94978,5,1,0
94979,",",1,0
94980,10,1,0
94981,",",1,0
94982,or,1,0
94983,15,1,1
94984,mg/day,1,1
94985,),1,1
94986,or,1,1
94987,placebo,1,1
94988,.,1,1
94989,Efficacy,0,0
94990,outcome,0,0
94991,measures,0,0
94992,included,0,0
94993,the,0,0
94994,Aberrant,0,0
94995,Behavior,0,0
94996,Checklist,0,0
94997,irritability,0,0
94998,subscale,0,0
94999,and,0,0
95000,the,0,0
95001,Clinical,0,0
95002,Global,0,0
95003,Impression-Improvement,0,1
95004,score,0,1
95005,(,0,1
95006,CGI-I,0,1
95007,),0,1
95008,.,0,0
95009,Safety,0,0
95010,and,0,0
95011,tolerability,0,1
95012,were,0,0
95013,also,0,0
95014,assessed,0,0
95015,.,0,0
95016,RESULTS,0,0
95017,Ninety-eight,0,0
95018,patients,0,0
95019,were,0,0
95020,randomly,0,0
95021,assigned,0,0
95022,to,0,0
95023,receive,0,1
95024,placebo,1,1
95025,(,0,0
95026,n,0,0
95027,=,0,0
95028,51,0,0
95029,),0,0
95030,or,0,0
95031,aripiprazole,0,1
95032,(,0,0
95033,n,0,0
95034,=,0,0
95035,47,0,0
95036,),0,0
95037,.,0,0
95038,Mean,0,0
95039,improvement,0,0
95040,in,0,0
95041,Aberrant,0,0
95042,Behavior,0,0
95043,Checklist,0,0
95044,irritability,0,0
95045,subscale,0,0
95046,score,0,0
95047,was,0,0
95048,significantly,0,0
95049,greater,0,0
95050,with,0,0
95051,aripiprazole,1,1
95052,than,0,1
95053,with,0,1
95054,placebo,1,1
95055,from,0,0
95056,week,0,0
95057,1,0,0
95058,through,0,0
95059,week,0,0
95060,8,0,0
95061,.,0,0
95062,Aripiprazole,0,1
95063,demonstrated,0,0
95064,significantly,0,0
95065,greater,0,0
95066,global,0,0
95067,improvements,0,1
95068,than,0,0
95069,placebo,0,1
95070,",",0,0
95071,as,0,0
95072,assessed,0,0
95073,by,0,0
95074,the,0,0
95075,mean,0,0
95076,CGI-I,0,0
95077,score,0,0
95078,from,0,0
95079,week,0,0
95080,1,0,0
95081,through,0,0
95082,week,0,0
95083,8,0,0
95084,;,0,0
95085,however,0,0
95086,",",0,0
95087,clinically,0,0
95088,significant,0,0
95089,residual,0,0
95090,symptoms,0,0
95091,may,0,0
95092,still,0,0
95093,persist,0,0
95094,for,0,0
95095,some,0,0
95096,patients,0,0
95097,.,0,0
95098,Discontinuation,0,0
95099,rates,0,0
95100,as,0,0
95101,a,0,0
95102,result,0,0
95103,of,0,0
95104,adverse,0,0
95105,events,0,0
95106,(,0,1
95107,AEs,0,1
95108,),0,0
95109,were,0,0
95110,10.6,0,0
95111,%,0,0
95112,for,0,0
95113,aripiprazole,1,0
95114,and,0,0
95115,5.9,0,0
95116,%,0,0
95117,for,0,0
95118,placebo,1,1
95119,.,1,1
95120,Extrapyramidal,0,1
95121,symptom-related,0,1
95122,AE,0,0
95123,rates,0,0
95124,were,0,0
95125,14.9,0,0
95126,%,0,0
95127,for,0,0
95128,aripiprazole,1,0
95129,and,0,0
95130,8.0,0,0
95131,%,0,0
95132,for,0,0
95133,placebo,1,1
95134,.,1,1
95135,No,0,1
95136,serious,0,0
95137,AEs,0,1
95138,were,0,0
95139,reported,0,0
95140,.,0,0
95141,Mean,0,0
95142,weight,0,0
95143,gain,0,0
95144,was,0,0
95145,2.0,0,0
95146,kg,0,0
95147,on,0,0
95148,aripiprazole,0,1
95149,and,0,0
95150,0.8,0,0
95151,kg,0,0
95152,on,0,0
95153,placebo,0,1
95154,at,0,0
95155,week,0,0
95156,8,0,0
95157,.,0,0
95158,CONCLUSIONS,0,1
95159,Aripiprazole,1,1
95160,was,0,0
95161,efficacious,0,1
95162,in,0,0
95163,children,0,0
95164,and,0,0
95165,adolescents,0,0
95166,with,0,0
95167,irritability,0,0
95168,associated,0,0
95169,with,0,0
95170,autistic,0,0
95171,disorder,0,0
95172,and,0,0
95173,was,0,0
95174,generally,0,0
95175,safe,0,0
95176,and,0,0
95177,well,0,0
95178,tolerated,0,1
95179,.,0,0
95180,The,0,0
95181,role,0,0
95182,of,0,0
95183,ethnic,0,0
95184,matching,0,0
95185,between,0,0
95186,patient,0,0
95187,and,0,0
95188,provider,0,0
95189,on,0,0
95190,the,0,0
95191,effectiveness,0,0
95192,of,0,0
95193,brief,1,1
95194,alcohol,1,1
95195,interventions,1,1
95196,with,0,0
95197,Hispanics,0,0
95198,.,0,0
95199,BACKGROUND,0,0
95200,Evaluating,0,0
95201,the,0,0
95202,effectiveness,0,0
95203,of,0,0
95204,treatments,0,0
95205,such,0,0
95206,as,0,0
95207,brief,0,1
95208,alcohol,0,1
95209,interventions,0,1
95210,among,0,0
95211,Hispanics,0,0
95212,is,0,0
95213,essential,0,0
95214,to,0,0
95215,effectively,0,0
95216,addressing,0,0
95217,their,0,0
95218,treatment,0,0
95219,needs,0,0
95220,.,0,0
95221,Clinicians,0,0
95222,of,0,0
95223,the,0,0
95224,same,0,0
95225,ethnicity,0,0
95226,as,0,0
95227,the,0,0
95228,client,0,0
95229,may,0,0
95230,be,0,0
95231,more,0,0
95232,likely,0,0
95233,to,0,0
95234,understand,0,0
95235,the,0,0
95236,culture-specific,0,0
95237,values,0,0
95238,",",0,0
95239,norms,0,0
95240,",",0,0
95241,and,0,0
95242,attitudes,0,0
95243,and,0,0
95244,",",0,0
95245,therefore,0,0
95246,",",0,0
95247,the,0,0
95248,intervention,0,0
95249,may,0,0
95250,be,0,0
95251,more,0,0
95252,effective,0,0
95253,.,0,0
95254,Thus,0,0
95255,",",0,0
95256,in,0,0
95257,cases,0,0
95258,in,0,0
95259,which,0,0
95260,Hispanic,0,0
95261,patients,0,0
95262,were,0,0
95263,provided,0,0
95264,intervention,0,0
95265,by,0,0
95266,a,0,0
95267,Hispanic,0,0
95268,clinician,0,0
95269,improved,0,0
95270,drinking,0,0
95271,outcomes,0,0
95272,were,0,0
95273,expected,0,0
95274,.,0,0
95275,METHODS,0,0
95276,Patients,0,0
95277,were,0,0
95278,recruited,0,0
95279,from,0,0
95280,an,0,0
95281,urban,0,0
95282,Level,0,0
95283,I,0,0
95284,Trauma,0,0
95285,following,0,0
95286,screening,0,0
95287,for,0,0
95288,an,0,0
95289,alcohol-related,0,0
95290,injury,0,1
95291,or,0,1
95292,alcohol,0,1
95293,problems,0,1
95294,.,0,0
95295,Five,0,0
95296,hundred,0,0
95297,thirty-seven,0,0
95298,Hispanics,0,0
95299,were,0,0
95300,randomly,0,0
95301,assigned,0,0
95302,to,0,0
95303,brief,1,0
95304,intervention,1,0
95305,or,1,0
95306,treatment,1,0
95307,as,1,0
95308,usual,1,0
95309,.,1,0
95310,Hierarchical,0,0
95311,linear,0,0
95312,modeling,0,0
95313,was,0,0
95314,used,0,0
95315,to,0,0
95316,determine,0,0
95317,the,0,0
95318,effects,0,0
95319,of,0,0
95320,ethnic,0,0
95321,match,0,0
95322,on,0,0
95323,drinking,0,0
95324,outcomes,0,0
95325,including,0,0
95326,volume,0,0
95327,per,0,0
95328,week,0,0
95329,",",0,0
95330,maximum,0,0
95331,amount,0,0
95332,",",0,0
95333,and,0,0
95334,frequency,0,0
95335,of,0,0
95336,5,0,0
95337,or,0,0
95338,more,0,0
95339,drinks,0,1
95340,per,0,0
95341,occasion,0,0
95342,.,0,0
95343,Analyses,0,0
95344,controlled,0,0
95345,for,0,0
95346,level,0,0
95347,of,0,0
95348,acculturation,0,0
95349,and,0,0
95350,immigration,0,0
95351,status,0,0
95352,.,0,0
95353,RESULTS,0,0
95354,For,0,0
95355,Hispanics,0,0
95356,who,0,0
95357,received,0,0
95358,brief,0,0
95359,motivational,0,0
95360,intervention,0,0
95361,",",0,0
95362,an,0,0
95363,ethnic,0,0
95364,match,0,0
95365,between,0,0
95366,patient,0,0
95367,and,0,0
95368,provider,0,0
95369,resulted,0,0
95370,in,0,0
95371,a,0,0
95372,significant,0,0
95373,reduction,0,0
95374,in,0,0
95375,drinking,0,0
95376,outcomes,0,0
95377,at,0,0
95378,12-month,0,0
95379,follow-up,0,0
95380,.,0,0
95381,In,0,0
95382,addition,0,0
95383,",",0,0
95384,there,0,0
95385,was,0,0
95386,a,0,0
95387,tendency,0,0
95388,for,0,0
95389,ethnic,0,0
95390,match,0,0
95391,to,0,0
95392,be,0,0
95393,most,0,0
95394,beneficial,0,0
95395,to,0,0
95396,foreign-born,0,0
95397,Hispanics,0,0
95398,and,0,0
95399,less,0,0
95400,acculturated,0,0
95401,Hispanics,0,0
95402,.,0,0
95403,CONCLUSION,0,0
95404,As,0,0
95405,hypothesized,0,0
95406,",",0,0
95407,an,0,0
95408,ethnic,0,0
95409,match,0,0
95410,between,0,0
95411,patient,0,0
95412,and,0,0
95413,provider,0,0
95414,significantly,0,0
95415,enhanced,0,0
95416,the,0,0
95417,effectiveness,0,0
95418,of,0,0
95419,brief,0,0
95420,intervention,0,0
95421,among,0,0
95422,Hispanics,0,0
95423,.,0,0
95424,Ethnic,0,0
95425,concordance,0,0
95426,between,0,0
95427,patient,0,0
95428,and,0,0
95429,provider,0,0
95430,may,0,0
95431,have,0,0
95432,impacted,0,0
95433,the,0,0
95434,effectiveness,0,0
95435,of,0,0
95436,the,0,0
95437,intervention,0,0
95438,through,0,0
95439,several,0,0
95440,mechanisms,0,0
95441,including,0,0
95442,cultural,0,0
95443,scripts,0,0
95444,",",0,0
95445,ethnic-specific,0,0
95446,perceptions,0,0
95447,pertaining,0,0
95448,to,0,0
95449,substance,0,0
95450,abuse,0,0
95451,",",0,0
95452,and,0,0
95453,ethnic-specific,0,0
95454,preferred,0,0
95455,channels,0,0
95456,of,0,0
95457,communication,0,0
95458,.,0,0
95459,A,0,1
95460,prospective,0,1
95461,",",0,0
95462,randomized,0,0
95463,trial,0,0
95464,of,0,0
95465,nerve,0,0
95466,monitoring,0,0
95467,of,0,0
95468,the,0,0
95469,external,0,0
95470,branch,0,0
95471,of,0,0
95472,the,0,0
95473,superior,0,0
95474,laryngeal,0,0
95475,nerve,0,0
95476,during,0,0
95477,thyroidectomy,1,0
95478,under,0,0
95479,local/regional,1,0
95480,anesthesia,1,0
95481,and,1,0
95482,IV,1,0
95483,sedation,1,0
95484,.,1,0
95485,BACKGROUND,0,0
95486,The,0,0
95487,aim,0,0
95488,of,0,0
95489,this,0,0
95490,study,0,0
95491,was,0,0
95492,to,0,0
95493,assess,0,0
95494,the,0,0
95495,impact,0,0
95496,of,0,0
95497,the,0,0
95498,neuromonitoring,0,0
95499,of,0,0
95500,the,0,0
95501,external,0,0
95502,branch,0,0
95503,of,0,0
95504,the,0,0
95505,superior,0,0
95506,laryngeal,0,0
95507,nerve,0,1
95508,(,0,1
95509,EBSLN,0,1
95510,),0,1
95511,on,0,0
95512,the,0,0
95513,voice,0,0
95514,quality,0,0
95515,after,0,0
95516,mini-incision,1,0
95517,thyroidectomy,1,0
95518,under,0,0
95519,local/regional,1,0
95520,anesthesia,1,1
95521,and,1,1
95522,intravenous,1,1
95523,sedation,1,1
95524,.,1,0
95525,METHODS,0,0
95526,Patients,0,0
95527,undergoing,0,0
95528,mini-incision,1,0
95529,thyroidectomy,1,0
95530,under,1,0
95531,local,1,0
95532,anesthesia,1,0
95533,were,0,0
95534,prospectively,0,0
95535,randomized,0,0
95536,for,0,0
95537,either,0,0
95538,nerve,1,0
95539,monitoring,1,0
95540,of,1,0
95541,the,1,0
95542,EBSLN,1,1
95543,(,0,1
95544,group,0,0
95545,1,0,1
95546,),0,0
95547,or,1,0
95548,no,1,0
95549,nerve,1,0
95550,monitoring,1,0
95551,(,0,1
95552,group,0,0
95553,2,0,1
95554,),0,0
95555,.,0,0
95556,Voice,0,0
95557,and,0,0
95558,swallowing,0,0
95559,assessment,0,0
95560,were,0,0
95561,obtained,0,0
95562,by,0,0
95563,using,0,0
95564,the,0,0
95565,Voice,0,0
95566,Handicap,0,1
95567,Index-10,0,1
95568,(,0,1
95569,VHI-10,0,1
95570,),0,1
95571,and,0,0
95572,the,0,0
95573,Reflux,0,1
95574,Symptom,0,1
95575,Index,0,1
95576,questionnaires,0,1
95577,(,0,1
95578,RSI,0,1
95579,),0,1
95580,before,0,0
95581,surgery,0,0
95582,and,0,0
95583,at,0,0
95584,3,0,0
95585,weeks,0,0
95586,and,0,0
95587,3,0,0
95588,months,0,0
95589,after,0,0
95590,surgery,0,0
95591,.,0,0
95592,RESULTS,0,0
95593,Recruitment,0,0
95594,led,0,0
95595,to,0,0
95596,22,0,0
95597,patients,0,0
95598,in,0,0
95599,group,0,0
95600,1,0,0
95601,and,0,0
95602,25,0,0
95603,patients,0,0
95604,in,0,0
95605,group,0,0
95606,2,0,0
95607,.,0,0
95608,The,0,0
95609,rate,0,0
95610,of,0,0
95611,visualized,0,0
95612,EBSLN,0,0
95613,was,0,0
95614,higher,0,0
95615,in,0,0
95616,group,0,0
95617,1,0,0
95618,(,0,0
95619,66,0,0
95620,%,0,0
95621,vs,0,0
95622,21,0,0
95623,%,0,0
95624,;,0,0
95625,P,0,0
95626,=,0,0
95627,.003,0,0
95628,),0,0
95629,.,0,0
95630,Contrary,0,0
95631,to,0,0
95632,group,0,0
95633,1,0,0
95634,",",0,0
95635,in,0,0
95636,group,0,0
95637,2,0,0
95638,",",0,0
95639,the,0,0
95640,median,0,0
95641,total,0,0
95642,VHI-10,0,0
95643,score,0,0
95644,was,0,0
95645,significantly,0,0
95646,higher,0,0
95647,3,0,0
95648,months,0,0
95649,after,0,0
95650,surgery,0,0
95651,(,0,0
95652,P,0,0
95653,=,0,0
95654,.034,0,0
95655,),0,0
95656,compared,0,0
95657,with,0,0
95658,preoperatively,0,0
95659,",",0,0
95660,indicating,0,0
95661,a,0,0
95662,subjective,0,0
95663,voice,0,0
95664,handicap,0,0
95665,.,0,0
95666,In,0,0
95667,both,0,0
95668,groups,0,0
95669,",",0,0
95670,there,0,0
95671,was,0,0
95672,no,0,0
95673,difference,0,0
95674,in,0,0
95675,median,0,0
95676,total,0,0
95677,RSI,0,0
95678,score,0,0
95679,before,0,0
95680,surgery,0,0
95681,or,0,0
95682,at,0,0
95683,3,0,0
95684,weeks,0,0
95685,and,0,0
95686,3,0,0
95687,months,0,0
95688,after,0,0
95689,surgery,0,0
95690,.,0,0
95691,CONCLUSION,0,0
95692,Nerve,0,0
95693,monitoring,0,0
95694,aids,0,0
95695,in,0,0
95696,the,0,0
95697,visualization,0,0
95698,of,0,0
95699,the,0,0
95700,EBSLN,0,0
95701,during,0,0
95702,mini-incision,1,0
95703,thyroidectomy,1,0
95704,under,0,0
95705,local/regional,1,0
95706,anesthesia,1,0
95707,and,0,0
95708,leads,0,0
95709,to,0,0
95710,an,0,0
95711,improvement,0,0
95712,in,0,0
95713,patient-assessed,0,0
95714,voice,0,0
95715,quality,0,0
95716,after,0,0
95717,surgery,0,0
95718,but,0,0
95719,does,0,0
95720,not,0,0
95721,impact,0,0
95722,swallowing,0,0
95723,.,0,0
95724,The,0,0
95725,impact,0,0
95726,on,0,0
95727,outcome,0,0
95728,of,0,0
95729,the,0,0
95730,addition,0,0
95731,of,0,0
95732,all-trans,1,1
95733,retinoic,1,1
95734,acid,1,1
95735,to,1,1
95736,intensive,1,0
95737,chemotherapy,1,0
95738,in,0,0
95739,younger,0,0
95740,patients,0,0
95741,with,0,0
95742,nonacute,0,1
95743,promyelocytic,0,1
95744,acute,0,1
95745,myeloid,0,1
95746,leukemia,0,0
95747,:,0,0
95748,overall,0,0
95749,results,0,0
95750,and,0,0
95751,results,0,0
95752,in,0,0
95753,genotypic,0,0
95754,subgroups,0,0
95755,defined,0,0
95756,by,0,0
95757,mutations,0,0
95758,in,0,0
95759,NPM1,0,0
95760,",",0,0
95761,FLT3,0,0
95762,",",0,0
95763,and,0,0
95764,CEBPA,0,0
95765,.,0,0
95766,We,0,0
95767,investigated,0,0
95768,the,0,0
95769,benefit,0,0
95770,of,0,0
95771,adding,0,0
95772,all-trans,1,1
95773,retinoic,1,1
95774,acid,1,1
95775,(,1,1
95776,ATRA,1,1
95777,),1,1
95778,to,0,0
95779,chemotherapy,1,0
95780,for,0,0
95781,younger,0,0
95782,patients,0,0
95783,with,0,0
95784,nonacute,0,1
95785,promyelocytic,0,1
95786,acute,0,1
95787,myeloid,0,1
95788,leukemia,0,0
95789,and,0,0
95790,high-risk,0,0
95791,myelodysplastic,0,0
95792,syndrome,0,0
95793,",",0,0
95794,and,0,0
95795,considered,0,0
95796,interactions,0,0
95797,between,0,0
95798,treatment,0,0
95799,and,0,0
95800,molecular,0,0
95801,markers,0,0
95802,.,0,0
95803,Overall,0,0
95804,",",0,0
95805,1075,0,0
95806,patients,0,0
95807,less,0,0
95808,than,0,0
95809,60,0,0
95810,years,0,0
95811,of,0,0
95812,age,0,0
95813,were,0,0
95814,randomized,0,0
95815,to,0,0
95816,receive,0,0
95817,or,0,0
95818,not,0,0
95819,receive,0,0
95820,ATRA,1,0
95821,in,0,0
95822,addition,0,0
95823,to,0,0
95824,daunorubicin/Ara-C/thioguanine,1,1
95825,chemotherapy,1,1
95826,with,1,0
95827,Ara-C,1,0
95828,at,1,0
95829,standard,1,0
95830,or,1,0
95831,double,1,0
95832,standard,1,1
95833,dose,1,1
95834,.,1,0
95835,There,0,0
95836,were,0,0
95837,data,0,0
95838,on,0,0
95839,FLT3,0,0
95840,internal,0,0
95841,tandem,0,0
95842,duplications,0,0
95843,and,0,0
95844,NPM1,0,1
95845,mutations,0,0
95846,(,0,0
95847,n,0,0
95848,=,0,0
95849,592,0,0
95850,),0,0
95851,",",0,0
95852,CEBPA,0,1
95853,mutations,0,0
95854,(,0,0
95855,n,0,0
95856,=,0,0
95857,423,0,0
95858,),0,0
95859,",",0,0
95860,and,0,0
95861,MN1,0,1
95862,expression,0,0
95863,(,0,0
95864,n,0,0
95865,=,0,0
95866,195,0,0
95867,),0,0
95868,.,0,0
95869,The,0,0
95870,complete,0,0
95871,remission,0,0
95872,rate,0,0
95873,was,0,0
95874,68,0,0
95875,%,0,0
95876,with,0,0
95877,complete,0,0
95878,remission,0,0
95879,with,0,0
95880,incomplete,0,0
95881,count,0,0
95882,recovery,0,0
95883,in,0,0
95884,an,0,0
95885,additional,0,0
95886,16,0,0
95887,%,0,0
95888,;,0,0
95889,8-year,0,0
95890,overall,0,0
95891,survival,0,0
95892,was,0,0
95893,32,0,0
95894,%,0,0
95895,.,0,0
95896,There,0,0
95897,was,0,0
95898,no,0,0
95899,significant,0,0
95900,treatment,0,0
95901,effect,0,0
95902,for,0,0
95903,any,0,0
95904,outcome,0,0
95905,",",0,0
95906,with,0,0
95907,no,0,0
95908,significant,0,0
95909,interactions,0,0
95910,between,0,0
95911,treatment,0,0
95912,and,0,0
95913,demographics,0,0
95914,",",0,0
95915,or,0,0
95916,cytarabine,0,1
95917,randomization,0,1
95918,.,0,0
95919,Importantly,0,0
95920,",",0,0
95921,there,0,0
95922,were,0,0
95923,no,0,0
95924,interactions,0,0
95925,by,0,0
95926,FLT3/internal,0,0
95927,tandem,0,0
95928,duplications,0,0
95929,",",0,0
95930,NPM1,0,0
95931,",",0,0
95932,or,0,0
95933,CEBPA,0,0
95934,mutation,0,0
95935,.,0,0
95936,There,0,0
95937,was,0,0
95938,a,0,0
95939,suggestion,0,0
95940,that,0,0
95941,ATRA,1,0
95942,reduced,0,0
95943,relapse,0,0
95944,in,0,0
95945,patients,0,0
95946,with,0,0
95947,lower,0,0
95948,MN1,0,0
95949,levels,0,0
95950,",",0,0
95951,but,0,0
95952,no,0,0
95953,significant,0,0
95954,effect,0,0
95955,on,0,0
95956,overall,0,0
95957,survival,0,0
95958,.,0,0
95959,Results,0,0
95960,were,0,0
95961,consistent,0,0
95962,when,0,0
95963,restricted,0,0
95964,to,0,0
95965,patients,0,0
95966,with,0,0
95967,normal,0,0
95968,karyotype,0,0
95969,.,0,0
95970,ATRA,1,0
95971,has,0,0
95972,no,0,0
95973,overall,0,0
95974,effect,0,0
95975,on,0,0
95976,treatment,0,0
95977,outcomes,0,0
95978,in,0,0
95979,this,0,0
95980,group,0,0
95981,of,0,0
95982,patients,0,0
95983,.,0,0
95984,The,0,0
95985,study,0,0
95986,did,0,0
95987,not,0,0
95988,identify,0,0
95989,any,0,0
95990,subgroup,0,0
95991,of,0,0
95992,patients,0,0
95993,likely,0,0
95994,to,0,0
95995,derive,0,0
95996,a,0,0
95997,significant,0,0
95998,survival,0,0
95999,benefit,0,0
96000,from,0,0
96001,the,0,0
96002,addition,0,0
96003,of,0,0
96004,ATRA,1,0
96005,to,1,0
96006,chemotherapy,1,0
96007,.,1,0
96008,The,0,0
96009,efficacy,0,0
96010,of,0,0
96011,melatonin,1,1
96012,for,0,0
96013,sleep,0,1
96014,problems,0,0
96015,in,0,0
96016,children,0,0
96017,with,0,0
96018,autism,0,0
96019,",",0,0
96020,fragile,0,0
96021,X,0,0
96022,syndrome,0,0
96023,",",0,0
96024,or,0,0
96025,autism,0,0
96026,and,0,0
96027,fragile,0,0
96028,X,0,0
96029,syndrome,0,0
96030,.,0,0
96031,STUDY,0,0
96032,OBJECTIVE,0,0
96033,To,0,0
96034,determine,0,0
96035,the,0,0
96036,efficacy,0,0
96037,of,0,0
96038,melatonin,1,1
96039,on,0,0
96040,sleep,0,0
96041,problems,0,0
96042,in,0,0
96043,children,0,0
96044,with,0,0
96045,autistic,0,0
96046,spectrum,0,0
96047,disorder,0,1
96048,(,0,1
96049,ASD,0,1
96050,),0,1
96051,and,0,0
96052,fragile,0,0
96053,X,0,1
96054,syndrome,0,1
96055,(,0,1
96056,FXS,0,1
96057,),0,1
96058,.,0,0
96059,METHODS,0,1
96060,A,0,1
96061,4-week,0,1
96062,",",0,1
96063,randomized,0,1
96064,",",0,0
96065,double,0,0
96066,blind,0,0
96067,",",0,0
96068,placebo-controlled,0,1
96069,",",0,1
96070,crossover,0,1
96071,design,0,1
96072,was,0,0
96073,conducted,0,0
96074,following,0,0
96075,a,0,0
96076,1-week,0,0
96077,baseline,0,0
96078,period,0,0
96079,.,0,0
96080,Either,0,0
96081,melatonin,1,1
96082,",",0,1
96083,3,0,1
96084,mg,0,1
96085,",",0,1
96086,or,0,1
96087,placebo,1,1
96088,was,0,0
96089,given,0,0
96090,to,0,0
96091,participants,0,0
96092,for,0,0
96093,2,0,0
96094,weeks,0,0
96095,and,0,0
96096,then,0,0
96097,alternated,0,0
96098,for,0,0
96099,another,0,0
96100,2,0,0
96101,weeks,0,0
96102,.,0,0
96103,Sleep,0,0
96104,variables,0,0
96105,",",0,0
96106,including,0,0
96107,sleep,0,0
96108,duration,0,0
96109,",",0,0
96110,sleep-onset,0,0
96111,time,0,0
96112,",",0,0
96113,sleep-onset,0,0
96114,latency,0,0
96115,time,0,0
96116,",",0,0
96117,and,0,0
96118,the,0,0
96119,number,0,0
96120,of,0,0
96121,night,0,0
96122,awakenings,0,0
96123,",",0,0
96124,were,0,0
96125,recorded,0,0
96126,using,0,0
96127,an,0,0
96128,Actiwatch,0,0
96129,and,0,0
96130,from,0,0
96131,sleep,0,0
96132,diaries,0,0
96133,completed,0,0
96134,by,0,0
96135,parents,0,0
96136,.,0,0
96137,All,0,0
96138,participants,0,0
96139,had,0,0
96140,been,0,0
96141,thoroughly,0,0
96142,assessed,0,0
96143,for,0,0
96144,ASD,0,0
96145,and,0,0
96146,also,0,0
96147,had,0,0
96148,DNA,0,0
96149,testing,0,0
96150,for,0,0
96151,the,0,0
96152,diagnosis,0,0
96153,of,0,0
96154,FXS,0,0
96155,.,0,0
96156,RESULTS,0,0
96157,Data,0,0
96158,were,0,0
96159,successfully,0,0
96160,obtained,0,0
96161,from,0,0
96162,the,0,0
96163,12,0,0
96164,of,0,0
96165,18,0,0
96166,subjects,0,0
96167,who,0,0
96168,completed,0,0
96169,the,0,0
96170,study,0,0
96171,(,0,0
96172,11,0,0
96173,males,0,0
96174,",",0,0
96175,age,0,0
96176,range,0,0
96177,2,0,0
96178,to,0,0
96179,15.25,0,0
96180,years,0,0
96181,",",0,0
96182,mean,0,0
96183,5.47,0,0
96184,",",0,0
96185,SD,0,0
96186,3.6,0,0
96187,),0,0
96188,.,0,0
96189,Five,0,0
96190,participants,0,0
96191,met,0,1
96192,diagnostic,0,0
96193,criteria,0,0
96194,for,0,0
96195,ASD,0,1
96196,",",0,0
96197,3,0,0
96198,for,0,0
96199,FXS,0,0
96200,alone,0,0
96201,",",0,0
96202,3,0,0
96203,for,0,0
96204,FXS,0,1
96205,and,0,0
96206,ASD,0,0
96207,",",0,0
96208,and,0,0
96209,1,0,0
96210,for,0,0
96211,fragile,0,0
96212,X,0,0
96213,premutation,0,0
96214,.,0,0
96215,Eight,0,0
96216,out,0,0
96217,of,0,0
96218,12,0,0
96219,had,0,0
96220,melatonin,1,1
96221,first,0,0
96222,.,0,0
96223,The,0,0
96224,conclusions,0,0
96225,from,0,0
96226,a,0,0
96227,nonparametric,0,0
96228,repeated-measures,0,0
96229,technique,0,0
96230,indicate,0,0
96231,that,0,0
96232,mean,0,0
96233,night,0,0
96234,sleep,0,0
96235,duration,0,0
96236,was,0,0
96237,longer,0,0
96238,on,0,0
96239,melatonin,1,1
96240,than,0,1
96241,placebo,1,1
96242,by,0,0
96243,21,0,0
96244,minutes,0,0
96245,(,0,0
96246,p,0,0
96247,=,0,0
96248,.02,0,0
96249,),0,0
96250,",",0,0
96251,mean,0,0
96252,sleep-onset,0,0
96253,latency,0,0
96254,was,0,0
96255,shorter,0,0
96256,by,0,0
96257,28,0,0
96258,minutes,0,0
96259,(,0,0
96260,p,0,0
96261,=,0,0
96262,.0001,0,0
96263,),0,0
96264,",",0,0
96265,and,0,0
96266,mean,0,0
96267,sleep-onset,0,0
96268,time,0,0
96269,was,0,0
96270,earlier,0,0
96271,by,0,0
96272,42,0,0
96273,minutes,0,0
96274,(,0,0
96275,p,0,0
96276,=,0,0
96277,.02,0,0
96278,),0,0
96279,.,0,0
96280,CONCLUSION,0,0
96281,The,0,0
96282,results,0,0
96283,of,0,0
96284,this,0,0
96285,study,0,0
96286,support,0,0
96287,the,0,0
96288,efficacy,0,0
96289,and,0,0
96290,tolerability,0,1
96291,of,0,1
96292,melatonin,1,1
96293,treatment,0,0
96294,for,0,0
96295,sleep,0,0
96296,problems,0,0
96297,in,0,0
96298,children,0,0
96299,with,0,0
96300,ASD,0,0
96301,and,0,0
96302,FXS,0,0
96303,.,0,0
96304,Bioequivalence,0,1
96305,evaluation,0,0
96306,of,0,0
96307,a,0,0
96308,fixed,1,0
96309,dose,1,1
96310,combination,1,1
96311,lamivudine,1,1
96312,+,1,1
96313,stavudine,1,1
96314,tablet,0,1
96315,with,0,1
96316,concurrent,0,0
96317,administration,0,1
96318,of,0,1
96319,lamivudine,1,1
96320,tablet,0,1
96321,and,0,1
96322,stavudine,1,1
96323,capsule,0,1
96324,in,0,0
96325,healthy,0,0
96326,volunteers,0,0
96327,.,0,0
96328,The,0,0
96329,study,0,0
96330,was,0,0
96331,designed,0,0
96332,to,0,0
96333,compare,0,0
96334,the,0,0
96335,rate,0,0
96336,and,0,0
96337,extent,0,0
96338,of,0,0
96339,absorption,0,0
96340,of,0,0
96341,a,0,0
96342,fixed,0,0
96343,dose,0,1
96344,combination,0,1
96345,tablet,0,1
96346,of,0,1
96347,lamivudine,1,1
96348,(,1,1
96349,CAS,1,1
96350,134678-17-4,1,0
96351,),1,0
96352,and,1,0
96353,stavudine,1,1
96354,(,1,1
96355,CAS,1,1
96356,3056-17-5,1,1
96357,),1,0
96358,with,0,0
96359,the,0,0
96360,concurrent,0,0
96361,administration,0,1
96362,of,0,1
96363,lamivudine,1,1
96364,tablet,1,1
96365,and,1,1
96366,stavudine,1,1
96367,capsule,1,1
96368,in,0,1
96369,24,0,0
96370,healthy,0,0
96371,volunteers,0,0
96372,under,0,0
96373,fasting,0,1
96374,conditions,0,0
96375,.,0,0
96376,The,0,0
96377,volunteers,0,0
96378,were,0,0
96379,randomly,0,0
96380,assigned,0,0
96381,to,0,0
96382,the,0,0
96383,test,0,0
96384,or,0,0
96385,reference,0,0
96386,treatment,0,0
96387,",",0,0
96388,with,0,0
96389,the,0,0
96390,two,0,0
96391,treatment,0,0
96392,periods,0,0
96393,separated,0,0
96394,by,0,0
96395,a,0,0
96396,washout,0,1
96397,period,0,1
96398,of,0,0
96399,at,0,0
96400,least,0,0
96401,7,0,0
96402,days,0,0
96403,.,0,1
96404,Plasma,0,1
96405,samples,0,0
96406,were,0,0
96407,analyzed,0,0
96408,for,0,0
96409,both,0,0
96410,analytes,0,1
96411,lamivudine,1,1
96412,and,0,1
96413,stavudine,1,1
96414,by,0,0
96415,a,0,0
96416,validated,0,0
96417,analytical,0,0
96418,method,0,0
96419,.,0,0
96420,Since,0,0
96421,the,0,0
96422,90,0,0
96423,%,0,0
96424,confidence,0,0
96425,intervals,0,0
96426,for,0,0
96427,the,0,0
96428,test/reference,0,0
96429,mean,0,0
96430,ratio,0,0
96431,of,0,0
96432,the,0,0
96433,In-transformed,0,0
96434,pharmacokinetic,0,1
96435,variables,0,1
96436,C,0,1
96437,(,0,1
96438,max,0,0
96439,),0,1
96440,AUC,0,1
96441,(,0,1
96442,0-t,0,1
96443,),0,1
96444,and,0,1
96445,AUC,0,1
96446,(,0,1
96447,0-infinity,0,1
96448,),0,1
96449,were,0,0
96450,clearly,0,0
96451,within,0,0
96452,the,0,0
96453,conventional,0,0
96454,bioequivalence,0,1
96455,range,0,0
96456,of,0,0
96457,80,0,0
96458,%,0,0
96459,to,0,0
96460,125,0,0
96461,%,0,0
96462,",",0,0
96463,the,0,0
96464,two,0,0
96465,treatments,0,0
96466,were,0,0
96467,considered,0,0
96468,bioequivalent,0,1
96469,.,0,0
96470,The,0,0
96471,safety,0,0
96472,profiles,0,0
96473,of,0,0
96474,both,0,0
96475,the,0,0
96476,test,0,0
96477,and,0,0
96478,reference,0,0
96479,formulations,0,1
96480,were,0,0
96481,comparable,0,0
96482,.,0,0
96483,Effects,0,0
96484,of,0,0
96485,Thai,0,0
96486,traditional,0,0
96487,massage,0,0
96488,on,0,0
96489,autistic,0,0
96490,children,0,0
96491,'s,0,0
96492,behavior,0,0
96493,.,0,0
96494,OBJECTIVES,0,0
96495,The,0,0
96496,objective,0,0
96497,of,0,0
96498,this,0,0
96499,study,0,0
96500,was,0,0
96501,to,0,0
96502,access,0,0
96503,whether,0,0
96504,there,0,0
96505,were,0,0
96506,any,0,0
96507,therapeutic,0,0
96508,effects,0,0
96509,of,0,0
96510,Thai,1,0
96511,Traditional,1,1
96512,Massage,1,1
96513,(,1,1
96514,TTM,1,1
96515,),1,1
96516,on,0,0
96517,major,0,0
96518,behavioral,0,0
96519,and,0,0
96520,emotional,0,0
96521,disturbances,0,0
96522,in,0,0
96523,Thai,0,1
96524,autistic,0,0
96525,children,0,0
96526,.,0,0
96527,DESIGN,0,0
96528,This,0,0
96529,was,0,0
96530,a,0,0
96531,randomized,0,0
96532,controlled,0,0
96533,trial,0,0
96534,study,0,0
96535,.,0,0
96536,SETTINGS/LOCATION,0,0
96537,The,0,0
96538,study,0,0
96539,was,0,0
96540,conducted,0,0
96541,at,0,0
96542,the,0,0
96543,Rehabilitation,0,0
96544,Centre,0,0
96545,of,0,0
96546,the,0,0
96547,Thai,0,0
96548,Red,0,0
96549,Cross,0,0
96550,Society,0,0
96551,.,0,0
96552,SUBJECTS,0,0
96553,A,0,0
96554,total,0,0
96555,of,0,0
96556,60,0,0
96557,autistic,0,0
96558,children,0,0
96559,between,0,0
96560,the,0,0
96561,ages,0,0
96562,of,0,0
96563,3,0,0
96564,and,0,0
96565,10,0,0
96566,completed,0,0
96567,this,0,0
96568,study,0,0
96569,.,0,0
96570,INTERVENTIONS,0,0
96571,Standard,1,0
96572,sensory,1,0
96573,integration,1,0
96574,therapy,1,1
96575,(,1,1
96576,SI,1,1
96577,),1,0
96578,was,0,0
96579,compared,0,0
96580,to,0,0
96581,the,0,0
96582,SI,0,0
96583,with,0,0
96584,TTM,1,0
96585,treatments,0,0
96586,.,0,0
96587,OUTCOME,0,0
96588,MEASURES,0,1
96589,Parents,0,1
96590,and,0,0
96591,teachers,0,0
96592,assessed,0,0
96593,major,0,0
96594,behavior,0,0
96595,disturbances,0,0
96596,using,0,0
96597,the,0,0
96598,Conners,0,0
96599,',0,0
96600,Rating,0,0
96601,Scales,0,0
96602,at,0,0
96603,0,0,0
96604,and,0,0
96605,8,0,0
96606,weeks,0,0
96607,.,0,0
96608,Sleep,0,0
96609,Diary,0,0
96610,(,0,1
96611,SD,0,1
96612,),0,1
96613,",",0,0
96614,recorded,0,0
96615,by,0,0
96616,the,0,0
96617,parents,0,0
96618,",",0,0
96619,assessed,0,0
96620,the,0,0
96621,patient,0,0
96622,'s,0,0
96623,sleeping,0,0
96624,patterns,0,0
96625,every,0,0
96626,week,0,0
96627,.,0,0
96628,RESULTS,0,1
96629,Sixty,0,1
96630,(,0,1
96631,60,0,0
96632,),0,1
96633,autistic,0,1
96634,children,0,0
96635,",",0,0
96636,mean,0,0
96637,age,0,0
96638,4.67,0,0
96639,+/-,0,0
96640,1.82,0,0
96641,",",0,0
96642,were,0,0
96643,recruited,0,0
96644,.,0,0
96645,No,0,1
96646,statistical,0,0
96647,differences,0,0
96648,were,0,0
96649,seen,0,0
96650,in,0,0
96651,the,0,0
96652,demographic,0,0
96653,and,0,0
96654,baseline,0,0
96655,data,0,0
96656,among,0,0
96657,both,0,0
96658,groups,0,0
96659,.,0,0
96660,From,0,0
96661,both,0,0
96662,the,0,0
96663,Conners,0,0
96664,',0,0
96665,Teacher,0,0
96666,Questionnaire,0,0
96667,and,0,0
96668,SD,0,1
96669,",",0,0
96670,statistical,0,0
96671,improvement,0,0
96672,was,0,0
96673,detected,0,0
96674,for,0,0
96675,conduct,0,0
96676,problem,0,0
96677,",",0,0
96678,hyperactivity,0,0
96679,",",0,0
96680,inattention-passivity,0,0
96681,",",0,0
96682,hyperactivity,0,0
96683,index,0,0
96684,",",0,0
96685,and,0,0
96686,sleeping,0,0
96687,behavior,0,0
96688,.,0,0
96689,However,0,0
96690,",",0,0
96691,results,0,0
96692,from,0,0
96693,the,0,0
96694,Conners,0,0
96695,',0,0
96696,Parent,0,0
96697,Questionnaire,0,0
96698,revealed,0,0
96699,an,0,0
96700,improvement,0,0
96701,only,0,0
96702,for,0,0
96703,anxiety,0,0
96704,(,0,0
96705,p,0,0
96706,=,0,0
96707,0.04,0,0
96708,),0,0
96709,in,0,0
96710,the,0,0
96711,massage,0,0
96712,group,0,0
96713,",",0,0
96714,whereas,0,0
96715,when,0,0
96716,both,0,0
96717,groups,0,0
96718,were,0,0
96719,compared,0,0
96720,",",0,0
96721,a,0,0
96722,significant,0,0
96723,improvement,0,0
96724,in,0,0
96725,conduct,0,1
96726,problem,0,0
96727,(,0,0
96728,p,0,0
96729,=,0,0
96730,0.03,0,0
96731,),0,0
96732,and,0,0
96733,anxiety,0,0
96734,(,0,0
96735,p,0,0
96736,=,0,0
96737,0.01,0,0
96738,),0,0
96739,was,0,0
96740,found,0,0
96741,.,0,0
96742,Results,0,0
96743,indicated,0,0
96744,that,0,0
96745,TTM,0,0
96746,may,0,0
96747,have,0,0
96748,a,0,0
96749,positive,0,0
96750,effect,0,0
96751,in,0,0
96752,improving,0,0
96753,stereotypical,0,0
96754,behaviors,0,0
96755,in,0,0
96756,autistic,0,0
96757,children,0,0
96758,.,0,0
96759,CONCLUSIONS,0,0
96760,Over,0,0
96761,a,0,0
96762,period,0,0
96763,of,0,0
96764,8,0,0
96765,weeks,0,0
96766,",",0,0
96767,our,0,0
96768,findings,0,0
96769,suggested,0,0
96770,that,0,0
96771,TTM,0,0
96772,could,0,0
96773,be,0,0
96774,used,0,0
96775,as,0,0
96776,a,0,0
96777,complementary,0,0
96778,therapy,0,0
96779,for,0,0
96780,autistic,0,0
96781,children,0,0
96782,in,0,0
96783,Thailand,0,0
96784,.,0,0
96785,A,0,1
96786,multi-center,0,1
96787,",",0,0
96788,randomized,0,0
96789,",",0,0
96790,controlled,0,0
96791,trial,0,0
96792,of,0,0
96793,parenteral,1,1
96794,nutrition,1,1
96795,titrated,0,1
96796,to,0,0
96797,resting,0,0
96798,energy,0,0
96799,expenditure,0,0
96800,in,0,0
96801,children,0,0
96802,undergoing,0,0
96803,hematopoietic,0,0
96804,stem,0,0
96805,cell,0,0
96806,transplantation,0,0
96807,(,0,1
96808,PNTREE,0,1
96809,),0,1
96810,:,0,0
96811,rationale,0,0
96812,and,0,0
96813,design,0,0
96814,.,0,0
96815,BACKGROUND,0,0
96816,Children,0,0
96817,undergoing,0,0
96818,hematopoietic,0,0
96819,stem,0,0
96820,cell,0,0
96821,transplantation,0,0
96822,(,0,1
96823,HSCT,0,1
96824,),0,0
96825,frequently,0,0
96826,require,0,0
96827,prolonged,0,0
96828,courses,0,0
96829,of,0,0
96830,parenteral,1,1
96831,nutrition,1,1
96832,(,1,1
96833,PN,1,1
96834,),1,0
96835,as,0,0
96836,a,0,0
96837,consequence,0,0
96838,of,0,0
96839,gastrointestinal,0,0
96840,dysfunction,0,0
96841,related,0,0
96842,to,0,0
96843,preparative,0,0
96844,chemotherapy,0,0
96845,and,0,0
96846,radiation,0,0
96847,.,0,0
96848,PN,0,0
96849,has,0,0
96850,been,0,0
96851,associated,0,0
96852,with,0,0
96853,shorter,0,0
96854,engraftment,0,0
96855,time,0,0
96856,and,0,0
96857,decreased,0,0
96858,mortality,0,0
96859,during,0,0
96860,HSCT,0,0
96861,",",0,0
96862,however,0,0
96863,",",0,0
96864,it,0,0
96865,is,0,0
96866,also,0,0
96867,linked,0,0
96868,with,0,0
96869,complications,0,0
96870,",",0,0
96871,including,0,0
96872,infections,0,0
96873,",",0,0
96874,liver,0,0
96875,disease,0,0
96876,",",0,0
96877,and,0,0
96878,metabolic,0,0
96879,disturbances,0,0
96880,.,0,0
96881,Some,0,0
96882,of,0,0
96883,these,0,0
96884,complications,0,0
96885,may,0,0
96886,be,0,0
96887,a,0,0
96888,result,0,0
96889,of,0,0
96890,providing,0,0
96891,PN,0,0
96892,in,0,0
96893,excess,0,0
96894,of,0,0
96895,nutrient,0,0
96896,requirements,0,0
96897,.,0,0
96898,We,0,0
96899,previously,0,0
96900,described,0,0
96901,significant,0,0
96902,reductions,0,0
96903,in,0,0
96904,resting,0,0
96905,energy,0,0
96906,expenditure,0,0
96907,(,0,1
96908,REE,0,1
96909,),0,1
96910,",",0,0
96911,as,0,0
96912,measured,0,0
96913,by,0,0
96914,indirect,0,0
96915,calorimetry,0,1
96916,",",0,0
96917,over,0,0
96918,the,0,0
96919,course,0,0
96920,of,0,0
96921,HSCT,0,0
96922,.,0,0
96923,We,0,0
96924,also,0,0
96925,documented,0,0
96926,a,0,0
96927,decline,0,0
96928,in,0,0
96929,mid-arm,0,0
96930,muscle,0,0
96931,area,0,0
96932,",",0,0
96933,suggesting,0,0
96934,depletion,0,0
96935,of,0,0
96936,muscle,0,0
96937,mass,0,0
96938,",",0,0
96939,while,0,0
96940,triceps,0,0
96941,skinfold,0,0
96942,",",0,0
96943,a,0,0
96944,marker,0,0
96945,of,0,0
96946,fat,0,0
96947,stores,0,0
96948,",",0,0
96949,was,0,0
96950,unchanged,0,0
96951,.,0,0
96952,These,0,0
96953,results,0,0
96954,suggested,0,0
96955,the,0,0
96956,need,0,0
96957,for,0,0
96958,further,0,0
96959,study,0,0
96960,of,0,0
96961,energy,0,0
96962,expenditure,0,0
96963,",",0,0
96964,body,0,0
96965,composition,0,0
96966,and,0,0
96967,nutritional,0,1
96968,intake,0,1
96969,in,0,0
96970,this,0,0
96971,group,0,0
96972,of,0,0
96973,high,0,0
96974,risk,0,0
96975,patients,0,0
96976,.,0,0
96977,DESIGN,0,0
96978,AND,0,1
96979,HYPOTHESIS,0,1
96980,We,0,0
96981,hypothesize,0,0
96982,that,0,0
96983,changes,0,0
96984,in,0,0
96985,body,0,0
96986,composition,0,0
96987,affect,0,0
96988,REE,0,0
96989,during,0,0
96990,HSCT,0,0
96991,",",0,0
96992,and,0,0
96993,that,0,0
96994,standard,0,0
96995,nutritional,0,0
96996,support,0,0
96997,may,0,0
96998,lead,0,0
96999,to,0,0
97000,overfeeding,0,1
97001,.,0,0
97002,We,0,0
97003,are,0,0
97004,performing,0,0
97005,a,0,0
97006,randomized,0,0
97007,controlled,0,0
97008,trial,0,0
97009,of,0,0
97010,parenteral,1,1
97011,nutrition,1,1
97012,among,0,0
97013,children,0,0
97014,undergoing,0,0
97015,allogeneic,0,0
97016,HSCT,0,1
97017,.,0,0
97018,Subjects,0,0
97019,are,0,0
97020,randomized,0,0
97021,to,0,0
97022,receive,1,0
97023,PN,1,0
97024,designed,1,0
97025,to,1,0
97026,provide,1,0
97027,100,1,0
97028,%,1,0
97029,of,1,0
97030,measured,1,0
97031,REE,1,0
97032,",",1,0
97033,or,1,0
97034,standard,1,0
97035,PN,1,1
97036,",",1,0
97037,i.e.,1,0
97038,",",0,0
97039,140,1,0
97040,%,1,0
97041,of,1,0
97042,estimated,1,0
97043,energy,1,0
97044,expenditure,1,0
97045,.,1,0
97046,The,0,0
97047,primary,0,0
97048,outcome,0,0
97049,variable,0,0
97050,is,0,0
97051,change,0,0
97052,in,0,0
97053,percent,0,0
97054,body,0,0
97055,fat,0,0
97056,.,0,0
97057,Secondary,0,0
97058,outcomes,0,0
97059,include,0,0
97060,glycemic,0,0
97061,control,0,0
97062,and,0,0
97063,frequency,0,0
97064,of,0,0
97065,infections,0,0
97066,",",0,0
97067,changes,0,0
97068,in,0,0
97069,REE,0,0
97070,and,0,0
97071,body,0,0
97072,composition,0,0
97073,.,0,0
97074,CONCLUSION,0,0
97075,This,0,0
97076,study,0,0
97077,will,0,0
97078,provide,0,0
97079,unique,0,0
97080,and,0,0
97081,comprehensive,0,0
97082,nutritional,0,0
97083,data,0,0
97084,and,0,0
97085,its,0,0
97086,results,0,0
97087,will,0,0
97088,guide,0,0
97089,nutritional,0,0
97090,therapy,0,0
97091,for,0,0
97092,children,0,0
97093,undergoing,0,0
97094,HSCT,0,1
97095,and,0,0
97096,possibly,0,0
97097,other,0,0
97098,catabolic,0,0
97099,patients,0,0
97100,.,0,0
97101,A,0,1
97102,phase,0,0
97103,II,0,0
97104,study,0,0
97105,of,0,0
97106,cetuximab,1,1
97107,",",1,1
97108,capecitabine,1,1
97109,and,0,1
97110,radiotherapy,1,0
97111,in,0,0
97112,neoadjuvant,0,0
97113,treatment,0,0
97114,of,0,0
97115,patients,0,0
97116,with,0,0
97117,locally,0,0
97118,advanced,0,0
97119,resectable,0,0
97120,rectal,0,0
97121,cancer,0,0
97122,.,0,0
97123,BACKGROUND,0,0
97124,Neoadjuvant,0,1
97125,chemoradiotherapy,1,1
97126,(,1,1
97127,CRT,1,1
97128,),1,0
97129,reduces,0,0
97130,local,0,0
97131,tumor,0,0
97132,recurrence,0,0
97133,in,0,0
97134,locally,0,0
97135,advanced,0,0
97136,rectal,0,1
97137,cancer,0,1
97138,(,0,1
97139,LARC,0,1
97140,),0,1
97141,.,0,0
97142,This,0,0
97143,phase,0,0
97144,II,0,0
97145,study,0,0
97146,assessed,0,0
97147,neoadjuvant,0,0
97148,cetuximab,0,1
97149,with,0,1
97150,capecitabine-based,0,1
97151,CRT,0,1
97152,in,0,0
97153,LARC,0,0
97154,.,0,0
97155,METHODS,0,0
97156,Patients,0,0
97157,with,0,0
97158,stage,0,0
97159,II/III,0,0
97160,LARC,0,1
97161,received,0,0
97162,capecitabine,1,1
97163,1250,0,1
97164,mg/m,0,1
97165,(,0,1
97166,2,0,1
97167,),0,1
97168,twice,0,1
97169,daily,0,1
97170,for,0,1
97171,2,0,0
97172,weeks,0,0
97173,followed,0,0
97174,by,0,0
97175,intravenous,1,1
97176,cetuximab,1,1
97177,400,0,1
97178,mg/m,0,1
97179,(,0,1
97180,2,0,1
97181,),0,0
97182,at,0,0
97183,week,0,0
97184,3,0,0
97185,",",0,0
97186,then,0,0
97187,weekly,0,1
97188,intravenous,0,1
97189,250,0,1
97190,mg/m,0,1
97191,(,0,1
97192,2,0,1
97193,),0,1
97194,cetuximab,1,1
97195,plus,1,0
97196,CRT,1,1
97197,including,0,0
97198,capecitabine,1,1
97199,825,0,1
97200,mg/m,0,1
97201,(,0,1
97202,2,0,1
97203,),0,1
97204,twice,0,1
97205,daily,0,1
97206,(,0,1
97207,including,0,0
97208,weekends,0,0
97209,during,0,0
97210,radiotherapy,0,0
97211,),0,0
97212,with,0,0
97213,radiotherapy,1,0
97214,of,0,0
97215,45,0,0
97216,Gy,0,0
97217,(,0,0
97218,25,0,0
97219,x,0,0
97220,1.8,0,0
97221,Gy,0,1
97222,),0,1
97223,",",0,0
97224,5,0,0
97225,days,0,0
97226,a,0,0
97227,week,0,0
97228,for,0,0
97229,5,0,0
97230,weeks,0,0
97231,.,0,0
97232,Total,0,0
97233,mesorectal,0,0
97234,excision,0,0
97235,was,0,0
97236,scheduled,0,0
97237,4-6,0,0
97238,weeks,0,0
97239,following,0,0
97240,completion,0,0
97241,of,0,0
97242,CRT,0,0
97243,.,0,0
97244,The,0,0
97245,primary,0,0
97246,endpoint,0,0
97247,was,0,0
97248,pathological,0,0
97249,complete,0,0
97250,response,0,0
97251,(,0,1
97252,pCR,0,1
97253,),0,1
97254,.,0,0
97255,RESULTS,0,0
97256,Thirty-seven,0,0
97257,patients,0,0
97258,were,0,0
97259,eligible,0,0
97260,for,0,0
97261,safety,0,0
97262,and,0,0
97263,efficacy,0,0
97264,.,0,0
97265,TMN,0,0
97266,staging,0,0
97267,at,0,0
97268,baseline,0,0
97269,was,0,0
97270,:,0,0
97271,T4N2,0,0
97272,",",0,0
97273,11,0,0
97274,%,0,0
97275,;,0,0
97276,T3N2,0,0
97277,",",0,0
97278,40,0,0
97279,%,0,0
97280,;,0,0
97281,T2N2,0,0
97282,",",0,0
97283,3,0,0
97284,%,0,0
97285,;,0,0
97286,T3N1,0,0
97287,",",0,0
97288,35,0,0
97289,%,0,0
97290,;,0,0
97291,T2N1,0,0
97292,",",0,0
97293,3,0,0
97294,%,0,0
97295,and,0,0
97296,T3N0,0,0
97297,8,0,0
97298,%,0,0
97299,.,0,0
97300,The,0,0
97301,most,0,0
97302,common,0,0
97303,adverse,0,0
97304,events,0,0
97305,included,0,0
97306,",",0,0
97307,grade,0,0
97308,1/2,0,0
97309,acneiform,0,1
97310,skin,0,1
97311,rash,0,0
97312,(,0,0
97313,86,0,0
97314,%,0,0
97315,),0,0
97316,",",0,0
97317,and,0,0
97318,grade,0,0
97319,3,0,0
97320,radiodermatitis,0,0
97321,",",0,1
97322,(,0,0
97323,16,0,0
97324,%,0,0
97325,),0,0
97326,",",0,0
97327,diarrhea,0,1
97328,(,0,0
97329,11,0,0
97330,%,0,0
97331,),0,0
97332,and,0,0
97333,hypersensitivity,0,1
97334,(,0,0
97335,5,0,0
97336,%,0,0
97337,),0,0
97338,.,0,0
97339,pCR,0,0
97340,was,0,0
97341,achieved,0,0
97342,in,0,0
97343,3,0,0
97344,patients,0,0
97345,(,0,0
97346,8,0,0
97347,%,0,0
97348,),0,0
97349,.,0,0
97350,Overall-,0,0
97351,",",0,0
97352,T-,0,0
97353,and,0,0
97354,N-downstaging,0,0
97355,rates,0,0
97356,were,0,0
97357,73,0,0
97358,%,0,0
97359,",",0,0
97360,57,0,0
97361,%,0,0
97362,and,0,0
97363,81,0,0
97364,%,0,0
97365,respectively,0,0
97366,.,0,0
97367,Total,0,0
97368,sphincter,0,0
97369,preservation,0,0
97370,rate,0,0
97371,was,0,0
97372,76,0,0
97373,%,0,0
97374,",",0,0
97375,and,0,0
97376,53,0,0
97377,%,0,0
97378,in,0,0
97379,17,0,0
97380,patients,0,0
97381,whose,0,0
97382,tumors,0,0
97383,were,0,0
97384,located,0,0
97385,within,0,0
97386,5,0,0
97387,cm,0,0
97388,from,0,0
97389,the,0,0
97390,anal,0,0
97391,verge,0,0
97392,.,0,0
97393,Non-fatal,0,0
97394,perioperative,0,0
97395,complications,0,0
97396,occurred,0,0
97397,in,0,0
97398,13,0,0
97399,patients,0,0
97400,(,0,0
97401,35,0,0
97402,%,0,0
97403,),0,0
97404,with,0,0
97405,delayed,0,0
97406,wound,0,0
97407,healing,0,0
97408,occurring,0,0
97409,in,0,0
97410,6,0,0
97411,patients,0,0
97412,(,0,0
97413,16,0,0
97414,%,0,0
97415,),0,0
97416,.,0,0
97417,One,0,0
97418,death,0,0
97419,was,0,0
97420,recorded,0,0
97421,due,0,0
97422,to,0,0
97423,sepsis,0,0
97424,following,0,0
97425,colonic,0,0
97426,necrosis,0,0
97427,.,0,0
97428,CONCLUSION,0,1
97429,Neoadjuvant,0,1
97430,cetuximab,1,1
97431,with,1,1
97432,capecitabine-based,1,1
97433,CRT,1,1
97434,is,0,1
97435,tolerable,0,1
97436,in,0,0
97437,patients,0,0
97438,with,0,0
97439,resectable,0,0
97440,LARC,0,0
97441,.,0,0
97442,Whilst,0,0
97443,the,0,0
97444,pCR,0,0
97445,rate,0,0
97446,was,0,0
97447,similar,0,0
97448,to,0,0
97449,recent,0,0
97450,reports,0,0
97451,",",0,0
97452,a,0,0
97453,high,0,0
97454,pathological,0,0
97455,downstaging,0,0
97456,rate,0,0
97457,was,0,0
97458,achieved,0,0
97459,.,0,0
97460,Evaluation,0,0
97461,of,0,0
97462,a,0,0
97463,new,0,0
97464,wound,0,0
97465,closure,0,0
97466,device,0,0
97467,for,0,0
97468,linear,0,0
97469,surgical,0,0
97470,incisions,0,0
97471,:,0,0
97472,3M,1,0
97473,Steri-Strip,1,1
97474,S,1,1
97475,Surgical,1,1
97476,Skin,1,1
97477,Closure,1,1
97478,versus,1,0
97479,subcuticular,1,0
97480,closure,1,0
97481,.,1,0
97482,BACKGROUND,0,0
97483,Technological,0,0
97484,innovations,0,0
97485,are,0,0
97486,often,0,0
97487,adopted,0,0
97488,before,0,0
97489,scientific,0,0
97490,comparison,0,0
97491,to,0,0
97492,an,0,0
97493,accepted,0,0
97494,standard,0,0
97495,.,0,0
97496,The,0,0
97497,authors,0,0
97498,',0,0
97499,study,0,0
97500,compared,0,0
97501,suture,0,0
97502,with,0,0
97503,a,0,0
97504,new,1,0
97505,coaptive,1,0
97506,film,1,1
97507,device,1,1
97508,",",1,0
97509,3M,1,0
97510,Steri-Strip,1,1
97511,S,1,1
97512,Surgical,1,1
97513,Skin,1,0
97514,Closure,1,0
97515,",",1,0
97516,on,1,0
97517,linear,1,0
97518,incisions,1,0
97519,.,1,0
97520,METHODS,0,0
97521,Patients,0,0
97522,undergoing,0,0
97523,Wise-pattern,0,0
97524,breast,0,0
97525,reduction,0,0
97526,or,0,0
97527,abdominal,0,0
97528,procedures,0,0
97529,had,0,0
97530,paired,0,0
97531,incisions,0,0
97532,randomly,0,0
97533,assigned,0,0
97534,to,0,0
97535,Steri-Strip,1,0
97536,S,1,1
97537,or,1,0
97538,suture,1,0
97539,closure,1,0
97540,.,1,0
97541,Key,0,0
97542,outcome,0,0
97543,measures,0,0
97544,were,0,0
97545,closure,0,0
97546,time,0,0
97547,",",0,0
97548,patient,0,0
97549,comfort,0,0
97550,",",0,0
97551,and,0,0
97552,scar,0,0
97553,quality,0,0
97554,at,0,0
97555,6,0,0
97556,months,0,0
97557,by,0,0
97558,patients,0,0
97559,and,0,0
97560,surgeons,0,0
97561,using,0,0
97562,a,0,0
97563,new,1,0
97564,scar,1,0
97565,evaluation,1,0
97566,tool,1,0
97567,",",0,0
97568,visual,0,0
97569,assessment,0,0
97570,of,0,0
97571,linear,0,0
97572,scars,0,0
97573,.,0,0
97574,Statistical,0,0
97575,differences,0,0
97576,between,0,0
97577,the,0,0
97578,two,0,0
97579,closure,0,0
97580,techniques,0,0
97581,were,0,0
97582,assessed,0,0
97583,by,0,0
97584,Wilcoxon,0,0
97585,signed,0,0
97586,rank,0,0
97587,test,0,0
97588,.,0,0
97589,RESULTS,0,0
97590,Of,0,0
97591,59,0,0
97592,patients,0,0
97593,",",0,0
97594,eight,0,0
97595,were,0,0
97596,excluded,0,0
97597,from,0,0
97598,randomization,0,0
97599,(,0,0
97600,a,0,0
97601,surgeon,0,0
97602,judged,0,0
97603,Steri-Strip,0,0
97604,S,0,0
97605,to,0,0
97606,be,0,0
97607,a,0,0
97608,nonviable,0,0
97609,closure,0,0
97610,technique,0,0
97611,for,0,0
97612,mismatched,0,0
97613,wound,0,0
97614,edges,0,0
97615,),0,0
97616,.,0,0
97617,Fifty-one,0,0
97618,patients,0,0
97619,(,0,0
97620,breast,0,1
97621,",",0,0
97622,n,0,0
97623,=,0,0
97624,24,0,0
97625,;,0,0
97626,abdomen,0,1
97627,",",0,0
97628,n,0,0
97629,=,0,0
97630,27,0,0
97631,),0,0
97632,were,0,0
97633,randomized,0,0
97634,.,0,0
97635,Operative,0,0
97636,time,0,0
97637,with,0,0
97638,Steri-Strip,1,0
97639,S,1,0
97640,for,0,0
97641,breast,0,0
97642,was,0,0
97643,2.0,0,0
97644,minutes,0,0
97645,(,0,0
97646,SD,0,0
97647,=,0,0
97648,1.1,0,0
97649,),0,0
97650,versus,0,0
97651,suture,1,0
97652,closure,1,0
97653,at,0,0
97654,4.6,0,0
97655,minutes,0,0
97656,(,0,0
97657,SD,0,0
97658,=,0,0
97659,1.5,0,0
97660,;,0,0
97661,p,0,0
97662,<,0,0
97663,0.001,0,0
97664,),0,0
97665,.,0,0
97666,Similarly,0,0
97667,",",0,0
97668,Steri-Strip,0,0
97669,S,0,1
97670,versus,0,0
97671,suture,0,0
97672,for,0,0
97673,the,0,0
97674,abdomen,0,0
97675,was,0,0
97676,faster,0,0
97677,(,0,0
97678,p,0,0
97679,<,0,0
97680,0.001,0,0
97681,;,0,0
97682,4.9,0,0
97683,minutes,0,0
97684,",",0,0
97685,SD,0,0
97686,=,0,0
97687,2.3,0,0
97688,versus,0,0
97689,10.1,0,0
97690,minutes,0,0
97691,",",0,0
97692,SD,0,0
97693,=,0,0
97694,3.4,0,0
97695,),0,0
97696,.,0,0
97697,Comfort,0,0
97698,scores,0,0
97699,did,0,0
97700,not,0,0
97701,differ,0,0
97702,between,0,0
97703,closures,0,0
97704,[,0,0
97705,5.8,0,0
97706,(,0,0
97707,SD,0,0
97708,=,0,0
97709,2.7,0,0
97710,),0,0
97711,versus,0,0
97712,6.9,0,0
97713,(,0,0
97714,SD,0,0
97715,=,0,0
97716,2.0,0,0
97717,),0,0
97718,",",0,0
97719,respectively,0,0
97720,",",0,0
97721,on,0,0
97722,breast,0,0
97723,(,0,0
97724,p,0,0
97725,=,0,0
97726,0.142,0,0
97727,),0,0
97728,and,0,0
97729,7.7,0,0
97730,(,0,0
97731,SD,0,0
97732,=,0,0
97733,1.8,0,0
97734,),0,0
97735,versus,0,0
97736,7.7,0,0
97737,(,0,0
97738,SD,0,0
97739,=,0,0
97740,2.3,0,0
97741,),0,0
97742,on,0,0
97743,abdomen,0,0
97744,(,0,0
97745,p,0,0
97746,=,0,0
97747,0.903,0,0
97748,),0,0
97749,],0,0
97750,.,0,0
97751,Complication,0,0
97752,rates,0,0
97753,did,0,0
97754,not,0,0
97755,differ,0,0
97756,between,0,0
97757,closure,0,0
97758,types,0,0
97759,.,0,0
97760,Patients,0,0
97761,',0,0
97762,visual,0,0
97763,assessment,0,0
97764,of,0,0
97765,linear,0,0
97766,scars,0,0
97767,rating,0,0
97768,of,0,0
97769,breasts,0,0
97770,was,0,0
97771,3.8,0,0
97772,(,0,0
97773,SD,0,0
97774,=,0,0
97775,2.9,0,0
97776,),0,0
97777,for,0,0
97778,Steri-Strip,0,1
97779,S,0,1
97780,and,0,0
97781,better,0,0
97782,at,0,0
97783,2.6,0,0
97784,(,0,0
97785,SD,0,0
97786,=,0,0
97787,2.9,0,0
97788,),0,0
97789,for,0,0
97790,suture,0,0
97791,(,0,0
97792,p,0,0
97793,=,0,0
97794,0.008,0,0
97795,),0,0
97796,.,0,0
97797,One,0,0
97798,surgeon,0,0
97799,rated,0,1
97800,breast,0,0
97801,Steri-Strip,0,1
97802,S,0,1
97803,scars,0,1
97804,worse,0,1
97805,than,0,0
97806,suture,0,1
97807,scars,0,1
97808,(,0,0
97809,4.3,0,0
97810,versus,0,0
97811,3.7,0,0
97812,;,0,0
97813,p,0,0
97814,=,0,0
97815,0.014,0,0
97816,),0,0
97817,.,0,0
97818,For,0,0
97819,abdominal,0,0
97820,scars,0,0
97821,",",0,0
97822,there,0,0
97823,was,0,0
97824,no,0,0
97825,difference,0,0
97826,in,0,0
97827,the,0,0
97828,patient,0,0
97829,or,0,0
97830,surgeon,0,0
97831,ratings,0,0
97832,.,0,0
97833,CONCLUSIONS,0,0
97834,Steri-Strip,1,0
97835,S,1,0
97836,permits,0,0
97837,faster,0,0
97838,wound,0,0
97839,closure,0,1
97840,than,0,0
97841,suture,1,0
97842,.,1,0
97843,On,0,0
97844,the,0,0
97845,basis,0,0
97846,of,0,0
97847,patient,0,0
97848,reports,0,0
97849,of,0,0
97850,comfort,0,0
97851,and,0,0
97852,scar,0,0
97853,quality,0,0
97854,",",0,0
97855,surgeons,0,0
97856,increase,0,0
97857,efficiency,0,0
97858,and,0,0
97859,maintain,0,0
97860,quality,0,0
97861,with,0,0
97862,the,0,0
97863,use,0,0
97864,of,0,0
97865,Steri-Strip,0,0
97866,S,0,1
97867,on,0,0
97868,abdominal,0,0
97869,wounds,0,0
97870,but,0,0
97871,not,0,0
97872,on,0,0
97873,breast,0,0
97874,wounds,0,0
97875,.,0,0
97876,A,0,1
97877,randomized,0,0
97878,controlled,0,0
97879,study,0,0
97880,of,0,0
97881,parent-assisted,1,0
97882,Children,1,0
97883,'s,1,1
97884,Friendship,1,0
97885,Training,1,0
97886,with,0,0
97887,children,0,0
97888,having,0,0
97889,autism,0,0
97890,spectrum,0,0
97891,disorders,0,0
97892,.,0,0
97893,This,0,0
97894,study,0,0
97895,evaluated,0,0
97896,Children,1,0
97897,'s,1,0
97898,Friendship,1,1
97899,Training,1,1
97900,(,1,1
97901,CFT,1,1
97902,),1,1
97903,",",1,0
97904,a,1,0
97905,manualized,1,0
97906,parent-assisted,1,0
97907,intervention,1,0
97908,to,0,0
97909,improve,0,0
97910,social,0,0
97911,skills,0,0
97912,among,0,0
97913,second,0,0
97914,to,0,0
97915,fifth,0,0
97916,grade,0,0
97917,children,0,0
97918,with,0,0
97919,autism,0,0
97920,spectrum,0,0
97921,disorders,0,0
97922,.,0,0
97923,Comparison,0,0
97924,was,0,0
97925,made,0,0
97926,with,0,0
97927,a,0,0
97928,delayed,1,0
97929,treatment,1,0
97930,control,1,0
97931,group,1,0
97932,(,1,1
97933,DTC,1,1
97934,),1,1
97935,.,0,0
97936,Targeted,0,0
97937,skills,0,0
97938,included,0,0
97939,conversational,0,0
97940,skills,0,0
97941,",",0,0
97942,peer,0,0
97943,entry,0,0
97944,skills,0,0
97945,",",0,0
97946,developing,0,0
97947,friendship,0,0
97948,networks,0,0
97949,",",0,0
97950,good,0,0
97951,sportsmanship,0,0
97952,",",0,0
97953,good,0,0
97954,host,0,0
97955,behavior,0,0
97956,during,0,0
97957,play,0,0
97958,dates,0,0
97959,",",0,0
97960,and,0,0
97961,handling,0,0
97962,teasing,0,0
97963,.,0,0
97964,At,0,0
97965,post-testing,0,0
97966,",",0,0
97967,the,0,0
97968,CFT,0,0
97969,group,0,0
97970,was,0,0
97971,superior,0,0
97972,to,0,0
97973,the,0,0
97974,DTC,0,1
97975,group,0,0
97976,on,0,0
97977,parent,0,0
97978,measures,0,0
97979,of,0,0
97980,social,0,0
97981,skill,0,0
97982,and,0,0
97983,play,0,0
97984,date,0,0
97985,behavior,0,0
97986,",",0,0
97987,and,0,0
97988,child,0,0
97989,measures,0,0
97990,of,0,0
97991,popularity,0,0
97992,and,0,0
97993,loneliness,0,0
97994,",",0,0
97995,At,0,1
97996,3-month,0,1
97997,follow-up,0,0
97998,",",0,0
97999,parent,0,0
98000,measures,0,0
98001,showed,0,0
98002,significant,0,0
98003,improvement,0,0
98004,from,0,0
98005,baseline,0,0
98006,.,0,0
98007,Post-hoc,0,0
98008,analysis,0,0
98009,indicated,0,0
98010,more,0,0
98011,than,0,0
98012,87,0,0
98013,%,0,0
98014,of,0,0
98015,children,0,0
98016,receiving,0,0
98017,CFT,1,0
98018,showed,0,0
98019,reliable,0,0
98020,change,0,0
98021,on,0,0
98022,at,0,0
98023,least,0,0
98024,one,0,0
98025,measure,0,0
98026,at,0,0
98027,post-test,0,0
98028,and,0,0
98029,66.7,0,0
98030,%,0,0
98031,after,0,0
98032,3,0,0
98033,months,0,0
98034,follow-up,0,0
98035,.,0,0
98036,PROCLAIM,0,1
98037,:,0,0
98038,pilot,0,0
98039,study,0,0
98040,to,0,0
98041,examine,0,0
98042,the,0,0
98043,effects,0,0
98044,of,0,0
98045,clopidogrel,1,1
98046,on,0,0
98047,inflammatory,0,0
98048,markers,0,0
98049,in,0,0
98050,patients,0,0
98051,with,0,0
98052,metabolic,0,0
98053,syndrome,0,0
98054,receiving,0,0
98055,low-dose,0,1
98056,aspirin,1,1
98057,.,1,1
98058,Metabolic,0,1
98059,syndrome,0,0
98060,is,0,0
98061,associated,0,0
98062,with,0,0
98063,intravascular,0,0
98064,inflammation,0,0
98065,",",0,0
98066,as,0,0
98067,determined,0,0
98068,by,0,0
98069,increased,0,0
98070,levels,0,0
98071,of,0,0
98072,inflammatory,0,0
98073,biomarkers,0,0
98074,and,0,0
98075,an,0,0
98076,increased,0,0
98077,risk,0,0
98078,of,0,0
98079,ischemic,0,0
98080,atherothrombotic,0,0
98081,events,0,0
98082,.,0,0
98083,Evidence,0,0
98084,suggests,0,0
98085,that,0,0
98086,atherothrombosis,0,0
98087,and,0,0
98088,intravascular,0,0
98089,inflammation,0,0
98090,share,0,0
98091,predictive,0,0
98092,biomarkers,0,0
98093,",",0,0
98094,including,0,0
98095,high-sensitivity,0,0
98096,C-reactive,0,0
98097,protein,0,0
98098,",",0,0
98099,CD40,0,0
98100,ligand,0,0
98101,",",0,0
98102,P-selectin,0,1
98103,",",0,0
98104,and,0,0
98105,N-terminal,0,0
98106,pro-brain,0,1
98107,natriuretic,0,1
98108,peptide,0,0
98109,.,0,0
98110,Patients,0,0
98111,who,0,0
98112,had,0,0
98113,metabolic,0,0
98114,syndrome,0,0
98115,were,0,0
98116,randomized,0,0
98117,to,0,0
98118,receive,0,0
98119,clopidogrel,1,1
98120,75,1,0
98121,mg/day,1,1
98122,plus,1,0
98123,aspirin,1,1
98124,81,1,1
98125,mg/day,1,1
98126,(,1,0
98127,n,1,0
98128,=,1,0
98129,89,1,0
98130,),1,0
98131,or,1,0
98132,placebo,1,1
98133,plus,1,0
98134,aspirin,1,1
98135,81,1,1
98136,mg/day,1,1
98137,(,1,0
98138,n,1,0
98139,=,1,0
98140,92,1,0
98141,),1,0
98142,for,1,0
98143,9,1,0
98144,weeks,1,0
98145,to,0,0
98146,assess,0,0
98147,the,0,0
98148,efficacy,0,0
98149,of,0,0
98150,each,0,0
98151,treatment,0,0
98152,in,0,0
98153,suppression,0,0
98154,of,0,0
98155,inflammatory,0,0
98156,markers,0,0
98157,.,0,0
98158,Change,0,0
98159,from,0,0
98160,baseline,0,0
98161,in,0,0
98162,the,0,0
98163,levels,0,0
98164,of,0,0
98165,high-sensitivity,0,0
98166,C-reactive,0,0
98167,protein,0,0
98168,",",0,0
98169,CD40,0,0
98170,ligand,0,0
98171,",",0,0
98172,P-selectin,0,1
98173,",",0,0
98174,and,0,0
98175,N-terminal,0,0
98176,pro-brain,0,1
98177,natriuretic,0,1
98178,peptide,0,0
98179,at,0,0
98180,6,0,0
98181,weeks,0,0
98182,was,0,0
98183,assessed,0,0
98184,to,0,0
98185,evaluate,0,0
98186,each,0,0
98187,treatment,0,0
98188,.,0,0
98189,There,0,0
98190,was,0,0
98191,a,0,0
98192,significant,0,0
98193,difference,0,0
98194,at,0,0
98195,Week,0,0
98196,6,0,0
98197,in,0,0
98198,model-adjusted,0,0
98199,CD40-ligand,0,0
98200,levels,0,0
98201,in,0,0
98202,favor,0,0
98203,of,0,0
98204,clopidogrel,1,1
98205,plus,1,0
98206,aspirin,1,1
98207,compared,0,0
98208,with,0,0
98209,placebo,1,1
98210,plus,1,1
98211,aspirin,1,1
98212,in,0,0
98213,both,0,0
98214,the,0,0
98215,intent-to-treat,0,0
98216,population,0,0
98217,(,0,0
98218,difference,0,0
98219,between,0,0
98220,least-squares,0,0
98221,means,0,0
98222,=,0,0
98223,-186.5,0,0
98224,;,0,0
98225,95,0,0
98226,%,0,0
98227,confidence,0,0
98228,interval,0,0
98229,",",0,0
98230,-342.3,0,0
98231,to,0,0
98232,-30.8,0,0
98233,;,0,0
98234,P,0,0
98235,=,0,0
98236,0.02,0,0
98237,),0,0
98238,and,0,0
98239,the,0,0
98240,per-protocol,0,0
98241,population,0,0
98242,(,0,0
98243,P,0,0
98244,=,0,0
98245,0.05,0,0
98246,),0,0
98247,.,0,0
98248,No,0,1
98249,significant,0,0
98250,differences,0,0
98251,were,0,0
98252,observed,0,0
98253,between,0,0
98254,the,0,0
98255,treatment,0,0
98256,arms,0,0
98257,for,0,0
98258,high-sensitivity,0,0
98259,C-reactive,0,0
98260,protein,0,0
98261,",",0,0
98262,P-selectin,0,1
98263,",",0,0
98264,and,0,0
98265,N-terminal,0,0
98266,pro-brain,0,1
98267,natriuretic,0,1
98268,peptide,0,0
98269,.,0,0
98270,There,0,0
98271,were,0,0
98272,no,0,0
98273,deaths,0,0
98274,or,0,0
98275,serious,0,0
98276,adverse,0,0
98277,events,0,0
98278,in,0,0
98279,either,0,0
98280,treatment,0,0
98281,arm,0,0
98282,.,0,0
98283,Data,0,0
98284,from,0,0
98285,this,0,0
98286,study,0,0
98287,suggest,0,0
98288,that,0,0
98289,clopidogrel,1,1
98290,can,0,0
98291,decrease,0,0
98292,the,0,0
98293,expression,0,0
98294,of,0,0
98295,the,0,0
98296,CD40-ligand,0,0
98297,biomarker,0,0
98298,.,0,0
98299,Efficacy,0,0
98300,of,0,0
98301,omeprazole,1,1
98302,versus,0,1
98303,high-dose,1,1
98304,famotidine,1,1
98305,for,0,1
98306,prevention,0,0
98307,of,0,0
98308,exercise-induced,0,0
98309,gastritis,0,0
98310,in,0,0
98311,racing,0,0
98312,Alaskan,0,0
98313,sled,0,0
98314,dogs,0,0
98315,.,0,0
98316,BACKGROUND,0,1
98317,Omeprazole,1,1
98318,and,0,1
98319,famotidine,1,1
98320,both,0,0
98321,reduce,0,0
98322,severity,0,0
98323,of,0,0
98324,exercise-induced,0,0
98325,gastritis,0,0
98326,",",0,0
98327,but,0,0
98328,administering,0,1
98329,famotidine,0,1
98330,is,0,1
98331,easier,0,0
98332,than,0,1
98333,administering,0,1
98334,omeprazole,0,1
98335,during,0,1
98336,racing,0,0
98337,competition,0,0
98338,.,0,0
98339,HYPOTHESIS,0,1
98340,Famotidine,0,1
98341,is,0,0
98342,more,0,0
98343,efficacious,0,1
98344,than,0,0
98345,no,0,0
98346,treatment,0,0
98347,in,0,0
98348,reducing,0,0
98349,severity,0,0
98350,of,0,0
98351,exercise-induced,0,1
98352,gastritis,0,1
98353,;,0,1
98354,and,0,1
98355,high-dose,0,1
98356,famotidine,0,1
98357,is,0,0
98358,more,0,0
98359,efficacious,0,1
98360,than,0,0
98361,omeprazole,0,1
98362,in,0,0
98363,reducing,0,0
98364,severity,0,0
98365,of,0,0
98366,exercise-induced,0,0
98367,gastritis,0,0
98368,.,0,0
98369,ANIMALS,0,0
98370,Experiment,0,0
98371,1,0,0
98372,:,0,0
98373,Randomized,0,1
98374,placebo-controlled,0,1
98375,study,0,0
98376,",",0,0
98377,36,0,0
98378,sled,0,0
98379,dogs,0,0
98380,(,0,0
98381,3-8,0,0
98382,years,0,0
98383,),0,0
98384,;,0,1
98385,Experiment,0,1
98386,2,0,0
98387,:,0,0
98388,Randomized,0,0
98389,positive-control,0,0
98390,study,0,0
98391,",",0,0
98392,52,0,0
98393,sled,0,0
98394,dogs,0,0
98395,(,0,0
98396,2-8,0,0
98397,years,0,1
98398,),0,0
98399,.,0,0
98400,METHODS,0,1
98401,Experiment,0,0
98402,1,0,0
98403,:,0,0
98404,Equal,0,0
98405,numbers,0,0
98406,of,0,0
98407,dogs,0,0
98408,randomly,0,0
98409,assigned,0,0
98410,to,0,0
98411,famotidine,1,1
98412,(,0,1
98413,20,0,1
98414,mg,0,1
98415,q24h,0,1
98416,),0,1
98417,or,0,0
98418,no,1,0
98419,treatment,1,0
98420,groups,0,0
98421,.,0,0
98422,Gastroscopy,0,0
98423,was,0,0
98424,performed,0,0
98425,24,0,0
98426,hours,0,0
98427,after,0,0
98428,the,0,0
98429,dogs,0,0
98430,ran,0,0
98431,330,0,0
98432,miles,0,0
98433,.,0,0
98434,Mucosal,0,0
98435,appearance,0,0
98436,was,0,0
98437,blindly,0,0
98438,scored,0,0
98439,by,0,0
98440,previously,0,0
98441,described,0,0
98442,scoring,0,0
98443,system,0,0
98444,.,0,0
98445,Experiment,0,0
98446,2,0,0
98447,:,0,0
98448,Equal,0,0
98449,numbers,0,0
98450,of,0,0
98451,dogs,0,0
98452,randomly,0,0
98453,assigned,0,0
98454,to,0,0
98455,omeprazole,1,1
98456,(,0,1
98457,20,0,1
98458,mg,0,1
98459,q24h,0,1
98460,),0,1
98461,or,0,1
98462,high-dose,0,1
98463,famotidine,1,1
98464,(,0,1
98465,40,0,1
98466,mg,0,1
98467,q12h,0,1
98468,),0,1
98469,groups,0,0
98470,.,0,0
98471,Gastroscopy,0,0
98472,was,0,0
98473,performed,0,0
98474,48,0,0
98475,hours,0,0
98476,before,0,0
98477,and,0,0
98478,24,0,0
98479,hours,0,0
98480,after,0,0
98481,the,0,0
98482,dogs,0,0
98483,ran,0,0
98484,300,0,0
98485,miles,0,0
98486,.,0,0
98487,Mucosal,0,0
98488,appearance,0,0
98489,was,0,0
98490,blindly,0,0
98491,scored,0,0
98492,by,0,0
98493,previously,0,0
98494,described,0,0
98495,scoring,0,0
98496,system,0,0
98497,.,0,0
98498,RESULTS,0,1
98499,Famotidine,1,1
98500,reduced,0,0
98501,the,0,0
98502,prevalence,0,0
98503,of,0,0
98504,clinically,0,0
98505,relevant,0,0
98506,",",0,0
98507,exercise-induced,0,0
98508,gastric,0,0
98509,lesions,0,0
98510,compared,0,0
98511,with,0,0
98512,no,0,0
98513,treatment,0,0
98514,(,0,0
98515,7/16,0,0
98516,versus,0,0
98517,11/16,0,0
98518,",",0,0
98519,P,0,0
98520,=,0,0
98521,.031,0,0
98522,),0,0
98523,.,0,0
98524,Compared,0,0
98525,with,0,0
98526,high-dose,0,1
98527,famotidine,1,1
98528,",",1,1
98529,omeprazole,1,1
98530,significantly,0,0
98531,decreased,0,0
98532,the,0,0
98533,severity,0,0
98534,(,0,0
98535,0.4,0,0
98536,versus,0,0
98537,1.2,0,0
98538,",",0,0
98539,P,0,0
98540,=,0,0
98541,.0002,0,0
98542,),0,0
98543,and,0,0
98544,prevalence,0,0
98545,(,0,0
98546,2/23,0,0
98547,versus,0,0
98548,7/21,0,0
98549,",",0,0
98550,P,0,0
98551,=,0,0
98552,.049,0,0
98553,),0,0
98554,of,0,0
98555,gastric,0,0
98556,lesions,0,0
98557,.,0,0
98558,CONCLUSIONS,0,0
98559,AND,0,1
98560,CLINICAL,0,1
98561,RELEVANCE,0,1
98562,Although,0,0
98563,famotidine,0,1
98564,provides,0,0
98565,some,0,0
98566,benefit,0,0
98567,in,0,0
98568,the,0,0
98569,prevention,0,0
98570,of,0,0
98571,exercise-induced,0,0
98572,gastric,0,0
98573,lesions,0,1
98574,",",0,0
98575,omeprazole,0,1
98576,is,0,0
98577,superior,0,0
98578,to,0,0
98579,famotidine,0,1
98580,in,0,0
98581,preventing,0,0
98582,gastritis,0,0
98583,in,0,0
98584,dogs,0,0
98585,running,0,0
98586,300,0,0
98587,miles,0,0
98588,.,0,0
98589,Routine,0,0
98590,administration,0,1
98591,of,0,1
98592,omeprazole,1,1
98593,is,0,0
98594,recommended,0,0
98595,to,0,0
98596,prevent,0,0
98597,stress-associated,0,0
98598,gastric,0,0
98599,disease,0,0
98600,in,0,0
98601,exercising,0,0
98602,and,0,0
98603,racing,0,0
98604,Alaskan,0,1
98605,sled,0,0
98606,dogs,0,0
98607,.,0,0
98608,Hunter,0,1
98609,DBT,0,1
98610,project,0,0
98611,:,0,0
98612,randomized,0,0
98613,controlled,0,0
98614,trial,0,0
98615,of,0,0
98616,dialectical,1,0
98617,behaviour,1,0
98618,therapy,1,0
98619,in,0,0
98620,women,0,0
98621,with,0,0
98622,borderline,0,0
98623,personality,0,0
98624,disorder,0,0
98625,.,0,0
98626,OBJECTIVE,0,0
98627,Deliberate,0,0
98628,self-harm,0,1
98629,(,0,1
98630,DSH,0,1
98631,),0,1
98632,",",0,0
98633,general,0,0
98634,hospital,0,0
98635,admission,0,0
98636,and,0,0
98637,psychiatric,0,0
98638,hospital,0,0
98639,admission,0,0
98640,are,0,0
98641,common,0,0
98642,in,0,0
98643,women,0,0
98644,meeting,0,0
98645,criteria,0,0
98646,for,0,0
98647,borderline,0,0
98648,personality,0,1
98649,disorder,0,1
98650,(,0,1
98651,BPD,0,1
98652,),0,1
98653,.,0,0
98654,Dialectical,1,0
98655,behaviour,1,0
98656,therapy,1,1
98657,(,1,1
98658,DBT,1,1
98659,),1,0
98660,has,0,0
98661,been,0,0
98662,reported,0,0
98663,to,0,0
98664,be,0,0
98665,effective,0,0
98666,in,0,0
98667,reducing,0,0
98668,DSH,0,0
98669,and,0,0
98670,hospitalization,0,0
98671,.,0,0
98672,METHOD,0,0
98673,A,0,1
98674,randomized,0,0
98675,controlled,0,0
98676,trial,0,0
98677,of,0,0
98678,73,0,0
98679,female,0,0
98680,subjects,0,0
98681,meeting,0,0
98682,criteria,0,0
98683,for,0,0
98684,BPD,0,0
98685,was,0,0
98686,carried,0,0
98687,out,0,0
98688,with,0,0
98689,intention-to-treat,0,0
98690,analyses,0,0
98691,and,0,0
98692,per-protocol,0,0
98693,analyses,0,0
98694,.,0,0
98695,The,0,0
98696,intervention,0,0
98697,was,0,0
98698,DBT,1,0
98699,and,0,0
98700,the,0,0
98701,control,0,0
98702,condition,0,0
98703,was,0,0
98704,treatment,1,0
98705,as,1,0
98706,usual,1,0
98707,plus,1,0
98708,waiting,1,0
98709,list,1,0
98710,for,1,0
98711,DBT,1,1
98712,(,1,1
98713,TAU+WL,1,1
98714,),1,1
98715,",",0,0
98716,with,0,0
98717,outcomes,0,0
98718,measured,0,0
98719,after,0,0
98720,6,0,0
98721,months,0,0
98722,.,0,0
98723,Primary,0,0
98724,outcomes,0,0
98725,were,0,0
98726,differences,0,0
98727,in,0,0
98728,proportions,0,0
98729,and,0,0
98730,event,0,0
98731,rates,0,0
98732,of,0,0
98733,:,0,0
98734,any,0,0
98735,DSH,0,1
98736,;,0,0
98737,general,0,0
98738,hospital,0,0
98739,admission,0,0
98740,for,0,0
98741,DSH,0,0
98742,and,0,0
98743,any,0,0
98744,psychiatric,0,1
98745,admission,0,1
98746,;,0,0
98747,and,0,0
98748,mean,0,0
98749,difference,0,0
98750,in,0,0
98751,length,0,0
98752,of,0,0
98753,stay,0,0
98754,for,0,0
98755,any,0,0
98756,hospitalization,0,0
98757,.,0,0
98758,Secondary,0,0
98759,outcomes,0,0
98760,were,0,0
98761,disability,0,0
98762,and,0,0
98763,quality,0,0
98764,of,0,0
98765,life,0,0
98766,measures,0,0
98767,.,0,0
98768,RESULTS,0,0
98769,Both,0,1
98770,groups,0,0
98771,showed,0,0
98772,a,0,0
98773,reduction,0,0
98774,in,0,0
98775,DSH,0,0
98776,and,0,0
98777,hospitalizations,0,0
98778,",",0,0
98779,but,0,0
98780,there,0,0
98781,were,0,0
98782,no,0,0
98783,significant,0,0
98784,differences,0,0
98785,in,0,0
98786,DSH,0,0
98787,",",0,0
98788,hospital,0,0
98789,admissions,0,0
98790,or,0,0
98791,length,0,0
98792,of,0,0
98793,stay,0,0
98794,in,0,0
98795,hospital,0,0
98796,between,0,0
98797,groups,0,0
98798,.,0,0
98799,Disability,0,1
98800,(,0,1
98801,days,0,0
98802,spent,0,1
98803,in,0,0
98804,bed,0,0
98805,),0,0
98806,and,0,0
98807,quality,0,0
98808,of,0,0
98809,life,0,1
98810,(,0,0
98811,Physical,0,0
98812,",",0,0
98813,Psychological,0,0
98814,and,0,0
98815,Environmental,0,0
98816,domains,0,0
98817,),0,0
98818,were,0,0
98819,significantly,0,0
98820,improved,0,0
98821,for,0,0
98822,the,0,0
98823,DBT,0,0
98824,group,0,0
98825,.,0,0
98826,CONCLUSION,0,0
98827,DBT,1,0
98828,produced,0,0
98829,non-significant,0,0
98830,reductions,0,0
98831,in,0,0
98832,DSH,0,0
98833,and,0,0
98834,hospitalization,0,0
98835,when,0,0
98836,compared,0,0
98837,to,0,0
98838,the,0,0
98839,TAU+WL,0,0
98840,control,0,0
98841,",",0,0
98842,due,0,0
98843,in,0,0
98844,part,0,0
98845,to,0,0
98846,the,0,0
98847,lower,0,0
98848,than,0,0
98849,expected,0,0
98850,rates,0,0
98851,of,0,0
98852,hospitalization,0,0
98853,in,0,0
98854,the,0,0
98855,control,0,0
98856,condition,0,0
98857,.,0,0
98858,Nevertheless,0,0
98859,",",0,0
98860,DBT,1,0
98861,showed,0,0
98862,significant,0,0
98863,benefits,0,0
98864,for,0,0
98865,the,0,0
98866,secondary,0,0
98867,outcomes,0,0
98868,of,0,0
98869,improved,0,0
98870,disability,0,0
98871,and,0,0
98872,quality,0,0
98873,of,0,0
98874,life,0,0
98875,scores,0,0
98876,",",0,0
98877,a,0,0
98878,clinically,0,0
98879,useful,0,0
98880,result,0,0
98881,that,0,0
98882,is,0,0
98883,also,0,0
98884,in,0,0
98885,keeping,0,0
98886,with,0,0
98887,the,0,0
98888,theoretical,0,0
98889,constructs,0,0
98890,of,0,0
98891,the,0,0
98892,benefits,0,0
98893,of,0,0
98894,DBT,1,0
98895,.,1,0
98896,[,0,1
98897,Value,0,0
98898,of,0,0
98899,combining,0,0
98900,64,1,0
98901,multi-slice,1,0
98902,spiral,1,0
98903,computer,1,0
98904,tomography,1,1
98905,and,1,1
98906,serum,1,1
98907,amyloid,1,1
98908,A,1,1
98909,protein,1,0
98910,in,0,0
98911,surgical,0,0
98912,decision-making,0,0
98913,in,0,0
98914,rectal,0,1
98915,cancer,0,1
98916,],0,0
98917,.,0,0
98918,OBJECTIVE,0,0
98919,To,0,0
98920,determine,0,0
98921,the,0,0
98922,accuracy,0,0
98923,and,0,0
98924,clinical,0,0
98925,value,0,0
98926,of,0,0
98927,combining,0,0
98928,64,1,0
98929,multi-slice,1,0
98930,spiral,1,0
98931,computer,1,1
98932,tomography,1,1
98933,(,1,1
98934,MSCT,1,1
98935,),1,1
98936,and,1,1
98937,serum,1,1
98938,amyloid,1,1
98939,A,1,1
98940,protein,1,0
98941,(,1,1
98942,SAA,1,1
98943,),1,0
98944,in,0,0
98945,the,0,0
98946,preoperative,0,0
98947,staging,0,0
98948,of,0,0
98949,rectal,0,0
98950,cancer,0,0
98951,.,0,0
98952,METHODS,0,0
98953,Prospectively,0,0
98954,enrolled,0,0
98955,patients,0,0
98956,with,0,0
98957,rectal,0,0
98958,cancer,0,0
98959,from,0,0
98960,October,0,0
98961,2007,0,0
98962,to,0,0
98963,October,0,0
98964,2008,0,0
98965,.,0,0
98966,The,0,0
98967,patients,0,0
98968,were,0,0
98969,randomly,0,0
98970,assigned,0,0
98971,into,0,0
98972,two,0,0
98973,groups,0,0
98974,:,0,0
98975,MSCT,1,0
98976,and,1,0
98977,SAA,1,0
98978,combined,0,0
98979,group,0,0
98980,:,0,0
98981,both,0,0
98982,MSCT,1,0
98983,and,1,0
98984,SAA,1,0
98985,combinative,0,0
98986,assessment,0,0
98987,were,0,0
98988,performed,0,0
98989,for,0,0
98990,preoperative,0,0
98991,evaluation,0,0
98992,;,0,0
98993,MSCT,1,1
98994,group,1,0
98995,:,1,0
98996,only,1,0
98997,MSCT,1,0
98998,was,0,0
98999,performed,0,0
99000,preoperatively,0,0
99001,for,0,0
99002,tumor,0,0
99003,staging,0,0
99004,.,0,0
99005,The,0,0
99006,accuracy,0,0
99007,of,0,0
99008,the,0,0
99009,preoperative,0,0
99010,T,0,1
99011,",",0,0
99012,N,0,1
99013,",",0,0
99014,M,0,0
99015,",",0,0
99016,and,0,0
99017,TNM,0,1
99018,staging,0,0
99019,and,0,0
99020,the,0,0
99021,concordance,0,0
99022,rate,0,0
99023,of,0,0
99024,predictive,0,0
99025,operative,0,0
99026,strategy,0,0
99027,were,0,0
99028,compared,0,0
99029,between,0,0
99030,the,0,0
99031,two,0,0
99032,groups,0,0
99033,.,0,0
99034,RESULTS,0,0
99035,Total,0,0
99036,of,0,0
99037,225,0,0
99038,cases,0,0
99039,with,0,0
99040,rectal,0,0
99041,cancer,0,0
99042,were,0,0
99043,enrolled,0,0
99044,in,0,0
99045,this,0,0
99046,study,0,0
99047,.,0,0
99048,There,0,0
99049,were,0,0
99050,110,0,0
99051,cases,0,0
99052,in,0,0
99053,MSCT,1,0
99054,and,1,0
99055,SAA,1,0
99056,combined,1,0
99057,group,0,0
99058,and,0,0
99059,115,0,0
99060,cases,0,0
99061,in,0,0
99062,MSCT,1,1
99063,group,0,0
99064,.,0,0
99065,The,0,0
99066,baseline,0,0
99067,characteristics,0,0
99068,was,0,0
99069,comparable,0,0
99070,between,0,0
99071,the,0,0
99072,two,0,0
99073,groups,0,0
99074,.,0,0
99075,For,0,0
99076,MSCT,1,0
99077,and,1,0
99078,SAA,1,0
99079,combined,1,0
99080,group,0,0
99081,",",0,0
99082,the,0,0
99083,accuracies,0,0
99084,of,0,0
99085,preoperative,0,0
99086,staging,0,0
99087,of,0,0
99088,T,0,0
99089,",",0,0
99090,N,0,1
99091,",",0,0
99092,M,0,1
99093,and,0,0
99094,TNM,0,0
99095,was,0,0
99096,87.3,0,0
99097,%,0,0
99098,",",0,0
99099,85.2,0,0
99100,%,0,0
99101,",",0,0
99102,100,0,0
99103,%,0,0
99104,and,0,0
99105,86.4,0,0
99106,%,0,0
99107,",",0,0
99108,respectively,0,0
99109,;,0,0
99110,and,0,0
99111,for,0,0
99112,MSCT,0,1
99113,group,0,0
99114,",",0,0
99115,the,0,0
99116,corresponding,0,0
99117,rates,0,0
99118,was,0,0
99119,85.2,0,0
99120,%,0,0
99121,",",0,0
99122,67.0,0,0
99123,%,0,0
99124,",",0,0
99125,100,0,0
99126,%,0,0
99127,and,0,0
99128,66.1,0,0
99129,%,0,0
99130,",",0,0
99131,respectively,0,0
99132,.,0,0
99133,Statistical,0,0
99134,differences,0,0
99135,was,0,0
99136,found,0,0
99137,in,0,0
99138,the,0,0
99139,accuracy,0,0
99140,of,0,0
99141,preoperative,0,0
99142,N,0,1
99143,and,0,0
99144,TNM,0,0
99145,staging,0,0
99146,between,0,0
99147,the,0,0
99148,two,0,0
99149,groups,0,0
99150,(,0,0
99151,P,0,0
99152,=,0,0
99153,0.009,0,0
99154,and,0,0
99155,0.001,0,0
99156,",",0,0
99157,respectively,0,0
99158,),0,0
99159,.,0,0
99160,In,0,0
99161,addition,0,0
99162,",",0,0
99163,there,0,0
99164,was,0,0
99165,statistical,0,0
99166,difference,0,0
99167,in,0,0
99168,the,0,0
99169,accuracy,0,0
99170,of,0,0
99171,prediction,0,0
99172,to,0,0
99173,operative,0,0
99174,procedures,0,0
99175,between,0,0
99176,the,0,0
99177,two,0,0
99178,groups,0,0
99179,(,0,0
99180,94.7,0,0
99181,%,0,0
99182,vs.,0,0
99183,81.7,0,0
99184,%,0,0
99185,",",0,0
99186,P,0,0
99187,=,0,0
99188,0.003,0,0
99189,),0,0
99190,.,0,0
99191,CONCLUSION,0,0
99192,Combinative,0,0
99193,assessment,0,0
99194,of,0,0
99195,MSCT,1,0
99196,and,1,0
99197,SAA,1,0
99198,could,0,0
99199,improve,0,0
99200,the,0,0
99201,accuracy,0,0
99202,of,0,0
99203,preoperative,0,0
99204,staging,0,0
99205,",",0,0
99206,and,0,0
99207,thus,0,0
99208,provide,0,0
99209,higher,0,0
99210,predictive,0,0
99211,coincidence,0,0
99212,rate,0,0
99213,of,0,0
99214,operative,0,0
99215,procedures,0,0
99216,.,0,0
99217,Biventricular,0,0
99218,pacing,0,0
99219,improves,0,0
99220,cardiac,0,0
99221,function,0,0
99222,and,0,0
99223,prevents,0,0
99224,further,0,0
99225,left,0,0
99226,atrial,0,0
99227,remodeling,0,0
99228,in,0,0
99229,patients,0,0
99230,with,0,0
99231,symptomatic,0,0
99232,atrial,0,0
99233,fibrillation,0,0
99234,after,0,0
99235,atrioventricular,0,0
99236,node,0,0
99237,ablation,0,0
99238,.,0,0
99239,BACKGROUND,0,0
99240,Randomized,0,0
99241,trials,0,0
99242,have,0,0
99243,demonstrated,0,0
99244,benefits,0,0
99245,of,0,0
99246,biventricular,1,1
99247,(,1,1
99248,BiV,1,1
99249,),1,1
99250,pacing,1,0
99251,in,0,0
99252,patients,0,0
99253,with,0,0
99254,advanced,0,0
99255,heart,0,0
99256,failure,0,0
99257,",",0,0
99258,intraventricular,0,0
99259,conduction,0,0
99260,delay,0,0
99261,",",0,0
99262,and,0,0
99263,atrial,0,1
99264,fibrillation,0,1
99265,(,0,1
99266,AF,0,1
99267,),0,1
99268,post-atrioventricular,0,0
99269,(,0,0
99270,AV,0,0
99271,),0,0
99272,node,0,0
99273,ablation,0,0
99274,.,0,0
99275,The,0,0
99276,AV,0,0
99277,Node,0,0
99278,Ablation,0,0
99279,with,0,0
99280,CLS,0,0
99281,and,0,0
99282,CRT,0,1
99283,Pacing,0,1
99284,Therapies,0,0
99285,for,0,0
99286,Treatment,0,0
99287,of,0,0
99288,AF,0,1
99289,trial,0,1
99290,(,0,0
99291,AVAIL,0,1
99292,CLS/CRT,0,1
99293,),0,0
99294,was,0,0
99295,designed,0,0
99296,to,0,0
99297,demonstrate,0,0
99298,superiority,0,0
99299,of,0,0
99300,BiV,0,0
99301,pacing,0,0
99302,in,0,0
99303,patients,0,0
99304,with,0,0
99305,AF,0,0
99306,after,0,0
99307,AV,0,0
99308,node,0,0
99309,ablation,0,0
99310,",",0,0
99311,to,0,0
99312,evaluate,0,0
99313,its,0,0
99314,effects,0,0
99315,on,0,0
99316,cardiac,0,0
99317,structure,0,0
99318,and,0,0
99319,function,0,0
99320,",",0,0
99321,and,0,0
99322,to,0,0
99323,investigate,0,0
99324,additional,0,0
99325,benefits,0,0
99326,of,0,0
99327,Closed,0,0
99328,Loop,0,0
99329,Stimulation,0,0
99330,(,0,1
99331,CLS,0,1
99332,),0,1
99333,(,0,0
99334,BIOTRONIK,0,1
99335,",",0,0
99336,Berlin,0,1
99337,",",0,1
99338,Germany,0,1
99339,),0,0
99340,.,0,0
99341,METHODS,0,0
99342,Patients,0,0
99343,with,0,0
99344,refractory,0,0
99345,AF,0,0
99346,underwent,0,0
99347,AV,0,0
99348,node,0,0
99349,ablation,0,0
99350,and,0,0
99351,were,0,0
99352,randomized,0,1
99353,(,0,1
99354,2:2:1,0,1
99355,),0,1
99356,to,0,0
99357,BiV,1,1
99358,pacing,1,0
99359,with,1,0
99360,CLS,1,0
99361,",",1,0
99362,BiV,1,0
99363,pacing,1,0
99364,with,1,0
99365,accelerometer,1,0
99366,",",1,0
99367,or,1,0
99368,right,1,1
99369,ventricular,1,1
99370,(,1,1
99371,RV,1,1
99372,),1,1
99373,pacing,1,0
99374,.,1,0
99375,Echocardiography,0,0
99376,was,0,0
99377,performed,0,0
99378,at,0,0
99379,baseline,0,0
99380,and,0,0
99381,6,0,0
99382,months,0,0
99383,",",0,0
99384,with,0,0
99385,paired,0,0
99386,data,0,0
99387,available,0,0
99388,for,0,0
99389,108,0,0
99390,patients,0,0
99391,.,0,0
99392,RESULTS,0,0
99393,The,0,0
99394,RV,0,0
99395,pacing,0,0
99396,contributed,0,0
99397,to,0,0
99398,significant,0,0
99399,increase,0,0
99400,in,0,0
99401,left,0,0
99402,atrial,0,0
99403,volume,0,0
99404,",",0,0
99405,left,0,1
99406,ventricular,0,1
99407,(,0,1
99408,LV,0,1
99409,),0,1
99410,end-systolic,0,0
99411,volume,0,1
99412,",",0,0
99413,and,0,0
99414,LV,0,0
99415,mass,0,0
99416,compared,0,0
99417,to,0,0
99418,BiV,0,0
99419,pacing,0,0
99420,.,0,0
99421,Ejection,0,0
99422,fraction,0,0
99423,decreased,0,0
99424,insignificantly,0,0
99425,with,0,0
99426,RV,0,0
99427,pacing,0,0
99428,compared,0,0
99429,to,0,0
99430,significant,0,0
99431,increase,0,0
99432,with,0,0
99433,BiV,0,0
99434,pacing,0,0
99435,.,0,0
99436,Interventricular,0,0
99437,dyssynchrony,0,0
99438,significantly,0,0
99439,decreased,0,0
99440,with,0,0
99441,BiV,0,0
99442,compared,0,0
99443,with,0,0
99444,RV,0,0
99445,pacing,0,0
99446,.,0,0
99447,Closed,0,0
99448,Loop,0,0
99449,Stimulation,0,0
99450,did,0,0
99451,not,0,0
99452,result,0,0
99453,in,0,0
99454,additional,0,0
99455,echocardiographic,0,0
99456,changes,0,0
99457,;,0,0
99458,heart,0,0
99459,rate,0,0
99460,distribution,0,0
99461,was,0,0
99462,significantly,0,0
99463,wider,0,0
99464,with,0,0
99465,CLS,0,0
99466,.,0,0
99467,All,0,0
99468,groups,0,0
99469,showed,0,0
99470,significant,0,0
99471,improvement,0,0
99472,in,0,0
99473,6-minute,0,0
99474,walk,0,0
99475,distance,0,0
99476,",",0,0
99477,quality-of-life,0,0
99478,score,0,0
99479,",",0,0
99480,and,0,0
99481,New,0,1
99482,York,0,1
99483,Heart,0,0
99484,Association,0,0
99485,class,0,0
99486,.,0,0
99487,CONCLUSION,0,0
99488,In,0,0
99489,conclusion,0,0
99490,",",0,0
99491,RV,0,0
99492,pacing,0,0
99493,results,0,0
99494,in,0,0
99495,significant,0,0
99496,increase,0,0
99497,in,0,0
99498,left,0,0
99499,atrial,0,0
99500,volume,0,0
99501,",",0,0
99502,LV,0,0
99503,mass,0,0
99504,",",0,0
99505,and,0,0
99506,worsening,0,0
99507,of,0,0
99508,LV,0,0
99509,contractility,0,0
99510,compared,0,0
99511,to,0,0
99512,patients,0,0
99513,receiving,0,0
99514,BiV,0,0
99515,pacing,0,1
99516,post-AV,0,1
99517,node,0,0
99518,ablation,0,0
99519,for,0,0
99520,refractory,0,0
99521,AF,0,0
99522,.,0,0
99523,Closed,0,0
99524,Loop,0,0
99525,Stimulation,0,0
99526,was,0,0
99527,not,0,0
99528,associated,0,0
99529,with,0,0
99530,additional,0,0
99531,structural,0,0
99532,changes,0,0
99533,but,0,0
99534,resulted,0,0
99535,in,0,0
99536,significantly,0,0
99537,wider,0,0
99538,heart,0,0
99539,rate,0,0
99540,distribution,0,0
99541,.,0,0
99542,Pilot,0,0
99543,randomized,0,0
99544,controlled,0,0
99545,trial,0,0
99546,of,0,0
99547,Reciprocal,1,0
99548,Imitation,1,0
99549,Training,1,0
99550,for,0,0
99551,teaching,0,0
99552,elicited,0,0
99553,and,0,0
99554,spontaneous,0,0
99555,imitation,0,0
99556,to,0,0
99557,children,0,0
99558,with,0,0
99559,autism,0,0
99560,.,0,0
99561,Children,0,0
99562,with,0,0
99563,autism,0,0
99564,exhibit,0,0
99565,significant,0,0
99566,deficits,0,0
99567,in,0,0
99568,imitation,0,0
99569,skills,0,0
99570,.,0,0
99571,Reciprocal,1,0
99572,Imitation,1,0
99573,Training,1,1
99574,(,1,1
99575,RIT,1,1
99576,),1,1
99577,",",0,0
99578,a,0,0
99579,naturalistic,0,0
99580,imitation,0,0
99581,intervention,0,0
99582,",",0,0
99583,was,0,0
99584,developed,0,0
99585,to,0,0
99586,teach,0,0
99587,young,0,0
99588,children,0,0
99589,with,0,0
99590,autism,0,0
99591,to,0,0
99592,imitate,0,0
99593,during,0,0
99594,play,0,0
99595,.,0,0
99596,This,0,0
99597,study,0,0
99598,used,0,0
99599,a,0,0
99600,randomized,0,0
99601,controlled,0,0
99602,trial,0,0
99603,to,0,0
99604,evaluate,0,0
99605,the,0,0
99606,efficacy,0,0
99607,of,0,0
99608,RIT,0,0
99609,on,0,0
99610,elicited,0,0
99611,and,0,0
99612,spontaneous,0,0
99613,imitation,0,0
99614,skills,0,0
99615,in,0,0
99616,21,0,0
99617,young,0,0
99618,children,0,0
99619,with,0,0
99620,autism,0,0
99621,.,0,0
99622,Results,0,0
99623,found,0,0
99624,that,0,0
99625,children,0,0
99626,in,0,0
99627,the,0,0
99628,treatment,0,0
99629,group,0,0
99630,made,0,0
99631,significantly,0,0
99632,more,0,0
99633,gains,0,0
99634,in,0,0
99635,elicited,0,0
99636,and,0,0
99637,spontaneous,0,0
99638,imitation,0,0
99639,",",0,0
99640,replicating,0,0
99641,previous,0,0
99642,single-subject,0,0
99643,design,0,0
99644,studies,0,0
99645,.,0,0
99646,Number,0,0
99647,of,0,0
99648,spontaneous,0,0
99649,play,0,0
99650,acts,0,0
99651,at,0,0
99652,pre-treatment,0,0
99653,was,0,0
99654,related,0,0
99655,to,0,0
99656,improvements,0,0
99657,in,0,0
99658,imitation,0,0
99659,during,0,0
99660,the,0,0
99661,intervention,0,0
99662,",",0,0
99663,suggesting,0,0
99664,that,0,0
99665,children,0,0
99666,with,0,0
99667,a,0,0
99668,greater,0,0
99669,play,0,0
99670,repertoire,0,0
99671,make,0,0
99672,greater,0,0
99673,gains,0,0
99674,during,0,0
99675,RIT,0,0
99676,.,0,0
99677,Can,0,1
99678,incentives,1,0
99679,undermine,0,0
99680,intrinsic,0,0
99681,motivation,0,0
99682,to,0,0
99683,participate,0,0
99684,in,0,0
99685,epidemiologic,0,0
99686,surveys,0,0
99687,?,0,0
99688,Response,0,0
99689,rates,0,0
99690,to,0,0
99691,surveys,0,0
99692,are,0,0
99693,decreasing,0,0
99694,.,0,0
99695,The,0,0
99696,purpose,0,0
99697,of,0,0
99698,this,0,0
99699,study,0,0
99700,was,0,0
99701,to,0,0
99702,evaluate,0,0
99703,the,0,0
99704,use,1,0
99705,of,1,0
99706,lottery,1,0
99707,tickets,1,0
99708,as,1,0
99709,incentives,1,0
99710,in,0,0
99711,an,0,0
99712,epidemiologic,0,0
99713,control,0,0
99714,group,0,0
99715,.,0,0
99716,A,0,0
99717,self-administered,0,0
99718,questionnaire,0,0
99719,was,0,0
99720,sent,0,0
99721,to,0,0
99722,parents,0,0
99723,in,0,0
99724,the,0,0
99725,municipality,0,0
99726,of,0,0
99727,Stockholm,0,0
99728,",",0,0
99729,Sweden,0,0
99730,",",0,0
99731,who,0,0
99732,were,0,0
99733,to,0,0
99734,be,0,0
99735,used,0,0
99736,as,0,0
99737,a,0,0
99738,control,0,0
99739,group,0,0
99740,in,0,0
99741,a,0,0
99742,study,0,0
99743,addressing,0,0
99744,stress,0,0
99745,in,0,0
99746,parents,0,0
99747,of,0,0
99748,children,0,0
99749,with,0,0
99750,cancer,0,0
99751,.,0,0
99752,A,0,0
99753,stratified,0,0
99754,random,0,0
99755,sample,0,0
99756,of,0,0
99757,450,0,0
99758,parents,0,0
99759,were,0,0
99760,randomized,0,0
99761,into,0,0
99762,three,1,0
99763,incentive,1,0
99764,groups,1,0
99765,:,1,0
99766,(,1,0
99767,a,1,0
99768,),1,0
99769,no,1,0
99770,incentive,1,1
99771,;,1,1
99772,(,1,1
99773,b,1,1
99774,),1,0
99775,a,1,0
99776,promised,1,0
99777,incentive,1,0
99778,of,1,0
99779,one,1,0
99780,lottery,1,0
99781,ticket,1,0
99782,to,1,0
99783,be,1,0
99784,received,1,0
99785,upon,1,0
99786,reply,1,1
99787,;,1,1
99788,(,1,1
99789,c,1,1
99790,),1,0
99791,a,1,0
99792,promised,1,0
99793,incentive,1,0
99794,of,1,0
99795,one,1,0
99796,lottery,1,0
99797,ticket,1,0
99798,to,1,0
99799,be,1,0
99800,received,1,0
99801,upon,1,0
99802,reply,1,0
99803,and,1,0
99804,an,1,0
99805,additional,1,0
99806,lottery,1,0
99807,ticket,1,0
99808,upon,1,0
99809,reply,1,0
99810,within,1,0
99811,1,1,0
99812,week,1,0
99813,.,1,0
99814,The,0,0
99815,overall,0,0
99816,response,0,0
99817,rate,0,0
99818,across,0,0
99819,the,0,0
99820,three,0,0
99821,groups,0,0
99822,was,0,0
99823,65.3,0,0
99824,%,0,0
99825,.,0,0
99826,The,0,0
99827,response,0,0
99828,rate,0,0
99829,was,0,0
99830,highest,0,0
99831,in,0,0
99832,the,0,0
99833,no,1,0
99834,incentive,1,0
99835,group,1,0
99836,(,0,0
99837,69.3,0,0
99838,%,0,0
99839,),0,0
99840,and,0,0
99841,lowest,0,0
99842,in,0,0
99843,the,0,0
99844,one,1,0
99845,plus,1,0
99846,one,1,0
99847,lottery,1,0
99848,ticket,1,1
99849,group,1,0
99850,(,0,0
99851,62.0,0,0
99852,%,0,0
99853,),0,0
99854,.,0,0
99855,In,0,0
99856,a,0,0
99857,survival,0,0
99858,analysis,0,0
99859,",",0,0
99860,the,0,0
99861,difference,0,0
99862,between,0,0
99863,the,0,0
99864,two,0,0
99865,response,0,0
99866,curves,0,0
99867,was,0,0
99868,significant,0,0
99869,by,0,0
99870,the,0,0
99871,log-rank,0,0
99872,test,0,0
99873,(,0,0
99874,P,0,0
99875,=,0,0
99876,0.04,0,0
99877,),0,0
99878,",",0,0
99879,with,0,0
99880,the,0,0
99881,no,0,0
99882,incentive,0,0
99883,group,0,0
99884,having,0,0
99885,a,0,0
99886,shorter,0,0
99887,time,0,0
99888,to,0,0
99889,response,0,0
99890,than,0,0
99891,the,0,0
99892,incentive,1,0
99893,group,1,0
99894,.,1,0
99895,Our,0,0
99896,findings,0,0
99897,suggest,0,0
99898,that,0,0
99899,the,0,0
99900,use,0,0
99901,of,0,0
99902,lottery,1,0
99903,tickets,1,0
99904,as,0,0
99905,incentives,0,0
99906,to,0,0
99907,increase,0,0
99908,participation,0,0
99909,in,0,0
99910,a,0,0
99911,mail,0,0
99912,questionnaire,0,0
99913,among,0,0
99914,parents,0,0
99915,may,0,0
99916,be,0,0
99917,less,0,0
99918,valuable,0,0
99919,or,0,0
99920,even,0,0
99921,harmful,0,0
99922,.,0,0
99923,Incentives,1,0
99924,may,0,0
99925,undermine,0,0
99926,motivation,0,0
99927,in,0,0
99928,studies,0,0
99929,in,0,0
99930,which,0,0
99931,the,0,0
99932,intrinsic,0,0
99933,motivation,0,0
99934,of,0,0
99935,the,0,0
99936,respondents,0,0
99937,is,0,0
99938,already,0,0
99939,high,0,0
99940,.,0,0
99941,Final,0,0
99942,analysis,0,0
99943,of,0,0
99944,the,0,0
99945,UKLG,0,0
99946,LY02,0,1
99947,trial,0,0
99948,comparing,0,0
99949,6-8,0,0
99950,cycles,0,0
99951,of,0,0
99952,CHOP,1,0
99953,with,0,0
99954,3,0,0
99955,cycles,0,0
99956,of,1,0
99957,CHOP,1,0
99958,followed,1,0
99959,by,1,0
99960,a,1,0
99961,BEAM,1,0
99962,autograft,1,0
99963,in,0,0
99964,patients,0,0
99965,<,0,0
99966,65,0,0
99967,years,0,0
99968,with,0,0
99969,poor,0,0
99970,prognosis,0,0
99971,histologically,0,0
99972,aggressive,0,0
99973,NHL,0,1
99974,.,0,0
99975,This,0,0
99976,trial,0,0
99977,involved,0,0
99978,457,0,0
99979,patients,0,0
99980,and,0,0
99981,sought,0,0
99982,to,0,0
99983,assess,0,0
99984,the,0,0
99985,value,0,0
99986,of,0,0
99987,early,0,0
99988,intensification,0,0
99989,with,0,0
99990,autologous,0,0
99991,transplantation,0,0
99992,in,0,0
99993,patients,0,0
99994,with,0,0
99995,poor,0,0
99996,prognosis,0,0
99997,histologically,0,0
99998,aggressive,0,1
99999,non-Hodgkin,0,1
100000,lymphoma,0,1
100001,(,0,1
100002,NHL,0,1
100003,),0,0
100004,showing,0,0
100005,a,0,0
100006,response,0,0
100007,to,0,0
100008,initial,0,0
100009,CHOP,1,1
100010,(,1,1
100011,cyclophosphamide,1,1
100012,",",1,1
100013,doxorubicin,1,1
100014,",",1,1
100015,vincristine,1,1
100016,",",1,1
100017,prednisolone,1,1
100018,),1,1
100019,chemotherapy,1,1
100020,.,1,0
100021,Randomization,0,0
100022,was,0,0
100023,made,0,0
100024,at,0,0
100025,the,0,0
100026,time,0,0
100027,of,0,0
100028,diagnosis,0,0
100029,with,0,0
100030,223,0,0
100031,assigned,0,0
100032,to,0,0
100033,continuing,0,0
100034,CHOP,1,0
100035,and,0,0
100036,234,0,0
100037,to,0,0
100038,3,0,0
100039,cycles,0,0
100040,of,0,0
100041,CHOP,1,0
100042,followed,1,0
100043,by,1,0
100044,a,1,0
100045,BEAM,1,1
100046,(,1,1
100047,carmustine,1,1
100048,",",1,1
100049,etoposide,1,1
100050,",",1,1
100051,cytarabine,1,1
100052,",",1,1
100053,melphalan,1,1
100054,),1,1
100055,autograft,1,1
100056,.,1,0
100057,Analysis,0,0
100058,was,0,0
100059,on,0,0
100060,an,0,0
100061,intention,0,0
100062,to,0,0
100063,treat,0,0
100064,basis,0,0
100065,.,0,0
100066,After,0,0
100067,the,0,0
100068,initial,0,0
100069,three,0,0
100070,cycles,0,0
100071,of,0,0
100072,CHOP,1,0
100073,19,0,0
100074,%,0,0
100075,of,0,0
100076,the,0,0
100077,whole,0,0
100078,group,0,0
100079,were,0,0
100080,in,0,0
100081,complete,0,0
100082,response,0,0
100083,(,0,0
100084,CR,0,1
100085,),0,0
100086,and,0,0
100087,53,0,0
100088,%,0,0
100089,in,0,0
100090,partial,0,0
100091,remission,0,0
100092,(,0,1
100093,PR,0,1
100094,),0,1
100095,.,0,0
100096,At,0,0
100097,the,0,0
100098,end,0,0
100099,of,0,0
100100,treatment,0,0
100101,86,0,0
100102,%,0,0
100103,of,0,0
100104,patients,0,0
100105,in,0,0
100106,the,0,0
100107,CHOP,1,0
100108,arm,0,0
100109,had,0,0
100110,responded,0,0
100111,with,0,0
100112,58,0,0
100113,%,0,0
100114,in,0,0
100115,CR,0,0
100116,.,0,0
100117,In,0,0
100118,the,0,0
100119,high-dose,0,1
100120,therapy,0,1
100121,arm,0,0
100122,the,0,0
100123,overall,0,0
100124,response,0,0
100125,rate,0,0
100126,was,0,0
100127,83,0,0
100128,%,0,0
100129,with,0,0
100130,64,0,0
100131,%,0,0
100132,in,0,0
100133,CR,0,0
100134,(,0,0
100135,difference,0,0
100136,between,0,0
100137,arms,0,0
100138,not,0,0
100139,significant,0,0
100140,),0,0
100141,.,0,0
100142,The,0,0
100143,progression-free,0,0
100144,survival,0,0
100145,(,0,1
100146,PFS,0,1
100147,),0,1
100148,and,0,0
100149,overall,0,0
100150,survival,0,0
100151,at,0,0
100152,5,0,0
100153,years,0,0
100154,for,0,0
100155,the,0,0
100156,continuing,0,0
100157,CHOP,0,0
100158,arm,0,0
100159,were,0,0
100160,38,0,0
100161,%,0,0
100162,and,0,0
100163,50,0,0
100164,%,0,0
100165,respectively,0,0
100166,",",0,0
100167,and,0,0
100168,for,0,0
100169,the,0,0
100170,autograft,0,0
100171,arm,0,0
100172,were,0,0
100173,44,0,0
100174,%,0,0
100175,and,0,0
100176,50,0,0
100177,%,0,0
100178,(,0,0
100179,differences,0,0
100180,not,0,0
100181,significant,0,0
100182,),0,0
100183,.,0,0
100184,Of,0,0
100185,the,0,0
100186,patients,0,0
100187,who,0,0
100188,attained,0,0
100189,CR,0,0
100190,and,0,0
100191,subsequently,0,0
100192,relapsed,0,0
100193,",",0,0
100194,there,0,0
100195,were,0,0
100196,no,0,0
100197,long-term,0,0
100198,survivors,0,0
100199,in,0,0
100200,the,0,0
100201,autograft,0,0
100202,recipients,0,0
100203,compared,0,0
100204,to,0,0
100205,46,0,0
100206,%,0,0
100207,of,0,0
100208,the,0,0
100209,continuing,0,0
100210,CHOP,1,1
100211,recipients,0,0
100212,(,0,0
100213,P,0,0
100214,=,0,0
100215,0.0008,0,0
100216,),0,0
100217,.,0,0
100218,In,0,0
100219,conclusion,0,0
100220,",",0,0
100221,no,0,0
100222,survival,0,0
100223,benefit,0,0
100224,was,0,0
100225,demonstrated,0,0
100226,for,0,0
100227,an,0,0
100228,early,0,0
100229,autograft,0,0
100230,in,0,0
100231,first,0,0
100232,response,0,0
100233,.,0,0
100234,Effect,0,0
100235,of,0,0
100236,membrane,0,0
100237,permeability,0,0
100238,on,0,0
100239,inflammation,0,0
100240,and,0,0
100241,arterial,0,0
100242,stiffness,0,0
100243,:,0,0
100244,a,0,0
100245,randomized,0,0
100246,trial,0,0
100247,.,0,0
100248,BACKGROUND,0,0
100249,AND,0,1
100250,OBJECTIVES,0,1
100251,Both,0,0
100252,larger,0,0
100253,molecule,0,0
100254,removal,0,0
100255,and,0,0
100256,dialyzer,0,1
100257,biocompatibility,0,1
100258,have,0,0
100259,been,0,0
100260,implicated,0,0
100261,in,0,0
100262,the,0,0
100263,high-flux,1,1
100264,hemodialysis,1,1
100265,(,0,1
100266,HD,0,1
100267,),0,1
100268,-associated,0,0
100269,favorable,0,0
100270,outcome,0,0
100271,.,0,0
100272,In,0,0
100273,an,0,0
100274,attempt,0,0
100275,to,0,0
100276,delineate,0,0
100277,the,0,0
100278,effect,0,0
100279,of,0,0
100280,membrane,0,0
100281,permeability,0,0
100282,",",0,0
100283,we,0,0
100284,performed,0,0
100285,a,0,0
100286,randomized,0,0
100287,",",0,0
100288,crossover,0,1
100289,study,0,0
100290,to,0,0
100291,compare,0,0
100292,the,0,0
100293,inflammatory,0,0
100294,biomarkers,0,0
100295,",",0,0
100296,lipid,0,0
100297,profile,0,0
100298,",",0,0
100299,and,0,0
100300,aortic,0,0
100301,pulse,0,1
100302,wave,0,1
100303,velocity,0,1
100304,(,0,1
100305,PWV,0,1
100306,),0,0
100307,of,0,0
100308,two,0,0
100309,dialyzers,0,1
100310,that,0,0
100311,are,0,0
100312,composed,0,0
100313,of,0,0
100314,identical,0,0
100315,membranes,0,0
100316,but,0,0
100317,with,0,0
100318,different,0,0
100319,flux,0,0
100320,characteristics,0,0
100321,.,0,0
100322,DESIGN,0,0
100323,",",0,0
100324,SETTING,0,1
100325,",",0,0
100326,PARTICIPANTS,0,1
100327,",",0,0
100328,&,0,0
100329,MEASUREMENTS,0,0
100330,Stable,0,0
100331,patients,0,0
100332,who,0,0
100333,had,0,0
100334,anuria,0,0
100335,and,0,0
100336,were,0,0
100337,on,0,0
100338,low-flux,0,1
100339,polysulfone,0,1
100340,membrane,0,0
100341,were,0,0
100342,randomly,0,0
100343,allocated,0,0
100344,either,0,0
100345,to,0,0
100346,HD,1,1
100347,with,1,1
100348,high-flux,1,1
100349,polyamide,1,1
100350,membrane,1,1
100351,(,0,1
100352,group,0,0
100353,A,0,1
100354,;,0,0
100355,22,0,0
100356,patients,0,0
100357,),0,0
100358,or,0,0
100359,to,0,0
100360,HD,1,1
100361,with,1,1
100362,low-flux,1,1
100363,polyamide,1,1
100364,membrane,1,1
100365,(,0,1
100366,group,0,0
100367,B,0,1
100368,;,0,1
100369,24,0,0
100370,patients,0,0
100371,),0,0
100372,for,0,0
100373,24,0,0
100374,weeks,0,0
100375,",",0,0
100376,then,0,0
100377,they,0,0
100378,were,0,0
100379,started,0,0
100380,on,0,0
100381,24,0,0
100382,weeks,0,0
100383,of,0,0
100384,the,0,0
100385,alternative,1,0
100386,HD,1,0
100387,treatment,1,0
100388,.,1,0
100389,Apart,0,0
100390,from,0,0
100391,the,0,0
100392,dialyzer,0,1
100393,",",0,0
100394,the,0,0
100395,dialysis,0,0
100396,prescription,0,0
100397,remained,0,0
100398,unchanged,0,0
100399,.,0,0
100400,RESULTS,0,0
100401,Nineteen,0,0
100402,patients,0,0
100403,from,0,0
100404,group,0,0
100405,A,0,0
100406,and,0,0
100407,23,0,0
100408,patients,0,0
100409,from,0,0
100410,group,0,0
100411,B,0,0
100412,completed,0,0
100413,the,0,0
100414,study,0,0
100415,.,0,0
100416,Predialysis,0,1
100417,beta,0,1
100418,(,0,1
100419,2,0,1
100420,),0,1
100421,-microglobulin,0,1
100422,levels,0,0
100423,decreased,0,0
100424,significantly,0,0
100425,when,0,0
100426,using,0,0
100427,the,0,0
100428,high-flux,1,1
100429,polyamide,1,1
100430,membrane,1,1
100431,.,1,0
100432,No,0,0
100433,difference,0,0
100434,between,0,0
100435,membranes,0,0
100436,was,0,0
100437,observed,0,0
100438,for,0,0
100439,serum,0,1
100440,albumin,0,1
100441,",",0,1
100442,high-sensitivity,0,1
100443,C-reactive,0,0
100444,protein,0,0
100445,",",0,0
100446,fibrinogen,0,1
100447,",",0,1
100448,IL-6,0,1
100449,",",0,1
100450,triglycerides,0,1
100451,",",0,1
100452,HDL,0,1
100453,cholesterol,0,1
100454,",",0,1
100455,LDL,0,1
100456,cholesterol,0,1
100457,",",0,1
100458,and,0,1
100459,lipoprotein,0,1
100460,(,0,1
100461,a,0,0
100462,),0,0
100463,during,0,0
100464,the,0,0
100465,study,0,0
100466,.,0,0
100467,A,0,0
100468,significant,0,0
100469,increase,0,0
100470,in,0,0
100471,aortic,0,0
100472,PWV,0,0
100473,",",0,0
100474,a,0,0
100475,marker,0,0
100476,of,0,0
100477,aortic,0,0
100478,stiffness,0,0
100479,",",0,0
100480,was,0,0
100481,noted,0,0
100482,after,0,0
100483,patients,0,0
100484,switched,0,0
100485,from,0,0
100486,high-flux,1,1
100487,to,0,1
100488,low-flux,1,1
100489,polyamide,1,1
100490,membranes,1,0
100491,.,1,0
100492,Similarly,0,0
100493,",",0,0
100494,the,0,0
100495,rate,0,0
100496,of,0,0
100497,change,0,0
100498,in,0,0
100499,aortic,0,0
100500,PWV,0,0
100501,was,0,0
100502,significantly,0,0
100503,decreased,0,0
100504,with,0,0
100505,the,0,0
100506,use,0,0
100507,of,0,0
100508,the,0,0
100509,high-flux,1,1
100510,polyamide,1,1
100511,membrane,1,0
100512,.,1,0
100513,CONCLUSIONS,0,0
100514,Our,0,0
100515,findings,0,0
100516,suggest,0,0
100517,that,0,0
100518,dialysis,0,0
100519,with,0,0
100520,polyamide,1,0
100521,membranes,1,0
100522,with,0,0
100523,different,0,0
100524,flux,0,0
100525,characteristics,0,0
100526,did,0,0
100527,not,0,0
100528,modify,0,0
100529,the,0,0
100530,inflammatory,0,0
100531,indices,0,0
100532,and,0,0
100533,lipid,0,0
100534,profile,0,0
100535,in,0,0
100536,stable,0,0
100537,HD,0,0
100538,patients,0,0
100539,;,0,0
100540,however,0,0
100541,",",0,0
100542,a,0,0
100543,seemingly,0,0
100544,beneficial,0,0
100545,effect,0,0
100546,on,0,0
100547,aortic,0,0
100548,stiffness,0,0
100549,was,0,0
100550,noted,0,0
100551,for,0,0
100552,patients,0,0
100553,who,0,0
100554,were,0,0
100555,maintained,0,0
100556,on,0,0
100557,high-flux,1,1
100558,polyamide,1,1
100559,membrane,1,0
100560,.,1,0
100561,Digestive,1,0
100562,enzyme,1,0
100563,supplementation,1,1
100564,for,0,0
100565,autism,0,0
100566,spectrum,0,0
100567,disorders,0,0
100568,:,0,0
100569,a,0,0
100570,double-blind,0,1
100571,randomized,0,1
100572,controlled,0,0
100573,trial,0,0
100574,.,0,0
100575,To,0,0
100576,examine,0,0
100577,the,0,0
100578,effects,0,0
100579,of,0,0
100580,a,0,0
100581,digestive,1,0
100582,enzyme,1,0
100583,supplement,1,1
100584,in,0,0
100585,improving,0,0
100586,expressive,0,0
100587,language,0,0
100588,",",0,0
100589,behaviour,0,0
100590,and,0,0
100591,other,0,0
100592,symptoms,0,0
100593,in,0,0
100594,children,0,0
100595,with,0,0
100596,Autism,0,0
100597,Spectrum,0,0
100598,Disorder,0,0
100599,.,0,0
100600,Randomized,0,0
100601,",",0,1
100602,double-blind,0,1
100603,placebo-controlled,1,1
100604,trial,0,1
100605,using,0,1
100606,crossover,0,1
100607,design,0,1
100608,over,0,0
100609,6,0,0
100610,months,0,0
100611,for,0,0
100612,43,0,0
100613,children,0,0
100614,",",0,0
100615,aged,0,0
100616,3-8,0,0
100617,years,0,0
100618,.,0,0
100619,Outcome,0,0
100620,measurement,0,0
100621,tools,0,0
100622,included,0,0
100623,monthly,0,0
100624,Global,0,0
100625,Behaviour,0,0
100626,Rating,0,0
100627,Scales,0,0
100628,",",0,0
100629,Additional,0,0
100630,Rating,0,0
100631,Scales,0,0
100632,of,0,0
100633,other,0,0
100634,symptoms,0,0
100635,by,0,0
100636,parents,0,0
100637,and,0,0
100638,therapists,0,0
100639,",",0,0
100640,and,0,0
100641,monthly,0,0
100642,completion,0,0
100643,of,0,0
100644,the,0,0
100645,Rescorla,0,0
100646,Language,0,0
100647,Development,0,0
100648,Survey,0,0
100649,.,0,0
100650,Compared,0,0
100651,with,0,0
100652,placebo,1,1
100653,",",0,0
100654,treatment,0,0
100655,with,0,0
100656,enzyme,1,0
100657,was,0,0
100658,not,0,0
100659,associated,0,0
100660,with,0,0
100661,clinically,0,0
100662,significant,0,0
100663,improvement,0,0
100664,in,0,0
100665,behaviour,0,0
100666,",",0,0
100667,food,0,0
100668,variety,0,0
100669,",",0,0
100670,gastrointestinal,0,0
100671,symptoms,0,0
100672,",",0,0
100673,sleep,0,0
100674,quality,0,0
100675,",",0,0
100676,engagement,0,0
100677,with,0,0
100678,therapist,0,0
100679,",",0,0
100680,or,0,0
100681,the,0,0
100682,Language,0,0
100683,Development,0,0
100684,Survey,0,0
100685,Vocabulary,0,0
100686,or,0,0
100687,Sentence,0,0
100688,Complexity,0,0
100689,Scores,0,0
100690,.,0,0
100691,A,0,0
100692,small,0,0
100693,statistically,0,0
100694,significant,0,0
100695,improvement,0,0
100696,on,0,0
100697,enzyme,0,0
100698,therapy,0,0
100699,was,0,0
100700,seen,0,0
100701,for,0,0
100702,the,0,0
100703,food,0,0
100704,variety,0,0
100705,scores,0,0
100706,.,0,0
100707,No,0,1
100708,clinically,0,0
100709,significant,0,0
100710,effect,0,0
100711,improvement,0,0
100712,of,0,0
100713,autism,0,0
100714,symptoms,0,0
100715,with,0,0
100716,enzyme,0,0
100717,use,0,0
100718,was,0,0
100719,shown,0,0
100720,with,0,0
100721,this,0,0
100722,trial,0,0
100723,",",0,0
100724,however,0,0
100725,",",0,0
100726,possible,0,0
100727,effects,0,0
100728,on,0,0
100729,improvement,0,0
100730,in,0,0
100731,food,0,0
100732,variety,0,0
100733,warrants,0,0
100734,further,0,0
100735,detailed,0,0
100736,investigation,0,0
100737,.,0,0
100738,Effect,0,0
100739,of,0,0
100740,enamel,1,0
100741,pretreatment,1,1
100742,on,0,0
100743,shear,0,0
100744,bond,0,0
100745,strength,0,0
100746,of,0,0
100747,brackets,0,0
100748,bonded,0,0
100749,with,0,1
100750,resin-modified,0,1
100751,glass-ionomer,0,1
100752,cement,0,1
100753,.,0,0
100754,AIM,0,0
100755,To,0,0
100756,evaluate,0,0
100757,the,0,0
100758,shear,0,0
100759,bond,0,0
100760,strength,0,0
100761,of,0,0
100762,brackets,0,0
100763,bonded,0,0
100764,with,0,1
100765,resin-modified,1,1
100766,glass-ionomer,1,1
100767,cement,1,1
100768,(,1,1
100769,RMGIC,1,1
100770,),1,0
100771,using,0,0
100772,various,0,0
100773,methods,0,0
100774,of,0,0
100775,enamel,1,0
100776,conditioning,0,0
100777,.,0,0
100778,METHODS,0,0
100779,Forty-five,0,0
100780,human,0,0
100781,premolars,0,0
100782,were,0,0
100783,randomly,0,0
100784,divided,0,0
100785,into,0,0
100786,five,0,0
100787,groups,0,0
100788,.,0,0
100789,The,0,0
100790,roots,0,0
100791,of,0,0
100792,these,0,0
100793,teeth,0,0
100794,were,0,0
100795,fixed,0,0
100796,in,0,0
100797,acrylic,0,1
100798,resin,0,1
100799,cylinders,0,1
100800,",",0,0
100801,and,0,0
100802,brackets,0,0
100803,were,0,0
100804,bonded,0,0
100805,to,0,0
100806,the,0,0
100807,teeth,0,0
100808,'s,0,0
100809,crowns,0,0
100810,using,0,0
100811,the,0,0
100812,following,0,0
100813,material,0,0
100814,combinations,0,0
100815,:,0,0
100816,RMGIC,1,0
100817,only,0,0
100818,;,0,0
100819,RMGIC,0,0
100820,and,0,0
100821,corresponding,0,0
100822,primer,1,0
100823,;,1,0
100824,RMGIC,0,1
100825,",",0,1
100826,acid,1,1
100827,etching,1,1
100828,",",0,1
100829,and,0,0
100830,Scotchbond,1,1
100831,Multipurpose,0,1
100832,;,0,0
100833,RMGIC,0,1
100834,and,0,0
100835,two-step,0,0
100836,self-etching,0,1
100837,primer,0,1
100838,;,0,1
100839,and,0,0
100840,RMGIC,1,1
100841,and,0,0
100842,one-step,0,0
100843,primer,0,0
100844,.,0,0
100845,All,0,0
100846,specimens,0,0
100847,were,0,0
100848,submitted,0,0
100849,to,0,0
100850,pH,0,0
100851,cycling,0,0
100852,for,0,0
100853,14,0,0
100854,days,0,0
100855,before,0,0
100856,shear,0,1
100857,bond,0,0
100858,strength,0,0
100859,was,0,0
100860,assessed,0,0
100861,in,0,0
100862,a,0,0
100863,universal,0,0
100864,test,0,0
100865,machine,0,0
100866,.,0,0
100867,RESULTS,0,0
100868,The,0,0
100869,medians,0,0
100870,and,0,0
100871,standard,0,0
100872,deviations,0,1
100873,(,0,0
100874,in,0,0
100875,MPa,0,1
100876,),0,0
100877,were,0,0
100878,RMGIC,1,0
100879,only,0,0
100880,=,0,0
100881,8.34,0,0
100882,?,0,0
100883,1.11,0,0
100884,;,0,0
100885,RMGIC,0,0
100886,and,0,0
100887,corresponding,0,0
100888,primer,0,0
100889,=,0,0
100890,7.05,0,0
100891,?,0,0
100892,2.24,0,0
100893,;,0,0
100894,RMGIC,0,0
100895,",",0,1
100896,acid,0,1
100897,etching,0,1
100898,",",0,1
100899,and,0,0
100900,Scotchbond,0,0
100901,Multipurpose,0,0
100902,=,0,0
100903,7.00,0,0
100904,?,0,0
100905,4.79,0,0
100906,;,0,0
100907,RMGIC,0,0
100908,and,0,0
100909,two-step,0,0
100910,self-etching,0,0
100911,primer,0,0
100912,=,0,0
100913,0.54,0,0
100914,?,0,0
100915,0.30,0,0
100916,;,0,0
100917,and,0,0
100918,RMGIC,0,1
100919,and,0,0
100920,one-step,0,0
100921,primer,0,0
100922,=,0,0
100923,10.61,0,0
100924,?,0,0
100925,4.58,0,0
100926,.,0,0
100927,The,0,0
100928,value,0,0
100929,for,1,0
100930,RMGIC,1,0
100931,and,1,0
100932,two-step,0,0
100933,self-etching,0,0
100934,primer,0,0
100935,was,0,0
100936,significantly,0,0
100937,lower,0,0
100938,than,0,0
100939,all,0,0
100940,other,0,0
100941,values,0,0
100942,.,0,0
100943,CONCLUSION,0,0
100944,It,0,0
100945,can,0,0
100946,be,0,0
100947,concluded,0,0
100948,that,0,0
100949,the,0,0
100950,tested,0,0
100951,RMGIC,0,0
100952,is,0,0
100953,suitable,0,0
100954,for,0,0
100955,bonding,0,0
100956,orthodontic,0,0
100957,brackets,0,0
100958,",",0,0
100959,even,0,0
100960,when,0,0
100961,used,0,0
100962,by,0,0
100963,itself,0,0
100964,.,0,0
100965,Different,0,0
100966,enamel,0,0
100967,preparations,0,0
100968,do,0,0
100969,not,0,0
100970,improve,0,0
100971,its,0,0
100972,performance,0,0
100973,.,0,0
100974,However,0,0
100975,",",0,0
100976,they,0,0
100977,can,0,0
100978,worsen,0,0
100979,its,0,0
100980,bonding,0,0
100981,capacity,0,0
100982,as,0,0
100983,the,0,0
100984,combination,0,0
100985,with,0,0
100986,the,0,0
100987,two-step,0,0
100988,primer,0,0
100989,system,0,0
100990,clearly,0,0
100991,shows,0,0
100992,.,0,0
100993,Comparison,0,0
100994,of,0,0
100995,laser,1,0
100996,photocoagulation,1,0
100997,for,0,0
100998,diabetic,0,0
100999,retinopathy,0,0
101000,using,0,0
101001,532-nm,0,1
101002,standard,0,1
101003,laser,0,1
101004,versus,0,0
101005,multispot,0,0
101006,pattern,0,0
101007,scan,0,0
101008,laser,0,0
101009,.,0,0
101010,PURPOSE,0,0
101011,The,0,0
101012,purpose,0,0
101013,of,0,0
101014,this,0,0
101015,study,0,0
101016,was,0,0
101017,to,0,0
101018,compare,0,0
101019,the,0,0
101020,efficacy,0,0
101021,",",0,0
101022,collateral,0,0
101023,damage,0,0
101024,",",0,0
101025,and,0,0
101026,convenience,0,0
101027,of,0,0
101028,panretinal,0,0
101029,photocoagulation,0,0
101030,for,0,0
101031,proliferative,0,0
101032,diabetic,0,0
101033,retinopathy,0,0
101034,or,0,0
101035,severe,0,0
101036,nonproliferative,0,1
101037,diabetic,0,0
101038,retinopathy,0,0
101039,using,0,0
101040,a,0,0
101041,532-nm,0,0
101042,solid-state,1,0
101043,green,1,0
101044,laser,1,1
101045,(,1,1
101046,GLX,1,1
101047,),1,1
101048,versus,0,0
101049,a,0,0
101050,multispot,1,1
101051,532-nm,1,1
101052,pattern,1,0
101053,scan,1,1
101054,laser,1,1
101055,(,0,1
101056,PASCAL,0,1
101057,),0,1
101058,.,0,0
101059,METHODS,0,0
101060,This,0,0
101061,study,0,0
101062,was,0,0
101063,a,0,0
101064,prospective,0,0
101065,randomized,0,0
101066,clinical,0,0
101067,trial,0,0
101068,.,0,0
101069,Sixty,0,0
101070,patients,0,0
101071,with,0,0
101072,bilaterally,0,0
101073,symmetrical,0,0
101074,proliferative,0,0
101075,diabetic,0,0
101076,retinopathy,0,0
101077,or,0,0
101078,severe,0,0
101079,nonproliferative,0,1
101080,diabetic,0,1
101081,retinopathy,0,0
101082,participated,0,0
101083,.,0,0
101084,Each,0,0
101085,patient,0,0
101086,underwent,0,0
101087,panretinal,0,0
101088,photocoagulation,0,0
101089,:,0,0
101090,one,1,0
101091,eye,1,0
101092,with,1,0
101093,GLX,1,0
101094,and,0,0
101095,the,0,0
101096,other,0,0
101097,with,0,0
101098,PASCAL,1,0
101099,",",0,0
101100,two,0,0
101101,sittings,0,0
101102,per,0,0
101103,eye,0,0
101104,.,0,0
101105,Grade,0,0
101106,3,0,0
101107,burns,0,0
101108,with,0,0
101109,a,0,0
101110,200-mum,0,0
101111,spot,0,0
101112,size,0,0
101113,were,0,0
101114,placed,0,0
101115,with,0,0
101116,both,0,0
101117,modalities,0,0
101118,.,0,0
101119,The,0,0
101120,fluence,0,0
101121,",",0,0
101122,pain,0,0
101123,using,0,0
101124,the,0,0
101125,visual,0,0
101126,analog,0,1
101127,scale,0,1
101128,",",0,0
101129,time,0,0
101130,",",0,0
101131,laser,0,0
101132,spot,0,0
101133,spread,0,0
101134,with,0,0
101135,infrared,0,0
101136,images,0,0
101137,",",0,0
101138,and,0,0
101139,retinal,0,0
101140,sensitivity,0,0
101141,were,0,0
101142,compared,0,0
101143,.,0,0
101144,RESULTS,0,0
101145,Pattern,0,0
101146,scan,0,0
101147,laser,0,0
101148,and,0,0
101149,GLX,0,0
101150,required,0,0
101151,an,0,0
101152,average,0,0
101153,fluence,0,0
101154,of,0,0
101155,40.33,0,0
101156,vs,0,0
101157,191,0,0
101158,J/cm,0,0
101159,(,0,0
101160,2,0,1
101161,),0,0
101162,",",0,0
101163,respectively,0,0
101164,.,0,0
101165,Average,0,0
101166,time,0,0
101167,required,0,0
101168,per,0,0
101169,sitting,0,0
101170,was,0,0
101171,1.43,0,0
101172,minutes,0,0
101173,with,0,0
101174,PASCAL,0,0
101175,and,0,0
101176,4.53,0,0
101177,minutes,0,0
101178,with,0,0
101179,GLX,0,0
101180,.,0,0
101181,Average,0,0
101182,visual,0,1
101183,analog,0,1
101184,scale,0,1
101185,reading,0,0
101186,for,0,0
101187,GLX,0,0
101188,was,0,0
101189,4.6,0,0
101190,",",0,0
101191,whereas,0,0
101192,that,0,0
101193,for,0,0
101194,PASCAL,0,0
101195,was,0,0
101196,0.33,0,0
101197,.,0,0
101198,Heidelberg,0,0
101199,retinal,0,0
101200,angiography,0,0
101201,images,0,0
101202,showed,0,0
101203,the,0,0
101204,spot,0,0
101205,spread,0,0
101206,as,0,0
101207,being,0,0
101208,430,0,0
101209,versus,0,0
101210,310,0,0
101211,microm,0,0
101212,at,0,0
101213,3,0,0
101214,months,0,0
101215,with,0,0
101216,GLX,0,0
101217,and,0,0
101218,PASCAL,0,0
101219,.,0,0
101220,The,0,0
101221,eyes,0,0
101222,treated,0,0
101223,with,0,0
101224,PASCAL,0,0
101225,showed,0,0
101226,higher,0,0
101227,average,0,0
101228,retinal,0,0
101229,sensitivity,0,0
101230,in,0,0
101231,the,0,0
101232,central,0,0
101233,15,0,0
101234,degrees,0,0
101235,and,0,0
101236,15,0,0
101237,degrees,0,0
101238,to,0,0
101239,30,0,0
101240,degrees,0,0
101241,zones,0,0
101242,(,0,0
101243,25.08,0,0
101244,and,0,0
101245,22.08,0,0
101246,dB,0,0
101247,",",0,0
101248,respectively,0,0
101249,),0,0
101250,than,0,0
101251,the,0,0
101252,eyes,0,0
101253,treated,0,0
101254,with,0,0
101255,GLX,0,0
101256,(,0,0
101257,23.16,0,0
101258,and,0,0
101259,17.14,0,0
101260,dB,0,0
101261,),0,0
101262,",",0,0
101263,respectively,0,0
101264,.,0,0
101265,CONCLUSION,0,0
101266,Pattern,0,0
101267,scan,0,0
101268,laser,0,0
101269,showed,0,0
101270,lesser,0,0
101271,collateral,0,0
101272,damage,0,0
101273,and,0,0
101274,similar,0,0
101275,regression,0,0
101276,of,0,0
101277,retinopathy,0,0
101278,compared,0,0
101279,with,0,0
101280,GLX,0,0
101281,.,0,0
101282,Pattern,0,0
101283,scan,0,0
101284,laser,0,0
101285,treatment,0,0
101286,was,0,0
101287,less,0,0
101288,time,0,0
101289,consuming,0,0
101290,and,0,0
101291,less,0,0
101292,painful,0,0
101293,for,0,0
101294,the,0,0
101295,patient,0,0
101296,compared,0,0
101297,with,0,0
101298,GLX,0,0
101299,.,0,0
101300,Comparison,0,0
101301,of,0,0
101302,the,0,0
101303,in,0,0
101304,vitro,0,0
101305,and,0,0
101306,in,0,0
101307,vivo,0,0
101308,release,0,0
101309,of,0,0
101310,digoxin,1,1
101311,from,0,0
101312,four,0,0
101313,different,0,0
101314,soft,0,1
101315,gelatin,0,1
101316,capsule,1,1
101317,formulations,1,1
101318,.,1,1
101319,A,0,1
101320,blinded,0,0
101321,",",0,0
101322,four-treatment,0,0
101323,crossover,0,1
101324,study,0,0
101325,in,0,0
101326,16,0,0
101327,normal,0,0
101328,adult,0,0
101329,male,0,0
101330,volunteers,0,0
101331,compared,0,0
101332,plasma,0,1
101333,concentrations,0,1
101334,and,0,1
101335,urinary,0,1
101336,excretion,0,1
101337,of,0,1
101338,digoxin,1,1
101339,",",0,0
101340,measured,0,0
101341,by,0,0
101342,radioimmunoassay,0,1
101343,",",0,1
101344,after,0,1
101345,oral,0,1
101346,administration,0,1
101347,of,0,1
101348,soft,1,1
101349,gelatin,1,1
101350,capsule,1,1
101351,formulations,1,1
101352,of,1,1
101353,digoxin,1,1
101354,.,1,1
101355,Four,0,1
101356,0.4-mg,0,1
101357,formulations,1,1
101358,with,1,1
101359,different,1,0
101360,in,1,0
101361,vitro,1,0
101362,burst,1,0
101363,times,1,1
101364,and,0,0
101365,dissolution,1,1
101366,rates,1,0
101367,were,0,0
101368,administered,0,1
101369,",",0,1
101370,with,0,1
101371,2-week,0,1
101372,intervals,0,0
101373,between,0,0
101374,treatments,0,0
101375,.,0,0
101376,The,0,0
101377,two,0,0
101378,capsules,0,1
101379,with,0,0
101380,lowest,0,0
101381,in,0,0
101382,vitro,0,0
101383,burst,0,0
101384,times,0,0
101385,(,0,0
101386,2.9,0,0
101387,and,0,0
101388,16,0,0
101389,min,0,0
101390,),0,0
101391,gave,0,0
101392,comparable,0,0
101393,in,0,0
101394,vivo,0,0
101395,results,0,0
101396,.,0,0
101397,The,0,0
101398,other,0,0
101399,two,0,0
101400,capsules,0,1
101401,",",0,0
101402,with,0,0
101403,in,0,0
101404,vitro,0,0
101405,burst,0,0
101406,times,0,0
101407,of,0,0
101408,62,0,0
101409,and,0,0
101410,229,0,0
101411,min,0,0
101412,",",0,0
101413,produced,0,0
101414,significant,0,0
101415,delays,0,0
101416,in,0,0
101417,digoxin,0,1
101418,absorption,0,1
101419,.,0,1
101420,In,0,0
101421,vitro-in,0,1
101422,vivo,0,0
101423,correlations,0,0
101424,were,0,0
101425,obtained,0,0
101426,by,0,0
101427,comparing,0,0
101428,the,0,0
101429,logarithm,0,0
101430,of,0,0
101431,the,0,0
101432,in,0,0
101433,vitro,0,0
101434,burst,0,0
101435,time,0,0
101436,with,0,0
101437,time,0,0
101438,to,0,0
101439,peak,0,0
101440,plasma,0,0
101441,level,0,0
101442,and,0,0
101443,the,0,0
101444,time,0,0
101445,to,0,0
101446,the,0,0
101447,first,0,0
101448,measurable,0,0
101449,plasma,0,1
101450,level,0,0
101451,(,0,0
101452,>,0,0
101453,or,0,0
101454,=,0,0
101455,0,0,0
101456,.,0,0
101457,05,0,0
101458,ng/ml,0,0
101459,),0,0
101460,.,0,0
101461,Also,0,0
101462,",",0,0
101463,the,0,0
101464,mean,0,0
101465,time,0,0
101466,to,0,0
101467,peak,0,0
101468,plasma,0,0
101469,level,0,0
101470,correlated,0,0
101471,with,0,0
101472,the,0,0
101473,logarithm,0,0
101474,of,0,0
101475,the,0,0
101476,time,0,0
101477,required,0,0
101478,to,0,0
101479,release,0,0
101480,either,0,0
101481,50,0,0
101482,%,0,0
101483,or,0,0
101484,85,0,0
101485,%,0,0
101486,of,0,0
101487,the,0,0
101488,digoxin,0,1
101489,in,0,0
101490,vitro,0,0
101491,.,0,0
101492,No,0,0
101493,significant,0,0
101494,changes,0,0
101495,were,0,0
101496,found,0,0
101497,in,0,0
101498,the,0,0
101499,amount,0,0
101500,of,0,0
101501,digoxin,1,1
101502,absorbed,0,1
101503,from,0,1
101504,each,0,0
101505,capsule,0,1
101506,as,0,0
101507,determined,0,0
101508,by,0,0
101509,urinary,0,1
101510,excretion,0,1
101511,or,0,1
101512,AUC0-infinity,0,1
101513,.,0,0
101514,The,0,0
101515,limit,0,0
101516,to,0,0
101517,exercise,0,0
101518,tolerance,0,0
101519,in,0,0
101520,humans,0,0
101521,:,0,0
101522,mind,0,0
101523,over,0,0
101524,muscle,0,0
101525,?,0,0
101526,In,0,0
101527,exercise,0,0
101528,physiology,0,0
101529,",",0,0
101530,it,0,0
101531,has,0,0
101532,been,0,0
101533,traditionally,0,0
101534,assumed,0,0
101535,that,0,0
101536,high-intensity,1,0
101537,aerobic,1,0
101538,exercise,1,0
101539,stops,0,0
101540,at,0,0
101541,the,0,0
101542,point,0,0
101543,commonly,0,0
101544,called,0,0
101545,exhaustion,0,0
101546,because,0,0
101547,fatigued,0,0
101548,subjects,0,0
101549,are,0,0
101550,no,0,0
101551,longer,0,0
101552,able,0,0
101553,to,0,0
101554,generate,0,0
101555,the,0,0
101556,power,0,0
101557,output,0,0
101558,required,0,0
101559,by,0,0
101560,the,0,0
101561,task,0,0
101562,despite,0,0
101563,their,0,0
101564,maximal,0,0
101565,voluntary,0,0
101566,effort,0,0
101567,.,0,0
101568,We,0,0
101569,tested,0,0
101570,the,0,0
101571,validity,0,0
101572,of,0,0
101573,this,0,0
101574,assumption,0,0
101575,by,0,0
101576,measuring,0,0
101577,maximal,0,0
101578,voluntary,0,0
101579,cycling,0,0
101580,power,0,0
101581,before,0,0
101582,(,0,0
101583,mean,0,0
101584,+/-,0,0
101585,SD,0,0
101586,",",0,0
101587,"1,075",0,0
101588,+/-,0,0
101589,214,0,0
101590,W,0,0
101591,),0,0
101592,and,0,0
101593,immediately,0,0
101594,after,0,0
101595,(,0,0
101596,731,0,0
101597,+/-,0,0
101598,206,0,0
101599,W,0,0
101600,),0,0
101601,(,0,0
101602,P,0,0
101603,<,0,0
101604,0.001,0,0
101605,),0,0
101606,exhaustive,1,0
101607,cycling,1,0
101608,exercise,1,0
101609,at,0,0
101610,242,0,0
101611,+/-,0,0
101612,24,0,0
101613,W,0,0
101614,(,0,0
101615,80,0,0
101616,%,0,0
101617,of,0,0
101618,peak,0,0
101619,aerobic,0,0
101620,power,0,0
101621,measured,0,0
101622,during,0,0
101623,a,0,0
101624,preliminary,0,0
101625,incremental,0,0
101626,exercise,0,1
101627,test,0,0
101628,),0,0
101629,in,0,0
101630,ten,0,0
101631,fit,0,0
101632,male,0,0
101633,human,0,0
101634,subjects,0,0
101635,.,0,0
101636,Perceived,0,0
101637,exertion,0,0
101638,during,0,0
101639,exhaustive,1,0
101640,cycling,1,0
101641,exercise,1,0
101642,was,0,0
101643,strongly,0,0
101644,correlated,0,0
101645,(,0,0
101646,r,0,0
101647,=,0,0
101648,-0.82,0,0
101649,",",0,0
101650,P,0,0
101651,=,0,0
101652,0.003,0,0
101653,),0,0
101654,with,0,0
101655,time,0,0
101656,to,0,0
101657,exhaustion,0,0
101658,(,0,0
101659,10.5,0,0
101660,+/-,0,0
101661,2.1,0,0
101662,min,0,0
101663,),0,0
101664,.,0,0
101665,These,0,0
101666,results,0,0
101667,challenge,0,0
101668,the,0,0
101669,long-standing,0,0
101670,assumption,0,0
101671,that,0,0
101672,muscle,0,0
101673,fatigue,0,0
101674,causes,0,0
101675,exhaustion,0,0
101676,during,0,0
101677,high-intensity,0,0
101678,aerobic,0,0
101679,exercise,0,0
101680,",",0,0
101681,and,0,0
101682,suggest,0,0
101683,that,0,0
101684,exercise,0,0
101685,tolerance,0,0
101686,in,0,0
101687,highly,0,0
101688,motivated,0,0
101689,subjects,0,0
101690,is,0,0
101691,ultimately,0,0
101692,limited,0,0
101693,by,0,0
101694,perception,0,0
101695,of,0,0
101696,effort,0,0
101697,.,0,0
101698,[,0,0
101699,Effect,0,0
101700,of,0,0
101701,zengjing,1,0
101702,no,1,0
101703,.,1,0
101704,1,1,0
101705,capsule,1,1
101706,on,0,0
101707,morphology,0,0
101708,and,0,0
101709,motility,0,0
101710,of,0,0
101711,sperm,0,0
101712,in,0,0
101713,patients,0,0
101714,with,0,0
101715,oligospermia,0,0
101716,],0,0
101717,.,0,0
101718,OBJECTIVE,0,0
101719,To,0,0
101720,explore,0,0
101721,the,0,0
101722,effect,0,0
101723,of,0,0
101724,Zengjing,1,1
101725,Capsule,1,1
101726,No,1,1
101727,.,1,1
101728,1,1,1
101729,(,1,0
101730,ZJC1,1,1
101731,),1,1
101732,on,0,0
101733,morphology,0,0
101734,and,0,0
101735,motility,0,0
101736,of,0,0
101737,sperm,0,0
101738,in,0,0
101739,patients,0,0
101740,with,0,0
101741,oligospermia,0,0
101742,(,0,1
101743,OSM,0,1
101744,),0,1
101745,.,0,0
101746,METHODS,0,0
101747,Seventy-two,0,0
101748,OSM,0,0
101749,patients,0,0
101750,were,0,0
101751,assigned,0,0
101752,to,0,0
101753,2,0,0
101754,groups,0,0
101755,by,0,0
101756,a,0,0
101757,randomizing,0,0
101758,digital,0,0
101759,table,0,0
101760,",",0,0
101761,the,0,0
101762,treated,0,0
101763,group,0,0
101764,and,0,0
101765,the,0,0
101766,control,0,0
101767,group,0,0
101768,",",0,0
101769,they,0,0
101770,were,0,0
101771,treated,0,0
101772,respectively,0,0
101773,by,0,0
101774,ZJC1,1,0
101775,and,0,0
101776,Wuzi,1,1
101777,Yanzong,1,1
101778,Pill,1,0
101779,(,0,1
101780,WYP,0,1
101781,),0,1
101782,.,0,0
101783,The,0,0
101784,changes,0,0
101785,of,0,0
101786,density,0,0
101787,",",0,0
101788,motility,0,0
101789,and,0,0
101790,morphology,0,0
101791,of,0,0
101792,sperm,0,0
101793,in,0,0
101794,patients,0,0
101795,before,0,0
101796,and,0,0
101797,after,0,0
101798,3-month,0,0
101799,treatment,0,0
101800,were,0,0
101801,examined,0,0
101802,using,0,0
101803,computerized,0,0
101804,WLJY-9000,0,1
101805,colour,0,0
101806,semen,0,0
101807,analysis,0,0
101808,system,0,0
101809,with,0,0
101810,refined,0,0
101811,Papanicolaou,0,0
101812,'s,0,0
101813,stain,0,0
101814,.,0,0
101815,RESULTS,0,0
101816,The,0,0
101817,density,0,0
101818,",",0,0
101819,motility,0,0
101820,and,0,0
101821,morphology,0,0
101822,of,0,0
101823,sperm,0,0
101824,were,0,0
101825,improved,0,0
101826,and,0,0
101827,sperm,0,0
101828,deformity,0,0
101829,rate,0,0
101830,was,0,0
101831,significantly,0,0
101832,decreased,0,0
101833,after,0,0
101834,treatment,0,0
101835,in,0,0
101836,both,0,0
101837,groups,0,0
101838,(,0,0
101839,P,0,0
101840,<,0,0
101841,0.01,0,0
101842,),0,0
101843,",",0,0
101844,but,0,0
101845,the,0,0
101846,effects,0,0
101847,in,0,0
101848,the,0,0
101849,treated,0,0
101850,group,0,0
101851,were,0,0
101852,better,0,0
101853,than,0,0
101854,those,0,0
101855,in,0,0
101856,the,0,0
101857,control,0,0
101858,group,0,0
101859,(,0,0
101860,P,0,0
101861,<,0,0
101862,0.01,0,0
101863,),0,0
101864,.,0,0
101865,CONCLUSION,0,0
101866,ZJC1,1,0
101867,can,0,0
101868,enhance,0,0
101869,the,0,0
101870,density,0,0
101871,and,0,0
101872,motility,0,0
101873,of,0,0
101874,sperm,0,0
101875,and,0,0
101876,reduce,0,0
101877,the,0,0
101878,sperm,0,0
101879,deformity,0,0
101880,rate,0,0
101881,in,0,0
101882,patients,0,0
101883,with,0,0
101884,OSM,0,0
101885,.,0,0
101886,The,0,0
101887,effect,0,0
101888,of,0,0
101889,prophylactic,1,1
101890,fentanyl,1,1
101891,on,0,0
101892,shivering,0,0
101893,in,0,0
101894,elective,0,0
101895,caesarean,0,0
101896,section,0,0
101897,under,0,0
101898,epidural,0,0
101899,analgesia,0,1
101900,.,0,1
101901,The,0,0
101902,aims,0,0
101903,of,0,0
101904,this,0,0
101905,randomised,0,0
101906,double-blind,0,1
101907,study,0,0
101908,were,0,0
101909,to,0,0
101910,investigate,0,0
101911,whether,0,0
101912,25,0,0
101913,micrograms,0,1
101914,of,0,1
101915,fentanyl,1,1
101916,administered,0,1
101917,prophylactically,0,1
101918,by,0,1
101919,the,0,0
101920,epidural,0,0
101921,route,0,0
101922,would,0,0
101923,influence,0,0
101924,the,0,0
101925,incidence,0,0
101926,of,0,0
101927,shivering,0,0
101928,in,0,0
101929,parturients,0,0
101930,who,0,0
101931,underwent,0,0
101932,elective,0,0
101933,Caesarean,0,0
101934,section,0,0
101935,under,0,0
101936,epidural,0,1
101937,analgesia,0,1
101938,and,0,0
101939,whether,0,0
101940,it,0,0
101941,would,0,0
101942,affect,0,0
101943,the,0,0
101944,axillary,0,0
101945,and,0,0
101946,calf,0,0
101947,temperatures,0,0
101948,.,0,0
101949,There,0,0
101950,was,0,0
101951,a,0,0
101952,50,0,0
101953,%,0,0
101954,reduction,0,0
101955,(,0,0
101956,p,0,0
101957,less,0,0
101958,than,0,0
101959,0.05,0,0
101960,),0,0
101961,in,0,0
101962,the,0,0
101963,overall,0,0
101964,incidence,0,0
101965,of,0,0
101966,shivering,0,0
101967,in,0,0
101968,patients,0,0
101969,who,0,0
101970,received,0,0
101971,fentanyl,1,1
101972,and,0,0
101973,there,0,0
101974,was,0,0
101975,some,0,0
101976,evidence,0,0
101977,to,0,0
101978,suggest,0,0
101979,that,0,0
101980,low-dose,0,1
101981,epidural,0,1
101982,fentanyl,0,1
101983,might,0,0
101984,reduce,0,0
101985,shivering,0,0
101986,by,0,0
101987,an,0,0
101988,influence,0,0
101989,on,0,0
101990,thermoregulation,0,0
101991,.,0,0
101992,Clonidine,1,1
101993,clearance,0,1
101994,matures,0,0
101995,rapidly,0,0
101996,during,0,0
101997,the,0,0
101998,early,0,0
101999,postnatal,0,0
102000,period,0,0
102001,:,0,0
102002,a,0,0
102003,population,0,0
102004,pharmacokinetic,0,1
102005,analysis,0,0
102006,in,0,0
102007,newborns,0,0
102008,with,0,0
102009,neonatal,0,0
102010,abstinence,0,0
102011,syndrome,0,0
102012,.,0,0
102013,The,0,0
102014,population,0,0
102015,pharmacokinetic,0,1
102016,(,0,1
102017,PK,0,1
102018,),0,1
102019,profile,0,0
102020,of,0,1
102021,oral,1,1
102022,clonidine,1,1
102023,was,0,0
102024,characterized,0,0
102025,in,0,0
102026,newborns,0,0
102027,with,0,0
102028,neonatal,0,0
102029,abstinence,0,0
102030,syndrome,0,0
102031,",",0,0
102032,and,0,0
102033,significant,0,0
102034,covariates,0,0
102035,affecting,0,0
102036,its,0,0
102037,PK,0,0
102038,parameters,0,0
102039,were,0,0
102040,identified,0,0
102041,.,0,1
102042,Plasma,0,1
102043,clonidine,1,1
102044,concentration,0,0
102045,data,0,0
102046,were,0,0
102047,obtained,0,0
102048,from,0,0
102049,a,0,0
102050,clinical,0,0
102051,trial,0,0
102052,in,0,0
102053,which,0,0
102054,36,0,0
102055,newborns,0,0
102056,",",0,0
102057,aged,0,0
102058,1,0,0
102059,to,0,0
102060,25,0,1
102061,days,0,1
102062,(,0,1
102063,postnatal,0,1
102064,age,0,1
102065,",",0,0
102066,PNA,0,1
102067,),0,1
102068,and,0,0
102069,weighing,0,0
102070,2.1,0,0
102071,to,0,0
102072,3.9,0,0
102073,kg,0,0
102074,",",0,0
102075,were,0,0
102076,enrolled,0,0
102077,to,0,0
102078,take,0,0
102079,multiple,0,0
102080,oral,0,1
102081,doses,0,1
102082,of,0,1
102083,clonidine,0,1
102084,.,0,0
102085,The,0,0
102086,population,0,0
102087,PK,0,0
102088,model,0,0
102089,of,0,0
102090,clonidine,1,1
102091,was,0,0
102092,developed,0,0
102093,by,0,0
102094,NONMEM,0,0
102095,",",0,0
102096,and,0,0
102097,significant,0,0
102098,covariates,0,0
102099,were,0,0
102100,identified,0,0
102101,",",0,0
102102,followed,0,0
102103,by,0,0
102104,nonparametric,0,1
102105,bootstraps,0,1
102106,(,0,0
102107,2000,0,0
102108,replicates,0,0
102109,),0,0
102110,and,0,0
102111,simulation,0,0
102112,experiments,0,0
102113,.,0,0
102114,A,0,0
102115,1-compartment,0,0
102116,open,0,0
102117,linear,0,0
102118,PK,0,1
102119,model,0,0
102120,was,0,0
102121,chosen,0,0
102122,to,0,0
102123,describe,0,0
102124,plasma,0,1
102125,concentrations,0,1
102126,of,0,1
102127,clonidine,1,1
102128,",",0,1
102129,and,0,0
102130,body,0,0
102131,weight,0,0
102132,and,0,0
102133,PNA,0,0
102134,were,0,0
102135,significant,0,0
102136,covariates,0,0
102137,for,0,0
102138,apparent,0,0
102139,clearance,0,1
102140,(,0,1
102141,CL/F,0,1
102142,),0,1
102143,as,0,0
102144,follows,0,0
102145,:,0,0
102146,CL/F,0,0
102147,(,0,1
102148,L/h,0,1
102149,),0,0
102150,=,0,0
102151,15.2,0,0
102152,?,0,0
102153,[,0,0
102154,body,0,1
102155,weight,0,1
102156,(,0,1
102157,kg,0,0
102158,),0,0
102159,/70,0,0
102160,],0,0
102161,(,0,0
102162,0.75,0,0
102163,),0,0
102164,?,0,0
102165,[,0,1
102166,PNA,0,1
102167,(,0,1
102168,day,0,1
102169,),0,1
102170,(,0,1
102171,0.441,0,0
102172,),0,0
102173,/,0,0
102174,(,0,0
102175,4.06,0,0
102176,(,0,0
102177,0.441,0,0
102178,),0,0
102179,+,0,0
102180,PNA,0,1
102181,(,0,1
102182,day,0,1
102183,),0,1
102184,(,0,1
102185,0.441,0,1
102186,),0,1
102187,),0,0
102188,],0,0
102189,.,0,0
102190,Furthermore,0,0
102191,",",0,0
102192,CL/F,0,0
102193,of,0,0
102194,clonidine,1,1
102195,increased,1,0
102196,rapidly,0,0
102197,with,0,0
102198,PNA,0,0
102199,during,0,0
102200,the,0,0
102201,first,0,0
102202,month,0,0
102203,of,0,0
102204,life,0,0
102205,after,0,0
102206,body,0,0
102207,weight,0,0
102208,was,0,0
102209,adjusted,0,0
102210,.,0,0
102211,Any,0,0
102212,optimal,0,0
102213,dosage,0,1
102214,regimen,0,1
102215,for,1,1
102216,clonidine,1,1
102217,in,1,0
102218,term,0,1
102219,neonates,0,0
102220,should,0,0
102221,be,0,0
102222,based,0,0
102223,on,0,0
102224,infant,0,0
102225,'s,0,0
102226,age,0,0
102227,and,0,0
102228,body,0,0
102229,weight,0,0
102230,",",0,0
102231,and,0,0
102232,1.5,0,1
102233,?g/kg,0,1
102234,every,0,1
102235,4,0,1
102236,hours,0,0
102237,is,0,0
102238,proposed,0,0
102239,starting,0,0
102240,the,0,0
102241,second,0,0
102242,week,0,0
102243,of,0,0
102244,life,0,0
102245,based,0,0
102246,on,0,0
102247,the,0,0
102248,simulation,0,0
102249,results,0,0
102250,.,0,0
102251,Parent-mediated,1,0
102252,communication-focused,1,0
102253,treatment,1,0
102254,in,0,0
102255,children,0,0
102256,with,0,0
102257,autism,0,0
102258,(,0,1
102259,PACT,0,1
102260,),0,1
102261,:,0,0
102262,a,0,0
102263,randomised,0,0
102264,controlled,0,0
102265,trial,0,0
102266,.,0,0
102267,BACKGROUND,0,0
102268,Results,0,0
102269,of,0,0
102270,small,0,0
102271,trials,0,0
102272,suggest,0,0
102273,that,0,0
102274,early,0,0
102275,interventions,0,0
102276,for,0,0
102277,social,0,0
102278,communication,0,0
102279,are,0,0
102280,effective,0,0
102281,for,0,0
102282,the,0,0
102283,treatment,0,0
102284,of,0,0
102285,autism,0,0
102286,in,0,0
102287,children,0,0
102288,.,0,0
102289,We,0,0
102290,therefore,0,0
102291,investigated,0,0
102292,the,0,0
102293,efficacy,0,0
102294,of,0,0
102295,such,0,0
102296,an,0,0
102297,intervention,0,0
102298,in,0,0
102299,a,0,0
102300,larger,0,0
102301,trial,0,0
102302,.,0,0
102303,METHODS,0,0
102304,Children,0,0
102305,with,0,0
102306,core,0,0
102307,autism,0,0
102308,(,0,0
102309,aged,0,0
102310,2,0,0
102311,years,0,0
102312,to,0,0
102313,4,0,0
102314,years,0,0
102315,and,0,0
102316,11,0,0
102317,months,0,0
102318,),0,0
102319,were,0,0
102320,randomly,0,0
102321,assigned,0,0
102322,in,0,0
102323,a,0,0
102324,one-to-one,0,0
102325,ratio,0,0
102326,to,0,0
102327,a,0,0
102328,parent-mediated,1,0
102329,communication-focused,1,1
102330,(,1,1
102331,Preschool,1,1
102332,Autism,1,1
102333,Communication,1,1
102334,Trial,1,0
102335,[,1,1
102336,PACT,1,1
102337,],1,1
102338,),1,1
102339,intervention,1,1
102340,or,0,0
102341,treatment,1,0
102342,as,1,0
102343,usual,1,0
102344,at,0,0
102345,three,0,0
102346,specialist,0,0
102347,centres,0,0
102348,in,0,0
102349,the,0,0
102350,UK,0,0
102351,.,0,0
102352,Those,0,0
102353,assigned,0,0
102354,to,0,0
102355,PACT,0,0
102356,were,0,0
102357,also,0,0
102358,given,0,0
102359,treatment,0,0
102360,as,0,0
102361,usual,0,0
102362,.,0,0
102363,Randomisation,0,0
102364,was,0,0
102365,by,0,0
102366,use,0,0
102367,of,0,0
102368,minimisation,0,0
102369,of,0,0
102370,probability,0,0
102371,in,0,0
102372,the,0,0
102373,marginal,0,0
102374,distribution,0,0
102375,of,0,0
102376,treatment,0,0
102377,centre,0,0
102378,",",0,0
102379,age,0,0
102380,(,0,0
102381,<,0,0
102382,/=42,0,0
102383,months,0,0
102384,or,0,0
102385,>,0,0
102386,42,0,0
102387,months,0,0
102388,),0,0
102389,",",0,0
102390,and,0,0
102391,autism,0,1
102392,severity,0,1
102393,(,0,1
102394,Autism,0,1
102395,Diagnostic,0,1
102396,Observation,0,1
102397,Schedule-Generic,0,1
102398,[,0,1
102399,ADOS-G,0,1
102400,],0,1
102401,algorithm,0,0
102402,score,0,0
102403,12-17,0,0
102404,or,0,0
102405,18-24,0,0
102406,),0,0
102407,.,0,0
102408,Primary,0,0
102409,outcome,0,0
102410,was,0,0
102411,severity,0,0
102412,of,0,0
102413,autism,0,1
102414,symptoms,0,1
102415,(,0,0
102416,a,0,0
102417,total,0,0
102418,score,0,0
102419,of,0,0
102420,social,0,0
102421,communication,0,0
102422,algorithm,0,0
102423,items,0,0
102424,from,0,0
102425,ADOS-G,0,0
102426,",",0,0
102427,higher,0,0
102428,score,0,0
102429,indicating,0,0
102430,greater,0,0
102431,severity,0,0
102432,),0,0
102433,at,0,0
102434,13,0,0
102435,months,0,0
102436,.,0,0
102437,Complementary,0,0
102438,secondary,0,0
102439,outcomes,0,0
102440,were,0,0
102441,measures,0,0
102442,of,0,0
102443,parent-child,0,0
102444,interaction,0,0
102445,",",0,0
102446,child,0,0
102447,language,0,0
102448,",",0,0
102449,and,0,0
102450,adaptive,0,0
102451,functioning,0,0
102452,in,0,0
102453,school,0,0
102454,.,0,0
102455,Analysis,0,0
102456,was,0,0
102457,by,0,0
102458,intention,0,0
102459,to,0,0
102460,treat,0,0
102461,.,0,0
102462,This,0,0
102463,study,0,0
102464,is,0,0
102465,registered,0,0
102466,as,0,0
102467,an,0,0
102468,International,0,0
102469,Standard,0,0
102470,Randomised,0,0
102471,Controlled,0,0
102472,Trial,0,0
102473,",",0,0
102474,number,0,0
102475,ISRCTN58133827,0,0
102476,.,0,0
102477,RESULTS,0,0
102478,152,0,0
102479,children,0,0
102480,were,0,0
102481,recruited,0,0
102482,.,0,0
102483,77,0,0
102484,were,0,0
102485,assigned,0,0
102486,to,0,0
102487,PACT,1,1
102488,(,0,1
102489,London,0,0
102490,[,0,0
102491,n=26,0,0
102492,],0,0
102493,",",0,0
102494,Manchester,0,0
102495,[,0,0
102496,n=26,0,0
102497,],0,0
102498,",",0,0
102499,and,0,0
102500,Newcastle,0,1
102501,[,0,0
102502,n=25,0,0
102503,],0,0
102504,),0,0
102505,;,0,0
102506,and,0,0
102507,75,0,0
102508,to,0,0
102509,treatment,1,0
102510,as,1,0
102511,usual,1,1
102512,(,0,1
102513,London,0,0
102514,[,0,0
102515,n=26,0,0
102516,],0,0
102517,",",0,0
102518,Manchester,0,0
102519,[,0,0
102520,n=26,0,0
102521,],0,0
102522,",",0,0
102523,and,0,0
102524,Newcastle,0,1
102525,[,0,0
102526,n=23,0,0
102527,],0,0
102528,),0,0
102529,.,0,0
102530,At,0,0
102531,the,0,0
102532,13-month,0,0
102533,endpoint,0,0
102534,",",0,0
102535,the,0,0
102536,severity,0,0
102537,of,0,0
102538,symptoms,0,0
102539,was,0,0
102540,reduced,0,0
102541,by,0,0
102542,3.9,0,0
102543,points,0,0
102544,(,0,0
102545,SD,0,0
102546,4.7,0,0
102547,),0,0
102548,on,0,0
102549,the,0,0
102550,ADOS-G,0,0
102551,algorithm,0,0
102552,in,0,0
102553,the,0,0
102554,group,0,0
102555,assigned,0,0
102556,to,0,0
102557,PACT,0,0
102558,",",0,0
102559,and,0,0
102560,2.9,0,0
102561,(,0,0
102562,3.9,0,0
102563,),0,0
102564,in,0,0
102565,the,0,0
102566,group,0,0
102567,assigned,0,0
102568,to,0,0
102569,treatment,0,0
102570,as,0,0
102571,usual,0,0
102572,",",0,0
102573,representing,0,0
102574,a,0,0
102575,between-group,0,0
102576,effect,0,0
102577,size,0,0
102578,of,0,0
102579,-0.24,0,0
102580,(,0,0
102581,95,0,0
102582,%,0,0
102583,CI,0,0
102584,-0.59,0,0
102585,to,0,0
102586,0.11,0,0
102587,),0,0
102588,",",0,0
102589,after,0,0
102590,adjustment,0,0
102591,for,0,0
102592,centre,0,0
102593,",",0,0
102594,sex,0,0
102595,",",0,0
102596,socioeconomic,0,0
102597,status,0,0
102598,",",0,0
102599,age,0,0
102600,",",0,0
102601,and,0,0
102602,verbal,0,0
102603,and,0,0
102604,non-verbal,0,0
102605,abilities,0,0
102606,.,0,0
102607,Treatment,0,0
102608,effect,0,0
102609,was,0,0
102610,positive,0,0
102611,for,0,0
102612,parental,0,0
102613,synchronous,0,0
102614,response,0,0
102615,to,0,0
102616,child,0,0
102617,(,0,0
102618,1.22,0,0
102619,",",0,0
102620,0.85,0,0
102621,to,0,0
102622,1.59,0,0
102623,),0,0
102624,",",0,0
102625,child,0,0
102626,initiations,0,0
102627,with,0,0
102628,parent,0,0
102629,(,0,0
102630,0.41,0,0
102631,",",0,0
102632,0.08,0,0
102633,to,0,0
102634,0.74,0,0
102635,),0,0
102636,",",0,0
102637,and,0,0
102638,for,0,0
102639,parent-child,0,0
102640,shared,0,0
102641,attention,0,0
102642,(,0,0
102643,0.33,0,0
102644,",",0,0
102645,-0.02,0,0
102646,to,0,0
102647,0.68,0,0
102648,),0,0
102649,.,0,0
102650,Effects,0,0
102651,on,0,0
102652,directly,0,0
102653,assessed,0,0
102654,language,0,0
102655,and,0,0
102656,adaptive,0,0
102657,functioning,0,0
102658,in,0,0
102659,school,0,0
102660,were,0,0
102661,small,0,0
102662,.,0,0
102663,INTERPRETATION,0,0
102664,On,0,0
102665,the,0,0
102666,basis,0,0
102667,of,0,0
102668,our,0,0
102669,findings,0,0
102670,",",0,0
102671,we,0,0
102672,can,0,0
102673,not,0,0
102674,recommend,0,0
102675,the,0,0
102676,addition,0,0
102677,of,0,0
102678,the,0,0
102679,PACT,1,0
102680,intervention,1,0
102681,to,0,0
102682,treatment,0,0
102683,as,0,0
102684,usual,0,0
102685,for,0,0
102686,the,0,0
102687,reduction,0,0
102688,of,0,0
102689,autism,0,0
102690,symptoms,0,1
102691,;,0,0
102692,however,0,0
102693,",",0,0
102694,a,0,0
102695,clear,0,0
102696,benefit,0,0
102697,was,0,0
102698,noted,0,0
102699,for,0,0
102700,parent-child,0,0
102701,dyadic,0,0
102702,social,0,0
102703,communication,0,0
102704,.,0,0
102705,FUNDING,0,0
102706,UK,0,1
102707,Medical,0,0
102708,Research,0,0
102709,Council,0,0
102710,",",0,0
102711,and,0,0
102712,UK,0,1
102713,Department,0,0
102714,for,0,0
102715,Children,0,0
102716,",",0,0
102717,Schools,0,0
102718,and,0,0
102719,Families,0,0
102720,.,0,0
102721,Ventilator-delivered,1,1
102722,mask,1,0
102723,ventilation,1,0
102724,compared,1,0
102725,with,1,0
102726,three,1,0
102727,standard,1,0
102728,methods,1,0
102729,of,1,0
102730,mask,1,0
102731,ventilation,1,0
102732,in,0,0
102733,a,0,0
102734,manikin,0,0
102735,model,0,0
102736,.,0,0
102737,BACKGROUND,0,0
102738,Little,0,0
102739,is,0,0
102740,known,0,0
102741,regarding,0,0
102742,the,0,0
102743,variations,0,0
102744,in,0,0
102745,effective,0,0
102746,ventilation,0,0
102747,during,0,0
102748,bag,1,0
102749,and,1,0
102750,mask,1,0
102751,resuscitation,1,0
102752,with,0,0
102753,standard,0,0
102754,methods,0,0
102755,compared,0,0
102756,with,0,0
102757,that,0,0
102758,delivered,0,0
102759,by,0,0
102760,ventilator-delivered,1,0
102761,mask,1,1
102762,ventilation,1,1
102763,(,1,1
102764,VDMV,1,1
102765,),1,1
102766,.,1,0
102767,AIM,0,0
102768,To,0,0
102769,measure,0,0
102770,the,0,0
102771,variations,0,0
102772,in,0,0
102773,delivered,0,0
102774,airway,0,0
102775,pressure,0,0
102776,",",0,0
102777,tidal,0,1
102778,volume,0,1
102779,(,0,1
102780,TV,0,1
102781,),0,1
102782,",",0,0
102783,minute,0,1
102784,ventilation,0,1
102785,(,0,1
102786,MV,0,1
102787,),0,1
102788,and,0,0
102789,inspiratory,0,0
102790,time,0,0
102791,during,0,0
102792,a,0,0
102793,3-min,0,0
102794,period,0,0
102795,of,0,0
102796,mask,0,0
102797,ventilation,0,0
102798,comparing,0,0
102799,VDMV,1,0
102800,with,0,0
102801,three,0,0
102802,commonly,0,0
102803,used,0,0
102804,hand-delivered,1,0
102805,methods,1,0
102806,of,1,0
102807,bag,1,0
102808,and,1,0
102809,mask,1,0
102810,ventilation,1,0
102811,:,1,0
102812,Laerdal,1,0
102813,self-inflating,1,1
102814,bag,1,1
102815,(,1,1
102816,SIB,1,1
102817,),1,1
102818,;,1,1
102819,anaesthetic,1,1
102820,bag,1,1
102821,and,1,0
102822,T-piece,1,0
102823,Neopuff,1,0
102824,.,1,0
102825,METHODS,0,0
102826,A,0,0
102827,modified,0,0
102828,resuscitation,0,0
102829,manikin,0,0
102830,was,0,0
102831,used,0,0
102832,to,0,0
102833,measure,0,0
102834,variation,0,0
102835,in,0,0
102836,mechanical,0,0
102837,ventilation,0,0
102838,during,0,0
102839,3-min,0,0
102840,periods,0,0
102841,of,0,0
102842,mask,1,0
102843,ventilation,1,0
102844,.,1,0
102845,Thirty-six,0,0
102846,experienced,0,0
102847,practitioners,0,0
102848,gave,0,0
102849,positive,0,0
102850,pressure,0,0
102851,mask,1,0
102852,ventilation,1,0
102853,targeting,0,0
102854,acceptable,0,0
102855,chest,0,0
102856,wall,0,0
102857,movement,0,0
102858,with,0,0
102859,a,0,0
102860,rate,0,0
102861,of,0,0
102862,60,0,0
102863,inflations/min,0,0
102864,and,0,0
102865,when,0,0
102866,pressures,0,0
102867,could,0,0
102868,be,0,0
102869,targeted,0,0
102870,or,0,0
102871,set,0,0
102872,",",0,0
102873,a,0,0
102874,peak,0,0
102875,inspiratory,0,0
102876,pressure,0,1
102877,(,0,1
102878,PIP,0,1
102879,),0,1
102880,of,0,0
102881,18,0,0
102882,cm,0,0
102883,water,0,0
102884,",",0,0
102885,positive,0,0
102886,end-expiratory,0,1
102887,pressure,0,1
102888,(,0,1
102889,PEEP,0,1
102890,),0,1
102891,of,0,0
102892,5,0,0
102893,cm,0,0
102894,water,0,0
102895,",",0,0
102896,for,0,0
102897,3,0,0
102898,min,0,0
102899,with,0,0
102900,each,0,0
102901,of,0,0
102902,the,0,0
102903,four,0,0
102904,mask,1,0
102905,ventilation,1,0
102906,methods,0,0
102907,.,0,0
102908,Each,0,0
102909,mode,0,0
102910,was,0,0
102911,randomly,0,0
102912,sequenced,0,0
102913,.,0,0
102914,RESULTS,0,0
102915,A,0,0
102916,total,0,0
102917,of,0,0
102918,21,0,0
102919,136,0,0
102920,inflations,0,0
102921,were,0,0
102922,recorded,0,0
102923,and,0,0
102924,analysed,0,0
102925,.,0,0
102926,VDMV,1,0
102927,achieved,0,0
102928,PIP,0,0
102929,and,0,0
102930,PEEP,0,0
102931,closest,0,0
102932,to,0,0
102933,that,0,0
102934,targeted,0,0
102935,and,0,0
102936,significantly,0,0
102937,lower,0,0
102938,variation,0,0
102939,in,0,0
102940,all,0,0
102941,measured,0,0
102942,parameters,0,0
102943,(,0,0
102944,p,0,0
102945,<,0,0
102946,0.001,0,0
102947,),0,0
102948,other,0,0
102949,than,0,0
102950,with,0,0
102951,PIP,0,0
102952,.,0,0
102953,SIB,0,0
102954,delivered,0,0
102955,TV,0,0
102956,and,0,0
102957,MV,0,1
102958,over,0,0
102959,twice,0,0
102960,that,0,0
102961,delivered,0,0
102962,by,0,0
102963,VDMV,1,0
102964,and,0,0
102965,Neopuff,1,0
102966,.,1,0
102967,CONCLUSION,0,0
102968,During,0,0
102969,3-min,0,0
102970,periods,0,0
102971,of,0,0
102972,mask,0,0
102973,ventilation,0,0
102974,on,0,0
102975,a,0,0
102976,manikin,0,0
102977,",",0,0
102978,VDMV,1,0
102979,produced,0,0
102980,the,0,0
102981,least,0,0
102982,variation,0,0
102983,in,0,0
102984,delivered,0,0
102985,ventilation,0,0
102986,.,0,0
102987,SIB,0,0
102988,produced,0,0
102989,wide,0,0
102990,variation,0,0
102991,and,0,0
102992,unacceptably,0,0
102993,high,0,0
102994,TV,0,0
102995,and,0,0
102996,MV,0,0
102997,in,0,0
102998,experienced,0,0
102999,hands,0,0
103000,.,0,0
103001,Hematologic,0,0
103002,patients,0,0
103003,',0,0
103004,clinical,0,0
103005,and,0,0
103006,psychosocial,0,0
103007,experiences,0,0
103008,with,0,0
103009,implanted,1,0
103010,long-term,1,0
103011,central,1,0
103012,venous,1,0
103013,catheter,1,0
103014,:,1,0
103015,self-management,0,0
103016,versus,0,0
103017,professionally,0,0
103018,controlled,0,0
103019,care,0,0
103020,.,0,0
103021,BACKGROUND,0,0
103022,A,0,0
103023,significant,0,0
103024,decrease,0,0
103025,in,0,0
103026,catheter-related,0,0
103027,infections,0,0
103028,was,0,0
103029,demonstrated,0,0
103030,in,0,0
103031,our,0,0
103032,earlier,0,0
103033,randomized,0,0
103034,controlled,0,0
103035,trial,0,0
103036,of,0,0
103037,central,0,0
103038,venous,0,0
103039,catheter,0,1
103040,(,0,1
103041,CVC,0,1
103042,),0,1
103043,care,0,0
103044,in,0,0
103045,hematologic,0,0
103046,patients,0,0
103047,.,0,0
103048,OBJECTIVE,0,0
103049,This,0,0
103050,article,0,0
103051,focuses,0,0
103052,on,0,0
103053,patients,0,0
103054,',0,0
103055,clinical,0,0
103056,and,0,0
103057,psychosocial,0,0
103058,experiences,0,0
103059,with,0,0
103060,CVC,1,0
103061,self-care,1,0
103062,compared,0,0
103063,with,0,0
103064,professionally,1,0
103065,controlled,1,0
103066,CVC,1,0
103067,care,1,0
103068,.,1,0
103069,METHODS,0,0
103070,Eighty-two,0,0
103071,patients,0,0
103072,with,0,0
103073,tunneled,0,0
103074,CVCs,0,0
103075,were,0,0
103076,enrolled,0,0
103077,in,0,0
103078,the,0,0
103079,randomized,0,0
103080,controlled,0,0
103081,trial,0,0
103082,.,0,0
103083,The,0,0
103084,intervention,0,0
103085,group,0,0
103086,(,0,0
103087,n,0,0
103088,=,0,0
103089,42,0,0
103090,),0,0
103091,was,0,0
103092,trained,0,0
103093,to,0,0
103094,perform,0,0
103095,CVC,1,0
103096,self-care,1,0
103097,.,1,0
103098,The,0,0
103099,control,0,0
103100,group,0,0
103101,(,0,0
103102,n,0,0
103103,=,0,0
103104,40,0,0
103105,),0,0
103106,followed,0,0
103107,standard,1,0
103108,CVC,1,1
103109,procedure,1,0
103110,provided,1,0
103111,by,1,0
103112,nurses,1,0
103113,.,1,0
103114,Eighteen,0,0
103115,patients,0,0
103116,were,0,0
103117,selected,0,0
103118,for,0,0
103119,semistructured,0,0
103120,interviews,0,0
103121,focusing,0,0
103122,on,0,0
103123,patients,0,0
103124,',0,0
103125,clinical,0,0
103126,and,0,0
103127,psychosocial,0,0
103128,experiences,0,0
103129,with,0,0
103130,CVCs,0,0
103131,.,0,0
103132,RESULTS,0,0
103133,Methods,0,0
103134,of,0,0
103135,CVC,0,0
103136,care,0,0
103137,have,0,0
103138,different,0,0
103139,influences,0,0
103140,on,0,0
103141,the,0,0
103142,patients,0,0
103143,',0,0
103144,clinical,0,0
103145,and,0,0
103146,psychosocial,0,0
103147,outcomes,0,0
103148,",",0,0
103149,depending,0,0
103150,on,0,0
103151,whether,0,0
103152,they,0,0
103153,were,0,0
103154,hospitalized,0,0
103155,or,0,0
103156,outpatients,0,0
103157,.,0,0
103158,Central,1,0
103159,venous,1,0
103160,catheter,1,0
103161,was,0,0
103162,viewed,0,0
103163,as,0,0
103164,important,0,0
103165,because,0,0
103166,it,0,0
103167,was,0,0
103168,the,0,0
103169,main,0,0
103170,port,0,0
103171,of,0,0
103172,treatment,0,0
103173,toward,0,0
103174,a,0,0
103175,cure,0,0
103176,",",0,0
103177,although,0,0
103178,patients,0,0
103179,constantly,0,0
103180,fear,0,0
103181,complications,0,0
103182,.,0,0
103183,Central,1,0
103184,venous,1,0
103185,catheter,1,0
103186,self-care,1,0
103187,increased,0,0
103188,patients,0,0
103189,',0,0
103190,independence,0,0
103191,from,0,0
103192,health,0,0
103193,professionals,0,0
103194,and,0,0
103195,supported,0,0
103196,perceived,0,0
103197,self-efficacy,0,0
103198,and,0,0
103199,control,0,0
103200,.,0,0
103201,Central,0,0
103202,venous,0,0
103203,catheters,0,0
103204,cause,0,0
103205,psychosocial,0,0
103206,problems,0,0
103207,including,0,0
103208,altered,0,0
103209,body,0,0
103210,perception,0,0
103211,",",0,0
103212,sexual,0,0
103213,activity,0,0
103214,avoidance,0,0
103215,",",0,0
103216,and,0,0
103217,feeling,0,0
103218,stigmatized,0,0
103219,.,0,0
103220,CONCLUSIONS,0,0
103221,Patients,0,0
103222,experience,0,0
103223,increased,0,0
103224,perceived,0,0
103225,self-control,0,0
103226,and,0,0
103227,independence,0,0
103228,when,0,0
103229,individually,0,0
103230,supervised,0,0
103231,and,0,0
103232,trained,0,0
103233,in,0,0
103234,CVC,1,0
103235,self-management,1,0
103236,.,1,0
103237,Assuming,0,0
103238,ownership,0,0
103239,of,0,0
103240,CVC,0,0
103241,care,0,0
103242,can,0,0
103243,encourage,0,0
103244,patients,0,0
103245,to,0,0
103246,feel,0,0
103247,less,0,0
103248,inhibited,0,0
103249,about,0,0
103250,sexual,0,0
103251,activity,0,0
103252,and,0,0
103253,socialization,0,0
103254,.,0,0
103255,IMPLICATIONS,0,0
103256,FOR,0,1
103257,PRACTICE,0,1
103258,Placement,0,0
103259,of,0,0
103260,a,0,0
103261,tunneled,0,0
103262,CVC,0,0
103263,should,0,0
103264,engage,0,0
103265,nurses,0,0
103266,to,0,0
103267,organize,0,0
103268,individualized,0,0
103269,structured,0,0
103270,and,0,0
103271,supervised,0,0
103272,patient,0,0
103273,education,0,0
103274,.,0,0
103275,Stigma,0,0
103276,originating,0,0
103277,from,0,0
103278,CVCs,0,0
103279,should,0,0
103280,be,0,0
103281,carefully,0,0
103282,considered,0,0
103283,by,0,0
103284,health,0,0
103285,professionals,0,0
103286,when,0,0
103287,maintaining,0,0
103288,CVC,0,0
103289,insertion,0,0
103290,for,0,0
103291,longer,0,0
103292,periods,0,0
103293,.,0,0
103294,Central,0,0
103295,venous,0,0
103296,catheters,0,0
103297,should,0,0
103298,be,0,0
103299,removed,0,0
103300,whenever,0,0
103301,the,0,0
103302,potential,0,0
103303,risks,0,0
103304,exceed,0,0
103305,the,0,0
103306,catheter,0,0
103307,'s,0,0
103308,functional,0,0
103309,necessity,0,0
103310,.,0,0
103311,Losartan,1,1
103312,vs.,1,1
103313,amlodipine,1,1
103314,treatment,0,0
103315,in,0,0
103316,elderly,0,0
103317,oncologic,0,0
103318,hypertensive,0,0
103319,patients,0,0
103320,:,0,0
103321,a,0,0
103322,randomized,0,0
103323,clinical,0,0
103324,trial,0,0
103325,.,0,0
103326,Elderly,0,0
103327,neoplastic,0,0
103328,patients,0,0
103329,frequently,0,0
103330,may,0,0
103331,show,0,0
103332,hypertension,0,0
103333,and,0,0
103334,hyperuricemia,0,0
103335,",",0,0
103336,before,0,0
103337,and,0,0
103338,after,0,0
103339,chemotherapeutic,0,1
103340,treatments,0,1
103341,.,0,0
103342,The,0,0
103343,purpose,0,0
103344,of,0,0
103345,this,0,0
103346,study,0,0
103347,was,0,0
103348,to,0,0
103349,evaluate,0,0
103350,the,0,0
103351,efficacy,0,0
103352,of,0,0
103353,losartan,1,1
103354,which,0,0
103355,is,0,0
103356,an,0,0
103357,antihypertensive,1,1
103358,drug,1,1
103359,with,0,1
103360,uricosuric,1,1
103361,properties,0,0
103362,vs.,0,0
103363,amlodipine,1,1
103364,in,0,0
103365,hypertensive,0,0
103366,neoplastic,0,0
103367,elderly,0,0
103368,patients,0,0
103369,.,0,0
103370,This,0,0
103371,was,0,0
103372,an,0,0
103373,open-labeled,0,1
103374,",",0,1
103375,randomized,0,1
103376,",",0,0
103377,comparative,0,0
103378,trial,0,0
103379,.,0,0
103380,The,0,0
103381,study,0,0
103382,was,0,0
103383,performed,0,0
103384,as,0,0
103385,a,0,0
103386,30-day,0,0
103387,study,0,0
103388,.,0,0
103389,Seventy,0,0
103390,patients,0,0
103391,with,0,0
103392,cancer,0,0
103393,were,0,0
103394,randomly,0,0
103395,assigned,0,0
103396,to,0,0
103397,receive,0,1
103398,losartan,1,1
103399,or,1,1
103400,amlodipine,1,1
103401,.,1,1
103402,Blood,0,1
103403,pressure,0,1
103404,(,0,1
103405,BP,0,1
103406,),0,1
103407,",",0,0
103408,blood,0,1
103409,urea,0,1
103410,nitrogen,0,1
103411,(,0,1
103412,BUN,0,1
103413,),0,0
103414,levels,0,0
103415,",",0,0
103416,creatinine,0,1
103417,",",0,1
103418,serum,0,1
103419,and,0,1
103420,urinary,0,1
103421,uric,0,1
103422,acid,0,1
103423,",",0,1
103424,creatinine,0,1
103425,and,0,1
103426,uric,0,1
103427,acid,0,1
103428,clearance,0,1
103429,were,0,0
103430,determined,0,0
103431,before,0,0
103432,and,0,0
103433,after,0,0
103434,chemotherapy,1,0
103435,.,1,0
103436,One,0,0
103437,day,0,0
103438,after,0,0
103439,chemotherapy,0,0
103440,in,0,0
103441,losartan,1,1
103442,group,0,0
103443,vs.,0,0
103444,amlodipine,1,1
103445,group,0,0
103446,we,0,0
103447,observed,0,0
103448,a,0,0
103449,significant,0,0
103450,difference,0,0
103451,in,0,0
103452,urinary,0,1
103453,uric,0,1
103454,acid,0,1
103455,(,0,0
103456,p,0,0
103457,<,0,0
103458,0.001,0,0
103459,),0,0
103460,of,0,0
103461,18,0,1
103462,mg/24,0,1
103463,h,0,0
103464,vs.,0,0
103465,40,0,0
103466,mg/24,0,1
103467,h.,0,1
103468,Thirty,0,1
103469,days,0,0
103470,after,0,0
103471,chemotherapy,1,0
103472,we,0,0
103473,observed,0,0
103474,a,0,0
103475,significant,0,0
103476,difference,0,0
103477,in,0,0
103478,azotemia,0,0
103479,of,0,0
103480,0.0,0,0
103481,mg/dl,0,0
103482,vs.,0,0
103483,3.8,0,0
103484,mg/dl,0,0
103485,(,0,0
103486,p,0,0
103487,<,0,0
103488,0.001,0,0
103489,),0,0
103490,",",0,0
103491,serum,0,1
103492,uric,0,1
103493,acid,0,1
103494,of,0,0
103495,0.05,0,0
103496,mg/dl,0,0
103497,vs.,0,0
103498,0.49,0,0
103499,mg/dl,0,0
103500,(,0,0
103501,p,0,0
103502,<,0,0
103503,0.001,0,0
103504,),0,0
103505,",",0,0
103506,urinary,0,1
103507,uric,0,1
103508,acid,0,1
103509,(,0,0
103510,p,0,0
103511,<,0,0
103512,0.001,0,0
103513,),0,0
103514,of,0,0
103515,23,0,0
103516,mg/24,0,0
103517,h,0,0
103518,vs.,0,0
103519,0.0,0,0
103520,mg/24,0,0
103521,h,0,0
103522,",",0,0
103523,GFR,0,1
103524,of,0,0
103525,2,0,0
103526,ml/min/1.73,0,0
103527,m,0,0
103528,(,0,0
103529,2,0,0
103530,),0,0
103531,vs.,0,0
103532,-8,0,0
103533,ml/min/1.73,0,0
103534,m,0,0
103535,(,0,0
103536,2,0,1
103537,),0,0
103538,(,0,0
103539,p,0,0
103540,<,0,0
103541,0.05,0,0
103542,),0,0
103543,and,0,0
103544,systolic,0,1
103545,BP,0,1
103546,(,0,1
103547,SBP,0,1
103548,),0,0
103549,of,0,0
103550,3.6,0,0
103551,mmHg,0,0
103552,vs.,0,0
103553,0.8,0,0
103554,mmHg,0,0
103555,(,0,0
103556,p,0,0
103557,<,0,0
103558,0.05,0,0
103559,),0,0
103560,.,0,0
103561,The,0,0
103562,findings,0,0
103563,of,0,0
103564,the,0,0
103565,present,0,0
103566,study,0,0
103567,support,0,0
103568,the,0,0
103569,effective,0,0
103570,role,0,0
103571,of,0,0
103572,losartan,1,1
103573,compared,0,0
103574,to,0,0
103575,amlodipine,1,1
103576,in,0,0
103577,treating,0,0
103578,hypertension,0,0
103579,and,0,0
103580,hyperuricemia,0,0
103581,in,0,0
103582,elderly,0,0
103583,patients,0,0
103584,under,0,0
103585,chemotherapeutic,0,1
103586,treatment,0,0
103587,.,0,0
103588,Comorbidity,0,0
103589,",",0,0
103590,age,0,0
103591,and,0,0
103592,overall,0,0
103593,survival,0,0
103594,in,0,0
103595,cetuximab-treated,1,0
103596,patients,0,0
103597,with,0,0
103598,advanced,0,0
103599,colorectal,0,1
103600,cancer,0,1
103601,(,0,1
103602,ACRC,0,1
103603,),0,1
103604,--,0,0
103605,results,0,0
103606,from,0,0
103607,NCIC,0,0
103608,CTG,0,0
103609,CO.17,0,0
103610,:,0,0
103611,a,0,0
103612,phase,0,0
103613,III,0,0
103614,trial,0,0
103615,of,0,0
103616,cetuximab,1,1
103617,versus,0,0
103618,best,1,0
103619,supportive,1,0
103620,care,1,0
103621,.,1,0
103622,BACKGROUND,0,0
103623,the,0,0
103624,interplay,0,0
103625,between,0,0
103626,comorbidity,0,0
103627,",",0,0
103628,age,0,0
103629,and,0,0
103630,performance,0,0
103631,status,0,1
103632,(,0,1
103633,PS,0,0
103634,),0,0
103635,as,0,0
103636,predictors,0,0
103637,of,0,0
103638,outcome,0,0
103639,in,0,0
103640,advanced,0,0
103641,colorectal,0,1
103642,cancer,0,1
103643,(,0,1
103644,ACRC,0,1
103645,),0,0
103646,is,0,0
103647,poorly,0,0
103648,understood,0,0
103649,.,0,0
103650,We,0,0
103651,examined,0,0
103652,these,0,0
103653,factors,0,0
103654,as,0,0
103655,predictors,0,0
103656,of,0,0
103657,treatment,0,0
103658,toxicity,0,0
103659,and,0,0
103660,outcome,0,0
103661,in,0,0
103662,cetuximab-treated,1,0
103663,patients,0,0
103664,with,0,0
103665,ACRC,0,0
103666,.,0,0
103667,PATIENTS,0,0
103668,AND,0,1
103669,METHODS,0,1
103670,comorbidity,0,0
103671,was,0,0
103672,independently,0,0
103673,evaluated,0,0
103674,using,0,0
103675,the,0,0
103676,Charlson,0,0
103677,Comorbidity,0,1
103678,Index,0,1
103679,(,0,1
103680,CCI,0,1
103681,),0,1
103682,",",0,0
103683,a,0,0
103684,validated,0,0
103685,measure,0,0
103686,of,0,0
103687,comorbidity,0,0
103688,based,0,0
103689,on,0,0
103690,the,0,0
103691,presence,0,0
103692,of,0,0
103693,medical,0,0
103694,conditions,0,0
103695,weighted,0,0
103696,according,0,0
103697,to,0,0
103698,their,0,0
103699,effect,0,0
103700,on,0,0
103701,mortality,0,0
103702,.,0,0
103703,CCI,0,0
103704,score,0,0
103705,was,0,0
103706,correlated,0,0
103707,with,0,0
103708,clinical,0,0
103709,and,0,0
103710,outcome,0,0
103711,data,0,0
103712,.,0,0
103713,RESULTS,0,0
103714,five,0,0
103715,hundred,0,0
103716,and,0,0
103717,seventy-two,0,0
103718,patients,0,0
103719,were,0,0
103720,included,0,0
103721,;,0,0
103722,41,0,0
103723,%,0,0
103724,were,0,0
103725,?,0,0
103726,65,0,0
103727,years,0,0
103728,and,0,0
103729,25,0,0
103730,%,0,0
103731,had,0,0
103732,comorbidities,0,0
103733,at,0,0
103734,randomization,0,0
103735,.,0,0
103736,In,0,0
103737,multivariate,0,0
103738,analysis,0,0
103739,(,0,1
103740,MVA,0,1
103741,),0,0
103742,of,0,0
103743,all,0,0
103744,covariates,0,0
103745,",",0,0
103746,only,0,0
103747,older,0,0
103748,age,0,0
103749,was,0,0
103750,associated,0,0
103751,with,0,0
103752,greater,0,0
103753,comorbidity,0,0
103754,(,0,0
103755,P,0,0
103756,=,0,0
103757,0.008,0,0
103758,),0,0
103759,.,0,0
103760,Overall,0,0
103761,survival,0,1
103762,(,0,1
103763,OS,0,1
103764,),0,0
103765,was,0,0
103766,significantly,0,0
103767,better,0,0
103768,for,0,0
103769,patients,0,0
103770,with,0,0
103771,greater,0,0
103772,comorbidity,0,0
103773,in,0,0
103774,univariate,0,0
103775,analysis,0,0
103776,(,0,0
103777,P,0,0
103778,=,0,0
103779,0.047,0,0
103780,),0,0
103781,.,0,0
103782,Conversely,0,0
103783,",",0,0
103784,better,0,0
103785,PS,0,0
103786,was,0,0
103787,associated,0,0
103788,with,0,0
103789,better,0,0
103790,OS,0,0
103791,in,0,0
103792,MVA,0,1
103793,(,0,1
103794,hazard,0,0
103795,ratio,0,0
103796,1.92,0,0
103797,for,0,0
103798,PS,0,0
103799,=,0,0
103800,2,0,0
103801,versus,0,0
103802,PS,0,0
103803,=,0,0
103804,0,0,0
103805,",",0,0
103806,P,0,0
103807,<,0,0
103808,0.0001,0,0
103809,),0,0
103810,.,0,0
103811,Age,0,0
103812,was,0,0
103813,not,0,0
103814,associated,0,0
103815,with,0,0
103816,OS,0,0
103817,(,0,0
103818,P,0,0
103819,=,0,0
103820,0.13,0,0
103821,),0,0
103822,.,0,0
103823,Elderly,0,0
103824,patients,0,0
103825,had,0,0
103826,significantly,0,0
103827,less,0,0
103828,grade,0,0
103829,?,0,0
103830,3,0,1
103831,vomiting,0,0
103832,(,0,0
103833,P,0,0
103834,=,0,0
103835,0.034,0,0
103836,),0,0
103837,but,0,0
103838,more,0,0
103839,dyspnea,0,0
103840,(,0,0
103841,P,0,0
103842,=,0,0
103843,0.005,0,0
103844,),0,0
103845,.,0,0
103846,Patients,0,0
103847,with,0,0
103848,greater,0,0
103849,comorbidity,0,0
103850,had,0,0
103851,significantly,0,0
103852,less,0,0
103853,grade,0,0
103854,?,0,0
103855,3,0,1
103856,vomiting,0,0
103857,(,0,0
103858,P,0,0
103859,=,0,0
103860,0.002,0,0
103861,),0,0
103862,but,0,0
103863,more,0,0
103864,non-neutropenic,0,0
103865,fever,0,0
103866,(,0,0
103867,P,0,0
103868,=,0,0
103869,0.005,0,0
103870,),0,0
103871,.,0,0
103872,CONCLUSION,0,0
103873,better,0,0
103874,PS,0,0
103875,was,0,0
103876,associated,0,0
103877,with,0,0
103878,improved,0,0
103879,OS,0,0
103880,.,0,0
103881,For,0,0
103882,patients,0,0
103883,with,0,0
103884,good,0,0
103885,PS,0,0
103886,",",0,0
103887,restricting,1,0
103888,cetuximab,1,1
103889,use,1,0
103890,in,1,0
103891,the,0,0
103892,setting,0,0
103893,of,0,0
103894,significant,0,0
103895,comorbidity,0,0
103896,does,0,0
103897,not,0,0
103898,appear,0,0
103899,justified,0,0
103900,.,0,0
103901,Types,0,0
103902,of,0,0
103903,parent,1,0
103904,verbal,1,0
103905,responsiveness,1,0
103906,that,0,0
103907,predict,0,0
103908,language,0,0
103909,in,0,0
103910,young,0,0
103911,children,0,0
103912,with,0,0
103913,autism,0,0
103914,spectrum,0,0
103915,disorder,0,0
103916,.,0,0
103917,PURPOSE,0,0
103918,This,0,0
103919,study,0,0
103920,examined,0,0
103921,short-term,0,0
103922,predictive,0,0
103923,associations,0,0
103924,between,0,0
103925,5,0,0
103926,different,0,0
103927,types,0,0
103928,of,0,0
103929,parent,1,0
103930,verbal,1,0
103931,responsiveness,1,0
103932,and,0,0
103933,later,0,0
103934,spoken,0,0
103935,vocabulary,0,0
103936,for,0,0
103937,32,0,0
103938,young,0,0
103939,children,0,0
103940,with,0,0
103941,a,0,0
103942,confirmed,0,0
103943,diagnosis,0,0
103944,of,0,0
103945,autism,0,0
103946,spectrum,0,0
103947,disorder,0,1
103948,(,0,1
103949,ASD,0,1
103950,),0,1
103951,.,0,0
103952,METHOD,0,0
103953,Parent,1,0
103954,verbal,1,0
103955,utterances,1,0
103956,were,0,0
103957,coded,0,0
103958,from,0,0
103959,videotapes,1,0
103960,of,1,0
103961,naturalistic,1,0
103962,parent-child,1,0
103963,play,1,0
103964,sessions,1,0
103965,using,0,0
103966,interval,1,0
103967,and,0,0
103968,event-based,1,0
103969,coding,1,0
103970,.,1,0
103971,A,0,0
103972,vocabulary,0,0
103973,difference,0,0
103974,score,0,0
103975,",",0,0
103976,calculated,0,0
103977,using,0,0
103978,the,0,0
103979,MacArthur,0,0
103980,Communicative,0,0
103981,Development,0,0
103982,Inventories,0,1
103983,(,0,0
103984,L.,0,1
103985,Fenson,0,1
103986,et,0,1
103987,al.,0,0
103988,",",0,0
103989,1993,0,1
103990,),0,0
103991,",",0,0
103992,was,0,0
103993,used,0,0
103994,as,0,0
103995,the,0,0
103996,outcome,0,0
103997,measure,0,0
103998,of,0,0
103999,spoken,0,0
104000,vocabulary,0,0
104001,6,0,0
104002,months,0,0
104003,later,0,0
104004,.,0,0
104005,RESULTS,0,0
104006,Parent,0,0
104007,follow-in,0,0
104008,comments,0,0
104009,and,0,0
104010,follow-in,0,0
104011,directives,0,0
104012,predicted,0,0
104013,spoken,0,0
104014,vocabulary,0,0
104015,after,0,0
104016,controlling,0,0
104017,for,0,0
104018,child,0,0
104019,engagement,0,0
104020,.,0,0
104021,Parent,0,0
104022,expansions,0,0
104023,of,0,0
104024,child,0,0
104025,verbal,0,0
104026,utterances,0,0
104027,predicted,0,0
104028,spoken,0,0
104029,vocabulary,0,0
104030,after,0,0
104031,controlling,0,0
104032,for,0,0
104033,child,0,0
104034,talkativeness,0,0
104035,.,0,0
104036,When,0,0
104037,entered,0,0
104038,together,0,0
104039,into,0,0
104040,a,0,0
104041,regression,0,0
104042,analysis,0,0
104043,",",0,0
104044,metrics,0,0
104045,that,0,0
104046,represented,0,0
104047,(,0,0
104048,a,0,0
104049,),0,0
104050,the,0,0
104051,number,0,0
104052,of,0,0
104053,parent,1,0
104054,utterances,1,0
104055,following,0,0
104056,into,0,0
104057,the,0,0
104058,child,0,0
104059,'s,0,0
104060,focus,0,0
104061,of,0,0
104062,attention,0,0
104063,and,0,1
104064,(,0,1
104065,b,0,1
104066,),0,0
104067,the,0,0
104068,number,0,0
104069,of,0,0
104070,parent,1,0
104071,utterances,1,0
104072,responding,0,0
104073,to,0,0
104074,child,0,0
104075,verbal,0,0
104076,communication,0,0
104077,acts,0,0
104078,both,0,0
104079,accounted,0,0
104080,for,0,0
104081,unique,0,0
104082,variance,0,0
104083,in,0,0
104084,predicting,0,0
104085,change,0,0
104086,in,0,0
104087,spoken,0,0
104088,vocabulary,0,0
104089,from,0,0
104090,Time,0,0
104091,1,0,0
104092,to,0,0
104093,Time,0,0
104094,2,0,0
104095,.,0,0
104096,CONCLUSION,0,0
104097,Parent,1,0
104098,verbal,1,0
104099,utterances,1,0
104100,that,0,0
104101,follow,0,0
104102,into,0,0
104103,the,0,0
104104,child,0,0
104105,'s,0,0
104106,current,0,0
104107,focus,0,0
104108,of,0,0
104109,attention,0,0
104110,or,0,0
104111,respond,0,0
104112,to,0,0
104113,child,0,0
104114,verbal,0,0
104115,communication,0,0
104116,acts,0,0
104117,may,0,0
104118,facilitate,0,0
104119,the,0,0
104120,process,0,0
104121,of,0,0
104122,early,0,0
104123,vocabulary,0,0
104124,acquisition,0,0
104125,by,0,0
104126,mitigating,0,0
104127,the,0,0
104128,need,0,0
104129,for,0,0
104130,children,0,0
104131,with,0,0
104132,ASD,0,0
104133,to,0,0
104134,use,0,0
104135,attention-following,0,0
104136,as,0,0
104137,a,0,0
104138,word-learning,0,0
104139,strategy,0,0
104140,.,0,0
104141,[,0,1
104142,Assessment,0,1
104143,of,0,0
104144,natriuretic,1,1
104145,peptide,1,0
104146,indices,0,0
104147,and,0,0
104148,oxidative,1,0
104149,stress,0,0
104150,in,0,0
104151,patients,0,0
104152,with,0,0
104153,chronic,0,0
104154,heart,0,1
104155,failure,0,1
104156,],0,0
104157,.,0,0
104158,The,0,0
104159,authors,0,0
104160,have,0,0
104161,studied,0,0
104162,indices,0,0
104163,of,0,0
104164,natriuretic,1,1
104165,peptide,1,0
104166,and,0,0
104167,oxidative,1,0
104168,stress,1,0
104169,in,0,0
104170,patients,0,0
104171,with,0,0
104172,chronic,0,0
104173,heart,0,1
104174,failure,0,1
104175,(,0,1
104176,CHF,0,1
104177,),0,1
104178,.,0,0
104179,52,1,0
104180,male,1,0
104181,patients,1,0
104182,with,1,0
104183,postinfarction,1,0
104184,cardiosclerosis,1,1
104185,(,1,1
104186,PICS,1,1
104187,),1,1
104188,who,1,0
104189,have,1,0
104190,developed,1,0
104191,CHF,1,0
104192,have,1,0
104193,been,1,0
104194,observed,1,0
104195,.,1,0
104196,The,0,0
104197,age,0,0
104198,of,0,0
104199,the,0,0
104200,patients,0,0
104201,varied,0,0
104202,from,0,0
104203,38,0,0
104204,till,0,0
104205,60,0,0
104206,.,0,0
104207,It,0,0
104208,was,0,0
104209,established,0,0
104210,that,0,0
104211,CHF,0,0
104212,patients,0,0
104213,with,0,0
104214,progression,0,0
104215,of,0,0
104216,the,0,0
104217,disease,0,0
104218,had,0,0
104219,worsening,0,0
104220,of,0,0
104221,their,0,0
104222,clinical,0,0
104223,condition,0,0
104224,together,0,0
104225,with,0,0
104226,an,0,0
104227,increase,0,0
104228,of,0,0
104229,oxidative,0,0
104230,stress,0,0
104231,which,0,0
104232,was,0,0
104233,characterized,0,0
104234,through,0,0
104235,decrease,0,0
104236,of,0,0
104237,NO,0,1
104238,metabolites,0,1
104239,",",0,0
104240,NADPH,0,1
104241,--,0,0
104242,diaphorase,0,0
104243,(,0,0
104244,eNOS,0,1
104245,),0,1
104246,",",0,0
104247,increase,0,0
104248,of,0,0
104249,nitrite,0,1
104250,reductase,0,1
104251,(,0,1
104252,iNOS,0,1
104253,),0,1
104254,and,0,1
104255,peroxinitrite,0,1
104256,(,0,1
104257,ONOO,0,1
104258,),0,1
104259,",",0,0
104260,correlative,0,0
104261,increase,0,0
104262,the,0,0
104263,level,0,0
104264,of,0,0
104265,brain,0,0
104266,natriuretic,0,1
104267,peptide,0,0
104268,in,0,0
104269,blood,0,0
104270,plazma,0,0
104271,.,0,0
104272,Reliable,0,0
104273,connection,0,0
104274,between,0,0
104275,considerable,0,0
104276,increase,0,0
104277,of,0,0
104278,oxidative,0,0
104279,stress,0,0
104280,and,0,0
104281,the,0,0
104282,level,0,0
104283,of,0,0
104284,NT-pro,0,0
104285,BNP,0,0
104286,was,0,0
104287,noted,0,0
104288,in,0,0
104289,CHF,0,0
104290,patients,0,0
104291,",",0,0
104292,which,0,0
104293,demands,0,0
104294,necessity,0,0
104295,of,0,0
104296,correction,0,0
104297,of,0,0
104298,observed,0,0
104299,disorders,0,0
104300,.,0,0
104301,Physician-pharmacist,1,0
104302,cooperation,1,0
104303,program,1,0
104304,for,0,0
104305,blood,0,0
104306,pressure,0,0
104307,control,0,0
104308,in,0,0
104309,patients,0,0
104310,with,0,0
104311,hypertension,0,0
104312,:,0,0
104313,a,0,0
104314,randomized-controlled,0,0
104315,trial,0,0
104316,.,0,0
104317,BACKGROUND,0,0
104318,The,0,0
104319,aim,0,0
104320,of,0,0
104321,the,0,0
104322,trial,0,0
104323,was,0,0
104324,to,0,0
104325,evaluate,0,0
104326,the,0,0
104327,effectiveness,0,0
104328,of,0,0
104329,a,0,0
104330,program,0,0
104331,of,0,0
104332,cooperation,1,0
104333,between,1,0
104334,physician,1,0
104335,and,1,0
104336,pharmacist,1,0
104337,to,0,0
104338,reduce,0,0
104339,cardiovascular,0,0
104340,risk,0,0
104341,factors,0,0
104342,in,0,0
104343,patients,0,0
104344,with,0,0
104345,mild,0,0
104346,to,0,0
104347,moderate,0,0
104348,hypertension,0,0
104349,by,0,0
104350,promoting,0,0
104351,better,0,0
104352,blood,0,0
104353,pressure,0,1
104354,(,0,1
104355,BP,0,1
104356,),0,0
104357,control,0,0
104358,",",0,0
104359,appropriate,0,0
104360,changes,0,0
104361,in,0,0
104362,antihypertensive,0,1
104363,medications,0,1
104364,",",0,1
104365,and,0,0
104366,beneficial,0,0
104367,changes,0,0
104368,in,0,0
104369,lifestyle,0,0
104370,.,0,0
104371,METHODS,0,0
104372,The,0,0
104373,132,0,0
104374,subjects,0,0
104375,in,0,0
104376,this,0,0
104377,randomized,0,0
104378,",",0,0
104379,controlled,0,0
104380,trial,0,0
104381,were,0,0
104382,in,0,0
104383,the,0,0
104384,age,0,0
104385,range,0,0
104386,of,0,0
104387,40-79,0,0
104388,years,0,0
104389,.,0,0
104390,The,0,0
104391,inclusion,0,0
104392,criteria,0,0
104393,were,0,0
104394,:,0,0
104395,systolic,0,0
104396,BP,0,1
104397,(,0,1
104398,SBP,0,1
104399,),0,1
104400,ranging,0,0
104401,from,0,0
104402,140-179,0,0
104403,mm,0,0
104404,Hg,0,0
104405,and/or,0,0
104406,diastolic,0,1
104407,BP,0,1
104408,(,0,1
104409,DBP,0,1
104410,),0,1
104411,ranging,0,0
104412,from,0,0
104413,90-99,0,0
104414,mm,0,0
104415,Hg,0,0
104416,and,0,1
104417,treatment-naive,0,1
104418,(,0,0
104419,untreated,0,0
104420,for,0,0
104421,hypertension,0,1
104422,),0,1
104423,;,0,0
104424,or,0,0
104425,on,0,0
104426,a,0,0
104427,regimen,0,1
104428,of,0,0
104429,medication,0,0
104430,for,0,0
104431,hypertension,0,0
104432,.,0,0
104433,Of,0,0
104434,these,0,0
104435,132,0,0
104436,subjects,0,0
104437,",",0,0
104438,124,0,0
104439,(,0,0
104440,94,0,0
104441,%,0,0
104442,),0,0
104443,were,0,0
104444,already,0,0
104445,receiving,0,0
104446,treatment,0,0
104447,with,0,1
104448,antihypertensive,0,1
104449,medications,0,1
104450,.,0,1
104451,Equal,0,0
104452,numbers,0,0
104453,of,0,0
104454,subjects,0,0
104455,were,0,0
104456,randomly,0,0
104457,assigned,0,0
104458,to,0,0
104459,one,0,0
104460,of,0,0
104461,two,0,0
104462,groups,0,0
104463,:,0,0
104464,a,0,0
104465,physician-pharmacist,1,0
104466,intervention,1,1
104467,group,1,1
104468,(,0,0
104469,n,0,0
104470,=,0,0
104471,66,0,0
104472,),0,0
104473,and,0,0
104474,a,0,0
104475,control,1,0
104476,group,1,0
104477,(,0,0
104478,n,0,0
104479,=,0,0
104480,66,0,0
104481,),0,0
104482,.,0,0
104483,RESULTS,0,0
104484,The,0,0
104485,6-month,0,0
104486,follow-up,0,0
104487,rate,0,0
104488,was,0,0
104489,97,0,0
104490,%,0,0
104491,in,0,0
104492,both,0,0
104493,groups,0,0
104494,.,0,0
104495,At,0,0
104496,6,0,0
104497,months,0,0
104498,",",0,0
104499,the,0,0
104500,mean,0,0
104501,decrease,0,0
104502,in,0,0
104503,SBP/DBP,0,0
104504,",",0,0
104505,as,0,0
104506,measured,0,0
104507,at,0,0
104508,home,0,0
104509,in,0,0
104510,the,0,0
104511,morning,0,0
104512,",",0,0
104513,was,0,0
104514,2.9/3.3,0,0
104515,mm,0,0
104516,Hg,0,0
104517,in,0,0
104518,the,0,0
104519,intervention,0,0
104520,group,0,0
104521,relative,0,0
104522,to,0,0
104523,baseline,0,0
104524,(,0,0
104525,P,0,0
104526,=,0,0
104527,0.02,0,0
104528,and,0,0
104529,P,0,0
104530,<,0,0
104531,0.0001,0,0
104532,for,0,0
104533,SBP,0,0
104534,and,0,0
104535,DBP,0,0
104536,",",0,0
104537,respectively,0,0
104538,),0,0
104539,.,0,0
104540,The,0,0
104541,mean,0,0
104542,decrease,0,0
104543,in,0,0
104544,home,0,0
104545,morning,0,0
104546,SBP,0,0
104547,in,0,0
104548,the,0,0
104549,intervention,0,0
104550,group,0,0
104551,was,0,0
104552,not,0,0
104553,significantly,0,0
104554,greater,0,0
104555,than,0,0
104556,in,0,0
104557,the,0,0
104558,control,0,0
104559,group,0,0
104560,.,0,0
104561,However,0,0
104562,",",0,0
104563,the,0,0
104564,DBP,0,0
104565,decline,0,0
104566,was,0,0
104567,significantly,0,0
104568,greater,0,0
104569,in,0,0
104570,the,0,0
104571,intervention,0,0
104572,than,0,0
104573,control,0,0
104574,groups,0,0
104575,",",0,0
104576,which,0,0
104577,showed,0,0
104578,a,0,0
104579,mean,0,0
104580,decrease,0,0
104581,of,0,0
104582,2.8,0,0
104583,mm,0,0
104584,Hg,0,0
104585,(,0,0
104586,confidence,0,0
104587,interval,0,0
104588,:,0,0
104589,-5.5,0,0
104590,to,0,0
104591,-0.1,0,0
104592,;,0,0
104593,P,0,0
104594,=,0,0
104595,0.04,0,0
104596,),0,0
104597,.,0,0
104598,The,0,0
104599,percentage,0,0
104600,of,0,0
104601,patients,0,0
104602,in,0,0
104603,whom,0,0
104604,control,0,0
104605,of,0,0
104606,home,0,0
104607,morning,0,0
104608,BP,0,0
104609,was,0,0
104610,achieved,0,0
104611,was,0,0
104612,53,0,0
104613,%,0,0
104614,in,0,0
104615,the,0,0
104616,intervention,0,0
104617,group,0,0
104618,and,0,0
104619,47,0,0
104620,%,0,0
104621,in,0,0
104622,the,0,0
104623,control,0,0
104624,group,0,0
104625,(,0,0
104626,P,0,0
104627,=,0,0
104628,0.40,0,0
104629,),0,0
104630,.,0,0
104631,A,0,0
104632,higher,0,0
104633,percentage,0,0
104634,of,0,0
104635,patients,0,0
104636,in,0,0
104637,the,0,0
104638,intervention,0,0
104639,group,0,0
104640,",",0,0
104641,relative,0,0
104642,to,0,0
104643,the,0,0
104644,control,0,0
104645,group,0,0
104646,",",0,0
104647,were,0,0
104648,able,0,0
104649,to,0,0
104650,reduce,0,0
104651,the,0,0
104652,use,0,0
104653,of,0,0
104654,antihypertensive,0,1
104655,medications,0,1
104656,(,0,0
104657,31,0,0
104658,vs.,0,0
104659,8,0,0
104660,%,0,0
104661,",",0,0
104662,P,0,0
104663,<,0,0
104664,0.0001,0,0
104665,),0,0
104666,",",0,0
104667,and,0,0
104668,fewer,0,0
104669,patients,0,0
104670,in,0,0
104671,this,0,0
104672,group,0,0
104673,required,0,0
104674,additional,0,0
104675,medications,0,1
104676,or,0,0
104677,increases,0,0
104678,in,0,0
104679,dosage,0,1
104680,relative,0,0
104681,to,0,0
104682,the,0,0
104683,controls,0,0
104684,(,0,0
104685,11,0,0
104686,vs.,0,0
104687,28,0,0
104688,%,0,0
104689,",",0,0
104690,P,0,0
104691,=,0,0
104692,0.03,0,0
104693,),0,0
104694,.,0,0
104695,Patients,0,0
104696,of,0,0
104697,the,0,0
104698,intervention,0,0
104699,group,0,0
104700,were,0,0
104701,more,0,0
104702,likely,0,0
104703,to,0,0
104704,show,0,0
104705,reduction,0,0
104706,in,0,0
104707,body,0,0
104708,mass,0,0
104709,index,0,0
104710,and,0,1
104711,sodium,0,1
104712,intake,0,1
104713,and,0,1
104714,to,0,0
104715,stop,0,1
104716,smoking,0,0
104717,",",0,0
104718,as,0,0
104719,compared,0,0
104720,with,0,0
104721,the,0,0
104722,control,0,0
104723,group,0,0
104724,.,0,0
104725,CONCLUSIONS,0,0
104726,A,0,1
104727,program,0,0
104728,of,0,0
104729,cooperation,0,0
104730,between,0,0
104731,physician,0,0
104732,and,0,0
104733,pharmacist,0,0
104734,was,0,0
104735,successful,0,0
104736,in,0,0
104737,reducing,0,0
104738,cardiovascular,0,0
104739,risk,0,0
104740,factors,0,0
104741,in,0,0
104742,patients,0,0
104743,with,0,0
104744,mild,0,0
104745,to,0,0
104746,moderate,0,0
104747,hypertension,0,0
104748,by,0,0
104749,promoting,0,0
104750,better,0,0
104751,blood,0,0
104752,pressure,0,1
104753,(,0,1
104754,BP,0,1
104755,),0,0
104756,control,0,0
104757,",",0,0
104758,appropriate,0,0
104759,changes,0,0
104760,in,0,0
104761,antihypertensive,0,1
104762,medications,0,1
104763,",",0,1
104764,and,0,0
104765,beneficial,0,0
104766,changes,0,0
104767,in,0,0
104768,lifestyle,0,0
104769,.,0,0
104770,Reversal,0,0
104771,of,0,0
104772,skeletal,0,0
104773,effects,0,0
104774,of,0,0
104775,endocrine,1,0
104776,treatments,1,0
104777,in,0,0
104778,the,0,0
104779,Intergroup,0,1
104780,Exemestane,0,1
104781,Study,0,1
104782,.,0,1
104783,The,0,0
104784,adjuvant,0,1
104785,use,0,0
104786,of,0,1
104787,aromatase,1,1
104788,inhibitors,1,1
104789,in,0,1
104790,breast,0,0
104791,cancer,0,0
104792,is,0,0
104793,associated,0,0
104794,with,0,0
104795,adverse,0,0
104796,effects,0,0
104797,on,0,0
104798,bone,0,0
104799,health,0,0
104800,.,0,0
104801,We,0,0
104802,previously,0,0
104803,reported,0,0
104804,a,0,0
104805,decline,0,0
104806,in,0,0
104807,bone,0,0
104808,mineral,0,1
104809,density,0,0
104810,(,0,1
104811,BMD,0,1
104812,),0,0
104813,following,0,0
104814,the,0,0
104815,switch,0,0
104816,from,0,0
104817,tamoxifen,1,1
104818,to,0,1
104819,exemestane,1,1
104820,in,0,0
104821,the,0,0
104822,Intergroup,0,1
104823,Exemestane,0,1
104824,Study,0,1
104825,(,0,1
104826,IES,0,1
104827,),0,0
104828,.,0,0
104829,Here,0,0
104830,we,0,0
104831,report,0,0
104832,effects,0,0
104833,of,0,0
104834,endocrine,1,0
104835,treatment,1,0
104836,withdrawal,0,0
104837,on,0,0
104838,BMD,0,0
104839,",",0,0
104840,bone,0,0
104841,turnover,0,0
104842,markers,0,0
104843,(,0,0
104844,BTM,0,1
104845,),0,1
104846,and,0,0
104847,fracture,0,0
104848,rates,0,0
104849,.,0,0
104850,"4,724",0,0
104851,patients,0,0
104852,took,0,0
104853,part,0,0
104854,in,0,0
104855,IES,0,0
104856,",",0,0
104857,and,0,0
104858,206,0,0
104859,patients,0,0
104860,were,0,0
104861,included,0,0
104862,in,0,0
104863,a,0,0
104864,bone,0,0
104865,sub-study,0,0
104866,.,0,0
104867,BMD,0,0
104868,and,0,0
104869,BTM,0,0
104870,were,0,0
104871,assessed,0,0
104872,pre-randomization,0,0
104873,",",0,0
104874,during,0,0
104875,and,0,0
104876,after,0,0
104877,the,0,0
104878,end,0,0
104879,of,0,0
104880,treatment,0,0
104881,(,0,1
104882,EOT,0,1
104883,),0,1
104884,.,0,0
104885,To,0,0
104886,evaluate,0,0
104887,treatment,0,0
104888,withdrawal,0,0
104889,effects,0,0
104890,",",0,0
104891,12-,0,0
104892,and,0,0
104893,24-month,0,1
104894,post,0,0
104895,EOT,0,0
104896,BMD,0,0
104897,results,0,0
104898,are,0,0
104899,available,0,0
104900,for,0,0
104901,122,0,0
104902,and,0,0
104903,126,0,0
104904,patients,0,0
104905,",",0,0
104906,respectively,0,0
104907,.,0,0
104908,Similar,0,0
104909,patient,0,0
104910,numbers,0,0
104911,had,0,0
104912,BTM,0,0
104913,measured,0,0
104914,post,0,0
104915,EOT,0,0
104916,.,0,0
104917,Following,0,0
104918,treatment,0,0
104919,withdrawal,0,0
104920,",",0,0
104921,the,0,0
104922,differences,0,0
104923,in,0,0
104924,BMD,0,0
104925,observed,0,0
104926,between,0,0
104927,the,0,0
104928,two,0,0
104929,endocrine,0,0
104930,strategies,0,0
104931,were,0,0
104932,partially,0,0
104933,reversed,0,0
104934,.,0,0
104935,At,0,0
104936,24,0,0
104937,months,0,0
104938,from,0,0
104939,EOT,0,0
104940,",",0,0
104941,spine,0,0
104942,BMD,0,0
104943,increased,0,0
104944,by,0,0
104945,1.53,0,0
104946,%,0,0
104947,(,0,0
104948,95,0,0
104949,%,0,0
104950,CI,0,0
104951,0.63-2.43,0,0
104952,;,0,0
104953,p,0,0
104954,=,0,0
104955,0.001,0,0
104956,),0,0
104957,after,0,0
104958,stopping,0,1
104959,exemestane,0,1
104960,and,0,0
104961,fell,0,0
104962,by,0,0
104963,1.93,0,0
104964,%,0,0
104965,(,0,0
104966,95,0,0
104967,%,0,0
104968,CI,0,0
104969,-2.91,0,0
104970,to,0,0
104971,0.95,0,0
104972,;,0,0
104973,p,0,0
104974,=,0,0
104975,0.0002,0,0
104976,),0,0
104977,following,0,0
104978,tamoxifen,1,1
104979,withdrawal,0,1
104980,.,0,0
104981,A,0,0
104982,similar,0,0
104983,pattern,0,0
104984,of,0,0
104985,changes,0,0
104986,was,0,0
104987,observed,0,0
104988,at,0,0
104989,the,0,0
104990,hip,0,0
104991,.,0,0
104992,At,0,0
104993,2,0,0
104994,years,0,0
104995,post,0,0
104996,EOT,0,0
104997,",",0,0
104998,BMD,0,0
104999,changes,0,0
105000,from,0,0
105001,baseline,0,0
105002,were,0,0
105003,similar,0,0
105004,with,0,0
105005,both,0,0
105006,treatment,0,0
105007,strategies,0,0
105008,.,0,0
105009,Corresponding,0,0
105010,inverse,0,0
105011,changes,0,0
105012,in,0,0
105013,BTM,0,0
105014,were,0,0
105015,seen,0,0
105016,",",0,0
105017,with,0,0
105018,an,0,0
105019,increase,0,0
105020,following,0,0
105021,tamoxifen,0,1
105022,withdrawal,0,1
105023,and,0,0
105024,a,0,0
105025,reduction,0,0
105026,after,0,0
105027,exemestane,0,1
105028,.,0,0
105029,A,0,0
105030,higher,0,0
105031,number,0,0
105032,of,0,0
105033,fractures,0,0
105034,occurred,0,0
105035,during,0,0
105036,exemestane,1,1
105037,treatment,0,0
105038,",",0,0
105039,but,0,0
105040,fracture,0,0
105041,rates,0,0
105042,were,0,0
105043,similar,0,0
105044,after,0,0
105045,treatment,0,0
105046,withdrawal,0,0
105047,.,0,0
105048,With,0,0
105049,the,0,0
105050,switch,0,0
105051,strategy,0,0
105052,used,0,0
105053,in,0,0
105054,IES,0,0
105055,",",0,0
105056,the,0,0
105057,on,0,0
105058,treatment,0,0
105059,adverse,0,0
105060,bone,0,0
105061,effects,0,0
105062,of,0,0
105063,exemestane,1,1
105064,are,0,0
105065,reversed,0,0
105066,.,0,0
105067,Ongoing,0,0
105068,monitoring,0,0
105069,of,0,0
105070,BMD,0,0
105071,is,0,0
105072,therefore,0,0
105073,not,0,0
105074,routinely,0,0
105075,required,0,0
105076,.,0,0
105077,Randomized,0,0
105078,controlled,0,0
105079,trial,0,0
105080,of,0,0
105081,electro-acupuncture,1,0
105082,for,0,0
105083,autism,0,0
105084,spectrum,0,0
105085,disorder,0,0
105086,.,0,0
105087,OBJECTIVE,0,0
105088,To,0,0
105089,study,0,0
105090,the,0,0
105091,efficacy,0,0
105092,",",0,0
105093,safety,0,0
105094,",",0,0
105095,and,0,0
105096,compliance,0,0
105097,of,0,0
105098,short-term,0,0
105099,electro-acupuncture,1,0
105100,for,0,0
105101,children,0,0
105102,with,0,0
105103,autism,0,0
105104,spectrum,0,0
105105,disorder,0,1
105106,(,0,1
105107,ASD,0,1
105108,),0,1
105109,.,0,0
105110,DESIGN,0,0
105111,Randomized,0,1
105112,",",0,0
105113,double-blind,0,1
105114,",",0,1
105115,sham-controlled,0,1
105116,",",0,0
105117,clinical,0,0
105118,trial,0,0
105119,.,0,0
105120,SUBJECTS,0,0
105121,AND,0,1
105122,METHODS,0,1
105123,Children,0,0
105124,with,0,0
105125,ASD,0,0
105126,were,0,0
105127,randomly,0,0
105128,assigned,0,0
105129,to,0,0
105130,an,0,0
105131,electro-acupuncture,1,0
105132,(,1,1
105133,EA,1,1
105134,),1,1
105135,group,1,0
105136,(,1,0
105137,n=30,1,0
105138,),1,0
105139,or,1,0
105140,a,1,0
105141,sham,1,1
105142,electro-acupuncture,1,1
105143,(,1,1
105144,SEA,1,1
105145,),1,1
105146,group,1,0
105147,(,0,0
105148,n=25,0,0
105149,),0,0
105150,matched,0,0
105151,by,0,0
105152,age,0,0
105153,and,0,0
105154,severity,0,0
105155,of,0,0
105156,autism,0,0
105157,.,0,0
105158,The,0,0
105159,EA,0,0
105160,group,0,0
105161,received,0,0
105162,electro-acupuncture,0,0
105163,for,0,0
105164,selected,0,0
105165,acupoints,0,0
105166,while,0,0
105167,the,0,0
105168,SEA,0,0
105169,group,0,0
105170,received,0,0
105171,sham,0,0
105172,electro-acupuncture,0,1
105173,to,0,1
105174,sham,0,0
105175,acupoints,0,0
105176,.,0,0
105177,A,0,0
105178,total,0,0
105179,of,0,0
105180,12,0,0
105181,EA,0,0
105182,and,0,0
105183,SEA,0,1
105184,sessions,0,0
105185,over,0,0
105186,four,0,0
105187,weeks,0,0
105188,were,0,0
105189,given,0,0
105190,.,0,0
105191,Primary,0,0
105192,outcome,0,0
105193,measures,0,0
105194,included,0,0
105195,Functional,0,0
105196,Independence,0,0
105197,Measure,0,0
105198,for,0,0
105199,Children,0,1
105200,(,0,1
105201,WeeFIM,0,1
105202,),0,1
105203,",",0,0
105204,Pediatric,0,0
105205,Evaluation,0,0
105206,of,0,0
105207,Disability,0,1
105208,Inventory,0,1
105209,(,0,1
105210,PEDI,0,1
105211,),0,1
105212,",",0,0
105213,Leiter,0,1
105214,International,0,1
105215,Performance,0,1
105216,Scale-Revised,0,1
105217,(,0,1
105218,Leiter-R,0,1
105219,),0,1
105220,",",0,0
105221,and,0,0
105222,Clinical,0,0
105223,Global,0,0
105224,Impression-Improvement,0,1
105225,(,0,1
105226,CGI-I,0,1
105227,),0,1
105228,scale,0,0
105229,.,0,0
105230,Secondary,0,0
105231,outcome,0,0
105232,measures,0,0
105233,consisted,0,0
105234,of,0,0
105235,Aberrant,0,0
105236,Behavior,0,0
105237,Checklist,0,1
105238,(,0,1
105239,ABC,0,1
105240,),0,1
105241,",",0,0
105242,Ritvo-Freeman,0,1
105243,Real,0,0
105244,Life,0,1
105245,Scale,0,1
105246,(,0,1
105247,RFRLS,0,1
105248,),0,1
105249,",",0,0
105250,Reynell,0,0
105251,Developmental,0,0
105252,Language,0,1
105253,Scale,0,1
105254,(,0,1
105255,RDLS,0,1
105256,),0,1
105257,",",0,0
105258,and,0,0
105259,a,0,0
105260,standardized,0,0
105261,parental,0,0
105262,report,0,0
105263,.,0,0
105264,Data,0,0
105265,were,0,0
105266,analyzed,0,0
105267,by,0,0
105268,the,0,0
105269,Mann-Whitney,0,0
105270,test,0,0
105271,.,0,0
105272,RESULTS,0,0
105273,There,0,0
105274,were,0,0
105275,significant,0,0
105276,improvements,0,0
105277,in,0,0
105278,the,0,0
105279,language,0,0
105280,comprehension,0,0
105281,domain,0,0
105282,of,0,0
105283,WeeFIM,0,0
105284,(,0,0
105285,p=0.02,0,0
105286,),0,0
105287,",",0,0
105288,self-care,0,1
105289,caregiver,0,0
105290,assistant,0,0
105291,domain,0,0
105292,of,0,0
105293,PEDI,0,0
105294,(,0,0
105295,p=0.028,0,0
105296,),0,0
105297,",",0,0
105298,and,0,0
105299,CGI-I,0,0
105300,(,0,0
105301,p=0.003,0,0
105302,),0,0
105303,in,0,0
105304,the,0,0
105305,EA,0,0
105306,group,0,0
105307,compared,0,0
105308,to,0,0
105309,the,0,0
105310,SEA,0,0
105311,group,0,0
105312,.,0,0
105313,As,0,0
105314,for,0,0
105315,the,0,0
105316,parental,0,0
105317,report,0,0
105318,",",0,0
105319,the,0,0
105320,EA,0,1
105321,group,0,0
105322,also,0,0
105323,showed,0,0
105324,significantly,0,0
105325,better,0,0
105326,social,0,0
105327,initiation,0,0
105328,(,0,0
105329,p=0.01,0,0
105330,),0,0
105331,",",0,0
105332,receptive,0,1
105333,language,0,0
105334,(,0,0
105335,p=0.006,0,0
105336,),0,0
105337,",",0,0
105338,motor,0,1
105339,skills,0,0
105340,(,0,0
105341,p=0.034,0,0
105342,),0,0
105343,",",0,0
105344,coordination,0,0
105345,(,0,0
105346,p=0.07,0,0
105347,),0,0
105348,",",0,0
105349,and,0,0
105350,attention,0,0
105351,span,0,0
105352,(,0,0
105353,p=0.003,0,0
105354,),0,0
105355,.,0,0
105356,More,0,0
105357,than,0,0
105358,70,0,0
105359,percent,0,0
105360,of,0,0
105361,children,0,0
105362,with,0,0
105363,ASD,0,0
105364,adapted,0,0
105365,to,0,0
105366,acupuncture,0,0
105367,easily,0,0
105368,",",0,0
105369,while,0,0
105370,eight,0,0
105371,percent,0,0
105372,had,0,0
105373,poor,0,0
105374,acupuncture,0,0
105375,compliance,0,0
105376,.,0,0
105377,Mild,0,0
105378,side,0,0
105379,effects,0,0
105380,of,0,0
105381,minor,0,0
105382,superficial,0,0
105383,bleeding,0,0
105384,or,0,0
105385,irritability,0,0
105386,during,0,0
105387,acupuncture,0,0
105388,were,0,0
105389,observed,0,0
105390,.,0,0
105391,CONCLUSION,0,0
105392,A,0,0
105393,short,0,0
105394,",",0,0
105395,four-week,0,1
105396,(,0,0
105397,12,0,0
105398,sessions,0,1
105399,),0,0
105400,course,0,0
105401,of,0,0
105402,electro-acupuncture,0,0
105403,is,0,0
105404,useful,0,0
105405,to,0,0
105406,improve,0,0
105407,specific,0,0
105408,functions,0,0
105409,in,0,0
105410,children,0,0
105411,with,0,0
105412,ASD,0,0
105413,",",0,0
105414,especially,0,0
105415,for,0,0
105416,language,0,0
105417,comprehension,0,0
105418,and,0,0
105419,self-care,0,0
105420,ability,0,0
105421,.,0,0
105422,Anti-angiogenic,0,0
105423,effects,0,0
105424,of,0,0
105425,epigallocatechin-3-gallate,1,1
105426,in,0,0
105427,human,0,0
105428,skin,0,0
105429,.,0,1
105430,Epigallocatechin-3-gallate,1,1
105431,(,1,1
105432,EGCG,1,1
105433,),1,0
105434,is,0,0
105435,the,0,0
105436,main,0,0
105437,polyphenol,0,1
105438,component,0,0
105439,of,0,0
105440,green,0,0
105441,tea,0,1
105442,.,0,1
105443,This,0,0
105444,compound,0,0
105445,exhibits,0,0
105446,antioxidant,0,1
105447,",",0,1
105448,immunomodulatory,0,1
105449,",",0,1
105450,photoprotective,0,1
105451,",",0,1
105452,anti-angiogenic,0,1
105453,",",0,1
105454,and,0,1
105455,anti-inflammatory,0,1
105456,properties,0,0
105457,.,0,0
105458,We,0,0
105459,conducted,0,0
105460,a,0,0
105461,small,0,0
105462,randomized,0,0
105463,",",0,0
105464,double,0,0
105465,blind,0,0
105466,",",0,0
105467,split,0,0
105468,face,0,0
105469,trial,0,0
105470,using,0,0
105471,a,0,0
105472,cream,1,1
105473,containing,1,0
105474,2.5,1,0
105475,%,1,0
105476,w/w,1,0
105477,of,1,0
105478,EGCG,1,1
105479,.,1,0
105480,Four,0,0
105481,healthy,0,0
105482,volunteers,0,0
105483,with,0,0
105484,significant,0,0
105485,erythema,0,0
105486,and,0,0
105487,telangiectasia,0,0
105488,on,0,0
105489,the,0,0
105490,face,0,0
105491,applied,0,0
105492,EGCG,1,1
105493,cream,1,1
105494,to,0,0
105495,one,0,0
105496,side,0,0
105497,of,0,0
105498,the,0,0
105499,face,0,0
105500,",",0,0
105501,and,0,0
105502,vehicle,1,1
105503,control,1,1
105504,cream,1,1
105505,to,0,0
105506,the,0,0
105507,other,0,0
105508,",",0,0
105509,twice,0,1
105510,daily,0,1
105511,for,0,0
105512,six,0,0
105513,weeks,0,0
105514,.,0,0
105515,After,0,0
105516,six,0,0
105517,weeks,0,0
105518,",",0,0
105519,biopsies,0,0
105520,were,0,0
105521,taken,0,0
105522,from,0,0
105523,EGCG,1,1
105524,and,0,0
105525,vehicle,1,1
105526,treated,1,0
105527,sites,0,0
105528,.,0,0
105529,Immunohistochemistry,0,0
105530,was,0,0
105531,used,0,0
105532,to,0,0
105533,measure,0,0
105534,VEGF,0,0
105535,and,0,0
105536,HIF-1,0,1
105537,?.,0,1
105538,HIF-1,0,1
105539,?,0,0
105540,expression,0,0
105541,was,0,0
105542,decreased,0,0
105543,in,0,0
105544,EGCG,1,0
105545,treated,1,0
105546,sites,0,0
105547,",",0,0
105548,such,0,0
105549,that,0,0
105550,28.4,0,0
105551,%,0,0
105552,of,0,0
105553,the,0,0
105554,epidermis,0,0
105555,showed,0,0
105556,positive,0,0
105557,staining,0,0
105558,in,0,0
105559,vehicle,0,0
105560,treated,0,0
105561,vs.,0,0
105562,13.8,0,0
105563,%,0,0
105564,in,0,0
105565,EGCG,1,0
105566,treated,1,0
105567,sites,0,0
105568,(,0,0
105569,p,0,0
105570,<,0,0
105571,0.001,0,0
105572,),0,0
105573,.,0,0
105574,A,0,0
105575,similar,0,0
105576,decrease,0,0
105577,in,0,0
105578,VEGF,0,0
105579,expression,0,0
105580,was,0,0
105581,found,0,0
105582,(,0,0
105583,6.7,0,0
105584,%,0,0
105585,in,0,0
105586,EGCG,1,0
105587,vs.,1,0
105588,11.0,0,0
105589,%,0,0
105590,in,0,0
105591,in,0,0
105592,vehicle-treated,1,0
105593,skin,1,0
105594,(,0,0
105595,p,0,0
105596,<,1,0
105597,0.005,1,0
105598,),1,0
105599,.,1,0
105600,EGCG,1,1
105601,topical,1,1
105602,treatments,0,1
105603,influence,0,0
105604,HIF-1,0,0
105605,?,0,0
105606,induction,0,0
105607,and,0,0
105608,VEGF,0,0
105609,expression,0,0
105610,and,0,0
105611,may,0,0
105612,serve,0,0
105613,as,0,0
105614,a,0,0
105615,potential,0,0
105616,agent,0,0
105617,in,0,0
105618,the,0,0
105619,prevention,0,0
105620,of,0,0
105621,telangiectasias,0,0
105622,.,0,0
105623,Effect,0,0
105624,of,0,0
105625,a,0,0
105626,synthetic,1,0
105627,appeasing,1,0
105628,pheromone,1,0
105629,on,0,0
105630,behavioral,0,0
105631,",",0,0
105632,neuroendocrine,0,0
105633,",",0,0
105634,immune,0,0
105635,",",0,0
105636,and,0,0
105637,acute-phase,0,0
105638,perioperative,0,0
105639,stress,0,0
105640,responses,0,0
105641,in,0,0
105642,dogs,0,0
105643,.,0,0
105644,OBJECTIVE,0,0
105645,To,0,0
105646,study,0,0
105647,the,0,0
105648,effects,0,0
105649,of,0,0
105650,a,0,0
105651,synthetic,1,0
105652,",",1,0
105653,dog-appeasing,1,0
105654,pheromone,1,0
105655,(,1,1
105656,sDAP,1,1
105657,),1,1
105658,on,0,0
105659,the,0,0
105660,behavioral,0,0
105661,",",0,0
105662,neuroendocrine,0,0
105663,",",0,0
105664,immune,0,0
105665,",",0,0
105666,and,0,0
105667,acute-phase,0,0
105668,perioperative,0,0
105669,stress,0,0
105670,responses,0,0
105671,in,0,0
105672,dogs,0,0
105673,undergoing,0,0
105674,elective,0,0
105675,orchiectomy,0,0
105676,or,0,0
105677,ovariohysterectomy,0,0
105678,.,0,0
105679,DESIGN,0,0
105680,Randomized,0,0
105681,",",0,0
105682,controlled,0,0
105683,clinical,0,0
105684,trial,0,0
105685,.,0,0
105686,ANIMALS,0,0
105687,46,0,0
105688,dogs,0,0
105689,housed,0,0
105690,in,0,0
105691,animal,0,0
105692,shelters,0,0
105693,and,0,0
105694,undergoing,0,0
105695,elective,0,0
105696,orchiectomy,0,0
105697,or,0,0
105698,ovariohysterectomy,0,0
105699,.,0,0
105700,PROCEDURES,0,0
105701,Intensive,0,0
105702,care,0,0
105703,unit,0,0
105704,cages,0,0
105705,were,0,0
105706,sprayed,0,1
105707,with,0,1
105708,sDAP,1,0
105709,solution,1,0
105710,or,1,0
105711,sham,1,0
105712,treated,1,0
105713,with,1,0
105714,the,1,0
105715,carrier,1,0
105716,used,1,0
105717,in,1,0
105718,the,1,0
105719,solution,1,0
105720,20,1,0
105721,minutes,1,0
105722,prior,1,0
105723,to,1,0
105724,use,1,0
105725,.,1,0
105726,Dogs,0,0
105727,(,0,0
105728,n,0,0
105729,=,0,0
105730,24,0,0
105731,and,0,0
105732,22,0,0
105733,in,0,0
105734,the,0,0
105735,sDAP,1,0
105736,and,0,0
105737,sham,1,0
105738,treatment,1,0
105739,exposure,0,0
105740,groups,0,0
105741,",",0,0
105742,respectively,0,0
105743,),0,0
105744,were,0,0
105745,placed,0,0
105746,in,0,0
105747,treated,0,0
105748,cages,0,0
105749,for,0,0
105750,30,0,0
105751,minutes,0,0
105752,before,0,0
105753,and,0,0
105754,after,0,0
105755,surgery,0,0
105756,.,0,0
105757,Indicators,0,0
105758,of,0,0
105759,stress,0,0
105760,(,0,0
105761,ie,0,0
105762,",",0,0
105763,alterations,0,0
105764,in,0,0
105765,behavioral,0,0
105766,",",0,0
105767,neuroendocrine,0,0
105768,",",0,0
105769,immune,0,0
105770,",",0,0
105771,and,0,0
105772,acute-phase,0,0
105773,responses,0,0
105774,),0,0
105775,were,0,0
105776,evaluated,0,0
105777,perioperatively,0,0
105778,.,0,0
105779,Behavioral,0,0
105780,response,0,0
105781,variables,0,0
105782,",",0,0
105783,salivary,0,0
105784,cortisol,0,1
105785,concentration,0,0
105786,",",0,0
105787,WBC,0,0
105788,count,0,0
105789,",",0,0
105790,and,0,1
105791,serum,0,1
105792,concentrations,0,1
105793,of,0,1
105794,glucose,0,1
105795,",",0,1
105796,prolactin,0,1
105797,",",0,1
105798,haptoglobin,0,1
105799,",",0,1
105800,and,0,0
105801,C-reactive,0,0
105802,protein,0,0
105803,were,0,0
105804,analyzed,0,0
105805,.,0,0
105806,RESULTS,0,0
105807,Behavioral,0,0
105808,response,0,0
105809,variables,0,0
105810,and,0,1
105811,serum,0,1
105812,prolactin,0,1
105813,concentration,0,0
105814,were,0,0
105815,influenced,0,0
105816,by,0,0
105817,sDAP,0,0
105818,exposure,0,0
105819,.,0,0
105820,Dogs,0,0
105821,exposed,0,0
105822,to,0,0
105823,sDAP,0,0
105824,were,0,0
105825,more,0,0
105826,likely,0,0
105827,to,0,0
105828,have,0,0
105829,alertness,0,0
105830,and,0,0
105831,visual,0,0
105832,exploration,0,0
105833,behaviors,0,0
105834,after,0,0
105835,surgery,0,0
105836,than,0,0
105837,were,0,0
105838,dogs,0,0
105839,exposed,0,0
105840,to,0,0
105841,sham,0,0
105842,treatment,0,0
105843,.,0,0
105844,Decreases,0,0
105845,in,0,0
105846,serum,0,1
105847,prolactin,0,1
105848,concentrations,0,1
105849,in,0,0
105850,response,0,0
105851,to,0,0
105852,perioperative,0,0
105853,stress,0,0
105854,were,0,0
105855,significantly,0,0
105856,smaller,0,0
105857,in,0,0
105858,dogs,0,0
105859,exposed,0,0
105860,to,0,0
105861,sDAP,0,0
105862,",",0,0
105863,compared,0,0
105864,with,0,0
105865,findings,0,0
105866,in,0,0
105867,dogs,0,0
105868,exposed,0,0
105869,to,0,0
105870,the,0,0
105871,sham,0,0
105872,treatment,0,0
105873,.,0,0
105874,Variables,0,0
105875,examined,0,0
105876,to,0,0
105877,evaluate,0,0
105878,the,0,0
105879,hypothalamic-pituitary-adrenal,0,0
105880,axis,0,0
105881,",",0,0
105882,immune,0,0
105883,system,0,0
105884,",",0,0
105885,and,0,0
105886,acute-phase,0,0
105887,responses,0,0
105888,were,0,0
105889,unaffected,0,0
105890,by,0,0
105891,treatment,0,0
105892,.,0,0
105893,CONCLUSIONS,0,0
105894,AND,0,1
105895,CLINICAL,0,1
105896,RELEVANCE,0,1
105897,sDAP,0,0
105898,appeared,0,0
105899,to,0,0
105900,affect,0,0
105901,behavioral,0,0
105902,and,0,0
105903,neuroendocrine,0,0
105904,perioperative,0,0
105905,stress,0,0
105906,responses,0,0
105907,by,0,0
105908,modification,0,0
105909,of,0,0
105910,lactotropic,0,1
105911,axis,0,0
105912,activity,0,0
105913,.,0,0
105914,Use,0,0
105915,of,0,0
105916,sDAP,1,0
105917,in,0,0
105918,a,0,0
105919,clinical,0,0
105920,setting,0,0
105921,may,0,0
105922,improve,0,0
105923,the,0,0
105924,recovery,0,0
105925,and,0,0
105926,welfare,0,0
105927,of,0,0
105928,dogs,0,0
105929,undergoing,0,0
105930,surgery,0,0
105931,.,0,0
105932,The,0,0
105933,immediate,0,0
105934,efficacy,0,0
105935,of,0,0
105936,adjunctive,1,1
105937,doxycycline,1,1
105938,in,0,0
105939,treatment,0,0
105940,of,0,0
105941,localized,0,0
105942,juvenile,0,0
105943,periodontitis,0,0
105944,.,0,0
105945,A,0,0
105946,randomized,0,1
105947,",",0,0
105948,double-blind,0,1
105949,",",0,1
105950,placebo-controlled,1,1
105951,study,0,0
105952,on,0,0
105953,the,0,0
105954,immediate,0,0
105955,clinical,0,0
105956,and,0,0
105957,microbiological,0,0
105958,efficacy,0,1
105959,of,0,1
105960,doxycycline,1,1
105961,(,0,1
105962,100,0,1
105963,mg,0,1
105964,for,0,1
105965,14,0,1
105966,days,0,0
105967,),0,0
105968,was,0,0
105969,carried,0,0
105970,out,0,0
105971,to,0,0
105972,determine,0,0
105973,the,0,0
105974,benefit,0,0
105975,of,0,0
105976,adjunctive,0,0
105977,medication,0,0
105978,in,0,0
105979,16,0,0
105980,patients,0,0
105981,with,0,0
105982,localized,0,0
105983,juvenile,0,0
105984,periodontitis,0,0
105985,.,0,0
105986,Measurements,0,0
105987,of,0,0
105988,gingival,0,0
105989,fluid,0,0
105990,flow,0,0
105991,",",0,0
105992,probing,0,0
105993,depths,0,0
105994,",",0,0
105995,bleeding,0,0
105996,on,0,0
105997,probing,0,0
105998,and,0,0
105999,suppuration,0,0
106000,were,0,0
106001,determined,0,0
106002,at,0,0
106003,2,0,0
106004,periodontal,0,0
106005,sites,0,0
106006,with,0,0
106007,and,0,0
106008,2,0,0
106009,without,0,0
106010,radiographic,0,0
106011,attachment,0,0
106012,loss,0,0
106013,",",0,0
106014,at,0,0
106015,weeks,0,0
106016,0,0,0
106017,",",0,0
106018,1,0,0
106019,",",0,0
106020,3,0,0
106021,and,0,0
106022,8,0,0
106023,.,0,0
106024,Subgingival,0,0
106025,bacterial,0,0
106026,samples,0,0
106027,were,0,0
106028,taken,0,0
106029,with,0,0
106030,curettes,0,0
106031,from,0,0
106032,the,0,0
106033,same,0,0
106034,sites,0,0
106035,.,0,0
106036,Spirochaetes,0,0
106037,were,0,0
106038,searched,0,0
106039,for,0,0
106040,by,0,0
106041,dark-field,0,0
106042,microscopy,0,0
106043,.,0,0
106044,Actinobacillus,0,1
106045,actinomycetemcomitans,0,1
106046,",",0,0
106047,pigmented,0,0
106048,and,0,0
106049,non-pigmented,0,0
106050,Bacteroides,0,0
106051,spp.,0,0
106052,",",0,0
106053,Capnocytophaga,0,0
106054,",",0,0
106055,Fusobacterium,0,1
106056,and,0,0
106057,Actinomyces,0,0
106058,spp,0,0
106059,.,0,0
106060,were,0,0
106061,cultured,0,0
106062,on,0,0
106063,various,0,0
106064,selective,0,0
106065,and,0,0
106066,non-selective,0,1
106067,media,0,0
106068,.,0,0
106069,Bacterial,0,0
106070,species,0,0
106071,found,0,0
106072,at,0,0
106073,least,0,0
106074,in,0,0
106075,50,0,0
106076,%,0,0
106077,of,0,0
106078,the,0,0
106079,patients,0,0
106080,and,0,0
106081,comprising,0,0
106082,on,0,0
106083,average,0,0
106084,5,0,0
106085,%,0,0
106086,or,0,0
106087,more,0,0
106088,of,0,0
106089,the,0,0
106090,cultivable,0,0
106091,flora,0,0
106092,were,0,0
106093,included,0,0
106094,in,0,0
106095,the,0,0
106096,analysis,0,0
106097,.,0,0
106098,Neither,0,0
106099,short-term,0,0
106100,clinical,0,0
106101,nor,0,0
106102,microbiological,0,0
106103,efficacy,0,0
106104,beyond,0,0
106105,that,0,0
106106,of,0,0
106107,a,0,0
106108,course,0,0
106109,of,0,0
106110,mechanical,1,0
106111,debridement,1,0
106112,alone,1,0
106113,was,0,0
106114,found,0,0
106115,by,0,0
106116,using,0,0
106117,systemic,0,0
106118,medication,0,0
106119,with,0,0
106120,doxycycline,1,1
106121,in,0,0
106122,patients,0,0
106123,with,0,0
106124,localized,0,0
106125,juvenile,0,0
106126,periodontitis,0,0
106127,.,0,0
106128,The,0,0
106129,use,0,0
106130,of,0,0
106131,vitamin,1,1
106132,E,1,0
106133,for,0,0
106134,the,0,0
106135,prevention,0,0
106136,of,0,0
106137,chemotherapy-induced,0,0
106138,peripheral,0,0
106139,neuropathy,0,0
106140,:,0,0
106141,results,0,0
106142,of,0,0
106143,a,0,0
106144,randomized,0,0
106145,phase,0,0
106146,III,0,1
106147,clinical,0,0
106148,trial,0,0
106149,.,0,0
106150,BACKGROUND,0,0
106151,Chemotherapy-induced,0,0
106152,peripheral,0,0
106153,neuropathy,0,1
106154,(,0,1
106155,CIPN,0,1
106156,),0,1
106157,continues,0,0
106158,to,0,0
106159,be,0,0
106160,a,0,0
106161,substantial,0,0
106162,problem,0,0
106163,for,0,0
106164,many,0,0
106165,cancer,0,0
106166,patients,0,0
106167,.,0,0
106168,Pursuant,0,0
106169,to,0,0
106170,promising,0,0
106171,appearing,0,0
106172,pilot,0,0
106173,data,0,0
106174,",",0,0
106175,the,0,0
106176,current,0,0
106177,study,0,0
106178,evaluated,0,0
106179,the,0,0
106180,use,0,0
106181,of,0,0
106182,vitamin,1,1
106183,E,1,0
106184,for,0,0
106185,the,0,0
106186,prevention,0,0
106187,of,0,0
106188,CIPN,0,0
106189,.,0,0
106190,METHODS,0,0
106191,A,0,0
106192,phase,0,0
106193,III,0,0
106194,",",0,0
106195,randomized,0,1
106196,",",0,1
106197,double-blind,0,1
106198,",",0,1
106199,placebo-controlled,0,1
106200,study,0,0
106201,was,0,0
106202,conducted,0,0
106203,in,0,0
106204,patients,0,0
106205,undergoing,0,0
106206,therapy,0,1
106207,with,0,1
106208,neurotoxic,0,1
106209,chemotherapy,0,1
106210,",",0,0
106211,utilizing,0,0
106212,twice,1,1
106213,daily,1,1
106214,dosing,1,1
106215,of,1,1
106216,vitamin,1,1
106217,E,1,1
106218,(,1,1
106219,400,1,1
106220,mg,1,1
106221,),1,1
106222,/placebo,1,1
106223,.,1,1
106224,The,0,0
106225,primary,0,0
106226,endpoint,0,0
106227,was,0,0
106228,the,0,0
106229,incidence,0,0
106230,of,0,0
106231,grade,0,0
106232,2+,0,0
106233,sensory,0,1
106234,neuropathy,0,1
106235,(,0,1
106236,SN,0,1
106237,),0,1
106238,toxicity,0,0
106239,(,0,0
106240,CTCAE,0,0
106241,v,0,0
106242,3.0,0,0
106243,),0,0
106244,in,0,0
106245,each,0,0
106246,treatment,0,0
106247,arm,0,0
106248,",",0,0
106249,analyzed,0,0
106250,by,0,0
106251,chi-square,0,0
106252,testing,0,0
106253,.,0,0
106254,Planned,0,0
106255,sample,0,0
106256,size,0,0
106257,was,0,0
106258,100,0,0
106259,patients,0,0
106260,per,0,0
106261,arm,0,0
106262,to,0,0
106263,provide,0,0
106264,80,0,0
106265,%,0,0
106266,power,0,0
106267,to,0,0
106268,detect,0,0
106269,a,0,0
106270,difference,0,0
106271,in,0,0
106272,incidence,0,0
106273,of,0,0
106274,grade,0,0
106275,2+,0,0
106276,SN,0,1
106277,toxicity,0,0
106278,from,0,0
106279,25,0,0
106280,%,0,0
106281,in,0,0
106282,the,0,0
106283,placebo,0,1
106284,group,0,0
106285,to,0,0
106286,10,0,0
106287,%,0,0
106288,in,0,0
106289,the,0,0
106290,vitamin,0,1
106291,E,0,0
106292,group,0,0
106293,.,0,0
106294,RESULTS,0,0
106295,Two-hundred,0,0
106296,seven,0,0
106297,patients,0,0
106298,were,0,0
106299,enrolled,0,0
106300,between,0,0
106301,December,0,0
106302,1,0,0
106303,",",0,0
106304,2006,0,0
106305,and,0,0
106306,December,0,0
106307,14,0,0
106308,",",0,0
106309,2007,0,0
106310,",",0,0
106311,producing,0,0
106312,189,0,0
106313,evaluable,0,0
106314,cases,0,0
106315,for,0,0
106316,analysis,0,0
106317,.,0,0
106318,Cytotoxic,0,0
106319,agents,0,0
106320,included,0,0
106321,taxanes,0,1
106322,(,0,0
106323,109,0,0
106324,),0,0
106325,",",0,0
106326,cisplatin,0,1
106327,(,0,1
106328,8,0,1
106329,),0,1
106330,",",0,1
106331,carboplatin,0,1
106332,(,0,1
106333,2,0,1
106334,),0,1
106335,",",0,1
106336,oxaliplatin,0,1
106337,(,0,1
106338,50,0,1
106339,),0,0
106340,",",0,0
106341,or,0,0
106342,combination,0,0
106343,(,0,1
106344,20,0,0
106345,),0,0
106346,.,0,0
106347,There,0,0
106348,was,0,0
106349,no,0,0
106350,difference,0,0
106351,in,0,0
106352,the,0,0
106353,incidence,0,0
106354,of,0,0
106355,grade,0,0
106356,2+,0,0
106357,SN,0,1
106358,between,0,0
106359,the,0,0
106360,two,0,0
106361,arms,0,0
106362,(,1,0
106363,34,1,0
106364,%,1,0
106365,-vitamin,1,0
106366,E,1,0
106367,",",0,0
106368,29,0,0
106369,%,0,0
106370,-placebo,0,0
106371,;,0,0
106372,P,0,0
106373,=,0,0
106374,0.43,0,0
106375,),0,0
106376,.,0,0
106377,There,0,0
106378,were,0,0
106379,no,0,0
106380,significant,0,0
106381,differences,0,0
106382,between,0,0
106383,treatment,0,0
106384,arms,0,0
106385,for,0,0
106386,time,0,0
106387,to,0,0
106388,onset,0,0
106389,of,0,0
106390,neuropathy,0,0
106391,(,0,0
106392,P,0,0
106393,=,0,0
106394,0.58,0,0
106395,),0,0
106396,",",0,0
106397,for,0,0
106398,chemotherapy,0,1
106399,dose,0,1
106400,reductions,0,0
106401,due,0,0
106402,to,0,0
106403,neuropathy,0,0
106404,(,0,0
106405,P,0,0
106406,=,0,0
106407,0.21,0,0
106408,),0,0
106409,",",0,0
106410,or,0,0
106411,for,0,0
106412,secondary,0,0
106413,endpoints,0,0
106414,derived,0,0
106415,from,0,0
106416,patient-reported,0,0
106417,neuropathy,0,0
106418,symptom,0,0
106419,assessments,0,0
106420,.,0,0
106421,The,0,0
106422,treatment,0,0
106423,was,0,0
106424,well,0,0
106425,tolerated,0,1
106426,overall,0,0
106427,.,0,1
106428,CONCLUSIONS,0,1
106429,Vitamin,1,1
106430,E,1,0
106431,did,1,0
106432,not,0,0
106433,appear,0,0
106434,to,0,0
106435,reduce,0,0
106436,the,0,0
106437,incidence,0,0
106438,of,0,0
106439,sensory,0,0
106440,neuropathy,0,0
106441,in,0,0
106442,the,0,0
106443,studied,0,0
106444,group,0,0
106445,of,0,0
106446,patients,0,0
106447,receiving,0,0
106448,neurotoxic,0,1
106449,chemotherapy,0,1
106450,.,0,0
106451,Randomized,0,0
106452,comparative,0,0
106453,study,0,0
106454,of,0,0
106455,group,1,0
106456,versus,1,0
106457,individual,1,0
106458,cognitive,1,0
106459,behavioural,1,0
106460,therapy,1,0
106461,for,0,0
106462,obsessive,0,0
106463,compulsive,0,0
106464,disorder,0,0
106465,.,0,0
106466,OBJECTIVE,0,0
106467,The,0,0
106468,primary,0,0
106469,aim,0,0
106470,of,0,0
106471,the,0,0
106472,study,0,0
106473,was,0,0
106474,to,0,0
106475,compare,0,0
106476,the,0,0
106477,effectiveness,0,0
106478,of,0,0
106479,group,1,0
106480,and,1,0
106481,individual,1,0
106482,cognitive,1,0
106483,behaviour,1,0
106484,therapy,1,1
106485,(,1,1
106486,CBT,1,1
106487,),1,1
106488,for,0,0
106489,obsessive,0,0
106490,compulsive,0,1
106491,disorder,0,1
106492,(,0,1
106493,OCD,0,1
106494,),0,1
106495,.,0,0
106496,METHOD,0,0
106497,One,0,0
106498,hundred,0,0
106499,and,0,0
106500,ten,0,0
106501,out-patients,0,0
106502,with,0,0
106503,OCD,0,0
106504,were,0,0
106505,randomly,0,0
106506,assigned,0,0
106507,to,0,0
106508,15,0,0
106509,sessions,0,0
106510,of,0,0
106511,either,0,0
106512,group,1,0
106513,CBT,1,0
106514,or,1,0
106515,individual,1,0
106516,CBT,1,0
106517,.,1,0
106518,Outcome,0,0
106519,measures,0,0
106520,were,0,0
106521,administered,0,1
106522,before,0,0
106523,and,0,0
106524,after,0,0
106525,treatment,0,0
106526,",",0,0
106527,as,0,0
106528,well,0,0
106529,as,0,0
106530,at,0,0
106531,6-,0,0
106532,and,0,0
106533,12-month,0,0
106534,follow-ups,0,0
106535,.,0,0
106536,The,0,0
106537,study,0,0
106538,was,0,0
106539,supplemented,0,0
106540,by,0,0
106541,a,0,0
106542,meta-analysis,0,0
106543,of,0,0
106544,accomplished,0,0
106545,comparative,0,0
106546,studies,0,0
106547,of,0,0
106548,group,1,0
106549,vs.,1,0
106550,individual,1,0
106551,CBT,1,0
106552,for,0,0
106553,OCD,0,0
106554,.,0,0
106555,RESULTS,0,0
106556,Large,0,0
106557,and,0,0
106558,stable,0,0
106559,pre-post,0,0
106560,effect,0,0
106561,sizes,0,0
106562,were,0,0
106563,found,0,0
106564,for,0,0
106565,both,0,0
106566,treatment,0,0
106567,conditions,0,0
106568,in,0,0
106569,the,0,0
106570,study,0,0
106571,(,0,0
106572,d,0,0
106573,=,0,0
106574,1.06-1.24,0,0
106575,on,0,0
106576,the,0,0
106577,Yale-Brown,0,0
106578,Obsessive,0,1
106579,Compulsive,0,1
106580,Scale,0,1
106581,),0,0
106582,.,0,0
106583,There,0,0
106584,were,0,0
106585,no,0,0
106586,significant,0,0
106587,between-group,0,0
106588,differences,0,0
106589,in,0,0
106590,outcome,0,0
106591,at,0,0
106592,any,0,0
106593,data,0,0
106594,point,0,0
106595,(,0,0
106596,ds=,0,1
106597,-0.13,0,0
106598,to,0,0
106599,0.15,0,0
106600,),0,0
106601,.,0,0
106602,The,0,0
106603,meta-analysis,0,0
106604,of,0,0
106605,four,0,0
106606,accomplished,0,0
106607,comparative,0,0
106608,studies,0,0
106609,(,0,0
106610,including,0,0
106611,the,0,0
106612,present,0,0
106613,one,0,0
106614,),0,0
106615,found,0,0
106616,a,0,0
106617,between-group,0,0
106618,mean,0,0
106619,effect,0,0
106620,size,0,0
106621,of,0,0
106622,(,0,0
106623,d=,0,0
106624,0.15,0,0
106625,favouring,0,0
106626,individual,0,0
106627,over,0,0
106628,group,0,0
106629,CBT,1,0
106630,at,0,1
106631,posttreatment,0,0
106632,(,0,0
106633,95,0,0
106634,%,0,0
106635,confidence,0,0
106636,interval,0,0
106637,",",0,0
106638,-0.12,0,0
106639,",",0,0
106640,0.42,0,0
106641,),0,0
106642,.,0,0
106643,CONCLUSION,0,0
106644,The,0,0
106645,results,0,0
106646,of,0,0
106647,this,0,0
106648,study,0,0
106649,suggest,0,0
106650,that,0,0
106651,OCD,0,0
106652,can,0,0
106653,be,0,0
106654,treated,0,0
106655,effectively,0,0
106656,with,0,0
106657,a,0,0
106658,group,1,0
106659,format,1,0
106660,of,1,0
106661,CBT,1,0
106662,",",0,0
106663,thus,0,0
106664,sparing,0,0
106665,some,0,0
106666,therapist,0,0
106667,resources,0,0
106668,",",0,0
106669,although,0,0
106670,the,0,0
106671,four,0,0
106672,accomplished,0,0
106673,comparative,0,0
106674,studies,0,0
106675,do,0,0
106676,not,0,0
106677,rule,0,0
106678,out,0,0
106679,the,0,0
106680,possibility,0,0
106681,of,0,0
106682,a,0,0
106683,small,0,0
106684,superiority,0,0
106685,of,0,0
106686,individually,0,0
106687,conducted,0,0
106688,CBT,1,0
106689,.,1,0
106690,An,0,1
106691,explorative,0,1
106692,study,0,0
106693,on,0,0
106694,the,0,0
106695,clinical,0,0
106696,utility,0,0
106697,of,0,0
106698,baseline,0,0
106699,and,0,0
106700,serial,0,0
106701,serum,0,1
106702,tumour,0,1
106703,marker,0,0
106704,measurements,0,0
106705,in,0,0
106706,advanced,0,0
106707,upper,0,0
106708,gastrointestinal,0,0
106709,cancer,0,0
106710,.,0,0
106711,The,0,0
106712,value,0,0
106713,of,0,0
106714,early,0,0
106715,tumour,0,0
106716,marker,0,0
106717,changes,0,0
106718,during,0,0
106719,palliative,0,0
106720,chemotherapy,0,0
106721,in,0,0
106722,patients,0,0
106723,with,0,0
106724,upper,0,0
106725,gastrointestinal,0,1
106726,adenocarcinoma,0,1
106727,(,0,1
106728,UGIA,0,1
106729,),0,0
106730,is,0,0
106731,unclear,0,0
106732,.,0,0
106733,Seventy-three,0,0
106734,patients,0,0
106735,with,0,0
106736,advanced,0,0
106737,UGIA,0,0
106738,were,0,0
106739,randomised,0,0
106740,to,0,0
106741,receive,0,0
106742,45,1,0
106743,mg/m2,1,1
106744,docetaxel,1,1
106745,or,1,1
106746,180,1,1
106747,mg/m2,1,1
106748,irinotecan,1,1
106749,with,1,1
106750,5-FU/leucovorin,1,1
106751,.,1,1
106752,After,0,1
106753,every,0,0
106754,2nd,1,1
106755,course,1,0
106756,the,1,0
106757,patients,1,0
106758,were,1,0
106759,crossed,1,0
106760,over,1,0
106761,to,1,0
106762,the,1,0
106763,other,1,0
106764,regimen,1,1
106765,.,1,0
106766,Serum,0,0
106767,was,0,0
106768,sampled,0,0
106769,before,0,0
106770,start,0,0
106771,of,0,0
106772,chemotherapy,0,0
106773,and,0,0
106774,every,0,0
106775,2nd,0,0
106776,week,0,0
106777,during,0,0
106778,8,0,0
106779,weeks,0,0
106780,for,0,0
106781,CEA,0,0
106782,",",0,0
106783,TPA,0,1
106784,",",0,0
106785,TPS,0,1
106786,",",0,0
106787,CA72-4,0,1
106788,",",0,0
106789,CA19-9,0,1
106790,and,0,0
106791,CA242,0,0
106792,measurements,0,0
106793,.,0,0
106794,Eighteen,0,0
106795,patients,0,0
106796,(,0,0
106797,25,0,0
106798,%,0,0
106799,),0,0
106800,had,0,0
106801,partial,0,0
106802,response,0,0
106803,(,0,0
106804,PR,0,1
106805,),0,1
106806,and,0,0
106807,21,0,0
106808,patients,0,0
106809,had,0,0
106810,stable,0,0
106811,disease,0,0
106812,for,0,0
106813,at,0,0
106814,least,0,0
106815,4,0,0
106816,months,0,0
106817,(,0,1
106818,SD4,0,1
106819,),0,1
106820,.,0,0
106821,All,0,0
106822,baseline,0,0
106823,marker,0,0
106824,levels,0,0
106825,",",0,0
106826,except,0,0
106827,CA72-4,0,0
106828,",",0,0
106829,correlated,0,0
106830,with,0,0
106831,time,0,0
106832,to,0,0
106833,progression,0,0
106834,and,0,0
106835,survival,0,0
106836,.,0,0
106837,Patients,0,0
106838,with,0,0
106839,normal,0,0
106840,levels,0,0
106841,",",0,0
106842,except,0,0
106843,CA72-4,0,0
106844,",",0,0
106845,also,0,0
106846,had,0,0
106847,more,0,0
106848,clinical,0,0
106849,responses,0,0
106850,(,0,1
106851,PR+SD4,0,1
106852,),0,1
106853,than,0,0
106854,patients,0,0
106855,with,0,0
106856,elevated,0,0
106857,values,0,0
106858,.,0,0
106859,Tumour,0,0
106860,marker,0,0
106861,changes,0,0
106862,early,0,0
106863,during,0,0
106864,treatment,0,0
106865,provided,0,0
106866,modest,0,0
106867,predictive,0,0
106868,information,0,0
106869,for,0,0
106870,tumour,0,0
106871,response,0,0
106872,and,0,0
106873,survival,0,0
106874,.,0,0
106875,A,0,0
106876,model,0,0
106877,combining,0,0
106878,baseline,0,0
106879,level,0,0
106880,",",0,0
106881,the,0,0
106882,change,0,0
106883,and,0,0
106884,the,0,0
106885,interaction,0,0
106886,between,0,0
106887,them,0,0
106888,gave,0,0
106889,the,0,0
106890,best,0,0
106891,prediction,0,0
106892,of,0,0
106893,outcome,0,0
106894,",",0,0
106895,however,0,0
106896,",",0,0
106897,insignificantly,0,0
106898,better,0,0
106899,than,0,0
106900,baseline,0,0
106901,level,0,0
106902,for,0,0
106903,all,0,0
106904,markers,0,0
106905,except,0,0
106906,CA242,0,0
106907,.,0,0
106908,Baseline,0,0
106909,tumour,0,0
106910,marker,0,0
106911,levels,0,0
106912,provide,0,0
106913,prognostic,0,0
106914,information,0,0
106915,for,0,0
106916,patients,0,0
106917,with,0,0
106918,UGIA,0,0
106919,on,0,0
106920,palliative,0,0
106921,chemotherapy,0,0
106922,.,0,0
106923,Early,0,0
106924,changes,0,0
106925,generally,0,0
106926,failed,0,0
106927,to,0,0
106928,provide,0,0
106929,accurate,0,0
106930,information,0,0
106931,for,0,0
106932,tumour,0,0
106933,response,0,0
106934,and,0,0
106935,survival,0,0
106936,.,0,0
106937,Dopexamine,1,1
106938,has,0,1
106939,no,0,0
106940,additional,0,0
106941,benefit,0,0
106942,in,0,0
106943,high-risk,0,0
106944,patients,0,0
106945,receiving,0,0
106946,goal-directed,1,0
106947,fluid,1,1
106948,therapy,1,0
106949,undergoing,1,0
106950,major,1,0
106951,abdominal,1,0
106952,surgery,1,0
106953,.,1,0
106954,BACKGROUND,0,1
106955,Dopexamine,1,1
106956,has,0,0
106957,been,0,0
106958,shown,0,0
106959,to,0,0
106960,reduce,0,0
106961,both,0,0
106962,mortality,0,0
106963,and,0,0
106964,morbidity,0,0
106965,in,0,0
106966,major,0,0
106967,surgery,0,0
106968,when,0,0
106969,it,0,0
106970,is,0,0
106971,used,0,0
106972,as,0,0
106973,part,0,0
106974,of,0,0
106975,a,0,0
106976,protocol,0,0
106977,to,0,0
106978,increase,0,0
106979,oxygen,0,0
106980,delivery,0,0
106981,in,0,0
106982,the,0,0
106983,perioperative,0,0
106984,period,0,0
106985,.,0,0
106986,A,0,0
106987,European,0,0
106988,multicenter,0,0
106989,study,0,0
106990,has,0,0
106991,examined,0,0
106992,the,0,0
106993,use,0,0
106994,of,0,0
106995,dopexamine,1,1
106996,in,0,0
106997,patients,0,0
106998,undergoing,0,0
106999,major,1,0
107000,abdominal,1,0
107001,surgery,1,0
107002,",",0,0
107003,showing,0,0
107004,a,0,0
107005,trend,0,0
107006,toward,0,0
107007,improved,0,0
107008,survival,0,0
107009,and,0,0
107010,reduced,0,0
107011,complications,0,0
107012,in,0,0
107013,high-risk,0,0
107014,patients,0,0
107015,when,0,0
107016,receiving,0,0
107017,low-dose,1,1
107018,dopexamine,1,1
107019,(,0,1
107020,0.5,0,1
107021,?g,0,1
107022,?,0,1
107023,kg,0,1
107024,(,0,1
107025,-1,0,1
107026,),0,1
107027,?,0,1
107028,min,0,1
107029,(,0,1
107030,-1,0,1
107031,),0,1
107032,),0,0
107033,.,0,0
107034,A,0,0
107035,reduced,0,0
107036,oxygen,0,0
107037,uptake,0,0
107038,at,0,0
107039,the,0,0
107040,anaerobic,0,1
107041,threshold,0,1
107042,(,0,1
107043,AT,0,1
107044,),0,0
107045,has,0,0
107046,been,0,0
107047,shown,0,0
107048,to,0,0
107049,confer,0,0
107050,a,0,0
107051,significant,0,0
107052,risk,0,0
107053,of,0,0
107054,mortality,0,0
107055,in,0,0
107056,patients,0,0
107057,undergoing,1,0
107058,major,1,0
107059,abdominal,1,0
107060,surgery,1,0
107061,and,1,0
107062,allows,0,0
107063,objective,0,0
107064,identification,0,0
107065,of,0,0
107066,a,0,0
107067,high-risk,0,0
107068,operative,0,0
107069,group,0,0
107070,.,0,0
107071,In,0,0
107072,this,0,0
107073,study,0,0
107074,",",0,0
107075,we,0,0
107076,assessed,0,0
107077,the,0,0
107078,effects,0,0
107079,of,0,0
107080,low-dose,1,1
107081,dopexamine,1,1
107082,on,1,1
107083,morbidity,0,0
107084,after,1,0
107085,major,1,0
107086,abdominal,1,0
107087,surgery,1,0
107088,in,1,0
107089,patients,0,0
107090,who,0,0
107091,were,0,0
107092,at,0,0
107093,increased,0,0
107094,risk,0,0
107095,by,0,0
107096,virtue,0,0
107097,of,0,0
107098,a,0,0
107099,reduced,0,0
107100,AT,0,0
107101,.,0,0
107102,METHODS,0,0
107103,Patients,0,0
107104,undergoing,0,0
107105,elective,0,0
107106,major,1,0
107107,colorectal,1,0
107108,or,1,0
107109,urological,1,0
107110,surgery,1,0
107111,who,1,0
107112,had,0,0
107113,an,0,0
107114,AT,0,0
107115,of,0,0
107116,<,0,0
107117,11,0,0
107118,mL,0,0
107119,?,0,1
107120,kg,0,1
107121,(,0,1
107122,-1,0,1
107123,),0,1
107124,?,0,1
107125,min,0,1
107126,(,0,1
107127,-1,0,0
107128,),0,0
107129,or,0,0
107130,an,0,0
107131,AT,0,0
107132,of,0,0
107133,11,0,0
107134,to,0,0
107135,14,0,0
107136,mL,0,0
107137,?,0,1
107138,kg,0,1
107139,(,0,1
107140,-1,0,1
107141,),0,1
107142,?,0,1
107143,min,0,1
107144,(,0,1
107145,-1,0,0
107146,),0,0
107147,with,0,0
107148,a,0,0
107149,history,0,0
107150,of,0,0
107151,ischemic,0,0
107152,heart,0,0
107153,disease,0,0
107154,were,0,0
107155,recruited,0,0
107156,.,0,0
107157,Before,0,0
107158,surgery,0,0
107159,",",0,0
107160,a,0,0
107161,radial,0,0
107162,arterial,0,0
107163,cannula,0,0
107164,was,0,0
107165,placed,0,0
107166,and,0,0
107167,attached,0,0
107168,to,0,0
107169,an,0,0
107170,Edwards,0,0
107171,Lifesciences,0,0
107172,FloTrac/Vigileo,0,0
107173,system,0,0
107174,for,0,0
107175,measuring,0,0
107176,cardiac,0,0
107177,output,0,0
107178,.,0,0
107179,Patients,0,0
107180,were,0,0
107181,given,0,0
107182,a,0,0
107183,250-mL,0,1
107184,bolus,0,1
107185,of,1,1
107186,Voluven,1,1
107187,(,1,0
107188,6,1,0
107189,%,1,0
107190,hydroxyethyl,1,1
107191,starch,1,1
107192,130/0.4,1,1
107193,in,1,0
107194,0.9,1,0
107195,%,1,0
107196,sodium,1,1
107197,chloride,1,1
107198,),1,1
107199,until,1,0
107200,the,0,0
107201,stroke,0,0
107202,volume,0,0
107203,no,0,0
107204,longer,0,0
107205,increased,0,0
107206,by,0,0
107207,10,0,0
107208,%,0,0
107209,",",0,0
107210,then,0,0
107211,received,0,0
107212,either,0,0
107213,dopexamine,1,1
107214,(,1,1
107215,0.5,1,1
107216,?g,1,1
107217,?,0,1
107218,kg,0,1
107219,(,0,1
107220,-1,0,1
107221,),0,1
107222,?,0,1
107223,min,0,1
107224,(,0,1
107225,-1,0,1
107226,),0,1
107227,),0,1
107228,or,1,0
107229,saline,1,1
107230,0.9,0,0
107231,%,0,0
107232,for,0,0
107233,24,0,0
107234,hours,0,0
107235,.,0,0
107236,During,0,0
107237,surgery,1,0
107238,",",1,0
107239,fluid,0,1
107240,boluses,0,1
107241,of,0,0
107242,Voluven,1,1
107243,were,1,0
107244,given,0,0
107245,if,0,0
107246,the,0,0
107247,stroke,0,0
107248,volume,0,0
107249,variation,0,0
107250,was,0,0
107251,>,0,0
107252,10,0,0
107253,%,0,0
107254,.,0,0
107255,No,0,0
107256,crystalloid,0,1
107257,was,0,0
107258,given,0,0
107259,during,0,0
107260,surgery,0,0
107261,.,0,0
107262,A,0,0
107263,standardized,0,1
107264,postoperative,0,1
107265,fluid,0,1
107266,regime,0,0
107267,with,1,0
107268,Hartmann,1,0
107269,solution,1,0
107270,was,0,0
107271,prescribed,0,0
107272,at,0,0
107273,1.5,0,0
107274,mL,0,0
107275,?,0,1
107276,kg,0,1
107277,(,0,1
107278,-1,0,1
107279,),0,1
107280,?,0,1
107281,h,0,1
107282,(,0,0
107283,-1,0,0
107284,),0,0
107285,for,0,0
107286,24,0,0
107287,hours,0,0
107288,.,0,0
107289,The,0,0
107290,primary,0,0
107291,outcome,0,0
107292,measure,0,0
107293,was,0,0
107294,postoperative,0,0
107295,morbidity,0,0
107296,measured,0,0
107297,by,0,0
107298,the,0,0
107299,Postoperative,0,0
107300,Morbidity,0,0
107301,Survey,0,0
107302,.,0,0
107303,RESULTS,0,0
107304,One,0,0
107305,hundred,0,0
107306,twenty-four,0,0
107307,patients,0,0
107308,were,0,0
107309,recruited,0,0
107310,over,0,0
107311,a,0,0
107312,23-month,0,0
107313,period,0,0
107314,.,0,0
107315,The,0,0
107316,incidence,0,0
107317,of,0,0
107318,morbidity,0,0
107319,as,0,0
107320,measured,0,0
107321,by,0,0
107322,the,0,0
107323,Postoperative,0,0
107324,Morbidity,0,0
107325,Survey,0,0
107326,on,0,0
107327,day,0,0
107328,5,0,0
107329,was,0,0
107330,55,0,0
107331,%,0,0
107332,in,0,0
107333,the,1,0
107334,control,1,0
107335,group,1,0
107336,versus,1,0
107337,47,0,0
107338,%,0,0
107339,in,1,0
107340,the,1,0
107341,dopexamine,1,1
107342,group,0,0
107343,(,0,0
107344,P,0,0
107345,=,0,0
107346,0.14,0,0
107347,),0,0
107348,.,0,0
107349,There,0,0
107350,was,0,0
107351,no,0,0
107352,significant,0,0
107353,reduction,0,0
107354,in,0,0
107355,morbidity,0,0
107356,on,0,0
107357,any,0,0
107358,measured,0,0
107359,postoperative,0,0
107360,day,0,0
107361,.,0,0
107362,Complication,0,0
107363,rates,0,0
107364,",",0,0
107365,mortality,0,0
107366,",",0,0
107367,and,0,0
107368,hospital,0,0
107369,length,0,0
107370,of,0,0
107371,stay,0,0
107372,were,0,0
107373,similar,0,0
107374,between,0,0
107375,the,0,0
107376,2,0,0
107377,groups,0,0
107378,;,0,0
107379,however,0,0
107380,",",0,0
107381,administration,1,1
107382,of,1,1
107383,dopexamine,1,1
107384,was,0,0
107385,associated,0,0
107386,with,0,0
107387,earlier,0,0
107388,return,0,0
107389,of,0,0
107390,tolerating,0,1
107391,an,0,1
107392,enteral,0,1
107393,diet,0,1
107394,.,0,1
107395,CONCLUSION,0,0
107396,With,0,0
107397,the,0,0
107398,effective,0,0
107399,use,1,0
107400,of,1,0
107401,goal-directed,1,0
107402,fluid,1,1
107403,therapy,1,0
107404,in,1,0
107405,elective,0,0
107406,surgical,0,0
107407,patients,0,0
107408,",",0,0
107409,the,0,0
107410,routine,0,0
107411,use,0,0
107412,of,1,0
107413,dopexamine,1,1
107414,does,0,0
107415,not,0,0
107416,confer,0,0
107417,an,0,0
107418,additional,0,0
107419,clinical,0,0
107420,benefit,0,0
107421,.,0,0
107422,Effect,0,0
107423,of,0,0
107424,total,0,0
107425,enteral,0,1
107426,nutrition,0,1
107427,on,0,0
107428,the,0,0
107429,short-term,0,0
107430,outcome,0,0
107431,of,0,0
107432,severely,0,0
107433,malnourished,0,0
107434,cirrhotics,0,0
107435,.,0,0
107436,A,0,0
107437,randomized,0,0
107438,controlled,0,0
107439,trial,0,0
107440,.,0,0
107441,Thirty-five,0,0
107442,severely,0,0
107443,malnourished,0,0
107444,cirrhotic,0,0
107445,patients,0,0
107446,were,0,0
107447,randomized,1,0
107448,to,1,0
107449,receive,1,0
107450,either,1,0
107451,enteral-tube,1,1
107452,feeding,1,0
107453,as,1,0
107454,the,1,0
107455,sole,1,0
107456,nutritional,1,0
107457,support,1,1
107458,(,1,0
107459,n,1,0
107460,=,1,0
107461,16,1,0
107462,),1,0
107463,or,1,0
107464,an,1,0
107465,isocaloric,1,1
107466,",",1,1
107467,isonitrogenous,1,1
107468,",",1,1
107469,low-sodium,1,1
107470,standard,1,1
107471,oral,1,1
107472,diet,1,1
107473,(,1,1
107474,n,1,0
107475,=,1,0
107476,19,1,0
107477,),1,0
107478,.,0,0
107479,Both,0,0
107480,groups,0,0
107481,were,0,0
107482,homogeneous,0,0
107483,regarding,0,0
107484,age,0,0
107485,",",0,0
107486,sex,0,0
107487,distribution,0,0
107488,",",0,0
107489,etiology,0,0
107490,of,0,0
107491,liver,0,0
107492,cirrhosis,0,0
107493,",",0,0
107494,history,0,0
107495,of,0,0
107496,previous,0,0
107497,complications,0,0
107498,",",0,0
107499,clinical,0,0
107500,status,0,0
107501,",",0,0
107502,liver,0,0
107503,and,0,0
107504,renal,0,0
107505,function,0,0
107506,",",0,0
107507,modified,0,0
107508,Child,0,0
107509,'s,0,0
107510,score,0,0
107511,",",0,0
107512,and,0,0
107513,nutritional,0,0
107514,status,0,0
107515,at,0,0
107516,admission,0,0
107517,.,0,0
107518,The,0,0
107519,enteral,1,1
107520,formula,1,1
107521,diet,1,1
107522,was,1,0
107523,energy,1,0
107524,dense,1,0
107525,",",1,0
107526,containing,1,0
107527,40,1,1
107528,mmol,1,1
107529,Na/day,1,1
107530,",",1,1
107531,whole,1,0
107532,protein,1,0
107533,plus,1,0
107534,branched-chain,1,1
107535,amino,1,0
107536,acids,1,1
107537,",",1,0
107538,medium-,1,0
107539,and,1,1
107540,long-chain,1,1
107541,triglycerides,1,1
107542,",",1,1
107543,and,1,1
107544,maltodextrin,1,1
107545,.,1,1
107546,It,1,0
107547,supplied,1,0
107548,2115,1,0
107549,kcal/day,1,0
107550,.,1,0
107551,The,1,0
107552,amount,1,0
107553,of,1,0
107554,vitamins,1,1
107555,and,1,0
107556,trace,1,0
107557,elements,1,0
107558,was,1,0
107559,at,1,0
107560,the,1,0
107561,upper,1,0
107562,limit,1,0
107563,of,1,0
107564,the,1,0
107565,recommended,1,1
107566,dietary,1,1
107567,allowances,1,1
107568,.,1,1
107569,The,1,0
107570,orally,1,1
107571,fed,1,0
107572,patients,1,0
107573,were,1,0
107574,encouraged,1,0
107575,to,1,0
107576,eat,1,0
107577,all,1,0
107578,meals,1,1
107579,served,1,0
107580,.,1,0
107581,Total,0,0
107582,enteral,0,1
107583,nutrition,0,1
107584,was,0,0
107585,well,0,0
107586,tolerated,0,1
107587,without,0,0
107588,major,0,0
107589,complications,0,0
107590,.,0,0
107591,Serum,0,1
107592,albumin,0,1
107593,and,0,1
107594,Child,0,0
107595,'s,0,0
107596,score,0,0
107597,improved,0,0
107598,in,0,0
107599,the,0,0
107600,enterally,0,1
107601,fed,0,0
107602,patients,0,0
107603,but,0,0
107604,not,0,0
107605,in,0,0
107606,controls,0,0
107607,.,0,0
107608,Mortality,0,0
107609,rate,0,0
107610,while,0,0
107611,in,0,0
107612,the,0,0
107613,hospital,0,0
107614,was,0,0
107615,lower,0,0
107616,in,0,0
107617,patients,0,0
107618,on,0,0
107619,enteral,0,1
107620,feeding,0,0
107621,than,0,0
107622,in,0,0
107623,controls,0,1
107624,(,0,0
107625,12,0,0
107626,%,0,0
107627,vs,0,0
107628,47,0,0
107629,%,0,0
107630,),0,0
107631,.,0,0
107632,These,0,0
107633,results,0,0
107634,show,0,0
107635,that,0,0
107636,total,0,0
107637,enteral,0,1
107638,nutrition,0,1
107639,is,0,0
107640,safe,0,0
107641,and,0,0
107642,effective,0,0
107643,in,0,0
107644,improving,0,0
107645,the,0,0
107646,short-term,0,0
107647,clinical,0,0
107648,outcome,0,0
107649,in,0,0
107650,severely,0,0
107651,malnourished,0,0
107652,cirrhotics,0,0
107653,.,0,0
107654,Effect,0,0
107655,of,0,0
107656,VX-770,1,0
107657,in,0,0
107658,persons,0,0
107659,with,0,0
107660,cystic,0,0
107661,fibrosis,0,0
107662,and,0,0
107663,the,0,0
107664,G551D-CFTR,0,0
107665,mutation,0,0
107666,.,0,0
107667,BACKGROUND,0,0
107668,A,0,0
107669,new,0,0
107670,approach,0,0
107671,in,0,0
107672,the,0,0
107673,treatment,0,0
107674,of,0,0
107675,cystic,0,0
107676,fibrosis,0,0
107677,involves,0,0
107678,improving,0,0
107679,the,0,0
107680,function,0,0
107681,of,0,0
107682,mutant,0,0
107683,cystic,0,0
107684,fibrosis,0,0
107685,transmembrane,0,0
107686,conductance,0,0
107687,regulator,0,0
107688,(,0,0
107689,CFTR,0,1
107690,),0,1
107691,.,0,0
107692,VX-770,0,0
107693,",",0,0
107694,a,0,0
107695,CFTR,0,1
107696,potentiator,0,1
107697,",",0,0
107698,has,0,0
107699,been,0,0
107700,shown,0,0
107701,to,0,0
107702,increase,0,0
107703,the,0,0
107704,activity,0,0
107705,of,0,0
107706,wild-type,0,0
107707,and,0,0
107708,defective,0,0
107709,cell-surface,0,0
107710,CFTR,0,0
107711,in,0,0
107712,vitro,0,0
107713,.,0,0
107714,METHODS,0,0
107715,We,0,0
107716,randomly,0,0
107717,assigned,0,0
107718,39,0,0
107719,adults,0,0
107720,with,0,0
107721,cystic,0,0
107722,fibrosis,0,0
107723,and,0,0
107724,at,0,0
107725,least,0,0
107726,one,0,0
107727,G551D-CFTR,0,0
107728,allele,0,0
107729,to,0,0
107730,receive,0,1
107731,oral,1,1
107732,VX-770,1,1
107733,every,0,1
107734,12,0,0
107735,hours,0,0
107736,at,0,0
107737,a,0,0
107738,dose,0,1
107739,of,0,0
107740,25,0,0
107741,",",0,0
107742,75,0,0
107743,",",0,0
107744,or,0,0
107745,150,0,1
107746,mg,0,1
107747,or,0,1
107748,placebo,1,1
107749,for,0,1
107750,14,0,1
107751,days,0,0
107752,(,0,0
107753,in,0,0
107754,part,0,0
107755,1,0,0
107756,of,0,0
107757,the,0,0
107758,study,0,0
107759,),0,0
107760,or,0,0
107761,VX-770,1,1
107762,every,0,1
107763,12,0,0
107764,hours,0,0
107765,at,0,0
107766,a,0,0
107767,dose,0,1
107768,of,0,0
107769,150,0,0
107770,or,0,0
107771,250,0,1
107772,mg,0,1
107773,or,0,1
107774,placebo,1,1
107775,for,0,0
107776,28,0,0
107777,days,0,0
107778,(,0,0
107779,in,0,0
107780,part,0,0
107781,2,0,0
107782,of,0,0
107783,the,0,0
107784,study,0,0
107785,),0,0
107786,.,0,0
107787,RESULTS,0,1
107788,At,0,1
107789,day,0,0
107790,28,0,0
107791,",",0,0
107792,in,0,0
107793,the,0,0
107794,group,0,0
107795,of,0,0
107796,subjects,0,0
107797,who,0,0
107798,received,0,0
107799,150,0,0
107800,mg,0,1
107801,of,0,0
107802,VX-770,0,1
107803,",",0,0
107804,the,0,0
107805,median,0,0
107806,change,0,0
107807,in,0,0
107808,the,0,0
107809,nasal,0,0
107810,potential,0,0
107811,difference,0,0
107812,(,0,0
107813,in,0,0
107814,response,0,0
107815,to,0,0
107816,the,0,0
107817,administration,0,1
107818,of,0,0
107819,a,0,1
107820,chloride-free,0,1
107821,isoproterenol,0,1
107822,solution,0,1
107823,),0,0
107824,from,0,0
107825,baseline,0,0
107826,was,0,0
107827,-3.5,0,0
107828,mV,0,0
107829,(,0,0
107830,range,0,0
107831,",",0,0
107832,-8.3,0,0
107833,to,0,0
107834,0.5,0,0
107835,;,0,0
107836,P=0.02,0,0
107837,for,0,0
107838,the,0,0
107839,within-subject,0,0
107840,comparison,0,0
107841,",",0,0
107842,P=0.13,0,0
107843,vs.,0,0
107844,placebo,0,1
107845,),0,0
107846,",",0,0
107847,and,0,0
107848,the,0,0
107849,median,0,0
107850,change,0,0
107851,in,0,0
107852,the,0,0
107853,level,0,0
107854,of,0,0
107855,sweat,0,0
107856,chloride,0,0
107857,was,0,0
107858,-59.5,0,0
107859,mmol,0,1
107860,per,0,1
107861,liter,0,1
107862,(,0,1
107863,range,0,0
107864,",",0,0
107865,-66.0,0,0
107866,to,0,0
107867,-19.0,0,0
107868,;,0,0
107869,P=0.008,0,0
107870,within-subject,0,0
107871,",",0,0
107872,P=0.02,0,0
107873,vs.,0,0
107874,placebo,0,0
107875,),0,0
107876,.,0,0
107877,The,0,0
107878,median,0,0
107879,change,0,0
107880,from,0,0
107881,baseline,0,0
107882,in,0,0
107883,the,0,0
107884,percent,0,0
107885,of,0,0
107886,predicted,0,0
107887,forced,0,0
107888,expiratory,0,0
107889,volume,0,0
107890,in,0,0
107891,1,0,0
107892,second,0,0
107893,was,0,0
107894,8.7,0,0
107895,%,0,0
107896,(,0,0
107897,range,0,0
107898,",",0,0
107899,2.3,0,0
107900,to,0,0
107901,31.3,0,0
107902,;,0,0
107903,P=0.008,0,0
107904,for,0,0
107905,the,0,0
107906,within-subject,0,0
107907,comparison,0,0
107908,",",0,0
107909,P=0.56,0,0
107910,vs.,0,0
107911,placebo,0,1
107912,),0,1
107913,.,0,1
107914,None,0,1
107915,of,0,0
107916,the,0,0
107917,subjects,0,0
107918,withdrew,0,0
107919,from,0,0
107920,the,0,0
107921,study,0,0
107922,.,0,0
107923,Six,0,1
107924,severe,0,1
107925,adverse,0,0
107926,events,0,0
107927,occurred,0,0
107928,in,0,0
107929,two,0,0
107930,subjects,0,0
107931,(,0,0
107932,diffuse,0,0
107933,macular,0,0
107934,rash,0,0
107935,in,0,0
107936,one,0,0
107937,subject,0,0
107938,and,0,0
107939,five,0,0
107940,incidents,0,0
107941,of,0,0
107942,elevated,0,0
107943,blood,0,0
107944,and,0,1
107945,urine,0,1
107946,glucose,0,1
107947,levels,0,0
107948,in,0,0
107949,one,0,0
107950,subject,0,0
107951,with,0,0
107952,diabetes,0,0
107953,),0,0
107954,.,0,0
107955,All,0,1
107956,severe,0,0
107957,adverse,0,0
107958,events,0,0
107959,resolved,0,0
107960,without,0,0
107961,the,0,0
107962,discontinuation,0,0
107963,of,0,0
107964,VX-770,0,0
107965,.,0,0
107966,CONCLUSIONS,0,0
107967,This,0,0
107968,study,0,0
107969,to,0,0
107970,evaluate,0,0
107971,the,0,0
107972,safety,0,0
107973,and,0,0
107974,adverse-event,0,0
107975,profile,0,0
107976,of,0,0
107977,VX-770,0,0
107978,showed,0,0
107979,that,0,0
107980,VX-770,0,0
107981,was,0,0
107982,associated,0,0
107983,with,0,0
107984,within-subject,0,0
107985,improvements,0,0
107986,in,0,0
107987,CFTR,0,0
107988,and,0,0
107989,lung,0,0
107990,function,0,0
107991,.,0,0
107992,These,0,0
107993,findings,0,0
107994,provide,0,0
107995,support,0,0
107996,for,0,0
107997,further,0,0
107998,studies,0,0
107999,of,0,0
108000,pharmacologic,0,0
108001,potentiation,0,0
108002,of,0,0
108003,CFTR,0,0
108004,as,0,0
108005,a,0,0
108006,means,0,0
108007,to,0,0
108008,treat,0,0
108009,cystic,0,0
108010,fibrosis,0,1
108011,.,0,0
108012,(,0,0
108013,Funded,0,0
108014,by,0,0
108015,Vertex,0,1
108016,Pharmaceuticals,0,1
108017,and,0,1
108018,others,0,0
108019,;,0,0
108020,ClinicalTrials.gov,0,0
108021,number,0,0
108022,",",0,0
108023,NCT00457821,0,1
108024,.,0,0
108025,),0,0
108026,.,0,0
108027,Phase,0,0
108028,III,0,0
108029,trial,0,0
108030,of,0,0
108031,gemcitabine,1,1
108032,plus,1,1
108033,docetaxel,1,1
108034,versus,0,1
108035,capecitabine,1,1
108036,plus,1,1
108037,docetaxel,1,1
108038,with,0,1
108039,planned,0,1
108040,crossover,0,1
108041,to,0,0
108042,the,0,0
108043,alternate,0,0
108044,single,0,0
108045,agent,0,0
108046,in,0,0
108047,metastatic,0,0
108048,breast,0,0
108049,cancer,0,0
108050,.,0,0
108051,BACKGROUND,0,0
108052,Safety,0,0
108053,and,0,0
108054,efficacy,0,0
108055,of,0,0
108056,gemcitabine,1,1
108057,plus,1,1
108058,docetaxel,1,1
108059,(,1,1
108060,GD,1,1
108061,),1,1
108062,and,0,0
108063,capecitabine,1,1
108064,plus,1,1
108065,docetaxel,1,1
108066,(,1,1
108067,CD,1,1
108068,),1,0
108069,were,0,0
108070,compared,0,0
108071,in,0,0
108072,patients,0,0
108073,with,0,0
108074,metastatic,0,0
108075,breast,0,0
108076,cancer,0,0
108077,",",0,0
108078,where,0,0
108079,the,0,0
108080,alternate,0,0
108081,crossover,0,1
108082,monotherapy,1,1
108083,(,1,1
108084,GD?C,1,1
108085,or,1,1
108086,CD?G,1,1
108087,),1,0
108088,was,1,0
108089,predetermined,0,0
108090,.,0,0
108091,PATIENTS,0,0
108092,AND,0,0
108093,METHODS,0,0
108094,Patients,0,0
108095,were,0,0
108096,randomly,0,0
108097,assigned,0,0
108098,to,0,0
108099,3-week,0,1
108100,cycles,0,0
108101,of,0,0
108102,either,1,0
108103,gemcitabine,1,1
108104,1000,1,1
108105,mg/m,0,1
108106,(,0,1
108107,2,0,1
108108,),0,1
108109,on,0,0
108110,days,0,0
108111,1,0,0
108112,and,0,0
108113,8,0,0
108114,plus,0,0
108115,docetaxel,1,1
108116,75,1,1
108117,mg/m,0,1
108118,(,0,1
108119,2,0,1
108120,),0,1
108121,on,0,0
108122,day,0,0
108123,1,0,0
108124,or,0,1
108125,capecitabine,1,1
108126,1000,1,1
108127,mg/m,0,1
108128,(,0,1
108129,2,0,1
108130,),0,1
108131,twice,0,1
108132,daily,0,1
108133,on,0,1
108134,days,0,0
108135,1-14,0,0
108136,plus,1,0
108137,docetaxel,1,1
108138,75,1,1
108139,mg/m,0,1
108140,(,0,1
108141,2,0,1
108142,),0,1
108143,day,0,0
108144,1,0,1
108145,.,0,0
108146,Upon,0,0
108147,progression,0,0
108148,",",0,0
108149,patients,0,0
108150,received,1,0
108151,crossover,1,1
108152,monotherapy,1,1
108153,.,1,1
108154,Primary,1,0
108155,end,0,0
108156,point,0,0
108157,was,0,0
108158,time,0,0
108159,to,0,0
108160,progression,0,0
108161,(,0,1
108162,TtP,0,1
108163,),0,1
108164,.,0,0
108165,Secondary,0,0
108166,end,0,0
108167,points,0,0
108168,evaluated,0,0
108169,overall,0,0
108170,response,0,0
108171,rate,0,0
108172,(,0,0
108173,ORR,0,1
108174,),0,1
108175,",",0,0
108176,overall,0,0
108177,survival,0,1
108178,(,0,1
108179,OS,0,1
108180,),0,1
108181,",",0,0
108182,and,0,0
108183,adverse,0,0
108184,events,0,0
108185,(,0,1
108186,AEs,0,1
108187,),0,1
108188,.,0,0
108189,RESULTS,0,1
108190,Despite,0,0
108191,over-accrual,0,0
108192,of,0,0
108193,475,0,0
108194,patients,0,0
108195,",",0,0
108196,the,0,0
108197,trial,0,0
108198,matured,0,0
108199,with,0,0
108200,only,0,0
108201,324,0,0
108202,of,0,0
108203,385,0,0
108204,planned,0,0
108205,TtP,0,0
108206,events,0,0
108207,due,0,0
108208,to,0,0
108209,patient,0,0
108210,discontinuations,0,0
108211,.,0,0
108212,Human,0,0
108213,epidermal,0,0
108214,growth,0,0
108215,factor,0,0
108216,receptor,0,0
108217,2,0,0
108218,status,0,0
108219,was,0,0
108220,not,0,0
108221,captured,0,0
108222,in,0,0
108223,this,0,0
108224,study,0,0
108225,.,0,0
108226,More,0,0
108227,CD,1,1
108228,patients,0,0
108229,(,0,0
108230,28,0,0
108231,%,0,0
108232,),0,0
108233,discontinued,0,1
108234,due,0,0
108235,to,0,0
108236,AEs,0,0
108237,than,0,0
108238,GD,1,0
108239,patients,0,0
108240,(,0,0
108241,18.0,0,0
108242,%,0,0
108243,",",0,0
108244,P,0,0
108245,=,0,0
108246,0.009,0,0
108247,),0,0
108248,.,0,0
108249,TtP,0,1
108250,[,0,0
108251,hazard,0,1
108252,ratio,0,1
108253,(,0,1
108254,HR,0,1
108255,),0,0
108256,=,0,0
108257,1.101,0,0
108258,",",0,0
108259,95,0,0
108260,%,0,0
108261,confidence,0,0
108262,interval,0,0
108263,(,0,0
108264,CI,0,0
108265,),0,0
108266,0.885-1.370,0,0
108267,",",0,0
108268,P,0,0
108269,=,0,0
108270,0.387,0,0
108271,],0,0
108272,and,0,0
108273,OS,0,1
108274,(,0,0
108275,HR,0,0
108276,=,0,0
108277,1.031,0,0
108278,",",0,0
108279,95,0,0
108280,%,0,0
108281,CI,0,0
108282,0.830-1.280,0,0
108283,",",0,0
108284,P,0,0
108285,=,0,0
108286,0.785,0,0
108287,),0,0
108288,were,0,0
108289,not,0,0
108290,significantly,0,0
108291,different,0,0
108292,comparing,1,0
108293,GD,1,0
108294,and,0,0
108295,CD,1,0
108296,.,1,0
108297,ORR,0,0
108298,was,0,0
108299,not,0,0
108300,statistically,0,0
108301,different,0,0
108302,(,0,0
108303,P,0,0
108304,=,0,0
108305,0.239,0,0
108306,),0,0
108307,comparing,0,0
108308,GD,0,0
108309,(,0,0
108310,72,0,0
108311,of,0,0
108312,207,0,0
108313,",",0,0
108314,34.8,0,0
108315,%,0,0
108316,),0,0
108317,and,0,0
108318,CD,0,1
108319,(,0,0
108320,78,0,0
108321,of,0,0
108322,191,0,0
108323,",",0,0
108324,40.8,0,0
108325,%,0,0
108326,),0,0
108327,.,0,0
108328,TtP,0,0
108329,",",0,0
108330,OS,0,0
108331,",",0,0
108332,and,0,0
108333,ORR,0,0
108334,were,0,0
108335,not,0,0
108336,significantly,0,0
108337,different,0,0
108338,comparing,0,0
108339,crossover,0,1
108340,groups,1,0
108341,.,1,0
108342,GD,1,0
108343,caused,0,0
108344,greater,0,0
108345,fatigue,0,0
108346,",",0,0
108347,hepatotoxicity,0,1
108348,",",0,1
108349,neutropenia,0,1
108350,",",0,0
108351,and,0,0
108352,thrombocytopenia,0,0
108353,but,0,0
108354,not,0,0
108355,febrile,0,0
108356,neutropenia,1,1
108357,;,1,0
108358,CD,1,0
108359,caused,0,0
108360,more,0,0
108361,hand-foot,0,0
108362,syndrome,0,0
108363,",",0,0
108364,gastrointestinal,0,0
108365,toxicity,0,0
108366,",",0,0
108367,and,0,0
108368,mucositis,0,0
108369,.,0,0
108370,CONCLUSIONS,1,0
108371,GD,1,0
108372,and,0,0
108373,CD,1,0
108374,produced,0,0
108375,similar,0,0
108376,efficacy,0,0
108377,and,0,0
108378,toxicity,0,0
108379,profiles,0,0
108380,consistent,0,0
108381,with,0,0
108382,prior,0,0
108383,clinical,0,0
108384,experience,0,0
108385,.,0,0
108386,Effects,0,0
108387,of,0,0
108388,the,0,0
108389,810-nm,1,1
108390,diode,1,1
108391,laser,1,1
108392,on,0,0
108393,hair,0,0
108394,and,0,0
108395,on,0,0
108396,the,0,0
108397,biophysical,0,0
108398,properties,0,0
108399,of,0,0
108400,skin,0,0
108401,.,0,0
108402,INTRODUCTION,0,0
108403,Laser,1,0
108404,therapy,1,0
108405,is,0,0
108406,clinically,0,0
108407,effective,0,0
108408,in,0,0
108409,hair,0,0
108410,removal,0,0
108411,;,0,0
108412,however,0,0
108413,",",0,0
108414,despite,0,0
108415,the,0,0
108416,development,0,0
108417,of,0,0
108418,various,0,0
108419,strategies,0,0
108420,",",0,0
108421,laser,0,0
108422,procedures,0,0
108423,still,0,0
108424,present,0,0
108425,a,0,0
108426,risk,0,0
108427,of,0,0
108428,adverse,0,0
108429,effects,0,0
108430,due,0,0
108431,to,0,0
108432,the,0,0
108433,overheating,0,0
108434,of,0,0
108435,the,0,0
108436,skin,0,0
108437,.,0,0
108438,OBJECTIVE,0,0
108439,To,0,0
108440,investigate,0,0
108441,the,0,0
108442,effects,0,0
108443,of,0,0
108444,810-nm,1,1
108445,diode,1,1
108446,laser,1,1
108447,treatment,1,0
108448,on,0,0
108449,hair,0,0
108450,and,0,0
108451,on,0,0
108452,the,0,0
108453,biophysical,0,0
108454,properties,0,0
108455,of,0,0
108456,skin,0,0
108457,by,0,0
108458,using,0,0
108459,various,0,0
108460,non-invasive,1,0
108461,techniques,1,0
108462,on,0,0
108463,various,0,0
108464,parameters,0,0
108465,",",0,0
108466,including,0,0
108467,hair,0,0
108468,analysis,0,0
108469,",",0,0
108470,surface,0,0
108471,color,0,0
108472,changes,0,0
108473,",",0,0
108474,integrity,0,0
108475,of,0,0
108476,skin,0,0
108477,barrier,0,0
108478,",",0,0
108479,sebum,0,1
108480,production,0,0
108481,rate,0,0
108482,and,0,0
108483,pH,0,0
108484,level,0,0
108485,.,0,0
108486,METHODS,0,0
108487,In,0,0
108488,this,0,0
108489,randomized,0,0
108490,",",0,0
108491,right-left,0,0
108492,comparison,0,0
108493,study,0,0
108494,",",0,0
108495,35,0,0
108496,women,0,0
108497,with,0,0
108498,axillary,0,0
108499,hair,0,0
108500,received,0,0
108501,single-session,1,0
108502,diode,1,1
108503,laser,1,0
108504,therapy,1,0
108505,.,1,0
108506,Hair,0,0
108507,analysis,0,0
108508,and,0,0
108509,biophysical,0,0
108510,properties,0,0
108511,of,0,0
108512,the,0,0
108513,skin,0,0
108514,were,0,0
108515,assessed,0,0
108516,before,0,0
108517,treatment,0,0
108518,and,0,0
108519,at,0,0
108520,weeks,0,0
108521,2,0,0
108522,",",0,0
108523,4,0,0
108524,and,0,0
108525,6,0,0
108526,after,0,0
108527,the,0,0
108528,therapy,0,0
108529,.,0,0
108530,RESULTS,0,0
108531,Hair,0,0
108532,density,0,0
108533,and,0,0
108534,thicknesses,0,0
108535,statistically,0,0
108536,significantly,0,0
108537,decreased,0,0
108538,after,0,0
108539,the,0,0
108540,first,0,0
108541,post-treatment,0,0
108542,evaluation,0,0
108543,.,0,0
108544,Regarding,0,0
108545,comparison,0,0
108546,of,0,0
108547,the,0,0
108548,biophysical,0,0
108549,properties,0,0
108550,of,0,0
108551,the,0,0
108552,skin,0,0
108553,",",0,0
108554,there,0,0
108555,was,0,0
108556,no,0,0
108557,statistically,0,0
108558,significant,0,0
108559,difference,0,0
108560,in,0,0
108561,the,0,0
108562,assessments,0,0
108563,",",0,0
108564,except,0,0
108565,for,0,0
108566,the,0,0
108567,increase,0,0
108568,determined,0,0
108569,during,0,0
108570,the,0,0
108571,second,0,0
108572,week,0,0
108573,in,0,0
108574,the,0,0
108575,erythema,0,0
108576,index,0,0
108577,in,0,0
108578,the,0,0
108579,laser-treated,0,0
108580,areas,0,0
108581,.,0,0
108582,CONCLUSION,0,0
108583,The,0,0
108584,findings,0,0
108585,of,0,0
108586,this,0,0
108587,study,0,0
108588,showed,0,0
108589,that,0,0
108590,the,0,0
108591,diode,1,0
108592,laser,1,0
108593,can,1,0
108594,perform,0,0
108595,a,0,0
108596,significant,0,0
108597,reduction,0,0
108598,in,0,0
108599,the,0,0
108600,hair,0,0
108601,amount,0,0
108602,without,0,0
108603,significant,0,0
108604,epidermal,0,0
108605,damage,0,0
108606,",",0,0
108607,at,0,0
108608,least,0,0
108609,for,0,0
108610,a,0,0
108611,short,0,0
108612,period,0,0
108613,.,0,0
108614,Cost-effectiveness,0,0
108615,of,0,0
108616,ablation,1,0
108617,surgery,1,0
108618,in,0,0
108619,patients,0,0
108620,with,0,0
108621,atrial,0,0
108622,fibrillation,0,0
108623,undergoing,0,1
108624,cardiac,0,0
108625,surgery,0,0
108626,.,0,0
108627,This,0,0
108628,study,0,0
108629,was,0,0
108630,performed,0,0
108631,to,0,0
108632,assess,0,0
108633,the,0,0
108634,cost-effectiveness,0,0
108635,of,0,0
108636,concomitant,0,0
108637,ablation,1,0
108638,surgery,1,1
108639,(,1,1
108640,AS,1,1
108641,),1,0
108642,compared,0,0
108643,to,0,0
108644,regular,0,0
108645,cardiac,1,0
108646,surgery,1,0
108647,in,0,0
108648,atrial,0,1
108649,fibrillation,0,1
108650,(,0,1
108651,AF,0,1
108652,),0,1
108653,patients,0,0
108654,over,0,0
108655,a,0,0
108656,one-year,0,0
108657,follow-up,0,0
108658,.,0,0
108659,Cost,0,0
108660,analysis,0,0
108661,was,0,0
108662,performed,0,0
108663,from,0,0
108664,a,0,0
108665,societal,0,0
108666,perspective,0,0
108667,alongside,0,0
108668,a,0,0
108669,prospective,0,0
108670,",",0,0
108671,randomised,0,1
108672,",",0,1
108673,double-blinded,0,1
108674,",",0,1
108675,multicentre,0,1
108676,trial,0,0
108677,.,0,0
108678,One,0,0
108679,hundred,0,0
108680,and,0,0
108681,fifty,0,0
108682,patients,0,0
108683,with,0,0
108684,documented,0,0
108685,AF,0,0
108686,were,0,0
108687,randomly,1,0
108688,assigned,1,0
108689,to,1,0
108690,undergo,1,0
108691,cardiac,1,0
108692,surgery,1,0
108693,with,1,0
108694,or,1,0
108695,without,1,0
108696,AS,1,0
108697,.,1,0
108698,One,0,0
108699,hundred,0,0
108700,and,0,0
108701,thirty-two,0,0
108702,patients,0,0
108703,were,0,0
108704,included,0,0
108705,in,0,0
108706,the,0,0
108707,cost-effectiveness,1,0
108708,study,0,0
108709,.,0,0
108710,All,0,1
108711,costs,0,1
108712,(,0,0
108713,medical,0,0
108714,and,0,1
108715,non-medical,0,0
108716,),0,0
108717,were,0,0
108718,measured,0,0
108719,during,0,0
108720,follow-up,0,0
108721,.,0,0
108722,Costs,0,0
108723,data,0,0
108724,were,0,0
108725,combined,0,0
108726,with,0,0
108727,quality,0,0
108728,adjusted,0,0
108729,life,0,1
108730,years,0,1
108731,(,0,1
108732,QALYs,0,1
108733,),0,0
108734,to,0,0
108735,obtain,0,0
108736,the,0,0
108737,incremental,0,0
108738,costs,0,0
108739,per,0,0
108740,QALY,0,0
108741,.,0,0
108742,Total,0,0
108743,costs,0,0
108744,of,0,0
108745,the,0,0
108746,AS,1,0
108747,group,0,0
108748,were,0,0
108749,significantly,0,0
108750,higher,0,0
108751,compared,0,0
108752,to,0,0
108753,the,0,0
108754,regular,0,0
108755,cardiac,0,0
108756,surgery,0,1
108757,group,0,1
108758,[,0,0
108759,cost,0,0
108760,difference,0,0
108761,bootstrap,0,0
108762,:,0,0
108763,"?4,724",0,0
108764,;,0,0
108765,95,0,0
108766,%,0,0
108767,uncertainty,0,0
108768,interval,0,0
108769,(,0,0
108770,UI,0,0
108771,),0,1
108772,",",0,0
108773,"?2,770-?6,678",0,1
108774,],0,0
108775,.,0,0
108776,The,0,0
108777,bootstrapped,0,0
108778,difference,0,0
108779,in,0,0
108780,QALYs,0,0
108781,was,0,0
108782,not,0,0
108783,statistically,0,0
108784,significant,0,0
108785,(,0,0
108786,0.06,0,0
108787,;,0,0
108788,95,0,0
108789,%,0,0
108790,UI,0,0
108791,:,0,0
108792,-0.024,0,0
108793,to,0,0
108794,0.14,0,0
108795,),0,0
108796,.,0,0
108797,The,0,0
108798,incremental,0,0
108799,cost-effectiveness,0,0
108800,ratio,0,0
108801,is,0,0
108802,"?73,359",0,0
108803,per,0,0
108804,QALY,0,0
108805,.,0,0
108806,The,0,0
108807,acceptability,0,0
108808,curve,0,0
108809,showed,0,0
108810,that,0,0
108811,",",0,0
108812,even,0,0
108813,in,0,0
108814,the,0,0
108815,case,0,0
108816,of,0,0
108817,a,0,0
108818,maximum,0,0
108819,threshold,0,0
108820,value,0,0
108821,of,0,0
108822,"?80,000",0,0
108823,per,0,0
108824,QALY,0,0
108825,gained,0,0
108826,",",0,0
108827,the,0,0
108828,probability,1,0
108829,of,1,0
108830,AS,1,0
108831,being,1,0
108832,more,0,0
108833,cost-effective,0,0
108834,than,0,0
108835,regular,0,0
108836,cardiac,0,0
108837,surgery,0,0
108838,did,0,0
108839,not,0,0
108840,reach,0,0
108841,beyond,0,0
108842,50,0,0
108843,%,0,0
108844,.,0,0
108845,Concluding,0,0
108846,that,0,0
108847,concomitant,1,0
108848,AS,1,0
108849,in,1,0
108850,AF,1,0
108851,is,0,0
108852,not,0,0
108853,cost-effective,0,0
108854,after,0,0
108855,a,0,0
108856,one-year,0,0
108857,follow-up,0,0
108858,compared,0,0
108859,to,0,0
108860,regular,0,0
108861,cardiac,0,0
108862,surgery,0,0
108863,.,0,0
108864,Effect,0,0
108865,of,0,0
108866,L-arginine,1,1
108867,or,1,1
108868,L-citrulline,1,1
108869,oral,1,1
108870,supplementation,1,1
108871,on,0,1
108872,blood,0,0
108873,pressure,0,0
108874,and,0,0
108875,right,0,0
108876,ventricular,0,0
108877,function,0,0
108878,in,0,0
108879,heart,0,0
108880,failure,0,0
108881,patients,0,0
108882,with,0,0
108883,preserved,0,0
108884,ejection,0,0
108885,fraction,0,0
108886,.,0,0
108887,BACKGROUND,0,0
108888,The,0,0
108889,effect,0,0
108890,of,0,0
108891,L-arginine,1,1
108892,and,1,1
108893,L-citrulline,1,1
108894,on,0,0
108895,blood,0,0
108896,pressure,0,0
108897,and,0,0
108898,right,0,0
108899,ventricular,0,0
108900,function,0,0
108901,in,0,0
108902,heart,0,0
108903,failure,0,0
108904,patients,0,0
108905,with,0,0
108906,preserved,0,0
108907,ejection,0,0
108908,fraction,0,0
108909,(,0,1
108910,HFpEF,0,1
108911,),0,0
108912,is,0,0
108913,unknown,0,0
108914,.,0,0
108915,We,0,0
108916,have,0,0
108917,therefore,0,0
108918,evaluated,0,0
108919,",",0,0
108920,in,0,0
108921,a,0,0
108922,randomized,0,0
108923,clinical,0,0
108924,trial,0,0
108925,",",0,0
108926,the,0,0
108927,effect,0,0
108928,of,0,0
108929,these,0,0
108930,aminoacids,0,0
108931,in,0,0
108932,chronic,0,0
108933,outstanding,0,0
108934,and,0,0
108935,stable,0,0
108936,patients,0,0
108937,with,0,0
108938,HFpEF,0,0
108939,.,0,0
108940,METHODS,0,0
108941,AND,0,1
108942,RESULTS,0,1
108943,All,0,0
108944,patients,0,0
108945,underwent,0,0
108946,an,0,0
108947,echocardiogram,1,0
108948,and,1,0
108949,radioisotopic,1,0
108950,ventriculography,1,0
108951,rest/exercise,1,0
108952,",",0,0
108953,and,0,0
108954,were,0,0
108955,randomized,0,0
108956,in,0,0
108957,a,0,0
108958,consecutive,0,0
108959,manner,0,0
108960,to,0,0
108961,the,0,0
108962,L-arginine,1,1
108963,group,1,1
108964,(,0,0
108965,n,0,0
108966,=,0,0
108967,15,0,0
108968,;,0,0
108969,8,0,1
108970,g/day,0,1
108971,),0,1
108972,;,0,1
108973,and,0,0
108974,the,0,0
108975,citrulline,1,1
108976,malate,1,1
108977,group,1,1
108978,(,0,0
108979,n,0,0
108980,=,0,0
108981,15,0,0
108982,;,0,0
108983,3,0,1
108984,g/day,0,1
108985,),0,1
108986,.,0,0
108987,The,0,0
108988,duration,0,0
108989,of,0,0
108990,follow-up,0,0
108991,was,0,0
108992,two,0,0
108993,months,0,0
108994,.,0,0
108995,The,0,0
108996,principal,0,0
108997,echocardiographic,0,0
108998,finding,0,0
108999,was,0,0
109000,a,0,0
109001,statistically,0,0
109002,significant,0,0
109003,decrease,0,0
109004,in,0,0
109005,pulmonary,0,0
109006,artery,0,0
109007,pressure,0,0
109008,in,0,0
109009,the,0,0
109010,L-arginine,1,1
109011,(,0,0
109012,56.3,0,0
109013,?,0,0
109014,10,0,0
109015,vs,0,0
109016,44,0,0
109017,?,0,0
109018,16.5,0,0
109019,mm,0,0
109020,Hg,0,0
109021,",",0,0
109022,p,0,0
109023,<,0,0
109024,0.05,0,0
109025,),0,0
109026,and,0,0
109027,the,1,1
109028,citrulline,1,1
109029,(,1,0
109030,56.67,0,0
109031,?,0,0
109032,7.96,0,0
109033,vs,0,0
109034,47.67,0,0
109035,?,0,0
109036,8.59,0,0
109037,mm,0,0
109038,Hg,0,0
109039,",",0,0
109040,p,0,0
109041,<,0,0
109042,0.05,0,0
109043,),0,0
109044,groups,0,0
109045,.,0,0
109046,Duration,0,0
109047,on,0,0
109048,treadmill,0,0
109049,and,0,0
109050,right,0,0
109051,ventricular,0,0
109052,ejection,0,0
109053,fraction,0,0
109054,post,0,0
109055,exercise,0,0
109056,increased,0,0
109057,",",0,0
109058,while,0,0
109059,diastolic,0,0
109060,and,0,0
109061,systolic,0,0
109062,artery,0,0
109063,pressure,0,0
109064,decreased,0,0
109065,significantly,0,0
109066,in,0,0
109067,both,0,0
109068,groups,0,0
109069,.,0,0
109070,There,0,0
109071,were,0,0
109072,no,0,0
109073,other,0,0
109074,statistically,0,0
109075,significant,0,0
109076,differences,0,0
109077,between,0,0
109078,the,0,0
109079,groups,0,0
109080,.,0,0
109081,CONCLUSIONS,0,0
109082,Administration,1,0
109083,of,1,0
109084,L-arginine,1,1
109085,and,1,1
109086,citrulline,1,1
109087,to,1,0
109088,patients,0,0
109089,with,0,0
109090,HFpEF,0,0
109091,improved,0,0
109092,right,0,0
109093,ventricular,0,0
109094,function,0,0
109095,by,0,0
109096,increasing,0,0
109097,right,0,0
109098,ventricular,0,0
109099,ejection,0,0
109100,fraction,0,0
109101,",",0,0
109102,and,0,0
109103,probably,0,0
109104,decreasing,0,0
109105,systolic,0,0
109106,pulmonary,0,0
109107,artery,0,0
109108,pressure,0,0
109109,.,0,0
109110,Cost,0,0
109111,effectiveness,0,0
109112,of,0,0
109113,training,0,0
109114,incontinent,0,0
109115,elderly,0,0
109116,in,0,0
109117,nursing,0,0
109118,homes,0,0
109119,:,0,0
109120,a,0,0
109121,randomized,0,0
109122,clinical,0,0
109123,trial,0,0
109124,.,0,0
109125,This,0,0
109126,study,0,0
109127,used,0,0
109128,a,0,0
109129,randomized,0,0
109130,clinical,0,0
109131,trial,0,0
109132,with,0,0
109133,133,0,0
109134,incontinent,0,0
109135,elderly,0,0
109136,in,0,0
109137,seven,0,0
109138,nursing,0,0
109139,homes,0,0
109140,to,0,0
109141,evaluate,0,0
109142,the,0,0
109143,effectiveness,0,0
109144,of,0,0
109145,a,0,0
109146,behavioral,1,0
109147,training,1,0
109148,therapy,1,0
109149,and,0,0
109150,its,0,0
109151,cost,0,0
109152,implications,0,0
109153,.,0,0
109154,The,0,0
109155,training,0,0
109156,program,0,0
109157,lasted,0,0
109158,three,0,0
109159,months,0,0
109160,",",0,0
109161,and,0,0
109162,a,0,0
109163,22-week,0,0
109164,follow-up,0,0
109165,period,0,0
109166,examined,0,0
109167,the,0,0
109168,durability,0,0
109169,of,0,0
109170,the,0,0
109171,treatment,0,0
109172,effect,0,0
109173,.,0,0
109174,The,0,0
109175,therapy,0,0
109176,became,0,0
109177,effective,0,0
109178,after,0,0
109179,six,0,0
109180,weeks,0,0
109181,of,0,0
109182,training,0,0
109183,.,0,0
109184,By,0,0
109185,the,0,0
109186,final,0,0
109187,months,0,0
109188,of,0,0
109189,training,0,0
109190,",",0,0
109191,the,0,0
109192,treatment,0,0
109193,participants,0,0
109194,',0,0
109195,wet,0,0
109196,episodes,0,0
109197,had,0,0
109198,been,0,0
109199,reduced,0,0
109200,by,0,0
109201,0.6,0,0
109202,episode,0,0
109203,per,0,0
109204,day,0,0
109205,",",0,0
109206,or,0,0
109207,a,0,0
109208,26,0,0
109209,percent,0,0
109210,reduction,0,0
109211,over,0,0
109212,baseline,0,0
109213,",",0,0
109214,and,0,0
109215,improvement,0,0
109216,was,0,0
109217,maintained,0,0
109218,during,0,0
109219,the,0,0
109220,follow-up,0,0
109221,period,0,0
109222,.,0,0
109223,Trainees,0,0
109224,with,0,0
109225,a,0,0
109226,high,0,0
109227,frequency,0,0
109228,of,0,0
109229,incontinence,0,0
109230,during,0,0
109231,baseline,0,0
109232,",",0,0
109233,relatively,0,0
109234,more,0,0
109235,cognitive,0,0
109236,residents,0,0
109237,",",0,0
109238,and,0,0
109239,residents,0,0
109240,with,0,0
109241,a,0,0
109242,normal,0,0
109243,bladder,0,0
109244,capacity,0,0
109245,responded,0,0
109246,better,0,0
109247,to,0,0
109248,this,0,0
109249,behavioral,1,0
109250,program,1,0
109251,.,1,0
109252,The,0,0
109253,cost,0,0
109254,of,0,0
109255,training,0,0
109256,was,0,0
109257,the,0,0
109258,equivalent,0,0
109259,of,0,0
109260,about,0,0
109261,one,0,0
109262,hour,0,0
109263,of,0,0
109264,nursing,0,1
109265,aide,0,0
109266,time,0,0
109267,per,0,0
109268,patient,0,0
109269,day,0,0
109270,.,0,0
109271,The,0,0
109272,reduction,0,0
109273,in,0,0
109274,incontinence,0,0
109275,during,0,0
109276,the,0,0
109277,follow-up,0,0
109278,period,0,0
109279,resulted,0,0
109280,in,0,0
109281,some,0,0
109282,small,0,0
109283,savings,0,0
109284,in,0,0
109285,laundry,0,0
109286,costs,0,0
109287,and,0,0
109288,supplies,0,0
109289,used,0,0
109290,",",0,0
109291,and,0,0
109292,some,0,0
109293,quantitatively,0,0
109294,unmeasurable,0,0
109295,but,0,0
109296,detectable,0,0
109297,improvement,0,0
109298,in,0,0
109299,psychosocial,0,0
109300,well-being,0,0
109301,among,0,0
109302,the,0,0
109303,trainees,0,0
109304,.,0,0
109305,Since,0,0
109306,the,0,0
109307,central,0,0
109308,figure,0,0
109309,in,0,0
109310,implementing,0,0
109311,this,0,0
109312,training,0,0
109313,protocol,0,0
109314,is,0,0
109315,the,0,0
109316,nursing,0,0
109317,aide,0,0
109318,",",0,0
109319,it,0,0
109320,is,0,0
109321,important,0,0
109322,to,0,0
109323,find,0,0
109324,an,0,0
109325,organizational,0,0
109326,management,0,0
109327,scheme,0,0
109328,that,0,0
109329,will,0,0
109330,stimulate,0,0
109331,nursing,0,0
109332,aides,0,0
109333,to,0,0
109334,reduce,0,0
109335,incontinence,0,0
109336,among,0,0
109337,nursing,0,0
109338,home,0,0
109339,residents,0,0
109340,.,0,0
109341,[,1,0
109342,Accelerated,1,0
109343,postoperative,1,0
109344,radiotherapy,1,0
109345,in,0,0
109346,patients,0,0
109347,with,0,0
109348,advanced,0,0
109349,larynx,0,1
109350,cancer,0,1
109351,],0,0
109352,.,0,0
109353,AIM,0,0
109354,The,0,0
109355,aim,0,0
109356,of,0,0
109357,study,0,0
109358,was,0,0
109359,test,0,0
109360,efficacy,0,0
109361,of,0,0
109362,accelerated,1,0
109363,postoperative,1,0
109364,radiotherapy,1,0
109365,--,1,0
109366,concomitant,1,0
109367,boost,1,0
109368,in,0,0
109369,patients,0,0
109370,with,0,0
109371,advanced,0,0
109372,larynx,0,0
109373,cancer,0,0
109374,.,0,0
109375,METHODS,0,0
109376,AND,0,0
109377,MATERIALS,0,1
109378,The,0,0
109379,prospective,0,0
109380,study,0,0
109381,included,0,0
109382,112,0,0
109383,patients,0,0
109384,with,0,0
109385,advanced,0,0
109386,larynx,0,0
109387,cancer,0,0
109388,after,0,0
109389,radical,1,0
109390,surgical,1,0
109391,treatment,1,0
109392,.,1,0
109393,Patients,0,0
109394,had,0,0
109395,postoperative,1,0
109396,radiation,1,0
109397,therapy,1,0
109398,",",1,0
109399,conventional,1,0
109400,(,1,1
109401,C,1,1
109402,),1,1
109403,or,1,0
109404,accelerated,1,0
109405,(,1,1
109406,CB,1,1
109407,),1,1
109408,.,1,0
109409,RESULTS,0,0
109410,The,0,0
109411,3-year,0,0
109412,overall,0,0
109413,survival,0,0
109414,in,0,0
109415,CB,1,0
109416,was,0,0
109417,59,0,0
109418,%,0,0
109419,",",0,0
109420,in,0,0
109421,C,0,0
109422,--,0,0
109423,58,0,0
109424,%,0,0
109425,(,0,0
109426,p,0,0
109427,=,0,0
109428,0.2,0,0
109429,),0,0
109430,",",0,0
109431,3-year,0,0
109432,locoregional,0,0
109433,control,0,0
109434,in,0,0
109435,CB,1,0
109436,--,1,0
109437,83,1,0
109438,%,1,0
109439,",",0,0
109440,in,0,0
109441,C,0,0
109442,--,0,0
109443,75,0,0
109444,%,0,0
109445,(,0,0
109446,p,0,0
109447,=,0,0
109448,0.01,0,0
109449,),0,0
109450,",",0,0
109451,the,0,0
109452,3-year,0,0
109453,disease,0,0
109454,free,0,0
109455,survival,0,0
109456,was,0,0
109457,in,0,0
109458,CB,1,0
109459,--,1,0
109460,72,1,0
109461,%,1,0
109462,",",0,0
109463,C,0,0
109464,--,0,0
109465,66,0,0
109466,%,0,0
109467,(,0,0
109468,p,0,0
109469,=,0,0
109470,0.1,0,0
109471,),0,0
109472,.,0,0
109473,CONCLUSION,0,1
109474,Concomitant,1,0
109475,boost,1,1
109476,postoperative,1,0
109477,radiation,1,0
109478,therapy,1,0
109479,did,0,0
109480,not,0,0
109481,improve,0,0
109482,overall,0,0
109483,survival,0,0
109484,",",0,0
109485,loco-regional,0,0
109486,control,0,0
109487,",",0,0
109488,disease,0,0
109489,free,0,0
109490,survival,0,0
109491,.,0,0
109492,Patients,0,0
109493,with,0,0
109494,close,0,0
109495,surgical,0,0
109496,margins,0,0
109497,",",0,0
109498,longer,0,0
109499,interval,0,0
109500,between,0,0
109501,surgery,0,0
109502,and,0,0
109503,radiation,0,0
109504,",",0,0
109505,high,0,0
109506,level,0,0
109507,of,0,0
109508,hemoglobin,0,1
109509,",",0,0
109510,T4,0,0
109511,had,0,0
109512,benefit,0,0
109513,from,0,0
109514,accelerated,1,0
109515,radiotherapy,1,0
109516,.,1,0
109517,Differential,0,0
109518,effects,0,0
109519,of,0,0
109520,vitamin,1,1
109521,K1,1,1
109522,on,0,0
109523,AFP,0,0
109524,and,0,0
109525,DCP,0,0
109526,levels,0,0
109527,in,0,0
109528,patients,0,0
109529,with,0,0
109530,unresectable,0,0
109531,HCC,0,0
109532,and,0,0
109533,in,0,0
109534,HCC,0,0
109535,cell,0,0
109536,lines,0,0
109537,.,0,0
109538,PURPOSE,0,0
109539,DCP,0,0
109540,is,0,0
109541,a,0,0
109542,useful,0,0
109543,HCC,0,0
109544,tumor,0,0
109545,marker,0,0
109546,",",0,0
109547,which,0,0
109548,reflects,0,0
109549,a,0,0
109550,defect,0,0
109551,in,0,0
109552,vitamin,0,1
109553,K,0,1
109554,metabolism,0,0
109555,.,0,0
109556,We,0,0
109557,tested,0,0
109558,the,0,0
109559,hypothesis,0,0
109560,that,0,0
109561,vitamin,1,1
109562,K,1,1
109563,treatment,0,0
109564,of,0,0
109565,HCC,0,0
109566,patients,0,0
109567,might,0,0
109568,suppress,0,0
109569,this,0,0
109570,marker,0,0
109571,and,0,0
109572,possibly,0,0
109573,AFP,0,0
109574,also,0,0
109575,.,0,0
109576,EXPERIMENTAL,0,0
109577,DESIGN,0,0
109578,HCC,0,1
109579,patients,0,0
109580,who,0,0
109581,had,0,0
109582,both,0,0
109583,elevated,0,0
109584,AFP,0,0
109585,and,0,0
109586,DCP,0,0
109587,were,0,0
109588,included,0,0
109589,.,0,0
109590,A,0,0
109591,phase,0,0
109592,I,0,0
109593,cohort,0,0
109594,was,0,0
109595,treated,0,0
109596,with,0,0
109597,escalating,0,1
109598,vitamin,1,1
109599,K1,1,1
109600,intravenous,0,1
109601,weekly,0,1
109602,doses,0,1
109603,and,0,1
109604,a,0,0
109605,27-patient,0,0
109606,phase,0,0
109607,II,0,0
109608,cohort,0,0
109609,was,0,0
109610,then,0,0
109611,treated,0,0
109612,with,0,0
109613,a,0,0
109614,fixed,0,0
109615,oral,0,1
109616,daily,0,1
109617,dose,0,1
109618,.,0,1
109619,RESULTS,0,1
109620,A,0,1
109621,maximum,0,1
109622,tolerated,0,1
109623,dose,0,1
109624,was,0,0
109625,not,0,0
109626,reached,0,0
109627,up,0,0
109628,to,0,0
109629,100-fold,0,0
109630,the,0,0
109631,normal,0,0
109632,vitamin,1,1
109633,K1,1,1
109634,dose,0,1
109635,.,0,1
109636,No,0,1
109637,toxicities,0,1
109638,were,0,0
109639,found,0,0
109640,up,0,0
109641,to,0,0
109642,"1,000",0,0
109643,mg/infusion,0,1
109644,.,0,1
109645,In,0,0
109646,the,0,0
109647,phase,0,0
109648,II,0,0
109649,cohort,0,0
109650,",",0,0
109651,93,0,0
109652,%,0,0
109653,of,0,0
109654,patients,0,0
109655,had,0,0
109656,tumor,0,0
109657,marker,0,0
109658,responses,0,0
109659,by,0,0
109660,decreased,0,0
109661,DCP,0,0
109662,levels,0,0
109663,",",0,0
109664,but,0,0
109665,only,0,0
109666,22,0,0
109667,%,0,0
109668,had,0,0
109669,responses,0,0
109670,by,0,0
109671,decreased,0,0
109672,AFP,0,0
109673,levels,0,0
109674,.,0,0
109675,CT,0,0
109676,scans,0,0
109677,showed,0,0
109678,11,0,0
109679,%,0,0
109680,of,0,0
109681,patients,0,0
109682,had,0,0
109683,PRs,0,0
109684,",",0,0
109685,59,0,0
109686,%,0,0
109687,had,0,0
109688,stable,0,0
109689,tumors,0,0
109690,and,0,0
109691,29.6,0,0
109692,%,0,0
109693,had,0,0
109694,tumor,0,0
109695,progression,0,0
109696,.,0,0
109697,Mechanism,0,0
109698,studies,0,0
109699,showed,0,0
109700,that,0,0
109701,vitamin,0,1
109702,K1,0,1
109703,induced,0,0
109704,phosphorylation,0,0
109705,of,0,0
109706,JNK,0,0
109707,and,0,0
109708,c-Jun,0,0
109709,and,0,0
109710,caspase-mediated,0,0
109711,apoptosis,0,0
109712,.,0,0
109713,CONCLUSIONS,0,1
109714,Vitamin,1,1
109715,K1,1,1
109716,was,0,0
109717,non-toxic,0,0
109718,at,0,0
109719,high,0,0
109720,doses,0,1
109721,",",0,0
109722,strongly,0,0
109723,inhibited,0,0
109724,plasma,0,1
109725,DCP,0,1
109726,levels,0,0
109727,",",0,0
109728,but,0,0
109729,weakly,0,0
109730,suppressed,0,0
109731,AFP,0,0
109732,levels,0,0
109733,.,0,0
109734,The,0,0
109735,results,0,0
109736,provide,0,0
109737,evidence,0,0
109738,that,0,0
109739,the,0,0
109740,two,0,0
109741,tumor,0,0
109742,markers,0,0
109743,are,0,0
109744,not,0,0
109745,directly,0,0
109746,linked,0,0
109747,and,0,0
109748,that,0,0
109749,DCP,0,0
109750,levels,0,0
109751,may,0,0
109752,not,0,0
109753,reflect,0,0
109754,HCC,0,0
109755,cell,0,0
109756,growth,0,0
109757,",",0,0
109758,as,0,0
109759,DCP,0,0
109760,levels,0,0
109761,were,0,0
109762,decreased,0,0
109763,in,0,0
109764,patients,0,0
109765,without,0,0
109766,AFP,0,0
109767,change,0,0
109768,",",0,0
109769,and,0,0
109770,were,0,0
109771,suppressed,0,0
109772,in,0,0
109773,vitro,0,0
109774,at,0,0
109775,1,0,0
109776,%,0,0
109777,of,0,0
109778,the,0,0
109779,vitamin,0,1
109780,K1,0,1
109781,concentration,0,0
109782,needed,0,0
109783,to,0,0
109784,inhibit,0,0
109785,AFP,0,0
109786,.,0,0
109787,In,0,0
109788,vitro,0,0
109789,determination,0,0
109790,of,0,0
109791,the,0,0
109792,chromatic,0,0
109793,effect,0,0
109794,of,0,0
109795,a,0,0
109796,silver,1,0
109797,nanoparticles,1,1
109798,solution,1,0
109799,linked,0,0
109800,to,0,0
109801,the,0,0
109802,gantrez,1,1
109803,S-97,1,1
109804,copolymer,1,1
109805,on,0,0
109806,tooth,0,0
109807,enamel,0,0
109808,.,0,0
109809,Silver,1,1
109810,nanoparticles,1,1
109811,(,1,1
109812,NNPs,1,1
109813,),1,1
109814,",",0,0
109815,alone,0,0
109816,or,0,0
109817,in,0,0
109818,combination,0,0
109819,with,0,0
109820,the,0,0
109821,bioadhesive,0,1
109822,Gantrez,1,1
109823,S-97,1,1
109824,",",0,0
109825,have,0,0
109826,demonstrated,0,0
109827,their,0,0
109828,efficacy,0,0
109829,against,0,0
109830,Streptococcus,0,1
109831,mutans,0,1
109832,;,0,1
109833,however,0,0
109834,",",0,0
109835,it,0,0
109836,is,0,0
109837,not,0,0
109838,known,0,0
109839,if,0,0
109840,this,0,0
109841,combination,0,0
109842,changes,0,0
109843,the,0,0
109844,color,0,0
109845,of,0,0
109846,teeth,0,0
109847,.,0,0
109848,The,0,0
109849,aim,0,0
109850,of,0,0
109851,this,0,0
109852,work,0,0
109853,was,0,0
109854,to,0,0
109855,measure,0,0
109856,the,0,0
109857,color,0,0
109858,changes,0,0
109859,occurring,0,0
109860,after,0,0
109861,the,0,0
109862,use,0,0
109863,of,0,0
109864,a,0,0
109865,Gantrez-NNP,1,0
109866,combination,1,0
109867,on,0,0
109868,enamel,0,0
109869,tooth,0,0
109870,blocks,0,0
109871,.,0,0
109872,Two,0,0
109873,study,0,0
109874,groups,0,0
109875,were,0,0
109876,randomly,0,0
109877,formed,0,0
109878,:,0,0
109879,enamel,0,0
109880,blocks,0,0
109881,brushed,0,0
109882,with,0,0
109883,(,0,0
109884,a,0,0
109885,),0,0
109886,the,1,0
109887,Gantrez-NNP,1,0
109888,combination,1,0
109889,and,1,1
109890,(,1,1
109891,b,1,1
109892,),1,1
109893,conventional,1,0
109894,toothpaste,1,1
109895,",",0,0
109896,for,0,0
109897,1,0,0
109898,minute,0,0
109899,once,0,1
109900,daily,0,1
109901,for,0,1
109902,4,0,0
109903,weeks,0,0
109904,",",0,0
109905,then,0,0
109906,rinsed,1,1
109907,with,1,1
109908,distilled,1,1
109909,water,1,0
109910,and,1,0
109911,placed,1,0
109912,in,1,0
109913,thymol,1,0
109914,solution,1,0
109915,.,1,0
109916,Color,0,0
109917,changes,0,0
109918,in,0,0
109919,the,0,0
109920,enamel,0,0
109921,blocks,0,0
109922,were,0,0
109923,measured,0,0
109924,using,0,0
109925,a,0,0
109926,Minolta,0,1
109927,colorimeter,0,0
109928,CR300,0,1
109929,.,0,0
109930,Analysis,0,0
109931,of,0,0
109932,mixed,0,0
109933,models,0,0
109934,was,0,0
109935,performed,0,0
109936,with,0,0
109937,R,0,0
109938,2.10.1,0,0
109939,at,0,0
109940,a,0,0
109941,95,0,0
109942,%,0,0
109943,confidence,0,0
109944,level,0,0
109945,",",0,0
109946,using,0,0
109947,the,0,0
109948,nonlinear,0,0
109949,mixed,0,0
109950,effects,0,0
109951,(,0,0
109952,NLME,0,1
109953,),0,1
109954,package,0,0
109955,.,0,0
109956,The,0,0
109957,results,0,0
109958,showed,0,0
109959,that,0,0
109960,there,0,0
109961,were,0,0
109962,no,0,0
109963,color,0,0
109964,changes,0,0
109965,over,0,0
109966,time,0,0
109967,",",0,0
109968,only,0,0
109969,a,0,0
109970,high,0,0
109971,luminosity,0,0
109972,equal,0,0
109973,in,0,0
109974,both,0,0
109975,groups,0,0
109976,.,0,0
109977,Our,0,0
109978,study,0,0
109979,showed,0,0
109980,that,0,0
109981,the,0,0
109982,use,0,0
109983,of,0,0
109984,the,0,0
109985,Gantrez-NNP,1,0
109986,combination,1,0
109987,is,0,0
109988,safe,0,0
109989,with,0,0
109990,respect,0,0
109991,to,0,0
109992,dental,0,0
109993,esthetics,0,0
109994,in,0,0
109995,the,0,0
109996,control,0,0
109997,of,0,0
109998,S.,0,1
109999,mutans,0,1
110000,.,0,0
110001,Impact,0,0
110002,of,0,0
110003,early,0,0
110004,parenteral,0,1
110005,nutrition,0,1
110006,completing,0,1
110007,enteral,0,1
110008,nutrition,0,1
110009,in,0,0
110010,adult,0,0
110011,critically,0,0
110012,ill,0,0
110013,patients,0,0
110014,(,0,0
110015,EPaNIC,0,1
110016,trial,0,1
110017,),0,0
110018,:,0,0
110019,a,0,0
110020,study,0,0
110021,protocol,0,0
110022,and,0,0
110023,statistical,0,0
110024,analysis,0,0
110025,plan,0,0
110026,for,0,0
110027,a,0,0
110028,randomized,0,0
110029,controlled,0,0
110030,trial,0,0
110031,.,0,0
110032,BACKGROUND,0,0
110033,For,0,0
110034,critically,0,0
110035,ill,0,0
110036,patients,0,0
110037,treated,0,0
110038,in,0,0
110039,intensive,0,0
110040,care,0,0
110041,units,0,1
110042,(,0,1
110043,ICU,0,1
110044,),0,1
110045,",",0,0
110046,two,0,0
110047,feeding,0,0
110048,strategies,0,0
110049,are,0,0
110050,currently,0,0
110051,being,0,0
110052,advocated,0,0
110053,",",0,0
110054,one,0,0
110055,by,0,0
110056,American/Canadian,0,0
110057,and,0,0
110058,the,0,0
110059,other,0,0
110060,by,0,0
110061,European,0,0
110062,expert,0,0
110063,guidelines,0,0
110064,.,0,0
110065,These,0,0
110066,guidelines,0,0
110067,differ,0,0
110068,particularly,0,0
110069,in,0,0
110070,the,0,0
110071,timing,0,0
110072,of,0,0
110073,initiating,0,0
110074,parenteral,0,1
110075,nutrition,0,1
110076,(,0,1
110077,PN,0,1
110078,),0,0
110079,in,0,0
110080,patients,0,0
110081,for,0,0
110082,whom,0,1
110083,enteral,0,1
110084,nutrition,0,1
110085,(,0,1
110086,EN,0,1
110087,),0,0
110088,does,0,0
110089,not,0,0
110090,reach,0,0
110091,caloric,0,0
110092,targets,0,0
110093,.,0,0
110094,METHODS/DESIGN,0,0
110095,The,0,0
110096,EPaNIC,0,0
110097,trial,0,0
110098,is,0,0
110099,an,0,0
110100,investigator-initiated,0,0
110101,",",0,0
110102,non-commercial,0,0
110103,",",0,0
110104,multi-center,0,0
110105,",",0,0
110106,randomized,0,0
110107,",",0,0
110108,controlled,0,0
110109,",",0,0
110110,clinical,0,0
110111,trial,0,0
110112,with,0,0
110113,a,0,0
110114,parallel,0,0
110115,group,0,0
110116,design,0,0
110117,.,0,0
110118,This,0,0
110119,study,0,0
110120,compares,0,0
110121,early,0,0
110122,(,0,0
110123,European,0,1
110124,guideline,0,1
110125,),0,1
110126,versus,0,0
110127,late,0,0
110128,(,0,0
110129,American/Canadian,0,0
110130,guideline,0,1
110131,),0,0
110132,initiation,1,0
110133,of,1,0
110134,PN,1,0
110135,when,1,0
110136,EN,1,0
110137,fails,1,0
110138,to,0,0
110139,reach,0,0
110140,a,0,0
110141,caloric,0,0
110142,target,0,0
110143,.,0,0
110144,In,1,0
110145,the,1,0
110146,early,1,0
110147,PN,1,0
110148,group,1,0
110149,",",1,0
110150,PN,1,0
110151,is,1,0
110152,initiated,1,0
110153,within,1,0
110154,24-48,1,0
110155,hours,1,1
110156,after,1,0
110157,ICU,1,1
110158,admission,1,0
110159,to,1,0
110160,complete,1,0
110161,early,1,0
110162,enteral,1,1
110163,nutrition,1,1
110164,(,1,1
110165,EN,1,1
110166,),1,0
110167,up,1,0
110168,to,1,0
110169,a,1,0
110170,calculated,1,0
110171,nutritional,1,0
110172,target,1,0
110173,.,1,0
110174,In,1,0
110175,the,1,0
110176,late,1,0
110177,PN,1,0
110178,group,1,0
110179,",",1,0
110180,PN,1,1
110181,completing,1,1
110182,EN,1,0
110183,is,1,0
110184,initiated,1,0
110185,when,1,0
110186,the,1,0
110187,target,1,0
110188,is,1,0
110189,not,1,0
110190,reached,1,0
110191,on,1,0
110192,day,1,0
110193,8,1,0
110194,.,1,0
110195,In,0,0
110196,both,0,0
110197,groups,0,0
110198,",",0,0
110199,the,0,0
110200,same,0,0
110201,early,0,0
110202,EN,1,0
110203,protocol,0,0
110204,is,0,0
110205,applied,0,0
110206,.,0,0
110207,The,0,0
110208,study,0,0
110209,is,0,0
110210,designed,0,0
110211,to,0,0
110212,compare,0,0
110213,clinical,0,0
110214,outcome,0,1
110215,(,0,0
110216,morbidity,0,0
110217,and,0,1
110218,mortality,0,1
110219,),0,0
110220,in,0,0
110221,the,0,0
110222,2,0,0
110223,study,0,0
110224,arms,0,0
110225,as,0,0
110226,well,0,0
110227,as,0,0
110228,to,0,0
110229,address,0,0
110230,several,0,0
110231,mechanistical,0,0
110232,questions,0,0
110233,.,0,0
110234,We,0,0
110235,here,0,0
110236,describe,0,0
110237,the,0,0
110238,EPaNIC,0,0
110239,study,0,0
110240,protocol,0,0
110241,and,0,0
110242,the,0,0
110243,statistical,0,0
110244,analysis,0,0
110245,plan,0,0
110246,for,0,0
110247,the,0,0
110248,primary,0,0
110249,report,0,0
110250,of,0,0
110251,the,0,0
110252,clinical,0,0
110253,results,0,0
110254,.,0,0
110255,DISCUSSION,0,0
110256,The,0,0
110257,study,0,0
110258,has,0,0
110259,been,0,0
110260,initiated,0,0
110261,as,0,0
110262,planned,0,0
110263,on,0,0
110264,august,0,0
110265,01,0,0
110266,2007,0,0
110267,.,0,0
110268,One,0,0
110269,interim,0,0
110270,analysis,0,0
110271,advised,0,0
110272,continuation,0,0
110273,of,0,0
110274,the,0,0
110275,trial,0,0
110276,.,0,0
110277,The,0,0
110278,study,0,0
110279,will,0,0
110280,be,0,0
110281,completed,0,0
110282,in,0,0
110283,February,0,0
110284,2011,0,0
110285,.,0,0
110286,TRIAL,0,0
110287,REGISTRATION,0,1
110288,ClinicalTrials,0,1
110289,(,0,1
110290,NCT,0,1
110291,),0,1
110292,:,0,0
110293,NCT00512122,0,0
110294,.,0,0
110295,Effects,0,0
110296,of,0,0
110297,maternal,0,0
110298,and,0,1
110299,dietary,1,1
110300,selenium,1,1
110301,(,1,1
110302,Se-enriched,1,0
110303,yeast,1,0
110304,),1,0
110305,on,0,0
110306,the,0,0
110307,expression,0,0
110308,of,0,0
110309,p34,0,1
110310,(,0,1
110311,cdc2,0,1
110312,),0,1
110313,and,0,0
110314,CyclinB1,0,0
110315,of,0,0
110316,germ,0,0
110317,cells,0,0
110318,of,0,0
110319,their,0,0
110320,offspring,0,0
110321,in,0,0
110322,goats,0,0
110323,.,0,0
110324,The,0,0
110325,aim,0,0
110326,of,0,0
110327,the,0,0
110328,study,0,0
110329,was,0,0
110330,to,0,0
110331,evaluate,0,0
110332,the,0,0
110333,effect,0,0
110334,of,0,0
110335,selenium,1,1
110336,on,0,0
110337,the,0,0
110338,expression,0,0
110339,of,0,0
110340,p34,0,1
110341,(,0,1
110342,cdc2,0,1
110343,),0,1
110344,and,0,0
110345,CyclinB1,0,1
110346,(,0,0
110347,two,0,0
110348,components,0,0
110349,of,0,0
110350,MPF,0,0
110351,regulating,0,0
110352,cell,0,0
110353,cycle,0,0
110354,),0,0
110355,of,0,0
110356,germ,0,0
110357,cells,0,0
110358,of,0,0
110359,their,0,0
110360,offspring,0,0
110361,in,0,0
110362,goats,0,0
110363,.,0,0
110364,A,0,0
110365,herd,0,0
110366,of,0,0
110367,119,0,0
110368,Taihang,0,0
110369,Black,0,0
110370,Goats,0,1
110371,",",0,0
110372,which,0,0
110373,was,0,0
110374,randomly,0,0
110375,divided,0,0
110376,into,0,0
110377,4,0,0
110378,treatments,0,0
110379,",",0,0
110380,received,0,0
110381,experimental,1,0
110382,diet,1,1
110383,with,1,0
110384,different,1,0
110385,Se,1,0
110386,levels,1,0
110387,(,0,0
110388,from,0,0
110389,Se-enriched,0,0
110390,yeast,0,0
110391,),0,0
110392,for,0,0
110393,174d,0,0
110394,.,0,0
110395,The,0,0
110396,four,0,0
110397,treatments,0,0
110398,",",0,0
110399,fed,0,0
110400,with,0,0
110401,a,0,0
110402,basal,0,0
110403,diet,0,1
110404,",",0,0
110405,were,0,0
110406,supplemented,0,0
110407,with,0,0
110408,0,0,0
110409,(,0,0
110410,control,0,0
110411,),0,0
110412,",",0,0
110413,0.5,0,0
110414,",",0,0
110415,2,0,0
110416,and,0,0
110417,4,0,0
110418,mgkg??,0,0
110419,DM,0,1
110420,Se,0,1
110421,.,0,0
110422,Testis,0,0
110423,samples,0,0
110424,were,0,0
110425,collected,0,0
110426,from,0,0
110427,the,0,0
110428,young,0,0
110429,male,0,0
110430,goats,0,0
110431,of,0,0
110432,each,0,0
110433,treatment,0,0
110434,group,0,0
110435,at,0,0
110436,the,0,0
110437,end,0,0
110438,of,0,0
110439,the,0,0
110440,study,0,0
110441,(,0,1
110442,30d,0,1
110443,after,0,1
110444,weaning,0,1
110445,),0,0
110446,for,0,0
110447,mRNA,0,0
110448,expression,0,0
110449,using,0,0
110450,real-time,1,0
110451,PCR,1,0
110452,and,1,0
110453,for,0,0
110454,protein,0,0
110455,expression,0,0
110456,by,0,0
110457,immunohistochemistry,0,0
110458,assay,0,0
110459,.,0,0
110460,Results,0,0
110461,show,0,0
110462,that,0,0
110463,a,0,0
110464,significant,0,0
110465,decrease,0,0
110466,was,0,0
110467,observed,0,0
110468,in,0,0
110469,mRNA,0,0
110470,expression,0,0
110471,of,0,0
110472,p34,0,1
110473,(,0,1
110474,cdc2,0,1
110475,),0,1
110476,and,0,0
110477,CyclinB1,0,0
110478,in,0,0
110479,the,0,0
110480,testis,0,0
110481,of,0,0
110482,Se-deficient,0,0
110483,(,0,0
110484,Group,0,0
110485,1,0,1
110486,),0,0
110487,and,0,0
110488,Se-excess,0,0
110489,(,0,0
110490,Group,0,0
110491,4,0,1
110492,),0,0
110493,animals,0,0
110494,compared,0,0
110495,with,0,0
110496,that,0,0
110497,in,0,0
110498,Groups,0,0
110499,2,0,0
110500,and,0,0
110501,3,0,0
110502,.,0,0
110503,However,0,0
110504,",",0,0
110505,no,0,0
110506,significant,0,0
110507,changes,0,0
110508,were,0,0
110509,found,0,0
110510,in,0,0
110511,mRNA,0,0
110512,expression,0,0
110513,of,0,0
110514,p34,0,1
110515,(,0,1
110516,cdc2,0,1
110517,),0,0
110518,between,0,0
110519,Se-deficient,0,0
110520,(,0,0
110521,Group,0,0
110522,1,0,1
110523,),0,0
110524,and,0,0
110525,Se-excess,0,0
110526,(,0,0
110527,Group,0,0
110528,4,0,0
110529,),0,0
110530,.,0,0
110531,Also,0,0
110532,the,0,0
110533,immunohistochemistry,0,0
110534,assay,0,0
110535,detected,0,0
110536,similar,0,0
110537,results,0,0
110538,of,0,0
110539,protein,0,0
110540,expression,0,0
110541,of,0,0
110542,these,0,0
110543,two,0,0
110544,genes,0,0
110545,.,0,0
110546,These,0,0
110547,results,0,0
110548,suggest,0,0
110549,",",0,0
110550,that,0,0
110551,maternal,0,0
110552,and,0,0
110553,dietary,0,1
110554,Se-induced,0,0
110555,oxidative,0,0
110556,stress,0,0
110557,can,0,0
110558,modulate,0,0
110559,the,0,0
110560,mRNA,0,0
110561,and,0,0
110562,protein,0,0
110563,expression,0,0
110564,of,0,0
110565,the,0,0
110566,cell,0,0
110567,cycle,0,0
110568,related,0,0
110569,genes,0,0
110570,(,0,0
110571,p34,0,1
110572,(,0,1
110573,cdc2,0,1
110574,),0,1
110575,and,0,0
110576,CyclinB1,0,1
110577,),0,0
110578,in,0,0
110579,the,0,0
110580,testis,0,0
110581,of,0,0
110582,their,0,0
110583,offspring,0,0
110584,.,0,0
110585,In,0,0
110586,addition,0,0
110587,",",0,0
110588,Se,0,0
110589,deficiency,0,0
110590,and,0,0
110591,Se,0,0
110592,excess,0,0
110593,could,0,0
110594,prevent,0,0
110595,the,0,0
110596,completion,0,0
110597,of,0,0
110598,the,0,0
110599,cell,0,0
110600,cycle,0,0
110601,.,0,0
110602,Using,0,0
110603,personalized,1,0
110604,feedback,1,0
110605,to,0,0
110606,reduce,0,0
110607,alcohol,0,0
110608,use,0,0
110609,among,0,0
110610,hazardous,0,0
110611,drinking,0,0
110612,college,0,0
110613,students,0,0
110614,:,0,0
110615,the,0,0
110616,moderating,0,0
110617,effect,0,0
110618,of,0,0
110619,alcohol-related,0,0
110620,negative,0,0
110621,consequences,0,0
110622,.,0,0
110623,UNLABELLED,0,0
110624,Web-based,1,0
110625,screening,1,0
110626,and,1,0
110627,brief,1,0
110628,interventions,1,0
110629,that,0,0
110630,include,0,0
110631,personalized,0,0
110632,feedback,0,0
110633,about,0,0
110634,their,0,0
110635,alcohol,0,0
110636,use,0,0
110637,have,0,0
110638,proven,0,0
110639,to,0,0
110640,be,0,0
110641,particularly,0,0
110642,promising,0,0
110643,for,0,0
110644,reducing,0,0
110645,hazardous,0,0
110646,drinking,0,0
110647,among,0,0
110648,university,0,0
110649,students,0,0
110650,.,0,0
110651,Despite,0,0
110652,the,0,0
110653,increasing,0,0
110654,use,0,0
110655,of,0,0
110656,these,0,0
110657,approaches,0,0
110658,",",0,0
110659,there,0,0
110660,is,0,0
110661,still,0,0
110662,relatively,0,0
110663,little,0,0
110664,known,0,0
110665,about,0,0
110666,how,0,0
110667,the,0,0
110668,content,0,0
110669,of,0,0
110670,these,0,0
110671,interventions,0,0
110672,may,0,0
110673,influence,0,0
110674,outcomes,0,0
110675,and,0,0
110676,who,0,0
110677,may,0,0
110678,benefit,0,0
110679,most,0,0
110680,from,0,0
110681,these,0,0
110682,approaches,0,0
110683,.,0,0
110684,The,0,0
110685,current,0,0
110686,study,0,0
110687,sought,0,0
110688,to,0,0
110689,address,0,0
110690,these,0,0
110691,issues,0,0
110692,by,0,0
110693,examining,0,0
110694,how,0,0
110695,individual,0,0
110696,differences,0,0
110697,in,0,0
110698,alcohol,0,0
110699,consequences,0,0
110700,influence,0,0
110701,outcomes,0,0
110702,of,0,0
110703,a,0,0
110704,laboratory-based,1,0
110705,computerized,1,0
110706,intervention,1,0
110707,.,1,0
110708,METHODS,0,0
110709,One-hundred,0,0
110710,and,0,0
110711,nineteen,0,0
110712,introductory,0,0
110713,psychology,0,0
110714,students,0,0
110715,who,0,0
110716,either,0,0
110717,had,0,0
110718,two,0,0
110719,episodes,0,0
110720,of,0,0
110721,heavy,0,0
110722,episodic,0,0
110723,drinking,0,0
110724,in,0,0
110725,the,0,0
110726,past,0,0
110727,month,0,0
110728,or,0,0
110729,scored,0,0
110730,?8,0,0
110731,on,0,0
110732,the,0,0
110733,AUDIT,0,0
110734,participated,0,0
110735,in,0,0
110736,this,0,0
110737,randomized,0,0
110738,controlled,0,0
110739,trial,0,0
110740,for,0,0
110741,course,0,0
110742,credit,0,0
110743,.,0,0
110744,Participants,0,0
110745,were,0,0
110746,assigned,0,0
110747,to,0,0
110748,1,0,0
110749,of,0,0
110750,4,0,0
110751,conditions,0,0
110752,in,0,0
110753,this,0,0
110754,2,0,0
110755,Intervention,1,1
110756,(,1,1
110757,Alcohol,1,1
110758,Feedback,1,0
110759,vs.,1,0
110760,Control,1,0
110761,),1,0
110762,?2,1,1
110763,Assessment,1,1
110764,(,1,1
110765,Motivational,1,0
110766,Assessment,1,0
110767,vs.,1,0
110768,No,1,1
110769,Motivational,1,1
110770,Assessment,1,1
110771,),1,1
110772,between-subjects,1,0
110773,design,0,0
110774,.,0,0
110775,Quantity,0,0
110776,of,0,0
110777,alcohol,0,1
110778,consumed,0,1
110779,per,0,1
110780,week,0,0
110781,and,0,0
110782,heavy,0,0
110783,episodic,0,0
110784,drinking,0,0
110785,one,0,0
110786,month,0,0
110787,later,0,0
110788,were,0,0
110789,the,0,0
110790,primary,0,0
110791,dependent,0,0
110792,variables,0,0
110793,.,0,0
110794,RESULTS,0,0
110795,Controlling,0,0
110796,for,0,0
110797,corresponding,0,0
110798,baseline,0,1
110799,alcohol,0,1
110800,measures,0,1
110801,",",0,0
110802,hierarchical,0,0
110803,linear,0,0
110804,regression,0,0
110805,analyses,0,0
110806,showed,0,0
110807,a,0,0
110808,significant,0,0
110809,interaction,0,0
110810,between,0,0
110811,intervention,0,0
110812,condition,0,0
110813,and,0,0
110814,baseline,0,0
110815,alcohol-related,0,0
110816,consequences,0,0
110817,.,0,0
110818,For,0,0
110819,those,0,0
110820,who,0,0
110821,reported,0,0
110822,more,0,0
110823,alcohol,0,0
110824,consequences,0,0
110825,at,0,0
110826,baseline,0,0
110827,",",0,0
110828,the,0,0
110829,alcohol,0,1
110830,intervention,0,1
110831,resulted,0,0
110832,in,0,0
110833,significantly,0,0
110834,less,0,0
110835,alcohol,0,0
110836,use,0,0
110837,and,0,0
110838,fewer,0,0
110839,heavy,0,0
110840,drinking,0,0
110841,episodes,0,0
110842,at,0,0
110843,follow-up,0,0
110844,",",0,0
110845,while,0,0
110846,no,0,0
110847,difference,0,0
110848,was,0,0
110849,observed,0,0
110850,between,0,0
110851,intervention,0,0
110852,conditions,0,0
110853,for,0,0
110854,those,0,0
110855,with,0,0
110856,few,0,0
110857,baseline,0,0
110858,consequences,0,0
110859,.,0,0
110860,Assessment,0,0
110861,did,0,0
110862,not,0,0
110863,moderate,0,0
110864,intervention,0,0
110865,effects,0,0
110866,.,0,0
110867,DISCUSSION,0,0
110868,These,0,0
110869,findings,0,0
110870,suggest,0,0
110871,that,1,0
110872,a,1,0
110873,feedback-based,1,0
110874,computerized,1,0
110875,intervention,1,0
110876,that,1,0
110877,includes,0,0
110878,normative,0,0
110879,information,0,0
110880,about,0,0
110881,alcohol,0,0
110882,use,0,0
110883,and,0,0
110884,consequences,0,0
110885,may,0,0
110886,be,0,0
110887,more,0,0
110888,effective,0,0
110889,for,0,0
110890,hazardous,0,0
110891,drinking,0,0
110892,students,0,0
110893,who,0,0
110894,are,0,0
110895,experiencing,0,0
110896,higher,0,0
110897,levels,0,0
110898,of,0,0
110899,alcohol-related,0,0
110900,consequences,0,0
110901,.,0,0
110902,Impact,0,0
110903,of,0,0
110904,prior,0,0
110905,pharmacotherapy,1,0
110906,on,0,0
110907,remission,0,0
110908,of,0,0
110909,psychotic,0,0
110910,depression,0,0
110911,in,0,0
110912,a,0,0
110913,randomized,0,0
110914,controlled,0,0
110915,trial,0,0
110916,.,0,0
110917,Having,0,0
110918,failed,0,0
110919,to,0,0
110920,respond,0,0
110921,to,0,0
110922,an,0,0
110923,adequate,0,1
110924,antidepressant,0,1
110925,treatment,0,1
110926,course,0,0
110927,predicts,0,0
110928,poorer,0,0
110929,treatment,0,0
110930,outcomes,0,0
110931,in,0,0
110932,patients,0,0
110933,with,0,0
110934,major,0,0
110935,depression,0,0
110936,.,0,0
110937,However,0,0
110938,",",0,0
110939,little,0,0
110940,is,0,0
110941,known,0,0
110942,about,0,0
110943,the,0,0
110944,impact,0,0
110945,of,0,0
110946,prior,0,0
110947,treatment,0,0
110948,on,0,0
110949,the,0,0
110950,outcome,0,0
110951,of,0,0
110952,major,0,0
110953,depression,0,0
110954,with,0,0
110955,psychotic,0,0
110956,features,0,0
110957,(,0,1
110958,MDpsy,0,1
110959,),0,1
110960,.,0,0
110961,We,0,0
110962,examined,0,0
110963,the,0,0
110964,effect,0,0
110965,of,0,0
110966,prior,0,0
110967,treatment,0,0
110968,history,0,0
110969,on,0,0
110970,the,0,0
110971,outcome,0,0
110972,of,0,0
110973,pharmacotherapy,1,0
110974,of,0,0
110975,MDpsy,0,0
110976,in,0,0
110977,patients,0,0
110978,who,0,0
110979,participated,0,0
110980,in,0,0
110981,the,0,0
110982,STOPD-PD,0,0
110983,study,0,0
110984,",",0,0
110985,a,0,0
110986,randomized,0,0
110987,",",0,0
110988,double-blind,0,1
110989,",",0,1
110990,clinical,0,1
110991,trial,0,0
110992,comparing,0,0
110993,a,0,0
110994,combination,0,0
110995,of,0,0
110996,olanzapine,1,1
110997,plus,1,0
110998,sertraline,1,1
110999,vs.,1,0
111000,olanzapine,1,1
111001,plus,1,0
111002,placebo,1,1
111003,.,1,1
111004,The,0,0
111005,strength,0,0
111006,of,0,0
111007,treatment,0,0
111008,courses,0,0
111009,received,0,0
111010,prior,0,0
111011,to,0,0
111012,randomization,0,0
111013,was,0,0
111014,classified,0,0
111015,using,0,0
111016,a,0,0
111017,validated,0,0
111018,method,0,0
111019,.,0,0
111020,A,0,0
111021,hierarchy,0,0
111022,of,0,0
111023,outcomes,0,0
111024,was,0,0
111025,hypothesized,0,0
111026,based,0,0
111027,on,0,0
111028,treatments,0,0
111029,received,0,0
111030,prior,0,0
111031,to,0,0
111032,randomization,0,0
111033,and,0,0
111034,randomized,0,0
111035,treatment,0,0
111036,.,0,0
111037,A,0,0
111038,high,0,0
111039,remission,0,0
111040,rate,0,0
111041,was,0,0
111042,observed,0,0
111043,in,0,0
111044,subjects,0,0
111045,with,0,0
111046,a,0,0
111047,history,0,0
111048,of,0,0
111049,no,0,0
111050,prior,0,0
111051,treatment,0,0
111052,or,0,0
111053,inadequate,0,0
111054,treatment,0,0
111055,who,0,0
111056,were,0,0
111057,treated,0,0
111058,with,0,0
111059,a,0,0
111060,combination,0,0
111061,of,0,0
111062,olanzapine,1,1
111063,and,0,1
111064,sertraline,1,1
111065,.,1,1
111066,A,0,0
111067,low,0,0
111068,remission,0,0
111069,rate,0,0
111070,was,0,0
111071,observed,0,0
111072,in,0,0
111073,subjects,0,0
111074,who,0,0
111075,had,0,0
111076,previously,0,0
111077,failed,0,0
111078,to,0,0
111079,respond,0,0
111080,to,0,0
111081,an,0,0
111082,antidepressant,0,1
111083,alone,0,0
111084,and,0,0
111085,who,0,0
111086,were,0,0
111087,treated,0,0
111088,with,0,0
111089,olanzapine,1,1
111090,monotherapy,0,1
111091,.,0,1
111092,A,0,0
111093,low,0,0
111094,remission,0,0
111095,rate,0,0
111096,was,0,0
111097,also,0,0
111098,observed,0,0
111099,in,0,0
111100,subjects,0,0
111101,who,0,0
111102,had,0,0
111103,previously,0,0
111104,failed,0,0
111105,to,0,0
111106,respond,0,0
111107,to,0,0
111108,a,0,0
111109,combination,0,0
111110,of,0,0
111111,an,0,0
111112,antipsychotic,0,1
111113,and,0,1
111114,an,0,0
111115,antidepressant,0,1
111116,.,0,0
111117,Similar,0,0
111118,to,0,0
111119,patients,0,0
111120,with,0,0
111121,major,0,0
111122,depression,0,0
111123,",",0,0
111124,these,0,0
111125,results,0,0
111126,emphasize,0,0
111127,the,0,0
111128,impact,0,0
111129,of,0,0
111130,prior,0,0
111131,pharmacotherapy,1,0
111132,on,0,0
111133,treatment,0,0
111134,outcomes,0,0
111135,in,0,0
111136,patients,0,0
111137,with,0,0
111138,MDpsy,0,0
111139,.,0,0
111140,Safety,0,0
111141,and,0,0
111142,efficacy,0,0
111143,of,0,0
111144,donepezil,1,1
111145,in,0,0
111146,children,0,1
111147,and,0,0
111148,adolescents,0,0
111149,with,0,0
111150,autism,0,0
111151,:,0,0
111152,neuropsychological,0,0
111153,measures,0,0
111154,.,0,0
111155,OBJECTIVE,0,0
111156,There,0,0
111157,has,0,0
111158,been,0,0
111159,recent,0,0
111160,interest,0,0
111161,in,0,0
111162,the,0,0
111163,use,0,0
111164,of,0,0
111165,cognitive,1,0
111166,enhancing,1,0
111167,drugs,1,1
111168,",",0,0
111169,such,0,0
111170,as,0,0
111171,cholinesterase,1,1
111172,inhibitors,1,1
111173,",",0,0
111174,as,0,0
111175,a,0,0
111176,possible,0,0
111177,treatment,0,0
111178,for,0,0
111179,executive,0,0
111180,functioning,0,0
111181,(,0,1
111182,EF,0,1
111183,),0,1
111184,deficits,0,0
111185,in,0,0
111186,autism,0,0
111187,spectrum,0,0
111188,disorder,0,1
111189,(,0,1
111190,ASD,0,1
111191,),0,1
111192,.,0,0
111193,The,0,0
111194,goal,0,0
111195,of,0,0
111196,this,0,0
111197,study,0,0
111198,was,0,0
111199,to,0,0
111200,assess,0,0
111201,the,0,0
111202,tolerability,0,1
111203,",",0,1
111204,safety,0,1
111205,",",0,0
111206,and,0,0
111207,efficacy,0,0
111208,of,0,0
111209,donepezil,0,1
111210,on,0,0
111211,EF,0,0
111212,in,0,0
111213,a,0,0
111214,sample,0,0
111215,of,0,0
111216,children,0,0
111217,and,0,0
111218,adolescents,0,0
111219,with,0,0
111220,ASD,0,0
111221,.,0,0
111222,METHOD,0,0
111223,Thirty-four,0,0
111224,children,0,0
111225,and,0,0
111226,adolescents,0,0
111227,with,0,0
111228,ASD,0,1
111229,(,0,0
111230,age,0,0
111231,range,0,0
111232,8-17,0,0
111233,years,0,0
111234,;,0,0
111235,IQ,0,0
111236,>,0,0
111237,75,0,0
111238,),0,0
111239,were,0,0
111240,enrolled,0,0
111241,in,0,0
111242,a,0,0
111243,10-week,0,0
111244,",",0,0
111245,double-blind,0,1
111246,",",0,1
111247,placebo-controlled,1,1
111248,trial,0,1
111249,of,0,1
111250,donepezil,1,1
111251,(,1,1
111252,doses,1,1
111253,of,1,0
111254,5,1,0
111255,and,1,0
111256,10,1,1
111257,mg,1,1
111258,),1,1
111259,",",1,0
111260,followed,1,0
111261,by,1,0
111262,a,1,0
111263,10-week,1,0
111264,open,1,0
111265,label,1,0
111266,trial,1,0
111267,for,1,0
111268,placebo,1,1
111269,nonresponders,1,0
111270,.,1,0
111271,RESULTS,0,0
111272,The,0,0
111273,effect,0,0
111274,of,0,0
111275,donepezil,1,1
111276,treatment,1,1
111277,on,0,0
111278,EF,0,0
111279,was,0,0
111280,examined,0,0
111281,.,0,0
111282,Despite,0,0
111283,improvement,0,0
111284,on,0,0
111285,a,0,0
111286,number,0,0
111287,of,0,0
111288,EF,0,0
111289,measures,0,0
111290,",",0,0
111291,no,0,0
111292,statistically,0,0
111293,significant,0,0
111294,between-group,0,0
111295,differences,0,0
111296,were,0,0
111297,found,0,0
111298,(,0,0
111299,with,0,0
111300,gains,0,0
111301,observed,0,0
111302,for,0,0
111303,both,0,0
111304,the,0,0
111305,placebo,0,1
111306,and,0,1
111307,donepezil,0,1
111308,groups,0,1
111309,),0,0
111310,.,0,0
111311,CONCLUSIONS,0,0
111312,The,0,0
111313,results,0,0
111314,suggest,0,0
111315,that,0,0
111316,short-term,0,0
111317,treatment,0,0
111318,with,0,0
111319,donepezil,0,1
111320,may,0,0
111321,have,0,0
111322,limited,0,0
111323,impact,0,0
111324,on,0,0
111325,cognitive,0,0
111326,functioning,0,0
111327,in,0,0
111328,ASD,0,0
111329,.,0,0
111330,Future,0,0
111331,controlled,0,0
111332,trials,0,0
111333,may,0,0
111334,need,0,0
111335,to,0,0
111336,consider,0,0
111337,a,0,0
111338,longer,0,0
111339,treatment,0,0
111340,period,0,0
111341,to,0,0
111342,detect,0,0
111343,significant,0,0
111344,gains,0,0
111345,on,0,0
111346,EF,0,0
111347,measures,0,0
111348,.,0,0
111349,Anastrozole,1,1
111350,single-dose,0,1
111351,protocol,0,1
111352,in,0,0
111353,women,0,0
111354,with,0,0
111355,oligo-,0,0
111356,or,0,0
111357,anovulatory,0,0
111358,infertility,0,0
111359,:,0,0
111360,results,0,0
111361,of,0,0
111362,a,0,0
111363,randomized,0,0
111364,phase,0,0
111365,II,0,1
111366,dose-response,0,1
111367,study,0,0
111368,.,0,0
111369,OBJECTIVE,0,0
111370,To,0,0
111371,compare,0,0
111372,the,0,0
111373,effects,0,0
111374,of,0,0
111375,anastrozole,1,1
111376,and,0,1
111377,clomiphene,1,1
111378,citrate,1,1
111379,(,1,1
111380,CC,1,1
111381,),1,1
111382,on,0,0
111383,follicular,0,0
111384,development,0,0
111385,and,0,0
111386,ovulation,0,1
111387,in,0,0
111388,infertile,0,1
111389,women,0,0
111390,with,0,0
111391,ovulatory,0,0
111392,dysfunction,0,0
111393,.,0,0
111394,DESIGN,0,0
111395,Phase,0,0
111396,II,0,0
111397,",",0,0
111398,prospective,0,0
111399,",",0,0
111400,randomized,0,0
111401,",",0,0
111402,assessor-blind,0,0
111403,",",0,0
111404,multicenter,0,1
111405,",",0,1
111406,dose-finding,0,1
111407,",",0,1
111408,noninferiority,0,0
111409,study,0,0
111410,.,0,0
111411,SETTING,0,0
111412,Outpatient,0,0
111413,.,0,0
111414,PATIENT,0,1
111415,(,0,1
111416,S,0,1
111417,),0,1
111418,Infertile,0,0
111419,women,0,1
111420,with,0,0
111421,ovulatory,0,0
111422,dysfunction,0,0
111423,",",0,0
111424,aged,0,0
111425,18-35,0,0
111426,years,0,0
111427,",",0,0
111428,and,0,0
111429,body,0,0
111430,mass,0,0
111431,index,0,0
111432,<,0,0
111433,35,0,0
111434,kg/m,0,0
111435,(,0,0
111436,2,0,0
111437,),0,0
111438,.,0,1
111439,INTERVENTION,0,1
111440,(,0,1
111441,S,0,1
111442,),0,1
111443,Single-dose,1,1
111444,anastrozole,1,1
111445,at,0,1
111446,5,0,1
111447,mg,0,1
111448,(,0,0
111449,n,0,0
111450,=,0,0
111451,39,0,0
111452,),0,0
111453,",",0,0
111454,10,0,1
111455,mg,0,1
111456,(,0,0
111457,n,0,0
111458,=,0,0
111459,39,0,0
111460,),0,0
111461,",",0,0
111462,20,0,1
111463,mg,0,1
111464,(,0,0
111465,n,0,0
111466,=,0,0
111467,39,0,0
111468,),0,0
111469,",",0,0
111470,or,0,1
111471,30,0,1
111472,mg,0,1
111473,(,0,0
111474,n,0,0
111475,=,0,0
111476,38,0,0
111477,),0,0
111478,or,0,0
111479,a,0,0
111480,5-day,1,1
111481,course,1,1
111482,of,1,0
111483,CC,1,0
111484,at,0,0
111485,50,0,0
111486,mg/d,0,1
111487,(,0,0
111488,n,0,0
111489,=,0,0
111490,39,0,0
111491,),0,0
111492,as,0,0
111493,starting,0,0
111494,doses,0,1
111495,.,0,1
111496,MAIN,0,1
111497,OUTCOME,0,1
111498,MEASURE,0,1
111499,(,0,1
111500,S,0,1
111501,),0,1
111502,The,0,0
111503,primary,0,0
111504,endpoint,0,0
111505,was,0,0
111506,the,0,0
111507,ovulation,0,0
111508,rate,0,0
111509,in,0,0
111510,the,0,0
111511,first,0,0
111512,treatment,0,0
111513,cycle,0,0
111514,(,0,0
111515,cycle,0,0
111516,1,0,1
111517,),0,0
111518,.,0,0
111519,Ovulation,0,0
111520,was,0,0
111521,defined,0,0
111522,as,0,0
111523,a,0,0
111524,midluteal,0,1
111525,phase,0,0
111526,serum,0,0
111527,P,0,0
111528,level,0,0
111529,?,0,0
111530,10,0,0
111531,ng/mL,0,0
111532,or,0,0
111533,clinical,0,0
111534,pregnancy,0,0
111535,.,0,0
111536,RESULT,0,1
111537,(,0,1
111538,S,0,1
111539,),0,1
111540,In,0,0
111541,cycle,0,0
111542,1,0,0
111543,the,0,0
111544,ovulation,0,1
111545,rates,0,0
111546,for,0,0
111547,a,0,0
111548,single,0,0
111549,dose,0,1
111550,of,0,1
111551,anastrozole,1,1
111552,at,1,0
111553,5,0,0
111554,",",0,0
111555,10,0,0
111556,",",0,0
111557,20,0,0
111558,",",0,0
111559,and,0,0
111560,30,0,0
111561,mg,0,0
111562,were,0,0
111563,46.2,0,0
111564,%,0,0
111565,",",0,0
111566,41.0,0,0
111567,%,0,0
111568,",",0,0
111569,23.1,0,0
111570,%,0,0
111571,",",0,0
111572,and,0,0
111573,28.9,0,0
111574,%,0,0
111575,",",0,0
111576,respectively,0,0
111577,",",0,0
111578,whereas,0,0
111579,that,0,0
111580,for,0,0
111581,CC,0,0
111582,at,0,0
111583,50,0,0
111584,mg/d,0,0
111585,was,0,0
111586,61.5,0,0
111587,%,0,0
111588,.,0,0
111589,Among,0,0
111590,women,0,0
111591,with,0,0
111592,fewer,0,0
111593,than,0,0
111594,six,0,0
111595,menses,0,0
111596,per,0,0
111597,year,0,0
111598,",",0,0
111599,the,0,0
111600,cumulative,0,1
111601,ovulation,0,1
111602,rates,0,0
111603,over,0,0
111604,three,0,0
111605,cycles,0,0
111606,were,0,0
111607,comparable,0,0
111608,in,0,0
111609,the,1,0
111610,anastrozole,1,1
111611,5,1,1
111612,mg,0,1
111613,(,0,0
111614,52.4,0,0
111615,%,0,0
111616,),0,0
111617,and,0,0
111618,CC,0,1
111619,50,0,1
111620,mg/d,0,1
111621,(,0,0
111622,42.3,0,0
111623,%,0,0
111624,),0,0
111625,groups,0,0
111626,.,0,0
111627,CONCLUSION,0,1
111628,(,0,1
111629,S,0,1
111630,),0,1
111631,In,0,0
111632,terms,0,0
111633,of,0,0
111634,ovulation,0,0
111635,rates,0,0
111636,in,0,0
111637,cycle,0,0
111638,1,0,0
111639,",",0,0
111640,single-dose,1,1
111641,anastrozole,1,1
111642,at,1,1
111643,5,0,0
111644,",",0,0
111645,10,0,0
111646,",",0,0
111647,20,0,0
111648,",",0,0
111649,and,0,0
111650,30,0,1
111651,mg,0,1
111652,was,0,0
111653,not,0,0
111654,as,0,0
111655,effective,0,0
111656,as,0,0
111657,CC,0,0
111658,at,0,0
111659,50,0,0
111660,mg/d,0,1
111661,for,0,1
111662,5,0,1
111663,days,0,1
111664,(,0,1
111665,noninferiority,0,1
111666,was,0,0
111667,not,0,0
111668,shown,0,0
111669,),0,0
111670,.,0,0
111671,Enhancing,0,0
111672,implementation,0,0
111673,of,0,0
111674,tobacco,1,0
111675,use,1,0
111676,prevention,1,0
111677,and,1,0
111678,cessation,1,0
111679,counselling,1,0
111680,guideline,1,0
111681,among,0,0
111682,dental,0,0
111683,providers,0,0
111684,:,0,0
111685,a,0,0
111686,cluster,0,0
111687,randomised,0,0
111688,controlled,0,0
111689,trial,0,0
111690,.,0,0
111691,BACKGROUND,0,0
111692,Tobacco,0,0
111693,use,0,0
111694,adversely,0,0
111695,affects,0,0
111696,oral,0,1
111697,health,0,1
111698,.,0,0
111699,Tobacco,1,0
111700,use,1,0
111701,prevention,1,0
111702,and,1,0
111703,cessation,1,1
111704,(,1,1
111705,TUPAC,1,1
111706,),1,1
111707,counselling,1,1
111708,guidelines,1,1
111709,recommend,0,0
111710,that,0,0
111711,healthcare,0,0
111712,providers,0,0
111713,ask,0,0
111714,about,0,0
111715,each,0,0
111716,patient,0,0
111717,'s,0,0
111718,tobacco,0,0
111719,use,0,0
111720,",",0,0
111721,assess,0,0
111722,the,0,0
111723,patient,0,0
111724,'s,0,0
111725,readiness,0,0
111726,and,0,0
111727,willingness,0,0
111728,to,0,0
111729,stop,0,0
111730,",",0,0
111731,document,0,0
111732,tobacco,0,0
111733,use,0,0
111734,habits,0,0
111735,",",0,0
111736,advise,0,0
111737,the,0,0
111738,patient,0,0
111739,to,0,0
111740,stop,0,0
111741,",",0,0
111742,assist,0,0
111743,and,0,0
111744,help,0,0
111745,in,0,0
111746,quitting,0,0
111747,",",0,0
111748,and,0,0
111749,arrange,0,0
111750,monitoring,0,0
111751,of,0,0
111752,progress,0,0
111753,at,0,0
111754,follow-up,0,0
111755,appointments,0,0
111756,.,0,0
111757,Adherence,0,0
111758,to,0,0
111759,such,0,0
111760,guidelines,0,0
111761,",",0,0
111762,especially,0,0
111763,among,0,0
111764,dental,0,0
111765,providers,0,0
111766,",",0,0
111767,is,0,0
111768,poor,0,0
111769,.,0,0
111770,To,0,0
111771,improve,0,0
111772,guideline,0,0
111773,implementation,0,0
111774,",",0,0
111775,it,0,0
111776,is,0,0
111777,essential,0,0
111778,to,0,0
111779,understand,0,0
111780,factors,0,0
111781,influencing,0,0
111782,it,0,0
111783,and,0,0
111784,find,0,0
111785,effective,0,0
111786,ways,0,0
111787,to,0,0
111788,influence,0,0
111789,those,0,0
111790,factors,0,0
111791,.,0,0
111792,The,0,0
111793,aim,0,0
111794,of,0,0
111795,the,0,0
111796,present,0,0
111797,study,0,0
111798,protocol,0,0
111799,is,0,0
111800,to,0,0
111801,introduce,0,0
111802,a,0,0
111803,theory-based,1,0
111804,approach,1,0
111805,to,1,0
111806,diagnose,1,0
111807,implementation,1,0
111808,difficulties,1,0
111809,of,1,0
111810,TUPAC,1,1
111811,counselling,1,0
111812,guidelines,1,0
111813,among,1,0
111814,dental,1,0
111815,providers,1,0
111816,.,1,0
111817,METHODS,0,0
111818,Theories,0,0
111819,of,0,0
111820,behaviour,0,0
111821,change,0,0
111822,have,0,0
111823,been,0,0
111824,used,0,0
111825,to,0,0
111826,identify,0,0
111827,key,0,0
111828,theoretical,0,0
111829,domains,0,0
111830,relevant,0,0
111831,to,0,0
111832,the,0,0
111833,behaviours,0,0
111834,of,0,0
111835,healthcare,0,0
111836,providers,0,0
111837,involved,0,0
111838,in,0,0
111839,implementing,0,0
111840,clinical,0,0
111841,guidelines,0,0
111842,.,0,0
111843,These,0,0
111844,theoretical,0,0
111845,domains,0,0
111846,will,0,0
111847,inform,0,0
111848,the,0,0
111849,development,0,0
111850,of,0,0
111851,a,0,0
111852,questionnaire,0,0
111853,aimed,0,0
111854,at,0,0
111855,assessing,0,0
111856,the,0,0
111857,implementation,0,0
111858,of,0,0
111859,the,0,0
111860,TUPAC,1,0
111861,counselling,1,0
111862,guidelines,1,0
111863,among,0,0
111864,Finnish,0,0
111865,municipal,0,0
111866,dental,0,0
111867,providers,0,0
111868,.,0,0
111869,Specific,0,0
111870,items,0,0
111871,will,0,0
111872,be,0,0
111873,drawn,0,0
111874,from,0,0
111875,the,0,0
111876,guidelines,0,0
111877,and,0,0
111878,the,0,0
111879,literature,0,0
111880,on,0,0
111881,TUPAC,1,0
111882,studies,0,0
111883,.,0,0
111884,After,0,0
111885,identifying,0,0
111886,potential,0,0
111887,implementation,0,0
111888,difficulties,0,0
111889,",",0,0
111890,we,0,0
111891,will,0,0
111892,design,0,0
111893,two,0,0
111894,interventions,0,0
111895,using,0,0
111896,theories,1,0
111897,of,1,0
111898,behaviour,1,0
111899,change,1,0
111900,to,0,0
111901,link,0,0
111902,them,0,0
111903,with,0,0
111904,relevant,0,0
111905,behaviour,0,0
111906,change,0,0
111907,techniques,0,0
111908,aiming,0,0
111909,to,0,0
111910,improve,0,0
111911,guideline,1,0
111912,adherence,1,0
111913,.,1,0
111914,For,0,0
111915,assessing,0,0
111916,the,0,0
111917,implementation,0,0
111918,of,0,0
111919,TUPAC,1,0
111920,guidelines,1,0
111921,",",0,0
111922,the,0,0
111923,electronic,0,0
111924,dental,0,0
111925,record,0,0
111926,audit,0,0
111927,and,0,0
111928,self-reported,0,0
111929,questionnaires,0,0
111930,will,0,0
111931,be,0,0
111932,used,0,0
111933,.,0,0
111934,DISCUSSION,0,0
111935,To,0,0
111936,improve,0,0
111937,guideline,0,0
111938,adherence,0,0
111939,",",0,0
111940,the,0,0
111941,theoretical-domains,0,0
111942,approach,0,0
111943,could,0,0
111944,provide,0,0
111945,a,0,0
111946,comprehensive,0,0
111947,basis,0,0
111948,for,0,0
111949,assessing,0,0
111950,implementation,0,0
111951,difficulties,0,0
111952,",",0,0
111953,as,0,0
111954,well,0,0
111955,as,0,0
111956,designing,0,0
111957,and,0,0
111958,evaluating,0,0
111959,interventions,0,0
111960,.,0,0
111961,After,0,0
111962,having,0,0
111963,identified,0,0
111964,implementation,0,0
111965,difficulties,0,0
111966,",",0,0
111967,we,0,0
111968,will,0,0
111969,design,0,0
111970,and,0,0
111971,test,0,0
111972,two,0,0
111973,interventions,0,0
111974,to,0,0
111975,enhance,0,0
111976,TUPAC,1,0
111977,guideline,1,0
111978,adherence,0,0
111979,.,0,0
111980,Using,0,0
111981,the,0,0
111982,cluster,0,0
111983,randomised,0,0
111984,controlled,0,0
111985,design,0,0
111986,",",0,0
111987,we,0,0
111988,aim,0,0
111989,to,0,0
111990,provide,0,0
111991,further,0,0
111992,evidence,0,0
111993,on,0,0
111994,intervention,0,0
111995,effects,0,0
111996,",",0,0
111997,as,0,0
111998,well,0,0
111999,as,0,0
112000,on,0,0
112001,the,0,0
112002,validity,0,0
112003,and,0,0
112004,feasibility,0,0
112005,of,0,0
112006,the,0,0
112007,theoretical-domain,0,0
112008,approach,0,0
112009,.,0,0
112010,The,0,0
112011,empirical,0,0
112012,data,0,0
112013,collected,0,0
112014,within,0,0
112015,this,0,0
112016,trial,0,0
112017,will,0,0
112018,be,0,0
112019,useful,0,0
112020,in,0,0
112021,testing,0,0
112022,whether,0,0
112023,this,0,0
112024,theoretical-domain,1,0
112025,approach,1,0
112026,can,0,0
112027,improve,0,0
112028,our,0,0
112029,understanding,0,0
112030,of,0,0
112031,the,0,0
112032,implementation,0,0
112033,of,0,0
112034,TUPAC,1,0
112035,guidelines,1,0
112036,among,0,0
112037,dental,0,0
112038,providers,0,0
112039,.,0,0
112040,TRIAL,0,0
112041,REGISTRATION,0,0
112042,Current,0,0
112043,Controlled,0,0
112044,Trials,0,0
112045,ISRCTN15427433,0,0
112046,.,0,0
112047,[,0,1
112048,Clinical,0,0
112049,observation,0,0
112050,on,0,0
112051,acupuncture,1,0
112052,for,0,0
112053,treatment,0,0
112054,of,0,0
112055,male,0,0
112056,osteoporosis,0,0
112057,],0,0
112058,.,0,0
112059,OBJECTIVE,0,0
112060,To,0,0
112061,compare,0,0
112062,the,0,0
112063,therapeutic,0,0
112064,effects,0,0
112065,of,0,0
112066,acupuncture,1,0
112067,combined,0,0
112068,with,0,0
112069,drug,0,1
112070,and,0,0
112071,simple,0,0
112072,drug,0,1
112073,for,0,0
112074,treatment,0,0
112075,of,0,0
112076,male,0,0
112077,osteoporosis,0,0
112078,.,0,0
112079,METHODS,0,0
112080,Fifty-five,0,0
112081,cases,0,0
112082,were,0,0
112083,divided,0,0
112084,into,0,0
112085,an,0,0
112086,observation,0,0
112087,group,0,0
112088,(,0,0
112089,25,0,0
112090,cases,0,0
112091,),0,0
112092,and,0,0
112093,a,0,0
112094,control,0,0
112095,group,0,0
112096,(,0,0
112097,30,0,0
112098,cases,0,0
112099,),0,0
112100,randomly,0,0
112101,.,0,0
112102,The,0,0
112103,observation,0,0
112104,group,0,0
112105,was,0,0
112106,treated,0,0
112107,with,0,0
112108,acupuncture,1,0
112109,and,1,0
112110,moxibustion,1,0
112111,at,1,0
112112,Pishu,1,0
112113,(,0,0
112114,BL,0,1
112115,20,0,1
112116,),0,0
112117,",",0,0
112118,Shenshu,1,1
112119,(,0,0
112120,BL,0,0
112121,23,0,0
112122,),0,0
112123,",",0,0
112124,Mingmen,1,1
112125,(,0,1
112126,GV,0,1
112127,4,0,1
112128,),0,0
112129,",",0,1
112130,Shenque,1,1
112131,(,0,1
112132,CV,0,1
112133,8,0,1
112134,),0,0
112135,and,0,0
112136,so,0,0
112137,on,0,0
112138,combined,0,0
112139,with,0,0
112140,taking,0,0
112141,Alendronate,1,1
112142,",",0,0
112143,while,0,0
112144,the,0,0
112145,control,0,0
112146,group,0,0
112147,was,0,0
112148,treated,0,0
112149,with,0,0
112150,taking,0,0
112151,Alendronate,1,1
112152,simply,1,0
112153,.,1,0
112154,The,0,0
112155,improvement,0,0
112156,of,0,0
112157,both,0,0
112158,Integral,0,0
112159,of,0,0
112160,Clinical,0,1
112161,Symptoms,0,1
112162,(,0,1
112163,ICS,0,1
112164,),0,1
112165,and,0,1
112166,Bone,0,1
112167,Mineral,0,1
112168,Density,0,1
112169,(,0,1
112170,BMD,0,1
112171,),0,0
112172,of,0,0
112173,two,0,0
112174,groups,0,0
112175,was,0,0
112176,observed,0,0
112177,after,0,0
112178,6,0,0
112179,months,0,0
112180,treatment,0,0
112181,.,0,0
112182,RESULTS,0,0
112183,The,0,0
112184,ICS,0,0
112185,of,0,0
112186,two,0,0
112187,groups,0,0
112188,after,0,0
112189,treatment,0,0
112190,both,0,0
112191,decreased,0,0
112192,significantly,0,0
112193,(,0,0
112194,both,0,0
112195,P,0,0
112196,<,0,0
112197,0.001,0,0
112198,),0,0
112199,",",0,0
112200,and,0,0
112201,the,0,0
112202,decreasing,0,0
112203,degree,0,0
112204,in,0,0
112205,observation,0,0
112206,group,0,0
112207,was,0,0
112208,more,0,0
112209,significant,0,0
112210,than,0,0
112211,that,0,0
112212,in,0,0
112213,control,0,0
112214,group,0,0
112215,(,0,0
112216,P,0,0
112217,<,0,0
112218,0.001,0,0
112219,),0,0
112220,.,0,0
112221,The,0,0
112222,BMD,0,0
112223,of,0,0
112224,lumbar,0,0
112225,vertebrae,0,0
112226,and,0,0
112227,femur,0,0
112228,in,0,0
112229,observation,0,0
112230,group,0,0
112231,increased,0,0
112232,obviously,0,0
112233,than,0,0
112234,that,0,0
112235,before,0,0
112236,treatment,0,0
112237,(,0,0
112238,P,0,0
112239,<,0,0
112240,0.01,0,0
112241,",",0,0
112242,P,0,0
112243,<,0,0
112244,0.05,0,0
112245,),0,0
112246,.,0,0
112247,The,0,0
112248,increasing,0,0
112249,degree,0,0
112250,of,0,0
112251,BMD,0,0
112252,of,0,0
112253,lumbar,0,0
112254,vertebrae,0,0
112255,in,0,0
112256,observation,0,0
112257,group,0,0
112258,after,0,0
112259,treatment,0,0
112260,was,0,0
112261,more,0,0
112262,obvious,0,0
112263,than,0,0
112264,that,0,0
112265,in,0,0
112266,control,0,0
112267,group,0,0
112268,(,0,0
112269,P,0,0
112270,<,0,0
112271,0.05,0,0
112272,),0,0
112273,.,0,0
112274,There,0,0
112275,were,0,0
112276,abdominal,0,0
112277,pain,0,0
112278,",",0,0
112279,diarrhea,0,1
112280,",",0,1
112281,nausea,0,1
112282,",",0,1
112283,vomiting,0,1
112284,",",0,0
112285,dyspepsia,0,0
112286,and,0,0
112287,other,0,0
112288,adverse,0,0
112289,reaction,0,0
112290,in,0,0
112291,control,0,0
112292,group,0,0
112293,",",0,0
112294,while,0,0
112295,the,0,0
112296,degree,0,0
112297,and,0,0
112298,occurrence,0,0
112299,rate,0,0
112300,of,0,0
112301,those,0,0
112302,in,0,0
112303,observation,0,0
112304,group,0,0
112305,alleviated,0,0
112306,and,0,0
112307,decreased,0,0
112308,obviously,0,0
112309,.,0,0
112310,CONCLUSION,0,0
112311,The,0,0
112312,effect,0,0
112313,of,0,0
112314,acupuncture,1,0
112315,combined,0,0
112316,with,0,0
112317,drug,0,1
112318,for,0,0
112319,treatment,0,0
112320,of,0,0
112321,male,0,0
112322,osteoporosis,0,0
112323,is,0,0
112324,good,0,0
112325,with,0,0
112326,little,0,0
112327,adverse,0,0
112328,reaction,0,0
112329,.,0,0
112330,This,0,0
112331,method,0,0
112332,is,0,0
112333,better,0,0
112334,than,0,0
112335,taking,0,0
112336,Alendronate,0,1
112337,.,0,0
112338,Sequential,0,0
112339,alternate,0,0
112340,administration,0,1
112341,of,0,1
112342,tamoxifen,1,1
112343,and,0,1
112344,medroxyprogesterone,1,1
112345,acetate,1,1
112346,in,0,1
112347,advanced,0,1
112348,breast,0,0
112349,cancer,0,0
112350,:,0,0
112351,clinical-biological,0,0
112352,randomized,0,0
112353,study,0,0
112354,.,0,0
112355,From,0,0
112356,January,0,0
112357,1985,0,0
112358,to,0,0
112359,September,0,0
112360,1988,0,0
112361,",",0,0
112362,60,0,0
112363,women,0,0
112364,with,0,0
112365,advanced,0,0
112366,breast,0,0
112367,cancer,0,0
112368,were,0,0
112369,randomized,0,0
112370,in,0,0
112371,two,1,0
112372,arms,1,0
112373,to,1,0
112374,receive,1,0
112375,:,1,0
112376,A,1,1
112377,),1,1
112378,tamoxifen,1,1
112379,(,1,1
112380,TAM,1,1
112381,),1,1
112382,(,1,1
112383,20,1,1
112384,mg/die,1,1
112385,),1,1
112386,until,1,1
112387,progression,1,0
112388,or,1,0
112389,B,1,1
112390,),1,1
112391,TAM,1,1
112392,(,1,1
112393,20,1,0
112394,mg/die,1,1
112395,for,1,1
112396,14,1,1
112397,days,1,0
112398,),1,1
112399,then,1,1
112400,medroxyprogesterone,1,1
112401,acetate,1,1
112402,(,1,1
112403,MPA,1,1
112404,),1,1
112405,(,1,1
112406,1500,1,1
112407,mg/die,1,1
112408,p.o,1,1
112409,.,1,1
112410,for,1,0
112411,14,1,0
112412,days,1,0
112413,),1,0
112414,followed,1,0
112415,by,1,0
112416,7,1,0
112417,days,1,0
112418,of,1,0
112419,wash-out,1,1
112420,before,1,0
112421,repeating,1,0
112422,the,1,0
112423,TAM/MPA,1,0
112424,treatment,1,0
112425,.,1,0
112426,All,0,0
112427,patients,0,0
112428,were,0,0
112429,post-menopausal,0,0
112430,",",0,0
112431,previously,0,0
112432,untreated,0,0
112433,with,0,0
112434,hormone,0,1
112435,therapy,0,1
112436,",",0,0
112437,and,0,0
112438,with,0,0
112439,tumor,0,0
112440,receptor,0,0
112441,status,0,0
112442,determined,0,0
112443,immediately,0,0
112444,before,0,0
112445,randomization,0,0
112446,;,0,0
112447,all,0,0
112448,had,0,0
112449,objectively,0,0
112450,evaluable,0,0
112451,lesions,0,0
112452,.,0,0
112453,In,0,0
112454,order,0,0
112455,to,0,0
112456,verify,0,0
112457,hormone,0,1
112458,receptor,0,0
112459,variations,0,0
112460,due,0,0
112461,to,0,0
112462,the,0,0
112463,antiestrogen,0,1
112464,",",0,0
112465,when,1,0
112466,possible,1,0
112467,a,1,0
112468,second,1,0
112469,biopsy,1,0
112470,was,1,0
112471,performed,1,0
112472,after,1,0
112473,the,1,0
112474,initial,1,0
112475,14,1,0
112476,day,1,0
112477,cycle,1,0
112478,of,1,0
112479,TAM,1,0
112480,.,1,0
112481,Thirty-one,0,0
112482,and,0,0
112483,29,0,0
112484,patients,0,0
112485,were,0,0
112486,included,0,0
112487,respectively,0,0
112488,in,0,0
112489,arms,0,0
112490,A,0,1
112491,and,0,0
112492,B,0,0
112493,.,0,0
112494,Objective,0,0
112495,regression,0,1
112496,(,0,1
112497,CR,0,1
112498,+,0,1
112499,PR,0,1
112500,),0,0
112501,was,0,0
112502,observed,0,0
112503,in,0,0
112504,58,0,0
112505,%,0,0
112506,of,0,0
112507,group,0,0
112508,A,0,0
112509,and,0,0
112510,75,0,0
112511,%,0,0
112512,of,0,0
112513,group,0,0
112514,B,0,0
112515,",",0,0
112516,with,0,0
112517,CR,0,0
112518,in,0,0
112519,11,0,0
112520,%,0,0
112521,and,0,0
112522,23,0,0
112523,%,0,0
112524,",",0,0
112525,respectively,0,0
112526,.,0,0
112527,Differences,0,0
112528,were,0,0
112529,not,0,0
112530,statistically,0,0
112531,significant,0,0
112532,.,0,0
112533,Median,0,0
112534,time,0,0
112535,to,0,0
112536,progression,0,0
112537,was,0,0
112538,12,0,0
112539,months,0,0
112540,for,0,0
112541,group,0,0
112542,A,0,0
112543,and,0,0
112544,9,0,0
112545,for,0,0
112546,group,0,0
112547,B,0,0
112548,.,0,0
112549,Overall,0,0
112550,survival,0,0
112551,has,0,0
112552,not,0,0
112553,yet,0,0
112554,been,0,0
112555,reached,0,0
112556,in,0,0
112557,group,0,0
112558,A,0,0
112559,while,0,0
112560,it,0,0
112561,was,0,0
112562,34,0,0
112563,months,0,0
112564,for,0,0
112565,patients,0,0
112566,of,0,0
112567,group,0,0
112568,B.,0,0
112569,Metrorrhagia,0,0
112570,was,0,0
112571,observed,0,0
112572,in,0,0
112573,two,0,0
112574,cases,0,0
112575,of,0,0
112576,group,0,0
112577,A,0,0
112578,and,0,0
112579,in,0,0
112580,6,0,0
112581,of,0,0
112582,group,0,0
112583,B,0,0
112584,",",0,0
112585,and,0,0
112586,thrombophlebitis,0,0
112587,in,0,0
112588,1,0,0
112589,and,0,0
112590,3,0,0
112591,cases,0,0
112592,",",0,0
112593,respectively,0,0
112594,.,0,0
112595,The,0,0
112596,second,0,0
112597,biopsy,0,0
112598,confirmed,0,0
112599,a,0,0
112600,clear,0,0
112601,increase,0,0
112602,of,0,0
112603,PgR,0,0
112604,content,0,0
112605,in,0,0
112606,8/11,0,0
112607,cases,0,0
112608,(,0,0
112609,75,0,0
112610,%,0,0
112611,),0,0
112612,.,0,0
112613,Plasma,0,1
112614,level,0,0
112615,variations,0,0
112616,of,0,0
112617,TAM,0,1
112618,",",0,1
112619,N-desmethyl,0,1
112620,TAM,0,1
112621,and,0,0
112622,MPA,0,0
112623,were,0,0
112624,checked,0,0
112625,at,0,0
112626,various,0,0
112627,intervals,0,0
112628,on,0,0
112629,3,0,0
112630,patients,0,0
112631,of,0,0
112632,group,0,0
112633,B,0,0
112634,",",0,0
112635,and,0,0
112636,confirmed,0,0
112637,that,0,0
112638,our,0,0
112639,schedule,0,0
112640,is,0,0
112641,able,0,0
112642,to,0,0
112643,produce,0,0
112644,a,0,0
112645,drug,0,1
112646,wash-out,0,1
112647,period,0,1
112648,for,0,0
112649,tumor,0,0
112650,cells,0,0
112651,.,0,0
112652,In,0,0
112653,conclusion,0,0
112654,",",0,0
112655,our,0,0
112656,study,0,0
112657,demonstrated,0,0
112658,that,0,0
112659,while,0,0
112660,the,0,0
112661,manipulation,0,0
112662,of,0,0
112663,hormone,0,1
112664,receptors,0,0
112665,seems,0,0
112666,possible,0,0
112667,",",0,0
112668,results,0,0
112669,indicating,0,0
112670,better,0,0
112671,overall,0,0
112672,survival,0,0
112673,and,0,0
112674,time,0,0
112675,to,0,0
112676,progression,0,0
112677,were,0,0
112678,not,0,0
112679,obtained,0,0
112680,with,0,0
112681,alternate,0,0
112682,sequential,0,0
112683,TAM-MPA,0,0
112684,therapy,0,0
112685,.,0,0
112686,Hepatobiliary,0,0
112687,response,0,0
112688,in,0,0
112689,postoperative,0,0
112690,lipid,1,0
112691,therapy,1,0
112692,in,0,0
112693,gastrointestinal,0,0
112694,surgery,0,0
112695,.,0,0
112696,BACKGROUND/AIMS,0,1
112697,Intravenous,0,1
112698,lipid,1,1
112699,emulsions,1,1
112700,may,0,0
112701,contribute,0,0
112702,to,0,0
112703,the,0,0
112704,development,0,0
112705,of,0,0
112706,total,0,0
112707,parenteral,0,1
112708,nutrition,0,1
112709,(,0,1
112710,TPN,0,1
112711,),0,1
112712,--,0,0
112713,induced,0,0
112714,hepatobiliary,0,0
112715,complications,0,0
112716,.,0,0
112717,METHODS,0,0
112718,In,0,0
112719,a,0,0
112720,prospective,0,0
112721,",",0,0
112722,randomised,0,0
112723,setting,0,0
112724,the,0,0
112725,authors,0,0
112726,compared,0,0
112727,the,0,0
112728,short-term,0,0
112729,hepatic,0,0
112730,effects,0,0
112731,of,0,0
112732,medium-chain,1,1
112733,triglycerides/short-chain,1,1
112734,triglycerides,1,1
112735,(,1,1
112736,MCT/LCT,1,1
112737,),1,1
112738,physical,1,0
112739,mixture,1,0
112740,with,1,0
112741,a,1,0
112742,four-component,1,0
112743,intravenous,1,1
112744,(,1,1
112745,i.v,1,1
112746,.,1,1
112747,),1,0
112748,lipid,1,0
112749,emulsion,1,1
112750,(,1,1
112751,LCT,1,1
112752,",",1,0
112753,MCT,1,1
112754,",",1,1
112755,Olive-oil,1,1
112756,and,1,1
112757,Fish-oil,1,1
112758,),1,1
112759,in,0,0
112760,patients,0,0
112761,undergoing,0,0
112762,elective,0,1
112763,gastrointestial,0,0
112764,surgery,0,0
112765,during,0,0
112766,the,0,0
112767,early,0,0
112768,postoperative,0,0
112769,period,0,0
112770,.,0,0
112771,RESULTS,0,0
112772,The,0,0
112773,authors,0,0
112774,demonstrated,0,0
112775,that,0,0
112776,total,0,0
112777,and,0,0
112778,conjugated,0,1
112779,bilirubin,0,1
112780,",",0,1
112781,alkaline,0,0
112782,phosphatase,0,1
112783,",",0,1
112784,alanine,0,1
112785,aminotransferase,0,1
112786,",",0,1
112787,aspartate,0,1
112788,amino,0,1
112789,transferase,0,1
112790,and,0,1
112791,cholinesterase,0,1
112792,did,0,0
112793,not,0,0
112794,change,0,0
112795,significantly,0,0
112796,during,0,0
112797,the,0,0
112798,5-days,0,0
112799,observation,0,0
112800,period,0,0
112801,.,0,0
112802,In,0,0
112803,contrast,0,0
112804,to,0,0
112805,this,0,0
112806,",",0,0
112807,gamma-glutamyl,0,1
112808,transferase,0,1
112809,(,0,1
112810,GGT,0,1
112811,),0,0
112812,activity,0,0
112813,increased,0,0
112814,by,0,0
112815,"2,4",0,0
112816,times,0,0
112817,during,0,0
112818,5-days,0,0
112819,therapy,1,0
112820,with,1,0
112821,the,1,0
112822,lipid,1,0
112823,emulsions,1,1
112824,mentioned,0,0
112825,above,0,0
112826,(,0,0
112827,SMOF,0,0
112828,lipid,0,0
112829,:,0,0
112830,"21,9",0,0
112831,to,0,0
112832,"52,9",0,0
112833,U/L,0,0
112834,",",0,0
112835,Lipofundin,0,1
112836,:,0,0
112837,from,0,0
112838,"32,5",0,0
112839,to,0,0
112840,"79,6",0,0
112841,U/L,0,0
112842,),0,0
112843,.,0,0
112844,CONCLUSION,0,0
112845,during,0,0
112846,a,0,0
112847,4-days,0,1
112848,administration,0,1
112849,hepatic,0,1
112850,effect,0,0
112851,of,0,0
112852,the,0,0
112853,intravenous,0,1
112854,lipid,1,1
112855,emulsions,1,1
112856,did,0,0
112857,not,0,0
112858,differ,0,0
112859,significantly,0,0
112860,.,0,0
112861,The,0,0
112862,changes,0,0
112863,in,0,0
112864,enzyme,0,0
112865,levels,0,0
112866,confirm,0,0
112867,the,0,0
112868,cholestatic,0,1
112869,type,0,0
112870,of,0,0
112871,hepatobiliary,0,0
112872,deviations,0,0
112873,without,0,0
112874,clinical,0,0
112875,impact,0,0
112876,on,0,0
112877,short-term,0,0
112878,TPN,1,0
112879,therapy,1,0
112880,.,1,0
112881,Nephrotoxicity,0,1
112882,of,0,1
112883,cyclosporin,1,1
112884,A,1,1
112885,in,0,0
112886,patients,0,0
112887,with,0,0
112888,newly,0,0
112889,diagnosed,0,0
112890,type,0,0
112891,1,0,0
112892,diabetes,0,0
112893,mellitus,0,0
112894,.,0,0
112895,Renal,0,0
112896,function,0,0
112897,was,0,0
112898,studied,0,0
112899,in,0,0
112900,18,0,0
112901,patients,0,0
112902,with,0,0
112903,Type,0,0
112904,1,0,0
112905,diabetes,0,0
112906,mellitus,0,0
112907,.,0,0
112908,All,0,0
112909,were,0,0
112910,participating,0,0
112911,in,0,0
112912,the,0,0
112913,Canadian-European,0,0
112914,randomized,0,1
112915,placebo-controlled,1,1
112916,cyclosporin,1,1
112917,trial,0,1
112918,in,0,0
112919,newly,0,0
112920,diagnosed,0,0
112921,Type,0,0
112922,1,0,0
112923,diabetic,0,0
112924,patients,0,0
112925,",",0,0
112926,nine,0,0
112927,being,0,0
112928,randomized,0,0
112929,to,0,0
112930,placebo,1,1
112931,",",0,0
112932,and,0,0
112933,nine,0,0
112934,to,0,0
112935,cyclosporin,1,1
112936,A,1,1
112937,.,1,0
112938,During,0,0
112939,treatment,0,0
112940,for,0,0
112941,12,0,0
112942,to,0,0
112943,18,0,0
112944,months,0,0
112945,",",0,0
112946,cyclosporin,1,1
112947,A,1,1
112948,caused,0,0
112949,significant,0,0
112950,reductions,0,0
112951,in,0,0
112952,the,0,0
112953,glomerular,0,0
112954,filtration,0,0
112955,rate,0,0
112956,(,0,0
112957,before,0,0
112958,drug,0,1
112959,withdrawal,0,1
112960,",",0,0
112961,cyclosporin,1,0
112962,97,0,0
112963,+/-,0,0
112964,18,0,0
112965,vs,0,0
112966,placebo,0,0
112967,125,0,0
112968,+/-,0,0
112969,16,0,0
112970,ml,0,0
112971,min-1,0,0
112972,1.73-m-2,0,0
112973,",",0,0
112974,p,0,0
112975,less,0,0
112976,than,0,0
112977,0.05,0,0
112978,),0,0
112979,",",0,0
112980,renal,0,1
112981,plasma,0,1
112982,flow,0,0
112983,(,0,0
112984,454,0,0
112985,+/-,0,0
112986,83,0,0
112987,vs,0,0
112988,536,0,0
112989,+/-,0,0
112990,70,0,0
112991,ml,0,0
112992,min-1,0,0
112993,1.73-m-2,0,0
112994,",",0,0
112995,p,0,0
112996,less,0,0
112997,than,0,0
112998,0.05,0,0
112999,),0,0
113000,",",0,0
113001,and,0,1
113002,lithium,0,1
113003,clearance,0,1
113004,(,0,1
113005,17,0,0
113006,+/-,0,0
113007,3,0,0
113008,vs,0,0
113009,28,0,0
113010,+/-,0,0
113011,5,0,0
113012,ml,0,0
113013,min-1,0,0
113014,1.73-m-2,0,0
113015,",",0,0
113016,p,0,0
113017,less,0,0
113018,than,0,0
113019,0.05,0,0
113020,),0,0
113021,.,0,0
113022,The,0,0
113023,fractional,0,0
113024,proximal,0,0
113025,reabsorption,0,1
113026,was,0,0
113027,increased,0,0
113028,(,0,0
113029,0.82,0,0
113030,+/-,0,0
113031,0.03,0,0
113032,vs,0,0
113033,0.78,0,0
113034,+/-,0,0
113035,0.03,0,0
113036,",",0,0
113037,p,0,0
113038,less,0,0
113039,than,0,0
113040,0.05,0,0
113041,),0,0
113042,",",0,0
113043,and,0,0
113044,the,0,0
113045,fractional,0,0
113046,distal,0,0
113047,sodium,0,1
113048,reabsorption,0,1
113049,reduced,0,1
113050,(,0,0
113051,0.88,0,0
113052,+/-,0,0
113053,0.03,0,0
113054,vs,0,0
113055,0.94,0,0
113056,+/-,0,0
113057,0.02,0,0
113058,",",0,0
113059,p,0,0
113060,less,0,0
113061,than,0,0
113062,0.05,0,0
113063,),0,0
113064,.,0,0
113065,These,0,0
113066,results,0,0
113067,are,0,0
113068,in,0,0
113069,accordance,0,0
113070,with,0,0
113071,the,0,0
113072,hypothesis,0,0
113073,that,0,0
113074,the,0,0
113075,nephrotoxic,0,1
113076,effect,0,0
113077,of,0,0
113078,cyclosporin,1,1
113079,A,1,1
113080,results,0,0
113081,from,0,0
113082,a,0,0
113083,preferential,0,0
113084,constriction,0,0
113085,of,0,0
113086,afferent,0,0
113087,glomerular,0,0
113088,vessels,0,0
113089,.,0,0
113090,One,0,0
113091,year,0,0
113092,after,0,0
113093,withdrawal,0,0
113094,of,0,0
113095,the,0,0
113096,drug,0,1
113097,",",0,0
113098,all,0,0
113099,variables,0,0
113100,were,0,0
113101,similar,0,0
113102,in,0,0
113103,the,0,0
113104,two,0,0
113105,groups,0,0
113106,",",0,0
113107,except,0,0
113108,for,0,0
113109,blood,0,0
113110,glucose,0,1
113111,control,0,0
113112,which,0,0
113113,was,0,0
113114,worse,0,0
113115,in,0,0
113116,the,0,0
113117,cyclosporin,1,1
113118,A,1,1
113119,treated,0,0
113120,group,0,0
113121,.,0,0
113122,When,0,0
113123,corrected,0,0
113124,for,0,0
113125,differences,0,0
113126,in,0,0
113127,blood,0,0
113128,glucose,0,1
113129,control,0,0
113130,it,0,0
113131,appeared,0,0
113132,that,0,0
113133,in,0,0
113134,three,0,0
113135,out,0,0
113136,of,0,0
113137,nine,0,0
113138,patients,0,0
113139,glomerular,0,0
113140,filtration,0,0
113141,rate,0,0
113142,had,0,0
113143,not,0,0
113144,completely,0,0
113145,returned,0,0
113146,to,0,0
113147,the,0,0
113148,reference,0,0
113149,range,0,0
113150,of,0,0
113151,the,0,0
113152,placebo,1,1
113153,group,0,1
113154,.,0,0
113155,We,0,0
113156,conclude,0,0
113157,that,0,0
113158,the,0,0
113159,nephrotoxic,0,1
113160,side-effects,0,1
113161,of,0,1
113162,cyclosporin,1,1
113163,A,1,1
113164,treatment,0,0
113165,for,0,0
113166,1,0,0
113167,year,0,0
113168,are,0,0
113169,reversible,0,0
113170,.,0,0
113171,There,0,0
113172,are,0,0
113173,",",0,0
113174,however,0,0
113175,",",0,0
113176,signs,0,0
113177,of,0,0
113178,minor,0,0
113179,and,0,0
113180,perhaps,0,0
113181,chronic,0,0
113182,renal,0,0
113183,injury,0,0
113184,.,0,0
113185,A,0,1
113186,randomised,0,0
113187,non-inferiority,0,0
113188,controlled,0,0
113189,trial,0,0
113190,of,0,0
113191,a,0,0
113192,single,0,0
113193,versus,0,0
113194,a,0,0
113195,four,0,0
113196,intradermal,0,1
113197,sterile,1,0
113198,water,1,0
113199,injection,1,1
113200,technique,1,1
113201,for,0,0
113202,relief,0,0
113203,of,0,0
113204,continuous,0,0
113205,lower,0,0
113206,back,0,0
113207,pain,0,0
113208,during,0,0
113209,labour,0,0
113210,.,0,0
113211,BACKGROUND,0,0
113212,Almost,0,0
113213,one,0,0
113214,third,0,0
113215,of,0,0
113216,women,0,0
113217,suffer,0,0
113218,continuous,0,0
113219,lower,0,0
113220,back,0,0
113221,pain,0,0
113222,during,0,0
113223,labour,0,0
113224,.,0,0
113225,Evidence,0,0
113226,from,0,0
113227,three,0,0
113228,systematic,0,0
113229,reviews,0,0
113230,demonstrates,0,0
113231,that,0,0
113232,sterile,1,0
113233,water,1,0
113234,injections,1,1
113235,(,1,1
113236,SWI,1,1
113237,),1,0
113238,provide,0,0
113239,statistically,0,0
113240,and,0,0
113241,clinically,0,0
113242,significant,0,0
113243,pain,0,0
113244,relief,0,0
113245,in,0,0
113246,women,0,0
113247,experiencing,0,0
113248,continuous,0,0
113249,lower,0,0
113250,back,0,0
113251,pain,0,0
113252,during,0,0
113253,labour,0,0
113254,.,0,0
113255,The,0,0
113256,most,0,0
113257,effective,0,0
113258,technique,0,0
113259,to,0,0
113260,administer,0,1
113261,SWI,1,1
113262,is,0,0
113263,yet,0,0
113264,to,0,0
113265,be,0,0
113266,determined,0,0
113267,.,0,0
113268,Therefore,0,0
113269,",",0,0
113270,the,0,0
113271,aim,0,0
113272,of,0,0
113273,this,0,0
113274,study,0,0
113275,is,0,0
113276,to,0,0
113277,determine,0,0
113278,if,0,0
113279,the,0,0
113280,single,0,0
113281,injection,0,1
113282,SWI,0,1
113283,technique,0,0
113284,is,0,0
113285,no,0,0
113286,less,0,0
113287,effective,0,0
113288,than,0,0
113289,the,0,0
113290,routinely,0,0
113291,used,0,0
113292,four,0,0
113293,injection,0,1
113294,SWI,1,1
113295,method,0,0
113296,in,0,0
113297,reducing,0,0
113298,continuous,0,0
113299,lower,0,0
113300,back,0,0
113301,pain,0,0
113302,during,0,0
113303,labour,0,0
113304,.,0,0
113305,METHODS/DESIGN,0,0
113306,The,0,0
113307,trial,0,0
113308,protocol,0,0
113309,was,0,0
113310,developed,0,0
113311,in,0,0
113312,consultation,0,0
113313,with,0,0
113314,an,0,0
113315,interdisciplinary,0,0
113316,team,0,0
113317,of,0,0
113318,clinical,0,0
113319,researchers,0,0
113320,.,0,0
113321,We,0,0
113322,aim,0,0
113323,to,0,0
113324,recruit,0,0
113325,319,0,0
113326,women,0,0
113327,presenting,0,0
113328,at,0,0
113329,term,0,0
113330,",",0,0
113331,seeking,0,1
113332,analgesia,0,1
113333,for,0,0
113334,continuous,0,0
113335,severe,0,0
113336,lower,0,0
113337,back,0,0
113338,pain,0,0
113339,during,0,0
113340,labour,0,0
113341,.,0,0
113342,Participants,0,0
113343,will,0,0
113344,be,0,0
113345,recruited,0,0
113346,from,0,0
113347,two,0,0
113348,major,0,0
113349,maternity,0,0
113350,hospitals,0,0
113351,in,0,0
113352,Australia,0,0
113353,.,0,0
113354,Randomised,0,0
113355,participants,0,0
113356,are,0,0
113357,allocated,0,0
113358,to,0,0
113359,receive,0,0
113360,a,0,0
113361,four,0,0
113362,or,0,0
113363,single,0,0
113364,intradermal,1,1
113365,needle,1,1
113366,SWI,1,1
113367,technique,1,0
113368,.,1,0
113369,The,0,0
113370,primary,0,0
113371,outcome,0,0
113372,is,0,0
113373,the,0,0
113374,change,0,0
113375,in,0,0
113376,self-reported,0,0
113377,pain,0,0
113378,measured,0,0
113379,by,0,0
113380,visual,0,1
113381,analogue,0,1
113382,scale,0,1
113383,at,0,0
113384,baseline,0,0
113385,and,0,0
113386,thirty,0,0
113387,minutes,0,0
113388,post,0,0
113389,intervention,0,0
113390,.,0,0
113391,Secondary,0,0
113392,outcomes,0,0
113393,include,0,0
113394,VAS,0,0
113395,change,0,0
113396,scores,0,0
113397,at,0,0
113398,10,0,0
113399,",",0,0
113400,60,0,0
113401,",",0,0
113402,90,0,0
113403,and,0,0
113404,120,0,0
113405,min,0,0
113406,",",0,0
113407,analgesia,0,1
113408,use,0,0
113409,",",0,0
113410,mode,0,0
113411,of,0,0
113412,birth,0,0
113413,and,0,0
113414,maternal,0,0
113415,satisfaction,0,0
113416,.,0,0
113417,STATISTICAL,0,0
113418,ANALYSIS,0,0
113419,Sample,0,0
113420,size,0,0
113421,was,0,0
113422,calculated,0,0
113423,to,0,0
113424,achieve,0,0
113425,90,0,0
113426,%,0,0
113427,power,0,0
113428,at,0,0
113429,an,0,0
113430,alpha,0,0
113431,of,0,0
113432,0.025,0,0
113433,to,0,0
113434,detect,0,0
113435,a,0,0
113436,non-inferiority,0,0
113437,margin,0,0
113438,of,0,0
113439,?1,0,0
113440,cm,0,0
113441,on,0,0
113442,the,0,0
113443,VAS,0,0
113444,",",0,0
113445,using,0,0
113446,a,0,0
113447,one-sided,0,0
113448,",",0,0
113449,two-sample,0,0
113450,t-test,0,0
113451,.,0,0
113452,Baseline,0,0
113453,demographic,0,0
113454,and,0,0
113455,clinical,0,0
113456,characteristics,0,0
113457,will,0,0
113458,be,0,0
113459,analysed,0,0
113460,for,0,0
113461,comparability,0,0
113462,between,0,0
113463,groups,0,0
113464,.,0,0
113465,Differences,0,0
113466,in,0,0
113467,primary,0,0
113468,(,0,0
113469,VAS,0,1
113470,pain,0,1
113471,score,0,1
113472,),0,0
113473,and,0,0
113474,secondary,0,0
113475,outcomes,0,0
113476,between,0,0
113477,groups,0,0
113478,will,0,0
113479,be,0,0
113480,analysed,0,0
113481,by,0,0
113482,intention,0,0
113483,to,0,0
113484,treat,0,0
113485,and,0,0
113486,per,0,0
113487,protocol,0,0
113488,analysis,0,0
113489,using,0,0
113490,Student,0,0
113491,'s,0,0
113492,t-test,0,0
113493,and,0,0
113494,ANOVA,0,0
113495,.,0,0
113496,CONCLUSION,0,0
113497,This,0,0
113498,study,0,0
113499,will,0,0
113500,determine,0,0
113501,if,0,0
113502,a,0,0
113503,single,0,0
113504,intradermal,1,1
113505,SWI,1,1
113506,technique,1,0
113507,is,0,0
113508,no,0,0
113509,less,0,0
113510,effective,0,0
113511,than,0,0
113512,the,0,0
113513,routinely,0,0
113514,used,0,0
113515,four,0,0
113516,injection,0,1
113517,technique,0,0
113518,for,0,0
113519,lower,0,0
113520,back,0,0
113521,pain,0,0
113522,during,0,0
113523,labour,0,0
113524,.,0,0
113525,The,0,0
113526,findings,0,0
113527,will,0,0
113528,allow,0,0
113529,midwives,0,0
113530,to,0,0
113531,offer,0,0
113532,women,0,0
113533,requesting,1,0
113534,SWI,1,0
113535,during,1,0
113536,labour,0,0
113537,an,0,0
113538,evidence-based,0,0
113539,alternative,0,0
113540,technique,0,0
113541,more,0,0
113542,easily,0,0
113543,administered,0,1
113544,by,0,0
113545,staff,0,0
113546,and,0,0
113547,accepted,0,0
113548,by,0,0
113549,labouring,0,0
113550,women,0,0
113551,.,0,0
113552,TRIAL,0,0
113553,REGISTRATION,0,0
113554,ACTRN12609000964213,0,1
113555,.,0,0
113556,Superior,0,0
113557,fixation,0,0
113558,of,0,0
113559,pegged,1,0
113560,trabecular,1,0
113561,metal,1,0
113562,over,0,0
113563,screw-fixed,1,0
113564,pegged,1,0
113565,porous,1,1
113566,titanium,1,1
113567,fiber,1,0
113568,mesh,1,0
113569,:,1,0
113570,a,0,0
113571,randomized,0,0
113572,clinical,0,0
113573,RSA,0,0
113574,study,0,0
113575,on,0,0
113576,cementless,0,0
113577,tibial,0,0
113578,components,0,0
113579,.,0,0
113580,BACKGROUND,0,0
113581,AND,0,0
113582,PURPOSE,0,0
113583,Lasting,0,0
113584,stability,0,0
113585,of,0,0
113586,cementless,0,0
113587,implants,0,0
113588,depends,0,0
113589,on,0,0
113590,osseointegration,0,0
113591,into,0,0
113592,the,0,0
113593,implant,0,0
113594,surface,0,0
113595,",",0,0
113596,and,0,0
113597,long-term,0,0
113598,implant,0,0
113599,fixation,0,0
113600,can,0,0
113601,be,0,0
113602,predicted,0,0
113603,using,0,0
113604,radiostereometric,0,0
113605,analysis,0,0
113606,(,0,1
113607,RSA,0,1
113608,),0,1
113609,with,0,0
113610,short-term,0,0
113611,follow-up,0,0
113612,.,0,0
113613,We,0,0
113614,hypothesized,0,0
113615,that,0,0
113616,there,0,0
113617,would,0,0
113618,be,0,0
113619,improved,0,0
113620,fixation,0,0
113621,of,0,0
113622,high-porosity,1,0
113623,trabecular,1,0
113624,metal,1,0
113625,(,1,1
113626,TM,1,1
113627,),1,1
113628,tibial,1,0
113629,components,1,0
113630,compared,0,0
113631,to,0,0
113632,low-porosity,1,1
113633,titanium,1,1
113634,pegged,1,1
113635,porous,1,1
113636,fiber-metal,1,1
113637,(,1,1
113638,Ti,1,1
113639,),1,1
113640,polyethylene,1,1
113641,metal,1,1
113642,backings,1,0
113643,.,1,0
113644,METHODS,0,0
113645,In,0,0
113646,a,0,0
113647,prospective,0,0
113648,",",0,0
113649,parallel-group,0,1
113650,",",0,1
113651,randomized,0,1
113652,unblinded,0,1
113653,clinical,0,0
113654,trial,0,0
113655,",",0,0
113656,we,0,0
113657,compared,0,0
113658,cementless,1,0
113659,tibial,1,0
113660,components,1,0
113661,in,0,0
113662,patients,0,0
113663,aged,0,0
113664,70,0,0
113665,years,0,0
113666,and,0,0
113667,younger,0,0
113668,with,0,0
113669,osteoarthritis,0,0
113670,.,0,0
113671,The,0,0
113672,pre-study,0,0
113673,sample,0,0
113674,size,0,0
113675,calculation,0,0
113676,was,0,0
113677,22,0,0
113678,patients,0,0
113679,per,0,0
113680,group,0,0
113681,.,0,0
113682,25,1,0
113683,TM,1,0
113684,tibial,1,0
113685,components,1,0
113686,were,1,0
113687,fixed,1,0
113688,press-fit,1,0
113689,by,1,0
113690,2,1,0
113691,hexagonal,1,0
113692,pegs,1,1
113693,(,0,0
113694,TM,0,1
113695,group,0,1
113696,),0,0
113697,and,0,0
113698,25,1,0
113699,Ti,1,0
113700,tibial,1,0
113701,components,1,0
113702,were,1,0
113703,fixed,1,0
113704,press-fit,1,0
113705,and,1,0
113706,by,1,0
113707,4,1,0
113708,supplemental,1,0
113709,screws,1,1
113710,(,0,1
113711,Ti,0,1
113712,group,0,1
113713,),0,0
113714,.,0,0
113715,Stereo,0,0
113716,radiographs,0,0
113717,for,0,0
113718,evaluation,0,0
113719,of,0,0
113720,absolute,0,0
113721,component,0,0
113722,migration,0,0
113723,(,0,0
113724,primary,0,0
113725,effect,0,0
113726,size,0,0
113727,),0,0
113728,and,0,0
113729,single-direction,0,0
113730,absolute,0,0
113731,component,0,0
113732,migration,0,0
113733,(,0,0
113734,secondary,0,0
113735,effect,0,0
113736,size,0,0
113737,),0,0
113738,were,0,0
113739,obtained,0,0
113740,within,0,0
113741,the,0,0
113742,first,0,0
113743,postoperative,0,0
113744,week,0,0
113745,and,0,0
113746,at,0,0
113747,6,0,0
113748,weeks,0,0
113749,",",0,0
113750,6,0,0
113751,months,0,0
113752,",",0,0
113753,1,0,0
113754,year,0,0
113755,",",0,0
113756,and,0,0
113757,2,0,0
113758,years,0,0
113759,.,0,0
113760,American,0,0
113761,Knee,0,0
113762,Society,0,0
113763,score,0,0
113764,was,0,0
113765,used,0,0
113766,for,0,0
113767,clinical,0,0
113768,assessment,0,0
113769,preoperatively,0,0
113770,",",0,0
113771,and,0,0
113772,at,0,0
113773,1,0,0
113774,and,0,0
113775,2,0,0
113776,years,0,0
113777,.,0,0
113778,RESULTS,0,0
113779,There,0,0
113780,were,0,0
113781,no,0,0
113782,intraoperative,0,0
113783,complications,0,0
113784,",",0,0
113785,and,0,0
113786,no,0,0
113787,postoperative,0,0
113788,infections,0,0
113789,or,0,0
113790,revisions,0,0
113791,.,0,0
113792,All,0,0
113793,patients,0,0
113794,had,0,0
113795,improved,0,0
113796,function,0,0
113797,and,0,0
113798,regained,0,0
113799,full,0,0
113800,extension,0,0
113801,.,0,0
113802,All,0,0
113803,tibial,0,0
113804,components,0,0
113805,migrated,0,0
113806,initially,0,0
113807,.,0,0
113808,Most,0,0
113809,migration,0,0
113810,of,0,0
113811,the,0,0
113812,TM,1,0
113813,components,1,0
113814,(,0,0
113815,n,0,0
113816,=,0,0
113817,24,0,0
113818,),0,0
113819,occurred,0,0
113820,within,0,0
113821,the,0,0
113822,first,0,0
113823,3,0,0
113824,months,0,0
113825,after,0,0
113826,surgery,0,0
113827,whereas,0,0
113828,migration,0,0
113829,of,0,0
113830,the,0,0
113831,Ti,1,0
113832,components,1,0
113833,(,0,0
113834,n,0,0
113835,=,0,0
113836,22,0,0
113837,),0,0
113838,appeared,0,0
113839,to,0,0
113840,stabilize,0,0
113841,first,0,0
113842,after,0,0
113843,1,0,0
113844,year,0,0
113845,.,0,0
113846,The,0,0
113847,TM,1,0
113848,components,1,0
113849,migrated,0,0
113850,less,0,0
113851,than,0,0
113852,the,0,0
113853,Ti,1,0
113854,components,1,0
113855,at,0,0
113856,1,0,0
113857,year,0,0
113858,(,0,0
113859,p,0,0
113860,=,0,0
113861,0.01,0,0
113862,),0,0
113863,and,0,0
113864,2,0,1
113865,years,0,0
113866,(,0,0
113867,p,0,0
113868,=,0,0
113869,0.004,0,0
113870,),0,0
113871,.,0,0
113872,INTERPRETATION,0,0
113873,We,0,0
113874,conclude,0,0
113875,that,0,0
113876,the,0,0
113877,mechanical,0,0
113878,fixation,0,0
113879,of,0,0
113880,TM,1,0
113881,tibial,1,0
113882,components,1,0
113883,is,0,0
113884,superior,0,0
113885,to,0,0
113886,that,0,0
113887,of,0,0
113888,screw-fixed,0,0
113889,Ti,1,0
113890,tibial,1,0
113891,components,1,0
113892,.,0,0
113893,We,0,0
113894,expect,0,0
113895,long-term,0,0
113896,implant,0,0
113897,survival,0,0
113898,to,0,0
113899,be,0,0
113900,better,0,0
113901,with,0,0
113902,the,0,0
113903,TM,1,0
113904,tibial,1,0
113905,component,1,0
113906,.,1,0
113907,Improving,0,0
113908,emotion,0,0
113909,regulation,0,0
113910,with,0,0
113911,CBT,1,0
113912,in,0,0
113913,young,0,0
113914,children,0,0
113915,with,0,0
113916,high,0,0
113917,functioning,0,0
113918,autism,0,0
113919,spectrum,0,0
113920,disorders,0,0
113921,:,0,0
113922,a,0,0
113923,pilot,0,0
113924,study,0,0
113925,.,0,0
113926,BACKGROUND,0,0
113927,AND,0,1
113928,AIMS,0,1
113929,This,0,0
113930,pilot,0,0
113931,study,0,0
113932,tested,0,0
113933,the,0,0
113934,efficacy,0,0
113935,of,0,0
113936,a,0,0
113937,developmentally,0,0
113938,modified,0,0
113939,CBT,1,0
113940,for,0,0
113941,young,0,0
113942,children,0,0
113943,with,0,0
113944,Autism,0,0
113945,Spectrum,0,0
113946,Disorders,0,1
113947,(,0,1
113948,ASD,0,1
113949,),0,1
113950,to,0,0
113951,teach,0,0
113952,emotion,0,0
113953,regulation,0,0
113954,strategies,0,0
113955,for,0,0
113956,reducing,0,0
113957,anger,0,0
113958,and,0,0
113959,anxiety,0,0
113960,",",0,0
113961,commonly,0,0
113962,noted,0,0
113963,problems,0,0
113964,in,0,0
113965,this,0,0
113966,population,0,0
113967,.,0,0
113968,METHOD,0,0
113969,Eleven,0,0
113970,5-7,0,0
113971,year-old,0,0
113972,children,0,0
113973,participated,0,0
113974,in,0,0
113975,a,0,0
113976,CBT-group,1,0
113977,while,0,0
113978,parents,0,0
113979,participated,1,0
113980,in,1,0
113981,psychoeducation,1,0
113982,.,1,0
113983,Children,1,0
113984,were,1,0
113985,randomly,1,0
113986,assigned,1,0
113987,to,1,0
113988,an,1,0
113989,experimental,1,0
113990,or,1,0
113991,delayed-treatment,1,0
113992,control,1,0
113993,group,1,0
113994,.,1,0
113995,RESULTS,0,0
113996,From,0,1
113997,pre-,0,0
113998,to,0,0
113999,post-treatment,0,0
114000,",",0,0
114001,all,0,0
114002,children,0,0
114003,had,0,0
114004,less,0,0
114005,parent,0,0
114006,reported,0,0
114007,negativity/lability,0,0
114008,",",0,0
114009,better,0,0
114010,parent,0,0
114011,reported,0,0
114012,emotion,0,0
114013,regulation,0,0
114014,",",0,0
114015,and,0,0
114016,shorter,0,0
114017,outbursts,0,0
114018,",",0,0
114019,and,0,0
114020,also,0,0
114021,generated,0,0
114022,more,0,0
114023,coping,0,0
114024,strategies,0,0
114025,in,0,0
114026,response,0,0
114027,to,0,0
114028,vignettes,0,0
114029,.,0,0
114030,Parents,0,0
114031,also,0,0
114032,reported,0,0
114033,increases,0,0
114034,in,0,0
114035,their,0,0
114036,own,0,0
114037,confidence,0,0
114038,and,0,0
114039,their,0,0
114040,child,0,0
114041,'s,0,0
114042,ability,0,0
114043,to,0,0
114044,deal,0,0
114045,with,0,0
114046,anger,0,0
114047,and,0,0
114048,anxiety,0,0
114049,.,0,0
114050,CONCLUSIONS,0,0
114051,This,0,0
114052,study,0,0
114053,suggests,0,0
114054,that,0,0
114055,young,0,0
114056,children,0,0
114057,with,0,0
114058,high,0,0
114059,functioning,0,0
114060,ASD,0,0
114061,may,0,0
114062,benefit,0,0
114063,from,0,0
114064,CBT,1,0
114065,to,0,0
114066,improve,0,0
114067,regulation,0,0
114068,of,0,0
114069,anger,0,0
114070,and,0,0
114071,anxiety,0,0
114072,",",0,0
114073,and,0,0
114074,parent,0,0
114075,training,0,0
114076,may,0,0
114077,improve,0,0
114078,parental,0,0
114079,self-efficacy,0,0
114080,.,0,0
114081,Future,0,0
114082,studies,0,0
114083,are,0,0
114084,needed,0,0
114085,to,0,0
114086,make,0,0
114087,conclusions,0,0
114088,about,0,0
114089,its,0,0
114090,efficacy,0,0
114091,.,0,0
114092,Specific,1,0
114093,exercises,1,0
114094,to,0,0
114095,treat,0,0
114096,pregnancy-related,0,0
114097,low,0,0
114098,back,0,0
114099,pain,0,0
114100,in,0,0
114101,a,0,0
114102,South,0,0
114103,African,0,0
114104,population,0,0
114105,.,0,0
114106,OBJECTIVE,0,0
114107,To,0,0
114108,investigate,0,0
114109,the,0,0
114110,effect,0,0
114111,of,0,0
114112,an,0,0
114113,exercise,1,0
114114,program,1,0
114115,",",1,0
114116,including,1,0
114117,specific,1,0
114118,stabilizing,1,0
114119,exercises,1,0
114120,",",0,0
114121,on,0,0
114122,pain,0,0
114123,intensity,0,0
114124,and,0,0
114125,functional,0,0
114126,ability,0,0
114127,in,0,0
114128,women,0,0
114129,with,0,0
114130,pregnancy-related,0,0
114131,low,0,0
114132,back,0,0
114133,pain,0,0
114134,.,0,0
114135,METHODS,0,0
114136,Fifty,0,0
114137,women,0,0
114138,between,0,0
114139,16,0,0
114140,and,0,0
114141,24,0,0
114142,weeks,0,0
114143,of,0,0
114144,pregnancy,0,0
114145,were,0,0
114146,recruited,0,0
114147,at,0,0
114148,Tygerberg,0,0
114149,and,0,0
114150,Paarl,0,1
114151,Hospitals,0,0
114152,",",0,0
114153,Western,0,0
114154,Cape,0,0
114155,",",0,0
114156,South,0,0
114157,Africa,0,0
114158,.,0,0
114159,Twenty-six,0,0
114160,women,0,0
114161,were,0,0
114162,randomized,0,0
114163,to,0,0
114164,a,0,0
114165,10-week,1,0
114166,exercise,1,0
114167,program,1,0
114168,and,1,0
114169,24,0,0
114170,were,0,0
114171,randomized,0,0
114172,as,0,0
114173,controls,1,0
114174,.,1,0
114175,RESULTS,0,0
114176,Overall,0,0
114177,",",0,0
114178,the,0,0
114179,most,0,0
114180,frequent,0,0
114181,type,0,0
114182,of,0,0
114183,back,0,0
114184,pain,0,0
114185,experienced,0,0
114186,was,0,0
114187,lumbar,0,0
114188,pain,0,0
114189,(,0,0
114190,36,0,0
114191,[,0,0
114192,72.0,0,0
114193,%,0,0
114194,],0,0
114195,),0,0
114196,.,0,0
114197,Pain,0,0
114198,intensity,0,0
114199,(,0,0
114200,P=0.76,0,0
114201,),0,0
114202,and,0,0
114203,functional,0,0
114204,ability,0,0
114205,(,0,0
114206,P=0.29,0,0
114207,),0,0
114208,were,0,0
114209,comparable,0,0
114210,between,0,0
114211,the,0,0
114212,groups,0,0
114213,on,0,0
114214,study,0,0
114215,entry,0,0
114216,.,0,0
114217,In,0,0
114218,the,0,0
114219,study,0,0
114220,group,0,0
114221,",",0,0
114222,there,0,0
114223,was,0,0
114224,a,0,0
114225,significant,0,0
114226,improvement,0,0
114227,in,0,0
114228,pain,0,0
114229,intensity,0,0
114230,(,0,0
114231,P,0,0
114232,<,0,0
114233,0.01,0,0
114234,),0,0
114235,and,0,0
114236,an,0,0
114237,improvement,0,0
114238,in,0,0
114239,functional,0,0
114240,ability,0,0
114241,(,0,0
114242,P=0.06,0,0
114243,),0,0
114244,at,0,0
114245,the,0,0
114246,end,0,0
114247,of,0,0
114248,the,0,0
114249,study,0,0
114250,.,0,0
114251,In,0,0
114252,the,0,0
114253,control,0,0
114254,group,0,0
114255,",",0,0
114256,there,0,0
114257,were,0,0
114258,no,0,0
114259,significant,0,0
114260,changes,0,0
114261,in,0,0
114262,pain,0,0
114263,intensity,0,0
114264,(,0,0
114265,P=0.89,0,0
114266,),0,0
114267,or,0,0
114268,functional,0,0
114269,ability,0,0
114270,(,0,0
114271,P=0.70,0,0
114272,),0,0
114273,at,0,0
114274,the,0,0
114275,end,0,0
114276,of,0,0
114277,the,0,0
114278,study,0,0
114279,.,0,0
114280,CONCLUSION,0,0
114281,A,0,0
114282,specific,1,0
114283,exercise,1,0
114284,program,1,0
114285,decreased,0,0
114286,back,0,0
114287,pain,0,0
114288,intensity,0,0
114289,and,0,0
114290,increased,0,0
114291,functional,0,0
114292,ability,0,0
114293,during,0,0
114294,pregnancy,0,0
114295,in,0,0
114296,South,0,0
114297,African,0,0
114298,women,0,0
114299,with,0,0
114300,lumbar,0,0
114301,and,0,0
114302,pelvic,0,0
114303,girdle,0,0
114304,pain,0,0
114305,.,0,0
114306,Direct,1,0
114307,trocar,1,0
114308,insertion,1,0
114309,vs.,1,0
114310,Verres,1,0
114311,needle,1,0
114312,use,1,0
114313,for,0,0
114314,laparoscopic,0,0
114315,sterilization,0,0
114316,.,0,0
114317,A,0,0
114318,randomized,0,0
114319,",",0,0
114320,prospective,0,0
114321,trial,0,0
114322,was,0,0
114323,designed,0,0
114324,to,0,0
114325,compare,0,0
114326,direct,1,0
114327,trocar,1,0
114328,insertion,1,0
114329,with,1,0
114330,prior,1,0
114331,peritoneal,1,0
114332,insufflation,1,0
114333,with,1,0
114334,a,1,0
114335,Verres,1,0
114336,needle,1,0
114337,for,1,0
114338,laparoscopic,1,0
114339,tubal,1,0
114340,sterilization,1,0
114341,.,1,0
114342,Direct,1,0
114343,trocar,1,0
114344,insertion,1,0
114345,resulted,0,0
114346,in,0,0
114347,fewer,0,0
114348,instrument,0,0
114349,insertions,0,0
114350,(,0,0
114351,21.8,0,0
114352,%,0,0
114353,vs.,0,0
114354,7.8,0,0
114355,%,0,0
114356,),0,0
114357,and,0,0
114358,use,0,0
114359,of,0,0
114360,smaller,0,0
114361,volumes,0,0
114362,of,0,0
114363,CO2,0,0
114364,(,0,0
114365,2.67,0,0
114366,vs.,0,0
114367,2.32,0,0
114368,L,0,0
114369,),0,0
114370,.,0,0
114371,Direct,1,0
114372,trocar,1,0
114373,use,0,0
114374,resulted,0,0
114375,in,0,0
114376,a,0,0
114377,decrease,0,0
114378,in,0,0
114379,operating,0,0
114380,time,0,0
114381,from,0,0
114382,9,0,0
114383,minutes,0,0
114384,",",0,0
114385,40,0,0
114386,seconds,0,0
114387,in,0,0
114388,the,0,0
114389,needle,0,0
114390,group,0,0
114391,to,0,0
114392,7,0,0
114393,minutes,0,0
114394,",",0,0
114395,30,0,0
114396,seconds,0,0
114397,in,0,0
114398,the,0,0
114399,trocar,0,0
114400,group,0,0
114401,.,0,0
114402,Minor,0,0
114403,omental,0,0
114404,injuries,0,0
114405,occurred,0,0
114406,in,0,0
114407,a,0,0
114408,small,0,0
114409,percentage,0,0
114410,of,0,0
114411,each,0,0
114412,group,0,0
114413,",",0,0
114414,while,0,0
114415,serious,0,0
114416,complications,0,0
114417,occurred,0,0
114418,once,0,0
114419,in,0,0
114420,each,0,0
114421,group,0,0
114422,.,0,0
114423,A,0,1
114424,double-blind,0,1
114425,",",0,1
114426,placebo-controlled,1,1
114427,trial,0,1
114428,of,0,1
114429,intravenous,1,1
114430,immunoglobulin,1,1
114431,therapy,1,1
114432,in,0,0
114433,patients,0,0
114434,with,0,0
114435,chronic,0,0
114436,fatigue,0,0
114437,syndrome,0,0
114438,.,0,0
114439,PURPOSE,0,0
114440,The,0,0
114441,chronic,0,0
114442,fatigue,0,0
114443,syndrome,0,1
114444,(,0,1
114445,CFS,0,1
114446,),0,0
114447,is,0,0
114448,characterized,0,0
114449,by,0,0
114450,profound,0,0
114451,fatigue,0,0
114452,",",0,0
114453,neuropsychiatric,0,0
114454,dysfunction,0,0
114455,",",0,0
114456,and,0,0
114457,frequent,0,0
114458,abnormalities,0,0
114459,in,0,0
114460,cell-mediated,0,0
114461,immunity,0,0
114462,.,0,0
114463,No,0,1
114464,effective,0,0
114465,therapy,0,0
114466,is,0,0
114467,known,0,0
114468,.,0,0
114469,PATIENTS,0,0
114470,AND,0,0
114471,METHODS,0,0
114472,Forty-nine,0,0
114473,patients,0,0
114474,(,0,0
114475,40,0,0
114476,with,0,0
114477,abnormal,0,0
114478,cell-mediated,0,0
114479,immunity,0,1
114480,),0,0
114481,participated,0,0
114482,in,0,0
114483,a,0,0
114484,randomized,0,0
114485,",",0,0
114486,double-blind,0,1
114487,",",0,1
114488,placebo-controlled,1,1
114489,trial,0,1
114490,to,0,0
114491,determine,0,0
114492,the,0,0
114493,effectiveness,0,0
114494,of,0,0
114495,high-dose,0,1
114496,intravenously,1,1
114497,administered,1,1
114498,immunoglobulin,1,1
114499,G.,1,1
114500,The,0,0
114501,patients,0,0
114502,received,0,0
114503,three,0,0
114504,intravenous,0,1
114505,infusions,0,1
114506,of,0,1
114507,a,0,0
114508,placebo,1,1
114509,solution,1,1
114510,or,1,1
114511,immunoglobulin,1,1
114512,at,0,1
114513,a,0,0
114514,dose,0,1
114515,of,0,1
114516,2,0,1
114517,g/kg/month,0,1
114518,.,0,1
114519,Assessment,0,0
114520,of,0,0
114521,the,0,0
114522,severity,0,0
114523,of,0,0
114524,symptoms,0,0
114525,and,0,0
114526,associated,0,0
114527,disability,0,0
114528,",",0,0
114529,both,0,0
114530,before,0,0
114531,and,0,0
114532,after,0,0
114533,treatment,0,0
114534,",",0,0
114535,was,0,0
114536,completed,0,0
114537,at,0,0
114538,detailed,0,0
114539,interviews,0,0
114540,by,0,0
114541,a,0,0
114542,physician,0,0
114543,and,0,0
114544,psychiatrist,0,0
114545,",",0,0
114546,who,0,0
114547,were,0,0
114548,unaware,0,0
114549,of,0,0
114550,the,0,0
114551,treatment,0,0
114552,status,0,0
114553,.,0,0
114554,In,0,0
114555,addition,0,0
114556,",",0,0
114557,any,0,0
114558,change,0,0
114559,in,0,0
114560,physical,0,0
114561,symptoms,0,0
114562,and,0,0
114563,functional,0,0
114564,capacity,0,0
114565,was,0,0
114566,recorded,0,0
114567,using,0,0
114568,visual,0,1
114569,analogue,0,1
114570,scales,0,1
114571,",",0,0
114572,while,0,0
114573,changes,0,0
114574,in,0,0
114575,psychologic,0,0
114576,morbidity,0,0
114577,were,0,0
114578,assessed,0,0
114579,using,0,0
114580,patient-rated,0,0
114581,indices,0,0
114582,of,0,0
114583,depression,0,0
114584,.,0,0
114585,Cell-mediated,0,0
114586,immunity,0,0
114587,was,0,0
114588,evaluated,0,0
114589,by,0,0
114590,T-cell,0,0
114591,subset,0,0
114592,analysis,0,0
114593,",",0,0
114594,delayed-type,0,1
114595,hypersensitivity,0,1
114596,skin,0,1
114597,testing,0,0
114598,",",0,0
114599,and,0,0
114600,lymphocyte,0,0
114601,transformation,0,0
114602,with,0,0
114603,phytohemagglutinin,0,1
114604,.,0,0
114605,RESULTS,0,1
114606,At,0,0
114607,the,0,0
114608,interview,0,0
114609,conducted,0,0
114610,by,0,0
114611,the,0,0
114612,physician,0,0
114613,3,0,0
114614,months,0,0
114615,after,0,0
114616,the,0,0
114617,final,0,0
114618,infusion,0,1
114619,",",0,0
114620,10,0,0
114621,of,0,0
114622,23,0,0
114623,(,0,0
114624,43,0,0
114625,%,0,0
114626,),0,0
114627,immunoglobulin,0,1
114628,recipients,0,0
114629,and,0,0
114630,three,0,0
114631,of,0,0
114632,the,0,0
114633,26,0,0
114634,(,0,0
114635,12,0,0
114636,%,0,0
114637,),0,0
114638,placebo,0,0
114639,recipients,0,0
114640,were,0,0
114641,assessed,0,0
114642,as,0,0
114643,having,0,0
114644,responded,0,0
114645,with,0,0
114646,a,0,0
114647,substantial,0,0
114648,reduction,0,0
114649,in,0,0
114650,their,0,0
114651,symptoms,0,0
114652,and,0,0
114653,recommencement,0,0
114654,of,0,0
114655,work,0,0
114656,",",0,0
114657,leisure,0,0
114658,",",0,0
114659,and,0,0
114660,social,0,0
114661,activities,0,0
114662,.,0,0
114663,The,0,0
114664,patients,0,0
114665,designated,0,0
114666,as,0,0
114667,having,0,0
114668,responded,0,0
114669,had,0,0
114670,improvement,0,0
114671,in,0,0
114672,physical,0,0
114673,",",0,0
114674,psychologic,0,0
114675,",",0,0
114676,and,0,0
114677,immunologic,0,1
114678,measures,0,0
114679,(,0,0
114680,p,0,0
114681,less,0,0
114682,than,0,0
114683,0.01,0,0
114684,for,0,0
114685,each,0,0
114686,),0,0
114687,.,0,0
114688,CONCLUSION,0,1
114689,Immunomodulatory,1,1
114690,treatment,1,1
114691,with,0,1
114692,immunoglobulin,1,1
114693,is,0,0
114694,effective,0,0
114695,in,0,0
114696,a,0,0
114697,significant,0,0
114698,number,0,0
114699,of,0,0
114700,patients,0,0
114701,with,0,0
114702,CFS,0,0
114703,",",0,0
114704,a,0,0
114705,finding,0,0
114706,that,0,0
114707,supports,0,0
114708,the,0,0
114709,concept,0,0
114710,that,0,0
114711,an,0,0
114712,immunologic,0,0
114713,disturbance,0,0
114714,may,0,0
114715,be,0,0
114716,important,0,0
114717,in,0,0
114718,the,0,0
114719,pathogenesis,0,0
114720,of,0,0
114721,this,0,0
114722,disorder,0,0
114723,.,0,0
114724,A,0,1
114725,randomized,0,0
114726,study,0,0
114727,on,0,0
114728,hormone-resistant,0,0
114729,prostatic,0,0
114730,cancer,0,1
114731,:,0,1
114732,estramustine,1,1
114733,phosphate,1,1
114734,versus,0,1
114735,low,1,1
114736,dose,1,1
114737,epirubicin,1,1
114738,with,1,1
114739,or,1,0
114740,without,1,0
114741,medroxyprogesterone,1,1
114742,acetate,1,1
114743,.,1,1
114744,A,0,1
114745,Norwegian,0,0
114746,multicenter,0,0
114747,study,0,0
114748,.,0,0
114749,A,0,0
114750,prospective,0,0
114751,randomized,0,0
114752,study,0,0
114753,has,0,0
114754,been,0,0
114755,carried,0,0
114756,out,0,0
114757,in,0,0
114758,order,0,0
114759,to,0,0
114760,compare,0,0
114761,three,0,0
114762,different,0,0
114763,treatment,0,0
114764,modalities,0,0
114765,for,0,0
114766,symptomatic,0,0
114767,metastatic,0,0
114768,hormone-resistant,0,0
114769,prostatic,0,0
114770,cancer,0,0
114771,.,0,0
114772,A,0,0
114773,total,0,0
114774,of,0,0
114775,79,0,0
114776,patients,0,0
114777,were,0,0
114778,included,0,0
114779,.,0,0
114780,One,0,0
114781,group,0,0
114782,was,0,0
114783,treated,1,0
114784,with,1,0
114785,estramustine,1,1
114786,phosphate,1,1
114787,",",1,0
114788,another,1,0
114789,with,1,0
114790,Epirubicin,1,1
114791,plus,1,1
114792,Medroxyprogesterone,1,1
114793,acetate,1,1
114794,(,1,1
114795,MPA,1,1
114796,),1,1
114797,",",1,0
114798,while,1,0
114799,the,1,0
114800,third,1,0
114801,arm,1,0
114802,consisted,1,0
114803,of,1,0
114804,Epirubicin,1,1
114805,plus,1,1
114806,placebo,1,1
114807,.,1,0
114808,Best,0,0
114809,palliation,0,0
114810,was,0,0
114811,obtained,0,0
114812,by,0,0
114813,the,0,0
114814,combination,0,0
114815,of,0,0
114816,Epirubicin,1,1
114817,and,1,0
114818,MPA,1,1
114819,.,1,0
114820,This,0,0
114821,combination,0,0
114822,also,0,0
114823,seemed,0,0
114824,to,0,0
114825,be,0,0
114826,associated,0,0
114827,with,0,0
114828,the,0,0
114829,longest,0,0
114830,response,0,0
114831,duration,0,0
114832,.,0,0
114833,A,0,1
114834,randomized,0,1
114835,placebo-controlled,1,1
114836,prevention,0,1
114837,trial,0,1
114838,of,0,0
114839,aspirin,1,1
114840,and/or,1,0
114841,resistant,1,0
114842,starch,1,1
114843,in,0,0
114844,young,0,1
114845,people,0,0
114846,with,0,0
114847,familial,0,0
114848,adenomatous,0,0
114849,polyposis,0,0
114850,.,0,0
114851,Evidence,0,0
114852,supporting,0,0
114853,aspirin,1,1
114854,and,1,1
114855,resistant,1,1
114856,starch,1,1
114857,(,1,1
114858,RS,1,1
114859,),1,1
114860,for,0,0
114861,colorectal,0,0
114862,cancer,0,0
114863,prevention,0,0
114864,comes,0,0
114865,from,0,0
114866,epidemiologic,0,0
114867,and,0,0
114868,laboratory,0,0
114869,studies,0,0
114870,(,1,1
114871,aspirin,1,1
114872,and,1,1
114873,RS,1,1
114874,),1,1
114875,and,0,0
114876,randomized,0,0
114877,controlled,0,0
114878,clinical,0,1
114879,trials,0,1
114880,(,1,1
114881,aspirin,1,1
114882,),1,1
114883,.,0,1
114884,Familial,0,0
114885,adenomatous,0,1
114886,polyposis,0,1
114887,(,0,1
114888,FAP,0,1
114889,),0,1
114890,strikes,0,1
114891,young,0,1
114892,people,0,0
114893,and,0,0
114894,",",0,0
114895,untreated,0,0
114896,",",0,0
114897,confers,0,0
114898,virtually,0,0
114899,a,0,0
114900,100,0,0
114901,%,0,0
114902,risk,0,0
114903,of,0,0
114904,colorectal,0,0
114905,cancer,0,0
114906,and,0,0
114907,early,0,0
114908,death,0,0
114909,.,0,0
114910,We,0,0
114911,conducted,0,0
114912,an,0,0
114913,international,0,0
114914,",",0,0
114915,multicenter,0,0
114916,",",0,0
114917,randomized,0,1
114918,",",0,1
114919,placebo-controlled,1,1
114920,trial,0,1
114921,of,0,1
114922,aspirin,1,1
114923,(,0,1
114924,600,0,1
114925,mg/d,0,1
114926,),0,1
114927,and/or,0,1
114928,RS,1,1
114929,(,0,1
114930,30,0,1
114931,g/d,0,1
114932,),0,1
114933,for,0,0
114934,from,0,0
114935,1,0,0
114936,to,0,0
114937,12,0,0
114938,years,0,0
114939,to,0,0
114940,prevent,0,0
114941,disease,0,0
114942,progression,0,0
114943,in,0,0
114944,FAP,0,0
114945,patients,0,0
114946,from,0,0
114947,10,0,0
114948,to,0,0
114949,21,0,0
114950,years,0,0
114951,of,0,0
114952,age,0,0
114953,.,0,0
114954,In,0,0
114955,a,0,0
114956,2,0,0
114957,?,0,0
114958,2,0,0
114959,factorial,0,0
114960,design,0,0
114961,",",0,0
114962,patients,0,0
114963,were,0,0
114964,randomly,0,0
114965,assigned,0,0
114966,to,0,0
114967,the,0,0
114968,following,0,0
114969,four,0,0
114970,study,0,0
114971,arms,1,0
114972,:,1,0
114973,aspirin,1,1
114974,plus,1,1
114975,RS,1,1
114976,placebo,1,1
114977,;,1,1
114978,RS,1,1
114979,plus,1,1
114980,aspirin,1,1
114981,placebo,1,1
114982,;,1,1
114983,aspirin,1,1
114984,plus,1,1
114985,RS,1,1
114986,;,1,1
114987,RS,1,1
114988,placebo,1,1
114989,plus,1,1
114990,aspirin,1,1
114991,placebo,1,1
114992,;,1,1
114993,they,0,0
114994,were,0,0
114995,followed,0,0
114996,with,0,0
114997,standard,0,0
114998,annual,0,0
114999,clinical,0,0
115000,examinations,0,0
115001,including,0,0
115002,endoscopy,0,0
115003,.,0,0
115004,The,0,0
115005,primary,0,0
115006,endpoint,0,0
115007,was,0,0
115008,polyp,0,0
115009,number,0,0
115010,in,0,0
115011,the,0,0
115012,rectum,0,0
115013,and,0,0
115014,sigmoid,0,1
115015,colon,0,0
115016,(,0,0
115017,at,0,0
115018,the,0,0
115019,end,0,0
115020,of,0,0
115021,intervention,0,0
115022,),0,0
115023,",",0,0
115024,and,0,0
115025,the,0,0
115026,major,0,0
115027,secondary,0,0
115028,endpoint,0,0
115029,was,0,0
115030,size,0,0
115031,of,0,0
115032,the,0,0
115033,largest,0,0
115034,polyp,0,0
115035,.,0,0
115036,A,0,0
115037,total,0,0
115038,of,0,0
115039,206,0,0
115040,randomized,0,0
115041,FAP,0,0
115042,patients,0,0
115043,commenced,0,0
115044,intervention,0,0
115045,",",0,0
115046,of,0,0
115047,whom,0,0
115048,133,0,0
115049,had,0,0
115050,at,0,0
115051,least,0,0
115052,one,0,0
115053,follow-up,0,0
115054,endoscopy,0,0
115055,and,0,0
115056,were,0,0
115057,therefore,0,0
115058,included,0,0
115059,in,0,0
115060,the,0,0
115061,primary,0,0
115062,analysis,0,0
115063,.,0,0
115064,Neither,0,0
115065,intervention,0,0
115066,significantly,0,0
115067,reduced,0,0
115068,polyp,0,0
115069,count,0,0
115070,in,0,0
115071,the,0,0
115072,rectum,0,0
115073,and,0,0
115074,sigmoid,0,0
115075,colon,0,0
115076,:,0,0
115077,aspirin,0,1
115078,relative,0,0
115079,risk,0,0
115080,=,0,0
115081,0.77,0,0
115082,(,0,0
115083,95,0,0
115084,%,0,0
115085,CI,0,0
115086,",",0,0
115087,0.54-1.10,0,0
115088,;,0,0
115089,versus,0,0
115090,nonaspirin,0,1
115091,arms,0,1
115092,),0,1
115093,;,0,1
115094,RS,0,1
115095,relative,0,0
115096,risk,0,0
115097,=,0,0
115098,1.05,0,0
115099,(,0,0
115100,95,0,0
115101,%,0,0
115102,CI,0,0
115103,",",0,0
115104,0.73-1.49,0,0
115105,;,0,0
115106,versus,0,0
115107,non-RS,0,0
115108,arms,0,0
115109,),0,0
115110,.,0,0
115111,There,0,0
115112,was,0,0
115113,a,0,0
115114,trend,0,0
115115,toward,0,0
115116,a,0,0
115117,smaller,0,0
115118,size,0,0
115119,of,0,0
115120,largest,0,0
115121,polyp,0,0
115122,in,0,0
115123,patients,0,0
115124,treated,0,0
115125,with,0,0
115126,aspirin,0,1
115127,versus,0,1
115128,nonaspirin,0,1
115129,--,0,0
115130,mean,0,0
115131,3.8,0,0
115132,mm,0,0
115133,versus,0,0
115134,5.5,0,0
115135,mm,0,0
115136,for,0,0
115137,patients,0,0
115138,treated,0,0
115139,1,0,0
115140,or,0,0
115141,more,0,0
115142,years,0,1
115143,(,0,0
115144,adjusted,0,0
115145,P,0,0
115146,=,0,0
115147,0.09,0,0
115148,),0,0
115149,and,0,0
115150,mean,0,0
115151,3.0,0,0
115152,mm,0,0
115153,versus,0,0
115154,6.0,0,0
115155,mm,0,0
115156,for,0,0
115157,patients,0,0
115158,treated,0,0
115159,more,0,0
115160,than,0,0
115161,1,0,0
115162,year,0,0
115163,(,0,0
115164,P,0,0
115165,=,0,0
115166,0.02,0,0
115167,),0,0
115168,;,0,0
115169,there,0,0
115170,were,0,0
115171,similar,0,0
115172,weaker,0,0
115173,trends,0,0
115174,with,0,0
115175,RS,0,1
115176,versus,0,0
115177,non-RS,0,0
115178,.,0,0
115179,Exploratory,0,0
115180,translational,0,0
115181,endpoints,0,0
115182,included,0,0
115183,crypt,0,0
115184,length,0,0
115185,(,0,0
115186,which,0,0
115187,was,0,0
115188,significantly,0,0
115189,shorter,0,0
115190,in,0,0
115191,normal-appearing,0,0
115192,mucosa,0,0
115193,in,0,0
115194,the,0,0
115195,RS,0,1
115196,group,0,0
115197,over,0,0
115198,time,0,0
115199,),0,0
115200,and,0,0
115201,laboratory,0,0
115202,measures,0,0
115203,of,0,0
115204,proliferation,0,0
115205,(,0,0
115206,including,0,0
115207,Ki67,0,1
115208,),0,0
115209,.,0,0
115210,This,0,0
115211,clinical,0,0
115212,trial,0,0
115213,is,0,0
115214,the,0,0
115215,largest,0,0
115216,ever,0,0
115217,conducted,0,0
115218,in,0,0
115219,the,0,0
115220,setting,0,0
115221,of,0,0
115222,FAP,0,0
115223,and,0,0
115224,found,0,0
115225,a,0,0
115226,trend,0,0
115227,of,0,0
115228,reduced,0,0
115229,polyp,0,0
115230,load,0,1
115231,(,0,0
115232,number,0,0
115233,and,0,0
115234,size,0,0
115235,),0,0
115236,with,0,0
115237,600,0,0
115238,mg,0,1
115239,of,1,1
115240,aspirin,1,1
115241,daily,0,1
115242,.,0,1
115243,RS,0,1
115244,had,0,0
115245,no,0,0
115246,clinical,0,0
115247,effect,0,0
115248,on,0,0
115249,adenomas,0,0
115250,.,0,0
115251,Pulsed,1,0
115252,azithromycin,1,1
115253,treatment,1,0
115254,is,0,0
115255,as,0,0
115256,effective,0,0
115257,and,0,0
115258,safe,0,0
115259,as,0,0
115260,2-week-longer,1,1
115261,daily,1,1
115262,doxycycline,1,1
115263,treatment,1,1
115264,of,0,0
115265,acne,0,0
115266,vulgaris,0,0
115267,:,0,0
115268,a,0,0
115269,randomized,0,0
115270,",",0,0
115271,double-blind,0,1
115272,",",0,1
115273,noninferiority,0,0
115274,study,0,0
115275,.,0,0
115276,Efficacy,0,0
115277,and,0,0
115278,safety,0,0
115279,of,0,0
115280,azithromycin,1,1
115281,and,1,1
115282,doxycycline,1,1
115283,for,0,0
115284,the,0,0
115285,treatment,0,0
115286,of,0,0
115287,moderate,0,0
115288,acne,0,0
115289,vulgaris,0,0
115290,were,0,0
115291,evaluated,0,0
115292,(,0,0
115293,240,0,0
115294,patients,0,0
115295,),0,0
115296,in,0,0
115297,both,0,0
115298,intention-to-treat,0,0
115299,and,0,0
115300,per-protocol,0,0
115301,populations,0,0
115302,.,0,0
115303,The,0,0
115304,evaluation,0,0
115305,of,0,0
115306,clinical,0,0
115307,efficacy,0,0
115308,was,0,0
115309,based,0,0
115310,on,0,0
115311,the,0,0
115312,change,0,0
115313,in,0,0
115314,the,0,0
115315,number,0,0
115316,of,0,0
115317,facial,0,0
115318,inflammatory,0,0
115319,lesions,0,0
115320,from,0,0
115321,baseline,0,0
115322,to,0,0
115323,the,0,0
115324,end,0,0
115325,of,0,0
115326,treatment,0,0
115327,",",0,0
115328,and,0,0
115329,noninferiority,0,0
115330,was,0,0
115331,defined,0,0
115332,by,0,0
115333,the,0,0
115334,upper,0,0
115335,95,0,0
115336,%,0,0
115337,confidence,0,0
115338,limit,0,0
115339,of,0,0
115340,the,0,0
115341,difference,0,0
115342,between,0,0
115343,two,0,0
115344,treatments,0,0
115345,being,0,0
115346,less,0,0
115347,than,0,0
115348,9,0,0
115349,.,0,0
115350,Reduction,0,0
115351,in,0,0
115352,the,0,0
115353,number,0,0
115354,of,0,0
115355,lesions,0,0
115356,was,0,0
115357,similar,0,0
115358,with,0,0
115359,both,0,0
115360,azithromycin,1,1
115361,and,1,1
115362,doxycycline,1,1
115363,treatments,1,1
115364,(,0,0
115365,27,0,0
115366,+/-,0,0
115367,12,0,0
115368,and,0,0
115369,30,0,0
115370,+/-,0,0
115371,12,0,0
115372,",",0,0
115373,respectively,0,0
115374,),0,0
115375,in,0,0
115376,both,0,0
115377,groups,0,0
115378,.,0,0
115379,Also,0,0
115380,",",0,0
115381,the,0,0
115382,upper,0,0
115383,95,0,0
115384,%,0,0
115385,confidence,0,0
115386,limit,0,0
115387,of,0,0
115388,5,0,0
115389,inflammatory,0,0
115390,lesions,0,0
115391,has,0,0
115392,satisfied,0,0
115393,the,0,0
115394,noninferiority,0,0
115395,criterion,0,0
115396,.,0,0
115397,The,0,0
115398,incidence,0,0
115399,of,0,0
115400,adverse,0,0
115401,events,0,0
115402,did,0,0
115403,not,0,0
115404,differ,0,0
115405,between,0,0
115406,the,0,0
115407,two,0,0
115408,treatment,0,0
115409,groups,0,0
115410,.,0,0
115411,The,0,0
115412,shorter,0,0
115413,and,0,0
115414,simpler,0,0
115415,treatment,0,0
115416,schedule,0,0
115417,of,0,0
115418,azithromycin,1,1
115419,had,0,0
115420,similar,0,0
115421,efficacy,0,0
115422,and,0,0
115423,safety,0,0
115424,as,0,0
115425,doxycycline,1,1
115426,in,0,0
115427,the,0,0
115428,treatment,0,0
115429,of,0,0
115430,moderate,0,0
115431,acne,0,0
115432,vulgaris,0,0
115433,",",0,0
115434,confirming,0,0
115435,noninferiority,0,0
115436,of,0,0
115437,azithromycin,1,1
115438,as,0,0
115439,compared,0,0
115440,with,0,0
115441,doxycycline,1,1
115442,.,1,0
115443,Effects,0,0
115444,of,0,0
115445,vitamin,1,1
115446,A,1,1
115447,or,1,1
115448,beta,1,1
115449,carotene,1,1
115450,supplementation,1,1
115451,on,0,1
115452,pregnancy-related,0,0
115453,mortality,0,0
115454,and,0,0
115455,infant,0,0
115456,mortality,0,0
115457,in,0,0
115458,rural,0,0
115459,Bangladesh,0,0
115460,:,0,0
115461,a,0,0
115462,cluster,0,0
115463,randomized,0,0
115464,trial,0,0
115465,.,0,0
115466,CONTEXT,0,0
115467,Maternal,0,0
115468,vitamin,0,1
115469,A,0,1
115470,deficiency,0,0
115471,is,0,0
115472,a,0,0
115473,public,0,0
115474,health,0,0
115475,concern,0,0
115476,in,0,0
115477,the,0,0
115478,developing,0,0
115479,world,0,0
115480,.,0,0
115481,Its,0,0
115482,prevention,0,0
115483,may,0,0
115484,improve,0,0
115485,maternal,0,0
115486,and,0,0
115487,infant,0,0
115488,survival,0,0
115489,.,0,0
115490,OBJECTIVE,0,0
115491,To,0,0
115492,assess,0,0
115493,efficacy,0,0
115494,of,0,0
115495,maternal,0,1
115496,vitamin,1,1
115497,A,1,1
115498,or,0,1
115499,beta,1,1
115500,carotene,1,1
115501,supplementation,0,1
115502,in,0,1
115503,reducing,0,0
115504,pregnancy-related,0,0
115505,and,0,0
115506,infant,0,0
115507,mortality,0,0
115508,.,0,0
115509,DESIGN,0,0
115510,",",0,0
115511,SETTING,0,1
115512,",",0,0
115513,AND,0,1
115514,PARTICIPANTS,0,1
115515,Cluster,0,0
115516,randomized,0,1
115517,",",0,0
115518,double-masked,0,1
115519,",",0,1
115520,placebo-controlled,1,1
115521,trial,0,1
115522,among,0,0
115523,pregnant,0,0
115524,women,0,0
115525,13,0,0
115526,to,0,0
115527,45,0,0
115528,years,0,0
115529,of,0,0
115530,age,0,0
115531,and,0,0
115532,their,0,0
115533,live-born,0,0
115534,infants,0,0
115535,to,0,0
115536,12,0,0
115537,weeks,0,0
115538,(,0,0
115539,84,0,0
115540,days,0,0
115541,),0,0
115542,postpartum,0,1
115543,in,0,0
115544,rural,0,0
115545,northern,0,0
115546,Bangladesh,0,0
115547,between,0,0
115548,2001,0,0
115549,and,0,0
115550,2007,0,0
115551,.,0,0
115552,Interventions,0,0
115553,Five,0,0
115554,hundred,0,0
115555,ninety-six,0,0
115556,community,0,0
115557,clusters,0,0
115558,(,0,0
115559,study,0,0
115560,sectors,0,0
115561,),0,0
115562,were,0,0
115563,randomized,0,0
115564,for,0,0
115565,pregnant,0,0
115566,women,0,0
115567,to,0,0
115568,receive,0,0
115569,weekly,0,0
115570,",",0,0
115571,from,0,0
115572,the,0,0
115573,first,0,0
115574,trimester,0,0
115575,through,0,0
115576,12,0,0
115577,weeks,0,0
115578,postpartum,0,0
115579,",",0,0
115580,7000,1,0
115581,?g,1,0
115582,of,1,0
115583,retinol,1,1
115584,equivalents,1,0
115585,as,1,1
115586,retinyl,1,1
115587,palmitate,1,1
115588,",",1,1
115589,42,1,0
115590,mg,1,1
115591,of,1,1
115592,all-trans,1,1
115593,beta,1,1
115594,carotene,1,1
115595,",",1,1
115596,or,1,1
115597,placebo,1,1
115598,.,1,1
115599,Married,0,1
115600,women,0,1
115601,(,0,0
115602,n,0,0
115603,=,0,0
115604,"125,257",0,0
115605,),0,0
115606,underwent,0,0
115607,5-week,0,0
115608,surveillance,0,0
115609,for,0,0
115610,pregnancy,0,0
115611,",",0,0
115612,ascertained,0,0
115613,by,0,0
115614,a,0,0
115615,history,0,0
115616,of,0,0
115617,amenorrhea,0,0
115618,and,0,0
115619,confirmed,0,0
115620,by,0,0
115621,urine,0,1
115622,test,0,1
115623,.,0,0
115624,Blood,0,0
115625,samples,0,0
115626,were,0,0
115627,obtained,0,0
115628,from,0,0
115629,participants,0,0
115630,in,0,0
115631,32,0,0
115632,sectors,0,0
115633,(,0,0
115634,5,0,0
115635,%,0,0
115636,),0,0
115637,for,0,0
115638,biochemical,0,0
115639,studies,0,0
115640,.,0,0
115641,MAIN,0,0
115642,OUTCOME,0,1
115643,MEASURES,0,1
115644,All-cause,0,0
115645,mortality,0,0
115646,of,0,0
115647,women,0,0
115648,related,0,0
115649,to,0,0
115650,pregnancy,0,0
115651,",",0,0
115652,stillbirth,0,0
115653,",",0,0
115654,and,0,0
115655,infant,0,0
115656,mortality,0,0
115657,to,0,0
115658,12,0,0
115659,weeks,0,0
115660,(,0,0
115661,84,0,0
115662,days,0,0
115663,),0,0
115664,following,0,0
115665,pregnancy,0,0
115666,outcome,0,0
115667,.,0,0
115668,RESULTS,0,0
115669,Groups,0,0
115670,were,0,0
115671,comparable,0,0
115672,across,0,0
115673,risk,0,0
115674,factors,0,0
115675,.,0,0
115676,For,0,0
115677,the,0,0
115678,mortality,0,0
115679,outcomes,0,0
115680,",",0,0
115681,neither,0,0
115682,of,0,0
115683,the,0,0
115684,supplement,0,1
115685,group,0,1
115686,outcomes,0,0
115687,was,0,0
115688,significantly,0,0
115689,different,0,0
115690,from,0,0
115691,the,0,0
115692,placebo,0,1
115693,group,0,1
115694,outcomes,0,0
115695,.,0,0
115696,The,0,0
115697,numbers,0,0
115698,of,0,0
115699,deaths,0,0
115700,and,0,0
115701,all-cause,0,0
115702,",",0,0
115703,pregnancy-related,0,0
115704,mortality,0,1
115705,rates,0,0
115706,(,0,0
115707,per,0,0
115708,"100,000",0,0
115709,pregnancies,0,0
115710,),0,0
115711,were,0,0
115712,41,0,0
115713,and,0,0
115714,206,0,0
115715,(,0,0
115716,95,0,0
115717,%,0,0
115718,confidence,0,0
115719,interval,0,0
115720,[,0,0
115721,CI,0,0
115722,],0,0
115723,",",0,0
115724,140-273,0,0
115725,),0,0
115726,in,0,0
115727,the,1,0
115728,placebo,1,1
115729,group,0,0
115730,",",0,0
115731,47,0,0
115732,and,0,0
115733,237,0,0
115734,(,0,0
115735,95,0,0
115736,%,0,0
115737,CI,0,0
115738,",",0,0
115739,166-309,0,0
115740,),0,0
115741,in,0,0
115742,the,0,0
115743,vitamin,0,1
115744,A,0,1
115745,group,0,1
115746,",",0,0
115747,and,0,0
115748,50,0,0
115749,and,0,0
115750,250,0,0
115751,(,0,0
115752,95,0,0
115753,%,0,0
115754,CI,0,0
115755,",",0,0
115756,177-323,0,0
115757,),0,0
115758,in,0,0
115759,the,0,0
115760,beta,0,1
115761,carotene,0,1
115762,group,0,1
115763,.,0,0
115764,Relative,0,0
115765,risks,0,0
115766,for,0,0
115767,mortality,0,0
115768,in,0,0
115769,the,1,0
115770,vitamin,1,1
115771,A,1,1
115772,and,1,1
115773,beta,1,1
115774,carotene,1,1
115775,groups,0,0
115776,were,0,0
115777,1.15,0,0
115778,(,0,0
115779,95,0,0
115780,%,0,0
115781,CI,0,0
115782,",",0,0
115783,0.75-1.76,0,0
115784,),0,0
115785,and,0,0
115786,1.21,0,0
115787,(,0,0
115788,95,0,0
115789,%,0,0
115790,CI,0,0
115791,",",0,0
115792,0.81-1.81,0,0
115793,),0,0
115794,",",0,0
115795,respectively,0,0
115796,.,0,0
115797,In,0,0
115798,the,1,0
115799,placebo,1,1
115800,",",1,1
115801,vitamin,1,1
115802,A,1,1
115803,",",1,1
115804,and,1,1
115805,beta,1,1
115806,carotene,1,1
115807,groups,0,1
115808,the,0,0
115809,rates,0,0
115810,of,0,0
115811,stillbirth,0,0
115812,and,0,0
115813,infant,0,0
115814,mortality,0,0
115815,were,0,0
115816,47.9,0,0
115817,(,0,0
115818,95,0,0
115819,%,0,0
115820,CI,0,0
115821,",",0,0
115822,44.3-51.5,0,0
115823,),0,0
115824,",",0,0
115825,45.6,0,0
115826,(,0,0
115827,95,0,0
115828,%,0,0
115829,CI,0,0
115830,",",0,0
115831,42.1-49.2,0,0
115832,),0,0
115833,",",0,0
115834,and,0,0
115835,51.8,0,0
115836,(,0,0
115837,95,0,0
115838,%,0,0
115839,CI,0,0
115840,",",0,0
115841,48.0-55.6,0,0
115842,),0,0
115843,per,0,0
115844,1000,0,0
115845,births,0,0
115846,and,0,0
115847,68.1,0,0
115848,(,0,0
115849,95,0,0
115850,%,0,0
115851,CI,0,0
115852,",",0,0
115853,63.7-72.5,0,0
115854,),0,0
115855,",",0,0
115856,65.0,0,0
115857,(,0,0
115858,95,0,0
115859,%,0,0
115860,CI,0,0
115861,",",0,0
115862,60.7-69.4,0,0
115863,),0,0
115864,",",0,0
115865,and,0,0
115866,69.8,0,0
115867,(,0,0
115868,95,0,0
115869,%,0,0
115870,CI,0,0
115871,",",0,0
115872,65.4-72.3,0,0
115873,),0,0
115874,per,0,0
115875,1000,0,0
115876,live,0,1
115877,births,0,0
115878,",",0,0
115879,respectively,0,0
115880,.,0,0
115881,Vitamin,0,0
115882,A,0,1
115883,compared,0,0
115884,with,0,0
115885,either,0,0
115886,placebo,0,1
115887,or,0,1
115888,beta,0,1
115889,carotene,0,1
115890,supplementation,0,1
115891,increased,0,1
115892,plasma,0,1
115893,retinol,0,1
115894,concentrations,0,1
115895,by,0,0
115896,end,0,0
115897,of,0,0
115898,study,0,0
115899,(,0,0
115900,1.46,0,0
115901,[,0,0
115902,95,0,0
115903,%,0,0
115904,CI,0,0
115905,",",0,0
115906,1.42-1.50,0,0
115907,],0,0
115908,?mol/L,0,0
115909,vs,0,0
115910,1.13,0,0
115911,[,0,0
115912,95,0,0
115913,%,0,0
115914,CI,0,0
115915,",",0,0
115916,1.09-1.17,0,0
115917,],0,0
115918,?mol/L,0,0
115919,and,0,0
115920,1.18,0,0
115921,[,0,0
115922,95,0,0
115923,%,0,0
115924,CI,0,0
115925,",",0,0
115926,1.14-1.22,0,0
115927,],0,0
115928,?mol/L,0,0
115929,",",0,0
115930,respectively,0,0
115931,;,0,0
115932,P,0,0
115933,<,0,0
115934,.001,0,0
115935,),0,0
115936,and,0,0
115937,reduced,0,0
115938,",",0,0
115939,but,0,0
115940,did,0,0
115941,not,0,0
115942,eliminate,0,0
115943,",",0,0
115944,gestational,0,0
115945,night,0,1
115946,blindness,0,1
115947,(,0,0
115948,7.1,0,0
115949,%,0,0
115950,for,0,0
115951,vitamin,0,0
115952,A,0,0
115953,vs,0,0
115954,9.2,0,0
115955,%,0,0
115956,for,0,0
115957,placebo,0,0
115958,and,0,0
115959,8.9,0,0
115960,%,0,0
115961,for,0,0
115962,beta,0,0
115963,carotene,0,1
115964,[,0,0
115965,P,0,0
115966,<,0,0
115967,.001,0,0
115968,for,0,0
115969,both,0,0
115970,],0,0
115971,),0,0
115972,.,0,0
115973,CONCLUSION,0,0
115974,Use,0,1
115975,of,0,0
115976,weekly,1,1
115977,vitamin,1,1
115978,A,1,1
115979,or,1,1
115980,beta,1,1
115981,carotene,1,1
115982,in,1,1
115983,pregnant,0,1
115984,women,0,0
115985,in,0,0
115986,Bangladesh,0,0
115987,",",0,0
115988,compared,0,0
115989,with,0,0
115990,placebo,0,1
115991,",",0,0
115992,did,0,0
115993,not,0,0
115994,reduce,0,0
115995,all-cause,0,0
115996,maternal,0,0
115997,",",0,0
115998,fetal,0,0
115999,",",0,0
116000,or,0,0
116001,infant,0,0
116002,mortality,0,0
116003,.,0,0
116004,TRIAL,0,0
116005,REGISTRATION,0,1
116006,clinicaltrials.gov,0,0
116007,Identifier,0,0
116008,:,0,0
116009,NCT00198822,0,0
116010,.,0,0
116011,Tailored,1,0
116012,",",1,0
116013,iterative,1,0
116014,",",1,0
116015,printed,1,1
116016,dietary,1,1
116017,feedback,1,1
116018,is,0,0
116019,as,0,0
116020,effective,0,0
116021,as,0,0
116022,group,0,0
116023,education,0,0
116024,in,0,0
116025,improving,0,0
116026,dietary,0,1
116027,behaviours,0,1
116028,:,0,0
116029,results,0,0
116030,from,0,0
116031,a,0,0
116032,randomised,0,0
116033,control,0,0
116034,trial,0,0
116035,in,0,0
116036,middle-aged,0,0
116037,adults,0,0
116038,with,0,0
116039,cardiovascular,0,0
116040,risk,0,0
116041,factors,0,0
116042,.,0,0
116043,BACKGROUND,0,0
116044,Tailored,0,0
116045,nutrition,0,0
116046,interventions,0,0
116047,have,0,0
116048,been,0,0
116049,shown,0,0
116050,to,0,0
116051,be,0,0
116052,more,0,0
116053,effective,0,0
116054,than,0,0
116055,non-tailored,0,0
116056,materials,0,0
116057,in,0,0
116058,changing,0,0
116059,dietary,0,1
116060,behaviours,0,1
116061,",",0,0
116062,particularly,0,0
116063,fat,0,1
116064,intake,0,1
116065,and,0,1
116066,fruit,0,1
116067,and,0,1
116068,vegetable,0,1
116069,intake,0,1
116070,.,0,1
116071,But,0,0
116072,further,0,0
116073,research,0,0
116074,examining,0,0
116075,efficacy,0,0
116076,of,0,0
116077,tailored,0,0
116078,nutrition,0,0
116079,education,0,0
116080,in,0,0
116081,comparison,0,0
116082,to,0,0
116083,other,0,0
116084,nutrition,0,0
116085,education,0,0
116086,methods,0,0
116087,and,0,0
116088,across,0,0
116089,a,0,0
116090,wider,0,0
116091,range,0,0
116092,of,0,0
116093,dietary,0,1
116094,behaviours,0,1
116095,is,0,0
116096,needed,0,0
116097,.,0,0
116098,The,0,0
116099,Stages,0,0
116100,to,0,0
116101,Healthy,0,0
116102,Eating,0,0
116103,Patterns,0,0
116104,Study,0,0
116105,(,0,1
116106,STEPs,0,1
116107,),0,0
116108,was,0,0
116109,an,0,0
116110,intervention,0,0
116111,study,0,0
116112,",",0,0
116113,in,0,0
116114,middle-aged,0,0
116115,adults,0,0
116116,with,0,0
116117,cardiovascular,0,0
116118,risk,0,0
116119,factors,0,0
116120,",",0,0
116121,to,0,0
116122,examine,0,0
116123,the,0,0
116124,effectiveness,0,0
116125,of,0,0
116126,printed,0,0
116127,",",0,0
116128,tailored,0,0
116129,",",0,0
116130,iterative,0,1
116131,dietary,0,1
116132,feedback,0,1
116133,delivered,0,0
116134,by,0,0
116135,mail,0,0
116136,in,0,0
116137,improving,0,0
116138,short-term,0,0
116139,dietary,0,1
116140,behaviour,0,0
116141,in,0,0
116142,the,0,0
116143,areas,0,0
116144,of,0,0
116145,saturated,0,0
116146,fat,0,0
116147,",",0,0
116148,fruit,0,0
116149,",",0,1
116150,vegetable,0,1
116151,and,0,0
116152,grain,0,0
116153,and,0,1
116154,cereal,0,1
116155,intake,0,1
116156,.,0,1
116157,METHODS,0,0
116158,STEPs,0,0
116159,was,0,0
116160,a,0,0
116161,3-month,0,0
116162,randomised,0,0
116163,controlled,0,0
116164,trial,0,0
116165,with,0,0
116166,a,0,0
116167,pre,0,0
116168,and,0,0
116169,post-test,0,0
116170,design,0,0
116171,.,0,0
116172,There,0,0
116173,were,0,0
116174,three,0,0
116175,experimental,0,0
116176,conditions,0,0
116177,:,0,0
116178,1,0,0
116179,),0,0
116180,tailored,1,1
116181,",",1,0
116182,iterative,1,0
116183,",",1,0
116184,printed,1,1
116185,dietary,1,1
116186,feedback,1,1
116187,(,1,1
116188,TF,1,1
116189,),1,1
116190,with,0,0
116191,three,0,0
116192,instalments,0,0
116193,mail-delivered,0,0
116194,over,0,0
116195,a,0,0
116196,3-month,0,0
116197,period,0,0
116198,that,0,0
116199,were,0,0
116200,re-tailored,0,0
116201,to,0,0
116202,most,0,0
116203,recent,0,0
116204,assessment,0,0
116205,of,0,0
116206,dietary,0,1
116207,intake,0,1
116208,",",0,1
116209,intention,0,0
116210,to,0,0
116211,change,0,0
116212,and,0,0
116213,assessment,0,0
116214,of,0,0
116215,self-adequacy,0,0
116216,of,0,0
116217,dietary,0,1
116218,intake,0,1
116219,.,0,1
116220,Tailoring,0,0
116221,for,0,0
116222,dietary,0,1
116223,intake,0,1
116224,was,0,0
116225,performed,0,0
116226,on,0,0
116227,data,0,0
116228,from,0,0
116229,a,0,0
116230,validated,0,0
116231,63-item,0,0
116232,combination,0,0
116233,FFQ,0,0
116234,designed,0,0
116235,for,0,0
116236,the,0,0
116237,purpose,0,0
116238,2,0,0
116239,),0,0
116240,small,0,0
116241,group,0,0
116242,nutrition,1,0
116243,education,1,1
116244,sessions,1,1
116245,(,0,1
116246,GE,0,1
116247,),0,1
116248,:,0,0
116249,consisting,0,0
116250,of,0,0
116251,two,0,0
116252,90-minute,0,0
116253,dietitian-led,0,0
116254,small,0,0
116255,group,0,0
116256,nutrition,0,0
116257,education,0,1
116258,sessions,0,1
116259,and,0,0
116260,3,0,1
116261,),0,0
116262,and,0,0
116263,a,0,0
116264,wait-listed,0,0
116265,control,0,0
116266,(,0,0
116267,C,0,1
116268,),0,1
116269,group,0,0
116270,who,0,0
116271,completed,0,1
116272,the,0,0
116273,dietary,1,1
116274,measures,1,1
116275,and,1,0
116276,socio-demographic,1,0
116277,questionnaires,1,0
116278,at,0,0
116279,baseline,0,0
116280,and,0,0
116281,3-months,0,0
116282,later,0,0
116283,.,0,0
116284,Dietary,0,0
116285,outcome,0,0
116286,measures,0,0
116287,in,0,0
116288,the,0,0
116289,areas,0,0
116290,of,0,0
116291,saturated,0,0
116292,fat,0,1
116293,intake,0,1
116294,(,0,1
116295,g,0,1
116296,),0,1
116297,",",0,0
116298,and,0,0
116299,the,0,0
116300,intake,0,1
116301,of,0,1
116302,fruit,0,1
116303,(,0,0
116304,serves,0,0
116305,),0,1
116306,",",0,1
116307,vegetables,0,1
116308,(,0,1
116309,serves,0,1
116310,),0,0
116311,",",0,0
116312,grain,0,0
116313,and,0,0
116314,cereals,0,0
116315,as,0,0
116316,total,0,0
116317,and,0,1
116318,wholegrain,0,1
116319,(,0,1
116320,serves,0,0
116321,),0,0
116322,were,0,0
116323,collected,0,0
116324,using,0,0
116325,7-day,0,1
116326,estimated,0,1
116327,dietary,0,1
116328,records,0,1
116329,.,0,0
116330,Descriptive,0,0
116331,statistics,0,0
116332,",",0,0
116333,paired,0,0
116334,t-tests,0,0
116335,and,0,0
116336,general,0,0
116337,linear,0,0
116338,models,0,0
116339,adjusted,0,0
116340,for,0,0
116341,baseline,0,1
116342,dietary,0,1
116343,intake,0,1
116344,",",0,1
116345,age,0,1
116346,and,0,0
116347,gender,0,0
116348,were,0,0
116349,used,0,0
116350,to,0,0
116351,examine,0,0
116352,the,0,0
116353,effectiveness,0,0
116354,of,0,0
116355,different,0,0
116356,nutrition,0,0
116357,interventions,0,0
116358,.,0,0
116359,RESULTS,0,0
116360,The,0,0
116361,TF,1,0
116362,group,0,0
116363,reported,0,0
116364,a,0,0
116365,significantly,0,0
116366,greater,0,0
116367,increase,0,0
116368,in,0,0
116369,fruit,0,1
116370,intake,0,1
116371,(,0,1
116372,0.3,0,0
116373,serves/d,0,0
116374,P,0,0
116375,=,0,0
116376,0.031,0,0
116377,),0,0
116378,in,0,0
116379,comparison,0,0
116380,to,0,0
116381,GE,0,0
116382,and,0,0
116383,the,0,0
116384,C,0,1
116385,group,0,0
116386,.,0,0
116387,All,0,0
116388,three,0,0
116389,intervention,0,0
116390,groups,0,0
116391,showed,0,0
116392,a,0,0
116393,reduction,0,0
116394,in,0,0
116395,total,0,0
116396,saturated,0,0
116397,fat,0,0
116398,intake,0,1
116399,.,0,1
116400,GE,0,0
116401,also,0,0
116402,had,0,0
116403,a,0,0
116404,within-group,0,0
116405,increase,0,0
116406,in,0,0
116407,mean,0,0
116408,vegetable,0,0
116409,intake,0,1
116410,after,0,1
116411,3,0,0
116412,months,0,0
116413,",",0,0
116414,but,0,0
116415,this,0,0
116416,increase,0,0
116417,was,0,0
116418,not,0,0
116419,different,0,0
116420,from,0,0
116421,changes,0,0
116422,in,0,0
116423,the,0,0
116424,other,0,0
116425,groups,0,0
116426,.,0,0
116427,CONCLUSIONS,0,0
116428,In,0,0
116429,this,0,0
116430,study,0,0
116431,",",0,0
116432,printed,0,0
116433,",",0,0
116434,tailored,0,0
116435,",",0,0
116436,iterative,0,1
116437,dietary,0,1
116438,feedback,0,1
116439,was,0,0
116440,more,0,0
116441,effective,0,0
116442,than,0,0
116443,small,0,0
116444,group,0,0
116445,nutrition,0,0
116446,education,0,0
116447,in,0,0
116448,improving,0,0
116449,the,0,0
116450,short-term,0,0
116451,fruit,0,0
116452,intake,0,1
116453,behaviour,0,0
116454,",",0,0
116455,and,0,0
116456,as,0,0
116457,effective,0,0
116458,in,0,0
116459,improving,0,0
116460,saturated,0,0
116461,fat,0,0
116462,intake,0,1
116463,of,0,0
116464,middle-aged,0,1
116465,adults,0,0
116466,with,0,0
116467,cardiovascular,0,0
116468,risk,0,0
116469,factors,0,0
116470,.,0,0
116471,This,0,0
116472,showed,0,0
116473,that,0,0
116474,a,0,0
116475,low-level,0,0
116476,dietary,0,1
116477,intervention,0,1
116478,could,0,0
116479,achieve,0,0
116480,modest,0,0
116481,dietary,0,1
116482,behaviour,0,0
116483,changes,0,0
116484,that,0,0
116485,are,0,0
116486,of,0,0
116487,public,0,0
116488,health,0,0
116489,significance,0,0
116490,.,0,0
116491,Poor,0,0
116492,self-rated,0,0
116493,health,0,0
116494,is,0,0
116495,not,0,0
116496,associated,0,0
116497,with,0,0
116498,a,0,0
116499,high,0,0
116500,total,0,0
116501,allostatic,0,0
116502,load,0,0
116503,in,0,0
116504,type,0,0
116505,2,0,0
116506,diabetic,0,0
116507,patients,0,0
116508,--,0,0
116509,but,0,0
116510,high,0,0
116511,blood,0,0
116512,pressure,0,0
116513,is,0,0
116514,.,0,0
116515,OBJECTIVE,0,0
116516,Allostatic,0,0
116517,load,0,0
116518,has,0,0
116519,been,0,0
116520,linked,0,0
116521,to,0,0
116522,self-rated,0,0
116523,health,0,1
116524,(,0,1
116525,SRH,0,1
116526,),0,1
116527,",",0,0
116528,cardiovascular,0,1
116529,disease,0,0
116530,and,0,0
116531,mortality,0,0
116532,in,0,0
116533,non-diabetic,0,0
116534,individuals,0,0
116535,.,0,0
116536,The,0,0
116537,aim,0,0
116538,of,0,0
116539,this,0,0
116540,study,0,0
116541,was,0,0
116542,to,0,0
116543,construct,0,0
116544,an,0,0
116545,allostatic,0,0
116546,load,0,0
116547,score,0,0
116548,and,0,0
116549,to,0,0
116550,find,0,0
116551,any,0,0
116552,correlations,0,0
116553,with,0,0
116554,SRH,0,0
116555,.,0,0
116556,METHODS,0,0
116557,The,0,0
116558,subjects,0,0
116559,included,0,0
116560,in,0,0
116561,the,0,0
116562,study,0,0
116563,came,0,0
116564,from,0,0
116565,a,0,0
116566,randomized,0,0
116567,",",0,0
116568,controlled,0,0
116569,trial,0,0
116570,of,0,0
116571,type,0,0
116572,2,0,0
116573,diabetes,0,0
116574,.,0,0
116575,Blood,0,0
116576,samples,0,0
116577,were,0,0
116578,drawn,0,0
116579,",",0,0
116580,urine,0,1
116581,was,0,0
116582,collected,0,0
116583,for,0,0
116584,24h,0,0
116585,",",0,0
116586,and,0,0
116587,questionnaires,0,0
116588,",",0,0
116589,including,0,0
116590,SRH,0,0
116591,",",0,0
116592,were,0,0
116593,filled,0,0
116594,out,0,0
116595,on,0,0
116596,three,0,0
116597,occasions,0,0
116598,:,0,0
116599,at,0,0
116600,baseline,0,0
116601,;,0,0
116602,after,0,0
116603,the,0,0
116604,10-week,0,0
116605,intervention,0,1
116606,;,0,0
116607,and,0,0
116608,at,0,0
116609,a,0,0
116610,follow-up,0,0
116611,3,0,0
116612,months,0,0
116613,after,0,0
116614,the,0,0
116615,intervention,0,0
116616,.,0,0
116617,Allostatic,0,0
116618,load,0,0
116619,was,0,0
116620,estimated,0,0
116621,using,0,0
116622,a,0,0
116623,wide,0,0
116624,range,0,0
116625,of,0,0
116626,variables,0,0
116627,",",0,0
116628,including,0,0
116629,systolic,0,0
116630,and,0,0
116631,diastolic,0,0
116632,blood,0,0
116633,pressure,0,0
116634,",",0,0
116635,pulse,0,0
116636,pressure,0,1
116637,",",0,0
116638,cortisol,0,1
116639,",",0,1
116640,catecholamines,0,1
116641,",",0,1
116642,HbA,0,1
116643,(,0,1
116644,1c,0,1
116645,),0,1
116646,",",0,1
116647,insulin,0,1
116648,",",0,1
116649,plasma,0,1
116650,glucose,0,1
116651,and,0,1
116652,waist,0,1
116653,circumference,0,0
116654,.,0,0
116655,RESULTS,0,0
116656,There,0,0
116657,was,0,0
116658,no,0,0
116659,association,0,0
116660,between,0,0
116661,SRH,0,0
116662,and,0,0
116663,allostatic,0,0
116664,load,0,0
116665,.,0,0
116666,However,0,0
116667,",",0,0
116668,three,0,0
116669,other,0,0
116670,components,0,0
116671,were,0,0
116672,significantly,0,0
116673,correlated,0,0
116674,with,0,0
116675,allostatic,0,0
116676,load,0,0
116677,at,0,0
116678,the,0,0
116679,baseline,0,0
116680,investigation,0,0
116681,and,0,0
116682,the,0,0
116683,two,0,0
116684,follow-up,0,0
116685,investigations,0,0
116686,-,0,0
116687,namely,0,0
116688,",",0,0
116689,systolic,0,0
116690,blood,0,0
116691,pressure,0,0
116692,",",0,0
116693,diastolic,0,0
116694,blood,0,0
116695,pressure,0,0
116696,and,0,0
116697,HbA,0,1
116698,(,0,1
116699,1c,0,1
116700,),0,1
116701,.,0,0
116702,CONCLUSION,0,0
116703,The,0,0
116704,absence,0,0
116705,of,0,0
116706,an,0,0
116707,association,0,0
116708,between,0,0
116709,allostatic,0,0
116710,load,0,0
116711,and,0,0
116712,SRH,0,0
116713,in,0,0
116714,diabetic,0,0
116715,individuals,0,0
116716,contrasts,0,0
116717,with,0,0
116718,previous,0,0
116719,findings,0,0
116720,in,0,0
116721,non-diabetic,0,0
116722,women,0,0
116723,",",0,0
116724,and,0,0
116725,shows,0,0
116726,that,0,0
116727,it,0,0
116728,is,0,0
116729,hazardous,0,0
116730,to,0,0
116731,apply,0,0
116732,findings,0,0
116733,in,0,0
116734,one,0,0
116735,population,0,0
116736,to,0,0
116737,another,0,0
116738,",",0,0
116739,especially,0,0
116740,diabetic,0,0
116741,and,0,0
116742,non-diabetic,0,0
116743,populations,0,0
116744,.,0,0
116745,Standardized,0,1
116746,preoperative,0,1
116747,corticosteroid,1,1
116748,treatment,0,0
116749,in,0,0
116750,neonates,0,0
116751,undergoing,0,0
116752,cardiac,0,0
116753,surgery,0,0
116754,:,0,0
116755,results,0,0
116756,from,0,0
116757,a,0,0
116758,randomized,0,0
116759,trial,0,0
116760,.,0,0
116761,OBJECTIVE,0,0
116762,A,0,0
116763,heightened,0,0
116764,inflammatory,0,0
116765,response,0,0
116766,occurs,0,0
116767,after,0,0
116768,cardiac,0,0
116769,surgery,0,0
116770,.,0,0
116771,The,0,0
116772,perioperative,0,0
116773,use,0,0
116774,of,0,0
116775,glucocorticoids,0,1
116776,has,0,0
116777,been,0,0
116778,advocated,0,0
116779,as,0,0
116780,a,0,0
116781,method,0,0
116782,to,0,0
116783,improve,0,0
116784,postoperative,0,0
116785,outcomes,0,0
116786,.,0,0
116787,Randomized,0,0
116788,prospective,0,0
116789,studies,0,0
116790,to,0,0
116791,quantify,0,0
116792,the,0,0
116793,effect,0,0
116794,of,0,0
116795,methylprednisolone,1,1
116796,on,0,0
116797,perioperative,0,0
116798,outcomes,0,0
116799,in,0,0
116800,neonatal,0,0
116801,cardiac,0,0
116802,surgery,0,0
116803,have,0,0
116804,not,0,0
116805,been,0,0
116806,performed,0,0
116807,.,0,0
116808,We,0,0
116809,sought,0,0
116810,to,0,0
116811,determine,0,0
116812,whether,0,0
116813,preoperative,0,0
116814,methylprednisolone,0,1
116815,would,0,0
116816,improve,0,0
116817,postoperative,0,0
116818,recovery,0,0
116819,in,0,0
116820,neonates,0,0
116821,requiring,0,0
116822,cardiac,0,0
116823,surgery,0,0
116824,.,0,0
116825,METHODS,0,0
116826,Neonates,0,0
116827,scheduled,0,0
116828,for,0,0
116829,cardiac,0,0
116830,surgery,0,0
116831,were,0,0
116832,randomly,0,0
116833,assigned,0,0
116834,to,0,0
116835,receive,0,0
116836,either,0,0
116837,2-dose,0,1
116838,(,0,1
116839,8,0,1
116840,hours,0,0
116841,preoperatively,0,1
116842,and,0,0
116843,operatively,0,0
116844,",",0,0
116845,n,0,0
116846,=,0,0
116847,39,0,0
116848,),0,0
116849,or,0,0
116850,single-dose,0,1
116851,(,0,1
116852,operatively,0,1
116853,",",0,0
116854,n,0,0
116855,=,1,0
116856,37,1,0
116857,),1,0
116858,methylprednisolone,1,1
116859,(,1,1
116860,30,1,1
116861,mg/kg,0,1
116862,per,0,1
116863,dose,0,1
116864,),0,1
116865,in,0,0
116866,a,0,0
116867,prospective,0,1
116868,double-blind,0,1
116869,trial,0,1
116870,.,0,0
116871,The,0,0
116872,primary,0,0
116873,outcome,0,0
116874,was,0,0
116875,the,0,0
116876,incidence,0,0
116877,of,0,0
116878,low,0,0
116879,cardiac,0,0
116880,output,0,1
116881,syndrome,0,1
116882,(,0,1
116883,standardized,0,1
116884,score,0,1
116885,),0,0
116886,or,0,0
116887,death,0,0
116888,36,0,0
116889,hours,0,0
116890,postoperatively,0,0
116891,.,0,0
116892,Secondary,0,0
116893,outcomes,0,0
116894,were,0,0
116895,death,0,0
116896,at,0,0
116897,30,0,0
116898,days,0,0
116899,",",0,1
116900,interleukin-6,0,1
116901,levels,0,1
116902,",",0,1
116903,inotropic,0,1
116904,score,0,1
116905,",",0,0
116906,fluid,0,0
116907,balance,0,0
116908,",",0,1
116909,serum,0,1
116910,creatinine,0,1
116911,",",0,1
116912,and,0,0
116913,intensive,0,0
116914,care,0,0
116915,unit,0,0
116916,and,0,0
116917,hospital,0,0
116918,stay,0,0
116919,.,0,0
116920,RESULTS,0,0
116921,Preoperative,0,1
116922,plasma,0,1
116923,levels,0,0
116924,of,0,0
116925,the,0,0
116926,inflammatory,0,0
116927,cytokine,0,0
116928,interleukin-6,0,1
116929,were,0,0
116930,reduced,0,0
116931,by,0,0
116932,2-fold,0,0
116933,(,0,0
116934,P,0,0
116935,<,0,0
116936,.001,0,0
116937,),0,0
116938,in,0,0
116939,the,0,1
116940,2-dose,0,1
116941,methylprednisolone,0,1
116942,group,0,1
116943,",",0,0
116944,consistent,0,0
116945,with,0,0
116946,the,0,0
116947,anti-inflammatory,0,1
116948,effects,0,0
116949,of,0,0
116950,methylprednisolone,0,1
116951,.,0,0
116952,However,0,0
116953,",",0,0
116954,the,0,0
116955,incidence,0,0
116956,of,0,0
116957,low,0,0
116958,cardiac,0,0
116959,output,0,0
116960,syndrome,0,0
116961,was,0,0
116962,46,0,0
116963,%,0,0
116964,(,0,0
116965,17/37,0,0
116966,),0,0
116967,in,0,0
116968,the,0,0
116969,single-dose,0,1
116970,and,0,0
116971,38,0,0
116972,%,0,0
116973,(,0,0
116974,15/39,0,0
116975,),0,0
116976,in,0,0
116977,the,0,1
116978,2-dose,0,1
116979,methylprednisolone,0,1
116980,groups,0,0
116981,(,0,0
116982,P,0,0
116983,=,0,0
116984,.51,0,0
116985,),0,0
116986,.,0,0
116987,Two-dose,0,1
116988,methylprednisolone,0,1
116989,was,0,0
116990,associated,0,0
116991,with,0,0
116992,a,0,0
116993,higher,0,0
116994,serum,0,1
116995,creatinine,0,1
116996,(,0,1
116997,0.61,0,0
116998,?,0,0
116999,0.18,0,0
117000,mg/dL,0,0
117001,vs,0,0
117002,0.53,0,0
117003,?,0,0
117004,0.12,0,0
117005,mg/dL,0,0
117006,",",0,0
117007,P,0,0
117008,=,0,0
117009,.03,0,0
117010,),0,0
117011,and,0,0
117012,poorer,0,1
117013,postoperative,0,1
117014,diuresis,0,1
117015,(,0,0
117016,-96,0,0
117017,?,0,0
117018,49,0,0
117019,mL,0,0
117020,",",0,0
117021,P,0,0
117022,=,0,0
117023,.05,0,0
117024,),0,0
117025,.,0,0
117026,Inotropic,0,0
117027,requirement,0,0
117028,",",0,0
117029,duration,0,0
117030,of,0,0
117031,mechanical,0,0
117032,ventilation,0,0
117033,",",0,0
117034,intensive,0,0
117035,care,0,0
117036,unit,0,0
117037,",",0,0
117038,and,0,0
117039,hospital,0,0
117040,stay,0,0
117041,did,0,0
117042,not,0,0
117043,differ,0,0
117044,between,0,0
117045,the,0,0
117046,2,0,0
117047,groups,0,0
117048,.,0,0
117049,CONCLUSIONS,0,0
117050,Combined,0,0
117051,preoperative,0,0
117052,and,0,0
117053,intraoperative,0,0
117054,use,0,0
117055,of,0,0
117056,glucocorticoids,0,1
117057,in,0,0
117058,neonatal,0,1
117059,cardiac,0,0
117060,surgery,0,0
117061,does,0,0
117062,not,0,0
117063,favorably,0,0
117064,affect,0,0
117065,early,0,0
117066,clinical,0,0
117067,outcomes,0,0
117068,and,0,0
117069,may,0,0
117070,exacerbate,0,0
117071,perioperative,0,0
117072,renal,0,0
117073,dysfunction,0,0
117074,.,0,0
117075,A,0,1
117076,prospective,0,1
117077,double-blind,0,1
117078,",",0,1
117079,randomized,0,1
117080,clinical,0,0
117081,trial,0,0
117082,of,0,0
117083,levocarnitine,1,1
117084,to,0,0
117085,treat,0,1
117086,autism,0,0
117087,spectrum,0,0
117088,disorders,0,0
117089,.,0,0
117090,BACKGROUND,0,1
117091,L-carnitine,1,1
117092,was,0,0
117093,proposed,0,0
117094,as,0,0
117095,a,0,0
117096,potential,0,0
117097,treatment,0,0
117098,for,0,0
117099,patients,0,0
117100,diagnosed,0,0
117101,with,0,0
117102,an,0,0
117103,autism,0,0
117104,spectrum,0,0
117105,disorder,0,0
117106,to,0,0
117107,improve,0,0
117108,mitochondrial,0,0
117109,dysfunction,0,0
117110,",",0,0
117111,but,0,0
117112,no,0,0
117113,prior,0,0
117114,randomized,0,0
117115,controlled,0,0
117116,trials,0,0
117117,have,0,0
117118,been,0,0
117119,conducted,0,0
117120,.,0,0
117121,MATERIAL/METHODS,0,0
117122,Thirty,0,0
117123,subjects,0,0
117124,diagnosed,0,0
117125,with,0,0
117126,an,0,0
117127,ASD,0,0
117128,were,0,0
117129,randomly,0,0
117130,assigned,0,0
117131,to,0,0
117132,receive,0,0
117133,a,0,0
117134,standardized,1,1
117135,regimen,1,1
117136,(,1,1
117137,50,1,1
117138,mg,1,1
117139,L-carnitine/kg,1,1
117140,bodyweight/day,1,1
117141,),1,1
117142,of,1,1
117143,liquid,1,1
117144,L-carnitine,1,1
117145,(,1,1
117146,n=19,1,0
117147,),1,0
117148,or,1,0
117149,placebo,1,1
117150,(,1,1
117151,n=11,1,0
117152,),1,0
117153,for,1,0
117154,3-months,1,0
117155,.,1,0
117156,Measures,0,0
117157,included,0,0
117158,changes,0,0
117159,in,0,0
117160,professionally,0,0
117161,completed,0,0
117162,Childhood,0,0
117163,Autism,0,0
117164,Rating,0,0
117165,Scale,0,1
117166,(,0,1
117167,CARS,0,1
117168,),0,1
117169,",",0,0
117170,hand,0,0
117171,muscle,0,0
117172,testing,0,0
117173,",",0,0
117174,and,0,0
117175,modified,0,0
117176,clinical,0,0
117177,global,0,0
117178,impression,0,1
117179,(,0,1
117180,CGI,0,0
117181,),0,1
117182,forms,0,0
117183,;,0,0
117184,parent,0,0
117185,completed,0,0
117186,Autism,0,0
117187,Treatment,0,1
117188,Evaluation,0,1
117189,Checklist,0,1
117190,(,0,1
117191,ATEC,0,1
117192,),0,1
117193,",",0,0
117194,treatment,0,0
117195,adherence,0,0
117196,measurement,0,0
117197,(,0,1
117198,TAM,0,1
117199,),0,1
117200,",",0,0
117201,frequency,0,0
117202,and,0,0
117203,intensity,0,0
117204,of,0,0
117205,side,0,0
117206,effect,0,0
117207,rating,0,0
117208,(,0,1
117209,FISER,0,1
117210,),0,1
117211,/global,0,0
117212,rating,0,0
117213,of,0,0
117214,side,0,0
117215,effect,0,0
117216,burden,0,0
117217,(,0,1
117218,GRSEB,0,1
117219,),0,1
117220,/patient,0,0
117221,report,0,0
117222,of,0,0
117223,incidence,0,0
117224,of,0,0
117225,side,0,0
117226,effects,0,0
117227,(,0,0
117228,PRISE,0,1
117229,),0,1
117230,forms,0,0
117231,;,0,0
117232,and,0,0
117233,lab,0,0
117234,testing,0,0
117235,.,0,0
117236,RESULTS,0,0
117237,Significant,0,0
117238,improvements,0,0
117239,were,0,0
117240,observed,0,0
117241,in,0,0
117242,CARS,0,0
117243,(,0,0
117244,-2.03,0,0
117245,",",0,0
117246,95,0,0
117247,%,0,0
117248,CI=-3.7,0,0
117249,to,0,0
117250,-0.31,0,0
117251,),0,0
117252,",",0,0
117253,CGI,0,0
117254,(,0,0
117255,-0.69,0,0
117256,",",0,0
117257,95,0,0
117258,%,0,0
117259,CI=-1.1,0,0
117260,to,0,0
117261,-0.06,0,0
117262,),0,0
117263,",",0,0
117264,and,0,0
117265,ATEC,0,1
117266,scores,0,0
117267,.,0,0
117268,Significant,0,0
117269,correlations,0,0
117270,between,0,0
117271,changes,0,0
117272,in,0,0
117273,serum,0,1
117274,free-carnitine,0,1
117275,levels,0,1
117276,and,0,0
117277,positive,0,0
117278,clinical,0,0
117279,changes,0,0
117280,were,0,0
117281,observed,0,0
117282,for,0,0
117283,hand,0,0
117284,muscle,0,0
117285,strength,0,0
117286,(,0,0
117287,R2=0.23,0,0
117288,",",0,0
117289,P=0.046,0,0
117290,),0,0
117291,",",0,0
117292,cognitive,0,1
117293,scores,0,0
117294,(,0,0
117295,R2=0.27,0,0
117296,",",0,0
117297,P=0.019,0,0
117298,),0,0
117299,",",0,0
117300,and,0,0
117301,CARS,0,1
117302,scores,0,1
117303,(,0,0
117304,R2=0.20,0,0
117305,",",0,0
117306,P=0.047,0,0
117307,),0,0
117308,.,0,0
117309,Study,0,0
117310,subjects,0,0
117311,were,0,0
117312,protocol-compliant,0,0
117313,(,0,0
117314,average,0,0
117315,adherence,0,0
117316,was,0,0
117317,>,0,0
117318,85,0,0
117319,%,0,0
117320,),0,0
117321,and,0,0
117322,generally,0,0
117323,well-tolerated,0,1
117324,the,0,1
117325,L-carnitine,1,1
117326,therapy,1,1
117327,given,0,1
117328,.,0,0
117329,CONCLUSIONS,0,1
117330,L-carnitine,1,1
117331,therapy,1,1
117332,(,0,1
117333,50,0,1
117334,mg/kilogram-bodyweight/day,0,1
117335,),0,1
117336,administered,0,1
117337,for,0,0
117338,3-months,0,0
117339,significantly,0,0
117340,improved,0,0
117341,several,0,0
117342,clinical,0,0
117343,measurements,0,0
117344,of,0,0
117345,ASD,0,0
117346,severity,0,0
117347,",",0,0
117348,but,0,0
117349,subsequent,0,0
117350,studies,0,0
117351,are,0,0
117352,recommended,0,0
117353,.,0,0
117354,Short-term,0,0
117355,metabolic,0,0
117356,effects,0,0
117357,of,0,0
117358,prednisone,1,1
117359,administration,0,1
117360,in,0,0
117361,healthy,0,0
117362,subjects,0,0
117363,.,0,0
117364,AIMS,0,1
117365,Supraphysiologic,0,1
117366,glucocorticoid,0,1
117367,activity,0,0
117368,is,0,0
117369,well,0,0
117370,established,0,0
117371,to,0,0
117372,cause,0,0
117373,impaired,0,0
117374,glucose,0,1
117375,tolerance,0,1
117376,and,0,1
117377,insulin,0,1
117378,resistance,0,0
117379,",",0,0
117380,yet,0,0
117381,no,0,0
117382,study,0,0
117383,has,0,0
117384,evaluated,0,0
117385,dose-dependent,0,0
117386,effects,0,0
117387,of,0,1
117388,low-dose,0,1
117389,prednisone,1,1
117390,during,0,1
117391,short-term,0,1
117392,oral,0,1
117393,administration,0,1
117394,.,0,1
117395,METHODS,0,1
117396,The,0,0
117397,objective,0,0
117398,of,0,0
117399,this,0,0
117400,study,0,0
117401,was,0,0
117402,to,0,0
117403,quantify,0,0
117404,the,0,0
117405,effects,0,0
117406,of,0,0
117407,daily,0,1
117408,10,1,1
117409,or,1,1
117410,25,1,1
117411,mg,1,1
117412,prednisone,1,1
117413,administration,0,1
117414,for,0,0
117415,one,0,0
117416,week,0,0
117417,on,0,0
117418,insulin,0,1
117419,sensitivity,0,0
117420,by,0,0
117421,employing,0,0
117422,a,0,0
117423,two-step,1,0
117424,hyperinsulinemic,1,1
117425,euglycemic,1,1
117426,glucose,1,1
117427,clamp,1,1
117428,(,0,1
117429,Step,0,1
117430,1,0,1
117431,:,0,1
117432,insulin,0,1
117433,infusion,0,1
117434,=,0,1
117435,20,0,0
117436,mU/m?/min,0,0
117437,;,0,1
117438,Step,0,1
117439,2,0,1
117440,:,1,1
117441,insulin,1,1
117442,infusion,1,1
117443,=,1,1
117444,80,1,0
117445,mU/m?/min,1,0
117446,),1,0
117447,in,1,0
117448,healthy,0,0
117449,",",0,0
117450,lean,0,0
117451,males,0,0
117452,.,0,0
117453,The,0,0
117454,amount,0,0
117455,of,0,0
117456,glucose,0,1
117457,infused,0,1
117458,at,0,1
117459,steady-state,0,0
117460,to,0,0
117461,maintain,0,0
117462,stable,0,0
117463,blood,0,1
117464,glucose,0,1
117465,[,0,1
117466,90,0,0
117467,mg/dl,0,0
117468,(,0,0
117469,4.95,0,0
117470,mmol/l,0,1
117471,),0,0
117472,],0,0
117473,was,0,0
117474,used,0,0
117475,to,0,0
117476,calculate,0,0
117477,several,0,0
117478,indices,0,0
117479,of,0,0
117480,insulin,0,1
117481,sensitivity,0,0
117482,.,0,0
117483,RESULTS,0,0
117484,During,0,0
117485,Step,0,0
117486,1,0,0
117487,of,0,0
117488,the,0,0
117489,clamp,0,1
117490,",",0,0
117491,whole,0,0
117492,body,0,1
117493,glucose,0,1
117494,disposal,0,1
117495,(,0,1
117496,M,0,1
117497,),0,0
117498,was,0,0
117499,reduced,0,0
117500,by,0,0
117501,35,0,0
117502,%,0,0
117503,(,0,0
117504,p,0,0
117505,=,0,0
117506,0.003,0,0
117507,),0,0
117508,and,0,0
117509,M/I,0,0
117510,was,0,0
117511,reduced,0,0
117512,by,0,0
117513,29,0,0
117514,%,0,0
117515,(,0,0
117516,p,0,0
117517,=,0,0
117518,0.025,0,0
117519,),0,0
117520,for,0,0
117521,25,0,1
117522,mg,0,1
117523,prednisone,1,1
117524,compared,1,1
117525,to,0,0
117526,placebo,1,1
117527,.,1,1
117528,No,0,1
117529,appreciable,0,0
117530,effect,0,0
117531,of,0,0
117532,10,0,1
117533,mg,0,1
117534,prednisone,0,1
117535,was,0,0
117536,observed,0,0
117537,.,0,0
117538,During,0,0
117539,Step,0,0
117540,2,0,0
117541,",",0,0
117542,M,0,0
117543,was,0,0
117544,reduced,0,0
117545,by,0,0
117546,33,0,0
117547,%,0,0
117548,(,0,0
117549,p,0,0
117550,=,0,0
117551,0.001,0,0
117552,),0,0
117553,and,0,0
117554,15,0,0
117555,%,0,0
117556,(,0,0
117557,p,0,0
117558,=,0,0
117559,0.006,0,0
117560,),0,0
117561,for,0,0
117562,25,0,0
117563,and,0,0
117564,10,0,1
117565,mg,0,1
117566,prednisone,1,1
117567,compared,1,1
117568,to,0,1
117569,placebo,1,1
117570,;,1,1
117571,and,1,1
117572,M/I,0,1
117573,ratio,0,0
117574,was,0,0
117575,reduced,0,0
117576,by,0,0
117577,31,0,0
117578,%,0,0
117579,(,0,0
117580,p,0,0
117581,<,0,0
117582,0.001,0,0
117583,),0,0
117584,and,0,0
117585,13,0,0
117586,%,0,0
117587,(,0,0
117588,p,0,0
117589,=,0,0
117590,0.026,0,0
117591,),0,0
117592,",",0,0
117593,respectively,0,0
117594,.,0,0
117595,The,0,0
117596,insulin,0,1
117597,sensitivity,0,0
117598,index,0,1
117599,",",0,0
117600,Si,0,0
117601,",",0,0
117602,calculated,0,0
117603,as,0,0
117604,the,0,0
117605,quotient,0,0
117606,of,0,0
117607,augmentation,0,0
117608,of,0,0
117609,M/I,0,0
117610,between,0,0
117611,Step,0,0
117612,1,0,0
117613,and,0,0
117614,2,0,0
117615,",",0,0
117616,was,0,0
117617,reduced,0,0
117618,by,0,0
117619,35.3,0,0
117620,%,0,0
117621,(,0,0
117622,p,0,0
117623,<,0,0
117624,0.01,0,0
117625,),0,0
117626,and,0,0
117627,23.5,0,0
117628,%,0,0
117629,(,0,0
117630,p,0,0
117631,<,0,0
117632,0.05,0,0
117633,),0,0
117634,for,0,0
117635,25,0,0
117636,and,0,0
117637,10,0,1
117638,mg,0,1
117639,prednisone,1,1
117640,",",1,0
117641,respectively,0,0
117642,.,0,0
117643,CONCLUSION,0,0
117644,Administration,0,0
117645,of,0,0
117646,relatively,0,0
117647,low,0,0
117648,pharmacological,0,0
117649,doses,0,1
117650,of,0,1
117651,prednisone,0,1
117652,for,0,0
117653,one,0,0
117654,week,0,0
117655,impaired,0,0
117656,insulin,0,1
117657,sensitivity,0,0
117658,in,0,0
117659,a,0,0
117660,dose-dependent,0,0
117661,manner,0,0
117662,in,0,0
117663,healthy,0,0
117664,males,0,0
117665,.,0,0
117666,These,0,0
117667,observed,0,0
117668,changes,0,0
117669,in,0,0
117670,insulin,0,1
117671,sensitivity,0,0
117672,are,0,0
117673,likely,0,0
117674,to,0,0
117675,be,0,0
117676,clinically,0,0
117677,relevant,0,0
117678,",",0,0
117679,especially,0,0
117680,in,0,0
117681,individuals,0,0
117682,predisposed,0,0
117683,to,0,0
117684,develop,0,0
117685,glucose,0,1
117686,intolerance,0,1
117687,.,0,0
117688,Design,0,0
117689,and,0,0
117690,subject,0,0
117691,characteristics,0,0
117692,in,0,0
117693,the,0,0
117694,federally-funded,0,1
117695,citalopram,1,1
117696,trial,0,1
117697,in,0,0
117698,children,0,0
117699,with,0,0
117700,pervasive,0,0
117701,developmental,0,0
117702,disorders,0,0
117703,.,0,0
117704,The,0,0
117705,Studies,0,0
117706,to,0,0
117707,Advance,0,0
117708,Autism,0,0
117709,Research,0,0
117710,and,0,0
117711,Treatment,0,0
117712,Network,0,0
117713,conducted,0,0
117714,a,0,0
117715,randomized,0,0
117716,trial,0,1
117717,with,0,0
117718,citalopram,1,1
117719,in,0,0
117720,children,0,0
117721,with,0,0
117722,Pervasive,0,0
117723,developmental,0,0
117724,disorders,0,0
117725,(,0,1
117726,PDDs,0,1
117727,),0,1
117728,.,0,0
117729,We,0,0
117730,present,0,0
117731,the,0,0
117732,rationale,0,0
117733,",",0,0
117734,design,0,0
117735,and,0,0
117736,sample,0,0
117737,characteristics,0,0
117738,of,0,0
117739,the,0,0
117740,citalopram,1,1
117741,trial,0,1
117742,.,0,1
117743,Subjects,0,0
117744,(,0,0
117745,128,0,0
117746,boys,0,0
117747,",",0,0
117748,21,0,0
117749,girls,0,0
117750,),0,0
117751,had,0,0
117752,a,0,0
117753,mean,0,0
117754,age,0,0
117755,of,0,0
117756,9.3,0,0
117757,(,0,0
117758,?3.12,0,0
117759,),0,0
117760,years,0,0
117761,;,0,0
117762,132,0,0
117763,(,0,0
117764,88.6,0,0
117765,%,0,0
117766,),0,0
117767,were,0,0
117768,diagnosed,0,0
117769,with,0,0
117770,autistic,0,0
117771,disorder,0,0
117772,(,0,0
117773,4.7,0,0
117774,%,0,0
117775,with,0,0
117776,Asperger,0,0
117777,'s,0,0
117778,Disorder,0,0
117779,;,0,0
117780,6.7,0,0
117781,%,0,0
117782,with,0,0
117783,PDD-not,0,0
117784,otherwise,0,0
117785,specified,0,0
117786,),0,0
117787,.,0,0
117788,Less,0,0
117789,than,0,0
117790,half,0,0
117791,of,0,0
117792,the,0,0
117793,subjects,0,0
117794,were,0,0
117795,intellectually,0,0
117796,disabled,0,0
117797,;,0,0
117798,117,0,0
117799,(,0,0
117800,78.5,0,0
117801,%,0,0
117802,),0,0
117803,were,0,0
117804,rated,0,0
117805,Moderate,0,0
117806,or,0,0
117807,Marked,0,0
117808,on,0,0
117809,the,0,0
117810,Clinical,0,0
117811,Global,0,0
117812,Impression,0,0
117813,for,0,0
117814,Severity,0,0
117815,.,0,0
117816,Study,0,0
117817,measures,0,0
117818,were,0,0
117819,similar,0,0
117820,to,0,0
117821,previous,0,0
117822,Research,0,0
117823,Units,0,0
117824,on,0,0
117825,Pediatric,0,0
117826,Psychopharmacology,0,0
117827,trials,0,0
117828,.,0,0
117829,Subjects,0,0
117830,in,0,0
117831,this,0,0
117832,trial,0,0
117833,were,0,0
117834,slightly,0,0
117835,older,0,0
117836,and,0,0
117837,more,0,0
117838,likely,0,0
117839,to,0,0
117840,have,0,0
117841,complaints,0,0
117842,of,0,0
117843,repetitive,0,0
117844,behavior,0,0
117845,than,0,0
117846,participants,0,0
117847,in,0,0
117848,RUPP,0,0
117849,trials,0,0
117850,.,0,0
117851,A,0,1
117852,randomized,0,1
117853,crossover,0,1
117854,study,0,0
117855,comparing,0,0
117856,patient,0,0
117857,preference,0,0
117858,for,0,0
117859,tamsulosin,1,1
117860,and,1,1
117861,silodosin,1,1
117862,in,0,0
117863,patients,0,0
117864,with,0,0
117865,lower,0,0
117866,urinary,0,0
117867,tract,0,0
117868,symptoms,0,0
117869,associated,0,0
117870,with,0,0
117871,benign,0,0
117872,prostatic,0,0
117873,hyperplasia,0,0
117874,.,0,0
117875,Patient,0,0
117876,preference,0,0
117877,for,0,0
117878,benign,0,0
117879,prostatic,0,1
117880,hyperplasia,0,1
117881,(,0,1
117882,BPH,0,1
117883,),0,0
117884,treatment,0,0
117885,with,0,0
117886,the,0,0
117887,?,1,1
117888,(,1,1
117889,1,1,1
117890,),1,1
117891,-blockers,1,1
117892,",",1,1
117893,tamsulosin,1,1
117894,or,1,1
117895,silodosin,1,1
117896,",",1,0
117897,was,0,0
117898,compared,0,0
117899,using,0,0
117900,patient-reported,0,0
117901,outcomes,0,0
117902,.,0,0
117903,Japanese,0,0
117904,patients,0,0
117905,with,0,0
117906,lower,0,0
117907,urinary,0,0
117908,tract,0,0
117909,symptoms,0,0
117910,associated,0,0
117911,with,0,0
117912,BPH,0,0
117913,were,0,0
117914,randomly,0,0
117915,allocated,0,0
117916,to,0,0
117917,either,0,0
117918,the,1,0
117919,T-S,1,1
117920,group,1,1
117921,(,1,0
117922,tamsulosin,1,1
117923,0.2,1,1
117924,mg,1,1
117925,orally,1,1
117926,once,1,1
117927,daily,1,1
117928,for,1,1
117929,4,1,0
117930,weeks,1,0
117931,then,1,0
117932,silodosin,1,1
117933,4,1,1
117934,mg,1,1
117935,orally,1,1
117936,twice,1,1
117937,daily,1,1
117938,for,1,1
117939,4,1,0
117940,weeks,1,0
117941,),1,0
117942,or,1,0
117943,the,1,0
117944,S-T,1,1
117945,group,1,1
117946,(,1,1
117947,silodosin,1,1
117948,4,1,1
117949,mg,1,1
117950,orally,1,1
117951,twice,1,1
117952,daily,1,1
117953,for,1,1
117954,4,1,0
117955,weeks,1,0
117956,then,1,0
117957,tamsulosin,1,1
117958,0.2,1,1
117959,mg,1,1
117960,orally,1,1
117961,once,1,1
117962,daily,1,1
117963,for,1,1
117964,4,1,0
117965,weeks,1,0
117966,),1,0
117967,.,1,0
117968,The,0,0
117969,primary,0,0
117970,endpoint,0,0
117971,was,0,0
117972,the,0,0
117973,preferred,0,0
117974,drug,0,1
117975,for,0,0
117976,treatment,0,0
117977,continuation,0,0
117978,at,0,0
117979,8,0,0
117980,weeks,0,0
117981,",",0,0
117982,determined,0,0
117983,by,0,0
117984,a,0,0
117985,patient-reported,0,0
117986,questionnaire,0,0
117987,.,0,0
117988,In,0,0
117989,total,0,0
117990,",",0,0
117991,102,0,0
117992,patients,0,0
117993,(,0,0
117994,mean,0,0
117995,age,0,0
117996,70.3,0,0
117997,years,0,0
117998,),0,0
117999,were,0,0
118000,enrolled,0,0
118001,and,0,0
118002,84,0,0
118003,(,0,0
118004,n,0,0
118005,=,0,0
118006,42,0,0
118007,per,0,0
118008,group,0,0
118009,),0,0
118010,completed,0,0
118011,the,0,0
118012,study,0,0
118013,.,0,0
118014,A,0,0
118015,significant,0,0
118016,difference,0,0
118017,was,0,0
118018,observed,0,0
118019,between,0,0
118020,the,0,0
118021,proportion,0,0
118022,of,0,0
118023,patients,0,0
118024,who,0,0
118025,preferred,1,1
118026,tamsulosin,1,1
118027,(,0,0
118028,59/84,0,0
118029,patients,0,0
118030,;,0,0
118031,70.2,0,0
118032,%,0,0
118033,),0,0
118034,and,0,0
118035,those,0,0
118036,who,0,0
118037,preferred,1,1
118038,silodosin,1,1
118039,(,0,0
118040,18/84,0,0
118041,patients,0,0
118042,;,0,0
118043,21.4,0,0
118044,%,0,0
118045,),0,0
118046,.,0,0
118047,A,0,0
118048,major,0,0
118049,reason,0,0
118050,for,0,0
118051,preference,0,0
118052,of,0,0
118053,either,0,0
118054,drug,0,1
118055,was,0,0
118056,'good,0,0
118057,efficacy,0,0
118058,',0,0
118059,.,0,0
118060,Incidence,0,0
118061,of,0,0
118062,adverse,0,0
118063,effects,0,0
118064,was,0,0
118065,significantly,0,0
118066,lower,0,0
118067,with,1,0
118068,tamsulosin,1,1
118069,(,0,0
118070,3/91,0,0
118071,patients,0,0
118072,;,0,0
118073,3.3,0,0
118074,%,0,0
118075,),0,0
118076,than,0,0
118077,with,1,1
118078,silodosin,1,1
118079,(,0,0
118080,25/88,0,0
118081,patients,0,0
118082,;,0,0
118083,28.4,0,0
118084,%,0,0
118085,),0,0
118086,.,0,0
118087,These,0,0
118088,findings,0,0
118089,indicate,0,0
118090,that,1,0
118091,tamsulosin,1,1
118092,is,0,0
118093,very,0,0
118094,effective,0,0
118095,for,0,0
118096,BPH,0,0
118097,",",0,0
118098,has,0,0
118099,few,0,0
118100,adverse,0,0
118101,effects,0,0
118102,and,0,0
118103,that,0,0
118104,patients,0,0
118105,want,0,0
118106,to,0,0
118107,continue,0,0
118108,to,0,0
118109,use,0,0
118110,it,0,0
118111,.,0,0
118112,Effects,0,0
118113,of,0,0
118114,dietary,1,1
118115,pyridoxine,1,1
118116,on,0,1
118117,haemato-immunological,0,0
118118,responses,0,0
118119,of,0,0
118120,Labeo,0,1
118121,rohita,0,1
118122,fingerlings,0,0
118123,reared,0,0
118124,at,0,0
118125,higher,0,0
118126,water,0,0
118127,temperature,0,0
118128,.,0,0
118129,A,0,0
118130,sixty-day,0,0
118131,feeding,0,0
118132,trial,0,0
118133,was,0,0
118134,carried,0,0
118135,out,0,0
118136,to,0,0
118137,elucidate,0,0
118138,the,0,0
118139,effect,0,0
118140,of,0,0
118141,dietary,1,1
118142,pyridoxine,1,1
118143,(,1,1
118144,PN,1,1
118145,),1,1
118146,on,0,0
118147,hemato-immunological,0,0
118148,parameters,0,0
118149,in,0,0
118150,Labeo,0,1
118151,rohita,0,1
118152,fingerlings,0,0
118153,exposed,0,0
118154,to,0,0
118155,an,0,0
118156,elevated,0,0
118157,temperature,0,0
118158,(,0,0
118159,ET,0,1
118160,),0,0
118161,of,0,0
118162,33,0,0
118163,?C,0,0
118164,.,0,0
118165,Two,0,0
118166,hundred,0,0
118167,and,0,0
118168,seventy,0,0
118169,fingerlings,0,0
118170,(,0,0
118171,6.71,0,0
118172,?,0,0
118173,0.32,0,0
118174,g,0,0
118175,),0,0
118176,were,0,0
118177,randomly,0,0
118178,distributed,0,0
118179,into,1,0
118180,six,1,0
118181,treatments,1,0
118182,in,1,0
118183,triplicates,1,0
118184,(,1,0
118185,15,0,0
118186,fish/tank,0,1
118187,),0,0
118188,.,0,0
118189,Five,1,1
118190,iso-nitrogenous,1,1
118191,(,1,0
118192,356.3,1,0
118193,?,1,0
118194,2.7,1,0
118195,g/kg,1,0
118196,crude,1,0
118197,protein,1,0
118198,),1,0
118199,purified,1,0
118200,diets,1,1
118201,were,1,0
118202,prepared,0,0
118203,with,0,0
118204,graded,0,0
118205,levels,0,0
118206,(,0,0
118207,0,0,0
118208,",",0,0
118209,10,0,0
118210,",",0,0
118211,50,0,0
118212,",",0,0
118213,100,0,0
118214,and,0,0
118215,200,0,1
118216,mg/kg,0,1
118217,diet,0,1
118218,),0,1
118219,of,0,0
118220,PN,0,1
118221,.,0,0
118222,Six,0,1
118223,treatment,0,0
118224,groups,0,0
118225,were,0,0
118226,P10T26,0,1
118227,(,0,1
118228,10,0,1
118229,mg,0,1
118230,PN,0,1
118231,+,0,1
118232,ambient,0,0
118233,temperature,0,0
118234,(,0,0
118235,26,0,0
118236,?C,0,0
118237,),0,0
118238,",",0,0
118239,P0T33,0,1
118240,(,0,1
118241,0,0,1
118242,mg,0,1
118243,PN,0,1
118244,+,0,1
118245,ET,0,1
118246,),0,1
118247,",",0,0
118248,P10T33,0,1
118249,(,0,1
118250,10,0,1
118251,mg,0,1
118252,PN,0,1
118253,+,0,1
118254,ET,0,1
118255,),0,1
118256,",",0,0
118257,P50T33,0,1
118258,(,0,1
118259,50,0,1
118260,mg,0,1
118261,PN,0,1
118262,+,0,1
118263,ET,0,1
118264,),0,1
118265,",",0,0
118266,P100T33,0,1
118267,(,0,1
118268,100,0,1
118269,mg,0,1
118270,PN,0,1
118271,+,0,1
118272,ET,0,1
118273,),0,1
118274,and,0,0
118275,P200T33,0,1
118276,(,0,1
118277,200,0,1
118278,mg,0,1
118279,PN,0,1
118280,+,0,1
118281,ET,0,1
118282,),0,1
118283,.,0,0
118284,The,0,0
118285,responses,0,0
118286,of,0,0
118287,L.,0,0
118288,rohita,0,0
118289,fingerlings,0,1
118290,to,0,0
118291,dietary,0,1
118292,PN,0,1
118293,were,0,0
118294,assessed,0,0
118295,in,0,0
118296,terms,0,0
118297,of,0,0
118298,growth,0,0
118299,and,0,0
118300,by,0,0
118301,analysing,0,0
118302,some,0,0
118303,hemato-immunological,0,0
118304,parameters,0,0
118305,.,0,0
118306,When,0,0
118307,PN,1,1
118308,supplementation,1,1
118309,increased,1,0
118310,from,0,0
118311,10,0,0
118312,to,0,0
118313,200,0,1
118314,mg/kg,0,1
118315,diet,0,1
118316,",",0,1
118317,a,0,0
118318,significant,0,0
118319,improvement,0,0
118320,in,0,0
118321,weight,0,0
118322,gain,0,0
118323,percentage,0,0
118324,was,0,0
118325,observed,0,0
118326,.,0,0
118327,Erythrocyte,0,0
118328,(,0,0
118329,RBC,0,1
118330,),0,1
118331,count,0,1
118332,",",0,1
118333,leucocyte,0,1
118334,(,0,1
118335,WBC,0,1
118336,),0,1
118337,count,0,1
118338,",",0,1
118339,haemoglobin,0,1
118340,content,0,0
118341,and,0,0
118342,respiratory,0,0
118343,burst,0,0
118344,activity,0,0
118345,were,0,0
118346,significantly,0,0
118347,(,0,0
118348,p,0,0
118349,<,0,0
118350,0.05,0,0
118351,),0,0
118352,higher,0,0
118353,in,0,0
118354,100,0,1
118355,mg,1,1
118356,PN/kg,1,1
118357,diet-fed,1,1
118358,group,1,1
118359,than,0,0
118360,their,1,0
118361,non-PN-fed,1,0
118362,counterpart,1,0
118363,.,0,0
118364,Also,0,0
118365,",",0,1
118366,serum,0,1
118367,albumin,0,1
118368,",",0,1
118369,globulin,0,1
118370,and,0,1
118371,lysozyme,0,0
118372,activity,0,0
118373,were,0,0
118374,found,0,0
118375,significantly,0,0
118376,(,0,0
118377,p,0,0
118378,<,0,0
118379,0.05,0,0
118380,),0,0
118381,higher,0,0
118382,in,0,0
118383,PN-fed,0,0
118384,groups,0,0
118385,.,0,0
118386,The,0,0
118387,overall,0,0
118388,results,0,0
118389,indicated,0,0
118390,that,0,0
118391,dietary,1,1
118392,PN,1,1
118393,supplementation,1,1
118394,at,1,1
118395,100,0,1
118396,mg/kg,0,1
118397,diet,0,1
118398,may,0,0
118399,reverse,0,0
118400,the,0,0
118401,negative,0,0
118402,effects,0,0
118403,caused,0,0
118404,by,0,0
118405,ET,0,0
118406,and,0,0
118407,may,0,0
118408,protect,0,0
118409,the,0,0
118410,haemato-immunological,0,0
118411,status,0,0
118412,of,0,0
118413,L.,0,0
118414,rohita,0,0
118415,fingerlings,0,0
118416,reared,0,0
118417,at,0,0
118418,higher,0,0
118419,water,0,0
118420,temperature,0,0
118421,.,0,0
118422,Pharmacodynamic,0,1
118423,effects,0,1
118424,on,0,0
118425,biochemical,0,0
118426,markers,0,0
118427,of,0,0
118428,bone,0,0
118429,turnover,0,0
118430,and,0,0
118431,pharmacokinetics,0,1
118432,of,0,0
118433,the,0,0
118434,cathepsin,1,1
118435,K,1,1
118436,inhibitor,1,1
118437,",",1,0
118438,ONO-5334,1,1
118439,",",0,0
118440,in,0,0
118441,an,0,0
118442,ascending,0,1
118443,multiple-dose,0,1
118444,",",0,1
118445,phase,0,0
118446,1,0,0
118447,study,0,0
118448,.,0,0
118449,Selective,0,0
118450,inhibitors,0,1
118451,of,0,1
118452,cathepsin,0,1
118453,K,0,1
118454,",",0,0
118455,which,0,0
118456,has,0,0
118457,a,0,0
118458,major,0,0
118459,role,0,0
118460,in,0,0
118461,the,0,0
118462,degradation,0,0
118463,of,0,0
118464,bone,0,0
118465,collagen,0,0
118466,",",0,0
118467,are,0,0
118468,potential,0,0
118469,new,0,0
118470,treatments,0,0
118471,for,0,0
118472,osteoporosis,0,0
118473,.,0,0
118474,The,0,0
118475,pharmacokinetics,0,1
118476,and,0,0
118477,the,0,0
118478,pharmacodynamic,0,1
118479,effects,0,0
118480,on,0,0
118481,biochemical,0,0
118482,markers,0,0
118483,of,0,0
118484,bone,0,0
118485,turnover,0,0
118486,of,0,0
118487,the,0,0
118488,new,0,0
118489,cathepsin,1,1
118490,K,1,1
118491,inhibitor,1,1
118492,",",1,0
118493,ONO-5334,1,0
118494,",",0,0
118495,were,0,0
118496,investigated,0,0
118497,in,0,0
118498,a,0,0
118499,multiple,0,0
118500,ascending,0,1
118501,dose,0,1
118502,",",0,1
118503,phase,0,0
118504,1,0,0
118505,study,0,0
118506,.,0,0
118507,A,0,0
118508,total,0,0
118509,of,0,0
118510,120,0,0
118511,healthy,0,0
118512,postmenopausal,0,0
118513,women,0,0
118514,were,0,0
118515,enrolled,0,0
118516,",",0,0
118517,and,0,0
118518,doses,1,1
118519,of,1,0
118520,10,1,0
118521,to,1,0
118522,600,1,1
118523,mg,1,1
118524,once,1,1
118525,daily,1,1
118526,and,1,1
118527,50,1,0
118528,and,1,0
118529,300,1,1
118530,mg,1,1
118531,twice,1,1
118532,daily,1,1
118533,were,1,0
118534,evaluated,1,0
118535,in,1,0
118536,15-,1,0
118537,and,1,0
118538,28-day,1,1
118539,multiple-dosing,1,1
118540,cohorts,1,1
118541,.,1,1
118542,Plasma,0,1
118543,ONO-5334,0,1
118544,concentration,0,0
118545,reached,0,0
118546,steady,0,0
118547,state,0,0
118548,within,0,0
118549,2,0,0
118550,days,0,0
118551,.,0,0
118552,Twenty-four,0,0
118553,hours,0,0
118554,after,0,0
118555,the,0,0
118556,last,0,0
118557,dose,0,1
118558,in,0,0
118559,the,0,1
118560,15-day,0,1
118561,multiple-dose,0,1
118562,cohort,0,1
118563,",",0,0
118564,100,0,0
118565,",",0,0
118566,300,0,0
118567,",",0,0
118568,and,0,0
118569,600,0,1
118570,mg,0,1
118571,once,0,1
118572,daily,0,1
118573,reduced,0,1
118574,urinary,0,1
118575,C-terminal,0,0
118576,telopeptide,0,1
118577,of,0,0
118578,type,0,0
118579,I,0,0
118580,collagen,0,0
118581,by,0,0
118582,a,0,0
118583,mean,0,0
118584,(,0,0
118585,?,0,0
118586,standard,0,1
118587,deviation,0,0
118588,),0,0
118589,44.9,0,0
118590,%,0,0
118591,?,0,0
118592,13.6,0,0
118593,%,0,0
118594,",",0,0
118595,84.5,0,0
118596,%,0,0
118597,?,0,0
118598,4.4,0,0
118599,%,0,0
118600,",",0,0
118601,and,0,0
118602,92.5,0,0
118603,%,0,0
118604,?,0,0
118605,1.3,0,0
118606,%,0,0
118607,",",0,0
118608,respectively,0,0
118609,.,0,0
118610,The,0,0
118611,28-day,0,1
118612,cohort,0,0
118613,showed,0,0
118614,similar,0,0
118615,effects,0,0
118616,.,0,0
118617,There,0,0
118618,were,0,0
118619,far,0,0
118620,smaller,0,0
118621,effects,0,0
118622,on,0,0
118623,bone-specific,0,0
118624,alkaline,0,0
118625,phosphatase,0,1
118626,(,0,1
118627,B-ALP,0,1
118628,),0,1
118629,",",0,1
118630,tartrate-resistant,0,1
118631,acid,0,1
118632,phosphatase,0,1
118633,5b,0,1
118634,(,0,1
118635,TRAP5b,0,1
118636,),0,1
118637,",",0,0
118638,or,0,1
118639,osteocalcin,0,1
118640,(,0,1
118641,OC,0,1
118642,),0,1
118643,(,0,0
118644,measured,0,0
118645,after,0,0
118646,28,0,0
118647,days,0,0
118648,),1,0
118649,.,1,0
118650,ONO-5334,1,0
118651,was,1,0
118652,well,0,0
118653,tolerated,0,0
118654,up,0,0
118655,to,0,0
118656,600,0,0
118657,mg/d,0,1
118658,and,0,0
118659,for,0,0
118660,up,0,0
118661,to,0,0
118662,28,0,0
118663,days,0,0
118664,of,0,0
118665,multiple,0,0
118666,dosing,0,1
118667,.,0,1
118668,Multiple,0,0
118669,dosing,0,1
118670,with,0,1
118671,ONO-5334,1,1
118672,100,1,1
118673,mg,0,1
118674,resulted,0,0
118675,in,0,0
118676,considerable,0,0
118677,suppression,0,0
118678,of,0,0
118679,bone,0,0
118680,resorption,0,0
118681,markers,0,0
118682,with,0,0
118683,no,0,0
118684,appreciable,0,0
118685,effects,0,0
118686,on,0,0
118687,bone,0,0
118688,formation,0,0
118689,markers,0,0
118690,(,0,0
118691,B-ALP,0,1
118692,",",0,1
118693,OC,0,1
118694,),0,1
118695,or,0,0
118696,osteoclast,0,1
118697,number,0,1
118698,(,0,1
118699,TRAP5b,0,1
118700,),0,1
118701,.,0,0
118702,Beverage,1,0
118703,vs.,1,0
118704,solid,1,0
118705,fruits,1,0
118706,and,1,1
118707,vegetables,1,1
118708,:,1,0
118709,effects,0,0
118710,on,0,0
118711,energy,0,0
118712,intake,0,1
118713,and,0,1
118714,body,0,1
118715,weight,0,0
118716,.,0,0
118717,Beverage,0,0
118718,consumption,0,0
118719,has,0,0
118720,been,0,0
118721,implicated,0,0
118722,in,0,0
118723,weight,0,0
118724,gain,0,0
118725,",",0,0
118726,but,0,0
118727,questions,0,0
118728,remain,0,0
118729,about,0,0
118730,the,0,0
118731,veracity,0,0
118732,of,0,0
118733,the,0,0
118734,association,0,0
118735,",",0,0
118736,whether,0,0
118737,the,0,0
118738,relationship,0,0
118739,is,0,0
118740,causal,0,0
118741,and,0,0
118742,what,0,0
118743,property,0,0
118744,of,0,0
118745,beverages,0,1
118746,is,0,0
118747,responsible,0,0
118748,.,0,0
118749,It,0,0
118750,was,0,0
118751,hypothesized,0,0
118752,that,0,0
118753,food,0,0
118754,form,0,0
118755,is,0,0
118756,the,0,0
118757,most,0,0
118758,salient,0,0
118759,attribute,0,0
118760,.,0,0
118761,Thus,0,0
118762,",",0,0
118763,a,0,0
118764,randomized,0,0
118765,controlled,0,0
118766,trial,0,0
118767,of,0,0
118768,food,0,0
118769,form,0,0
118770,was,0,0
118771,conducted,0,0
118772,.,0,0
118773,Energy-matched,1,0
118774,beverage,1,1
118775,or,1,0
118776,solid,1,0
118777,forms,1,0
118778,of,1,0
118779,fruits,1,1
118780,and,1,1
118781,vegetables,1,1
118782,were,0,0
118783,provided,0,0
118784,to,0,0
118785,34,0,0
118786,",",0,0
118787,lean,0,0
118788,or,0,0
118789,overweight/obese,0,0
118790,adults,0,0
118791,for,0,0
118792,two,0,0
118793,8-week,0,0
118794,periods,0,0
118795,with,0,0
118796,a,0,0
118797,3-week,0,1
118798,washout,0,1
118799,interspersed,0,1
118800,.,0,0
118801,Dietary,0,0
118802,compensation,0,0
118803,was,0,0
118804,incomplete,0,0
118805,(,0,0
118806,beverage,0,0
118807,53,0,0
118808,%,0,0
118809,;,0,0
118810,solid,0,0
118811,78,0,0
118812,%,0,0
118813,),0,0
118814,and,0,0
118815,body,0,0
118816,weight,0,0
118817,increased,0,0
118818,after,0,0
118819,the,0,0
118820,beverage,0,1
118821,(,0,0
118822,1.95,0,0
118823,?,0,0
118824,0.33,0,0
118825,kg,0,0
118826,),0,0
118827,(,0,0
118828,77,0,0
118829,%,0,0
118830,fat,0,0
118831,mass,0,0
118832,),0,0
118833,and,0,0
118834,solid,0,0
118835,(,0,0
118836,1.36,0,0
118837,?,0,0
118838,0.30,0,0
118839,kg,0,0
118840,),0,0
118841,(,0,0
118842,85,0,0
118843,%,0,0
118844,fat,0,0
118845,mass,0,0
118846,),0,1
118847,treatments,0,1
118848,(,0,0
118849,both,0,0
118850,P,0,0
118851,<,0,0
118852,0.0005,0,0
118853,),0,0
118854,.,0,0
118855,Differences,0,0
118856,between,0,0
118857,food,0,0
118858,forms,0,0
118859,were,0,0
118860,not,0,0
118861,significant,0,0
118862,.,0,0
118863,The,0,0
118864,lean,0,0
118865,group,0,0
118866,had,0,0
118867,the,0,0
118868,highest,0,0
118869,dietary,0,1
118870,compensation,0,0
118871,(,0,0
118872,119,0,0
118873,%,0,0
118874,),0,0
118875,and,0,0
118876,no,0,0
118877,significant,0,0
118878,weight,0,0
118879,change,0,0
118880,(,0,0
118881,0.84,0,0
118882,?,0,0
118883,0.53,0,0
118884,kg,0,0
118885,),0,0
118886,after,0,0
118887,consuming,0,0
118888,the,0,0
118889,solid,0,0
118890,fruits,0,1
118891,and,0,1
118892,vegetables,0,1
118893,whereas,0,0
118894,the,0,0
118895,overweight/obese,0,0
118896,group,0,0
118897,had,0,0
118898,lower,0,0
118899,compensation,0,0
118900,and,0,0
118901,significant,0,0
118902,weight,0,0
118903,gain,0,0
118904,during,0,0
118905,the,0,0
118906,solid,0,0
118907,arm,0,0
118908,(,0,0
118909,46,0,0
118910,%,0,0
118911,",",0,0
118912,1.77,0,0
118913,?,0,0
118914,0.32,0,0
118915,kg,0,0
118916,",",0,0
118917,P,0,0
118918,<,0,0
118919,0.0001,0,0
118920,),0,0
118921,.,0,0
118922,In,0,0
118923,contrast,0,0
118924,",",0,0
118925,incomplete,0,0
118926,dietary,0,1
118927,compensation,0,0
118928,and,0,0
118929,weight,0,0
118930,gain,0,0
118931,occurred,0,0
118932,in,0,0
118933,both,0,0
118934,the,0,0
118935,lean,0,0
118936,(,0,0
118937,43,0,0
118938,%,0,0
118939,",",0,0
118940,1.61,0,0
118941,?,0,0
118942,0.44,0,0
118943,kg,0,0
118944,",",0,0
118945,P,0,0
118946,=,0,0
118947,0.003,0,0
118948,),0,0
118949,and,0,0
118950,overweight/obese,0,0
118951,(,0,0
118952,61,0,0
118953,%,0,0
118954,",",0,0
118955,2.22,0,0
118956,?,0,0
118957,0.47,0,0
118958,kg,0,0
118959,",",0,0
118960,P,0,0
118961,<,0,0
118962,0.0005,0,0
118963,),0,0
118964,groups,0,0
118965,during,0,0
118966,the,0,0
118967,beverage,0,1
118968,arm,0,1
118969,.,0,0
118970,Secondary,0,0
118971,analyses,0,0
118972,revealed,0,0
118973,the,0,0
118974,obese,0,0
118975,group,0,0
118976,gained,0,0
118977,more,0,0
118978,weight,0,0
118979,than,0,0
118980,the,0,0
118981,lean,0,0
118982,and,0,0
118983,overweight,0,0
118984,groups,0,0
118985,during,0,0
118986,the,0,0
118987,beverage,0,1
118988,intervention,0,0
118989,(,0,0
118990,P,0,0
118991,=,0,0
118992,0.024,0,0
118993,),0,0
118994,.,0,0
118995,These,0,0
118996,data,0,0
118997,demonstrate,0,0
118998,energy,0,0
118999,consumed,0,1
119000,as,0,1
119001,beverages,0,1
119002,may,0,0
119003,be,0,0
119004,especially,0,0
119005,problematic,0,0
119006,for,0,0
119007,weight,0,0
119008,gain,0,0
119009,.,0,0
119010,They,0,0
119011,also,0,0
119012,indicate,0,0
119013,that,0,0
119014,advice,0,0
119015,to,0,0
119016,increase,0,0
119017,fruit,0,0
119018,and,0,1
119019,vegetable,0,1
119020,consumption,0,1
119021,should,0,0
119022,emphasize,0,0
119023,total,0,0
119024,energy,0,0
119025,intake,0,1
119026,because,0,0
119027,the,0,0
119028,additional,0,0
119029,energy,0,0
119030,contributed,0,0
119031,may,0,0
119032,promote,0,0
119033,weight,0,0
119034,gain,0,0
119035,",",0,0
119036,especially,0,0
119037,among,0,0
119038,overweight,0,0
119039,and,0,0
119040,obese,0,0
119041,individuals,0,0
119042,.,0,0
119043,The,0,0
119044,IDvIP,0,0
119045,trial,0,0
119046,:,0,0
119047,a,0,0
119048,two-centre,0,0
119049,randomised,0,1
119050,double-blind,0,1
119051,controlled,0,0
119052,trial,0,1
119053,comparing,0,0
119054,intramuscular,0,1
119055,diamorphine,1,1
119056,and,0,1
119057,intramuscular,0,1
119058,pethidine,1,1
119059,for,0,1
119060,labour,0,1
119061,analgesia,0,1
119062,.,0,1
119063,BACKGROUND,0,1
119064,Intramuscular,0,1
119065,pethidine,1,1
119066,is,0,0
119067,routinely,0,0
119068,used,0,0
119069,throughout,0,0
119070,the,0,0
119071,UK,0,0
119072,for,0,0
119073,labour,0,1
119074,analgesia,0,1
119075,.,0,1
119076,Studies,0,0
119077,have,0,0
119078,suggested,0,0
119079,that,0,0
119080,pethidine,1,1
119081,provides,0,0
119082,little,0,0
119083,pain,0,0
119084,relief,0,0
119085,in,0,0
119086,labour,0,0
119087,and,0,0
119088,has,0,0
119089,a,0,0
119090,number,0,0
119091,of,0,0
119092,side,0,0
119093,effects,0,0
119094,affecting,0,0
119095,mother,0,0
119096,and,0,0
119097,neonate,0,0
119098,.,0,0
119099,It,0,0
119100,can,0,0
119101,cause,0,0
119102,nausea,0,1
119103,",",0,1
119104,vomiting,0,1
119105,and,0,0
119106,dysphoria,0,0
119107,in,0,0
119108,mothers,0,0
119109,and,0,0
119110,can,0,0
119111,cause,0,0
119112,reduced,0,0
119113,fetal,0,0
119114,heart,0,0
119115,rate,0,0
119116,variability,0,0
119117,and,0,0
119118,accelerations,0,0
119119,.,0,0
119120,Neonatal,0,0
119121,effects,0,0
119122,include,0,0
119123,respiratory,0,0
119124,depression,0,0
119125,and,0,0
119126,impaired,0,0
119127,feeding,0,0
119128,.,0,0
119129,There,0,0
119130,are,0,0
119131,few,0,0
119132,large,0,0
119133,studies,0,0
119134,comparing,0,0
119135,the,0,0
119136,relative,0,0
119137,side,0,0
119138,effects,0,0
119139,and,0,0
119140,efficacy,0,0
119141,of,0,0
119142,different,0,0
119143,opioids,0,1
119144,in,0,0
119145,labour,0,0
119146,.,0,0
119147,A,0,0
119148,small,0,0
119149,trial,0,0
119150,comparing,0,0
119151,intramuscular,0,1
119152,pethidine,1,1
119153,with,0,1
119154,diamorphine,1,1
119155,",",0,1
119156,showed,0,0
119157,diamorphine,1,1
119158,to,0,0
119159,have,0,0
119160,some,0,0
119161,benefits,0,0
119162,over,0,0
119163,pethidine,1,1
119164,when,0,0
119165,used,0,0
119166,for,0,0
119167,labour,0,0
119168,analgesia,0,1
119169,but,0,0
119170,the,0,0
119171,study,0,0
119172,did,0,0
119173,not,0,0
119174,investigate,0,0
119175,the,0,0
119176,adverse,0,0
119177,effects,0,0
119178,of,0,0
119179,either,0,0
119180,opioid,0,1
119181,.,0,0
119182,METHODS,0,1
119183,The,0,0
119184,Intramuscular,0,1
119185,Diamorphine,1,1
119186,versus,0,1
119187,Intramuscular,0,1
119188,Pethidine,1,1
119189,(,0,1
119190,IDvIP,0,1
119191,),0,1
119192,trial,0,0
119193,is,0,0
119194,a,0,0
119195,randomised,0,0
119196,double-blind,0,1
119197,two,0,0
119198,centre,0,0
119199,controlled,0,0
119200,trial,0,0
119201,comparing,0,0
119202,intramuscular,0,1
119203,diamorphine,1,1
119204,and,0,1
119205,pethidine,1,1
119206,regarding,0,0
119207,their,0,0
119208,analgesic,0,1
119209,efficacy,0,1
119210,in,0,0
119211,labour,0,0
119212,and,0,0
119213,their,0,0
119214,side,0,0
119215,effects,0,0
119216,in,0,0
119217,mother,0,0
119218,",",0,0
119219,fetus,0,0
119220,and,0,0
119221,neonate,0,0
119222,.,0,0
119223,Information,0,0
119224,about,0,0
119225,the,0,0
119226,trial,0,0
119227,will,0,0
119228,be,0,0
119229,provided,0,0
119230,to,0,0
119231,women,0,0
119232,in,0,0
119233,the,0,0
119234,antenatal,0,0
119235,period,0,0
119236,or,0,0
119237,in,0,0
119238,early,0,0
119239,labour,0,0
119240,.,0,0
119241,Consent,0,0
119242,and,0,0
119243,recruitment,0,0
119244,to,0,0
119245,the,0,0
119246,trial,0,0
119247,will,0,0
119248,be,0,0
119249,obtained,0,0
119250,when,0,0
119251,the,0,0
119252,mother,0,0
119253,requests,0,1
119254,opioid,0,1
119255,analgesia,0,1
119256,.,0,1
119257,The,0,0
119258,sample,0,0
119259,size,0,0
119260,requirement,0,0
119261,is,0,0
119262,406,0,0
119263,women,0,0
119264,with,0,0
119265,data,0,0
119266,on,0,0
119267,primary,0,0
119268,outcomes,0,0
119269,.,0,0
119270,The,0,0
119271,maternal,0,0
119272,primary,0,0
119273,outcomes,0,0
119274,are,0,0
119275,pain,0,0
119276,relief,0,0
119277,during,0,0
119278,the,0,0
119279,first,0,0
119280,3,0,0
119281,hours,0,0
119282,after,0,0
119283,trial,0,1
119284,analgesia,0,1
119285,and,0,0
119286,specifically,0,0
119287,pain,0,0
119288,relief,0,0
119289,after,0,0
119290,60,0,0
119291,minutes,0,0
119292,.,0,0
119293,The,0,0
119294,neonatal,0,0
119295,primary,0,0
119296,outcomes,0,0
119297,are,0,0
119298,need,0,0
119299,for,0,0
119300,resuscitation,0,0
119301,and,0,0
119302,Apgar,0,0
119303,Score,0,0
119304,<,0,0
119305,7,0,0
119306,at,0,0
119307,1,0,0
119308,minute,0,0
119309,.,0,0
119310,The,0,0
119311,secondary,0,0
119312,outcomes,0,0
119313,are,0,0
119314,an,0,0
119315,additional,0,0
119316,measure,0,0
119317,of,0,0
119318,pain,0,0
119319,relief,0,0
119320,",",0,0
119321,maternal,0,0
119322,sedation,0,1
119323,",",0,0
119324,nausea,0,1
119325,and,0,1
119326,vomiting,0,1
119327,",",0,0
119328,maternal,0,0
119329,oxygen,0,0
119330,saturation,0,0
119331,",",0,0
119332,satisfaction,0,0
119333,with,0,1
119334,analgesia,0,1
119335,",",0,0
119336,whether,0,0
119337,method,0,0
119338,of,0,0
119339,analgesia,0,1
119340,would,0,0
119341,be,0,0
119342,used,0,0
119343,again,0,0
119344,",",0,0
119345,use,0,0
119346,of,0,0
119347,Entonox,0,1
119348,",",0,1
119349,umbilical,0,1
119350,arterial,0,0
119351,and,0,0
119352,venous,0,0
119353,pH,0,1
119354,",",0,0
119355,fetal,0,0
119356,heart,0,0
119357,rate,0,0
119358,",",0,0
119359,meconium,0,0
119360,staining,0,0
119361,",",0,0
119362,time,0,0
119363,from,0,0
119364,delivery,0,0
119365,to,0,0
119366,first,0,0
119367,breath,0,0
119368,",",0,0
119369,Apgar,0,0
119370,scores,0,1
119371,at,0,0
119372,5,0,0
119373,mins,0,0
119374,",",0,0
119375,naloxone,0,1
119376,requirement,0,0
119377,",",0,0
119378,transfer,0,0
119379,to,0,0
119380,neonatal,0,0
119381,intensive,0,0
119382,care,0,0
119383,unit,0,0
119384,",",0,0
119385,neonatal,0,1
119386,haemoglobin,0,1
119387,oxygen,0,0
119388,saturation,0,0
119389,at,0,0
119390,30,0,0
119391,",",0,0
119392,60,0,0
119393,",",0,0
119394,90,0,0
119395,",",0,0
119396,and,0,0
119397,120,0,0
119398,mins,0,0
119399,after,0,0
119400,delivery,0,0
119401,",",0,0
119402,and,0,0
119403,neonatal,0,0
119404,sedation,0,0
119405,and,0,0
119406,feeding,0,0
119407,behaviour,0,0
119408,during,0,0
119409,first,0,0
119410,2,0,0
119411,hours,0,0
119412,.,0,0
119413,DISCUSSION,0,1
119414,If,0,0
119415,the,0,0
119416,trial,0,0
119417,demonstrates,0,0
119418,that,0,0
119419,diamorphine,1,1
119420,provides,0,0
119421,better,0,0
119422,analgesia,0,1
119423,with,0,0
119424,fewer,0,0
119425,side,0,0
119426,effects,0,0
119427,in,0,0
119428,mother,0,0
119429,and,0,0
119430,neonate,0,0
119431,this,0,0
119432,could,0,0
119433,lead,0,0
119434,to,0,0
119435,a,0,0
119436,change,0,0
119437,in,0,0
119438,national,0,0
119439,practice,0,0
119440,and,0,0
119441,result,0,0
119442,in,0,0
119443,diamorphine,1,1
119444,becoming,0,0
119445,the,0,0
119446,preferred,0,0
119447,intramuscular,0,1
119448,opioid,1,1
119449,for,0,1
119450,analgesia,0,1
119451,in,0,0
119452,labour,0,0
119453,.,0,0
119454,TRIAL,0,0
119455,REGISTRATION,0,1
119456,ISRCTN14898678Eudra,0,1
119457,No,0,1
119458,:,0,1
119459,2006-003250-18,0,0
119460,",",0,0
119461,REC,0,1
119462,Reference,0,1
119463,No,0,1
119464,:,0,0
119465,06/Q1702/95,0,0
119466,",",0,0
119467,MHRA,0,1
119468,Authorisation,0,1
119469,No,0,1
119470,:,0,0
119471,1443/0001/001-0001,0,0
119472,",",0,0
119473,NIHR,0,0
119474,UKCRN,0,0
119475,reference,0,0
119476,6895,0,0
119477,",",0,0
119478,RfPB,0,0
119479,grant,0,0
119480,PB-PG-0407-13170_IR5,0,0
119481,.,0,0
119482,Influence,0,0
119483,of,0,0
119484,chestnut,0,1
119485,tannins,0,1
119486,on,0,0
119487,welfare,0,0
119488,",",0,0
119489,carcass,0,0
119490,characteristics,0,0
119491,",",0,0
119492,meat,0,0
119493,quality,0,0
119494,",",0,0
119495,and,0,0
119496,lipid,0,0
119497,oxidation,0,0
119498,in,0,0
119499,rabbits,0,0
119500,under,0,0
119501,high,0,0
119502,ambient,0,0
119503,temperature,0,0
119504,.,0,0
119505,A,0,0
119506,study,0,0
119507,was,0,0
119508,conducted,0,0
119509,to,0,0
119510,evaluate,0,0
119511,the,0,0
119512,influence,0,0
119513,of,0,0
119514,chestnut,1,1
119515,tannins,1,1
119516,(,0,1
119517,CT,0,1
119518,),0,0
119519,on,0,0
119520,welfare,0,0
119521,",",0,0
119522,carcass,0,0
119523,characteristics,0,0
119524,",",0,0
119525,meat,0,0
119526,quality,0,0
119527,",",0,0
119528,and,0,0
119529,lipid,0,0
119530,oxidation,0,0
119531,in,0,0
119532,rabbits,0,0
119533,under,0,0
119534,high,0,0
119535,ambient,0,0
119536,temperature,0,0
119537,.,0,0
119538,Rabbits,1,0
119539,in,0,0
119540,one,0,0
119541,group,0,0
119542,were,0,0
119543,raised,1,0
119544,at,1,0
119545,20?C,1,0
119546,and,1,0
119547,fed,1,0
119548,with,1,0
119549,basal,1,0
119550,diet,1,1
119551,(,1,1
119552,N,1,1
119553,),1,1
119554,and,1,0
119555,other,1,0
119556,three,1,0
119557,groups,1,0
119558,(,1,0
119559,33?C,1,1
119560,),1,1
119561,were,1,0
119562,fed,1,0
119563,basal,1,0
119564,diet,1,1
119565,with,1,1
119566,0,1,0
119567,(,1,0
119568,C,1,1
119569,),1,1
119570,",",1,0
119571,5,1,1
119572,(,1,1
119573,CT5,1,1
119574,),1,1
119575,",",1,0
119576,and,1,1
119577,10,1,1
119578,g,1,0
119579,(,1,1
119580,CT10,1,1
119581,),1,1
119582,of,1,0
119583,CT/kg,1,1
119584,of,1,1
119585,diet,1,1
119586,.,1,0
119587,Compared,0,0
119588,with,0,0
119589,the,0,0
119590,C,0,0
119591,group,0,0
119592,",",0,0
119593,rabbits,0,0
119594,in,0,0
119595,CT10,0,0
119596,had,0,0
119597,higher,0,0
119598,pH,0,1
119599,(,0,1
119600,24,0,0
119601,),0,0
119602,and,0,0
119603,lower,0,0
119604,cooking,0,0
119605,loss,0,0
119606,and,0,0
119607,thiobarbituric,0,1
119608,acid,0,1
119609,reacting,0,0
119610,substance,0,0
119611,values,0,0
119612,at,0,0
119613,0,0,0
119614,",",0,0
119615,30,0,0
119616,",",0,0
119617,and,0,0
119618,60,0,0
119619,min,0,0
119620,of,0,0
119621,forced,0,0
119622,oxidation,0,0
119623,.,0,0
119624,Rabbits,0,0
119625,in,0,0
119626,C,0,0
119627,group,0,0
119628,had,0,0
119629,higher,0,0
119630,cortisol,0,1
119631,levels,0,1
119632,",",0,1
119633,creatine,0,1
119634,kinase,0,1
119635,activities,0,0
119636,",",0,0
119637,white,0,0
119638,blood,0,0
119639,cell,0,0
119640,counts,0,0
119641,",",0,0
119642,neutrophil,0,1
119643,percentage,0,0
119644,",",0,0
119645,neutrophil,0,1
119646,:,0,1
119647,lymphocyte,0,0
119648,ratio,0,0
119649,and,0,0
119650,lower,0,0
119651,T,0,1
119652,(,0,1
119653,3,0,1
119654,),0,0
119655,",",0,1
119656,T,0,1
119657,(,0,1
119658,4,0,1
119659,),0,0
119660,levels,0,0
119661,",",0,0
119662,lymphocyte,0,0
119663,percentage,0,0
119664,than,0,0
119665,N,0,0
119666,and,0,0
119667,CT10,0,1
119668,groups,0,0
119669,.,0,0
119670,Supplementation,0,0
119671,of,0,0
119672,CT,0,0
119673,seemed,0,0
119674,to,0,0
119675,have,0,0
119676,a,0,0
119677,positive,0,0
119678,effect,0,0
119679,on,0,0
119680,growth,0,0
119681,performance,0,0
119682,",",0,0
119683,welfare,0,0
119684,",",0,0
119685,and,0,0
119686,meat,0,0
119687,quality,0,0
119688,of,0,0
119689,rabbits,0,0
119690,under,0,0
119691,high,0,0
119692,ambient,0,0
119693,temperature,0,0
119694,.,0,0
119695,A,0,1
119696,high,0,0
119697,intake,0,1
119698,of,0,0
119699,trans,1,1
119700,fatty,1,1
119701,acids,1,1
119702,has,0,0
119703,little,0,0
119704,effect,0,0
119705,on,0,0
119706,markers,0,0
119707,of,0,0
119708,inflammation,0,0
119709,and,0,0
119710,oxidative,0,0
119711,stress,0,0
119712,in,0,0
119713,humans,0,0
119714,.,0,0
119715,Consumption,1,0
119716,of,1,0
119717,industrial,1,0
119718,trans,1,0
119719,fatty,1,1
119720,acids,1,1
119721,(,1,1
119722,iTFA,1,1
119723,),1,1
119724,increases,0,0
119725,LDL,0,1
119726,cholesterol,0,1
119727,",",0,0
119728,decreases,0,0
119729,HDL,0,1
119730,cholesterol,0,1
119731,",",0,0
119732,and,0,0
119733,is,0,0
119734,strongly,0,0
119735,associated,0,0
119736,with,0,0
119737,a,0,0
119738,higher,0,0
119739,risk,0,0
119740,of,0,0
119741,cardiovascular,0,1
119742,disease,0,1
119743,(,0,1
119744,CVD,0,1
119745,),0,1
119746,.,0,0
119747,However,0,0
119748,",",0,0
119749,changes,0,0
119750,in,0,0
119751,circulating,0,0
119752,cholesterol,0,1
119753,can,0,0
119754,not,0,0
119755,explain,0,0
119756,the,0,0
119757,entire,0,0
119758,effect,0,0
119759,.,0,0
119760,Therefore,0,0
119761,",",0,0
119762,we,0,0
119763,studied,0,0
119764,whether,0,0
119765,iTFA,1,0
119766,and,0,1
119767,conjugated,1,1
119768,linoleic,1,1
119769,acid,1,1
119770,(,1,1
119771,CLA,1,1
119772,),1,0
119773,affect,0,0
119774,markers,0,0
119775,of,0,0
119776,inflammation,0,0
119777,and,0,0
119778,oxidative,0,0
119779,stress,0,0
119780,.,0,0
119781,Sixty-one,0,0
119782,healthy,0,0
119783,adults,0,0
119784,consumed,0,1
119785,each,0,0
119786,of,0,0
119787,3,0,0
119788,diets,1,1
119789,for,0,1
119790,3,0,1
119791,wk,0,0
119792,",",0,0
119793,in,0,0
119794,random,0,0
119795,order,0,0
119796,.,0,0
119797,Diets,0,0
119798,were,0,0
119799,identical,0,0
119800,except,0,0
119801,for,0,0
119802,7,0,0
119803,%,0,0
119804,of,0,0
119805,energy,0,0
119806,provided,0,0
119807,by,0,0
119808,oleic,1,1
119809,acid,1,1
119810,(,1,1
119811,control,1,1
119812,diet,1,1
119813,),1,1
119814,",",1,0
119815,iTFA,1,1
119816,",",1,0
119817,or,1,0
119818,CLA,1,0
119819,.,1,0
119820,At,0,0
119821,the,0,0
119822,end,0,0
119823,of,0,0
119824,the,0,0
119825,3,0,0
119826,wk,0,0
119827,",",0,0
119828,we,0,0
119829,measured,0,0
119830,plasma,0,1
119831,inflammatory,0,0
119832,markers,0,0
119833,IL-6,0,0
119834,",",0,0
119835,C-reactive,0,0
119836,protein,0,0
119837,",",0,0
119838,tumor,0,0
119839,necrosis,0,0
119840,factor,0,0
119841,receptors,0,0
119842,I,0,0
119843,and,0,0
119844,II,0,1
119845,(,0,1
119846,TNF-RI,0,0
119847,and,0,1
119848,-RII,0,1
119849,),0,1
119850,",",0,1
119851,monocyte,0,1
119852,chemotactic,0,1
119853,protein-1,0,1
119854,and,0,1
119855,E-selectin,0,1
119856,",",0,0
119857,and,0,0
119858,urinary,0,1
119859,8-iso-PGF,0,1
119860,(,0,1
119861,2?,0,1
119862,),0,1
119863,",",0,0
119864,a,0,0
119865,marker,0,0
119866,of,0,0
119867,lipid,0,0
119868,peroxidation,0,1
119869,.,0,0
119870,Consumption,0,0
119871,of,1,0
119872,iTFA,1,0
119873,caused,0,0
119874,4,0,0
119875,%,0,0
119876,lower,0,0
119877,TNF-RI,0,0
119878,concentrations,0,1
119879,and,0,0
119880,6,0,0
119881,%,0,0
119882,higher,0,0
119883,E-selectin,0,0
119884,concentrations,0,0
119885,compared,0,0
119886,with,0,0
119887,oleic,0,1
119888,acid,0,1
119889,(,0,1
119890,control,0,0
119891,),0,0
119892,and,0,0
119893,had,0,0
119894,no,0,0
119895,significant,0,0
119896,effect,0,0
119897,on,0,0
119898,other,0,0
119899,inflammatory,0,0
119900,markers,0,0
119901,.,0,0
119902,CLA,0,0
119903,did,0,0
119904,not,0,0
119905,significantly,0,0
119906,affect,0,0
119907,inflammatory,0,0
119908,markers,0,0
119909,.,0,0
119910,The,0,0
119911,urine,0,1
119912,concentration,0,0
119913,of,0,0
119914,8-iso-PGF,0,1
119915,(,0,1
119916,2?,0,1
119917,),0,1
119918,[,0,0
119919,geometric,0,0
119920,mean,0,0
119921,(,0,0
119922,95,0,0
119923,%,0,0
119924,CI,0,0
119925,),0,0
119926,],0,0
119927,was,0,0
119928,greater,0,0
119929,after,0,0
119930,the,0,0
119931,iTFA,0,0
119932,[,0,0
119933,0.54,0,0
119934,(,0,0
119935,0.48,0,0
119936,",",0,0
119937,0.60,0,0
119938,),0,0
119939,nmol/mmol,0,0
119940,creatinine,0,1
119941,],0,0
119942,and,0,0
119943,the,0,0
119944,CLA,0,1
119945,[,0,1
119946,1.2,0,0
119947,(,0,0
119948,1.1,0,0
119949,",",0,0
119950,1.3,0,0
119951,),0,0
119952,nmol/mmol,0,0
119953,creatinine,0,1
119954,],0,1
119955,diet,0,1
119956,periods,0,1
119957,than,0,0
119958,after,0,0
119959,the,0,0
119960,control,0,0
119961,period,0,0
119962,[,0,0
119963,0.45,0,0
119964,(,0,0
119965,0.41,0,0
119966,",",0,0
119967,0.50,0,0
119968,),0,0
119969,nmol/mmol,0,0
119970,creatinine,0,0
119971,;,0,0
119972,P,0,0
119973,<,0,0
119974,0.05,0,0
119975,],0,0
119976,.,0,0
119977,In,0,0
119978,conclusion,0,0
119979,",",0,0
119980,high,0,0
119981,intakes,0,1
119982,of,0,0
119983,iTFA,1,1
119984,and,1,0
119985,CLA,1,0
119986,did,1,0
119987,not,0,0
119988,substantially,0,0
119989,affect,0,0
119990,plasma,0,1
119991,concentrations,0,1
119992,of,0,0
119993,inflammatory,0,0
119994,markers,0,0
119995,",",0,0
119996,but,0,0
119997,they,0,0
119998,increased,0,0
119999,the,0,0
120000,urine,0,1
120001,8-iso-PGF,0,1
120002,(,0,1
120003,2?,0,1
120004,),0,0
120005,concentration,0,0
120006,.,0,0
120007,However,0,0
120008,",",0,0
120009,it,0,0
120010,is,0,0
120011,unlikely,0,0
120012,this,0,0
120013,plays,0,0
120014,a,0,0
120015,major,0,0
120016,role,0,0
120017,in,0,0
120018,the,0,0
120019,mechanism,0,0
120020,by,0,0
120021,which,1,0
120022,iTFA,1,0
120023,increase,1,0
120024,the,0,0
120025,risk,0,0
120026,of,0,0
120027,CVD,0,0
120028,.,0,0
120029,However,0,0
120030,",",0,0
120031,more,0,0
120032,research,0,0
120033,is,0,0
120034,needed,0,0
120035,to,0,0
120036,fully,0,0
120037,understand,0,0
120038,the,0,0
120039,implications,0,0
120040,of,0,0
120041,these,0,0
120042,findings,0,0
120043,.,0,0
120044,To,0,0
120045,share,0,0
120046,or,0,0
120047,not,0,0
120048,to,0,0
120049,share,0,0
120050,:,0,0
120051,a,0,0
120052,randomized,0,0
120053,trial,0,0
120054,of,0,0
120055,consent,1,0
120056,for,1,0
120057,data,1,0
120058,sharing,1,0
120059,in,0,0
120060,genome,0,0
120061,research,0,0
120062,.,0,0
120063,PURPOSE,0,0
120064,Despite,0,0
120065,growing,0,0
120066,concerns,0,0
120067,toward,0,0
120068,maintaining,0,0
120069,participants,0,0
120070,',0,0
120071,privacy,0,0
120072,",",0,0
120073,individual,0,0
120074,investigators,0,0
120075,collecting,0,0
120076,tissue,0,0
120077,and,0,0
120078,other,0,0
120079,biological,0,0
120080,specimens,0,0
120081,for,0,0
120082,genomic,0,0
120083,analysis,0,0
120084,are,0,0
120085,encouraged,0,0
120086,to,0,0
120087,obtain,0,0
120088,informed,1,0
120089,consent,1,0
120090,for,0,0
120091,broad,0,0
120092,data,0,0
120093,sharing,0,0
120094,.,0,0
120095,Our,0,0
120096,purpose,0,0
120097,was,0,0
120098,to,0,0
120099,assess,0,0
120100,the,0,0
120101,effect,0,0
120102,on,0,0
120103,research,0,0
120104,enrollment,0,0
120105,and,0,0
120106,data,0,0
120107,sharing,0,0
120108,decisions,0,0
120109,of,0,0
120110,three,0,0
120111,different,0,0
120112,consent,0,0
120113,types,0,0
120114,(,0,0
120115,traditional,0,0
120116,",",0,0
120117,binary,0,0
120118,",",0,0
120119,or,0,0
120120,tiered,0,1
120121,),0,0
120122,with,0,0
120123,varying,0,0
120124,levels,0,0
120125,of,0,0
120126,control,0,0
120127,and,0,0
120128,choices,0,0
120129,regarding,0,0
120130,data,0,0
120131,sharing,0,0
120132,.,0,0
120133,METHODS,0,0
120134,A,0,0
120135,single-blinded,0,1
120136,",",0,0
120137,randomized,0,0
120138,controlled,1,0
120139,trial,0,0
120140,was,0,0
120141,conducted,0,0
120142,with,0,0
120143,323,0,0
120144,eligible,0,0
120145,adult,0,0
120146,participants,0,0
120147,being,0,0
120148,recruited,0,0
120149,into,0,0
120150,one,0,0
120151,of,0,0
120152,six,0,0
120153,genome,0,0
120154,studies,0,0
120155,at,0,0
120156,Baylor,0,0
120157,College,0,0
120158,of,0,0
120159,Medicine,0,0
120160,in,0,0
120161,Houston,0,0
120162,",",0,0
120163,Texas,0,0
120164,",",0,0
120165,between,0,0
120166,January,0,0
120167,2008,0,0
120168,and,0,0
120169,August,0,0
120170,2009,0,0
120171,.,0,0
120172,Participants,0,0
120173,were,0,0
120174,randomly,0,0
120175,assigned,0,0
120176,to,0,0
120177,one,0,0
120178,of,0,0
120179,three,0,0
120180,experimental,1,0
120181,consent,1,0
120182,documents,1,1
120183,(,0,0
120184,traditional,0,0
120185,",",0,0
120186,n,0,0
120187,=,0,0
120188,110,0,0
120189,;,0,0
120190,binary,0,0
120191,",",0,0
120192,n,0,0
120193,=,0,0
120194,103,0,0
120195,;,0,0
120196,and,0,0
120197,tiered,0,1
120198,",",0,0
120199,n,0,0
120200,=,0,0
120201,110,0,0
120202,),0,0
120203,.,0,0
120204,Debriefing,0,0
120205,in,0,0
120206,follow-up,0,0
120207,visits,0,0
120208,provided,0,0
120209,participants,0,0
120210,a,0,0
120211,detailed,0,0
120212,review,0,0
120213,of,0,0
120214,all,0,0
120215,consent,0,0
120216,types,0,0
120217,and,0,0
120218,the,0,0
120219,chance,0,0
120220,to,0,0
120221,change,0,0
120222,data,0,0
120223,sharing,0,0
120224,choices,0,0
120225,or,0,0
120226,decline,0,0
120227,genome,0,0
120228,study,0,0
120229,participation,0,0
120230,.,0,0
120231,RESULTS,0,0
120232,Before,0,0
120233,debriefing,0,0
120234,",",0,0
120235,83.9,0,0
120236,%,0,0
120237,of,0,0
120238,participants,0,0
120239,chose,0,0
120240,public,0,0
120241,data,0,0
120242,release,0,0
120243,.,0,0
120244,After,0,0
120245,debriefing,0,0
120246,",",0,0
120247,53.1,0,0
120248,%,0,0
120249,chose,0,0
120250,public,0,0
120251,data,0,0
120252,release,0,0
120253,",",0,0
120254,33.1,0,0
120255,%,0,0
120256,chose,0,0
120257,restricted,0,0
120258,(,0,0
120259,controlled,0,0
120260,access,0,1
120261,database,0,1
120262,),0,1
120263,release,0,0
120264,",",0,0
120265,and,0,0
120266,13.7,0,0
120267,%,0,0
120268,opted,0,0
120269,out,0,0
120270,of,0,0
120271,data,1,0
120272,sharing,1,0
120273,.,1,0
120274,Only,0,0
120275,one,0,0
120276,participant,0,0
120277,declined,0,0
120278,genome,0,0
120279,study,0,0
120280,participation,0,0
120281,due,0,0
120282,to,0,0
120283,data,0,0
120284,sharing,0,0
120285,concerns,0,0
120286,.,0,0
120287,CONCLUSION,0,0
120288,Our,0,0
120289,findings,0,0
120290,indicate,0,0
120291,that,0,0
120292,most,0,0
120293,participants,0,0
120294,are,0,0
120295,willing,0,0
120296,to,0,0
120297,publicly,0,0
120298,release,0,0
120299,their,0,0
120300,genomic,0,0
120301,data,0,0
120302,;,0,0
120303,however,0,0
120304,",",0,0
120305,a,0,0
120306,significant,0,0
120307,portion,0,0
120308,prefers,0,0
120309,restricted,0,0
120310,release,0,0
120311,.,0,0
120312,These,0,0
120313,results,0,0
120314,suggest,0,0
120315,discordance,0,0
120316,between,0,0
120317,existing,0,0
120318,data,0,0
120319,sharing,0,0
120320,policies,0,0
120321,and,0,0
120322,participants,0,0
120323,',0,0
120324,judgments,0,0
120325,and,0,0
120326,desires,0,0
120327,.,0,0
120328,Low-dose,1,1
120329,magnesium,1,1
120330,sulfate,1,1
120331,versus,1,1
120332,Pritchard,1,1
120333,regimen,1,1
120334,for,0,0
120335,the,0,0
120336,treatment,0,0
120337,of,0,0
120338,eclampsia,0,0
120339,imminent,0,0
120340,eclampsia,0,0
120341,.,0,0
120342,Nasal,1,1
120343,versus,1,1
120344,oronasal,1,0
120345,continuous,1,0
120346,positive,1,0
120347,airway,1,0
120348,pressure,1,0
120349,masks,1,0
120350,for,0,0
120351,obstructive,0,0
120352,sleep,0,0
120353,apnea,0,0
120354,:,0,0
120355,a,0,0
120356,pilot,0,0
120357,investigation,0,0
120358,of,0,0
120359,pressure,0,0
120360,requirement,0,0
120361,",",0,0
120362,residual,0,0
120363,disease,0,0
120364,",",0,0
120365,and,0,0
120366,leak,0,0
120367,.,0,0
120368,PURPOSE,0,0
120369,This,0,0
120370,single-blinded,0,1
120371,",",0,0
120372,randomized,0,0
120373,",",0,0
120374,controlled,0,0
120375,pilot,0,0
120376,study,0,0
120377,aimed,0,0
120378,to,0,0
120379,investigate,0,0
120380,whether,0,0
120381,there,0,0
120382,is,0,0
120383,a,0,0
120384,difference,0,0
120385,between,0,0
120386,nasal,1,0
120387,and,1,0
120388,oronasal,1,0
120389,masks,1,0
120390,in,0,0
120391,therapeutic,0,0
120392,continuous,0,0
120393,positive,0,0
120394,airway,0,0
120395,pressure,0,1
120396,(,0,1
120397,CPAP,0,1
120398,),0,0
120399,requirement,0,0
120400,",",0,0
120401,residual,0,0
120402,disease,0,0
120403,",",0,0
120404,or,0,0
120405,leak,0,0
120406,when,0,0
120407,treating,0,0
120408,obstructive,0,0
120409,sleep,0,1
120410,apnea,0,1
120411,(,0,1
120412,OSA,0,1
120413,),0,1
120414,and,0,0
120415,if,0,0
120416,differences,0,0
120417,were,0,0
120418,related,0,0
120419,to,0,0
120420,measures,0,0
120421,of,0,0
120422,upper,0,0
120423,airway,0,0
120424,size,0,0
120425,.,0,0
120426,METHODS,0,0
120427,Patients,0,0
120428,with,0,0
120429,severe,0,0
120430,OSA,0,0
120431,currently,0,0
120432,using,0,0
120433,CPAP,0,0
120434,at,0,0
120435,?4,0,1
120436,h/night,0,1
120437,with,0,0
120438,a,0,0
120439,nasal,1,0
120440,mask,1,0
120441,were,1,0
120442,examined,0,0
120443,(,0,0
120444,including,0,0
120445,Mallampati,0,0
120446,scale,0,0
120447,",",0,0
120448,incisal,0,0
120449,relationship,0,0
120450,",",0,0
120451,and,0,0
120452,mandibular,0,1
120453,protrusion,0,0
120454,),0,0
120455,and,0,0
120456,then,0,0
120457,randomized,0,0
120458,to,0,0
120459,receive,1,0
120460,auto-positive,1,0
120461,airway,1,1
120462,pressure,1,1
120463,(,1,1
120464,PAP,1,1
120465,),1,1
120466,or,1,0
120467,fixed,1,0
120468,CPAP,1,0
120469,at,1,0
120470,a,1,0
120471,manually,1,0
120472,titrated,1,1
120473,pressure,1,1
120474,for,1,0
120475,1,0,0
120476,week,0,0
120477,each,0,0
120478,at,0,0
120479,home,0,0
120480,",",0,0
120481,with,0,0
120482,immediate,0,0
120483,crossover,0,1
120484,.,0,0
120485,Within,0,0
120486,each,0,0
120487,week,0,0
120488,",",0,0
120489,a,0,0
120490,nasal,1,0
120491,mask,1,0
120492,and,1,0
120493,two,1,0
120494,oronasal,1,0
120495,masks,1,0
120496,were,1,0
120497,to,0,0
120498,be,0,0
120499,used,0,0
120500,for,0,0
120501,two,0,0
120502,or,0,0
120503,three,0,0
120504,nights,0,0
120505,each,0,0
120506,in,0,0
120507,random,0,0
120508,order,0,0
120509,.,0,0
120510,Data,0,0
120511,were,0,0
120512,downloaded,0,0
120513,from,0,0
120514,the,0,0
120515,device,0,0
120516,.,0,0
120517,RESULTS,0,0
120518,Twelve,0,0
120519,patients,0,0
120520,completed,0,0
120521,the,0,0
120522,trial,0,0
120523,(,0,0
120524,mean,0,0
120525,?,0,0
120526,SD,0,0
120527,AHI,0,0
120528,59.8,0,0
120529,?,0,0
120530,28.6,0,0
120531,events/h,0,0
120532,;,0,0
120533,CPAP,0,0
120534,11.1,0,0
120535,?,0,0
120536,3.2,0,0
120537,cmH,0,1
120538,(,0,1
120539,2,0,1
120540,),0,1
120541,O,0,1
120542,;,0,0
120543,BMI,0,0
120544,37.7,0,0
120545,?,0,0
120546,5.0,0,0
120547,kg/m,0,0
120548,(,0,0
120549,2,0,0
120550,),0,1
120551,),0,0
120552,.,0,0
120553,During,0,0
120554,auto-PAP,0,0
120555,",",0,0
120556,the,0,0
120557,median,0,0
120558,95th,0,0
120559,percentile,0,0
120560,pressure,0,0
120561,delivered,0,0
120562,with,0,0
120563,all,0,0
120564,masks,0,0
120565,was,0,0
120566,within,0,0
120567,0.5,0,0
120568,cmH,0,1
120569,(,0,1
120570,2,0,1
120571,),0,1
120572,O,0,1
120573,(,0,0
120574,p,0,0
120575,>,0,0
120576,0.05,0,0
120577,),0,0
120578,.,0,0
120579,During,0,0
120580,CPAP,0,0
120581,",",0,0
120582,median,0,0
120583,residual,0,0
120584,AHI,0,0
120585,was,0,0
120586,0.61,0,0
120587,(,0,0
120588,IQR,0,0
120589,=,0,0
120590,1.18,0,0
120591,),0,0
120592,for,0,0
120593,the,1,0
120594,nasal,1,0
120595,mask,1,0
120596,",",1,0
120597,1.70,0,0
120598,(,0,0
120599,IQR,0,0
120600,=,0,0
120601,4.04,0,0
120602,),0,0
120603,for,1,0
120604,oronasal,1,1
120605,mask,1,0
120606,1,0,0
120607,",",0,0
120608,and,0,0
120609,2.48,0,0
120610,(,0,0
120611,IQR,0,0
120612,=,0,0
120613,3.74,0,0
120614,),0,0
120615,for,1,0
120616,oronasal,1,1
120617,mask,1,1
120618,2,0,0
120619,(,0,0
120620,p,0,0
120621,=,0,0
120622,0.03,0,0
120623,),0,0
120624,.,0,0
120625,The,0,0
120626,95th,0,0
120627,percentile,0,0
120628,leak,0,0
120629,was,0,0
120630,lowest,0,0
120631,with,0,0
120632,the,0,0
120633,nasal,0,0
120634,mask,0,0
120635,during,0,0
120636,both,0,0
120637,CPAP,0,0
120638,and,0,0
120639,auto-PAP,0,1
120640,(,0,0
120641,both,0,0
120642,p,0,0
120643,<,0,0
120644,0.01,0,0
120645,),0,0
120646,.,0,0
120647,Differences,0,0
120648,in,0,0
120649,pressure,0,0
120650,or,0,0
120651,residual,0,0
120652,disease,0,0
120653,were,0,0
120654,not,0,0
120655,related,0,0
120656,to,0,0
120657,measures,0,0
120658,of,0,0
120659,upper,0,0
120660,airway,0,0
120661,shape,0,0
120662,or,0,0
120663,body,0,0
120664,habitus,0,0
120665,.,0,0
120666,CONCLUSIONS,0,0
120667,In,0,0
120668,obese,0,0
120669,OSA,0,0
120670,patients,0,0
120671,changing,0,0
120672,from,0,0
120673,a,0,0
120674,nasal,0,0
120675,to,1,0
120676,oronasal,1,0
120677,mask,1,0
120678,increased,0,0
120679,leak,0,0
120680,and,0,0
120681,residual,0,0
120682,AHI,0,0
120683,but,0,0
120684,did,0,0
120685,not,0,0
120686,affect,0,0
120687,the,0,0
120688,therapeutic,0,0
120689,pressure,0,0
120690,requirement,0,0
120691,.,0,0
120692,The,0,0
120693,findings,0,0
120694,of,0,0
120695,the,0,0
120696,current,0,0
120697,study,0,0
120698,highlight,0,0
120699,mask,0,0
120700,leak,0,0
120701,as,0,0
120702,the,0,0
120703,major,0,0
120704,difficulty,0,0
120705,in,0,0
120706,the,0,0
120707,use,0,0
120708,of,0,0
120709,oronasal,1,0
120710,masks,1,0
120711,.,0,0
120712,Variability,0,1
120713,of,0,0
120714,thrombolytic,1,1
120715,coronary,1,1
120716,reperfusion,1,1
120717,:,1,0
120718,an,0,0
120719,angiographic,0,0
120720,study,0,0
120721,of,0,0
120722,streptokinase,1,1
120723,and,0,1
120724,anistreplase,1,1
120725,.,1,1
120726,A,0,0
120727,total,0,0
120728,of,0,0
120729,"1,615",0,0
120730,angiographic,0,0
120731,readings,0,0
120732,in,0,0
120733,240,0,0
120734,patients,0,0
120735,with,0,0
120736,acute,0,0
120737,myocardial,0,0
120738,infarction,0,0
120739,were,0,0
120740,analyzed,0,0
120741,from,0,0
120742,a,0,0
120743,randomized,0,0
120744,trial,0,0
120745,of,0,1
120746,intravenous,1,1
120747,anistreplase,1,1
120748,(,1,1
120749,Eminase,1,1
120750,),1,1
120751,",",1,0
120752,also,1,0
120753,known,1,0
120754,as,1,0
120755,anisoylated,1,1
120756,plasminogen,1,1
120757,streptokinase,1,1
120758,activator,1,1
120759,complex,1,1
120760,(,1,1
120761,APSAC,1,1
120762,),1,1
120763,",",0,1
120764,versus,0,1
120765,intracoronary,0,1
120766,streptokinase,1,1
120767,.,1,1
120768,Coronary,0,0
120769,arteriography,0,0
120770,was,0,0
120771,performed,0,0
120772,at,0,0
120773,baseline,0,0
120774,and,0,0
120775,at,0,0
120776,15,0,0
120777,",",0,0
120778,30,0,0
120779,",",0,0
120780,45,0,0
120781,",",0,0
120782,60,0,0
120783,",",0,0
120784,75,0,0
120785,",",0,0
120786,and,0,0
120787,90,0,0
120788,minutes,0,0
120789,after,0,0
120790,drug,0,1
120791,infusion,0,1
120792,.,0,1
120793,Coronary,0,0
120794,flow,0,0
120795,in,0,0
120796,the,0,0
120797,infarct-related,0,0
120798,artery,0,0
120799,was,0,0
120800,defined,0,0
120801,using,0,0
120802,the,0,0
120803,TIMI,0,0
120804,criteria,0,0
120805,.,0,0
120806,Some,0,0
120807,serial,0,0
120808,change,0,0
120809,in,0,0
120810,perfusion,0,0
120811,was,0,0
120812,noted,0,0
120813,in,0,0
120814,25,0,0
120815,%,0,0
120816,of,0,0
120817,the,0,0
120818,total,0,0
120819,patient,0,0
120820,population,0,0
120821,and,0,0
120822,in,0,0
120823,49,0,0
120824,%,0,0
120825,of,0,0
120826,all,0,0
120827,reperfusion,0,1
120828,patients,0,0
120829,.,0,0
120830,Complete,0,0
120831,loss,0,0
120832,of,0,0
120833,perfusion,0,1
120834,(,0,1
120835,grade,0,0
120836,2,0,1
120837,or,0,0
120838,3,0,0
120839,to,0,0
120840,grade,0,0
120841,0,0,0
120842,or,0,0
120843,1,0,0
120844,),0,0
120845,occurred,0,0
120846,in,0,0
120847,35,0,0
120848,%,0,0
120849,of,0,0
120850,all,0,0
120851,reperfused,0,1
120852,patients,0,0
120853,.,0,0
120854,Half,0,0
120855,of,0,0
120856,these,0,0
120857,patients,0,0
120858,ultimately,0,0
120859,developed,0,0
120860,complete,0,0
120861,loss,0,0
120862,of,0,0
120863,perfusion,0,0
120864,at,0,0
120865,the,0,0
120866,study,0,0
120867,endpoint,0,0
120868,.,0,0
120869,All,0,0
120870,of,0,0
120871,these,0,0
120872,changes,0,0
120873,in,0,0
120874,flow,0,0
120875,were,0,0
120876,statistically,0,0
120877,more,0,0
120878,common,0,0
120879,for,0,0
120880,the,0,0
120881,circumflex,0,0
120882,coronary,0,0
120883,artery,0,0
120884,and,0,0
120885,early,0,0
120886,treatment,0,0
120887,(,0,0
120888,less,0,0
120889,than,0,0
120890,4,0,0
120891,h,0,1
120892,),0,0
120893,",",0,0
120894,but,0,0
120895,did,0,0
120896,not,0,0
120897,differ,0,0
120898,for,0,0
120899,anistreplase,1,1
120900,or,0,1
120901,streptokinase,1,1
120902,.,1,1
120903,We,0,0
120904,conclude,0,0
120905,that,0,0
120906,frequent,0,0
120907,alterations,0,0
120908,in,0,0
120909,coronary,0,0
120910,blood,0,0
120911,flow,0,0
120912,occur,0,0
120913,early,0,0
120914,during,0,0
120915,reperfusion,1,1
120916,therapy,1,1
120917,and,0,0
120918,that,0,0
120919,these,0,0
120920,findings,0,0
120921,may,0,0
120922,explain,0,0
120923,reports,0,0
120924,with,0,0
120925,varying,0,0
120926,results,0,0
120927,of,0,0
120928,thrombolytic,1,0
120929,therapy,1,0
120930,.,1,0
120931,Any,0,0
120932,angiographic,0,0
120933,assessment,0,0
120934,of,0,0
120935,thrombolytic,1,1
120936,drug,1,1
120937,efficacy,0,1
120938,should,0,0
120939,take,0,0
120940,these,0,0
120941,variations,0,0
120942,as,0,0
120943,well,0,0
120944,as,0,0
120945,interobserver,0,0
120946,variability,0,0
120947,into,0,0
120948,account,0,0
120949,.,0,0
120950,Treatment,0,0
120951,of,0,0
120952,renal,0,0
120953,failure,0,0
120954,associated,0,0
120955,with,0,0
120956,multiple,0,0
120957,myeloma,0,0
120958,.,0,0
120959,Plasmapheresis,0,0
120960,",",0,0
120961,hemodialysis,0,0
120962,",",0,0
120963,and,0,0
120964,chemotherapy,0,0
120965,.,0,0
120966,The,0,0
120967,aims,0,0
120968,of,0,0
120969,this,0,0
120970,study,0,0
120971,were,0,0
120972,to,0,0
120973,examine,0,0
120974,in,0,0
120975,a,0,0
120976,prospective,0,0
120977,",",0,0
120978,randomized,0,0
120979,trial,0,0
120980,the,0,0
120981,efficacy,0,0
120982,of,0,0
120983,plasmapheresis,0,1
120984,in,0,0
120985,preventing,0,0
120986,irreversible,0,0
120987,renal,0,0
120988,failure,0,0
120989,in,0,0
120990,patients,0,0
120991,with,0,0
120992,multiple,0,0
120993,myeloma,0,0
120994,and,0,0
120995,to,0,0
120996,study,0,0
120997,the,0,0
120998,renal,0,0
120999,biopsy,0,0
121000,tissues,0,0
121001,from,0,0
121002,such,0,0
121003,patients,0,0
121004,.,0,0
121005,Twenty-one,0,0
121006,patients,0,0
121007,with,0,0
121008,active,0,0
121009,myeloma,0,0
121010,and,0,0
121011,progressive,0,0
121012,renal,0,0
121013,failure,0,0
121014,were,0,0
121015,randomized,1,0
121016,to,1,0
121017,one,1,0
121018,of,1,0
121019,two,1,0
121020,groups,1,0
121021,:,1,0
121022,group,1,0
121023,1,1,0
121024,",",1,0
121025,forced,1,0
121026,diuresis,1,1
121027,and,1,1
121028,chemotherapy,1,1
121029,(,1,0
121030,10,1,0
121031,patients,1,0
121032,),1,0
121033,",",1,0
121034,and,1,0
121035,group,1,0
121036,2,1,0
121037,",",1,0
121038,forced,1,0
121039,diuresis,1,1
121040,",",1,1
121041,chemotherapy,1,1
121042,",",1,0
121043,and,1,1
121044,plasmapheresis,1,1
121045,(,1,1
121046,11,1,1
121047,patients,1,0
121048,),1,0
121049,.,1,0
121050,Plasmapheresis,0,0
121051,and,0,0
121052,chemotherapy,0,0
121053,lowered,0,0
121054,the,0,0
121055,serum,0,1
121056,myeloma,0,1
121057,protein,0,0
121058,value,0,0
121059,much,0,0
121060,more,0,0
121061,rapidly,0,0
121062,than,0,0
121063,chemotherapy,0,0
121064,alone,0,0
121065,.,0,0
121066,Of,0,0
121067,5,0,0
121068,patients,0,0
121069,who,0,0
121070,were,0,0
121071,oliguric,0,1
121072,and,0,1
121073,undergoing,0,1
121074,dialysis,0,0
121075,at,0,0
121076,presentation,0,0
121077,",",0,0
121078,only,0,0
121079,3,0,0
121080,who,0,0
121081,were,0,0
121082,treated,0,0
121083,by,0,0
121084,plasmapheresis,0,1
121085,recovered,0,0
121086,.,0,0
121087,Of,0,0
121088,16,0,0
121089,polyuric,0,1
121090,patients,0,0
121091,",",0,0
121092,5,0,0
121093,in,0,0
121094,group,0,0
121095,1,0,0
121096,and,0,0
121097,7,0,0
121098,in,0,0
121099,group,0,0
121100,2,0,0
121101,showed,0,0
121102,improvement,0,0
121103,in,0,0
121104,renal,0,0
121105,function,0,0
121106,.,0,0
121107,The,0,0
121108,main,0,0
121109,factor,0,0
121110,that,0,0
121111,determined,0,0
121112,irreversibility,0,0
121113,of,0,0
121114,renal,0,0
121115,failure,0,0
121116,was,0,0
121117,the,0,0
121118,severity,0,0
121119,of,0,0
121120,myeloma,0,0
121121,cast,0,0
121122,formation,0,0
121123,.,0,0
121124,Comparative,0,0
121125,effectiveness,0,0
121126,of,0,0
121127,exercise,0,0
121128,electrocardiography,0,0
121129,with,0,0
121130,or,0,0
121131,without,0,0
121132,myocardial,0,0
121133,perfusion,0,0
121134,single,0,0
121135,photon,0,0
121136,emission,0,0
121137,computed,0,0
121138,tomography,0,0
121139,in,0,0
121140,women,0,0
121141,with,0,0
121142,suspected,0,0
121143,coronary,0,0
121144,artery,0,0
121145,disease,0,0
121146,:,0,0
121147,results,0,0
121148,from,0,0
121149,the,0,0
121150,What,0,0
121151,Is,0,0
121152,the,0,0
121153,Optimal,0,0
121154,Method,0,0
121155,for,0,0
121156,Ischemia,0,0
121157,Evaluation,0,0
121158,in,0,0
121159,Women,0,1
121160,(,0,1
121161,WOMEN,0,1
121162,),0,1
121163,trial,0,0
121164,.,0,0
121165,BACKGROUND,0,0
121166,There,0,0
121167,is,0,0
121168,a,0,0
121169,paucity,0,0
121170,of,0,0
121171,randomized,0,0
121172,trials,0,0
121173,regarding,0,0
121174,diagnostic,0,0
121175,testing,0,0
121176,in,0,0
121177,women,0,0
121178,with,0,0
121179,suspected,0,0
121180,coronary,0,0
121181,artery,0,1
121182,disease,0,1
121183,(,0,1
121184,CAD,0,1
121185,),0,1
121186,.,0,0
121187,It,0,0
121188,remains,0,0
121189,unclear,0,0
121190,whether,0,0
121191,the,0,0
121192,addition,0,0
121193,of,0,0
121194,myocardial,0,0
121195,perfusion,0,1
121196,imaging,0,1
121197,(,0,1
121198,MPI,0,1
121199,),0,0
121200,to,0,0
121201,the,0,0
121202,standard,0,0
121203,ECG,0,1
121204,exercise,0,1
121205,treadmill,0,1
121206,test,0,0
121207,(,0,1
121208,ETT,0,1
121209,),0,1
121210,provides,0,0
121211,incremental,0,0
121212,information,0,0
121213,to,0,0
121214,improve,0,0
121215,clinical,0,0
121216,decision,0,0
121217,making,0,0
121218,in,0,0
121219,women,0,0
121220,with,0,0
121221,suspected,0,0
121222,CAD,0,1
121223,.,0,1
121224,METHODS,0,1
121225,AND,0,1
121226,RESULTS,0,1
121227,We,0,1
121228,randomized,0,1
121229,symptomatic,0,0
121230,women,0,0
121231,with,0,0
121232,suspected,0,0
121233,CAD,0,1
121234,",",0,0
121235,an,1,0
121236,interpretable,1,0
121237,ECG,1,0
121238,",",1,0
121239,and,1,0
121240,?5,1,0
121241,metabolic,1,0
121242,equivalents,1,0
121243,on,1,0
121244,the,0,0
121245,Duke,0,0
121246,Activity,0,0
121247,Status,0,0
121248,Index,0,0
121249,to,0,0
121250,1,0,0
121251,of,0,0
121252,2,0,0
121253,diagnostic,0,0
121254,strategies,1,0
121255,:,1,0
121256,ETT,1,0
121257,or,1,0
121258,exercise,1,0
121259,MPI,1,0
121260,.,1,0
121261,The,0,0
121262,primary,0,0
121263,end,0,0
121264,point,0,0
121265,was,0,0
121266,2-year,0,0
121267,incidence,0,0
121268,of,0,0
121269,major,0,0
121270,adverse,0,0
121271,cardiac,0,0
121272,events,0,0
121273,",",0,0
121274,defined,0,0
121275,as,0,0
121276,CAD,0,1
121277,death,0,1
121278,or,0,0
121279,hospitalization,0,0
121280,for,0,0
121281,an,0,0
121282,acute,0,0
121283,coronary,0,0
121284,syndrome,0,0
121285,or,0,0
121286,heart,0,0
121287,failure,0,0
121288,.,0,0
121289,A,0,0
121290,total,0,0
121291,of,0,0
121292,824,0,0
121293,women,0,0
121294,were,0,0
121295,randomized,0,0
121296,to,0,0
121297,ETT,1,0
121298,or,1,0
121299,exercise,1,0
121300,MPI,1,0
121301,.,1,0
121302,For,0,0
121303,women,0,0
121304,randomized,0,0
121305,to,0,0
121306,ETT,1,0
121307,",",1,0
121308,ECG,0,0
121309,results,0,0
121310,were,0,0
121311,normal,0,0
121312,in,0,0
121313,64,0,0
121314,%,0,0
121315,",",0,0
121316,indeterminate,0,0
121317,in,0,0
121318,16,0,0
121319,%,0,0
121320,",",0,0
121321,and,0,0
121322,abnormal,0,0
121323,in,0,0
121324,20,0,0
121325,%,0,0
121326,.,0,0
121327,By,0,0
121328,comparison,0,0
121329,",",0,0
121330,the,0,0
121331,exercise,0,0
121332,MPI,0,0
121333,results,0,0
121334,were,0,0
121335,normal,0,0
121336,in,0,0
121337,91,0,0
121338,%,0,0
121339,",",0,0
121340,mildly,0,0
121341,abnormal,0,0
121342,in,0,0
121343,3,0,0
121344,%,0,0
121345,",",0,0
121346,and,0,0
121347,moderate,0,0
121348,to,0,0
121349,severely,0,0
121350,abnormal,0,0
121351,in,0,0
121352,6,0,0
121353,%,0,0
121354,.,0,0
121355,At,0,0
121356,2,0,0
121357,years,0,0
121358,",",0,0
121359,there,0,0
121360,was,0,0
121361,no,0,0
121362,difference,0,0
121363,in,0,0
121364,major,0,0
121365,adverse,0,0
121366,cardiac,0,0
121367,events,0,0
121368,(,0,0
121369,98.0,0,0
121370,%,0,0
121371,for,0,0
121372,ETT,0,0
121373,and,0,0
121374,97.7,0,0
121375,%,0,0
121376,for,0,0
121377,MPI,0,0
121378,;,0,0
121379,P=0.59,0,0
121380,),0,0
121381,.,0,0
121382,Compared,0,0
121383,with,0,0
121384,ETT,0,0
121385,",",0,0
121386,index,0,0
121387,testing,0,0
121388,costs,0,0
121389,were,0,0
121390,higher,0,0
121391,for,0,0
121392,exercise,0,0
121393,MPI,0,0
121394,(,0,0
121395,P,0,0
121396,<,0,0
121397,0.001,0,0
121398,),0,0
121399,",",0,0
121400,whereas,0,0
121401,downstream,0,0
121402,procedural,0,0
121403,costs,0,0
121404,were,0,0
121405,slightly,0,0
121406,lower,0,0
121407,(,0,0
121408,P=0.0008,0,0
121409,),0,0
121410,.,0,0
121411,Overall,0,0
121412,",",0,0
121413,the,0,0
121414,cumulative,0,0
121415,diagnostic,0,0
121416,cost,0,0
121417,savings,0,0
121418,was,0,0
121419,48,0,0
121420,%,0,0
121421,for,0,0
121422,ETT,0,0
121423,compared,0,0
121424,with,0,0
121425,exercise,0,0
121426,MPI,0,0
121427,(,0,0
121428,P,0,0
121429,<,0,0
121430,0.001,0,0
121431,),0,0
121432,.,0,0
121433,CONCLUSIONS,0,0
121434,In,0,0
121435,low-risk,0,0
121436,",",0,0
121437,exercising,0,0
121438,women,0,0
121439,",",0,0
121440,a,0,0
121441,diagnostic,0,0
121442,strategy,0,0
121443,that,0,0
121444,uses,0,0
121445,ETT,0,1
121446,versus,0,0
121447,exercise,0,0
121448,MPI,0,0
121449,yields,0,0
121450,similar,0,0
121451,2-year,0,0
121452,posttest,0,0
121453,outcomes,0,0
121454,while,0,0
121455,providing,0,0
121456,significant,0,0
121457,diagnostic,0,0
121458,cost,0,0
121459,savings,0,0
121460,.,0,0
121461,The,0,0
121462,ETT,0,0
121463,with,0,0
121464,selective,0,0
121465,follow-up,0,0
121466,testing,0,0
121467,should,0,0
121468,be,0,0
121469,considered,0,0
121470,as,0,0
121471,the,0,0
121472,initial,0,0
121473,diagnostic,0,0
121474,strategy,0,0
121475,in,0,0
121476,symptomatic,0,0
121477,women,0,0
121478,with,0,0
121479,suspected,0,0
121480,CAD,0,1
121481,.,0,1
121482,CLINICAL,0,1
121483,TRIAL,0,1
121484,REGISTRATION,0,1
121485,http,0,0
121486,:,0,0
121487,//www.clinicaltrials.gov,0,0
121488,.,0,0
121489,Unique,0,0
121490,identifier,0,0
121491,:,0,0
121492,NCT00282711,0,0
121493,.,0,0
121494,[,0,1
121495,The,0,0
121496,Antonio,1,0
121497,Raichs,1,0
121498,memorial,1,0
121499,lecture,1,0
121500,.,1,0
121501,Future,0,0
121502,trends,0,0
121503,in,0,0
121504,marrow,1,0
121505,transplantation,1,1
121506,],1,0
121507,.,0,0
121508,Effects,0,0
121509,of,0,0
121510,a,0,0
121511,Chinese,0,0
121512,medical,0,1
121513,herbs,0,1
121514,complex,0,0
121515,on,0,0
121516,cellular,0,0
121517,immunity,0,0
121518,and,0,0
121519,toxicity-related,0,0
121520,conditions,0,0
121521,of,0,0
121522,breast,0,0
121523,cancer,0,0
121524,patients,0,0
121525,.,0,1
121526,Rose,1,1
121527,geranium,1,1
121528,(,0,1
121529,Pelargonium,0,1
121530,graveolens,0,1
121531,",",0,1
121532,Geraniaceae,0,1
121533,),0,1
121534,has,0,0
121535,anti-cancer,0,1
121536,and,0,1
121537,anti-inflammatory,0,1
121538,properties,0,0
121539,",",0,0
121540,and,0,0
121541,promotes,0,0
121542,wound,0,0
121543,healing,0,0
121544,.,0,0
121545,Similarly,0,0
121546,",",0,0
121547,Ganoderma,1,1
121548,tsugae,1,1
121549,(,0,1
121550,Ganodermataceae,0,1
121551,),0,0
121552,",",0,0
121553,Codonopsis,1,1
121554,pilosula,1,1
121555,(,0,1
121556,Campanulaceae,0,1
121557,),0,1
121558,and,0,0
121559,Angelica,1,1
121560,sinensis,1,1
121561,(,0,1
121562,Apiaceae,0,1
121563,),0,0
121564,are,0,0
121565,traditional,0,0
121566,Chinese,0,0
121567,herbs,0,1
121568,associated,0,1
121569,with,0,1
121570,immunomodulatory,0,1
121571,functions,0,0
121572,.,0,0
121573,In,0,0
121574,the,0,0
121575,present,0,0
121576,study,0,0
121577,",",0,0
121578,a,0,0
121579,randomised,0,0
121580,",",0,0
121581,double-blind,0,1
121582,",",0,1
121583,placebo-controlled,0,1
121584,study,0,0
121585,was,0,0
121586,conducted,0,0
121587,to,0,0
121588,examine,0,0
121589,whether,0,0
121590,the,0,0
121591,Chinese,1,0
121592,medicinal,1,1
121593,herb,1,1
121594,complex,1,0
121595,",",1,0
121596,RG-CMH,1,0
121597,",",0,0
121598,which,0,0
121599,represents,0,0
121600,a,0,0
121601,mixture,1,0
121602,of,1,0
121603,rose,1,0
121604,geranium,1,1
121605,and,1,0
121606,extracts,1,0
121607,of,1,0
121608,G.,1,0
121609,tsugae,1,1
121610,",",1,0
121611,C.,1,1
121612,pilosula,1,1
121613,and,1,0
121614,A.,1,1
121615,sinensis,1,0
121616,",",0,0
121617,can,0,0
121618,improve,0,0
121619,the,0,0
121620,immune,0,0
121621,cell,0,0
121622,count,0,0
121623,of,0,0
121624,cancer,0,0
121625,patients,0,0
121626,receiving,0,0
121627,chemotherapy,0,0
121628,and/or,0,0
121629,radiotherapy,0,0
121630,to,0,0
121631,prevent,0,0
121632,leucopenia,0,1
121633,and,0,1
121634,immune,0,1
121635,impairment,0,0
121636,that,0,0
121637,usually,0,0
121638,occurs,0,0
121639,during,0,0
121640,cancer,0,0
121641,therapy,0,0
121642,.,0,0
121643,A,0,0
121644,total,0,0
121645,of,0,0
121646,fifty-eight,0,0
121647,breast,0,0
121648,cancer,0,0
121649,patients,0,0
121650,who,0,0
121651,received,0,0
121652,chemotherapy,1,0
121653,or,0,0
121654,radiotherapy,1,0
121655,were,0,0
121656,enrolled,0,0
121657,.,0,0
121658,Immune,0,0
121659,cell,0,0
121660,levels,0,0
121661,in,0,0
121662,patient,0,0
121663,serum,0,1
121664,were,0,0
121665,determined,0,0
121666,before,0,0
121667,",",0,0
121668,and,0,0
121669,following,0,0
121670,",",0,0
121671,6,0,0
121672,weeks,0,0
121673,of,0,0
121674,cancer,0,0
121675,treatment,0,0
121676,for,0,0
121677,patients,0,0
121678,receiving,0,0
121679,either,0,0
121680,an,0,0
121681,RG-CMH,1,0
121682,or,1,0
121683,a,1,0
121684,placebo,1,1
121685,.,1,0
121686,Administration,0,0
121687,of,0,0
121688,RG-CMH,0,0
121689,was,0,0
121690,associated,0,0
121691,with,0,0
121692,a,0,0
121693,significant,0,0
121694,reduction,0,0
121695,in,0,0
121696,levels,0,0
121697,of,0,0
121698,leucocytes,0,0
121699,from,0,0
121700,31?5,0,0
121701,%,0,0
121702,for,0,0
121703,the,1,0
121704,placebo,1,1
121705,group,1,0
121706,to,0,0
121707,13?4,0,0
121708,%,0,0
121709,for,0,0
121710,the,0,0
121711,RG-CMH,0,0
121712,group,0,0
121713,.,0,0
121714,Similarly,0,0
121715,",",0,0
121716,levels,0,0
121717,of,0,0
121718,neutrophils,0,0
121719,significantly,0,0
121720,decreased,0,0
121721,from,0,0
121722,35?6,0,0
121723,%,0,0
121724,for,0,0
121725,the,0,0
121726,placebo,0,1
121727,group,0,0
121728,to,0,0
121729,11?0,0,0
121730,%,0,0
121731,for,0,0
121732,the,0,0
121733,RG-CMH,0,0
121734,group,0,0
121735,.,0,0
121736,RG-CMH,0,0
121737,intervention,0,0
121738,was,0,0
121739,also,0,0
121740,associated,0,0
121741,with,0,0
121742,a,0,0
121743,decrease,0,0
121744,in,0,0
121745,levels,0,0
121746,of,0,0
121747,T,0,0
121748,cells,0,0
121749,",",0,0
121750,helper,0,0
121751,T,0,0
121752,cells,0,0
121753,",",0,0
121754,cytotoxic,0,1
121755,T,0,1
121756,cells,0,0
121757,and,0,0
121758,natural,0,0
121759,killer,0,0
121760,cells,0,0
121761,compared,0,0
121762,with,0,0
121763,the,0,0
121764,placebo,0,1
121765,group,0,0
121766,.,0,0
121767,However,0,0
121768,",",0,0
121769,these,0,0
121770,differences,0,0
121771,between,0,0
121772,the,0,0
121773,two,0,0
121774,groups,0,0
121775,were,0,0
121776,not,0,0
121777,statistically,0,0
121778,significant,0,0
121779,.,0,0
121780,In,0,0
121781,conclusion,0,0
121782,",",0,0
121783,administration,0,1
121784,of,0,0
121785,RG-CMH,0,0
121786,to,0,0
121787,patients,0,0
121788,receiving,0,0
121789,chemotherapy/radiotherapy,0,0
121790,may,0,0
121791,have,0,0
121792,the,0,0
121793,capacity,0,0
121794,to,0,0
121795,delay,0,0
121796,",",0,0
121797,or,0,0
121798,ease,0,0
121799,",",0,0
121800,the,0,0
121801,reduction,0,0
121802,in,0,0
121803,levels,0,0
121804,of,0,0
121805,leucocytes,0,0
121806,and,0,0
121807,neutrophils,0,0
121808,that,0,0
121809,are,0,0
121810,experienced,0,0
121811,by,0,0
121812,patients,0,0
121813,during,0,0
121814,cancer,0,0
121815,treatment,0,0
121816,.,0,0
121817,[,0,1
121818,Clinical,0,0
121819,study,0,0
121820,on,0,0
121821,treatment,0,0
121822,of,0,0
121823,endometriosis-related,0,0
121824,infertility,0,0
121825,patients,0,0
121826,by,0,0
121827,laparoscopic,1,0
121828,surgery,1,0
121829,in,1,0
121830,combination,1,0
121831,of,1,0
121832,quyu,1,1
121833,jiedu,1,1
121834,recipe,1,1
121835,],1,1
121836,.,0,0
121837,OBJECTIVE,0,0
121838,To,0,0
121839,study,0,0
121840,the,0,0
121841,clinical,0,0
121842,efficacy,0,0
121843,of,0,0
121844,the,0,0
121845,laparoscopic,1,0
121846,surgery,1,0
121847,in,1,0
121848,combination,1,0
121849,of,1,0
121850,Quyu,1,0
121851,Jiedu,1,1
121852,Recipe,1,1
121853,(,1,1
121854,QYJDR,1,1
121855,),1,1
121856,on,0,0
121857,endometriosis,0,1
121858,(,0,1
121859,EMs,0,1
121860,),0,1
121861,-related,0,0
121862,infertility,0,0
121863,patients,0,0
121864,.,0,0
121865,METHODS,0,0
121866,130,0,0
121867,EMs-related,0,0
121868,infertility,0,0
121869,patients,0,0
121870,of,0,0
121871,blood,0,0
121872,stasis,0,0
121873,and,0,0
121874,toxin,0,1
121875,accumulation,0,0
121876,syndrome,0,0
121877,diagnosed,0,0
121878,and,0,0
121879,treated,0,0
121880,by,0,0
121881,laparoscopic,1,0
121882,surgery,1,0
121883,were,0,0
121884,randomly,0,0
121885,assigned,0,0
121886,to,0,0
121887,two,0,0
121888,groups,0,0
121889,",",0,0
121890,i.e.,0,0
121891,",",0,0
121892,the,0,0
121893,test,1,0
121894,group,1,0
121895,(,0,0
121896,75,0,0
121897,cases,0,0
121898,),0,0
121899,and,0,0
121900,the,0,0
121901,control,1,0
121902,group,1,0
121903,(,0,0
121904,55,0,0
121905,cases,0,0
121906,),0,0
121907,.,0,0
121908,All,0,0
121909,patients,0,0
121910,received,0,0
121911,routine,0,1
121912,progesterone,1,1
121913,treatment,1,1
121914,after,1,0
121915,laparoscopic,1,0
121916,surgery,1,0
121917,.,1,0
121918,QYJDR,1,0
121919,was,0,0
121920,given,0,0
121921,to,0,0
121922,patients,0,0
121923,in,0,0
121924,the,0,0
121925,test,0,0
121926,group,0,0
121927,after,0,0
121928,laparoscopic,1,0
121929,surgery,1,0
121930,",",0,0
121931,lasting,0,0
121932,for,0,0
121933,twelve,0,0
121934,months,0,0
121935,.,0,0
121936,The,0,0
121937,pregnancy,0,0
121938,rate,0,0
121939,within,0,0
121940,one,0,0
121941,year,0,0
121942,after,0,0
121943,laparoscopic,1,0
121944,surgery,1,0
121945,were,0,0
121946,compared,0,0
121947,between,0,0
121948,the,0,0
121949,two,0,0
121950,groups,0,0
121951,.,0,0
121952,The,0,0
121953,Chinese,1,0
121954,medicine,1,0
121955,syndrome,0,0
121956,integrals,0,1
121957,",",0,1
121958,serum,0,1
121959,endometrium,0,1
121960,antibody,0,1
121961,(,0,1
121962,EMAb,0,1
121963,),0,1
121964,and,0,0
121965,cancer,0,0
121966,antigen,0,0
121967,125,0,0
121968,(,0,0
121969,CA125,0,0
121970,),0,0
121971,levels,0,0
121972,were,0,0
121973,compared,0,0
121974,between,0,0
121975,before,0,0
121976,drug,1,1
121977,therapy,1,1
121978,and,0,0
121979,three,0,0
121980,months,0,0
121981,after,0,0
121982,drug,1,1
121983,therapy,1,1
121984,.,1,0
121985,RESULTS,0,0
121986,The,0,0
121987,pregnancy,0,0
121988,rate,0,0
121989,within,0,0
121990,one,0,0
121991,year,0,0
121992,after,0,0
121993,laparoscopic,1,0
121994,surgery,1,0
121995,was,0,0
121996,higher,0,0
121997,in,0,0
121998,the,0,0
121999,test,1,0
122000,group,1,0
122001,than,0,0
122002,in,0,0
122003,the,0,0
122004,control,1,0
122005,group,1,0
122006,[,0,0
122007,61.33,0,0
122008,%,0,0
122009,(,0,0
122010,46/75,0,0
122011,),0,0
122012,vs,0,0
122013,45.45,0,0
122014,%,0,0
122015,(,0,0
122016,25/55,0,0
122017,),0,0
122018,],0,0
122019,",",0,0
122020,showing,0,0
122021,significant,0,0
122022,difference,0,0
122023,(,0,0
122024,P,0,0
122025,<,0,0
122026,0.05,0,0
122027,),0,0
122028,.,0,0
122029,The,0,0
122030,Chinese,1,0
122031,medicine,1,0
122032,syndrome,0,0
122033,integral,0,0
122034,was,0,0
122035,(,0,0
122036,16.07,0,0
122037,+/-,0,0
122038,6.77,0,0
122039,),0,0
122040,score,0,0
122041,and,0,0
122042,(,0,0
122043,7.25,0,0
122044,+/-,0,0
122045,3.27,0,0
122046,),0,0
122047,score,0,0
122048,before,0,0
122049,and,0,0
122050,3,0,0
122051,months,0,0
122052,after,0,0
122053,drug,1,1
122054,therapy,1,0
122055,in,0,0
122056,the,0,0
122057,test,1,0
122058,group,1,0
122059,",",0,0
122060,while,0,0
122061,it,0,0
122062,was,0,0
122063,(,0,0
122064,15.92,0,0
122065,+/-,0,0
122066,7.51,0,0
122067,),0,0
122068,score,0,0
122069,and,0,0
122070,(,0,0
122071,12.73,0,0
122072,+/-,0,0
122073,6.12,0,0
122074,),0,0
122075,score,0,0
122076,in,0,0
122077,the,0,0
122078,control,1,0
122079,group,1,0
122080,.,1,0
122081,The,0,0
122082,Chinese,1,0
122083,medicine,1,0
122084,syndrome,0,0
122085,integral,0,0
122086,after,0,0
122087,drug,1,1
122088,therapy,1,0
122089,was,0,0
122090,lower,0,0
122091,than,0,0
122092,that,0,0
122093,before,0,0
122094,drug,1,1
122095,therapy,1,1
122096,in,0,0
122097,the,0,0
122098,same,0,0
122099,group,0,0
122100,.,0,0
122101,Besides,0,0
122102,",",0,0
122103,the,0,0
122104,integral,0,0
122105,difference,0,0
122106,between,0,0
122107,before,0,0
122108,and,0,0
122109,after,0,0
122110,drug,1,1
122111,therapy,1,0
122112,was,0,0
122113,higher,0,0
122114,in,0,0
122115,the,0,0
122116,test,1,0
122117,group,1,0
122118,than,0,0
122119,in,0,0
122120,the,0,0
122121,control,1,0
122122,group,1,0
122123,[,0,0
122124,(,0,0
122125,9.12,0,0
122126,+/-,0,0
122127,6.16,0,0
122128,),0,0
122129,score,0,0
122130,vs,0,0
122131,(,0,0
122132,3.48,0,0
122133,+/-,0,0
122134,2.06,0,0
122135,),0,0
122136,score,0,1
122137,),0,1
122138,],0,0
122139,",",0,0
122140,showing,0,0
122141,statistical,0,0
122142,difference,0,0
122143,(,0,0
122144,P,0,0
122145,<,0,0
122146,0.05,0,0
122147,),0,0
122148,.,0,0
122149,After,0,1
122150,three-month,0,1
122151,drug,0,1
122152,therapy,0,1
122153,",",0,0
122154,the,0,0
122155,serum,0,1
122156,EMAb,0,1
122157,negative,0,0
122158,conversion,0,0
122159,rate,0,0
122160,was,0,0
122161,obviously,0,0
122162,higher,0,0
122163,in,0,0
122164,the,0,0
122165,test,1,0
122166,group,1,0
122167,than,0,0
122168,in,0,0
122169,the,0,0
122170,control,1,0
122171,group,1,0
122172,(,0,0
122173,44.44,0,0
122174,%,0,0
122175,vs,0,0
122176,15.62,0,0
122177,%,0,0
122178,),0,0
122179,",",0,0
122180,showing,0,0
122181,statistical,0,0
122182,difference,0,0
122183,(,0,0
122184,P,0,0
122185,<,0,0
122186,0.05,0,0
122187,),0,0
122188,.,0,0
122189,The,0,0
122190,serum,0,1
122191,CA125,0,0
122192,level,0,0
122193,was,0,0
122194,(,0,0
122195,31.88,0,0
122196,+/-,0,0
122197,15.78,0,0
122198,),0,0
122199,U/mL,0,0
122200,before,0,1
122201,drug,1,1
122202,therapy,1,1
122203,and,0,0
122204,(,0,0
122205,18.82,0,0
122206,+/-,0,0
122207,10.08,0,0
122208,),0,0
122209,U/mL,0,0
122210,three,0,0
122211,months,0,0
122212,after,0,0
122213,drug,1,1
122214,therapy,1,0
122215,in,0,0
122216,the,0,0
122217,test,0,0
122218,group,0,0
122219,",",0,0
122220,while,0,0
122221,it,0,0
122222,was,0,0
122223,(,0,0
122224,30.63,0,0
122225,+/-,0,0
122226,19.28,0,0
122227,),0,0
122228,U/mL,0,0
122229,and,0,0
122230,(,0,0
122231,18.05,0,0
122232,+/-,0,0
122233,11.20,0,0
122234,),0,0
122235,U/mL,0,0
122236,respectively,0,0
122237,in,0,0
122238,the,0,0
122239,control,1,0
122240,group,1,0
122241,.,1,0
122242,It,0,0
122243,was,0,0
122244,lowered,0,0
122245,after,0,0
122246,drug,1,1
122247,therapy,1,0
122248,in,0,0
122249,the,0,0
122250,two,0,0
122251,groups,0,0
122252,with,0,0
122253,statistical,0,0
122254,difference,0,0
122255,(,0,0
122256,P,0,0
122257,<,0,0
122258,0.05,0,0
122259,),0,0
122260,.,0,0
122261,There,0,0
122262,was,0,0
122263,no,0,0
122264,statistical,0,0
122265,difference,0,0
122266,between,0,0
122267,the,0,0
122268,two,0,0
122269,groups,0,0
122270,after,0,0
122271,drug,1,1
122272,therapy,1,0
122273,(,0,0
122274,P,0,0
122275,>,0,0
122276,0.05,0,0
122277,),0,0
122278,.,0,0
122279,CONCLUSIONS,0,0
122280,The,0,0
122281,laparoscopic,1,0
122282,surgery,1,0
122283,in,1,0
122284,combination,1,0
122285,of,1,0
122286,QYJDR,1,0
122287,could,0,0
122288,effectively,0,0
122289,improve,0,0
122290,clinical,0,0
122291,symptoms,0,0
122292,of,0,0
122293,EMs,0,0
122294,patients,0,0
122295,of,0,0
122296,blood,0,0
122297,stasis,0,0
122298,and,0,0
122299,toxin,0,1
122300,accumulation,0,0
122301,syndrome,0,0
122302,",",0,0
122303,promote,0,0
122304,negative,0,0
122305,conversion,0,0
122306,of,0,0
122307,EMAb,0,0
122308,",",0,0
122309,lower,0,0
122310,serum,0,1
122311,CA125,0,1
122312,levels,0,0
122313,",",0,0
122314,and,0,0
122315,elevate,0,0
122316,the,0,0
122317,clinical,0,0
122318,pregnancy,0,0
122319,rate,0,0
122320,.,0,0
122321,QYJDR,1,0
122322,is,0,0
122323,an,0,0
122324,effective,0,0
122325,formula,0,0
122326,in,0,0
122327,treatment,0,0
122328,of,0,0
122329,EMs-related,0,0
122330,infertility,0,0
122331,.,0,0
122332,Effects,0,0
122333,of,0,0
122334,three,0,0
122335,oral,0,1
122336,analgesics,1,1
122337,on,0,1
122338,postoperative,0,0
122339,pain,0,0
122340,following,0,0
122341,root,0,0
122342,canal,0,0
122343,preparation,0,0
122344,:,0,0
122345,a,0,0
122346,controlled,0,0
122347,clinical,0,0
122348,trial,0,0
122349,.,0,0
122350,AIM,0,0
122351,To,0,0
122352,compare,0,0
122353,the,0,0
122354,effects,0,0
122355,of,0,0
122356,single,0,0
122357,doses,0,1
122358,of,0,0
122359,three,0,1
122360,oral,0,1
122361,medications,0,1
122362,on,0,1
122363,postoperative,0,0
122364,pain,0,0
122365,following,0,0
122366,instrumentation,0,0
122367,of,0,0
122368,root,0,0
122369,canals,0,0
122370,in,0,0
122371,teeth,0,0
122372,with,0,0
122373,irreversible,0,0
122374,pulpitis,0,0
122375,.,0,0
122376,METHODOLOGY,0,0
122377,In,0,0
122378,this,0,0
122379,double-blind,0,1
122380,clinical,0,1
122381,trial,0,1
122382,",",0,0
122383,100,0,0
122384,patients,0,0
122385,who,0,0
122386,had,0,0
122387,anterior,0,0
122388,or,0,0
122389,premolar,0,0
122390,teeth,0,0
122391,with,0,0
122392,irreversible,0,0
122393,pulpitis,0,0
122394,without,0,0
122395,any,0,0
122396,signs,0,0
122397,and,0,0
122398,symptoms,0,0
122399,of,0,0
122400,acute,0,0
122401,or,0,0
122402,chronic,0,0
122403,apical,0,0
122404,periodontitis,0,0
122405,and,0,0
122406,moderate,0,0
122407,to,0,0
122408,severe,0,0
122409,pain,0,0
122410,were,0,0
122411,divided,0,0
122412,by,0,0
122413,balanced,0,0
122414,block,0,0
122415,random,0,0
122416,allocation,0,0
122417,into,0,0
122418,four,0,0
122419,groups,0,0
122420,of,0,0
122421,25,0,0
122422,each,0,0
122423,",",0,0
122424,a,0,0
122425,control,1,0
122426,group,1,0
122427,receiving,1,0
122428,a,1,0
122429,placebo,1,1
122430,medication,1,1
122431,",",1,0
122432,and,1,0
122433,three,1,0
122434,experimental,1,0
122435,groups,1,0
122436,receiving,1,0
122437,a,1,0
122438,single,1,0
122439,dose,1,1
122440,of,1,0
122441,either,1,1
122442,Tramadol,1,1
122443,(,1,1
122444,100,1,1
122445,mg,1,1
122446,),1,1
122447,",",1,1
122448,Novafen,1,1
122449,(,1,1
122450,325,1,0
122451,mg,1,1
122452,of,1,0
122453,paracetamol,1,1
122454,",",1,1
122455,200,1,1
122456,mg,1,1
122457,ibuprofen,1,1
122458,and,1,1
122459,40,1,1
122460,mg,1,1
122461,caffeine,1,1
122462,anhydrous,1,1
122463,),1,1
122464,or,1,1
122465,Naproxen,1,1
122466,(,1,1
122467,500,1,1
122468,mg,1,1
122469,),1,1
122470,immediately,1,0
122471,after,1,0
122472,the,1,0
122473,first,1,0
122474,appointment,1,0
122475,where,1,0
122476,the,1,0
122477,pulp,1,0
122478,was,1,0
122479,removed,1,0
122480,",",1,0
122481,and,1,0
122482,the,1,0
122483,canals,1,0
122484,were,1,0
122485,fully,1,0
122486,prepared,1,0
122487,.,1,0
122488,The,0,0
122489,intensity,0,0
122490,of,0,0
122491,pain,0,0
122492,was,0,0
122493,scored,0,0
122494,based,0,0
122495,on,0,0
122496,10-point,0,0
122497,VAS,0,0
122498,before,0,0
122499,and,0,0
122500,after,0,0
122501,treatment,0,0
122502,for,0,0
122503,up,0,0
122504,to,0,0
122505,24,0,0
122506,h,0,0
122507,postoperatively,0,0
122508,.,0,0
122509,Data,0,0
122510,were,0,0
122511,submitted,0,0
122512,to,0,0
122513,repeated,0,0
122514,analysis,0,0
122515,of,0,0
122516,variance,0,0
122517,.,0,0
122518,RESULTS,0,0
122519,At,0,0
122520,the,0,0
122521,6,0,0
122522,",",0,0
122523,12,0,0
122524,and,0,0
122525,24,0,0
122526,h,0,0
122527,postoperative,0,0
122528,intervals,0,1
122529,after,0,0
122530,drug,0,1
122531,administration,0,1
122532,",",0,1
122533,the,0,0
122534,intensity,0,0
122535,of,0,0
122536,pain,0,0
122537,was,0,0
122538,significantly,0,0
122539,lower,0,0
122540,in,0,0
122541,the,0,0
122542,experimental,0,0
122543,groups,0,0
122544,than,0,0
122545,in,0,0
122546,the,1,0
122547,placebo,1,1
122548,group,1,0
122549,(,0,0
122550,P,0,0
122551,<,0,0
122552,0.01,1,0
122553,),1,0
122554,.,1,0
122555,Tramadol,1,1
122556,was,1,0
122557,significantly,1,0
122558,less,0,0
122559,effective,0,0
122560,(,0,0
122561,P,0,0
122562,<,0,0
122563,0.05,1,0
122564,),1,0
122565,than,1,0
122566,Naproxen,1,1
122567,",",1,1
122568,and,1,1
122569,Novafen,1,1
122570,that,0,0
122571,were,0,0
122572,similar,0,0
122573,to,0,0
122574,each,0,0
122575,other,0,0
122576,(,0,0
122577,P,0,0
122578,>,0,0
122579,0.05,0,0
122580,),0,0
122581,.,0,0
122582,CONCLUSION,0,0
122583,A,0,1
122584,single,0,1
122585,oral,0,1
122586,dose,1,1
122587,of,1,1
122588,Naproxen,1,1
122589,",",1,1
122590,Novafen,1,1
122591,and,1,1
122592,Tramadol,1,1
122593,taken,1,0
122594,immediately,0,0
122595,after,0,0
122596,treatment,0,0
122597,reduced,0,0
122598,postoperative,0,0
122599,pain,0,0
122600,following,0,0
122601,pulpectomy,0,0
122602,and,0,0
122603,root,0,0
122604,canal,0,0
122605,preparation,0,0
122606,of,0,0
122607,teeth,0,0
122608,with,0,0
122609,irreversible,0,0
122610,pulpitis,0,0
122611,.,0,0
122612,Randomised,0,1
122613,multicentre,0,0
122614,trial,0,0
122615,of,0,0
122616,circular,1,0
122617,stapling,1,0
122618,devices,1,0
122619,.,1,0
122620,PURPOSE,0,0
122621,In,0,0
122622,a,0,0
122623,register,0,0
122624,study,0,0
122625,",",0,0
122626,the,0,0
122627,risk,0,0
122628,of,0,0
122629,anastomotic,0,0
122630,leakage,0,0
122631,correlated,0,0
122632,to,0,0
122633,the,0,0
122634,choice,0,0
122635,of,0,0
122636,circular,1,0
122637,stapling,1,0
122638,device,1,0
122639,with,0,0
122640,a,0,0
122641,4,0,0
122642,%,0,0
122643,difference,0,0
122644,between,0,0
122645,the,0,0
122646,two,0,0
122647,brands,0,0
122648,used,0,0
122649,.,0,0
122650,Based,0,0
122651,on,0,0
122652,those,0,0
122653,data,0,0
122654,",",0,0
122655,a,0,0
122656,randomised,0,0
122657,multicentre,0,0
122658,study,0,0
122659,was,0,0
122660,started,0,0
122661,to,0,0
122662,explore,0,0
122663,the,0,0
122664,risk,0,0
122665,of,0,0
122666,an,0,0
122667,anastomotic,0,0
122668,leakage,0,0
122669,based,0,0
122670,upon,0,0
122671,the,0,0
122672,surgical,1,0
122673,device,1,0
122674,.,1,0
122675,METHODS,0,0
122676,Patients,0,0
122677,above,0,0
122678,18,0,0
122679,years,0,0
122680,with,0,0
122681,a,0,0
122682,rectal,0,0
122683,cancer,0,0
122684,",",0,0
122685,able,0,0
122686,to,0,0
122687,give,0,0
122688,informed,0,0
122689,consent,0,0
122690,",",0,0
122691,and,0,0
122692,scheduled,0,0
122693,for,0,0
122694,an,0,0
122695,anterior,0,0
122696,resection,0,0
122697,were,0,0
122698,eligible,0,0
122699,for,0,0
122700,the,0,0
122701,study,0,0
122702,.,0,0
122703,Perioperative,0,0
122704,randomisation,0,0
122705,was,0,0
122706,to,0,0
122707,Ethicon?,1,0
122708,PROXIMATE?,1,1
122709,ILS?,1,1
122710,or,1,0
122711,Autosuture?,1,0
122712,Premium,1,0
122713,Plus,1,0
122714,CEEA?,1,0
122715,.,1,0
122716,Anastomotic,0,0
122717,leakage,0,0
122718,was,0,0
122719,defined,0,0
122720,as,0,0
122721,a,0,0
122722,clinically,0,0
122723,manifest,0,0
122724,leak,0,0
122725,.,0,0
122726,RESULTS,0,0
122727,Five,0,0
122728,hundred,0,0
122729,twenty-nine,0,0
122730,patients,0,0
122731,were,0,0
122732,randomised,0,0
122733,(,0,0
122734,58,0,0
122735,%,0,0
122736,male,0,0
122737,),0,0
122738,.,0,0
122739,A,0,0
122740,leak,0,0
122741,occurred,0,0
122742,in,0,0
122743,8.3,0,0
122744,%,0,0
122745,.,0,0
122746,The,0,0
122747,anastomoses,0,0
122748,created,0,0
122749,by,0,0
122750,PROXIMATE?,1,0
122751,ILS?,1,0
122752,leaked,1,0
122753,in,0,0
122754,25/265,0,0
122755,(,0,0
122756,9.4,0,0
122757,%,0,0
122758,),0,0
122759,anastomoses,0,0
122760,",",0,0
122761,and,1,0
122762,the,1,0
122763,Premium,1,0
122764,Plus,1,0
122765,CEEA?,1,0
122766,leaked,1,0
122767,in,0,0
122768,19/260,0,0
122769,(,0,0
122770,7.3,0,0
122771,%,0,0
122772,),0,0
122773,",",0,0
122774,p,0,0
122775,=,0,0
122776,.419,0,0
122777,.,0,0
122778,CONCLUSION,0,0
122779,No,0,1
122780,difference,0,0
122781,in,0,0
122782,the,0,0
122783,leak,0,0
122784,rate,0,0
122785,could,0,0
122786,be,0,0
122787,revealed,0,0
122788,.,0,0
122789,Several,0,0
122790,centres,0,0
122791,replaced,0,0
122792,one,0,0
122793,of,0,0
122794,the,0,0
122795,staplers,0,0
122796,by,0,0
122797,a,0,0
122798,new,0,0
122799,product,0,0
122800,",",0,0
122801,and,0,0
122802,the,0,0
122803,study,0,0
122804,was,0,0
122805,ended,0,0
122806,before,0,0
122807,the,0,0
122808,stipulated,0,0
122809,number,0,0
122810,of,0,0
122811,patients,0,0
122812,was,0,0
122813,reached,0,0
122814,.,0,0
122815,In,0,0
122816,the,0,0
122817,future,0,0
122818,",",0,0
122819,surgical,0,0
122820,devices,0,0
122821,may,0,0
122822,have,0,0
122823,to,0,0
122824,prove,0,0
122825,superiority,0,0
122826,in,0,0
122827,randomised,0,0
122828,trials,0,0
122829,or,0,0
122830,be,0,0
122831,monitored,0,0
122832,in,0,0
122833,quality,0,0
122834,registers,0,0
122835,before,0,0
122836,they,0,0
122837,can,0,0
122838,be,0,0
122839,introduced,0,0
122840,into,0,0
122841,day,0,0
122842,to,0,0
122843,day,0,1
122844,surgical,0,1
122845,practice,0,1
122846,.,0,0
122847,The,0,0
122848,study,0,0
122849,was,0,0
122850,registered,0,0
122851,at,0,0
122852,ClinicalTrials.gov,0,0
122853,:,0,0
122854,NCT00399009,0,0
122855,.,0,0
122856,The,0,0
122857,effect,0,0
122858,of,0,0
122859,visual,0,0
122860,supports,0,0
122861,on,0,0
122862,performance,0,0
122863,of,0,0
122864,the,0,0
122865,TGMD-2,1,0
122866,for,0,0
122867,children,0,0
122868,with,0,0
122869,autism,0,0
122870,spectrum,0,0
122871,disorder,0,0
122872,.,0,0
122873,The,0,0
122874,purpose,0,0
122875,of,0,0
122876,this,0,0
122877,study,0,0
122878,was,0,0
122879,to,0,0
122880,examine,0,0
122881,the,0,0
122882,effects,0,0
122883,of,0,0
122884,visual,0,0
122885,supports,0,0
122886,on,0,0
122887,the,0,0
122888,performance,0,0
122889,of,0,0
122890,the,0,0
122891,Test,1,0
122892,of,1,0
122893,Gross,1,0
122894,Motor,1,0
122895,Development,1,0
122896,(,1,0
122897,TGMD-2,1,1
122898,),1,1
122899,for,0,0
122900,children,0,0
122901,with,0,0
122902,autism,0,0
122903,spectrum,0,0
122904,disorder,0,1
122905,(,0,1
122906,ASD,0,1
122907,),0,1
122908,.,0,0
122909,Participants,0,1
122910,(,0,0
122911,N,0,0
122912,=,0,0
122913,22,0,0
122914,),0,0
122915,performed,0,0
122916,the,0,0
122917,TGMD-2,1,0
122918,under,0,0
122919,three,0,0
122920,different,0,0
122921,protocols,0,0
122922,(,1,0
122923,traditional,1,0
122924,protocol,1,0
122925,",",1,0
122926,picture,1,0
122927,task,1,0
122928,card,1,0
122929,protocol,1,0
122930,",",1,0
122931,and,1,0
122932,picture,1,0
122933,activity,1,0
122934,schedule,1,0
122935,protocol,1,1
122936,),1,0
122937,.,0,0
122938,Gross,0,1
122939,motor,0,0
122940,quotient,0,0
122941,scores,0,0
122942,on,0,0
122943,the,0,0
122944,TGMD-2,1,0
122945,were,0,0
122946,measured,0,0
122947,and,0,0
122948,statistically,0,0
122949,analyzed,0,0
122950,using,0,0
122951,a,0,0
122952,within-subjects,0,0
122953,repeated-measures,0,0
122954,ANOVA,0,1
122955,.,0,0
122956,Results,0,0
122957,indicated,0,0
122958,statistically,0,0
122959,significant,0,0
122960,differences,0,0
122961,between,0,0
122962,protocols,0,0
122963,",",0,0
122964,while,0,0
122965,post,0,0
122966,hoc,0,0
122967,tests,0,0
122968,indicated,0,0
122969,that,0,0
122970,the,0,0
122971,picture,0,0
122972,task,0,0
122973,card,0,0
122974,condition,0,0
122975,produced,0,0
122976,significantly,0,0
122977,higher,0,0
122978,gross,0,0
122979,motor,0,0
122980,quotient,0,0
122981,scores,0,0
122982,than,0,0
122983,the,0,0
122984,traditional,0,0
122985,protocol,0,0
122986,and,0,0
122987,the,0,0
122988,picture,0,0
122989,activity,0,0
122990,schedule,0,0
122991,.,0,0
122992,The,0,0
122993,results,0,0
122994,suggest,0,0
122995,that,0,0
122996,more,0,0
122997,accurate,0,0
122998,gross,0,0
122999,motor,0,0
123000,quotient,0,0
123001,scores,0,0
123002,on,0,0
123003,the,0,0
123004,TGMD-2,1,0
123005,by,0,0
123006,children,0,0
123007,with,0,0
123008,ASD,0,0
123009,can,0,0
123010,be,0,0
123011,elicited,0,0
123012,using,0,0
123013,the,0,0
123014,picture,0,0
123015,task,0,0
123016,card,0,0
123017,protocol,0,0
123018,.,0,0
123019,Enhancing,0,0
123020,the,0,0
123021,application,0,0
123022,and,0,0
123023,evaluation,0,0
123024,of,0,0
123025,a,0,0
123026,discrete,1,0
123027,trial,1,0
123028,intervention,1,0
123029,package,1,0
123030,for,0,0
123031,eliciting,0,0
123032,first,0,0
123033,words,0,0
123034,in,0,0
123035,preverbal,0,0
123036,preschoolers,0,0
123037,with,0,0
123038,ASD,0,0
123039,.,0,0
123040,This,0,0
123041,study,0,0
123042,evaluates,0,0
123043,the,0,0
123044,effectiveness,0,0
123045,of,0,0
123046,an,0,0
123047,intervention,0,0
123048,package,0,0
123049,including,0,0
123050,a,0,0
123051,discrete,1,0
123052,trial,1,0
123053,program,1,1
123054,(,1,0
123055,Rapid,1,0
123056,Motor,1,0
123057,Imitation,1,0
123058,Antecedent,1,0
123059,Training,1,1
123060,(,0,0
123061,Tsiouri,0,1
123062,and,0,0
123063,Greer,0,0
123064,",",0,0
123065,J,0,1
123066,Behav,0,1
123067,Educat,0,0
123068,12:185-206,0,0
123069,",",0,0
123070,2003,0,0
123071,),0,0
123072,combined,1,0
123073,with,1,0
123074,parent,1,0
123075,education,1,0
123076,for,1,0
123077,eliciting,0,0
123078,first,0,0
123079,words,0,0
123080,in,0,0
123081,children,0,0
123082,with,0,0
123083,ASD,0,0
123084,who,0,0
123085,had,0,0
123086,little,0,0
123087,or,0,0
123088,no,0,0
123089,spoken,0,0
123090,language,0,0
123091,.,0,0
123092,Evaluation,0,0
123093,of,0,0
123094,the,0,0
123095,approach,0,0
123096,includes,0,0
123097,specific,0,0
123098,intervention,0,0
123099,targets,0,0
123100,and,0,0
123101,functional,0,0
123102,spoken,0,0
123103,language,0,1
123104,outcomes,0,1
123105,(,0,1
123106,Tager-Flusberg,0,1
123107,et,0,1
123108,al.,0,1
123109,",",0,0
123110,J,0,1
123111,Speech,0,1
123112,Lang,0,0
123113,Hear,0,0
123114,Res,0,0
123115,52:643-652,0,0
123116,",",0,0
123117,2009,0,1
123118,),0,0
123119,.,0,0
123120,Results,0,0
123121,suggest,0,0
123122,that,0,0
123123,RMIA,0,0
123124,",",0,0
123125,with,0,0
123126,parent,0,0
123127,training,0,0
123128,",",0,0
123129,catalyzes,0,0
123130,development,0,0
123131,of,0,0
123132,verbal,0,0
123133,imitation,0,0
123134,and,0,0
123135,production,0,0
123136,for,0,0
123137,some,0,0
123138,children,0,0
123139,.,0,0
123140,Three,0,0
123141,of,0,0
123142,five,0,0
123143,participants,0,0
123144,acquired,0,0
123145,word,0,0
123146,production,0,0
123147,within,0,0
123148,the,0,0
123149,DTT,0,0
123150,framework,0,0
123151,and,0,0
123152,achieved,0,0
123153,milestones,0,0
123154,of,0,0
123155,early,0,0
123156,functional,0,0
123157,spoken,0,0
123158,language,0,0
123159,use,0,0
123160,(,0,0
123161,Tager-Flusberg,0,1
123162,et,0,1
123163,al.,0,1
123164,",",0,0
123165,J,0,1
123166,Speech,0,1
123167,Lang,0,0
123168,Hear,0,0
123169,Res,0,0
123170,52:643-652,0,0
123171,",",0,0
123172,2009,0,1
123173,),0,0
123174,.,0,0
123175,The,0,0
123176,implications,0,0
123177,of,0,0
123178,these,0,0
123179,findings,0,0
123180,for,0,0
123181,understanding,0,0
123182,the,0,0
123183,role,0,0
123184,of,0,0
123185,discrete,0,0
123186,trial,0,0
123187,approaches,0,0
123188,to,0,0
123189,language,0,0
123190,intervention,0,0
123191,are,0,0
123192,discussed,0,0
123193,.,0,0
123194,[,0,1
123195,The,0,0
123196,equipotency,0,1
123197,of,0,0
123198,ropivacaine,1,1
123199,",",1,1
123200,bupivacaine,1,1
123201,and,0,1
123202,etidocaine,1,1
123203,],1,1
123204,.,0,1
123205,Ropivacaine,1,1
123206,",",0,0
123207,congenerate,0,0
123208,to,0,0
123209,bupivacaine,0,1
123210,and,0,1
123211,mepivacaine,0,1
123212,has,0,0
123213,been,0,0
123214,widely,0,0
123215,studied,0,0
123216,in,0,0
123217,laboratory,0,0
123218,animals,0,0
123219,",",0,0
123220,but,0,0
123221,there,0,0
123222,have,0,0
123223,been,0,0
123224,few,0,0
123225,investigations,0,0
123226,of,0,0
123227,its,0,0
123228,efficacy,0,0
123229,in,0,0
123230,human,0,0
123231,epidural,0,0
123232,anesthesia,0,0
123233,and,0,0
123234,peripheral,0,0
123235,nerve,0,0
123236,blocks,0,0
123237,.,0,0
123238,The,0,0
123239,aim,0,0
123240,of,0,0
123241,this,0,0
123242,study,0,0
123243,was,0,0
123244,to,0,0
123245,compare,0,0
123246,the,0,0
123247,three,0,0
123248,long-acting,0,1
123249,local,0,1
123250,anesthetics,0,1
123251,(,1,1
123252,bupivacaine,1,1
123253,0.75,0,0
123254,%,0,0
123255,",",0,0
123256,ropivacaine,1,0
123257,1,0,0
123258,%,0,0
123259,and,0,0
123260,etidocaine,1,0
123261,1,0,1
123262,%,0,0
123263,),0,0
123264,and,0,0
123265,to,0,0
123266,try,0,0
123267,",",0,0
123268,with,0,0
123269,reference,0,0
123270,to,0,0
123271,previous,0,0
123272,studies,0,0
123273,",",0,0
123274,to,0,0
123275,make,0,0
123276,some,0,0
123277,statement,0,0
123278,about,0,0
123279,the,0,0
123280,equipotency,0,1
123281,of,0,1
123282,ropivacaine,1,1
123283,relative,0,0
123284,to,0,0
123285,bupivacaine,1,1
123286,and,0,1
123287,etidocaine,1,1
123288,.,1,1
123289,METHODS,0,0
123290,.,0,0
123291,In,0,0
123292,a,0,0
123293,double,0,0
123294,blind,0,0
123295,randomized,0,0
123296,study,0,0
123297,",",0,0
123298,epidural,0,0
123299,anesthesia,0,0
123300,was,0,0
123301,carried,0,0
123302,out,0,0
123303,with,0,0
123304,20,0,0
123305,ml,0,0
123306,bupivacaine,1,0
123307,0.75,0,0
123308,%,0,0
123309,(,0,0
123310,n,0,0
123311,=,0,0
123312,24,0,0
123313,),0,0
123314,and,0,1
123315,ropivacaine,1,1
123316,1,0,1
123317,%,0,0
123318,(,0,0
123319,n,0,0
123320,=,0,0
123321,21,0,0
123322,),0,0
123323,.,0,0
123324,Following,0,0
123325,this,0,0
123326,study,0,0
123327,epidural,0,0
123328,anesthesia,0,0
123329,was,0,0
123330,carried,0,0
123331,out,0,0
123332,with,0,0
123333,20,0,0
123334,ml,0,0
123335,etidocaine,1,1
123336,1,0,1
123337,%,0,0
123338,(,0,0
123339,n,0,0
123340,=,0,0
123341,20,0,0
123342,),0,0
123343,in,0,0
123344,an,0,0
123345,open,0,0
123346,study,0,0
123347,.,0,0
123348,Patients,0,0
123349,with,0,0
123350,ASA,0,0
123351,I,0,0
123352,or,0,0
123353,II,0,0
123354,were,0,0
123355,enrolled,0,0
123356,in,0,0
123357,the,0,0
123358,study,0,0
123359,.,0,0
123360,All,0,0
123361,patients,0,0
123362,were,0,0
123363,scheduled,0,0
123364,for,0,0
123365,varicose,0,0
123366,vein,0,0
123367,stripping,0,0
123368,.,0,0
123369,Male,0,0
123370,and,0,0
123371,female,0,0
123372,patients,0,0
123373,aged,0,0
123374,18-70,0,0
123375,years,0,0
123376,and,0,0
123377,weighing,0,1
123378,50-100,0,0
123379,kg,0,0
123380,were,0,0
123381,included,0,0
123382,in,0,0
123383,the,0,0
123384,study,0,0
123385,.,0,0
123386,Patients,0,0
123387,were,0,0
123388,all,0,0
123389,placed,0,0
123390,in,0,0
123391,a,0,0
123392,sitting,0,0
123393,position,0,0
123394,",",0,0
123395,after,0,0
123396,which,0,0
123397,the,0,0
123398,epidural,0,0
123399,space,0,0
123400,was,0,0
123401,identified,0,0
123402,by,0,0
123403,the,0,0
123404,loss,0,0
123405,of,0,0
123406,resistance,0,0
123407,technique,0,0
123408,and,0,0
123409,a,0,0
123410,midline,0,0
123411,approach,0,0
123412,",",0,0
123413,at,0,0
123414,the,0,0
123415,L-3/4,0,0
123416,interspace,0,0
123417,.,0,0
123418,Injections,1,0
123419,of,1,0
123420,3,1,0
123421,ml,1,0
123422,of,1,0
123423,the,1,0
123424,local,1,0
123425,anesthetic,1,1
123426,were,0,0
123427,given,0,0
123428,",",0,0
123429,followed,1,0
123430,by,1,0
123431,the,1,0
123432,remainder,1,0
123433,of,1,0
123434,the,1,0
123435,local,1,0
123436,anesthetic,1,1
123437,at,1,0
123438,10,1,0
123439,ml/min,1,0
123440,1,1,0
123441,min,1,0
123442,later,1,0
123443,.,1,0
123444,Following,0,0
123445,injection,0,1
123446,patients,0,0
123447,were,0,0
123448,immediately,0,0
123449,positioned,0,0
123450,supine,0,0
123451,.,0,0
123452,Analgesia,0,1
123453,was,0,0
123454,determined,0,0
123455,by,0,0
123456,the,0,0
123457,pin-prick,0,0
123458,method,0,0
123459,and,0,0
123460,motor,0,1
123461,blockade,0,1
123462,was,0,0
123463,assessed,0,0
123464,according,0,0
123465,to,0,0
123466,the,0,0
123467,Bromage,0,0
123468,scale,0,0
123469,.,0,0
123470,Heart,0,0
123471,rate,0,0
123472,and,0,0
123473,blood,0,0
123474,pressure,0,0
123475,were,0,0
123476,monitored,0,0
123477,until,0,0
123478,3,0,0
123479,h,0,0
123480,after,0,0
123481,injection,0,1
123482,.,0,0
123483,RESULTS,0,0
123484,.,0,0
123485,The,0,0
123486,latency,0,0
123487,of,0,0
123488,analgesia,0,1
123489,for,0,0
123490,the,0,0
123491,first,0,0
123492,blocked,0,0
123493,segment,0,0
123494,(,0,0
123495,T,0,0
123496,12,0,0
123497,for,0,0
123498,bupivacaine,0,1
123499,and,0,1
123500,ropivacaine,0,1
123501,and,0,0
123502,L-1,0,1
123503,for,0,1
123504,etidocaine,0,1
123505,),0,0
123506,was,0,0
123507,6.0,0,0
123508,min,0,0
123509,for,0,0
123510,bupivacaine,1,1
123511,0.75,0,0
123512,",",0,0
123513,5.5,0,0
123514,min,0,0
123515,for,0,0
123516,ropivacaine,1,1
123517,1,0,0
123518,%,0,0
123519,",",0,0
123520,and,0,0
123521,5.2,0,0
123522,min,0,0
123523,for,0,0
123524,etidocaine,1,1
123525,1,0,0
123526,%,0,0
123527,",",0,0
123528,and,0,0
123529,the,0,0
123530,highest,0,0
123531,thoracic,0,0
123532,dermatome,0,1
123533,(,0,1
123534,T,0,1
123535,5,0,0
123536,for,0,0
123537,bupivacaine,1,1
123538,",",0,1
123539,T,0,1
123540,4,0,0
123541,for,0,0
123542,ropivacaine,1,1
123543,and,0,1
123544,T,0,1
123545,7,0,0
123546,for,0,0
123547,etidocaine,1,1
123548,),1,1
123549,was,0,0
123550,reached,0,0
123551,after,0,0
123552,24,0,0
123553,+/-,0,0
123554,10,0,0
123555,",",0,0
123556,26,0,0
123557,+/-,0,0
123558,9,0,0
123559,",",0,0
123560,and,0,0
123561,30,0,0
123562,+/-,0,0
123563,18,0,0
123564,min,0,0
123565,for,0,0
123566,bupivacaine,1,1
123567,",",1,1
123568,ropivacaine,1,1
123569,",",0,1
123570,and,0,1
123571,etidocaine,1,1
123572,",",0,0
123573,respectively,0,0
123574,.,0,0
123575,The,0,0
123576,duration,0,0
123577,of,0,0
123578,sensory,0,0
123579,anesthesia,0,0
123580,at,0,0
123581,the,0,0
123582,T,0,0
123583,10,0,0
123584,dermatomal,0,0
123585,level,0,0
123586,was,0,0
123587,257,0,0
123588,+/-,0,0
123589,102,0,0
123590,",",0,0
123591,278,0,0
123592,+/-,0,0
123593,67,0,0
123594,",",0,0
123595,and,0,0
123596,191,0,0
123597,+/-,0,0
123598,86,0,0
123599,min,0,0
123600,for,0,0
123601,bupivacaine,1,1
123602,",",1,1
123603,ropivacaine,1,1
123604,",",0,1
123605,and,0,1
123606,etidocaine,1,1
123607,",",0,0
123608,respectively,0,0
123609,.,0,0
123610,The,0,0
123611,two-segment,0,0
123612,regression,0,0
123613,time,0,0
123614,was,0,0
123615,199,0,0
123616,+/-,0,0
123617,80,0,0
123618,min,0,0
123619,for,0,0
123620,bupivacaine,1,1
123621,",",0,0
123622,201,0,0
123623,+/-,0,0
123624,52,0,0
123625,min,0,0
123626,for,0,0
123627,ropivacaine,1,1
123628,",",0,0
123629,and,0,0
123630,174,0,0
123631,+/-,0,0
123632,81,0,0
123633,min,0,0
123634,for,0,0
123635,etidocaine,1,1
123636,.,1,0
123637,The,0,0
123638,total,0,0
123639,duration,0,0
123640,of,0,0
123641,sensory,0,0
123642,block,0,0
123643,was,0,0
123644,340,0,0
123645,+/-,0,0
123646,103,0,0
123647,min,0,0
123648,for,0,0
123649,bupivacaine,1,1
123650,",",0,0
123651,428,0,0
123652,+/-,0,0
123653,65,0,0
123654,min,0,0
123655,for,0,0
123656,ropivacaine,1,1
123657,and,0,0
123658,223,0,0
123659,+/-,0,0
123660,62,0,0
123661,min,0,0
123662,for,0,0
123663,etidocaine,1,1
123664,",",0,0
123665,respectively,0,0
123666,.,0,0
123667,In,0,0
123668,the,0,0
123669,ropivacaine,1,1
123670,and,0,1
123671,bupivacaine,1,1
123672,groups,0,1
123673,sensory,0,0
123674,anesthesia,0,0
123675,was,0,0
123676,considered,0,0
123677,adequate,0,0
123678,for,0,0
123679,surgery,0,0
123680,in,0,0
123681,all,0,0
123682,cases,0,0
123683,but,0,0
123684,one,0,0
123685,in,0,0
123686,each,0,0
123687,group,0,0
123688,;,0,0
123689,in,0,0
123690,the,0,0
123691,etidocaine,1,1
123692,group,0,0
123693,",",0,0
123694,however,0,0
123695,60,0,0
123696,%,0,0
123697,of,0,0
123698,the,0,0
123699,patients,0,0
123700,showed,0,0
123701,inadequate,0,1
123702,analgesia,0,1
123703,and,0,0
123704,all,0,0
123705,these,0,0
123706,patients,0,0
123707,(,0,0
123708,12/20,0,0
123709,),0,0
123710,required,0,0
123711,additional,0,0
123712,analgesics,0,1
123713,.,0,1
123714,Bupivacaine,1,1
123715,achieved,0,0
123716,an,0,0
123717,average,0,0
123718,of,0,0
123719,motor,0,0
123720,block,0,0
123721,2.1,0,0
123722,",",0,0
123723,ropivacaine,1,0
123724,2.3,0,0
123725,",",0,0
123726,and,0,0
123727,etidocaine,1,1
123728,2.4,0,0
123729,.,0,0
123730,CONCLUSION,0,0
123731,.,0,0
123732,The,0,0
123733,results,0,0
123734,of,0,0
123735,this,0,0
123736,study,0,0
123737,indicate,0,0
123738,that,0,0
123739,ropivacaine,1,1
123740,is,0,0
123741,an,0,0
123742,effective,0,0
123743,local,0,0
123744,anesthetic,0,1
123745,agent,0,0
123746,.,0,0
123747,Its,0,0
123748,potency,0,0
123749,is,0,0
123750,about,0,0
123751,equal,0,0
123752,to,0,0
123753,that,0,0
123754,of,0,0
123755,bupivacaine,1,1
123756,and,0,0
123757,much,0,0
123758,higher,0,0
123759,than,0,0
123760,that,0,0
123761,of,0,0
123762,etidocaine,1,1
123763,...,1,1
123764,Side,0,1
123765,branch,0,0
123766,occlusion,0,1
123767,with,0,0
123768,everolimus-eluting,1,1
123769,and,1,1
123770,paclitaxel-eluting,1,1
123771,stents,1,1
123772,:,1,0
123773,three-year,0,0
123774,results,0,0
123775,from,0,0
123776,the,0,0
123777,SPIRIT,0,0
123778,III,0,1
123779,randomised,0,0
123780,trial,0,0
123781,.,0,0
123782,AIMS,0,0
123783,AND,0,0
123784,METHODS,0,1
123785,The,0,0
123786,rates,0,0
123787,of,0,0
123788,side,0,0
123789,branch,0,0
123790,occlusion,0,0
123791,and,0,0
123792,subsequent,0,0
123793,periprocedural,0,0
123794,MI,0,1
123795,during,0,0
123796,everolimus-eluting,1,1
123797,stent,1,1
123798,(,1,1
123799,EES,1,1
123800,),1,1
123801,and,0,1
123802,paclitaxel-eluting,1,1
123803,stent,1,1
123804,(,1,1
123805,PES,1,1
123806,),1,1
123807,placement,0,0
123808,were,0,0
123809,examined,0,0
123810,in,0,0
123811,the,0,0
123812,randomised,0,0
123813,SPIRIT,0,1
123814,III,0,1
123815,trial,0,0
123816,.,0,0
123817,Periprocedural,0,0
123818,myocardial,0,1
123819,infarction,0,1
123820,(,0,1
123821,MI,0,1
123822,),0,1
123823,following,0,0
123824,drug-eluting,0,0
123825,stent,0,0
123826,placement,0,0
123827,is,0,0
123828,associated,0,0
123829,with,0,0
123830,long-term,0,0
123831,adverse,0,0
123832,outcomes,0,0
123833,.,0,0
123834,Occlusion,0,0
123835,of,0,0
123836,side,0,0
123837,branches,0,0
123838,may,0,0
123839,be,0,0
123840,an,0,0
123841,important,0,0
123842,factor,0,0
123843,contributing,0,0
123844,to,0,0
123845,periprocedural,0,0
123846,MIs,0,0
123847,.,0,0
123848,Consecutive,1,0
123849,procedural,1,0
123850,angiograms,1,0
123851,of,0,0
123852,patients,0,0
123853,randomly,0,0
123854,assigned,0,0
123855,to,0,0
123856,EES,1,0
123857,(,0,0
123858,n=669,0,0
123859,),0,0
123860,or,1,0
123861,PES,1,1
123862,(,0,0
123863,n=333,0,0
123864,),0,0
123865,were,0,0
123866,analysed,0,0
123867,by,0,0
123868,an,0,0
123869,independent,0,0
123870,angiographic,0,0
123871,core,0,0
123872,laboratory,0,0
123873,.,0,0
123874,Side,0,0
123875,branch,0,0
123876,occlusion,0,0
123877,was,0,0
123878,defined,0,0
123879,as,0,0
123880,Thrombolysis,0,0
123881,In,0,0
123882,Myocardial,0,1
123883,Infarction,0,1
123884,(,0,1
123885,TIMI,0,1
123886,),0,1
123887,flow,0,0
123888,grade,0,0
123889,0,0,0
123890,or,0,0
123891,1,0,0
123892,.,0,0
123893,Clinical,0,0
123894,outcomes,0,0
123895,through,0,0
123896,three,0,0
123897,years,0,0
123898,were,0,0
123899,compared,0,0
123900,by,0,0
123901,stent,0,0
123902,type,0,0
123903,and,0,0
123904,presence,0,0
123905,of,0,0
123906,side,0,0
123907,branch,0,0
123908,occlusion,0,0
123909,.,0,0
123910,CONCLUSIONS,0,0
123911,A,0,0
123912,total,0,0
123913,of,0,0
123914,"2,048",0,0
123915,side,0,0
123916,branches,0,0
123917,were,0,0
123918,evaluated,0,0
123919,(,0,0
123920,EES,0,1
123921,"N=1,345",0,1
123922,side,0,0
123923,branches,0,0
123924,in,0,0
123925,688,0,0
123926,stented,0,0
123927,lesions,0,0
123928,",",0,0
123929,PES,0,0
123930,N=703,0,0
123931,side,0,0
123932,branches,0,0
123933,in,0,0
123934,346,0,0
123935,stented,0,0
123936,lesions,0,0
123937,),0,0
123938,.,0,0
123939,Patients,0,0
123940,with,0,0
123941,compared,0,0
123942,to,0,0
123943,those,0,0
123944,without,0,0
123945,transient,0,0
123946,or,0,0
123947,final,0,0
123948,side,0,0
123949,branch,0,0
123950,occlusion,0,0
123951,had,0,0
123952,significantly,0,0
123953,higher,0,0
123954,non-Q-wave,0,0
123955,MI,0,1
123956,(,0,1
123957,NQMI,0,1
123958,),0,1
123959,rates,0,0
123960,in-hospital,0,1
123961,(,0,0
123962,9.0,0,0
123963,%,0,0
123964,vs.,0,0
123965,0.5,0,0
123966,%,0,0
123967,",",0,0
123968,p,0,0
123969,<,0,0
123970,0.0001,0,0
123971,),0,0
123972,.,0,0
123973,By,0,0
123974,multivariable,0,0
123975,analysis,0,0
123976,side,0,0
123977,branch,0,0
123978,occlusion,0,0
123979,was,0,0
123980,an,0,0
123981,independent,0,0
123982,predictor,0,0
123983,of,0,0
123984,NQMI,0,1
123985,(,0,0
123986,OR,0,0
123987,4.45,0,0
123988,;,0,0
123989,95,0,0
123990,%,0,0
123991,CI,0,0
123992,[,0,0
123993,1.82,0,0
123994,",",0,0
123995,10.85,0,0
123996,],0,0
123997,),0,0
123998,.,0,0
123999,Transient,0,0
124000,or,0,0
124001,final,0,0
124002,side,0,0
124003,branch,0,0
124004,occlusion,0,0
124005,occurred,0,0
124006,less,0,0
124007,frequently,0,0
124008,in,0,0
124009,patients,0,0
124010,receiving,0,0
124011,EES,0,0
124012,compared,0,0
124013,to,0,0
124014,PES,0,1
124015,(,0,0
124016,2.8,0,0
124017,%,0,0
124018,vs.,0,0
124019,5.2,0,0
124020,%,0,0
124021,",",0,0
124022,p=0.009,0,0
124023,),0,0
124024,",",0,0
124025,contributing,0,0
124026,to,0,0
124027,the,0,0
124028,numerically,0,0
124029,lower,0,0
124030,rates,0,0
124031,of,0,0
124032,in-hospital,0,0
124033,NQMI,0,0
124034,with,0,0
124035,EES,0,0
124036,arm,0,0
124037,compared,0,0
124038,to,0,0
124039,PES,0,0
124040,(,0,0
124041,0.7,0,0
124042,%,0,0
124043,vs.,0,0
124044,2.3,0,0
124045,%,0,0
124046,",",0,0
124047,p=0.05,0,0
124048,),0,0
124049,.,0,0
124050,Patients,0,0
124051,treated,0,0
124052,with,0,0
124053,EES,1,0
124054,rather,0,0
124055,than,0,0
124056,PES,1,0
124057,were,0,0
124058,less,0,0
124059,likely,0,0
124060,to,0,0
124061,develop,0,0
124062,side,0,0
124063,branch,0,0
124064,occlusion,0,0
124065,during,0,0
124066,stent,0,0
124067,placement,0,0
124068,",",0,0
124069,contributing,0,0
124070,to,0,0
124071,lower,0,0
124072,rates,0,0
124073,of,0,0
124074,periprocedural,0,0
124075,MI,0,0
124076,with,0,0
124077,EES,1,0
124078,compared,0,0
124079,to,0,0
124080,PES,1,0
124081,.,1,0
124082,A,0,1
124083,controlled,0,0
124084,crossover,0,1
124085,trial,0,1
124086,of,0,1
124087,fenfluramine,1,1
124088,in,0,0
124089,autism,0,0
124090,.,0,0
124091,We,0,0
124092,report,0,0
124093,a,0,0
124094,12,0,0
124095,month,0,0
124096,double-blind,0,1
124097,randomized,0,1
124098,crossover,0,1
124099,trial,0,1
124100,of,0,1
124101,fenfluramine,1,1
124102,in,0,0
124103,20,0,0
124104,children,0,0
124105,with,0,0
124106,the,0,0
124107,syndrome,0,0
124108,of,0,0
124109,autism,0,0
124110,.,0,0
124111,On,0,0
124112,active,0,0
124113,drug,0,1
124114,most,0,0
124115,of,0,0
124116,the,0,0
124117,children,0,0
124118,lost,0,0
124119,weight,0,0
124120,and,0,0
124121,blood,0,1
124122,serotonin,0,1
124123,levels,0,0
124124,fell,0,0
124125,by,0,0
124126,an,0,0
124127,average,0,0
124128,of,0,0
124129,60,0,0
124130,%,0,0
124131,.,0,0
124132,There,0,0
124133,was,0,0
124134,a,0,0
124135,fall,0,0
124136,in,0,0
124137,urinary,0,1
124138,dopamine,0,1
124139,(,0,1
124140,DA,0,1
124141,),0,1
124142,and,0,1
124143,noradrenaline,0,1
124144,(,0,1
124145,NA,0,1
124146,),0,0
124147,levels,0,0
124148,and,0,0
124149,increased,0,0
124150,excretion,0,1
124151,of,0,1
124152,homovanillic,0,1
124153,acid,0,1
124154,(,0,1
124155,HVA,0,1
124156,),0,1
124157,.,0,0
124158,Some,0,0
124159,of,0,0
124160,the,0,0
124161,children,0,0
124162,showed,0,0
124163,improvement,0,0
124164,in,0,0
124165,tests,0,0
124166,of,0,0
124167,cognitive,0,0
124168,and,0,0
124169,language,0,0
124170,function,0,0
124171,",",0,0
124172,although,0,0
124173,the,0,0
124174,results,0,0
124175,did,0,0
124176,not,0,0
124177,achieve,0,0
124178,overall,0,0
124179,statistical,0,0
124180,significance,0,0
124181,.,0,0
124182,Event-related,0,0
124183,brain,0,0
124184,potentials,0,0
124185,(,0,0
124186,ERPs,0,1
124187,),0,0
124188,were,0,0
124189,obtained,0,0
124190,in,0,0
124191,seven,0,0
124192,subjects,0,0
124193,on,0,0
124194,an,0,0
124195,auditory,0,0
124196,choice,0,0
124197,reaction,0,0
124198,time,0,0
124199,task,0,0
124200,.,0,0
124201,Side,0,0
124202,effects,0,0
124203,of,0,0
124204,the,0,0
124205,drug,0,1
124206,included,0,0
124207,irritability,0,0
124208,and,0,0
124209,lethargy,0,0
124210,.,0,0
124211,Fenfluramine,0,1
124212,may,0,0
124213,have,0,0
124214,a,0,0
124215,limited,0,0
124216,place,0,0
124217,in,0,0
124218,the,0,0
124219,management,0,0
124220,of,0,0
124221,some,0,0
124222,patients,0,0
124223,with,0,0
124224,autistic,0,0
124225,disorder,0,0
124226,.,0,0
124227,Design,0,0
124228,and,0,0
124229,implementation,0,0
124230,of,0,0
124231,the,0,0
124232,TRACIA,0,1
124233,:,0,1
124234,intracoronary,0,1
124235,autologous,0,1
124236,transplant,0,1
124237,of,0,0
124238,bone,0,0
124239,marrow-derived,0,0
124240,stem,0,0
124241,cells,0,0
124242,for,0,0
124243,acute,0,0
124244,ST,0,0
124245,elevation,0,0
124246,myocardial,0,0
124247,infarction,0,0
124248,.,0,0
124249,OBJECTIVE,0,0
124250,To,0,0
124251,describe,0,0
124252,the,0,0
124253,design,0,0
124254,of,0,0
124255,a,0,0
124256,protocol,0,0
124257,of,0,0
124258,intracoronary,1,1
124259,autologous,1,1
124260,transplant,1,1
124261,of,1,0
124262,bone,1,0
124263,marrow-derived,1,0
124264,stem,1,0
124265,cells,1,0
124266,for,0,0
124267,acute,0,0
124268,ST-elevation,0,0
124269,myocardial,0,1
124270,infarction,0,1
124271,(,0,1
124272,STEMI,0,1
124273,),0,1
124274,and,0,0
124275,to,0,0
124276,report,0,0
124277,the,0,0
124278,safety,0,0
124279,of,0,0
124280,the,0,0
124281,procedure,0,0
124282,in,0,0
124283,the,0,0
124284,first,0,0
124285,patients,0,0
124286,included,0,0
124287,.,0,0
124288,METHODS,0,0
124289,The,0,0
124290,TRACIA,0,0
124291,study,0,0
124292,was,0,0
124293,implemented,0,0
124294,following,0,0
124295,predetermined,0,0
124296,inclusion,0,0
124297,and,0,0
124298,exclusion,0,0
124299,criteria,0,0
124300,.,0,0
124301,The,0,0
124302,protocol,0,0
124303,includes,0,0
124304,procedures,0,0
124305,such,0,0
124306,as,0,0
124307,randomization,1,0
124308,",",1,0
124309,bone,1,0
124310,marrow,1,0
124311,retrieval,1,0
124312,",",1,0
124313,stem,1,0
124314,cells,1,0
124315,processing,1,0
124316,",",1,0
124317,intracoronary,1,1
124318,infusion,1,1
124319,of,1,0
124320,stem,1,0
124321,cells,1,0
124322,in,1,0
124323,the,1,0
124324,infarct-related,1,0
124325,artery,1,0
124326,",",1,0
124327,preand-,1,0
124328,post,1,0
124329,MRI,1,0
124330,",",1,0
124331,pre-and-post,1,0
124332,SPECT,1,1
124333,with,1,0
124334,radioisotope,1,0
124335,ventriculography,1,0
124336,",",1,0
124337,and,1,0
124338,clinical,1,0
124339,follow-up,1,0
124340,at,1,0
124341,6,1,0
124342,months,1,0
124343,.,1,0
124344,RESULTS,0,0
124345,Eight,0,0
124346,patients,0,0
124347,with,0,0
124348,a,0,0
124349,diagnosis,0,0
124350,of,0,0
124351,acute,0,0
124352,STEMI,0,1
124353,and,0,0
124354,duration,0,0
124355,of,0,0
124356,symptoms,0,0
124357,of,0,0
124358,?,0,0
124359,24,0,0
124360,hours,0,0
124361,that,0,0
124362,were,0,0
124363,perfused,0,1
124364,successfully,0,0
124365,through,0,0
124366,primary,0,0
124367,percutaneous,0,0
124368,coronary,0,1
124369,intervention,0,1
124370,(,0,1
124371,PPCI,0,1
124372,),0,1
124373,with,0,0
124374,a,0,0
124375,LVEF,0,0
124376,of,0,0
124377,?,0,0
124378,45,0,0
124379,%,0,0
124380,were,0,0
124381,assigned,0,0
124382,randomly,0,0
124383,to,0,0
124384,two,0,0
124385,groups,0,0
124386,(,0,0
124387,n,0,0
124388,=,0,0
124389,4,0,0
124390,each,0,0
124391,),0,0
124392,.,0,0
124393,One,0,0
124394,group,0,0
124395,treated,0,0
124396,with,0,0
124397,stem,1,0
124398,cells,1,0
124399,and,0,0
124400,the,0,0
124401,other,0,0
124402,corresponded,0,0
124403,to,0,0
124404,the,0,0
124405,control,1,0
124406,group,1,0
124407,.,1,0
124408,Neither,0,0
124409,death,0,0
124410,",",0,0
124411,re-infarction,0,0
124412,",",0,0
124413,no,0,0
124414,need,0,0
124415,for,0,0
124416,revascularization,0,0
124417,or,0,0
124418,thrombosis,0,0
124419,of,0,0
124420,the,0,0
124421,stent,0,0
124422,were,0,0
124423,observed,0,0
124424,at,0,0
124425,follow-up,0,0
124426,.,0,0
124427,CONCLUSIONS,0,0
124428,The,0,0
124429,initial,0,0
124430,experience,0,0
124431,at,0,0
124432,the,0,0
124433,Instituto,0,0
124434,Nacional,0,0
124435,de,0,0
124436,Cardiolog?a,0,0
124437,Ignacio,0,1
124438,Ch?vez,0,0
124439,in,0,0
124440,the,0,0
124441,treatment,0,0
124442,of,0,0
124443,acute,0,0
124444,STEMI,0,0
124445,by,0,0
124446,means,0,0
124447,of,0,0
124448,autologous,0,0
124449,transplantation,0,0
124450,of,0,0
124451,bone,1,0
124452,marrow-derived,1,0
124453,stem,1,0
124454,cells,1,0
124455,is,1,0
124456,encouraging,0,0
124457,.,0,0
124458,Implementation,0,0
124459,was,0,0
124460,possible,0,0
124461,in,0,0
124462,the,0,0
124463,first,0,0
124464,eight,0,0
124465,patients,0,0
124466,with,0,0
124467,no,0,0
124468,complications,0,0
124469,.,0,0
124470,[,0,1
124471,Treatment,0,0
124472,of,0,0
124473,primary,0,0
124474,osteoporosis,0,0
124475,with,0,0
124476,calcium,1,1
124477,and,1,1
124478,salmon,1,1
124479,calcitonin,1,1
124480,],1,1
124481,.,0,0
124482,Fifty-nine,0,0
124483,consecutive,0,0
124484,patients,0,0
124485,(,0,0
124486,19,0,0
124487,men,0,0
124488,",",0,0
124489,40,0,0
124490,women,0,0
124491,",",0,0
124492,mean,0,0
124493,age,0,0
124494,60.8,0,0
124495,[,0,0
124496,27-80,0,0
124497,],0,0
124498,years,0,0
124499,),0,0
124500,with,0,0
124501,primary,0,0
124502,osteoporosis,0,0
124503,were,0,0
124504,studied,0,0
124505,to,0,0
124506,see,0,0
124507,if,0,0
124508,there,0,0
124509,was,0,0
124510,any,0,0
124511,significant,0,0
124512,gain,0,0
124513,in,0,0
124514,bone,0,0
124515,mass,0,0
124516,after,0,0
124517,treatment,0,0
124518,with,0,0
124519,salmon,1,0
124520,calcitonin,1,1
124521,.,1,1
124522,All,0,0
124523,the,0,0
124524,patients,0,0
124525,were,0,0
124526,given,0,0
124527,1,0,1
124528,g,0,0
124529,calcium,1,1
124530,by,0,1
124531,mouth,0,1
124532,every,0,1
124533,morning,0,1
124534,.,0,0
124535,Group,0,0
124536,1,0,0
124537,(,0,0
124538,n,0,0
124539,=,0,0
124540,20,0,0
124541,),0,0
124542,received,0,0
124543,no,0,0
124544,other,0,0
124545,specific,0,0
124546,medication,0,0
124547,while,0,0
124548,group,0,0
124549,2,0,0
124550,(,0,0
124551,n,0,0
124552,=,0,0
124553,19,0,0
124554,),0,0
124555,were,0,0
124556,given,0,0
124557,100,1,0
124558,I.U,1,0
124559,.,1,1
124560,calcitonin,1,1
124561,subcutaneously,1,1
124562,every,1,1
124563,second,1,0
124564,evening,1,1
124565,and,1,0
124566,group,1,0
124567,3,1,1
124568,(,1,0
124569,n,1,0
124570,=,1,0
124571,20,1,0
124572,),1,0
124573,received,1,0
124574,the,1,0
124575,same,1,0
124576,dose,1,1
124577,every,1,1
124578,evening,1,1
124579,.,1,0
124580,The,0,0
124581,pain,0,0
124582,reported,0,0
124583,by,0,0
124584,the,0,0
124585,patients,0,0
124586,was,0,0
124587,subdivided,0,0
124588,into,0,0
124589,four,0,0
124590,severity,0,0
124591,grades,0,0
124592,",",0,0
124593,and,0,1
124594,analgesic,0,1
124595,consumption,0,1
124596,was,0,0
124597,recorded,0,0
124598,.,0,0
124599,In,0,0
124600,group,0,0
124601,1,0,0
124602,there,0,0
124603,was,0,0
124604,a,0,0
124605,nonsignificant,0,0
124606,decrease,0,0
124607,in,0,0
124608,pain,0,0
124609,",",0,0
124610,but,0,0
124611,in,0,0
124612,groups,0,0
124613,2,0,0
124614,and,0,0
124615,3,0,0
124616,there,0,0
124617,was,0,0
124618,a,0,0
124619,highly,0,0
124620,significant,0,0
124621,diminution,0,0
124622,in,0,0
124623,pain,0,0
124624,(,0,0
124625,P,0,0
124626,less,0,0
124627,than,0,0
124628,0.005,0,0
124629,),0,0
124630,and,0,0
124631,in,0,1
124632,analgesic,0,1
124633,intake,0,1
124634,(,0,0
124635,P,0,0
124636,less,0,0
124637,than,0,0
124638,0.01,0,0
124639,),0,0
124640,.,0,0
124641,Measurements,0,0
124642,of,0,0
124643,bone,0,0
124644,density,0,0
124645,carried,0,0
124646,out,0,0
124647,by,0,0
124648,photon,0,0
124649,absorption,0,1
124650,at,0,0
124651,the,0,0
124652,end,0,0
124653,of,0,0
124654,12,0,0
124655,months,0,0
124656,showed,0,0
124657,a,0,0
124658,5.5,0,0
124659,%,0,0
124660,increase,0,0
124661,in,0,0
124662,the,0,0
124663,distal,0,0
124664,radius,0,0
124665,in,0,0
124666,group,0,0
124667,2,0,0
124668,(,0,0
124669,P,0,0
124670,=,0,0
124671,0.0001,0,0
124672,),0,0
124673,and,0,0
124674,a,0,0
124675,7.1,0,0
124676,%,0,0
124677,increase,0,0
124678,in,0,0
124679,group,0,0
124680,3,0,0
124681,(,0,0
124682,P,0,0
124683,=,0,0
124684,0.0001,0,0
124685,),0,0
124686,",",0,0
124687,while,0,0
124688,in,0,0
124689,group,0,0
124690,1,0,0
124691,mineral,0,0
124692,content,0,0
124693,had,0,0
124694,decreased,0,0
124695,by,0,0
124696,4.3,0,0
124697,%,0,0
124698,(,0,0
124699,nonsignificant,0,0
124700,),0,0
124701,.,0,0
124702,These,0,0
124703,results,0,0
124704,show,0,0
124705,that,0,0
124706,a,0,0
124707,significant,0,0
124708,gain,0,0
124709,in,0,0
124710,bone,0,0
124711,mass,0,0
124712,can,0,0
124713,be,0,0
124714,achieved,0,0
124715,by,0,0
124716,administration,0,1
124717,of,0,1
124718,calcitonin,0,1
124719,",",0,1
124720,either,0,0
124721,daily,0,1
124722,or,0,0
124723,on,0,0
124724,alternate,0,0
124725,days,0,0
124726,.,0,0
124727,The,0,0
124728,incidence,0,0
124729,of,0,0
124730,extravertebral,0,0
124731,fractures,0,0
124732,and,0,0
124733,of,0,0
124734,new,0,0
124735,or,0,0
124736,progressive,0,0
124737,vertebral,0,0
124738,deformity,0,0
124739,tended,0,0
124740,to,0,0
124741,be,0,0
124742,lower,0,0
124743,in,0,0
124744,groups,0,0
124745,2,0,0
124746,and,0,0
124747,3,0,0
124748,than,0,0
124749,in,0,0
124750,group,0,0
124751,1,0,0
124752,.,0,0
124753,Predictors,0,0
124754,of,0,0
124755,recruited,0,0
124756,melanoma,0,0
124757,families,0,0
124758,into,0,0
124759,a,0,0
124760,behavioral,1,0
124761,intervention,1,0
124762,project,1,0
124763,.,1,0
124764,BACKGROUND,0,0
124765,Examination,0,0
124766,of,0,0
124767,families,0,0
124768,represents,0,0
124769,an,0,0
124770,important,0,0
124771,priority,0,0
124772,in,0,0
124773,health,0,0
124774,research,0,0
124775,.,0,0
124776,In,0,0
124777,this,0,0
124778,paper,0,0
124779,we,0,0
124780,report,0,0
124781,on,0,0
124782,individual,0,0
124783,and,0,0
124784,family-level,0,0
124785,factors,0,0
124786,associated,0,0
124787,with,0,0
124788,enrollment,0,0
124789,in,0,0
124790,a,0,0
124791,cancer,0,0
124792,prevention,0,0
124793,research,0,0
124794,project,0,0
124795,.,0,0
124796,We,0,0
124797,approached,0,0
124798,families,0,0
124799,affected,0,0
124800,by,0,0
124801,melanoma,0,0
124802,for,0,0
124803,possible,0,0
124804,participation,0,0
124805,in,0,0
124806,a,0,0
124807,randomized,0,0
124808,controlled,0,0
124809,trial,0,0
124810,of,0,0
124811,a,0,0
124812,web-based,1,0
124813,communication,1,0
124814,and,1,0
124815,support,1,0
124816,intervention,1,0
124817,.,1,0
124818,METHODS,0,0
124819,We,0,0
124820,recruited,0,0
124821,three,0,0
124822,family,0,0
124823,members,0,0
124824,per,0,0
124825,family,0,0
124826,for,0,0
124827,assessment,0,0
124828,-,0,0
124829,the,0,0
124830,melanoma,0,0
124831,case,0,0
124832,",",0,0
124833,a,0,0
124834,first-degree,0,0
124835,relative,0,0
124836,(,0,1
124837,FDR,0,1
124838,),0,1
124839,",",0,0
124840,and,0,0
124841,a,0,0
124842,relative,0,0
124843,who,0,0
124844,is,0,0
124845,a,0,0
124846,parent,0,0
124847,of,0,0
124848,a,0,0
124849,child,0,0
124850,age,0,0
124851,18,0,0
124852,or,0,0
124853,younger,0,0
124854,.,0,0
124855,Recruitment,0,0
124856,involved,0,0
124857,three,0,0
124858,steps,0,0
124859,:,0,0
124860,requesting,0,0
124861,the,0,0
124862,physician,0,0
124863,'s,0,0
124864,consent,0,0
124865,to,0,0
124866,approach,0,0
124867,the,0,0
124868,melanoma,0,0
124869,case,0,0
124870,",",0,0
124871,approaching,0,0
124872,the,0,0
124873,case,0,0
124874,to,0,0
124875,request,0,0
124876,their,0,0
124877,participation,0,0
124878,and,0,0
124879,family,0,0
124880,contact,0,0
124881,information,0,0
124882,",",0,0
124883,and,0,0
124884,they,0,0
124885,approaching,0,0
124886,the,0,0
124887,FDRs,0,0
124888,and,0,0
124889,parents,0,0
124890,.,0,0
124891,RESULTS,0,0
124892,Of,0,0
124893,the,0,0
124894,1380,0,0
124895,families,0,0
124896,approached,0,0
124897,",",0,0
124898,313,0,0
124899,were,0,0
124900,enrolled,0,0
124901,",",0,0
124902,263,0,0
124903,were,0,0
124904,excluded,0,0
124905,because,0,0
124906,we,0,0
124907,could,0,0
124908,not,0,0
124909,find,0,0
124910,or,0,0
124911,contact,0,0
124912,a,0,0
124913,family,0,0
124914,member,0,0
124915,(,0,0
124916,FDR,0,0
124917,or,0,0
124918,parent,0,0
124919,),0,0
124920,",",0,0
124921,331,0,0
124922,did,0,0
124923,not,0,0
124924,have,0,0
124925,eligible,0,0
124926,family,0,0
124927,members,0,0
124928,",",0,0
124929,and,0,0
124930,473,0,0
124931,refused,0,0
124932,.,0,0
124933,The,0,0
124934,most,0,0
124935,frequently,0,0
124936,noted,0,0
124937,reason,0,0
124938,for,0,0
124939,refusal,0,0
124940,was,0,0
124941,being,0,0
124942,too,0,0
124943,busy,0,0
124944,or,0,0
124945,having,0,0
124946,no,0,0
124947,time,0,0
124948,.,0,0
124949,The,0,0
124950,primary,0,0
124951,predictors,0,0
124952,of,0,0
124953,participation,0,0
124954,for,0,0
124955,cases,0,0
124956,(,0,0
124957,OR=1.6,0,0
124958,;,0,0
124959,CI=1.01-2.51,0,0
124960,),0,0
124961,and,0,0
124962,FDRs,0,1
124963,(,0,0
124964,OR=2.15,0,0
124965,;,0,0
124966,CI=1.11-4.13,0,0
124967,),0,0
124968,included,0,0
124969,higher,0,0
124970,educational,0,0
124971,attainment,0,0
124972,.,0,0
124973,FDRs,0,0
124974,were,0,0
124975,more,0,0
124976,likely,0,0
124977,to,0,0
124978,enroll,0,0
124979,if,0,0
124980,they,0,0
124981,were,0,0
124982,female,0,0
124983,(,0,0
124984,OR=1.77,0,0
124985,;,0,0
124986,CI=1.1-.85,0,0
124987,),0,1
124988,and,0,0
124989,parents,0,0
124990,were,0,0
124991,more,0,0
124992,likely,0,0
124993,to,0,0
124994,enroll,0,0
124995,if,0,0
124996,the,0,0
124997,case,0,0
124998,had,0,0
124999,been,0,0
125000,diagnosed,0,0
125001,more,0,0
125002,recently,0,0
125003,(,0,0
125004,OR=3.3,0,1
125005,;,0,0
125006,CI=1.9-5.93,0,0
125007,),0,0
125008,",",0,0
125009,if,0,0
125010,the,0,0
125011,parent,0,0
125012,was,0,0
125013,partnered,0,0
125014,(,0,0
125015,OR=4.37,0,0
125016,;,0,0
125017,CI=1.86-10.26,0,0
125018,),0,0
125019,",",0,0
125020,and,0,0
125021,if,0,0
125022,the,0,0
125023,parent,0,0
125024,lived,0,0
125025,in,0,0
125026,the,0,0
125027,same,0,0
125028,city,0,0
125029,as,0,0
125030,the,0,0
125031,case,0,0
125032,(,0,0
125033,OR=2.88,0,0
125034,;,0,0
125035,CI=1.08-7.68,0,0
125036,),0,0
125037,.,0,0
125038,CONCLUSIONS,0,0
125039,The,0,0
125040,results,0,0
125041,can,0,0
125042,provide,0,0
125043,information,0,0
125044,on,0,0
125045,potential,0,0
125046,directions,0,0
125047,for,0,0
125048,future,0,0
125049,family,0,0
125050,recruitment,0,0
125051,.,0,0
125052,Use,1,0
125053,of,1,0
125054,an,1,0
125055,Internet,1,0
125056,portal,1,0
125057,to,0,0
125058,improve,0,0
125059,community-based,0,0
125060,pediatric,0,0
125061,ADHD,0,1
125062,care,0,0
125063,:,0,0
125064,a,0,0
125065,cluster,0,0
125066,randomized,0,0
125067,trial,0,0
125068,.,0,0
125069,OBJECTIVE,0,0
125070,To,0,0
125071,determine,0,0
125072,the,0,0
125073,effectiveness,0,0
125074,of,0,0
125075,a,0,0
125076,quality,1,0
125077,improvement,1,0
125078,program,1,0
125079,to,0,0
125080,improve,0,0
125081,pediatricians,0,0
125082,',0,0
125083,adherence,0,0
125084,to,0,0
125085,existing,0,0
125086,",",0,0
125087,evidence-based,0,0
125088,",",0,0
125089,attention-deficit/hyperactivity,0,1
125090,disorder,0,1
125091,(,0,1
125092,ADHD,0,1
125093,),0,1
125094,practice,0,0
125095,guidelines,0,1
125096,.,0,0
125097,METHODS,0,0
125098,Forty-nine,0,0
125099,community-based,0,0
125100,pediatricians,0,0
125101,at,0,0
125102,8,0,0
125103,practices,0,0
125104,participated,0,0
125105,in,0,0
125106,a,0,0
125107,cluster-randomized,0,0
125108,trial,0,0
125109,.,0,0
125110,Practices,0,0
125111,were,0,0
125112,matched,0,0
125113,according,0,0
125114,to,0,0
125115,the,0,0
125116,numbers,0,0
125117,of,0,0
125118,pediatricians,0,0
125119,and,0,0
125120,the,0,0
125121,proportions,0,0
125122,of,0,0
125123,patients,0,0
125124,receiving,0,0
125125,Medicaid,0,0
125126,.,0,0
125127,The,0,0
125128,medical,0,0
125129,charts,0,0
125130,for,0,0
125131,a,0,0
125132,random,0,0
125133,sample,0,0
125134,of,0,0
125135,patients,0,0
125136,with,0,0
125137,ADHD,0,0
125138,for,0,0
125139,each,0,0
125140,of,0,0
125141,the,0,0
125142,participating,0,0
125143,pediatricians,0,0
125144,were,0,0
125145,examined,0,0
125146,at,0,0
125147,baseline,0,0
125148,and,0,0
125149,6,0,0
125150,months,0,0
125151,.,0,0
125152,All,0,0
125153,practices,0,0
125154,participated,0,0
125155,in,0,0
125156,4,0,0
125157,sessions,0,0
125158,of,0,0
125159,training,1,0
125160,",",1,0
125161,including,1,0
125162,didactic,1,0
125163,lectures,1,0
125164,and,1,0
125165,office,1,0
125166,flow,1,0
125167,modification,1,0
125168,workshops,1,0
125169,.,1,0
125170,Practices,0,0
125171,were,0,0
125172,then,0,0
125173,given,0,0
125174,access,0,0
125175,to,0,0
125176,an,0,0
125177,ADHD,1,0
125178,Internet,1,0
125179,portal,1,0
125180,that,0,0
125181,allowed,0,0
125182,parents,0,0
125183,",",0,0
125184,teachers,0,0
125185,",",0,0
125186,and,0,0
125187,pediatricians,0,0
125188,to,0,0
125189,input,0,0
125190,information,0,0
125191,(,0,0
125192,eg,0,0
125193,",",0,0
125194,rating,0,1
125195,scales,0,1
125196,),0,0
125197,about,0,0
125198,patients,0,0
125199,",",0,0
125200,after,0,0
125201,which,0,0
125202,information,0,0
125203,was,0,0
125204,scored,0,0
125205,",",0,0
125206,interpreted,0,0
125207,",",0,0
125208,and,0,0
125209,formatted,0,0
125210,in,0,0
125211,a,0,0
125212,report,0,0
125213,style,0,0
125214,that,0,0
125215,was,0,0
125216,helpful,0,0
125217,for,0,0
125218,assessment,0,0
125219,and,0,0
125220,treatment,0,0
125221,of,0,0
125222,patients,0,0
125223,with,0,0
125224,ADHD,0,0
125225,.,0,0
125226,Physicians,0,0
125227,evaluated,0,0
125228,their,0,0
125229,practice,0,0
125230,behaviors,0,1
125231,quarterly,0,0
125232,and,0,0
125233,addressed,0,0
125234,underperforming,0,0
125235,areas,0,0
125236,.,0,0
125237,RESULTS,0,0
125238,Pediatricians,0,0
125239,in,0,0
125240,the,0,0
125241,intervention,0,0
125242,group,0,0
125243,",",0,0
125244,compared,0,0
125245,with,0,0
125246,those,0,0
125247,in,0,0
125248,the,0,0
125249,control,1,0
125250,group,0,0
125251,",",0,0
125252,demonstrated,0,0
125253,significantly,0,0
125254,higher,0,0
125255,rates,0,0
125256,of,0,0
125257,many,0,0
125258,American,0,0
125259,Academy,0,0
125260,of,0,0
125261,Pediatrics-recommended,0,0
125262,ADHD,0,1
125263,care,0,1
125264,practices,0,0
125265,",",0,0
125266,including,0,0
125267,collection,0,0
125268,of,0,0
125269,parent,0,0
125270,(,0,0
125271,Cohen,0,1
125272,'s,0,0
125273,d,0,0
125274,=,0,0
125275,0.69,0,0
125276,),0,0
125277,and,0,0
125278,teacher,0,1
125279,(,0,0
125280,d,0,0
125281,=,0,0
125282,0.68,0,0
125283,),0,0
125284,rating,0,0
125285,scales,0,0
125286,for,0,0
125287,assessment,0,0
125288,of,0,0
125289,children,0,0
125290,with,0,0
125291,ADHD,0,0
125292,",",0,0
125293,use,0,0
125294,of,0,0
125295,Diagnostic,0,0
125296,and,0,0
125297,Statistical,0,1
125298,Manual,0,0
125299,of,0,0
125300,Mental,0,0
125301,Disorders,0,0
125302,",",0,0
125303,Fourth,0,0
125304,Edition,0,0
125305,",",0,0
125306,criteria,0,1
125307,(,0,0
125308,d,0,0
125309,=,0,0
125310,0.85,0,0
125311,),0,0
125312,",",0,0
125313,and,0,0
125314,use,0,0
125315,of,0,0
125316,teacher,0,0
125317,rating,0,0
125318,scales,0,0
125319,to,0,0
125320,monitor,0,0
125321,treatment,0,0
125322,responses,0,0
125323,(,0,0
125324,d,0,0
125325,=,0,0
125326,1.01,0,0
125327,),0,0
125328,.,0,0
125329,CONCLUSION,0,1
125330,A,1,1
125331,quality,1,1
125332,improvement,1,0
125333,intervention,1,0
125334,that,0,0
125335,can,0,0
125336,be,0,0
125337,widely,0,0
125338,disseminated,0,0
125339,by,0,0
125340,using,0,0
125341,Internet-based,1,0
125342,information,1,0
125343,technology,1,0
125344,significantly,0,0
125345,improved,0,0
125346,the,0,0
125347,quality,0,0
125348,of,0,0
125349,ADHD,0,0
125350,care,0,0
125351,in,0,0
125352,community-based,0,0
125353,pediatric,0,0
125354,settings,0,0
125355,.,0,0
125356,Midlife,0,1
125357,women,0,0
125358,online,0,0
125359,:,0,0
125360,evaluation,0,0
125361,of,0,0
125362,an,0,0
125363,internet-based,0,0
125364,program,0,0
125365,to,0,0
125366,prevent,0,0
125367,unintended,0,0
125368,pregnancy,0,0
125369,&,0,1
125370,STIs,0,0
125371,.,0,0
125372,BACKGROUND,0,0
125373,Midlife,0,0
125374,women,0,0
125375,are,0,0
125376,an,0,0
125377,underserved,0,0
125378,population,0,0
125379,in,0,0
125380,the,0,0
125381,areas,0,0
125382,of,0,0
125383,unintended,0,0
125384,pregnancy,0,0
125385,and,0,0
125386,STI,0,0
125387,prevention,0,0
125388,yet,0,0
125389,remain,0,0
125390,at,0,0
125391,risk,0,0
125392,for,0,0
125393,both,0,0
125394,health,0,0
125395,conditions,0,0
125396,.,0,0
125397,METHODS,0,0
125398,A,0,1
125399,randomized,0,0
125400,controlled,0,0
125401,trial,0,0
125402,of,0,0
125403,an,0,0
125404,Internet-based,1,0
125405,multimedia,1,0
125406,program,1,0
125407,to,0,0
125408,reduce,0,0
125409,risk,0,0
125410,of,0,0
125411,unintended,0,0
125412,pregnancy,0,0
125413,and,0,0
125414,STIs,0,0
125415,among,0,0
125416,midlife,0,0
125417,women,0,0
125418,was,0,0
125419,conducted,0,0
125420,with,0,0
125421,164,0,0
125422,women,0,0
125423,ages,0,0
125424,40-55,0,0
125425,years,0,0
125426,of,0,0
125427,age,0,0
125428,.,0,0
125429,RESULTS,0,0
125430,Women,0,0
125431,in,0,0
125432,the,0,0
125433,treatment,0,0
125434,condition,0,0
125435,compared,0,0
125436,to,0,0
125437,the,0,0
125438,control,0,0
125439,condition,0,0
125440,reported,0,0
125441,significant,0,0
125442,gains,0,0
125443,in,0,0
125444,attitudes,0,0
125445,",",0,0
125446,self-efficacy,0,0
125447,",",0,0
125448,and,0,0
125449,behavioral,0,0
125450,intentions,0,0
125451,at,0,0
125452,posttest,0,0
125453,.,0,0
125454,CONCLUSION,0,0
125455,Interventions,0,0
125456,specifically,0,0
125457,targeted,0,0
125458,to,0,0
125459,midlife,0,0
125460,women,0,0
125461,can,0,0
125462,impact,0,0
125463,constructs,0,0
125464,known,0,0
125465,to,0,0
125466,reduce,0,0
125467,risk,0,0
125468,.,0,0
125469,Implications,0,0
125470,for,0,0
125471,future,0,0
125472,research,0,0
125473,and,0,0
125474,intervention,0,0
125475,development,0,0
125476,are,0,0
125477,presented,0,0
125478,.,0,0
125479,Benefits,0,0
125480,of,0,0
125481,adding,0,0
125482,fluticasone,1,1
125483,propionate/salmeterol,1,1
125484,to,0,1
125485,tiotropium,1,1
125486,in,0,0
125487,moderate,0,0
125488,to,0,0
125489,severe,0,0
125490,COPD,0,0
125491,.,0,0
125492,BACKGROUND,0,0
125493,Combining,0,0
125494,maintenance,0,0
125495,medications,0,1
125496,with,0,0
125497,different,0,0
125498,mechanisms,0,0
125499,of,0,0
125500,action,0,0
125501,may,0,0
125502,improve,0,0
125503,outcomes,0,0
125504,in,0,0
125505,COPD,0,0
125506,.,0,0
125507,In,0,0
125508,this,0,0
125509,study,0,0
125510,we,0,0
125511,evaluated,0,0
125512,the,0,0
125513,efficacy,0,0
125514,and,0,0
125515,safety,0,0
125516,of,0,1
125517,fluticasone/salmeterol,1,1
125518,(,1,1
125519,FSC,1,1
125520,),1,1
125521,(,0,1
125522,250/50,0,1
125523,mcg,0,1
125524,twice,0,1
125525,daily,0,1
125526,),0,1
125527,when,0,0
125528,added,0,0
125529,to,1,0
125530,tiotropium,1,1
125531,(,0,1
125532,18,0,1
125533,mcg,0,1
125534,once,0,1
125535,daily,1,1
125536,),1,1
125537,(,1,1
125538,TIO,0,1
125539,),0,0
125540,in,0,0
125541,subjects,0,0
125542,with,0,0
125543,symptomatic,0,0
125544,moderate,0,0
125545,to,0,0
125546,severe,0,0
125547,COPD,0,0
125548,.,0,0
125549,METHODS,0,0
125550,This,0,0
125551,was,0,0
125552,a,0,0
125553,24-week,0,0
125554,",",0,0
125555,randomized,0,1
125556,",",0,1
125557,double-blind,0,1
125558,",",0,1
125559,parallel,0,0
125560,group,0,0
125561,",",0,0
125562,multi-center,0,0
125563,study,0,0
125564,.,0,0
125565,Subjects,0,0
125566,40,0,0
125567,years,0,0
125568,or,0,0
125569,older,0,0
125570,with,0,0
125571,cigarette,0,0
125572,smoking,0,0
125573,history,0,0
125574,?10,0,1
125575,pack-years,0,0
125576,and,0,0
125577,with,0,0
125578,the,0,0
125579,diagnosis,0,0
125580,of,0,0
125581,COPD,0,0
125582,and,0,0
125583,post-bronchodilator,0,1
125584,FEV,0,1
125585,(,0,1
125586,1,0,1
125587,),0,0
125588,?40,0,1
125589,to,0,0
125590,?,0,0
125591,80,0,0
125592,%,0,0
125593,of,0,0
125594,predicted,0,0
125595,normal,0,0
125596,and,0,0
125597,FEV,0,1
125598,(,0,1
125599,1,0,1
125600,),0,0
125601,/FVC,0,0
125602,of,0,0
125603,?0.70,0,0
125604,were,0,0
125605,enrolled,0,0
125606,.,0,0
125607,Following,0,0
125608,a,0,0
125609,4-week,0,1
125610,treatment,0,1
125611,with,0,1
125612,open-label,0,1
125613,TIO,1,1
125614,18,1,1
125615,mcg,1,1
125616,once,0,1
125617,daily,0,1
125618,",",0,1
125619,subjects,0,0
125620,were,0,0
125621,randomized,0,0
125622,in,0,0
125623,a,0,0
125624,double-blind,0,1
125625,fashion,0,0
125626,to,0,0
125627,either,0,0
125628,the,0,0
125629,addition,0,0
125630,of,0,0
125631,FSC,0,1
125632,250/50,0,1
125633,DISKUS,0,1
125634,twice,0,1
125635,daily,0,1
125636,or,0,1
125637,matching,0,0
125638,placebo,0,1
125639,.,0,0
125640,The,0,0
125641,primary,0,0
125642,efficacy,0,0
125643,endpoint,0,0
125644,was,0,0
125645,AM,0,1
125646,pre-dose,0,1
125647,FEV,0,1
125648,(,0,1
125649,1,0,1
125650,),0,0
125651,and,0,0
125652,secondary,0,0
125653,endpoints,0,0
125654,included,0,0
125655,other,0,0
125656,measures,0,0
125657,of,0,0
125658,lung,0,0
125659,function,0,0
125660,",",0,0
125661,rescue,0,0
125662,albuterol,0,1
125663,use,0,0
125664,",",0,0
125665,health,0,0
125666,status,0,0
125667,and,0,0
125668,exacerbations,0,0
125669,.,0,0
125670,RESULTS,0,0
125671,The,0,0
125672,addition,0,0
125673,of,0,0
125674,FSC,1,0
125675,to,1,0
125676,TIO,0,0
125677,significantly,0,0
125678,improved,0,0
125679,lung,0,0
125680,function,0,0
125681,indices,0,0
125682,including,0,0
125683,AM,0,1
125684,pre-dose,0,1
125685,FEV,0,1
125686,(,0,1
125687,1,0,1
125688,),0,1
125689,",",0,0
125690,2,0,1
125691,h,0,1
125692,post-dose,0,1
125693,FEV,0,1
125694,(,0,1
125695,1,0,1
125696,),0,0
125697,",",0,1
125698,AM,0,1
125699,pre-dose,0,1
125700,FVC,0,1
125701,",",0,1
125702,2,0,0
125703,h,0,1
125704,post-dose,0,1
125705,FVC,0,1
125706,and,0,1
125707,AM,0,1
125708,pre-dose,0,1
125709,IC,0,1
125710,compared,0,0
125711,with,0,0
125712,TIO,0,0
125713,alone,0,0
125714,.,0,0
125715,Furthermore,0,0
125716,",",0,0
125717,this,0,0
125718,combination,0,0
125719,was,0,0
125720,superior,0,0
125721,to,0,0
125722,TIO,0,0
125723,alone,0,0
125724,in,0,0
125725,reducing,0,0
125726,rescue,0,0
125727,albuterol,0,1
125728,use,0,0
125729,.,0,0
125730,However,0,0
125731,",",0,0
125732,there,0,0
125733,were,0,0
125734,no,0,0
125735,significant,0,0
125736,differences,0,0
125737,between,0,0
125738,the,0,0
125739,treatment,0,0
125740,groups,0,0
125741,in,0,0
125742,health,0,0
125743,status,0,0
125744,or,0,0
125745,COPD,0,0
125746,exacerbations,0,0
125747,.,0,0
125748,The,0,0
125749,incidence,0,0
125750,of,0,0
125751,adverse,0,0
125752,events,0,0
125753,was,0,0
125754,similar,0,0
125755,in,0,0
125756,both,0,0
125757,groups,0,0
125758,.,0,0
125759,CONCLUSIONS,0,0
125760,The,0,0
125761,addition,0,0
125762,of,0,0
125763,FSC,0,0
125764,to,0,0
125765,subjects,0,0
125766,with,0,0
125767,COPD,0,0
125768,treated,0,0
125769,with,0,0
125770,TIO,0,0
125771,significantly,0,0
125772,improves,0,0
125773,lung,0,0
125774,function,0,0
125775,without,0,0
125776,increasing,0,0
125777,the,0,0
125778,risk,0,0
125779,of,0,0
125780,adverse,0,0
125781,events,0,0
125782,.,0,0
125783,NCT00784550,0,0
125784,.,0,0
125785,Effect,0,0
125786,of,0,0
125787,motivational,1,0
125788,music,1,1
125789,on,0,0
125790,lactate,0,1
125791,levels,0,0
125792,during,0,0
125793,recovery,0,0
125794,from,0,0
125795,intense,0,0
125796,exercise,0,0
125797,.,0,0
125798,The,0,0
125799,effects,0,0
125800,of,0,0
125801,music,0,0
125802,played,0,0
125803,during,0,0
125804,an,0,0
125805,exercise,0,0
125806,task,0,0
125807,on,0,0
125808,athletic,0,0
125809,performance,0,0
125810,have,0,0
125811,been,0,0
125812,previously,0,0
125813,studied,0,0
125814,.,0,0
125815,Yet,0,0
125816,",",0,0
125817,these,0,0
125818,results,0,0
125819,are,0,0
125820,not,0,0
125821,applicable,0,0
125822,for,0,0
125823,competitive,0,0
125824,athletes,0,0
125825,",",0,0
125826,who,0,0
125827,can,0,0
125828,use,0,0
125829,music,0,0
125830,only,0,0
125831,during,0,0
125832,warm-up,0,0
125833,or,0,0
125834,recovery,0,0
125835,from,0,0
125836,exercise,0,0
125837,.,0,0
125838,Therefore,0,0
125839,",",0,0
125840,the,0,0
125841,aim,0,0
125842,of,0,0
125843,this,0,0
125844,study,0,0
125845,was,0,0
125846,to,0,0
125847,determine,0,0
125848,the,0,0
125849,effect,0,0
125850,of,0,0
125851,motivational,1,0
125852,music,1,1
125853,(,1,0
125854,music,1,0
125855,that,1,0
125856,stimulates,1,0
125857,or,1,0
125858,inspires,1,0
125859,physical,1,1
125860,activity,1,0
125861,),1,0
125862,during,0,0
125863,recovery,0,0
125864,from,0,0
125865,intense,0,0
125866,exercise,0,0
125867,",",0,0
125868,on,0,0
125869,activity,0,0
125870,pattern,0,0
125871,",",0,0
125872,rate,0,0
125873,of,0,0
125874,perceived,0,0
125875,exertion,0,1
125876,(,0,1
125877,RPE,0,1
125878,),0,1
125879,",",0,0
125880,and,0,0
125881,blood,0,1
125882,lactate,0,1
125883,concentration,0,0
125884,.,0,0
125885,Twenty,0,0
125886,young,0,0
125887,",",0,0
125888,active,0,0
125889,men,0,0
125890,(,0,0
125891,mean,0,0
125892,age,0,0
125893,26.2,0,0
125894,?,0,0
125895,2.1,0,0
125896,years,0,0
125897,),0,0
125898,performed,0,0
125899,a,0,0
125900,6-minute,1,0
125901,run,1,0
125902,at,1,0
125903,peak,1,0
125904,oxygen,1,0
125905,consumption,1,1
125906,speed,1,1
125907,(,0,0
125908,predetermined,0,0
125909,from,0,0
125910,the,0,0
125911,VO,0,0
125912,(,0,0
125913,2,0,0
125914,),0,0
125915,max,0,1
125916,test,0,0
125917,),0,0
125918,.,0,0
125919,The,0,0
125920,mean,0,0
125921,heart,0,0
125922,rate,0,0
125923,(,0,1
125924,HR,0,1
125925,),0,1
125926,",",0,0
125927,RPE,0,1
125928,",",0,0
125929,number,0,0
125930,of,0,0
125931,steps,0,0
125932,(,0,0
125933,determined,0,0
125934,by,0,0
125935,step,0,0
125936,counter,0,0
125937,),0,0
125938,",",0,0
125939,and,0,0
125940,blood,0,1
125941,lactate,0,1
125942,concentrations,0,1
125943,were,0,0
125944,determined,0,0
125945,at,0,0
125946,3,0,0
125947,",",0,0
125948,6,0,0
125949,",",0,0
125950,9,0,0
125951,",",0,0
125952,12,0,0
125953,",",0,0
125954,and,0,0
125955,15,0,0
125956,minutes,0,0
125957,during,0,0
125958,the,0,0
125959,recovery,0,0
125960,from,0,0
125961,the,0,0
125962,exercise,0,0
125963,",",0,0
125964,with,0,0
125965,and,0,0
125966,without,0,0
125967,motivational,0,0
125968,music,0,1
125969,(,0,0
125970,2,0,0
125971,separate,0,0
125972,sessions,0,0
125973,",",0,0
125974,at,0,0
125975,random,0,0
125976,order,0,0
125977,),0,0
125978,.,0,0
125979,There,0,0
125980,was,0,0
125981,no,0,0
125982,difference,0,0
125983,in,0,0
125984,the,0,0
125985,mean,0,0
125986,HR,0,0
125987,during,0,0
125988,the,0,0
125989,recovery,0,0
125990,with,0,0
125991,and,1,0
125992,without,1,0
125993,music,1,0
125994,.,1,0
125995,Listening,0,0
125996,to,0,0
125997,motivational,0,0
125998,music,0,0
125999,during,0,0
126000,the,0,0
126001,recovery,0,0
126002,was,0,0
126003,associated,0,0
126004,with,0,0
126005,increased,0,0
126006,voluntary,0,0
126007,activity,0,0
126008,of,0,0
126009,the,0,0
126010,participants,0,0
126011,",",0,0
126012,determined,0,0
126013,by,0,0
126014,increased,0,0
126015,number,0,0
126016,of,0,0
126017,steps,0,0
126018,(,0,0
126019,499.4,0,0
126020,?,0,0
126021,220.1,0,0
126022,vs.,0,0
126023,413.2,0,0
126024,?,0,0
126025,150.6,0,0
126026,steps,0,0
126027,",",0,0
126028,with,0,0
126029,and,0,0
126030,without,0,0
126031,music,0,0
126032,",",0,0
126033,respectively,0,0
126034,;,0,0
126035,p,0,0
126036,?,0,0
126037,0.05,0,0
126038,),0,0
126039,.,0,0
126040,The,0,0
126041,increased,0,0
126042,number,0,0
126043,of,0,0
126044,steps,0,0
126045,during,0,0
126046,the,0,0
126047,recovery,0,0
126048,was,0,0
126049,accompanied,0,0
126050,by,0,0
126051,a,0,0
126052,significantly,0,0
126053,greater,0,0
126054,decrease,0,0
126055,in,0,0
126056,blood,0,0
126057,lactate,0,1
126058,concentration,0,0
126059,percentage,0,0
126060,(,0,0
126061,28.1,0,0
126062,?,0,0
126063,12.2,0,0
126064,vs.,0,0
126065,22.8,0,0
126066,?,0,0
126067,10.9,0,0
126068,%,0,0
126069,",",0,0
126070,with,0,0
126071,and,0,0
126072,without,0,0
126073,music,0,0
126074,",",0,0
126075,respectively,0,0
126076,",",0,0
126077,p,0,0
126078,?,0,0
126079,0.05,0,0
126080,),0,0
126081,.,0,0
126082,This,0,0
126083,was,0,0
126084,associated,0,0
126085,with,0,0
126086,a,0,0
126087,greater,0,0
126088,decrease,0,0
126089,in,0,0
126090,RPE,0,0
126091,(,0,0
126092,77.7,0,0
126093,?,0,0
126094,14.4,0,0
126095,vs.,0,0
126096,73.1,0,0
126097,?,0,0
126098,14.7,0,0
126099,%,0,0
126100,with,0,0
126101,and,0,0
126102,without,0,0
126103,music,0,0
126104,",",0,0
126105,respectively,0,0
126106,;,0,0
126107,p,0,0
126108,?,0,0
126109,0.05,0,0
126110,),0,0
126111,.,0,0
126112,Our,0,0
126113,results,0,0
126114,suggest,0,0
126115,that,0,0
126116,listening,0,0
126117,to,0,0
126118,motivational,0,0
126119,music,0,0
126120,during,0,0
126121,nonstructured,0,0
126122,recovery,0,0
126123,from,0,0
126124,intense,0,0
126125,exercise,0,0
126126,leads,0,0
126127,to,0,0
126128,increased,0,0
126129,activity,0,0
126130,",",0,0
126131,faster,0,0
126132,lactate,0,1
126133,clearance,0,1
126134,",",0,1
126135,and,0,0
126136,reduced,0,0
126137,RPE,0,0
126138,and,0,0
126139,therefore,0,0
126140,may,0,0
126141,be,0,0
126142,used,0,0
126143,by,0,0
126144,athletes,0,0
126145,in,0,0
126146,their,0,0
126147,effort,0,0
126148,to,0,0
126149,enhance,0,0
126150,recovery,0,0
126151,.,0,0
126152,Safety,0,0
126153,and,0,0
126154,efficacy,0,0
126155,of,0,0
126156,sitaxsentan,1,1
126157,50,0,1
126158,and,0,1
126159,100,0,1
126160,mg,0,1
126161,in,0,0
126162,patients,0,0
126163,with,0,0
126164,pulmonary,0,0
126165,arterial,0,0
126166,hypertension,0,0
126167,.,0,0
126168,OBJECTIVE,0,0
126169,To,0,0
126170,assess,0,0
126171,safety,0,0
126172,and,0,0
126173,efficacy,0,0
126174,of,1,0
126175,sitaxsentan,1,1
126176,50,0,1
126177,and,0,1
126178,100,0,1
126179,mg,0,1
126180,in,0,0
126181,patients,0,0
126182,with,0,0
126183,pulmonary,0,0
126184,arterial,0,1
126185,hypertension,0,1
126186,(,0,1
126187,PAH,0,1
126188,),0,1
126189,.,0,0
126190,BACKGROUND,1,1
126191,Sitaxsentan,1,1
126192,is,1,0
126193,a,0,0
126194,highly,0,0
126195,selective,0,0
126196,endothelin-A,0,1
126197,receptor,0,1
126198,antagonist,0,1
126199,that,0,0
126200,was,0,0
126201,recently,0,0
126202,withdrawn,0,0
126203,by,0,0
126204,the,0,0
126205,manufacturer,0,0
126206,because,0,0
126207,of,0,0
126208,a,0,0
126209,pattern,0,0
126210,of,0,0
126211,idiosyncratic,0,0
126212,liver,0,0
126213,injury,0,0
126214,.,0,0
126215,METHODS,0,0
126216,Before,1,0
126217,sitaxsentan,1,1
126218,withdrawal,1,1
126219,",",0,0
126220,this,0,0
126221,18-week,0,1
126222,double-blind,0,1
126223,",",0,1
126224,placebo-controlled,0,1
126225,study,0,0
126226,randomized,0,0
126227,patients,0,0
126228,with,0,0
126229,PAH,0,0
126230,to,0,0
126231,receive,1,1
126232,placebo,1,1
126233,or,1,1
126234,sitaxsentan,1,1
126235,50,1,1
126236,or,0,1
126237,100,0,1
126238,mg,0,1
126239,once,0,1
126240,daily,0,1
126241,.,0,1
126242,The,0,0
126243,primary,0,0
126244,efficacy,0,0
126245,endpoint,0,0
126246,was,0,0
126247,change,0,0
126248,from,0,0
126249,baseline,0,0
126250,in,0,0
126251,6-min,0,0
126252,walk,0,1
126253,distance,0,0
126254,(,0,1
126255,6MWD,0,1
126256,),0,1
126257,at,0,0
126258,week,0,0
126259,18,0,0
126260,.,0,0
126261,Changes,0,0
126262,in,0,0
126263,World,0,0
126264,Health,0,1
126265,Organization,0,1
126266,(,0,1
126267,WHO,0,1
126268,),0,0
126269,functional,0,0
126270,class,0,0
126271,and,0,0
126272,time,0,0
126273,to,0,0
126274,clinical,0,0
126275,worsening,0,1
126276,(,0,1
126277,TTCW,0,1
126278,),0,0
126279,were,0,0
126280,secondary,0,0
126281,endpoints,0,0
126282,.,0,0
126283,The,0,0
126284,primary,0,0
126285,efficacy,0,0
126286,analysis,0,0
126287,was,0,0
126288,powered,0,0
126289,for,0,0
126290,sitaxsentan,1,1
126291,100,1,1
126292,mg,0,1
126293,versus,1,1
126294,placebo,1,1
126295,.,1,1
126296,RESULTS,1,0
126297,Of,0,0
126298,98,0,0
126299,randomized,0,0
126300,patients,0,0
126301,",",0,0
126302,61,0,0
126303,%,0,0
126304,were,0,0
126305,WHO,0,0
126306,functional,0,0
126307,class,0,0
126308,II,0,0
126309,at,0,0
126310,baseline,0,0
126311,.,0,0
126312,Improvement,0,0
126313,from,0,0
126314,baseline,0,0
126315,to,0,0
126316,week,0,0
126317,18,0,0
126318,in,0,0
126319,6MWD,0,0
126320,occurred,0,0
126321,with,0,0
126322,sitaxsentan,1,1
126323,100,1,0
126324,but,0,0
126325,not,0,0
126326,50,0,1
126327,mg,0,1
126328,;,0,1
126329,a,0,0
126330,strong,1,0
126331,placebo,1,1
126332,effect,1,0
126333,was,0,0
126334,observed,0,0
126335,.,0,0
126336,At,0,0
126337,week,0,0
126338,18,0,0
126339,",",0,0
126340,WHO,0,0
126341,functional,0,0
126342,class,0,0
126343,was,0,0
126344,improved,0,0
126345,or,0,0
126346,maintained,0,0
126347,in,0,0
126348,more,0,0
126349,patients,0,0
126350,receiving,1,0
126351,sitaxsentan,1,1
126352,100,1,1
126353,mg,1,1
126354,than,1,1
126355,placebo,1,1
126356,(,1,0
126357,P,1,0
126358,=,1,0
126359,0.038,0,0
126360,),0,0
126361,;,0,0
126362,0,0,0
126363,%,0,0
126364,versus,0,0
126365,12,0,0
126366,%,0,0
126367,of,0,0
126368,patients,0,0
126369,deteriorated,0,0
126370,",",0,0
126371,respectively,0,0
126372,.,0,0
126373,TTCW,0,0
126374,was,0,0
126375,not,0,0
126376,significantly,0,0
126377,different,0,0
126378,for,0,0
126379,100-mg,1,1
126380,sitaxsentan,1,1
126381,patients,1,1
126382,than,1,1
126383,placebo,1,1
126384,(,0,0
126385,P,0,0
126386,=,0,0
126387,0.090,0,0
126388,),0,0
126389,.,0,0
126390,Adverse,0,0
126391,events,0,0
126392,(,0,0
126393,AEs,0,1
126394,),0,0
126395,occurring,0,0
126396,more,0,0
126397,frequently,0,0
126398,with,1,1
126399,sitaxsentan,1,1
126400,(,1,1
126401,50,1,0
126402,or,1,0
126403,100,1,1
126404,mg,0,1
126405,),0,1
126406,included,0,0
126407,headache,0,0
126408,",",0,0
126409,peripheral,0,0
126410,edema,0,0
126411,",",0,0
126412,dizziness,0,1
126413,",",0,1
126414,nausea,0,1
126415,",",0,1
126416,extremity,0,1
126417,pain,0,0
126418,",",0,0
126419,and,0,0
126420,fatigue,0,1
126421,;,0,0
126422,most,0,0
126423,AEs,0,0
126424,were,0,0
126425,of,0,0
126426,mild,0,0
126427,or,0,0
126428,moderate,0,0
126429,severity,0,0
126430,.,0,0
126431,CONCLUSION,0,1
126432,Sitaxsentan,1,1
126433,100,1,1
126434,mg,1,1
126435,improved,1,0
126436,functional,0,0
126437,class,0,0
126438,but,0,0
126439,not,0,0
126440,6MWD,0,0
126441,in,0,0
126442,PAH,0,0
126443,patients,0,0
126444,who,0,0
126445,were,0,0
126446,mostly,0,0
126447,WHO,0,0
126448,functional,0,0
126449,class,0,0
126450,II,0,0
126451,at,0,0
126452,baseline,0,0
126453,.,0,0
126454,No,0,1
126455,patient,0,1
126456,receiving,1,1
126457,sitaxsentan,1,1
126458,100,0,1
126459,mg,0,1
126460,experienced,0,1
126461,clinical,0,1
126462,worsening,1,1
126463,;,1,1
126464,sitaxsentan,1,1
126465,was,0,0
126466,well,0,0
126467,tolerated,0,1
126468,.,0,0
126469,Alkalinized,1,1
126470,lidocaine,1,1
126471,and,1,1
126472,heparin,1,1
126473,provide,0,0
126474,immediate,0,0
126475,relief,0,0
126476,of,0,0
126477,pain,0,0
126478,and,0,0
126479,urgency,0,0
126480,in,0,0
126481,patients,0,0
126482,with,0,0
126483,interstitial,0,0
126484,cystitis,0,0
126485,.,0,0
126486,INTRODUCTION,0,0
126487,It,0,0
126488,has,0,0
126489,been,0,0
126490,reported,0,0
126491,in,0,0
126492,an,0,0
126493,open-label,0,1
126494,study,0,0
126495,that,0,0
126496,the,0,0
126497,combination,0,0
126498,of,0,0
126499,alkalinized,1,1
126500,lidocaine,1,1
126501,and,1,1
126502,heparin,1,1
126503,can,0,0
126504,immediately,0,0
126505,relieve,0,0
126506,the,0,0
126507,symptoms,0,0
126508,of,0,0
126509,urinary,0,0
126510,urgency,0,0
126511,",",0,0
126512,frequency,0,0
126513,",",0,0
126514,and,0,0
126515,pain,0,0
126516,associated,0,0
126517,with,0,0
126518,interstitial,0,0
126519,cystitis,0,0
126520,(,0,1
126521,IC,0,1
126522,),0,1
126523,.,0,0
126524,This,0,0
126525,combination,0,0
126526,has,0,0
126527,also,0,0
126528,been,0,0
126529,reported,0,0
126530,to,0,0
126531,relieve,0,0
126532,pain,0,0
126533,associated,0,0
126534,with,0,0
126535,sex,0,0
126536,in,0,0
126537,patients,0,0
126538,with,0,0
126539,IC,0,0
126540,.,0,0
126541,AIM,0,0
126542,The,0,0
126543,aim,0,0
126544,of,0,0
126545,this,0,0
126546,study,0,0
126547,was,0,0
126548,to,0,0
126549,corroborate,0,0
126550,these,0,0
126551,findings,0,0
126552,in,0,0
126553,a,0,0
126554,multicenter,0,0
126555,setting,0,0
126556,.,0,0
126557,METHODS,0,0
126558,The,0,0
126559,study,0,0
126560,design,0,0
126561,was,0,0
126562,a,0,0
126563,multicenter,0,0
126564,prospective,0,1
126565,",",0,0
126566,double-blind,0,1
126567,",",0,1
126568,crossover,0,1
126569,",",0,1
126570,placebo-controlled,1,1
126571,trial,0,1
126572,.,0,0
126573,Each,0,0
126574,participant,0,0
126575,met,0,0
126576,all,0,0
126577,of,0,0
126578,the,0,0
126579,clinical,0,0
126580,National,0,0
126581,Institute,0,0
126582,of,0,0
126583,Diabetes,0,0
126584,and,0,0
126585,Digestive,0,0
126586,and,0,0
126587,Kidney,0,0
126588,Diseases,0,1
126589,criteria,0,1
126590,(,0,0
126591,excluding,0,0
126592,cystoscopy,0,1
126593,),0,0
126594,for,0,0
126595,IC,0,1
126596,.,0,0
126597,Each,0,0
126598,patient,0,1
126599,received,0,0
126600,drug,0,1
126601,and,0,0
126602,control,0,0
126603,",",0,0
126604,in,0,0
126605,random,0,0
126606,order,0,0
126607,",",0,0
126608,within,0,0
126609,48,0,0
126610,hours,0,0
126611,of,0,0
126612,enrolling,0,0
126613,in,0,0
126614,the,0,0
126615,study,0,0
126616,.,0,0
126617,MAIN,0,0
126618,OUTCOME,0,0
126619,MEASURES,0,1
126620,The,0,0
126621,primary,0,0
126622,outcome,0,0
126623,measure,0,0
126624,was,0,0
126625,percent,0,0
126626,change,0,0
126627,in,0,0
126628,pain,0,0
126629,score,0,1
126630,(,0,1
126631,11-point,0,1
126632,analog,0,1
126633,pain,0,1
126634,scale,0,1
126635,),0,1
126636,12,0,0
126637,hours,0,0
126638,after,0,0
126639,receiving,0,0
126640,the,0,0
126641,drug,0,1
126642,or,0,0
126643,control,0,0
126644,.,0,0
126645,Secondary,0,0
126646,measures,0,0
126647,were,0,0
126648,the,0,0
126649,global,0,0
126650,assessment,0,0
126651,response,0,0
126652,(,0,1
126653,GAR,0,1
126654,),0,1
126655,of,0,0
126656,symptoms,0,1
126657,and,0,0
126658,12-hour,0,1
126659,average,0,0
126660,urgency,0,0
126661,reduction,0,0
126662,determined,0,0
126663,from,0,0
126664,11-point,0,0
126665,urgency,0,0
126666,scales,0,0
126667,.,0,0
126668,RESULTS,0,1
126669,Eighteen,0,1
126670,(,0,1
126671,18,0,0
126672,),0,0
126673,patients,0,0
126674,completed,0,0
126675,the,0,0
126676,trial,0,0
126677,.,0,0
126678,The,0,0
126679,average,0,0
126680,reduction,0,0
126681,of,0,0
126682,pain,0,0
126683,over,0,0
126684,12,0,0
126685,hours,0,0
126686,was,0,0
126687,21,0,0
126688,%,0,0
126689,for,0,0
126690,control,0,0
126691,and,0,0
126692,42,0,0
126693,%,0,0
126694,for,0,0
126695,active,0,0
126696,drug,0,1
126697,(,0,0
126698,P,0,0
126699,=,0,0
126700,0.0363,0,0
126701,),0,0
126702,.,0,0
126703,GAR,0,0
126704,was,0,0
126705,13,0,0
126706,%,0,0
126707,for,0,0
126708,control,0,0
126709,and,0,0
126710,50,0,0
126711,%,0,0
126712,for,0,0
126713,drug,0,0
126714,(,0,0
126715,P,0,0
126716,=,0,0
126717,0.0137,0,0
126718,),0,0
126719,.,0,0
126720,Average,0,0
126721,urgency,0,0
126722,reduction,0,0
126723,was,0,0
126724,13,0,0
126725,%,0,0
126726,for,0,0
126727,control,0,0
126728,and,0,0
126729,35,0,0
126730,%,0,0
126731,for,0,0
126732,drug,0,0
126733,(,0,0
126734,P,0,0
126735,=,0,0
126736,0.0328,0,0
126737,),0,0
126738,.,0,0
126739,CONCLUSIONS,0,0
126740,The,0,0
126741,combination,0,0
126742,of,0,0
126743,alkalinized,0,1
126744,lidocaine,0,1
126745,and,0,1
126746,heparin,0,1
126747,provides,0,0
126748,up,0,0
126749,to,0,0
126750,12,0,0
126751,hours,0,0
126752,of,0,0
126753,relief,0,0
126754,from,0,0
126755,urgency,0,0
126756,and,0,0
126757,pain,0,0
126758,associated,0,0
126759,with,0,0
126760,IC,0,0
126761,.,0,0
126762,This,0,0
126763,combination,0,0
126764,provides,0,0
126765,significant,0,0
126766,immediate,0,0
126767,relief,0,0
126768,of,0,0
126769,symptoms,0,0
126770,for,0,0
126771,patients,0,0
126772,with,0,0
126773,IC,0,0
126774,.,0,0
126775,A,0,1
126776,clinical,0,0
126777,trial,0,0
126778,of,0,1
126779,glutathione,0,1
126780,supplementation,0,1
126781,in,0,1
126782,autism,0,0
126783,spectrum,0,0
126784,disorders,0,0
126785,.,0,0
126786,BACKGROUND,0,0
126787,Recent,0,0
126788,evidence,0,0
126789,shows,0,0
126790,that,0,0
126791,subjects,0,0
126792,diagnosed,0,0
126793,with,0,0
126794,an,0,0
126795,autism,0,0
126796,spectrum,0,0
126797,disorder,0,1
126798,(,0,1
126799,ASD,0,1
126800,),0,0
126801,have,0,0
126802,significantly,0,0
126803,lower,0,0
126804,levels,0,0
126805,of,0,0
126806,glutathione,0,1
126807,than,0,0
126808,typically,0,0
126809,developing,0,0
126810,children,0,0
126811,.,0,0
126812,The,0,0
126813,purpose,0,0
126814,of,0,0
126815,this,0,0
126816,study,0,0
126817,was,0,0
126818,to,0,0
126819,examine,0,0
126820,the,0,0
126821,use,0,0
126822,of,0,0
126823,two,0,0
126824,commonly,0,0
126825,used,0,0
126826,glutathione,0,1
126827,supplements,0,1
126828,in,0,1
126829,subjects,0,0
126830,diagnosed,0,0
126831,with,0,0
126832,an,0,0
126833,ASD,0,0
126834,to,0,0
126835,determine,0,0
126836,their,0,0
126837,efficacy,0,0
126838,in,0,0
126839,increasing,0,0
126840,blood,0,0
126841,glutathione,0,1
126842,levels,0,0
126843,in,0,0
126844,subjects,0,0
126845,diagnosed,0,0
126846,with,0,0
126847,an,0,0
126848,ASD,0,0
126849,.,0,0
126850,MATERIAL/METHODS,0,0
126851,The,0,0
126852,study,0,0
126853,was,0,0
126854,an,0,0
126855,eight-week,0,0
126856,",",0,0
126857,open-label,0,1
126858,trial,0,1
126859,using,0,1
126860,oral,1,1
126861,lipoceutical,1,1
126862,glutathione,1,1
126863,(,1,1
126864,n=13,1,0
126865,),1,0
126866,or,1,0
126867,transdermal,1,1
126868,glutathione,1,1
126869,(,1,1
126870,n=13,1,0
126871,),1,0
126872,in,0,0
126873,children,0,0
126874,",",0,0
126875,3-13,0,0
126876,years,0,0
126877,of,0,0
126878,age,0,0
126879,",",0,0
126880,with,0,0
126881,a,0,0
126882,diagnosis,0,0
126883,of,0,0
126884,an,0,0
126885,ASD,0,0
126886,.,0,0
126887,Subjects,0,0
126888,underwent,0,0
126889,pre-,0,0
126890,and,0,0
126891,post-treatment,0,0
126892,lab,0,0
126893,testing,0,0
126894,to,0,0
126895,evaluate,0,0
126896,plasma,0,1
126897,reduced,0,0
126898,glutathione,1,1
126899,",",0,1
126900,oxidized,0,0
126901,glutathione,1,1
126902,",",0,1
126903,cysteine,0,1
126904,",",0,1
126905,taurine,0,1
126906,",",0,0
126907,free,0,0
126908,and,0,0
126909,total,0,0
126910,sulfate,0,1
126911,",",0,1
126912,and,0,1
126913,whole-blood,0,1
126914,glutathione,0,1
126915,levels,0,1
126916,.,0,0
126917,RESULTS,0,0
126918,The,0,0
126919,oral,0,1
126920,treatment,0,0
126921,group,0,0
126922,showed,0,0
126923,significant,0,0
126924,increases,0,0
126925,in,0,0
126926,plasma,0,1
126927,reduced,0,0
126928,glutathione,0,1
126929,",",0,0
126930,but,0,0
126931,not,0,0
126932,whole-blood,0,1
126933,glutathione,0,1
126934,levels,0,1
126935,following,0,0
126936,supplementation,0,1
126937,.,0,0
126938,Both,0,1
126939,the,0,0
126940,oral,0,1
126941,and,0,1
126942,transdermal,0,1
126943,treatment,0,1
126944,groups,0,0
126945,showed,0,0
126946,significant,0,0
126947,increases,0,0
126948,in,0,0
126949,plasma,0,1
126950,sulfate,0,1
126951,",",0,1
126952,cysteine,0,1
126953,",",0,1
126954,and,0,1
126955,taurine,0,1
126956,following,0,1
126957,supplementation,0,1
126958,.,0,0
126959,CONCLUSIONS,0,0
126960,The,0,0
126961,results,0,0
126962,suggest,0,0
126963,that,0,0
126964,oral,0,1
126965,and,0,1
126966,transdermal,0,1
126967,glutathione,0,1
126968,supplementation,0,1
126969,may,0,0
126970,have,0,0
126971,some,0,0
126972,benefit,0,0
126973,in,0,0
126974,improving,0,0
126975,some,0,0
126976,of,0,0
126977,the,0,0
126978,transsulfuration,0,1
126979,metabolites,0,1
126980,.,0,1
126981,Future,0,0
126982,studies,0,0
126983,among,0,0
126984,subjects,0,0
126985,diagnosed,0,0
126986,with,0,0
126987,an,0,0
126988,ASD,0,0
126989,should,0,0
126990,further,0,0
126991,explore,0,0
126992,the,0,0
126993,pharmacokinetics,0,1
126994,of,0,1
126995,glutathione,0,1
126996,supplementation,0,1
126997,and,0,1
126998,evaluate,0,0
126999,the,0,0
127000,potential,0,0
127001,effects,0,0
127002,of,0,0
127003,glutathione,0,1
127004,supplementation,0,1
127005,upon,0,1
127006,clinical,0,1
127007,symptoms,0,0
127008,.,0,0
127009,Response,0,0
127010,prediction,0,0
127011,in,0,0
127012,metastasised,0,0
127013,colorectal,0,0
127014,cancer,0,0
127015,using,0,0
127016,intratumoural,0,1
127017,thymidylate,0,1
127018,synthase,0,1
127019,:,0,0
127020,results,0,0
127021,of,0,0
127022,a,0,0
127023,randomised,0,0
127024,multicentre,0,0
127025,trial,0,0
127026,.,0,0
127027,BACKGROUND,0,0
127028,Molecular,0,0
127029,markers,0,0
127030,to,0,0
127031,predict,0,0
127032,response,0,0
127033,to,0,0
127034,5-fluorouracil,1,1
127035,(,1,1
127036,FU,1,1
127037,),1,0
127038,-based,1,0
127039,treatment,0,0
127040,of,0,0
127041,recurrent,0,0
127042,or,0,0
127043,metastasised,0,0
127044,colorectal,0,1
127045,cancer,0,1
127046,(,0,1
127047,mCRC,0,1
127048,),0,0
127049,are,0,0
127050,not,0,0
127051,established,0,0
127052,.,0,0
127053,The,0,0
127054,aim,0,0
127055,of,0,0
127056,this,0,0
127057,trial,0,0
127058,was,0,0
127059,to,0,0
127060,determine,0,0
127061,the,0,0
127062,value,0,0
127063,of,0,0
127064,thymidylate,0,1
127065,synthase,0,1
127066,(,0,1
127067,TS,0,1
127068,),0,1
127069,",",0,0
127070,a,0,0
127071,key,0,0
127072,enzyme,0,0
127073,of,0,0
127074,DNA,0,0
127075,synthesis,0,0
127076,and,0,0
127077,target,0,0
127078,of,0,0
127079,5-FU,0,0
127080,",",0,0
127081,to,0,0
127082,predict,0,0
127083,response,0,0
127084,to,0,0
127085,chemotherapy,0,0
127086,of,0,0
127087,mCRC,0,0
127088,.,0,0
127089,METHODS,0,0
127090,Tumour,0,0
127091,tissue,0,0
127092,was,0,0
127093,obtained,0,0
127094,from,0,0
127095,168,0,0
127096,patients,0,0
127097,with,0,0
127098,mCRC,0,0
127099,for,0,0
127100,relative,0,0
127101,thymidylate,1,1
127102,synthase,1,1
127103,(,0,1
127104,TS,0,1
127105,),0,1
127106,mRNA,0,0
127107,quantitation,0,0
127108,.,0,0
127109,Patients,0,0
127110,were,0,0
127111,randomised,0,0
127112,to,0,0
127113,receive,0,0
127114,either,0,0
127115,5-FU/folinic,1,1
127116,acid,1,1
127117,(,1,1
127118,FA,1,1
127119,",",1,1
127120,FUFA,1,1
127121,),1,0
127122,alone,1,0
127123,or,1,0
127124,in,1,0
127125,combination,1,0
127126,with,1,1
127127,irinotecan,1,1
127128,5-fluorouracil/folinic,1,1
127129,acid,1,1
127130,and,1,1
127131,irinotecan,1,1
127132,(,1,1
127133,FOLFIRI,1,1
127134,),1,1
127135,stratified,1,0
127136,by,1,0
127137,TS,1,1
127138,(,1,0
127139,low,1,0
127140,versus,1,0
127141,high,1,0
127142,),1,0
127143,.,0,0
127144,Primary,0,0
127145,end-point,0,0
127146,was,0,0
127147,overall,0,0
127148,response,0,0
127149,to,0,0
127150,first-line,0,0
127151,treatment,0,0
127152,among,0,0
127153,TS,0,0
127154,high,0,0
127155,patients,0,0
127156,.,0,0
127157,All,0,0
127158,parties,0,0
127159,",",0,0
127160,except,0,0
127161,for,0,0
127162,the,0,0
127163,randomisation,0,0
127164,centre,0,0
127165,",",0,0
127166,were,0,0
127167,blinded,0,0
127168,for,0,0
127169,TS,0,0
127170,status,0,0
127171,.,0,0
127172,RESULTS,0,1
127173,Biopsies,0,0
127174,(,0,0
127175,n=168,0,0
127176,),0,0
127177,were,0,0
127178,taken,0,0
127179,without,0,0
127180,complications,0,0
127181,.,0,0
127182,TS,0,0
127183,levels,0,0
127184,were,0,0
127185,available,0,0
127186,for,0,0
127187,147,0,0
127188,patients,0,0
127189,(,0,0
127190,87.5,0,0
127191,%,0,0
127192,),0,0
127193,.,0,0
127194,Analysing,0,0
127195,response,0,0
127196,to,0,0
127197,FUFA,0,0
127198,and,0,0
127199,FOLFIRI,0,0
127200,in,0,0
127201,the,0,0
127202,per,0,0
127203,protocol,0,0
127204,set,0,0
127205,(,0,0
127206,n=119,0,0
127207,),0,0
127208,after,0,0
127209,un-blinding,0,0
127210,TS,0,0
127211,in,0,0
127212,the,0,0
127213,data,0,0
127214,base,0,0
127215,revealed,0,0
127216,a,0,0
127217,trend,0,0
127218,to,0,0
127219,better,0,0
127220,overall,0,0
127221,response,0,0
127222,to,0,0
127223,FOLFIRI,0,0
127224,(,0,0
127225,9/19,0,0
127226,",",0,0
127227,47,0,0
127228,%,0,0
127229,),0,0
127230,in,0,0
127231,TS,0,0
127232,high,0,0
127233,compared,0,0
127234,to,0,0
127235,FUFA,0,0
127236,(,0,0
127237,5/23,0,0
127238,",",0,0
127239,22,0,0
127240,%,0,0
127241,",",0,0
127242,p=0.077,0,0
127243,),0,0
127244,.,0,0
127245,In,0,0
127246,patients,0,0
127247,with,0,0
127248,biopsies,0,0
127249,taken,0,0
127250,from,0,0
127251,liver,0,0
127252,lesions,0,0
127253,(,0,0
127254,n=91,0,0
127255,),0,0
127256,overall,0,0
127257,response,0,0
127258,to,0,0
127259,FOLFIRI,0,0
127260,and,0,0
127261,FUFA,0,0
127262,in,0,0
127263,TS,0,0
127264,high,0,0
127265,was,0,0
127266,53,0,0
127267,%,0,0
127268,(,0,0
127269,9/17,0,0
127270,),0,0
127271,and,0,0
127272,18,0,0
127273,%,0,0
127274,(,0,0
127275,3/17,0,0
127276,),0,0
127277,",",0,0
127278,respectively,0,0
127279,(,0,0
127280,p=0.035,0,0
127281,),0,0
127282,.,0,0
127283,In,0,0
127284,patients,0,0
127285,with,0,0
127286,low,0,0
127287,TS,0,0
127288,",",0,0
127289,no,0,0
127290,remarkable,0,0
127291,difference,0,0
127292,in,0,0
127293,overall,0,0
127294,response,0,0
127295,to,0,0
127296,FOLFIRI,0,0
127297,and,0,0
127298,FUFA,0,0
127299,was,0,0
127300,observed,0,0
127301,.,0,0
127302,CONCLUSIONS,0,0
127303,Taking,0,0
127304,a,0,0
127305,pre-treatment,0,0
127306,biopsy,0,0
127307,is,0,0
127308,a,0,0
127309,safe,0,0
127310,and,0,0
127311,feasible,0,0
127312,procedure,0,0
127313,in,0,0
127314,mCRC,0,0
127315,.,0,0
127316,After,0,0
127317,validation,0,0
127318,of,0,0
127319,our,0,0
127320,data,0,0
127321,in,0,0
127322,a,0,0
127323,larger,0,0
127324,group,0,0
127325,TS,0,0
127326,determination,0,0
127327,may,0,0
127328,have,0,0
127329,the,0,0
127330,potential,0,0
127331,to,0,0
127332,better,0,0
127333,help,0,0
127334,direct,0,0
127335,systemic,0,0
127336,treatment,0,0
127337,in,0,0
127338,patients,0,0
127339,with,0,0
127340,primarily,0,0
127341,non-resectable,0,0
127342,mCRC,0,0
127343,.,0,0
127344,Safety,0,1
127345,",",0,0
127346,tolerability,0,1
127347,",",0,1
127348,and,0,1
127349,immunogenicity,0,1
127350,after,0,0
127351,1,0,0
127352,and,0,0
127353,2,0,1
127354,doses,0,1
127355,of,0,1
127356,zoster,1,1
127357,vaccine,1,0
127358,in,0,0
127359,healthy,0,0
127360,adults,0,0
127361,?60,0,1
127362,years,0,1
127363,of,0,0
127364,age,0,0
127365,.,0,0
127366,BACKGROUND,0,0
127367,Incidence,0,0
127368,and,0,0
127369,severity,0,0
127370,of,0,0
127371,herpes,0,1
127372,zoster,0,1
127373,(,0,1
127374,HZ,0,1
127375,),0,1
127376,and,0,0
127377,postherpetic,0,0
127378,neuralgia,0,0
127379,increase,0,0
127380,with,0,0
127381,age,0,0
127382,",",0,0
127383,associated,0,0
127384,with,0,0
127385,age-related,0,0
127386,decrease,0,0
127387,in,0,0
127388,immunity,0,0
127389,to,0,0
127390,varicella-zoster,0,1
127391,virus,0,1
127392,(,0,1
127393,VZV,0,1
127394,),0,1
127395,.,0,0
127396,One,0,0
127397,dose,0,1
127398,of,0,1
127399,zoster,1,1
127400,vaccine,1,1
127401,(,1,1
127402,ZV,1,1
127403,),1,0
127404,has,1,0
127405,demonstrated,0,0
127406,substantial,0,0
127407,protection,0,0
127408,against,0,0
127409,HZ,0,1
127410,;,0,0
127411,this,0,0
127412,study,0,0
127413,examined,0,0
127414,impact,0,0
127415,of,0,0
127416,a,0,0
127417,second,0,0
127418,dose,0,1
127419,of,0,0
127420,ZV,1,1
127421,.,1,0
127422,METHODS,0,0
127423,Randomized,0,1
127424,",",0,0
127425,double-blind,0,1
127426,",",0,1
127427,multicenter,0,0
127428,study,0,0
127429,with,0,0
127430,210,0,0
127431,subjects,0,0
127432,?60,0,0
127433,years,0,1
127434,old,0,1
127435,compared,0,0
127436,immunity,0,0
127437,and,0,0
127438,safety,0,0
127439,profiles,0,0
127440,after,0,0
127441,one,0,0
127442,and,0,0
127443,two,0,0
127444,doses,1,1
127445,of,1,0
127446,ZV,1,1
127447,",",1,0
127448,separated,0,0
127449,by,0,0
127450,6,0,0
127451,weeks,0,0
127452,",",0,0
127453,vs.,0,0
127454,placebo,1,1
127455,.,1,0
127456,Immunogenicity,1,0
127457,was,0,0
127458,evaluated,0,0
127459,using,0,0
127460,VZV,0,1
127461,interferon-gamma,0,1
127462,(,0,1
127463,IFN-?,0,1
127464,),0,1
127465,enzyme-linked,0,1
127466,immunospot,0,1
127467,(,0,1
127468,ELISPOT,0,1
127469,),0,0
127470,assay,0,0
127471,and,0,0
127472,VZV,0,1
127473,glycoprotein,0,1
127474,enzyme-linked,0,1
127475,immunosorbent,0,1
127476,antibody,0,1
127477,(,0,1
127478,gpELISA,0,1
127479,),0,0
127480,assay,0,0
127481,.,0,0
127482,Adverse,0,0
127483,experiences,0,0
127484,(,0,1
127485,AEs,0,1
127486,),0,0
127487,were,0,0
127488,recorded,0,0
127489,on,0,0
127490,a,0,0
127491,standardized,0,0
127492,Vaccination,0,0
127493,Report,0,0
127494,Card,0,0
127495,.,0,0
127496,RESULTS,0,1
127497,No,0,1
127498,serious,0,1
127499,vaccine-related,0,1
127500,AEs,0,0
127501,occurred,0,0
127502,.,0,0
127503,VZV,0,0
127504,IFN-?,0,0
127505,ELISPOT,0,0
127506,geometric,0,0
127507,mean,0,0
127508,count,0,0
127509,(,0,0
127510,GMC,0,1
127511,),0,1
127512,of,0,0
127513,spot-forming,0,0
127514,cells,0,0
127515,per,0,0
127516,10,0,0
127517,(,0,1
127518,6,0,0
127519,),0,0
127520,peripheral,0,0
127521,blood,0,0
127522,mononuclear,0,0
127523,cells,0,0
127524,increased,0,0
127525,in,0,0
127526,the,0,0
127527,ZV,1,0
127528,group,1,0
127529,from,0,0
127530,16.9,0,0
127531,prevaccination,0,0
127532,to,0,0
127533,49.5,0,0
127534,and,0,0
127535,32.8,0,0
127536,at,0,0
127537,2,0,0
127538,and,0,0
127539,6,0,0
127540,weeks,0,0
127541,postdose,0,1
127542,1,0,0
127543,",",0,0
127544,respectively,0,0
127545,.,0,0
127546,Two,0,0
127547,weeks,0,0
127548,",",0,0
127549,6,0,0
127550,weeks,0,0
127551,and,0,0
127552,6,0,0
127553,months,0,0
127554,postdose,0,1
127555,2,0,1
127556,",",0,0
127557,GMC,0,0
127558,was,0,0
127559,44.3,0,0
127560,",",0,0
127561,42.9,0,0
127562,",",0,0
127563,and,0,0
127564,36.5,0,0
127565,",",0,0
127566,respectively,0,0
127567,.,0,0
127568,GMC,0,0
127569,in,0,0
127570,the,0,0
127571,placebo,1,1
127572,group,1,0
127573,did,0,0
127574,not,0,0
127575,change,0,0
127576,during,0,0
127577,the,0,0
127578,study,0,0
127579,.,0,0
127580,The,0,0
127581,peak,0,0
127582,ELISPOT,0,0
127583,response,0,0
127584,occurred,0,0
127585,?2,0,0
127586,weeks,0,0
127587,after,0,0
127588,each,1,0
127589,ZV,1,1
127590,dose,0,1
127591,.,0,1
127592,The,0,0
127593,gpELISA,0,0
127594,geometric,0,0
127595,mean,0,0
127596,titers,0,0
127597,(,0,0
127598,GMTs,0,1
127599,),0,0
127600,in,1,0
127601,the,1,0
127602,ZV,1,0
127603,group,0,0
127604,were,0,0
127605,higher,0,0
127606,than,0,0
127607,in,0,0
127608,the,1,0
127609,placebo,1,1
127610,group,0,1
127611,at,0,0
127612,6,0,0
127613,weeks,0,0
127614,after,0,0
127615,each,0,0
127616,dose,0,1
127617,.,0,0
127618,Correlation,0,0
127619,between,0,0
127620,the,0,0
127621,IFN-?,0,0
127622,ELISPOT,0,1
127623,and,0,0
127624,gpELISA,0,0
127625,assays,0,0
127626,was,0,0
127627,poor,0,0
127628,.,0,0
127629,CONCLUSIONS,1,0
127630,ZV,1,0
127631,was,1,0
127632,generally,1,0
127633,well-tolerated,0,1
127634,and,0,0
127635,immunogenic,0,0
127636,in,0,0
127637,adults,0,1
127638,?60,0,1
127639,years,0,1
127640,old,0,1
127641,.,0,0
127642,A,0,0
127643,second,0,0
127644,dose,0,1
127645,of,1,0
127646,ZV,1,0
127647,was,0,0
127648,generally,0,0
127649,safe,0,0
127650,",",0,0
127651,but,0,0
127652,did,0,0
127653,not,0,0
127654,boost,0,0
127655,VZV-specific,0,0
127656,immunity,0,0
127657,beyond,0,0
127658,levels,0,0
127659,achieved,0,0
127660,postdose,0,1
127661,1,0,1
127662,.,0,0
127663,Impact,0,0
127664,of,0,0
127665,antisecretory,1,1
127666,treatment,1,1
127667,on,0,0
127668,respiratory,0,0
127669,symptoms,0,0
127670,of,0,0
127671,gastroesophageal,0,0
127672,reflux,0,0
127673,disease,0,0
127674,in,0,0
127675,children,0,0
127676,.,0,0
127677,The,0,0
127678,effect,0,0
127679,of,0,0
127680,antisecretory,1,1
127681,treatment,1,1
127682,on,0,0
127683,extraesophageal,0,0
127684,symptoms,0,0
127685,of,0,0
127686,gastroesophageal,0,0
127687,reflux,0,0
127688,disease,0,0
127689,was,0,0
127690,evaluated,0,0
127691,.,0,0
127692,Seventy-eight,0,0
127693,children,0,0
127694,presenting,0,0
127695,with,0,0
127696,typical,0,0
127697,and,0,0
127698,extraesophageal,0,0
127699,symptoms,0,0
127700,of,0,0
127701,gastroesophageal,0,0
127702,reflux,0,0
127703,disease,0,0
127704,underwent,0,0
127705,a,0,0
127706,multichannel,0,0
127707,intraluminal,0,0
127708,impedance,0,0
127709,and,0,0
127710,pH,0,1
127711,monitoring,0,0
127712,(,0,1
127713,MII/pH,0,1
127714,),0,1
127715,.,0,0
127716,Children,0,0
127717,with,0,0
127718,a,0,0
127719,positive,0,0
127720,MII/pH,0,0
127721,were,0,0
127722,randomly,0,0
127723,treated,0,0
127724,with,0,0
127725,proton,1,0
127726,pump,1,1
127727,inhibitors,1,1
127728,(,1,1
127729,PPIs,1,1
127730,),1,1
127731,or,1,1
127732,histamine,1,1
127733,H,1,1
127734,(,1,1
127735,2,1,1
127736,),1,1
127737,-receptor,1,1
127738,antagonists,1,1
127739,(,1,1
127740,H,1,1
127741,(,1,1
127742,2,1,1
127743,),1,1
127744,RAs,1,1
127745,),1,1
127746,during,0,0
127747,3,0,0
127748,months,0,0
127749,.,0,0
127750,At,0,0
127751,the,0,0
127752,end,0,0
127753,of,0,0
127754,the,0,0
127755,treatment,0,0
127756,period,0,0
127757,",",0,0
127758,all,0,0
127759,patients,0,0
127760,were,0,0
127761,recalled,0,0
127762,.,0,0
127763,A,0,0
127764,second,0,0
127765,treatment,0,0
127766,period,0,0
127767,of,0,0
127768,3,0,0
127769,months,0,0
127770,was,0,0
127771,given,0,0
127772,to,0,0
127773,those,0,0
127774,patients,0,0
127775,who,0,0
127776,were,0,0
127777,not,0,0
127778,symptom-free,0,0
127779,after,0,0
127780,3,0,0
127781,months,0,0
127782,.,0,0
127783,Thirty-five,0,0
127784,of,0,0
127785,the,0,0
127786,forty-one,0,0
127787,(,0,0
127788,85.4,0,0
127789,%,0,0
127790,),0,0
127791,children,0,0
127792,with,0,0
127793,a,0,0
127794,pathologic,0,0
127795,MII/pH,0,0
127796,presented,0,0
127797,with,0,0
127798,extraesophageal,0,0
127799,symptoms,0,0
127800,and,0,0
127801,were,0,0
127802,treated,0,0
127803,with,0,0
127804,PPIs,1,1
127805,(,1,1
127806,omeprazole,1,1
127807,;,1,1
127808,n:19,0,0
127809,),0,0
127810,or,0,0
127811,H,1,1
127812,(,1,1
127813,2,1,1
127814,),1,1
127815,RAs,1,1
127816,(,1,1
127817,ranitidine,1,1
127818,;,1,1
127819,n:16,0,0
127820,),0,0
127821,for,0,0
127822,12,0,0
127823,weeks,0,0
127824,.,0,0
127825,After,0,0
127826,3,0,0
127827,months,0,0
127828,",",0,0
127829,11/19,0,0
127830,(,0,0
127831,57.9,0,0
127832,%,0,0
127833,),0,0
127834,PPI-treated,1,0
127835,patients,0,0
127836,had,0,0
127837,a,0,0
127838,complete,0,0
127839,resolution,0,0
127840,of,0,0
127841,symptoms,0,0
127842,;,0,0
127843,6/8,0,0
127844,nonresponders,0,0
127845,were,0,0
127846,treated,0,0
127847,with,0,0
127848,PPI,1,0
127849,for,0,0
127850,another,0,0
127851,3,0,0
127852,months,0,0
127853,and,0,0
127854,became,0,0
127855,all,0,0
127856,symptom-free,0,0
127857,.,0,0
127858,The,0,0
127859,other,0,0
127860,two,0,0
127861,underwent,0,0
127862,a,0,0
127863,Nissen,0,0
127864,fundoplication,0,0
127865,.,0,0
127866,Only,0,0
127867,5/16,0,0
127868,(,0,0
127869,31.2,0,0
127870,%,0,0
127871,),0,0
127872,patients,0,0
127873,treated,0,0
127874,with,0,0
127875,H,1,1
127876,(,1,1
127877,2,1,1
127878,),1,0
127879,RAs,1,0
127880,had,0,0
127881,a,0,0
127882,complete,0,0
127883,resolution,0,0
127884,of,0,0
127885,symptoms,0,0
127886,after,0,0
127887,3,0,0
127888,months,0,0
127889,;,0,0
127890,1/11,0,0
127891,was,0,0
127892,treated,0,0
127893,again,0,0
127894,with,0,0
127895,H,1,0
127896,(,1,1
127897,2,1,1
127898,),1,0
127899,RAs,1,1
127900,during,0,0
127901,3,0,0
127902,months,0,0
127903,",",0,0
127904,and,0,0
127905,10/11,0,0
127906,were,0,0
127907,changed,0,0
127908,to,0,0
127909,PPIs,1,0
127910,.,1,0
127911,In,0,0
127912,3/10,0,0
127913,",",0,0
127914,a,0,0
127915,partial,0,0
127916,resolution,0,0
127917,of,0,0
127918,symptoms,0,0
127919,was,0,0
127920,achieved,0,0
127921,",",0,0
127922,while,0,0
127923,in,0,0
127924,7/10,0,0
127925,",",0,0
127926,a,0,0
127927,complete,0,0
127928,remission,0,0
127929,was,0,0
127930,obtained,0,0
127931,(,0,0
127932,P,0,0
127933,<,0,0
127934,0.05,0,0
127935,),0,0
127936,.,0,0
127937,Antisecretory,1,1
127938,reflux,1,1
127939,treatment,1,0
127940,improves,0,0
127941,extraesophageal,0,0
127942,reflux,0,0
127943,symptoms,0,0
127944,.,0,0
127945,The,0,0
127946,efficacy,0,0
127947,of,0,0
127948,PPIs,1,0
127949,is,0,0
127950,superior,0,0
127951,to,0,0
127952,that,0,0
127953,of,0,0
127954,H,1,1
127955,(,1,1
127956,2,1,1
127957,),1,0
127958,RAs,1,0
127959,in,0,0
127960,these,0,0
127961,children,0,0
127962,.,0,0
127963,[,0,1
127964,Pharmacological,0,0
127965,correction,0,0
127966,of,0,0
127967,free,0,0
127968,radical,0,0
127969,disturbances,0,1
127970,and,0,0
127971,endotoxicosis,0,1
127972,in,0,0
127973,patients,0,0
127974,with,0,0
127975,diffuse,0,0
127976,peritonitis,0,0
127977,at,0,0
127978,the,0,0
127979,postoperative,0,0
127980,period,0,1
127981,],0,0
127982,.,0,0
127983,The,0,0
127984,examination,0,0
127985,and,0,0
127986,treatment,0,0
127987,of,0,0
127988,64,0,0
127989,patients,0,0
127990,have,0,0
127991,shown,0,0
127992,that,0,0
127993,inclusion,0,0
127994,of,0,0
127995,complex,1,0
127996,antioxidant,1,1
127997,cytoflavin,1,1
127998,in,0,1
127999,intensive,0,1
128000,therapy,0,0
128001,at,0,0
128002,the,0,0
128003,postoperative,0,0
128004,period,0,0
128005,of,0,0
128006,diffuse,0,0
128007,peritonitis,0,0
128008,allows,0,0
128009,the,0,0
128010,hypoxia,0,0
128011,degree,0,0
128012,to,0,0
128013,be,0,0
128014,decreased,0,0
128015,that,0,0
128016,in,0,0
128017,its,0,0
128018,turn,0,0
128019,results,0,0
128020,in,0,0
128021,quicker,0,0
128022,recovery,0,0
128023,of,0,0
128024,the,0,0
128025,antioxidant,0,1
128026,system,0,0
128027,and,0,0
128028,decreased,0,0
128029,activity,0,0
128030,of,0,0
128031,peroxidation,0,1
128032,and,0,1
128033,endotoxicosis,0,1
128034,level,0,0
128035,.,0,0
128036,The,0,0
128037,clinical,0,0
128038,course,0,0
128039,of,0,0
128040,the,0,0
128041,postoperative,0,0
128042,period,0,0
128043,of,0,0
128044,diffuse,0,0
128045,peritonitis,0,0
128046,with,0,0
128047,cytoflavin,1,1
128048,included,0,0
128049,in,0,0
128050,intensive,0,0
128051,therapy,0,0
128052,is,0,0
128053,characterized,0,0
128054,by,0,0
128055,shorter,0,0
128056,terms,0,0
128057,of,0,0
128058,artificial,0,0
128059,lung,0,0
128060,ventilation,0,0
128061,",",0,0
128062,shorter,0,0
128063,time,0,0
128064,of,0,0
128065,staying,0,0
128066,in,0,0
128067,critical,0,0
128068,condition,0,0
128069,",",0,0
128070,more,0,0
128071,favorable,0,0
128072,course,0,0
128073,of,0,0
128074,complications,0,0
128075,.,0,0
128076,Randomized,0,0
128077,controlled,0,0
128078,study,0,0
128079,of,0,0
128080,chemoimmunotherapy,1,1
128081,with,1,1
128082,bestatin,1,1
128083,of,0,0
128084,acute,0,1
128085,nonlymphocytic,0,0
128086,leukemia,0,0
128087,in,0,0
128088,adults,0,0
128089,.,0,0
128090,A,0,0
128091,new,0,0
128092,immunomodulating,1,1
128093,agent,1,1
128094,",",1,1
128095,bestatin,1,1
128096,(,0,1
128097,INN,0,1
128098,:,0,1
128099,Ubenimex,1,0
128100,has,0,0
128101,low,0,0
128102,toxicity,0,0
128103,even,0,0
128104,after,0,0
128105,long-term,0,1
128106,oral,0,1
128107,administration,0,1
128108,and,0,1
128109,has,0,0
128110,significant,0,0
128111,modifications,0,0
128112,in,0,0
128113,immunological,0,0
128114,response,0,0
128115,.,0,0
128116,A,0,0
128117,cooperative,0,0
128118,randomized,0,0
128119,controlled,0,0
128120,study,0,0
128121,of,0,0
128122,bestatin,1,1
128123,immunotherapy,1,1
128124,in,0,0
128125,combination,0,0
128126,with,0,0
128127,remission,1,0
128128,maintenance,1,0
128129,chemotherapy,1,0
128130,for,0,0
128131,adult,0,0
128132,acute,0,0
128133,nonlymphocytic,0,1
128134,leukemia,0,1
128135,(,0,1
128136,ANLL,0,1
128137,),0,0
128138,was,0,0
128139,performed,0,0
128140,.,0,0
128141,After,0,0
128142,induction,0,0
128143,of,0,0
128144,complete,0,0
128145,remission,0,0
128146,",",0,0
128147,patients,0,0
128148,were,0,0
128149,randomized,0,0
128150,to,0,0
128151,the,0,0
128152,bestatin,1,1
128153,group,1,1
128154,(,0,1
128155,30,0,1
128156,mg/bw,0,1
128157,per,0,1
128158,os,0,1
128159,(,0,1
128160,po,0,1
128161,),0,1
128162,daily,0,1
128163,),0,1
128164,and,0,0
128165,the,0,0
128166,control,1,0
128167,group,1,0
128168,.,1,0
128169,The,0,0
128170,101,0,0
128171,eligible,0,0
128172,cases,0,0
128173,(,1,1
128174,bestatin,1,1
128175,:,1,1
128176,48,0,0
128177,",",0,0
128178,control,0,0
128179,:,0,0
128180,53,0,0
128181,),0,0
128182,were,0,0
128183,analyzed,0,0
128184,;,0,0
128185,the,0,0
128186,bestatin,1,1
128187,group,0,0
128188,achieved,0,0
128189,longer,0,0
128190,remission,0,0
128191,than,0,0
128192,the,0,0
128193,control,0,0
128194,group,0,0
128195,and,0,0
128196,a,0,0
128197,statistically,0,0
128198,significant,0,0
128199,longer,0,0
128200,survival,0,0
128201,.,0,0
128202,Though,0,0
128203,this,0,0
128204,prolongation,0,0
128205,of,0,0
128206,remission,0,0
128207,was,0,0
128208,not,0,0
128209,significant,0,0
128210,in,0,0
128211,the,0,0
128212,bestatin,1,1
128213,group,0,0
128214,compared,0,0
128215,to,0,0
128216,the,0,0
128217,control,0,0
128218,group,0,0
128219,in,0,0
128220,the,0,0
128221,15-49,0,0
128222,yr,0,0
128223,age,0,0
128224,group,0,0
128225,",",0,0
128226,in,0,0
128227,the,0,0
128228,50-65,0,0
128229,yr,0,0
128230,age,0,0
128231,group,0,0
128232,it,0,0
128233,was,0,0
128234,significantly,0,0
128235,longer,0,0
128236,.,0,0
128237,Bestatin,1,1
128238,is,0,0
128239,shown,0,0
128240,to,0,0
128241,be,0,0
128242,a,0,0
128243,clinically,0,0
128244,useful,0,0
128245,drug,0,1
128246,for,0,0
128247,immunotherapy,1,0
128248,of,0,0
128249,adult,0,0
128250,ANLL,0,0
128251,",",0,0
128252,since,0,0
128253,it,0,0
128254,has,0,0
128255,prolonged,0,0
128256,survival,0,0
128257,and,0,0
128258,remission,0,0
128259,especially,0,0
128260,in,0,0
128261,elderly,0,0
128262,patients,0,0
128263,",",0,0
128264,with,0,0
128265,few,0,0
128266,side-effects,0,0
128267,.,0,0
128268,Randomized,0,0
128269,comparison,0,0
128270,of,0,0
128271,the,0,0
128272,efficacy,0,0
128273,and,0,0
128274,safety,0,0
128275,of,0,0
128276,zotarolimus-eluting,1,1
128277,stents,1,1
128278,vs.,0,0
128279,sirolimus-eluting,1,1
128280,stents,1,0
128281,for,0,0
128282,percutaneous,0,0
128283,coronary,0,0
128284,intervention,0,0
128285,in,0,0
128286,chronic,0,0
128287,total,0,0
128288,occlusion,0,0
128289,--,0,0
128290,CAtholic,0,0
128291,Total,0,0
128292,Occlusion,0,1
128293,Study,0,1
128294,(,0,1
128295,CATOS,0,1
128296,),0,1
128297,trial,0,0
128298,.,0,0
128299,BACKGROUND,0,0
128300,Limited,0,0
128301,data,0,0
128302,are,0,0
128303,available,0,0
128304,regarding,0,0
128305,the,0,0
128306,direct,0,0
128307,comparison,0,0
128308,of,0,0
128309,angiographic,0,0
128310,and,0,0
128311,clinical,0,0
128312,outcomes,0,0
128313,after,0,0
128314,percutaneous,0,0
128315,coronary,0,1
128316,intervention,0,1
128317,(,0,1
128318,PCI,0,1
128319,),0,1
128320,with,0,0
128321,drug-eluting,1,1
128322,stents,1,1
128323,(,0,1
128324,DESs,0,1
128325,),0,1
128326,for,0,0
128327,chronic,0,0
128328,total,0,0
128329,occlusion,0,1
128330,(,0,1
128331,CTO,0,1
128332,),0,1
128333,.,0,0
128334,METHODS,0,0
128335,AND,0,1
128336,RESULTS,0,1
128337,A,0,1
128338,prospective,0,1
128339,",",0,0
128340,randomized,0,0
128341,",",0,0
128342,multicenter,0,0
128343,trial,0,0
128344,was,0,0
128345,conducted,0,0
128346,to,0,0
128347,evaluate,0,0
128348,the,0,0
128349,non-inferiority,0,0
128350,of,0,0
128351,a,0,0
128352,zotarolimus-eluting,1,1
128353,stent,1,1
128354,(,1,1
128355,ZES,1,1
128356,;,1,1
128357,Endeavor,1,0
128358,Sprint?,1,0
128359,",",1,0
128360,n=80,0,0
128361,),0,0
128362,to,0,0
128363,a,0,0
128364,sirolimus-eluting,1,1
128365,stent,1,1
128366,(,1,1
128367,SES,1,1
128368,;,1,1
128369,Cypher?,1,0
128370,",",1,0
128371,n=80,0,0
128372,),0,0
128373,in,0,0
128374,patients,0,0
128375,with,0,0
128376,CTO,0,0
128377,lesion,0,0
128378,with,0,0
128379,a,0,0
128380,reference,0,0
128381,vessel,0,0
128382,diameter,0,1
128383,?,0,1
128384,2.5mm,0,0
128385,.,0,0
128386,The,0,0
128387,primary,0,0
128388,endpoint,0,0
128389,was,0,0
128390,in-segment,0,0
128391,binary,0,0
128392,restenosis,0,0
128393,rate,0,0
128394,at,0,0
128395,9-month,0,0
128396,angiographic,0,0
128397,follow-up,0,0
128398,.,0,0
128399,Key,0,0
128400,secondary,0,0
128401,endpoints,0,0
128402,included,0,0
128403,target,0,0
128404,vessel,0,0
128405,failure,0,1
128406,(,0,1
128407,TVF,0,1
128408,;,0,1
128409,including,0,0
128410,cardiac,0,0
128411,death,0,0
128412,",",0,0
128413,myocardial,0,0
128414,infarction,0,0
128415,",",0,0
128416,and,0,0
128417,target,0,0
128418,vessel,0,1
128419,revascularization,0,1
128420,),0,0
128421,and,0,0
128422,Academic,0,1
128423,Research,0,0
128424,Consortium-defined,0,0
128425,definite/probable,0,0
128426,stent,0,1
128427,thrombosis,0,1
128428,(,0,1
128429,ST,0,1
128430,),0,1
128431,within,0,0
128432,12,0,0
128433,months,0,0
128434,.,0,0
128435,The,0,0
128436,ZES,0,0
128437,was,0,0
128438,non-inferior,0,1
128439,to,0,0
128440,the,0,0
128441,SES,0,0
128442,with,0,0
128443,respect,0,0
128444,to,0,0
128445,the,0,0
128446,primary,0,0
128447,endpoint,0,0
128448,",",0,0
128449,which,0,0
128450,occurred,0,0
128451,in,0,0
128452,14.1,0,0
128453,%,0,0
128454,(,0,0
128455,95,0,0
128456,%,0,0
128457,confidence,0,0
128458,interval,0,0
128459,[,0,0
128460,CI,0,0
128461,],0,0
128462,:,0,0
128463,6.0-22.2,0,0
128464,),0,0
128465,and,0,0
128466,in,0,0
128467,13.7,0,0
128468,%,0,0
128469,(,0,0
128470,95,0,0
128471,%,0,0
128472,CI,0,0
128473,:,0,0
128474,5.8-21.6,0,0
128475,),0,0
128476,of,0,0
128477,patients,0,0
128478,",",0,0
128479,respectively,0,0
128480,(,0,0
128481,non-inferiority,0,0
128482,margin,0,0
128483,",",0,0
128484,15.0,0,0
128485,%,0,0
128486,;,0,0
128487,P,0,0
128488,for,0,0
128489,non-inferiority,0,0
128490,<,0,0
128491,0.001,0,0
128492,),0,0
128493,.,0,0
128494,There,0,0
128495,were,0,0
128496,no,0,0
128497,significant,0,0
128498,between-group,0,0
128499,differences,0,0
128500,in,0,0
128501,the,0,0
128502,rate,0,0
128503,of,0,0
128504,TVF,0,0
128505,(,0,0
128506,10.0,0,0
128507,%,0,0
128508,vs.,0,0
128509,17.5,0,0
128510,%,0,0
128511,;,0,0
128512,P=0.168,0,0
128513,),0,0
128514,nor,0,0
128515,in,0,0
128516,the,0,0
128517,rate,0,0
128518,of,0,0
128519,ST,0,0
128520,(,0,0
128521,0.0,0,0
128522,%,0,0
128523,vs.,0,0
128524,1.3,0,0
128525,%,0,0
128526,;,0,0
128527,P=0.316,0,0
128528,),0,0
128529,during,0,0
128530,the,0,0
128531,12-month,0,0
128532,clinical,0,0
128533,follow-up,0,0
128534,.,0,0
128535,CONCLUSIONS,0,0
128536,The,0,0
128537,effectiveness,0,0
128538,and,0,0
128539,safety,0,0
128540,of,0,0
128541,ZES,0,0
128542,are,0,0
128543,similar,0,0
128544,to,0,0
128545,those,0,0
128546,of,0,0
128547,SES,0,0
128548,and,0,0
128549,therefore,0,0
128550,it,0,0
128551,is,0,0
128552,a,0,0
128553,good,0,0
128554,treatment,0,0
128555,option,0,0
128556,in,0,0
128557,patients,0,0
128558,undergoing,0,0
128559,PCI,0,0
128560,for,0,0
128561,CTO,0,0
128562,with,0,0
128563,DESs,0,0
128564,.,0,0
128565,Predictors,0,0
128566,of,0,0
128567,response,0,0
128568,to,0,0
128569,ziprasidone,1,1
128570,:,1,0
128571,results,0,0
128572,from,0,0
128573,a,0,0
128574,6-week,0,0
128575,randomized,0,1
128576,double-blind,0,1
128577,",",0,1
128578,placebo-controlled,1,1
128579,trial,0,1
128580,for,0,0
128581,acute,0,0
128582,depressive,0,0
128583,mixed,0,0
128584,state,0,0
128585,.,0,0
128586,INTRODUCTION,0,0
128587,The,0,0
128588,present,0,0
128589,study,0,0
128590,is,0,0
128591,aimed,0,0
128592,at,0,0
128593,investigating,0,0
128594,possible,0,0
128595,predictors,0,0
128596,of,0,0
128597,response,0,0
128598,to,0,0
128599,ziprasidone,0,1
128600,in,0,0
128601,a,0,0
128602,sample,0,0
128603,of,0,0
128604,patients,0,0
128605,with,0,0
128606,mixed,0,0
128607,depressive,0,0
128608,state,0,0
128609,.,0,0
128610,METHODS,0,0
128611,72,0,0
128612,patients,0,0
128613,were,0,0
128614,randomized,0,0
128615,to,0,0
128616,either,0,0
128617,ziprasidone,1,1
128618,or,1,1
128619,placebo,1,1
128620,and,0,0
128621,treated,0,0
128622,prospectively,0,0
128623,for,0,0
128624,6,0,0
128625,weeks,0,0
128626,.,0,0
128627,The,0,0
128628,clinical,0,0
128629,response,0,0
128630,and,0,0
128631,remission,0,0
128632,were,0,0
128633,defined,0,0
128634,with,0,0
128635,various,0,0
128636,clinical,0,0
128637,variables,0,0
128638,including,0,0
128639,Montgomery,0,0
128640,Asberg,0,0
128641,Depression,0,0
128642,Rating,0,0
128643,Scale,0,0
128644,.,0,0
128645,Further,0,0
128646,outcome,0,0
128647,measures,0,0
128648,included,0,0
128649,predictors,0,0
128650,of,0,0
128651,remission,0,0
128652,and,0,0
128653,other,0,0
128654,clinical,0,0
128655,variables,0,0
128656,over,0,0
128657,time,0,0
128658,.,0,0
128659,RESULTS,0,1
128660,None,0,1
128661,of,0,0
128662,the,0,0
128663,variables,0,0
128664,under,0,0
128665,investigation,0,0
128666,were,0,0
128667,significantly,0,0
128668,associated,0,0
128669,with,0,0
128670,response,0,0
128671,or,0,0
128672,remission,0,0
128673,at,0,0
128674,6,0,0
128675,weeks,0,0
128676,(,0,0
128677,all,0,0
128678,p-values,0,0
128679,>,0,0
128680,0.003,0,0
128681,",",0,0
128682,respectively,0,0
128683,),0,0
128684,.,0,0
128685,CONCLUSIONS,0,0
128686,Further,0,0
128687,investigations,0,0
128688,are,0,0
128689,warranted,0,0
128690,due,0,0
128691,to,0,0
128692,clear,0,0
128693,limitations,0,0
128694,",",0,0
128695,mostly,0,0
128696,small,0,0
128697,sample,0,0
128698,size,0,0
128699,and,0,0
128700,use,0,0
128701,of,0,0
128702,concomitant,0,0
128703,medications,0,1
128704,.,0,0
128705,Azathioprine,1,1
128706,and,0,1
128707,the,0,0
128708,treatment,0,0
128709,of,0,0
128710,chronic,0,0
128711,inflammatory,0,0
128712,bowel,0,0
128713,disease,0,0
128714,.,0,0
128715,The,0,0
128716,influence,0,0
128717,of,0,0
128718,penbutolol,1,1
128719,and,0,1
128720,placebo,1,1
128721,on,0,1
128722,blood,0,1
128723,sugar,0,0
128724,levels,0,0
128725,and,0,1
128726,insulin,0,1
128727,consumption,0,1
128728,in,0,0
128729,the,0,0
128730,glucose-controlled,0,1
128731,insulin,0,1
128732,infusion,0,1
128733,system,0,1
128734,(,0,0
128735,artificial,0,0
128736,endocrine,0,1
128737,pancreas,0,1
128738,),0,0
128739,.,0,0
128740,The,0,0
128741,aim,0,0
128742,of,0,0
128743,the,0,0
128744,study,0,0
128745,was,0,0
128746,to,0,0
128747,investigate,0,0
128748,the,0,0
128749,influence,0,0
128750,of,0,0
128751,40,0,0
128752,mg,0,1
128753,of,0,0
128754,the,0,1
128755,beta-blocker,0,1
128756,penbutolol,1,1
128757,(,0,1
128758,Betapressin,0,1
128759,TM,0,1
128760,;,0,1
128761,Hoechst,0,1
128762,Ltd.,0,1
128763,",",0,1
128764,Frankfurt/Main,0,1
128765,),0,0
128766,in,0,0
128767,comparison,0,0
128768,to,0,0
128769,placebo,1,1
128770,on,0,0
128771,the,0,0
128772,insulin,0,1
128773,consumption,0,1
128774,on,0,0
128775,the,0,0
128776,blood,0,0
128777,sugar,0,0
128778,profile,0,0
128779,in,0,0
128780,twelve,0,0
128781,insulin-dependent,0,0
128782,diabetes,0,0
128783,(,0,1
128784,IDDM,0,1
128785,),0,1
128786,patients,0,0
128787,.,0,0
128788,The,0,0
128789,patients,0,0
128790,were,0,0
128791,treated,1,0
128792,with,1,0
128793,penbutolol,1,1
128794,and,1,1
128795,placebo,1,1
128796,for,1,0
128797,a,1,0
128798,period,1,0
128799,of,1,0
128800,three,1,0
128801,days,1,0
128802,",",1,0
128803,and,1,0
128804,then,1,0
128805,were,1,0
128806,examined,1,0
128807,with,1,0
128808,the,1,0
128809,help,1,0
128810,of,1,0
128811,the,1,0
128812,glucose-controlled,1,1
128813,insulin,1,1
128814,infusion,1,1
128815,system,1,1
128816,.,1,0
128817,The,0,0
128818,blood,0,0
128819,sugar,0,0
128820,profile,0,0
128821,and,0,1
128822,insulin,0,1
128823,consumption,0,1
128824,over,0,0
128825,a,0,0
128826,24,0,0
128827,hour,0,0
128828,period,0,0
128829,was,0,0
128830,not,0,0
128831,affected,0,0
128832,by,0,0
128833,either,0,0
128834,penbutolol,0,1
128835,or,0,1
128836,placebo,0,1
128837,",",0,0
128838,nor,0,0
128839,could,0,0
128840,any,0,0
128841,changes,0,0
128842,be,0,0
128843,measured,0,0
128844,in,0,0
128845,these,0,0
128846,parameters,0,0
128847,when,0,0
128848,measured,0,0
128849,after,0,0
128850,food,0,0
128851,intake,0,1
128852,.,0,1
128853,After,0,0
128854,a,0,0
128855,submaximal,0,1
128856,exercise,0,1
128857,load,0,1
128858,on,0,0
128859,the,0,0
128860,bicycle,0,0
128861,ergometer,0,1
128862,(,0,0
128863,1,0,0
128864,watt,0,0
128865,per,0,0
128866,kg,0,0
128867,body,0,1
128868,weight,0,1
128869,),0,0
128870,following,0,0
128871,an,0,0
128872,evening,0,1
128873,meal,0,1
128874,",",0,0
128875,no,0,0
128876,difference,0,0
128877,could,0,0
128878,be,0,0
128879,observed,0,0
128880,between,0,0
128881,penbutolol,0,1
128882,and,0,1
128883,placebo,0,1
128884,in,0,0
128885,the,0,0
128886,above-mentioned,0,0
128887,parameters,0,0
128888,.,0,0
128889,The,0,0
128890,same,0,0
128891,was,0,0
128892,also,0,0
128893,true,0,0
128894,for,0,0
128895,hormonal,0,0
128896,parameters,0,0
128897,as,0,0
128898,STH,0,0
128899,",",0,0
128900,ACTH,0,1
128901,",",0,1
128902,cortisol,0,1
128903,",",0,1
128904,and,0,1
128905,catecholamines,0,1
128906,.,0,1
128907,These,0,0
128908,findings,0,0
128909,demonstrated,0,0
128910,that,0,0
128911,medication,0,0
128912,of,0,0
128913,penbutolol,0,1
128914,over,0,0
128915,a,0,0
128916,three-day,0,0
128917,period,0,1
128918,has,0,0
128919,no,0,0
128920,influence,0,0
128921,on,0,0
128922,the,0,0
128923,baseline,0,0
128924,blood,0,1
128925,sugar,0,1
128926,profile,0,0
128927,and,0,1
128928,insulin,0,1
128929,consumption,0,1
128930,or,0,1
128931,on,0,0
128932,insulin,0,1
128933,consumption,0,1
128934,after,0,1
128935,food,0,0
128936,intake,0,1
128937,during,0,0
128938,rest,0,0
128939,and,0,0
128940,physical,0,0
128941,exercise,0,0
128942,.,0,0
128943,Infrared,1,1
128944,LED,1,0
128945,irradiation,1,0
128946,applied,0,0
128947,during,0,0
128948,high-intensity,0,0
128949,treadmill,0,0
128950,training,0,0
128951,improves,0,0
128952,maximal,0,0
128953,exercise,0,0
128954,tolerance,0,0
128955,in,0,0
128956,postmenopausal,0,0
128957,women,0,0
128958,:,0,0
128959,a,0,0
128960,6-month,0,0
128961,longitudinal,0,0
128962,study,0,0
128963,.,0,0
128964,Reduced,0,0
128965,aerobic,0,0
128966,fitness,0,0
128967,is,0,0
128968,associated,0,0
128969,with,0,0
128970,an,0,0
128971,increased,0,0
128972,risk,0,0
128973,of,0,0
128974,cardiovascular,0,0
128975,diseases,0,0
128976,among,0,0
128977,the,0,0
128978,older,0,0
128979,population,0,0
128980,.,0,0
128981,The,0,0
128982,aim,0,0
128983,of,0,0
128984,this,0,0
128985,study,0,0
128986,was,0,0
128987,to,0,0
128988,investigate,0,0
128989,the,0,0
128990,effects,0,0
128991,of,0,0
128992,LED,1,0
128993,irradiation,1,0
128994,(,0,0
128995,850,0,0
128996,nm,0,0
128997,),0,0
128998,applied,0,0
128999,during,0,0
129000,treadmill,0,0
129001,training,0,0
129002,on,0,0
129003,the,0,0
129004,maximal,0,0
129005,exercise,0,0
129006,tolerance,0,0
129007,in,0,0
129008,postmenopausal,0,0
129009,women,0,0
129010,.,0,0
129011,At,0,0
129012,the,0,0
129013,beginning,0,0
129014,of,0,0
129015,the,0,0
129016,study,0,0
129017,",",0,0
129018,45,0,0
129019,postmenopausal,0,0
129020,women,0,0
129021,were,0,0
129022,assigned,0,0
129023,randomly,0,0
129024,to,0,0
129025,three,0,0
129026,groups,0,0
129027,",",0,0
129028,and,0,0
129029,30,0,0
129030,women,0,0
129031,completed,0,0
129032,the,0,0
129033,entire,0,0
129034,6,0,0
129035,months,0,0
129036,of,0,0
129037,the,0,0
129038,study,0,0
129039,.,0,0
129040,The,0,0
129041,groups,0,0
129042,were,0,0
129043,:,0,0
129044,(,1,0
129045,1,1,0
129046,),1,0
129047,the,1,0
129048,LED,1,1
129049,group,1,0
129050,(,1,0
129051,treadmill,1,1
129052,training,1,0
129053,associated,1,0
129054,with,1,0
129055,phototherapy,1,1
129056,",",1,0
129057,n,1,0
129058,=,1,0
129059,10,1,0
129060,),1,0
129061,",",1,1
129062,(,1,1
129063,2,1,1
129064,),1,0
129065,the,1,0
129066,exercise,1,1
129067,group,1,0
129068,(,1,0
129069,treadmill,1,1
129070,training,1,1
129071,",",1,0
129072,n,1,0
129073,=,1,0
129074,10,1,0
129075,),1,0
129076,",",1,0
129077,and,1,1
129078,(,1,1
129079,3,1,1
129080,),1,0
129081,the,1,0
129082,sedentary,1,1
129083,group,1,0
129084,(,1,0
129085,neither,1,0
129086,physical,1,0
129087,training,1,0
129088,nor,1,0
129089,phototherapy,1,1
129090,",",1,0
129091,n,1,0
129092,=,1,0
129093,10,1,0
129094,),1,0
129095,.,1,0
129096,The,1,0
129097,training,1,0
129098,was,0,0
129099,performed,0,0
129100,for,0,0
129101,45,0,0
129102,min,0,0
129103,twice,0,0
129104,a,0,0
129105,week,0,0
129106,for,0,0
129107,6,0,0
129108,months,0,0
129109,at,0,0
129110,intensities,0,0
129111,between,0,0
129112,85,0,0
129113,%,0,0
129114,and,0,0
129115,90,0,0
129116,%,0,0
129117,maximal,0,0
129118,heart,0,0
129119,rate,0,0
129120,(,0,1
129121,HRmax,0,1
129122,),0,1
129123,.,0,0
129124,The,0,0
129125,irradiation,0,0
129126,parameters,0,0
129127,were,0,0
129128,39,0,0
129129,mW/cm,0,0
129130,(,0,0
129131,2,0,1
129132,),0,0
129133,",",0,0
129134,45,0,0
129135,min,0,0
129136,and,0,0
129137,108,0,0
129138,J/cm,0,0
129139,(,0,0
129140,2,0,1
129141,),0,0
129142,.,0,0
129143,The,0,0
129144,cardiovascular,0,0
129145,parameters,0,0
129146,were,0,0
129147,measured,0,0
129148,at,0,0
129149,baseline,0,0
129150,and,0,0
129151,after,0,0
129152,6,0,0
129153,months,0,0
129154,.,0,0
129155,As,0,0
129156,expected,0,0
129157,",",0,0
129158,no,0,0
129159,significant,0,0
129160,differences,0,0
129161,were,0,0
129162,found,0,0
129163,in,0,0
129164,the,0,0
129165,sedentary,0,1
129166,group,0,0
129167,(,0,0
129168,p,0,0
129169,?,0,0
129170,0.05,0,0
129171,),0,0
129172,.,0,0
129173,The,0,0
129174,maximal,0,0
129175,time,0,0
129176,of,0,0
129177,tolerance,0,0
129178,(,0,0
129179,Tlim,0,1
129180,),0,1
129181,",",0,0
129182,metabolic,0,0
129183,equivalents,0,0
129184,(,0,0
129185,METs,0,1
129186,),0,1
129187,and,0,0
129188,Bruce,0,0
129189,stage,0,0
129190,reached,0,0
129191,significantly,0,0
129192,higher,0,0
129193,values,0,0
129194,in,0,0
129195,the,1,0
129196,LED,1,0
129197,group,0,0
129198,and,0,0
129199,the,0,0
129200,exercise,1,1
129201,group,0,0
129202,(,0,0
129203,p,0,0
129204,<,0,0
129205,0.01,0,0
129206,),0,0
129207,.,0,0
129208,Furthermore,0,0
129209,",",0,0
129210,the,0,0
129211,HR,0,0
129212,",",0,0
129213,double,0,0
129214,product,0,0
129215,and,0,0
129216,Borg,0,0
129217,score,0,1
129218,at,0,0
129219,isotime,0,0
129220,were,0,0
129221,significantly,0,0
129222,lower,0,0
129223,in,0,0
129224,the,0,0
129225,LED,0,0
129226,group,0,0
129227,and,0,0
129228,in,0,0
129229,the,0,0
129230,exercise,0,1
129231,group,0,0
129232,(,0,0
129233,p,0,0
129234,<,0,0
129235,0.05,0,0
129236,),0,0
129237,.,0,0
129238,However,0,0
129239,",",0,0
129240,the,0,0
129241,time,0,0
129242,of,0,0
129243,recovery,0,0
129244,showed,0,0
129245,a,0,0
129246,significant,0,0
129247,decrease,0,0
129248,only,0,0
129249,in,0,0
129250,the,0,0
129251,LED,0,0
129252,group,0,0
129253,(,0,0
129254,p,0,0
129255,=,0,0
129256,0.003,0,0
129257,),0,0
129258,.,0,0
129259,Moreover,0,0
129260,",",0,0
129261,the,0,0
129262,differences,0,0
129263,between,0,0
129264,before,0,0
129265,and,0,0
129266,after,0,0
129267,training,0,1
129268,(,0,0
129269,delta,0,0
129270,values,0,0
129271,),0,0
129272,for,0,0
129273,the,0,0
129274,Tlim,0,0
129275,",",0,0
129276,METs,0,1
129277,and,0,0
129278,HR,0,1
129279,at,0,1
129280,isotime,0,0
129281,were,0,0
129282,greater,0,0
129283,in,0,0
129284,the,0,0
129285,LED,0,0
129286,group,0,0
129287,than,0,0
129288,in,0,0
129289,the,0,0
129290,exercise,0,0
129291,group,0,0
129292,with,0,0
129293,a,0,0
129294,significant,0,0
129295,intergroup,0,0
129296,difference,0,0
129297,(,0,0
129298,p,0,0
129299,<,0,0
129300,0.05,0,0
129301,),0,0
129302,.,0,0
129303,Therefore,1,0
129304,",",1,0
129305,the,1,0
129306,infrared,1,0
129307,LED,1,0
129308,irradiation,1,0
129309,during,0,0
129310,treadmill,0,0
129311,training,0,0
129312,can,0,0
129313,improve,0,0
129314,maximal,0,0
129315,performance,0,0
129316,and,0,0
129317,post-exercise,0,0
129318,recovery,0,0
129319,in,0,0
129320,postmenopausal,0,0
129321,women,0,0
129322,.,0,0
129323,Efficiency,0,0
129324,of,0,0
129325,slush,1,0
129326,nitrogen,1,0
129327,vitrification,1,0
129328,of,0,0
129329,human,0,0
129330,oocytes,0,0
129331,vitrified,1,0
129332,with,1,0
129333,or,1,0
129334,without,1,0
129335,cumulus,1,0
129336,cells,1,0
129337,in,0,0
129338,relation,0,0
129339,to,0,0
129340,survival,0,0
129341,rate,0,0
129342,and,0,0
129343,meiotic,0,0
129344,spindle,0,0
129345,competence,0,0
129346,.,0,0
129347,OBJECTIVE,0,0
129348,To,0,0
129349,evaluate,0,0
129350,the,0,0
129351,efficiency,0,0
129352,of,0,0
129353,slush,1,0
129354,nitrogen,1,0
129355,vitrification,1,0
129356,of,0,0
129357,human,0,0
129358,oocytes,0,0
129359,with,1,0
129360,or,1,0
129361,without,1,0
129362,cumulus,1,0
129363,cells,1,0
129364,in,0,0
129365,terms,0,0
129366,of,0,0
129367,survival,0,0
129368,rate,0,0
129369,and,0,0
129370,maintenance,0,0
129371,of,0,0
129372,meiotic,0,0
129373,spindle,0,0
129374,.,0,0
129375,DESIGN,0,0
129376,Randomized,0,0
129377,",",0,0
129378,comparative,0,0
129379,study,0,0
129380,.,0,0
129381,SETTING,0,0
129382,Medical,0,0
129383,center,0,0
129384,.,0,0
129385,PATIENT,0,1
129386,(,0,1
129387,S,0,1
129388,),0,1
129389,A,0,0
129390,total,0,0
129391,of,0,0
129392,274,0,0
129393,oocytes,0,0
129394,obtained,0,0
129395,from,0,0
129396,46,0,0
129397,couples,0,0
129398,undergoing,0,0
129399,infertility,0,0
129400,treatment,0,0
129401,.,0,0
129402,INTERVENTION,0,1
129403,(,0,1
129404,S,0,1
129405,),0,1
129406,Metaphase,0,1
129407,II,0,1
129408,oocytes,0,0
129409,were,0,0
129410,divided,0,0
129411,into,0,0
129412,groups,0,0
129413,A,0,0
129414,and,0,0
129415,B,0,1
129416,",",0,0
129417,vitrified,1,0
129418,with,1,0
129419,and,1,0
129420,without,1,0
129421,cumulus,1,0
129422,cells,1,0
129423,",",0,0
129424,respectively,0,0
129425,.,0,0
129426,MAIN,0,0
129427,OUTCOMES,0,1
129428,MEASURE,0,1
129429,(,0,1
129430,S,0,1
129431,),0,1
129432,Survival,0,0
129433,rates,0,0
129434,and,0,0
129435,maintenance,0,0
129436,of,0,0
129437,meiotic,0,0
129438,spindle,0,0
129439,observed,0,0
129440,immediately,0,0
129441,after,0,0
129442,warming,0,0
129443,and,0,0
129444,3,0,0
129445,hours,0,0
129446,after,0,0
129447,incubation,0,0
129448,.,0,0
129449,RESULT,0,1
129450,(,0,1
129451,S,0,1
129452,),0,1
129453,No,0,1
129454,statistically,0,0
129455,significant,0,0
129456,difference,0,0
129457,was,0,0
129458,detected,0,0
129459,between,0,0
129460,the,0,0
129461,two,0,0
129462,groups,0,0
129463,in,0,0
129464,terms,0,0
129465,of,0,0
129466,survival,0,0
129467,rate,0,0
129468,",",0,0
129469,but,0,0
129470,a,0,0
129471,significantly,0,0
129472,higher,0,0
129473,percentage,0,0
129474,of,0,0
129475,detectable,0,0
129476,spindle,0,0
129477,was,0,0
129478,observed,0,0
129479,in,0,0
129480,group,0,0
129481,B,0,1
129482,(,0,1
129483,completely,0,0
129484,denuded,0,1
129485,oocytes,0,1
129486,),0,0
129487,",",0,0
129488,either,0,0
129489,immediately,0,0
129490,after,0,0
129491,warming,0,0
129492,or,0,0
129493,3,0,0
129494,hours,0,0
129495,after,0,0
129496,incubation,0,0
129497,.,0,0
129498,CONCLUSION,0,1
129499,(,0,1
129500,S,0,1
129501,),0,1
129502,Complete,0,0
129503,denudation,0,0
129504,of,0,0
129505,oocytes,0,0
129506,before,0,0
129507,slush,0,0
129508,nitrogen,0,0
129509,vitrification,0,0
129510,does,0,0
129511,not,0,0
129512,influence,0,0
129513,survival,0,0
129514,rates,0,0
129515,but,0,0
129516,positively,0,0
129517,affects,0,0
129518,oocyte,0,0
129519,meiotic,0,0
129520,spindle,0,0
129521,competence,0,0
129522,.,0,0
129523,These,0,0
129524,data,0,0
129525,support,0,0
129526,the,0,0
129527,hypothesis,0,0
129528,that,0,0
129529,cumulus,0,0
129530,cells,0,0
129531,during,0,0
129532,vitrification,0,0
129533,represent,0,0
129534,an,0,0
129535,obstacle,0,0
129536,to,0,0
129537,cryoprotectant,0,1
129538,penetration,0,0
129539,more,0,0
129540,than,0,0
129541,having,0,0
129542,a,0,0
129543,protective,0,0
129544,role,0,0
129545,for,0,0
129546,the,0,0
129547,oocyte,0,0
129548,.,0,0
129549,Group,1,0
129550,cognitive,1,0
129551,behavior,1,0
129552,therapy,1,0
129553,for,0,0
129554,children,0,0
129555,with,0,0
129556,high-functioning,0,0
129557,autism,0,0
129558,spectrum,0,0
129559,disorders,0,0
129560,and,0,0
129561,anxiety,0,0
129562,:,0,0
129563,a,0,0
129564,randomized,0,0
129565,trial,0,0
129566,.,0,0
129567,BACKGROUND,0,0
129568,Children,0,0
129569,with,0,0
129570,high-functioning,0,0
129571,autism,0,0
129572,spectrum,0,0
129573,disorders,0,1
129574,(,0,1
129575,ASD,0,1
129576,),0,0
129577,are,0,0
129578,at,0,0
129579,high,0,0
129580,risk,0,0
129581,for,0,0
129582,developing,0,0
129583,significant,0,0
129584,anxiety,0,0
129585,.,0,0
129586,Anxiety,0,0
129587,can,0,0
129588,adversely,0,0
129589,impact,0,0
129590,functioning,0,0
129591,across,0,0
129592,school,0,0
129593,",",0,0
129594,home,0,0
129595,and,0,0
129596,community,0,0
129597,environments,0,0
129598,.,0,0
129599,Cognitive,1,0
129600,behavioral,1,1
129601,therapies,1,1
129602,(,1,1
129603,CBT,1,1
129604,),1,0
129605,are,0,0
129606,frequently,0,0
129607,used,0,0
129608,with,0,0
129609,success,0,0
129610,for,0,0
129611,children,0,0
129612,with,0,0
129613,anxiety,0,0
129614,symptoms,0,0
129615,.,0,0
129616,Modified,1,0
129617,CBT,1,0
129618,interventions,1,0
129619,for,0,0
129620,anxiety,0,0
129621,in,0,0
129622,children,0,0
129623,with,0,0
129624,ASD,0,0
129625,have,0,0
129626,also,0,0
129627,yielded,0,0
129628,promising,0,0
129629,results,0,0
129630,.,0,0
129631,METHODS,0,0
129632,Fifty,0,0
129633,children,0,0
129634,with,0,0
129635,high-functioning,0,0
129636,ASD,0,0
129637,and,0,0
129638,anxiety,0,0
129639,were,0,0
129640,randomizedto,0,0
129641,group,1,0
129642,CBT,1,0
129643,or,0,1
129644,treatment-as-usual,1,1
129645,(,1,1
129646,TAU,1,1
129647,),1,1
129648,for,0,0
129649,12,0,0
129650,weeks,0,0
129651,.,0,0
129652,Independent,0,0
129653,clinical,0,0
129654,evaluators,0,0
129655,",",0,0
129656,blind,0,0
129657,to,0,0
129658,condition,0,0
129659,",",0,0
129660,completed,0,0
129661,structured,0,0
129662,interviews,0,1
129663,(,0,0
129664,Anxiety,0,1
129665,Disorders,0,1
129666,Interview,0,1
129667,Schedule,0,1
129668,?,0,1
129669,Parent,0,1
129670,Version,0,1
129671,;,0,1
129672,ADIS-P,0,1
129673,),0,1
129674,pre-,0,0
129675,and,0,0
129676,post-intervention,0,0
129677,condition,0,0
129678,.,0,0
129679,RESULTS,0,0
129680,Forty-seven,0,0
129681,children,0,0
129682,completed,0,0
129683,either,0,0
129684,the,1,0
129685,CBT,1,0
129686,or,1,0
129687,TAU,1,0
129688,condition,1,1
129689,.,0,0
129690,Results,0,0
129691,indicated,0,0
129692,markedly,0,0
129693,better,0,0
129694,outcomes,0,0
129695,for,0,0
129696,the,1,0
129697,CBT,1,0
129698,group,1,0
129699,.,0,0
129700,Significant,0,0
129701,differences,0,0
129702,by,0,0
129703,group,0,0
129704,were,0,0
129705,noted,0,0
129706,in,0,0
129707,Clinician,0,0
129708,Severity,0,0
129709,Ratings,0,0
129710,",",0,0
129711,diagnostic,0,0
129712,status,0,0
129713,",",0,0
129714,and,0,0
129715,clinician,0,0
129716,ratings,0,0
129717,of,0,0
129718,global,0,0
129719,improvement,0,0
129720,.,0,0
129721,In,0,0
129722,the,0,0
129723,intent-to-treat,0,0
129724,sample,0,0
129725,",",0,0
129726,10,0,0
129727,of,0,0
129728,20,0,0
129729,children,0,1
129730,(,0,0
129731,50,0,0
129732,%,0,0
129733,),0,0
129734,in,0,0
129735,the,1,0
129736,CBT,1,0
129737,group,1,0
129738,had,0,0
129739,a,0,0
129740,clinically,0,0
129741,meaningful,0,0
129742,positive,0,0
129743,treatment,0,0
129744,response,0,0
129745,",",0,0
129746,compared,0,0
129747,to,0,0
129748,2,0,0
129749,of,0,0
129750,23,0,0
129751,children,0,0
129752,(,0,0
129753,8.7,0,0
129754,%,0,0
129755,),0,0
129756,in,0,0
129757,the,1,0
129758,TAU,1,0
129759,group,1,0
129760,.,0,0
129761,CONCLUSIONS,0,0
129762,Initial,0,0
129763,results,0,0
129764,from,0,0
129765,this,0,0
129766,randomized,0,0
129767,",",0,0
129768,designed,0,0
129769,treatment,0,0
129770,study,0,0
129771,suggest,0,0
129772,that,0,0
129773,agroup,1,0
129774,CBT,1,0
129775,intervention,1,0
129776,specifically,1,0
129777,developed,0,0
129778,for,0,0
129779,children,0,0
129780,with,0,0
129781,ASD,0,0
129782,may,0,0
129783,be,0,0
129784,effective,0,0
129785,in,0,0
129786,decreasing,0,0
129787,anxiety,0,0
129788,.,0,0
129789,Limitations,0,0
129790,of,0,0
129791,this,0,0
129792,study,0,0
129793,include,0,0
129794,small,0,0
129795,sample,0,0
129796,size,0,0
129797,",",0,0
129798,lack,0,0
129799,of,0,0
129800,an,0,0
129801,attention,0,0
129802,control,0,0
129803,group,0,0
129804,",",0,0
129805,and,0,0
129806,use,0,0
129807,of,0,0
129808,outcome,0,0
129809,measures,0,0
129810,normed,0,0
129811,with,0,0
129812,typically,0,0
129813,developing,0,0
129814,children,0,0
129815,Elevated,0,0
129816,concentration,0,0
129817,of,0,0
129818,placental,0,0
129819,growth,0,0
129820,factor,0,0
129821,(,0,0
129822,PlGF,0,1
129823,),0,1
129824,and,0,0
129825,long,0,0
129826,term,0,0
129827,risk,0,0
129828,in,0,0
129829,patients,0,0
129830,with,0,0
129831,acute,0,0
129832,coronary,0,0
129833,syndrome,0,0
129834,in,0,0
129835,the,0,0
129836,PROVE,0,0
129837,IT-TIMI,0,0
129838,22,0,0
129839,trial,0,0
129840,.,0,0
129841,Placental,1,0
129842,growth,1,0
129843,factor,1,0
129844,(,0,0
129845,PlGF,0,1
129846,),0,1
129847,",",0,0
129848,a,0,0
129849,member,0,0
129850,of,0,0
129851,the,0,0
129852,vascular,0,0
129853,endothelial,0,0
129854,growth,0,0
129855,factor,0,0
129856,(,0,0
129857,VEGF,0,1
129858,),0,0
129859,family,0,0
129860,",",0,0
129861,acts,0,0
129862,via,0,0
129863,the,0,0
129864,flt-1,0,1
129865,receptor,0,0
129866,and,0,0
129867,promotes,0,0
129868,endothelial,0,0
129869,activation,0,0
129870,and,0,0
129871,macrophage,0,0
129872,recruitment,0,0
129873,into,0,0
129874,atherosclerotic,0,0
129875,lesions,0,0
129876,.,0,0
129877,We,0,0
129878,investigated,0,0
129879,the,0,0
129880,relationship,0,0
129881,of,0,0
129882,PlGF,0,0
129883,with,0,0
129884,cardiovascular,0,0
129885,outcomes,0,0
129886,in,0,0
129887,a,0,0
129888,large,0,0
129889,cohort,0,0
129890,of,0,0
129891,patients,0,0
129892,presenting,0,0
129893,across,0,0
129894,the,0,0
129895,spectrum,0,0
129896,of,0,0
129897,ACS,0,0
129898,.,0,0
129899,PlGF,0,0
129900,was,0,0
129901,measured,0,0
129902,at,0,0
129903,baseline,0,0
129904,(,0,0
129905,n,0,0
129906,=,0,0
129907,"3,761",0,0
129908,),0,0
129909,and,0,0
129910,at,0,1
129911,four-months,0,1
129912,(,0,0
129913,n,0,0
129914,=,0,0
129915,"3,369",0,0
129916,),0,0
129917,in,0,0
129918,patients,0,0
129919,randomized,0,0
129920,to,0,0
129921,atorvastatin,1,1
129922,80,1,1
129923,mg,1,1
129924,or,1,1
129925,pravastatin,1,1
129926,40,1,1
129927,mg,1,1
129928,after,1,0
129929,ACS,1,0
129930,in,0,0
129931,the,0,0
129932,PROVE,0,0
129933,IT-TIMI,0,0
129934,22,0,0
129935,trial,0,0
129936,.,0,0
129937,The,0,0
129938,primary,0,0
129939,endpoint,0,0
129940,was,0,0
129941,death,0,0
129942,",",0,0
129943,myocardial,0,1
129944,infarction,0,1
129945,(,0,1
129946,MI,0,1
129947,),0,1
129948,",",0,0
129949,unstable,0,0
129950,angina,0,0
129951,",",0,0
129952,revascularization,0,0
129953,or,0,0
129954,stroke,0,0
129955,(,0,0
129956,mean,0,0
129957,follow-up,0,0
129958,24,0,0
129959,months,0,0
129960,),0,0
129961,.,0,0
129962,Elevated,0,0
129963,baseline,0,0
129964,PlGF,0,0
129965,was,0,0
129966,associated,0,0
129967,with,0,0
129968,a,0,0
129969,higher,0,0
129970,incidence,0,0
129971,of,0,0
129972,the,0,0
129973,primary,0,0
129974,endpoint,0,0
129975,through,0,0
129976,2,0,0
129977,years,0,0
129978,(,0,0
129979,Q1,0,0
129980,vs.,0,0
129981,Q5,0,0
129982,:,0,0
129983,18.7,0,0
129984,vs.,0,0
129985,29.3,0,0
129986,%,0,0
129987,",",0,0
129988,p,0,0
129989,<,0,0
129990,0.0001,0,0
129991,),0,0
129992,.,0,0
129993,The,0,0
129994,risk,0,0
129995,of,0,0
129996,death,0,0
129997,or,0,0
129998,MI,0,0
129999,was,0,0
130000,also,0,0
130001,higher,0,0
130002,in,0,0
130003,patients,0,0
130004,with,0,0
130005,elevated,0,0
130006,baseline,0,0
130007,PlGF,0,1
130008,(,0,0
130009,Q1,0,0
130010,vs.,0,0
130011,Q5,0,0
130012,:,0,0
130013,7.0,0,0
130014,vs.,0,0
130015,11.6,0,0
130016,%,0,0
130017,",",0,0
130018,p,0,0
130019,=,0,0
130020,0.029,0,0
130021,),0,0
130022,.,0,0
130023,Adjusting,0,0
130024,for,0,0
130025,baseline,0,0
130026,characteristics,0,0
130027,and,0,0
130028,risk,0,0
130029,factors,0,0
130030,",",0,0
130031,elevated,0,0
130032,baseline,0,0
130033,PlGF,0,0
130034,was,0,0
130035,independently,0,0
130036,associated,0,0
130037,with,0,0
130038,the,0,0
130039,risk,0,0
130040,of,0,0
130041,the,0,0
130042,primary,0,0
130043,endpoint,0,1
130044,(,0,0
130045,adjusted-HR,0,0
130046,for,0,0
130047,Q5,0,0
130048,vs.,0,0
130049,Q1,0,0
130050,1.45,0,0
130051,;,0,0
130052,95,0,0
130053,%,0,0
130054,CI,0,0
130055,1.16-1.83,0,0
130056,;,0,0
130057,p,0,0
130058,=,0,0
130059,0.001,0,0
130060,),0,0
130061,.,0,0
130062,Elevated,0,0
130063,PlGF,0,0
130064,at,0,0
130065,four,0,0
130066,months,0,0
130067,was,0,0
130068,associated,0,0
130069,with,0,0
130070,higher,0,0
130071,risk,0,0
130072,of,0,0
130073,death,0,0
130074,or,0,0
130075,MI,0,1
130076,(,0,1
130077,Adjusted,0,0
130078,HR,0,0
130079,Q5,0,0
130080,vs.,0,0
130081,Q1,0,0
130082,2.79,0,0
130083,",",0,0
130084,95,0,0
130085,%,0,0
130086,CI,0,0
130087,:,0,0
130088,1.37-5.68,0,0
130089,;,0,0
130090,p,0,0
130091,=,0,0
130092,0.005,0,0
130093,),0,0
130094,",",0,0
130095,and,0,0
130096,higher,0,0
130097,risk,0,0
130098,of,0,0
130099,the,0,0
130100,primary,0,0
130101,endpoint,0,1
130102,(,0,0
130103,Adjusted,0,0
130104,HR,0,0
130105,Q5,0,0
130106,vs.,0,0
130107,Q1,0,0
130108,1.78,0,0
130109,",",0,0
130110,95,0,0
130111,%,0,0
130112,CI,0,0
130113,:,0,0
130114,1.26-2.51,0,0
130115,;,0,0
130116,p,0,0
130117,=,0,0
130118,0.001,0,0
130119,),0,0
130120,.,0,0
130121,Higher,0,0
130122,concentration,0,0
130123,of,0,0
130124,PlGF,0,0
130125,after,0,0
130126,ACS,0,0
130127,is,0,0
130128,associated,0,0
130129,with,0,0
130130,long-term,0,0
130131,risk,0,0
130132,of,0,0
130133,recurrent,0,0
130134,cardiovascular,0,0
130135,events,0,0
130136,independent,0,0
130137,of,0,0
130138,traditional,0,0
130139,risk,0,0
130140,factors,0,0
130141,.,0,0
130142,This,0,0
130143,association,0,0
130144,is,0,0
130145,present,0,0
130146,early,0,0
130147,after,0,0
130148,ACS,0,0
130149,and,0,0
130150,appears,0,0
130151,to,0,0
130152,be,0,0
130153,stronger,0,0
130154,at,0,0
130155,four,0,0
130156,months,0,0
130157,.,0,0
130158,[,1,1
130159,Simvastatin,1,1
130160,versus,1,1
130161,gemfibrozil,1,1
130162,in,0,0
130163,the,0,0
130164,treatment,0,0
130165,of,0,0
130166,primary,0,0
130167,hypercholesterolemia,0,0
130168,in,0,0
130169,hypertensive,0,0
130170,patients,0,0
130171,treated,0,0
130172,with,0,0
130173,hydrochlorothiazide,1,1
130174,],1,1
130175,.,0,0
130176,Recent,0,0
130177,pharmacological,0,0
130178,studies,0,0
130179,confirmed,0,0
130180,the,0,0
130181,role,0,0
130182,of,0,0
130183,hypercholesterolemia,0,0
130184,in,0,0
130185,the,0,0
130186,pathogenesis,0,0
130187,of,0,0
130188,coronary,0,0
130189,atherosclerosis,0,0
130190,.,0,0
130191,A,0,0
130192,10,0,0
130193,%,0,0
130194,reduction,0,0
130195,in,0,0
130196,cholesterol,0,1
130197,levels,0,0
130198,can,0,0
130199,reduce,0,0
130200,the,0,0
130201,risk,0,0
130202,of,0,0
130203,coronary,0,0
130204,heart,0,0
130205,disease,0,0
130206,by,0,0
130207,15,0,0
130208,%,0,0
130209,.,0,0
130210,However,0,0
130211,many,0,0
130212,hypercholesterolemic,0,1
130213,patients,0,0
130214,often,0,0
130215,suffer,0,0
130216,from,0,0
130217,arterial,0,0
130218,hypertension,0,1
130219,and,0,0
130220,drugs,0,1
130221,such,0,0
130222,as,0,1
130223,thiazide,1,1
130224,diuretics,1,1
130225,cause,0,0
130226,an,0,0
130227,imbalance,0,0
130228,in,0,0
130229,lipid,0,0
130230,metabolism,0,0
130231,.,0,0
130232,The,0,0
130233,efficacy,0,0
130234,and,0,0
130235,the,0,0
130236,tolerability,0,1
130237,of,0,1
130238,simvastatin,1,1
130239,(,0,1
130240,a,0,0
130241,inhibitor,0,1
130242,of,0,0
130243,HGM-CoA,0,1
130244,reductase,0,1
130245,),0,1
130246,with,0,0
130247,that,0,0
130248,of,0,0
130249,gemfibrozil,1,1
130250,(,0,1
130251,a,0,1
130252,fibric,0,1
130253,acid,0,1
130254,derivative,0,1
130255,",",0,0
130256,which,0,0
130257,can,0,0
130258,reduce,0,0
130259,the,0,0
130260,VLDL,0,0
130261,level,0,0
130262,),0,0
130263,were,0,0
130264,compared,0,0
130265,in,0,0
130266,a,0,0
130267,placebo-controlled,1,1
130268,study,0,0
130269,in,0,0
130270,2,0,0
130271,groups,0,0
130272,of,0,0
130273,patients,0,0
130274,with,0,0
130275,primary,0,0
130276,hypercholesterolemia,0,0
130277,and,0,0
130278,mild-to-moderate,0,0
130279,essential,0,0
130280,hypertension,0,0
130281,treated,0,0
130282,with,0,0
130283,hydrochlorothiazide,0,1
130284,.,0,1
130285,After,0,0
130286,10,0,0
130287,weeks,0,0
130288,standard,1,1
130289,hypolipidemic,1,1
130290,diet,1,1
130291,and,1,1
130292,hydrochlorothiazide,1,1
130293,(,0,1
130294,25,0,1
130295,mg,0,1
130296,od,0,1
130297,),0,1
130298,therapy,0,1
130299,",",0,0
130300,30,0,0
130301,patients,0,0
130302,whose,0,0
130303,cholesterol,0,1
130304,levels,0,0
130305,were,0,0
130306,still,0,0
130307,greater,0,0
130308,than,0,0
130309,or,0,0
130310,equal,0,0
130311,to,0,0
130312,250,0,0
130313,mg/100,0,1
130314,ml,0,1
130315,and,0,0
130316,whose,0,0
130317,diastolic,0,0
130318,blood,0,0
130319,pressure,0,0
130320,was,0,0
130321,less,0,0
130322,than,0,0
130323,95,0,0
130324,mmHg,0,0
130325,were,0,0
130326,randomized,0,0
130327,to,0,0
130328,one,0,0
130329,of,0,0
130330,the,0,0
130331,following,0,0
130332,treatments,0,0
130333,:,0,0
130334,simvastatin,1,1
130335,",",0,1
130336,20,0,1
130337,mg,0,1
130338,od,0,1
130339,",",0,1
130340,gemfibrozil,1,1
130341,",",0,1
130342,600,0,1
130343,mg,0,1
130344,bid,0,1
130345,or,1,1
130346,placebo,1,1
130347,",",0,0
130348,while,0,0
130349,continuing,0,0
130350,dietetic,0,1
130351,and,0,0
130352,diuretic,0,1
130353,treatment,0,1
130354,.,0,0
130355,After,0,0
130356,24,0,0
130357,weeks,0,0
130358,treatment,0,0
130359,",",0,0
130360,simvastatin,1,1
130361,induced,0,0
130362,a,0,0
130363,37,0,0
130364,%,0,0
130365,reduction,0,0
130366,in,0,0
130367,cholesterol,0,1
130368,plasma,0,1
130369,levels,0,0
130370,",",0,0
130371,a,0,0
130372,9,0,0
130373,%,0,0
130374,increase,0,0
130375,of,0,0
130376,HDL,0,0
130377,and,0,0
130378,a,0,0
130379,16,0,0
130380,%,0,0
130381,reduction,0,0
130382,of,0,0
130383,LDL,0,0
130384,.,0,0
130385,APO-A1,0,0
130386,showed,0,0
130387,a,0,0
130388,4,0,0
130389,%,0,0
130390,increase,0,0
130391,",",0,0
130392,while,0,0
130393,APO-B,0,0
130394,showed,0,0
130395,a,0,0
130396,3,0,0
130397,%,0,0
130398,reduction,0,0
130399,.,0,0
130400,Gemfibrozil,1,1
130401,induced,0,0
130402,a,0,0
130403,20,0,0
130404,%,0,0
130405,reduction,0,0
130406,in,0,0
130407,plasma,0,1
130408,triglycerides,0,1
130409,and,0,1
130410,a,0,0
130411,13,0,0
130412,%,0,0
130413,decrease,0,0
130414,in,0,0
130415,plasma,0,1
130416,cholesterol,0,1
130417,",",0,1
130418,with,0,0
130419,a,0,0
130420,significant,0,0
130421,19,0,0
130422,%,0,0
130423,increase,0,0
130424,in,0,0
130425,HDL,0,0
130426,and,0,0
130427,a,0,0
130428,11,0,0
130429,%,0,0
130430,reduction,0,0
130431,in,0,0
130432,LDL,0,0
130433,.,0,0
130434,No,0,0
130435,significant,0,0
130436,variations,0,0
130437,in,0,0
130438,any,0,0
130439,of,0,0
130440,the,0,0
130441,lipid,0,0
130442,parameters,0,0
130443,monitored,0,0
130444,were,0,0
130445,observed,0,0
130446,in,0,0
130447,the,0,0
130448,placebo,1,1
130449,group,0,1
130450,.,0,0
130451,Treatment,0,0
130452,with,0,0
130453,simvastatin,1,1
130454,or,0,1
130455,gemfibrozil,1,1
130456,in,0,0
130457,hypertensive,0,0
130458,patients,0,0
130459,in,0,0
130460,hydrochlorothiazide,1,1
130461,monotherapy,0,1
130462,can,0,0
130463,reduce,0,0
130464,total,0,0
130465,cholesterol,0,1
130466,and,0,1
130467,LDL-cholesterol,0,1
130468,plasma,0,1
130469,levels,0,0
130470,",",0,0
130471,while,0,0
130472,significantly,0,0
130473,increasing,0,0
130474,HDL,0,1
130475,plasma,0,0
130476,levels,0,0
130477,compared,0,0
130478,to,0,0
130479,placebo,0,1
130480,.,0,1
130481,Simvastatin,1,1
130482,",",0,0
130483,however,0,0
130484,",",0,0
130485,resulted,0,0
130486,more,0,0
130487,efficient,0,0
130488,than,0,0
130489,gemfibrozil,1,1
130490,on,0,1
130491,total,0,0
130492,cholesterol,0,1
130493,or,0,1
130494,cholesterol,0,1
130495,fractions,0,0
130496,.,0,0
130497,Evaluation,0,0
130498,of,0,0
130499,oral,1,1
130500,zinc,1,1
130501,sulfate,1,1
130502,effect,0,1
130503,on,0,0
130504,obsessive-compulsive,0,0
130505,disorder,0,0
130506,:,0,0
130507,a,0,0
130508,randomized,0,1
130509,placebo-controlled,1,1
130510,clinical,0,1
130511,trial,0,1
130512,.,0,0
130513,OBJECTIVE,0,0
130514,Obsessive-compulsive,0,0
130515,disorder,0,0
130516,is,0,0
130517,a,0,0
130518,common,0,0
130519,neuropsychiatric,0,0
130520,condition,0,0
130521,.,0,0
130522,Although,0,0
130523,various,0,0
130524,pharmaceutical,0,1
130525,agents,0,0
130526,are,0,0
130527,available,0,0
130528,for,0,0
130529,the,0,0
130530,treatment,0,0
130531,of,0,0
130532,obsessive-compulsive,0,0
130533,disorder,0,0
130534,",",0,0
130535,psychiatrists,0,0
130536,often,0,0
130537,find,0,0
130538,that,0,0
130539,many,0,0
130540,patients,0,0
130541,can,0,0
130542,not,0,0
130543,tolerate,0,0
130544,the,0,0
130545,side,0,0
130546,effects,0,0
130547,of,0,0
130548,these,0,0
130549,medications,0,1
130550,",",0,0
130551,the,0,0
130552,patients,0,0
130553,do,0,0
130554,not,0,0
130555,respond,0,0
130556,properly,0,0
130557,to,0,0
130558,the,0,0
130559,treatment,0,0
130560,",",0,0
130561,or,0,0
130562,the,0,0
130563,medications,0,1
130564,lose,0,0
130565,their,0,0
130566,effectiveness,0,0
130567,after,0,0
130568,a,0,0
130569,period,0,0
130570,of,0,0
130571,treatment,0,0
130572,.,0,0
130573,The,0,0
130574,augmentation,0,0
130575,with,0,0
130576,safe,0,0
130577,supplementation,0,1
130578,of,0,0
130579,medication,0,0
130580,",",0,0
130581,such,0,0
130582,as,0,0
130583,with,0,0
130584,trace,0,0
130585,elements,0,0
130586,",",0,0
130587,may,0,0
130588,be,0,0
130589,a,0,0
130590,solution,0,0
130591,to,0,0
130592,some,0,0
130593,of,0,0
130594,these,0,0
130595,problems,0,0
130596,.,0,0
130597,METHODS,0,0
130598,This,0,0
130599,study,0,0
130600,was,0,0
130601,a,0,0
130602,prospective,0,0
130603,",",0,0
130604,double-blinded,0,1
130605,",",0,1
130606,8-wk,0,1
130607,trial,0,1
130608,.,0,0
130609,Twelve,0,0
130610,patients,0,0
130611,were,0,0
130612,given,0,1
130613,fluoxetine,1,1
130614,(,0,1
130615,20,0,1
130616,mg/d,0,1
130617,),0,1
130618,plus,1,1
130619,zinc,1,1
130620,(,0,0
130621,440,0,0
130622,mg/d,0,1
130623,),0,0
130624,and,0,0
130625,11,0,0
130626,patients,0,0
130627,were,0,0
130628,given,0,0
130629,fluoxetine,1,1
130630,plus,1,1
130631,placebo,1,1
130632,for,0,1
130633,8,0,0
130634,wk,0,0
130635,.,0,0
130636,RESULTS,0,1
130637,Both,0,1
130638,groups,0,0
130639,showed,0,0
130640,a,0,0
130641,decrease,0,0
130642,in,0,0
130643,the,0,0
130644,mean,0,0
130645,Yale-Brown,0,0
130646,Obsessive-Compulsive,0,0
130647,Scale,0,0
130648,score,0,0
130649,.,0,0
130650,Based,0,0
130651,on,0,0
130652,t,0,0
130653,tests,0,0
130654,",",0,0
130655,in,0,0
130656,weeks,0,0
130657,2,0,0
130658,and,0,0
130659,8,0,0
130660,",",0,0
130661,patients,0,0
130662,treated,0,0
130663,with,1,0
130664,fluoxetine,1,1
130665,plus,1,0
130666,zinc,1,1
130667,had,0,0
130668,significantly,0,0
130669,lower,0,0
130670,scores,0,0
130671,than,0,0
130672,those,0,0
130673,treated,0,0
130674,with,1,0
130675,fluoxetine,1,1
130676,plus,1,1
130677,placebo,1,1
130678,.,1,1
130679,CONCLUSION,0,0
130680,The,0,0
130681,results,0,0
130682,show,0,0
130683,that,1,0
130684,zinc,1,0
130685,",",1,0
130686,as,0,0
130687,adjuvant,0,1
130688,agent,0,0
130689,for,0,0
130690,obsessive-compulsive,0,0
130691,disorder,0,0
130692,",",0,0
130693,produces,0,0
130694,improved,0,0
130695,outcomes,0,0
130696,.,0,0
130697,Moclobemide,1,1
130698,",",1,1
130699,imipramine,1,1
130700,and,1,1
130701,placebo,1,1
130702,in,0,0
130703,the,0,0
130704,treatment,0,0
130705,of,0,0
130706,major,0,0
130707,depression,0,0
130708,.,0,0
130709,Moclobemide,1,1
130710,was,0,0
130711,compared,0,0
130712,with,0,0
130713,imipramine,1,1
130714,and,0,1
130715,placebo,1,1
130716,in,0,0
130717,the,0,0
130718,treatment,0,0
130719,of,0,0
130720,major,0,0
130721,depressive,0,0
130722,episodes,0,0
130723,in,0,0
130724,75,0,0
130725,outpatients,0,0
130726,.,0,0
130727,The,0,0
130728,dosage,0,1
130729,of,0,1
130730,moclobemide,1,1
130731,(,1,1
130732,25,1,1
130733,patients,1,0
130734,),1,0
130735,was,1,0
130736,300,1,1
130737,mg,1,1
130738,daily,1,1
130739,for,1,0
130740,the,1,0
130741,first,1,0
130742,5,1,0
130743,days,1,0
130744,",",1,0
130745,after,1,0
130746,which,1,0
130747,it,1,0
130748,could,1,0
130749,be,1,0
130750,increased,1,0
130751,to,1,0
130752,600,1,0
130753,mg.,1,1
130754,Imipramine,1,1
130755,(,1,1
130756,25,1,1
130757,patients,1,0
130758,),1,0
130759,was,1,0
130760,given,1,0
130761,in,1,0
130762,a,1,0
130763,dosage,1,1
130764,starting,1,0
130765,with,1,0
130766,33,1,0
130767,mg,1,0
130768,and,1,0
130769,gradually,1,0
130770,increased,1,0
130771,to,1,0
130772,100,1,0
130773,mg/day,1,1
130774,in,1,0
130775,the,1,0
130776,first,1,0
130777,5,1,0
130778,days,1,0
130779,",",0,0
130780,after,0,0
130781,which,0,0
130782,it,0,0
130783,could,0,0
130784,be,0,0
130785,further,0,0
130786,increased,0,0
130787,;,0,0
130788,25,0,0
130789,patients,0,0
130790,received,0,0
130791,placebo,1,1
130792,.,1,1
130793,Both,0,1
130794,drugs,0,1
130795,were,0,0
130796,equally,0,0
130797,effective,0,0
130798,as,0,0
130799,measured,0,0
130800,by,0,0
130801,the,0,0
130802,Hamilton,0,0
130803,Rating,0,0
130804,Scale,0,0
130805,for,0,0
130806,Depression,0,0
130807,",",0,0
130808,the,0,0
130809,overall,0,0
130810,assessment,0,0
130811,of,0,0
130812,efficacy,0,0
130813,and,0,0
130814,the,0,0
130815,Zung,0,0
130816,Self-rating,0,0
130817,Scale,0,0
130818,",",0,0
130819,and,0,0
130820,clearly,0,0
130821,superior,0,0
130822,to,0,0
130823,placebo,0,1
130824,;,0,0
130825,there,0,0
130826,were,0,0
130827,no,0,0
130828,significant,0,0
130829,differences,0,0
130830,between,0,0
130831,the,0,0
130832,2,0,0
130833,active,0,0
130834,drugs,0,1
130835,.,0,1
130836,Moclobemide,1,1
130837,was,0,0
130838,better,0,0
130839,tolerated,0,1
130840,than,0,1
130841,imipramine,1,1
130842,",",0,1
130843,and,0,0
130844,was,0,0
130845,almost,0,0
130846,comparable,0,0
130847,to,0,0
130848,placebo,0,1
130849,in,0,0
130850,this,0,0
130851,respect,0,0
130852,.,0,0
130853,Laryngeal,0,0
130854,preservation,0,0
130855,with,0,0
130856,induction,1,0
130857,chemotherapy,1,0
130858,for,0,0
130859,hypopharyngeal,0,0
130860,squamous,0,0
130861,cell,0,0
130862,carcinoma,0,0
130863,:,0,0
130864,10-year,0,0
130865,results,0,0
130866,of,0,0
130867,EORTC,0,0
130868,trial,0,0
130869,24891,0,0
130870,.,0,0
130871,BACKGROUND,0,0
130872,We,0,0
130873,report,0,0
130874,the,0,0
130875,10-year,0,0
130876,results,0,0
130877,of,0,0
130878,the,0,0
130879,EORTC,0,0
130880,trial,0,0
130881,24891,0,0
130882,comparing,0,0
130883,a,0,0
130884,larynx-preservation,1,0
130885,approach,1,0
130886,to,0,0
130887,immediate,1,0
130888,surgery,1,0
130889,in,0,0
130890,hypopharynx,0,0
130891,and,0,0
130892,lateral,0,0
130893,epilarynx,0,0
130894,squamous,0,0
130895,cell,0,0
130896,carcinoma,0,0
130897,.,0,0
130898,MATERIAL,0,0
130899,AND,0,1
130900,METHODS,0,0
130901,Two,0,0
130902,hundred,0,0
130903,and,0,0
130904,two,0,0
130905,patients,0,0
130906,were,0,0
130907,randomized,0,0
130908,to,0,0
130909,either,0,0
130910,the,0,0
130911,surgical,0,0
130912,approach,0,0
130913,(,1,0
130914,total,1,0
130915,laryngectomy,1,0
130916,with,1,0
130917,partial,1,0
130918,pharyngectomy,1,0
130919,and,1,0
130920,neck,1,0
130921,dissection,1,0
130922,",",1,0
130923,followed,1,0
130924,by,1,0
130925,irradiation,1,0
130926,),1,0
130927,or,1,0
130928,to,1,0
130929,the,1,0
130930,chemotherapy,1,0
130931,arm,1,0
130932,up,1,0
130933,to,1,0
130934,three,1,0
130935,cycles,1,0
130936,of,1,0
130937,induction,1,0
130938,chemotherapy,1,1
130939,(,1,1
130940,cisplatin,1,1
130941,100,0,1
130942,mg/m,0,1
130943,(,0,1
130944,2,0,1
130945,),0,1
130946,day,0,1
130947,1,0,1
130948,+,0,1
130949,5-FU,0,1
130950,1000,0,1
130951,mg/m,0,1
130952,(,0,1
130953,2,0,1
130954,),0,1
130955,day,0,1
130956,1-5,0,1
130957,),0,1
130958,followed,0,0
130959,for,0,0
130960,complete,0,0
130961,responders,0,0
130962,by,0,0
130963,irradiation,1,0
130964,and,0,0
130965,otherwise,0,0
130966,by,0,0
130967,conventional,1,0
130968,treatment,1,0
130969,.,1,0
130970,The,0,0
130971,end,0,0
130972,points,0,0
130973,were,0,0
130974,overall,0,0
130975,survival,0,1
130976,[,0,0
130977,OS,0,0
130978,",",0,0
130979,noninferiority,0,0
130980,:,0,0
130981,hazard,0,1
130982,ratio,0,0
130983,(,0,1
130984,preservation/surgery,0,1
130985,),0,0
130986,?,0,0
130987,1.428,0,0
130988,",",0,0
130989,one-sided,0,0
130990,?,0,0
130991,=,0,0
130992,0.05,0,0
130993,],0,0
130994,",",0,0
130995,progression-free,0,1
130996,survival,0,1
130997,(,0,1
130998,PFS,0,1
130999,),0,1
131000,and,0,0
131001,survival,0,0
131002,with,0,0
131003,a,0,0
131004,functional,0,0
131005,larynx,0,0
131006,(,0,1
131007,SFL,0,1
131008,),0,1
131009,.,0,0
131010,RESULTS,0,0
131011,At,0,0
131012,a,0,0
131013,median,0,0
131014,follow-up,0,0
131015,of,0,0
131016,10.5,0,0
131017,years,0,0
131018,on,0,0
131019,194,0,0
131020,eligible,0,0
131021,patients,0,0
131022,",",0,0
131023,disease,0,0
131024,evolution,0,0
131025,was,0,0
131026,seen,0,0
131027,in,0,0
131028,54,0,0
131029,and,0,0
131030,49,0,0
131031,patients,0,0
131032,in,0,0
131033,the,0,0
131034,surgery,0,0
131035,and,0,0
131036,chemotherapy,0,0
131037,arm,0,0
131038,",",0,0
131039,respectively,0,0
131040,",",0,0
131041,and,0,0
131042,81,0,0
131043,and,0,0
131044,83,0,0
131045,patients,0,0
131046,had,0,0
131047,died,0,0
131048,.,0,0
131049,The,0,0
131050,10-year,0,0
131051,OS,0,0
131052,rate,0,0
131053,was,0,0
131054,13.8,0,0
131055,%,0,0
131056,in,0,0
131057,the,0,0
131058,surgery,0,0
131059,arm,0,0
131060,and,0,0
131061,13.1,0,0
131062,%,0,0
131063,in,0,0
131064,the,0,0
131065,chemotherapy,0,0
131066,arm,0,0
131067,.,0,0
131068,The,0,0
131069,10-year,0,0
131070,PFS,0,0
131071,rates,0,0
131072,were,0,0
131073,8.5,0,0
131074,%,0,0
131075,and,0,0
131076,10.8,0,0
131077,%,0,0
131078,",",0,0
131079,respectively,0,0
131080,.,0,0
131081,In,0,0
131082,the,0,0
131083,chemotherapy,0,0
131084,arm,0,0
131085,",",0,0
131086,the,0,0
131087,10-year,0,0
131088,SFL,0,0
131089,rate,0,0
131090,was,0,0
131091,8.7,0,0
131092,%,0,0
131093,.,0,0
131094,CONCLUSION,0,0
131095,This,0,0
131096,strategy,0,0
131097,did,0,0
131098,not,0,0
131099,compromise,0,0
131100,disease,0,0
131101,control,0,0
131102,or,0,0
131103,survival,0,1
131104,(,0,0
131105,that,0,0
131106,remained,0,0
131107,poor,0,0
131108,),0,0
131109,and,0,0
131110,allowed,0,0
131111,more,0,0
131112,than,0,0
131113,half,0,0
131114,of,0,0
131115,the,0,0
131116,survivors,0,0
131117,to,0,0
131118,retain,0,0
131119,their,0,0
131120,larynx,0,0
131121,.,0,0
131122,Kata,1,1
131123,techniques,1,0
131124,training,1,0
131125,consistently,0,0
131126,decreases,0,0
131127,stereotypy,0,0
131128,in,0,0
131129,children,0,0
131130,with,0,0
131131,autism,0,0
131132,spectrum,0,0
131133,disorder,0,0
131134,.,0,0
131135,The,0,0
131136,effects,0,0
131137,of,0,0
131138,14,0,0
131139,weeks,0,0
131140,of,0,0
131141,Kata,1,0
131142,techniques,1,0
131143,training,1,0
131144,on,0,0
131145,stereotypic,0,0
131146,behaviors,0,0
131147,of,0,0
131148,children,0,0
131149,with,0,0
131150,autism,0,0
131151,spectrum,0,0
131152,disorders,0,1
131153,(,0,1
131154,ASD,0,1
131155,),0,0
131156,were,0,0
131157,investigated,0,0
131158,.,0,0
131159,The,0,0
131160,study,0,0
131161,included,0,0
131162,30,0,0
131163,eligible,0,0
131164,(,0,1
131165,diagnosed,0,0
131166,ASD,0,1
131167,",",0,0
131168,school,0,1
131169,age,0,1
131170,),0,0
131171,children,0,0
131172,with,0,0
131173,ages,0,0
131174,ranging,0,0
131175,from,0,0
131176,5,0,0
131177,to,0,0
131178,16,0,0
131179,years,0,0
131180,whom,0,0
131181,they,0,0
131182,assigned,0,0
131183,to,0,0
131184,an,0,0
131185,exercise,0,0
131186,(,0,0
131187,n=15,0,0
131188,),0,0
131189,or,0,0
131190,a,0,0
131191,no-exercise,1,0
131192,control,1,0
131193,group,1,0
131194,(,0,0
131195,n=15,0,0
131196,),0,0
131197,.,0,0
131198,Participants,0,0
131199,of,0,0
131200,the,0,0
131201,exercise,0,0
131202,group,0,0
131203,received,0,0
131204,Kata,1,0
131205,techniques,1,0
131206,instruction,1,0
131207,four,0,0
131208,times,0,0
131209,per,0,0
131210,week,0,0
131211,for,0,0
131212,14,0,0
131213,weeks,0,0
131214,(,0,0
131215,56,0,0
131216,sessions,0,0
131217,),0,0
131218,.,0,0
131219,Stereotypy,1,0
131220,was,0,0
131221,assessed,0,0
131222,at,0,0
131223,baseline,0,0
131224,(,0,1
131225,pre-intervention,0,1
131226,),0,1
131227,",",0,0
131228,week,0,0
131229,14,0,0
131230,(,0,1
131231,post-intervention,0,1
131232,),0,1
131233,",",0,0
131234,and,0,0
131235,at,0,0
131236,one,0,0
131237,month,0,0
131238,follow,0,0
131239,up,0,0
131240,in,0,0
131241,both,0,0
131242,groups,0,0
131243,.,0,0
131244,Results,0,0
131245,showed,0,0
131246,that,0,0
131247,Kata,0,0
131248,techniques,0,0
131249,training,0,0
131250,significantly,0,0
131251,reduced,0,0
131252,stereotypy,0,0
131253,in,0,0
131254,the,0,0
131255,exercise,0,0
131256,group,0,0
131257,.,0,0
131258,Following,0,0
131259,participation,0,0
131260,in,0,0
131261,Kata,0,0
131262,techniques,0,0
131263,training,0,0
131264,",",0,0
131265,stereotypy,0,0
131266,decreased,0,0
131267,from,0,0
131268,baseline,0,0
131269,levels,0,0
131270,by,0,0
131271,a,0,0
131272,M,0,0
131273,of,0,0
131274,42.54,0,0
131275,%,0,0
131276,across,0,0
131277,participants,0,0
131278,.,0,0
131279,Interestingly,0,0
131280,",",0,0
131281,after,0,0
131282,30,0,0
131283,days,0,0
131284,of,0,0
131285,no,0,0
131286,practice,0,0
131287,",",0,0
131288,stereotypy,0,0
131289,in,0,0
131290,the,0,0
131291,exercise,0,0
131292,group,0,0
131293,remained,0,0
131294,significantly,0,0
131295,decreased,0,0
131296,compared,0,0
131297,to,0,0
131298,pre-intervention,0,0
131299,time,0,0
131300,.,0,0
131301,The,0,0
131302,participants,0,0
131303,of,0,0
131304,the,0,0
131305,control,0,0
131306,group,0,0
131307,did,0,0
131308,not,0,0
131309,show,0,0
131310,significant,0,0
131311,changes,0,0
131312,in,0,0
131313,the,0,0
131314,stereotypy,0,0
131315,.,0,0
131316,Teaching,0,0
131317,martial,0,0
131318,arts,0,0
131319,techniques,0,0
131320,to,0,0
131321,children,0,0
131322,with,0,0
131323,ASD,0,0
131324,for,0,0
131325,a,0,0
131326,long,0,0
131327,period,0,0
131328,of,0,0
131329,time,0,0
131330,consistently,0,0
131331,decreased,0,0
131332,their,0,0
131333,stereotypic,0,0
131334,behaviors,0,0
131335,.,0,0
131336,The,0,0
131337,Social,0,0
131338,Communication,0,0
131339,Intervention,0,0
131340,Project,0,0
131341,:,0,0
131342,a,0,0
131343,randomized,0,0
131344,controlled,0,0
131345,trial,0,0
131346,of,0,0
131347,the,0,0
131348,effectiveness,0,0
131349,of,0,0
131350,speech,0,0
131351,and,0,0
131352,language,0,0
131353,therapy,0,0
131354,for,0,0
131355,school-age,0,0
131356,children,0,0
131357,who,0,0
131358,have,0,0
131359,pragmatic,0,0
131360,and,0,0
131361,social,0,0
131362,communication,0,0
131363,problems,0,0
131364,with,0,0
131365,or,0,0
131366,without,0,0
131367,autism,0,0
131368,spectrum,0,0
131369,disorder,0,0
131370,.,0,0
131371,BACKGROUND,0,0
131372,Children,0,0
131373,who,0,0
131374,show,0,0
131375,disproportionate,0,0
131376,difficulty,0,0
131377,with,0,0
131378,the,0,0
131379,pragmatic,0,0
131380,as,0,0
131381,compared,0,0
131382,with,0,0
131383,the,0,0
131384,structural,0,0
131385,aspects,0,0
131386,of,0,0
131387,language,0,0
131388,are,0,0
131389,described,0,0
131390,as,0,0
131391,having,0,0
131392,pragmatic,0,0
131393,language,0,1
131394,impairment,0,1
131395,(,0,1
131396,PLI,0,1
131397,),0,1
131398,or,0,0
131399,social,0,1
131400,communication,0,1
131401,disorder,0,1
131402,(,0,1
131403,SCD,0,1
131404,),0,1
131405,.,0,0
131406,Some,0,0
131407,children,0,0
131408,who,0,0
131409,have,0,0
131410,PLI,0,0
131411,also,0,0
131412,show,0,0
131413,mild,0,0
131414,social,0,0
131415,impairments,0,0
131416,associated,0,0
131417,with,0,0
131418,high-functioning,0,0
131419,autism,0,0
131420,or,0,0
131421,autism,0,0
131422,spectrum,0,0
131423,disorder,0,1
131424,(,0,1
131425,ASD,0,1
131426,),0,1
131427,.,0,0
131428,There,0,0
131429,is,0,0
131430,little,0,0
131431,robust,0,0
131432,evidence,0,0
131433,of,0,0
131434,effectiveness,0,0
131435,of,0,0
131436,speech-language,0,0
131437,interventions,0,0
131438,which,0,0
131439,target,0,0
131440,the,0,0
131441,language,0,0
131442,",",0,0
131443,pragmatic,0,0
131444,or,0,0
131445,social,0,0
131446,communication,0,0
131447,needs,0,0
131448,of,0,0
131449,these,0,0
131450,children,0,0
131451,.,0,0
131452,AIMS,0,0
131453,To,0,0
131454,evaluate,0,0
131455,the,0,0
131456,effectiveness,0,0
131457,of,0,0
131458,an,0,0
131459,intensive,1,0
131460,manualized,1,0
131461,social,1,1
131462,communication,1,1
131463,intervention,1,1
131464,(,1,1
131465,SCIP,1,1
131466,),1,1
131467,for,0,0
131468,children,0,0
131469,who,0,0
131470,have,0,0
131471,PLI,0,0
131472,with,0,0
131473,or,0,0
131474,without,0,0
131475,features,0,0
131476,of,0,0
131477,ASD,0,0
131478,.,0,0
131479,METHODS,0,0
131480,&,0,1
131481,PROCEDURES,0,0
131482,In,0,0
131483,a,0,0
131484,single-blind,0,1
131485,RCT,0,1
131486,design,0,0
131487,",",0,0
131488,88,0,0
131489,children,0,0
131490,with,0,0
131491,pragmatic,0,0
131492,and,0,0
131493,social,0,0
131494,communication,0,0
131495,needs,0,0
131496,aged,0,0
131497,5,0,0
131498,;,0,0
131499,11-10,0,0
131500,;,0,0
131501,8,0,0
131502,",",0,0
131503,recruited,0,0
131504,from,0,0
131505,UK,0,1
131506,speech,0,0
131507,and,0,0
131508,language,0,0
131509,therapy,0,0
131510,services,0,0
131511,",",0,0
131512,were,0,0
131513,randomly,0,0
131514,assigned,0,0
131515,in,0,0
131516,a,0,0
131517,2:1,0,0
131518,ratio,0,0
131519,to,0,0
131520,SCIP,1,0
131521,or,0,0
131522,to,0,0
131523,treatment-as-usual,1,0
131524,.,1,0
131525,Children,0,0
131526,in,0,0
131527,the,0,0
131528,SCIP,1,0
131529,condition,0,0
131530,received,0,0
131531,up,0,0
131532,to,0,0
131533,20,1,0
131534,sessions,1,0
131535,of,1,0
131536,direct,1,0
131537,intervention,1,0
131538,from,1,0
131539,a,1,0
131540,specialist,1,0
131541,research,1,0
131542,speech,1,0
131543,and,1,0
131544,language,1,0
131545,therapist,1,0
131546,working,1,0
131547,with,1,0
131548,supervised,1,0
131549,assistants,1,0
131550,.,1,0
131551,All,0,0
131552,therapy,0,0
131553,content,0,0
131554,and,0,0
131555,methodology,0,0
131556,was,0,0
131557,derived,0,0
131558,from,0,0
131559,an,0,0
131560,intervention,0,0
131561,manual,0,0
131562,.,0,0
131563,A,0,0
131564,primary,0,0
131565,outcome,0,0
131566,measure,0,0
131567,of,0,0
131568,structural,0,0
131569,language,0,0
131570,and,0,0
131571,secondary,0,0
131572,outcome,0,0
131573,measures,0,0
131574,of,0,0
131575,narrative,0,0
131576,",",0,0
131577,parent-reported,0,0
131578,pragmatic,0,0
131579,functioning,0,0
131580,and,0,0
131581,social,0,0
131582,communication,0,0
131583,",",0,0
131584,blind-rated,0,0
131585,perceptions,0,0
131586,of,0,0
131587,conversational,0,0
131588,competence,0,0
131589,and,0,0
131590,teacher-reported,0,0
131591,ratings,0,0
131592,of,0,0
131593,classroom,0,0
131594,learning,0,0
131595,skills,0,0
131596,were,0,0
131597,taken,0,0
131598,pre-intervention,0,0
131599,",",0,0
131600,immediately,0,0
131601,post-intervention,0,0
131602,and,0,0
131603,at,0,0
131604,6-month,0,0
131605,follow-up,0,0
131606,.,0,0
131607,Analysis,0,0
131608,was,0,0
131609,by,0,0
131610,intention,0,0
131611,to,0,0
131612,treat,0,0
131613,.,0,0
131614,OUTCOMES,0,0
131615,&,0,1
131616,RESULTS,0,1
131617,No,0,1
131618,significant,0,0
131619,treatment,0,0
131620,effect,0,0
131621,was,0,0
131622,found,0,0
131623,for,0,0
131624,the,0,0
131625,primary,0,0
131626,outcome,0,0
131627,measure,0,0
131628,of,0,0
131629,structural,0,0
131630,language,0,0
131631,ability,0,0
131632,or,0,0
131633,for,0,0
131634,a,0,0
131635,measure,0,0
131636,of,0,0
131637,narrative,0,0
131638,ability,0,0
131639,.,0,0
131640,Significant,0,0
131641,treatment,0,0
131642,effects,0,0
131643,were,0,0
131644,found,0,0
131645,for,0,0
131646,blind-rated,0,0
131647,perceptions,0,0
131648,of,0,0
131649,conversational,0,0
131650,competence,0,0
131651,",",0,0
131652,for,0,0
131653,parent-reported,0,0
131654,measures,0,0
131655,of,0,0
131656,pragmatic,0,0
131657,functioning,0,0
131658,and,0,0
131659,social,0,0
131660,communication,0,0
131661,",",0,0
131662,and,0,0
131663,for,0,0
131664,teacher-reported,0,0
131665,ratings,0,0
131666,of,0,0
131667,classroom,0,0
131668,learning,0,0
131669,skills,0,0
131670,.,0,0
131671,CONCLUSIONS,0,0
131672,&,0,1
131673,IMPLICATIONS,0,0
131674,There,0,0
131675,is,0,0
131676,some,0,0
131677,evidence,0,0
131678,of,0,0
131679,an,0,0
131680,intervention,0,0
131681,effect,0,0
131682,on,0,0
131683,blind,0,0
131684,and,0,0
131685,parent/teacher-reported,0,0
131686,communication,0,0
131687,outcomes,0,0
131688,",",0,0
131689,but,0,0
131690,not,0,0
131691,standardized,0,0
131692,language,0,0
131693,assessment,0,0
131694,outcomes,0,0
131695,",",0,0
131696,for,0,0
131697,6-11-year-old,0,0
131698,children,0,0
131699,who,0,0
131700,have,0,0
131701,pragmatic,0,0
131702,and,0,0
131703,social,0,0
131704,communication,0,0
131705,needs,0,0
131706,.,0,0
131707,These,0,0
131708,findings,0,0
131709,are,0,0
131710,discussed,0,0
131711,in,0,0
131712,the,0,0
131713,context,0,0
131714,of,0,0
131715,the,0,0
131716,increasingly,0,0
131717,central,0,0
131718,role,0,0
131719,of,0,0
131720,service,0,0
131721,user,0,0
131722,outcomes,0,0
131723,in,0,0
131724,providing,0,0
131725,evidence,0,0
131726,for,0,0
131727,an,0,0
131728,intervention,0,0
131729,.,0,0
131730,The,0,0
131731,substantial,0,0
131732,overlap,0,0
131733,between,0,0
131734,the,0,0
131735,presence,0,0
131736,of,0,0
131737,PLI,0,0
131738,and,0,0
131739,ASD,0,1
131740,(,0,0
131741,75,0,0
131742,%,0,0
131743,),0,0
131744,across,0,0
131745,the,0,0
131746,whole,0,0
131747,cohort,0,0
131748,suggests,0,0
131749,that,0,0
131750,the,0,0
131751,intervention,0,0
131752,may,0,0
131753,also,0,0
131754,be,0,0
131755,applicable,0,0
131756,to,0,0
131757,some,0,0
131758,verbally,0,0
131759,able,0,0
131760,children,0,0
131761,with,0,0
131762,ASD,0,0
131763,who,0,0
131764,have,0,0
131765,pragmatic,0,0
131766,communication,0,0
131767,needs,0,0
131768,.,0,0
131769,Successful,0,0
131770,treatment,0,0
131771,of,0,0
131772,blepharitis,0,0
131773,with,0,1
131774,bibrocathol,1,1
131775,(,1,1
131776,Posiformin?,1,0
131777,2,1,0
131778,%,1,0
131779,),1,0
131780,.,1,0
131781,BACKGROUND,1,0
131782,Bibrocathol,1,0
131783,is,0,0
131784,a,0,0
131785,well-established,1,0
131786,antiseptic,1,1
131787,drug,1,1
131788,for,0,0
131789,the,0,0
131790,treatment,0,0
131791,of,0,0
131792,acute,0,0
131793,eyelid,0,0
131794,diseases,0,0
131795,like,0,0
131796,blepharitis,0,0
131797,.,0,0
131798,Despite,0,0
131799,its,0,0
131800,frequent,0,0
131801,use,0,0
131802,in,0,0
131803,clinical,0,0
131804,practice,0,0
131805,",",0,0
131806,no,0,0
131807,controlled,0,0
131808,clinical,0,0
131809,trial,0,0
131810,on,0,0
131811,the,0,0
131812,efficacy,0,0
131813,of,1,0
131814,bibrocathol,1,0
131815,2,1,0
131816,%,1,0
131817,eye,0,0
131818,ointment,0,1
131819,has,0,0
131820,been,0,0
131821,performed,0,0
131822,until,0,0
131823,now,0,0
131824,.,0,0
131825,The,0,0
131826,aim,0,0
131827,of,0,0
131828,the,0,0
131829,study,0,0
131830,was,0,0
131831,to,0,0
131832,investigate,0,0
131833,efficacy,0,0
131834,",",0,0
131835,safety,0,1
131836,and,0,0
131837,tolerability,0,1
131838,of,1,1
131839,bibrocathol,1,1
131840,(,1,1
131841,Posiformin?,1,0
131842,2,1,0
131843,%,0,0
131844,),0,0
131845,eye,0,0
131846,ointment,0,1
131847,in,0,0
131848,patients,0,0
131849,diagnosed,0,0
131850,with,0,0
131851,blepharitis,0,0
131852,.,0,0
131853,METHODS,0,0
131854,In,0,0
131855,this,0,0
131856,multi-center,0,0
131857,",",0,0
131858,randomized,0,1
131859,",",0,1
131860,double-masked,1,1
131861,",",1,1
131862,placebo-controlled,1,1
131863,parallel-group,1,1
131864,comparison,0,0
131865,",",0,0
131866,the,0,0
131867,change,0,0
131868,of,0,0
131869,signs,0,0
131870,and,0,0
131871,symptoms,0,1
131872,(,0,0
131873,sum,0,0
131874,score,0,1
131875,),0,0
131876,of,0,0
131877,blepharitis,0,0
131878,in,0,0
131879,197,0,0
131880,patients,0,0
131881,(,0,0
131882,ITT,0,1
131883,(,0,1
131884,intention-to-treat-group,0,1
131885,),0,1
131886,;,0,0
131887,mean,0,0
131888,age,0,0
131889,56,0,0
131890,?,0,0
131891,18,0,0
131892,years,0,0
131893,",",0,0
131894,56,0,0
131895,%,0,0
131896,female,0,0
131897,",",0,0
131898,active,0,0
131899,drug,0,1
131900,:,0,0
131901,vehicle,0,0
131902,=,0,0
131903,97:100,0,0
131904,),0,0
131905,over,0,0
131906,2,0,0
131907,weeks,0,0
131908,treatment,0,0
131909,with,0,1
131910,bibrocathol,1,0
131911,2,1,0
131912,%,1,0
131913,eye,1,0
131914,ointment,1,1
131915,was,1,0
131916,evaluated,0,0
131917,.,0,0
131918,RESULTS,0,0
131919,Patients,0,0
131920,receiving,1,0
131921,bibrocathol,1,0
131922,2,1,0
131923,%,1,0
131924,showed,0,0
131925,greater,0,0
131926,improvement,0,0
131927,in,0,0
131928,the,0,0
131929,sum,0,0
131930,score,0,0
131931,than,0,0
131932,the,1,0
131933,placebo,1,1
131934,patients,0,0
131935,(,0,0
131936,p,0,0
131937,<,0,0
131938,0.0001,0,0
131939,",",0,0
131940,Cohen,0,0
131941,'s,0,0
131942,effect,0,0
131943,size,0,0
131944,d,0,0
131945,=,0,0
131946,0.73,0,0
131947,),0,0
131948,.,0,0
131949,Also,0,0
131950,",",0,0
131951,the,0,0
131952,results,0,0
131953,from,0,0
131954,further,0,0
131955,efficacy,0,0
131956,assessments,0,0
131957,improvement,0,0
131958,of,0,0
131959,single,0,0
131960,symptoms,0,0
131961,and,0,0
131962,ocular,0,0
131963,discomfort,0,0
131964,measured,0,0
131965,by,0,0
131966,a,0,0
131967,VAS,0,1
131968,(,0,1
131969,visual,0,1
131970,analogue,0,1
131971,scale,0,1
131972,),0,0
131973,supported,0,0
131974,treatment,0,0
131975,with,0,0
131976,bibrocathol,1,1
131977,.,1,0
131978,Patients,1,0
131979,and,0,0
131980,investigators,0,0
131981,provided,0,0
131982,favorable,0,0
131983,tolerability,0,1
131984,ratings,0,1
131985,preferring,1,1
131986,bibrocathol,1,1
131987,over,1,0
131988,placebo,1,1
131989,.,0,1
131990,No,0,1
131991,safety,0,0
131992,issues,0,0
131993,were,0,0
131994,observed,0,0
131995,with,0,0
131996,regard,0,0
131997,to,0,0
131998,intraocular,0,0
131999,pressure,0,0
132000,",",0,0
132001,visual,0,0
132002,acuity,0,0
132003,",",0,0
132004,or,0,0
132005,occurrence,0,0
132006,of,0,0
132007,adverse,0,0
132008,events,0,0
132009,.,0,0
132010,CONCLUSIONS,0,0
132011,Blepharitis,0,0
132012,therapy,0,0
132013,with,0,0
132014,the,1,0
132015,antiseptic,1,1
132016,bibrocathol,1,1
132017,2,1,0
132018,%,1,0
132019,in,1,0
132020,this,1,0
132021,trial,0,0
132022,was,0,0
132023,highly,0,0
132024,efficacious,0,1
132025,and,0,0
132026,safe,0,0
132027,.,0,0
132028,Carbon,1,0
132029,dioxide,1,1
132030,insufflation,1,1
132031,in,0,0
132032,open-chamber,0,0
132033,cardiac,0,0
132034,surgery,0,0
132035,:,0,0
132036,a,0,0
132037,double-blind,0,1
132038,",",0,1
132039,randomized,0,1
132040,clinical,0,0
132041,trial,0,0
132042,of,0,0
132043,neurocognitive,0,0
132044,effects,0,0
132045,.,0,0
132046,OBJECTIVE,0,0
132047,The,0,0
132048,aims,0,0
132049,of,0,0
132050,this,0,0
132051,study,0,0
132052,were,0,0
132053,first,0,0
132054,to,0,0
132055,analyze,0,0
132056,neurocognitive,0,0
132057,outcomes,0,0
132058,of,0,0
132059,patients,0,0
132060,after,0,0
132061,open-chamber,0,0
132062,cardiac,0,0
132063,surgery,0,0
132064,to,0,0
132065,determine,0,0
132066,whether,0,0
132067,carbon,1,0
132068,dioxide,1,1
132069,pericardial,1,1
132070,insufflation,1,1
132071,reduces,0,0
132072,incidence,0,0
132073,of,0,0
132074,neurocognitive,0,0
132075,decline,0,0
132076,(,0,0
132077,primary,0,0
132078,end,0,0
132079,point,0,0
132080,),0,0
132081,as,0,0
132082,measured,0,0
132083,6,0,0
132084,weeks,0,0
132085,postoperatively,0,0
132086,and,0,0
132087,second,0,0
132088,to,0,0
132089,assess,0,0
132090,the,0,0
132091,utility,0,0
132092,of,0,0
132093,carbon,1,0
132094,dioxide,1,1
132095,insufflation,1,1
132096,in,0,0
132097,cardiac,0,1
132098,chamber,0,1
132099,deairing,0,0
132100,as,0,0
132101,assessed,0,0
132102,by,0,0
132103,transesophageal,0,0
132104,echocardiography,0,0
132105,.,0,0
132106,METHODS,0,0
132107,A,0,1
132108,multicenter,0,1
132109,",",0,0
132110,prospective,0,1
132111,",",0,1
132112,double-blind,0,1
132113,",",0,1
132114,randomized,0,1
132115,",",0,0
132116,controlled,0,0
132117,trial,0,0
132118,compared,0,0
132119,neurocognitive,0,0
132120,outcomes,0,0
132121,in,0,0
132122,patients,0,0
132123,undergoing,0,0
132124,open-chamber,0,1
132125,(,0,1
132126,left-sided,0,1
132127,),0,1
132128,cardiac,0,1
132129,surgery,0,0
132130,who,0,0
132131,were,0,0
132132,assigned,0,0
132133,carbon,1,0
132134,dioxide,1,1
132135,insufflation,1,1
132136,or,1,1
132137,placebo,1,1
132138,(,0,1
132139,control,0,1
132140,group,0,0
132141,),0,0
132142,in,0,0
132143,addition,0,0
132144,to,0,0
132145,standardized,0,0
132146,mechanical,0,0
132147,deairing,0,0
132148,maneuvers,0,0
132149,.,0,0
132150,RESULTS,0,0
132151,One,0,0
132152,hundred,0,0
132153,twenty-five,0,0
132154,patients,0,0
132155,underwent,0,0
132156,surgery,0,0
132157,and,0,0
132158,were,0,0
132159,randomly,0,0
132160,allocated,0,0
132161,.,0,0
132162,Neurocognitive,0,0
132163,testing,0,0
132164,showed,0,0
132165,no,0,0
132166,clinically,0,0
132167,significant,0,0
132168,differences,0,0
132169,in,0,0
132170,z,0,0
132171,scores,0,0
132172,between,0,0
132173,preoperative,0,0
132174,and,0,0
132175,postoperative,0,0
132176,testing,0,0
132177,.,0,0
132178,Linear,0,0
132179,regression,0,0
132180,was,0,0
132181,used,0,0
132182,to,0,0
132183,identify,0,0
132184,factors,0,0
132185,associated,0,0
132186,with,0,0
132187,neurocognitive,0,0
132188,decline,0,0
132189,.,0,0
132190,Factors,0,0
132191,most,0,0
132192,strongly,0,0
132193,associated,0,0
132194,with,0,0
132195,neurocognitive,0,0
132196,decline,0,0
132197,were,0,0
132198,hypercholesterolemia,0,0
132199,",",0,0
132200,aortic,0,0
132201,atheroma,0,0
132202,grade,0,0
132203,",",0,0
132204,and,0,0
132205,coronary,0,0
132206,artery,0,0
132207,disease,0,0
132208,.,0,0
132209,There,0,0
132210,was,0,0
132211,significantly,0,0
132212,more,0,0
132213,intracardiac,0,0
132214,gas,0,0
132215,noted,0,0
132216,on,0,0
132217,intraoperative,0,0
132218,transesophageal,0,0
132219,echocardiography,0,0
132220,in,0,0
132221,all,0,0
132222,cardiac,0,0
132223,chambers,0,0
132224,(,0,0
132225,left,0,0
132226,atrium,0,1
132227,",",0,0
132228,left,0,0
132229,ventricle,0,0
132230,",",0,0
132231,and,0,0
132232,aorta,0,1
132233,),0,0
132234,at,0,0
132235,all,0,0
132236,measured,0,0
132237,times,0,1
132238,(,0,0
132239,after,0,0
132240,crossclamp,0,0
132241,removal,0,0
132242,",",0,0
132243,during,0,0
132244,weaning,0,0
132245,from,0,0
132246,cardiopulmonary,0,0
132247,bypass,0,0
132248,",",0,0
132249,and,0,0
132250,at,0,0
132251,declaration,0,0
132252,of,0,0
132253,adequate,0,0
132254,deairing,0,0
132255,by,0,0
132256,the,0,0
132257,anesthetist,0,0
132258,),0,0
132259,in,0,0
132260,the,0,0
132261,control,0,0
132262,group,0,0
132263,than,0,0
132264,in,0,0
132265,the,0,0
132266,carbon,0,0
132267,dioxide,0,1
132268,group,0,0
132269,(,0,0
132270,P,0,0
132271,<,0,0
132272,.04,0,0
132273,),0,0
132274,.,0,0
132275,Deairing,0,0
132276,time,0,0
132277,was,0,0
132278,also,0,0
132279,significantly,0,0
132280,longer,0,0
132281,in,0,0
132282,the,0,0
132283,control,0,0
132284,group,0,0
132285,(,0,0
132286,12,0,0
132287,minutes,0,0
132288,[,0,0
132289,interquartile,0,0
132290,range,0,0
132291,",",0,0
132292,9-18,0,0
132293,],0,0
132294,versus,0,0
132295,9,0,0
132296,minutes,0,0
132297,[,0,0
132298,interquartile,0,0
132299,range,0,0
132300,",",0,0
132301,7-14,0,0
132302,minutes,0,0
132303,],0,0
132304,;,0,0
132305,P,0,0
132306,=,0,0
132307,.002,0,0
132308,),0,0
132309,.,0,0
132310,CONCLUSIONS,0,1
132311,Carbon,1,0
132312,dioxide,1,1
132313,pericardial,0,1
132314,insufflation,0,1
132315,in,0,0
132316,open-chamber,0,0
132317,cardiac,0,0
132318,surgery,0,0
132319,does,0,0
132320,not,0,0
132321,affect,0,0
132322,postoperative,0,0
132323,neurocognitive,0,0
132324,decline,0,0
132325,.,0,0
132326,The,0,0
132327,most,0,0
132328,important,0,0
132329,factor,0,0
132330,is,0,0
132331,atheromatous,0,0
132332,vascular,0,0
132333,disease,0,0
132334,.,0,0
132335,Immunologic,0,0
132336,response,0,0
132337,after,0,0
132338,laparoscopic,0,0
132339,colon,0,0
132340,cancer,0,0
132341,operation,0,0
132342,within,0,0
132343,an,0,0
132344,enhanced,0,0
132345,recovery,0,0
132346,program,0,0
132347,.,0,0
132348,OBJECTIVE,0,0
132349,It,0,0
132350,has,0,0
132351,been,0,0
132352,demonstrated,0,0
132353,that,0,0
132354,colon,0,0
132355,operation,0,0
132356,combined,0,0
132357,with,0,0
132358,fast-track,0,0
132359,(,0,1
132360,FT,0,1
132361,),0,1
132362,surgery,0,0
132363,and,0,0
132364,laparoscopic,0,0
132365,technique,0,0
132366,can,0,0
132367,shorten,0,0
132368,the,0,0
132369,length,0,0
132370,of,0,0
132371,hospital,0,0
132372,stay,0,0
132373,",",0,0
132374,accelerate,0,0
132375,recovery,0,0
132376,of,0,0
132377,intestinal,0,0
132378,function,0,0
132379,",",0,0
132380,and,0,0
132381,reduce,0,0
132382,the,0,0
132383,occurrence,0,0
132384,of,0,0
132385,post-operative,0,0
132386,complications,0,0
132387,.,0,0
132388,However,0,0
132389,",",0,0
132390,there,0,0
132391,are,0,0
132392,no,0,0
132393,reports,0,0
132394,regarding,0,0
132395,the,0,0
132396,combined,0,0
132397,effects,0,0
132398,of,0,0
132399,FT,0,0
132400,colon,0,0
132401,operation,0,0
132402,and,0,0
132403,laparoscopic,0,0
132404,technique,0,0
132405,on,0,0
132406,humoral,0,0
132407,inflammatory,0,0
132408,cellular,0,0
132409,immunity,0,0
132410,.,0,0
132411,METHODS,0,0
132412,This,0,0
132413,was,0,0
132414,a,0,0
132415,prospective,0,0
132416,",",0,0
132417,controlled,0,0
132418,study,0,0
132419,.,0,0
132420,One,0,0
132421,hundred,0,0
132422,sixty-three,0,0
132423,colon,0,0
132424,cancer,0,0
132425,patients,0,0
132426,underwent,0,0
132427,the,0,0
132428,traditional,1,0
132429,protocol,1,0
132430,and,1,0
132431,open,1,1
132432,operation,1,1
132433,(,0,0
132434,traditional,0,0
132435,open,0,1
132436,group,0,0
132437,",",0,0
132438,n=42,0,0
132439,),0,0
132440,",",0,0
132441,the,0,0
132442,traditional,1,0
132443,protocol,1,0
132444,and,1,0
132445,laparoscopic,1,1
132446,operation,1,1
132447,(,0,0
132448,traditional,0,0
132449,laparoscopic,0,1
132450,group,0,0
132451,",",0,0
132452,n=40,0,0
132453,),0,0
132454,",",0,0
132455,the,0,0
132456,FT,1,0
132457,protocol,1,0
132458,and,1,0
132459,open,1,1
132460,operation,1,1
132461,(,0,1
132462,FT,0,1
132463,open,0,1
132464,group,0,0
132465,",",0,0
132466,n=41,0,0
132467,),0,0
132468,",",0,0
132469,or,0,0
132470,the,0,0
132471,FT,1,0
132472,protocol,1,0
132473,and,1,0
132474,laparoscopic,1,1
132475,operation,1,1
132476,(,0,1
132477,FT,0,1
132478,laparoscopic,0,1
132479,group,0,0
132480,",",0,0
132481,n=40,0,0
132482,),0,0
132483,.,0,0
132484,Blood,0,0
132485,samples,0,0
132486,were,0,0
132487,taken,0,0
132488,prior,0,0
132489,to,0,0
132490,operation,0,0
132491,as,0,0
132492,well,0,0
132493,as,0,0
132494,on,0,0
132495,days,0,0
132496,1,0,0
132497,",",0,0
132498,3,0,0
132499,",",0,0
132500,and,0,0
132501,5,0,0
132502,after,0,0
132503,operation,0,0
132504,.,0,0
132505,The,0,0
132506,number,0,0
132507,of,0,0
132508,lymphocyte,0,0
132509,subpopulations,0,0
132510,was,0,0
132511,determined,0,0
132512,by,0,0
132513,flow,0,0
132514,cytometry,0,0
132515,",",0,0
132516,and,0,1
132517,serum,0,1
132518,interleukin-6,0,1
132519,and,0,1
132520,C-reactive,0,0
132521,protein,0,0
132522,levels,0,0
132523,were,0,0
132524,measured,0,0
132525,.,0,0
132526,Post-operative,0,0
132527,hospital,0,0
132528,stay,0,0
132529,",",0,0
132530,post-operative,0,0
132531,morbidity,0,0
132532,",",0,0
132533,readmission,0,0
132534,rate,0,0
132535,",",0,0
132536,and,0,0
132537,in-hospital,0,0
132538,mortality,0,0
132539,were,0,0
132540,recorded,0,0
132541,.,0,0
132542,RESULTS,0,0
132543,Compared,0,0
132544,with,0,0
132545,open,0,0
132546,operation,0,0
132547,",",0,0
132548,laparoscopic,0,0
132549,colon,0,0
132550,operation,0,0
132551,effectively,0,0
132552,inhibited,0,0
132553,the,0,0
132554,release,0,0
132555,of,0,0
132556,post-operative,0,0
132557,inflammatory,0,0
132558,factors,0,0
132559,and,0,0
132560,yielded,0,0
132561,good,0,0
132562,protection,0,0
132563,via,0,0
132564,post-operative,0,0
132565,cell,0,0
132566,immunity,0,0
132567,.,0,0
132568,FT,0,0
132569,surgery,0,0
132570,had,0,0
132571,a,0,0
132572,better,0,0
132573,protective,0,0
132574,role,0,0
132575,with,0,0
132576,respect,0,0
132577,to,0,0
132578,the,0,0
132579,post-operative,0,0
132580,immune,0,0
132581,system,0,0
132582,compared,0,0
132583,with,0,0
132584,traditional,0,0
132585,peri-operative,0,0
132586,care,0,0
132587,.,0,0
132588,Inflammatory,0,0
132589,reactions,0,0
132590,",",0,0
132591,based,0,0
132592,on,0,0
132593,interleukin-6,0,1
132594,and,0,0
132595,C-reactive,0,0
132596,protein,0,0
132597,levels,0,0
132598,",",0,0
132599,were,0,0
132600,less,0,0
132601,intense,0,0
132602,following,0,0
132603,FT,0,0
132604,laparoscopic,0,0
132605,operation,0,0
132606,compared,0,0
132607,to,0,0
132608,FT,0,0
132609,open,0,1
132610,operation,0,1
132611,;,0,0
132612,however,0,0
132613,",",0,0
132614,there,0,0
132615,were,0,0
132616,no,0,0
132617,differences,0,0
132618,in,0,0
132619,specific,0,0
132620,immunity,0,0
132621,(,0,0
132622,CD3+,0,1
132623,and,0,0
132624,CD4+,0,0
132625,counts,0,0
132626,",",0,0
132627,and,0,0
132628,the,0,0
132629,CD4+/CD8+,0,1
132630,ratio,0,0
132631,),0,0
132632,during,0,0
132633,these,0,0
132634,two,0,0
132635,types,0,0
132636,of,0,0
132637,surgical,0,0
132638,procedures,0,0
132639,.,0,0
132640,Post-operative,0,0
132641,hospital,0,0
132642,stay,0,0
132643,in,0,0
132644,patients,0,0
132645,randomized,0,0
132646,to,0,0
132647,the,0,0
132648,FT,0,0
132649,laparoscopic,0,0
132650,group,0,0
132651,was,0,0
132652,significantly,0,0
132653,shorter,0,0
132654,than,0,0
132655,in,0,0
132656,the,0,0
132657,other,0,0
132658,three,0,0
132659,treatment,0,0
132660,groups,0,0
132661,(,0,0
132662,P,0,0
132663,<,0,0
132664,0.01,0,0
132665,),0,0
132666,.,0,0
132667,Post-operative,0,0
132668,complications,0,0
132669,in,0,0
132670,patients,0,0
132671,who,0,0
132672,underwent,0,0
132673,FT,0,0
132674,laparoscopic,0,0
132675,treatment,0,0
132676,were,0,0
132677,less,0,0
132678,than,0,0
132679,in,0,0
132680,the,0,0
132681,other,0,0
132682,three,0,0
132683,treatment,0,0
132684,groups,0,0
132685,(,0,0
132686,P,0,0
132687,<,0,0
132688,0.05,0,0
132689,),0,0
132690,.,0,0
132691,There,0,0
132692,were,0,0
132693,no,0,0
132694,significant,0,0
132695,differences,0,0
132696,between,0,0
132697,the,0,0
132698,four,0,0
132699,treatment,0,0
132700,groups,0,0
132701,regarding,0,0
132702,readmission,0,0
132703,rate,0,0
132704,and,0,0
132705,in-hospital,0,0
132706,mortality,0,0
132707,.,0,0
132708,CONCLUSIONS,0,0
132709,The,0,0
132710,laparoscopic,0,0
132711,technique,0,0
132712,and,0,0
132713,FT,0,1
132714,surgery,0,1
132715,rehabilitation,0,0
132716,program,0,0
132717,effectively,0,0
132718,inhibited,0,0
132719,release,0,0
132720,of,0,0
132721,post-operative,0,0
132722,inflammatory,0,0
132723,factors,0,0
132724,with,0,0
132725,a,0,0
132726,reduction,0,0
132727,in,0,0
132728,peri-operative,0,0
132729,trauma,0,0
132730,and,0,0
132731,stress,0,0
132732,",",0,0
132733,which,0,0
132734,together,0,0
132735,played,0,0
132736,a,0,0
132737,protective,0,0
132738,role,0,0
132739,on,0,0
132740,the,0,0
132741,post-operative,0,0
132742,immune,0,0
132743,system,0,0
132744,.,0,0
132745,Combining,0,0
132746,two,0,0
132747,treatment,0,0
132748,measures,0,0
132749,during,0,0
132750,colon,0,0
132751,operation,0,0
132752,produced,0,0
132753,better,0,0
132754,protective,0,0
132755,effects,0,0
132756,via,0,0
132757,the,0,0
132758,immune,0,0
132759,system,0,0
132760,.,0,0
132761,The,0,0
132762,beneficial,0,0
132763,clinical,0,0
132764,effects,0,0
132765,support,0,0
132766,that,0,0
132767,the,0,0
132768,better-preserved,0,0
132769,post-operative,0,0
132770,immune,0,0
132771,system,0,0
132772,may,0,0
132773,also,0,0
132774,contribute,0,0
132775,to,0,0
132776,the,0,0
132777,improvement,0,0
132778,of,0,0
132779,post-operative,0,0
132780,results,0,0
132781,in,0,0
132782,FT,0,0
132783,laparoscopic,0,0
132784,patients,0,0
132785,.,0,0
132786,Effects,0,0
132787,of,0,0
132788,skin-to-skin,1,0
132789,contact,1,0
132790,on,0,0
132791,autonomic,0,0
132792,pain,0,0
132793,responses,0,0
132794,in,0,0
132795,preterm,0,0
132796,infants,0,0
132797,.,0,0
132798,UNLABELLED,0,0
132799,The,0,0
132800,purpose,0,0
132801,of,0,0
132802,this,0,0
132803,randomized,0,1
132804,crossover,0,1
132805,trial,0,1
132806,was,0,0
132807,to,0,0
132808,determine,0,0
132809,the,0,0
132810,effects,0,0
132811,on,0,0
132812,autonomic,0,0
132813,responses,0,0
132814,in,0,0
132815,preterm,0,0
132816,infants,0,0
132817,of,0,0
132818,longer,0,0
132819,Kangaroo,1,0
132820,Care,1,0
132821,(,0,0
132822,30,0,0
132823,minutes,0,0
132824,",",0,0
132825,KC30,1,1
132826,),1,0
132827,and,0,0
132828,shorter,0,0
132829,KC,1,1
132830,(,0,0
132831,15,0,0
132832,minutes,0,0
132833,",",0,0
132834,KC15,1,1
132835,),1,0
132836,before,0,0
132837,and,0,0
132838,throughout,0,0
132839,heel,0,0
132840,stick,0,0
132841,compared,0,0
132842,with,0,0
132843,incubator,1,0
132844,care,1,1
132845,(,1,1
132846,IC,1,1
132847,),1,1
132848,.,0,0
132849,Beat-to-beat,0,0
132850,heart,0,0
132851,rate,0,0
132852,(,0,1
132853,HR,0,1
132854,),0,1
132855,and,0,0
132856,spectral,0,0
132857,power,0,0
132858,analysis,0,0
132859,of,0,0
132860,heart,0,0
132861,rate,0,0
132862,variability,0,0
132863,",",0,0
132864,low,0,0
132865,frequency,0,0
132866,power,0,0
132867,(,0,1
132868,LF,0,1
132869,),0,1
132870,",",0,0
132871,high,0,0
132872,frequency,0,0
132873,power,0,0
132874,(,0,1
132875,HF,0,1
132876,),0,1
132877,",",0,0
132878,and,0,0
132879,LF/HF,0,0
132880,ratio,0,0
132881,were,0,0
132882,measured,0,0
132883,in,0,0
132884,26,0,0
132885,infants,0,0
132886,.,0,0
132887,HR,0,0
132888,changes,0,0
132889,from,0,0
132890,Baseline,0,0
132891,to,0,0
132892,Heel,0,1
132893,Stick,0,1
132894,were,0,0
132895,significantly,0,0
132896,less,0,0
132897,in,0,0
132898,KC30,0,0
132899,and,0,0
132900,KC15,0,1
132901,than,0,0
132902,in,0,0
132903,IC,0,1
132904,",",0,0
132905,and,0,0
132906,more,0,0
132907,infants,0,0
132908,had,0,0
132909,HR,0,0
132910,decrease,0,0
132911,in,0,0
132912,IC,0,0
132913,than,0,0
132914,in,0,0
132915,2,0,0
132916,KC,0,0
132917,conditions,0,0
132918,.,0,0
132919,In,0,0
132920,IC,0,0
132921,",",0,0
132922,LF,0,1
132923,and,0,0
132924,HF,0,0
132925,significantly,0,0
132926,increased,0,0
132927,from,0,0
132928,Baseline,0,0
132929,to,0,0
132930,Heel,0,1
132931,Stick,0,1
132932,and,0,0
132933,dropped,0,0
132934,from,0,0
132935,Heel,0,1
132936,Stick,0,1
132937,to,0,1
132938,Recovery,0,1
132939,;,0,0
132940,in,0,0
132941,2,0,0
132942,KC,0,0
132943,conditions,0,0
132944,",",0,0
132945,no,0,0
132946,changes,0,0
132947,across,0,0
132948,study,0,0
132949,phases,0,0
132950,were,0,0
132951,found,0,0
132952,.,0,0
132953,During,0,0
132954,Heel,0,1
132955,Stick,0,1
132956,",",0,0
132957,LF,0,1
132958,and,0,0
132959,HF,0,0
132960,were,0,0
132961,significantly,0,0
132962,higher,0,0
132963,in,0,0
132964,IC,0,0
132965,than,0,0
132966,in,0,0
132967,KC30,1,0
132968,.,1,0
132969,In,0,0
132970,all,0,0
132971,3,0,0
132972,conditions,0,0
132973,",",0,0
132974,LF/HF,0,0
132975,ratio,0,0
132976,decreased,0,0
132977,from,0,0
132978,Baseline,0,0
132979,to,0,0
132980,Heel,0,1
132981,Stick,0,1
132982,and,0,0
132983,increased,0,0
132984,to,0,0
132985,Recovery,0,1
132986,;,0,0
132987,no,0,0
132988,differences,0,0
132989,were,0,0
132990,found,0,0
132991,between,0,0
132992,IC,1,0
132993,and,0,0
132994,two,0,0
132995,KC,1,0
132996,conditions,0,0
132997,.,0,0
132998,Both,0,0
132999,longer,0,0
133000,and,0,0
133001,shorter,0,0
133002,KC,1,0
133003,before,0,0
133004,and,0,0
133005,throughout,0,0
133006,heel,0,0
133007,stick,0,0
133008,can,0,0
133009,stabilize,0,0
133010,HR,0,0
133011,response,0,0
133012,in,0,0
133013,preterm,0,0
133014,infants,0,0
133015,",",0,0
133016,and,0,0
133017,longer,0,0
133018,KC,1,0
133019,significantly,0,0
133020,affected,0,0
133021,infants,0,0
133022,',0,0
133023,sympathetic,0,0
133024,and,0,0
133025,parasympathetic,0,0
133026,responses,0,0
133027,during,0,0
133028,heel,0,0
133029,stick,0,0
133030,compared,0,0
133031,with,0,0
133032,incubator,1,0
133033,care,1,0
133034,.,1,0
133035,PERSPECTIVE,0,0
133036,This,0,0
133037,study,0,0
133038,showed,0,0
133039,that,0,0
133040,KC,1,0
133041,has,0,0
133042,a,0,0
133043,significant,0,0
133044,effect,0,0
133045,on,0,0
133046,reducing,0,0
133047,autonomic,0,0
133048,pain,0,0
133049,responses,0,0
133050,in,0,0
133051,preterm,0,0
133052,infants,0,0
133053,.,0,0
133054,The,0,0
133055,findings,0,0
133056,support,0,0
133057,that,0,0
133058,KC,1,0
133059,is,0,0
133060,a,0,0
133061,safe,0,0
133062,and,0,0
133063,effective,0,0
133064,pain,0,0
133065,intervention,0,0
133066,in,0,0
133067,the,0,0
133068,neonatal,0,0
133069,intensive,0,0
133070,care,0,0
133071,unit,0,0
133072,.,0,0
133073,Enhancing,0,1
133074,HIV,0,1
133075,medication,0,0
133076,adherence,0,0
133077,in,0,0
133078,India,0,0
133079,.,0,0
133080,BACKGROUND,0,0
133081,This,0,0
133082,pilot,0,0
133083,study,0,0
133084,evaluated,0,0
133085,an,0,0
133086,intervention,0,0
133087,designed,0,0
133088,to,0,0
133089,enhance,0,0
133090,adherence,0,0
133091,among,0,0
133092,those,0,0
133093,new,0,0
133094,to,0,0
133095,antiretroviral,0,1
133096,therapy,0,1
133097,.,0,0
133098,METHODS,0,1
133099,Participants,0,1
133100,(,0,0
133101,n,0,0
133102,=,0,0
133103,80,0,0
133104,),0,0
133105,were,0,0
133106,recruited,0,0
133107,from,0,0
133108,a,0,0
133109,hospital,0,0
133110,clinic,0,0
133111,in,0,0
133112,Chandigarh,0,0
133113,",",0,0
133114,India,0,0
133115,",",0,0
133116,and,0,0
133117,randomized,0,0
133118,to,0,0
133119,a,0,0
133120,3-month,1,0
133121,group,1,0
133122,intervention,1,0
133123,or,1,0
133124,individual,1,0
133125,enhanced,1,0
133126,standard,1,0
133127,of,1,0
133128,care,1,0
133129,followed,1,0
133130,by,1,0
133131,crossover,1,1
133132,of,1,0
133133,condition,1,0
133134,and,1,0
133135,assessed,1,0
133136,over,1,0
133137,6,1,0
133138,months,1,0
133139,.,1,0
133140,Adherence,0,0
133141,was,0,0
133142,measured,0,0
133143,by,0,0
133144,prescription,0,0
133145,refill,0,1
133146,",",0,1
133147,pill,0,1
133148,count,0,1
133149,",",0,0
133150,and,0,0
133151,self-report,0,0
133152,.,0,0
133153,RESULTS,0,0
133154,At,0,1
133155,baseline,0,0
133156,",",0,0
133157,56,0,0
133158,%,0,0
133159,of,0,0
133160,group,0,0
133161,condition,0,1
133162,(,0,1
133163,immediate,0,1
133164,intervention,0,1
133165,),0,0
133166,and,0,0
133167,54,0,0
133168,%,0,0
133169,of,0,0
133170,individual,0,0
133171,condition,0,1
133172,(,0,0
133173,delayed,0,1
133174,intervention,0,1
133175,),0,0
133176,participants,0,0
133177,were,0,0
133178,nonadherent,0,0
133179,by,0,0
133180,pill,0,1
133181,count,0,1
133182,and,0,0
133183,23,0,0
133184,%,0,0
133185,of,0,0
133186,group,0,0
133187,and,0,0
133188,26,0,0
133189,%,0,0
133190,of,0,0
133191,individual,0,0
133192,condition,0,0
133193,participants,0,0
133194,self-reported,0,1
133195,skipping,0,0
133196,medication,0,0
133197,at,0,0
133198,least,0,0
133199,once,0,0
133200,over,0,0
133201,the,0,0
133202,last,0,0
133203,3,0,0
133204,months,0,0
133205,.,0,0
133206,From,0,0
133207,the,0,0
133208,postintervention,0,0
133209,to,0,0
133210,long-term,0,0
133211,follow-up,0,0
133212,",",0,0
133213,adherence,0,0
133214,in,0,0
133215,the,0,0
133216,group,0,0
133217,condition,0,1
133218,(,0,1
133219,immediate,0,1
133220,intervention,0,1
133221,),0,0
133222,improved,0,0
133223,in,0,0
133224,comparison,0,0
133225,with,0,0
133226,adherence,0,0
133227,in,0,0
133228,the,0,0
133229,individual,0,0
133230,condition,0,1
133231,(,0,0
133232,delayed,0,1
133233,intervention,0,1
133234,;,0,1
133235,?,0,1
133236,(,0,1
133237,2,0,0
133238,),0,0
133239,=,0,0
133240,5.67,0,0
133241,",",0,0
133242,P,0,0
133243,=,0,0
133244,.02,0,0
133245,),0,0
133246,.,0,0
133247,CONCLUSIONS,0,0
133248,Results,0,0
133249,support,0,0
133250,the,0,0
133251,use,0,0
133252,of,0,0
133253,interventions,0,0
133254,early,0,0
133255,in,0,0
133256,treatment,0,0
133257,to,0,0
133258,provide,0,0
133259,information,0,0
133260,and,0,0
133261,social,0,0
133262,support,0,0
133263,to,0,0
133264,establish,0,0
133265,long-term,0,0
133266,healthy,0,0
133267,adherence,0,0
133268,behaviors,0,1
133269,.,0,0
133270,Propofol,1,1
133271,sedation,0,1
133272,with,0,0
133273,bispectral,0,0
133274,index,0,0
133275,monitoring,0,0
133276,is,0,0
133277,useful,0,0
133278,for,0,0
133279,endoscopic,0,0
133280,submucosal,1,0
133281,dissection,0,0
133282,:,0,0
133283,a,0,0
133284,randomized,0,0
133285,prospective,0,0
133286,phase,0,0
133287,II,0,1
133288,clinical,0,0
133289,trial,0,0
133290,.,0,0
133291,BACKGROUND,0,0
133292,AND,0,1
133293,STUDY,0,1
133294,AIMS,0,1
133295,Endoscopic,0,1
133296,submucosal,0,1
133297,dissection,0,1
133298,(,0,1
133299,ESD,0,1
133300,),0,0
133301,has,0,0
133302,become,0,0
133303,a,0,0
133304,standard,0,0
133305,treatment,0,0
133306,.,0,0
133307,However,0,0
133308,",",0,0
133309,the,0,0
133310,treatment,0,0
133311,time,0,0
133312,tends,0,0
133313,to,0,0
133314,be,0,0
133315,relatively,0,0
133316,long,0,0
133317,and,0,0
133318,insufflation,0,0
133319,and,0,0
133320,manipulation,0,0
133321,of,0,0
133322,the,0,0
133323,endoscope,0,0
133324,can,0,0
133325,increase,0,0
133326,pain,0,0
133327,and,0,0
133328,discomfort,0,0
133329,.,0,0
133330,We,0,0
133331,aimed,0,0
133332,to,0,0
133333,find,0,0
133334,an,0,0
133335,optimal,0,0
133336,method,0,0
133337,for,0,0
133338,sedation,0,0
133339,during,0,0
133340,ESD,0,0
133341,.,0,0
133342,PATIENTS,0,0
133343,AND,0,0
133344,METHODS,0,1
133345,Patients,0,0
133346,scheduled,0,0
133347,to,0,0
133348,undergo,0,0
133349,ESD,0,0
133350,for,0,0
133351,early,0,0
133352,gastric,0,0
133353,cancer,0,0
133354,or,0,0
133355,adenoma,0,0
133356,were,0,0
133357,randomly,0,0
133358,assigned,0,0
133359,to,0,0
133360,sedation,0,0
133361,with,0,0
133362,midazolam,1,1
133363,or,1,1
133364,propofol,1,1
133365,",",0,1
133366,and,0,0
133367,consciousness,0,0
133368,level,0,0
133369,was,0,0
133370,evaluated,0,0
133371,by,0,0
133372,bispectral,0,0
133373,index,0,1
133374,(,0,1
133375,BIS,0,1
133376,),0,0
133377,monitoring,0,0
133378,.,0,0
133379,Primary,0,0
133380,end,0,0
133381,points,0,0
133382,of,0,0
133383,effectiveness,0,0
133384,(,0,0
133385,three,0,0
133386,parameters,0,0
133387,),0,0
133388,and,0,0
133389,secondary,0,0
133390,end,0,0
133391,points,0,0
133392,of,0,0
133393,safety,0,0
133394,during,0,0
133395,ESD,0,0
133396,and,0,0
133397,after,0,0
133398,return,0,0
133399,to,0,0
133400,the,0,0
133401,ward,0,0
133402,were,0,0
133403,compared,0,0
133404,between,0,0
133405,the,0,0
133406,groups,0,0
133407,.,0,0
133408,Study,0,0
133409,registration,0,0
133410,was,0,0
133411,in,0,0
133412,the,0,0
133413,UMIN,0,0
133414,Clinical,0,0
133415,Trial,0,0
133416,Registry,0,1
133417,(,0,0
133418,UMIN,0,0
133419,000001497,0,0
133420,),0,0
133421,",",0,0
133422,and,0,0
133423,the,0,0
133424,institutional,0,0
133425,trial,0,0
133426,number,0,0
133427,was,0,0
133428,KDOG,0,0
133429,0801,0,0
133430,.,0,0
133431,RESULTS,0,0
133432,From,0,1
133433,June,0,0
133434,2008,0,0
133435,through,0,0
133436,June,0,0
133437,2009,0,0
133438,",",0,0
133439,we,0,0
133440,enrolled,0,0
133441,178,0,0
133442,patients,0,0
133443,(,0,0
133444,90,0,1
133445,midazolam,0,1
133446,",",0,0
133447,88,0,1
133448,propofol,0,1
133449,),0,0
133450,.,0,0
133451,Regarding,0,0
133452,safety,0,0
133453,after,0,0
133454,ESD,0,0
133455,",",0,0
133456,recovery,0,0
133457,was,0,0
133458,significantly,0,0
133459,better,0,0
133460,in,0,0
133461,the,0,0
133462,propofol,0,1
133463,group,0,0
133464,immediately,0,0
133465,after,0,0
133466,and,0,0
133467,at,0,0
133468,1,0,0
133469,hour,0,0
133470,and,0,1
133471,2,0,1
133472,hours,0,0
133473,after,0,0
133474,return,0,0
133475,to,0,0
133476,the,0,0
133477,ward,0,0
133478,(,0,0
133479,P,0,0
133480,<,0,0
133481,0.001,0,0
133482,),0,0
133483,.,0,0
133484,The,0,0
133485,number,0,0
133486,of,0,0
133487,patients,0,0
133488,who,0,0
133489,required,0,0
133490,a,0,0
133491,continuous,0,0
133492,supply,0,0
133493,of,0,0
133494,oxygen,0,0
133495,2,0,0
133496,hours,0,0
133497,after,0,0
133498,returning,0,0
133499,to,0,0
133500,the,0,0
133501,ward,0,0
133502,was,0,0
133503,significantly,0,0
133504,lower,0,0
133505,in,0,0
133506,the,0,0
133507,propofol,0,1
133508,group,0,1
133509,(,0,1
133510,midazolam,0,1
133511,18,0,1
133512,;,0,1
133513,propofol,0,1
133514,6,0,0
133515,;,0,0
133516,P,0,0
133517,=,0,0
133518,0.010,0,0
133519,),0,0
133520,.,0,0
133521,Though,0,1
133522,propofol,0,1
133523,seemed,0,0
133524,to,0,0
133525,be,0,0
133526,better,0,0
133527,for,0,0
133528,effectiveness,0,0
133529,and,0,0
133530,safety,0,0
133531,",",0,0
133532,there,0,0
133533,were,0,0
133534,no,0,0
133535,statistically,0,0
133536,significant,0,0
133537,differences,0,0
133538,for,0,0
133539,all,0,0
133540,three,0,0
133541,primary,0,0
133542,end,0,0
133543,points,0,0
133544,and,0,0
133545,the,0,0
133546,safety,0,0
133547,parameters,0,0
133548,(,0,0
133549,hypotension,0,0
133550,",",0,0
133551,hypoxia,0,0
133552,",",0,0
133553,bradycardia,0,1
133554,),0,0
133555,.,0,0
133556,CONCLUSIONS,0,1
133557,Propofol,1,1
133558,with,0,1
133559,BIS,0,0
133560,monitoring,0,0
133561,improved,0,0
133562,recovery,0,0
133563,of,0,0
133564,patients,0,0
133565,after,0,0
133566,ESD,0,0
133567,",",0,0
133568,though,0,0
133569,this,0,0
133570,study,0,0
133571,was,0,0
133572,underpowered,0,0
133573,to,0,0
133574,prove,0,0
133575,the,0,0
133576,effectiveness,0,0
133577,and,0,0
133578,safety,0,0
133579,of,0,0
133580,propofol,0,1
133581,.,0,0
133582,Tumor,1,0
133583,budding,1,0
133584,is,0,0
133585,an,0,0
133586,independent,0,0
133587,predictor,0,0
133588,of,0,0
133589,outcome,0,0
133590,in,0,0
133591,AJCC/UICC,0,0
133592,stage,0,0
133593,II,0,0
133594,colorectal,0,0
133595,cancer,0,0
133596,.,0,0
133597,BACKGROUND,0,0
133598,In,0,0
133599,colorectal,0,0
133600,cancer,0,0
133601,",",0,0
133602,the,0,0
133603,morphology,0,0
133604,of,0,0
133605,the,0,0
133606,invasive,0,0
133607,tumor,0,0
133608,margin,0,0
133609,may,0,0
133610,reflect,0,0
133611,aggressiveness,0,0
133612,of,0,0
133613,tumor,0,0
133614,growth,0,0
133615,",",0,0
133616,thus,0,0
133617,providing,0,0
133618,important,0,0
133619,prognostic,0,0
133620,information,0,0
133621,.,0,0
133622,The,0,0
133623,tumor,0,0
133624,growth,0,0
133625,pattern,0,0
133626,according,0,0
133627,to,0,0
133628,Jass,0,0
133629,and,0,0
133630,the,0,0
133631,extent,0,0
133632,of,0,0
133633,tumor,1,0
133634,budding,1,0
133635,were,0,0
133636,analyzed,0,0
133637,in,0,0
133638,patients,0,0
133639,with,0,0
133640,American,0,0
133641,Joint,0,0
133642,Committee,0,0
133643,on,0,0
133644,Cancer/Union,0,0
133645,for,0,0
133646,International,0,0
133647,Cancer,0,1
133648,Control,0,0
133649,(,0,1
133650,AJCC/UICC,0,1
133651,),0,1
133652,stage,0,0
133653,II,0,1
133654,disease,0,0
133655,.,0,0
133656,METHODS,0,0
133657,Tumors,0,0
133658,of,0,0
133659,120,0,0
133660,randomly,0,0
133661,selected,0,0
133662,patients,0,0
133663,with,0,0
133664,AJCC/UICC,0,0
133665,stage,0,0
133666,II,0,0
133667,disease,0,0
133668,were,0,0
133669,retrospectively,0,0
133670,reviewed,0,0
133671,for,0,0
133672,tumor,0,0
133673,growth,0,0
133674,pattern,0,0
133675,(,0,0
133676,expanding,0,0
133677,vs.,0,0
133678,infiltrating,0,0
133679,),0,0
133680,and,0,0
133681,the,0,0
133682,extent,0,0
133683,of,0,0
133684,tumor,1,0
133685,budding,1,0
133686,",",0,0
133687,with,0,0
133688,high-grade,0,0
133689,budding,0,0
133690,reflecting,0,0
133691,presence,0,0
133692,of,0,0
133693,10,0,0
133694,or,0,0
133695,more,0,0
133696,budding,0,0
133697,foci,0,0
133698,scattered,0,0
133699,at,0,0
133700,the,0,0
133701,invasive,0,0
133702,tumor,0,0
133703,margin,0,0
133704,.,0,0
133705,Progression-free,0,0
133706,and,0,0
133707,cancer-specific,0,0
133708,survivals,0,0
133709,were,0,0
133710,determined,0,0
133711,by,0,0
133712,the,0,0
133713,Kaplan-Meier,0,0
133714,method,0,0
133715,.,0,0
133716,For,0,0
133717,multivariable,1,0
133718,analysis,1,0
133719,",",0,0
133720,Cox,0,0
133721,'s,0,0
133722,proportional,0,0
133723,hazards,0,0
133724,regression,0,0
133725,models,0,0
133726,were,0,0
133727,performed,0,0
133728,.,0,0
133729,RESULTS,0,0
133730,The,0,0
133731,infiltrating,0,0
133732,growth,0,0
133733,pattern,0,0
133734,was,0,0
133735,significantly,0,0
133736,associated,0,0
133737,with,0,0
133738,histological,0,0
133739,subtype,0,0
133740,and,0,0
133741,lymphovascular,0,0
133742,invasion,0,0
133743,",",0,0
133744,while,0,0
133745,high-grade,0,0
133746,budding,0,0
133747,was,0,0
133748,significantly,0,0
133749,associated,0,0
133750,with,0,0
133751,tumor,0,0
133752,grade,0,0
133753,and,0,0
133754,lymphovascular,0,0
133755,invasion,0,0
133756,.,0,0
133757,High-grade,1,0
133758,budding,1,0
133759,",",0,0
133760,but,0,0
133761,not,0,0
133762,the,0,0
133763,infiltrating,0,0
133764,growth,0,0
133765,pattern,0,0
133766,",",0,0
133767,was,0,0
133768,significantly,0,0
133769,associated,0,0
133770,with,0,0
133771,outcome,0,0
133772,in,0,0
133773,univariable,0,0
133774,analysis,0,0
133775,.,0,0
133776,Cox,0,0
133777,'s,0,0
133778,proportional,0,0
133779,hazards,0,0
133780,regression,0,0
133781,models,0,0
133782,proved,0,0
133783,tumor,1,0
133784,budding,1,0
133785,to,0,0
133786,be,0,0
133787,an,0,0
133788,independent,0,0
133789,predictor,0,0
133790,of,0,0
133791,disease,0,0
133792,progression,0,0
133793,(,0,0
133794,hazard,0,0
133795,ratio,0,0
133796,3.91,0,0
133797,",",0,0
133798,95,0,0
133799,%,0,0
133800,confidence,0,0
133801,interval,0,0
133802,1.3-11.77,0,0
133803,;,0,0
133804,P,0,0
133805,=,0,0
133806,0.02,0,0
133807,),0,0
133808,and,0,0
133809,cancer-related,0,1
133810,death,0,1
133811,(,0,1
133812,hazard,0,0
133813,ratio,0,0
133814,5.90,0,0
133815,",",0,0
133816,95,0,0
133817,%,0,0
133818,confidence,0,0
133819,interval,0,0
133820,1.62-21.51,0,0
133821,;,0,0
133822,P,0,0
133823,=,0,0
133824,0.007,0,0
133825,),0,0
133826,.,0,0
133827,The,0,0
133828,combination,0,0
133829,of,0,0
133830,infiltrating,0,0
133831,growth,0,0
133832,pattern,0,0
133833,and,0,0
133834,high-grade,0,0
133835,budding,0,0
133836,did,0,0
133837,not,0,0
133838,have,0,0
133839,a,0,0
133840,stronger,0,0
133841,prognostic,0,0
133842,significance,1,0
133843,than,1,0
133844,tumor,1,0
133845,budding,1,0
133846,alone,1,0
133847,.,0,0
133848,CONCLUSIONS,0,0
133849,Tumor,0,0
133850,budding,0,0
133851,independently,0,0
133852,predicted,0,0
133853,patient,0,0
133854,outcome,0,0
133855,in,0,0
133856,patients,0,0
133857,with,0,0
133858,AJCC/UICC,0,0
133859,stage,0,0
133860,II,0,0
133861,colorectal,0,0
133862,cancer,0,0
133863,and,0,0
133864,may,0,0
133865,therefore,0,0
133866,be,0,0
133867,used,0,0
133868,for,0,0
133869,accurate,0,0
133870,prognostication,0,0
133871,",",0,0
133872,patient,0,0
133873,counseling,0,0
133874,",",0,0
133875,and,0,0
133876,design,0,0
133877,of,0,0
133878,clinical,0,0
133879,trials,0,0
133880,by,0,0
133881,using,0,0
133882,integrated,1,0
133883,multimodal,1,0
133884,therapy,1,0
133885,.,1,0
133886,Effectiveness,0,0
133887,and,0,0
133888,durability,0,0
133889,of,0,0
133890,Interceptor?,1,0
133891,long-lasting,1,0
133892,insecticidal,1,1
133893,nets,1,0
133894,in,0,0
133895,a,0,0
133896,malaria,0,0
133897,endemic,0,0
133898,area,0,0
133899,of,0,0
133900,central,0,0
133901,India,0,0
133902,.,0,0
133903,BACKGROUND,0,0
133904,In,0,0
133905,the,0,0
133906,present,0,0
133907,study,0,0
133908,",",0,0
133909,Interceptor?,1,0
133910,",",1,0
133911,long-lasting,1,0
133912,polyester,1,0
133913,net,1,0
133914,",",1,0
133915,75,1,0
133916,denier,1,0
133917,and,1,0
133918,bursting,1,0
133919,strength,1,0
133920,of,1,0
133921,minimum,1,0
133922,250,1,0
133923,kPa,1,0
133924,coated,1,0
133925,with,1,1
133926,alpha-cypermethrin,1,1
133927,@,1,1
133928,200,1,1
133929,mg/m?,1,1
133930,was,1,0
133931,evaluated,0,0
133932,for,0,0
133933,its,0,0
133934,efficacy,0,0
133935,in,0,0
133936,reducing,0,0
133937,the,0,0
133938,mosquito,0,0
133939,density,0,0
133940,",",0,0
133941,blood,0,0
133942,feeding,0,0
133943,inhibition,0,0
133944,and,0,0
133945,malaria,0,0
133946,incidence,0,0
133947,in,0,0
133948,a,0,0
133949,tribal,0,0
133950,dominated,0,0
133951,malaria,0,0
133952,endemic,0,0
133953,area,0,0
133954,in,0,0
133955,Chhattisgarh,0,0
133956,state,0,0
133957,",",0,0
133958,central,0,0
133959,India,0,0
133960,.,0,0
133961,Its,0,0
133962,durability,0,0
133963,",",0,0
133964,washing,0,0
133965,practices,0,0
133966,and,0,0
133967,usage,0,0
133968,pattern,0,0
133969,by,0,0
133970,the,0,0
133971,community,0,0
133972,was,0,0
133973,also,0,0
133974,assessed,0,0
133975,up,0,0
133976,to,0,0
133977,a,0,0
133978,period,0,0
133979,of,0,0
133980,three,0,0
133981,years,0,0
133982,.,0,0
133983,METHODS,0,0
133984,The,0,0
133985,study,0,0
133986,was,0,0
133987,carried,0,0
133988,out,0,0
133989,in,0,0
133990,two,0,0
133991,phases,0,0
133992,.,0,0
133993,In,0,0
133994,the,0,0
133995,first,0,0
133996,phase,0,0
133997,(,0,0
133998,September,0,0
133999,2006,0,0
134000,to,0,0
134001,August,0,1
134002,2007,0,1
134003,),0,0
134004,",",0,0
134005,16,0,0
134006,malaria,0,0
134007,endemic,0,0
134008,villages,0,0
134009,in,0,0
134010,district,0,0
134011,Kanker,0,0
134012,were,0,0
134013,randomized,0,0
134014,into,0,0
134015,three,0,0
134016,groups,0,0
134017,",",0,0
134018,viz,0,1
134019,.,1,0
134020,Interceptor,1,0
134021,net,1,0
134022,(,1,1
134023,LN,1,1
134024,),1,1
134025,",",1,0
134026,untreated,1,0
134027,polyester,1,0
134028,net,1,0
134029,(,1,0
134030,100,1,0
134031,denier,1,0
134032,),1,0
134033,and,1,0
134034,without,1,0
134035,net,1,0
134036,.,1,0
134037,Malaria,1,0
134038,cases,0,0
134039,were,0,0
134040,detected,0,0
134041,by,0,0
134042,undertaking,0,0
134043,fortnightly,0,0
134044,surveillance,0,0
134045,by,0,0
134046,home,0,0
134047,visits,0,0
134048,and,0,0
134049,treated,0,0
134050,as,0,0
134051,per,0,0
134052,the,0,0
134053,national,0,1
134054,drug,0,1
134055,policy,0,1
134056,.,0,0
134057,Mosquito,0,0
134058,collections,0,0
134059,were,0,0
134060,made,0,0
134061,by,0,0
134062,hand,0,0
134063,catch,0,0
134064,and,0,0
134065,pyrethrum,0,1
134066,space,0,1
134067,spray,0,1
134068,methods,0,0
134069,from,0,0
134070,human,0,0
134071,dwellings,0,1
134072,once,0,1
134073,every,0,0
134074,month,0,1
134075,.,0,0
134076,Slide,0,0
134077,positivity,0,0
134078,rate,0,0
134079,(,0,0
134080,SPR,0,1
134081,),0,1
134082,and,0,0
134083,malaria,0,1
134084,incidence,0,1
134085,per,0,0
134086,1000,0,0
134087,population,0,0
134088,(,0,1
134089,PI,0,1
134090,),0,0
134091,were,0,0
134092,compared,0,0
134093,between,0,0
134094,the,0,0
134095,three,0,0
134096,study,0,0
134097,arms,0,0
134098,to,0,0
134099,assess,0,0
134100,the,0,0
134101,impact,0,0
134102,of,0,0
134103,use,0,0
134104,of,0,0
134105,Interceptor,0,0
134106,nets,0,0
134107,.,0,0
134108,Simultaneously,0,0
134109,",",0,0
134110,wash,0,0
134111,resistance,0,0
134112,studies,0,0
134113,were,0,0
134114,carried,0,0
134115,out,0,0
134116,in,0,0
134117,the,0,0
134118,laboratory,0,0
134119,by,0,0
134120,doing,0,0
134121,cone,0,0
134122,bioassays,0,0
134123,on,0,0
134124,Interceptor,1,0
134125,LNs,1,0
134126,washed,1,0
134127,up,0,0
134128,to,0,0
134129,20,0,0
134130,times,0,0
134131,.,0,0
134132,Activities,0,0
134133,undertaken,0,0
134134,in,0,0
134135,second,0,0
134136,Phase,0,0
134137,(,0,1
134138,April,0,1
134139,2008,0,1
134140,to,0,0
134141,October,0,1
134142,2009,0,1
134143,),0,0
134144,after,0,0
134145,an,0,0
134146,interval,0,0
134147,of,0,0
134148,about,0,0
134149,18,0,0
134150,months,0,0
134151,post-net,0,0
134152,distribution,0,0
134153,included,0,0
134154,questionnaire,0,0
134155,based,0,0
134156,surveys,0,0
134157,at,0,0
134158,every,0,0
134159,six,0,0
134160,months,0,0
134161,",",0,0
134162,i.e,0,0
134163,.,0,0
134164,18,0,0
134165,",",0,0
134166,24,0,0
134167,",",0,0
134168,30,0,0
134169,and,0,0
134170,36,0,0
134171,months,0,0
134172,to,0,0
134173,observe,0,0
134174,durability,0,0
134175,",",0,0
134176,usage,0,0
134177,pattern,0,0
134178,of,0,0
134179,LNs,0,0
134180,and,0,0
134181,washing,0,0
134182,practices,0,0
134183,by,0,0
134184,the,0,0
134185,community,0,0
134186,.,0,0
134187,After,0,0
134188,36,0,0
134189,months,0,0
134190,of,0,0
134191,field,0,0
134192,use,0,0
134193,",",0,0
134194,30,0,0
134195,nets,0,0
134196,were,0,0
134197,retrieved,0,0
134198,and,0,0
134199,sampled,0,0
134200,destructively,0,0
134201,for,0,0
134202,chemical,0,0
134203,analysis,0,0
134204,.,0,0
134205,RESULTS,1,0
134206,Interceptor,1,0
134207,nets,1,0
134208,were,1,0
134209,found,0,0
134210,effective,0,0
134211,in,0,0
134212,reducing,0,0
134213,the,0,0
134214,density,0,0
134215,",",0,0
134216,parity,0,0
134217,rate,0,0
134218,and,0,0
134219,blood,0,0
134220,feeding,0,0
134221,success,0,0
134222,rate,0,0
134223,of,0,0
134224,main,0,0
134225,malaria,0,0
134226,vector,0,0
134227,Anopheles,0,0
134228,culicifacies,0,0
134229,as,0,0
134230,compared,0,0
134231,to,0,0
134232,that,0,0
134233,in,0,0
134234,untreated,1,0
134235,net,1,0
134236,and,1,0
134237,no,1,0
134238,net,1,0
134239,villages,1,0
134240,.,0,0
134241,SPR,0,0
134242,in,0,0
134243,LN,0,0
134244,villages,0,0
134245,was,0,0
134246,3.7,0,0
134247,%,0,0
134248,as,0,0
134249,compared,0,0
134250,to,0,0
134251,6.5,0,0
134252,%,0,0
134253,in,0,0
134254,untreated,0,0
134255,and,0,0
134256,11,0,0
134257,%,0,0
134258,in,0,0
134259,no,0,0
134260,net,0,0
134261,villages,0,0
134262,.,0,0
134263,PI,0,0
134264,in,0,0
134265,LN,0,0
134266,villages,0,0
134267,was,0,0
134268,16.4,0,0
134269,in,0,0
134270,comparison,0,0
134271,to,0,0
134272,24.8,0,0
134273,and,0,0
134274,44.2,0,0
134275,in,0,0
134276,untreated,0,0
134277,polyester,0,0
134278,net,0,0
134279,and,0,0
134280,no,0,0
134281,net,0,0
134282,villages,0,0
134283,respectively,0,0
134284,.,0,0
134285,In,0,0
134286,surveys,0,0
134287,carried,0,0
134288,out,0,0
134289,after,0,0
134290,three,0,0
134291,years,0,0
134292,of,0,0
134293,initial,0,0
134294,distribution,0,0
134295,",",0,0
134296,78.7,0,0
134297,%,0,0
134298,(,0,0
134299,737/936,0,0
134300,),0,0
134301,nets,0,0
134302,were,0,0
134303,still,0,0
134304,in,0,0
134305,possession,0,0
134306,with,0,0
134307,the,0,0
134308,households,0,0
134309,",",0,0
134310,of,0,0
134311,which,0,0
134312,68,0,0
134313,%,0,0
134314,were,0,0
134315,used,0,0
134316,every,0,0
134317,night,0,1
134318,.,0,1
134319,An,0,1
134320,.,0,0
134321,culicifacies,0,0
134322,mortality,0,0
134323,was,0,0
134324,>,0,0
134325,80,0,0
134326,%,0,0
134327,in,0,0
134328,cone,0,0
134329,bioassays,0,0
134330,done,0,0
134331,on,0,0
134332,LNs,0,0
134333,washed,0,0
134334,up,0,0
134335,to,0,0
134336,20,0,0
134337,times,0,0
134338,in,0,0
134339,laboratory,0,0
134340,.,0,0
134341,Mean,0,0
134342,alpha-cypermethrin,0,1
134343,content,0,0
134344,was,0,0
134345,43.5,0,0
134346,?,0,0
134347,31.7,0,0
134348,mg/m?,0,0
134349,on,0,0
134350,Interceptor,0,1
134351,LNs,0,1
134352,withdrawn,0,0
134353,after,0,0
134354,three,0,0
134355,years,0,0
134356,of,0,0
134357,household,0,0
134358,use,0,0
134359,against,0,0
134360,the,0,0
134361,baseline,0,0
134362,specification,0,0
134363,of,0,0
134364,200,0,0
134365,mg/m?,0,1
134366,.,0,1
134367,A,0,0
134368,gradual,0,0
134369,increase,0,0
134370,in,0,0
134371,the,0,0
134372,proportion,0,0
134373,of,0,0
134374,holed,0,0
134375,nets,0,0
134376,was,0,0
134377,observed,0,0
134378,with,0,0
134379,the,0,0
134380,increased,0,0
134381,period,0,0
134382,of,0,0
134383,usage,0,0
134384,.,0,0
134385,CONCLUSION,1,0
134386,Interceptor,1,0
134387,nets,1,0
134388,were,0,0
134389,highly,0,0
134390,effective,0,0
134391,in,0,0
134392,reducing,0,0
134393,vector,0,0
134394,densities,0,0
134395,as,0,0
134396,well,0,0
134397,as,0,0
134398,malaria,0,0
134399,incidence,0,0
134400,in,0,0
134401,the,0,0
134402,study,0,0
134403,villages,0,0
134404,.,0,0
134405,Availability,0,0
134406,of,0,0
134407,78,0,0
134408,%,0,0
134409,nets,0,0
134410,with,0,0
134411,the,0,0
134412,households,0,0
134413,in,0,0
134414,usable,0,0
134415,condition,0,0
134416,clearly,0,0
134417,indicated,0,0
134418,durability,0,0
134419,of,0,0
134420,Interceptor,0,0
134421,LNs,0,0
134422,up,0,0
134423,to,0,0
134424,three,0,0
134425,years,0,0
134426,in,0,0
134427,the,0,0
134428,rural,0,0
134429,setting,0,0
134430,of,0,0
134431,India,0,0
134432,.,0,0
134433,The,0,0
134434,nets,0,0
134435,were,0,0
134436,found,0,0
134437,to,0,0
134438,contain,0,0
134439,an,0,0
134440,effective,0,0
134441,concentration,0,0
134442,of,0,0
134443,alpha-cypermethrin,0,1
134444,against,0,0
134445,malaria,0,0
134446,vector,0,0
134447,after,0,0
134448,three,0,0
134449,years,0,0
134450,of,0,0
134451,household,0,0
134452,use,0,0
134453,.,0,0
134454,Can,0,1
134455,simvastatin,1,1
134456,improve,0,0
134457,erectile,0,0
134458,function,0,0
134459,and,0,0
134460,health-related,0,0
134461,quality,0,0
134462,of,0,0
134463,life,0,0
134464,in,0,0
134465,men,0,0
134466,aged,0,0
134467,?40,0,0
134468,years,0,0
134469,with,0,0
134470,erectile,0,0
134471,dysfunction,0,0
134472,?,0,0
134473,Results,0,0
134474,of,0,0
134475,the,0,0
134476,Erectile,0,0
134477,Dysfunction,0,0
134478,and,0,0
134479,Statins,0,1
134480,Trial,0,1
134481,[,0,1
134482,ISRCTN66772971,0,1
134483,],0,1
134484,.,0,0
134485,OBJECTIVE,0,0
134486,To,0,0
134487,evaluate,0,0
134488,the,0,0
134489,effectiveness,0,0
134490,and,0,0
134491,cost-effectiveness,0,0
134492,of,0,0
134493,simvastatin,1,1
134494,on,1,0
134495,erectile,0,0
134496,function,0,0
134497,and,0,0
134498,health-related,0,0
134499,quality,0,0
134500,of,0,0
134501,life,0,0
134502,in,0,0
134503,men,0,0
134504,aged,0,0
134505,?40,0,0
134506,years,0,0
134507,with,0,0
134508,erectile,0,0
134509,dysfunction,0,1
134510,(,0,1
134511,ED,0,1
134512,),0,1
134513,.,0,0
134514,PATIENTS,0,0
134515,AND,0,1
134516,METHODS,0,1
134517,ED,0,0
134518,is,0,0
134519,common,0,0
134520,in,0,0
134521,men,0,0
134522,aged,0,0
134523,?40,0,0
134524,years,0,0
134525,and,0,0
134526,impacts,0,0
134527,upon,0,0
134528,their,0,0
134529,overall,0,0
134530,health-related,0,0
134531,quality,0,0
134532,of,0,0
134533,life,0,0
134534,and,0,0
134535,that,0,0
134536,of,0,0
134537,their,0,0
134538,partners,0,0
134539,.,0,0
134540,Men,0,0
134541,aged,0,0
134542,?40,0,0
134543,years,0,0
134544,who,0,0
134545,were,0,0
134546,not,0,0
134547,receiving,0,0
134548,lipid,0,0
134549,lowering,0,0
134550,or,0,0
134551,anti-hypertensive,0,1
134552,medication,0,1
134553,and,0,0
134554,not,0,0
134555,at,0,0
134556,high,0,0
134557,cardiovascular,0,0
134558,risk,0,0
134559,were,0,0
134560,recruited,0,0
134561,from,0,0
134562,10,0,0
134563,general,0,0
134564,practices,0,0
134565,in,0,0
134566,the,0,0
134567,East,0,0
134568,of,0,0
134569,England,0,0
134570,.,0,0
134571,In,0,0
134572,total,0,0
134573,",",0,0
134574,173,0,0
134575,eligible,0,0
134576,men,0,0
134577,with,0,0
134578,untreated,0,0
134579,ED,0,0
134580,were,0,0
134581,randomized,0,0
134582,to,0,0
134583,double-blind,0,1
134584,treatment,1,1
134585,with,1,1
134586,40,1,0
134587,mg,1,1
134588,of,1,1
134589,simvastatin,1,1
134590,or,1,1
134591,placebo,1,1
134592,once,0,1
134593,daily,0,1
134594,for,0,1
134595,6,0,0
134596,months,0,0
134597,.,0,0
134598,Data,0,0
134599,were,0,0
134600,collected,0,0
134601,at,0,0
134602,three,0,0
134603,points,0,0
134604,over,0,0
134605,30,0,0
134606,weeks,0,0
134607,.,0,0
134608,The,0,0
134609,main,0,0
134610,outcome,0,0
134611,was,0,0
134612,erectile,0,0
134613,function,0,0
134614,(,0,0
134615,International,0,0
134616,Index,0,0
134617,of,0,0
134618,Erectile,0,0
134619,Function-5,0,0
134620,score,0,1
134621,),0,0
134622,.,0,0
134623,Secondary,0,0
134624,outcomes,0,0
134625,included,0,0
134626,male,0,0
134627,ED-specific,0,0
134628,quality,0,0
134629,of,0,0
134630,life,0,1
134631,(,0,1
134632,MED-QoL,0,1
134633,),0,1
134634,",",0,0
134635,quality-adjusted,0,1
134636,life,0,1
134637,years,0,1
134638,(,0,1
134639,QALYs,0,1
134640,),0,0
134641,using,0,0
134642,the,0,0
134643,generic,0,0
134644,Euroqol,0,0
134645,measure,0,0
134646,(,0,1
134647,EQ-5D,0,1
134648,),0,1
134649,",",0,0
134650,endothelial,0,0
134651,function,0,0
134652,",",0,0
134653,cardiovascular,0,0
134654,risk,0,1
134655,",",0,0
134656,cholesterol,0,1
134657,and,0,1
134658,health,0,1
134659,service,0,0
134660,costs,0,0
134661,.,0,0
134662,RESULTS,0,0
134663,There,0,0
134664,was,0,0
134665,no,0,0
134666,significant,0,0
134667,difference,0,0
134668,in,0,0
134669,erectile,0,0
134670,function,0,0
134671,between,0,0
134672,the,1,0
134673,simvastatin,1,1
134674,and,1,1
134675,placebo,1,1
134676,groups,0,1
134677,(,0,0
134678,mean,0,0
134679,change,0,0
134680,",",0,0
134681,1.28,0,0
134682,vs,0,0
134683,0.07,0,0
134684,",",0,0
134685,z,0,0
134686,=,0,0
134687,1.1,0,0
134688,",",0,0
134689,p,0,0
134690,=,0,0
134691,0.27,0,0
134692,),0,0
134693,",",0,0
134694,although,0,0
134695,a,0,0
134696,significant,0,0
134697,improvement,0,0
134698,in,0,0
134699,MED-QoL,0,0
134700,was,0,0
134701,observed,0,0
134702,(,0,0
134703,5,0,0
134704,%,0,0
134705,vs,0,0
134706,2,0,0
134707,%,0,0
134708,",",0,0
134709,z,0,0
134710,=,0,0
134711,2.09,0,0
134712,",",0,0
134713,p,0,0
134714,=,0,0
134715,0.04,0,0
134716,),0,0
134717,.,0,0
134718,Both,0,1
134719,10-year,0,0
134720,cardiovascular,0,0
134721,risk,0,0
134722,and,0,0
134723,low-density,0,0
134724,lipoprotein,0,1
134725,were,0,0
134726,reduced,0,0
134727,(,0,0
134728,cardiovascular,0,0
134729,risk,0,1
134730,",",0,0
134731,z,0,0
134732,=,0,0
134733,-3.67,0,0
134734,",",0,0
134735,p,0,0
134736,<,0,0
134737,0.001,0,0
134738,;,0,0
134739,low-density,0,0
134740,lipoprotein,0,1
134741,",",0,0
134742,z,0,0
134743,=,0,0
134744,-5.46,0,0
134745,",",0,0
134746,p,0,0
134747,<,0,0
134748,0.001,0,0
134749,),0,0
134750,",",0,0
134751,with,0,0
134752,no,0,0
134753,consistent,0,0
134754,change,0,0
134755,in,0,0
134756,endothelial,0,0
134757,function,0,0
134758,.,0,0
134759,The,0,0
134760,frequency,0,0
134761,of,0,0
134762,sexual,0,0
134763,encounters,0,0
134764,is,0,0
134765,correlated,0,0
134766,with,0,0
134767,improved,0,0
134768,erectile,0,0
134769,function,0,0
134770,.,0,0
134771,The,0,0
134772,joint,0,0
134773,distribution,0,0
134774,of,0,0
134775,costs,0,0
134776,and,0,0
134777,QALY,0,0
134778,benefits,0,0
134779,indicates,0,0
134780,that,0,0
134781,the,0,0
134782,probability,0,0
134783,of,0,0
134784,simvastatin,0,1
134785,being,0,0
134786,cost-effective,0,0
134787,for,0,0
134788,willingness-to-pay,0,0
134789,thresholds,0,0
134790,of,0,0
134791,"?20,000",0,0
134792,and,0,0
134793,"?30,000",0,0
134794,is,0,0
134795,86,0,0
134796,%,0,0
134797,and,0,0
134798,83,0,0
134799,%,0,0
134800,",",0,0
134801,respectively,0,0
134802,.,0,0
134803,CONCLUSIONS,0,0
134804,Identifying,0,0
134805,men,0,0
134806,with,0,0
134807,ED,0,0
134808,provides,0,0
134809,an,0,0
134810,opportunity,0,0
134811,to,0,0
134812,modify,0,0
134813,future,0,0
134814,cardiovascular,0,0
134815,risk,0,0
134816,and,0,0
134817,to,0,0
134818,improve,0,0
134819,MED-QoL,0,0
134820,by,0,0
134821,treating,0,0
134822,them,0,0
134823,with,0,0
134824,40,0,0
134825,mg,0,1
134826,of,1,1
134827,simvastatin,1,1
134828,.,1,0
134829,The,1,0
134830,joint,1,0
134831,analysis,0,0
134832,of,0,0
134833,costs,0,0
134834,and,0,0
134835,QALY,0,0
134836,benefits,0,0
134837,suggests,0,0
134838,that,0,0
134839,there,0,0
134840,is,0,0
134841,high,0,0
134842,probability,0,0
134843,that,0,0
134844,simvastatin,0,1
134845,is,0,0
134846,a,0,0
134847,cost-effective,0,0
134848,strategy,0,0
134849,in,0,0
134850,men,0,0
134851,with,0,0
134852,ED,0,0
134853,.,0,0
134854,The,0,0
134855,findings,0,0
134856,could,0,0
134857,influence,0,0
134858,urological,0,0
134859,and,0,0
134860,primary,0,0
134861,care,0,0
134862,practice,0,0
134863,by,0,0
134864,including,0,0
134865,questions,0,0
134866,on,0,0
134867,ED,0,0
134868,during,0,0
134869,routine,0,0
134870,consultations,0,0
134871,and,0,0
134872,relevant,0,0
134873,clinical,0,0
134874,protocols,0,0
134875,.,0,0
134876,This,0,0
134877,provides,0,0
134878,an,0,0
134879,opportunity,0,0
134880,to,0,0
134881,impart,0,0
134882,lifestyle,0,0
134883,advice,0,0
134884,.,0,0
134885,Pilot,0,0
134886,randomized,0,0
134887,controlled,0,0
134888,dosing,0,1
134889,study,0,0
134890,of,0,1
134891,cranberry,1,1
134892,capsules,1,1
134893,for,0,0
134894,reduction,0,0
134895,of,0,0
134896,bacteriuria,0,0
134897,plus,0,0
134898,pyuria,0,0
134899,in,0,0
134900,female,0,0
134901,nursing,0,0
134902,home,0,0
134903,residents,0,0
134904,.,0,0
134905,The,0,0
134906,effects,0,0
134907,of,0,0
134908,orthotic,1,0
134909,heel,1,0
134910,lifts,1,0
134911,on,0,0
134912,Achilles,0,0
134913,tendon,0,0
134914,force,0,0
134915,and,0,0
134916,strain,0,0
134917,during,0,0
134918,running,0,0
134919,.,0,0
134920,This,0,0
134921,study,0,0
134922,assessed,0,0
134923,the,0,0
134924,effects,0,0
134925,of,0,0
134926,orthotic,1,0
134927,heel,1,0
134928,lifts,1,0
134929,on,0,0
134930,Achilles,0,0
134931,tendon,0,0
134932,(,0,1
134933,AT,0,1
134934,),0,0
134935,force,0,0
134936,and,0,0
134937,strain,0,0
134938,during,0,0
134939,running,0,0
134940,.,0,0
134941,Ten,0,0
134942,females,0,0
134943,ran,0,0
134944,barefoot,0,0
134945,over,0,0
134946,a,0,0
134947,force,0,0
134948,plate,0,0
134949,in,0,0
134950,three,0,0
134951,conditions,0,0
134952,:,0,0
134953,no,1,0
134954,heel,1,0
134955,lifts,1,1
134956,(,0,1
134957,NHL,0,1
134958,),0,1
134959,",",0,0
134960,with,0,0
134961,12,1,0
134962,mm,1,0
134963,heel,1,1
134964,lifts,1,1
134965,(,0,1
134966,12HL,0,1
134967,),0,0
134968,and,0,0
134969,with,0,0
134970,18,1,0
134971,mm,1,0
134972,heel,1,1
134973,lifts,1,1
134974,(,0,1
134975,18HL,0,1
134976,),0,1
134977,.,0,0
134978,Kinematics,0,0
134979,for,0,0
134980,the,0,0
134981,right,0,0
134982,lower,0,0
134983,limb,0,0
134984,were,0,0
134985,collected,0,0
134986,(,0,0
134987,200,0,0
134988,Hz,0,1
134989,),0,0
134990,.,0,0
134991,AT,0,0
134992,force,0,0
134993,was,0,0
134994,calculated,0,0
134995,from,0,0
134996,inverse,0,0
134997,dynamics,0,0
134998,.,0,0
134999,AT,0,0
135000,strain,0,0
135001,was,0,0
135002,determined,0,0
135003,from,0,0
135004,kinematics,0,0
135005,and,0,0
135006,ultrasound,0,0
135007,images,0,0
135008,of,0,0
135009,medial,0,1
135010,gastrocnemius,0,1
135011,(,0,0
135012,50,0,0
135013,Hz,0,1
135014,),0,0
135015,.,0,0
135016,Peak,0,0
135017,AT,0,0
135018,strain,0,0
135019,was,0,0
135020,less,0,0
135021,for,0,0
135022,18HL,0,1
135023,(,0,0
135024,5.5,0,0
135025,?,0,0
135026,4.4,0,0
135027,%,0,0
135028,),0,0
135029,than,0,0
135030,for,0,0
135031,NHL,0,1
135032,(,0,0
135033,7.4,0,0
135034,?,0,0
135035,4.2,0,0
135036,%,0,0
135037,),0,0
135038,(,0,0
135039,p,0,0
135040,=,0,0
135041,.029,0,0
135042,",",0,0
135043,effect,0,0
135044,size,0,0
135045,[,0,0
135046,ES,0,0
135047,],0,0
135048,=,0,0
135049,0.44,0,0
135050,),0,0
135051,but,0,0
135052,not,0,0
135053,for,0,0
135054,12HL,0,0
135055,(,0,0
135056,5.8,0,0
135057,?,0,0
135058,4.8,0,0
135059,%,0,0
135060,),0,0
135061,versus,0,0
135062,NHL,0,1
135063,(,0,0
135064,ES,0,0
135065,=,0,0
135066,0.35,0,0
135067,),0,0
135068,.,0,0
135069,Peak,0,0
135070,AT,0,0
135071,force,0,0
135072,was,0,0
135073,significantly,0,0
135074,(,0,0
135075,p,0,0
135076,=,0,0
135077,.024,0,0
135078,",",0,0
135079,ES,0,0
135080,=,0,0
135081,0.42,0,0
135082,),0,0
135083,less,0,0
135084,for,0,0
135085,18HL,0,0
135086,(,0,0
135087,2382,0,0
135088,?,0,0
135089,717,0,0
135090,N,0,0
135091,),0,0
135092,than,0,0
135093,for,0,0
135094,NHL,0,1
135095,(,0,0
135096,2710,0,0
135097,?,0,0
135098,830,0,0
135099,N,0,0
135100,),0,0
135101,but,0,0
135102,not,0,0
135103,for,0,0
135104,12HL,0,0
135105,(,0,0
135106,2538,0,0
135107,?,0,0
135108,823,0,0
135109,N,0,0
135110,",",0,0
135111,ES,0,0
135112,=,0,0
135113,0.21,0,0
135114,),0,0
135115,.,0,0
135116,The,0,0
135117,18HL,0,0
135118,reduced,0,0
135119,ankle,0,0
135120,dorsiflexion,0,0
135121,but,0,0
135122,not,0,0
135123,flexion-extension,0,0
135124,ankle,0,0
135125,moments,0,0
135126,and,0,0
135127,increased,0,0
135128,the,0,0
135129,AT,0,0
135130,moment,0,0
135131,arm,0,0
135132,compared,0,0
135133,with,0,0
135134,NHL,0,0
135135,.,0,0
135136,Thus,0,0
135137,",",0,0
135138,18HL,0,0
135139,reduced,0,0
135140,force,0,0
135141,and,0,0
135142,strain,0,0
135143,on,0,0
135144,the,0,0
135145,AT,0,0
135146,during,0,0
135147,running,0,0
135148,via,0,0
135149,a,0,0
135150,reduction,0,0
135151,in,0,0
135152,dorsiflexion,0,0
135153,",",0,0
135154,which,0,0
135155,lengthened,0,0
135156,the,0,0
135157,AT,0,0
135158,moment,0,0
135159,arm,0,0
135160,.,0,0
135161,Therefore,1,0
135162,",",1,0
135163,heel,1,0
135164,lifts,1,0
135165,could,0,0
135166,be,0,0
135167,used,0,0
135168,to,0,0
135169,reduce,0,0
135170,AT,0,0
135171,loading,0,0
135172,and,0,0
135173,strain,0,0
135174,during,0,0
135175,the,0,0
135176,rehabilitation,0,0
135177,of,0,0
135178,AT,0,0
135179,injuries,0,0
135180,.,0,0
135181,A,0,1
135182,randomized,0,1
135183,double-blind,0,1
135184,study,0,0
135185,of,0,0
135186,atomoxetine,1,1
135187,versus,0,1
135188,placebo,1,1
135189,for,0,1
135190,attention-deficit/hyperactivity,0,1
135191,disorder,0,0
135192,symptoms,0,0
135193,in,0,0
135194,children,0,0
135195,with,0,0
135196,autism,0,0
135197,spectrum,0,0
135198,disorder,0,0
135199,.,0,0
135200,OBJECTIVE,0,0
135201,The,0,0
135202,efficacy,0,0
135203,of,0,0
135204,atomoxetine,1,1
135205,as,0,0
135206,treatment,0,0
135207,of,0,0
135208,symptoms,0,0
135209,of,0,0
135210,attention-deficit/hyperactivity,0,1
135211,disorder,0,1
135212,(,0,1
135213,ADHD,0,1
135214,),0,0
135215,in,0,0
135216,patients,0,0
135217,with,0,0
135218,autism,0,0
135219,spectrum,0,0
135220,disorder,0,1
135221,(,0,1
135222,ASD,0,1
135223,),0,0
135224,has,0,0
135225,not,0,0
135226,been,0,0
135227,established,0,0
135228,.,0,0
135229,METHOD,0,0
135230,In,0,0
135231,this,0,0
135232,study,0,0
135233,",",0,0
135234,97,0,0
135235,patients,0,0
135236,aged,0,0
135237,6,0,0
135238,to,0,0
135239,17,0,0
135240,years,0,0
135241,with,0,0
135242,ADHD,0,0
135243,and,0,0
135244,ASD,0,0
135245,were,0,0
135246,randomly,0,0
135247,assigned,0,0
135248,to,0,0
135249,double-blind,0,1
135250,treatment,0,1
135251,with,0,1
135252,1.2,0,0
135253,mg/kg/day,0,1
135254,atomoxetine,1,1
135255,or,1,1
135256,placebo,1,1
135257,for,0,0
135258,8,0,0
135259,weeks,0,0
135260,.,0,0
135261,The,0,0
135262,primary,0,0
135263,endpoint,0,0
135264,was,0,0
135265,the,0,0
135266,ADHD,0,0
135267,Rating,0,0
135268,Scale,0,1
135269,(,0,1
135270,ADHD-RS,0,1
135271,),0,1
135272,score,0,1
135273,;,0,0
135274,secondary,0,0
135275,endpoints,0,0
135276,were,0,0
135277,the,0,0
135278,Clinical,0,0
135279,Global,0,0
135280,Impression,0,0
135281,of,0,0
135282,ADHD-Improvement,0,1
135283,(,0,1
135284,CGI-I,0,1
135285,),0,1
135286,and,0,0
135287,the,0,0
135288,Conners,0,0
135289,Teacher,0,0
135290,Rating,0,0
135291,Scale-Revised,0,0
135292,:,0,0
135293,Short,0,0
135294,Form,0,1
135295,(,0,0
135296,CTRS-R,0,1
135297,:,0,1
135298,S,0,1
135299,),0,0
135300,score,0,0
135301,.,0,0
135302,RESULTS,0,0
135303,Baseline,0,0
135304,mean,0,0
135305,ADHD-RS,0,0
135306,scores,0,0
135307,for,0,0
135308,atomoxetine,1,1
135309,versus,0,1
135310,placebo,1,1
135311,were,0,0
135312,40.7,0,0
135313,and,0,0
135314,38.6,0,0
135315,;,0,0
135316,after,0,0
135317,8,0,0
135318,weeks,0,0
135319,",",0,0
135320,mixed-effect,0,0
135321,model,0,0
135322,repeated-measure,0,0
135323,means,0,0
135324,were,0,0
135325,31.6,0,0
135326,(,0,0
135327,95,0,0
135328,%,0,0
135329,confidence,0,0
135330,interval,0,0
135331,29.2-33.9,0,0
135332,),0,0
135333,and,0,0
135334,38.3,0,0
135335,(,0,0
135336,36.0-40.6,0,0
135337,),0,0
135338,",",0,0
135339,respectively,0,0
135340,",",0,0
135341,with,0,0
135342,a,0,0
135343,difference,0,0
135344,in,0,0
135345,least,0,0
135346,square,0,0
135347,means,0,0
135348,of,0,0
135349,-6.7,0,0
135350,(,0,0
135351,-10.0,0,0
135352,to,0,0
135353,-3.4,0,0
135354,;,0,0
135355,p,0,0
135356,<,0,0
135357,.001,0,0
135358,),0,0
135359,.,0,0
135360,The,0,0
135361,CTRS-R,0,0
135362,:,0,0
135363,S,0,0
135364,Hyperactivity,0,0
135365,subscore,0,0
135366,also,0,0
135367,improved,0,0
135368,significantly,0,0
135369,for,0,0
135370,atomoxetine,1,1
135371,compared,0,0
135372,with,0,0
135373,placebo,1,1
135374,",",0,0
135375,but,0,0
135376,not,0,0
135377,the,0,0
135378,other,0,0
135379,CTRS-R,0,0
135380,:,0,0
135381,S,0,0
135382,subscores,0,0
135383,.,0,0
135384,However,0,0
135385,",",0,0
135386,there,0,0
135387,were,0,0
135388,not,0,0
135389,significantly,0,0
135390,more,0,0
135391,patients,0,0
135392,on,0,0
135393,atomoxetine,1,1
135394,(,0,0
135395,20.9,0,0
135396,%,0,0
135397,),0,0
135398,who,0,0
135399,improved,0,0
135400,much,0,0
135401,",",0,0
135402,or,0,0
135403,very,0,0
135404,much,0,0
135405,according,0,0
135406,to,0,0
135407,the,0,0
135408,CGI-I,0,0
135409,",",0,0
135410,than,0,0
135411,on,0,0
135412,placebo,1,1
135413,(,0,0
135414,8.7,0,0
135415,%,0,0
135416,;,0,0
135417,p,0,0
135418,=,0,0
135419,0.14,0,0
135420,),0,0
135421,.,0,0
135422,Adverse,0,0
135423,events,0,0
135424,(,0,0
135425,mostly,0,0
135426,nausea,0,1
135427,",",0,0
135428,decrease,0,0
135429,in,0,0
135430,appetite,0,1
135431,",",0,1
135432,fatigue,0,1
135433,",",0,0
135434,and,0,0
135435,early,0,0
135436,morning,0,1
135437,awakening,0,0
135438,),0,0
135439,were,0,0
135440,reported,0,0
135441,in,0,0
135442,81.3,0,0
135443,%,0,0
135444,of,0,0
135445,atomoxetine,1,0
135446,patients,0,0
135447,and,0,0
135448,65.3,0,0
135449,%,0,0
135450,of,0,0
135451,placebo,1,1
135452,patients,0,0
135453,(,0,0
135454,p,0,0
135455,>,0,0
135456,.1,0,0
135457,),0,0
135458,.,0,0
135459,There,0,0
135460,were,0,0
135461,no,0,0
135462,serious,0,0
135463,adverse,0,0
135464,events,0,0
135465,.,0,0
135466,CONCLUSIONS,0,0
135467,Atomoxetine,1,1
135468,moderately,0,0
135469,improved,0,0
135470,ADHD,0,0
135471,symptoms,0,0
135472,in,0,0
135473,patients,0,0
135474,with,0,0
135475,ASD,0,0
135476,and,0,0
135477,was,0,0
135478,generally,0,0
135479,well,0,0
135480,tolerated,0,1
135481,.,0,0
135482,Adverse,0,0
135483,events,0,0
135484,in,0,0
135485,this,0,0
135486,study,0,0
135487,were,0,0
135488,similar,0,0
135489,to,0,0
135490,those,0,0
135491,in,0,0
135492,other,0,0
135493,studies,0,0
135494,with,0,0
135495,ADHD,0,0
135496,patients,0,0
135497,without,0,0
135498,ASD,0,0
135499,.,0,0
135500,Clinical,0,0
135501,trial,0,0
135502,registration,0,0
135503,information-A,0,0
135504,Randomized,0,0
135505,Double-Blind,0,0
135506,Study,0,1
135507,of,0,0
135508,Atomoxetine,1,1
135509,Versus,0,1
135510,Placebo,1,1
135511,for,0,1
135512,ADHD,0,1
135513,Symptoms,0,0
135514,in,0,0
135515,Children,0,0
135516,with,0,0
135517,ASD,0,1
135518,;,0,1
135519,www.clinicaltrials.gov,0,1
135520,;,0,1
135521,NCT00380692,0,0
135522,.,0,0
135523,Effect,0,0
135524,of,0,0
135525,chelation,1,1
135526,therapy,1,1
135527,on,0,0
135528,progressive,0,0
135529,diabetic,0,0
135530,nephropathy,0,0
135531,in,0,0
135532,patients,0,0
135533,with,0,0
135534,type,0,0
135535,2,0,0
135536,diabetes,0,0
135537,and,0,0
135538,high-normal,0,0
135539,body,0,0
135540,lead,0,0
135541,burdens,0,0
135542,.,0,0
135543,BACKGROUND,0,0
135544,A,0,0
135545,previous,0,0
135546,study,0,0
135547,in,0,0
135548,type,0,0
135549,2,0,0
135550,diabetic,0,0
135551,patients,0,0
135552,with,0,0
135553,high-normal,0,0
135554,body,0,0
135555,lead,0,0
135556,burdens,0,0
135557,showed,0,0
135558,that,0,0
135559,EDTA,1,1
135560,chelation,1,1
135561,therapy,1,1
135562,for,0,0
135563,3,0,0
135564,months,0,0
135565,slows,0,0
135566,progressive,0,0
135567,diabetic,0,0
135568,nephropathy,0,0
135569,during,0,0
135570,a,0,0
135571,12-month,0,0
135572,follow-up,0,0
135573,.,0,0
135574,The,0,0
135575,effect,0,0
135576,of,0,0
135577,a,0,0
135578,longer,0,0
135579,course,0,0
135580,of,0,0
135581,therapy,0,0
135582,on,0,0
135583,kidney,0,0
135584,function,0,0
135585,decrease,0,0
135586,over,0,0
135587,a,0,0
135588,longer,0,0
135589,follow-up,0,0
135590,is,0,0
135591,not,0,0
135592,known,0,0
135593,.,0,0
135594,STUDY,0,0
135595,DESIGN,0,1
135596,A,0,1
135597,12-month,0,1
135598,run-in,0,1
135599,phase,0,0
135600,",",0,0
135601,then,0,0
135602,a,0,0
135603,randomized,0,0
135604,single-blind,0,1
135605,study,0,0
135606,with,0,0
135607,a,0,0
135608,27-month,0,0
135609,intervention,0,0
135610,.,0,0
135611,SETTING,0,0
135612,&,0,1
135613,PARTICIPANTS,0,1
135614,University,0,0
135615,medical,0,1
135616,center,0,0
135617,;,0,0
135618,50,0,0
135619,patients,0,0
135620,(,0,1
135621,serum,0,1
135622,creatinine,0,1
135623,",",0,0
135624,1.5-3.9,0,0
135625,mg/dL,0,1
135626,),0,0
135627,with,0,1
135628,high-normal,0,0
135629,body,0,0
135630,lead,0,0
135631,burden,0,1
135632,(,0,0
135633,?80-,0,0
135634,<,0,0
135635,600,0,0
135636,?g,0,0
135637,),0,0
135638,were,0,0
135639,randomly,0,0
135640,assigned,0,0
135641,to,0,0
135642,the,0,0
135643,treatment,1,0
135644,and,1,0
135645,control,1,0
135646,groups,1,0
135647,.,1,0
135648,INTERVENTION,1,0
135649,The,0,0
135650,treatment,0,0
135651,group,0,0
135652,received,0,0
135653,weekly,1,1
135654,chelation,1,1
135655,therapy,1,1
135656,for,1,0
135657,3,0,0
135658,months,0,0
135659,to,0,0
135660,reduce,0,0
135661,their,0,0
135662,body,0,0
135663,lead,0,0
135664,burden,0,0
135665,to,0,0
135666,<,0,0
135667,60,0,0
135668,?g,0,0
135669,and,0,0
135670,then,0,0
135671,as,0,0
135672,needed,0,0
135673,for,0,0
135674,24,0,0
135675,months,0,0
135676,to,0,0
135677,maintain,0,0
135678,this,0,0
135679,level,0,0
135680,.,0,0
135681,The,0,0
135682,control,0,0
135683,group,0,0
135684,received,1,0
135685,placebo,1,1
135686,for,1,0
135687,3,0,0
135688,months,0,0
135689,and,0,0
135690,then,0,0
135691,weekly,0,0
135692,for,0,0
135693,5,0,0
135694,weeks,0,0
135695,at,0,0
135696,6-month,0,0
135697,intervals,0,0
135698,for,0,0
135699,24,0,0
135700,months,0,0
135701,.,0,0
135702,OUTCOMES,0,0
135703,The,0,0
135704,primary,0,0
135705,end,0,0
135706,point,0,0
135707,was,0,0
135708,change,0,0
135709,in,0,0
135710,estimated,0,0
135711,glomerular,0,0
135712,filtration,0,0
135713,rate,0,0
135714,(,0,1
135715,eGFR,0,1
135716,),0,1
135717,over,0,0
135718,time,0,0
135719,.,0,0
135720,A,0,0
135721,secondary,0,0
135722,end,0,0
135723,point,0,0
135724,was,0,0
135725,a,0,0
135726,2-fold,0,0
135727,increase,0,0
135728,in,0,0
135729,baseline,0,1
135730,serum,0,1
135731,creatinine,0,1
135732,level,0,1
135733,or,0,0
135734,the,0,0
135735,requirement,0,0
135736,for,0,0
135737,renal,0,0
135738,replacement,0,0
135739,therapy,0,0
135740,.,0,0
135741,MEASUREMENTS,0,0
135742,Body,0,0
135743,lead,0,0
135744,burdens,0,0
135745,were,0,0
135746,assessed,0,0
135747,by,0,0
135748,EDTA,0,0
135749,mobilization,0,0
135750,tests,0,0
135751,and,0,0
135752,eGFR,0,0
135753,was,0,0
135754,calculated,0,0
135755,using,0,0
135756,the,0,0
135757,equation,0,0
135758,for,0,0
135759,Chinese,0,0
135760,patients,0,0
135761,with,0,0
135762,type,0,0
135763,2,0,0
135764,diabetes,0,0
135765,.,0,0
135766,RESULTS,0,0
135767,Mean,0,0
135768,baseline,0,0
135769,eGFRs,0,0
135770,in,0,0
135771,the,0,0
135772,treatment,0,0
135773,and,0,0
135774,control,0,0
135775,groups,0,0
135776,were,0,0
135777,similar,0,0
135778,.,0,0
135779,After,0,0
135780,3,0,0
135781,months,0,0
135782,of,0,0
135783,chelation,0,1
135784,therapy,0,1
135785,",",0,0
135786,the,0,0
135787,change,0,0
135788,in,0,0
135789,eGFR,0,0
135790,in,0,0
135791,the,0,0
135792,treatment,0,0
135793,group,0,0
135794,(,0,0
135795,+1.0,0,0
135796,?,0,0
135797,4.8,0,0
135798,mL/min/1.73,0,0
135799,m,0,0
135800,(,0,0
135801,2,0,1
135802,),0,1
135803,),0,0
135804,differed,0,0
135805,significantly,0,0
135806,from,0,0
135807,that,0,0
135808,in,0,0
135809,the,0,0
135810,control,0,0
135811,group,0,0
135812,(,0,0
135813,-1.5,0,0
135814,?,0,0
135815,4.8,0,0
135816,mL/min/1.73,0,0
135817,m,0,0
135818,(,0,0
135819,2,0,1
135820,),0,0
135821,;,0,0
135822,P,0,0
135823,=,0,0
135824,0.04,0,0
135825,),0,0
135826,.,0,0
135827,In,0,0
135828,the,0,0
135829,subsequent,0,0
135830,24-month,0,0
135831,intervention,0,0
135832,",",0,0
135833,the,0,0
135834,yearly,0,0
135835,rate,0,0
135836,of,0,0
135837,decrease,0,0
135838,in,0,0
135839,eGFR,0,0
135840,(,0,0
135841,5.6,0,0
135842,?,0,0
135843,5.0,0,0
135844,mL/min/1.73,0,0
135845,m,0,0
135846,(,0,0
135847,2,0,1
135848,),0,0
135849,per,0,1
135850,year,0,1
135851,),0,0
135852,in,0,0
135853,the,0,0
135854,treatment,0,0
135855,group,0,0
135856,was,0,0
135857,slower,0,0
135858,than,0,0
135859,that,0,0
135860,(,0,0
135861,9.2,0,0
135862,?,0,0
135863,3.6,0,0
135864,mL/min/1.73,0,0
135865,m,0,0
135866,(,0,0
135867,2,0,1
135868,),0,0
135869,per,0,1
135870,year,0,0
135871,;,0,0
135872,P,0,0
135873,=,0,0
135874,0.04,0,0
135875,),0,0
135876,in,0,0
135877,the,0,0
135878,control,0,0
135879,group,0,0
135880,.,0,0
135881,17,0,0
135882,(,0,0
135883,68,0,0
135884,%,0,0
135885,),0,0
135886,control-group,0,0
135887,patients,0,0
135888,and,0,0
135889,9,0,0
135890,(,0,0
135891,36,0,0
135892,%,0,0
135893,),0,0
135894,treatment-group,0,0
135895,patients,0,0
135896,achieved,0,0
135897,the,0,0
135898,secondary,0,0
135899,end,0,0
135900,point,0,0
135901,.,0,0
135902,LIMITATIONS,0,0
135903,Small,0,0
135904,sample,0,0
135905,size,0,0
135906,",",0,0
135907,not,0,0
135908,double,0,0
135909,blind,0,0
135910,.,0,0
135911,CONCLUSIONS,0,0
135912,A,0,1
135913,27-month,0,0
135914,course,0,0
135915,of,0,0
135916,EDTA,0,1
135917,chelation,0,1
135918,therapy,0,1
135919,retards,0,0
135920,the,0,0
135921,progression,0,0
135922,of,0,0
135923,diabetic,0,0
135924,nephropathy,0,0
135925,in,0,0
135926,type,0,0
135927,2,0,0
135928,diabetic,0,0
135929,patients,0,0
135930,with,0,0
135931,high-normal,0,0
135932,body,0,0
135933,lead,0,0
135934,burdens,0,0
135935,.,0,0
135936,Rosiglitazone,1,1
135937,and,0,1
135938,cognitive,0,0
135939,function,0,0
135940,in,0,0
135941,clozapine-treated,1,0
135942,patients,0,0
135943,with,0,0
135944,schizophrenia,0,0
135945,:,0,0
135946,a,0,0
135947,pilot,0,0
135948,study,0,0
135949,.,0,0
135950,Studies,0,0
135951,have,0,0
135952,shown,0,0
135953,that,0,0
135954,insulin,0,1
135955,resistance,0,0
135956,is,0,0
135957,associated,0,0
135958,with,0,0
135959,cognitive,0,0
135960,impairment,0,0
135961,.,0,1
135962,Peroxisome,1,1
135963,proliferator-activated,1,1
135964,receptor-?,1,1
135965,(,1,1
135966,PPAR-?,1,1
135967,),1,1
135968,agonists,1,1
135969,improve,0,1
135970,insulin,0,1
135971,sensitivity,0,0
135972,.,0,0
135973,The,0,0
135974,purpose,0,0
135975,of,0,0
135976,this,0,0
135977,study,0,0
135978,was,0,0
135979,to,0,0
135980,evaluate,0,0
135981,the,0,0
135982,effect,0,0
135983,of,0,0
135984,rosiglitazone,1,1
135985,",",1,0
135986,a,0,0
135987,PPAR-?,0,1
135988,agonist,0,1
135989,",",0,1
135990,on,0,0
135991,cognition,0,0
135992,in,0,0
135993,clozapine-treated,0,0
135994,patients,0,0
135995,with,0,0
135996,schizophrenia,0,0
135997,.,0,0
135998,In,0,0
135999,an,0,0
136000,eight-week,0,1
136001,double-blind,0,1
136002,",",0,1
136003,placebo-controlled,0,1
136004,pilot,0,1
136005,trial,0,1
136006,",",0,0
136007,clozapine-treated,0,0
136008,patients,0,0
136009,with,0,0
136010,schizophrenia,0,0
136011,were,0,0
136012,randomized,0,0
136013,to,0,0
136014,receive,1,1
136015,rosiglitazone,1,1
136016,(,1,1
136017,4mg/day,1,1
136018,),1,1
136019,or,1,1
136020,placebo,1,1
136021,.,1,1
136022,A,1,1
136023,neuropsychological,0,0
136024,battery,0,0
136025,including,0,0
136026,the,0,0
136027,Digit,0,0
136028,Span,0,0
136029,subtest,0,0
136030,from,0,0
136031,the,0,0
136032,Wechsler,0,0
136033,Adult,0,1
136034,Intelligence,0,1
136035,Scale-III,0,1
136036,(,0,1
136037,WAIS-III,1,1
136038,),1,1
136039,",",1,0
136040,the,1,0
136041,verbal,1,0
136042,fluency,1,0
136043,test,1,0
136044,",",1,0
136045,the,1,0
136046,Hopkins,1,0
136047,Verbal,1,0
136048,Learning,1,1
136049,Test,1,1
136050,(,1,1
136051,HVLT,1,1
136052,),1,1
136053,",",1,0
136054,the,1,0
136055,Trail-Making,1,1
136056,Test,1,1
136057,(,1,1
136058,TMT,1,1
136059,),1,1
136060,and,1,0
136061,the,1,0
136062,Wisconsin,1,0
136063,Card,1,0
136064,Sorting,1,0
136065,Test,1,1
136066,(,1,1
136067,WCST,1,1
136068,),1,1
136069,was,1,0
136070,administered,0,1
136071,at,0,1
136072,baseline,0,0
136073,and,0,0
136074,week,0,0
136075,eight,0,0
136076,.,0,0
136077,Nineteen,0,0
136078,patients,0,0
136079,completed,0,0
136080,the,0,0
136081,study,0,0
136082,.,0,0
136083,There,0,0
136084,were,0,0
136085,no,0,0
136086,significant,0,0
136087,differences,0,0
136088,on,0,0
136089,any,0,0
136090,demographic,0,0
136091,or,0,0
136092,general,0,0
136093,clinical,0,0
136094,variables,0,0
136095,between,0,0
136096,the,0,0
136097,rosiglitazone,1,1
136098,group,1,1
136099,(,0,0
136100,n=9,0,0
136101,),0,0
136102,and,0,0
136103,the,0,0
136104,placebo,1,1
136105,group,1,1
136106,(,0,0
136107,n=10,0,0
136108,),0,0
136109,.,0,0
136110,When,0,0
136111,baseline,0,0
136112,scores,0,0
136113,were,0,0
136114,controlled,0,0
136115,",",0,0
136116,there,0,0
136117,were,0,0
136118,no,0,0
136119,significant,0,0
136120,differences,0,0
136121,in,0,0
136122,change,0,0
136123,scores,0,0
136124,of,0,0
136125,cognitive,0,0
136126,performance,0,0
136127,over,0,0
136128,eight,0,0
136129,weeks,0,0
136130,between,0,0
136131,the,0,0
136132,two,0,0
136133,groups,0,0
136134,.,0,0
136135,In,0,0
136136,this,0,0
136137,pilot,0,0
136138,study,1,0
136139,",",1,0
136140,rosiglitazone,1,1
136141,had,1,0
136142,no,0,0
136143,cognitive,0,0
136144,benefit,0,0
136145,in,0,0
136146,clozapine-treated,0,0
136147,patients,0,0
136148,with,0,0
136149,schizophrenia,0,0
136150,.,0,0
136151,Future,0,0
136152,studies,0,0
136153,with,0,0
136154,longer,0,0
136155,treatment,0,0
136156,duration,0,0
136157,and,0,0
136158,larger,0,0
136159,sample,0,0
136160,size,0,0
136161,are,0,0
136162,needed,0,0
136163,to,0,0
136164,further,0,0
136165,explore,0,0
136166,the,0,0
136167,potential,0,0
136168,role,0,0
136169,of,0,0
136170,rosiglitazone,1,1
136171,in,1,0
136172,improving,0,0
136173,cognitive,0,0
136174,function,0,0
136175,in,0,0
136176,patients,0,0
136177,with,0,0
136178,schizophrenia,0,0
136179,.,0,0
136180,Phase,0,0
136181,II,0,0
136182,trial,0,0
136183,of,0,0
136184,nab-paclitaxel,0,1
136185,compared,0,0
136186,with,0,0
136187,docetaxel,1,1
136188,as,0,0
136189,first-line,0,1
136190,chemotherapy,0,0
136191,in,0,0
136192,patients,0,0
136193,with,0,0
136194,metastatic,0,0
136195,breast,0,0
136196,cancer,0,0
136197,:,0,0
136198,final,0,0
136199,analysis,0,0
136200,of,0,0
136201,overall,0,0
136202,survival,0,0
136203,.,0,0
136204,BACKGROUND,0,0
136205,A,0,1
136206,randomized,0,0
136207,phase,0,0
136208,II,0,0
136209,study,0,0
136210,in,0,0
136211,first-line,0,0
136212,MBC,0,0
136213,demonstrated,0,0
136214,superior,0,0
136215,efficacy,0,0
136216,and,0,0
136217,safety,0,0
136218,of,0,0
136219,weekly,0,0
136220,nab-paclitaxel,0,1
136221,compared,0,1
136222,with,0,0
136223,docetaxel,1,1
136224,.,1,0
136225,Final,0,0
136226,survival,0,0
136227,analyses,0,0
136228,and,0,0
136229,updated,0,0
136230,safety,0,0
136231,results,0,0
136232,are,0,0
136233,reported,0,0
136234,.,0,0
136235,PATIENTS,0,0
136236,AND,0,1
136237,METHODS,0,0
136238,Three,0,0
136239,hundred,0,0
136240,two,0,0
136241,patients,0,0
136242,with,0,0
136243,no,0,0
136244,previous,0,0
136245,chemotherapy,0,0
136246,for,0,0
136247,MBC,0,0
136248,were,0,0
136249,randomized,1,0
136250,to,1,0
136251,receive,1,1
136252,nab-paclitaxel,1,1
136253,300,1,1
136254,mg/m,1,1
136255,(,1,1
136256,2,1,1
136257,),1,1
136258,q3w,1,1
136259,",",1,1
136260,nab-paclitaxel,1,1
136261,100,1,1
136262,mg/m,1,1
136263,(,1,1
136264,2,1,1
136265,),1,0
136266,or,1,0
136267,150,1,1
136268,mg/m,1,1
136269,(,1,1
136270,2,1,1
136271,),1,0
136272,the,1,0
136273,first,1,0
136274,3,1,0
136275,of,1,0
136276,4,1,0
136277,weeks,1,0
136278,(,1,1
136279,qw,1,1
136280,3/4,1,1
136281,),1,1
136282,",",1,0
136283,or,1,1
136284,docetaxel,1,1
136285,100,1,1
136286,mg/m,1,1
136287,(,1,1
136288,2,1,1
136289,),1,1
136290,q3w,1,1
136291,.,1,1
136292,The,0,0
136293,trial,0,0
136294,was,0,0
136295,powered,0,0
136296,for,0,0
136297,analyses,0,0
136298,of,0,0
136299,antitumor,0,1
136300,activity,0,0
136301,and,0,0
136302,safety,0,0
136303,.,0,0
136304,RESULTS,0,0
136305,Treatment,0,1
136306,with,0,1
136307,nab-paclitaxel,0,1
136308,150,0,1
136309,mg/m,0,1
136310,(,0,1
136311,2,0,1
136312,),0,1
136313,qw,0,1
136314,3/4,0,1
136315,resulted,0,0
136316,in,0,0
136317,a,0,0
136318,median,0,0
136319,overall,0,0
136320,survival,0,0
136321,(,0,1
136322,OS,0,1
136323,),0,0
136324,of,0,0
136325,33.8,0,0
136326,months,0,0
136327,compared,0,0
136328,with,0,0
136329,22.2,0,0
136330,",",0,0
136331,27.7,0,0
136332,",",0,0
136333,and,0,0
136334,26.6,0,0
136335,months,0,0
136336,for,0,0
136337,nab-paclitaxel,0,1
136338,100,0,1
136339,mg/m,0,1
136340,(,0,1
136341,2,0,1
136342,),0,1
136343,qw,0,1
136344,3/4,0,1
136345,",",0,1
136346,nab-paclitaxel,0,1
136347,300,0,1
136348,mg/m,0,1
136349,(,0,1
136350,2,0,1
136351,),0,1
136352,q3w,0,1
136353,",",0,1
136354,and,0,1
136355,docetaxel,1,1
136356,",",0,0
136357,respectively,0,0
136358,(,0,0
136359,overall,0,0
136360,P,0,0
136361,=,0,0
136362,.047,0,0
136363,),0,0
136364,.,0,0
136365,Patients,0,0
136366,receiving,0,0
136367,150,0,1
136368,mg/m,0,1
136369,(,0,1
136370,2,0,1
136371,),0,1
136372,nab-paclitaxel,0,1
136373,had,0,0
136374,prolonged,0,0
136375,median,0,0
136376,OS,0,0
136377,compared,0,0
136378,with,0,0
136379,those,0,0
136380,in,0,0
136381,the,0,0
136382,100,0,1
136383,mg/m,0,1
136384,(,0,1
136385,2,0,1
136386,),0,1
136387,nab-paclitaxel,0,1
136388,arm,0,1
136389,(,0,1
136390,hazard,0,1
136391,ratio,0,0
136392,",",0,0
136393,0.575,0,0
136394,;,0,0
136395,P,0,0
136396,=,0,0
136397,.008,0,0
136398,),0,0
136399,.,0,0
136400,A,0,1
136401,trend,0,0
136402,toward,0,0
136403,a,0,0
136404,longer,0,0
136405,OS,0,0
136406,was,0,0
136407,noted,0,0
136408,in,0,0
136409,the,0,0
136410,150,0,1
136411,mg/m,0,1
136412,(,0,1
136413,2,0,1
136414,),0,1
136415,nab-paclitaxel,0,1
136416,arm,0,1
136417,versus,0,1
136418,docetaxel,1,1
136419,arm,0,1
136420,(,0,1
136421,hazard,0,1
136422,ratio,0,0
136423,",",0,0
136424,0.688,0,0
136425,),0,0
136426,.,0,0
136427,Grade,0,0
136428,3,0,0
136429,or,0,0
136430,4,0,0
136431,fatigue,0,0
136432,",",0,0
136433,neutropenia,0,0
136434,",",0,0
136435,and,0,0
136436,febrile,0,0
136437,neutropenia,0,0
136438,were,0,0
136439,less,0,0
136440,frequent,0,0
136441,in,0,0
136442,all,0,0
136443,nab-paclitaxel,0,1
136444,arms,0,1
136445,compared,0,0
136446,with,0,0
136447,docetaxel,1,1
136448,.,1,0
136449,CONCLUSIONS,0,0
136450,Consistent,0,0
136451,with,0,0
136452,previously,0,0
136453,published,0,0
136454,efficacy,0,0
136455,results,0,0
136456,",",0,0
136457,these,0,0
136458,data,0,0
136459,suggest,0,0
136460,that,0,0
136461,150,0,1
136462,mg/m,0,1
136463,(,0,1
136464,2,0,1
136465,),0,1
136466,qw,0,1
136467,3/4,0,1
136468,may,0,0
136469,represent,0,0
136470,the,0,0
136471,most,0,0
136472,clinically,0,0
136473,efficacious,0,1
136474,nab-paclitaxel,0,1
136475,dosing,0,1
136476,regimen,0,1
136477,for,0,0
136478,patients,0,0
136479,with,0,0
136480,no,0,0
136481,previous,0,0
136482,chemotherapy,0,0
136483,for,0,0
136484,MBC,0,0
136485,.,0,0
136486,A,0,0
136487,phase,0,0
136488,III,0,0
136489,trial,0,0
136490,confirming,0,0
136491,these,0,0
136492,results,0,0
136493,would,0,0
136494,be,0,0
136495,necessary,0,0
136496,and,0,0
136497,prudent,0,0
136498,before,0,0
136499,widespread,0,0
136500,adoption,0,0
136501,of,0,0
136502,the,0,0
136503,150,0,1
136504,mg/m,0,1
136505,(,0,1
136506,2,0,1
136507,),0,1
136508,dose,0,1
136509,in,0,1
136510,clinical,0,1
136511,practice,0,0
136512,.,0,0
136513,Nutritional,0,0
136514,orientation,0,0
136515,",",0,0
136516,knowledge,0,0
136517,and,0,0
136518,quality,0,0
136519,of,0,0
136520,diet,0,1
136521,in,0,0
136522,heart,0,1
136523,failure,0,0
136524,:,0,0
136525,randomized,0,0
136526,clinical,0,0
136527,trial,0,0
136528,.,0,0
136529,BACKGROUND,0,0
136530,Non-pharmacological,0,0
136531,measures,0,0
136532,are,0,0
136533,recommended,0,0
136534,for,0,0
136535,heart,0,0
136536,failure,0,0
136537,patients,0,0
136538,.,0,0
136539,However,0,0
136540,",",0,0
136541,most,0,0
136542,studies,0,0
136543,evaluate,0,0
136544,low,0,0
136545,sodium,0,1
136546,diet,0,1
136547,",",0,1
136548,while,0,0
136549,little,0,0
136550,is,0,0
136551,known,0,0
136552,about,0,0
136553,the,0,0
136554,effects,0,0
136555,of,0,0
136556,interventions,0,0
136557,to,0,0
136558,improve,0,0
136559,adherence,0,0
136560,and,0,0
136561,knowledge,0,0
136562,of,0,0
136563,patients,0,0
136564,about,0,0
136565,diet,0,1
136566,content,0,0
136567,.,0,0
136568,OBJECTIVE,0,0
136569,To,0,0
136570,evaluate,0,0
136571,if,0,0
136572,a,0,0
136573,global,0,0
136574,nutritional,1,0
136575,orientation,1,0
136576,could,0,0
136577,affect,0,0
136578,nutritional,0,0
136579,knowledge,0,0
136580,",",0,0
136581,adherence,0,0
136582,to,0,0
136583,food,0,0
136584,guidelines,0,0
136585,",",0,0
136586,anthropometrics,0,0
136587,and,0,0
136588,quality,0,0
136589,of,0,0
136590,life,0,0
136591,in,0,0
136592,heart,0,0
136593,failure,0,0
136594,patients,0,0
136595,.,0,0
136596,METHODS,0,0
136597,Forty,0,0
136598,six,0,0
136599,patients,0,0
136600,were,0,0
136601,randomized,0,0
136602,to,0,0
136603,intervention,0,0
136604,or,0,0
136605,control,0,0
136606,group,0,0
136607,.,0,0
136608,Both,0,0
136609,groups,0,0
136610,received,0,0
136611,usual,1,0
136612,care,1,0
136613,with,1,0
136614,medical,1,0
136615,and,1,0
136616,nursing,1,1
136617,staff,1,1
136618,;,1,0
136619,the,1,0
136620,intervention,1,0
136621,group,1,0
136622,received,1,0
136623,additional,1,0
136624,nutritional,1,0
136625,guidance,1,0
136626,about,1,0
136627,diet,1,1
136628,and,1,0
136629,its,1,0
136630,relationship,1,0
136631,with,1,0
136632,disease,1,0
136633,",",1,0
136634,sources,1,0
136635,of,1,0
136636,nutrients,1,0
136637,",",1,0
136638,and,1,0
136639,reduction,1,0
136640,of,1,0
136641,dietary,1,1
136642,sodium,1,1
136643,and,1,1
136644,fats,1,1
136645,.,1,1
136646,Enforcement,1,0
136647,of,1,0
136648,the,1,0
136649,nutritional,1,0
136650,guidance,1,0
136651,was,1,0
136652,performed,1,0
136653,after,1,0
136654,4,1,0
136655,weeks,1,0
136656,.,1,0
136657,Both,1,0
136658,groups,1,0
136659,were,1,0
136660,evaluated,1,0
136661,at,1,0
136662,baseline,1,0
136663,",",1,0
136664,and,1,0
136665,after,1,0
136666,6,1,0
136667,weeks,1,0
136668,and,1,0
136669,6,1,0
136670,months,1,0
136671,.,1,0
136672,Evaluations,0,0
136673,included,0,0
136674,anthropometric,0,0
136675,parameters,0,0
136676,",",0,1
136677,sodium,0,1
136678,excretion,0,1
136679,in,0,1
136680,24-hour,0,1
136681,urine,0,1
136682,",",0,1
136683,dietary,0,1
136684,recall,0,1
136685,",",0,0
136686,nutrition,0,0
136687,knowledge,0,0
136688,and,0,0
136689,quality,0,0
136690,of,0,0
136691,life,0,0
136692,questionnaires,0,0
136693,.,0,0
136694,RESULTS,0,0
136695,Mean,0,0
136696,age,0,0
136697,of,0,0
136698,included,0,0
136699,patients,0,0
136700,was,0,0
136701,58,0,0
136702,?,0,0
136703,10,0,0
136704,years,0,0
136705,and,0,0
136706,70,0,0
136707,%,0,0
136708,were,0,0
136709,male,0,0
136710,.,0,0
136711,After,0,0
136712,6,0,0
136713,months,0,0
136714,of,0,0
136715,follow-up,0,0
136716,",",0,0
136717,the,0,0
136718,nutritional,0,0
136719,knowledge,0,0
136720,of,0,0
136721,intervention,0,0
136722,group,0,0
136723,increased,0,0
136724,compared,0,0
136725,to,0,0
136726,control,0,0
136727,(,0,0
136728,p,0,0
136729,<,0,0
136730,0.05,0,0
136731,),0,0
136732,.,0,0
136733,Caloric,0,1
136734,",",0,0
136735,fat,0,1
136736,and,0,1
136737,sodium,0,1
136738,intake,0,1
136739,decreased,0,0
136740,in,0,0
136741,the,0,0
136742,intervention,0,0
136743,group,0,0
136744,compared,0,0
136745,to,0,0
136746,control,0,0
136747,(,0,0
136748,p,0,0
136749,<,0,0
136750,0.05,0,0
136751,),0,0
136752,.,0,0
136753,No,0,1
136754,significant,0,0
136755,differences,0,0
136756,were,0,0
136757,seen,0,0
136758,in,0,0
136759,quality,0,0
136760,of,0,0
136761,life,0,0
136762,or,0,0
136763,anthropometric,0,0
136764,parameters,0,0
136765,.,0,0
136766,CONCLUSIONS,1,0
136767,Nutritional,1,0
136768,orientation,1,0
136769,was,0,0
136770,effective,0,0
136771,to,0,0
136772,modify,0,0
136773,1,0,0
136774,),0,0
136775,knowledge,0,0
136776,about,0,0
136777,food,0,0
136778,and,0,0
136779,nutrition,0,0
136780,",",0,0
136781,and,0,0
136782,2,0,1
136783,),0,0
136784,quality,0,1
136785,of,0,0
136786,diet,0,1
136787,in,0,0
136788,outpatients,0,0
136789,with,0,0
136790,heart,0,0
136791,failure,0,0
136792,.,0,0
136793,Further,0,0
136794,studies,0,0
136795,are,0,0
136796,necessary,0,0
136797,to,0,0
136798,evaluate,0,0
136799,the,0,0
136800,benefits,0,0
136801,on,0,0
136802,quality,0,0
136803,of,0,0
136804,life,0,0
136805,and,0,0
136806,prognosis,0,0
136807,.,0,0
136808,Celecoxib,1,1
136809,as,0,1
136810,adjunctive,0,0
136811,treatment,0,0
136812,to,0,0
136813,risperidone,1,1
136814,in,0,0
136815,children,0,0
136816,with,0,0
136817,autistic,0,0
136818,disorder,0,0
136819,:,0,0
136820,a,0,0
136821,randomized,0,0
136822,",",0,0
136823,double-blind,0,1
136824,",",0,1
136825,placebo-controlled,0,1
136826,trial,0,1
136827,.,0,0
136828,RATIONAL,0,0
136829,Autism,0,0
136830,is,0,0
136831,associated,0,0
136832,with,0,0
136833,activation,0,0
136834,of,0,0
136835,the,0,0
136836,inflammatory,0,0
136837,response,0,0
136838,system,0,0
136839,.,0,0
136840,OBJECTIVE,0,0
136841,This,0,0
136842,study,0,0
136843,aims,0,0
136844,to,0,0
136845,assess,0,0
136846,the,0,0
136847,efficacy,0,0
136848,of,0,0
136849,a,0,0
136850,cyclooxygenase-2,1,1
136851,inhibitor,1,1
136852,",",1,1
136853,celecoxib,1,1
136854,",",0,0
136855,as,0,0
136856,adjunctive,0,0
136857,therapy,0,0
136858,in,0,0
136859,the,0,0
136860,treatment,0,0
136861,of,0,0
136862,autism,0,0
136863,METHODS,0,0
136864,In,0,0
136865,a,0,0
136866,10-week,0,0
136867,randomized,0,1
136868,double-blind,0,1
136869,placebo-controlled,0,1
136870,study,0,1
136871,",",0,0
136872,40,0,0
136873,outpatient,0,0
136874,children,0,0
136875,with,0,0
136876,a,0,0
136877,Diagnostic,0,0
136878,and,0,0
136879,Statistical,0,1
136880,Manual,0,0
136881,of,0,0
136882,Mental,0,0
136883,Disorders,0,0
136884,",",0,0
136885,fourth,0,0
136886,edition,0,0
136887,",",0,0
136888,text,0,0
136889,revision,0,1
136890,clinical,0,0
136891,diagnosis,0,0
136892,of,0,0
136893,autism,0,0
136894,were,0,0
136895,randomly,0,0
136896,allocated,0,0
136897,to,0,0
136898,celecoxib,1,1
136899,plus,1,1
136900,risperidone,1,1
136901,or,1,1
136902,placebo,1,1
136903,plus,1,1
136904,risperidone,1,1
136905,.,1,1
136906,The,0,0
136907,dose,0,1
136908,of,0,0
136909,risperidone,1,1
136910,and,0,1
136911,celecoxib,1,1
136912,were,0,1
136913,titrated,0,1
136914,up,0,0
136915,to,0,0
136916,3,0,0
136917,and,0,0
136918,300,0,0
136919,mg/day,0,1
136920,",",0,0
136921,respectively,0,0
136922,.,0,0
136923,Patients,0,0
136924,were,0,0
136925,assessed,0,0
136926,at,0,0
136927,baseline,0,0
136928,and,0,0
136929,after,0,0
136930,2,0,0
136931,",",0,0
136932,4,0,0
136933,",",0,0
136934,6,0,0
136935,",",0,0
136936,and,0,0
136937,10,0,0
136938,weeks,0,0
136939,of,0,0
136940,starting,0,0
136941,medication,0,0
136942,using,0,0
136943,the,0,0
136944,Aberrant,0,0
136945,Behavior,0,0
136946,Checklist-Community,0,1
136947,(,0,1
136948,ABC-C,0,1
136949,),0,1
136950,Rating,0,0
136951,Scale,0,0
136952,.,0,0
136953,Primary,0,0
136954,outcome,0,0
136955,measure,0,0
136956,was,0,0
136957,the,0,0
136958,change,0,0
136959,in,0,0
136960,irritability,0,0
136961,subscale,0,0
136962,of,0,0
136963,ABC-C,0,0
136964,.,0,0
136965,RESULTS,0,0
136966,Significant,0,0
136967,time,0,0
136968,?,0,0
136969,treatment,0,0
136970,interaction,0,0
136971,was,0,0
136972,observed,0,0
136973,for,0,0
136974,Irritability,0,0
136975,(,0,1
136976,F,0,1
136977,(,0,0
136978,1.658,0,0
136979,",",0,0
136980,63.021,0,0
136981,),0,0
136982,=,0,0
136983,13.580,0,0
136984,",",0,0
136985,P,0,0
136986,<,0,0
136987,0.001,0,0
136988,),0,0
136989,",",0,0
136990,Lethargy/Social,0,1
136991,Withdrawal,0,1
136992,(,0,1
136993,F,0,1
136994,(,0,0
136995,1.948,0,0
136996,",",0,0
136997,74.032,0,0
136998,),0,0
136999,=,0,0
137000,16.811,0,0
137001,",",0,0
137002,P,0,0
137003,<,0,0
137004,0.001,0,0
137005,),0,0
137006,",",0,0
137007,and,0,0
137008,Stereotypic,0,1
137009,Behavior,0,1
137010,(,0,1
137011,F,0,0
137012,(,0,0
137013,1.742,0,0
137014,",",0,0
137015,66.198,0,0
137016,),0,0
137017,=,0,0
137018,12.104,0,0
137019,",",0,0
137020,P,0,0
137021,<,0,0
137022,0.001,0,0
137023,),0,0
137024,",",0,0
137025,but,0,0
137026,not,0,0
137027,for,0,0
137028,Hyperactivity/Noncompliance,0,0
137029,(,0,1
137030,F,0,1
137031,(,0,0
137032,2.564,0,0
137033,",",0,0
137034,97.424,0,0
137035,),0,0
137036,=,0,0
137037,1.469,0,0
137038,",",0,0
137039,P,0,0
137040,=,0,0
137041,0.232,0,0
137042,),0,0
137043,",",0,0
137044,and,0,0
137045,Inappropriate,0,0
137046,Speech,0,1
137047,subscales,0,1
137048,(,0,1
137049,F,0,1
137050,(,0,0
137051,1.607,0,0
137052,",",0,0
137053,61.075,0,0
137054,),0,0
137055,=,0,0
137056,0.173,0,0
137057,",",0,0
137058,P,0,0
137059,=,0,0
137060,0.794,0,0
137061,),0,0
137062,.,0,0
137063,By,0,0
137064,week,0,0
137065,10,0,0
137066,",",0,0
137067,patients,0,0
137068,in,0,0
137069,the,0,0
137070,celecoxib,1,1
137071,group,1,0
137072,showed,0,0
137073,significantly,0,0
137074,greater,0,0
137075,improvement,0,0
137076,in,0,0
137077,the,0,0
137078,Irritability,0,0
137079,(,0,0
137080,P,0,0
137081,<,0,0
137082,0.001,0,0
137083,),0,0
137084,",",0,0
137085,Lethargy/Social,0,1
137086,Withdrawal,0,0
137087,(,0,0
137088,P,0,0
137089,<,0,0
137090,0.001,0,0
137091,),0,0
137092,",",0,0
137093,and,0,0
137094,Stereotypic,0,1
137095,Behavior,0,0
137096,(,0,0
137097,P,0,0
137098,<,0,0
137099,0.00,0,0
137100,),0,0
137101,but,0,0
137102,not,0,0
137103,in,0,0
137104,Hyperactivity/Noncompliance,0,0
137105,(,0,0
137106,P,0,0
137107,=,0,0
137108,0.202,0,0
137109,),0,0
137110,and,0,0
137111,Inappropriate,0,1
137112,Speech,0,0
137113,(,0,0
137114,P,0,0
137115,=,0,0
137116,0.802,0,0
137117,),0,0
137118,subscales,1,0
137119,than,1,0
137120,the,1,0
137121,placebo,1,1
137122,group,0,1
137123,.,0,0
137124,Complete,0,0
137125,response,0,0
137126,was,0,0
137127,achieved,0,0
137128,by,0,0
137129,four,0,0
137130,(,0,0
137131,20,0,0
137132,%,0,0
137133,),0,0
137134,patients,0,0
137135,in,0,0
137136,the,1,0
137137,placebo,1,1
137138,group,1,1
137139,and,0,0
137140,11,0,0
137141,(,0,0
137142,55,0,0
137143,%,0,0
137144,),0,0
137145,patients,0,0
137146,in,0,0
137147,the,0,0
137148,celecoxib,0,1
137149,group,0,1
137150,(,0,1
137151,?,0,1
137152,(,0,1
137153,2,0,1
137154,),0,1
137155,(,0,1
137156,1,0,0
137157,),0,0
137158,=,0,0
137159,5.227,0,0
137160,",",0,0
137161,P,0,0
137162,=,0,0
137163,0.022,0,0
137164,),0,0
137165,.,0,0
137166,Frequency,0,0
137167,of,0,0
137168,side,0,0
137169,effects,0,0
137170,was,0,0
137171,similar,0,0
137172,between,0,0
137173,the,0,0
137174,two,0,0
137175,groups,0,0
137176,.,0,0
137177,CONCLUSIONS,0,0
137178,Combination,0,0
137179,of,1,0
137180,risperidone,1,1
137181,and,1,1
137182,celecoxib,1,1
137183,was,1,0
137184,superior,0,0
137185,to,0,0
137186,risperidone,0,1
137187,alone,0,0
137188,in,0,0
137189,treating,0,0
137190,irritability,0,0
137191,",",0,0
137192,social,0,0
137193,withdrawal,0,0
137194,",",0,0
137195,and,0,0
137196,stereotypy,0,0
137197,of,0,0
137198,children,0,0
137199,with,0,0
137200,autism,0,0
137201,.,0,0
137202,(,0,0
137203,Registration,0,0
137204,",",0,1
137205,www.irct.ir,0,1
137206,;,0,1
137207,IRCT138711091556N2,0,1
137208,),0,1
137209,.,0,0
137210,In,0,0
137211,vitro,0,0
137212,biocompatibility,0,0
137213,tests,0,0
137214,of,0,0
137215,glass,0,1
137216,ionomer,0,1
137217,cements,0,1
137218,impregnated,0,0
137219,with,0,0
137220,collagen,0,0
137221,or,0,0
137222,bioactive,0,0
137223,glass,0,0
137224,to,0,0
137225,fibroblasts,0,0
137226,.,0,0
137227,AIM,0,0
137228,AND,0,1
137229,DESIGN,0,1
137230,To,0,0
137231,evaluate,0,0
137232,the,0,0
137233,biocompatibility,0,0
137234,of,0,0
137235,glass,0,0
137236,ionomer,0,1
137237,cement,0,1
137238,(,0,1
137239,GIC,0,0
137240,),0,0
137241,impregnated,0,0
137242,with,0,0
137243,collagen,0,0
137244,or,0,0
137245,bioactive,0,0
137246,glass,0,0
137247,to,0,0
137248,BHK-21,0,0
137249,fibroblasts,0,0
137250,in,0,0
137251,vitro,0,0
137252,.,0,1
137253,Mineral,0,1
137254,Trioxide,0,1
137255,Aggregate,0,0
137256,was,0,0
137257,used,0,0
137258,as,0,0
137259,the,0,0
137260,standard,0,0
137261,for,0,0
137262,comparison,0,0
137263,.,0,0
137264,Human,0,0
137265,maxillary,0,0
137266,central,0,0
137267,incisors,0,1
137268,(,0,0
137269,n,0,0
137270,=,0,0
137271,70,0,0
137272,),0,0
137273,were,0,0
137274,instrumented,0,0
137275,with,0,0
137276,a,0,0
137277,rotary,0,0
137278,NiTi,0,0
137279,system,0,0
137280,and,0,0
137281,filled,0,0
137282,.,0,0
137283,Following,0,0
137284,resection,0,0
137285,of,0,0
137286,the,0,0
137287,apical,0,0
137288,3mm,0,0
137289,",",0,0
137290,root,0,0
137291,end,0,0
137292,cavities,0,0
137293,were,0,0
137294,prepared,0,0
137295,and,0,0
137296,restored,0,0
137297,with,0,0
137298,conventional,1,0
137299,GIC,1,0
137300,(,1,1
137301,group,1,0
137302,1,1,1
137303,),1,0
137304,or,1,0
137305,GIC,1,0
137306,with,1,0
137307,0.01,1,0
137308,%,1,0
137309,",",1,0
137310,0.1,1,0
137311,%,1,0
137312,or,1,0
137313,1,1,0
137314,%,1,0
137315,collagen,1,0
137316,(,1,0
137317,groups,1,0
137318,2,1,0
137319,",",1,0
137320,3,1,0
137321,",",1,0
137322,4,1,0
137323,respectively,1,0
137324,),1,0
137325,or,1,0
137326,",",1,0
137327,10,1,0
137328,%,1,0
137329,",",1,0
137330,30,1,0
137331,%,1,0
137332,or,1,0
137333,50,1,0
137334,%,1,0
137335,bioactive,1,0
137336,glass,1,0
137337,(,1,0
137338,groups,1,0
137339,5,1,0
137340,",",1,0
137341,6,1,0
137342,",",1,0
137343,7,1,0
137344,respectively,1,0
137345,),1,0
137346,",",1,0
137347,or,1,1
137348,Mineral,1,1
137349,Trioxide,1,1
137350,Aggregate,1,1
137351,(,1,1
137352,group,1,0
137353,8,1,0
137354,),1,0
137355,.,1,0
137356,The,0,0
137357,root,0,0
137358,slices,0,0
137359,were,0,0
137360,incubated,0,0
137361,in,0,0
137362,tissue,0,0
137363,culture,0,0
137364,plates,0,0
137365,with,0,0
137366,BHK-21,0,0
137367,fibroblast,0,0
137368,cell,0,0
137369,line,0,0
137370,.,0,0
137371,Phase,0,0
137372,contrast,0,0
137373,and,0,0
137374,scanning,0,0
137375,electron,0,0
137376,microscopes,0,0
137377,were,0,0
137378,used,0,0
137379,to,0,0
137380,score,0,0
137381,cell,0,0
137382,quantity,0,0
137383,",",0,0
137384,morphology,0,0
137385,and,0,0
137386,cell,0,0
137387,attachment,0,0
137388,.,0,0
137389,The,0,0
137390,data,0,0
137391,were,0,0
137392,statistically,0,0
137393,analyzed,0,0
137394,by,0,0
137395,one,0,0
137396,way,0,0
137397,ANOVA,0,0
137398,with,0,0
137399,Post,0,0
137400,Hoc,0,0
137401,Tukey,0,0
137402,HSD,0,1
137403,test,0,0
137404,(,0,0
137405,p,0,0
137406,=,0,0
137407,0.05,0,0
137408,),0,0
137409,.,0,0
137410,RESULTS,0,0
137411,AND,0,0
137412,CONCLUSIONS,0,1
137413,Group,0,0
137414,5,0,0
137415,showed,0,0
137416,the,0,0
137417,highest,0,0
137418,scores,0,0
137419,which,0,0
137420,was,0,0
137421,significantly,0,0
137422,higher,0,0
137423,than,0,0
137424,all,0,0
137425,other,0,0
137426,groups,0,0
137427,(,0,0
137428,p,0,0
137429,<,0,0
137430,0.05,0,0
137431,),0,0
137432,except,0,0
137433,group,0,0
137434,8,0,0
137435,",",0,0
137436,with,0,0
137437,which,0,0
137438,there,0,0
137439,was,0,0
137440,no,0,0
137441,significant,0,0
137442,difference,0,0
137443,(,0,0
137444,p,0,0
137445,>,0,0
137446,0.05,0,0
137447,),0,0
137448,.,0,0
137449,Glass,0,0
137450,ionomer,0,1
137451,cement,0,1
137452,with,0,0
137453,10,0,0
137454,%,0,0
137455,bioactive,0,0
137456,glass,0,0
137457,showed,0,0
137458,better,0,0
137459,adhesion,0,0
137460,and,0,0
137461,spreading,0,0
137462,of,0,0
137463,cells,0,0
137464,than,0,0
137465,glass,0,0
137466,ionomer,0,1
137467,cement,0,0
137468,with,0,0
137469,0.01,0,0
137470,%,0,0
137471,collagen,0,0
137472,.,0,0
137473,The,0,0
137474,biocompatibility,0,0
137475,of,0,0
137476,collagen,0,0
137477,and,0,0
137478,bioactive,0,0
137479,glass,0,0
137480,was,0,0
137481,concentration,0,0
137482,dependent,0,0
137483,.,0,0
137484,The,0,0
137485,addition,0,0
137486,of,0,0
137487,bioactive,0,0
137488,glass,0,0
137489,improved,0,0
137490,the,0,0
137491,biocompatibility,0,0
137492,of,0,0
137493,glass,0,0
137494,ionomer,0,1
137495,cement,0,1
137496,to,0,0
137497,fibroblasts,0,0
137498,better,0,0
137499,than,0,0
137500,addition,0,0
137501,of,0,0
137502,collagen,0,0
137503,.,0,0
137504,Long-term,0,0
137505,effects,0,0
137506,of,0,0
137507,ezetimibe-plus-statin,1,1
137508,therapy,1,1
137509,on,0,0
137510,low-density,0,1
137511,lipoprotein,0,1
137512,cholesterol,0,1
137513,levels,0,0
137514,as,0,0
137515,compared,0,0
137516,with,0,0
137517,double-dose,1,1
137518,statin,1,1
137519,therapy,1,1
137520,in,0,0
137521,patients,0,0
137522,with,0,0
137523,coronary,0,0
137524,artery,0,0
137525,disease,0,0
137526,.,0,0
137527,OBJECTIVE,0,0
137528,To,0,0
137529,assess,0,0
137530,the,0,0
137531,mechanism,0,0
137532,of,0,0
137533,long-term,0,0
137534,LDL-C-lowering,0,1
137535,effect,0,0
137536,of,0,0
137537,ezetimibe-plus-statin,1,1
137538,.,1,1
137539,METHODS,0,1
137540,Coronary,0,0
137541,artery,0,0
137542,disease,0,0
137543,patients,0,0
137544,whose,0,0
137545,LDL-C,0,0
137546,?,0,0
137547,70,0,0
137548,mg/dL,0,0
137549,after,0,0
137550,treatment,0,0
137551,with,1,0
137552,atorvastatin,1,1
137553,10,1,1
137554,mg/day,1,1
137555,or,1,1
137556,rosuvastatin,1,1
137557,2.5,1,1
137558,mg/day,1,1
137559,were,1,0
137560,randomly,0,0
137561,assigned,0,0
137562,to,0,0
137563,receive,1,1
137564,ezetimibe,1,1
137565,10,1,1
137566,mg/day,1,1
137567,+,1,1
137568,statin,1,1
137569,(,1,1
137570,n,0,0
137571,=,0,0
137572,78,0,0
137573,),0,0
137574,or,0,0
137575,double-dose,1,1
137576,statin,1,1
137577,(,1,1
137578,n,0,0
137579,=,0,0
137580,72,0,0
137581,),0,0
137582,for,0,0
137583,52,0,0
137584,weeks,0,0
137585,.,0,0
137586,RESULTS,0,0
137587,Greater,0,0
137588,LDL-C,0,0
137589,reduction,0,0
137590,was,0,0
137591,observed,0,0
137592,and,0,0
137593,maintained,0,0
137594,until,0,0
137595,52,0,0
137596,weeks,0,0
137597,in,0,0
137598,ezetimibe-plus-statin,1,1
137599,",",1,0
137600,while,0,0
137601,LDL-C,0,0
137602,levels,0,0
137603,re-increased,0,0
137604,after,0,0
137605,12,0,0
137606,weeks,0,0
137607,in,0,0
137608,double-dose,0,1
137609,statin,0,1
137610,.,0,1
137611,Although,0,0
137612,lathosterol/TC,0,1
137613,increased,0,0
137614,",",0,0
137615,campesterol/TC,0,1
137616,decreased,0,0
137617,more,0,0
137618,in,0,0
137619,ezetimibe-plus-statin,1,1
137620,.,1,0
137621,In,0,0
137622,contrast,0,0
137623,",",0,0
137624,lathosterol/TC,0,1
137625,unchanged,0,0
137626,and,0,0
137627,campesterol/TC,0,1
137628,increased,0,0
137629,",",0,0
137630,increasing,0,0
137631,campesterol/lathosterol,0,1
137632,ratio,0,0
137633,for,0,0
137634,52,0,0
137635,weeks,0,0
137636,in,0,0
137637,double-dose,1,1
137638,statin,1,1
137639,.,1,1
137640,Plasma,0,1
137641,PCSK9,0,0
137642,levels,0,0
137643,were,0,0
137644,higher,0,0
137645,in,0,0
137646,double-dose,1,1
137647,statin,1,1
137648,than,1,1
137649,in,0,0
137650,ezetimibe-plus-statin,1,1
137651,at,1,0
137652,12,0,0
137653,weeks,0,0
137654,",",0,0
137655,but,0,0
137656,similar,0,0
137657,at,0,0
137658,52,0,0
137659,weeks,0,0
137660,.,0,0
137661,CONCLUSION,0,0
137662,Although,0,0
137663,the,0,0
137664,difference,0,0
137665,in,0,0
137666,PCSK9,0,0
137667,between,0,0
137668,2,0,0
137669,groups,0,0
137670,was,0,0
137671,transient,0,0
137672,",",0,0
137673,that,0,0
137674,in,0,0
137675,both,0,0
137676,campesterol,0,1
137677,and,0,1
137678,lathosterol,0,1
137679,persisted,0,0
137680,until,0,0
137681,52,0,0
137682,weeks,0,0
137683,.,0,0
137684,These,0,0
137685,results,0,0
137686,demonstrated,0,0
137687,simultaneous,0,0
137688,inhibition,0,0
137689,of,0,0
137690,cholesterol,0,1
137691,absorption,0,1
137692,and,0,0
137693,synthesis,0,0
137694,provides,0,0
137695,stable,0,0
137696,and,0,0
137697,greater,0,0
137698,decrease,0,0
137699,in,0,0
137700,LDL-C,0,0
137701,levels,0,0
137702,.,0,0
137703,A,0,0
137704,comparison,0,0
137705,between,0,0
137706,oral,0,1
137707,ciprofloxacin,1,1
137708,and,0,1
137709,intra-peritoneal,1,1
137710,vancomycin,1,1
137711,and,0,1
137712,gentamicin,1,1
137713,in,0,0
137714,the,0,0
137715,treatment,0,0
137716,of,0,0
137717,CAPD,0,0
137718,peritonitis,0,0
137719,.,0,0
137720,Fifty-one,0,0
137721,patients,0,0
137722,were,0,0
137723,included,0,0
137724,in,0,0
137725,a,0,0
137726,prospective,0,0
137727,",",0,0
137728,randomized,0,0
137729,comparison,0,0
137730,of,0,0
137731,oral,1,1
137732,ciprofloxacin,1,1
137733,and,1,1
137734,intraperitoneal,1,1
137735,vancomycin/gentamicin,1,1
137736,in,0,0
137737,the,0,0
137738,treatment,0,0
137739,of,0,0
137740,CAPD,0,0
137741,peritonitis,0,1
137742,.,0,0
137743,Staphylococcal,0,1
137744,species,0,0
137745,accounted,0,0
137746,for,0,0
137747,40,0,0
137748,%,0,0
137749,of,0,0
137750,the,0,0
137751,isolates,0,0
137752,with,0,0
137753,an,0,0
137754,equal,0,0
137755,incidence,0,0
137756,of,0,0
137757,Staphylococcus,0,1
137758,aureus,0,1
137759,and,0,1
137760,coagulase,0,1
137761,negative,0,1
137762,staphylococci,0,1
137763,.,0,0
137764,Although,0,0
137765,",",0,0
137766,overall,0,0
137767,",",0,0
137768,there,0,0
137769,was,0,0
137770,no,0,0
137771,significant,0,0
137772,difference,0,0
137773,between,0,0
137774,the,0,0
137775,regimens,0,1
137776,in,0,0
137777,outcome,0,1
137778,",",0,0
137779,ciprofloxacin,1,1
137780,was,0,0
137781,significantly,0,0
137782,less,0,0
137783,effective,0,0
137784,when,0,0
137785,peritonitis,0,0
137786,was,0,0
137787,due,0,0
137788,to,0,0
137789,coagulase,0,1
137790,negative,0,1
137791,staphylococci,0,1
137792,.,0,0
137793,Preschool,0,0
137794,based,0,0
137795,JASPER,1,0
137796,intervention,1,0
137797,in,0,0
137798,minimally,0,0
137799,verbal,0,0
137800,children,0,0
137801,with,0,0
137802,autism,0,0
137803,:,0,0
137804,pilot,0,0
137805,RCT,0,0
137806,.,0,0
137807,In,0,0
137808,this,0,0
137809,pilot,0,0
137810,study,0,0
137811,",",0,0
137812,we,0,0
137813,tested,0,0
137814,the,0,0
137815,effects,0,0
137816,of,0,0
137817,a,0,0
137818,novel,0,0
137819,intervention,0,0
137820,(,1,0
137821,JASPER,1,1
137822,",",1,0
137823,Joint,1,0
137824,Attention,1,1
137825,Symbolic,1,0
137826,Play,1,1
137827,Engagement,1,0
137828,and,1,0
137829,Regulation,1,0
137830,),1,0
137831,on,0,0
137832,3,0,0
137833,to,0,0
137834,5,0,0
137835,year,0,0
137836,old,0,0
137837,",",0,0
137838,minimally,0,0
137839,verbal,0,0
137840,children,0,0
137841,with,0,0
137842,autism,0,0
137843,who,0,0
137844,were,0,0
137845,attending,0,0
137846,a,0,0
137847,non-public,0,0
137848,preschool,0,0
137849,.,0,0
137850,Participants,0,0
137851,were,1,0
137852,randomized,1,0
137853,to,1,0
137854,a,1,0
137855,control,1,0
137856,group,1,0
137857,(,1,0
137858,treatment,1,0
137859,as,1,0
137860,usual,1,0
137861,",",1,0
137862,30,1,0
137863,h,1,0
137864,of,1,0
137865,ABA-based,1,0
137866,therapy,1,0
137867,per,1,0
137868,week,1,0
137869,),1,0
137870,or,1,0
137871,a,1,0
137872,treatment,1,0
137873,group,1,0
137874,(,1,0
137875,substitution,1,0
137876,of,1,0
137877,30,1,0
137878,min,1,0
137879,of,1,0
137880,JASPER,1,0
137881,treatment,1,0
137882,",",1,0
137883,twice,1,1
137884,weekly,1,0
137885,during,1,0
137886,their,1,0
137887,regular,1,0
137888,program,1,1
137889,),1,0
137890,.,1,0
137891,A,1,0
137892,baseline,0,0
137893,of,0,0
137894,12,0,0
137895,weeks,0,0
137896,in,0,0
137897,which,0,0
137898,no,0,0
137899,changes,0,0
137900,were,0,0
137901,noted,0,0
137902,in,0,0
137903,core,0,0
137904,deficits,0,0
137905,was,0,0
137906,followed,0,0
137907,by,0,0
137908,12,0,0
137909,weeks,0,0
137910,of,0,0
137911,intervention,0,0
137912,for,0,0
137913,children,0,0
137914,randomized,0,0
137915,to,0,0
137916,the,0,0
137917,JASPER,1,0
137918,treatment,1,0
137919,.,0,0
137920,Participants,0,0
137921,in,0,0
137922,the,0,0
137923,treatment,0,0
137924,group,0,0
137925,demonstrated,0,0
137926,greater,0,0
137927,play,0,0
137928,diversity,0,0
137929,on,0,0
137930,a,0,0
137931,standardized,0,0
137932,assessment,0,0
137933,.,0,0
137934,Effects,0,0
137935,also,0,0
137936,generalized,0,0
137937,to,0,0
137938,the,0,0
137939,classroom,0,0
137940,",",0,0
137941,where,0,0
137942,participants,0,0
137943,in,0,0
137944,the,0,0
137945,treatment,0,0
137946,group,0,0
137947,initiated,0,0
137948,more,0,0
137949,gestures,0,0
137950,and,0,0
137951,spent,0,0
137952,less,0,0
137953,time,0,0
137954,unengaged,0,0
137955,.,0,0
137956,These,0,0
137957,results,0,0
137958,provide,0,0
137959,further,0,0
137960,support,0,0
137961,that,0,0
137962,even,0,0
137963,brief,0,0
137964,",",0,0
137965,targeted,0,0
137966,interventions,0,0
137967,on,0,0
137968,joint,0,0
137969,attention,0,0
137970,and,0,0
137971,play,0,0
137972,can,0,0
137973,improve,0,0
137974,core,0,0
137975,deficits,0,0
137976,in,0,0
137977,minimally,0,0
137978,verbal,0,0
137979,children,0,0
137980,with,0,0
137981,ASD,0,0
137982,.,0,0
137983,Clinical,0,0
137984,efficacy,0,0
137985,of,0,0
137986,antazoline,1,1
137987,in,0,0
137988,rapid,0,0
137989,cardioversion,0,0
137990,of,0,0
137991,paroxysmal,0,0
137992,atrial,0,0
137993,fibrillation,0,0
137994,--,0,0
137995,a,0,0
137996,protocol,0,0
137997,of,0,0
137998,a,0,0
137999,single,0,0
138000,center,0,0
138001,",",0,0
138002,randomized,0,0
138003,",",0,1
138004,double-blind,0,1
138005,",",0,1
138006,placebo-controlled,0,1
138007,study,0,1
138008,(,0,0
138009,the,0,0
138010,AnPAF,0,1
138011,Study,0,1
138012,),0,0
138013,.,0,0
138014,BACKGROUND,0,0
138015,Rapid,0,0
138016,conversion,0,0
138017,of,0,0
138018,atrial,0,0
138019,fibrillation,0,1
138020,(,0,1
138021,AF,0,1
138022,),0,1
138023,to,0,0
138024,sinus,0,0
138025,rhythm,0,0
138026,may,0,0
138027,be,0,0
138028,achieved,0,0
138029,by,0,0
138030,the,0,0
138031,administration,0,1
138032,of,0,0
138033,class,1,0
138034,IA,1,0
138035,",",1,0
138036,IC,1,1
138037,and,1,1
138038,III,1,1
138039,antiarrhythmic,1,1
138040,drugs,1,1
138041,or,1,1
138042,vernakalant,1,1
138043,hydrochloride,1,1
138044,.,1,1
138045,However,0,0
138046,",",0,0
138047,that,0,0
138048,treatment,0,0
138049,may,0,0
138050,be,0,0
138051,related,0,0
138052,to,0,0
138053,potential,0,0
138054,pro-arrhythmia,0,0
138055,",",0,0
138056,lack,0,0
138057,of,0,0
138058,efficacy,0,0
138059,or,0,0
138060,the,0,0
138061,exceptionally,0,0
138062,high,0,0
138063,cost,0,0
138064,of,0,0
138065,a,0,0
138066,compound,0,0
138067,used,0,0
138068,.,0,0
138069,Antazoline,1,1
138070,is,0,0
138071,a,0,0
138072,first,0,0
138073,generation,0,0
138074,antihistaminic,0,1
138075,agent,0,0
138076,with,0,1
138077,chinidin-like,0,0
138078,properties,0,0
138079,.,0,0
138080,When,0,1
138081,administered,0,1
138082,intravenously,0,1
138083,",",0,1
138084,antazoline,1,1
138085,exerts,0,0
138086,a,0,0
138087,strong,0,0
138088,antiarrhythmic,0,1
138089,effect,0,0
138090,on,0,0
138091,supraventricular,0,0
138092,arrhythmia,0,0
138093,",",0,0
138094,especially,0,0
138095,on,0,0
138096,AF,0,0
138097,",",0,0
138098,facilitating,0,0
138099,rapid,0,0
138100,conversion,0,0
138101,to,0,0
138102,sinus,0,0
138103,rhythm,0,0
138104,.,0,0
138105,Despite,0,0
138106,a,0,0
138107,relative,0,0
138108,lack,0,0
138109,of,0,0
138110,published,0,0
138111,data,0,0
138112,antazoline,0,1
138113,has,0,0
138114,been,0,0
138115,marketed,0,1
138116,in,0,0
138117,Poland,0,0
138118,and,0,0
138119,widely,0,0
138120,used,0,0
138121,in,0,0
138122,cardiology,0,0
138123,wards,0,0
138124,and,0,0
138125,emergency,0,0
138126,rooms,0,0
138127,for,0,0
138128,many,0,0
138129,years,0,0
138130,due,0,0
138131,to,0,0
138132,its,0,0
138133,efficacy,0,0
138134,",",0,0
138135,safety,0,0
138136,and,0,0
138137,rapid,0,0
138138,onset,0,0
138139,of,0,0
138140,action,0,0
138141,within,0,0
138142,minutes,0,0
138143,of,0,0
138144,administration,0,1
138145,.,0,1
138146,METHODS/DESIGN,0,1
138147,A,0,1
138148,randomized,0,0
138149,",",0,0
138150,double,0,0
138151,blind,0,0
138152,",",0,0
138153,placebo-controlled,1,1
138154,",",0,1
138155,superiority,0,1
138156,clinical,0,0
138157,trial,0,0
138158,was,0,0
138159,designed,0,0
138160,to,0,0
138161,assess,0,0
138162,clinical,0,0
138163,efficacy,0,0
138164,of,0,0
138165,antazoline,1,1
138166,in,0,0
138167,rapid,0,0
138168,conversion,0,0
138169,of,0,0
138170,AF,0,0
138171,to,0,0
138172,sinus,0,0
138173,rhythm,0,0
138174,.,0,0
138175,Eligible,0,0
138176,patients,0,0
138177,will,0,0
138178,present,0,0
138179,AF,0,0
138180,lasting,0,0
138181,less,0,0
138182,than,0,0
138183,43,0,0
138184,hours,0,0
138185,",",0,0
138186,will,0,0
138187,be,0,0
138188,in,0,0
138189,stable,0,0
138190,cardio-pulmonary,0,0
138191,condition,0,0
138192,and,0,0
138193,will,0,0
138194,have,0,0
138195,no,0,0
138196,prior,0,0
138197,history,0,0
138198,of,0,0
138199,advanced,0,0
138200,heart,0,0
138201,failure,0,0
138202,or,0,0
138203,significant,0,0
138204,valvular,0,0
138205,disease,0,0
138206,.,0,0
138207,Long-term,0,1
138208,antiarrhythmic,0,1
138209,therapy,0,1
138210,is,0,0
138211,not,0,0
138212,considered,0,0
138213,an,0,0
138214,exclusion,0,0
138215,criterion,0,0
138216,.,0,0
138217,Subjects,0,0
138218,who,0,0
138219,fulfill,0,0
138220,selection,0,0
138221,criteria,0,0
138222,will,0,0
138223,be,0,0
138224,randomly,0,0
138225,assigned,0,0
138226,to,0,0
138227,receive,0,1
138228,intravenously,0,1
138229,either,0,1
138230,antazoline,1,1
138231,or,0,1
138232,placebo,1,1
138233,in,0,1
138234,divided,0,0
138235,doses,0,1
138236,and,0,0
138237,observed,0,0
138238,for,0,0
138239,1.5,0,0
138240,hours,0,0
138241,after,0,0
138242,conversion,0,0
138243,to,0,0
138244,sinus,0,0
138245,rhythm,0,0
138246,or,0,0
138247,after,0,0
138248,the,0,0
138249,last,0,0
138250,i.v,0,1
138251,.,0,1
138252,bolus,0,1
138253,.,0,0
138254,Primary,0,0
138255,end,0,0
138256,point,0,0
138257,will,0,0
138258,be,0,0
138259,the,0,0
138260,conversion,0,0
138261,of,0,0
138262,AF,0,0
138263,to,0,0
138264,sinus,0,0
138265,rhythm,0,0
138266,confirmed,0,0
138267,in,0,0
138268,an,0,0
138269,electrocardiogram,0,0
138270,(,0,1
138271,ECG,0,1
138272,),0,0
138273,during,0,0
138274,the,0,0
138275,observation,0,0
138276,period,0,0
138277,.,0,0
138278,Secondary,0,0
138279,end,0,0
138280,points,0,0
138281,will,0,0
138282,be,0,0
138283,comprised,0,0
138284,of,0,0
138285,time,0,0
138286,to,0,0
138287,conversion,0,0
138288,and,0,0
138289,return,0,0
138290,of,0,0
138291,AF,0,0
138292,during,0,0
138293,the,0,0
138294,observation,0,0
138295,period,0,0
138296,.,0,0
138297,Special,0,0
138298,consideration,0,0
138299,will,0,0
138300,be,0,0
138301,given,0,0
138302,to,0,0
138303,the,0,0
138304,observation,0,0
138305,of,0,0
138306,any,0,0
138307,adverse,0,0
138308,events,0,0
138309,.,0,0
138310,A,0,0
138311,sample,0,0
138312,size,0,0
138313,of,0,0
138314,80,0,0
138315,patients,0,0
138316,was,0,0
138317,calculated,0,0
138318,based,0,0
138319,on,0,0
138320,the,0,0
138321,following,0,0
138322,assumptions,0,0
138323,:,0,0
138324,two-tailed,0,0
138325,test,0,0
138326,",",0,0
138327,a,0,0
138328,type,0,0
138329,I,0,0
138330,error,0,0
138331,of,0,0
138332,0.01,0,0
138333,",",0,0
138334,a,0,0
138335,power,0,0
138336,of,0,0
138337,90,0,0
138338,%,0,0
138339,",",0,0
138340,efficacy,0,0
138341,of,0,0
138342,placebo,1,1
138343,5,0,0
138344,%,0,0
138345,",",0,0
138346,efficacy,0,0
138347,of,0,0
138348,antazoline,1,1
138349,50,0,0
138350,%,0,0
138351,and,0,0
138352,20,0,0
138353,%,0,0
138354,drop-out,0,0
138355,rate,0,0
138356,to,0,0
138357,fulfill,0,0
138358,the,0,0
138359,criteria,0,0
138360,of,0,0
138361,intention-to-treat,0,0
138362,analysis,0,0
138363,.,0,0
138364,Due,0,0
138365,to,0,0
138366,the,0,0
138367,presumed,0,0
138368,lack,0,0
138369,of,0,0
138370,statistical,0,0
138371,power,0,0
138372,",",0,0
138373,the,0,0
138374,secondary,0,0
138375,end,0,0
138376,points,0,0
138377,and,0,0
138378,safety,0,0
138379,endpoints,0,0
138380,will,0,0
138381,be,0,0
138382,considered,0,0
138383,exploratory,0,0
138384,.,0,0
138385,CLINICAL,0,0
138386,TRIALS,0,1
138387,REGISTRY,0,1
138388,ClinicalTrials.gov,0,1
138389,",",0,0
138390,NCT01527279,0,0
138391,.,0,0
138392,Junctional,0,0
138393,ectopic,0,0
138394,tachycardia,0,0
138395,after,0,0
138396,congenital,0,0
138397,heart,0,0
138398,surgery,0,0
138399,in,0,0
138400,the,0,0
138401,current,0,0
138402,surgical,0,0
138403,era,0,0
138404,.,0,0
138405,To,0,0
138406,determine,0,0
138407,the,0,0
138408,incidence,0,0
138409,of,0,0
138410,postoperative,0,0
138411,junctional,1,0
138412,ectopic,1,0
138413,tachycardia,1,0
138414,(,0,1
138415,JET,0,1
138416,),0,0
138417,in,0,0
138418,a,0,0
138419,modern,0,0
138420,cohort,0,0
138421,of,0,0
138422,pediatric,0,0
138423,patients,0,0
138424,",",0,0
138425,evaluate,0,0
138426,possible,0,0
138427,risk,0,0
138428,factors,0,0
138429,for,0,0
138430,JET,0,0
138431,",",0,0
138432,and,0,0
138433,examine,0,0
138434,the,0,0
138435,effects,0,0
138436,of,0,0
138437,JET,0,0
138438,on,0,0
138439,postoperative,0,0
138440,morbidity,0,0
138441,and,0,0
138442,mortality,0,0
138443,.,0,0
138444,JET,0,0
138445,is,0,0
138446,common,0,0
138447,after,0,0
138448,congenital,0,0
138449,heart,0,0
138450,surgery,0,0
138451,.,0,0
138452,JET-related,0,0
138453,mortality,0,0
138454,has,0,0
138455,been,0,0
138456,a,0,0
138457,rare,0,0
138458,event,0,0
138459,at,0,0
138460,our,0,0
138461,center,0,0
138462,",",0,0
138463,which,0,0
138464,is,0,0
138465,different,0,0
138466,from,0,0
138467,previous,0,0
138468,reports,0,0
138469,.,0,0
138470,We,0,0
138471,reviewed,0,0
138472,records,0,0
138473,for,0,0
138474,pediatric,0,0
138475,patients,0,0
138476,who,0,0
138477,had,0,0
138478,postoperative,0,0
138479,arrhythmias,0,0
138480,between,0,0
138481,January,0,0
138482,2006,0,0
138483,and,0,0
138484,June,0,0
138485,2010,0,0
138486,at,0,0
138487,a,0,0
138488,large,0,0
138489,tertiary-care,0,0
138490,children,0,0
138491,'s,0,0
138492,hospital,0,0
138493,.,0,0
138494,We,0,0
138495,performed,0,0
138496,a,0,0
138497,matched,0,0
138498,case-control,0,0
138499,study,0,0
138500,to,0,0
138501,identify,0,0
138502,risk,0,0
138503,factors,0,0
138504,for,0,0
138505,JET,0,0
138506,and,0,0
138507,a,0,0
138508,matched-cohort,0,0
138509,study,0,0
138510,to,0,0
138511,compare,0,0
138512,outcomes,0,0
138513,between,0,0
138514,patients,0,0
138515,and,0,0
138516,controls,0,0
138517,.,0,0
138518,Whenever,0,0
138519,possible,0,0
138520,",",0,0
138521,each,0,0
138522,JET,0,0
138523,case,0,0
138524,was,0,0
138525,randomly,0,0
138526,matched,0,0
138527,to,0,0
138528,two,0,0
138529,controls,0,0
138530,on,0,0
138531,the,0,0
138532,basis,0,0
138533,of,0,0
138534,lesion,0,0
138535,",",0,0
138536,repair,0,0
138537,",",0,0
138538,and,0,0
138539,surgical,0,0
138540,period,0,0
138541,.,0,0
138542,We,0,0
138543,identified,0,0
138544,54,0,0
138545,patients,0,0
138546,with,0,0
138547,JET,0,1
138548,(,0,0
138549,incidence,0,0
138550,=,0,0
138551,1.4,0,0
138552,%,0,0
138553,),0,0
138554,.,0,0
138555,After,0,0
138556,multivariate,0,0
138557,logistic,0,0
138558,regression,0,0
138559,analysis,0,0
138560,",",0,0
138561,low,0,0
138562,operative,0,0
138563,weight,0,0
138564,",",0,0
138565,cardiopulmonary,0,1
138566,bypass,0,1
138567,(,0,1
138568,CPB,0,1
138569,),0,1
138570,duration,0,1
138571,>,0,0
138572,100,0,0
138573,min,0,0
138574,",",0,0
138575,and,0,0
138576,immediate,0,1
138577,postoperative,0,1
138578,serum,0,1
138579,lactic,0,1
138580,acid,0,1
138581,level,0,1
138582,>,0,0
138583,20,0,0
138584,mg/dl,0,0
138585,were,0,0
138586,associated,0,0
138587,with,0,0
138588,increased,0,0
138589,odds,0,0
138590,of,0,0
138591,developing,0,0
138592,JET,0,0
138593,.,0,0
138594,Patients,0,0
138595,with,0,0
138596,JET,1,0
138597,had,0,0
138598,longer,0,0
138599,mechanical,0,0
138600,ventilation,0,0
138601,time,0,0
138602,",",0,0
138603,cardiac,0,0
138604,intensive,0,0
138605,care,0,1
138606,unit,0,0
138607,(,0,1
138608,CICU,0,1
138609,),0,1
138610,stay,0,0
138611,",",0,0
138612,and,0,0
138613,hospital,0,0
138614,stay,0,0
138615,.,0,0
138616,There,0,0
138617,was,0,0
138618,only,0,0
138619,one,0,0
138620,death,0,0
138621,in,0,0
138622,JET,0,1
138623,group,0,1
138624,(,0,0
138625,1.8,0,0
138626,%,0,0
138627,),0,0
138628,with,0,0
138629,no,0,0
138630,significant,0,0
138631,difference,0,0
138632,compared,0,0
138633,with,0,0
138634,the,0,0
138635,control,0,0
138636,group,0,0
138637,.,0,0
138638,JET,0,0
138639,remains,0,0
138640,a,0,0
138641,relatively,0,0
138642,common,0,0
138643,postoperative,0,0
138644,arrhythmia,0,0
138645,",",0,0
138646,but,0,0
138647,it,0,0
138648,is,0,0
138649,less,0,0
138650,frequent,0,0
138651,than,0,0
138652,previously,0,0
138653,reported,0,0
138654,.,0,0
138655,JET,0,0
138656,occurs,0,0
138657,more,0,0
138658,commonly,0,0
138659,in,0,0
138660,smaller,0,0
138661,patients,0,0
138662,with,0,0
138663,longer,0,0
138664,CPB,0,0
138665,runs,0,0
138666,and,0,0
138667,significant,0,0
138668,postoperative,0,1
138669,lactic,0,1
138670,acidosis,0,1
138671,levels,0,0
138672,.,0,0
138673,Mortality,0,0
138674,associated,0,0
138675,with,0,0
138676,JET,0,0
138677,is,0,0
138678,lower,0,0
138679,than,0,0
138680,historically,0,0
138681,reported,0,0
138682,",",0,0
138683,but,0,0
138684,morbidity,0,0
138685,remains,0,0
138686,high,0,0
138687,.,0,0
138688,Airway,0,0
138689,responses,0,0
138690,and,0,0
138691,inflammation,0,0
138692,in,0,0
138693,subjects,0,0
138694,with,0,0
138695,asthma,0,0
138696,after,0,0
138697,four,0,0
138698,days,0,0
138699,of,0,0
138700,repeated,1,1
138701,high-single-dose,1,1
138702,allergen,1,1
138703,challenge,1,1
138704,.,1,0
138705,BACKGROUND,0,0
138706,Both,0,1
138707,standard,0,1
138708,and,0,1
138709,low-dose,0,1
138710,allergen,0,1
138711,provocations,0,1
138712,are,0,0
138713,an,0,0
138714,established,0,0
138715,tool,0,0
138716,in,0,0
138717,asthma,0,0
138718,research,0,0
138719,to,0,0
138720,improve,0,0
138721,our,0,0
138722,understanding,0,0
138723,of,0,0
138724,the,0,0
138725,pathophysiological,0,0
138726,mechanism,0,0
138727,of,0,0
138728,allergic,0,0
138729,asthma,0,0
138730,.,0,0
138731,However,0,0
138732,",",0,0
138733,clinical,0,0
138734,symptoms,0,0
138735,are,0,0
138736,less,0,0
138737,likely,0,0
138738,to,0,0
138739,be,0,0
138740,induced,0,0
138741,.,0,0
138742,Therefore,0,0
138743,",",0,0
138744,we,0,0
138745,designed,0,0
138746,a,0,0
138747,protocol,0,0
138748,for,0,0
138749,repetitive,0,0
138750,high-dose,0,1
138751,bronchial,0,1
138752,allergen,0,1
138753,challenges,0,1
138754,to,0,0
138755,generate,0,0
138756,clinical,0,0
138757,symptoms,0,0
138758,and,0,0
138759,airway,0,0
138760,inflammation,0,0
138761,.,0,0
138762,METHODS,0,0
138763,A,0,0
138764,total,0,0
138765,of,0,0
138766,27,0,0
138767,patients,0,0
138768,aged,0,0
138769,18,0,0
138770,to,0,0
138771,40,0,0
138772,years,0,0
138773,with,0,0
138774,positive,0,0
138775,skin-prick,0,0
138776,tests,0,0
138777,and,0,0
138778,mild,0,0
138779,asthma,0,0
138780,underwent,0,0
138781,repetitive,1,0
138782,high-dose,1,1
138783,allergen,1,1
138784,challenges,1,1
138785,with,1,0
138786,household,1,0
138787,dust,1,0
138788,mites,1,0
138789,for,1,0
138790,four,1,0
138791,consecutive,1,0
138792,days,1,0
138793,.,1,0
138794,Pulmonary,0,0
138795,function,0,0
138796,and,0,0
138797,exhaled,0,1
138798,NO,0,1
138799,were,0,0
138800,measured,0,0
138801,at,0,0
138802,every,0,0
138803,visit,0,0
138804,.,0,0
138805,Induced,0,0
138806,sputum,0,0
138807,was,0,0
138808,analysed,0,0
138809,before,0,0
138810,and,0,0
138811,after,0,0
138812,the,0,0
138813,allergen,0,1
138814,challenges,0,1
138815,for,0,0
138816,cell,0,0
138817,counts,0,0
138818,",",0,0
138819,ECP,0,1
138820,",",0,0
138821,IL-5,0,1
138822,",",0,0
138823,INF-?,0,1
138824,",",0,0
138825,IL-8,0,0
138826,",",0,0
138827,and,0,0
138828,the,0,0
138829,transcription,0,0
138830,factor,0,0
138831,Foxp3,0,0
138832,.,0,0
138833,RESULTS,0,0
138834,We,0,0
138835,found,0,0
138836,a,0,0
138837,significant,0,0
138838,decrease,0,0
138839,in,0,0
138840,pulmonary,0,0
138841,function,0,0
138842,",",0,0
138843,an,0,0
138844,increased,0,0
138845,use,0,0
138846,of,0,0
138847,salbutamol,0,1
138848,and,0,0
138849,the,0,0
138850,development,0,0
138851,of,0,0
138852,a,0,0
138853,late,0,0
138854,asthmatic,0,0
138855,response,0,0
138856,and,0,0
138857,bronchial,0,0
138858,hyperresponsiveness,0,0
138859,",",0,0
138860,as,0,0
138861,well,0,0
138862,as,0,0
138863,a,0,0
138864,significant,0,0
138865,induction,0,0
138866,of,0,0
138867,eNO,0,1
138868,",",0,0
138869,eosinophils,0,1
138870,",",0,1
138871,and,0,1
138872,Th-2,0,1
138873,cytokines,0,1
138874,.,0,0
138875,Repeated,0,0
138876,provocation,0,0
138877,was,0,0
138878,feasible,0,0
138879,in,0,0
138880,the,0,0
138881,majority,0,0
138882,of,0,0
138883,patients,0,0
138884,.,0,0
138885,Two,0,0
138886,subjects,0,0
138887,had,0,0
138888,severe,0,0
138889,adverse,0,0
138890,events,0,0
138891,requiring,1,1
138892,prednisolone,1,1
138893,to,0,0
138894,cope,0,0
138895,with,0,0
138896,nocturnal,0,0
138897,asthma,0,0
138898,symptoms,0,0
138899,.,0,0
138900,CONCLUSIONS,0,0
138901,Repeated,0,0
138902,high-dose,0,1
138903,bronchial,0,1
138904,allergen,0,1
138905,challenges,0,1
138906,resulted,0,0
138907,in,0,0
138908,severe,0,0
138909,asthma,0,0
138910,symptoms,0,0
138911,and,0,0
138912,marked,0,0
138913,Th-2-mediated,0,0
138914,allergic,0,0
138915,airway,0,0
138916,inflammation,0,0
138917,.,0,0
138918,The,0,0
138919,high-dose,0,1
138920,challenge,0,0
138921,model,0,0
138922,is,0,0
138923,suitable,0,0
138924,only,0,0
138925,in,0,0
138926,an,0,0
138927,attenuated,0,0
138928,form,0,0
138929,in,0,0
138930,diseased,0,0
138931,volunteers,0,0
138932,for,0,0
138933,proof-of-concept,0,0
138934,studies,0,0
138935,and,0,0
138936,in,0,0
138937,clinical,0,0
138938,settings,0,0
138939,to,0,0
138940,reduce,0,0
138941,the,0,0
138942,risk,0,0
138943,of,0,0
138944,severe,0,0
138945,asthma,0,0
138946,exacerbations,0,0
138947,.,0,0
138948,TRIAL,0,0
138949,REGISTRATION,0,0
138950,ClinicalTrials.govNCT00677209,0,1
138951,.,0,0
138952,Duration,0,0
138953,of,0,0
138954,untreated,0,0
138955,negative,0,0
138956,and,0,0
138957,positive,0,0
138958,symptoms,0,0
138959,of,0,0
138960,psychosis,0,0
138961,and,0,0
138962,cognitive,0,0
138963,impairment,0,0
138964,in,0,0
138965,first,0,0
138966,episode,0,0
138967,psychosis,0,0
138968,.,0,0
138969,BACKGROUND,0,0
138970,Duration,0,0
138971,of,0,0
138972,untreated,0,0
138973,psychosis,0,0
138974,(,0,1
138975,DUP,0,1
138976,),0,0
138977,has,0,0
138978,been,0,0
138979,significantly,0,0
138980,associated,0,0
138981,with,0,0
138982,poor,0,0
138983,clinical,0,0
138984,and,0,0
138985,social,0,0
138986,outcomes,0,0
138987,in,0,0
138988,First,0,0
138989,Episode,0,1
138990,Psychosis,0,1
138991,(,0,1
138992,FEP,0,1
138993,),0,1
138994,patients,0,0
138995,",",0,0
138996,but,0,0
138997,an,0,0
138998,association,0,0
138999,with,0,0
139000,cognitive,0,0
139001,outcomes,0,0
139002,has,0,0
139003,not,0,0
139004,been,0,0
139005,clearly,0,0
139006,established,0,0
139007,.,0,0
139008,METHOD,0,0
139009,Seventy-seven,0,0
139010,consecutively,0,0
139011,admitted,0,0
139012,",",0,0
139013,drug-na?ve,0,1
139014,patients,0,0
139015,with,0,0
139016,FEP,0,0
139017,were,0,0
139018,assessed,0,0
139019,at,0,0
139020,baseline,0,0
139021,and,0,0
139022,at,0,0
139023,1month,0,0
139024,and,0,0
139025,6months,0,0
139026,.,0,0
139027,Underlying,0,0
139028,dimensions,0,0
139029,of,0,0
139030,DUP,0,1
139031,(,0,0
139032,general,0,0
139033,prodrome,0,0
139034,and,0,0
139035,positive,0,0
139036,",",0,0
139037,negative,0,0
139038,and,0,0
139039,disorganisation,0,0
139040,symptoms,0,0
139041,),0,0
139042,were,0,0
139043,assessed,0,0
139044,using,0,0
139045,the,0,0
139046,Symptom,0,0
139047,Onset,0,0
139048,in,0,0
139049,Schizophrenia,0,1
139050,(,0,1
139051,SOS,0,1
139052,),0,1
139053,inventory,0,1
139054,(,0,1
139055,Perkins,0,1
139056,et,0,1
139057,al.,0,1
139058,",",0,0
139059,2000,0,0
139060,),0,0
139061,.,0,0
139062,To,0,0
139063,assess,0,0
139064,the,0,0
139065,effect,0,0
139066,of,0,0
139067,DUP,0,0
139068,on,0,0
139069,the,0,0
139070,neuropsychological,0,0
139071,status,0,0
139072,of,0,0
139073,the,0,0
139074,patients,0,0
139075,",",0,0
139076,a,0,0
139077,linear,0,0
139078,mixed-effect,0,0
139079,model,0,0
139080,was,0,0
139081,fitted,0,0
139082,to,0,0
139083,each,0,0
139084,neuropsychological,0,0
139085,dimension,0,0
139086,.,0,0
139087,These,0,0
139088,models,0,0
139089,included,0,0
139090,a,0,0
139091,dichotomised,0,0
139092,version,0,0
139093,of,0,0
139094,DUP,0,1
139095,(,0,0
139096,short,0,0
139097,versus,0,0
139098,long,0,0
139099,duration,0,1
139100,),0,0
139101,as,0,0
139102,a,0,0
139103,fixed,0,0
139104,effect,0,0
139105,",",0,0
139106,several,0,0
139107,adjusting,0,0
139108,variables,0,0
139109,to,0,0
139110,account,0,0
139111,for,0,0
139112,patient,0,0
139113,differences,0,0
139114,",",0,0
139115,and,0,0
139116,a,0,0
139117,random,0,0
139118,effect,0,0
139119,to,0,0
139120,incorporate,0,0
139121,the,0,0
139122,longitudinal,0,0
139123,structure,0,0
139124,of,0,0
139125,the,0,0
139126,data,0,0
139127,.,0,0
139128,RESULTS,0,0
139129,Patients,0,0
139130,with,0,0
139131,a,0,0
139132,short,0,0
139133,duration,0,0
139134,of,0,0
139135,untreated,0,0
139136,negative,0,0
139137,symptoms,0,0
139138,(,0,1
139139,DUNS,0,1
139140,),0,1
139141,or,0,0
139142,a,0,0
139143,short,0,0
139144,duration,0,0
139145,of,0,0
139146,untreated,0,0
139147,positive,0,0
139148,symptoms,0,0
139149,(,0,1
139150,DUPS,0,1
139151,),0,0
139152,outperformed,0,0
139153,patients,0,0
139154,with,0,0
139155,a,0,0
139156,long,0,0
139157,duration,0,0
139158,of,0,0
139159,untreated,0,0
139160,symptoms,0,0
139161,on,1,0
139162,memory,1,0
139163,tasks,1,0
139164,and,1,0
139165,a,1,0
139166,pre-attentional,1,0
139167,visual,1,0
139168,task,1,0
139169,but,0,0
139170,not,0,0
139171,on,1,0
139172,measures,1,0
139173,of,1,0
139174,verbal,1,0
139175,fluency,1,0
139176,",",1,0
139177,attention,1,0
139178,",",1,0
139179,reaction,1,0
139180,time,1,0
139181,",",1,0
139182,visual,1,0
139183,processing,1,0
139184,and,1,0
139185,executive,1,0
139186,functions,1,0
139187,.,1,0
139188,CONCLUSIONS,0,0
139189,This,0,0
139190,study,0,0
139191,provides,0,0
139192,additional,0,0
139193,support,0,0
139194,for,0,0
139195,an,0,0
139196,early,0,0
139197,intervention,0,0
139198,to,0,0
139199,shorten,0,0
139200,DUP,0,0
139201,to,0,0
139202,facilitate,0,0
139203,a,0,0
139204,better,0,0
139205,outcome,0,0
139206,in,0,0
139207,memory,0,0
139208,and,0,0
139209,attentional,0,0
139210,domains,0,0
139211,of,0,0
139212,FEP,0,0
139213,patients,0,0
139214,.,0,0
139215,Multiple,0,0
139216,courses,0,0
139217,of,0,0
139218,rituximab,1,1
139219,produce,0,0
139220,sustained,0,0
139221,clinical,0,0
139222,and,0,0
139223,radiographic,0,0
139224,efficacy,0,0
139225,and,0,0
139226,safety,0,0
139227,in,0,0
139228,patients,0,0
139229,with,0,0
139230,rheumatoid,0,0
139231,arthritis,0,0
139232,and,0,0
139233,an,0,0
139234,inadequate,0,0
139235,response,0,0
139236,to,0,0
139237,1,0,0
139238,or,0,0
139239,more,0,0
139240,tumor,1,0
139241,necrosis,1,0
139242,factor,1,0
139243,inhibitors,1,1
139244,:,1,0
139245,5-year,0,0
139246,data,0,0
139247,from,0,0
139248,the,0,0
139249,REFLEX,0,0
139250,study,0,0
139251,.,0,0
139252,OBJECTIVE,0,0
139253,This,0,0
139254,5-year,0,0
139255,observational,0,0
139256,posthoc,0,0
139257,analysis,0,0
139258,of,0,0
139259,the,0,0
139260,REFLEX,0,0
139261,study,0,0
139262,and,0,0
139263,its,0,0
139264,open-label,0,1
139265,extension,0,0
139266,assessed,0,0
139267,clinical,0,0
139268,efficacy,0,0
139269,",",0,0
139270,radiographic,0,0
139271,response,0,0
139272,",",0,0
139273,and,0,0
139274,safety,0,0
139275,of,0,1
139276,rituximab,1,1
139277,(,1,1
139278,RTX,1,1
139279,),1,0
139280,in,0,0
139281,patients,0,0
139282,with,0,0
139283,rheumatoid,0,0
139284,arthritis,0,1
139285,(,0,1
139286,RA,0,1
139287,),0,1
139288,who,0,0
139289,had,0,0
139290,an,0,0
139291,inadequate,0,0
139292,response,0,0
139293,to,0,0
139294,tumor,1,0
139295,necrosis,1,0
139296,factor,1,0
139297,(,1,1
139298,TNF,1,1
139299,),1,1
139300,inhibitors,1,1
139301,.,1,1
139302,METHODS,0,0
139303,Patients,0,0
139304,in,0,0
139305,REFLEX,0,0
139306,were,0,0
139307,originally,0,0
139308,randomized,0,0
139309,to,0,0
139310,placebo,1,1
139311,(,1,1
139312,PBO,1,1
139313,),1,1
139314,+,1,1
139315,methotrexate,1,1
139316,(,1,1
139317,MTX,1,1
139318,;,1,1
139319,PBO-randomized,1,1
139320,),1,1
139321,or,1,0
139322,RTX,1,1
139323,+,1,1
139324,MTX,1,1
139325,(,1,1
139326,RTX-randomized,1,1
139327,),1,1
139328,.,1,0
139329,PBO-randomized,0,0
139330,patients,0,0
139331,were,0,0
139332,rescued,0,0
139333,with,0,0
139334,RTX,0,0
139335,as,0,0
139336,appropriate,0,0
139337,.,0,0
139338,Patients,0,0
139339,responding,0,0
139340,to,0,0
139341,initial,0,0
139342,RTX,1,0
139343,treatment,0,0
139344,could,0,0
139345,receive,0,0
139346,further,0,0
139347,RTX,1,0
139348,courses,0,0
139349,.,0,0
139350,For,0,0
139351,clinical,0,0
139352,efficacy,0,0
139353,and,0,0
139354,safety,0,0
139355,analyses,0,0
139356,",",0,0
139357,PBO-randomized,0,0
139358,patients,0,0
139359,were,0,0
139360,re-baselined,0,0
139361,prior,0,0
139362,to,0,0
139363,first,0,0
139364,RTX,1,0
139365,treatment,0,0
139366,and,0,0
139367,the,0,0
139368,data,0,0
139369,were,0,0
139370,pooled,0,0
139371,with,0,0
139372,RTX-randomized,1,0
139373,patient,0,0
139374,data,0,0
139375,.,0,0
139376,Efficacy,0,0
139377,outcomes,0,0
139378,24,0,0
139379,weeks,0,0
139380,after,0,0
139381,each,0,0
139382,course,0,0
139383,were,0,0
139384,calculated,0,0
139385,relative,0,0
139386,to,0,0
139387,first,0,0
139388,RTX,1,1
139389,pretreatment,0,1
139390,baseline,0,1
139391,.,0,0
139392,Radiographic,0,0
139393,outcomes,0,0
139394,were,0,0
139395,assessed,0,0
139396,relative,0,0
139397,to,0,0
139398,randomization,0,0
139399,baseline,0,0
139400,for,0,0
139401,both,0,0
139402,PBO-randomized,0,0
139403,and,0,0
139404,RTX-randomized,1,0
139405,groups,0,0
139406,.,0,0
139407,RESULTS,0,0
139408,A,0,0
139409,total,0,0
139410,of,0,0
139411,480,0,0
139412,patients,0,0
139413,received,0,0
139414,?,0,0
139415,1,0,0
139416,RTX,1,0
139417,course,1,1
139418,.,0,0
139419,At,0,0
139420,24,0,0
139421,weeks,0,0
139422,",",0,0
139423,American,0,0
139424,College,0,0
139425,of,0,0
139426,Rheumatology,0,0
139427,20/50/70,0,0
139428,responses,0,0
139429,were,0,0
139430,62.0,0,0
139431,%,0,0
139432,",",0,0
139433,30.8,0,0
139434,%,0,0
139435,",",0,0
139436,and,0,0
139437,13.0,0,0
139438,%,0,0
139439,",",0,0
139440,respectively,0,0
139441,at,0,0
139442,course,0,0
139443,1,0,1
139444,(,0,0
139445,n,0,0
139446,=,0,0
139447,400,0,0
139448,),0,0
139449,and,0,0
139450,70.3,0,0
139451,%,0,0
139452,",",0,0
139453,41.8,0,0
139454,%,0,0
139455,",",0,0
139456,and,0,0
139457,22.0,0,0
139458,%,0,0
139459,at,0,0
139460,course,0,0
139461,5,0,0
139462,(,0,0
139463,n,0,0
139464,=,0,0
139465,91,0,0
139466,),0,0
139467,.,0,0
139468,European,0,0
139469,League,0,0
139470,Against,0,0
139471,Rheumatism,0,0
139472,good/moderate,0,0
139473,responses,0,0
139474,were,0,0
139475,77.2,0,0
139476,%,0,0
139477,and,0,0
139478,84.4,0,0
139479,%,0,0
139480,at,0,0
139481,courses,0,0
139482,1,0,1
139483,(,0,0
139484,n,0,0
139485,=,0,0
139486,390,0,0
139487,),0,0
139488,and,0,0
139489,5,0,1
139490,(,0,0
139491,n,0,0
139492,=,0,0
139493,90,0,0
139494,),0,0
139495,.,0,0
139496,Rates,0,0
139497,of,0,0
139498,adverse,0,0
139499,events,0,0
139500,(,0,1
139501,AE,0,1
139502,),0,1
139503,",",0,0
139504,serious,0,1
139505,AE,0,1
139506,",",0,0
139507,and,0,0
139508,infections,0,0
139509,generally,0,0
139510,remained,0,0
139511,stable,0,0
139512,.,0,0
139513,Rate,0,0
139514,of,0,0
139515,progressive,0,0
139516,joint,0,0
139517,damage,0,0
139518,(,0,1
139519,PJD,0,1
139520,;,0,0
139521,change,0,0
139522,in,0,0
139523,mean,0,0
139524,Total,0,0
139525,Sharp,0,0
139526,Score,0,0
139527,),0,0
139528,decreased,0,0
139529,over,0,0
139530,time,0,0
139531,in,0,0
139532,both,1,0
139533,PBO-randomized,1,1
139534,(,1,0
139535,n,0,0
139536,=,0,0
139537,79,0,0
139538,),0,0
139539,and,1,0
139540,RTX-randomized,1,1
139541,(,1,0
139542,n,0,0
139543,=,0,0
139544,105,0,0
139545,),0,0
139546,groups,0,0
139547,.,0,0
139548,Mean,0,0
139549,change,0,0
139550,from,0,0
139551,baseline,0,0
139552,in,0,0
139553,PJD,0,0
139554,over,0,0
139555,5,0,0
139556,years,0,0
139557,was,0,0
139558,greater,0,0
139559,in,0,0
139560,PBO-randomized,1,0
139561,versus,1,0
139562,RTX-randomized,1,0
139563,patients,1,0
139564,(,0,0
139565,5.51,0,0
139566,vs,0,0
139567,3.21,0,0
139568,),0,0
139569,.,0,0
139570,CONCLUSION,1,1
139571,RTX,1,1
139572,re-treatment,1,1
139573,over,1,0
139574,5,0,0
139575,years,0,0
139576,is,0,0
139577,associated,0,0
139578,with,0,0
139579,maintained,0,0
139580,or,0,0
139581,improved,0,0
139582,efficacy,0,0
139583,",",0,0
139584,continued,0,0
139585,inhibition,0,0
139586,of,0,0
139587,PJD,0,0
139588,",",0,0
139589,and,0,0
139590,a,0,0
139591,safety,0,0
139592,profile,0,0
139593,consistent,0,0
139594,with,0,0
139595,that,0,0
139596,previously,0,0
139597,reported,0,0
139598,.,0,0
139599,A,0,0
139600,delay,0,0
139601,in,0,0
139602,initiating,1,0
139603,RTX,1,0
139604,treatment,1,0
139605,may,1,0
139606,result,0,0
139607,in,0,0
139608,increased,0,0
139609,PJD,0,0
139610,.,0,0
139611,The,0,0
139612,effects,0,0
139613,of,0,0
139614,a,0,0
139615,six-week,0,0
139616,supervised,0,0
139617,multimodal,1,1
139618,exercise,1,0
139619,intervention,1,0
139620,during,0,0
139621,chemotherapy,1,0
139622,on,0,0
139623,cancer-related,0,0
139624,fatigue,0,0
139625,.,0,0
139626,PURPOSE,0,0
139627,Cancer,0,0
139628,related,0,0
139629,fatigue,0,1
139630,(,0,1
139631,CRF,0,1
139632,),0,0
139633,is,0,0
139634,a,0,0
139635,common,0,0
139636,problem,0,0
139637,for,0,0
139638,cancer,0,0
139639,patients,0,0
139640,across,0,0
139641,diagnoses,0,0
139642,during,0,0
139643,chemotherapy,1,0
139644,and,0,0
139645,is,0,0
139646,associated,0,0
139647,with,0,0
139648,physical,0,0
139649,inactivity,0,0
139650,",",0,0
139651,lower,0,0
139652,functional,0,0
139653,level,0,0
139654,and,0,0
139655,lack,0,0
139656,of,0,0
139657,energy,0,0
139658,.,0,0
139659,Few,0,0
139660,RCT,0,1
139661,exercise,1,0
139662,intervention,1,0
139663,studies,0,0
139664,have,0,0
139665,included,0,0
139666,cancer,0,0
139667,patients,0,0
139668,undergoing,0,0
139669,chemotherapy,0,0
139670,.,0,0
139671,The,0,0
139672,objective,0,0
139673,of,0,0
139674,this,0,0
139675,study,0,0
139676,is,0,0
139677,to,0,0
139678,evaluate,0,0
139679,whether,0,0
139680,a,0,0
139681,six-week,0,0
139682,supervised,1,0
139683,multimodal,1,1
139684,exercise,1,0
139685,intervention,1,0
139686,",",1,0
139687,adjunct,1,0
139688,to,1,0
139689,chemotherapy,1,0
139690,and,1,0
139691,standard,1,0
139692,care,1,0
139693,",",0,0
139694,can,0,0
139695,reduce,0,0
139696,the,0,0
139697,patient,0,0
139698,'s,0,0
139699,CRF,0,0
139700,level,0,0
139701,.,0,0
139702,METHODS,0,0
139703,Data,0,0
139704,is,0,0
139705,based,0,0
139706,on,0,0
139707,analyses,0,0
139708,of,0,0
139709,a,0,0
139710,prospective,0,0
139711,randomised,0,0
139712,controlled,0,0
139713,trial,0,0
139714,'The,0,1
139715,Body,0,1
139716,&,0,1
139717,Cancer,0,0
139718,Trial,0,0
139719,',0,0
139720,.,0,0
139721,213,0,0
139722,cancer,0,0
139723,patients,0,0
139724,with,0,0
139725,different,0,0
139726,diagnoses,0,0
139727,were,0,0
139728,randomised,0,0
139729,into,0,0
139730,an,0,0
139731,intervention,1,0
139732,group,1,0
139733,or,0,0
139734,wait-list,1,0
139735,control,1,0
139736,group,1,0
139737,.,1,0
139738,The,0,0
139739,primary,0,0
139740,outcome,0,0
139741,",",0,0
139742,Fatigue,0,0
139743,score,0,1
139744,(,0,1
139745,CRF,0,1
139746,),0,1
139747,",",0,0
139748,was,0,0
139749,evaluated,0,0
139750,by,0,0
139751,the,0,0
139752,Functional,0,0
139753,Assessment,0,0
139754,of,0,0
139755,Cancer,0,0
139756,Therapy-Anaemia,0,1
139757,Questionnaire,0,1
139758,(,0,1
139759,FACT-An-,0,1
139760,),0,1
139761,(,0,1
139762,FACT-G,0,1
139763,score,0,1
139764,&,0,1
139765,FACT-An,0,1
139766,Anemia,0,1
139767,subscale,0,1
139768,),0,0
139769,.,0,0
139770,INTERVENTION,0,1
139771,Supervised,1,0
139772,exercise,1,0
139773,",",1,0
139774,comprising,1,0
139775,high-intensity,1,0
139776,cardiovascular,1,0
139777,and,1,0
139778,heavy,1,0
139779,resistance,1,0
139780,training,1,0
139781,",",1,0
139782,relaxation-,1,1
139783,and,1,0
139784,body,1,0
139785,awareness,1,0
139786,training,1,0
139787,and,1,0
139788,massage,1,0
139789,",",0,0
139790,9,0,0
139791,h,0,0
139792,weekly,0,0
139793,for,0,0
139794,6,0,0
139795,weeks,0,0
139796,.,0,0
139797,RESULTS,0,0
139798,CRF,0,0
139799,was,0,0
139800,significantly,0,0
139801,reduced,0,0
139802,in,0,0
139803,the,0,0
139804,intervention,0,0
139805,group,0,0
139806,",",0,0
139807,corresponding,0,0
139808,to,0,0
139809,a,0,0
139810,Fatigue,0,0
139811,score,0,0
139812,reduction,0,0
139813,of,0,0
139814,3.04,0,0
139815,(,0,0
139816,effect,0,0
139817,size,0,0
139818,of,0,0
139819,0.44,0,0
139820,",",0,0
139821,95,0,0
139822,%,0,0
139823,CI,0,0
139824,0.17-0.72,0,0
139825,),0,0
139826,(,0,0
139827,P,0,0
139828,=,0,0
139829,.002,0,0
139830,),0,0
139831,",",0,0
139832,the,0,0
139833,FACT-An,0,0
139834,score,0,0
139835,by,0,0
139836,5.40,0,0
139837,(,0,0
139838,P,0,0
139839,=,0,0
139840,.015,0,0
139841,),0,0
139842,",",0,0
139843,the,0,0
139844,FACT-An,0,1
139845,Toi,0,1
139846,score,0,0
139847,by,0,0
139848,5.22,0,0
139849,(,0,0
139850,P,0,0
139851,=,0,0
139852,.009,0,0
139853,),0,0
139854,and,0,0
139855,the,0,0
139856,Anaemia-ANS,0,0
139857,by,0,0
139858,3.76,0,0
139859,(,0,0
139860,P,0,0
139861,=,0,0
139862,.002,0,0
139863,),0,0
139864,.,0,0
139865,There,0,0
139866,was,0,0
139867,no,0,0
139868,statistically,0,0
139869,significant,0,0
139870,effect,0,0
139871,on,0,0
139872,the,0,0
139873,General,0,0
139874,Quality,0,0
139875,of,0,0
139876,Life,0,1
139877,score,0,1
139878,(,0,1
139879,FACT-G,0,1
139880,),0,1
139881,or,0,0
139882,on,0,0
139883,any,0,0
139884,of,0,0
139885,the,0,0
139886,individual,0,0
139887,wellbeing,0,0
139888,scores,0,1
139889,;,0,1
139890,Physical,0,0
139891,(,0,0
139892,P,0,0
139893,=,0,0
139894,.13,0,0
139895,),0,0
139896,",",0,0
139897,Emotional,0,0
139898,(,0,0
139899,P,0,0
139900,=,0,0
139901,.87,0,0
139902,),0,0
139903,",",0,0
139904,Social,0,0
139905,(,0,0
139906,P,0,0
139907,=,0,0
139908,.83,0,0
139909,),0,0
139910,and,0,0
139911,Functional,0,0
139912,(,0,0
139913,P,0,0
139914,=,0,0
139915,.26,0,0
139916,),0,0
139917,.,0,0
139918,CONCLUSION,0,0
139919,In,0,0
139920,summary,0,0
139921,",",0,0
139922,this,0,0
139923,six-week,0,0
139924,supervised,1,0
139925,multimodal,1,1
139926,exercise,1,0
139927,intervention,1,0
139928,can,0,0
139929,lead,0,0
139930,to,0,0
139931,significant,0,0
139932,reduction,0,0
139933,in,0,0
139934,self-reported,0,0
139935,CRF,0,0
139936,in,0,0
139937,cancer,0,0
139938,patients,0,0
139939,undergoing,0,0
139940,chemotherapy,0,0
139941,.,0,0
139942,End-expiratory,0,1
139943,lung,0,0
139944,volume,0,0
139945,recovers,0,0
139946,more,0,0
139947,slowly,0,0
139948,after,0,0
139949,closed,1,0
139950,endotracheal,1,0
139951,suctioning,1,1
139952,than,0,0
139953,after,0,0
139954,open,1,0
139955,suctioning,1,0
139956,:,1,0
139957,a,0,0
139958,randomized,0,0
139959,crossover,0,1
139960,study,0,0
139961,.,0,0
139962,PURPOSE,0,0
139963,Endotracheal,0,0
139964,suctioning,0,0
139965,causes,0,0
139966,significant,0,0
139967,lung,0,0
139968,derecruitment,0,0
139969,.,0,0
139970,Closed,1,0
139971,suction,1,0
139972,(,1,1
139973,CS,1,1
139974,),1,1
139975,minimizes,0,0
139976,lung,0,0
139977,volume,0,0
139978,loss,0,0
139979,during,0,0
139980,suction,0,0
139981,",",0,0
139982,and,0,0
139983,therefore,0,0
139984,",",0,0
139985,volumes,0,0
139986,are,0,0
139987,presumed,0,0
139988,to,0,0
139989,recover,0,0
139990,more,0,0
139991,quickly,0,0
139992,postsuctioning,0,0
139993,.,0,0
139994,Conflicting,0,0
139995,evidence,0,0
139996,exists,0,0
139997,regarding,0,0
139998,this,0,0
139999,.,0,0
140000,We,0,0
140001,examined,0,0
140002,the,0,0
140003,effects,0,0
140004,of,0,0
140005,open,1,0
140006,suction,1,1
140007,(,1,1
140008,OS,1,1
140009,),1,1
140010,and,1,0
140011,CS,1,1
140012,on,0,0
140013,lung,0,0
140014,volume,0,0
140015,loss,0,0
140016,during,0,0
140017,suctioning,1,0
140018,",",0,0
140019,and,0,0
140020,recovery,0,0
140021,of,0,0
140022,end-expiratory,0,0
140023,lung,0,1
140024,volume,0,1
140025,(,0,1
140026,EELV,0,1
140027,),0,0
140028,up,0,0
140029,to,0,0
140030,30,0,0
140031,minutes,0,0
140032,postsuction,0,0
140033,.,0,0
140034,MATERIAL,0,0
140035,AND,0,1
140036,METHODS,0,1
140037,Randomized,0,1
140038,crossover,0,1
140039,study,0,0
140040,examining,0,0
140041,20,0,0
140042,patients,0,0
140043,postcardiac,0,0
140044,surgery,0,0
140045,.,0,0
140046,CS,1,0
140047,and,0,0
140048,OS,1,0
140049,were,0,0
140050,performed,0,0
140051,in,0,0
140052,random,0,0
140053,order,0,0
140054,",",0,0
140055,30,0,0
140056,minutes,0,0
140057,apart,0,0
140058,.,0,0
140059,Lung,0,0
140060,impedance,0,0
140061,was,0,0
140062,measured,0,0
140063,during,0,0
140064,suction,0,0
140065,",",0,0
140066,and,0,0
140067,end-expiratory,0,0
140068,lung,0,0
140069,impedance,0,0
140070,was,0,0
140071,measured,0,0
140072,at,0,0
140073,baseline,0,0
140074,and,0,0
140075,postsuctioning,0,0
140076,using,0,0
140077,electrical,0,0
140078,impedance,0,0
140079,tomography,0,0
140080,.,0,0
140081,Oximetry,0,0
140082,",",0,0
140083,partial,0,0
140084,pressure,0,0
140085,of,0,0
140086,oxygen,0,0
140087,in,0,0
140088,the,0,0
140089,alveoli/fraction,0,0
140090,of,0,0
140091,inspired,0,0
140092,oxygen,0,0
140093,ratio,0,0
140094,and,0,0
140095,compliance,0,0
140096,were,0,0
140097,collected,0,0
140098,.,0,0
140099,RESULTS,0,0
140100,Reductions,0,0
140101,in,0,0
140102,lung,0,0
140103,impedance,0,0
140104,during,0,0
140105,suctioning,0,0
140106,were,0,0
140107,less,0,0
140108,for,0,0
140109,CS,1,0
140110,than,0,0
140111,for,0,0
140112,OS,1,0
140113,(,0,0
140114,mean,0,0
140115,difference,0,0
140116,",",0,0
140117,-905,0,0
140118,impedance,0,0
140119,units,0,0
140120,;,0,0
140121,95,0,0
140122,%,0,0
140123,confidence,0,0
140124,interval,0,0
140125,[,0,0
140126,CI,0,0
140127,],0,0
140128,",",0,0
140129,-1234,0,0
140130,to,0,0
140131,-587,0,0
140132,;,0,0
140133,P,0,0
140134,<,0,0
140135,.001,0,0
140136,),0,0
140137,.,0,0
140138,However,0,0
140139,",",0,0
140140,at,0,0
140141,all,0,0
140142,points,0,0
140143,postsuctioning,0,0
140144,",",0,0
140145,EELV,0,0
140146,recovered,0,0
140147,more,0,0
140148,slowly,0,0
140149,after,0,0
140150,CS,1,0
140151,than,0,0
140152,after,0,0
140153,OS,1,0
140154,.,1,0
140155,There,0,0
140156,were,0,0
140157,no,0,0
140158,statistically,0,0
140159,significant,0,0
140160,differences,0,0
140161,in,0,0
140162,the,0,0
140163,other,0,0
140164,respiratory,0,0
140165,parameters,0,0
140166,.,0,0
140167,CONCLUSIONS,0,0
140168,Closed,1,0
140169,suctioning,1,0
140170,minimized,0,0
140171,lung,0,0
140172,volume,0,0
140173,loss,0,0
140174,during,0,0
140175,suctioning,0,0
140176,but,0,0
140177,",",0,0
140178,counterintuitively,0,0
140179,",",0,0
140180,resulted,0,0
140181,in,0,0
140182,slower,0,0
140183,recovery,0,0
140184,of,0,0
140185,EELV,0,0
140186,postsuction,0,0
140187,compared,0,0
140188,with,0,0
140189,OS,1,0
140190,.,1,0
140191,Therefore,0,0
140192,",",0,0
140193,the,0,0
140194,use,0,0
140195,of,0,0
140196,CS,1,0
140197,can,0,0
140198,not,0,0
140199,be,0,0
140200,assumed,0,0
140201,to,0,0
140202,be,0,0
140203,protective,0,0
140204,of,0,0
140205,lung,0,0
140206,volumes,0,0
140207,postsuctioning,0,0
140208,.,0,0
140209,Consideration,0,0
140210,should,0,0
140211,be,0,0
140212,given,0,0
140213,to,0,0
140214,restoring,0,0
140215,EELV,0,0
140216,after,0,0
140217,either,0,0
140218,suction,0,0
140219,method,0,0
140220,via,0,0
140221,a,0,0
140222,recruitment,0,0
140223,maneuver,0,0
140224,.,0,0
140225,Dysfunctional,0,0
140226,attitudes,0,0
140227,as,0,0
140228,a,0,0
140229,moderator,0,0
140230,of,0,0
140231,pharmacotherapy,1,0
140232,and,0,0
140233,psychotherapy,1,0
140234,for,0,0
140235,chronic,0,0
140236,depression,0,0
140237,.,0,0
140238,OBJECTIVE,0,0
140239,Individuals,0,0
140240,with,0,0
140241,chronic,0,0
140242,depression,0,0
140243,exhibit,0,0
140244,heterogeneous,0,0
140245,responses,0,0
140246,to,0,0
140247,treatment,0,0
140248,.,0,0
140249,Important,0,0
140250,individual,0,0
140251,differences,0,0
140252,may,0,0
140253,therefore,0,0
140254,exist,0,0
140255,within,0,0
140256,this,0,0
140257,particularly,0,0
140258,difficult,0,0
140259,to,0,0
140260,treat,0,0
140261,population,0,0
140262,that,0,0
140263,act,0,0
140264,as,0,0
140265,moderators,0,0
140266,of,0,0
140267,treatment,0,0
140268,response,0,0
140269,.,0,0
140270,METHOD,0,0
140271,The,0,0
140272,present,0,0
140273,study,0,0
140274,examined,0,0
140275,whether,0,0
140276,pretreatment,0,0
140277,levels,0,0
140278,of,0,0
140279,dysfunctional,0,0
140280,attitudes,0,0
140281,(,0,1
140282,DA,0,1
140283,),0,1
140284,moderated,0,0
140285,treatment,0,0
140286,response,0,0
140287,in,0,0
140288,a,0,0
140289,large,0,0
140290,sample,0,0
140291,of,0,0
140292,chronically,0,0
140293,depressed,0,0
140294,individuals,0,0
140295,.,0,0
140296,Data,0,0
140297,were,0,0
140298,taken,0,0
140299,from,0,0
140300,the,0,0
140301,Research,0,0
140302,Evaluating,0,0
140303,the,0,0
140304,Value,0,0
140305,of,0,0
140306,Augmenting,0,0
140307,Medication,0,0
140308,with,0,0
140309,Psychotherapy,0,0
140310,(,0,1
140311,REVAMP,0,1
140312,),0,0
140313,treatment,0,0
140314,study,0,0
140315,--,0,0
140316,a,0,0
140317,multi-site,0,0
140318,treatment,0,0
140319,and,0,0
140320,augmentation,0,0
140321,study,0,0
140322,of,0,0
140323,808,0,0
140324,chronically,0,0
140325,depressed,0,0
140326,individuals,0,0
140327,.,0,0
140328,REVAMP,0,0
140329,comprised,0,0
140330,two,0,0
140331,phases,0,0
140332,:,0,0
140333,1,0,0
140334,),0,0
140335,a,0,0
140336,12-week,1,1
140337,open-label,1,1
140338,antidepressant,1,1
140339,trial,1,1
140340,and,0,1
140341,2,0,1
140342,),0,0
140343,",",0,0
140344,a,0,0
140345,subsequent,0,0
140346,phase,0,0
140347,",",0,0
140348,in,0,0
140349,which,0,0
140350,phase,0,0
140351,1,0,0
140352,non-remitters,0,0
140353,(,0,0
140354,N,0,0
140355,=,0,0
140356,491,0,0
140357,),0,0
140358,were,0,0
140359,randomized,0,0
140360,to,0,0
140361,either,0,0
140362,receive,0,0
140363,an,0,0
140364,ongoing,1,0
140365,medication,1,0
140366,algorithm,1,0
140367,alone,1,0
140368,",",1,0
140369,medication,1,0
140370,plus,1,0
140371,cognitive,1,0
140372,behavioral,1,0
140373,analysis,1,0
140374,system,1,0
140375,of,1,0
140376,psychotherapy,1,0
140377,",",1,0
140378,or,1,0
140379,medication,1,0
140380,plus,1,0
140381,brief,1,0
140382,supportive,1,0
140383,psychotherapy,1,0
140384,.,1,0
140385,RESULT,0,0
140386,In,0,0
140387,phase,0,0
140388,1,0,0
140389,",",0,0
140390,compared,0,0
140391,to,0,0
140392,the,0,0
140393,pharmacotherapy,0,0
140394,response,0,0
140395,of,0,0
140396,patients,0,0
140397,with,0,0
140398,lower,0,0
140399,DA,0,0
140400,scores,0,0
140401,",",0,0
140402,the,0,0
140403,response,0,0
140404,for,0,0
140405,patients,0,0
140406,with,0,0
140407,higher,0,0
140408,DA,0,0
140409,scores,0,0
140410,was,0,0
140411,steeper,0,0
140412,",",0,0
140413,but,0,0
140414,leveled,0,0
140415,off,0,0
140416,toward,0,0
140417,the,0,0
140418,end,0,0
140419,of,0,0
140420,the,0,0
140421,phase,0,0
140422,.,0,0
140423,In,0,0
140424,phase,0,0
140425,2,0,0
140426,",",0,0
140427,DA,0,0
140428,predicted,0,0
140429,a,0,0
140430,differential,0,0
140431,response,0,0
140432,in,0,0
140433,the,0,0
140434,medication,0,0
140435,only,0,0
140436,arm,0,0
140437,",",0,0
140438,but,0,0
140439,not,0,0
140440,in,0,0
140441,the,0,0
140442,two,0,0
140443,psychotherapy,1,1
140444,+,1,0
140445,medication,1,0
140446,conditions,0,0
140447,.,0,0
140448,Specifically,0,0
140449,",",0,0
140450,in,0,0
140451,the,0,0
140452,phase,0,0
140453,2,0,0
140454,medication,1,0
140455,only,0,0
140456,condition,0,0
140457,",",0,0
140458,patients,0,0
140459,with,0,0
140460,higher,0,0
140461,DA,0,0
140462,improved,0,0
140463,while,0,0
140464,those,0,0
140465,with,0,0
140466,lower,0,0
140467,DA,0,0
140468,scores,0,0
140469,did,0,0
140470,not,0,0
140471,.,0,0
140472,CONCLUSION,0,0
140473,These,0,0
140474,results,0,0
140475,indicate,0,0
140476,that,0,0
140477,the,0,0
140478,relation,0,0
140479,between,0,0
140480,DA,0,0
140481,and,0,0
140482,treatment,0,0
140483,response,0,0
140484,in,0,0
140485,chronic,0,0
140486,depression,0,0
140487,is,0,0
140488,complex,0,0
140489,",",0,0
140490,but,0,0
140491,suggest,0,0
140492,that,0,0
140493,greater,0,0
140494,DA,0,0
140495,may,0,0
140496,be,0,0
140497,associated,0,0
140498,with,0,0
140499,a,0,0
140500,steeper,0,0
140501,reduction,0,0
140502,and/or,0,0
140503,better,0,0
140504,response,0,0
140505,to,0,0
140506,pharmacotherapy,1,0
140507,.,1,0
140508,Role,0,1
140509,of,0,0
140510,posterior,1,0
140511,tibial,1,0
140512,nerve,1,0
140513,stimulation,1,0
140514,in,0,0
140515,the,0,0
140516,treatment,0,0
140517,of,0,0
140518,refractory,0,0
140519,monosymptomatic,0,0
140520,nocturnal,0,0
140521,enuresis,0,0
140522,:,0,0
140523,a,0,0
140524,pilot,0,0
140525,study,0,0
140526,.,0,0
140527,PURPOSE,0,0
140528,We,0,0
140529,evaluated,0,0
140530,the,0,0
140531,early,0,0
140532,clinical,0,0
140533,and,0,0
140534,urodynamic,0,0
140535,results,0,0
140536,of,0,0
140537,posterior,1,0
140538,tibial,1,0
140539,nerve,1,0
140540,stimulation,1,0
140541,in,0,0
140542,patients,0,0
140543,with,0,0
140544,refractory,0,0
140545,monosymptomatic,0,0
140546,nocturnal,0,0
140547,enuresis,0,0
140548,.,0,0
140549,MATERIALS,0,0
140550,AND,0,1
140551,METHODS,0,1
140552,We,0,0
140553,randomly,0,0
140554,assigned,0,0
140555,28,0,0
140556,patients,0,0
140557,with,0,0
140558,refractory,0,0
140559,monosymptomatic,0,0
140560,nocturnal,0,0
140561,enuresis,0,0
140562,to,0,0
140563,2,0,0
140564,equal,0,0
140565,groups,0,0
140566,.,0,0
140567,Group,0,0
140568,1,0,0
140569,received,0,0
140570,a,0,0
140571,weekly,0,0
140572,session,0,0
140573,of,0,0
140574,posterior,1,0
140575,tibial,1,0
140576,nerve,1,0
140577,stimulation,1,0
140578,for,0,0
140579,12,0,0
140580,weeks,0,0
140581,and,0,0
140582,group,0,0
140583,2,0,0
140584,was,0,0
140585,the,0,0
140586,placebo,1,1
140587,group,1,1
140588,.,1,0
140589,Evaluation,0,0
140590,was,0,0
140591,performed,0,0
140592,in,0,0
140593,each,0,0
140594,group,0,0
140595,at,0,0
140596,baseline,0,0
140597,and,0,0
140598,after,0,0
140599,posterior,0,0
140600,tibial,0,0
140601,nerve,0,0
140602,stimulation,0,0
140603,to,0,0
140604,compare,0,0
140605,clinical,0,0
140606,and,0,0
140607,urodynamic,0,0
140608,findings,0,0
140609,.,0,0
140610,Another,0,0
140611,clinical,0,0
140612,assessment,0,0
140613,was,0,0
140614,done,0,0
140615,3,0,0
140616,months,0,0
140617,after,0,0
140618,the,0,0
140619,first,0,0
140620,followup,0,0
140621,.,0,0
140622,RESULTS,0,0
140623,The,0,0
140624,2,0,0
140625,groups,0,0
140626,were,0,0
140627,comparable,0,0
140628,in,0,0
140629,baseline,0,0
140630,clinical,0,0
140631,and,0,0
140632,urodynamic,0,0
140633,data,0,0
140634,.,0,0
140635,Overall,0,0
140636,",",0,0
140637,13,0,0
140638,patients,0,0
140639,(,0,0
140640,46.4,0,0
140641,%,0,0
140642,),0,0
140643,had,0,0
140644,detrusor,0,0
140645,overactivity,0,0
140646,and,0,0
140647,14,0,0
140648,(,0,0
140649,50,0,0
140650,%,0,0
140651,),0,0
140652,had,0,0
140653,decreased,0,0
140654,bladder,0,0
140655,capacity,0,0
140656,.,0,0
140657,After,0,0
140658,treatment,0,0
140659,11,0,0
140660,group,0,0
140661,1,0,0
140662,patients,0,0
140663,(,0,0
140664,78.6,0,0
140665,%,0,0
140666,),0,0
140667,had,0,0
140668,a,0,0
140669,partial,0,0
140670,or,0,0
140671,full,0,0
140672,response,0,0
140673,to,0,0
140674,posterior,0,0
140675,tibial,0,0
140676,nerve,0,0
140677,stimulation,0,0
140678,but,0,0
140679,only,0,0
140680,2,0,0
140681,(,0,0
140682,14.3,0,0
140683,%,0,0
140684,),0,0
140685,in,0,0
140686,group,0,0
140687,2,0,0
140688,had,0,0
140689,a,0,0
140690,partial,0,0
140691,response,0,0
140692,(,0,0
140693,p,0,0
140694,=,0,0
140695,0.002,0,0
140696,),0,0
140697,.,0,0
140698,Also,0,0
140699,",",0,0
140700,the,0,0
140701,average,0,0
140702,number,0,0
140703,of,0,0
140704,wet,0,0
140705,nights,0,0
140706,in,0,0
140707,group,0,0
140708,1,0,0
140709,was,0,0
140710,significantly,0,0
140711,lower,0,0
140712,than,0,0
140713,at,0,0
140714,baseline,0,0
140715,(,0,0
140716,p,0,0
140717,=,0,0
140718,0.002,0,0
140719,),0,0
140720,.,0,0
140721,All,0,0
140722,urodynamic,0,0
140723,parameters,0,0
140724,significantly,0,0
140725,improved,0,0
140726,in,0,0
140727,group,0,0
140728,1,0,0
140729,.,0,0
140730,In,0,0
140731,contrast,0,0
140732,",",0,0
140733,the,0,0
140734,number,0,0
140735,of,0,0
140736,wet,0,0
140737,nights,0,0
140738,and,0,0
140739,urodynamic,0,0
140740,parameters,0,0
140741,did,0,0
140742,not,0,0
140743,change,0,0
140744,significantly,0,0
140745,in,0,0
140746,group,0,0
140747,2,0,0
140748,.,0,0
140749,At,0,0
140750,3-month,0,0
140751,followup,0,0
140752,the,0,0
140753,number,0,0
140754,of,0,0
140755,patients,0,0
140756,with,0,0
140757,a,0,0
140758,partial,0,0
140759,or,0,0
140760,full,0,0
140761,response,0,0
140762,in,0,0
140763,group,0,0
140764,1,0,0
140765,had,0,0
140766,decreased,0,0
140767,from,0,0
140768,11,0,0
140769,(,0,0
140770,78.6,0,0
140771,%,0,0
140772,),0,0
140773,to,0,0
140774,6,0,0
140775,(,0,0
140776,42.9,0,0
140777,%,0,0
140778,),0,0
140779,.,0,0
140780,No,0,1
140781,change,0,0
140782,was,0,0
140783,evident,0,0
140784,in,0,0
140785,group,0,0
140786,2,0,0
140787,.,0,0
140788,CONCLUSIONS,0,0
140789,Posterior,1,0
140790,tibial,1,0
140791,nerve,1,0
140792,stimulation,1,0
140793,can,0,0
140794,be,0,0
140795,a,0,0
140796,viable,0,0
140797,treatment,0,0
140798,option,0,0
140799,in,0,0
140800,some,0,0
140801,patients,0,0
140802,with,0,0
140803,refractory,0,0
140804,monosymptomatic,0,0
140805,nocturnal,0,0
140806,enuresis,0,0
140807,.,0,0
140808,However,0,0
140809,",",0,0
140810,deterioration,0,0
140811,in,0,0
140812,some,0,0
140813,responders,0,0
140814,with,0,0
140815,time,0,0
140816,suggests,0,0
140817,the,0,0
140818,need,0,0
140819,for,0,0
140820,maintenance,0,0
140821,protocols,0,0
140822,.,0,0
140823,Acceleration,0,0
140824,of,0,0
140825,insulin,0,1
140826,pharmacodynamic,0,1
140827,profile,0,0
140828,by,0,0
140829,a,0,0
140830,novel,0,0
140831,insulin,1,1
140832,infusion,1,1
140833,site,1,1
140834,warming,1,1
140835,device,1,0
140836,.,1,0
140837,BACKGROUND,0,0
140838,AND,0,1
140839,OBJECTIVE,0,1
140840,Subcutaneously,0,1
140841,injected,0,1
140842,rapid-acting,0,1
140843,insulin,0,1
140844,analogs,0,1
140845,do,0,0
140846,not,0,0
140847,replicate,0,0
140848,physiologic,0,0
140849,insulin,0,1
140850,action,0,0
140851,due,0,0
140852,to,0,0
140853,delays,0,0
140854,in,0,0
140855,their,0,0
140856,onset,0,0
140857,and,0,0
140858,peak,0,0
140859,action,0,0
140860,resulting,0,0
140861,in,0,0
140862,postprandial,0,1
140863,glucose,0,1
140864,excursions,0,1
140865,.,0,0
140866,The,1,0
140867,InsuPatch,1,0
140868,(,1,0
140869,IP,1,1
140870,),1,0
140871,is,0,0
140872,a,0,0
140873,novel,0,0
140874,insulin,0,1
140875,infusion,0,1
140876,site,0,1
140877,warming,0,1
140878,device,0,0
140879,developed,0,0
140880,to,0,0
140881,accelerate,0,0
140882,insulin,0,1
140883,action,0,0
140884,by,0,0
140885,increasing,0,0
140886,blood,0,0
140887,flow,0,0
140888,to,0,0
140889,the,0,0
140890,area,0,0
140891,of,0,0
140892,insulin,0,1
140893,absorption,0,1
140894,.,0,1
140895,Thirteen,0,0
140896,adolescents,0,0
140897,with,0,0
140898,type,0,0
140899,1,0,0
140900,diabetes,0,0
140901,(,0,1
140902,T1D,0,0
140903,",",0,0
140904,mean,0,0
140905,age,0,0
140906,14,0,0
140907,?,0,0
140908,4,0,0
140909,yr,0,0
140910,),0,0
140911,were,0,0
140912,enrolled,0,0
140913,in,0,0
140914,this,0,0
140915,study,0,0
140916,to,0,0
140917,investigate,0,0
140918,the,0,0
140919,effect,0,0
140920,of,0,0
140921,the,0,0
140922,IP,1,0
140923,on,0,0
140924,the,0,0
140925,pharmacodynamics,0,1
140926,and,0,1
140927,pharmacokinetics,0,1
140928,of,0,0
140929,a,0,0
140930,0.2,0,0
140931,unit/kg,0,1
140932,bolus,0,1
140933,dose,1,1
140934,of,1,1
140935,aspart,1,1
140936,insulin,1,1
140937,using,1,1
140938,the,1,1
140939,euglycemic,1,1
140940,clamp,1,1
140941,technique,1,1
140942,.,1,0
140943,RESEARCH,1,0
140944,DESIGN,0,1
140945,AND,0,1
140946,METHODS,0,1
140947,Each,0,0
140948,subject,0,0
140949,underwent,0,0
140950,two,1,0
140951,euglycemic,1,1
140952,clamp,1,1
140953,procedures,1,1
140954,on,1,0
140955,separate,1,0
140956,occasions,0,0
140957,:,0,0
140958,one,0,0
140959,with,0,0
140960,IP,1,0
140961,and,0,0
140962,one,1,0
140963,without,1,0
140964,IP,1,0
140965,activation,1,0
140966,in,0,0
140967,random,0,0
140968,order,0,0
140969,.,0,0
140970,RESULTS,0,0
140971,When,0,0
140972,the,0,1
140973,insulin,0,1
140974,bolus,0,1
140975,was,0,0
140976,given,0,0
140977,with,0,0
140978,IP,0,0
140979,activation,0,0
140980,as,0,0
140981,compared,0,0
140982,to,0,0
140983,without,0,0
140984,IP,0,0
140985,activation,0,0
140986,",",0,0
140987,time,0,0
140988,to,0,0
140989,reach,0,0
140990,maximum,0,0
140991,insulin,0,1
140992,action,0,1
140993,(,0,1
140994,T,0,1
140995,(,0,1
140996,GIRmax,0,1
140997,),0,1
140998,),0,0
140999,and,0,0
141000,to,0,0
141001,reach,0,0
141002,50,0,0
141003,%,0,0
141004,maximum,0,0
141005,action,0,0
141006,(,0,0
141007,T,0,1
141008,(,0,0
141009,50,0,0
141010,%,0,0
141011,GIRmax,0,1
141012,),0,0
141013,),0,0
141014,were,0,0
141015,35,0,0
141016,and,0,0
141017,18,0,0
141018,min,0,0
141019,earlier,0,0
141020,(,0,0
141021,125,0,0
141022,?,0,0
141023,8,0,0
141024,min,0,0
141025,vs.,0,0
141026,90,0,0
141027,?,0,0
141028,6,0,0
141029,min,0,0
141030,",",0,0
141031,p,0,0
141032,=,0,0
141033,0.002,0,0
141034,and,0,0
141035,58,0,0
141036,?,0,0
141037,5,0,0
141038,min,0,0
141039,.,0,0
141040,vs.,0,0
141041,40,0,0
141042,?,0,0
141043,3,0,0
141044,min,0,0
141045,",",0,0
141046,p,0,0
141047,=,0,0
141048,0.01,0,0
141049,",",0,0
141050,respectively,0,0
141051,),0,0
141052,",",0,0
141053,and,0,0
141054,the,0,0
141055,area,0,0
141056,under,0,0
141057,curve,0,0
141058,",",0,0
141059,AUC,0,1
141060,(,0,0
141061,GIR,0,0
141062,0-90,0,0
141063,min,0,0
141064,),0,0
141065,",",0,0
141066,reflecting,0,0
141067,early,0,0
141068,glucodynamic,0,1
141069,action,0,0
141070,",",0,0
141071,was,0,0
141072,significantly,0,0
141073,greater,0,0
141074,(,0,0
141075,p,0,0
141076,=,0,0
141077,0.001,0,0
141078,),0,0
141079,.,0,0
141080,IP,0,0
141081,activation,0,0
141082,also,0,0
141083,accelerated,0,0
141084,the,0,0
141085,rise,0,0
141086,in,0,0
141087,plasma,0,1
141088,insulin,0,1
141089,levels,0,0
141090,after,0,0
141091,the,0,0
141092,bolus,0,1
141093,(,0,0
141094,p,0,0
141095,=,0,0
141096,0.03,0,0
141097,),0,0
141098,and,0,0
141099,resulted,0,0
141100,in,0,0
141101,a,0,0
141102,higher,0,0
141103,peak,0,0
141104,(,0,0
141105,p,0,0
141106,=,0,0
141107,0.04,0,0
141108,),0,0
141109,and,0,0
141110,greater,0,0
141111,overall,0,0
141112,increase,0,0
141113,(,0,0
141114,p,0,0
141115,=,0,0
141116,0.02,0,0
141117,),0,0
141118,in,0,0
141119,plasma,0,1
141120,insulin,0,1
141121,levels,0,0
141122,.,0,0
141123,CONCLUSIONS,0,0
141124,Our,0,0
141125,results,1,0
141126,show,1,0
141127,that,1,0
141128,insulin,1,1
141129,infusion,1,1
141130,site,0,1
141131,warming,0,0
141132,with,0,0
141133,IP,0,0
141134,activation,0,0
141135,accelerates,0,0
141136,the,0,0
141137,time,0,0
141138,action,0,0
141139,profile,0,0
141140,of,0,0
141141,aspart,0,1
141142,insulin,0,1
141143,which,0,0
141144,may,0,0
141145,be,0,0
141146,of,0,0
141147,benefit,0,0
141148,to,0,0
141149,current,0,0
141150,open-loop,0,0
141151,and,0,0
141152,future,0,1
141153,closed-loop,0,1
141154,insulin,0,1
141155,delivery,0,1
141156,in,0,0
141157,patients,0,0
141158,with,0,0
141159,T1D,0,0
141160,.,0,0
141161,Prognostic,0,0
141162,interaction,0,0
141163,between,0,0
141164,expression,0,0
141165,of,0,0
141166,p53,0,0
141167,and,0,0
141168,estrogen,0,1
141169,receptor,0,0
141170,in,0,0
141171,patients,0,0
141172,with,0,0
141173,node-negative,0,0
141174,breast,0,0
141175,cancer,0,0
141176,:,0,0
141177,results,0,0
141178,from,0,0
141179,IBCSG,0,0
141180,Trials,0,0
141181,VIII,0,1
141182,and,0,0
141183,IX,0,0
141184,.,0,0
141185,INTRODUCTION,0,0
141186,The,0,0
141187,prognostic,0,0
141188,significance,0,0
141189,of,0,0
141190,p53,0,0
141191,protein,0,0
141192,expression,0,0
141193,in,0,0
141194,early,0,0
141195,breast,0,0
141196,cancer,0,0
141197,remains,0,0
141198,uncertain,0,0
141199,",",0,0
141200,with,0,0
141201,some,0,0
141202,but,0,0
141203,not,0,0
141204,all,0,0
141205,studies,0,0
141206,finding,0,0
141207,an,0,0
141208,association,0,0
141209,with,0,0
141210,poorer,0,0
141211,outcomes,0,0
141212,.,0,0
141213,Estrogen,0,0
141214,receptor,0,0
141215,(,0,1
141216,ER,0,1
141217,),0,0
141218,expression,0,0
141219,is,0,0
141220,both,0,0
141221,a,0,0
141222,positive,0,0
141223,prognostic,0,0
141224,marker,0,0
141225,and,0,0
141226,predictive,0,0
141227,of,0,0
141228,response,0,0
141229,to,0,0
141230,endocrine,0,0
141231,therapies,0,0
141232,.,0,0
141233,The,0,0
141234,relationship,0,0
141235,between,0,0
141236,these,0,0
141237,biomarkers,0,0
141238,is,0,0
141239,unknown,0,0
141240,.,0,0
141241,METHODS,0,0
141242,We,0,0
141243,constructed,0,0
141244,tissue,0,0
141245,microarrays,0,0
141246,(,0,0
141247,TMAs,0,1
141248,),0,0
141249,from,0,0
141250,available,0,0
141251,pathological,0,0
141252,material,0,0
141253,from,0,0
141254,1113,0,0
141255,patients,0,0
141256,participating,0,0
141257,in,0,0
141258,two,0,0
141259,randomized,0,0
141260,clinical,0,0
141261,trials,0,0
141262,comparing,0,0
141263,endocrine,1,0
141264,therapy,1,0
141265,alone,1,0
141266,versus,1,0
141267,chemo-endocrine,1,0
141268,therapy,1,0
141269,in,1,0
141270,node-negative,0,0
141271,breast,0,0
141272,cancer,0,0
141273,.,0,0
141274,Expression,0,0
141275,of,0,0
141276,p53,0,0
141277,defined,0,0
141278,as,0,0
141279,>,0,0
141280,10,0,0
141281,%,0,0
141282,positive,0,0
141283,nuclei,0,0
141284,was,0,0
141285,analyzed,0,0
141286,together,0,0
141287,with,0,0
141288,prior,0,0
141289,immunohistochemical,0,0
141290,assays,0,0
141291,of,0,0
141292,ER,0,0
141293,performed,0,0
141294,at,0,0
141295,central,0,0
141296,pathological,0,0
141297,review,0,0
141298,of,0,0
141299,whole,0,0
141300,tumor,0,0
141301,sections,0,0
141302,.,0,0
141303,RESULTS,0,0
141304,ER,0,0
141305,was,0,0
141306,present,0,0
141307,(,0,0
141308,i.e,0,0
141309,.,0,0
141310,>,0,0
141311,1,0,0
141312,%,0,0
141313,positive,0,0
141314,tumor,0,0
141315,cell,0,0
141316,nuclei,0,0
141317,),0,0
141318,in,0,0
141319,80.1,0,0
141320,%,0,0
141321,(,0,0
141322,880/1092,0,0
141323,),0,0
141324,.,0,0
141325,p53,0,0
141326,expression,0,0
141327,was,0,0
141328,significantly,0,0
141329,more,0,0
141330,frequent,0,0
141331,when,0,0
141332,ER,0,0
141333,was,0,0
141334,absent,0,0
141335,",",0,0
141336,125/212,0,0
141337,(,0,0
141338,59,0,0
141339,%,0,0
141340,),0,0
141341,than,0,0
141342,when,0,0
141343,ER,0,0
141344,was,0,0
141345,present,0,0
141346,",",0,0
141347,171/880,0,0
141348,(,0,0
141349,19,0,0
141350,%,0,0
141351,),0,0
141352,",",0,0
141353,p,0,0
141354,<,0,0
141355,0.0001,0,0
141356,.,0,0
141357,A,0,0
141358,significant,0,0
141359,qualitative,0,0
141360,interaction,0,0
141361,was,0,0
141362,observed,0,0
141363,such,0,0
141364,that,0,0
141365,p53,0,0
141366,expression,0,0
141367,was,0,0
141368,associated,0,0
141369,with,0,0
141370,better,0,0
141371,disease-free,0,0
141372,survival,0,1
141373,(,0,1
141374,DFS,0,1
141375,),0,1
141376,and,0,0
141377,overall,0,0
141378,survival,0,1
141379,(,0,1
141380,OS,0,1
141381,),0,0
141382,among,0,0
141383,patients,0,0
141384,whose,0,0
141385,tumors,0,0
141386,did,0,0
141387,not,0,0
141388,express,0,0
141389,ER,0,0
141390,",",0,0
141391,but,0,0
141392,worse,0,0
141393,DFS,0,1
141394,and,0,0
141395,OS,0,0
141396,among,0,0
141397,patients,0,0
141398,whose,0,0
141399,tumors,0,0
141400,expressed,0,0
141401,ER,0,0
141402,.,0,0
141403,The,0,0
141404,interaction,0,0
141405,remained,0,0
141406,significant,0,0
141407,after,0,0
141408,allowance,0,0
141409,for,0,0
141410,pathologic,0,0
141411,variables,0,0
141412,",",0,0
141413,and,0,0
141414,treatment,0,0
141415,.,0,0
141416,Similar,0,0
141417,effects,0,0
141418,were,0,0
141419,seen,0,0
141420,when,0,0
141421,luminal,0,0
141422,and,0,0
141423,non-luminal,0,0
141424,intrinsic,0,0
141425,subtypes,0,0
141426,were,0,0
141427,compared,0,0
141428,.,0,0
141429,CONCLUSIONS,0,0
141430,Interpretation,0,0
141431,of,0,0
141432,the,0,0
141433,prognostic,0,0
141434,significance,0,0
141435,of,0,0
141436,p53,0,0
141437,expression,0,0
141438,requires,0,0
141439,knowledge,0,0
141440,of,0,0
141441,concurrent,0,0
141442,expression,0,0
141443,of,0,0
141444,ER,0,0
141445,.,0,0
141446,The,0,0
141447,reason,0,0
141448,for,0,0
141449,the,0,0
141450,interaction,0,0
141451,between,0,0
141452,p53,0,0
141453,and,0,0
141454,ER,0,0
141455,is,0,0
141456,unknown,0,0
141457,but,0,0
141458,may,0,0
141459,reflect,0,0
141460,qualitatively,0,0
141461,different,0,0
141462,p53,0,0
141463,mutations,0,0
141464,underlying,0,0
141465,the,0,0
141466,p53,0,0
141467,expression,0,0
141468,in,0,0
141469,tumors,0,0
141470,with,0,0
141471,or,0,0
141472,without,0,0
141473,ER,0,0
141474,expression,0,0
141475,.,0,0
141476,TRIAL,0,0
141477,REGISTRATION,0,0
141478,Current,0,0
141479,Controlled,0,0
141480,Trials,0,1
141481,ACTRN12607000037404,0,1
141482,(,0,0
141483,Trial,0,0
141484,VIII,0,1
141485,),0,0
141486,and,0,0
141487,ACTRN12607000029493,0,1
141488,(,0,0
141489,Trial,0,0
141490,IX,0,1
141491,),0,0
141492,.,0,0
141493,[,0,1
141494,Therapeutic,0,1
141495,efficacy,0,0
141496,of,0,0
141497,youdujing,1,0
141498,preparation,1,0
141499,in,0,0
141500,treating,0,0
141501,cervical,0,0
141502,high-risk,0,0
141503,human,0,0
141504,papilloma,0,0
141505,virus,0,0
141506,infection,0,1
141507,patients,0,0
141508,],0,0
141509,.,0,0
141510,OBJECTIVE,0,0
141511,To,0,0
141512,study,0,0
141513,the,0,0
141514,clinical,0,0
141515,efficacy,0,0
141516,and,0,0
141517,mechanisms,0,0
141518,of,0,0
141519,Youdujing,1,0
141520,(,1,1
141521,YDJ,1,1
141522,),1,0
141523,preparation,1,0
141524,in,0,0
141525,treating,0,0
141526,the,0,0
141527,cervical,0,0
141528,high-risk,0,0
141529,human,0,0
141530,papilloma,0,0
141531,virus,0,1
141532,(,0,1
141533,HR-HPV,0,1
141534,),0,1
141535,infection,0,0
141536,.,0,0
141537,METHODS,0,0
141538,Totally,0,0
141539,HR-HPV,0,0
141540,infection,0,0
141541,70,0,0
141542,patients,0,0
141543,were,0,0
141544,assigned,0,0
141545,to,0,0
141546,the,0,0
141547,treatment,1,0
141548,group,0,0
141549,and,0,0
141550,the,0,0
141551,control,1,0
141552,group,0,0
141553,using,0,0
141554,random,0,0
141555,single,0,0
141556,blind,0,0
141557,method,0,0
141558,",",0,0
141559,35,0,0
141560,cases,0,0
141561,in,0,0
141562,each,0,0
141563,group,0,0
141564,.,0,0
141565,YDJ,1,0
141566,external,1,0
141567,lotion,1,1
141568,and,1,1
141569,YDJ,1,1
141570,cream,1,1
141571,were,0,0
141572,applied,0,0
141573,to,0,0
141574,patients,0,0
141575,in,0,0
141576,the,0,0
141577,treatment,0,0
141578,group,0,0
141579,",",0,0
141580,while,0,0
141581,normal,1,0
141582,saline,1,1
141583,was,0,0
141584,applied,0,0
141585,for,0,0
141586,those,0,0
141587,in,0,0
141588,the,0,0
141589,control,1,0
141590,group,0,0
141591,.,0,0
141592,HR-HPV,0,0
141593,DNA,0,0
141594,detection,0,0
141595,was,0,0
141596,performed,0,0
141597,by,0,0
141598,the,0,0
141599,end,0,0
141600,of,0,0
141601,the,0,0
141602,1st,0,0
141603,menstruation,0,0
141604,after,0,0
141605,3,0,0
141606,menstrual,0,0
141607,cycles,0,0
141608,.,0,0
141609,The,0,0
141610,cervical,0,0
141611,biopsy,0,0
141612,and,0,0
141613,cervical,0,0
141614,smear,0,0
141615,were,0,0
141616,performed,0,0
141617,using,0,0
141618,vaginoscope,0,0
141619,before,0,0
141620,and,0,0
141621,after,0,0
141622,treatment,0,0
141623,.,0,0
141624,The,0,0
141625,mRNA,0,0
141626,expression,0,0
141627,of,0,0
141628,human,0,0
141629,telomerase,0,0
141630,reverse,0,0
141631,transcriptase,0,1
141632,(,0,1
141633,hTERT,0,1
141634,),0,0
141635,was,0,0
141636,detected,0,0
141637,from,0,0
141638,fresh,0,0
141639,tissues,0,0
141640,of,0,0
141641,the,0,0
141642,cervical,0,0
141643,lesion,0,0
141644,.,0,0
141645,RESULTS,0,0
141646,The,0,0
141647,total,0,0
141648,effective,0,0
141649,rate,0,0
141650,was,0,0
141651,96.6,0,0
141652,%,0,0
141653,in,0,0
141654,the,0,0
141655,treatment,0,0
141656,group,0,0
141657,",",0,0
141658,higher,0,0
141659,than,0,0
141660,that,0,0
141661,of,0,0
141662,the,0,0
141663,control,0,0
141664,group,0,0
141665,(,0,0
141666,70.00,0,0
141667,%,0,0
141668,",",0,0
141669,P,0,0
141670,<,0,0
141671,0.01,0,0
141672,),0,0
141673,.,0,0
141674,Before,0,0
141675,treatment,0,0
141676,there,0,0
141677,was,0,0
141678,no,0,0
141679,statistical,0,0
141680,difference,0,0
141681,in,0,0
141682,the,0,0
141683,pathological,0,0
141684,results,0,0
141685,of,0,0
141686,the,0,0
141687,cervix,0,0
141688,and,0,0
141689,the,0,0
141690,mRNA,0,0
141691,expression,0,0
141692,of,0,0
141693,hTERT,0,0
141694,between,0,0
141695,the,0,0
141696,two,0,0
141697,groups,0,0
141698,(,0,0
141699,P,0,0
141700,>,0,0
141701,0.05,0,0
141702,),0,0
141703,.,0,0
141704,The,0,0
141705,mRNA,0,0
141706,expression,0,0
141707,of,0,0
141708,hTERT,0,0
141709,decreased,0,0
141710,in,0,0
141711,the,0,0
141712,two,0,0
141713,groups,0,0
141714,after,0,0
141715,treatment,0,0
141716,",",0,0
141717,showing,0,0
141718,statistical,0,0
141719,difference,0,0
141720,(,0,0
141721,P,0,0
141722,<,0,0
141723,0.01,0,0
141724,),0,0
141725,.,0,0
141726,Better,0,0
141727,effects,0,0
141728,on,0,0
141729,the,0,0
141730,pathological,0,0
141731,results,0,0
141732,of,0,0
141733,the,0,0
141734,cervix,0,0
141735,and,0,0
141736,the,0,0
141737,mRNA,0,0
141738,expression,0,0
141739,of,0,0
141740,hTERT,0,0
141741,were,0,0
141742,obtained,0,0
141743,in,0,0
141744,the,0,0
141745,treatment,0,0
141746,group,0,0
141747,after,0,0
141748,treatment,0,0
141749,(,0,0
141750,P,0,0
141751,<,0,0
141752,0.05,0,0
141753,),0,0
141754,.,0,0
141755,CONCLUSION,0,0
141756,YDJ,1,0
141757,played,0,0
141758,a,0,0
141759,role,0,0
141760,in,0,0
141761,clearing,0,0
141762,HR-HPV,0,0
141763,infection,0,0
141764,and,0,0
141765,reversing,0,0
141766,the,0,0
141767,cervical,0,0
141768,precancerous,0,0
141769,changes,0,0
141770,possibly,0,0
141771,through,0,0
141772,down-regulating,0,0
141773,the,0,0
141774,mRNA,0,0
141775,expression,0,0
141776,of,0,0
141777,hTERT,0,0
141778,and,0,0
141779,lowering,0,0
141780,the,0,0
141781,telomerase,0,0
141782,activation,0,0
141783,.,0,0
141784,Risperidone,1,1
141785,dosing,0,1
141786,in,0,1
141787,children,0,1
141788,and,0,0
141789,adolescents,0,0
141790,with,0,0
141791,autistic,0,0
141792,disorder,0,0
141793,:,0,0
141794,a,0,0
141795,double-blind,0,1
141796,",",0,1
141797,placebo-controlled,0,1
141798,study,0,0
141799,.,0,0
141800,Efficacy,0,0
141801,and,0,0
141802,safety,0,0
141803,of,0,0
141804,2,0,1
141805,risperidone,1,1
141806,doses,0,1
141807,were,0,0
141808,evaluated,0,0
141809,in,0,0
141810,children,0,0
141811,and,0,0
141812,adolescents,0,0
141813,with,0,0
141814,autism,0,0
141815,.,0,0
141816,Patients,0,0
141817,(,0,0
141818,N,0,0
141819,=,0,0
141820,96,0,0
141821,;,0,0
141822,5-17,0,0
141823,years,0,0
141824,),0,0
141825,",",0,0
141826,received,1,1
141827,risperidone,1,1
141828,(,1,1
141829,low-dose,1,1
141830,:,1,1
141831,0.125,1,1
141832,mg/day,1,1
141833,[,1,1
141834,20,1,0
141835,to,1,0
141836,<,1,0
141837,45,1,0
141838,kg,1,0
141839,],1,0
141840,",",1,0
141841,0.175,1,0
141842,mg/day,1,1
141843,[,1,0
141844,>,1,0
141845,45,1,0
141846,kg,1,0
141847,],1,0
141848,or,1,0
141849,high-dose,1,1
141850,:,1,1
141851,1.25,1,1
141852,mg/day,1,1
141853,[,1,1
141854,20,1,0
141855,to,1,0
141856,<,1,0
141857,45,1,0
141858,kg,1,0
141859,],1,0
141860,",",1,0
141861,1.75,1,0
141862,mg/day,1,1
141863,[,1,0
141864,>,1,0
141865,45,1,0
141866,kg,1,0
141867,],1,0
141868,),1,1
141869,or,1,1
141870,placebo,1,1
141871,.,0,1
141872,Mean,0,0
141873,baseline,0,1
141874,(,0,0
141875,range,0,0
141876,27-29,0,0
141877,),0,0
141878,to,0,0
141879,endpoint,0,0
141880,change,0,0
141881,in,0,0
141882,Aberrant,0,0
141883,Behavior,0,0
141884,Checklist-Irritability,0,0
141885,(,0,0
141886,primary,0,0
141887,endpoint,0,1
141888,),0,0
141889,was,0,0
141890,significantly,0,0
141891,greater,0,0
141892,in,0,0
141893,the,0,0
141894,high-dose-,0,1
141895,(,0,1
141896,-12.4,0,0
141897,[,0,0
141898,6.5,0,0
141899,],0,0
141900,;,0,0
141901,p,0,0
141902,<,0,0
141903,0.001,0,0
141904,),0,0
141905,",",0,0
141906,but,0,0
141907,not,0,0
141908,low-dose,0,1
141909,(,0,0
141910,-7.4,0,0
141911,[,0,0
141912,8.1,0,0
141913,],0,0
141914,;,0,0
141915,p,0,0
141916,=,0,0
141917,0.164,0,0
141918,),0,0
141919,group,0,0
141920,",",0,0
141921,versus,0,1
141922,placebo,0,1
141923,(,0,1
141924,-3.5,0,0
141925,[,0,0
141926,10.7,0,0
141927,],0,0
141928,),0,0
141929,.,0,0
141930,Clinical,0,0
141931,Global,0,0
141932,Impressions-Severity,0,0
141933,and,0,0
141934,Children,0,0
141935,'s,0,1
141936,Yale-Brown,0,1
141937,Obsessive,0,1
141938,Compulsive,0,1
141939,Scale,0,0
141940,scores,0,0
141941,improved,0,0
141942,significantly,0,0
141943,only,0,0
141944,in,0,0
141945,the,0,0
141946,high-dose,0,1
141947,group,0,0
141948,",",0,0
141949,consistent,0,0
141950,with,0,0
141951,ABC-I,0,0
141952,results,0,0
141953,.,0,0
141954,Somnolence,0,0
141955,",",0,0
141956,sedation,0,0
141957,and,0,0
141958,increased,0,0
141959,appetite,0,1
141960,occurred,0,0
141961,more,0,0
141962,frequently,0,0
141963,in,0,0
141964,high-versus,0,0
141965,low-dose,0,1
141966,groups,0,1
141967,.,0,0
141968,Overall,0,0
141969,",",0,0
141970,increased,0,0
141971,appetite,0,1
141972,occurred,0,0
141973,most,0,0
141974,frequently,0,0
141975,.,0,0
141976,Parents,0,0
141977,',0,0
141978,state,0,0
141979,and,0,0
141980,trait,0,0
141981,anxiety,0,0
141982,:,0,0
141983,relationships,0,0
141984,with,0,0
141985,anxiety,0,0
141986,severity,0,0
141987,and,0,0
141988,treatment,0,0
141989,response,0,0
141990,in,0,0
141991,adolescents,0,0
141992,with,0,0
141993,autism,0,0
141994,spectrum,0,0
141995,disorders,0,0
141996,.,0,0
141997,Comorbid,0,0
141998,anxiety,0,0
141999,is,0,0
142000,common,0,0
142001,among,0,0
142002,children,0,0
142003,with,0,0
142004,Autism,0,0
142005,Spectrum,0,0
142006,Disorder,0,0
142007,(,0,0
142008,ASD,0,1
142009,),0,1
142010,",",0,0
142011,and,0,0
142012,parents,0,0
142013,of,0,0
142014,children,0,0
142015,with,0,0
142016,ASD,0,0
142017,are,0,0
142018,more,0,0
142019,likely,0,0
142020,to,0,0
142021,have,0,0
142022,anxiety,0,0
142023,disorders,0,0
142024,.,0,0
142025,This,0,0
142026,study,0,0
142027,investigated,0,0
142028,the,0,0
142029,relationship,0,0
142030,between,0,0
142031,parents,1,0
142032,',1,0
142033,state,1,0
142034,and,1,0
142035,trait,1,0
142036,anxiety,1,0
142037,and,0,0
142038,parent-reported,1,0
142039,internalizing,1,0
142040,and,1,0
142041,externalizing,1,0
142042,symptoms,1,0
142043,among,1,0
142044,adolescents,1,0
142045,(,0,0
142046,n,0,0
142047,=,0,0
142048,30,0,0
142049,),0,0
142050,with,0,0
142051,ASD,0,0
142052,",",0,0
142053,as,0,0
142054,well,0,0
142055,as,0,0
142056,the,0,0
142057,relationship,0,0
142058,of,0,0
142059,parents,0,0
142060,',0,0
142061,anxiety,0,0
142062,symptoms,0,0
142063,and,0,0
142064,adolescent,0,0
142065,treatment,0,0
142066,response,0,0
142067,in,0,0
142068,the,0,0
142069,context,0,0
142070,of,0,0
142071,a,0,0
142072,randomized,0,0
142073,controlled,0,0
142074,trial,0,0
142075,.,0,0
142076,Parental,0,0
142077,state,0,0
142078,anxiety,0,0
142079,correlated,0,0
142080,with,0,0
142081,severity,0,0
142082,of,0,0
142083,adolescent,0,0
142084,anxiety,0,0
142085,",",0,0
142086,and,0,0
142087,trait,0,0
142088,anxiety,0,0
142089,in,0,0
142090,parents,0,0
142091,correlated,0,0
142092,with,0,0
142093,parent-reported,0,0
142094,adolescent,0,0
142095,internalizing,0,0
142096,and,0,0
142097,externalizing,0,0
142098,symptoms,0,0
142099,.,0,0
142100,Also,0,0
142101,",",0,0
142102,parents,0,0
142103,of,0,0
142104,adolescent,0,0
142105,treatment,0,0
142106,responders,0,0
142107,experienced,0,0
142108,a,0,0
142109,decrease,0,0
142110,in,0,0
142111,their,0,0
142112,own,0,0
142113,trait,0,0
142114,anxiety,0,0
142115,.,0,0
142116,Findings,0,0
142117,highlight,0,0
142118,the,0,0
142119,importance,0,0
142120,of,0,0
142121,considering,1,0
142122,parental,1,0
142123,anxiety,1,0
142124,when,1,0
142125,targeting,0,0
142126,anxiety,0,0
142127,among,0,0
142128,youth,0,0
142129,with,0,0
142130,ASD,0,0
142131,.,0,0
142132,Pseudoephedrine,1,1
142133,and,0,1
142134,preexercise,1,1
142135,feeding,1,1
142136,:,1,0
142137,influence,0,0
142138,on,0,0
142139,performance,0,0
142140,.,0,0
142141,PURPOSE,0,0
142142,This,0,0
142143,study,0,0
142144,examined,0,0
142145,the,0,0
142146,influence,0,0
142147,of,0,0
142148,preexercise,0,1
142149,food,0,1
142150,intake,0,1
142151,on,0,1
142152,plasma,0,1
142153,pseudoephedrine,0,1
142154,(,0,1
142155,PSE,0,1
142156,),0,1
142157,concentrations,0,1
142158,and,0,0
142159,subsequent,0,0
142160,high-intensity,0,0
142161,exercise,0,0
142162,.,0,0
142163,In,0,0
142164,addition,0,0
142165,",",0,0
142166,urinary,0,0
142167,PSE,0,1
142168,concentrations,0,1
142169,were,0,0
142170,measured,0,0
142171,under,0,0
142172,the,0,0
142173,same,0,0
142174,conditions,0,0
142175,and,0,0
142176,compared,0,0
142177,with,0,0
142178,the,0,0
142179,present,0,0
142180,threshold,0,0
142181,of,0,0
142182,the,0,0
142183,World,0,0
142184,Anti-Doping,0,1
142185,Agency,0,1
142186,(,0,1
142187,WADA,0,1
142188,),0,1
142189,.,0,0
142190,METHODS,0,0
142191,Ten,0,0
142192,highly,0,0
142193,trained,0,0
142194,male,0,0
142195,cyclists,0,0
142196,and,0,0
142197,triathletes,0,1
142198,(,0,0
142199,age,0,0
142200,=,0,0
142201,30.6,0,0
142202,?,0,0
142203,6.6,0,0
142204,yr,0,0
142205,",",0,0
142206,body,0,0
142207,mass,0,0
142208,[,0,1
142209,BM,0,0
142210,],0,0
142211,=,0,0
142212,72.9,0,0
142213,?,0,0
142214,5.1,0,0
142215,kg,0,0
142216,",",0,0
142217,and,0,0
142218,V?O2max,0,0
142219,=,0,0
142220,64.8,0,0
142221,?,0,0
142222,4.5,0,0
142223,mL?kg?min,0,0
142224,;,0,0
142225,mean,0,0
142226,?,0,0
142227,SD,0,0
142228,),0,1
142229,undertook,0,0
142230,four,0,0
142231,cycling,0,0
142232,time,0,0
142233,trials,0,0
142234,(,0,1
142235,TT,0,1
142236,),0,1
142237,",",0,0
142238,each,0,0
142239,requiring,0,0
142240,the,0,0
142241,completion,0,0
142242,of,0,0
142243,a,0,0
142244,set,0,0
142245,amount,0,0
142246,of,0,0
142247,work,0,0
142248,(,0,0
142249,7,0,0
142250,kJ?kg,0,1
142251,BM,0,1
142252,),0,0
142253,in,0,0
142254,the,0,0
142255,shortest,0,0
142256,possible,0,0
142257,time,0,0
142258,.,0,0
142259,Participants,0,0
142260,were,0,0
142261,randomized,1,0
142262,into,1,0
142263,a,1,0
142264,fed,1,0
142265,or,1,0
142266,nonfed,1,0
142267,condition,1,1
142268,and,1,1
142269,orally,1,1
142270,ingested,1,1
142271,2.8,1,1
142272,mg?kg,1,0
142273,BM,1,0
142274,of,1,0
142275,PSE,1,0
142276,or,1,0
142277,a,1,0
142278,placebo,1,1
142279,(,1,1
142280,PLA,1,1
142281,),1,1
142282,90,1,0
142283,min,1,0
142284,before,1,0
142285,exercise,1,1
142286,;,1,0
142287,in,1,0
142288,the,1,0
142289,fed,1,0
142290,trials,1,0
142291,",",1,0
142292,they,1,0
142293,consumed,1,1
142294,a,1,1
142295,meal,1,1
142296,providing,1,0
142297,1.5,1,0
142298,g?kg,1,0
142299,BM,1,0
142300,of,1,0
142301,CHO,1,0
142302,.,0,0
142303,Venous,0,0
142304,blood,0,0
142305,was,0,0
142306,sampled,0,0
142307,at,0,0
142308,30,0,0
142309,",",0,0
142310,50,0,0
142311,",",0,0
142312,and,0,0
142313,70,0,0
142314,min,0,0
142315,and,0,0
142316,pre-warm-up,0,0
142317,and,0,0
142318,postexercise,0,0
142319,for,0,0
142320,the,0,0
142321,analysis,0,0
142322,of,0,0
142323,plasma,0,1
142324,PSE,0,1
142325,and,0,1
142326,catecholamine,0,1
142327,concentrations,0,1
142328,",",0,1
142329,and,0,0
142330,urine,0,1
142331,was,0,0
142332,also,0,0
142333,collected,0,0
142334,for,0,0
142335,the,0,0
142336,analysis,0,0
142337,of,0,0
142338,PSE,0,0
142339,concentration,0,0
142340,.,0,0
142341,RESULTS,0,0
142342,Independent,0,0
142343,of,0,0
142344,the,0,0
142345,preexercise,0,1
142346,meal,0,1
142347,",",0,1
142348,2.8,0,0
142349,mg?kg,0,0
142350,BM,0,0
142351,of,0,0
142352,PSE,0,0
142353,did,0,0
142354,not,0,0
142355,significantly,0,0
142356,improve,0,0
142357,cycling,0,0
142358,TT,0,0
142359,performance,0,0
142360,.,0,0
142361,The,0,0
142362,fed,0,0
142363,trials,0,0
142364,resulted,0,0
142365,in,0,0
142366,lower,0,0
142367,plasma,0,1
142368,PSE,0,1
142369,concentrations,0,1
142370,at,0,0
142371,all,0,0
142372,time,0,0
142373,points,0,0
142374,compared,0,0
142375,with,0,0
142376,the,0,0
142377,nonfed,0,0
142378,trials,0,0
142379,.,0,0
142380,Both,0,1
142381,plasma,0,1
142382,epinephrine,0,1
142383,and,0,1
142384,blood,0,1
142385,lactate,0,1
142386,concentrations,0,1
142387,were,0,0
142388,higher,0,0
142389,in,0,0
142390,the,0,0
142391,PSE,0,0
142392,compared,0,0
142393,with,0,0
142394,the,0,0
142395,PLA,0,0
142396,trials,0,0
142397,",",0,0
142398,and,0,0
142399,preexercise,0,1
142400,and,0,1
142401,postexercise,0,1
142402,urinary,0,1
142403,PSE,0,1
142404,concentrations,0,1
142405,were,0,0
142406,significantly,0,0
142407,higher,0,0
142408,than,0,0
142409,the,0,0
142410,threshold,0,1
142411,(,0,0
142412,150,0,0
142413,?g?mL,0,1
142414,),0,0
142415,used,0,0
142416,by,0,0
142417,WADA,0,0
142418,to,0,0
142419,determine,0,0
142420,illicit,0,0
142421,PSE,0,0
142422,use,0,0
142423,.,0,0
142424,CONCLUSION,0,0
142425,Irrespective,0,0
142426,of,0,0
142427,the,0,0
142428,preexercise,0,1
142429,meal,0,1
142430,",",0,1
142431,cycling,0,0
142432,TT,0,0
142433,performance,0,0
142434,of,0,0
142435,approximately,0,0
142436,30,0,0
142437,min,0,0
142438,was,0,0
142439,not,0,0
142440,improved,0,0
142441,after,0,0
142442,PSE,0,1
142443,supplementation,0,1
142444,.,0,0
142445,Furthermore,0,0
142446,",",0,0
142447,2.8,0,0
142448,mg?kg,0,0
142449,BM,0,0
142450,of,0,0
142451,PSE,0,0
142452,taken,0,0
142453,90,0,0
142454,min,0,0
142455,before,0,0
142456,exercise,0,0
142457,",",0,0
142458,with,0,0
142459,or,0,0
142460,without,0,0
142461,food,0,0
142462,",",0,0
142463,resulted,0,0
142464,in,0,0
142465,urinary,0,0
142466,PSE,0,1
142467,concentrations,0,1
142468,exceeding,0,0
142469,the,0,0
142470,present,0,0
142471,WADA,0,0
142472,threshold,0,0
142473,.,0,0
142474,No,0,1
142475,pain,0,1
142476,relief,0,0
142477,with,0,0
142478,the,0,0
142479,rubber,1,0
142480,hand,1,0
142481,illusion,1,0
142482,.,1,0
142483,The,0,0
142484,sense,0,0
142485,of,0,0
142486,body,0,0
142487,ownership,0,0
142488,can,0,0
142489,be,0,0
142490,easily,0,0
142491,disrupted,0,0
142492,during,0,0
142493,illusions,0,0
142494,and,0,0
142495,the,0,0
142496,most,0,0
142497,common,0,0
142498,illusion,0,0
142499,is,0,0
142500,the,0,0
142501,rubber,1,0
142502,hand,1,0
142503,illusion,1,0
142504,.,1,0
142505,An,0,1
142506,idea,0,0
142507,that,0,0
142508,is,0,0
142509,rapidly,0,0
142510,gaining,0,0
142511,popularity,0,0
142512,in,0,0
142513,clinical,0,0
142514,pain,0,0
142515,medicine,0,0
142516,is,0,0
142517,that,0,0
142518,body,1,0
142519,ownership,1,0
142520,illusions,1,0
142521,can,0,0
142522,be,0,0
142523,used,0,0
142524,to,0,0
142525,modify,0,0
142526,pathological,0,0
142527,pain,0,0
142528,sensations,0,0
142529,and,0,0
142530,induce,0,0
142531,analgesia,0,1
142532,.,0,0
142533,However,0,0
142534,",",0,0
142535,this,0,0
142536,idea,0,0
142537,has,0,0
142538,not,0,0
142539,been,0,0
142540,empirically,0,0
142541,evaluated,0,0
142542,.,0,0
142543,Two,0,0
142544,separate,0,0
142545,research,0,0
142546,laboratories,0,0
142547,undertook,0,0
142548,independent,0,0
142549,randomized,0,0
142550,repeated,0,0
142551,measures,0,0
142552,experiments,0,0
142553,",",0,0
142554,both,0,0
142555,designed,0,0
142556,to,0,0
142557,detect,0,0
142558,an,0,0
142559,effect,0,0
142560,of,0,0
142561,the,0,0
142562,rubber,1,0
142563,hand,1,0
142564,illusion,1,0
142565,on,0,0
142566,experimentally,0,0
142567,induced,0,0
142568,hand,0,0
142569,pain,0,0
142570,.,0,0
142571,In,0,0
142572,Experiment,0,0
142573,1,0,0
142574,",",0,0
142575,16,0,0
142576,healthy,0,0
142577,volunteers,0,0
142578,rated,0,0
142579,the,0,0
142580,pain,0,0
142581,evoked,0,0
142582,by,0,0
142583,noxious,1,0
142584,heat,1,0
142585,stimuli,1,1
142586,(,0,0
142587,5,0,0
142588,s,0,1
142589,duration,0,1
142590,;,0,0
142591,interstimulus,0,0
142592,interval,0,0
142593,25,0,0
142594,s,0,0
142595,),0,0
142596,of,0,0
142597,set,0,0
142598,temperatures,0,0
142599,(,0,0
142600,47?,0,0
142601,",",0,0
142602,48?,0,0
142603,and,0,1
142604,49?C,0,1
142605,),0,0
142606,during,0,0
142607,the,0,0
142608,rubber,1,0
142609,hand,1,0
142610,illusion,1,0
142611,or,1,0
142612,during,1,0
142613,a,1,0
142614,control,1,0
142615,condition,1,0
142616,.,1,0
142617,There,1,0
142618,was,0,0
142619,a,0,0
142620,main,0,0
142621,effect,0,0
142622,of,0,0
142623,stimulus,0,0
142624,temperature,0,0
142625,on,0,0
142626,pain,0,0
142627,ratings,0,0
142628,",",0,0
142629,but,0,0
142630,no,0,0
142631,main,0,0
142632,effect,0,0
142633,of,0,0
142634,condition,0,0
142635,(,0,0
142636,p,0,0
142637,=,0,0
142638,0.32,0,0
142639,),0,0
142640,",",0,0
142641,nor,0,0
142642,a,0,0
142643,condition,0,0
142644,x,0,0
142645,temperature,0,0
142646,interaction,0,0
142647,(,0,0
142648,p,0,0
142649,=,0,0
142650,0.31,0,0
142651,),0,0
142652,.,0,0
142653,In,0,0
142654,Experiment,0,0
142655,2,0,0
142656,",",0,0
142657,20,0,0
142658,healthy,0,0
142659,volunteers,0,0
142660,underwent,0,0
142661,quantitative,0,0
142662,sensory,0,0
142663,testing,0,0
142664,to,0,0
142665,determine,0,0
142666,heat,0,0
142667,and,0,0
142668,cold,0,0
142669,pain,0,0
142670,thresholds,0,0
142671,during,0,0
142672,the,0,0
142673,rubber,1,0
142674,hand,1,0
142675,illusion,1,0
142676,or,1,0
142677,during,0,0
142678,a,0,0
142679,control,0,0
142680,condition,0,0
142681,.,0,0
142682,Secondary,0,0
142683,analyses,0,0
142684,involved,0,0
142685,heat,0,0
142686,and,0,0
142687,cold,0,0
142688,detection,0,0
142689,thresholds,0,0
142690,and,0,0
142691,paradoxical,0,0
142692,heat,0,0
142693,sensations,0,0
142694,.,0,0
142695,Again,0,0
142696,",",0,0
142697,there,0,0
142698,was,0,0
142699,no,0,0
142700,main,0,0
142701,effect,0,0
142702,of,0,0
142703,condition,0,0
142704,on,0,0
142705,heat,0,0
142706,pain,0,0
142707,threshold,0,0
142708,(,0,0
142709,p,0,0
142710,=,0,0
142711,0.17,0,0
142712,),0,0
142713,",",0,0
142714,nor,0,0
142715,on,0,0
142716,cold,0,0
142717,pain,0,0
142718,threshold,0,0
142719,(,0,0
142720,p,0,0
142721,=,0,0
142722,0.65,0,0
142723,),0,0
142724,",",0,0
142725,nor,0,0
142726,on,0,0
142727,any,0,0
142728,of,0,0
142729,the,0,0
142730,secondary,0,0
142731,measures,0,0
142732,(,0,0
142733,p,0,0
142734,<,0,0
142735,0.56,0,0
142736,for,0,0
142737,all,0,0
142738,),0,0
142739,.,0,0
142740,We,0,0
142741,conclude,0,0
142742,that,0,0
142743,the,0,0
142744,rubber,1,0
142745,hand,1,0
142746,illusion,1,0
142747,does,1,0
142748,not,0,0
142749,induce,0,0
142750,analgesia,0,1
142751,.,0,0
142752,Contingency,1,0
142753,management,1,0
142754,for,0,0
142755,the,0,0
142756,treatment,0,0
142757,of,0,0
142758,antipsychotic-induced,0,0
142759,weight,0,0
142760,gain,0,0
142761,:,0,0
142762,a,0,0
142763,randomized,0,0
142764,controlled,0,0
142765,pilot,0,0
142766,study,0,0
142767,.,0,0
142768,OBJECTIVE,0,0
142769,Weight,0,0
142770,gain,0,0
142771,is,0,0
142772,common,0,0
142773,for,0,0
142774,individuals,0,0
142775,with,0,0
142776,serious,0,0
142777,mental,0,1
142778,illness,0,1
142779,(,0,1
142780,SMI,0,1
142781,),0,1
142782,receiving,0,1
142783,antipsychotic,0,1
142784,drug,0,1
142785,therapy,0,1
142786,.,0,0
142787,Contingency,1,0
142788,management,1,1
142789,(,1,1
142790,CM,1,1
142791,),1,0
142792,is,0,0
142793,a,0,0
142794,behavioral,0,0
142795,intervention,0,0
142796,that,0,0
142797,rewards,0,0
142798,positive,0,0
142799,performance,0,0
142800,and,0,0
142801,has,0,0
142802,demonstrated,0,0
142803,effectiveness,0,0
142804,in,0,0
142805,reducing,0,0
142806,drug,0,1
142807,use,0,0
142808,in,0,0
142809,SMI,0,0
142810,populations,0,0
142811,.,0,0
142812,This,0,0
142813,study,0,0
142814,evaluated,0,0
142815,the,0,0
142816,feasibility,0,0
142817,of,0,0
142818,using,0,0
142819,CM,1,0
142820,to,0,0
142821,promote,0,0
142822,weight,0,0
142823,loss,0,0
142824,in,0,0
142825,individuals,0,0
142826,with,0,0
142827,SMI,0,0
142828,over,0,0
142829,8,0,0
142830,weeks,0,0
142831,.,0,0
142832,METHOD,0,0
142833,30,0,0
142834,individuals,0,0
142835,(,0,0
142836,BMI,0,1
142837,?,0,0
142838,28,0,0
142839,kg/m,0,0
142840,(,0,0
142841,2,0,0
142842,),0,1
142843,),0,0
142844,were,0,0
142845,randomized,0,0
142846,to,0,0
142847,one,0,0
142848,of,0,0
142849,three,0,0
142850,conditions,0,0
142851,:,0,0
142852,i,0,0
142853,),0,0
142854,The,1,0
142855,combination,1,0
142856,of,1,0
142857,a,1,0
142858,standardized,1,0
142859,lifestyle,1,0
142860,modification,1,0
142861,(,1,1
142862,LM,1,1
142863,),1,1
142864,program,1,0
142865,for,1,0
142866,individuals,1,0
142867,with,1,0
142868,SMI,1,0
142869,and,1,0
142870,payment,1,0
142871,for,1,0
142872,group,1,0
142873,attendance,1,0
142874,(,1,1
142875,CM,1,1
142876,(,1,1
142877,attendance,1,1
142878,),1,1
142879,),1,0
142880,",",1,0
142881,ii,1,0
142882,),1,0
142883,The,1,0
142884,combination,1,0
142885,of,1,0
142886,LM,1,0
142887,and,1,0
142888,payment,1,0
142889,for,1,0
142890,weight,1,0
142891,loss,1,0
142892,(,1,1
142893,CM,1,1
142894,(,1,1
142895,weight,1,1
142896,),1,1
142897,),1,0
142898,",",1,0
142899,and,1,0
142900,iii,1,0
142901,),1,0
142902,waitlist,1,0
142903,control,1,0
142904,(,1,0
142905,CON,1,1
142906,),1,1
142907,.,1,0
142908,After,0,0
142909,the,0,0
142910,waitlist,0,0
142911,period,0,0
142912,",",0,0
142913,those,0,0
142914,participants,0,0
142915,joined,0,0
142916,a,0,0
142917,LM,1,0
142918,group,1,0
142919,and,1,0
142920,received,1,0
142921,payment,1,0
142922,for,1,0
142923,behavioral,1,0
142924,change,1,0
142925,(,1,1
142926,CM,1,1
142927,(,1,1
142928,behavior,1,1
142929,),1,1
142930,),1,0
142931,.,1,0
142932,RESULTS,0,0
142933,Subjects,0,0
142934,in,0,0
142935,the,0,0
142936,CM,0,1
142937,(,0,1
142938,attendance,0,1
142939,),0,1
142940,and,0,0
142941,in,0,0
142942,the,0,0
142943,CM,0,1
142944,(,0,1
142945,weight,0,1
142946,),0,1
142947,group,0,0
142948,lost,0,0
142949,a,0,0
142950,mean,0,0
142951,of,0,0
142952,1.16,0,0
142953,kg,0,0
142954,and,0,0
142955,1.23,0,0
142956,kg,0,0
142957,",",0,0
142958,respectively,0,0
142959,",",0,0
142960,while,0,0
142961,subjects,0,0
142962,in,0,0
142963,the,0,0
142964,CON,0,0
142965,gained,0,0
142966,a,0,0
142967,mean,0,0
142968,of,0,0
142969,0.68,0,0
142970,kg,0,0
142971,.,0,0
142972,Subjects,0,0
142973,receiving,0,0
142974,CM,0,1
142975,(,0,1
142976,behavior,0,0
142977,),0,0
142978,",",0,0
142979,lost,0,0
142980,a,0,0
142981,mean,0,0
142982,of,0,0
142983,2.54,0,0
142984,kg,0,0
142985,",",0,0
142986,which,0,0
142987,was,0,0
142988,a,0,0
142989,significant,0,0
142990,weight,0,0
142991,loss,0,0
142992,compared,0,0
142993,to,0,0
142994,the,0,0
142995,control,0,0
142996,period,0,0
142997,.,0,0
142998,CONCLUSION,1,0
142999,LM,1,1
143000,supplemented,1,0
143001,with,1,0
143002,CM,1,0
143003,may,1,0
143004,facilitate,0,0
143005,weight,0,0
143006,loss,0,0
143007,in,0,0
143008,patients,0,0
143009,taking,0,0
143010,antipsychotic,0,1
143011,medications,0,1
143012,;,0,1
143013,financial,0,1
143014,reimbursement,0,0
143015,for,0,0
143016,behavioral,0,0
143017,change,0,0
143018,may,0,0
143019,be,0,0
143020,particularly,0,0
143021,effective,0,0
143022,in,0,0
143023,this,0,0
143024,population,0,0
143025,.,0,0
143026,Influence,0,0
143027,of,0,0
143028,Aloe,1,0
143029,arborescens,1,0
143030,Mill,1,1
143031,.,1,0
143032,extract,1,0
143033,on,0,0
143034,selected,0,0
143035,parameters,0,0
143036,of,0,0
143037,pro-oxidant-antioxidant,0,1
143038,equilibrium,0,0
143039,and,0,0
143040,cytokine,0,0
143041,synthesis,0,0
143042,in,0,0
143043,rowers,0,0
143044,.,0,0
143045,This,0,0
143046,investigation,0,0
143047,examined,0,0
143048,the,0,0
143049,effect,0,0
143050,of,0,0
143051,supplementation,1,1
143052,with,1,1
143053,Biostimine,1,1
143054,",",1,1
143055,extract,1,1
143056,from,1,0
143057,Aloe,1,1
143058,arborescens,1,0
143059,Mill,1,0
143060,.,1,0
143061,leaves,1,0
143062,",",0,0
143063,on,0,0
143064,the,0,0
143065,levels,0,0
143066,of,0,0
143067,pro-oxidant-antioxidant,0,1
143068,equilibrium,0,0
143069,markers,0,0
143070,and,0,0
143071,anti-,0,0
143072,and,0,0
143073,proinflammatory,0,0
143074,cytokines,0,0
143075,in,0,0
143076,rowers,0,0
143077,subjected,0,0
143078,to,0,0
143079,exhaustive,0,0
143080,exercise,0,0
143081,.,0,0
143082,This,0,0
143083,double-blind,0,1
143084,study,0,0
143085,included,0,0
143086,18,0,0
143087,members,0,0
143088,of,0,0
143089,the,0,0
143090,Polish,0,0
143091,Rowing,0,0
143092,Team,0,0
143093,.,0,0
143094,Subjects,0,0
143095,were,0,0
143096,randomly,0,0
143097,assigned,0,0
143098,to,0,0
143099,the,0,0
143100,supplemented,0,0
143101,group,0,1
143102,(,0,0
143103,n,0,0
143104,=,0,0
143105,9,0,0
143106,),0,0
143107,",",0,0
143108,which,0,0
143109,received,0,0
143110,one,0,0
143111,ampoule,0,1
143112,of,0,1
143113,Biostimine,1,1
143114,once,0,1
143115,daily,0,1
143116,for,0,1
143117,4,0,0
143118,weeks,0,0
143119,",",0,0
143120,or,0,0
143121,to,0,0
143122,the,0,0
143123,placebo,1,1
143124,group,0,1
143125,(,0,0
143126,n,0,0
143127,=,0,0
143128,9,0,0
143129,),0,0
143130,.,0,0
143131,Subjects,0,0
143132,performed,0,0
143133,a,0,0
143134,"2,000-meter-maximum",0,0
143135,test,0,0
143136,on,0,0
143137,a,0,0
143138,rowing,0,0
143139,ergometer,0,0
143140,at,0,0
143141,the,0,0
143142,beginning,0,0
143143,and,0,0
143144,end,0,0
143145,of,0,0
143146,the,0,0
143147,preparatory,0,0
143148,camp,0,1
143149,.,0,0
143150,Blood,0,0
143151,samples,0,0
143152,were,0,0
143153,obtained,0,0
143154,from,0,0
143155,the,0,0
143156,antecubital,0,0
143157,vein,0,0
143158,before,0,0
143159,each,0,0
143160,exercise,0,0
143161,test,0,0
143162,",",0,0
143163,1,0,0
143164,min,0,0
143165,after,0,0
143166,completing,0,0
143167,the,0,0
143168,test,0,0
143169,and,0,0
143170,after,0,0
143171,a,0,0
143172,24-hr,0,1
143173,recovery,0,0
143174,period,0,1
143175,.,0,1
143176,Superoxide,0,1
143177,dismutase,0,1
143178,and,0,1
143179,glutathione,0,1
143180,peroxidase,0,1
143181,activity,0,0
143182,as,0,0
143183,well,0,0
143184,as,0,0
143185,the,0,0
143186,concentration,0,0
143187,of,0,0
143188,thiobarbituric,0,1
143189,acid,0,1
143190,reactive,0,1
143191,substances,0,0
143192,(,0,0
143193,TBARS,0,1
143194,),0,0
143195,were,0,0
143196,assessed,0,0
143197,in,0,0
143198,erythrocytes,0,0
143199,.,0,0
143200,In,0,0
143201,addition,0,0
143202,",",0,0
143203,total,0,0
143204,antioxidant,0,1
143205,capacity,0,1
143206,(,0,1
143207,TAC,0,1
143208,),0,1
143209,and,0,1
143210,creatine,0,1
143211,kinase,0,1
143212,activity,0,0
143213,were,0,0
143214,measured,0,0
143215,in,0,0
143216,plasma,0,0
143217,samples,0,0
143218,",",0,0
143219,and,0,0
143220,cytokine,0,1
143221,(,0,0
143222,IL-6,0,1
143223,",",0,1
143224,IL-10,0,1
143225,),0,1
143226,concentrations,0,1
143227,were,0,0
143228,determined,0,0
143229,in,0,0
143230,the,0,0
143231,serum,0,1
143232,.,0,0
143233,Before,0,0
143234,and,0,0
143235,after,0,0
143236,Biostimine,1,1
143237,supplementation,1,1
143238,",",0,1
143239,exercise,0,0
143240,significantly,0,0
143241,increased,0,0
143242,the,0,0
143243,values,0,0
143244,of,0,0
143245,SOD,0,0
143246,",",0,0
143247,IL-6,0,1
143248,",",0,0
143249,IL-10,0,0
143250,",",0,0
143251,and,0,0
143252,TBARS,0,0
143253,in,0,0
143254,both,0,0
143255,groups,0,0
143256,.,0,0
143257,However,0,0
143258,",",0,0
143259,postexercise,0,0
143260,and,0,0
143261,recovery,0,0
143262,levels,0,0
143263,of,0,0
143264,TBARS,0,0
143265,were,0,0
143266,significantly,0,0
143267,lower,0,0
143268,in,0,0
143269,athletes,0,0
143270,receiving,0,0
143271,Biostimine,1,1
143272,than,0,1
143273,in,0,0
143274,controls,0,0
143275,.,0,0
143276,After,0,1
143277,supplementation,0,1
143278,",",0,1
143279,TAC,0,1
143280,was,0,0
143281,the,0,0
143282,only,0,0
143283,variable,0,0
143284,with,0,0
143285,the,0,0
143286,level,0,0
143287,being,0,0
143288,significantly,0,0
143289,higher,0,0
143290,in,0,0
143291,the,0,0
143292,supplemented,0,0
143293,group,0,0
143294,than,0,0
143295,in,0,0
143296,the,0,0
143297,placebo,1,1
143298,group,0,0
143299,.,0,0
143300,Consequently,0,0
143301,",",0,0
143302,we,0,0
143303,can,0,0
143304,conclude,0,0
143305,that,0,0
143306,Biostimine,1,1
143307,supplementation,1,1
143308,reduces,0,1
143309,the,0,0
143310,postexercise,0,0
143311,level,0,0
143312,of,0,0
143313,TBARS,0,0
143314,by,0,0
143315,increasing,0,0
143316,the,0,0
143317,antioxidant,0,1
143318,activity,0,0
143319,of,0,0
143320,plasma,0,0
143321,but,0,0
143322,has,0,0
143323,no,0,0
143324,effect,0,0
143325,on,0,0
143326,inflammatory,0,0
143327,markers,0,0
143328,.,0,0
143329,The,0,0
143330,effect,0,0
143331,of,0,0
143332,cognitive-behavioral,1,0
143333,therapy,1,0
143334,versus,0,0
143335,treatment,1,0
143336,as,1,0
143337,usual,1,0
143338,for,0,0
143339,anxiety,0,0
143340,in,0,0
143341,children,0,0
143342,with,0,0
143343,autism,0,0
143344,spectrum,0,0
143345,disorders,0,0
143346,:,0,0
143347,a,0,0
143348,randomized,0,0
143349,",",0,0
143350,controlled,0,0
143351,trial,0,0
143352,.,0,0
143353,OBJECTIVE,0,0
143354,To,0,0
143355,examine,0,0
143356,the,0,0
143357,efficacy,0,0
143358,of,0,0
143359,a,0,0
143360,modular,1,0
143361,cognitive-behavioral,1,0
143362,therapy,1,1
143363,(,1,1
143364,CBT,1,1
143365,),1,1
143366,protocol,1,0
143367,relative,0,0
143368,to,0,0
143369,treatment,1,0
143370,as,1,0
143371,usual,1,1
143372,(,1,1
143373,TAU,1,1
143374,),1,1
143375,among,0,0
143376,children,0,0
143377,with,0,0
143378,high-functioning,0,0
143379,autism,0,0
143380,spectrum,0,0
143381,disorders,0,1
143382,(,0,1
143383,ASD,0,1
143384,),0,1
143385,and,0,0
143386,clinically,0,0
143387,significant,0,0
143388,anxiety,0,0
143389,.,0,0
143390,METHOD,0,0
143391,A,0,0
143392,total,0,0
143393,of,0,0
143394,45,0,0
143395,children,0,0
143396,(,0,0
143397,7-11,0,0
143398,years,0,0
143399,of,0,0
143400,age,0,0
143401,),0,0
143402,with,0,0
143403,high-functioning,0,0
143404,ASD,0,0
143405,and,0,0
143406,clinically,0,0
143407,significant,0,0
143408,anxiety,0,0
143409,were,0,0
143410,randomized,0,0
143411,to,0,0
143412,receive,0,0
143413,16,0,0
143414,sessions,0,0
143415,of,0,0
143416,weekly,1,0
143417,CBT,1,1
143418,or,1,0
143419,TAU,1,0
143420,for,0,0
143421,an,0,0
143422,equivalent,0,0
143423,duration,0,0
143424,.,0,0
143425,After,0,0
143426,screening,0,0
143427,",",0,0
143428,assessments,0,0
143429,were,0,0
143430,conducted,0,0
143431,at,0,0
143432,baseline,0,0
143433,",",0,0
143434,post-treatment,0,0
143435,",",0,0
143436,and,0,0
143437,3-month,0,0
143438,follow-up,0,0
143439,.,0,0
143440,Raters,0,0
143441,were,0,0
143442,blind,0,0
143443,to,0,0
143444,treatment,0,0
143445,condition,0,0
143446,.,0,0
143447,RESULTS,0,0
143448,Youth,0,0
143449,receiving,0,0
143450,CBT,1,0
143451,showed,0,0
143452,substantial,0,0
143453,improvement,0,0
143454,relative,0,0
143455,to,0,0
143456,TAU,1,0
143457,on,0,0
143458,primary,0,0
143459,anxiety,0,0
143460,outcomes,0,0
143461,.,0,0
143462,Of,0,0
143463,24,0,0
143464,children,0,0
143465,randomized,0,0
143466,to,0,0
143467,the,0,0
143468,CBT,1,0
143469,arm,0,0
143470,",",0,0
143471,18,0,0
143472,(,0,0
143473,75,0,0
143474,%,0,0
143475,),0,0
143476,were,0,0
143477,treatment,0,0
143478,responders,0,0
143479,",",0,0
143480,versus,0,0
143481,only,0,0
143482,3,0,0
143483,of,0,0
143484,21,0,0
143485,children,0,1
143486,(,0,0
143487,14,0,0
143488,%,0,0
143489,),0,0
143490,in,0,0
143491,the,0,0
143492,TAU,1,0
143493,arm,0,0
143494,.,0,0
143495,Gains,0,0
143496,were,0,0
143497,generally,0,0
143498,maintained,0,0
143499,at,0,0
143500,3-month,0,0
143501,follow-up,0,0
143502,for,0,0
143503,CBT,1,0
143504,responders,0,0
143505,.,0,0
143506,CONCLUSIONS,0,0
143507,Relative,0,0
143508,to,0,0
143509,usual,0,0
143510,care,0,0
143511,",",0,0
143512,CBT,1,0
143513,adapted,0,0
143514,for,0,0
143515,anxious,0,0
143516,youth,0,0
143517,with,0,0
143518,high-functioning,0,0
143519,ASD,0,0
143520,demonstrates,0,0
143521,large,0,0
143522,effects,0,0
143523,in,0,0
143524,reducing,0,0
143525,anxiety,0,0
143526,symptoms,0,0
143527,.,0,0
143528,This,0,0
143529,study,0,0
143530,contributes,0,0
143531,to,0,0
143532,the,0,0
143533,growing,0,0
143534,literature,0,0
143535,supporting,0,0
143536,adapted,0,0
143537,CBT,1,0
143538,approaches,0,0
143539,for,0,0
143540,treating,0,0
143541,anxiety,0,0
143542,in,0,0
143543,youth,0,0
143544,with,0,0
143545,ASD,0,0
143546,.,0,0
143547,Temporal,0,0
143548,expectation,0,0
143549,in,0,0
143550,focal,0,0
143551,hand,0,0
143552,dystonia,0,0
143553,.,0,0
143554,Patients,0,0
143555,with,0,0
143556,writer,0,0
143557,'s,0,0
143558,cramp,0,0
143559,present,0,0
143560,sensory,0,0
143561,and,0,0
143562,representational,0,0
143563,abnormalities,0,0
143564,relevant,0,0
143565,to,0,0
143566,motor,0,0
143567,control,0,0
143568,",",0,0
143569,such,0,0
143570,as,0,0
143571,impairment,0,0
143572,in,0,0
143573,the,0,0
143574,temporal,0,0
143575,discrimination,0,0
143576,between,0,0
143577,tactile,0,0
143578,stimuli,0,0
143579,and,0,0
143580,in,0,0
143581,pure,0,0
143582,motor,0,0
143583,imagery,0,0
143584,tasks,0,0
143585,",",0,0
143586,like,0,0
143587,the,0,0
143588,mental,0,0
143589,rotation,0,0
143590,of,0,0
143591,corporeal,0,0
143592,and,0,0
143593,inanimate,0,0
143594,objects,0,0
143595,.,0,0
143596,However,0,0
143597,",",0,0
143598,only,0,0
143599,limited,0,0
143600,information,0,0
143601,is,0,0
143602,available,0,0
143603,on,0,0
143604,the,0,0
143605,ability,0,0
143606,of,0,0
143607,patients,0,0
143608,with,0,0
143609,dystonia,0,0
143610,to,0,0
143611,process,0,0
143612,the,0,0
143613,time-dependent,0,0
143614,features,0,0
143615,(,0,0
143616,e.g,0,0
143617,.,0,1
143618,speed,0,0
143619,),0,0
143620,of,0,0
143621,movement,0,0
143622,in,0,0
143623,real,0,0
143624,time,0,0
143625,.,0,0
143626,The,0,0
143627,processing,0,0
143628,of,0,0
143629,time-dependent,0,0
143630,features,0,0
143631,of,0,0
143632,movement,0,0
143633,has,0,0
143634,a,0,0
143635,crucial,0,0
143636,role,0,0
143637,in,0,0
143638,predicting,0,0
143639,whether,0,0
143640,the,0,0
143641,outcome,0,0
143642,of,0,0
143643,a,0,0
143644,complex,0,0
143645,motor,0,0
143646,sequence,0,0
143647,",",0,0
143648,such,0,0
143649,as,0,0
143650,handwriting,0,0
143651,or,0,0
143652,playing,0,0
143653,a,0,0
143654,musical,0,0
143655,passage,0,0
143656,",",0,0
143657,will,0,0
143658,be,0,0
143659,consistent,0,0
143660,with,0,0
143661,its,0,0
143662,ultimate,0,0
143663,goal,0,0
143664,",",0,0
143665,or,0,0
143666,results,0,0
143667,instead,0,0
143668,in,0,0
143669,an,0,0
143670,execution,0,0
143671,error,0,0
143672,.,0,0
143673,In,0,0
143674,this,0,0
143675,study,0,0
143676,",",0,0
143677,we,0,0
143678,sought,0,0
143679,to,0,0
143680,evaluate,0,0
143681,the,0,0
143682,implicit,0,0
143683,ability,0,0
143684,to,0,0
143685,perceive,0,0
143686,the,0,0
143687,temporal,1,0
143688,outcome,1,0
143689,of,0,0
143690,different,0,0
143691,movements,0,0
143692,in,0,0
143693,a,0,0
143694,group,0,0
143695,of,0,0
143696,patients,0,0
143697,with,0,0
143698,writer,0,0
143699,'s,0,0
143700,cramp,0,0
143701,.,0,0
143702,Fourteen,0,0
143703,patients,0,0
143704,affected,0,0
143705,by,0,0
143706,writer,0,0
143707,'s,0,0
143708,cramp,0,0
143709,in,0,0
143710,the,0,0
143711,right,0,0
143712,hand,0,0
143713,and,0,0
143714,17,0,0
143715,age-,0,0
143716,and,0,0
143717,gender-matched,0,0
143718,healthy,0,0
143719,subjects,0,0
143720,were,0,0
143721,recruited,0,0
143722,for,0,0
143723,the,0,0
143724,study,0,0
143725,.,0,0
143726,Subjects,0,0
143727,were,0,0
143728,asked,0,0
143729,to,0,0
143730,perform,0,0
143731,a,0,0
143732,temporal,1,0
143733,expectation,1,0
143734,task,1,0
143735,by,0,0
143736,predicting,0,0
143737,the,0,0
143738,end,0,0
143739,of,0,0
143740,visually,0,0
143741,perceived,0,0
143742,human,0,0
143743,body,0,1
143744,motion,0,1
143745,(,0,0
143746,handwriting,0,0
143747,",",0,0
143748,i.e,0,0
143749,.,0,0
143750,the,0,0
143751,action,0,0
143752,performed,0,0
143753,by,0,0
143754,the,0,0
143755,human,0,0
143756,body,0,0
143757,segment,0,0
143758,specifically,0,0
143759,affected,0,0
143760,by,0,0
143761,writer,0,0
143762,'s,0,1
143763,cramp,0,1
143764,),0,0
143765,or,0,0
143766,inanimate,0,1
143767,object,0,1
143768,motion,0,1
143769,(,0,0
143770,a,0,0
143771,moving,0,0
143772,circle,0,0
143773,reaching,0,0
143774,a,0,0
143775,spatial,0,0
143776,target,0,0
143777,),0,0
143778,.,0,0
143779,Videos,1,0
143780,representing,1,0
143781,movements,1,0
143782,were,0,0
143783,shown,0,0
143784,in,0,0
143785,full,0,0
143786,before,0,0
143787,experimental,0,0
143788,trials,0,0
143789,;,0,0
143790,the,0,0
143791,actual,0,0
143792,tasks,0,0
143793,consisted,0,0
143794,of,0,0
143795,watching,0,0
143796,the,0,0
143797,same,0,0
143798,videos,0,0
143799,",",0,0
143800,but,0,0
143801,interrupted,0,0
143802,after,0,0
143803,a,0,0
143804,variable,0,0
143805,interval,0,0
143806,(,0,0
143807,'pre-dark,0,0
143808,',0,0
143809,),0,0
143810,from,0,0
143811,its,0,0
143812,onset,0,0
143813,by,0,0
143814,a,0,0
143815,dark,0,0
143816,interval,0,0
143817,of,0,0
143818,variable,0,0
143819,duration,0,0
143820,.,0,0
143821,During,0,0
143822,the,0,0
143823,'dark,0,0
143824,',0,0
143825,interval,0,0
143826,",",0,0
143827,subjects,0,0
143828,were,0,0
143829,asked,0,0
143830,to,0,0
143831,indicate,0,0
143832,when,0,0
143833,the,0,0
143834,movement,0,0
143835,represented,0,0
143836,in,0,0
143837,the,0,0
143838,video,0,0
143839,reached,0,0
143840,its,0,0
143841,end,0,0
143842,by,0,0
143843,clicking,0,0
143844,on,0,0
143845,the,0,0
143846,space,0,0
143847,bar,0,0
143848,of,0,0
143849,the,0,0
143850,keyboard,0,0
143851,.,0,0
143852,We,0,0
143853,also,0,0
143854,included,0,0
143855,a,0,0
143856,visual,0,0
143857,working,0,0
143858,memory,0,0
143859,task,0,0
143860,.,0,0
143861,Performance,0,0
143862,on,0,0
143863,the,0,0
143864,timing,0,0
143865,task,0,0
143866,was,0,0
143867,analysed,0,0
143868,measuring,0,0
143869,the,0,0
143870,absolute,0,0
143871,value,0,0
143872,of,0,0
143873,timing,0,0
143874,error,0,0
143875,",",0,0
143876,the,0,0
143877,coefficient,0,0
143878,of,0,0
143879,variability,0,0
143880,and,0,0
143881,the,0,0
143882,percentage,0,0
143883,of,0,0
143884,anticipation,0,0
143885,responses,0,0
143886,.,0,0
143887,Patients,0,0
143888,with,0,0
143889,writer,0,0
143890,'s,0,0
143891,cramp,0,0
143892,exhibited,0,0
143893,greater,0,0
143894,absolute,0,0
143895,timing,0,0
143896,error,0,0
143897,compared,0,0
143898,with,0,0
143899,control,0,0
143900,subjects,0,0
143901,in,0,0
143902,the,0,0
143903,human,0,0
143904,body,0,0
143905,motion,0,1
143906,task,0,1
143907,(,0,0
143908,whereas,0,0
143909,no,0,0
143910,difference,0,0
143911,was,0,0
143912,observed,0,0
143913,in,0,0
143914,the,0,0
143915,inanimate,0,0
143916,object,0,0
143917,motion,0,1
143918,task,0,1
143919,),0,1
143920,.,0,0
143921,No,0,1
143922,effect,0,0
143923,of,0,0
143924,group,0,0
143925,was,0,0
143926,documented,0,0
143927,on,0,0
143928,the,0,0
143929,visual,0,0
143930,working,0,0
143931,memory,0,0
143932,tasks,0,0
143933,.,0,0
143934,Absolute,0,0
143935,timing,0,0
143936,error,0,0
143937,on,0,0
143938,the,0,0
143939,human,0,0
143940,body,0,0
143941,motion,0,0
143942,task,0,0
143943,did,0,0
143944,not,0,0
143945,significantly,0,0
143946,correlate,0,0
143947,with,0,0
143948,symptom,0,0
143949,severity,0,0
143950,",",0,0
143951,disease,0,0
143952,duration,0,0
143953,or,0,0
143954,writing,0,0
143955,speed,0,0
143956,.,0,0
143957,Our,0,0
143958,findings,0,0
143959,suggest,0,0
143960,an,0,0
143961,alteration,0,0
143962,of,0,0
143963,the,0,0
143964,writing,0,0
143965,movement,0,0
143966,representation,0,0
143967,at,0,0
143968,a,0,0
143969,central,0,0
143970,level,0,0
143971,and,0,0
143972,are,0,0
143973,consistent,0,0
143974,with,0,0
143975,the,0,0
143976,view,0,0
143977,that,0,0
143978,dystonia,0,0
143979,is,0,0
143980,not,0,0
143981,a,0,0
143982,purely,0,0
143983,motor,0,0
143984,disorder,0,0
143985,",",0,0
143986,but,0,0
143987,it,0,0
143988,also,0,0
143989,involves,0,0
143990,non-motor,0,1
143991,(,0,0
143992,sensory,0,0
143993,",",0,1
143994,cognitive,0,1
143995,),0,0
143996,aspects,0,0
143997,related,0,0
143998,to,0,0
143999,movement,0,0
144000,processing,0,0
144001,and,0,0
144002,planning,0,0
144003,.,0,0
144004,Contribution,0,0
144005,of,0,0
144006,endogenous,0,0
144007,bradykinin,0,1
144008,to,0,0
144009,fibrinolysis,0,1
144010,",",0,0
144011,inflammation,0,0
144012,",",0,0
144013,and,0,0
144014,blood,0,0
144015,product,0,0
144016,transfusion,0,0
144017,following,0,0
144018,cardiac,0,0
144019,surgery,0,0
144020,:,0,0
144021,a,0,0
144022,randomized,0,0
144023,clinical,0,0
144024,trial,0,1
144025,.,0,0
144026,Bradykinin,0,1
144027,increases,0,0
144028,during,0,0
144029,cardiopulmonary,0,0
144030,bypass,0,1
144031,(,0,1
144032,CPB,0,1
144033,),0,1
144034,and,0,0
144035,stimulates,0,0
144036,the,0,0
144037,release,0,0
144038,of,0,0
144039,nitric,0,1
144040,oxide,0,1
144041,",",0,1
144042,inflammatory,0,0
144043,cytokines,0,0
144044,",",0,0
144045,and,0,1
144046,tissue-type,0,1
144047,plasminogen,0,1
144048,activator,0,1
144049,(,0,1
144050,t-PA,0,1
144051,),0,1
144052,",",0,0
144053,acting,0,0
144054,through,0,0
144055,its,0,0
144056,B2,0,0
144057,receptor,0,0
144058,.,0,0
144059,This,0,0
144060,study,0,0
144061,tested,0,0
144062,the,0,0
144063,hypothesis,0,0
144064,that,0,0
144065,endogenous,0,0
144066,bradykinin,0,1
144067,contributes,0,0
144068,to,0,0
144069,the,0,0
144070,fibrinolytic,0,1
144071,and,0,0
144072,inflammatory,0,0
144073,response,0,0
144074,to,0,0
144075,CPB,0,0
144076,and,0,0
144077,that,0,0
144078,bradykinin,0,1
144079,B2,0,1
144080,receptor,0,1
144081,antagonism,0,1
144082,reduces,0,0
144083,fibrinolysis,0,1
144084,",",0,0
144085,inflammation,0,0
144086,",",0,0
144087,and,0,0
144088,subsequent,0,0
144089,transfusion,0,0
144090,requirements,0,0
144091,.,0,0
144092,Patients,0,0
144093,(,0,0
144094,N,0,0
144095,=,0,0
144096,115,0,0
144097,),0,0
144098,were,0,0
144099,prospectively,0,0
144100,randomized,0,0
144101,to,0,0
144102,placebo,1,1
144103,",",1,1
144104,?-aminocaproic,1,1
144105,acid,1,1
144106,(,1,1
144107,EACA,1,1
144108,),1,1
144109,",",1,0
144110,or,1,0
144111,HOE,1,0
144112,140,1,0
144113,",",1,0
144114,a,0,0
144115,bradykinin,0,1
144116,B2,0,1
144117,receptor,0,1
144118,antagonist,0,1
144119,.,0,1
144120,Bradykinin,0,1
144121,B2,0,1
144122,receptor,0,1
144123,antagonism,0,1
144124,decreased,0,0
144125,intraoperative,0,1
144126,fibrinolytic,0,1
144127,capacity,0,0
144128,as,0,0
144129,much,0,0
144130,as,1,0
144131,EACA,1,0
144132,",",1,0
144133,but,0,0
144134,only,1,0
144135,EACA,1,0
144136,decreased,0,0
144137,D-dimer,0,0
144138,formation,0,0
144139,and,0,0
144140,tended,0,0
144141,to,0,0
144142,decrease,0,0
144143,postoperative,0,0
144144,bleeding,0,0
144145,.,0,0
144146,Although,1,0
144147,EACA,1,0
144148,and,1,0
144149,HOE,1,0
144150,140,1,0
144151,decreased,0,0
144152,fibrinolysis,0,0
144153,and,1,0
144154,EACA,1,0
144155,attenuated,0,0
144156,blood,0,0
144157,loss,0,0
144158,",",0,0
144159,these,0,0
144160,treatments,0,0
144161,did,0,0
144162,not,0,0
144163,reduce,0,0
144164,the,0,0
144165,proportion,0,0
144166,of,0,0
144167,patients,0,0
144168,transfused,0,0
144169,.,0,0
144170,These,0,0
144171,data,0,0
144172,suggest,0,0
144173,that,0,0
144174,endogenous,0,0
144175,bradykinin,0,1
144176,contributes,0,0
144177,to,0,0
144178,t-PA,0,0
144179,generation,0,0
144180,in,0,0
144181,patients,0,0
144182,undergoing,0,0
144183,CPB,0,1
144184,",",0,0
144185,but,0,0
144186,that,0,0
144187,additional,0,0
144188,effects,0,0
144189,on,0,0
144190,plasmin,0,1
144191,generation,0,0
144192,contribute,0,0
144193,to,0,0
144194,decreased,0,0
144195,D-dimer,0,0
144196,concentrations,0,0
144197,during,1,0
144198,EACA,1,0
144199,treatment,0,0
144200,.,0,0
144201,Design,0,0
144202,and,0,0
144203,development,0,0
144204,of,0,0
144205,a,0,0
144206,Virtual,1,0
144207,Dolphinarium,1,0
144208,for,0,0
144209,children,0,0
144210,with,0,0
144211,autism,0,0
144212,.,0,0
144213,The,0,0
144214,recent,0,0
144215,proliferation,0,0
144216,of,0,0
144217,virtual,1,0
144218,reality,1,1
144219,(,1,1
144220,VR,1,1
144221,),1,1
144222,technology,1,0
144223,applications,1,0
144224,in,0,0
144225,the,0,0
144226,autism,0,0
144227,therapy,0,0
144228,to,0,0
144229,promote,0,0
144230,learning,0,0
144231,and,0,0
144232,positive,0,0
144233,behavior,0,0
144234,among,0,0
144235,such,0,0
144236,children,0,0
144237,has,0,0
144238,produced,0,0
144239,optimistic,0,0
144240,results,0,0
144241,in,0,0
144242,developing,0,0
144243,a,0,0
144244,variety,0,0
144245,of,0,0
144246,skills,0,0
144247,and,0,0
144248,abilities,0,0
144249,in,0,0
144250,them,0,0
144251,.,0,0
144252,Dolphin-assisted,1,0
144253,therapy,1,0
144254,has,0,0
144255,also,0,0
144256,become,0,0
144257,a,0,0
144258,topic,0,0
144259,of,0,0
144260,public,0,0
144261,and,0,0
144262,research,0,0
144263,interest,0,0
144264,for,0,0
144265,autism,0,0
144266,intervention,0,0
144267,and,0,0
144268,treatment,0,0
144269,.,0,0
144270,This,0,0
144271,paper,0,0
144272,will,0,0
144273,present,0,0
144274,an,0,0
144275,innovative,0,0
144276,design,0,0
144277,and,0,0
144278,development,0,0
144279,of,0,0
144280,a,0,0
144281,Virtual,1,0
144282,Dolphinarium,1,0
144283,for,0,0
144284,potential,0,0
144285,autism,0,0
144286,intervention,0,0
144287,.,0,0
144288,Instead,0,0
144289,of,0,0
144290,emulating,0,0
144291,the,0,0
144292,swimming,0,0
144293,with,0,0
144294,dolphins,0,0
144295,",",0,0
144296,our,0,0
144297,virtual,0,0
144298,dolphin,0,0
144299,interaction,0,0
144300,program,0,0
144301,will,0,0
144302,allow,0,0
144303,children,0,0
144304,with,0,0
144305,autism,0,0
144306,to,0,0
144307,act,0,0
144308,as,0,0
144309,dolphin,0,0
144310,trainers,0,0
144311,at,0,0
144312,the,0,0
144313,poolside,0,0
144314,and,0,0
144315,to,0,0
144316,learn,0,1
144317,(,0,1
144318,nonverbal,0,1
144319,),0,1
144320,communication,0,0
144321,through,0,0
144322,hand,0,0
144323,gestures,0,0
144324,with,0,0
144325,the,0,0
144326,virtual,0,0
144327,dolphins,0,0
144328,.,0,0
144329,Immersive,1,0
144330,visualization,1,0
144331,and,0,0
144332,gesture-based,1,0
144333,interaction,1,0
144334,are,0,0
144335,implemented,0,0
144336,to,0,0
144337,engage,0,0
144338,children,0,0
144339,with,0,0
144340,autism,0,0
144341,within,0,0
144342,an,0,0
144343,immersive,0,0
144344,room,0,0
144345,equipped,0,0
144346,with,0,0
144347,a,0,0
144348,curved,0,0
144349,screen,0,0
144350,spanning,0,0
144351,a,0,0
144352,320,0,0
144353,(,0,0
144354,?,0,0
144355,),0,1
144356,and,0,0
144357,a,0,0
144358,high-end,0,0
144359,five-panel,0,0
144360,projection,0,0
144361,system,0,0
144362,.,0,0
144363,This,0,0
144364,paper,0,0
144365,will,0,0
144366,also,0,0
144367,report,0,0
144368,a,0,0
144369,pilot,0,0
144370,study,0,0
144371,to,0,0
144372,establish,0,0
144373,trial,0,0
144374,protocol,0,0
144375,of,0,0
144376,autism,0,0
144377,screening,0,0
144378,to,0,0
144379,explore,0,0
144380,the,0,0
144381,participants,0,0
144382,',0,0
144383,readiness,0,0
144384,for,0,0
144385,the,1,0
144386,virtual,1,0
144387,dolphin,1,0
144388,interaction,1,0
144389,.,1,0
144390,This,0,0
144391,research,0,0
144392,will,0,0
144393,have,0,0
144394,two,0,0
144395,potential,0,0
144396,benefits,0,0
144397,in,0,0
144398,the,0,0
144399,sense,0,0
144400,of,0,0
144401,helping,0,0
144402,children,0,0
144403,with,0,0
144404,autism,0,0
144405,and,0,0
144406,protecting,0,0
144407,the,0,0
144408,endangered,0,0
144409,species,0,0
144410,.,0,0
144411,[,1,1
144412,Afala,1,1
144413,in,0,0
144414,the,0,0
144415,treatment,0,0
144416,of,0,0
144417,patients,0,0
144418,with,0,0
144419,BPH,0,0
144420,:,0,0
144421,efficacy,0,0
144422,and,0,0
144423,safety,0,1
144424,],0,0
144425,.,0,0
144426,The,0,0
144427,double-blind,0,1
144428,",",0,1
144429,placebo-controlled,1,1
144430,",",0,1
144431,randomized,0,1
144432,clinical,0,0
144433,trial,0,0
144434,involving,0,0
144435,94,0,0
144436,patients,0,0
144437,has,0,0
144438,evaluated,0,0
144439,the,0,0
144440,efficacy,0,0
144441,and,0,0
144442,safety,0,0
144443,of,0,0
144444,domestic,0,0
144445,preparation,0,0
144446,afala,1,0
144447,in,0,0
144448,patients,0,0
144449,with,0,0
144450,symptoms,0,0
144451,of,0,0
144452,I-II,0,0
144453,stages,0,0
144454,benign,0,0
144455,prostatic,0,1
144456,hyperplasia,0,1
144457,(,0,1
144458,BPH,0,1
144459,),0,1
144460,.,0,0
144461,It,0,0
144462,was,0,0
144463,shown,0,0
144464,that,0,0
144465,a,0,0
144466,6-month,0,0
144467,course,0,0
144468,of,0,0
144469,treatment,0,0
144470,with,0,0
144471,afala,1,0
144472,at,1,0
144473,a,1,0
144474,dose,1,1
144475,of,1,1
144476,2,1,1
144477,tablets,1,1
144478,4,1,1
144479,times,1,1
144480,a,1,0
144481,day,1,0
144482,resulted,0,0
144483,in,0,0
144484,a,0,0
144485,significant,0,0
144486,reduction,0,0
144487,in,0,0
144488,the,0,0
144489,severity,0,0
144490,of,0,0
144491,urinary,0,0
144492,disorders,0,0
144493,",",0,0
144494,estimated,0,0
144495,by,0,0
144496,total,0,0
144497,IPSS,0,0
144498,score,0,0
144499,",",0,0
144500,relative,0,0
144501,to,0,0
144502,baseline,0,0
144503,values,0,0
144504,and,0,0
144505,compared,0,0
144506,to,0,0
144507,placebo,1,1
144508,therapy,0,1
144509,.,0,0
144510,The,0,0
144511,most,0,0
144512,pronounced,0,0
144513,therapeutic,0,0
144514,effects,0,0
144515,of,0,0
144516,the,0,0
144517,drug,0,1
144518,were,0,0
144519,registered,0,0
144520,in,0,0
144521,respect,0,0
144522,of,0,0
144523,irritative,0,0
144524,symptoms,0,0
144525,of,0,0
144526,BPH,0,0
144527,.,0,0
144528,According,0,0
144529,uroflowmetry,0,0
144530,",",0,0
144531,peak,0,0
144532,flow,0,0
144533,rate,0,0
144534,after,0,0
144535,6,0,0
144536,months,0,0
144537,of,0,0
144538,treatment,0,0
144539,was,0,0
144540,increased,0,0
144541,by,0,0
144542,more,0,0
144543,than,0,0
144544,50,0,0
144545,%,0,0
144546,.,0,0
144547,Significant,0,0
144548,clinical,0,0
144549,benefit,0,0
144550,persisted,0,0
144551,not,0,0
144552,only,0,0
144553,within,0,0
144554,the,0,0
144555,6-month,0,0
144556,course,0,0
144557,of,0,0
144558,therapy,0,0
144559,",",0,0
144560,but,0,0
144561,3,0,0
144562,months,0,0
144563,after,0,0
144564,.,0,0
144565,Long-term,0,0
144566,therapy,0,0
144567,had,0,0
144568,no,0,0
144569,effect,0,0
144570,on,0,0
144571,the,0,0
144572,concentration,0,0
144573,of,0,0
144574,total,0,0
144575,",",0,0
144576,free,0,0
144577,and,0,0
144578,complex,0,0
144579,PSA,0,1
144580,",",0,1
144581,testosterone,0,1
144582,(,0,1
144583,total,0,0
144584,and,0,0
144585,free,0,0
144586,),0,1
144587,",",0,0
144588,dihydrotestosterone,0,1
144589,",",0,1
144590,and,0,1
144591,prolactin,0,1
144592,in,0,0
144593,the,0,0
144594,blood,0,0
144595,.,0,0
144596,Absence,0,0
144597,of,0,0
144598,adverse,0,0
144599,effects,0,0
144600,",",0,0
144601,biochemical,0,0
144602,abnormalities,0,0
144603,",",0,0
144604,changes,0,0
144605,in,0,0
144606,clinical,0,0
144607,blood,0,1
144608,and,0,0
144609,urine,0,1
144610,confirmed,0,0
144611,the,0,0
144612,safety,0,0
144613,of,0,0
144614,6-month,0,0
144615,therapy,0,0
144616,.,0,0
144617,Practice,0,0
144618,makes,0,0
144619,improvement,0,0
144620,:,0,0
144621,how,0,0
144622,adults,0,0
144623,with,0,0
144624,autism,0,0
144625,out-perform,0,0
144626,others,0,0
144627,in,0,0
144628,a,0,0
144629,naturalistic,0,0
144630,visual,0,0
144631,search,0,0
144632,task,0,0
144633,.,0,0
144634,People,0,0
144635,with,0,0
144636,autism,0,0
144637,spectrum,0,0
144638,disorder,0,1
144639,(,0,1
144640,ASD,0,1
144641,),0,0
144642,often,0,0
144643,exhibit,0,0
144644,superior,0,0
144645,performance,0,0
144646,in,0,0
144647,visual,0,0
144648,search,0,0
144649,compared,0,0
144650,to,0,0
144651,others,0,0
144652,.,0,0
144653,However,0,0
144654,",",0,0
144655,most,0,0
144656,studies,0,0
144657,demonstrating,0,0
144658,this,0,0
144659,advantage,0,0
144660,have,0,0
144661,employed,0,0
144662,simple,0,0
144663,",",0,0
144664,uncluttered,0,0
144665,images,0,0
144666,with,0,0
144667,fully,0,0
144668,visible,0,0
144669,targets,0,0
144670,.,0,0
144671,We,0,0
144672,compare,0,0
144673,the,0,0
144674,performance,0,0
144675,of,0,0
144676,high-functioning,0,0
144677,adults,0,0
144678,with,0,0
144679,ASD,0,0
144680,and,0,0
144681,matched,0,0
144682,controls,0,0
144683,on,0,0
144684,a,0,0
144685,naturalistic,1,0
144686,luggage,1,0
144687,screening,1,0
144688,task,1,0
144689,.,1,0
144690,Although,0,0
144691,the,0,0
144692,two,0,0
144693,groups,0,0
144694,were,0,0
144695,equally,0,0
144696,accurate,0,0
144697,in,0,0
144698,detecting,0,0
144699,targets,0,0
144700,",",0,0
144701,the,0,0
144702,ASD,0,0
144703,adults,0,0
144704,improve,0,0
144705,in,0,0
144706,their,0,0
144707,correct,0,0
144708,elimination,0,0
144709,of,0,0
144710,target-absent,0,1
144711,bags,0,1
144712,faster,0,1
144713,than,0,0
144714,controls,0,0
144715,.,0,0
144716,This,0,0
144717,feature,0,0
144718,of,0,0
144719,their,0,0
144720,behavior,0,0
144721,is,0,0
144722,extremely,0,0
144723,important,0,0
144724,for,0,0
144725,many,0,0
144726,real-world,0,0
144727,monitoring,0,0
144728,tasks,0,0
144729,that,0,0
144730,require,0,0
144731,sustained,0,0
144732,attention,0,0
144733,for,0,0
144734,long,0,0
144735,time,0,0
144736,periods,0,0
144737,.,0,0
144738,Further,0,0
144739,analyses,0,0
144740,suggest,0,0
144741,that,0,0
144742,this,0,0
144743,improvement,0,0
144744,is,0,0
144745,attributable,0,0
144746,neither,0,0
144747,to,0,0
144748,the,0,0
144749,motor,0,0
144750,speed,0,0
144751,nor,0,0
144752,to,0,0
144753,the,0,0
144754,level,0,0
144755,of,0,0
144756,intelligence,0,0
144757,of,0,0
144758,the,0,0
144759,adults,0,0
144760,with,0,0
144761,ASD,0,0
144762,.,0,0
144763,These,0,0
144764,findings,0,0
144765,may,0,0
144766,have,0,0
144767,possible,0,0
144768,implications,0,0
144769,for,0,0
144770,employment,0,0
144771,opportunities,0,0
144772,of,0,0
144773,adult,0,0
144774,individuals,0,0
144775,with,0,0
144776,ASD,0,0
144777,.,0,0
144778,Plasma,0,1
144779,Epstein-Barr,0,1
144780,virus,0,1
144781,DNA,0,0
144782,predicts,0,0
144783,outcome,0,0
144784,in,0,0
144785,advanced,0,0
144786,Hodgkin,0,0
144787,lymphoma,0,0
144788,:,0,0
144789,correlative,0,0
144790,analysis,0,0
144791,from,0,0
144792,a,0,0
144793,large,0,0
144794,North,0,0
144795,American,0,0
144796,cooperative,0,0
144797,group,0,0
144798,trial,0,0
144799,.,0,0
144800,Epstein-Barr,0,1
144801,virus,0,1
144802,(,0,1
144803,EBV,0,1
144804,),0,0
144805,is,0,0
144806,associated,0,0
144807,with,0,0
144808,Hodgkin,0,0
144809,lymphoma,0,1
144810,(,0,1
144811,HL,0,1
144812,),0,1
144813,and,0,0
144814,can,0,0
144815,be,0,0
144816,detected,0,0
144817,by,0,0
144818,in,0,0
144819,situ,0,0
144820,hybridization,0,0
144821,(,0,0
144822,ISH,0,1
144823,),0,0
144824,of,0,0
144825,viral,0,0
144826,nucleic,0,0
144827,acid,0,1
144828,(,0,1
144829,EBER,0,1
144830,),0,1
144831,in,0,0
144832,tumor,0,0
144833,cells,0,0
144834,.,0,0
144835,We,0,0
144836,sought,0,0
144837,to,0,0
144838,determine,0,0
144839,whether,0,0
144840,plasma,0,1
144841,EBV-DNA,0,1
144842,could,0,0
144843,serve,0,0
144844,as,0,0
144845,a,0,0
144846,surrogate,0,0
144847,for,0,0
144848,EBER-ISH,0,0
144849,and,0,0
144850,to,0,0
144851,explore,0,0
144852,its,0,0
144853,prognostic,0,0
144854,utility,0,0
144855,in,0,0
144856,HL,0,0
144857,.,0,0
144858,Specimens,0,0
144859,from,0,0
144860,the,0,0
144861,Cancer,0,0
144862,Cooperative,0,0
144863,Intergroup,0,0
144864,Trial,0,0
144865,E2496,0,0
144866,were,0,0
144867,used,0,0
144868,to,0,0
144869,compare,1,0
144870,pretreatment,1,1
144871,plasma,1,1
144872,EBV-DNA,1,1
144873,quantification,1,0
144874,with,1,0
144875,EBV,1,0
144876,tumor,1,0
144877,status,1,0
144878,by,1,0
144879,EBER-ISH,1,0
144880,.,1,0
144881,A,0,0
144882,cutoff,0,0
144883,of,0,0
144884,>,0,0
144885,60,0,0
144886,viral,0,0
144887,copies/100,0,0
144888,?L,0,0
144889,plasma,0,0
144890,yielded,0,0
144891,96,0,0
144892,%,0,0
144893,concordance,0,0
144894,with,0,0
144895,EBER-ISH,0,0
144896,.,0,0
144897,Pretreatment,0,0
144898,and,0,0
144899,month,0,0
144900,6,0,0
144901,plasma,0,0
144902,specimens,0,0
144903,were,0,0
144904,designated,0,0
144905,EBV,0,1
144906,(,0,1
144907,-,0,1
144908,),0,1
144909,or,0,1
144910,EBV,0,1
144911,(,0,1
144912,+,0,1
144913,),0,0
144914,by,0,0
144915,this,0,0
144916,cutoff,0,0
144917,.,0,0
144918,Patients,0,0
144919,with,0,0
144920,pretreatment,0,1
144921,EBV,0,1
144922,(,0,1
144923,+,0,1
144924,),0,1
144925,plasma,0,1
144926,(,0,0
144927,n,0,0
144928,=,0,0
144929,54,0,0
144930,),0,0
144931,had,0,0
144932,inferior,0,0
144933,failure-free,0,1
144934,survival,0,1
144935,(,0,1
144936,FFS,0,1
144937,),0,0
144938,compared,0,0
144939,with,0,0
144940,those,0,0
144941,with,0,0
144942,pretreatment,0,1
144943,EBV,0,1
144944,(,0,1
144945,-,0,1
144946,),0,1
144947,plasma,0,1
144948,(,0,0
144949,n,0,0
144950,=,0,0
144951,274,0,0
144952,),0,0
144953,",",0,0
144954,log-rank,0,0
144955,P,0,0
144956,=,0,0
144957,.009,0,0
144958,.,0,0
144959,By,0,0
144960,contrast,0,0
144961,",",0,0
144962,no,0,0
144963,difference,0,0
144964,in,0,0
144965,FFS,0,0
144966,was,0,0
144967,observed,0,0
144968,when,0,0
144969,patients,0,0
144970,were,0,0
144971,stratified,0,0
144972,by,0,0
144973,EBER-ISH,0,0
144974,.,0,0
144975,Pretreatment,0,0
144976,plasma,0,1
144977,EBV,0,1
144978,positivity,0,0
144979,was,0,0
144980,an,0,0
144981,independent,0,0
144982,predictor,0,0
144983,of,0,0
144984,treatment,0,0
144985,failure,0,0
144986,on,0,0
144987,multivariate,0,0
144988,analyses,0,0
144989,.,0,0
144990,At,0,0
144991,month,0,0
144992,6,0,0
144993,",",0,0
144994,plasma,0,1
144995,EBV,0,1
144996,(,0,1
144997,+,0,1
144998,),0,1
144999,patients,0,0
145000,(,0,0
145001,n,0,0
145002,=,0,0
145003,7,0,0
145004,),0,0
145005,had,0,0
145006,inferior,0,0
145007,FFS,0,0
145008,compared,0,0
145009,with,0,0
145010,plasma,0,1
145011,EBV,0,1
145012,(,0,1
145013,-,0,1
145014,),0,1
145015,patients,0,0
145016,(,0,0
145017,n,0,0
145018,=,0,0
145019,125,0,0
145020,),0,0
145021,",",0,0
145022,log-rank,0,0
145023,P,0,0
145024,=,0,0
145025,.007,0,0
145026,.,0,0
145027,These,0,0
145028,results,0,0
145029,confirm,0,0
145030,that,0,0
145031,plasma,0,1
145032,EBV-DNA,0,1
145033,is,0,0
145034,highly,0,0
145035,concordant,0,0
145036,with,0,0
145037,EBER-ISH,0,0
145038,in,0,0
145039,HL,0,0
145040,and,0,0
145041,suggest,0,0
145042,that,0,0
145043,it,0,0
145044,may,0,0
145045,have,0,0
145046,prognostic,0,0
145047,utility,0,0
145048,both,0,0
145049,at,0,0
145050,baseline,0,0
145051,and,0,0
145052,after,0,0
145053,therapy,0,0
145054,.,0,0
145055,This,0,0
145056,trial,0,0
145057,was,0,0
145058,registered,0,0
145059,at,0,0
145060,www.clinicaltrials.gov,0,0
145061,as,0,0
145062,#,0,0
145063,NCT00003389,0,0
145064,.,0,0
145065,Rifampicin,1,1
145066,plus,1,1
145067,isoniazid,1,1
145068,for,0,0
145069,the,0,0
145070,prevention,0,0
145071,of,0,0
145072,tuberculosis,0,0
145073,in,0,0
145074,an,0,0
145075,immigrant,0,0
145076,population,0,0
145077,.,0,0
145078,OBJECTIVES,0,0
145079,To,0,0
145080,compare,0,0
145081,the,0,0
145082,tolerance,0,0
145083,",",0,0
145084,adherence,0,0
145085,and,0,0
145086,effectiveness,0,0
145087,of,0,0
145088,two,0,0
145089,approaches,0,0
145090,for,0,0
145091,the,0,0
145092,treatment,0,0
145093,of,0,0
145094,latent,0,0
145095,tuberculosis,0,0
145096,infection,0,1
145097,(,0,1
145098,LTBI,0,1
145099,),0,1
145100,:,0,0
145101,6,0,0
145102,months,0,0
145103,of,0,0
145104,isoniazid,1,1
145105,(,1,1
145106,6H,1,1
145107,),1,0
145108,vs.,0,0
145109,3,0,0
145110,months,0,0
145111,of,0,0
145112,isoniazid,1,1
145113,plus,1,1
145114,rifampicin,1,1
145115,(,1,1
145116,3RH,1,1
145117,),1,1
145118,.,1,0
145119,POPULATION,0,0
145120,Immigrants,0,1
145121,with,0,0
145122,LTBI,0,1
145123,.,0,1
145124,METHODS,0,0
145125,Participants,0,0
145126,were,0,0
145127,enrolled,0,0
145128,in,0,0
145129,a,0,0
145130,controlled,0,0
145131,",",0,0
145132,randomised,0,0
145133,clinical,0,0
145134,trial,0,0
145135,in,0,0
145136,Barcelona,0,0
145137,",",0,0
145138,Spain,0,0
145139,",",0,0
145140,from,0,0
145141,April,0,1
145142,2001,0,1
145143,to,0,1
145144,April,0,1
145145,2005,0,1
145146,.,0,0
145147,Monthly,0,0
145148,follow-up,0,0
145149,was,0,0
145150,done,0,0
145151,to,0,0
145152,assess,0,0
145153,tolerance,0,0
145154,",",0,0
145155,side,0,0
145156,effects,0,0
145157,and,0,0
145158,adherence,0,0
145159,.,0,0
145160,Effectiveness,0,0
145161,was,0,0
145162,evaluated,0,0
145163,at,0,0
145164,5,0,0
145165,years,0,0
145166,.,0,0
145167,RESULTS,0,0
145168,In,0,0
145169,the,0,0
145170,590,0,0
145171,subjects,0,0
145172,enrolled,0,0
145173,",",0,0
145174,the,0,0
145175,rate,0,0
145176,of,0,0
145177,adherence,0,0
145178,was,0,0
145179,greater,0,0
145180,in,0,0
145181,the,0,0
145182,3RH,0,0
145183,than,0,0
145184,in,0,0
145185,the,0,0
145186,6H,0,1
145187,arm,0,0
145188,(,0,0
145189,72,0,0
145190,%,0,0
145191,vs.,0,0
145192,52.4,0,0
145193,%,0,0
145194,",",0,0
145195,P,0,0
145196,=,0,0
145197,0.001,0,0
145198,),0,0
145199,.,0,0
145200,No,0,1
145201,differences,0,0
145202,between,0,0
145203,study,0,0
145204,arms,0,0
145205,were,0,0
145206,observed,0,0
145207,with,0,0
145208,respect,0,0
145209,to,0,0
145210,hepatotoxicity,0,1
145211,or,0,0
145212,side,0,0
145213,effects,0,0
145214,.,0,0
145215,Variables,0,0
145216,associated,0,0
145217,with,0,0
145218,non-adherence,0,0
145219,were,0,0
145220,diagnosis,0,0
145221,by,0,0
145222,screening,0,0
145223,(,0,0
145224,OR,0,0
145225,1.88,0,0
145226,",",0,0
145227,95,0,0
145228,%,0,0
145229,CI,0,0
145230,1.26-2.82,0,0
145231,",",0,0
145232,P,0,0
145233,=,0,0
145234,0.001,0,0
145235,),0,0
145236,",",0,0
145237,illegal,0,1
145238,immigration,0,1
145239,status,0,1
145240,(,0,0
145241,OR,0,0
145242,1.48,0,0
145243,",",0,0
145244,95,0,0
145245,%,0,0
145246,CI,0,0
145247,1.01-2.15,0,0
145248,",",0,0
145249,P,0,0
145250,=,0,0
145251,0.03,0,0
145252,),0,0
145253,",",0,0
145254,unemployment,0,1
145255,(,0,0
145256,OR,0,0
145257,1.91,0,0
145258,",",0,0
145259,95,0,0
145260,%,0,0
145261,CI,0,0
145262,1.28-2.85,0,0
145263,",",0,0
145264,P,0,0
145265,=,0,0
145266,0.0008,0,0
145267,),0,0
145268,",",0,0
145269,illiteracy,0,1
145270,(,0,0
145271,OR,0,0
145272,1.73,0,0
145273,",",0,0
145274,95,0,0
145275,%,0,0
145276,CI,0,0
145277,1.04-2.88,0,0
145278,",",0,0
145279,P,0,0
145280,=,0,0
145281,0.02,0,0
145282,),0,0
145283,",",0,0
145284,lack,0,0
145285,of,0,0
145286,family,0,0
145287,support,0,0
145288,(,0,0
145289,OR,0,0
145290,3.7,0,0
145291,",",0,0
145292,95,0,0
145293,%,0,0
145294,CI,0,0
145295,2.54-5.4,0,0
145296,",",0,0
145297,P,0,0
145298,=,0,0
145299,0.001,0,0
145300,),0,0
145301,and,0,0
145302,the,0,0
145303,6-month,0,0
145304,treatment,0,1
145305,regimen,0,1
145306,(,0,1
145307,OR,0,0
145308,2.45,0,0
145309,",",0,0
145310,95,0,0
145311,%,0,0
145312,CI,0,0
145313,1.68-3.57,0,0
145314,",",0,0
145315,P,0,0
145316,=,0,0
145317,0.0001,0,0
145318,),0,0
145319,.,0,0
145320,None,0,1
145321,of,0,0
145322,the,0,0
145323,patients,0,0
145324,who,0,0
145325,completed,0,0
145326,either,0,0
145327,treatment,0,0
145328,developed,0,0
145329,tuberculosis,0,0
145330,.,0,0
145331,CONCLUSIONS,0,0
145332,The,0,0
145333,3RH,1,1
145334,regimen,1,1
145335,facilitates,0,0
145336,adherence,0,1
145337,to,0,0
145338,LTBI,0,1
145339,treatment,0,0
145340,and,0,0
145341,offers,0,0
145342,a,0,0
145343,safe,0,0
145344,",",0,0
145345,well-tolerated,0,1
145346,and,0,0
145347,effective,0,0
145348,alternative,0,0
145349,.,0,0
145350,Modulation,0,0
145351,of,0,0
145352,the,0,0
145353,intestinal,0,0
145354,environment,0,0
145355,",",0,0
145356,innate,0,0
145357,immune,0,0
145358,response,0,0
145359,",",0,0
145360,and,0,0
145361,barrier,0,0
145362,function,0,0
145363,by,0,0
145364,dietary,1,1
145365,threonine,1,1
145366,and,1,0
145367,purified,1,0
145368,fiber,1,0
145369,during,0,0
145370,a,0,0
145371,coccidiosis,0,1
145372,challenge,0,0
145373,in,0,1
145374,broiler,0,1
145375,chicks,0,1
145376,.,0,1
145377,Coccidiosis,0,0
145378,is,0,0
145379,a,0,0
145380,major,0,0
145381,contributor,0,0
145382,to,0,0
145383,economic,0,0
145384,losses,0,0
145385,in,0,0
145386,the,0,0
145387,poultry,0,0
145388,industry,0,0
145389,due,0,0
145390,to,0,0
145391,its,0,0
145392,detrimental,0,0
145393,effects,0,0
145394,on,0,0
145395,growth,0,0
145396,performance,0,0
145397,and,0,0
145398,nutrient,0,0
145399,utilization,0,0
145400,.,0,0
145401,We,0,0
145402,hypothesized,0,0
145403,that,0,0
145404,the,0,0
145405,combined,0,0
145406,effects,0,0
145407,of,0,0
145408,supplemental,1,0
145409,dietary,1,1
145410,Thr,1,0
145411,and,1,0
145412,purified,1,0
145413,fiber,1,0
145414,may,0,0
145415,modulate,0,0
145416,the,0,0
145417,intestinal,0,0
145418,environment,0,0
145419,and,0,0
145420,positively,0,0
145421,affect,0,0
145422,intestinal,0,0
145423,immune,0,0
145424,responses,0,0
145425,and,0,0
145426,barrier,0,0
145427,function,0,0
145428,in,0,0
145429,broiler,0,1
145430,chicks,0,1
145431,infected,0,0
145432,with,0,0
145433,Eimeria,0,0
145434,maxima,0,0
145435,.,0,0
145436,A,0,0
145437,Thr-deficient,1,0
145438,basal,1,0
145439,diet,0,1
145440,(,0,1
145441,3.1,0,0
145442,g,0,0
145443,of,0,0
145444,Thr/kg,0,1
145445,of,0,1
145446,diet,0,1
145447,),0,1
145448,was,0,0
145449,supplemented,0,0
145450,with,0,0
145451,70,1,0
145452,g/kg,1,0
145453,of,1,0
145454,silica,1,1
145455,sand,1,0
145456,(,1,1
145457,control,1,0
145458,),1,1
145459,or,1,1
145460,high-methoxy,1,1
145461,pectin,1,1
145462,and,1,1
145463,1,1,0
145464,of,1,0
145465,2,1,0
145466,concentrations,1,0
145467,of,1,0
145468,Thr,1,0
145469,(,0,0
145470,1.8,0,0
145471,or,0,0
145472,5.3,0,0
145473,g/kg,0,1
145474,of,0,1
145475,diet,0,1
145476,;,0,1
145477,4,0,1
145478,diets,0,1
145479,total,0,1
145480,),0,1
145481,",",0,0
145482,and,0,0
145483,fed,0,0
145484,to,0,0
145485,chicks,0,1
145486,from,0,0
145487,hatch,0,0
145488,to,0,0
145489,d,0,0
145490,16,0,0
145491,posthatch,0,1
145492,.,0,1
145493,On,0,1
145494,d,0,1
145495,10,0,0
145496,posthatch,0,1
145497,",",0,1
145498,chicks,0,1
145499,received,0,0
145500,0.5,1,0
145501,mL,1,1
145502,of,1,0
145503,distilled,1,1
145504,water,1,0
145505,or,1,0
145506,an,1,0
145507,acute,1,1
145508,dose,1,1
145509,of,1,0
145510,Eimeria,1,1
145511,maxima,1,1
145512,(,0,0
145513,1.5,0,0
145514,?,0,1
145515,10,0,1
145516,(,0,1
145517,3,0,1
145518,),0,0
145519,sporulated,0,0
145520,oocytes,0,0
145521,),0,0
145522,with,0,0
145523,6,0,0
145524,replicate,0,0
145525,pens,0,0
145526,of,0,0
145527,6,0,0
145528,chicks,0,1
145529,per,0,0
145530,each,0,0
145531,of,0,0
145532,8,0,0
145533,treatment,0,0
145534,combinations,0,0
145535,(,0,1
145536,4,0,1
145537,diets,0,1
145538,and,0,1
145539,2,0,0
145540,inoculation,0,0
145541,states,0,0
145542,),0,0
145543,.,0,0
145544,Body,0,0
145545,weight,0,0
145546,gain,0,0
145547,",",0,1
145548,feed,0,1
145549,intake,0,1
145550,",",0,1
145551,and,0,0
145552,G,0,0
145553,:,0,0
145554,F,0,0
145555,increased,0,0
145556,(,0,0
145557,P,0,0
145558,<,0,0
145559,0.01,0,0
145560,),0,0
145561,with,0,0
145562,addition,0,0
145563,of,0,0
145564,5.3,0,0
145565,g,0,0
145566,of,0,0
145567,Thr/kg,0,1
145568,of,0,0
145569,diet,0,1
145570,.,0,1
145571,Eimeria,0,1
145572,maxima,0,0
145573,schizonts,0,1
145574,were,0,0
145575,present,0,0
145576,only,0,0
145577,in,0,0
145578,intestinal,0,0
145579,tissue,0,0
145580,sampled,0,0
145581,from,0,0
145582,infected,0,0
145583,birds,0,0
145584,(,0,0
145585,P,0,0
145586,<,0,0
145587,0.01,0,0
145588,),0,0
145589,.,0,0
145590,Weights,0,0
145591,of,0,0
145592,cecal,0,0
145593,digesta,0,1
145594,were,0,0
145595,highest,0,0
145596,(,0,0
145597,P,0,0
145598,<,0,0
145599,0.01,0,0
145600,),0,0
145601,in,0,0
145602,pectin-fed,0,1
145603,birds,0,1
145604,",",0,0
145605,and,0,0
145606,ceca,0,0
145607,with,0,0
145608,the,0,0
145609,heaviest,0,0
145610,weights,0,0
145611,also,0,0
145612,had,0,0
145613,the,0,0
145614,highest,0,0
145615,concentrations,0,0
145616,of,0,0
145617,total,0,0
145618,short-chain,0,1
145619,fatty,0,1
145620,acids,0,1
145621,.,0,1
145622,Expression,0,1
145623,of,0,0
145624,interleukin-12,0,1
145625,in,0,0
145626,ileal,0,0
145627,mucosa,0,0
145628,was,0,0
145629,highest,0,0
145630,(,0,0
145631,P,0,0
145632,<,0,0
145633,0.01,0,0
145634,),0,0
145635,in,0,0
145636,infected,0,0
145637,birds,0,0
145638,receiving,0,0
145639,the,0,0
145640,control,0,0
145641,diet,0,1
145642,with,0,0
145643,5.3,0,0
145644,g,0,0
145645,of,0,0
145646,supplemental,0,1
145647,Thr/kg,0,1
145648,.,0,1
145649,In,0,0
145650,cecal,0,0
145651,tonsils,0,1
145652,",",0,0
145653,interferon-?,0,1
145654,expression,0,0
145655,was,0,0
145656,highest,0,0
145657,in,0,0
145658,infected,0,0
145659,birds,0,0
145660,receiving,0,0
145661,the,0,0
145662,control,0,0
145663,diet,0,1
145664,(,0,1
145665,fiber,0,0
145666,?,0,0
145667,infection,0,0
145668,",",0,0
145669,P,0,0
145670,<,0,0
145671,0.05,0,0
145672,),0,0
145673,;,0,0
145674,interferon-?,0,1
145675,expression,0,0
145676,was,0,0
145677,lowest,0,0
145678,in,0,0
145679,infected,0,0
145680,birds,0,0
145681,fed,0,0
145682,the,0,0
145683,high,0,0
145684,Thr,0,0
145685,diet,0,1
145686,(,0,1
145687,Thr,0,0
145688,?,0,0
145689,infection,0,0
145690,",",0,0
145691,P,0,0
145692,<,0,0
145693,0.05,0,0
145694,),0,0
145695,.,0,0
145696,There,0,0
145697,were,0,0
145698,no,0,0
145699,differences,0,0
145700,due,0,0
145701,to,0,0
145702,infection,1,0
145703,or,1,0
145704,Thr,1,0
145705,supplementation,1,1
145706,for,1,0
145707,cytokine,0,0
145708,expression,0,0
145709,in,0,0
145710,birds,0,0
145711,fed,0,0
145712,pectin-containing,0,0
145713,treatments,0,0
145714,.,0,0
145715,Overall,0,0
145716,",",0,0
145717,we,0,0
145718,conclude,0,0
145719,that,0,0
145720,although,0,0
145721,pectin,0,1
145722,has,0,0
145723,some,0,0
145724,protective,0,0
145725,function,0,0
145726,against,0,0
145727,coccidiosis,0,1
145728,",",0,1
145729,Thr,0,0
145730,supplementation,0,1
145731,had,0,0
145732,the,0,0
145733,greatest,0,0
145734,effect,0,0
145735,on,0,0
145736,intestinal,0,0
145737,immune,0,0
145738,response,0,0
145739,and,0,0
145740,maintenance,0,0
145741,of,0,0
145742,near,0,0
145743,normal,0,0
145744,growth,0,0
145745,in,0,0
145746,young,0,1
145747,broiler,0,1
145748,chicks,0,1
145749,infected,0,0
145750,with,0,0
145751,E.,0,0
145752,maxima,0,0
145753,.,0,0
145754,Neurophysiological,0,0
145755,responses,0,0
145756,to,0,0
145757,faces,0,0
145758,and,0,0
145759,gaze,0,0
145760,direction,0,0
145761,differentiate,0,0
145762,children,0,0
145763,with,0,0
145764,ASD,0,0
145765,",",0,0
145766,ADHD,0,1
145767,and,0,0
145768,ASD+ADHD,0,0
145769,.,0,0
145770,Children,0,0
145771,with,0,0
145772,autism,0,0
145773,spectrum,0,0
145774,disorder,0,1
145775,(,0,1
145776,ASD,0,1
145777,),0,1
145778,and,0,0
145779,attention,0,1
145780,deficit,0,1
145781,hyperactivity,0,1
145782,disorder,0,1
145783,(,0,1
145784,ADHD,0,1
145785,),0,0
145786,demonstrate,0,0
145787,face,0,0
145788,processing,0,0
145789,abnormalities,0,0
145790,that,0,0
145791,may,0,0
145792,underlie,0,0
145793,social,0,0
145794,impairment,0,0
145795,.,0,0
145796,Despite,0,0
145797,substantial,0,0
145798,overlap,0,0
145799,between,0,0
145800,ASD,0,0
145801,and,0,0
145802,ADHD,0,1
145803,",",0,0
145804,ERP,0,0
145805,markers,0,0
145806,of,0,0
145807,face,0,0
145808,and,0,0
145809,gaze,0,0
145810,processing,0,0
145811,have,0,0
145812,not,0,0
145813,been,0,0
145814,directly,0,0
145815,compared,0,0
145816,across,0,0
145817,pure,0,0
145818,and,0,0
145819,comorbid,0,0
145820,cases,0,0
145821,.,0,0
145822,Children,0,0
145823,with,0,0
145824,ASD,0,0
145825,(,0,0
145826,n=19,0,0
145827,),0,0
145828,",",0,0
145829,ADHD,0,1
145830,(,0,0
145831,n=18,0,0
145832,),0,0
145833,",",0,0
145834,comorbid,0,1
145835,ASD+ADHD,0,1
145836,(,0,0
145837,n=29,0,0
145838,),0,0
145839,and,0,0
145840,typically,0,0
145841,developing,0,0
145842,(,0,0
145843,TD,0,1
145844,),0,1
145845,controls,0,0
145846,(,0,0
145847,n=26,0,0
145848,),0,0
145849,were,0,0
145850,presented,0,0
145851,with,0,0
145852,upright/inverted,1,0
145853,faces,1,0
145854,with,1,0
145855,direct/averted,1,0
145856,gaze,1,0
145857,",",0,0
145858,with,0,0
145859,concurrent,0,0
145860,recording,0,0
145861,of,0,0
145862,the,0,0
145863,P1,0,0
145864,and,0,0
145865,N170,0,0
145866,components,0,0
145867,.,0,0
145868,While,0,0
145869,the,0,0
145870,N170,0,0
145871,was,0,0
145872,predominant,0,0
145873,in,0,0
145874,the,0,0
145875,right,0,0
145876,hemisphere,0,0
145877,in,0,0
145878,TD,0,0
145879,and,0,0
145880,ADHD,0,1
145881,",",0,0
145882,children,0,0
145883,with,0,0
145884,ASD,0,1
145885,(,0,1
145886,ASD/ASD+ADHD,0,1
145887,),0,0
145888,showed,0,0
145889,a,0,0
145890,bilateral,0,0
145891,distribution,0,0
145892,.,0,0
145893,In,0,0
145894,addition,0,0
145895,",",0,0
145896,children,0,0
145897,with,0,0
145898,ASD,0,0
145899,demonstrated,0,0
145900,altered,0,0
145901,response,0,0
145902,to,0,0
145903,gaze,0,0
145904,direction,0,0
145905,on,0,0
145906,P1,0,0
145907,latency,0,0
145908,and,0,0
145909,no,0,0
145910,sensitivity,0,0
145911,to,0,0
145912,gaze,0,0
145913,direction,0,0
145914,on,0,0
145915,midline-N170,0,0
145916,amplitude,0,0
145917,compared,0,0
145918,to,0,0
145919,TD,0,0
145920,and,0,0
145921,ADHD,0,0
145922,.,0,0
145923,In,0,0
145924,contrast,0,0
145925,",",0,0
145926,children,0,0
145927,with,0,0
145928,ADHD,0,1
145929,(,0,1
145930,ADHD/ASD+ADHD,0,1
145931,),0,0
145932,exhibited,0,0
145933,a,0,0
145934,reduced,0,0
145935,face,0,0
145936,inversion,0,0
145937,effect,0,0
145938,on,0,0
145939,P1,0,0
145940,latency,0,0
145941,compared,0,0
145942,to,0,0
145943,TD,0,0
145944,and,0,0
145945,ASD,0,0
145946,.,0,0
145947,These,0,0
145948,findings,0,0
145949,suggest,0,0
145950,children,0,0
145951,with,0,0
145952,ASD,0,0
145953,have,0,0
145954,specific,0,0
145955,abnormalities,0,0
145956,in,0,0
145957,gaze,0,0
145958,processing,0,0
145959,and,0,0
145960,altered,0,0
145961,neural,0,0
145962,specialisation,0,0
145963,",",0,0
145964,whereas,0,0
145965,children,0,0
145966,with,0,0
145967,ADHD,0,0
145968,show,0,0
145969,abnormalities,0,0
145970,at,0,0
145971,early,0,0
145972,visual,0,0
145973,attention,0,0
145974,stages,0,0
145975,.,0,0
145976,Children,0,0
145977,with,0,0
145978,ASD+ADHD,0,0
145979,are,0,0
145980,an,0,0
145981,additive,0,0
145982,co-occurrence,0,0
145983,with,0,0
145984,deficits,0,0
145985,of,0,0
145986,both,0,0
145987,disorders,0,0
145988,.,0,0
145989,Elucidating,0,0
145990,the,0,0
145991,neural,0,0
145992,basis,0,0
145993,of,0,0
145994,the,0,0
145995,overlap,0,0
145996,between,0,0
145997,ASD,0,0
145998,and,0,0
145999,ADHD,0,0
146000,is,0,0
146001,likely,0,0
146002,to,0,0
146003,inform,0,0
146004,aetiological,0,0
146005,investigation,0,0
146006,and,0,0
146007,clinical,0,0
146008,assessment,0,0
146009,.,0,0
146010,MEG,0,1
146011,premotor,0,0
146012,abnormalities,0,0
146013,in,0,0
146014,children,0,0
146015,with,0,0
146016,Asperger,0,0
146017,'s,0,0
146018,syndrome,0,0
146019,:,0,0
146020,determinants,0,0
146021,of,0,0
146022,social,0,0
146023,behavior,0,0
146024,?,0,0
146025,Children,0,0
146026,with,0,0
146027,Asperger,0,0
146028,'s,0,0
146029,syndrome,0,0
146030,show,0,0
146031,deficits,0,0
146032,in,0,0
146033,social,0,0
146034,functioning,0,0
146035,while,0,0
146036,their,0,0
146037,intellectual,0,0
146038,and,0,0
146039,language,0,0
146040,development,0,0
146041,is,0,0
146042,intact,0,0
146043,suggesting,0,0
146044,a,0,0
146045,specific,0,0
146046,dysfunction,0,0
146047,in,0,0
146048,mechanisms,0,0
146049,mediating,0,0
146050,social,0,0
146051,cognition,0,1
146052,.,0,0
146053,An,0,1
146054,action,0,0
146055,observation/execution,0,0
146056,matching,0,0
146057,system,0,0
146058,might,0,0
146059,be,0,0
146060,one,0,0
146061,such,0,0
146062,mechanism,0,0
146063,.,0,0
146064,Recent,0,0
146065,studies,0,0
146066,indeed,0,0
146067,showed,0,0
146068,that,0,0
146069,electrophysiological,0,0
146070,modulation,0,0
146071,of,0,0
146072,the,0,0
146073,Mu-rhythm,0,0
146074,in,0,0
146075,the,0,0
146076,10-12Hz,0,0
146077,range,0,0
146078,is,0,0
146079,weaker,0,0
146080,when,0,0
146081,individuals,0,0
146082,with,0,0
146083,Asperger,0,0
146084,'s,0,0
146085,syndrome,0,0
146086,observe,0,0
146087,actions,0,0
146088,performed,0,0
146089,by,0,0
146090,others,0,0
146091,compared,0,0
146092,to,0,0
146093,controls,0,0
146094,.,0,0
146095,However,0,0
146096,",",0,0
146097,electrophysiological,0,0
146098,studies,0,0
146099,typically,0,0
146100,fall,0,0
146101,short,0,0
146102,in,0,0
146103,revealing,0,0
146104,the,0,0
146105,neural,0,0
146106,generators,0,0
146107,of,0,0
146108,this,0,0
146109,activity,0,0
146110,.,0,0
146111,To,0,0
146112,fill,0,0
146113,this,0,0
146114,gap,0,0
146115,we,0,0
146116,assessed,0,0
146117,magnetoencephalographic,1,0
146118,Mu-modulations,1,0
146119,in,0,0
146120,Asperger,0,0
146121,'s,0,0
146122,and,0,0
146123,typically,0,0
146124,developed,0,0
146125,children,0,0
146126,",",0,0
146127,while,0,0
146128,observing,1,0
146129,grasping,1,0
146130,movements,1,0
146131,.,1,0
146132,Mu-power,0,0
146133,increased,0,0
146134,at,0,0
146135,frontal,0,0
146136,and,0,0
146137,central,0,0
146138,sensors,0,0
146139,during,0,0
146140,movement,0,0
146141,observation,0,0
146142,.,0,0
146143,This,0,0
146144,modulation,0,0
146145,was,0,0
146146,stronger,0,0
146147,in,0,0
146148,typical,0,0
146149,than,0,0
146150,in,0,0
146151,Asperger,0,0
146152,children,0,0
146153,.,0,0
146154,Source,0,0
146155,localization,0,0
146156,revealed,0,0
146157,stronger,0,0
146158,sources,0,0
146159,in,0,0
146160,premotor,0,0
146161,cortex,0,0
146162,",",0,0
146163,the,0,0
146164,intraparietal,0,1
146165,lobule,0,1
146166,(,0,1
146167,IPL,0,1
146168,),0,1
146169,and,0,0
146170,the,0,0
146171,mid-occipito-temporal,0,1
146172,gyrus,0,1
146173,(,0,1
146174,MOTG,0,1
146175,),0,1
146176,and,0,0
146177,weaker,0,0
146178,sources,0,0
146179,in,0,0
146180,prefrontal,0,0
146181,cortex,0,0
146182,in,0,0
146183,typical,0,0
146184,participants,0,0
146185,compared,0,0
146186,to,0,0
146187,Asperger,0,0
146188,.,0,0
146189,Activity,0,0
146190,in,0,0
146191,premotor,0,0
146192,regions,0,0
146193,",",0,0
146194,IPL,0,0
146195,and,0,0
146196,MOTG,0,0
146197,correlated,0,0
146198,positively,0,0
146199,with,0,0
146200,social,0,0
146201,competence,0,0
146202,",",0,0
146203,whereas,0,0
146204,prefrontal,0,0
146205,Mu-sources,0,0
146206,correlated,0,0
146207,negatively,0,0
146208,with,0,0
146209,social,0,0
146210,competence,0,0
146211,.,0,0
146212,No,0,0
146213,correlation,0,0
146214,with,0,0
146215,intellectual,0,0
146216,ability,0,0
146217,was,0,0
146218,found,0,0
146219,at,0,0
146220,any,0,0
146221,of,0,0
146222,these,0,0
146223,sites,0,0
146224,.,0,0
146225,These,0,0
146226,findings,0,0
146227,localize,0,0
146228,abnormal,0,0
146229,Mu-activity,0,0
146230,in,0,0
146231,the,0,0
146232,brain,0,0
146233,of,0,0
146234,Asperger,0,0
146235,children,0,0
146236,providing,0,0
146237,evidence,0,0
146238,which,0,0
146239,associates,0,0
146240,motor-system,0,0
146241,abnormalities,0,0
146242,with,0,0
146243,social-function,0,0
146244,deficits,0,0
146245,.,0,0
146246,A,0,1
146247,randomized,0,1
146248,cross-over,0,1
146249,study,0,0
146250,of,0,0
146251,inhalation,0,1
146252,of,0,1
146253,diesel,0,1
146254,exhaust,0,0
146255,",",0,0
146256,hematological,0,0
146257,indices,0,0
146258,",",0,0
146259,and,0,0
146260,endothelial,0,0
146261,markers,0,0
146262,in,0,0
146263,humans,0,0
146264,.,0,0
146265,BACKGROUND,0,0
146266,Exposure,0,0
146267,to,0,0
146268,traffic-related,0,0
146269,air,0,1
146270,pollution,0,1
146271,(,0,1
146272,TRAP,0,1
146273,),0,0
146274,is,0,0
146275,considered,0,0
146276,a,0,0
146277,trigger,0,0
146278,for,0,0
146279,acute,0,0
146280,cardiovascular,0,0
146281,events,0,0
146282,.,0,0
146283,Diesel,0,0
146284,Exhaust,0,1
146285,(,0,1
146286,DE,0,1
146287,),0,0
146288,is,0,0
146289,a,0,0
146290,major,0,0
146291,contributor,0,0
146292,to,0,0
146293,TRAP,0,0
146294,in,0,0
146295,the,0,0
146296,world,0,0
146297,.,0,0
146298,We,0,0
146299,evaluated,0,0
146300,the,0,0
146301,effect,0,0
146302,of,0,0
146303,DE,0,1
146304,inhalation,0,1
146305,on,0,0
146306,circulating,0,0
146307,blood,0,0
146308,cell,0,0
146309,populations,0,0
146310,",",0,0
146311,hematological,0,0
146312,indices,0,0
146313,",",0,0
146314,and,0,0
146315,systemic,0,0
146316,inflammatory,0,0
146317,cytokines,0,0
146318,in,0,0
146319,humans,0,0
146320,using,0,0
146321,a,0,0
146322,specialized,0,0
146323,facility,0,0
146324,.,0,0
146325,METHODS,0,0
146326,In,0,0
146327,a,0,0
146328,randomized,0,1
146329,double-blind,0,1
146330,crossover,0,1
146331,study,0,0
146332,balanced,0,0
146333,to,0,0
146334,order,0,0
146335,",",0,0
146336,17,0,0
146337,metabolic,0,0
146338,syndrome,0,1
146339,(,0,1
146340,MetS,0,1
146341,),0,1
146342,and,0,0
146343,15,0,0
146344,healthy,0,0
146345,subjects,0,0
146346,inhaled,1,1
146347,filtered,1,1
146348,air,1,1
146349,(,1,1
146350,FA,1,1
146351,),1,1
146352,or,1,0
146353,DE,1,0
146354,exposure,1,0
146355,in,0,0
146356,two-hour,0,1
146357,sessions,0,1
146358,on,0,0
146359,different,0,0
146360,days,0,0
146361,with,0,0
146362,a,0,0
146363,minimum,0,0
146364,2-week,0,1
146365,washout,0,1
146366,period,0,1
146367,.,0,0
146368,We,0,0
146369,collected,0,0
146370,blood,0,0
146371,pre-exposure,0,1
146372,",",0,1
146373,7,0,0
146374,",",0,0
146375,and,0,0
146376,22,0,0
146377,hours,0,0
146378,after,0,0
146379,exposure,0,0
146380,initiation,0,0
146381,and,0,0
146382,measured,0,0
146383,the,0,0
146384,complete,0,0
146385,blood,0,0
146386,count,0,0
146387,and,0,0
146388,differential,0,0
146389,.,0,0
146390,We,0,0
146391,performed,0,0
146392,multiplex,0,0
146393,cytokine,0,0
146394,assay,0,0
146395,to,0,0
146396,measure,0,0
146397,the,0,0
146398,changes,0,0
146399,in,0,0
146400,the,0,0
146401,systemic,0,0
146402,inflammatory,0,0
146403,cytokines,0,0
146404,",",0,0
146405,and,0,0
146406,endothelial,0,0
146407,adhesion,0,0
146408,molecules,0,0
146409,(,0,0
146410,n=15,0,0
146411,),0,0
146412,.,0,0
146413,A,0,0
146414,paired,0,0
146415,analysis,0,0
146416,compared,0,0
146417,the,0,0
146418,effect,0,0
146419,of,0,0
146420,DE,0,0
146421,and,0,0
146422,FA,0,0
146423,exposures,0,0
146424,for,0,0
146425,the,0,0
146426,change,0,0
146427,from,0,0
146428,pre-exposure,0,1
146429,to,0,0
146430,the,0,0
146431,subsequent,0,0
146432,time,0,0
146433,points,0,0
146434,.,0,0
146435,RESULTS,0,0
146436,A,0,0
146437,significant,0,0
146438,increase,0,0
146439,in,0,0
146440,the,0,0
146441,hematocrit,0,0
146442,was,0,0
146443,noted,0,0
146444,7,0,0
146445,hrs,0,0
146446,after,0,0
146447,DE,0,1
146448,[,0,0
146449,1.4,0,0
146450,%,0,0
146451,(,0,0
146452,95,0,0
146453,%,0,0
146454,CI,0,0
146455,:,0,0
146456,0.9,0,0
146457,to,0,0
146458,1.9,0,0
146459,%,0,0
146460,),0,0
146461,],0,0
146462,compared,0,0
146463,to,0,0
146464,FA,0,0
146465,exposure,0,0
146466,[,0,0
146467,0.5,0,0
146468,%,0,0
146469,(,0,0
146470,95,0,0
146471,%,0,0
146472,CI,0,0
146473,:,0,0
146474,-0.09,0,0
146475,to,0,0
146476,1.0,0,0
146477,%,0,0
146478,),0,0
146479,;,0,0
146480,p=0.008,0,0
146481,.,0,0
146482,The,0,0
146483,hemoglobin,0,1
146484,levels,0,0
146485,increased,0,0
146486,non-significantly,0,0
146487,at,0,0
146488,7,0,0
146489,hrs,0,0
146490,post,0,1
146491,DE,0,1
146492,[,0,0
146493,0.3,0,0
146494,gm/dL,0,0
146495,(,0,0
146496,95,0,0
146497,%,0,0
146498,CI,0,0
146499,:,0,0
146500,0.2,0,0
146501,to,0,0
146502,0.5,0,0
146503,gm/dL,0,1
146504,),0,1
146505,],0,1
146506,versus,0,0
146507,FA,0,1
146508,exposure,0,0
146509,[,0,0
146510,0.2,0,0
146511,gm/dL,0,0
146512,(,0,0
146513,95,0,0
146514,%,0,0
146515,CI,0,0
146516,:,0,0
146517,0,0,0
146518,to,0,0
146519,0.3,0,0
146520,gm/dL,0,1
146521,),0,1
146522,],0,0
146523,;,0,0
146524,p=0.06,0,0
146525,.,0,0
146526,Furthermore,0,0
146527,",",0,0
146528,the,0,0
146529,platelet,0,1
146530,count,0,0
146531,increased,0,0
146532,22,0,0
146533,hrs,0,0
146534,after,0,0
146535,DE,0,0
146536,exposure,0,0
146537,in,0,0
146538,healthy,0,0
146539,",",0,0
146540,but,0,0
146541,not,0,0
146542,in,0,0
146543,MetS,0,1
146544,subjects,0,0
146545,[,0,0
146546,DE,0,0
146547,:,0,0
146548,16.6,0,0
146549,(,0,0
146550,95,0,0
146551,%,0,0
146552,CI,0,0
146553,:,0,0
146554,10.2,0,0
146555,to,0,0
146556,23,0,0
146557,),0,0
146558,thousand,0,0
146559,platelets/mL,0,1
146560,versus,0,0
146561,[,0,1
146562,FA,0,0
146563,:,0,0
146564,3.4,0,0
146565,(,0,0
146566,95,0,0
146567,%,0,0
146568,CI,0,0
146569,:,0,0
146570,-9.5,0,0
146571,to,0,0
146572,16.3,0,0
146573,),0,0
146574,thousand,0,0
146575,platelets/mL,0,1
146576,),0,1
146577,],0,1
146578,;,0,0
146579,p=0.04,0,0
146580,.,0,0
146581,No,0,0
146582,DE,0,0
146583,effect,0,0
146584,was,0,0
146585,observed,0,0
146586,for,0,0
146587,WBC,0,0
146588,",",0,0
146589,neutrophils,0,0
146590,",",0,0
146591,lymphocytes,0,0
146592,or,0,0
146593,erythrocytes,0,0
146594,.,0,0
146595,Using,0,0
146596,the,0,0
146597,multiplex,0,0
146598,assay,0,0
146599,",",0,0
146600,small,0,0
146601,borderline,0,0
146602,significant,0,0
146603,increases,0,0
146604,in,0,0
146605,matrix,0,0
146606,metalloproteinase-9,0,1
146607,",",0,1
146608,interleukins,0,1
146609,(,0,1
146610,IL,0,1
146611,),0,1
146612,-1,0,0
146613,beta,0,0
146614,",",0,0
146615,6,0,0
146616,and,0,0
146617,10,0,0
146618,occurred,0,0
146619,7,0,0
146620,hrs,0,0
146621,post,0,0
146622,exposure,0,0
146623,initiation,0,0
146624,",",0,0
146625,whereas,0,0
146626,E-selectin,0,0
146627,",",0,0
146628,intercellular,0,0
146629,adhesion,0,0
146630,molecule-1,0,1
146631,",",0,1
146632,and,0,0
146633,vascular,0,0
146634,cell,0,0
146635,adhesion,0,0
146636,molecule,0,0
146637,-1,0,0
146638,",",0,0
146639,and,0,0
146640,myeloperoxidase,0,1
146641,22,0,0
146642,hrs,0,0
146643,post,0,0
146644,exposure,0,0
146645,.,0,0
146646,CONCLUSIONS,0,0
146647,Our,0,0
146648,results,0,0
146649,suggest,0,0
146650,that,0,0
146651,short-term,0,0
146652,DE,0,0
146653,exposure,0,0
146654,results,0,0
146655,in,0,0
146656,hemoconcentration,0,0
146657,and,0,0
146658,thrombocytosis,0,0
146659,",",0,0
146660,which,0,0
146661,are,0,0
146662,important,0,0
146663,determinants,0,0
146664,of,0,0
146665,acute,0,0
146666,cardiovascular,0,0
146667,events,0,0
146668,.,0,0
146669,Multiplex,0,0
146670,assay,0,0
146671,showed,0,0
146672,a,0,0
146673,non-significant,0,0
146674,increase,0,0
146675,in,0,0
146676,IL-1?,0,0
146677,and,0,0
146678,IL-6,0,0
146679,immediately,0,0
146680,post,0,0
146681,exposure,0,0
146682,followed,0,0
146683,by,0,0
146684,myeloperoxidase,0,1
146685,and,0,0
146686,endothelial,0,0
146687,activation,0,0
146688,molecules,0,0
146689,.,0,0
146690,Further,0,0
146691,specific,0,0
146692,assays,0,0
146693,in,0,0
146694,a,0,0
146695,larger,0,0
146696,population,0,0
146697,will,0,0
146698,improve,0,0
146699,our,0,0
146700,understanding,0,0
146701,of,0,0
146702,the,0,0
146703,systemic,0,0
146704,inflammatory,0,0
146705,mechanisms,0,0
146706,following,0,0
146707,acute,0,0
146708,exposure,0,0
146709,to,0,0
146710,TRAP,0,0
146711,.,0,0
146712,Long-term,0,0
146713,treatment,0,0
146714,with,0,0
146715,atomoxetine,1,1
146716,for,0,0
146717,attention-deficit/hyperactivity,0,1
146718,disorder,0,0
146719,symptoms,0,0
146720,in,0,0
146721,children,0,0
146722,and,0,0
146723,adolescents,0,0
146724,with,0,0
146725,autism,0,0
146726,spectrum,0,0
146727,disorder,0,0
146728,:,0,0
146729,an,0,0
146730,open-label,0,1
146731,extension,0,0
146732,study,0,0
146733,.,0,0
146734,OBJECTIVE,0,0
146735,The,0,0
146736,efficacy,0,0
146737,and,0,0
146738,tolerability,0,1
146739,of,0,0
146740,long-term,0,0
146741,treatment,0,0
146742,with,0,0
146743,atomoxetine,1,1
146744,for,0,0
146745,symptoms,0,0
146746,of,0,0
146747,attention-deficit/hyperactivity,0,1
146748,disorder,0,1
146749,(,0,1
146750,ADHD,0,1
146751,),0,1
146752,in,0,0
146753,children,0,0
146754,with,0,0
146755,autism,0,0
146756,spectrum,0,0
146757,disorder,0,1
146758,(,0,1
146759,ASD,0,1
146760,),0,0
146761,has,0,0
146762,not,0,0
146763,been,0,0
146764,established,0,0
146765,.,0,0
146766,METHODS,0,0
146767,In,0,0
146768,this,0,0
146769,study,0,0
146770,",",0,0
146771,88,0,0
146772,patients,0,0
146773,6-17,0,0
146774,years,0,0
146775,of,0,0
146776,age,0,0
146777,",",0,0
146778,with,0,0
146779,ADHD,0,0
146780,and,0,0
146781,ASD,0,0
146782,",",0,0
146783,were,0,0
146784,treated,0,0
146785,with,0,0
146786,1.2,0,0
146787,mg/kg/day,0,1
146788,atomoxetine,1,1
146789,for,0,1
146790,20,0,0
146791,weeks,0,0
146792,as,0,0
146793,follow-up,0,0
146794,of,0,0
146795,an,0,0
146796,8,0,0
146797,week,0,0
146798,double-blind,0,1
146799,placebo-controlled,1,1
146800,period,0,1
146801,.,0,0
146802,Primary,0,0
146803,endpoint,0,0
146804,was,0,0
146805,the,0,0
146806,ADHD,0,0
146807,Rating,0,0
146808,Scale,0,1
146809,(,0,1
146810,ADHD-RS,0,1
146811,),0,1
146812,.,0,0
146813,RESULTS,0,1
146814,After,0,0
146815,8,0,0
146816,weeks,0,0
146817,of,0,0
146818,initial,0,0
146819,treatment,0,0
146820,",",0,0
146821,the,0,0
146822,mean,0,0
146823,total,0,0
146824,",",0,0
146825,inattention,0,0
146826,",",0,0
146827,and,0,0
146828,hyperactivity-impulsivity,0,0
146829,ADHD-RS,0,0
146830,further,0,0
146831,decreased,0,0
146832,significantly,0,0
146833,from,0,0
146834,34.9,0,0
146835,to,0,0
146836,27.0,0,0
146837,for,0,0
146838,the,0,0
146839,total,0,0
146840,ADHD-RS,0,0
146841,",",0,0
146842,from,0,0
146843,18.3,0,0
146844,to,0,0
146845,14.5,0,0
146846,for,0,0
146847,the,0,0
146848,ADHD-RS,0,0
146849,inattention,0,0
146850,subscale,0,0
146851,",",0,0
146852,and,0,0
146853,from,0,0
146854,16.5,0,0
146855,to,0,0
146856,12.6,0,0
146857,for,0,0
146858,the,0,0
146859,hyperactivity-impulsivity,0,0
146860,subscale,0,0
146861,.,0,0
146862,Adverse,0,0
146863,events,0,0
146864,were,0,0
146865,mild,0,0
146866,and,0,0
146867,tended,0,0
146868,to,0,0
146869,diminish,0,0
146870,over,0,0
146871,time,0,0
146872,during,0,0
146873,continued,0,0
146874,treatment,0,0
146875,",",0,0
146876,especially,0,0
146877,regarding,0,0
146878,nausea,0,1
146879,and,0,0
146880,fatigue,0,1
146881,.,0,0
146882,There,0,0
146883,were,0,0
146884,no,0,0
146885,serious,0,0
146886,adverse,0,0
146887,events,0,0
146888,.,0,0
146889,CONCLUSIONS,0,0
146890,The,0,0
146891,results,0,0
146892,of,0,0
146893,the,0,0
146894,present,0,0
146895,analysis,0,0
146896,suggest,0,0
146897,that,0,0
146898,continued,0,0
146899,treatment,0,0
146900,with,0,0
146901,atomoxetine,1,1
146902,up,0,0
146903,to,0,0
146904,28,0,0
146905,weeks,0,0
146906,further,0,0
146907,improve,0,0
146908,ADHD,0,0
146909,symptoms,0,0
146910,in,0,0
146911,children,0,0
146912,and,0,0
146913,adolescents,0,0
146914,with,0,0
146915,ASD,0,0
146916,",",0,0
146917,while,0,0
146918,adverse,0,0
146919,events,0,0
146920,tend,0,0
146921,to,0,0
146922,subside,0,0
146923,.,0,0
146924,Future,0,0
146925,studies,0,0
146926,investigating,0,0
146927,the,0,0
146928,long-term,0,0
146929,efficacy,0,0
146930,of,0,0
146931,atomoxetine,1,1
146932,in,0,0
146933,children,0,1
146934,and,0,0
146935,adolescents,0,0
146936,with,0,0
146937,ASD,0,0
146938,should,0,0
146939,be,0,0
146940,randomized,0,0
146941,and,0,0
146942,placebo,0,1
146943,controlled,0,0
146944,.,0,0
146945,This,0,0
146946,study,0,0
146947,has,0,0
146948,been,0,0
146949,registered,0,0
146950,in,0,0
146951,ClinicalTrials.gov,0,1
146952,(,0,1
146953,www.clinicaltrials.gov,0,1
146954,),0,0
146955,under,0,0
146956,registration,0,0
146957,number,0,0
146958,NCT00380692,0,0
146959,.,0,0
146960,Memantine,1,1
146961,add-on,1,1
146962,to,1,1
146963,risperidone,1,1
146964,for,0,0
146965,treatment,0,0
146966,of,0,0
146967,negative,0,0
146968,symptoms,0,0
146969,in,0,0
146970,patients,0,0
146971,with,0,0
146972,stable,0,0
146973,schizophrenia,0,0
146974,:,0,0
146975,randomized,0,0
146976,",",0,0
146977,double-blind,0,1
146978,",",0,1
146979,placebo-controlled,0,1
146980,study,0,0
146981,.,0,0
146982,We,0,0
146983,aimed,0,0
146984,to,0,0
146985,evaluate,0,0
146986,the,0,0
146987,efficacy,0,0
146988,of,0,0
146989,memantine,1,1
146990,add-on,0,1
146991,in,0,0
146992,the,0,0
146993,treatment,0,0
146994,of,0,0
146995,primary,0,0
146996,negative,0,0
146997,symptoms,0,0
146998,of,0,0
146999,patients,0,0
147000,with,0,0
147001,stable,0,0
147002,schizophrenia,0,0
147003,.,0,0
147004,In,0,0
147005,a,0,0
147006,double-blind,0,1
147007,placebo-controlled,0,1
147008,clinical,0,1
147009,trial,0,1
147010,",",0,0
147011,40,0,0
147012,patients,0,0
147013,with,0,0
147014,schizophrenia,0,0
147015,(,0,0
147016,Diagnostic,0,1
147017,and,0,0
147018,Statistical,0,1
147019,Manual,0,0
147020,of,0,0
147021,Mental,0,0
147022,Disorders,0,0
147023,",",0,0
147024,Fourth,0,0
147025,Edition,0,1
147026,),0,0
147027,who,0,0
147028,were,0,0
147029,stabilized,0,0
147030,on,0,0
147031,risperidone,1,1
147032,for,0,0
147033,a,0,0
147034,minimum,0,0
147035,of,0,0
147036,8,0,0
147037,weeks,0,0
147038,were,0,0
147039,randomized,0,0
147040,to,0,0
147041,either,0,0
147042,memantine,1,1
147043,(,0,1
147044,20,0,1
147045,mg,0,1
147046,),0,1
147047,or,0,1
147048,placebo,1,1
147049,in,0,0
147050,addition,0,0
147051,to,0,0
147052,risperidone,1,1
147053,",",0,1
147054,6,0,1
147055,mg/d,0,1
147056,",",0,0
147057,for,0,0
147058,eight,0,0
147059,weeks,0,0
147060,.,0,0
147061,Assessment,0,0
147062,was,0,0
147063,done,0,0
147064,using,0,0
147065,the,0,0
147066,Positive,0,0
147067,and,0,0
147068,Negative,0,0
147069,Syndrome,0,0
147070,Scale,0,0
147071,at,0,0
147072,baseline,0,0
147073,",",0,0
147074,week,0,0
147075,4,0,0
147076,",",0,0
147077,and,0,0
147078,week,0,0
147079,8,0,0
147080,.,0,0
147081,The,0,0
147082,Hamilton,0,0
147083,Depression,0,0
147084,Rating,0,0
147085,Scale,0,0
147086,and,0,0
147087,the,0,0
147088,Extrapyramidal,0,1
147089,Symptom,0,1
147090,Rating,0,0
147091,Scale,0,0
147092,at,0,0
147093,baseline,0,0
147094,and,0,0
147095,week,0,0
147096,8,0,0
147097,were,0,0
147098,used,0,0
147099,to,0,0
147100,assess,0,0
147101,depression,0,0
147102,and,0,0
147103,extrapyramidal,0,0
147104,symptoms,0,0
147105,",",0,0
147106,respectively,0,0
147107,.,0,0
147108,All,0,0
147109,40,0,0
147110,patients,0,0
147111,had,0,0
147112,at,0,0
147113,least,0,0
147114,one,0,0
147115,postbaseline,0,0
147116,measurement,0,0
147117,",",0,0
147118,and,0,0
147119,38,0,0
147120,patients,0,0
147121,completed,0,0
147122,the,0,0
147123,trial,0,0
147124,.,0,0
147125,Patients,0,0
147126,in,0,0
147127,the,0,0
147128,memantine,0,1
147129,group,0,0
147130,showed,0,0
147131,a,0,0
147132,significantly,0,0
147133,greater,0,0
147134,improvement,0,0
147135,on,0,0
147136,negative,0,0
147137,subscale,0,0
147138,than,0,0
147139,the,0,0
147140,placebo,1,1
147141,group,0,0
147142,at,0,0
147143,end,0,0
147144,point,0,0
147145,(,0,0
147146,P,0,0
147147,<,0,0
147148,0.001,0,0
147149,),0,0
147150,.,0,0
147151,The,0,0
147152,same,0,0
147153,effect,0,0
147154,was,0,0
147155,observed,0,0
147156,for,0,0
147157,the,0,0
147158,total,0,0
147159,score,0,0
147160,(,0,0
147161,P,0,0
147162,<,0,0
147163,0.001,0,0
147164,),0,0
147165,and,0,0
147166,the,0,0
147167,general,0,0
147168,psychopathology,0,0
147169,subscale,0,1
147170,score,0,0
147171,(,0,0
147172,P,0,0
147173,=,0,0
147174,0.002,0,0
147175,),0,0
147176,.,0,0
147177,There,0,0
147178,was,0,0
147179,no,0,0
147180,significant,0,0
147181,difference,0,0
147182,in,0,0
147183,reduction,0,0
147184,of,0,0
147185,positive,0,0
147186,symptoms,0,0
147187,score,0,0
147188,between,0,0
147189,the,0,0
147190,2,0,0
147191,groups,0,0
147192,(,0,0
147193,P,0,0
147194,=,0,0
147195,0.757,0,0
147196,),0,0
147197,.,0,0
147198,Changes,0,0
147199,in,0,0
147200,the,0,0
147201,Hamilton,0,0
147202,Depression,0,0
147203,Rating,0,0
147204,Scale,0,0
147205,and,0,0
147206,the,0,0
147207,Extrapyramidal,0,1
147208,Symptom,0,1
147209,Rating,0,0
147210,Scale,0,0
147211,scores,0,0
147212,and,0,0
147213,frequency,0,0
147214,of,0,0
147215,adverse,0,0
147216,effects,0,0
147217,did,0,0
147218,not,0,0
147219,differ,0,0
147220,between,0,0
147221,the,0,0
147222,2,0,0
147223,groups,0,0
147224,.,0,0
147225,Our,0,0
147226,study,0,0
147227,showed,0,0
147228,that,0,0
147229,memantine,0,1
147230,is,0,0
147231,a,0,0
147232,tolerable,0,1
147233,and,0,1
147234,efficacious,0,1
147235,add-on,0,1
147236,treatment,0,0
147237,for,0,0
147238,primary,0,0
147239,negative,0,0
147240,symptoms,0,0
147241,of,0,0
147242,schizophrenia,0,0
147243,.,0,0
147244,The,0,0
147245,effects,0,0
147246,of,0,0
147247,a,0,0
147248,multi-component,0,0
147249,higher-functioning,0,0
147250,autism,0,0
147251,anti-stigma,0,0
147252,program,0,0
147253,on,0,0
147254,adolescent,0,0
147255,boys,0,0
147256,.,0,0
147257,A,0,0
147258,six-session,0,0
147259,higher-functioning,0,0
147260,autism,0,0
147261,anti-stigma,0,0
147262,program,0,0
147263,incorporating,0,0
147264,descriptive,0,0
147265,",",0,0
147266,explanatory,0,0
147267,and,0,0
147268,directive,0,0
147269,information,0,0
147270,was,0,0
147271,delivered,0,0
147272,to,0,0
147273,adolescent,0,0
147274,boys,0,0
147275,and,0,0
147276,the,0,0
147277,impact,0,0
147278,upon,0,0
147279,knowledge,0,0
147280,",",0,0
147281,attitudes,0,0
147282,and,0,0
147283,behavioural,0,0
147284,intentions,0,0
147285,towards,0,0
147286,peers,0,0
147287,with,0,0
147288,autism,0,0
147289,was,0,0
147290,evaluated,0,0
147291,.,0,0
147292,Participants,0,0
147293,were,0,0
147294,seventh-,0,0
147295,",",0,0
147296,eighth-,0,0
147297,and,0,0
147298,ninth-grade,0,1
147299,students,0,1
147300,(,0,0
147301,N,0,0
147302,=,0,0
147303,395,0,0
147304,),0,0
147305,from,0,0
147306,regular,0,0
147307,classes,0,0
147308,in,0,0
147309,a,0,0
147310,mainstream,0,0
147311,school,0,0
147312,.,0,0
147313,Two-eighth-grade,0,0
147314,classes,0,0
147315,were,1,0
147316,randomly,1,0
147317,allocated,1,0
147318,to,1,0
147319,the,1,0
147320,intervention,1,0
147321,condition,1,0
147322,and,1,0
147323,all,1,0
147324,remaining,1,0
147325,students,1,0
147326,were,1,0
147327,either,1,0
147328,allocated,1,0
147329,to,1,0
147330,the,1,0
147331,no-intervention,1,0
147332,peer,1,0
147333,or,1,0
147334,no-intervention,1,0
147335,non-peer,1,0
147336,condition,1,0
147337,.,1,0
147338,The,0,0
147339,anti-stigma,0,0
147340,program,0,0
147341,improved,0,0
147342,the,0,0
147343,knowledge,0,0
147344,and,0,0
147345,attitudes,0,0
147346,",",0,0
147347,but,0,0
147348,not,0,0
147349,the,0,0
147350,behavioural,0,0
147351,intentions,0,0
147352,of,0,0
147353,participants,0,0
147354,towards,0,0
147355,their,0,0
147356,peers,0,0
147357,with,0,0
147358,autism,0,0
147359,.,0,0
147360,Knowledge,0,0
147361,and,0,0
147362,attitudinal,0,0
147363,changes,0,0
147364,were,0,0
147365,maintained,0,0
147366,at,0,0
147367,follow-up,0,0
147368,.,0,0
147369,There,0,0
147370,were,0,0
147371,no,0,0
147372,spill-over,0,0
147373,effects,0,0
147374,of,0,0
147375,the,0,0
147376,program,0,0
147377,to,0,0
147378,non-targeted,0,0
147379,students,0,0
147380,.,0,0
147381,These,0,0
147382,results,0,0
147383,provide,0,0
147384,some,0,0
147385,preliminary,0,0
147386,evidence,0,0
147387,for,0,0
147388,the,0,0
147389,effectiveness,0,0
147390,of,0,0
147391,multi-session,0,0
147392,anti-stigma,0,0
147393,programs,0,0
147394,incorporating,0,0
147395,combined,0,0
147396,information,0,0
147397,for,0,0
147398,adolescent,0,0
147399,students,0,0
147400,in,0,0
147401,inclusive,0,0
147402,educational,0,0
147403,environments,0,0
147404,.,0,0
147405,Galactomannan,1,1
147406,and,1,1
147407,PCR,1,1
147408,versus,0,0
147409,culture,0,0
147410,and,0,0
147411,histology,0,0
147412,for,0,0
147413,directing,0,0
147414,use,0,0
147415,of,0,0
147416,antifungal,0,1
147417,treatment,0,0
147418,for,0,0
147419,invasive,0,0
147420,aspergillosis,0,0
147421,in,0,0
147422,high-risk,0,0
147423,haematology,0,0
147424,patients,0,0
147425,:,0,0
147426,a,0,0
147427,randomised,0,0
147428,controlled,0,0
147429,trial,0,0
147430,.,0,0
147431,BACKGROUND,0,0
147432,Empirical,0,0
147433,treatment,0,0
147434,with,0,1
147435,antifungal,0,1
147436,drugs,0,1
147437,is,0,0
147438,often,0,0
147439,used,0,0
147440,in,0,0
147441,haematology,0,0
147442,patients,0,0
147443,at,0,0
147444,high,0,0
147445,risk,0,0
147446,of,0,0
147447,invasive,0,0
147448,aspergillosis,0,0
147449,.,0,0
147450,We,0,0
147451,compared,0,0
147452,a,0,0
147453,standard,0,0
147454,diagnostic,0,0
147455,strategy,0,0
147456,(,0,0
147457,culture,0,0
147458,and,0,0
147459,histology,0,0
147460,),0,0
147461,with,0,0
147462,a,0,0
147463,rapid,0,0
147464,biomarker-based,0,0
147465,diagnostic,0,0
147466,strategy,0,0
147467,(,0,1
147468,aspergillus,0,1
147469,galactomannan,0,1
147470,and,0,1
147471,PCR,0,1
147472,),0,0
147473,for,0,0
147474,directing,0,0
147475,the,0,0
147476,use,0,0
147477,of,0,0
147478,antifungal,0,1
147479,treatment,0,0
147480,in,0,0
147481,this,0,0
147482,group,0,0
147483,of,0,0
147484,patients,0,0
147485,.,0,0
147486,METHODS,0,0
147487,In,0,0
147488,this,0,0
147489,open-label,0,1
147490,",",0,1
147491,parallel-group,0,1
147492,",",0,1
147493,randomised,0,0
147494,controlled,0,0
147495,trial,0,0
147496,",",0,0
147497,eligible,0,0
147498,patients,0,0
147499,were,0,0
147500,adults,0,0
147501,undergoing,0,0
147502,allogeneic,0,1
147503,stem-cell,0,0
147504,transplantation,0,0
147505,or,0,0
147506,chemotherapy,1,0
147507,for,0,0
147508,acute,0,0
147509,leukaemia,0,0
147510,",",0,0
147511,with,0,0
147512,no,0,0
147513,history,0,0
147514,of,0,0
147515,invasive,0,0
147516,fungal,0,0
147517,disease,0,0
147518,.,0,0
147519,Enrolled,0,0
147520,patients,0,0
147521,were,0,0
147522,randomly,0,0
147523,assigned,0,0
147524,(,0,1
147525,1:1,0,1
147526,),0,1
147527,by,0,0
147528,a,0,0
147529,computer-generated,0,0
147530,schedule,0,0
147531,to,0,0
147532,follow,0,0
147533,either,0,0
147534,a,0,0
147535,standard,1,0
147536,diagnostic,1,0
147537,strategy,1,0
147538,(,0,0
147539,based,0,0
147540,on,0,0
147541,culture,0,0
147542,and,0,0
147543,histology,0,1
147544,),0,0
147545,or,0,0
147546,a,0,0
147547,biomarker-based,1,0
147548,diagnostic,1,0
147549,strategy,1,0
147550,(,1,1
147551,aspergillus,1,1
147552,galactomannan,1,1
147553,and,1,1
147554,PCR,1,1
147555,),1,0
147556,to,0,0
147557,direct,0,0
147558,treatment,0,0
147559,with,0,1
147560,antifungal,0,1
147561,drugs,0,1
147562,.,0,1
147563,Patients,0,0
147564,",",0,0
147565,were,0,0
147566,followed,0,0
147567,up,0,0
147568,for,0,0
147569,26,0,0
147570,weeks,0,0
147571,or,0,0
147572,until,0,0
147573,death,0,0
147574,.,0,0
147575,Masking,0,0
147576,of,0,0
147577,the,0,0
147578,use,0,0
147579,of,0,0
147580,different,0,0
147581,diagnostic,0,0
147582,tests,0,0
147583,was,0,0
147584,not,0,0
147585,possible,0,0
147586,for,0,0
147587,patients,0,0
147588,",",0,0
147589,treating,0,0
147590,physicians,0,0
147591,",",0,0
147592,or,0,0
147593,investigators,0,0
147594,.,0,0
147595,The,0,0
147596,primary,0,0
147597,endpoint,0,0
147598,was,0,0
147599,empirical,0,0
147600,treatment,0,0
147601,with,0,1
147602,antifungal,0,1
147603,drugs,0,1
147604,in,0,0
147605,the,0,0
147606,26,0,0
147607,weeks,0,0
147608,after,0,0
147609,enrolment,0,0
147610,(,0,0
147611,for,0,0
147612,the,0,0
147613,biomarker-based,0,0
147614,diagnostic,0,0
147615,strategy,0,0
147616,",",0,0
147617,a,0,0
147618,single,0,0
147619,postive,0,0
147620,galactomannan,0,1
147621,or,0,0
147622,PCR,0,0
147623,result,0,0
147624,was,0,0
147625,deemed,0,0
147626,insufficient,0,0
147627,to,0,0
147628,confirm,0,0
147629,invasive,0,0
147630,aspergillosis,0,0
147631,",",0,0
147632,so,0,0
147633,treatment,0,0
147634,in,0,0
147635,this,0,0
147636,context,0,0
147637,was,0,0
147638,classified,0,0
147639,as,0,0
147640,empirical,0,0
147641,),0,0
147642,.,0,0
147643,This,0,0
147644,outcome,0,0
147645,was,0,0
147646,assessed,0,0
147647,by,0,0
147648,an,0,0
147649,independent,0,0
147650,data,0,0
147651,review,0,0
147652,committee,0,0
147653,from,0,0
147654,which,0,0
147655,the,0,0
147656,study,0,0
147657,allocations,0,0
147658,were,0,0
147659,masked,0,0
147660,.,0,0
147661,Analyses,0,0
147662,were,0,0
147663,by,0,0
147664,intention,0,0
147665,to,0,0
147666,treat,0,0
147667,and,0,0
147668,included,0,0
147669,all,0,0
147670,enrolled,0,0
147671,patients,0,0
147672,.,0,0
147673,This,0,0
147674,study,0,0
147675,is,0,0
147676,registered,0,0
147677,with,0,0
147678,ClinicalTrial.gov,0,0
147679,",",0,0
147680,number,0,0
147681,NCT00163722,0,0
147682,.,0,0
147683,FINDINGS,0,0
147684,240,0,0
147685,eligible,0,0
147686,patients,0,0
147687,were,0,0
147688,recruited,0,0
147689,from,0,0
147690,six,0,0
147691,Australian,0,0
147692,centres,0,0
147693,between,0,0
147694,Sept,0,1
147695,30,0,1
147696,",",0,0
147697,2005,0,0
147698,",",0,0
147699,and,0,0
147700,Nov,0,1
147701,19,0,0
147702,",",0,0
147703,2009,0,0
147704,.,0,0
147705,122,0,0
147706,were,0,0
147707,assigned,0,0
147708,the,0,0
147709,standard,0,0
147710,diagnostic,0,0
147711,strategy,0,0
147712,and,0,0
147713,118,0,0
147714,the,0,0
147715,biomarker-based,0,0
147716,diagnostic,0,0
147717,strategy,0,0
147718,.,0,0
147719,39,0,0
147720,patients,0,0
147721,(,0,0
147722,32,0,0
147723,%,0,0
147724,),0,0
147725,in,0,0
147726,the,0,0
147727,standard,0,0
147728,diagnosis,0,0
147729,group,0,0
147730,and,0,0
147731,18,0,1
147732,(,0,0
147733,15,0,0
147734,%,0,0
147735,),0,0
147736,in,0,0
147737,the,0,0
147738,biomarker,0,0
147739,diagnosis,0,0
147740,group,0,0
147741,received,0,0
147742,empirical,0,1
147743,antifungal,0,1
147744,treatment,0,1
147745,(,0,1
147746,difference,0,0
147747,17,0,0
147748,%,0,0
147749,",",0,0
147750,95,0,0
147751,%,0,0
147752,CI,0,0
147753,4-26,0,0
147754,;,0,0
147755,p=0?002,0,0
147756,),0,0
147757,.,0,0
147758,The,0,0
147759,numbers,0,0
147760,of,0,0
147761,patients,0,0
147762,who,0,0
147763,had,0,0
147764,hepatotoxic,0,1
147765,and,0,1
147766,nephrotoxic,0,1
147767,effects,0,0
147768,did,0,0
147769,not,0,0
147770,differ,0,0
147771,significantly,0,0
147772,between,0,0
147773,the,0,0
147774,standard,0,0
147775,diagnosis,0,0
147776,and,0,0
147777,biomarker,0,0
147778,diagnosis,0,1
147779,groups,0,1
147780,(,0,1
147781,hepatotoxic,0,1
147782,effects,0,1
147783,:,0,0
147784,21,0,0
147785,[,0,0
147786,17,0,0
147787,%,0,0
147788,],0,0
147789,vs,0,0
147790,12,0,0
147791,[,0,0
147792,10,0,0
147793,%,0,0
147794,],0,0
147795,",",0,0
147796,p=0?11,0,1
147797,;,0,1
147798,nephrotoxic,0,1
147799,effects,0,0
147800,:,0,0
147801,52,0,0
147802,[,0,0
147803,43,0,0
147804,%,0,0
147805,],0,0
147806,vs,0,0
147807,60,0,0
147808,[,0,0
147809,51,0,0
147810,%,0,0
147811,],0,0
147812,",",0,0
147813,p=0?20,0,1
147814,),0,0
147815,.,0,0
147816,INTERPRETATION,0,0
147817,Use,0,0
147818,of,0,0
147819,aspergillus,0,1
147820,galactomannan,0,1
147821,and,0,1
147822,PCR,0,1
147823,to,0,0
147824,direct,0,0
147825,treatment,0,0
147826,reduced,0,0
147827,use,0,0
147828,of,0,0
147829,empirical,1,1
147830,antifungal,1,1
147831,treatment,1,1
147832,.,1,0
147833,This,1,0
147834,approach,0,0
147835,is,0,0
147836,an,0,0
147837,effective,0,0
147838,strategy,0,0
147839,for,0,0
147840,the,0,0
147841,management,0,0
147842,of,0,0
147843,invasive,0,0
147844,aspergillosis,0,0
147845,in,0,0
147846,high-risk,0,0
147847,haematology,0,0
147848,patients,0,0
147849,.,0,0
147850,FUNDING,0,0
147851,Australian,0,0
147852,National,0,0
147853,Health,0,0
147854,and,0,0
147855,Medical,0,0
147856,Research,0,0
147857,Council,0,0
147858,",",0,0
147859,Cancer,0,0
147860,Council,0,1
147861,New,0,1
147862,South,0,0
147863,Wales,0,0
147864,",",0,0
147865,Pfizer,0,0
147866,",",0,0
147867,Merck,0,1
147868,",",0,0
147869,Gilead,0,0
147870,Sciences,0,0
147871,.,0,0
147872,Predicting,0,0
147873,the,0,0
147874,effect,0,0
147875,of,0,0
147876,anthelmintic,1,1
147877,treatment,1,1
147878,on,0,0
147879,milk,0,1
147880,production,0,0
147881,of,0,0
147882,dairy,0,0
147883,cattle,0,0
147884,in,0,0
147885,Canada,0,0
147886,using,0,0
147887,an,0,0
147888,Ostertagia,0,1
147889,ostertagi,0,1
147890,ELISA,0,1
147891,from,0,0
147892,individual,0,0
147893,milk,0,1
147894,samples,0,0
147895,.,0,0
147896,Gastrointestinal,0,0
147897,nematodes,0,0
147898,",",0,0
147899,such,0,0
147900,as,0,0
147901,Ostertagia,0,1
147902,ostertagi,0,1
147903,and,0,1
147904,several,0,0
147905,species,0,0
147906,of,0,0
147907,Cooperia,0,0
147908,",",0,0
147909,are,0,0
147910,ubiquitous,0,0
147911,in,0,0
147912,temperate,0,0
147913,climates,0,0
147914,and,0,0
147915,have,0,0
147916,been,0,0
147917,shown,0,0
147918,to,0,0
147919,have,0,0
147920,detrimental,0,0
147921,effects,0,0
147922,on,0,0
147923,production,0,0
147924,in,0,0
147925,adult,0,0
147926,dairy,0,0
147927,cattle,0,0
147928,.,0,0
147929,A,0,0
147930,published,0,0
147931,meta-analysis,0,0
147932,demonstrated,0,0
147933,that,0,0
147934,overall,0,0
147935,",",0,0
147936,producers,0,0
147937,lose,0,0
147938,approximately,0,0
147939,0.35,0,0
147940,kg,0,0
147941,of,0,0
147942,milk,0,1
147943,per,0,0
147944,parasitized,0,0
147945,cow,0,0
147946,per,0,0
147947,day,0,0
147948,.,0,1
147949,Enzyme-linked,1,0
147950,immunosorbent,1,1
147951,assays,1,1
147952,(,0,1
147953,ELISAs,0,1
147954,),0,0
147955,have,0,0
147956,the,0,0
147957,ability,0,0
147958,to,0,0
147959,quantify,0,0
147960,nematode,0,0
147961,infections,0,0
147962,in,0,0
147963,cattle,0,0
147964,",",0,0
147965,and,0,0
147966,thus,0,0
147967,",",0,0
147968,could,0,0
147969,be,0,0
147970,used,0,0
147971,to,0,0
147972,estimate,0,0
147973,the,0,0
147974,amount,0,0
147975,of,0,0
147976,milk,0,1
147977,production,0,0
147978,loss,0,0
147979,due,0,0
147980,to,0,0
147981,differing,0,0
147982,levels,0,0
147983,of,0,0
147984,parasitism,0,0
147985,at,0,0
147986,the,0,0
147987,individual,0,0
147988,cow,0,0
147989,level,0,0
147990,.,0,0
147991,ELISA,0,0
147992,results,0,0
147993,from,0,0
147994,individual,0,0
147995,cow,0,0
147996,milk,0,1
147997,samples,0,0
147998,were,0,0
147999,used,0,0
148000,to,0,0
148001,predict,0,0
148002,milk,0,1
148003,production,0,0
148004,response,0,0
148005,following,0,0
148006,a,0,0
148007,randomized,0,1
148008,anthelmintic,0,1
148009,treatment,0,0
148010,in,0,0
148011,a,0,0
148012,large,0,0
148013,field,0,0
148014,trial,0,0
148015,.,0,0
148016,To,0,0
148017,increase,0,0
148018,statistical,0,0
148019,power,0,0
148020,",",0,0
148021,the,0,0
148022,data,0,0
148023,collected,0,0
148024,from,0,0
148025,this,0,0
148026,field,0,0
148027,trial,0,0
148028,was,0,0
148029,pooled,0,0
148030,with,0,0
148031,data,0,0
148032,from,0,0
148033,two,0,0
148034,other,0,0
148035,published,0,0
148036,field,0,0
148037,trials,0,0
148038,to,0,0
148039,form,0,0
148040,an,0,0
148041,individual,0,0
148042,patient,0,0
148043,data,0,0
148044,meta-analysis,0,1
148045,(,0,1
148046,IPDMA,0,1
148047,),0,1
148048,.,0,0
148049,The,0,0
148050,ability,0,0
148051,to,0,0
148052,predict,0,0
148053,the,0,0
148054,effect,0,0
148055,of,0,0
148056,anthelmintic,0,1
148057,treatment,0,1
148058,on,0,0
148059,milk,0,1
148060,production,0,0
148061,depends,0,0
148062,on,0,0
148063,the,0,0
148064,level,0,0
148065,of,0,0
148066,parasitism,0,0
148067,quantified,0,0
148068,by,0,0
148069,an,0,0
148070,ELISA,0,0
148071,measuring,0,0
148072,milk,0,1
148073,antibodies,0,0
148074,against,0,0
148075,O.,0,0
148076,ostertagi,0,1
148077,",",0,0
148078,and,0,0
148079,reported,0,0
148080,as,0,0
148081,optical,0,0
148082,density,0,0
148083,ratios,0,0
148084,(,0,0
148085,ODRs,0,1
148086,),0,1
148087,.,0,0
148088,Therefore,0,0
148089,",",0,0
148090,the,0,0
148091,estimates,0,0
148092,from,0,0
148093,the,0,0
148094,interaction,0,0
148095,between,0,0
148096,ODR,0,0
148097,and,0,0
148098,treatment,0,0
148099,on,0,0
148100,milk,0,1
148101,production,0,0
148102,were,0,0
148103,used,0,0
148104,to,0,0
148105,determine,0,0
148106,how,0,0
148107,well,0,0
148108,the,0,0
148109,ODR,0,0
148110,predicted,0,0
148111,the,0,0
148112,response,0,0
148113,of,0,0
148114,the,0,0
148115,treatment,0,0
148116,.,0,0
148117,It,0,0
148118,was,0,0
148119,anticipated,0,0
148120,that,0,0
148121,the,0,0
148122,relationship,0,0
148123,between,0,0
148124,milk,0,1
148125,production,0,0
148126,and,0,0
148127,ODR,0,0
148128,was,0,0
148129,unlikely,0,0
148130,to,0,0
148131,be,0,0
148132,linear,0,0
148133,",",0,0
148134,so,0,0
148135,fractional,0,0
148136,polynomials,0,0
148137,were,0,0
148138,applied,0,0
148139,to,0,0
148140,the,0,0
148141,continuous,0,0
148142,ODR,0,0
148143,values,0,0
148144,.,0,0
148145,The,0,0
148146,interaction,0,0
148147,in,0,0
148148,the,0,0
148149,field,0,0
148150,trial,0,0
148151,showed,0,0
148152,a,0,0
148153,trend,0,0
148154,(,0,0
148155,p=0.138,0,0
148156,),0,0
148157,toward,0,0
148158,a,0,0
148159,beneficial,0,0
148160,treatment,0,0
148161,effect,0,0
148162,when,0,0
148163,the,0,0
148164,individual,0,0
148165,ODR,0,0
148166,values,0,0
148167,",",0,0
148168,measured,0,0
148169,in,0,0
148170,late,0,0
148171,lactation,0,1
148172,and,0,0
148173,using,0,1
148174,Svanovir,0,1
148175,(,0,1
148176,?,0,1
148177,),0,0
148178,",",0,0
148179,were,0,0
148180,greater,0,0
148181,than,0,0
148182,0.12,0,0
148183,.,0,0
148184,When,0,0
148185,individual,0,0
148186,data,0,0
148187,from,0,0
148188,two,0,0
148189,other,0,0
148190,similar,0,0
148191,studies,0,0
148192,were,0,0
148193,included,0,0
148194,in,0,0
148195,an,0,0
148196,IPDMA,0,0
148197,",",0,0
148198,the,0,0
148199,interaction,0,0
148200,terms,0,0
148201,became,0,0
148202,statistically,0,0
148203,significant,0,0
148204,(,0,0
148205,p=0.009,0,0
148206,),0,0
148207,indicating,0,0
148208,that,0,0
148209,there,0,0
148210,is,0,0
148211,a,0,0
148212,beneficial,0,0
148213,treatment,0,0
148214,effect,0,0
148215,when,0,0
148216,ODR,0,0
148217,values,0,0
148218,are,0,0
148219,slightly,0,0
148220,elevated,0,0
148221,.,0,0
148222,A,0,0
148223,graph,0,0
148224,was,0,0
148225,used,0,0
148226,to,0,0
148227,demonstrate,0,0
148228,the,0,0
148229,treatment,0,0
148230,effect,0,0
148231,(,0,0
148232,the,0,0
148233,estimated,0,0
148234,difference,0,0
148235,of,0,0
148236,kg/cow/day,0,1
148237,of,0,1
148238,milk,0,1
148239,yield,0,0
148240,between,0,0
148241,the,0,0
148242,treated,0,0
148243,and,0,0
148244,placebo,0,1
148245,cows,0,1
148246,),0,1
148247,",",0,0
148248,with,0,0
148249,95,0,0
148250,%,0,0
148251,confidence,0,0
148252,intervals,0,0
148253,",",0,0
148254,as,0,0
148255,the,0,0
148256,ODR,0,0
148257,values,0,0
148258,increase,0,0
148259,.,0,0
148260,It,0,0
148261,is,0,0
148262,important,0,0
148263,to,0,0
148264,note,0,0
148265,that,0,0
148266,the,0,0
148267,methods,0,0
148268,of,0,0
148269,quantifying,0,0
148270,the,0,0
148271,ODR,0,0
148272,values,0,0
148273,differed,0,0
148274,between,0,0
148275,the,0,0
148276,three,0,0
148277,studies,0,0
148278,in,0,0
148279,the,0,0
148280,IPDMA,0,0
148281,",",0,0
148282,therefore,0,0
148283,some,0,0
148284,caution,0,0
148285,should,0,0
148286,be,0,0
148287,used,0,0
148288,when,0,0
148289,using,0,0
148290,these,0,0
148291,final,0,0
148292,estimated,0,0
148293,values,0,0
148294,.,0,0
148295,However,0,0
148296,",",0,0
148297,the,0,0
148298,shape,0,0
148299,and,0,0
148300,magnitude,0,0
148301,of,0,0
148302,the,0,0
148303,treatment,0,0
148304,effects,0,0
148305,",",0,0
148306,as,0,0
148307,well,0,0
148308,as,0,0
148309,the,0,0
148310,other,0,0
148311,fixed,0,0
148312,model,0,0
148313,estimates,0,0
148314,",",0,0
148315,were,0,0
148316,very,0,0
148317,similar,0,0
148318,between,0,0
148319,the,0,0
148320,field,0,0
148321,trial,0,0
148322,and,0,0
148323,the,0,0
148324,IPDMA,0,0
148325,suggesting,0,0
148326,that,0,0
148327,any,0,0
148328,bias,0,0
148329,would,0,0
148330,likely,0,0
148331,be,0,0
148332,minimal,0,0
148333,.,0,0
148334,[,0,1
148335,Study,0,0
148336,of,0,0
148337,setting,1,0
148338,of,1,0
148339,ventilator,1,0
148340,volume,1,0
148341,tidal,1,0
148342,and,1,0
148343,airway,1,0
148344,pressure,1,1
148345,alarm,1,0
148346,threshold,1,0
148347,with,0,0
148348,continuous,1,0
148349,extra-sternum,1,0
148350,heart,1,0
148351,compression,1,0
148352,in,0,0
148353,cardiopulmonary,0,1
148354,resuscitation,0,1
148355,],0,0
148356,.,0,0
148357,OBJECTIVE,0,0
148358,To,0,0
148359,investigate,0,0
148360,the,0,0
148361,setting,0,0
148362,of,0,0
148363,ventilator,1,0
148364,volume,1,1
148365,tidal,1,1
148366,(,1,1
148367,VT,1,1
148368,),1,1
148369,and,1,0
148370,airway,1,1
148371,pressure,1,1
148372,alarm,1,1
148373,threshold,1,0
148374,during,0,0
148375,cardiopulmonary,1,1
148376,resuscitation,1,1
148377,(,1,1
148378,CPR,1,1
148379,),1,0
148380,by,0,0
148381,continuous,1,0
148382,extra-sternum,1,0
148383,heart,1,0
148384,compression,1,0
148385,.,1,0
148386,METHODS,0,0
148387,Forty,0,0
148388,cases,0,0
148389,with,0,0
148390,respiration,0,0
148391,and,0,0
148392,cardiac,0,0
148393,arrest,0,0
148394,in,0,0
148395,the,0,0
148396,department,0,0
148397,of,0,0
148398,critical,0,0
148399,care,0,0
148400,medicine,0,0
148401,were,0,0
148402,randomly,0,0
148403,divided,0,0
148404,into,0,0
148405,low,1,0
148406,VT,1,0
148407,ventilation,1,1
148408,group,1,0
148409,and,1,0
148410,conventional,1,0
148411,VT,1,1
148412,group,1,0
148413,.,1,0
148414,Both,0,0
148415,groups,0,0
148416,were,0,0
148417,given,0,0
148418,the,0,0
148419,volume,0,0
148420,control,0,0
148421,mode,0,0
148422,.,0,0
148423,In,0,0
148424,the,0,0
148425,low,1,0
148426,VT,1,0
148427,ventilation,1,1
148428,group,0,0
148429,",",0,0
148430,VT,0,0
148431,was,0,0
148432,set,0,0
148433,on,0,0
148434,6,0,0
148435,-,0,0
148436,7,0,1
148437,ml/kg,0,1
148438,",",0,1
148439,and,0,0
148440,high,0,0
148441,pressure,0,0
148442,alarm,0,0
148443,threshold,0,1
148444,was,0,0
148445,adjusted,0,0
148446,to,0,0
148447,60,0,0
148448,cm,0,0
148449,H2O,0,0
148450,by,0,0
148451,the,0,0
148452,conventional,1,0
148453,40,0,0
148454,cm,0,0
148455,H2O,0,0
148456,during,0,0
148457,CPR,0,0
148458,.,0,0
148459,In,0,0
148460,the,0,0
148461,conventional,1,0
148462,VT,1,0
148463,group,1,0
148464,",",0,0
148465,VT,0,1
148466,and,0,0
148467,high,0,0
148468,pressure,0,0
148469,alarm,0,0
148470,threshold,0,0
148471,were,0,0
148472,set,0,0
148473,at,0,0
148474,8,0,0
148475,-,0,0
148476,12,0,1
148477,ml/kg,0,1
148478,and,0,1
148479,40,0,0
148480,cm,0,0
148481,H2O,0,0
148482,",",0,0
148483,respectively,0,0
148484,.,0,0
148485,Real-time,0,0
148486,actual,0,0
148487,VT,0,0
148488,",",0,0
148489,peak,0,0
148490,inspiratory,0,1
148491,pressure,0,1
148492,(,0,1
148493,PIP,0,1
148494,),0,1
148495,",",0,0
148496,and,0,0
148497,arterial,0,0
148498,blood,0,0
148499,gas,0,0
148500,test,0,0
148501,",",0,0
148502,blood,0,1
148503,lactic,0,1
148504,acid,0,1
148505,at,0,1
148506,10,0,0
148507,minutes,0,0
148508,and,0,0
148509,30,0,0
148510,minutes,0,0
148511,after,0,0
148512,CPR,0,0
148513,were,0,0
148514,observed,0,0
148515,.,0,0
148516,RESULTS,0,0
148517,At,0,0
148518,10,0,0
148519,minutes,0,0
148520,after,0,0
148521,CPR,0,0
148522,",",0,0
148523,in,0,0
148524,the,0,0
148525,low,1,0
148526,VT,1,0
148527,ventilation,1,1
148528,group,0,0
148529,",",0,0
148530,arterial,0,1
148531,blood,0,0
148532,pH,0,1
148533,",",0,0
148534,arterial,0,0
148535,partial,0,0
148536,pressure,0,0
148537,of,0,0
148538,oxygen,0,0
148539,(,0,0
148540,PaO2,0,1
148541,),0,1
148542,",",0,0
148543,arterial,0,0
148544,partial,0,0
148545,pressure,0,0
148546,of,0,0
148547,carbon,0,0
148548,dioxide,0,1
148549,(,0,1
148550,PaCO2,0,1
148551,),0,1
148552,",",0,0
148553,HCO3,0,1
148554,(,0,1
148555,-,0,1
148556,),0,1
148557,",",0,0
148558,arterial,0,0
148559,oxygen,0,0
148560,saturation,0,0
148561,(,0,0
148562,SaO2,0,1
148563,),0,1
148564,and,0,0
148565,blood,0,1
148566,lactic,0,1
148567,acid,0,1
148568,were,0,0
148569,better,0,0
148570,as,0,0
148571,compared,0,0
148572,with,0,0
148573,those,0,0
148574,in,0,0
148575,the,0,0
148576,conventional,1,0
148577,VT,1,0
148578,ventilation,1,1
148579,group,0,1
148580,(,0,0
148581,pH,0,0
148582,:,0,0
148583,7.21?0.09,0,0
148584,vs.,0,0
148585,7.13?0.07,0,0
148586,",",0,0
148587,PaO2,0,0
148588,:,0,0
148589,45.35?5.92,0,0
148590,mm,0,0
148591,Hg,0,0
148592,vs.,0,0
148593,40.70?4.70,0,0
148594,mm,0,0
148595,Hg,0,0
148596,",",0,0
148597,PaCO2,0,0
148598,:,0,0
148599,57.10?7.59,0,0
148600,mm,0,0
148601,Hg,0,0
148602,vs.,0,0
148603,61.60?5.47,0,0
148604,mm,0,0
148605,Hg,0,0
148606,",",0,1
148607,HCO3,0,1
148608,(,0,1
148609,-,0,1
148610,),0,0
148611,:,0,0
148612,18.50?3.50,0,0
148613,mmol/L,0,0
148614,vs.,0,0
148615,14.75?2.65,0,0
148616,mmol/L,0,0
148617,",",0,0
148618,SaO2,0,0
148619,:,0,0
148620,0.796?0.069,0,0
148621,vs.,0,0
148622,0.699?0.066,0,0
148623,",",0,0
148624,blood,0,0
148625,lactic,0,1
148626,acid,0,1
148627,:,0,0
148628,7.07?1.60,0,0
148629,mmol/L,0,0
148630,vs.,0,0
148631,8.13?1.56,0,0
148632,mmol/L,0,0
148633,",",0,0
148634,all,0,0
148635,P,0,0
148636,<,0,0
148637,0.05,0,0
148638,),0,0
148639,.,0,0
148640,The,0,0
148641,success,0,0
148642,rate,0,0
148643,of,0,0
148644,resuscitation,1,0
148645,in,1,0
148646,the,1,0
148647,low,1,0
148648,VT,1,0
148649,ventilation,1,0
148650,group,0,0
148651,was,0,0
148652,higher,0,0
148653,than,0,0
148654,that,0,0
148655,of,0,0
148656,the,0,0
148657,conventional,1,0
148658,VT,1,0
148659,ventilation,1,1
148660,group,0,0
148661,(,0,0
148662,45,0,0
148663,%,0,0
148664,vs.,0,0
148665,15,0,0
148666,%,0,0
148667,",",0,0
148668,P,0,0
148669,<,0,0
148670,0.05,0,0
148671,),0,0
148672,",",0,0
148673,and,0,0
148674,PIP,0,1
148675,(,0,1
148676,cm,0,0
148677,H2O,0,1
148678,),0,0
148679,of,0,0
148680,low,1,0
148681,VT,1,0
148682,ventilation,1,0
148683,group,0,0
148684,was,0,0
148685,lower,0,0
148686,than,0,0
148687,that,0,0
148688,of,0,0
148689,the,0,0
148690,conventional,1,0
148691,VT,1,1
148692,group,1,0
148693,(,1,0
148694,37.25?7.99,1,0
148695,cm,0,0
148696,H2O,0,0
148697,vs.,0,0
148698,42.70?7.40,0,0
148699,cm,0,0
148700,H2O,0,0
148701,",",0,0
148702,P,0,0
148703,<,0,0
148704,0.05,0,0
148705,),0,0
148706,.,0,0
148707,In,0,0
148708,all,0,0
148709,the,0,0
148710,patients,0,0
148711,in,0,0
148712,both,0,0
148713,groups,0,0
148714,barotrauma,0,0
148715,did,0,0
148716,not,0,0
148717,occur,0,0
148718,.,0,0
148719,CONCLUSION,0,0
148720,The,0,0
148721,strategy,0,0
148722,of,1,0
148723,low,1,0
148724,ventilator,1,0
148725,VT,1,1
148726,(,0,1
148727,6,0,1
148728,-,0,1
148729,7,0,1
148730,ml/kg,0,1
148731,),0,1
148732,with,0,0
148733,appropriate,0,0
148734,elevation,0,0
148735,of,0,0
148736,airway,0,0
148737,pressure,0,1
148738,alarm,0,0
148739,threshold,0,0
148740,was,0,0
148741,better,0,0
148742,than,0,0
148743,that,1,0
148744,of,1,0
148745,conventional,1,0
148746,ventilation,1,0
148747,setting,1,0
148748,",",0,0
148749,with,0,0
148750,no,0,0
148751,increase,0,0
148752,in,0,0
148753,incidence,0,0
148754,of,0,0
148755,barotraumas,0,0
148756,during,0,0
148757,CPR,0,0
148758,.,0,0
148759,Effects,0,0
148760,of,0,0
148761,exposure,0,0
148762,to,0,0
148763,thin-ideal,0,0
148764,media,0,0
148765,images,0,0
148766,on,0,0
148767,body,0,0
148768,dissatisfaction,0,0
148769,:,0,0
148770,testing,0,0
148771,the,0,0
148772,inclusion,0,0
148773,of,0,0
148774,a,0,0
148775,disclaimer,1,0
148776,versus,1,0
148777,warning,1,0
148778,label,1,0
148779,.,1,0
148780,The,0,0
148781,current,0,0
148782,study,0,0
148783,was,0,0
148784,designed,0,0
148785,to,0,0
148786,determine,0,0
148787,whether,0,0
148788,the,0,0
148789,inclusion,0,0
148790,of,0,0
148791,a,0,0
148792,disclaimer,0,0
148793,(,0,0
148794,i.e.,0,0
148795,",",0,0
148796,Retouched,0,0
148797,photograph,0,0
148798,aimed,0,0
148799,at,0,0
148800,changing,0,0
148801,a,0,0
148802,person,0,0
148803,'s,0,0
148804,physical,0,0
148805,appearance,0,0
148806,.,0,0
148807,),0,0
148808,or,0,0
148809,warning,0,1
148810,(,0,0
148811,i.e.,0,0
148812,",",0,0
148813,Warning,0,0
148814,:,0,0
148815,Trying,0,0
148816,to,0,0
148817,look,0,0
148818,as,0,0
148819,thin,0,0
148820,as,0,0
148821,this,0,0
148822,model,0,0
148823,may,0,0
148824,be,0,0
148825,dangerous,0,0
148826,to,0,0
148827,your,0,0
148828,health,0,1
148829,.,0,0
148830,),0,0
148831,added,0,0
148832,to,0,0
148833,images,0,0
148834,of,0,0
148835,thin/attractive,0,0
148836,models,0,0
148837,would,0,0
148838,affect,0,0
148839,body,0,0
148840,dissatisfaction,0,0
148841,and,0,0
148842,intent,0,0
148843,to,0,0
148844,diet,0,1
148845,in,0,0
148846,female,0,1
148847,undergraduate,0,1
148848,students,0,0
148849,(,0,0
148850,n=342,0,0
148851,),0,0
148852,.,0,0
148853,Participants,0,0
148854,were,0,0
148855,randomly,0,0
148856,assigned,0,0
148857,to,0,0
148858,one,0,0
148859,of,0,0
148860,four,0,0
148861,groups,1,0
148862,:,1,0
148863,(,1,0
148864,a,1,0
148865,),1,0
148866,disclaimer,1,1
148867,",",1,1
148868,(,1,1
148869,b,1,1
148870,),1,1
148871,warning,1,1
148872,",",1,1
148873,(,1,1
148874,c,1,1
148875,),1,0
148876,model,1,0
148877,control,1,0
148878,",",1,0
148879,or,1,0
148880,(,1,1
148881,d,1,1
148882,),1,0
148883,car,1,0
148884,control,1,0
148885,.,1,0
148886,Results,0,0
148887,revealed,0,0
148888,a,0,0
148889,significant,0,0
148890,interaction,0,0
148891,between,0,0
148892,group,0,0
148893,and,0,0
148894,time,0,0
148895,",",0,0
148896,whereby,0,0
148897,only,0,0
148898,the,0,0
148899,car,0,0
148900,control,0,0
148901,group,0,0
148902,reported,0,0
148903,a,0,0
148904,significant,0,0
148905,change,0,0
148906,(,0,0
148907,i.e.,0,0
148908,",",0,0
148909,decrease,0,0
148910,),0,0
148911,in,0,0
148912,body,0,0
148913,dissatisfaction,0,0
148914,over,0,0
148915,time,0,0
148916,.,0,0
148917,Groups,0,0
148918,did,0,0
148919,not,0,0
148920,differ,0,0
148921,on,0,0
148922,intent,0,0
148923,to,0,0
148924,diet,0,1
148925,measured,0,0
148926,at,0,0
148927,post-exposure,0,0
148928,.,0,0
148929,The,0,0
148930,results,0,0
148931,largely,0,0
148932,replicate,0,0
148933,other,0,0
148934,findings,0,0
148935,in,0,0
148936,this,0,0
148937,area,0,0
148938,and,0,0
148939,call,0,0
148940,into,0,0
148941,question,0,0
148942,advocacy,0,0
148943,efforts,0,0
148944,to,0,0
148945,label,0,0
148946,media,0,0
148947,images,0,0
148948,as,0,0
148949,a,0,0
148950,strategy,0,0
148951,to,0,0
148952,decrease,0,0
148953,women,0,0
148954,'s,0,0
148955,identification,0,0
148956,with,0,0
148957,the,0,0
148958,stimuli,0,0
148959,.,0,0
148960,The,0,0
148961,aging,0,0
148962,motor,0,0
148963,system,0,0
148964,as,0,0
148965,a,0,0
148966,model,0,0
148967,for,0,0
148968,plastic,0,0
148969,changes,0,0
148970,of,0,0
148971,GABA-mediated,0,0
148972,intracortical,0,0
148973,inhibition,0,0
148974,and,0,0
148975,their,0,0
148976,behavioral,0,0
148977,relevance,0,0
148978,.,0,0
148979,Since,0,0
148980,GABAA-mediated,0,0
148981,intracortical,0,0
148982,inhibition,0,0
148983,has,0,0
148984,been,0,0
148985,shown,0,0
148986,to,0,0
148987,underlie,0,0
148988,plastic,0,0
148989,changes,0,0
148990,throughout,0,0
148991,the,0,0
148992,lifespan,0,0
148993,from,0,0
148994,development,0,0
148995,to,0,0
148996,aging,0,0
148997,",",0,0
148998,here,0,0
148999,",",0,0
149000,the,0,0
149001,aging,0,0
149002,motor,0,0
149003,system,0,0
149004,was,0,0
149005,used,0,0
149006,as,0,0
149007,a,0,0
149008,model,0,0
149009,to,0,0
149010,analyze,0,0
149011,the,0,0
149012,interdependence,0,0
149013,of,0,0
149014,plastic,0,0
149015,alterations,0,0
149016,within,0,0
149017,the,0,0
149018,inhibitory,0,0
149019,motorcortical,0,0
149020,network,0,0
149021,and,0,0
149022,level,0,0
149023,of,0,0
149024,behavioral,0,0
149025,performance,0,0
149026,.,0,0
149027,Double-pulse,1,0
149028,transcranial,1,0
149029,magnetic,1,1
149030,stimulation,1,0
149031,(,1,1
149032,dpTMS,1,1
149033,),1,0
149034,was,1,0
149035,used,1,0
149036,to,1,0
149037,examine,1,0
149038,inhibition,1,0
149039,by,1,0
149040,means,1,0
149041,of,1,0
149042,short-interval,1,0
149043,intracortical,1,0
149044,inhibition,1,0
149045,(,1,1
149046,SICI,1,1
149047,),1,0
149048,of,1,0
149049,the,1,0
149050,contralateral,1,0
149051,primary,1,0
149052,motor,1,0
149053,cortex,1,0
149054,in,0,0
149055,a,0,0
149056,sample,0,0
149057,of,0,0
149058,64,0,0
149059,healthy,0,0
149060,right-handed,0,0
149061,human,0,0
149062,subjects,0,0
149063,covering,0,0
149064,a,0,0
149065,wide,0,0
149066,range,0,0
149067,of,0,0
149068,the,0,0
149069,adult,0,0
149070,lifespan,0,1
149071,(,0,1
149072,age,0,0
149073,range,0,0
149074,20-88,0,0
149075,years,0,0
149076,",",0,0
149077,mean,0,0
149078,47.6,0,0
149079,?,0,0
149080,20.7,0,0
149081,",",0,0
149082,34,0,0
149083,female,0,0
149084,),0,0
149085,.,0,0
149086,SICI,0,0
149087,was,0,0
149088,evaluated,0,0
149089,during,0,0
149090,resting,0,0
149091,state,0,0
149092,and,0,0
149093,in,0,0
149094,an,0,0
149095,event-related,0,0
149096,condition,0,0
149097,during,0,0
149098,movement,0,0
149099,preparation,0,0
149100,in,0,0
149101,a,0,0
149102,visually,0,0
149103,triggered,0,0
149104,simple,0,0
149105,reaction,0,0
149106,time,0,0
149107,task,0,0
149108,.,0,0
149109,In,0,0
149110,a,0,0
149111,subgroup,0,0
149112,(,0,0
149113,N,0,0
149114,=,0,0
149115,23,0,0
149116,),0,0
149117,",",0,0
149118,manual,0,1
149119,motor,0,0
149120,performance,0,0
149121,was,0,0
149122,tested,0,0
149123,with,0,0
149124,tasks,0,0
149125,of,0,0
149126,graded,0,0
149127,dexterous,0,0
149128,demand,0,0
149129,.,0,0
149130,Weak,0,0
149131,resting-state,0,0
149132,inhibition,0,0
149133,was,0,0
149134,associated,0,0
149135,with,0,0
149136,an,0,0
149137,overall,0,0
149138,lower,0,0
149139,manual,0,0
149140,motor,0,0
149141,performance,0,0
149142,.,0,0
149143,Better,0,0
149144,event-related,0,0
149145,modulation,0,0
149146,of,0,0
149147,inhibition,0,0
149148,correlated,0,0
149149,with,0,0
149150,better,0,0
149151,performance,0,0
149152,in,0,0
149153,more,0,0
149154,demanding,0,0
149155,tasks,0,0
149156,",",0,0
149157,in,0,0
149158,which,0,0
149159,fast,0,0
149160,alternating,0,0
149161,activation,0,0
149162,of,0,0
149163,cortical,0,0
149164,representations,0,0
149165,are,0,0
149166,necessary,0,0
149167,.,0,0
149168,Declining,0,0
149169,resting-state,0,0
149170,inhibition,0,0
149171,was,0,0
149172,associated,0,0
149173,with,0,0
149174,weakened,0,0
149175,event-related,0,0
149176,modulation,0,0
149177,of,0,0
149178,inhibition,0,0
149179,.,0,0
149180,Therefore,0,0
149181,",",0,0
149182,reduced,0,0
149183,resting-state,0,0
149184,inhibition,0,0
149185,might,0,0
149186,lead,0,0
149187,to,0,0
149188,a,0,0
149189,subsequent,0,0
149190,loss,0,0
149191,of,0,0
149192,modulatory,0,0
149193,capacity,0,0
149194,",",0,0
149195,possibly,0,0
149196,reflecting,0,0
149197,malfunctioning,0,0
149198,precision,0,0
149199,in,0,0
149200,GABAAergic,0,1
149201,neurotransmission,0,1
149202,;,0,0
149203,the,0,0
149204,consequence,0,0
149205,is,0,0
149206,an,0,0
149207,inevitable,0,0
149208,decline,0,0
149209,in,0,0
149210,motor,0,0
149211,function,0,0
149212,.,0,0
149213,The,0,0
149214,effectiveness,0,0
149215,of,0,0
149216,educational,1,0
149217,interventions,1,0
149218,to,0,0
149219,enhance,0,0
149220,the,0,0
149221,adoption,0,0
149222,of,0,0
149223,fee-based,0,1
149224,arsenic,0,1
149225,testing,0,0
149226,in,0,0
149227,Bangladesh,0,0
149228,:,0,0
149229,a,0,0
149230,cluster,0,0
149231,randomized,0,0
149232,controlled,0,0
149233,trial,0,0
149234,.,0,1
149235,Arsenic,0,1
149236,(,0,1
149237,As,0,1
149238,),0,1
149239,testing,0,0
149240,could,0,0
149241,help,0,0
149242,22,0,0
149243,million,0,0
149244,people,0,0
149245,",",0,0
149246,using,0,0
149247,drinking,0,0
149248,water,0,0
149249,sources,0,0
149250,that,0,0
149251,exceed,0,0
149252,the,0,0
149253,Bangladesh,0,0
149254,As,0,0
149255,standard,0,0
149256,",",0,0
149257,to,0,0
149258,identify,0,0
149259,safe,0,0
149260,sources,0,0
149261,.,0,0
149262,A,0,0
149263,cluster,0,0
149264,randomized,0,0
149265,controlled,0,0
149266,trial,0,0
149267,was,0,0
149268,conducted,0,0
149269,to,0,0
149270,evaluate,0,0
149271,the,0,0
149272,effectiveness,0,0
149273,of,0,0
149274,household,1,0
149275,education,1,0
149276,and,1,0
149277,local,1,0
149278,media,1,0
149279,in,0,0
149280,the,0,0
149281,increasing,0,0
149282,demand,0,0
149283,for,0,0
149284,fee-based,0,0
149285,As,0,0
149286,testing,0,0
149287,.,0,0
149288,Randomly,0,0
149289,selected,0,0
149290,households,0,1
149291,(,0,0
149292,N,0,0
149293,=,0,0
149294,452,0,0
149295,),0,0
149296,were,0,0
149297,divided,0,0
149298,into,0,0
149299,three,1,0
149300,interventions,1,0
149301,implemented,1,0
149302,by,1,0
149303,community,1,0
149304,workers,1,0
149305,:,1,0
149306,1,1,0
149307,),1,0
149308,fee-based,1,1
149309,As,1,1
149310,testing,1,0
149311,with,1,0
149312,household,1,0
149313,education,1,1
149314,(,1,1
149315,HE,1,1
149316,),1,1
149317,;,1,1
149318,2,1,1
149319,),1,0
149320,fee-based,1,1
149321,As,1,1
149322,testing,1,0
149323,with,1,0
149324,household,1,0
149325,education,1,0
149326,and,1,0
149327,a,1,0
149328,local,1,0
149329,media,1,0
149330,campaign,1,0
149331,(,1,1
149332,HELM,1,1
149333,),1,1
149334,;,1,1
149335,and,1,1
149336,3,1,1
149337,),1,0
149338,fee-based,1,1
149339,As,1,1
149340,testing,1,0
149341,alone,1,0
149342,(,1,0
149343,Control,1,0
149344,),1,0
149345,.,1,0
149346,The,0,0
149347,fee,0,0
149348,for,0,0
149349,the,0,0
149350,As,0,0
149351,test,0,0
149352,was,0,0
149353,US,0,0
149354,$,0,0
149355,0.28,0,0
149356,",",0,0
149357,higher,0,0
149358,than,0,0
149359,the,0,0
149360,cost,0,0
149361,of,0,0
149362,the,0,0
149363,test,0,0
149364,(,0,0
149365,US,0,0
149366,$,0,0
149367,0.16,0,0
149368,),0,0
149369,.,0,0
149370,Of,0,0
149371,households,0,0
149372,with,0,0
149373,untested,0,0
149374,wells,0,0
149375,",",0,0
149376,93,0,0
149377,%,0,0
149378,in,0,0
149379,both,0,0
149380,intervention,0,0
149381,groups,0,0
149382,HE,0,0
149383,and,0,0
149384,HELM,0,0
149385,purchased,0,0
149386,an,0,0
149387,As,0,0
149388,test,0,0
149389,",",0,0
149390,whereas,0,0
149391,only,0,0
149392,53,0,0
149393,%,0,0
149394,in,0,0
149395,the,0,0
149396,control,0,0
149397,group,0,0
149398,.,0,0
149399,In,0,0
149400,conclusion,0,0
149401,",",0,0
149402,fee-based,1,0
149403,As,1,1
149404,testing,1,0
149405,with,1,0
149406,household,1,0
149407,education,1,0
149408,is,0,0
149409,effective,0,0
149410,in,0,0
149411,the,0,0
149412,increasing,0,0
149413,demand,0,0
149414,for,0,0
149415,As,0,0
149416,testing,0,0
149417,in,0,0
149418,rural,0,0
149419,Bangladesh,0,0
149420,.,0,0
149421,Ultracision,1,1
149422,versus,1,0
149423,electrocautery,1,0
149424,in,0,0
149425,performing,0,0
149426,modified,0,0
149427,radical,0,0
149428,mastectomy,0,0
149429,and,0,0
149430,axillary,0,0
149431,lymph,0,1
149432,node,0,0
149433,dissection,0,0
149434,for,0,0
149435,breast,0,0
149436,cancer,0,0
149437,:,0,0
149438,a,0,0
149439,prospective,0,0
149440,randomized,0,0
149441,control,0,0
149442,trial,0,0
149443,.,0,0
149444,BACKGROUND,0,0
149445,Treatment,0,0
149446,for,0,0
149447,breast,0,0
149448,cancer,0,0
149449,has,0,0
149450,improved,0,0
149451,dramatically,0,0
149452,over,0,0
149453,the,0,0
149454,decades,0,0
149455,.,0,0
149456,Nevertheless,0,0
149457,",",0,0
149458,modified,0,0
149459,radical,0,0
149460,mastectomy,0,0
149461,with,0,0
149462,axillary,0,0
149463,dissection,0,0
149464,remains,0,0
149465,the,0,0
149466,standard,0,0
149467,treatment,0,0
149468,for,0,0
149469,most,0,0
149470,patients,0,0
149471,",",0,0
149472,especially,0,0
149473,those,0,0
149474,with,0,0
149475,big,0,0
149476,tumours,0,0
149477,.,0,0
149478,The,0,0
149479,conventional,0,0
149480,technology,0,0
149481,is,0,0
149482,to,0,0
149483,use,0,0
149484,diathermy,0,0
149485,to,0,0
149486,cut,0,0
149487,and,0,0
149488,coagulate,0,0
149489,blood,0,0
149490,vessels,0,0
149491,.,0,0
149492,The,0,0
149493,Ultracision,0,0
149494,dissector,0,0
149495,has,0,0
149496,been,0,0
149497,widely,0,0
149498,used,0,0
149499,in,0,0
149500,laparoscopic,0,0
149501,surgery,0,0
149502,and,0,0
149503,is,0,0
149504,documented,0,0
149505,to,0,0
149506,be,0,0
149507,safe,0,0
149508,and,0,0
149509,fast,0,0
149510,for,0,0
149511,cutting,0,0
149512,and,0,0
149513,coagulating,0,0
149514,tissue,0,0
149515,.,0,0
149516,The,0,0
149517,aim,0,0
149518,of,0,0
149519,this,0,0
149520,study,0,0
149521,is,0,0
149522,to,0,0
149523,compare,0,0
149524,ultracision,1,0
149525,to,1,0
149526,electrocautery,1,0
149527,",",0,0
149528,looking,0,0
149529,in,0,0
149530,terms,0,0
149531,of,0,0
149532,amount,0,0
149533,of,0,0
149534,post,0,0
149535,operative,0,0
149536,drainage,0,0
149537,",",0,0
149538,duration,0,0
149539,of,0,0
149540,drain,0,0
149541,days,0,0
149542,",",0,0
149543,seroma,0,0
149544,formation,0,0
149545,and,0,0
149546,other,0,0
149547,complications,0,0
149548,.,0,0
149549,METHODOLOGY,0,0
149550,This,0,0
149551,study,0,0
149552,was,0,0
149553,a,0,0
149554,prospective,0,0
149555,randomized,0,0
149556,control,0,0
149557,trial,0,0
149558,of,0,0
149559,modified,1,0
149560,radical,1,0
149561,mastectomy,1,0
149562,performed,0,0
149563,for,0,0
149564,breast,0,0
149565,cancer,0,0
149566,in,0,0
149567,Pusat,0,1
149568,Perubatan,0,0
149569,Universiti,0,0
149570,Kebangsaan,0,0
149571,Malaysia,0,1
149572,(,0,1
149573,PPUKM,0,1
149574,),0,1
149575,between,0,0
149576,1st,0,0
149577,June,0,0
149578,2007,0,0
149579,to,0,0
149580,31st,0,0
149581,December,0,0
149582,2008,0,0
149583,.,0,0
149584,Patients,0,0
149585,were,0,0
149586,randomized,0,0
149587,in,0,0
149588,two,0,0
149589,groups,0,0
149590,:,0,0
149591,group,0,0
149592,A,0,1
149593,(,0,0
149594,n,0,0
149595,=,0,0
149596,20,0,0
149597,),0,0
149598,underwent,0,0
149599,modified,1,0
149600,radical,1,0
149601,mastectomy,1,0
149602,using,1,0
149603,ultracision,1,0
149604,(,1,0
149605,UC,1,0
149606,),1,0
149607,and,0,0
149608,group,0,1
149609,B,0,1
149610,(,0,0
149611,n,0,0
149612,=,0,0
149613,20,0,0
149614,),0,0
149615,with,0,0
149616,the,0,0
149617,conventional,1,0
149618,electrocautery,1,0
149619,(,1,1
149620,EC,1,1
149621,),1,0
149622,method,1,0
149623,.,1,1
149624,Main,0,1
149625,outcome,0,1
149626,measures,0,0
149627,were,0,0
149628,amount,0,0
149629,of,0,0
149630,drainage,0,0
149631,and,0,0
149632,duration,0,0
149633,of,0,0
149634,drain,0,0
149635,days,0,1
149636,.,0,1
149637,An,0,1
149638,unpaired,0,0
149639,2-tailed,0,1
149640,Student,0,1
149641,'s,0,1
149642,t,0,0
149643,test,0,0
149644,and,0,0
149645,the,0,0
149646,?2,0,0
149647,test,0,0
149648,to,0,0
149649,compare,0,0
149650,the,0,0
149651,groups,0,0
149652,.,0,0
149653,RESULTS,0,0
149654,A,0,0
149655,total,0,0
149656,of,0,0
149657,40,0,0
149658,patients,0,0
149659,were,0,0
149660,involved,0,0
149661,in,0,0
149662,this,0,0
149663,study,0,0
149664,.,0,0
149665,The,0,0
149666,majority,0,0
149667,of,0,0
149668,patients,0,0
149669,were,0,0
149670,Malay,0,0
149671,(,0,0
149672,55,0,0
149673,%,0,0
149674,),0,0
149675,followed,0,0
149676,by,0,0
149677,Chinese,0,0
149678,(,0,0
149679,35,0,0
149680,%,0,0
149681,),0,0
149682,",",0,0
149683,Indian,0,1
149684,(,0,0
149685,5,0,0
149686,%,0,0
149687,),0,0
149688,and,0,0
149689,others,0,0
149690,(,0,0
149691,5,0,0
149692,%,0,0
149693,),0,0
149694,.,0,0
149695,The,0,0
149696,mean,0,0
149697,volume,0,0
149698,of,0,0
149699,drainage,0,0
149700,from,0,0
149701,the,0,0
149702,axilla,0,0
149703,in,0,0
149704,the,0,0
149705,EC,0,0
149706,group,0,0
149707,was,0,0
149708,significantly,0,0
149709,higher,0,0
149710,than,0,0
149711,UC,0,0
149712,group,0,0
149713,[,0,0
149714,489.5,0,0
149715,versus,0,0
149716,188.1,0,0
149717,mls,0,0
149718,(,0,0
149719,p,0,0
149720,<,0,0
149721,0.001,0,0
149722,),0,0
149723,],0,0
149724,.,0,0
149725,The,0,0
149726,mean,0,0
149727,volume,0,0
149728,of,0,0
149729,drainage,0,0
149730,from,0,0
149731,the,0,0
149732,breast,0,0
149733,and,0,0
149734,the,0,0
149735,total,0,0
149736,drainage,0,0
149737,from,0,0
149738,both,0,0
149739,the,0,0
149740,breast,0,0
149741,and,0,0
149742,axilla,0,0
149743,was,0,0
149744,also,0,0
149745,significantly,0,0
149746,higher,0,0
149747,in,0,0
149748,the,0,0
149749,EC,0,0
149750,group,0,0
149751,compared,0,0
149752,to,0,0
149753,UC,0,0
149754,[,0,0
149755,169.3,0,0
149756,versus,0,0
149757,58.8,0,0
149758,mls,0,0
149759,(,0,0
149760,p,0,0
149761,=,0,0
149762,0.004,0,0
149763,),0,0
149764,and,0,0
149765,663.7,0,0
149766,versus,0,0
149767,247.0,0,0
149768,mls,0,0
149769,(,0,0
149770,p,0,0
149771,<,0,0
149772,0.002,0,0
149773,),0,0
149774,respectively,0,0
149775,],0,0
149776,.,0,0
149777,The,0,0
149778,drainage,0,0
149779,consequently,0,0
149780,showed,0,0
149781,significant,0,0
149782,reduction,0,0
149783,in,0,0
149784,terms,0,0
149785,of,0,0
149786,drain,0,0
149787,days,0,0
149788,in,0,0
149789,the,0,0
149790,axilla,0,1
149791,[,0,1
149792,6,0,0
149793,days,0,1
149794,versus,0,0
149795,3,0,1
149796,days,0,0
149797,(,0,0
149798,p,0,0
149799,<,0,0
149800,0.002,0,0
149801,),0,0
149802,],0,0
149803,and,0,0
149804,the,0,0
149805,breast,0,1
149806,[,0,1
149807,3,0,1
149808,days,0,1
149809,versus,0,0
149810,2,0,1
149811,days,0,0
149812,(,0,0
149813,p,0,0
149814,<,0,0
149815,0.002,0,0
149816,),0,0
149817,],0,0
149818,in,0,0
149819,the,0,0
149820,UC,0,0
149821,compared,0,0
149822,to,0,0
149823,the,0,0
149824,EC,0,0
149825,.,0,0
149826,There,0,0
149827,was,0,0
149828,no,0,0
149829,significant,0,0
149830,complication,0,0
149831,in,0,0
149832,both,0,0
149833,arms,0,0
149834,.,0,0
149835,In,0,0
149836,conclusion,0,0
149837,",",0,0
149838,the,0,0
149839,use,0,0
149840,of,0,0
149841,ultracision,0,0
149842,able,0,0
149843,to,0,0
149844,reduce,0,0
149845,the,0,0
149846,amount,0,0
149847,of,0,0
149848,drainage,0,0
149849,and,0,0
149850,the,0,0
149851,number,0,0
149852,of,0,0
149853,drain,0,0
149854,days,0,0
149855,after,0,0
149856,performing,0,0
149857,modified,0,0
149858,radical,0,0
149859,mastectomy,0,0
149860,.,0,0
149861,In,0,0
149862,doing,0,0
149863,so,0,0
149864,",",0,0
149865,the,0,0
149866,use,0,0
149867,of,0,0
149868,this,0,0
149869,technology,0,0
149870,enable,0,0
149871,us,0,0
149872,to,0,0
149873,discharge,0,0
149874,patients,0,0
149875,earlier,0,0
149876,without,0,0
149877,significant,0,0
149878,morbidities,0,0
149879,.,0,0
149880,Targeting,0,0
149881,alpha-7,1,1
149882,nicotinic,1,1
149883,neurotransmission,1,1
149884,in,0,0
149885,schizophrenia,0,0
149886,:,0,0
149887,a,0,0
149888,novel,0,0
149889,agonist,0,1
149890,strategy,0,0
149891,.,0,1
149892,Alpha7,1,1
149893,nicotinic,1,1
149894,acetylcholine,1,1
149895,receptor,1,1
149896,(,1,1
149897,?7,1,1
149898,nAChR,1,1
149899,),1,1
149900,agonists,1,1
149901,may,0,0
149902,be,0,0
149903,valuable,0,0
149904,treatments,0,0
149905,for,0,0
149906,negative,0,0
149907,symptoms,0,0
149908,and,0,0
149909,cognitive,0,0
149910,impairment,0,0
149911,in,0,0
149912,schizophrenia,0,0
149913,.,0,0
149914,Unfortunately,0,0
149915,",",0,0
149916,chronic,0,0
149917,exposure,0,0
149918,to,0,0
149919,an,0,0
149920,agonist,0,1
149921,may,0,0
149922,reduce,0,0
149923,the,0,0
149924,receptor,0,0
149925,'s,0,0
149926,sensitivity,0,0
149927,.,0,0
149928,Therefore,0,0
149929,",",0,0
149930,we,0,0
149931,combined,1,0
149932,CDP-choline,1,1
149933,",",1,1
149934,a,0,0
149935,dietary,0,1
149936,source,0,0
149937,of,0,0
149938,the,0,0
149939,direct,0,0
149940,agonist,0,1
149941,choline,0,1
149942,",",0,1
149943,with,1,1
149944,galantamine,1,1
149945,",",1,0
149946,a,1,0
149947,positive,1,0
149948,allosteric,1,0
149949,modulator,1,0
149950,(,1,0
149951,PAM,1,1
149952,),1,1
149953,of,1,1
149954,nicotinic,1,1
149955,acetylcholine,1,1
149956,receptors,1,1
149957,",",1,0
149958,to,0,0
149959,improve,0,0
149960,the,0,0
149961,efficiency,0,0
149962,of,0,0
149963,transducing,0,0
149964,the,0,0
149965,choline,0,0
149966,signal,0,0
149967,and,0,0
149968,",",0,0
149969,possibly,0,0
149970,",",0,0
149971,preserve,0,0
149972,the,0,0
149973,receptor,0,0
149974,in,0,0
149975,a,0,0
149976,sensitive,0,0
149977,state,0,0
149978,.,0,0
149979,We,0,0
149980,conducted,0,0
149981,a,0,0
149982,single-site,0,0
149983,",",0,0
149984,double-blind,0,1
149985,randomized,0,1
149986,clinical,0,1
149987,trial,0,1
149988,comparing,1,0
149989,galantamine/CDP-choline,1,1
149990,to,1,1
149991,placebos,1,1
149992,in,0,0
149993,schizophrenia,0,0
149994,patients,0,0
149995,with,0,0
149996,negative,0,0
149997,symptoms,0,0
149998,who,0,0
149999,were,0,0
150000,receiving,0,0
150001,second,0,0
150002,generation,0,0
150003,antipsychotics,0,1
150004,.,0,0
150005,Forty-three,0,0
150006,subjects,0,0
150007,received,1,0
150008,galantamine,1,1
150009,and,1,1
150010,CDP-choline,1,1
150011,or,0,1
150012,matching,1,0
150013,placebos,1,1
150014,for,0,0
150015,16weeks,0,0
150016,.,0,0
150017,The,0,0
150018,primary,0,0
150019,outcome,0,0
150020,measure,0,0
150021,was,0,0
150022,the,0,0
150023,5-item,0,0
150024,Marder,0,0
150025,negative-symptoms,0,0
150026,factor,0,0
150027,of,0,0
150028,the,0,0
150029,Positive,0,0
150030,and,0,0
150031,Negative,0,0
150032,Syndrome,0,1
150033,Scale,0,1
150034,(,0,1
150035,PANSS,0,1
150036,),0,1
150037,.,0,0
150038,Cognition,0,0
150039,and,0,0
150040,functioning,0,0
150041,were,0,0
150042,also,0,0
150043,assessed,0,0
150044,.,0,0
150045,Trial,0,0
150046,completion,0,0
150047,was,0,0
150048,high,0,0
150049,;,0,0
150050,79,0,0
150051,%,0,0
150052,.,0,0
150053,There,0,0
150054,was,0,0
150055,no,0,0
150056,significant,0,0
150057,treatment,0,0
150058,effect,0,0
150059,on,0,0
150060,negative,0,0
150061,symptoms,0,0
150062,",",0,0
150063,other,0,0
150064,PANSS,0,0
150065,symptom,0,0
150066,factors,0,0
150067,",",0,0
150068,or,0,0
150069,the,0,0
150070,MATRICS,0,1
150071,Cognitive,0,1
150072,Consensus,0,1
150073,Battery,0,0
150074,.,0,0
150075,There,0,0
150076,were,0,0
150077,significant,0,0
150078,treatment,0,0
150079,effects,0,0
150080,in,0,0
150081,overall,0,0
150082,functioning,0,0
150083,and,0,0
150084,a,0,0
150085,test,0,0
150086,of,0,0
150087,free,0,0
150088,verbal,0,0
150089,recall,0,0
150090,.,0,0
150091,Three,0,0
150092,subjects,0,0
150093,discontinued,0,1
150094,treatment,0,0
150095,in,0,0
150096,the,0,0
150097,active,0,0
150098,treatment,0,0
150099,group,0,0
150100,for,0,0
150101,gastro-intestinal,0,0
150102,adverse,0,0
150103,events,0,0
150104,(,0,1
150105,AE,0,1
150106,),0,1
150107,.,0,0
150108,The,0,0
150109,most,0,0
150110,common,0,0
150111,AE,0,0
150112,for,1,0
150113,galantamine/CDP-choline,1,1
150114,was,0,0
150115,abdominal,0,1
150116,pain,0,1
150117,;,0,1
150118,for,1,0
150119,placebo,1,1
150120,it,0,0
150121,was,0,0
150122,headache,0,0
150123,and,0,0
150124,sweating,0,0
150125,.,0,0
150126,Although,0,0
150127,there,0,0
150128,was,0,0
150129,no,0,0
150130,significant,0,0
150131,treatment,0,0
150132,effect,0,0
150133,on,0,0
150134,negative,0,0
150135,symptoms,0,0
150136,",",0,0
150137,the,0,0
150138,direction,0,0
150139,of,0,0
150140,effect,0,0
150141,mirrored,0,0
150142,the,0,0
150143,effects,0,0
150144,on,0,0
150145,a,0,0
150146,cognitive,0,0
150147,measure,0,0
150148,and,0,0
150149,overall,0,0
150150,functioning,0,0
150151,.,0,0
150152,Further,0,0
150153,study,0,0
150154,of,1,0
150155,?7,1,1
150156,nAChR,1,1
150157,agonist/PAMs,1,1
150158,is,1,0
150159,warranted,0,0
150160,in,0,0
150161,larger,0,0
150162,studies,0,0
150163,that,0,0
150164,will,0,0
150165,have,0,0
150166,greater,0,0
150167,power,0,0
150168,.,0,0
150169,Randomized,0,0
150170,controlled,0,0
150171,trial,0,0
150172,of,0,0
150173,entecavir,1,1
150174,prophylaxis,1,1
150175,for,0,0
150176,rituximab-associated,0,0
150177,hepatitis,0,0
150178,B,0,1
150179,virus,0,0
150180,reactivation,0,0
150181,in,0,0
150182,patients,0,0
150183,with,0,0
150184,lymphoma,0,0
150185,and,0,0
150186,resolved,0,0
150187,hepatitis,0,0
150188,B,0,0
150189,.,0,0
150190,PURPOSE,0,0
150191,The,0,0
150192,role,0,0
150193,of,0,0
150194,antiviral,1,1
150195,prophylaxis,1,1
150196,in,0,0
150197,preventing,0,0
150198,hepatitis,0,0
150199,B,0,1
150200,virus,0,1
150201,(,0,1
150202,HBV,0,1
150203,),0,0
150204,reactivation,0,0
150205,before,0,0
150206,rituximab-based,1,0
150207,chemotherapy,1,0
150208,in,0,0
150209,patients,0,0
150210,with,0,0
150211,lymphoma,0,0
150212,and,0,0
150213,resolved,0,0
150214,hepatitis,0,0
150215,B,0,0
150216,is,0,0
150217,unclear,0,0
150218,.,0,0
150219,PATIENTS,0,0
150220,AND,0,1
150221,METHODS,0,1
150222,Eighty,0,0
150223,patients,0,0
150224,with,0,0
150225,CD20,0,1
150226,(,0,1
150227,+,0,1
150228,),0,1
150229,lymphoma,0,1
150230,and,0,0
150231,resolved,0,0
150232,hepatitis,0,0
150233,B,0,0
150234,were,0,0
150235,randomly,0,0
150236,assigned,0,0
150237,to,0,0
150238,receive,0,0
150239,either,0,0
150240,prophylactic,1,1
150241,entecavir,1,1
150242,(,1,1
150243,ETV,1,1
150244,),1,1
150245,before,1,0
150246,chemotherapy,1,0
150247,to,1,0
150248,3,1,0
150249,months,1,0
150250,after,1,0
150251,completing,1,0
150252,chemotherapy,1,1
150253,(,1,1
150254,ETV,1,1
150255,prophylactic,1,1
150256,group,1,0
150257,",",1,0
150258,n,1,0
150259,=,1,0
150260,41,1,0
150261,),1,0
150262,or,1,0
150263,to,1,0
150264,receive,1,0
150265,therapeutic,1,0
150266,ETV,1,0
150267,at,1,0
150268,the,1,0
150269,time,1,0
150270,of,1,0
150271,HBV,1,0
150272,reactivation,1,0
150273,and,1,0
150274,hepatitis,1,0
150275,B,1,0
150276,surface,1,0
150277,antigen,1,0
150278,(,1,0
150279,HBsAg,1,1
150280,),1,1
150281,reverse,1,0
150282,seroconversion,1,0
150283,since,1,0
150284,chemotherapy,1,0
150285,(,1,0
150286,control,1,0
150287,group,1,0
150288,",",1,0
150289,n,1,0
150290,=,1,0
150291,39,1,0
150292,),1,0
150293,.,1,0
150294,RESULTS,0,0
150295,Fifty-eight,0,0
150296,patients,0,0
150297,(,0,0
150298,72.5,0,0
150299,%,0,0
150300,),0,0
150301,were,0,0
150302,positive,0,0
150303,for,0,0
150304,hepatitis,0,0
150305,B,0,0
150306,surface,0,0
150307,antibody,0,0
150308,",",0,0
150309,and,0,0
150310,HBV,0,0
150311,DNA,0,0
150312,was,0,0
150313,undetectable,0,0
150314,in,0,0
150315,50,0,0
150316,patients,0,0
150317,(,0,0
150318,62.5,0,0
150319,%,0,0
150320,),0,0
150321,.,0,0
150322,During,0,0
150323,a,0,0
150324,mean,0,0
150325,18-month,0,0
150326,follow-up,0,0
150327,period,0,0
150328,",",0,0
150329,one,0,0
150330,patient,0,0
150331,(,0,0
150332,2.4,0,0
150333,%,0,0
150334,),0,0
150335,in,0,0
150336,the,0,0
150337,ETV,1,0
150338,prophylactic,0,1
150339,group,0,0
150340,and,0,0
150341,seven,0,0
150342,patients,0,0
150343,(,0,0
150344,17.9,0,0
150345,%,0,0
150346,),0,0
150347,in,0,0
150348,the,0,0
150349,control,0,0
150350,group,0,0
150351,developed,0,0
150352,HBV,0,1
150353,reactivation,0,0
150354,(,0,0
150355,P,0,0
150356,=,0,0
150357,.027,0,0
150358,),0,0
150359,.,0,0
150360,The,0,0
150361,cumulative,0,0
150362,HBV,0,0
150363,reactivation,0,0
150364,rates,0,0
150365,at,0,0
150366,months,0,0
150367,6,0,0
150368,",",0,0
150369,12,0,0
150370,",",0,0
150371,and,0,0
150372,18,0,0
150373,after,0,0
150374,chemotherapy,0,0
150375,were,0,0
150376,8,0,0
150377,%,0,0
150378,",",0,0
150379,11.2,0,0
150380,%,0,0
150381,",",0,0
150382,and,0,0
150383,25.9,0,0
150384,%,0,0
150385,",",0,0
150386,respectively,0,0
150387,",",0,0
150388,in,0,0
150389,the,0,0
150390,control,0,0
150391,group,0,0
150392,",",0,0
150393,and,0,0
150394,0,0,0
150395,%,0,0
150396,",",0,0
150397,0,0,0
150398,%,0,0
150399,",",0,0
150400,and,0,0
150401,4.3,0,0
150402,%,0,0
150403,in,0,0
150404,the,0,0
150405,ETV,0,0
150406,prophylactic,0,1
150407,group,0,0
150408,(,0,0
150409,P,0,0
150410,=,0,0
150411,.019,0,0
150412,),0,0
150413,.,0,0
150414,Four,0,0
150415,patients,0,0
150416,(,0,0
150417,50,0,0
150418,%,0,0
150419,),0,0
150420,in,0,0
150421,the,0,0
150422,control,0,0
150423,group,0,0
150424,had,0,0
150425,HBsAg,0,0
150426,reverse,0,0
150427,seroconversion,0,0
150428,after,0,0
150429,HBV,0,0
150430,reactivation,0,0
150431,.,0,0
150432,The,0,0
150433,cumulative,0,0
150434,HBsAg,0,0
150435,reverse,0,0
150436,seroconversion,0,0
150437,rates,0,0
150438,at,0,0
150439,months,0,0
150440,6,0,0
150441,",",0,0
150442,12,0,0
150443,",",0,0
150444,and,0,0
150445,18,0,0
150446,since,0,0
150447,chemotherapy,0,0
150448,were,0,0
150449,0,0,0
150450,%,0,0
150451,",",0,0
150452,6.4,0,0
150453,%,0,0
150454,",",0,0
150455,and,0,0
150456,16.3,0,0
150457,%,0,0
150458,in,0,0
150459,the,0,0
150460,control,0,0
150461,group,0,0
150462,",",0,0
150463,respectively,0,0
150464,",",0,0
150465,which,0,0
150466,were,0,0
150467,significantly,0,0
150468,higher,0,0
150469,than,0,0
150470,those,0,0
150471,in,0,0
150472,the,0,0
150473,ETV,0,0
150474,prophylactic,0,1
150475,group,0,0
150476,(,0,0
150477,P,0,0
150478,=,0,0
150479,.032,0,0
150480,),0,0
150481,.,0,0
150482,Patients,0,0
150483,with,0,0
150484,detectable,0,0
150485,or,0,0
150486,undetectable,0,0
150487,viral,0,0
150488,load,0,0
150489,could,0,0
150490,develop,0,0
150491,HBV,0,0
150492,reactivation,0,0
150493,and,0,0
150494,HBsAg,0,0
150495,reverse,0,0
150496,seroconversion,0,0
150497,.,0,0
150498,CONCLUSION,0,0
150499,Undetectable,0,0
150500,HBV,0,0
150501,viral,0,0
150502,load,0,0
150503,before,0,0
150504,chemotherapy,0,0
150505,did,0,0
150506,not,0,0
150507,confer,0,0
150508,reactivation-free,0,0
150509,status,0,0
150510,.,0,0
150511,Antiviral,1,0
150512,prophylaxis,1,0
150513,can,0,0
150514,potentially,0,0
150515,prevent,0,0
150516,rituximab-associated,0,0
150517,HBV,0,0
150518,reactivation,0,0
150519,in,0,0
150520,patients,0,0
150521,with,0,0
150522,lymphoma,0,0
150523,and,0,0
150524,resolved,0,0
150525,hepatitis,0,0
150526,B,0,0
150527,.,0,0
150528,A,0,1
150529,head-to-head,0,0
150530,comparison,0,0
150531,of,0,0
150532,aripiprazole,1,1
150533,and,1,1
150534,risperidone,1,1
150535,for,0,0
150536,safety,0,0
150537,and,0,0
150538,treating,0,0
150539,autistic,0,0
150540,disorders,0,0
150541,",",0,0
150542,a,0,0
150543,randomized,0,0
150544,double,0,0
150545,blind,0,0
150546,clinical,0,0
150547,trial,0,1
150548,.,0,1
150549,Aripiprazole,1,1
150550,and,1,1
150551,risperidone,1,1
150552,are,0,0
150553,the,0,0
150554,only,0,0
150555,FDA,0,1
150556,approved,0,1
150557,medications,0,1
150558,for,0,0
150559,treating,0,0
150560,irritability,0,0
150561,in,0,0
150562,autistic,0,0
150563,disorder,0,0
150564,",",0,0
150565,however,0,0
150566,there,0,0
150567,are,0,0
150568,no,0,0
150569,head-to-head,0,0
150570,data,0,0
150571,comparing,0,0
150572,these,0,0
150573,agents,0,0
150574,.,0,0
150575,This,0,0
150576,is,0,0
150577,the,0,0
150578,first,0,0
150579,prospective,0,0
150580,randomized,0,0
150581,clinical,0,0
150582,trial,0,0
150583,comparing,0,0
150584,the,0,0
150585,safety,0,0
150586,and,0,0
150587,efficacy,0,0
150588,of,0,0
150589,these,0,0
150590,two,0,0
150591,medications,0,1
150592,in,0,0
150593,patients,0,0
150594,with,0,0
150595,autism,0,0
150596,spectrum,0,0
150597,disorders,0,0
150598,.,0,0
150599,Fifty,0,0
150600,nine,0,0
150601,children,0,0
150602,and,0,0
150603,adolescents,0,0
150604,with,0,0
150605,autism,0,0
150606,spectrum,0,0
150607,disorders,0,0
150608,were,0,0
150609,randomized,0,0
150610,to,0,0
150611,receive,0,0
150612,either,0,0
150613,aripiprazole,1,1
150614,or,1,1
150615,risperidone,1,1
150616,for,0,0
150617,2,0,0
150618,months,0,0
150619,.,0,0
150620,The,0,0
150621,primary,0,0
150622,outcome,0,0
150623,measure,0,0
150624,was,0,0
150625,change,0,0
150626,in,0,0
150627,Aberrant,0,0
150628,Behavior,0,0
150629,Checklist,0,1
150630,(,0,1
150631,ABC,0,1
150632,),0,1
150633,scores,0,0
150634,.,0,0
150635,Adverse,0,0
150636,events,0,0
150637,were,0,0
150638,assessed,0,0
150639,.,0,0
150640,Aripiprazole,1,1
150641,as,0,0
150642,well,0,0
150643,as,0,0
150644,risperidone,0,1
150645,lowered,0,0
150646,ABC,0,1
150647,scores,0,0
150648,during,0,0
150649,2,0,0
150650,months,0,0
150651,.,0,0
150652,The,0,0
150653,rates,0,0
150654,of,0,0
150655,adverse,0,0
150656,effects,0,0
150657,were,0,0
150658,not,0,0
150659,significantly,0,0
150660,different,0,0
150661,between,0,0
150662,the,0,0
150663,two,0,0
150664,groups,0,0
150665,.,0,0
150666,The,0,0
150667,safety,0,0
150668,and,0,0
150669,efficacy,0,0
150670,of,0,1
150671,aripiprazole,0,1
150672,(,0,1
150673,mean,0,0
150674,dose,0,1
150675,5.5,0,0
150676,mg/day,0,1
150677,),0,1
150678,and,0,1
150679,risperidone,0,1
150680,(,0,1
150681,mean,0,0
150682,dose,0,1
150683,1.12,0,0
150684,mg/day,0,1
150685,),0,0
150686,were,0,0
150687,comparable,0,0
150688,.,0,0
150689,The,0,0
150690,choice,0,0
150691,between,0,0
150692,these,0,0
150693,two,0,0
150694,medications,0,1
150695,should,0,0
150696,be,0,0
150697,on,0,0
150698,the,0,0
150699,basis,0,0
150700,of,0,0
150701,clinical,0,0
150702,equipoise,0,0
150703,considering,0,0
150704,the,0,0
150705,patient,0,0
150706,'s,0,0
150707,preference,0,0
150708,and,0,0
150709,clinical,0,0
150710,profile,0,0
150711,.,0,0
150712,Impact,0,0
150713,of,0,0
150714,MET,0,0
150715,expression,0,0
150716,on,0,0
150717,outcome,0,0
150718,in,0,0
150719,BRAF,0,1
150720,(,0,1
150721,V600E/K,0,1
150722,),0,1
150723,advanced,0,0
150724,melanoma,0,1
150725,.,0,0
150726,AIMS,0,0
150727,Preclinical,0,0
150728,data,0,0
150729,suggest,0,0
150730,that,0,0
150731,signalling,0,0
150732,through,0,0
150733,the,0,0
150734,HGF-MET,0,0
150735,pathway,0,0
150736,may,0,0
150737,confer,0,0
150738,resistance,0,0
150739,to,0,0
150740,BRAF,0,0
150741,inhibition,0,0
150742,in,0,0
150743,BRAF,0,1
150744,(,0,1
150745,V600E/K,0,1
150746,),0,1
150747,melanoma,0,0
150748,.,0,0
150749,Therefore,0,0
150750,",",0,0
150751,blockade,0,1
150752,of,0,0
150753,HGF-MET,0,0
150754,signalling,0,0
150755,might,0,0
150756,be,0,0
150757,a,0,0
150758,valid,0,0
150759,therapeutic,0,0
150760,strategy,0,0
150761,",",0,0
150762,in,0,0
150763,combination,0,0
150764,with,0,0
150765,BRAF,1,0
150766,inhibition,1,0
150767,",",0,0
150768,in,0,0
150769,BRAF,0,1
150770,(,0,1
150771,V600E/K,0,1
150772,),0,1
150773,melanoma,0,0
150774,.,0,0
150775,The,0,0
150776,aim,0,0
150777,of,0,0
150778,this,0,0
150779,study,0,0
150780,was,0,0
150781,to,0,0
150782,investigate,0,0
150783,the,0,0
150784,clinical,0,0
150785,relevance,0,0
150786,of,0,0
150787,these,0,0
150788,observations,0,0
150789,by,0,0
150790,evaluating,0,0
150791,the,0,0
150792,survival,0,0
150793,impact,0,0
150794,of,0,0
150795,MET,0,0
150796,expression,0,0
150797,in,0,0
150798,patients,0,0
150799,with,0,0
150800,BRAF,0,1
150801,(,0,1
150802,V600E/K,0,1
150803,),0,1
150804,advanced,0,0
150805,melanoma,0,0
150806,treated,0,0
150807,with,0,0
150808,vemurafenib,0,1
150809,.,0,0
150810,METHODS,0,1
150811,AND,0,0
150812,RESULTS,0,0
150813,Formalin-fixed,0,0
150814,tissue,0,0
150815,blocks,0,0
150816,were,0,0
150817,obtained,0,0
150818,of,0,0
150819,tumours,0,0
150820,from,0,0
150821,patients,0,0
150822,enrolled,0,0
150823,in,0,0
150824,the,0,0
150825,BRIM2,0,1
150826,(,0,0
150827,n,0,0
150828,=,0,0
150829,59,0,0
150830,),0,0
150831,and,0,0
150832,BRIM3,0,1
150833,(,0,0
150834,n,0,0
150835,=,0,0
150836,150,0,0
150837,),0,0
150838,trials,0,1
150839,of,0,0
150840,vemurafenib,1,1
150841,in,0,0
150842,advanced,0,1
150843,BRAF,0,1
150844,(,0,1
150845,V600E/K,0,1
150846,),0,1
150847,melanoma,0,0
150848,.,0,0
150849,Immunohistochemistry,0,0
150850,for,0,0
150851,MET,0,1
150852,(,0,0
150853,SP44,0,1
150854,rabbit,0,0
150855,monoclonal,0,1
150856,antibody,0,0
150857,),0,0
150858,was,0,0
150859,performed,0,0
150860,with,0,0
150861,a,0,0
150862,highly,0,0
150863,validated,0,0
150864,assay,0,0
150865,and,0,0
150866,clinically,0,0
150867,validated,0,0
150868,scoring,0,0
150869,system,0,0
150870,.,0,0
150871,Pretreatment,0,0
150872,MET,0,0
150873,expression,0,0
150874,was,0,0
150875,frequent,0,0
150876,at,0,0
150877,the,0,0
150878,?1,0,0
150879,+,0,0
150880,cutoff,0,0
150881,(,0,1
150882,BRIM3,0,0
150883,",",0,0
150884,31,0,0
150885,%,0,0
150886,;,0,0
150887,BRIM2,0,0
150888,",",0,0
150889,49,0,0
150890,%,0,0
150891,),0,0
150892,",",0,0
150893,but,0,0
150894,relatively,0,0
150895,infrequent,0,0
150896,at,0,0
150897,the,0,0
150898,?2,0,1
150899,+,0,1
150900,cutoff,0,1
150901,(,0,1
150902,BRIM3,0,1
150903,",",0,0
150904,9,0,0
150905,%,0,0
150906,;,0,0
150907,BRIM2,0,0
150908,",",0,0
150909,19,0,0
150910,%,0,0
150911,),0,0
150912,.,0,0
150913,Retrospective,0,0
150914,subset,0,0
150915,analyses,0,0
150916,showed,0,0
150917,that,0,0
150918,",",0,0
150919,irrespective,0,0
150920,of,0,0
150921,the,0,0
150922,cutoff,0,0
150923,used,0,0
150924,or,0,0
150925,the,0,0
150926,treatment,0,0
150927,arm,0,0
150928,",",0,0
150929,MET,0,0
150930,expression,0,0
150931,did,0,0
150932,not,0,0
150933,show,0,0
150934,prognostic,0,0
150935,significance,0,0
150936,",",0,0
150937,in,0,0
150938,terms,0,0
150939,of,0,0
150940,objective,0,0
150941,response,0,0
150942,rate,0,0
150943,",",0,0
150944,progression-free,0,0
150945,survival,0,0
150946,",",0,0
150947,or,0,0
150948,overall,0,0
150949,survival,0,0
150950,.,0,0
150951,CONCLUSIONS,0,0
150952,MET,0,0
150953,is,0,0
150954,expressed,0,0
150955,in,0,0
150956,a,0,0
150957,proportion,0,0
150958,of,0,0
150959,BRAF,0,1
150960,(,0,1
150961,V600E/K,0,1
150962,),0,1
150963,advanced,0,0
150964,melanomas,0,0
150965,.,0,0
150966,Further,0,0
150967,analyses,0,0
150968,on,0,0
150969,appropriately,0,0
150970,powered,0,0
150971,subsets,0,0
150972,are,0,0
150973,needed,0,0
150974,to,0,0
150975,determine,0,0
150976,the,0,0
150977,prognostic,0,0
150978,and,0,0
150979,predictive,0,0
150980,significance,0,0
150981,of,0,0
150982,MET,0,0
150983,in,0,0
150984,vemurafenib-treated,0,1
150985,melanoma,0,0
150986,.,0,0
150987,Perceptual,1,0
150988,learning,1,0
150989,of,1,0
150990,speech,1,0
150991,under,0,0
150992,optimal,0,0
150993,and,0,0
150994,adverse,0,0
150995,conditions,0,0
150996,.,0,0
150997,Humans,0,0
150998,have,0,0
150999,a,0,0
151000,remarkable,0,0
151001,ability,0,0
151002,to,0,0
151003,understand,0,0
151004,spoken,0,0
151005,language,0,0
151006,despite,0,0
151007,the,0,0
151008,large,0,0
151009,amount,0,0
151010,of,0,0
151011,variability,0,0
151012,in,0,0
151013,speech,0,0
151014,.,0,0
151015,Previous,0,0
151016,research,0,0
151017,has,0,0
151018,shown,0,0
151019,that,0,0
151020,listeners,0,0
151021,can,0,0
151022,use,0,0
151023,lexical,1,0
151024,information,1,0
151025,to,0,0
151026,guide,0,0
151027,their,0,0
151028,interpretation,0,0
151029,of,0,0
151030,atypical,0,0
151031,sounds,0,0
151032,in,0,0
151033,speech,0,1
151034,(,0,0
151035,Norris,0,1
151036,",",0,0
151037,McQueen,0,1
151038,",",0,0
151039,&,0,1
151040,Cutler,0,0
151041,",",0,0
151042,2003,0,1
151043,),0,0
151044,.,0,0
151045,This,0,0
151046,kind,0,0
151047,of,0,0
151048,lexically,1,0
151049,induced,1,0
151050,perceptual,1,0
151051,learning,1,0
151052,enables,0,0
151053,people,0,0
151054,to,0,0
151055,adjust,0,0
151056,to,0,0
151057,the,0,0
151058,variations,0,0
151059,in,0,0
151060,utterances,0,0
151061,due,0,0
151062,to,0,0
151063,talker-specific,0,0
151064,characteristics,0,0
151065,",",0,0
151066,such,0,0
151067,as,0,0
151068,individual,0,0
151069,identity,0,0
151070,and,0,0
151071,dialect,0,0
151072,.,0,0
151073,The,0,0
151074,current,0,0
151075,study,0,0
151076,investigated,0,0
151077,perceptual,1,0
151078,learning,1,0
151079,in,0,0
151080,two,0,0
151081,optimal,0,0
151082,conditions,0,0
151083,:,0,0
151084,conversational,1,0
151085,speech,1,1
151086,(,1,1
151087,Experiment,1,1
151088,1,0,1
151089,),0,0
151090,versus,0,0
151091,clear,1,1
151092,speech,1,1
151093,(,0,1
151094,Experiment,0,1
151095,2,0,1
151096,),0,0
151097,",",0,0
151098,and,0,0
151099,three,0,0
151100,adverse,0,0
151101,conditions,0,0
151102,:,0,0
151103,noise,1,0
151104,(,0,0
151105,Experiment,0,1
151106,3a,0,1
151107,),0,1
151108,versus,0,0
151109,two,1,0
151110,cognitive,1,1
151111,loads,1,1
151112,(,0,1
151113,Experiments,0,0
151114,4a,0,1
151115,and,0,1
151116,4b,0,1
151117,),0,1
151118,.,0,0
151119,Perceptual,1,0
151120,learning,1,0
151121,occurred,0,0
151122,in,0,0
151123,the,0,0
151124,two,0,0
151125,optimal,1,0
151126,conditions,1,0
151127,and,0,0
151128,in,0,0
151129,the,0,0
151130,two,0,0
151131,cognitive,1,0
151132,load,1,0
151133,conditions,1,0
151134,",",0,0
151135,but,0,0
151136,not,0,0
151137,in,0,0
151138,the,0,0
151139,noise,1,0
151140,condition,1,0
151141,.,1,0
151142,Furthermore,0,0
151143,",",0,0
151144,perceptual,1,0
151145,learning,1,0
151146,occurred,0,0
151147,only,0,0
151148,in,0,0
151149,the,0,0
151150,first,0,0
151151,of,0,0
151152,two,0,0
151153,sessions,0,0
151154,for,0,0
151155,each,0,0
151156,participant,0,0
151157,",",0,0
151158,and,0,0
151159,only,0,0
151160,for,0,0
151161,atypical,0,0
151162,/s/,0,0
151163,sounds,0,0
151164,and,0,0
151165,not,0,0
151166,for,0,0
151167,atypical,0,0
151168,/f/,0,0
151169,sounds,0,0
151170,.,0,0
151171,This,0,0
151172,pattern,0,0
151173,of,0,0
151174,learning,0,0
151175,and,0,0
151176,nonlearning,0,0
151177,reflects,0,0
151178,a,0,0
151179,balance,0,0
151180,between,0,0
151181,flexibility,0,0
151182,and,0,0
151183,stability,0,0
151184,that,0,0
151185,the,0,0
151186,speech,0,0
151187,system,0,0
151188,must,0,0
151189,have,0,0
151190,to,0,0
151191,deal,0,0
151192,with,0,0
151193,speech,0,0
151194,variability,0,0
151195,in,0,0
151196,the,0,0
151197,diverse,0,0
151198,conditions,0,0
151199,that,0,0
151200,speech,0,0
151201,is,0,0
151202,encountered,0,0
151203,.,0,0
151204,Serum,0,1
151205,selenium,1,1
151206,concentration,0,1
151207,and,0,1
151208,antioxidant,0,1
151209,activity,0,0
151210,in,0,0
151211,cervical,0,0
151212,cancer,0,0
151213,patients,0,0
151214,before,0,0
151215,and,0,0
151216,after,0,0
151217,treatment,0,0
151218,.,0,0
151219,AIM,0,0
151220,In,0,0
151221,the,0,0
151222,present,0,0
151223,study,0,0
151224,",",0,0
151225,the,0,0
151226,effect,0,0
151227,of,0,0
151228,chemo,0,0
151229,and,0,0
151230,radio,0,0
151231,therapies,0,1
151232,on,0,0
151233,serum,0,1
151234,trace,0,0
151235,elements,0,0
151236,content,0,0
151237,and,0,0
151238,antioxidant,0,1
151239,activity,0,0
151240,in,0,0
151241,blood,0,0
151242,serum,0,1
151243,of,0,0
151244,cervical,0,0
151245,cancer,0,0
151246,patients,0,0
151247,was,0,0
151248,evaluated,0,0
151249,.,0,0
151250,METHODS,0,0
151251,Among,0,0
151252,104,0,0
151253,cervical,0,0
151254,cancer,0,0
151255,patients,0,0
151256,selected,0,0
151257,for,0,0
151258,the,0,0
151259,present,0,0
151260,study,0,0
151261,",",0,0
151262,54,0,0
151263,and,0,0
151264,50,0,0
151265,patients,0,0
151266,were,0,0
151267,treated,0,0
151268,with,0,0
151269,chemo-,1,0
151270,and,1,0
151271,radiotherapy,1,0
151272,respectively,0,0
151273,.,0,0
151274,Plasma,0,0
151275,Se,0,1
151276,",",0,0
151277,Zn,0,1
151278,",",0,0
151279,Cu,0,0
151280,and,0,0
151281,some,0,0
151282,enzymatic,0,0
151283,antioxidants,0,1
151284,activities,0,0
151285,were,0,0
151286,estimated,0,0
151287,in,0,0
151288,serum,0,1
151289,before,0,0
151290,and,0,0
151291,after,0,0
151292,the,0,0
151293,treatment,0,0
151294,.,0,0
151295,RESULTS,0,0
151296,The,0,0
151297,decreased,0,0
151298,levels,0,0
151299,of,0,0
151300,serum,0,1
151301,trace,0,0
151302,elements,0,0
151303,",",0,0
151304,glutathione,0,1
151305,peroxidase,0,1
151306,activity,0,0
151307,and,0,0
151308,total,0,0
151309,antioxidant,0,1
151310,capacity,0,0
151311,",",0,0
151312,and,0,0
151313,increased,0,0
151314,malondialdehyde,0,1
151315,",",0,1
151316,glutathion,0,1
151317,reductase,0,1
151318,was,0,0
151319,observed,0,0
151320,in,0,0
151321,cervical,0,0
151322,cancer,0,0
151323,patients,0,0
151324,when,0,0
151325,compared,0,0
151326,to,0,0
151327,healthy,0,0
151328,controls,0,0
151329,.,0,0
151330,The,0,0
151331,increased,0,0
151332,concentration,0,0
151333,of,0,0
151334,serum,0,1
151335,Se,0,1
151336,",",0,0
151337,Zn,0,0
151338,was,0,0
151339,observed,0,0
151340,in,0,0
151341,patients,0,0
151342,treated,0,0
151343,with,0,0
151344,chemotherapy,1,0
151345,.,1,0
151346,Simultaneously,0,0
151347,there,0,0
151348,was,0,0
151349,a,0,0
151350,significant,0,0
151351,(,0,0
151352,P,0,0
151353,<,0,0
151354,0.001,0,0
151355,),0,0
151356,increase,0,0
151357,in,0,0
151358,glutathione,0,1
151359,peroxidase,0,1
151360,and,0,1
151361,total,0,0
151362,antioxidant,0,1
151363,capacity,0,0
151364,",",0,0
151365,and,0,0
151366,significant,0,0
151367,decrease,0,0
151368,(,0,0
151369,P,0,0
151370,<,0,0
151371,0.05,0,0
151372,),0,0
151373,in,0,0
151374,malondialdehyde,0,1
151375,and,0,1
151376,glutathion,0,1
151377,reductase,0,1
151378,levels,0,0
151379,in,0,0
151380,the,0,0
151381,serum,0,1
151382,of,0,0
151383,patients,0,0
151384,treated,0,0
151385,with,0,0
151386,chemotherapy,1,0
151387,compared,0,0
151388,to,0,0
151389,the,0,0
151390,patients,0,0
151391,treated,0,0
151392,with,0,0
151393,radiotherapy,1,0
151394,.,1,0
151395,CONCLUSION,0,0
151396,The,0,0
151397,results,0,0
151398,demonstrated,0,0
151399,that,0,0
151400,chemotherapy,1,0
151401,but,0,0
151402,not,0,0
151403,radiotherapy,1,0
151404,results,0,0
151405,in,0,0
151406,significant,0,0
151407,increase,0,0
151408,in,0,0
151409,the,0,0
151410,trace,0,0
151411,elements,0,0
151412,levels,0,0
151413,and,0,0
151414,antioxidant,0,1
151415,activities,0,0
151416,in,0,0
151417,blood,0,0
151418,serum,0,1
151419,of,0,0
151420,cervical,0,0
151421,cancer,0,0
151422,patients,0,0
151423,.,0,0
151424,Can,0,0
151425,a,0,0
151426,questionnaire,1,0
151427,predict,0,0
151428,vitamin,0,1
151429,D,0,1
151430,status,0,1
151431,in,0,0
151432,postmenopausal,0,0
151433,women,0,0
151434,?,0,0
151435,OBJECTIVE,0,1
151436,Our,0,0
151437,objective,0,0
151438,was,0,0
151439,to,0,0
151440,determine,0,0
151441,whether,0,0
151442,a,0,0
151443,questionnaire,1,0
151444,can,0,0
151445,identify,0,0
151446,individuals,0,0
151447,with,0,0
151448,vitamin,0,1
151449,D,0,1
151450,insufficiency,0,1
151451,(,0,1
151452,VDI,0,1
151453,),0,1
151454,.,0,0
151455,DESIGN,0,1
151456,Women,0,0
151457,completed,0,0
151458,the,0,0
151459,Vitamin,1,1
151460,D,1,1
151461,&,1,1
151462,Sun,1,1
151463,(,1,1
151464,VIDSUN,1,1
151465,),1,1
151466,questionnaire,1,0
151467,and,0,0
151468,we,0,0
151469,measured,1,0
151470,their,1,0
151471,serum,1,1
151472,25-hydrocyvitamin,1,1
151473,D,1,1
151474,(,1,1
151475,25,1,0
151476,(,1,1
151477,OH,1,1
151478,),1,1
151479,D,1,1
151480,),1,0
151481,levels,1,0
151482,.,1,0
151483,We,0,0
151484,assessed,0,0
151485,the,0,0
151486,sensitivity,0,0
151487,and,0,0
151488,specificity,0,0
151489,of,0,0
151490,the,0,0
151491,questionnaire,0,0
151492,to,0,0
151493,identify,0,0
151494,VDI,0,1
151495,(,0,1
151496,25,0,0
151497,(,0,1
151498,OH,0,1
151499,),0,1
151500,D,0,0
151501,level,0,0
151502,<,0,0
151503,50,0,0
151504,nmol/l,0,0
151505,),0,0
151506,.,0,0
151507,SETTING,0,0
151508,Clinical,0,0
151509,Research,0,0
151510,Unit,0,0
151511,",",0,0
151512,University,0,0
151513,of,0,0
151514,Wisconsin-Madison,0,0
151515,.,0,0
151516,SUBJECTS,0,0
151517,Postmenopausal,0,0
151518,women,0,0
151519,.,0,0
151520,RESULTS,0,0
151521,We,0,0
151522,recruited,0,0
151523,609,0,0
151524,postmenopausal,0,0
151525,women,0,0
151526,with,0,0
151527,a,0,0
151528,mean,0,0
151529,age,0,0
151530,of,0,0
151531,61,0,0
151532,(,0,0
151533,sd,0,0
151534,6,0,0
151535,years,0,0
151536,),0,0
151537,",",0,0
151538,of,0,0
151539,whom,0,0
151540,113,0,0
151541,(,0,0
151542,19,0,0
151543,%,0,0
151544,),0,0
151545,had,0,0
151546,VDI,0,0
151547,.,0,0
151548,Women,0,0
151549,with,0,0
151550,VDI,0,0
151551,were,0,0
151552,more,0,0
151553,likely,0,0
151554,to,0,0
151555,be,0,0
151556,black,0,1
151557,(,0,0
151558,17,0,0
151559,%,0,0
151560,v.,0,0
151561,2,0,0
151562,%,0,0
151563,",",0,0
151564,P,0,0
151565,<,0,0
151566,0.001,0,0
151567,),0,0
151568,",",0,0
151569,heavier,0,0
151570,(,0,0
151571,BMI,0,0
151572,33.0,0,0
151573,(,0,0
151574,sd,0,0
151575,7,0,0
151576,),0,0
151577,kg/m2,0,0
151578,v.,0,0
151579,29.0,0,0
151580,(,0,0
151581,sd,0,0
151582,7,0,0
151583,),0,0
151584,kg/m2,0,0
151585,",",0,0
151586,P,0,0
151587,<,0,0
151588,0.001,0,0
151589,),0,0
151590,and,0,0
151591,less,0,0
151592,likely,0,0
151593,to,0,0
151594,tan,0,0
151595,in,0,0
151596,the,0,0
151597,past,0,0
151598,year,0,0
151599,(,0,0
151600,49,0,0
151601,%,0,0
151602,v.,0,0
151603,72,0,0
151604,%,0,0
151605,",",0,0
151606,P,0,0
151607,<,0,0
151608,0.001,0,0
151609,),0,0
151610,",",0,0
151611,use,0,1
151612,sunscreen,0,1
151613,(,0,0
151614,57,0,0
151615,%,0,0
151616,v.,0,0
151617,72,0,0
151618,%,0,0
151619,",",0,0
151620,P,0,0
151621,<,0,0
151622,0.001,0,0
151623,),0,0
151624,or,0,0
151625,report,0,0
151626,sun,0,0
151627,exposure,0,0
151628,in,0,0
151629,the,0,0
151630,last,0,0
151631,3,0,0
151632,months,0,0
151633,.,0,0
151634,They,0,0
151635,consumed,0,1
151636,less,0,1
151637,vitamin,0,1
151638,D,0,1
151639,from,0,1
151640,supplements,0,1
151641,(,0,1
151642,2.15,0,0
151643,(,0,0
151644,sd,0,0
151645,5.24,0,0
151646,),0,0
151647,?g/d,0,1
151648,(,0,1
151649,86,0,0
151650,(,0,0
151651,sd,0,0
151652,210,0,0
151653,),0,0
151654,IU/d,0,1
151655,),0,0
151656,v.,0,0
151657,4.55,0,0
151658,(,0,0
151659,sd,0,0
151660,8.48,0,0
151661,),0,0
151662,?g/d,0,1
151663,(,0,1
151664,188,0,0
151665,(,0,0
151666,sd,0,0
151667,344,0,0
151668,),0,0
151669,IU/d,0,0
151670,),0,0
151671,",",0,0
151672,P,0,0
151673,=,0,0
151674,0.003,0,0
151675,),0,0
151676,.,0,0
151677,In,0,0
151678,logistic,0,0
151679,regression,0,0
151680,models,0,0
151681,",",0,0
151682,black,0,0
151683,race,0,0
151684,",",0,0
151685,BMI,0,1
151686,",",0,1
151687,suntan,0,1
151688,within,0,0
151689,the,0,0
151690,past,0,0
151691,year,0,0
151692,",",0,0
151693,sun,0,0
151694,exposure,0,0
151695,in,0,0
151696,the,0,0
151697,past,0,0
151698,3,0,0
151699,months,0,0
151700,",",0,0
151701,sunscreen,0,1
151702,use,0,0
151703,and,0,1
151704,supplemental,0,1
151705,vitamin,0,1
151706,D,0,1
151707,intake,0,1
151708,were,0,0
151709,the,0,0
151710,most,0,0
151711,useful,0,0
151712,questions,0,0
151713,to,0,0
151714,identify,0,0
151715,VDI,0,0
151716,.,0,0
151717,From,0,0
151718,these,0,0
151719,six,0,0
151720,items,0,0
151721,",",0,0
151722,a,0,0
151723,composite,0,0
151724,score,0,0
151725,of,0,0
151726,?,0,0
151727,2.25,0,0
151728,demonstrated,0,0
151729,?89,0,0
151730,%,0,0
151731,sensitivity,0,0
151732,but,0,0
151733,?35,0,0
151734,%,0,0
151735,specificity,0,0
151736,for,0,0
151737,VDI,0,0
151738,.,0,0
151739,CONCLUSIONS,0,0
151740,The,0,0
151741,VIDSUN,0,0
151742,questionnaire,0,0
151743,provides,0,0
151744,an,0,0
151745,initial,0,0
151746,tool,0,0
151747,to,0,0
151748,identify,0,0
151749,postmenopausal,0,0
151750,women,0,0
151751,at,0,0
151752,high,0,0
151753,or,0,0
151754,low,0,0
151755,risk,0,0
151756,of,0,0
151757,VDI,0,0
151758,.,0,0
151759,Existing,0,0
151760,studies,0,0
151761,suggest,0,0
151762,that,0,0
151763,inclusion,0,0
151764,of,0,0
151765,physical,0,0
151766,activity,0,0
151767,and,0,0
151768,TAG,0,0
151769,levels,0,0
151770,might,0,0
151771,improve,0,0
151772,the,0,0
151773,performance,0,0
151774,of,0,0
151775,the,0,0
151776,VIDSUN,0,0
151777,questionnaire,0,0
151778,.,0,0
151779,A,0,1
151780,chinese,0,0
151781,mind-body,0,0
151782,exercise,0,0
151783,improves,0,0
151784,self-control,0,0
151785,of,0,0
151786,children,0,0
151787,with,0,0
151788,autism,0,0
151789,:,0,0
151790,a,0,0
151791,randomized,0,0
151792,controlled,0,0
151793,trial,0,0
151794,.,0,0
151795,Self-control,0,0
151796,problems,0,0
151797,commonly,0,0
151798,manifest,0,0
151799,as,0,0
151800,temper,0,0
151801,outbursts,0,0
151802,and,0,0
151803,repetitive/rigid/impulsive,0,0
151804,behaviors,0,1
151805,",",0,0
151806,in,0,0
151807,children,0,0
151808,with,0,0
151809,autism,0,0
151810,spectrum,0,0
151811,disorders,0,1
151812,(,0,1
151813,ASD,0,1
151814,),0,1
151815,",",0,0
151816,which,0,0
151817,often,0,0
151818,contributes,0,0
151819,to,0,0
151820,learning,0,0
151821,difficulties,0,0
151822,and,0,0
151823,caregiver,0,0
151824,burden,0,0
151825,.,0,0
151826,The,0,0
151827,present,0,0
151828,study,0,0
151829,aims,0,0
151830,to,0,0
151831,compare,0,0
151832,the,0,0
151833,effect,0,0
151834,of,0,0
151835,a,0,0
151836,traditional,1,0
151837,Chinese,1,0
151838,Chan-based,1,0
151839,mind-body,1,0
151840,exercise,1,0
151841,",",1,0
151842,Nei,1,1
151843,Yang,1,1
151844,Gong,1,0
151845,",",0,0
151846,with,0,0
151847,that,0,0
151848,of,0,0
151849,the,0,0
151850,conventional,1,0
151851,Progressive,1,0
151852,Muscle,1,0
151853,Relaxation,1,0
151854,(,1,1
151855,PMR,1,1
151856,),1,1
151857,technique,1,0
151858,in,0,0
151859,enhancing,0,0
151860,the,0,0
151861,self-control,0,0
151862,of,0,0
151863,children,0,0
151864,with,0,0
151865,ASD,0,0
151866,.,0,0
151867,Forty-six,0,0
151868,age-,0,0
151869,and,0,0
151870,IQ-matched,0,0
151871,ASD,0,0
151872,children,0,0
151873,were,0,0
151874,randomly,1,0
151875,assigned,1,0
151876,to,1,0
151877,receive,1,0
151878,group,1,0
151879,training,1,0
151880,in,1,0
151881,Nei,1,1
151882,Yang,1,1
151883,Gong,1,1
151884,(,1,0
151885,experimental,1,0
151886,group,1,0
151887,),1,0
151888,or,1,1
151889,PMR,1,1
151890,(,1,0
151891,control,1,0
151892,group,1,1
151893,),1,1
151894,twice,1,1
151895,per,1,0
151896,week,1,0
151897,for,1,0
151898,four,1,0
151899,weeks,1,0
151900,.,1,0
151901,The,0,0
151902,participants,0,0
151903,',0,0
151904,self-control,0,0
151905,was,0,0
151906,measured,1,0
151907,by,1,0
151908,three,1,0
151909,neuropsychological,1,0
151910,tests,1,0
151911,and,1,0
151912,parental,1,0
151913,rating,1,0
151914,on,1,0
151915,standardized,1,0
151916,questionnaires,1,0
151917,",",1,0
151918,and,1,0
151919,the,1,0
151920,underlying,1,0
151921,neural,1,0
151922,mechanism,1,0
151923,was,1,0
151924,assessed,1,0
151925,by,1,0
151926,the,1,0
151927,participants,1,0
151928,',1,0
151929,brain,1,0
151930,EEG,1,0
151931,activity,1,0
151932,during,1,0
151933,an,1,0
151934,inhibitory-control,1,0
151935,task,1,0
151936,before,1,0
151937,and,1,0
151938,after,1,0
151939,intervention,1,0
151940,.,1,0
151941,The,0,0
151942,results,0,0
151943,show,0,0
151944,that,0,0
151945,the,0,0
151946,experimental,0,0
151947,group,0,0
151948,demonstrated,0,0
151949,significantly,0,0
151950,greater,0,0
151951,improvement,0,0
151952,in,0,0
151953,self-control,0,0
151954,than,0,0
151955,the,0,0
151956,control,0,0
151957,group,0,0
151958,",",0,0
151959,which,0,0
151960,concurs,0,0
151961,with,0,0
151962,the,0,0
151963,parental,0,0
151964,reports,0,0
151965,of,0,0
151966,reduced,0,0
151967,autistic,0,0
151968,symptoms,0,0
151969,and,0,0
151970,increased,0,0
151971,control,0,0
151972,of,0,0
151973,temper,0,0
151974,and,0,0
151975,behaviors,0,0
151976,.,0,0
151977,In,0,0
151978,addition,0,0
151979,",",0,0
151980,the,0,0
151981,experimental,0,0
151982,group,0,0
151983,showed,0,0
151984,enhanced,0,0
151985,EEG,0,0
151986,activity,0,0
151987,in,0,0
151988,the,0,0
151989,anterior,0,0
151990,cingulate,0,0
151991,cortex,0,0
151992,",",0,0
151993,a,0,0
151994,region,0,0
151995,that,0,0
151996,mediates,0,0
151997,self-control,0,0
151998,",",0,0
151999,whereas,0,0
152000,the,0,0
152001,PMR,0,0
152002,group,0,0
152003,did,0,0
152004,not,0,0
152005,.,0,0
152006,The,0,0
152007,present,0,0
152008,findings,0,0
152009,support,0,0
152010,the,0,0
152011,potential,0,0
152012,application,0,0
152013,of,0,0
152014,Chinese,0,0
152015,Chan-based,1,0
152016,mind-body,1,0
152017,exercises,1,0
152018,as,0,0
152019,a,0,0
152020,form,0,0
152021,of,0,0
152022,neuropsychological,0,0
152023,rehabilitation,0,0
152024,for,0,0
152025,patients,0,0
152026,with,0,0
152027,self-control,0,0
152028,problems,0,0
152029,.,0,0
152030,Chinese,0,0
152031,Clinical,0,0
152032,Trial,0,0
152033,Registry,0,1
152034,;,0,1
152035,Registration,0,1
152036,No,0,1
152037,.,0,0
152038,:,0,0
152039,ChiCTR-TRC-12002561,0,0
152040,;,0,0
152041,URL,0,1
152042,:,0,0
152043,www.chictr.org,0,0
152044,.,0,0
152045,Ilioinguinal-iliohypogastric,0,0
152046,nerve,0,0
152047,block,0,0
152048,within,0,0
152049,travenous,0,1
152050,dexketoprofen,1,1
152051,improves,0,1
152052,postoperative,0,1
152053,analgesia,0,1
152054,in,0,0
152055,abdominal,0,1
152056,hysterectomies,0,0
152057,.,0,0
152058,BACKGROUND,0,0
152059,AND,0,1
152060,OBJECTIVE,0,1
152061,In,0,0
152062,this,0,0
152063,study,0,0
152064,",",0,0
152065,our,0,0
152066,aim,0,0
152067,was,0,0
152068,to,0,0
152069,evaluate,0,0
152070,the,0,0
152071,effects,0,0
152072,of,0,0
152073,intravenous,0,1
152074,dexketoprofen,1,1
152075,trometamol,1,1
152076,with,0,1
152077,ilioinguinal,0,0
152078,and,0,0
152079,iliohypogastric,0,0
152080,nerve,0,0
152081,block,0,0
152082,on,0,0
152083,analgesic,0,1
152084,quality,0,1
152085,and,0,1
152086,morphine,0,1
152087,consumption,0,1
152088,after,0,0
152089,total,0,0
152090,abdominal,0,0
152091,hysterectomy,0,0
152092,operations,0,0
152093,.,0,0
152094,METHODS,0,0
152095,We,0,0
152096,conducted,0,0
152097,this,0,0
152098,randomized,0,0
152099,controlled,0,0
152100,clinical,0,0
152101,study,0,0
152102,on,0,0
152103,61,0,0
152104,patients,0,0
152105,.,0,0
152106,The,0,0
152107,study,0,0
152108,was,0,0
152109,conducted,0,0
152110,in,0,0
152111,the,0,0
152112,operation,0,0
152113,room,0,0
152114,",",0,0
152115,post-anesthesia,0,0
152116,care,0,0
152117,unit,0,0
152118,",",0,0
152119,and,0,0
152120,inpatient,0,0
152121,clinic,0,0
152122,.,0,0
152123,We,0,0
152124,randomly,0,0
152125,grouped,0,0
152126,the,0,0
152127,61,0,0
152128,patients,0,0
152129,into,0,0
152130,control,1,0
152131,group,1,0
152132,(,0,0
152133,group,0,1
152134,C,0,1
152135,),0,1
152136,",",0,0
152137,block,1,0
152138,group,1,0
152139,(,0,0
152140,group,0,1
152141,B,0,1
152142,),0,1
152143,and,0,1
152144,dexketoprofen-block,1,1
152145,group,1,1
152146,(,0,1
152147,group,0,1
152148,DB,0,1
152149,),0,0
152150,.,0,0
152151,Before,0,0
152152,the,0,0
152153,skin,0,0
152154,incision,0,0
152155,performed,0,0
152156,after,0,0
152157,anesthesia,0,0
152158,induction,0,0
152159,",",0,0
152160,we,0,0
152161,performed,0,0
152162,ilioinguinal,1,0
152163,iliohypogastric,1,0
152164,block,1,0
152165,(,0,0
152166,group,0,0
152167,C,0,1
152168,given,0,1
152169,saline,1,1
152170,and,0,0
152171,group,0,0
152172,P,0,0
152173,and,0,0
152174,DB,1,0
152175,given,0,1
152176,levobupivacaine,1,1
152177,),1,1
152178,.,0,0
152179,In,0,0
152180,contrast,0,0
152181,to,0,0
152182,group,0,0
152183,C,0,0
152184,and,0,0
152185,B,0,1
152186,",",0,0
152187,group,0,0
152188,DB,0,0
152189,was,0,0
152190,given,0,0
152191,dexketoprofen,1,1
152192,.,1,1
152193,We,0,1
152194,administered,0,1
152195,morphine,1,1
152196,analgesia,1,1
152197,to,0,0
152198,all,0,0
152199,patients,0,0
152200,by,0,0
152201,patient-controlled,0,1
152202,analgesia,0,1
152203,(,0,1
152204,PCA,0,1
152205,),0,0
152206,during,0,0
152207,the,0,0
152208,postoperative,0,0
152209,24,0,0
152210,hours,0,0
152211,.,0,0
152212,We,0,0
152213,recorded,0,0
152214,Visual,0,0
152215,Analogue,0,1
152216,Scale,0,1
152217,(,0,1
152218,VAS,0,1
152219,),0,1
152220,",",0,0
152221,satisfaction,0,1
152222,scores,0,1
152223,",",0,1
152224,morphine,0,1
152225,consumption,0,1
152226,and,0,0
152227,side,0,0
152228,effects,0,0
152229,during,0,0
152230,postoperative,0,0
152231,24,0,0
152232,hours,0,0
152233,.,0,0
152234,RESULTS,0,1
152235,We,0,0
152236,found,0,0
152237,the,0,0
152238,DB,0,0
152239,group?s,0,0
152240,VAS,0,0
152241,scores,0,0
152242,to,0,0
152243,be,0,0
152244,lower,0,0
152245,than,0,0
152246,the,0,0
152247,control,0,0
152248,group,0,0
152249,and,0,0
152250,block,0,0
152251,group?s,0,0
152252,(,0,0
152253,p,0,0
152254,<,0,0
152255,0.05,0,0
152256,),0,0
152257,values,0,0
152258,at,0,0
152259,postoperative,0,0
152260,1st,0,0
152261,",",0,0
152262,2nd,0,0
152263,",",0,0
152264,6th,0,0
152265,and,0,0
152266,12th,0,0
152267,hours,0,0
152268,.,0,0
152269,VAS,0,1
152270,scores,0,0
152271,of,0,0
152272,group,0,0
152273,C,0,0
152274,were,0,0
152275,higher,0,0
152276,than,0,0
152277,of,0,0
152278,group,0,0
152279,B,0,0
152280,at,0,0
152281,postoperative,0,0
152282,fi,0,1
152283,rst,0,1
152284,2,0,1
152285,hours,0,0
152286,.,0,0
152287,Time,0,0
152288,to,0,0
152289,fi,0,0
152290,rst,0,1
152291,PCA,0,1
152292,demand,0,0
152293,was,0,0
152294,longer,0,0
152295,",",0,0
152296,morphine,0,1
152297,consumption,0,1
152298,values,0,0
152299,were,0,0
152300,lower,0,0
152301,and,0,0
152302,satisfaction,0,0
152303,scores,0,0
152304,were,0,0
152305,higher,0,0
152306,in,0,0
152307,group,0,0
152308,DB,0,0
152309,than,0,0
152310,in,0,0
152311,the,0,0
152312,other,0,0
152313,two,0,0
152314,groups,0,0
152315,(,0,0
152316,p,0,0
152317,<,0,0
152318,0.05,0,0
152319,),0,0
152320,.,0,0
152321,CONCLUSIONS,0,1
152322,Ilioinguinal-iliohypogastric,0,0
152323,nerve,0,0
152324,block,0,0
152325,with,0,0
152326,IV,1,1
152327,dexketoprofen,1,1
152328,increases,1,0
152329,patient,0,1
152330,satisfaction,0,0
152331,by,0,0
152332,decreasing,0,0
152333,opioid,0,1
152334,consumption,0,1
152335,",",0,0
152336,increasing,0,0
152337,patient,0,0
152338,satisfaction,0,0
152339,",",0,0
152340,which,0,0
152341,suggests,0,0
152342,that,0,0
152343,dexketoprofen,0,1
152344,trometamol,0,1
152345,is,0,0
152346,an,0,0
152347,effective,0,0
152348,non-steroidal,0,1
152349,anti-inflammatory,0,1
152350,analgesic,0,1
152351,in,0,1
152352,postoperative,0,1
152353,analgesia,0,1
152354,.,0,0
152355,Impact,0,0
152356,of,0,0
152357,a,0,0
152358,leptin,0,1
152359,single,0,0
152360,nucleotide,0,0
152361,polymorphism,0,0
152362,and,0,1
152363,zilpaterol,1,1
152364,hydrochloride,1,1
152365,on,0,0
152366,growth,0,0
152367,and,0,0
152368,carcass,0,0
152369,characteristics,0,0
152370,in,0,0
152371,finishing,0,0
152372,steers,0,0
152373,.,0,0
152374,A,0,0
152375,total,0,0
152376,of,0,0
152377,"4,178",0,0
152378,steers,0,0
152379,(,0,0
152380,mean,0,0
152381,initial,0,0
152382,BW,0,0
152383,=,0,0
152384,403.9,0,0
152385,?,0,0
152386,16.04,0,0
152387,kg,0,0
152388,),0,0
152389,were,0,0
152390,used,0,0
152391,to,0,0
152392,test,0,0
152393,the,0,0
152394,interactive,0,0
152395,effects,0,0
152396,",",0,0
152397,if,0,0
152398,any,0,0
152399,",",0,0
152400,of,1,0
152401,leptin,1,1
152402,R25C,1,1
152403,genotypes,1,1
152404,(,0,0
152405,CC,0,1
152406,",",0,0
152407,CT,0,0
152408,",",0,0
152409,or,0,0
152410,TT,0,1
152411,),0,1
152412,and,1,1
152413,zilpaterol,1,1
152414,hydrochloride,1,1
152415,(,1,1
152416,ZH,1,1
152417,),1,1
152418,feeding,0,0
152419,duration,0,0
152420,on,0,0
152421,growth,0,0
152422,performance,0,0
152423,and,0,0
152424,carcass,0,0
152425,traits,0,0
152426,.,0,0
152427,Steers,0,0
152428,were,0,0
152429,blocked,0,0
152430,by,0,0
152431,arrival,0,0
152432,at,0,0
152433,the,0,0
152434,feed,0,0
152435,yard,0,0
152436,",",0,0
152437,genotyped,0,0
152438,for,0,0
152439,the,0,0
152440,leptin,0,1
152441,SNP,0,1
152442,",",0,0
152443,allotted,0,0
152444,to,0,0
152445,genotype-specific,0,0
152446,pens,0,1
152447,(,0,1
152448,90,0,1
152449,steers/pen,0,1
152450,),0,1
152451,",",0,0
152452,and,0,0
152453,assigned,0,0
152454,randomly,0,0
152455,within,0,0
152456,genotype,0,0
152457,and,0,0
152458,block,0,0
152459,to,0,0
152460,0,0,0
152461,or,0,0
152462,21,0,0
152463,d,0,0
152464,of,0,0
152465,dietary,0,1
152466,ZH,0,1
152467,.,0,1
152468,All,0,0
152469,pens,0,0
152470,within,0,0
152471,a,0,0
152472,block,0,0
152473,were,0,0
152474,slaughtered,0,0
152475,on,0,0
152476,the,0,0
152477,same,0,0
152478,day,0,0
152479,(,0,0
152480,132.1,0,0
152481,?,0,0
152482,10.9,0,0
152483,d,0,0
152484,on,0,0
152485,feed,0,1
152486,),0,0
152487,.,0,0
152488,Final,0,0
152489,BW,0,0
152490,of,0,0
152491,steers,0,0
152492,fed,0,0
152493,ZH,0,0
152494,was,0,0
152495,6.0,0,0
152496,kg,0,0
152497,heavier,0,0
152498,(,0,0
152499,P,0,0
152500,=,0,0
152501,0.008,0,0
152502,),0,0
152503,",",0,0
152504,and,0,1
152505,ZH-fed,0,0
152506,steers,0,0
152507,had,0,0
152508,greater,0,0
152509,(,0,0
152510,P,0,0
152511,=,0,0
152512,0.003,0,0
152513,),0,0
152514,ADG,0,0
152515,than,0,1
152516,steers,0,0
152517,not,0,0
152518,fed,0,0
152519,ZH,0,0
152520,.,0,0
152521,Feeding,0,0
152522,ZH,0,0
152523,decreased,0,0
152524,DMI,0,0
152525,in,0,0
152526,steers,0,0
152527,with,0,0
152528,increased,0,0
152529,frequency,0,0
152530,of,0,0
152531,the,0,0
152532,T,0,1
152533,allele,0,0
152534,(,0,0
152535,9.67,0,0
152536,",",0,0
152537,9.53,0,0
152538,",",0,0
152539,and,0,0
152540,9.28,0,0
152541,kg/d,0,0
152542,for,0,0
152543,CC,0,1
152544,",",0,0
152545,CT,0,0
152546,",",0,0
152547,and,0,0
152548,TT,0,0
152549,",",0,0
152550,respectively,0,0
152551,),0,0
152552,",",0,0
152553,but,0,0
152554,DMI,0,0
152555,increased,0,0
152556,with,0,0
152557,the,0,0
152558,frequency,0,0
152559,of,0,0
152560,the,0,0
152561,T,0,1
152562,allele,0,0
152563,(,0,0
152564,9.68,0,0
152565,",",0,0
152566,9.90,0,0
152567,",",0,0
152568,and,0,0
152569,10.1,0,0
152570,kg,0,0
152571,for,0,0
152572,CC,0,0
152573,",",0,0
152574,CT,0,0
152575,",",0,0
152576,and,0,0
152577,TT,0,0
152578,",",0,0
152579,respectively,0,0
152580,),0,0
152581,when,0,0
152582,ZH,0,0
152583,was,0,0
152584,not,0,0
152585,fed,0,0
152586,(,0,0
152587,leptin,0,1
152588,genotype,0,1
152589,?,0,1
152590,ZH,0,0
152591,",",0,0
152592,P,0,0
152593,=,0,0
152594,0.011,0,0
152595,),0,0
152596,.,0,0
152597,At,0,0
152598,the,0,0
152599,conclusion,0,0
152600,of,0,0
152601,the,0,0
152602,study,0,0
152603,",",0,0
152604,ultrasonic,0,0
152605,fat,0,0
152606,was,0,0
152607,greatest,0,0
152608,for,0,0
152609,TT,0,1
152610,steers,0,0
152611,(,0,0
152612,11.4,0,0
152613,?,0,0
152614,0.28,0,0
152615,mm,0,0
152616,),0,0
152617,and,0,0
152618,least,0,0
152619,(,0,0
152620,P,0,0
152621,=,0,0
152622,0.003,0,0
152623,),0,0
152624,for,0,0
152625,CC,0,1
152626,steers,0,0
152627,(,0,0
152628,11.0,0,0
152629,?,0,0
152630,0.25,0,0
152631,mm,0,0
152632,),0,0
152633,.,0,0
152634,Regardless,0,0
152635,of,0,0
152636,ZH-feeding,0,1
152637,duration,0,0
152638,",",0,0
152639,TT,0,1
152640,steers,0,0
152641,produced,0,0
152642,a,0,0
152643,greater,0,0
152644,(,0,0
152645,P,0,0
152646,=,0,0
152647,0.006,0,0
152648,),0,0
152649,percentage,0,0
152650,of,0,0
152651,USDA,0,0
152652,yield,0,0
152653,grade,0,1
152654,(,0,1
152655,YG,0,1
152656,),0,1
152657,4,0,0
152658,or,0,0
152659,higher,0,0
152660,carcasses,0,0
152661,(,0,0
152662,5.4,0,0
152663,vs.,0,0
152664,2.7,0,0
152665,%,0,0
152666,),0,0
152667,and,0,0
152668,a,0,0
152669,lesser,0,0
152670,(,0,0
152671,P,0,0
152672,=,0,0
152673,0.006,0,0
152674,),0,0
152675,percentage,0,0
152676,of,0,0
152677,YG,0,0
152678,1,0,1
152679,carcasses,0,0
152680,(,0,0
152681,17.7,0,0
152682,vs.,0,0
152683,26.8,0,0
152684,%,0,0
152685,),0,0
152686,than,0,0
152687,CC,0,1
152688,steers,0,0
152689,.,0,0
152690,In,0,0
152691,addition,0,0
152692,",",0,0
152693,ZH-fed,0,0
152694,steers,0,0
152695,produced,0,0
152696,a,0,0
152697,greater,0,0
152698,(,0,0
152699,P,0,0
152700,<,0,0
152701,0.001,0,0
152702,),0,0
152703,percentage,0,0
152704,of,0,0
152705,USDA,0,0
152706,YG,0,1
152707,1,0,1
152708,carcasses,0,0
152709,(,0,0
152710,25.9,0,0
152711,vs.,0,0
152712,16.2,0,0
152713,%,0,0
152714,),0,0
152715,and,0,0
152716,a,0,0
152717,lesser,0,0
152718,(,0,0
152719,P,0,0
152720,<,0,0
152721,0.001,0,0
152722,),0,0
152723,percentage,0,0
152724,of,0,0
152725,YG,0,0
152726,4,0,0
152727,or,0,0
152728,higher,0,0
152729,carcasses,0,1
152730,(,0,0
152731,1.6,0,0
152732,vs.,0,0
152733,6.0,0,0
152734,%,0,0
152735,),0,0
152736,than,0,0
152737,steers,0,0
152738,fed,0,0
152739,the,0,0
152740,control,0,0
152741,diet,0,1
152742,.,0,1
152743,Marbling,0,1
152744,scores,0,0
152745,and,0,0
152746,the,0,0
152747,percentage,0,0
152748,of,0,0
152749,carcasses,0,0
152750,grading,0,0
152751,USDA,0,1
152752,Choice,0,1
152753,and,0,0
152754,Prime,0,0
152755,were,0,0
152756,greater,0,0
152757,in,0,0
152758,TT,0,0
152759,than,0,0
152760,CC,0,1
152761,steers,0,0
152762,when,0,0
152763,fed,0,1
152764,diets,0,1
152765,devoid,0,0
152766,of,0,0
152767,ZH,0,0
152768,",",0,0
152769,but,0,0
152770,both,0,0
152771,marbling,0,0
152772,and,0,0
152773,quality,0,0
152774,grades,0,0
152775,did,0,0
152776,not,0,0
152777,differ,0,0
152778,among,0,0
152779,leptin,0,1
152780,genotypes,0,0
152781,when,0,0
152782,fed,0,0
152783,ZH,0,0
152784,for,0,0
152785,21,0,0
152786,d,0,1
152787,(,0,1
152788,leptin,0,1
152789,genotype,0,1
152790,?,0,1
152791,ZH,0,0
152792,",",0,0
152793,P,0,0
152794,?,0,0
152795,0.03,0,0
152796,),0,0
152797,.,0,0
152798,The,0,0
152799,amount,0,0
152800,of,0,0
152801,HCW,0,0
152802,gain,0,0
152803,tended,0,0
152804,to,0,0
152805,be,0,0
152806,less,0,0
152807,(,0,0
152808,P,0,0
152809,=,0,0
152810,0.095,0,0
152811,),0,0
152812,for,0,0
152813,steers,0,0
152814,of,0,0
152815,the,0,0
152816,TT,0,1
152817,genotype,0,0
152818,(,0,0
152819,12.7,0,0
152820,kg,0,0
152821,),0,0
152822,than,0,0
152823,either,0,0
152824,CC,0,1
152825,(,0,0
152826,16.3,0,0
152827,kg,0,0
152828,),0,0
152829,or,0,0
152830,CT,0,0
152831,(,0,0
152832,17.0,0,0
152833,kg,0,0
152834,),0,0
152835,genotypes,0,0
152836,.,0,0
152837,Results,0,0
152838,indicated,0,0
152839,that,0,0
152840,leptin,0,1
152841,R25C,0,1
152842,genotype,0,0
152843,impacted,0,0
152844,most,0,0
152845,traits,0,0
152846,associated,0,0
152847,with,0,0
152848,fatness,0,0
152849,whereas,0,0
152850,feeding,0,0
152851,ZH,0,0
152852,for,0,0
152853,21,0,0
152854,d,0,0
152855,affected,0,0
152856,HCW,0,1
152857,and,0,0
152858,ADG,0,0
152859,positively,0,0
152860,but,0,0
152861,impacted,0,0
152862,feed,0,1
152863,intake,0,1
152864,",",0,1
152865,marbling,0,1
152866,",",0,0
152867,and,0,0
152868,USDA,0,1
152869,quality,0,1
152870,grades,0,0
152871,negatively,0,0
152872,.,0,0
152873,Infant,0,0
152874,distress,0,0
152875,and,0,0
152876,development,0,0
152877,of,0,0
152878,functional,0,0
152879,gastrointestinal,0,0
152880,disorders,0,0
152881,in,0,0
152882,childhood,0,0
152883,:,0,0
152884,is,0,0
152885,there,0,0
152886,a,0,0
152887,connection,0,0
152888,?,0,0
152889,Assessment,0,0
152890,of,0,0
152891,global,0,0
152892,functioning,0,0
152893,in,0,0
152894,adolescents,0,0
152895,with,0,0
152896,autism,0,0
152897,spectrum,0,0
152898,disorders,0,0
152899,:,0,0
152900,utility,0,0
152901,of,0,0
152902,the,0,0
152903,Developmental,1,0
152904,Disability-Child,1,0
152905,Global,1,0
152906,Assessment,1,0
152907,Scale,1,0
152908,.,1,0
152909,Assessment,0,0
152910,of,0,0
152911,global,0,0
152912,functioning,0,0
152913,is,0,0
152914,an,0,0
152915,important,0,0
152916,consideration,0,0
152917,in,0,0
152918,treatment,0,0
152919,outcome,0,1
152920,research,0,1
152921,;,0,0
152922,yet,0,0
152923,",",0,0
152924,there,0,0
152925,is,0,0
152926,little,0,0
152927,guidance,0,0
152928,on,0,0
152929,its,0,0
152930,evidence-based,0,0
152931,assessment,0,0
152932,for,0,0
152933,children,0,0
152934,with,0,0
152935,autism,0,0
152936,spectrum,0,0
152937,disorders,0,0
152938,.,0,0
152939,This,0,0
152940,study,0,0
152941,investigated,0,0
152942,the,0,0
152943,utility,0,0
152944,and,0,0
152945,validity,0,0
152946,of,0,0
152947,clinician-rated,0,0
152948,global,0,0
152949,functioning,0,0
152950,using,0,0
152951,the,0,0
152952,Developmental,1,0
152953,Disability-Child,1,0
152954,Global,1,0
152955,Assessment,1,0
152956,Scale,1,0
152957,in,0,0
152958,a,0,0
152959,sample,0,0
152960,of,0,0
152961,higher,0,0
152962,functioning,0,0
152963,adolescents,0,0
152964,with,0,0
152965,autism,0,0
152966,spectrum,0,0
152967,disorders,0,0
152968,and,0,0
152969,comorbid,0,0
152970,anxiety,0,1
152971,disorders,0,0
152972,enrolled,0,0
152973,in,0,0
152974,a,0,0
152975,randomized,0,0
152976,controlled,1,0
152977,trial,0,1
152978,(,0,0
152979,n,0,0
152980,=,0,0
152981,30,0,0
152982,),0,0
152983,.,0,0
152984,Pretreatment,0,0
152985,Developmental,1,0
152986,Disability-Child,1,0
152987,Global,1,0
152988,Assessment,1,0
152989,Scale,1,0
152990,scores,0,0
152991,correlated,0,0
152992,with,0,0
152993,severity,0,0
152994,of,0,0
152995,autism,0,0
152996,spectrum,0,0
152997,disorders,0,0
152998,core,0,0
152999,symptoms,0,1
153000,(,0,0
153001,r,0,0
153002,=,0,0
153003,-.388,0,0
153004,",",0,0
153005,p,0,0
153006,=,0,0
153007,.034,0,0
153008,),0,0
153009,",",0,0
153010,pragmatic,0,1
153011,communication,0,1
153012,(,0,0
153013,r,0,0
153014,=,0,0
153015,.407,0,0
153016,",",0,0
153017,p,0,0
153018,=,0,0
153019,.032,0,0
153020,),0,0
153021,",",0,0
153022,and,0,0
153023,verbal,0,0
153024,ability,0,1
153025,(,0,0
153026,r,0,0
153027,=,0,0
153028,.449,0,0
153029,",",0,0
153030,p,0,0
153031,=,0,0
153032,.013,0,0
153033,),0,0
153034,and,0,0
153035,did,0,0
153036,not,0,0
153037,correlate,0,0
153038,with,0,0
153039,severity,0,0
153040,of,0,0
153041,anxiety,0,0
153042,symptoms,0,0
153043,or,0,0
153044,with,0,0
153045,parent-reported,0,0
153046,adaptive,0,0
153047,behavior,0,0
153048,.,0,0
153049,Change,0,0
153050,in,0,0
153051,Developmental,1,0
153052,Disability-Child,1,0
153053,Global,1,0
153054,Assessment,1,0
153055,Scale,1,0
153056,scores,0,0
153057,during,0,0
153058,treatment,0,0
153059,was,0,0
153060,associated,0,0
153061,with,0,0
153062,autism,0,0
153063,spectrum,0,0
153064,disorders,0,0
153065,symptomatic,0,1
153066,improvement,0,1
153067,(,0,0
153068,r,0,0
153069,=,0,0
153070,.414,0,0
153071,",",0,0
153072,p,0,0
153073,=,0,0
153074,.040,0,0
153075,),0,0
153076,and,0,0
153077,with,0,0
153078,improved,0,0
153079,general,0,0
153080,communication,0,1
153081,(,0,0
153082,r,0,0
153083,=,0,0
153084,.499,0,0
153085,",",0,0
153086,p,0,0
153087,=,0,0
153088,.013,0,0
153089,),0,0
153090,.,0,0
153091,Results,0,0
153092,support,0,0
153093,the,0,0
153094,importance,0,0
153095,of,0,0
153096,assessing,0,0
153097,global,0,0
153098,functioning,0,0
153099,in,0,0
153100,addition,0,0
153101,to,0,0
153102,symptom,0,0
153103,change,0,0
153104,and,0,0
153105,treatment,0,0
153106,response,0,0
153107,in,0,0
153108,clinical,0,0
153109,trials,0,0
153110,.,0,0
153111,Intravesical,1,0
153112,seeding,1,0
153113,of,1,0
153114,upper,1,0
153115,urinary,1,0
153116,tract,1,1
153117,urothelial,1,0
153118,carcinoma,1,0
153119,cells,1,0
153120,during,0,0
153121,nephroureterectomy,1,0
153122,:,1,0
153123,an,0,0
153124,exploratory,0,0
153125,analysis,0,0
153126,from,0,0
153127,the,0,0
153128,THPMG,0,0
153129,trial,0,0
153130,.,0,0
153131,OBJECTIVE,0,0
153132,The,0,0
153133,Pirarubicin,0,1
153134,Monotherapy,0,1
153135,Study,0,1
153136,Group,0,0
153137,trial,0,0
153138,was,0,0
153139,a,0,0
153140,randomized,0,0
153141,Phase,0,0
153142,II,0,0
153143,study,0,0
153144,that,0,0
153145,evaluated,0,0
153146,the,0,0
153147,efficacy,0,0
153148,of,0,0
153149,intravesical,0,1
153150,instillation,0,1
153151,of,0,1
153152,pirarubicin,1,1
153153,in,0,0
153154,the,0,0
153155,prevention,0,0
153156,of,0,0
153157,bladder,0,0
153158,recurrence,0,0
153159,after,0,0
153160,nephroureterectomy,0,0
153161,for,0,0
153162,upper,0,0
153163,urinary,0,0
153164,tract,0,1
153165,urothelial,0,0
153166,carcinoma,0,0
153167,.,0,0
153168,This,0,0
153169,study,0,0
153170,conducted,0,0
153171,further,0,0
153172,analysis,0,0
153173,of,0,0
153174,the,0,0
153175,Pirarubicin,0,1
153176,Monotherapy,0,1
153177,Study,0,1
153178,Group,0,0
153179,cohort,0,0
153180,",",0,0
153181,focusing,0,0
153182,on,0,0
153183,intravesical,1,1
153184,seeding,1,0
153185,of,1,0
153186,cancer,1,0
153187,cells,1,0
153188,.,1,0
153189,METHODS,0,0
153190,Using,0,0
153191,the,0,0
153192,data,0,0
153193,from,0,0
153194,the,0,0
153195,Pirarubicin,0,1
153196,Monotherapy,0,1
153197,Study,0,1
153198,Group,0,0
153199,trial,0,0
153200,",",0,0
153201,bladder,0,0
153202,recurrence-free,0,0
153203,survival,0,0
153204,rates,0,0
153205,and,0,0
153206,factors,0,0
153207,associated,0,0
153208,with,0,0
153209,bladder,0,0
153210,recurrence,0,0
153211,in,0,0
153212,the,0,0
153213,control,0,0
153214,group,0,0
153215,were,0,0
153216,analyzed,0,0
153217,.,0,0
153218,RESULTS,0,0
153219,Of,0,0
153220,36,0,0
153221,patients,0,0
153222,in,0,0
153223,the,0,0
153224,control,1,0
153225,group,0,0
153226,",",0,0
153227,14,0,0
153228,with,0,0
153229,positive,0,0
153230,urine,0,1
153231,cytology,0,1
153232,had,0,0
153233,more,0,0
153234,frequent,0,0
153235,recurrence,0,0
153236,when,0,0
153237,compared,0,0
153238,with,0,0
153239,the,0,0
153240,22,0,0
153241,patients,0,0
153242,with,0,0
153243,negative,0,0
153244,cytology,0,0
153245,(,0,0
153246,P,0,0
153247,=,0,0
153248,0.004,0,0
153249,),0,0
153250,.,0,0
153251,Based,0,0
153252,on,0,0
153253,the,0,0
153254,multivariate,0,0
153255,analysis,0,0
153256,in,0,0
153257,the,0,0
153258,control,0,0
153259,group,0,0
153260,",",0,0
153261,voided,0,1
153262,urine,0,1
153263,cytology,0,1
153264,was,0,0
153265,an,0,0
153266,independent,0,0
153267,predictive,0,0
153268,factor,0,0
153269,of,0,0
153270,bladder,0,0
153271,recurrence,0,1
153272,(,0,1
153273,hazard,0,1
153274,ratio,0,0
153275,",",0,0
153276,5.54,0,0
153277,;,0,0
153278,95,0,0
153279,%,0,0
153280,confidence,0,0
153281,interval,0,0
153282,1.12-27.5,0,0
153283,;,0,0
153284,P,0,0
153285,=,0,0
153286,0.036,0,0
153287,),0,0
153288,.,0,0
153289,Of,0,0
153290,72,0,0
153291,patients,0,0
153292,in,0,0
153293,the,0,0
153294,Pirarubicin,0,1
153295,Monotherapy,0,1
153296,Study,0,1
153297,Group,0,0
153298,trial,0,0
153299,",",0,0
153300,31,0,0
153301,had,0,0
153302,positive,0,0
153303,urine,0,1
153304,cytology,0,1
153305,.,0,0
153306,Among,0,0
153307,the,0,0
153308,31,0,0
153309,patients,0,0
153310,",",0,0
153311,17,0,0
153312,patients,0,0
153313,who,0,0
153314,received,0,1
153315,pirarubicin,1,1
153316,instillation,1,1
153317,had,0,0
153318,fewer,0,0
153319,recurrences,0,0
153320,when,0,0
153321,compared,0,0
153322,with,0,0
153323,14,0,0
153324,patients,0,0
153325,who,0,0
153326,received,0,0
153327,control,1,0
153328,treatment,0,0
153329,(,0,0
153330,P,0,0
153331,=,0,0
153332,0.0001,0,0
153333,),0,0
153334,.,0,0
153335,On,0,0
153336,multivariate,0,0
153337,analysis,0,0
153338,",",0,1
153339,pirarubicin,1,1
153340,instillation,1,1
153341,was,0,0
153342,an,0,0
153343,independent,0,0
153344,predictor,0,0
153345,of,0,0
153346,better,0,0
153347,recurrence-free,0,0
153348,survival,0,0
153349,rates,0,0
153350,in,0,0
153351,the,0,0
153352,patients,0,0
153353,with,0,0
153354,positive,0,0
153355,urine,0,1
153356,cytology,0,1
153357,(,0,1
153358,hazard,0,1
153359,ratio,0,0
153360,",",0,0
153361,0.02,0,0
153362,;,0,0
153363,95,0,0
153364,%,0,0
153365,confidence,0,0
153366,interval,0,0
153367,",",0,0
153368,0.00-0.53,0,0
153369,;,0,0
153370,P,0,0
153371,=,0,0
153372,0.018,0,0
153373,),0,0
153374,.,0,0
153375,Of,0,0
153376,21,0,0
153377,patients,0,0
153378,with,0,0
153379,bladder,0,0
153380,recurrence,0,0
153381,",",0,0
153382,17,0,0
153383,had,0,0
153384,recurrent,0,0
153385,tumor,0,0
153386,around,0,0
153387,cystotomy,0,0
153388,or,0,0
153389,in,0,0
153390,the,0,0
153391,bladder,0,0
153392,neck,0,0
153393,compromised,0,0
153394,by,0,0
153395,the,0,0
153396,urethral,0,0
153397,catheter,0,0
153398,",",0,0
153399,supporting,0,0
153400,the,0,0
153401,notion,0,0
153402,that,0,0
153403,tumor,0,0
153404,cells,0,0
153405,seeded,0,0
153406,in,0,0
153407,the,0,0
153408,injured,0,0
153409,urothelium,0,0
153410,.,0,0
153411,CONCLUSIONS,0,1
153412,Intravesical,1,1
153413,instillation,1,1
153414,of,1,1
153415,pirarubicin,1,1
153416,immediately,0,0
153417,after,0,0
153418,nephroureterectomy,1,0
153419,significantly,0,0
153420,reduced,0,0
153421,the,0,0
153422,bladder,0,0
153423,recurrence,0,0
153424,rate,0,0
153425,in,0,0
153426,patients,0,0
153427,with,0,0
153428,positive,0,0
153429,voided,0,1
153430,urine,0,1
153431,cytology,0,1
153432,.,0,0
153433,The,0,0
153434,results,0,0
153435,suggest,0,0
153436,that,0,0
153437,intravesical,0,1
153438,seeding,0,0
153439,of,0,0
153440,upper,0,0
153441,urinary,0,0
153442,tract,0,1
153443,urothelial,0,0
153444,carcinoma,0,0
153445,occurs,0,0
153446,during,0,0
153447,nephroureterectomy,0,0
153448,.,0,0
153449,Network,0,0
153450,coordination,0,0
153451,following,0,0
153452,discharge,0,0
153453,from,0,0
153454,psychiatric,1,0
153455,inpatient,1,0
153456,treatment,1,0
153457,:,1,0
153458,a,0,0
153459,study,0,0
153460,protocol,0,0
153461,.,0,0
153462,BACKGROUND,0,0
153463,Inadequate,0,0
153464,discharge,0,0
153465,planning,0,0
153466,following,0,0
153467,inpatient,0,0
153468,stays,0,0
153469,is,0,0
153470,a,0,0
153471,major,0,0
153472,issue,0,0
153473,in,0,0
153474,the,0,0
153475,provision,0,0
153476,of,0,0
153477,a,0,0
153478,high,0,0
153479,standard,0,0
153480,of,0,0
153481,care,0,0
153482,for,0,0
153483,patients,0,0
153484,who,0,0
153485,receive,0,0
153486,psychiatric,1,0
153487,treatment,1,0
153488,.,1,0
153489,Studies,0,0
153490,have,0,0
153491,shown,0,0
153492,that,0,0
153493,half,0,0
153494,of,0,0
153495,patients,0,0
153496,who,0,0
153497,had,0,0
153498,no,0,0
153499,pre-discharge,0,0
153500,contact,0,0
153501,with,0,0
153502,outpatient,0,0
153503,services,0,0
153504,do,0,0
153505,not,0,0
153506,keep,0,0
153507,their,0,0
153508,first,0,0
153509,outpatient,0,0
153510,appointment,0,0
153511,.,0,0
153512,Additionally,0,0
153513,",",0,0
153514,discharged,0,0
153515,patients,0,0
153516,who,0,0
153517,are,0,0
153518,not,0,0
153519,well,0,0
153520,linked,0,0
153521,to,0,0
153522,their,0,0
153523,outpatient,0,0
153524,care,0,0
153525,networks,0,0
153526,are,0,0
153527,at,0,0
153528,twice,0,0
153529,the,0,0
153530,risk,0,0
153531,of,0,0
153532,re-hospitalization,0,0
153533,.,0,0
153534,The,0,0
153535,aim,0,0
153536,of,0,0
153537,this,0,0
153538,study,0,0
153539,is,0,0
153540,to,0,0
153541,investigate,0,0
153542,if,0,0
153543,the,0,0
153544,Post-Discharge,0,0
153545,Network,0,0
153546,Coordination,0,0
153547,Program,0,0
153548,at,0,0
153549,ipw,0,0
153550,has,0,0
153551,a,0,0
153552,demonstrably,0,0
153553,significant,0,0
153554,impact,0,0
153555,on,0,0
153556,the,0,0
153557,frequency,0,0
153558,and,0,0
153559,duration,0,0
153560,of,0,0
153561,patient,0,0
153562,re-hospitalization,0,0
153563,.,0,0
153564,Subjects,0,0
153565,are,0,0
153566,randomly,0,0
153567,assigned,0,0
153568,to,0,0
153569,either,0,0
153570,the,0,0
153571,treatment,0,0
153572,group,0,0
153573,or,0,0
153574,to,0,0
153575,the,0,0
153576,control,0,0
153577,group,0,0
153578,.,0,0
153579,The,0,0
153580,treatment,0,0
153581,group,0,0
153582,participates,0,0
153583,in,0,0
153584,the,0,0
153585,Post-Discharge,1,0
153586,Network,1,0
153587,Coordination,1,0
153588,Program,1,0
153589,.,1,0
153590,The,0,0
153591,control,0,0
153592,group,0,0
153593,receives,0,0
153594,treatment,1,0
153595,as,1,0
153596,usual,1,0
153597,with,0,0
153598,no,0,0
153599,additional,0,0
153600,social,0,0
153601,support,0,0
153602,.,0,0
153603,Further,0,0
153604,outcome,0,0
153605,variables,0,0
153606,include,0,0
153607,:,0,0
153608,social,0,0
153609,support,0,0
153610,",",0,0
153611,change,0,0
153612,in,0,0
153613,psychiatric,0,0
153614,symptoms,0,0
153615,",",0,0
153616,quality,0,0
153617,of,0,0
153618,life,0,0
153619,",",0,0
153620,and,0,0
153621,independence,0,0
153622,in,0,0
153623,daily,0,1
153624,functioning,0,0
153625,.,0,0
153626,METHODS/DESIGN,0,0
153627,The,0,0
153628,study,0,0
153629,is,0,0
153630,conducted,0,0
153631,as,0,0
153632,a,0,0
153633,randomized,0,0
153634,controlled,0,0
153635,trial,0,0
153636,.,0,0
153637,Subjects,0,0
153638,are,0,0
153639,randomly,0,0
153640,assigned,0,0
153641,to,0,0
153642,either,0,0
153643,the,0,0
153644,control,1,0
153645,group,0,0
153646,or,0,0
153647,to,0,0
153648,the,0,0
153649,treatment,1,0
153650,group,0,0
153651,.,0,0
153652,Computer,1,0
153653,generated,1,0
153654,block,1,0
153655,randomization,1,0
153656,is,0,0
153657,used,0,0
153658,to,0,0
153659,assure,0,0
153660,both,0,0
153661,groups,0,0
153662,have,0,0
153663,the,0,0
153664,same,0,0
153665,number,0,0
153666,of,0,0
153667,subjects,0,0
153668,.,0,0
153669,Stratified,1,0
153670,block,1,0
153671,randomization,1,0
153672,is,0,0
153673,used,0,0
153674,for,0,0
153675,the,0,0
153676,psychiatric,0,0
153677,diagnosis,0,0
153678,of,0,0
153679,ICD-10,0,0
153680,",",0,0
153681,F1,0,0
153682,.,0,0
153683,Approximately,0,0
153684,160,0,0
153685,patients,0,0
153686,are,0,0
153687,recruited,0,0
153688,in,0,0
153689,two,0,0
153690,care,0,0
153691,units,0,0
153692,at,0,0
153693,Psychiatrie-Zentrum,0,0
153694,Hard,0,0
153695,Embrach,0,0
153696,and,0,0
153697,two,0,0
153698,care,0,0
153699,units,0,0
153700,at,0,0
153701,Klinik,0,0
153702,Schlosstal,0,0
153703,Winterthur,0,0
153704,.,0,0
153705,DISCUSSION,0,0
153706,The,0,0
153707,proposed,0,0
153708,post-discharge,1,0
153709,network,1,0
153710,coordination,1,0
153711,program,1,0
153712,intervenes,0,0
153713,during,0,0
153714,the,0,0
153715,critical,0,0
153716,post-discharge,0,0
153717,period,0,0
153718,.,0,0
153719,It,0,0
153720,focuses,0,0
153721,primarily,0,0
153722,on,0,0
153723,promoting,0,0
153724,the,0,0
153725,integration,0,0
153726,of,0,0
153727,the,0,0
153728,patients,0,0
153729,into,0,0
153730,their,0,0
153731,social,0,0
153732,networks,0,0
153733,",",0,0
153734,and,0,0
153735,additionally,0,0
153736,to,0,0
153737,coordinating,0,0
153738,outpatient,0,0
153739,care,0,0
153740,and,0,0
153741,addressing,0,0
153742,concerns,0,0
153743,of,0,0
153744,daily,0,1
153745,life,0,1
153746,.,0,0
153747,TRIAL,0,0
153748,REGISTRATION,0,1
153749,ISRCTN,0,1
153750,ISRCTN58280620,0,1
153751,.,0,0
153752,Why,0,1
153753,does,0,0
153754,lag,1,0
153755,affect,0,0
153756,the,0,0
153757,durability,0,0
153758,of,0,0
153759,memory-based,0,0
153760,automaticity,0,0
153761,:,0,0
153762,loss,0,0
153763,of,0,0
153764,memory,0,0
153765,strength,0,0
153766,or,0,0
153767,interference,0,0
153768,?,0,0
153769,In,0,0
153770,Rickard,0,0
153771,",",0,0
153772,Lau,0,0
153773,",",0,0
153774,and,0,0
153775,Pashler,0,1
153776,'s,0,1
153777,(,0,1
153778,2008,0,1
153779,),0,0
153780,investigation,0,0
153781,of,0,0
153782,the,0,0
153783,lag,0,0
153784,effect,0,0
153785,on,0,0
153786,memory-based,0,0
153787,automaticity,0,0
153788,",",0,0
153789,response,0,0
153790,times,0,0
153791,were,0,0
153792,faster,0,0
153793,and,0,0
153794,proportion,0,0
153795,of,0,0
153796,trials,1,0
153797,retrieved,0,0
153798,was,0,0
153799,higher,0,0
153800,at,0,0
153801,the,0,0
153802,end,0,0
153803,of,0,0
153804,practice,1,0
153805,for,0,0
153806,short,0,0
153807,lag,0,0
153808,items,0,0
153809,than,0,0
153810,for,0,0
153811,long,0,0
153812,lag,0,0
153813,items,0,0
153814,.,0,0
153815,However,0,0
153816,",",0,0
153817,during,0,0
153818,testing,1,0
153819,after,1,0
153820,a,1,0
153821,delay,1,0
153822,",",0,0
153823,response,0,0
153824,times,0,0
153825,were,0,0
153826,slower,0,0
153827,and,0,0
153828,proportion,0,0
153829,of,0,0
153830,trials,0,0
153831,retrieved,0,0
153832,was,0,0
153833,lower,0,0
153834,for,0,0
153835,short,0,0
153836,lag,0,0
153837,items,0,0
153838,than,0,0
153839,for,0,0
153840,long,0,0
153841,lag,0,0
153842,items,0,0
153843,.,0,0
153844,The,0,0
153845,current,0,0
153846,study,0,0
153847,investigated,0,0
153848,the,0,0
153849,extent,0,0
153850,to,0,0
153851,which,0,0
153852,the,0,0
153853,lag,0,0
153854,effect,0,0
153855,on,0,0
153856,the,0,0
153857,durability,0,0
153858,of,0,0
153859,memory-based,0,0
153860,automaticity,0,0
153861,is,0,0
153862,due,0,0
153863,to,0,0
153864,interference,0,0
153865,or,0,0
153866,to,0,0
153867,the,0,0
153868,loss,0,0
153869,of,0,0
153870,memory,0,0
153871,strength,0,0
153872,with,0,0
153873,time,0,0
153874,.,0,0
153875,Participants,0,0
153876,repeatedly,0,0
153877,practiced,0,0
153878,alphabet,1,0
153879,subtraction,1,0
153880,items,1,0
153881,in,1,0
153882,short,1,0
153883,lag,1,0
153884,and,1,0
153885,long,1,0
153886,lag,1,0
153887,conditions,1,0
153888,.,1,0
153889,After,0,0
153890,practice,0,0
153891,",",0,0
153892,half,0,0
153893,of,0,0
153894,the,0,0
153895,participants,0,0
153896,were,0,0
153897,immediately,1,0
153898,tested,1,0
153899,and,0,0
153900,the,0,0
153901,other,0,0
153902,half,0,0
153903,were,0,0
153904,tested,1,0
153905,after,1,0
153906,a,1,0
153907,7-day,1,1
153908,delay,1,1
153909,.,1,0
153910,Results,0,0
153911,indicate,0,0
153912,that,0,0
153913,the,0,0
153914,lag,0,0
153915,effect,0,0
153916,on,0,0
153917,the,0,0
153918,durability,0,0
153919,of,0,0
153920,memory-based,0,0
153921,automaticity,0,0
153922,is,0,0
153923,primarily,0,0
153924,due,0,0
153925,to,0,0
153926,interference,0,0
153927,.,0,0
153928,We,0,0
153929,discuss,0,0
153930,potential,0,0
153931,modification,0,0
153932,of,0,0
153933,current,0,0
153934,memory-based,0,0
153935,processing,0,0
153936,theories,0,0
153937,to,0,0
153938,account,0,0
153939,for,0,0
153940,these,0,0
153941,effects,0,0
153942,.,0,0
153943,Oxytocin,1,1
153944,promotes,0,1
153945,facial,0,0
153946,emotion,0,0
153947,recognition,0,0
153948,and,0,0
153949,amygdala,0,0
153950,reactivity,0,0
153951,in,0,0
153952,adults,0,0
153953,with,0,0
153954,asperger,0,0
153955,syndrome,0,0
153956,.,0,0
153957,The,0,0
153958,neuropeptide,1,1
153959,oxytocin,1,1
153960,has,0,0
153961,recently,0,0
153962,been,0,0
153963,shown,0,0
153964,to,0,0
153965,enhance,0,0
153966,eye,0,0
153967,gaze,0,0
153968,and,0,0
153969,emotion,0,0
153970,recognition,0,0
153971,in,0,0
153972,healthy,0,0
153973,men,0,0
153974,.,0,0
153975,Here,0,0
153976,",",0,0
153977,we,0,0
153978,report,0,0
153979,a,0,0
153980,randomized,0,1
153981,double-blind,0,1
153982,",",0,1
153983,placebo-controlled,1,1
153984,trial,0,1
153985,that,0,0
153986,examined,0,0
153987,the,0,0
153988,neural,0,0
153989,and,0,0
153990,behavioral,0,0
153991,effects,0,0
153992,of,0,0
153993,a,0,0
153994,single,0,0
153995,dose,0,1
153996,of,0,1
153997,intranasal,1,1
153998,oxytocin,1,1
153999,on,0,1
154000,emotion,0,0
154001,recognition,0,0
154002,in,0,0
154003,individuals,0,0
154004,with,0,0
154005,Asperger,0,0
154006,syndrome,0,1
154007,(,0,1
154008,AS,0,1
154009,),0,1
154010,",",0,0
154011,a,0,0
154012,clinical,0,0
154013,condition,0,0
154014,characterized,0,0
154015,by,0,0
154016,impaired,0,0
154017,eye,0,0
154018,gaze,0,0
154019,and,0,0
154020,facial,0,0
154021,emotion,0,0
154022,recognition,0,0
154023,.,0,0
154024,Using,0,0
154025,functional,1,0
154026,magnetic,1,0
154027,resonance,1,0
154028,imaging,1,0
154029,",",0,0
154030,we,0,0
154031,examined,0,0
154032,whether,0,0
154033,oxytocin,1,1
154034,would,0,0
154035,enhance,0,0
154036,emotion,0,0
154037,recognition,0,0
154038,from,0,0
154039,facial,0,0
154040,sections,0,0
154041,of,0,0
154042,the,0,0
154043,eye,0,0
154044,vs,0,0
154045,the,0,0
154046,mouth,0,0
154047,region,0,0
154048,and,0,0
154049,modulate,0,0
154050,regional,0,0
154051,activity,0,0
154052,in,0,0
154053,brain,0,0
154054,areas,0,0
154055,associated,0,0
154056,with,0,0
154057,face,0,0
154058,perception,0,0
154059,in,0,0
154060,both,0,0
154061,adults,0,0
154062,with,0,0
154063,AS,0,0
154064,",",0,0
154065,and,0,0
154066,a,0,0
154067,neurotypical,1,0
154068,control,1,0
154069,group,0,0
154070,.,0,1
154071,Intranasal,0,1
154072,administration,0,1
154073,of,0,1
154074,the,0,1
154075,neuropeptide,1,1
154076,oxytocin,1,1
154077,improved,0,1
154078,performance,0,0
154079,in,0,0
154080,a,0,0
154081,facial,0,0
154082,emotion,0,0
154083,recognition,0,0
154084,task,0,0
154085,in,0,0
154086,individuals,0,0
154087,with,0,0
154088,AS,0,0
154089,.,0,0
154090,This,0,0
154091,was,0,0
154092,linked,0,0
154093,to,0,0
154094,increased,0,0
154095,left,0,0
154096,amygdala,0,0
154097,reactivity,0,0
154098,in,0,0
154099,response,0,0
154100,to,0,0
154101,facial,0,0
154102,stimuli,0,0
154103,and,0,0
154104,increased,0,0
154105,activity,0,0
154106,in,0,0
154107,the,0,0
154108,neural,0,0
154109,network,0,0
154110,involved,0,0
154111,in,0,0
154112,social,0,0
154113,cognition,0,0
154114,.,0,0
154115,Our,0,0
154116,data,0,0
154117,suggest,0,0
154118,that,0,0
154119,the,0,0
154120,amygdala,0,0
154121,",",0,0
154122,together,0,0
154123,with,0,0
154124,functionally,0,0
154125,associated,0,0
154126,cortical,0,0
154127,areas,0,0
154128,mediate,0,0
154129,the,0,0
154130,positive,0,0
154131,effect,0,0
154132,of,0,0
154133,oxytocin,1,1
154134,on,0,0
154135,social,0,0
154136,cognitive,0,0
154137,functioning,0,0
154138,in,0,0
154139,AS,0,0
154140,.,0,0
154141,Effectiveness,0,0
154142,of,0,0
154143,nonpharmacologic,1,0
154144,treatments,1,0
154145,for,0,0
154146,acute,0,0
154147,seasonal,0,0
154148,allergic,0,0
154149,conjunctivitis,0,0
154150,.,0,0
154151,OBJECTIVE,0,0
154152,To,0,0
154153,investigate,0,0
154154,whether,0,0
154155,artificial,0,0
154156,tears,0,0
154157,and,0,0
154158,cold,0,0
154159,compress,0,0
154160,alone,0,0
154161,or,0,0
154162,in,0,0
154163,combination,0,0
154164,provide,0,0
154165,a,0,0
154166,treatment,0,0
154167,benefit,0,0
154168,and,0,0
154169,whether,0,0
154170,they,0,0
154171,were,0,0
154172,as,0,0
154173,effective,0,0
154174,as,0,0
154175,or,0,0
154176,could,0,0
154177,enhance,0,0
154178,topical,1,1
154179,antiallergic,1,1
154180,medication,1,1
154181,.,1,0
154182,DESIGN,0,0
154183,Randomized,0,0
154184,",",0,0
154185,masked,0,0
154186,clinical,0,0
154187,trial,0,0
154188,.,0,0
154189,PARTICIPANTS,0,0
154190,Eighteen,0,1
154191,subjects,0,0
154192,(,0,0
154193,mean,0,0
154194,age,0,0
154195,",",0,0
154196,29.5?11.0,0,0
154197,years,0,0
154198,),0,0
154199,allergic,0,1
154200,to,0,1
154201,grass,0,1
154202,pollen,0,1
154203,.,0,1
154204,INTERVENTION,1,0
154205,Controlled,1,0
154206,exposure,1,0
154207,to,1,0
154208,grass,1,1
154209,pollen,1,1
154210,using,1,0
154211,an,1,0
154212,environmental,1,0
154213,chamber,1,0
154214,to,1,0
154215,stimulate,1,0
154216,an,1,0
154217,ocular,1,0
154218,allergic,1,0
154219,reaction,1,0
154220,followed,1,0
154221,by,1,0
154222,application,1,0
154223,of,1,0
154224,artificial,1,0
154225,tears,1,0
154226,(,1,1
154227,ATs,1,1
154228,),1,1
154229,",",1,0
154230,5,1,0
154231,minutes,1,0
154232,of,1,0
154233,cold,1,0
154234,compress,1,0
154235,(,1,1
154236,CC,1,1
154237,),1,1
154238,",",1,0
154239,ATs,1,0
154240,combined,1,0
154241,with,1,0
154242,CC,1,0
154243,",",1,0
154244,or,1,0
154245,no,1,0
154246,treatment,1,0
154247,applied,1,0
154248,at,1,0
154249,each,1,0
154250,separate,1,0
154251,visit,1,0
154252,in,1,0
154253,random,1,0
154254,order,1,0
154255,.,1,0
154256,A,0,0
154257,subset,0,0
154258,of,0,0
154259,11,0,0
154260,subjects,0,0
154261,also,0,0
154262,had,1,0
154263,epinastine,1,1
154264,hydrochloride,1,1
154265,(,1,1
154266,EH,1,1
154267,),1,0
154268,applied,1,0
154269,alone,1,0
154270,and,1,0
154271,combined,1,0
154272,with,1,0
154273,CC,1,0
154274,in,1,0
154275,random,1,0
154276,order,1,0
154277,or,1,0
154278,instillation,1,1
154279,of,1,0
154280,a,1,0
154281,volume-matched,1,0
154282,saline,1,1
154283,control,1,0
154284,.,1,0
154285,MAIN,0,0
154286,OUTCOME,0,1
154287,MEASURES,0,1
154288,Bulbar,0,1
154289,conjunctival,0,0
154290,hyperemia,0,0
154291,",",0,0
154292,ocular,0,0
154293,surface,0,0
154294,temperature,0,0
154295,",",0,0
154296,and,0,0
154297,ocular,0,0
154298,symptoms,0,0
154299,repeated,0,0
154300,before,0,0
154301,and,0,0
154302,every,0,0
154303,10,0,0
154304,minutes,0,0
154305,after,0,0
154306,treatment,0,0
154307,for,0,0
154308,1,0,0
154309,hour,0,0
154310,.,0,0
154311,RESULTS,0,1
154312,Bulbar,0,0
154313,conjunctival,0,0
154314,hyperemia,0,0
154315,and,0,0
154316,ocular,0,0
154317,symptoms,0,0
154318,decreased,0,0
154319,and,0,0
154320,temperature,0,0
154321,recovered,0,0
154322,to,0,0
154323,baseline,0,0
154324,faster,0,0
154325,with,1,0
154326,nonpharmaceutical,1,0
154327,treatments,1,0
154328,compared,0,0
154329,with,1,0
154330,no,1,0
154331,treatment,1,0
154332,(,0,0
154333,P,0,0
154334,<,0,0
154335,0.05,0,0
154336,),0,0
154337,.,0,0
154338,Artificial,0,0
154339,tears,0,0
154340,combined,0,0
154341,with,1,0
154342,CC,1,0
154343,reduced,0,0
154344,hyperemia,0,0
154345,more,0,0
154346,than,0,0
154347,other,0,0
154348,treatments,0,0
154349,(,0,0
154350,P,0,0
154351,<,0,0
154352,0.05,0,0
154353,),0,0
154354,.,0,0
154355,The,0,0
154356,treatment,0,0
154357,effect,1,0
154358,of,1,0
154359,EH,1,0
154360,was,1,0
154361,enhanced,0,0
154362,by,0,0
154363,combining,0,0
154364,it,0,0
154365,with,0,0
154366,a,0,0
154367,CC,0,0
154368,(,0,0
154369,P,0,0
154370,<,0,0
154371,0.001,0,0
154372,),0,0
154373,.,0,0
154374,Cold,0,0
154375,compress,0,0
154376,combined,1,0
154377,with,1,0
154378,ATs,1,0
154379,or,1,0
154380,EH,1,0
154381,lowered,0,0
154382,the,0,0
154383,antigen-raised,0,0
154384,ocular,0,0
154385,surface,0,0
154386,temperature,0,0
154387,to,0,0
154388,less,0,0
154389,than,0,0
154390,the,0,0
154391,pre-exposure,0,1
154392,baseline,0,1
154393,.,0,0
154394,Artificial,0,0
154395,tear,0,1
154396,instillation,0,1
154397,alone,0,0
154398,or,1,0
154399,CC,1,0
154400,combined,0,0
154401,with,0,0
154402,ATs,0,0
154403,or,0,0
154404,EH,0,0
154405,significantly,0,0
154406,reduced,0,0
154407,the,0,0
154408,temperature,0,0
154409,(,0,0
154410,P,0,0
154411,<,0,0
154412,0.05,0,0
154413,),0,0
154414,.,0,0
154415,Cold,0,0
154416,compress,0,0
154417,combined,0,0
154418,with,1,0
154419,ATs,1,0
154420,or,1,0
154421,EH,1,0
154422,had,1,0
154423,a,0,0
154424,similar,0,0
154425,cooling,0,0
154426,effect,0,0
154427,(,0,0
154428,P,0,0
154429,>,0,0
154430,0.05,0,0
154431,),0,0
154432,.,0,0
154433,At,0,0
154434,all,0,0
154435,measurement,0,0
154436,intervals,0,0
154437,",",0,0
154438,symptoms,0,0
154439,were,0,0
154440,reduced,0,0
154441,for,0,0
154442,both,0,0
154443,EH,0,0
154444,and,0,0
154445,EH,0,0
154446,combined,0,0
154447,with,0,0
154448,CC,0,0
154449,than,0,0
154450,CC,0,0
154451,or,0,0
154452,ATs,0,0
154453,alone,0,0
154454,or,0,0
154455,in,0,0
154456,combination,0,0
154457,(,0,0
154458,P,0,0
154459,<,0,0
154460,0.014,0,0
154461,),0,0
154462,.,0,0
154463,CONCLUSIONS,0,0
154464,After,0,0
154465,controlled,0,0
154466,exposure,0,0
154467,to,0,0
154468,grass,0,1
154469,pollen,0,1
154470,",",0,1
154471,CC,0,1
154472,and,0,0
154473,AT,0,0
154474,treatment,0,0
154475,showed,0,0
154476,a,0,0
154477,therapeutic,0,0
154478,effect,0,0
154479,on,0,0
154480,the,0,0
154481,signs,0,0
154482,and,0,0
154483,symptoms,0,0
154484,of,0,0
154485,allergic,0,0
154486,conjunctivitis,0,0
154487,.,0,0
154488,A,0,0
154489,CC,0,0
154490,enhanced,0,0
154491,the,0,0
154492,use,0,0
154493,of,0,0
154494,EH,0,0
154495,alone,0,0
154496,and,0,0
154497,was,0,0
154498,the,0,0
154499,only,0,0
154500,treatment,0,0
154501,to,0,0
154502,reduce,0,0
154503,symptoms,0,0
154504,to,0,0
154505,baseline,0,0
154506,within,0,0
154507,1,0,0
154508,hour,0,0
154509,of,0,0
154510,antigenic,0,0
154511,challenge,0,0
154512,.,0,0
154513,Signs,0,0
154514,of,0,0
154515,allergic,0,0
154516,conjunctivitis,0,0
154517,generally,0,0
154518,were,0,0
154519,reduced,0,0
154520,most,0,0
154521,by,0,0
154522,a,0,0
154523,combination,0,0
154524,of,1,0
154525,a,1,0
154526,CC,1,0
154527,in,1,0
154528,combination,1,0
154529,with,1,0
154530,ATs,1,0
154531,or,1,0
154532,EH,1,0
154533,.,1,0
154534,Local,0,0
154535,contextual,0,0
154536,processing,0,0
154537,in,0,0
154538,major,0,0
154539,depressive,0,0
154540,disorder,0,0
154541,.,0,0
154542,OBJECTIVE,0,0
154543,The,0,0
154544,study,0,0
154545,investigated,0,0
154546,local,0,0
154547,contextual,0,0
154548,processing,0,0
154549,in,0,0
154550,patients,0,0
154551,with,0,0
154552,major,0,0
154553,depressive,0,0
154554,disorder,0,1
154555,(,0,1
154556,MDD,0,1
154557,),0,1
154558,.,0,0
154559,This,0,0
154560,was,0,0
154561,defined,0,0
154562,as,0,0
154563,the,0,0
154564,ability,0,0
154565,to,0,0
154566,utilize,0,0
154567,predictive,0,0
154568,contextual,0,0
154569,information,0,0
154570,to,0,0
154571,facilitate,0,0
154572,detection,0,0
154573,of,0,0
154574,predictable,0,0
154575,versus,0,0
154576,random,0,0
154577,targets,0,0
154578,.,0,0
154579,METHOD,0,0
154580,We,0,0
154581,recorded,0,0
154582,EEG,1,0
154583,in,0,0
154584,15,0,0
154585,MDD,0,0
154586,patients,0,0
154587,and,0,0
154588,14,0,0
154589,age-matched,0,0
154590,controls,0,0
154591,.,0,0
154592,Recording,1,0
154593,blocks,1,0
154594,consisted,1,0
154595,of,1,0
154596,targets,1,0
154597,preceded,1,0
154598,by,1,0
154599,randomized,1,0
154600,sequences,1,0
154601,of,1,0
154602,standards,1,0
154603,and,1,0
154604,by,1,0
154605,sequences,1,0
154606,of,1,0
154607,standards,1,0
154608,that,1,0
154609,included,1,0
154610,a,1,0
154611,predictive,1,0
154612,sequence,1,0
154613,signaling,1,0
154614,the,1,0
154615,occurrence,1,0
154616,of,1,0
154617,a,1,0
154618,subsequent,1,0
154619,target,1,0
154620,event,1,0
154621,.,1,0
154622,RESULTS,0,0
154623,Both,0,0
154624,MDD,0,1
154625,patients,0,0
154626,and,0,0
154627,age-matched,0,0
154628,controls,0,0
154629,demonstrated,0,0
154630,a,0,0
154631,significant,0,0
154632,reaction,0,0
154633,time,0,0
154634,(,0,0
154635,RT,0,1
154636,),0,1
154637,and,0,0
154638,P3b,0,1
154639,latency,0,0
154640,differences,0,0
154641,between,0,0
154642,predicted,0,0
154643,and,0,0
154644,random,0,0
154645,targets,0,0
154646,.,0,0
154647,However,0,0
154648,",",0,0
154649,patients,0,0
154650,demonstrated,0,0
154651,a,0,0
154652,specific,0,0
154653,prolongation,0,0
154654,of,0,0
154655,these,0,0
154656,measures,0,0
154657,during,0,0
154658,processing,0,0
154659,of,0,0
154660,predicted,0,0
154661,targets,0,0
154662,",",0,0
154663,as,0,0
154664,well,0,0
154665,as,0,0
154666,an,0,0
154667,attenuation,0,0
154668,of,0,0
154669,P3b,0,0
154670,amplitudes,0,0
154671,for,0,0
154672,the,0,0
154673,predictive,0,0
154674,sequence,0,0
154675,.,0,0
154676,In,0,0
154677,addition,0,0
154678,",",0,0
154679,patients,0,0
154680,target,0,0
154681,N1,0,0
154682,amplitudes,0,0
154683,were,0,0
154684,attenuated,0,0
154685,compared,0,0
154686,with,0,0
154687,controls,1,0
154688,.,1,0
154689,CONCLUSION,0,0
154690,MDD,0,0
154691,patients,0,0
154692,were,0,0
154693,able,0,0
154694,to,0,0
154695,utilize,0,0
154696,predictive,0,0
154697,context,0,0
154698,in,0,0
154699,order,0,0
154700,to,0,0
154701,facilitate,0,0
154702,processing,0,0
154703,of,0,0
154704,deterministic,0,0
154705,targets,0,0
154706,",",0,0
154707,however,0,0
154708,",",0,0
154709,this,0,0
154710,ability,0,0
154711,was,0,0
154712,limited,0,0
154713,compared,0,0
154714,to,0,0
154715,controls,0,0
154716,",",0,0
154717,as,0,0
154718,demonstrated,0,0
154719,by,0,0
154720,context-dependent,0,0
154721,P3b,0,0
154722,deficits,0,0
154723,.,0,0
154724,SIGNIFICANCE,0,0
154725,These,0,0
154726,findings,0,0
154727,suggest,0,0
154728,that,0,0
154729,patients,0,0
154730,with,0,0
154731,major,0,0
154732,depression,0,0
154733,have,0,0
154734,altered,0,0
154735,processing,0,0
154736,of,0,0
154737,local,0,0
154738,contextual,0,0
154739,processing,0,0
154740,.,0,0
154741,Long-term,0,0
154742,exposure,0,0
154743,to,0,0
154744,belatacept,0,1
154745,in,0,0
154746,recipients,0,0
154747,of,0,0
154748,extended,0,0
154749,criteria,0,0
154750,donor,0,0
154751,kidneys,0,0
154752,.,0,0
154753,Patients,0,0
154754,in,0,0
154755,the,0,0
154756,BENEFIT-EXT,0,0
154757,study,0,0
154758,received,0,0
154759,extended,0,0
154760,criteria,0,0
154761,donor,0,0
154762,kidneys,0,0
154763,and,0,0
154764,a,0,0
154765,more,1,0
154766,intensive,1,0
154767,(,1,1
154768,MI,1,1
154769,),1,0
154770,or,1,0
154771,less,1,0
154772,intensive,1,0
154773,(,1,1
154774,LI,1,1
154775,),1,1
154776,belatacept,1,1
154777,immunosuppression,1,1
154778,regimen,1,1
154779,",",1,1
154780,or,1,1
154781,cyclosporine,1,1
154782,A,1,1
154783,(,1,1
154784,CsA,1,1
154785,),1,1
154786,.,1,0
154787,Patients,0,0
154788,who,0,0
154789,remained,0,0
154790,on,0,0
154791,assigned,0,0
154792,therapy,0,0
154793,through,0,0
154794,year,0,0
154795,3,0,0
154796,were,0,0
154797,eligible,0,0
154798,to,0,0
154799,enter,0,0
154800,a,0,0
154801,long-term,0,0
154802,extension,0,0
154803,(,0,1
154804,LTE,0,1
154805,),0,0
154806,study,0,0
154807,.,0,0
154808,Three,0,0
154809,hundred,0,0
154810,four,0,0
154811,patients,0,0
154812,entered,0,0
154813,the,0,0
154814,LTE,0,1
154815,(,0,0
154816,n,0,0
154817,=,0,0
154818,104,0,0
154819,MI,0,0
154820,;,0,0
154821,n,0,0
154822,=,0,0
154823,113,0,0
154824,LI,0,0
154825,;,0,0
154826,n,0,0
154827,=,0,0
154828,87,0,0
154829,CsA,0,0
154830,),0,0
154831,",",0,0
154832,and,0,0
154833,260,0,0
154834,continued,0,0
154835,treatment,0,0
154836,through,0,0
154837,year,0,1
154838,5,0,0
154839,(,0,0
154840,n,0,0
154841,=,0,0
154842,91,0,0
154843,MI,0,0
154844,;,0,0
154845,n,0,0
154846,=,0,0
154847,100,0,0
154848,LI,0,0
154849,;,0,0
154850,n,0,0
154851,=,0,0
154852,69,0,0
154853,CsA,0,0
154854,),0,0
154855,.,0,0
154856,Twenty,0,0
154857,patients,0,0
154858,died,0,0
154859,during,0,0
154860,the,0,0
154861,LTE,0,1
154862,(,0,0
154863,n,0,0
154864,=,0,0
154865,5,0,0
154866,MI,0,0
154867,;,0,0
154868,n,0,0
154869,=,0,0
154870,9,0,0
154871,LI,0,0
154872,;,0,0
154873,n,0,0
154874,=,0,0
154875,6,0,0
154876,CsA,0,0
154877,),0,1
154878,",",0,0
154879,and,0,0
154880,eight,0,0
154881,experienced,0,0
154882,graft,0,0
154883,loss,0,0
154884,(,0,0
154885,n,0,0
154886,=,0,0
154887,2,0,0
154888,MI,0,0
154889,;,0,0
154890,n,0,0
154891,=,0,0
154892,1,0,0
154893,LI,0,0
154894,;,0,0
154895,n,0,0
154896,=,0,0
154897,5,0,0
154898,CsA,0,0
154899,),0,0
154900,.,0,0
154901,Three,0,0
154902,patients,0,0
154903,experienced,0,0
154904,an,0,0
154905,acute,0,0
154906,rejection,0,1
154907,episode,0,1
154908,(,0,0
154909,n,0,0
154910,=,0,0
154911,2,0,0
154912,MI,0,0
154913,;,0,0
154914,n,0,0
154915,=,0,0
154916,1,0,0
154917,LI,0,0
154918,),0,0
154919,.,0,0
154920,The,0,0
154921,incidence,0,0
154922,rate,0,0
154923,of,0,0
154924,serious,0,0
154925,adverse,0,0
154926,events,0,0
154927,",",0,0
154928,viral,0,0
154929,infections,0,0
154930,and,0,0
154931,fungal,0,0
154932,infections,0,0
154933,was,0,0
154934,similar,0,0
154935,across,0,0
154936,groups,0,0
154937,during,0,0
154938,the,0,0
154939,LTE,0,0
154940,.,0,0
154941,There,0,0
154942,were,0,0
154943,four,0,0
154944,cases,0,0
154945,of,0,0
154946,posttransplant,0,0
154947,lymphoproliferative,0,1
154948,disorder,0,1
154949,(,0,1
154950,PTLD,0,1
154951,),0,0
154952,from,0,0
154953,the,0,0
154954,beginning,0,0
154955,of,0,0
154956,the,0,0
154957,LTE,0,0
154958,to,0,0
154959,year,0,0
154960,5,0,0
154961,(,0,0
154962,n,0,0
154963,=,0,0
154964,3,0,0
154965,LI,0,0
154966,;,0,0
154967,n,0,0
154968,=,0,0
154969,1,0,0
154970,CsA,0,0
154971,),0,1
154972,;,0,0
154973,two,0,0
154974,of,0,0
154975,three,0,0
154976,PTLD,0,0
154977,cases,0,0
154978,in,0,0
154979,the,0,0
154980,LI,0,0
154981,group,0,0
154982,were,0,0
154983,in,0,0
154984,patients,0,0
154985,who,0,0
154986,were,0,0
154987,seronegative,0,0
154988,for,0,0
154989,Epstein-Barr,0,1
154990,virus,0,1
154991,(,0,1
154992,EBV,0,1
154993,(,0,1
154994,-,0,1
154995,),0,1
154996,),0,1
154997,at,0,0
154998,transplantation,0,0
154999,.,0,0
155000,Mean,0,0
155001,?,0,0
155002,SD,0,0
155003,calculated,0,0
155004,GFR,0,0
155005,at,0,0
155006,year,0,0
155007,5,0,0
155008,was,0,0
155009,55.9,0,0
155010,?,0,0
155011,17.5,0,0
155012,(,0,0
155013,MI,0,0
155014,),0,0
155015,",",0,0
155016,59.0,0,0
155017,?,0,0
155018,29.1,0,0
155019,(,0,0
155020,LI,0,0
155021,),0,0
155022,and,0,0
155023,44.6,0,0
155024,?,0,0
155025,16.4,0,0
155026,(,0,0
155027,CsA,0,0
155028,),0,1
155029,mL/min/1.73,0,0
155030,m,0,0
155031,(,0,0
155032,2,0,1
155033,),0,0
155034,.,0,0
155035,Continued,0,0
155036,treatment,0,0
155037,with,0,0
155038,belatacept,0,1
155039,was,0,0
155040,associated,0,0
155041,with,0,0
155042,a,0,0
155043,consistent,0,0
155044,safety,0,0
155045,profile,0,0
155046,and,0,0
155047,sustained,0,0
155048,improvement,0,0
155049,in,0,0
155050,renal,0,0
155051,function,0,0
155052,versus,0,0
155053,CsA,0,0
155054,over,0,0
155055,time,0,0
155056,.,0,0
155057,See,0,1
155058,what,0,1
155059,I,0,0
155060,see,0,0
155061,",",0,0
155062,do,0,0
155063,as,0,0
155064,I,0,0
155065,do,0,0
155066,:,0,0
155067,promoting,1,0
155068,joint,1,0
155069,attention,1,0
155070,and,1,0
155071,imitation,1,0
155072,in,0,0
155073,preschoolers,0,0
155074,with,0,0
155075,autism,0,0
155076,spectrum,0,0
155077,disorder,0,0
155078,.,0,0
155079,Since,0,0
155080,imitation,0,0
155081,and,0,0
155082,joint,0,0
155083,attention,0,0
155084,are,0,0
155085,both,0,0
155086,important,0,0
155087,abilities,0,0
155088,for,0,0
155089,young,0,0
155090,children,0,0
155091,and,0,0
155092,since,0,0
155093,children,0,0
155094,with,0,0
155095,autism,0,0
155096,spectrum,0,0
155097,disorder,0,0
155098,show,0,0
155099,a,0,0
155100,range,0,0
155101,of,0,0
155102,problems,0,0
155103,in,0,0
155104,these,0,0
155105,domains,0,0
155106,",",0,0
155107,imitation,1,0
155108,and,0,0
155109,joint,1,0
155110,attention,1,0
155111,are,0,0
155112,important,0,0
155113,targets,0,0
155114,for,0,0
155115,intervention,0,0
155116,.,0,0
155117,In,0,0
155118,this,0,0
155119,study,0,0
155120,",",0,0
155121,we,0,0
155122,examined,0,0
155123,the,0,0
155124,possibility,0,0
155125,of,0,0
155126,promoting,0,0
155127,imitation,1,0
155128,and,0,0
155129,joint,1,0
155130,attention,1,0
155131,by,0,0
155132,means,0,0
155133,of,0,0
155134,a,0,0
155135,training,1,0
155136,programme,1,0
155137,specifically,1,0
155138,designed,1,0
155139,for,1,0
155140,low-intensity,1,0
155141,",",1,0
155142,non-residential,1,0
155143,treatment,1,0
155144,.,1,0
155145,Two,0,1
155146,matched,0,0
155147,groups,0,0
155148,of,0,0
155149,18,0,0
155150,children,0,0
155151,each,0,0
155152,participated,0,0
155153,in,0,0
155154,the,0,0
155155,study,0,0
155156,.,0,0
155157,The,0,0
155158,experimental,0,0
155159,group,0,0
155160,",",0,0
155161,receiving,0,0
155162,the,0,0
155163,training,1,0
155164,programme,1,0
155165,",",0,0
155166,improved,0,0
155167,significantly,0,0
155168,more,0,0
155169,on,0,0
155170,joint,0,0
155171,attention,0,0
155172,than,0,0
155173,the,0,0
155174,group,0,0
155175,receiving,0,0
155176,only,0,0
155177,treatment,0,0
155178,as,0,0
155179,usual,0,0
155180,.,0,0
155181,Only,0,0
155182,the,0,0
155183,experimental,0,0
155184,group,0,0
155185,obtained,0,0
155186,a,0,0
155187,significantly,0,0
155188,higher,0,0
155189,imitation,0,0
155190,score,0,0
155191,during,0,0
155192,the,0,0
155193,post-test,0,0
155194,compared,0,0
155195,to,0,0
155196,the,0,0
155197,pre-test,0,0
155198,.,0,0
155199,This,0,0
155200,study,0,0
155201,shows,0,0
155202,that,0,0
155203,it,0,0
155204,is,0,0
155205,possible,0,0
155206,to,0,0
155207,promote,0,0
155208,joint,1,0
155209,attention,1,0
155210,with,0,0
155211,a,0,0
155212,low-intensity,0,0
155213,treatment,0,0
155214,programme,0,0
155215,.,0,0
155216,The,0,0
155217,results,0,0
155218,concerning,0,0
155219,imitation,0,0
155220,are,0,0
155221,more,0,0
155222,modest,0,0
155223,.,0,0
155224,Future,0,0
155225,replications,0,0
155226,should,0,0
155227,involve,0,0
155228,measures,0,0
155229,of,0,0
155230,stability,0,0
155231,and,0,0
155232,generalization,0,0
155233,.,0,0
155234,Comparison,1,0
155235,of,1,0
155236,three,1,0
155237,software,1,0
155238,systems,1,0
155239,for,0,0
155240,semi-automatic,0,0
155241,volumetry,0,0
155242,of,0,0
155243,pulmonary,0,0
155244,nodules,0,0
155245,on,0,0
155246,baseline,0,0
155247,and,0,0
155248,follow-up,0,0
155249,CT,0,0
155250,examinations,0,0
155251,.,0,0
155252,BACKGROUND,0,0
155253,Early,0,0
155254,diagnosis,0,0
155255,of,0,0
155256,lung,0,0
155257,cancer,0,0
155258,in,0,0
155259,a,0,0
155260,treatable,0,0
155261,stage,0,0
155262,is,0,0
155263,the,0,0
155264,main,0,0
155265,purpose,0,0
155266,of,0,0
155267,lung,0,0
155268,cancer,0,0
155269,screening,0,0
155270,by,0,0
155271,computed,1,0
155272,tomography,1,1
155273,(,1,1
155274,CT,1,0
155275,),1,0
155276,.,1,0
155277,Accurate,0,0
155278,three-dimensional,0,0
155279,size,0,0
155280,and,0,0
155281,growth,0,0
155282,measurements,0,0
155283,are,0,0
155284,essential,0,0
155285,to,0,0
155286,assess,0,0
155287,the,0,0
155288,risk,0,0
155289,of,0,0
155290,malignancy,0,0
155291,.,0,0
155292,Nodule,0,0
155293,volumes,0,0
155294,can,0,0
155295,be,0,0
155296,calculated,0,0
155297,by,0,0
155298,using,0,0
155299,semi-automated,0,0
155300,volumetric,0,0
155301,software,0,0
155302,.,0,0
155303,Systematic,0,0
155304,differences,0,0
155305,in,0,0
155306,volume,0,0
155307,measurements,0,0
155308,between,0,0
155309,packages,0,0
155310,could,0,0
155311,influence,0,0
155312,nodule,0,0
155313,categorization,0,0
155314,and,0,0
155315,management,0,0
155316,decisions,0,0
155317,.,0,0
155318,PURPOSE,0,0
155319,To,0,0
155320,compare,0,0
155321,volumetric,0,0
155322,measurements,0,0
155323,of,0,0
155324,solid,0,0
155325,pulmonary,0,0
155326,nodules,0,0
155327,on,0,0
155328,baseline,0,0
155329,and,0,0
155330,follow-up,0,0
155331,CT,1,0
155332,scans,1,0
155333,as,0,0
155334,well,0,0
155335,as,0,0
155336,the,0,0
155337,volume,0,0
155338,doubling,0,0
155339,time,0,0
155340,(,0,0
155341,VDT,0,1
155342,),0,0
155343,for,0,0
155344,three,1,0
155345,software,1,0
155346,packages,1,0
155347,.,1,0
155348,MATERIAL,0,0
155349,AND,0,1
155350,METHODS,0,1
155351,From,0,1
155352,a,0,0
155353,Lung,0,0
155354,Cancer,0,0
155355,Screening,0,0
155356,study,0,0
155357,(,0,0
155358,NELSON,0,1
155359,),0,1
155360,",",0,0
155361,50,0,0
155362,participants,0,0
155363,were,0,0
155364,randomly,0,0
155365,selected,0,0
155366,from,0,0
155367,the,0,0
155368,baseline,0,0
155369,round,0,0
155370,.,0,0
155371,The,0,0
155372,study,0,0
155373,population,0,0
155374,comprised,0,0
155375,participants,0,0
155376,with,0,0
155377,at,0,0
155378,least,0,0
155379,one,0,0
155380,pulmonary,0,0
155381,nodule,0,0
155382,at,0,0
155383,the,0,0
155384,baseline,0,0
155385,and,0,0
155386,consecutive,0,0
155387,CT,0,0
155388,examination,0,0
155389,.,0,0
155390,The,0,0
155391,volume,0,0
155392,of,0,0
155393,each,0,0
155394,nodule,0,0
155395,was,0,0
155396,determined,0,0
155397,for,0,0
155398,both,0,0
155399,time,0,0
155400,points,0,0
155401,using,0,0
155402,three,1,0
155403,semi-automated,1,0
155404,software,1,1
155405,packages,1,1
155406,(,1,0
155407,P1,1,0
155408,",",1,0
155409,P2,1,0
155410,",",1,0
155411,and,1,0
155412,P3,1,1
155413,),1,1
155414,.,0,0
155415,Manual,0,0
155416,modification,0,0
155417,was,0,0
155418,performed,0,0
155419,when,0,0
155420,automated,0,0
155421,assessment,0,0
155422,was,0,0
155423,visually,0,0
155424,inaccurate,0,0
155425,.,0,0
155426,VDT,0,0
155427,was,0,0
155428,calculated,0,0
155429,to,0,0
155430,evaluate,0,0
155431,nodule,0,0
155432,growth,0,0
155433,.,0,0
155434,Volume,0,0
155435,",",0,0
155436,VDT,0,0
155437,",",0,0
155438,and,0,0
155439,nodule,0,0
155440,management,0,0
155441,were,0,0
155442,compared,0,0
155443,for,0,0
155444,the,0,0
155445,three,0,0
155446,software,0,0
155447,packages,0,0
155448,",",0,0
155449,using,0,0
155450,P1,0,0
155451,as,0,0
155452,the,0,0
155453,reference,0,0
155454,standard,0,0
155455,.,0,0
155456,RESULTS,0,0
155457,In,0,0
155458,25,0,0
155459,participants,0,0
155460,",",0,0
155461,147,0,0
155462,nodules,0,0
155463,were,0,0
155464,present,0,0
155465,on,0,0
155466,both,0,0
155467,examinations,0,0
155468,(,0,0
155469,volume,0,0
155470,:,0,0
155471,12.0-436.6,0,0
155472,mm,0,0
155473,(,0,0
155474,3,0,1
155475,),0,1
155476,),0,1
155477,.,0,0
155478,Initial,0,0
155479,segmentation,0,0
155480,at,0,0
155481,baseline,0,0
155482,was,0,0
155483,evaluated,0,0
155484,to,0,0
155485,be,0,0
155486,satisfactory,0,0
155487,in,0,0
155488,93.9,0,0
155489,%,0,0
155490,of,0,0
155491,nodules,0,0
155492,for,0,0
155493,P1,0,0
155494,",",0,0
155495,84.4,0,0
155496,%,0,0
155497,for,0,0
155498,P2,0,0
155499,",",0,0
155500,and,0,0
155501,88.4,0,0
155502,%,0,0
155503,for,0,0
155504,P3,0,0
155505,.,0,0
155506,Significant,0,0
155507,difference,0,0
155508,was,0,0
155509,found,0,0
155510,in,0,0
155511,measured,0,0
155512,volume,0,0
155513,between,0,0
155514,P1,0,0
155515,and,0,0
155516,the,0,0
155517,other,0,0
155518,two,0,0
155519,packages,0,0
155520,(,0,0
155521,P,0,0
155522,<,0,0
155523,0.001,0,0
155524,),0,0
155525,.,0,0
155526,P2,0,0
155527,overestimated,0,0
155528,the,0,0
155529,volume,0,0
155530,by,0,0
155531,38,0,0
155532,?,0,0
155533,24,0,0
155534,%,0,0
155535,",",0,0
155536,and,0,0
155537,P3,0,0
155538,by,0,0
155539,50,0,0
155540,?,0,0
155541,22,0,0
155542,%,0,0
155543,.,0,0
155544,At,0,0
155545,baseline,0,0
155546,",",0,0
155547,there,0,0
155548,was,0,0
155549,consensus,0,0
155550,on,0,0
155551,nodule,0,0
155552,size,0,0
155553,categorization,0,0
155554,in,0,0
155555,80,0,0
155556,%,0,0
155557,for,0,0
155558,P1,0,0
155559,&,0,1
155560,P2,0,0
155561,and,0,0
155562,74,0,0
155563,%,0,0
155564,for,0,0
155565,P1,0,0
155566,&,0,0
155567,P3,0,0
155568,.,0,0
155569,At,0,0
155570,follow-up,0,0
155571,",",0,0
155572,consensus,0,0
155573,on,0,0
155574,VDT,0,0
155575,categorization,0,0
155576,was,0,0
155577,present,0,0
155578,in,0,0
155579,47,0,0
155580,%,0,0
155581,for,0,0
155582,P1,0,0
155583,&,0,1
155584,P2,0,0
155585,and,0,0
155586,44,0,0
155587,%,0,0
155588,for,0,0
155589,P1,0,0
155590,&,0,0
155591,P3,0,0
155592,.,0,0
155593,CONCLUSION,1,0
155594,Software,1,0
155595,packages,1,0
155596,for,1,0
155597,lung,1,0
155598,nodule,1,0
155599,evaluation,1,0
155600,yield,1,0
155601,significant,0,0
155602,differences,0,0
155603,in,0,0
155604,volumetric,0,0
155605,measurements,0,0
155606,and,0,0
155607,VDT,0,0
155608,.,0,0
155609,This,0,0
155610,variation,0,0
155611,affects,0,0
155612,the,0,0
155613,classification,0,0
155614,of,0,0
155615,lung,0,0
155616,nodules,0,0
155617,",",0,0
155618,especially,0,0
155619,in,0,0
155620,follow-up,0,0
155621,examinations,0,0
155622,.,0,0
155623,Comparison,0,0
155624,of,0,0
155625,meloxicam,1,1
155626,and,1,1
155627,a,1,1
155628,glucosamine-chondroitin,1,1
155629,supplement,1,1
155630,in,0,1
155631,management,0,0
155632,of,0,0
155633,feline,0,0
155634,osteoarthritis,0,0
155635,.,0,0
155636,A,0,1
155637,double-blind,0,1
155638,randomised,0,1
155639,",",0,1
155640,placebo-controlled,0,1
155641,",",0,1
155642,prospective,0,1
155643,trial,0,0
155644,.,0,0
155645,OBJECTIVE,0,0
155646,To,0,0
155647,compare,0,0
155648,the,0,0
155649,efficacy,0,0
155650,of,0,0
155651,meloxicam,1,1
155652,and,1,1
155653,a,1,1
155654,glucosamine-chondroitin,1,1
155655,(,1,1
155656,Glu-Ch,1,1
155657,),1,1
155658,supplement,1,1
155659,in,0,0
155660,the,0,0
155661,management,0,0
155662,of,0,0
155663,feline,0,0
155664,osteoarthritis,0,0
155665,(,0,1
155666,OA,0,1
155667,),0,1
155668,.,0,0
155669,METHODS,0,0
155670,Prospective,0,0
155671,",",0,0
155672,blinded,0,0
155673,",",0,0
155674,randomized,0,0
155675,clinical,0,0
155676,trial,0,0
155677,.,0,0
155678,Cats,0,0
155679,over,0,0
155680,eight,0,0
155681,years,0,0
155682,of,0,0
155683,age,0,0
155684,with,0,0
155685,clinical,0,0
155686,signs,0,0
155687,of,0,0
155688,chronic,0,0
155689,OA,0,0
155690,were,0,0
155691,assigned,0,0
155692,to,0,0
155693,one,0,0
155694,of,0,0
155695,two,0,0
155696,groups,0,0
155697,and,0,0
155698,Glu-Ch,1,1
155699,or,1,1
155700,meloxicam,1,1
155701,was,0,1
155702,administered,0,1
155703,orally,0,1
155704,for,0,0
155705,70,0,0
155706,days,0,0
155707,",",0,0
155708,followed,0,0
155709,by,0,0
155710,a,0,0
155711,placebo,1,1
155712,until,0,1
155713,day,0,0
155714,98,0,0
155715,.,0,0
155716,Cats,0,0
155717,were,0,0
155718,assessed,0,0
155719,by,0,0
155720,a,0,0
155721,veterinarian,0,0
155722,on,0,0
155723,five,0,0
155724,occasions,0,0
155725,and,0,0
155726,the,0,0
155727,owner,0,0
155728,completed,0,0
155729,an,0,0
155730,assessment,0,0
155731,form,0,0
155732,at,0,0
155733,the,0,0
155734,same,0,0
155735,time,0,0
155736,.,0,0
155737,RESULTS,0,0
155738,Data,0,0
155739,were,0,0
155740,collected,0,0
155741,from,0,0
155742,thirty,0,0
155743,cats,0,0
155744,.,0,0
155745,Pre-treatment,0,0
155746,disease,0,0
155747,scores,0,0
155748,were,0,0
155749,significantly,0,0
155750,higher,0,0
155751,in,0,0
155752,the,0,0
155753,meloxicam,1,1
155754,group,0,0
155755,for,0,0
155756,owner,0,0
155757,mobility,0,0
155758,(,0,0
155759,p=0.01,0,0
155760,),0,0
155761,and,0,0
155762,veterinary,0,1
155763,lameness,0,0
155764,(,0,0
155765,p=0.02,0,0
155766,),0,0
155767,.,0,0
155768,Owner,0,0
155769,mobility,0,0
155770,scores,0,0
155771,at,0,0
155772,day,0,0
155773,14,0,0
155774,(,0,0
155775,p=0.01,0,0
155776,),0,0
155777,and,0,0
155778,day,0,0
155779,42,0,0
155780,(,0,0
155781,p=0.002,0,0
155782,),0,0
155783,were,0,0
155784,significantly,0,0
155785,improved,0,0
155786,compared,0,0
155787,to,0,0
155788,pre-treatment,0,0
155789,scores,0,0
155790,for,0,0
155791,the,0,0
155792,meloxicam,1,1
155793,group,0,1
155794,.,0,1
155795,When,0,1
155796,meloxicam,1,1
155797,and,0,0
155798,Glu-Ch,0,1
155799,were,0,0
155800,discontinued,0,1
155801,and,0,1
155802,the,0,0
155803,placebo,1,1
155804,commenced,0,0
155805,",",0,0
155806,a,0,0
155807,significant,0,0
155808,proportion,0,0
155809,of,0,0
155810,the,0,0
155811,meloxicam,1,1
155812,group,0,0
155813,showed,0,0
155814,worsening,0,0
155815,of,0,0
155816,all,0,0
155817,the,0,0
155818,owner-assessed,0,0
155819,scores,0,0
155820,between,0,0
155821,day,0,0
155822,70,0,0
155823,and,0,0
155824,day,0,0
155825,98,0,0
155826,",",0,0
155827,when,0,0
155828,compared,0,0
155829,to,0,0
155830,the,0,0
155831,Glu-Ch,0,1
155832,group,0,0
155833,(,0,0
155834,mobility,0,0
155835,p=0.01,0,0
155836,;,0,0
155837,activity,0,0
155838,p=0.02,0,0
155839,;,0,0
155840,temperament,0,0
155841,p=0.04,0,0
155842,;,0,0
155843,lifestyle,0,0
155844,p=0.01,0,0
155845,),0,0
155846,.,0,0
155847,CONCLUSIONS,0,0
155848,Treatment,0,1
155849,with,0,0
155850,meloxicam,1,1
155851,resulted,0,0
155852,in,0,0
155853,a,0,0
155854,significant,0,0
155855,improvement,0,0
155856,in,0,0
155857,mobility,0,0
155858,and,0,0
155859,activity,0,0
155860,levels,0,0
155861,of,0,0
155862,cats,0,0
155863,with,0,0
155864,OA,0,0
155865,until,0,0
155866,the,0,0
155867,placebo,1,1
155868,was,0,0
155869,introduced,0,0
155870,.,0,0
155871,A,0,0
155872,greater,0,0
155873,proportion,0,0
155874,of,0,0
155875,cats,0,0
155876,receiving,0,0
155877,meloxicam,1,1
155878,medication,0,1
155879,showed,0,0
155880,a,0,0
155881,significant,0,0
155882,worsening,0,0
155883,of,0,0
155884,owner,0,0
155885,assessment,0,1
155886,scores,0,1
155887,once,0,0
155888,the,0,0
155889,placed,0,0
155890,was,0,0
155891,introduced,0,0
155892,",",0,0
155893,when,0,0
155894,compared,0,0
155895,to,0,0
155896,the,0,0
155897,Glu-Ch,0,0
155898,group,0,0
155899,.,0,0
155900,Iron,1,0
155901,supplementation,1,1
155902,improves,0,0
155903,energetic,0,0
155904,efficiency,0,0
155905,in,0,0
155906,iron-depleted,0,1
155907,female,0,1
155908,rowers,0,1
155909,.,0,0
155910,PURPOSE,0,0
155911,Studies,0,0
155912,in,0,0
155913,both,0,0
155914,animals,0,0
155915,and,0,0
155916,humans,0,0
155917,show,0,0
155918,a,0,0
155919,relationship,0,0
155920,between,0,0
155921,iron,0,0
155922,depletion,0,0
155923,without,0,0
155924,anemia,0,0
155925,(,0,1
155926,IDNA,0,1
155927,),0,1
155928,and,0,0
155929,physical,0,0
155930,performance,0,0
155931,.,0,0
155932,Compared,0,0
155933,with,0,0
155934,their,0,0
155935,sedentary,0,0
155936,counterparts,0,0
155937,",",0,0
155938,female,0,0
155939,endurance,0,0
155940,athletes,0,0
155941,are,0,0
155942,at,0,0
155943,greater,0,0
155944,risk,0,0
155945,of,0,0
155946,IDNA,0,0
155947,",",0,0
155948,and,0,0
155949,consequences,0,0
155950,relevant,0,0
155951,to,0,0
155952,endurance,0,0
155953,athletes,0,0
155954,include,0,0
155955,reduced,0,0
155956,work,0,0
155957,capacity,0,0
155958,and,0,0
155959,energetic,0,0
155960,efficiency,0,0
155961,(,0,1
155962,EF,0,1
155963,),0,1
155964,.,0,0
155965,We,0,0
155966,conducted,0,0
155967,a,0,0
155968,randomized,0,1
155969,placebo-controlled,1,1
155970,trial,0,1
155971,to,0,0
155972,investigate,0,0
155973,the,0,0
155974,effects,0,0
155975,of,0,0
155976,iron,1,1
155977,(,1,1
155978,Fe,1,1
155979,),1,1
155980,supplementation,1,1
155981,on,0,1
155982,Fe,0,1
155983,status,0,0
155984,and,0,0
155985,performance,0,0
155986,in,0,0
155987,nonanemic,0,0
155988,female,0,0
155989,rowers,0,0
155990,during,0,0
155991,training,0,0
155992,.,0,0
155993,METHODS,0,0
155994,At,0,0
155995,the,0,0
155996,beginning,0,0
155997,of,0,0
155998,a,0,0
155999,training,0,0
156000,season,0,0
156001,",",0,0
156002,40,0,0
156003,rowers,0,0
156004,were,0,0
156005,randomized,0,0
156006,to,0,0
156007,receive,0,0
156008,either,0,0
156009,100,1,0
156010,mg?d,1,1
156011,FeSO4,1,1
156012,(,0,0
156013,n,0,0
156014,=,0,0
156015,21,0,0
156016,),0,0
156017,or,1,1
156018,placebo,1,1
156019,(,0,0
156020,n,0,0
156021,=,0,0
156022,19,0,0
156023,),0,0
156024,using,0,0
156025,a,0,0
156026,double-blind,0,1
156027,design,0,0
156028,.,0,0
156029,Thirty-one,0,0
156030,(,0,0
156031,n,0,0
156032,=,0,0
156033,15,1,0
156034,Fe,1,0
156035,",",1,0
156036,16,1,1
156037,placebo,1,1
156038,),1,1
156039,completed,0,1
156040,the,0,0
156041,6-wk,0,1
156042,trial,0,1
156043,.,0,0
156044,Fe,0,1
156045,status,0,1
156046,(,0,1
156047,hemoglobin,0,1
156048,",",0,1
156049,serum,0,1
156050,ferritin,0,1
156051,",",0,1
156052,soluble,0,0
156053,transferrin,0,1
156054,receptor,0,0
156055,),0,0
156056,",",0,0
156057,body,0,0
156058,composition,0,0
156059,",",0,0
156060,and,0,0
156061,laboratory,0,0
156062,tests,0,0
156063,of,0,0
156064,physical,0,1
156065,performance,0,0
156066,(,0,0
156067,4-km,0,0
156068,time,0,0
156069,trial,0,0
156070,",",0,0
156071,V?O2peak,0,0
156072,",",0,0
156073,energetic,0,0
156074,EF,0,0
156075,",",0,0
156076,and,0,0
156077,blood,0,1
156078,lactate,0,1
156079,),0,1
156080,were,0,0
156081,assessed,0,0
156082,at,0,0
156083,baseline,0,0
156084,and,0,0
156085,after,0,0
156086,training,0,0
156087,.,0,0
156088,RESULTS,0,0
156089,Rowers,0,0
156090,in,0,0
156091,both,0,0
156092,groups,0,0
156093,increased,0,0
156094,their,0,0
156095,fat-free,0,1
156096,mass,0,0
156097,(,0,0
156098,P,0,0
156099,<,0,0
156100,0.001,0,0
156101,),0,0
156102,and,0,0
156103,V?O2peak,0,0
156104,(,0,0
156105,P,0,0
156106,<,0,0
156107,0.001,0,0
156108,),0,0
156109,after,0,0
156110,training,0,0
156111,.,0,0
156112,Multiple,0,0
156113,regression,0,0
156114,analyses,0,0
156115,revealed,0,0
156116,improvements,0,0
156117,in,0,0
156118,Fe,0,1
156119,stores,0,0
156120,(,0,1
156121,serum,0,1
156122,ferritin,0,1
156123,),0,1
156124,in,0,0
156125,the,0,0
156126,Fe,0,0
156127,treatment,0,0
156128,group,0,0
156129,after,0,0
156130,controlling,0,0
156131,for,0,0
156132,baseline,0,0
156133,Fe,0,1
156134,stores,0,0
156135,(,0,0
156136,P,0,0
156137,=,0,0
156138,0.07,0,0
156139,),0,0
156140,.,0,0
156141,Rowers,0,0
156142,in,0,0
156143,the,0,0
156144,Fe,0,0
156145,group,0,0
156146,had,0,0
156147,slower,0,0
156148,lactate,0,1
156149,response,0,0
156150,during,0,0
156151,the,0,0
156152,first,0,0
156153,half,0,0
156154,of,0,0
156155,the,0,0
156156,time,0,0
156157,trial,0,0
156158,and,0,0
156159,after,0,0
156160,5,0,0
156161,min,0,0
156162,of,0,0
156163,recovery,0,0
156164,(,0,0
156165,P,0,0
156166,=,0,0
156167,0.05,0,0
156168,),0,0
156169,and,0,0
156170,showed,0,0
156171,greater,0,0
156172,improvements,0,0
156173,in,0,0
156174,energy,0,0
156175,expenditure,0,0
156176,(,0,0
156177,P,0,0
156178,=,0,0
156179,0.01,0,0
156180,for,0,0
156181,group-by,0,0
156182,time,0,0
156183,),0,0
156184,and,0,0
156185,energetic,0,0
156186,EF,0,0
156187,compared,0,0
156188,with,0,0
156189,placebo,0,0
156190,(,0,0
156191,P,0,0
156192,=,0,0
156193,0.03,0,0
156194,for,0,0
156195,group-by,0,0
156196,time,0,0
156197,),0,0
156198,.,0,0
156199,CONCLUSIONS,0,0
156200,Female,0,0
156201,rowers,0,0
156202,with,0,0
156203,depleted,0,0
156204,Fe,0,0
156205,stores,0,0
156206,who,0,1
156207,consumed,0,1
156208,supplemental,0,1
156209,Fe,0,1
156210,during,0,0
156211,training,0,0
156212,improved,0,0
156213,their,0,0
156214,Fe,0,0
156215,status,0,0
156216,and,0,0
156217,energetic,0,0
156218,EF,0,0
156219,during,0,0
156220,endurance,0,0
156221,exercise,0,0
156222,.,0,0
156223,These,0,0
156224,results,0,0
156225,are,0,0
156226,important,0,0
156227,for,0,0
156228,endurance,0,0
156229,athletes,0,0
156230,whose,0,0
156231,dietary,0,1
156232,patterns,0,0
156233,and,0,0
156234,physical,0,0
156235,training,0,0
156236,increase,0,0
156237,their,0,0
156238,risk,0,0
156239,of,0,0
156240,IDNA,0,0
156241,and,0,0
156242,suggest,0,0
156243,that,0,0
156244,Fe,0,1
156245,supplementation,0,1
156246,may,0,0
156247,maximize,0,0
156248,the,0,0
156249,benefits,0,0
156250,of,0,0
156251,endurance,0,0
156252,training,0,0
156253,.,0,0
156254,Etomidate,1,1
156255,with,1,1
156256,or,1,0
156257,without,1,0
156258,flumazenil,1,1
156259,anesthesia,1,0
156260,for,0,0
156261,stem,0,0
156262,cell,0,0
156263,transplantation,0,0
156264,in,0,0
156265,autistic,0,0
156266,children,0,0
156267,.,0,0
156268,BACKGROUND,0,0
156269,The,0,0
156270,aim,0,0
156271,of,0,0
156272,this,0,0
156273,study,0,0
156274,was,0,0
156275,to,0,0
156276,investigate,0,0
156277,etomidate,1,1
156278,administration,1,1
156279,with,1,1
156280,or,1,0
156281,without,1,0
156282,flumazenil,1,1
156283,in,0,0
156284,autistic,0,1
156285,children,0,0
156286,who,0,1
156287,underwent,0,0
156288,intrathecal,0,1
156289,transplantation,0,1
156290,of,0,0
156291,stem,0,0
156292,cells,0,0
156293,by,0,0
156294,lumbar,0,0
156295,puncture,0,0
156296,.,0,0
156297,METHODS,0,0
156298,Forty,0,0
156299,autistic,0,0
156300,children,0,0
156301,aged,0,0
156302,2-12,0,0
156303,",",0,0
156304,who,0,0
156305,were,0,0
156306,scheduled,0,0
156307,for,0,0
156308,stem,0,0
156309,cell,0,0
156310,transplantation,0,0
156311,via,0,0
156312,lumbar,0,0
156313,puncture,0,0
156314,under,0,0
156315,anesthesia,0,0
156316,",",0,0
156317,were,0,0
156318,randomized,0,0
156319,for,0,0
156320,a,0,0
156321,double-blind,0,1
156322,study,0,0
156323,.,0,0
156324,The,0,0
156325,children,0,0
156326,were,0,0
156327,randomly,0,0
156328,assigned,0,0
156329,to,0,0
156330,two,0,0
156331,groups,0,0
156332,:,0,0
156333,the,1,0
156334,flumazenil,1,1
156335,group,1,1
156336,(,0,1
156337,group,0,0
156338,F,0,0
156339,",",0,0
156340,n=20,0,0
156341,),0,0
156342,and,0,0
156343,the,1,0
156344,etomidate,1,1
156345,group,1,1
156346,(,0,1
156347,group,0,0
156348,E,0,0
156349,",",0,0
156350,n=20,0,0
156351,),0,0
156352,.,0,0
156353,All,0,0
156354,children,0,0
156355,received,0,0
156356,0.2,0,0
156357,mg/kg,0,1
156358,of,0,0
156359,etomidate,1,1
156360,.,1,0
156361,In,0,0
156362,the,0,0
156363,case,0,0
156364,of,0,0
156365,inadequate,0,0
156366,anesthesia,0,0
156367,",",0,0
156368,patients,0,0
156369,received,0,0
156370,repeated,0,0
156371,doses,0,1
156372,of,0,0
156373,0.1,0,0
156374,mg/kg,0,1
156375,of,0,0
156376,etomidate,1,1
156377,until,0,1
156378,reaching,0,0
156379,deep,0,0
156380,sedation,0,0
156381,.,0,0
156382,After,0,0
156383,operation,0,0
156384,",",0,0
156385,children,0,0
156386,in,0,0
156387,group,0,0
156388,F,0,0
156389,were,0,0
156390,given,0,1
156391,flumazenil,1,1
156392,(,0,1
156393,0.01,0,1
156394,mg/kg,0,1
156395,),0,0
156396,and,0,0
156397,children,0,0
156398,in,0,0
156399,group,0,0
156400,E,0,0
156401,received,0,0
156402,placebo,1,1
156403,.,1,1
156404,Heart,0,0
156405,rate,0,0
156406,(,0,1
156407,HR,0,1
156408,),0,0
156409,",",0,0
156410,mean,0,0
156411,arterial,0,0
156412,pressure,0,0
156413,",",0,0
156414,oxygen,0,0
156415,saturation,0,0
156416,",",0,0
156417,respiratory,0,0
156418,rate,0,0
156419,",",0,0
156420,the,0,0
156421,Ramsay,0,1
156422,sedation,0,1
156423,score,0,1
156424,(,0,1
156425,RSS,0,1
156426,),0,0
156427,",",0,0
156428,and,0,0
156429,recovery,0,0
156430,time,0,0
156431,of,0,0
156432,all,0,0
156433,children,0,0
156434,were,0,0
156435,continuously,0,0
156436,monitored,0,0
156437,and,0,0
156438,recorded,0,0
156439,during,0,0
156440,the,0,0
156441,entire,0,0
156442,procedure,0,0
156443,.,0,0
156444,RESULTS,0,0
156445,After,0,0
156446,anesthesia,0,0
156447,",",0,0
156448,blood,0,0
156449,pressure,0,0
156450,and,0,0
156451,HR,0,0
156452,measurements,0,0
156453,were,0,0
156454,not,0,0
156455,significantly,0,0
156456,changed,0,0
156457,in,0,0
156458,both,0,0
156459,groups,0,0
156460,compared,0,0
156461,with,0,0
156462,the,0,0
156463,baseline,0,0
156464,.,0,0
156465,There,0,0
156466,were,0,0
156467,no,0,0
156468,respiratory,0,0
156469,depression,0,0
156470,",",0,0
156471,bradycardia,0,0
156472,",",0,0
156473,hypotension,0,1
156474,",",0,1
156475,nausea,0,1
156476,",",0,1
156477,and,0,0
156478,vomiting,0,0
156479,.,0,0
156480,Five,0,0
156481,patients,0,0
156482,complained,0,0
156483,of,0,0
156484,pain,0,0
156485,on,0,0
156486,the,0,0
156487,site,0,0
156488,of,0,0
156489,injection,0,1
156490,.,0,0
156491,Myoclonus,0,0
156492,occurred,0,0
156493,in,0,0
156494,seven,0,0
156495,patients,0,0
156496,.,0,0
156497,Recovery,0,0
156498,time,0,0
156499,in,0,0
156500,group,0,0
156501,F,0,0
156502,was,0,0
156503,significantly,0,0
156504,shorter,0,0
156505,than,0,0
156506,in,0,0
156507,group,0,0
156508,E,0,0
156509,(,0,0
156510,p,0,0
156511,<,0,0
156512,0.001,0,0
156513,),0,0
156514,",",0,0
156515,and,0,0
156516,after,0,0
156517,the,0,0
156518,injection,0,1
156519,of,0,1
156520,flumazenil,1,1
156521,",",0,0
156522,RSS,0,0
156523,in,0,0
156524,group,0,0
156525,F,0,0
156526,significantly,0,0
156527,decreased,0,0
156528,than,0,0
156529,in,0,0
156530,group,0,0
156531,E.,0,0
156532,There,0,0
156533,were,0,0
156534,no,0,0
156535,significant,0,0
156536,differences,0,0
156537,in,0,0
156538,operation,0,0
156539,time,0,0
156540,.,0,0
156541,Physician,0,0
156542,satisfaction,0,0
156543,in,0,0
156544,both,0,0
156545,groups,0,0
156546,was,0,0
156547,similar,0,0
156548,.,0,0
156549,CONCLUSIONS,0,1
156550,Etomidate,1,1
156551,resulted,0,0
156552,in,0,0
156553,stable,0,0
156554,hemodynamic,0,0
156555,responses,0,0
156556,and,0,0
156557,relatively,0,0
156558,less,0,0
156559,adverse,0,0
156560,effects,0,0
156561,",",0,0
156562,and,0,1
156563,flumazenil,1,1
156564,antagonized,0,1
156565,the,0,1
156566,anesthetic,0,1
156567,effect,0,0
156568,of,0,1
156569,etomidate,0,1
156570,;,0,1
156571,thus,0,0
156572,",",0,0
156573,etomidate,0,1
156574,with,0,1
156575,flumazenil,0,1
156576,is,0,0
156577,suitable,0,0
156578,for,0,0
156579,performing,0,0
156580,stem,0,0
156581,cell,0,0
156582,transplantation,0,0
156583,in,0,0
156584,autistic,0,0
156585,children,0,0
156586,.,0,0
156587,Examination,0,0
156588,of,0,0
156589,aggression,0,0
156590,and,0,0
156591,self-injury,0,0
156592,in,0,0
156593,children,0,0
156594,with,0,0
156595,autism,0,0
156596,spectrum,0,0
156597,disorders,0,0
156598,and,0,0
156599,serious,0,0
156600,behavioral,0,0
156601,problems,0,0
156602,.,0,0
156603,This,0,0
156604,study,0,0
156605,identified,0,0
156606,subtypes,0,0
156607,of,0,0
156608,aggression,0,0
156609,in,0,0
156610,a,0,0
156611,sample,0,0
156612,of,0,0
156613,206,0,0
156614,children,0,0
156615,with,0,0
156616,autism,0,0
156617,spectrum,0,0
156618,disorder,0,1
156619,(,0,1
156620,ASD,0,1
156621,),0,1
156622,who,0,0
156623,participated,0,1
156624,in,0,0
156625,2,1,1
156626,risperidone,1,1
156627,trials,1,1
156628,.,1,0
156629,The,0,0
156630,narratives,0,0
156631,were,0,0
156632,derived,0,0
156633,from,0,0
156634,a,0,0
156635,parent,0,0
156636,interview,0,0
156637,about,0,0
156638,each,0,0
156639,child,0,0
156640,'s,0,0
156641,2,0,0
156642,most,0,0
156643,pressing,0,0
156644,problems,0,0
156645,.,0,0
156646,Five,0,0
156647,subtypes,0,0
156648,of,0,0
156649,aggression,0,0
156650,emerged,0,0
156651,:,0,0
156652,hot,0,0
156653,aggression,0,0
156654,only,0,0
156655,",",0,0
156656,cold,0,0
156657,aggression,0,0
156658,only,0,0
156659,",",0,0
156660,self-injurious,0,0
156661,behavior,0,0
156662,(,0,1
156663,SIB,0,1
156664,),0,0
156665,only,0,0
156666,",",0,0
156667,aggression,0,0
156668,and,0,0
156669,SIB,0,0
156670,",",0,0
156671,and,0,0
156672,nonaggressive,0,0
156673,.,0,0
156674,All,0,0
156675,groups,0,0
156676,showed,0,0
156677,a,0,0
156678,high,0,0
156679,rate,0,0
156680,of,0,0
156681,positive,0,0
156682,response,0,0
156683,to,0,0
156684,risperidone,0,1
156685,with,0,0
156686,no,0,0
156687,differences,0,0
156688,across,0,0
156689,subtypes,0,0
156690,.,0,0
156691,These,0,0
156692,study,0,0
156693,findings,0,0
156694,extend,0,0
156695,understanding,0,0
156696,of,0,0
156697,aggression,0,0
156698,in,0,0
156699,ASD,0,0
156700,and,0,0
156701,may,0,0
156702,be,0,0
156703,useful,0,0
156704,to,0,0
156705,guide,0,0
156706,further,0,0
156707,study,0,0
156708,on,0,0
156709,biological,0,0
156710,mechanisms,0,0
156711,and,0,0
156712,individualized,0,0
156713,treatment,0,0
156714,in,0,0
156715,ASD,0,0
156716,.,0,0
156717,Effect,0,0
156718,of,0,0
156719,augmented,1,0
156720,sensorimotor,1,0
156721,input,1,0
156722,on,0,0
156723,learning,0,0
156724,verbal,0,0
156725,and,0,0
156726,nonverbal,0,0
156727,tasks,0,0
156728,among,0,0
156729,children,0,0
156730,with,0,0
156731,autism,0,0
156732,spectrum,0,0
156733,disorders,0,0
156734,.,0,0
156735,Thirty-four,0,0
156736,children,0,0
156737,",",0,0
156738,with,0,0
156739,autism,0,0
156740,spectrum,0,0
156741,disorders,0,0
156742,",",0,0
156743,ages,0,0
156744,4-14,0,0
156745,years,0,0
156746,",",0,0
156747,were,0,0
156748,matched,0,0
156749,and,0,0
156750,randomly,0,0
156751,assigned,0,0
156752,to,0,0
156753,one,0,0
156754,of,0,0
156755,two,0,0
156756,conditions,0,0
156757,for,0,0
156758,learning,0,0
156759,a,0,0
156760,novel,0,0
156761,juice-making,0,0
156762,task,0,0
156763,and,0,0
156764,producing,0,0
156765,two,0,0
156766,novel,0,0
156767,words,0,0
156768,about,0,0
156769,the,0,0
156770,event,0,0
156771,.,0,0
156772,Seventeen,0,0
156773,sighted,0,0
156774,children,0,0
156775,were,0,0
156776,manually,1,0
156777,guided,1,0
156778,to,0,0
156779,perform,0,0
156780,the,0,0
156781,task,0,0
156782,and,0,0
156783,tactually,0,0
156784,prompted,0,0
156785,during,0,0
156786,imitated,0,0
156787,productions,0,0
156788,of,0,0
156789,novel,0,0
156790,words,0,0
156791,for,0,0
156792,the,0,0
156793,event,0,0
156794,.,0,0
156795,Their,0,0
156796,matched,0,0
156797,controls,0,0
156798,heard,0,0
156799,the,0,0
156800,novel,0,0
156801,words,0,0
156802,and,0,0
156803,watched,0,0
156804,the,0,0
156805,juice-making,0,0
156806,task,0,0
156807,being,0,0
156808,performed,0,0
156809,.,0,0
156810,Performances,0,0
156811,on,0,0
156812,four,0,0
156813,verbal,0,0
156814,and,0,0
156815,two,0,0
156816,nonverbal,0,0
156817,measures,0,0
156818,right,0,0
156819,after,0,0
156820,instruction,0,0
156821,and,0,0
156822,at,0,0
156823,24-48,0,0
156824,h,0,0
156825,post-instruction,0,0
156826,",",0,0
156827,revealed,0,0
156828,higher,0,0
156829,scores,0,0
156830,for,0,0
156831,the,0,0
156832,??hands-on??,0,0
156833,",",0,0
156834,participation,0,0
156835,than,0,0
156836,observation,0,0
156837,group,0,0
156838,on,0,0
156839,both,0,0
156840,verbal,0,0
156841,and,0,0
156842,nonverbal,0,0
156843,tasks,0,0
156844,.,0,0
156845,This,0,0
156846,study,0,0
156847,offers,0,0
156848,a,0,0
156849,paradigm,0,0
156850,for,0,0
156851,exploring,0,0
156852,the,0,0
156853,instructional,0,0
156854,advantage,0,0
156855,of,0,0
156856,enhanced,0,0
156857,participatory,0,0
156858,experience,0,0
156859,.,0,0
156860,Remission,0,0
156861,in,0,0
156862,rheumatoid,0,0
156863,arthritis,0,0
156864,patients,0,0
156865,treated,0,0
156866,with,0,0
156867,etanercept,1,1
156868,monotherapy,1,1
156869,:,1,1
156870,clinical,0,0
156871,practice,0,0
156872,and,0,0
156873,clinical,0,0
156874,trial,0,0
156875,experience,0,0
156876,.,0,0
156877,OBJECTIVES,0,0
156878,To,0,0
156879,assess,0,0
156880,",",0,0
156881,in,0,0
156882,a,0,0
156883,randomised,0,0
156884,controlled,0,0
156885,trial,0,1
156886,(,0,1
156887,RCT,0,1
156888,),0,1
156889,and,0,0
156890,in,0,0
156891,clinical,0,0
156892,practice,0,0
156893,",",0,0
156894,an,0,0
156895,association,0,0
156896,of,0,0
156897,time,0,0
156898,to,0,0
156899,remission,0,0
156900,and,0,0
156901,baseline,0,0
156902,disease,0,0
156903,activity,0,0
156904,with,0,0
156905,both,0,0
156906,induction,0,0
156907,of,0,0
156908,remission,0,0
156909,and,0,0
156910,sustained,0,0
156911,remission,0,0
156912,in,0,0
156913,etanercept-treated,1,0
156914,patients,0,0
156915,with,0,0
156916,rheumatoid,0,0
156917,arthritis,0,1
156918,(,0,1
156919,RA,0,1
156920,),0,1
156921,.,0,0
156922,METHODS,0,0
156923,Data,0,0
156924,from,0,0
156925,an,0,0
156926,RCT,0,1
156927,(,0,0
156928,Trial,0,0
156929,of,0,0
156930,Etanercept,1,1
156931,and,1,1
156932,Methotrexate,1,1
156933,with,0,1
156934,Radiographic,0,0
156935,Patient,0,1
156936,Outcomes,0,1
156937,[,0,1
156938,TEMPO,0,1
156939,],0,1
156940,;,0,0
156941,n=682,0,0
156942,),0,0
156943,and,0,0
156944,an,0,0
156945,observational,0,1
156946,registry,0,1
156947,(,0,1
156948,Rheumatoid,0,1
156949,Arthritis,0,1
156950,DMARD,0,1
156951,Intervention,0,0
156952,and,0,0
156953,Utilization,0,0
156954,Study,0,1
156955,[,0,0
156956,RADIUS,0,1
156957,II,0,1
156958,],0,0
156959,;,0,0
156960,n=4341,0,0
156961,),0,0
156962,were,0,0
156963,used,0,0
156964,to,0,0
156965,evaluate,0,0
156966,disease,0,0
156967,activity,0,0
156968,(,0,0
156969,Clinical,0,0
156970,Disease,0,0
156971,Activity,0,0
156972,Index,0,1
156973,[,0,1
156974,CDAI,0,1
156975,],0,1
156976,score,0,1
156977,),0,0
156978,over,0,0
156979,time,0,0
156980,in,0,0
156981,patients,0,0
156982,initiating,0,0
156983,etanercept,1,1
156984,(,1,1
156985,monotherapy,1,1
156986,or,1,1
156987,with,1,1
156988,methotrexate,1,1
156989,),1,1
156990,.,1,1
156991,CDAI,0,1
156992,remission,0,1
156993,(,0,1
156994,CDAI?2.8,0,1
156995,),0,1
156996,and,0,0
156997,sustained,0,0
156998,remission,0,1
156999,(,0,0
157000,?6,0,1
157001,months,0,0
157002,),0,0
157003,were,0,0
157004,determined,0,0
157005,through,0,0
157006,year,0,0
157007,3,0,0
157008,by,0,0
157009,treatment,0,0
157010,group,0,0
157011,",",0,0
157012,study,0,0
157013,",",0,0
157014,time,0,0
157015,to,0,0
157016,remission,0,0
157017,",",0,0
157018,and,0,0
157019,disease,0,0
157020,severity,0,0
157021,.,0,0
157022,RESULTS,0,0
157023,Patients,0,0
157024,from,0,0
157025,TEMPO,0,0
157026,and,0,0
157027,RADIUS,0,1
157028,II,0,1
157029,who,0,1
157030,received,1,1
157031,etanercept,1,1
157032,monotherapy,1,1
157033,showed,1,0
157034,similar,0,0
157035,CDAI,0,0
157036,remission,0,1
157037,rates,0,0
157038,(,0,0
157039,39,0,0
157040,%,0,0
157041,and,0,0
157042,35,0,0
157043,%,0,0
157044,",",0,0
157045,respectively,0,0
157046,",",0,0
157047,at,0,0
157048,3,0,0
157049,years,0,0
157050,),0,0
157051,.,0,0
157052,Among,0,0
157053,patients,0,0
157054,who,0,0
157055,received,1,0
157056,etanercept,1,1
157057,with,1,1
157058,methotrexate,1,1
157059,",",1,0
157060,remission,1,0
157061,rates,0,0
157062,were,0,0
157063,54,0,0
157064,%,0,0
157065,and,0,0
157066,36,0,0
157067,%,0,0
157068,",",0,0
157069,respectively,0,0
157070,.,0,0
157071,Remission,0,0
157072,occurred,0,0
157073,more,0,0
157074,rapidly,0,0
157075,in,0,0
157076,TEMPO,0,1
157077,than,0,0
157078,RADIUS,0,0
157079,II,0,1
157080,perhaps,0,0
157081,from,0,0
157082,differences,0,0
157083,in,0,0
157084,compliance,0,0
157085,",",0,0
157086,patient,0,0
157087,populations,0,0
157088,",",0,0
157089,or,0,0
157090,sequence,0,0
157091,of,0,0
157092,combination,0,0
157093,therapy,0,0
157094,initiation,0,0
157095,.,0,0
157096,Generally,0,0
157097,",",0,0
157098,more,0,0
157099,patients,0,0
157100,with,0,0
157101,lower,0,0
157102,baseline,0,0
157103,CDAI,0,0
157104,scores,0,0
157105,achieved,0,0
157106,remission,0,0
157107,than,0,0
157108,those,0,0
157109,with,0,0
157110,higher,0,0
157111,scores,0,0
157112,.,0,0
157113,Continued,0,0
157114,remission,0,0
157115,appeared,0,0
157116,more,0,0
157117,likely,0,0
157118,in,0,0
157119,patients,0,0
157120,achieving,0,0
157121,remission,0,0
157122,earlier,0,0
157123,in,0,0
157124,the,0,0
157125,course,0,0
157126,of,0,0
157127,their,0,0
157128,therapy,0,0
157129,(,0,0
157130,0-6,0,0
157131,months,0,0
157132,),0,0
157133,.,0,0
157134,CONCLUSIONS,0,0
157135,Remission,0,0
157136,by,0,0
157137,year,0,0
157138,3,0,0
157139,in,0,0
157140,etanercept-treated,1,0
157141,(,1,0
157142,with,1,0
157143,and,1,0
157144,without,1,0
157145,methotrexate,1,1
157146,),1,1
157147,patients,1,0
157148,with,0,0
157149,RA,0,0
157150,occurred,0,0
157151,in,0,0
157152,?35,0,0
157153,%,0,0
157154,of,0,0
157155,patients,0,0
157156,in,0,0
157157,both,0,0
157158,an,0,0
157159,RCT,0,1
157160,(,0,1
157161,TEMPO,0,1
157162,),0,1
157163,and,0,0
157164,a,0,0
157165,clinical,0,0
157166,practice,0,1
157167,setting,0,1
157168,(,0,0
157169,RADIUS,0,1
157170,II,0,1
157171,),0,0
157172,",",0,0
157173,and,0,0
157174,more,0,0
157175,frequently,0,0
157176,in,0,0
157177,those,0,0
157178,with,0,0
157179,lower,0,0
157180,baseline,0,0
157181,disease,0,0
157182,severity,0,0
157183,.,0,0
157184,Patients,0,0
157185,with,0,0
157186,lower,0,0
157187,RA,0,0
157188,disease,0,0
157189,activity,0,0
157190,were,0,0
157191,more,0,0
157192,likely,0,0
157193,to,0,0
157194,reach,0,0
157195,remission,0,0
157196,.,0,0
157197,Continued,0,0
157198,remission,0,0
157199,may,0,0
157200,be,0,0
157201,more,0,0
157202,likely,0,0
157203,in,0,0
157204,patients,0,0
157205,who,0,0
157206,achieved,0,0
157207,remission,0,0
157208,earlier,0,0
157209,.,0,0
157210,Testing,0,0
157211,the,0,0
157212,efficacy,0,0
157213,of,0,0
157214,an,0,0
157215,HIV,1,0
157216,stigma,1,0
157217,reduction,1,0
157218,intervention,1,0
157219,with,0,0
157220,medical,0,0
157221,students,0,0
157222,in,0,0
157223,Puerto,0,0
157224,Rico,0,0
157225,:,0,0
157226,the,0,0
157227,SPACES,0,0
157228,project,0,0
157229,.,0,0
157230,INTRODUCTION,0,0
157231,Stigma,0,0
157232,associated,0,0
157233,with,0,0
157234,HIV,0,0
157235,has,0,0
157236,been,0,0
157237,documented,0,0
157238,as,0,0
157239,a,0,0
157240,barrier,0,0
157241,for,0,0
157242,accessing,0,0
157243,quality,0,0
157244,health-related,0,0
157245,services,0,0
157246,.,0,0
157247,When,0,0
157248,the,0,0
157249,stigma,0,0
157250,manifests,0,0
157251,in,0,0
157252,the,0,0
157253,health,0,0
157254,care,0,0
157255,setting,0,0
157256,",",0,0
157257,people,0,0
157258,living,0,0
157259,with,0,0
157260,HIV,0,0
157261,receive,0,0
157262,substandard,0,0
157263,services,0,0
157264,or,0,0
157265,even,0,0
157266,be,0,0
157267,denied,0,0
157268,care,0,0
157269,altogether,0,0
157270,.,0,0
157271,Although,0,0
157272,the,0,0
157273,consequences,0,0
157274,of,0,0
157275,HIV,0,0
157276,stigma,0,0
157277,have,0,0
157278,been,0,0
157279,documented,0,0
157280,extensively,0,0
157281,",",0,0
157282,efforts,0,0
157283,to,0,0
157284,reduce,0,0
157285,these,0,0
157286,negative,0,0
157287,attitudes,0,0
157288,have,0,0
157289,been,0,0
157290,scarce,0,0
157291,.,0,0
157292,Interventions,1,0
157293,to,1,0
157294,reduce,1,0
157295,HIV,1,0
157296,stigma,1,0
157297,should,0,0
157298,be,0,0
157299,implemented,0,0
157300,as,0,0
157301,part,0,0
157302,of,0,0
157303,the,0,0
157304,formal,0,0
157305,training,0,0
157306,of,0,0
157307,future,0,0
157308,health,0,0
157309,care,0,0
157310,professionals,0,0
157311,.,0,0
157312,The,0,0
157313,interventions,0,0
157314,that,0,0
157315,have,0,0
157316,been,0,0
157317,tested,0,0
157318,with,0,0
157319,health,0,0
157320,care,0,0
157321,professionals,0,0
157322,and,0,0
157323,published,0,0
157324,have,0,0
157325,several,0,0
157326,limitations,0,0
157327,that,0,0
157328,must,0,0
157329,be,0,0
157330,surpassed,0,0
157331,(,0,0
157332,i.e,0,0
157333,.,0,0
157334,lack,0,0
157335,of,0,0
157336,comparison,0,0
157337,groups,0,0
157338,in,0,0
157339,research,0,0
157340,designs,0,0
157341,and,0,0
157342,longitudinal,0,0
157343,follow-up,0,1
157344,data,0,0
157345,),0,0
157346,.,0,0
157347,Furthermore,0,0
157348,",",0,0
157349,Latino,0,0
157350,health,0,0
157351,care,0,0
157352,professionals,0,0
157353,have,0,0
157354,been,0,0
157355,absent,0,0
157356,from,0,0
157357,these,0,0
157358,intervention,0,0
157359,efforts,0,0
157360,even,0,0
157361,though,0,0
157362,the,0,0
157363,epidemic,0,0
157364,has,0,0
157365,affected,0,0
157366,this,0,0
157367,population,0,0
157368,disproportionately,0,0
157369,.,0,0
157370,METHODS,0,0
157371,In,0,0
157372,this,0,0
157373,article,0,0
157374,",",0,0
157375,we,0,0
157376,describe,0,0
157377,an,0,0
157378,intervention,1,0
157379,developed,1,0
157380,to,1,0
157381,reduce,1,0
157382,HIV,1,0
157383,stigma,1,0
157384,among,1,0
157385,medical,1,0
157386,students,1,0
157387,in,1,0
157388,Puerto,1,0
157389,Rico,1,1
157390,.,1,0
157391,A,0,0
157392,total,0,0
157393,of,0,0
157394,507,0,0
157395,medical,0,0
157396,students,0,0
157397,were,0,0
157398,randomly,0,0
157399,introduced,0,0
157400,into,0,0
157401,our,0,0
157402,intervention,1,0
157403,and,1,0
157404,control,1,0
157405,conditions,1,0
157406,.,1,0
157407,RESULTS,0,0
157408,The,0,0
157409,results,0,0
157410,show,0,0
157411,statistically,0,0
157412,significant,0,0
157413,differences,0,0
157414,between,0,0
157415,the,0,0
157416,intervention,1,0
157417,and,0,0
157418,control,1,0
157419,groups,0,0
157420,;,0,0
157421,intervention,0,1
157422,group,0,0
157423,participants,0,0
157424,had,0,0
157425,lower,0,0
157426,HIV,0,0
157427,stigma,0,0
157428,levels,0,0
157429,than,0,0
157430,control,0,0
157431,participants,0,0
157432,after,0,0
157433,the,0,0
157434,intervention,0,0
157435,.,0,0
157436,In,0,0
157437,addition,0,0
157438,",",0,0
157439,differences,0,0
157440,in,0,0
157441,HIV,0,0
157442,stigma,0,0
157443,levels,0,0
157444,between,0,0
157445,the,0,0
157446,groups,0,0
157447,were,0,0
157448,sustained,0,0
157449,for,0,0
157450,a,0,0
157451,12-month,0,0
157452,period,0,0
157453,.,0,0
157454,CONCLUSION,0,0
157455,The,0,0
157456,results,0,0
157457,of,0,0
157458,our,0,0
157459,study,0,0
157460,demonstrate,0,0
157461,the,0,0
157462,efficacy,0,0
157463,of,0,0
157464,the,0,0
157465,modes,0,0
157466,of,0,0
157467,intervention,0,0
157468,developed,0,0
157469,by,0,0
157470,us,0,0
157471,and,0,0
157472,serve,0,0
157473,as,0,0
157474,a,0,0
157475,new,0,0
157476,training,0,0
157477,tool,0,0
157478,for,0,0
157479,future,0,0
157480,health,0,0
157481,care,0,0
157482,professionals,0,0
157483,with,0,0
157484,regard,0,0
157485,to,0,0
157486,stigma,0,0
157487,reduction,0,0
157488,.,0,0
157489,The,0,0
157490,peroxisome,0,1
157491,proliferator,0,1
157492,activated,0,1
157493,receptor-?,1,1
157494,pioglitazone,1,1
157495,improves,0,1
157496,vascular,0,0
157497,function,0,0
157498,and,0,0
157499,decreases,0,0
157500,disease,0,0
157501,activity,0,0
157502,in,0,0
157503,patients,0,0
157504,with,0,0
157505,rheumatoid,0,0
157506,arthritis,0,0
157507,.,0,0
157508,BACKGROUND,0,0
157509,Rheumatoid,0,1
157510,arthritis,0,1
157511,(,0,1
157512,RA,0,1
157513,),0,0
157514,is,0,0
157515,associated,0,0
157516,with,0,0
157517,heightened,0,0
157518,mortality,0,0
157519,due,0,0
157520,to,0,0
157521,atherosclerotic,0,0
157522,cardiovascular,0,1
157523,disease,0,1
157524,(,0,1
157525,CVD,0,1
157526,),0,1
157527,.,0,0
157528,Inflammatory,0,0
157529,pathways,0,0
157530,in,0,0
157531,RA,0,0
157532,negatively,0,0
157533,affect,0,0
157534,vascular,0,0
157535,physiology,0,0
157536,and,0,0
157537,promote,0,0
157538,metabolic,0,0
157539,disturbances,0,0
157540,that,0,0
157541,contribute,0,0
157542,to,0,0
157543,CVD,0,0
157544,.,0,0
157545,We,0,0
157546,hypothesized,0,0
157547,that,0,0
157548,the,0,0
157549,peroxisome,0,1
157550,proliferator,0,1
157551,activated,0,1
157552,receptor-?,0,1
157553,(,0,1
157554,PPAR-?,1,1
157555,),1,1
157556,pioglitazone,1,1
157557,could,1,0
157558,promote,0,0
157559,potent,0,1
157560,vasculoprotective,0,1
157561,and,0,1
157562,anti-inflammatory,0,1
157563,effects,0,0
157564,in,0,0
157565,RA,0,0
157566,.,0,0
157567,METHODS,0,0
157568,AND,0,1
157569,RESULTS,0,0
157570,One,0,0
157571,hundred,0,0
157572,forty-three,0,0
157573,non-diabetic,0,0
157574,adult,0,0
157575,RA,0,1
157576,patients,0,0
157577,(,0,0
157578,76.2,0,0
157579,%,0,0
157580,female,0,0
157581,",",0,0
157582,age,0,0
157583,55.2,0,0
157584,?,0,0
157585,12.1,0,0
157586,[,0,0
157587,mean,0,0
157588,?,0,0
157589,SD,0,1
157590,],0,1
157591,),0,0
157592,on,0,0
157593,stable,0,0
157594,RA,0,0
157595,standard,0,0
157596,of,0,0
157597,care,0,0
157598,treatment,0,0
157599,were,0,0
157600,enrolled,0,0
157601,in,0,0
157602,a,0,0
157603,randomized,0,0
157604,",",0,1
157605,double-blind,0,1
157606,placebo,0,1
157607,controlled,0,1
157608,crossover,0,1
157609,trial,0,0
157610,of,1,0
157611,45,1,0
157612,mg,1,1
157613,daily,1,1
157614,pioglitazone,1,1
157615,versus,1,1
157616,placebo,1,1
157617,",",1,0
157618,with,1,0
157619,a,1,0
157620,3-month,1,0
157621,duration/arm,1,0
157622,and,1,0
157623,a,1,0
157624,2-month,1,1
157625,washout,1,1
157626,period,1,1
157627,.,1,0
157628,Pulse,1,0
157629,wave,0,0
157630,velocity,0,0
157631,of,0,0
157632,the,0,0
157633,aorta,0,0
157634,(,0,1
157635,PWV,0,1
157636,),0,1
157637,",",0,0
157638,brachial,0,0
157639,artery,0,0
157640,flow,0,0
157641,mediated,0,0
157642,dilatation,0,0
157643,(,0,1
157644,FMD,0,1
157645,),0,1
157646,",",0,0
157647,nitroglycerin,0,1
157648,mediated,0,1
157649,dilatation,0,1
157650,(,0,1
157651,NMD,0,1
157652,),0,1
157653,",",0,0
157654,microvascular,0,0
157655,endothelial,0,0
157656,function,0,0
157657,(,0,0
157658,reactive,0,0
157659,hyperemia,0,1
157660,index,0,1
157661,[,0,1
157662,RHI,0,1
157663,],0,1
157664,),0,0
157665,",",0,0
157666,and,0,0
157667,circulating,0,0
157668,biomarkers,0,0
157669,of,0,0
157670,inflammation,0,0
157671,",",0,0
157672,insulin,0,1
157673,resistance,0,0
157674,",",0,0
157675,and,0,0
157676,atherosclerosis,0,0
157677,risk,0,0
157678,all,0,0
157679,were,0,0
157680,quantified,0,0
157681,.,0,0
157682,RA,0,0
157683,disease,0,0
157684,activity,0,0
157685,was,0,0
157686,assessed,0,0
157687,with,0,0
157688,the,0,0
157689,28-Joint,0,0
157690,Count,0,0
157691,Disease,0,0
157692,Activity,0,0
157693,Score,0,0
157694,(,0,0
157695,DAS-28,0,1
157696,),0,0
157697,C-reactive,0,0
157698,protein,0,0
157699,(,0,0
157700,CRP,0,1
157701,),0,1
157702,and,0,0
157703,the,0,0
157704,Short,0,1
157705,Form,0,1
157706,(,0,0
157707,36,0,0
157708,),0,0
157709,Health,0,0
157710,Survey,0,0
157711,quality,0,0
157712,of,0,0
157713,life,0,0
157714,questionnaire,0,0
157715,.,0,0
157716,When,0,0
157717,added,0,0
157718,to,0,0
157719,standard,0,0
157720,of,0,0
157721,care,0,0
157722,RA,0,0
157723,treatment,1,0
157724,",",1,0
157725,pioglitazone,1,1
157726,significantly,1,0
157727,decreased,0,0
157728,pulse,0,0
157729,wave,0,1
157730,velocity,0,1
157731,(,0,0
157732,ie,0,0
157733,",",0,0
157734,aortic,0,1
157735,stiffness,0,1
157736,),0,0
157737,(,0,0
157738,P=0.01,0,0
157739,),0,0
157740,",",0,0
157741,while,0,0
157742,FMD,0,0
157743,and,0,0
157744,RHI,0,0
157745,remained,0,0
157746,unchanged,0,0
157747,when,0,0
157748,compared,0,0
157749,to,0,0
157750,treatment,0,0
157751,with,0,0
157752,placebo,1,1
157753,.,1,0
157754,Further,1,0
157755,",",1,0
157756,pioglitazone,1,1
157757,significantly,1,0
157758,reduced,0,0
157759,RA,0,0
157760,disease,0,1
157761,activity,0,0
157762,(,0,0
157763,P=0.02,0,0
157764,),0,0
157765,and,0,0
157766,CRP,0,1
157767,levels,0,0
157768,(,0,0
157769,P=0.001,0,0
157770,),0,0
157771,",",0,0
157772,while,0,0
157773,improving,0,0
157774,lipid,0,0
157775,profiles,0,0
157776,.,0,0
157777,The,0,0
157778,drug,0,1
157779,was,0,0
157780,well,0,0
157781,tolerated,0,1
157782,.,0,0
157783,CONCLUSIONS,0,0
157784,Addition,1,0
157785,of,1,0
157786,pioglitazone,1,1
157787,to,1,0
157788,RA,1,1
157789,standard,0,0
157790,of,0,0
157791,care,0,0
157792,significantly,0,0
157793,improves,0,0
157794,aortic,0,0
157795,elasticity,0,0
157796,and,0,0
157797,decreases,0,0
157798,inflammation,0,0
157799,and,0,0
157800,disease,0,0
157801,activity,0,0
157802,with,0,0
157803,minimal,0,0
157804,safety,0,0
157805,issues,0,0
157806,.,0,0
157807,The,0,0
157808,clinical,0,0
157809,implications,0,0
157810,of,0,0
157811,these,0,0
157812,findings,0,0
157813,remain,0,0
157814,to,0,0
157815,be,0,0
157816,established,0,0
157817,.,0,0
157818,CLINICAL,0,0
157819,TRIAL,0,1
157820,REGISTRATION,0,1
157821,URL,0,1
157822,ClinicalTrials.gov,0,1
157823,Unique,0,0
157824,Identifier,0,0
157825,:,0,0
157826,NCT00554853,0,0
157827,.,0,0
157828,The,0,0
157829,efficacy,0,0
157830,and,0,0
157831,safety,0,0
157832,of,0,0
157833,cyclosporine,1,1
157834,reduction,1,0
157835,in,0,0
157836,de,0,0
157837,novo,0,0
157838,renal,0,0
157839,allograft,0,0
157840,patients,0,0
157841,receiving,0,0
157842,sirolimus,0,1
157843,and,0,1
157844,corticosteroids,0,1
157845,:,0,0
157846,results,0,0
157847,from,0,0
157848,an,0,0
157849,open-label,0,1
157850,comparative,0,0
157851,study,0,0
157852,.,0,0
157853,This,0,0
157854,study,0,0
157855,evaluated,0,0
157856,the,0,0
157857,safety,0,0
157858,and,0,0
157859,efficacy,0,0
157860,of,0,0
157861,a,0,0
157862,sirolimus,1,1
157863,",",1,1
157864,corticosteroid,1,1
157865,",",1,1
157866,and,1,1
157867,cyclosporine,1,1
157868,reduction,1,1
157869,regimen,0,1
157870,in,0,0
157871,an,0,0
157872,open-label,0,1
157873,",",0,1
157874,12-month,0,1
157875,trial,0,0
157876,of,0,0
157877,420,0,0
157878,de,0,0
157879,novo,0,0
157880,renal,0,0
157881,allograft,0,0
157882,recipients,0,0
157883,at,0,0
157884,49,0,0
157885,European,0,0
157886,transplant,0,0
157887,centers,0,0
157888,.,0,0
157889,One,0,0
157890,month,0,0
157891,post-transplantation,0,0
157892,",",0,0
157893,357,0,0
157894,patients,0,0
157895,were,0,0
157896,randomized,0,0
157897,to,0,0
157898,receive,0,1
157899,standard-dose,1,1
157900,cyclosporine,1,1
157901,(,1,1
157902,sCsA,1,1
157903,",",0,0
157904,n,0,0
157905,=,0,0
157906,179,0,0
157907,),0,0
157908,or,0,0
157909,reduced-dose,1,1
157910,cyclosporine,1,1
157911,(,1,1
157912,rCsA,1,1
157913,",",0,0
157914,n,0,0
157915,=,0,0
157916,178,0,0
157917,),0,0
157918,.,0,0
157919,All,0,0
157920,patients,0,0
157921,also,0,0
157922,received,0,0
157923,sirolimus,1,1
157924,and,1,1
157925,corticosteroids,1,1
157926,.,1,0
157927,The,0,0
157928,primary,0,0
157929,end,0,0
157930,points,0,0
157931,were,0,0
157932,the,0,0
157933,rate,0,0
157934,of,0,0
157935,biopsy-confirmed,0,0
157936,acute,0,1
157937,rejection,0,1
157938,(,0,1
157939,BCAR,0,1
157940,),0,1
157941,and,0,0
157942,renal,0,0
157943,function,0,0
157944,",",0,0
157945,as,0,0
157946,measured,0,0
157947,by,0,0
157948,serum,0,1
157949,creatinine,0,1
157950,.,0,1
157951,Baseline,0,0
157952,demographic,0,0
157953,and,0,0
157954,donor,0,0
157955,characteristics,0,0
157956,were,0,0
157957,similar,0,0
157958,between,0,0
157959,groups,0,0
157960,.,0,0
157961,BCAR,0,0
157962,rates,0,0
157963,at,0,0
157964,12,0,0
157965,months,0,0
157966,were,0,0
157967,not,0,0
157968,significantly,0,0
157969,different,0,0
157970,:,0,0
157971,11.2,0,0
157972,%,0,0
157973,for,0,0
157974,rCsA,0,0
157975,patients,0,0
157976,and,0,0
157977,16.2,0,0
157978,%,0,0
157979,for,0,0
157980,sCsA,0,0
157981,patients,0,0
157982,.,0,0
157983,Mean,0,1
157984,serum,0,1
157985,creatinine,0,1
157986,(,0,1
157987,?SEM,0,1
157988,),0,0
157989,was,0,0
157990,significantly,0,0
157991,lower,0,0
157992,(,0,0
157993,1.75,0,0
157994,?,0,0
157995,0.10,0,0
157996,vs.,0,0
157997,1.97,0,0
157998,?,0,0
157999,0.07,0,0
158000,mg/dl,0,0
158001,",",0,0
158002,P,0,0
158003,<,0,0
158004,0.001,0,0
158005,),0,0
158006,",",0,0
158007,and,0,1
158008,creatinine,0,1
158009,clearance,0,1
158010,(,0,1
158011,?SEM,0,1
158012,;,0,1
158013,Nankivell,0,1
158014,method,0,0
158015,),0,0
158016,was,0,0
158017,significantly,0,0
158018,higher,0,0
158019,(,0,0
158020,57.8,0,0
158021,?,0,0
158022,1.78,0,0
158023,vs.,0,0
158024,49.5,0,0
158025,?,0,0
158026,2.46,0,0
158027,ml/min,0,0
158028,",",0,0
158029,P,0,0
158030,<,0,0
158031,0.001,0,0
158032,),0,0
158033,in,0,0
158034,patients,0,0
158035,receiving,0,0
158036,rCsA,0,1
158037,versus,0,0
158038,sCsA,0,0
158039,at,0,0
158040,1,0,0
158041,year,0,0
158042,",",0,0
158043,respectively,0,0
158044,.,0,0
158045,Patient,0,0
158046,and,0,0
158047,graft,0,0
158048,survival,0,0
158049,exceeded,0,0
158050,98,0,0
158051,%,0,0
158052,in,0,0
158053,both,0,0
158054,groups,0,0
158055,.,0,0
158056,No,0,1
158057,significant,0,0
158058,differences,0,0
158059,in,0,0
158060,infection,0,0
158061,or,0,0
158062,malignancy,0,0
158063,were,0,0
158064,noted,0,0
158065,between,0,0
158066,groups,0,0
158067,.,0,0
158068,The,0,0
158069,rCsA,0,0
158070,with,0,0
158071,sirolimus,0,1
158072,and,0,1
158073,corticosteroid,0,1
158074,regimen,0,1
158075,resulted,0,0
158076,in,0,0
158077,excellent,0,0
158078,12-month,0,0
158079,patient,0,0
158080,and,0,0
158081,graft,0,0
158082,survival,0,0
158083,",",0,0
158084,a,0,0
158085,low,0,0
158086,incidence,0,0
158087,of,0,0
158088,BCAR,0,0
158089,",",0,0
158090,and,0,0
158091,improved,0,0
158092,renal,0,0
158093,function,0,0
158094,in,0,0
158095,renal,0,0
158096,allograft,0,0
158097,recipients,0,0
158098,.,0,1
158099,Sirolimus,0,1
158100,administered,0,1
158101,with,0,1
158102,rCsA,0,1
158103,and,0,0
158104,corticosteroids,0,1
158105,provided,0,0
158106,adequate,0,1
158107,immunosuppression,0,0
158108,while,0,0
158109,reducing,0,0
158110,the,0,0
158111,potential,0,0
158112,for,0,0
158113,the,0,0
158114,nephrotoxic,0,1
158115,effects,0,0
158116,of,0,0
158117,cyclosporine,0,1
158118,.,0,0
158119,These,0,0
158120,findings,0,0
158121,may,0,0
158122,help,0,0
158123,to,0,0
158124,improve,0,0
158125,long-term,0,0
158126,renal,0,0
158127,allograft,0,0
158128,outcomes,0,0
158129,.,0,0
158130,Neuropsychological,0,0
158131,outcomes,0,0
158132,after,0,0
158133,psychosocial,1,0
158134,intervention,1,0
158135,for,0,0
158136,depression,0,0
158137,in,0,0
158138,Parkinson,0,0
158139,'s,0,0
158140,disease,0,0
158141,.,0,0
158142,The,0,0
158143,authors,0,0
158144,describe,0,0
158145,neuropsychological,0,0
158146,outcomes,0,0
158147,in,0,0
158148,people,0,0
158149,with,0,0
158150,Parkinson,0,0
158151,'s,0,0
158152,disease,0,1
158153,(,0,1
158154,PD,0,1
158155,),0,1
158156,after,0,0
158157,their,0,0
158158,participation,0,0
158159,in,0,0
158160,an,0,0
158161,NIH-sponsored,0,0
158162,",",0,0
158163,randomized,0,0
158164,",",0,0
158165,controlled,0,0
158166,trial,0,0
158167,of,0,0
158168,cognitive-behavioral,1,0
158169,treatment,1,0
158170,for,0,0
158171,depression,0,0
158172,.,0,0
158173,Improvements,0,0
158174,in,0,0
158175,mood,0,0
158176,were,0,0
158177,associated,0,0
158178,with,0,0
158179,modest,0,0
158180,gains,0,0
158181,in,0,0
158182,verbal,0,0
158183,memory,0,0
158184,and,0,0
158185,executive,0,0
158186,functioning,0,0
158187,over,0,0
158188,the,0,0
158189,10-week,0,0
158190,treatment,0,0
158191,period,0,0
158192,and,0,0
158193,accounted,0,0
158194,for,0,0
158195,greater,0,0
158196,variance,0,0
158197,in,0,0
158198,neuropsychological,0,0
158199,outcomes,0,0
158200,at,0,0
158201,the,0,0
158202,end,0,0
158203,of,0,0
158204,treatment,0,0
158205,than,0,0
158206,other,0,0
158207,known,0,0
158208,correlates,0,0
158209,of,0,0
158210,cognitive,0,0
158211,functioning,0,0
158212,in,0,0
158213,PD,0,0
158214,",",0,0
158215,such,0,0
158216,as,0,0
158217,disease,0,0
158218,severity,0,0
158219,",",0,0
158220,age,0,0
158221,",",0,0
158222,and,0,0
158223,education,0,0
158224,.,0,0
158225,Baseline,0,0
158226,working,0,0
158227,memory,0,0
158228,and,0,0
158229,executive,0,0
158230,skills,0,0
158231,were,0,0
158232,also,0,0
158233,associated,0,0
158234,with,0,0
158235,depression,0,0
158236,improvement,0,0
158237,over,0,0
158238,time,0,0
158239,.,0,0
158240,Comparative,0,0
158241,evaluation,0,0
158242,of,0,0
158243,percutaneous,1,0
158244,laser,1,0
158245,and,0,0
158246,radiofrequency,1,0
158247,ablation,1,0
158248,in,0,0
158249,patients,0,0
158250,with,0,0
158251,HCC,0,0
158252,smaller,0,0
158253,than,0,0
158254,4,0,0
158255,cm,0,0
158256,.,0,0
158257,OBJECTIVE,0,0
158258,This,0,0
158259,study,0,0
158260,was,0,0
158261,done,0,0
158262,to,0,0
158263,compare,0,0
158264,percutaneous,1,0
158265,laser,1,1
158266,ablation,1,1
158267,(,1,1
158268,PLA,1,1
158269,),1,1
158270,and,0,0
158271,radiofrequency,1,1
158272,thermoablation,1,1
158273,(,1,1
158274,RFA,1,1
158275,),1,0
158276,for,0,0
158277,the,0,0
158278,treatment,0,0
158279,of,0,0
158280,hepatocellular,0,1
158281,carcinoma,0,1
158282,(,0,1
158283,HCC,0,1
158284,),0,1
158285,?,0,1
158286,4,0,0
158287,cm,0,0
158288,",",0,0
158289,in,0,0
158290,patients,0,0
158291,with,0,0
158292,liver,0,0
158293,cirrhosis,0,0
158294,.,0,0
158295,MATERIALS,0,0
158296,AND,0,1
158297,METHODS,0,1
158298,Thirty,0,0
158299,patients,0,0
158300,with,0,0
158301,single,0,0
158302,HCC,0,0
158303,?,0,0
158304,4,0,0
158305,cm,0,0
158306,in,0,0
158307,diameter,0,0
158308,were,0,0
158309,randomly,0,0
158310,assigned,0,0
158311,to,0,0
158312,one,0,0
158313,of,0,0
158314,two,0,0
158315,treatments,0,0
158316,:,0,0
158317,15,0,0
158318,patients,0,0
158319,were,0,0
158320,treated,0,0
158321,with,0,0
158322,PLA,1,0
158323,",",0,0
158324,using,1,0
158325,a,1,0
158326,multifibre,1,0
158327,system,1,0
158328,connected,1,0
158329,to,1,0
158330,a,1,0
158331,neodymium,1,1
158332,yttrium-aluminium-garnet,1,1
158333,laser,1,1
158334,source,1,1
158335,;,1,0
158336,15,1,0
158337,patients,0,0
158338,were,0,0
158339,treated,0,0
158340,with,0,0
158341,RFA,1,0
158342,",",1,0
158343,using,1,0
158344,an,1,0
158345,expandable,1,0
158346,needle,1,0
158347,electrode,1,0
158348,.,1,0
158349,Patients,1,0
158350,were,0,0
158351,followed,0,0
158352,up,0,0
158353,for,0,0
158354,up,0,0
158355,to,0,0
158356,12,0,0
158357,months,0,0
158358,.,0,0
158359,RESULTS,0,0
158360,A,0,0
158361,complete,0,0
158362,response,0,0
158363,was,0,0
158364,obtained,0,0
158365,in,0,0
158366,87,0,0
158367,%,0,0
158368,lesions,0,0
158369,treated,0,0
158370,with,0,0
158371,PLA,0,0
158372,and,0,0
158373,in,0,0
158374,93,0,0
158375,%,0,0
158376,lesions,0,0
158377,treated,0,0
158378,with,0,0
158379,RFA,0,0
158380,(,0,0
158381,p,0,0
158382,=,0,0
158383,ns,0,0
158384,),0,0
158385,.,0,0
158386,The,0,0
158387,overall,0,0
158388,local,0,0
158389,recurrence-free,0,0
158390,survival,0,0
158391,rates,0,0
158392,at,0,0
158393,3,0,0
158394,",",0,0
158395,6,0,0
158396,and,0,0
158397,12,0,0
158398,months,0,0
158399,were,0,0
158400,comparable,0,0
158401,.,0,0
158402,However,0,0
158403,",",0,0
158404,a,0,0
158405,higher,0,0
158406,rate,0,0
158407,of,0,0
158408,recurrence,0,0
158409,was,0,0
158410,observed,0,0
158411,in,0,0
158412,the,0,0
158413,PLA,0,0
158414,group,0,0
158415,for,0,0
158416,lesions,0,0
158417,?,0,0
158418,21,0,0
158419,mm,0,0
158420,(,0,0
158421,p,0,0
158422,=,0,0
158423,0.0081,0,0
158424,),0,0
158425,.,0,0
158426,A,0,1
158427,postablation,0,0
158428,syndrome,0,0
158429,was,0,0
158430,documented,0,0
158431,in,0,0
158432,13,0,0
158433,patients,0,0
158434,(,0,0
158435,1,0,1
158436,PLA,0,1
158437,;,0,1
158438,12,0,0
158439,RFA,0,1
158440,),0,1
158441,.,0,0
158442,Tumour,0,0
158443,necrosis,0,0
158444,factor-?,0,0
158445,was,0,0
158446,significantly,0,0
158447,higher,0,0
158448,in,0,0
158449,the,0,0
158450,RFA,0,1
158451,group,0,0
158452,(,0,0
158453,p,0,0
158454,<,0,0
158455,0.05,0,0
158456,),0,0
158457,.,0,0
158458,CONCLUSIONS,0,0
158459,RFA,0,0
158460,is,0,0
158461,more,0,0
158462,effective,0,0
158463,in,0,0
158464,the,0,0
158465,treatment,0,0
158466,of,0,0
158467,HCC,0,0
158468,compared,1,0
158469,to,1,0
158470,PLA,1,0
158471,for,0,0
158472,lesions,0,0
158473,?,0,0
158474,21,0,0
158475,mm,0,0
158476,.,0,0
158477,However,0,0
158478,",",0,0
158479,PLA,0,0
158480,should,0,0
158481,be,0,0
158482,considered,0,0
158483,a,0,0
158484,viable,0,0
158485,treatment,0,0
158486,option,0,0
158487,for,0,0
158488,HCC,0,1
158489,?,0,0
158490,20,0,0
158491,mm,0,0
158492,",",0,0
158493,in,0,0
158494,view,0,0
158495,of,0,0
158496,the,0,0
158497,lower,0,0
158498,incidence,0,0
158499,of,0,0
158500,complications,0,0
158501,.,0,0
158502,A,0,0
158503,novel,0,0
158504,methodology,0,0
158505,for,0,0
158506,generating,0,0
158507,3D,1,1
158508,finite,1,1
158509,element,1,0
158510,models,1,0
158511,of,0,0
158512,the,0,0
158513,hip,0,0
158514,from,0,0
158515,2D,1,0
158516,radiographs,1,0
158517,.,1,0
158518,Finite,1,0
158519,element,1,0
158520,(,1,1
158521,FE,1,1
158522,),1,0
158523,modelling,1,0
158524,has,0,0
158525,been,0,0
158526,proposed,0,0
158527,as,0,0
158528,a,0,0
158529,tool,0,0
158530,for,0,0
158531,estimating,0,0
158532,fracture,0,0
158533,risk,0,0
158534,and,0,0
158535,patient-specific,1,0
158536,FE,1,0
158537,models,1,0
158538,are,0,0
158539,commonly,0,0
158540,based,0,0
158541,on,0,0
158542,computed,1,0
158543,tomography,1,0
158544,(,0,1
158545,CT,0,0
158546,),0,0
158547,.,0,0
158548,Here,0,0
158549,",",0,0
158550,we,0,0
158551,present,0,0
158552,a,0,0
158553,novel,0,0
158554,method,0,0
158555,to,0,0
158556,automatically,0,0
158557,create,1,0
158558,personalised,1,0
158559,3D,1,1
158560,models,1,0
158561,from,1,0
158562,standard,1,0
158563,2D,1,1
158564,hip,1,0
158565,radiographs,1,0
158566,.,1,0
158567,A,0,0
158568,set,0,0
158569,of,0,0
158570,geometrical,0,0
158571,parameters,0,0
158572,of,0,0
158573,the,0,0
158574,femur,0,0
158575,were,0,0
158576,determined,0,0
158577,from,0,0
158578,seven,0,0
158579,a-p,1,0
158580,hip,1,0
158581,radiographs,1,0
158582,and,0,0
158583,compared,0,0
158584,to,0,0
158585,the,0,0
158586,3D,1,1
158587,femoral,1,1
158588,shape,1,0
158589,obtained,1,0
158590,from,1,0
158591,CT,1,0
158592,as,0,0
158593,training,0,0
158594,material,0,0
158595,;,0,0
158596,the,0,0
158597,error,0,0
158598,in,0,0
158599,reconstructing,0,0
158600,the,0,0
158601,3D,0,1
158602,model,0,0
158603,from,0,0
158604,the,0,0
158605,2D,0,0
158606,radiographs,0,0
158607,was,0,0
158608,assessed,0,0
158609,.,0,0
158610,Using,0,0
158611,the,0,0
158612,geometry,0,0
158613,parameters,0,0
158614,as,0,0
158615,the,0,0
158616,input,0,0
158617,",",0,0
158618,the,0,0
158619,3D,0,1
158620,shape,0,0
158621,of,0,0
158622,another,0,0
158623,21,0,0
158624,femora,0,0
158625,was,0,0
158626,built,0,0
158627,and,0,0
158628,meshed,0,0
158629,",",0,0
158630,separating,0,0
158631,a,0,0
158632,cortical,0,0
158633,and,0,0
158634,trabecular,0,0
158635,compartment,0,0
158636,.,0,0
158637,The,0,0
158638,material,0,0
158639,properties,0,0
158640,were,0,0
158641,derived,0,0
158642,from,0,0
158643,the,0,0
158644,homogeneity,0,0
158645,index,0,0
158646,assessed,0,0
158647,by,0,0
158648,texture,0,0
158649,analysis,0,0
158650,of,0,0
158651,the,0,0
158652,radiographs,0,0
158653,",",0,0
158654,with,0,0
158655,focus,0,0
158656,on,0,0
158657,the,0,0
158658,principal,0,0
158659,tensile,0,0
158660,and,0,0
158661,compressive,0,0
158662,trabecular,0,0
158663,systems,0,0
158664,.,0,0
158665,The,0,0
158666,ability,0,0
158667,of,0,0
158668,these,0,0
158669,FE,1,0
158670,models,1,0
158671,to,0,0
158672,predict,0,0
158673,failure,0,0
158674,load,0,0
158675,as,0,0
158676,determined,0,0
158677,by,0,0
158678,experimental,0,0
158679,biomechanical,0,0
158680,testing,0,0
158681,was,0,0
158682,evaluated,0,0
158683,and,0,0
158684,compared,0,0
158685,to,0,0
158686,the,0,0
158687,predictive,0,0
158688,ability,0,0
158689,of,0,0
158690,DXA,0,0
158691,.,0,0
158692,The,0,0
158693,average,0,0
158694,reconstruction,0,0
158695,error,0,0
158696,of,0,0
158697,the,0,0
158698,3D,0,1
158699,models,0,0
158700,was,0,0
158701,1.77,0,0
158702,mm,0,0
158703,(,0,0
158704,?1.17,0,0
158705,mm,0,0
158706,),0,0
158707,",",0,0
158708,with,0,0
158709,the,0,0
158710,error,0,0
158711,being,0,0
158712,smallest,0,0
158713,in,0,0
158714,the,0,0
158715,femoral,0,0
158716,head,0,0
158717,and,0,0
158718,neck,0,0
158719,",",0,0
158720,and,0,0
158721,greatest,0,0
158722,in,0,0
158723,the,0,0
158724,trochanter,0,0
158725,.,0,0
158726,The,0,0
158727,correlation,0,0
158728,of,0,0
158729,the,0,0
158730,FE,0,0
158731,predicted,0,0
158732,failure,0,0
158733,load,0,0
158734,with,0,0
158735,the,0,0
158736,experimental,0,0
158737,failure,0,0
158738,load,0,0
158739,was,0,0
158740,r,0,1
158741,(,0,1
158742,2,0,0
158743,),0,0
158744,=64,0,0
158745,%,0,0
158746,for,0,0
158747,the,0,0
158748,reconstruction,0,0
158749,FE,0,0
158750,model,0,0
158751,",",0,0
158752,which,0,0
158753,was,0,0
158754,significantly,0,0
158755,better,0,0
158756,(,0,0
158757,p,0,0
158758,<,0,0
158759,0.05,0,0
158760,),0,0
158761,than,0,0
158762,that,0,0
158763,for,0,0
158764,DXA,0,1
158765,(,0,1
158766,r,0,1
158767,(,0,1
158768,2,0,0
158769,),0,0
158770,=24,0,0
158771,%,0,0
158772,),0,0
158773,.,0,0
158774,This,0,0
158775,novel,0,0
158776,method,0,0
158777,for,0,0
158778,automatically,0,0
158779,constructing,0,0
158780,a,0,0
158781,patient-specific,1,1
158782,3D,1,1
158783,finite,1,1
158784,element,1,0
158785,model,1,0
158786,from,1,0
158787,standard,1,0
158788,2D,1,0
158789,radiographs,1,0
158790,shows,0,0
158791,encouraging,0,0
158792,results,0,0
158793,in,0,0
158794,estimating,0,0
158795,patient-specific,0,0
158796,failure,0,0
158797,loads,0,0
158798,.,0,0
158799,Influence,0,0
158800,of,0,0
158801,two,0,0
158802,different,0,0
158803,doses,0,1
158804,of,0,1
158805,antithymocyte,1,1
158806,globulin,1,1
158807,in,0,0
158808,patients,0,0
158809,with,0,0
158810,standard-risk,0,0
158811,disease,0,0
158812,following,0,0
158813,haploidentical,0,0
158814,transplantation,0,0
158815,:,0,0
158816,a,0,0
158817,randomized,0,0
158818,trial,0,0
158819,.,0,0
158820,To,0,0
158821,evaluate,0,0
158822,the,0,0
158823,effect,0,0
158824,of,0,0
158825,the,0,0
158826,different,0,0
158827,doses,0,1
158828,of,0,1
158829,antithymocyte,1,1
158830,globulin,1,1
158831,(,1,1
158832,ATG,1,1
158833,),1,1
158834,on,0,0
158835,the,0,0
158836,incidence,0,0
158837,of,0,0
158838,acute,0,0
158839,GVHD,0,0
158840,among,0,0
158841,patients,0,0
158842,receiving,0,0
158843,hematopoietic,0,0
158844,SCT,0,1
158845,without,0,0
158846,ex,0,0
158847,vivo,0,0
158848,T-cell-depletion,0,1
158849,from,0,0
158850,haploidentical,0,0
158851,donors,0,0
158852,",",0,0
158853,224,0,0
158854,patients,0,0
158855,with,0,0
158856,standard-risk,0,0
158857,hematological,0,0
158858,malignancy,0,0
158859,were,0,0
158860,randomized,0,0
158861,in,0,0
158862,this,0,0
158863,study,0,0
158864,.,0,0
158865,One,0,0
158866,hundred,0,0
158867,and,0,0
158868,twelve,0,0
158869,patients,0,0
158870,received,0,0
158871,6,1,1
158872,mg/kg,1,1
158873,ATG,1,1
158874,",",1,0
158875,whereas,0,0
158876,the,0,0
158877,remaining,0,0
158878,patients,0,0
158879,received,1,0
158880,10,1,1
158881,mg/kg,1,1
158882,ATG,1,1
158883,.,0,1
158884,This,0,0
158885,study,0,0
158886,was,0,0
158887,registered,0,0
158888,at,0,0
158889,http,0,0
158890,:,0,0
158891,//www.chictr.org,0,0
158892,as,0,0
158893,No,0,1
158894,.,0,0
158895,ChiCTR-TRC-11001761,0,0
158896,.,0,0
158897,The,0,0
158898,incidence,0,0
158899,of,0,0
158900,grade,0,0
158901,III-IV,0,1
158902,acute,0,0
158903,GVHD,0,0
158904,was,0,0
158905,higher,0,0
158906,in,0,0
158907,the,0,0
158908,ATG-6,1,1
158909,group,1,0
158910,(,0,0
158911,16.1,0,0
158912,%,0,0
158913,",",0,0
158914,95,0,0
158915,%,0,0
158916,confidence,0,0
158917,interval,0,0
158918,(,0,0
158919,CI,0,0
158920,),0,0
158921,",",0,0
158922,9.1-23.1,0,0
158923,%,0,0
158924,),0,0
158925,than,0,0
158926,in,0,0
158927,the,0,0
158928,ATG-10,1,1
158929,group,1,0
158930,(,0,0
158931,4.5,0,0
158932,%,0,0
158933,",",0,0
158934,CI,0,0
158935,",",0,0
158936,0.7-8.3,0,0
158937,%,0,0
158938,",",0,0
158939,P=0.005,0,0
158940,",",0,0
158941,95,0,0
158942,%,0,0
158943,CI,0,0
158944,for,0,0
158945,the,0,0
158946,difference,0,0
158947,",",0,0
158948,-19.4,0,0
158949,%,0,0
158950,to,0,0
158951,-3.8,0,0
158952,%,0,0
158953,),0,0
158954,.,0,0
158955,EBV,0,0
158956,reactivation,0,0
158957,occurred,0,0
158958,more,0,0
158959,frequently,0,0
158960,in,0,0
158961,the,0,0
158962,ATG-10,1,1
158963,group,1,0
158964,(,0,0
158965,25.3,0,0
158966,%,0,0
158967,",",0,0
158968,17.1-33.5,0,0
158969,%,0,0
158970,),0,0
158971,than,0,0
158972,in,0,0
158973,the,0,0
158974,ATG-6,1,1
158975,group,1,0
158976,(,0,0
158977,9.6,0,0
158978,%,0,0
158979,(,0,0
158980,4.0-15.2,0,0
158981,%,0,0
158982,),0,0
158983,",",0,0
158984,P=0.001,0,0
158985,),0,0
158986,.,0,0
158987,The,0,0
158988,1-year,0,0
158989,disease-free,0,0
158990,survival,0,0
158991,rates,0,0
158992,were,0,0
158993,84.3,0,0
158994,%,0,0
158995,(,0,0
158996,77.3-91.3,0,0
158997,%,0,0
158998,),0,0
158999,and,0,0
159000,86.0,0,0
159001,%,0,0
159002,(,0,0
159003,79.2-92.8,0,0
159004,%,0,0
159005,),0,0
159006,for,0,0
159007,the,0,0
159008,ATG-6,1,0
159009,group,1,0
159010,and,0,0
159011,ATG-10,1,1
159012,groups,1,0
159013,",",0,0
159014,respectively,0,0
159015,(,0,0
159016,P=0.88,0,0
159017,),0,0
159018,.,0,0
159019,In,0,0
159020,conclusion,0,0
159021,",",0,0
159022,although,1,0
159023,6,1,1
159024,mg/kg,1,1
159025,ATG,1,1
159026,applied,1,0
159027,in,0,0
159028,haploidentical,0,0
159029,transplantation,0,0
159030,decreased,0,0
159031,the,0,0
159032,risk,0,0
159033,of,0,0
159034,EBV,0,0
159035,reactivation,0,0
159036,compared,1,0
159037,with,1,0
159038,10,1,0
159039,mg/kg,1,1
159040,ATG,1,1
159041,",",1,0
159042,this,1,0
159043,treatment,0,0
159044,exposes,0,0
159045,patients,0,0
159046,to,0,0
159047,a,0,0
159048,higher,0,0
159049,risk,0,0
159050,for,0,0
159051,severe,0,0
159052,acute,0,0
159053,GVHD,0,0
159054,.,0,0
159055,TGF-beta,0,1
159056,receptor,0,0
159057,type-2,0,0
159058,expression,0,0
159059,in,0,0
159060,cancer-associated,0,0
159061,fibroblasts,0,0
159062,regulates,0,0
159063,breast,0,0
159064,cancer,0,0
159065,cell,0,0
159066,growth,0,0
159067,and,0,0
159068,survival,0,0
159069,and,0,0
159070,is,0,0
159071,a,0,0
159072,prognostic,0,0
159073,marker,0,0
159074,in,0,0
159075,pre-menopausal,0,0
159076,breast,0,0
159077,cancer,0,0
159078,.,0,0
159079,Transforming,0,0
159080,growth,0,0
159081,factor-beta,0,1
159082,(,1,1
159083,TGF-?,1,1
159084,),1,0
159085,is,0,0
159086,a,0,0
159087,pleiotropic,0,0
159088,cytokine,0,0
159089,with,0,0
159090,the,0,0
159091,capability,0,0
159092,to,0,0
159093,act,0,0
159094,as,0,0
159095,tumour,0,0
159096,suppressor,0,0
159097,or,0,0
159098,tumour,0,0
159099,promoter,0,0
159100,depending,0,0
159101,on,0,0
159102,the,0,0
159103,cellular,0,0
159104,context,0,0
159105,.,0,0
159106,TGF-beta,1,0
159107,receptor,1,0
159108,type-2,1,1
159109,(,1,1
159110,TGFBR2,1,1
159111,),1,0
159112,is,0,0
159113,the,0,0
159114,ligand-binding,0,0
159115,receptor,0,0
159116,for,0,0
159117,all,0,0
159118,members,0,0
159119,of,0,0
159120,the,0,0
159121,TGF-?,0,0
159122,family,0,0
159123,.,0,0
159124,Data,0,0
159125,from,0,0
159126,mouse,0,0
159127,model,0,0
159128,experiments,0,0
159129,demonstrated,0,0
159130,that,0,0
159131,loss,0,0
159132,of,0,0
159133,Tgfbr2,0,0
159134,expression,0,0
159135,in,0,0
159136,mammary,0,0
159137,fibroblasts,0,0
159138,was,0,0
159139,linked,0,0
159140,to,0,0
159141,tumour,0,0
159142,initiation,0,0
159143,and,0,0
159144,metastasis,0,0
159145,.,0,0
159146,Using,0,0
159147,a,0,0
159148,randomised,1,1
159149,tamoxifen,1,1
159150,trial,1,1
159151,cohort,0,0
159152,including,0,0
159153,in,0,0
159154,total,0,0
159155,564,0,0
159156,invasive,0,0
159157,breast,0,0
159158,carcinomas,0,0
159159,",",0,0
159160,we,0,0
159161,examined,1,0
159162,TGFBR2,1,0
159163,expression,1,0
159164,(,0,0
159165,n=252,0,0
159166,),0,0
159167,and,0,0
159168,phosphorylation,0,0
159169,level,0,0
159170,of,0,0
159171,downstream,0,0
159172,target,1,0
159173,SMAD2,1,1
159174,(,1,1
159175,pSMAD2,1,1
159176,),1,1
159177,(,1,0
159178,n=319,0,0
159179,),0,0
159180,in,0,0
159181,cancer-associated,1,0
159182,fibroblasts,1,0
159183,(,1,0
159184,CAFs,1,1
159185,),1,1
159186,and,1,0
159187,assessed,0,0
159188,links,0,0
159189,to,0,0
159190,clinicopathological,0,0
159191,markers,0,0
159192,",",0,0
159193,prognostic,0,0
159194,and,0,0
159195,treatment-predictive,0,0
159196,values,0,0
159197,.,0,0
159198,The,0,0
159199,study,0,0
159200,revealed,0,0
159201,that,0,0
159202,CAF-specific,0,0
159203,TGFBR2,0,0
159204,expression,0,0
159205,correlated,0,0
159206,with,0,0
159207,improved,0,0
159208,recurrence-free,0,0
159209,survival,0,0
159210,.,0,0
159211,Multivariate,0,0
159212,analysis,0,0
159213,confirmed,0,0
159214,CAF-TGFBR2,0,0
159215,to,0,0
159216,be,0,0
159217,an,0,0
159218,independent,0,0
159219,prognostic,0,0
159220,marker,0,0
159221,(,0,0
159222,multivariate,0,0
159223,Cox,0,1
159224,regression,0,1
159225,",",0,0
159226,hazard,0,0
159227,ratio,0,0
159228,:,0,0
159229,0.534,0,0
159230,",",0,0
159231,95,0,0
159232,%,0,0
159233,(,0,0
159234,CI,0,0
159235,),0,0
159236,:,0,0
159237,0.360-0.793,0,0
159238,",",0,0
159239,P=0.002,0,0
159240,),0,0
159241,.,0,0
159242,CAF-specific,0,0
159243,pSMAD2,0,0
159244,levels,0,0
159245,",",0,0
159246,however,0,0
159247,",",0,0
159248,did,0,0
159249,not,0,0
159250,associate,0,0
159251,with,0,0
159252,survival,0,0
159253,outcome,0,0
159254,.,0,0
159255,Experimentally,0,0
159256,",",0,0
159257,TGF-?,0,0
159258,signalling,0,0
159259,in,0,0
159260,fibroblasts,0,0
159261,was,0,0
159262,modulated,0,0
159263,using,0,0
159264,a,0,0
159265,TGF-?,0,0
159266,ligand,0,0
159267,and,0,0
159268,inhibitor,0,1
159269,or,0,0
159270,through,0,0
159271,lentiviral,0,0
159272,short,0,0
159273,hairpin,0,0
159274,RNA-mediated,0,0
159275,TGFBR2-specific,0,0
159276,knockdown,0,0
159277,.,0,0
159278,To,0,0
159279,determine,0,0
159280,the,0,0
159281,role,0,0
159282,of,0,0
159283,fibroblastic,0,0
159284,TGF-?,0,0
159285,pathway,0,0
159286,on,0,0
159287,breast,0,0
159288,cancer,0,0
159289,cells,0,0
159290,",",0,0
159291,we,0,0
159292,used,0,0
159293,cell,0,0
159294,contact-dependent,0,0
159295,cell,0,0
159296,growth,0,0
159297,and,0,0
159298,clonogenicity,0,0
159299,assays,0,0
159300,",",0,0
159301,which,0,0
159302,showed,0,0
159303,that,0,0
159304,knockdown,0,0
159305,of,0,0
159306,TGFBR2,0,0
159307,in,0,0
159308,CAFs,0,0
159309,resulted,0,0
159310,in,0,0
159311,increased,0,0
159312,cell,0,0
159313,growth,0,0
159314,",",0,0
159315,proliferation,0,0
159316,and,0,0
159317,clonogenic,0,1
159318,survival,0,1
159319,.,0,0
159320,Further,0,0
159321,",",0,0
159322,in,0,0
159323,a,0,0
159324,mouse,0,0
159325,model,0,0
159326,transfected,1,0
159327,CAFs,1,0
159328,were,0,0
159329,co-injected,0,0
159330,with,0,0
159331,MCF7,1,0
159332,and,0,0
159333,tumour,0,0
159334,weight,0,0
159335,and,0,0
159336,proportion,0,0
159337,was,0,0
159338,monitored,0,0
159339,.,0,0
159340,We,0,0
159341,found,0,0
159342,that,0,0
159343,mouse,0,0
159344,xenograft,0,1
159345,tumours,0,1
159346,comprising,0,0
159347,TGFBR2,0,0
159348,knockdown,0,0
159349,fibroblasts,0,0
159350,were,0,0
159351,slightly,0,0
159352,bigger,0,0
159353,and,0,0
159354,displayed,0,0
159355,increased,0,0
159356,tumour,0,0
159357,cell,0,0
159358,capacity,0,0
159359,.,0,0
159360,Overall,0,0
159361,",",0,0
159362,our,0,0
159363,data,0,0
159364,demonstrate,0,0
159365,that,0,0
159366,fibroblast-related,0,0
159367,biomarkers,0,0
159368,possess,0,0
159369,clinically,0,0
159370,relevant,0,0
159371,information,0,0
159372,and,0,0
159373,that,0,0
159374,fibroblasts,0,0
159375,confer,0,0
159376,effects,0,0
159377,on,0,0
159378,breast,0,0
159379,cancer,0,0
159380,cell,0,0
159381,growth,0,0
159382,and,0,0
159383,survival,0,0
159384,.,0,0
159385,Regulation,0,0
159386,of,0,0
159387,tumour-stromal,0,0
159388,cross-talk,0,0
159389,through,0,0
159390,fibroblastic,0,0
159391,TGF-?,0,0
159392,pathway,0,0
159393,may,0,0
159394,depend,0,0
159395,on,0,0
159396,fibroblast,0,0
159397,phenotype,0,0
159398,",",0,0
159399,emphasising,0,0
159400,the,0,0
159401,importance,0,0
159402,to,0,0
159403,characterise,0,0
159404,tumour,0,0
159405,microenvironment,0,0
159406,subtypes,0,0
159407,.,0,0
159408,Low-dose,0,1
159409,versus,0,1
159410,standard-dose,0,1
159411,gemcitabine,1,1
159412,infusion,1,1
159413,and,0,1
159414,cisplatin,1,1
159415,for,0,0
159416,patients,0,0
159417,with,0,0
159418,advanced,0,0
159419,bladder,0,0
159420,cancer,0,0
159421,:,0,0
159422,a,0,0
159423,randomized,0,0
159424,phase,0,0
159425,II,0,1
159426,trial-an,0,0
159427,update,0,0
159428,.,0,0
159429,Prolonged,0,0
159430,infusion,0,1
159431,of,0,1
159432,low-dose,0,1
159433,gemcitabine,1,1
159434,and,1,1
159435,cisplatin,1,1
159436,(,1,1
159437,GC,1,1
159438,),1,0
159439,proved,0,0
159440,to,0,0
159441,be,0,0
159442,an,0,0
159443,effective,0,0
159444,treatment,0,0
159445,for,0,0
159446,patients,0,0
159447,with,0,0
159448,advanced,0,0
159449,bladder,0,0
159450,cancer,0,0
159451,.,0,0
159452,One,0,0
159453,hundred,0,0
159454,and,0,0
159455,twenty,0,0
159456,untreated,0,0
159457,patients,0,0
159458,with,0,0
159459,stage,0,0
159460,III/IV,0,0
159461,bladder,0,0
159462,cancer,0,0
159463,were,0,0
159464,randomized,0,0
159465,to,0,0
159466,receive,0,0
159467,either,0,0
159468,gemcitabine,1,1
159469,(,0,1
159470,250,0,1
159471,mg/m,0,1
159472,(,0,1
159473,2,0,1
159474,),0,1
159475,),0,1
159476,6-h,0,1
159477,infusion,0,1
159478,on,0,1
159479,days,0,0
159480,1,0,0
159481,and,0,0
159482,8,0,0
159483,",",0,0
159484,and,1,1
159485,cisplatin,1,1
159486,(,0,1
159487,70,0,1
159488,mg/m,0,1
159489,(,0,1
159490,2,0,1
159491,),0,1
159492,),0,1
159493,on,0,0
159494,day,0,0
159495,2,0,1
159496,every,0,1
159497,21-day,0,1
159498,cycle,0,1
159499,(,0,1
159500,arm,0,1
159501,1,0,1
159502,),0,0
159503,or,0,1
159504,gemcitabine,1,1
159505,(,0,1
159506,"1,250",0,1
159507,mg/m,0,1
159508,(,0,1
159509,2,0,1
159510,),0,1
159511,),0,1
159512,30-min,0,1
159513,infusion,0,1
159514,on,0,1
159515,days,0,0
159516,1,0,0
159517,and,0,0
159518,8,0,0
159519,",",0,0
159520,with,0,0
159521,the,0,0
159522,same,0,0
159523,dose,0,1
159524,of,0,1
159525,cisplatin,1,1
159526,(,0,1
159527,arm,0,1
159528,2,0,1
159529,),0,0
159530,.,0,0
159531,The,0,0
159532,92,0,0
159533,males,0,0
159534,and,0,0
159535,28,0,0
159536,females,0,0
159537,included,0,0
159538,in,0,0
159539,the,0,0
159540,study,0,0
159541,had,0,0
159542,a,0,0
159543,median,0,0
159544,age,0,0
159545,of,0,0
159546,62,0,0
159547,years,0,0
159548,(,0,0
159549,range,0,0
159550,40-85,0,0
159551,years,0,0
159552,),0,0
159553,.,0,0
159554,Among,0,0
159555,the,0,0
159556,120,0,0
159557,patient,0,0
159558,",",0,0
159559,complete,0,0
159560,response,0,0
159561,was,0,0
159562,achieved,0,0
159563,in,0,0
159564,11.7,0,0
159565,%,0,0
159566,(,0,0
159567,7/60,0,0
159568,patients,0,0
159569,of,0,0
159570,arm,0,1
159571,1,0,1
159572,),0,0
159573,and,0,0
159574,5,0,0
159575,%,0,0
159576,(,0,0
159577,3/60,0,0
159578,patients,0,0
159579,of,0,0
159580,arm,0,1
159581,2,0,0
159582,),0,0
159583,.,0,0
159584,Eighteen,0,0
159585,patients,0,0
159586,in,0,0
159587,arm,0,1
159588,1,0,1
159589,(,0,0
159590,30,0,0
159591,%,0,0
159592,),0,0
159593,and,0,0
159594,17,0,0
159595,patients,0,0
159596,(,0,0
159597,28.3,0,0
159598,%,0,0
159599,),0,0
159600,in,0,0
159601,arm,0,0
159602,2,0,0
159603,had,0,0
159604,partial,0,0
159605,response,0,0
159606,on,0,0
159607,therapy,0,0
159608,.,0,0
159609,Thus,0,0
159610,",",0,0
159611,the,0,0
159612,overall,0,0
159613,response,0,0
159614,rate,0,0
159615,of,0,0
159616,patients,0,0
159617,in,0,0
159618,arm,0,0
159619,1,0,0
159620,and,0,0
159621,arm,0,0
159622,2,0,0
159623,was,0,0
159624,41.7,0,0
159625,%,0,0
159626,(,0,0
159627,25/60,0,0
159628,patients,0,0
159629,),0,0
159630,and,0,0
159631,33.3,0,0
159632,%,0,0
159633,(,0,0
159634,20/60,0,0
159635,patients,0,0
159636,),0,0
159637,",",0,0
159638,respectively,0,0
159639,(,0,0
159640,p,0,0
159641,=,0,0
159642,0.37,0,0
159643,),0,0
159644,.,0,0
159645,No,0,1
159646,significant,0,0
159647,difference,0,0
159648,in,0,0
159649,median,0,0
159650,time,0,0
159651,to,0,0
159652,disease,0,0
159653,progression,0,0
159654,(,0,0
159655,26,0,0
159656,vs.,0,0
159657,24,0,0
159658,months,0,0
159659,",",0,0
159660,p,0,0
159661,=,0,0
159662,0.4,0,0
159663,),0,0
159664,",",0,0
159665,median,0,0
159666,survival,0,0
159667,(,0,0
159668,12,0,0
159669,vs.,0,0
159670,16,0,0
159671,months,0,0
159672,",",0,0
159673,p,0,0
159674,=,0,0
159675,0.8,0,0
159676,),0,0
159677,",",0,0
159678,and,0,0
159679,1-year,0,1
159680,survival,0,0
159681,(,0,0
159682,49.9,0,0
159683,vs.,0,0
159684,54.7,0,0
159685,%,0,0
159686,",",0,0
159687,p,0,0
159688,=,0,0
159689,0.8,0,0
159690,),0,0
159691,was,0,0
159692,detected,0,0
159693,between,0,0
159694,arms,0,0
159695,1,0,0
159696,and,0,0
159697,2,0,0
159698,",",0,0
159699,respectively,0,0
159700,.,0,0
159701,Main,0,1
159702,toxicities,0,1
159703,were,0,0
159704,similar,0,0
159705,in,0,0
159706,both,0,0
159707,arms,0,0
159708,with,0,0
159709,no,0,0
159710,statistically,0,0
159711,significant,0,0
159712,differences,0,0
159713,.,0,0
159714,Low-dose,0,1
159715,",",0,0
159716,prolonged,0,1
159717,infusion,0,1
159718,gemcitabine,1,1
159719,in,1,0
159720,combination,1,0
159721,with,1,0
159722,cisplatin,1,1
159723,is,0,0
159724,not,0,0
159725,inferior,0,0
159726,to,0,0
159727,the,0,0
159728,standard,1,0
159729,GC,1,1
159730,regimen,1,1
159731,with,0,0
159732,favorable,0,0
159733,toxicity,0,0
159734,profile,0,0
159735,and,0,0
159736,less,0,0
159737,financial,0,0
159738,costs,0,0
159739,.,0,0
159740,Does,0,0
159741,an,0,0
159742,in-season,1,0
159743,detraining,1,0
159744,period,0,0
159745,affect,0,0
159746,the,0,0
159747,shoulder,0,0
159748,rotator,0,1
159749,cuff,0,1
159750,strength,0,1
159751,and,0,0
159752,balance,0,0
159753,of,0,0
159754,young,0,0
159755,swimmers,0,0
159756,?,0,0
159757,Imbalance,0,0
159758,in,0,0
159759,shoulder,0,0
159760,rotator,0,0
159761,muscles,0,0
159762,is,0,0
159763,a,0,0
159764,well-documented,0,0
159765,problem,0,0
159766,in,0,0
159767,swimmers,0,0
159768,",",0,0
159769,and,0,0
159770,it,0,0
159771,is,0,0
159772,important,0,0
159773,to,0,0
159774,implement,0,0
159775,land-based,0,1
159776,strength,0,1
159777,training,0,0
159778,programs,0,0
159779,.,0,0
159780,Meanwhile,0,0
159781,",",0,0
159782,the,0,0
159783,effects,0,0
159784,of,0,0
159785,a,0,0
159786,detraining,0,0
159787,period,0,0
159788,on,0,0
159789,swimmers,0,0
159790,',0,0
159791,shoulder,0,0
159792,rotator,0,0
159793,muscles,0,0
159794,are,0,0
159795,unknown,0,0
159796,.,0,0
159797,The,0,0
159798,purpose,0,0
159799,of,0,0
159800,this,0,0
159801,study,0,0
159802,was,0,0
159803,to,0,0
159804,analyze,0,0
159805,the,0,0
159806,effects,0,0
159807,of,0,0
159808,a,0,0
159809,strength,1,0
159810,training,1,0
159811,program,1,0
159812,and,1,0
159813,detraining,1,0
159814,on,0,0
159815,the,0,0
159816,strength,0,0
159817,and,0,0
159818,balance,0,0
159819,of,0,0
159820,shoulder,0,0
159821,rotator,0,0
159822,cuff,0,0
159823,muscles,0,0
159824,in,0,0
159825,young,0,0
159826,swimmers,0,0
159827,",",0,0
159828,despite,0,0
159829,the,0,0
159830,continuity,0,0
159831,of,0,0
159832,usual,0,0
159833,water,0,0
159834,training,0,0
159835,.,0,0
159836,An,0,1
159837,experimental,0,1
159838,group,0,1
159839,(,0,0
159840,n,0,0
159841,=,0,0
159842,20,0,0
159843,),0,0
159844,and,0,0
159845,a,0,0
159846,control,0,0
159847,group,0,0
159848,(,0,0
159849,n,0,0
159850,=,0,0
159851,20,0,0
159852,),0,0
159853,of,0,0
159854,young,0,0
159855,male,0,0
159856,swimmers,0,0
159857,with,0,0
159858,the,0,0
159859,same,0,0
159860,characteristics,0,0
159861,(,0,0
159862,age,0,0
159863,",",0,0
159864,body,0,0
159865,mass,0,0
159866,",",0,0
159867,height,0,0
159868,",",0,0
159869,training,0,0
159870,volume,0,0
159871,",",0,0
159872,and,0,0
159873,maturational,0,0
159874,state,0,0
159875,),0,0
159876,were,0,0
159877,evaluated,0,0
159878,.,0,0
159879,In,0,0
159880,both,0,0
159881,groups,0,0
159882,",",0,0
159883,the,0,0
159884,peak,0,0
159885,torques,0,0
159886,of,0,0
159887,shoulder,0,0
159888,internal,0,0
159889,(,0,1
159890,IR,0,1
159891,),0,1
159892,and,0,0
159893,external,0,0
159894,(,0,1
159895,ER,0,1
159896,),0,0
159897,rotators,0,0
159898,were,0,0
159899,assessed,0,0
159900,during,0,0
159901,preseason,0,0
159902,",",0,0
159903,midseason,0,1
159904,(,0,0
159905,16,0,0
159906,weeks,0,0
159907,),0,0
159908,",",0,0
159909,and,0,1
159910,postseason,0,0
159911,(,0,0
159912,32,0,0
159913,weeks,0,0
159914,),0,0
159915,.,0,0
159916,The,0,0
159917,experimental,0,0
159918,group,0,0
159919,underwent,0,0
159920,a,0,0
159921,strength,1,1
159922,training,1,1
159923,regimen,1,1
159924,from,0,0
159925,baseline,0,0
159926,to,0,0
159927,16,0,0
159928,weeks,0,0
159929,and,0,0
159930,a,0,0
159931,detraining,1,0
159932,period,0,0
159933,from,0,0
159934,16,0,0
159935,to,0,0
159936,32,0,0
159937,weeks,0,0
159938,.,0,0
159939,Concentric,0,0
159940,action,0,0
159941,at,0,0
159942,60??s-1,0,0
159943,and,0,0
159944,180??s-1,0,0
159945,was,0,0
159946,measured,0,0
159947,using,0,0
159948,an,0,0
159949,isokinetic,0,0
159950,dynamometer,0,0
159951,.,0,0
159952,The,0,0
159953,ER/IR,0,0
159954,strength,0,0
159955,ratios,0,0
159956,were,0,0
159957,obtained,0,0
159958,.,0,0
159959,At,0,0
159960,60??s-1,0,0
159961,",",0,0
159962,there,0,0
159963,were,0,0
159964,significant,0,0
159965,increments,0,0
159966,in,0,0
159967,IR,0,0
159968,strength,0,1
159969,and,0,0
159970,the,0,0
159971,ER/IR,0,1
159972,ratio,0,0
159973,in,0,0
159974,both,0,0
159975,shoulders,0,0
159976,.,0,0
159977,This,0,0
159978,trend,0,0
159979,was,0,0
159980,the,0,0
159981,same,0,0
159982,throughout,0,0
159983,the,0,0
159984,competitive,0,0
159985,season,0,0
159986,.,0,0
159987,The,0,0
159988,tendency,0,0
159989,was,0,0
159990,the,0,0
159991,same,0,0
159992,at,0,0
159993,180??s-1,0,0
159994,because,0,0
159995,training,0,0
159996,effects,0,0
159997,were,0,0
159998,noted,0,0
159999,primarily,0,0
160000,in,0,0
160001,IR,0,0
160002,and,0,0
160003,ER/IR,0,0
160004,ratios,0,0
160005,.,0,0
160006,Moreover,0,0
160007,",",0,0
160008,the,0,0
160009,absence,0,0
160010,of,0,0
160011,land-based,0,0
160012,strength,0,1
160013,training,0,0
160014,",",0,0
160015,from,0,0
160016,16,0,0
160017,to,0,0
160018,32,0,0
160019,weeks,0,0
160020,",",0,0
160021,revealed,0,0
160022,a,0,0
160023,reduction,0,0
160024,in,0,0
160025,the,0,0
160026,ER/IR,0,0
160027,ratio,0,0
160028,values,0,0
160029,in,0,0
160030,both,0,0
160031,shoulders,0,0
160032,.,0,0
160033,Our,0,0
160034,findings,0,0
160035,suggest,0,0
160036,that,0,0
160037,young,0,0
160038,swimmers,0,0
160039,',0,0
160040,coaches,0,0
160041,should,0,0
160042,use,1,0
160043,dry-land,1,0
160044,strength,1,1
160045,training,1,1
160046,protocols,1,0
160047,",",1,0
160048,and,1,0
160049,that,1,0
160050,it,0,0
160051,is,0,0
160052,recommended,0,0
160053,that,0,0
160054,these,0,0
160055,should,0,0
160056,be,0,0
160057,conducted,0,0
160058,on,0,0
160059,a,0,0
160060,regular,0,0
160061,basis,0,0
160062,(,0,0
160063,during,0,0
160064,the,0,0
160065,whole,0,0
160066,season,0,0
160067,),0,0
160068,.,0,0
160069,Households,0,0
160070,with,0,0
160071,young,0,0
160072,children,0,0
160073,and,0,0
160074,use,0,0
160075,of,0,0
160076,freely,0,0
160077,distributed,0,0
160078,bednets,1,0
160079,in,0,0
160080,rural,0,0
160081,Madagascar,0,0
160082,.,0,0
160083,BACKGROUND,0,0
160084,Malaria,0,1
160085,infections,0,0
160086,are,0,0
160087,the,0,0
160088,leading,0,0
160089,cause,0,0
160090,of,0,0
160091,death,0,0
160092,for,0,0
160093,children,0,0
160094,in,0,0
160095,Madagascar,0,0
160096,.,0,0
160097,Insecticide-treated,1,0
160098,bednets,1,0
160099,offer,0,0
160100,effective,0,0
160101,prevention,0,0
160102,",",0,0
160103,but,0,0
160104,it,0,0
160105,is,0,0
160106,unclear,0,0
160107,how,0,0
160108,well,0,0
160109,free,1,0
160110,bednet,1,0
160111,distribution,1,0
160112,programs,1,0
160113,reach,0,0
160114,young,0,0
160115,children,0,0
160116,.,0,0
160117,METHODS,0,0
160118,We,0,0
160119,conducted,0,0
160120,a,0,0
160121,secondary,0,0
160122,analysis,0,0
160123,of,0,0
160124,a,0,0
160125,free,1,0
160126,bednet,1,0
160127,distribution,1,0
160128,program,1,0
160129,in,0,0
160130,Madagascar,0,0
160131,from,0,0
160132,2007-2008,0,0
160133,.,0,0
160134,Interviews,1,0
160135,were,0,0
160136,performed,0,0
160137,at,0,0
160138,baseline,0,0
160139,and,0,0
160140,6,0,0
160141,months,0,0
160142,.,0,0
160143,Principal,0,0
160144,components,0,0
160145,analysis,0,0
160146,was,0,0
160147,used,0,0
160148,to,0,0
160149,construct,0,0
160150,a,0,0
160151,wealth,0,0
160152,and,0,0
160153,malaria,0,0
160154,knowledge,0,0
160155,index,0,0
160156,.,0,0
160157,Coverage,0,0
160158,efficiency,0,0
160159,was,0,0
160160,calculated,0,0
160161,as,0,0
160162,coverage,1,0
160163,of,1,0
160164,children,1,0
160165,per,1,0
160166,bednet,1,0
160167,owned,1,0
160168,.,1,0
160169,Univariable,0,0
160170,and,0,0
160171,multivariable,0,0
160172,regressions,0,0
160173,were,0,0
160174,used,0,0
160175,to,0,0
160176,determine,0,0
160177,predictors,0,0
160178,of,0,0
160179,bednet,1,0
160180,use,0,0
160181,.,0,0
160182,RESULTS,0,0
160183,Bednet,0,0
160184,use,0,0
160185,",",0,0
160186,among,0,0
160187,the,0,0
160188,560,0,0
160189,households,0,0
160190,in,0,0
160191,the,0,0
160192,study,0,0
160193,",",0,0
160194,increased,0,0
160195,from,0,0
160196,6,0,0
160197,to,0,0
160198,91,0,0
160199,%,0,0
160200,after,0,0
160201,6,0,0
160202,months,0,0
160203,.,0,0
160204,Coverage,0,0
160205,efficiency,0,0
160206,increased,0,0
160207,from,0,0
160208,1.29,0,0
160209,to,0,0
160210,1.56,0,0
160211,children,0,0
160212,covered,0,0
160213,per,0,0
160214,bednet,0,0
160215,owned,0,0
160216,.,0,0
160217,In,0,0
160218,multivariable,0,0
160219,analysis,0,0
160220,",",0,0
160221,having,0,0
160222,a,0,0
160223,child,0,0
160224,under,0,0
160225,5,0,0
160226,years,0,0
160227,of,0,0
160228,age,0,0
160229,was,0,0
160230,the,0,0
160231,only,0,0
160232,variable,0,0
160233,associated,0,0
160234,with,0,0
160235,bednet,0,0
160236,use,0,0
160237,(,0,0
160238,OR,0,0
160239,9.10,0,0
160240,;,0,0
160241,p=0.001,0,0
160242,),0,0
160243,",",0,0
160244,yielding,0,0
160245,a,0,0
160246,99,0,0
160247,%,0,0
160248,likelihood,0,0
160249,of,0,0
160250,using,0,0
160251,a,0,0
160252,bednet,0,0
160253,(,0,0
160254,95,0,0
160255,%,0,0
160256,CI,0,0
160257,96.4,0,0
160258,to,0,0
160259,99.9,0,0
160260,%,0,0
160261,),0,0
160262,versus,0,0
160263,82,0,0
160264,%,0,0
160265,(,0,0
160266,95,0,0
160267,%,0,0
160268,CI,0,0
160269,72.2,0,0
160270,to,0,0
160271,88.4,0,0
160272,%,0,0
160273,),0,0
160274,in,0,0
160275,households,0,0
160276,without,0,0
160277,young,0,0
160278,children,0,0
160279,.,0,0
160280,CONCLUSION,0,0
160281,This,0,0
160282,free,1,0
160283,bednet,1,0
160284,distribution,1,0
160285,program,1,0
160286,achieved,0,0
160287,high,0,0
160288,levels,0,0
160289,of,0,0
160290,adherence,0,0
160291,after,0,0
160292,6,0,0
160293,months,0,0
160294,.,0,0
160295,Household,0,0
160296,presence,0,0
160297,of,0,0
160298,children,0,0
160299,was,0,0
160300,associated,0,0
160301,with,0,0
160302,bednet,0,0
160303,use,0,0
160304,",",0,0
160305,but,0,0
160306,not,0,0
160307,household,0,0
160308,income,0,0
160309,or,0,0
160310,education,0,0
160311,",",0,0
160312,suggesting,0,0
160313,that,0,0
160314,distribution,0,0
160315,to,0,0
160316,priority,0,0
160317,groups,0,0
160318,may,0,0
160319,help,0,0
160320,overcome,0,0
160321,traditional,0,0
160322,barriers,0,0
160323,to,0,0
160324,adoption,0,0
160325,in,0,0
160326,some,0,0
160327,settings,0,0
160328,.,0,0
160329,Effect,0,0
160330,of,0,0
160331,camel,1,0
160332,milk,1,1
160333,on,0,0
160334,thymus,0,0
160335,and,0,0
160336,activation-regulated,0,0
160337,chemokine,0,1
160338,in,0,0
160339,autistic,0,1
160340,children,0,1
160341,:,0,0
160342,double-blind,0,1
160343,study,0,0
160344,.,0,0
160345,BACKGROUND,0,0
160346,This,0,0
160347,study,0,0
160348,aimed,0,0
160349,to,0,0
160350,investigate,0,0
160351,the,0,0
160352,role,0,0
160353,of,0,0
160354,the,0,0
160355,effectiveness,0,0
160356,of,0,0
160357,camel,1,0
160358,milk,1,1
160359,(,1,1
160360,CM,1,1
160361,),1,1
160362,(,1,0
160363,raw,1,0
160364,and,1,1
160365,boiled,1,1
160366,),1,1
160367,on,0,0
160368,thymus,0,0
160369,and,0,0
160370,activation-regulated,0,0
160371,chemokine,0,1
160372,(,0,1
160373,TARC,0,1
160374,),0,1
160375,serum,0,1
160376,levels,0,1
160377,and,0,0
160378,childhood,0,0
160379,autism,0,1
160380,rating,0,1
160381,scale,0,1
160382,(,0,1
160383,CARS,0,1
160384,),0,1
160385,score,0,0
160386,in,0,0
160387,subjects,0,0
160388,with,0,0
160389,autism,0,0
160390,and,0,0
160391,compared,0,0
160392,to,0,0
160393,placebo,1,1
160394,group,1,1
160395,(,1,1
160396,cow,1,1
160397,milk,1,1
160398,),1,1
160399,.,0,0
160400,METHODS,0,0
160401,Forty-five,0,0
160402,subjects,0,0
160403,diagnosed,0,0
160404,with,0,0
160405,autism,0,0
160406,were,0,0
160407,randomly,0,0
160408,assigned,0,0
160409,to,0,0
160410,receive,0,1
160411,boiled,1,1
160412,CM,1,1
160413,for,1,0
160414,group,1,0
160415,I,1,0
160416,(,0,0
160417,n,0,0
160418,=,0,0
160419,15,0,0
160420,),0,0
160421,",",0,0
160422,raw,1,0
160423,CM,1,0
160424,for,1,0
160425,group,1,0
160426,II,1,1
160427,(,0,0
160428,n,0,0
160429,=,0,0
160430,15,0,0
160431,),0,0
160432,",",0,0
160433,and,0,1
160434,placebo,1,1
160435,for,1,1
160436,group,1,1
160437,III,1,1
160438,(,0,0
160439,n,0,0
160440,=,0,0
160441,15,0,0
160442,),0,0
160443,for,0,0
160444,2,0,0
160445,wk,0,0
160446,.,0,0
160447,Measures,0,0
160448,included,0,0
160449,changes,0,0
160450,in,0,0
160451,professionally,0,0
160452,completed,0,0
160453,CARS,0,1
160454,score,0,1
160455,and,0,0
160456,blood,0,0
160457,samples,0,0
160458,for,0,0
160459,TARC,0,1
160460,serum,0,1
160461,level,0,0
160462,were,0,0
160463,taken,0,0
160464,before,0,0
160465,and,0,0
160466,after,0,0
160467,milk,0,1
160468,consumption,0,1
160469,of,0,0
160470,500,0,0
160471,ml,0,0
160472,per,0,0
160473,day,0,0
160474,in,0,0
160475,children,0,1
160476,'s,0,1
160477,regular,0,1
160478,daily,0,1
160479,diet,0,1
160480,.,0,1
160481,RESULTS,0,1
160482,The,0,0
160483,serum,0,1
160484,levels,0,0
160485,of,0,0
160486,TARC,0,0
160487,decreased,0,0
160488,significantly,0,0
160489,(,0,0
160490,P,0,0
160491,=,0,0
160492,0.004,0,0
160493,),0,0
160494,in,0,0
160495,boiled,0,1
160496,CM,0,1
160497,and,0,0
160498,in,0,0
160499,raw,0,0
160500,CM,0,1
160501,group,0,0
160502,(,0,0
160503,P,0,0
160504,=,0,0
160505,0.01,0,0
160506,),0,0
160507,too,0,0
160508,",",0,0
160509,but,0,0
160510,no,0,0
160511,effect,0,0
160512,was,0,0
160513,observed,0,0
160514,(,0,0
160515,P,0,0
160516,=,0,0
160517,0.68,0,0
160518,),0,0
160519,in,0,0
160520,placebo,0,1
160521,group,0,0
160522,.,0,0
160523,Furthermore,0,0
160524,",",0,0
160525,significant,0,0
160526,improvements,0,0
160527,were,0,0
160528,observed,0,0
160529,in,0,0
160530,CARS,0,1
160531,score,0,0
160532,(,0,0
160533,P,0,0
160534,=,0,0
160535,0.04,0,0
160536,),0,0
160537,in,0,0
160538,raw,0,0
160539,CM,0,0
160540,group,0,0
160541,only,0,0
160542,.,0,0
160543,There,0,0
160544,were,0,0
160545,no,0,0
160546,significant,0,0
160547,relationships,0,0
160548,between,0,0
160549,the,0,0
160550,serum,0,1
160551,of,0,0
160552,TARC,0,1
160553,level,0,0
160554,and,0,0
160555,the,0,0
160556,CARS,0,0
160557,score,0,0
160558,",",0,0
160559,age,0,0
160560,",",0,0
160561,or,0,0
160562,gender,0,0
160563,for,0,0
160564,any,0,0
160565,group,0,0
160566,.,0,0
160567,CONCLUSION,0,1
160568,CM,0,1
160569,administered,0,1
160570,for,0,1
160571,2,0,1
160572,wk,0,0
160573,significantly,0,0
160574,improved,0,0
160575,clinical,0,0
160576,measurements,0,0
160577,of,0,0
160578,autism,0,0
160579,severity,0,0
160580,and,0,0
160581,decreased,0,0
160582,serum,0,1
160583,level,0,0
160584,of,0,0
160585,TARC,0,0
160586,in,0,0
160587,autistic,0,0
160588,children,0,0
160589,",",0,0
160590,but,0,0
160591,subsequent,0,0
160592,studies,0,0
160593,are,0,0
160594,recommended,0,0
160595,.,0,0
160596,Weight,0,0
160597,and,0,0
160598,lean,0,0
160599,body,0,0
160600,mass,0,0
160601,change,0,0
160602,with,0,0
160603,antiretroviral,1,1
160604,initiation,1,0
160605,and,0,0
160606,impact,0,0
160607,on,0,0
160608,bone,0,0
160609,mineral,0,0
160610,density,0,0
160611,.,0,0
160612,OBJECTIVE,0,0
160613,To,0,0
160614,compare,0,0
160615,the,0,0
160616,effect,0,0
160617,that,0,0
160618,initiating,0,0
160619,different,0,0
160620,antiretroviral,1,1
160621,therapy,1,1
160622,(,1,1
160623,ART,1,1
160624,),1,1
160625,regimens,0,1
160626,has,0,1
160627,on,0,0
160628,weight,0,0
160629,",",0,0
160630,BMI,0,0
160631,",",0,0
160632,and,0,0
160633,lean,0,0
160634,body,0,1
160635,mass,0,0
160636,(,0,1
160637,LBM,0,1
160638,),0,1
160639,and,0,0
160640,explore,0,0
160641,how,0,0
160642,changes,0,0
160643,in,0,0
160644,body,0,0
160645,composition,0,0
160646,are,0,0
160647,associated,0,0
160648,with,0,0
160649,bone,0,0
160650,mineral,0,1
160651,density,0,0
160652,(,0,1
160653,BMD,0,1
160654,),0,1
160655,.,0,0
160656,METHODS,0,0
160657,A5224s,0,0
160658,was,0,0
160659,a,0,0
160660,sub-study,0,0
160661,of,0,0
160662,A5202,0,0
160663,",",0,0
160664,a,0,0
160665,prospective,0,0
160666,trial,0,0
160667,of,0,0
160668,1857,0,0
160669,ART-naive,0,0
160670,participants,0,0
160671,randomized,0,0
160672,to,0,0
160673,blinded,1,1
160674,abacavir-lamivudine,1,1
160675,(,1,1
160676,ABC/3TC,1,1
160677,),1,1
160678,or,1,1
160679,tenofovir,1,1
160680,DF-emtricitabine,1,1
160681,(,1,1
160682,TDF/FTC,1,1
160683,),1,1
160684,with,1,1
160685,open-label,1,1
160686,efavirenz,1,1
160687,(,1,1
160688,EFV,1,1
160689,),1,1
160690,or,1,1
160691,atazanavir-ritonavir,1,1
160692,(,1,1
160693,ATV/r,1,1
160694,),1,1
160695,.,1,0
160696,All,0,0
160697,participants,0,0
160698,underwent,0,0
160699,dual-energy,1,1
160700,absorptiometry,1,1
160701,(,1,1
160702,DXA,1,1
160703,),1,1
160704,and,1,0
160705,abdominal,1,1
160706,computed,1,0
160707,tomography,1,0
160708,for,1,0
160709,body,1,0
160710,composition,1,0
160711,.,1,0
160712,Analyses,0,0
160713,used,0,0
160714,two-sample,0,0
160715,t-tests,0,0
160716,and,0,0
160717,linear,0,0
160718,regression,0,0
160719,.,0,0
160720,RESULTS,0,0
160721,A5224s,0,0
160722,included,0,0
160723,269,0,0
160724,participants,0,0
160725,:,0,0
160726,85,0,0
160727,%,0,0
160728,men,0,0
160729,",",0,0
160730,47,0,0
160731,%,0,0
160732,white,0,0
160733,non-Hispanic,0,0
160734,",",0,0
160735,median,0,0
160736,age,0,0
160737,38,0,0
160738,years,0,0
160739,",",0,0
160740,HIV-1,0,0
160741,RNA,0,0
160742,4.6,0,0
160743,log10,0,0
160744,copies/ml,0,0
160745,",",0,0
160746,and,0,0
160747,CD4,0,0
160748,cell,0,0
160749,count,0,0
160750,233,0,0
160751,cells/?l,0,0
160752,.,0,0
160753,Overall,0,0
160754,",",0,0
160755,significant,0,0
160756,gains,0,0
160757,occurred,0,0
160758,in,0,0
160759,weight,0,0
160760,",",0,0
160761,BMI,0,0
160762,",",0,0
160763,and,0,0
160764,LBM,0,0
160765,at,0,0
160766,96,0,0
160767,weeks,0,0
160768,post-randomization,0,0
160769,(,0,0
160770,all,0,0
160771,P,0,0
160772,<,0,0
160773,0.001,0,0
160774,),0,0
160775,.,0,0
160776,Assignment,0,0
160777,to,1,0
160778,ATV/r,1,0
160779,(,1,0
160780,vs.,1,0
160781,EFV,1,0
160782,),1,0
160783,resulted,0,0
160784,in,0,0
160785,significantly,0,0
160786,greater,0,0
160787,weight,0,0
160788,(,0,0
160789,mean,0,0
160790,difference,0,0
160791,3.35,0,0
160792,kg,0,0
160793,),0,0
160794,and,0,0
160795,BMI,0,1
160796,gain,0,0
160797,(,0,0
160798,0.88,0,0
160799,kg/m,0,0
160800,;,0,0
160801,both,0,0
160802,P=0.02,0,0
160803,),0,0
160804,",",0,0
160805,but,0,0
160806,not,0,0
160807,LBM,0,0
160808,(,0,0
160809,0.67,0,0
160810,kg,0,0
160811,;,0,0
160812,P=0.15,0,0
160813,),0,0
160814,",",0,0
160815,whereas,0,0
160816,ABC/3TC,0,0
160817,and,0,0
160818,TDF/FTC,0,0
160819,were,0,0
160820,not,0,0
160821,significantly,0,0
160822,different,0,0
160823,(,0,0
160824,P?0.10,0,1
160825,),0,1
160826,.,0,0
160827,In,0,0
160828,multivariable,0,0
160829,analysis,0,0
160830,",",0,0
160831,only,0,0
160832,lower,0,0
160833,baseline,0,0
160834,CD4,0,0
160835,cell,0,0
160836,count,0,0
160837,and,0,0
160838,higher,0,0
160839,HIV-1,0,0
160840,RNA,0,0
160841,were,0,0
160842,associated,0,0
160843,with,0,0
160844,greater,0,0
160845,increase,0,0
160846,in,0,0
160847,weight,0,0
160848,",",0,0
160849,BMI,0,0
160850,",",0,0
160851,or,0,0
160852,LBM,0,0
160853,.,0,0
160854,In,0,0
160855,multivariable,0,0
160856,analyses,0,0
160857,",",0,0
160858,increased,0,0
160859,LBM,0,0
160860,was,0,0
160861,associated,0,0
160862,with,0,0
160863,an,0,0
160864,increased,0,0
160865,hip,0,0
160866,BMD,0,0
160867,.,0,0
160868,CONCLUSION,0,0
160869,ABC/3TC,0,0
160870,vs.,0,0
160871,TDF/FTC,1,0
160872,did,1,0
160873,not,0,0
160874,differ,0,0
160875,in,0,0
160876,change,0,0
160877,in,0,0
160878,weight,0,0
160879,",",0,0
160880,BMI,0,0
160881,",",0,0
160882,or,0,0
160883,LBM,0,1
160884,;,0,0
160885,ATV/r,0,0
160886,vs.,0,0
160887,EFV,0,0
160888,resulted,0,0
160889,in,0,0
160890,greater,0,0
160891,weight,0,0
160892,and,0,0
160893,BMI,0,0
160894,gain,0,0
160895,but,0,0
160896,not,0,0
160897,LBM,0,0
160898,.,0,0
160899,A,0,0
160900,positive,0,0
160901,association,0,0
160902,between,0,0
160903,increased,0,0
160904,LBM,0,0
160905,and,0,0
160906,increased,0,0
160907,hip,0,0
160908,BMD,0,0
160909,should,0,0
160910,be,0,0
160911,further,0,0
160912,investigated,0,0
160913,through,0,0
160914,prospective,0,0
160915,interventional,0,0
160916,studies,0,0
160917,to,0,0
160918,verify,0,0
160919,the,0,0
160920,impact,0,0
160921,of,0,0
160922,increased,0,0
160923,LBM,0,0
160924,on,0,0
160925,hip,0,0
160926,BMD,0,0
160927,.,0,0
160928,Early,0,1
160929,psychosocial,0,0
160930,intervention,0,0
160931,in,0,0
160932,Alzheimer,0,0
160933,'s,0,0
160934,disease,0,0
160935,:,0,0
160936,cost,1,0
160937,utility,1,0
160938,evaluation,1,0
160939,alongside,0,0
160940,the,0,0
160941,Danish,0,0
160942,Alzheimer,0,0
160943,'s,0,0
160944,Intervention,0,1
160945,Study,0,1
160946,(,0,1
160947,DAISY,0,1
160948,),0,1
160949,.,0,0
160950,OBJECTIVE,0,0
160951,To,0,0
160952,assess,0,0
160953,the,0,0
160954,cost,1,0
160955,utility,1,0
160956,of,0,0
160957,early,0,0
160958,psychosocial,0,0
160959,intervention,0,0
160960,for,0,0
160961,patients,0,0
160962,with,0,0
160963,Alzheimer,0,0
160964,'s,0,0
160965,disease,0,0
160966,and,0,0
160967,their,0,0
160968,primary,0,0
160969,caregivers,0,0
160970,.,0,0
160971,DESIGN,0,0
160972,Cost,1,0
160973,utility,1,0
160974,evaluation,0,0
160975,alongside,0,0
160976,a,0,0
160977,multicentre,0,0
160978,",",0,0
160979,randomised,0,0
160980,controlled,0,0
160981,trial,0,0
160982,with,0,0
160983,3,0,0
160984,years,0,0
160985,of,0,0
160986,follow-up,0,0
160987,.,0,0
160988,SETTING,0,0
160989,Primary,0,0
160990,care,0,0
160991,and,0,0
160992,memory,0,0
160993,clinics,0,0
160994,in,0,0
160995,five,0,0
160996,Danish,0,0
160997,districts,0,0
160998,.,0,0
160999,PARTICIPANTS,0,0
161000,330,0,0
161001,community-dwelling,0,0
161002,patients,0,0
161003,and,0,0
161004,their,0,0
161005,primary,0,0
161006,caregivers,0,0
161007,.,0,0
161008,INTERVENTION,0,0
161009,Psychosocial,1,0
161010,counselling,1,0
161011,and,1,0
161012,support,1,0
161013,lasting,0,0
161014,8-12,0,0
161015,months,0,0
161016,after,0,0
161017,diagnosis,0,0
161018,and,0,0
161019,follow-up,1,0
161020,at,0,0
161021,3,0,0
161022,",",0,0
161023,6,0,0
161024,",",0,0
161025,12,0,0
161026,and,0,0
161027,36,0,0
161028,months,0,0
161029,in,0,0
161030,the,0,0
161031,intervention,0,0
161032,group,0,0
161033,or,0,0
161034,follow-up,0,0
161035,only,0,0
161036,in,0,0
161037,the,0,0
161038,control,1,0
161039,group,1,0
161040,.,1,0
161041,MAIN,0,0
161042,OUTCOME,0,0
161043,MEASURES,0,1
161044,The,0,0
161045,primary,0,0
161046,outcome,0,0
161047,measure,0,0
161048,was,0,0
161049,the,0,0
161050,cost,0,0
161051,of,0,0
161052,additional,0,0
161053,quality-adjusted,0,0
161054,life,0,1
161055,years,0,1
161056,(,0,1
161057,QALYs,0,1
161058,),0,1
161059,.,0,0
161060,Costs,0,0
161061,were,0,0
161062,measured,0,0
161063,from,0,0
161064,a,0,0
161065,societal,0,0
161066,perspective,0,0
161067,",",0,0
161068,including,0,0
161069,the,0,0
161070,costs,0,0
161071,of,0,0
161072,healthcare,0,0
161073,",",0,0
161074,social,0,0
161075,care,0,0
161076,",",0,0
161077,informal,0,0
161078,care,0,0
161079,and,0,0
161080,production,0,0
161081,loss,0,0
161082,.,0,0
161083,QALYs,0,0
161084,were,0,0
161085,estimated,0,0
161086,separately,0,0
161087,for,0,0
161088,the,0,0
161089,patient,0,0
161090,and,0,0
161091,the,0,0
161092,caregiver,0,0
161093,before,0,0
161094,aggregation,0,0
161095,for,0,0
161096,the,0,0
161097,main,0,0
161098,analysis,0,0
161099,.,0,0
161100,RESULTS,0,1
161101,None,0,1
161102,of,0,0
161103,the,0,0
161104,observed,0,0
161105,cost,0,0
161106,and,0,0
161107,QALY,0,0
161108,measures,0,0
161109,were,0,0
161110,significantly,0,0
161111,different,0,0
161112,between,0,0
161113,the,0,0
161114,intervention,0,0
161115,and,0,0
161116,control,1,0
161117,groups,1,0
161118,",",0,0
161119,although,0,0
161120,a,0,0
161121,tendency,0,0
161122,was,0,0
161123,noted,0,0
161124,for,0,0
161125,psychosocial,0,0
161126,care,0,0
161127,leading,0,0
161128,to,0,0
161129,cost,0,0
161130,increases,0,0
161131,with,0,0
161132,informal,0,0
161133,care,0,0
161134,that,0,0
161135,was,0,0
161136,not,0,0
161137,outweighed,0,0
161138,by,0,0
161139,the,0,0
161140,tendency,0,0
161141,for,0,0
161142,cost,0,0
161143,savings,0,0
161144,with,0,0
161145,formal,0,0
161146,care,0,0
161147,.,0,0
161148,The,0,0
161149,probability,0,0
161150,of,0,0
161151,psychosocial,0,0
161152,intervention,0,0
161153,being,0,0
161154,cost-effective,0,0
161155,did,0,0
161156,not,0,0
161157,exceed,0,0
161158,36,0,0
161159,%,0,0
161160,for,0,0
161161,any,0,0
161162,threshold,0,0
161163,value,0,0
161164,.,0,0
161165,The,0,0
161166,alternative,0,0
161167,scenario,0,0
161168,analysis,0,0
161169,showed,0,0
161170,that,0,0
161171,the,0,0
161172,probability,0,0
161173,of,0,0
161174,cost-effectiveness,0,0
161175,increased,0,0
161176,over,0,0
161177,the,0,0
161178,range,0,0
161179,of,0,0
161180,threshold,0,0
161181,values,0,0
161182,used,0,0
161183,if,0,0
161184,the,0,0
161185,cost,0,0
161186,perspective,0,0
161187,was,0,0
161188,restricted,0,0
161189,to,0,0
161190,formal,0,0
161191,healthcare,0,0
161192,.,0,0
161193,CONCLUSIONS,0,0
161194,A,0,0
161195,multifaceted,0,0
161196,",",0,0
161197,psychosocial,0,0
161198,intervention,0,0
161199,programme,0,0
161200,was,0,0
161201,found,0,0
161202,unlikely,0,0
161203,to,0,0
161204,be,0,0
161205,cost-effective,0,0
161206,from,0,0
161207,a,0,0
161208,societal,0,0
161209,perspective,0,0
161210,.,0,0
161211,The,0,0
161212,recommendation,0,0
161213,for,0,0
161214,practice,0,0
161215,in,0,0
161216,settings,0,0
161217,that,0,0
161218,are,0,0
161219,similar,0,0
161220,to,0,0
161221,the,0,0
161222,Danish,0,0
161223,setting,0,0
161224,is,0,0
161225,to,0,0
161226,provide,0,0
161227,follow-up,0,0
161228,with,0,0
161229,referral,0,0
161230,to,0,0
161231,available,0,0
161232,local,0,0
161233,support,0,0
161234,programmes,0,0
161235,when,0,0
161236,needed,0,0
161237,",",0,0
161238,and,0,0
161239,to,0,0
161240,restrict,0,0
161241,large,0,0
161242,multifaceted,0,0
161243,intervention,0,0
161244,programmes,0,0
161245,to,0,0
161246,patients,0,0
161247,and,0,0
161248,caregivers,0,0
161249,with,0,0
161250,special,0,0
161251,needs,0,0
161252,until,0,0
161253,further,0,0
161254,evidence,0,0
161255,for,0,0
161256,cost-effectiveness,0,0
161257,emerges,0,0
161258,.,0,0
161259,TRIAL,0,0
161260,REGISTRATION,0,0
161261,The,0,0
161262,study,0,0
161263,was,0,0
161264,registered,0,0
161265,in,0,0
161266,the,0,0
161267,Clinical,0,0
161268,Trial,0,0
161269,Database,0,0
161270,as,0,0
161271,ISRCTN74848736,0,0
161272,.,0,0
161273,Phosphorylated,1,0
161274,p-70S6K,1,0
161275,predicts,0,0
161276,tamoxifen,1,1
161277,resistance,0,0
161278,in,0,0
161279,postmenopausal,0,0
161280,breast,0,0
161281,cancer,0,0
161282,patients,0,0
161283,randomized,0,0
161284,between,0,1
161285,adjuvant,0,1
161286,tamoxifen,1,1
161287,versus,0,1
161288,no,1,0
161289,systemic,1,0
161290,treatment,1,0
161291,.,1,0
161292,INTRODUCTION,0,0
161293,Activation,0,0
161294,of,0,0
161295,the,0,0
161296,phosphatidylinositol-3-kinase,1,1
161297,(,1,1
161298,PI3K,1,1
161299,),1,1
161300,and/or,0,0
161301,mitogen-activated,1,1
161302,protein,1,1
161303,kinase,1,1
161304,(,1,1
161305,MAPK,1,1
161306,),1,0
161307,pathways,0,0
161308,results,0,0
161309,in,0,0
161310,anti-estrogen,0,1
161311,resistance,0,0
161312,in,0,0
161313,vitro,0,0
161314,",",0,0
161315,but,0,0
161316,a,0,0
161317,biomarker,0,0
161318,with,0,0
161319,clinical,0,0
161320,validity,0,0
161321,to,0,0
161322,predict,0,0
161323,intrinsic,0,0
161324,resistance,0,0
161325,has,0,0
161326,not,0,0
161327,been,0,0
161328,identified,0,0
161329,.,0,0
161330,In,0,0
161331,metastatic,0,0
161332,breast,0,0
161333,cancer,0,0
161334,patients,0,0
161335,with,0,0
161336,previous,0,0
161337,exposure,0,0
161338,to,0,0
161339,endocrine,1,0
161340,therapy,1,0
161341,",",0,0
161342,the,0,0
161343,addition,0,0
161344,of,0,0
161345,a,0,0
161346,mammalian,0,0
161347,target,0,0
161348,of,0,0
161349,rapamycine,1,1
161350,(,1,1
161351,mTOR,1,1
161352,),1,1
161353,inhibitor,0,1
161354,has,0,0
161355,been,0,0
161356,shown,0,0
161357,to,0,0
161358,be,0,0
161359,beneficial,0,0
161360,.,0,0
161361,Whether,0,0
161362,or,0,0
161363,not,0,0
161364,patients,0,0
161365,on,0,0
161366,adjuvant,1,1
161367,endocrine,1,0
161368,treatment,1,0
161369,might,0,0
161370,benefit,0,0
161371,from,0,0
161372,these,0,0
161373,drugs,0,1
161374,is,0,0
161375,currently,0,0
161376,unclear,0,0
161377,.,0,0
161378,A,0,0
161379,biomarker,0,0
161380,that,0,0
161381,predicts,0,0
161382,intrinsic,0,0
161383,resistance,0,0
161384,could,0,0
161385,potentially,0,0
161386,be,0,0
161387,used,0,0
161388,as,0,0
161389,companion,0,0
161390,diagnostic,0,0
161391,in,0,0
161392,this,0,0
161393,setting,0,0
161394,.,0,0
161395,We,0,0
161396,tested,0,0
161397,the,0,0
161398,clinical,0,0
161399,validity,0,0
161400,of,0,0
161401,different,0,0
161402,downstream-activated,0,0
161403,proteins,0,0
161404,in,0,0
161405,the,0,0
161406,PI3K,0,0
161407,and/or,0,0
161408,MAPK,0,0
161409,pathways,0,0
161410,to,0,0
161411,predict,0,0
161412,intrinsic,0,0
161413,tamoxifen,1,1
161414,resistance,0,0
161415,in,0,0
161416,postmenopausal,0,0
161417,primary,0,0
161418,breast,0,0
161419,cancer,0,0
161420,patients,0,0
161421,.,0,0
161422,METHODS,0,0
161423,We,0,1
161424,recollected,0,0
161425,primary,0,0
161426,tumor,0,0
161427,tissue,0,0
161428,from,0,0
161429,patients,0,0
161430,who,0,0
161431,participated,0,0
161432,in,0,0
161433,a,0,0
161434,randomized,0,0
161435,trial,0,0
161436,of,0,1
161437,adjuvant,1,1
161438,tamoxifen,1,1
161439,(,1,1
161440,1-3,1,1
161441,years,1,1
161442,),1,0
161443,versus,1,0
161444,observation,1,0
161445,.,1,0
161446,After,0,0
161447,constructing,0,0
161448,a,0,0
161449,tissue,1,0
161450,micro-array,1,0
161451,",",0,0
161452,cores,0,0
161453,from,0,0
161454,563,0,0
161455,estrogen,0,0
161456,receptor,0,0
161457,?,0,0
161458,positive,0,0
161459,were,0,0
161460,immunostained,0,0
161461,for,0,0
161462,p-AKT,0,1
161463,(,0,1
161464,Thr308,0,1
161465,),0,1
161466,",",0,0
161467,p-AKT,0,1
161468,(,0,1
161469,Ser473,0,1
161470,),0,1
161471,",",0,0
161472,p-mTOR,0,1
161473,",",0,0
161474,p-p706SK,0,1
161475,and,0,0
161476,p-ERK1/2,0,0
161477,.,0,0
161478,Cox,0,0
161479,proportional,0,0
161480,hazard,0,0
161481,models,0,0
161482,for,0,0
161483,recurrence,0,0
161484,free,0,0
161485,interval,0,0
161486,were,0,0
161487,used,0,0
161488,to,0,0
161489,assess,0,0
161490,hazard,0,0
161491,ratios,0,0
161492,and,0,0
161493,interactions,0,0
161494,between,0,0
161495,these,0,0
161496,markers,0,0
161497,and,1,0
161498,tamoxifen,1,1
161499,treatment,0,1
161500,efficacy,0,1
161501,.,0,0
161502,RESULTS,0,0
161503,Interactions,0,0
161504,were,0,0
161505,identified,0,0
161506,between,1,0
161507,tamoxifen,1,1
161508,and,1,1
161509,p-AKT,1,1
161510,(,1,1
161511,Thr308,1,1
161512,),1,1
161513,",",1,0
161514,p-mTOR,1,1
161515,",",1,0
161516,p-p70S6K,1,1
161517,and,1,0
161518,p-ERK1/2,1,0
161519,.,1,0
161520,Applying,0,0
161521,a,0,0
161522,conservative,0,0
161523,level,0,0
161524,of,0,0
161525,significance,0,0
161526,",",0,0
161527,p-p70S6K,1,0
161528,remained,0,0
161529,significantly,0,0
161530,associated,0,0
161531,with,1,0
161532,tamoxifen,1,1
161533,resistance,0,0
161534,.,0,0
161535,Patients,0,0
161536,with,0,0
161537,p-p70S6K,0,0
161538,negative,0,0
161539,tumors,0,0
161540,derived,0,0
161541,significant,0,0
161542,benefit,0,0
161543,from,1,0
161544,tamoxifen,1,1
161545,(,0,0
161546,HR,0,0
161547,0.24,0,0
161548,",",0,0
161549,P,0,0
161550,<,0,0
161551,0.0001,0,0
161552,),0,0
161553,",",0,0
161554,while,0,0
161555,patients,0,0
161556,whose,0,0
161557,tumor,0,0
161558,did,0,0
161559,express,0,0
161560,p-p70S6K,0,0
161561,did,0,0
161562,not,0,0
161563,(,0,0
161564,HR,0,0
161565,=,0,0
161566,1.02,0,0
161567,",",0,0
161568,P,0,0
161569,=0.95,0,0
161570,),0,0
161571,",",0,0
161572,P,0,0
161573,for,0,0
161574,interaction,0,0
161575,0.004,0,0
161576,.,0,0
161577,In,0,0
161578,systemically,0,0
161579,untreated,0,0
161580,breast,0,0
161581,cancer,0,0
161582,patients,0,0
161583,",",0,0
161584,p-p70S6K,0,0
161585,was,0,0
161586,associated,0,0
161587,with,0,0
161588,a,0,0
161589,decreased,0,0
161590,risk,0,0
161591,for,0,0
161592,recurrence,0,0
161593,.,0,0
161594,CONCLUSIONS,0,0
161595,Patients,0,0
161596,whose,0,0
161597,tumor,0,0
161598,expresses,0,0
161599,p-p70S6K,0,0
161600,",",0,0
161601,as,0,0
161602,a,0,0
161603,marker,0,0
161604,of,0,0
161605,downstream,0,0
161606,PI3K,0,0
161607,and/or,0,0
161608,MAPK,0,0
161609,pathway,0,0
161610,activation,0,0
161611,",",0,0
161612,have,0,0
161613,a,0,0
161614,favorable,0,0
161615,prognosis,0,0
161616,",",0,0
161617,but,0,0
161618,do,0,0
161619,not,0,0
161620,benefit,0,0
161621,from,0,0
161622,adjuvant,0,1
161623,tamoxifen,1,1
161624,.,1,1
161625,A,1,0
161626,potential,1,0
161627,benefit,0,0
161628,from,0,0
161629,inhibitors,0,0
161630,of,0,0
161631,the,0,0
161632,PI3K/Akt/mTOR,0,0
161633,pathway,0,0
161634,in,0,0
161635,these,0,0
161636,patients,0,0
161637,needs,0,0
161638,to,0,0
161639,be,0,0
161640,further,0,0
161641,explored,0,0
161642,.,0,0
161643,Economic,0,0
161644,burden,0,0
161645,of,0,0
161646,childhood,0,0
161647,autism,0,0
161648,spectrum,0,0
161649,disorders,0,0
161650,.,0,0
161651,OBJECTIVE,0,0
161652,To,0,0
161653,estimate,0,0
161654,the,0,0
161655,associations,0,0
161656,between,0,0
161657,autism,0,0
161658,spectrum,0,0
161659,disorder,0,1
161660,(,0,1
161661,ASD,0,1
161662,),0,1
161663,diagnoses,0,0
161664,and,0,0
161665,service,0,0
161666,use,0,0
161667,",",0,0
161668,caregiver,0,0
161669,time,0,0
161670,",",0,0
161671,and,0,0
161672,cost,0,0
161673,outcomes,0,0
161674,.,0,0
161675,METHODS,0,0
161676,We,0,0
161677,used,0,0
161678,national,1,0
161679,data,1,0
161680,from,1,0
161681,the,1,0
161682,Medical,1,0
161683,Expenditure,1,0
161684,Panel,1,0
161685,Survey,1,0
161686,linked,1,0
161687,to,1,0
161688,the,1,0
161689,National,1,0
161690,Health,1,0
161691,Interview,1,0
161692,Survey,1,0
161693,and,1,0
161694,a,1,0
161695,study-specific,1,0
161696,survey,1,0
161697,to,0,0
161698,estimate,0,0
161699,the,0,0
161700,annual,0,0
161701,utilization,0,0
161702,and,0,0
161703,costs,0,0
161704,for,0,0
161705,health,0,0
161706,care,0,0
161707,",",0,0
161708,school,0,0
161709,",",0,0
161710,ASD-related,0,0
161711,therapy,0,0
161712,",",0,0
161713,family-coordinated,0,0
161714,services,0,0
161715,",",0,0
161716,as,0,0
161717,well,0,0
161718,as,0,0
161719,caregiver,0,0
161720,time,0,0
161721,in,0,0
161722,children,0,0
161723,aged,0,0
161724,3,0,0
161725,to,0,0
161726,17,0,0
161727,years,0,0
161728,",",0,0
161729,with,0,0
161730,and,0,0
161731,without,0,0
161732,parent-reported,0,0
161733,ASD,0,0
161734,.,0,0
161735,Regression,1,0
161736,analyses,1,0
161737,estimated,0,0
161738,the,0,0
161739,association,0,0
161740,between,0,0
161741,ASD,0,0
161742,diagnosis,0,0
161743,and,0,0
161744,cost,0,0
161745,",",0,0
161746,controlling,0,0
161747,for,0,0
161748,child,0,0
161749,gender,0,0
161750,",",0,0
161751,age,0,0
161752,",",0,0
161753,race/ethnicity,0,0
161754,",",0,0
161755,insurance,0,0
161756,status,0,0
161757,",",0,0
161758,household,0,0
161759,income,0,0
161760,",",0,0
161761,country,0,0
161762,region,0,0
161763,and,0,0
161764,urban/rural,0,0
161765,classification,0,0
161766,",",0,0
161767,and,0,0
161768,non-ASD-related,0,0
161769,illnesses,0,0
161770,.,0,0
161771,RESULTS,0,0
161772,Children,0,0
161773,with,0,0
161774,parent-reported,0,0
161775,ASD,0,0
161776,had,0,0
161777,higher,0,0
161778,levels,0,0
161779,of,0,0
161780,health,0,0
161781,care,0,0
161782,office,0,0
161783,visits,0,0
161784,and,0,0
161785,prescription,0,1
161786,drug,0,1
161787,use,0,0
161788,compared,0,0
161789,with,0,0
161790,children,0,0
161791,without,0,0
161792,ASD,0,0
161793,(,0,0
161794,P,0,0
161795,<,0,0
161796,.05,0,0
161797,),0,0
161798,.,0,0
161799,A,0,0
161800,greater,0,0
161801,proportion,0,0
161802,of,0,0
161803,children,0,0
161804,in,0,0
161805,the,0,0
161806,ASD,0,0
161807,group,0,0
161808,used,0,0
161809,special,0,0
161810,educational,0,0
161811,services,0,0
161812,(,0,0
161813,76,0,0
161814,%,0,0
161815,vs.,0,0
161816,7,0,0
161817,%,0,0
161818,in,0,0
161819,the,0,0
161820,control,0,0
161821,group,0,0
161822,",",0,0
161823,P,0,0
161824,<,0,0
161825,.05,0,0
161826,),0,0
161827,.,0,0
161828,After,0,0
161829,adjusting,0,0
161830,for,0,0
161831,child,0,0
161832,demographic,0,0
161833,characteristics,0,0
161834,and,0,0
161835,non-ASD-associated,0,0
161836,illnesses,0,0
161837,",",0,0
161838,ASD,0,0
161839,was,0,0
161840,associated,0,0
161841,with,0,0
161842,$,0,0
161843,3020,0,0
161844,(,0,0
161845,95,0,0
161846,%,0,0
161847,confidence,0,0
161848,interval,0,0
161849,[,0,0
161850,CI,0,0
161851,],0,0
161852,:,0,0
161853,$,0,0
161854,1017-,0,0
161855,$,0,0
161856,4259,0,0
161857,),0,0
161858,higher,0,0
161859,health,0,0
161860,care,0,0
161861,costs,0,0
161862,and,0,0
161863,$,0,0
161864,"14,061",0,0
161865,(,0,0
161866,95,0,0
161867,%,0,0
161868,CI,0,0
161869,:,0,0
161870,$,0,0
161871,4390-,0,0
161872,$,0,0
161873,"24,302",0,0
161874,),0,0
161875,higher,0,0
161876,aggregate,0,0
161877,non-health,0,0
161878,care,0,0
161879,costs,0,0
161880,",",0,0
161881,including,0,0
161882,$,0,0
161883,8610,0,0
161884,(,0,0
161885,95,0,0
161886,%,0,0
161887,CI,0,0
161888,:,0,0
161889,$,0,0
161890,6595-,0,0
161891,$,0,0
161892,"10,421",0,0
161893,),0,0
161894,higher,0,0
161895,school,0,0
161896,costs,0,0
161897,.,0,0
161898,In,0,0
161899,adjusted,0,0
161900,analyses,0,0
161901,",",0,0
161902,parents,0,0
161903,who,0,0
161904,reported,0,0
161905,that,0,0
161906,their,0,0
161907,child,0,0
161908,had,0,0
161909,ASD,0,0
161910,did,0,0
161911,not,0,0
161912,have,0,0
161913,significantly,0,0
161914,higher,0,0
161915,out-of-pocket,0,0
161916,costs,0,0
161917,or,0,0
161918,spend,0,0
161919,more,0,0
161920,time,0,0
161921,on,0,0
161922,caregiving,0,0
161923,activities,0,0
161924,compared,0,0
161925,with,0,0
161926,control,0,0
161927,parents,0,0
161928,.,0,0
161929,CONCLUSIONS,0,0
161930,The,0,0
161931,economic,0,0
161932,burden,0,0
161933,associated,0,0
161934,with,0,0
161935,ASD,0,0
161936,is,0,0
161937,substantial,0,0
161938,and,0,0
161939,can,0,0
161940,be,0,0
161941,measured,0,0
161942,across,0,0
161943,multiple,0,0
161944,sectors,0,0
161945,of,0,0
161946,our,0,0
161947,society,0,0
161948,.,0,0
161949,Previous,0,0
161950,analyses,0,0
161951,that,0,0
161952,focused,0,0
161953,on,0,0
161954,health,0,0
161955,care,0,0
161956,underestimated,0,0
161957,this,0,0
161958,economic,0,0
161959,burden,0,0
161960,",",0,0
161961,particularly,0,0
161962,for,0,0
161963,school,0,0
161964,systems,0,0
161965,.,0,0
161966,Psychological,0,0
161967,functioning,0,0
161968,1,0,0
161969,year,0,0
161970,after,0,0
161971,a,0,0
161972,brief,0,0
161973,intervention,0,0
161974,using,0,0
161975,micronutrients,1,1
161976,to,0,0
161977,treat,0,0
161978,stress,0,0
161979,and,0,0
161980,anxiety,0,0
161981,related,0,0
161982,to,0,0
161983,the,0,0
161984,2011,0,0
161985,Christchurch,0,0
161986,earthquakes,0,0
161987,:,0,0
161988,a,0,0
161989,naturalistic,0,0
161990,follow-up,0,0
161991,.,0,0
161992,OBJECTIVE,0,0
161993,We,0,0
161994,investigated,0,0
161995,whether,0,0
161996,micronutrients,1,1
161997,given,0,1
161998,acutely,0,0
161999,following,0,0
162000,the,0,0
162001,Christchurch,0,0
162002,earthquakes,0,0
162003,continued,0,0
162004,to,0,0
162005,confer,0,0
162006,benefit,0,0
162007,1,0,0
162008,year,0,0
162009,following,0,0
162010,the,0,0
162011,treatment,0,0
162012,.,0,0
162013,METHODS,0,0
162014,Sixty-four,0,0
162015,adults,0,0
162016,from,0,0
162017,the,0,0
162018,original,0,0
162019,91,0,0
162020,participants,0,0
162021,experiencing,0,0
162022,heightened,0,0
162023,anxiety,0,0
162024,or,0,0
162025,stress,0,0
162026,2-3,0,0
162027,months,0,0
162028,following,0,0
162029,the,0,0
162030,22nd,0,0
162031,February,0,0
162032,2011,0,0
162033,earthquake,0,0
162034,and,0,0
162035,who,0,0
162036,had,0,0
162037,been,0,0
162038,randomized,0,0
162039,to,0,0
162040,receive,0,0
162041,three,1,0
162042,different,1,0
162043,doses,1,1
162044,of,1,1
162045,micronutrients,1,1
162046,completed,0,1
162047,on-line,0,1
162048,questionnaires,0,0
162049,assessing,0,0
162050,mood,0,0
162051,",",0,0
162052,anxiety,0,0
162053,",",0,0
162054,stress,0,0
162055,",",0,0
162056,and,0,0
162057,symptoms,0,0
162058,associated,0,0
162059,with,0,0
162060,post-traumatic,0,0
162061,stress,0,0
162062,disorder,0,0
162063,1,0,0
162064,year,0,0
162065,after,0,0
162066,completing,0,0
162067,the,0,0
162068,initial,0,0
162069,study,0,0
162070,.,0,0
162071,Twenty-one,0,0
162072,out,0,0
162073,of,0,0
162074,29,0,0
162075,nonrandomized,0,0
162076,controls,0,0
162077,who,0,0
162078,did,0,0
162079,not,0,0
162080,receive,0,0
162081,the,0,0
162082,treatment,0,0
162083,also,0,0
162084,completed,0,0
162085,the,0,0
162086,questionnaires,0,0
162087,.,0,0
162088,RESULTS,0,0
162089,Both,0,0
162090,the,0,0
162091,treated,0,0
162092,and,0,0
162093,control,0,0
162094,groups,0,0
162095,experienced,0,0
162096,significant,0,0
162097,improvement,0,0
162098,in,0,0
162099,psychological,0,0
162100,functioning,0,0
162101,compared,0,0
162102,with,0,0
162103,end-of-trial,0,0
162104,.,0,0
162105,However,0,0
162106,",",0,0
162107,treated,0,0
162108,participants,0,0
162109,had,0,0
162110,better,0,0
162111,long-term,0,0
162112,outcomes,0,0
162113,on,0,0
162114,most,0,0
162115,measures,0,0
162116,compared,0,0
162117,with,0,0
162118,controls,0,0
162119,(,0,0
162120,ES=0.69-1.31,0,0
162121,),0,0
162122,.,0,0
162123,Those,0,0
162124,who,0,0
162125,stayed,0,0
162126,on,0,0
162127,micronutrients,0,1
162128,through,0,0
162129,to,0,0
162130,follow-up,0,0
162131,or,0,0
162132,stopped,0,1
162133,all,0,0
162134,treatment,0,0
162135,reported,0,0
162136,better,0,0
162137,psychological,0,0
162138,functioning,0,0
162139,than,0,0
162140,those,0,0
162141,who,0,0
162142,switched,0,0
162143,to,0,0
162144,other,0,0
162145,treatments,0,0
162146,including,0,0
162147,medications,0,1
162148,.,0,1
162149,About,0,0
162150,10,0,0
162151,%,0,0
162152,of,0,0
162153,the,0,0
162154,sample,0,0
162155,continued,0,0
162156,to,0,0
162157,have,0,0
162158,post-traumatic,0,0
162159,stress,0,0
162160,disorder,0,0
162161,symptoms,0,0
162162,.,0,0
162163,CONCLUSIONS,0,0
162164,Disaster,0,0
162165,survivors,0,0
162166,improve,0,0
162167,psychologically,0,0
162168,over,0,0
162169,time,0,0
162170,regardless,0,0
162171,of,0,0
162172,receiving,0,0
162173,intervention,0,0
162174,;,0,0
162175,however,0,0
162176,",",0,0
162177,those,0,0
162178,taking,0,0
162179,micronutrients,1,1
162180,during,0,0
162181,the,0,0
162182,acute,0,0
162183,phase,0,0
162184,following,0,0
162185,a,0,0
162186,disaster,0,0
162187,show,0,0
162188,better,0,0
162189,outcomes,0,0
162190,",",0,0
162191,identifying,0,0
162192,micronutrients,1,1
162193,as,0,0
162194,a,0,0
162195,viable,0,0
162196,treatment,0,0
162197,for,0,0
162198,acute,0,0
162199,stress,0,0
162200,following,0,0
162201,a,0,0
162202,natural,0,0
162203,disaster,0,0
162204,with,0,0
162205,maintenance,0,0
162206,of,0,0
162207,benefits,0,0
162208,1,0,0
162209,year,0,0
162210,later,0,0
162211,.,0,0
162212,ACTRN,0,0
162213,12611000460909,0,1
162214,Evaluation,0,0
162215,of,0,0
162216,the,0,0
162217,efficacy,0,0
162218,and,0,0
162219,safety,0,0
162220,of,0,0
162221,the,0,0
162222,ophthalmic,1,0
162223,insert,1,0
162224,Mydriasert,1,0
162225,in,0,0
162226,patients,0,0
162227,undergoing,0,0
162228,retinal,0,0
162229,angiography,0,0
162230,.,0,0
162231,PURPOSE,0,0
162232,To,0,0
162233,verify,0,0
162234,the,0,0
162235,efficacy,0,0
162236,to,0,0
162237,obtain,0,0
162238,mydriasis,0,1
162239,and,0,1
162240,cardiovascular,0,1
162241,safety,0,0
162242,of,0,0
162243,Mydriasert,1,1
162244,(,1,0
162245,ophthalmic,1,0
162246,insert,1,0
162247,containing,1,0
162248,tropicamide,1,1
162249,and,1,1
162250,phenylephrine,1,1
162251,),1,1
162252,in,0,0
162253,diabetic,0,0
162254,and,0,0
162255,nondiabetic,0,0
162256,patients,0,0
162257,undergoing,0,0
162258,retinal,0,0
162259,angiography,0,0
162260,by,0,0
162261,comparing,0,0
162262,it,0,0
162263,with,0,0
162264,usually,0,0
162265,administered,0,1
162266,eyedrops,0,1
162267,(,1,1
162268,tropicamide,1,1
162269,1,1,0
162270,%,1,0
162271,and,1,0
162272,phenylephrine,1,0
162273,10,1,0
162274,%,1,0
162275,),1,0
162276,.,0,0
162277,METHODS,0,0
162278,This,0,0
162279,was,0,0
162280,a,0,0
162281,prospective,0,0
162282,randomized,0,0
162283,study,0,0
162284,.,0,0
162285,A,0,0
162286,total,0,0
162287,of,0,0
162288,154,0,0
162289,eyes,0,0
162290,of,0,0
162291,77,0,0
162292,patients,0,0
162293,were,0,0
162294,randomly,0,0
162295,divided,0,0
162296,into,0,0
162297,2,0,0
162298,groups,0,0
162299,:,0,0
162300,group,0,0
162301,1,0,0
162302,consisted,0,0
162303,of,0,0
162304,78,0,0
162305,eyes,0,0
162306,",",0,0
162307,group,0,0
162308,2,0,0
162309,consisted,0,0
162310,of,0,0
162311,76,0,0
162312,eyes,0,0
162313,",",0,0
162314,and,0,0
162315,the,0,0
162316,patients,0,0
162317,were,0,0
162318,monitored,0,0
162319,for,0,0
162320,pupillary,0,0
162321,dilation,0,0
162322,",",0,0
162323,blood,0,0
162324,pressure,0,0
162325,",",0,0
162326,heart,0,0
162327,rate,0,0
162328,",",0,0
162329,and,0,0
162330,possible,0,0
162331,adverse,0,0
162332,effects,0,0
162333,at,0,0
162334,0,0,0
162335,",",0,0
162336,20,0,0
162337,",",0,0
162338,40,0,0
162339,",",0,0
162340,60,0,0
162341,",",0,0
162342,and,0,0
162343,90,0,0
162344,minutes,0,0
162345,.,0,0
162346,RESULTS,0,1
162347,No,0,1
162348,severe,0,1
162349,adverse,0,0
162350,effects,0,0
162351,were,0,0
162352,observed,0,0
162353,in,0,0
162354,either,0,0
162355,group,0,0
162356,.,0,0
162357,In,0,0
162358,the,0,0
162359,entire,0,0
162360,sample,0,0
162361,studied,0,0
162362,",",0,0
162363,the,0,0
162364,mean,0,0
162365,pupillary,0,0
162366,diameter,0,0
162367,was,0,0
162368,greater,0,0
162369,in,0,0
162370,the,0,0
162371,eyedrops,0,1
162372,group,0,1
162373,after,0,0
162374,20,0,0
162375,and,0,0
162376,40,0,0
162377,minutes,0,0
162378,",",0,0
162379,while,0,0
162380,mydriasis,0,1
162381,was,0,0
162382,similar,0,0
162383,in,0,0
162384,the,0,0
162385,2,0,0
162386,groups,0,0
162387,after,0,0
162388,60,0,0
162389,minutes,0,0
162390,.,0,0
162391,The,0,0
162392,diabetic,0,0
162393,patients,0,0
162394,treated,0,0
162395,with,0,0
162396,Mydriasert,1,0
162397,had,0,0
162398,less,0,0
162399,mydriasis,0,0
162400,than,0,0
162401,those,0,0
162402,treated,0,0
162403,with,0,0
162404,eyedrops,0,1
162405,after,0,0
162406,20,0,0
162407,and,0,0
162408,40,0,0
162409,minutes,0,0
162410,",",0,0
162411,and,0,0
162412,diabetic,0,0
162413,patients,0,0
162414,showed,0,0
162415,less,0,0
162416,mydriasis,0,1
162417,than,0,0
162418,the,0,0
162419,nondiabetic,0,0
162420,patients,0,0
162421,after,0,0
162422,60,0,0
162423,and,0,0
162424,90,0,0
162425,minutes,0,0
162426,.,0,0
162427,There,0,0
162428,was,0,0
162429,no,0,0
162430,significant,0,0
162431,between-group,0,0
162432,difference,0,0
162433,in,0,0
162434,mean,0,0
162435,heart,0,0
162436,rate,0,0
162437,or,0,0
162438,systolic,0,0
162439,and,0,0
162440,diastolic,0,0
162441,blood,0,0
162442,pressure,0,0
162443,at,0,0
162444,any,0,0
162445,of,0,0
162446,the,0,0
162447,time,0,0
162448,points,0,0
162449,.,0,0
162450,CONCLUSIONS,0,0
162451,Mydriasert,1,0
162452,assures,0,0
162453,an,0,0
162454,adequate,0,0
162455,degree,0,0
162456,of,0,0
162457,mydriasis,0,0
162458,for,0,0
162459,retinal,0,0
162460,angiography,0,0
162461,in,0,0
162462,both,0,0
162463,diabetic,0,0
162464,and,0,0
162465,nondiabetic,0,0
162466,patients,0,0
162467,.,0,0
162468,There,0,0
162469,are,0,0
162470,no,0,0
162471,differences,0,0
162472,in,0,0
162473,efficacy,0,0
162474,or,0,0
162475,safety,0,0
162476,between,0,0
162477,the,0,0
162478,insert,0,0
162479,and,0,0
162480,the,0,0
162481,usually,0,0
162482,administered,0,1
162483,eyedrops,0,1
162484,",",0,1
162485,but,0,0
162486,the,0,0
162487,low,0,0
162488,total,0,0
162489,drug,0,1
162490,dose,0,1
162491,administered,0,1
162492,with,0,1
162493,the,0,0
162494,insert,0,0
162495,reduces,0,0
162496,the,0,0
162497,risk,0,0
162498,of,0,0
162499,cardiovascular,0,0
162500,side,0,0
162501,effects,0,0
162502,.,0,0
162503,Decreased,0,0
162504,expression,0,0
162505,of,0,0
162506,Yes-associated,0,0
162507,protein,0,0
162508,is,0,0
162509,associated,0,0
162510,with,0,0
162511,outcome,0,0
162512,in,0,0
162513,the,0,0
162514,luminal,0,0
162515,A,0,0
162516,breast,0,0
162517,cancer,0,0
162518,subgroup,0,0
162519,and,0,0
162520,with,0,0
162521,an,0,0
162522,impaired,0,0
162523,tamoxifen,1,1
162524,response,0,0
162525,.,0,0
162526,BACKGROUND,0,0
162527,Yes-associated,0,0
162528,protein,0,0
162529,(,0,0
162530,YAP1,0,1
162531,),0,0
162532,is,0,0
162533,frequently,0,0
162534,reported,0,0
162535,to,0,0
162536,function,0,0
162537,as,0,0
162538,an,0,0
162539,oncogene,0,0
162540,in,0,0
162541,many,0,0
162542,types,0,0
162543,of,0,0
162544,cancer,0,0
162545,",",0,0
162546,but,0,0
162547,in,0,0
162548,breast,0,0
162549,cancer,0,0
162550,results,0,0
162551,remain,0,0
162552,controversial,0,0
162553,.,0,0
162554,We,0,0
162555,set,0,0
162556,out,0,0
162557,to,0,0
162558,clarify,0,0
162559,the,0,0
162560,role,0,0
162561,of,0,0
162562,YAP1,0,0
162563,in,0,0
162564,breast,0,0
162565,cancer,0,0
162566,by,0,0
162567,examining,0,0
162568,gene,0,0
162569,and,0,0
162570,protein,0,0
162571,expression,0,0
162572,in,0,0
162573,subgroups,0,0
162574,of,0,0
162575,patient,0,0
162576,material,0,0
162577,and,0,0
162578,by,0,0
162579,downregulating,0,0
162580,YAP1,0,0
162581,in,0,0
162582,vitro,0,0
162583,and,0,0
162584,studying,0,0
162585,its,0,0
162586,role,0,0
162587,in,0,0
162588,response,0,0
162589,to,0,0
162590,the,0,0
162591,widely,0,0
162592,used,0,0
162593,anti-estrogen,0,1
162594,tamoxifen,1,1
162595,.,1,1
162596,METHODS,0,1
162597,YAP1,0,0
162598,protein,0,0
162599,intensity,0,0
162600,was,0,0
162601,scored,0,0
162602,as,0,0
162603,absent,0,0
162604,",",0,0
162605,weak,0,0
162606,",",0,0
162607,intermediate,0,0
162608,or,0,0
162609,strong,0,0
162610,in,0,0
162611,two,0,0
162612,primary,0,0
162613,breast,0,0
162614,cancer,0,1
162615,cohorts,0,1
162616,(,0,0
162617,n,0,0
162618,=,0,0
162619,144,0,0
162620,and,0,0
162621,n,0,0
162622,=,0,0
162623,564,0,0
162624,),0,0
162625,and,0,0
162626,mRNA,0,0
162627,expression,0,0
162628,of,0,0
162629,YAP1,0,0
162630,was,0,0
162631,evaluated,0,0
162632,in,0,0
162633,a,0,0
162634,gene,0,0
162635,expression,0,0
162636,dataset,0,1
162637,(,0,0
162638,n,0,0
162639,=,0,0
162640,1107,0,0
162641,),0,0
162642,.,0,0
162643,Recurrence-free,0,0
162644,survival,0,0
162645,was,0,0
162646,analysed,0,0
162647,using,0,0
162648,the,0,0
162649,log-rank,0,0
162650,test,0,0
162651,and,0,0
162652,Cox,0,0
162653,multivariate,0,0
162654,analysis,0,0
162655,was,0,0
162656,used,0,0
162657,to,0,0
162658,test,0,0
162659,for,0,0
162660,independence,0,0
162661,.,0,0
162662,WST-1,1,0
162663,assay,1,0
162664,was,0,0
162665,employed,0,0
162666,to,0,0
162667,measure,0,0
162668,cell,0,0
162669,viability,0,0
162670,and,0,0
162671,a,0,0
162672,luciferase,0,0
162673,ERE,0,0
162674,(,0,0
162675,estrogen,0,1
162676,responsive,0,1
162677,element,0,0
162678,),0,0
162679,construct,0,0
162680,was,0,0
162681,used,0,0
162682,to,0,0
162683,study,0,0
162684,the,0,0
162685,effect,0,0
162686,of,0,0
162687,tamoxifen,1,1
162688,",",0,0
162689,following,0,0
162690,downregulation,0,0
162691,of,0,0
162692,YAP1,0,0
162693,using,0,0
162694,siRNAs,0,0
162695,.,0,0
162696,RESULTS,0,0
162697,In,0,0
162698,the,0,0
162699,ER+,0,1
162700,(,0,1
162701,Estrogen,0,1
162702,Receptor,0,1
162703,?,0,1
162704,positive,0,0
162705,),0,0
162706,subgroup,0,0
162707,of,0,0
162708,the,0,0
162709,randomised,0,0
162710,cohort,0,0
162711,",",0,0
162712,YAP1,0,0
162713,expression,0,0
162714,was,0,0
162715,inversely,0,0
162716,correlated,0,0
162717,to,0,0
162718,histological,0,0
162719,grade,0,0
162720,and,0,0
162721,proliferation,0,0
162722,(,0,0
162723,p,0,0
162724,=,0,0
162725,0.001,0,0
162726,and,0,0
162727,p,0,0
162728,=,0,0
162729,0.016,0,0
162730,",",0,0
162731,respectively,0,0
162732,),0,0
162733,whereas,0,0
162734,in,0,0
162735,the,0,0
162736,ER-,0,1
162737,(,0,1
162738,Estrogen,0,0
162739,Receptor,0,1
162740,?,0,1
162741,negative,0,0
162742,),0,0
162743,subgroup,0,0
162744,YAP1,0,0
162745,expression,0,0
162746,correlated,0,0
162747,positively,0,0
162748,to,0,0
162749,proliferation,0,0
162750,(,0,0
162751,p,0,0
162752,=,0,0
162753,0.005,0,0
162754,),0,0
162755,.,0,0
162756,Notably,0,0
162757,",",0,0
162758,low,0,0
162759,YAP1,0,0
162760,mRNA,0,0
162761,was,0,0
162762,independently,0,0
162763,associated,0,0
162764,with,0,0
162765,decreased,0,0
162766,recurrence-free,0,0
162767,survival,0,0
162768,in,0,0
162769,the,0,0
162770,gene,0,0
162771,expression,0,0
162772,dataset,0,0
162773,",",0,0
162774,specifically,0,0
162775,for,0,0
162776,the,0,0
162777,luminal,0,0
162778,A,0,1
162779,subgroup,0,0
162780,(,0,0
162781,p,0,0
162782,<,0,0
162783,0.001,0,0
162784,),0,0
162785,which,0,0
162786,includes,0,0
162787,low,0,0
162788,proliferating,0,0
162789,tumours,0,0
162790,of,0,0
162791,lower,0,0
162792,grade,0,0
162793,",",0,0
162794,usually,0,0
162795,associated,0,0
162796,with,0,0
162797,a,0,0
162798,good,0,0
162799,prognosis,0,0
162800,.,0,0
162801,This,0,0
162802,subgroup,0,0
162803,specificity,0,0
162804,led,0,0
162805,us,0,0
162806,to,0,0
162807,hypothesize,0,0
162808,that,0,0
162809,YAP1,0,0
162810,may,0,0
162811,be,0,0
162812,important,0,0
162813,for,0,0
162814,response,0,0
162815,to,0,0
162816,endocrine,0,0
162817,therapies,0,0
162818,",",0,0
162819,such,0,0
162820,as,0,0
162821,tamoxifen,1,1
162822,",",1,0
162823,extensively,0,0
162824,used,0,0
162825,for,0,0
162826,luminal,0,0
162827,A,0,0
162828,breast,0,0
162829,cancers,0,0
162830,.,0,0
162831,In,0,0
162832,a,0,0
162833,tamoxifen,1,1
162834,randomised,1,1
162835,patient,0,1
162836,material,0,0
162837,",",0,0
162838,absent,0,0
162839,YAP1,0,0
162840,protein,0,0
162841,expression,0,0
162842,was,0,0
162843,associated,0,0
162844,with,0,0
162845,impaired,1,0
162846,tamoxifen,1,1
162847,response,1,0
162848,which,0,0
162849,was,0,0
162850,significant,0,0
162851,upon,0,0
162852,interaction,0,0
162853,analysis,0,0
162854,(,0,0
162855,p,0,0
162856,=,0,0
162857,0.042,0,0
162858,),0,0
162859,.,0,0
162860,YAP1,0,0
162861,downregulation,0,0
162862,resulted,0,0
162863,in,0,0
162864,increased,0,0
162865,progesterone,0,1
162866,receptor,0,1
162867,(,0,1
162868,PgR,0,1
162869,),0,0
162870,expression,0,0
162871,and,0,0
162872,a,0,0
162873,delayed,0,0
162874,and,0,0
162875,weaker,1,0
162876,tamoxifen,1,1
162877,in,1,0
162878,support,0,0
162879,of,0,0
162880,the,0,0
162881,clinical,0,0
162882,data,0,0
162883,.,0,0
162884,CONCLUSIONS,0,0
162885,Decreased,0,0
162886,YAP1,0,0
162887,expression,0,0
162888,is,0,0
162889,an,0,0
162890,independent,0,0
162891,prognostic,0,0
162892,factor,0,0
162893,for,0,0
162894,recurrence,0,0
162895,in,0,0
162896,the,0,0
162897,less,0,0
162898,aggressive,0,0
162899,luminal,0,0
162900,A,0,1
162901,breast,0,0
162902,cancer,0,0
162903,subgroup,0,0
162904,",",0,0
162905,likely,0,0
162906,due,0,0
162907,to,0,0
162908,the,0,0
162909,decreased,1,0
162910,tamoxifen,1,1
162911,sensitivity,1,0
162912,conferred,0,0
162913,by,0,0
162914,YAP1,0,0
162915,downregulation,0,0
162916,.,0,0
162917,Comparison,0,0
162918,of,0,0
162919,the,0,0
162920,cardiorespiratory,0,0
162921,effects,0,0
162922,of,0,0
162923,a,0,0
162924,combination,1,0
162925,of,1,0
162926,ketamine,1,1
162927,and,1,1
162928,propofol,1,1
162929,",",1,1
162930,propofol,1,1
162931,alone,1,0
162932,",",1,0
162933,or,1,0
162934,a,1,0
162935,combination,1,0
162936,of,1,0
162937,ketamine,1,1
162938,and,1,1
162939,diazepam,1,1
162940,before,1,0
162941,and,1,0
162942,after,1,0
162943,induction,1,0
162944,of,1,0
162945,anesthesia,1,0
162946,in,1,0
162947,dogs,1,0
162948,sedated,1,1
162949,with,1,1
162950,acepromazine,1,1
162951,and,1,1
162952,oxymorphone,1,1
162953,.,1,1
162954,OBJECTIVE,0,1
162955,To,0,0
162956,evaluate,0,0
162957,the,0,0
162958,cardiorespiratory,0,0
162959,effects,0,0
162960,of,0,0
162961,IV,0,1
162962,administration,0,1
162963,of,0,1
162964,propofol,1,1
162965,(,0,1
162966,4,0,1
162967,mg/kg,0,1
162968,),0,1
162969,",",0,1
162970,ketamine,1,1
162971,hydrochloride,1,1
162972,and,1,1
162973,propofol,1,1
162974,(,0,1
162975,2,0,1
162976,mg/kg,0,1
162977,each,0,1
162978,;,0,1
162979,K-P,0,1
162980,),0,1
162981,",",0,0
162982,or,0,1
162983,ketamine,1,1
162984,hydrochloride,1,1
162985,(,0,1
162986,5,0,1
162987,mg/kg,0,1
162988,),0,1
162989,and,0,1
162990,diazepam,1,1
162991,(,0,1
162992,0.2,0,1
162993,mg/kg,0,1
162994,;,0,1
162995,K-D,0,1
162996,),0,0
162997,before,0,0
162998,and,0,0
162999,after,0,0
163000,induction,0,0
163001,of,0,0
163002,anesthesia,1,0
163003,(,0,1
163004,IoA,0,1
163005,),0,0
163006,in,0,0
163007,dogs,0,0
163008,sedated,0,1
163009,with,0,1
163010,acepromazine,1,1
163011,maleate,1,1
163012,and,0,1
163013,oxymorphone,1,1
163014,hydrochloride,1,1
163015,.,1,1
163016,ANIMALS,0,0
163017,10,0,0
163018,healthy,0,0
163019,adult,0,0
163020,Beagles,0,0
163021,.,0,0
163022,PROCEDURES,0,0
163023,Each,0,0
163024,dog,0,0
163025,was,0,0
163026,randomly,0,0
163027,allocated,0,0
163028,to,0,0
163029,receive,0,0
163030,2,0,0
163031,of,0,0
163032,3,0,1
163033,treatments,0,0
163034,(,0,0
163035,1-week,0,0
163036,interval,0,0
163037,),0,0
163038,.,0,0
163039,For,0,0
163040,instrumentation,0,0
163041,prior,0,0
163042,to,0,0
163043,each,0,0
163044,treatment,0,0
163045,",",0,0
163046,each,0,0
163047,dog,0,0
163048,was,0,0
163049,anesthetized,1,1
163050,with,1,1
163051,isoflurane,1,1
163052,.,1,0
163053,After,0,0
163054,full,0,0
163055,recovery,0,0
163056,",",0,1
163057,acepromazine,1,1
163058,(,0,1
163059,0.02,0,1
163060,mg/kg,0,1
163061,),0,1
163062,and,0,1
163063,oxymorphone,1,1
163064,(,0,1
163065,0.05,0,1
163066,mg/kg,0,1
163067,),0,0
163068,were,0,1
163069,administered,0,1
163070,IV,0,1
163071,.,0,0
163072,Fifteen,0,0
163073,minutes,0,0
163074,later,0,0
163075,(,0,0
163076,before,0,0
163077,IoA,0,1
163078,),0,0
163079,",",0,0
163080,each,0,0
163081,dog,0,0
163082,received,0,0
163083,treatment,0,0
163084,IV,0,1
163085,with,0,1
163086,propofol,1,1
163087,",",1,0
163088,K-P,1,1
163089,",",1,0
163090,or,1,0
163091,K-D.,1,1
163092,Cardiorespiratory,0,1
163093,and,0,0
163094,arterial,0,0
163095,blood,0,0
163096,gas,0,0
163097,variables,0,0
163098,were,0,0
163099,assessed,0,0
163100,before,0,0
163101,",",0,0
163102,immediately,0,0
163103,after,0,0
163104,",",0,0
163105,and,0,0
163106,5,0,0
163107,minutes,0,0
163108,after,0,0
163109,IoA,0,0
163110,.,0,0
163111,RESULTS,0,0
163112,Compared,0,0
163113,with,0,0
163114,findings,0,0
163115,before,0,0
163116,IoA,0,0
163117,",",0,0
163118,dogs,0,0
163119,receiving,0,0
163120,the,0,0
163121,K-P,1,0
163122,or,0,0
163123,K-D,1,0
163124,treatment,0,0
163125,had,0,0
163126,increased,0,0
163127,cardiac,0,0
163128,output,0,0
163129,",",0,0
163130,oxygen,0,0
163131,delivery,0,0
163132,",",0,0
163133,and,0,0
163134,heart,0,0
163135,rate,0,0
163136,5,0,0
163137,minutes,0,0
163138,after,0,0
163139,IoA,0,1
163140,;,0,1
163141,K-P,1,1
163142,administration,0,1
163143,did,0,0
163144,not,0,0
163145,change,0,0
163146,mean,0,0
163147,arterial,0,0
163148,blood,0,0
163149,pressure,0,0
163150,or,0,0
163151,stroke,0,0
163152,volume,0,0
163153,and,0,0
163154,decreased,0,0
163155,systemic,0,0
163156,vascular,0,0
163157,resistance,0,0
163158,.,0,0
163159,Propofol,0,1
163160,decreased,0,0
163161,mean,0,0
163162,arterial,0,0
163163,blood,0,0
163164,pressure,0,0
163165,and,0,0
163166,systemic,0,0
163167,vascular,0,0
163168,resistance,0,0
163169,immediately,0,0
163170,after,0,0
163171,IoA,0,0
163172,but,0,0
163173,did,0,0
163174,not,0,0
163175,change,0,0
163176,heart,0,0
163177,rate,0,0
163178,",",0,0
163179,cardiac,0,0
163180,output,0,0
163181,",",0,0
163182,or,0,0
163183,oxygen,0,0
163184,delivery,0,0
163185,.,0,0
163186,All,0,0
163187,treatments,0,0
163188,caused,0,0
163189,some,0,0
163190,degree,0,0
163191,of,0,0
163192,apnea,0,0
163193,",",0,0
163194,hypoventilation,0,0
163195,",",0,0
163196,and,0,0
163197,hypoxemia,0,1
163198,(,0,0
163199,Pao2,0,0
163200,<,0,0
163201,80,0,0
163202,mm,0,0
163203,Hg,0,1
163204,),0,0
163205,.,0,0
163206,CONCLUSIONS,0,0
163207,AND,0,1
163208,CLINICAL,0,1
163209,RELEVANCE,0,1
163210,In,0,0
163211,dogs,0,0
163212,",",0,0
163213,K-P,1,0
163214,treatment,0,0
163215,maintained,0,0
163216,mean,0,0
163217,arterial,0,0
163218,blood,0,0
163219,pressure,0,0
163220,better,0,0
163221,than,0,0
163222,propofol,0,1
163223,alone,0,0
163224,and,0,0
163225,increased,0,0
163226,heart,0,0
163227,rate,0,0
163228,",",0,0
163229,cardiac,0,0
163230,output,0,0
163231,",",0,0
163232,or,0,0
163233,oxygen,0,0
163234,delivery,0,0
163235,",",0,0
163236,as,0,0
163237,did,0,0
163238,the,0,0
163239,K-D,1,0
163240,treatment,0,0
163241,.,0,0
163242,Supplemental,0,0
163243,100,0,0
163244,%,0,0
163245,oxygen,0,0
163246,should,0,0
163247,be,0,0
163248,provided,0,0
163249,during,0,0
163250,IoA,0,0
163251,with,0,0
163252,all,0,0
163253,3,0,0
163254,treatments,0,0
163255,.,0,0
163256,The,0,0
163257,effect,0,0
163258,of,0,0
163259,lowering,0,0
163260,LDL,0,1
163261,cholesterol,0,1
163262,on,0,0
163263,vascular,0,0
163264,access,0,0
163265,patency,0,0
163266,:,0,0
163267,post,0,0
163268,hoc,0,0
163269,analysis,0,0
163270,of,0,0
163271,the,0,0
163272,Study,0,0
163273,of,0,0
163274,Heart,0,0
163275,and,0,0
163276,Renal,0,0
163277,Protection,0,0
163278,.,0,0
163279,BACKGROUND,0,0
163280,AND,0,1
163281,OBJECTIVES,0,1
163282,Reducing,0,1
163283,LDL,0,1
163284,cholesterol,0,1
163285,(,0,1
163286,LDL-C,0,1
163287,),0,1
163288,with,0,0
163289,statin-based,1,0
163290,therapy,1,0
163291,reduces,0,0
163292,the,0,0
163293,risk,0,0
163294,of,0,0
163295,major,0,0
163296,atherosclerotic,0,0
163297,events,0,0
163298,among,0,0
163299,patients,0,0
163300,with,0,0
163301,CKD,0,0
163302,",",0,0
163303,including,0,0
163304,dialysis,0,0
163305,patients,0,0
163306,",",0,0
163307,but,0,0
163308,the,0,0
163309,effect,0,0
163310,of,0,0
163311,lowering,0,0
163312,LDL-C,0,0
163313,on,0,0
163314,vascular,0,0
163315,access,0,0
163316,patency,0,0
163317,is,0,0
163318,unclear,0,0
163319,.,0,0
163320,DESIGN,0,0
163321,",",0,0
163322,SETTING,0,1
163323,",",0,0
163324,PARTICIPANTS,0,1
163325,",",0,0
163326,&,0,0
163327,MEASUREMENTS,0,0
163328,The,0,0
163329,Study,0,0
163330,of,0,0
163331,Heart,0,0
163332,and,0,0
163333,Renal,0,0
163334,Protection,0,0
163335,(,0,0
163336,SHARP,0,1
163337,),0,1
163338,randomized,0,0
163339,patients,0,0
163340,with,0,0
163341,CKD,0,0
163342,to,0,0
163343,20,1,1
163344,mg,1,1
163345,simvastatin,1,1
163346,plus,1,1
163347,10,1,1
163348,mg,1,1
163349,ezetimibe,1,1
163350,daily,1,1
163351,versus,1,1
163352,matching,1,0
163353,placebo,1,1
163354,.,1,1
163355,This,0,0
163356,study,0,0
163357,aimed,0,0
163358,to,0,0
163359,explore,0,0
163360,the,0,0
163361,effects,0,0
163362,of,0,0
163363,treatment,0,0
163364,on,0,0
163365,vascular,0,0
163366,access,0,0
163367,occlusive,0,0
163368,events,0,0
163369,",",0,0
163370,defined,0,0
163371,as,0,0
163372,any,0,0
163373,access,0,0
163374,revision,0,0
163375,procedure,0,0
163376,",",0,0
163377,access,0,0
163378,thrombosis,0,0
163379,",",0,0
163380,removal,0,0
163381,of,0,0
163382,an,0,0
163383,old,0,0
163384,dialysis,0,0
163385,access,0,0
163386,",",0,0
163387,or,0,0
163388,formation,0,0
163389,of,0,0
163390,new,0,0
163391,permanent,0,0
163392,dialysis,0,0
163393,access,0,0
163394,.,0,0
163395,RESULTS,0,0
163396,Among,0,0
163397,2353,0,0
163398,SHARP,0,0
163399,participants,0,0
163400,who,0,0
163401,had,0,0
163402,functioning,0,0
163403,vascular,0,0
163404,access,0,0
163405,at,0,0
163406,randomization,0,0
163407,",",0,0
163408,allocation,0,0
163409,to,0,0
163410,simvastatin,0,1
163411,plus,0,1
163412,ezetimibe,0,1
163413,resulted,0,0
163414,in,0,0
163415,a,0,0
163416,13,0,0
163417,%,0,0
163418,proportional,0,0
163419,reduction,0,0
163420,in,0,0
163421,vascular,0,0
163422,access,0,0
163423,occlusive,0,1
163424,events,0,0
163425,(,0,0
163426,355,0,0
163427,[,0,0
163428,29.7,0,0
163429,%,0,0
163430,],0,0
163431,for,0,0
163432,simvastatin/ezetimibe,1,1
163433,versus,0,0
163434,388,0,0
163435,[,0,0
163436,33.5,0,0
163437,%,0,0
163438,],0,0
163439,for,0,0
163440,placebo,1,1
163441,;,1,1
163442,risk,0,1
163443,ratio,0,1
163444,[,0,1
163445,RR,0,1
163446,],0,0
163447,",",0,0
163448,0.87,0,0
163449,;,0,0
163450,95,0,0
163451,%,0,0
163452,confidence,0,0
163453,interval,0,0
163454,[,0,0
163455,95,0,0
163456,%,0,0
163457,CI,0,0
163458,],0,0
163459,",",0,0
163460,0.75,0,0
163461,to,0,0
163462,1.00,0,0
163463,;,0,0
163464,P=0.05,0,0
163465,),0,0
163466,.,0,0
163467,There,0,0
163468,was,0,0
163469,no,0,0
163470,evidence,0,0
163471,that,0,0
163472,the,0,0
163473,effects,0,0
163474,of,0,0
163475,treatment,0,0
163476,differed,0,0
163477,for,0,0
163478,any,0,0
163479,of,0,0
163480,the,0,0
163481,separate,0,0
163482,components,0,0
163483,of,0,0
163484,this,0,0
163485,outcome,0,0
163486,.,0,0
163487,To,0,0
163488,test,0,0
163489,the,0,0
163490,hypothesis,0,0
163491,raised,0,0
163492,by,0,0
163493,SHARP,0,0
163494,",",0,0
163495,comparable,0,0
163496,analyses,0,0
163497,were,0,0
163498,performed,0,0
163499,using,0,0
163500,the,0,0
163501,AURORA,0,1
163502,(,0,1
163503,A,0,1
163504,Study,0,0
163505,to,0,0
163506,Evaluate,0,0
163507,the,0,0
163508,Use,0,0
163509,of,0,0
163510,Rosuvastatin,0,1
163511,in,0,0
163512,Subjects,0,1
163513,on,0,0
163514,Regular,0,0
163515,Hemodialysis,0,0
163516,:,0,1
163517,An,0,1
163518,Assessment,0,1
163519,of,0,0
163520,Survival,0,0
163521,and,0,0
163522,Cardiovascular,0,0
163523,Events,0,0
163524,),0,0
163525,trial,0,0
163526,cohort,0,1
163527,.,0,0
163528,AURORA,0,0
163529,did,0,0
163530,not,0,0
163531,provide,0,0
163532,independent,0,0
163533,confirmation,0,0
163534,(,0,0
163535,vascular,0,0
163536,access,0,1
163537,occlusive,0,0
163538,events,0,0
163539,:,0,0
163540,352,0,0
163541,[,0,0
163542,28.9,0,0
163543,%,0,0
163544,],0,0
163545,for,0,0
163546,rosuvastatin,0,1
163547,versus,0,0
163548,337,0,0
163549,[,0,0
163550,27.6,0,0
163551,%,0,0
163552,],0,0
163553,for,0,0
163554,placebo,0,1
163555,;,0,1
163556,RR,0,1
163557,",",0,0
163558,1.06,0,0
163559,",",0,0
163560,95,0,0
163561,%,0,0
163562,CI,0,0
163563,",",0,0
163564,0.91,0,0
163565,to,0,0
163566,1.23,0,0
163567,;,0,0
163568,P=0.44,0,0
163569,),0,0
163570,.,0,0
163571,After,0,0
163572,combining,0,0
163573,the,0,0
163574,two,0,0
163575,trials,0,0
163576,",",0,0
163577,the,0,0
163578,overall,0,0
163579,effect,0,0
163580,of,0,0
163581,reducing,0,0
163582,LDL-C,0,0
163583,with,0,0
163584,a,0,0
163585,statin-based,0,1
163586,regimen,0,1
163587,on,0,0
163588,vascular,0,0
163589,access,0,0
163590,occlusive,0,0
163591,events,0,0
163592,was,0,0
163593,not,0,0
163594,statistically,0,0
163595,significant,0,0
163596,(,0,0
163597,707,0,0
163598,[,0,0
163599,29.3,0,0
163600,%,0,0
163601,],0,0
163602,with,0,0
163603,any,0,0
163604,LDL-C-lowering,0,1
163605,therapy,0,1
163606,versus,0,0
163607,725,0,0
163608,[,0,0
163609,30.5,0,0
163610,%,0,0
163611,],0,0
163612,with,0,0
163613,placebo,0,1
163614,;,0,1
163615,RR,0,0
163616,",",0,0
163617,0.95,0,0
163618,",",0,0
163619,95,0,0
163620,%,0,0
163621,CI,0,0
163622,",",0,0
163623,0.85,0,0
163624,to,0,0
163625,1.05,0,0
163626,;,0,0
163627,P=0.29,0,0
163628,),0,0
163629,.,0,0
163630,CONCLUSIONS,0,0
163631,Exploratory,0,0
163632,analyses,0,0
163633,from,0,0
163634,SHARP,0,0
163635,suggest,0,0
163636,that,0,0
163637,lowering,0,0
163638,LDL-C,0,0
163639,with,0,0
163640,statin-based,1,0
163641,therapy,1,0
163642,may,0,0
163643,improve,0,0
163644,vascular,0,0
163645,access,0,0
163646,patency,0,0
163647,",",0,0
163648,but,0,0
163649,there,0,0
163650,was,0,0
163651,no,0,0
163652,evidence,0,0
163653,of,0,0
163654,benefit,0,0
163655,in,0,0
163656,AURORA,0,0
163657,.,0,0
163658,Taken,0,0
163659,together,0,0
163660,",",0,0
163661,the,0,0
163662,available,0,0
163663,evidence,0,0
163664,suggests,0,0
163665,that,0,0
163666,any,0,0
163667,benefits,0,0
163668,of,0,0
163669,lowering,0,0
163670,LDL-C,0,0
163671,on,0,0
163672,vascular,0,0
163673,access,0,0
163674,patency,0,0
163675,are,0,0
163676,likely,0,0
163677,to,0,0
163678,be,0,0
163679,modest,0,0
163680,.,0,0
163681,The,0,0
163682,effect,0,0
163683,of,0,0
163684,modified,1,0
163685,eggs,1,0
163686,and,1,0
163687,an,1,0
163688,egg-yolk,1,1
163689,based,1,1
163690,beverage,1,1
163691,on,0,1
163692,serum,0,1
163693,lutein,1,1
163694,and,0,1
163695,zeaxanthin,0,1
163696,concentrations,0,1
163697,and,0,1
163698,macular,0,0
163699,pigment,0,0
163700,optical,0,0
163701,density,0,0
163702,:,0,0
163703,results,0,0
163704,from,0,0
163705,a,0,0
163706,randomized,0,0
163707,trial,0,0
163708,.,0,0
163709,UNLABELLED,0,0
163710,Increasing,0,0
163711,evidence,0,0
163712,suggests,0,0
163713,a,0,0
163714,beneficial,0,0
163715,effect,0,0
163716,of,0,0
163717,lutein,0,1
163718,and,0,1
163719,zeaxanthin,0,1
163720,on,0,0
163721,the,0,0
163722,progression,0,0
163723,of,0,0
163724,age-related,0,0
163725,macular,0,0
163726,degeneration,0,0
163727,.,0,0
163728,The,0,0
163729,aim,0,0
163730,of,0,0
163731,this,0,0
163732,study,0,0
163733,was,0,0
163734,to,0,0
163735,investigate,0,0
163736,the,0,0
163737,effect,0,0
163738,of,0,0
163739,lutein,1,1
163740,or,1,1
163741,zeaxanthin,1,1
163742,enriched,1,0
163743,eggs,1,0
163744,or,1,0
163745,a,1,0
163746,lutein,1,1
163747,enriched,1,1
163748,egg-yolk,1,1
163749,based,1,1
163750,buttermilk,1,1
163751,beverage,1,1
163752,on,0,1
163753,serum,0,1
163754,lutein,0,1
163755,and,0,1
163756,zeaxanthin,0,1
163757,concentrations,0,1
163758,and,0,1
163759,macular,0,0
163760,pigment,0,0
163761,levels,0,0
163762,.,0,0
163763,Naturally,1,0
163764,enriched,1,0
163765,eggs,1,0
163766,were,0,0
163767,made,0,0
163768,by,0,0
163769,increasing,0,0
163770,the,0,0
163771,levels,0,0
163772,of,0,0
163773,the,0,0
163774,xanthophylls,0,1
163775,lutein,0,1
163776,and,0,1
163777,zeaxanthin,1,1
163778,in,0,0
163779,the,0,1
163780,feed,0,0
163781,given,0,0
163782,to,0,0
163783,laying,0,0
163784,hens,0,1
163785,.,0,0
163786,One,0,0
163787,hundred,0,0
163788,healthy,0,0
163789,volunteers,0,0
163790,were,0,0
163791,recruited,0,0
163792,and,0,0
163793,randomized,0,0
163794,into,0,0
163795,5,0,0
163796,groups,0,0
163797,for,0,0
163798,90,0,0
163799,days,0,0
163800,.,0,0
163801,Group,0,0
163802,one,0,0
163803,added,0,0
163804,one,1,0
163805,normal,1,0
163806,egg,1,0
163807,to,1,0
163808,their,1,0
163809,daily,1,1
163810,diet,1,1
163811,and,0,1
163812,group,1,0
163813,two,1,0
163814,received,1,0
163815,a,1,0
163816,lutein,1,1
163817,enriched,1,1
163818,egg-yolk,1,1
163819,based,1,0
163820,beverage,1,1
163821,.,1,0
163822,Group,0,0
163823,three,0,0
163824,added,0,0
163825,one,1,0
163826,lutein,1,1
163827,enriched,1,0
163828,egg,1,1
163829,and,0,0
163830,group,1,0
163831,four,1,0
163832,one,1,0
163833,zeaxanthin,1,1
163834,enriched,1,0
163835,egg,1,0
163836,to,1,0
163837,their,1,0
163838,diet,1,1
163839,.,1,0
163840,Group,0,0
163841,five,0,0
163842,was,0,0
163843,the,0,0
163844,control,1,0
163845,group,1,0
163846,and,1,0
163847,individuals,1,0
163848,in,1,0
163849,this,1,0
163850,group,1,0
163851,did,1,0
163852,not,1,0
163853,modify,1,0
163854,their,1,0
163855,daily,1,1
163856,diet,1,1
163857,.,1,1
163858,Serum,0,1
163859,lutein,0,1
163860,and,0,1
163861,zeaxanthin,0,1
163862,concentrations,0,1
163863,and,0,1
163864,macular,0,0
163865,pigment,0,0
163866,densities,0,0
163867,were,0,0
163868,obtained,0,0
163869,at,0,0
163870,baseline,0,0
163871,",",0,0
163872,day,0,0
163873,45,0,0
163874,and,0,0
163875,day,0,0
163876,90,0,0
163877,.,0,0
163878,Macular,0,0
163879,pigment,0,0
163880,density,0,0
163881,was,0,0
163882,measured,0,0
163883,by,0,0
163884,heterochromatic,0,0
163885,flicker,0,0
163886,photometry,0,0
163887,.,0,0
163888,Serum,0,1
163889,lutein,0,1
163890,concentration,0,0
163891,in,0,0
163892,the,0,0
163893,lutein,0,1
163894,enriched,0,0
163895,egg,0,1
163896,and,0,0
163897,egg,0,1
163898,yolk-based,0,1
163899,beverage,0,1
163900,groups,0,0
163901,increased,0,0
163902,significantly,0,0
163903,(,0,0
163904,p,0,0
163905,<,0,0
163906,0.001,0,0
163907,",",0,0
163908,76,0,0
163909,%,0,0
163910,and,0,0
163911,77,0,0
163912,%,0,0
163913,),0,0
163914,.,0,0
163915,A,0,0
163916,strong,0,0
163917,increase,0,0
163918,in,0,0
163919,the,0,0
163920,serum,0,1
163921,zeaxanthin,0,1
163922,concentration,0,0
163923,was,0,0
163924,observed,0,0
163925,in,0,0
163926,individuals,0,0
163927,receiving,0,0
163928,zeaxanthin,1,1
163929,enriched,1,0
163930,eggs,1,0
163931,(,0,0
163932,P,0,0
163933,<,0,0
163934,0.001,0,0
163935,",",0,0
163936,430,0,0
163937,%,0,0
163938,),0,0
163939,.,0,0
163940,No,0,1
163941,changes,0,0
163942,were,0,0
163943,observed,0,0
163944,in,0,0
163945,macular,0,0
163946,pigment,0,0
163947,density,0,0
163948,in,0,0
163949,the,0,0
163950,various,0,0
163951,groups,0,0
163952,tested,0,0
163953,.,0,0
163954,The,0,0
163955,results,0,0
163956,indicate,0,0
163957,that,0,0
163958,daily,0,1
163959,consumption,0,1
163960,of,0,1
163961,lutein,1,1
163962,or,1,1
163963,zeaxanthin,1,1
163964,enriched,1,1
163965,egg,1,1
163966,yolks,1,1
163967,as,0,0
163968,well,0,0
163969,as,0,0
163970,an,0,0
163971,egg,1,1
163972,yolk-based,1,1
163973,beverage,1,1
163974,show,0,0
163975,increases,0,0
163976,in,0,0
163977,serum,0,1
163978,lutein,0,1
163979,and,0,1
163980,zeaxanthin,0,1
163981,levels,0,0
163982,that,0,0
163983,are,0,0
163984,comparable,0,0
163985,with,0,0
163986,a,0,0
163987,daily,0,1
163988,use,0,0
163989,of,0,0
163990,5,0,1
163991,mg,0,1
163992,supplements,0,1
163993,.,0,1
163994,TRIAL,0,1
163995,REGISTRATION,0,1
163996,ClinicalTrials.gov,0,0
163997,NCT00527553,0,0
163998,.,0,0
163999,A,0,0
164000,study,0,0
164001,of,0,0
164002,noninvasive,1,0
164003,positive-pressure,1,0
164004,mechanical,1,0
164005,ventilation,1,0
164006,in,0,0
164007,the,0,0
164008,treatment,0,0
164009,of,0,0
164010,acute,0,0
164011,lung,0,0
164012,injury,0,0
164013,with,0,0
164014,a,0,0
164015,complex,0,0
164016,critical,0,0
164017,care,0,0
164018,ventilator,0,0
164019,.,0,0
164020,OBJECTIVE,0,0
164021,To,0,0
164022,test,0,0
164023,the,0,0
164024,hypothesis,0,0
164025,that,0,0
164026,there,0,0
164027,would,0,0
164028,be,0,0
164029,better,0,0
164030,clinical,0,0
164031,outcomes,0,0
164032,following,0,0
164033,the,0,0
164034,treatment,0,0
164035,of,0,0
164036,patients,0,0
164037,with,0,0
164038,acute,0,0
164039,lung,0,1
164040,injury,0,1
164041,(,0,1
164042,ALI,0,1
164043,),0,1
164044,using,0,0
164045,noninvasive,1,0
164046,positive-pressure,1,0
164047,mechanical,1,0
164048,ventilation,1,1
164049,(,1,1
164050,NIPPV,1,1
164051,),1,1
164052,delivered,1,0
164053,via,1,0
164054,a,1,0
164055,complex,1,0
164056,critical,1,0
164057,care,1,0
164058,ventilator,1,0
164059,compared,1,0
164060,with,1,0
164061,a,1,0
164062,conventional,1,0
164063,mini-ventilator,1,0
164064,.,1,0
164065,METHODS,0,0
164066,Patients,0,0
164067,with,0,0
164068,ALI,0,0
164069,who,0,0
164070,required,0,0
164071,NIPPV,0,0
164072,were,0,0
164073,prospectively,0,0
164074,enrolled,0,0
164075,and,0,0
164076,randomly,0,0
164077,divided,0,0
164078,between,0,0
164079,three,0,0
164080,intervention,0,0
164081,groups,0,0
164082,:,0,0
164083,group,0,0
164084,A,0,0
164085,was,0,0
164086,ventilated,0,0
164087,using,0,0
164088,a,0,0
164089,mini-ventilator,1,1
164090,;,1,1
164091,groups,0,0
164092,B,0,1
164093,and,0,0
164094,C,0,0
164095,were,0,0
164096,ventilated,0,0
164097,using,0,0
164098,a,0,0
164099,complex,1,0
164100,critical,1,0
164101,care,1,0
164102,ventilator,1,0
164103,using,1,0
164104,different,1,0
164105,settings,1,0
164106,.,1,0
164107,Clinical,0,0
164108,parameters,0,0
164109,were,0,0
164110,recorded,0,0
164111,before,0,0
164112,and,0,0
164113,after,0,0
164114,8,0,0
164115,h,0,0
164116,of,0,0
164117,mechanical,0,0
164118,ventilation,0,0
164119,.,0,0
164120,RESULTS,0,0
164121,A,0,0
164122,total,0,0
164123,of,0,0
164124,51,0,0
164125,patients,0,0
164126,with,0,0
164127,ALI,0,0
164128,were,0,0
164129,enrolled,0,0
164130,in,0,0
164131,the,0,0
164132,study,0,0
164133,.,0,0
164134,Clinical,0,0
164135,parameters,0,0
164136,in,0,0
164137,groups,0,0
164138,B,0,0
164139,and,0,0
164140,C,0,0
164141,underwent,0,0
164142,greater,0,0
164143,improvements,0,0
164144,than,0,0
164145,those,0,0
164146,in,0,0
164147,group,0,0
164148,A,0,0
164149,.,0,0
164150,Group,0,0
164151,C,0,0
164152,demonstrated,0,0
164153,the,0,0
164154,lowest,0,0
164155,treatment,0,0
164156,failure,0,0
164157,rate,0,0
164158,(,0,0
164159,23.5,0,0
164160,%,0,0
164161,),0,0
164162,.,0,0
164163,Failure,0,0
164164,rates,0,0
164165,were,0,0
164166,highest,0,0
164167,in,0,0
164168,group,0,0
164169,A,0,0
164170,(,0,0
164171,58.8,0,0
164172,%,0,0
164173,),0,0
164174,.,0,0
164175,CONCLUSION,0,0
164176,The,0,0
164177,findings,0,0
164178,of,0,0
164179,this,0,0
164180,present,0,0
164181,study,0,0
164182,suggest,0,0
164183,that,0,0
164184,there,0,0
164185,were,0,0
164186,more,0,0
164187,satisfactory,0,0
164188,clinical,0,0
164189,outcomes,0,0
164190,following,0,0
164191,the,0,0
164192,treatment,0,0
164193,of,0,0
164194,patients,0,0
164195,with,0,0
164196,ALI,0,0
164197,when,0,0
164198,NIPPV,0,0
164199,was,0,0
164200,delivered,0,0
164201,using,0,0
164202,a,0,0
164203,complex,0,0
164204,critical,0,0
164205,care,0,0
164206,ventilator,0,0
164207,compared,0,0
164208,with,0,0
164209,a,0,0
164210,conventional,0,0
164211,mini-ventilator,0,0
164212,.,0,0
164213,Cobedding,1,0
164214,of,1,0
164215,twin,1,0
164216,premature,1,0
164217,infants,1,0
164218,:,1,0
164219,calming,0,0
164220,effects,0,0
164221,on,0,0
164222,pain,0,0
164223,responses,0,0
164224,.,0,0
164225,BACKGROUND,0,0
164226,The,0,0
164227,purpose,0,0
164228,of,0,0
164229,this,0,0
164230,trial,0,0
164231,was,0,0
164232,to,0,0
164233,determine,0,0
164234,whether,0,0
164235,cobedding,1,0
164236,of,1,0
164237,preterm,1,0
164238,twins,1,0
164239,has,0,0
164240,analgesic,0,1
164241,effects,0,0
164242,during,0,0
164243,heel,0,0
164244,lancing,0,0
164245,or,0,0
164246,not,0,0
164247,.,0,0
164248,METHODS,0,0
164249,One,0,0
164250,hundred,0,0
164251,premature,0,0
164252,twins,0,0
164253,(,0,0
164254,50,0,0
164255,sets,0,0
164256,),0,0
164257,born,0,0
164258,between,0,0
164259,26,0,0
164260,weeks,0,0
164261,',0,0
164262,and,0,0
164263,34,0,0
164264,weeks,0,0
164265,',0,0
164266,gestation,0,0
164267,undergoing,0,0
164268,heel,0,1
164269,blood,0,0
164270,sampling,0,0
164271,were,0,0
164272,randomly,0,0
164273,assigned,0,0
164274,into,0,0
164275,two,0,0
164276,groups,0,0
164277,:,0,0
164278,the,0,0
164279,cobedding,1,1
164280,group,1,0
164281,(,1,0
164282,receiving,1,0
164283,care,1,0
164284,in,1,0
164285,the,1,0
164286,same,1,0
164287,incubator,1,0
164288,),1,0
164289,and,0,0
164290,the,0,0
164291,standard,1,0
164292,care,1,1
164293,group,1,0
164294,(,1,0
164295,receiving,1,0
164296,care,1,0
164297,in,1,0
164298,separate,1,0
164299,incubators,1,0
164300,),1,0
164301,.,1,0
164302,Pain,0,0
164303,was,0,0
164304,assessed,0,0
164305,using,0,0
164306,the,0,0
164307,premature,0,0
164308,infant,0,0
164309,pain,0,0
164310,profile,0,0
164311,score,0,0
164312,.,0,0
164313,Duration,0,0
164314,of,0,0
164315,crying,0,0
164316,was,0,0
164317,measured,0,0
164318,after,0,0
164319,heel,0,0
164320,blood,0,0
164321,sampling,0,0
164322,",",0,0
164323,and,0,0
164324,salivary,0,0
164325,cortisol,0,1
164326,was,0,0
164327,measured,0,0
164328,prior,0,0
164329,to,0,0
164330,and,0,0
164331,after,0,0
164332,heel,0,0
164333,blood,0,0
164334,sampling,0,0
164335,.,0,0
164336,RESULTS,0,0
164337,Infants,0,0
164338,in,0,0
164339,the,0,0
164340,standard,1,0
164341,care,1,1
164342,group,0,0
164343,cried,0,0
164344,for,0,0
164345,a,0,0
164346,longer,0,0
164347,time,0,0
164348,during,0,0
164349,heel,0,0
164350,lancing,0,0
164351,than,0,0
164352,those,0,0
164353,in,0,0
164354,the,0,0
164355,cobedding,1,1
164356,group,0,0
164357,(,0,0
164358,42.6,0,0
164359,?,0,0
164360,19.8,0,0
164361,seconds,0,0
164362,vs.,0,0
164363,36.4,0,0
164364,?,0,0
164365,21.7,0,0
164366,seconds,0,0
164367,",",0,0
164368,p,0,0
164369,=,0,0
164370,0.03,0,0
164371,),0,0
164372,.,0,0
164373,The,0,0
164374,mean,0,0
164375,premature,0,0
164376,infant,0,0
164377,pain,0,0
164378,profile,0,0
164379,score,0,0
164380,after,0,0
164381,heel,0,0
164382,lancing,0,0
164383,was,0,0
164384,significantly,0,0
164385,higher,0,0
164386,in,0,0
164387,the,1,0
164388,standard,1,0
164389,care,1,1
164390,group,1,0
164391,(,0,0
164392,9.8,0,0
164393,?,0,0
164394,2.6,0,0
164395,vs.,0,0
164396,8.06,0,0
164397,?,0,0
164398,2.8,0,0
164399,",",0,0
164400,p,0,0
164401,=,0,0
164402,0.002,0,0
164403,),0,0
164404,.,0,0
164405,The,0,0
164406,mean,0,0
164407,salivary,0,0
164408,cortisol,0,1
164409,after,0,0
164410,heel,0,0
164411,lancing,0,0
164412,was,0,0
164413,also,0,0
164414,significantly,0,0
164415,higher,0,0
164416,in,0,0
164417,the,0,0
164418,standard,1,0
164419,care,1,1
164420,group,1,0
164421,(,0,0
164422,24.3,0,0
164423,?,0,0
164424,7.4,0,0
164425,nmol/L,0,0
164426,vs.,0,0
164427,20.8,0,0
164428,?,0,0
164429,7.4,0,0
164430,nmol/L,0,0
164431,",",0,0
164432,p,0,0
164433,=,0,0
164434,0.02,0,0
164435,),0,0
164436,.,0,0
164437,No,0,1
164438,significant,0,0
164439,adverse,0,0
164440,effects,0,0
164441,were,0,0
164442,seen,0,0
164443,with,1,0
164444,cobedding,1,0
164445,.,1,0
164446,CONCLUSION,1,0
164447,Cobedding,1,0
164448,is,1,0
164449,a,1,0
164450,comforting,0,0
164451,measure,0,0
164452,for,0,0
164453,twin,0,0
164454,premature,0,0
164455,infants,0,0
164456,during,0,0
164457,heel,0,0
164458,lancing,0,0
164459,",",0,0
164460,which,0,0
164461,can,0,0
164462,be,0,0
164463,performed,0,0
164464,without,0,0
164465,any,0,0
164466,significant,0,0
164467,adverse,0,0
164468,effects,0,0
164469,.,0,0
164470,An,0,1
164471,RCT,0,1
164472,comparing,0,0
164473,patient-centred,0,0
164474,outcome,0,0
164475,variables,0,0
164476,of,0,0
164477,guided,0,0
164478,surgery,0,1
164479,(,1,0
164480,bone,1,1
164481,or,1,0
164482,mucosa,1,0
164483,supported,1,0
164484,),1,0
164485,with,0,0
164486,conventional,0,0
164487,implant,0,0
164488,placement,0,0
164489,.,0,0
164490,AIM,0,0
164491,To,0,0
164492,assess,0,0
164493,in,0,0
164494,a,0,0
164495,randomized,0,0
164496,study,0,0
164497,the,0,0
164498,patient-centred,0,0
164499,outcome,0,0
164500,of,0,0
164501,two,0,0
164502,guided,0,0
164503,surgery,1,0
164504,systems,0,0
164505,(,1,0
164506,mucosa,1,0
164507,or,1,0
164508,bone,1,0
164509,supported,1,0
164510,),1,0
164511,compared,0,0
164512,to,0,0
164513,conventional,1,0
164514,implant,1,0
164515,placement,1,0
164516,",",0,0
164517,in,0,0
164518,fully,0,0
164519,edentulous,0,0
164520,patients,0,0
164521,.,0,0
164522,MATERIAL,0,0
164523,AND,0,0
164524,METHODS,0,0
164525,Fifty-nine,0,0
164526,patients,0,0
164527,(,0,0
164528,72,0,0
164529,jaws,0,0
164530,),0,0
164531,with,0,0
164532,edentulous,0,0
164533,maxillas,0,0
164534,and/,0,0
164535,or,0,0
164536,mandibles,0,0
164537,",",0,0
164538,were,0,0
164539,consecutively,0,0
164540,recruited,0,0
164541,and,0,0
164542,randomly,0,0
164543,assigned,0,0
164544,to,0,0
164545,one,0,0
164546,of,0,0
164547,the,0,0
164548,treatment,0,0
164549,groups,0,0
164550,.,0,0
164551,Outcome,0,0
164552,measures,0,0
164553,were,0,0
164554,the,0,0
164555,Dutch,0,0
164556,version,0,0
164557,of,0,0
164558,the,0,0
164559,McGill,0,0
164560,Pain,0,0
164561,Questionnaire,0,1
164562,(,0,1
164563,MPQ-DLV,0,1
164564,),0,1
164565,",",0,0
164566,the,0,0
164567,Health-related,0,0
164568,quality,0,0
164569,of,0,0
164570,life,0,1
164571,instrument,0,1
164572,(,0,1
164573,HRQOL,0,1
164574,),0,1
164575,",",0,0
164576,visual,0,1
164577,analogue,0,1
164578,scales,0,1
164579,(,0,1
164580,VAS,0,1
164581,),0,1
164582,",",0,0
164583,the,0,0
164584,duration,0,0
164585,of,0,0
164586,the,0,0
164587,procedure,0,0
164588,",",0,0
164589,and,0,0
164590,the,0,0
164591,analgesic,0,1
164592,doses,0,1
164593,taken,0,1
164594,each,0,0
164595,day,0,0
164596,.,0,0
164597,RESULTS,0,0
164598,Three,0,0
164599,hundred,0,0
164600,and,0,0
164601,fourteen,0,0
164602,implants,0,0
164603,were,0,0
164604,placed,0,0
164605,successfully,0,0
164606,.,0,0
164607,No,0,1
164608,statistical,0,0
164609,differences,0,0
164610,could,0,0
164611,be,0,0
164612,shown,0,0
164613,between,0,0
164614,treatment,0,0
164615,groups,0,0
164616,on,0,0
164617,pain,0,0
164618,response,0,0
164619,(,0,1
164620,MPQ-DLV,0,1
164621,),0,1
164622,",",0,0
164623,treatment,0,1
164624,perception,0,1
164625,(,0,1
164626,VAS,0,1
164627,),0,1
164628,or,0,0
164629,number,0,0
164630,or,0,0
164631,kind,0,0
164632,of,0,0
164633,pain,0,0
164634,killers,0,0
164635,.,0,0
164636,For,0,0
164637,the,0,0
164638,HRQOLI-instrument,0,0
164639,",",0,0
164640,a,0,0
164641,significant,0,0
164642,difference,0,0
164643,was,0,0
164644,found,0,0
164645,between,0,0
164646,the,0,0
164647,Materialise,1,0
164648,Mucosa,1,0
164649,and,0,1
164650,Materialise,1,1
164651,Bone,1,1
164652,group,0,1
164653,at,0,1
164654,day,0,0
164655,1,0,0
164656,(,0,0
164657,p,0,0
164658,=,0,0
164659,0.02,0,0
164660,),0,0
164661,and,0,0
164662,day,0,1
164663,2,0,0
164664,(,0,0
164665,p,0,0
164666,=,0,0
164667,0.01,0,0
164668,),0,0
164669,.,0,0
164670,For,0,0
164671,the,0,0
164672,duration,0,0
164673,of,0,0
164674,the,0,0
164675,surgery,0,0
164676,",",0,0
164677,a,0,0
164678,statistical,0,0
164679,difference,0,0
164680,(,0,0
164681,p,0,0
164682,=,0,0
164683,0.005,0,0
164684,),0,0
164685,was,0,0
164686,found,0,0
164687,between,0,0
164688,the,0,0
164689,Materialise,1,0
164690,mucosa,1,0
164691,and,0,0
164692,the,0,0
164693,Mental,0,0
164694,group,0,0
164695,",",0,0
164696,in,0,0
164697,favour,0,0
164698,of,0,0
164699,the,0,0
164700,first,0,0
164701,.,0,0
164702,CONCLUSION,0,0
164703,In,0,0
164704,this,0,0
164705,study,0,0
164706,little,0,0
164707,difference,0,0
164708,could,0,0
164709,be,0,0
164710,found,0,0
164711,in,0,0
164712,the,0,0
164713,patient,0,0
164714,outcome,0,0
164715,variables,0,0
164716,of,0,0
164717,the,0,0
164718,different,0,0
164719,treatment,0,0
164720,groups,0,0
164721,.,0,0
164722,However,0,0
164723,there,0,0
164724,was,0,0
164725,a,0,0
164726,tendency,0,0
164727,for,0,0
164728,patients,0,0
164729,treated,0,0
164730,with,0,0
164731,conventional,0,0
164732,flapped,0,0
164733,implant,0,0
164734,placement,0,0
164735,to,0,0
164736,experience,0,0
164737,the,0,0
164738,pain,0,0
164739,for,0,0
164740,a,0,0
164741,longer,0,0
164742,period,0,0
164743,of,0,0
164744,time,0,0
164745,.,0,0
164746,Salivary,0,1
164747,testosterone,0,1
164748,and,0,1
164749,immunoglobulin,0,1
164750,A,0,1
164751,were,0,0
164752,increased,0,0
164753,by,0,0
164754,resistance,1,0
164755,training,1,0
164756,in,0,0
164757,adults,0,0
164758,with,0,0
164759,Down,0,0
164760,syndrome,0,0
164761,.,0,0
164762,This,0,0
164763,study,0,0
164764,was,0,0
164765,designed,0,0
164766,to,0,0
164767,assess,0,0
164768,the,0,0
164769,influence,0,0
164770,of,0,0
164771,resistance,0,0
164772,training,0,0
164773,on,0,0
164774,salivary,0,0
164775,immunoglobulin,0,1
164776,A,0,1
164777,(,0,1
164778,IgA,0,1
164779,),0,0
164780,levels,0,0
164781,and,0,0
164782,hormone,0,1
164783,profile,0,0
164784,in,0,0
164785,sedentary,0,0
164786,adults,0,0
164787,with,0,0
164788,Down,0,0
164789,syndrome,0,1
164790,(,0,1
164791,DS,0,1
164792,),0,1
164793,.,0,0
164794,A,0,0
164795,total,0,0
164796,of,0,0
164797,40,0,0
164798,male,0,0
164799,adults,0,0
164800,with,0,0
164801,DS,0,0
164802,were,0,0
164803,recruited,0,0
164804,for,0,0
164805,the,0,0
164806,trial,0,0
164807,through,0,0
164808,different,0,0
164809,community,0,0
164810,support,0,0
164811,groups,0,0
164812,for,0,0
164813,people,0,0
164814,with,0,0
164815,intellectual,0,0
164816,disabilities,0,0
164817,.,0,0
164818,All,0,0
164819,participants,0,0
164820,had,0,0
164821,medical,0,0
164822,approval,0,0
164823,for,0,0
164824,participation,0,0
164825,in,0,0
164826,physical,0,0
164827,activity,0,0
164828,.,0,0
164829,Twenty-four,0,0
164830,adults,0,0
164831,were,0,0
164832,randomly,0,0
164833,assigned,0,0
164834,to,0,0
164835,perform,0,0
164836,resistance,1,0
164837,training,1,0
164838,in,0,0
164839,a,0,0
164840,circuit,0,0
164841,with,0,0
164842,six,0,0
164843,stations,0,0
164844,",",0,0
164845,3,0,1
164846,days,0,0
164847,per,0,0
164848,week,0,0
164849,for,0,0
164850,12,0,0
164851,weeks,0,0
164852,.,0,0
164853,Training,0,0
164854,intensity,0,0
164855,was,0,0
164856,based,0,0
164857,on,0,0
164858,functioning,0,0
164859,in,0,0
164860,the,0,0
164861,eight-repetition,0,0
164862,maximum,0,0
164863,(,0,1
164864,8RM,0,1
164865,),0,1
164866,test,0,0
164867,for,0,0
164868,each,0,0
164869,exercise,1,0
164870,.,1,0
164871,The,0,0
164872,control,0,0
164873,group,0,0
164874,included,0,0
164875,16,0,0
164876,age-,0,0
164877,",",0,0
164878,gender-,0,0
164879,",",0,0
164880,and,0,0
164881,BMI-matched,0,0
164882,adults,0,0
164883,with,0,0
164884,DS,0,0
164885,.,0,0
164886,Salivary,0,0
164887,IgA,0,0
164888,",",0,0
164889,testosterone,0,1
164890,",",0,1
164891,and,0,1
164892,cortisol,0,1
164893,levels,0,0
164894,were,0,0
164895,measured,0,0
164896,by,0,0
164897,ELISA,1,0
164898,.,0,0
164899,Work,0,0
164900,task,0,0
164901,performance,0,0
164902,was,0,0
164903,assessed,0,0
164904,using,0,0
164905,the,0,0
164906,repetitive,0,0
164907,weighted-box-stacking,0,0
164908,test,0,0
164909,.,0,0
164910,Resistance,0,0
164911,training,0,0
164912,significantly,0,0
164913,increased,0,0
164914,salivary,0,0
164915,IgA,0,0
164916,concentration,0,0
164917,(,0,0
164918,P=0.0120,0,0
164919,;,0,0
164920,d=0.94,0,0
164921,),0,0
164922,and,0,0
164923,testosterone,0,1
164924,levels,0,0
164925,(,0,0
164926,P=0.0088,0,0
164927,;,0,0
164928,d=1.57,0,0
164929,),0,0
164930,in,0,0
164931,the,0,0
164932,exercising,0,0
164933,group,0,0
164934,.,0,0
164935,Furthermore,0,0
164936,",",0,0
164937,it,0,0
164938,also,0,0
164939,improved,0,0
164940,work,0,0
164941,task,0,0
164942,performance,0,0
164943,.,0,0
164944,No,0,0
164945,changes,0,0
164946,were,0,0
164947,seen,0,0
164948,in,0,0
164949,the,0,0
164950,controls,0,0
164951,who,0,0
164952,had,0,0
164953,not,0,0
164954,exercised,0,0
164955,.,0,0
164956,In,0,0
164957,conclusion,0,0
164958,",",0,0
164959,a,0,0
164960,short-term,0,0
164961,resistance,1,0
164962,training,1,0
164963,protocol,0,0
164964,improved,0,0
164965,mucosal,0,0
164966,immunity,0,0
164967,response,0,0
164968,as,0,0
164969,well,0,0
164970,as,0,0
164971,salivary,0,0
164972,testosterone,0,1
164973,levels,0,0
164974,in,0,0
164975,sedentary,0,0
164976,adults,0,0
164977,with,0,0
164978,DS,0,0
164979,.,0,0
164980,Cytokine,1,1
164981,and,0,1
164982,clinical,0,0
164983,response,0,0
164984,to,0,0
164985,Saccharomyces,1,1
164986,boulardii,1,1
164987,therapy,1,1
164988,in,0,0
164989,diarrhea-dominant,0,0
164990,irritable,0,0
164991,bowel,0,0
164992,syndrome,0,0
164993,:,0,0
164994,a,0,0
164995,randomized,0,0
164996,trial,0,0
164997,.,0,0
164998,INTRODUCTION,0,0
164999,This,0,0
165000,preliminary,0,0
165001,study,0,0
165002,aimed,0,0
165003,to,0,0
165004,investigate,0,0
165005,the,0,0
165006,effects,0,0
165007,of,0,0
165008,the,0,0
165009,probiotic,1,1
165010,Saccharomyces,1,1
165011,boulardii,1,1
165012,on,0,0
165013,proinflammatory,0,1
165014,and,0,0
165015,anti-inflammatory,0,1
165016,cytokines,0,1
165017,in,0,0
165018,patients,0,0
165019,with,0,0
165020,diarrhea-dominant,0,0
165021,irritable,0,0
165022,bowel,0,1
165023,syndrome,0,1
165024,(,0,1
165025,IBS-D,0,1
165026,),0,1
165027,.,0,0
165028,The,0,0
165029,other,0,0
165030,objectives,0,0
165031,were,0,0
165032,to,0,0
165033,document,0,0
165034,any,0,0
165035,clinical,0,0
165036,improvement,0,0
165037,as,0,0
165038,judged,0,0
165039,by,0,0
165040,symptoms,0,0
165041,",",0,0
165042,quality,0,0
165043,of,0,0
165044,life,0,0
165045,",",0,0
165046,and,0,0
165047,histology,0,0
165048,.,0,0
165049,PATIENTS,0,0
165050,AND,0,1
165051,METHODS,0,1
165052,This,0,0
165053,was,0,0
165054,a,0,0
165055,randomized,0,0
165056,",",0,0
165057,double,0,0
165058,blind,0,0
165059,",",0,0
165060,placebo-controlled,1,1
165061,trial,0,1
165062,in,0,0
165063,which,0,0
165064,S.,1,1
165065,boulardii,1,1
165066,",",1,1
165067,750,1,1
165068,mg/day,1,1
165069,",",1,1
165070,or,1,1
165071,placebo,1,1
165072,was,1,0
165073,administered,1,1
165074,for,1,0
165075,6,1,0
165076,weeks,1,0
165077,in,1,0
165078,IBS-D,1,0
165079,patients,1,0
165080,",",1,0
165081,in,1,0
165082,addition,1,0
165083,to,1,0
165084,ispaghula,1,1
165085,husk,1,1
165086,standard,1,1
165087,treatment,1,0
165088,.,1,0
165089,RESULTS,0,0
165090,Thirty-seven,0,0
165091,patients,0,0
165092,received,0,0
165093,S.,1,1
165094,boulardii,1,1
165095,and,0,0
165096,35,0,0
165097,patients,0,0
165098,received,0,0
165099,the,0,0
165100,placebo,1,1
165101,.,1,0
165102,As,0,0
165103,compared,0,0
165104,with,0,0
165105,placebo,1,1
165106,",",0,0
165107,the,0,0
165108,S.,1,1
165109,boulardii,1,1
165110,group,0,0
165111,showed,0,0
165112,a,0,0
165113,significant,0,0
165114,decrease,0,0
165115,in,0,0
165116,blood,0,0
165117,and,0,0
165118,tissue,0,0
165119,levels,0,0
165120,of,0,0
165121,proinflammatory,0,0
165122,cytokines,0,1
165123,interleukin-8,0,1
165124,(,0,1
165125,IL-8,0,1
165126,),0,1
165127,and,0,0
165128,tumor,0,0
165129,necrosis,0,1
165130,factor-?,0,0
165131,(,0,0
165132,P,0,0
165133,<,0,0
165134,0.001,0,0
165135,),0,0
165136,and,0,0
165137,an,0,0
165138,increase,0,0
165139,in,0,0
165140,anti-inflammatory,0,1
165141,IL-10,0,1
165142,levels,0,0
165143,",",0,0
165144,as,0,0
165145,well,0,0
165146,as,0,0
165147,an,0,0
165148,increase,0,0
165149,in,0,0
165150,the,0,0
165151,tissue,0,0
165152,IL-10/IL-12,0,1
165153,ratio,0,0
165154,(,0,0
165155,P,0,0
165156,<,0,0
165157,0.001,0,0
165158,),0,0
165159,.,0,0
165160,No,0,1
165161,significant,0,0
165162,change,0,0
165163,in,0,0
165164,the,0,0
165165,blood,0,0
165166,and,0,0
165167,tissue,0,0
165168,levels,0,0
165169,of,0,0
165170,cytokines,0,0
165171,was,0,0
165172,found,0,0
165173,in,0,0
165174,the,0,0
165175,placebo,0,1
165176,group,0,1
165177,.,0,0
165178,Bowel-related,0,0
165179,IBS-D,0,0
165180,symptoms,0,0
165181,reported,0,0
165182,in,0,0
165183,the,0,0
165184,patients,0,0
165185,',0,0
165186,daily,0,1
165187,diary,0,1
165188,improved,0,0
165189,in,0,0
165190,both,0,0
165191,groups,0,0
165192,.,0,0
165193,However,0,0
165194,",",0,0
165195,overall,0,0
165196,improvement,0,0
165197,in,0,0
165198,the,0,0
165199,quality,0,0
165200,of,0,0
165201,life,0,0
165202,was,0,0
165203,more,0,0
165204,marked,0,0
165205,in,0,0
165206,the,1,0
165207,S.,1,1
165208,boulardii,1,1
165209,group,0,1
165210,.,0,0
165211,Although,0,0
165212,baseline,0,0
165213,histological,0,0
165214,findings,0,0
165215,were,0,0
165216,mild,0,0
165217,",",0,0
165218,an,0,0
165219,improvement,0,0
165220,was,0,0
165221,observed,0,0
165222,in,0,0
165223,the,0,0
165224,probiotic,0,1
165225,group,0,0
165226,in,0,0
165227,the,0,0
165228,lymphocyte,0,0
165229,and,0,0
165230,neutrophil,0,1
165231,infiltrates,0,1
165232,(,0,0
165233,P=0.017,0,0
165234,and,0,0
165235,0.018,0,0
165236,),0,0
165237,",",0,0
165238,epithelial,0,0
165239,mitosis,0,0
165240,(,0,0
165241,P=0.003,0,0
165242,),0,0
165243,",",0,0
165244,and,0,0
165245,intraepithelial,0,1
165246,lymphocytes,0,0
165247,(,0,0
165248,P=0.024,0,0
165249,),0,0
165250,.,0,0
165251,No,0,1
165252,serious,0,1
165253,adverse,0,0
165254,events,0,0
165255,were,0,0
165256,found,0,0
165257,in,0,0
165258,either,0,0
165259,group,0,0
165260,.,0,0
165261,CONCLUSION,0,1
165262,S.,1,1
165263,boulardii,1,1
165264,with,0,1
165265,ispaghula,0,1
165266,husk,0,1
165267,was,0,0
165268,superior,0,0
165269,to,0,0
165270,placebo,0,1
165271,with,0,1
165272,ispaghula,0,1
165273,husk,0,1
165274,in,0,0
165275,improving,0,0
165276,the,0,0
165277,cytokine,0,0
165278,profile,0,0
165279,",",0,0
165280,histology,0,0
165281,",",0,0
165282,and,0,0
165283,quality,0,0
165284,of,0,0
165285,life,0,0
165286,of,0,0
165287,patients,0,0
165288,with,0,0
165289,IBS-D,0,0
165290,.,0,0
165291,These,0,0
165292,preliminary,0,0
165293,results,0,0
165294,need,0,0
165295,to,0,0
165296,be,0,0
165297,confirmed,0,0
165298,in,0,0
165299,a,0,0
165300,well-powered,0,0
165301,trial,0,0
165302,.,0,0
165303,Classification,0,0
165304,of,0,0
165305,motor,0,0
165306,imagery,0,0
165307,performance,0,0
165308,in,0,0
165309,acute,0,0
165310,stroke,0,0
165311,.,0,0
165312,OBJECTIVE,0,0
165313,Effective,0,0
165314,motor,0,0
165315,imagery,0,0
165316,performance,0,0
165317,",",0,0
165318,seen,0,0
165319,as,0,0
165320,strong,0,0
165321,suppression,0,0
165322,of,0,0
165323,the,0,0
165324,sensorimotor,0,0
165325,rhythm,0,0
165326,",",0,0
165327,is,0,0
165328,the,0,0
165329,key,0,0
165330,element,0,0
165331,in,0,0
165332,motor,1,0
165333,imagery,1,0
165334,therapy,1,0
165335,.,1,0
165336,Therefore,0,0
165337,",",0,0
165338,optimization,0,0
165339,of,0,0
165340,methods,0,0
165341,to,0,0
165342,classify,0,0
165343,whether,0,0
165344,the,0,0
165345,subject,0,0
165346,is,0,0
165347,performing,0,0
165348,the,0,0
165349,imagery,0,0
165350,task,0,0
165351,is,0,0
165352,a,0,0
165353,prerequisite,0,0
165354,.,0,0
165355,An,0,1
165356,optimal,0,0
165357,classification,0,0
165358,method,0,0
165359,should,0,0
165360,have,0,0
165361,high,0,0
165362,performance,0,0
165363,accuracy,0,0
165364,and,0,0
165365,use,0,0
165366,a,0,0
165367,small,0,0
165368,number,0,0
165369,of,0,0
165370,channels,0,0
165371,.,0,0
165372,We,0,0
165373,investigated,0,0
165374,the,0,0
165375,additional,0,0
165376,benefit,0,0
165377,of,0,0
165378,the,0,0
165379,common,0,0
165380,spatial,0,0
165381,pattern,0,0
165382,filtering,0,0
165383,(,0,1
165384,CSP,0,1
165385,),0,0
165386,to,0,0
165387,a,0,0
165388,linear,0,0
165389,discriminant,0,0
165390,analysis,0,0
165391,(,0,1
165392,LDA,0,1
165393,),0,1
165394,classifier,0,0
165395,",",0,0
165396,for,0,0
165397,different,0,0
165398,channel,0,0
165399,configurations,0,0
165400,.,0,0
165401,METHODS,0,0
165402,Ten,0,0
165403,hemispheric,0,1
165404,acute,0,0
165405,stroke,0,0
165406,patients,0,0
165407,and,0,0
165408,11,0,0
165409,healthy,0,0
165410,subjects,0,0
165411,were,0,0
165412,included,0,0
165413,.,0,0
165414,EEGs,1,0
165415,were,0,0
165416,recorded,0,0
165417,using,0,0
165418,60,0,0
165419,channels,0,0
165420,.,0,0
165421,The,0,0
165422,classifier,0,0
165423,was,0,0
165424,trained,0,0
165425,with,0,0
165426,a,0,0
165427,motor,0,0
165428,execution,0,0
165429,task,0,0
165430,.,0,0
165431,For,0,0
165432,both,0,0
165433,healthy,0,0
165434,controls,0,0
165435,and,0,0
165436,patients,0,0
165437,",",0,0
165438,analysis,0,0
165439,of,0,0
165440,recordings,0,0
165441,was,0,0
165442,initially,0,0
165443,limited,0,0
165444,to,0,0
165445,3,0,0
165446,and,0,0
165447,11,0,0
165448,electrodes,0,0
165449,recording,0,0
165450,from,0,0
165451,the,0,0
165452,motor,0,0
165453,cortex,0,0
165454,area,0,0
165455,",",0,0
165456,and,0,0
165457,later,0,0
165458,repeated,0,0
165459,using,0,0
165460,45,0,0
165461,electrodes,0,0
165462,.,0,0
165463,RESULTS,0,1
165464,No,0,1
165465,significant,0,0
165466,improvement,0,0
165467,on,0,0
165468,the,0,0
165469,addition,0,0
165470,of,0,0
165471,CSP,0,0
165472,to,0,0
165473,LDA,0,0
165474,was,0,0
165475,found,0,0
165476,(,0,0
165477,in,0,0
165478,both,0,0
165479,cases,0,0
165480,",",0,0
165481,the,0,0
165482,area,0,0
165483,under,0,0
165484,the,0,0
165485,receiving,0,0
165486,operating,0,0
165487,characteristic,0,0
165488,(,0,0
165489,AU-ROC,0,1
165490,),0,0
165491,?,0,0
165492,0.70,0,0
165493,(,0,0
165494,acceptable,0,1
165495,),0,1
165496,),0,0
165497,.,0,0
165498,We,0,0
165499,then,0,0
165500,repeated,0,0
165501,the,0,0
165502,LDA+CSP,0,0
165503,method,0,0
165504,on,0,0
165505,recordings,0,0
165506,of,0,0
165507,45,0,0
165508,electrodes,0,0
165509,",",0,0
165510,since,0,0
165511,the,0,0
165512,use,0,0
165513,of,0,0
165514,imagery,0,0
165515,neuronal,0,0
165516,circuits,0,0
165517,may,0,0
165518,well,0,0
165519,extend,0,0
165520,beyond,0,0
165521,the,0,0
165522,motor,0,0
165523,area,0,0
165524,.,0,0
165525,AU-ROC,0,0
165526,rose,0,0
165527,to,0,0
165528,0.90,0,0
165529,",",0,0
165530,but,0,0
165531,no,0,0
165532,virtual,0,0
165533,'most,0,0
165534,responsible,0,0
165535,',0,0
165536,electrode,0,0
165537,was,0,0
165538,observed,0,0
165539,.,0,0
165540,Finally,0,0
165541,",",0,0
165542,in,0,0
165543,mild-to-moderate,0,0
165544,stroke,0,0
165545,patients,0,0
165546,we,0,0
165547,could,0,0
165548,successfully,0,0
165549,use,0,0
165550,the,0,0
165551,EEG,0,0
165552,data,0,0
165553,recorded,0,0
165554,from,0,0
165555,the,0,0
165556,healthy,0,0
165557,hemisphere,0,0
165558,to,0,0
165559,train,0,0
165560,the,0,0
165561,classifier,0,1
165562,(,0,0
165563,AU-ROC,0,0
165564,?,0,1
165565,0.70,0,0
165566,),0,0
165567,.,0,0
165568,SIGNIFICANCE,0,0
165569,Including,0,0
165570,only,0,0
165571,the,0,0
165572,channels,0,0
165573,on,0,0
165574,the,0,0
165575,unaffected,0,0
165576,motor,0,0
165577,cortex,0,0
165578,is,0,0
165579,sufficient,0,0
165580,to,0,0
165581,train,0,0
165582,a,0,0
165583,classifier,0,0
165584,.,0,0
165585,Correlations,0,0
165586,between,0,0
165587,the,0,0
165588,clinical,0,0
165589,",",0,0
165590,histological,0,0
165591,and,0,0
165592,neurophysiological,0,0
165593,examinations,0,0
165594,in,0,0
165595,patients,0,0
165596,before,0,0
165597,and,0,0
165598,after,0,0
165599,parotid,1,0
165600,gland,1,0
165601,tumor,1,0
165602,surgery,1,0
165603,:,1,0
165604,verification,0,0
165605,of,0,0
165606,facial,0,0
165607,nerve,0,0
165608,transmission,0,0
165609,.,0,0
165610,Parotid,0,0
165611,gland,0,0
165612,tumor,0,0
165613,surgery,0,0
165614,sometimes,0,0
165615,leads,0,0
165616,to,0,0
165617,facial,0,0
165618,nerve,0,0
165619,paralysis,0,0
165620,.,0,0
165621,Malignant,0,0
165622,more,0,0
165623,than,0,0
165624,benign,0,0
165625,tumors,0,0
165626,determine,0,0
165627,nerve,0,0
165628,function,0,0
165629,preoperatively,0,0
165630,",",0,0
165631,while,0,0
165632,postoperative,0,0
165633,observations,0,0
165634,based,0,0
165635,on,0,0
165636,clinical,0,0
165637,",",0,0
165638,histological,0,0
165639,and,0,0
165640,neurophysiological,0,0
165641,studies,0,0
165642,have,0,0
165643,not,0,0
165644,been,0,0
165645,reported,0,0
165646,in,0,0
165647,detail,0,0
165648,.,0,0
165649,The,0,0
165650,aims,0,0
165651,of,0,0
165652,this,0,0
165653,pilot,0,0
165654,study,0,0
165655,were,0,0
165656,evaluation,0,0
165657,and,0,0
165658,correlations,0,0
165659,of,0,0
165660,histological,0,0
165661,properties,0,0
165662,of,0,0
165663,tumor,0,0
165664,(,0,0
165665,its,0,0
165666,size,0,0
165667,and,0,0
165668,location,0,0
165669,),0,0
165670,and,0,0
165671,clinical,0,1
165672,and,0,0
165673,neurophysiological,0,0
165674,assessment,0,0
165675,of,0,0
165676,facial,0,0
165677,nerve,0,0
165678,function,0,0
165679,pre-,1,0
165680,and,1,0
165681,post-operatively,1,1
165682,(,0,0
165683,1,0,0
165684,and,0,0
165685,6,0,0
165686,months,0,0
165687,),0,0
165688,.,0,0
165689,Comparative,0,0
165690,studies,0,0
165691,included,0,0
165692,17,0,0
165693,patients,0,0
165694,with,0,0
165695,benign,0,1
165696,(,0,0
165697,n,0,0
165698,=,0,0
165699,13,0,0
165700,),0,0
165701,and,0,0
165702,malignant,0,1
165703,(,0,0
165704,n,0,0
165705,=,0,0
165706,4,0,0
165707,),0,0
165708,tumors,0,0
165709,.,0,0
165710,Clinical,0,0
165711,assessment,0,0
165712,was,0,0
165713,based,0,0
165714,on,0,0
165715,House-Brackmann,0,1
165716,scale,0,1
165717,(,0,1
165718,H-B,0,1
165719,),0,1
165720,",",0,0
165721,neurophysiological,0,0
165722,diagnostics,0,0
165723,included,0,0
165724,facial,1,0
165725,electroneurography,1,1
165726,[,0,0
165727,ENG,0,1
165728,",",0,0
165729,compound,0,0
165730,muscle,0,0
165731,action,0,0
165732,potential,0,0
165733,(,0,0
165734,CMAP,0,1
165735,),0,1
165736,],0,0
165737,",",0,0
165738,mimetic,1,0
165739,muscle,1,0
165740,electromyography,1,0
165741,(,0,1
165742,EMG,0,0
165743,),0,1
165744,and,0,0
165745,blink-reflex,1,1
165746,examinations,1,1
165747,(,0,1
165748,BR,0,1
165749,),0,1
165750,.,0,0
165751,Mainly,0,0
165752,grade,0,0
165753,I,0,0
165754,of,0,0
165755,H-B,0,0
165756,was,0,0
165757,recorded,0,0
165758,both,0,0
165759,pre-,0,1
165760,(,0,0
165761,n,0,0
165762,=,0,0
165763,13,0,0
165764,),0,0
165765,and,0,0
165766,post-operatively,0,1
165767,(,0,0
165768,n,0,0
165769,=,0,0
165770,12,0,0
165771,),0,0
165772,in,0,0
165773,patients,0,0
165774,with,0,0
165775,small,0,0
165776,(,0,0
165777,1.5-2.4,0,0
165778,cm,0,0
165779,),0,0
165780,benign,0,0
165781,tumors,0,0
165782,located,0,0
165783,in,0,0
165784,superficial,0,0
165785,lobes,0,0
165786,.,0,0
165787,Patients,0,0
165788,with,0,0
165789,medium,0,0
165790,size,0,0
165791,(,0,0
165792,2.5-3.4,0,0
165793,cm,0,0
165794,),0,0
165795,malignant,0,0
165796,tumors,0,0
165797,in,0,0
165798,both,0,0
165799,lobes,0,0
165800,were,0,0
165801,scored,0,0
165802,at,0,0
165803,grade,0,0
165804,I,0,0
165805,(,0,0
165806,n,0,0
165807,=,0,0
165808,2,0,0
165809,),0,0
165810,and,0,1
165811,III,0,1
165812,(,0,0
165813,n,0,0
165814,=,0,0
165815,2,0,0
165816,),0,0
165817,pre-,0,0
165818,and,0,0
165819,mainly,0,0
165820,VI,0,1
165821,(,0,0
165822,n,0,0
165823,=,0,0
165824,4,0,0
165825,),0,0
165826,post-operatively,0,0
165827,.,0,0
165828,CMAP,0,0
165829,amplitudes,0,0
165830,after,0,0
165831,stimulation,0,0
165832,of,0,0
165833,mandibular,0,0
165834,marginal,0,0
165835,branch,0,0
165836,were,0,0
165837,reduced,0,0
165838,at,0,0
165839,about,0,0
165840,25,0,0
165841,%,0,0
165842,in,0,0
165843,patients,0,0
165844,with,0,0
165845,benign,0,0
165846,tumors,0,0
165847,after,0,0
165848,surgery,0,0
165849,.,0,0
165850,In,0,0
165851,the,0,0
165852,cases,0,0
165853,of,0,0
165854,malignant,0,0
165855,tumors,0,0
165856,CMAPs,0,0
165857,were,0,0
165858,not,0,0
165859,recorded,0,0
165860,following,0,0
165861,stimulation,0,0
165862,of,0,0
165863,any,0,0
165864,branch,0,0
165865,.,0,0
165866,A,0,0
165867,similar,0,0
165868,trend,0,0
165869,was,0,0
165870,found,0,0
165871,for,0,0
165872,BR,0,0
165873,results,0,0
165874,.,0,0
165875,H-B,0,0
165876,and,0,0
165877,ENG,0,0
165878,results,0,0
165879,revealed,0,0
165880,positive,0,0
165881,correlations,0,0
165882,between,0,0
165883,the,0,0
165884,type,0,0
165885,of,0,0
165886,tumor,0,0
165887,and,0,0
165888,surgery,0,0
165889,with,0,0
165890,facial,0,0
165891,nerve,0,0
165892,function,0,0
165893,.,0,0
165894,Neurophysiological,0,0
165895,studies,0,0
165896,detected,0,0
165897,clinically,0,0
165898,silent,0,0
165899,facial,0,0
165900,nerve,0,0
165901,neuropathy,0,0
165902,of,0,0
165903,mandibular,0,0
165904,marginal,0,0
165905,branch,0,0
165906,in,0,0
165907,postoperative,0,0
165908,period,0,0
165909,.,0,0
165910,Needle,0,0
165911,EMG,0,0
165912,",",0,0
165913,ENG,0,1
165914,and,0,0
165915,BR,0,0
165916,examinations,0,0
165917,allow,0,0
165918,for,0,0
165919,the,0,0
165920,evaluation,0,0
165921,of,0,0
165922,face,0,0
165923,muscles,0,0
165924,reinnervation,0,0
165925,and,0,0
165926,facial,0,0
165927,nerve,0,0
165928,regeneration,0,0
165929,.,0,0
165930,Virtual,1,0
165931,reality,1,0
165932,job,1,0
165933,interview,1,0
165934,training,1,0
165935,in,0,0
165936,adults,0,0
165937,with,0,0
165938,autism,0,0
165939,spectrum,0,0
165940,disorder,0,0
165941,.,0,0
165942,The,0,0
165943,feasibility,0,0
165944,and,0,0
165945,efficacy,0,0
165946,of,0,0
165947,virtual,1,0
165948,reality,1,0
165949,job,1,0
165950,interview,1,1
165951,training,1,1
165952,(,1,1
165953,VR-JIT,1,1
165954,),1,0
165955,was,0,0
165956,assessed,0,0
165957,in,0,0
165958,a,0,0
165959,single-blinded,0,1
165960,randomized,0,0
165961,controlled,0,0
165962,trial,0,0
165963,.,0,0
165964,Adults,0,0
165965,with,0,0
165966,autism,0,0
165967,spectrum,0,0
165968,disorder,0,0
165969,were,0,0
165970,randomized,0,0
165971,to,0,0
165972,VR-JIT,1,1
165973,(,0,0
165974,n,0,0
165975,=,0,0
165976,16,0,0
165977,),0,0
165978,or,0,0
165979,treatment-as-usual,1,1
165980,(,1,1
165981,TAU,1,1
165982,),1,1
165983,(,0,0
165984,n,0,0
165985,=,0,0
165986,10,0,0
165987,),0,0
165988,groups,0,0
165989,.,0,0
165990,VR-JIT,1,0
165991,consisted,1,0
165992,of,1,0
165993,simulated,1,0
165994,job,1,0
165995,interviews,1,0
165996,with,1,0
165997,a,1,0
165998,virtual,1,0
165999,character,1,0
166000,and,1,0
166001,didactic,1,0
166002,training,1,0
166003,.,1,0
166004,Participants,0,0
166005,attended,0,0
166006,90,0,0
166007,%,0,0
166008,of,0,0
166009,laboratory-based,0,0
166010,training,0,0
166011,sessions,0,0
166012,",",0,0
166013,found,0,0
166014,VR-JIT,1,1
166015,easy,0,0
166016,to,0,0
166017,use,0,0
166018,and,0,0
166019,enjoyable,0,0
166020,",",0,0
166021,and,0,0
166022,they,0,0
166023,felt,0,0
166024,prepared,0,0
166025,for,0,0
166026,future,0,0
166027,interviews,0,0
166028,.,0,0
166029,VR-JIT,1,0
166030,participants,0,0
166031,had,0,0
166032,greater,0,0
166033,improvement,0,0
166034,during,0,0
166035,live,0,0
166036,standardized,0,0
166037,job,0,0
166038,interview,0,0
166039,role-play,0,0
166040,performances,0,0
166041,than,0,0
166042,TAU,1,1
166043,participants,0,1
166044,(,0,0
166045,p,0,0
166046,=,0,0
166047,0.046,0,0
166048,),0,0
166049,.,0,0
166050,A,0,0
166051,similar,0,0
166052,pattern,0,0
166053,was,0,0
166054,observed,0,0
166055,for,0,0
166056,self-reported,0,0
166057,self-confidence,0,0
166058,at,0,0
166059,a,0,0
166060,trend,0,0
166061,level,0,0
166062,(,0,0
166063,p,0,0
166064,=,0,0
166065,0.060,0,0
166066,),0,0
166067,.,0,0
166068,VR-JIT,1,0
166069,simulation,0,0
166070,performance,0,0
166071,scores,0,0
166072,increased,0,0
166073,over,0,0
166074,time,0,0
166075,(,0,0
166076,R,0,1
166077,(,0,1
166078,2,0,0
166079,),0,0
166080,=,0,0
166081,0.83,0,0
166082,),0,0
166083,.,0,0
166084,Results,0,0
166085,indicate,0,0
166086,preliminary,0,0
166087,support,0,0
166088,for,0,0
166089,the,0,0
166090,feasibility,0,0
166091,and,0,0
166092,efficacy,0,0
166093,of,0,0
166094,VR-JIT,1,0
166095,",",0,0
166096,which,0,0
166097,can,0,0
166098,be,0,0
166099,administered,0,1
166100,using,0,0
166101,computer,0,1
166102,software,0,0
166103,or,0,0
166104,via,0,0
166105,the,0,0
166106,internet,0,0
166107,.,0,0
166108,Poor,0,0
166109,prognosis,0,0
166110,patients,0,0
166111,with,0,0
166112,inoperable,0,0
166113,locally,0,0
166114,advanced,0,0
166115,NSCLC,0,0
166116,and,0,0
166117,large,0,0
166118,tumors,0,0
166119,benefit,0,0
166120,from,0,0
166121,palliative,1,0
166122,chemoradiotherapy,1,0
166123,:,1,0
166124,a,0,0
166125,subset,0,0
166126,analysis,0,0
166127,from,0,0
166128,a,0,0
166129,randomized,0,0
166130,clinical,0,0
166131,phase,0,0
166132,III,0,0
166133,trial,0,0
166134,.,0,0
166135,INTRODUCTION,0,0
166136,Poor,0,0
166137,prognosis,0,0
166138,patients,0,0
166139,with,0,0
166140,bulky,0,0
166141,stage,0,0
166142,III,0,0
166143,locally,0,0
166144,advanced,0,0
166145,non-small-cell,0,0
166146,lung,0,0
166147,cancer,0,0
166148,may,0,0
166149,not,0,0
166150,be,0,0
166151,offered,0,0
166152,concurrent,0,0
166153,chemoradiotherapy,0,0
166154,(,0,1
166155,CRT,0,1
166156,),0,1
166157,.,0,0
166158,Following,0,0
166159,a,0,0
166160,phase,0,0
166161,III,0,0
166162,trial,0,0
166163,concerning,0,0
166164,the,0,0
166165,effect,0,0
166166,of,0,0
166167,palliative,0,0
166168,CRT,1,0
166169,in,0,0
166170,inoperable,0,0
166171,poor,0,0
166172,prognosis,0,0
166173,patients,0,0
166174,",",0,0
166175,this,0,0
166176,analysis,0,0
166177,was,0,0
166178,performed,0,0
166179,to,0,0
166180,explore,0,0
166181,how,0,0
166182,tumor,0,0
166183,size,0,0
166184,influenced,0,0
166185,survival,0,0
166186,and,0,0
166187,health-related,0,0
166188,quality,0,0
166189,of,0,0
166190,life,0,1
166191,(,0,1
166192,HRQOL,0,1
166193,),0,1
166194,.,0,0
166195,METHODS,0,0
166196,A,0,0
166197,total,0,0
166198,of,0,0
166199,188,0,0
166200,poor,0,0
166201,prognosis,0,0
166202,patients,0,0
166203,recruited,0,0
166204,in,0,0
166205,a,0,0
166206,randomized,0,0
166207,clinical,0,0
166208,trial,0,0
166209,received,0,0
166210,four,0,0
166211,courses,0,1
166212,intravenous,1,1
166213,carboplatin,1,1
166214,day,1,1
166215,1,1,1
166216,and,1,1
166217,oral,1,1
166218,vinorelbine,1,1
166219,day,1,1
166220,1,1,1
166221,and,1,0
166222,8,1,0
166223,",",1,0
166224,at,1,0
166225,3-week,1,1
166226,intervals,1,0
166227,.,1,0
166228,The,0,0
166229,experimental,0,0
166230,arm,0,0
166231,(,0,0
166232,N,0,0
166233,=,0,0
166234,94,0,0
166235,),0,0
166236,received,0,0
166237,radiotherapy,1,0
166238,with,1,0
166239,fractionation,1,0
166240,42,1,0
166241,Gy/15,1,0
166242,",",0,0
166243,starting,0,0
166244,at,0,0
166245,the,0,0
166246,second,0,0
166247,chemotherapy,0,0
166248,course,0,0
166249,.,0,0
166250,This,0,0
166251,subset,0,0
166252,study,0,0
166253,compares,0,0
166254,outcomes,0,0
166255,in,0,0
166256,patients,0,0
166257,with,0,0
166258,tumors,0,0
166259,larger,0,0
166260,than,0,0
166261,7,0,0
166262,cm,0,0
166263,(,0,0
166264,N,0,0
166265,=,0,0
166266,108,0,0
166267,),0,0
166268,versus,0,0
166269,tumors,0,0
166270,7,0,0
166271,cm,0,0
166272,or,0,0
166273,smaller,0,0
166274,(,0,0
166275,N,0,0
166276,=,0,0
166277,76,0,0
166278,),0,0
166279,.,0,0
166280,RESULTS,0,0
166281,Among,0,0
166282,those,0,0
166283,with,0,0
166284,tumors,0,0
166285,larger,0,0
166286,than,0,0
166287,7,0,0
166288,cm,0,0
166289,",",0,0
166290,the,0,0
166291,median,0,0
166292,overall,0,0
166293,survival,0,0
166294,in,0,0
166295,the,0,0
166296,chemotherapy,1,0
166297,versus,0,0
166298,CRT,1,0
166299,arm,0,0
166300,was,0,0
166301,9.7,0,0
166302,and,0,0
166303,13.4,0,0
166304,months,0,0
166305,",",0,0
166306,respectively,0,0
166307,(,0,0
166308,p,0,0
166309,=,0,0
166310,0.001,0,0
166311,),0,0
166312,.,0,0
166313,The,0,0
166314,1-year,0,0
166315,survival,0,0
166316,was,0,0
166317,33,0,0
166318,%,0,0
166319,and,0,0
166320,56,0,0
166321,%,0,0
166322,",",0,0
166323,respectively,0,0
166324,(,0,0
166325,p,0,0
166326,=,0,0
166327,0.01,0,0
166328,),0,0
166329,.,0,0
166330,Except,0,0
166331,for,0,0
166332,a,0,0
166333,temporary,0,0
166334,decline,0,0
166335,during,0,0
166336,treatment,0,0
166337,",",0,0
166338,HRQOL,0,0
166339,was,0,0
166340,maintained,0,0
166341,in,0,0
166342,the,0,0
166343,CRT,1,0
166344,arm,0,0
166345,",",0,0
166346,regardless,0,0
166347,of,0,0
166348,tumor,0,0
166349,size,0,0
166350,.,0,0
166351,Among,0,0
166352,those,0,0
166353,who,0,0
166354,did,0,0
166355,not,0,0
166356,receive,0,0
166357,CRT,1,0
166358,",",0,0
166359,patients,0,0
166360,with,0,0
166361,tumors,0,0
166362,larger,0,0
166363,than,0,0
166364,7,0,0
166365,cm,0,0
166366,experienced,0,0
166367,a,0,0
166368,gradual,0,0
166369,decline,0,0
166370,in,0,0
166371,the,0,0
166372,HRQOL,0,0
166373,.,0,0
166374,The,0,0
166375,CRT,1,0
166376,group,0,0
166377,had,0,0
166378,significantly,0,0
166379,more,0,0
166380,esophagitis,0,0
166381,and,0,0
166382,hospitalizations,0,0
166383,because,0,0
166384,of,0,0
166385,side,0,0
166386,effects,0,0
166387,regardless,0,0
166388,of,0,0
166389,tumor,0,0
166390,size,0,0
166391,.,0,0
166392,CONCLUSION,0,0
166393,In,0,0
166394,patients,0,0
166395,with,0,0
166396,poor,0,0
166397,prognosis,0,0
166398,and,0,0
166399,inoperable,0,0
166400,locally,0,0
166401,advanced,0,0
166402,non-small-cell,0,0
166403,lung,0,0
166404,cancer,0,0
166405,",",0,0
166406,large,0,0
166407,tumor,0,0
166408,size,0,0
166409,should,0,0
166410,not,0,0
166411,be,0,0
166412,considered,0,0
166413,a,0,0
166414,negative,0,0
166415,predictive,0,0
166416,factor,0,0
166417,.,0,0
166418,Except,0,0
166419,for,0,0
166420,performance,0,0
166421,status,0,0
166422,2,0,0
166423,",",0,0
166424,patients,0,0
166425,with,0,0
166426,tumors,0,0
166427,larger,0,0
166428,than,0,0
166429,7,0,0
166430,cm,0,0
166431,apparently,0,0
166432,benefit,0,0
166433,from,0,0
166434,CRT,1,0
166435,.,1,0
166436,Oral,1,1
166437,magnesium,1,1
166438,supplementation,1,1
166439,improves,0,0
166440,the,0,0
166441,metabolic,0,0
166442,profile,0,0
166443,of,0,0
166444,metabolically,0,0
166445,obese,0,0
166446,",",0,0
166447,normal-weight,0,0
166448,individuals,0,0
166449,:,0,0
166450,a,0,0
166451,randomized,0,1
166452,double-blind,0,1
166453,placebo-controlled,0,1
166454,trial,0,1
166455,.,0,0
166456,BACKGROUND,0,0
166457,AND,0,1
166458,AIMS,0,1
166459,We,0,1
166460,undertook,0,0
166461,this,0,0
166462,study,0,0
166463,to,0,0
166464,determine,0,0
166465,the,0,0
166466,efficacy,0,0
166467,of,0,0
166468,oral,0,1
166469,magnesium,1,1
166470,supplementation,0,1
166471,in,0,1
166472,the,0,0
166473,improvement,0,0
166474,of,0,0
166475,the,0,0
166476,metabolic,0,0
166477,profile,0,0
166478,and,0,0
166479,blood,0,0
166480,pressure,0,0
166481,in,0,0
166482,metabolically,0,0
166483,obese,0,0
166484,",",0,0
166485,normal-weight,0,1
166486,(,0,1
166487,MONW,0,1
166488,),0,1
166489,individuals,0,0
166490,.,0,0
166491,METHODS,0,0
166492,A,0,0
166493,total,0,0
166494,of,0,0
166495,47,0,0
166496,MONW,0,0
166497,individuals,0,0
166498,with,0,0
166499,hypomagnesemia,0,1
166500,were,0,0
166501,enrolled,0,0
166502,in,0,0
166503,clinical,0,0
166504,a,0,0
166505,randomized,0,1
166506,double-blind,0,1
166507,placebo-controlled,0,1
166508,trial,0,1
166509,.,0,0
166510,Individuals,0,0
166511,in,0,0
166512,the,0,0
166513,intervention,0,0
166514,group,0,0
166515,received,0,0
166516,30,1,0
166517,mL,1,0
166518,of,1,0
166519,MgCl2,1,0
166520,5,1,0
166521,%,1,0
166522,solution,1,0
166523,(,1,0
166524,equivalent,1,0
166525,to,1,0
166526,382,1,0
166527,mg,1,0
166528,of,1,0
166529,magnesium,1,1
166530,),1,1
166531,and,1,0
166532,individuals,1,0
166533,in,1,0
166534,the,1,0
166535,control,1,0
166536,group,1,0
166537,30,1,0
166538,mL,1,1
166539,of,1,0
166540,placebo,1,1
166541,solution,1,0
166542,",",1,1
166543,once,1,1
166544,daily,1,1
166545,during,1,1
166546,4,1,0
166547,months,1,0
166548,.,1,0
166549,In,0,0
166550,the,0,0
166551,absence,0,0
166552,of,0,0
166553,obesity,0,0
166554,or,0,0
166555,overweight,0,0
166556,",",0,0
166557,the,0,0
166558,presence,0,0
166559,of,0,0
166560,fasting,0,1
166561,glucose,0,1
166562,levels,0,1
166563,?100,0,1
166564,mg/dL,0,1
166565,",",0,1
166566,HOMA-IR,0,1
166567,index,0,1
166568,?3,0,1
166569,",",0,1
166570,triglyceride,0,1
166571,levels,0,0
166572,?150,0,0
166573,mg/dL,0,0
166574,and/or,0,0
166575,systolic,0,1
166576,and,0,0
166577,diastolic,0,0
166578,blood,0,1
166579,pressure,0,1
166580,?140,0,1
166581,and,0,1
166582,90,0,0
166583,mmHg,0,0
166584,defined,0,0
166585,the,0,0
166586,presence,0,0
166587,of,0,0
166588,the,0,0
166589,MONW,0,0
166590,phenotype,0,0
166591,.,0,0
166592,Hypomagnesemia,0,1
166593,was,0,0
166594,defined,0,0
166595,by,0,0
166596,serum,0,1
166597,magnesium,0,1
166598,concentration,0,0
166599,?1.8,0,0
166600,mg/dL,0,0
166601,.,0,0
166602,RESULTS,0,1
166603,At,0,0
166604,basal,0,0
166605,conditions,0,0
166606,there,0,0
166607,were,0,0
166608,no,0,0
166609,significant,0,0
166610,differences,0,0
166611,between,0,0
166612,groups,0,0
166613,.,0,0
166614,At,0,0
166615,the,0,0
166616,end,0,0
166617,of,0,0
166618,follow-up,0,0
166619,",",0,0
166620,changes,0,0
166621,in,0,0
166622,the,0,0
166623,mean,0,0
166624,of,0,0
166625,systolic,0,0
166626,(,0,0
166627,-2.1,0,0
166628,vs.,0,0
166629,3.9,0,0
166630,%,0,0
166631,mmHg,0,0
166632,",",0,0
166633,p,0,0
166634,<,0,0
166635,0.05,0,0
166636,),0,0
166637,and,0,0
166638,diastolic,0,0
166639,(,0,0
166640,-3.8,0,0
166641,vs.,0,0
166642,7.5,0,0
166643,%,0,0
166644,mmHg,0,0
166645,",",0,0
166646,p,0,0
166647,<,0,0
166648,0.05,0,0
166649,),0,0
166650,blood,0,0
166651,pressures,0,1
166652,",",0,0
166653,HOMA-IR,0,1
166654,index,0,0
166655,(,0,0
166656,-46.5,0,0
166657,vs.,0,0
166658,-5.4,0,0
166659,%,0,0
166660,",",0,0
166661,p,0,0
166662,<,0,0
166663,0.0001,0,0
166664,),0,0
166665,",",0,0
166666,fasting,0,1
166667,glucose,0,1
166668,(,0,0
166669,-12.3,0,0
166670,vs.,0,0
166671,-1.8,0,0
166672,%,0,0
166673,mg/dL,0,0
166674,",",0,0
166675,p,0,0
166676,<,0,0
166677,0.05,0,0
166678,),0,0
166679,and,0,0
166680,triglyceride,0,1
166681,levels,0,0
166682,(,0,0
166683,-47.4,0,0
166684,%,0,0
166685,vs.,0,0
166686,10.1,0,0
166687,%,0,0
166688,mg/dL,0,0
166689,",",0,0
166690,p,0,0
166691,<,0,0
166692,0.0001,0,0
166693,),0,0
166694,were,0,0
166695,significantly,0,0
166696,lower,0,0
166697,in,0,0
166698,the,0,0
166699,subjects,0,0
166700,who,0,0
166701,received,1,0
166702,MgCl2,1,0
166703,compared,1,0
166704,with,0,0
166705,individuals,1,0
166706,in,1,0
166707,the,1,0
166708,control,1,0
166709,group,1,0
166710,.,0,0
166711,CONCLUSIONS,1,1
166712,Oral,1,1
166713,magnesium,1,1
166714,supplementation,0,1
166715,improves,0,0
166716,the,0,0
166717,metabolic,0,0
166718,profile,0,0
166719,and,0,0
166720,blood,0,0
166721,pressure,0,0
166722,of,0,0
166723,MONW,0,0
166724,individuals,0,0
166725,.,0,0
166726,A,0,1
166727,randomized,0,1
166728,clinical,0,0
166729,trial,0,0
166730,comparison,0,0
166731,between,0,0
166732,pivotal,1,0
166733,response,1,0
166734,treatment,1,0
166735,(,1,1
166736,PRT,1,1
166737,),1,1
166738,and,1,0
166739,structured,1,0
166740,applied,1,0
166741,behavior,1,0
166742,analysis,1,0
166743,(,1,0
166744,ABA,1,1
166745,),1,1
166746,intervention,0,0
166747,for,0,0
166748,children,0,0
166749,with,0,0
166750,autism,0,0
166751,.,0,0
166752,Accumulating,0,0
166753,studies,0,0
166754,are,0,0
166755,documenting,0,0
166756,specific,0,0
166757,motivational,0,0
166758,variables,0,0
166759,that,0,0
166760,",",0,0
166761,when,0,0
166762,combined,0,0
166763,into,0,0
166764,a,0,0
166765,naturalistic,1,0
166766,teaching,1,0
166767,paradigm,1,0
166768,",",0,0
166769,can,0,0
166770,positively,0,0
166771,influence,0,0
166772,the,0,0
166773,effectiveness,0,0
166774,of,0,0
166775,interventions,0,0
166776,for,0,0
166777,children,0,0
166778,with,0,0
166779,autism,0,0
166780,spectrum,0,0
166781,disorder,0,1
166782,(,0,1
166783,ASD,0,1
166784,),0,1
166785,.,0,0
166786,The,0,0
166787,purpose,0,0
166788,of,0,0
166789,this,0,0
166790,study,0,0
166791,was,0,0
166792,to,0,0
166793,compare,0,0
166794,two,0,0
166795,applied,1,0
166796,behavior,1,0
166797,analysis,1,0
166798,(,1,0
166799,ABA,1,1
166800,),1,1
166801,intervention,1,0
166802,procedures,1,0
166803,",",1,0
166804,a,1,0
166805,naturalistic,1,0
166806,approach,1,0
166807,",",1,0
166808,pivotal,1,0
166809,response,1,0
166810,treatment,1,0
166811,(,1,1
166812,PRT,1,1
166813,),1,1
166814,with,1,0
166815,a,1,0
166816,structured,1,0
166817,ABA,1,0
166818,approach,1,0
166819,in,0,0
166820,a,0,0
166821,school,0,0
166822,setting,0,0
166823,.,0,0
166824,A,0,0
166825,randomized,0,0
166826,clinical,0,1
166827,trial,0,0
166828,design,0,0
166829,using,0,0
166830,two,0,0
166831,groups,0,0
166832,of,0,0
166833,children,0,0
166834,",",0,0
166835,matched,0,0
166836,according,0,0
166837,to,0,0
166838,age,0,0
166839,",",0,0
166840,sex,0,0
166841,and,0,0
166842,mean,0,0
166843,length,0,0
166844,of,0,0
166845,utterance,0,0
166846,was,0,0
166847,used,0,0
166848,to,0,0
166849,compare,0,0
166850,the,0,0
166851,interventions,0,0
166852,.,0,0
166853,The,0,0
166854,data,0,0
166855,showed,0,0
166856,that,0,0
166857,the,0,0
166858,PRT,1,0
166859,approach,0,0
166860,was,0,0
166861,significantly,0,0
166862,more,0,0
166863,effective,0,0
166864,in,0,0
166865,improving,0,0
166866,targeted,0,0
166867,and,0,0
166868,untargeted,0,0
166869,areas,0,0
166870,after,0,0
166871,3,0,0
166872,months,0,0
166873,of,0,0
166874,intervention,0,0
166875,.,0,0
166876,The,0,0
166877,results,0,0
166878,are,0,0
166879,discussed,0,0
166880,in,0,0
166881,terms,0,0
166882,of,0,0
166883,variables,0,0
166884,that,0,0
166885,produce,0,0
166886,more,0,0
166887,rapid,0,0
166888,improvements,0,0
166889,in,0,0
166890,communication,0,0
166891,for,0,0
166892,children,0,0
166893,with,0,0
166894,ASD,0,0
166895,.,0,0
166896,Effect,0,0
166897,of,0,0
166898,glycemic,0,1
166899,load,0,1
166900,on,0,0
166901,eating,0,0
166902,behavior,0,0
166903,self-efficacy,0,0
166904,during,0,0
166905,weight,0,0
166906,loss,0,0
166907,.,0,0
166908,High,0,0
166909,eating,0,0
166910,behavior,0,0
166911,self-efficacy,0,0
166912,may,0,0
166913,contribute,0,0
166914,to,0,0
166915,successful,0,0
166916,weight,0,0
166917,loss,0,0
166918,.,0,0
166919,Diet,1,0
166920,interventions,1,0
166921,that,0,0
166922,maximize,0,0
166923,eating,0,0
166924,behavior,0,0
166925,self-efficacy,0,0
166926,may,0,0
166927,therefore,0,0
166928,improve,0,0
166929,weight,0,0
166930,loss,0,0
166931,outcomes,0,0
166932,.,0,0
166933,However,0,0
166934,",",0,0
166935,data,0,0
166936,on,0,0
166937,the,0,0
166938,effect,0,0
166939,of,0,0
166940,diet,0,1
166941,composition,0,0
166942,on,0,0
166943,eating,0,0
166944,behavior,0,0
166945,self-efficacy,0,0
166946,are,0,0
166947,sparse,0,0
166948,.,0,0
166949,To,0,0
166950,determine,0,0
166951,the,0,0
166952,effects,0,0
166953,of,0,0
166954,dietary,0,1
166955,glycemic,0,1
166956,load,0,1
166957,(,0,1
166958,GL,0,1
166959,),0,1
166960,on,0,0
166961,eating,0,0
166962,behavior,0,0
166963,self-efficacy,0,0
166964,during,0,0
166965,weight,0,0
166966,loss,0,0
166967,",",0,0
166968,body,0,0
166969,weight,0,0
166970,and,0,0
166971,eating,0,0
166972,behavior,0,0
166973,self-efficacy,0,0
166974,were,0,0
166975,measured,0,0
166976,every,0,0
166977,six,0,0
166978,months,0,0
166979,in,0,0
166980,overweight,0,0
166981,adults,0,0
166982,participating,0,0
166983,in,0,0
166984,a,0,0
166985,12-mo,0,0
166986,randomized,0,0
166987,trial,0,1
166988,testing,1,1
166989,energy-restricted,1,1
166990,diets,1,1
166991,differing,1,0
166992,in,1,0
166993,GL,1,0
166994,.,1,0
166995,All,0,0
166996,food,0,0
166997,was,0,0
166998,provided,0,0
166999,during,0,0
167000,the,0,0
167001,first,0,0
167002,six,0,0
167003,months,0,0
167004,and,0,0
167005,self-selected,0,0
167006,thereafter,0,0
167007,.,0,0
167008,Total,0,0
167009,mean,0,0
167010,weight,0,0
167011,loss,0,0
167012,did,0,0
167013,not,0,0
167014,differ,0,0
167015,between,0,0
167016,groups,0,0
167017,",",0,0
167018,and,0,0
167019,GL-level,0,0
167020,had,0,0
167021,no,0,0
167022,significant,0,0
167023,effect,0,0
167024,on,0,0
167025,eating,0,0
167026,behavior,0,0
167027,self-efficacy,0,0
167028,.,0,0
167029,In,0,0
167030,the,0,0
167031,combined,0,0
167032,cohort,0,0
167033,",",0,0
167034,individuals,0,0
167035,losing,0,0
167036,the,0,0
167037,most,0,0
167038,weight,0,0
167039,reported,0,0
167040,improvements,0,0
167041,in,0,0
167042,eating,0,0
167043,behavior,0,0
167044,self-efficacy,0,0
167045,",",0,0
167046,whereas,0,0
167047,those,0,0
167048,achieving,0,0
167049,less,0,0
167050,weight,0,0
167051,loss,0,0
167052,reported,0,0
167053,decrements,0,0
167054,in,0,0
167055,eating,0,0
167056,behavior,0,0
167057,self-efficacy,0,0
167058,.,0,0
167059,Decrements,0,0
167060,in,0,0
167061,eating,0,0
167062,behavior,0,0
167063,self-efficacy,0,0
167064,were,0,0
167065,associated,0,0
167066,with,0,0
167067,subsequent,0,0
167068,weight,0,0
167069,regain,0,0
167070,when,0,0
167071,diets,0,1
167072,were,0,0
167073,self-selected,0,0
167074,.,0,0
167075,While,0,0
167076,GL,0,0
167077,does,0,0
167078,not,0,0
167079,appear,0,0
167080,to,0,0
167081,influence,0,0
167082,eating,0,0
167083,behavior,0,0
167084,self-efficacy,0,0
167085,",",0,0
167086,lesser,0,0
167087,amounts,0,0
167088,of,0,0
167089,weight,0,0
167090,loss,0,0
167091,on,0,0
167092,provided-food,1,0
167093,energy,1,0
167094,restricted,1,0
167095,diets,1,1
167096,may,0,0
167097,deter,0,0
167098,successful,0,0
167099,maintenance,0,0
167100,of,0,0
167101,weight,0,0
167102,loss,0,0
167103,by,0,0
167104,attenuating,0,0
167105,improvements,0,0
167106,in,0,0
167107,eating,0,0
167108,behavior,0,0
167109,self-efficacy,0,0
167110,.,0,0
167111,Changes,0,0
167112,in,0,0
167113,motor,0,0
167114,cortex,0,0
167115,excitability,0,0
167116,associated,0,0
167117,with,0,0
167118,temporal,1,0
167119,repetitive,1,0
167120,transcranial,1,0
167121,magnetic,1,0
167122,stimulation,1,0
167123,in,0,0
167124,tinnitus,0,0
167125,:,0,0
167126,hints,0,0
167127,for,0,0
167128,cross-modal,0,0
167129,plasticity,0,0
167130,?,0,0
167131,BACKGROUND,0,0
167132,Motor,0,0
167133,cortex,0,0
167134,excitability,0,0
167135,was,0,0
167136,found,0,0
167137,to,0,0
167138,be,0,0
167139,changed,0,0
167140,after,0,0
167141,repetitive,1,0
167142,transcranial,1,0
167143,magnetic,1,0
167144,stimulation,1,0
167145,(,1,1
167146,rTMS,1,1
167147,),1,0
167148,of,0,0
167149,the,0,0
167150,temporal,0,0
167151,cortex,0,0
167152,highlighting,0,0
167153,the,0,0
167154,occurrence,0,0
167155,of,0,0
167156,cross-modal,0,0
167157,plasticity,0,0
167158,in,0,0
167159,non-invasive,0,0
167160,brain,0,0
167161,stimulation,0,0
167162,.,0,0
167163,Here,0,0
167164,",",0,0
167165,we,0,0
167166,investigated,0,0
167167,the,0,0
167168,effects,0,0
167169,of,0,0
167170,temporal,1,0
167171,low-frequency,1,0
167172,rTMS,1,1
167173,on,0,0
167174,motor,0,0
167175,cortex,0,0
167176,plasticity,0,0
167177,in,0,0
167178,a,0,0
167179,large,0,0
167180,sample,0,0
167181,of,0,0
167182,tinnitus,0,0
167183,patients,0,0
167184,.,0,0
167185,In,0,0
167186,116,0,0
167187,patients,0,0
167188,with,0,0
167189,chronic,0,0
167190,tinnitus,0,0
167191,different,0,0
167192,parameters,0,0
167193,of,0,0
167194,cortical,0,0
167195,excitability,0,0
167196,were,0,0
167197,assessed,0,0
167198,before,0,0
167199,and,0,0
167200,after,0,0
167201,ten,0,0
167202,rTMS,1,0
167203,treatment,0,0
167204,sessions,0,0
167205,.,0,0
167206,Patients,0,0
167207,received,0,0
167208,one,0,0
167209,of,0,0
167210,three,0,0
167211,different,0,0
167212,protocols,0,0
167213,all,0,0
167214,including,0,0
167215,1,1,0
167216,Hz,1,0
167217,rTMS,1,1
167218,over,1,0
167219,the,1,0
167220,left,1,0
167221,temporal,1,0
167222,cortex,1,0
167223,.,1,0
167224,Treatment,0,0
167225,response,0,0
167226,was,0,0
167227,defined,0,0
167228,as,0,0
167229,improvement,0,0
167230,by,0,0
167231,at,0,0
167232,least,0,0
167233,five,0,0
167234,points,0,0
167235,in,0,0
167236,the,0,0
167237,tinnitus,0,0
167238,questionnaire,0,1
167239,(,0,1
167240,TQ,0,1
167241,),0,1
167242,.,0,0
167243,Variables,0,0
167244,of,0,0
167245,interest,0,0
167246,were,0,0
167247,resting,0,0
167248,motor,0,1
167249,threshold,0,1
167250,(,0,1
167251,RMT,0,1
167252,),0,1
167253,",",0,0
167254,short-interval,0,0
167255,intra-cortical,0,1
167256,inhibition,0,0
167257,(,0,1
167258,SICI,0,1
167259,),0,1
167260,",",0,0
167261,intracortical,0,1
167262,facilitation,0,0
167263,(,0,1
167264,ICF,0,1
167265,),0,1
167266,",",0,0
167267,and,0,0
167268,cortical,0,0
167269,silent,0,0
167270,period,0,0
167271,(,0,1
167272,CSP,0,1
167273,),0,1
167274,.,0,0
167275,RESULTS,0,1
167276,After,0,0
167277,rTMS,1,0
167278,treatment,0,0
167279,RMT,0,0
167280,was,0,0
167281,decreased,0,0
167282,by,0,0
167283,about,0,0
167284,1,0,0
167285,%,0,0
167286,of,0,0
167287,stimulator,0,0
167288,output,0,0
167289,near-significantly,0,0
167290,in,0,0
167291,the,0,0
167292,whole,0,0
167293,group,0,0
167294,of,0,0
167295,patients,0,0
167296,.,0,0
167297,SICI,0,0
167298,was,0,0
167299,associated,0,0
167300,with,0,0
167301,significant,0,0
167302,changes,0,0
167303,with,0,0
167304,respect,0,0
167305,to,0,0
167306,treatment,0,0
167307,response,0,0
167308,.,0,0
167309,The,0,0
167310,group,0,0
167311,of,0,0
167312,treatment,0,0
167313,responders,0,0
167314,showed,0,0
167315,a,0,0
167316,decrease,0,0
167317,of,0,0
167318,SICI,0,0
167319,over,0,0
167320,the,0,0
167321,course,0,0
167322,of,0,0
167323,treatment,0,0
167324,",",0,0
167325,the,0,0
167326,group,0,0
167327,of,0,0
167328,non-responders,0,0
167329,the,0,0
167330,reverse,0,0
167331,pattern,0,0
167332,.,0,0
167333,CONCLUSIONS,0,0
167334,Minor,0,0
167335,RMT,0,0
167336,changes,0,0
167337,during,0,0
167338,rTMS,1,0
167339,treatment,0,0
167340,do,0,0
167341,not,0,0
167342,necessarily,0,0
167343,suggest,0,0
167344,the,0,0
167345,need,0,0
167346,for,0,0
167347,systematic,0,0
167348,re-examination,0,0
167349,of,0,0
167350,the,0,0
167351,RMT,0,0
167352,for,0,0
167353,safety,0,0
167354,and,0,0
167355,efficacy,0,0
167356,issues,0,0
167357,.,0,0
167358,Treatment,0,0
167359,response,0,0
167360,to,0,0
167361,rTMS,1,0
167362,was,0,0
167363,shown,0,0
167364,to,0,0
167365,be,0,0
167366,related,0,0
167367,to,0,0
167368,changes,0,0
167369,in,0,0
167370,SICI,0,0
167371,that,0,0
167372,might,0,0
167373,reflect,0,0
167374,modulation,0,0
167375,of,0,0
167376,GABAergic,0,0
167377,mechanisms,0,0
167378,directly,0,0
167379,or,0,0
167380,indirectly,0,0
167381,related,0,0
167382,to,0,0
167383,rTMS,0,0
167384,treatment,0,0
167385,effects,0,0
167386,.,0,0
167387,Intramedullary,1,1
167388,repair,1,0
167389,device,0,0
167390,against,0,0
167391,volar,0,0
167392,plating,0,0
167393,in,0,0
167394,the,0,0
167395,reconstruction,0,0
167396,of,0,0
167397,extra-articular,0,0
167398,and,0,0
167399,simple,0,0
167400,articular,0,0
167401,distal,0,0
167402,radius,0,1
167403,fractures,0,1
167404,;,0,0
167405,a,0,0
167406,randomized,0,0
167407,pilot,0,0
167408,study,0,0
167409,.,0,0
167410,PURPOSE,0,0
167411,This,0,0
167412,prospective,0,0
167413,randomized,0,0
167414,pilot,0,0
167415,study,0,0
167416,reports,0,0
167417,our,0,0
167418,institutional,0,0
167419,experience,0,0
167420,and,0,0
167421,early,0,0
167422,results,0,0
167423,using,0,0
167424,Sonoma,0,0
167425,Wrx,0,1
167426,(,0,0
167427,Sonoma,0,0
167428,Orthopedic,0,0
167429,Products,0,0
167430,",",0,0
167431,Santa,0,0
167432,Rosa,0,1
167433,",",0,1
167434,CA,0,1
167435,),0,0
167436,in,0,0
167437,the,0,0
167438,treatment,0,0
167439,of,0,0
167440,extra-articular,0,0
167441,and,0,0
167442,simple,0,0
167443,intra-articular,0,1
167444,distal,0,0
167445,radius,0,1
167446,fractures,0,0
167447,.,0,0
167448,MATERIAL,0,0
167449,AND,0,1
167450,METHODS,0,1
167451,A,0,0
167452,total,0,0
167453,of,0,0
167454,64,0,0
167455,patients,0,0
167456,",",0,0
167457,were,0,0
167458,enrolled,0,0
167459,in,0,0
167460,the,0,0
167461,study,0,0
167462,.,0,0
167463,They,0,0
167464,were,0,0
167465,considered,0,0
167466,eligible,0,0
167467,if,0,0
167468,they,0,0
167469,had,0,0
167470,;,0,0
167471,unstable,0,0
167472,extra-articular,0,0
167473,distal,0,0
167474,radius,0,0
167475,fractures,0,0
167476,and,0,0
167477,simple,0,0
167478,intra-articular,0,1
167479,distal,0,0
167480,radius,0,1
167481,fractures,0,0
167482,suitable,0,0
167483,for,0,0
167484,closed,0,0
167485,reduction,0,0
167486,(,0,0
167487,AO,0,1
167488,types,0,0
167489,;,0,0
167490,A2.2,0,0
167491,",",0,0
167492,A2.3,0,0
167493,",",0,0
167494,A3.1,0,0
167495,C2.1,0,0
167496,",",0,0
167497,C2.2,0,0
167498,),0,0
167499,.,0,0
167500,Patients,0,0
167501,in,0,0
167502,group,0,0
167503,I,0,0
167504,received,0,0
167505,intramedullary,1,0
167506,fixation,1,0
167507,using,1,0
167508,the,1,0
167509,Sonoma,1,0
167510,Wrx,1,0
167511,device,1,0
167512,and,0,0
167513,patients,0,0
167514,in,0,0
167515,group,0,0
167516,II,0,0
167517,received,0,0
167518,standard,1,0
167519,volar,1,0
167520,locking,1,0
167521,plate,1,0
167522,fixation,1,0
167523,.,1,0
167524,Radiographic,0,0
167525,criteria,0,0
167526,of,0,0
167527,acceptable,0,0
167528,healing,0,0
167529,were,0,0
167530,used,0,0
167531,for,0,0
167532,evaluation,0,0
167533,.,0,0
167534,RESULTS,0,0
167535,Two,0,1
167536,groups,0,0
167537,were,0,0
167538,similar,0,0
167539,in,0,0
167540,terms,0,0
167541,of,0,0
167542,baseline,0,0
167543,characteristics,0,0
167544,.,0,0
167545,Mean,0,0
167546,time,0,0
167547,of,0,0
167548,operation,0,0
167549,was,0,0
167550,significantly,0,0
167551,shorter,0,0
167552,in,0,0
167553,Group,0,0
167554,1,0,0
167555,vs.,0,0
167556,in,0,0
167557,group,0,0
167558,2,0,0
167559,(,0,0
167560,36.81,0,0
167561,?,0,0
167562,7.11,0,0
167563,vs.,0,0
167564,48.97,0,0
167565,?,0,0
167566,5.9,0,0
167567,minutes,0,0
167568,",",0,0
167569,p,0,0
167570,=,0,0
167571,0.001,0,0
167572,),0,0
167573,.,0,0
167574,Time,0,0
167575,to,0,0
167576,healing,0,0
167577,of,0,0
167578,the,0,0
167579,fracture,0,0
167580,was,0,0
167581,not,0,0
167582,different,0,0
167583,between,0,0
167584,two,0,0
167585,groups,0,0
167586,(,0,0
167587,5.45,0,0
167588,?,0,0
167589,1.09,0,0
167590,vs.,0,0
167591,5.70,0,0
167592,?,0,0
167593,1.04,0,0
167594,weeks,0,0
167595,for,0,0
167596,Group,0,0
167597,1,0,0
167598,vs.,0,0
167599,2,0,0
167600,",",0,0
167601,respectively,0,0
167602,p,0,0
167603,=,0,0
167604,0.36,0,0
167605,),0,0
167606,.,0,0
167607,Overall,0,0
167608,complications,0,0
167609,occurred,0,0
167610,in,0,0
167611,9,0,0
167612,patients,0,0
167613,in,0,0
167614,group,0,0
167615,1,0,0
167616,and,0,0
167617,in,0,0
167618,15,0,0
167619,patients,0,0
167620,in,0,0
167621,group,0,0
167622,2,0,0
167623,(,0,0
167624,p,0,0
167625,=,0,0
167626,0.17,0,0
167627,),0,0
167628,.,0,0
167629,Follow-up,0,0
167630,was,0,0
167631,completed,0,0
167632,in,0,0
167633,all,0,0
167634,patients,0,0
167635,with,0,0
167636,a,0,0
167637,median,0,0
167638,time,0,0
167639,of,0,0
167640,12,0,0
167641,months,0,0
167642,and,0,0
167643,13,0,0
167644,months,0,0
167645,in,0,0
167646,group,0,0
167647,1,0,0
167648,and,0,0
167649,2,0,0
167650,",",0,0
167651,respectively,0,0
167652,.,0,0
167653,On,0,0
167654,radiographic,0,0
167655,evaluation,0,0
167656,radial,0,0
167657,inclination,0,0
167658,",",0,0
167659,radial,0,0
167660,height,0,0
167661,and,0,0
167662,volar,0,0
167663,tilt,0,0
167664,were,0,0
167665,not,0,0
167666,significantly,0,0
167667,different,0,0
167668,between,0,0
167669,group,0,0
167670,1,0,0
167671,and,0,0
167672,2,0,0
167673,",",0,0
167674,respectively,0,0
167675,.,0,0
167676,There,0,0
167677,were,0,0
167678,no,0,0
167679,significant,0,0
167680,differences,0,0
167681,between,0,0
167682,two,0,0
167683,groups,0,0
167684,in,0,0
167685,regard,0,0
167686,to,0,0
167687,wrist,0,0
167688,rotational,0,0
167689,degrees,0,0
167690,measured,0,0
167691,in,0,0
167692,last,0,0
167693,follow-up,0,0
167694,visit,0,0
167695,.,0,0
167696,CONCLUSION,0,0
167697,Sonoma,1,0
167698,Wrx,1,0
167699,Device,1,0
167700,is,1,0
167701,reliable,0,0
167702,and,0,0
167703,effective,0,0
167704,in,0,0
167705,terms,0,0
167706,of,0,0
167707,achieving,0,0
167708,satisfactory,0,0
167709,outcomes,0,0
167710,in,0,0
167711,treatment,0,0
167712,of,0,0
167713,distal,0,0
167714,radius,0,0
167715,fractures,0,0
167716,.,0,0
167717,It,0,0
167718,may,0,0
167719,be,0,0
167720,reasonable,0,0
167721,to,0,0
167722,use,0,0
167723,this,0,0
167724,device,0,0
167725,to,0,0
167726,prevent,0,0
167727,complications,0,0
167728,that,0,0
167729,are,0,0
167730,related,0,0
167731,to,0,0
167732,extensive,0,0
167733,soft,0,0
167734,tissue,0,0
167735,dissection,0,0
167736,.,0,0
167737,Quantifying,0,0
167738,narrative,0,0
167739,ability,0,0
167740,in,0,0
167741,autism,0,0
167742,spectrum,0,0
167743,disorder,0,0
167744,:,0,0
167745,a,0,0
167746,computational,0,0
167747,linguistic,0,0
167748,analysis,0,0
167749,of,0,0
167750,narrative,0,0
167751,coherence,0,0
167752,.,0,0
167753,Autism,0,0
167754,is,0,0
167755,a,0,0
167756,neurodevelopmental,0,0
167757,disorder,0,0
167758,characterized,0,0
167759,by,0,0
167760,serious,0,0
167761,difficulties,0,0
167762,with,0,0
167763,the,0,0
167764,social,0,0
167765,use,0,0
167766,of,0,0
167767,language,0,0
167768,",",0,0
167769,along,0,0
167770,with,0,0
167771,impaired,0,0
167772,social,0,0
167773,functioning,0,0
167774,and,0,0
167775,ritualistic/repetitive,0,1
167776,behaviors,0,1
167777,(,0,1
167778,American,0,0
167779,Psychiatric,0,0
167780,Association,0,0
167781,in,0,0
167782,Diagnostic,0,0
167783,and,0,0
167784,statistical,0,0
167785,manual,0,0
167786,of,0,0
167787,mental,0,0
167788,disorders,0,0
167789,:,0,0
167790,DSM-5,0,0
167791,",",0,0
167792,5th,0,0
167793,edn,0,0
167794,.,0,0
167795,American,0,0
167796,Psychiatric,0,0
167797,Association,0,0
167798,",",0,0
167799,Arlington,0,0
167800,",",0,0
167801,2013,0,1
167802,),0,0
167803,.,0,0
167804,While,0,0
167805,substantial,0,0
167806,heterogeneity,0,0
167807,exists,0,0
167808,in,0,0
167809,symptom,0,0
167810,expression,0,0
167811,",",0,0
167812,impairments,0,0
167813,in,0,0
167814,language,0,0
167815,discourse,0,0
167816,skills,0,0
167817,",",0,0
167818,including,0,0
167819,narrative,0,1
167820,(,0,0
167821,or,0,0
167822,storytelling,0,1
167823,),0,0
167824,",",0,0
167825,are,0,0
167826,universally,0,0
167827,observed,0,0
167828,in,0,0
167829,autism,0,0
167830,(,0,0
167831,Tager-Flusberg,0,1
167832,et,0,1
167833,al,0,0
167834,.,0,0
167835,in,0,0
167836,Handbook,0,0
167837,on,0,0
167838,autism,0,0
167839,and,0,0
167840,pervasive,0,0
167841,developmental,0,0
167842,disorders,0,0
167843,",",0,0
167844,3rd,0,0
167845,edn,0,0
167846,.,0,0
167847,Wiley,0,0
167848,",",0,0
167849,New,0,1
167850,York,0,1
167851,",",0,0
167852,pp,0,0
167853,335-364,0,0
167854,",",0,0
167855,2005,0,0
167856,),0,0
167857,.,0,0
167858,This,0,0
167859,study,0,0
167860,applied,0,0
167861,a,0,0
167862,computational,1,0
167863,linguistic,1,0
167864,tool,1,0
167865,",",1,0
167866,Latent,1,0
167867,Semantic,1,1
167868,Analysis,1,1
167869,(,1,1
167870,LSA,1,1
167871,),1,1
167872,",",0,0
167873,to,0,0
167874,objectively,0,0
167875,characterize,0,0
167876,narrative,0,0
167877,performance,0,0
167878,in,0,0
167879,high-functioning,0,0
167880,individuals,0,0
167881,with,0,0
167882,autism,0,0
167883,and,0,0
167884,typically-developing,0,0
167885,controls,0,0
167886,",",0,0
167887,across,0,0
167888,two,0,0
167889,different,0,0
167890,narrative,0,0
167891,contexts,0,0
167892,that,0,0
167893,differ,0,0
167894,in,0,0
167895,the,0,0
167896,interpersonal,0,0
167897,and,0,0
167898,cognitive,0,0
167899,demands,0,0
167900,placed,0,0
167901,on,0,0
167902,the,0,0
167903,narrator,0,0
167904,.,0,0
167905,Results,0,0
167906,indicated,0,0
167907,that,0,0
167908,high-functioning,0,0
167909,individuals,0,0
167910,with,0,0
167911,autism,0,0
167912,produced,0,0
167913,narratives,0,0
167914,comparable,0,0
167915,in,0,0
167916,semantic,0,0
167917,content,0,0
167918,to,0,0
167919,those,0,0
167920,produced,0,0
167921,by,0,0
167922,controls,0,0
167923,when,0,0
167924,narrating,0,0
167925,from,0,0
167926,a,0,0
167927,picture,0,0
167928,book,0,0
167929,",",0,0
167930,but,0,0
167931,produced,0,0
167932,narratives,0,0
167933,diminished,0,0
167934,in,0,0
167935,semantic,0,0
167936,quality,0,0
167937,in,0,0
167938,a,0,0
167939,more,0,0
167940,demanding,0,0
167941,narrative,0,0
167942,recall,0,0
167943,task,0,0
167944,.,0,0
167945,This,0,0
167946,pattern,0,0
167947,is,0,0
167948,similar,0,0
167949,to,0,0
167950,that,0,0
167951,detected,0,0
167952,from,0,0
167953,analyses,0,0
167954,of,0,0
167955,hand-coded,0,0
167956,picture,0,0
167957,book,0,0
167958,narratives,0,0
167959,in,0,0
167960,prior,0,0
167961,research,0,0
167962,",",0,0
167963,and,0,0
167964,extends,0,0
167965,findings,0,0
167966,to,0,0
167967,an,0,0
167968,additional,0,0
167969,narrative,0,0
167970,context,0,0
167971,that,0,0
167972,proves,0,0
167973,particularly,0,0
167974,challenging,0,0
167975,for,0,0
167976,individuals,0,0
167977,with,0,0
167978,autism,0,0
167979,.,0,0
167980,Results,0,0
167981,are,0,0
167982,discussed,0,0
167983,in,0,0
167984,terms,0,0
167985,of,0,0
167986,the,0,0
167987,utility,0,0
167988,of,0,0
167989,LSA,0,0
167990,as,0,0
167991,a,0,0
167992,quantitative,0,0
167993,",",0,0
167994,objective,0,0
167995,",",0,0
167996,and,0,0
167997,efficient,0,0
167998,measure,0,0
167999,of,0,0
168000,narrative,0,0
168001,ability,0,0
168002,.,0,0
168003,PTK2,0,0
168004,expression,0,0
168005,and,0,0
168006,immunochemotherapy,0,1
168007,outcome,0,0
168008,in,0,0
168009,chronic,0,0
168010,lymphocytic,0,0
168011,leukemia,0,0
168012,.,0,0
168013,Addition,0,0
168014,of,0,0
168015,rituximab,1,1
168016,(,1,1
168017,R,1,1
168018,),1,1
168019,to,1,0
168020,fludarabine,1,1
168021,and,1,1
168022,cyclophosphamide,1,1
168023,(,0,1
168024,FC,0,1
168025,),0,0
168026,has,0,0
168027,significantly,0,0
168028,improved,0,0
168029,patient,0,0
168030,outcomes,0,0
168031,in,0,0
168032,chronic,0,0
168033,lymphocytic,0,1
168034,leukemia,0,1
168035,(,0,1
168036,CLL,0,1
168037,),0,1
168038,.,0,0
168039,Whether,0,0
168040,baseline,0,0
168041,gene,0,0
168042,expression,0,0
168043,can,0,0
168044,identify,0,0
168045,patients,0,0
168046,who,0,0
168047,will,0,0
168048,benefit,0,0
168049,from,0,0
168050,immunochemotherapy,0,1
168051,over,0,0
168052,chemotherapy,0,0
168053,alone,0,0
168054,has,0,0
168055,not,0,0
168056,been,0,0
168057,determined,0,0
168058,.,0,0
168059,We,0,0
168060,assessed,0,0
168061,genome-wide,0,0
168062,expression,0,0
168063,of,0,0
168064,300,0,0
168065,pretreatment,0,0
168066,specimens,0,0
168067,from,0,0
168068,a,0,0
168069,subset,0,0
168070,of,0,0
168071,552,0,0
168072,patients,0,0
168073,in,0,0
168074,REACH,0,0
168075,",",0,0
168076,a,0,0
168077,study,0,0
168078,of,0,0
168079,FC,1,0
168080,or,0,0
168081,R-FC,1,0
168082,in,0,0
168083,relapsed,0,0
168084,CLL,0,1
168085,.,0,1
168086,An,0,1
168087,independent,0,0
168088,test,0,0
168089,set,0,0
168090,was,0,0
168091,derived,0,0
168092,from,0,0
168093,282,0,0
168094,pretreatment,0,0
168095,specimens,0,0
168096,from,0,0
168097,CLL8,0,0
168098,",",0,0
168099,a,0,0
168100,study,0,0
168101,of,0,0
168102,FC,0,0
168103,or,0,0
168104,R-FC,0,0
168105,in,0,0
168106,treatment-na?ve,0,0
168107,patients,0,0
168108,.,0,0
168109,Genes,0,0
168110,specific,0,0
168111,for,0,0
168112,benefit,0,0
168113,from,1,0
168114,R-FC,1,0
168115,were,0,0
168116,determined,0,0
168117,by,0,0
168118,assessing,0,0
168119,treatment-gene,0,0
168120,interactions,0,0
168121,in,0,0
168122,Cox,0,0
168123,proportional,0,0
168124,hazards,0,0
168125,models,0,0
168126,.,0,0
168127,REACH,0,0
168128,patients,0,0
168129,with,0,0
168130,higher,0,0
168131,pretreatment,0,0
168132,protein,0,0
168133,tyrosine,0,1
168134,kinase,0,1
168135,2,0,1
168136,(,0,1
168137,PTK2,0,1
168138,),0,1
168139,messenger,0,0
168140,RNA,0,0
168141,levels,0,0
168142,derived,0,0
168143,greater,0,0
168144,benefit,0,0
168145,from,1,0
168146,R-FC,1,0
168147,",",1,0
168148,with,0,0
168149,significant,0,0
168150,improvements,0,0
168151,in,0,0
168152,progression-free,0,0
168153,survival,0,0
168154,",",0,0
168155,independent,0,0
168156,of,0,0
168157,known,0,0
168158,prognostic,0,0
168159,factors,0,0
168160,in,0,0
168161,a,0,0
168162,multivariate,0,0
168163,model,0,0
168164,.,0,0
168165,Examination,0,0
168166,of,0,0
168167,PTK2,0,0
168168,gene,0,0
168169,expression,0,0
168170,in,0,0
168171,CLL8,0,0
168172,patients,0,0
168173,yielded,0,0
168174,similar,0,0
168175,results,0,0
168176,.,0,0
168177,Furthermore,0,0
168178,",",0,0
168179,PTK2,0,0
168180,inhibition,0,0
168181,blunted,0,0
168182,R-dependent,0,0
168183,cell,0,0
168184,death,0,0
168185,in,0,0
168186,vitro,0,0
168187,.,0,0
168188,This,0,0
168189,retrospective,0,0
168190,analysis,0,0
168191,from,0,0
168192,2,0,0
168193,independent,0,0
168194,trials,0,0
168195,revealed,0,0
168196,that,0,0
168197,increased,0,0
168198,PTK2,0,0
168199,expression,0,0
168200,is,0,0
168201,associated,0,0
168202,with,0,0
168203,improved,0,0
168204,outcomes,0,0
168205,for,0,0
168206,CLL,0,0
168207,patients,0,0
168208,treated,0,0
168209,with,1,0
168210,R-FC,1,0
168211,vs,1,0
168212,FC,1,0
168213,.,1,0
168214,PTK2,0,0
168215,expression,0,0
168216,may,0,0
168217,be,0,0
168218,a,0,0
168219,useful,0,0
168220,biomarker,0,0
168221,for,0,0
168222,patient,0,0
168223,selection,0,0
168224,in,0,0
168225,future,0,0
168226,trials,0,0
168227,.,0,0
168228,These,0,0
168229,trials,0,0
168230,were,0,0
168231,registered,0,0
168232,at,0,0
168233,www.clinicaltrials.gov,0,0
168234,as,0,0
168235,#,0,0
168236,NCT00090051,0,1
168237,(,0,1
168238,REACH,0,1
168239,),0,1
168240,and,0,0
168241,#,0,0
168242,NCT00281918,0,1
168243,(,0,1
168244,CLL8,0,1
168245,),0,1
168246,.,0,0
168247,Video-feedback,1,0
168248,Intervention,1,0
168249,to,0,0
168250,promote,0,0
168251,Positive,0,0
168252,Parenting,0,0
168253,adapted,0,0
168254,to,0,0
168255,Autism,0,0
168256,(,0,1
168257,VIPP-AUTI,0,1
168258,),0,1
168259,:,0,0
168260,A,0,0
168261,randomized,0,0
168262,controlled,0,0
168263,trial,0,0
168264,.,0,0
168265,In,0,0
168266,a,0,0
168267,randomized,0,0
168268,controlled,0,0
168269,trial,0,0
168270,",",0,0
168271,we,0,0
168272,evaluated,0,0
168273,the,0,0
168274,early,0,0
168275,intervention,0,0
168276,program,0,0
168277,Video-feedback,1,0
168278,Intervention,1,0
168279,to,0,0
168280,promote,0,0
168281,Positive,0,0
168282,Parenting,0,0
168283,adapted,0,0
168284,to,0,0
168285,Autism,0,0
168286,(,0,1
168287,VIPP-AUTI,0,1
168288,),0,0
168289,with,0,0
168290,78,0,0
168291,primary,0,0
168292,caregivers,0,0
168293,and,0,0
168294,their,0,0
168295,child,0,0
168296,(,0,0
168297,16-61,0,0
168298,months,0,0
168299,),0,0
168300,with,0,0
168301,Autism,0,0
168302,Spectrum,0,0
168303,Disorder,0,0
168304,.,0,0
168305,VIPP-AUTI,1,0
168306,is,0,0
168307,a,0,0
168308,brief,0,0
168309,attachment-based,1,0
168310,intervention,1,0
168311,program,1,0
168312,",",0,0
168313,focusing,0,0
168314,on,0,0
168315,improving,0,0
168316,parent-child,0,0
168317,interaction,0,0
168318,and,0,0
168319,reducing,0,0
168320,the,0,0
168321,child,0,0
168322,'s,0,0
168323,individual,0,0
168324,Autism,0,0
168325,Spectrum,0,0
168326,Disorder-related,0,0
168327,symptomatology,0,0
168328,in,0,0
168329,five,0,0
168330,home,0,0
168331,visits,0,0
168332,.,0,0
168333,VIPP-AUTI,1,0
168334,",",0,0
168335,as,0,0
168336,compared,0,0
168337,with,0,0
168338,usual,0,0
168339,care,0,0
168340,",",0,0
168341,demonstrated,0,0
168342,efficacy,0,0
168343,in,0,0
168344,reducing,0,0
168345,parental,0,0
168346,intrusiveness,0,0
168347,.,0,0
168348,Moreover,0,0
168349,",",0,0
168350,parents,0,0
168351,who,0,0
168352,received,0,0
168353,VIPP-AUTI,1,0
168354,showed,0,0
168355,increased,0,0
168356,feelings,0,0
168357,of,0,0
168358,self-efficacy,0,0
168359,in,0,0
168360,child,0,0
168361,rearing,0,0
168362,.,0,0
168363,No,0,1
168364,significant,0,0
168365,group,0,0
168366,differences,0,0
168367,were,0,0
168368,found,0,0
168369,on,0,0
168370,other,0,0
168371,aspects,0,0
168372,of,0,0
168373,parent-child,0,0
168374,interaction,0,0
168375,or,0,0
168376,on,0,0
168377,child,0,0
168378,play,0,0
168379,behavior,0,0
168380,.,0,0
168381,At,0,0
168382,3-months,0,0
168383,follow-up,0,0
168384,",",0,0
168385,intervention,0,0
168386,effects,0,0
168387,were,0,0
168388,found,0,0
168389,on,0,0
168390,child-initiated,0,0
168391,joint,0,0
168392,attention,0,0
168393,skills,0,0
168394,",",0,0
168395,not,0,0
168396,mediated,0,0
168397,by,0,0
168398,intervention,0,0
168399,effects,0,0
168400,on,0,0
168401,parenting,0,0
168402,.,0,0
168403,Implementation,0,0
168404,of,0,0
168405,VIPP-AUTI,1,0
168406,in,0,0
168407,clinical,0,0
168408,practice,0,0
168409,is,0,0
168410,facilitated,0,0
168411,by,0,0
168412,the,0,0
168413,use,0,0
168414,of,0,0
168415,a,0,0
168416,detailed,0,0
168417,manual,0,0
168418,and,0,0
168419,a,0,0
168420,relatively,0,0
168421,brief,0,0
168422,training,0,0
168423,of,0,0
168424,interveners,0,0
168425,.,0,0
168426,The,0,0
168427,effects,0,0
168428,of,0,0
168429,prism,0,0
168430,adaptation,0,0
168431,on,0,0
168432,egocentric,0,0
168433,metric,0,0
168434,distance,0,0
168435,estimation,0,0
168436,.,0,0
168437,OBJECTIVE,0,0
168438,The,0,0
168439,present,0,0
168440,experiment,0,0
168441,evaluated,0,0
168442,whether,0,0
168443,training,0,0
168444,involving,0,0
168445,throwing,0,0
168446,transferred,0,0
168447,to,0,0
168448,metric,0,0
168449,distance,0,0
168450,estimation,0,0
168451,(,0,0
168452,i.e.,0,0
168453,",",0,0
168454,describing,0,0
168455,in,0,0
168456,feet,0,0
168457,and,0,0
168458,inches,0,0
168459,the,0,0
168460,distance,0,0
168461,between,0,0
168462,oneself,0,0
168463,and,0,0
168464,targets,0,0
168465,),0,0
168466,.,0,0
168467,BACKGROUND,0,0
168468,In,0,0
168469,prior,0,0
168470,work,0,0
168471,",",0,0
168472,we,0,0
168473,found,0,0
168474,that,0,0
168475,metric,0,0
168476,estimation,0,0
168477,training,0,0
168478,negatively,0,0
168479,transferred,0,0
168480,to,0,0
168481,throwing,0,0
168482,.,0,0
168483,We,0,0
168484,explained,0,0
168485,our,0,0
168486,results,0,0
168487,in,0,0
168488,terms,0,0
168489,of,0,0
168490,cognitive,0,0
168491,intrusion,0,0
168492,.,0,0
168493,The,0,0
168494,present,0,0
168495,study,0,0
168496,tested,0,0
168497,that,0,0
168498,possibility,0,0
168499,by,0,0
168500,swapping,0,0
168501,our,0,0
168502,training,0,0
168503,and,0,0
168504,transfer,0,0
168505,tasks,0,0
168506,.,0,0
168507,METHOD,0,0
168508,During,0,0
168509,pretesting,0,0
168510,",",0,0
168511,participants,0,0
168512,verbally,1,0
168513,estimated,1,0
168514,the,1,0
168515,metric,1,0
168516,distances,1,0
168517,between,0,0
168518,themselves,0,0
168519,and,0,0
168520,targets,0,0
168521,",",0,0
168522,or,0,0
168523,they,0,0
168524,threw,1,0
168525,a,1,0
168526,beanbag,1,0
168527,to,1,0
168528,targets,1,0
168529,.,1,0
168530,During,0,0
168531,training,0,0
168532,",",0,0
168533,participants,1,0
168534,donned,1,0
168535,goggles,1,0
168536,that,0,0
168537,distorted,0,0
168538,their,0,0
168539,vision,0,0
168540,.,0,0
168541,While,0,0
168542,wearing,0,0
168543,the,0,0
168544,goggles,0,0
168545,",",0,0
168546,they,0,0
168547,threw,1,0
168548,a,1,0
168549,beanbag,1,0
168550,to,1,0
168551,targets,1,0
168552,.,1,0
168553,Half,0,0
168554,received,0,0
168555,feedback,0,0
168556,.,0,0
168557,During,0,0
168558,posttesting,0,0
168559,",",0,0
168560,participants,0,0
168561,removed,0,0
168562,the,0,0
168563,distorting,0,0
168564,goggles,1,0
168565,and,0,0
168566,completed,0,0
168567,the,0,0
168568,same,0,0
168569,task,0,0
168570,that,0,0
168571,they,0,0
168572,performed,0,0
168573,during,0,0
168574,pretesting,0,0
168575,.,0,0
168576,RESULTS,0,0
168577,The,0,0
168578,results,0,0
168579,indicated,0,0
168580,that,0,0
168581,the,0,0
168582,distorting,0,0
168583,goggles,0,0
168584,degraded,0,0
168585,throwing,0,0
168586,at,0,0
168587,the,0,0
168588,beginning,0,0
168589,of,0,0
168590,training,0,0
168591,",",0,0
168592,visual,0,0
168593,feedback,0,0
168594,improved,0,0
168595,throwing,0,0
168596,during,0,0
168597,training,0,0
168598,",",0,0
168599,the,0,0
168600,effects,0,0
168601,of,0,0
168602,training,0,0
168603,with,0,0
168604,feedback,0,0
168605,persisted,0,0
168606,into,0,0
168607,the,0,0
168608,throwing,0,0
168609,posttest,0,0
168610,",",0,0
168611,and,0,0
168612,the,0,0
168613,effects,0,0
168614,of,0,0
168615,training,0,0
168616,with,0,0
168617,feedback,0,0
168618,did,0,0
168619,not,0,0
168620,transfer,0,0
168621,to,0,0
168622,the,0,0
168623,verbal,0,0
168624,metric,0,0
168625,estimation,0,0
168626,posttest,0,0
168627,.,0,0
168628,CONCLUSION,0,0
168629,Training,0,0
168630,involving,0,0
168631,throwing,0,0
168632,was,0,0
168633,effective,0,0
168634,",",0,0
168635,but,0,0
168636,did,0,0
168637,not,0,0
168638,transfer,0,0
168639,to,0,0
168640,verbal,0,0
168641,metric,0,0
168642,distance,0,0
168643,estimation,0,0
168644,.,0,0
168645,This,0,0
168646,supports,0,0
168647,our,0,0
168648,argument,0,0
168649,that,0,0
168650,the,0,0
168651,negative,0,0
168652,transfer,0,0
168653,observed,0,0
168654,in,0,0
168655,our,0,0
168656,previous,0,0
168657,study,0,0
168658,stemmed,0,0
168659,from,0,0
168660,cognitive,0,0
168661,intrusion,0,0
168662,.,0,0
168663,APPLICATION,0,0
168664,The,0,0
168665,present,0,0
168666,experiment,0,0
168667,suggests,0,0
168668,that,0,0
168669,the,0,0
168670,creation,0,0
168671,of,0,0
168672,distance,0,0
168673,estimation,0,0
168674,training,0,0
168675,should,0,0
168676,begin,0,0
168677,with,0,0
168678,a,0,0
168679,careful,0,0
168680,analysis,0,0
168681,of,0,0
168682,the,0,0
168683,transfer,0,0
168684,task,0,0
168685,",",0,0
168686,and,0,0
168687,that,0,0
168688,distance,0,0
168689,estimation,0,0
168690,training,0,0
168691,programs,0,0
168692,should,0,0
168693,explicitly,0,0
168694,teach,0,0
168695,trainees,0,0
168696,that,0,0
168697,their,0,0
168698,training,0,0
168699,will,0,0
168700,not,0,0
168701,generalize,0,0
168702,to,0,0
168703,all,0,0
168704,distance,0,0
168705,estimation,0,0
168706,tasks,0,0
168707,.,0,0
168708,Intravenous,1,1
168709,flecainide,1,1
168710,versus,1,1
168711,verapamil,1,1
168712,for,0,0
168713,acute,0,0
168714,conversion,0,0
168715,of,0,0
168716,paroxysmal,0,0
168717,atrial,0,0
168718,fibrillation,0,0
168719,or,0,0
168720,flutter,0,0
168721,to,0,0
168722,sinus,0,0
168723,rhythm,0,0
168724,.,0,0
168725,In,0,0
168726,a,0,0
168727,single-blind,0,1
168728,randomized,0,1
168729,study,0,0
168730,",",0,0
168731,the,0,0
168732,efficacy,0,0
168733,of,0,0
168734,intravenous,1,1
168735,flecainide,1,1
168736,(,0,1
168737,2,0,1
168738,mg/kg/10,0,1
168739,minutes,0,1
168740,),0,1
168741,versus,1,1
168742,verapamil,1,1
168743,(,0,1
168744,10,0,1
168745,mg/1,0,1
168746,minute,0,1
168747,),0,0
168748,was,0,0
168749,assessed,0,0
168750,in,0,0
168751,40,0,0
168752,patients,0,0
168753,with,0,0
168754,paroxysmal,0,0
168755,atrial,0,1
168756,fibrillation,0,1
168757,(,0,1
168758,AF,0,1
168759,),0,1
168760,or,0,0
168761,atrial,0,1
168762,flutter,0,1
168763,(,0,1
168764,AFI,0,1
168765,),0,1
168766,.,0,0
168767,The,0,0
168768,treatment,0,0
168769,was,0,0
168770,considered,0,0
168771,successful,0,0
168772,if,0,0
168773,sinus,0,0
168774,rhythm,0,0
168775,occurred,0,0
168776,within,0,0
168777,1,0,0
168778,hour,0,0
168779,.,0,1
168780,Of,0,0
168781,20,0,0
168782,patients,0,0
168783,receiving,0,0
168784,flecainide,1,1
168785,",",0,1
168786,14,0,0
168787,of,0,0
168788,17,0,0
168789,(,0,0
168790,82,0,0
168791,%,0,0
168792,),0,0
168793,with,0,0
168794,AF,0,0
168795,converted,0,0
168796,to,0,0
168797,sinus,0,0
168798,rhythm,0,0
168799,",",0,0
168800,but,0,0
168801,in,0,0
168802,3,0,0
168803,patients,0,0
168804,with,0,0
168805,AFI,0,1
168806,flecainide,1,1
168807,failed,0,0
168808,.,0,0
168809,All,0,0
168810,patients,0,0
168811,treated,0,0
168812,with,0,0
168813,verapamil,1,1
168814,(,0,1
168815,17,0,0
168816,AF,0,1
168817,",",0,0
168818,3,0,1
168819,AFI,0,1
168820,),0,0
168821,showed,0,0
168822,lower,0,0
168823,ventricular,0,0
168824,rates,0,0
168825,after,0,0
168826,1,0,0
168827,hour,0,0
168828,;,0,1
168829,however,0,0
168830,",",0,0
168831,only,0,0
168832,1,0,1
168833,(,0,0
168834,6,0,0
168835,%,0,0
168836,),0,0
168837,with,0,0
168838,AF,0,0
168839,converted,0,0
168840,to,0,0
168841,sinus,0,0
168842,rhythm,0,0
168843,and,0,0
168844,1,0,1
168845,(,0,0
168846,6,0,0
168847,%,0,0
168848,),0,0
168849,converted,0,0
168850,to,0,0
168851,AFI,0,0
168852,.,0,0
168853,Patients,0,0
168854,who,0,0
168855,did,0,0
168856,not,0,0
168857,convert,0,0
168858,to,0,0
168859,sinus,0,0
168860,rhythm,0,0
168861,after,0,0
168862,treatment,0,0
168863,with,0,0
168864,verapamil,1,1
168865,were,0,0
168866,treated,0,0
168867,with,0,0
168868,flecainide,1,1
168869,and,0,0
168870,observed,0,0
168871,for,0,0
168872,another,0,0
168873,hour,0,0
168874,.,0,0
168875,After,0,0
168876,the,0,0
168877,change,0,0
168878,to,0,0
168879,flecainide,0,1
168880,",",0,0
168881,9,0,0
168882,of,0,0
168883,15,0,0
168884,patients,0,0
168885,(,0,0
168886,60,0,0
168887,%,0,0
168888,),0,0
168889,with,0,0
168890,AF,0,0
168891,still,0,0
168892,converted,0,0
168893,.,0,0
168894,Thus,0,0
168895,",",0,0
168896,23,0,0
168897,of,0,0
168898,32,0,0
168899,patients,0,0
168900,(,0,0
168901,72,0,0
168902,%,0,0
168903,),0,0
168904,with,0,0
168905,AF,0,0
168906,and,0,0
168907,none,0,0
168908,of,0,0
168909,7,0,0
168910,with,0,0
168911,AFI,0,0
168912,converted,0,0
168913,to,0,0
168914,sinus,0,0
168915,rhythm,0,0
168916,after,0,0
168917,treatment,0,0
168918,with,0,0
168919,flecainide,0,1
168920,.,0,0
168921,Conversion,0,0
168922,to,0,0
168923,sinus,0,0
168924,rhythm,0,0
168925,was,0,0
168926,achieved,0,0
168927,in,0,0
168928,19,0,0
168929,of,0,0
168930,22,0,0
168931,patients,0,0
168932,(,0,0
168933,86,0,0
168934,%,0,0
168935,),0,0
168936,when,0,0
168937,AF,0,0
168938,lasted,0,0
168939,less,0,0
168940,than,0,0
168941,24,0,0
168942,hours,0,0
168943,and,0,0
168944,in,0,0
168945,4,0,0
168946,of,0,0
168947,10,0,0
168948,(,0,0
168949,40,0,0
168950,%,0,0
168951,),0,0
168952,when,0,0
168953,the,0,0
168954,arrhythmia,0,0
168955,lasted,0,0
168956,greater,0,0
168957,than,0,0
168958,24,0,0
168959,hours,0,0
168960,.,0,0
168961,Transient,0,0
168962,adverse,0,0
168963,effects,0,0
168964,were,0,0
168965,noted,0,0
168966,in,0,0
168967,10,0,0
168968,patients,0,0
168969,(,0,0
168970,26,0,0
168971,%,0,0
168972,),0,0
168973,after,0,0
168974,flecainide,0,1
168975,.,0,0
168976,In,0,0
168977,summary,0,0
168978,",",0,0
168979,flecainide,1,1
168980,is,0,0
168981,an,0,0
168982,effective,0,0
168983,and,0,0
168984,safe,0,1
168985,drug,0,1
168986,for,0,0
168987,conversion,0,0
168988,of,0,0
168989,paroxysmal,0,0
168990,AF,0,0
168991,to,0,0
168992,sinus,0,0
168993,rhythm,0,0
168994,",",0,0
168995,but,0,0
168996,ineffective,0,0
168997,for,0,0
168998,AFI,0,1
168999,.,0,0
169000,Verapamil,1,1
169001,appears,0,0
169002,to,0,0
169003,be,0,0
169004,of,0,0
169005,no,0,0
169006,use,0,0
169007,for,0,0
169008,conversion,0,0
169009,of,0,0
169010,AF,0,0
169011,or,0,0
169012,AFI,0,0
169013,to,0,0
169014,sinus,0,0
169015,rhythm,0,0
169016,.,0,0
169017,Caregiver-mediated,0,0
169018,intervention,1,0
169019,for,0,0
169020,low-resourced,0,0
169021,preschoolers,0,0
169022,with,0,0
169023,autism,0,0
169024,:,0,0
169025,an,0,0
169026,RCT,0,0
169027,.,0,0
169028,OBJECTIVES,0,0
169029,To,0,0
169030,compare,0,0
169031,2,0,0
169032,short-term,0,0
169033,",",0,0
169034,community,1,0
169035,caregiver,1,1
169036,training,1,0
169037,interventions,1,0
169038,for,0,0
169039,preschool-aged,0,0
169040,children,0,0
169041,with,0,0
169042,Autism,0,0
169043,Spectrum,0,0
169044,Disorder,0,0
169045,who,0,0
169046,had,0,0
169047,low,0,0
169048,resources,0,0
169049,.,0,0
169050,Low,0,0
169051,resource,0,0
169052,was,0,0
169053,defined,0,0
169054,by,0,0
169055,the,0,0
169056,US,0,0
169057,Department,0,0
169058,of,0,0
169059,Housing,0,0
169060,and,0,0
169061,Urban,0,0
169062,Development,0,0
169063,low-income,0,0
169064,index,0,0
169065,or,0,0
169066,1,0,0
169067,indicator,0,0
169068,",",0,0
169069,(,0,0
169070,e.g.,0,0
169071,",",0,0
169072,Medicaid,0,1
169073,eligibility,0,1
169074,),0,0
169075,.,0,0
169076,Child,0,0
169077,outcomes,0,0
169078,focused,0,0
169079,on,0,0
169080,joint,0,0
169081,engagement,0,0
169082,",",0,0
169083,joint,0,0
169084,attention,0,0
169085,",",0,0
169086,and,0,0
169087,play,0,0
169088,.,0,0
169089,METHODS,0,0
169090,Participants,0,0
169091,included,0,0
169092,112,0,0
169093,families,0,0
169094,of,0,0
169095,a,0,0
169096,child,0,0
169097,who,0,0
169098,had,0,0
169099,Autism,0,0
169100,Spectrum,0,0
169101,Disorder,0,0
169102,who,0,0
169103,met,0,0
169104,criteria,0,0
169105,for,0,0
169106,being,0,0
169107,low-resourced,0,0
169108,and,0,0
169109,who,0,0
169110,were,0,0
169111,randomly,0,0
169112,assigned,0,0
169113,to,0,0
169114,1,0,0
169115,of,0,0
169116,2,1,0
169117,3-month,1,0
169118,interventions,1,1
169119,",",1,0
169120,group,1,0
169121,caregiver,1,0
169122,education,1,1
169123,or,1,0
169124,individualized,1,0
169125,caregiver-mediated,1,1
169126,intervention,1,1
169127,(,1,1
169128,CMM,1,1
169129,),1,1
169130,.,1,0
169131,Children,0,0
169132,were,0,0
169133,assessed,0,0
169134,for,0,0
169135,social,0,0
169136,communication,0,0
169137,skills,0,0
169138,pre-,0,0
169139,and,0,0
169140,post-treatment,0,0
169141,",",0,0
169142,and,0,0
169143,followed,0,0
169144,up,0,0
169145,at,0,0
169146,3,0,0
169147,months,0,0
169148,.,0,0
169149,RESULTS,0,0
169150,All,0,1
169151,children,0,0
169152,improved,0,0
169153,in,0,0
169154,joint,0,0
169155,engagement,0,0
169156,and,0,0
169157,initiating,0,0
169158,joint,0,0
169159,attention,0,0
169160,",",0,0
169161,with,0,0
169162,significantly,0,0
169163,greater,0,0
169164,improvement,0,0
169165,by,0,0
169166,the,0,0
169167,CMM,1,0
169168,group,0,0
169169,.,0,0
169170,Outcomes,0,0
169171,on,0,0
169172,play,0,0
169173,skills,0,0
169174,were,0,0
169175,mixed,0,0
169176,",",0,0
169177,with,0,0
169178,improvement,0,0
169179,of,0,0
169180,symbolic,0,0
169181,play,0,0
169182,for,0,0
169183,the,0,0
169184,CMM,0,0
169185,group,0,0
169186,and,0,0
169187,no,0,0
169188,change,0,0
169189,in,0,0
169190,functional,0,0
169191,play,0,0
169192,skills,0,0
169193,.,0,0
169194,Joint,0,0
169195,engagement,0,0
169196,maintained,0,0
169197,over,0,0
169198,time,0,0
169199,for,0,0
169200,the,0,0
169201,CMM,1,0
169202,group,0,0
169203,",",0,0
169204,and,0,0
169205,initiating,0,0
169206,joint,0,0
169207,attention,0,0
169208,maintained,0,0
169209,for,0,0
169210,both,0,0
169211,groups,0,0
169212,over,0,0
169213,time,0,0
169214,.,0,0
169215,CONCLUSIONS,0,0
169216,This,0,0
169217,study,0,0
169218,is,0,0
169219,among,0,0
169220,the,0,0
169221,first,0,0
169222,randomized,0,0
169223,trials,0,0
169224,comparing,0,0
169225,2,0,0
169226,active,0,0
169227,interventions,0,0
169228,with,0,0
169229,a,0,0
169230,large,0,0
169231,sample,0,0
169232,of,0,0
169233,low-resourced,0,0
169234,families,0,0
169235,.,0,0
169236,Results,0,0
169237,suggest,0,0
169238,improvements,0,0
169239,in,0,0
169240,core,0,0
169241,autism,0,0
169242,deficits,0,0
169243,of,0,0
169244,joint,0,0
169245,engagement,0,0
169246,",",0,0
169247,joint,0,0
169248,attention,0,0
169249,",",0,0
169250,and,0,0
169251,symbolic,0,0
169252,play,0,0
169253,with,0,0
169254,relatively,0,0
169255,brief,0,0
169256,",",0,0
169257,caregiver-mediated,0,0
169258,interventions,0,0
169259,",",0,0
169260,but,0,0
169261,additional,0,0
169262,support,0,0
169263,is,0,0
169264,necessary,0,0
169265,to,0,0
169266,maintain,0,0
169267,and,0,0
169268,generalize,0,0
169269,these,0,0
169270,gains,0,0
169271,over,0,0
169272,time,0,0
169273,.,0,0
169274,The,0,0
169275,effects,0,0
169276,of,0,0
169277,two,0,0
169278,Chinese,1,1
169279,herbal,1,1
169280,medicinal,1,1
169281,formulae,1,1
169282,vs.,0,0
169283,placebo,1,1
169284,controls,0,0
169285,for,0,0
169286,treatment,0,0
169287,of,0,0
169288,allergic,0,0
169289,rhinitis,0,0
169290,:,0,0
169291,a,0,0
169292,randomised,0,0
169293,controlled,0,0
169294,trial,0,0
169295,.,0,0
169296,BACKGROUND,0,0
169297,Allergic,0,0
169298,rhinitis,0,0
169299,is,0,0
169300,a,0,0
169301,chronic,0,0
169302,illness,0,0
169303,",",0,0
169304,affecting,0,0
169305,10,0,0
169306,to,0,0
169307,40,0,0
169308,%,0,0
169309,of,0,0
169310,the,0,0
169311,worldwide,0,0
169312,population,0,0
169313,.,0,0
169314,Chinese,0,0
169315,herbal,0,1
169316,medicines,0,1
169317,",",0,0
169318,the,0,0
169319,treatment,0,0
169320,of,0,0
169321,allergic,0,0
169322,rhinitis,0,0
169323,",",0,0
169324,adopted,0,0
169325,thousands,0,0
169326,of,0,0
169327,years,0,0
169328,in,0,0
169329,ancient,0,0
169330,China,0,0
169331,",",0,0
169332,has,0,0
169333,recently,0,0
169334,raised,0,0
169335,much,0,0
169336,attention,0,0
169337,among,0,0
169338,researchers,0,0
169339,globally,0,0
169340,.,0,0
169341,This,0,0
169342,study,0,0
169343,evaluates,0,0
169344,the,0,0
169345,effects,0,0
169346,of,0,0
169347,two,0,0
169348,Chinese,1,1
169349,herbal,1,1
169350,formulae,1,1
169351,[,1,1
169352,Cure-allergic-rhinitis,1,1
169353,Syrup,1,1
169354,(,1,1
169355,CS,1,1
169356,),1,1
169357,and,1,0
169358,Yu-ping-feng,1,1
169359,San,1,1
169360,(,1,1
169361,YS,1,1
169362,),1,1
169363,],1,0
169364,in,0,0
169365,treating,0,0
169366,undergraduate,0,0
169367,nursing,0,0
169368,students,0,0
169369,with,0,0
169370,allergic,0,0
169371,rhinitis,0,0
169372,over,0,0
169373,a,0,0
169374,3-month,0,0
169375,follow-up,0,0
169376,",",0,0
169377,when,0,0
169378,compared,0,0
169379,to,0,0
169380,a,0,0
169381,placebo,0,1
169382,control,0,0
169383,group,0,0
169384,.,0,0
169385,METHODS,0,1
169386,A,0,1
169387,double-blind,0,1
169388,",",0,1
169389,randomised,0,0
169390,controlled,0,0
169391,trial,0,0
169392,with,0,0
169393,repeated-measures,0,0
169394,",",0,0
169395,three-parallel-groups,0,1
169396,design,0,1
169397,was,0,0
169398,conducted,0,0
169399,in,0,0
169400,a,0,0
169401,random,0,0
169402,sample,0,0
169403,of,0,0
169404,249,0,0
169405,participants,0,0
169406,recruited,0,0
169407,from,0,0
169408,one,0,0
169409,university,0,0
169410,in,0,0
169411,Hong,0,0
169412,Kong,0,0
169413,.,0,0
169414,After,0,0
169415,baseline,0,0
169416,measurements,0,0
169417,",",0,0
169418,participants,0,0
169419,were,0,0
169420,randomly,0,0
169421,assigned,0,0
169422,to,0,0
169423,CS,1,0
169424,",",1,0
169425,YS,1,0
169426,",",1,0
169427,or,1,0
169428,placebo,1,1
169429,groups,0,1
169430,(,0,0
169431,n=83,0,0
169432,per,0,0
169433,group,0,0
169434,),0,0
169435,.,0,0
169436,The,0,0
169437,main,0,0
169438,outcomes,0,0
169439,",",0,0
169440,including,0,0
169441,symptom,0,0
169442,severity,0,0
169443,",",0,0
169444,quality,0,0
169445,of,0,0
169446,life,0,0
169447,",",0,0
169448,and,0,0
169449,body,0,0
169450,constitution,0,0
169451,",",0,0
169452,were,0,0
169453,measured,0,0
169454,with,0,0
169455,self-administered,0,0
169456,questionnaires,0,0
169457,at,0,0
169458,baseline,0,0
169459,and,0,0
169460,immediately,0,0
169461,",",0,0
169462,1,0,0
169463,and,0,0
169464,3,0,0
169465,months,0,0
169466,after,0,0
169467,the,0,0
169468,4-week,0,1
169469,interventions,0,1
169470,.,0,0
169471,RESULTS,0,0
169472,240,0,0
169473,participants,0,0
169474,completed,0,0
169475,the,0,0
169476,trial,0,0
169477,",",0,0
169478,with,0,0
169479,9,0,0
169480,(,0,0
169481,3.6,0,0
169482,%,0,0
169483,),0,0
169484,drop-outs,0,0
169485,.,0,0
169486,The,0,0
169487,results,0,0
169488,of,0,0
169489,Generalised,0,0
169490,Estimating,0,0
169491,Equations,0,0
169492,test,0,0
169493,followed,0,0
169494,by,0,0
169495,pairwise,0,0
169496,contrasts,0,0
169497,tests,0,0
169498,indicated,0,0
169499,that,0,0
169500,the,0,0
169501,participants,0,0
169502,who,0,0
169503,received,0,0
169504,CS,1,0
169505,showed,0,0
169506,significantly,0,0
169507,greater,0,0
169508,reduction,0,0
169509,of,0,0
169510,symptoms,0,0
169511,(,0,0
169512,mean,0,0
169513,difference,0,0
169514,of,0,0
169515,CS,0,0
169516,vs.,0,0
169517,placebo=26.13-34.55,0,0
169518,",",0,0
169519,P,0,0
169520,<,0,0
169521,0.0005,0,0
169522,),0,0
169523,and,0,0
169524,improvements,0,0
169525,in,0,0
169526,quality,0,0
169527,of,0,0
169528,life,0,0
169529,(,0,0
169530,mean,0,0
169531,difference,0,0
169532,of,0,0
169533,CS,0,0
169534,vs.,0,0
169535,placebo=12.81-16.76,0,0
169536,",",0,0
169537,P,0,0
169538,<,0,0
169539,0.001,0,0
169540,),0,0
169541,",",0,0
169542,and,0,0
169543,body,0,0
169544,constitution,0,0
169545,in,0,0
169546,'Qi-deficiency,0,0
169547,',0,0
169548,",",0,0
169549,'Yang-deficiency,0,0
169550,',0,0
169551,",",0,0
169552,and,0,0
169553,'Inherited,0,0
169554,Special,0,0
169555,',0,0
169556,(,0,0
169557,mean,0,0
169558,difference,0,0
169559,of,0,0
169560,CS,0,0
169561,vs.,0,0
169562,placebo=7.05-8.12,0,0
169563,",",0,0
169564,7.56-8.92,0,0
169565,",",0,0
169566,and,0,0
169567,4.48-8.10,0,0
169568,",",0,0
169569,P=0.01-,0,0
169570,<,0,0
169571,0.0005,0,0
169572,",",0,0
169573,0.001-0.004,0,0
169574,",",0,0
169575,and,0,0
169576,0.01-,0,0
169577,<,0,0
169578,0.0005,0,0
169579,",",0,0
169580,accordingly,0,0
169581,",",0,0
169582,at,0,0
169583,three,0,0
169584,post-tests,0,0
169585,),0,0
169586,.,0,0
169587,The,0,0
169588,participants,0,0
169589,who,0,0
169590,received,0,0
169591,YS,0,0
169592,also,0,0
169593,indicated,0,0
169594,significant,0,0
169595,greater,0,0
169596,improvements,0,0
169597,in,0,0
169598,symptom,0,0
169599,severity,0,0
169600,",",0,0
169601,quality,0,0
169602,of,0,0
169603,life,0,0
169604,",",0,0
169605,and,0,0
169606,a,0,0
169607,few,0,0
169608,patterns,0,0
169609,of,0,0
169610,body,0,0
169611,constitution,0,0
169612,when,0,0
169613,compared,0,0
169614,to,0,0
169615,the,0,0
169616,placebo,0,1
169617,group,0,0
169618,.,0,0
169619,However,0,0
169620,",",0,0
169621,its,0,0
169622,effects,0,0
169623,were,0,0
169624,lesser,0,0
169625,in,0,0
169626,strength,0,1
169627,(,0,0
169628,i.e.,0,0
169629,",",0,0
169630,smaller,0,0
169631,effect,0,0
169632,sizes,0,0
169633,),0,0
169634,",",0,0
169635,varieties,0,0
169636,of,0,0
169637,symptoms,0,0
169638,",",0,0
169639,and,0,0
169640,body,0,0
169641,constitution,0,0
169642,and,0,0
169643,sustainability,0,0
169644,over,0,0
169645,the,0,0
169646,3,0,0
169647,months,0,0
169648,.,0,0
169649,CONCLUSIONS,0,0
169650,The,0,0
169651,herbal,0,1
169652,formula,0,1
169653,CS,0,1
169654,was,0,0
169655,found,0,0
169656,effective,0,0
169657,to,0,0
169658,reduce,0,0
169659,symptoms,0,0
169660,and,0,0
169661,enhance,0,0
169662,quality,0,0
169663,of,0,0
169664,life,0,0
169665,in,0,0
169666,young,0,1
169667,adults,0,1
169668,(,0,1
169669,nursing,0,1
169670,students,0,1
169671,),0,0
169672,with,0,0
169673,allergic,0,0
169674,rhinitis,0,0
169675,in,0,0
169676,'Yang-,0,0
169677,and/or,0,0
169678,Qi-deficiency,0,0
169679,',0,0
169680,body,0,0
169681,constitution,0,0
169682,.,0,0
169683,Further,0,0
169684,controlled,0,0
169685,trials,0,0
169686,of,0,0
169687,its,0,0
169688,effects,0,0
169689,in,0,0
169690,Chinese,0,0
169691,and/or,0,0
169692,Asians,0,0
169693,with,0,0
169694,allergic,0,0
169695,rhinitis,0,0
169696,in,0,0
169697,terms,0,0
169698,of,0,0
169699,socio-demographic,0,0
169700,",",0,0
169701,ethnic,0,0
169702,and,0,0
169703,illness,0,0
169704,characteristics,0,0
169705,and,0,0
169706,a,0,0
169707,longer-term,0,0
169708,follow-up,0,0
169709,are,0,0
169710,recommended,0,0
169711,.,0,0
169712,TRIAL,0,0
169713,REGISTRATION,0,0
169714,The,0,0
169715,trial,0,0
169716,has,0,0
169717,registered,0,0
169718,at,0,0
169719,ClinicalTrials.gov,0,0
169720,with,0,0
169721,an,0,0
169722,ID,0,0
169723,:,0,0
169724,NCT02027194,0,1
169725,(,0,0
169726,3,0,0
169727,January,0,1
169728,2014,0,1
169729,),0,0
169730,.,0,0
169731,Comparison,0,0
169732,of,0,0
169733,clinical,0,0
169734,effectiveness,0,0
169735,of,0,0
169736,acupuncture,1,0
169737,and,0,0
169738,a,0,0
169739,Western,1,0
169740,drug,1,1
169741,on,0,0
169742,allergic,0,0
169743,rhinitis,0,0
169744,:,0,0
169745,study,0,0
169746,protocol,0,0
169747,for,0,0
169748,a,0,0
169749,randomized,0,0
169750,controlled,0,0
169751,trial,0,0
169752,.,0,0
169753,OBJECTIVE,0,0
169754,To,0,0
169755,compare,0,0
169756,the,0,0
169757,efficacy,0,0
169758,of,0,0
169759,an,0,0
169760,acupuncture,1,0
169761,regimen,1,1
169762,for,0,0
169763,persistent,0,0
169764,allergic,0,0
169765,rhinitis,0,1
169766,(,0,1
169767,PER,0,1
169768,),0,1
169769,",",0,0
169770,aimed,0,0
169771,at,0,0
169772,improving,0,0
169773,a,0,0
169774,patient,0,0
169775,'s,0,0
169776,mind,0,0
169777,or,0,0
169778,Shen,0,0
169779,in,0,0
169780,Traditional,1,0
169781,Chinese,1,0
169782,Medicine,1,0
169783,",",0,0
169784,to,0,0
169785,that,0,0
169786,of,0,0
169787,a,0,0
169788,second-generation,1,1
169789,Hi-receptor,1,1
169790,antagonist,1,1
169791,",",1,1
169792,cetirizine,1,1
169793,hydrochloride,1,1
169794,.,1,1
169795,METHODS,0,1
169796,This,0,0
169797,multicenter,0,0
169798,",",0,0
169799,randomized,0,0
169800,",",0,0
169801,controlled,0,0
169802,clinical,0,0
169803,trial,0,0
169804,on,0,0
169805,PER,0,0
169806,will,0,0
169807,be,0,0
169808,conducted,0,0
169809,at,0,0
169810,three,0,0
169811,institutions,0,0
169812,in,0,0
169813,China,0,0
169814,.,0,0
169815,The,0,0
169816,total,0,0
169817,study,0,0
169818,period,0,0
169819,will,0,0
169820,be,0,0
169821,9,0,0
169822,weeks,0,0
169823,.,0,0
169824,After,0,0
169825,a,0,0
169826,1-week,0,0
169827,preparatory,0,0
169828,screening,0,0
169829,period,0,0
169830,",",0,0
169831,240,0,0
169832,eligible,0,0
169833,participants,0,0
169834,with,0,0
169835,PER,0,0
169836,will,0,0
169837,be,0,0
169838,randomized,0,0
169839,to,0,0
169840,receive,0,0
169841,acupuncture,1,0
169842,or,1,0
169843,pharmacotherapy,1,1
169844,(,0,1
169845,1:1,0,1
169846,),0,1
169847,for,0,0
169848,4,0,0
169849,weeks,0,0
169850,with,0,0
169851,a,0,0
169852,4-week,0,1
169853,follow-up,0,1
169854,.,0,0
169855,The,0,0
169856,primary,0,0
169857,outcome,0,0
169858,will,0,0
169859,be,0,0
169860,changes,0,0
169861,in,0,0
169862,7-day,0,0
169863,average,0,0
169864,total,0,0
169865,nasal,0,0
169866,symptom,0,0
169867,score,0,0
169868,.,0,0
169869,Secondary,0,0
169870,outcome,0,0
169871,measures,0,0
169872,include,0,0
169873,rhinoconjunctivitis,0,0
169874,quality,0,0
169875,of,0,0
169876,life,0,0
169877,questionnaire,0,0
169878,score,0,0
169879,and,0,0
169880,total,0,0
169881,non-nasal,0,0
169882,symptom,0,0
169883,score,0,0
169884,.,0,0
169885,RESULTS,0,0
169886,The,0,0
169887,presence,0,0
169888,and,0,0
169889,seriousness,0,0
169890,of,0,0
169891,psychological,0,0
169892,and,0,0
169893,emotional,0,0
169894,impairments,0,0
169895,should,0,0
169896,be,0,0
169897,considered,0,0
169898,in,0,0
169899,therapeutic,0,0
169900,programs,0,0
169901,for,0,0
169902,allergic,0,0
169903,rhinitis,0,0
169904,.,0,0
169905,No,0,1
169906,clinical,0,1
169907,trial,0,0
169908,for,0,0
169909,treating,0,0
169910,allergic,0,0
169911,rhinitis,0,0
169912,via,0,0
169913,acupuncture,1,0
169914,regulation,0,0
169915,of,0,0
169916,psychological,0,0
169917,and,0,0
169918,emotional,0,0
169919,activities,0,0
169920,has,0,0
169921,been,0,0
169922,reported,0,0
169923,.,0,0
169924,CONCLUSION,0,0
169925,The,0,0
169926,findings,0,0
169927,of,0,0
169928,the,0,0
169929,trial,0,0
169930,will,0,0
169931,allow,0,0
169932,us,0,0
169933,to,0,0
169934,determine,0,0
169935,the,0,0
169936,effects,0,0
169937,of,0,0
169938,the,0,0
169939,mind,1,0
169940,(,1,0
169941,Shen,1,1
169942,),1,0
169943,-regulation,1,0
169944,treatment,1,0
169945,approach,0,0
169946,.,0,0
169947,We,0,0
169948,will,0,0
169949,also,0,0
169950,be,0,0
169951,able,0,0
169952,to,0,0
169953,confirm,0,0
169954,if,0,0
169955,the,0,0
169956,effects,0,0
169957,of,0,0
169958,acupuncture,1,0
169959,are,0,0
169960,equivalent,0,0
169961,to,0,0
169962,those,0,0
169963,of,0,0
169964,the,0,0
169965,conventional,0,0
169966,drug,0,1
169967,cetirizine,1,1
169968,hydrochloride,1,1
169969,.,1,1
169970,Evidence,0,0
169971,for,0,0
169972,diminished,0,0
169973,multisensory,0,0
169974,integration,0,0
169975,in,0,0
169976,autism,0,0
169977,spectrum,0,0
169978,disorders,0,0
169979,.,0,0
169980,Individuals,0,0
169981,with,0,0
169982,autism,0,0
169983,spectrum,0,0
169984,disorders,0,1
169985,(,0,1
169986,ASD,0,1
169987,),0,0
169988,exhibit,0,0
169989,alterations,0,0
169990,in,0,0
169991,sensory,0,0
169992,processing,0,0
169993,",",0,0
169994,including,0,0
169995,changes,0,0
169996,in,0,0
169997,the,0,0
169998,integration,0,0
169999,of,0,0
170000,information,0,0
170001,across,0,0
170002,the,0,0
170003,different,0,0
170004,sensory,0,0
170005,modalities,0,0
170006,.,0,0
170007,In,0,0
170008,the,0,0
170009,current,0,0
170010,study,0,0
170011,",",0,0
170012,we,0,0
170013,used,0,0
170014,the,0,0
170015,sound-induced,1,0
170016,flash,1,0
170017,illusion,1,0
170018,to,0,0
170019,assess,0,0
170020,multisensory,0,0
170021,integration,0,0
170022,in,0,0
170023,children,0,0
170024,with,0,0
170025,ASD,0,0
170026,and,0,0
170027,typically-developing,0,1
170028,(,0,1
170029,TD,0,1
170030,),0,1
170031,controls,0,0
170032,.,0,0
170033,Thirty-one,0,0
170034,children,0,0
170035,with,0,0
170036,ASD,0,0
170037,and,0,0
170038,31,0,0
170039,age,0,0
170040,and,0,0
170041,IQ,0,0
170042,matched,0,0
170043,TD,0,1
170044,children,0,1
170045,(,0,0
170046,average,0,0
170047,age,0,0
170048,=,0,0
170049,12,0,0
170050,years,0,0
170051,),0,0
170052,were,0,0
170053,presented,0,0
170054,with,1,0
170055,simple,1,0
170056,visual,1,0
170057,(,1,0
170058,i.e.,1,0
170059,",",1,1
170060,flash,1,1
170061,),1,1
170062,and,1,0
170063,auditory,1,1
170064,(,1,0
170065,i.e.,1,0
170066,",",1,0
170067,beep,1,1
170068,),1,0
170069,stimuli,1,0
170070,of,1,0
170071,varying,1,0
170072,number,1,0
170073,.,1,0
170074,In,1,0
170075,illusory,0,0
170076,conditions,0,0
170077,",",0,0
170078,a,0,0
170079,single,0,0
170080,flash,0,0
170081,was,0,0
170082,presented,0,0
170083,with,0,0
170084,2-4,0,0
170085,beeps,0,0
170086,.,0,0
170087,In,0,0
170088,TD,0,0
170089,children,0,0
170090,",",0,0
170091,these,0,0
170092,conditions,0,0
170093,generally,0,0
170094,result,0,0
170095,in,0,0
170096,the,0,0
170097,perception,0,0
170098,of,0,0
170099,multiple,0,0
170100,flashes,0,0
170101,",",0,0
170102,implying,0,0
170103,a,0,0
170104,perceptual,0,0
170105,fusion,0,0
170106,across,0,0
170107,vision,0,0
170108,and,0,0
170109,audition,0,0
170110,.,0,0
170111,In,0,0
170112,the,0,0
170113,present,0,0
170114,study,0,0
170115,",",0,0
170116,children,0,0
170117,with,0,0
170118,ASD,0,0
170119,were,0,0
170120,significantly,0,0
170121,less,0,0
170122,likely,0,0
170123,to,0,0
170124,perceive,0,0
170125,the,0,0
170126,illusion,0,0
170127,relative,0,0
170128,to,0,0
170129,TD,0,0
170130,controls,0,0
170131,",",0,0
170132,suggesting,0,0
170133,that,0,0
170134,multisensory,0,0
170135,integration,0,0
170136,and,0,0
170137,cross-modal,0,0
170138,binding,0,0
170139,may,0,0
170140,be,0,0
170141,weaker,0,0
170142,in,0,0
170143,some,0,0
170144,children,0,0
170145,with,0,0
170146,ASD,0,0
170147,.,0,0
170148,These,0,0
170149,results,0,0
170150,are,0,0
170151,discussed,0,0
170152,in,0,0
170153,the,0,0
170154,context,0,0
170155,of,0,0
170156,previous,0,0
170157,findings,0,0
170158,for,0,0
170159,multisensory,0,0
170160,integration,0,0
170161,in,0,0
170162,ASD,0,0
170163,and,0,0
170164,future,0,0
170165,directions,0,0
170166,for,0,0
170167,research,0,0
170168,.,0,0
170169,[,0,0
170170,Case-controll,0,0
170171,study,0,0
170172,on,0,0
170173,the,0,0
170174,synergistic,0,0
170175,effects,0,0
170176,of,0,0
170177,electroacupuncture,1,1
170178,on,0,0
170179,knee,0,0
170180,osteoarthritis,0,0
170181,after,0,0
170182,arthroscopic,1,0
170183,debridement,1,0
170184,],1,0
170185,.,0,0
170186,OBJECTIVE,0,0
170187,To,0,0
170188,study,0,0
170189,the,0,0
170190,synergistic,0,0
170191,effects,0,0
170192,of,0,0
170193,electroacupuncture,1,1
170194,on,0,0
170195,the,0,0
170196,treatment,0,0
170197,of,0,0
170198,knee,0,0
170199,osteoarthritis,0,0
170200,after,0,0
170201,arthroscopic,1,0
170202,debridement,1,0
170203,.,1,0
170204,METHODS,0,0
170205,From,0,1
170206,May,0,1
170207,2008,0,0
170208,to,0,0
170209,July,0,0
170210,2010,0,0
170211,",",0,0
170212,78,0,0
170213,patients,0,0
170214,with,0,0
170215,knee,0,0
170216,osteoarthritis,0,0
170217,were,0,0
170218,randomly,0,0
170219,divided,0,0
170220,into,0,0
170221,two,0,0
170222,groups,0,0
170223,.,0,0
170224,There,0,0
170225,were,0,0
170226,42,0,0
170227,patients,0,0
170228,in,0,0
170229,the,0,0
170230,experimental,0,0
170231,group,0,0
170232,",",0,0
170233,including,0,0
170234,16,0,0
170235,males,0,0
170236,and,0,0
170237,26,0,0
170238,females,0,0
170239,",",0,0
170240,ranging,0,0
170241,in,0,0
170242,age,0,0
170243,from,0,0
170244,41,0,0
170245,to,0,0
170246,63,0,0
170247,years,0,0
170248,",",0,0
170249,with,0,0
170250,an,0,0
170251,average,0,0
170252,of,0,0
170253,(,0,0
170254,53.62,0,0
170255,+/-,0,0
170256,6.53,0,0
170257,),0,0
170258,years,0,0
170259,;,0,0
170260,the,0,0
170261,disease,0,1
170262,course,0,0
170263,ranged,0,0
170264,from,0,0
170265,8,0,0
170266,to,0,0
170267,24,0,0
170268,months,0,0
170269,",",0,0
170270,with,0,0
170271,an,0,0
170272,average,0,0
170273,of,0,0
170274,(,0,0
170275,10.35,0,0
170276,+/-,0,0
170277,6.42,0,0
170278,),0,0
170279,months,0,0
170280,.,0,0
170281,The,0,0
170282,patients,0,0
170283,were,0,0
170284,treated,0,0
170285,with,0,0
170286,arthroscopic,1,0
170287,debridement,1,0
170288,combined,1,0
170289,with,1,0
170290,electroacupuncture,1,1
170291,after,1,0
170292,operation,1,0
170293,.,1,0
170294,There,0,0
170295,were,0,0
170296,36,0,0
170297,patients,0,0
170298,in,0,0
170299,the,0,0
170300,control,0,0
170301,group,0,0
170302,",",0,0
170303,including,0,0
170304,14,0,0
170305,males,0,0
170306,and,0,0
170307,22,0,0
170308,females,0,0
170309,",",0,0
170310,ranging,0,0
170311,in,0,0
170312,age,0,0
170313,from,0,0
170314,40,0,0
170315,to,0,0
170316,62,0,0
170317,years,0,0
170318,",",0,0
170319,with,0,0
170320,an,0,0
170321,average,0,0
170322,of,0,0
170323,(,0,0
170324,54.34,0,0
170325,+/-,0,0
170326,7.67,0,0
170327,),0,0
170328,years,0,0
170329,;,0,0
170330,the,0,0
170331,disease,0,1
170332,course,0,0
170333,ranged,0,0
170334,from,0,0
170335,6,0,0
170336,to,0,0
170337,25,0,0
170338,months,0,0
170339,",",0,0
170340,with,0,0
170341,an,0,0
170342,average,0,0
170343,of,0,0
170344,(,0,0
170345,11.94,0,0
170346,+/-,0,0
170347,5.13,0,0
170348,),0,0
170349,months,0,0
170350,.,0,0
170351,Those,0,0
170352,patients,0,0
170353,were,0,0
170354,treated,0,0
170355,only,0,0
170356,with,0,0
170357,arthroscopic,1,0
170358,debridment,1,0
170359,.,1,0
170360,All,0,0
170361,the,0,0
170362,patients,0,0
170363,performed,0,0
170364,isometric,1,0
170365,quadriceps,1,0
170366,femoris,1,0
170367,contraction,1,0
170368,exercise,1,0
170369,and,1,0
170370,knee,1,0
170371,flexion,1,0
170372,and,1,0
170373,extension,1,0
170374,activities,1,0
170375,after,1,0
170376,operation,1,0
170377,.,1,0
170378,The,0,0
170379,visual,0,0
170380,analog,0,1
170381,scale,0,1
170382,(,0,1
170383,VAS,0,1
170384,),0,1
170385,score,0,0
170386,and,0,0
170387,Lysholm,0,0
170388,knee,0,0
170389,score,0,0
170390,were,0,0
170391,used,0,0
170392,to,0,0
170393,evaluate,0,0
170394,the,0,0
170395,therapeutic,0,0
170396,effects,0,0
170397,.,0,0
170398,RESULTS,0,0
170399,All,0,0
170400,the,0,0
170401,patients,0,0
170402,were,0,0
170403,followed,0,0
170404,up,0,0
170405,",",0,0
170406,and,0,0
170407,the,0,0
170408,duration,0,0
170409,ranged,0,0
170410,from,0,0
170411,12,0,0
170412,to,0,0
170413,30,0,0
170414,months,0,0
170415,",",0,0
170416,with,0,0
170417,an,0,0
170418,average,0,0
170419,of,0,0
170420,15.6,0,0
170421,months,0,0
170422,.,0,0
170423,At,0,0
170424,the,0,0
170425,final,0,0
170426,follow-up,0,0
170427,",",0,0
170428,VAS,0,0
170429,score,0,0
170430,was,0,0
170431,significantly,0,0
170432,decreased,0,0
170433,",",0,0
170434,and,0,0
170435,the,0,0
170436,Lysholm,0,0
170437,score,0,0
170438,",",0,0
170439,except,0,0
170440,for,0,0
170441,the,0,0
170442,item,0,0
170443,demanding,0,0
170444,for,0,0
170445,support,0,0
170446,",",0,0
170447,significantly,0,0
170448,increased,0,0
170449,",",0,0
170450,compared,0,0
170451,with,0,0
170452,those,0,0
170453,before,0,0
170454,surgery,0,0
170455,respectively,0,0
170456,in,0,0
170457,both,0,0
170458,groups,0,0
170459,.,0,0
170460,There,0,0
170461,was,0,0
170462,significant,0,0
170463,difference,0,0
170464,in,0,0
170465,VAS,0,0
170466,score,0,0
170467,between,0,0
170468,two,0,0
170469,groups,0,0
170470,after,0,0
170471,treatment,0,0
170472,.,0,0
170473,As,0,0
170474,to,0,0
170475,Lysholm,0,0
170476,score,0,0
170477,",",0,0
170478,there,0,0
170479,were,0,0
170480,significant,0,0
170481,differences,0,0
170482,in,0,0
170483,limp,0,0
170484,",",0,0
170485,pain,0,0
170486,",",0,0
170487,swelling,0,0
170488,",",0,0
170489,stair,0,0
170490,activity,0,0
170491,and,0,0
170492,squat,0,0
170493,",",0,0
170494,but,0,0
170495,there,0,0
170496,were,0,0
170497,no,0,0
170498,significant,0,0
170499,differences,0,0
170500,in,0,0
170501,items,0,0
170502,of,0,0
170503,interlocking,0,0
170504,and,0,0
170505,instability,0,0
170506,between,0,0
170507,two,0,0
170508,groups,0,0
170509,after,0,0
170510,treatment,0,0
170511,.,0,0
170512,CONCLUSION,0,1
170513,Electroacupuncture,0,1
170514,can,0,0
170515,effectively,0,0
170516,improve,0,0
170517,the,0,0
170518,clinical,0,0
170519,symptoms,0,0
170520,and,0,0
170521,knee,0,0
170522,joint,0,1
170523,'s,0,0
170524,motor,0,0
170525,function,0,0
170526,of,0,0
170527,knee,0,0
170528,joints,0,0
170529,in,0,0
170530,patients,0,0
170531,with,0,0
170532,knee,0,0
170533,osteoarthritis,0,0
170534,",",0,0
170535,as,0,0
170536,well,0,0
170537,as,0,0
170538,the,0,0
170539,synergistic,0,0
170540,effects,0,0
170541,on,0,0
170542,the,0,0
170543,treatment,0,0
170544,of,0,0
170545,knee,0,0
170546,osteoarthritis,0,0
170547,after,0,0
170548,arthroscopic,0,0
170549,debridement,0,0
170550,",",0,0
170551,leading,0,0
170552,to,0,0
170553,a,0,0
170554,much,0,0
170555,better,0,0
170556,long-term,0,0
170557,therapeutic,0,0
170558,effect,0,0
170559,with,0,0
170560,respect,0,0
170561,of,0,0
170562,improving,0,0
170563,the,0,0
170564,function,0,0
170565,of,0,0
170566,knee,0,0
170567,joint,0,0
170568,.,0,0
170569,This,0,0
170570,therapy,0,0
170571,",",0,0
170572,combined,0,0
170573,with,0,0
170574,traditional,0,0
170575,Chinese,0,0
170576,medicine,0,0
170577,and,0,0
170578,Western,0,0
170579,Medicine,0,0
170580,",",0,0
170581,is,0,0
170582,worth,0,0
170583,of,0,0
170584,clinical,0,0
170585,application,0,0
170586,in,0,0
170587,the,0,0
170588,treatment,0,0
170589,of,0,0
170590,knee,0,0
170591,osteoarthritis,0,0
170592,.,0,0
170593,The,0,0
170594,addition,0,0
170595,of,0,0
170596,tramadol,1,1
170597,to,0,0
170598,the,0,0
170599,standard,0,0
170600,of,0,0
170601,i.v,0,1
170602,.,0,1
170603,acetaminophen,1,1
170604,and,1,1
170605,morphine,1,1
170606,infusion,0,1
170607,for,0,1
170608,postoperative,0,1
170609,analgesia,0,1
170610,in,0,0
170611,neonates,0,0
170612,offers,0,0
170613,no,0,0
170614,clinical,0,0
170615,benefit,0,0
170616,:,0,0
170617,a,0,0
170618,randomized,0,1
170619,placebo-controlled,1,1
170620,trial,0,1
170621,.,0,1
170622,BACKGROUND,0,1
170623,Tramadol,1,1
170624,is,0,0
170625,used,0,0
170626,following,0,0
170627,neonatal,0,0
170628,cardiac,0,0
170629,and,0,0
170630,general,0,0
170631,surgery,0,0
170632,.,0,0
170633,However,0,0
170634,",",0,0
170635,its,0,0
170636,ability,0,0
170637,to,0,0
170638,opioid-spare,0,1
170639,or,0,0
170640,facilitate,0,0
170641,earlier,0,0
170642,extubation,0,0
170643,in,0,0
170644,postoperative,0,0
170645,neonates,0,0
170646,is,0,0
170647,unquantified,0,0
170648,.,0,0
170649,OBJECTIVE,0,0
170650,This,0,1
170651,randomized,0,1
170652,placebo-controlled,0,1
170653,trial,0,1
170654,aimed,0,0
170655,to,0,0
170656,assess,0,0
170657,whether,0,0
170658,tramadol,1,1
170659,'s,1,1
170660,addition,0,0
170661,to,0,0
170662,standard,1,0
170663,analgesia,1,1
170664,resulted,0,0
170665,in,0,0
170666,earlier,0,0
170667,extubation,0,0
170668,or,0,0
170669,reduced,0,0
170670,analgesic/sedative,0,1
170671,requirements,0,0
170672,in,0,0
170673,postsurgical,0,0
170674,neonates,0,0
170675,.,0,0
170676,METHODS,0,0
170677,Neonates,0,0
170678,born,0,0
170679,?32,0,0
170680,weeks,0,0
170681,postmenstrual,0,0
170682,age,0,0
170683,received,0,0
170684,either,1,0
170685,tramadol,1,1
170686,[,1,1
170687,T,0,1
170688,],0,1
170689,2,0,1
170690,mg?kg,0,1
170691,(,0,1
170692,-1,0,1
170693,),0,1
170694,or,0,1
170695,placebo,1,1
170696,[,1,0
170697,P,1,1
170698,],0,0
170699,6-hourly,0,0
170700,for,0,0
170701,up,0,0
170702,to,0,0
170703,5,0,0
170704,days,0,0
170705,postthoracoabdominal,0,1
170706,surgery,0,0
170707,in,0,0
170708,addition,0,0
170709,to,0,0
170710,morphine,1,1
170711,(,1,1
170712,commenced,1,0
170713,at,0,0
170714,20,0,0
170715,mcg?kg,0,1
170716,(,0,1
170717,-1,0,1
170718,),0,1
170719,?h,0,1
170720,(,0,1
170721,-1,0,1
170722,),0,1
170723,),0,1
170724,and,0,1
170725,6-hourly,0,1
170726,i.v,0,1
170727,.,0,1
170728,acetaminophen,0,1
170729,.,0,0
170730,Time,0,0
170731,to,0,0
170732,extubation,0,0
170733,",",0,0
170734,morphine,0,1
170735,and,0,1
170736,midazolam,0,1
170737,amounts,0,1
170738,",",0,0
170739,hourly,0,0
170740,pain,0,1
170741,scores,0,1
170742,",",0,0
170743,and,0,0
170744,seizure,0,0
170745,activity,0,0
170746,were,0,0
170747,compared,0,0
170748,using,0,0
170749,an,0,0
170750,intention-to-treat,0,0
170751,and,0,0
170752,per-protocol,0,0
170753,analysis,0,0
170754,.,0,0
170755,RESULTS,0,0
170756,Seventy-one,0,0
170757,neonates,0,0
170758,participated,0,0
170759,.,0,0
170760,Median,0,0
170761,survival,0,0
170762,time,0,0
170763,to,0,0
170764,extubation,0,0
170765,was,0,0
170766,similar,0,0
170767,between,0,0
170768,the,0,0
170769,groups,0,0
170770,(,0,0
170771,T,0,0
170772,67,0,0
170773,h,0,0
170774,[,0,0
170775,95,0,0
170776,%,0,0
170777,CI,0,0
170778,51,0,0
170779,",",0,0
170780,84,0,0
170781,],0,0
170782,vs,0,0
170783,P,0,0
170784,52,0,0
170785,h,0,0
170786,[,0,0
170787,95,0,0
170788,%,0,0
170789,CI,0,0
170790,43,0,0
170791,",",0,0
170792,65,0,0
170793,],0,0
170794,;,0,0
170795,P,0,0
170796,=,0,0
170797,0.4,0,0
170798,),0,0
170799,",",0,0
170800,and,0,0
170801,similar,0,0
170802,numbers,0,0
170803,were,0,0
170804,extubated,0,0
170805,by,0,0
170806,96,0,0
170807,h,0,0
170808,(,0,0
170809,T,0,0
170810,69,0,0
170811,%,0,0
170812,vs,0,0
170813,P,0,0
170814,77,0,0
170815,%,0,0
170816,;,0,0
170817,difference,0,0
170818,-8,0,0
170819,%,0,0
170820,",",0,0
170821,95,0,0
170822,%,0,0
170823,CI,0,0
170824,-28,0,0
170825,",",0,0
170826,13,0,0
170827,%,0,0
170828,),0,0
170829,.,0,0
170830,Morphine,0,1
170831,and,0,1
170832,midazolam,0,1
170833,exposure,0,0
170834,was,0,0
170835,similar,0,0
170836,",",0,0
170837,with,0,0
170838,low,0,0
170839,pain,0,0
170840,scores,0,0
170841,in,0,0
170842,both,0,0
170843,groups,0,0
170844,(,0,0
170845,mean,0,0
170846,percentage,0,0
170847,of,0,0
170848,time,0,0
170849,with,0,0
170850,a,0,0
170851,pain,0,0
170852,score,0,0
170853,>,0,0
170854,5/20,0,0
170855,during,0,0
170856,the,0,0
170857,5,0,0
170858,days,0,0
170859,:,0,0
170860,T,0,0
170861,13,0,0
170862,%,0,0
170863,vs,0,0
170864,P,0,0
170865,11,0,0
170866,%,0,0
170867,",",0,0
170868,difference,0,0
170869,in,0,0
170870,means,0,0
170871,2.8,0,0
170872,[,0,0
170873,95,0,0
170874,%,0,0
170875,CI,0,0
170876,-1.8,0,0
170877,",",0,0
170878,7.6,0,0
170879,],0,0
170880,",",0,0
170881,P,0,0
170882,=,0,0
170883,0.20,0,0
170884,),0,0
170885,.,0,0
170886,Most,0,0
170887,participants,0,0
170888,had,0,0
170889,normal,0,0
170890,cranial,0,0
170891,ultrasounds,0,1
170892,(,0,0
170893,T,0,0
170894,86,0,0
170895,%,0,0
170896,vs,0,0
170897,P,0,0
170898,86,0,0
170899,%,0,0
170900,),0,0
170901,;,0,0
170902,no,0,0
170903,seizures,0,0
170904,occurred,0,0
170905,clinically,0,0
170906,or,0,0
170907,electroencephalographically,0,0
170908,.,0,0
170909,CONCLUSION,0,1
170910,Tramadol,0,1
170911,'s,0,1
170912,addition,0,0
170913,to,0,0
170914,standard,0,0
170915,analgesia,0,1
170916,in,0,0
170917,this,0,0
170918,small,0,0
170919,group,0,0
170920,of,0,0
170921,postsurgical,0,0
170922,neonates,0,0
170923,did,0,0
170924,not,0,0
170925,appear,0,0
170926,to,0,0
170927,have,0,0
170928,any,0,0
170929,positive,0,0
170930,effect,0,0
170931,on,0,0
170932,time,0,0
170933,to,0,0
170934,extubation,0,0
170935,",",0,0
170936,morphine,0,1
170937,or,0,1
170938,midazolam,0,1
170939,exposure,0,0
170940,",",0,0
170941,or,0,0
170942,pain,0,0
170943,scores,0,0
170944,.,0,0
170945,This,0,0
170946,questions,0,0
170947,the,0,0
170948,benefit,0,0
170949,of,0,0
170950,tramadol,0,1
170951,for,0,0
170952,postsurgical,0,1
170953,neonates,0,0
170954,.,0,0
170955,Importantly,0,0
170956,",",0,0
170957,no,0,0
170958,seizures,0,0
170959,occurred,0,0
170960,in,0,0
170961,these,0,0
170962,ill,0,0
170963,neonates,0,0
170964,who,0,0
170965,may,0,0
170966,potentially,0,0
170967,be,0,0
170968,at,0,0
170969,greater,0,0
170970,risk,0,0
170971,of,0,0
170972,tramadol,0,1
170973,toxicity,0,0
170974,compared,0,0
170975,with,0,0
170976,adults,0,0
170977,.,0,0
170978,Effects,0,0
170979,of,0,0
170980,a,0,0
170981,music,1,0
170982,therapy,1,1
170983,group,1,0
170984,intervention,1,0
170985,on,0,0
170986,enhancing,0,0
170987,social,0,0
170988,skills,0,0
170989,in,0,0
170990,children,0,0
170991,with,0,0
170992,autism,0,0
170993,.,0,0
170994,BACKGROUND,0,0
170995,Research,0,0
170996,indicates,0,0
170997,that,0,0
170998,music,1,0
170999,therapy,1,0
171000,can,0,0
171001,improve,0,0
171002,social,0,0
171003,behaviors,0,1
171004,and,0,0
171005,joint,0,0
171006,attention,0,0
171007,in,0,0
171008,children,0,0
171009,with,0,0
171010,Autism,0,0
171011,Spectrum,0,0
171012,Disorder,0,0
171013,(,0,0
171014,ASD,0,1
171015,),0,1
171016,;,0,0
171017,however,0,0
171018,",",0,0
171019,more,0,0
171020,research,0,0
171021,on,0,0
171022,the,0,0
171023,use,0,0
171024,of,0,0
171025,music,0,0
171026,therapy,0,0
171027,interventions,0,0
171028,for,0,0
171029,social,0,0
171030,skills,0,0
171031,is,0,0
171032,needed,0,0
171033,to,0,0
171034,determine,0,0
171035,the,0,0
171036,impact,0,0
171037,of,0,0
171038,group,0,0
171039,music,0,0
171040,therapy,0,0
171041,.,0,0
171042,OBJECTIVE,0,0
171043,To,0,0
171044,examine,0,0
171045,the,0,0
171046,effects,0,0
171047,of,0,0
171048,a,0,0
171049,music,1,0
171050,therapy,1,1
171051,group,0,0
171052,intervention,0,0
171053,on,0,0
171054,eye,0,0
171055,gaze,0,0
171056,",",0,0
171057,joint,0,0
171058,attention,0,0
171059,",",0,0
171060,and,0,0
171061,communication,0,0
171062,in,0,0
171063,children,0,0
171064,with,0,0
171065,ASD,0,0
171066,.,0,0
171067,METHOD,0,0
171068,Seventeen,0,0
171069,children,0,0
171070,",",0,0
171071,ages,0,0
171072,6,0,0
171073,to,0,0
171074,9,0,0
171075,",",0,0
171076,with,0,0
171077,a,0,0
171078,diagnosis,0,0
171079,of,0,0
171080,ASD,0,0
171081,were,0,0
171082,randomly,0,0
171083,assigned,0,0
171084,to,0,0
171085,the,0,0
171086,music,1,0
171087,therapy,1,1
171088,group,1,1
171089,(,1,1
171090,MTG,1,1
171091,),1,1
171092,or,0,0
171093,the,0,0
171094,no-music,1,0
171095,social,1,0
171096,skills,1,1
171097,group,1,1
171098,(,1,1
171099,SSG,1,1
171100,),1,1
171101,.,1,0
171102,Children,0,0
171103,participated,0,0
171104,in,0,0
171105,ten,0,0
171106,50-minute,0,0
171107,group,0,0
171108,sessions,0,0
171109,over,0,0
171110,a,0,0
171111,period,0,0
171112,of,0,0
171113,5,0,0
171114,weeks,0,0
171115,.,0,0
171116,All,0,0
171117,group,0,0
171118,sessions,0,0
171119,were,0,0
171120,designed,0,0
171121,to,0,0
171122,target,0,0
171123,social,0,0
171124,skills,0,0
171125,.,0,0
171126,The,0,0
171127,Social,0,0
171128,Responsiveness,0,0
171129,Scale,0,1
171130,(,0,1
171131,SRS,0,1
171132,),0,1
171133,",",0,0
171134,the,0,0
171135,Autism,0,0
171136,Treatment,0,0
171137,Evaluation,0,1
171138,Checklist,0,1
171139,(,0,1
171140,ATEC,0,1
171141,),0,1
171142,",",0,0
171143,and,0,0
171144,video,0,0
171145,analysis,0,0
171146,of,0,0
171147,sessions,0,0
171148,were,0,0
171149,used,0,0
171150,to,0,0
171151,evaluate,0,0
171152,changes,0,0
171153,in,0,0
171154,social,0,0
171155,behavior,0,0
171156,.,0,0
171157,RESULTS,0,0
171158,There,0,0
171159,were,0,0
171160,significant,0,0
171161,between-group,0,0
171162,differences,0,0
171163,for,0,0
171164,joint,0,0
171165,attention,0,0
171166,with,0,0
171167,peers,0,0
171168,and,0,0
171169,eye,0,0
171170,gaze,0,0
171171,towards,0,0
171172,persons,0,0
171173,",",0,0
171174,with,0,0
171175,participants,0,0
171176,in,0,0
171177,the,0,0
171178,MTG,0,0
171179,demonstrating,0,0
171180,greater,0,0
171181,gains,0,0
171182,.,0,0
171183,There,0,0
171184,were,0,0
171185,no,0,0
171186,significant,0,0
171187,between-group,0,0
171188,differences,0,0
171189,for,0,0
171190,initiation,0,0
171191,of,0,0
171192,communication,0,0
171193,",",0,0
171194,response,0,0
171195,to,0,0
171196,communication,0,0
171197,",",0,0
171198,or,0,0
171199,social,0,0
171200,withdraw/behaviors,0,0
171201,.,0,0
171202,There,0,0
171203,was,0,0
171204,a,0,0
171205,significant,0,0
171206,interaction,0,0
171207,between,0,0
171208,time,0,0
171209,and,0,0
171210,group,0,0
171211,for,0,0
171212,SRS,0,1
171213,scores,0,0
171214,",",0,0
171215,with,0,0
171216,improvements,0,0
171217,for,0,0
171218,the,0,0
171219,MTG,0,0
171220,but,0,0
171221,not,0,0
171222,the,0,0
171223,SSG,0,0
171224,.,0,0
171225,Scores,0,0
171226,on,0,0
171227,the,0,0
171228,ATEC,0,0
171229,did,0,0
171230,not,0,0
171231,differ,0,0
171232,over,0,0
171233,time,0,0
171234,between,0,0
171235,the,0,0
171236,MTG,1,0
171237,and,0,0
171238,SSG,0,0
171239,.,0,0
171240,CONCLUSIONS,0,0
171241,The,0,0
171242,results,0,0
171243,of,0,0
171244,this,0,0
171245,study,0,0
171246,support,0,0
171247,further,0,0
171248,research,0,0
171249,on,0,0
171250,the,0,0
171251,use,0,0
171252,of,0,0
171253,music,0,0
171254,therapy,0,1
171255,group,0,0
171256,interventions,0,0
171257,for,0,0
171258,social,0,0
171259,skills,0,0
171260,in,0,0
171261,children,0,0
171262,with,0,0
171263,ASD,0,0
171264,.,0,0
171265,Statistical,0,0
171266,results,0,0
171267,demonstrate,0,0
171268,initial,0,0
171269,support,0,0
171270,for,0,0
171271,the,0,0
171272,use,0,0
171273,of,0,0
171274,music,0,0
171275,therapy,0,0
171276,social,0,0
171277,groups,0,0
171278,to,0,0
171279,develop,0,0
171280,joint,0,0
171281,attention,0,0
171282,.,0,0
171283,Contact,0,0
171284,lens,0,0
171285,lipid,0,0
171286,spoliation,0,0
171287,of,0,0
171288,hydrogel,0,1
171289,and,0,1
171290,silicone,0,1
171291,hydrogel,0,1
171292,lenses,0,1
171293,.,0,0
171294,PURPOSE,0,0
171295,The,0,0
171296,purpose,0,0
171297,of,0,0
171298,the,0,0
171299,study,0,0
171300,was,0,0
171301,to,0,0
171302,measure,0,0
171303,contact,1,0
171304,lens,1,0
171305,lipid,1,0
171306,spoliation,1,0
171307,of,1,0
171308,silicone,1,1
171309,hydrogel,1,1
171310,PureVision,1,1
171311,(,1,1
171312,balafilcon,1,1
171313,A,1,1
171314,),1,1
171315,and,1,1
171316,hydrogel,1,1
171317,Acuvue,1,1
171318,2,1,1
171319,(,1,1
171320,etafilcon,1,1
171321,A,1,1
171322,),1,1
171323,contact,1,0
171324,lenses,1,0
171325,worn,0,0
171326,for,0,0
171327,10,0,0
171328,hours,0,0
171329,single,0,0
171330,use,0,0
171331,(,0,0
171332,DD,0,1
171333,),0,1
171334,and,0,0
171335,7,0,0
171336,days,0,0
171337,of,0,0
171338,extended,0,0
171339,wear,0,1
171340,(,0,1
171341,EW,0,1
171342,),0,1
171343,.,0,0
171344,METHODS,0,0
171345,Two,0,1
171346,similar,0,0
171347,study,0,0
171348,populations,0,0
171349,(,0,0
171350,DD,0,1
171351,",",0,0
171352,n,0,0
171353,=,0,0
171354,55,0,0
171355,;,0,0
171356,EW,0,1
171357,",",0,0
171358,n,0,0
171359,=,0,0
171360,53,0,0
171361,),0,0
171362,",",0,0
171363,were,0,0
171364,enrolled,0,0
171365,at,0,0
171366,four,0,0
171367,study,0,0
171368,sites,0,0
171369,.,0,0
171370,In,0,0
171371,each,0,0
171372,population,0,0
171373,",",0,0
171374,a,0,0
171375,bilateral,0,0
171376,",",0,0
171377,randomized,0,1
171378,",",0,1
171379,crossover,0,1
171380,(,0,1
171381,lens,0,0
171382,material,0,0
171383,),0,0
171384,",",0,0
171385,subject-masked,0,0
171386,experimental,0,0
171387,design,0,0
171388,was,0,0
171389,followed,0,0
171390,.,0,0
171391,Worn,0,0
171392,contact,0,0
171393,lenses,0,0
171394,were,0,0
171395,analyzed,0,0
171396,for,0,0
171397,lipid,0,0
171398,uptake,0,0
171399,using,0,0
171400,high-performance,0,1
171401,liquid,1,1
171402,chromatography,1,1
171403,by,0,0
171404,two,0,0
171405,laboratories,0,0
171406,:,0,0
171407,Alcon,0,1
171408,Laboratories,0,0
171409,(,0,0
171410,right,0,0
171411,lens,0,0
171412,total,0,0
171413,uptake,0,0
171414,),0,0
171415,and,0,0
171416,OTG,0,1
171417,Research,0,0
171418,&,0,1
171419,Consultancy,0,1
171420,(,0,0
171421,left,0,0
171422,lens,0,0
171423,total,0,0
171424,uptake,0,0
171425,and,0,0
171426,individual,0,0
171427,lipid,0,0
171428,classes,0,0
171429,),0,0
171430,.,0,0
171431,RESULTS,0,0
171432,Lipid,0,0
171433,uptake,0,0
171434,was,0,0
171435,different,0,0
171436,for,0,0
171437,the,0,0
171438,two,0,0
171439,materials,0,0
171440,:,0,0
171441,total,0,0
171442,lipid,0,0
171443,(,0,0
171444,p,0,0
171445,<,0,0
171446,0.007,0,0
171447,),0,0
171448,",",0,0
171449,cholesterol,0,1
171450,esters,0,1
171451,(,0,0
171452,p,0,0
171453,<,0,0
171454,0.001,0,0
171455,),0,0
171456,",",0,0
171457,cholesterol,0,1
171458,(,0,0
171459,p,0,0
171460,<,0,0
171461,0.001,0,0
171462,EW,0,0
171463,only,0,0
171464,),0,0
171465,",",0,0
171466,and,0,1
171467,triglycerides/phospholipids,0,1
171468,(,0,0
171469,p,0,0
171470,<,0,0
171471,0.001,0,0
171472,),0,0
171473,were,0,0
171474,higher,0,0
171475,for,0,0
171476,balafilcon,0,1
171477,A,0,1
171478,",",0,1
171479,whereas,0,0
171480,fatty,0,1
171481,acid,0,1
171482,(,0,0
171483,p,0,0
171484,<,0,0
171485,0.0025,0,0
171486,EW,0,0
171487,only,0,0
171488,),0,0
171489,was,0,0
171490,higher,0,0
171491,for,0,0
171492,etafilcon,0,1
171493,A,0,1
171494,.,0,0
171495,The,0,0
171496,ratio,0,0
171497,of,0,0
171498,the,0,0
171499,extracted,0,0
171500,lipids,0,0
171501,was,0,0
171502,also,0,0
171503,different,0,0
171504,:,0,0
171505,higher,0,0
171506,percentages,0,0
171507,of,0,0
171508,triglycerides/phospholipids,0,1
171509,(,0,0
171510,p,0,0
171511,<,0,0
171512,0.001,0,0
171513,),0,0
171514,and,0,0
171515,cholesterol,0,1
171516,(,0,0
171517,p,0,0
171518,<,0,0
171519,0.001,0,0
171520,EW,0,0
171521,only,0,0
171522,),0,1
171523,for,0,0
171524,balafilcon,0,1
171525,A,0,1
171526,and,0,0
171527,higher,0,0
171528,percentages,0,0
171529,of,0,0
171530,fatty,0,1
171531,acids/di-,0,1
171532,and,0,1
171533,monoglycerides,0,1
171534,(,0,0
171535,p,0,0
171536,<,0,0
171537,0.014,0,0
171538,),0,0
171539,for,0,0
171540,etafilcon,0,1
171541,A,0,1
171542,.,0,1
171543,CONCLUSIONS,0,0
171544,Total,0,0
171545,lipid,0,0
171546,uptake,0,0
171547,was,0,0
171548,highly,0,0
171549,material,0,0
171550,dependent,0,0
171551,.,0,0
171552,Both,0,0
171553,laboratories,0,0
171554,measured,0,0
171555,a,0,0
171556,greater,0,0
171557,uptake,0,0
171558,of,0,0
171559,lipids,0,0
171560,by,0,0
171561,the,0,0
171562,silicone,0,1
171563,hydrogel,0,1
171564,than,0,1
171565,the,0,0
171566,hydrogel,0,1
171567,material,0,0
171568,",",0,0
171569,a,0,0
171570,difference,0,0
171571,that,0,0
171572,was,0,0
171573,evident,0,0
171574,after,0,0
171575,only,0,0
171576,10,0,0
171577,hours,0,0
171578,of,0,0
171579,DD,0,1
171580,.,0,0
171581,Total,0,0
171582,lipid,0,0
171583,uptake,0,0
171584,was,0,0
171585,greater,0,0
171586,after,0,0
171587,7,0,0
171588,days,0,0
171589,of,0,0
171590,EW,0,1
171591,compared,0,0
171592,with,0,0
171593,10,0,0
171594,hours,0,0
171595,of,0,0
171596,DD,0,1
171597,.,0,0
171598,Of,0,0
171599,interest,0,0
171600,for,0,0
171601,contact,0,0
171602,lens,0,0
171603,spoliation,0,0
171604,and,0,0
171605,its,0,0
171606,avoidance,0,0
171607,was,0,0
171608,the,0,0
171609,differential,0,0
171610,lipid,0,0
171611,uptake,0,0
171612,profile,0,0
171613,",",0,0
171614,indicating,0,0
171615,material,0,0
171616,selectivity,0,0
171617,.,0,0
171618,Whereas,0,0
171619,greater,0,0
171620,differentiation,0,0
171621,between,0,0
171622,materials,0,0
171623,was,0,0
171624,possible,0,0
171625,after,0,0
171626,7,0,0
171627,days,0,0
171628,of,0,0
171629,EW,0,1
171630,for,0,0
171631,each,0,0
171632,material,0,0
171633,",",0,0
171634,the,0,0
171635,lipid,0,0
171636,uptake,0,0
171637,profile,0,0
171638,was,0,0
171639,similar,0,0
171640,for,0,0
171641,DD,0,1
171642,and,0,0
171643,EW,0,1
171644,",",0,0
171645,indicating,0,0
171646,a,0,0
171647,greater,0,0
171648,material,0,0
171649,effect,0,0
171650,than,0,0
171651,a,0,0
171652,wear,0,0
171653,modality,0,0
171654,effect,0,0
171655,.,0,0
171656,Complex,1,0
171657,decongestive,1,0
171658,therapy,1,0
171659,and,1,0
171660,taping,1,0
171661,for,0,0
171662,patients,0,0
171663,with,0,0
171664,postmastectomy,0,0
171665,lymphedema,0,0
171666,:,0,0
171667,a,0,0
171668,randomized,0,0
171669,controlled,0,0
171670,study,0,0
171671,.,0,0
171672,PURPOSE,0,0
171673,The,0,0
171674,purpose,0,0
171675,of,0,0
171676,our,0,0
171677,study,0,0
171678,was,0,0
171679,to,0,0
171680,investigate,0,0
171681,the,0,0
171682,effects,0,0
171683,of,0,0
171684,Kinesio,1,1
171685,Taping,1,1
171686,(,1,1
171687,?,1,1
171688,),1,0
171689,Application,1,0
171690,with,1,0
171691,Complex,1,0
171692,Decongestive,1,0
171693,Therapy,1,1
171694,(,1,1
171695,CDT,1,1
171696,),1,0
171697,in,0,0
171698,patients,0,0
171699,with,0,0
171700,lymphedema,0,0
171701,.,0,0
171702,MATERIALS,0,0
171703,AND,0,0
171704,METHODS,0,0
171705,45,0,0
171706,patients,0,0
171707,were,0,0
171708,randomly,0,0
171709,divided,0,0
171710,into,0,0
171711,3,0,1
171712,groups,0,0
171713,(,0,0
171714,CDT,1,1
171715,including,1,0
171716,Bandage,1,0
171717,",",1,0
171718,CDT,1,0
171719,including,1,0
171720,Bandage,1,1
171721,+,1,1
171722,Kinesio,1,1
171723,Tape,1,1
171724,(,1,1
171725,?,1,1
171726,),1,1
171727,",",1,0
171728,CDT,1,1
171729,including,1,0
171730,Kinesio,1,1
171731,Tape,1,1
171732,(,1,1
171733,?,1,1
171734,),1,1
171735,without,1,0
171736,bandage,1,1
171737,),1,0
171738,.,1,0
171739,Assessments,1,0
171740,included,0,0
171741,the,0,0
171742,severity,0,0
171743,of,0,0
171744,the,0,0
171745,symptoms,0,0
171746,such,0,0
171747,as,0,0
171748,pain,0,0
171749,",",0,0
171750,discomfort,0,0
171751,",",0,0
171752,heaviness,0,0
171753,",",0,0
171754,tension,0,0
171755,",",0,0
171756,stiffness,0,0
171757,and,0,0
171758,weakness,0,0
171759,.,0,0
171760,Bilateral,0,0
171761,circumference,0,0
171762,measurements,0,0
171763,were,0,0
171764,done,0,0
171765,for,0,0
171766,evaluation,0,0
171767,of,0,0
171768,the,0,0
171769,edema,0,0
171770,.,0,0
171771,RESULTS,0,0
171772,Symptoms,0,0
171773,were,0,0
171774,decreased,0,0
171775,in,0,0
171776,all,0,0
171777,three,0,0
171778,groups,0,0
171779,(,0,0
171780,p,0,0
171781,<,0,0
171782,0.05,0,0
171783,),0,0
171784,.,0,0
171785,CDT,0,0
171786,was,0,0
171787,found,0,0
171788,effective,0,0
171789,only,0,0
171790,during,0,0
171791,treatment,0,0
171792,in,0,0
171793,arm,0,1
171794,volume,0,0
171795,(,0,0
171796,p,0,0
171797,<,0,0
171798,0.05,1,0
171799,),1,0
171800,.,1,0
171801,Kinesio,1,1
171802,Taping,1,1
171803,(,1,1
171804,?,1,1
171805,),1,0
171806,applied,1,0
171807,with,0,0
171808,CDT,1,0
171809,had,0,0
171810,effect,0,0
171811,of,0,0
171812,decreasing,0,0
171813,edema,0,0
171814,after,0,0
171815,10,0,0
171816,days,0,0
171817,of,0,0
171818,treatment,0,1
171819,period,0,0
171820,(,0,0
171821,p,0,0
171822,<,0,0
171823,0.05,0,0
171824,),0,0
171825,and,0,0
171826,for,0,0
171827,control,0,0
171828,period,0,0
171829,(,0,0
171830,p,0,0
171831,<,0,0
171832,0.05,0,0
171833,),0,0
171834,.,0,0
171835,Only,0,0
171836,the,0,0
171837,application,1,0
171838,of,1,0
171839,Kinesio,1,1
171840,Taping,1,1
171841,(,1,1
171842,?,1,1
171843,),1,1
171844,group,1,0
171845,also,0,0
171846,had,0,0
171847,significant,0,0
171848,decrease,0,0
171849,at,0,0
171850,edema,0,0
171851,(,0,0
171852,p,0,0
171853,<,0,0
171854,0.05,0,0
171855,),0,0
171856,.,0,0
171857,CONCLUSION,1,1
171858,Kinesio,1,1
171859,Taping,1,1
171860,(,1,1
171861,?,1,1
171862,),1,0
171863,Application,1,0
171864,along,0,0
171865,with,1,0
171866,CDT,1,0
171867,may,1,0
171868,have,0,0
171869,a,0,0
171870,better,0,0
171871,effect,0,0
171872,on,0,0
171873,decreasing,0,0
171874,lymphedema,0,0
171875,which,0,0
171876,can,0,0
171877,stimulate,0,0
171878,the,0,0
171879,reduction,0,0
171880,of,0,0
171881,edema,0,0
171882,for,0,0
171883,long,0,0
171884,term,0,0
171885,effects,0,0
171886,.,0,0
171887,Modelling,0,0
171888,broilers,0,0
171889,',0,0
171890,abdominal,0,0
171891,fat,0,0
171892,in,0,0
171893,response,0,0
171894,to,0,0
171895,dietary,0,1
171896,treatments,0,1
171897,.,0,0
171898,Neural,0,0
171899,networks,0,0
171900,are,0,0
171901,capable,0,0
171902,of,0,0
171903,modelling,0,0
171904,any,0,0
171905,complex,0,0
171906,function,0,0
171907,and,0,0
171908,can,0,0
171909,be,0,0
171910,used,0,0
171911,in,0,0
171912,poultry,0,0
171913,production,0,0
171914,.,0,0
171915,Dietary,1,0
171916,crude,1,0
171917,fibre,1,0
171918,(,1,1
171919,CF,1,1
171920,),1,1
171921,and,0,0
171922,exogenous,1,0
171923,enzymes,1,0
171924,(,1,0
171925,exEn,1,1
171926,),1,0
171927,extensively,0,0
171928,affected,0,0
171929,abdominal,0,0
171930,fat,0,1
171931,(,0,1
171932,AF,0,1
171933,),0,1
171934,of,0,0
171935,broilers,0,0
171936,.,0,0
171937,Current,0,0
171938,methods,0,0
171939,to,0,0
171940,study,0,0
171941,AF,0,0
171942,and,0,0
171943,its,0,0
171944,correlation,0,0
171945,with,0,0
171946,dietary,0,1
171947,CF,0,1
171948,levels,0,0
171949,and,0,0
171950,exEn,0,1
171951,supplements,0,1
171952,are,0,0
171953,costly,0,0
171954,",",0,0
171955,laborious,0,0
171956,and,0,0
171957,time-consuming,0,0
171958,.,0,0
171959,The,0,0
171960,purpose,0,0
171961,of,0,0
171962,this,0,0
171963,study,0,0
171964,was,0,0
171965,to,0,0
171966,develop,0,0
171967,an,0,0
171968,artificial,0,0
171969,neural,0,0
171970,network-genetic,0,0
171971,algorithm,0,1
171972,(,0,1
171973,ANN-GA,0,1
171974,),0,0
171975,to,0,0
171976,model,0,0
171977,data,0,0
171978,on,0,0
171979,the,0,0
171980,response,0,0
171981,of,0,0
171982,broiler,0,1
171983,chickens,0,1
171984,(,0,1
171985,AF,0,1
171986,),0,1
171987,to,0,0
171988,CF,1,1
171989,and,0,0
171990,exEn,1,0
171991,from,0,0
171992,0,0,0
171993,to,0,0
171994,42,0,0
171995,days,0,0
171996,of,0,0
171997,age,0,0
171998,.,0,0
171999,A,0,0
172000,data,0,0
172001,set,0,0
172002,containing,0,0
172003,eight,0,0
172004,treatments,0,0
172005,was,0,0
172006,divided,0,0
172007,to,0,0
172008,the,0,0
172009,train,0,0
172010,",",0,0
172011,validation,0,0
172012,",",0,0
172013,and,0,0
172014,test,0,0
172015,data,0,0
172016,set,0,0
172017,of,0,0
172018,the,0,0
172019,ANN,0,0
172020,models,0,0
172021,.,0,0
172022,The,0,0
172023,information,0,0
172024,about,0,0
172025,feeding,0,0
172026,eight,0,0
172027,diets,0,1
172028,at,0,0
172029,two,0,0
172030,periods,0,1
172031,[,0,1
172032,starter,0,1
172033,(,0,1
172034,0-21,0,0
172035,days,0,0
172036,of,0,0
172037,age,0,1
172038,),0,0
172039,and,0,0
172040,grower,0,0
172041,(,0,0
172042,22-42,0,0
172043,days,0,0
172044,of,0,0
172045,age,0,1
172046,),0,0
172047,],0,0
172048,were,0,0
172049,used,0,0
172050,to,0,0
172051,estimate,0,0
172052,AF,0,0
172053,of,0,0
172054,broilers,0,0
172055,by,0,0
172056,ANN-GA.,0,0
172057,A,0,0
172058,multilayer,0,0
172059,feed-forward,0,0
172060,neural,0,0
172061,network,0,0
172062,with,0,0
172063,different,0,0
172064,structures,0,0
172065,was,0,0
172066,developed,0,0
172067,using,0,0
172068,matlab,0,0
172069,software,0,0
172070,",",0,0
172071,and,0,0
172072,optimal,0,0
172073,values,0,0
172074,for,0,0
172075,the,0,0
172076,ANN,0,0
172077,weights,0,0
172078,were,0,0
172079,obtained,0,0
172080,using,0,0
172081,the,0,0
172082,genetic,0,0
172083,algorithm,0,1
172084,(,0,1
172085,GA,0,1
172086,),1,1
172087,.,1,0
172088,Crude,1,0
172089,fibre,1,0
172090,",",1,0
172091,and,1,0
172092,exEn,1,0
172093,were,1,0
172094,used,0,0
172095,as,0,0
172096,input,0,0
172097,variables,0,0
172098,and,0,0
172099,AF,0,0
172100,of,0,0
172101,broilers,0,0
172102,was,0,0
172103,output,0,0
172104,variable,0,0
172105,.,0,0
172106,The,0,0
172107,best,0,0
172108,model,0,0
172109,of,0,0
172110,ANN-GA,0,0
172111,was,0,0
172112,determined,0,0
172113,based,0,0
172114,on,0,0
172115,the,0,0
172116,train,0,0
172117,root,0,0
172118,mean,0,0
172119,square,0,0
172120,error,0,0
172121,(,0,1
172122,RMSE,0,1
172123,),0,1
172124,.,0,0
172125,The,0,0
172126,best,0,0
172127,selected,0,0
172128,ANN-GA,0,0
172129,showed,0,0
172130,desirable,0,0
172131,results,0,0
172132,",",0,0
172133,RMSE,0,0
172134,",",0,0
172135,0.1286,0,0
172136,%,0,0
172137,and,0,0
172138,R,0,0
172139,(,0,1
172140,2,0,1
172141,),0,0
172142,coefficient,0,0
172143,",",0,0
172144,0.876,0,0
172145,for,0,0
172146,test,0,0
172147,data,0,0
172148,.,0,0
172149,Impact,0,0
172150,of,0,0
172151,early,1,0
172152,mobilization,1,0
172153,on,0,0
172154,glycemic,0,0
172155,control,0,0
172156,and,0,0
172157,ICU-acquired,0,0
172158,weakness,0,0
172159,in,0,0
172160,critically,0,0
172161,ill,0,0
172162,patients,0,0
172163,who,0,0
172164,are,0,0
172165,mechanically,0,0
172166,ventilated,0,0
172167,.,0,0
172168,BACKGROUND,0,0
172169,ICU-acquired,0,1
172170,weakness,0,1
172171,(,0,1
172172,ICU-AW,0,1
172173,),0,1
172174,has,0,0
172175,immediate,0,0
172176,and,0,0
172177,long-term,0,0
172178,consequences,0,0
172179,for,0,0
172180,critically,0,0
172181,ill,0,0
172182,patients,0,0
172183,.,0,0
172184,Strategies,0,0
172185,for,0,0
172186,the,0,0
172187,prevention,0,0
172188,of,0,0
172189,weakness,0,0
172190,include,0,0
172191,modification,0,0
172192,of,0,0
172193,known,0,0
172194,risk,0,0
172195,factors,0,0
172196,",",0,0
172197,such,0,0
172198,as,0,0
172199,hyperglycemia,0,1
172200,and,0,0
172201,immobility,0,0
172202,.,0,0
172203,Intensive,1,0
172204,insulin,1,1
172205,therapy,1,1
172206,(,0,1
172207,IIT,0,1
172208,),0,0
172209,has,0,0
172210,been,0,0
172211,proposed,0,0
172212,to,0,0
172213,prevent,0,0
172214,critical,0,0
172215,illness,0,0
172216,polyneuropathy,0,0
172217,.,0,0
172218,However,0,0
172219,",",0,0
172220,the,0,0
172221,effect,0,0
172222,of,0,0
172223,insulin,0,1
172224,and,0,0
172225,early,0,0
172226,mobilization,0,0
172227,on,0,0
172228,clinically,0,0
172229,apparent,0,0
172230,weakness,0,0
172231,is,0,0
172232,not,0,0
172233,well,0,0
172234,known,0,0
172235,.,0,0
172236,METHODS,0,0
172237,This,0,0
172238,is,0,0
172239,a,0,0
172240,secondary,0,0
172241,analysis,0,0
172242,of,0,0
172243,all,0,0
172244,patients,0,0
172245,with,0,0
172246,mechanical,0,0
172247,ventilation,0,0
172248,(,0,0
172249,N,0,0
172250,=,0,0
172251,104,0,0
172252,),0,0
172253,previously,0,0
172254,enrolled,0,0
172255,in,0,0
172256,a,0,0
172257,randomized,0,0
172258,controlled,0,0
172259,trial,0,0
172260,of,0,0
172261,early,0,0
172262,occupational,0,0
172263,and,0,0
172264,physical,0,0
172265,therapy,0,0
172266,vs,0,0
172267,conventional,0,0
172268,therapy,0,0
172269,",",0,0
172270,which,0,0
172271,evaluated,0,0
172272,the,0,0
172273,end,0,0
172274,point,0,0
172275,of,0,0
172276,functional,0,0
172277,independence,0,0
172278,.,0,0
172279,Every,0,0
172280,patient,0,0
172281,had,0,0
172282,IIT,0,0
172283,and,0,0
172284,blinded,0,0
172285,muscle,0,0
172286,strength,0,0
172287,testing,0,0
172288,on,0,0
172289,hospital,0,0
172290,discharge,0,0
172291,to,0,0
172292,determine,0,0
172293,the,0,0
172294,incidence,0,0
172295,of,0,0
172296,clinically,0,0
172297,apparent,0,0
172298,weakness,0,0
172299,.,0,0
172300,The,0,0
172301,effects,0,0
172302,of,0,0
172303,insulin,0,1
172304,dose,0,1
172305,and,0,1
172306,early,0,0
172307,mobilization,0,0
172308,on,0,0
172309,the,0,0
172310,incidence,0,0
172311,of,0,0
172312,ICU-AW,0,0
172313,were,0,0
172314,assessed,0,0
172315,.,0,0
172316,RESULTS,0,0
172317,On,0,1
172318,logistic,0,0
172319,regression,0,0
172320,analyses,0,0
172321,",",0,0
172322,early,0,0
172323,mobilization,0,0
172324,and,0,0
172325,increasing,0,0
172326,insulin,0,1
172327,dose,0,1
172328,prevented,0,1
172329,the,0,0
172330,incidence,0,0
172331,of,0,0
172332,ICU-AW,0,1
172333,(,0,0
172334,OR,0,0
172335,",",0,0
172336,0.18,0,0
172337,",",0,0
172338,P,0,0
172339,=,0,0
172340,.001,0,0
172341,;,0,0
172342,OR,0,0
172343,",",0,0
172344,0.001,0,0
172345,",",0,0
172346,P,0,0
172347,=,0,0
172348,.011,0,0
172349,;,0,0
172350,respectively,0,0
172351,),0,0
172352,independent,0,0
172353,of,0,0
172354,known,0,0
172355,risk,0,0
172356,factors,0,0
172357,for,0,0
172358,weakness,0,0
172359,.,0,0
172360,Early,0,0
172361,mobilization,0,0
172362,also,0,0
172363,significantly,0,0
172364,reduced,0,0
172365,insulin,0,1
172366,requirements,0,0
172367,to,0,0
172368,achieve,0,0
172369,similar,0,0
172370,glycemic,0,1
172371,goals,0,0
172372,as,0,0
172373,compared,0,0
172374,with,0,0
172375,control,0,0
172376,patients,0,0
172377,(,0,0
172378,0.07,0,0
172379,units/kg/d,0,0
172380,vs,0,0
172381,0.2,0,0
172382,units/kg/d,0,0
172383,",",0,0
172384,P,0,0
172385,<,0,0
172386,.001,0,0
172387,),0,0
172388,.,0,0
172389,CONCLUSIONS,0,0
172390,The,0,0
172391,duel,0,0
172392,effect,0,0
172393,of,0,0
172394,early,0,0
172395,mobilization,0,0
172396,in,0,0
172397,reducing,0,0
172398,clinically,0,0
172399,relevant,0,0
172400,ICU-AW,0,0
172401,and,0,0
172402,promoting,0,0
172403,euglycemia,0,1
172404,suggests,0,0
172405,its,0,0
172406,potential,0,0
172407,usefulness,0,0
172408,as,0,0
172409,an,0,0
172410,alternative,0,0
172411,to,0,0
172412,IIT,0,0
172413,.,0,0
172414,Measuring,0,0
172415,and,0,0
172416,supporting,0,0
172417,language,0,0
172418,function,0,0
172419,for,0,0
172420,children,0,0
172421,with,0,0
172422,autism,0,0
172423,:,0,0
172424,evidence,0,0
172425,from,0,0
172426,a,0,0
172427,randomized,0,0
172428,control,0,0
172429,trial,0,0
172430,of,0,0
172431,a,0,0
172432,social-interaction-based,1,0
172433,therapy,1,0
172434,.,1,0
172435,In,0,0
172436,a,0,0
172437,report,0,0
172438,of,0,0
172439,the,0,0
172440,effectiveness,0,0
172441,of,0,0
172442,MEHRIT,1,0
172443,",",1,0
172444,a,1,0
172445,social-interaction-based,1,0
172446,intervention,1,0
172447,for,0,0
172448,autism,0,0
172449,",",0,0
172450,Casenhiser,0,1
172451,et,0,1
172452,al,0,1
172453,.,0,1
172454,(,0,0
172455,Autism,0,1
172456,17,0,1
172457,(,0,1
172458,2,0,1
172459,),0,0
172460,:220-241,0,1
172461,",",0,1
172462,2013,0,1
172463,),0,0
172464,failed,0,0
172465,to,0,0
172466,find,0,0
172467,a,0,0
172468,significant,0,0
172469,advantage,0,0
172470,for,0,0
172471,language,0,0
172472,development,0,0
172473,in,0,0
172474,the,0,0
172475,treatment,0,0
172476,group,0,0
172477,using,0,0
172478,standardized,0,0
172479,language,0,0
172480,assessments,0,0
172481,.,0,0
172482,We,0,0
172483,present,0,0
172484,the,0,0
172485,results,0,0
172486,from,0,0
172487,a,0,0
172488,re-analysis,0,0
172489,of,0,0
172490,their,0,0
172491,results,0,0
172492,to,0,0
172493,illustrate,0,0
172494,the,0,0
172495,importance,0,0
172496,of,0,0
172497,measuring,0,0
172498,communicative,0,0
172499,language,0,0
172500,acts,0,0
172501,(,0,0
172502,formally,0,0
172503,called,0,0
172504,speech,0,0
172505,acts,0,0
172506,),0,0
172507,.,0,0
172508,Reanalysis,0,0
172509,confirmed,0,0
172510,that,0,0
172511,children,0,0
172512,in,0,0
172513,the,0,0
172514,MEHRIT,1,0
172515,group,0,0
172516,outperformed,0,0
172517,the,0,0
172518,community,0,0
172519,treatment,0,0
172520,group,0,0
172521,on,0,0
172522,measures,0,0
172523,of,0,0
172524,MLUm,0,0
172525,",",0,0
172526,number,0,0
172527,of,0,0
172528,utterances,0,0
172529,produced,0,0
172530,",",0,0
172531,and,0,0
172532,various,0,0
172533,speech,0,0
172534,act,0,0
172535,categories,0,0
172536,.,0,0
172537,The,0,0
172538,study,0,0
172539,underscores,0,0
172540,the,0,0
172541,importance,0,0
172542,of,0,0
172543,functional,0,0
172544,language,0,0
172545,measures,0,0
172546,in,0,0
172547,guiding,0,0
172548,and,0,0
172549,evaluating,0,0
172550,treatment,0,0
172551,for,0,0
172552,children,0,0
172553,with,0,0
172554,autism,0,0
172555,",",0,0
172556,and,0,0
172557,suggests,0,0
172558,that,0,0
172559,MEHRIT,0,0
172560,is,0,0
172561,effective,0,0
172562,in,0,0
172563,improving,0,0
172564,children,0,0
172565,'s,0,0
172566,use,0,0
172567,of,0,0
172568,language,0,0
172569,during,0,0
172570,parent-child,0,0
172571,interactions,0,0
172572,.,0,0
172573,[,0,0
172574,The,0,0
172575,comparation,0,0
172576,of,0,0
172577,the,0,0
172578,efficacy,0,0
172579,of,0,0
172580,surgical,0,0
172581,treatment,0,0
172582,for,0,0
172583,lung,0,0
172584,cancer,0,0
172585,by,0,0
172586,minimally,1,0
172587,invasive,1,0
172588,thoracoscopic,1,0
172589,and,0,0
172590,by,0,0
172591,traditional,1,0
172592,thoracotomy,1,0
172593,],1,0
172594,.,0,0
172595,OBJECTIVE,0,0
172596,To,0,0
172597,observe,0,0
172598,the,0,0
172599,clinical,0,0
172600,effects,0,0
172601,of,0,0
172602,lung,0,0
172603,cancer,0,0
172604,",",0,0
172605,75,0,0
172606,patients,0,0
172607,with,0,0
172608,lung,0,0
172609,cancer,0,0
172610,were,0,0
172611,randomly,0,0
172612,divided,0,0
172613,into,0,0
172614,two,1,0
172615,groups,1,0
172616,",",1,0
172617,observation,1,0
172618,group,1,0
172619,underwent,1,0
172620,minimally,1,0
172621,invasive,1,0
172622,thoracic,1,0
172623,surgery,1,0
172624,38,1,0
172625,cases,1,0
172626,and,1,0
172627,the,1,0
172628,control,1,0
172629,group,1,0
172630,underwent,1,0
172631,conventional,1,0
172632,thoracotomy,1,0
172633,37,1,0
172634,cases,1,0
172635,.,1,0
172636,RESULTS,0,0
172637,Observation,0,0
172638,group,0,0
172639,was,0,0
172640,significantly,0,0
172641,reduced,0,0
172642,compared,0,0
172643,with,0,0
172644,the,0,0
172645,control,0,0
172646,group,0,0
172647,in,0,0
172648,blood,0,0
172649,loss,0,0
172650,",",0,0
172651,postoperative,0,0
172652,pleural,0,1
172653,fluid,0,1
172654,drainage,0,1
172655,",",0,0
172656,postoperative,0,0
172657,hospital,0,0
172658,stay,0,0
172659,",",0,0
172660,the,0,0
172661,difference,0,0
172662,was,0,0
172663,statistically,0,0
172664,significant,0,0
172665,.,0,0
172666,While,0,0
172667,there,0,0
172668,was,0,0
172669,no,0,0
172670,statistically,0,0
172671,significant,0,0
172672,in,0,0
172673,the,0,0
172674,number,0,0
172675,of,0,0
172676,lymph,0,0
172677,node,0,0
172678,dissection,0,0
172679,",",0,0
172680,operative,0,0
172681,time,0,0
172682,and,0,0
172683,postoperative,0,0
172684,chest,0,1
172685,tube,0,0
172686,drainage,0,0
172687,time,0,0
172688,.,0,0
172689,Randomized,0,0
172690,controlled,0,0
172691,trial,0,0
172692,of,0,0
172693,parental,1,0
172694,responsiveness,1,0
172695,intervention,1,0
172696,for,0,0
172697,toddlers,0,0
172698,at,0,0
172699,high,0,0
172700,risk,0,0
172701,for,0,0
172702,autism,0,0
172703,.,0,0
172704,This,0,0
172705,study,0,0
172706,tested,0,0
172707,the,0,0
172708,effects,0,0
172709,of,0,0
172710,a,0,0
172711,parent-mediated,1,0
172712,intervention,1,0
172713,on,1,0
172714,parental,1,0
172715,responsiveness,1,0
172716,with,0,0
172717,their,0,0
172718,toddlers,0,0
172719,at,0,0
172720,high,0,0
172721,risk,0,0
172722,for,0,0
172723,an,0,0
172724,autism,0,0
172725,spectrum,0,0
172726,disorder,0,1
172727,(,0,1
172728,ASD,0,1
172729,),0,1
172730,.,0,0
172731,Participants,0,0
172732,included,0,0
172733,caregivers,0,0
172734,and,0,0
172735,their,0,0
172736,66,0,0
172737,toddlers,0,0
172738,at,0,0
172739,high,0,0
172740,risk,0,0
172741,for,0,0
172742,ASD,0,0
172743,.,0,0
172744,Caregivers,0,0
172745,were,0,0
172746,randomized,0,0
172747,to,0,0
172748,12,0,0
172749,sessions,0,0
172750,of,0,0
172751,an,0,0
172752,individualized,1,0
172753,parent,1,0
172754,education,1,0
172755,intervention,1,0
172756,aimed,0,0
172757,at,0,0
172758,improving,0,0
172759,parental,0,0
172760,responsiveness,0,0
172761,or,0,0
172762,to,0,0
172763,a,0,0
172764,monitoring,0,0
172765,control,0,0
172766,group,0,0
172767,involving,0,0
172768,4,0,0
172769,sessions,0,0
172770,of,0,0
172771,behavioral,0,0
172772,support,0,0
172773,.,0,0
172774,Parental,1,0
172775,responsiveness,1,0
172776,and,0,0
172777,child,0,0
172778,outcomes,0,0
172779,were,0,0
172780,measured,0,0
172781,at,0,0
172782,three,0,0
172783,time,0,0
172784,points,0,0
172785,:,0,0
172786,at,0,0
172787,beginning,0,0
172788,and,0,0
172789,end,0,0
172790,of,0,0
172791,the,0,0
172792,3-month,0,0
172793,treatment,0,0
172794,and,0,0
172795,at,0,0
172796,12-months,0,0
172797,post-study,0,0
172798,entry,0,0
172799,.,0,0
172800,Parental,1,0
172801,responsiveness,1,0
172802,improved,0,0
172803,significantly,0,0
172804,in,0,0
172805,the,0,0
172806,treatment,0,0
172807,group,0,0
172808,but,0,0
172809,not,0,0
172810,the,0,0
172811,control,0,0
172812,group,0,0
172813,.,0,0
172814,However,0,0
172815,",",0,0
172816,parental,0,0
172817,responsiveness,0,0
172818,was,0,0
172819,not,0,0
172820,fully,0,0
172821,maintained,0,0
172822,at,0,0
172823,follow,0,0
172824,up,0,0
172825,.,0,0
172826,There,0,0
172827,were,0,0
172828,no,0,0
172829,treatment,0,0
172830,effects,0,0
172831,on,0,0
172832,child,0,0
172833,outcomes,0,0
172834,of,0,0
172835,joint,0,0
172836,attention,0,0
172837,or,0,0
172838,language,0,0
172839,.,0,0
172840,Children,0,0
172841,in,0,0
172842,both,0,0
172843,groups,0,0
172844,made,0,0
172845,significant,0,0
172846,developmental,0,0
172847,gains,0,0
172848,in,0,0
172849,cognition,0,0
172850,and,0,0
172851,language,0,0
172852,skills,0,0
172853,over,0,0
172854,one,0,0
172855,year,0,0
172856,.,0,0
172857,These,0,0
172858,results,0,0
172859,support,0,0
172860,parental,1,0
172861,responsiveness,1,0
172862,as,0,0
172863,an,0,0
172864,important,0,0
172865,intervention,0,0
172866,target,0,0
172867,given,0,0
172868,its,0,0
172869,general,0,0
172870,association,0,0
172871,with,0,0
172872,child,0,0
172873,outcomes,0,0
172874,in,0,0
172875,the,0,0
172876,extant,0,0
172877,literature,0,0
172878,;,0,0
172879,however,0,0
172880,",",0,0
172881,additional,0,0
172882,supports,0,0
172883,are,0,0
172884,likely,0,0
172885,needed,0,0
172886,to,0,0
172887,fully,0,0
172888,maintain,0,0
172889,the,0,0
172890,treatment,0,0
172891,effect,0,0
172892,and,0,0
172893,to,0,0
172894,affect,0,0
172895,child,0,0
172896,outcomes,0,0
172897,.,0,0
172898,Inhibition,0,0
172899,of,0,0
172900,PCSK9,0,1
172901,with,0,0
172902,evolocumab,1,1
172903,in,0,0
172904,homozygous,0,1
172905,familial,0,1
172906,hypercholesterolaemia,0,1
172907,(,0,1
172908,TESLA,0,1
172909,Part,0,1
172910,B,0,1
172911,),0,0
172912,:,0,0
172913,a,0,0
172914,randomised,0,0
172915,",",0,0
172916,double-blind,0,1
172917,",",0,1
172918,placebo-controlled,1,1
172919,trial,0,1
172920,.,0,0
172921,BACKGROUND,0,0
172922,Homozygous,0,0
172923,familial,0,0
172924,hypercholesterolaemia,0,0
172925,is,0,0
172926,a,0,0
172927,rare,0,0
172928,",",0,0
172929,serious,0,0
172930,disorder,0,0
172931,caused,0,0
172932,by,0,0
172933,very,0,0
172934,low,0,0
172935,or,0,0
172936,absent,0,0
172937,plasma,0,1
172938,clearance,0,1
172939,of,0,1
172940,LDL,0,1
172941,",",0,0
172942,substantially,0,0
172943,raised,0,0
172944,LDL,0,1
172945,cholesterol,0,1
172946,",",0,0
172947,and,0,0
172948,accelerated,0,0
172949,development,0,0
172950,of,0,0
172951,cardiovascular,0,0
172952,disease,0,0
172953,.,0,0
172954,Conventional,0,0
172955,lipid-lowering,0,1
172956,treatments,0,1
172957,are,0,0
172958,modestly,0,0
172959,effective,0,0
172960,.,0,0
172961,Evolocumab,1,1
172962,",",0,0
172963,a,0,0
172964,monoclonal,1,1
172965,antibody,1,0
172966,to,0,1
172967,proprotein,1,1
172968,convertase,1,1
172969,subtilisin/kexin,1,1
172970,type,1,1
172971,9,1,1
172972,(,0,0
172973,PCSK9,0,1
172974,),0,1
172975,",",0,0
172976,reduced,0,0
172977,LDL,0,1
172978,cholesterol,0,1
172979,by,0,0
172980,16,0,0
172981,%,0,0
172982,in,0,0
172983,a,0,0
172984,pilot,0,0
172985,study,0,0
172986,.,0,0
172987,We,0,0
172988,now,0,0
172989,report,0,0
172990,results,0,0
172991,with,0,0
172992,evolocumab,1,1
172993,in,0,0
172994,a,0,0
172995,randomised,0,0
172996,",",0,0
172997,double-blind,0,1
172998,",",0,1
172999,placebo-controlled,1,1
173000,phase,0,0
173001,3,0,0
173002,trial,0,0
173003,.,0,0
173004,METHODS,0,0
173005,This,0,0
173006,randomised,0,1
173007,",",0,0
173008,double-blind,0,1
173009,",",0,1
173010,placebo-controlled,1,1
173011,phase,0,0
173012,3,0,0
173013,trial,0,0
173014,was,0,0
173015,undertaken,0,0
173016,at,0,0
173017,17,0,0
173018,sites,0,0
173019,in,0,0
173020,ten,0,0
173021,countries,0,0
173022,in,0,0
173023,North,0,0
173024,America,0,1
173025,",",0,0
173026,Europe,0,0
173027,",",0,0
173028,the,0,0
173029,Middle,0,0
173030,East,0,0
173031,",",0,0
173032,and,0,0
173033,South,0,0
173034,Africa,0,0
173035,.,0,0
173036,50,0,0
173037,eligible,0,0
173038,patients,0,0
173039,(,0,0
173040,aged,0,0
173041,?12,0,1
173042,years,0,1
173043,),0,1
173044,with,0,0
173045,homozygous,0,0
173046,familial,0,0
173047,hypercholesterolaemia,0,0
173048,",",0,0
173049,on,0,0
173050,stable,1,0
173051,lipid-regulating,1,0
173052,therapy,1,0
173053,for,1,0
173054,at,0,0
173055,least,0,0
173056,4,0,0
173057,weeks,0,0
173058,",",0,0
173059,and,0,0
173060,not,0,0
173061,receiving,0,0
173062,lipoprotein,0,1
173063,apheresis,0,1
173064,",",0,0
173065,were,0,0
173066,randomly,0,0
173067,allocated,0,0
173068,by,0,0
173069,a,0,0
173070,computer-generated,0,0
173071,randomisation,0,0
173072,sequence,0,0
173073,in,0,0
173074,a,0,0
173075,2:1,0,0
173076,ratio,0,0
173077,to,0,0
173078,receive,1,1
173079,subcutaneous,1,1
173080,evolocumab,1,1
173081,420,1,1
173082,mg,1,1
173083,or,1,1
173084,placebo,1,1
173085,every,1,1
173086,4,0,0
173087,weeks,0,0
173088,for,0,0
173089,12,0,0
173090,weeks,0,0
173091,.,0,0
173092,Randomisation,0,0
173093,was,0,0
173094,stratified,0,0
173095,by,0,0
173096,LDL,0,1
173097,cholesterol,0,1
173098,at,0,1
173099,screening,0,0
173100,(,0,0
173101,<,0,0
173102,11,0,0
173103,mmol/L,0,0
173104,or,0,1
173105,?11,0,1
173106,mmol/L,0,1
173107,),0,1
173108,and,0,0
173109,implemented,0,0
173110,by,0,0
173111,a,0,0
173112,computerised,1,0
173113,interactive,1,0
173114,voice-response,1,0
173115,system,1,0
173116,.,1,0
173117,Patients,1,0
173118,",",0,0
173119,study,0,0
173120,personnel,0,0
173121,",",0,0
173122,and,0,0
173123,the,0,0
173124,funder,0,0
173125,were,0,0
173126,masked,0,0
173127,to,0,0
173128,treatment,0,0
173129,and,0,0
173130,to,0,0
173131,the,0,0
173132,efficacy,0,0
173133,results,0,0
173134,by,0,0
173135,the,0,0
173136,central,0,0
173137,laboratory,0,0
173138,not,0,0
173139,returning,0,1
173140,LDL,0,1
173141,cholesterol,0,1
173142,or,0,0
173143,any,0,0
173144,lipid,0,0
173145,results,0,0
173146,to,0,0
173147,the,0,0
173148,clinical,0,0
173149,sites,0,0
173150,after,0,0
173151,the,0,0
173152,baseline,0,0
173153,visit,0,0
173154,.,0,0
173155,The,0,0
173156,primary,0,0
173157,endpoint,0,0
173158,was,0,0
173159,percentage,0,0
173160,change,0,0
173161,in,0,0
173162,ultracentrifugation,0,1
173163,LDL,0,1
173164,cholesterol,0,1
173165,from,0,0
173166,baseline,0,0
173167,at,0,0
173168,week,0,0
173169,12,0,0
173170,compared,0,0
173171,with,0,0
173172,placebo,0,1
173173,",",0,0
173174,analysed,0,0
173175,by,0,0
173176,intention-to-treat,0,0
173177,.,0,0
173178,This,0,0
173179,trial,0,0
173180,is,0,0
173181,registered,0,0
173182,with,0,0
173183,ClinicalTrials.gov,0,0
173184,",",0,0
173185,number,0,0
173186,NCT01588496,0,0
173187,.,0,0
173188,FINDINGS,0,0
173189,Of,0,0
173190,the,0,0
173191,50,0,0
173192,eligible,0,0
173193,patients,0,0
173194,randomly,0,0
173195,assigned,0,0
173196,to,0,0
173197,the,0,0
173198,two,0,0
173199,treatment,0,0
173200,groups,0,0
173201,",",0,0
173202,49,0,0
173203,actually,0,0
173204,received,0,0
173205,the,0,0
173206,study,0,0
173207,drug,0,1
173208,and,0,0
173209,completed,0,0
173210,the,0,0
173211,study,0,0
173212,(,0,0
173213,16,0,0
173214,in,0,0
173215,the,0,0
173216,placebo,1,1
173217,group,1,0
173218,and,0,0
173219,33,0,0
173220,in,0,0
173221,the,0,0
173222,evolocumab,1,1
173223,group,1,1
173224,),0,0
173225,.,0,0
173226,Compared,0,0
173227,with,0,0
173228,placebo,1,1
173229,",",1,1
173230,evolocumab,1,1
173231,significantly,1,0
173232,reduced,0,0
173233,ultracentrifugation,0,1
173234,LDL,0,1
173235,cholesterol,0,1
173236,at,0,1
173237,12,0,0
173238,weeks,0,0
173239,by,0,0
173240,30?9,0,0
173241,%,0,0
173242,(,0,0
173243,95,0,0
173244,%,0,0
173245,CI,0,0
173246,-43?9,0,0
173247,%,0,0
173248,to,0,0
173249,-18?0,0,0
173250,%,0,0
173251,;,0,0
173252,p,0,0
173253,<,0,0
173254,0?0001,0,0
173255,),0,0
173256,.,0,0
173257,Treatment-emergent,0,0
173258,adverse,0,0
173259,events,0,0
173260,occurred,0,0
173261,in,0,0
173262,ten,0,0
173263,(,0,0
173264,63,0,0
173265,%,0,0
173266,),0,0
173267,of,0,0
173268,16,0,0
173269,patients,0,0
173270,in,1,0
173271,the,1,0
173272,placebo,1,1
173273,group,0,1
173274,and,0,0
173275,12,0,0
173276,(,0,0
173277,36,0,0
173278,%,0,0
173279,),0,0
173280,of,0,0
173281,33,0,0
173282,in,0,0
173283,the,1,0
173284,evolocumab,1,1
173285,group,1,1
173286,.,1,1
173287,No,0,1
173288,serious,0,1
173289,clinical,0,1
173290,or,0,0
173291,laboratory,0,0
173292,adverse,0,0
173293,events,0,0
173294,occurred,0,0
173295,",",0,0
173296,and,0,0
173297,no,0,0
173298,anti-evolocumab,1,1
173299,antibody,1,0
173300,development,0,0
173301,was,0,0
173302,detected,0,0
173303,during,0,0
173304,the,0,0
173305,study,0,0
173306,.,0,0
173307,INTERPRETATION,0,0
173308,In,0,0
173309,patients,0,0
173310,with,0,0
173311,homozygous,0,0
173312,familial,0,0
173313,hypercholesterolaemia,0,0
173314,receiving,0,0
173315,stable,0,0
173316,background,0,0
173317,lipid-lowering,0,1
173318,treatment,0,0
173319,and,0,0
173320,not,0,0
173321,on,0,0
173322,apheresis,1,0
173323,",",1,0
173324,evolocumab,1,1
173325,420,1,1
173326,mg,1,1
173327,administered,0,1
173328,every,0,1
173329,4,0,0
173330,weeks,0,0
173331,was,0,0
173332,well,0,0
173333,tolerated,0,1
173334,and,0,0
173335,significantly,0,0
173336,reduced,0,0
173337,LDL,0,1
173338,cholesterol,0,1
173339,compared,0,1
173340,with,1,0
173341,placebo,1,1
173342,.,0,0
173343,FUNDING,0,1
173344,Amgen,0,1
173345,Inc,0,0
173346,.,0,0
173347,Pharmacodynamic,0,1
173348,analysis,0,1
173349,of,0,1
173350,intravenous,1,1
173351,recombinant,1,1
173352,urate,1,1
173353,oxidase,1,1
173354,using,0,0
173355,an,0,0
173356,indirect,0,0
173357,pharmacological,0,0
173358,response,0,0
173359,model,0,0
173360,in,0,0
173361,healthy,0,0
173362,subjects,0,0
173363,.,0,0
173364,AIM,0,1
173365,Pharmacodynamic,0,1
173366,analysis,0,0
173367,of,0,1
173368,intravenous,1,1
173369,recombinant,1,1
173370,urate,1,1
173371,oxidase,1,1
173372,produced,0,0
173373,by,0,0
173374,Escherichia,0,0
173375,coli,0,0
173376,was,0,0
173377,performed,0,0
173378,in,0,0
173379,healthy,0,0
173380,subjects,0,0
173381,using,0,0
173382,a,0,0
173383,pharmacokinetic/pharmacodynamic,0,1
173384,(,0,1
173385,PK/PD,0,1
173386,),0,0
173387,model,0,0
173388,.,0,0
173389,METHODS,0,0
173390,A,0,1
173391,randomized,0,1
173392,",",0,0
173393,single-blind,0,1
173394,",",0,1
173395,placebo-controlled,1,1
173396,study,0,0
173397,was,0,0
173398,performed,0,0
173399,in,0,0
173400,40,0,0
173401,healthy,0,0
173402,Chinese,0,0
173403,subjects,0,0
173404,(,0,0
173405,4,0,0
173406,groups,0,0
173407,of,0,0
173408,10,0,0
173409,subjects,0,0
173410,each,0,0
173411,",",0,0
173412,placebo,0,1
173413,4:1,0,1
173414,ratio,0,1
173415,),0,0
173416,who,0,1
173417,received,0,0
173418,infusions,0,1
173419,of,0,1
173420,uricase,1,1
173421,(,0,1
173422,single,0,1
173423,doses,0,1
173424,of,0,0
173425,0.1,0,0
173426,",",0,0
173427,0.2,0,0
173428,",",0,0
173429,and,0,0
173430,0.3,0,1
173431,mg/kg,0,1
173432,;,0,0
173433,multiple,0,1
173434,doses,0,1
173435,of,0,0
173436,0.2,0,1
173437,mg?kg,0,1
173438,(,0,1
173439,-1,0,1
173440,),0,1
173441,?d,0,1
173442,(,0,1
173443,-1,0,0
173444,),0,0
173445,for,0,0
173446,7,0,0
173447,d,0,0
173448,),0,0
173449,.,0,1
173450,PK,0,1
173451,profiles,0,0
173452,were,0,0
173453,determined,0,0
173454,through,0,0
173455,plasma,0,1
173456,uricase,0,1
173457,activity,0,0
173458,",",0,0
173459,and,0,0
173460,PD,0,0
173461,profiles,0,0
173462,were,0,0
173463,established,0,0
173464,using,0,0
173465,uric,0,1
173466,acid,0,1
173467,levels,0,0
173468,in,0,0
173469,plasma,0,1
173470,and,0,1
173471,urine,0,1
173472,.,0,1
173473,The,0,0
173474,plasma,0,0
173475,PD,0,0
173476,parameter,0,0
173477,was,0,0
173478,estimated,0,0
173479,as,0,0
173480,changes,0,0
173481,in,0,0
173482,plasma,0,1
173483,uric,0,1
173484,acid,0,1
173485,levels,0,0
173486,as,0,0
173487,the,0,0
173488,effect,0,0
173489,in,0,0
173490,the,0,0
173491,indirect,0,0
173492,response,0,0
173493,model,0,0
173494,.,0,0
173495,Adverse,0,0
173496,events,0,0
173497,were,0,0
173498,also,0,0
173499,monitored,0,0
173500,.,0,0
173501,RESULTS,0,0
173502,A,0,1
173503,two-compartment,0,1
173504,PK,0,1
173505,model,0,0
173506,with,0,0
173507,constant,0,0
173508,iv,0,1
173509,input,0,0
173510,and,0,0
173511,first-order,0,0
173512,output,0,0
173513,was,0,0
173514,used,0,0
173515,to,0,0
173516,describe,0,0
173517,the,0,0
173518,kinetic,0,0
173519,process,0,0
173520,of,0,0
173521,plasma,0,1
173522,uricase,0,1
173523,.,0,1
173524,The,0,0
173525,low,0,0
173526,value,0,0
173527,(,0,0
173528,2.8,0,0
173529,U/L,0,0
173530,),0,0
173531,of,0,0
173532,drug,0,1
173533,concentration,0,0
173534,that,0,0
173535,achieved,0,0
173536,50,0,0
173537,%,0,0
173538,of,0,0
173539,maximum,0,0
173540,effect,0,0
173541,(,0,0
173542,EC50,0,1
173543,),0,0
173544,indicated,0,0
173545,that,0,0
173546,low,0,0
173547,plasma,0,1
173548,uricase,0,1
173549,concentrations,0,1
173550,were,0,0
173551,sufficient,0,0
173552,to,0,0
173553,produce,0,0
173554,pharmacological,0,0
173555,effects,0,0
173556,.,0,0
173557,A,0,0
173558,strong,0,0
173559,relationship,0,0
173560,(,0,1
173561,r,0,1
173562,(,0,1
173563,2,0,1
173564,),0,1
173565,=0.9991,0,1
173566,),0,1
173567,between,0,0
173568,the,0,0
173569,mean,0,0
173570,uric,0,1
173571,acid,0,1
173572,concentration,0,0
173573,in,0,0
173574,blood,0,0
173575,and,0,0
173576,the,0,0
173577,mean,0,0
173578,uric,0,1
173579,acid,0,1
173580,excretion,0,1
173581,rate,0,1
173582,in,0,0
173583,urine,0,1
173584,in,0,0
173585,the,0,0
173586,range,0,0
173587,of,0,0
173588,11,0,0
173589,to,0,0
173590,30,0,0
173591,h,0,0
173592,after,0,0
173593,single,0,0
173594,dosing,0,1
173595,was,0,0
173596,found,0,0
173597,.,0,0
173598,Infusions,0,0
173599,of,0,0
173600,uricase,1,1
173601,were,1,0
173602,well,0,0
173603,tolerated,0,1
173604,in,0,0
173605,all,0,0
173606,subjects,0,0
173607,.,0,0
173608,CONCLUSION,0,0
173609,The,0,0
173610,PK/PD,0,0
173611,model,0,0
173612,predicted,0,0
173613,the,0,0
173614,effective,0,0
173615,dose,0,1
173616,to,0,0
173617,be,0,0
173618,0.1,0,0
173619,mg/kg,0,0
173620,in,0,0
173621,healthy,0,0
173622,subjects,0,0
173623,.,0,0
173624,The,0,0
173625,excretion,0,1
173626,rate,0,0
173627,of,0,1
173628,uric,0,1
173629,acid,0,1
173630,in,0,1
173631,urine,0,1
173632,may,0,0
173633,be,0,0
173634,used,0,0
173635,as,0,0
173636,a,0,0
173637,new,0,0
173638,index,0,0
173639,for,0,0
173640,pharmacological,0,0
173641,effects,0,0
173642,in,0,0
173643,further,0,0
173644,clinical,0,0
173645,trials,0,0
173646,.,0,0
173647,Disorder-dissociated,0,0
173648,effects,0,0
173649,of,0,0
173650,fluoxetine,1,1
173651,on,0,0
173652,brain,0,0
173653,function,0,0
173654,of,0,0
173655,working,0,0
173656,memory,0,0
173657,in,0,0
173658,attention,0,0
173659,deficit,0,0
173660,hyperactivity,0,0
173661,disorder,0,0
173662,and,0,0
173663,autism,0,0
173664,spectrum,0,0
173665,disorder,0,0
173666,.,0,0
173667,BACKGROUND,0,0
173668,Attention,0,0
173669,deficit,0,1
173670,hyperactivity,0,1
173671,disorder,0,1
173672,(,0,1
173673,ADHD,0,1
173674,),0,1
173675,and,0,0
173676,autism,0,0
173677,spectrum,0,0
173678,disorder,0,1
173679,(,0,1
173680,ASD,0,1
173681,),0,0
173682,are,0,0
173683,often,0,0
173684,co-morbid,0,0
173685,and,0,0
173686,share,0,0
173687,performance,0,0
173688,and,0,0
173689,brain,0,0
173690,dysfunctions,0,0
173691,during,0,0
173692,working,0,1
173693,memory,0,1
173694,(,0,1
173695,WM,0,1
173696,),0,1
173697,.,0,1
173698,Serotonin,0,1
173699,agonists,0,1
173700,modulate,0,1
173701,WM,0,1
173702,and,0,0
173703,there,0,0
173704,is,0,0
173705,evidence,0,0
173706,of,0,0
173707,positive,0,0
173708,behavioural,0,0
173709,effects,0,0
173710,in,0,0
173711,both,0,0
173712,disorders,0,0
173713,.,0,0
173714,We,0,0
173715,therefore,0,0
173716,used,0,0
173717,functional,0,0
173718,magnetic,0,0
173719,resonance,0,1
173720,imaging,0,1
173721,(,0,1
173722,fMRI,0,1
173723,),0,0
173724,to,0,0
173725,investigate,0,0
173726,shared,0,0
173727,and,0,0
173728,disorder-specific,0,0
173729,brain,0,0
173730,dysfunctions,0,0
173731,of,0,0
173732,WM,0,0
173733,in,0,0
173734,these,0,0
173735,disorders,0,0
173736,",",0,0
173737,and,0,0
173738,the,0,0
173739,effects,0,0
173740,of,0,0
173741,a,0,0
173742,single,0,0
173743,dose,0,1
173744,of,0,0
173745,the,0,0
173746,selective,0,0
173747,serotonin,1,1
173748,reuptake,1,1
173749,inhibitor,1,1
173750,(,1,1
173751,SSRI,1,1
173752,),1,1
173753,fluoxetine,1,1
173754,.,1,1
173755,METHOD,0,0
173756,Age-matched,0,0
173757,boys,0,0
173758,with,0,0
173759,ADHD,0,1
173760,(,0,0
173761,n,0,0
173762,=,0,0
173763,17,0,0
173764,),0,0
173765,",",0,0
173766,ASD,0,1
173767,(,0,0
173768,n,0,0
173769,=,0,0
173770,17,0,0
173771,),0,0
173772,and,0,1
173773,controls,0,1
173774,(,0,0
173775,n,0,0
173776,=,0,0
173777,22,0,0
173778,),0,0
173779,were,0,0
173780,compared,0,0
173781,using,0,0
173782,fMRI,1,0
173783,during,0,0
173784,an,0,0
173785,N-back,0,0
173786,WM,0,0
173787,task,0,0
173788,.,0,0
173789,Patients,0,0
173790,were,0,0
173791,scanned,0,0
173792,twice,0,0
173793,",",0,0
173794,under,0,0
173795,either,0,0
173796,an,0,0
173797,acute,0,0
173798,dose,0,1
173799,of,1,1
173800,fluoxetine,1,1
173801,or,1,1
173802,placebo,1,1
173803,in,1,0
173804,a,1,0
173805,double-blind,0,1
173806,",",0,1
173807,placebo-controlled,0,1
173808,randomized,0,1
173809,design,0,1
173810,.,0,0
173811,Repeated-measures,0,0
173812,analyses,0,0
173813,within,0,0
173814,patients,0,0
173815,assessed,0,0
173816,drug,0,1
173817,effects,0,0
173818,on,0,0
173819,performance,0,0
173820,and,0,0
173821,brain,0,0
173822,function,0,0
173823,.,0,0
173824,To,0,0
173825,test,0,0
173826,for,0,0
173827,normalization,0,0
173828,effects,0,0
173829,of,0,0
173830,brain,0,0
173831,dysfunctions,0,0
173832,",",0,0
173833,patients,0,0
173834,under,0,0
173835,each,0,0
173836,drug,0,1
173837,condition,0,0
173838,were,0,0
173839,compared,0,0
173840,to,0,0
173841,controls,0,0
173842,.,0,0
173843,RESULTS,0,1
173844,Under,0,1
173845,placebo,1,1
173846,",",1,0
173847,relative,1,0
173848,to,0,0
173849,controls,0,0
173850,",",0,0
173851,both,0,0
173852,ADHD,0,0
173853,and,0,0
173854,ASD,0,0
173855,boys,0,0
173856,shared,0,0
173857,underactivation,0,0
173858,in,0,0
173859,the,0,0
173860,right,0,0
173861,dorsolateral,0,0
173862,prefrontal,0,1
173863,cortex,0,1
173864,(,0,1
173865,DLPFC,0,1
173866,),0,1
173867,.,0,0
173868,Fluoxetine,0,1
173869,significantly,0,0
173870,normalized,0,0
173871,the,0,0
173872,DLPFC,0,0
173873,underactivation,0,0
173874,in,0,0
173875,ASD,0,0
173876,relative,0,0
173877,to,0,0
173878,controls,0,0
173879,whereas,0,0
173880,it,0,0
173881,increased,0,0
173882,posterior,0,0
173883,cingulate,0,1
173884,cortex,0,1
173885,(,0,1
173886,PCC,0,1
173887,),0,0
173888,deactivation,0,0
173889,in,0,0
173890,ADHD,0,0
173891,relative,0,0
173892,to,0,0
173893,control,0,0
173894,boys,0,0
173895,.,0,0
173896,Within-patient,0,0
173897,analyses,0,0
173898,showed,0,0
173899,inverse,0,0
173900,effects,0,0
173901,of,0,0
173902,fluoxetine,0,1
173903,on,0,0
173904,PCC,0,0
173905,deactivation,0,0
173906,",",0,0
173907,which,0,0
173908,it,0,0
173909,enhanced,0,0
173910,in,0,0
173911,ADHD,0,0
173912,and,0,0
173913,decreased,0,0
173914,in,0,0
173915,ASD,0,0
173916,.,0,0
173917,CONCLUSIONS,0,0
173918,The,0,0
173919,findings,0,0
173920,show,0,0
173921,that,0,0
173922,fluoxetine,0,1
173923,modulates,0,0
173924,brain,0,0
173925,activation,0,0
173926,during,0,0
173927,WM,0,0
173928,in,0,0
173929,a,0,0
173930,disorder-specific,0,0
173931,manner,0,0
173932,by,0,0
173933,normalizing,0,0
173934,task-positive,0,0
173935,DLPFC,0,0
173936,dysfunction,0,0
173937,in,0,0
173938,ASD,0,0
173939,boys,0,0
173940,and,0,0
173941,enhancing,0,0
173942,task-negative,0,0
173943,default,0,0
173944,mode,0,0
173945,network,0,0
173946,(,0,0
173947,DMN,0,1
173948,),0,0
173949,deactivation,0,0
173950,in,0,0
173951,ADHD,0,0
173952,.,0,0
173953,Effect,0,0
173954,of,0,0
173955,orlistat,1,1
173956,on,0,0
173957,weight,0,0
173958,loss,0,0
173959,",",0,0
173960,hormonal,0,0
173961,and,0,0
173962,metabolic,0,0
173963,profiles,0,0
173964,in,0,0
173965,women,0,0
173966,with,0,0
173967,polycystic,0,0
173968,ovarian,0,0
173969,syndrome,0,0
173970,:,0,0
173971,a,0,0
173972,randomized,0,1
173973,double-blind,0,1
173974,placebo-controlled,0,1
173975,trial,0,1
173976,.,0,0
173977,Comparing,0,0
173978,antipsychotic,0,1
173979,treatments,0,1
173980,for,0,0
173981,schizophrenia,0,0
173982,:,0,0
173983,a,0,0
173984,health,0,0
173985,state,0,0
173986,approach,0,0
173987,.,0,0
173988,The,0,0
173989,overall,0,0
173990,impact,0,0
173991,of,0,0
173992,first,0,0
173993,and,0,0
173994,second,0,0
173995,generation,0,0
173996,antipsychotics,1,1
173997,on,0,0
173998,quality,0,0
173999,of,0,0
174000,life,0,0
174001,and,0,0
174002,symptoms,0,0
174003,of,0,0
174004,people,0,0
174005,with,0,0
174006,schizophrenia,0,0
174007,remains,0,0
174008,controversial,0,0
174009,.,0,0
174010,We,0,0
174011,applied,0,0
174012,health,0,0
174013,state,0,0
174014,modeling,0,0
174015,to,0,0
174016,data,0,0
174017,from,0,0
174018,the,0,0
174019,Clinical,0,0
174020,Antipsychotic,0,0
174021,Trials,0,0
174022,of,0,0
174023,Intervention,0,1
174024,Effectiveness,0,1
174025,(,0,1
174026,CATIE,0,1
174027,),0,1
174028,Schizophrenia,0,0
174029,study,0,0
174030,",",0,0
174031,a,0,0
174032,randomized,0,0
174033,trial,0,0
174034,of,0,1
174035,antipsychotic,1,1
174036,medications,1,1
174037,",",0,1
174038,and,0,0
174039,evaluated,0,0
174040,the,0,0
174041,likelihood,0,0
174042,of,0,0
174043,patients,0,0
174044,moving,0,0
174045,to,0,0
174046,more,0,0
174047,favorable,0,0
174048,health,0,0
174049,states,0,0
174050,over,0,0
174051,time,0,0
174052,.,0,0
174053,We,0,0
174054,applied,0,0
174055,K-means,0,0
174056,clustering,0,0
174057,to,0,0
174058,the,0,0
174059,data,0,0
174060,to,0,0
174061,create,0,0
174062,discrete,0,0
174063,groupings,0,0
174064,of,0,0
174065,patients,0,0
174066,with,0,0
174067,symptom,0,0
174068,and,0,0
174069,side,0,0
174070,effect,0,0
174071,characteristics,0,0
174072,that,0,0
174073,were,0,0
174074,then,0,0
174075,validated,0,0
174076,using,0,0
174077,quality,0,0
174078,of,0,0
174079,life,0,0
174080,measures,0,0
174081,.,0,0
174082,We,0,0
174083,compared,0,0
174084,cluster,0,0
174085,distributions,0,0
174086,across,0,0
174087,medications,0,1
174088,at,0,1
174089,baseline,0,0
174090,and,0,0
174091,6,0,0
174092,months,0,0
174093,after,0,0
174094,randomization,0,0
174095,.,0,0
174096,"1,049",0,0
174097,patients,0,0
174098,were,0,0
174099,included,0,0
174100,in,0,0
174101,the,0,0
174102,initial,0,0
174103,cluster,0,0
174104,analysis,0,0
174105,.,0,0
174106,Five,0,0
174107,health,0,0
174108,states,0,0
174109,were,0,0
174110,identified,0,0
174111,:,0,0
174112,(,0,0
174113,1,0,0
174114,),0,0
174115,low,0,0
174116,symptoms,0,0
174117,and,0,0
174118,low,0,0
174119,side,0,0
174120,effects,0,0
174121,(,0,0
174122,LS,0,1
174123,+,0,1
174124,LSE,0,1
174125,),0,1
174126,(,0,1
174127,2,0,1
174128,),0,0
174129,low,0,0
174130,symptoms,0,0
174131,and,0,0
174132,obesity,0,1
174133,(,0,1
174134,LS,0,1
174135,+,0,1
174136,Ob,0,1
174137,),0,1
174138,(,0,1
174139,3,0,1
174140,),0,0
174141,high,0,0
174142,symptoms,0,0
174143,and,0,0
174144,low,0,0
174145,side,0,0
174146,effects,0,0
174147,(,0,0
174148,HS,0,1
174149,+,0,1
174150,LSE,0,1
174151,),0,1
174152,(,0,1
174153,4,0,1
174154,),0,0
174155,high,0,0
174156,symptoms,0,0
174157,with,0,0
174158,depression,0,0
174159,and,0,0
174160,akathisia,0,1
174161,(,0,1
174162,HS,0,1
174163,+,0,1
174164,Dp,0,1
174165,+,0,1
174166,Ak,0,0
174167,),0,1
174168,and,0,1
174169,(,0,1
174170,5,0,0
174171,),0,0
174172,moderate,0,0
174173,symptoms,0,0
174174,and,0,0
174175,high,0,0
174176,side,0,0
174177,effects,0,0
174178,(,0,0
174179,MS,0,1
174180,+,0,1
174181,HSE,0,1
174182,),0,1
174183,.,0,0
174184,Six-month,0,0
174185,outcomes,0,0
174186,among,0,0
174187,patients,0,0
174188,randomly,0,0
174189,assigned,0,0
174190,to,0,0
174191,perphenazine,1,1
174192,",",1,1
174193,olanzapine,1,1
174194,",",1,1
174195,risperidone,1,1
174196,and,0,1
174197,quetiapine,1,1
174198,were,0,0
174199,compared,0,0
174200,.,0,0
174201,At,0,0
174202,baseline,0,0
174203,",",0,0
174204,almost,0,0
174205,20,0,0
174206,%,0,0
174207,of,0,0
174208,patients,0,0
174209,were,0,0
174210,in,0,0
174211,the,0,0
174212,worst,0,0
174213,health,0,0
174214,state,0,0
174215,(,0,1
174216,HS,0,1
174217,+,0,1
174218,Dp,0,1
174219,+,0,1
174220,Ak,0,0
174221,),0,0
174222,",",0,0
174223,with,0,0
174224,greater,0,0
174225,decreases,0,0
174226,at,0,0
174227,6,0,0
174228,months,0,0
174229,in,0,0
174230,this,0,0
174231,health,0,0
174232,state,0,0
174233,for,0,0
174234,perphenazine,1,1
174235,(,0,0
174236,9.2,0,0
174237,%,0,0
174238,decrease,0,0
174239,),0,0
174240,and,0,1
174241,olanzapine,1,1
174242,(,0,0
174243,11.1,0,0
174244,%,0,0
174245,),0,0
174246,groups,0,0
174247,compared,0,0
174248,to,0,0
174249,risperidone,1,1
174250,(,0,0
174251,4.7,0,0
174252,%,0,0
174253,),0,0
174254,and,0,0
174255,quetiapine,0,1
174256,(,0,0
174257,6.7,0,0
174258,%,0,0
174259,),0,0
174260,.,0,0
174261,This,0,0
174262,study,0,0
174263,demonstrated,0,0
174264,that,0,0
174265,health,0,0
174266,state,0,0
174267,analysis,0,0
174268,can,0,0
174269,provide,0,0
174270,insight,0,0
174271,into,0,0
174272,the,0,0
174273,overall,0,0
174274,clinical,0,0
174275,state,0,0
174276,of,0,0
174277,patients,0,0
174278,beyond,0,0
174279,the,0,0
174280,mere,0,0
174281,comparison,0,0
174282,of,0,0
174283,average,0,0
174284,scores,0,0
174285,and,0,0
174286,largely,0,0
174287,confirmed,0,0
174288,original,0,0
174289,CATIE,0,0
174290,findings,0,0
174291,.,0,0
174292,Sulforaphane,1,1
174293,treatment,0,1
174294,of,0,0
174295,autism,0,0
174296,spectrum,0,0
174297,disorder,0,1
174298,(,0,1
174299,ASD,0,1
174300,),0,1
174301,.,0,0
174302,Autism,0,0
174303,spectrum,0,0
174304,disorder,0,1
174305,(,0,1
174306,ASD,0,1
174307,),0,1
174308,",",0,0
174309,characterized,0,0
174310,by,0,0
174311,both,0,0
174312,impaired,0,0
174313,communication,0,0
174314,and,0,0
174315,social,0,0
174316,interaction,0,0
174317,",",0,0
174318,and,0,0
174319,by,0,0
174320,stereotypic,0,0
174321,behavior,0,0
174322,",",0,0
174323,affects,0,0
174324,about,0,0
174325,1,0,0
174326,in,0,0
174327,68,0,0
174328,",",0,0
174329,predominantly,0,0
174330,males,0,0
174331,.,0,0
174332,The,0,0
174333,medico-economic,0,0
174334,burdens,0,0
174335,of,0,0
174336,ASD,0,0
174337,are,0,0
174338,enormous,0,0
174339,",",0,0
174340,and,0,0
174341,no,0,0
174342,recognized,0,0
174343,treatment,0,0
174344,targets,0,0
174345,the,0,0
174346,core,0,0
174347,features,0,0
174348,of,0,0
174349,ASD,0,0
174350,.,0,0
174351,In,0,0
174352,a,0,0
174353,placebo-controlled,0,1
174354,",",0,1
174355,double-blind,0,1
174356,",",0,1
174357,randomized,0,1
174358,trial,0,0
174359,",",0,0
174360,young,0,1
174361,men,0,1
174362,(,0,0
174363,aged,0,0
174364,13-27,0,0
174365,),0,0
174366,with,0,0
174367,moderate,0,0
174368,to,0,0
174369,severe,0,0
174370,ASD,0,0
174371,received,0,0
174372,the,0,0
174373,phytochemical,1,1
174374,sulforaphane,1,1
174375,(,1,1
174376,n,1,0
174377,=,1,0
174378,29,1,0
174379,),1,0
174380,--,1,0
174381,derived,1,0
174382,from,1,0
174383,broccoli,1,1
174384,sprout,1,0
174385,extracts,1,0
174386,--,1,0
174387,or,1,0
174388,indistinguishable,1,0
174389,placebo,1,1
174390,(,0,0
174391,n,0,0
174392,=,0,0
174393,15,0,0
174394,),0,0
174395,.,0,0
174396,The,0,0
174397,effects,0,0
174398,on,0,0
174399,behavior,0,0
174400,of,0,0
174401,daily,0,1
174402,oral,0,1
174403,doses,0,1
174404,of,0,1
174405,sulforaphane,1,1
174406,(,0,1
174407,50-150,0,1
174408,?mol,0,1
174409,),0,0
174410,for,0,0
174411,18,0,0
174412,wk,0,0
174413,",",0,0
174414,followed,0,0
174415,by,0,0
174416,4,0,0
174417,wk,0,0
174418,without,0,0
174419,treatment,0,0
174420,",",0,0
174421,were,0,0
174422,quantified,0,0
174423,by,0,0
174424,three,0,0
174425,widely,0,0
174426,accepted,0,0
174427,behavioral,0,0
174428,measures,0,0
174429,completed,0,0
174430,by,0,0
174431,parents/caregivers,0,0
174432,and,0,0
174433,physicians,0,0
174434,:,0,0
174435,the,0,0
174436,Aberrant,0,0
174437,Behavior,0,0
174438,Checklist,0,1
174439,(,0,1
174440,ABC,0,1
174441,),0,1
174442,",",0,0
174443,Social,0,0
174444,Responsiveness,0,0
174445,Scale,0,1
174446,(,0,1
174447,SRS,0,1
174448,),0,1
174449,",",0,0
174450,and,0,0
174451,Clinical,0,0
174452,Global,0,0
174453,Impression,0,0
174454,Improvement,0,1
174455,Scale,0,1
174456,(,0,1
174457,CGI-I,0,1
174458,),0,1
174459,.,0,0
174460,Initial,0,0
174461,scores,0,0
174462,for,0,0
174463,ABC,0,0
174464,and,0,0
174465,SRS,0,0
174466,were,0,0
174467,closely,0,0
174468,matched,0,0
174469,for,0,0
174470,participants,0,0
174471,assigned,0,0
174472,to,1,0
174473,placebo,1,1
174474,and,1,1
174475,sulforaphane,1,1
174476,.,1,1
174477,After,0,1
174478,18,0,0
174479,wk,0,0
174480,",",0,0
174481,participants,0,1
174482,receiving,1,0
174483,placebo,1,1
174484,experienced,0,1
174485,minimal,0,0
174486,change,0,0
174487,(,0,0
174488,<,0,0
174489,3.3,0,0
174490,%,0,0
174491,),0,0
174492,",",0,0
174493,whereas,0,0
174494,those,0,0
174495,receiving,1,0
174496,sulforaphane,1,1
174497,showed,0,0
174498,substantial,0,0
174499,declines,0,0
174500,(,0,0
174501,improvement,0,0
174502,of,0,0
174503,behavior,0,0
174504,),0,0
174505,:,0,0
174506,34,0,0
174507,%,0,0
174508,for,0,0
174509,ABC,0,0
174510,(,0,0
174511,P,0,0
174512,<,0,0
174513,0.001,0,0
174514,",",0,0
174515,comparing,0,0
174516,treatments,0,0
174517,),0,0
174518,and,0,0
174519,17,0,0
174520,%,0,0
174521,for,0,0
174522,SRS,0,0
174523,scores,0,0
174524,(,0,0
174525,P,0,0
174526,=,0,0
174527,0.017,0,0
174528,),0,0
174529,.,0,0
174530,On,0,0
174531,CGI-I,0,0
174532,",",0,0
174533,a,0,0
174534,significantly,0,0
174535,greater,0,0
174536,number,0,0
174537,of,0,0
174538,participants,0,0
174539,receiving,1,0
174540,sulforaphane,1,1
174541,had,0,0
174542,improvement,0,0
174543,in,0,0
174544,social,0,0
174545,interaction,0,0
174546,",",0,0
174547,abnormal,0,0
174548,behavior,0,0
174549,",",0,0
174550,and,0,0
174551,verbal,0,1
174552,communication,0,0
174553,(,0,0
174554,P,0,0
174555,=,0,0
174556,0.015-0.007,0,0
174557,),0,0
174558,.,0,0
174559,Upon,0,0
174560,discontinuation,0,0
174561,of,1,0
174562,sulforaphane,1,1
174563,",",1,0
174564,total,0,0
174565,scores,0,0
174566,on,0,0
174567,all,0,0
174568,scales,0,0
174569,rose,0,0
174570,toward,0,0
174571,pretreatment,0,0
174572,levels,0,0
174573,.,0,0
174574,Dietary,1,0
174575,sulforaphane,1,1
174576,",",1,0
174577,of,0,0
174578,recognized,0,0
174579,low,0,0
174580,toxicity,0,0
174581,",",0,0
174582,was,0,0
174583,selected,0,0
174584,for,0,0
174585,its,0,0
174586,capacity,0,0
174587,to,0,0
174588,reverse,0,0
174589,abnormalities,0,0
174590,that,0,0
174591,have,0,0
174592,been,0,0
174593,associated,0,0
174594,with,0,0
174595,ASD,0,0
174596,",",0,0
174597,including,0,0
174598,oxidative,0,0
174599,stress,0,0
174600,and,0,0
174601,lower,0,0
174602,antioxidant,0,1
174603,capacity,0,0
174604,",",0,0
174605,depressed,0,0
174606,glutathione,0,1
174607,synthesis,0,0
174608,",",0,0
174609,reduced,0,0
174610,mitochondrial,0,0
174611,function,0,0
174612,and,0,0
174613,oxidative,0,0
174614,phosphorylation,0,0
174615,",",0,0
174616,increased,0,0
174617,lipid,0,0
174618,peroxidation,0,1
174619,",",0,1
174620,and,0,0
174621,neuroinflammmation,0,0
174622,.,0,0
174623,A,0,1
174624,randomized,0,0
174625,controlled,0,0
174626,trial,0,0
174627,of,0,0
174628,Pivotal,1,0
174629,Response,1,0
174630,Treatment,1,0
174631,Group,1,0
174632,for,0,0
174633,parents,0,0
174634,of,0,0
174635,children,0,0
174636,with,0,0
174637,autism,0,0
174638,.,0,0
174639,BACKGROUND,0,0
174640,With,0,0
174641,rates,0,0
174642,of,0,0
174643,autism,0,0
174644,diagnosis,0,0
174645,continuing,0,0
174646,to,0,0
174647,rise,0,0
174648,",",0,0
174649,there,0,0
174650,is,0,0
174651,an,0,0
174652,urgent,0,0
174653,need,0,0
174654,for,0,0
174655,effective,0,0
174656,and,0,0
174657,efficient,0,0
174658,service,0,0
174659,delivery,0,0
174660,models,0,0
174661,.,0,0
174662,Pivotal,1,0
174663,Response,1,0
174664,Treatment,1,1
174665,(,1,1
174666,PRT,1,1
174667,),1,0
174668,is,0,0
174669,considered,0,0
174670,an,0,0
174671,established,0,0
174672,treatment,0,0
174673,for,0,0
174674,autism,0,0
174675,spectrum,0,0
174676,disorder,0,1
174677,(,0,1
174678,ASD,0,1
174679,),0,1
174680,;,0,0
174681,however,0,0
174682,",",0,0
174683,there,0,0
174684,have,0,0
174685,been,0,0
174686,few,0,0
174687,well-controlled,0,0
174688,studies,0,0
174689,with,0,0
174690,adequate,0,0
174691,sample,0,0
174692,size,0,0
174693,.,0,0
174694,The,0,0
174695,aim,0,0
174696,of,0,0
174697,this,0,0
174698,study,0,0
174699,was,0,0
174700,to,0,0
174701,conduct,0,0
174702,a,0,0
174703,randomized,0,0
174704,controlled,0,0
174705,trial,0,0
174706,to,0,0
174707,evaluate,0,0
174708,PRT,1,0
174709,parent,1,0
174710,training,1,1
174711,group,1,0
174712,(,1,1
174713,PRTG,1,1
174714,),1,0
174715,for,0,0
174716,targeting,0,0
174717,language,0,0
174718,deficits,0,0
174719,in,0,0
174720,young,0,0
174721,children,0,0
174722,with,0,0
174723,ASD,0,0
174724,.,0,0
174725,METHODS,0,0
174726,Fifty-three,0,0
174727,children,0,0
174728,with,0,0
174729,autism,0,0
174730,and,0,0
174731,significant,0,0
174732,language,0,0
174733,delay,0,0
174734,between,0,0
174735,2,0,0
174736,and,0,0
174737,6,0,0
174738,years,0,0
174739,old,0,0
174740,were,0,0
174741,randomized,0,0
174742,to,1,0
174743,PRTG,1,1
174744,(,1,0
174745,N,1,0
174746,=,1,0
174747,27,1,0
174748,),1,0
174749,or,1,0
174750,psychoeducation,1,1
174751,group,1,1
174752,(,1,1
174753,PEG,1,1
174754,;,0,0
174755,N,0,0
174756,=,0,0
174757,26,0,0
174758,),0,0
174759,for,0,0
174760,12,0,0
174761,weeks,0,0
174762,.,0,0
174763,The,0,0
174764,PRTG,0,0
174765,taught,0,0
174766,parents,0,0
174767,behavioral,0,0
174768,techniques,0,0
174769,to,0,0
174770,facilitate,0,0
174771,language,0,0
174772,development,0,0
174773,.,0,0
174774,The,0,0
174775,PEG,0,0
174776,taught,0,0
174777,general,0,0
174778,information,0,0
174779,about,0,0
174780,ASD,0,1
174781,(,0,1
174782,clinical,0,1
174783,trial,0,1
174784,NCT01881750,0,1
174785,;,0,0
174786,http,0,0
174787,:,0,0
174788,//www.clinicaltrials.gov,0,0
174789,),0,0
174790,.,0,0
174791,RESULTS,0,0
174792,Analysis,0,0
174793,of,0,0
174794,child,0,0
174795,utterances,0,0
174796,during,0,0
174797,the,0,0
174798,structured,0,0
174799,laboratory,0,0
174800,observation,0,0
174801,(,0,0
174802,primary,0,0
174803,outcome,0,1
174804,),0,0
174805,indicated,0,0
174806,that,0,0
174807,",",0,0
174808,compared,0,0
174809,with,0,0
174810,children,0,0
174811,in,0,0
174812,the,0,0
174813,PEG,0,0
174814,",",0,0
174815,children,0,0
174816,in,0,0
174817,the,0,0
174818,PRTG,0,0
174819,demonstrated,0,0
174820,greater,0,0
174821,improvement,0,0
174822,in,0,0
174823,frequency,0,0
174824,of,0,0
174825,utterances,0,0
174826,(,0,1
174827,F,0,1
174828,(,0,1
174829,2,0,0
174830,",",0,0
174831,43,0,0
174832,),0,0
174833,=,0,0
174834,3.53,0,0
174835,",",0,0
174836,p,0,0
174837,=,0,0
174838,.038,0,0
174839,",",0,0
174840,d,0,0
174841,=,0,0
174842,0.42,0,0
174843,),0,0
174844,.,0,0
174845,Results,0,0
174846,indicated,0,0
174847,that,0,0
174848,parents,0,0
174849,were,0,0
174850,able,0,0
174851,to,0,0
174852,learn,1,0
174853,PRT,1,0
174854,in,1,0
174855,a,0,0
174856,group,0,0
174857,format,0,0
174858,",",0,0
174859,as,0,0
174860,the,0,0
174861,majority,0,0
174862,of,0,0
174863,parents,0,0
174864,in,0,0
174865,the,0,0
174866,PRTG,0,0
174867,(,0,0
174868,84,0,0
174869,%,0,0
174870,),0,0
174871,met,0,0
174872,fidelity,0,0
174873,of,0,0
174874,implementation,0,0
174875,criteria,0,0
174876,after,0,0
174877,12,0,0
174878,weeks,0,0
174879,.,0,0
174880,Children,0,0
174881,also,0,0
174882,demonstrated,0,0
174883,greater,0,0
174884,improvement,0,0
174885,in,0,0
174886,adaptive,0,0
174887,communication,0,0
174888,skills,0,1
174889,(,0,1
174890,Vineland-II,0,1
174891,),0,1
174892,following,0,0
174893,PRTG,0,1
174894,and,0,0
174895,baseline,0,0
174896,Mullen,0,1
174897,visual,0,0
174898,reception,0,0
174899,scores,0,0
174900,predicted,0,0
174901,treatment,0,0
174902,response,0,0
174903,to,0,0
174904,PRTG,0,0
174905,.,0,0
174906,CONCLUSIONS,0,0
174907,This,0,0
174908,is,0,0
174909,the,0,0
174910,first,0,0
174911,randomized,0,0
174912,controlled,0,0
174913,trial,0,0
174914,of,0,0
174915,group-delivered,0,0
174916,PRT,0,0
174917,and,0,0
174918,one,0,0
174919,of,0,0
174920,the,0,0
174921,largest,0,0
174922,experimental,0,0
174923,investigations,0,0
174924,of,0,0
174925,the,0,0
174926,PRT,0,0
174927,model,0,0
174928,to,0,0
174929,date,0,0
174930,.,0,0
174931,The,0,0
174932,findings,0,0
174933,suggest,0,0
174934,that,0,0
174935,specific,0,0
174936,instruction,0,0
174937,in,1,0
174938,PRT,1,0
174939,results,1,0
174940,in,0,0
174941,greater,0,0
174942,skill,0,0
174943,acquisition,0,0
174944,for,0,0
174945,both,0,0
174946,parents,0,0
174947,and,0,0
174948,children,0,0
174949,",",0,0
174950,especially,0,0
174951,in,0,0
174952,functional,0,0
174953,and,0,0
174954,adaptive,0,0
174955,communication,0,0
174956,skills,0,0
174957,.,0,0
174958,Further,0,0
174959,research,1,0
174960,in,1,0
174961,PRT,1,0
174962,is,1,0
174963,warranted,1,0
174964,to,0,0
174965,replicate,0,0
174966,the,0,0
174967,observed,0,0
174968,results,0,0
174969,and,0,0
174970,address,0,0
174971,other,0,0
174972,core,0,0
174973,ASD,0,0
174974,symptoms,0,0
174975,.,0,0
174976,A,0,1
174977,5-year,0,1
174978,randomized,0,0
174979,trial,0,0
174980,to,0,0
174981,compare,0,0
174982,1,0,0
174983,or,0,0
174984,2,0,0
174985,implants,1,0
174986,for,0,0
174987,implant,0,0
174988,overdentures,0,0
174989,.,0,0
174990,The,0,0
174991,hypothesis,0,0
174992,of,0,0
174993,this,0,0
174994,5-y,0,0
174995,randomized,0,0
174996,clinical,0,0
174997,trial,0,0
174998,was,0,0
174999,that,0,0
175000,there,0,0
175001,would,0,0
175002,be,0,0
175003,no,0,0
175004,significant,0,0
175005,difference,0,0
175006,in,0,0
175007,the,0,0
175008,satisfaction,0,0
175009,of,0,0
175010,edentulous,0,0
175011,participants,0,0
175012,with,0,0
175013,removable,0,0
175014,complete,0,0
175015,overdentures,0,0
175016,attached,0,0
175017,to,0,0
175018,1,0,0
175019,or,0,0
175020,2,0,0
175021,mandibular,1,0
175022,implants,1,0
175023,.,1,0
175024,Secondary,0,0
175025,aims,0,0
175026,were,0,0
175027,to,0,0
175028,test,0,0
175029,changes,0,0
175030,in,0,0
175031,satisfaction,0,0
175032,between,0,0
175033,and,0,0
175034,within,0,0
175035,the,0,0
175036,groups,0,0
175037,from,0,0
175038,baseline,0,0
175039,to,0,0
175040,5,0,0
175041,y,0,0
175042,and,0,0
175043,differences,0,0
175044,between,0,0
175045,the,0,0
175046,groups,0,0
175047,in,0,0
175048,implant,0,0
175049,survival,0,0
175050,and,0,0
175051,prosthodontic,0,0
175052,maintenance,0,0
175053,over,0,0
175054,5,0,0
175055,y,0,0
175056,.,0,0
175057,Each,0,0
175058,of,0,0
175059,the,0,0
175060,86,0,0
175061,participants,0,0
175062,(,0,0
175063,mean,0,0
175064,age,0,0
175065,",",0,0
175066,67,0,0
175067,y,0,0
175068,),0,0
175069,was,0,0
175070,randomly,0,0
175071,allocated,0,0
175072,to,0,0
175073,receive,0,0
175074,either,0,0
175075,1,1,0
175076,implant,1,0
175077,in,1,0
175078,the,1,0
175079,midline,1,1
175080,(,0,1
175081,group,0,0
175082,1,0,1
175083,),0,0
175084,or,0,0
175085,2,1,0
175086,implants,1,0
175087,in,1,0
175088,the,1,0
175089,canine,1,0
175090,areas,1,0
175091,(,0,0
175092,group,0,0
175093,2,0,1
175094,),0,0
175095,attached,0,0
175096,to,0,0
175097,a,0,0
175098,mandibular,0,0
175099,overdenture,0,0
175100,opposing,0,0
175101,a,0,0
175102,maxillary,0,0
175103,complete,0,0
175104,denture,0,0
175105,.,0,0
175106,Satisfaction,0,0
175107,was,0,0
175108,self-assessed,0,0
175109,by,0,0
175110,participants,0,0
175111,on,0,0
175112,a,0,0
175113,visual,0,0
175114,analog,0,1
175115,scale,0,1
175116,at,0,0
175117,baseline,0,0
175118,prior,0,0
175119,to,0,0
175120,implants,0,0
175121,",",0,0
175122,as,0,0
175123,well,0,0
175124,as,0,0
175125,at,0,0
175126,2,0,0
175127,mo,0,0
175128,and,0,0
175129,1,0,0
175130,",",0,0
175131,3,0,0
175132,",",0,0
175133,and,0,0
175134,5,0,0
175135,y,0,0
175136,with,0,0
175137,implant,0,0
175138,overdentures,0,0
175139,",",0,0
175140,whereas,0,0
175141,implant,0,0
175142,survival,0,0
175143,and,0,0
175144,prosthodontic,0,0
175145,maintenance,0,0
175146,were,0,0
175147,assessed,0,0
175148,by,0,0
175149,clinical,0,0
175150,examination,0,0
175151,.,0,0
175152,After,0,0
175153,5,0,0
175154,y,0,0
175155,",",0,0
175156,29,0,0
175157,participants,0,0
175158,in,0,0
175159,group,0,0
175160,1,0,0
175161,and,0,0
175162,33,0,0
175163,in,0,0
175164,group,0,0
175165,2,0,0
175166,were,0,0
175167,available,0,0
175168,",",0,0
175169,with,0,0
175170,most,0,0
175171,dropouts,0,0
175172,due,0,0
175173,to,0,0
175174,death,0,0
175175,.,0,0
175176,Satisfaction,0,0
175177,with,0,0
175178,the,0,0
175179,implant,0,0
175180,denture,0,0
175181,after,0,0
175182,5,0,0
175183,y,0,0
175184,was,0,0
175185,significantly,0,0
175186,(,0,0
175187,P,0,0
175188,<,0,0
175189,0.001,0,0
175190,),0,0
175191,higher,0,0
175192,than,0,0
175193,at,0,0
175194,baseline,0,0
175195,in,0,0
175196,both,0,0
175197,groups,0,0
175198,and,0,0
175199,remained,0,0
175200,with,0,0
175201,no,0,0
175202,significant,0,0
175203,difference,0,0
175204,(,0,0
175205,P,0,0
175206,=,0,0
175207,0.32,0,0
175208,),0,0
175209,between,0,0
175210,the,0,0
175211,groups,0,0
175212,.,0,0
175213,No,0,1
175214,implants,0,0
175215,failed,0,0
175216,in,0,0
175217,group,0,0
175218,1,0,0
175219,but,0,0
175220,5,0,0
175221,failed,0,0
175222,before,0,0
175223,loading,0,0
175224,in,0,0
175225,4,0,0
175226,participants,0,0
175227,in,0,0
175228,group,0,0
175229,2,0,0
175230,.,0,0
175231,Most,0,0
175232,participants,0,0
175233,required,0,0
175234,maintenance,0,0
175235,or,0,0
175236,occasionally,0,0
175237,denture,0,0
175238,replacement,0,0
175239,",",0,0
175240,and,0,0
175241,although,0,0
175242,differences,0,0
175243,between,0,0
175244,the,0,0
175245,groups,0,0
175246,were,0,0
175247,not,0,0
175248,statistically,0,0
175249,significant,0,0
175250,",",0,0
175251,group,0,0
175252,1,0,0
175253,experienced,0,0
175254,almost,0,0
175255,twice,0,0
175256,as,0,0
175257,many,0,0
175258,fractured,0,0
175259,dentures,0,0
175260,usually,0,0
175261,adjacent,0,0
175262,to,0,0
175263,the,0,0
175264,implant,0,0
175265,attachment,0,0
175266,.,0,0
175267,We,0,0
175268,conclude,0,0
175269,that,0,0
175270,there,0,0
175271,were,0,0
175272,no,0,0
175273,significant,0,0
175274,differences,0,0
175275,after,0,0
175276,5,0,0
175277,y,0,0
175278,in,0,0
175279,satisfaction,0,0
175280,or,0,0
175281,survival,0,0
175282,of,0,0
175283,implants,0,0
175284,with,0,0
175285,mandibular,0,0
175286,overdentures,0,0
175287,retained,0,0
175288,by,0,0
175289,1,0,0
175290,implant,0,0
175291,or,0,0
175292,2,0,0
175293,implants,0,0
175294,.,0,0
175295,Additional,0,0
175296,research,0,0
175297,is,0,0
175298,required,0,0
175299,to,0,0
175300,confirm,0,0
175301,long-term,0,0
175302,treatment,0,0
175303,effectiveness,0,0
175304,of,0,0
175305,single-implant,0,0
175306,dentures,0,0
175307,and,0,0
175308,the,0,0
175309,implications,0,0
175310,of,0,0
175311,prosthetic,0,0
175312,maintenance,0,0
175313,with,0,0
175314,implant,0,0
175315,overdentures,0,1
175316,(,0,0
175317,ClinicalTrials.gov,0,0
175318,:,0,1
175319,NCT02117856,0,1
175320,),0,0
175321,.,0,0
175322,The,0,0
175323,effect,0,0
175324,of,0,0
175325,endoscopic,1,0
175326,fundoplication,1,0
175327,and,1,0
175328,proton,1,0
175329,pump,1,1
175330,inhibitors,1,1
175331,on,0,1
175332,baseline,0,0
175333,impedance,0,0
175334,and,0,0
175335,heartburn,0,0
175336,severity,0,0
175337,in,0,0
175338,GERD,0,0
175339,patients,0,0
175340,.,0,0
175341,BACKGROUND,0,0
175342,Antireflux,0,0
175343,therapy,0,0
175344,may,0,0
175345,lead,0,0
175346,to,0,0
175347,recovery,0,0
175348,of,0,0
175349,impaired,0,0
175350,mucosal,0,0
175351,integrity,0,0
175352,in,0,0
175353,gastro-esophageal,0,0
175354,reflux,0,1
175355,disease,0,1
175356,(,0,1
175357,GERD,0,1
175358,),0,1
175359,patients,0,0
175360,as,0,0
175361,reflected,0,0
175362,by,0,0
175363,an,0,0
175364,increase,0,0
175365,in,0,0
175366,baseline,0,0
175367,impedance,0,0
175368,.,0,0
175369,The,0,0
175370,study,0,0
175371,objective,0,0
175372,was,0,0
175373,to,0,0
175374,evaluate,0,0
175375,the,0,0
175376,effect,0,0
175377,of,0,0
175378,endoscopic,1,0
175379,fundoplication,1,0
175380,and,1,0
175381,proton,1,0
175382,pump,1,1
175383,inhibitor,1,1
175384,(,1,1
175385,PPI,1,1
175386,),1,1
175387,PPI,1,1
175388,therapy,1,1
175389,on,0,0
175390,baseline,0,0
175391,impedance,0,0
175392,and,0,0
175393,heartburn,0,0
175394,severity,0,0
175395,in,0,0
175396,GERD,0,0
175397,patients,0,0
175398,.,0,0
175399,METHODS,0,0
175400,Forty-seven,0,0
175401,GERD,0,0
175402,patients,0,0
175403,randomized,0,0
175404,to,0,0
175405,endoscopic,1,1
175406,fundoplication,1,1
175407,(,0,0
175408,n,0,0
175409,=,0,0
175410,32,0,0
175411,),0,0
175412,or,0,0
175413,PPI,1,1
175414,therapy,1,1
175415,(,1,0
175416,n,0,0
175417,=,0,0
175418,15,0,0
175419,),0,0
175420,",",0,0
175421,and,0,0
175422,29,0,0
175423,healthy,0,0
175424,controls,0,0
175425,were,0,0
175426,included,0,0
175427,.,0,0
175428,Before,0,0
175429,randomization,0,0
175430,and,0,0
175431,6,0,0
175432,months,0,0
175433,after,0,0
175434,treatment,1,0
175435,",",1,0
175436,baseline,1,0
175437,impedance,1,0
175438,was,1,0
175439,obtained,1,0
175440,during,1,0
175441,24-h,1,1
175442,pH-impedance,1,0
175443,monitoring,1,0
175444,.,1,0
175445,Heartburn,1,1
175446,severity,1,1
175447,was,1,0
175448,evaluated,1,0
175449,using,1,0
175450,the,1,0
175451,GERD-HRQL,1,0
175452,questionnaire,1,0
175453,.,1,0
175454,KEY,1,0
175455,RESULTS,0,0
175456,Before,0,0
175457,treatment,0,0
175458,",",0,0
175459,baseline,0,0
175460,impedance,0,0
175461,in,0,0
175462,GERD,0,0
175463,patients,0,0
175464,was,0,0
175465,lower,0,0
175466,than,0,0
175467,in,0,0
175468,healthy,0,0
175469,controls,0,0
175470,(,0,0
175471,p,0,0
175472,<,0,0
175473,0.001,0,0
175474,),0,0
175475,.,0,0
175476,Antireflux,0,0
175477,therapy,0,0
175478,increased,0,0
175479,baseline,0,1
175480,impedance,0,1
175481,(,0,0
175482,from,0,0
175483,1498,0,0
175484,[,0,0
175485,IQR,0,0
175486,951-2472,0,1
175487,],0,0
175488,to,0,0
175489,2393,0,0
175490,[,0,0
175491,IQR,0,0
175492,1353-3027,0,0
175493,],0,0
175494,?,0,0
175495,",",0,0
175496,p,0,0
175497,=,0,0
175498,0.001,0,0
175499,),0,0
175500,",",0,0
175501,however,0,0
175502,it,0,0
175503,only,0,0
175504,led,0,0
175505,to,0,0
175506,a,0,0
175507,partial,0,0
175508,recovery,0,0
175509,when,0,0
175510,compared,0,0
175511,to,0,0
175512,healthy,0,0
175513,controls,0,0
175514,(,0,0
175515,2393,0,0
175516,[,0,0
175517,IQR,0,0
175518,1353-3027,0,0
175519,],0,0
175520,vs,0,0
175521,2983,0,0
175522,[,0,0
175523,2335-3810,0,0
175524,],0,1
175525,?,0,0
175526,",",0,0
175527,p,0,0
175528,<,0,0
175529,0.01,0,0
175530,),0,0
175531,.,0,0
175532,The,0,0
175533,effect,0,0
175534,of,0,0
175535,both,0,0
175536,treatment,0,0
175537,options,0,0
175538,was,0,0
175539,not,0,0
175540,significantly,0,0
175541,different,0,0
175542,(,0,0
175543,p,0,0
175544,=,0,0
175545,0.13,0,0
175546,),0,0
175547,despite,0,0
175548,the,0,0
175549,increased,0,0
175550,number,0,0
175551,of,0,0
175552,non-acid,0,1
175553,reflux,0,1
175554,events,0,0
175555,in,1,0
175556,the,1,0
175557,PPI,1,0
175558,group,1,0
175559,.,0,0
175560,No,0,1
175561,correlation,0,0
175562,was,0,0
175563,found,0,0
175564,between,0,0
175565,baseline,0,0
175566,impedance,0,0
175567,and,0,0
175568,GERD,0,0
175569,symptoms,0,0
175570,before,0,0
175571,or,0,0
175572,after,0,0
175573,treatment,0,0
175574,.,0,0
175575,CONCLUSIONS,0,0
175576,&,0,1
175577,INFERENCES,0,0
175578,Reduction,0,0
175579,in,0,0
175580,acid,0,1
175581,reflux,0,0
175582,by,0,0
175583,endoscopic,1,0
175584,fundoplication,1,0
175585,or,1,0
175586,PPI,1,0
175587,therapy,1,0
175588,leads,0,0
175589,to,0,0
175590,an,0,0
175591,increase,0,0
175592,in,0,0
175593,baseline,0,0
175594,impedance,0,0
175595,in,0,0
175596,GERD,0,0
175597,patients,0,0
175598,",",0,0
175599,likely,0,0
175600,to,0,0
175601,reflect,0,0
175602,recovery,0,0
175603,of,0,0
175604,mucosal,0,0
175605,integrity,0,0
175606,.,0,0
175607,The,0,0
175608,impact,0,0
175609,of,0,0
175610,non-acid,0,1
175611,reflux,0,1
175612,events,0,0
175613,on,0,0
175614,esophageal,0,0
175615,mucosal,0,0
175616,integrity,0,0
175617,may,0,0
175618,be,0,0
175619,limited,0,0
175620,as,0,0
175621,no,0,0
175622,difference,0,0
175623,in,0,0
175624,the,0,0
175625,increase,0,0
175626,in,0,0
175627,baseline,0,0
175628,impedance,0,0
175629,was,0,0
175630,observed,0,0
175631,after,0,0
175632,both,0,0
175633,treatment,0,0
175634,options,0,0
175635,.,0,0
175636,The,0,0
175637,lack,0,0
175638,of,0,0
175639,association,0,0
175640,between,0,0
175641,impedance,0,0
175642,baseline,0,0
175643,and,0,0
175644,heartburn,0,0
175645,severity,0,0
175646,indicates,0,0
175647,that,0,0
175648,other,0,0
175649,factors,0,0
175650,may,0,0
175651,contribute,0,0
175652,to,0,0
175653,heartburn,0,0
175654,perception,0,0
175655,in,0,0
175656,GERD,0,0
175657,.,0,0
175658,Intratunnel,1,1
175659,versus,1,0
175660,extratunnel,1,0
175661,autologous,1,1
175662,hamstring,1,1
175663,double-bundle,1,0
175664,graft,1,0
175665,for,0,0
175666,anterior,0,0
175667,cruciate,0,0
175668,ligament,0,0
175669,reconstruction,0,0
175670,:,0,0
175671,a,0,0
175672,comparison,0,0
175673,of,0,0
175674,2,0,0
175675,femoral,0,0
175676,fixation,0,0
175677,procedures,0,0
175678,.,0,0
175679,BACKGROUND,0,0
175680,Anatomic,0,0
175681,double-bundle,0,1
175682,anterior,0,1
175683,cruciate,0,1
175684,ligament,0,1
175685,(,0,1
175686,ACL,0,1
175687,),0,1
175688,reconstruction,0,0
175689,provides,0,0
175690,excellent,0,0
175691,results,0,0
175692,for,0,0
175693,restoring,0,0
175694,normal,0,0
175695,kinematics,0,0
175696,to,0,0
175697,the,0,0
175698,knee,0,0
175699,.,0,0
175700,Nevertheless,0,0
175701,",",0,0
175702,strong,0,0
175703,evidence,0,0
175704,supporting,0,0
175705,an,0,0
175706,ideal,0,0
175707,method,0,0
175708,for,0,0
175709,fixation,0,0
175710,of,0,0
175711,the,0,0
175712,ACL,0,0
175713,graft,0,0
175714,is,0,0
175715,lacking,0,0
175716,.,0,0
175717,HYPOTHESIS,0,0
175718,Intratunnel,1,1
175719,femoral,1,0
175720,fixation,1,0
175721,of,1,0
175722,the,1,0
175723,ACL,1,0
175724,graft,1,0
175725,via,1,0
175726,a,1,0
175727,cross-pin,1,0
175728,fixation,1,0
175729,technique,1,0
175730,would,0,0
175731,provide,0,0
175732,better,0,0
175733,clinical,0,0
175734,and,0,0
175735,objective,0,0
175736,results,0,0
175737,than,0,0
175738,the,0,0
175739,extratunnel,1,0
175740,femoral,1,0
175741,fixation,1,0
175742,with,1,0
175743,cortical,1,0
175744,buttons,1,0
175745,.,1,0
175746,STUDY,0,0
175747,DESIGN,0,1
175748,Randomized,0,1
175749,clinical,0,1
175750,trial,0,1
175751,;,0,0
175752,Level,0,0
175753,of,0,0
175754,evidence,0,0
175755,",",0,0
175756,2,0,0
175757,.,0,0
175758,METHODS,0,0
175759,Seventy,0,0
175760,patients,0,0
175761,with,0,0
175762,a,0,0
175763,unilateral,0,0
175764,ACL-deficient,0,0
175765,knee,0,0
175766,were,0,0
175767,randomly,0,0
175768,assigned,0,0
175769,to,0,0
175770,1,0,0
175771,of,0,0
175772,2,0,0
175773,femoral,0,0
175774,fixation,0,1
175775,groups,0,0
175776,.,0,0
175777,Group,0,0
175778,A,0,0
175779,(,0,0
175780,35,0,0
175781,patients,0,0
175782,),0,0
175783,was,0,0
175784,fixed,1,0
175785,with,1,0
175786,2,1,0
175787,bioabsorbable,1,1
175788,Rigidfix,1,1
175789,pins,1,1
175790,",",1,0
175791,1,1,0
175792,cross-pin,1,0
175793,per,1,0
175794,bundle,1,0
175795,",",1,0
175796,while,1,0
175797,group,1,0
175798,B,1,0
175799,(,1,0
175800,35,1,0
175801,patients,1,0
175802,),1,0
175803,was,1,0
175804,secured,1,0
175805,with,1,0
175806,1,1,0
175807,EndoButton,1,0
175808,cortical,1,0
175809,button,1,0
175810,per,1,0
175811,bundle,1,0
175812,.,1,0
175813,All,0,0
175814,femoral,0,0
175815,tunnels,0,0
175816,were,0,0
175817,created,0,0
175818,via,0,0
175819,an,0,0
175820,anteromedial,0,0
175821,portal,0,0
175822,",",0,0
175823,and,0,0
175824,a,0,0
175825,bioabsorbable,0,1
175826,Biointrafix,0,1
175827,interference,0,0
175828,screw,0,0
175829,was,0,0
175830,used,0,0
175831,for,0,0
175832,tibial,0,0
175833,fixation,0,0
175834,for,0,0
175835,both,0,0
175836,groups,0,0
175837,.,0,0
175838,The,0,0
175839,evaluation,0,0
175840,of,0,0
175841,the,0,0
175842,patients,0,0
175843,was,0,0
175844,performed,0,0
175845,by,0,0
175846,history,0,0
175847,details,0,0
175848,",",0,0
175849,clinical,0,0
175850,examination,0,0
175851,findings,0,0
175852,",",0,0
175853,measurement,0,0
175854,of,0,0
175855,the,0,0
175856,joint,0,0
175857,laxity,0,0
175858,by,0,0
175859,KT-1000,1,1
175860,arthrometer,1,1
175861,",",0,0
175862,and,0,0
175863,use,0,0
175864,of,0,0
175865,validated,0,0
175866,patient,0,0
175867,outcome,0,0
175868,questionnaires,0,0
175869,.,0,0
175870,Statistical,0,0
175871,analysis,0,0
175872,was,0,0
175873,carried,0,0
175874,out,0,0
175875,with,0,0
175876,Fisher,0,0
175877,exact,0,0
175878,and,0,0
175879,Mann-Whitney,0,1
175880,U,0,1
175881,tests,0,1
175882,",",0,0
175883,with,0,0
175884,P,0,0
175885,<,0,0
175886,.05,0,0
175887,considered,0,0
175888,the,0,0
175889,cutoff,0,0
175890,level,0,0
175891,of,0,0
175892,significance,0,0
175893,.,0,0
175894,RESULTS,0,0
175895,At,0,0
175896,a,0,0
175897,mean,0,0
175898,follow-up,0,0
175899,of,0,0
175900,30,0,0
175901,months,0,0
175902,",",0,0
175903,34,0,0
175904,and,0,0
175905,32,0,0
175906,patients,0,0
175907,of,0,0
175908,group,0,0
175909,A,0,0
175910,and,0,0
175911,B,0,0
175912,",",0,0
175913,respectively,0,0
175914,",",0,0
175915,were,0,0
175916,available,0,0
175917,for,0,0
175918,evaluation,0,0
175919,.,0,0
175920,There,0,0
175921,were,0,0
175922,no,0,0
175923,statistically,0,0
175924,significant,0,0
175925,differences,0,0
175926,between,0,0
175927,the,0,0
175928,treatment,0,0
175929,groups,0,0
175930,regarding,0,0
175931,the,0,0
175932,subjective,0,0
175933,and,0,0
175934,objective,0,0
175935,outcomes,0,0
175936,",",0,0
175937,except,0,0
175938,for,0,0
175939,KT-1000,0,1
175940,arthrometer,0,0
175941,values,0,0
175942,.,0,0
175943,The,0,0
175944,median,0,0
175945,KT-1000,0,0
175946,value,0,0
175947,of,0,0
175948,patients,0,0
175949,in,0,0
175950,the,0,0
175951,cross-pin,0,0
175952,fixation,0,0
175953,group,0,0
175954,was,0,0
175955,1.30,0,0
175956,mm,0,0
175957,",",0,0
175958,while,0,0
175959,the,0,0
175960,median,0,0
175961,value,0,0
175962,in,0,0
175963,the,0,0
175964,cortical,1,0
175965,button,1,0
175966,fixation,1,0
175967,group,0,0
175968,was,0,0
175969,1.95,0,0
175970,mm,0,0
175971,(,0,0
175972,P,0,0
175973,<,0,0
175974,.001,0,0
175975,),0,0
175976,.,0,0
175977,Four,0,0
175978,patients,0,0
175979,with,0,0
175980,ACL,0,0
175981,grafts,0,0
175982,that,0,0
175983,were,0,0
175984,fixed,0,0
175985,with,0,0
175986,cortical,1,0
175987,buttons,1,0
175988,demonstrated,0,0
175989,failure,0,0
175990,of,0,0
175991,stability,0,0
175992,via,0,0
175993,the,0,0
175994,instrumented,0,0
175995,knee,0,0
175996,laxity,0,0
175997,testing,0,0
175998,",",0,0
175999,while,0,0
176000,patients,0,0
176001,from,0,0
176002,the,0,0
176003,other,0,0
176004,group,0,0
176005,had,0,0
176006,no,0,0
176007,failures,0,0
176008,.,0,0
176009,CONCLUSION,0,0
176010,Intratunnel,1,1
176011,femoral,1,0
176012,fixation,1,0
176013,of,1,0
176014,the,1,0
176015,double-bundle,1,0
176016,ACL,1,0
176017,graft,1,0
176018,from,0,0
176019,the,0,0
176020,cross-pin,0,0
176021,fixation,0,0
176022,technique,0,0
176023,provided,0,0
176024,better,0,0
176025,instrumented,0,0
176026,knee,0,0
176027,laxity,0,0
176028,results,0,0
176029,than,0,0
176030,did,0,0
176031,the,0,0
176032,extratunnel,1,0
176033,femoral,1,0
176034,fixation,1,0
176035,with,1,0
176036,cortical,1,0
176037,buttons,1,0
176038,.,1,0
176039,Future,0,0
176040,larger,0,0
176041,studies,0,0
176042,comparing,0,0
176043,these,0,0
176044,2,0,0
176045,techniques,0,0
176046,should,0,0
176047,be,0,0
176048,conducted,0,0
176049,to,0,0
176050,ensure,0,0
176051,the,0,0
176052,availability,0,0
176053,of,0,0
176054,stronger,0,0
176055,evidence,0,0
176056,supporting,0,0
176057,the,0,0
176058,findings,0,0
176059,of,0,0
176060,this,0,0
176061,study,0,0
176062,.,0,0
176063,Prospective,0,0
176064,randomized,0,0
176065,comparison,0,0
176066,between,0,0
176067,transperitoneal,1,0
176068,laparoscopic,1,0
176069,pyeloplasty,1,0
176070,and,0,0
176071,retroperitoneoscopic,1,0
176072,pyeloplasty,1,0
176073,for,0,0
176074,primary,0,0
176075,ureteropelvic,0,0
176076,junction,0,0
176077,obstruction,0,0
176078,.,0,0
176079,BACKGROUND,0,0
176080,AND,0,1
176081,OBJECTIVES,0,1
176082,To,0,1
176083,compare,0,0
176084,laparoscopic,1,0
176085,transperitoneal,1,1
176086,versus,0,0
176087,retroperitoneoscopic,1,0
176088,pyeloplasty,1,0
176089,for,0,0
176090,primary,0,0
176091,ureteropelvic,0,0
176092,junction,0,0
176093,obstruction,0,0
176094,in,0,0
176095,a,0,0
176096,prospective,0,0
176097,randomized,0,0
176098,manner,0,0
176099,and,0,0
176100,assess,0,0
176101,overall,0,0
176102,results,0,0
176103,with,0,0
176104,long-term,0,0
176105,follow-up,0,0
176106,.,0,0
176107,METHODS,0,0
176108,In,0,0
176109,this,0,0
176110,prospective,0,0
176111,study,0,0
176112,",",0,0
176113,from,0,0
176114,2008,0,0
176115,to,0,0
176116,2012,0,0
176117,",",0,0
176118,112,0,0
176119,cases,0,0
176120,of,0,0
176121,primary,0,0
176122,ureteropelvic,0,0
176123,junction,0,0
176124,obstruction,0,0
176125,were,0,0
176126,randomized,0,0
176127,in,0,0
176128,a,0,0
176129,1:1,0,1
176130,ratio,0,0
176131,into,0,0
176132,2,0,0
176133,groups,0,0
176134,.,0,0
176135,Group,1,0
176136,I,1,0
176137,included,1,0
176138,patients,1,0
176139,who,1,0
176140,underwent,1,0
176141,transperitoneal,1,0
176142,laparoscopic,1,0
176143,pyeloplasty,1,0
176144,",",1,0
176145,and,1,0
176146,group,1,0
176147,II,1,0
176148,consisted,1,0
176149,of,1,0
176150,patients,1,0
176151,who,1,0
176152,underwent,1,0
176153,retroperitoneoscopic,1,0
176154,laparoscopic,1,0
176155,pyeloplasty,1,0
176156,.,1,0
176157,Demographic,0,0
176158,and,0,0
176159,clinical,0,0
176160,characteristics,0,0
176161,and,0,0
176162,postoperative,0,0
176163,and,0,0
176164,operative,0,0
176165,data,0,0
176166,were,0,0
176167,collected,0,0
176168,and,0,0
176169,analyzed,0,0
176170,.,0,0
176171,The,0,0
176172,statistical,0,0
176173,analysis,0,0
176174,was,0,0
176175,performed,0,0
176176,with,0,0
176177,the,0,0
176178,Fisher,0,0
176179,exact,0,0
176180,test,0,0
176181,",",0,0
176182,?2,0,0
176183,test,0,0
176184,",",0,0
176185,and,0,0
176186,Mann-Whitney,0,1
176187,U,0,1
176188,test,0,0
176189,for,0,0
176190,independent,0,0
176191,groups,0,0
176192,",",0,0
176193,and,0,0
176194,P,0,0
176195,<,0,0
176196,.05,0,0
176197,was,0,0
176198,considered,0,0
176199,statistically,0,0
176200,significant,0,0
176201,.,0,0
176202,RESULTS,0,0
176203,The,0,0
176204,total,0,0
176205,operative,0,0
176206,time,0,0
176207,and,0,0
176208,intracorporeal,0,0
176209,suturing,0,0
176210,time,0,0
176211,were,0,0
176212,significantly,0,0
176213,higher,0,0
176214,in,0,0
176215,group,0,0
176216,II,0,0
176217,than,0,0
176218,in,0,0
176219,group,0,0
176220,I,0,0
176221,(,0,0
176222,P,0,0
176223,<,0,0
176224,.001,0,0
176225,),0,0
176226,.,0,0
176227,The,0,0
176228,visual,0,0
176229,analog,0,1
176230,scale,0,1
176231,score,0,0
176232,for,0,0
176233,pain,0,0
176234,on,0,0
176235,postoperative,0,0
176236,day,0,0
176237,1,0,0
176238,and,0,0
176239,the,0,0
176240,requirement,0,0
176241,for,0,0
176242,tramadol,0,1
176243,were,0,0
176244,significantly,0,0
176245,higher,0,0
176246,in,0,0
176247,group,0,0
176248,I,0,0
176249,than,0,0
176250,in,0,0
176251,group,0,0
176252,II,0,1
176253,(,0,1
176254,P=.004,0,1
176255,),0,1
176256,.,0,0
176257,The,0,0
176258,hospital,0,0
176259,stay,0,0
176260,and,0,0
176261,the,0,0
176262,rate,0,0
176263,of,0,0
176264,temporary,0,0
176265,ileus,0,0
176266,were,0,0
176267,significantly,0,0
176268,greater,0,0
176269,(,0,0
176270,P,0,0
176271,<,0,0
176272,.036,0,0
176273,and,0,0
176274,P,0,0
176275,<,0,0
176276,.02,0,0
176277,",",0,0
176278,respectively,0,0
176279,),0,0
176280,in,0,0
176281,group,0,0
176282,I,0,0
176283,than,0,0
176284,in,0,0
176285,group,0,0
176286,II,0,0
176287,.,0,0
176288,The,0,0
176289,success,0,0
176290,rate,0,0
176291,of,1,0
176292,transperitoneal,1,0
176293,laparoscopic,1,0
176294,pyeloplasty,1,1
176295,versus,1,0
176296,retroperitoneoscopic,1,0
176297,laparoscopic,1,0
176298,pyeloplasty,1,0
176299,was,0,0
176300,96.4,0,0
176301,%,0,0
176302,versus,0,0
176303,96.6,0,0
176304,%,0,0
176305,with,0,0
176306,a,0,0
176307,mean,0,0
176308,follow-up,0,0
176309,period,0,0
176310,of,0,0
176311,30.75?4.85,0,0
176312,months,0,0
176313,versus,0,0
176314,30.99?5.59,0,0
176315,months,0,0
176316,(,0,0
176317,P,0,0
176318,<,0,0
176319,.88,0,0
176320,),0,0
176321,.,0,0
176322,CONCLUSION,1,1
176323,Transperitoneal,1,0
176324,laparoscopic,1,0
176325,pyeloplasty,1,0
176326,is,1,0
176327,associated,0,0
176328,with,0,0
176329,significantly,0,0
176330,greater,0,0
176331,postoperative,0,0
176332,pain,0,0
176333,",",0,0
176334,a,0,0
176335,higher,0,0
176336,tramadol,0,1
176337,dose,0,1
176338,",",0,1
176339,a,0,0
176340,higher,0,0
176341,rate,0,0
176342,of,0,0
176343,ileus,0,0
176344,",",0,0
176345,and,0,0
176346,a,0,0
176347,longer,0,0
176348,hospital,0,0
176349,stay,0,0
176350,in,0,0
176351,comparison,0,0
176352,with,0,0
176353,retroperitoneoscopic,0,0
176354,laparoscopic,0,0
176355,pyeloplasty,0,0
176356,.,0,0
176357,Although,0,0
176358,the,0,0
176359,operative,0,0
176360,time,0,0
176361,for,0,0
176362,retroperitoneoscopic,1,0
176363,laparoscopic,1,0
176364,pyeloplasty,1,0
176365,is,1,0
176366,significantly,0,0
176367,longer,0,0
176368,",",0,0
176369,the,0,0
176370,success,0,0
176371,rate,0,0
176372,remains,0,0
176373,the,0,0
176374,same,0,0
176375,for,0,0
176376,both,0,0
176377,procedures,0,0
176378,.,0,0
176379,Duration,0,0
176380,of,0,0
176381,chemotherapy,0,0
176382,in,0,0
176383,small,0,0
176384,cell,0,0
176385,lung,0,0
176386,cancer,0,0
176387,:,0,0
176388,a,0,0
176389,Cancer,0,0
176390,Research,0,0
176391,Campaign,0,0
176392,trial,0,0
176393,.,0,0
176394,A,0,0
176395,total,0,0
176396,of,0,0
176397,610,0,0
176398,patients,0,0
176399,with,0,0
176400,small,0,0
176401,cell,0,0
176402,lung,0,0
176403,cancer,0,0
176404,were,0,0
176405,entered,0,0
176406,into,0,0
176407,a,0,0
176408,randomised,0,0
176409,trial,0,0
176410,designed,0,0
176411,to,0,0
176412,assess,0,0
176413,the,0,0
176414,effect,0,0
176415,of,0,0
176416,duration,0,0
176417,of,0,0
176418,initial,0,0
176419,chemotherapy,0,0
176420,on,0,0
176421,survival,0,0
176422,.,0,0
176423,Patients,0,0
176424,were,0,0
176425,randomised,0,0
176426,to,0,0
176427,receive,0,0
176428,either,0,0
176429,four,0,0
176430,or,0,0
176431,eight,0,0
176432,courses,0,0
176433,of,0,0
176434,cytotoxic,1,1
176435,chemotherapy,1,1
176436,with,1,1
176437,cyclophosphamide,1,1
176438,",",1,1
176439,vincristine,1,1
176440,and,1,1
176441,etoposide,1,1
176442,and,0,0
176443,also,0,0
176444,randomised,0,0
176445,to,0,0
176446,receive,0,0
176447,",",0,0
176448,on,0,0
176449,disease,0,0
176450,progression,0,0
176451,",",0,0
176452,either,0,0
176453,second,1,0
176454,line,1,0
176455,chemotherapy,1,1
176456,(,1,1
176457,methotrexate,1,1
176458,and,1,1
176459,doxorubicin,1,1
176460,),1,1
176461,or,1,0
176462,symptomatic,1,0
176463,treatment,1,0
176464,only,1,0
176465,.,1,0
176466,In,0,0
176467,the,0,0
176468,whole,0,0
176469,study,0,0
176470,196,0,0
176471,(,0,0
176472,32.1,0,0
176473,%,0,0
176474,),0,0
176475,had,0,0
176476,limited,0,0
176477,disease,0,0
176478,and,0,0
176479,414,0,0
176480,(,0,0
176481,67.9,0,0
176482,%,0,0
176483,),0,0
176484,extensive,0,0
176485,disease,0,0
176486,.,0,0
176487,During,0,0
176488,initial,0,0
176489,chemotherapy,0,0
176490,the,0,0
176491,response,0,0
176492,rate,0,0
176493,(,0,0
176494,complete,0,0
176495,and,0,0
176496,partial,0,0
176497,responses,0,0
176498,),0,0
176499,after,0,0
176500,four,0,0
176501,courses,0,0
176502,of,0,0
176503,treatment,0,0
176504,was,0,0
176505,61,0,0
176506,%,0,0
176507,with,0,0
176508,no,0,0
176509,significant,0,0
176510,increase,0,0
176511,in,0,0
176512,patients,0,0
176513,receiving,0,0
176514,eight,0,0
176515,courses,0,0
176516,(,0,0
176517,63,0,0
176518,%,0,0
176519,),0,0
176520,.,0,0
176521,In,0,0
176522,those,0,0
176523,randomised,0,0
176524,to,0,0
176525,receive,0,0
176526,relapse,0,0
176527,chemotherapy,0,0
176528,the,0,0
176529,response,0,0
176530,rate,0,0
176531,was,0,0
176532,improved,0,0
176533,slightly,0,0
176534,for,0,0
176535,those,0,0
176536,who,0,0
176537,had,0,0
176538,originally,0,0
176539,received,0,0
176540,four,0,0
176541,courses,0,0
176542,of,0,0
176543,chemotherapy,0,0
176544,(,0,0
176545,25.6,0,0
176546,%,0,0
176547,),0,0
176548,over,0,0
176549,those,0,0
176550,receiving,0,0
176551,eight,0,0
176552,(,0,0
176553,18.7,0,0
176554,%,0,0
176555,),0,0
176556,.,0,0
176557,The,0,0
176558,overall,0,0
176559,results,0,0
176560,show,0,0
176561,that,0,0
176562,of,0,0
176563,the,0,0
176564,four,0,0
176565,possible,0,0
176566,treatment,0,0
176567,randomizations,0,0
176568,",",0,0
176569,four,0,0
176570,courses,0,0
176571,of,0,0
176572,chemotherapy,0,0
176573,alone,0,0
176574,is,0,0
176575,inferior,0,0
176576,in,0,0
176577,terms,0,0
176578,of,0,0
176579,overall,0,0
176580,survival,0,1
176581,(,0,0
176582,30,0,0
176583,weeks,0,0
176584,median,0,0
176585,survival,0,0
176586,),0,0
176587,to,0,0
176588,the,0,0
176589,other,0,0
176590,three,0,0
176591,treatment,0,0
176592,options,0,0
176593,(,0,0
176594,39,0,0
176595,weeks,0,0
176596,median,0,0
176597,survival,0,0
176598,",",0,0
176599,P,0,0
176600,less,0,0
176601,than,0,0
176602,0.01,0,0
176603,),0,0
176604,.,0,0
176605,In,0,0
176606,patients,0,0
176607,responding,0,0
176608,to,0,0
176609,initial,0,0
176610,chemotherapy,0,0
176611,the,0,0
176612,disadvantage,0,0
176613,of,0,0
176614,four,0,0
176615,courses,0,0
176616,of,0,0
176617,chemotherapy,0,0
176618,alone,0,0
176619,was,0,0
176620,apparent,0,0
176621,(,0,0
176622,median,0,0
176623,survival,0,0
176624,of,0,0
176625,40,0,0
176626,weeks,0,0
176627,versus,0,0
176628,49,0,0
176629,weeks,0,0
176630,",",0,0
176631,P,0,0
176632,=,0,0
176633,0.003,0,0
176634,),0,0
176635,but,0,0
176636,not,0,0
176637,if,0,0
176638,drug,0,1
176639,treatment,0,1
176640,was,0,0
176641,given,0,0
176642,on,0,0
176643,relapse,0,0
176644,.,0,0
176645,The,0,0
176646,study,0,0
176647,shows,0,0
176648,that,0,0
176649,limiting,0,0
176650,treatment,0,0
176651,to,0,0
176652,four,0,0
176653,courses,0,0
176654,of,0,0
176655,chemotherapy,0,0
176656,alone,0,0
176657,is,0,0
176658,associated,0,0
176659,with,0,0
176660,inferior,0,0
176661,survival,0,0
176662,",",0,0
176663,but,0,0
176664,this,0,0
176665,is,0,0
176666,not,0,0
176667,the,0,0
176668,case,0,0
176669,if,0,0
176670,chemotherapy,0,0
176671,is,0,0
176672,given,0,0
176673,at,0,0
176674,relapse,0,0
176675,.,0,0
176676,Reducing,0,1
176677,iodine,0,1
176678,load,0,1
176679,in,0,0
176680,hepatic,0,0
176681,CT,0,0
176682,for,0,0
176683,patients,0,0
176684,with,0,0
176685,chronic,0,0
176686,liver,0,0
176687,disease,0,0
176688,with,0,0
176689,a,0,0
176690,combination,1,0
176691,of,1,0
176692,low-tube-voltage,1,0
176693,and,1,0
176694,adaptive,1,0
176695,statistical,1,0
176696,iterative,1,0
176697,reconstruction,1,0
176698,.,1,0
176699,PURPOSE,0,0
176700,To,0,1
176701,prospectively,0,0
176702,assess,0,0
176703,the,0,0
176704,effect,0,0
176705,of,0,0
176706,reduced,0,0
176707,iodine,0,1
176708,load,0,1
176709,to,0,0
176710,contrast,0,0
176711,enhancement,0,0
176712,",",0,0
176713,image,0,0
176714,quality,0,0
176715,",",0,0
176716,and,0,0
176717,detectability,0,0
176718,of,0,0
176719,hepatocellular,0,0
176720,carcinomas,0,1
176721,(,0,1
176722,HCCs,0,1
176723,),0,1
176724,in,0,0
176725,hepatic,0,0
176726,CT,0,0
176727,with,0,0
176728,a,0,0
176729,combination,0,0
176730,of,0,0
176731,80,1,0
176732,kVp,1,1
176733,tube,1,1
176734,voltage,1,1
176735,setting,1,0
176736,and,1,0
176737,adaptive,1,0
176738,statistical,1,0
176739,iterative,1,1
176740,reconstruction,1,1
176741,(,1,1
176742,ASIR,1,1
176743,),1,1
176744,technique,1,0
176745,in,0,0
176746,patients,0,0
176747,with,0,0
176748,chronic,0,0
176749,liver,0,0
176750,disease,0,0
176751,.,0,0
176752,MATERIALS,0,0
176753,AND,0,1
176754,METHODS,0,1
176755,This,0,0
176756,HIPAA-compliant,0,0
176757,study,0,0
176758,was,0,0
176759,approved,0,0
176760,by,0,0
176761,our,0,0
176762,institutional,0,0
176763,review,0,0
176764,board,0,0
176765,and,0,0
176766,written,0,0
176767,informed,0,0
176768,consent,0,0
176769,was,0,0
176770,obtained,0,0
176771,in,0,0
176772,all,0,0
176773,patients,0,0
176774,.,0,0
176775,During,0,0
176776,a,0,0
176777,recent,0,0
176778,9-month,0,0
176779,period,0,0
176780,",",0,0
176781,170,0,0
176782,consecutive,0,0
176783,patients,0,0
176784,(,0,0
176785,114,0,0
176786,men,0,0
176787,and,0,0
176788,56,0,0
176789,women,0,0
176790,;,0,0
176791,age,0,0
176792,range,0,0
176793,",",0,0
176794,40-85,0,0
176795,years,0,0
176796,;,0,0
176797,mean,0,0
176798,",",0,0
176799,67.7,0,0
176800,years,0,0
176801,),0,0
176802,with,0,0
176803,suspected,0,0
176804,chronic,0,0
176805,liver,0,0
176806,diseases,0,0
176807,were,0,0
176808,randomized,1,0
176809,into,1,0
176810,three,1,0
176811,CT,1,0
176812,groups,1,0
176813,according,0,0
176814,to,0,0
176815,the,0,0
176816,following,0,0
176817,iodine-load,1,1
176818,and,1,1
176819,tube-voltage,1,1
176820,protocols,1,0
176821,:,1,0
176822,600,1,0
176823,milligram,1,1
176824,per,1,1
176825,kilogram,1,1
176826,body,1,1
176827,weight,1,1
176828,(,1,1
176829,mg/kg,1,1
176830,),1,1
176831,iodine,1,1
176832,load,1,1
176833,and,1,0
176834,120,1,0
176835,peak,1,0
176836,kilovolt,1,1
176837,(,1,1
176838,kVp,1,1
176839,),1,1
176840,tube,1,1
176841,voltage,1,1
176842,setting,1,1
176843,(,1,0
176844,600-120,1,0
176845,group,1,0
176846,),1,0
176847,",",1,1
176848,500,1,1
176849,mg/kg,1,1
176850,and,1,1
176851,80,1,1
176852,kVp,1,1
176853,(,1,0
176854,500-80,1,0
176855,group,1,0
176856,),1,0
176857,",",1,0
176858,and,1,1
176859,400mg/kg,1,1
176860,and,1,1
176861,80,1,1
176862,kVp,1,1
176863,(,1,1
176864,400-80,1,1
176865,group,1,1
176866,),1,0
176867,.,0,0
176868,Analysis,0,0
176869,of,0,0
176870,variance,0,0
176871,was,0,0
176872,conducted,0,0
176873,to,0,0
176874,evaluate,0,0
176875,differences,0,0
176876,in,0,0
176877,CT,0,0
176878,number,0,0
176879,",",0,0
176880,background,0,0
176881,noise,0,0
176882,",",0,0
176883,signal-to-noise,0,1
176884,ratio,0,0
176885,(,0,1
176886,SNR,0,1
176887,),0,1
176888,",",0,0
176889,effective,0,0
176890,dose,0,1
176891,",",0,1
176892,HCC-to-liver,0,1
176893,contrast-to-noise,0,1
176894,ratio,0,0
176895,(,0,1
176896,CNR,0,1
176897,),0,1
176898,",",0,0
176899,and,0,0
176900,figure,0,0
176901,of,0,0
176902,merit,0,1
176903,(,0,1
176904,FOM,0,1
176905,),0,1
176906,.,0,0
176907,Sensitivity,0,0
176908,",",0,0
176909,specificity,0,0
176910,",",0,0
176911,and,0,0
176912,area,0,0
176913,under,0,0
176914,the,0,0
176915,receiver-operating-characteristic,0,1
176916,curve,0,1
176917,(,0,1
176918,AUC,0,1
176919,),0,0
176920,were,0,0
176921,compared,0,0
176922,to,0,0
176923,assess,0,0
176924,the,0,0
176925,detectability,0,0
176926,of,0,0
176927,HCCs,0,0
176928,.,0,0
176929,RESULTS,0,0
176930,Vascular,0,0
176931,and,0,0
176932,hepatic,0,0
176933,enhancement,0,0
176934,in,0,0
176935,the,0,0
176936,400-80,0,1
176937,and,0,0
176938,500-80,0,0
176939,groups,0,0
176940,was,0,0
176941,comparable,0,0
176942,to,0,0
176943,or,0,0
176944,greater,0,0
176945,than,0,0
176946,that,0,0
176947,in,0,0
176948,the,0,0
176949,600-120,0,0
176950,group,0,0
176951,(,0,0
176952,P,0,0
176953,<,0,0
176954,.05,0,0
176955,),0,0
176956,.,0,0
176957,Subjective,0,0
176958,image,0,0
176959,quality,0,0
176960,was,0,0
176961,comparable,0,0
176962,among,0,0
176963,the,0,0
176964,three,0,0
176965,groups,0,0
176966,.,0,0
176967,Sensitivity,0,0
176968,",",0,0
176969,specificity,0,0
176970,",",0,0
176971,and,0,0
176972,AUC,0,0
176973,for,0,0
176974,detecting,0,0
176975,HCCs,0,0
176976,were,0,0
176977,comparable,0,0
176978,among,0,0
176979,the,0,0
176980,groups,0,0
176981,.,0,0
176982,The,0,0
176983,effective,0,0
176984,dose,0,1
176985,was,0,0
176986,kept,0,0
176987,low,0,0
176988,(,0,0
176989,3.3-4.1,0,0
176990,mSv,0,0
176991,),0,0
176992,in,0,0
176993,all,0,0
176994,three,0,0
176995,groups,0,0
176996,.,0,0
176997,CONCLUSION,0,1
176998,Iodine,0,1
176999,load,0,0
177000,can,0,0
177001,be,0,0
177002,reduced,0,0
177003,by,0,0
177004,33,0,0
177005,%,0,0
177006,in,0,0
177007,CT,0,0
177008,of,0,0
177009,the,0,0
177010,liver,0,0
177011,with,0,0
177012,a,0,0
177013,combination,0,0
177014,of,0,0
177015,80,1,0
177016,kVp,1,1
177017,tube,1,1
177018,voltage,1,1
177019,setting,1,0
177020,and,1,0
177021,ASIR,1,0
177022,technique,1,0
177023,",",0,0
177024,without,0,0
177025,compromising,0,0
177026,the,0,0
177027,contrast,0,0
177028,enhancement,0,0
177029,",",0,0
177030,image,0,0
177031,quality,0,0
177032,",",0,0
177033,and,0,0
177034,detection,0,0
177035,of,0,0
177036,HCCs,0,0
177037,.,0,0
177038,The,0,0
177039,durability,0,0
177040,of,0,0
177041,endovascular,1,0
177042,coiling,1,1
177043,versus,1,0
177044,neurosurgical,1,0
177045,clipping,1,0
177046,of,0,0
177047,ruptured,0,0
177048,cerebral,0,0
177049,aneurysms,0,0
177050,:,0,0
177051,18,0,0
177052,year,0,0
177053,follow-up,0,0
177054,of,0,0
177055,the,0,0
177056,UK,0,0
177057,cohort,0,0
177058,of,0,0
177059,the,0,0
177060,International,0,0
177061,Subarachnoid,0,0
177062,Aneurysm,0,1
177063,Trial,0,0
177064,(,0,1
177065,ISAT,0,1
177066,),0,1
177067,.,0,0
177068,BACKGROUND,0,0
177069,Previous,0,0
177070,analyses,0,0
177071,of,0,0
177072,the,0,0
177073,International,0,0
177074,Subarachnoid,0,0
177075,Aneurysm,0,1
177076,Trial,0,0
177077,(,0,1
177078,ISAT,0,1
177079,),0,1
177080,cohort,0,0
177081,have,0,0
177082,reported,0,0
177083,on,0,0
177084,the,0,0
177085,risks,0,0
177086,of,0,0
177087,recurrent,0,0
177088,subarachnoid,0,0
177089,haemorrhage,0,0
177090,and,0,0
177091,death,0,0
177092,or,0,0
177093,dependency,0,0
177094,for,0,0
177095,a,0,0
177096,minimum,0,0
177097,of,0,0
177098,5,0,0
177099,years,0,0
177100,and,0,0
177101,up,0,0
177102,to,0,0
177103,a,0,0
177104,maximum,0,0
177105,of,0,0
177106,14,0,0
177107,years,0,0
177108,after,0,0
177109,treatment,0,0
177110,of,0,0
177111,a,0,0
177112,ruptured,0,0
177113,intracranial,0,0
177114,aneurysm,0,0
177115,with,0,0
177116,either,0,0
177117,neurosurgical,0,0
177118,clipping,0,0
177119,or,0,0
177120,endovascular,0,0
177121,coiling,0,0
177122,.,0,0
177123,At,0,0
177124,1,0,0
177125,year,0,0
177126,there,0,0
177127,was,0,0
177128,a,0,0
177129,7,0,0
177130,%,0,0
177131,absolute,0,0
177132,and,0,0
177133,a,0,0
177134,24,0,0
177135,%,0,0
177136,relative,0,0
177137,risk,0,0
177138,reduction,0,0
177139,of,0,0
177140,death,0,0
177141,and,0,0
177142,dependency,0,0
177143,in,0,0
177144,the,0,0
177145,coiling,0,0
177146,group,0,0
177147,compared,0,0
177148,with,0,0
177149,the,0,0
177150,clipping,0,0
177151,group,0,0
177152,",",0,0
177153,but,0,0
177154,the,0,0
177155,medium-term,0,0
177156,results,0,0
177157,showed,0,0
177158,the,0,0
177159,increased,0,0
177160,need,0,0
177161,for,0,0
177162,re-treatment,0,0
177163,of,0,0
177164,the,0,0
177165,target,0,0
177166,aneurysm,0,0
177167,in,0,0
177168,the,0,0
177169,patients,0,0
177170,given,0,0
177171,coiling,0,0
177172,.,0,0
177173,We,0,0
177174,report,0,0
177175,the,0,0
177176,long-term,0,0
177177,follow-up,0,0
177178,of,0,0
177179,patients,0,0
177180,in,0,0
177181,this,0,0
177182,UK,0,0
177183,cohort,0,0
177184,.,0,0
177185,METHODS,0,0
177186,In,0,0
177187,ISAT,0,0
177188,",",0,0
177189,patients,0,0
177190,were,0,0
177191,randomly,0,0
177192,allocated,0,0
177193,to,0,0
177194,either,0,0
177195,neurosurgical,1,0
177196,clipping,1,0
177197,or,0,0
177198,endovascular,1,0
177199,coiling,1,0
177200,after,0,0
177201,a,0,0
177202,subarachnoid,0,0
177203,haemorrhage,0,0
177204,",",0,0
177205,assuming,0,0
177206,treatment,0,0
177207,equipoise,0,0
177208,",",0,0
177209,between,0,0
177210,Sept,0,1
177211,12,0,1
177212,",",0,0
177213,1994,0,0
177214,",",0,0
177215,and,0,0
177216,May,0,1
177217,1,0,0
177218,",",0,0
177219,2002,0,0
177220,.,0,0
177221,We,0,0
177222,followed,0,0
177223,up,0,0
177224,1644,0,0
177225,patients,0,0
177226,in,0,0
177227,22,0,0
177228,UK,0,0
177229,neurosurgical,0,0
177230,centres,0,0
177231,for,0,0
177232,death,0,0
177233,and,0,0
177234,clinical,0,0
177235,outcomes,0,0
177236,for,0,0
177237,10?0-18?5,0,0
177238,years,0,0
177239,.,0,0
177240,We,0,0
177241,assessed,0,0
177242,dependency,0,0
177243,as,0,0
177244,self-reported,0,0
177245,modified,0,0
177246,Rankin,0,0
177247,scale,0,0
177248,score,0,0
177249,obtained,0,0
177250,through,0,0
177251,yearly,0,0
177252,questionnaires,0,0
177253,.,0,0
177254,Data,0,0
177255,for,0,0
177256,recurrent,0,0
177257,aneurysms,0,0
177258,and,0,0
177259,rebleeding,0,0
177260,events,0,0
177261,were,0,0
177262,collected,0,0
177263,from,0,0
177264,questionnaires,0,0
177265,and,0,0
177266,from,0,0
177267,hospital,0,0
177268,and,0,0
177269,general,0,0
177270,practitioner,0,0
177271,records,0,0
177272,.,0,0
177273,The,0,0
177274,Office,0,0
177275,for,0,0
177276,National,0,0
177277,Statistics,0,0
177278,supplied,0,0
177279,data,0,0
177280,on,0,0
177281,deaths,0,0
177282,.,0,0
177283,This,0,0
177284,study,0,0
177285,is,0,0
177286,registered,0,0
177287,",",0,0
177288,number,0,0
177289,ISRCTN49866681,0,0
177290,.,0,0
177291,FINDINGS,0,0
177292,At,0,1
177293,10,0,0
177294,years,0,0
177295,",",0,0
177296,674,0,0
177297,(,0,0
177298,83,0,0
177299,%,0,0
177300,),0,0
177301,of,0,0
177302,809,0,0
177303,patients,0,0
177304,allocated,0,0
177305,endovascular,0,0
177306,coiling,0,0
177307,and,0,0
177308,657,0,0
177309,(,0,0
177310,79,0,0
177311,%,0,0
177312,),0,0
177313,of,0,0
177314,835,0,0
177315,patients,0,0
177316,allocated,0,0
177317,neurosurgical,0,0
177318,clipping,0,0
177319,were,0,0
177320,alive,0,0
177321,(,0,1
177322,odds,0,1
177323,ratio,0,1
177324,[,0,1
177325,OR,0,1
177326,],0,1
177327,1?35,0,0
177328,",",0,0
177329,95,0,0
177330,%,0,0
177331,CI,0,0
177332,1?06-1?73,0,0
177333,),0,0
177334,.,0,0
177335,Of,0,0
177336,1003,0,0
177337,individuals,0,0
177338,who,0,0
177339,returned,0,0
177340,a,0,0
177341,questionnaire,0,0
177342,at,0,0
177343,10,0,0
177344,years,0,0
177345,",",0,0
177346,435,0,0
177347,(,0,0
177348,82,0,0
177349,%,0,0
177350,),0,0
177351,patients,0,0
177352,treated,0,0
177353,with,0,0
177354,endovascular,0,0
177355,coiling,0,0
177356,and,0,0
177357,370,0,0
177358,(,0,0
177359,78,0,0
177360,%,0,0
177361,),0,0
177362,patients,0,0
177363,treated,0,0
177364,with,0,0
177365,neurosurgical,1,0
177366,clipping,1,0
177367,were,1,0
177368,independent,0,0
177369,(,0,0
177370,modified,0,0
177371,Rankin,0,0
177372,scale,0,0
177373,score,0,0
177374,0-2,0,0
177375,;,0,0
177376,OR,0,1
177377,1?25,0,1
177378,;,0,0
177379,95,0,0
177380,%,0,0
177381,CI,0,0
177382,0?92-1?71,0,0
177383,),0,0
177384,.,0,0
177385,Patients,0,0
177386,in,0,0
177387,the,0,0
177388,endovascular,0,0
177389,treatment,0,0
177390,group,0,0
177391,were,0,0
177392,more,0,0
177393,likely,0,0
177394,to,0,0
177395,be,0,0
177396,alive,0,0
177397,and,0,0
177398,independent,0,0
177399,at,0,0
177400,10,0,0
177401,years,0,0
177402,than,0,0
177403,were,0,0
177404,patients,0,0
177405,in,0,0
177406,the,0,0
177407,neurosurgery,0,1
177408,group,0,0
177409,(,0,0
177410,OR,0,1
177411,1?34,0,0
177412,",",0,0
177413,95,0,0
177414,%,0,0
177415,CI,0,0
177416,1?07-1?67,0,0
177417,),0,0
177418,.,0,0
177419,33,0,0
177420,patients,0,0
177421,had,0,0
177422,a,0,0
177423,recurrent,0,0
177424,subarachnoid,0,0
177425,haemorrhage,0,0
177426,more,0,0
177427,than,0,0
177428,1,0,0
177429,year,0,0
177430,after,0,0
177431,their,0,0
177432,initial,0,0
177433,haemorrhage,0,1
177434,(,0,0
177435,17,0,0
177436,from,0,0
177437,the,0,0
177438,target,0,0
177439,aneurysm,0,0
177440,),0,0
177441,.,0,0
177442,INTERPRETATION,0,0
177443,Although,0,0
177444,rates,0,0
177445,of,0,0
177446,increased,0,0
177447,dependency,0,0
177448,alone,0,0
177449,did,0,0
177450,not,0,0
177451,differ,0,0
177452,between,0,0
177453,groups,0,0
177454,",",0,0
177455,the,0,0
177456,probability,0,0
177457,of,0,0
177458,death,0,0
177459,or,0,0
177460,dependency,0,0
177461,was,0,0
177462,significantly,0,0
177463,greater,0,0
177464,in,0,0
177465,the,0,0
177466,neurosurgical,0,0
177467,group,0,0
177468,than,0,0
177469,in,0,0
177470,the,0,0
177471,endovascular,0,0
177472,group,0,0
177473,.,0,0
177474,Rebleeding,0,0
177475,was,0,0
177476,more,0,0
177477,likely,0,0
177478,after,0,0
177479,endovascular,0,0
177480,coiling,0,0
177481,than,0,0
177482,after,0,0
177483,neurosurgical,0,0
177484,clipping,0,0
177485,",",0,0
177486,but,0,0
177487,the,0,0
177488,risk,0,0
177489,was,0,0
177490,small,0,0
177491,and,0,0
177492,the,0,0
177493,probability,0,0
177494,of,0,0
177495,disability-free,0,0
177496,survival,0,0
177497,was,0,0
177498,significantly,0,0
177499,greater,0,0
177500,in,0,0
177501,the,0,0
177502,endovascular,0,0
177503,group,0,0
177504,than,0,0
177505,in,0,0
177506,the,0,0
177507,neurosurgical,0,0
177508,group,0,0
177509,at,0,0
177510,10,0,0
177511,years,0,0
177512,.,0,0
177513,FUNDING,0,0
177514,UK,0,1
177515,Medical,0,0
177516,Research,0,0
177517,Council,0,0
177518,.,0,0
177519,Mediation,0,0
177520,analysis,0,0
177521,demonstrates,0,0
177522,that,0,0
177523,trans-eQTLs,0,0
177524,are,0,0
177525,often,0,0
177526,explained,0,0
177527,by,0,0
177528,cis-mediation,0,0
177529,:,0,0
177530,a,0,0
177531,genome-wide,0,0
177532,analysis,0,0
177533,among,0,0
177534,"1,800",0,0
177535,South,0,0
177536,Asians,0,0
177537,.,0,0
177538,A,0,0
177539,large,0,0
177540,fraction,0,0
177541,of,0,0
177542,human,0,0
177543,genes,0,0
177544,are,0,0
177545,regulated,0,0
177546,by,0,0
177547,genetic,0,0
177548,variation,0,0
177549,near,0,0
177550,the,0,0
177551,transcribed,0,0
177552,sequence,0,0
177553,(,0,0
177554,cis-eQTL,0,0
177555,",",0,0
177556,expression,0,0
177557,quantitative,0,0
177558,trait,0,0
177559,locus,0,0
177560,),0,0
177561,",",0,0
177562,and,0,0
177563,many,0,0
177564,cis-eQTLs,0,0
177565,have,0,0
177566,implications,0,0
177567,for,0,0
177568,human,0,0
177569,disease,0,0
177570,.,0,0
177571,Less,0,0
177572,is,0,0
177573,known,0,0
177574,regarding,0,0
177575,the,0,0
177576,effects,0,0
177577,of,0,0
177578,genetic,0,0
177579,variation,0,0
177580,on,0,0
177581,expression,0,0
177582,of,0,0
177583,distant,0,0
177584,genes,0,0
177585,(,0,1
177586,trans-eQTLs,0,1
177587,),0,1
177588,and,0,0
177589,their,0,0
177590,biological,0,0
177591,mechanisms,0,0
177592,.,0,0
177593,In,0,0
177594,this,0,0
177595,work,0,0
177596,",",0,0
177597,we,0,0
177598,use,0,0
177599,genome-wide,1,0
177600,data,1,0
177601,on,1,0
177602,SNPs,1,0
177603,and,0,0
177604,array-based,1,0
177605,expression,1,0
177606,measures,1,0
177607,from,0,0
177608,mononuclear,0,0
177609,cells,0,0
177610,obtained,0,0
177611,from,0,0
177612,a,0,0
177613,population-based,0,0
177614,cohort,0,0
177615,of,0,0
177616,"1,799",0,0
177617,Bangladeshi,0,0
177618,individuals,0,0
177619,to,0,0
177620,characterize,0,0
177621,cis-,0,1
177622,and,0,0
177623,trans-eQTLs,0,1
177624,and,0,0
177625,determine,0,0
177626,if,0,0
177627,observed,0,0
177628,trans-eQTL,0,0
177629,associations,0,0
177630,are,0,0
177631,mediated,0,0
177632,by,0,0
177633,expression,0,0
177634,of,0,0
177635,transcripts,0,0
177636,in,0,0
177637,cis,0,0
177638,with,0,0
177639,the,0,0
177640,SNPs,0,0
177641,showing,0,0
177642,trans-association,0,0
177643,",",0,0
177644,using,0,0
177645,Sobel,0,0
177646,tests,0,0
177647,of,0,0
177648,mediation,0,0
177649,.,0,0
177650,We,0,0
177651,observed,0,0
177652,434,0,0
177653,independent,0,0
177654,trans-eQTL,0,0
177655,associations,0,0
177656,at,0,0
177657,a,0,0
177658,false-discovery,0,0
177659,rate,0,0
177660,of,0,0
177661,0.05,0,0
177662,",",0,0
177663,and,0,0
177664,189,0,0
177665,of,0,0
177666,these,0,0
177667,trans-eQTLs,0,0
177668,were,0,0
177669,also,0,0
177670,cis-eQTLs,0,1
177671,(,0,0
177672,enrichment,0,0
177673,P,0,0
177674,<,0,0
177675,0.0001,0,0
177676,),0,0
177677,.,0,0
177678,Among,0,0
177679,these,0,0
177680,189,0,0
177681,trans-eQTL,0,0
177682,associations,0,0
177683,",",0,0
177684,39,0,0
177685,were,0,0
177686,significantly,0,0
177687,attenuated,0,0
177688,after,0,0
177689,adjusting,0,0
177690,for,0,0
177691,a,0,0
177692,cis-mediator,0,0
177693,based,0,0
177694,on,0,0
177695,Sobel,0,0
177696,P,0,0
177697,<,0,0
177698,10-5,0,0
177699,.,0,0
177700,We,0,0
177701,attempted,0,0
177702,to,0,0
177703,replicate,0,0
177704,21,0,0
177705,of,0,0
177706,these,0,0
177707,mediation,0,0
177708,signals,0,0
177709,in,0,0
177710,two,0,0
177711,European,0,0
177712,cohorts,0,0
177713,",",0,0
177714,and,0,0
177715,while,0,0
177716,only,0,0
177717,7,0,0
177718,trans-eQTL,0,0
177719,associations,0,0
177720,were,0,0
177721,present,0,0
177722,in,0,0
177723,one,0,0
177724,or,0,0
177725,both,0,0
177726,cohorts,0,0
177727,",",0,0
177728,6,0,0
177729,showed,0,0
177730,evidence,0,0
177731,of,0,0
177732,cis-mediation,0,0
177733,.,0,0
177734,Analyses,0,0
177735,of,0,0
177736,simulated,0,0
177737,data,0,0
177738,show,0,0
177739,that,0,0
177740,complete,0,0
177741,mediation,0,0
177742,will,0,0
177743,be,0,0
177744,observed,0,0
177745,as,0,0
177746,partial,0,0
177747,mediation,0,0
177748,in,0,0
177749,the,0,0
177750,presence,0,0
177751,of,0,0
177752,mediator,0,0
177753,measurement,0,0
177754,error,0,0
177755,or,0,0
177756,imperfect,0,0
177757,LD,0,0
177758,between,0,0
177759,measured,0,0
177760,and,0,0
177761,causal,0,0
177762,variants,0,0
177763,.,0,0
177764,Our,0,0
177765,data,0,0
177766,demonstrates,0,0
177767,that,0,0
177768,trans-associations,0,0
177769,can,0,0
177770,become,0,0
177771,significantly,0,0
177772,stronger,0,0
177773,or,0,0
177774,switch,0,0
177775,directions,0,0
177776,after,0,0
177777,adjusting,0,0
177778,for,0,0
177779,a,0,0
177780,potential,0,0
177781,mediator,0,0
177782,.,0,0
177783,Using,0,0
177784,simulated,0,0
177785,data,0,0
177786,",",0,0
177787,we,0,0
177788,demonstrate,0,0
177789,that,0,0
177790,this,0,0
177791,phenomenon,0,0
177792,is,0,0
177793,expected,0,0
177794,in,0,0
177795,the,0,0
177796,presence,0,0
177797,of,0,0
177798,strong,0,0
177799,cis-trans,0,0
177800,confounding,0,0
177801,and,0,0
177802,when,0,0
177803,the,0,0
177804,measured,0,0
177805,cis-transcript,0,0
177806,is,0,0
177807,correlated,0,0
177808,with,0,0
177809,the,0,0
177810,true,0,0
177811,(,0,1
177812,unmeasured,0,1
177813,),0,0
177814,mediator,0,0
177815,.,0,0
177816,In,0,0
177817,conclusion,0,0
177818,",",0,0
177819,by,0,0
177820,applying,0,0
177821,mediation,0,0
177822,analysis,0,0
177823,to,0,0
177824,eQTL,0,0
177825,data,0,0
177826,",",0,0
177827,we,0,0
177828,show,0,0
177829,that,0,0
177830,a,0,0
177831,substantial,0,0
177832,fraction,0,0
177833,of,0,0
177834,observed,0,0
177835,trans-eQTL,0,0
177836,associations,0,0
177837,can,0,0
177838,be,0,0
177839,explained,0,0
177840,by,0,0
177841,cis-mediation,0,0
177842,.,0,0
177843,Future,0,0
177844,studies,0,0
177845,should,0,0
177846,focus,0,0
177847,on,0,0
177848,understanding,0,0
177849,the,0,0
177850,mechanisms,0,0
177851,underlying,0,0
177852,widespread,0,0
177853,cis-mediation,0,0
177854,and,0,0
177855,their,0,0
177856,relevance,0,0
177857,to,0,0
177858,disease,0,0
177859,biology,0,0
177860,",",0,0
177861,as,0,0
177862,well,0,0
177863,as,0,0
177864,using,0,0
177865,mediation,0,0
177866,analysis,0,0
177867,to,0,0
177868,improve,0,0
177869,eQTL,0,0
177870,discovery,0,0
177871,.,0,0
177872,Institutional,0,1
177873,clinical,0,1
177874,trial,0,1
177875,accrual,0,0
177876,volume,0,0
177877,and,0,0
177878,survival,0,0
177879,of,0,0
177880,patients,0,0
177881,with,0,0
177882,head,0,0
177883,and,0,0
177884,neck,0,0
177885,cancer,0,0
177886,.,0,0
177887,PURPOSE,0,0
177888,National,0,0
177889,Comprehensive,0,0
177890,Cancer,0,0
177891,Network,0,1
177892,guidelines,0,0
177893,recommend,0,0
177894,patients,0,0
177895,with,0,0
177896,head,0,0
177897,and,0,0
177898,neck,0,1
177899,cancer,0,1
177900,(,0,1
177901,HNC,0,1
177902,),0,1
177903,receive,0,0
177904,treatment,0,0
177905,at,0,0
177906,centers,0,0
177907,with,0,0
177908,expertise,0,0
177909,",",0,0
177910,but,0,0
177911,whether,0,0
177912,provider,0,0
177913,experience,0,0
177914,affects,0,0
177915,survival,0,0
177916,is,0,0
177917,unknown,0,0
177918,.,0,0
177919,PATIENTS,0,0
177920,AND,0,0
177921,METHODS,0,1
177922,The,0,0
177923,effect,0,0
177924,of,0,0
177925,institutional,0,0
177926,experience,0,0
177927,on,0,0
177928,overall,0,0
177929,survival,0,0
177930,(,0,1
177931,OS,0,1
177932,),0,0
177933,in,0,0
177934,patients,0,0
177935,with,0,0
177936,stage,0,0
177937,III,0,0
177938,or,0,0
177939,IV,0,0
177940,HNC,0,0
177941,was,0,0
177942,investigated,0,0
177943,within,0,0
177944,a,0,0
177945,randomized,0,0
177946,trial,0,0
177947,of,0,0
177948,the,0,0
177949,Radiation,0,0
177950,Therapy,0,0
177951,Oncology,0,1
177952,Group,0,0
177953,(,0,0
177954,RTOG,0,1
177955,0129,0,1
177956,),0,0
177957,",",0,0
177958,which,0,0
177959,compared,0,0
177960,cisplatin,1,1
177961,concurrent,1,0
177962,with,1,0
177963,standard,1,0
177964,versus,1,0
177965,accelerated,1,0
177966,fractionation,1,0
177967,radiotherapy,1,0
177968,.,1,0
177969,As,0,0
177970,a,0,0
177971,surrogate,0,0
177972,for,0,0
177973,experience,0,0
177974,",",0,0
177975,institutions,0,0
177976,were,0,0
177977,classified,0,0
177978,as,0,0
177979,historically,0,0
177980,low-,0,0
177981,(,0,0
177982,HLACs,0,1
177983,),0,1
177984,or,0,0
177985,high-accruing,0,1
177986,centers,0,0
177987,(,0,1
177988,HHACs,0,1
177989,),0,1
177990,based,0,0
177991,on,0,0
177992,accrual,0,0
177993,to,0,0
177994,21,0,0
177995,RTOG,0,0
177996,HNC,0,1
177997,trials,0,1
177998,(,0,0
177999,1997,0,0
178000,to,0,0
178001,2002,0,0
178002,),0,0
178003,.,0,0
178004,The,0,0
178005,effect,0,0
178006,of,0,0
178007,accrual,0,0
178008,volume,0,0
178009,on,0,0
178010,OS,0,0
178011,was,0,0
178012,estimated,0,0
178013,by,0,0
178014,Cox,0,0
178015,proportional,0,0
178016,hazards,0,0
178017,models,0,0
178018,.,0,0
178019,RESULTS,0,0
178020,Median,0,0
178021,RTOG,0,1
178022,accrual,0,1
178023,(,0,0
178024,1997,0,0
178025,to,0,0
178026,2002,0,0
178027,),0,0
178028,at,0,0
178029,HLACs,0,0
178030,was,0,0
178031,four,0,0
178032,versus,0,0
178033,65,0,0
178034,patients,0,0
178035,at,0,0
178036,HHACs,0,0
178037,.,0,0
178038,Analysis,0,0
178039,included,0,0
178040,471,0,0
178041,patients,0,0
178042,in,0,0
178043,RTOG,0,1
178044,0129,0,1
178045,(,0,1
178046,2002,0,0
178047,to,0,0
178048,2005,0,0
178049,),0,0
178050,with,0,0
178051,known,0,0
178052,human,0,0
178053,papillomavirus,0,0
178054,and,0,0
178055,smoking,0,0
178056,status,0,0
178057,.,0,0
178058,Patients,0,0
178059,at,0,0
178060,HLACs,0,0
178061,versus,0,0
178062,HHACs,0,0
178063,had,0,0
178064,better,0,0
178065,performance,0,0
178066,status,0,1
178067,(,0,0
178068,0,0,0
178069,:,0,0
178070,62,0,0
178071,%,0,0
178072,v,0,0
178073,52,0,0
178074,%,0,0
178075,;,0,0
178076,P,0,0
178077,=,0,0
178078,.04,0,0
178079,),0,0
178080,and,0,0
178081,lower,0,0
178082,T,0,0
178083,stage,0,0
178084,(,0,0
178085,T4,0,0
178086,:,0,0
178087,26.5,0,0
178088,%,0,0
178089,v,0,0
178090,35.3,0,0
178091,%,0,0
178092,;,0,0
178093,P,0,0
178094,=,0,0
178095,.002,0,0
178096,),0,0
178097,but,0,0
178098,were,0,0
178099,otherwise,0,0
178100,similar,0,0
178101,.,0,0
178102,Radiotherapy,0,0
178103,protocol,0,0
178104,deviations,0,0
178105,were,0,0
178106,higher,0,0
178107,at,0,0
178108,HLACs,0,0
178109,versus,0,0
178110,HHACs,0,1
178111,(,0,0
178112,18,0,0
178113,%,0,0
178114,v,0,0
178115,6,0,0
178116,%,0,0
178117,;,0,0
178118,P,0,0
178119,<,0,0
178120,.001,0,0
178121,),0,0
178122,.,0,0
178123,When,0,0
178124,compared,0,0
178125,with,0,0
178126,HHACs,0,0
178127,",",0,0
178128,patients,0,0
178129,at,0,0
178130,HLACs,0,0
178131,had,0,0
178132,worse,0,0
178133,OS,0,1
178134,(,0,0
178135,5,0,0
178136,years,0,0
178137,:,0,0
178138,51.0,0,0
178139,%,0,0
178140,v,0,0
178141,69.1,0,0
178142,%,0,0
178143,;,0,0
178144,P,0,0
178145,=,0,0
178146,.002,0,0
178147,),0,0
178148,.,0,0
178149,Treatment,0,0
178150,at,0,0
178151,HLACs,0,0
178152,was,0,0
178153,associated,0,0
178154,with,0,0
178155,increased,0,0
178156,death,0,0
178157,risk,0,0
178158,of,0,0
178159,91,0,0
178160,%,0,0
178161,(,0,0
178162,hazard,0,0
178163,ratio,0,1
178164,[,0,1
178165,HR,0,1
178166,],0,0
178167,",",0,0
178168,1.91,0,0
178169,;,0,0
178170,95,0,0
178171,%,0,0
178172,CI,0,0
178173,",",0,0
178174,1.37,0,0
178175,to,0,0
178176,2.65,0,0
178177,),0,0
178178,after,0,0
178179,adjustment,0,0
178180,for,0,0
178181,prognostic,0,0
178182,factors,0,0
178183,and,0,0
178184,72,0,0
178185,%,0,0
178186,(,0,0
178187,HR,0,0
178188,",",0,0
178189,1.72,0,0
178190,;,0,0
178191,95,0,0
178192,%,0,0
178193,CI,0,0
178194,",",0,0
178195,1.23,0,0
178196,to,0,0
178197,2.40,0,0
178198,),0,0
178199,after,0,0
178200,radiotherapy,0,0
178201,compliance,0,0
178202,adjustment,0,0
178203,.,0,0
178204,CONCLUSION,0,0
178205,OS,0,0
178206,is,0,0
178207,worse,0,0
178208,for,0,0
178209,patients,0,0
178210,with,0,0
178211,HNC,0,0
178212,treated,0,0
178213,at,0,0
178214,HLACs,0,0
178215,versus,0,0
178216,HHACs,0,0
178217,to,0,0
178218,cooperative,0,0
178219,group,0,0
178220,trials,0,0
178221,after,0,0
178222,accounting,0,0
178223,for,0,0
178224,radiotherapy,0,0
178225,protocol,0,0
178226,deviations,0,0
178227,.,0,0
178228,Institutional,0,0
178229,experience,0,0
178230,substantially,0,0
178231,influences,0,0
178232,survival,0,0
178233,in,0,0
178234,locally,0,0
178235,advanced,0,0
178236,HNC,0,0
178237,.,0,0
178238,Crohn,0,1
178239,'s,0,1
178240,disease,0,0
178241,management,0,0
178242,after,0,0
178243,intestinal,0,0
178244,resection,0,0
178245,:,0,0
178246,a,0,0
178247,randomised,0,0
178248,trial,0,0
178249,.,0,0
178250,BACKGROUND,0,0
178251,Most,0,0
178252,patients,0,0
178253,with,0,0
178254,Crohn,0,0
178255,'s,0,0
178256,disease,0,0
178257,need,0,0
178258,an,0,0
178259,intestinal,0,0
178260,resection,0,0
178261,",",0,0
178262,but,0,0
178263,a,0,0
178264,majority,0,0
178265,will,0,0
178266,subsequently,0,0
178267,experience,0,0
178268,disease,0,0
178269,recurrence,0,0
178270,and,0,0
178271,require,0,0
178272,further,0,0
178273,surgery,0,0
178274,.,0,0
178275,This,0,0
178276,study,0,0
178277,aimed,0,0
178278,to,0,0
178279,identify,0,0
178280,the,0,0
178281,optimal,0,0
178282,strategy,0,0
178283,to,0,0
178284,prevent,0,0
178285,postoperative,0,0
178286,disease,0,0
178287,recurrence,0,0
178288,.,0,0
178289,METHODS,0,0
178290,In,0,0
178291,this,0,0
178292,randomised,0,0
178293,trial,0,0
178294,",",0,0
178295,consecutive,0,0
178296,patients,0,0
178297,from,0,0
178298,17,0,0
178299,centres,0,0
178300,in,0,0
178301,Australia,0,0
178302,and,0,0
178303,New,0,1
178304,Zealand,0,1
178305,undergoing,0,0
178306,intestinal,1,0
178307,resection,1,0
178308,of,0,0
178309,all,0,0
178310,macroscopic,0,0
178311,Crohn,0,0
178312,'s,0,0
178313,disease,0,0
178314,",",0,0
178315,with,0,0
178316,an,0,0
178317,endoscopically,0,0
178318,accessible,0,0
178319,anastomosis,0,0
178320,",",0,0
178321,received,0,0
178322,3,0,0
178323,months,0,0
178324,of,0,0
178325,metronidazole,1,1
178326,therapy,0,1
178327,.,0,0
178328,Patients,0,0
178329,at,0,0
178330,high,0,0
178331,risk,0,0
178332,of,0,0
178333,recurrence,0,0
178334,also,0,0
178335,received,0,0
178336,a,0,0
178337,thiopurine,1,1
178338,",",1,1
178339,or,1,1
178340,adalimumab,1,1
178341,if,0,0
178342,they,0,0
178343,were,0,0
178344,intolerant,0,0
178345,to,0,0
178346,thiopurines,0,1
178347,.,0,0
178348,Patients,0,0
178349,were,0,0
178350,randomly,0,0
178351,assigned,0,0
178352,to,0,0
178353,parallel,0,0
178354,groups,0,0
178355,:,0,0
178356,colonoscopy,1,0
178357,at,1,0
178358,6,1,0
178359,months,1,0
178360,(,1,0
178361,active,1,0
178362,care,1,1
178363,),1,0
178364,or,0,0
178365,no,1,1
178366,colonoscopy,1,0
178367,(,1,0
178368,standard,1,1
178369,care,1,1
178370,),1,0
178371,.,1,0
178372,We,0,0
178373,used,0,0
178374,computer-generated,0,0
178375,block,0,0
178376,randomisation,0,0
178377,to,0,0
178378,allocate,0,0
178379,patients,0,0
178380,in,0,0
178381,each,0,0
178382,centre,0,0
178383,to,0,0
178384,active,0,0
178385,or,0,0
178386,standard,0,0
178387,care,0,0
178388,in,0,0
178389,a,0,0
178390,2:1,0,0
178391,ratio,0,0
178392,.,0,0
178393,For,0,0
178394,endoscopic,0,0
178395,recurrence,0,1
178396,(,0,1
178397,Rutgeerts,0,1
178398,score,0,1
178399,?i2,0,1
178400,),0,1
178401,at,0,0
178402,6,0,0
178403,months,0,0
178404,",",0,0
178405,patients,0,0
178406,stepped-up,0,0
178407,to,0,0
178408,thiopurine,0,1
178409,",",0,1
178410,fortnightly,1,1
178411,adalimumab,1,1
178412,with,1,1
178413,thiopurine,1,1
178414,",",1,1
178415,or,0,1
178416,weekly,0,1
178417,adalimumab,0,1
178418,.,0,1
178419,The,0,0
178420,primary,0,0
178421,endpoint,0,0
178422,was,0,0
178423,endoscopic,0,0
178424,recurrence,0,0
178425,at,0,0
178426,18,0,0
178427,months,0,0
178428,.,0,0
178429,Patients,0,0
178430,and,0,0
178431,treating,0,0
178432,physicians,0,0
178433,were,0,0
178434,aware,0,0
178435,of,0,0
178436,the,0,0
178437,patient,0,0
178438,'s,0,0
178439,study,0,0
178440,group,0,0
178441,and,0,0
178442,treatment,0,0
178443,",",0,0
178444,but,0,0
178445,central,0,0
178446,reading,0,0
178447,of,0,0
178448,the,0,0
178449,endoscopic,0,0
178450,findings,0,0
178451,was,0,0
178452,undertaken,0,0
178453,blind,0,0
178454,to,0,0
178455,the,0,0
178456,study,0,0
178457,group,0,0
178458,and,0,0
178459,treatment,0,0
178460,.,0,0
178461,Analysis,0,0
178462,included,0,0
178463,all,0,0
178464,patients,0,0
178465,who,0,0
178466,received,0,0
178467,at,0,0
178468,least,0,0
178469,one,0,0
178470,dose,0,1
178471,of,0,0
178472,study,0,0
178473,drug,0,1
178474,.,0,1
178475,This,0,0
178476,trial,0,0
178477,is,0,0
178478,registered,0,0
178479,with,0,0
178480,ClinicalTrials.gov,0,0
178481,",",0,0
178482,number,0,0
178483,NCT00989560,0,0
178484,.,0,0
178485,FINDINGS,0,0
178486,Between,0,0
178487,Oct,0,0
178488,13,0,0
178489,",",0,0
178490,2009,0,0
178491,",",0,0
178492,and,0,0
178493,Sept,0,1
178494,28,0,0
178495,",",0,0
178496,2011,0,0
178497,",",0,0
178498,174,0,0
178499,(,0,0
178500,83,0,0
178501,%,0,0
178502,high,0,0
178503,risk,0,0
178504,across,0,0
178505,both,0,0
178506,active,0,0
178507,and,0,0
178508,standard,0,0
178509,care,0,1
178510,groups,0,0
178511,),0,0
178512,patients,0,0
178513,were,0,0
178514,enrolled,0,0
178515,and,0,0
178516,received,0,0
178517,at,0,0
178518,least,0,0
178519,one,0,0
178520,dose,0,1
178521,of,0,0
178522,study,0,0
178523,drug,0,1
178524,.,0,0
178525,Of,0,0
178526,122,0,0
178527,patients,0,0
178528,in,0,0
178529,the,0,0
178530,active,0,0
178531,care,0,0
178532,group,0,0
178533,",",0,0
178534,47,0,0
178535,(,0,0
178536,39,0,0
178537,%,0,0
178538,),0,0
178539,stepped-up,0,0
178540,treatment,0,0
178541,.,0,0
178542,At,0,0
178543,18,0,0
178544,months,0,0
178545,",",0,0
178546,endoscopic,0,0
178547,recurrence,0,0
178548,occurred,0,0
178549,in,0,0
178550,60,0,0
178551,(,0,0
178552,49,0,0
178553,%,0,0
178554,),0,0
178555,patients,0,0
178556,in,0,0
178557,the,0,0
178558,active,0,0
178559,care,0,0
178560,group,0,0
178561,and,0,0
178562,35,0,0
178563,(,0,0
178564,67,0,0
178565,%,0,0
178566,),0,0
178567,patients,0,0
178568,in,0,0
178569,the,0,0
178570,standard,0,0
178571,care,0,1
178572,group,0,0
178573,(,0,0
178574,p=0.03,0,0
178575,),0,0
178576,.,0,0
178577,Complete,0,0
178578,mucosal,0,0
178579,normality,0,0
178580,was,0,0
178581,maintained,0,0
178582,in,0,0
178583,27,0,0
178584,(,0,0
178585,22,0,0
178586,%,0,0
178587,),0,0
178588,of,0,0
178589,122,0,0
178590,patients,0,0
178591,in,0,0
178592,the,0,0
178593,active,0,0
178594,care,0,0
178595,group,0,0
178596,versus,0,0
178597,four,0,0
178598,(,0,0
178599,8,0,0
178600,%,0,0
178601,),0,0
178602,in,0,0
178603,the,0,0
178604,standard,0,0
178605,care,0,1
178606,group,0,0
178607,(,0,0
178608,p=0.03,0,0
178609,),0,0
178610,.,0,0
178611,In,0,0
178612,the,0,0
178613,active,0,0
178614,care,0,0
178615,arm,0,0
178616,",",0,0
178617,of,0,0
178618,those,0,0
178619,with,0,0
178620,6,0,0
178621,months,0,0
178622,recurrence,0,0
178623,who,0,0
178624,stepped,0,0
178625,up,0,0
178626,treatment,0,0
178627,",",0,0
178628,18,0,0
178629,(,0,0
178630,38,0,0
178631,%,0,0
178632,),0,0
178633,of,0,0
178634,47,0,0
178635,patients,0,0
178636,were,0,0
178637,in,0,0
178638,remission,0,0
178639,12,0,0
178640,months,0,0
178641,later,0,0
178642,;,0,0
178643,conversely,0,0
178644,",",0,0
178645,of,0,0
178646,those,0,0
178647,in,0,0
178648,remission,0,0
178649,at,0,0
178650,6,0,0
178651,months,0,0
178652,who,0,0
178653,did,0,0
178654,not,0,0
178655,change,0,0
178656,therapy,0,0
178657,recurrence,0,0
178658,occurred,0,0
178659,in,0,0
178660,31,0,0
178661,(,0,0
178662,41,0,0
178663,%,0,0
178664,),0,0
178665,of,0,0
178666,75,0,0
178667,patients,0,0
178668,12,0,0
178669,months,0,0
178670,later,0,0
178671,.,0,0
178672,Smoking,0,0
178673,(,0,0
178674,odds,0,1
178675,ratio,0,1
178676,[,0,1
178677,OR,0,1
178678,],0,0
178679,2.4,0,0
178680,",",0,0
178681,95,0,0
178682,%,0,0
178683,CI,0,0
178684,1.2-4.8,0,0
178685,",",0,0
178686,p=0.02,0,0
178687,),0,0
178688,and,0,0
178689,the,0,0
178690,presence,0,0
178691,of,0,0
178692,two,0,0
178693,or,0,0
178694,more,0,0
178695,clinical,0,0
178696,risk,0,0
178697,factors,0,0
178698,including,0,0
178699,smoking,0,0
178700,(,0,0
178701,OR,0,0
178702,2.8,0,0
178703,",",0,0
178704,95,0,0
178705,%,0,0
178706,CI,0,0
178707,1.01-7.7,0,0
178708,",",0,0
178709,p=0.05,0,0
178710,),0,0
178711,increased,0,0
178712,the,0,0
178713,risk,0,0
178714,of,0,0
178715,endoscopic,0,0
178716,recurrence,0,0
178717,.,0,0
178718,The,0,0
178719,incidence,0,0
178720,and,0,0
178721,type,0,0
178722,of,0,0
178723,adverse,0,0
178724,and,0,0
178725,severe,0,0
178726,adverse,0,0
178727,events,0,0
178728,did,0,0
178729,not,0,0
178730,differ,0,0
178731,significantly,0,0
178732,between,0,0
178733,patients,0,0
178734,in,0,0
178735,the,0,0
178736,active,0,0
178737,care,0,0
178738,and,0,0
178739,standard,0,0
178740,care,0,1
178741,groups,0,1
178742,(,0,0
178743,100,0,0
178744,[,0,0
178745,82,0,0
178746,%,0,0
178747,],0,0
178748,of,0,0
178749,122,0,0
178750,vs,0,0
178751,45,0,0
178752,[,0,0
178753,87,0,0
178754,%,0,0
178755,],0,0
178756,of,0,0
178757,52,0,0
178758,;,0,0
178759,p=0.51,0,0
178760,),0,0
178761,and,0,0
178762,(,0,0
178763,33,0,0
178764,[,0,0
178765,27,0,0
178766,%,0,0
178767,],0,0
178768,of,0,0
178769,122,0,0
178770,vs,0,0
178771,18,0,0
178772,[,0,0
178773,35,0,0
178774,%,0,0
178775,],0,0
178776,of,0,0
178777,52,0,0
178778,;,0,0
178779,p=0.36,0,0
178780,),0,0
178781,",",0,0
178782,respectively,0,0
178783,.,0,0
178784,INTERPRETATION,0,0
178785,Treatment,0,0
178786,according,0,0
178787,to,0,0
178788,clinical,0,0
178789,risk,0,0
178790,of,0,0
178791,recurrence,0,0
178792,",",0,0
178793,with,0,0
178794,early,0,0
178795,colonoscopy,0,0
178796,and,0,0
178797,treatment,0,0
178798,step-up,0,0
178799,for,0,0
178800,recurrence,0,0
178801,",",0,0
178802,is,0,0
178803,better,0,0
178804,than,0,0
178805,conventional,0,0
178806,drug,0,1
178807,therapy,0,1
178808,alone,0,0
178809,for,0,0
178810,prevention,0,0
178811,of,0,0
178812,postoperative,0,0
178813,Crohn,0,1
178814,'s,0,1
178815,disease,0,0
178816,recurrence,0,0
178817,.,0,0
178818,Selective,0,0
178819,immune,0,0
178820,suppression,0,0
178821,",",0,0
178822,adjusted,0,0
178823,for,0,0
178824,early,0,0
178825,recurrence,0,0
178826,",",0,0
178827,rather,0,0
178828,than,0,0
178829,routine,0,0
178830,use,0,0
178831,",",0,0
178832,leads,0,0
178833,to,0,0
178834,disease,0,0
178835,control,0,0
178836,in,0,0
178837,most,0,0
178838,patients,0,0
178839,.,0,0
178840,Clinical,0,0
178841,risk,0,0
178842,factors,0,0
178843,predict,0,0
178844,recurrence,0,0
178845,",",0,0
178846,but,0,0
178847,patients,0,0
178848,at,0,0
178849,low,0,0
178850,risk,0,0
178851,also,0,0
178852,need,0,0
178853,monitoring,0,0
178854,.,0,0
178855,Early,0,0
178856,remission,0,0
178857,does,0,0
178858,not,0,0
178859,preclude,0,0
178860,the,0,0
178861,need,0,0
178862,for,0,0
178863,ongoing,0,0
178864,monitoring,0,0
178865,.,0,0
178866,FUNDING,0,0
178867,AbbVie,0,1
178868,",",0,0
178869,Gutsy,0,0
178870,Group,0,0
178871,",",0,0
178872,Gandel,0,1
178873,Philanthropy,0,1
178874,",",0,0
178875,Angior,0,0
178876,Foundation,0,0
178877,",",0,0
178878,Crohn,0,1
178879,'s,0,1
178880,Colitis,0,0
178881,Australia,0,0
178882,",",0,0
178883,and,0,0
178884,the,0,0
178885,National,0,0
178886,Health,0,0
178887,and,0,0
178888,Medical,0,0
178889,Research,0,0
178890,Council,0,0
178891,.,0,0
178892,Effects,0,0
178893,of,0,0
178894,stellate,1,1
178895,ganglionic,1,1
178896,block,1,0
178897,on,0,0
178898,hemodynamic,0,0
178899,changes,0,0
178900,and,0,0
178901,intrapulmonary,0,0
178902,shunt,0,0
178903,in,0,0
178904,perioperative,0,0
178905,patients,0,0
178906,with,0,0
178907,esophageal,0,0
178908,cancer,0,0
178909,.,0,0
178910,OBJECTIVE,0,0
178911,The,0,0
178912,aim,0,0
178913,of,0,0
178914,this,0,0
178915,study,0,0
178916,was,0,0
178917,to,0,0
178918,observe,0,0
178919,the,0,0
178920,effects,0,0
178921,of,1,0
178922,stellate,1,0
178923,ganglion,1,0
178924,block,1,0
178925,(,1,1
178926,SGB,1,1
178927,),1,1
178928,on,0,0
178929,hemodynamic,0,0
178930,changes,0,0
178931,and,0,0
178932,intrapulmonary,0,0
178933,shunt,0,0
178934,during,0,0
178935,one-lung,0,1
178936,ventilation,0,1
178937,(,0,1
178938,OLV,0,1
178939,),0,1
178940,.,0,0
178941,PATIENTS,0,0
178942,AND,0,1
178943,METHODS,0,1
178944,Thirty,0,0
178945,ASA,0,0
178946,class,0,0
178947,I-II,0,0
178948,patients,0,0
178949,undergoing,0,0
178950,elective,0,1
178951,esophageal,0,0
178952,surgery,0,0
178953,were,0,0
178954,randomly,0,0
178955,divided,0,0
178956,into,0,0
178957,two,0,0
178958,groups,1,0
178959,:,1,0
178960,general,1,0
178961,anesthesia,1,1
178962,group,1,0
178963,(,1,0
178964,group,1,0
178965,N,1,0
178966,",",1,0
178967,n=15,1,0
178968,),1,0
178969,and,1,0
178970,general,1,0
178971,anesthesia,1,0
178972,combined,1,0
178973,SGB,1,1
178974,group,1,1
178975,(,1,0
178976,group,1,0
178977,S,1,0
178978,",",1,0
178979,n=15,1,0
178980,),1,0
178981,",",1,0
178982,patients,1,0
178983,in,1,0
178984,group,1,0
178985,S,1,0
178986,were,1,0
178987,received,1,0
178988,left,1,0
178989,SGB,1,0
178990,before,1,0
178991,induction,1,0
178992,.,1,0
178993,Radial,1,0
178994,artery,1,0
178995,was,1,0
178996,cannulated,1,0
178997,for,1,0
178998,arterial,1,0
178999,blood,1,1
179000,pressure,1,1
179001,(,1,1
179002,ABP,1,1
179003,),1,0
179004,monitoring,1,0
179005,and,1,0
179006,blood,1,0
179007,sampling,1,0
179008,and,1,0
179009,Swan-Ganz,1,0
179010,catheter,1,0
179011,was,1,0
179012,position,1,0
179013,in,1,0
179014,the,1,0
179015,pulmonary,1,0
179016,artery,1,0
179017,via,1,0
179018,right,1,0
179019,internal,1,0
179020,jugular,1,0
179021,vein,1,0
179022,under,1,0
179023,local,1,0
179024,anesthesia,1,0
179025,.,1,0
179026,ECG,1,0
179027,",",1,0
179028,MAP,1,1
179029,",",1,0
179030,HR,1,1
179031,",",1,0
179032,CVP,1,0
179033,",",1,0
179034,continuous,1,0
179035,cardiac,1,1
179036,output,1,1
179037,(,1,1
179038,CCO,1,1
179039,),1,1
179040,index,1,0
179041,and,1,0
179042,BIS,1,0
179043,were,0,0
179044,continuously,0,0
179045,monitored,0,0
179046,during,0,0
179047,anesthesia,0,0
179048,.,0,0
179049,General,0,0
179050,anesthesia,0,0
179051,was,0,0
179052,induced,0,0
179053,with,0,0
179054,propofol,0,1
179055,1.5-2.0,0,0
179056,mg/kg,0,1
179057,",",0,0
179058,sufentanil,0,1
179059,0.4,0,1
179060,?g/kg,0,1
179061,",",0,0
179062,and,0,0
179063,Rocuronium,0,1
179064,0.6-0.9,0,1
179065,mg/kg,0,1
179066,.,0,0
179067,Endobronchial,0,0
179068,occluder,0,0
179069,was,0,0
179070,placed,0,0
179071,blindly,0,0
179072,after,0,0
179073,tracheal,0,0
179074,indubation,0,0
179075,and,0,0
179076,the,0,0
179077,correct,0,0
179078,position,0,0
179079,was,0,0
179080,verified,0,0
179081,by,0,0
179082,auscultation,0,0
179083,and,0,0
179084,fiberoptic,0,0
179085,bronchoscopy,0,0
179086,.,0,0
179087,The,0,0
179088,patients,0,0
179089,were,0,0
179090,mechanically,0,0
179091,ventilated,0,0
179092,.,0,0
179093,The,0,0
179094,ventilation,0,0
179095,conditions,0,0
179096,were,0,0
179097,Fio2=100,0,0
179098,%,0,0
179099,",",0,0
179100,VT,0,0
179101,=,0,0
179102,8-10,0,0
179103,ml/kg,0,1
179104,",",0,1
179105,I,0,0
179106,:,0,0
179107,E,0,0
179108,=,0,0
179109,1:2,0,0
179110,and,0,0
179111,respiratory,0,0
179112,rate,0,0
179113,was,0,0
179114,adjusted,0,0
179115,to,0,0
179116,maintained,0,0
179117,PETCO2,0,0
179118,at,0,0
179119,35-45,0,0
179120,mmHg,0,0
179121,during,0,0
179122,both,0,0
179123,two-lung,0,0
179124,ventilation,0,1
179125,(,0,1
179126,TLV,0,1
179127,),0,1
179128,and,0,0
179129,OLV,0,1
179130,.,0,0
179131,Anesthesia,0,0
179132,was,0,0
179133,maintained,0,0
179134,with,0,0
179135,continuous,0,0
179136,infusion,0,1
179137,of,0,0
179138,propofol,0,1
179139,4-10,0,1
179140,mg/kg?h,0,1
179141,",",0,0
179142,sufentanil,0,1
179143,0.2,0,0
179144,?g/kg?h,0,1
179145,",",0,0
179146,vecuronium,0,1
179147,o.1,0,1
179148,mg/kg?h,0,1
179149,",",0,1
179150,BIS,0,1
179151,was,0,0
179152,maintained,0,0
179153,at,0,0
179154,45-55,0,0
179155,.,0,0
179156,Blood,0,0
179157,samples,0,0
179158,were,0,0
179159,taken,0,0
179160,from,0,0
179161,radial,0,0
179162,artery,0,0
179163,and,0,0
179164,S-G,0,0
179165,catheter,0,0
179166,for,0,0
179167,blood,0,0
179168,gas,0,0
179169,analysis,0,0
179170,at,0,0
179171,following,0,0
179172,intervals,0,0
179173,:,0,0
179174,during,0,0
179175,spontaneous,0,0
179176,breathing,0,0
179177,when,0,0
179178,the,0,0
179179,patient,0,0
179180,was,0,0
179181,awake,0,0
179182,(,0,1
179183,T0,0,1
179184,),0,1
179185,",",0,0
179186,1,0,0
179187,min,0,0
179188,after,0,0
179189,tracheal,0,0
179190,indubation,0,1
179191,(,0,1
179192,T1,0,1
179193,),0,1
179194,",",0,0
179195,1,0,0
179196,min,0,0
179197,after,0,0
179198,patient,0,0
179199,was,0,0
179200,placed,0,0
179201,in,0,0
179202,lateral,0,0
179203,position,0,0
179204,(,0,0
179205,T2,0,1
179206,),0,1
179207,and,0,0
179208,15,0,0
179209,min,0,0
179210,after,0,0
179211,it,0,0
179212,(,0,0
179213,T3,0,1
179214,),0,1
179215,",",0,0
179216,1,0,0
179217,min,0,0
179218,after,0,0
179219,ribs,0,0
179220,was,0,0
179221,braced,0,0
179222,(,0,0
179223,T4,0,0
179224,),0,0
179225,",",0,0
179226,30,0,0
179227,",",0,0
179228,60,0,0
179229,",",0,0
179230,120,0,0
179231,min,0,0
179232,during,0,0
179233,the,0,0
179234,course,0,0
179235,of,0,0
179236,OLV,0,1
179237,(,0,0
179238,T5,0,1
179239,",",0,0
179240,T6,0,1
179241,",",0,1
179242,T7,0,1
179243,),0,0
179244,",",0,0
179245,the,0,0
179246,two,0,0
179247,lungs,0,0
179248,were,0,0
179249,ventilated,0,0
179250,again,0,0
179251,for,0,0
179252,30,0,0
179253,min,0,0
179254,(,0,1
179255,T8,0,1
179256,),0,1
179257,and,0,0
179258,Qs/Qt,0,0
179259,was,0,0
179260,calculated,0,0
179261,.,0,0
179262,RESULTS,0,0
179263,SVRI,0,1
179264,",",0,0
179265,MAP,0,1
179266,",",0,0
179267,HR,0,0
179268,in,0,0
179269,group,0,0
179270,N,0,0
179271,increased,0,0
179272,significantly,0,0
179273,at,0,0
179274,T1,0,0
179275,",",0,0
179276,T2,0,0
179277,",",0,0
179278,T4,0,0
179279,compared,0,0
179280,with,0,0
179281,group,0,0
179282,S,0,0
179283,(,0,0
179284,p,0,0
179285,<,0,0
179286,0.05,0,0
179287,),0,0
179288,.,0,0
179289,Qs/Qt,0,0
179290,was,0,0
179291,significantly,0,0
179292,increased,0,0
179293,after,0,0
179294,patient,0,0
179295,was,0,0
179296,placed,0,0
179297,in,0,0
179298,lateral,0,0
179299,position,0,0
179300,and,0,0
179301,increased,0,0
179302,further,0,0
179303,during,0,0
179304,OLV,0,1
179305,;,0,0
179306,the,0,0
179307,calculated,0,0
179308,Qs/Qt,0,0
179309,values,0,0
179310,were,0,0
179311,highest,0,0
179312,at,0,0
179313,T5?,0,0
179314,PaO2,0,0
179315,was,0,0
179316,significantly,0,0
179317,lower,0,0
179318,after,0,0
179319,OLV,0,0
179320,was,0,0
179321,started,0,0
179322,and,0,0
179323,reached,0,0
179324,the,0,0
179325,lowest,0,0
179326,level,0,0
179327,at,0,0
179328,T6,0,0
179329,then,0,0
179330,was,0,0
179331,gradually,0,0
179332,increasing,0,0
179333,.,0,0
179334,There,0,0
179335,was,0,0
179336,no,0,0
179337,significant,0,0
179338,difference,0,0
179339,in,0,0
179340,Qs/Qt,0,0
179341,and,0,0
179342,PaO2,0,0
179343,at,0,0
179344,all,0,0
179345,time,0,0
179346,points,0,0
179347,between,0,0
179348,two,0,0
179349,groups,0,0
179350,.,0,0
179351,CONCLUSIONS,1,0
179352,SGB,1,0
179353,before,1,0
179354,induction,0,0
179355,effectively,0,0
179356,suppress,0,0
179357,the,0,0
179358,stress,0,0
179359,response,0,0
179360,work,0,0
179361,as,0,0
179362,stable,0,0
179363,blood,0,0
179364,dynamics,0,0
179365,and,0,0
179366,does,0,0
179367,not,0,0
179368,affect,0,0
179369,Qs/Qt,0,0
179370,and,0,0
179371,arterial,0,0
179372,oxygenation,0,0
179373,during,0,0
179374,OLV,0,0
179375,",",0,0
179376,SGB,0,0
179377,is,0,0
179378,a,0,0
179379,safe,0,0
179380,technique,0,0
179381,of,0,0
179382,anesthesia,0,0
179383,for,0,0
179384,general,0,0
179385,thoracic,0,0
179386,surgery,0,0
179387,.,0,0
179388,Inclusion,0,0
179389,of,0,0
179390,anti-phospholipase,1,1
179391,A2,1,1
179392,antibody,1,0
179393,to,0,0
179394,backgrounding,0,0
179395,diets,0,1
179396,on,0,0
179397,performance,0,0
179398,",",0,0
179399,feed,0,0
179400,efficiency,0,0
179401,",",0,0
179402,in,0,0
179403,vitro,0,0
179404,fermentation,0,1
179405,",",0,0
179406,and,0,0
179407,the,0,0
179408,acute-phase,0,0
179409,response,0,0
179410,of,0,0
179411,growing,0,0
179412,beef,0,1
179413,calves,0,0
179414,.,0,0
179415,In,0,0
179416,Exp,0,0
179417,.,0,0
179418,1,0,0
179419,",",0,0
179420,individual,0,0
179421,performance,0,0
179422,and,0,0
179423,daily,0,1
179424,DMI,0,1
179425,was,0,0
179426,measured,0,0
179427,on,0,0
179428,70,0,0
179429,crossbred,0,0
179430,weaned,0,0
179431,calves,0,0
179432,during,0,0
179433,a,0,0
179434,70-d,0,0
179435,period,0,0
179436,using,0,0
179437,a,0,0
179438,GrowSafe,0,0
179439,system,0,0
179440,(,0,0
179441,GrowSafe,0,0
179442,Systems,0,0
179443,Ltd.,0,0
179444,",",0,0
179445,Airdrie,0,1
179446,",",0,0
179447,AB,0,1
179448,",",0,1
179449,Canada,0,1
179450,),0,0
179451,at,0,0
179452,the,0,0
179453,University,0,0
179454,of,0,0
179455,Florida,0,0
179456,North,0,0
179457,Florida,0,0
179458,Research,0,0
179459,and,0,0
179460,Education,0,0
179461,Center,0,0
179462,Feed,0,0
179463,Efficiency,0,0
179464,Facility,0,1
179465,(,0,1
179466,FEF,0,1
179467,),0,1
179468,.,0,0
179469,Calves,0,0
179470,were,0,0
179471,fed,0,0
179472,a,0,0
179473,low-concentrate,1,0
179474,(,1,0
179475,LC,1,1
179476,),1,1
179477,growing,1,0
179478,diet,1,1
179479,",",0,0
179480,blocked,0,0
179481,by,0,0
179482,weight,0,0
179483,and,0,0
179484,sex,0,0
179485,",",0,0
179486,and,0,0
179487,then,0,0
179488,randomly,0,0
179489,assigned,0,0
179490,to,0,0
179491,pens,0,0
179492,to,0,0
179493,receive,0,0
179494,either,1,0
179495,no,1,0
179496,additional,1,0
179497,supplement,1,1
179498,(,0,1
179499,CON,0,1
179500,;,0,0
179501,n,0,0
179502,=,0,0
179503,35,0,0
179504,),0,0
179505,or,1,0
179506,receive,1,1
179507,a,1,0
179508,supplement,1,1
179509,of,1,1
179510,anti-phospholipase,1,1
179511,A2,1,1
179512,antibody,1,1
179513,(,1,1
179514,aPLA2,1,1
179515,),1,1
179516,at,0,0
179517,an,0,0
179518,inclusion,0,0
179519,rate,0,0
179520,of,0,0
179521,0.6,0,0
179522,%,0,0
179523,of,0,0
179524,the,0,0
179525,diet,0,1
179526,DM,0,1
179527,(,0,0
179528,n,0,0
179529,=,0,0
179530,35,0,0
179531,),0,0
179532,.,0,0
179533,After,0,0
179534,the,0,0
179535,70-d,0,1
179536,feed,0,1
179537,efficiency,0,0
179538,(,0,1
179539,FE,0,1
179540,),0,1
179541,trial,0,1
179542,(,0,1
179543,Phase,0,0
179544,1,0,1
179545,),0,0
179546,",",0,0
179547,calves,0,0
179548,were,0,0
179549,loaded,0,0
179550,into,0,0
179551,a,0,0
179552,commercial,0,0
179553,livestock,0,0
179554,trailer,0,0
179555,and,0,0
179556,were,0,0
179557,driven,0,0
179558,for,0,0
179559,approximately,0,0
179560,"1,600",0,0
179561,km,0,0
179562,during,0,0
179563,24,0,0
179564,h.,0,0
179565,Upon,0,0
179566,return,0,0
179567,to,0,0
179568,the,0,0
179569,FEF,0,1
179570,(,0,0
179571,Phase,0,0
179572,2,0,1
179573,),0,0
179574,",",0,0
179575,calves,0,0
179576,were,0,0
179577,relocated,0,0
179578,to,0,0
179579,the,0,0
179580,same,0,0
179581,pens,0,0
179582,and,0,0
179583,groups,0,0
179584,and,0,0
179585,received,0,0
179586,the,0,0
179587,same,0,0
179588,diets,0,1
179589,and,0,0
179590,treatments,0,0
179591,for,0,0
179592,28,0,0
179593,d.,0,0
179594,Blood,0,0
179595,samples,0,0
179596,from,0,0
179597,each,0,0
179598,calf,0,0
179599,were,0,0
179600,collected,0,0
179601,on,0,0
179602,d,0,0
179603,0,0,0
179604,",",0,0
179605,1,0,0
179606,",",0,0
179607,3,0,0
179608,",",0,0
179609,5,0,0
179610,",",0,0
179611,7,0,0
179612,",",0,0
179613,14,0,0
179614,",",0,0
179615,21,0,0
179616,",",0,0
179617,and,0,0
179618,28,0,0
179619,relative,0,0
179620,to,0,0
179621,initiation,0,0
179622,of,0,0
179623,transportation,0,0
179624,and,0,0
179625,were,0,0
179626,analyzed,0,0
179627,for,0,0
179628,determination,0,0
179629,of,0,0
179630,concentrations,0,0
179631,of,0,1
179632,plasma,0,1
179633,ceruloplasmin,0,1
179634,and,0,1
179635,haptoglobin,0,1
179636,.,0,1
179637,In,0,0
179638,Phase,0,0
179639,1,0,0
179640,",",0,0
179641,initial,0,0
179642,BW,0,0
179643,(,0,0
179644,242.0,0,0
179645,?,0,0
179646,3.7,0,0
179647,kg,0,0
179648,;,0,0
179649,P,0,0
179650,=,0,0
179651,0.92,0,0
179652,),0,0
179653,",",0,0
179654,BW,0,1
179655,at,0,0
179656,d,0,0
179657,70,0,0
179658,(,0,0
179659,313.0,0,0
179660,?,0,0
179661,4.1,0,0
179662,kg,0,0
179663,;,0,0
179664,P,0,0
179665,=,0,0
179666,0.79,0,0
179667,),0,0
179668,",",0,0
179669,and,0,0
179670,ADG,0,0
179671,(,0,0
179672,1.01,0,0
179673,?,0,0
179674,0.02,0,0
179675,kg,0,0
179676,;,0,0
179677,P,0,0
179678,=,0,0
179679,0.95,0,0
179680,),0,0
179681,were,0,0
179682,similar,0,0
179683,between,0,0
179684,treatments,0,0
179685,.,0,0
179686,However,0,0
179687,",",0,0
179688,daily,0,1
179689,DMI,0,1
179690,was,0,0
179691,greater,0,0
179692,(,0,0
179693,P,0,0
179694,=,0,0
179695,0.01,0,0
179696,),0,0
179697,for,0,0
179698,CON,0,1
179699,(,0,0
179700,9.18,0,0
179701,?,0,0
179702,0.15,0,0
179703,kg,0,0
179704,),0,0
179705,than,0,1
179706,aPLA2,0,0
179707,(,0,0
179708,8.53,0,0
179709,?,0,0
179710,0.15,0,0
179711,kg,0,0
179712,),0,0
179713,.,0,0
179714,In,0,0
179715,addition,0,0
179716,",",0,0
179717,residual,0,0
179718,feed,0,1
179719,intake,0,1
179720,was,0,0
179721,greater,0,0
179722,(,0,0
179723,P,0,0
179724,=,0,0
179725,0.002,0,0
179726,),0,0
179727,for,0,0
179728,CON,0,0
179729,(,0,0
179730,0.389,0,0
179731,?,0,0
179732,0.110,0,0
179733,kg/d,0,1
179734,),0,0
179735,than,0,0
179736,aPLA2,0,1
179737,calves,0,0
179738,(,0,0
179739,-0.272,0,0
179740,?,0,0
179741,0.110,0,0
179742,kg/d,0,1
179743,),0,0
179744,.,0,0
179745,In,0,0
179746,Phase,0,0
179747,2,0,0
179748,",",0,0
179749,after,0,0
179750,transportation,0,0
179751,",",0,0
179752,there,0,0
179753,were,0,0
179754,no,0,0
179755,differences,0,0
179756,between,0,0
179757,treatments,0,0
179758,on,0,0
179759,BW,0,0
179760,loss,0,0
179761,due,0,0
179762,to,0,0
179763,transportation,0,0
179764,shrink,0,0
179765,(,0,0
179766,26.0,0,0
179767,?,0,0
179768,0.6,0,0
179769,kg,0,0
179770,;,0,0
179771,P,0,0
179772,=,0,0
179773,0.86,0,0
179774,),0,0
179775,",",0,0
179776,BW,0,1
179777,at,0,0
179778,d,0,0
179779,28,0,0
179780,(,0,0
179781,339.0,0,0
179782,?,0,0
179783,4.1,0,0
179784,kg,0,0
179785,;,0,0
179786,P,0,0
179787,=,0,0
179788,0.72,0,0
179789,),0,0
179790,",",0,0
179791,ADG,0,1
179792,(,0,0
179793,1.28,0,0
179794,?,0,0
179795,0.03,0,0
179796,kg/d,0,0
179797,;,0,0
179798,P,0,0
179799,=,0,0
179800,0.72,0,0
179801,),0,0
179802,",",0,0
179803,G,0,1
179804,:,0,1
179805,F,0,0
179806,(,0,0
179807,0.164,0,0
179808,?,0,0
179809,0.004,0,0
179810,;,0,0
179811,P,0,0
179812,=,0,0
179813,0.83,0,0
179814,),0,0
179815,",",0,0
179816,and,0,0
179817,concentrations,0,1
179818,of,0,1
179819,plasma,0,1
179820,haptoglobin,0,1
179821,(,0,1
179822,0.08,0,0
179823,?,0,0
179824,0.02,0,0
179825,mg/mL,0,0
179826,;,0,0
179827,P,0,0
179828,=,0,0
179829,0.41,0,0
179830,),0,0
179831,.,0,0
179832,However,0,0
179833,",",0,0
179834,concentrations,0,1
179835,of,0,1
179836,plasma,0,1
179837,ceruloplasmin,0,1
179838,were,0,1
179839,greater,0,0
179840,(,0,0
179841,P,0,0
179842,<,0,0
179843,0.001,0,0
179844,),0,0
179845,for,0,0
179846,CON,0,1
179847,calves,0,0
179848,(,0,0
179849,14.3,0,0
179850,?,0,0
179851,0.3,0,0
179852,mg/dL,0,1
179853,),0,0
179854,compared,0,0
179855,to,0,0
179856,aPLA2,0,1
179857,calves,0,0
179858,(,0,0
179859,13.0,0,0
179860,?,0,0
179861,0.3,0,0
179862,mg/dL,0,1
179863,),0,0
179864,.,0,0
179865,In,0,0
179866,Exp,0,0
179867,.,0,0
179868,2,0,0
179869,",",0,0
179870,the,0,0
179871,effects,0,0
179872,of,0,0
179873,aPLA2,0,0
179874,inclusion,0,0
179875,on,0,0
179876,LC,0,0
179877,and,0,1
179878,high-concentrate,0,1
179879,(,0,1
179880,HC,0,1
179881,),0,1
179882,substrates,0,0
179883,on,0,0
179884,in,0,0
179885,vitro,0,0
179886,fermentation,0,1
179887,parameters,0,0
179888,were,0,0
179889,assessed,0,0
179890,.,0,0
179891,Addition,0,0
179892,of,0,0
179893,aPLA2,0,0
179894,had,0,0
179895,no,0,0
179896,effects,0,0
179897,on,0,0
179898,in,0,0
179899,vitro,0,0
179900,fermentation,0,1
179901,parameters,0,0
179902,of,0,0
179903,LC,0,0
179904,and,0,0
179905,HC,0,0
179906,substrates,0,0
179907,.,0,0
179908,In,0,0
179909,conclusion,0,0
179910,",",0,0
179911,supplementation,1,1
179912,of,1,0
179913,aPLA2,1,1
179914,improved,1,0
179915,FE,0,0
179916,of,0,0
179917,growing,0,0
179918,beef,0,1
179919,calves,0,0
179920,when,0,0
179921,fed,0,0
179922,LC,0,1
179923,diets,0,1
179924,in,0,0
179925,Phase,0,0
179926,1,0,0
179927,and,0,0
179928,addition,0,0
179929,of,0,0
179930,aPLA2,0,0
179931,had,0,0
179932,no,0,0
179933,effect,0,0
179934,on,0,0
179935,fermentation,0,1
179936,parameters,0,0
179937,of,0,0
179938,LC,0,0
179939,and,0,0
179940,HC,0,0
179941,substrates,0,0
179942,.,0,0
179943,In,0,0
179944,addition,0,0
179945,",",0,0
179946,calves,0,0
179947,supplemented,0,0
179948,with,0,0
179949,aPLA2,0,0
179950,had,0,0
179951,reduced,0,0
179952,concentrations,0,0
179953,of,0,1
179954,plasma,0,1
179955,ceruloplasmin,0,1
179956,after,0,1
179957,24,0,0
179958,h,0,0
179959,of,0,0
179960,transportation,0,0
179961,.,0,0
179962,Exploring,0,0
179963,the,0,0
179964,role,0,0
179965,of,0,0
179966,tanezumab,1,1
179967,as,0,0
179968,a,0,0
179969,novel,0,0
179970,treatment,0,0
179971,for,0,0
179972,the,0,0
179973,relief,0,0
179974,of,0,0
179975,neuropathic,0,0
179976,pain,0,0
179977,.,0,0
179978,OBJECTIVE,0,0
179979,Evaluate,0,0
179980,efficacy,0,0
179981,and,0,0
179982,safety,0,0
179983,of,0,0
179984,tanezumab,1,1
179985,",",0,1
179986,a,0,1
179987,humanized,0,1
179988,monoclonal,0,1
179989,antibody,0,1
179990,against,0,0
179991,nerve,0,0
179992,growth,0,0
179993,factor,0,0
179994,",",0,0
179995,in,0,0
179996,neuropathic,0,0
179997,pain,0,0
179998,.,0,0
179999,DESIGN,0,0
180000,Two,0,1
180001,randomized,0,0
180002,controlled,0,0
180003,trials,0,0
180004,.,0,0
180005,SUBJECTS,0,0
180006,Patients,0,0
180007,with,0,0
180008,pain,0,0
180009,due,0,0
180010,to,0,0
180011,diabetic,0,0
180012,peripheral,0,0
180013,neuropathy,0,1
180014,(,0,1
180015,DPN,0,1
180016,),0,1
180017,or,0,0
180018,postherpetic,0,1
180019,neuralgia,0,1
180020,(,0,1
180021,PHN,0,1
180022,),0,1
180023,.,0,0
180024,METHODS,0,0
180025,In,0,0
180026,the,0,0
180027,DPN,0,0
180028,study,0,0
180029,",",0,0
180030,patients,0,0
180031,received,0,0
180032,subcutaneous,0,1
180033,tanezumab,1,1
180034,20,1,1
180035,mg,1,1
180036,or,1,1
180037,placebo,1,1
180038,on,0,1
180039,Day,0,1
180040,1,0,0
180041,and,0,0
180042,Week,0,0
180043,8,0,0
180044,.,0,0
180045,Evaluations,0,0
180046,included,0,0
180047,change,0,0
180048,from,0,0
180049,baseline,0,0
180050,in,0,0
180051,average,0,0
180052,DPN,0,0
180053,pain,0,0
180054,(,0,0
180055,primary,0,0
180056,endpoint,0,1
180057,),0,0
180058,",",0,0
180059,Patient,0,0
180060,'s,0,0
180061,Global,0,0
180062,Assessment,0,0
180063,of,0,0
180064,DPN,0,0
180065,",",0,0
180066,and,0,0
180067,safety,0,1
180068,(,0,0
180069,including,0,0
180070,neuropathy,0,1
180071,assessments,0,1
180072,),0,0
180073,.,0,0
180074,Due,0,0
180075,to,0,0
180076,a,0,0
180077,partial,0,0
180078,clinical,0,0
180079,hold,0,0
180080,limiting,0,0
180081,enrollment,0,0
180082,and,0,0
180083,treatment,0,0
180084,duration,0,0
180085,",",0,0
180086,the,0,0
180087,prespecified,0,0
180088,landmark,0,0
180089,analysis,0,0
180090,was,0,0
180091,modified,0,0
180092,post,0,0
180093,hoc,0,0
180094,from,0,0
180095,Week,0,0
180096,16,0,0
180097,to,0,0
180098,Week,0,0
180099,8,0,0
180100,.,0,0
180101,In,0,0
180102,the,0,0
180103,PHN,0,0
180104,study,0,0
180105,",",0,0
180106,patients,0,0
180107,received,0,0
180108,intravenous,0,1
180109,tanezumab,1,1
180110,50,0,1
180111,?g/kg,0,1
180112,",",0,1
180113,tanezumab,1,1
180114,200,0,1
180115,?g/kg,0,1
180116,",",0,1
180117,or,0,1
180118,placebo,1,1
180119,on,1,1
180120,Day,0,0
180121,1,0,0
180122,.,0,0
180123,Evaluations,0,0
180124,included,0,0
180125,change,0,0
180126,from,0,0
180127,baseline,0,0
180128,in,0,0
180129,average,0,0
180130,daily,0,1
180131,pain,0,1
180132,(,0,1
180133,primary,0,0
180134,endpoint,0,1
180135,),0,0
180136,",",0,0
180137,Brief,0,0
180138,Pain,0,0
180139,Inventory-short,0,0
180140,form,0,0
180141,",",0,0
180142,Patient,0,0
180143,'s,0,0
180144,Global,0,0
180145,Assessment,0,0
180146,of,0,0
180147,pain,0,0
180148,from,0,0
180149,PHN,0,0
180150,",",0,0
180151,and,0,0
180152,safety,0,0
180153,.,0,0
180154,RESULTS,0,0
180155,Mean,0,0
180156,DPN,0,0
180157,pain,0,0
180158,reduction,0,0
180159,from,0,0
180160,baseline,0,0
180161,to,0,0
180162,Week,0,0
180163,8,0,0
180164,was,0,0
180165,greater,0,0
180166,with,1,0
180167,tanezumab,1,1
180168,vs,1,1
180169,placebo,1,1
180170,(,1,0
180171,P,0,0
180172,=,0,0
180173,0.009,0,0
180174,),0,0
180175,;,0,0
180176,differences,0,0
180177,in,0,0
180178,Patient,0,0
180179,'s,0,0
180180,Global,0,0
180181,Assessment,0,0
180182,of,0,0
180183,DPN,0,0
180184,were,0,0
180185,not,0,0
180186,significant,0,0
180187,(,0,0
180188,P,0,0
180189,>,0,0
180190,0.05,0,0
180191,),0,0
180192,.,0,0
180193,Neither,1,0
180194,tanezumab,1,1
180195,dose,1,1
180196,resulted,0,0
180197,in,0,0
180198,significant,0,0
180199,differences,0,0
180200,vs,0,0
180201,placebo,1,1
180202,in,1,0
180203,efficacy,0,0
180204,in,0,0
180205,PHN,0,0
180206,(,0,0
180207,P,0,0
180208,>,0,0
180209,0.05,0,0
180210,),0,0
180211,",",0,0
180212,although,0,0
180213,tanezumab,0,1
180214,200,0,1
180215,?g/kg,0,1
180216,provided,0,0
180217,some,0,0
180218,benefit,0,0
180219,.,0,0
180220,Neuropathy,0,0
180221,assessments,0,0
180222,showed,0,0
180223,no,0,0
180224,meaningful,0,0
180225,changes,0,0
180226,.,0,0
180227,CONCLUSIONS,1,1
180228,Tanezumab,1,1
180229,provided,1,0
180230,effective,0,0
180231,pain,0,0
180232,reduction,0,0
180233,in,0,0
180234,DPN,0,0
180235,.,0,0
180236,In,0,0
180237,PHN,0,0
180238,",",0,0
180239,only,0,0
180240,the,0,0
180241,highest,1,0
180242,tanezumab,1,1
180243,dose,1,1
180244,reduced,0,1
180245,pain,0,1
180246,;,0,0
180247,treatment,0,0
180248,differences,0,0
180249,were,0,0
180250,not,0,0
180251,significant,0,0
180252,.,0,0
180253,No,0,1
180254,new,0,0
180255,safety,0,0
180256,concerns,0,0
180257,were,0,0
180258,observed,0,0
180259,despite,0,0
180260,preexisting,0,0
180261,neuropathy,0,0
180262,.,0,0
180263,Effect,0,0
180264,of,0,0
180265,self-collection,1,0
180266,of,1,0
180267,HPV,1,0
180268,DNA,1,0
180269,offered,0,0
180270,by,0,0
180271,community,0,0
180272,health,0,0
180273,workers,0,0
180274,at,0,0
180275,home,0,0
180276,visits,0,0
180277,on,0,0
180278,uptake,0,0
180279,of,0,0
180280,screening,0,0
180281,for,0,0
180282,cervical,0,0
180283,cancer,0,1
180284,(,0,0
180285,the,0,0
180286,EMA,0,1
180287,study,0,0
180288,),0,0
180289,:,0,0
180290,a,0,0
180291,population-based,0,0
180292,cluster-randomised,0,0
180293,trial,0,0
180294,.,0,0
180295,BACKGROUND,0,0
180296,Control,0,0
180297,of,0,0
180298,cervical,0,0
180299,cancer,0,0
180300,in,0,0
180301,developing,0,0
180302,countries,0,0
180303,has,0,0
180304,been,0,0
180305,hampered,0,0
180306,by,0,0
180307,a,0,0
180308,failure,0,0
180309,to,0,0
180310,achieve,0,0
180311,high,0,0
180312,screening,0,0
180313,uptake,0,0
180314,.,0,0
180315,HPV,1,0
180316,DNA,1,1
180317,self-collection,1,0
180318,could,0,0
180319,increase,0,0
180320,screening,0,0
180321,coverage,0,0
180322,",",0,0
180323,but,0,0
180324,implementation,0,0
180325,of,0,0
180326,this,0,0
180327,technology,0,0
180328,is,0,0
180329,difficult,0,0
180330,in,0,0
180331,countries,0,0
180332,of,0,0
180333,middle,0,0
180334,and,0,0
180335,low,0,0
180336,income,0,0
180337,.,0,0
180338,We,0,0
180339,investigated,0,0
180340,whether,0,0
180341,offering,0,0
180342,HPV,1,0
180343,DNA,1,1
180344,self-collection,1,0
180345,during,0,0
180346,routine,0,0
180347,home,0,0
180348,visits,0,0
180349,by,0,0
180350,community,0,0
180351,health,0,0
180352,workers,0,0
180353,could,0,0
180354,increase,0,0
180355,cervical,0,0
180356,screening,0,0
180357,.,0,0
180358,METHODS,0,0
180359,We,0,0
180360,did,0,0
180361,a,0,0
180362,population-based,0,0
180363,cluster-randomised,0,0
180364,trial,0,0
180365,in,0,0
180366,the,0,0
180367,province,0,0
180368,of,0,0
180369,Jujuy,0,0
180370,",",0,0
180371,Argentina,0,0
180372,",",0,0
180373,between,0,0
180374,July,0,0
180375,1,0,0
180376,",",0,0
180377,2012,0,0
180378,",",0,0
180379,and,0,0
180380,Dec,0,0
180381,31,0,0
180382,",",0,0
180383,2012,0,0
180384,.,0,0
180385,Community,0,0
180386,health,0,0
180387,workers,0,0
180388,were,0,0
180389,eligible,0,0
180390,for,0,0
180391,the,0,0
180392,study,0,0
180393,if,0,0
180394,they,0,0
180395,scored,0,0
180396,highly,0,0
180397,on,0,0
180398,a,0,0
180399,performance,0,0
180400,score,0,0
180401,",",0,0
180402,and,0,0
180403,women,0,0
180404,aged,0,0
180405,30,0,0
180406,years,0,0
180407,or,0,0
180408,older,0,0
180409,were,0,0
180410,eligible,0,0
180411,for,0,0
180412,enrolment,0,0
180413,by,0,0
180414,the,0,0
180415,community,0,0
180416,health,0,0
180417,worker,0,0
180418,.,0,0
180419,200,0,0
180420,community,0,0
180421,health,0,0
180422,workers,0,0
180423,were,0,0
180424,randomly,0,0
180425,allocated,0,0
180426,in,0,0
180427,a,0,0
180428,1:1,0,1
180429,ratio,0,0
180430,to,0,0
180431,either,0,0
180432,the,0,0
180433,intervention,1,1
180434,group,1,0
180435,(,1,0
180436,offered,1,0
180437,women,1,0
180438,the,1,0
180439,chance,1,0
180440,to,1,0
180441,self-collect,1,0
180442,a,1,0
180443,sample,1,0
180444,for,1,0
180445,cervical,1,0
180446,screening,1,0
180447,during,1,0
180448,a,1,0
180449,home,1,0
180450,visit,1,1
180451,),1,0
180452,or,0,0
180453,the,0,0
180454,control,1,0
180455,group,1,0
180456,(,1,0
180457,advised,1,1
180458,women,1,0
180459,to,1,0
180460,attend,1,0
180461,a,1,0
180462,health,1,0
180463,clinic,1,0
180464,for,1,0
180465,cervical,1,0
180466,screening,1,0
180467,),1,0
180468,.,0,0
180469,The,0,0
180470,primary,0,0
180471,outcome,0,0
180472,was,0,0
180473,screening,0,0
180474,uptake,0,0
180475,",",0,0
180476,measured,0,0
180477,as,0,0
180478,the,0,0
180479,proportion,0,0
180480,of,0,0
180481,women,0,0
180482,having,0,0
180483,any,0,0
180484,HPV,0,0
180485,screening,0,0
180486,test,0,0
180487,within,0,0
180488,6,0,0
180489,months,0,0
180490,of,0,0
180491,the,0,0
180492,community,0,0
180493,health,0,0
180494,worker,0,0
180495,visit,0,0
180496,.,0,0
180497,Analysis,0,0
180498,was,0,0
180499,by,0,0
180500,intention,0,0
180501,to,0,0
180502,treat,0,0
180503,.,0,0
180504,This,0,0
180505,trial,0,0
180506,is,0,0
180507,registered,0,0
180508,with,0,0
180509,ClinicalTrials.gov,0,0
180510,",",0,0
180511,number,0,0
180512,NCT02095561,0,0
180513,.,0,0
180514,FINDINGS,0,0
180515,100,0,0
180516,community,0,0
180517,health,0,0
180518,workers,0,0
180519,were,0,0
180520,randomly,0,0
180521,allocated,0,0
180522,to,0,0
180523,the,0,0
180524,intervention,0,0
180525,group,0,0
180526,and,0,0
180527,100,0,0
180528,were,0,0
180529,assigned,0,0
180530,to,0,0
180531,the,0,0
180532,control,0,0
180533,group,0,0
180534,;,0,0
180535,nine,0,0
180536,did,0,0
180537,not,0,0
180538,take,0,0
180539,part,0,0
180540,.,0,0
180541,191,0,0
180542,participating,0,0
180543,community,0,0
180544,health,0,1
180545,workers,0,0
180546,(,0,0
180547,94,0,0
180548,in,0,0
180549,the,0,0
180550,intervention,0,0
180551,group,0,0
180552,and,0,0
180553,97,0,0
180554,in,0,0
180555,the,0,0
180556,control,0,0
180557,group,0,0
180558,),0,0
180559,initially,0,0
180560,contacted,0,0
180561,7650,0,0
180562,women,0,0
180563,;,0,0
180564,of,0,0
180565,3632,0,0
180566,women,0,0
180567,contacted,0,0
180568,by,0,0
180569,community,0,0
180570,health,0,0
180571,workers,0,0
180572,in,0,0
180573,the,0,0
180574,intervention,0,0
180575,group,0,0
180576,",",0,0
180577,3049,0,0
180578,agreed,0,0
180579,to,0,0
180580,participate,0,0
180581,;,0,0
180582,of,0,0
180583,4018,0,0
180584,women,0,0
180585,contacted,0,0
180586,by,0,0
180587,community,0,0
180588,health,0,0
180589,workers,0,0
180590,in,0,0
180591,the,0,0
180592,control,0,0
180593,group,0,0
180594,",",0,0
180595,2964,0,0
180596,agreed,0,0
180597,to,0,0
180598,participate,0,0
180599,.,0,0
180600,2618,0,0
180601,(,0,0
180602,86,0,0
180603,%,0,0
180604,),0,0
180605,of,0,0
180606,3049,0,0
180607,women,0,0
180608,in,0,0
180609,the,0,0
180610,intervention,0,0
180611,group,0,0
180612,had,0,0
180613,any,0,0
180614,HPV,0,0
180615,test,0,0
180616,within,0,0
180617,6,0,0
180618,months,0,0
180619,of,0,0
180620,the,0,0
180621,community,0,0
180622,health,0,0
180623,worker,0,0
180624,visit,0,0
180625,",",0,0
180626,compared,0,0
180627,with,0,0
180628,599,0,0
180629,(,0,0
180630,20,0,0
180631,%,0,0
180632,),0,0
180633,of,0,0
180634,2964,0,0
180635,in,0,0
180636,the,0,0
180637,control,0,0
180638,group,0,0
180639,(,0,0
180640,risk,0,1
180641,ratio,0,0
180642,4?02,0,0
180643,",",0,0
180644,95,0,0
180645,%,0,0
180646,CI,0,0
180647,3?44-4?71,0,0
180648,),0,0
180649,.,0,0
180650,INTERPRETATION,0,0
180651,Offering,0,0
180652,self-collection,0,0
180653,of,0,0
180654,samples,0,0
180655,for,0,0
180656,HPV,1,0
180657,testing,1,0
180658,by,1,0
180659,community,0,0
180660,health,0,0
180661,workers,0,0
180662,during,0,0
180663,home,0,0
180664,visits,0,0
180665,resulted,0,0
180666,in,0,0
180667,a,0,0
180668,four-fold,0,0
180669,increase,0,0
180670,in,0,0
180671,screening,0,0
180672,uptake,0,0
180673,",",0,0
180674,showing,0,0
180675,that,0,0
180676,this,0,0
180677,strategy,0,0
180678,is,0,0
180679,effective,0,0
180680,to,0,0
180681,improve,0,0
180682,cervical,0,0
180683,screening,0,0
180684,coverage,0,0
180685,.,0,0
180686,This,0,0
180687,intervention,0,0
180688,reduces,0,0
180689,women,0,0
180690,'s,0,0
180691,barriers,0,0
180692,to,0,0
180693,screening,0,0
180694,and,0,0
180695,results,0,0
180696,in,0,0
180697,a,0,0
180698,substantial,0,0
180699,and,0,0
180700,rapid,0,0
180701,increase,0,0
180702,in,0,0
180703,coverage,0,0
180704,.,0,0
180705,Our,0,0
180706,findings,0,0
180707,suggest,0,0
180708,that,0,0
180709,HPV,0,0
180710,testing,0,0
180711,could,0,0
180712,be,0,0
180713,extended,0,0
180714,throughout,0,0
180715,Argentina,0,0
180716,and,0,0
180717,in,0,0
180718,other,0,0
180719,countries,0,0
180720,to,0,0
180721,increase,0,0
180722,cervical,0,0
180723,screening,0,0
180724,coverage,0,0
180725,.,0,0
180726,FUNDING,0,0
180727,Instituto,0,1
180728,Nacional,0,0
180729,del,0,1
180730,C?ncer,0,1
180731,(,0,1
180732,Argentina,0,1
180733,),0,0
180734,.,0,0
180735,The,0,0
180736,effects,0,0
180737,of,0,0
180738,stimulation,0,0
180739,of,0,0
180740,the,0,0
180741,autonomic,0,0
180742,nervous,0,0
180743,system,0,0
180744,via,0,0
180745,perioperative,1,0
180746,nutrition,1,0
180747,on,0,0
180748,postoperative,0,0
180749,ileus,0,0
180750,and,0,0
180751,anastomotic,0,0
180752,leakage,0,0
180753,following,0,0
180754,colorectal,0,0
180755,surgery,0,1
180756,(,0,0
180757,SANICS,0,1
180758,II,0,1
180759,trial,0,1
180760,),0,0
180761,:,0,0
180762,a,0,0
180763,study,0,0
180764,protocol,0,0
180765,for,0,0
180766,a,0,0
180767,double-blind,0,1
180768,randomized,0,1
180769,controlled,0,0
180770,trial,0,0
180771,.,0,0
180772,BACKGROUND,0,0
180773,Postoperative,0,0
180774,ileus,0,0
180775,and,0,0
180776,anastomotic,0,0
180777,leakage,0,0
180778,are,0,0
180779,important,0,0
180780,complications,0,0
180781,following,0,0
180782,colorectal,0,0
180783,surgery,0,0
180784,associated,0,0
180785,with,0,0
180786,short-term,0,0
180787,morbidity,0,0
180788,and,0,0
180789,mortality,0,0
180790,.,0,0
180791,Previous,0,0
180792,experimental,0,0
180793,and,0,0
180794,preclinical,0,0
180795,studies,0,0
180796,have,0,0
180797,shown,0,0
180798,that,0,0
180799,a,0,0
180800,short,0,0
180801,intervention,0,0
180802,with,0,0
180803,enriched,0,0
180804,enteral,0,1
180805,nutrition,0,1
180806,dampens,0,0
180807,inflammation,0,0
180808,via,0,0
180809,stimulation,0,0
180810,of,0,0
180811,the,0,0
180812,autonomic,0,0
180813,nervous,0,0
180814,system,0,0
180815,and,0,0
180816,thereby,0,0
180817,reduces,0,0
180818,postoperative,0,0
180819,ileus,0,0
180820,.,0,0
180821,Furthermore,0,0
180822,",",0,0
180823,early,0,0
180824,administration,0,1
180825,of,0,1
180826,enteral,0,1
180827,nutrition,0,1
180828,reduced,0,0
180829,anastomotic,0,0
180830,leakage,0,0
180831,.,0,0
180832,This,0,0
180833,study,0,0
180834,will,0,0
180835,investigate,0,0
180836,the,0,0
180837,effect,0,0
180838,of,0,0
180839,nutritional,0,0
180840,stimulation,0,0
180841,of,0,0
180842,the,0,0
180843,autonomic,0,0
180844,nervous,0,0
180845,system,0,0
180846,just,0,0
180847,before,0,0
180848,",",0,0
180849,during,0,0
180850,and,0,0
180851,early,0,0
180852,after,0,0
180853,colorectal,0,0
180854,surgery,0,0
180855,on,0,0
180856,inflammation,0,0
180857,",",0,0
180858,postoperative,0,0
180859,ileus,0,0
180860,and,0,0
180861,anastomotic,0,0
180862,leakage,0,0
180863,.,0,0
180864,METHODS/DESIGN,0,0
180865,This,0,0
180866,multicenter,0,0
180867,",",0,0
180868,prospective,0,1
180869,",",0,1
180870,double-blind,0,1
180871,",",0,1
180872,randomized,0,0
180873,controlled,0,0
180874,trial,0,0
180875,will,0,0
180876,include,0,0
180877,280,0,0
180878,patients,0,0
180879,undergoing,0,0
180880,colorectal,0,0
180881,surgery,0,0
180882,.,0,0
180883,All,0,0
180884,patients,0,0
180885,will,0,0
180886,receive,0,0
180887,a,0,0
180888,selfmigrating,1,0
180889,nasojejunal,1,0
180890,tube,1,0
180891,that,0,0
180892,will,0,0
180893,be,0,0
180894,connected,0,0
180895,to,0,0
180896,a,0,0
180897,specially,0,0
180898,designed,0,0
180899,blinded,0,0
180900,tubing,0,0
180901,system,0,0
180902,.,0,0
180903,Patients,0,0
180904,will,0,0
180905,be,0,0
180906,allocated,0,0
180907,either,0,0
180908,to,0,0
180909,the,0,0
180910,intervention,0,0
180911,group,0,0
180912,",",0,0
180913,receiving,1,0
180914,perioperative,1,0
180915,nutrition,1,0
180916,",",0,0
180917,or,0,0
180918,to,0,0
180919,the,0,0
180920,control,0,0
180921,group,0,0
180922,",",0,0
180923,receiving,1,0
180924,no,1,0
180925,nutrition,1,0
180926,.,1,0
180927,The,0,0
180928,primary,0,0
180929,endpoint,0,0
180930,is,0,0
180931,postoperative,0,0
180932,ileus,0,0
180933,.,0,0
180934,Secondary,0,0
180935,endpoints,0,0
180936,include,0,0
180937,anastomotic,0,0
180938,leakage,0,0
180939,",",0,0
180940,local,0,0
180941,and,0,0
180942,systemic,0,0
180943,inflammation,0,1
180944,",",0,0
180945,(,0,1
180946,aspiration,0,1
180947,),0,1
180948,pneumonia,0,0
180949,",",0,0
180950,surgical,0,0
180951,complications,0,0
180952,classified,0,0
180953,according,0,0
180954,to,0,0
180955,Clavien-Dindo,0,0
180956,",",0,0
180957,quality,0,0
180958,of,0,0
180959,life,0,0
180960,",",0,0
180961,gut,0,0
180962,barrier,0,0
180963,integrity,0,0
180964,and,0,0
180965,time,0,0
180966,until,0,0
180967,functional,0,0
180968,recovery,0,0
180969,.,0,0
180970,Furthermore,0,0
180971,",",0,0
180972,a,0,0
180973,cost-effectiveness,0,0
180974,analysis,0,0
180975,will,0,0
180976,be,0,0
180977,performed,0,0
180978,.,0,0
180979,DISCUSSION,0,0
180980,Activation,0,0
180981,of,0,0
180982,the,0,0
180983,autonomic,0,0
180984,nervous,0,0
180985,system,0,0
180986,via,0,0
180987,perioperative,0,0
180988,enteral,0,1
180989,feeding,0,0
180990,is,0,0
180991,expected,0,0
180992,to,0,0
180993,dampen,0,0
180994,the,0,0
180995,local,0,0
180996,and,0,0
180997,systemic,0,0
180998,inflammatory,0,0
180999,response,0,0
181000,.,0,0
181001,Consequently,0,0
181002,",",0,0
181003,postoperative,0,0
181004,ileus,0,0
181005,will,0,0
181006,be,0,0
181007,reduced,0,0
181008,as,0,0
181009,well,0,0
181010,as,0,0
181011,anastomotic,0,0
181012,leakage,0,0
181013,.,0,0
181014,The,0,0
181015,present,0,0
181016,study,0,0
181017,is,0,0
181018,the,0,0
181019,first,0,0
181020,to,0,0
181021,investigate,0,0
181022,the,0,0
181023,effects,0,0
181024,of,0,0
181025,enriched,0,0
181026,nutrition,0,0
181027,given,0,0
181028,shortly,0,0
181029,before,0,0
181030,",",0,0
181031,during,0,0
181032,and,0,0
181033,after,0,0
181034,surgery,0,0
181035,in,0,0
181036,a,0,0
181037,clinical,0,0
181038,setting,0,0
181039,.,0,0
181040,TRIAL,0,0
181041,REGISTRATION,0,1
181042,ClinicalTrials.gov,0,0
181043,:,0,0
181044,NCT02175979,0,1
181045,-,0,0
181046,date,0,0
181047,of,0,0
181048,registration,0,0
181049,:,0,0
181050,25,0,0
181051,June,0,0
181052,2014,0,0
181053,.,0,0
181054,Dutch,0,0
181055,Trial,0,0
181056,Registry,0,0
181057,:,0,0
181058,NTR4670,0,1
181059,-,0,0
181060,date,0,0
181061,of,0,0
181062,registration,0,0
181063,:,0,0
181064,1,0,0
181065,August,0,0
181066,2014,0,0
181067,.,0,0
181068,Randomized,0,0
181069,trial,0,0
181070,of,0,0
181071,interferon-,1,1
181072,and,0,1
181073,ribavirin-free,1,1
181074,ombitasvir/paritaprevir/ritonavir,1,1
181075,in,0,1
181076,treatment-experienced,0,1
181077,hepatitis,0,0
181078,C,0,0
181079,virus-infected,0,0
181080,patients,0,0
181081,.,0,0
181082,UNLABELLED,0,0
181083,Approximately,0,0
181084,2,0,0
181085,million,0,0
181086,Japanese,0,0
181087,individuals,0,0
181088,are,0,0
181089,infected,0,0
181090,with,0,0
181091,hepatitis,0,0
181092,C,0,0
181093,virus,0,0
181094,and,0,0
181095,are,0,0
181096,at,0,0
181097,risk,0,0
181098,for,0,0
181099,cirrhosis,0,0
181100,",",0,0
181101,end-stage,0,0
181102,liver,0,0
181103,disease,0,0
181104,",",0,0
181105,and,0,0
181106,hepatocellular,0,0
181107,carcinoma,0,0
181108,.,0,0
181109,Patients,0,0
181110,in,0,0
181111,whom,0,1
181112,interferon,1,1
181113,(,1,1
181114,IFN,1,1
181115,),1,1
181116,/ribavirin,1,1
181117,(,1,1
181118,RBV,1,1
181119,),1,1
181120,therapy,1,0
181121,has,0,0
181122,failed,0,0
181123,remain,0,0
181124,at,0,0
181125,risk,0,0
181126,as,0,0
181127,effective,0,0
181128,therapeutic,0,0
181129,options,0,0
181130,are,0,0
181131,limited,0,0
181132,.,0,0
181133,This,0,0
181134,phase,0,0
181135,2,0,0
181136,",",0,0
181137,randomized,0,1
181138,",",0,0
181139,open-label,0,1
181140,study,0,0
181141,evaluated,0,0
181142,an,0,0
181143,IFN-,1,0
181144,and,1,0
181145,RBV-free,1,1
181146,regimen,0,1
181147,of,0,1
181148,once-daily,0,1
181149,ombitasvir,1,1
181150,(,1,1
181151,ABT-267,1,1
181152,),1,1
181153,",",0,0
181154,an,0,0
181155,NS5A,1,1
181156,inhibitor,1,1
181157,",",1,0
181158,plus,1,1
181159,paritaprevir,1,1
181160,(,1,1
181161,ABT-450,1,1
181162,),1,1
181163,",",0,0
181164,an,0,0
181165,NS3/4A,1,0
181166,protease,1,0
181167,inhibitor,1,1
181168,dosed,1,1
181169,with,1,1
181170,ritonavir,1,1
181171,(,1,1
181172,paritaprevir/ritonavir,1,1
181173,),1,1
181174,",",0,1
181175,in,0,0
181176,pegylated,0,1
181177,IFN/RBV,1,1
181178,treatment-experienced,0,1
181179,Japanese,0,0
181180,patients,0,0
181181,with,0,0
181182,hepatitis,0,0
181183,C,0,0
181184,virus,0,0
181185,subtype,0,0
181186,1b,0,0
181187,or,0,0
181188,genotype,0,0
181189,2,0,0
181190,infection,0,0
181191,.,0,0
181192,Patients,0,0
181193,without,0,0
181194,cirrhosis,0,0
181195,(,0,0
181196,aged,0,0
181197,18-75,0,0
181198,years,0,0
181199,),0,0
181200,with,0,0
181201,subtype,0,0
181202,1b,0,0
181203,infection,0,1
181204,received,0,0
181205,ombitasvir,1,1
181206,25,1,1
181207,mg,1,1
181208,plus,1,1
181209,paritaprevir/ritonavir,1,1
181210,100/100,0,1
181211,mg,0,1
181212,or,0,0
181213,150/100,0,1
181214,mg,0,1
181215,for,0,0
181216,12,0,0
181217,or,0,0
181218,24,0,0
181219,weeks,0,0
181220,;,0,0
181221,patients,0,0
181222,with,0,0
181223,genotype,0,0
181224,2,0,0
181225,infection,0,0
181226,received,0,0
181227,ombitasvir,1,1
181228,25,1,1
181229,mg,1,1
181230,plus,1,1
181231,paritaprevir/ritonavir,1,1
181232,100/100,1,1
181233,mg,1,1
181234,or,1,0
181235,150/100,1,1
181236,mg,1,1
181237,for,1,0
181238,12,1,0
181239,weeks,1,0
181240,.,1,0
181241,Sustained,0,0
181242,virologic,0,0
181243,response,0,0
181244,(,0,1
181245,SVR,0,1
181246,),0,1
181247,at,0,0
181248,posttreatment,0,0
181249,week,0,0
181250,24,0,0
181251,(,0,1
181252,SVR24,0,1
181253,),0,0
181254,was,0,0
181255,the,0,0
181256,primary,0,0
181257,endpoint,0,0
181258,.,0,0
181259,Adverse,0,0
181260,events,0,0
181261,were,0,0
181262,collected,0,0
181263,throughout,0,0
181264,the,0,0
181265,study,0,0
181266,.,0,0
181267,One,0,0
181268,hundred,0,0
181269,ten,0,0
181270,patients,0,0
181271,received,0,0
181272,?1,0,0
181273,dose,0,1
181274,of,0,0
181275,study,0,0
181276,medication,0,0
181277,.,0,0
181278,In,0,0
181279,the,0,0
181280,subtype,0,0
181281,1b,0,0
181282,cohort,0,0
181283,",",0,0
181284,SVR24,0,0
181285,rates,0,0
181286,were,0,0
181287,high,0,0
181288,(,0,0
181289,88.9,0,0
181290,%,0,0
181291,-100,0,0
181292,%,0,0
181293,),0,0
181294,regardless,0,0
181295,of,0,1
181296,paritaprevir,0,1
181297,dose,0,1
181298,or,0,1
181299,treatment,0,0
181300,duration,0,0
181301,.,0,0
181302,In,0,0
181303,the,0,0
181304,genotype,0,0
181305,2,0,0
181306,cohort,0,0
181307,",",0,0
181308,SVR24,0,0
181309,rates,0,0
181310,were,0,0
181311,57.9,0,0
181312,%,0,0
181313,and,0,0
181314,72.2,0,0
181315,%,0,0
181316,with,0,0
181317,100,0,0
181318,mg,0,1
181319,and,0,1
181320,150,0,1
181321,mg,0,1
181322,of,0,1
181323,paritaprevir,0,1
181324,",",0,0
181325,respectively,0,0
181326,.,0,0
181327,The,0,0
181328,SVR24,0,0
181329,rate,0,0
181330,was,0,0
181331,higher,0,0
181332,in,0,0
181333,patients,0,0
181334,with,0,0
181335,subtype,0,0
181336,2a,0,1
181337,(,0,0
181338,90,0,0
181339,%,0,0
181340,),0,0
181341,than,0,0
181342,2b,0,1
181343,(,0,0
181344,27,0,0
181345,%,0,0
181346,),0,0
181347,.,0,0
181348,Concordance,0,0
181349,between,0,0
181350,SVR12,0,0
181351,and,0,0
181352,SVR24,0,0
181353,was,0,0
181354,100,0,0
181355,%,0,0
181356,.,0,0
181357,The,0,0
181358,most,0,0
181359,common,0,0
181360,adverse,0,0
181361,events,0,0
181362,overall,0,0
181363,were,0,0
181364,nasopharyngitis,0,0
181365,(,0,0
181366,29,0,0
181367,%,0,0
181368,),0,0
181369,and,0,0
181370,headache,0,1
181371,(,0,0
181372,14,0,0
181373,%,0,0
181374,),0,0
181375,.,0,0
181376,CONCLUSION,0,0
181377,In,0,0
181378,this,0,0
181379,difficult-to-treat,0,0
181380,population,0,0
181381,of,0,0
181382,patients,0,0
181383,in,0,0
181384,whom,0,0
181385,prior,0,0
181386,pegylated,0,1
181387,IFN/RBV,0,1
181388,had,0,0
181389,failed,1,0
181390,",",1,0
181391,ombitasvir/paritaprevir/ritonavir,1,1
181392,demonstrated,1,1
181393,potent,0,1
181394,antiviral,0,1
181395,activity,0,0
181396,with,0,0
181397,a,0,0
181398,favorable,0,0
181399,safety,0,0
181400,profile,0,0
181401,among,0,0
181402,Japanese,0,0
181403,patients,0,0
181404,with,0,0
181405,hepatitis,0,0
181406,C,0,0
181407,virus,0,0
181408,genotype,0,0
181409,1b,0,0
181410,or,0,0
181411,2a,0,0
181412,infection,0,0
181413,.,0,0
181414,A,0,1
181415,randomized,0,0
181416,controlled,0,0
181417,trial,0,0
181418,of,0,0
181419,guided,1,0
181420,self-help,1,0
181421,for,0,0
181422,improving,0,0
181423,the,0,0
181424,experience,0,0
181425,of,0,0
181426,caring,0,0
181427,for,0,0
181428,carers,0,0
181429,of,0,0
181430,clients,0,0
181431,with,0,0
181432,depression,0,0
181433,.,0,0
181434,AIM,0,0
181435,To,0,0
181436,evaluate,0,0
181437,the,0,0
181438,effectiveness,0,0
181439,of,0,0
181440,a,0,0
181441,cognitive,1,0
181442,behaviour,1,0
181443,therapy,1,0
181444,guided,1,0
181445,self-help,1,0
181446,manual,1,0
181447,for,0,0
181448,enhancing,0,0
181449,the,0,0
181450,experience,0,0
181451,of,0,0
181452,caregiving,0,0
181453,of,0,0
181454,family,0,0
181455,carers,0,0
181456,of,0,0
181457,individuals,0,0
181458,with,0,0
181459,depression,0,0
181460,.,0,0
181461,BACKGROUND,0,0
181462,The,0,0
181463,prevalence,0,0
181464,of,0,0
181465,depression,0,0
181466,is,0,0
181467,increasing,0,0
181468,markedly,0,0
181469,in,0,0
181470,Thailand,0,0
181471,.,0,0
181472,While,0,0
181473,primary,0,0
181474,carers,0,0
181475,give,0,0
181476,most,0,0
181477,of,0,0
181478,the,0,0
181479,support,0,0
181480,for,0,0
181481,individuals,0,0
181482,with,0,0
181483,depression,0,0
181484,",",0,0
181485,they,0,0
181486,receive,0,0
181487,little,0,0
181488,support,0,0
181489,from,0,0
181490,mental,0,0
181491,health,0,0
181492,services,0,0
181493,in,0,0
181494,this,0,0
181495,critical,0,0
181496,role,0,0
181497,.,0,0
181498,DESIGN,0,0
181499,A,0,1
181500,randomized,0,0
181501,controlled,0,0
181502,trial,0,0
181503,.,0,0
181504,METHOD,0,0
181505,Carers,0,0
181506,were,0,0
181507,randomized,0,0
181508,to,0,0
181509,guided,1,0
181510,self-help,1,1
181511,(,0,0
181512,n,0,0
181513,=,0,0
181514,27,0,0
181515,),0,0
181516,",",0,0
181517,while,0,0
181518,the,0,0
181519,control,1,0
181520,group,1,0
181521,received,1,0
181522,standard,1,0
181523,information,1,0
181524,and,1,0
181525,support,1,1
181526,(,0,0
181527,n,0,0
181528,=,0,0
181529,27,0,0
181530,),0,0
181531,.,0,0
181532,Both,0,1
181533,groups,0,0
181534,also,0,0
181535,received,0,0
181536,a,0,0
181537,short,1,0
181538,weekly,1,0
181539,telephone,1,1
181540,call,1,1
181541,.,1,0
181542,Participants,0,0
181543,were,0,0
181544,assessed,0,0
181545,at,0,0
181546,three,0,0
181547,time,0,0
181548,points,0,0
181549,;,0,0
181550,the,0,0
181551,outcome,0,0
181552,measure,0,0
181553,was,0,0
181554,the,0,0
181555,Experience,0,0
181556,of,0,0
181557,Caregiving,1,0
181558,Inventory,1,0
181559,.,1,0
181560,A,0,0
181561,doubly,0,0
181562,multivariate,0,0
181563,analysis,0,0
181564,of,0,0
181565,variance,0,1
181566,(,0,1
181567,anova,0,1
181568,),0,1
181569,procedure,0,0
181570,",",0,0
181571,including,0,0
181572,between-group,0,0
181573,and,0,0
181574,within-group,0,0
181575,factors,0,0
181576,",",0,0
181577,was,0,0
181578,implemented,0,0
181579,.,0,0
181580,Fieldwork,0,0
181581,was,0,0
181582,from,0,0
181583,October,0,0
181584,2007-May,0,0
181585,2008,0,0
181586,.,0,0
181587,RESULTS,0,0
181588,Fifty-four,0,0
181589,carers,0,0
181590,completed,0,0
181591,the,0,0
181592,study,0,0
181593,and,0,0
181594,intent-to-treat,0,0
181595,analyses,0,0
181596,were,0,0
181597,undertaken,0,0
181598,.,0,0
181599,The,0,0
181600,findings,0,0
181601,showed,0,0
181602,there,0,0
181603,was,0,0
181604,a,0,0
181605,significant,0,0
181606,reduction,0,0
181607,in,0,0
181608,the,0,0
181609,total,0,0
181610,negative,0,0
181611,experience,0,0
181612,of,0,0
181613,caring,0,0
181614,",",0,0
181615,from,0,0
181616,baseline,0,0
181617,to,0,0
181618,post-treatment,0,0
181619,",",0,0
181620,in,0,0
181621,the,0,0
181622,intervention,0,0
181623,group,0,0
181624,recipients,0,0
181625,of,0,0
181626,the,0,0
181627,manual,0,0
181628,compared,0,0
181629,with,0,0
181630,the,0,0
181631,control,0,0
181632,group,0,0
181633,and,0,0
181634,treatment,0,0
181635,effects,0,0
181636,were,0,0
181637,maintained,0,0
181638,at,0,0
181639,one-month,0,0
181640,follow-up,0,0
181641,.,0,0
181642,Similarly,0,0
181643,",",0,0
181644,a,0,0
181645,significant,0,0
181646,improvement,0,0
181647,in,0,0
181648,the,0,0
181649,total,0,0
181650,positive,0,0
181651,experience,0,0
181652,of,0,0
181653,caring,0,0
181654,occurred,0,0
181655,",",0,0
181656,from,0,0
181657,baseline,0,0
181658,to,0,0
181659,post-treatment,0,0
181660,",",0,0
181661,in,0,0
181662,the,0,0
181663,intervention,0,0
181664,group,0,0
181665,in,0,0
181666,contrast,0,0
181667,with,0,0
181668,the,0,0
181669,control,0,0
181670,group,0,0
181671,and,0,0
181672,these,0,0
181673,outcomes,0,0
181674,were,0,0
181675,sustained,0,0
181676,at,0,0
181677,one-month,0,0
181678,follow-up,0,0
181679,.,0,0
181680,CONCLUSION,0,0
181681,Guided,1,0
181682,self-help,1,0
181683,strengthen,0,0
181684,carers,0,0
181685,',0,0
181686,positive,0,0
181687,and,0,0
181688,reduces,0,0
181689,their,0,0
181690,negative,0,0
181691,",",0,0
181692,experience,0,0
181693,of,0,0
181694,caring,0,0
181695,.,0,0
181696,The,0,0
181697,study,0,0
181698,contributes,0,0
181699,to,0,0
181700,the,0,0
181701,limited,0,0
181702,evidence,0,0
181703,base,0,0
181704,about,0,0
181705,this,0,0
181706,approach,0,0
181707,in,0,0
181708,a,0,0
181709,developing,0,0
181710,country,0,0
181711,such,0,0
181712,as,0,0
181713,Thailand,0,0
181714,.,0,0
181715,Effects,0,0
181716,of,0,0
181717,adjunctive,0,1
181718,zonisamide,1,1
181719,treatment,0,1
181720,on,0,0
181721,weight,0,0
181722,and,0,0
181723,body,0,0
181724,mass,0,0
181725,index,0,0
181726,in,0,0
181727,children,0,0
181728,with,0,0
181729,partial,0,0
181730,epilepsy,0,0
181731,.,0,0
181732,BACKGROUND,0,1
181733,Zonisamide,1,1
181734,has,0,0
181735,been,0,0
181736,associated,0,0
181737,with,0,0
181738,weight,0,0
181739,loss,0,0
181740,in,0,0
181741,children,0,0
181742,and,0,0
181743,adults,0,0
181744,.,0,0
181745,AIMS,0,0
181746,OF,0,1
181747,THE,0,1
181748,STUDY,0,1
181749,To,0,0
181750,assess,0,0
181751,the,0,0
181752,effects,0,0
181753,of,0,0
181754,adjunctive,0,1
181755,zonisamide,1,1
181756,on,0,0
181757,weight,0,0
181758,and,0,0
181759,body,0,0
181760,mass,0,0
181761,index,0,1
181762,(,0,1
181763,BMI,0,1
181764,),0,1
181765,in,0,0
181766,children,0,0
181767,with,0,0
181768,partial,0,0
181769,epilepsy,0,0
181770,.,0,0
181771,METHODS,0,0
181772,A,0,0
181773,subanalysis,0,0
181774,was,0,0
181775,conducted,0,0
181776,of,0,0
181777,a,0,0
181778,Phase,0,0
181779,III,0,0
181780,trial,0,0
181781,and,0,0
181782,extension,0,0
181783,study,0,0
181784,",",0,0
181785,in,0,0
181786,which,0,0
181787,children,0,0
181788,with,0,0
181789,partial,0,0
181790,epilepsy,0,0
181791,received,0,0
181792,adjunctive,1,1
181793,zonisamide,1,1
181794,(,1,1
181795,target,1,1
181796,dose,1,1
181797,8,1,1
181798,mg/kg/day,1,1
181799,;,1,1
181800,maximum,1,0
181801,500,1,1
181802,mg/day,1,1
181803,),1,1
181804,.,0,0
181805,Changes,0,0
181806,in,0,0
181807,weight,0,0
181808,were,0,0
181809,correlated,0,0
181810,with,0,0
181811,skeletal,0,0
181812,development,0,0
181813,and,0,0
181814,sexual,0,0
181815,maturation,0,0
181816,.,0,0
181817,RESULTS,0,0
181818,Overall,0,0
181819,",",0,0
181820,179,0,0
181821,children,0,0
181822,(,0,0
181823,93,0,0
181824,male,0,0
181825,",",0,0
181826,86,0,0
181827,female,0,0
181828,;,0,0
181829,age,0,0
181830,6-18,0,0
181831,years,0,0
181832,),0,0
181833,received,0,1
181834,zonisamide,1,1
181835,(,0,1
181836,mean,0,0
181837,duration,0,0
181838,370.6,0,0
181839,days,0,0
181840,),0,0
181841,.,0,0
181842,Weight,0,0
181843,loss,0,0
181844,?,0,0
181845,5,0,0
181846,%,0,0
181847,was,0,0
181848,reported,0,0
181849,for,0,0
181850,64,0,0
181851,of,0,0
181852,179,0,0
181853,(,0,0
181854,35.8,1,0
181855,%,1,0
181856,),1,0
181857,zonisamide-treated,1,1
181858,children,1,1
181859,.,0,0
181860,Of,0,0
181861,these,0,0
181862,",",0,0
181863,46.9,0,0
181864,%,0,0
181865,were,0,0
181866,overweight/obese,0,0
181867,at,0,0
181868,study,0,0
181869,entry,0,0
181870,",",0,0
181871,compared,0,0
181872,with,0,0
181873,23.4,0,0
181874,%,0,0
181875,at,0,0
181876,study,0,0
181877,end,0,0
181878,(,0,0
181879,P,0,0
181880,=,0,0
181881,0.0007,0,0
181882,),0,0
181883,;,0,0
181884,48.4,0,0
181885,%,0,0
181886,had,0,0
181887,normal,0,0
181888,weight,0,0
181889,at,0,0
181890,study,0,0
181891,entry,0,0
181892,",",0,0
181893,compared,0,0
181894,with,0,0
181895,65.6,0,0
181896,%,0,0
181897,at,0,0
181898,study,0,0
181899,end,0,0
181900,(,0,0
181901,P,0,0
181902,=,0,0
181903,0.03,0,0
181904,),0,0
181905,.,0,0
181906,Three,0,0
181907,patients,0,0
181908,were,0,0
181909,underweight,0,0
181910,at,0,0
181911,study,0,0
181912,entry,0,0
181913,",",0,0
181914,and,0,0
181915,four,0,0
181916,more,0,0
181917,became,0,0
181918,underweight,0,0
181919,by,0,0
181920,study,0,0
181921,end,0,0
181922,.,0,0
181923,No,0,0
181924,consistent,0,0
181925,correlations,0,0
181926,between,0,0
181927,weight,0,0
181928,loss,0,0
181929,and,0,0
181930,skeletal,0,0
181931,development,0,0
181932,or,0,0
181933,sexual,0,0
181934,maturation,0,0
181935,were,0,0
181936,observed,0,0
181937,.,0,0
181938,CONCLUSIONS,0,0
181939,Approximately,0,0
181940,one-third,0,0
181941,of,0,0
181942,children,0,0
181943,treated,0,0
181944,with,1,0
181945,zonisamide,1,1
181946,experienced,1,1
181947,?,0,0
181948,5,0,0
181949,%,0,0
181950,weight,0,0
181951,loss,0,0
181952,.,0,0
181953,Weight,0,0
181954,loss,0,0
181955,was,0,0
181956,most,0,0
181957,apparent,0,0
181958,in,0,0
181959,children,0,0
181960,with,0,0
181961,high,0,0
181962,baseline,0,0
181963,BMI,0,0
181964,values,0,0
181965,and,0,0
181966,did,0,0
181967,not,0,0
181968,appear,0,0
181969,to,0,0
181970,be,0,0
181971,associated,0,0
181972,with,0,0
181973,any,0,0
181974,consistent,0,0
181975,effects,0,0
181976,on,0,0
181977,growth,0,0
181978,and,0,0
181979,development,0,0
181980,.,0,0
181981,Real-Time,0,1
181982,Assessment,0,0
181983,of,0,0
181984,the,0,0
181985,Effect,0,0
181986,of,0,0
181987,Biofeedback,1,0
181988,Therapy,1,0
181989,with,0,0
181990,Migraine,0,0
181991,:,0,0
181992,A,0,0
181993,Pilot,0,0
181994,Study,0,0
181995,.,0,0
181996,BACKGROUND,0,0
181997,Biofeedback,1,0
181998,therapy,1,0
181999,has,0,0
182000,been,0,0
182001,reported,0,0
182002,to,0,0
182003,be,0,0
182004,effective,0,0
182005,in,0,0
182006,the,0,0
182007,treatment,0,0
182008,of,0,0
182009,migraine,0,0
182010,.,0,0
182011,However,0,0
182012,",",0,0
182013,previous,0,0
182014,studies,0,0
182015,have,0,0
182016,assessed,0,0
182017,its,0,0
182018,effectiveness,0,0
182019,using,0,0
182020,paper-and-pencil,0,0
182021,diaries,0,0
182022,",",0,0
182023,which,0,0
182024,are,0,0
182025,not,0,0
182026,very,0,0
182027,reliable,0,0
182028,.,0,0
182029,PURPOSE,0,0
182030,The,0,0
182031,objective,0,0
182032,of,0,0
182033,the,0,0
182034,present,0,0
182035,pilot,0,0
182036,study,0,0
182037,was,0,0
182038,to,0,0
182039,investigate,0,0
182040,the,0,0
182041,feasibility,0,0
182042,of,0,0
182043,using,0,0
182044,computerized,0,0
182045,ecological,0,0
182046,momentary,0,1
182047,assessment,0,1
182048,(,0,1
182049,EMA,0,1
182050,),0,0
182051,for,0,0
182052,evaluating,0,0
182053,the,0,0
182054,efficacy,0,0
182055,of,0,0
182056,BF,1,0
182057,treatment,1,0
182058,for,0,0
182059,migraine,0,0
182060,in,0,0
182061,a,0,0
182062,randomized,0,0
182063,controlled,0,0
182064,trial,0,0
182065,.,0,0
182066,METHOD,0,0
182067,The,0,0
182068,subjects,0,0
182069,comprised,0,0
182070,one,0,0
182071,male,0,0
182072,and,0,0
182073,26,0,0
182074,female,0,0
182075,patients,0,0
182076,with,0,0
182077,migraine,0,0
182078,.,0,0
182079,They,0,0
182080,were,0,0
182081,randomly,0,0
182082,assigned,0,0
182083,to,0,0
182084,either,0,0
182085,biofeedback,1,0
182086,or,0,0
182087,wait-list,1,0
182088,control,1,0
182089,groups,1,0
182090,.,1,0
182091,Patients,0,0
182092,were,0,0
182093,asked,0,0
182094,to,0,0
182095,carry,0,0
182096,a,0,0
182097,palmtop-type,0,0
182098,computer,0,0
182099,to,0,0
182100,record,0,0
182101,momentary,0,0
182102,symptoms,0,0
182103,for,0,0
182104,4,0,0
182105,weeks,0,0
182106,before,0,0
182107,and,0,0
182108,after,0,0
182109,biofeedback,1,0
182110,treatment,1,0
182111,.,1,0
182112,The,0,0
182113,primary,0,0
182114,outcome,0,0
182115,measure,0,0
182116,was,0,0
182117,headache,0,0
182118,intensity,0,0
182119,.,0,0
182120,The,0,0
182121,secondary,0,0
182122,outcome,0,0
182123,measures,0,0
182124,included,0,0
182125,psychological,0,0
182126,stress,0,0
182127,",",0,0
182128,anxiety,0,0
182129,",",0,0
182130,irritation,0,0
182131,",",0,0
182132,headache-related,0,0
182133,disability,0,0
182134,and,0,0
182135,the,0,0
182136,frequency,0,0
182137,(,0,0
182138,number,0,0
182139,of,0,0
182140,days,0,0
182141,per,0,0
182142,month,0,0
182143,),0,0
182144,of,0,0
182145,migraine,0,0
182146,attack,0,0
182147,and,0,0
182148,of,0,0
182149,headache,0,0
182150,of,0,0
182151,at,0,0
182152,least,0,0
182153,moderate,0,0
182154,intensity,0,0
182155,(,0,0
182156,pain,0,0
182157,rating,0,0
182158,?50,0,0
182159,),0,0
182160,.,0,0
182161,RESULTS,0,0
182162,Headache,0,0
182163,intensity,0,0
182164,showed,0,0
182165,significant,0,0
182166,main,0,0
182167,effects,0,0
182168,of,0,0
182169,period,0,0
182170,(,0,0
182171,before,0,0
182172,vs.,0,0
182173,after,0,0
182174,therapy,0,0
182175,",",0,0
182176,p,0,0
182177,=,0,0
182178,0.02,0,0
182179,),0,0
182180,and,0,0
182181,group,0,1
182182,(,0,0
182183,biofeedback,0,0
182184,vs.,0,0
182185,control,0,0
182186,groups,0,0
182187,",",0,0
182188,p,0,0
182189,=,0,0
182190,0.42,0,0
182191,),0,0
182192,and,0,0
182193,a,0,0
182194,significant,0,0
182195,period,0,0
182196,?,0,0
182197,group,0,0
182198,interaction,0,0
182199,(,0,0
182200,p,0,0
182201,<,1,0
182202,0.001,1,0
182203,),1,0
182204,.,1,0
182205,Biofeedback,1,0
182206,reduced,1,0
182207,the,0,0
182208,duration,0,0
182209,of,0,0
182210,headaches,0,0
182211,by,0,0
182212,1.9,0,0
182213,days,0,0
182214,",",0,0
182215,and,0,0
182216,the,0,0
182217,frequency,0,0
182218,of,0,0
182219,days,0,0
182220,when,0,0
182221,headache,0,0
182222,intensity,0,0
182223,was,0,0
182224,?50,0,0
182225,by,0,0
182226,2.4,0,0
182227,times,0,0
182228,.,0,0
182229,In,0,0
182230,addition,0,0
182231,",",0,0
182232,headache-related,0,0
182233,disability,0,0
182234,",",0,0
182235,psychological,0,0
182236,stress,0,0
182237,",",0,0
182238,depression,0,0
182239,",",0,0
182240,anxiety,0,0
182241,",",0,0
182242,and,0,0
182243,irritation,0,0
182244,were,0,0
182245,significantly,0,0
182246,improved,0,0
182247,.,0,0
182248,CONCLUSION,0,0
182249,The,0,0
182250,present,0,0
182251,study,0,0
182252,used,0,0
182253,computerized,0,0
182254,EMA,0,0
182255,to,0,0
182256,show,1,0
182257,that,1,0
182258,biofeedback,1,0
182259,could,1,0
182260,improve,0,0
182261,the,0,0
182262,symptoms,0,0
182263,of,0,0
182264,migraine,0,0
182265,",",0,0
182266,including,0,0
182267,psychological,0,0
182268,stress,0,0
182269,and,0,0
182270,headache-related,0,0
182271,disability,0,0
182272,.,0,0
182273,Hyperfractionated,1,0
182274,accelerated,1,0
182275,radiation,1,0
182276,therapy,1,0
182277,(,1,1
182278,HART,1,1
182279,),1,0
182280,of,0,0
182281,70.6,0,0
182282,Gy,0,0
182283,with,0,0
182284,concurrent,0,0
182285,5-FU/Mitomycin,1,0
182286,C,1,0
182287,is,0,0
182288,superior,0,0
182289,to,0,0
182290,HART,1,0
182291,of,0,0
182292,77.6,0,0
182293,Gy,0,0
182294,alone,0,0
182295,in,0,0
182296,locally,0,0
182297,advanced,0,0
182298,head,0,0
182299,and,0,0
182300,neck,0,0
182301,cancer,0,0
182302,:,0,0
182303,long-term,0,0
182304,results,0,0
182305,of,0,0
182306,the,0,0
182307,ARO,0,0
182308,95-06,0,0
182309,randomized,0,0
182310,phase,0,0
182311,III,0,0
182312,trial,0,0
182313,.,0,0
182314,PURPOSE,0,0
182315,To,0,0
182316,report,0,0
182317,the,0,0
182318,long-term,0,0
182319,results,0,0
182320,of,0,0
182321,the,0,0
182322,ARO,0,0
182323,95-06,0,0
182324,randomized,0,0
182325,trial,0,0
182326,comparing,0,0
182327,hyperfractionated,0,1
182328,accelerated,0,0
182329,chemoradiation,0,1
182330,with,0,1
182331,mitomycin,1,1
182332,C/5-fluorouracil,1,1
182333,(,1,1
182334,C-HART,1,1
182335,),1,1
182336,with,0,0
182337,hyperfractionated,1,1
182338,accelerated,1,0
182339,radiation,1,0
182340,therapy,1,0
182341,(,1,1
182342,HART,1,1
182343,),1,0
182344,alone,1,0
182345,in,0,0
182346,locally,0,0
182347,advanced,0,0
182348,head,0,0
182349,and,0,0
182350,neck,0,0
182351,cancer,0,0
182352,.,0,0
182353,PATIENTS,0,0
182354,AND,0,0
182355,METHODS,0,1
182356,The,0,0
182357,primary,0,0
182358,endpoint,0,0
182359,was,0,0
182360,locoregional,0,0
182361,control,0,0
182362,(,0,0
182363,LRC,0,1
182364,),0,1
182365,.,0,0
182366,Three,0,0
182367,hundred,0,0
182368,eighty-four,0,0
182369,patients,0,0
182370,with,0,0
182371,stage,0,0
182372,III,0,1
182373,(,0,0
182374,6,0,0
182375,%,0,0
182376,),0,0
182377,and,0,0
182378,IV,0,1
182379,(,0,0
182380,94,0,0
182381,%,0,0
182382,),0,0
182383,oropharyngeal,0,0
182384,(,0,0
182385,59.4,0,0
182386,%,0,0
182387,),0,0
182388,",",0,0
182389,hypopharyngeal,0,0
182390,(,0,0
182391,32.3,0,0
182392,%,0,0
182393,),0,0
182394,",",0,0
182395,and,0,1
182396,oral,0,1
182397,cavity,0,1
182398,(,0,0
182399,8.3,0,0
182400,%,0,0
182401,),0,0
182402,cancer,0,0
182403,were,0,0
182404,randomly,0,0
182405,assigned,0,0
182406,to,0,0
182407,30,1,0
182408,Gy/2,1,1
182409,Gy,1,1
182410,daily,1,1
182411,followed,1,1
182412,by,1,0
182413,twice-daily,1,1
182414,1.4,1,0
182415,Gy,1,0
182416,to,1,0
182417,a,1,0
182418,total,1,0
182419,of,1,0
182420,70.6,1,0
182421,Gy,1,0
182422,concurrently,1,0
182423,with,1,0
182424,mitomycin,1,1
182425,C/5-FU,1,1
182426,(,1,1
182427,C-HART,1,1
182428,),1,1
182429,or,1,0
182430,16,1,0
182431,Gy/2,1,1
182432,Gy,1,1
182433,daily,1,1
182434,followed,1,1
182435,by,1,0
182436,twice-daily,1,1
182437,1.4,1,0
182438,Gy,1,0
182439,to,1,0
182440,a,1,0
182441,total,1,0
182442,dose,1,0
182443,of,1,0
182444,77.6,1,0
182445,Gy,1,0
182446,alone,1,0
182447,(,1,0
182448,HART,1,1
182449,),1,1
182450,.,1,0
182451,Statistical,0,0
182452,analyses,0,0
182453,were,0,0
182454,done,0,0
182455,with,0,0
182456,the,0,0
182457,log-rank,0,0
182458,test,0,0
182459,and,0,0
182460,univariate,0,0
182461,and,0,0
182462,multivariate,0,0
182463,Cox,0,1
182464,regression,0,0
182465,analyses,0,0
182466,.,0,0
182467,RESULTS,0,0
182468,The,0,0
182469,median,0,0
182470,follow-up,0,0
182471,time,0,0
182472,was,0,0
182473,8.7,0,0
182474,years,0,0
182475,(,0,0
182476,95,0,0
182477,%,0,0
182478,confidence,0,0
182479,interval,0,0
182480,[,0,0
182481,CI,0,0
182482,],0,0
182483,:,0,0
182484,7.8-9.7,0,0
182485,years,0,0
182486,),0,0
182487,.,0,0
182488,At,0,0
182489,10,0,0
182490,years,0,0
182491,",",0,0
182492,the,0,0
182493,LRC,0,0
182494,rates,0,0
182495,were,0,0
182496,38.0,0,0
182497,%,0,0
182498,(,1,0
182499,C-HART,1,0
182500,),1,0
182501,versus,1,0
182502,26.0,0,0
182503,%,1,0
182504,(,1,0
182505,HART,1,0
182506,",",1,1
182507,P=.002,1,1
182508,),0,0
182509,.,0,0
182510,The,0,0
182511,cancer-specific,0,0
182512,survival,0,0
182513,and,0,0
182514,overall,0,0
182515,survival,0,0
182516,rates,0,0
182517,were,0,0
182518,39,0,0
182519,%,0,0
182520,and,0,0
182521,10,0,0
182522,%,0,0
182523,(,1,0
182524,C-HART,1,0
182525,),1,1
182526,versus,1,0
182527,30.0,0,0
182528,%,0,0
182529,and,0,0
182530,9,0,0
182531,%,1,0
182532,(,1,0
182533,HART,1,0
182534,",",1,0
182535,P=.042,0,1
182536,and,0,1
182537,P=.049,0,1
182538,),0,0
182539,",",0,0
182540,respectively,0,0
182541,.,0,0
182542,According,0,0
182543,to,0,0
182544,multivariate,0,0
182545,Cox,0,0
182546,regression,0,0
182547,analysis,0,0
182548,",",0,0
182549,the,0,0
182550,combined,0,0
182551,treatment,0,0
182552,was,0,0
182553,associated,0,0
182554,with,0,0
182555,improved,0,0
182556,LRC,0,1
182557,(,0,1
182558,hazard,0,1
182559,ratio,0,1
182560,[,0,1
182561,HR,0,1
182562,],0,0
182563,:,0,0
182564,0.6,0,0
182565,[,0,0
182566,95,0,0
182567,%,0,0
182568,CI,0,0
182569,:,0,0
182570,0.5-0.8,0,0
182571,;,0,0
182572,P=.002,0,1
182573,],0,1
182574,),0,0
182575,.,0,0
182576,The,0,0
182577,association,0,0
182578,between,0,0
182579,combined,0,0
182580,treatment,0,0
182581,arm,0,0
182582,and,0,0
182583,increased,0,0
182584,LRC,0,0
182585,appeared,0,0
182586,to,0,0
182587,be,0,0
182588,limited,0,0
182589,to,0,0
182590,oropharyngeal,0,0
182591,cancer,0,1
182592,(,0,1
182593,P=.003,0,1
182594,),0,0
182595,as,0,0
182596,compared,0,0
182597,with,0,0
182598,hypopharyngeal,0,0
182599,or,0,0
182600,oral,0,1
182601,cavity,0,1
182602,cancer,0,1
182603,(,0,1
182604,P=.264,0,1
182605,),0,1
182606,.,0,0
182607,CONCLUSIONS,0,0
182608,C-HART,1,0
182609,remains,1,0
182610,superior,0,0
182611,to,0,0
182612,HART,1,0
182613,in,1,0
182614,terms,0,0
182615,of,0,0
182616,LRC,0,0
182617,.,0,0
182618,However,0,0
182619,",",0,0
182620,this,0,0
182621,effect,0,0
182622,may,0,0
182623,be,0,0
182624,limited,0,0
182625,to,0,0
182626,oropharyngeal,0,0
182627,cancer,0,0
182628,patients,0,0
182629,.,0,0
182630,The,0,0
182631,nature,0,0
182632,of,0,0
182633,placebo,1,1
182634,response,0,0
182635,in,0,0
182636,clinical,0,0
182637,studies,0,0
182638,of,0,0
182639,major,0,0
182640,depressive,0,0
182641,disorder,0,0
182642,.,0,0
182643,OBJECTIVE,0,0
182644,To,0,1
182645,review,0,0
182646,factors,0,0
182647,influencing,0,0
182648,placebo,1,1
182649,response,0,0
182650,and,0,0
182651,clinical,0,0
182652,trial,0,0
182653,outcome,0,0
182654,in,0,0
182655,depression,0,0
182656,",",0,0
182657,and,0,0
182658,suggest,0,0
182659,ways,0,0
182660,to,0,0
182661,optimize,0,0
182662,trial,0,0
182663,success,0,0
182664,in,0,0
182665,mood,0,0
182666,disorders,0,0
182667,.,0,0
182668,DATA,0,0
182669,SOURCES,0,1
182670,PubMed,0,1
182671,searches,0,0
182672,were,0,0
182673,conducted,0,0
182674,by,0,0
182675,cross-referencing,0,0
182676,the,0,0
182677,terms,0,0
182678,depression,0,0
182679,",",0,0
182680,depressive,0,0
182681,with,0,1
182682,placebo,1,1
182683,",",0,1
182684,clinical,0,1
182685,trial,0,0
182686,",",0,0
182687,and,0,0
182688,clinical,0,0
182689,trials,0,0
182690,for,0,0
182691,studies,0,0
182692,published,0,0
182693,in,0,0
182694,English,0,0
182695,between,0,0
182696,1970,0,0
182697,and,0,0
182698,September,0,0
182699,2013,0,0
182700,.,0,0
182701,STUDY,0,0
182702,SELECTION,0,0
182703,Relevant,0,0
182704,abstracts,0,0
182705,were,0,0
182706,identified,0,0
182707,in,0,0
182708,PubMed,0,0
182709,",",0,0
182710,including,0,0
182711,clinical,0,0
182712,trials,0,0
182713,",",0,0
182714,quantitative,0,0
182715,studies,0,0
182716,",",0,0
182717,and,0,0
182718,qualitative,0,0
182719,research,0,0
182720,.,0,0
182721,We,0,0
182722,obtained,0,0
182723,and,0,0
182724,reviewed,0,0
182725,relevant,0,0
182726,articles,0,0
182727,and,0,0
182728,utilized,0,0
182729,their,0,0
182730,information,0,0
182731,to,0,0
182732,synthesize,0,0
182733,the,0,0
182734,present,0,0
182735,review,0,0
182736,.,0,0
182737,DATA,0,0
182738,EXTRACTION,0,0
182739,Included,0,0
182740,articles,0,0
182741,were,0,0
182742,grouped,0,0
182743,in,0,0
182744,the,0,0
182745,following,0,0
182746,areas,0,0
182747,of,0,0
182748,relevance,0,0
182749,:,0,0
182750,(,0,0
182751,1,0,0
182752,),0,0
182753,biological,0,0
182754,validity,0,0
182755,of,0,0
182756,illness,0,0
182757,",",0,0
182758,(,0,1
182759,2,0,1
182760,),0,0
182761,baseline,0,1
182762,severity,0,0
182763,of,0,0
182764,illness,0,0
182765,",",0,0
182766,(,0,1
182767,3,0,1
182768,),0,0
182769,chronicity,0,0
182770,of,0,0
182771,the,0,0
182772,index,0,0
182773,episode,0,0
182774,of,0,0
182775,depression,0,0
182776,",",0,0
182777,(,0,1
182778,4,0,1
182779,),0,0
182780,age,0,0
182781,of,0,0
182782,participants,0,0
182783,",",0,0
182784,(,0,1
182785,5,0,1
182786,),0,0
182787,medical,0,0
182788,and,0,0
182789,psychiatric,0,0
182790,comorbidity,0,1
182791,",",0,1
182792,(,0,1
182793,6,0,1
182794,),0,1
182795,probability,0,0
182796,of,0,0
182797,receiving,1,0
182798,placebo,1,1
182799,",",0,1
182800,(,0,1
182801,7,0,0
182802,),0,0
182803,use,0,0
182804,of,0,0
182805,prospective,0,0
182806,treatment,0,0
182807,phases,0,0
182808,(,0,1
182809,lead-in,0,1
182810,),0,1
182811,(,0,1
182812,8,0,1
182813,),0,1
182814,dosing,0,1
182815,schedule,0,1
182816,",",0,1
182817,(,0,1
182818,9,0,1
182819,),0,1
182820,trial,0,1
182821,duration,0,1
182822,",",0,1
182823,(,0,1
182824,10,0,0
182825,),0,0
182826,frequency,0,0
182827,of,0,0
182828,follow-up,0,0
182829,assessments,0,0
182830,",",0,0
182831,and,0,0
182832,(,0,1
182833,11,0,0
182834,),0,0
182835,study,0,0
182836,outcome,0,0
182837,measure,0,0
182838,.,0,0
182839,RESULTS,0,0
182840,Several,0,0
182841,key,0,0
182842,elements,0,0
182843,emerge,0,0
182844,as,0,0
182845,critical,0,0
182846,to,0,0
182847,the,0,0
182848,ultimate,0,0
182849,success,0,0
182850,of,0,0
182851,a,0,0
182852,clinical,0,0
182853,trial,0,0
182854,",",0,0
182855,including,0,0
182856,the,0,0
182857,probability,0,0
182858,of,0,0
182859,receiving,0,0
182860,placebo,1,1
182861,",",0,0
182862,study,0,0
182863,duration,0,0
182864,",",0,0
182865,dosing,0,1
182866,schedule,0,1
182867,",",0,0
182868,visit,0,0
182869,frequency,0,0
182870,",",0,0
182871,the,0,0
182872,use,0,0
182873,of,0,0
182874,blinded,0,0
182875,lead-in,0,1
182876,phases,0,0
182877,",",0,0
182878,the,0,0
182879,use,0,0
182880,of,0,0
182881,centralized,0,0
182882,raters,0,0
182883,",",0,0
182884,illness,0,0
182885,severity,0,0
182886,and,0,0
182887,duration,0,0
182888,",",0,0
182889,and,0,0
182890,comorbid,0,0
182891,anxiety,0,0
182892,.,0,0
182893,CONCLUSIONS,0,0
182894,Our,0,0
182895,increasing,0,0
182896,understanding,0,0
182897,of,0,0
182898,the,0,0
182899,placebo,1,1
182900,response,0,0
182901,in,0,0
182902,clinical,0,0
182903,trials,0,0
182904,of,0,0
182905,major,0,0
182906,depressive,0,0
182907,disorder,0,0
182908,lends,0,0
182909,to,0,0
182910,a,0,0
182911,",",0,0
182912,gradually,0,0
182913,",",0,0
182914,more,0,0
182915,predictable,0,0
182916,phenomenon,0,0
182917,and,0,0
182918,",",0,0
182919,hopefully,0,0
182920,",",0,0
182921,to,0,0
182922,one,0,0
182923,that,0,0
182924,becomes,0,0
182925,lesser,0,0
182926,in,0,0
182927,magnitude,0,0
182928,and,0,0
182929,variability,0,0
182930,.,0,0
182931,Several,0,0
182932,elements,0,0
182933,have,0,0
182934,emerged,0,0
182935,that,0,0
182936,seem,0,0
182937,to,0,0
182938,play,0,0
182939,a,0,0
182940,critical,0,0
182941,role,0,0
182942,in,0,0
182943,trial,0,0
182944,success,0,0
182945,",",0,0
182946,gradually,0,0
182947,reshaping,0,0
182948,the,0,0
182949,design,0,0
182950,of,0,0
182951,clinical,0,0
182952,",",0,0
182953,translational,0,0
182954,",",0,0
182955,as,0,0
182956,well,0,0
182957,as,0,0
182958,mechanistic,0,0
182959,studies,0,0
182960,in,0,0
182961,depression,0,0
182962,.,0,0
182963,Mask,1,1
182964,ventilation,1,0
182965,with,0,0
182966,two,0,0
182967,different,0,0
182968,face,0,0
182969,masks,0,0
182970,in,0,0
182971,the,0,0
182972,delivery,0,0
182973,room,0,0
182974,for,0,0
182975,preterm,0,0
182976,infants,0,0
182977,:,0,0
182978,a,0,0
182979,randomized,0,0
182980,controlled,0,0
182981,trial,0,0
182982,.,0,0
182983,BACKGROUND,0,0
182984,If,0,0
182985,an,0,0
182986,infant,0,0
182987,fails,0,0
182988,to,0,0
182989,initiate,0,0
182990,spontaneous,0,0
182991,breathing,0,0
182992,after,0,0
182993,birth,0,0
182994,",",0,0
182995,international,0,0
182996,guidelines,0,0
182997,recommend,0,0
182998,a,0,0
182999,positive,0,0
183000,pressure,0,0
183001,ventilation,0,1
183002,(,0,1
183003,PPV,0,1
183004,),0,1
183005,.,0,0
183006,However,0,0
183007,",",0,0
183008,PPV,0,0
183009,by,0,0
183010,face,1,0
183011,mask,1,0
183012,is,0,0
183013,frequently,0,0
183014,inadequate,0,0
183015,because,0,0
183016,of,0,0
183017,leak,0,0
183018,between,0,0
183019,the,0,0
183020,face,0,0
183021,and,0,0
183022,mask,0,0
183023,.,0,0
183024,Despite,0,0
183025,a,0,0
183026,variety,0,0
183027,of,0,0
183028,available,0,0
183029,face,0,0
183030,masks,0,0
183031,",",0,0
183032,none,0,0
183033,have,0,0
183034,been,0,0
183035,prospectively,0,0
183036,compared,0,0
183037,in,0,0
183038,a,0,0
183039,randomized,0,0
183040,fashion,0,0
183041,.,0,0
183042,We,0,0
183043,aimed,0,0
183044,to,0,0
183045,evaluate,0,0
183046,and,0,0
183047,compare,0,0
183048,leak,0,0
183049,between,0,0
183050,two,0,0
183051,commercially,0,0
183052,available,0,0
183053,round,1,0
183054,face,1,0
183055,masks,1,0
183056,(,1,0
183057,Fisher,1,0
183058,&,1,1
183059,Paykel,1,1
183060,(,1,1
183061,F,1,0
183062,&,1,0
183063,P,1,0
183064,),1,0
183065,and,1,0
183066,Laerdal,1,1
183067,),1,0
183068,in,0,0
183069,preterm,0,0
183070,infants,0,0
183071,<,0,0
183072,33,0,0
183073,weeks,0,0
183074,gestational,0,0
183075,age,0,0
183076,in,0,0
183077,the,0,0
183078,delivery,0,0
183079,room,0,0
183080,.,0,0
183081,METHODS,0,0
183082,Infants,0,0
183083,born,0,0
183084,at,0,0
183085,the,0,0
183086,Royal,0,0
183087,Alexandra,0,0
183088,Hospital,0,1
183089,from,0,0
183090,April,0,1
183091,to,0,0
183092,September,0,1
183093,2013,0,0
183094,at,0,0
183095,<,0,0
183096,33,0,0
183097,weeks,0,0
183098,gestational,0,0
183099,age,0,0
183100,who,0,0
183101,received,0,0
183102,mask,1,0
183103,PPV,1,0
183104,in,0,0
183105,the,0,0
183106,delivery,0,0
183107,room,0,0
183108,routinely,0,0
183109,had,0,0
183110,a,0,0
183111,flow,0,0
183112,sensor,0,0
183113,placed,0,0
183114,between,0,0
183115,the,0,0
183116,mask,0,0
183117,and,0,0
183118,T-piece,0,0
183119,resuscitator,0,0
183120,.,0,0
183121,Infants,0,0
183122,were,0,0
183123,randomly,0,0
183124,assigned,0,0
183125,to,0,0
183126,receive,0,0
183127,PPV,1,0
183128,with,1,0
183129,either,1,0
183130,a,1,0
183131,F,1,0
183132,&,1,0
183133,P,1,0
183134,or,1,0
183135,Laerdal,1,0
183136,face,1,0
183137,mask,1,0
183138,.,1,0
183139,All,0,0
183140,resuscitators,0,0
183141,were,0,0
183142,trained,0,0
183143,in,0,0
183144,the,0,0
183145,use,0,0
183146,of,0,0
183147,both,0,0
183148,face,0,0
183149,masks,0,0
183150,.,0,0
183151,We,0,0
183152,compared,0,0
183153,mask,0,0
183154,leak,0,0
183155,",",0,0
183156,airway,0,0
183157,pressures,0,0
183158,",",0,0
183159,tidal,0,0
183160,volume,0,0
183161,and,0,0
183162,ventilation,0,0
183163,rate,0,0
183164,between,0,0
183165,the,0,0
183166,two,0,0
183167,groups,0,0
183168,.,0,0
183169,RESULTS,0,0
183170,Fifty-six,0,0
183171,preterm,0,0
183172,infants,0,0
183173,(,0,0
183174,n=28,0,0
183175,in,0,0
183176,each,0,0
183177,group,0,0
183178,),0,0
183179,were,0,0
183180,enrolled,0,1
183181,;,0,0
183182,mean?s.d,0,1
183183,.,0,0
183184,gestational,0,0
183185,age,0,0
183186,28?3,0,1
183187,weeks,0,0
183188,;,0,0
183189,birth,0,1
183190,weight,0,1
183191,1210?448,0,1
183192,g,0,1
183193,;,0,1
183194,and,0,1
183195,30,0,0
183196,(,0,0
183197,52,0,0
183198,%,0,0
183199,),0,0
183200,were,0,0
183201,male,0,0
183202,.,0,0
183203,Apgar,0,0
183204,scores,0,0
183205,at,0,0
183206,1,0,0
183207,and,0,0
183208,5,0,0
183209,min,0,0
183210,were,0,0
183211,5?3,0,0
183212,and,0,0
183213,7?2,0,0
183214,",",0,0
183215,respectively,0,0
183216,.,0,0
183217,Infants,0,0
183218,randomized,1,0
183219,to,1,0
183220,the,1,0
183221,F,1,0
183222,&,1,0
183223,P,1,0
183224,face,1,0
183225,mask,1,0
183226,and,1,0
183227,Laerdal,1,0
183228,face,1,0
183229,mask,1,0
183230,had,1,0
183231,similar,0,0
183232,mask,0,0
183233,leak,0,1
183234,(,0,1
183235,30,0,0
183236,(,0,0
183237,25-38,0,0
183238,),0,0
183239,versus,0,0
183240,35,0,0
183241,(,0,0
183242,24-46,0,0
183243,),0,0
183244,%,0,0
183245,",",0,0
183246,median,0,0
183247,(,0,0
183248,interquartile,0,0
183249,range,0,0
183250,),0,0
183251,",",0,0
183252,respectively,0,0
183253,",",0,0
183254,P=0.40,0,0
183255,),0,0
183256,and,0,0
183257,tidal,0,1
183258,volume,0,1
183259,(,0,0
183260,7.1,0,0
183261,(,0,0
183262,4.9-8.9,0,0
183263,),0,0
183264,versus,0,0
183265,6.6,0,0
183266,(,0,0
183267,5.2-8.9,0,0
183268,),0,0
183269,ml,0,0
183270,kg,0,0
183271,(,0,1
183272,-1,0,0
183273,),0,0
183274,",",0,0
183275,P=0.69,0,0
183276,),0,0
183277,during,0,0
183278,PPV,0,1
183279,.,0,0
183280,There,0,0
183281,were,0,0
183282,no,0,0
183283,significant,0,0
183284,differences,0,0
183285,in,0,0
183286,ventilation,0,0
183287,rate,0,0
183288,",",0,0
183289,inflation,0,0
183290,time,0,0
183291,or,0,0
183292,airway,0,0
183293,pressures,0,0
183294,between,0,0
183295,groups,0,0
183296,.,0,0
183297,CONCLUSION,0,0
183298,The,0,0
183299,use,0,0
183300,of,0,0
183301,either,0,0
183302,face,0,0
183303,mask,0,0
183304,during,0,0
183305,PPV,0,0
183306,in,0,0
183307,the,0,0
183308,delivery,0,0
183309,room,0,0
183310,yields,0,0
183311,similar,0,0
183312,mask,0,0
183313,leak,0,0
183314,in,0,0
183315,preterm,0,0
183316,infants,0,0
183317,<,0,0
183318,33,0,0
183319,weeks,0,0
183320,gestational,0,0
183321,age,0,0
183322,.,0,0
183323,Lateral,1,0
183324,MI,1,1
183325,Explains,0,0
183326,the,0,0
183327,Presence,0,0
183328,of,0,0
183329,Prominent,0,0
183330,R,0,1
183331,Wave,0,1
183332,(,0,0
183333,R,0,1
183334,?,0,1
183335,S,0,1
183336,),0,0
183337,in,0,0
183338,V1,0,1
183339,.,0,0
183340,AIMS,0,0
183341,It,0,0
183342,is,0,0
183343,necessary,0,0
183344,to,0,0
183345,clarify,0,0
183346,if,0,0
183347,the,0,0
183348,presence,0,0
183349,of,0,0
183350,a,0,0
183351,prominent,0,0
183352,R,0,0
183353,wave,0,0
183354,in,0,0
183355,V1,0,0
183356,",",0,0
183357,in,0,0
183358,post-myocardial,0,1
183359,infarction,0,1
183360,(,0,1
183361,MI,0,1
183362,),0,1
183363,patients,0,0
183364,",",0,0
183365,is,0,0
183366,due,0,0
183367,to,0,0
183368,the,0,0
183369,involvement,0,0
183370,of,0,0
183371,the,1,0
183372,posterior,1,0
183373,wall,1,0
183374,(,1,0
183375,currently,1,0
183376,inferobasal,1,0
183377,segment,1,0
183378,),1,0
183379,or,1,0
183380,the,1,0
183381,lateral,1,0
183382,wall,1,0
183383,(,1,0
183384,as,0,0
183385,has,0,0
183386,been,0,0
183387,demonstrated,0,0
183388,recently,0,0
183389,by,0,0
183390,electrocardiographic,0,0
183391,contrast-enhanced,0,0
183392,cardiac,0,1
183393,magnetic,0,1
183394,resonance,0,1
183395,[,0,1
183396,ECG-CE-CMR,0,1
183397,],0,0
183398,correlations,0,0
183399,studies,0,0
183400,),0,0
183401,.,0,0
183402,METHODS,0,0
183403,In,0,0
183404,155,0,0
183405,patients,0,0
183406,with,0,0
183407,inferolateral,0,0
183408,zone,0,0
183409,MI,0,0
183410,",",0,0
183411,as,0,0
183412,detected,0,0
183413,by,0,0
183414,CE-CMR,0,0
183415,",",0,0
183416,the,0,0
183417,following,0,0
183418,ECG,0,0
183419,parameters,0,0
183420,were,0,0
183421,evaluated,0,0
183422,and,0,0
183423,correlated,0,0
183424,with,0,0
183425,MI,0,0
183426,location,0,0
183427,according,0,0
183428,to,0,0
183429,CE-CMR,0,0
183430,:,0,0
183431,R/S,0,0
183432,ratio,0,0
183433,in,0,0
183434,V1,0,1
183435,?,0,1
183436,1,0,1
183437,(,0,0
183438,classic,0,0
183439,criteria,0,0
183440,for,0,0
183441,posterior,0,1
183442,MI,0,1
183443,),0,1
183444,",",0,0
183445,R/S,0,1
183446,ratio,0,0
183447,in,0,0
183448,V1,0,1
183449,?,0,0
183450,0.5,0,0
183451,",",0,0
183452,and,0,0
183453,R,0,0
183454,in,0,0
183455,V1,0,1
183456,?,0,0
183457,3,0,0
183458,mm,0,0
183459,.,0,0
183460,RESULTS,0,0
183461,R/S,0,1
183462,?,0,1
183463,1,0,0
183464,criterion,0,0
183465,:,0,0
183466,Present,0,0
183467,in,0,0
183468,20,0,0
183469,cases,0,0
183470,:,0,0
183471,3,0,0
183472,of,1,0
183473,lateral,1,0
183474,MI,1,0
183475,",",1,0
183476,17,1,0
183477,of,1,0
183478,inferolateral,1,0
183479,MI,1,1
183480,",",1,0
183481,0,1,0
183482,of,1,0
183483,inferior,1,0
183484,MI,1,0
183485,.,1,0
183486,Absent,1,0
183487,in,0,0
183488,135,0,0
183489,cases,0,0
183490,",",0,0
183491,81,0,0
183492,of,1,0
183493,lateral/inferolateral,1,0
183494,MI,1,0
183495,(,1,0
183496,28/53,1,0
183497,),0,0
183498,",",0,0
183499,54,0,0
183500,of,0,0
183501,inferior,0,0
183502,MI,0,1
183503,(,0,0
183504,SE,0,0
183505,19.8,0,0
183506,%,0,0
183507,",",0,0
183508,SP,0,0
183509,100,0,0
183510,%,0,0
183511,),0,0
183512,.,0,0
183513,R/S,0,1
183514,?,0,0
183515,0.5,0,0
183516,criterion,0,0
183517,:,0,0
183518,Present,0,0
183519,in,0,0
183520,47,0,0
183521,cases,0,0
183522,:,0,0
183523,6,0,0
183524,of,0,0
183525,lateral,1,0
183526,MI,1,0
183527,",",1,0
183528,39,1,0
183529,of,1,0
183530,inferolateral,1,0
183531,MI,1,1
183532,",",1,0
183533,2,1,0
183534,of,1,0
183535,inferior,1,0
183536,MI,0,0
183537,.,0,0
183538,Absent,0,0
183539,in,0,0
183540,108,0,0
183541,cases,0,0
183542,",",0,0
183543,56,0,0
183544,of,0,0
183545,lateral/inferolateral,1,0
183546,MI,1,0
183547,(,1,0
183548,25/31,1,0
183549,),1,0
183550,",",1,0
183551,52,0,0
183552,of,1,0
183553,inferior,1,0
183554,MI,1,1
183555,(,0,0
183556,SE,0,0
183557,44.6,0,0
183558,%,0,0
183559,",",0,0
183560,SP,0,0
183561,96.4,0,0
183562,%,0,0
183563,),0,0
183564,.,0,0
183565,R,0,1
183566,?,0,0
183567,3,0,0
183568,mm,0,0
183569,criterion,0,0
183570,:,0,0
183571,Present,0,0
183572,in,0,0
183573,30,0,0
183574,cases,0,0
183575,:,0,0
183576,5,0,0
183577,of,0,0
183578,IM,1,0
183579,lateral,1,0
183580,",",0,0
183581,23,0,0
183582,of,0,0
183583,inferolateral,1,0
183584,MI,1,1
183585,",",1,0
183586,2,1,0
183587,of,1,0
183588,inferior,1,0
183589,MI,1,0
183590,.,1,0
183591,Absent,0,0
183592,in,0,0
183593,125,0,0
183594,cases,0,0
183595,",",0,0
183596,73,0,0
183597,lateral/inferolateral,1,0
183598,MI,1,0
183599,(,1,0
183600,26/47,1,0
183601,),1,0
183602,",",1,0
183603,52,1,0
183604,inferior,1,0
183605,MI,1,0
183606,(,1,0
183607,SE,0,0
183608,27.7,0,0
183609,%,0,0
183610,",",0,0
183611,SP,0,0
183612,96.4,0,0
183613,%,0,0
183614,),0,0
183615,.,0,0
183616,CONCLUSIONS,0,0
183617,The,0,0
183618,presence,0,0
183619,of,0,0
183620,prominent,0,0
183621,the,0,0
183622,R,0,0
183623,wave,0,0
183624,in,0,0
183625,V1,0,0
183626,is,0,0
183627,due,0,0
183628,to,0,0
183629,the,0,0
183630,lateral,1,0
183631,MI,1,0
183632,and,1,0
183633,not,0,0
183634,to,0,0
183635,the,0,0
183636,involvement,0,0
183637,of,0,0
183638,inferobasal,0,0
183639,segment,0,0
183640,of,0,0
183641,inferior,0,0
183642,wall,0,0
183643,(,0,0
183644,old,0,0
183645,posterior,0,1
183646,wall,0,0
183647,),0,0
183648,.,0,0
183649,[,0,1
183650,European,0,1
183651,topic,0,0
183652,:,0,0
183653,liver,1,0
183654,surgery,1,0
183655,II,1,0
183656,--,1,0
183657,regional,1,0
183658,chemotherapy,1,0
183659,],1,0
183660,.,0,0
183661,The,0,0
183662,most,0,0
183663,important,0,0
183664,methods,0,0
183665,of,0,0
183666,regional,1,0
183667,chemotherapy,1,0
183668,are,0,0
183669,exemplified,0,0
183670,by,0,0
183671,657,0,0
183672,cases,0,0
183673,of,0,0
183674,primary,0,0
183675,and,0,0
183676,secondary,0,0
183677,liver,0,0
183678,only,0,0
183679,malignancies,0,0
183680,.,0,0
183681,I,0,0
183682,.,0,0
183683,Adjuvant,1,1
183684,portal,1,1
183685,therapy,1,0
183686,of,1,0
183687,the,1,0
183688,liver,1,0
183689,with,1,0
183690,resection,1,0
183691,of,1,0
183692,the,1,0
183693,colorectal,1,0
183694,primary,1,0
183695,malignancy,1,0
183696,seems,0,0
183697,to,0,0
183698,be,0,0
183699,advantageous,0,0
183700,for,0,0
183701,advanced,0,0
183702,tumors,0,0
183703,.,0,0
183704,II,0,0
183705,.,0,0
183706,It,0,0
183707,is,0,0
183708,still,0,0
183709,unresolved,0,0
183710,whether,0,0
183711,survival,0,0
183712,is,0,0
183713,prolonged,0,0
183714,by,0,0
183715,adjuvant,0,1
183716,treatment,0,0
183717,of,0,0
183718,the,0,0
183719,liver,0,0
183720,following,0,0
183721,curative,1,0
183722,resection,1,0
183723,of,1,0
183724,colorectal,1,0
183725,liver,1,0
183726,metastases,1,0
183727,.,1,0
183728,III,0,0
183729,.,0,0
183730,The,0,0
183731,median,0,0
183732,survival,0,0
183733,time,0,0
183734,(,0,0
183735,FUDR,0,1
183736,",",0,1
183737,pump,0,1
183738,),0,1
183739,is,0,0
183740,17,0,0
183741,months,0,0
183742,for,0,0
183743,palliative,1,0
183744,local,1,0
183745,chemotherapy,1,0
183746,of,0,0
183747,unresectable,0,0
183748,colorectal,0,0
183749,liver,0,0
183750,metastases,0,0
183751,.,0,0
183752,IV,0,0
183753,.,0,0
183754,Primary,0,0
183755,non-resectable,0,0
183756,liver,0,0
183757,malignancies,0,0
183758,show,0,0
183759,the,0,0
183760,best,0,0
183761,results,0,0
183762,after,0,0
183763,chemoembolisation,0,1
183764,(,0,1
183765,Frankfurt,0,1
183766,method,0,0
183767,),0,0
183768,.,0,0
183769,Magnetic,1,0
183770,resonance,1,0
183771,imaging,1,0
183772,in,0,0
183773,the,0,0
183774,evaluation,0,0
183775,of,0,0
183776,clinical,0,0
183777,treatment,0,0
183778,of,0,0
183779,otospongiosis,0,0
183780,:,0,0
183781,a,0,0
183782,pilot,0,0
183783,study,0,0
183784,.,0,0
183785,OBJECTIVES,0,0
183786,To,0,0
183787,evaluate,0,0
183788,the,0,0
183789,applicability,0,0
183790,of,0,0
183791,magnetic,1,0
183792,resonance,1,1
183793,imaging,1,1
183794,(,1,1
183795,MRI,1,1
183796,),1,0
183797,as,0,0
183798,a,0,0
183799,method,0,0
183800,for,0,0
183801,monitoring,0,0
183802,the,0,0
183803,activity,0,0
183804,of,0,0
183805,otospongiotic,0,0
183806,lesions,0,0
183807,before,0,0
183808,and,0,0
183809,after,0,0
183810,clinical,0,0
183811,treatment,0,0
183812,.,0,0
183813,STUDY,0,0
183814,DESIGN,0,1
183815,Prospective,0,1
183816,",",0,0
183817,randomized,0,0
183818,",",0,0
183819,controlled,0,0
183820,",",0,0
183821,double-blind,0,1
183822,study,0,0
183823,.,0,0
183824,SETTING,0,0
183825,One,0,0
183826,single,0,0
183827,tertiary,0,0
183828,care,0,0
183829,institution,0,0
183830,in,0,0
183831,a,0,0
183832,large,0,0
183833,",",0,0
183834,cosmopolitan,0,0
183835,city,0,0
183836,.,0,0
183837,METHODS,0,0
183838,Twenty-six,0,0
183839,patients,0,0
183840,(,0,0
183841,n,0,0
183842,=,0,0
183843,42,0,0
183844,ears,0,0
183845,),0,0
183846,with,0,0
183847,clinical,0,0
183848,",",0,0
183849,audiometric,0,0
183850,",",0,0
183851,and,0,0
183852,tomographic,0,0
183853,diagnosis,0,0
183854,of,0,0
183855,otosclerosis,0,0
183856,were,0,0
183857,enrolled,0,0
183858,.,0,0
183859,If,0,0
183860,computed,1,1
183861,tomography,1,1
183862,(,0,1
183863,CT,0,0
183864,),0,0
183865,demonstrated,0,0
183866,active,0,0
183867,lesions,0,0
183868,",",0,0
183869,these,0,0
183870,patients,0,0
183871,underwent,1,0
183872,MRI,1,0
183873,to,0,0
183874,detect,0,0
183875,otospongiotic,0,0
183876,foci,0,0
183877,",",0,0
183878,seen,0,0
183879,as,0,0
183880,areas,0,0
183881,of,0,0
183882,gadolinium,0,1
183883,enhancement,0,0
183884,.,0,0
183885,Patients,0,0
183886,were,0,0
183887,divided,0,0
183888,into,0,0
183889,3,0,0
183890,groups,0,0
183891,and,0,0
183892,received,0,0
183893,treatment,0,0
183894,with,0,0
183895,placebo,1,1
183896,",",1,1
183897,sodium,1,1
183898,alendronate,1,1
183899,",",1,1
183900,or,1,1
183901,sodium,1,1
183902,fluoride,1,1
183903,for,0,1
183904,6,0,0
183905,months,0,0
183906,.,0,0
183907,After,0,0
183908,this,0,0
183909,period,0,0
183910,",",0,0
183911,clinical,0,0
183912,and,0,0
183913,audiometric,0,0
183914,evaluations,0,0
183915,and,0,0
183916,a,0,0
183917,second,0,0
183918,MRI,1,0
183919,were,0,0
183920,performed,0,0
183921,.,0,0
183922,Each,0,0
183923,MRI,1,0
183924,was,0,0
183925,evaluated,0,0
183926,by,0,0
183927,both,0,0
183928,a,0,0
183929,neuroradiologist,0,0
183930,and,0,0
183931,an,0,0
183932,otolaryngologist,0,0
183933,in,0,0
183934,a,0,0
183935,subjective,0,1
183936,(,0,1
183937,visual,0,1
183938,),0,1
183939,and,0,0
183940,objective,0,1
183941,(,0,0
183942,using,0,0
183943,specific,0,0
183944,eFilm,0,0
183945,Workstation,0,1
183946,software,0,1
183947,),0,0
183948,manner,0,0
183949,.,0,0
183950,RESULTS,0,0
183951,Otospongiosis,0,0
183952,was,0,0
183953,most,0,0
183954,predominantly,0,0
183955,identified,0,0
183956,in,0,0
183957,the,0,0
183958,region,0,0
183959,anterior,0,0
183960,to,0,0
183961,the,0,0
183962,oval,0,0
183963,window,0,0
183964,",",0,0
183965,and,0,0
183966,this,0,0
183967,site,0,0
183968,was,0,0
183969,reliable,0,0
183970,for,0,0
183971,comparing,0,0
183972,pre-,0,0
183973,and,0,0
183974,posttreatment,0,0
183975,scans,0,0
183976,.,0,0
183977,The,0,0
183978,patients,0,0
183979,in,0,0
183980,the,0,0
183981,alendronate,0,1
183982,and,0,1
183983,sodium,0,1
183984,fluoride,0,1
183985,groups,0,1
183986,had,0,0
183987,MRI,1,0
183988,findings,0,0
183989,that,0,0
183990,suggested,0,0
183991,a,0,0
183992,decrease,0,0
183993,in,0,0
183994,activity,0,0
183995,of,0,0
183996,otospongiotic,0,0
183997,lesions,0,0
183998,",",0,0
183999,more,0,0
184000,relevant,0,0
184001,in,0,0
184002,the,0,0
184003,alendronate,0,1
184004,group,0,1
184005,.,0,0
184006,These,0,0
184007,findings,0,0
184008,were,0,0
184009,statistically,0,0
184010,significant,0,0
184011,for,0,0
184012,both,0,0
184013,subjective,0,0
184014,and,0,0
184015,objective,0,0
184016,MRI,1,1
184017,evaluations,0,0
184018,.,0,0
184019,CONCLUSIONS,0,0
184020,MRI,0,0
184021,shows,0,0
184022,higher,0,0
184023,sensitivity,0,0
184024,than,0,0
184025,clinical,0,0
184026,or,0,0
184027,audiometric,0,0
184028,assessment,0,0
184029,for,0,0
184030,detecting,0,0
184031,reduction,0,0
184032,in,0,0
184033,activity,0,0
184034,of,0,0
184035,otospongiosis,0,0
184036,.,0,0
184037,The,0,0
184038,objective,0,0
184039,MRI,1,0
184040,evaluation,0,0
184041,based,0,0
184042,on,0,0
184043,software,0,0
184044,analysis,0,0
184045,was,0,0
184046,the,0,0
184047,most,0,0
184048,accurate,0,0
184049,method,0,0
184050,of,0,0
184051,monitoring,0,0
184052,clinical,0,0
184053,treatment,0,0
184054,response,0,0
184055,in,0,0
184056,otospongiosis,0,0
184057,.,0,0
184058,Offering,0,0
184059,personalized,1,0
184060,health,1,0
184061,behavior,1,0
184062,feedback,1,0
184063,did,0,0
184064,not,0,0
184065,increase,0,0
184066,response,0,0
184067,rate,0,0
184068,:,0,0
184069,a,0,0
184070,randomized,0,0
184071,controlled,0,0
184072,trial,0,0
184073,.,0,0
184074,Visual,1,0
184075,Assessment,1,0
184076,of,1,0
184077,Relative,1,0
184078,Apical,1,0
184079,Sparing,1,0
184080,Pattern,1,0
184081,Is,0,0
184082,More,0,1
184083,Useful,0,0
184084,Than,0,0
184085,Quantitative,0,0
184086,Assessment,0,0
184087,for,0,0
184088,Diagnosing,0,0
184089,Cardiac,0,0
184090,Amyloidosis,0,0
184091,in,0,0
184092,Borderline,0,0
184093,or,0,0
184094,Mildly,0,0
184095,Increased,0,0
184096,Left,0,0
184097,Ventricular,0,0
184098,Wall,0,1
184099,Thickness,0,0
184100,.,0,0
184101,BACKGROUND,0,0
184102,Relative,1,0
184103,apical,1,0
184104,sparing,1,0
184105,pattern,1,0
184106,of,1,0
184107,longitudinal,1,0
184108,strain,1,0
184109,(,1,1
184110,RapSP-LS,1,1
184111,),1,0
184112,was,0,0
184113,suggested,0,0
184114,in,0,0
184115,advanced,0,0
184116,cardiac,0,1
184117,amyloidosis,0,1
184118,(,0,1
184119,CA,0,1
184120,),0,1
184121,.,0,0
184122,It,0,0
184123,is,0,0
184124,unclear,0,0
184125,whether,0,0
184126,it,0,0
184127,is,0,0
184128,present,0,0
184129,in,0,0
184130,less,0,0
184131,advanced,0,0
184132,CA,0,0
184133,.,0,0
184134,METHODS,0,0
184135,AND,0,0
184136,RESULTS,0,1
184137,Patients,0,0
184138,with,0,0
184139,presumptive,0,0
184140,diagnosis,0,0
184141,of,0,0
184142,CA,0,0
184143,and,0,0
184144,mean,0,0
184145,left,0,0
184146,ventricular,0,0
184147,wall,0,0
184148,thickness,0,1
184149,(,0,1
184150,LVWT,0,1
184151,),0,1
184152,?14,0,0
184153,mm,0,0
184154,were,0,0
184155,recruited,0,0
184156,.,0,0
184157,Apart,0,0
184158,from,1,0
184159,RapSP-LS,1,0
184160,visually,1,0
184161,identified,1,0
184162,",",1,0
184163,relative,1,0
184164,apical,1,0
184165,longitudinal,1,0
184166,strain,1,0
184167,index,1,1
184168,(,1,1
184169,RapLSI,1,1
184170,),1,0
184171,was,1,0
184172,defined,0,0
184173,as,0,0
184174,[,0,0
184175,average,0,0
184176,apical,0,0
184177,LS/,0,0
184178,(,0,0
184179,average,0,0
184180,basal,0,0
184181,LS+average,0,0
184182,mid-ventricle,0,1
184183,LS,0,1
184184,),0,1
184185,],0,0
184186,.,0,0
184187,Among,0,0
184188,119,0,0
184189,patients,0,0
184190,included,0,0
184191,",",0,0
184192,47,0,0
184193,were,0,0
184194,finally,0,0
184195,diagnosed,0,0
184196,with,0,0
184197,CA,0,0
184198,.,1,0
184199,RapLSI,1,0
184200,was,1,0
184201,higher,0,0
184202,in,0,0
184203,the,0,0
184204,CA,0,0
184205,group,0,0
184206,compared,0,0
184207,to,0,0
184208,other,0,0
184209,causes,0,0
184210,of,0,0
184211,increased,0,0
184212,mean,0,0
184213,LVWT,0,0
184214,(,0,0
184215,P,0,0
184216,<,0,0
184217,0.001,0,0
184218,),0,0
184219,",",0,0
184220,but,0,0
184221,with,0,0
184222,a,0,0
184223,significant,0,0
184224,range,0,0
184225,of,0,0
184226,overlap,0,0
184227,noted,0,0
184228,.,0,0
184229,In,0,0
184230,contrast,1,0
184231,",",1,0
184232,RapSP-LS,1,0
184233,visually,1,0
184234,assessed,0,0
184235,was,0,0
184236,noted,0,0
184237,in,0,0
184238,most,0,0
184239,CA,0,0
184240,patients,0,0
184241,(,0,0
184242,31/47,0,0
184243,",",0,0
184244,66.0,0,0
184245,%,0,0
184246,),0,0
184247,except,0,0
184248,in,0,0
184249,those,0,0
184250,with,0,0
184251,preserved,0,0
184252,LV,0,0
184253,ejection,0,0
184254,fraction,0,0
184255,",",0,0
184256,normal,0,0
184257,LVWT,0,0
184258,",",0,0
184259,and,0,0
184260,mildly,0,0
184261,decreased,0,0
184262,global,0,0
184263,LS,0,0
184264,",",0,0
184265,suggesting,0,0
184266,least,0,0
184267,advanced,0,0
184268,CA,0,0
184269,.,0,0
184270,On,0,0
184271,multivariate,0,0
184272,analysis,0,0
184273,of,0,0
184274,the,0,0
184275,added,0,0
184276,diagnostic,0,0
184277,role,0,0
184278,of,0,0
184279,RapSP-LS,1,0
184280,or,1,0
184281,RapLSI,1,0
184282,on,1,0
184283,top,0,0
184284,of,0,0
184285,clinical,0,0
184286,",",0,0
184287,electrocardiographic,0,0
184288,",",0,0
184289,and,0,0
184290,conventional,0,0
184291,echocardiographic,0,0
184292,parameters,0,0
184293,",",0,0
184294,addition,0,0
184295,of,0,0
184296,RapLSI,1,0
184297,produced,1,0
184298,only,0,0
184299,borderline,0,0
184300,increase,0,0
184301,in,0,0
184302,area,0,0
184303,under,0,0
184304,the,0,0
184305,curve,0,0
184306,of,0,0
184307,the,0,0
184308,multivariate,0,0
184309,model,0,0
184310,(,0,0
184311,P=0.05,0,0
184312,),0,0
184313,",",0,0
184314,whereas,0,0
184315,addition,0,0
184316,of,0,0
184317,RapSP-LS,1,0
184318,significantly,1,0
184319,increased,0,0
184320,it,0,0
184321,(,0,0
184322,P,0,0
184323,<,0,0
184324,0.001,0,0
184325,),0,0
184326,.,0,0
184327,CONCLUSIONS,0,0
184328,Visual,0,0
184329,identification,0,0
184330,of,0,0
184331,RapSP-LS,1,0
184332,is,1,0
184333,useful,0,0
184334,in,0,0
184335,terms,0,0
184336,of,0,0
184337,added,0,0
184338,diagnostic,0,0
184339,value,0,0
184340,compared,0,0
184341,with,0,0
184342,quantitative,0,0
184343,calculation,0,0
184344,of,0,0
184345,RapLSI,1,0
184346,.,1,0
184347,Its,0,0
184348,clinical,0,0
184349,application,0,0
184350,",",0,0
184351,however,0,0
184352,",",0,0
184353,should,0,0
184354,be,0,0
184355,used,0,0
184356,with,0,0
184357,caution,0,0
184358,in,0,0
184359,patients,0,0
184360,with,0,0
184361,less,0,0
184362,advanced,0,0
184363,CA,0,0
184364,.,0,0
184365,The,0,0
184366,short-term,0,0
184367,effects,0,0
184368,of,0,0
184369,transcranial,1,0
184370,direct,1,0
184371,current,1,0
184372,stimulation,1,0
184373,on,0,0
184374,electroencephalography,0,0
184375,in,0,0
184376,children,0,0
184377,with,0,0
184378,autism,0,0
184379,:,0,0
184380,a,0,0
184381,randomized,0,0
184382,crossover,0,1
184383,controlled,0,0
184384,trial,0,0
184385,.,0,0
184386,Abnormal,0,0
184387,synaptic,0,0
184388,maturation,0,0
184389,and,0,0
184390,connectivity,0,0
184391,are,0,0
184392,possible,0,0
184393,etiologies,0,0
184394,of,0,0
184395,autism,0,0
184396,.,0,0
184397,Previous,0,0
184398,studies,0,0
184399,showed,0,0
184400,significantly,0,0
184401,less,0,0
184402,alpha,0,0
184403,activity,0,0
184404,in,0,0
184405,autism,0,0
184406,than,0,0
184407,normal,0,0
184408,children,0,0
184409,.,0,0
184410,Therefore,0,0
184411,",",0,0
184412,we,0,0
184413,studied,0,0
184414,the,0,0
184415,effects,0,0
184416,of,0,0
184417,anodal,1,0
184418,tDCS,1,0
184419,on,0,0
184420,peak,0,0
184421,alpha,0,0
184422,frequency,0,0
184423,(,0,0
184424,PAF,0,1
184425,),0,0
184426,related,0,0
184427,to,0,0
184428,autism,0,0
184429,treatment,0,0
184430,evaluation,0,0
184431,checklist,0,1
184432,(,0,1
184433,ATEC,0,1
184434,),0,1
184435,.,0,0
184436,Twenty,0,0
184437,male,0,0
184438,children,0,0
184439,with,0,0
184440,autism,0,0
184441,were,0,0
184442,randomly,0,0
184443,assigned,0,0
184444,in,0,0
184445,a,0,0
184446,crossover,0,1
184447,design,0,1
184448,to,0,0
184449,receive,0,0
184450,a,0,0
184451,single,0,0
184452,session,0,0
184453,of,0,0
184454,both,0,0
184455,active,1,0
184456,and,1,0
184457,sham,1,0
184458,tDCS,1,1
184459,stimulation,1,1
184460,(,0,0
184461,11,0,0
184462,mA,0,1
184463,),0,1
184464,over,0,0
184465,F3,0,1
184466,(,0,0
184467,left,0,1
184468,dorsolateral,0,1
184469,prefrontal,0,1
184470,cortex,0,1
184471,),0,0
184472,.,0,0
184473,Pre-,0,0
184474,to,0,0
184475,postsession,0,0
184476,changes,0,0
184477,in,0,0
184478,a,0,0
184479,measure,0,0
184480,of,0,0
184481,cortical,0,0
184482,activity,0,0
184483,impacted,0,0
184484,by,0,0
184485,tDCS,0,1
184486,(,0,1
184487,PAF,0,1
184488,),0,1
184489,and,0,0
184490,ATEC,0,0
184491,were,0,0
184492,compared,0,0
184493,between,0,0
184494,groups,0,0
184495,.,0,0
184496,We,0,0
184497,also,0,0
184498,examined,0,0
184499,the,0,0
184500,associations,0,0
184501,between,0,0
184502,pre-,0,0
184503,and,0,0
184504,postsession,0,0
184505,changes,0,0
184506,in,0,0
184507,the,0,0
184508,PAF,0,0
184509,and,0,0
184510,ATEC,0,0
184511,.,0,0
184512,The,0,0
184513,results,0,0
184514,show,0,0
184515,significant,0,0
184516,pre-,0,0
184517,to,0,0
184518,postsession,0,0
184519,improvements,0,0
184520,in,0,0
184521,two,0,0
184522,domains,0,0
184523,of,0,0
184524,ATEC,0,1
184525,(,0,0
184526,social,0,0
184527,and,0,0
184528,health/behavior,0,0
184529,domains,0,0
184530,),0,0
184531,following,0,0
184532,active,0,0
184533,tDCS,0,0
184534,",",0,0
184535,relative,0,0
184536,to,0,0
184537,sham,0,0
184538,treatment,0,0
184539,.,0,0
184540,PAF,0,0
184541,also,0,0
184542,significantly,0,0
184543,increased,0,0
184544,at,0,0
184545,the,0,0
184546,stimulation,0,0
184547,site,0,0
184548,",",0,0
184549,and,0,0
184550,an,0,0
184551,increase,0,0
184552,in,0,0
184553,PAF,0,0
184554,was,0,0
184555,significantly,0,0
184556,associated,0,0
184557,with,0,0
184558,improvements,0,0
184559,in,0,0
184560,the,0,0
184561,two,0,0
184562,domains,0,0
184563,of,0,0
184564,ATEC,0,0
184565,impacted,0,0
184566,by,0,0
184567,tDCS,0,0
184568,.,0,0
184569,The,0,0
184570,findings,0,0
184571,suggest,0,0
184572,that,0,0
184573,a,0,0
184574,single,0,0
184575,session,0,0
184576,of,0,0
184577,anodal,1,0
184578,tDCS,1,0
184579,over,0,0
184580,the,0,0
184581,F3,0,0
184582,may,0,0
184583,have,0,0
184584,clinical,0,0
184585,benefits,0,0
184586,in,0,0
184587,children,0,0
184588,with,0,0
184589,autism,0,0
184590,and,0,0
184591,that,0,0
184592,those,0,0
184593,benefits,0,0
184594,may,0,0
184595,be,0,0
184596,related,0,0
184597,to,0,0
184598,an,0,0
184599,increase,0,0
184600,in,0,0
184601,PAF,0,0
184602,.,0,0
184603,A,0,1
184604,randomised,0,0
184605,controlled,0,0
184606,trial,0,0
184607,of,0,0
184608,personalised,1,0
184609,decision,1,0
184610,support,1,0
184611,delivered,0,0
184612,via,0,0
184613,the,0,0
184614,internet,0,0
184615,for,0,0
184616,bowel,0,0
184617,cancer,0,0
184618,screening,0,0
184619,with,0,0
184620,a,0,0
184621,faecal,0,0
184622,occult,0,0
184623,blood,0,0
184624,test,0,0
184625,:,0,0
184626,the,0,0
184627,effects,0,0
184628,of,0,0
184629,tailoring,0,0
184630,of,0,0
184631,messages,0,0
184632,according,0,0
184633,to,0,0
184634,social,0,0
184635,cognitive,0,0
184636,variables,0,0
184637,on,0,0
184638,participation,0,0
184639,.,0,0
184640,BACKGROUND,0,0
184641,In,0,0
184642,Australia,0,0
184643,",",0,0
184644,bowel,0,0
184645,cancer,0,0
184646,screening,0,0
184647,participation,0,0
184648,using,0,0
184649,faecal,0,0
184650,occult,0,0
184651,blood,0,1
184652,testing,0,0
184653,(,0,1
184654,FOBT,0,1
184655,),0,0
184656,is,0,0
184657,low,0,0
184658,.,0,0
184659,Decision,0,0
184660,support,0,0
184661,tailored,0,0
184662,to,0,0
184663,psychological,0,0
184664,predictors,0,0
184665,of,0,0
184666,participation,0,0
184667,may,0,0
184668,increase,0,0
184669,screening,0,0
184670,.,0,0
184671,The,0,0
184672,study,0,0
184673,compared,0,0
184674,tailored,1,0
184675,computerised,1,0
184676,decision,1,0
184677,support,1,0
184678,to,0,0
184679,non-tailored,0,0
184680,computer,0,0
184681,or,0,0
184682,paper,0,0
184683,information,0,0
184684,.,0,0
184685,The,0,0
184686,primary,0,0
184687,outcome,0,0
184688,was,0,0
184689,FOBT,0,0
184690,return,0,0
184691,within,0,0
184692,12,0,0
184693,weeks,0,0
184694,.,0,0
184695,Additional,0,0
184696,analyses,0,0
184697,were,0,0
184698,conducted,0,0
184699,on,0,0
184700,movement,0,0
184701,in,0,0
184702,decision,0,0
184703,to,0,0
184704,screen,0,0
184705,and,0,0
184706,change,0,0
184707,on,0,0
184708,psychological,0,0
184709,variables,0,0
184710,.,0,0
184711,METHODS,0,0
184712,A,0,0
184713,parallel,0,0
184714,",",0,0
184715,randomised,0,0
184716,controlled,0,0
184717,",",0,0
184718,trial,0,0
184719,invited,0,0
184720,"25,511",0,0
184721,people,0,0
184722,aged,0,0
184723,50-74,0,0
184724,years,0,0
184725,to,0,0
184726,complete,0,0
184727,an,0,0
184728,eligibility,0,0
184729,questionnaire,0,0
184730,.,0,0
184731,Eligible,0,0
184732,respondents,0,1
184733,(,0,0
184734,n,0,0
184735,=,0,0
184736,"3,408",0,0
184737,),0,0
184738,were,0,0
184739,assigned,1,0
184740,to,1,0
184741,Tailored,1,0
184742,Personalised,1,0
184743,Decision,1,1
184744,Support,1,1
184745,(,1,1
184746,TPDS,1,1
184747,),1,1
184748,",",1,0
184749,Non-Tailored,1,1
184750,PDS,1,1
184751,(,1,1
184752,NTPDS,1,1
184753,),1,1
184754,",",1,0
184755,or,1,0
184756,Control,1,0
184757,(,1,1
184758,CG,1,1
184759,),1,1
184760,(,0,1
184761,intention-to-treat,0,1
184762,",",0,0
184763,ITT,0,1
184764,sample,1,0
184765,),1,0
184766,.,1,0
184767,TPDS,1,0
184768,and,1,0
184769,NTPDS,1,1
184770,groups,1,0
184771,completed,1,0
184772,an,1,0
184773,on-line,1,1
184774,baseline,1,1
184775,survey,1,1
184776,(,1,1
184777,BS,1,1
184778,),1,1
184779,and,0,0
184780,accessed,0,0
184781,generic,0,0
184782,information,0,0
184783,.,0,0
184784,The,0,0
184785,TPDS,1,0
184786,group,0,0
184787,additionally,0,0
184788,received,1,0
184789,a,1,0
184790,tailored,1,0
184791,intervention,1,0
184792,.,1,0
184793,CG,1,0
184794,participants,0,0
184795,completed,0,0
184796,a,0,0
184797,paper,0,0
184798,BS,0,0
184799,only,0,0
184800,.,0,0
184801,Those,0,0
184802,completing,0,0
184803,the,0,0
184804,BS,0,1
184805,(,0,0
184806,n,0,0
184807,=,0,0
184808,2270,0,0
184809,),0,0
184810,were,0,0
184811,mailed,0,0
184812,an,0,0
184813,FOBT,0,0
184814,and,0,0
184815,requested,0,0
184816,to,0,0
184817,complete,0,0
184818,an,0,0
184819,endpoint,0,0
184820,survey,0,1
184821,(,0,1
184822,ES,0,1
184823,),0,1
184824,that,0,0
184825,re-measured,0,0
184826,BS,0,1
184827,variables,0,1
184828,(,0,0
184829,per-protocol,0,0
184830,",",0,0
184831,PP,0,1
184832,sample,0,0
184833,),0,0
184834,.,0,0
184835,RESULTS,0,1
184836,FOBT,0,1
184837,return,0,0
184838,:,0,0
184839,In,0,0
184840,the,0,0
184841,ITT,0,0
184842,sample,0,0
184843,",",0,0
184844,there,0,0
184845,was,0,0
184846,no,0,0
184847,significant,0,0
184848,difference,0,0
184849,between,0,0
184850,any,0,0
184851,group,0,0
184852,(,0,0
184853,?,0,1
184854,(,0,1
184855,2,0,1
184856,),0,1
184857,(,0,1
184858,2,0,0
184859,),0,0
184860,=,0,0
184861,2.57,0,0
184862,",",0,0
184863,p,0,0
184864,=,0,0
184865,.26,0,0
184866,;,0,0
184867,TPDS,0,0
184868,",",0,0
184869,32.5,0,0
184870,%,0,0
184871,;,0,0
184872,NTPDS,0,0
184873,",",0,0
184874,33,0,0
184875,%,0,0
184876,;,0,0
184877,and,0,0
184878,CG,0,0
184879,",",0,0
184880,34.5,0,0
184881,%,0,0
184882,),0,0
184883,.,0,0
184884,In,0,0
184885,the,0,0
184886,PP,0,0
184887,sample,0,0
184888,",",0,0
184889,FOBT,0,0
184890,return,0,0
184891,in,0,0
184892,the,0,0
184893,internet,0,0
184894,groups,0,0
184895,was,0,0
184896,significantly,0,0
184897,higher,0,0
184898,than,0,0
184899,the,0,0
184900,paper,0,0
184901,group,0,0
184902,(,0,0
184903,?,0,1
184904,(,0,1
184905,2,0,1
184906,),0,1
184907,(,0,1
184908,2,0,0
184909,),0,0
184910,=,0,0
184911,17.01,0,0
184912,",",0,0
184913,p,0,0
184914,<,0,0
184915,.001,0,0
184916,;,0,0
184917,TPDS,0,0
184918,",",0,0
184919,80,0,0
184920,%,0,0
184921,;,0,0
184922,NTPDS,0,0
184923,",",0,0
184924,83,0,0
184925,%,0,0
184926,;,0,0
184927,and,0,0
184928,CG,0,0
184929,",",0,0
184930,74,0,0
184931,%,0,0
184932,),0,0
184933,.,0,0
184934,FOBT,0,0
184935,completion,0,0
184936,by,1,0
184937,TPDS,1,0
184938,and,1,0
184939,NTPDS,1,0
184940,did,1,0
184941,not,1,0
184942,differ,0,0
184943,(,0,0
184944,?,0,1
184945,(,0,1
184946,2,0,1
184947,),0,1
184948,(,0,1
184949,1,0,0
184950,),0,0
184951,=,0,0
184952,2.23,0,0
184953,",",0,0
184954,p,0,0
184955,=,0,0
184956,.13,0,0
184957,),0,0
184958,.,0,0
184959,Age,0,0
184960,was,0,0
184961,positively,0,0
184962,associated,0,0
184963,with,0,0
184964,kit,0,0
184965,return,0,0
184966,.,0,0
184967,Decision,0,0
184968,to,0,0
184969,screen,0,0
184970,:,0,0
184971,2227/2270,0,0
184972,of,0,0
184973,the,0,0
184974,PP,0,0
184975,sample,0,0
184976,provided,0,0
184977,complete,0,0
184978,BS,0,0
184979,data,0,0
184980,.,0,0
184981,Participants,0,0
184982,not,0,0
184983,wanting,0,0
184984,to,0,0
184985,screen,0,0
184986,at,0,0
184987,baseline,0,0
184988,(,0,0
184989,1083/2227,0,0
184990,),0,0
184991,and,0,0
184992,allocated,0,0
184993,to,0,0
184994,TPDS,0,0
184995,and,0,0
184996,NTPDS,0,0
184997,were,0,0
184998,significantly,0,0
184999,more,0,0
185000,likely,0,0
185001,to,0,0
185002,decide,0,0
185003,to,0,0
185004,screen,0,0
185005,and,0,0
185006,return,0,0
185007,an,0,0
185008,FOBT,0,0
185009,than,0,0
185010,those,0,0
185011,assigned,0,0
185012,to,0,0
185013,the,0,0
185014,CG,0,0
185015,.,0,0
185016,FOBT,0,0
185017,return,1,0
185018,by,1,0
185019,TPDS,1,0
185020,and,1,0
185021,NTPDS,1,0
185022,did,1,0
185023,not,0,0
185024,differ,0,0
185025,from,0,0
185026,one,0,0
185027,another,0,0
185028,(,0,0
185029,OR,0,0
185030,=,0,0
185031,1.16,0,0
185032,",",0,0
185033,p,0,0
185034,=,0,0
185035,.42,0,0
185036,),0,0
185037,.,0,0
185038,Change,0,0
185039,on,0,0
185040,psychosocial,0,0
185041,predictors,0,0
185042,:,0,0
185043,Analysis,0,0
185044,of,0,0
185045,change,0,0
185046,indicated,0,0
185047,that,0,0
185048,salience,0,0
185049,and,0,0
185050,coherence,0,0
185051,of,0,0
185052,screening,0,0
185053,and,0,0
185054,self-efficacy,0,0
185055,were,0,0
185056,improved,0,0
185057,and,0,0
185058,faecal,0,0
185059,aversion,0,0
185060,decreased,0,0
185061,by,0,0
185062,tailored,0,0
185063,messaging,0,0
185064,.,0,0
185065,CONCLUSIONS,0,0
185066,Online,1,0
185067,information,1,0
185068,resources,1,0
185069,may,1,0
185070,have,0,0
185071,a,0,0
185072,role,0,0
185073,in,0,0
185074,encouraging,0,0
185075,internet-enabled,0,0
185076,people,0,0
185077,who,0,0
185078,are,0,0
185079,uncommitted,0,0
185080,to,0,0
185081,screening,0,0
185082,to,0,0
185083,change,0,0
185084,their,0,0
185085,attitudes,0,0
185086,",",0,0
185087,perceptions,0,0
185088,and,0,0
185089,behaviour,0,0
185090,.,0,0
185091,TRIAL,0,0
185092,REGISTRATION,0,1
185093,Australian,0,1
185094,New,0,1
185095,Zealand,0,1
185096,Clinical,0,1
185097,Trials,0,0
185098,Registry,0,0
185099,ACTRN12610000095066,0,0
185100,.,0,0
185101,Icosapent,1,1
185102,Ethyl,1,1
185103,(,1,1
185104,Eicosapentaenoic,1,1
185105,Acid,1,1
185106,Ethyl,1,1
185107,Ester,1,1
185108,),1,0
185109,:,1,0
185110,Effects,0,0
185111,Upon,0,0
185112,High-Sensitivity,0,0
185113,C-Reactive,0,0
185114,Protein,0,0
185115,and,0,0
185116,Lipid,0,0
185117,Parameters,0,0
185118,in,0,0
185119,Patients,0,0
185120,With,0,0
185121,Metabolic,0,1
185122,Syndrome,0,1
185123,.,0,0
185124,BACKGROUND,0,0
185125,The,0,0
185126,aim,0,0
185127,of,0,0
185128,this,0,0
185129,analysis,0,0
185130,was,0,0
185131,to,0,0
185132,examine,0,0
185133,the,0,0
185134,effects,0,0
185135,of,0,0
185136,icosapent,1,1
185137,ethyl,1,1
185138,(,1,1
185139,eicosapentaenoic,1,1
185140,acid,1,1
185141,ethyl,1,1
185142,ester,1,1
185143,",",1,1
185144,IPE,1,1
185145,),1,1
185146,on,0,0
185147,high-sensitivity,0,0
185148,C-reactive,0,0
185149,protein,0,0
185150,(,0,0
185151,hsCRP,0,1
185152,),0,1
185153,and,0,0
185154,lipid,0,0
185155,parameters,0,0
185156,in,0,0
185157,patients,0,0
185158,with,0,0
185159,metabolic,0,0
185160,syndrome,0,0
185161,",",0,0
185162,with,0,0
185163,and,0,0
185164,without,0,0
185165,stable,0,0
185166,statin,0,1
185167,therapy,0,1
185168,.,0,0
185169,METHODS,0,0
185170,This,0,0
185171,post,0,0
185172,hoc,0,0
185173,exploratory,0,0
185174,analysis,0,0
185175,evaluated,0,0
185176,patients,0,0
185177,with,0,0
185178,metabolic,0,0
185179,syndrome,0,0
185180,treated,0,0
185181,with,0,0
185182,IPE,1,0
185183,4,0,1
185184,grams/day,0,1
185185,",",0,1
185186,IPE,0,1
185187,2,0,1
185188,grams/day,0,1
185189,",",0,1
185190,or,0,1
185191,placebo,1,1
185192,in,0,0
185193,phase,0,0
185194,3,0,0
185195,",",0,0
185196,randomized,0,1
185197,",",0,0
185198,placebo-controlled,0,1
185199,studies,0,0
185200,entitled,0,0
185201,:,0,0
185202,MARINE,0,1
185203,[,0,1
185204,triglyceride,0,1
185205,(,0,1
185206,TG,0,1
185207,),0,1
185208,levels,0,0
185209,?500,0,1
185210,and,0,0
185211,?2000,0,1
185212,mg/dL,0,1
185213,],0,1
185214,and,0,1
185215,ANCHOR,0,1
185216,[,0,1
185217,TG,0,0
185218,levels,0,0
185219,?200,0,0
185220,and,0,0
185221,<,0,0
185222,500,0,0
185223,mg/dL,0,0
185224,",",0,1
185225,despite,0,0
185226,low-density,0,1
185227,lipoprotein,0,1
185228,cholesterol,0,1
185229,(,0,1
185230,LDL-C,0,1
185231,),0,0
185232,control,0,0
185233,with,0,0
185234,stable,0,0
185235,statin,0,1
185236,therapy,0,1
185237,],0,1
185238,.,0,0
185239,RESULTS,0,0
185240,Compared,0,0
185241,with,1,0
185242,placebo,1,1
185243,in,1,0
185244,patients,0,0
185245,with,0,0
185246,metabolic,0,0
185247,syndrome,0,0
185248,in,0,0
185249,MARINE,0,0
185250,(,0,0
185251,n=204,0,0
185252,),0,0
185253,and,0,0
185254,ANCHOR,0,1
185255,(,0,0
185256,n=645,0,0
185257,),0,0
185258,",",0,0
185259,at,0,0
185260,the,0,0
185261,approved,0,0
185262,dose,0,1
185263,of,0,1
185264,4,0,1
185265,grams/day,0,1
185266,",",0,1
185267,IPE,0,1
185268,significantly,0,0
185269,lowered,0,0
185270,hsCRP,0,0
185271,levels,0,0
185272,40.0,0,0
185273,%,0,0
185274,(,0,0
185275,P=0.0007,0,0
185276,),0,0
185277,in,0,0
185278,MARINE,0,0
185279,and,0,0
185280,23.0,0,0
185281,%,0,0
185282,(,0,0
185283,P=0.0003,0,0
185284,),0,0
185285,in,0,0
185286,ANCHOR,0,0
185287,.,0,0
185288,Compared,0,0
185289,with,1,0
185290,placebo,1,1
185291,in,1,0
185292,MARINE,0,1
185293,",",0,0
185294,which,0,0
185295,included,0,0
185296,patients,0,0
185297,with,0,0
185298,and,0,0
185299,without,0,0
185300,statin,0,1
185301,therapy,1,1
185302,",",1,1
185303,IPE,1,1
185304,4,1,1
185305,grams/day,1,1
185306,significantly,0,0
185307,reduced,0,0
185308,hsCRP,0,0
185309,levels,0,0
185310,78.0,0,0
185311,%,0,0
185312,in,0,0
185313,statin-treated,0,0
185314,patients,0,0
185315,(,0,0
185316,P=0.0035,0,0
185317,",",0,0
185318,n=16,0,0
185319,),0,0
185320,.,0,0
185321,Compared,0,0
185322,with,1,0
185323,placebo,1,1
185324,in,1,0
185325,MARINE,0,1
185326,",",0,0
185327,IPE,0,1
185328,4,0,1
185329,grams/day,0,1
185330,significantly,0,0
185331,reduced,0,0
185332,TG,0,0
185333,levels,0,0
185334,(,0,0
185335,35.0,0,0
185336,%,0,0
185337,;,0,0
185338,P,0,0
185339,<,0,0
185340,0.0001,0,0
185341,),0,0
185342,",",0,0
185343,non-high-density,0,1
185344,lipoprotein,0,1
185345,cholesterol,0,1
185346,(,0,1
185347,non-HDL-C,0,1
185348,;,0,0
185349,19.9,0,0
185350,%,0,0
185351,;,0,0
185352,P,0,0
185353,<,0,0
185354,0.0001,0,0
185355,),0,0
185356,",",0,0
185357,and,0,1
185358,apolipoprotein,0,1
185359,B,0,1
185360,levels,0,1
185361,(,0,1
185362,ApoB,0,1
185363,),0,1
185364,(,0,0
185365,9.1,0,0
185366,%,0,0
185367,;,0,0
185368,P=0.0015,0,0
185369,),0,0
185370,without,0,0
185371,raising,0,0
185372,LDL-C,0,0
185373,levels,0,0
185374,.,0,0
185375,Compared,0,0
185376,with,0,0
185377,placebo,0,1
185378,in,0,0
185379,ANCHOR,0,1
185380,",",0,0
185381,IPE,1,1
185382,4,1,1
185383,grams/day,1,1
185384,significantly,0,0
185385,reduced,0,0
185386,TG,0,0
185387,(,0,0
185388,21.7,0,0
185389,%,0,0
185390,;,0,0
185391,P,0,0
185392,<,0,0
185393,0.0001,0,0
185394,),0,0
185395,",",0,0
185396,non-HDL-C,0,1
185397,(,0,0
185398,13.5,0,0
185399,%,0,0
185400,;,0,0
185401,P,0,0
185402,<,0,0
185403,0.0001,0,0
185404,),0,0
185405,",",0,0
185406,ApoB,0,1
185407,(,0,0
185408,8.8,0,0
185409,%,0,0
185410,;,0,0
185411,P,0,0
185412,<,0,0
185413,0.0001,0,0
185414,),0,0
185415,",",0,0
185416,LDL-C,0,1
185417,(,0,0
185418,5.2,0,0
185419,%,0,0
185420,;,0,0
185421,P=0.0236,0,0
185422,),0,1
185423,",",0,0
185424,and,0,0
185425,HDL-C,0,1
185426,levels,0,0
185427,(,0,0
185428,4.0,0,0
185429,%,0,0
185430,;,0,0
185431,P=0.0053,0,0
185432,),0,0
185433,.,0,0
185434,CONCLUSIONS,0,0
185435,Compared,0,0
185436,with,0,0
185437,placebo,0,1
185438,",",0,1
185439,IPE,0,1
185440,4,0,1
185441,grams/day,0,1
185442,significantly,0,0
185443,lowered,0,0
185444,hsCRP,0,0
185445,levels,0,0
185446,and,0,0
185447,improved,0,0
185448,lipids,0,0
185449,without,0,0
185450,raising,0,0
185451,LDL-C,0,0
185452,levels,0,0
185453,in,0,0
185454,patients,0,0
185455,with,0,0
185456,metabolic,0,0
185457,syndrome,0,0
185458,and,0,0
185459,high,0,0
185460,(,0,0
185461,?200,0,0
185462,and,0,0
185463,<,0,0
185464,500,0,0
185465,mg/dL,0,1
185466,),0,1
185467,or,0,0
185468,very,0,0
185469,high,0,0
185470,(,0,0
185471,?500,0,1
185472,and,0,1
185473,?2000,0,1
185474,mg/dL,0,1
185475,),0,1
185476,TG,0,1
185477,levels,0,0
185478,",",0,0
185479,with,0,0
185480,or,0,0
185481,without,0,0
185482,stable,0,0
185483,statin,0,1
185484,therapy,0,1
185485,.,0,0
185486,The,0,0
185487,impact,0,0
185488,of,0,0
185489,amalgam,1,0
185490,dental,1,0
185491,fillings,1,0
185492,on,0,0
185493,the,0,0
185494,frequency,0,0
185495,of,0,0
185496,Helicobacter,0,1
185497,pylori,0,1
185498,infection,0,1
185499,and,0,0
185500,H.,0,1
185501,pylori,0,1
185502,eradication,0,0
185503,rates,0,0
185504,in,0,0
185505,patients,0,0
185506,treated,0,0
185507,with,0,0
185508,concomitant,1,0
185509,",",1,0
185510,quadruple,1,0
185511,",",1,0
185512,and,1,0
185513,levofloxacin-based,1,1
185514,therapies,1,1
185515,.,1,0
185516,BACKGROUND,0,0
185517,AND,0,1
185518,AIM,0,1
185519,Mercury,0,0
185520,exposure,0,0
185521,is,0,0
185522,encountered,0,0
185523,most,0,0
185524,commonly,0,0
185525,in,0,0
185526,individuals,0,0
185527,with,0,0
185528,amalgam,1,0
185529,fillings,1,0
185530,.,1,0
185531,The,0,0
185532,toxic,0,0
185533,",",0,0
185534,bactericidal,0,1
185535,",",0,1
185536,and,0,1
185537,immunosuppressive,0,1
185538,effects,0,0
185539,of,0,0
185540,mercury,0,1
185541,are,0,0
185542,well,0,0
185543,known,0,0
185544,.,0,0
185545,Furthermore,0,0
185546,",",0,0
185547,multiple,0,0
185548,antibiotic,0,1
185549,resistance,0,0
185550,can,0,0
185551,be,0,0
185552,transferred,0,0
185553,",",0,0
185554,together,0,0
185555,with,0,0
185556,mercury,0,0
185557,resistance,0,0
185558,.,0,0
185559,The,0,0
185560,aim,0,0
185561,of,0,0
185562,this,0,0
185563,study,0,0
185564,was,0,0
185565,to,0,0
185566,investigate,0,0
185567,the,0,0
185568,frequency,0,0
185569,of,0,0
185570,Helicobacter,0,1
185571,pylori,0,1
185572,infection,0,1
185573,in,0,0
185574,dyspeptic,0,0
185575,patients,0,0
185576,with,0,0
185577,amalgam,0,0
185578,fillings,0,0
185579,and,0,0
185580,the,0,0
185581,effect,0,0
185582,of,0,0
185583,the,0,0
185584,amalgam,0,0
185585,fillings,0,0
185586,on,0,0
185587,H.,0,0
185588,pylori,0,0
185589,eradication,0,0
185590,rates,0,0
185591,in,0,0
185592,these,0,0
185593,patients,0,0
185594,.,0,0
185595,PATIENTS,0,0
185596,AND,0,1
185597,METHODS,0,0
185598,Four,0,0
185599,hundred,0,0
185600,and,0,0
185601,seventy-five,0,0
185602,patients,0,0
185603,who,0,0
185604,presented,0,0
185605,with,0,0
185606,dyspeptic,0,0
185607,complaints,0,0
185608,and,0,0
185609,underwent,0,0
185610,upper,0,0
185611,gastrointestinal,0,0
185612,endoscopy,0,0
185613,and,0,0
185614,gastric,0,0
185615,biopsy,0,0
185616,were,0,0
185617,included,0,0
185618,in,0,0
185619,this,0,0
185620,study,0,0
185621,.,0,0
185622,One,0,0
185623,hundred,0,0
185624,and,0,0
185625,sixty-nine,0,0
185626,(,0,0
185627,35.6,0,0
185628,%,0,0
185629,),0,0
185630,patients,0,0
185631,were,0,0
185632,negative,0,0
185633,and,0,0
185634,306,0,0
185635,(,0,0
185636,64.4,0,0
185637,%,0,0
185638,),0,0
185639,patients,0,0
185640,were,0,0
185641,positive,0,0
185642,for,0,0
185643,H.,0,0
185644,pylori,0,0
185645,.,0,0
185646,All,0,0
185647,of,0,0
185648,the,0,0
185649,participants,0,0
185650,underwent,0,0
185651,dental,0,0
185652,examinations,0,0
185653,in,0,0
185654,a,0,0
185655,blinded,0,0
185656,manner,0,0
185657,.,0,0
185658,The,0,0
185659,participants,0,0
185660,were,0,0
185661,divided,0,0
185662,into,0,0
185663,two,0,0
185664,groups,0,0
185665,on,0,0
185666,the,0,0
185667,basis,0,0
185668,of,0,0
185669,the,0,0
185670,presence,0,0
185671,of,0,0
185672,amalgam,0,0
185673,fillings,0,0
185674,.,0,0
185675,The,0,0
185676,H.,0,0
185677,pylori-positive,0,0
185678,patients,0,0
185679,were,0,0
185680,divided,0,0
185681,randomly,0,0
185682,into,0,0
185683,three,0,0
185684,subgroups,0,0
185685,:,0,0
185686,patients,0,0
185687,who,0,0
185688,received,0,0
185689,concomitant,1,0
185690,therapy,1,1
185691,(,1,1
185692,CT,1,1
185693,),1,1
185694,(,1,1
185695,rabeprazole-amoxicillin-clarithromycin-metronidazole,1,1
185696,for,0,1
185697,14,0,1
185698,days,0,0
185699,;,0,0
185700,n=122,0,0
185701,),0,0
185702,;,0,0
185703,patients,0,0
185704,who,0,0
185705,received,0,0
185706,quadruple,1,0
185707,therapy,1,1
185708,(,1,1
185709,QT,1,1
185710,),1,1
185711,(,1,1
185712,rabeprazole-tetracycline-metronidazole-colloidal,1,1
185713,bismuth,1,1
185714,subcitrate,1,1
185715,for,0,1
185716,10,0,1
185717,days,0,0
185718,;,0,0
185719,n=97,0,0
185720,),0,0
185721,;,0,0
185722,and,0,0
185723,patients,0,0
185724,who,0,0
185725,received,0,0
185726,levofloxacin-based,1,1
185727,therapy,1,1
185728,(,1,1
185729,LT,1,1
185730,),1,1
185731,(,1,1
185732,rabeprazole-amoxicillin-levofloxacin,1,1
185733,for,0,1
185734,10,0,1
185735,days,0,0
185736,;,0,0
185737,n=87,0,0
185738,),0,0
185739,.,0,0
185740,Eradication,0,0
185741,success,0,0
185742,was,0,0
185743,detected,0,0
185744,by,0,0
185745,a,0,0
185746,urea,0,1
185747,breath,0,1
185748,test,0,0
185749,6,0,0
185750,weeks,0,0
185751,after,0,0
185752,the,0,0
185753,end,0,0
185754,of,0,0
185755,treatment,0,0
185756,.,0,0
185757,RESULTS,0,0
185758,The,0,0
185759,frequency,0,0
185760,of,0,0
185761,H.,0,0
185762,pylori,0,0
185763,infection,0,0
185764,was,0,0
185765,significantly,0,0
185766,lower,0,0
185767,in,0,0
185768,the,0,0
185769,filling,1,0
185770,group,0,0
185771,compared,0,0
185772,with,0,0
185773,the,0,0
185774,nonfilling,0,0
185775,group,0,0
185776,(,0,0
185777,53.7,0,0
185778,and,0,0
185779,78.8,0,0
185780,%,0,0
185781,",",0,0
185782,respectively,0,0
185783,;,0,0
185784,P,0,0
185785,<,0,0
185786,0.001,0,0
185787,),0,0
185788,.,0,0
185789,The,0,0
185790,eradication,0,0
185791,rates,0,0
185792,in,0,0
185793,the,0,0
185794,CT,1,0
185795,",",1,0
185796,QT,1,0
185797,",",1,0
185798,and,1,0
185799,LT,1,0
185800,groups,0,0
185801,were,0,0
185802,65.5,0,0
185803,",",0,0
185804,67.0,0,0
185805,",",0,0
185806,and,0,0
185807,58.6,0,0
185808,%,0,0
185809,",",0,0
185810,respectively,0,0
185811,",",0,0
185812,in,0,0
185813,the,0,0
185814,intention-to-treat,0,0
185815,(,0,1
185816,ITT,0,1
185817,),0,0
185818,analysis,0,0
185819,and,0,0
185820,69.6,0,0
185821,",",0,0
185822,70.7,0,0
185823,",",0,0
185824,and,0,0
185825,62.2,0,0
185826,%,0,0
185827,",",0,0
185828,respectively,0,0
185829,",",0,0
185830,in,0,0
185831,the,0,0
185832,per-protocol,0,0
185833,(,0,1
185834,PP,0,1
185835,),0,0
185836,analysis,0,0
185837,.,0,0
185838,In,0,0
185839,all,0,0
185840,of,0,0
185841,the,0,0
185842,H.,0,0
185843,pylori-positive,0,1
185844,patients,0,0
185845,and,0,0
185846,separately,0,0
185847,in,0,0
185848,the,0,0
185849,CT,1,0
185850,and,0,0
185851,LT,1,1
185852,groups,0,0
185853,",",0,0
185854,the,0,0
185855,eradication,0,0
185856,rates,0,0
185857,were,0,0
185858,significantly,0,0
185859,lower,0,0
185860,in,0,0
185861,the,0,0
185862,filling,1,0
185863,group,0,0
185864,compared,0,0
185865,with,0,0
185866,the,0,0
185867,nonfilling,1,0
185868,group,0,0
185869,.,0,0
185870,However,0,0
185871,",",0,0
185872,in,0,0
185873,the,0,0
185874,QT,1,0
185875,group,0,0
185876,",",0,0
185877,there,0,0
185878,was,0,0
185879,no,0,0
185880,significant,0,0
185881,difference,0,0
185882,between,0,0
185883,the,0,0
185884,patients,0,0
185885,with,0,0
185886,and,0,0
185887,without,0,0
185888,fillings,0,0
185889,(,0,0
185890,P=0.001,0,0
185891,",",0,0
185892,0.003,0,0
185893,",",0,0
185894,0.012,0,0
185895,",",0,0
185896,0.14,0,0
185897,",",0,0
185898,respectively,0,0
185899,),0,0
185900,.,0,0
185901,Logistic,0,0
185902,regression,0,0
185903,analysis,0,0
185904,showed,0,0
185905,that,0,0
185906,the,0,0
185907,absence,0,0
185908,of,0,0
185909,amalgam,0,0
185910,filling,0,0
185911,exerts,0,0
185912,independent,0,0
185913,effects,0,0
185914,on,0,0
185915,the,0,0
185916,increased,0,0
185917,frequency,0,0
185918,of,0,0
185919,H.,0,0
185920,pylori,0,0
185921,infection,0,0
185922,and,0,0
185923,increased,0,0
185924,rate,0,0
185925,of,0,0
185926,H.,0,0
185927,pylori,0,0
185928,eradication,0,0
185929,.,0,0
185930,CONCLUSION,0,0
185931,This,0,0
185932,is,0,0
185933,the,0,0
185934,first,0,0
185935,study,0,0
185936,to,0,0
185937,show,0,0
185938,a,0,0
185939,lower,0,0
185940,frequency,0,0
185941,of,0,0
185942,H.,0,0
185943,pylori,0,0
185944,colonization,0,0
185945,in,0,0
185946,patients,0,0
185947,with,0,0
185948,amalgam,1,0
185949,fillings,1,0
185950,than,0,0
185951,without,0,0
185952,and,0,0
185953,that,0,0
185954,H.,0,1
185955,pylori,0,0
185956,eradication,0,0
185957,rates,0,0
185958,are,0,0
185959,lower,0,0
185960,in,0,0
185961,patients,0,0
185962,with,0,0
185963,amalgam,1,0
185964,fillings,1,0
185965,compared,0,0
185966,to,0,0
185967,those,0,0
185968,without,0,0
185969,.,0,0
185970,Effect,0,0
185971,of,0,0
185972,motor,1,0
185973,training,1,0
185974,involving,0,0
185975,the,0,0
185976,less-affected,0,0
185977,side,0,0
185978,(,0,1
185979,MTLA,0,1
185980,),0,1
185981,in,0,0
185982,post-stroke,0,0
185983,subjects,0,0
185984,:,0,0
185985,a,0,0
185986,pilot,0,0
185987,randomized,0,0
185988,controlled,0,0
185989,trial,0,0
185990,.,0,0
185991,INTRODUCTION,0,0
185992,Poststroke,0,0
185993,",",0,0
185994,less-severe,0,0
185995,motor,0,0
185996,impairment,0,0
185997,occurs,0,0
185998,on,0,0
185999,the,0,0
186000,ipsilesional,0,0
186001,side,0,0
186002,of,0,0
186003,body,0,0
186004,.,0,0
186005,The,0,0
186006,objective,0,0
186007,of,0,0
186008,the,0,0
186009,present,0,0
186010,study,0,0
186011,was,0,0
186012,to,0,0
186013,evaluate,0,0
186014,the,0,0
186015,effectiveness,0,0
186016,of,0,0
186017,the,0,0
186018,motor,1,0
186019,training,1,0
186020,involving,0,0
186021,the,0,0
186022,less-affected,0,0
186023,side,0,0
186024,(,0,1
186025,MTLA,0,1
186026,),0,1
186027,in,0,0
186028,stroke,0,0
186029,.,0,0
186030,METHODS,0,0
186031,This,0,0
186032,was,0,0
186033,a,0,0
186034,randomized,0,0
186035,",",0,0
186036,controlled,0,0
186037,",",0,0
186038,double-blinded,0,1
186039,pilot,0,1
186040,study,0,0
186041,conducted,0,0
186042,in,0,0
186043,the,0,0
186044,occupational,0,0
186045,therapy,0,0
186046,unit,0,0
186047,of,0,0
186048,a,0,0
186049,rehabilitation,0,0
186050,Institute,0,0
186051,.,0,0
186052,A,0,0
186053,convenience,0,0
186054,sample,0,0
186055,of,0,0
186056,35,0,0
186057,stroke,0,0
186058,subjects,0,0
186059,(,0,0
186060,mean,0,0
186061,poststroke,0,0
186062,duration,0,0
186063,",",0,0
186064,28.76,0,0
186065,weeks,0,0
186066,),0,0
186067,was,0,0
186068,randomized,0,0
186069,into,0,0
186070,two,0,0
186071,groups,0,0
186072,(,0,0
186073,the,0,0
186074,experimental,0,0
186075,group,0,0
186076,:,0,0
186077,17,0,0
186078,and,0,0
186079,control,0,0
186080,group,0,0
186081,:,0,0
186082,18,0,0
186083,),0,0
186084,.,0,0
186085,Thirty-two,0,0
186086,participants,0,0
186087,completed,0,0
186088,the,0,0
186089,entire,0,0
186090,study,0,0
186091,protocol,0,0
186092,.,0,0
186093,The,0,0
186094,experimental,0,0
186095,group,0,0
186096,and,0,0
186097,control,0,0
186098,group,0,0
186099,were,0,0
186100,provided,0,0
186101,MTLA,1,0
186102,and,1,0
186103,neurophysiological-based,1,0
186104,conventional,1,0
186105,therapy,1,0
186106,respectively,1,0
186107,.,1,0
186108,Both,0,0
186109,the,0,0
186110,groups,0,0
186111,received,0,0
186112,24,0,0
186113,treatment,0,0
186114,sessions,0,1
186115,(,0,0
186116,60,0,0
186117,minutes,0,0
186118,each,0,0
186119,),0,0
186120,over,0,0
186121,the,0,0
186122,period,0,0
186123,of,0,0
186124,two,0,0
186125,months,0,0
186126,.,0,0
186127,The,0,0
186128,Affected,0,0
186129,side,0,0
186130,was,0,0
186131,assessed,0,0
186132,using,0,0
186133,Brunnstrom,0,0
186134,recovery,0,0
186135,stage,0,0
186136,(,0,0
186137,BRS,0,1
186138,),0,1
186139,and,0,0
186140,Fugl-Meyer,0,1
186141,assessment,0,1
186142,(,0,1
186143,FMA,0,1
186144,),0,0
186145,whereas,0,0
186146,the,0,0
186147,less-affected,0,0
186148,side,0,0
186149,was,0,0
186150,evaluated,0,0
186151,by,0,0
186152,Minnesota,0,0
186153,manual,0,0
186154,dexterity,0,1
186155,test,0,0
186156,(,0,1
186157,MMDT,0,1
186158,),0,1
186159,",",0,1
186160,Purdue,0,1
186161,peg,0,1
186162,board,0,1
186163,test,0,1
186164,(,0,1
186165,PPBT,0,1
186166,),0,1
186167,and,0,0
186168,Manual,0,0
186169,Muscle,0,1
186170,Testing,0,0
186171,(,0,1
186172,MMT,0,1
186173,),0,1
186174,.,0,0
186175,RESULTS,0,0
186176,Postintervention,0,0
186177,",",0,0
186178,the,0,0
186179,less-affected,0,0
186180,side,0,0
186181,of,0,0
186182,experimental,0,0
186183,group,0,0
186184,demonstrated,0,0
186185,significant,0,0
186186,improvement,0,0
186187,for,0,0
186188,MMDT,0,0
186189,(,0,0
186190,P,0,0
186191,=,0,0
186192,0.003,0,0
186193,),0,0
186194,",",0,0
186195,PPBT,0,0
186196,(,0,0
186197,P,0,0
186198,=,0,0
186199,0.01,0,0
186200,),0,0
186201,and,0,0
186202,MMT,0,0
186203,(,0,0
186204,P,0,0
186205,<,0,0
186206,0.001,0,0
186207,to,0,0
186208,0.043,0,0
186209,),0,0
186210,in,0,0
186211,comparison,0,0
186212,to,0,0
186213,the,0,0
186214,control,0,0
186215,group,0,0
186216,.,0,0
186217,Further,0,0
186218,",",0,0
186219,as,0,0
186220,compared,0,0
186221,to,0,0
186222,the,0,0
186223,control,0,0
186224,group,0,0
186225,",",0,0
186226,the,0,0
186227,experimental,0,0
186228,group,0,0
186229,exhibited,0,0
186230,positive,0,0
186231,significant,0,0
186232,change,0,0
186233,for,0,0
186234,the,0,0
186235,measure,0,0
186236,of,0,0
186237,affected,0,0
186238,side,0,0
186239,[,0,0
186240,BRS,0,0
186241,(,0,0
186242,P,0,0
186243,<,0,0
186244,0.001,0,0
186245,),0,0
186246,and,0,0
186247,FMA,0,0
186248,(,0,0
186249,P,0,0
186250,<,0,0
186251,0.001,0,0
186252,to,0,0
186253,0.03,0,0
186254,),0,0
186255,],0,0
186256,at,0,0
186257,post,0,0
186258,assessment,0,0
186259,.,0,0
186260,CONCLUSION,0,0
186261,MTLA,0,0
186262,enhanced,0,0
186263,the,0,0
186264,muscle,0,0
186265,strength,0,0
186266,",",0,0
186267,dexterity,0,0
186268,and,0,0
186269,coordination,0,0
186270,of,0,0
186271,the,0,0
186272,less-affected,0,0
186273,side,0,0
186274,as,0,0
186275,well,0,0
186276,as,0,0
186277,the,0,0
186278,motor,0,0
186279,recovery,0,0
186280,of,0,0
186281,the,0,0
186282,affected,0,0
186283,side,0,0
186284,in,0,0
186285,poststroke,0,0
186286,hemiparetic,0,0
186287,subjects,0,0
186288,.,0,0
186289,A,0,1
186290,trial,0,1
186291,of,0,0
186292,d-cycloserine,1,1
186293,to,0,0
186294,treat,0,0
186295,the,0,0
186296,social,0,0
186297,deficit,0,0
186298,in,0,0
186299,older,0,0
186300,adolescents,0,0
186301,and,0,0
186302,young,0,0
186303,adults,0,0
186304,with,0,0
186305,autism,0,0
186306,spectrum,0,0
186307,disorders,0,0
186308,.,0,0
186309,Autism,0,0
186310,spectrum,0,0
186311,disorders,0,0
186312,are,0,0
186313,difficult,0,0
186314,for,0,0
186315,older,0,0
186316,adolescents,0,0
186317,and,0,0
186318,young,0,0
186319,adults,0,0
186320,as,0,0
186321,impaired,0,0
186322,social,0,0
186323,communication,0,0
186324,affects,0,0
186325,the,0,0
186326,transition,0,0
186327,to,0,0
186328,adult,0,0
186329,life,0,0
186330,.,0,1
186331,d-Cycloserine,1,1
186332,",",0,0
186333,a,0,0
186334,partial,0,0
186335,glycine,0,1
186336,agonist,0,1
186337,at,0,1
186338,the,0,0
186339,N-methyl-d-aspartic,0,1
186340,acid,0,1
186341,receptor,0,0
186342,",",0,0
186343,was,0,0
186344,tested,0,0
186345,in,0,0
186346,a,0,0
186347,double-blind,0,1
186348,randomized,0,1
186349,trial,0,1
186350,in,0,0
186351,20,0,0
186352,older,0,0
186353,adolescents,0,0
186354,and,0,0
186355,young,0,0
186356,adults,0,0
186357,with,0,0
186358,autism,0,0
186359,spectrum,0,0
186360,disorders,0,0
186361,using,0,0
186362,two,0,0
186363,dosing,0,1
186364,strategies,0,1
186365,(,0,1
186366,50,0,1
186367,mg,0,1
186368,daily,0,1
186369,versus,0,1
186370,50,0,1
186371,mg,0,1
186372,weekly,0,1
186373,),0,1
186374,for,0,0
186375,8,0,0
186376,weeks,0,0
186377,with,0,0
186378,a,0,0
186379,2-week,0,1
186380,follow-up,0,1
186381,after,0,0
186382,discontinuation,0,0
186383,.,0,0
186384,d-Cycloserine,1,1
186385,caused,0,0
186386,statistically,0,0
186387,and,0,0
186388,clinically,0,0
186389,significant,0,0
186390,improvement,0,0
186391,with,0,0
186392,no,0,0
186393,differentiation,0,0
186394,between,0,0
186395,dosing,0,1
186396,strategies,0,1
186397,on,0,0
186398,the,0,0
186399,Social,0,0
186400,Responsiveness,0,0
186401,Scale,0,0
186402,and,0,0
186403,the,0,0
186404,Aberrant,0,0
186405,Behavior,0,0
186406,Checklist,0,0
186407,before,0,0
186408,and,0,0
186409,after,0,0
186410,d-cycloserine,1,1
186411,administration,0,1
186412,.,0,1
186413,Sensory,1,0
186414,Adapted,1,0
186415,Dental,1,0
186416,Environments,1,0
186417,to,0,0
186418,Enhance,0,0
186419,Oral,0,0
186420,Care,0,0
186421,for,0,0
186422,Children,0,0
186423,with,0,0
186424,Autism,0,0
186425,Spectrum,0,0
186426,Disorders,0,0
186427,:,0,0
186428,A,0,0
186429,Randomized,0,0
186430,Controlled,0,0
186431,Pilot,0,0
186432,Study,0,0
186433,.,0,0
186434,This,0,0
186435,pilot,0,0
186436,and,0,0
186437,feasibility,0,0
186438,study,0,0
186439,examined,0,0
186440,the,0,0
186441,impact,0,0
186442,of,0,0
186443,a,0,0
186444,sensory,1,0
186445,adapted,1,0
186446,dental,1,0
186447,environment,1,0
186448,(,1,1
186449,SADE,1,1
186450,),1,0
186451,to,0,0
186452,reduce,0,0
186453,distress,0,0
186454,",",0,0
186455,sensory,0,0
186456,discomfort,0,0
186457,",",0,0
186458,and,0,0
186459,perception,0,0
186460,of,0,0
186461,pain,0,0
186462,during,0,0
186463,oral,1,1
186464,prophylaxis,1,1
186465,for,0,0
186466,children,0,0
186467,with,0,0
186468,autism,0,0
186469,spectrum,0,0
186470,disorder,0,1
186471,(,0,1
186472,ASD,0,1
186473,),0,1
186474,.,0,0
186475,Participants,0,0
186476,were,0,0
186477,44,0,0
186478,children,0,0
186479,ages,0,0
186480,6-12,0,0
186481,(,0,0
186482,n,0,0
186483,=,0,0
186484,22,0,0
186485,typical,0,0
186486,",",0,0
186487,n,0,0
186488,=,0,0
186489,22,0,0
186490,ASD,0,0
186491,),0,0
186492,.,0,0
186493,In,0,0
186494,an,0,0
186495,experimental,0,0
186496,crossover,0,1
186497,design,0,1
186498,",",0,0
186499,each,0,0
186500,participant,0,0
186501,underwent,0,0
186502,two,0,0
186503,professional,0,0
186504,dental,1,0
186505,cleanings,1,0
186506,",",0,0
186507,one,0,0
186508,in,0,0
186509,a,0,0
186510,regular,1,0
186511,dental,1,0
186512,environment,1,0
186513,(,1,1
186514,RDE,1,1
186515,),1,1
186516,and,0,0
186517,one,0,0
186518,in,0,0
186519,a,0,0
186520,SADE,1,1
186521,",",0,0
186522,administered,0,1
186523,in,0,0
186524,a,0,0
186525,randomized,0,0
186526,and,0,0
186527,counterbalanced,0,0
186528,order,0,0
186529,3-4,0,0
186530,months,0,0
186531,apart,0,0
186532,.,0,0
186533,Outcomes,0,0
186534,included,0,0
186535,measures,0,0
186536,of,0,0
186537,physiological,0,0
186538,anxiety,0,0
186539,",",0,0
186540,behavioral,0,0
186541,distress,0,0
186542,",",0,0
186543,pain,0,0
186544,intensity,0,0
186545,",",0,0
186546,and,0,0
186547,sensory,0,0
186548,discomfort,0,0
186549,.,0,0
186550,Both,0,0
186551,groups,0,0
186552,exhibited,0,0
186553,decreased,0,0
186554,physiological,0,0
186555,anxiety,0,0
186556,and,0,0
186557,reported,0,0
186558,lower,0,0
186559,pain,0,0
186560,and,0,0
186561,sensory,0,0
186562,discomfort,0,0
186563,in,0,0
186564,the,0,0
186565,SADE,1,0
186566,condition,0,0
186567,compared,0,0
186568,to,0,0
186569,RDE,1,0
186570,",",0,0
186571,indicating,0,0
186572,a,0,0
186573,beneficial,0,0
186574,effect,0,0
186575,of,0,0
186576,the,0,0
186577,SADE,1,0
186578,.,1,0
186579,Three-year,0,0
186580,efficacy,0,0
186581,and,0,0
186582,safety,0,0
186583,of,0,0
186584,a,0,0
186585,new,0,0
186586,52-mg,0,1
186587,levonorgestrel-releasing,1,1
186588,intrauterine,0,1
186589,system,0,0
186590,.,0,0
186591,OBJECTIVE,0,0
186592,To,0,0
186593,assess,0,0
186594,3-year,0,0
186595,data,0,0
186596,on,0,0
186597,the,0,0
186598,efficacy,0,0
186599,and,0,0
186600,safety,0,0
186601,of,0,0
186602,a,0,0
186603,new,0,0
186604,52-mg,0,1
186605,levonorgestrel,1,1
186606,intrauterine,1,1
186607,contraceptive,1,1
186608,(,1,1
186609,LNG20,1,1
186610,),1,0
186611,designed,0,0
186612,for,0,0
186613,up,0,0
186614,to,0,0
186615,7,0,0
186616,years,0,0
186617,use,0,0
186618,.,0,0
186619,STUDY,0,0
186620,DESIGN,0,1
186621,Nulliparous,0,1
186622,and,0,0
186623,parous,0,0
186624,women,0,0
186625,aged,0,0
186626,16-45,0,0
186627,years,0,0
186628,at,0,0
186629,enrollment,0,0
186630,with,0,0
186631,regular,0,0
186632,menstrual,0,0
186633,cycles,0,0
186634,and,0,0
186635,requesting,0,0
186636,contraception,0,0
186637,were,0,0
186638,enrolled,0,0
186639,in,0,0
186640,an,0,0
186641,open-label,0,1
186642,",",0,0
186643,partially,0,0
186644,randomized,0,0
186645,trial,0,0
186646,to,0,0
186647,evaluate,0,0
186648,LNG20,1,0
186649,.,1,0
186650,The,0,0
186651,primary,0,0
186652,outcome,0,0
186653,was,0,0
186654,pregnancy,0,0
186655,rate,0,0
186656,for,0,0
186657,women,0,0
186658,aged,0,0
186659,16-35,0,0
186660,years,0,0
186661,calculated,0,0
186662,as,0,0
186663,the,0,0
186664,Pearl,0,0
186665,Index,0,0
186666,.,0,0
186667,Women,0,0
186668,aged,0,0
186669,36-45,0,0
186670,years,0,0
186671,received,0,0
186672,LNG20,1,0
186673,for,0,0
186674,safety,0,0
186675,evaluation,0,0
186676,only,0,0
186677,.,0,0
186678,All,0,0
186679,participants,0,0
186680,had,0,0
186681,in-person,0,0
186682,or,0,0
186683,phone,0,0
186684,follow-up,0,0
186685,approximately,0,0
186686,every,0,0
186687,3,0,0
186688,months,0,0
186689,during,0,0
186690,the,0,0
186691,study,0,0
186692,.,0,0
186693,RESULTS,0,0
186694,A,0,0
186695,total,0,0
186696,of,0,0
186697,1600,0,0
186698,women,0,0
186699,aged,0,0
186700,16-35,0,0
186701,years,0,0
186702,and,0,0
186703,151,0,0
186704,women,0,0
186705,aged,0,0
186706,36-45,0,0
186707,years,0,0
186708,agreed,0,0
186709,to,0,0
186710,LNG20,1,0
186711,placement,0,0
186712,",",0,0
186713,including,0,0
186714,1011,0,0
186715,(,0,0
186716,57.7,0,0
186717,%,0,0
186718,),0,0
186719,nulliparous,0,0
186720,and,0,0
186721,438,0,0
186722,(,0,0
186723,25.1,0,0
186724,%,0,0
186725,),0,0
186726,obese,0,0
186727,women,0,1
186728,.,0,0
186729,Successful,0,0
186730,placement,0,0
186731,occurred,0,0
186732,in,0,0
186733,1714,0,0
186734,(,0,0
186735,97.9,0,0
186736,%,0,0
186737,),0,0
186738,women,0,0
186739,.,0,1
186740,Six,0,1
186741,pregnancies,0,0
186742,occurred,0,0
186743,",",0,0
186744,four,0,0
186745,of,0,0
186746,which,0,0
186747,were,0,0
186748,ectopic,0,0
186749,.,0,0
186750,The,0,0
186751,Pearl,0,0
186752,Index,0,0
186753,for,0,0
186754,LNG20,1,0
186755,was,0,0
186756,0.15,0,0
186757,(,0,0
186758,95,0,0
186759,%,0,0
186760,CI,0,0
186761,0.02-0.55,0,0
186762,),0,0
186763,through,0,0
186764,Year,0,0
186765,1,0,0
186766,",",0,0
186767,0.26,0,0
186768,(,0,0
186769,95,0,0
186770,%,0,0
186771,CI,0,0
186772,0.10-0.57,0,0
186773,),0,0
186774,through,0,0
186775,Year,0,0
186776,2,0,0
186777,",",0,0
186778,and,0,0
186779,0.22,0,0
186780,(,0,0
186781,95,0,0
186782,%,0,0
186783,CI,0,0
186784,0.08-0.49,0,0
186785,),0,0
186786,through,0,0
186787,Year,0,0
186788,3,0,0
186789,.,0,0
186790,The,0,0
186791,cumulative,0,0
186792,life-table,0,0
186793,pregnancy,0,0
186794,rate,0,0
186795,was,0,0
186796,0.55,0,0
186797,(,0,0
186798,95,0,0
186799,%,0,0
186800,CI,0,0
186801,0.24-1.23,0,0
186802,),0,0
186803,through,0,0
186804,3,0,0
186805,years,0,0
186806,.,0,0
186807,Expulsion,0,0
186808,was,0,0
186809,reported,0,0
186810,in,0,0
186811,62,0,0
186812,(,0,0
186813,3.5,0,0
186814,%,0,0
186815,),0,0
186816,participants,0,0
186817,",",0,0
186818,most,0,0
186819,(,0,1
186820,50,0,0
186821,[,0,0
186822,80.6,0,0
186823,%,0,0
186824,],0,0
186825,),0,0
186826,during,0,0
186827,the,0,0
186828,first,0,0
186829,year,0,0
186830,of,0,0
186831,use,0,0
186832,.,0,0
186833,Of,0,0
186834,women,0,1
186835,who,0,1
186836,discontinued,0,1
186837,LNG20,1,1
186838,and,0,0
186839,desired,0,0
186840,pregnancy,0,0
186841,",",0,0
186842,86.8,0,0
186843,%,0,0
186844,conceived,0,0
186845,spontaneously,0,0
186846,within,0,0
186847,12,0,0
186848,months,0,0
186849,.,0,0
186850,Pelvic,0,0
186851,infection,0,0
186852,was,0,0
186853,diagnosed,0,0
186854,in,0,0
186855,10,0,0
186856,(,0,0
186857,0.6,0,0
186858,%,0,0
186859,),0,0
186860,women,0,0
186861,.,0,0
186862,Only,0,0
186863,26,0,0
186864,(,0,0
186865,1.5,0,0
186866,%,0,0
186867,),0,0
186868,LNG20,1,0
186869,users,0,1
186870,discontinued,0,1
186871,due,0,0
186872,to,0,0
186873,bleeding,0,0
186874,complaints,0,0
186875,.,0,0
186876,CONCLUSION,0,0
186877,The,0,0
186878,LNG20,1,0
186879,intrauterine,0,0
186880,system,0,0
186881,is,0,0
186882,highly,0,0
186883,effective,0,0
186884,and,0,0
186885,safe,0,0
186886,over,0,0
186887,3,0,0
186888,years,0,0
186889,of,0,0
186890,use,0,0
186891,in,0,0
186892,nulliparous,0,0
186893,and,0,0
186894,parous,0,0
186895,women,0,0
186896,.,0,0
186897,IMPLICATIONS,0,0
186898,STATEMENT,0,0
186899,A,0,1
186900,new,0,1
186901,52-mg,0,1
186902,levonorgestrel-releasing,1,1
186903,intrauterine,1,1
186904,system,1,0
186905,is,0,0
186906,effective,0,0
186907,and,0,0
186908,safe,0,0
186909,for,0,0
186910,nulliparous,0,0
186911,and,0,0
186912,parous,0,0
186913,women,0,0
186914,for,0,0
186915,at,0,0
186916,least,0,0
186917,3,0,0
186918,years,0,0
186919,.,0,0
186920,Effect,0,0
186921,of,0,0
186922,Chinese,1,1
186923,herbal,1,1
186924,medicine,1,1
186925,on,0,0
186926,vascular,0,0
186927,functions,0,0
186928,during,0,0
186929,60-day,0,0
186930,head-down,0,0
186931,bed,0,0
186932,rest,0,0
186933,.,0,0
186934,PURPOSE,0,0
186935,Chinese,1,1
186936,herbal,1,1
186937,medicine,1,1
186938,is,0,0
186939,a,0,0
186940,promising,0,0
186941,countermeasure,0,0
186942,against,0,0
186943,cardiovascular,0,0
186944,dysfunction,0,0
186945,associated,0,0
186946,with,0,0
186947,a,0,0
186948,sedentary,0,0
186949,lifestyle,0,0
186950,.,0,0
186951,We,0,0
186952,examined,0,0
186953,the,0,0
186954,impact,0,0
186955,of,0,0
186956,the,0,0
186957,Chinese,1,0
186958,herb,1,1
186959,",",1,1
186960,Taikong,1,1
186961,Yangxin,1,1
186962,",",0,0
186963,on,0,0
186964,the,0,0
186965,micro-,0,0
186966,and,0,0
186967,macrovascular,0,0
186968,dysfunction,0,0
186969,associated,0,0
186970,with,0,0
186971,a,0,0
186972,60-day,0,0
186973,bed,0,0
186974,rest,0,0
186975,.,0,0
186976,METHODS,0,0
186977,Fourteen,0,0
186978,healthy,0,0
186979,men,0,0
186980,were,0,0
186981,randomly,0,0
186982,divided,0,0
186983,into,0,0
186984,two,0,0
186985,groups,0,0
186986,:,0,0
186987,those,0,0
186988,given,0,1
186989,herbal,1,1
186990,supplement,1,1
186991,",",0,1
186992,and,0,0
186993,the,0,0
186994,control,0,0
186995,group,0,0
186996,;,0,0
186997,the,0,0
186998,two,0,0
186999,groups,0,0
187000,underwent,0,0
187001,a,0,0
187002,60-day,1,0
187003,bed,1,0
187004,rest,1,0
187005,.,1,0
187006,The,0,0
187007,macrovasculature,0,0
187008,was,0,0
187009,assessed,0,0
187010,by,0,0
187011,sonography,0,0
187012,.,0,0
187013,Skin,0,0
187014,microvascular,0,0
187015,functions,0,0
187016,were,0,0
187017,assessed,0,0
187018,with,0,0
187019,laser,0,0
187020,Doppler,0,0
187021,.,0,0
187022,The,0,0
187023,plasma,0,0
187024,level,0,0
187025,of,0,0
187026,endothelial,0,1
187027,microparticles,0,1
187028,(,0,1
187029,EMPs,0,1
187030,),0,1
187031,",",0,0
187032,markers,0,0
187033,of,0,0
187034,endothelial,0,0
187035,injury,0,0
187036,",",0,0
187037,was,0,0
187038,determined,0,0
187039,.,0,0
187040,RESULTS,0,0
187041,Bed,0,0
187042,rest,0,0
187043,induced,0,0
187044,a,0,0
187045,33,0,0
187046,%,0,0
187047,decrease,0,0
187048,in,0,0
187049,the,0,0
187050,femoral,0,0
187051,artery,0,0
187052,diameter,0,0
187053,and,0,0
187054,compliance,0,0
187055,whereas,0,0
187056,carotid,0,0
187057,wall,0,0
187058,thickness,0,0
187059,",",0,0
187060,diameter,0,0
187061,",",0,0
187062,and,0,0
187063,compliance,0,0
187064,remained,0,0
187065,unchanged,0,0
187066,.,0,0
187067,The,0,0
187068,early,0,0
187069,phase,0,0
187070,of,0,0
187071,endothelium-dependent,0,1
187072,vasodilation,0,1
187073,to,0,1
187074,ACh,0,0
187075,was,0,0
187076,unmodified,0,0
187077,by,0,0
187078,bed,0,0
187079,rest,0,0
187080,",",0,0
187081,while,0,0
187082,the,0,0
187083,late,0,0
187084,phase,0,0
187085,was,0,0
187086,reduced,0,0
187087,by,0,0
187088,30,0,0
187089,%,0,0
187090,along,0,0
187091,with,0,0
187092,a,0,0
187093,twofold,0,0
187094,increase,0,0
187095,in,0,0
187096,EMPs,0,0
187097,.,0,0
187098,In,0,0
187099,those,0,0
187100,given,0,0
187101,Taikong,1,1
187102,Yangxin,1,1
187103,",",0,0
187104,the,0,0
187105,early,0,0
187106,phase,0,0
187107,was,0,0
187108,amplified,0,0
187109,by,0,0
187110,2.5-fold,0,0
187111,",",0,0
187112,and,0,0
187113,the,0,0
187114,effects,0,0
187115,of,0,0
187116,bed,0,0
187117,rest,0,0
187118,on,0,0
187119,the,0,0
187120,late,0,0
187121,phase,0,0
187122,were,0,0
187123,prevented,0,0
187124,.,0,0
187125,CONCLUSION,0,0
187126,These,0,0
187127,findings,0,0
187128,indicate,0,0
187129,that,0,0
187130,Taikong,0,1
187131,Yangxin,0,1
187132,ameliorates,0,1
187133,endothelium-dependent,0,1
187134,vasodilation,0,1
187135,",",0,1
187136,likely,0,0
187137,by,0,0
187138,improving,0,0
187139,the,0,0
187140,NO,0,0
187141,pathway,0,0
187142,.,0,0
187143,The,0,0
187144,study,0,0
187145,suggests,0,0
187146,Taikong,0,1
187147,Yangxin,0,1
187148,as,0,0
187149,a,0,0
187150,new,0,0
187151,countermeasure,0,0
187152,to,0,0
187153,prevent,0,0
187154,the,0,0
187155,changes,0,0
187156,in,0,0
187157,microvascular,0,0
187158,function,0,0
187159,induced,0,0
187160,by,0,0
187161,physical,0,0
187162,inactivity,0,0
187163,.,0,0
187164,The,0,0
187165,Beyond,0,0
187166,Ageing,0,0
187167,Project,0,0
187168,Phase,0,0
187169,2,0,0
187170,--,0,0
187171,a,0,0
187172,double-blind,0,1
187173,",",0,0
187174,selective,0,0
187175,prevention,0,0
187176,",",0,0
187177,randomised,0,1
187178,",",0,1
187179,placebo-controlled,0,1
187180,trial,0,1
187181,of,0,1
187182,omega-3,1,1
187183,fatty,1,1
187184,acids,1,1
187185,and,1,1
187186,sertraline,1,1
187187,in,0,0
187188,an,0,0
187189,older,0,0
187190,age,0,0
187191,cohort,0,0
187192,at,0,0
187193,risk,0,0
187194,for,0,0
187195,depression,0,0
187196,:,0,0
187197,study,0,0
187198,protocol,0,0
187199,for,0,0
187200,a,0,0
187201,randomized,0,0
187202,controlled,0,0
187203,trial,0,0
187204,.,0,0
187205,BACKGROUND,0,0
187206,Late-life,0,0
187207,depression,0,0
187208,is,0,0
187209,associated,0,0
187210,with,0,0
187211,high,0,0
187212,rates,0,0
187213,of,0,0
187214,morbidity,0,0
187215,",",0,0
187216,premature,0,0
187217,mortality,0,0
187218,",",0,0
187219,disability,0,0
187220,",",0,0
187221,functional,0,0
187222,decline,0,0
187223,",",0,0
187224,caregiver,0,0
187225,burden,0,0
187226,and,0,0
187227,increased,0,0
187228,health,0,0
187229,care,0,0
187230,costs,0,0
187231,.,0,0
187232,While,0,0
187233,clinical,0,0
187234,and,0,0
187235,public,0,0
187236,health,0,0
187237,approaches,0,0
187238,are,0,0
187239,focused,0,0
187240,on,0,0
187241,prevention,0,0
187242,or,0,0
187243,early,0,0
187244,intervention,0,0
187245,strategies,0,0
187246,",",0,0
187247,the,0,0
187248,ideal,0,0
187249,method,0,0
187250,of,0,0
187251,intervention,0,0
187252,remains,0,0
187253,unclear,0,0
187254,.,0,0
187255,No,0,0
187256,study,0,0
187257,has,0,0
187258,set,0,0
187259,out,0,0
187260,to,0,0
187261,evaluate,0,0
187262,the,0,0
187263,role,0,0
187264,of,0,0
187265,neurobiological,0,0
187266,agents,0,0
187267,in,0,0
187268,preventing,0,0
187269,depressive,0,0
187270,symptoms,0,0
187271,in,0,0
187272,older,0,0
187273,populations,0,0
187274,at,0,0
187275,risk,0,0
187276,of,0,0
187277,depression,0,0
187278,.,0,0
187279,METHODS/DESIGN,0,0
187280,Subjects,0,0
187281,with,0,0
187282,previously,0,0
187283,reported,0,0
187284,sub-threshold,0,0
187285,depressive,0,0
187286,symptoms,0,0
187287,",",0,0
187288,aged,0,0
187289,60,0,0
187290,to,0,0
187291,74,0,0
187292,years,0,0
187293,",",0,0
187294,will,0,0
187295,be,0,0
187296,screened,0,0
187297,to,0,0
187298,participate,0,0
187299,in,0,0
187300,a,0,0
187301,single-centre,0,0
187302,",",0,0
187303,double-blind,0,1
187304,",",0,1
187305,randomised,0,0
187306,controlled,0,0
187307,trial,0,0
187308,with,1,0
187309,three,1,0
187310,parallel,1,0
187311,groups,1,0
187312,involving,1,0
187313,omega-3,1,1
187314,fatty,1,1
187315,acid,1,1
187316,supplementation,1,1
187317,or,1,1
187318,sertraline,1,1
187319,hydrochloride,1,1
187320,",",1,1
187321,compared,1,0
187322,with,1,0
187323,matching,1,0
187324,placebo,1,1
187325,.,1,0
187326,Subjects,0,0
187327,will,0,0
187328,be,0,0
187329,excluded,0,0
187330,if,0,0
187331,they,0,0
187332,have,0,0
187333,current,0,0
187334,depression,0,0
187335,or,0,0
187336,suicide,0,1
187337,ideation,0,1
187338,;,0,0
187339,are,0,0
187340,taking,0,1
187341,antidepressants,0,1
187342,or,0,1
187343,any,0,0
187344,supplement,0,1
187345,containing,0,1
187346,omega-3,0,1
187347,fatty,0,1
187348,acid,0,1
187349,;,0,1
187350,or,0,0
187351,have,0,0
187352,a,0,0
187353,prior,0,0
187354,history,0,0
187355,of,0,0
187356,stroke,0,0
187357,or,0,0
187358,other,0,0
187359,serious,0,0
187360,cerebrovascular,0,0
187361,or,0,0
187362,cardiovascular,0,0
187363,disease,0,0
187364,",",0,0
187365,neurological,0,0
187366,disease,0,0
187367,",",0,0
187368,significant,0,0
187369,psychiatric,0,1
187370,disease,0,1
187371,(,0,0
187372,other,0,0
187373,than,0,1
187374,depression,0,0
187375,),0,1
187376,or,0,0
187377,neurodegenerative,0,0
187378,disease,0,0
187379,.,0,0
187380,The,0,0
187381,trial,0,0
187382,will,0,0
187383,consist,0,0
187384,of,0,0
187385,a,0,0
187386,12,0,0
187387,month,0,0
187388,treatment,0,0
187389,phase,0,0
187390,with,0,0
187391,follow-up,0,0
187392,at,0,0
187393,three,0,0
187394,months,0,0
187395,and,0,0
187396,12,0,0
187397,months,0,0
187398,to,0,0
187399,assess,0,0
187400,outcome,0,0
187401,events,0,0
187402,.,0,0
187403,At,1,0
187404,three,1,0
187405,months,1,0
187406,",",1,0
187407,subjects,1,0
187408,will,1,0
187409,undergo,1,0
187410,structural,1,0
187411,neuroimaging,1,0
187412,to,1,0
187413,assess,1,0
187414,whether,1,0
187415,treatment,1,0
187416,effects,1,0
187417,on,1,0
187418,depressive,1,0
187419,symptoms,1,0
187420,correlate,1,0
187421,with,1,0
187422,brain,1,0
187423,changes,1,0
187424,.,1,0
187425,Additionally,0,0
187426,",",0,0
187427,proton,0,0
187428,spectroscopy,0,0
187429,techniques,0,0
187430,will,0,0
187431,be,0,0
187432,used,0,0
187433,to,0,0
187434,capture,0,0
187435,brain-imaging,0,0
187436,markers,0,0
187437,of,0,0
187438,the,0,0
187439,biological,0,0
187440,effects,0,0
187441,of,0,0
187442,the,0,0
187443,interventions,0,0
187444,.,0,0
187445,The,0,0
187446,trial,0,0
187447,will,0,0
187448,be,0,0
187449,conducted,0,0
187450,in,0,0
187451,urban,0,0
187452,New,0,1
187453,South,0,0
187454,Wales,0,0
187455,",",0,0
187456,Australia,0,0
187457,",",0,0
187458,and,0,0
187459,will,0,0
187460,recruit,0,0
187461,a,0,0
187462,community-based,0,0
187463,sample,0,0
187464,of,0,0
187465,450,0,0
187466,adults,0,0
187467,.,0,0
187468,Using,0,0
187469,intention-to-treat,0,0
187470,methods,0,0
187471,",",0,0
187472,the,0,0
187473,primary,0,0
187474,endpoint,0,0
187475,is,0,0
187476,an,0,0
187477,absence,0,0
187478,of,0,0
187479,clinically,0,0
187480,relevant,0,0
187481,depression,0,0
187482,scores,0,0
187483,at,0,0
187484,12,0,0
187485,months,0,0
187486,between,0,0
187487,the,0,0
187488,omega-3,0,1
187489,fatty,0,1
187490,acid,0,1
187491,and,0,1
187492,sertraline,0,1
187493,interventions,0,1
187494,and,0,0
187495,the,0,0
187496,placebo,0,1
187497,condition,0,1
187498,.,0,0
187499,DISCUSSION,0,0
187500,The,0,0
187501,current,0,0
187502,health,0,0
187503,",",0,0
187504,social,0,0
187505,and,0,0
187506,economic,0,0
187507,costs,0,0
187508,of,0,0
187509,late-life,0,0
187510,depression,0,0
187511,make,0,0
187512,prevention,0,0
187513,imperative,0,0
187514,from,0,0
187515,a,0,0
187516,public,0,0
187517,health,0,0
187518,perspective,0,0
187519,.,0,0
187520,This,0,0
187521,innovative,0,0
187522,trial,0,0
187523,aims,0,0
187524,to,0,0
187525,address,0,0
187526,the,0,0
187527,long-neglected,0,0
187528,area,0,0
187529,of,0,0
187530,prevention,0,0
187531,of,0,0
187532,depression,0,0
187533,in,0,0
187534,older,0,0
187535,adults,0,0
187536,.,0,0
187537,The,0,0
187538,interventions,0,0
187539,are,0,0
187540,targeted,0,0
187541,to,0,0
187542,the,0,0
187543,pathophysiology,0,0
187544,of,0,0
187545,disease,0,0
187546,",",0,0
187547,and,0,0
187548,regardless,0,0
187549,of,0,0
187550,the,0,0
187551,effect,0,0
187552,size,0,0
187553,of,0,0
187554,treatment,0,0
187555,",",0,0
187556,the,0,0
187557,outcomes,0,0
187558,will,0,0
187559,offer,0,0
187560,major,0,0
187561,scientific,0,0
187562,advances,0,0
187563,regarding,0,0
187564,the,0,0
187565,neurobiological,0,0
187566,action,0,0
187567,of,0,0
187568,these,0,0
187569,agents,0,0
187570,.,0,0
187571,The,0,0
187572,main,0,0
187573,results,0,0
187574,are,0,0
187575,expected,0,0
187576,to,0,0
187577,be,0,0
187578,available,0,0
187579,in,0,0
187580,2017,0,0
187581,.,0,0
187582,TRIAL,0,0
187583,REGISTRATION,0,1
187584,Australian,0,1
187585,and,0,0
187586,New,0,1
187587,Zealand,0,1
187588,Clinical,0,1
187589,Trials,0,0
187590,Registry,0,1
187591,ACTRN12610000032055,0,1
187592,(,0,1
187593,12,0,0
187594,January,0,1
187595,2010,0,1
187596,),0,0
187597,.,0,0
187598,Self-management,0,0
187599,education,0,0
187600,for,0,0
187601,adults,0,0
187602,with,0,0
187603,poorly,0,0
187604,controlled,0,0
187605,epilepsy,0,0
187606,(,0,1
187607,SMILE,0,1
187608,(,0,1
187609,UK,0,1
187610,),0,1
187611,),0,0
187612,:,0,0
187613,statistical,0,0
187614,",",0,0
187615,economic,0,0
187616,and,0,0
187617,qualitative,0,0
187618,analysis,0,0
187619,plan,0,0
187620,for,0,0
187621,a,0,0
187622,randomised,0,0
187623,controlled,0,0
187624,trial,0,0
187625,.,0,0
187626,BACKGROUND,0,0
187627,There,0,0
187628,is,0,0
187629,a,0,0
187630,need,0,0
187631,to,0,0
187632,test,0,0
187633,the,0,0
187634,effectiveness,0,0
187635,of,0,0
187636,new,0,0
187637,educational,1,0
187638,interventions,0,0
187639,for,0,0
187640,people,0,0
187641,with,0,0
187642,poorly,0,0
187643,controlled,0,0
187644,epilepsy,0,0
187645,.,0,0
187646,The,0,0
187647,SMILE,0,0
187648,(,0,0
187649,self-management,0,0
187650,education,0,0
187651,for,0,0
187652,adults,0,0
187653,with,0,0
187654,poorly,0,0
187655,controlled,0,0
187656,epilepsy,0,1
187657,),0,0
187658,trial,0,0
187659,evaluates,0,0
187660,a,0,0
187661,complex,0,0
187662,service,0,0
187663,intervention,0,0
187664,that,0,0
187665,involves,0,0
187666,a,0,0
187667,2-day,0,0
187668,self-management,0,0
187669,course,0,0
187670,with,0,0
187671,the,0,0
187672,aim,0,0
187673,of,0,0
187674,improving,0,0
187675,quality,0,0
187676,of,0,0
187677,life,0,0
187678,and,0,0
187679,clinical,0,0
187680,outcomes,0,0
187681,.,0,0
187682,This,0,0
187683,article,0,0
187684,describes,0,0
187685,the,0,0
187686,statistical,0,0
187687,",",0,0
187688,economic,0,0
187689,",",0,0
187690,and,0,0
187691,qualitative,0,0
187692,analysis,0,0
187693,plan,0,0
187694,for,0,0
187695,the,0,0
187696,trial,0,0
187697,.,0,0
187698,METHODS,0,0
187699,AND,0,1
187700,DESIGN,0,1
187701,SMILE,0,0
187702,is,0,0
187703,a,0,0
187704,pragmatic,0,0
187705,",",0,0
187706,parallel,0,0
187707,design,0,0
187708,",",0,0
187709,two-arm,0,0
187710,",",0,0
187711,multi-centre,0,0
187712,randomised,0,0
187713,controlled,0,0
187714,superiority,0,0
187715,trial,0,0
187716,of,0,0
187717,a,1,0
187718,group-based,1,0
187719,interactive,1,0
187720,course,1,0
187721,compared,1,0
187722,with,1,0
187723,treatment,1,0
187724,as,1,0
187725,usual,1,0
187726,for,0,0
187727,people,0,0
187728,who,0,0
187729,have,0,0
187730,experienced,0,0
187731,two,0,0
187732,or,0,0
187733,more,0,0
187734,seizures,0,0
187735,in,0,0
187736,the,0,0
187737,past,0,0
187738,12,0,0
187739,months,0,0
187740,.,0,0
187741,RESULTS,0,0
187742,A,0,0
187743,summary,0,0
187744,of,0,0
187745,the,0,0
187746,objectives,0,0
187747,and,0,0
187748,design,0,0
187749,of,0,0
187750,the,0,0
187751,trial,0,0
187752,are,0,0
187753,reported,0,0
187754,as,0,0
187755,well,0,0
187756,as,0,0
187757,the,0,0
187758,manner,0,0
187759,in,0,0
187760,which,0,0
187761,the,0,0
187762,data,0,0
187763,will,0,0
187764,be,0,0
187765,summarised,0,0
187766,and,0,0
187767,inferentially,0,0
187768,analysed,0,0
187769,.,0,0
187770,This,0,0
187771,includes,0,0
187772,the,0,0
187773,type,0,0
187774,of,0,0
187775,modelling,0,0
187776,that,0,0
187777,will,0,0
187778,be,0,0
187779,employed,0,0
187780,for,0,0
187781,each,0,0
187782,of,0,0
187783,the,0,0
187784,primary,0,0
187785,and,0,0
187786,secondary,0,0
187787,outcomes,0,0
187788,and,0,0
187789,the,0,0
187790,methods,0,0
187791,by,0,0
187792,which,0,0
187793,the,0,0
187794,assumptions,0,0
187795,of,0,0
187796,these,0,0
187797,models,0,0
187798,will,0,0
187799,be,0,0
187800,checked,0,0
187801,.,0,0
187802,Strategies,0,0
187803,are,0,0
187804,described,0,0
187805,for,0,0
187806,handling,0,0
187807,clustering,0,0
187808,of,0,0
187809,outcome,0,0
187810,data,0,0
187811,",",0,0
187812,missing,0,0
187813,observations,0,0
187814,",",0,0
187815,and,0,0
187816,treatment,0,0
187817,non-compliance,0,0
187818,.,0,0
187819,CONCLUSION,0,0
187820,This,0,0
187821,update,0,0
187822,to,0,0
187823,the,0,0
187824,previously,0,0
187825,published,0,0
187826,trial,0,0
187827,protocol,0,0
187828,provides,0,0
187829,a,0,0
187830,description,0,0
187831,of,0,0
187832,the,0,0
187833,trial,0,0
187834,analysis,0,0
187835,which,0,0
187836,is,0,0
187837,transparent,0,0
187838,and,0,0
187839,specified,0,0
187840,before,0,0
187841,any,0,0
187842,outcome,0,0
187843,data,0,0
187844,are,0,0
187845,available,0,0
187846,.,0,0
187847,It,0,0
187848,also,0,0
187849,provides,0,0
187850,guidance,0,0
187851,to,0,0
187852,those,0,0
187853,planning,0,0
187854,the,0,0
187855,analysis,0,0
187856,of,0,0
187857,similar,0,0
187858,trials,0,0
187859,.,0,0
187860,TRIAL,0,0
187861,REGISTRATION,0,0
187862,Current,0,0
187863,Controlled,0,0
187864,Trials,0,1
187865,ISRCTN57937389,0,1
187866,;,0,0
187867,date,0,0
187868,assigned,0,0
187869,:,0,0
187870,27,0,0
187871,March,0,0
187872,2013,0,0
187873,.,0,0
187874,[,0,0
187875,Effect,0,0
187876,of,0,0
187877,Preoperative,1,0
187878,Oral,1,0
187879,Rehydration,1,0
187880,on,0,0
187881,Onset,0,0
187882,Time,0,0
187883,and,0,0
187884,Recovery,0,0
187885,Time,0,0
187886,of,0,0
187887,Rocuronium,0,1
187888,],0,1
187889,.,0,1
187890,BACKGROUND,0,1
187891,Preoperative,0,1
187892,oral,1,1
187893,rehydration,1,1
187894,solution,1,1
187895,(,1,1
187896,ORS,1,1
187897,),1,1
187898,prevents,0,0
187899,hypovolemia,0,0
187900,.,0,0
187901,The,0,0
187902,aim,0,0
187903,of,0,0
187904,this,0,0
187905,study,0,0
187906,was,0,0
187907,to,0,0
187908,compare,0,0
187909,the,0,0
187910,effect,0,0
187911,of,0,0
187912,intubating,0,0
187913,dose,0,1
187914,of,0,1
187915,rocuronium,1,1
187916,in,0,0
187917,patients,0,0
187918,taking,0,0
187919,and,0,0
187920,those,0,0
187921,not,0,0
187922,taking,0,0
187923,preoperative,0,0
187924,ORS,1,1
187925,.,1,1
187926,METHODS,0,0
187927,Twenty,0,0
187928,patients,0,0
187929,",",0,0
187930,ASA,0,0
187931,I,0,0
187932,aged,0,0
187933,20-50,0,0
187934,years,0,0
187935,scheduled,0,0
187936,for,0,0
187937,elective,0,0
187938,surgery,0,0
187939,",",0,0
187940,were,0,0
187941,investigated,0,0
187942,and,0,0
187943,randomly,0,0
187944,assigned,0,0
187945,to,0,0
187946,two,0,0
187947,groups,0,0
187948,:,0,0
187949,drinking,0,0
187950,"1,500",0,0
187951,ml,0,0
187952,ORS,1,1
187953,6,0,0
187954,to,0,0
187955,2,0,0
187956,hours,0,0
187957,before,0,1
187958,anesthesia,0,1
187959,(,1,1
187960,ORS,1,1
187961,group,1,1
187962,),1,0
187963,and,0,0
187964,nothing,1,0
187965,by,1,0
187966,mouth,1,0
187967,from,0,0
187968,6,0,0
187969,hours,0,0
187970,before,0,0
187971,anesthesia,0,1
187972,(,1,0
187973,control,1,0
187974,group,1,0
187975,),1,0
187976,.,0,0
187977,Anesthesia,0,0
187978,was,0,0
187979,maintained,0,0
187980,with,0,0
187981,propofol,1,1
187982,and,0,1
187983,remifentanil,1,1
187984,",",0,1
187985,and,0,0
187986,rocuronium,1,1
187987,0.6,0,1
187988,mg,0,1
187989,x,0,0
187990,kg,0,1
187991,(,0,1
187992,-1,0,0
187993,),0,1
187994,was,0,0
187995,administrated,0,1
187996,.,0,0
187997,To,0,0
187998,evaluate,0,0
187999,the,0,0
188000,effect,0,0
188001,of,0,0
188002,rocuronium,0,1
188003,",",0,0
188004,acceleromyography,0,0
188005,at,0,0
188006,the,0,0
188007,adductor,0,0
188008,pollicis,0,0
188009,was,0,0
188010,performed,0,0
188011,using,0,0
188012,0.1,0,0
188013,Hz,0,0
188014,stimulation,0,0
188015,.,0,0
188016,Cardiac,0,0
188017,index,0,1
188018,(,0,1
188019,CI,0,1
188020,),0,1
188021,and,0,0
188022,stroke,0,0
188023,volume,0,1
188024,variation,0,0
188025,(,0,1
188026,SVV,0,1
188027,),0,1
188028,from,0,0
188029,FloTra/Vigileo,0,1
188030,",",0,0
188031,times,0,0
188032,to,0,0
188033,95,0,0
188034,%,0,0
188035,twitch,0,0
188036,depression,0,0
188037,as,0,0
188038,onset,0,0
188039,time,0,0
188040,(,0,1
188041,OT,0,1
188042,),0,1
188043,",",0,0
188044,and,0,0
188045,times,0,0
188046,to,0,0
188047,first,0,0
188048,twitch,0,1
188049,re-detection,0,1
188050,(,0,1
188051,TR,0,1
188052,),0,0
188053,were,0,0
188054,recorded,0,0
188055,.,0,0
188056,RESULTS,0,0
188057,SVV,0,0
188058,was,0,0
188059,significantly,0,0
188060,lower,0,0
188061,in,0,0
188062,ORS,1,1
188063,group,0,0
188064,(,0,0
188065,P,0,0
188066,=,0,0
188067,0.03,0,0
188068,),0,0
188069,",",0,0
188070,and,0,0
188071,CI,0,0
188072,showed,0,0
188073,no,0,0
188074,difference,0,0
188075,.,0,0
188076,In,0,0
188077,ORS,1,1
188078,group,0,0
188079,",",0,0
188080,TR,0,0
188081,was,0,0
188082,significantly,0,0
188083,shorter,0,0
188084,than,0,0
188085,that,0,0
188086,of,0,0
188087,control,0,0
188088,group,0,0
188089,(,0,0
188090,P=0.002,0,0
188091,),0,0
188092,",",0,0
188093,and,0,0
188094,OT,0,0
188095,tended,0,0
188096,to,0,0
188097,be,0,0
188098,prolonged,0,0
188099,(,0,0
188100,99.0,0,0
188101,?,0,0
188102,36.3,0,0
188103,s,0,0
188104,vs.,0,0
188105,84.0,0,0
188106,?,0,0
188107,37.5,0,0
188108,s,0,0
188109,),0,0
188110,",",0,0
188111,but,0,0
188112,not,0,0
188113,significantly,0,0
188114,.,0,0
188115,CONCLUSIONS,0,0
188116,Preoperative,0,1
188117,oral,0,1
188118,rehydration,0,1
188119,possibly,0,0
188120,increases,0,0
188121,circulating,0,0
188122,blood,0,0
188123,volume,0,0
188124,",",0,0
188125,and,0,0
188126,shortens,0,0
188127,the,0,0
188128,duration,0,0
188129,of,0,0
188130,rocuronium,0,1
188131,effect,0,0
188132,.,0,0
188133,Expanding,0,0
188134,care,0,0
188135,for,0,0
188136,perinatal,0,0
188137,women,0,0
188138,with,0,0
188139,depression,0,0
188140,(,0,1
188141,EXPONATE,0,1
188142,),0,1
188143,:,0,0
188144,study,0,0
188145,protocol,0,0
188146,for,0,0
188147,a,0,0
188148,randomized,0,0
188149,controlled,0,0
188150,trial,0,0
188151,of,0,0
188152,an,0,0
188153,intervention,0,0
188154,package,0,0
188155,for,0,0
188156,perinatal,0,0
188157,depression,0,0
188158,in,0,0
188159,primary,0,0
188160,care,0,0
188161,.,0,0
188162,BACKGROUND,0,0
188163,Depression,0,0
188164,is,0,0
188165,common,0,0
188166,among,0,0
188167,women,0,0
188168,during,0,0
188169,perinatal,0,0
188170,period,0,0
188171,and,0,0
188172,is,0,0
188173,associated,0,0
188174,with,0,0
188175,long-term,0,0
188176,adverse,0,0
188177,consequences,0,0
188178,for,0,0
188179,the,0,0
188180,mother,0,0
188181,and,0,0
188182,infant,0,0
188183,.,0,0
188184,In,0,0
188185,Nigeria,0,0
188186,",",0,0
188187,as,0,0
188188,in,0,0
188189,many,0,0
188190,other,0,0
188191,low-,0,0
188192,and-middle-income,0,0
188193,countries,0,1
188194,(,0,1
188195,LMIC,0,1
188196,),0,1
188197,",",0,0
188198,perinatal,0,0
188199,depression,0,0
188200,usually,0,0
188201,goes,0,0
188202,unrecognized,0,0
188203,and,0,0
188204,untreated,0,0
188205,.,0,0
188206,The,0,0
188207,aim,0,0
188208,of,0,0
188209,EXPONATE,0,0
188210,is,0,0
188211,to,0,0
188212,test,0,0
188213,the,0,0
188214,effectiveness,0,0
188215,and,0,0
188216,cost-effectiveness,0,0
188217,of,0,0
188218,an,0,0
188219,intervention,1,0
188220,package,1,0
188221,for,1,0
188222,perinatal,1,0
188223,depression,1,0
188224,delivered,0,0
188225,by,0,0
188226,community,0,0
188227,midwives,0,0
188228,in,0,0
188229,primary,0,0
188230,maternal,0,0
188231,care,0,0
188232,in,0,0
188233,which,0,0
188234,physician,0,0
188235,support,0,0
188236,and,0,0
188237,enhanced,0,0
188238,patient,0,0
188239,compliance,0,0
188240,are,0,0
188241,implemented,0,0
188242,using,0,0
188243,mobile,0,0
188244,phones,0,0
188245,.,0,0
188246,METHODS/STUDY,0,0
188247,DESIGN,0,1
188248,A,0,1
188249,pragmatic,0,0
188250,two-arm,0,0
188251,parallel,0,0
188252,cluster,0,0
188253,randomized,0,0
188254,controlled,0,0
188255,trial,0,0
188256,was,0,0
188257,designed,0,0
188258,.,0,0
188259,The,0,0
188260,units,0,0
188261,of,0,0
188262,allocation,0,0
188263,are,0,0
188264,the,0,0
188265,primary,0,0
188266,maternal,0,0
188267,care,0,0
188268,clinics,0,0
188269,.,0,0
188270,Thirty,0,0
188271,eligible,0,0
188272,and,0,0
188273,consenting,0,0
188274,clinics,0,0
188275,were,0,0
188276,randomized,0,0
188277,but,0,0
188278,",",0,0
188279,due,0,0
188280,to,0,0
188281,problems,0,0
188282,with,0,0
188283,logistics,0,0
188284,",",0,0
188285,29,0,0
188286,eventually,0,0
188287,participated,0,0
188288,.,0,0
188289,Consenting,0,0
188290,pregnant,0,0
188291,women,0,0
188292,with,0,0
188293,a,0,0
188294,gestational,0,0
188295,age,0,0
188296,between,0,0
188297,16,0,0
188298,and,0,0
188299,28,0,0
188300,weeks,0,0
188301,who,0,0
188302,screened,0,0
188303,positive,0,0
188304,on,0,0
188305,the,0,0
188306,Edinburgh,0,0
188307,Postnatal,0,0
188308,Depression,0,1
188309,Scale,0,1
188310,(,0,1
188311,EPDS,0,1
188312,score,0,1
188313,?12,0,1
188314,),0,1
188315,",",0,0
188316,absent,0,0
188317,psychosis,0,0
188318,or,0,0
188319,bipolar,0,0
188320,disorder,0,0
188321,",",0,0
188322,and,0,0
188323,not,0,0
188324,actively,0,0
188325,suicidal,0,0
188326,were,0,0
188327,recruited,0,0
188328,into,0,0
188329,the,0,0
188330,trial,0,0
188331,(,0,0
188332,N,0,0
188333,=,0,0
188334,686,1,0
188335,),1,0
188336,.,1,0
188337,Midwives,1,0
188338,in,1,0
188339,the,1,0
188340,intervention,1,0
188341,arm,1,0
188342,were,1,0
188343,trained,1,0
188344,to,1,0
188345,deliver,1,0
188346,psychoeducation,1,0
188347,",",1,0
188348,problem,1,0
188349,solving,1,0
188350,treatment,1,0
188351,",",1,0
188352,and,1,0
188353,parenting,1,0
188354,skills,1,0
188355,.,1,0
188356,Eight,0,0
188357,weekly,0,0
188358,sessions,0,0
188359,were,0,0
188360,delivered,0,0
188361,following,0,0
188362,entry,0,0
188363,into,0,0
188364,the,0,0
188365,study,0,0
188366,.,0,0
188367,Further,0,0
188368,sessions,0,0
188369,during,0,0
188370,pregnancy,0,0
188371,and,0,0
188372,6,0,0
188373,weeks,0,0
188374,following,0,0
188375,childbirth,0,0
188376,were,0,0
188377,determined,0,0
188378,by,0,0
188379,level,0,0
188380,of,0,0
188381,depressive,0,0
188382,symptoms,0,0
188383,.,0,0
188384,Clinical,0,0
188385,support,0,0
188386,and,0,0
188387,supervision,0,0
188388,",",0,0
188389,delivered,0,0
188390,mainly,0,0
188391,by,0,0
188392,mobile,0,0
188393,phone,0,0
188394,",",0,0
188395,were,0,0
188396,provided,0,0
188397,by,0,0
188398,general,0,0
188399,physicians,0,0
188400,and,0,0
188401,psychiatrists,0,0
188402,.,0,0
188403,Automated,0,0
188404,text,0,0
188405,and,0,0
188406,voice,0,0
188407,messages,0,0
188408,",",0,0
188409,also,0,0
188410,delivered,0,0
188411,by,0,0
188412,mobile,0,0
188413,phones,0,0
188414,",",0,0
188415,were,0,0
188416,used,0,0
188417,to,0,0
188418,facilitate,0,0
188419,patient,0,0
188420,compliance,0,0
188421,with,0,0
188422,clinic,0,0
188423,appointments,0,0
188424,and,0,0
188425,'homework,0,0
188426,',0,0
188427,tasks,1,0
188428,.,1,0
188429,Patients,1,0
188430,in,1,0
188431,the,1,0
188432,control,1,0
188433,arm,1,0
188434,received,1,0
188435,care,1,0
188436,as,1,0
188437,usual,1,0
188438,enhanced,1,0
188439,by,1,0
188440,further,1,0
188441,training,1,0
188442,of,1,0
188443,the,1,0
188444,providers,1,0
188445,in,1,0
188446,that,1,0
188447,arm,1,0
188448,in,1,0
188449,the,1,0
188450,recognition,1,0
188451,and,1,0
188452,standard,1,0
188453,treatment,1,0
188454,of,1,0
188455,depression,1,0
188456,.,1,0
188457,Assessments,0,0
188458,are,0,0
188459,undertaken,0,0
188460,at,0,0
188461,baseline,0,0
188462,",",0,0
188463,2,0,0
188464,months,0,0
188465,following,0,0
188466,recruitment,0,0
188467,into,0,0
188468,the,0,0
188469,study,0,0
188470,and,0,0
188471,3,0,0
188472,",",0,0
188473,6,0,0
188474,",",0,0
188475,9,0,0
188476,and,0,0
188477,12,0,0
188478,months,0,0
188479,after,0,0
188480,childbirth,0,0
188481,.,0,0
188482,The,0,0
188483,primary,0,0
188484,outcome,0,0
188485,is,0,0
188486,recovery,0,0
188487,from,0,0
188488,depression,0,0
188489,(,0,0
188490,EPDS,0,0
188491,<,0,0
188492,6,0,0
188493,),0,0
188494,at,0,0
188495,6,0,0
188496,months,0,0
188497,.,0,0
188498,Secondary,0,0
188499,outcomes,0,0
188500,include,0,0
188501,measures,0,0
188502,of,0,0
188503,disability,0,0
188504,",",0,0
188505,parenting,0,0
188506,skills,0,0
188507,",",0,0
188508,maternal,0,0
188509,attitudes,0,0
188510,",",0,0
188511,health,0,0
188512,care,0,0
188513,utilization,0,0
188514,as,0,0
188515,well,0,0
188516,as,0,0
188517,infant,0,0
188518,physical,0,0
188519,and,0,0
188520,cognitive,0,0
188521,development,0,0
188522,comprehensively,0,0
188523,assessed,0,0
188524,using,0,0
188525,the,0,0
188526,Bayley,0,0
188527,'s,0,0
188528,Scales,0,0
188529,.,0,0
188530,DISCUSSION,0,0
188531,To,0,0
188532,the,0,0
188533,best,0,0
188534,of,0,0
188535,our,0,0
188536,knowledge,0,0
188537,",",0,0
188538,this,0,0
188539,is,0,0
188540,the,0,0
188541,largest,0,0
188542,randomized,0,0
188543,controlled,0,0
188544,trial,0,0
188545,of,0,0
188546,an,0,0
188547,intervention,0,0
188548,package,0,0
188549,delivered,0,0
188550,by,0,0
188551,community,0,0
188552,midwives,0,0
188553,in,0,0
188554,sub-Saharan,0,0
188555,Africa,0,0
188556,.,0,0
188557,TRIAL,0,0
188558,REGISTRATION,0,0
188559,Trial,0,0
188560,is,0,0
188561,registered,0,0
188562,with,0,0
188563,the,0,0
188564,ISRTCN,0,0
188565,registry,0,0
188566,at,0,0
188567,isrtcn.com,0,0
188568,;,0,0
188569,Trial,0,0
188570,number,0,0
188571,ISRCTN60041127,0,1
188572,.,0,0
188573,Date,0,1
188574,of,0,0
188575,registration,0,0
188576,is,0,0
188577,15/05/2013,0,0
188578,.,0,0
188579,Physical,1,0
188580,exercise,1,0
188581,at,1,0
188582,the,1,0
188583,workplace,1,0
188584,reduces,0,0
188585,perceived,0,0
188586,physical,0,0
188587,exertion,0,0
188588,during,0,0
188589,healthcare,0,0
188590,work,0,0
188591,:,0,0
188592,cluster,0,0
188593,randomized,0,0
188594,controlled,0,0
188595,trial,0,0
188596,.,0,0
188597,BACKGROUND,0,0
188598,High,1,0
188599,physical,1,0
188600,exertion,1,0
188601,during,0,0
188602,work,0,0
188603,is,0,0
188604,a,0,0
188605,risk,0,0
188606,factor,0,0
188607,for,0,0
188608,musculoskeletal,0,0
188609,pain,0,0
188610,and,0,0
188611,long-term,0,0
188612,sickness,0,0
188613,absence,0,0
188614,.,0,0
188615,Physical,0,0
188616,exertion,0,1
188617,(,0,1
188618,RPE,0,1
188619,),0,0
188620,reflects,0,0
188621,the,0,0
188622,balance,0,0
188623,between,0,0
188624,physical,0,0
188625,work,0,0
188626,demands,0,0
188627,and,0,0
188628,physical,0,0
188629,capacity,0,0
188630,of,0,0
188631,the,0,0
188632,individual,0,0
188633,.,0,0
188634,Thus,0,0
188635,",",0,0
188636,increasing,0,0
188637,the,0,0
188638,physical,0,0
188639,capacity,0,0
188640,through,0,0
188641,physical,0,0
188642,exercise,0,0
188643,may,0,0
188644,decrease,0,0
188645,physical,0,0
188646,exertion,0,0
188647,during,0,0
188648,work,0,0
188649,.,0,0
188650,This,0,0
188651,study,0,0
188652,investigates,0,0
188653,the,0,0
188654,effect,0,0
188655,of,0,0
188656,workplace-based,0,0
188657,versus,0,0
188658,home-based,0,0
188659,physical,0,1
188660,exercise,0,0
188661,on,0,0
188662,physical,0,0
188663,exertion,0,0
188664,during,0,0
188665,work,0,0
188666,(,0,0
188667,WRPE,0,1
188668,),0,1
188669,among,0,0
188670,healthcare,0,0
188671,workers,0,0
188672,.,0,0
188673,METHODS,0,0
188674,200,0,0
188675,female,0,0
188676,healthcare,0,1
188677,workers,0,1
188678,(,0,0
188679,age,0,0
188680,:,0,0
188681,42.0,0,0
188682,",",0,0
188683,body,0,0
188684,mass,0,0
188685,index,0,0
188686,:,0,0
188687,24.1,0,0
188688,",",0,0
188689,average,0,0
188690,pain,0,0
188691,intensity,0,0
188692,:,0,0
188693,3.1,0,0
188694,on,0,0
188695,a,0,0
188696,scale,0,0
188697,of,0,0
188698,0,0,0
188699,to,0,0
188700,10,0,0
188701,",",0,0
188702,average,0,0
188703,WRPE,0,0
188704,:,0,0
188705,3.6,0,0
188706,on,0,0
188707,a,0,0
188708,scale,0,0
188709,of,0,0
188710,0,0,0
188711,to,0,0
188712,10,0,0
188713,),0,0
188714,from,0,0
188715,18,0,0
188716,departments,0,0
188717,at,0,0
188718,three,0,0
188719,participating,0,0
188720,hospitals,0,0
188721,.,0,0
188722,Participants,0,0
188723,were,0,0
188724,randomly,0,0
188725,allocated,0,0
188726,at,0,0
188727,the,0,0
188728,cluster,0,0
188729,level,0,0
188730,to,0,0
188731,10,0,0
188732,weeks,0,0
188733,of,0,0
188734,:,0,0
188735,(,1,0
188736,1,1,1
188737,),1,0
188738,workplace,1,1
188739,physical,1,1
188740,exercise,1,1
188741,(,1,1
188742,WORK,1,1
188743,),1,0
188744,performed,1,0
188745,in,1,0
188746,groups,1,0
188747,during,1,0
188748,working,1,1
188749,hours,1,0
188750,for,1,0
188751,5?10,1,1
188752,minutes,1,0
188753,per,1,0
188754,week,1,0
188755,and,1,0
188756,up,1,0
188757,to,1,0
188758,five,1,0
188759,group-based,1,0
188760,coaching,1,0
188761,sessions,1,0
188762,on,1,0
188763,motivation,1,0
188764,for,1,0
188765,regular,1,0
188766,physical,1,0
188767,exercise,1,0
188768,",",1,0
188769,or,1,0
188770,(,1,1
188771,2,1,1
188772,),1,0
188773,home-based,1,1
188774,physical,1,1
188775,exercise,1,1
188776,(,1,1
188777,HOME,1,1
188778,),1,0
188779,performed,1,0
188780,during,1,0
188781,leisure,1,0
188782,time,1,0
188783,for,1,0
188784,5?10,1,0
188785,minutes,1,0
188786,per,1,0
188787,week,1,0
188788,.,1,0
188789,Physical,0,0
188790,exertion,0,0
188791,was,0,0
188792,assessed,0,0
188793,at,0,0
188794,baseline,0,0
188795,and,0,0
188796,at,0,0
188797,10-week,0,0
188798,follow-up,0,0
188799,.,0,0
188800,RESULTS,0,0
188801,2.2,0,0
188802,(,0,0
188803,SD,0,0
188804,:,0,0
188805,1.1,0,0
188806,),0,0
188807,and,0,0
188808,1.0,0,1
188809,(,0,0
188810,SD,0,1
188811,:,0,1
188812,1.2,0,0
188813,),0,0
188814,training,0,0
188815,sessions,0,0
188816,were,0,0
188817,performed,0,0
188818,per,0,0
188819,week,0,0
188820,in,0,0
188821,WORK,0,0
188822,and,0,0
188823,HOME,0,0
188824,",",0,0
188825,respectively,0,0
188826,.,0,0
188827,Physical,0,0
188828,exertion,0,0
188829,was,0,0
188830,reduced,0,0
188831,more,0,0
188832,in,0,0
188833,WORK,0,1
188834,than,0,0
188835,HOME,0,0
188836,(,0,0
188837,p,0,0
188838,<,0,0
188839,0.01,0,0
188840,),0,0
188841,.,0,0
188842,Between-group,0,0
188843,differences,0,0
188844,in,0,0
188845,physical,0,0
188846,exertion,0,0
188847,at,0,0
188848,follow-up,0,0
188849,(,0,0
188850,WORK,0,0
188851,vs.,0,0
188852,HOME,0,0
188853,),0,0
188854,was,0,0
188855,-0.5,0,0
188856,points,0,0
188857,(,0,0
188858,95,0,0
188859,%,0,0
188860,CI,0,0
188861,-0.8,0,0
188862,to,0,0
188863,-0.2,0,0
188864,),0,0
188865,.,0,0
188866,Within-group,0,0
188867,effect,0,0
188868,size,0,0
188869,(,0,0
188870,Cohen,0,1
188871,'s,0,1
188872,d,0,1
188873,),0,0
188874,in,0,0
188875,WORK,0,1
188876,and,0,0
188877,HOME,0,0
188878,was,0,0
188879,0.43,0,0
188880,and,0,0
188881,0.13,0,0
188882,",",0,0
188883,respectively,0,0
188884,.,0,0
188885,CONCLUSIONS,1,0
188886,Physical,1,0
188887,exercise,1,0
188888,performed,1,0
188889,at,0,0
188890,the,0,0
188891,workplace,0,0
188892,appears,0,0
188893,more,0,0
188894,effective,0,0
188895,than,1,0
188896,home-based,1,0
188897,exercise,1,0
188898,in,1,0
188899,reducing,0,0
188900,physical,0,0
188901,exertion,0,0
188902,during,0,0
188903,daily,0,1
188904,work,0,0
188905,tasks,0,0
188906,in,0,0
188907,healthcare,0,0
188908,workers,0,0
188909,.,0,0
188910,Transcranial,1,0
188911,Magnetic,1,0
188912,Stimulation,1,0
188913,to,0,0
188914,Address,0,0
188915,Mild,0,0
188916,Cognitive,0,0
188917,Impairment,0,0
188918,in,0,0
188919,the,0,0
188920,Elderly,0,0
188921,:,0,0
188922,A,0,0
188923,Randomized,0,0
188924,Controlled,0,0
188925,Study,0,0
188926,.,0,0
188927,Transcranial,1,0
188928,magnetic,1,0
188929,stimulation,1,0
188930,(,1,1
188931,TMS,1,1
188932,),1,0
188933,is,0,0
188934,a,0,0
188935,noninvasive,0,0
188936,brain,0,0
188937,stimulation,0,0
188938,technique,0,0
188939,with,0,0
188940,potential,0,0
188941,to,0,0
188942,improve,0,0
188943,memory,0,0
188944,.,0,0
188945,Mild,0,0
188946,cognitive,0,0
188947,impairment,0,1
188948,(,0,1
188949,MCI,0,1
188950,),0,1
188951,",",0,0
188952,which,0,0
188953,still,0,0
188954,lacks,0,0
188955,a,0,0
188956,specific,0,0
188957,therapy,0,0
188958,",",0,0
188959,is,0,0
188960,a,0,0
188961,clinical,0,0
188962,syndrome,0,0
188963,associated,0,0
188964,with,0,0
188965,increased,0,0
188966,risk,0,0
188967,of,0,0
188968,dementia,0,0
188969,.,0,0
188970,This,0,0
188971,study,0,0
188972,aims,0,0
188973,to,0,0
188974,assess,0,0
188975,the,0,0
188976,effects,0,0
188977,of,0,0
188978,high-frequency,1,0
188979,repetitive,1,0
188980,TMS,1,1
188981,(,1,1
188982,HF,1,1
188983,rTMS,1,1
188984,),1,1
188985,on,0,0
188986,everyday,0,0
188987,memory,0,0
188988,of,0,0
188989,the,0,0
188990,elderly,0,0
188991,with,0,0
188992,MCI,0,0
188993,.,0,0
188994,We,0,0
188995,conducted,0,0
188996,a,0,0
188997,double-blinded,0,1
188998,randomized,0,1
188999,sham-controlled,0,1
189000,trial,0,0
189001,using,0,0
189002,rTMS,1,0
189003,over,0,0
189004,the,0,0
189005,left,0,0
189006,dorsolateral,0,0
189007,prefrontal,0,1
189008,cortex,0,1
189009,(,0,1
189010,DLPFC,0,1
189011,),0,0
189012,.,0,0
189013,Thirty-four,0,0
189014,elderly,0,0
189015,outpatients,0,0
189016,meeting,0,0
189017,Petersen,0,1
189018,'s,0,1
189019,MCI,0,0
189020,criteria,0,0
189021,were,0,0
189022,randomly,0,0
189023,assigned,0,0
189024,to,0,0
189025,receive,1,0
189026,10,1,0
189027,sessions,1,0
189028,of,1,0
189029,either,1,0
189030,active,1,0
189031,TMS,1,0
189032,or,1,0
189033,sham,1,0
189034,",",1,0
189035,10,1,0
189036,Hz,1,0
189037,rTMS,1,0
189038,at,1,0
189039,110,1,0
189040,%,1,0
189041,of,1,0
189042,motor,1,0
189043,threshold,1,1
189044,",",1,0
189045,"2,000",1,0
189046,pulses,1,1
189047,per,1,0
189048,session,1,0
189049,.,1,0
189050,Neuropsychological,1,0
189051,assessment,1,0
189052,at,1,0
189053,baseline,1,0
189054,",",1,0
189055,after,1,0
189056,the,1,0
189057,last,1,0
189058,session,1,0
189059,(,1,1
189060,10th,1,1
189061,),1,1
189062,and,1,0
189063,at,1,0
189064,one-month,1,0
189065,follow-up,1,0
189066,",",1,0
189067,was,1,0
189068,applied,1,0
189069,.,1,0
189070,ANOVA,0,0
189071,on,0,0
189072,the,0,0
189073,primary,0,0
189074,efficacy,0,0
189075,measure,0,0
189076,",",0,0
189077,the,0,0
189078,Rivermead,0,0
189079,Behavioural,0,0
189080,Memory,0,0
189081,Test,0,0
189082,",",0,0
189083,revealed,0,0
189084,a,0,0
189085,significant,0,0
189086,group-by-time,0,0
189087,interaction,0,0
189088,(,0,0
189089,p,0,0
189090,=,0,0
189091,0.05,0,0
189092,),0,0
189093,",",0,0
189094,favoring,0,0
189095,the,0,0
189096,active,0,0
189097,group,0,0
189098,.,0,0
189099,The,0,0
189100,improvement,0,0
189101,was,0,0
189102,kept,0,0
189103,after,0,0
189104,one,0,0
189105,month,0,0
189106,.,0,0
189107,Other,0,0
189108,neuropsychological,0,0
189109,tests,0,0
189110,were,0,0
189111,heterogeneous,1,0
189112,.,1,0
189113,rTMS,1,0
189114,at,1,0
189115,10,0,0
189116,Hz,0,0
189117,enhanced,0,0
189118,everyday,0,0
189119,memory,0,0
189120,in,0,0
189121,elderly,0,0
189122,with,0,0
189123,MCI,0,0
189124,after,0,0
189125,10,0,0
189126,sessions,0,0
189127,.,0,0
189128,These,0,0
189129,findings,0,0
189130,suggest,0,0
189131,that,0,0
189132,rTMS,1,0
189133,might,1,0
189134,be,0,0
189135,effective,0,0
189136,as,0,0
189137,a,0,0
189138,therapy,0,0
189139,for,0,0
189140,MCI,0,0
189141,and,0,0
189142,probably,0,0
189143,a,0,0
189144,tool,0,0
189145,to,0,0
189146,delay,0,0
189147,deterioration,0,0
189148,.,0,0
189149,Fixed-dose,0,1
189150,combination,0,0
189151,of,0,0
189152,AR-13324,1,1
189153,and,1,0
189154,latanoprost,1,1
189155,:,1,1
189156,a,0,0
189157,double-masked,0,1
189158,",",0,1
189159,28-day,0,1
189160,",",0,1
189161,randomised,0,1
189162,",",0,0
189163,controlled,0,0
189164,study,0,0
189165,in,0,0
189166,patients,0,0
189167,with,0,0
189168,open-angle,0,0
189169,glaucoma,0,0
189170,or,0,0
189171,ocular,0,0
189172,hypertension,0,0
189173,.,0,0
189174,BACKGROUND/AIMS,0,0
189175,To,0,0
189176,evaluate,0,0
189177,the,0,0
189178,ocular,0,1
189179,hypotensive,0,1
189180,efficacy,0,1
189181,of,0,1
189182,fixed-dose,0,1
189183,combinations,0,0
189184,of,0,0
189185,the,0,0
189186,Rho,1,1
189187,kinase,1,1
189188,inhibitor,1,1
189189,and,1,1
189190,norepinephrine,1,1
189191,transport,1,1
189192,inhibitor,1,1
189193,AR-13324,1,1
189194,(,0,0
189195,0.01,0,0
189196,%,0,0
189197,and,0,0
189198,0.02,0,0
189199,%,0,0
189200,),0,0
189201,and,0,0
189202,latanoprost,1,1
189203,(,0,1
189204,PG324,0,1
189205,Ophthalmic,0,1
189206,Solution,0,0
189207,),0,0
189208,relative,0,0
189209,to,0,0
189210,the,0,0
189211,active,0,0
189212,components,0,0
189213,AR-13324,1,0
189214,0.02,0,0
189215,%,0,0
189216,and,0,0
189217,latanoprost,0,0
189218,0.005,0,0
189219,%,0,0
189220,",",0,0
189221,used,0,0
189222,bilaterally,0,0
189223,at,0,0
189224,night,0,0
189225,.,0,0
189226,METHODS,0,0
189227,This,0,0
189228,was,0,0
189229,a,0,0
189230,double-masked,0,1
189231,",",0,1
189232,randomised,0,1
189233,",",0,0
189234,parallel,0,0
189235,comparison,0,0
189236,study,0,0
189237,in,0,0
189238,patients,0,0
189239,with,0,0
189240,open-angle,0,0
189241,glaucoma,0,0
189242,or,0,0
189243,ocular,0,0
189244,hypertension,0,0
189245,.,0,0
189246,After,0,0
189247,washout,0,1
189248,",",0,0
189249,patients,0,0
189250,were,0,0
189251,randomised,0,0
189252,to,0,0
189253,one,0,0
189254,of,0,0
189255,four,0,0
189256,treatment,0,0
189257,arms,0,0
189258,and,0,0
189259,treated,0,0
189260,for,0,0
189261,28,0,0
189262,days,0,0
189263,.,0,0
189264,The,0,0
189265,primary,0,0
189266,efficacy,0,0
189267,variable,0,0
189268,was,0,0
189269,mean,0,0
189270,diurnal,0,0
189271,intraocular,0,0
189272,pressure,0,1
189273,(,0,1
189274,IOP,0,1
189275,),0,1
189276,at,0,0
189277,day,0,0
189278,29,0,0
189279,.,0,0
189280,RESULTS,0,0
189281,We,0,0
189282,randomised,0,0
189283,298,0,0
189284,patients,0,0
189285,",",0,0
189286,of,0,0
189287,whom,0,0
189288,292,0,0
189289,(,0,0
189290,98,0,0
189291,%,0,0
189292,),0,0
189293,completed,0,0
189294,the,0,0
189295,study,0,0
189296,.,0,0
189297,Mean,0,0
189298,unmedicated,0,0
189299,diurnal,0,1
189300,IOPs,0,1
189301,(,0,0
189302,study,0,0
189303,eye,0,1
189304,),0,0
189305,was,0,0
189306,25.1,0,0
189307,",",0,0
189308,25.1,0,0
189309,",",0,0
189310,26.0,0,0
189311,and,0,0
189312,25.4,0,0
189313,in,0,0
189314,the,0,0
189315,PG324,0,0
189316,0.01,0,0
189317,%,0,0
189318,",",0,0
189319,PG324,0,0
189320,0.02,0,0
189321,%,0,0
189322,",",0,0
189323,latanoprost,0,1
189324,and,0,0
189325,AR-13324,0,0
189326,0.02,0,0
189327,%,0,0
189328,groups,0,0
189329,",",0,0
189330,respectively,0,0
189331,.,0,0
189332,On,0,0
189333,day,0,0
189334,29,0,0
189335,",",0,0
189336,mean,0,0
189337,diurnal,0,0
189338,IOP,0,0
189339,decreased,0,0
189340,to,0,0
189341,17.3,0,0
189342,",",0,0
189343,16.5,0,0
189344,",",0,0
189345,18.4,0,0
189346,and,0,0
189347,19.1,0,0
189348,mm,0,0
189349,Hg,0,0
189350,",",0,0
189351,respectively,0,0
189352,.,0,0
189353,For,0,0
189354,the,0,0
189355,primary,0,0
189356,efficacy,0,0
189357,variable,0,0
189358,of,0,0
189359,mean,0,0
189360,diurnal,0,0
189361,IOP,0,0
189362,at,0,0
189363,day,0,0
189364,29,0,0
189365,",",0,0
189366,PG324,0,0
189367,0.02,0,0
189368,%,0,0
189369,met,0,0
189370,the,0,0
189371,criterion,0,0
189372,for,0,0
189373,statistical,0,0
189374,superiority,0,0
189375,relative,0,0
189376,to,0,0
189377,both,0,0
189378,latanoprost,0,1
189379,and,0,0
189380,AR-13324,0,0
189381,0.02,0,0
189382,%,0,0
189383,(,0,0
189384,p,0,0
189385,<,0,0
189386,0.0001,0,0
189387,),0,0
189388,",",0,0
189389,providing,0,0
189390,additional,0,0
189391,IOP,0,0
189392,lowering,0,0
189393,of,0,0
189394,1.9,0,0
189395,and,0,0
189396,2.6,0,0
189397,mm,0,0
189398,Hg,0,0
189399,",",0,0
189400,respectively,0,0
189401,.,0,0
189402,PG324,0,0
189403,0.01,0,0
189404,%,0,0
189405,also,0,0
189406,met,0,0
189407,the,0,0
189408,criterion,0,0
189409,for,0,0
189410,superiority,0,0
189411,.,0,0
189412,The,0,0
189413,most,0,0
189414,frequently,0,0
189415,reported,0,0
189416,adverse,0,0
189417,event,0,0
189418,was,0,0
189419,conjunctival,0,0
189420,hyperaemia,0,0
189421,with,0,0
189422,an,0,0
189423,incidence,0,0
189424,of,0,0
189425,41,0,0
189426,%,0,0
189427,(,0,0
189428,30/73,0,0
189429,),0,0
189430,",",0,0
189431,40,0,0
189432,%,0,0
189433,(,0,0
189434,29/73,0,0
189435,),0,0
189436,",",0,0
189437,14,0,0
189438,%,0,0
189439,(,0,0
189440,10/73,0,0
189441,),0,0
189442,and,0,0
189443,40,0,0
189444,%,0,0
189445,(,0,0
189446,31/78,0,0
189447,),0,0
189448,in,0,0
189449,the,0,0
189450,PG324,0,0
189451,0.01,0,0
189452,%,0,0
189453,",",0,0
189454,PG324,0,0
189455,0.02,0,0
189456,%,0,0
189457,",",0,0
189458,latanoprost,1,1
189459,and,1,0
189460,AR-13324,1,0
189461,0.02,0,0
189462,%,0,0
189463,groups,0,0
189464,",",0,0
189465,respectively,0,0
189466,.,0,0
189467,CONCLUSIONS,0,0
189468,In,0,0
189469,this,0,0
189470,short-term,0,0
189471,study,0,0
189472,",",0,0
189473,the,0,0
189474,fixed-dose,0,1
189475,combination,1,0
189476,of,1,0
189477,AR-13324,1,0
189478,0.02,0,0
189479,%,0,0
189480,and,0,0
189481,latanoprost,0,0
189482,0.005,0,0
189483,%,0,0
189484,in,0,0
189485,PG324,0,0
189486,Ophthalmic,0,0
189487,Solution,0,0
189488,provides,0,0
189489,clinically,0,0
189490,and,0,0
189491,statistically,0,0
189492,superior,0,0
189493,ocular,0,1
189494,hypotensive,0,1
189495,efficacy,0,1
189496,relative,0,0
189497,to,0,0
189498,its,0,0
189499,individual,0,0
189500,active,0,0
189501,components,0,0
189502,at,0,0
189503,the,0,0
189504,same,0,0
189505,concentrations,0,0
189506,.,0,0
189507,The,0,0
189508,only,0,0
189509,safety,0,0
189510,finding,0,0
189511,of,0,0
189512,note,0,0
189513,was,0,0
189514,transient,0,0
189515,asymptomatic,0,0
189516,conjunctival,0,0
189517,hyperaemia,0,0
189518,which,0,0
189519,was,0,0
189520,typically,0,0
189521,of,0,0
189522,mild,0,0
189523,severity,0,0
189524,.,0,0
189525,TRIAL,0,0
189526,REGISTRATION,0,1
189527,NUMBER,0,1
189528,NCT02207491,0,1
189529,.,0,0
189530,Women,0,0
189531,With,0,0
189532,Gestational,0,0
189533,Diabetes,0,0
189534,Mellitus,0,0
189535,Randomized,0,0
189536,to,0,0
189537,a,0,0
189538,Higher-Complex,0,0
189539,Carbohydrate/Low-Fat,0,1
189540,Diet,0,0
189541,Manifest,0,0
189542,Lower,0,0
189543,Adipose,0,0
189544,Tissue,0,0
189545,Insulin,0,1
189546,Resistance,0,0
189547,",",0,0
189548,Inflammation,0,0
189549,",",0,0
189550,Glucose,0,1
189551,",",0,0
189552,and,0,0
189553,Free,0,1
189554,Fatty,0,0
189555,Acids,0,0
189556,:,0,0
189557,A,0,0
189558,Pilot,0,0
189559,Study,0,0
189560,.,0,0
189561,OBJECTIVE,0,0
189562,Diet,0,0
189563,therapy,0,0
189564,in,0,0
189565,gestational,0,0
189566,diabetes,0,1
189567,mellitus,0,1
189568,(,0,1
189569,GDM,0,1
189570,),0,0
189571,has,0,0
189572,focused,0,0
189573,on,0,0
189574,carbohydrate,0,0
189575,restriction,0,0
189576,but,0,0
189577,is,0,0
189578,poorly,0,0
189579,substantiated,0,0
189580,.,0,0
189581,In,0,0
189582,this,0,0
189583,pilot,0,0
189584,randomized,0,0
189585,clinical,0,0
189586,trial,0,0
189587,",",0,0
189588,we,0,0
189589,challenged,0,0
189590,the,0,0
189591,conventional,1,0
189592,low-carbohydrate/higher-fat,1,0
189593,(,1,1
189594,LC/CONV,1,1
189595,),1,1
189596,diet,1,1
189597,",",0,1
189598,hypothesizing,0,0
189599,that,0,0
189600,a,0,0
189601,higher-complex,1,0
189602,carbohydrate/lower-fat,1,1
189603,(,1,1
189604,CHOICE,1,1
189605,),1,1
189606,diet,1,1
189607,would,0,0
189608,improve,0,0
189609,maternal,0,0
189610,insulin,0,1
189611,resistance,0,1
189612,(,0,1
189613,IR,0,1
189614,),0,1
189615,",",0,0
189616,adipose,0,1
189617,tissue,0,0
189618,(,0,1
189619,AT,0,1
189620,),0,1
189621,lipolysis,0,1
189622,",",0,1
189623,and,0,0
189624,infant,0,0
189625,adiposity,0,0
189626,.,0,0
189627,RESEARCH,0,0
189628,DESIGN,0,1
189629,AND,0,1
189630,METHODS,0,1
189631,At,0,0
189632,31,0,0
189633,weeks,0,0
189634,",",0,0
189635,12,0,0
189636,diet-controlled,0,0
189637,overweight/obese,0,0
189638,women,0,0
189639,with,0,0
189640,GDM,0,0
189641,were,0,0
189642,randomized,0,0
189643,to,0,0
189644,an,0,0
189645,isocaloric,0,1
189646,LC/CONV,0,1
189647,(,0,0
189648,40,0,0
189649,%,0,0
189650,carbohydrate/45,0,0
189651,%,0,0
189652,fat/15,0,0
189653,%,0,0
189654,protein,0,0
189655,;,0,0
189656,n,0,0
189657,=,0,0
189658,6,0,0
189659,),0,0
189660,or,0,0
189661,CHOICE,1,1
189662,(,0,0
189663,60,0,0
189664,%,0,0
189665,/25,0,0
189666,%,0,0
189667,/15,0,0
189668,%,0,0
189669,;,0,0
189670,n,0,0
189671,=,0,0
189672,6,0,0
189673,),0,0
189674,diet,1,1
189675,.,1,1
189676,All,0,1
189677,meals,1,1
189678,were,0,0
189679,provided,0,0
189680,.,0,0
189681,AT,0,0
189682,was,0,0
189683,biopsied,0,0
189684,at,0,0
189685,37,0,0
189686,weeks,0,0
189687,.,0,0
189688,RESULTS,0,0
189689,After,0,0
189690,?7,0,0
189691,weeks,0,0
189692,",",0,1
189693,fasting,0,1
189694,glucose,0,1
189695,(,0,0
189696,P,0,0
189697,=,0,0
189698,0.03,0,0
189699,),0,0
189700,and,0,0
189701,free,0,0
189702,fatty,0,1
189703,acids,0,1
189704,(,0,0
189705,P,0,0
189706,=,0,0
189707,0.06,0,0
189708,),0,0
189709,decreased,0,0
189710,on,0,0
189711,CHOICE,0,0
189712,",",0,0
189713,whereas,0,0
189714,fasting,0,1
189715,glucose,0,1
189716,increased,0,1
189717,on,0,0
189718,LC/CONV,0,0
189719,(,0,0
189720,P,0,0
189721,=,0,0
189722,0.03,0,0
189723,),0,0
189724,.,0,0
189725,Insulin,0,1
189726,suppression,0,0
189727,of,0,0
189728,AT,0,1
189729,lipolysis,0,1
189730,was,0,0
189731,improved,0,0
189732,on,0,0
189733,CHOICE,0,0
189734,versus,0,0
189735,LC/CONV,0,0
189736,(,0,0
189737,56,0,0
189738,vs.,0,0
189739,31,0,0
189740,%,0,0
189741,",",0,0
189742,P,0,0
189743,=,0,0
189744,0.005,0,0
189745,),0,0
189746,",",0,0
189747,consistent,0,0
189748,with,0,0
189749,improved,0,0
189750,IR,0,0
189751,.,0,0
189752,AT,0,0
189753,expression,0,0
189754,of,0,0
189755,multiple,0,0
189756,proinflammatory,0,0
189757,genes,0,0
189758,was,0,0
189759,lower,0,0
189760,on,0,0
189761,CHOICE,0,0
189762,(,0,0
189763,P,0,0
189764,<,0,0
189765,0.01,0,0
189766,),0,0
189767,.,0,0
189768,Infant,0,0
189769,adiposity,0,0
189770,trended,0,0
189771,lower,0,0
189772,with,0,0
189773,CHOICE,0,0
189774,(,0,0
189775,10.1,0,0
189776,?,0,0
189777,1.4,0,0
189778,vs.,0,0
189779,12.6,0,0
189780,?,0,0
189781,2,0,0
189782,%,0,0
189783,",",0,0
189784,respectively,0,0
189785,),0,0
189786,.,0,0
189787,CONCLUSIONS,0,0
189788,A,0,1
189789,CHOICE,0,1
189790,diet,0,1
189791,may,0,0
189792,improve,0,0
189793,maternal,0,0
189794,IR,0,1
189795,and,0,0
189796,infant,0,0
189797,adiposity,0,0
189798,",",0,0
189799,challenging,0,0
189800,recommendations,0,0
189801,for,0,0
189802,a,0,0
189803,LC/CONV,0,1
189804,diet,0,1
189805,.,0,0
189806,Cost,0,0
189807,effectiveness,0,0
189808,of,0,0
189809,treatment,1,0
189810,with,1,0
189811,percutaneous,1,0
189812,Kirschner,1,0
189813,wires,1,0
189814,versus,1,0
189815,volar,1,0
189816,locking,1,0
189817,plate,1,0
189818,for,0,0
189819,adult,0,0
189820,patients,0,0
189821,with,0,0
189822,a,0,0
189823,dorsally,0,0
189824,displaced,0,0
189825,fracture,0,0
189826,of,0,0
189827,the,0,0
189828,distal,0,0
189829,radius,0,0
189830,:,0,0
189831,analysis,0,0
189832,from,0,0
189833,the,0,0
189834,DRAFFT,0,0
189835,trial,0,0
189836,.,0,0
189837,We,0,0
189838,present,0,0
189839,an,0,0
189840,economic,0,0
189841,evaluation,0,0
189842,using,0,0
189843,data,0,0
189844,from,0,0
189845,the,0,0
189846,Distal,0,0
189847,Radius,0,0
189848,Acute,0,0
189849,Fracture,0,0
189850,Fixation,0,0
189851,Trial,0,0
189852,(,0,0
189853,DRAFFT,0,1
189854,),0,0
189855,to,0,0
189856,compare,0,0
189857,the,0,0
189858,relative,0,0
189859,cost,0,0
189860,effectiveness,0,0
189861,of,0,0
189862,percutaneous,1,0
189863,Kirschner,1,0
189864,wire,1,1
189865,(,1,1
189866,K-wire,1,1
189867,),1,1
189868,fixation,1,0
189869,and,1,0
189870,volar,1,0
189871,locking-plate,1,0
189872,fixation,1,0
189873,for,0,0
189874,patients,0,0
189875,with,0,0
189876,dorsally-displaced,0,0
189877,fractures,0,0
189878,of,0,0
189879,the,0,0
189880,distal,0,0
189881,radius,0,0
189882,.,0,0
189883,The,0,0
189884,cost,0,0
189885,effectiveness,0,0
189886,analysis,0,0
189887,(,0,0
189888,cost,0,0
189889,per,0,0
189890,quality-adjusted,0,0
189891,life,0,1
189892,year,0,1
189893,;,0,1
189894,QALY,0,1
189895,),0,0
189896,was,0,0
189897,derived,0,0
189898,from,0,0
189899,a,0,0
189900,multi-centre,0,0
189901,",",0,0
189902,two-arm,0,0
189903,",",0,0
189904,parallel,0,0
189905,group,0,0
189906,",",0,0
189907,assessor-blind,0,0
189908,",",0,0
189909,randomised,0,0
189910,controlled,0,0
189911,trial,0,0
189912,which,0,0
189913,took,0,0
189914,place,0,0
189915,in,0,0
189916,18,0,0
189917,trauma,0,0
189918,centres,0,0
189919,in,0,0
189920,the,0,0
189921,United,0,0
189922,Kingdom,0,0
189923,.,0,0
189924,Data,0,0
189925,from,0,0
189926,460,0,0
189927,patients,0,0
189928,were,0,0
189929,available,0,0
189930,for,0,0
189931,analysis,0,0
189932,",",0,0
189933,which,0,0
189934,includes,0,0
189935,both,0,0
189936,a,0,0
189937,National,0,0
189938,Health,0,0
189939,Service,0,0
189940,cost,0,0
189941,perspective,0,0
189942,including,0,0
189943,costs,0,0
189944,of,0,0
189945,surgery,0,0
189946,",",0,0
189947,implants,0,0
189948,and,0,0
189949,healthcare,0,0
189950,resource,0,0
189951,use,0,0
189952,over,0,0
189953,a,0,0
189954,12-month,0,0
189955,period,0,0
189956,after,0,0
189957,surgery,0,0
189958,",",0,0
189959,and,0,0
189960,a,0,0
189961,societal,0,0
189962,perspective,0,0
189963,",",0,0
189964,which,0,0
189965,includes,0,0
189966,the,0,0
189967,cost,0,0
189968,of,0,0
189969,time,0,0
189970,off,0,0
189971,work,0,0
189972,and,0,0
189973,the,0,0
189974,need,0,0
189975,for,0,0
189976,additional,0,0
189977,private,0,0
189978,care,0,0
189979,.,0,0
189980,There,0,0
189981,was,0,0
189982,only,0,0
189983,a,0,0
189984,small,0,0
189985,difference,0,0
189986,in,0,0
189987,QALYs,0,0
189988,gained,0,0
189989,for,0,0
189990,patients,0,0
189991,treated,0,0
189992,with,0,0
189993,locking-plate,1,0
189994,fixation,1,0
189995,over,0,0
189996,those,0,0
189997,treated,0,0
189998,with,0,0
189999,K-wires,1,0
190000,.,1,0
190001,At,0,0
190002,a,0,0
190003,mean,0,0
190004,additional,0,0
190005,cost,0,0
190006,of,0,0
190007,?714,0,0
190008,(,0,0
190009,95,0,0
190010,%,0,0
190011,confidence,0,0
190012,interval,0,0
190013,588,0,0
190014,to,0,0
190015,865,0,0
190016,),0,0
190017,per,0,0
190018,patient,0,0
190019,",",0,0
190020,locking-plate,0,0
190021,fixation,0,0
190022,presented,0,0
190023,an,0,0
190024,incremental,0,0
190025,cost,0,0
190026,effectiveness,0,1
190027,ratio,0,0
190028,(,0,1
190029,ICER,0,1
190030,),0,0
190031,of,0,0
190032,"?89,322",0,0
190033,per,0,0
190034,QALY,0,0
190035,within,0,0
190036,the,0,0
190037,first,0,0
190038,12,0,0
190039,months,0,0
190040,of,0,0
190041,treatment,0,0
190042,.,0,0
190043,Sensitivity,0,0
190044,analyses,0,0
190045,were,0,0
190046,undertaken,0,0
190047,to,0,0
190048,assess,0,0
190049,the,0,0
190050,ICER,0,0
190051,of,0,0
190052,locking-plate,1,0
190053,fixation,1,0
190054,compared,1,0
190055,with,1,0
190056,K-wires,1,0
190057,.,1,0
190058,These,0,0
190059,were,0,0
190060,greater,0,0
190061,than,0,0
190062,"?30,000",0,0
190063,.,0,0
190064,Compared,0,0
190065,with,1,0
190066,locking-plate,1,0
190067,fixation,1,0
190068,",",1,0
190069,K-wire,1,0
190070,fixation,1,0
190071,is,0,0
190072,a,0,0
190073,'cost,0,0
190074,saving,0,0
190075,',0,0
190076,intervention,0,0
190077,",",0,0
190078,with,0,0
190079,similar,0,0
190080,health,0,0
190081,benefits,0,0
190082,.,0,0
190083,Recruitment,0,0
190084,and,0,0
190085,Reasons,0,0
190086,for,0,0
190087,Non-Participation,0,0
190088,in,0,0
190089,a,0,0
190090,Family-Coping-Orientated,1,0
190091,Palliative,1,0
190092,Home,1,0
190093,Care,1,0
190094,Trial,0,0
190095,(,0,1
190096,FamCope,0,1
190097,),0,1
190098,.,0,0
190099,Cancer,0,0
190100,patients,0,0
190101,and,0,0
190102,their,0,0
190103,family,0,0
190104,caregivers,0,0
190105,need,0,0
190106,support,0,0
190107,to,0,0
190108,cope,0,0
190109,with,0,0
190110,physical,0,0
190111,",",0,0
190112,psychosocial,0,0
190113,",",0,0
190114,and,0,0
190115,existential,0,0
190116,problems,0,0
190117,early,0,0
190118,in,0,0
190119,the,0,0
190120,palliative,0,0
190121,care,0,0
190122,trajectory,0,0
190123,.,0,0
190124,Many,0,0
190125,interventions,0,0
190126,target,0,0
190127,patient,0,0
190128,symptomatology,0,0
190129,",",0,0
190130,with,0,0
190131,health,0,0
190132,care,0,0
190133,professionals,0,0
190134,acting,0,0
190135,as,0,0
190136,problem-solvers,0,0
190137,.,0,0
190138,Family,0,0
190139,coping,0,0
190140,",",0,0
190141,however,0,0
190142,",",0,0
190143,is,0,0
190144,a,0,0
190145,new,0,0
190146,research,0,0
190147,area,0,0
190148,within,0,0
190149,palliative,0,0
190150,care,0,0
190151,.,0,0
190152,The,0,0
190153,FamCope,1,0
190154,intervention,1,0
190155,was,0,0
190156,developed,0,0
190157,to,0,0
190158,test,0,0
190159,if,0,0
190160,a,0,0
190161,nurse-led,1,0
190162,family-coping-orientated,1,0
190163,palliative,1,1
190164,home,1,1
190165,care,1,0
190166,intervention,1,0
190167,would,0,0
190168,help,0,0
190169,families,0,0
190170,cope,0,0
190171,with,0,0
190172,physical,0,0
190173,and,0,0
190174,psychosocial,0,0
190175,problems,0,0
190176,at,0,0
190177,home,0,0
190178,--,0,0
190179,together,0,0
190180,as,0,0
190181,a,0,0
190182,family,0,0
190183,and,0,0
190184,in,0,0
190185,interaction,0,0
190186,with,0,0
190187,health,0,0
190188,care,0,0
190189,professionals,0,0
190190,.,0,0
190191,However,0,0
190192,",",0,0
190193,an,0,0
190194,unexpectedly,0,0
190195,high,0,0
190196,number,0,0
190197,of,0,0
190198,families,0,0
190199,declined,0,0
190200,participation,0,0
190201,in,0,0
190202,the,0,0
190203,trial,0,0
190204,.,0,0
190205,We,0,0
190206,describe,0,0
190207,and,0,0
190208,discuss,0,0
190209,the,0,0
190210,recruitment,0,0
190211,strategy,0,0
190212,and,0,0
190213,patient,0,0
190214,reported,0,0
190215,reasons,0,0
190216,for,0,0
190217,non-participation,0,0
190218,to,0,0
190219,add,0,0
190220,to,0,0
190221,the,0,0
190222,knowledge,0,0
190223,about,0,0
190224,what,0,0
190225,impedes,0,0
190226,recruitment,0,0
190227,and,0,0
190228,to,0,0
190229,identify,0,0
190230,the,0,0
190231,factors,0,0
190232,that,0,0
190233,influence,0,0
190234,willingness,0,0
190235,to,0,0
190236,participate,0,0
190237,in,0,0
190238,research,0,0
190239,aimed,0,0
190240,at,0,0
190241,family,0,0
190242,coping,0,0
190243,early,0,0
190244,in,0,0
190245,the,0,0
190246,palliative,0,0
190247,care,0,0
190248,trajectory,0,0
190249,.,0,0
190250,Patients,0,0
190251,with,0,0
190252,advanced,0,0
190253,cancer,0,0
190254,and,0,0
190255,their,0,0
190256,closest,0,0
190257,relative,0,0
190258,were,0,0
190259,recruited,0,0
190260,from,0,0
190261,medical,0,0
190262,",",0,0
190263,surgical,0,0
190264,",",0,0
190265,and,0,0
190266,oncological,0,0
190267,departments,0,0
190268,.,0,0
190269,Reasons,0,0
190270,for,0,0
190271,non-participation,0,0
190272,were,0,0
190273,registered,0,0
190274,and,0,0
190275,characteristics,0,0
190276,of,0,0
190277,participants,0,0
190278,and,0,0
190279,non-participants,0,0
190280,were,0,0
190281,compared,0,0
190282,to,0,0
190283,evaluate,0,0
190284,differences,0,0
190285,between,0,0
190286,subgroups,0,0
190287,of,0,0
190288,non-participants,0,0
190289,based,0,0
190290,on,0,0
190291,reasons,0,0
190292,not,0,0
190293,to,0,0
190294,participate,0,0
190295,and,0,0
190296,reasons,0,0
190297,to,0,0
190298,participate,0,0
190299,in,0,0
190300,the,0,0
190301,trial,0,0
190302,.,0,0
190303,A,0,0
190304,total,0,0
190305,of,0,0
190306,65.9,0,0
190307,%,0,0
190308,of,0,0
190309,the,0,0
190310,families,0,0
190311,declined,0,0
190312,participation,0,0
190313,.,0,0
190314,Two,0,0
190315,main,0,0
190316,categories,0,0
190317,for,0,0
190318,declining,0,0
190319,participation,0,0
190320,emerged,0,0
190321,:,0,0
190322,first,0,0
190323,",",0,0
190324,that,0,0
190325,the,0,0
190326,burden,0,0
190327,of,0,0
190328,illness,0,0
190329,is,0,0
190330,too,0,0
190331,great,0,0
190332,and,0,0
190333,",",0,0
190334,second,0,0
190335,",",0,0
190336,that,0,0
190337,it,0,0
190338,was,0,0
190339,too,0,0
190340,soon,0,0
190341,to,0,0
190342,receive,0,0
190343,this,0,0
190344,kind,0,0
190345,of,0,0
190346,support,0,0
190347,.,0,0
190348,Men,0,0
190349,were,0,0
190350,more,0,0
190351,likely,0,0
190352,to,0,0
190353,participate,0,0
190354,than,0,0
190355,women,0,0
190356,.,0,0
190357,Patients,0,0
190358,in,0,0
190359,the,0,0
190360,too,0,0
190361,soon,0,0
190362,group,0,0
190363,had,0,0
190364,similar,0,0
190365,characteristics,0,0
190366,to,0,0
190367,participants,0,0
190368,in,0,0
190369,the,0,0
190370,trial,0,0
190371,.,0,0
190372,Timing,0,0
190373,of,0,0
190374,interventions,0,0
190375,and,0,0
190376,readiness,0,0
190377,of,0,0
190378,patients,0,0
190379,and,0,0
190380,their,0,0
190381,relatives,0,0
190382,seems,0,0
190383,to,0,0
190384,affect,0,0
190385,willingness,0,0
190386,to,0,0
190387,receive,0,0
190388,a,0,0
190389,family-coping-orientated,0,0
190390,care,0,0
190391,approach,0,0
190392,and,0,0
190393,impeded,0,0
190394,recruitment,0,0
190395,to,0,0
190396,this,0,0
190397,trial,0,0
190398,.,0,0
190399,Our,0,0
190400,findings,0,0
190401,can,0,0
190402,be,0,0
190403,used,0,0
190404,in,0,0
190405,further,0,0
190406,research,0,0
190407,and,0,0
190408,in,0,0
190409,clinical,0,0
190410,practice,0,0
190411,in,0,0
190412,order,0,0
190413,to,0,0
190414,construct,0,0
190415,interventions,0,0
190416,and,0,0
190417,target,0,0
190418,relevant,0,0
190419,populations,0,0
190420,for,0,0
190421,early,0,0
190422,family-coping-orientated,0,0
190423,palliative,1,0
190424,care,1,0
190425,.,1,0
190426,Oxygen,0,0
190427,saturation,0,0
190428,targets,0,0
190429,in,0,0
190430,infants,0,0
190431,with,0,0
190432,bronchiolitis,0,0
190433,(,0,1
190434,BIDS,0,1
190435,),0,1
190436,:,0,0
190437,a,0,0
190438,double-blind,0,1
190439,",",0,1
190440,randomised,0,1
190441,",",0,0
190442,equivalence,0,0
190443,trial,0,0
190444,.,0,0
190445,BACKGROUND,0,0
190446,The,0,0
190447,American,0,0
190448,Academy,0,0
190449,of,0,0
190450,Pediatrics,0,0
190451,recommends,0,0
190452,a,0,0
190453,permissive,0,0
190454,hypoxaemic,0,0
190455,target,0,0
190456,for,0,0
190457,an,0,0
190458,oxygen,0,0
190459,saturation,0,0
190460,of,0,0
190461,90,0,0
190462,%,0,0
190463,for,0,0
190464,children,0,0
190465,with,0,0
190466,bronchiolitis,0,0
190467,",",0,0
190468,which,0,0
190469,is,0,0
190470,consistent,0,0
190471,with,0,0
190472,the,0,0
190473,WHO,0,0
190474,recommendations,0,0
190475,for,0,0
190476,targets,0,0
190477,in,0,0
190478,children,0,0
190479,with,0,0
190480,lower,0,0
190481,respiratory,0,0
190482,tract,0,0
190483,infections,0,1
190484,.,0,0
190485,No,0,0
190486,evidence,0,0
190487,exists,0,0
190488,to,0,0
190489,support,0,0
190490,this,0,0
190491,threshold,0,0
190492,.,0,0
190493,We,0,0
190494,aimed,0,0
190495,to,0,0
190496,assess,0,0
190497,whether,0,0
190498,the,0,0
190499,90,0,0
190500,%,0,0
190501,or,0,0
190502,higher,0,0
190503,target,0,0
190504,for,0,0
190505,management,0,0
190506,of,0,0
190507,oxygen,1,0
190508,supplementation,1,1
190509,was,0,0
190510,equivalent,0,0
190511,to,0,0
190512,a,0,0
190513,normoxic,0,0
190514,94,0,0
190515,%,0,0
190516,or,0,0
190517,higher,0,0
190518,target,0,0
190519,for,0,0
190520,infants,0,0
190521,admitted,0,0
190522,to,0,0
190523,hospital,0,0
190524,with,0,0
190525,viral,0,0
190526,bronchiolitis,0,0
190527,.,0,0
190528,METHODS,0,0
190529,We,0,0
190530,did,0,0
190531,a,0,0
190532,parallel-group,0,1
190533,",",0,1
190534,randomised,0,1
190535,",",0,0
190536,controlled,0,0
190537,",",0,0
190538,equivalence,0,0
190539,trial,0,0
190540,of,0,0
190541,infants,0,0
190542,aged,0,0
190543,6,0,0
190544,weeks,0,0
190545,to,0,0
190546,12,0,0
190547,months,0,0
190548,of,0,0
190549,age,0,0
190550,with,0,0
190551,physician-diagnosed,0,0
190552,bronchiolitis,0,0
190553,newly,0,0
190554,admitted,0,0
190555,into,0,0
190556,eight,0,0
190557,paediatric,0,0
190558,hospital,0,0
190559,units,0,0
190560,in,0,0
190561,the,0,0
190562,UK,0,1
190563,(,0,0
190564,the,0,0
190565,Bronchiolitis,0,0
190566,of,0,0
190567,Infancy,0,0
190568,Discharge,0,1
190569,Study,0,1
190570,[,0,1
190571,BIDS,0,1
190572,],0,1
190573,),0,0
190574,.,0,0
190575,A,0,0
190576,central,0,0
190577,computer,0,0
190578,randomly,0,0
190579,allocated,0,0
190580,(,0,1
190581,1:1,0,1
190582,),0,1
190583,infants,0,1
190584,",",0,0
190585,in,0,0
190586,varying,0,0
190587,length,0,0
190588,blocks,0,0
190589,of,0,0
190590,four,0,0
190591,and,0,0
190592,six,0,0
190593,and,0,0
190594,without,0,0
190595,stratification,0,0
190596,",",0,0
190597,to,0,0
190598,be,0,0
190599,clipped,0,0
190600,to,0,0
190601,standard,1,0
190602,oximeters,1,1
190603,(,0,0
190604,patients,0,0
190605,treated,0,0
190606,with,0,0
190607,oxygen,0,0
190608,if,0,0
190609,pulse,0,0
190610,oxygen,0,0
190611,saturation,0,0
190612,[,0,0
190613,SpO2,0,0
190614,],0,0
190615,<,0,0
190616,94,0,0
190617,%,0,0
190618,),0,0
190619,or,0,0
190620,modified,1,0
190621,oximeters,1,0
190622,(,0,0
190623,displayed,0,0
190624,a,0,0
190625,measured,0,0
190626,value,0,0
190627,of,0,0
190628,90,0,0
190629,%,0,0
190630,as,0,0
190631,94,0,0
190632,%,0,0
190633,",",0,0
190634,therefore,0,0
190635,oxygen,0,0
190636,not,0,0
190637,given,0,0
190638,until,0,0
190639,SpO2,0,0
190640,<,0,0
190641,90,0,0
190642,%,0,0
190643,),0,0
190644,.,0,0
190645,All,0,0
190646,parents,0,0
190647,",",0,0
190648,clinical,0,0
190649,staff,0,0
190650,",",0,0
190651,and,0,0
190652,outcome,0,0
190653,assessors,0,0
190654,were,0,0
190655,masked,0,0
190656,to,0,0
190657,allocation,0,0
190658,.,0,0
190659,The,0,0
190660,primary,0,0
190661,outcome,0,0
190662,was,0,0
190663,time,0,0
190664,to,0,0
190665,resolution,0,0
190666,of,0,0
190667,cough,0,1
190668,(,0,0
190669,prespecified,0,0
190670,equivalence,0,0
190671,limits,0,0
190672,of,0,0
190673,plus,0,0
190674,or,0,0
190675,minus,0,0
190676,2,0,1
190677,days,0,1
190678,),0,0
190679,in,0,0
190680,the,0,0
190681,intention-to-treat,0,0
190682,population,0,0
190683,.,0,0
190684,This,0,0
190685,trial,0,0
190686,is,0,0
190687,registered,0,0
190688,with,0,0
190689,ISRCTN,0,0
190690,",",0,0
190691,number,0,0
190692,ISRCTN28405428,0,0
190693,.,0,0
190694,FINDINGS,0,0
190695,Between,0,1
190696,Oct,0,0
190697,3,0,0
190698,",",0,0
190699,and,0,0
190700,March,0,1
190701,30,0,0
190702,",",0,0
190703,2012,0,0
190704,",",0,0
190705,and,0,0
190706,Oct,0,0
190707,1,0,0
190708,",",0,0
190709,and,0,0
190710,March,0,0
190711,29,0,0
190712,",",0,0
190713,2013,0,0
190714,",",0,0
190715,we,0,0
190716,randomly,0,0
190717,assigned,0,0
190718,308,0,0
190719,infants,0,0
190720,to,0,0
190721,standard,0,0
190722,oximeters,0,0
190723,and,0,0
190724,307,0,0
190725,infants,0,0
190726,to,0,0
190727,modified,0,0
190728,oximeters,0,0
190729,.,0,0
190730,Cough,0,0
190731,resolved,0,0
190732,by,0,0
190733,15?0,0,1
190734,days,0,0
190735,(,0,0
190736,median,0,0
190737,),0,0
190738,in,0,0
190739,both,0,0
190740,groups,0,0
190741,(,0,0
190742,95,0,0
190743,%,0,0
190744,CI,0,0
190745,for,0,0
190746,difference,0,0
190747,-1,0,0
190748,to,0,0
190749,2,0,0
190750,),0,0
190751,and,0,0
190752,so,0,0
190753,oxygen,0,0
190754,thresholds,0,0
190755,were,0,0
190756,equivalent,0,0
190757,.,0,0
190758,We,0,0
190759,recorded,0,0
190760,35,0,0
190761,serious,0,0
190762,adverse,0,0
190763,events,0,0
190764,in,0,0
190765,32,0,0
190766,infants,0,0
190767,in,0,0
190768,the,0,0
190769,standard,0,0
190770,care,0,0
190771,group,0,0
190772,and,0,0
190773,25,0,0
190774,serious,0,0
190775,adverse,0,0
190776,events,0,0
190777,in,0,0
190778,24,0,0
190779,infants,0,0
190780,in,0,0
190781,the,0,0
190782,modified,0,0
190783,care,0,0
190784,group,0,0
190785,.,0,0
190786,In,0,0
190787,the,0,0
190788,standard,0,0
190789,care,0,0
190790,group,0,0
190791,",",0,0
190792,eight,0,0
190793,infants,0,0
190794,transferred,0,0
190795,to,0,0
190796,a,0,0
190797,high-dependency,0,0
190798,unit,0,0
190799,",",0,0
190800,23,0,0
190801,were,0,0
190802,readmitted,0,0
190803,",",0,0
190804,and,0,0
190805,one,0,0
190806,had,0,0
190807,a,0,0
190808,prolonged,0,0
190809,hospital,0,0
190810,stay,0,0
190811,.,0,0
190812,In,0,0
190813,the,0,0
190814,modified,0,0
190815,care,0,0
190816,group,0,0
190817,",",0,0
190818,12,0,0
190819,infants,0,0
190820,were,0,0
190821,transferred,0,0
190822,to,0,0
190823,a,0,0
190824,high-dependency,0,0
190825,unit,0,0
190826,and,0,0
190827,12,0,0
190828,were,0,0
190829,readmitted,0,0
190830,to,0,0
190831,hospital,0,0
190832,.,0,0
190833,Recorded,0,0
190834,adverse,0,0
190835,events,0,0
190836,did,0,0
190837,not,0,0
190838,differ,0,0
190839,significantly,0,0
190840,.,0,0
190841,INTERPRETATION,0,0
190842,Management,0,0
190843,of,0,0
190844,infants,0,0
190845,with,0,0
190846,bronchiolitis,0,0
190847,to,0,0
190848,an,0,0
190849,oxygen,0,0
190850,saturation,0,0
190851,target,0,0
190852,of,0,0
190853,90,0,0
190854,%,0,0
190855,or,0,0
190856,higher,0,0
190857,is,0,0
190858,as,0,0
190859,safe,0,0
190860,and,0,0
190861,clinically,0,0
190862,effective,0,0
190863,as,0,0
190864,one,0,0
190865,of,0,0
190866,94,0,0
190867,%,0,0
190868,or,0,0
190869,higher,0,0
190870,.,0,0
190871,Future,0,0
190872,research,0,0
190873,should,0,0
190874,assess,0,0
190875,the,0,0
190876,benefits,0,0
190877,and,0,0
190878,risks,0,0
190879,of,0,0
190880,different,0,0
190881,oxygen,0,0
190882,saturation,0,0
190883,targets,0,0
190884,in,0,0
190885,acute,0,0
190886,respiratory,0,0
190887,infection,0,0
190888,in,0,0
190889,older,0,0
190890,children,0,0
190891,",",0,0
190892,particularly,0,0
190893,in,0,0
190894,developing,0,0
190895,nations,0,0
190896,where,0,0
190897,resources,0,0
190898,are,0,0
190899,scarce,0,0
190900,.,0,0
190901,FUNDING,0,0
190902,National,0,0
190903,Institute,0,0
190904,for,0,0
190905,Health,0,0
190906,Research,0,0
190907,",",0,0
190908,Health,0,0
190909,Technology,0,1
190910,Assessment,0,0
190911,programme,0,0
190912,.,0,0
190913,DESFLURANE,0,1
190914,COMPARED,0,1
190915,TO,0,1
190916,SEVOFLURANE,0,1
190917,FOR,0,1
190918,CIRRHOTIC,0,1
190919,PATIENTS,0,1
190920,UNDERGOING,0,1
190921,MAJOR,0,1
190922,LIVER,0,1
190923,RESECTION,0,1
190924,.,0,0
190925,A,0,0
190926,RANDOMIZED,0,1
190927,CONTROL,0,1
190928,STUDY,0,1
190929,.,0,0
190930,BACKGROUND,0,0
190931,Major,0,0
190932,liver,0,0
190933,resection,0,0
190934,is,0,0
190935,associated,0,0
190936,with,0,0
190937,haemodynamic,0,0
190938,",",0,0
190939,hepatic,0,0
190940,and,0,0
190941,renal,0,0
190942,changes,0,0
190943,as,0,0
190944,a,0,0
190945,result,0,0
190946,of,0,0
190947,the,0,0
190948,procedure,0,0
190949,.,0,0
190950,AIM,0,0
190951,To,0,1
190952,compare,0,1
190953,Desflurane,1,1
190954,(,1,1
190955,D,1,1
190956,),1,1
190957,versus,1,1
190958,Sevoflurane,1,1
190959,(,1,1
190960,S,1,1
190961,),1,1
190962,on,0,0
190963,hepatic,0,0
190964,",",0,0
190965,renal,0,0
190966,functions,0,0
190967,",",0,0
190968,haemodynamics,0,0
190969,and,0,0
190970,perioperative,0,0
190971,course,0,0
190972,for,0,0
190973,cirrhotic,0,0
190974,patients,0,0
190975,undergoing,0,0
190976,major,0,0
190977,liver,0,0
190978,resection,0,0
190979,.,0,0
190980,PATIENTS,0,0
190981,AND,0,1
190982,METHODS,0,1
190983,A,0,1
190984,prospective,0,0
190985,randomized,0,0
190986,control,0,0
190987,study,0,0
190988,with,0,0
190989,50,0,0
190990,patients,0,0
190991,(,0,0
190992,Child,0,1
190993,A,0,1
190994,),0,1
190995,(,0,0
190996,D,0,1
190997,",",0,0
190998,n,0,0
190999,=,0,0
191000,25,0,0
191001,and,0,0
191002,S,0,1
191003,",",0,0
191004,n,0,0
191005,=,0,0
191006,25,0,0
191007,),0,0
191008,.,0,0
191009,End,0,1
191010,tidal,0,0
191011,D,0,1
191012,or,0,0
191013,S,0,0
191014,adjusted,0,0
191015,with,0,0
191016,Entropy,0,0
191017,(,0,0
191018,40-60,0,0
191019,),0,0
191020,.,0,0
191021,Haemodynamics,1,0
191022,monitored,1,0
191023,with,1,0
191024,invasive,1,0
191025,blood,1,0
191026,pressure,1,0
191027,and,1,0
191028,trans-oesophageal,1,1
191029,Doppler,1,1
191030,(,1,1
191031,TED,1,1
191032,),1,1
191033,.,1,0
191034,Liver,1,0
191035,and,1,0
191036,kidney,1,0
191037,function,1,0
191038,tests,1,0
191039,",",1,0
191040,blood,1,1
191041,Glutathione-S-transferase,1,1
191042,(,1,1
191043,GST,1,1
191044,),1,1
191045,",",1,0
191046,urinary,1,1
191047,microalbuminuria,1,1
191048,(,1,1
191049,Microalb,1,1
191050,),1,0
191051,were,1,0
191052,assayed,1,0
191053,.,1,0
191054,Extubation,0,0
191055,time,0,0
191056,and,0,0
191057,anaesthetic,0,0
191058,consumption,0,0
191059,were,0,0
191060,recorded,0,0
191061,.,0,0
191062,RESULTS,0,0
191063,Systemic,0,0
191064,vascular,0,0
191065,resistance,0,0
191066,(,0,1
191067,SVR,0,1
191068,),0,1
191069,post-resection,0,0
191070,and,0,0
191071,stroke,0,0
191072,volume,0,0
191073,of,0,0
191074,D,0,0
191075,vs,0,0
191076,S,0,0
191077,were,0,0
191078,835.04,0,0
191079,?,0,0
191080,12.02,0,0
191081,vs,0,0
191082,778.16,0,0
191083,?,0,0
191084,11.97,0,0
191085,dyn.sec.cm,0,0
191086,(,0,0
191087,-5,0,0
191088,),0,0
191089,",",0,0
191090,P,0,0
191091,<,0,0
191092,0.01,0,0
191093,",",0,0
191094,and,0,0
191095,85.72,0,0
191096,?,0,0
191097,2.95,0,0
191098,vs,0,0
191099,76.16,0,0
191100,?,0,0
191101,6.52,0,0
191102,ml,0,0
191103,",",0,0
191104,P,0,0
191105,<,0,0
191106,0.01,0,0
191107,respectively,0,0
191108,.,0,0
191109,Doppler,0,0
191110,corrected,0,0
191111,flow,0,0
191112,time,0,0
191113,(,0,0
191114,FTc,0,1
191115,),0,1
191116,between,0,0
191117,groups,0,0
191118,were,0,0
191119,comparable,0,0
191120,(,0,0
191121,P,0,0
191122,>,0,0
191123,0.05,0,0
191124,),0,0
191125,.,0,0
191126,No,0,1
191127,difference,0,0
191128,post-operatively,0,0
191129,regarding,0,0
191130,hepatic,0,0
191131,and,0,0
191132,renal,0,0
191133,functions,0,0
191134,",",0,0
191135,and,0,0
191136,urine,0,1
191137,Microalb,0,1
191138,(,0,0
191139,14.76,0,0
191140,?,0,0
191141,3.95,0,0
191142,vs,0,0
191143,l4.24,0,0
191144,?,0,0
191145,8.65,0,0
191146,?g/ml,0,0
191147,",",0,0
191148,P,0,0
191149,=,0,0
191150,0.78,0,0
191151,),0,0
191152,",",0,0
191153,but,0,0
191154,a,0,0
191155,statistically,0,0
191156,difference,0,0
191157,was,0,0
191158,found,0,0
191159,with,0,0
191160,GST,0,0
191161,(,0,0
191162,0.046,0,0
191163,?,0,0
191164,[,0,0
191165,symbols,0,0
191166,:,0,0
191167,see,0,0
191168,text,0,1
191169,],0,0
191170,",",0,0
191171,vs,0,0
191172,0.043,0,0
191173,?,0,0
191174,[,0,0
191175,symbols,0,0
191176,:,0,0
191177,see,0,0
191178,text,0,1
191179,],0,1
191180,IU/ml,0,0
191181,",",0,0
191182,P,0,0
191183,<,0,0
191184,0.01,0,0
191185,),0,0
191186,.,0,0
191187,Despite,0,0
191188,a,0,0
191189,higher,0,0
191190,D,0,1
191191,consumption,0,1
191192,(,0,0
191193,73,0,0
191194,?,0,0
191195,17,0,0
191196,vs,0,0
191197,64,0,0
191198,?,0,0
191199,22,0,0
191200,ml,0,0
191201,",",0,0
191202,P,0,0
191203,=,0,0
191204,0.102,0,0
191205,),0,0
191206,",",0,0
191207,cost,0,0
191208,in,0,0
191209,Egyptian,0,0
191210,pounds,0,1
191211,(,0,1
191212,LE,0,1
191213,),0,0
191214,was,0,0
191215,lower,0,0
191216,with,0,0
191217,D,0,0
191218,(,0,0
191219,141.14,0,0
191220,?,0,0
191221,32.90,0,0
191222,vs,0,0
191223,320.60,0,0
191224,?,0,0
191225,114.01,0,0
191226,",",0,0
191227,LE,0,0
191228,",",0,0
191229,P,0,0
191230,<,0,0
191231,0.01,0,0
191232,),0,0
191233,.,0,0
191234,Extubation,0,0
191235,time,0,0
191236,and,0,0
191237,ICU,0,0
191238,stay,0,0
191239,with,0,0
191240,D,0,1
191241,vS,0,0
191242,(,0,0
191243,4.52,0,0
191244,?,0,0
191245,2,0,0
191246,vs,0,0
191247,7.72,0,0
191248,?,0,0
191249,2,0,0
191250,min,0,0
191251,",",0,0
191252,P,0,0
191253,<,0,0
191254,0.01,0,0
191255,),0,0
191256,and,0,0
191257,(,0,0
191258,1.40,0,0
191259,0.50,0,0
191260,vs,0,0
191261,1.64,0,0
191262,?,0,0
191263,0.48,0,0
191264,",",0,0
191265,days,0,0
191266,P,0,0
191267,=,0,0
191268,0.09,0,0
191269,),0,0
191270,respectively,0,0
191271,.,0,0
191272,CONCLUSION,0,0
191273,Neither,0,0
191274,D,0,0
191275,nor,0,0
191276,S,0,0
191277,were,0,0
191278,clinically,0,0
191279,superior,0,0
191280,to,0,0
191281,the,0,0
191282,other,0,0
191283,with,0,0
191284,respect,0,0
191285,to,0,0
191286,liver,0,0
191287,and,0,0
191288,kidneys,0,0
191289,functions,0,0
191290,",",0,0
191291,but,0,0
191292,D,0,0
191293,was,0,0
191294,found,0,0
191295,to,0,0
191296,preserve,0,0
191297,better,0,0
191298,the,0,0
191299,haemodynamic,0,0
191300,parameters,0,0
191301,and,0,0
191302,enhance,0,0
191303,recovery,0,0
191304,at,0,0
191305,a,0,0
191306,lower,0,0
191307,cost,0,0
191308,.,0,0
191309,Computer,1,1
191310,Decision,1,0
191311,Support,1,0
191312,Changes,0,0
191313,Physician,0,0
191314,Practice,0,0
191315,But,0,1
191316,Not,0,1
191317,Knowledge,0,0
191318,Regarding,0,0
191319,Autism,0,0
191320,Spectrum,0,0
191321,Disorders,0,0
191322,.,0,0
191323,OBJECTIVE,0,0
191324,To,0,0
191325,examine,0,0
191326,whether,0,0
191327,adding,0,0
191328,an,0,0
191329,autism,0,0
191330,module,0,0
191331,promoting,0,0
191332,adherence,0,0
191333,to,0,0
191334,clinical,0,0
191335,guidelines,0,0
191336,to,0,0
191337,an,0,0
191338,existing,0,0
191339,computer,1,0
191340,decision,1,0
191341,support,1,1
191342,system,1,0
191343,(,0,1
191344,CDSS,0,1
191345,),0,1
191346,changed,0,0
191347,physician,0,0
191348,knowledge,0,0
191349,and,0,0
191350,self-reported,0,0
191351,clinical,0,0
191352,practice,0,0
191353,.,0,0
191354,METHODS,0,0
191355,The,0,0
191356,CHICA,1,1
191357,(,1,0
191358,Child,1,0
191359,Health,1,0
191360,Improvement,1,0
191361,through,1,0
191362,Computer,1,1
191363,Automation,1,1
191364,),1,0
191365,system,1,0
191366,",",0,0
191367,a,0,0
191368,CDSS,1,0
191369,",",0,0
191370,was,0,0
191371,enhanced,0,0
191372,with,0,0
191373,a,0,0
191374,module,0,0
191375,to,0,0
191376,improve,0,0
191377,management,0,0
191378,of,0,0
191379,autism,0,0
191380,in,0,0
191381,2,0,0
191382,of,0,0
191383,the,0,0
191384,4,0,0
191385,community,0,0
191386,pediatric,0,0
191387,clinics,0,0
191388,using,0,0
191389,the,0,0
191390,system,0,0
191391,.,0,0
191392,We,0,0
191393,examined,0,0
191394,the,0,0
191395,knowledge,0,0
191396,and,0,0
191397,beliefs,0,0
191398,of,0,0
191399,pediatric,0,0
191400,users,0,0
191401,using,0,0
191402,cross-sectional,0,1
191403,surveys,0,1
191404,administered,0,1
191405,at,0,1
191406,3,0,0
191407,time,0,0
191408,points,0,1
191409,(,0,0
191410,baseline,0,1
191411,",",0,0
191412,12,0,0
191413,months,0,0
191414,and,0,0
191415,24,0,0
191416,months,0,0
191417,post-implementation,0,0
191418,),0,0
191419,between,0,0
191420,November,0,0
191421,2010,0,0
191422,and,0,0
191423,January,0,0
191424,2013,0,0
191425,.,0,0
191426,Surveys,0,0
191427,measured,0,0
191428,knowledge,0,0
191429,",",0,0
191430,beliefs,0,0
191431,and,0,0
191432,self-reported,0,0
191433,practice,0,0
191434,patterns,0,0
191435,related,0,0
191436,to,0,0
191437,autism,0,0
191438,.,0,0
191439,RESULTS,0,0
191440,A,0,0
191441,total,0,0
191442,of,0,0
191443,45,0,0
191444,",",0,0
191445,39,0,0
191446,",",0,0
191447,and,0,0
191448,42,0,0
191449,pediatricians,0,0
191450,responded,0,0
191451,at,0,0
191452,each,0,0
191453,time,0,0
191454,point,0,0
191455,",",0,0
191456,respectively,0,0
191457,",",0,0
191458,a,0,0
191459,95-100,0,0
191460,%,0,0
191461,response,0,0
191462,rate,0,0
191463,.,0,0
191464,Respondents,0,0
191465,',0,0
191466,knowledge,0,0
191467,of,0,0
191468,autism,0,0
191469,and,0,0
191470,perception,0,0
191471,of,0,0
191472,role,0,0
191473,for,0,0
191474,diagnosis,0,0
191475,did,0,0
191476,not,0,0
191477,vary,0,0
191478,between,0,0
191479,control,0,0
191480,and,0,0
191481,intervention,0,0
191482,groups,0,0
191483,either,0,0
191484,at,0,0
191485,baseline,0,0
191486,or,0,0
191487,any,0,0
191488,of,0,0
191489,the,0,0
191490,two,0,0
191491,post-intervention,0,0
191492,time,0,0
191493,points,0,0
191494,.,0,0
191495,At,0,0
191496,baseline,0,0
191497,",",0,0
191498,there,0,0
191499,was,0,0
191500,no,0,0
191501,difference,0,0
191502,between,0,0
191503,these,0,0
191504,groups,0,0
191505,in,0,0
191506,rates,0,0
191507,in,0,0
191508,the,0,0
191509,routine,0,0
191510,use,0,0
191511,of,0,0
191512,parent-rated,0,0
191513,screening,0,0
191514,instruments,0,0
191515,for,0,0
191516,autism,0,0
191517,.,0,0
191518,However,0,0
191519,",",0,0
191520,by,0,0
191521,12,0,0
191522,and,0,0
191523,24,0,0
191524,months,0,0
191525,post-implementation,0,0
191526,there,0,0
191527,was,0,0
191528,a,0,0
191529,significant,0,0
191530,difference,0,0
191531,between,0,0
191532,intervention,0,0
191533,and,0,0
191534,control,0,0
191535,clinics,0,0
191536,in,0,0
191537,terms,0,0
191538,of,0,0
191539,the,0,0
191540,intervention,0,0
191541,clinics,0,0
191542,consistently,0,0
191543,screening,0,0
191544,eligible,0,0
191545,patients,0,0
191546,with,0,0
191547,a,0,0
191548,validated,0,0
191549,autism,0,0
191550,tool,0,0
191551,.,0,0
191552,Physicians,0,0
191553,at,0,0
191554,all,0,0
191555,clinics,0,0
191556,reported,0,0
191557,ongoing,0,0
191558,challenges,0,0
191559,to,0,0
191560,community,0,0
191561,resources,0,0
191562,for,0,0
191563,further,0,0
191564,work-up,0,0
191565,and,0,0
191566,treatment,0,0
191567,related,0,0
191568,to,0,0
191569,autism,0,0
191570,.,0,0
191571,CONCLUSIONS,0,0
191572,A,0,0
191573,CDSS,1,0
191574,module,0,0
191575,to,0,0
191576,improve,0,0
191577,primary,0,0
191578,care,0,0
191579,management,0,0
191580,of,0,0
191581,ASD,0,0
191582,in,0,0
191583,pediatric,0,0
191584,practice,0,0
191585,led,0,0
191586,to,0,0
191587,significant,0,0
191588,improvements,0,0
191589,in,0,0
191590,physician-reported,0,0
191591,use,0,0
191592,of,0,0
191593,validated,0,0
191594,screening,0,0
191595,tools,0,0
191596,to,0,0
191597,screen,0,0
191598,for,0,0
191599,ASDs,0,0
191600,.,0,0
191601,However,0,0
191602,it,0,0
191603,did,0,0
191604,not,0,0
191605,lead,0,0
191606,to,0,0
191607,corresponding,0,0
191608,changes,0,0
191609,in,0,0
191610,physician,0,0
191611,knowledge,0,0
191612,or,0,0
191613,attitudes,0,0
191614,.,0,0
191615,The,0,0
191616,neuropeptide,1,1
191617,oxytocin,1,1
191618,modulates,0,1
191619,consumer,0,1
191620,brand,0,0
191621,relationships,0,0
191622,.,0,0
191623,Each,0,0
191624,year,0,0
191625,",",0,0
191626,companies,0,0
191627,invest,0,0
191628,billions,0,0
191629,of,0,0
191630,dollars,0,0
191631,into,0,0
191632,marketing,0,0
191633,activities,0,0
191634,to,0,0
191635,embellish,0,0
191636,brands,0,0
191637,as,0,0
191638,valuable,0,0
191639,relationship,0,0
191640,partners,0,0
191641,assuming,0,0
191642,that,0,0
191643,consumer,0,0
191644,brand,0,0
191645,relationships,0,0
191646,(,0,1
191647,CBRs,0,1
191648,),0,1
191649,and,0,0
191650,interpersonal,0,0
191651,relationships,0,0
191652,rest,0,0
191653,upon,0,0
191654,the,0,0
191655,same,0,0
191656,neurobiological,0,0
191657,underpinnings,0,0
191658,.,0,0
191659,Given,0,0
191660,the,0,0
191661,crucial,0,0
191662,role,0,0
191663,of,0,0
191664,the,0,0
191665,neuropeptide,1,1
191666,oxytocin,1,1
191667,(,1,1
191668,OXT,1,1
191669,),1,0
191670,in,0,0
191671,social,0,0
191672,bonding,0,0
191673,",",0,0
191674,this,0,0
191675,study,0,0
191676,tests,0,0
191677,whether,0,0
191678,OXT-based,0,0
191679,mechanisms,0,0
191680,also,0,0
191681,determine,0,0
191682,the,0,0
191683,bond,0,0
191684,between,0,0
191685,consumers,0,0
191686,and,0,0
191687,brands,0,0
191688,.,0,0
191689,We,0,0
191690,conducted,0,0
191691,a,0,0
191692,randomized,0,0
191693,",",0,0
191694,placebo-controlled,0,1
191695,study,0,0
191696,involving,0,0
191697,101,0,0
191698,subjects,0,0
191699,and,0,0
191700,analyzed,0,0
191701,the,0,0
191702,effect,0,0
191703,of,0,0
191704,intranasal,1,1
191705,OXT,1,1
191706,on,0,0
191707,consumers,0,0
191708,',0,0
191709,attribution,0,0
191710,of,0,0
191711,relationship,0,0
191712,qualities,0,0
191713,to,0,0
191714,brands,0,0
191715,",",0,0
191716,brands,0,0
191717,paired,0,0
191718,with,0,0
191719,human,0,0
191720,celebrity,0,0
191721,endorsers,0,0
191722,",",0,0
191723,and,0,0
191724,familiar,0,0
191725,persons,0,0
191726,.,0,0
191727,OXT,1,0
191728,indeed,0,0
191729,promoted,0,0
191730,the,0,0
191731,attribution,0,0
191732,of,0,0
191733,relationship,0,0
191734,qualities,0,0
191735,not,0,0
191736,only,0,0
191737,in,0,0
191738,the,0,0
191739,case,0,0
191740,of,0,0
191741,social,0,0
191742,and,0,0
191743,semi-social,0,0
191744,stimuli,0,0
191745,",",0,0
191746,but,0,0
191747,also,0,0
191748,brands,0,0
191749,.,0,0
191750,Intriguingly,0,0
191751,",",0,0
191752,for,0,0
191753,subjects,0,0
191754,scoring,0,0
191755,high,0,0
191756,on,0,0
191757,autistic-like,0,0
191758,traits,0,0
191759,",",0,0
191760,the,0,0
191761,effect,0,0
191762,of,0,0
191763,OXT,1,0
191764,was,0,0
191765,completely,0,0
191766,reversed,0,0
191767,",",0,0
191768,evident,0,0
191769,in,0,0
191770,even,0,0
191771,lower,0,0
191772,relationship,0,0
191773,qualities,0,0
191774,across,0,0
191775,all,0,0
191776,stimulus,0,0
191777,categories,0,0
191778,.,0,0
191779,The,0,0
191780,importance,0,0
191781,of,0,0
191782,OXT,1,0
191783,in,0,0
191784,a,0,0
191785,CBR,0,0
191786,context,0,0
191787,is,0,0
191788,further,0,0
191789,corroborated,0,0
191790,by,0,0
191791,a,0,0
191792,three-fold,0,0
191793,increase,0,0
191794,in,0,0
191795,endogenous,0,0
191796,release,0,0
191797,of,0,0
191798,OXT,1,0
191799,following,0,0
191800,exposure,0,0
191801,to,0,0
191802,one,0,0
191803,'s,0,0
191804,favorite,0,1
191805,brand,0,0
191806,and,0,0
191807,positive,0,0
191808,associations,0,0
191809,between,0,0
191810,baseline,0,0
191811,peripheral,0,0
191812,OXT,1,0
191813,concentrations,0,1
191814,and,0,0
191815,brand,0,0
191816,relationship,0,0
191817,qualities,0,0
191818,.,0,0
191819,Collectively,0,0
191820,",",0,0
191821,our,0,0
191822,findings,0,0
191823,indicate,0,0
191824,that,0,0
191825,OXT,1,0
191826,not,0,0
191827,only,0,0
191828,plays,0,0
191829,a,0,0
191830,fundamental,0,0
191831,role,0,0
191832,in,0,0
191833,developing,0,0
191834,interpersonal,0,0
191835,relationships,0,0
191836,",",0,0
191837,but,0,0
191838,also,0,0
191839,enables,0,0
191840,relationship,0,0
191841,formation,0,0
191842,with,0,0
191843,objects,0,0
191844,such,0,0
191845,as,0,0
191846,brands,0,0
191847,.,0,0
191848,Chronic,0,1
191849,fatigue,0,1
191850,syndrome,0,1
191851,(,0,1
191852,CFS,0,1
191853,),0,1
191854,or,0,0
191855,myalgic,0,1
191856,encephalomyelitis,0,1
191857,(,0,1
191858,ME,0,1
191859,),0,0
191860,is,0,0
191861,different,0,0
191862,in,0,0
191863,children,0,0
191864,compared,0,0
191865,to,0,0
191866,in,0,0
191867,adults,0,0
191868,:,0,0
191869,a,0,0
191870,study,0,0
191871,of,0,0
191872,UK,0,0
191873,and,0,0
191874,Dutch,0,0
191875,clinical,0,0
191876,cohorts,0,0
191877,.,0,0
191878,OBJECTIVE,0,0
191879,To,0,0
191880,investigate,0,0
191881,differences,0,0
191882,between,0,0
191883,young,0,0
191884,children,0,0
191885,",",0,0
191886,adolescents,0,0
191887,and,0,0
191888,adults,0,0
191889,with,0,0
191890,chronic,0,0
191891,fatigue,0,0
191892,syndrome/myalgic,0,1
191893,encephalomyelitis,0,1
191894,(,0,1
191895,CFS/ME,0,1
191896,),0,1
191897,.,0,0
191898,STUDY,0,1
191899,DESIGN,0,0
191900,Comparison,0,0
191901,of,0,0
191902,clinical,0,0
191903,cohorts,0,0
191904,from,0,0
191905,8,0,0
191906,paediatric,0,0
191907,and,0,0
191908,27,0,0
191909,adult,0,0
191910,CFS/ME,0,0
191911,services,0,0
191912,in,0,0
191913,the,0,0
191914,UK,0,0
191915,and,0,0
191916,a,0,0
191917,paediatric,0,0
191918,randomised,0,0
191919,controlled,0,0
191920,trial,0,0
191921,from,0,0
191922,the,0,0
191923,Netherlands,0,0
191924,.,0,0
191925,Outcome,0,0
191926,measures,0,0
191927,include,0,0
191928,:,0,0
191929,fatigue,0,0
191930,(,0,0
191931,the,0,0
191932,UK-Chalder,0,1
191933,Fatigue,0,1
191934,Scale,0,1
191935,),0,1
191936,;,0,1
191937,Disability,0,1
191938,(,0,0
191939,the,0,0
191940,UK-SF-36,0,1
191941,physical,0,0
191942,function,0,0
191943,subscale,0,0
191944,;,0,0
191945,the,0,0
191946,Netherlands-CHQ-CF87,0,1
191947,),0,1
191948,;,0,1
191949,school,0,1
191950,attendance,0,1
191951,",",0,0
191952,pain,0,0
191953,",",0,0
191954,anxiety,0,0
191955,and,0,0
191956,depression,0,1
191957,(,0,0
191958,the,0,0
191959,UK-Hospital,0,1
191960,Anxiety,0,0
191961,&,0,1
191962,Depression,0,0
191963,Scale,0,0
191964,",",0,0
191965,Spence,0,0
191966,Children,0,1
191967,'s,0,0
191968,Anxiety,0,1
191969,Scale,0,1
191970,;,0,0
191971,the,0,0
191972,Netherlands-Spielberger,0,0
191973,State-Trait,0,1
191974,Anxiety,0,0
191975,Inventory,0,0
191976,for,0,0
191977,Children,0,0
191978,",",0,0
191979,Children,0,0
191980,'s,0,0
191981,Depression,0,1
191982,Inventory,0,1
191983,),0,1
191984,;,0,1
191985,symptoms,0,1
191986,;,0,1
191987,time-to-assessment,0,1
191988,;,0,1
191989,and,0,0
191990,body,0,0
191991,mass,0,0
191992,index,0,0
191993,.,0,0
191994,We,0,0
191995,used,0,0
191996,multinomial,1,0
191997,regression,1,0
191998,to,0,0
191999,compare,0,0
192000,younger,0,0
192001,(,0,0
192002,aged,0,0
192003,<,0,0
192004,12,0,0
192005,years,0,0
192006,),0,0
192007,and,0,0
192008,older,0,1
192009,(,0,0
192010,aged,0,0
192011,12-18,0,0
192012,years,0,0
192013,),0,0
192014,children,0,0
192015,with,0,0
192016,adults,0,0
192017,",",0,0
192018,and,0,0
192019,logistic,0,0
192020,regression,0,0
192021,to,0,0
192022,compare,0,0
192023,UK,0,0
192024,and,0,0
192025,Dutch,0,0
192026,adolescents,0,0
192027,.,0,0
192028,RESULTS,0,0
192029,Younger,0,0
192030,children,0,0
192031,had,0,0
192032,a,0,0
192033,more,0,0
192034,equal,0,0
192035,gender,0,0
192036,balance,0,0
192037,compared,0,0
192038,to,0,0
192039,adolescents,0,0
192040,and,0,0
192041,adults,0,0
192042,.,0,0
192043,Adults,0,0
192044,had,0,0
192045,more,0,0
192046,disability,0,0
192047,and,0,0
192048,fatigue,0,0
192049,",",0,0
192050,and,0,0
192051,had,0,0
192052,been,0,0
192053,ill,0,0
192054,for,0,0
192055,longer,0,0
192056,.,0,0
192057,Younger,0,0
192058,children,0,0
192059,were,0,0
192060,less,0,0
192061,likely,0,0
192062,to,0,0
192063,have,0,0
192064,cognitive,0,0
192065,symptoms,0,1
192066,(,0,0
192067,OR,0,0
192068,0.18,0,0
192069,(,0,0
192070,95,0,0
192071,%,0,0
192072,CI,0,0
192073,0.13,0,0
192074,to,0,0
192075,0.25,0,0
192076,),0,0
192077,),0,0
192078,and,0,0
192079,more,0,0
192080,likely,0,0
192081,to,0,0
192082,present,0,0
192083,with,0,0
192084,a,0,0
192085,sore,0,0
192086,throat,0,1
192087,(,0,0
192088,OR,0,0
192089,1.42,0,0
192090,(,0,0
192091,1.07,0,0
192092,to,0,0
192093,1.90,0,0
192094,),0,0
192095,.,0,0
192096,Adolescents,0,0
192097,were,0,0
192098,more,0,0
192099,likely,0,0
192100,to,0,0
192101,have,0,0
192102,headaches,0,0
192103,(,0,0
192104,81.1,0,0
192105,%,0,0
192106,",",0,0
192107,OR,0,0
192108,1.56,0,0
192109,(,0,0
192110,1.36,0,0
192111,%,0,0
192112,to,0,0
192113,1.80,0,0
192114,%,0,0
192115,),0,0
192116,),0,0
192117,and,0,0
192118,less,0,0
192119,likely,0,0
192120,to,0,0
192121,have,0,0
192122,tender,0,0
192123,lymph,0,0
192124,nodes,0,0
192125,",",0,0
192126,palpitations,0,0
192127,",",0,0
192128,dizziness,0,0
192129,",",0,0
192130,general,0,0
192131,malaise,0,0
192132,and,0,0
192133,pain,0,0
192134,",",0,0
192135,compared,0,0
192136,to,0,0
192137,adults,0,0
192138,.,0,0
192139,Adolescents,0,0
192140,were,0,0
192141,more,0,0
192142,likely,0,0
192143,to,0,0
192144,have,0,0
192145,comorbid,0,0
192146,depression,0,1
192147,(,0,0
192148,OR,0,0
192149,1.51,0,0
192150,(,0,0
192151,1.33,0,0
192152,to,0,0
192153,1.72,0,0
192154,),0,0
192155,),0,0
192156,and,0,0
192157,less,0,0
192158,likely,0,0
192159,to,0,0
192160,have,0,0
192161,anxiety,0,0
192162,(,0,0
192163,OR,0,0
192164,0.46,0,0
192165,(,0,0
192166,0.41,0,0
192167,to,0,0
192168,0.53,0,0
192169,),0,0
192170,),0,0
192171,compared,0,0
192172,to,0,0
192173,adults,0,0
192174,.,0,0
192175,CONCLUSIONS,0,0
192176,Paediatricians,0,0
192177,need,0,0
192178,to,0,0
192179,recognise,0,0
192180,that,0,0
192181,children,0,0
192182,with,0,0
192183,CFS/ME,0,0
192184,present,0,0
192185,differently,0,0
192186,from,0,0
192187,adults,0,0
192188,.,0,0
192189,Whether,0,0
192190,these,0,0
192191,differences,0,0
192192,reflect,0,0
192193,an,0,0
192194,underlying,0,0
192195,aetiopathology,0,0
192196,requires,0,0
192197,further,0,0
192198,investigation,0,0
192199,.,0,0
192200,TRIAL,0,0
192201,REGISTRATION,0,1
192202,NUMBERS,0,1
192203,FITNET,0,1
192204,trial,0,0
192205,registration,0,0
192206,numbers,0,0
192207,are,0,0
192208,ISRCTN59878666,0,0
192209,and,0,0
192210,NCT00893438,0,0
192211,.,0,0
192212,This,0,0
192213,paper,0,0
192214,includes,0,0
192215,secondary,0,0
192216,(,0,1
192217,post-results,0,1
192218,),0,0
192219,analysis,0,0
192220,of,0,0
192221,data,0,0
192222,from,0,0
192223,this,0,0
192224,trial,0,0
192225,",",0,0
192226,but,0,0
192227,are,0,0
192228,unrelated,0,0
192229,to,0,0
192230,trial,0,0
192231,outcomes,0,0
192232,.,0,0
192233,Ultrasound,1,0
192234,is,0,0
192235,at,0,0
192236,least,0,0
192237,as,0,0
192238,good,0,0
192239,as,0,0
192240,magnetic,1,0
192241,resonance,1,0
192242,imaging,1,0
192243,in,0,0
192244,predicting,0,0
192245,tumour,0,0
192246,size,0,0
192247,post-neoadjuvant,0,0
192248,chemotherapy,0,0
192249,in,0,0
192250,breast,0,0
192251,cancer,0,0
192252,.,0,0
192253,BACKGROUND,0,0
192254,The,0,0
192255,aim,0,0
192256,of,0,0
192257,this,0,0
192258,study,0,0
192259,was,0,0
192260,to,0,0
192261,evaluate,0,0
192262,the,0,0
192263,accuracy,0,0
192264,of,0,0
192265,clinical,0,0
192266,imaging,0,0
192267,of,0,0
192268,the,0,0
192269,primary,1,0
192270,breast,1,0
192271,tumour,1,0
192272,post-neoadjuvant,1,1
192273,chemotherapy,1,1
192274,(,1,1
192275,NAC,1,1
192276,),1,0
192277,related,0,0
192278,to,0,0
192279,the,0,0
192280,post-neoadjuvant,0,0
192281,histological,0,0
192282,tumour,0,1
192283,size,0,0
192284,(,0,0
192285,gold,0,0
192286,standard,0,1
192287,),0,0
192288,and,0,0
192289,whether,0,0
192290,this,0,0
192291,varies,0,0
192292,with,0,0
192293,breast,0,0
192294,cancer,0,0
192295,subtype,0,0
192296,.,0,0
192297,In,0,0
192298,this,0,0
192299,study,0,0
192300,",",0,0
192301,results,0,0
192302,of,0,0
192303,both,0,0
192304,magnetic,1,0
192305,resonance,1,1
192306,imaging,1,1
192307,(,1,1
192308,MRI,1,1
192309,),1,1
192310,and,1,0
192311,ultrasound,1,1
192312,(,1,1
192313,US,1,1
192314,),1,0
192315,were,0,0
192316,reported,0,0
192317,.,0,0
192318,METHODS,0,0
192319,Patients,0,0
192320,with,0,0
192321,invasive,0,0
192322,breast,0,0
192323,cancer,0,0
192324,were,0,0
192325,enrolled,0,0
192326,in,0,0
192327,the,0,0
192328,INTENS,0,0
192329,study,0,0
192330,between,0,0
192331,2006,0,0
192332,and,0,0
192333,2009,0,0
192334,.,0,0
192335,We,0,0
192336,included,0,0
192337,182,0,0
192338,patients,0,0
192339,",",0,0
192340,of,0,0
192341,whom,0,0
192342,data,0,0
192343,were,0,0
192344,available,0,0
192345,for,0,0
192346,post-NAC,0,0
192347,MRI,1,0
192348,(,0,0
192349,n=155,0,0
192350,),0,0
192351,",",0,0
192352,US,1,1
192353,(,0,0
192354,n=123,0,0
192355,),0,0
192356,",",0,0
192357,and,0,0
192358,histopathological,0,0
192359,tumour,0,0
192360,size,0,0
192361,.,0,0
192362,RESULTS,0,0
192363,MRI,0,0
192364,estimated,0,0
192365,residual,0,0
192366,tumour,0,0
192367,size,0,0
192368,with,0,0
192369,<,0,0
192370,10-mm,0,0
192371,discordance,0,0
192372,in,0,0
192373,54,0,0
192374,%,0,0
192375,of,0,0
192376,patients,0,0
192377,",",0,0
192378,overestimated,0,0
192379,size,0,0
192380,in,0,0
192381,28,0,0
192382,%,0,0
192383,and,0,0
192384,underestimated,0,0
192385,size,0,0
192386,in,0,0
192387,18,0,0
192388,%,0,0
192389,of,0,0
192390,patients,0,0
192391,.,0,0
192392,With,0,0
192393,US,0,0
192394,",",0,0
192395,this,0,0
192396,was,0,0
192397,63,0,0
192398,%,0,0
192399,",",0,0
192400,20,0,0
192401,%,0,0
192402,and,0,0
192403,17,0,0
192404,%,0,0
192405,",",0,0
192406,respectively,0,0
192407,.,0,0
192408,The,0,0
192409,negative,0,0
192410,predictive,0,0
192411,value,0,0
192412,in,0,0
192413,hormone,0,1
192414,receptor-positive,0,1
192415,tumours,0,1
192416,for,0,0
192417,both,0,0
192418,MRI,0,0
192419,and,0,0
192420,US,0,0
192421,was,0,0
192422,low,0,0
192423,",",0,0
192424,26,0,0
192425,%,0,0
192426,and,0,0
192427,33,0,0
192428,%,0,0
192429,",",0,0
192430,respectively,0,0
192431,.,0,0
192432,The,0,0
192433,median,0,0
192434,deviation,0,0
192435,in,0,0
192436,clinical,0,0
192437,tumour,0,0
192438,size,0,0
192439,as,0,0
192440,percentage,0,0
192441,of,0,0
192442,pathological,0,0
192443,tumour,0,0
192444,was,0,0
192445,63,0,0
192446,%,0,0
192447,(,0,0
192448,P25=26,0,0
192449,",",0,0
192450,P75=100,0,0
192451,),0,0
192452,and,0,0
192453,49,0,0
192454,%,0,0
192455,(,0,0
192456,P25=22,0,0
192457,",",0,0
192458,P75=100,0,0
192459,),0,0
192460,for,0,0
192461,MRI,0,1
192462,and,0,0
192463,US,0,0
192464,",",0,0
192465,respectively,0,0
192466,(,0,0
192467,P=0.06,0,0
192468,),0,0
192469,.,0,0
192470,CONCLUSIONS,0,0
192471,In,0,0
192472,this,0,0
192473,study,0,0
192474,",",0,0
192475,US,0,0
192476,was,0,0
192477,at,0,0
192478,least,0,0
192479,as,0,0
192480,good,0,0
192481,as,0,0
192482,breast,0,0
192483,MRI,0,0
192484,in,0,0
192485,providing,0,0
192486,information,0,0
192487,on,0,0
192488,residual,0,0
192489,tumour,0,0
192490,size,0,0
192491,post-neoadjuvant,0,0
192492,chemotherapy,0,0
192493,.,0,0
192494,However,0,0
192495,",",0,0
192496,both,0,0
192497,modalities,0,0
192498,suffered,0,0
192499,from,0,0
192500,a,0,0
192501,substantial,0,0
192502,percentage,0,0
192503,of,0,0
192504,over-,0,0
192505,and,0,0
192506,underestimation,0,0
192507,of,0,0
192508,tumour,0,0
192509,size,0,0
192510,and,0,0
192511,in,0,0
192512,addition,0,0
192513,both,0,0
192514,showed,0,0
192515,a,0,0
192516,low,0,0
192517,negative,0,0
192518,predictive,0,0
192519,value,0,0
192520,of,0,0
192521,pathologic,0,0
192522,complete,0,0
192523,remission,0,1
192524,(,0,0
192525,Gov,0,1
192526,nr,0,1
192527,:,0,1
192528,NCT00314977,0,1
192529,),0,0
192530,.,0,0
192531,Cost-effectiveness,0,0
192532,analysis,0,0
192533,of,0,0
192534,a,0,0
192535,communication-focused,1,0
192536,therapy,1,0
192537,for,0,0
192538,pre-school,0,0
192539,children,0,0
192540,with,0,0
192541,autism,0,0
192542,:,0,0
192543,results,0,0
192544,from,0,0
192545,a,0,0
192546,randomised,0,0
192547,controlled,0,0
192548,trial,0,0
192549,.,0,0
192550,BACKGROUND,0,0
192551,Autism,0,0
192552,is,0,0
192553,associated,0,0
192554,with,0,0
192555,impairments,0,0
192556,that,0,0
192557,have,0,0
192558,life-time,0,0
192559,consequences,0,0
192560,for,0,0
192561,diagnosed,0,0
192562,individuals,0,0
192563,and,0,0
192564,a,0,0
192565,substantial,0,0
192566,impact,0,0
192567,on,0,0
192568,families,0,0
192569,.,0,0
192570,There,0,0
192571,is,0,0
192572,growing,0,0
192573,interest,0,0
192574,in,0,0
192575,early,0,0
192576,interventions,0,0
192577,for,0,0
192578,children,0,0
192579,with,0,0
192580,autism,0,0
192581,",",0,0
192582,yet,0,0
192583,despite,0,0
192584,the,0,0
192585,substantial,0,0
192586,economic,0,0
192587,burden,0,0
192588,",",0,0
192589,there,0,0
192590,is,0,0
192591,little,0,0
192592,evidence,0,0
192593,of,0,0
192594,the,0,0
192595,cost-effectiveness,0,0
192596,of,0,0
192597,such,0,0
192598,interventions,0,0
192599,with,0,0
192600,which,0,0
192601,to,0,0
192602,support,0,0
192603,resource,0,0
192604,allocation,0,0
192605,decisions,0,0
192606,.,0,0
192607,This,0,0
192608,study,0,0
192609,reports,0,0
192610,an,0,0
192611,economic,0,0
192612,evaluation,0,0
192613,of,0,0
192614,a,0,0
192615,parent-mediated,1,0
192616,",",1,0
192617,communication-focused,1,0
192618,therapy,1,0
192619,carried,0,0
192620,out,0,0
192621,within,0,0
192622,the,0,0
192623,Pre-School,1,0
192624,Autism,1,0
192625,Communication,1,0
192626,Trial,1,0
192627,(,1,1
192628,PACT,1,1
192629,),1,1
192630,.,1,0
192631,METHODS,0,0
192632,152,0,0
192633,pre-school,0,0
192634,children,0,0
192635,with,0,0
192636,autism,0,0
192637,were,0,0
192638,randomly,0,0
192639,assigned,0,0
192640,to,0,0
192641,treatment,1,0
192642,as,1,0
192643,usual,1,1
192644,(,1,1
192645,TAU,1,1
192646,),1,1
192647,or,1,0
192648,PACT,1,1
192649,+,1,1
192650,TAU,1,1
192651,.,1,0
192652,Primary,1,0
192653,outcome,0,0
192654,was,0,0
192655,severity,0,0
192656,of,0,0
192657,autism,0,0
192658,symptoms,0,0
192659,at,0,0
192660,13-month,0,0
192661,follow-up,0,0
192662,.,0,0
192663,Economic,0,0
192664,data,0,0
192665,included,0,0
192666,health,0,0
192667,",",0,0
192668,education,0,0
192669,and,0,0
192670,social,0,0
192671,services,0,0
192672,",",0,0
192673,childcare,0,0
192674,",",0,0
192675,parental,0,0
192676,productivity,0,0
192677,losses,0,0
192678,and,0,0
192679,informal,0,0
192680,care,0,0
192681,.,0,0
192682,RESULTS,0,0
192683,Clinically,0,0
192684,meaningful,0,0
192685,symptom,0,0
192686,improvement,0,0
192687,was,0,0
192688,evident,0,0
192689,for,0,0
192690,53,0,0
192691,%,0,0
192692,of,0,0
192693,PACT,1,0
192694,+,1,1
192695,TAU,1,0
192696,versus,1,0
192697,41,0,0
192698,%,0,0
192699,of,0,0
192700,TAU,1,0
192701,(,0,1
192702,odds,0,1
192703,ratio,0,0
192704,1.91,0,0
192705,",",0,0
192706,p,0,0
192707,=,0,0
192708,0.074,0,0
192709,),0,0
192710,.,0,0
192711,Service,0,0
192712,costs,0,0
192713,were,0,0
192714,significantly,1,0
192715,higher,1,0
192716,for,1,0
192717,PACT,1,1
192718,+,1,1
192719,TAU,1,1
192720,(,0,0
192721,mean,0,0
192722,difference,0,0
192723,"?4,489",0,0
192724,",",0,0
192725,p,0,0
192726,<,0,0
192727,0.001,0,0
192728,),0,0
192729,",",0,0
192730,but,0,0
192731,the,0,0
192732,difference,0,0
192733,in,0,0
192734,societal,0,0
192735,costs,0,0
192736,was,0,0
192737,smaller,0,0
192738,and,0,0
192739,non-significant,0,0
192740,(,0,0
192741,mean,0,0
192742,difference,0,0
192743,"?1,385",0,0
192744,",",0,0
192745,p,0,0
192746,=,0,0
192747,0.788,0,0
192748,),0,0
192749,due,0,0
192750,to,0,0
192751,lower,0,0
192752,informal,0,0
192753,care,0,0
192754,rates,0,0
192755,for,1,0
192756,PACT,1,1
192757,+,1,0
192758,TAU,1,1
192759,.,0,0
192760,CONCLUSIONS,0,0
192761,Improvements,0,0
192762,in,0,0
192763,outcome,0,0
192764,generated,1,0
192765,by,1,0
192766,PACT,1,0
192767,come,0,0
192768,at,0,0
192769,a,0,0
192770,cost,0,0
192771,.,0,0
192772,Although,0,0
192773,this,0,0
192774,cost,0,0
192775,is,0,0
192776,lower,0,0
192777,when,0,0
192778,burden,0,0
192779,on,0,0
192780,parents,0,0
192781,is,0,0
192782,included,0,0
192783,",",0,0
192784,the,0,0
192785,cost,0,0
192786,and,0,0
192787,effectiveness,0,0
192788,results,0,0
192789,presented,0,0
192790,do,0,0
192791,not,0,0
192792,support,0,0
192793,the,0,0
192794,cost-effectiveness,0,0
192795,of,1,0
192796,PACT,1,1
192797,+,1,0
192798,TAU,1,0
192799,compared,1,0
192800,to,1,0
192801,TAU,1,0
192802,alone,1,0
192803,.,1,0
192804,TRIAL,1,0
192805,REGISTRATION,1,0
192806,Current,0,0
192807,Controlled,0,0
192808,Trials,0,0
192809,ISRCTN58133827,0,0
192810,.,0,0
192811,[,1,1
192812,Cannulation,1,0
192813,of,1,0
192814,the,1,0
192815,internal,1,0
192816,jugular,1,0
192817,vein,1,0
192818,using,1,0
192819,2,1,0
192820,ultrasonic,1,0
192821,technics,1,0
192822,.,1,0
192823,A,0,0
192824,comparative,0,0
192825,controlled,0,0
192826,study,0,0
192827,],0,0
192828,.,0,0
192829,The,0,0
192830,internal,0,0
192831,jugular,0,0
192832,vein,0,1
192833,(,0,1
192834,IJV,0,1
192835,),0,0
192836,is,0,0
192837,a,0,0
192838,common,0,0
192839,access,0,0
192840,route,0,0
192841,to,0,0
192842,the,0,0
192843,central,0,0
192844,venous,0,0
192845,system,0,0
192846,.,0,0
192847,Anatomical,0,0
192848,landmarks,0,1
192849,(,0,1
192850,group,0,0
192851,I,0,0
192852,),0,0
192853,are,0,0
192854,normally,0,0
192855,used,0,0
192856,for,0,0
192857,localization,0,0
192858,of,0,0
192859,the,0,0
192860,IJV,0,0
192861,.,0,0
192862,We,0,0
192863,have,0,0
192864,compared,0,0
192865,this,0,0
192866,method,0,0
192867,with,0,0
192868,two,0,0
192869,other,0,0
192870,methods,0,0
192871,based,0,0
192872,on,0,0
192873,ultrasonic,0,0
192874,waves,0,0
192875,to,0,0
192876,identify,0,0
192877,the,0,0
192878,IJV,0,0
192879,and,0,0
192880,the,0,0
192881,carotid,0,1
192882,artery,0,1
192883,(,0,1
192884,CA,0,1
192885,),0,1
192886,(,0,0
192887,even,0,0
192888,in,0,0
192889,atypical,0,0
192890,positions,0,0
192891,),0,0
192892,.,0,0
192893,We,0,0
192894,employed,0,0
192895,an,1,0
192896,ultrasound,1,0
192897,Doppler,1,0
192898,device,1,0
192899,in,1,0
192900,group,1,0
192901,II,1,0
192902,and,1,0
192903,a,1,0
192904,real-time,1,0
192905,ultrasonograph,1,0
192906,in,1,0
192907,group,1,0
192908,III,1,0
192909,.,1,0
192910,Central,1,0
192911,venous,1,0
192912,catheters,1,0
192913,were,1,0
192914,placed,1,0
192915,into,1,0
192916,the,1,0
192917,right,1,0
192918,IJV,1,0
192919,by,1,0
192920,the,1,0
192921,Seldinger,1,0
192922,technique,1,0
192923,.,1,0
192924,The,0,0
192925,IJV,0,0
192926,could,0,0
192927,be,0,0
192928,located,0,0
192929,in,0,0
192930,all,0,0
192931,patients,0,0
192932,with,0,0
192933,both,0,0
192934,ultrasound,0,0
192935,methods,0,0
192936,",",0,0
192937,but,0,0
192938,the,0,0
192939,course,0,0
192940,of,0,0
192941,the,0,0
192942,IJV,0,0
192943,could,0,0
192944,only,0,0
192945,be,0,0
192946,identified,0,0
192947,by,0,0
192948,ultrasonography,0,0
192949,.,0,0
192950,For,0,0
192951,this,0,0
192952,reason,0,0
192953,",",0,0
192954,the,0,0
192955,direction,0,0
192956,of,0,0
192957,the,0,0
192958,IJV,0,0
192959,was,0,0
192960,classified,0,0
192961,as,0,0
192962,typical,0,0
192963,in,0,0
192964,80,0,0
192965,%,0,0
192966,of,0,0
192967,group,0,0
192968,I,0,0
192969,",",0,0
192970,in,0,0
192971,85,0,0
192972,%,0,0
192973,of,0,0
192974,group,0,0
192975,II,0,0
192976,",",0,0
192977,but,0,0
192978,in,0,0
192979,only,0,0
192980,45,0,0
192981,%,0,0
192982,of,0,0
192983,group,0,0
192984,III,0,0
192985,.,0,1
192986,No,0,1
192987,intergroup,0,0
192988,differences,0,0
192989,were,0,0
192990,found,0,0
192991,with,0,0
192992,respect,0,0
192993,to,0,0
192994,the,0,0
192995,number,0,0
192996,of,0,0
192997,punctures,0,0
192998,(,0,0
192999,mean,0,0
193000,value,0,0
193001,1.6,0,0
193002,+/-,0,0
193003,0.83,0,0
193004,),0,0
193005,and,0,0
193006,the,0,0
193007,incidence,0,0
193008,of,0,0
193009,complications,0,0
193010,.,0,0
193011,The,0,0
193012,time,0,0
193013,required,0,0
193014,to,0,0
193015,locate,0,0
193016,the,0,0
193017,site,0,0
193018,and,0,0
193019,direction,0,0
193020,of,0,0
193021,puncture,0,0
193022,increased,0,0
193023,with,0,0
193024,technical,0,0
193025,sophistication,0,0
193026,.,0,0
193027,There,0,0
193028,was,0,0
193029,",",0,0
193030,however,0,0
193031,",",0,0
193032,no,0,0
193033,difference,0,0
193034,in,0,0
193035,the,0,0
193036,total,0,0
193037,time,0,0
193038,for,0,0
193039,catheter,0,0
193040,placement,0,0
193041,",",0,0
193042,because,0,0
193043,puncture,0,0
193044,was,0,0
193045,performed,0,0
193046,faster,0,0
193047,when,0,0
193048,aided,0,0
193049,by,0,0
193050,sonography,0,0
193051,.,0,0
193052,In,0,0
193053,four,0,0
193054,patients,0,0
193055,in,0,0
193056,groups,0,0
193057,I,0,0
193058,and,0,0
193059,II,0,0
193060,",",0,0
193061,in,0,0
193062,whom,0,0
193063,attempts,0,0
193064,to,0,0
193065,puncture,0,0
193066,the,0,0
193067,IJV,0,0
193068,had,0,0
193069,not,0,0
193070,been,0,0
193071,successful,0,0
193072,",",0,0
193073,this,0,0
193074,could,0,0
193075,subsequently,0,0
193076,be,0,0
193077,achieved,0,0
193078,with,0,0
193079,ultrasonographic,0,0
193080,aid,0,0
193081,.,0,0
193082,One,0,0
193083,patient,0,1
193084,(,0,1
193085,group,0,0
193086,I,0,0
193087,),0,0
193088,displayed,0,0
193089,a,0,0
193090,hematoma,0,0
193091,following,0,0
193092,inadvertent,0,0
193093,puncture,0,0
193094,of,0,0
193095,the,0,0
193096,CA,0,0
193097,.,0,0
193098,In,0,0
193099,one,0,0
193100,patient,0,0
193101,in,0,0
193102,group,0,0
193103,II,0,0
193104,the,0,0
193105,IJV,0,0
193106,and,0,0
193107,CA,0,0
193108,could,0,0
193109,not,0,0
193110,be,0,0
193111,distinguished,0,0
193112,as,0,0
193113,one,0,0
193114,was,0,0
193115,overlying,0,0
193116,the,0,0
193117,other,0,0
193118,.,0,0
193119,The,0,0
193120,echocamera,0,0
193121,provided,0,0
193122,improved,0,0
193123,localization,0,0
193124,of,0,0
193125,the,0,0
193126,IJV,0,0
193127,and,0,0
193128,the,0,0
193129,CA,0,0
193130,in,0,0
193131,comparison,0,0
193132,with,0,0
193133,the,0,0
193134,Doppler,0,0
193135,ultrasound,0,1
193136,.,0,0
193137,(,0,0
193138,ABSTRACT,0,1
193139,TRUNCATED,0,1
193140,AT,0,1
193141,250,0,1
193142,WORDS,0,1
193143,),0,1
193144,A,0,0
193145,comparison,0,0
193146,of,0,0
193147,high,1,0
193148,and,1,0
193149,low,1,0
193150,fat,1,1
193151,meals,1,1
193152,on,0,1
193153,postprandial,0,1
193154,esophageal,0,1
193155,acid,0,1
193156,exposure,0,0
193157,.,0,0
193158,Fatty,0,0
193159,foods,0,0
193160,have,0,0
193161,been,0,0
193162,identified,0,0
193163,as,0,0
193164,precipitating,0,0
193165,factors,0,0
193166,in,0,0
193167,symptomatic,0,0
193168,gastroesophageal,0,1
193169,reflux,0,1
193170,(,0,1
193171,GER,0,1
193172,),0,1
193173,.,0,0
193174,A,0,1
193175,fat,0,1
193176,meal,0,1
193177,has,0,0
193178,also,0,0
193179,been,0,0
193180,found,0,0
193181,to,0,0
193182,decrease,0,0
193183,lower,0,0
193184,esophageal,0,0
193185,sphincter,0,1
193186,pressure,0,1
193187,(,0,1
193188,LESP,0,1
193189,),0,0
193190,in,0,0
193191,normal,0,0
193192,subjects,0,0
193193,.,0,0
193194,We,0,0
193195,used,0,0
193196,the,0,0
193197,ambulatory,0,1
193198,24-h,0,1
193199,pH,0,1
193200,monitor,0,1
193201,to,0,0
193202,assess,0,0
193203,esophageal,0,0
193204,acid,0,0
193205,exposure,0,0
193206,in,0,0
193207,10,0,0
193208,normal,0,0
193209,subjects,0,0
193210,and,0,0
193211,10,0,0
193212,GER,0,1
193213,patients,0,0
193214,following,0,0
193215,low,1,0
193216,and,1,0
193217,high,1,0
193218,fat,1,1
193219,meals,1,1
193220,eaten,1,1
193221,in,1,0
193222,two,1,0
193223,body,1,0
193224,positions,1,0
193225,.,1,0
193226,The,0,0
193227,meals,0,1
193228,had,0,0
193229,nearly,0,0
193230,identical,0,0
193231,protein,0,0
193232,content,0,0
193233,",",0,0
193234,volumes,0,0
193235,",",0,0
193236,and,0,0
193237,calories,0,1
193238,.,0,1
193239,On,0,1
193240,successive,0,0
193241,days,0,0
193242,",",0,0
193243,patients,0,0
193244,ingested,0,0
193245,one,0,0
193246,of,0,0
193247,the,0,0
193248,meals,1,1
193249,twice,0,1
193250,",",0,0
193251,followed,0,0
193252,by,0,0
193253,random,0,0
193254,assignment,0,0
193255,to,0,0
193256,3,0,0
193257,h,0,0
193258,upright,1,0
193259,and,1,0
193260,3,0,0
193261,h,0,0
193262,recumbent,1,0
193263,position,1,0
193264,.,1,0
193265,Acid,0,0
193266,exposure,0,0
193267,for,0,0
193268,each,0,0
193269,hour,0,0
193270,over,0,0
193271,a,0,1
193272,3-h,0,1
193273,postprandial,0,1
193274,(,0,1
193275,PP,0,1
193276,),0,1
193277,period,0,0
193278,was,0,0
193279,assessed,0,0
193280,as,0,0
193281,the,0,0
193282,percent,0,0
193283,time,0,0
193284,pH,0,0
193285,less,0,0
193286,than,0,0
193287,4.0,0,0
193288,.,0,0
193289,Increased,0,0
193290,upright,0,0
193291,acid,0,0
193292,exposure,0,0
193293,occurred,0,0
193294,in,0,0
193295,normals,0,0
193296,after,0,0
193297,the,0,0
193298,high,0,0
193299,fat,0,0
193300,(,0,0
193301,6.2,0,0
193302,+/-,0,0
193303,2.1,0,0
193304,%,0,0
193305,;,0,0
193306,mean,0,0
193307,+/-,0,0
193308,SE,0,0
193309,),0,0
193310,compared,0,0
193311,with,0,0
193312,the,0,0
193313,low,0,0
193314,fat,0,1
193315,meal,0,1
193316,(,0,0
193317,1.5,0,0
193318,+/-,0,0
193319,0.5,0,0
193320,%,0,0
193321,;,0,0
193322,p,0,0
193323,less,0,0
193324,than,0,0
193325,0.05,0,0
193326,),0,0
193327,.,0,0
193328,GER,0,1
193329,patients,0,0
193330,had,0,0
193331,greater,0,0
193332,(,0,0
193333,p,0,0
193334,less,0,0
193335,than,0,0
193336,0.05,0,0
193337,),0,0
193338,acid,0,0
193339,exposure,0,0
193340,than,0,0
193341,normals,0,0
193342,in,0,0
193343,all,0,0
193344,study,0,0
193345,periods,0,0
193346,",",0,0
193347,but,0,0
193348,no,0,0
193349,differences,0,0
193350,were,0,0
193351,found,0,0
193352,between,0,0
193353,low,0,0
193354,and,0,0
193355,high,0,0
193356,fat,0,1
193357,meals,0,1
193358,in,0,0
193359,either,0,0
193360,study,0,0
193361,position,0,0
193362,.,0,0
193363,High,0,0
193364,fat,0,1
193365,meals,0,1
193366,induce,0,1
193367,upright,0,1
193368,GER,0,1
193369,in,0,0
193370,normals,0,0
193371,",",0,0
193372,but,0,0
193373,do,0,0
193374,not,0,0
193375,significantly,0,0
193376,affect,0,0
193377,the,0,0
193378,abnormal,0,0
193379,amount,0,0
193380,of,0,0
193381,GER,0,1
193382,in,0,0
193383,patients,0,0
193384,.,0,0
193385,In,0,0
193386,addition,0,0
193387,",",0,0
193388,progressive,0,0
193389,increases,0,0
193390,in,0,0
193391,acid,0,0
193392,exposure,0,0
193393,were,0,0
193394,found,0,0
193395,over,0,0
193396,the,0,0
193397,3,0,0
193398,postprandial,0,1
193399,hours,0,1
193400,in,0,1
193401,GER,0,1
193402,patients,0,0
193403,in,0,0
193404,a,0,0
193405,recumbent,0,0
193406,position,0,0
193407,.,0,0
193408,The,0,0
193409,findings,0,0
193410,are,0,0
193411,consistent,0,0
193412,with,0,0
193413,prior,0,0
193414,data,0,0
193415,showing,0,0
193416,decreased,0,0
193417,LESP,0,0
193418,with,0,0
193419,a,0,0
193420,fat,0,0
193421,meal,0,1
193422,in,0,0
193423,normals,0,0
193424,.,0,0
193425,[,0,1
193426,Preventive,0,0
193427,use,0,0
193428,of,0,0
193429,Pentaglobin,1,1
193430,in,0,0
193431,intensive,0,1
193432,care,0,0
193433,treatment,0,0
193434,of,0,0
193435,trauma,0,0
193436,patients,0,0
193437,],0,0
193438,.,0,0
193439,Basing,0,0
193440,on,0,0
193441,50,0,0
193442,posttraumatic,0,0
193443,intensive-care,0,0
193444,patients,0,0
193445,with,0,0
193446,medium,0,0
193447,grade,0,0
193448,lesions,0,1
193449,(,0,1
193450,ISS,0,1
193451,criteria,0,1
193452,),0,0
193453,",",0,0
193454,the,0,0
193455,prophylactic,0,0
193456,effect,0,0
193457,of,0,0
193458,an,0,0
193459,intravenously,0,1
193460,applicable,0,0
193461,IgM,0,0
193462,preparation,0,0
193463,(,1,1
193464,Pentaglobin,1,1
193465,),1,1
193466,against,0,0
193467,nosocomial,0,0
193468,infections,0,0
193469,was,0,0
193470,investigated,0,0
193471,.,0,0
193472,The,0,0
193473,prophylaxis,0,0
193474,group,0,0
193475,received,0,0
193476,on,0,0
193477,the,0,0
193478,3rd,0,0
193479,",",0,0
193480,4th,0,0
193481,and,0,0
193482,5th,0,0
193483,day,0,0
193484,a,0,1
193485,daily,0,1
193486,dose,0,1
193487,of,0,1
193488,10,0,1
193489,g,0,0
193490,each,0,0
193491,.,0,0
193492,At,0,0
193493,the,0,0
193494,same,0,0
193495,times,0,0
193496,the,0,0
193497,controls,0,0
193498,were,0,0
193499,given,0,0
193500,12.5,1,0
193501,g,1,0
193502,human,1,0
193503,albumin,1,1
193504,each,0,0
193505,.,0,0
193506,Whereas,0,0
193507,no,0,0
193508,difference,0,0
193509,was,0,0
193510,seen,0,0
193511,between,0,0
193512,both,0,0
193513,groups,0,0
193514,regarding,0,0
193515,the,0,0
193516,definitive,0,0
193517,outcome,0,0
193518,of,0,0
193519,the,0,0
193520,treatment,0,0
193521,",",0,0
193522,the,0,0
193523,prophylaxis,0,0
193524,group,0,0
193525,clearly,0,0
193526,showed,0,0
193527,fewer,0,0
193528,infection,0,0
193529,pointers,0,0
193530,during,0,0
193531,the,0,0
193532,clinical,0,0
193533,course,0,0
193534,.,0,0
193535,In,0,0
193536,particular,0,0
193537,",",0,0
193538,the,0,0
193539,incidence,0,0
193540,and,0,0
193541,magnitude,0,0
193542,of,0,0
193543,febrile,0,0
193544,temperatures,0,0
193545,were,0,0
193546,significantly,0,0
193547,lower,0,0
193548,between,0,0
193549,the,0,0
193550,4th,0,0
193551,and,0,0
193552,8th,0,0
193553,days,0,0
193554,of,0,0
193555,treatment,0,0
193556,.,0,0
193557,Our,0,0
193558,results,0,0
193559,indicate,0,0
193560,",",0,0
193561,however,0,0
193562,",",0,0
193563,that,0,0
193564,the,0,0
193565,prophylactic,0,0
193566,use,0,0
193567,those,0,0
193568,patients,0,0
193569,who,0,0
193570,are,0,0
193571,at,0,0
193572,particularly,0,0
193573,high,0,0
193574,infection,0,0
193575,exposure,0,0
193576,risk,0,0
193577,",",0,0
193578,e.g,0,0
193579,.,0,0
193580,through,0,0
193581,reintervention,0,0
193582,surgery,0,0
193583,",",0,0
193584,haemorrhage,0,0
193585,complications,0,0
193586,or,0,0
193587,extensive,0,0
193588,diagnostic,0,0
193589,interventions,0,0
193590,.,0,0
193591,Rate-modulated,0,0
193592,cardiac,0,0
193593,pacing,0,0
193594,based,0,0
193595,on,0,0
193596,transthoracic,0,0
193597,impedance,0,0
193598,measurements,0,0
193599,of,0,0
193600,minute,0,0
193601,ventilation,0,0
193602,:,0,0
193603,correlation,0,0
193604,with,0,0
193605,exercise,0,0
193606,gas,0,0
193607,exchange,0,0
193608,.,0,0
193609,The,0,0
193610,relation,0,0
193611,of,0,0
193612,pacing,0,0
193613,rate,0,0
193614,to,0,0
193615,physiologic,0,0
193616,variables,0,0
193617,of,0,0
193618,metabolic,0,0
193619,demand,0,0
193620,was,0,0
193621,examined,0,0
193622,in,0,0
193623,10,0,0
193624,consecutive,0,0
193625,patients,0,0
193626,with,0,0
193627,a,0,0
193628,minute,0,0
193629,ventilation-sensing,0,0
193630,",",0,0
193631,rate-modulating,0,0
193632,ventricular,0,0
193633,pacemaker,0,0
193634,implanted,0,0
193635,for,0,0
193636,complete,0,0
193637,heart,0,0
193638,block,0,0
193639,.,0,0
193640,All,0,0
193641,patients,0,0
193642,had,0,0
193643,paroxysmal,0,0
193644,(,0,0
193645,seven,0,0
193646,patients,0,0
193647,),0,0
193648,or,0,1
193649,chronic,0,1
193650,(,0,0
193651,three,0,0
193652,patients,0,0
193653,),0,0
193654,atrial,0,1
193655,fibrillation,0,0
193656,and,0,0
193657,were,0,0
193658,referred,0,0
193659,for,0,0
193660,catheter,1,0
193661,ablation,1,0
193662,of,1,0
193663,the,1,0
193664,atrioventricular,1,0
193665,junction,1,0
193666,.,1,0
193667,Treadmill,1,0
193668,exercise,1,0
193669,testing,1,0
193670,with,0,0
193671,measurement,0,0
193672,of,0,0
193673,expired,0,0
193674,gas,0,0
193675,exchange,0,0
193676,and,0,0
193677,respiratory,0,0
193678,flow,0,0
193679,was,0,0
193680,performed,0,0
193681,before,0,0
193682,ablation,0,0
193683,and,0,0
193684,4,0,0
193685,weeks,0,0
193686,after,0,0
193687,pacemaker,0,0
193688,implantation,0,0
193689,",",0,0
193690,with,0,0
193691,the,0,0
193692,pacemaker,0,0
193693,programmed,0,0
193694,to,0,0
193695,both,0,0
193696,the,0,0
193697,fixed-rate,0,0
193698,VVI,0,0
193699,and,0,0
193700,rate-modulating,0,0
193701,minute,0,0
193702,ventilation,0,0
193703,VVIR,0,1
193704,pacing,0,0
193705,modes,0,0
193706,in,0,0
193707,random,0,0
193708,sequence,0,0
193709,.,0,0
193710,The,0,0
193711,relation,0,0
193712,of,0,0
193713,pacing,0,0
193714,rate,0,0
193715,to,0,0
193716,oxygen,0,0
193717,consumption,0,1
193718,(,0,1
193719,VO2,0,1
193720,),0,1
193721,",",0,0
193722,expired,0,1
193723,carbon,0,0
193724,dioxide,0,1
193725,concentration,0,1
193726,(,0,1
193727,VCO2,0,1
193728,),0,1
193729,",",0,0
193730,respiratory,0,1
193731,quotient,0,0
193732,",",0,0
193733,tidal,0,0
193734,volume,0,0
193735,",",0,0
193736,respiratory,0,0
193737,rate,0,0
193738,and,0,0
193739,minute,0,0
193740,ventilation,0,0
193741,was,0,0
193742,determined,0,0
193743,during,0,0
193744,exercise,0,0
193745,in,0,0
193746,the,0,0
193747,rate-modulating,0,0
193748,minute,0,0
193749,ventilation,0,0
193750,pacing,0,0
193751,mode,0,0
193752,.,0,0
193753,Pacing,0,0
193754,rate,0,0
193755,was,0,0
193756,highly,0,0
193757,correlated,0,0
193758,with,0,0
193759,minute,0,0
193760,ventilation,0,1
193761,(,0,0
193762,r,0,0
193763,=,0,0
193764,0.89,0,0
193765,),0,0
193766,",",0,0
193767,respiratory,0,1
193768,quotient,0,1
193769,(,0,0
193770,r,0,0
193771,=,0,0
193772,0.89,0,0
193773,),0,0
193774,",",0,0
193775,VCO2,0,1
193776,(,0,0
193777,r,0,0
193778,=,0,0
193779,0.87,0,0
193780,),0,0
193781,",",0,0
193782,tidal,0,1
193783,volume,0,1
193784,(,0,0
193785,r,0,0
193786,=,0,0
193787,0.87,0,0
193788,),0,0
193789,",",0,0
193790,VO2,0,1
193791,(,0,0
193792,r,0,0
193793,=,0,0
193794,0.84,0,0
193795,),0,0
193796,and,0,0
193797,respiratory,0,1
193798,rate,0,1
193799,(,0,0
193800,r,0,0
193801,=,0,0
193802,0.84,0,0
193803,),0,0
193804,.,0,0
193805,The,0,0
193806,mean,0,0
193807,exercise,0,0
193808,duration,0,0
193809,increased,0,0
193810,from,0,0
193811,8.3,0,0
193812,+/-,0,0
193813,2.8,0,0
193814,min,0,0
193815,in,0,0
193816,the,0,0
193817,fixed,0,0
193818,rate,0,0
193819,pacing,0,0
193820,mode,0,0
193821,to,0,0
193822,10.2,0,0
193823,+/-,0,0
193824,3.4,0,0
193825,min,0,0
193826,in,0,0
193827,the,0,0
193828,rate-modulating,0,0
193829,",",0,0
193830,minute,0,0
193831,ventilation,0,0
193832,mode,0,0
193833,(,0,0
193834,p,0,0
193835,=,0,0
193836,0.0001,0,0
193837,),0,0
193838,.,0,0
193839,The,0,0
193840,maximal,0,0
193841,VO2,0,0
193842,increased,0,0
193843,from,0,0
193844,13.4,0,0
193845,+/-,0,0
193846,3.4,0,0
193847,to,0,0
193848,16.3,0,0
193849,+/-,0,0
193850,4.1,0,0
193851,cc/kg,0,0
193852,per,0,0
193853,min,0,0
193854,(,0,0
193855,p,0,0
193856,=,0,0
193857,0.0004,0,0
193858,),0,0
193859,.,0,0
193860,The,0,0
193861,maximal,0,0
193862,heart,0,0
193863,rate,0,0
193864,achieved,0,0
193865,in,0,0
193866,the,0,0
193867,minute,0,0
193868,ventilation,0,0
193869,pacing,0,0
193870,mode,0,0
193871,was,0,0
193872,136,0,0
193873,+/-,0,0
193874,9.7,0,0
193875,beats/min,0,0
193876,",",0,0
193877,similar,0,0
193878,to,0,0
193879,that,0,0
193880,observed,0,0
193881,in,0,0
193882,the,0,0
193883,patient,0,0
193884,'s,0,0
193885,intrinsic,0,0
193886,cardiac,0,0
193887,rhythm,0,0
193888,before,0,0
193889,ablation,0,0
193890,(,0,0
193891,134.9,0,0
193892,+/-,0,0
193893,30.1,0,0
193894,beats/min,0,0
193895,",",0,0
193896,p,0,0
193897,=,0,0
193898,NS,0,0
193899,),0,0
193900,.,0,0
193901,(,0,0
193902,ABSTRACT,0,1
193903,TRUNCATED,0,1
193904,AT,0,1
193905,250,0,1
193906,WORDS,0,1
193907,),0,1
193908,[,0,0
193909,Potentiation,0,0
193910,of,0,0
193911,the,0,0
193912,effect,0,0
193913,of,0,0
193914,non-depolarizing,0,1
193915,muscle,0,1
193916,relaxants,0,1
193917,by,0,1
193918,acylaminopenicillins,1,1
193919,.,1,1
193920,Studies,0,0
193921,on,0,0
193922,the,0,0
193923,example,0,0
193924,of,0,0
193925,vecuronium,0,1
193926,],0,1
193927,.,0,0
193928,In,0,0
193929,a,0,0
193930,prospective,0,0
193931,controlled,0,0
193932,clinical,0,0
193933,study,0,0
193934,interactions,0,0
193935,between,0,0
193936,nondepolarizing,1,1
193937,muscle,1,1
193938,relaxants,1,1
193939,and,1,1
193940,acylaminopenicillins,1,1
193941,were,0,0
193942,investigated,0,0
193943,electromyographically,0,0
193944,.,0,0
193945,Six,0,1
193946,patients,0,0
193947,in,0,0
193948,each,0,0
193949,group,0,0
193950,received,0,0
193951,either,0,0
193952,apalcillin,1,1
193953,",",1,1
193954,azlocillin,1,1
193955,",",1,1
193956,mezlocillin,1,1
193957,or,1,1
193958,piperacillin,1,1
193959,during,0,0
193960,the,0,0
193961,operation,0,0
193962,.,0,0
193963,Muscle,0,0
193964,relaxation,0,0
193965,was,0,0
193966,maintained,0,0
193967,using,0,0
193968,the,0,0
193969,short,0,0
193970,acting,0,0
193971,nondepolarizing,0,1
193972,relaxant,0,1
193973,vecuronium,0,1
193974,",",0,1
193975,which,0,0
193976,shows,0,0
193977,no,0,0
193978,cumulative,0,0
193979,effect,0,0
193980,within,0,0
193981,clinical,0,0
193982,dosages,0,1
193983,.,0,1
193984,The,0,0
193985,intra-individual,0,0
193986,comparison,0,0
193987,with,0,0
193988,the,0,0
193989,control,0,0
193990,period,0,0
193991,(,0,0
193992,100,0,0
193993,%,0,0
193994,),0,0
193995,showed,0,0
193996,a,0,0
193997,significant,0,0
193998,prolongation,0,0
193999,of,0,0
194000,the,0,0
194001,duration,0,0
194002,of,0,0
194003,action,0,0
194004,after,0,0
194005,a,0,0
194006,fixed,0,0
194007,dose,0,1
194008,of,0,1
194009,vecuronium,0,1
194010,.,0,0
194011,The,0,0
194012,mean,0,0
194013,increase,0,0
194014,was,0,0
194015,+26,0,0
194016,%,0,0
194017,following,0,0
194018,apalcillin,0,0
194019,",",0,0
194020,+46,0,0
194021,%,0,0
194022,after,0,0
194023,piperacillin,0,0
194024,",",0,0
194025,+38,0,0
194026,%,0,0
194027,following,0,0
194028,mezlocillin,0,0
194029,and,0,0
194030,+55,0,0
194031,%,0,0
194032,following,0,0
194033,azlocillin,0,0
194034,.,0,0
194035,The,0,0
194036,shortest,0,0
194037,time,0,0
194038,of,0,0
194039,the,0,0
194040,control,0,0
194041,periods,0,0
194042,was,0,0
194043,8.6,0,0
194044,min,0,0
194045,and,0,0
194046,the,0,0
194047,maximum,0,0
194048,time,0,0
194049,was,0,0
194050,32.6,0,0
194051,min,0,0
194052,.,0,0
194053,We,0,0
194054,also,0,0
194055,found,0,0
194056,a,0,0
194057,significant,0,0
194058,depression,0,0
194059,of,0,0
194060,the,0,0
194061,EMG-response,0,0
194062,.,0,0
194063,No,0,0
194064,significant,0,0
194065,differences,0,0
194066,could,0,0
194067,be,0,0
194068,detected,0,0
194069,between,0,0
194070,the,0,0
194071,four,0,0
194072,antibiotics,0,1
194073,.,0,0
194074,The,0,0
194075,method,0,0
194076,described,0,0
194077,here,0,0
194078,has,0,0
194079,proven,0,0
194080,to,0,0
194081,be,0,0
194082,sensitive,0,0
194083,enough,0,0
194084,to,0,0
194085,detect,0,0
194086,clinically,0,0
194087,relevant,0,0
194088,interactions,0,0
194089,with,0,0
194090,muscle,0,0
194091,relaxants,0,1
194092,.,0,0
194093,As,0,0
194094,a,0,0
194095,result,0,0
194096,of,0,0
194097,our,0,0
194098,study,0,0
194099,",",0,0
194100,caution,0,0
194101,seems,0,0
194102,to,0,0
194103,be,0,0
194104,necessary,0,0
194105,if,0,0
194106,acylaminopenicillins,1,1
194107,are,0,1
194108,administered,0,1
194109,in,0,0
194110,the,0,0
194111,early,0,0
194112,postoperative,0,0
194113,period,0,0
194114,.,0,0
194115,Propranolol,1,1
194116,in,0,1
194117,acute,0,1
194118,myocardial,0,0
194119,infarction,0,0
194120,:,0,0
194121,the,0,0
194122,MILIS,0,0
194123,experience,0,0
194124,.,0,0
194125,The,0,0
194126,results,0,0
194127,of,0,0
194128,the,0,0
194129,propranolol,1,1
194130,limb,0,1
194131,of,0,0
194132,the,0,0
194133,Multicenter,0,0
194134,Investigation,0,0
194135,of,0,0
194136,the,0,0
194137,Limitation,0,0
194138,of,0,0
194139,Infarct,0,0
194140,Size,0,0
194141,are,0,0
194142,reviewed,0,0
194143,.,0,0
194144,A,0,0
194145,total,0,0
194146,of,0,0
194147,269,0,0
194148,patients,0,0
194149,",",0,0
194150,who,0,0
194151,presented,0,0
194152,with,0,0
194153,symptoms,0,0
194154,and,0,0
194155,electrocardiographic,0,0
194156,signs,0,0
194157,suggesting,0,0
194158,acute,0,0
194159,myocardial,0,0
194160,infarction,0,0
194161,were,0,0
194162,randomized,0,0
194163,to,0,0
194164,acute,0,1
194165,intravenous,0,1
194166,and,0,1
194167,subsequent,0,1
194168,oral,0,1
194169,therapy,0,1
194170,with,0,1
194171,propranolol,1,1
194172,(,0,0
194173,n,0,0
194174,=,0,0
194175,134,0,0
194176,),0,0
194177,or,1,0
194178,placebo,1,1
194179,(,0,0
194180,n,0,0
194181,=,0,0
194182,135,0,0
194183,),0,0
194184,.,0,0
194185,Eligibility,0,0
194186,for,0,0
194187,acute,0,1
194188,beta-blocker,0,1
194189,therapy,0,1
194190,was,0,0
194191,determined,0,0
194192,on,0,0
194193,the,0,0
194194,basis,0,0
194195,of,0,0
194196,readily,0,0
194197,available,0,0
194198,",",0,0
194199,noninvasive,0,0
194200,tests,0,0
194201,.,0,0
194202,Therapy,0,0
194203,was,0,0
194204,started,0,0
194205,at,0,0
194206,an,0,0
194207,average,0,0
194208,time,0,0
194209,of,0,0
194210,8.5,0,0
194211,hours,0,0
194212,after,0,0
194213,onset,0,0
194214,of,0,0
194215,symptoms,0,0
194216,.,0,0
194217,The,0,0
194218,full,0,0
194219,induction,0,0
194220,dose,0,1
194221,of,0,1
194222,intravenous,0,1
194223,propranolol,1,1
194224,(,0,1
194225,0.1,0,1
194226,mg/kg,0,1
194227,),0,0
194228,was,0,0
194229,tolerated,0,1
194230,by,0,0
194231,90,0,0
194232,%,0,0
194233,of,0,0
194234,treated,0,0
194235,patients,0,0
194236,",",0,0
194237,and,0,0
194238,oral,0,1
194239,maintenance,0,0
194240,therapy,0,0
194241,was,0,0
194242,being,0,0
194243,continued,0,0
194244,in,0,0
194245,82,0,0
194246,%,0,0
194247,of,0,0
194248,treated,0,0
194249,patients,0,0
194250,on,0,0
194251,the,0,0
194252,second,0,0
194253,hospital,0,0
194254,day,0,0
194255,.,0,0
194256,There,0,0
194257,was,0,0
194258,a,0,0
194259,significant,0,0
194260,reduction,0,0
194261,in,0,0
194262,heart,0,0
194263,rate,0,0
194264,throughout,0,0
194265,maintenance,0,0
194266,therapy,0,0
194267,with,0,0
194268,propranolol,0,1
194269,",",0,0
194270,which,0,0
194271,continued,0,0
194272,through,0,0
194273,the,0,0
194274,tenth,0,0
194275,hospital,0,0
194276,day,0,0
194277,.,0,0
194278,There,0,0
194279,was,0,0
194280,no,0,0
194281,significant,0,0
194282,difference,0,0
194283,in,0,0
194284,the,0,0
194285,incidence,0,0
194286,of,0,0
194287,congestive,0,0
194288,heart,0,0
194289,failure,0,0
194290,between,0,0
194291,propranolol-,1,1
194292,and,0,1
194293,placebo-treated,1,1
194294,groups,0,0
194295,.,0,0
194296,There,0,0
194297,was,0,0
194298,also,0,0
194299,no,0,0
194300,significant,0,0
194301,difference,0,0
194302,between,0,0
194303,the,0,0
194304,2,0,0
194305,groups,0,0
194306,in,0,0
194307,infarct,0,0
194308,size,0,0
194309,estimated,0,0
194310,by,0,0
194311,measurement,0,0
194312,of,0,0
194313,serum,0,1
194314,CK-MB,0,1
194315,",",0,0
194316,planimetry,0,0
194317,of,0,0
194318,infarct,0,0
194319,area,0,0
194320,on,0,0
194321,technetium,0,1
194322,pyrophosphate,0,1
194323,myocardial,0,1
194324,scintigrams,0,1
194325,or,0,0
194326,R-wave,0,0
194327,measurements,0,0
194328,in,0,0
194329,patients,0,0
194330,with,0,0
194331,transmural,0,0
194332,anterior,0,0
194333,and,0,0
194334,inferior,0,0
194335,infarcts,0,0
194336,.,0,0
194337,There,0,0
194338,was,0,0
194339,no,0,0
194340,significant,0,0
194341,difference,0,0
194342,in,0,0
194343,mortality,0,0
194344,between,0,0
194345,the,0,0
194346,2,0,0
194347,groups,0,0
194348,during,0,0
194349,an,0,0
194350,average,0,0
194351,of,0,0
194352,36,0,0
194353,months,0,0
194354,',0,0
194355,follow-up,0,0
194356,.,0,0
194357,Although,0,0
194358,propranolol,1,1
194359,can,0,0
194360,be,0,0
194361,administered,0,1
194362,safely,0,1
194363,to,0,0
194364,patients,0,0
194365,with,0,0
194366,acute,0,0
194367,myocardial,0,0
194368,infarction,0,0
194369,who,0,0
194370,are,0,0
194371,selected,0,0
194372,on,0,0
194373,the,0,0
194374,basis,0,0
194375,of,0,0
194376,simple,0,0
194377,clinical,0,0
194378,criteria,0,0
194379,",",0,0
194380,there,0,0
194381,is,0,0
194382,no,0,0
194383,evidence,0,0
194384,of,0,0
194385,reduction,0,0
194386,of,0,0
194387,infarct,0,0
194388,size,0,0
194389,when,0,0
194390,beta,0,1
194391,blockade,0,1
194392,is,0,0
194393,begun,0,0
194394,8.5,0,0
194395,hours,0,0
194396,after,0,0
194397,the,0,0
194398,onset,0,0
194399,of,0,0
194400,symptoms,0,0
194401,.,0,0
194402,Protective,0,0
194403,effect,0,0
194404,of,0,0
194405,high-dose,1,1
194406,medroxyprogesterone,1,1
194407,acetate,1,1
194408,(,1,1
194409,HD-MPA,1,1
194410,),1,1
194411,on,0,0
194412,hematological,0,0
194413,toxicity,0,0
194414,induced,0,0
194415,by,0,0
194416,chemotherapy,1,0
194417,for,0,0
194418,advanced,0,0
194419,solid,0,0
194420,tumors,0,0
194421,:,0,0
194422,a,0,0
194423,multicentric,0,0
194424,controlled,0,0
194425,clinical,0,0
194426,trial,0,0
194427,.,0,0
194428,MPA-Hematology,0,0
194429,Italian,0,0
194430,Cooperative,0,0
194431,Group,0,0
194432,.,0,0
194433,A,0,0
194434,multicenter,0,0
194435,",",0,0
194436,randomized,0,0
194437,",",0,0
194438,controlled,0,0
194439,trial,0,0
194440,was,0,0
194441,conducted,0,0
194442,comparing,0,0
194443,active,0,0
194444,treatment,0,0
194445,with,0,0
194446,placebo,1,0
194447,in,0,0
194448,227,0,0
194449,patients,0,0
194450,with,0,0
194451,breast,0,0
194452,",",0,0
194453,colorectal,0,0
194454,",",0,0
194455,lung,0,0
194456,and,0,0
194457,other,0,0
194458,solid,0,0
194459,forms,0,0
194460,of,0,0
194461,cancer,0,0
194462,.,0,0
194463,Combination,1,0
194464,therapy,1,0
194465,",",1,0
194466,(,1,1
194467,CT,1,1
194468,),1,0
194469,conventionally,0,0
194470,employed,0,0
194471,for,0,0
194472,the,0,0
194473,various,0,0
194474,types,0,0
194475,of,0,0
194476,tumor,0,0
194477,involved,0,0
194478,",",0,0
194479,was,0,0
194480,associated,0,0
194481,with,0,0
194482,MPA,1,0
194483,(,0,0
194484,117,0,0
194485,patients,0,0
194486,),0,0
194487,or,0,1
194488,placebo,1,1
194489,(,0,0
194490,110,0,0
194491,patients,0,0
194492,),0,0
194493,.,0,0
194494,MPA,0,0
194495,was,0,0
194496,given,0,0
194497,orally,0,1
194498,as,0,1
194499,tablets,0,1
194500,",",0,0
194501,as,0,0
194502,a,0,0
194503,dose,0,1
194504,of,0,1
194505,500,0,1
194506,mg,0,1
194507,b.i.d,0,1
194508,.,0,1
194509,for,0,0
194510,6,0,0
194511,months,0,0
194512,.,0,0
194513,The,0,0
194514,results,0,0
194515,were,0,0
194516,",",0,0
194517,briefly,0,0
194518,",",0,0
194519,as,0,0
194520,follows,0,0
194521,:,0,0
194522,The,0,0
194523,incidence,0,0
194524,of,0,0
194525,leukopenia,0,1
194526,was,0,0
194527,significantly,0,0
194528,lower,0,0
194529,in,0,0
194530,the,0,0
194531,groups,0,0
194532,receiving,0,0
194533,MPA,1,0
194534,in,0,0
194535,patients,0,0
194536,with,0,0
194537,breast,0,0
194538,and,0,0
194539,colorectal,0,1
194540,cancer,0,0
194541,(,0,0
194542,P,0,0
194543,less,0,0
194544,than,0,0
194545,0.02,0,0
194546,),0,0
194547,.,0,0
194548,Tumors,0,0
194549,of,0,0
194550,the,0,0
194551,lung,0,0
194552,and,0,0
194553,other,0,0
194554,solid,0,0
194555,forms,0,0
194556,showed,0,0
194557,no,0,0
194558,such,0,0
194559,difference,0,0
194560,.,0,0
194561,The,0,0
194562,incidence,0,0
194563,of,0,0
194564,thrombocytopenia,0,0
194565,was,0,0
194566,the,0,0
194567,same,0,0
194568,in,0,0
194569,all,0,0
194570,disease,0,0
194571,groups,0,0
194572,.,0,0
194573,Objective,0,0
194574,responses,0,0
194575,(,0,1
194576,CR,0,1
194577,+,0,1
194578,PR,0,1
194579,),0,0
194580,were,0,0
194581,observed,0,0
194582,in,0,0
194583,23/46,0,0
194584,(,0,0
194585,50,0,0
194586,%,0,0
194587,),0,0
194588,of,0,0
194589,breast,0,0
194590,cancer,0,0
194591,patients,0,0
194592,treated,0,0
194593,with,0,0
194594,CT,1,0
194595,+,1,0
194596,MPA,1,1
194597,",",0,0
194598,and,0,0
194599,in,0,0
194600,13/47,0,0
194601,(,0,0
194602,28,0,0
194603,%,0,0
194604,),0,0
194605,of,0,0
194606,those,0,0
194607,given,0,0
194608,CT,1,1
194609,+,1,1
194610,placebo,1,1
194611,.,1,1
194612,The,0,0
194613,difference,0,0
194614,was,0,0
194615,significant,0,0
194616,(,0,0
194617,P,0,0
194618,less,0,0
194619,than,0,0
194620,0.02,0,0
194621,),0,0
194622,.,0,0
194623,Subjective,0,0
194624,parameters,0,0
194625,also,0,0
194626,showed,0,0
194627,more,0,0
194628,improvement,0,0
194629,in,0,0
194630,the,0,0
194631,MPA,1,1
194632,group,0,0
194633,than,0,0
194634,in,0,0
194635,the,0,0
194636,patients,0,0
194637,given,0,0
194638,CT,0,0
194639,alone,0,0
194640,.,0,0
194641,No,0,0
194642,significant,0,0
194643,differences,0,0
194644,were,0,0
194645,found,0,0
194646,for,0,0
194647,the,0,0
194648,other,0,0
194649,types,0,0
194650,of,0,0
194651,tumor,0,0
194652,",",0,0
194653,but,0,0
194654,the,0,0
194655,numbers,0,0
194656,in,0,0
194657,this,0,0
194658,population,0,0
194659,were,0,0
194660,very,0,0
194661,limited,0,0
194662,.,0,0
194663,In,0,0
194664,a,0,0
194665,group,0,0
194666,of,0,0
194667,45,0,0
194668,patients,0,0
194669,",",0,0
194670,antithrombin,0,1
194671,III,0,1
194672,a,0,0
194673,(,0,0
194674,%,0,0
194675,),0,0
194676,",",0,0
194677,antithrombin,0,1
194678,III,0,1
194679,R,0,1
194680,:,0,1
194681,Ag,0,0
194682,(,0,0
194683,%,0,0
194684,),0,0
194685,",",0,0
194686,plasminogen,0,1
194687,(,0,1
194688,mg/dl,0,0
194689,),0,0
194690,",",0,0
194691,alpha-2,0,1
194692,macroglobulin,0,1
194693,(,0,1
194694,%,0,0
194695,),0,0
194696,",",0,0
194697,factor,0,0
194698,VIII,0,1
194699,C,0,0
194700,(,0,0
194701,%,0,0
194702,),0,0
194703,",",0,0
194704,factor,0,0
194705,VIII,0,0
194706,R,0,1
194707,:,0,1
194708,Ag,0,0
194709,(,0,0
194710,%,0,0
194711,),0,0
194712,and,0,0
194713,factor,0,0
194714,IX,0,1
194715,C,0,0
194716,(,0,0
194717,%,0,0
194718,),0,0
194719,were,0,0
194720,determined,0,0
194721,.,0,0
194722,The,0,0
194723,most,0,0
194724,interesting,0,0
194725,post-treatment,0,0
194726,findings,0,0
194727,were,0,0
194728,an,0,0
194729,increase,0,0
194730,in,0,0
194731,anti-thrombin,0,1
194732,III,0,1
194733,(,0,1
194734,activity,0,0
194735,and,0,0
194736,antigen,0,0
194737,level,0,0
194738,),0,0
194739,and,0,0
194740,in,0,0
194741,plasminogen,0,1
194742,.,0,1
194743,This,0,0
194744,suggests,0,0
194745,that,0,0
194746,MPA,0,0
194747,does,0,0
194748,not,0,0
194749,increase,0,0
194750,the,0,0
194751,risk,0,0
194752,of,0,0
194753,thrombosis,0,0
194754,",",0,0
194755,and,0,0
194756,might,0,0
194757,even,0,0
194758,",",0,0
194759,to,0,0
194760,some,0,0
194761,extent,0,0
194762,",",0,0
194763,impede,0,0
194764,tumor-induced,0,0
194765,thrombophilia,0,0
194766,.,0,0
194767,(,0,0
194768,ABSTRACT,0,1
194769,TRUNCATED,0,1
194770,AT,0,1
194771,250,0,1
194772,WORDS,0,1
194773,),0,1
194774,Comparison,0,0
194775,of,0,0
194776,endotracheal,1,0
194777,and,1,0
194778,peripheral,1,0
194779,intravenous,1,1
194780,adrenaline,1,1
194781,in,0,1
194782,cardiac,0,1
194783,arrest,0,0
194784,.,0,0
194785,Is,0,0
194786,the,0,0
194787,endotracheal,0,0
194788,route,0,0
194789,reliable,0,0
194790,?,0,0
194791,Twelve,0,0
194792,patients,0,0
194793,presenting,0,0
194794,to,0,0
194795,an,0,0
194796,accident,0,0
194797,and,0,0
194798,emergency,0,0
194799,department,0,0
194800,in,0,0
194801,asystolic,0,0
194802,cardiac,0,0
194803,arrest,0,0
194804,were,0,0
194805,randomly,0,0
194806,allocated,0,0
194807,to,0,0
194808,treatment,0,0
194809,with,0,0
194810,endotracheal,1,1
194811,adrenaline,1,1
194812,(,0,1
194813,five,0,0
194814,patients,0,0
194815,),0,0
194816,or,0,0
194817,peripheral,1,1
194818,intravenous,1,1
194819,adrenaline,1,1
194820,(,0,1
194821,seven,0,0
194822,patients,0,0
194823,),0,0
194824,.,0,0
194825,Femoral-artery,0,0
194826,blood,0,0
194827,samples,0,0
194828,were,0,0
194829,taken,0,0
194830,for,0,0
194831,assay,0,0
194832,of,0,0
194833,adrenaline,1,1
194834,and,1,1
194835,noradrenaline,1,1
194836,.,1,1
194837,After,0,1
194838,intravenous,0,1
194839,adrenaline,1,1
194840,there,0,0
194841,was,0,0
194842,a,0,0
194843,good,0,0
194844,clinical,0,0
194845,and,0,0
194846,biochemical,0,0
194847,response,0,0
194848,",",0,0
194849,but,0,0
194850,after,0,0
194851,endotracheal,0,0
194852,adrenaline,0,1
194853,there,0,0
194854,was,0,0
194855,no,0,0
194856,change,0,0
194857,in,0,0
194858,serum,0,1
194859,adrenaline,0,1
194860,and,0,1
194861,no,0,0
194862,measurable,0,0
194863,clinical,0,0
194864,response,0,0
194865,.,0,0
194866,The,0,0
194867,endotracheal,0,0
194868,route,0,0
194869,of,0,0
194870,adrenaline,1,1
194871,administration,0,1
194872,is,0,0
194873,not,0,0
194874,reliable,0,0
194875,in,0,0
194876,out-of-hospital,0,0
194877,cardiac,0,0
194878,arrest,0,0
194879,.,0,0
194880,Lithium,1,1
194881,and,0,1
194882,granulocytopenia,0,1
194883,during,0,0
194884,induction,0,0
194885,therapy,0,0
194886,of,0,0
194887,acute,0,0
194888,myelogenous,0,0
194889,leukemia,0,0
194890,.,0,0
194891,Twenty-seven,0,0
194892,patients,0,0
194893,receiving,0,0
194894,a,0,0
194895,standard,1,1
194896,cytosine,1,1
194897,arabinoside,1,1
194898,and,1,1
194899,daunorubicin,1,1
194900,regimen,1,1
194901,as,0,0
194902,induction,0,0
194903,of,0,0
194904,reinduction,0,1
194905,therapy,0,1
194906,of,0,0
194907,acute,0,0
194908,myelogenous,0,0
194909,leukemia,0,0
194910,were,0,0
194911,randomly,0,0
194912,assigned,0,0
194913,to,0,0
194914,receive,0,1
194915,lithium,1,1
194916,carbonate,1,1
194917,",",1,1
194918,300,1,1
194919,mg,1,1
194920,t.i.d.,1,1
194921,",",0,1
194922,or,1,0
194923,no,1,0
194924,lithium,1,1
194925,.,1,1
194926,Treatment,0,0
194927,groups,0,0
194928,were,0,0
194929,comparable,0,0
194930,with,0,0
194931,respect,0,0
194932,to,0,0
194933,age,0,0
194934,and,0,0
194935,baseline,0,1
194936,granulocyte,0,1
194937,counts,0,0
194938,.,0,0
194939,All,0,0
194940,patients,0,0
194941,developed,0,0
194942,granulocyte,0,1
194943,nadirs,0,1
194944,below,0,0
194945,100/cu,0,0
194946,mm,0,0
194947,.,0,0
194948,By,0,0
194949,actuarial,0,0
194950,analysis,0,0
194951,",",0,0
194952,the,0,0
194953,median,0,0
194954,duration,0,0
194955,of,0,0
194956,granulocytopenia,0,1
194957,",",0,0
194958,less,0,0
194959,than,0,0
194960,1000/cu,0,0
194961,mm,0,0
194962,",",0,0
194963,was,0,0
194964,16.0,0,0
194965,days,0,0
194966,in,0,0
194967,the,0,0
194968,lithium,1,1
194969,group,0,0
194970,and,0,0
194971,24.6,0,0
194972,days,0,0
194973,in,0,0
194974,the,0,0
194975,no-lithium,1,1
194976,group,0,0
194977,",",0,0
194978,p,0,0
194979,=,0,0
194980,0.013,0,0
194981,.,0,0
194982,The,0,0
194983,median,0,0
194984,duration,0,0
194985,of,0,0
194986,granulocytes,0,0
194987,less,0,0
194988,than,0,0
194989,500/cu,0,0
194990,mm,0,0
194991,also,0,0
194992,favored,0,0
194993,the,0,0
194994,lithium,1,1
194995,group,0,0
194996,but,0,0
194997,only,0,0
194998,approached,0,0
194999,statistical,0,0
195000,significance,0,0
195001,:,0,0
195002,14.0,0,0
195003,days,0,0
195004,versus,0,0
195005,20.5,0,0
195006,days,0,0
195007,",",0,0
195008,p,0,0
195009,=,0,0
195010,0.054,0,0
195011,.,0,0
195012,Lithium,1,0
195013,levels,0,0
195014,between,0,0
195015,0.5,0,0
195016,and,0,0
195017,1.0,0,0
195018,meq/liter,0,1
195019,were,0,0
195020,easily,0,0
195021,maintained,0,0
195022,in,0,0
195023,11,0,0
195024,of,0,0
195025,12,0,0
195026,patients,0,0
195027,receiving,0,0
195028,lithium,1,1
195029,",",0,1
195030,300,0,1
195031,mg,0,1
195032,t.i.d.,0,1
195033,",",0,1
195034,and,0,0
195035,toxicity,0,0
195036,directly,0,0
195037,attributable,0,0
195038,to,0,0
195039,lithium,1,1
195040,was,0,0
195041,not,0,0
195042,observed,0,0
195043,.,0,0
195044,Despite,0,0
195045,the,0,0
195046,shortened,0,0
195047,duration,0,0
195048,of,0,0
195049,neutropenia,0,0
195050,",",0,0
195051,the,0,0
195052,incidence,0,0
195053,of,0,0
195054,infections,0,0
195055,and,0,0
195056,the,0,0
195057,rate,0,0
195058,of,0,0
195059,remission,0,0
195060,were,0,0
195061,not,0,0
195062,affected,0,0
195063,.,0,0
195064,Multicenter,0,0
195065,trial,0,0
195066,of,0,0
195067,cryotherapy,1,0
195068,for,0,0
195069,retinopathy,0,0
195070,of,0,0
195071,prematurity,0,0
195072,:,0,0
195073,preliminary,0,0
195074,results,0,0
195075,.,0,0
195076,Cryotherapy,1,0
195077,for,0,0
195078,Retinopathy,0,0
195079,of,0,0
195080,Prematurity,0,0
195081,Cooperative,0,0
195082,Group,0,0
195083,.,0,0
195084,We,0,0
195085,report,0,0
195086,the,0,0
195087,preliminary,0,0
195088,3-month,0,0
195089,outcome,0,0
195090,of,0,0
195091,a,0,0
195092,multicenter,0,0
195093,randomized,0,0
195094,trial,0,0
195095,of,0,0
195096,cryotherapy,1,0
195097,for,1,0
195098,treatment,1,0
195099,of,1,0
195100,retinopathy,1,0
195101,of,1,0
195102,prematurity,1,1
195103,(,0,1
195104,ROP,0,1
195105,),0,1
195106,.,0,0
195107,Transscleral,1,0
195108,cryotherapy,1,0
195109,to,0,0
195110,the,0,0
195111,avascular,0,0
195112,retina,0,0
195113,was,0,0
195114,applied,0,0
195115,to,0,0
195116,one,0,0
195117,randomly,0,0
195118,selected,0,0
195119,eye,0,0
195120,when,0,0
195121,there,0,0
195122,was,0,0
195123,threshold,0,1
195124,disease,0,1
195125,(,0,0
195126,defined,0,0
195127,as,0,0
195128,five,0,0
195129,or,0,0
195130,more,0,0
195131,contiguous,0,0
195132,or,0,0
195133,eight,0,0
195134,cumulative,0,0
195135,30,0,0
195136,degree,0,0
195137,sectors,0,0
195138,[,0,0
195139,clock,0,0
195140,hours,0,1
195141,],0,0
195142,of,0,0
195143,stage,0,0
195144,3,0,0
195145,ROP,0,0
195146,in,0,0
195147,zone,0,0
195148,1,0,0
195149,or,0,0
195150,2,0,0
195151,in,0,0
195152,the,0,0
195153,presence,0,0
195154,of,0,0
195155,plus,0,0
195156,disease,0,0
195157,),0,1
195158,.,0,0
195159,An,0,1
195160,unfavorable,0,0
195161,outcome,0,0
195162,was,0,0
195163,defined,0,0
195164,as,0,0
195165,posterior,0,0
195166,retinal,0,0
195167,detachment,0,0
195168,",",0,0
195169,retinal,0,0
195170,fold,0,0
195171,involving,0,0
195172,the,0,0
195173,macula,0,0
195174,",",0,0
195175,or,0,0
195176,retrolental,0,0
195177,tissue,0,0
195178,.,0,0
195179,At,0,0
195180,this,0,0
195181,writing,0,0
195182,",",0,0
195183,172,0,0
195184,infants,0,0
195185,had,0,0
195186,been,0,0
195187,examined,0,0
195188,3,0,0
195189,months,0,0
195190,after,0,0
195191,randomization,0,0
195192,.,0,0
195193,An,0,1
195194,unfavorable,0,0
195195,outcome,0,0
195196,was,0,0
195197,significantly,0,0
195198,less,0,0
195199,frequent,0,0
195200,in,0,0
195201,the,0,0
195202,eyes,0,0
195203,undergoing,0,1
195204,cryotherapy,1,0
195205,(,0,0
195206,21.8,0,0
195207,%,0,0
195208,),0,0
195209,compared,0,0
195210,with,0,0
195211,the,0,0
195212,untreated,0,0
195213,eyes,0,0
195214,(,0,0
195215,43,0,0
195216,%,0,0
195217,),0,0
195218,.,0,0
195219,While,0,0
195220,the,0,0
195221,surgery,0,0
195222,was,0,0
195223,stressful,0,0
195224,",",0,0
195225,no,0,0
195226,unexpected,0,0
195227,complications,0,0
195228,occurred,0,0
195229,during,0,0
195230,or,0,0
195231,following,0,0
195232,treatment,0,0
195233,.,0,0
195234,These,0,0
195235,data,0,0
195236,support,0,0
195237,the,0,0
195238,efficacy,0,0
195239,of,0,0
195240,cryotherapy,1,0
195241,in,0,0
195242,reducing,0,0
195243,by,0,0
195244,approximately,0,0
195245,one,0,0
195246,half,0,0
195247,the,0,0
195248,risk,0,0
195249,of,0,0
195250,unfavorable,0,0
195251,retinal,0,0
195252,outcome,0,0
195253,from,0,0
195254,threshold,0,0
195255,ROP,0,0
195256,.,0,0
195257,No,0,1
195258,effect,0,1
195259,of,0,0
195260,acetylsalicylic,1,1
195261,acid,1,1
195262,on,0,1
195263,B-thromboglobulin,0,1
195264,and,0,1
195265,platelet,0,1
195266,factor,0,0
195267,4,0,1
195268,plasma,0,0
195269,levels,0,0
195270,in,0,0
195271,patients,0,0
195272,with,0,0
195273,transient,0,0
195274,ischaemic,0,0
195275,attacks,0,0
195276,.,0,0
195277,We,0,0
195278,studied,0,0
195279,the,0,0
195280,effect,0,0
195281,of,0,0
195282,acetylsalicylic,1,1
195283,acid,1,1
195284,(,1,1
195285,ASA,1,1
195286,),1,1
195287,versus,1,0
195288,placebo,1,1
195289,on,0,1
195290,B-thromboglobulin,0,1
195291,(,0,1
195292,B-TG,0,1
195293,),0,1
195294,and,0,0
195295,platelet,0,1
195296,factor,0,1
195297,4,0,1
195298,(,0,0
195299,PF4,0,1
195300,),0,1
195301,plasma,0,1
195302,levels,0,0
195303,and,0,0
195304,ADP-induced,0,0
195305,platelet,0,1
195306,aggregation,0,0
195307,in,0,0
195308,25,0,0
195309,male,0,0
195310,patients,0,0
195311,with,0,0
195312,transient,0,0
195313,ischaemic,0,0
195314,attacks,0,1
195315,(,0,1
195316,TIA,0,1
195317,),0,1
195318,.,0,0
195319,The,0,0
195320,patients,0,0
195321,were,0,0
195322,allocated,0,0
195323,randomly,0,0
195324,to,0,0
195325,two,0,0
195326,groups,0,0
195327,:,0,0
195328,14,0,0
195329,patients,0,0
195330,received,0,0
195331,oral,0,1
195332,treatment,0,1
195333,with,0,0
195334,ASA,1,1
195335,500,0,1
195336,mg,0,1
195337,b.i.d,0,1
195338,.,0,1
195339,for,0,0
195340,14,0,0
195341,days,0,0
195342,",",0,0
195343,11,0,0
195344,patients,0,0
195345,placebo,1,1
195346,b.i.d,0,1
195347,.,0,1
195348,for,0,0
195349,the,0,0
195350,same,0,0
195351,period,0,0
195352,.,0,0
195353,B-TG,0,0
195354,and,0,0
195355,PF4,0,1
195356,plasma,0,1
195357,levels,0,0
195358,and,0,0
195359,ADP-induced,0,0
195360,platelet,0,1
195361,aggregation,0,0
195362,were,0,0
195363,determined,0,0
195364,in,0,0
195365,basal,0,0
195366,conditions,0,0
195367,",",0,0
195368,and,0,0
195369,two,0,0
195370,hours,0,0
195371,",",0,0
195372,and,0,0
195373,seven,0,0
195374,and,0,0
195375,fourteen,0,0
195376,days,0,0
195377,after,0,0
195378,starting,0,0
195379,with,0,0
195380,ASA,0,0
195381,or,0,0
195382,placebo,0,1
195383,.,0,1
195384,In,0,0
195385,addition,0,0
195386,",",0,0
195387,the,0,0
195388,same,0,0
195389,parameters,0,0
195390,were,0,0
195391,studied,0,0
195392,in,0,0
195393,a,0,0
195394,group,0,0
195395,of,0,0
195396,20,0,0
195397,healthy,0,0
195398,males,0,0
195399,of,0,0
195400,matched,0,0
195401,age,0,0
195402,.,0,0
195403,Basal,0,0
195404,levels,0,0
195405,of,0,0
195406,plasma,0,1
195407,B-TG,0,1
195408,and,0,0
195409,PF4,0,0
195410,and,0,0
195411,the,0,0
195412,maximal,0,0
195413,amplitude,0,0
195414,of,0,0
195415,ADP-induced,0,0
195416,platelet,0,1
195417,aggregation,0,0
195418,were,0,0
195419,abnormally,0,0
195420,high,0,0
195421,in,0,0
195422,TIA,0,0
195423,patients,0,0
195424,.,0,0
195425,ASA,0,0
195426,caused,0,0
195427,a,0,0
195428,significant,0,0
195429,reduction,0,0
195430,of,0,0
195431,B-TG,0,1
195432,plasma,0,1
195433,levels,0,0
195434,in,0,0
195435,TIA,0,0
195436,patients,0,0
195437,2,0,0
195438,hours,0,0
195439,after,0,0
195440,the,0,0
195441,first,0,0
195442,administration,0,1
195443,",",0,0
195444,but,0,0
195445,no,0,0
195446,effect,0,0
195447,was,0,0
195448,observed,0,0
195449,at,0,0
195450,the,0,0
195451,7th,0,0
195452,and,0,0
195453,14th,0,0
195454,day,0,0
195455,of,0,0
195456,treatment,0,0
195457,.,0,0
195458,PF4,0,0
195459,plasma,0,0
195460,levels,0,0
195461,were,0,0
195462,unaffected,0,0
195463,by,0,0
195464,ASA,0,0
195465,treatment,0,0
195466,.,0,0
195467,It,0,0
195468,is,0,0
195469,concluded,0,0
195470,that,0,0
195471,ASA,0,0
195472,",",0,0
195473,at,0,0
195474,the,0,0
195475,dose,0,1
195476,conventionally,0,0
195477,used,0,0
195478,in,0,0
195479,clinical,0,0
195480,trials,0,0
195481,",",0,0
195482,does,0,0
195483,not,0,0
195484,affect,0,0
195485,the,0,0
195486,release,0,0
195487,of,0,0
195488,two,0,0
195489,alpha-granule,0,1
195490,proteins,0,0
195491,.,0,0
195492,Lack,0,0
195493,of,0,0
195494,effect,0,0
195495,of,0,0
195496,warfarin,1,1
195497,on,0,0
195498,the,0,0
195499,restenosis,0,0
195500,rate,0,0
195501,or,0,0
195502,on,0,0
195503,clinical,0,0
195504,outcome,0,0
195505,after,0,0
195506,balloon,0,0
195507,coronary,0,0
195508,angioplasty,0,0
195509,.,0,0
195510,Between,0,0
195511,September,0,0
195512,1985,0,1
195513,and,0,1
195514,April,0,1
195515,1987,0,1
195516,",",0,0
195517,110,0,0
195518,consecutive,0,0
195519,patients,0,0
195520,who,0,0
195521,had,0,0
195522,successful,0,0
195523,coronary,0,0
195524,angioplasty,0,0
195525,were,0,0
195526,included,0,0
195527,in,0,0
195528,a,0,0
195529,randomised,0,0
195530,prospective,0,0
195531,controlled,0,0
195532,evaluation,0,0
195533,of,0,0
195534,the,0,0
195535,effects,0,0
195536,of,0,0
195537,warfarin,1,1
195538,on,0,0
195539,restenosis,0,0
195540,.,0,0
195541,The,0,0
195542,warfarin,1,1
195543,(,0,0
195544,n,0,0
195545,=,0,0
195546,56,0,0
195547,),0,0
195548,and,0,0
195549,the,0,0
195550,control,1,0
195551,(,0,0
195552,n,0,0
195553,=,0,0
195554,54,0,0
195555,),0,0
195556,groups,0,0
195557,were,0,0
195558,not,0,0
195559,different,0,0
195560,in,0,0
195561,terms,0,0
195562,of,0,0
195563,age,0,0
195564,",",0,0
195565,sex,0,0
195566,",",0,0
195567,previous,0,0
195568,coronary,0,0
195569,bypass,0,0
195570,surgery,0,0
195571,or,0,0
195572,coronary,0,0
195573,balloon,0,0
195574,angioplasty,0,0
195575,",",0,0
195576,severity,0,0
195577,of,0,0
195578,symptoms,0,0
195579,",",0,0
195580,and,0,0
195581,frequency,0,0
195582,of,0,0
195583,multivessel,0,0
195584,disease,0,0
195585,or,0,0
195586,of,0,0
195587,total,0,0
195588,coronary,0,0
195589,occlusions,0,1
195590,.,0,0
195591,Warfarin,1,1
195592,was,0,0
195593,started,0,0
195594,on,0,0
195595,the,0,0
195596,day,0,0
195597,of,0,0
195598,the,0,0
195599,procedure,0,0
195600,and,0,0
195601,the,0,0
195602,dosage,0,1
195603,was,0,0
195604,adjusted,0,0
195605,to,0,0
195606,maintain,0,0
195607,the,0,0
195608,thromboplastin,0,1
195609,international,0,1
195610,normalised,0,0
195611,ratio,0,0
195612,greater,0,0
195613,than,0,0
195614,or,0,0
195615,equal,0,0
195616,to,0,0
195617,2.5,0,0
195618,.,0,0
195619,One,0,0
195620,hundred,0,0
195621,and,0,0
195622,five,0,0
195623,(,0,0
195624,96,0,0
195625,%,0,0
195626,),0,0
195627,of,0,0
195628,the,0,0
195629,patients,0,0
195630,were,0,0
195631,given,0,0
195632,verapamil,1,1
195633,and,0,1
195634,other,1,1
195635,antianginal,1,1
195636,drugs,1,1
195637,were,0,1
195638,prescribed,0,0
195639,as,0,0
195640,needed,0,0
195641,.,0,0
195642,Low,1,0
195643,molecular,1,0
195644,weight,1,1
195645,dextran,1,1
195646,and,1,1
195647,heparin,1,1
195648,were,0,0
195649,given,0,0
195650,during,0,0
195651,the,0,0
195652,procedure,0,0
195653,and,0,0
195654,heparin,1,1
195655,was,0,0
195656,continued,0,0
195657,for,0,0
195658,24,0,0
195659,hours,0,0
195660,in,0,0
195661,all,0,0
195662,patients,0,0
195663,.,0,0
195664,One,0,0
195665,hundred,0,0
195666,and,0,0
195667,eight,0,0
195668,(,0,0
195669,98,0,0
195670,%,0,0
195671,),0,0
195672,of,0,0
195673,patients,0,0
195674,were,0,0
195675,followed,0,0
195676,up,0,0
195677,clinically,0,0
195678,after,0,0
195679,a,0,0
195680,median,0,0
195681,of,0,0
195682,five,0,0
195683,months,0,0
195684,(,0,0
195685,range,0,0
195686,1-20,0,0
195687,),0,0
195688,.,0,0
195689,Eighty,0,0
195690,five,0,0
195691,(,0,0
195692,77,0,0
195693,%,0,0
195694,),0,0
195695,had,0,0
195696,follow,0,0
195697,up,0,0
195698,angiography,0,0
195699,at,0,0
195700,five,0,0
195701,months,0,0
195702,.,0,0
195703,In,0,0
195704,the,0,0
195705,warfarin,1,1
195706,group,0,1
195707,symptoms,0,0
195708,improved,0,0
195709,in,0,0
195710,46,0,0
195711,(,0,0
195712,85,0,0
195713,%,0,0
195714,),0,0
195715,patients,0,0
195716,by,0,0
195717,at,0,0
195718,least,0,0
195719,1,0,0
195720,angina,0,0
195721,class,0,0
195722,and,0,0
195723,31,0,0
195724,(,0,0
195725,57,0,0
195726,%,0,0
195727,),0,0
195728,were,0,0
195729,symptom,0,0
195730,free,0,0
195731,;,0,0
195732,the,0,0
195733,exercise,0,0
195734,test,0,0
195735,remained,0,0
195736,positive,0,0
195737,in,0,0
195738,20,0,0
195739,(,0,0
195740,36,0,0
195741,%,0,0
195742,),0,0
195743,patients,0,0
195744,and,0,0
195745,the,0,0
195746,angiographic,0,0
195747,restenosis,0,0
195748,rate,0,0
195749,was,0,0
195750,25,0,0
195751,%,0,0
195752,per,0,0
195753,lesion,0,0
195754,and,0,0
195755,29,0,0
195756,%,0,0
195757,per,0,0
195758,patient,0,0
195759,.,0,0
195760,There,0,0
195761,were,0,0
195762,no,0,0
195763,major,0,0
195764,bleeding,0,0
195765,complications,0,0
195766,.,0,0
195767,In,0,0
195768,the,0,0
195769,control,1,0
195770,group,0,0
195771,46,0,0
195772,(,0,0
195773,85,0,0
195774,%,0,0
195775,),0,0
195776,patients,0,0
195777,were,0,0
195778,improved,0,0
195779,by,0,0
195780,at,0,0
195781,least,0,0
195782,1,0,0
195783,angina,0,0
195784,class,0,0
195785,and,0,0
195786,31,0,0
195787,(,0,0
195788,57,0,0
195789,%,0,0
195790,),0,0
195791,were,0,0
195792,symptom,0,0
195793,free,0,0
195794,;,0,0
195795,the,0,0
195796,exercise,0,0
195797,test,0,0
195798,was,0,0
195799,positive,0,0
195800,in,0,0
195801,11,0,0
195802,(,0,0
195803,21,0,0
195804,%,0,0
195805,),0,0
195806,patients,0,0
195807,and,0,0
195808,the,0,0
195809,angiographic,0,0
195810,restenosis,0,0
195811,rate,0,0
195812,was,0,0
195813,33,0,0
195814,%,0,0
195815,per,0,0
195816,lesion,0,0
195817,and,0,0
195818,37,0,0
195819,%,0,0
195820,per,0,0
195821,patient,0,0
195822,.,0,0
195823,Although,0,0
195824,the,0,0
195825,incidence,0,0
195826,of,0,0
195827,angiographic,0,0
195828,restenosis,0,0
195829,tended,0,0
195830,to,0,0
195831,be,0,0
195832,lower,0,0
195833,with,0,0
195834,warfarin,1,1
195835,",",0,0
195836,none,0,0
195837,of,0,0
195838,these,0,0
195839,differences,0,0
195840,was,0,0
195841,significant,0,0
195842,.,0,0
195843,These,0,0
195844,data,0,0
195845,suggest,0,0
195846,that,0,0
195847,the,0,0
195848,combination,0,0
195849,of,0,0
195850,verapamil,1,1
195851,and,0,1
195852,warfarin,1,1
195853,",",0,0
195854,in,0,0
195855,the,0,0
195856,absence,0,0
195857,of,0,0
195858,aspirin,1,1
195859,",",0,0
195860,is,0,0
195861,not,0,0
195862,significantly,0,0
195863,better,0,0
195864,than,0,0
195865,verapamil,0,1
195866,alone,0,0
195867,in,0,0
195868,preventing,0,0
195869,symptom,0,0
195870,recurrence,0,0
195871,or,0,0
195872,angiographic,0,0
195873,restenosis,0,0
195874,after,0,0
195875,coronary,0,0
195876,angioplasty,0,0
195877,.,0,0
195878,Arginine,1,1
195879,vasopressin,1,1
195880,dissociates,0,1
195881,the,0,0
195882,diuresis,0,1
195883,and,0,1
195884,natriuresis,0,1
195885,due,0,0
195886,to,0,0
195887,atrial,0,0
195888,natriuretic,0,1
195889,factor,0,0
195890,in,0,0
195891,man,0,0
195892,.,0,0
195893,The,0,0
195894,possible,0,0
195895,interaction,0,0
195896,between,0,0
195897,arginine,1,1
195898,vasopressin,1,1
195899,(,1,1
195900,AVP,1,1
195901,),1,1
195902,and,0,0
195903,atrial,0,1
195904,natriuretic,0,1
195905,factor,0,1
195906,(,0,1
195907,ANF,0,1
195908,),0,0
195909,in,0,0
195910,the,0,0
195911,control,0,0
195912,of,0,0
195913,urinary,0,1
195914,sodium,0,1
195915,and,0,1
195916,water,0,0
195917,excretion,0,1
195918,was,0,0
195919,investigated,0,0
195920,in,0,0
195921,man,0,0
195922,.,0,0
195923,Nine,0,1
195924,healthy,0,0
195925,male,0,0
195926,volunteers,0,0
195927,undergoing,0,0
195928,stable,0,0
195929,maximal,0,0
195930,water,0,0
195931,diuresis,0,1
195932,were,0,0
195933,studied,0,0
195934,on,0,0
195935,four,0,0
195936,separate,0,0
195937,occasions,0,0
195938,.,0,0
195939,Atrial,1,0
195940,natriuretic,1,1
195941,factor,1,1
195942,15,1,1
195943,pmol,1,1
195944,kg-1,1,1
195945,min-1,1,1
195946,or,1,1
195947,placebo,1,1
195948,(,0,0
195949,P,0,0
195950,),0,0
195951,was,0,0
195952,concomitantly,0,0
195953,administered,0,1
195954,against,0,0
195955,a,0,0
195956,background,0,0
195957,infusion,0,1
195958,of,0,0
195959,either,0,0
195960,AVP,1,0
195961,0.003,1,1
195962,pmol,1,1
195963,kg-1,1,1
195964,min-1,1,1
195965,or,1,0
195966,P,1,0
195967,;,1,0
195968,thus,0,0
195969,the,0,0
195970,combinations,0,0
195971,P,1,0
195972,+,1,0
195973,P,1,0
195974,",",1,0
195975,AVP,1,0
195976,+,0,0
195977,P,0,0
195978,",",0,0
195979,P,1,0
195980,+,1,0
195981,ANF,1,0
195982,and,1,1
195983,AVP,1,1
195984,+,1,0
195985,ANF,1,0
195986,were,0,0
195987,studied,0,0
195988,.,0,0
195989,Atrial,1,0
195990,natriuretic,1,1
195991,factor,1,0
195992,caused,0,0
195993,a,0,0
195994,significant,0,0
195995,increase,0,0
195996,in,0,0
195997,sodium,0,1
195998,excretion,0,1
195999,(,0,1
196000,UNaV,0,1
196001,),0,1
196002,[,0,0
196003,+56,0,0
196004,%,0,0
196005,],0,0
196006,",",0,0
196007,urinary,0,0
196008,flow,0,0
196009,rate,0,0
196010,(,0,0
196011,V,0,1
196012,),0,1
196013,[,0,0
196014,+17,0,0
196015,%,0,0
196016,],0,0
196017,and,0,0
196018,free,0,0
196019,water,0,0
196020,clearance,0,1
196021,(,0,1
196022,CH2O,0,1
196023,),0,1
196024,[,0,0
196025,+23,0,0
196026,%,0,0
196027,],0,0
196028,;,0,1
196029,creatinine,0,1
196030,clearance,0,1
196031,(,0,1
196032,Ccr,0,1
196033,),0,0
196034,did,0,0
196035,not,0,0
196036,change,0,0
196037,.,0,0
196038,Arginine,1,1
196039,vasopressin,1,1
196040,reduced,0,1
196041,V,0,1
196042,(,0,0
196043,-58,0,0
196044,%,0,0
196045,),0,0
196046,and,0,0
196047,CH2O,0,1
196048,(,0,0
196049,-68,0,0
196050,%,0,0
196051,),0,0
196052,but,0,0
196053,did,0,0
196054,not,0,0
196055,alter,0,0
196056,UNaV,0,0
196057,or,0,0
196058,Ccr,0,0
196059,.,0,0
196060,On,0,0
196061,the,0,0
196062,AVP,1,1
196063,+,1,0
196064,ANF,1,1
196065,study,0,0
196066,day,0,0
196067,",",0,0
196068,UNaV,0,1
196069,increased,0,0
196070,(,0,0
196071,+64,0,0
196072,%,0,0
196073,),0,0
196074,as,0,0
196075,with,0,0
196076,P,1,0
196077,+,1,0
196078,ANF,1,0
196079,",",0,0
196080,but,0,0
196081,V,0,0
196082,(,0,0
196083,-44,0,0
196084,%,0,0
196085,),0,0
196086,and,0,0
196087,CH2O,0,1
196088,(,0,0
196089,-52,0,0
196090,%,0,0
196091,),0,0
196092,continued,0,0
196093,to,0,0
196094,decrease,0,0
196095,below,0,0
196096,baseline,0,0
196097,levels,0,0
196098,;,0,0
196099,analysis,0,0
196100,of,0,0
196101,variance,0,0
196102,showed,0,0
196103,this,0,0
196104,antidiuresis,0,1
196105,reflected,0,0
196106,the,0,0
196107,prevalent,0,0
196108,effect,0,0
196109,of,0,0
196110,AVP,0,0
196111,rather,0,0
196112,than,0,0
196113,any,0,0
196114,specific,0,0
196115,interaction,0,0
196116,.,0,0
196117,These,0,0
196118,results,0,0
196119,show,0,0
196120,that,0,0
196121,AVP,1,0
196122,is,0,0
196123,able,0,0
196124,to,0,0
196125,dissociate,0,0
196126,the,0,0
196127,natriuretic,0,1
196128,and,0,1
196129,diuretic,0,1
196130,effects,0,0
196131,of,0,0
196132,ANF,1,0
196133,.,1,0
196134,Caudal,0,1
196135,analgesia,0,1
196136,for,0,0
196137,perianal,0,1
196138,surgery,0,0
196139,.,0,0
196140,A,0,0
196141,comparison,0,0
196142,between,0,0
196143,bupivacaine,1,1
196144,and,0,1
196145,diamorphine,1,1
196146,.,1,0
196147,Seventy-three,0,0
196148,patients,0,0
196149,undergoing,0,0
196150,elective,0,1
196151,perianal,0,0
196152,surgery,0,0
196153,were,0,0
196154,randomly,0,0
196155,divided,0,0
196156,into,0,0
196157,a,1,0
196158,control,1,0
196159,group,1,0
196160,",",1,0
196161,a,1,0
196162,group,1,0
196163,who,1,0
196164,received,1,0
196165,a,1,0
196166,caudal,1,1
196167,injection,1,1
196168,of,1,0
196169,20,1,0
196170,ml,1,0
196171,bupivacaine,1,1
196172,0.5,1,0
196173,%,1,0
196174,plain,1,0
196175,and,1,0
196176,a,1,0
196177,group,1,0
196178,who,1,0
196179,received,1,0
196180,diamorphine,1,1
196181,2.5,1,1
196182,mg,1,1
196183,in,1,0
196184,10,1,0
196185,ml,1,0
196186,normal,1,0
196187,saline,1,1
196188,by,1,1
196189,caudal,1,1
196190,injection,1,1
196191,;,1,1
196192,a,1,0
196193,comparison,1,0
196194,was,1,0
196195,then,1,0
196196,made,1,0
196197,of,1,0
196198,postoperative,1,0
196199,analgesia,1,1
196200,requirements,1,0
196201,.,1,0
196202,The,0,0
196203,bupivacaine,1,1
196204,group,0,0
196205,had,0,0
196206,better,0,0
196207,analgesia,0,1
196208,than,0,0
196209,the,0,0
196210,control,0,0
196211,group,0,0
196212,for,0,0
196213,the,0,0
196214,first,0,0
196215,8,0,0
196216,hours,0,0
196217,",",0,0
196218,after,0,0
196219,which,0,0
196220,there,0,0
196221,was,0,0
196222,no,0,0
196223,difference,0,0
196224,.,0,0
196225,The,0,0
196226,diamorphine,1,1
196227,group,0,0
196228,had,0,0
196229,better,0,0
196230,analgesia,0,1
196231,than,0,0
196232,the,0,0
196233,control,0,0
196234,group,0,0
196235,for,0,0
196236,the,0,0
196237,first,0,0
196238,24,0,0
196239,hours,0,0
196240,postoperatively,0,1
196241,.,0,1
196242,Side,0,0
196243,effects,0,0
196244,were,0,0
196245,less,0,0
196246,in,0,0
196247,the,0,0
196248,diamorphine,1,1
196249,group,0,1
196250,than,0,0
196251,the,0,0
196252,control,0,0
196253,",",0,0
196254,or,0,0
196255,the,0,0
196256,bupivacaine,1,1
196257,group,0,0
196258,.,0,0
196259,In,0,0
196260,particular,0,0
196261,",",0,0
196262,41,0,0
196263,%,0,0
196264,of,0,0
196265,the,0,0
196266,bupivacaine,1,1
196267,group,0,1
196268,complained,0,0
196269,of,0,0
196270,some,0,0
196271,degree,0,0
196272,of,0,0
196273,urinary,0,0
196274,retention,0,0
196275,and,0,0
196276,one,0,0
196277,patient,0,0
196278,required,0,0
196279,temporary,0,0
196280,catheterisation,0,0
196281,.,0,0
196282,It,0,0
196283,is,0,0
196284,concluded,0,0
196285,that,0,0
196286,caudal,0,1
196287,diamorphine,1,1
196288,gives,0,0
196289,good,0,1
196290,postoperative,0,1
196291,analgesia,0,1
196292,for,0,0
196293,perianal,0,1
196294,operations,0,0
196295,",",0,0
196296,particularly,0,0
196297,when,0,0
196298,motor,0,0
196299,blockade,0,1
196300,is,0,0
196301,not,0,0
196302,wanted,0,0
196303,by,0,0
196304,the,0,0
196305,surgeon,0,0
196306,.,0,0
196307,Chemotherapy,0,0
196308,of,0,0
196309,advanced,0,0
196310,gastric,0,1
196311,carcinoma,0,1
196312,(,0,0
196313,stage,0,0
196314,IV,0,1
196315,),0,0
196316,:,0,0
196317,a,0,0
196318,randomized,0,0
196319,study,0,0
196320,of,0,0
196321,FAM,1,1
196322,versus,0,0
196323,5-FU,1,0
196324,plus,1,0
196325,BCNU,1,0
196326,.,1,0
196327,Forty-six,0,0
196328,patients,0,0
196329,with,0,0
196330,advanced,0,0
196331,gastric,0,1
196332,carcinoma,0,1
196333,(,0,0
196334,Stage,0,0
196335,IV,0,1
196336,),0,0
196337,were,0,0
196338,evaluated,0,0
196339,in,0,0
196340,a,0,0
196341,prospective,0,0
196342,randomized,0,0
196343,comparison,0,0
196344,of,0,0
196345,two,0,0
196346,chemotherapy,1,1
196347,regimens,0,1
196348,(,1,1
196349,FAM,1,1
196350,versus,1,0
196351,5-FU,1,0
196352,plus,1,0
196353,BCNU,1,1
196354,),1,0
196355,to,0,0
196356,identify,0,0
196357,therapeutic,0,0
196358,activity,0,0
196359,.,0,0
196360,Treatment,0,0
196361,groups,0,0
196362,were,0,0
196363,well,0,0
196364,balanced,0,0
196365,with,0,0
196366,respect,0,0
196367,to,0,0
196368,known,0,0
196369,prognostic,0,0
196370,factors,0,0
196371,.,0,0
196372,Thirty-three,0,0
196373,patients,0,0
196374,had,0,0
196375,measurable,0,0
196376,disease,0,0
196377,and,0,0
196378,thirteen,0,0
196379,had,0,0
196380,only,0,0
196381,microscopic,0,0
196382,residual,0,0
196383,disease,0,0
196384,in,0,0
196385,the,0,0
196386,resection,0,0
196387,margins,0,0
196388,.,0,0
196389,The,0,0
196390,overall,0,0
196391,median,0,0
196392,survival,0,0
196393,of,0,0
196394,the,0,0
196395,entire,0,0
196396,group,0,0
196397,was,0,0
196398,13.2,0,0
196399,months,0,0
196400,.,0,0
196401,Two,0,1
196402,(,0,0
196403,6,0,0
196404,%,0,0
196405,),0,0
196406,patients,0,0
196407,with,0,0
196408,measurable,0,0
196409,disease,0,0
196410,reached,0,0
196411,complete,0,0
196412,response,0,0
196413,(,0,0
196414,CR,0,1
196415,),0,1
196416,",",0,0
196417,1,0,1
196418,(,0,0
196419,3,0,0
196420,%,0,0
196421,),0,0
196422,partial,0,0
196423,response,0,0
196424,(,0,0
196425,PR,0,1
196426,),0,1
196427,",",0,0
196428,12,0,0
196429,(,0,0
196430,36,0,0
196431,%,0,0
196432,),0,0
196433,had,0,0
196434,stable,0,0
196435,disease,0,0
196436,(,0,1
196437,SD,0,1
196438,),0,1
196439,and,0,0
196440,18,0,0
196441,(,0,0
196442,56,0,0
196443,%,0,0
196444,),0,0
196445,had,0,0
196446,progressive,0,0
196447,disease,0,0
196448,(,0,1
196449,PD,0,1
196450,),0,1
196451,.,0,0
196452,The,0,0
196453,responders,0,0
196454,had,0,0
196455,not,0,0
196456,reached,0,0
196457,the,0,0
196458,median,0,0
196459,survival,0,0
196460,yet,0,0
196461,",",0,0
196462,the,0,0
196463,patients,0,0
196464,with,0,0
196465,SD,0,0
196466,had,0,0
196467,a,0,0
196468,median,0,0
196469,survival,0,0
196470,of,0,0
196471,14.7,0,0
196472,months,0,0
196473,and,0,0
196474,the,0,0
196475,PD,0,0
196476,9.5,0,0
196477,months,0,0
196478,.,0,0
196479,In,0,0
196480,the,0,0
196481,FAM,1,0
196482,arm,0,0
196483,there,0,0
196484,were,0,0
196485,3,0,0
196486,(,0,0
196487,18,0,0
196488,%,0,0
196489,),0,0
196490,responders,0,0
196491,(,0,0
196492,2,0,0
196493,CR,0,1
196494,and,0,0
196495,1,0,0
196496,PR,0,0
196497,),0,1
196498,",",0,0
196499,7,0,0
196500,(,0,0
196501,41,0,0
196502,%,0,0
196503,),0,0
196504,SD,0,0
196505,and,0,1
196506,7,0,0
196507,(,0,0
196508,41,0,0
196509,%,0,0
196510,),0,0
196511,PD,0,0
196512,",",0,1
196513,versus,0,0
196514,O,0,0
196515,responders,0,0
196516,",",0,0
196517,5,0,0
196518,(,0,0
196519,31,0,0
196520,%,0,0
196521,),0,0
196522,SD,0,0
196523,and,0,1
196524,11,0,0
196525,(,0,0
196526,69,0,0
196527,%,0,0
196528,),0,0
196529,PD,0,0
196530,in,0,0
196531,the,0,0
196532,5-FU,0,0
196533,plus,0,0
196534,BCNU,0,0
196535,arm,0,0
196536,.,0,0
196537,In,0,0
196538,the,0,0
196539,FAM,1,0
196540,arm,0,0
196541,the,0,0
196542,median,0,0
196543,survival,0,0
196544,was,0,0
196545,15.7,0,0
196546,months,0,0
196547,versus,0,0
196548,9.9,0,0
196549,months,0,0
196550,in,0,0
196551,the,0,0
196552,other,0,0
196553,therapeutic,0,0
196554,arm,0,0
196555,.,0,0
196556,The,0,0
196557,statistical,0,0
196558,analysis,0,0
196559,indicated,0,0
196560,that,0,0
196561,survival,0,0
196562,associated,0,0
196563,with,0,0
196564,FAM,1,0
196565,regimen,0,1
196566,was,0,0
196567,superior,0,0
196568,to,0,0
196569,that,0,0
196570,reached,0,0
196571,with,0,0
196572,the,0,0
196573,5-FU,1,0
196574,plus,1,0
196575,BCNU,1,1
196576,regimen,0,1
196577,.,0,1
196578,Thirteen,0,0
196579,patients,0,0
196580,with,0,0
196581,unmeasurable,0,0
196582,disease,0,0
196583,had,0,0
196584,a,0,0
196585,median,0,0
196586,survival,0,0
196587,of,0,0
196588,15.9,0,0
196589,months,0,0
196590,.,0,0
196591,Transdermal,1,1
196592,nitroglycerin,1,1
196593,in,0,1
196594,angina,0,1
196595,pectoris,0,0
196596,:,0,0
196597,efficacy,0,0
196598,of,0,0
196599,intermittent,0,0
196600,application,0,0
196601,.,0,0
196602,Continuous,0,0
196603,application,0,0
196604,of,0,0
196605,transdermal,1,1
196606,nitroglycerin,1,1
196607,appears,0,0
196608,to,0,0
196609,result,0,0
196610,in,0,0
196611,tolerance,0,0
196612,to,0,0
196613,the,0,0
196614,antianginal,0,1
196615,effect,0,0
196616,.,0,0
196617,In,0,0
196618,a,0,0
196619,double-blind,0,1
196620,study,0,0
196621,the,0,0
196622,effects,0,0
196623,of,0,0
196624,continuous,0,0
196625,(,0,0
196626,24,0,1
196627,h/day,0,1
196628,),0,1
196629,and,0,1
196630,intermittent,0,1
196631,(,0,1
196632,16,0,1
196633,h/day,0,1
196634,),0,0
196635,application,0,0
196636,of,0,1
196637,transdermal,1,1
196638,nitroglycerin,1,1
196639,in,1,1
196640,a,0,0
196641,dosage,0,1
196642,of,0,1
196643,10,0,0
196644,mg/day,0,1
196645,were,0,0
196646,compared,0,0
196647,with,0,0
196648,the,0,0
196649,effects,0,0
196650,of,0,0
196651,placebo,1,1
196652,in,0,0
196653,12,0,0
196654,patients,0,0
196655,with,0,0
196656,chronic,0,0
196657,stable,0,0
196658,angina,0,0
196659,receiving,0,0
196660,treatment,0,0
196661,with,0,0
196662,beta-adrenergic,1,1
196663,blocking,1,0
196664,or,1,1
196665,calcium,1,1
196666,channel,1,0
196667,blocking,1,0
196668,agents,1,0
196669,.,1,0
196670,Exercise,0,0
196671,performance,0,0
196672,was,0,0
196673,assessed,0,0
196674,2,0,0
196675,to,0,0
196676,4,0,0
196677,hours,0,0
196678,after,0,0
196679,initial,0,0
196680,application,0,0
196681,and,0,0
196682,after,0,0
196683,1,0,0
196684,week,0,0
196685,of,0,0
196686,each,0,0
196687,treatment,0,0
196688,given,0,0
196689,in,0,0
196690,random,0,0
196691,order,0,0
196692,with,0,0
196693,a,0,0
196694,3,0,0
196695,day,0,0
196696,interval,0,0
196697,between,0,0
196698,treatments,0,0
196699,.,0,0
196700,Exercise,0,0
196701,time,0,0
196702,to,0,0
196703,onset,0,0
196704,of,0,0
196705,angina,0,0
196706,",",0,0
196707,total,0,0
196708,exercise,0,0
196709,duration,0,0
196710,and,0,0
196711,time,0,0
196712,to,0,0
196713,1,0,0
196714,mm,0,0
196715,ST,0,0
196716,segment,0,0
196717,depression,0,0
196718,were,0,0
196719,all,0,0
196720,significantly,0,0
196721,increased,0,0
196722,after,0,0
196723,initial,0,0
196724,application,0,0
196725,during,0,0
196726,the,0,0
196727,continuous,0,0
196728,and,0,0
196729,intermittent,0,0
196730,treatment,0,0
196731,periods,0,0
196732,.,0,0
196733,These,0,0
196734,increases,0,0
196735,were,0,0
196736,maintained,0,0
196737,after,0,0
196738,1,0,0
196739,week,0,0
196740,of,0,0
196741,intermittent,0,0
196742,but,0,0
196743,not,0,0
196744,continuous,0,0
196745,treatment,0,0
196746,.,0,0
196747,Thus,0,0
196748,the,0,0
196749,benefit,0,0
196750,of,0,0
196751,initial,0,0
196752,application,0,0
196753,of,0,0
196754,transdermal,1,1
196755,nitroglycerin,1,1
196756,is,0,1
196757,maintained,0,0
196758,with,0,0
196759,intermittent,0,0
196760,treatment,0,0
196761,and,0,0
196762,a,0,0
196763,daily,0,1
196764,nitrate-free,0,1
196765,interval,0,0
196766,",",0,0
196767,whereas,0,0
196768,tolerance,0,0
196769,to,0,0
196770,antianginal,0,1
196771,effect,0,0
196772,occurs,0,0
196773,with,0,0
196774,continuous,0,0
196775,treatment,0,0
196776,.,0,0
196777,Comparison,0,0
196778,of,0,0
196779,mastectomy,1,0
196780,with,1,0
196781,tamoxifen,1,1
196782,for,0,0
196783,treating,0,0
196784,elderly,0,0
196785,patients,0,0
196786,with,0,0
196787,operable,0,0
196788,breast,0,0
196789,cancer,0,0
196790,.,0,0
196791,STUDY,0,0
196792,OBJECTIVE,0,0
196793,Comparison,0,1
196794,of,0,0
196795,tamoxifen,1,1
196796,and,1,0
196797,mastectomy,1,0
196798,in,0,0
196799,treatment,0,0
196800,of,0,0
196801,breast,0,0
196802,cancer,0,0
196803,in,0,0
196804,elderly,0,0
196805,patients,0,0
196806,.,0,0
196807,DESIGN,0,0
196808,Randomised,0,0
196809,trial,0,0
196810,of,0,0
196811,treatment,0,0
196812,of,0,0
196813,operable,0,0
196814,breast,0,0
196815,cancer,0,0
196816,by,0,0
196817,wedge,1,0
196818,mastectomy,1,1
196819,or,1,0
196820,tamoxifen,1,1
196821,",",0,0
196822,with,0,0
196823,median,0,0
196824,follow,0,0
196825,up,0,0
196826,24,0,0
196827,and,0,0
196828,25,0,0
196829,months,0,0
196830,respectively,0,0
196831,(,0,0
196832,range,0,0
196833,1-63,0,0
196834,),0,0
196835,.,0,0
196836,SETTING,0,1
196837,University,0,1
196838,hospital,0,1
196839,;,0,0
196840,most,0,0
196841,patients,0,0
196842,from,0,0
196843,primary,0,0
196844,catchment,0,0
196845,area,0,0
196846,.,0,0
196847,PATIENTS,0,0
196848,135,0,0
196849,consecutive,0,0
196850,patients,0,0
196851,with,0,0
196852,breast,0,0
196853,cancer,0,0
196854,aged,0,0
196855,over,0,0
196856,70,0,0
196857,with,0,0
196858,operable,0,0
196859,tumours,0,0
196860,(,0,0
196861,less,0,0
196862,than,0,0
196863,5,0,0
196864,cm,0,0
196865,maximum,0,0
196866,diameter,0,1
196867,),0,0
196868,;,0,0
196869,68,0,0
196870,were,0,0
196871,allocated,0,0
196872,to,0,0
196873,tamoxifen,1,1
196874,group,1,0
196875,and,0,0
196876,67,0,0
196877,to,0,0
196878,mastectomy,1,0
196879,group,1,0
196880,.,1,0
196881,Histological,0,0
196882,diagnosis,0,0
196883,by,0,0
196884,biopsy,0,0
196885,.,0,0
196886,Two,0,1
196887,incorrect,0,0
196888,randomisations,0,0
196889,in,0,0
196890,each,0,0
196891,group,0,0
196892,.,0,0
196893,Patient,0,0
196894,characteristics,0,0
196895,similar,0,0
196896,in,0,0
196897,the,0,0
196898,two,0,0
196899,groups,0,0
196900,and,0,0
196901,all,0,0
196902,under,0,0
196903,care,0,0
196904,of,0,0
196905,one,0,0
196906,surgical,0,0
196907,team,0,0
196908,.,0,0
196909,INTERVENTIONS,0,0
196910,Mastectomy,0,0
196911,group,0,0
196912,received,0,0
196913,wedge,1,0
196914,mastectomy,1,0
196915,plus,1,0
196916,excision,1,0
196917,of,1,0
196918,symptomatic,1,0
196919,axillary,1,0
196920,lymph,1,0
196921,nodes,1,1
196922,.,1,1
196923,Tamoxifen,1,1
196924,group,0,0
196925,received,0,0
196926,continuous,0,0
196927,treatment,0,0
196928,with,0,0
196929,tamoxifen,1,1
196930,20,1,1
196931,mg,1,1
196932,twice,0,1
196933,daily,0,1
196934,.,0,1
196935,Patients,0,0
196936,in,0,0
196937,tamoxifen,0,1
196938,group,0,1
196939,received,0,0
196940,wedge,1,0
196941,mastectomy,1,0
196942,if,1,0
196943,there,1,0
196944,was,1,0
196945,sign,1,0
196946,of,1,0
196947,local,1,0
196948,progression,1,0
196949,.,1,0
196950,Those,0,0
196951,in,0,0
196952,mastectomy,0,0
196953,group,0,0
196954,received,0,0
196955,further,0,0
196956,excision,0,0
196957,or,0,0
196958,radiotherapy,1,0
196959,for,0,0
196960,locoregional,0,0
196961,recurrence,0,0
196962,and,0,0
196963,when,0,0
196964,local,0,0
196965,treatments,0,0
196966,had,0,0
196967,been,0,0
196968,exhausted,0,0
196969,or,0,0
196970,metastatic,0,0
196971,disease,0,0
196972,diagnosed,0,0
196973,they,0,0
196974,received,0,0
196975,tamoxifen,1,1
196976,.,1,1
196977,END,0,1
196978,POINT,0,1
196979,Treatment,0,0
196980,efficacy,0,0
196981,was,0,0
196982,assessed,0,0
196983,by,0,0
196984,local,0,0
196985,control,0,0
196986,of,0,0
196987,disease,0,0
196988,and,0,0
196989,by,0,0
196990,survival,0,0
196991,.,0,0
196992,MAIN,0,0
196993,RESULTS,0,1
196994,Mortality,0,0
196995,from,0,0
196996,metastatic,0,0
196997,cancer,0,0
196998,in,0,0
196999,tamoxifen,1,1
197000,group,0,1
197001,was,0,0
197002,7,0,0
197003,(,0,0
197004,10.6,0,0
197005,%,0,0
197006,),0,0
197007,and,0,0
197008,in,0,0
197009,mastectomy,1,1
197010,group,0,0
197011,10,0,0
197012,(,0,0
197013,15.3,0,0
197014,%,0,0
197015,),0,0
197016,(,0,0
197017,NS,0,1
197018,),0,1
197019,.,0,0
197020,There,0,0
197021,was,0,0
197022,no,0,0
197023,difference,0,0
197024,in,0,0
197025,survival,0,0
197026,between,0,0
197027,the,0,0
197028,two,0,0
197029,groups,0,0
197030,.,0,0
197031,In,0,0
197032,mastectomy,0,0
197033,group,0,0
197034,70,0,0
197035,%,0,0
197036,remained,0,0
197037,alive,0,0
197038,and,0,0
197039,free,0,0
197040,of,0,0
197041,local,0,0
197042,recurrence,0,0
197043,at,0,0
197044,24,0,0
197045,months,0,0
197046,;,0,0
197047,in,0,0
197048,tamoxifen,0,1
197049,group,0,0
197050,only,0,0
197051,47,0,0
197052,%,0,0
197053,remained,0,0
197054,alive,0,0
197055,and,0,0
197056,free,0,0
197057,of,0,0
197058,local,0,0
197059,progression,0,0
197060,.,0,0
197061,In,0,0
197062,mastectomy,0,0
197063,group,0,0
197064,locoregional,0,0
197065,recurrence,0,0
197066,occurred,0,0
197067,in,0,0
197068,16,0,0
197069,patients,0,0
197070,and,0,0
197071,metastatic,0,0
197072,disease,0,0
197073,in,0,0
197074,13,0,0
197075,;,0,0
197076,in,0,0
197077,tamoxifen,0,1
197078,group,0,1
197079,locoregional,0,0
197080,progression,0,0
197081,occurred,0,0
197082,in,0,0
197083,29,0,0
197084,patients,0,0
197085,and,0,0
197086,metastatic,0,0
197087,disease,0,0
197088,in,0,0
197089,seven,0,0
197090,.,0,0
197091,CONCLUSIONS,0,0
197092,As,0,0
197093,a,0,0
197094,high,0,0
197095,proportion,0,0
197096,of,0,0
197097,patients,0,0
197098,treated,0,0
197099,with,0,0
197100,tamoxifen,0,1
197101,eventually,0,0
197102,required,0,0
197103,surgery,0,0
197104,treatment,0,0
197105,of,0,0
197106,elderly,0,0
197107,patients,0,0
197108,with,0,0
197109,breast,0,0
197110,cancer,0,0
197111,should,0,0
197112,include,0,0
197113,mastectomy,0,0
197114,.,0,0
197115,Optimum,0,0
197116,treatment,0,0
197117,may,0,0
197118,include,0,0
197119,both,0,0
197120,mastectomy,0,0
197121,and,0,0
197122,tamoxifen,0,1
197123,.,0,0
197124,BCG,1,1
197125,(,1,1
197126,RIVM,1,1
197127,),1,1
197128,versus,0,1
197129,mitomycin,1,1
197130,intravesical,1,1
197131,therapy,1,1
197132,in,0,0
197133,superficial,0,0
197134,bladder,0,0
197135,cancer,0,0
197136,.,0,0
197137,First,0,0
197138,results,0,0
197139,of,0,0
197140,randomized,0,0
197141,prospective,0,0
197142,trial,0,0
197143,.,0,0
197144,This,0,0
197145,study,0,0
197146,presents,0,0
197147,the,0,0
197148,preliminary,0,0
197149,results,0,0
197150,of,0,0
197151,a,0,0
197152,randomized,0,0
197153,prospective,0,0
197154,two-arm,0,0
197155,study,0,0
197156,in,0,0
197157,which,0,0
197158,bacillus,1,0
197159,Calmette-Gu?rin,1,1
197160,(,1,1
197161,BCG,1,1
197162,),1,1
197163,RIVM,1,1
197164,",",1,0
197165,a,1,0
197166,Dutch,1,0
197167,BCG,1,0
197168,preparation,0,0
197169,",",0,0
197170,is,0,0
197171,compared,0,0
197172,with,1,0
197173,mitomycin,1,1
197174,C,1,1
197175,(,0,1
197176,MMC,0,1
197177,),0,0
197178,in,0,0
197179,patients,0,0
197180,with,0,0
197181,primary,0,0
197182,or,0,0
197183,recurrent,0,0
197184,superficial,0,1
197185,bladder,0,0
197186,tumors,0,0
197187,",",0,0
197188,including,0,0
197189,carcinoma,0,0
197190,in,0,0
197191,situ,0,0
197192,(,0,0
197193,CIS,0,1
197194,),0,1
197195,.,0,0
197196,Therapeutic,0,0
197197,regimens,0,1
197198,were,0,0
197199,as,0,0
197200,follows,0,0
197201,:,0,0
197202,after,0,0
197203,complete,0,0
197204,transurethral,0,0
197205,resection,0,0
197206,of,0,0
197207,all,0,0
197208,visible,0,0
197209,tumors,0,0
197210,",",0,0
197211,BCG,1,1
197212,RIVM,1,1
197213,(,0,1
197214,1,0,0
197215,x,0,0
197216,10,0,0
197217,(,0,1
197218,9,0,1
197219,),0,0
197220,bacilli,0,0
197221,in,0,0
197222,50,0,0
197223,mL,0,1
197224,saline,0,1
197225,),0,1
197226,was,0,1
197227,instilled,0,1
197228,once,0,1
197229,a,0,0
197230,week,0,0
197231,for,0,0
197232,six,0,0
197233,consecutive,0,0
197234,weeks,0,0
197235,",",0,0
197236,and,1,0
197237,mitomycin,1,1
197238,C,1,1
197239,(,0,1
197240,30,0,1
197241,mg,0,1
197242,in,0,0
197243,50,0,1
197244,mL,0,1
197245,saline,0,1
197246,),0,1
197247,was,0,1
197248,administered,0,1
197249,once,0,1
197250,a,0,0
197251,week,0,0
197252,for,0,0
197253,one,0,0
197254,month,0,0
197255,(,0,0
197256,weeks,0,0
197257,1,0,0
197258,to,0,0
197259,4,0,1
197260,),0,0
197261,and,0,0
197262,thereafter,0,0
197263,once,0,0
197264,a,0,0
197265,month,0,0
197266,for,0,0
197267,a,0,0
197268,total,0,0
197269,of,0,0
197270,six,0,0
197271,months,0,0
197272,.,0,0
197273,Reported,0,0
197274,are,0,0
197275,the,0,0
197276,incidence,0,0
197277,of,0,0
197278,side,0,0
197279,effects,0,0
197280,in,0,0
197281,165,0,0
197282,patients,0,0
197283,and,0,0
197284,the,0,0
197285,recurrence,0,0
197286,rate,0,0
197287,of,0,0
197288,tumors,0,0
197289,in,0,0
197290,308,0,0
197291,patients,0,0
197292,after,0,0
197293,a,0,0
197294,follow-up,0,0
197295,period,0,0
197296,of,0,0
197297,twelve,0,0
197298,months,0,0
197299,.,0,0
197300,Drug-induced,0,0
197301,",",0,0
197302,or,0,0
197303,chemical,0,0
197304,cystitis,0,0
197305,was,0,0
197306,observed,0,0
197307,in,0,0
197308,13,0,0
197309,(,0,0
197310,16.7,0,0
197311,%,0,0
197312,),0,0
197313,of,0,0
197314,78,0,0
197315,BCG-treated,0,0
197316,patients,0,0
197317,and,0,0
197318,in,0,0
197319,12,0,0
197320,(,0,0
197321,13.8,0,0
197322,%,0,0
197323,),0,0
197324,of,0,0
197325,87,0,0
197326,MMC-treated,0,0
197327,patients,0,0
197328,.,0,0
197329,In,0,0
197330,the,0,0
197331,same,0,0
197332,groups,0,0
197333,bacterial,0,0
197334,cystitis,0,0
197335,occurred,0,0
197336,in,0,0
197337,17,0,0
197338,(,0,0
197339,21.8,0,0
197340,%,0,0
197341,),0,0
197342,patients,0,0
197343,and,0,0
197344,in,0,0
197345,16,0,0
197346,(,0,0
197347,18.4,0,0
197348,%,0,0
197349,),0,0
197350,patients,0,0
197351,",",0,0
197352,respectively,0,0
197353,.,0,0
197354,In,0,0
197355,the,0,0
197356,BCG-treated,0,0
197357,group,0,0
197358,(,0,0
197359,N,0,0
197360,=,0,0
197361,148,0,0
197362,),0,0
197363,",",0,0
197364,44,0,0
197365,(,0,0
197366,29.8,0,0
197367,%,0,0
197368,),0,0
197369,had,0,0
197370,recurrent,0,0
197371,tumors,0,0
197372,",",0,0
197373,while,0,0
197374,in,0,0
197375,the,0,0
197376,MMC-treated,0,0
197377,group,0,0
197378,(,0,0
197379,N,0,0
197380,=,0,0
197381,160,0,0
197382,),0,0
197383,",",0,0
197384,40,0,0
197385,(,0,0
197386,25.0,0,0
197387,%,0,0
197388,),0,0
197389,had,0,0
197390,a,0,0
197391,recurrence,0,0
197392,.,0,0
197393,The,0,0
197394,recurrence,0,0
197395,rate,0,0
197396,for,1,0
197397,BCG-treated,1,0
197398,patients,0,0
197399,was,0,0
197400,0.33,0,0
197401,;,0,0
197402,the,0,0
197403,recurrence,0,0
197404,rate,0,0
197405,for,1,0
197406,MMC-treated,1,0
197407,patients,0,0
197408,was,0,0
197409,0.29,0,0
197410,(,0,0
197411,P,0,0
197412,=,0,0
197413,0.560,0,0
197414,",",0,0
197415,not,0,0
197416,significant,0,0
197417,),0,0
197418,.,0,0
197419,These,0,0
197420,preliminary,0,0
197421,data,0,0
197422,demonstrated,0,0
197423,no,0,0
197424,statistically,0,0
197425,significant,0,0
197426,difference,0,0
197427,between,0,0
197428,the,0,0
197429,two,0,0
197430,arms,0,0
197431,with,0,0
197432,regard,0,0
197433,to,0,0
197434,toxicity,0,0
197435,and,0,0
197436,recurrence,0,0
197437,of,0,0
197438,tumors,0,0
197439,.,0,0
197440,[,0,1
197441,Prevention,0,0
197442,of,0,0
197443,thromboembolism,0,0
197444,in,0,0
197445,patients,0,0
197446,operated,0,0
197447,on,0,0
197448,for,0,0
197449,hip,0,0
197450,prosthesis,0,1
197451,],0,0
197452,.,0,0
197453,The,0,0
197454,latest,0,0
197455,research,0,0
197456,into,0,0
197457,the,0,0
197458,prevention,0,0
197459,of,0,0
197460,peri-,0,0
197461,and,0,0
197462,postoperative,0,0
197463,thromboembolic,0,0
197464,disease,0,0
197465,has,0,0
197466,found,0,0
197467,orthopaedic,0,0
197468,surgery,0,0
197469,patients,0,0
197470,to,0,0
197471,be,0,0
197472,most,0,0
197473,at,0,0
197474,risk,0,0
197475,.,0,0
197476,As,0,0
197477,the,0,0
197478,genesis,0,0
197479,of,0,0
197480,deep,0,0
197481,venous,0,1
197482,thrombosis,0,1
197483,(,0,1
197484,DVT,0,1
197485,),0,0
197486,is,0,0
197487,due,0,0
197488,to,0,0
197489,haemodynamic,0,0
197490,",",0,0
197491,hemorheologic,0,0
197492,and,0,0
197493,parietal,0,0
197494,factors,0,0
197495,",",0,0
197496,various,0,0
197497,prophylactic,0,0
197498,measures,0,0
197499,have,0,0
197500,been,0,0
197501,considered,0,0
197502,in,0,0
197503,the,0,0
197504,past,0,0
197505,",",0,0
197506,measures,0,0
197507,which,0,0
197508,have,0,0
197509,not,0,0
197510,proved,0,0
197511,able,0,0
197512,to,0,0
197513,provide,0,0
197514,satisfactory,0,0
197515,protection,0,0
197516,in,0,0
197517,orthopaedics,0,0
197518,.,0,0
197519,The,0,0
197520,results,0,0
197521,obtained,0,0
197522,with,0,0
197523,Defibrotide,1,1
197524,in,0,0
197525,a,0,0
197526,random,0,0
197527,and,0,0
197528,controlled,0,0
197529,clinical,0,0
197530,study,0,0
197531,versus,0,0
197532,calcium,1,1
197533,heparin,1,1
197534,involving,0,0
197535,211,0,0
197536,patients,0,0
197537,of,0,0
197538,both,0,0
197539,sexes,0,0
197540,candidates,0,0
197541,to,0,0
197542,receive,0,0
197543,total,0,0
197544,hip,0,0
197545,arthroplasty,0,0
197546,and,0,0
197547,presenting,0,0
197548,at,0,0
197549,least,0,0
197550,one,0,0
197551,major,0,0
197552,thromboembolic,0,0
197553,risk,0,0
197554,factor,0,0
197555,are,0,0
197556,reported,0,0
197557,.,0,0
197558,The,0,0
197559,patients,0,0
197560,were,0,0
197561,assigned,0,0
197562,at,0,0
197563,random,0,0
197564,to,0,0
197565,one,0,0
197566,of,0,0
197567,the,0,0
197568,following,0,0
197569,treatments,0,0
197570,:,0,0
197571,1,0,1
197572,),0,0
197573,Defibrotide,1,1
197574,at,1,1
197575,a,1,0
197576,dose,1,1
197577,of,1,1
197578,400,1,1
197579,mg,1,1
197580,b.i.d,1,1
197581,.,1,1
197582,i.v,1,1
197583,.,1,0
197584,in,1,0
197585,50,1,0
197586,ml,1,0
197587,phleboclysis,1,1
197588,in,1,0
197589,5,1,0
197590,minutes,1,0
197591,(,1,0
197592,n,1,0
197593,=,1,0
197594,108,1,0
197595,),1,0
197596,;,1,0
197597,2,1,1
197598,),1,1
197599,calcium,1,1
197600,heparin,1,1
197601,at,1,1
197602,a,1,0
197603,dose,1,1
197604,of,1,0
197605,5000,1,1
197606,IU,1,1
197607,t.i.d,1,1
197608,.,1,1
197609,subcutaneously,1,1
197610,(,1,0
197611,n,1,0
197612,=,1,0
197613,103,1,0
197614,),1,0
197615,.,0,0
197616,The,1,0
197617,treatment,1,0
197618,began,1,0
197619,the,1,0
197620,day,1,0
197621,before,1,0
197622,operation,1,1
197623,and,1,0
197624,continued,1,0
197625,on,1,0
197626,average,1,0
197627,up,1,0
197628,to,1,0
197629,the,1,0
197630,eighth,1,0
197631,day,1,0
197632,for,1,0
197633,the,1,0
197634,Defibrotide,1,1
197635,group,1,0
197636,.,1,0
197637,With,0,0
197638,the,0,0
197639,control,0,0
197640,group,0,0
197641,it,0,0
197642,continued,0,0
197643,until,0,1
197644,discharge,0,1
197645,(,0,0
197646,usually,0,0
197647,on,0,0
197648,the,0,0
197649,15th,0,1
197650,day,0,1
197651,),0,1
197652,and,0,0
197653,at,0,0
197654,home,0,0
197655,for,0,0
197656,about,0,0
197657,three,0,0
197658,weeks,0,0
197659,until,0,0
197660,the,0,0
197661,completion,0,0
197662,of,0,0
197663,the,0,0
197664,physiotherapy,0,0
197665,cycle,0,0
197666,.,0,0
197667,In,0,0
197668,the,0,0
197669,108,0,0
197670,patients,0,0
197671,treated,0,0
197672,with,0,0
197673,Defibrotide,1,1
197674,only,0,0
197675,one,0,0
197676,case,0,0
197677,of,0,0
197678,DVT,0,0
197679,was,0,0
197680,reported,0,0
197681,and,0,0
197682,in,0,0
197683,none,0,0
197684,of,0,0
197685,these,0,0
197686,patients,0,0
197687,were,0,0
197688,symptoms,0,0
197689,or,0,0
197690,signs,0,0
197691,of,0,0
197692,pulmonary,0,0
197693,embolism,0,0
197694,encountered,0,0
197695,.,0,0
197696,In,0,0
197697,the,0,0
197698,group,0,0
197699,treated,0,0
197700,with,0,1
197701,calcium,0,1
197702,heparin,0,1
197703,2,0,1
197704,cases,0,0
197705,of,0,0
197706,clinically,0,0
197707,and,0,0
197708,radiologically,0,0
197709,diagnosed,0,1
197710,pulmonary,0,0
197711,embolism,0,1
197712,and,0,0
197713,4,0,0
197714,cases,0,0
197715,of,0,0
197716,DVT,0,0
197717,were,0,0
197718,observed,0,0
197719,.,0,0
197720,Although,0,0
197721,the,0,0
197722,differences,0,0
197723,were,0,0
197724,not,0,0
197725,statistically,0,0
197726,significant,0,0
197727,",",0,0
197728,the,0,0
197729,tendency,0,0
197730,favours,0,0
197731,Defibrotide,0,1
197732,.,0,0
197733,Statistically,0,0
197734,significant,0,0
197735,(,0,0
197736,p,0,0
197737,less,0,0
197738,than,0,0
197739,0.01,0,0
197740,),0,0
197741,was,0,0
197742,the,0,0
197743,difference,0,0
197744,in,0,0
197745,postoperative,0,0
197746,bleeding,0,0
197747,evaluated,0,0
197748,with,0,0
197749,particular,0,0
197750,attention,0,0
197751,in,0,0
197752,patients,0,0
197753,of,0,0
197754,advanced,0,0
197755,age,0,0
197756,.,0,0
197757,Further,0,0
197758,",",0,0
197759,in,0,0
197760,the,0,0
197761,Defibrotide,1,1
197762,group,0,1
197763,",",0,0
197764,scarring,0,0
197765,was,0,0
197766,considered,0,0
197767,excellent,0,0
197768,in,0,0
197769,96,0,0
197770,%,0,0
197771,of,0,0
197772,cases,0,0
197773,while,0,0
197774,in,0,0
197775,the,0,0
197776,heparin,0,1
197777,group,0,1
197778,scarring,0,0
197779,was,0,0
197780,excellent,0,0
197781,in,0,0
197782,85,0,0
197783,%,0,0
197784,(,0,0
197785,p,0,0
197786,less,0,0
197787,than,0,0
197788,0.05,0,0
197789,),0,0
197790,.,0,0
197791,To,0,0
197792,conclude,0,0
197793,",",0,0
197794,the,0,0
197795,sure,0,0
197796,clinical,0,0
197797,effectiveness,0,0
197798,",",0,0
197799,tolerance,0,0
197800,",",0,0
197801,handiness,0,0
197802,and,0,0
197803,lack,0,0
197804,of,0,0
197805,interference,0,0
197806,with,0,0
197807,clotting,0,0
197808,functions,0,0
197809,make,0,0
197810,Defibrotide,1,1
197811,a,0,0
197812,really,0,0
197813,useful,0,0
197814,drug,0,1
197815,for,0,0
197816,the,0,0
197817,prevention,0,0
197818,of,0,0
197819,thromboembolic,0,0
197820,episodes,0,0
197821,in,0,0
197822,patients,0,0
197823,undergoing,0,0
197824,major,0,0
197825,orthopaedic,0,0
197826,surgery,0,0
197827,.,0,0
197828,Antihypertensive,0,1
197829,efficacy,0,1
197830,of,0,1
197831,cetamolol,1,1
197832,:,1,1
197833,a,0,0
197834,dose-titrated,0,1
197835,study,0,0
197836,.,0,1
197837,This,0,0
197838,double-blind,0,1
197839,",",0,1
197840,placebo-controlled,1,1
197841,",",0,1
197842,randomized,0,1
197843,multicenter,0,0
197844,study,0,0
197845,evaluated,0,0
197846,the,0,0
197847,antihypertensive,0,1
197848,efficacy,0,1
197849,and,0,0
197850,safety,0,0
197851,of,0,1
197852,cetamolol,1,1
197853,hydrochloride,1,1
197854,in,0,0
197855,108,0,0
197856,patients,0,0
197857,diagnosed,0,0
197858,as,0,0
197859,having,0,0
197860,mild,0,0
197861,to,0,0
197862,moderate,0,0
197863,hypertension,0,0
197864,.,0,0
197865,After,0,0
197866,a,0,0
197867,placebo,1,1
197868,lead-in,0,1
197869,period,0,1
197870,",",0,0
197871,patients,0,0
197872,received,0,0
197873,either,0,0
197874,cetamolol,1,1
197875,5-10-15,1,1
197876,mg/d,1,1
197877,(,0,1
197878,low,0,1
197879,dose,0,1
197880,),0,1
197881,",",0,1
197882,cetamolol,1,1
197883,15-25-50,1,1
197884,mg/d,1,1
197885,(,0,1
197886,high,0,1
197887,dose,0,1
197888,),0,1
197889,",",0,1
197890,or,0,1
197891,placebo,1,1
197892,",",0,1
197893,once,0,1
197894,daily,0,1
197895,for,0,0
197896,four,0,0
197897,weeks,0,0
197898,.,0,0
197899,Patients,0,0
197900,began,0,0
197901,at,0,0
197902,the,0,0
197903,lowest,0,0
197904,dose,0,1
197905,and,0,1
197906,were,0,0
197907,titrated,0,1
197908,to,0,0
197909,higher,0,0
197910,doses,0,1
197911,based,0,0
197912,on,0,0
197913,the,0,0
197914,first,0,0
197915,two,0,0
197916,assessments,0,0
197917,of,0,0
197918,diastolic,0,0
197919,blood,0,0
197920,pressure,0,0
197921,and,0,0
197922,heart,0,0
197923,rate,0,0
197924,",",0,0
197925,which,0,0
197926,were,0,0
197927,conducted,0,0
197928,each,0,0
197929,week,0,0
197930,after,0,0
197931,double-blind,0,1
197932,treatment,0,0
197933,was,0,0
197934,dispensed,0,1
197935,.,0,0
197936,After,0,0
197937,four,0,0
197938,weeks,0,0
197939,of,0,0
197940,treatment,0,0
197941,82.4,0,0
197942,%,0,0
197943,",",0,0
197944,81.3,0,0
197945,%,0,0
197946,",",0,0
197947,and,0,0
197948,93.3,0,0
197949,%,0,0
197950,of,0,0
197951,the,0,0
197952,low-dose,1,1
197953,group,0,1
197954,",",0,1
197955,high-dose,1,1
197956,group,0,1
197957,",",0,0
197958,and,0,1
197959,placebo,1,1
197960,group,0,0
197961,",",0,0
197962,respectively,0,0
197963,",",0,0
197964,were,0,0
197965,titrated,0,1
197966,to,0,0
197967,the,0,0
197968,maximum,0,0
197969,dose,0,1
197970,level,0,0
197971,.,0,0
197972,After,0,0
197973,four,0,0
197974,weeks,0,0
197975,of,0,0
197976,treatment,0,0
197977,and,0,0
197978,24,0,0
197979,hours,0,0
197980,since,0,0
197981,the,0,0
197982,patient,0,0
197983,'s,0,0
197984,last,0,0
197985,dose,0,1
197986,",",0,1
197987,both,0,1
197988,cetamolol,1,1
197989,groups,0,0
197990,showed,0,0
197991,a,0,0
197992,significantly,0,0
197993,greater,0,0
197994,(,0,0
197995,P,0,0
197996,less,0,0
197997,than,0,0
197998,or,0,0
197999,equal,0,0
198000,to,0,0
198001,.05,0,0
198002,),0,0
198003,reduction,0,0
198004,in,0,0
198005,supine,0,0
198006,systolic/diastolic,0,0
198007,blood,0,1
198008,pressure,0,0
198009,(,0,0
198010,-18.1,0,0
198011,+/-,0,0
198012,2.3/-9.2,0,0
198013,+/-,0,0
198014,1.5,0,0
198015,mm,0,0
198016,Hg,0,1
198017,[,0,1
198018,low,0,1
198019,dose,0,1
198020,],0,0
198021,and,0,0
198022,-17.3,0,0
198023,+/-,0,0
198024,2.3/-8.3,0,0
198025,+/-,0,0
198026,1.6,0,0
198027,mm,0,0
198028,Hg,0,1
198029,[,0,1
198030,high,0,1
198031,dose,0,1
198032,],0,1
198033,),0,1
198034,than,0,0
198035,the,0,0
198036,placebo,0,1
198037,group,0,1
198038,(,0,0
198039,-9.9,0,0
198040,+/-,0,0
198041,2.5/-3.5,0,0
198042,+/-,0,0
198043,1.7,0,0
198044,mm,0,0
198045,Hg,0,0
198046,),0,0
198047,.,0,0
198048,In,0,0
198049,general,0,0
198050,",",0,0
198051,the,0,0
198052,changes,0,0
198053,in,0,0
198054,standing,0,0
198055,(,0,0
198056,stabilized,0,0
198057,),0,0
198058,systolic,0,0
198059,and,0,0
198060,diastolic,0,0
198061,blood,0,0
198062,pressure,0,0
198063,were,0,0
198064,similar,0,0
198065,to,0,0
198066,those,0,0
198067,seen,0,0
198068,in,0,0
198069,supine,0,0
198070,measurements,0,0
198071,.,0,0
198072,Significantly,0,0
198073,more,0,0
198074,patients,0,0
198075,receiving,0,0
198076,cetamolol,0,1
198077,than,0,0
198078,those,0,0
198079,receiving,0,0
198080,placebo,0,1
198081,showed,0,0
198082,a,0,0
198083,good,0,0
198084,response,0,0
198085,(,0,0
198086,a,0,0
198087,decrease,0,0
198088,in,0,0
198089,diastolic,0,0
198090,blood,0,0
198091,pressure,0,0
198092,of,0,0
198093,10,0,0
198094,mm,0,0
198095,Hg,0,0
198096,or,0,0
198097,more,0,0
198098,or,0,0
198099,measuring,0,0
198100,less,0,0
198101,than,0,0
198102,90,0,0
198103,mm,0,0
198104,Hg,0,0
198105,with,0,0
198106,a,0,0
198107,decrease,0,0
198108,of,0,0
198109,at,0,0
198110,least,0,0
198111,4,0,0
198112,mm,0,0
198113,Hg,0,1
198114,),0,1
198115,.,0,0
198116,(,0,0
198117,ABSTRACT,0,1
198118,TRUNCATED,0,1
198119,AT,0,1
198120,250,0,1
198121,WORDS,0,1
198122,),0,1
198123,Dexamethasone,1,1
198124,therapy,1,1
198125,and,0,1
198126,cortisol,0,1
198127,excretion,0,1
198128,in,0,1
198129,severe,0,1
198130,pediatric,0,0
198131,head,0,0
198132,injury,0,1
198133,.,0,0
198134,Glucocorticoids,1,1
198135,are,0,0
198136,used,0,0
198137,in,0,0
198138,an,0,0
198139,attempt,0,0
198140,to,0,0
198141,reduce,0,0
198142,brain,0,0
198143,edema,0,0
198144,secondary,0,0
198145,to,0,0
198146,head,0,0
198147,injury,0,0
198148,.,0,0
198149,Nevertheless,0,0
198150,",",0,0
198151,their,0,0
198152,usefulness,0,0
198153,remains,0,0
198154,uncertain,0,0
198155,and,0,0
198156,contradictory,0,0
198157,.,0,0
198158,In,0,0
198159,a,0,0
198160,randomized,0,0
198161,study,0,0
198162,of,0,0
198163,24,0,0
198164,children,0,0
198165,with,0,0
198166,severe,0,0
198167,head,0,0
198168,injury,0,0
198169,",",0,0
198170,urinary,0,0
198171,free,0,0
198172,cortisol,0,1
198173,was,0,0
198174,measured,0,0
198175,by,0,0
198176,radioimmunoassay,1,1
198177,.,1,0
198178,Twelve,0,1
198179,patients,0,0
198180,(,0,0
198181,group,0,1
198182,1,0,0
198183,),0,1
198184,received,0,0
198185,dexamethasone,1,1
198186,and,0,1
198187,12,0,1
198188,(,0,1
198189,group,0,0
198190,2,0,0
198191,),0,0
198192,did,0,0
198193,not,0,0
198194,.,0,0
198195,All,0,0
198196,patients,0,0
198197,were,0,0
198198,treated,0,0
198199,with,0,0
198200,a,0,0
198201,standardized,0,0
198202,regimen,0,1
198203,.,0,1
198204,In,0,0
198205,group,0,0
198206,1,0,0
198207,there,0,0
198208,was,0,0
198209,complete,0,0
198210,suppression,0,0
198211,of,0,0
198212,endogenous,0,0
198213,cortisol,0,1
198214,production,0,0
198215,.,0,0
198216,In,0,0
198217,group,0,0
198218,2,0,0
198219,free,0,0
198220,cortisol,0,1
198221,was,0,0
198222,up,0,0
198223,to,0,0
198224,20-fold,0,0
198225,higher,0,0
198226,than,0,0
198227,under,0,0
198228,basal,0,0
198229,conditions,0,0
198230,and,0,0
198231,reached,0,0
198232,maximum,0,0
198233,values,0,0
198234,on,0,0
198235,days,0,0
198236,1-3,0,0
198237,.,0,0
198238,Since,0,0
198239,the,0,0
198240,excretion,0,1
198241,of,0,1
198242,cortisol,0,1
198243,in,0,1
198244,urine,0,1
198245,reflects,0,0
198246,the,0,0
198247,production,0,0
198248,rate,0,0
198249,closely,0,0
198250,and,0,0
198251,is,0,0
198252,not,0,0
198253,influenced,0,0
198254,by,0,0
198255,liver,0,0
198256,function,0,0
198257,and,0,0
198258,barbiturates,0,1
198259,",",0,0
198260,the,0,0
198261,results,0,0
198262,in,0,0
198263,group,0,0
198264,2,0,0
198265,show,0,0
198266,that,0,0
198267,the,0,0
198268,endogenous,0,0
198269,production,0,0
198270,of,0,0
198271,steroids,0,1
198272,is,0,0
198273,an,0,0
198274,adequate,0,0
198275,reaction,0,0
198276,to,0,0
198277,severe,0,0
198278,head,0,0
198279,injury,0,0
198280,.,0,0
198281,Exogenous,0,0
198282,glucocorticoids,1,1
198283,are,0,0
198284,thus,0,0
198285,unlikely,0,0
198286,to,0,0
198287,have,0,0
198288,any,0,0
198289,more,0,0
198290,beneficial,0,0
198291,effects,0,0
198292,than,0,0
198293,endogenous,0,0
198294,cortisol,1,1
198295,.,1,0
198296,Effects,0,0
198297,of,0,0
198298,maternal,1,1
198299,glucose,1,1
198300,infusion,1,1
198301,on,0,1
198302,fetal,0,0
198303,acid-base,0,0
198304,status,0,0
198305,in,0,0
198306,human,0,0
198307,pregnancy,0,0
198308,.,0,0
198309,The,0,0
198310,maternal,0,0
198311,and,0,0
198312,fetal,0,0
198313,metabolic,0,0
198314,effects,0,0
198315,of,0,0
198316,three,0,0
198317,commonly,0,0
198318,used,0,0
198319,intravenous,0,1
198320,fluids,0,1
198321,administered,0,1
198322,before,0,1
198323,regional,0,0
198324,anesthesia,0,0
198325,were,0,0
198326,studied,0,0
198327,in,0,0
198328,32,0,0
198329,gravid,0,0
198330,women,0,0
198331,undergoing,0,1
198332,elective,0,0
198333,cesarean,0,0
198334,section,0,0
198335,at,0,0
198336,term,0,0
198337,.,0,0
198338,Patients,0,0
198339,were,0,0
198340,randomized,0,0
198341,into,0,0
198342,one,0,0
198343,of,0,0
198344,three,0,0
198345,groups,0,0
198346,to,0,0
198347,receive,0,0
198348,1,0,0
198349,L,0,0
198350,of,0,0
198351,either,0,0
198352,5,1,0
198353,%,1,0
198354,dextrose,1,1
198355,(,0,1
198356,50,0,1
198357,gm,0,1
198358,of,0,1
198359,glucose,1,1
198360,),1,1
198361,or,1,1
198362,Ringer,1,1
198363,'s,1,1
198364,lactate,1,1
198365,or,1,1
198366,isotonic,1,1
198367,saline,1,1
198368,solution,1,1
198369,before,0,0
198370,epidural,1,0
198371,anesthesia,1,0
198372,.,1,0
198373,Acute,0,0
198374,glucose,0,1
198375,infusion,0,1
198376,resulted,0,1
198377,in,0,0
198378,maternal,0,1
198379,hyperglycemia,0,1
198380,",",0,1
198381,hyperinsulinemia,0,1
198382,",",0,1
198383,and,0,0
198384,an,0,0
198385,increase,0,0
198386,in,0,0
198387,the,0,0
198388,blood,0,0
198389,lactate,0,1
198390,level,0,0
198391,.,0,0
198392,Cord,0,0
198393,blood,0,1
198394,glucose,0,1
198395,",",0,1
198396,insulin,0,1
198397,",",0,1
198398,and,0,1
198399,lactate,0,1
198400,levels,0,0
198401,were,0,0
198402,also,0,0
198403,increased,0,0
198404,in,0,0
198405,this,0,0
198406,group,0,0
198407,.,0,0
198408,The,0,0
198409,key,0,0
198410,finding,0,0
198411,of,0,0
198412,this,0,0
198413,study,0,0
198414,was,0,0
198415,the,0,0
198416,significant,0,0
198417,lowering,0,0
198418,of,0,0
198419,pH,0,0
198420,in,0,0
198421,the,0,0
198422,umbilical,0,0
198423,cord,0,1
198424,vein,0,0
198425,(,0,0
198426,7.31,0,0
198427,+/-,0,0
198428,0.04,0,0
198429,),0,0
198430,and,0,0
198431,artery,0,0
198432,(,0,0
198433,7.21,0,0
198434,+/-,0,0
198435,0.06,0,0
198436,),0,0
198437,in,0,0
198438,the,0,0
198439,glucose-infused,0,1
198440,group,0,0
198441,when,0,0
198442,compared,0,0
198443,with,0,0
198444,the,0,0
198445,non-glucose,0,1
198446,infusion,0,1
198447,groups,0,1
198448,(,0,0
198449,p,0,0
198450,less,0,0
198451,than,0,0
198452,0.05,0,0
198453,),0,0
198454,.,0,0
198455,Confounding,0,0
198456,perinatal,0,0
198457,factors,0,0
198458,such,0,0
198459,as,0,0
198460,maternal,0,0
198461,position,0,0
198462,",",0,0
198463,maternal,0,0
198464,hypotension,0,0
198465,",",0,0
198466,and,0,0
198467,prolonged,0,0
198468,time,0,0
198469,of,0,0
198470,surgery,0,0
198471,did,0,0
198472,not,0,0
198473,influence,0,0
198474,the,0,0
198475,fetal,0,0
198476,acid-base,0,0
198477,status,0,0
198478,.,0,0
198479,Thus,0,0
198480,acute,0,1
198481,maternal,0,1
198482,glucose,0,1
198483,infusion,0,1
198484,in,0,0
198485,normal,0,0
198486,patients,0,0
198487,can,0,0
198488,cause,0,0
198489,fetal,0,0
198490,hyperglycemia,0,1
198491,",",0,0
198492,metabolic,0,0
198493,acidosis,0,0
198494,",",0,0
198495,and,0,0
198496,neonatal,0,1
198497,hypoglycemia,0,1
198498,.,0,1
198499,These,0,0
198500,findings,0,0
198501,may,0,0
198502,be,0,0
198503,of,0,0
198504,particular,0,0
198505,clinical,0,0
198506,importance,0,0
198507,when,0,0
198508,fetal,0,0
198509,distress,0,0
198510,or,0,0
198511,fetal,0,0
198512,hypoxemia,0,0
198513,is,0,0
198514,due,0,0
198515,to,0,0
198516,other,0,0
198517,perinatal,0,0
198518,events,0,0
198519,.,0,0
198520,Under,0,0
198521,these,0,0
198522,circumstances,0,0
198523,",",0,0
198524,acute,0,1
198525,maternal,0,1
198526,glucose,0,1
198527,infusion,0,1
198528,may,0,0
198529,further,0,0
198530,contribute,0,0
198531,to,0,0
198532,fetal,0,0
198533,metabolic,0,0
198534,acidosis,0,0
198535,.,0,0
198536,Iron,1,0
198537,intake,1,1
198538,and,1,1
198539,iron,1,1
198540,nutritional,1,1
198541,status,1,0
198542,of,0,0
198543,infants,0,1
198544,fed,0,1
198545,iron-fortified,1,1
198546,beikost,1,1
198547,with,1,1
198548,meat,1,0
198549,.,1,0
198550,We,0,0
198551,compared,0,0
198552,iron,0,1
198553,intake,0,1
198554,and,0,1
198555,iron,0,1
198556,nutritional,0,1
198557,status,0,0
198558,of,0,0
198559,two,0,0
198560,groups,0,0
198561,of,0,0
198562,healthy,0,0
198563,term,0,0
198564,infants,0,0
198565,who,0,0
198566,received,0,0
198567,meat-containing,1,0
198568,baby,1,1
198569,foods,1,1
198570,fortified,1,1
198571,with,1,1
198572,ferrous,1,1
198573,sulphate,1,1
198574,(,0,1
198575,2,0,1
198576,mg,0,1
198577,Fe/100,0,1
198578,g,0,0
198579,),0,0
198580,.,0,1
198581,One,0,0
198582,group,0,0
198583,received,0,0
198584,an,0,0
198585,Fe-fortified,1,1
198586,formula,1,1
198587,(,0,1
198588,1.6,0,1
198589,mg,0,1
198590,Fe/100,0,1
198591,kcal,0,1
198592,),0,0
198593,and,1,0
198594,the,1,0
198595,other,1,0
198596,a,1,0
198597,nonfortified,1,1
198598,formula,1,1
198599,.,1,1
198600,Fe,1,1
198601,intake,1,1
198602,of,0,0
198603,the,0,0
198604,group,0,0
198605,fed,0,0
198606,the,0,1
198607,nonfortified,0,1
198608,formula,0,1
198609,was,0,0
198610,significantly,0,0
198611,lower,0,0
198612,(,0,0
198613,p,0,0
198614,less,0,0
198615,than,0,0
198616,0.0001,0,0
198617,),0,0
198618,.,0,0
198619,These,0,0
198620,infants,0,0
198621,received,0,0
198622,Fe,1,0
198623,mainly,1,0
198624,from,1,0
198625,fortification,1,1
198626,Fe,1,1
198627,with,1,1
198628,beikost,1,0
198629,(,0,0
198630,75-86,0,0
198631,%,0,0
198632,),0,0
198633,and,0,0
198634,less,0,0
198635,than,0,0
198636,10,0,0
198637,%,0,0
198638,met,0,0
198639,the,0,0
198640,recommended,0,1
198641,intake,0,1
198642,of,0,1
198643,1,0,1
198644,mg.kg-1.d-1,0,1
198645,;,0,1
198646,whereas,0,0
198647,80-85,0,0
198648,%,0,0
198649,of,0,0
198650,the,0,0
198651,infants,0,0
198652,fed,0,0
198653,the,0,0
198654,Fe-fortified,1,1
198655,formula,1,1
198656,did,0,0
198657,.,0,0
198658,Hb,0,0
198659,",",0,0
198660,Hct,0,0
198661,",",0,0
198662,FEP,0,0
198663,",",0,0
198664,and,0,0
198665,ferritin,0,1
198666,were,0,0
198667,similar,0,0
198668,in,0,0
198669,both,0,0
198670,groups,0,0
198671,with,0,0
198672,the,0,0
198673,exception,0,0
198674,of,0,0
198675,lower,0,0
198676,ferritin,0,1
198677,values,0,0
198678,at,0,0
198679,age,0,0
198680,365,0,0
198681,d,0,0
198682,(,0,0
198683,p,0,0
198684,less,0,0
198685,than,0,0
198686,0.05,0,0
198687,),0,0
198688,in,0,0
198689,the,0,0
198690,group,0,0
198691,fed,0,0
198692,the,0,1
198693,nonfortified,0,1
198694,formula,0,1
198695,.,0,1
198696,No,0,1
198697,infant,0,1
198698,had,0,0
198699,hemoglobin,0,1
198700,less,0,0
198701,than,0,0
198702,100,0,0
198703,g/L,0,0
198704,.,0,0
198705,We,0,0
198706,conclude,0,0
198707,that,0,0
198708,regular,0,0
198709,consumption,0,0
198710,of,0,0
198711,commercially,1,0
198712,prepared,1,0
198713,Fe-fortified,1,1
198714,beikost,1,1
198715,with,1,1
198716,meat,1,0
198717,prevents,0,0
198718,most,0,0
198719,healthy,0,0
198720,term,0,0
198721,infants,0,0
198722,from,0,0
198723,Fe,0,0
198724,deficiency,0,0
198725,even,0,0
198726,if,0,0
198727,Fe,0,1
198728,intake,0,1
198729,is,0,0
198730,substantially,0,0
198731,below,0,0
198732,the,0,0
198733,recommended,0,0
198734,intake,0,1
198735,.,0,0
198736,Topical,1,0
198737,fibronectin,1,0
198738,therapy,1,0
198739,for,0,0
198740,treatment,0,0
198741,of,0,0
198742,a,0,0
198743,patient,0,0
198744,with,0,0
198745,chronic,0,0
198746,stasis,0,0
198747,ulcers,0,0
198748,.,0,0
198749,[,0,0
198750,The,0,0
198751,effect,0,0
198752,of,0,0
198753,thoracic,1,0
198754,peridural,1,1
198755,analgesia,1,1
198756,on,0,0
198757,the,0,0
198758,cortisol,0,1
198759,and,0,1
198760,glucose,0,1
198761,response,0,0
198762,in,0,0
198763,surgery,0,0
198764,of,0,0
198765,the,0,0
198766,abdominal,0,0
198767,aorta,0,1
198768,],0,0
198769,.,0,0
198770,UNLABELLED,0,0
198771,It,0,0
198772,has,0,0
198773,been,0,0
198774,shown,0,0
198775,that,0,0
198776,the,0,0
198777,stress,0,0
198778,response,0,0
198779,to,0,0
198780,lower,0,0
198781,abdominal,0,0
198782,surgery,0,0
198783,can,0,0
198784,be,0,0
198785,inhibited,0,0
198786,by,0,0
198787,epidural,1,1
198788,analgesia,1,1
198789,(,1,1
198790,EA,1,1
198791,),1,1
198792,.,1,0
198793,But,0,0
198794,EA,0,0
198795,seems,0,0
198796,to,0,0
198797,have,0,0
198798,little,0,0
198799,influence,0,0
198800,on,0,0
198801,the,0,0
198802,stress,0,0
198803,reaction,0,0
198804,to,0,0
198805,major,0,0
198806,abdominal,0,0
198807,surgery,0,0
198808,.,0,0
198809,The,0,0
198810,purpose,0,0
198811,of,0,0
198812,our,0,0
198813,study,0,0
198814,was,0,0
198815,to,0,0
198816,find,0,0
198817,out,0,0
198818,whether,0,0
198819,EA,0,0
198820,is,0,0
198821,able,0,0
198822,to,0,0
198823,diminish,0,0
198824,the,0,0
198825,cortisol,0,1
198826,and,0,1
198827,glucose,0,1
198828,response,0,0
198829,to,0,0
198830,major,0,0
198831,transabdominal,0,0
198832,surgery,0,0
198833,.,0,0
198834,METHODS,0,0
198835,31,0,0
198836,patients,0,0
198837,undergoing,0,0
198838,elective,0,0
198839,surgery,0,0
198840,of,0,0
198841,the,0,0
198842,abdominal,0,0
198843,aorta,0,0
198844,were,0,0
198845,subdivided,0,0
198846,at,0,0
198847,random,0,0
198848,into,0,0
198849,3,0,0
198850,different,0,0
198851,anaesthesia,0,0
198852,groups,0,0
198853,:,0,0
198854,1.,0,1
198855,halothane,1,1
198856,anesthesia,1,1
198857,",",0,0
198858,2.,0,1
198859,neuroleptanalgesia,1,1
198860,(,1,1
198861,NLA,1,1
198862,),1,1
198863,and,0,0
198864,3.,0,0
198865,thoracic,1,0
198866,EA,1,1
198867,with,1,1
198868,bupivacaine,1,1
198869,(,1,0
198870,0.5,1,0
198871,%,1,0
198872,),1,0
198873,in,0,0
198874,combination,1,0
198875,with,1,0
198876,a,1,0
198877,light,1,0
198878,general,1,0
198879,anesthesia,1,0
198880,.,1,0
198881,Some,0,0
198882,patients,0,0
198883,of,0,0
198884,each,0,0
198885,group,0,0
198886,received,0,0
198887,an,0,0
198888,intravenous,0,1
198889,infusion,0,1
198890,of,0,0
198891,5,0,0
198892,%,0,0
198893,glucose,0,1
198894,.,0,0
198895,Blood,0,0
198896,samples,0,0
198897,were,0,0
198898,drawn,0,0
198899,before,0,0
198900,anesthesia,0,0
198901,",",0,0
198902,after,0,0
198903,intubation,0,0
198904,",",0,0
198905,5,0,0
198906,times,0,0
198907,during,0,0
198908,surgery,0,0
198909,and,0,0
198910,at,0,0
198911,the,0,0
198912,end,0,0
198913,of,0,0
198914,the,0,0
198915,operation,0,0
198916,and,0,0
198917,were,0,0
198918,analysed,0,0
198919,for,0,0
198920,cortisol,0,1
198921,and,0,1
198922,glucose,0,1
198923,.,0,0
198924,During,0,0
198925,the,0,0
198926,early,0,0
198927,postoperative,0,0
198928,period,0,0
198929,",",0,0
198930,1,0,0
198931,",",0,0
198932,2,0,0
198933,and,0,0
198934,24,0,0
198935,h,0,0
198936,after,0,0
198937,surgery,0,0
198938,",",0,0
198939,only,0,0
198940,cortisol,0,1
198941,was,0,0
198942,measured,0,0
198943,.,0,0
198944,RESULTS,0,0
198945,Only,0,0
198946,the,0,0
198947,glucose,0,1
198948,levels,0,0
198949,of,0,0
198950,patients,0,0
198951,who,0,0
198952,received,0,0
198953,no,0,0
198954,carbohydrate-containing,0,0
198955,infusion,0,1
198956,fluids,0,1
198957,were,0,0
198958,used,0,0
198959,for,0,0
198960,evaluation,0,0
198961,of,0,0
198962,the,0,0
198963,stress,0,0
198964,response,0,0
198965,.,0,0
198966,In,0,0
198967,the,0,0
198968,halothane,0,1
198969,group,0,0
198970,",",0,0
198971,there,0,0
198972,was,0,0
198973,a,0,0
198974,significant,0,0
198975,increase,0,0
198976,of,0,0
198977,the,0,0
198978,mean,0,0
198979,cortisol,0,1
198980,and,0,0
198981,glucose,0,1
198982,levels,0,0
198983,after,0,0
198984,the,0,0
198985,start,0,0
198986,of,0,0
198987,surgery,0,0
198988,.,0,0
198989,No,0,1
198990,intraoperative,0,0
198991,elevations,0,0
198992,of,0,0
198993,blood,0,1
198994,glucose,0,1
198995,and,0,1
198996,cortisol,0,1
198997,were,0,0
198998,seen,0,0
198999,in,0,0
199000,the,0,0
199001,EA,0,0
199002,group,0,0
199003,.,0,0
199004,Patients,0,0
199005,of,0,0
199006,the,0,0
199007,NLA,0,0
199008,group,0,0
199009,showed,0,0
199010,no,0,0
199011,hyperglycaemia,0,1
199012,and,0,0
199013,only,0,0
199014,mild,0,0
199015,elevations,0,0
199016,of,0,0
199017,the,0,0
199018,cortisol,0,1
199019,levels,0,0
199020,during,0,0
199021,the,0,0
199022,intraoperative,0,0
199023,period,0,1
199024,.,0,0
199025,(,0,0
199026,ABSTRACT,0,1
199027,TRUNCATED,0,1
199028,AT,0,1
199029,250,0,1
199030,WORDS,0,1
199031,),0,1
199032,Effect,0,0
199033,of,0,0
199034,negative,1,0
199035,air,1,0
199036,ionization,1,0
199037,on,0,0
199038,hyperactive,0,0
199039,and,0,0
199040,autistic,0,0
199041,children,0,0
199042,.,0,0
199043,Twenty-one,0,0
199044,attention,0,0
199045,deficit,0,0
199046,disorder,0,0
199047,with,0,0
199048,hyperactivity,0,0
199049,and,0,0
199050,seven,0,0
199051,autistic,0,0
199052,children,0,0
199053,were,0,0
199054,randomly,1,0
199055,exposed,1,0
199056,to,1,0
199057,negatively,1,0
199058,ionized,1,0
199059,and,1,0
199060,ambient,1,0
199061,atmospheres,1,1
199062,under,1,0
199063,rigorously,1,0
199064,controlled,1,0
199065,experimental,1,0
199066,conditions,1,0
199067,.,1,0
199068,The,0,0
199069,negatively,1,0
199070,ionized,1,0
199071,condition,1,0
199072,did,0,0
199073,not,0,0
199074,significantly,0,0
199075,affect,0,0
199076,measurements,0,0
199077,of,0,0
199078,activity,0,0
199079,level,0,0
199080,",",0,0
199081,impulsivity,0,0
199082,",",0,0
199083,reality,0,0
199084,orientation,0,0
199085,",",0,0
199086,destructive/constructiveness,0,0
199087,",",0,0
199088,attention,0,0
199089,",",0,0
199090,or,0,0
199091,task,0,0
199092,performance,0,0
199093,.,0,0
199094,Significant,0,0
199095,results,0,0
199096,might,0,0
199097,be,0,0
199098,obtained,0,0
199099,if,0,0
199100,subgroups,0,0
199101,of,0,0
199102,known,0,0
199103,hyperserotoninemic,0,1
199104,autistic,0,1
199105,and,0,0
199106,attention,0,0
199107,deficit,0,1
199108,disorder,0,0
199109,children,0,0
199110,were,0,0
199111,exposed,0,0
199112,to,0,0
199113,negatively,1,0
199114,ionized,1,0
199115,conditions,1,0
199116,.,1,0
199117,Hemolytic,1,1
199118,streptococcus,1,1
199119,preparation,1,1
199120,OK-432,1,1
199121,;,1,1
199122,beneficial,0,1
199123,adjuvant,0,1
199124,therapy,0,1
199125,in,0,0
199126,recurrent,0,0
199127,gastric,0,0
199128,carcinoma,0,0
199129,.,0,0
199130,The,0,0
199131,administration,0,1
199132,of,0,0
199133,a,0,1
199134,hemolytic,1,1
199135,streptococcus,1,1
199136,preparation,1,1
199137,",",0,0
199138,OK-432,0,0
199139,",",0,0
199140,is,0,0
199141,thought,0,0
199142,to,0,0
199143,be,0,0
199144,of,0,0
199145,therapeutic,0,0
199146,value,0,0
199147,in,0,0
199148,the,0,0
199149,treatment,0,0
199150,of,0,0
199151,cancer,0,0
199152,patients,0,0
199153,through,0,0
199154,a,0,0
199155,stimulatory,0,0
199156,effect,0,0
199157,on,0,0
199158,the,0,0
199159,immune,0,0
199160,system,0,0
199161,.,0,0
199162,In,0,0
199163,order,0,0
199164,to,0,0
199165,evaluate,0,0
199166,any,0,0
199167,beneficial,0,0
199168,effect,0,0
199169,of,0,0
199170,such,0,0
199171,an,0,0
199172,administration,0,1
199173,",",0,0
199174,a,0,0
199175,group,0,0
199176,of,0,0
199177,patients,0,0
199178,with,0,0
199179,recurrent,0,0
199180,gastric,0,0
199181,cancer,0,0
199182,was,0,0
199183,studied,0,0
199184,.,0,0
199185,This,0,0
199186,group,0,0
199187,was,0,0
199188,randomly,0,0
199189,subdivided,0,0
199190,into,0,0
199191,3,1,0
199192,groups,1,0
199193,:,1,0
199194,1,1,1
199195,),1,1
199196,Intradermal,1,1
199197,group,1,1
199198,(,1,0
199199,ID,1,1
199200,Group,1,0
199201,),1,0
199202,",",1,0
199203,42,1,0
199204,patients,1,0
199205,given,1,0
199206,an,1,0
199207,intradermal,1,1
199208,injections,1,1
199209,of,1,1
199210,OK-432,1,1
199211,.,1,0
199212,2,1,1
199213,),1,1
199214,Intramuscular,1,1
199215,group,1,1
199216,(,1,0
199217,IM,1,1
199218,Group,1,0
199219,),1,0
199220,",",1,0
199221,40,1,0
199222,patients,1,0
199223,given,1,0
199224,an,1,0
199225,intramuscular,1,1
199226,injections,1,1
199227,of,1,1
199228,OK-432,1,1
199229,.,1,0
199230,3,1,0
199231,),1,0
199232,Control,1,0
199233,group,1,0
199234,(,1,0
199235,C,1,1
199236,Group,1,0
199237,),1,0
199238,",",1,0
199239,39,1,0
199240,patients,1,0
199241,not,1,0
199242,given,1,1
199243,injections,1,1
199244,.,1,1
199245,Each,0,1
199246,group,0,0
199247,was,0,0
199248,studied,0,0
199249,in,0,0
199250,regards,0,0
199251,to,0,0
199252,the,0,0
199253,length,0,0
199254,of,0,0
199255,survival,0,0
199256,",",0,0
199257,the,0,0
199258,host,0,0
199259,immune,0,0
199260,response,0,0
199261,and,0,0
199262,the,0,0
199263,incidence,0,0
199264,of,0,0
199265,side,0,0
199266,effects,0,0
199267,.,0,0
199268,When,0,0
199269,compared,0,0
199270,to,0,0
199271,the,0,0
199272,IM,0,0
199273,and,0,0
199274,C,0,0
199275,Groups,0,0
199276,",",0,0
199277,the,0,0
199278,ID,0,0
199279,Group,0,0
199280,showed,0,0
199281,improved,0,0
199282,survival,0,0
199283,.,0,0
199284,Accompanying,0,0
199285,this,0,0
199286,improved,0,0
199287,survival,0,0
199288,",",0,0
199289,the,0,0
199290,ID,0,0
199291,Group,0,0
199292,also,0,0
199293,had,0,0
199294,greater,0,0
199295,white,0,0
199296,cell,0,0
199297,and,0,0
199298,lymphocyte,0,0
199299,counts,0,0
199300,",",0,0
199301,a,0,0
199302,greater,0,0
199303,number,0,0
199304,of,0,0
199305,T,0,0
199306,cells,0,0
199307,",",0,0
199308,and,0,0
199309,a,0,0
199310,more,0,0
199311,dramatic,0,0
199312,skin,0,0
199313,reaction,0,0
199314,to,0,0
199315,the,0,0
199316,extracted,0,0
199317,cell,0,0
199318,wall,0,0
199319,polysaccharide,0,1
199320,of,0,1
199321,hemolytic,0,1
199322,streptococcus,0,1
199323,Su-strain,0,1
199324,(,0,1
199325,Su-PS,0,1
199326,),0,1
199327,.,0,0
199328,The,0,0
199329,ID,0,0
199330,Group,0,0
199331,",",0,0
199332,following,0,0
199333,OK-432,0,1
199334,injection,0,1
199335,",",0,0
199336,had,0,0
199337,a,0,0
199338,4.8,0,0
199339,%,0,0
199340,incidence,0,0
199341,of,0,0
199342,fever,0,0
199343,and,0,0
199344,a,0,0
199345,52.4,0,0
199346,%,0,0
199347,incidence,0,0
199348,of,0,0
199349,local,0,0
199350,abscess,0,0
199351,formation,0,0
199352,at,0,0
199353,the,0,0
199354,injection,0,1
199355,site,0,0
199356,.,0,0
199357,90,0,0
199358,%,0,0
199359,of,0,0
199360,the,0,0
199361,IM,0,0
199362,Group,0,0
199363,developed,0,0
199364,fever,0,0
199365,but,0,0
199366,abscess,0,0
199367,formation,0,0
199368,was,0,0
199369,absent,0,0
199370,in,0,0
199371,all,0,0
199372,patients,0,0
199373,.,0,0
199374,From,0,0
199375,these,0,0
199376,results,0,0
199377,",",0,0
199378,it,0,0
199379,was,0,0
199380,concluded,0,0
199381,that,0,0
199382,in,0,0
199383,the,0,0
199384,patients,0,0
199385,tested,0,0
199386,",",0,1
199387,intradermal,0,1
199388,injection,0,1
199389,of,0,1
199390,OK-432,0,0
199391,appears,0,0
199392,to,0,0
199393,be,0,0
199394,clinically,0,0
199395,superior,0,0
199396,to,0,0
199397,intramuscular,0,1
199398,injection,0,1
199399,.,0,1
199400,A,0,1
199401,randomized,0,0
199402,comparison,0,0
199403,of,0,0
199404,tamoxifen,1,1
199405,with,0,1
199406,surgical,1,0
199407,oophorectomy,1,0
199408,in,0,0
199409,premenopausal,0,0
199410,patients,0,0
199411,with,0,0
199412,advanced,0,0
199413,breast,0,0
199414,cancer,0,0
199415,.,0,0
199416,We,0,0
199417,randomized,0,0
199418,122,0,0
199419,premenopausal,0,0
199420,women,0,0
199421,to,0,0
199422,receive,0,1
199423,tamoxifen,1,1
199424,or,0,0
199425,to,0,0
199426,undergo,1,0
199427,a,1,0
199428,surgical,1,0
199429,oophorectomy,1,0
199430,.,1,0
199431,Of,0,0
199432,54,0,0
199433,evaluable,0,0
199434,women,0,0
199435,treated,0,0
199436,with,0,0
199437,tamoxifen,1,1
199438,",",0,0
199439,24,0,0
199440,%,0,0
199441,had,0,0
199442,an,0,0
199443,objective,0,0
199444,response,0,0
199445,",",0,0
199446,as,0,0
199447,compared,0,0
199448,with,0,0
199449,21,0,0
199450,%,0,0
199451,of,0,0
199452,53,0,0
199453,women,0,0
199454,having,0,0
199455,an,0,0
199456,oophorectomy,1,0
199457,.,1,0
199458,The,0,0
199459,median,0,0
199460,duration,0,0
199461,of,0,0
199462,response,0,0
199463,for,0,0
199464,tamoxifen,1,1
199465,(,0,1
199466,20,0,0
199467,months,0,0
199468,),0,0
199469,was,0,0
199470,longer,0,0
199471,than,0,0
199472,that,0,0
199473,for,0,0
199474,surgical,1,0
199475,oophorectomy,1,1
199476,(,0,0
199477,7,0,0
199478,months,0,0
199479,),0,0
199480,",",0,0
199481,but,0,0
199482,this,0,0
199483,did,0,0
199484,not,0,0
199485,achieve,0,0
199486,statistical,0,0
199487,significance,0,0
199488,(,0,0
199489,P,0,0
199490,=,0,0
199491,.056,0,0
199492,),0,0
199493,.,0,0
199494,Overall,0,0
199495,median,0,0
199496,survival,0,0
199497,was,0,0
199498,15,0,0
199499,months,0,0
199500,for,0,0
199501,58,0,0
199502,patients,0,0
199503,receiving,0,0
199504,tamoxifen,0,1
199505,and,0,1
199506,25,0,0
199507,months,0,0
199508,for,0,0
199509,53,0,0
199510,patients,0,0
199511,undergoing,0,0
199512,oophorectomy,0,0
199513,(,0,0
199514,P,0,0
199515,=,0,0
199516,.18,0,0
199517,),0,0
199518,.,0,0
199519,Toxicity,0,0
199520,was,0,0
199521,greater,0,0
199522,in,0,0
199523,those,0,0
199524,undergoing,0,0
199525,oophorectomy,0,0
199526,",",0,0
199527,though,0,0
199528,both,0,0
199529,treatments,0,0
199530,were,0,0
199531,well,0,0
199532,tolerated,0,1
199533,.,0,0
199534,In,0,0
199535,those,0,0
199536,premenopausal,0,0
199537,women,0,0
199538,for,0,0
199539,whom,0,0
199540,hormonal,0,0
199541,therapy,0,0
199542,is,0,0
199543,indicated,0,0
199544,",",0,0
199545,tamoxifen,1,1
199546,is,0,0
199547,a,0,0
199548,suitable,0,0
199549,alternative,0,0
199550,to,0,0
199551,surgical,1,0
199552,oophorectomy,1,0
199553,.,1,0
199554,An,0,1
199555,international,0,1
199556,multi-clinic,0,0
199557,study,0,0
199558,comparing,0,0
199559,the,0,0
199560,therapeutic,0,0
199561,efficacy,0,0
199562,of,0,1
199563,colloidal,1,1
199564,bismuth,1,1
199565,subcitrate,1,1
199566,coated,1,1
199567,tablets,1,1
199568,with,0,1
199569,chewing,1,1
199570,tablets,1,1
199571,in,0,0
199572,the,0,0
199573,treatment,0,0
199574,of,0,0
199575,duodenal,0,0
199576,ulceration,0,0
199577,.,0,0
199578,The,0,0
199579,results,0,0
199580,of,0,0
199581,a,0,0
199582,randomized,0,0
199583,",",0,0
199584,single-blind,0,1
199585,",",0,1
199586,multi-clinic,0,0
199587,study,0,0
199588,comparing,0,0
199589,the,0,0
199590,therapeutic,0,0
199591,efficacy,0,0
199592,and,0,0
199593,degree,0,0
199594,of,0,0
199595,oral,0,1
199596,staining,0,0
199597,of,0,0
199598,new,0,0
199599,colloidal,1,1
199600,bismuth,1,1
199601,subcitrate,1,1
199602,(,1,1
199603,CBS,1,1
199604,),1,1
199605,coated,1,0
199606,tablets,1,1
199607,over,0,0
199608,4,0,0
199609,weeks,0,0
199610,of,0,0
199611,treatment,0,0
199612,in,0,0
199613,patients,0,0
199614,suffering,0,0
199615,from,0,0
199616,duodenal,0,0
199617,ulceration,0,0
199618,are,0,0
199619,reported,0,0
199620,.,0,0
199621,The,0,0
199622,data,0,0
199623,were,0,0
199624,collected,0,0
199625,from,0,0
199626,9,0,0
199627,clinics,0,0
199628,in,0,0
199629,the,0,0
199630,Netherlands,0,0
199631,",",0,0
199632,Belgium,0,0
199633,",",0,0
199634,Ireland,0,0
199635,",",0,0
199636,the,0,0
199637,United,0,0
199638,Kingdom,0,0
199639,",",0,0
199640,and,0,0
199641,Italy,0,0
199642,.,0,0
199643,The,0,0
199644,results,0,0
199645,from,0,0
199646,94,0,0
199647,patients,0,0
199648,treated,0,0
199649,with,0,0
199650,CBS,1,0
199651,coated,1,0
199652,tablets,1,1
199653,and,0,0
199654,95,0,0
199655,patients,0,0
199656,treated,0,0
199657,with,0,0
199658,CBS,1,1
199659,chewing,1,1
199660,tablets,1,1
199661,were,0,0
199662,statistically,0,0
199663,evaluated,0,0
199664,.,0,0
199665,Healing,0,0
199666,rates,0,0
199667,after,0,0
199668,4,0,0
199669,weeks,0,0
199670,of,0,0
199671,therapy,0,0
199672,appeared,0,0
199673,to,0,0
199674,be,0,0
199675,76,0,0
199676,%,0,0
199677,for,0,0
199678,CBS,1,0
199679,coated,1,0
199680,tablets,1,1
199681,and,0,0
199682,72,0,0
199683,%,0,0
199684,for,0,0
199685,CBS,1,0
199686,chewing,1,1
199687,tablets,1,1
199688,",",0,0
199689,so,0,0
199690,no,0,0
199691,statistically,0,0
199692,significant,0,0
199693,difference,0,0
199694,in,0,0
199695,therapeutic,0,0
199696,efficacy,0,0
199697,was,0,0
199698,seen,0,0
199699,.,0,0
199700,A,0,0
199701,highly,0,0
199702,significant,0,0
199703,degree,0,0
199704,of,0,0
199705,discolouration,0,0
199706,of,0,0
199707,all,0,0
199708,parts,0,0
199709,of,0,0
199710,the,0,0
199711,oral,0,1
199712,cavity,0,0
199713,was,0,0
199714,observed,0,0
199715,in,0,0
199716,patients,0,0
199717,treated,0,0
199718,with,0,0
199719,CBS,1,1
199720,chewing,1,1
199721,tablets,1,1
199722,",",0,0
199723,whereas,0,0
199724,only,0,0
199725,a,0,0
199726,few,0,0
199727,patients,0,0
199728,treated,0,0
199729,with,0,0
199730,CBS,1,0
199731,coated,1,0
199732,tablets,1,1
199733,experienced,0,1
199734,a,0,0
199735,slight,0,0
199736,staining,0,0
199737,of,0,0
199738,the,0,0
199739,tongue,0,0
199740,.,0,0
199741,Blood,0,1
199742,bismuth,0,1
199743,concentrations,0,1
199744,during,0,0
199745,the,0,0
199746,study,0,0
199747,had,0,0
199748,a,0,0
199749,range,0,0
199750,of,0,0
199751,less,0,0
199752,than,0,0
199753,or,0,0
199754,equal,0,0
199755,to,0,0
199756,3,0,0
199757,to,0,0
199758,33,0,0
199759,micrograms/l,0,0
199760,.,0,0
199761,The,0,0
199762,new,0,0
199763,CBS,1,0
199764,coated,1,0
199765,tablet,1,1
199766,form,0,0
199767,has,0,0
199768,an,0,0
199769,excellent,0,0
199770,patient,0,0
199771,compliance,0,0
199772,as,0,0
199773,compared,0,0
199774,to,0,0
199775,the,0,0
199776,chewing,1,0
199777,tablets,1,1
199778,.,1,0
199779,The,0,0
199780,UKEP,0,0
199781,study,0,0
199782,:,0,0
199783,multicentre,0,0
199784,clinical,0,0
199785,trial,0,0
199786,on,0,0
199787,two,0,0
199788,local,0,0
199789,regimens,0,1
199790,of,0,1
199791,urokinase,1,1
199792,in,0,0
199793,massive,0,0
199794,pulmonary,0,0
199795,embolism,0,0
199796,.,0,0
199797,The,0,0
199798,UKEP,0,0
199799,Study,0,0
199800,Research,0,0
199801,Group,0,0
199802,.,0,0
199803,A,1,0
199804,multicentre,1,1
199805,trial,1,1
199806,(,1,0
199807,10,1,0
199808,centres,1,1
199809,),1,1
199810,of,1,1
199811,urokinase,1,1
199812,(,1,1
199813,UK,1,1
199814,),1,0
199815,was,0,0
199816,performed,0,0
199817,in,0,0
199818,patients,0,0
199819,with,0,0
199820,acute,0,0
199821,severe,0,0
199822,pulmonary,0,1
199823,embolism,0,1
199824,(,0,1
199825,PE,0,1
199826,),0,1
199827,.,0,0
199828,The,0,0
199829,aim,0,0
199830,of,0,0
199831,this,0,0
199832,trial,0,0
199833,was,0,0
199834,",",0,0
199835,to,0,0
199836,compare,0,0
199837,the,0,0
199838,efficacy,0,0
199839,of,0,0
199840,two,1,0
199841,doses,1,1
199842,of,1,1
199843,UK,1,1
199844,administered,1,1
199845,via,1,0
199846,a,1,0
199847,catheter,1,0
199848,in,1,0
199849,the,1,0
199850,pulmonary,1,0
199851,artery,1,0
199852,:,1,0
199853,2000,1,0
199854,IU,1,1
199855,kg-1,1,1
199856,h-1,1,1
199857,for,1,1
199858,24,1,1
199859,hours,1,1
199860,(,1,1
199861,UK,1,1
199862,2000,1,1
199863,),1,0
199864,in,1,0
199865,conjunction,1,0
199866,with,1,0
199867,heparin,1,1
199868,versus,1,0
199869,4400,1,0
199870,IU,1,0
199871,kg-1,1,1
199872,h-1,1,1
199873,UK,1,1
199874,alone,1,0
199875,for,1,0
199876,12,1,0
199877,hours,1,1
199878,(,1,0
199879,UK,1,1
199880,4400,1,0
199881,),1,0
199882,followed,1,0
199883,by,1,0
199884,heparin,1,1
199885,.,1,0
199886,PE,0,0
199887,was,0,0
199888,less,0,0
199889,than,0,0
199890,5,0,0
199891,days,0,0
199892,old,0,1
199893,and,0,0
199894,the,0,0
199895,clinical,0,0
199896,diagnosis,0,0
199897,was,0,0
199898,confirmed,0,0
199899,by,0,0
199900,pulmonary,0,0
199901,angiograms,0,0
199902,demonstrating,0,0
199903,a,0,0
199904,vascular,0,0
199905,obstruction,0,0
199906,of,0,0
199907,more,0,0
199908,than,0,0
199909,30,0,0
199910,%,0,0
199911,(,0,0
199912,Miller,0,0
199913,'s,0,1
199914,index,0,0
199915,greater,0,0
199916,than,0,0
199917,11,0,0
199918,),0,0
199919,.,0,0
199920,The,0,0
199921,efficacy,0,0
199922,of,0,0
199923,treatment,0,0
199924,was,0,0
199925,evaluated,0,0
199926,by,0,0
199927,the,0,0
199928,degree,0,0
199929,of,0,0
199930,early,0,0
199931,revascularization,0,1
199932,(,0,0
199933,pulmonary,0,0
199934,angiograms,0,0
199935,were,0,0
199936,performed,0,0
199937,30,0,0
199938,to,0,0
199939,48,0,0
199940,hours,0,0
199941,after,0,0
199942,initiation,0,0
199943,of,0,0
199944,thrombolytic,1,0
199945,treatment,1,0
199946,and,0,0
199947,analysed,0,0
199948,blindly,0,0
199949,by,0,0
199950,four,0,0
199951,independent,0,0
199952,vascular,0,0
199953,radiologists,0,1
199954,),0,0
199955,.,0,0
199956,133,0,0
199957,patients,0,0
199958,were,0,0
199959,included,0,0
199960,in,0,0
199961,this,0,0
199962,trial,0,0
199963,:,0,0
199964,two,0,0
199965,patients,0,0
199966,died,0,0
199967,before,0,0
199968,treatment,0,0
199969,and,0,0
199970,two,0,0
199971,were,0,0
199972,excluded,0,0
199973,retrospectively,0,0
199974,",",0,0
199975,leaving,0,0
199976,129,0,0
199977,patients,0,0
199978,for,0,0
199979,final,0,0
199980,analysis,0,0
199981,(,0,0
199982,67,0,0
199983,:,0,0
199984,UK,0,0
199985,2000,0,1
199986,+,0,1
199987,heparin,0,1
199988,;,0,0
199989,62,0,0
199990,:,0,0
199991,UK,0,0
199992,4400,0,0
199993,),0,0
199994,.,0,0
199995,The,0,0
199996,two,0,0
199997,groups,0,0
199998,had,0,0
199999,similar,0,0
200000,pretreatment,0,1
200001,clinical,0,1
200002,",",0,0
200003,haemodynamic,0,0
200004,and,0,0
200005,angiographic,0,0
200006,characteristics,0,0
200007,:,0,0
200008,the,0,0
200009,Miller,0,0
200010,angiographic,0,0
200011,index,0,0
200012,of,0,0
200013,severity,0,0
200014,averaged,0,0
200015,22.6,0,0
200016,+/-,0,0
200017,3.7,0,0
200018,for,0,0
200019,patients,0,0
200020,in,0,0
200021,the,0,0
200022,UK,0,0
200023,2000,0,0
200024,group,0,0
200025,",",0,0
200026,and,0,0
200027,22.6,0,0
200028,+/-,0,0
200029,3.4,0,0
200030,for,0,0
200031,patients,0,0
200032,in,0,0
200033,the,0,0
200034,UK,0,0
200035,4400,0,0
200036,group,0,0
200037,(,0,0
200038,average,0,0
200039,filling,0,0
200040,defect,0,0
200041,of,0,0
200042,66,0,0
200043,%,0,0
200044,on,0,0
200045,pulmonary,0,0
200046,angiograms,0,0
200047,),0,0
200048,.,0,0
200049,There,0,0
200050,was,0,0
200051,a,0,0
200052,similar,0,0
200053,and,0,0
200054,significant,0,0
200055,degree,0,0
200056,of,0,0
200057,resolution,0,0
200058,in,0,0
200059,the,0,0
200060,two,0,0
200061,groups,0,0
200062,:,0,0
200063,26,0,0
200064,%,0,0
200065,and,0,0
200066,20,0,0
200067,%,0,0
200068,",",0,0
200069,respectively,0,0
200070,.,0,0
200071,Minor,0,0
200072,and,0,0
200073,major,0,0
200074,bleeding,0,0
200075,problems,0,0
200076,were,0,0
200077,observed,0,0
200078,with,0,0
200079,equal,0,0
200080,frequency,0,0
200081,in,0,0
200082,the,0,0
200083,two,0,0
200084,groups,0,0
200085,(,0,0
200086,24,0,0
200087,%,0,0
200088,and,0,0
200089,29,0,0
200090,%,0,0
200091,",",0,0
200092,respectively,0,0
200093,),0,0
200094,.,0,0
200095,These,0,1
200096,bleeding,0,0
200097,complications,0,0
200098,were,0,0
200099,severe,0,0
200100,in,0,0
200101,only,0,0
200102,4.5,0,0
200103,%,0,0
200104,and,0,0
200105,3,0,0
200106,%,0,0
200107,",",0,0
200108,respectively,0,0
200109,.,0,0
200110,(,0,0
200111,ABSTRACT,0,1
200112,TRUNCATED,0,1
200113,AT,0,1
200114,250,0,1
200115,WORDS,0,1
200116,),0,1
200117,Circadian,0,0
200118,changes,0,0
200119,in,0,0
200120,the,0,0
200121,pharmacokinetics,0,1
200122,of,0,1
200123,oral,0,1
200124,ketoprofen,1,1
200125,.,1,1
200126,Several,0,0
200127,investigations,0,0
200128,which,0,0
200129,have,0,0
200130,taken,0,0
200131,treatment,0,0
200132,time,0,0
200133,into,0,0
200134,account,0,0
200135,have,0,0
200136,shown,0,0
200137,that,0,0
200138,the,0,0
200139,pharmacokinetic,0,1
200140,parameters,0,0
200141,",",0,0
200142,the,0,0
200143,therapeutic,0,0
200144,efficacy,0,0
200145,and,0,0
200146,even,0,0
200147,the,0,0
200148,toxicity,0,0
200149,of,0,0
200150,a,0,0
200151,large,0,0
200152,number,0,0
200153,of,0,0
200154,products,0,0
200155,may,0,0
200156,vary,0,0
200157,according,0,0
200158,to,0,0
200159,the,0,0
200160,administration,0,1
200161,schedule,0,1
200162,.,0,0
200163,The,0,0
200164,present,0,0
200165,study,0,0
200166,was,0,0
200167,carried,0,0
200168,out,0,0
200169,in,0,0
200170,order,0,0
200171,to,0,0
200172,evaluate,0,0
200173,any,0,0
200174,circadian,0,0
200175,changes,0,0
200176,in,0,0
200177,pharmacokinetic,0,1
200178,parameters,0,0
200179,of,0,0
200180,ketoprofen,1,1
200181,",",0,0
200182,a,0,0
200183,new,0,0
200184,non-steroidal,0,1
200185,anti-inflammatory,0,1
200186,drug,0,1
200187,(,0,1
200188,NSAID,0,1
200189,),0,1
200190,.,0,0
200191,This,0,1
200192,randomised,0,1
200193,crossover,0,1
200194,study,0,0
200195,consisted,0,0
200196,of,0,0
200197,a,0,0
200198,single,0,0
200199,oral,0,1
200200,dose,0,1
200201,of,0,1
200202,ketoprofen,1,1
200203,100mg,0,1
200204,administered,0,1
200205,to,0,1
200206,8,0,0
200207,healthy,0,0
200208,male,0,0
200209,volunteers,0,0
200210,",",0,0
200211,mean,0,0
200212,age,0,0
200213,27.2,0,0
200214,years,0,0
200215,",",0,0
200216,at,0,0
200217,07.00,0,0
200218,hours,0,0
200219,",",0,0
200220,13.00,0,0
200221,hours,0,0
200222,",",0,0
200223,19.00,0,0
200224,hours,0,0
200225,or,0,0
200226,01.00,0,0
200227,hours,0,0
200228,in,0,0
200229,4,0,0
200230,study,0,0
200231,periods,0,0
200232,during,0,0
200233,the,0,0
200234,first,0,0
200235,3,0,0
200236,months,0,0
200237,of,0,0
200238,the,0,0
200239,year,0,0
200240,.,0,0
200241,The,0,0
200242,order,0,0
200243,of,0,0
200244,administration,0,1
200245,was,0,0
200246,randomised,0,0
200247,",",0,0
200248,with,0,0
200249,each,0,0
200250,subject,0,0
200251,acting,0,0
200252,as,0,0
200253,his,0,0
200254,own,0,0
200255,control,0,0
200256,.,0,0
200257,A,0,0
200258,total,0,0
200259,of,0,0
200260,14,0,0
200261,blood,0,0
200262,and,0,0
200263,4,0,0
200264,urine,0,1
200265,samples,0,0
200266,were,0,0
200267,taken,0,0
200268,over,0,0
200269,a,0,0
200270,12-hour,0,1
200271,period,0,1
200272,.,0,0
200273,The,0,0
200274,peak,0,0
200275,plasma,0,0
200276,concentration,0,0
200277,was,0,0
200278,twice,0,0
200279,as,0,0
200280,high,0,0
200281,after,0,0
200282,drug,0,1
200283,administration,0,1
200284,at,0,1
200285,07.00,0,1
200286,hours,0,1
200287,(,0,0
200288,13.4,0,0
200289,+/-,0,0
200290,1,0,0
200291,mg/L,0,1
200292,),0,1
200293,than,0,0
200294,after,0,0
200295,other,0,0
200296,administration,0,1
200297,times,0,1
200298,(,0,0
200299,13.00,0,0
200300,hours,0,0
200301,:,0,0
200302,6.9,0,0
200303,+/-,0,0
200304,1,0,0
200305,;,0,0
200306,19.00,0,0
200307,hours,0,0
200308,:,0,0
200309,7.2,0,0
200310,+/-,0,0
200311,0.7,0,0
200312,;,0,0
200313,01.00,0,0
200314,hours,0,0
200315,:,0,0
200316,6.3,0,0
200317,+/-,0,0
200318,0.5,0,0
200319,mg/L,0,1
200320,),0,1
200321,[,0,0
200322,p,0,0
200323,less,0,0
200324,than,0,0
200325,0.001,0,0
200326,],0,0
200327,.,0,0
200328,The,0,0
200329,time,0,0
200330,to,0,0
200331,reach,0,0
200332,peak,0,0
200333,concentration,0,0
200334,was,0,0
200335,much,0,0
200336,longer,0,0
200337,after,0,0
200338,drug,0,1
200339,administration,0,1
200340,at,0,0
200341,01.00,0,0
200342,hours,0,0
200343,(,0,0
200344,135,0,0
200345,+/-,0,0
200346,16.7,0,0
200347,min,0,0
200348,),0,0
200349,than,0,0
200350,at,0,1
200351,07.00,0,0
200352,(,0,0
200353,73.1,0,0
200354,+/-,0,0
200355,14.1,0,0
200356,min,0,0
200357,),0,0
200358,",",0,0
200359,13.00,0,0
200360,(,0,0
200361,75,0,0
200362,+/-,0,0
200363,16.5,0,0
200364,min,0,0
200365,),0,0
200366,or,0,0
200367,19.00,0,0
200368,hours,0,0
200369,(,0,0
200370,82.5,0,0
200371,+/-,0,0
200372,12.7,0,0
200373,min,0,0
200374,),0,0
200375,[,0,0
200376,p,0,0
200377,less,0,0
200378,than,0,0
200379,0.05,0,0
200380,],0,0
200381,.,0,0
200382,The,0,0
200383,lag,0,0
200384,time,0,0
200385,was,0,0
200386,significantly,0,0
200387,longer,0,0
200388,at,0,0
200389,01.00,0,0
200390,hours,0,0
200391,than,0,0
200392,at,0,0
200393,13.00,0,0
200394,hours,0,0
200395,(,0,0
200396,p,0,0
200397,less,0,0
200398,than,0,0
200399,0.01,0,0
200400,),0,0
200401,.,0,0
200402,The,0,0
200403,absorption,0,0
200404,rate,0,0
200405,constant,0,0
200406,after,0,0
200407,treatment,0,0
200408,at,0,0
200409,01.00,0,0
200410,hours,0,0
200411,was,0,0
200412,less,0,0
200413,than,0,0
200414,at,0,0
200415,the,0,0
200416,other,0,0
200417,times,0,0
200418,of,0,0
200419,administration,0,1
200420,(,0,0
200421,p,0,0
200422,less,0,0
200423,than,0,0
200424,0.05,0,0
200425,),0,0
200426,.,0,0
200427,The,0,0
200428,bodyweight-corrected,0,0
200429,area,0,0
200430,under,0,0
200431,the,0,0
200432,curve,0,1
200433,(,0,1
200434,AUC0-12,0,1
200435,),0,0
200436,was,0,0
200437,greater,0,0
200438,after,0,0
200439,07.00,0,0
200440,hours,0,1
200441,than,0,0
200442,after,0,0
200443,13.00,0,0
200444,(,0,0
200445,p,0,0
200446,less,0,0
200447,than,0,0
200448,0.01,0,0
200449,),0,0
200450,or,0,0
200451,19.00,0,0
200452,hours,0,0
200453,(,0,0
200454,p,0,0
200455,less,0,0
200456,than,0,0
200457,0.05,0,0
200458,),0,0
200459,and,0,0
200460,greater,0,0
200461,after,0,0
200462,01.00,0,0
200463,hours,0,0
200464,than,0,0
200465,after,0,0
200466,13.00,0,0
200467,hours,0,0
200468,(,0,0
200469,p,0,0
200470,less,0,0
200471,than,0,0
200472,0.05,0,0
200473,),0,0
200474,.,0,0
200475,The,0,0
200476,elimination,0,0
200477,half-life,0,0
200478,was,0,0
200479,significantly,0,0
200480,longer,0,0
200481,after,0,0
200482,administration,0,0
200483,at,0,0
200484,01.00,0,0
200485,hours,0,0
200486,than,0,0
200487,after,0,0
200488,19.00,0,0
200489,hours,0,0
200490,(,0,0
200491,p,0,0
200492,less,0,0
200493,than,0,0
200494,0.05,0,0
200495,),0,0
200496,",",0,0
200497,while,0,0
200498,the,0,0
200499,total,0,0
200500,clearance,0,1
200501,was,0,0
200502,lowest,0,0
200503,at,0,0
200504,07.00,0,0
200505,hours,0,1
200506,.,0,1
200507,Cosinor,0,1
200508,analysis,0,0
200509,demonstrated,0,0
200510,statistically,0,0
200511,significant,0,0
200512,circadian,0,0
200513,rhythms,0,0
200514,for,0,0
200515,all,0,0
200516,pharmacokinetic,0,1
200517,parameters,0,0
200518,described,0,0
200519,above,0,0
200520,.,0,0
200521,The,0,0
200522,amount,0,0
200523,of,0,0
200524,ketoprofen,1,1
200525,eliminated,0,0
200526,in,0,0
200527,the,0,0
200528,urine,0,1
200529,was,0,0
200530,delayed,0,0
200531,",",0,0
200532,and,0,0
200533,was,0,0
200534,significantly,0,0
200535,greater,0,0
200536,after,0,0
200537,the,0,0
200538,administration,0,0
200539,at,0,0
200540,01.00,0,0
200541,hours,0,0
200542,than,0,0
200543,07.00,0,1
200544,hours,0,1
200545,or,0,0
200546,19.00,0,0
200547,hours,0,0
200548,(,0,0
200549,p,0,0
200550,less,0,0
200551,than,0,0
200552,0.01,0,0
200553,),0,0
200554,.,0,0
200555,The,0,0
200556,relationship,0,0
200557,between,0,0
200558,absorption,0,0
200559,",",0,0
200560,diffusion,0,0
200561,and/or,0,0
200562,elimination,0,0
200563,mechanisms,0,0
200564,of,0,0
200565,the,0,0
200566,drug,0,1
200567,are,0,0
200568,discussed,0,0
200569,.,0,0
200570,Deleterious,0,0
200571,effects,0,0
200572,of,0,0
200573,low-dose,1,1
200574,oestrogen,1,1
200575,therapy,1,1
200576,on,0,0
200577,coronary,0,0
200578,status,0,0
200579,in,0,0
200580,patients,0,0
200581,with,0,0
200582,prostatic,0,0
200583,cancer,0,0
200584,.,0,0
200585,The,0,0
200586,effects,0,0
200587,of,0,0
200588,oestrogen,1,1
200589,therapy,1,1
200590,and,0,0
200591,of,0,0
200592,orchidectomy,1,0
200593,on,0,0
200594,coronary,0,0
200595,status,0,0
200596,",",0,0
200597,as,0,0
200598,reflected,0,0
200599,by,0,0
200600,exercise,0,0
200601,ECG-testing,0,0
200602,before,0,0
200603,and,0,0
200604,after,0,0
200605,one,0,0
200606,year,0,0
200607,of,0,0
200608,treatment,0,0
200609,",",0,0
200610,were,0,0
200611,assessed,0,0
200612,in,0,0
200613,a,0,0
200614,randomized,0,0
200615,study,0,0
200616,of,0,0
200617,patients,0,0
200618,(,0,0
200619,N,0,0
200620,=,0,0
200621,100,0,0
200622,),0,0
200623,with,0,0
200624,prostatic,0,0
200625,cancer,0,0
200626,.,0,0
200627,Oestrogen,1,1
200628,was,0,0
200629,given,0,0
200630,as,0,0
200631,polyestradiol,1,1
200632,phosphate,1,1
200633,80,0,1
200634,mg,0,1
200635,i.m,0,1
200636,.,0,1
200637,per,0,0
200638,month,0,0
200639,in,0,0
200640,combination,0,0
200641,with,0,0
200642,150,1,0
200643,micrograms,1,1
200644,ethinylestradiol,1,1
200645,p.o,0,1
200646,.,0,1
200647,per,0,0
200648,day,0,0
200649,.,0,0
200650,There,0,0
200651,were,0,0
200652,no,0,0
200653,significant,0,0
200654,inter-group,0,0
200655,differences,0,0
200656,in,0,0
200657,conventional,0,0
200658,risk,0,0
200659,factors,0,0
200660,or,0,0
200661,in,0,0
200662,pre-treatment,0,0
200663,exercise,0,0
200664,test,0,0
200665,results,0,0
200666,.,0,0
200667,Twelve,0,0
200668,months,0,0
200669,after,0,0
200670,the,0,0
200671,start,0,0
200672,of,0,0
200673,therapy,0,0
200674,the,0,0
200675,oestrogen,0,1
200676,group,0,0
200677,showed,0,0
200678,a,0,0
200679,significantly,0,0
200680,greater,0,0
200681,depression,0,0
200682,of,0,0
200683,the,0,0
200684,ST-segment,0,0
200685,during,0,0
200686,maximal,0,0
200687,exercise,0,0
200688,in,0,0
200689,leads,0,0
200690,CH2,0,0
200691,(,0,0
200692,P,0,0
200693,less,0,0
200694,than,0,0
200695,0.0005,0,0
200696,),0,0
200697,and,0,0
200698,CH5,0,0
200699,(,0,0
200700,P,0,0
200701,less,0,0
200702,than,0,0
200703,0.01,0,0
200704,),0,0
200705,compared,0,0
200706,with,0,0
200707,the,0,0
200708,pre-treatment,0,0
200709,depression,0,0
200710,.,0,0
200711,Twenty-five,0,0
200712,per,0,0
200713,cent,0,0
200714,(,0,0
200715,N,0,0
200716,=,0,0
200717,13,0,0
200718,),0,0
200719,of,0,0
200720,the,0,0
200721,patients,0,0
200722,in,0,0
200723,the,0,0
200724,oestrogen,0,1
200725,group,0,1
200726,suffered,0,0
200727,cardiovascular,0,0
200728,complications,0,0
200729,during,0,0
200730,the,0,0
200731,year,0,0
200732,of,0,0
200733,therapy,0,0
200734,",",0,0
200735,whereas,0,0
200736,no,0,0
200737,such,0,0
200738,complications,0,0
200739,were,0,0
200740,observed,0,0
200741,in,0,0
200742,the,0,0
200743,orchidectomy,0,0
200744,group,0,0
200745,.,0,0
200746,However,0,0
200747,",",0,0
200748,even,0,0
200749,the,0,0
200750,patients,0,0
200751,in,0,0
200752,the,0,0
200753,oestrogen,0,1
200754,group,0,1
200755,who,0,0
200756,had,0,0
200757,not,0,0
200758,suffered,0,0
200759,cardiovascular,0,0
200760,complications,0,0
200761,had,0,0
200762,significantly,0,0
200763,greater,0,0
200764,depressions,0,0
200765,of,0,0
200766,the,0,0
200767,ST-segment,0,0
200768,during,0,0
200769,exercise,0,0
200770,both,0,0
200771,in,0,0
200772,lead,0,0
200773,CH2,0,0
200774,(,0,0
200775,P,0,0
200776,less,0,0
200777,than,0,0
200778,0.0005,0,0
200779,),0,0
200780,and,0,0
200781,in,0,0
200782,CH5,0,0
200783,(,0,0
200784,P,0,0
200785,less,0,0
200786,than,0,0
200787,0.05,0,0
200788,),0,0
200789,.,0,0
200790,There,0,0
200791,was,0,0
200792,no,0,0
200793,significant,0,0
200794,change,0,0
200795,in,0,0
200796,the,0,0
200797,ST-segment,0,0
200798,level,0,0
200799,in,0,0
200800,the,0,0
200801,orchidectomy,0,0
200802,group,0,0
200803,twelve,0,0
200804,months,0,0
200805,after,0,0
200806,surgery,0,0
200807,.,0,0
200808,In,0,0
200809,summary,0,0
200810,",",0,0
200811,we,0,0
200812,found,0,0
200813,evidence,0,0
200814,of,0,0
200815,an,0,0
200816,induction,0,0
200817,of,0,0
200818,myocardial,0,0
200819,ischaemia,0,0
200820,during,0,0
200821,treatment,0,0
200822,with,0,0
200823,exogenous,1,0
200824,oestrogens,1,1
200825,at,0,1
200826,low,0,0
200827,dosage,0,1
200828,in,0,0
200829,patients,0,0
200830,with,0,0
200831,prostatic,0,0
200832,cancer,0,0
200833,.,0,0
200834,This,0,0
200835,deleterious,0,0
200836,effect,0,0
200837,of,0,0
200838,oestrogen,1,1
200839,on,0,0
200840,the,0,0
200841,coronary,0,0
200842,status,0,0
200843,argues,0,0
200844,against,0,0
200845,oestrogen,0,1
200846,therapy,0,1
200847,",",0,0
200848,since,0,0
200849,oestrogen,1,1
200850,has,0,0
200851,not,0,0
200852,been,0,0
200853,shown,0,0
200854,to,0,0
200855,be,0,0
200856,more,0,0
200857,beneficial,0,0
200858,than,0,0
200859,orchidectomy,0,0
200860,against,0,0
200861,prostatic,0,0
200862,carcinoma,0,0
200863,.,0,0
200864,A,0,1
200865,randomised,0,0
200866,comparison,0,0
200867,of,0,0
200868,three,0,0
200869,drainage,0,0
200870,systems,0,0
200871,following,0,0
200872,cholecystectomy,0,0
200873,.,0,0
200874,The,0,0
200875,efficacy,0,0
200876,of,0,0
200877,low,1,0
200878,pressure,1,0
200879,",",1,0
200880,high,1,0
200881,pressure,1,0
200882,and,1,0
200883,passive,1,0
200884,drainage,1,0
200885,systems,1,0
200886,have,0,0
200887,been,0,0
200888,compared,0,0
200889,after,0,0
200890,cholecystectomy,0,0
200891,.,0,0
200892,Symptoms,0,0
200893,of,0,0
200894,pain,0,0
200895,",",0,0
200896,discomfort,0,1
200897,and,0,0
200898,nausea,0,1
200899,were,0,0
200900,compared,0,0
200901,using,0,0
200902,linear,0,0
200903,analogue,0,1
200904,scales,0,1
200905,and,0,0
200906,spirometry,0,0
200907,was,0,0
200908,used,0,0
200909,to,0,0
200910,examine,0,0
200911,pre-operative,0,0
200912,and,0,0
200913,postoperative,0,0
200914,respiratory,0,0
200915,function,0,0
200916,.,0,0
200917,The,0,0
200918,low,1,0
200919,pressure,1,0
200920,suction,1,0
200921,drain,1,0
200922,removed,0,0
200923,an,0,0
200924,intraperitoneal,0,1
200925,marker,0,1
200926,",",0,1
200927,gentamicin,0,1
200928,",",0,0
200929,more,0,0
200930,effectively,0,0
200931,than,0,0
200932,the,0,0
200933,high,1,0
200934,pressure,1,0
200935,suction,1,0
200936,drain,1,0
200937,",",0,0
200938,but,0,0
200939,not,0,0
200940,more,0,0
200941,effectively,0,0
200942,than,0,0
200943,the,0,0
200944,passive,1,0
200945,drain,1,0
200946,.,1,0
200947,There,0,0
200948,were,0,0
200949,no,0,0
200950,differences,0,0
200951,in,0,0
200952,postoperative,0,0
200953,respiratory,0,0
200954,function,0,0
200955,nor,0,0
200956,in,0,0
200957,the,0,0
200958,amount,0,0
200959,of,0,0
200960,pain,0,0
200961,or,0,0
200962,discomfort,0,0
200963,between,0,0
200964,the,0,0
200965,groups,0,0
200966,.,0,0
200967,The,0,0
200968,passive,0,0
200969,drain,0,0
200970,group,0,0
200971,reported,0,0
200972,less,0,0
200973,nausea,0,1
200974,than,0,0
200975,the,0,0
200976,suction,0,0
200977,drain,0,0
200978,groups,0,0
200979,.,0,0
200980,If,0,0
200981,a,0,0
200982,negative,0,0
200983,pressure,0,0
200984,drainage,0,0
200985,system,0,0
200986,is,0,0
200987,to,0,0
200988,be,0,0
200989,used,0,0
200990,",",0,0
200991,a,0,0
200992,low,0,0
200993,pressure,0,0
200994,suction,0,0
200995,drain,0,0
200996,should,0,0
200997,be,0,0
200998,used,0,0
200999,in,0,0
201000,preference,0,0
201001,to,0,0
201002,a,0,0
201003,high,0,0
201004,pressure,0,0
201005,system,0,0
201006,.,0,0
201007,Therapeutic,0,0
201008,recommendations,0,0
201009,in,0,0
201010,polycythemia,0,1
201011,vera,0,1
201012,based,0,0
201013,on,0,0
201014,Polycythemia,0,0
201015,Vera,0,0
201016,Study,0,0
201017,Group,0,0
201018,protocols,0,0
201019,.,0,0
201020,The,0,0
201021,PVSG,0,0
201022,was,0,0
201023,organized,0,0
201024,in,0,0
201025,1967,0,0
201026,to,0,0
201027,establish,0,0
201028,effective,0,0
201029,diagnostic,0,0
201030,criteria,0,0
201031,for,0,0
201032,polycythemia,0,1
201033,vera,0,1
201034,",",0,0
201035,to,0,0
201036,study,0,0
201037,the,0,0
201038,natural,0,0
201039,history,0,0
201040,of,0,0
201041,the,0,0
201042,disease,0,0
201043,and,0,0
201044,to,0,0
201045,define,0,0
201046,the,0,0
201047,optimal,0,0
201048,treatment,0,0
201049,.,0,0
201050,Although,0,0
201051,polycythemia,0,0
201052,vera,0,1
201053,and,0,0
201054,the,0,0
201055,other,0,0
201056,myeloproliferative,0,0
201057,diseases,0,0
201058,are,0,0
201059,relatively,0,0
201060,uncommon,0,0
201061,",",0,0
201062,the,0,0
201063,PVSG,0,0
201064,was,0,0
201065,able,0,0
201066,to,0,0
201067,accumulate,0,0
201068,well,0,0
201069,over,0,0
201070,"1,000",0,0
201071,patients,0,0
201072,with,0,0
201073,these,0,0
201074,various,0,0
201075,disorders,0,0
201076,and,0,0
201077,to,0,0
201078,study,0,0
201079,them,0,0
201080,according,0,0
201081,to,0,0
201082,a,0,0
201083,total,0,0
201084,of,0,0
201085,15,0,0
201086,different,0,0
201087,protocols,0,0
201088,.,0,0
201089,PVSG-01,0,0
201090,",",0,0
201091,a,0,0
201092,long-term,0,0
201093,randomized,0,0
201094,controlled,0,0
201095,study,0,0
201096,of,0,0
201097,phlebotomy,1,0
201098,alone,1,0
201099,compared,0,0
201100,with,0,0
201101,the,0,0
201102,myelosuppressive,1,1
201103,agents,1,0
201104,",",1,0
201105,32P,1,0
201106,or,1,0
201107,chlorambucil,1,1
201108,supplemented,1,0
201109,by,1,0
201110,phlebotomy,1,0
201111,",",0,0
201112,continues,0,0
201113,to,0,0
201114,receive,0,0
201115,follow-up,0,0
201116,data,0,0
201117,on,0,0
201118,93,0,0
201119,%,0,0
201120,of,0,0
201121,surviving,0,0
201122,patients,0,0
201123,18,0,0
201124,years,0,0
201125,after,0,0
201126,initiation,0,0
201127,of,0,0
201128,the,0,0
201129,study,0,0
201130,.,0,0
201131,During,0,0
201132,its,0,0
201133,lifetime,0,0
201134,",",0,0
201135,PVSG,0,0
201136,has,0,0
201137,developed,0,0
201138,a,0,0
201139,widely,0,0
201140,accepted,0,0
201141,and,0,0
201142,highly,0,0
201143,effective,0,0
201144,set,0,0
201145,of,0,0
201146,criteria,0,0
201147,for,0,0
201148,the,0,0
201149,specific,0,0
201150,diagnosis,0,0
201151,of,0,0
201152,polycythemia,0,1
201153,vera,0,1
201154,as,0,0
201155,well,0,0
201156,as,0,0
201157,useful,0,0
201158,criteria,0,0
201159,for,0,0
201160,the,0,0
201161,diagnosis,0,0
201162,of,0,0
201163,essential,0,0
201164,thrombocythemia,0,0
201165,.,0,0
201166,It,0,0
201167,has,0,0
201168,gathered,0,0
201169,an,0,0
201170,enormous,0,0
201171,volume,0,0
201172,of,0,0
201173,data,0,0
201174,on,0,0
201175,the,0,0
201176,natural,0,0
201177,history,0,0
201178,of,0,0
201179,the,0,0
201180,myeloproliferative,0,0
201181,diseases,0,0
201182,and,0,0
201183,in,0,0
201184,particular,0,0
201185,on,0,0
201186,the,0,0
201187,nature,0,0
201188,of,0,0
201189,the,0,0
201190,prevalent,0,0
201191,complications,0,0
201192,",",0,0
201193,such,0,0
201194,as,0,0
201195,thrombotic,0,0
201196,events,0,0
201197,and,0,0
201198,hematologic,0,0
201199,and,0,0
201200,nonhematologic,0,0
201201,malignancies,0,0
201202,.,0,0
201203,With,0,0
201204,respect,0,0
201205,to,0,0
201206,the,0,0
201207,final,0,0
201208,question,0,0
201209,",",0,0
201210,the,0,0
201211,optimal,0,0
201212,treatment,0,0
201213,for,0,0
201214,polycythemia,0,1
201215,vera,0,1
201216,",",0,0
201217,it,0,0
201218,is,0,0
201219,apparent,0,0
201220,that,0,0
201221,the,0,0
201222,expectation,0,0
201223,of,0,0
201224,a,0,0
201225,single,1,0
201226,optimal,1,0
201227,therapy,1,0
201228,that,0,0
201229,would,0,0
201230,apply,0,0
201231,to,0,0
201232,all,0,0
201233,patients,0,0
201234,at,0,0
201235,all,0,0
201236,ages,0,0
201237,and,0,0
201238,stages,0,0
201239,of,0,0
201240,the,0,0
201241,disease,0,0
201242,was,0,0
201243,naive,0,0
201244,.,0,0
201245,Nevertheless,0,0
201246,considerable,0,0
201247,progress,0,0
201248,has,0,0
201249,been,0,0
201250,made,0,0
201251,.,0,0
201252,Moreover,0,0
201253,",",0,0
201254,the,0,0
201255,group,0,0
201256,has,0,0
201257,defined,0,0
201258,more,0,0
201259,precisely,0,0
201260,than,0,0
201261,ever,0,0
201262,before,0,0
201263,the,0,0
201264,nature,0,0
201265,of,0,0
201266,the,0,0
201267,complications,0,0
201268,of,0,0
201269,the,0,0
201270,disease,0,0
201271,and,0,0
201272,the,0,0
201273,association,0,0
201274,of,0,0
201275,the,0,0
201276,risks,0,0
201277,of,0,0
201278,specific,0,0
201279,complications,0,0
201280,with,0,0
201281,specific,0,0
201282,forms,0,0
201283,of,0,0
201284,therapy,0,0
201285,.,0,0
201286,It,0,0
201287,thus,0,0
201288,has,0,0
201289,made,0,0
201290,it,0,0
201291,possible,0,0
201292,to,0,0
201293,pose,0,0
201294,the,0,0
201295,next,0,0
201296,series,0,0
201297,of,0,0
201298,therapeutic,0,0
201299,questions,0,0
201300,that,0,0
201301,must,0,0
201302,be,0,0
201303,addressed,0,0
201304,in,0,0
201305,this,0,0
201306,disorder,0,0
201307,with,0,0
201308,a,0,0
201309,greater,0,0
201310,degree,0,0
201311,of,0,0
201312,sophistication,0,0
201313,than,0,0
201314,was,0,0
201315,previously,0,0
201316,possible,0,0
201317,.,0,0
201318,Domperidone,1,1
201319,",",1,1
201320,metoclopramide,1,1
201321,",",1,1
201322,and,1,1
201323,placebo,1,1
201324,.,1,1
201325,All,0,0
201326,give,0,0
201327,symptomatic,0,0
201328,improvement,0,0
201329,in,0,0
201330,gastroesophageal,0,0
201331,reflux,0,0
201332,.,0,0
201333,A,0,1
201334,double-blind,0,1
201335,crossover,0,1
201336,study,0,0
201337,was,0,0
201338,conducted,0,0
201339,of,0,0
201340,two,0,0
201341,gastric,1,1
201342,prokinetic,1,1
201343,drugs,1,1
201344,in,0,0
201345,23,0,0
201346,patients,0,0
201347,with,0,0
201348,gastroesophageal,0,0
201349,reflux,0,0
201350,.,0,0
201351,Patients,0,0
201352,were,0,0
201353,divided,0,0
201354,into,0,0
201355,two,0,0
201356,groups,0,0
201357,on,0,0
201358,the,0,0
201359,basis,0,0
201360,of,0,0
201361,a,0,0
201362,dual-isotope,0,1
201363,mixed-meal,0,1
201364,study,0,0
201365,of,0,0
201366,their,0,0
201367,gastric,0,1
201368,emptying,0,1
201369,(,0,1
201370,GE,0,1
201371,),0,1
201372,.,0,0
201373,Group,0,0
201374,I,0,0
201375,had,0,0
201376,normal,0,0
201377,GE,0,0
201378,and,0,0
201379,group,0,0
201380,II,0,0
201381,delayed,0,1
201382,GE,0,1
201383,.,0,1
201384,Nine,0,1
201385,gastrointestinal,0,1
201386,symptoms,0,0
201387,were,0,0
201388,assessed,0,0
201389,for,0,0
201390,frequency,0,0
201391,and,0,0
201392,severity,0,0
201393,before,0,0
201394,treatment,0,0
201395,.,0,0
201396,The,0,0
201397,trial,0,0
201398,had,0,0
201399,three,0,0
201400,1-month,0,0
201401,treatment,0,0
201402,periods,0,0
201403,using,0,0
201404,metoclopramide,1,1
201405,10,0,1
201406,mg,0,1
201407,q.i.d.,0,1
201408,",",0,1
201409,domperidone,1,1
201410,20,0,1
201411,mg,0,1
201412,q.i.d.,0,1
201413,",",0,1
201414,or,1,1
201415,placebo,1,1
201416,on,0,0
201417,a,0,0
201418,random,0,0
201419,basis,0,0
201420,.,0,0
201421,Symptoms,0,0
201422,were,0,0
201423,reassessed,0,0
201424,at,0,0
201425,the,0,0
201426,end,0,0
201427,of,0,0
201428,each,0,0
201429,month,0,0
201430,.,0,0
201431,Taken,0,0
201432,as,0,0
201433,a,0,0
201434,whole,0,0
201435,",",0,0
201436,the,0,0
201437,group,0,0
201438,showed,0,0
201439,a,0,0
201440,significant,0,0
201441,symptomatic,0,0
201442,response,0,0
201443,in,0,0
201444,all,0,0
201445,three,0,0
201446,treatment,0,0
201447,periods,0,0
201448,(,0,0
201449,p,0,0
201450,less,0,0
201451,than,0,0
201452,0.0001,0,0
201453,),0,0
201454,",",0,0
201455,but,0,0
201456,patients,0,0
201457,with,0,0
201458,delayed,0,0
201459,or,0,0
201460,normal,0,0
201461,GE,0,0
201462,did,0,0
201463,not,0,0
201464,differ,0,0
201465,significantly,0,0
201466,in,0,0
201467,their,0,0
201468,symptomatic,0,0
201469,response,0,0
201470,.,0,0
201471,Eleven,0,0
201472,patients,0,0
201473,complained,0,0
201474,of,0,0
201475,side,0,0
201476,effects,0,0
201477,with,0,0
201478,metoclopramide,1,1
201479,and,0,0
201480,three,0,1
201481,stopped,0,1
201482,therapy,0,1
201483,before,0,0
201484,the,0,0
201485,1-month,0,0
201486,course,0,0
201487,was,0,0
201488,completed,0,0
201489,.,0,0
201490,Two,0,0
201491,patients,0,0
201492,described,0,0
201493,side,0,0
201494,effects,0,0
201495,with,0,0
201496,domperidone,1,1
201497,",",0,0
201498,including,0,0
201499,one,0,0
201500,woman,0,0
201501,with,0,0
201502,galactorrhea,0,0
201503,after,0,0
201504,36,0,0
201505,h,0,0
201506,of,0,0
201507,treatment,0,0
201508,.,0,0
201509,Three,0,0
201510,patients,0,0
201511,on,0,0
201512,placebo,1,1
201513,also,0,0
201514,complained,0,0
201515,of,0,0
201516,important,0,0
201517,side,0,0
201518,effects,0,0
201519,.,0,0
201520,We,0,0
201521,conclude,0,0
201522,that,0,0
201523,a,0,0
201524,significant,0,0
201525,placebo,0,1
201526,effect,0,0
201527,is,0,0
201528,present,0,0
201529,in,0,0
201530,the,0,0
201531,treatment,0,0
201532,of,0,0
201533,gastroesophageal,0,0
201534,reflux,0,0
201535,.,0,0
201536,No,0,0
201537,significant,0,0
201538,difference,0,0
201539,was,0,0
201540,demonstrated,0,0
201541,in,0,0
201542,symptomatic,0,0
201543,improvement,0,0
201544,between,0,0
201545,placebo,1,1
201546,",",1,1
201547,domperidone,1,1
201548,",",0,1
201549,and,0,1
201550,metoclopramide,1,1
201551,in,0,0
201552,this,0,0
201553,study,0,0
201554,.,0,0
201555,The,0,0
201556,Eastern,0,0
201557,Cooperative,0,0
201558,Oncology,0,0
201559,Group,0,0
201560,experience,0,0
201561,with,0,1
201562,cyclophosphamide,1,1
201563,",",1,1
201564,adriamycin,1,1
201565,",",1,1
201566,and,1,1
201567,5-fluorouracil,1,1
201568,(,1,1
201569,CAF,1,1
201570,),1,0
201571,in,0,0
201572,patients,0,0
201573,with,0,0
201574,metastatic,0,0
201575,breast,0,0
201576,cancer,0,0
201577,.,0,0
201578,Data,0,0
201579,on,0,0
201580,162,0,0
201581,women,0,0
201582,(,0,0
201583,90,0,0
201584,premenopausal,0,0
201585,and,0,0
201586,72,0,0
201587,postmenopausal,0,0
201588,),0,0
201589,with,0,0
201590,metastatic,0,0
201591,breast,0,0
201592,cancer,0,0
201593,randomized,0,0
201594,to,0,0
201595,receive,0,1
201596,cyclophosphamide,1,1
201597,",",1,1
201598,Adriamycin,1,1
201599,(,1,1
201600,doxorubicin,1,1
201601,),1,1
201602,and,1,1
201603,5-fluorouracil,1,1
201604,(,1,1
201605,CAF,1,1
201606,),1,1
201607,on,0,0
201608,two,0,0
201609,Eastern,0,0
201610,Cooperative,0,0
201611,Oncology,0,1
201612,Group,0,0
201613,(,0,1
201614,ECOG,0,1
201615,),0,1
201616,protocols,0,0
201617,were,0,0
201618,analyzed,0,0
201619,.,0,0
201620,Twenty-three,0,0
201621,percent,0,0
201622,had,0,0
201623,complete,0,0
201624,remission,0,0
201625,;,0,0
201626,39,0,0
201627,%,0,0
201628,had,0,0
201629,partial,0,0
201630,remission,0,0
201631,;,0,0
201632,28,0,0
201633,%,0,0
201634,had,0,0
201635,no,0,0
201636,change,0,0
201637,;,0,0
201638,and,0,0
201639,3,0,0
201640,%,0,0
201641,had,0,0
201642,disease,0,0
201643,progression,0,0
201644,.,0,0
201645,Of,0,0
201646,those,0,0
201647,patients,0,0
201648,in,0,0
201649,whom,0,0
201650,receptors,0,0
201651,were,0,0
201652,known,0,0
201653,",",0,0
201654,response,0,0
201655,rates,0,0
201656,were,0,0
201657,65,0,0
201658,%,0,0
201659,for,0,0
201660,estrogen,0,1
201661,(,0,1
201662,ER,0,1
201663,),0,1
201664,-receptor,0,1
201665,positive,0,0
201666,and,0,0
201667,70,0,0
201668,%,0,0
201669,for,0,0
201670,ER-negative,0,0
201671,patients,0,0
201672,.,0,0
201673,The,0,0
201674,median,0,0
201675,duration,0,0
201676,of,0,0
201677,response,0,0
201678,was,0,0
201679,11.4,0,0
201680,months,0,0
201681,.,0,0
201682,The,0,0
201683,median,0,0
201684,survival,0,0
201685,time,0,0
201686,from,0,0
201687,the,0,0
201688,start,0,0
201689,of,0,0
201690,CAF,0,0
201691,was,0,0
201692,20.2,0,0
201693,months,0,0
201694,.,0,0
201695,The,0,0
201696,response,0,0
201697,rate,0,0
201698,",",0,0
201699,time,0,0
201700,to,0,0
201701,treatment,0,0
201702,failure,0,1
201703,(,0,1
201704,TTF,0,1
201705,),0,1
201706,",",0,0
201707,and,0,0
201708,median,0,0
201709,survival,0,0
201710,time,0,0
201711,were,0,0
201712,superior,0,0
201713,in,0,0
201714,the,0,0
201715,premenopausal,0,0
201716,women,0,0
201717,.,0,0
201718,These,0,0
201719,differences,0,0
201720,ceased,0,0
201721,",",0,0
201722,however,0,0
201723,",",0,0
201724,to,0,0
201725,be,0,0
201726,statistically,0,0
201727,significant,0,0
201728,in,0,0
201729,logistic,0,0
201730,models,0,0
201731,.,0,0
201732,Factors,0,0
201733,significantly,0,0
201734,associated,0,0
201735,with,0,0
201736,longer,0,0
201737,TTF,0,0
201738,and,0,0
201739,longer,0,0
201740,survival,0,0
201741,were,0,0
201742,as,0,0
201743,follows,0,0
201744,:,0,0
201745,one,0,0
201746,or,0,0
201747,two,0,0
201748,organs,0,0
201749,with,0,0
201750,metastases,0,0
201751,(,0,0
201752,TTF,0,0
201753,",",0,0
201754,P,0,0
201755,less,0,0
201756,than,0,0
201757,0.0001,0,0
201758,;,0,0
201759,survival,0,0
201760,",",0,0
201761,P,0,0
201762,less,0,0
201763,than,0,0
201764,0.0001,0,0
201765,),0,0
201766,;,0,0
201767,dominant,0,0
201768,site,0,0
201769,other,0,0
201770,than,0,0
201771,soft,0,0
201772,tissue,0,0
201773,(,0,0
201774,TTF,0,0
201775,",",0,0
201776,P,0,0
201777,less,0,0
201778,than,0,0
201779,0.0001,0,0
201780,;,0,0
201781,survival,0,0
201782,",",0,0
201783,P,0,0
201784,=,0,0
201785,0.05,0,0
201786,),0,0
201787,;,0,0
201788,and,0,0
201789,an,0,0
201790,initial,0,0
201791,good,0,0
201792,performance,0,0
201793,status,0,1
201794,(,0,0
201795,TTF,0,0
201796,",",0,0
201797,P,0,0
201798,=,0,0
201799,0.007,0,0
201800,;,0,0
201801,survival,0,0
201802,",",0,0
201803,P,0,0
201804,=,0,0
201805,0.02,0,0
201806,),0,0
201807,.,0,0
201808,Patients,0,0
201809,with,0,0
201810,ER-positive,0,0
201811,disease,0,0
201812,had,0,0
201813,a,0,0
201814,significantly,0,0
201815,longer,0,0
201816,median,0,0
201817,survival,0,0
201818,time,0,0
201819,(,0,0
201820,P,0,0
201821,=,0,0
201822,0.003,0,0
201823,),0,0
201824,.,0,0
201825,Hodgkin,0,1
201826,'s,0,0
201827,disease,0,0
201828,in,0,0
201829,childhood,0,0
201830,and,0,0
201831,adolescence,0,0
201832,:,0,0
201833,results,0,0
201834,of,0,0
201835,chemotherapy-radiotherapy,0,0
201836,in,0,0
201837,clinical,0,0
201838,stages,0,0
201839,IA-IIB,0,0
201840,.,0,0
201841,From,0,1
201842,April,0,1
201843,1972,0,1
201844,to,0,0
201845,May,0,0
201846,1980,0,0
201847,",",0,0
201848,72,0,0
201849,children,0,0
201850,and,0,0
201851,adolescents,0,1
201852,(,0,0
201853,aged,0,0
201854,5,0,0
201855,to,0,0
201856,19,0,0
201857,years,0,0
201858,old,0,0
201859,",",0,0
201860,median,0,0
201861,16,0,0
201862,),0,0
201863,with,0,0
201864,Hodgkin,0,0
201865,'s,0,0
201866,disease,0,0
201867,",",0,0
201868,clinical,0,0
201869,stages,0,0
201870,IA-IIB,0,1
201871,(,0,0
201872,IA,0,1
201873,",",0,1
201874,18,0,0
201875,;,0,0
201876,II2A,0,1
201877,",",0,0
201878,two,0,0
201879,areas,0,0
201880,involved,0,0
201881,on,0,0
201882,the,0,0
201883,same,0,0
201884,side,0,0
201885,of,0,0
201886,the,0,0
201887,diaphragm,0,0
201888,",",0,0
201889,23,0,0
201890,;,0,0
201891,II3+A,0,0
201892,",",0,0
201893,three,0,0
201894,areas,0,0
201895,or,0,0
201896,more,0,0
201897,",",0,0
201898,16,0,0
201899,;,0,0
201900,IIB,0,1
201901,",",0,1
201902,15,0,0
201903,),0,0
201904,were,0,0
201905,prospectively,0,0
201906,treated,0,0
201907,in,0,0
201908,two,0,0
201909,successive,0,0
201910,clinical,0,0
201911,trials,0,1
201912,(,0,0
201913,H,0,0
201914,72,0,0
201915,and,0,0
201916,H,0,0
201917,77,0,0
201918,),0,0
201919,.,0,0
201920,Clinical,0,0
201921,stages,0,0
201922,IA,0,0
201923,and,0,0
201924,II2A,0,0
201925,received,0,0
201926,three,0,0
201927,courses,0,0
201928,of,0,0
201929,mechlorethamine,1,1
201930,",",1,1
201931,Oncovin,1,1
201932,",",1,1
201933,procarbazine,1,1
201934,",",1,1
201935,and,1,1
201936,prednisone,1,1
201937,(,1,1
201938,MOPP,1,1
201939,),1,1
201940,and,1,0
201941,supradiaphragmatic,1,1
201942,radiotherapy,1,1
201943,(,1,0
201944,40,1,0
201945,Gy,1,1
201946,),1,0
201947,",",1,0
201948,and,1,0
201949,no,1,0
201950,laparotomy,1,0
201951,was,0,0
201952,performed,0,0
201953,.,0,0
201954,Clinical,0,0
201955,stages,0,0
201956,II3+A,0,0
201957,and,0,0
201958,IIB,0,0
201959,received,0,0
201960,either,0,0
201961,six,0,0
201962,cycles,0,0
201963,of,0,0
201964,MOPP,1,1
201965,(,0,0
201966,H,0,0
201967,72,0,0
201968,),0,0
201969,",",0,0
201970,three,0,0
201971,cycles,0,0
201972,of,0,0
201973,MOPP,0,0
201974,",",0,0
201975,or,0,0
201976,three,0,0
201977,cycles,0,0
201978,of,0,0
201979,CCNU,1,1
201980,",",1,0
201981,vinblastine,1,1
201982,",",1,1
201983,procarbazine,1,1
201984,",",0,1
201985,and,0,1
201986,prednisone,1,1
201987,(,0,1
201988,CVPP,0,1
201989,),0,1
201990,(,0,0
201991,H,0,0
201992,77,0,0
201993,),0,0
201994,and,0,0
201995,subsequently,0,0
201996,had,0,0
201997,a,0,0
201998,laparotomy,1,0
201999,followed,0,0
202000,by,0,0
202001,supradiaphragmatic,1,0
202002,radiotherapy,1,0
202003,and,0,0
202004,a,0,0
202005,lumboaortic,0,0
202006,field,0,0
202007,if,0,0
202008,results,0,0
202009,of,0,0
202010,laparotomy,0,0
202011,were,0,0
202012,positive,0,0
202013,.,0,0
202014,Patients,0,0
202015,without,0,0
202016,evidence,0,0
202017,of,0,0
202018,mediastinal,0,0
202019,involvement,0,0
202020,did,0,0
202021,not,0,0
202022,have,0,0
202023,mediastinal,0,0
202024,radiotherapy,0,0
202025,.,0,0
202026,At,0,0
202027,the,0,0
202028,completion,0,0
202029,of,0,0
202030,therapy,0,0
202031,",",0,0
202032,the,0,0
202033,disease,0,0
202034,in,0,0
202035,70,0,0
202036,of,0,0
202037,72,0,0
202038,patients,0,0
202039,was,0,0
202040,in,0,0
202041,complete,0,0
202042,remission,0,0
202043,(,0,0
202044,one,0,0
202045,failure,0,0
202046,",",0,0
202047,one,0,0
202048,death,0,0
202049,during,0,0
202050,treatment,0,0
202051,),0,0
202052,.,0,0
202053,Eight,0,0
202054,patients,0,0
202055,relapsed,0,0
202056,(,0,0
202057,in,0,0
202058,situ,0,0
202059,",",0,0
202060,1,0,0
202061,;,0,0
202062,marginal,0,0
202063,",",0,0
202064,1,0,0
202065,;,0,0
202066,nonirradiated,0,0
202067,subdiaphragmatic,0,0
202068,area,0,0
202069,",",0,0
202070,6,0,0
202071,),0,0
202072,after,0,0
202073,three,0,0
202074,to,0,0
202075,57,0,0
202076,months,0,0
202077,of,0,0
202078,complete,0,0
202079,remission,0,0
202080,(,0,0
202081,median,0,0
202082,20,0,0
202083,months,0,0
202084,),0,0
202085,;,0,0
202086,one,0,0
202087,patient,0,0
202088,died,0,0
202089,after,0,0
202090,relapse,0,0
202091,.,0,0
202092,There,0,0
202093,were,0,0
202094,three,0,0
202095,deaths,0,0
202096,after,0,0
202097,complete,0,0
202098,remission,0,0
202099,of,0,0
202100,the,0,0
202101,disease,0,1
202102,(,0,0
202103,infection,0,0
202104,",",0,0
202105,two,0,0
202106,;,0,0
202107,acute,0,0
202108,nonlymphocytic,0,1
202109,leukemia,0,1
202110,[,0,1
202111,ANLL,0,1
202112,],0,1
202113,",",0,0
202114,one,0,0
202115,),0,0
202116,.,0,0
202117,As,0,0
202118,of,0,0
202119,June,0,0
202120,1984,0,0
202121,the,0,0
202122,median,0,0
202123,follow-up,0,0
202124,was,0,0
202125,82,0,0
202126,months,0,0
202127,(,0,0
202128,range,0,0
202129,",",0,0
202130,49,0,0
202131,to,0,0
202132,145,0,0
202133,months,0,0
202134,),0,0
202135,",",0,0
202136,the,0,0
202137,actuarial,0,0
202138,probabilities,0,0
202139,for,0,0
202140,survival,0,0
202141,and,0,0
202142,freedom,0,0
202143,from,0,0
202144,relapse,0,0
202145,for,0,0
202146,all,0,0
202147,patients,0,0
202148,being,0,0
202149,91.6,0,0
202150,%,0,0
202151,and,0,0
202152,87.6,0,0
202153,%,0,0
202154,",",0,0
202155,respectively,0,0
202156,.,0,0
202157,There,0,0
202158,was,0,0
202159,no,0,0
202160,statistical,0,0
202161,difference,0,0
202162,according,0,0
202163,to,0,0
202164,clinical,0,0
202165,stage,0,0
202166,",",0,0
202167,age,0,0
202168,(,0,0
202169,greater,0,0
202170,than,0,0
202171,15,0,0
202172,or,0,0
202173,less,0,0
202174,than,0,0
202175,15,0,0
202176,years,0,1
202177,),0,0
202178,",",0,0
202179,sex,0,0
202180,",",0,0
202181,or,0,0
202182,number,0,0
202183,of,0,0
202184,cycles,0,0
202185,of,0,0
202186,chemotherapy,0,0
202187,(,0,0
202188,six,0,0
202189,or,0,0
202190,three,0,0
202191,),0,1
202192,.,0,1
202193,Bone,0,1
202194,growth,0,0
202195,defects,0,0
202196,related,0,0
202197,to,0,0
202198,radiotherapy,0,0
202199,were,0,0
202200,reduced,0,0
202201,particularly,0,0
202202,in,0,0
202203,the,0,0
202204,29,0,0
202205,patients,0,0
202206,who,0,0
202207,did,0,0
202208,not,0,0
202209,receive,0,0
202210,mediastinal,0,0
202211,radiotherapy,0,1
202212,.,0,0
202213,None,0,1
202214,of,0,0
202215,these,0,0
202216,patients,0,0
202217,had,0,0
202218,a,0,0
202219,mediastinal,0,0
202220,relapse,0,0
202221,.,0,0
202222,Azoospermia,0,0
202223,was,0,0
202224,the,0,0
202225,rule,0,0
202226,for,0,0
202227,the,0,0
202228,male,0,0
202229,patients,0,0
202230,studied,0,0
202231,",",0,0
202232,but,0,0
202233,young,0,0
202234,girls,0,0
202235,and,0,0
202236,young,0,0
202237,women,0,0
202238,retained,0,0
202239,reproductive,0,0
202240,integrity,0,0
202241,.,0,0
202242,Nutrient,0,0
202243,retention,0,0
202244,in,0,0
202245,preterm,0,0
202246,infants,0,1
202247,fed,0,0
202248,standard,0,0
202249,infant,0,1
202250,formulas,0,0
202251,.,0,0
202252,Our,0,0
202253,purpose,0,0
202254,was,0,0
202255,to,0,0
202256,compare,0,0
202257,nitrogen,0,0
202258,",",0,0
202259,mineral,0,0
202260,",",0,0
202261,and,0,0
202262,zinc,0,1
202263,balance,0,0
202264,in,0,0
202265,preterm,0,0
202266,infants,0,1
202267,fed,0,0
202268,standard,1,0
202269,infant,1,1
202270,formulas,1,1
202271,",",1,1
202272,Similac,1,1
202273,With,1,0
202274,Iron,1,0
202275,and,1,0
202276,Similac,1,1
202277,With,1,1
202278,Whey,1,1
202279,+,1,0
202280,Iron,1,0
202281,.,1,0
202282,Nitrogen,0,1
202283,and,0,1
202284,magnesium,0,1
202285,balances,0,0
202286,were,0,0
202287,similar,0,0
202288,during,0,0
202289,both,0,0
202290,feeds,0,1
202291,",",0,1
202292,and,0,0
202293,met,0,0
202294,estimated,0,0
202295,fetal,0,0
202296,requirements,0,0
202297,.,0,0
202298,Infants,0,0
202299,absorbed,0,1
202300,and,0,0
202301,retained,0,1
202302,(,0,1
202303,milligrams,0,1
202304,per,0,1
202305,kilogram,0,1
202306,per,0,1
202307,day,0,1
202308,),0,1
202309,more,0,1
202310,calcium,0,1
202311,",",0,1
202312,phosphorus,0,1
202313,",",0,1
202314,and,0,0
202315,zinc,0,1
202316,when,0,1
202317,fed,0,1
202318,Similac,1,1
202319,With,1,1
202320,Iron,1,0
202321,.,1,0
202322,However,0,0
202323,",",0,0
202324,retention,0,0
202325,of,0,0
202326,calcium,0,1
202327,",",0,1
202328,phosphorus,0,1
202329,(,0,1
202330,both,0,1
202331,formulas,0,1
202332,),0,0
202333,",",0,0
202334,and,0,1
202335,zinc,0,1
202336,(,0,1
202337,Similac,0,1
202338,With,0,1
202339,Whey,0,1
202340,+,0,1
202341,Iron,0,0
202342,),0,0
202343,was,0,0
202344,inadequate,0,0
202345,to,0,0
202346,meet,0,0
202347,estimated,0,0
202348,fetal,0,0
202349,requirements,0,0
202350,.,0,0
202351,These,0,0
202352,findings,0,0
202353,are,0,0
202354,important,0,0
202355,in,0,0
202356,the,0,0
202357,rapidly,0,0
202358,growing,0,0
202359,preterm,0,0
202360,infant,0,0
202361,",",0,0
202362,who,0,0
202363,is,0,0
202364,already,0,0
202365,at,0,0
202366,risk,0,0
202367,for,0,0
202368,the,0,0
202369,development,0,0
202370,of,0,0
202371,rickets,0,0
202372,and,0,0
202373,zinc,0,1
202374,deficiency,0,0
202375,and,0,0
202376,may,0,0
202377,be,0,0
202378,fed,0,0
202379,either,0,0
202380,formula,0,1
202381,on,0,0
202382,discharge,0,0
202383,from,0,0
202384,the,0,0
202385,newborn,0,0
202386,nursery,0,0
202387,.,0,0
202388,An,0,1
202389,analysis,0,0
202390,of,0,0
202391,the,0,0
202392,mortality,0,0
202393,effect,0,0
202394,in,0,0
202395,a,0,0
202396,breast,1,0
202397,cancer,1,0
202398,screening,1,0
202399,study,0,0
202400,.,0,0
202401,In,0,0
202402,order,0,0
202403,to,0,0
202404,better,0,0
202405,understand,0,0
202406,the,0,0
202407,effect,0,0
202408,of,0,0
202409,breast,0,0
202410,cancer,0,0
202411,screening,0,0
202412,on,0,0
202413,mortality,0,0
202414,",",0,0
202415,we,0,0
202416,use,0,0
202417,the,0,0
202418,theory,0,0
202419,of,0,0
202420,competing,0,0
202421,risks,0,0
202422,to,0,0
202423,analyse,0,0
202424,deaths,0,0
202425,from,0,0
202426,the,0,0
202427,long-term,0,0
202428,follow-up,0,0
202429,of,0,0
202430,the,0,0
202431,HIP,1,0
202432,breast,1,0
202433,cancer,1,0
202434,screening,1,0
202435,trial,1,0
202436,.,1,0
202437,We,0,0
202438,conclude,0,0
202439,that,0,0
202440,some,0,0
202441,",",0,0
202442,but,0,0
202443,not,0,0
202444,all,0,0
202445,",",0,0
202446,of,0,0
202447,the,0,0
202448,breast,0,0
202449,cancer,0,0
202450,cases,0,0
202451,detected,0,0
202452,early,0,0
202453,as,0,0
202454,a,0,0
202455,result,0,0
202456,of,0,0
202457,screening,1,0
202458,realized,0,0
202459,a,0,0
202460,benefit,0,0
202461,in,0,0
202462,terms,0,0
202463,of,0,0
202464,elimination,0,0
202465,of,0,0
202466,the,0,0
202467,risk,0,0
202468,of,0,0
202469,breast,0,0
202470,cancer,0,0
202471,mortality,0,0
202472,.,0,0
202473,Breast,1,0
202474,cancer,1,0
202475,screening,1,0
202476,appears,0,0
202477,not,0,0
202478,to,0,0
202479,affect,0,0
202480,the,0,0
202481,rate,0,0
202482,of,0,0
202483,mortality,0,0
202484,from,0,0
202485,causes,0,0
202486,of,0,0
202487,death,0,0
202488,other,0,0
202489,than,0,0
202490,breast,0,0
202491,cancer,0,0
202492,.,0,0
202493,Methodologically,0,0
202494,",",0,0
202495,we,0,0
202496,demonstrate,0,0
202497,the,0,0
202498,importance,0,0
202499,of,0,0
202500,analysing,0,0
202501,mortality,0,0
202502,separately,0,0
202503,for,0,0
202504,the,0,0
202505,breast,0,0
202506,cancer,0,0
202507,cases,0,0
202508,as,0,0
202509,well,0,0
202510,as,0,0
202511,for,0,0
202512,the,0,0
202513,entire,0,0
202514,population,0,0
202515,in,0,0
202516,a,0,0
202517,trial,0,0
202518,.,0,0
202519,Therapist,0,0
202520,success,0,0
202521,and,0,0
202522,its,0,0
202523,determinants,0,0
202524,.,0,0
202525,This,0,0
202526,study,0,0
202527,examined,0,0
202528,the,0,0
202529,relatively,0,0
202530,unexplored,0,0
202531,contribution,0,0
202532,of,0,0
202533,the,0,0
202534,therapist,0,0
202535,'s,0,0
202536,performance,0,0
202537,in,0,0
202538,determining,0,0
202539,outcomes,0,0
202540,of,0,0
202541,treatment,0,0
202542,.,0,1
202543,Nine,0,1
202544,therapists,0,0
202545,were,0,0
202546,studied,1,0
202547,:,1,0
202548,three,1,0
202549,performed,1,0
202550,supportive-expressive,1,0
202551,psychotherapy,1,1
202552,;,1,0
202553,three,1,0
202554,",",1,0
202555,cognitive-behavioral,1,1
202556,psychotherapy,1,1
202557,;,1,0
202558,and,1,0
202559,three,1,0
202560,",",1,0
202561,drug,1,1
202562,counseling,1,1
202563,.,1,0
202564,Profound,0,0
202565,differences,0,0
202566,were,0,0
202567,discovered,0,0
202568,in,0,0
202569,the,0,0
202570,therapists,0,0
202571,',0,0
202572,success,0,0
202573,with,0,0
202574,the,0,0
202575,patients,0,0
202576,in,0,0
202577,their,0,0
202578,case,0,0
202579,loads,0,0
202580,.,0,0
202581,Four,0,0
202582,potential,0,0
202583,determinants,0,0
202584,of,0,0
202585,these,0,0
202586,differences,0,0
202587,were,0,0
202588,explored,0,0
202589,:,0,0
202590,patient,0,0
202591,factors,0,0
202592,;,0,0
202593,therapist,0,0
202594,factors,0,0
202595,;,0,0
202596,patient-therapist,0,0
202597,relationship,0,0
202598,factors,0,0
202599,;,0,0
202600,and,0,0
202601,therapy,0,0
202602,factors,0,0
202603,.,0,0
202604,Results,0,0
202605,showed,0,0
202606,that,0,0
202607,patient,0,0
202608,characteristics,0,0
202609,within,0,0
202610,each,0,0
202611,case,0,0
202612,load,0,0
202613,(,0,0
202614,after,0,0
202615,random,0,0
202616,assignments,0,0
202617,),0,0
202618,were,0,0
202619,similar,0,0
202620,and,0,0
202621,disclosed,0,0
202622,no,0,0
202623,differences,0,0
202624,that,0,0
202625,would,0,0
202626,have,0,0
202627,explained,0,0
202628,the,0,0
202629,differences,0,0
202630,in,0,0
202631,success,0,1
202632,;,0,0
202633,therapist,0,1
202634,'s,0,1
202635,personal,0,0
202636,qualities,0,0
202637,were,0,0
202638,correlated,0,0
202639,with,0,0
202640,outcomes,0,0
202641,but,0,0
202642,not,0,0
202643,significantly,0,0
202644,(,0,0
202645,mean,0,0
202646,r,0,0
202647,=,0,0
202648,.32,0,0
202649,),0,0
202650,;,0,0
202651,an,0,0
202652,early-in-treatment,0,0
202653,measure,0,0
202654,of,0,0
202655,the,0,0
202656,patient-therapist,0,0
202657,relationship,0,0
202658,",",0,0
202659,the,0,0
202660,Helping,0,0
202661,Alliance,0,0
202662,Questionnaire,0,0
202663,",",0,0
202664,yielded,0,0
202665,significant,0,0
202666,correlations,0,0
202667,with,0,0
202668,outcomes,0,0
202669,(,0,0
202670,mean,0,0
202671,r,0,0
202672,=,0,0
202673,.65,0,0
202674,),0,0
202675,;,0,0
202676,among,0,0
202677,the,0,0
202678,therapy,0,0
202679,techniques,0,0
202680,",",0,0
202681,purity,0,0
202682,provided,0,0
202683,significant,0,0
202684,correlations,0,0
202685,with,0,0
202686,outcomes,0,0
202687,(,0,0
202688,mean,0,0
202689,r,0,0
202690,=,0,0
202691,.44,0,0
202692,),0,0
202693,",",0,0
202694,both,0,0
202695,across,0,0
202696,therapists,0,0
202697,and,0,0
202698,within,0,0
202699,each,0,0
202700,therapist,0,0
202701,'s,0,0
202702,case,0,0
202703,load,0,0
202704,.,0,0
202705,The,0,0
202706,three,0,0
202707,therapist-related,0,0
202708,factors,0,0
202709,were,0,0
202710,moderately,0,0
202711,associated,0,0
202712,with,0,0
202713,each,0,0
202714,other,0,0
202715,.,0,0
202716,A,0,0
202717,study,0,0
202718,of,0,0
202719,a,0,0
202720,Self-Care,1,0
202721,Rehabilitation,1,0
202722,Program,1,0
202723,in,0,0
202724,pediatric,0,0
202725,asthma,0,0
202726,.,0,0
202727,The,0,0
202728,Self-Care,1,0
202729,Rehabilitation,1,0
202730,in,0,0
202731,Pediatric,0,1
202732,Asthma,0,1
202733,(,0,1
202734,SCRPA,0,1
202735,),0,1
202736,project,0,0
202737,was,0,0
202738,designed,0,0
202739,to,0,0
202740,ascertain,0,0
202741,the,0,0
202742,level,0,0
202743,to,0,0
202744,which,0,0
202745,children,0,0
202746,with,0,0
202747,asthma,0,0
202748,are,0,0
202749,able,0,0
202750,to,0,0
202751,acquire,0,0
202752,the,0,0
202753,asthma,0,0
202754,knowledge,0,0
202755,and,0,0
202756,skills,0,0
202757,presented,0,0
202758,in,0,0
202759,a,0,0
202760,self-management,0,0
202761,training,0,0
202762,program,0,0
202763,conducted,0,0
202764,by,0,0
202765,the,0,0
202766,American,0,0
202767,Lung,0,0
202768,Association,0,0
202769,of,0,0
202770,Utah,0,0
202771,and,0,0
202772,the,0,0
202773,effect,0,0
202774,of,0,0
202775,such,0,0
202776,training,0,0
202777,on,0,0
202778,the,0,0
202779,asthma,0,0
202780,experience,0,0
202781,.,0,0
202782,The,0,0
202783,preschool,0,0
202784,SCRPA,0,1
202785,Curriculum,0,1
202786,(,0,1
202787,ages,0,1
202788,2-5,0,0
202789,),0,0
202790,consisted,0,0
202791,of,0,0
202792,six,1,0
202793,1-hour,1,1
202794,classes,1,1
202795,scheduled,1,1
202796,twice,1,0
202797,a,1,0
202798,week,1,0
202799,for,1,0
202800,3,1,0
202801,weeks,1,0
202802,.,1,0
202803,The,0,0
202804,first,0,0
202805,and,0,0
202806,last,0,0
202807,classes,0,0
202808,were,0,0
202809,for,0,0
202810,one,0,0
202811,or,0,0
202812,both,0,0
202813,parents,0,0
202814,only,0,0
202815,",",0,0
202816,and,0,0
202817,the,0,0
202818,middle,0,0
202819,four,0,0
202820,sessions,0,0
202821,were,0,0
202822,for,0,0
202823,the,0,0
202824,child,0,0
202825,and,0,0
202826,parent,0,0
202827,(,0,1
202828,s,0,0
202829,),0,0
202830,.,0,0
202831,The,0,0
202832,school-age,0,0
202833,SCRPA,0,1
202834,curriculum,0,1
202835,(,0,0
202836,ages,0,0
202837,6-14,0,0
202838,),0,0
202839,consisted,0,0
202840,of,0,0
202841,eight,1,0
202842,90-minute,1,0
202843,classes,1,0
202844,for,1,0
202845,both,1,0
202846,child,1,0
202847,and,1,0
202848,parent,1,0
202849,(,1,1
202850,s,1,1
202851,),1,1
202852,scheduled,1,1
202853,twice,0,0
202854,a,0,0
202855,week,0,0
202856,for,0,0
202857,4,0,0
202858,weeks,0,0
202859,.,0,0
202860,Private,0,0
202861,physicians,0,0
202862,referred,0,0
202863,21,0,0
202864,preschool,0,0
202865,children,0,0
202866,and,0,0
202867,38,0,0
202868,school-age,0,0
202869,children,0,0
202870,into,0,0
202871,the,0,0
202872,program,0,0
202873,.,0,0
202874,The,0,0
202875,school-age,0,0
202876,children,0,0
202877,were,0,0
202878,randomly,0,0
202879,assigned,0,0
202880,to,0,0
202881,a,0,0
202882,study,0,0
202883,or,0,0
202884,control,0,0
202885,group,0,0
202886,",",0,0
202887,and,0,0
202888,the,0,0
202889,preschool,0,0
202890,children,0,0
202891,served,0,0
202892,as,0,0
202893,their,0,0
202894,own,0,0
202895,controls,0,0
202896,.,0,0
202897,A,0,0
202898,comparison,0,0
202899,of,0,0
202900,asthma,0,0
202901,episodes,0,0
202902,during,0,0
202903,the,0,0
202904,3,0,0
202905,months,0,0
202906,before,0,0
202907,and,0,0
202908,after,0,0
202909,training,0,0
202910,showed,0,0
202911,a,0,0
202912,statistically,0,0
202913,significant,0,0
202914,decrease,0,0
202915,in,0,0
202916,the,0,0
202917,number,0,0
202918,of,0,0
202919,episodes,0,0
202920,but,0,0
202921,no,0,0
202922,change,0,0
202923,in,0,0
202924,severity,0,0
202925,in,0,0
202926,the,0,0
202927,preschool,0,0
202928,",",0,0
202929,school,0,0
202930,study,0,0
202931,",",0,0
202932,and,0,0
202933,school,0,0
202934,control,0,0
202935,groups,0,0
202936,.,0,0
202937,The,0,0
202938,decrease,0,0
202939,in,0,0
202940,episodes,0,0
202941,for,0,0
202942,the,0,0
202943,control,0,0
202944,groups,0,0
202945,suggest,0,0
202946,that,0,0
202947,the,0,0
202948,family,0,0
202949,record,0,0
202950,keeping,0,0
202951,required,0,0
202952,of,0,0
202953,all,0,0
202954,subjects,0,0
202955,may,0,0
202956,have,0,0
202957,a,0,0
202958,beneficial,0,0
202959,effect,0,0
202960,",",0,0
202961,a,0,0
202962,phenomenon,0,0
202963,worth,0,0
202964,further,0,0
202965,investigation,0,0
202966,.,0,0
202967,Also,0,0
202968,",",0,0
202969,the,0,0
202970,school-age,0,0
202971,group,0,0
202972,",",0,0
202973,in,0,0
202974,pre-,0,0
202975,and,0,0
202976,posttesting,0,0
202977,",",0,0
202978,demonstrated,0,0
202979,that,0,0
202980,the,0,0
202981,SCRPA,1,0
202982,curriculum,0,0
202983,increased,0,0
202984,knowledge,0,0
202985,and,0,0
202986,skills,0,0
202987,in,0,0
202988,the,0,0
202989,study,0,0
202990,group,0,0
202991,",",0,0
202992,changes,0,0
202993,not,0,0
202994,found,0,0
202995,in,0,0
202996,the,0,0
202997,control,0,0
202998,group,0,0
202999,.,0,0
203000,Beta-cytotrophic,0,0
203001,effects,0,0
203002,of,0,0
203003,glucose,1,1
203004,",",1,1
203005,glucagon,1,1
203006,",",0,1
203007,and,0,1
203008,tolbutamide,1,1
203009,in,0,0
203010,man,0,0
203011,.,0,0
203012,[,1,1
203013,Prognostic,1,1
203014,experiences,1,0
203015,in,0,0
203016,the,0,0
203017,long-term,1,0
203018,differential,1,0
203019,therapy,1,0
203020,of,0,0
203021,chronic,0,0
203022,aggressive,0,1
203023,hepatitides,0,1
203024,],0,0
203025,.,0,0
203026,Letter,0,0
203027,:,0,0
203028,Cephaloridine,1,1
203029,and,1,1
203030,gentamicin,1,1
203031,in,0,0
203032,prophylaxis,0,0
203033,of,0,0
203034,surgical,0,0
203035,wound,0,0
203036,infection,0,0
203037,.,0,0
203038,[,0,1
203039,Psychoexperimental,0,0
203040,studies,0,0
203041,on,0,0
203042,the,0,0
203043,effect,0,0
203044,of,0,0
203045,a,0,0
203046,valepotriate,1,1
203047,combination,1,0
203048,as,0,0
203049,well,0,0
203050,as,0,0
203051,the,0,0
203052,combined,0,0
203053,effects,0,0
203054,of,0,0
203055,valtratum,1,1
203056,and,1,1
203057,alcohol,1,1
203058,],1,1
203059,.,0,0
203060,Joint,0,0
203061,study,0,0
203062,of,0,0
203063,extracranial,0,0
203064,arterial,0,0
203065,occlusion,0,0
203066,.,0,0
203067,VI,0,0
203068,.,0,0
203069,Racial,0,0
203070,differences,0,0
203071,in,0,0
203072,hospitalized,0,0
203073,patients,0,0
203074,with,0,0
203075,ischemic,0,0
203076,stroke,0,0
203077,.,0,0
203078,[,0,1
203079,Folic,0,1
203080,acid,0,1
203081,deficiency,0,0
203082,in,0,0
203083,pregnant,0,0
203084,women,0,0
203085,in,0,0
203086,Switzerland,0,0
203087,],0,0
203088,.,0,0
203089,A,0,0
203090,controlled,0,0
203091,study,0,0
203092,of,0,0
203093,early,1,0
203094,discharge,1,0
203095,after,0,0
203096,uncomplicated,0,0
203097,myocardial,0,0
203098,infarction,0,0
203099,.,0,0
203100,Out,0,0
203101,of,0,0
203102,383,0,0
203103,myocardial,0,0
203104,infarction,0,0
203105,(,0,1
203106,MI,0,1
203107,),0,0
203108,patients,0,0
203109,aged,0,0
203110,below,0,0
203111,70,0,0
203112,years,0,0
203113,",",0,0
203114,252,0,0
203115,(,0,0
203116,66,0,0
203117,%,0,0
203118,),0,0
203119,were,0,0
203120,judged,0,0
203121,after,0,0
203122,the,0,0
203123,third,0,0
203124,day,0,0
203125,in,0,0
203126,hospital,0,0
203127,to,0,0
203128,have,0,0
203129,had,0,0
203130,uncomplicated,0,0
203131,infarctions,0,0
203132,.,0,0
203133,These,0,0
203134,patients,0,0
203135,were,0,0
203136,allocated,0,0
203137,at,0,0
203138,random,0,0
203139,to,0,0
203140,two,0,0
203141,groups,0,0
203142,",",0,0
203143,one,1,0
203144,of,1,0
203145,which,1,0
203146,was,1,0
203147,given,1,0
203148,treatment,1,0
203149,for,1,0
203150,8,1,0
203151,days,1,0
203152,and,1,0
203153,the,1,0
203154,other,1,0
203155,for,1,0
203156,15,1,0
203157,days,1,0
203158,.,1,1
203159,No,0,1
203160,significant,0,0
203161,differences,0,0
203162,in,0,0
203163,mortality,0,0
203164,",",0,0
203165,morbidity,0,0
203166,or,0,0
203167,incapacity,0,0
203168,for,0,0
203169,work,0,0
203170,could,0,0
203171,be,0,0
203172,detected,0,0
203173,during,0,0
203174,the,0,0
203175,three-month,0,0
203176,period,0,0
203177,of,0,0
203178,follow-up,0,0
203179,.,0,0
203180,The,0,0
203181,findings,0,0
203182,thus,0,0
203183,support,0,0
203184,previous,0,0
203185,conclusions,0,0
203186,that,0,0
203187,early,1,0
203188,discharge,1,0
203189,from,0,0
203190,hospital,0,0
203191,after,0,0
203192,uncomplicated,0,0
203193,MI,0,0
203194,is,0,0
203195,not,0,0
203196,associated,0,0
203197,with,0,0
203198,greater,0,0
203199,risk,0,0
203200,for,0,0
203201,the,0,0
203202,patient,0,0
203203,than,0,0
203204,later,0,0
203205,discharge,0,0
203206,.,0,0
203207,New,1,0
203208,methods,1,0
203209,applied,0,0
203210,to,0,0
203211,the,0,0
203212,analysis,0,0
203213,and,0,0
203214,treatment,0,0
203215,of,0,0
203216,ovarian,0,0
203217,cancer,0,0
203218,.,0,0
203219,Incidence,0,0
203220,of,0,0
203221,candida,0,0
203222,in,0,0
203223,hospital,0,1
203224,in-patients,0,0
203225,and,0,0
203226,the,0,0
203227,effects,0,0
203228,of,0,0
203229,antibiotic,1,1
203230,therapy,1,1
203231,.,1,0
203232,The,0,0
203233,need,0,0
203234,for,0,0
203235,chemotherapy,1,0
203236,after,0,0
203237,prolonged,0,0
203238,complete,0,0
203239,remission,0,0
203240,in,0,0
203241,acute,0,0
203242,leukemia,0,0
203243,of,0,0
203244,childhood,0,0
203245,.,0,0
203246,Generalizability,0,0
203247,and,0,0
203248,durability,0,0
203249,of,0,0
203250,treatment,0,0
203251,effects,0,0
203252,in,0,0
203253,an,0,0
203254,intervention,1,0
203255,program,1,0
203256,for,0,0
203257,coronary-prone,0,1
203258,(,0,0
203259,Type,0,1
203260,A,0,1
203261,),0,1
203262,managers,0,0
203263,.,0,0
203264,To,0,0
203265,test,0,0
203266,the,0,0
203267,reliability,0,0
203268,and,0,0
203269,durability,0,0
203270,of,0,0
203271,positive,0,0
203272,treatment,0,0
203273,effects,0,0
203274,obtained,0,0
203275,in,0,0
203276,a,0,0
203277,type,1,0
203278,A,1,0
203279,intervention,1,0
203280,project,1,0
203281,for,0,0
203282,healthy,0,0
203283,managers,0,0
203284,",",0,0
203285,the,0,0
203286,analysis,0,0
203287,was,0,0
203288,extended,0,0
203289,to,0,0
203290,data,0,0
203291,available,0,0
203292,from,0,0
203293,a,0,0
203294,third,0,0
203295,treatment,0,0
203296,group,0,0
203297,(,1,0
203298,a,1,0
203299,special,1,0
203300,behavior,1,0
203301,therapy,1,0
203302,group,1,0
203303,for,0,0
203304,participants,0,0
203305,eliminated,0,0
203306,from,0,0
203307,the,0,0
203308,main,0,0
203309,sample,0,0
203310,because,0,0
203311,of,0,0
203312,manifestations,0,0
203313,of,0,0
203314,clinical,0,1
203315,CHD,0,1
203316,),0,0
203317,and,0,0
203318,to,0,0
203319,measures,0,0
203320,obtained,0,0
203321,6,0,0
203322,months,0,0
203323,following,0,0
203324,the,0,0
203325,end,0,0
203326,of,0,0
203327,treatment,0,0
203328,.,0,0
203329,Immediately,0,0
203330,after,0,0
203331,treatment,0,0
203332,all,0,0
203333,three,0,0
203334,groups,0,0
203335,showed,0,0
203336,a,0,0
203337,similar,0,0
203338,pattern,0,0
203339,of,0,0
203340,improvement,0,0
203341,",",0,0
203342,although,0,0
203343,the,0,0
203344,two,0,0
203345,behavior,1,0
203346,therapy,1,0
203347,groups,0,0
203348,did,0,0
203349,show,0,0
203350,a,0,0
203351,greater,0,0
203352,decrease,0,0
203353,in,0,0
203354,serum,0,1
203355,cholesterol,0,1
203356,levels,0,1
203357,.,0,1
203358,Six,0,0
203359,months,0,0
203360,after,0,0
203361,treatment,0,0
203362,the,0,0
203363,sample,0,0
203364,as,0,0
203365,a,0,0
203366,whole,0,0
203367,showed,0,0
203368,good,0,0
203369,maintenance,0,0
203370,of,0,0
203371,treatment,0,0
203372,effects,0,0
203373,",",0,0
203374,but,0,0
203375,the,0,0
203376,differences,0,0
203377,between,0,0
203378,groups,0,0
203379,had,0,0
203380,become,0,0
203381,somewhat,0,0
203382,sharper,0,0
203383,",",0,0
203384,with,0,0
203385,the,0,0
203386,special,1,0
203387,behavior,1,0
203388,therapy,1,0
203389,group,0,0
203390,faring,0,0
203391,best,0,0
203392,",",0,0
203393,the,0,0
203394,regular,1,0
203395,behavior,1,0
203396,therapy,1,0
203397,group,0,0
203398,intermediate,0,0
203399,",",0,0
203400,and,0,0
203401,the,0,0
203402,psychotherapy,1,0
203403,group,0,0
203404,worst,0,0
203405,.,0,0
203406,The,0,0
203407,logical,0,0
203408,consistency,0,0
203409,of,0,0
203410,these,0,0
203411,findings,0,0
203412,increases,0,0
203413,our,0,0
203414,confidence,0,0
203415,in,0,0
203416,the,0,0
203417,initial,0,0
203418,treatment,0,0
203419,results,0,0
203420,",",0,0
203421,as,0,0
203422,well,0,0
203423,as,0,0
203424,permitting,0,0
203425,cautious,0,0
203426,optimism,0,0
203427,concerning,0,0
203428,the,0,0
203429,possibility,0,0
203430,of,0,0
203431,developing,0,0
203432,effective,0,0
203433,intervention,0,0
203434,programs,0,0
203435,for,0,0
203436,coronary-type,0,0
203437,(,0,0
203438,type,0,0
203439,A,0,1
203440,),0,0
203441,behavior,0,0
203442,.,0,0
203443,One-trial,1,0
203444,learning,1,0
203445,with,0,0
203446,control,0,0
203447,of,0,0
203448,item-difficulty,1,0
203449,.,1,0
203450,Double-blind,0,1
203451,comparison,0,0
203452,of,0,0
203453,ketazolam,1,1
203454,",",1,1
203455,diazepam,1,1
203456,and,1,1
203457,placebo,1,1
203458,in,0,0
203459,once-a-day,0,1
203460,vs,0,0
203461,t.i.d,0,1
203462,.,0,0
203463,dosing,0,1
203464,.,0,0
203465,Comparison,0,0
203466,of,0,0
203467,ketazolam,1,1
203468,given,0,1
203469,once-a-day,0,1
203470,with,0,1
203471,diazepam,1,1
203472,given,0,0
203473,three,0,0
203474,times,0,0
203475,a,0,0
203476,day,0,1
203477,and,1,1
203478,placebo,1,1
203479,given,0,1
203480,either,0,0
203481,once,0,0
203482,or,0,0
203483,3,0,0
203484,times,0,0
203485,a,0,0
203486,day,0,0
203487,in,0,0
203488,101,0,0
203489,anxious,0,0
203490,outpatients,0,0
203491,showed,0,0
203492,ketazolam,0,1
203493,to,0,0
203494,be,0,0
203495,significantly,0,0
203496,better,0,0
203497,than,0,0
203498,placebo,0,1
203499,in,0,0
203500,alleviating,0,0
203501,the,0,0
203502,symptoms,0,0
203503,of,0,0
203504,anxiety,0,0
203505,and,0,0
203506,",",0,0
203507,on,0,0
203508,several,0,0
203509,measures,0,0
203510,of,0,0
203511,efficacy,0,0
203512,",",0,0
203513,better,0,0
203514,than,0,0
203515,diazepam,0,1
203516,as,0,0
203517,well,0,0
203518,.,0,0
203519,Significantly,0,0
203520,fewer,0,0
203521,patients,0,0
203522,on,0,0
203523,ketazolam,1,1
203524,dropped,0,0
203525,out,0,0
203526,of,0,0
203527,the,0,0
203528,study,0,0
203529,due,0,0
203530,to,0,0
203531,ineffective,0,0
203532,medication,0,0
203533,than,0,0
203534,on,0,0
203535,the,0,0
203536,other,0,0
203537,3,0,0
203538,treatments,0,0
203539,.,0,0
203540,The,0,0
203541,incidence,0,0
203542,of,0,0
203543,side,0,0
203544,effects,0,0
203545,was,0,0
203546,lowest,0,0
203547,in,0,0
203548,the,0,0
203549,ketazolam,0,1
203550,group,0,1
203551,.,0,0
203552,Of,0,0
203553,particular,0,0
203554,note,0,0
203555,",",0,0
203556,drowsiness,0,0
203557,was,0,0
203558,reported,0,0
203559,twice,0,0
203560,as,0,0
203561,often,0,0
203562,by,0,0
203563,diazepam,1,1
203564,patients,0,0
203565,as,0,0
203566,by,0,0
203567,ketazolam,1,1
203568,patients,0,0
203569,.,0,0
203570,Acute,0,0
203571,intervention,0,0
203572,studies,0,0
203573,in,0,0
203574,patients,0,0
203575,with,0,0
203576,myocardial,0,0
203577,infarction,0,0
203578,using,0,0
203579,atenolol,1,1
203580,",",1,1
203581,propranolol,1,1
203582,",",1,1
203583,oxprenolol,1,1
203584,and,0,1
203585,disopyramide,1,1
203586,phosphate,1,1
203587,.,1,1
203588,The,0,0
203589,value,0,0
203590,of,0,0
203591,beta-blockade,1,1
203592,and,0,1
203593,of,0,1
203594,disopyramide,1,1
203595,phosphate,1,1
203596,in,0,0
203597,the,0,0
203598,immediate,0,0
203599,treatment,0,0
203600,of,0,0
203601,patients,0,0
203602,with,0,0
203603,suspected,0,0
203604,acute,0,0
203605,myocardial,0,0
203606,infarction,0,0
203607,was,0,0
203608,assessed,0,0
203609,in,0,0
203610,two,0,0
203611,placebo,0,1
203612,controlled,0,0
203613,trials,0,0
203614,.,0,0
203615,In,0,0
203616,the,0,0
203617,first,0,0
203618,study,0,0
203619,388,0,0
203620,patients,0,0
203621,with,0,0
203622,suspected,0,0
203623,acute,0,0
203624,myocardial,0,0
203625,infarction,0,0
203626,were,0,0
203627,randomly,0,0
203628,allocated,0,0
203629,to,0,0
203630,treatment,0,0
203631,with,0,0
203632,propranolol,1,1
203633,",",1,1
203634,atenolol,1,1
203635,",",1,1
203636,or,1,1
203637,placebo,1,1
203638,",",0,1
203639,and,0,0
203640,when,0,0
203641,analysed,0,0
203642,on,0,0
203643,an,0,0
203644,initial,0,0
203645,intention,0,0
203646,to,0,0
203647,treat,0,0
203648,basis,0,0
203649,there,0,0
203650,was,0,0
203651,no,0,0
203652,significant,0,0
203653,difference,0,0
203654,between,0,0
203655,the,0,0
203656,three,0,0
203657,groups,0,0
203658,in,0,0
203659,respect,0,0
203660,of,0,0
203661,the,0,0
203662,mortality,0,0
203663,at,0,0
203664,one,0,0
203665,year,0,0
203666,.,0,0
203667,In,0,0
203668,addition,0,0
203669,",",0,0
203670,there,0,0
203671,was,0,0
203672,no,0,0
203673,evidence,0,0
203674,to,0,0
203675,suggest,0,0
203676,that,0,0
203677,either,0,0
203678,atenolol,1,1
203679,",",0,1
203680,or,0,1
203681,propranolol,1,1
203682,reduced,0,0
203683,the,0,0
203684,incidence,0,0
203685,of,0,0
203686,'serious,0,0
203687,',0,0
203688,ventricular,0,0
203689,arrhythmias,0,0
203690,in,0,0
203691,the,0,0
203692,coronary,0,0
203693,care,0,0
203694,unit,0,0
203695,.,0,0
203696,In,0,0
203697,the,0,0
203698,second,0,0
203699,study,0,0
203700,473,0,0
203701,patients,0,0
203702,with,0,0
203703,suspected,0,0
203704,acute,0,0
203705,myocardial,0,0
203706,infarction,0,0
203707,were,0,0
203708,randomly,0,0
203709,allocated,0,0
203710,to,0,0
203711,treatment,0,0
203712,with,0,0
203713,oxprenolol,1,1
203714,",",1,1
203715,disopyramide,1,1
203716,phosphate,1,1
203717,",",1,1
203718,or,1,1
203719,placebo,1,1
203720,.,1,0
203721,Again,0,0
203722,no,0,0
203723,significant,0,0
203724,differences,0,0
203725,were,0,0
203726,seen,0,0
203727,with,0,0
203728,respect,0,0
203729,to,0,0
203730,the,0,0
203731,mortality,0,0
203732,at,0,0
203733,six,0,0
203734,weeks,0,0
203735,.,0,0
203736,There,0,0
203737,was,0,0
203738,",",0,0
203739,however,0,0
203740,",",0,0
203741,a,0,0
203742,significantly,0,0
203743,increased,0,0
203744,incidence,0,0
203745,of,0,0
203746,heart,0,0
203747,failure,0,0
203748,in,0,0
203749,the,0,0
203750,group,0,0
203751,which,0,0
203752,received,0,0
203753,disopyramide,1,1
203754,phosphate,1,1
203755,.,1,1
203756,Patients,0,0
203757,who,0,0
203758,received,0,0
203759,this,0,0
203760,drug,0,1
203761,also,0,0
203762,showed,0,0
203763,a,0,0
203764,reduced,0,0
203765,number,0,0
203766,of,0,0
203767,dysrhythmic,0,0
203768,episodes,0,1
203769,on,0,0
203770,24-hour,0,1
203771,ECG,0,1
203772,recordings,0,1
203773,",",0,0
203774,but,0,0
203775,this,0,0
203776,trend,0,0
203777,did,0,0
203778,not,0,0
203779,achieve,0,0
203780,statistical,0,0
203781,significance,0,0
203782,.,0,0
203783,These,0,0
203784,results,0,0
203785,suggest,0,0
203786,that,0,0
203787,none,0,0
203788,of,0,0
203789,the,0,0
203790,three,1,0
203791,beta-blockers,1,1
203792,tested,0,0
203793,nor,0,1
203794,disopyramide,1,1
203795,phosphate,1,1
203796,is,0,0
203797,likely,0,0
203798,to,0,0
203799,reduce,0,0
203800,the,0,0
203801,mortality,0,0
203802,from,0,0
203803,acute,0,0
203804,myocardial,0,0
203805,infarction,0,0
203806,when,0,0
203807,given,0,1
203808,prophylactically,0,1
203809,",",0,1
203810,although,0,1
203811,disopyramide,1,1
203812,phosphate,1,1
203813,does,0,0
203814,reduce,0,0
203815,the,0,0
203816,incidence,0,0
203817,of,0,0
203818,'serious,0,0
203819,',0,0
203820,ventriicular,0,0
203821,arrhythmias,0,0
203822,.,0,0
203823,An,0,1
203824,assessment,0,1
203825,of,0,1
203826,beta-adrenoceptor,0,1
203827,blockade,0,1
203828,in,0,0
203829,man,0,0
203830,by,0,0
203831,prizidilol,1,1
203832,hydrochloride,1,1
203833,.,1,1
203834,1,0,1
203835,Prizidilol,1,1
203836,hydrochloride,1,1
203837,(,0,1
203838,SK,0,1
203839,&,0,1
203840,F,0,0
203841,92657,0,0
203842,),0,0
203843,is,0,0
203844,a,0,0
203845,new,0,0
203846,compound,0,0
203847,which,0,0
203848,causes,0,0
203849,both,0,0
203850,arteriolar,0,0
203851,dilatation,0,1
203852,and,0,1
203853,beta-adrenoceptor,0,1
203854,blockade,0,1
203855,.,0,1
203856,The,0,0
203857,effect,0,0
203858,of,0,0
203859,a,0,0
203860,single,0,0
203861,oral,0,1
203862,dose,0,1
203863,on,0,0
203864,the,0,0
203865,responses,0,0
203866,of,0,0
203867,heart,0,0
203868,rate,0,0
203869,and,0,0
203870,blood,0,0
203871,pressure,0,1
203872,to,0,1
203873,isoprenaline,0,1
203874,infusion,0,1
203875,has,0,0
203876,been,0,0
203877,studied,0,0
203878,in,0,0
203879,healthy,0,0
203880,volunteers,0,0
203881,.,0,0
203882,2,0,0
203883,Isoprenaline,1,1
203884,heart,0,1
203885,rate,0,1
203886,dose-response,0,1
203887,curves,0,0
203888,showed,0,0
203889,parallel,0,0
203890,shifts,0,0
203891,to,0,0
203892,the,0,0
203893,right,0,0
203894,after,0,0
203895,oral,0,1
203896,prizidilol,1,1
203897,",",0,1
203898,indicating,0,0
203899,antagonism,0,1
203900,by,0,0
203901,this,0,0
203902,compound,0,0
203903,at,0,0
203904,beta-adrenoceptors,0,1
203905,in,0,0
203906,the,0,0
203907,heart,0,0
203908,.,0,0
203909,3,0,1
203910,Isoprenaline,0,1
203911,dose-response,0,1
203912,curves,0,0
203913,for,0,0
203914,decreases,0,0
203915,in,0,0
203916,diastolic,0,0
203917,blood,0,0
203918,pressure,0,0
203919,also,0,0
203920,showed,0,0
203921,shifts,0,0
203922,to,0,0
203923,the,0,0
203924,right,0,0
203925,after,0,0
203926,oral,0,1
203927,prizidilol,1,1
203928,",",0,1
203929,providing,0,0
203930,evidence,0,0
203931,of,0,0
203932,beta-adrenoceptor,0,1
203933,antagonism,0,1
203934,by,0,1
203935,this,0,0
203936,drug,0,1
203937,in,0,0
203938,peripheral,0,0
203939,resistance,0,0
203940,vessels,0,0
203941,.,0,0
203942,4,0,0
203943,The,0,0
203944,peak,0,0
203945,effect,0,0
203946,of,0,0
203947,a,0,0
203948,40,0,1
203949,mg,0,1
203950,dose,0,1
203951,of,0,1
203952,propranolol,1,1
203953,was,0,0
203954,greater,0,0
203955,than,0,0
203956,that,0,0
203957,of,0,0
203958,a,0,0
203959,200,0,1
203960,mg,0,1
203961,dose,0,1
203962,of,0,1
203963,prizidilol,1,1
203964,but,0,0
203965,both,0,0
203966,drugs,0,1
203967,caused,0,0
203968,persistent,0,1
203969,beta-adrenoceptor,0,1
203970,blockade,0,1
203971,for,0,1
203972,at,0,0
203973,least,0,0
203974,7,0,0
203975,h,0,0
203976,after,0,0
203977,ingestion,0,1
203978,.,0,0
203979,The,0,0
203980,influence,0,0
203981,of,0,0
203982,beta-adrenoceptor,1,1
203983,blockade,0,1
203984,on,0,1
203985,left,0,0
203986,ventricular,0,0
203987,function,0,0
203988,.,0,0
203989,1,0,0
203990,This,0,0
203991,study,0,0
203992,was,0,0
203993,designed,0,0
203994,to,0,0
203995,compare,0,0
203996,in,0,0
203997,a,0,0
203998,randomized,0,1
203999,cross-over,0,1
204000,trial,0,1
204001,pindolol,1,1
204002,",",0,1
204003,a,0,0
204004,beta-adrenoceptor,1,1
204005,blocking,1,0
204006,agent,1,0
204007,with,0,0
204008,intrinsic,0,0
204009,sympathomimetic,0,1
204010,activity,0,1
204011,and,0,1
204012,metoprolol,1,1
204013,",",0,1
204014,a,0,1
204015,cardioselective,0,1
204016,beta-adrenoceptor,0,1
204017,blocker,0,1
204018,lacking,0,1
204019,sympathomimetic,0,1
204020,activity,0,0
204021,in,0,0
204022,hypertensives,0,0
204023,with,0,0
204024,incipient,0,0
204025,heart,0,0
204026,failure,0,0
204027,.,0,0
204028,Cardiac,0,0
204029,function,0,0
204030,was,0,0
204031,investigated,0,0
204032,by,0,0
204033,M-Mode,0,0
204034,and,0,0
204035,2D-echo-cardiography,0,0
204036,.,0,0
204037,2,0,0
204038,Both,0,1
204039,pindolol,1,1
204040,and,1,1
204041,metoprolol,1,1
204042,in,0,1
204043,equipotent,0,1
204044,doses,0,1
204045,lowered,0,0
204046,blood,0,0
204047,pressure,0,0
204048,to,0,0
204049,the,0,0
204050,same,0,0
204051,extent,0,0
204052,.,0,0
204053,3,0,0
204054,There,0,0
204055,was,0,0
204056,no,0,0
204057,difference,0,0
204058,in,0,0
204059,overall,0,0
204060,left,0,0
204061,ventricular,0,0
204062,function,0,0
204063,in,0,0
204064,ventricular,0,0
204065,geometry,0,0
204066,or,0,0
204067,in,0,0
204068,wall,0,0
204069,dynamics,0,0
204070,after,0,0
204071,either,0,0
204072,drug,0,1
204073,.,0,0
204074,4,0,0
204075,In,0,0
204076,comparison,0,0
204077,to,0,0
204078,metoprolol,1,1
204079,",",1,1
204080,pindolol,1,1
204081,produced,0,0
204082,less,0,0
204083,reduction,0,0
204084,in,0,0
204085,resting,0,0
204086,heart,0,0
204087,rate,0,0
204088,",",0,0
204089,cardiac,0,0
204090,index,0,0
204091,and,0,0
204092,ejection,0,0
204093,velocity,0,0
204094,reflecting,0,0
204095,the,0,0
204096,intrinsic,0,0
204097,sympathomimetic,0,1
204098,activity,0,0
204099,of,0,0
204100,the,0,0
204101,drug,0,1
204102,.,0,0
204103,Ceftriaxone,1,1
204104,versus,1,1
204105,ampicillin,1,1
204106,and,1,1
204107,chloramphenicol,1,1
204108,for,0,0
204109,treatment,0,0
204110,of,0,0
204111,bacterial,0,0
204112,meningitis,0,0
204113,in,0,0
204114,children,0,0
204115,.,0,0
204116,78,0,0
204117,patients,0,0
204118,with,0,0
204119,bacterial,0,0
204120,meningitis,0,0
204121,were,0,0
204122,evaluated,0,0
204123,in,0,0
204124,a,0,0
204125,prospective,0,0
204126,",",0,0
204127,randomised,0,0
204128,study,0,0
204129,comparing,0,0
204130,twice-daily,0,1
204131,ceftriaxone,1,1
204132,as,0,1
204133,single-drug,0,1
204134,therapy,0,1
204135,with,0,1
204136,ampicillin,1,1
204137,and,1,1
204138,chloramphenicol,1,1
204139,given,0,1
204140,every,0,1
204141,6,0,0
204142,h.,0,1
204143,The,0,0
204144,groups,0,0
204145,were,0,0
204146,comparable,0,0
204147,in,0,0
204148,age,0,0
204149,",",0,0
204150,sex,0,1
204151,",",0,0
204152,days,0,0
204153,of,0,0
204154,illness,0,0
204155,before,0,0
204156,admission,0,0
204157,",",0,0
204158,and,0,0
204159,bacterial,0,0
204160,colony,0,0
204161,counts,0,0
204162,in,0,0
204163,cerebrospinal,0,1
204164,fluid,0,1
204165,(,0,1
204166,CSF,0,1
204167,),0,1
204168,.,0,0
204169,The,0,0
204170,pathogens,0,0
204171,were,0,0
204172,Haemophilus,0,1
204173,influenzae,0,1
204174,type,0,1
204175,b,0,1
204176,(,0,0
204177,54,0,0
204178,cases,0,0
204179,),0,0
204180,",",0,1
204181,streptococci,0,1
204182,(,0,1
204183,9,0,1
204184,cases,0,0
204185,),0,0
204186,",",0,1
204187,meningococci,0,1
204188,(,0,0
204189,9,0,0
204190,cases,0,0
204191,),0,0
204192,",",0,0
204193,and,0,0
204194,unknown,0,0
204195,(,0,0
204196,6,0,0
204197,cases,0,0
204198,),0,0
204199,.,0,0
204200,In,0,0
204201,40,0,0
204202,CSF,0,0
204203,specimens,0,0
204204,obtained,0,0
204205,4-12,0,0
204206,h,0,0
204207,after,0,0
204208,initiation,0,0
204209,of,0,0
204210,therapy,0,0
204211,",",0,0
204212,cultures,0,0
204213,were,0,0
204214,negative,0,0
204215,in,0,0
204216,57,0,0
204217,%,0,0
204218,of,0,0
204219,the,0,0
204220,ceftriaxone,0,1
204221,patients,0,0
204222,and,0,0
204223,in,0,0
204224,42,0,0
204225,%,0,0
204226,of,0,0
204227,the,0,0
204228,others,0,0
204229,.,0,0
204230,The,0,0
204231,mean,0,0
204232,falls,0,0
204233,in,0,0
204234,the,0,0
204235,CSF,0,0
204236,bacterial,0,0
204237,colony,0,0
204238,counts,0,0
204239,were,0,0
204240,4.7,0,0
204241,and,0,0
204242,5.0,0,0
204243,log10,0,0
204244,colony-forming,0,0
204245,units/ml,0,1
204246,",",0,0
204247,respectively,0,0
204248,.,0,0
204249,Mean,0,0
204250,bactericidal,0,1
204251,activity,0,0
204252,in,0,0
204253,CSF,0,0
204254,was,0,0
204255,significantly,0,0
204256,greater,0,0
204257,in,0,0
204258,the,0,0
204259,ceftriaxone,1,1
204260,than,0,0
204261,in,0,0
204262,the,0,0
204263,conventional,0,0
204264,treatment,0,0
204265,group,0,0
204266,at,0,0
204267,the,0,0
204268,beginning,0,0
204269,and,0,0
204270,end,0,0
204271,of,0,0
204272,therapy,0,0
204273,.,0,0
204274,There,0,0
204275,were,0,0
204276,no,0,0
204277,significant,0,0
204278,differences,0,0
204279,in,0,0
204280,clinical,0,0
204281,responses,0,0
204282,or,0,0
204283,in,0,0
204284,frequency,0,0
204285,of,0,0
204286,complications,0,0
204287,",",0,0
204288,except,0,0
204289,for,0,0
204290,mild,0,0
204291,diarrhoea,0,0
204292,",",0,0
204293,which,0,0
204294,occurred,0,0
204295,in,0,0
204296,16,0,0
204297,ceftriaxone,1,1
204298,patients,0,0
204299,and,0,0
204300,in,0,0
204301,8,0,0
204302,in,0,0
204303,the,0,0
204304,other,0,0
204305,group,0,0
204306,(,0,0
204307,p,0,0
204308,less,0,0
204309,than,0,0
204310,0.05,0,0
204311,),0,0
204312,.,0,0
204313,Effect,0,0
204314,of,0,0
204315,betamethasone,1,1
204316,valerate,1,1
204317,on,0,0
204318,the,0,0
204319,normal,0,0
204320,human,0,0
204321,facial,0,0
204322,skin,0,0
204323,flora,0,0
204324,.,0,0
204325,Eighteen,0,0
204326,volunteers,0,0
204327,were,0,0
204328,randomly,0,0
204329,divided,0,0
204330,into,0,0
204331,two,0,0
204332,groups,0,0
204333,and,0,0
204334,allocated,0,0
204335,either,0,0
204336,an,0,0
204337,active,1,0
204338,corticosteroid,1,1
204339,preparation,1,1
204340,(,1,1
204341,Betamethasone,1,1
204342,valerate,1,1
204343,),1,1
204344,or,0,0
204345,the,0,0
204346,basal,1,0
204347,formulation,1,1
204348,only,1,1
204349,(,1,1
204350,placebo,1,1
204351,),1,1
204352,.,1,1
204353,The,0,0
204354,cream,0,1
204355,was,0,0
204356,applied,0,0
204357,to,0,0
204358,the,0,0
204359,face,0,0
204360,twice,0,1
204361,daily,0,1
204362,for,0,0
204363,one,0,0
204364,month,0,0
204365,.,0,0
204366,The,0,0
204367,treated,0,0
204368,area,0,0
204369,was,0,0
204370,sampled,0,0
204371,by,0,0
204372,the,0,0
204373,scrub-wash,0,0
204374,method,0,0
204375,immediately,0,0
204376,before,0,0
204377,treatment,0,0
204378,began,0,0
204379,and,0,0
204380,after,0,0
204381,2,0,0
204382,and,0,0
204383,4,0,0
204384,weeks,0,0
204385,",",0,0
204386,and,0,0
204387,microorganisms,0,0
204388,were,0,0
204389,enumerated,0,0
204390,and,0,0
204391,identified,0,0
204392,.,0,0
204393,Application,0,0
204394,of,0,0
204395,either,0,0
204396,cream,0,1
204397,produced,0,0
204398,a,0,0
204399,very,0,0
204400,slight,0,0
204401,increase,0,0
204402,(,0,0
204403,less,0,0
204404,than,0,0
204405,or,0,0
204406,equal,0,0
204407,to,0,0
204408,0.5,0,0
204409,log,0,0
204410,cycle,0,0
204411,),0,0
204412,in,0,0
204413,the,0,0
204414,skin,0,0
204415,flora,0,0
204416,during,0,0
204417,the,0,0
204418,first,0,0
204419,2,0,0
204420,weeks,0,0
204421,of,0,0
204422,treatment,0,0
204423,.,0,0
204424,There,0,0
204425,were,0,0
204426,no,0,0
204427,significant,0,0
204428,differences,0,0
204429,in,0,0
204430,the,0,0
204431,changes,0,0
204432,occurring,0,0
204433,between,0,0
204434,volunteers,0,0
204435,treated,0,0
204436,with,0,0
204437,placebo,0,1
204438,and,0,0
204439,those,0,0
204440,on,0,0
204441,the,0,0
204442,steroid,0,1
204443,formulation,0,1
204444,.,0,1
204445,The,0,0
204446,results,0,0
204447,are,0,0
204448,discussed,0,0
204449,in,0,0
204450,relation,0,0
204451,to,0,0
204452,theories,0,0
204453,of,0,0
204454,pathogenesis,0,0
204455,of,0,0
204456,perioral,0,0
204457,dermatitis,0,1
204458,and,0,1
204459,steroid,0,1
204460,acne,0,1
204461,.,0,0
204462,[,0,0
204463,Effect,0,0
204464,on,0,0
204465,pressure,0,0
204466,after,0,0
204467,instillation,0,1
204468,of,0,0
204469,a,0,0
204470,drop,0,0
204471,of,0,0
204472,depot-pilocarpine,1,1
204473,.,1,0
204474,Clinical,0,0
204475,results,0,0
204476,of,0,0
204477,its,0,0
204478,medium-term,0,0
204479,action,0,0
204480,],0,0
204481,.,0,0
204482,A,0,0
204483,clinical,0,0
204484,comparison,0,0
204485,of,0,0
204486,an,0,0
204487,emulsion,0,1
204488,containing,0,0
204489,a,0,0
204490,new,1,0
204491,pilocarpine,1,1
204492,polymer,1,1
204493,(,1,1
204494,Polym,1,1
204495,),1,0
204496,compound,0,0
204497,to,0,0
204498,that,0,0
204499,of,0,0
204500,a,0,0
204501,traditional,1,0
204502,pilocarpine,1,1
204503,salt,1,1
204504,solution,1,1
204505,(,1,1
204506,Plc,1,1
204507,),1,1
204508,on,0,0
204509,the,0,0
204510,intraocular,0,0
204511,pressure,0,1
204512,(,0,1
204513,IOP,0,1
204514,),0,0
204515,has,0,0
204516,been,0,0
204517,performed,0,0
204518,in,0,0
204519,40,0,0
204520,open-angle,0,0
204521,patients,0,0
204522,treated,0,0
204523,with,0,0
204524,the,0,0
204525,long,0,0
204526,acting,0,0
204527,pilocarpine-complex,0,1
204528,for,0,0
204529,120,0,0
204530,days,0,0
204531,.,0,0
204532,The,0,0
204533,treatment,0,0
204534,protocol,0,0
204535,was,0,0
204536,divided,0,0
204537,into,0,0
204538,3,0,0
204539,stages,0,0
204540,:,0,0
204541,Stage,0,0
204542,1,0,0
204543,is,0,0
204544,a,0,0
204545,single,0,0
204546,dose,0,1
204547,treatment,0,0
204548,where,0,0
204549,12,0,0
204550,patients,0,0
204551,were,0,0
204552,divided,0,0
204553,randomly,0,0
204554,into,0,0
204555,2,0,0
204556,groups,0,0
204557,of,0,0
204558,6,0,0
204559,each,0,0
204560,.,0,0
204561,The,0,0
204562,patients,0,0
204563,of,0,0
204564,each,0,0
204565,group,0,0
204566,were,0,0
204567,given,1,0
204568,1,1,0
204569,drop,1,0
204570,into,1,0
204571,each,1,0
204572,eye,1,0
204573,:,1,0
204574,1,1,0
204575,drop,1,1
204576,every,1,1
204577,12,1,0
204578,hours,1,0
204579,for,1,0
204580,Polym,1,1
204581,",",1,0
204582,1,1,1
204583,drop,1,1
204584,every,1,1
204585,6,1,0
204586,hours,1,0
204587,for,1,0
204588,Plc,1,1
204589,.,1,0
204590,The,1,0
204591,patients,1,0
204592,were,1,0
204593,observed,1,0
204594,for,1,0
204595,a,1,0
204596,period,1,0
204597,of,1,0
204598,24,1,0
204599,hours,1,0
204600,.,1,0
204601,After,0,1
204602,24,0,0
204603,hours,0,0
204604,without,0,0
204605,medication,0,0
204606,",",0,0
204607,the,0,0
204608,treatments,0,0
204609,were,0,0
204610,crossed,0,0
204611,over,0,0
204612,and,0,0
204613,nycthemeral,0,0
204614,graph,0,0
204615,curves,0,0
204616,were,0,0
204617,registered,0,0
204618,for,0,0
204619,both,0,0
204620,groups,0,0
204621,.,0,0
204622,Stage,0,0
204623,2,0,0
204624,is,0,0
204625,a,0,0
204626,medium,0,0
204627,term,0,0
204628,study,0,0
204629,were,0,0
204630,the,0,0
204631,12,0,0
204632,patients,0,0
204633,used,0,0
204634,in,0,0
204635,Stage,0,0
204636,1,0,0
204637,were,0,0
204638,added,0,0
204639,to,0,0
204640,another,0,0
204641,28,0,0
204642,patients,0,0
204643,.,0,0
204644,All,0,0
204645,40,0,0
204646,were,0,0
204647,then,0,0
204648,assigned,0,0
204649,to,0,0
204650,1,0,0
204651,of,0,0
204652,2,0,0
204653,treatment,0,0
204654,groups,0,1
204655,(,0,0
204656,2,0,1
204657,groups,0,0
204658,of,0,0
204659,20,0,0
204660,patients,0,0
204661,each,0,0
204662,),0,0
204663,according,0,0
204664,to,0,0
204665,a,0,0
204666,table,0,0
204667,of,0,0
204668,random,0,0
204669,numbers,0,0
204670,.,0,0
204671,Treatments,0,0
204672,were,0,0
204673,administered,0,1
204674,during,0,0
204675,one,0,0
204676,month,0,0
204677,",",0,0
204678,then,0,0
204679,cross-overed,0,0
204680,again,0,0
204681,during,0,0
204682,4,0,0
204683,weeks,0,0
204684,.,0,0
204685,Stage,0,0
204686,3,0,0
204687,:,0,0
204688,finally,0,0
204689,",",0,0
204690,every,0,0
204691,patient,0,1
204692,could,0,0
204693,choose,0,0
204694,his,0,0
204695,treatment,0,0
204696,(,0,0
204697,either,0,0
204698,Polym,1,0
204699,or,0,0
204700,Plc,1,1
204701,),1,0
204702,for,0,0
204703,the,0,0
204704,rest,0,0
204705,of,0,0
204706,the,0,0
204707,period,0,1
204708,(,0,0
204709,2,0,0
204710,months,0,0
204711,),0,0
204712,.,0,0
204713,The,0,0
204714,clinical,0,0
204715,study,0,0
204716,shows,0,0
204717,that,0,0
204718,the,0,0
204719,polymer,0,0
204720,complex,0,0
204721,(,0,1
204722,Polym,0,1
204723,),0,0
204724,produced,0,0
204725,a,0,0
204726,prolonged,0,0
204727,therapeutic,0,0
204728,effect,0,0
204729,",",0,0
204730,this,0,0
204731,being,0,0
204732,consistant,0,0
204733,with,0,0
204734,a,0,0
204735,slow,0,0
204736,release,0,0
204737,pattern,0,0
204738,and,0,0
204739,maintained,0,0
204740,a,0,0
204741,more,0,0
204742,effective,0,0
204743,around-the-clock,0,0
204744,control,0,0
204745,than,0,0
204746,pilocarpine,1,1
204747,solution,0,0
204748,.,0,0
204749,These,0,0
204750,results,0,0
204751,were,0,0
204752,accomplished,0,0
204753,by,0,0
204754,two,0,0
204755,applications,0,0
204756,per,0,0
204757,day,0,0
204758,as,0,0
204759,compared,0,0
204760,to,0,0
204761,the,0,0
204762,four,0,0
204763,necessary,0,0
204764,applications,0,0
204765,of,0,0
204766,Plc,1,0
204767,",",0,0
204768,on,0,0
204769,a,0,0
204770,half,0,0
204771,daily,0,1
204772,pilocarpine,1,1
204773,dose,0,1
204774,with,0,1
204775,Polym,1,0
204776,.,1,0
204777,The,0,0
204778,medium,0,0
204779,term,0,0
204780,results,0,0
204781,confirmed,0,0
204782,the,0,0
204783,efficacity,0,0
204784,noted,0,0
204785,in,0,0
204786,the,0,0
204787,short,0,0
204788,term,0,0
204789,survey,0,0
204790,.,0,0
204791,Most,0,0
204792,patients,0,0
204793,preferred,0,0
204794,Polym,1,0
204795,to,0,0
204796,Plc,1,0
204797,when,0,0
204798,they,0,0
204799,were,0,0
204800,asked,0,0
204801,.,0,0
204802,Throughout,0,0
204803,the,0,0
204804,4,0,0
204805,months,0,0
204806,study,0,0
204807,period,0,0
204808,",",0,0
204809,no,0,0
204810,adverse,0,0
204811,side,0,0
204812,effects,0,0
204813,were,0,0
204814,reported,0,0
204815,.,0,0
204816,Visual,0,0
204817,disturbances,0,0
204818,characteristic,0,0
204819,of,0,0
204820,pilocarpine,1,1
204821,eye-drops,0,1
204822,were,0,0
204823,reduced,0,0
204824,from,0,0
204825,3,0,0
204826,times,0,0
204827,a,0,0
204828,day,0,1
204829,on,0,1
204830,pilocarpine,1,1
204831,salt,1,1
204832,solution,0,0
204833,to,0,0
204834,once,0,0
204835,a,0,0
204836,day,0,1
204837,on,0,0
204838,pilocarpine,1,1
204839,polymer,1,0
204840,complex,0,0
204841,.,0,0
204842,Fat,0,1
204843,embolism,0,0
204844,prophylaxis,0,1
204845,with,0,0
204846,corticosteroids,1,1
204847,.,1,1
204848,A,0,1
204849,prospective,0,0
204850,study,0,0
204851,in,0,0
204852,high-risk,0,0
204853,patients,0,0
204854,.,0,0
204855,The,0,0
204856,efficacy,0,0
204857,of,0,0
204858,corticosteroid,1,1
204859,treatment,0,0
204860,in,0,0
204861,the,0,0
204862,prophylaxis,0,0
204863,of,0,0
204864,the,0,0
204865,fat,0,0
204866,embolism,0,0
204867,syndrome,0,0
204868,was,0,0
204869,evaluated,0,0
204870,in,0,0
204871,a,0,0
204872,prospective,0,0
204873,",",0,0
204874,randomized,0,1
204875,",",0,0
204876,double-blind,0,1
204877,study,0,0
204878,of,0,0
204879,high-risk,0,0
204880,patients,0,0
204881,with,0,0
204882,long-bone,0,0
204883,fractures,0,0
204884,.,0,0
204885,Using,0,0
204886,a,0,0
204887,set,0,0
204888,of,0,0
204889,objective,0,0
204890,diagnostic,0,0
204891,criteria,0,0
204892,",",0,0
204893,we,0,0
204894,saw,0,0
204895,a,0,0
204896,significant,0,0
204897,difference,0,0
204898,in,0,0
204899,the,0,0
204900,incidence,0,0
204901,of,0,0
204902,the,0,0
204903,syndrome,0,0
204904,between,0,0
204905,corticosteroid-,1,1
204906,(,0,1
204907,0,0,0
204908,of,0,0
204909,21,0,0
204910,),0,0
204911,and,0,0
204912,placebo-treated,1,1
204913,patients,0,1
204914,(,0,0
204915,9,0,0
204916,of,0,0
204917,41,0,0
204918,),0,0
204919,(,0,0
204920,p,0,0
204921,less,0,0
204922,than,0,0
204923,0.05,0,0
204924,),0,0
204925,.,0,0
204926,There,0,0
204927,were,0,0
204928,no,0,0
204929,complications,0,0
204930,related,0,0
204931,to,0,0
204932,corticosteroid,1,1
204933,treatment,0,1
204934,.,0,1
204935,No,0,1
204936,routine,0,1
204937,laboratory,0,1
204938,or,0,0
204939,physical,0,0
204940,findings,0,0
204941,reliably,0,0
204942,predicted,0,0
204943,the,0,0
204944,development,0,0
204945,of,0,0
204946,the,0,0
204947,fat,0,0
204948,embolism,0,0
204949,syndrome,0,0
204950,except,0,0
204951,petechial,0,0
204952,rash,0,0
204953,",",0,0
204954,which,0,0
204955,occurred,0,0
204956,only,0,0
204957,in,0,0
204958,5,0,0
204959,placebo-treated,0,0
204960,patients,0,0
204961,who,0,0
204962,developed,0,0
204963,the,0,0
204964,syndrome,0,0
204965,.,0,0
204966,Complement,0,0
204967,activation,0,0
204968,was,0,0
204969,present,0,0
204970,in,0,0
204971,all,0,0
204972,patients,0,0
204973,studied,0,0
204974,who,0,0
204975,had,0,0
204976,the,0,0
204977,syndrome,0,1
204978,(,0,0
204979,5,0,0
204980,of,0,0
204981,27,0,0
204982,),0,0
204983,but,0,0
204984,also,0,0
204985,in,0,0
204986,many,0,0
204987,patients,0,0
204988,who,0,0
204989,did,0,0
204990,not,0,0
204991,meet,0,0
204992,our,0,0
204993,diagnostic,0,0
204994,criteria,0,0
204995,",",0,0
204996,suggesting,0,0
204997,a,0,0
204998,multifactorial,0,0
204999,cause,0,0
205000,.,0,0
205001,These,0,0
205002,data,0,0
205003,support,0,0
205004,the,0,0
205005,prophylactic,0,0
205006,value,0,0
205007,of,0,0
205008,corticosteroid,1,1
205009,treatment,0,0
205010,in,0,0
205011,patients,0,0
205012,at,0,0
205013,high,0,0
205014,risk,0,0
205015,for,0,0
205016,the,0,0
205017,fat,0,0
205018,embolism,0,0
205019,syndrome,0,0
205020,",",0,0
205021,particularly,0,0
205022,if,0,0
205023,several,0,0
205024,unfavorable,0,0
205025,predictors,0,0
205026,are,0,0
205027,present,0,0
205028,.,0,0
205029,Effect,0,0
205030,of,0,0
205031,oral,0,1
205032,diuretics,1,1
205033,on,0,1
205034,pulmonary,0,0
205035,mechanics,0,0
205036,in,0,0
205037,infants,0,0
205038,with,0,0
205039,chronic,0,0
205040,bronchopulmonary,0,0
205041,dysplasia,0,0
205042,:,0,0
205043,results,0,0
205044,of,0,0
205045,a,0,0
205046,double-blind,0,1
205047,crossover,0,1
205048,sequential,0,1
205049,trial,0,0
205050,.,0,0
205051,In,0,0
205052,a,0,0
205053,randomized,0,1
205054,double-blind,0,1
205055,crossover,0,1
205056,trial,0,1
205057,with,0,0
205058,sequential,0,0
205059,analysis,0,0
205060,",",0,0
205061,the,0,0
205062,effects,0,0
205063,of,0,0
205064,oral,0,1
205065,diuretics,1,1
205066,were,0,0
205067,compared,0,0
205068,with,0,0
205069,the,0,0
205070,effects,0,0
205071,of,0,0
205072,placebo,1,1
205073,on,0,0
205074,pulmonary,0,0
205075,mechanics,0,0
205076,in,0,0
205077,ten,0,0
205078,infants,0,0
205079,with,0,0
205080,bronchopulmonary,0,0
205081,dysplasia,0,1
205082,(,0,1
205083,BPD,0,1
205084,),0,1
205085,.,0,0
205086,Pulmonary,0,0
205087,mechanics,0,0
205088,were,0,0
205089,measured,0,0
205090,before,0,0
205091,and,0,0
205092,at,0,0
205093,the,0,0
205094,end,0,0
205095,of,0,0
205096,a,0,0
205097,week,0,0
205098,of,0,0
205099,treatment,0,0
205100,with,0,1
205101,oral,1,1
205102,diuretics,1,1
205103,(,1,1
205104,chlorothiazide,1,1
205105,",",1,1
205106,20,1,1
205107,mg/kg/dose,1,1
205108,and,1,1
205109,spironolactone,1,1
205110,",",1,1
205111,1.5,1,1
205112,mg/kg/dose,1,1
205113,),1,1
205114,given,1,1
205115,twice,1,1
205116,daily,1,1
205117,",",1,1
205118,or,1,1
205119,placebo,1,1
205120,.,1,1
205121,Mean,0,0
205122,airway,0,0
205123,resistance,0,0
205124,decreased,0,0
205125,35.3,0,0
205126,cm,0,0
205127,H2O/L/s,0,0
205128,",",0,0
205129,mean,0,0
205130,specific,0,0
205131,airway,0,0
205132,conductance,0,0
205133,increased,0,0
205134,0.095,0,0
205135,1/L/s/cm,0,0
205136,H2O,0,0
205137,",",0,0
205138,and,0,0
205139,mean,0,0
205140,dynamic,0,0
205141,pulmonary,0,0
205142,compliance,0,0
205143,increased,0,0
205144,1.74,0,0
205145,mL/cm,0,0
205146,H2O,0,0
205147,during,0,0
205148,treatment,0,0
205149,with,0,1
205150,diuretics,0,1
205151,(,0,0
205152,all,0,0
205153,P,0,0
205154,less,0,0
205155,than,0,0
205156,.001,0,0
205157,),0,0
205158,",",0,0
205159,but,0,0
205160,not,0,0
205161,during,0,0
205162,treatment,0,0
205163,with,0,0
205164,placebo,0,1
205165,.,0,0
205166,The,0,0
205167,infants,0,0
205168,',0,0
205169,rate,0,0
205170,of,0,0
205171,weight,0,0
205172,gain,0,0
205173,decreased,0,0
205174,on,0,0
205175,the,0,0
205176,first,0,0
205177,three,0,0
205178,days,0,0
205179,of,0,0
205180,diuretic,0,1
205181,treatment,0,0
205182,",",0,0
205183,but,0,0
205184,was,0,0
205185,thereafter,0,0
205186,comparable,0,0
205187,with,0,0
205188,weight,0,0
205189,gain,0,0
205190,during,0,0
205191,treatment,0,0
205192,with,0,0
205193,placebo,1,1
205194,.,1,1
205195,Fluid,0,0
205196,intake,0,1
205197,was,0,0
205198,similar,0,0
205199,in,0,0
205200,infants,0,0
205201,receiving,0,0
205202,diuretics,0,1
205203,and,0,1
205204,placebo,1,1
205205,.,1,1
205206,But,0,1
205207,",",0,0
205208,infants,0,0
205209,receiving,0,0
205210,diuretics,0,1
205211,not,0,0
205212,only,0,0
205213,had,0,0
205214,significantly,0,0
205215,increased,0,0
205216,urine,0,1
205217,output,0,1
205218,",",0,1
205219,osmolal,0,1
205220,clearance,0,1
205221,",",0,1
205222,and,0,1
205223,potassium,0,1
205224,and,0,1
205225,phosphorus,0,1
205226,excretion,0,1
205227,",",0,1
205228,but,0,0
205229,these,0,0
205230,infants,0,0
205231,also,0,0
205232,retained,0,0
205233,less,0,0
205234,fluid,0,0
205235,",",0,0
205236,and,0,0
205237,",",0,0
205238,in,0,0
205239,addition,0,0
205240,",",0,0
205241,excreted,0,1
205242,less,0,1
205243,calcium,0,1
205244,than,0,1
205245,infants,0,1
205246,receiving,0,0
205247,placebo,0,1
205248,.,0,1
205249,It,0,0
205250,is,0,0
205251,concluded,0,0
205252,that,0,0
205253,oral,0,1
205254,diuretics,1,1
205255,improve,0,1
205256,lung,0,0
205257,function,0,0
205258,in,0,0
205259,infants,0,0
205260,with,0,0
205261,chronic,0,0
205262,bronchopulmonary,0,1
205263,dysplasia,0,1
205264,;,0,0
205265,however,0,0
205266,",",0,0
205267,potassium,0,1
205268,and,0,1
205269,phosphorus,0,1
205270,depletion,0,0
205271,are,0,0
205272,potential,0,0
205273,complications,0,0
205274,of,0,0
205275,treatment,0,0
205276,.,0,0
205277,[,0,1
205278,Randomized,0,0
205279,controlled,0,0
205280,study,0,0
205281,of,0,0
205282,OK-432,1,0
205283,in,0,0
205284,the,0,0
205285,treatment,0,0
205286,of,0,0
205287,cancerous,0,1
205288,pleurisy,0,1
205289,],0,0
205290,.,0,0
205291,A,0,0
205292,randomized,0,0
205293,controlled,0,0
205294,study,0,0
205295,was,0,0
205296,performed,0,0
205297,to,0,0
205298,evaluate,0,0
205299,the,0,0
205300,efficacy,0,0
205301,of,0,0
205302,intrapleural,0,1
205303,and,0,1
205304,systemic,0,1
205305,administration,0,1
205306,of,0,0
205307,OK-432,1,1
205308,",",1,0
205309,streptococcus,1,1
205310,preparation,1,0
205311,",",0,0
205312,in,0,0
205313,patients,0,0
205314,with,0,0
205315,cancerous,0,0
205316,pleurisy,0,0
205317,.,0,0
205318,A,0,0
205319,total,0,0
205320,of,0,0
205321,53,0,0
205322,patients,0,0
205323,were,0,0
205324,accessed,0,0
205325,to,0,0
205326,the,0,0
205327,study,0,0
205328,:,0,0
205329,29,0,0
205330,patients,0,0
205331,for,0,0
205332,the,0,0
205333,OK-432,1,0
205334,group,0,0
205335,and,0,0
205336,24,0,0
205337,patients,0,0
205338,for,0,0
205339,the,0,0
205340,control,1,0
205341,group,1,0
205342,.,1,0
205343,Intrapleural,0,1
205344,instillation,0,1
205345,of,0,1
205346,50,1,1
205347,mg,1,1
205348,of,1,1
205349,adriamycin,1,1
205350,and,1,0
205351,a,1,0
205352,combination,1,0
205353,chemotherapy,1,0
205354,of,1,0
205355,MFC,1,1
205356,(,1,1
205357,mitomycin,1,1
205358,C,0,1
205359,0.08,0,1
205360,mg/kg,0,1
205361,",",0,0
205362,5-FU,0,1
205363,10,0,1
205364,mg/kg,0,1
205365,",",0,0
205366,ara-C,1,1
205367,0.8,0,1
205368,mg/kg,0,1
205369,iv,0,1
205370,",",0,1
205371,weekly,0,1
205372,),0,1
205373,were,0,1
205374,administered,0,1
205375,in,0,0
205376,both,0,0
205377,groups,0,0
205378,.,0,0
205379,In,0,0
205380,the,0,0
205381,OK-432,0,1
205382,group,0,1
205383,intrapleural,0,1
205384,instillation,0,1
205385,of,0,1
205386,2,0,0
205387,units,0,0
205388,of,0,0
205389,OK-432,1,1
205390,was,0,0
205391,administered,0,1
205392,daily,0,1
205393,until,0,1
205394,disappearance,0,0
205395,of,0,0
205396,pleural,0,0
205397,effusion,0,1
205398,;,0,0
205399,thereafter,0,0
205400,",",0,0
205401,2,0,0
205402,to,0,0
205403,5,0,0
205404,units,0,0
205405,of,0,0
205406,OK-432,0,0
205407,were,0,1
205408,administered,0,1
205409,intradermally,0,1
205410,every,0,1
205411,other,0,1
205412,day,0,0
205413,.,0,0
205414,Patients,0,0
205415,with,0,0
205416,stage,0,0
205417,III,0,0
205418,in,0,0
205419,the,0,0
205420,OK-432,0,0
205421,group,0,0
205422,survived,0,0
205423,significantly,0,0
205424,longer,0,0
205425,than,0,0
205426,those,0,0
205427,in,0,0
205428,the,0,0
205429,control,0,0
205430,group,0,0
205431,(,0,0
205432,P,0,0
205433,less,0,0
205434,than,0,0
205435,0.05,0,0
205436,),0,0
205437,",",0,0
205438,but,0,0
205439,there,0,0
205440,was,0,0
205441,no,0,0
205442,significance,0,0
205443,between,0,0
205444,in,0,0
205445,patients,0,0
205446,with,0,0
205447,stage,0,0
205448,IV,0,0
205449,of,0,0
205450,both,0,0
205451,treatment,0,0
205452,groups,0,0
205453,.,0,0
205454,Also,0,0
205455,patients,0,0
205456,with,0,0
205457,PPD,0,0
205458,negative,0,0
205459,skin,0,0
205460,reaction,0,0
205461,at,0,0
205462,the,0,0
205463,time,0,0
205464,of,0,0
205465,beginning,0,0
205466,of,0,0
205467,treatment,0,0
205468,in,0,0
205469,the,0,0
205470,OK-432,0,0
205471,group,0,0
205472,survived,0,0
205473,significantly,0,0
205474,longer,0,0
205475,than,0,0
205476,those,0,0
205477,in,0,0
205478,the,0,0
205479,control,0,0
205480,group,0,0
205481,(,0,0
205482,P,0,0
205483,less,0,0
205484,than,0,0
205485,0.001,0,0
205486,),0,0
205487,",",0,0
205488,but,0,0
205489,there,0,0
205490,was,0,0
205491,no,0,0
205492,significance,0,0
205493,between,0,0
205494,both,0,0
205495,treatment,0,0
205496,groups,0,0
205497,in,0,0
205498,patients,0,0
205499,with,0,0
205500,PPD,0,0
205501,positive,0,0
205502,skin,0,0
205503,reaction,0,0
205504,at,0,0
205505,the,0,0
205506,time,0,0
205507,of,0,0
205508,beginning,0,0
205509,of,0,0
205510,treatment,0,0
205511,.,0,0
205512,Eighteen,0,0
205513,(,0,0
205514,62,0,0
205515,%,0,0
205516,),0,0
205517,of,0,0
205518,29,0,0
205519,patients,0,0
205520,treated,0,0
205521,with,0,0
205522,OK-432,0,0
205523,had,0,0
205524,a,0,0
205525,fever,0,0
205526,",",0,0
205527,but,0,0
205528,well,0,0
205529,tolerated,0,1
205530,.,0,0
205531,[,0,1
205532,Randomized,0,0
205533,study,0,0
205534,on,0,0
205535,the,0,0
205536,long-term,1,0
205537,adjuvant,1,1
205538,chemotherapy,1,1
205539,with,0,1
205540,ftorafur,1,1
205541,and,0,1
205542,mitomycin,1,1
205543,C,1,1
205544,for,0,0
205545,stomach,0,0
205546,cancer,0,0
205547,:,0,0
205548,second,0,0
205549,report,0,0
205550,],0,0
205551,.,0,0
205552,In,0,0
205553,view,0,0
205554,of,0,0
205555,the,0,0
205556,usefulness,0,0
205557,of,0,0
205558,long-term,1,1
205559,adjuvant,1,1
205560,chemotherapy,1,1
205561,",",0,0
205562,the,0,0
205563,Cooperative,0,0
205564,Study,0,0
205565,Group,0,0
205566,of,0,0
205567,Surgical,0,1
205568,Adjuvant,0,1
205569,Chemotherapy,0,1
205570,for,0,0
205571,Gastric,0,0
205572,Cancer,0,0
205573,adopted,0,0
205574,as,0,0
205575,the,0,0
205576,second,0,0
205577,cooperative,0,0
205578,study,0,0
205579,a,0,0
205580,prospective,0,0
205581,randomized,0,0
205582,trial,0,0
205583,on,0,0
205584,three,0,0
205585,groups,0,0
205586,;,0,0
205587,MMC,1,1
205588,alone,1,0
205589,",",1,0
205590,Futraful,1,0
205591,alone,1,0
205592,and,1,0
205593,a,1,0
205594,combination,1,0
205595,of,1,0
205596,MMC,1,0
205597,and,1,0
205598,Futraful,1,0
205599,.,1,0
205600,In,0,0
205601,the,0,0
205602,group,0,0
205603,of,0,0
205604,Futraful,1,0
205605,alone,0,0
205606,the,0,0
205607,survival,0,0
205608,and,0,0
205609,disease-free,0,0
205610,rate,0,0
205611,were,0,0
205612,improved,0,0
205613,in,0,0
205614,three,0,0
205615,years,0,0
205616,after,0,0
205617,operation,0,0
205618,",",0,0
205619,especially,0,0
205620,marked,0,0
205621,in,0,0
205622,patients,0,0
205623,with,0,0
205624,the,0,0
205625,advanced,0,0
205626,stage,0,0
205627,.,0,0
205628,Moreover,0,0
205629,",",0,0
205630,the,0,0
205631,survival,0,0
205632,and,0,0
205633,disease-free,0,0
205634,rate,0,0
205635,in,0,0
205636,the,0,0
205637,group,0,0
205638,of,0,0
205639,the,0,0
205640,combination,1,0
205641,therapy,1,0
205642,were,0,0
205643,higher,0,0
205644,than,0,0
205645,those,0,0
205646,in,0,0
205647,the,0,0
205648,group,0,0
205649,of,0,0
205650,Futraful,1,0
205651,alone,0,0
205652,",",0,0
205653,and,0,0
205654,the,0,0
205655,relapse,0,0
205656,rate,0,0
205657,was,0,0
205658,lower,0,0
205659,in,0,0
205660,the,0,0
205661,former,0,0
205662,.,0,0
205663,Therefore,0,0
205664,",",0,0
205665,a,0,0
205666,long-term,1,0
205667,combined,1,0
205668,adjuvant,1,1
205669,chemotherapy,1,1
205670,with,1,0
205671,MMC,1,0
205672,and,1,0
205673,Futraful,1,0
205674,seems,0,0
205675,to,0,0
205676,be,0,0
205677,one,0,0
205678,of,0,0
205679,the,0,0
205680,most,0,0
205681,effective,0,0
205682,chemotherapy,1,0
205683,regimens,0,1
205684,for,0,0
205685,resectable,0,1
205686,advanced,0,0
205687,gastric,0,0
205688,cancer,0,0
205689,.,0,0
205690,Blood,0,0
205691,pressure,0,0
205692,control,0,0
205693,during,0,0
205694,weight,0,0
205695,reduction,0,0
205696,in,0,0
205697,obese,0,0
205698,hypertensive,0,0
205699,men,0,0
205700,:,0,0
205701,separate,0,0
205702,effects,0,0
205703,of,0,0
205704,sodium,0,1
205705,and,0,0
205706,energy,0,0
205707,restriction,0,0
205708,.,0,0
205709,The,0,0
205710,separate,0,0
205711,and,0,0
205712,combined,0,0
205713,effects,0,0
205714,of,0,0
205715,dietary,0,1
205716,energy,0,1
205717,and,0,1
205718,sodium,1,1
205719,restriction,1,0
205720,on,0,0
205721,regulation,0,0
205722,of,0,0
205723,blood,0,0
205724,pressure,0,0
205725,were,0,0
205726,investigated,0,0
205727,in,0,0
205728,30,0,0
205729,middle,0,0
205730,aged,0,0
205731,obese,0,0
205732,men,0,0
205733,with,0,0
205734,essential,0,0
205735,hypertension,0,0
205736,attending,0,0
205737,the,0,0
205738,outpatient,0,0
205739,department,0,0
205740,.,0,0
205741,In,0,0
205742,group,0,0
205743,1,0,0
205744,(,0,0
205745,n,0,0
205746,=,0,0
205747,15,0,0
205748,),0,0
205749,a,0,0
205750,basal,0,0
205751,period,0,0
205752,with,0,0
205753,no,1,0
205754,dietary,1,1
205755,restriction,1,0
205756,was,0,0
205757,followed,0,0
205758,by,0,0
205759,a,0,0
205760,period,0,0
205761,taking,0,0
205762,an,1,0
205763,energy,1,0
205764,reduced,1,0
205765,diet,1,1
205766,(,0,0
205767,5.1,0,0
205768,MJ,0,0
205769,;,0,0
205770,1230,0,0
205771,kcal,0,1
205772,),0,0
205773,",",0,0
205774,the,0,1
205775,sodium,1,1
205776,intake,1,1
205777,being,1,1
205778,supplemented,1,0
205779,and,1,0
205780,hence,1,0
205781,unchanged,1,0
205782,(,0,0
205783,1,0,0
205784,:,0,0
205785,ErSn,0,1
205786,),0,0
205787,.,0,0
205788,In,0,0
205789,group,0,0
205790,2,0,0
205791,(,0,0
205792,n,0,0
205793,=,0,0
205794,15,0,0
205795,),0,0
205796,the,0,0
205797,basal,0,0
205798,period,0,0
205799,preceded,0,0
205800,a,0,0
205801,control,0,0
205802,period,0,0
205803,with,0,0
205804,no,1,0
205805,intervention,1,0
205806,",",1,0
205807,which,1,0
205808,was,1,0
205809,followed,1,0
205810,by,1,0
205811,taking,1,0
205812,a,1,0
205813,diet,1,1
205814,restricted,1,0
205815,in,1,0
205816,energy,1,0
205817,(,0,0
205818,5.1,0,0
205819,MJ,0,0
205820,;,0,0
205821,1220,0,0
205822,kcal,0,1
205823,),0,1
205824,and,0,1
205825,sodium,1,1
205826,(,0,1
205827,2,0,1
205828,:,0,0
205829,ErSr,0,1
205830,),0,0
205831,.,0,0
205832,During,0,0
205833,period,0,0
205834,1,0,0
205835,:,0,0
205836,ErSn,0,0
205837,there,0,0
205838,were,0,0
205839,reductions,0,0
205840,in,0,0
205841,heart,0,0
205842,rate,0,0
205843,and,0,0
205844,urinary,0,1
205845,noradrenaline,0,1
205846,output,0,1
205847,but,0,0
205848,not,0,0
205849,in,0,0
205850,systolic,0,0
205851,or,0,0
205852,diastolic,0,0
205853,blood,0,0
205854,pressure,0,0
205855,.,0,0
205856,Body,0,0
205857,weight,0,0
205858,decreased,0,0
205859,by,0,0
205860,4.9-11.7,0,0
205861,kg,0,0
205862,and,0,0
205863,urinary,0,1
205864,sodium,0,1
205865,excretion,0,1
205866,did,0,0
205867,not,0,0
205868,change,0,0
205869,.,0,0
205870,In,0,0
205871,period,0,0
205872,2,0,0
205873,:,0,0
205874,ErSr,0,1
205875,urinary,0,1
205876,sodium,0,1
205877,output,0,1
205878,was,0,0
205879,reduced,0,0
205880,by,0,0
205881,81.4,0,0
205882,(,0,0
205883,SEM,0,0
205884,17.8,0,0
205885,),0,0
205886,mmol,0,1
205887,(,0,1
205888,mEq,0,1
205889,),0,0
205890,/24,0,0
205891,h,0,0
205892,and,0,0
205893,there,0,0
205894,was,0,0
205895,a,0,0
205896,weight,0,0
205897,loss,0,0
205898,of,0,0
205899,8.2,0,0
205900,(,0,0
205901,SEM,0,0
205902,0.7,0,0
205903,),0,0
205904,kg,0,0
205905,.,0,0
205906,Systolic,0,0
205907,and,0,0
205908,diastolic,0,0
205909,blood,0,0
205910,pressures,0,0
205911,fell,0,0
205912,significantly,0,0
205913,",",0,0
205914,as,0,0
205915,did,0,0
205916,the,0,0
205917,heart,0,0
205918,rate,0,0
205919,and,0,0
205920,urinary,0,1
205921,noradrenaline,0,1
205922,excretion,0,1
205923,.,0,1
205924,These,0,0
205925,results,0,0
205926,show,0,0
205927,that,0,0
205928,in,0,0
205929,hypertensive,0,0
205930,obese,0,0
205931,men,0,0
205932,a,0,0
205933,moderate,0,0
205934,weight,0,0
205935,reducing,0,0
205936,diet,0,1
205937,decreases,0,0
205938,indices,0,0
205939,of,0,0
205940,sympathetic,0,0
205941,nervous,0,0
205942,system,0,0
205943,activity,0,0
205944,.,0,0
205945,Reduction,0,0
205946,of,0,0
205947,blood,0,0
205948,pressure,0,0
205949,to,0,0
205950,the,0,0
205951,normotensive,0,1
205952,range,0,0
205953,was,0,0
205954,observed,0,0
205955,only,0,0
205956,when,0,0
205957,there,0,0
205958,was,0,0
205959,a,0,0
205960,concomitant,0,0
205961,restriction,0,0
205962,of,0,0
205963,sodium,0,1
205964,intake,0,1
205965,.,0,1
205966,Evaluation,0,0
205967,of,0,0
205968,AMSA,1,0
205969,in,0,0
205970,children,0,0
205971,with,0,0
205972,acute,0,0
205973,leukemia,0,0
205974,.,0,0
205975,A,0,0
205976,Pediatric,0,0
205977,Oncology,0,0
205978,Group,0,0
205979,study,0,0
205980,.,0,0
205981,One,0,0
205982,hundred,0,0
205983,four,0,0
205984,children,0,0
205985,with,0,0
205986,advanced,0,0
205987,leukemia,0,0
205988,in,0,0
205989,relapse,0,0
205990,(,0,0
205991,74,0,0
205992,with,0,0
205993,acute,0,0
205994,lymphocytic,0,1
205995,leukemia,0,1
205996,[,0,1
205997,ALL,0,1
205998,],0,1
205999,and,0,0
206000,30,0,0
206001,with,0,0
206002,acute,0,0
206003,nonlymphocytic,0,1
206004,leukemia,0,1
206005,[,0,1
206006,ANLL,0,1
206007,],0,1
206008,),0,0
206009,received,0,0
206010,AMSA,1,1
206011,(,1,1
206012,4'-,1,1
206013,(,1,1
206014,9-Acridinylamino,1,1
206015,),1,1
206016,methanesulfon,1,1
206017,-m-anisidide,1,1
206018,),1,1
206019,at,0,0
206020,a,0,0
206021,dose,0,1
206022,of,0,1
206023,120,0,1
206024,mg/m2/day,0,1
206025,for,0,1
206026,5,0,1
206027,days,0,1
206028,(,0,1
206029,Regimen,0,1
206030,I,0,1
206031,),0,1
206032,or,0,0
206033,60,0,1
206034,mg/m2/day,0,1
206035,for,0,1
206036,10,0,1
206037,days,0,1
206038,(,0,1
206039,Regimen,0,1
206040,II,0,1
206041,),0,1
206042,.,0,0
206043,Children,0,0
206044,with,0,0
206045,ALL,0,0
206046,were,0,0
206047,randomized,0,0
206048,between,0,0
206049,Regimens,0,0
206050,I,0,0
206051,and,0,0
206052,II,0,1
206053,(,0,0
206054,31,0,0
206055,and,0,0
206056,36,0,0
206057,evaluable,0,0
206058,patients,0,0
206059,",",0,0
206060,respectively,0,0
206061,),0,0
206062,.,0,0
206063,All,0,0
206064,29,0,0
206065,evaluable,0,0
206066,patients,0,0
206067,with,0,0
206068,ANLL,0,0
206069,were,0,0
206070,treated,0,0
206071,on,0,0
206072,Regimen,0,1
206073,I.,0,0
206074,Eighty-eight,0,0
206075,percent,0,0
206076,of,0,0
206077,evaluable,0,0
206078,patients,0,0
206079,experienced,0,0
206080,severe,0,0
206081,or,0,0
206082,life-threatening,0,0
206083,toxicity,0,0
206084,",",0,0
206085,with,0,0
206086,no,0,0
206087,statistical,0,0
206088,differences,0,0
206089,between,0,0
206090,Regimens,0,0
206091,I,0,0
206092,and,0,0
206093,II,0,0
206094,.,0,0
206095,Bacterial,0,0
206096,or,0,0
206097,fungal,0,0
206098,infections,0,1
206099,(,0,0
206100,considered,0,0
206101,life-threatening,0,0
206102,or,0,0
206103,fatal,0,1
206104,),0,0
206105,occurred,0,0
206106,in,0,0
206107,17,0,0
206108,children,0,0
206109,with,0,0
206110,ALL,0,0
206111,and,0,0
206112,in,0,0
206113,7,0,0
206114,with,0,0
206115,ANLL,0,0
206116,.,0,0
206117,Fatal,0,0
206118,cardiac,0,0
206119,toxicity,0,0
206120,occurred,0,0
206121,in,0,0
206122,one,0,0
206123,patient,0,0
206124,.,0,0
206125,Complete,0,0
206126,or,0,0
206127,partial,0,0
206128,response,0,0
206129,occurred,0,0
206130,in,0,0
206131,25.0,0,0
206132,%,0,0
206133,(,0,0
206134,SE,0,0
206135,=,0,0
206136,8.8,0,0
206137,%,0,0
206138,),0,0
206139,",",0,0
206140,28.1,0,0
206141,%,0,0
206142,(,0,0
206143,SE,0,0
206144,=,0,0
206145,8.0,0,0
206146,%,0,0
206147,),0,0
206148,",",0,0
206149,and,0,0
206150,25.9,0,0
206151,%,0,0
206152,(,0,0
206153,SE,0,0
206154,=,0,0
206155,8.4,0,0
206156,%,0,0
206157,),0,0
206158,of,0,0
206159,evaluable,0,0
206160,patients,0,0
206161,on,0,0
206162,ALL,0,1
206163,Regimen,0,1
206164,I,0,1
206165,",",0,1
206166,ALL,0,1
206167,Regimen,0,1
206168,II,0,1
206169,",",0,0
206170,and,0,0
206171,ANLL,0,0
206172,",",0,0
206173,respectively,0,0
206174,.,0,0
206175,However,0,0
206176,",",0,0
206177,responses,0,0
206178,were,0,0
206179,of,0,0
206180,short,0,0
206181,duration,0,0
206182,(,0,0
206183,16-91,0,0
206184,days,0,0
206185,),0,0
206186,.,0,0
206187,There,0,0
206188,was,0,0
206189,no,0,0
206190,significant,0,0
206191,difference,0,0
206192,in,0,0
206193,the,0,0
206194,duration,0,0
206195,of,0,0
206196,survival,0,0
206197,from,0,0
206198,treatment,0,0
206199,start,0,0
206200,for,0,0
206201,the,0,0
206202,two,0,0
206203,ALL,0,1
206204,regimens,0,1
206205,(,0,0
206206,P,0,0
206207,=,0,0
206208,0.46,0,0
206209,),0,0
206210,.,0,0
206211,The,0,0
206212,median,0,0
206213,duration,0,0
206214,of,0,0
206215,survival,0,0
206216,for,0,0
206217,ANLL,0,0
206218,patients,0,0
206219,was,0,0
206220,significantly,0,0
206221,longer,0,0
206222,(,0,0
206223,P,0,0
206224,=,0,0
206225,0.004,0,0
206226,),0,0
206227,than,0,0
206228,that,0,0
206229,of,0,0
206230,ALL,0,0
206231,patients,0,0
206232,treated,0,0
206233,on,0,0
206234,Regimens,0,0
206235,I,0,0
206236,and,0,0
206237,II,0,0
206238,combined,0,0
206239,.,0,0
206240,Eighty-two,0,0
206241,percent,0,0
206242,of,0,0
206243,the,0,0
206244,complete,0,0
206245,or,0,0
206246,partial,0,0
206247,responses,0,0
206248,(,0,0
206249,18,0,0
206250,of,0,0
206251,22,0,0
206252,),0,0
206253,occurred,0,0
206254,after,0,0
206255,the,0,0
206256,first,0,0
206257,course,0,0
206258,of,0,0
206259,AMSA,1,0
206260,.,1,0
206261,At,0,0
206262,the,0,0
206263,dose,0,1
206264,schedules,0,1
206265,investigated,0,0
206266,",",0,0
206267,and,0,0
206268,in,0,0
206269,a,0,0
206270,heavily,0,0
206271,pretreated,0,0
206272,patient,0,0
206273,population,0,0
206274,",",0,0
206275,AMSA,0,0
206276,had,0,0
206277,activity,0,0
206278,in,0,0
206279,childhood,0,0
206280,leukemia,0,0
206281,.,0,0
206282,However,0,0
206283,",",0,0
206284,the,0,0
206285,high,0,0
206286,incidence,0,0
206287,of,0,0
206288,severe,0,0
206289,",",0,0
206290,life-threatening,0,0
206291,",",0,0
206292,or,0,0
206293,fatal,0,0
206294,infections,0,0
206295,meant,0,0
206296,that,0,0
206297,the,0,0
206298,quality,0,0
206299,and,0,0
206300,quantity,0,0
206301,of,0,0
206302,responses,0,0
206303,and,0,0
206304,survival,0,0
206305,was,0,0
206306,not,0,0
206307,commensurate,0,0
206308,with,0,0
206309,the,0,0
206310,toxicity,0,0
206311,",",0,0
206312,and,0,0
206313,that,0,0
206314,it,0,0
206315,would,0,0
206316,be,0,0
206317,difficult,0,0
206318,to,0,0
206319,incorporate,0,0
206320,this,0,0
206321,drug,0,1
206322,into,0,0
206323,combination,0,0
206324,chemotherapy,0,0
206325,with,0,0
206326,other,0,0
206327,myelosuppressive,0,1
206328,agents,0,0
206329,.,0,0
206330,Carbon,1,0
206331,dioxide,1,1
206332,laser,1,1
206333,treatment,1,0
206334,of,0,0
206335,vaginal,0,0
206336,adenosis,0,0
206337,in,0,0
206338,DES-exposed,0,0
206339,offspring,0,0
206340,:,0,0
206341,a,0,0
206342,prospective,0,0
206343,study,0,0
206344,.,0,0
206345,Seventy-nine,0,0
206346,patients,0,0
206347,with,0,0
206348,history,0,0
206349,and,0,0
206350,physical,0,0
206351,findings,0,0
206352,characteristic,0,0
206353,of,0,0
206354,antenatal,0,0
206355,DES,0,0
206356,exposure,0,0
206357,were,0,0
206358,randomly,0,0
206359,divided,0,0
206360,into,0,0
206361,two,0,0
206362,groups,0,0
206363,.,0,0
206364,Fourty-four,0,0
206365,DES-exposed,0,0
206366,offspring,0,0
206367,had,0,0
206368,their,0,0
206369,vaginal,0,0
206370,adenosis,0,0
206371,treated,0,0
206372,with,0,0
206373,the,0,0
206374,carbon,1,0
206375,dioxide,1,1
206376,laser,1,1
206377,(,0,1
206378,group,0,0
206379,I,0,0
206380,),0,0
206381,",",0,0
206382,and,0,0
206383,the,0,0
206384,remaining,0,0
206385,35,0,0
206386,DES-exposed,0,0
206387,offspring,0,0
206388,(,0,1
206389,group,0,1
206390,II,0,1
206391,),0,0
206392,did,1,0
206393,not,1,0
206394,receive,1,0
206395,any,1,0
206396,specific,1,0
206397,treatment,1,0
206398,for,0,0
206399,this,0,0
206400,condition,0,0
206401,.,0,0
206402,Additionally,0,0
206403,",",0,0
206404,the,0,0
206405,79,0,0
206406,DES-exposed,0,0
206407,offspring,0,0
206408,were,0,0
206409,compared,0,0
206410,to,0,0
206411,an,0,0
206412,age-matched,0,0
206413,control,0,0
206414,population,0,0
206415,(,0,0
206416,group,0,0
206417,III,0,1
206418,),0,1
206419,.,0,0
206420,Treatment,0,0
206421,of,0,0
206422,vaginal,0,0
206423,adenosis,0,0
206424,with,0,0
206425,the,0,0
206426,carbon,1,0
206427,dioxide,1,1
206428,laser,1,1
206429,did,0,0
206430,not,0,0
206431,significantly,0,0
206432,reduce,0,0
206433,the,0,0
206434,incidence,0,0
206435,of,0,0
206436,development,0,0
206437,of,0,0
206438,new,0,0
206439,dysplasia,0,0
206440,in,0,0
206441,the,0,0
206442,DES-exposed,0,0
206443,offspring,0,0
206444,.,0,0
206445,This,0,0
206446,study,0,0
206447,also,0,0
206448,showed,0,0
206449,no,0,0
206450,statistical,0,0
206451,difference,0,0
206452,(,0,0
206453,p,0,0
206454,less,0,0
206455,than,0,0
206456,or,0,0
206457,equal,0,0
206458,to,0,0
206459,0.05,0,0
206460,),0,0
206461,in,0,0
206462,the,0,0
206463,incidence,0,0
206464,of,0,0
206465,dysplasia,0,0
206466,in,0,0
206467,DES-exposed,0,0
206468,offspring,0,0
206469,as,0,0
206470,compared,0,0
206471,to,0,0
206472,a,0,0
206473,control,0,0
206474,population,0,0
206475,.,0,0
206476,High-dose,1,1
206477,weekly,1,1
206478,fractionation,1,0
206479,radiotherapy,1,0
206480,in,0,0
206481,advanced,0,0
206482,cancer,0,0
206483,of,0,0
206484,the,0,0
206485,uterine,0,0
206486,cervix,0,0
206487,.,0,0
206488,A,0,0
206489,trial,0,0
206490,comparing,0,0
206491,two,0,0
206492,different,0,0
206493,radiotherapy,1,0
206494,techniques,0,0
206495,and,0,0
206496,schedules,0,0
206497,in,0,0
206498,the,0,0
206499,treatment,0,0
206500,of,0,0
206501,83,0,0
206502,patients,0,0
206503,with,0,0
206504,advanced,0,0
206505,cancer,0,0
206506,of,0,0
206507,the,0,0
206508,uterine,0,0
206509,cervix,0,1
206510,(,0,0
206511,stage,0,0
206512,IIIB,0,1
206513,),0,0
206514,employing,0,0
206515,external,1,0
206516,irradiation,1,0
206517,alone,0,0
206518,is,0,0
206519,described,0,0
206520,.,0,0
206521,The,0,0
206522,one,0,0
206523,technique,0,0
206524,",",0,0
206525,used,0,0
206526,routinely,0,0
206527,in,0,0
206528,this,0,0
206529,department,0,0
206530,",",0,0
206531,employed,0,0
206532,a,0,0
206533,conventional,0,0
206534,daily,0,1
206535,fractionation,0,0
206536,schedule,0,0
206537,while,0,0
206538,the,0,0
206539,other,0,0
206540,used,0,0
206541,a,0,0
206542,high-dose,0,1
206543,weekly,0,1
206544,fractionation,0,1
206545,regimen,0,1
206546,.,0,0
206547,The,0,0
206548,techniques,0,0
206549,are,0,0
206550,described,0,0
206551,.,0,0
206552,The,0,0
206553,aim,0,0
206554,of,0,0
206555,the,0,0
206556,trial,0,0
206557,was,0,0
206558,to,0,0
206559,compare,0,0
206560,the,0,0
206561,efficacy,0,0
206562,and,0,0
206563,morbidity,0,0
206564,of,0,0
206565,these,0,0
206566,two,0,0
206567,methods,0,0
206568,of,0,0
206569,treatment,0,0
206570,.,0,0
206571,Dose,0,0
206572,distribution,0,0
206573,curves,0,0
206574,in,0,0
206575,cross-section,0,0
206576,and,0,0
206577,midsagittal,0,0
206578,planes,0,0
206579,are,0,0
206580,shown,0,0
206581,and,0,0
206582,calculations,0,0
206583,or,0,0
206584,equivalent,0,0
206585,doses,0,1
206586,at,0,0
206587,various,0,0
206588,selected,0,0
206589,points,0,0
206590,using,0,0
206591,Ellis,0,0
206592,'s,0,0
206593,nominal,0,1
206594,single-dose,0,1
206595,formula,0,1
206596,are,0,1
206597,tabulated,0,0
206598,.,0,0
206599,The,0,0
206600,2-year,0,0
206601,survival,0,0
206602,figures,0,0
206603,were,0,0
206604,33,0,0
206605,%,0,0
206606,for,0,0
206607,the,0,0
206608,daily,0,1
206609,fractionation,0,0
206610,technique,0,0
206611,and,0,0
206612,22,0,0
206613,%,0,0
206614,for,0,0
206615,the,0,0
206616,weekly,0,1
206617,regimen,0,1
206618,.,0,1
206619,Serious,0,0
206620,late,0,0
206621,complication,0,0
206622,rates,0,0
206623,were,0,0
206624,6,0,0
206625,%,0,0
206626,for,0,0
206627,the,0,0
206628,daily,0,1
206629,regimen,0,1
206630,and,0,0
206631,22,0,0
206632,%,0,0
206633,for,0,0
206634,the,0,0
206635,weekly,0,0
206636,schedule,0,0
206637,.,0,0
206638,These,0,0
206639,differences,0,0
206640,are,0,0
206641,not,0,0
206642,statistically,0,0
206643,significant,0,0
206644,.,0,0
206645,Late,0,0
206646,complication,0,0
206647,rates,0,0
206648,in,0,0
206649,the,0,0
206650,weekly,0,0
206651,fractionation,0,0
206652,regimen,0,1
206653,appeared,0,0
206654,to,0,0
206655,be,0,0
206656,lower,0,0
206657,than,0,0
206658,figures,0,0
206659,quoted,0,0
206660,by,0,0
206661,other,0,0
206662,authors,0,0
206663,.,0,0
206664,Local,0,0
206665,control,0,0
206666,within,0,0
206667,the,0,0
206668,irradiated,0,0
206669,volume,0,0
206670,was,0,0
206671,better,0,0
206672,in,0,0
206673,the,0,0
206674,group,0,0
206675,treated,0,0
206676,by,0,0
206677,the,0,0
206678,daily,0,1
206679,fractionation,0,0
206680,method,0,0
206681,.,0,0
206682,Two,0,1
206683,blind,0,1
206684,randomized,0,1
206685,cross-over,0,1
206686,trials,0,1
206687,in,0,0
206688,the,0,0
206689,treatment,0,0
206690,of,0,0
206691,primary,0,0
206692,open,0,0
206693,angle,0,0
206694,glaucoma,0,0
206695,.,0,0
206696,We,0,0
206697,present,0,0
206698,the,0,0
206699,results,0,0
206700,of,0,0
206701,two,0,0
206702,blind,0,0
206703,randomized,0,0
206704,trials,0,0
206705,comparing,0,0
206706,both,0,0
206707,guanethidine,1,1
206708,3,1,0
206709,per,1,0
206710,cent,1,0
206711,and,1,0
206712,adrenaline,1,1
206713,0.5,1,0
206714,per,1,0
206715,cent,1,0
206716,(,1,0
206717,Ganda,1,0
206718,3.0/0.5,1,0
206719,),1,0
206720,and,0,0
206721,guanethidine,1,1
206722,1,1,1
206723,per,1,0
206724,cent,1,0
206725,and,0,0
206726,adrenaline,1,0
206727,0.2,1,0
206728,per,1,0
206729,cent,1,0
206730,(,1,0
206731,Ganda,1,0
206732,1.0/0.2,1,0
206733,),1,0
206734,in,0,0
206735,single,0,0
206736,drop,0,0
206737,form,0,0
206738,with,0,1
206739,Timolol,1,1
206740,(,1,1
206741,Timoptol,1,1
206742,),1,1
206743,0.25,1,0
206744,per,1,0
206745,cent,1,0
206746,.,1,0
206747,Results,0,0
206748,of,0,0
206749,48-hour,0,1
206750,phasing,0,0
206751,at,0,0
206752,the,0,0
206753,end,0,0
206754,of,0,0
206755,one,0,0
206756,month,0,0
206757,'s,0,0
206758,treatment,0,0
206759,demonstrated,0,0
206760,a,0,0
206761,significantly,0,0
206762,greater,0,0
206763,fall,0,0
206764,in,0,0
206765,intraocular,0,0
206766,pressure,0,0
206767,with,0,0
206768,Ganda,1,0
206769,3.0/0.5,1,0
206770,(,0,0
206771,9.8,0,0
206772,mm,0,0
206773,Hg,0,0
206774,),0,1
206775,than,0,0
206776,with,0,1
206777,Timolol,1,1
206778,0.25,1,0
206779,per,1,0
206780,cent,1,0
206781,(,0,0
206782,7.67,0,0
206783,mm,0,0
206784,Hg,0,0
206785,),0,0
206786,P,0,0
206787,less,0,0
206788,than,0,0
206789,0.001,0,0
206790,.,0,0
206791,There,0,0
206792,was,0,0
206793,no,0,0
206794,significant,0,0
206795,difference,0,0
206796,in,0,0
206797,the,0,0
206798,fall,0,0
206799,in,0,0
206800,intraocular,0,0
206801,pressure,0,0
206802,between,0,0
206803,Ganda,1,0
206804,1.0/0.2,1,0
206805,(,0,0
206806,8.87,0,0
206807,mm,0,0
206808,Hg,0,0
206809,),0,1
206810,and,0,1
206811,Timolol,1,1
206812,0.25,1,0
206813,per,1,0
206814,cent,1,0
206815,(,0,0
206816,8.24,0,0
206817,mm,0,0
206818,Hg,0,0
206819,),0,0
206820,.,0,0
206821,Changes,0,0
206822,in,0,0
206823,heart,0,0
206824,rate,0,0
206825,and,0,0
206826,forearm,0,0
206827,blood,0,0
206828,flow,0,0
206829,following,0,0
206830,intravenous,0,1
206831,boluses,0,1
206832,of,0,1
206833,isoprenaline,1,1
206834,in,0,0
206835,the,0,0
206836,presence,0,0
206837,of,0,0
206838,practolol,0,1
206839,and,0,1
206840,propranolol,0,1
206841,.,0,1
206842,1,0,0
206843,Increases,0,0
206844,in,0,0
206845,heart,0,0
206846,rate,0,0
206847,and,0,0
206848,forearm,0,0
206849,blood,0,0
206850,flow,0,0
206851,following,0,0
206852,graded,0,0
206853,intravenous,0,1
206854,bolus,0,1
206855,injections,0,1
206856,of,0,1
206857,isoprenaline,1,1
206858,sulphate,1,1
206859,",",0,1
206860,were,0,0
206861,measured,0,0
206862,in,0,0
206863,a,0,0
206864,double-blind,0,1
206865,randomised,0,1
206866,study,0,0
206867,of,0,0
206868,six,0,0
206869,subjects,0,0
206870,who,0,0
206871,received,0,0
206872,either,0,0
206873,placebo,1,1
206874,",",1,1
206875,practolol,1,1
206876,50,1,1
206877,mg,1,1
206878,",",1,1
206879,practolol,1,1
206880,200,1,1
206881,mg,1,1
206882,",",1,1
206883,propranolol,1,1
206884,10,1,1
206885,mg,1,1
206886,or,1,1
206887,propranolol,1,1
206888,40,1,1
206889,mg.,1,1
206890,2,0,1
206891,Dose,0,0
206892,related,0,0
206893,increases,0,0
206894,in,0,0
206895,forearm,0,0
206896,blood,0,0
206897,flow,0,0
206898,were,0,0
206899,produced,0,0
206900,by,0,0
206901,the,0,0
206902,graded,0,0
206903,boluses,0,1
206904,of,0,1
206905,isoprenaline,1,1
206906,sulphate,1,1
206907,.,1,1
206908,3,0,1
206909,Practolol,1,1
206910,50,0,1
206911,mg,0,1
206912,attenuated,0,0
206913,the,0,0
206914,heart,0,0
206915,rate,0,0
206916,response,0,0
206917,to,0,0
206918,isoprenaline,0,1
206919,but,0,0
206920,did,0,0
206921,not,0,0
206922,significantly,0,0
206923,affect,0,0
206924,the,0,0
206925,changes,0,0
206926,in,0,0
206927,forearm,0,0
206928,blood,0,0
206929,flow,0,0
206930,.,0,0
206931,Practolol,1,1
206932,200,0,1
206933,mg,0,1
206934,further,0,0
206935,attenuated,0,0
206936,the,0,0
206937,heart,0,0
206938,rate,0,0
206939,responses,0,0
206940,but,0,0
206941,also,0,0
206942,decreased,0,0
206943,the,0,0
206944,forearm,0,0
206945,blood,0,0
206946,flow,0,0
206947,responses,0,0
206948,.,0,0
206949,4,0,0
206950,Propranolol,1,1
206951,10,0,1
206952,mg,0,1
206953,and,0,1
206954,propranolol,0,1
206955,40,0,1
206956,mg,0,1
206957,significantly,0,0
206958,attenuated,0,0
206959,both,0,0
206960,the,0,0
206961,heart,0,0
206962,rate,0,0
206963,and,0,0
206964,forearm,0,0
206965,blood,0,0
206966,flow,0,0
206967,responses,0,0
206968,.,0,0
206969,The,0,0
206970,effect,0,0
206971,on,0,0
206972,forearm,0,0
206973,blood,0,0
206974,flow,0,0
206975,tended,0,0
206976,to,0,0
206977,be,0,0
206978,greater,0,0
206979,than,0,0
206980,the,0,0
206981,effect,0,0
206982,on,0,0
206983,heart,0,0
206984,rate,0,0
206985,.,0,0
206986,5,0,0
206987,Practolol,1,1
206988,200,0,1
206989,mg,0,1
206990,had,0,0
206991,the,0,0
206992,same,0,0
206993,effect,0,0
206994,on,0,0
206995,heart,0,0
206996,rate,0,0
206997,responses,0,0
206998,as,0,0
206999,propranolol,1,1
207000,10,0,1
207001,mg,0,1
207002,but,0,0
207003,a,0,0
207004,significantly,0,0
207005,smaller,0,0
207006,effect,0,0
207007,on,0,0
207008,the,0,0
207009,forearm,0,0
207010,blood,0,0
207011,flow,0,0
207012,responses,0,0
207013,.,0,0
207014,6,0,0
207015,The,0,0
207016,measurement,0,0
207017,of,0,0
207018,forearm,0,0
207019,blood,0,0
207020,flow,0,0
207021,following,0,0
207022,intravenous,0,1
207023,bolus,0,1
207024,injections,0,1
207025,of,0,1
207026,isoprenaline,0,1
207027,provides,0,0
207028,useful,0,0
207029,information,0,0
207030,about,0,0
207031,the,0,0
207032,beta,0,1
207033,2-adrenoceptor,0,1
207034,antagonism,0,1
207035,of,0,1
207036,propranolol,1,1
207037,and,0,1
207038,practolol,1,1
207039,.,0,0
207040,However,0,0
207041,",",0,0
207042,application,0,0
207043,of,0,0
207044,the,0,0
207045,technique,0,0
207046,may,0,0
207047,be,0,0
207048,limited,0,0
207049,by,0,0
207050,the,0,0
207051,magnitude,0,0
207052,of,0,0
207053,the,0,0
207054,heart,0,0
207055,rate,0,0
207056,response,0,0
207057,and,0,0
207058,by,0,0
207059,the,0,0
207060,short-lived,0,0
207061,nature,0,0
207062,of,0,0
207063,the,0,0
207064,increase,0,0
207065,in,0,0
207066,forearm,0,0
207067,blood,0,0
207068,flow,0,0
207069,.,0,0
207070,Postoperative,0,0
207071,dreaming,0,0
207072,.,0,0
207073,A,0,0
207074,comparison,0,0
207075,of,0,0
207076,the,0,0
207077,incidence,0,0
207078,following,0,0
207079,pentazocine,1,1
207080,and,0,1
207081,morphine,1,1
207082,premedication,0,1
207083,.,0,1
207084,The,0,0
207085,incidence,0,0
207086,of,0,0
207087,postoperative,0,0
207088,dreaming,0,0
207089,following,0,0
207090,the,0,0
207091,use,0,0
207092,of,0,0
207093,morphine,1,1
207094,and,1,1
207095,pentazocine,1,1
207096,as,0,1
207097,premedicants,0,1
207098,in,0,0
207099,an,0,0
207100,otherwise,0,0
207101,standard,0,0
207102,anaesthetic,0,0
207103,sequence,0,0
207104,is,0,0
207105,compared,0,0
207106,in,0,0
207107,healthy,0,0
207108,volunteers,0,0
207109,.,0,0
207110,No,0,1
207111,statistically,0,0
207112,significant,0,0
207113,difference,0,0
207114,was,0,0
207115,demonstrated,0,0
207116,between,0,0
207117,the,0,0
207118,two,0,0
207119,drugs,0,1
207120,.,0,0
207121,The,0,0
207122,causes,0,0
207123,of,0,0
207124,psychotomimetic,0,1
207125,problems,0,1
207126,in,0,0
207127,the,0,0
207128,postoperative,0,0
207129,period,0,0
207130,and,0,0
207131,the,0,0
207132,difficulty,0,0
207133,of,0,0
207134,precise,0,0
207135,definition,0,0
207136,of,0,0
207137,hallucinations,0,0
207138,are,0,0
207139,discussed,0,0
207140,.,0,0
207141,[,1,1
207142,Median,1,0
207143,and,1,0
207144,mediolateral,1,1
207145,episiotomy,1,1
207146,],1,0
207147,.,0,0
207148,Comparison,0,0
207149,of,0,0
207150,antihypertensive,0,1
207151,effects,0,0
207152,of,0,0
207153,captopril,1,1
207154,and,1,1
207155,propranolol,1,1
207156,in,0,0
207157,essential,0,0
207158,hypertension,0,0
207159,.,0,0
207160,The,0,0
207161,antihypertensive,0,1
207162,effects,0,0
207163,of,0,0
207164,the,0,0
207165,oral,0,1
207166,converting,0,0
207167,enzyme,0,0
207168,inhibitor,0,1
207169,captopril,1,1
207170,and,1,1
207171,of,1,0
207172,propranolol,1,1
207173,were,0,0
207174,evaluated,0,0
207175,in,0,0
207176,a,0,0
207177,single-blind,0,1
207178,trial,0,1
207179,of,0,0
207180,12,0,0
207181,weeks,0,0
207182,in,0,0
207183,19,0,0
207184,ambulatory,0,0
207185,men,0,0
207186,with,0,0
207187,moderated,0,0
207188,essential,0,0
207189,hypertension,0,0
207190,(,0,0
207191,supine,0,1
207192,diastolic,0,1
207193,blood,0,1
207194,pressure,0,1
207195,[,0,1
207196,DPB,0,1
207197,],0,1
207198,",",0,0
207199,100,0,0
207200,to,0,0
207201,120,0,0
207202,mm,0,0
207203,Hg,0,0
207204,after,0,0
207205,receiving,0,0
207206,placebo,1,1
207207,for,0,0
207208,two,0,0
207209,weeks,0,0
207210,),0,0
207211,whose,0,1
207212,sodium,0,1
207213,intake,0,1
207214,was,0,0
207215,unrestricted,0,0
207216,.,0,0
207217,The,0,0
207218,captopril,1,1
207219,group,0,0
207220,included,0,0
207221,12,0,0
207222,patients,0,0
207223,and,0,0
207224,the,0,0
207225,propranolol,1,1
207226,group,0,0
207227,seven,0,0
207228,.,0,0
207229,After,0,0
207230,the,0,0
207231,initial,0,0
207232,dose-finding,0,1
207233,period,0,1
207234,of,0,0
207235,four,0,0
207236,weeks,0,0
207237,",",0,0
207238,supine,0,0
207239,DBP,0,0
207240,was,0,0
207241,significantly,0,0
207242,reduced,0,0
207243,in,0,0
207244,eight,0,0
207245,patients,0,0
207246,receiving,0,0
207247,captopril,1,1
207248,and,0,0
207249,in,0,0
207250,four,0,0
207251,of,0,0
207252,the,0,0
207253,patients,0,0
207254,receiving,0,0
207255,propranolol,1,1
207256,.,1,1
207257,In,0,0
207258,these,0,0
207259,patients,0,0
207260,DBP,0,0
207261,decreased,0,0
207262,throughout,0,0
207263,the,0,0
207264,following,0,0
207265,eight,0,0
207266,weeks,0,0
207267,.,0,0
207268,In,0,0
207269,the,0,0
207270,remaining,0,0
207271,patients,0,0
207272,from,0,0
207273,each,0,0
207274,group,0,0
207275,",",0,0
207276,DBP,0,0
207277,was,0,0
207278,not,0,0
207279,reduced,0,0
207280,by,0,0
207281,either,0,0
207282,drug,0,1
207283,given,0,1
207284,alone,0,0
207285,at,0,0
207286,maximum,0,0
207287,allowable,0,0
207288,dosages,0,1
207289,during,0,1
207290,dose-finding,0,1
207291,periods,0,1
207292,",",0,0
207293,nor,0,0
207294,by,0,0
207295,combined,0,0
207296,administration,0,1
207297,in,0,0
207298,following,0,0
207299,weeks,0,0
207300,.,0,0
207301,No,0,1
207302,adverse,0,0
207303,side,0,0
207304,effects,0,0
207305,attributable,0,0
207306,to,0,0
207307,captopril,1,1
207308,were,0,0
207309,noted,0,0
207310,",",0,0
207311,except,0,0
207312,in,0,0
207313,one,0,0
207314,patient,0,0
207315,in,0,0
207316,whom,0,1
207317,proteinuria,0,1
207318,developed,0,0
207319,after,0,0
207320,seven,0,0
207321,weeks,0,0
207322,.,0,0
207323,Captopril,1,1
207324,has,0,0
207325,potential,0,0
207326,value,0,0
207327,in,0,0
207328,the,0,0
207329,treatment,0,0
207330,of,0,0
207331,moderate,0,0
207332,essential,0,0
207333,hypertension,0,0
207334,.,0,0
207335,Bacteremia,0,0
207336,due,0,0
207337,to,0,0
207338,Bacteroides,0,1
207339,fragilis,0,1
207340,after,0,0
207341,elective,0,0
207342,appendectomy,0,0
207343,in,0,0
207344,renal,0,0
207345,transplant,0,0
207346,recipients,0,0
207347,.,0,0
207348,Bacteremia,0,0
207349,caused,0,0
207350,by,0,0
207351,Bacteroides,0,1
207352,fragilis,0,1
207353,occurred,0,0
207354,in,0,0
207355,four,0,0
207356,of,0,0
207357,75,0,0
207358,children,0,0
207359,after,0,0
207360,renal,0,0
207361,transplantation,0,0
207362,",",0,0
207363,and,0,0
207364,B.,0,1
207365,fragilis,0,1
207366,was,0,0
207367,the,0,0
207368,most,0,0
207369,common,0,0
207370,cause,0,0
207371,of,0,0
207372,postoperative,0,0
207373,bacteremia,0,0
207374,.,0,0
207375,Bacteroides,0,0
207376,bacteremia,0,0
207377,was,0,0
207378,significantly,0,0
207379,associated,0,0
207380,with,0,0
207381,performance,0,0
207382,of,0,0
207383,elective,1,0
207384,appendectomy,1,0
207385,at,0,0
207386,the,0,0
207387,time,0,0
207388,of,0,0
207389,transplantation,0,0
207390,(,0,0
207391,P,0,0
207392,less,0,0
207393,than,0,0
207394,0.01,0,0
207395,),0,0
207396,and,0,0
207397,with,0,0
207398,profound,0,0
207399,lymphocytopenia,0,0
207400,(,0,0
207401,P,0,0
207402,=,0,0
207403,0.01,0,0
207404,),0,0
207405,.,0,0
207406,No,0,1
207407,patient,0,1
207408,received,0,0
207409,antibiotics,1,1
207410,at,0,0
207411,the,0,0
207412,time,0,0
207413,of,0,0
207414,surgery,0,0
207415,or,0,0
207416,prior,0,0
207417,to,0,0
207418,the,0,0
207419,first,0,0
207420,positive,0,0
207421,blood,0,0
207422,culture,0,0
207423,",",0,0
207424,yet,0,0
207425,B.,0,1
207426,fragilis,0,1
207427,was,0,0
207428,the,0,0
207429,single,0,0
207430,organism,0,0
207431,isolated,0,0
207432,from,0,0
207433,blood,0,0
207434,and,0,0
207435,abscesses,0,0
207436,in,0,0
207437,these,0,0
207438,patients,0,0
207439,.,0,0
207440,A,0,0
207441,role,0,0
207442,for,0,0
207443,lymphocytes,0,0
207444,in,0,0
207445,containment,0,0
207446,of,0,0
207447,B.,0,1
207448,fragilis,0,1
207449,has,0,0
207450,not,0,0
207451,been,0,0
207452,suggested,0,0
207453,previously,0,0
207454,",",0,0
207455,although,0,0
207456,unexplained,0,0
207457,occurrence,0,0
207458,of,0,0
207459,bacteroides,0,1
207460,bacteremia,0,1
207461,in,0,0
207462,immunocompromised,0,0
207463,patients,0,0
207464,has,0,0
207465,occasionally,0,0
207466,been,0,0
207467,reported,0,0
207468,.,0,0
207469,Lymphocytes,0,0
207470,themselves,0,0
207471,may,0,0
207472,be,0,0
207473,important,0,0
207474,in,0,0
207475,this,0,0
207476,host-bacterium,0,0
207477,interaction,0,0
207478,",",0,0
207479,or,0,0
207480,lymphocytopenia,0,0
207481,may,0,0
207482,be,0,0
207483,the,0,0
207484,marker,0,0
207485,for,0,0
207486,a,0,0
207487,more,0,0
207488,generalized,0,0
207489,deficiency,0,0
207490,in,0,0
207491,host,0,0
207492,defenses,0,0
207493,.,0,0
207494,Multimodal,0,0
207495,therapy,0,0
207496,for,0,0
207497,the,0,0
207498,management,0,0
207499,of,0,0
207500,primary,0,0
207501,",",0,0
207502,nonmetastatic,0,0
207503,Ewing,0,0
207504,'s,0,0
207505,sarcoma,0,0
207506,of,0,0
207507,bone,0,0
207508,:,0,0
207509,an,0,0
207510,Intergroup,0,0
207511,Study,0,0
207512,.,0,0
207513,A,0,0
207514,randomized,0,0
207515,study,0,0
207516,of,0,0
207517,264,0,0
207518,children,0,0
207519,and,0,0
207520,adults,0,0
207521,with,0,0
207522,previously,0,0
207523,untreated,0,0
207524,localized,0,0
207525,Ewing,0,0
207526,'s,0,0
207527,sarcoma,0,0
207528,of,0,0
207529,bone,0,0
207530,was,0,0
207531,undertaken,0,0
207532,between,0,0
207533,1973,0,0
207534,and,0,0
207535,1978,0,0
207536,by,0,0
207537,83,0,0
207538,institutions,0,0
207539,of,0,0
207540,three,0,0
207541,national,0,0
207542,study,0,0
207543,groups,0,0
207544,:,0,0
207545,Children,0,0
207546,'s,0,0
207547,Cancer,0,0
207548,Study,0,0
207549,Group,0,0
207550,",",0,0
207551,Southwest,0,0
207552,Oncology,0,0
207553,Group,0,0
207554,",",0,0
207555,and,0,0
207556,Cancer,0,0
207557,and,0,0
207558,Leukemia,0,0
207559,Group,0,0
207560,B,0,0
207561,.,0,0
207562,The,0,0
207563,Intergroup,0,0
207564,Study,0,0
207565,was,0,0
207566,designed,0,0
207567,to,0,0
207568,determine,0,0
207569,if,0,0
207570,the,0,0
207571,addition,1,0
207572,of,1,0
207573,adriamycin,1,1
207574,(,1,1
207575,ADR,1,1
207576,),1,1
207577,or,1,0
207578,bilateral,1,1
207579,pulmonary,1,1
207580,radiotherapy,1,1
207581,(,1,1
207582,RT,1,1
207583,),1,1
207584,to,1,0
207585,vincristine,1,1
207586,",",1,1
207587,dactinomycin,1,1
207588,",",1,1
207589,and,1,1
207590,cyclophosphamide,1,1
207591,(,1,1
207592,VAC,1,1
207593,therapy,1,1
207594,),1,0
207595,would,0,0
207596,improve,0,0
207597,survival,0,0
207598,and,0,0
207599,reduce,0,0
207600,local,0,0
207601,recurrences,0,0
207602,and,0,0
207603,metastases,0,0
207604,.,0,0
207605,All,0,0
207606,patients,0,0
207607,received,0,0
207608,RT,1,0
207609,to,0,0
207610,the,0,0
207611,primary,0,0
207612,lesion,0,0
207613,",",0,0
207614,and,0,0
207615,the,0,0
207616,survival,0,0
207617,rate,0,0
207618,after,0,0
207619,3,0,0
207620,years,0,0
207621,was,0,0
207622,65,0,0
207623,%,0,0
207624,.,0,0
207625,The,0,0
207626,most,0,0
207627,effective,0,0
207628,treatment,0,0
207629,regimen,0,1
207630,was,0,0
207631,VAC,0,0
207632,plus,0,0
207633,ADR,0,0
207634,;,0,0
207635,74,0,0
207636,%,0,0
207637,of,0,0
207638,the,0,0
207639,patients,0,0
207640,were,0,0
207641,free,0,0
207642,of,0,0
207643,disease,0,0
207644,at,0,0
207645,2,0,0
207646,years,0,0
207647,.,0,0
207648,The,0,0
207649,lengths,0,0
207650,of,0,0
207651,disease-free,0,0
207652,status,0,0
207653,and,0,0
207654,survival,0,0
207655,of,0,0
207656,patients,0,0
207657,treated,0,0
207658,with,0,0
207659,VAC,0,0
207660,plus,0,0
207661,ADR,0,0
207662,or,0,0
207663,VAC,0,0
207664,plus,0,0
207665,RT,0,0
207666,did,0,0
207667,not,0,0
207668,differ,0,0
207669,.,0,0
207670,However,0,0
207671,",",0,0
207672,both,0,0
207673,regimens,0,1
207674,were,0,0
207675,significantly,0,0
207676,superior,0,0
207677,to,0,0
207678,treatment,0,0
207679,with,0,0
207680,VAC,0,0
207681,alone,0,0
207682,.,0,0
207683,The,0,0
207684,addition,0,0
207685,of,0,0
207686,ADR,1,0
207687,or,0,0
207688,bilateral,0,0
207689,pulmonary,0,0
207690,RT,0,0
207691,to,0,0
207692,VAC,1,0
207693,was,0,0
207694,highly,0,0
207695,advantageous,0,0
207696,to,0,0
207697,patients,0,0
207698,with,0,0
207699,nonpelvic,0,0
207700,primaries,0,1
207701,.,0,1
207702,Bone,0,1
207703,and,0,0
207704,lung,0,0
207705,were,0,0
207706,the,0,0
207707,major,0,0
207708,sites,0,0
207709,of,0,0
207710,distant,0,0
207711,relapse,0,0
207712,",",0,0
207713,but,0,0
207714,the,0,0
207715,addition,0,0
207716,of,0,0
207717,bilateral,0,0
207718,pulmonary,0,0
207719,RT,0,0
207720,showed,0,0
207721,no,0,0
207722,advantage,0,0
207723,over,0,0
207724,that,0,0
207725,of,0,0
207726,ADR,0,0
207727,in,0,0
207728,reducing,0,0
207729,the,0,0
207730,occurrence,0,0
207731,of,0,0
207732,lung,0,0
207733,metastases,0,0
207734,.,0,0
207735,These,0,0
207736,recent,0,0
207737,results,0,0
207738,should,0,0
207739,eliminate,0,0
207740,some,0,0
207741,of,0,0
207742,the,0,0
207743,pessimism,0,0
207744,that,0,0
207745,has,0,0
207746,accompanied,0,0
207747,a,0,0
207748,diagnosis,0,0
207749,of,0,0
207750,Ewing,0,0
207751,'s,0,0
207752,sarcoma,0,0
207753,",",0,0
207754,although,0,0
207755,distant,0,0
207756,metastases,0,0
207757,continued,0,0
207758,to,0,0
207759,be,0,0
207760,a,0,0
207761,major,0,0
207762,reason,0,0
207763,for,0,0
207764,failure,0,0
207765,in,0,0
207766,the,0,0
207767,control,0,0
207768,of,0,0
207769,this,0,0
207770,tumor,0,0
207771,.,0,0
207772,Survival,0,0
207773,of,0,0
207774,these,0,0
207775,patients,0,0
207776,can,0,0
207777,be,0,0
207778,improved,0,0
207779,through,0,0
207780,well-controlled,0,0
207781,clinical,0,0
207782,trials,0,0
207783,designed,0,0
207784,to,0,0
207785,determine,0,0
207786,optimal,0,0
207787,adjuvant,0,1
207788,chemotherapy,0,1
207789,and,0,0
207790,treatment,0,0
207791,of,0,0
207792,the,0,0
207793,primary,0,0
207794,lesion,0,0
207795,.,0,0
207796,Antibiotic,0,0
207797,therapy,0,0
207798,of,0,0
207799,acute,0,0
207800,exacerbations,0,0
207801,of,0,0
207802,chronic,0,0
207803,bronchitis,0,0
207804,.,0,0
207805,A,0,0
207806,controlled,0,0
207807,study,0,0
207808,using,0,0
207809,tetracycline,1,1
207810,.,1,0
207811,We,0,0
207812,conducted,0,0
207813,a,0,0
207814,double-blind,0,1
207815,",",0,1
207816,randomized,0,1
207817,",",0,1
207818,placebo-controlled,1,1
207819,trial,0,1
207820,in,0,0
207821,40,0,0
207822,patients,0,0
207823,to,0,0
207824,evaluate,0,0
207825,the,0,0
207826,need,0,0
207827,for,0,0
207828,antibiotics,0,1
207829,in,0,0
207830,acute,0,1
207831,exacerbations,0,0
207832,of,0,0
207833,chronic,0,0
207834,bronchitis,0,0
207835,.,0,0
207836,All,0,0
207837,patients,0,0
207838,were,0,0
207839,sufficiently,0,0
207840,ill,0,0
207841,to,0,0
207842,require,0,0
207843,hospitalization,0,0
207844,although,0,0
207845,none,0,0
207846,needed,0,0
207847,ventilatory,0,1
207848,support,0,1
207849,;,0,0
207850,the,0,0
207851,presence,0,0
207852,of,0,0
207853,pneumonia,0,0
207854,was,0,0
207855,excluded,0,0
207856,.,0,0
207857,Treatment,0,0
207858,consisted,0,0
207859,of,0,0
207860,bronchodilators,1,1
207861,",",1,1
207862,corticosteroids,1,1
207863,",",0,1
207864,and,0,0
207865,either,0,0
207866,tetracycline,1,1
207867,",",0,1
207868,500,0,1
207869,mg,0,1
207870,",",0,1
207871,or,1,1
207872,placebo,1,1
207873,by,0,1
207874,mouth,0,1
207875,every,0,1
207876,6,0,1
207877,hours,0,0
207878,for,0,0
207879,1,0,0
207880,week,0,0
207881,.,0,0
207882,Arterial,0,0
207883,blood,0,0
207884,gases,0,1
207885,",",0,0
207886,spirometric,0,0
207887,tests,0,0
207888,",",0,0
207889,bacteriologic,0,0
207890,evaluation,0,0
207891,of,0,0
207892,sputum,0,0
207893,",",0,0
207894,and,0,0
207895,patient,0,0
207896,and,0,0
207897,physician,0,0
207898,evaluation,0,0
207899,of,0,0
207900,the,0,0
207901,severity,0,0
207902,of,0,0
207903,illness,0,0
207904,were,0,0
207905,assessed,0,0
207906,at,0,0
207907,the,0,0
207908,beginning,0,0
207909,and,0,0
207910,end,0,0
207911,of,0,0
207912,the,0,0
207913,study,0,0
207914,.,0,0
207915,All,0,0
207916,patients,0,0
207917,improved,0,0
207918,both,0,0
207919,symptomatically,0,0
207920,and,0,0
207921,by,0,0
207922,objective,0,0
207923,measures,0,0
207924,of,0,0
207925,lung,0,0
207926,function,0,0
207927,.,0,0
207928,At,0,0
207929,the,0,0
207930,end,0,0
207931,of,0,0
207932,the,0,0
207933,study,0,0
207934,period,0,0
207935,there,0,0
207936,were,0,0
207937,no,0,0
207938,differences,0,0
207939,between,0,0
207940,those,0,0
207941,patients,0,0
207942,receiving,0,0
207943,tetracycline,0,1
207944,and,0,0
207945,those,0,0
207946,receiving,0,0
207947,placebo,1,1
207948,.,1,1
207949,We,0,0
207950,conclude,0,0
207951,that,0,0
207952,antibiotic,0,1
207953,therapy,0,1
207954,is,0,0
207955,not,0,0
207956,needed,0,0
207957,in,0,0
207958,moderately,0,0
207959,ill,0,0
207960,patients,0,0
207961,with,0,0
207962,exacerbations,0,0
207963,of,0,0
207964,chronic,0,0
207965,bronchitis,0,0
207966,.,0,0
207967,Intraoperative,1,0
207968,microscopy,1,0
207969,of,0,0
207970,bile,0,1
207971,--,0,0
207972,is,0,0
207973,it,0,0
207974,useful,0,0
207975,?,0,0
207976,Direct,1,0
207977,microscopy,1,0
207978,of,1,0
207979,the,1,0
207980,bile,1,1
207981,was,0,0
207982,performed,0,0
207983,during,0,0
207984,cholecystectomy,1,0
207985,in,0,0
207986,111,0,0
207987,patients,0,0
207988,in,0,0
207989,an,0,0
207990,attempt,0,0
207991,to,0,0
207992,identify,0,0
207993,those,0,0
207994,with,0,0
207995,a,0,0
207996,high,0,0
207997,risk,0,0
207998,of,0,0
207999,wound,0,0
208000,infection,0,0
208001,.,0,0
208002,Bacteria,0,0
208003,were,0,0
208004,identified,0,0
208005,in,0,0
208006,23,0,0
208007,patients,0,0
208008,",",0,0
208009,11,0,0
208010,of,0,0
208011,83,0,0
208012,undergoing,0,0
208013,cholecystectomy,1,0
208014,alone,0,0
208015,and,0,0
208016,12,0,0
208017,of,0,0
208018,28,0,0
208019,undergoing,0,0
208020,exploration,0,0
208021,of,0,0
208022,the,0,0
208023,common,0,0
208024,bile,0,1
208025,duct,0,0
208026,(,0,0
208027,P,0,0
208028,less,0,0
208029,than,0,0
208030,0.01,0,0
208031,),0,0
208032,.,0,0
208033,These,0,0
208034,23,0,0
208035,patients,0,0
208036,were,0,0
208037,randomly,0,0
208038,allocated,0,0
208039,to,0,0
208040,an,0,0
208041,antibiotic,1,1
208042,group,1,0
208043,or,0,0
208044,a,0,0
208045,control,0,0
208046,group,0,0
208047,;,0,0
208048,there,0,0
208049,was,0,0
208050,one,0,0
208051,wound,0,0
208052,infection,0,0
208053,in,0,0
208054,the,0,0
208055,antibiotic,1,1
208056,group,1,0
208057,and,0,0
208058,two,0,0
208059,in,0,0
208060,the,0,0
208061,control,1,0
208062,group,1,0
208063,.,1,0
208064,A,0,0
208065,total,0,0
208066,of,0,0
208067,14,0,0
208068,patients,0,0
208069,developed,0,0
208070,wound,0,0
208071,sepsis,0,0
208072,.,0,0
208073,Infection,0,0
208074,was,0,0
208075,more,0,0
208076,likely,0,0
208077,if,0,0
208078,the,0,0
208079,common,0,0
208080,bile,0,1
208081,duct,0,1
208082,was,0,0
208083,explored,0,0
208084,(,0,0
208085,6,0,0
208086,of,0,0
208087,28,0,0
208088,),0,0
208089,rather,0,0
208090,than,0,0
208091,cholecystectomy,1,0
208092,alone,0,0
208093,(,0,0
208094,8,0,0
208095,of,0,0
208096,83,0,0
208097,),0,0
208098,.,0,0
208099,There,0,0
208100,was,0,0
208101,a,0,0
208102,poor,0,0
208103,correlation,0,0
208104,between,0,0
208105,microscopy,0,0
208106,and,0,0
208107,culture,0,0
208108,of,0,0
208109,the,0,0
208110,bile,0,1
208111,for,0,0
208112,bacteria,0,0
208113,and,0,0
208114,there,0,0
208115,was,0,0
208116,no,0,0
208117,increase,0,0
208118,in,0,0
208119,sepsis,0,0
208120,when,0,0
208121,bacteria,0,0
208122,were,0,0
208123,observed,0,0
208124,on,0,0
208125,microscopy,0,0
208126,.,0,0
208127,We,0,0
208128,were,0,0
208129,not,0,0
208130,able,0,0
208131,to,0,0
208132,identify,0,0
208133,a,0,0
208134,high,0,0
208135,risk,0,0
208136,group,0,0
208137,of,0,0
208138,patients,0,0
208139,by,0,0
208140,intraoperative,0,0
208141,microscopy,0,0
208142,of,0,0
208143,bile,0,1
208144,.,0,0
208145,The,0,0
208146,pharmacokinetics,0,1
208147,of,0,0
208148,metronidazole,1,1
208149,and,1,1
208150,tinidazole,1,1
208151,in,0,0
208152,patients,0,0
208153,with,0,0
208154,mixed,0,0
208155,aerobic,0,0
208156,--,0,0
208157,anaerobic,0,0
208158,infections,0,0
208159,.,0,0
208160,Inhibition,0,0
208161,of,0,0
208162,spontaneous,0,0
208163,platelet,0,1
208164,aggregation,0,0
208165,and,0,0
208166,adhesion,0,0
208167,by,0,0
208168,indobufen,1,1
208169,(,1,1
208170,K,1,1
208171,3920,1,0
208172,),1,0
208173,.,1,0
208174,A,0,0
208175,randomized,0,1
208176,",",0,1
208177,double-blind,0,1
208178,crossover,0,1
208179,study,0,1
208180,on,0,0
208181,platelet,0,1
208182,",",0,0
208183,coagulation,0,1
208184,and,0,0
208185,fibrinolysis,0,0
208186,function,0,0
208187,tests,0,0
208188,.,0,0
208189,In,0,0
208190,a,0,0
208191,randomized,0,1
208192,double-blind,0,1
208193,crossover,0,1
208194,study,0,1
208195,in,0,0
208196,12,0,0
208197,patients,0,0
208198,with,0,0
208199,atherosclerotic,0,0
208200,disease,0,0
208201,",",0,0
208202,the,0,0
208203,effect,0,0
208204,of,0,0
208205,2,0,1
208206,dosages,0,1
208207,(,0,1
208208,100,0,0
208209,and,0,0
208210,200,0,1
208211,mg,0,1
208212,twice,0,1
208213,daily,0,1
208214,),0,1
208215,of,0,1
208216,indobufen,1,1
208217,",",0,0
208218,a,0,0
208219,new,0,0
208220,synthetic,0,0
208221,inhibition,0,0
208222,of,0,0
208223,platelet,0,1
208224,aggregation,0,0
208225,",",0,0
208226,on,0,0
208227,some,0,0
208228,platelet,0,1
208229,functions,0,0
208230,",",0,0
208231,coagulation,0,0
208232,and,0,0
208233,fibrinolysis,0,0
208234,tests,0,0
208235,was,0,0
208236,investigated,0,0
208237,.,0,0
208238,Regardless,0,0
208239,of,0,0
208240,the,0,0
208241,dosage,0,1
208242,used,0,1
208243,",",0,1
208244,indobufen,1,1
208245,was,0,0
208246,shown,0,0
208247,to,0,0
208248,induce,0,0
208249,a,0,0
208250,prompt,0,0
208251,normalization,0,0
208252,of,0,0
208253,the,0,0
208254,enhanced,0,0
208255,platelet,0,1
208256,aggregation,0,0
208257,of,0,0
208258,these,0,0
208259,patients,0,0
208260,.,0,0
208261,The,0,0
208262,effect,0,0
208263,lasted,0,0
208264,for,0,0
208265,the,0,0
208266,entire,0,0
208267,period,0,0
208268,of,0,0
208269,drug,0,1
208270,administration,0,1
208271,and,0,1
208272,in,0,0
208273,50,0,0
208274,%,0,0
208275,of,0,0
208276,patients,0,0
208277,a,0,0
208278,normal,0,0
208279,platelet,0,1
208280,aggregation,0,0
208281,was,0,0
208282,maintained,0,0
208283,until,0,0
208284,the,0,0
208285,fourth,0,0
208286,day,0,0
208287,after,0,0
208288,discontinuation,0,0
208289,of,0,0
208290,the,0,0
208291,drug,0,1
208292,.,0,1
208293,Indobufen,1,1
208294,was,0,0
208295,also,0,0
208296,able,0,0
208297,to,0,0
208298,reduce,0,0
208299,platelet,0,1
208300,adhesiveness,0,0
208301,and,0,0
208302,to,0,0
208303,lengthen,0,0
208304,bleeding,0,0
208305,time,0,0
208306,",",0,0
208307,especially,0,0
208308,when,0,0
208309,the,0,0
208310,higher,0,0
208311,dosage,0,1
208312,was,0,0
208313,used,0,0
208314,.,0,0
208315,Treatment,0,0
208316,of,0,0
208317,familial,0,0
208318,hypercholesterolemia,0,0
208319,with,0,0
208320,a,0,0
208321,combination,1,0
208322,of,1,0
208323,bezafibrate,1,1
208324,and,1,1
208325,guar,1,1
208326,.,1,0
208327,The,0,0
208328,effect,0,0
208329,of,0,0
208330,guar,1,1
208331,(,0,1
208332,15.6,0,1
208333,g/day,0,1
208334,),0,0
208335,",",0,1
208336,a,1,0
208337,dietary,1,1
208338,fibre,1,0
208339,",",0,0
208340,and,0,0
208341,simultaneous,0,0
208342,administration,0,1
208343,of,0,1
208344,bezafibrate,1,1
208345,(,0,1
208346,600,0,1
208347,mg/day,0,1
208348,),0,1
208349,during,0,0
208350,dietetic,0,0
208351,treatment,0,0
208352,on,0,0
208353,the,0,0
208354,plasma,0,1
208355,lipoproteins,0,1
208356,and,0,1
208357,apolipoproteins,0,1
208358,was,0,0
208359,investigated,0,0
208360,in,0,0
208361,12,0,0
208362,patients,0,0
208363,with,0,0
208364,familial,0,0
208365,hypercholesterolemia,0,1
208366,(,0,0
208367,corresponding,0,0
208368,to,0,0
208369,the,0,0
208370,HLP,0,0
208371,type,0,0
208372,IIa,0,1
208373,pattern,0,0
208374,),0,0
208375,.,0,0
208376,Either,1,0
208377,bezafibrate,1,1
208378,alone,1,0
208379,or,1,0
208380,bezafibrate,1,1
208381,in,1,0
208382,combination,1,0
208383,with,1,0
208384,guar,1,1
208385,was,1,0
208386,administered,1,1
208387,in,1,0
208388,a,1,0
208389,cross-over,1,1
208390,study,1,0
208391,for,1,0
208392,3,1,0
208393,months,1,0
208394,.,1,0
208395,Guar,1,0
208396,led,0,0
208397,to,0,0
208398,an,0,0
208399,additional,0,0
208400,lowering,0,0
208401,of,0,0
208402,the,0,0
208403,total,0,0
208404,cholesterol,0,1
208405,in,0,0
208406,the,0,0
208407,plasma,0,0
208408,by,0,0
208409,7,0,0
208410,%,0,0
208411,(,0,0
208412,P,0,0
208413,less,0,0
208414,than,0,0
208415,or,0,0
208416,equal,0,0
208417,to,0,0
208418,0.05,0,0
208419,),0,0
208420,associated,0,0
208421,with,0,0
208422,a,0,0
208423,fall,0,0
208424,of,0,0
208425,the,0,0
208426,low,0,0
208427,density,0,0
208428,lipoprotein,0,1
208429,cholesterol,0,1
208430,(,0,1
208431,LDL-cholesterol,0,1
208432,(,0,1
208433,LDL-cholesterol,0,1
208434,),0,1
208435,by,0,0
208436,13,0,0
208437,%,0,0
208438,(,0,0
208439,P,0,0
208440,less,0,0
208441,than,0,0
208442,or,0,0
208443,equal,0,0
208444,to,0,0
208445,0.01,0,0
208446,),0,0
208447,without,0,0
208448,any,0,0
208449,changes,0,0
208450,in,0,0
208451,the,0,0
208452,very,0,0
208453,low,0,0
208454,density,0,0
208455,lipoprotein,0,1
208456,(,0,1
208457,VLDL,0,1
208458,),0,1
208459,and,0,0
208460,high,0,0
208461,density,0,0
208462,lipoprotein,0,1
208463,(,0,1
208464,HDL,0,1
208465,),0,1
208466,cholesterols,0,1
208467,.,0,1
208468,In,0,0
208469,parallel,0,0
208470,with,0,0
208471,the,0,0
208472,decrease,0,0
208473,in,0,0
208474,LDL-cholesterol,0,1
208475,",",0,0
208476,the,0,0
208477,apoprotein,0,1
208478,B,0,1
208479,also,0,0
208480,was,0,0
208481,diminished,0,0
208482,by,0,0
208483,20,0,0
208484,%,0,0
208485,(,0,0
208486,P,0,0
208487,less,0,0
208488,than,0,0
208489,or,0,0
208490,equal,0,0
208491,to,0,0
208492,0.05,0,0
208493,),0,0
208494,.,0,0
208495,The,0,0
208496,plasma,0,1
208497,triglyceride,0,1
208498,level,0,0
208499,and,0,0
208500,the,0,0
208501,triglyceride,0,1
208502,distribution,0,0
208503,within,0,0
208504,the,0,0
208505,individual,0,0
208506,lipoprotein,0,1
208507,fractions,0,0
208508,were,0,0
208509,not,0,0
208510,altered,0,0
208511,in,0,0
208512,any,0,0
208513,consistent,0,0
208514,manner,0,0
208515,by,0,0
208516,the,0,0
208517,addition,0,0
208518,of,0,0
208519,guar,1,1
208520,.,1,0
208521,Neither,0,0
208522,the,0,0
208523,fasting,0,1
208524,plasma,0,1
208525,glucose,0,1
208526,level,0,0
208527,nor,0,0
208528,the,0,0
208529,body,0,0
208530,weight,0,0
208531,were,0,0
208532,affected,0,0
208533,.,0,0
208534,The,0,0
208535,side-effects,0,0
208536,due,0,0
208537,to,0,0
208538,guar,1,1
208539,treatment,1,0
208540,consisted,0,0
208541,of,0,0
208542,slight,0,0
208543,nausea,0,1
208544,",",0,1
208545,meteorism,0,1
208546,and,0,0
208547,constipation,0,0
208548,",",0,0
208549,but,0,0
208550,this,0,0
208551,did,0,0
208552,not,0,0
208553,in,0,0
208554,any,0,0
208555,of,0,0
208556,the,0,0
208557,cases,0,0
208558,lead,0,0
208559,to,0,0
208560,early,0,0
208561,termination,0,0
208562,of,0,0
208563,the,0,0
208564,study,0,0
208565,.,0,0
208566,These,0,0
208567,results,0,0
208568,demonstrate,0,0
208569,that,0,0
208570,guar,1,1
208571,exerts,0,0
208572,its,0,0
208573,cholesterol-lowering,0,1
208574,effect,0,0
208575,in,0,0
208576,addition,0,0
208577,to,0,0
208578,that,0,0
208579,of,0,0
208580,bezafibrate,1,1
208581,.,1,0
208582,Scaling,0,1
208583,clinical,0,0
208584,judgments,0,0
208585,of,0,0
208586,symptom,0,0
208587,pathology,0,0
208588,by,0,0
208589,means,0,0
208590,of,0,0
208591,the,0,0
208592,psychophysiological,0,0
208593,method,0,0
208594,of,0,0
208595,magnitude,0,0
208596,estimation,0,0
208597,.,0,0
208598,Summing,0,0
208599,scores,0,0
208600,across,0,0
208601,heterogeneous,0,0
208602,symptom,0,0
208603,items,0,0
208604,without,0,0
208605,consideration,0,0
208606,of,0,0
208607,their,0,0
208608,differing,0,0
208609,psychopathological,0,0
208610,significance,0,0
208611,has,0,0
208612,been,0,0
208613,criticized,0,0
208614,as,0,0
208615,producing,0,0
208616,an,0,0
208617,inadequate,0,0
208618,picture,0,0
208619,of,0,0
208620,an,0,0
208621,individual,0,0
208622,'s,0,0
208623,clinical,0,0
208624,status,0,0
208625,.,0,0
208626,The,0,0
208627,purpose,0,0
208628,of,0,0
208629,this,0,0
208630,study,0,0
208631,was,0,0
208632,to,0,0
208633,derive,0,0
208634,symptom,0,0
208635,item,0,0
208636,weights,0,0
208637,representing,0,0
208638,clinically,0,0
208639,judged,0,0
208640,seriousness,0,0
208641,of,0,0
208642,each,0,0
208643,symptom,0,0
208644,through,0,0
208645,the,0,0
208646,application,0,0
208647,of,0,0
208648,Steven,1,0
208649,'s,1,0
208650,psychophysical,1,0
208651,method,1,0
208652,of,1,0
208653,magnitude,1,0
208654,estimation,1,0
208655,.,1,0
208656,A,0,0
208657,nationwide,0,0
208658,sample,0,0
208659,of,0,0
208660,129,0,0
208661,clinicians,0,0
208662,rated,0,0
208663,the,0,0
208664,pathological,0,0
208665,significance,0,0
208666,of,0,0
208667,221,0,0
208668,symptom,0,0
208669,items,0,0
208670,in,0,0
208671,a,0,0
208672,design,0,0
208673,such,0,0
208674,that,0,0
208675,every,0,0
208676,rater,0,0
208677,rated,0,0
208678,121,0,0
208679,items,0,0
208680,",",0,0
208681,21,0,0
208682,of,0,0
208683,which,0,0
208684,were,0,0
208685,rated,0,0
208686,by,0,0
208687,all,0,0
208688,raters,0,0
208689,and,0,0
208690,100,0,0
208691,of,0,0
208692,which,0,0
208693,were,0,0
208694,rated,0,0
208695,only,0,0
208696,by,0,0
208697,the,0,0
208698,A,0,0
208699,or,0,0
208700,B,0,0
208701,subgroup,0,0
208702,to,0,0
208703,which,0,0
208704,each,0,0
208705,rater,0,0
208706,was,0,0
208707,randomly,0,0
208708,assigned,0,0
208709,.,0,0
208710,Each,0,0
208711,item,0,0
208712,was,0,0
208713,rated,0,0
208714,as,0,0
208715,to,0,0
208716,the,0,0
208717,seriousness,0,0
208718,of,0,0
208719,the,0,0
208720,pathology,0,0
208721,it,0,0
208722,would,0,0
208723,represent,0,0
208724,if,0,0
208725,manifested,0,0
208726,by,0,0
208727,either,0,0
208728,a,0,0
208729,boy,0,0
208730,child,0,0
208731,",",0,0
208732,girl,0,0
208733,child,0,0
208734,",",0,0
208735,boy,0,0
208736,adolescent,0,0
208737,",",0,0
208738,or,0,0
208739,girl,0,0
208740,adolescent,0,0
208741,",",0,0
208742,with,0,0
208743,one-fourth,0,0
208744,of,0,0
208745,the,0,0
208746,raters,0,0
208747,assigned,0,0
208748,to,0,0
208749,each,0,0
208750,condition,0,0
208751,.,0,0
208752,The,0,0
208753,results,0,0
208754,of,0,0
208755,211,0,0
208756,two-way,1,0
208757,analyses,1,0
208758,of,1,0
208759,variance,1,0
208760,revealed,0,0
208761,that,0,0
208762,age,0,0
208763,and,0,0
208764,age,0,0
208765,and,0,0
208766,sex,0,0
208767,in,0,0
208768,interaction,0,0
208769,",",0,0
208770,but,0,0
208771,not,0,0
208772,sex,0,0
208773,alone,0,0
208774,",",0,0
208775,significantly,0,0
208776,influenced,0,0
208777,the,0,0
208778,clinical,0,0
208779,ratings,0,0
208780,.,0,0
208781,The,0,0
208782,resulting,0,0
208783,magnitude,0,0
208784,estimation,0,0
208785,ratings,0,0
208786,of,0,0
208787,symptom,0,0
208788,pathology,0,0
208789,ranged,0,0
208790,from,0,0
208791,1.0,0,0
208792,to,0,0
208793,9.9,0,0
208794,.,0,0
208795,They,0,0
208796,were,0,0
208797,demonstrated,0,0
208798,to,0,0
208799,have,0,0
208800,satisfactoy,0,0
208801,reliability,0,0
208802,and,0,0
208803,convergent,0,0
208804,validity,0,0
208805,and,0,0
208806,to,0,0
208807,have,0,0
208808,the,0,0
208809,psychophysical,0,0
208810,characteristics,0,0
208811,of,0,0
208812,a,0,0
208813,prothetic,0,0
208814,continuum,0,0
208815,.,0,0
208816,Liquid,1,0
208817,antacids,1,1
208818,:,1,1
208819,palatability,0,1
208820,and,0,1
208821,predictability,0,1
208822,study,0,0
208823,.,0,0
208824,Corticosteroids,1,1
208825,plus,1,1
208826,pulse,1,1
208827,cyclophosphamide,1,1
208828,and,1,1
208829,plasma,1,1
208830,exchanges,1,1
208831,versus,0,0
208832,corticosteroids,1,1
208833,plus,1,1
208834,pulse,1,1
208835,cyclophosphamide,1,1
208836,alone,1,0
208837,in,0,0
208838,the,0,0
208839,treatment,0,0
208840,of,0,0
208841,polyarteritis,0,0
208842,nodosa,0,0
208843,and,0,0
208844,Churg-Strauss,0,0
208845,syndrome,0,0
208846,patients,0,0
208847,with,0,0
208848,factors,0,0
208849,predicting,0,0
208850,poor,0,0
208851,prognosis,0,0
208852,.,0,0
208853,A,0,0
208854,prospective,0,0
208855,",",0,0
208856,randomized,0,0
208857,trial,0,0
208858,in,0,0
208859,sixty-two,0,0
208860,patients,0,0
208861,.,0,0
208862,OBJECTIVE,0,0
208863,To,0,0
208864,define,0,0
208865,the,0,0
208866,most,0,0
208867,effective,0,0
208868,treatment,0,0
208869,for,0,0
208870,severe,0,0
208871,polyarteritis,0,1
208872,nodosa,0,1
208873,(,0,1
208874,PAN,0,1
208875,),0,1
208876,and,0,0
208877,Churg-Strauss,0,1
208878,syndrome,0,1
208879,(,0,1
208880,CSS,0,1
208881,),0,1
208882,and,0,0
208883,to,0,0
208884,investigate,0,0
208885,the,0,0
208886,indication,0,0
208887,for,0,0
208888,plasma,0,0
208889,exchange,0,0
208890,treatment,0,0
208891,.,0,0
208892,METHODS,0,0
208893,We,0,0
208894,conducted,0,0
208895,a,0,0
208896,prospective,0,0
208897,",",0,0
208898,randomized,0,0
208899,",",0,0
208900,multicenter,0,0
208901,trial,0,0
208902,in,0,0
208903,which,0,0
208904,62,0,0
208905,patients,0,0
208906,were,0,0
208907,randomly,0,0
208908,assigned,0,0
208909,to,0,0
208910,receive,0,0
208911,either,0,0
208912,prednisone,1,1
208913,plus,1,1
208914,cyclophosphamide,1,1
208915,(,1,1
208916,intravenous,1,1
208917,bolus,1,1
208918,),1,1
208919,(,1,1
208920,group,1,1
208921,A,1,1
208922,;,1,0
208923,n,1,0
208924,=,1,0
208925,28,1,0
208926,),1,0
208927,or,1,0
208928,prednisone,1,1
208929,plus,1,1
208930,cyclophosphamide,1,1
208931,(,1,1
208932,intravenous,1,1
208933,bolus,1,1
208934,),1,1
208935,plus,1,0
208936,plasma,1,1
208937,exchanges,1,1
208938,(,0,1
208939,group,0,0
208940,B,0,1
208941,;,0,0
208942,n,0,0
208943,=,0,0
208944,34,0,0
208945,),0,0
208946,as,0,0
208947,first-line,0,0
208948,treatment,0,0
208949,for,0,0
208950,severe,0,0
208951,PAN,0,1
208952,or,0,0
208953,CSS,0,0
208954,.,0,0
208955,Factors,0,0
208956,predicting,0,0
208957,poor,0,0
208958,prognosis,0,0
208959,were,0,0
208960,renal,0,0
208961,symptoms,0,0
208962,",",0,0
208963,gastrointestinal,0,0
208964,tract,0,0
208965,involvement,0,0
208966,",",0,0
208967,cardiomyopathy,0,0
208968,",",0,0
208969,central,0,0
208970,nervous,0,0
208971,system,0,0
208972,involvement,0,0
208973,",",0,0
208974,weight,0,0
208975,loss,0,0
208976,>,0,0
208977,10,0,0
208978,%,0,0
208979,of,0,0
208980,body,0,0
208981,weight,0,0
208982,",",0,0
208983,and,0,0
208984,age,0,0
208985,>,0,0
208986,50,0,0
208987,years,0,0
208988,old,0,0
208989,.,0,0
208990,Patients,0,0
208991,with,0,0
208992,hepatitis,0,0
208993,B,0,1
208994,virus-related,0,0
208995,PAN,0,0
208996,were,0,0
208997,not,0,0
208998,included,0,0
208999,in,0,0
209000,this,0,0
209001,study,0,0
209002,.,0,0
209003,The,0,0
209004,end,0,0
209005,point,0,0
209006,of,0,0
209007,the,0,0
209008,study,0,0
209009,was,0,0
209010,control,0,0
209011,of,0,0
209012,the,0,0
209013,disease,0,0
209014,(,0,0
209015,recovery,0,0
209016,or,0,0
209017,remission,0,1
209018,),0,0
209019,or,0,0
209020,death,0,0
209021,.,0,0
209022,RESULTS,0,0
209023,Clinical,0,0
209024,symptoms,0,0
209025,and,0,0
209026,laboratory,0,0
209027,findings,0,0
209028,did,0,0
209029,not,0,0
209030,differ,0,0
209031,significantly,0,0
209032,in,0,0
209033,the,0,0
209034,2,0,0
209035,groups,0,0
209036,.,0,0
209037,Initial,0,0
209038,control,0,0
209039,of,0,0
209040,the,0,0
209041,disease,0,0
209042,was,0,0
209043,similar,0,0
209044,in,0,0
209045,both,0,0
209046,groups,0,0
209047,.,0,0
209048,Relapse,0,0
209049,after,0,0
209050,initial,0,0
209051,control,0,0
209052,of,0,0
209053,the,0,0
209054,disease,0,0
209055,was,0,0
209056,observed,0,0
209057,in,0,0
209058,7,0,0
209059,patients,0,0
209060,(,0,0
209061,4,0,0
209062,in,0,0
209063,group,0,0
209064,A,0,0
209065,and,0,0
209066,3,0,0
209067,in,0,0
209068,group,0,0
209069,B,0,1
209070,),0,0
209071,.,0,0
209072,The,0,0
209073,mean,0,0
209074,+/-,0,0
209075,SD,0,0
209076,followup,0,0
209077,period,0,0
209078,was,0,0
209079,31.1,0,0
209080,+/-,0,0
209081,20,0,0
209082,months,0,0
209083,for,0,0
209084,group,0,0
209085,A,0,0
209086,and,0,0
209087,35.9,0,0
209088,+/-,0,0
209089,16.8,0,0
209090,months,0,0
209091,for,0,0
209092,group,0,0
209093,B,0,0
209094,.,0,0
209095,At,0,0
209096,5,0,0
209097,years,0,0
209098,of,0,0
209099,followup,0,0
209100,",",0,0
209101,38,0,0
209102,patients,0,0
209103,(,0,0
209104,61.3,0,0
209105,%,0,0
209106,),0,0
209107,were,0,0
209108,cured,0,0
209109,(,0,0
209110,16,0,0
209111,in,0,0
209112,group,0,0
209113,A,0,0
209114,and,0,0
209115,22,0,0
209116,in,0,0
209117,group,0,0
209118,B,0,1
209119,),0,1
209120,",",0,0
209121,and,0,0
209122,5,0,0
209123,(,0,0
209124,8.1,0,0
209125,%,0,0
209126,),0,0
209127,were,0,0
209128,in,0,0
209129,remission,0,0
209130,without,0,0
209131,treatment,0,0
209132,but,0,0
209133,had,0,0
209134,not,0,0
209135,yet,0,0
209136,completed,0,0
209137,the,0,0
209138,cure-defining,0,0
209139,period,0,0
209140,of,0,0
209141,18,0,0
209142,months,0,0
209143,(,0,0
209144,3,0,0
209145,in,0,0
209146,group,0,0
209147,A,0,0
209148,and,0,0
209149,2,0,0
209150,in,0,0
209151,group,0,0
209152,B,0,1
209153,),0,0
209154,.,0,0
209155,Eight,0,0
209156,(,0,0
209157,12.9,0,0
209158,%,0,0
209159,),0,0
209160,(,0,0
209161,2,0,0
209162,in,0,0
209163,group,0,0
209164,A,0,0
209165,and,0,0
209166,2,0,0
209167,in,0,0
209168,group,0,0
209169,B,0,0
209170,),0,0
209171,were,0,0
209172,considered,0,0
209173,to,0,0
209174,be,0,0
209175,in,0,0
209176,clinical,0,0
209177,remission,0,0
209178,and,0,0
209179,required,0,0
209180,a,0,0
209181,maintenance,0,0
209182,regimen,0,1
209183,of,0,1
209184,low-dose,0,1
209185,corticosteroids,0,1
209186,.,0,1
209187,Eleven,0,0
209188,patients,0,0
209189,died,0,0
209190,during,0,0
209191,the,0,0
209192,study,0,0
209193,period,0,1
209194,(,0,0
209195,7,0,0
209196,in,0,0
209197,group,0,0
209198,A,0,1
209199,[,0,0
209200,25,0,0
209201,%,0,0
209202,],0,0
209203,",",0,0
209204,4,0,0
209205,in,0,0
209206,group,0,0
209207,B,0,0
209208,[,0,0
209209,11.8,0,0
209210,%,0,0
209211,],0,0
209212,),0,0
209213,.,0,0
209214,Uncontrolled,0,0
209215,vasculitis,0,0
209216,was,0,0
209217,responsible,0,0
209218,for,0,0
209219,4,0,0
209220,deaths,0,1
209221,(,0,0
209222,2,0,0
209223,in,0,0
209224,each,0,0
209225,group,0,0
209226,),0,0
209227,",",0,0
209228,and,0,0
209229,treatment,0,0
209230,side,0,0
209231,effects,0,0
209232,caused,0,0
209233,the,0,0
209234,death,0,0
209235,of,0,0
209236,1,0,0
209237,patient,0,0
209238,in,0,0
209239,group,0,0
209240,A,0,0
209241,.,0,0
209242,There,0,0
209243,was,0,0
209244,no,0,0
209245,significant,0,0
209246,difference,0,0
209247,between,0,0
209248,the,0,0
209249,5-year,0,0
209250,cumulative,0,0
209251,survival,0,0
209252,rates,0,0
209253,of,0,0
209254,the,0,0
209255,2,0,0
209256,groups,0,0
209257,(,0,0
209258,75,0,0
209259,%,0,0
209260,and,0,0
209261,88,0,0
209262,%,0,0
209263,",",0,0
209264,respectively,0,0
209265,),0,0
209266,.,0,0
209267,CONCLUSION,0,0
209268,Based,0,0
209269,on,0,0
209270,our,0,0
209271,data,0,0
209272,",",0,0
209273,combined,0,0
209274,treatment,0,0
209275,with,0,0
209276,prednisone,1,1
209277,",",1,1
209278,cyclophosphamide,1,1
209279,",",0,1
209280,and,0,0
209281,plasma,1,1
209282,exchanges,1,0
209283,is,0,0
209284,not,0,0
209285,superior,0,0
209286,to,0,0
209287,treatment,0,0
209288,with,0,0
209289,prednisone,1,1
209290,and,0,1
209291,cyclophosphamide,1,1
209292,alone,0,0
209293,",",0,0
209294,and,0,0
209295,plasma,0,1
209296,exchanges,0,0
209297,should,0,0
209298,not,0,0
209299,be,0,0
209300,systematically,0,0
209301,proposed,0,0
209302,for,0,0
209303,initial,0,0
209304,treatment,0,0
209305,of,0,0
209306,severe,0,0
209307,PAN,0,1
209308,or,0,0
209309,CSS,0,0
209310,.,0,0
209311,Effect,0,0
209312,of,0,0
209313,six-hour,0,0
209314,exposure,0,0
209315,to,0,0
209316,nitrogen,1,0
209317,dioxide,1,1
209318,on,0,0
209319,early-phase,0,0
209320,nasal,0,0
209321,response,0,0
209322,to,0,0
209323,allergen,0,1
209324,challenge,0,0
209325,in,0,0
209326,patients,0,0
209327,with,0,0
209328,a,0,0
209329,history,0,0
209330,of,0,0
209331,seasonal,0,0
209332,allergic,0,0
209333,rhinitis,0,0
209334,.,0,0
209335,BACKGROUND,0,0
209336,Recent,0,0
209337,studies,0,0
209338,have,0,0
209339,suggested,0,0
209340,that,0,0
209341,exposure,0,0
209342,to,0,0
209343,air,0,0
209344,pollutants,0,0
209345,may,0,0
209346,enhance,0,0
209347,the,0,0
209348,airway,0,0
209349,responsiveness,0,0
209350,of,0,0
209351,susceptible,0,0
209352,individuals,0,0
209353,to,0,0
209354,inhaled,0,1
209355,allergen,0,1
209356,.,0,1
209357,METHODS,0,1
209358,To,0,0
209359,investigate,0,0
209360,the,0,0
209361,effect,0,0
209362,of,0,0
209363,exposure,0,0
209364,to,0,0
209365,nitrogen,1,0
209366,dioxide,1,1
209367,(,1,1
209368,NO2,1,1
209369,),1,1
209370,on,0,0
209371,nasal,0,0
209372,airways,0,0
209373,resistance,0,0
209374,(,0,1
209375,NAR,0,1
209376,),0,1
209377,and,0,0
209378,inflammatory,0,0
209379,mediators,0,0
209380,in,0,0
209381,nasal,0,0
209382,lavage,0,0
209383,fluid,0,0
209384,",",0,0
209385,eight,0,0
209386,subjects,0,0
209387,with,0,0
209388,a,0,0
209389,history,0,0
209390,of,0,0
209391,seasonal,0,0
209392,allergic,0,0
209393,rhinitis,0,0
209394,",",0,0
209395,who,0,0
209396,were,0,0
209397,tested,0,0
209398,out,0,0
209399,of,0,0
209400,season,0,0
209401,",",0,0
209402,were,0,0
209403,exposed,0,0
209404,in,0,0
209405,a,0,0
209406,randomized,0,1
209407,single-blind,0,1
209408,",",0,1
209409,crossover,0,1
209410,study,0,0
209411,to,0,0
209412,either,0,0
209413,air,1,0
209414,or,0,0
209415,400,0,0
209416,ppb,0,0
209417,NO2,1,0
209418,for,0,0
209419,6,0,0
209420,hours,0,0
209421,.,0,0
209422,The,0,0
209423,changes,0,0
209424,in,0,0
209425,NAR,0,1
209426,and,0,0
209427,eosinophil,0,1
209428,cationic,0,0
209429,protein,0,0
209430,(,0,0
209431,ECP,0,1
209432,),0,1
209433,",",0,0
209434,mast,0,1
209435,cell,0,1
209436,tryptase,0,1
209437,(,0,1
209438,MCT,0,1
209439,),0,1
209440,",",0,1
209441,neutrophil,0,1
209442,myeloperoxidase,0,1
209443,(,0,1
209444,MPO,0,1
209445,),0,1
209446,",",0,0
209447,and,0,1
209448,interleukin-8,0,1
209449,(,0,1
209450,IL-8,0,1
209451,),0,1
209452,in,0,0
209453,nasal,0,1
209454,lavage,0,0
209455,fluid,0,0
209456,before,0,0
209457,and,0,0
209458,after,0,0
209459,exposure,0,0
209460,were,0,0
209461,evaluated,0,0
209462,.,0,0
209463,Another,0,0
209464,group,0,0
209465,of,0,0
209466,eight,0,0
209467,subjects,0,0
209468,with,0,0
209469,a,0,0
209470,history,0,0
209471,of,0,0
209472,seasonal,0,0
209473,allergic,0,0
209474,rhinitis,0,0
209475,were,0,0
209476,also,0,0
209477,randomized,0,0
209478,to,0,0
209479,exposure,0,0
209480,to,0,0
209481,air,0,0
209482,or,0,0
209483,400,0,0
209484,ppb,0,0
209485,NO2,1,0
209486,for,0,0
209487,6,0,0
209488,hours,0,0
209489,and,0,0
209490,then,0,0
209491,challenged,0,0
209492,with,0,0
209493,allergen,0,1
209494,",",0,0
209495,before,0,0
209496,evaluation,0,0
209497,for,0,0
209498,changes,0,0
209499,in,0,0
209500,NAR,0,0
209501,and,0,0
209502,changes,0,0
209503,in,0,0
209504,ECP,0,0
209505,",",0,0
209506,MCT,0,1
209507,",",0,0
209508,MPO,0,0
209509,",",0,0
209510,and,0,0
209511,IL-8,0,0
209512,in,0,0
209513,nasal,0,0
209514,lavage,0,0
209515,fluid,0,1
209516,.,0,0
209517,RESULTS,0,0
209518,Exposure,0,0
209519,to,0,0
209520,air,0,0
209521,or,0,0
209522,NO2,1,0
209523,did,0,0
209524,not,0,0
209525,alter,0,0
209526,either,0,0
209527,NAR,0,0
209528,or,0,0
209529,the,0,0
209530,levels,0,0
209531,of,0,0
209532,ECP,0,0
209533,",",0,0
209534,MCT,0,1
209535,",",0,0
209536,MPO,0,0
209537,",",0,0
209538,or,0,0
209539,IL-8,0,0
209540,in,0,0
209541,nasal,0,0
209542,lavage,0,0
209543,fluid,0,1
209544,.,0,1
209545,Allergen,0,1
209546,challenge,0,0
209547,after,0,0
209548,exposure,0,0
209549,to,0,0
209550,both,0,0
209551,air,0,0
209552,and,0,0
209553,NO2,1,1
209554,significantly,0,0
209555,(,0,0
209556,p,0,0
209557,<,0,0
209558,0.05,0,0
209559,),0,0
209560,increased,0,0
209561,levels,0,0
209562,of,0,0
209563,MCT,0,0
209564,",",0,0
209565,but,0,0
209566,not,0,0
209567,MPO,0,0
209568,and,0,0
209569,IL-8,0,0
209570,in,0,0
209571,the,0,0
209572,nasal,0,0
209573,lavage,0,0
209574,fluid,0,1
209575,.,0,0
209576,In,0,0
209577,addition,0,0
209578,",",0,0
209579,allergen,0,1
209580,challenge,0,0
209581,after,0,0
209582,exposure,0,0
209583,to,0,0
209584,NO2,1,0
209585,but,0,0
209586,not,0,0
209587,air,0,0
209588,",",0,0
209589,significantly,0,0
209590,increased,0,0
209591,levels,0,0
209592,of,0,0
209593,only,0,0
209594,ECP,0,0
209595,in,0,0
209596,nasal,0,0
209597,lavage,0,1
209598,fluid,0,1
209599,(,0,0
209600,p,0,0
209601,<,0,0
209602,0.05,0,0
209603,),0,0
209604,.,0,0
209605,CONCLUSIONS,0,0
209606,These,0,0
209607,results,0,0
209608,suggest,0,0
209609,that,0,0
209610,acute,0,0
209611,exposure,0,0
209612,to,0,0
209613,NO2,1,0
209614,at,0,0
209615,concentrations,0,0
209616,found,0,0
209617,at,0,0
209618,the,0,0
209619,curbside,0,0
209620,in,0,0
209621,heavy,0,0
209622,traffic,0,0
209623,during,0,0
209624,episodes,0,0
209625,of,0,0
209626,pollution,0,0
209627,",",0,0
209628,may,0,0
209629,prime,0,0
209630,eosinophils,0,1
209631,for,0,0
209632,subsequent,0,0
209633,activation,0,0
209634,by,0,0
209635,allergen,0,1
209636,in,0,0
209637,individuals,0,0
209638,with,0,0
209639,a,0,0
209640,history,0,0
209641,of,0,0
209642,seasonal,0,0
209643,allergic,0,0
209644,rhinitis,0,0
209645,.,0,0
209646,Multicyclic,1,0
209647,",",1,0
209648,dose-intensive,1,1
209649,chemotherapy,1,1
209650,supported,0,0
209651,by,0,0
209652,sequential,0,0
209653,reinfusion,0,1
209654,of,0,0
209655,hematopoietic,1,0
209656,progenitors,1,0
209657,in,0,0
209658,whole,0,0
209659,blood,0,0
209660,.,0,0
209661,PURPOSE,0,0
209662,To,0,1
209663,support,0,0
209664,multicyclic,0,0
209665,",",0,0
209666,dose-intensive,1,1
209667,chemotherapy,1,1
209668,",",0,0
209669,we,0,0
209670,assessed,0,0
209671,the,0,0
209672,effects,0,0
209673,of,0,0
209674,reinfusing,1,1
209675,hematopoietic,1,0
209676,progenitors,1,0
209677,collected,0,0
209678,at,0,0
209679,each,0,0
209680,cycle,0,0
209681,in,0,0
209682,leukapheresis,0,1
209683,product,0,0
209684,or,0,0
209685,whole,0,0
209686,blood,0,0
209687,.,0,0
209688,PATIENTS,0,0
209689,AND,0,0
209690,METHODS,0,0
209691,Twenty-five,0,0
209692,patients,0,0
209693,with,0,0
209694,small-cell,0,0
209695,lung,0,1
209696,cancer,0,1
209697,(,0,1
209698,SCLC,0,1
209699,),0,0
209700,were,0,0
209701,treated,0,0
209702,with,0,0
209703,six,0,0
209704,cycles,0,0
209705,of,0,0
209706,ifosfamide,1,1
209707,",",1,1
209708,carboplatin,1,1
209709,",",1,1
209710,and,1,1
209711,etoposide,1,1
209712,(,1,1
209713,ICE,1,1
209714,),1,1
209715,with,1,1
209716,granulocyte,1,1
209717,colony-stimulating,1,1
209718,factor,1,1
209719,(,1,1
209720,G-CSF,1,1
209721,),1,1
209722,300,0,1
209723,micrograms/d,0,1
209724,subcutaneously,0,1
209725,(,0,1
209726,SC,0,1
209727,),0,1
209728,on,0,0
209729,days,0,0
209730,4,0,0
209731,to,0,0
209732,15,0,0
209733,.,0,0
209734,Hematopoietic,0,0
209735,progenitors,0,0
209736,collected,0,0
209737,during,0,0
209738,each,0,0
209739,cycle,0,0
209740,were,0,0
209741,reinfused,0,1
209742,on,0,1
209743,day,0,0
209744,3,0,0
209745,of,0,0
209746,the,0,0
209747,next,0,0
209748,cycle,0,0
209749,.,0,0
209750,Cohort,0,0
209751,1,0,1
209752,(,0,0
209753,n,0,0
209754,=,0,0
209755,6,0,0
209756,),0,0
209757,was,0,0
209758,treated,0,0
209759,every,0,0
209760,3,0,0
209761,weeks,0,0
209762,",",0,0
209763,with,0,0
209764,leukapheresis,1,1
209765,after,0,0
209766,2,0,0
209767,weeks,0,0
209768,and,0,0
209769,cryopreservation,1,0
209770,of,1,0
209771,the,1,0
209772,leukapheresis,1,1
209773,product,1,0
209774,.,1,0
209775,Chemotherapy,1,0
209776,was,0,0
209777,given,0,0
209778,if,0,0
209779,the,0,0
209780,WBC,0,0
209781,count,0,0
209782,was,0,0
209783,>,0,0
209784,or,0,0
209785,=,0,0
209786,3,0,0
209787,x,0,0
209788,10,0,0
209789,(,0,1
209790,9,0,1
209791,),0,0
209792,/L,0,1
209793,and,0,1
209794,platelet,0,1
209795,count,0,1
209796,>,0,0
209797,or,0,0
209798,=,0,0
209799,100,0,0
209800,x,0,0
209801,10,0,0
209802,(,0,1
209803,9,0,1
209804,),0,0
209805,/L,0,1
209806,.,0,1
209807,Cohort,0,0
209808,2,0,1
209809,(,0,0
209810,n,0,0
209811,=,0,0
209812,7,0,0
209813,),0,0
209814,was,0,0
209815,treated,0,0
209816,every,0,0
209817,2,0,0
209818,weeks,0,0
209819,",",0,0
209820,with,0,0
209821,leukapheresis,1,1
209822,on,0,1
209823,day,0,0
209824,1,0,0
209825,of,0,0
209826,the,0,0
209827,next,0,0
209828,cycle,0,0
209829,and,0,0
209830,storage,0,0
209831,of,0,0
209832,the,0,0
209833,leukapheresis,1,1
209834,product,1,0
209835,at,0,0
209836,4,0,0
209837,degrees,0,0
209838,C.,0,1
209839,Cohort,0,1
209840,3,0,1
209841,(,0,0
209842,n,0,0
209843,=,0,0
209844,12,0,0
209845,),0,0
209846,was,0,0
209847,treated,0,0
209848,every,0,0
209849,2,0,0
209850,weeks,0,0
209851,",",0,0
209852,with,0,0
209853,500,0,0
209854,to,0,0
209855,750,0,0
209856,mL,0,0
209857,of,0,0
209858,blood,0,0
209859,drawn,0,0
209860,by,0,0
209861,venesection,0,0
209862,on,0,0
209863,day,0,0
209864,1,0,0
209865,of,0,0
209866,the,0,0
209867,next,0,0
209868,cycle,0,0
209869,and,0,0
209870,stored,0,0
209871,at,0,0
209872,4,0,0
209873,degrees,0,0
209874,C.,0,1
209875,In,0,0
209876,cohorts,0,0
209877,2,0,0
209878,and,0,0
209879,3,0,0
209880,",",0,0
209881,chemotherapy,1,0
209882,was,0,0
209883,given,0,0
209884,if,0,0
209885,the,0,0
209886,WBC,0,0
209887,count,0,0
209888,was,0,0
209889,>,0,0
209890,or,0,0
209891,=,0,0
209892,3,0,0
209893,x,0,0
209894,10,0,0
209895,(,0,1
209896,9,0,1
209897,),0,0
209898,/L,0,1
209899,and,0,1
209900,platelet,0,1
209901,count,0,1
209902,>,0,0
209903,or,0,0
209904,=,0,0
209905,30,0,0
209906,x,0,0
209907,10,0,0
209908,(,0,1
209909,9,0,1
209910,),0,0
209911,/L,0,1
209912,.,0,0
209913,Blood,0,0
209914,and,0,0
209915,leukapheresis,0,1
209916,products,0,0
209917,were,0,0
209918,assayed,0,0
209919,for,0,0
209920,hematopoietic,0,0
209921,progenitors,0,0
209922,.,0,0
209923,RESULTS,0,0
209924,ICE,1,1
209925,chemotherapy,1,0
209926,with,0,0
209927,G-CSF,0,0
209928,was,0,0
209929,effective,0,0
209930,in,0,0
209931,mobilizing,0,0
209932,blood,0,0
209933,progenitors,0,0
209934,(,0,0
209935,median,0,0
209936,",",0,0
209937,120-fold,0,0
209938,),0,0
209939,.,0,0
209940,Long-term,0,0
209941,cultures,0,0
209942,showed,0,0
209943,no,0,0
209944,evidence,0,0
209945,of,0,0
209946,stem-cell,0,0
209947,depletion,0,0
209948,.,0,0
209949,The,0,0
209950,cytotoxic,0,1
209951,dose-intensity,0,1
209952,of,0,1
209953,standard,0,1
209954,every-4-weeks,0,1
209955,ICE,0,1
209956,is,0,0
209957,100,0,0
209958,%,0,0
209959,.,0,0
209960,In,0,0
209961,the,0,0
209962,first,0,0
209963,three,0,0
209964,cycles,0,0
209965,",",0,0
209966,it,0,0
209967,was,0,0
209968,134,0,0
209969,%,0,0
209970,(,0,0
209971,median,0,0
209972,),0,0
209973,in,0,0
209974,cohort,0,0
209975,1,0,0
209976,and,0,0
209977,200,0,0
209978,%,0,0
209979,in,0,0
209980,cohorts,0,0
209981,2,0,0
209982,and,0,0
209983,3,0,0
209984,(,0,0
209985,P,0,0
209986,<,0,0
209987,.0001,0,0
209988,),0,0
209989,.,0,0
209990,Toxicity,0,0
209991,and,0,0
209992,supportive,0,0
209993,care,0,0
209994,requirements,0,0
209995,were,0,0
209996,not,0,0
209997,increased,0,0
209998,.,0,0
209999,CONCLUSION,0,0
210000,The,0,0
210001,dose-intensity,0,1
210002,of,0,0
210003,ICE,1,1
210004,chemotherapy,1,0
210005,can,0,0
210006,be,0,0
210007,doubled,0,0
210008,by,0,0
210009,reinfusing,0,1
210010,hematopoietic,0,0
210011,progenitors,0,0
210012,collected,0,0
210013,by,0,0
210014,leukapheresis,0,1
210015,or,0,1
210016,venesection,0,1
210017,and,0,0
210018,stored,0,0
210019,at,0,0
210020,4,0,0
210021,degrees,0,0
210022,C,0,0
210023,.,0,0
210024,A,0,1
210025,randomized,0,0
210026,study,0,0
210027,comparing,0,0
210028,glucagon,1,1
210029,and,1,1
210030,hyoscine,1,1
210031,N-butyl,1,1
210032,bromide,1,1
210033,before,0,1
210034,endoscopic,1,1
210035,retrograde,1,0
210036,cholangiopancreatography,1,0
210037,.,1,0
210038,BACKGROUND,0,0
210039,This,0,0
210040,study,0,0
210041,tried,0,0
210042,to,0,0
210043,resolve,0,0
210044,whether,0,0
210045,glucagon,1,1
210046,is,0,0
210047,a,0,0
210048,better,0,0
210049,premedication,0,1
210050,for,0,0
210051,endoscopic,0,1
210052,retrograde,0,1
210053,cholangiopancreatography,0,1
210054,(,0,1
210055,ERCP,0,1
210056,),0,1
210057,.,0,0
210058,METHODS,0,0
210059,We,0,0
210060,first,0,0
210061,measured,0,0
210062,the,0,0
210063,basal,0,0
210064,blood,0,0
210065,sugar,0,1
210066,and,0,1
210067,amylase,0,1
210068,levels,0,0
210069,.,0,0
210070,Then,0,0
210071,an,0,0
210072,endoscope,0,0
210073,was,0,0
210074,placed,0,0
210075,in,0,0
210076,the,0,0
210077,duodenum,0,0
210078,without,0,0
210079,premedication,0,1
210080,",",0,0
210081,and,0,0
210082,basal,0,0
210083,pulse,0,0
210084,and,0,0
210085,duodenal,0,0
210086,peristaltic,0,0
210087,rates,0,0
210088,were,0,0
210089,measured,0,0
210090,.,0,0
210091,ERCP,0,0
210092,began,0,0
210093,after,0,0
210094,studied,0,0
210095,subjects,0,0
210096,were,0,0
210097,randomly,0,0
210098,premedicated,0,1
210099,with,0,1
210100,either,0,0
210101,1,1,1
210102,mg,1,1
210103,glucagon,1,1
210104,(,0,1
210105,n,0,0
210106,=,0,0
210107,38,0,0
210108,),0,0
210109,or,0,0
210110,40,1,1
210111,mg,1,1
210112,hyoscine,1,1
210113,N-butyl,1,1
210114,bromide,1,1
210115,(,0,1
210116,n,0,0
210117,=,0,0
210118,36,0,0
210119,),0,0
210120,intravenously,0,1
210121,.,0,1
210122,Ten,0,0
210123,minutes,0,0
210124,later,0,0
210125,the,0,0
210126,variables,0,0
210127,were,0,0
210128,measured,0,0
210129,again,0,0
210130,.,0,0
210131,RESULTS,0,0
210132,Glucagon,1,1
210133,elicited,0,1
210134,hyperglycemia,0,1
210135,whereas,0,1
210136,hyoscine,1,1
210137,N-butyl,1,1
210138,bromide,1,1
210139,manifested,0,1
210140,an,0,0
210141,anticholinergic,0,1
210142,effect,0,0
210143,.,0,0
210144,No,0,0
210145,difference,0,0
210146,was,0,0
210147,found,0,0
210148,between,0,0
210149,these,0,0
210150,two,0,0
210151,groups,0,0
210152,with,0,0
210153,regard,0,0
210154,to,0,0
210155,the,0,0
210156,necessary,0,0
210157,interval,0,0
210158,for,0,0
210159,ERCP,0,0
210160,(,0,0
210161,20.6,0,0
210162,+/-,0,0
210163,14.1,0,0
210164,min,0,0
210165,versus,0,0
210166,21.4,0,0
210167,+/-,0,0
210168,14.7,0,0
210169,min,0,0
210170,;,0,0
210171,NS,0,1
210172,),0,1
210173,or,0,0
210174,the,0,0
210175,success,0,0
210176,rate,0,0
210177,for,0,0
210178,cholangiopancreatography,0,0
210179,(,0,0
210180,92.1,0,0
210181,%,0,0
210182,versus,0,0
210183,91.7,0,0
210184,%,0,0
210185,;,0,0
210186,NS,0,0
210187,),0,1
210188,.,0,0
210189,Neither,0,0
210190,hyperamylasemia,0,0
210191,nor,0,0
210192,pancreatitis,0,0
210193,was,0,0
210194,preventable,0,0
210195,when,0,0
210196,glucagon,1,1
210197,was,0,0
210198,used,0,0
210199,.,0,0
210200,CONCLUSIONS,0,0
210201,The,0,0
210202,two,0,0
210203,premedications,0,1
210204,appear,0,0
210205,equally,0,0
210206,effective,0,0
210207,in,0,0
210208,the,0,0
210209,performance,0,0
210210,of,0,0
210211,ERCP,0,0
210212,.,0,0
210213,Why,0,0
210214,are,0,0
210215,there,0,0
210216,sometimes,0,0
210217,concreteness,0,0
210218,effects,0,0
210219,in,0,0
210220,memory,0,0
210221,for,0,0
210222,prose,0,0
210223,?,0,0
210224,Four,0,0
210225,experiments,0,0
210226,explored,0,0
210227,on-line,0,0
210228,encoding,0,0
210229,strategies,0,0
210230,and,0,0
210231,memory,0,0
210232,for,0,0
210233,high,0,0
210234,imagery,0,0
210235,and,0,0
210236,low,0,0
210237,imagery,0,0
210238,texts,0,0
210239,.,0,0
210240,Results,0,0
210241,consistently,0,0
210242,indicated,0,0
210243,that,0,0
210244,concreteness,0,0
210245,effects,0,0
210246,in,0,0
210247,memory,0,0
210248,for,0,0
210249,text,0,0
210250,depend,0,0
210251,on,0,0
210252,how,0,0
210253,materials,0,0
210254,are,0,0
210255,presented,0,0
210256,in,0,0
210257,several,0,0
210258,different,0,0
210259,respects,0,0
210260,.,0,0
210261,Most,0,0
210262,importantly,0,0
210263,",",0,0
210264,the,0,0
210265,experiments,0,0
210266,clarified,0,0
210267,apparently,0,0
210268,contradictory,0,0
210269,results,0,0
210270,of,0,0
210271,previous,0,0
210272,studies,0,0
210273,by,0,0
210274,indicating,0,0
210275,that,0,0
210276,concreteness,0,0
210277,effects,0,0
210278,generally,0,0
210279,do,0,0
210280,not,0,0
210281,occur,0,0
210282,in,0,0
210283,memory,0,0
210284,for,0,0
210285,prose,0,0
210286,when,0,0
210287,imageability,0,0
210288,is,0,0
210289,manipulated,0,0
210290,between-subjects,0,0
210291,",",0,0
210292,and,0,0
210293,that,0,0
210294,their,0,0
210295,occurrence,0,0
210296,when,0,0
210297,imageability,0,0
210298,is,0,0
210299,manipulated,0,0
210300,within-subjects,0,0
210301,depends,0,0
210302,on,0,0
210303,the,0,0
210304,order,0,0
210305,occurrence,0,0
210306,when,0,0
210307,imageability,0,0
210308,is,0,0
210309,manipulated,0,0
210310,within-subjects,0,0
210311,depends,0,0
210312,on,0,0
210313,the,0,0
210314,order,0,0
210315,of,0,0
210316,presentation,0,0
210317,.,0,0
210318,In,0,0
210319,addition,0,0
210320,",",0,0
210321,moving,0,0
210322,window,0,0
210323,analyses,0,0
210324,of,0,0
210325,text,1,0
210326,processing,1,0
210327,strategies,1,0
210328,indicated,0,0
210329,that,0,0
210330,differential,0,0
210331,strategies,0,0
210332,observed,0,0
210333,in,0,0
210334,previous,0,0
210335,studies,0,0
210336,when,0,0
210337,subjects,0,0
210338,listened,0,0
210339,to,0,0
210340,high,0,0
210341,vs,0,0
210342,low,0,0
210343,imagery,0,0
210344,text,0,0
210345,do,0,0
210346,not,0,0
210347,generalize,0,0
210348,to,0,0
210349,reading,0,0
210350,of,0,0
210351,the,0,0
210352,same,0,0
210353,materials,0,0
210354,.,0,0
210355,Potential,0,0
210356,explanations,0,0
210357,for,0,0
210358,the,0,0
210359,pattern,0,0
210360,of,0,0
210361,results,0,0
210362,are,0,0
210363,evaluated,0,0
210364,",",0,0
210365,and,0,0
210366,implications,0,0
210367,for,0,0
210368,theories,0,0
210369,of,0,0
210370,mental,0,0
210371,imagery,0,0
210372,and,0,0
210373,memory,0,0
210374,are,0,0
210375,considered,0,0
210376,.,0,0
210377,The,0,0
210378,efficacy,0,0
210379,of,0,0
210380,a,0,0
210381,herbal-based,1,1
210382,toothpaste,1,1
210383,on,0,0
210384,the,0,0
210385,control,0,0
210386,of,0,0
210387,plaque,0,0
210388,and,0,0
210389,gingivitis,0,0
210390,.,0,0
210391,A,0,1
210392,double-blind,0,1
210393,controlled,0,0
210394,clinical,0,1
210395,trial,0,0
210396,with,0,0
210397,parallel,0,0
210398,groups,0,0
210399,was,0,0
210400,designed,0,0
210401,to,0,0
210402,investigate,0,0
210403,the,0,0
210404,effectiveness,0,0
210405,of,0,0
210406,a,0,0
210407,herbal-based,1,0
210408,toothpaste,1,1
210409,in,0,0
210410,the,0,0
210411,control,0,0
210412,of,0,0
210413,plaque,0,0
210414,and,0,0
210415,gingivitis,0,0
210416,as,0,0
210417,compared,0,0
210418,with,0,0
210419,a,0,0
210420,conventional,1,0
210421,dentifrice,1,1
210422,.,1,0
210423,70,0,0
210424,subjects,0,0
210425,with,0,0
210426,gingivitis,0,0
210427,completed,0,0
210428,the,0,0
210429,6-week,0,0
210430,study,0,0
210431,.,0,0
210432,All,0,0
210433,participants,0,0
210434,had,0,0
210435,at,0,0
210436,least,0,0
210437,20,0,0
210438,natural,0,0
210439,teeth,0,0
210440,with,0,0
210441,no,0,0
210442,probing,0,0
210443,depths,0,0
210444,greater,0,0
210445,than,0,0
210446,3,0,0
210447,mm,0,0
210448,and,0,0
210449,a,0,0
210450,plaque,0,0
210451,index,0,0
210452,of,0,0
210453,2,0,0
210454,or,0,0
210455,more,0,0
210456,at,0,0
210457,baseline,0,0
210458,.,0,0
210459,At,0,0
210460,baseline,0,0
210461,",",0,0
210462,both,0,0
210463,groups,0,0
210464,were,0,0
210465,balanced,0,0
210466,for,0,0
210467,the,0,0
210468,parameters,0,0
210469,measured,0,0
210470,:,0,0
210471,plaque,0,0
210472,index,0,0
210473,",",0,0
210474,plaque,0,0
210475,vitality,0,0
210476,",",0,0
210477,gingival,0,0
210478,index,0,0
210479,",",0,0
210480,bleeding,0,0
210481,on,0,0
210482,probing,0,0
210483,and,0,0
210484,gingival,0,1
210485,crevicular,0,1
210486,fluid,0,1
210487,flow,0,0
210488,.,0,0
210489,At,0,0
210490,the,0,0
210491,end,0,0
210492,of,0,0
210493,the,0,0
210494,trial,0,0
210495,",",0,0
210496,there,0,0
210497,were,0,0
210498,reductions,0,0
210499,within,0,0
210500,both,0,0
210501,groups,0,0
210502,",",0,0
210503,however,0,0
210504,",",0,0
210505,there,0,0
210506,were,0,0
210507,no,0,0
210508,significant,0,0
210509,differences,0,0
210510,between,0,0
210511,the,0,0
210512,groups,0,0
210513,.,0,0
210514,It,0,0
210515,was,0,0
210516,concluded,0,0
210517,that,0,0
210518,the,0,0
210519,herbal,1,1
210520,based,1,1
210521,toothpaste,1,1
210522,was,0,0
210523,as,0,0
210524,effective,0,0
210525,as,0,0
210526,the,0,0
210527,conventionally,1,0
210528,formulated,1,0
210529,dentifrice,1,1
210530,in,0,0
210531,the,0,0
210532,control,0,0
210533,of,0,0
210534,plaque,0,0
210535,and,0,0
210536,gingivitis,0,0
210537,.,0,0
210538,Hemodynamic,0,0
210539,effects,0,0
210540,during,0,0
210541,induction,0,0
210542,",",0,0
210543,laryngoscopy,0,0
210544,",",0,0
210545,and,0,0
210546,intubation,0,1
210547,with,0,1
210548,eltanolone,1,1
210549,(,1,1
210550,5,1,1
210551,beta-pregnanolone,1,1
210552,),1,1
210553,or,0,1
210554,propofol,1,1
210555,.,1,1
210556,A,0,0
210557,study,0,0
210558,in,0,0
210559,ASA,0,0
210560,I,0,0
210561,and,0,0
210562,II,0,0
210563,patients,0,0
210564,.,0,0
210565,STUDY,0,0
210566,OBJECTIVE,0,0
210567,To,0,0
210568,evaluate,0,0
210569,the,0,0
210570,cardiovascular,0,0
210571,changes,0,0
210572,following,0,0
210573,induction,0,0
210574,of,0,0
210575,anesthesia,0,0
210576,",",0,0
210577,laryngoscopy,0,0
210578,",",0,0
210579,and,0,0
210580,intubation,0,0
210581,in,0,0
210582,patients,0,0
210583,receiving,0,0
210584,a,0,0
210585,bolus,0,1
210586,dose,0,1
210587,of,0,1
210588,either,0,0
210589,eltanolone,1,1
210590,or,0,1
210591,propofol,1,1
210592,.,1,1
210593,DESIGN,0,1
210594,Randomized,0,0
210595,",",0,0
210596,controlled,0,0
210597,",",0,0
210598,blind,0,0
210599,",",0,0
210600,prospective,0,0
210601,clinical,0,0
210602,study,0,0
210603,.,0,0
210604,SETTING,0,0
210605,General,0,0
210606,operating,0,0
210607,theaters,0,0
210608,of,0,0
210609,a,0,0
210610,university,0,0
210611,hospital,0,0
210612,.,0,0
210613,PATIENTS,0,0
210614,40,0,0
210615,ASA,0,0
210616,status,0,1
210617,I,0,0
210618,and,0,0
210619,II,0,0
210620,patients,0,0
210621,scheduled,0,0
210622,for,0,0
210623,elective,0,0
210624,surgery,0,0
210625,.,0,0
210626,INTERVENTIONS,0,0
210627,Patients,0,0
210628,were,0,0
210629,premedicated,1,1
210630,with,1,1
210631,oral,1,1
210632,temazepam,1,1
210633,20,1,1
210634,mg.,1,1
210635,Anesthesia,1,1
210636,was,0,0
210637,induced,0,0
210638,with,0,0
210639,either,0,0
210640,eltanolone,1,1
210641,0.58,1,1
210642,mg/kg,1,1
210643,or,1,0
210644,propofol,1,1
210645,1.7,1,1
210646,mg/kg,1,1
210647,",",1,0
210648,neuromuscular,1,1
210649,blockade,1,1
210650,was,1,0
210651,achieved,1,0
210652,with,1,0
210653,vecuronium,1,1
210654,0.1,1,1
210655,mg/kg,1,1
210656,",",1,0
210657,and,1,0
210658,anesthesia,1,0
210659,was,1,0
210660,maintained,1,0
210661,with,1,0
210662,enflurane,1,0
210663,0.5,1,0
210664,%,1,0
210665,to,1,0
210666,1.0,1,0
210667,%,1,0
210668,in,1,0
210669,nitrous,1,1
210670,oxide,1,1
210671,(,1,0
210672,67,1,0
210673,%,1,0
210674,),1,0
210675,.,1,0
210676,MEASUREMENTS,0,0
210677,AND,0,1
210678,MAIN,0,1
210679,RESULTS,0,1
210680,Blood,0,0
210681,pressure,0,0
210682,was,0,0
210683,measured,0,0
210684,using,0,0
210685,an,0,0
210686,automatic,0,0
210687,oscillometric,0,0
210688,technique,0,0
210689,",",0,0
210690,heart,0,0
210691,rate,0,0
210692,(,0,1
210693,HR,0,1
210694,),0,0
210695,was,0,0
210696,derived,0,0
210697,from,0,0
210698,the,0,0
210699,ECG,0,0
210700,",",0,0
210701,oxygen,0,0
210702,saturation,0,0
210703,was,0,0
210704,measured,0,0
210705,by,0,0
210706,pulse,0,0
210707,oximetry,0,0
210708,",",0,0
210709,and,0,0
210710,cardiac,0,1
210711,output,0,1
210712,(,0,1
210713,Q,0,1
210714,),0,0
210715,was,0,0
210716,measured,0,0
210717,by,0,0
210718,a,0,0
210719,thoracic,0,0
210720,bioimpedance,0,0
210721,technique,0,0
210722,.,0,0
210723,Induction,0,0
210724,of,0,0
210725,anesthesia,0,0
210726,with,0,0
210727,either,0,0
210728,drug,0,1
210729,",",0,1
210730,eltanolone,1,1
210731,or,1,1
210732,propofol,1,1
210733,",",0,1
210734,decreased,0,0
210735,arterial,0,0
210736,systolic,0,1
210737,(,0,1
210738,SAP,0,1
210739,),0,1
210740,and,0,0
210741,diastolic,0,1
210742,(,0,1
210743,DAP,0,1
210744,),0,1
210745,blood,0,0
210746,pressure,0,1
210747,",",0,0
210748,Q,0,0
210749,",",0,0
210750,and,0,0
210751,stroke,0,1
210752,volume,0,1
210753,(,0,1
210754,SV,0,1
210755,),0,1
210756,.,0,0
210757,HR,0,0
210758,increased,0,0
210759,.,0,0
210760,Systemic,0,0
210761,vascular,0,0
210762,resistance,0,0
210763,(,0,1
210764,SVR,0,1
210765,),0,0
210766,was,0,0
210767,unaltered,0,0
210768,.,0,0
210769,After,0,0
210770,laryngoscopy,0,0
210771,and,0,0
210772,intubation,0,0
210773,",",0,0
210774,SAP,0,1
210775,and,0,0
210776,DAP,0,0
210777,increased,0,0
210778,secondary,0,0
210779,to,0,0
210780,an,0,0
210781,increase,0,0
210782,in,0,0
210783,SVR,0,0
210784,.,0,0
210785,HR,0,0
210786,also,0,0
210787,increased,0,0
210788,;,0,0
210789,SV,0,0
210790,decreased,0,0
210791,in,0,0
210792,patients,0,0
210793,receiving,0,0
210794,eltanolone,0,1
210795,.,0,1
210796,Side,0,1
210797,effects,0,0
210798,(,0,0
210799,e.g.,0,0
210800,",",0,0
210801,apnea,0,0
210802,occurring,0,0
210803,for,0,0
210804,more,0,0
210805,than,0,0
210806,30,0,0
210807,seconds,0,0
210808,",",0,0
210809,involuntary,0,0
210810,movements,0,0
210811,",",0,0
210812,limb,0,1
210813,hypertonus,0,1
210814,),0,0
210815,occurred,0,0
210816,at,0,0
210817,a,0,0
210818,similar,0,0
210819,incidence,0,0
210820,with,0,0
210821,both,0,0
210822,treatments,0,0
210823,",",0,0
210824,but,0,0
210825,pain,0,0
210826,following,0,0
210827,injection,0,1
210828,was,0,0
210829,greater,0,0
210830,with,0,0
210831,propofol,0,1
210832,(,0,0
210833,59,0,0
210834,%,0,0
210835,vs.,0,0
210836,9,0,0
210837,%,0,0
210838,),0,0
210839,.,0,0
210840,CONCLUSIONS,0,0
210841,Patients,0,0
210842,receiving,0,0
210843,either,0,0
210844,eltanolone,1,1
210845,or,1,1
210846,propofol,1,1
210847,showed,0,0
210848,similar,0,0
210849,cardiovascular,0,0
210850,changes,0,0
210851,to,0,0
210852,induction,0,0
210853,of,0,0
210854,anesthesia,0,0
210855,",",0,0
210856,although,0,0
210857,there,0,0
210858,were,0,0
210859,greater,0,0
210860,increases,0,0
210861,in,0,0
210862,arterial,0,0
210863,pressure,0,0
210864,and,0,0
210865,HR,0,0
210866,in,0,0
210867,those,0,0
210868,patients,0,0
210869,receiving,0,0
210870,eltanolone,1,1
210871,.,1,0
210872,Effect,0,0
210873,of,0,0
210874,postmenopausal,1,0
210875,hormonal,1,0
210876,replacement,1,0
210877,therapy,1,0
210878,on,0,0
210879,mammographic,0,0
210880,density,0,0
210881,and,0,0
210882,parenchymal,0,0
210883,pattern,0,0
210884,.,0,0
210885,PURPOSE,0,0
210886,To,0,0
210887,measure,0,0
210888,changes,0,0
210889,and,0,0
210890,predictors,0,0
210891,of,0,0
210892,change,0,0
210893,in,0,0
210894,mammograms,0,0
210895,obtained,0,0
210896,in,0,0
210897,postmenopausal,0,0
210898,women,0,0
210899,undergoing,0,0
210900,continuous,0,0
210901,combined,0,0
210902,hormonal,1,0
210903,replacement,1,0
210904,therapy,1,1
210905,(,1,1
210906,HRT,1,1
210907,),1,1
210908,.,1,0
210909,MATERIALS,0,0
210910,AND,0,1
210911,METHODS,0,1
210912,Mammograms,1,0
210913,of,0,0
210914,41,0,0
210915,postmenopausal,0,0
210916,women,0,0
210917,obtained,0,0
210918,before,0,0
210919,and,0,0
210920,1,0,0
210921,year,0,0
210922,after,0,0
210923,the,0,0
210924,initiation,0,0
210925,of,0,0
210926,HRT,1,0
210927,were,0,0
210928,evaluated,0,0
210929,blindly,0,0
210930,according,0,0
210931,to,0,0
210932,the,0,0
210933,quantitative,0,0
210934,density,0,0
210935,percentage,0,0
210936,method,0,0
210937,and,0,0
210938,the,0,0
210939,Wolfe,0,0
210940,classification,0,0
210941,system,0,0
210942,.,0,0
210943,RESULTS,0,0
210944,Mammographic,0,0
210945,densities,0,0
210946,increased,0,0
210947,compared,0,0
210948,with,0,0
210949,baseline,0,0
210950,values,0,0
210951,in,0,0
210952,73,0,0
210953,%,0,0
210954,of,0,0
210955,subjects,0,0
210956,(,0,0
210957,mean,0,0
210958,increase,0,0
210959,",",0,0
210960,6.7,0,0
210961,%,0,0
210962,;,0,0
210963,95,0,0
210964,%,0,0
210965,confidence,0,0
210966,interval,0,0
210967,",",0,0
210968,2.5,0,0
210969,%,0,0
210970,",",0,0
210971,11.0,0,0
210972,%,0,0
210973,;,0,0
210974,P,0,0
210975,=,0,0
210976,.003,0,0
210977,),0,0
210978,.,0,0
210979,A,0,0
210980,shift,0,0
210981,in,0,0
210982,Wolfe,0,0
210983,classification,0,0
210984,from,0,0
210985,lower,0,0
210986,to,0,0
210987,greater,0,0
210988,parenchymal,0,0
210989,density,0,0
210990,was,0,0
210991,noted,0,0
210992,in,0,0
210993,24,0,0
210994,%,0,0
210995,of,0,0
210996,subjects,0,0
210997,(,0,0
210998,P,0,0
210999,=,0,0
211000,.016,0,0
211001,),0,0
211002,.,0,0
211003,Multivariate,0,0
211004,analysis,0,0
211005,results,0,0
211006,indicated,0,0
211007,that,0,0
211008,the,0,0
211009,lower,0,0
211010,the,0,0
211011,tissue,0,0
211012,density,0,0
211013,percentage,0,0
211014,before,0,0
211015,treatment,0,0
211016,",",0,0
211017,the,0,0
211018,greater,0,0
211019,the,0,0
211020,increase,0,0
211021,in,0,0
211022,density,0,0
211023,percentage,0,0
211024,after,0,0
211025,treatment,0,0
211026,.,0,0
211027,CONCLUSION,0,1
211028,An,0,1
211029,increase,0,0
211030,in,0,0
211031,mammographic,0,0
211032,density,0,0
211033,was,0,0
211034,demonstrated,0,0
211035,in,0,0
211036,most,0,0
211037,subjects,0,0
211038,undergoing,0,0
211039,continuous,0,0
211040,combined,0,0
211041,HRT,0,0
211042,and,0,0
211043,was,0,0
211044,most,0,0
211045,pronounced,0,0
211046,in,0,0
211047,subjects,0,0
211048,with,0,0
211049,a,0,0
211050,lower,0,0
211051,baseline,0,0
211052,density,0,0
211053,percentage,0,0
211054,.,0,0
211055,A,0,1
211056,randomized,0,0
211057,trial,0,0
211058,of,0,0
211059,exercise,1,0
211060,therapy,1,0
211061,in,0,0
211062,patients,0,0
211063,with,0,0
211064,acute,0,0
211065,low,0,0
211066,back,0,0
211067,pain,0,0
211068,.,0,0
211069,Efficacy,0,0
211070,on,0,0
211071,sickness,0,0
211072,absence,0,0
211073,.,0,0
211074,STUDY,0,0
211075,DESIGN,0,1
211076,A,0,1
211077,randomized,0,1
211078,",",0,1
211079,placebo-controlled,1,1
211080,trial,0,1
211081,in,0,0
211082,which,0,0
211083,patients,0,0
211084,received,0,0
211085,either,0,0
211086,usual,1,0
211087,care,1,0
211088,by,0,0
211089,a,0,0
211090,general,0,0
211091,practitioner,0,0
211092,(,0,0
211093,information,0,0
211094,and,0,1
211095,analgesics,0,1
211096,),0,1
211097,",",0,1
211098,or,0,1
211099,placebo,1,1
211100,physiotherapy,1,1
211101,given,0,0
211102,by,0,0
211103,a,0,0
211104,physiotherapist,0,0
211105,",",0,0
211106,or,0,0
211107,exercise,1,1
211108,therapy,1,0
211109,given,0,0
211110,by,0,0
211111,a,0,0
211112,physiotherapist,0,0
211113,.,0,0
211114,OBJECTIVE,0,0
211115,To,0,0
211116,assess,0,0
211117,the,0,0
211118,efficacy,0,0
211119,of,0,0
211120,exercise,1,0
211121,therapy,1,0
211122,on,0,0
211123,sickness,0,0
211124,absence,0,0
211125,from,0,0
211126,work,0,0
211127,in,0,0
211128,patients,0,0
211129,with,0,0
211130,acute,0,0
211131,low,0,0
211132,back,0,0
211133,pain,0,0
211134,.,0,0
211135,SUMMARY,0,0
211136,OF,0,1
211137,BACKGROUND,0,1
211138,DATA,0,1
211139,Exercise,1,0
211140,therapy,1,0
211141,during,0,0
211142,the,0,0
211143,nonchronic,0,0
211144,phase,0,0
211145,of,0,0
211146,back,0,0
211147,pain,0,0
211148,is,0,0
211149,considered,0,0
211150,to,0,0
211151,reduce,0,0
211152,sickness,0,0
211153,absence,0,0
211154,",",0,0
211155,but,0,0
211156,this,0,0
211157,opinion,0,0
211158,is,0,0
211159,controversial,0,0
211160,.,0,0
211161,METHODS,0,0
211162,Patients,0,0
211163,with,0,0
211164,acute,0,0
211165,nonspecific,0,0
211166,low,0,0
211167,back,0,0
211168,pain,0,0
211169,and,0,0
211170,a,0,0
211171,paid,0,0
211172,job,0,0
211173,were,0,0
211174,included,0,0
211175,for,0,0
211176,analysis,0,0
211177,.,0,0
211178,Sickness,0,0
211179,absence,0,0
211180,(,0,0
211181,number,0,0
211182,of,0,0
211183,days,0,0
211184,),0,0
211185,was,0,0
211186,checked,0,0
211187,monthly,0,0
211188,during,0,0
211189,the,0,0
211190,1-year,0,0
211191,follow-up,0,0
211192,period,0,0
211193,and,0,0
211194,compliance,0,0
211195,was,0,0
211196,also,0,0
211197,assessed,0,0
211198,.,0,0
211199,RESULTS,0,0
211200,From,0,0
211201,40,0,0
211202,general,0,0
211203,practices,0,0
211204,363,0,0
211205,patients,0,0
211206,who,0,0
211207,were,0,0
211208,gainfully,0,0
211209,employed,0,0
211210,were,0,0
211211,included,0,0
211212,.,0,0
211213,In,0,0
211214,the,0,0
211215,exercise,1,0
211216,therapy,1,0
211217,group,0,0
211218,the,0,0
211219,percentage,0,0
211220,of,0,0
211221,patients,0,0
211222,with,0,0
211223,sickness,0,0
211224,absence,0,0
211225,was,0,0
211226,higher,0,0
211227,and,0,0
211228,the,0,0
211229,duration,0,0
211230,of,0,0
211231,absence,0,0
211232,was,0,0
211233,longer,0,0
211234,than,0,0
211235,in,0,0
211236,the,0,0
211237,placebo,1,1
211238,and,0,1
211239,usual,1,1
211240,care,1,1
211241,groups,0,0
211242,",",0,0
211243,but,0,0
211244,these,0,0
211245,differences,0,0
211246,were,0,0
211247,not,0,0
211248,significant,0,0
211249,.,0,0
211250,Indications,0,0
211251,of,0,0
211252,more,0,0
211253,absence,0,0
211254,in,0,0
211255,the,0,0
211256,exercise,1,0
211257,therapy,1,0
211258,group,1,0
211259,appeared,0,0
211260,to,0,0
211261,be,0,0
211262,based,0,0
211263,largely,0,0
211264,on,0,0
211265,a,0,0
211266,greater,0,0
211267,number,0,0
211268,of,0,0
211269,patients,0,0
211270,with,0,0
211271,absences,0,0
211272,during,0,0
211273,the,0,0
211274,first,0,0
211275,3,0,0
211276,months,0,0
211277,.,0,0
211278,Patients,0,0
211279,in,0,0
211280,the,0,0
211281,exercise,1,0
211282,group,1,0
211283,who,0,0
211284,had,0,0
211285,not,0,0
211286,reported,0,0
211287,sick,0,0
211288,at,0,0
211289,entry,0,0
211290,had,0,0
211291,more,0,0
211292,sickness,0,0
211293,absences,0,0
211294,during,0,0
211295,the,0,0
211296,follow-up,0,0
211297,year,0,0
211298,than,0,0
211299,patients,0,0
211300,in,0,0
211301,the,0,0
211302,usual,1,0
211303,care,1,1
211304,and,0,1
211305,placebo,1,1
211306,group,0,1
211307,.,0,0
211308,Good,0,0
211309,compliance,0,0
211310,did,0,0
211311,not,0,0
211312,affect,0,0
211313,the,0,0
211314,results,0,0
211315,.,0,0
211316,CONCLUSIONS,0,0
211317,Exercise,1,0
211318,therapy,1,0
211319,for,0,0
211320,patients,0,0
211321,with,0,0
211322,acute,0,0
211323,low,0,0
211324,back,0,0
211325,pain,0,0
211326,does,0,0
211327,not,0,0
211328,reduce,0,0
211329,sickness,0,0
211330,absence,0,0
211331,.,0,0
211332,Are,0,1
211333,PRO,1,1
211334,discharge,1,0
211335,screens,1,0
211336,associated,0,0
211337,with,0,0
211338,postdischarge,0,0
211339,adverse,0,0
211340,outcomes,0,0
211341,?,0,0
211342,OBJECTIVE,0,1
211343,We,0,0
211344,evaluate,0,0
211345,whether,0,0
211346,patient,0,0
211347,outcomes,0,0
211348,may,0,0
211349,be,0,0
211350,affected,0,0
211351,by,0,0
211352,possible,0,0
211353,errors,0,0
211354,in,0,0
211355,care,0,0
211356,at,0,0
211357,discharge,0,0
211358,as,0,0
211359,assessed,0,0
211360,by,0,0
211361,Peer,0,0
211362,Review,0,1
211363,Organizations,0,1
211364,(,0,1
211365,PROs,0,1
211366,),0,1
211367,.,0,0
211368,DATA,0,0
211369,SOURCES/STUDY,0,0
211370,SETTING,0,1
211371,The,0,0
211372,three,0,0
211373,data,0,0
211374,sources,0,0
211375,for,0,0
211376,the,0,0
211377,study,0,0
211378,were,0,0
211379,(,0,0
211380,1,0,1
211381,),0,0
211382,the,0,0
211383,generic,1,0
211384,screen,1,0
211385,results,1,0
211386,of,0,0
211387,a,0,0
211388,3,0,0
211389,percent,0,0
211390,random,0,0
211391,sample,0,0
211392,of,0,0
211393,Medicare,0,0
211394,beneficiaries,0,0
211395,age,0,0
211396,65,0,0
211397,years,0,0
211398,or,0,0
211399,older,0,0
211400,who,0,0
211401,were,0,0
211402,admitted,0,0
211403,to,0,0
211404,California,0,0
211405,hospitals,0,0
211406,between,0,0
211407,1,0,0
211408,July,0,0
211409,1987,0,0
211410,and,0,0
211411,30,0,0
211412,June,0,0
211413,1988,0,1
211414,(,0,0
211415,n,0,0
211416,=,0,0
211417,"20,136",0,0
211418,patients,0,0
211419,),0,0
211420,;,0,1
211421,(,0,1
211422,2,0,1
211423,),0,0
211424,the,0,0
211425,1987,0,0
211426,and,0,0
211427,1988,0,0
211428,California,0,0
211429,Medicare,0,0
211430,Provided,0,0
211431,Analysis,1,0
211432,and,1,0
211433,Review,1,1
211434,(,1,1
211435,MEDPAR,1,1
211436,),1,1
211437,data,1,0
211438,files,1,1
211439,;,1,1
211440,and,0,1
211441,(,0,1
211442,3,0,1
211443,),0,0
211444,the,0,0
211445,American,1,0
211446,Hospital,1,0
211447,Association,1,0
211448,(,1,1
211449,AHA,1,1
211450,),1,1
211451,1988,1,1
211452,Annual,1,1
211453,Survey,1,0
211454,of,1,0
211455,Hospitals,1,0
211456,.,1,0
211457,STUDY,0,0
211458,DESIGN,0,1
211459,Multivariate,1,1
211460,logistic,1,0
211461,regression,1,0
211462,analysis,1,0
211463,was,0,0
211464,used,0,0
211465,to,0,0
211466,evaluate,0,0
211467,the,0,0
211468,association,0,0
211469,between,0,0
211470,the,0,0
211471,results,0,0
211472,of,0,0
211473,generic,0,0
211474,discharge,0,0
211475,administered,0,1
211476,by,0,0
211477,the,0,0
211478,PROs,0,0
211479,and,0,0
211480,two,0,0
211481,patient,0,0
211482,outcomes,0,0
211483,:,0,0
211484,mortality,0,0
211485,and,0,0
211486,readmission,0,0
211487,within,0,0
211488,30,0,0
211489,days,0,0
211490,.,0,0
211491,The,0,0
211492,analysis,0,0
211493,was,0,0
211494,adjusted,0,0
211495,for,0,0
211496,other,0,0
211497,patient,0,0
211498,characteristics,0,0
211499,recorded,0,0
211500,on,0,0
211501,the,0,0
211502,uniform,0,0
211503,discharge,0,0
211504,abstract,0,0
211505,.,0,0
211506,PRINCIPAL,0,0
211507,FINDINGS,0,1
211508,Four,0,0
211509,discharge,0,0
211510,screens,0,0
211511,indicated,0,0
211512,an,0,0
211513,increased,0,0
211514,risk,0,0
211515,of,0,0
211516,an,0,0
211517,adverse,0,0
211518,outcome-absence,0,0
211519,of,0,0
211520,documentation,0,0
211521,of,0,0
211522,discharge,0,0
211523,planning,0,0
211524,",",0,0
211525,elevated,0,0
211526,temperature,0,0
211527,",",0,0
211528,abnormal,0,0
211529,pulse,0,0
211530,",",0,0
211531,and,0,0
211532,unaddressed,0,0
211533,abnormal,0,0
211534,test,0,0
211535,results,0,0
211536,at,0,0
211537,discharge,0,0
211538,.,0,0
211539,The,0,0
211540,other,0,0
211541,three,0,0
211542,discharge,0,0
211543,screens,0,0
211544,examined-abnormal,0,0
211545,blood,0,0
211546,pressure,0,0
211547,",",0,0
211548,IV,0,1
211549,fluids,0,1
211550,or,0,1
211551,drugs,0,1
211552,",",0,1
211553,and,0,0
211554,wound,0,0
211555,drainage,0,0
211556,before,0,0
211557,discharge-were,0,0
211558,unrelated,0,0
211559,to,0,0
211560,postdischarge,0,0
211561,adverse,0,0
211562,outcomes,0,0
211563,.,0,0
211564,CONCLUSIONS,0,0
211565,Generic,1,0
211566,discharge,1,0
211567,screens,1,0
211568,based,0,0
211569,on,0,0
211570,inadequate,0,0
211571,discharge,0,0
211572,planning,0,0
211573,",",0,0
211574,abnormal,0,0
211575,pulse,0,0
211576,",",0,0
211577,increased,0,0
211578,temperature,0,0
211579,",",0,0
211580,or,0,0
211581,unaddressed,0,0
211582,abnormal,0,0
211583,tests,0,0
211584,may,0,0
211585,be,0,0
211586,important,0,0
211587,indicators,0,0
211588,of,0,0
211589,substandard,0,0
211590,care,0,0
211591,.,0,0
211592,Other,0,0
211593,discharge,0,0
211594,screens,0,0
211595,apparently,0,0
211596,do,0,0
211597,not,0,0
211598,detect,0,0
211599,errors,0,0
211600,in,0,0
211601,care,0,0
211602,associated,0,0
211603,with,0,0
211604,major,0,0
211605,consequences,0,0
211606,for,0,0
211607,patients,0,0
211608,.,0,0
211609,Movement-related,1,0
211610,potentials,1,0
211611,in,0,0
211612,Parkinson,0,0
211613,'s,0,0
211614,disease,0,0
211615,.,0,0
211616,Presence,0,0
211617,and,0,0
211618,predictability,0,0
211619,of,0,0
211620,temporal,1,0
211621,and,1,0
211622,spatial,1,0
211623,cues,1,0
211624,.,1,0
211625,Activity,0,0
211626,of,0,0
211627,the,0,0
211628,supplementary,0,0
211629,motor,0,0
211630,area,0,0
211631,may,0,0
211632,be,0,0
211633,inferred,0,0
211634,from,0,0
211635,movement-related,1,0
211636,potentials,1,0
211637,(,1,1
211638,MRPs,1,1
211639,),1,0
211640,which,0,0
211641,are,0,0
211642,associated,0,0
211643,with,0,0
211644,the,0,0
211645,preparation,0,0
211646,and,0,0
211647,execution,0,0
211648,of,0,0
211649,voluntary,0,0
211650,",",0,0
211651,or,0,0
211652,internally,0,0
211653,determined,0,0
211654,movements,0,0
211655,.,0,0
211656,Supplementary,0,0
211657,motor,0,0
211658,area,0,0
211659,activity,0,0
211660,may,0,0
211661,be,0,0
211662,abnormal,0,0
211663,in,0,0
211664,Parkinson,0,0
211665,'s,0,0
211666,disease,0,0
211667,since,0,0
211668,its,0,0
211669,major,0,0
211670,input,0,0
211671,from,0,0
211672,the,0,0
211673,basal,0,0
211674,ganglia,0,0
211675,is,0,0
211676,disrupted,0,0
211677,.,0,0
211678,Investigation,0,0
211679,of,0,0
211680,the,0,0
211681,abnormalities,0,0
211682,in,0,0
211683,supplementary,0,0
211684,motor,0,0
211685,area,0,0
211686,activity,0,0
211687,associated,0,0
211688,with,0,0
211689,movement,0,0
211690,deficits,0,0
211691,in,0,0
211692,Parkinson,0,0
211693,'s,0,0
211694,disease,0,0
211695,may,0,0
211696,therefore,0,0
211697,reveal,0,0
211698,functions,0,0
211699,of,0,0
211700,the,0,0
211701,basal,0,0
211702,ganglia,0,0
211703,and,0,0
211704,the,0,0
211705,supplementary,0,0
211706,motor,0,0
211707,area,0,0
211708,.,0,0
211709,Movement-related,1,0
211710,potentials,1,0
211711,associated,1,0
211712,with,1,0
211713,sequential,1,0
211714,movements,1,0
211715,were,1,0
211716,investigated,1,0
211717,under,1,0
211718,various,1,0
211719,cueing,1,0
211720,conditions,1,0
211721,in,0,0
211722,Parkinson,0,0
211723,'s,0,0
211724,disease,0,0
211725,subjects,0,0
211726,and,0,0
211727,age-matched,0,0
211728,controls,1,0
211729,.,1,0
211730,In,0,0
211731,controls,0,0
211732,",",0,0
211733,MRPs,0,0
211734,revealed,0,0
211735,involvement,0,0
211736,of,0,0
211737,the,0,0
211738,supplementary,0,0
211739,motor,0,0
211740,area,0,0
211741,in,0,0
211742,movements,0,0
211743,which,0,0
211744,can,0,0
211745,be,0,0
211746,internally,0,0
211747,determined,0,0
211748,(,1,0
211749,non-cued,1,0
211750,and,0,0
211751,externally,1,0
211752,cued,1,0
211753,",",1,0
211754,predictable,1,0
211755,movements,0,0
211756,",",0,0
211757,but,0,0
211758,not,1,0
211759,unpredictable,1,0
211760,movements,0,1
211761,),0,0
211762,.,0,0
211763,In,0,0
211764,Parkinson,0,0
211765,'s,0,0
211766,disease,0,0
211767,",",0,0
211768,however,0,0
211769,",",0,0
211770,the,0,0
211771,supplementary,0,0
211772,motor,0,0
211773,area,0,0
211774,was,0,0
211775,only,0,0
211776,involved,0,0
211777,in,0,0
211778,movements,0,0
211779,which,0,0
211780,must,0,0
211781,be,0,0
211782,internally,0,0
211783,determined,0,0
211784,(,1,0
211785,non-cued,1,0
211786,movements,0,0
211787,",",0,0
211788,but,0,0
211789,not,1,0
211790,externally,1,0
211791,cued,1,0
211792,movements,0,1
211793,),0,1
211794,;,0,0
211795,therefore,0,0
211796,impaired,0,0
211797,internal,0,0
211798,control,0,0
211799,mechanisms,0,0
211800,",",0,0
211801,operating,0,0
211802,via,0,0
211803,the,0,0
211804,supplementary,0,0
211805,motor,0,0
211806,area,0,0
211807,",",0,0
211808,are,0,0
211809,bypassed,0,0
211810,when,0,0
211811,external,1,0
211812,cues,1,0
211813,are,1,0
211814,given,1,0
211815,.,1,0
211816,As,0,0
211817,a,0,0
211818,result,0,0
211819,",",0,0
211820,Parkinson,0,0
211821,'s,0,0
211822,disease,0,0
211823,patients,0,0
211824,are,0,0
211825,more,0,0
211826,reliant,0,0
211827,on,0,0
211828,external,1,0
211829,cues,1,0
211830,and,0,0
211831,are,0,0
211832,unable,0,0
211833,to,0,0
211834,use,0,0
211835,predictive,0,0
211836,models,0,0
211837,to,0,0
211838,internally,0,0
211839,guide,0,0
211840,movement,0,0
211841,.,0,0
211842,Supplementary,0,0
211843,motor,0,0
211844,area,0,0
211845,involvement,0,0
211846,also,0,0
211847,relied,0,0
211848,on,0,0
211849,the,0,0
211850,predictability,0,0
211851,(,0,0
211852,in,0,0
211853,controls,0,0
211854,),0,0
211855,or,0,0
211856,presence,0,0
211857,(,0,0
211858,in,0,0
211859,Parkinson,0,0
211860,'s,0,1
211861,disease,0,1
211862,),0,0
211863,of,0,0
211864,timing,1,0
211865,cues,1,0
211866,and,0,0
211867,not,1,0
211868,spatial,1,0
211869,cues,1,0
211870,",",0,0
211871,indicating,0,0
211872,a,0,0
211873,role,0,0
211874,of,0,0
211875,the,0,0
211876,supplementary,0,0
211877,motor,0,0
211878,area,0,0
211879,and,0,0
211880,basal,0,0
211881,ganglia,0,0
211882,in,0,0
211883,the,0,0
211884,temporal,0,0
211885,organizations,0,0
211886,of,0,0
211887,sequential,0,0
211888,movement,0,0
211889,rather,0,0
211890,than,0,0
211891,the,0,0
211892,programming,0,0
211893,of,0,0
211894,specific,0,0
211895,movements,0,0
211896,.,0,0
211897,For,0,0
211898,non-cued,1,0
211899,movements,0,0
211900,",",0,0
211901,abnormalities,0,0
211902,in,0,0
211903,MRPs,0,0
211904,for,0,0
211905,Parkinson,0,0
211906,'s,0,0
211907,disease,0,0
211908,subjects,0,0
211909,consisted,0,0
211910,of,0,0
211911,delayed,0,0
211912,MRP,0,1
211913,onset,0,0
211914,and,0,0
211915,peak,0,0
211916,times,0,0
211917,",",0,0
211918,and,0,0
211919,prolonged,0,0
211920,cortical,0,0
211921,activity,0,0
211922,following,0,0
211923,movement,0,0
211924,.,0,0
211925,These,0,0
211926,observations,0,0
211927,led,0,0
211928,to,0,0
211929,a,0,0
211930,proposed,0,0
211931,model,0,0
211932,of,0,0
211933,the,0,0
211934,interaction,0,0
211935,between,0,0
211936,the,0,0
211937,basal,0,0
211938,ganglia,0,0
211939,and,0,0
211940,the,0,0
211941,supplementary,0,0
211942,motor,0,0
211943,area,0,0
211944,",",0,0
211945,involving,0,0
211946,the,0,0
211947,temporal,0,0
211948,organization,0,0
211949,of,0,0
211950,voluntary,0,0
211951,and,0,0
211952,internally,0,0
211953,determined,0,0
211954,sequential,0,0
211955,movements,0,0
211956,.,0,0
211957,Cyproheptadine,0,1
211958,augmentation,0,1
211959,of,0,1
211960,haloperidol,1,1
211961,in,0,0
211962,chronic,0,0
211963,schizophrenic,0,0
211964,patients,0,0
211965,:,0,0
211966,a,0,0
211967,double-blind,0,1
211968,placebo-controlled,0,1
211969,study,0,1
211970,.,0,0
211971,A,0,0
211972,6,0,0
211973,week,0,0
211974,double-blind,0,1
211975,placebo-controlled,1,1
211976,trial,0,1
211977,of,0,1
211978,cyproheptadine,1,1
211979,augmentation,1,1
211980,of,0,0
211981,ongoing,0,1
211982,haloperidol,1,1
211983,treatment,0,0
211984,was,0,0
211985,conducted,0,0
211986,in,0,0
211987,40,0,0
211988,chronic,0,0
211989,schizophrenic,0,0
211990,in-patients,0,1
211991,.,0,1
211992,Cyproheptadine,0,1
211993,augmentation,0,0
211994,",",0,0
211995,compared,0,0
211996,to,0,0
211997,administration,0,1
211998,of,0,1
211999,haloperidol,1,1
212000,with,1,1
212001,placebo,1,1
212002,",",0,0
212003,did,0,0
212004,not,0,0
212005,produce,0,0
212006,a,0,0
212007,statistically,0,0
212008,significant,0,0
212009,improvement,0,0
212010,in,0,0
212011,psychotic,0,0
212012,symptoms,0,1
212013,.,0,1
212014,Cyproheptadine,0,1
212015,augmentation,0,0
212016,caused,0,0
212017,significant,0,0
212018,reduction,0,0
212019,in,0,0
212020,the,0,0
212021,extrapyramidal,0,0
212022,symptoms,0,0
212023,",",0,0
212024,which,0,0
212025,supports,0,0
212026,the,0,0
212027,atypical,0,0
212028,profile,0,0
212029,of,0,0
212030,antipsychotics,0,1
212031,.,0,0
212032,As,0,0
212033,to,0,0
212034,the,0,0
212035,neuroendocrinological,0,0
212036,effect,0,0
212037,",",0,0
212038,cyproheptadine,0,1
212039,augmentation,0,1
212040,did,0,0
212041,not,0,0
212042,reduce,0,0
212043,the,0,0
212044,plasma,0,1
212045,prolactin,0,1
212046,level,0,0
212047,but,0,0
212048,did,0,0
212049,induce,0,0
212050,a,0,0
212051,decrease,0,0
212052,in,0,0
212053,the,0,0
212054,plasma,0,1
212055,cortisol,0,1
212056,level,0,0
212057,.,0,0
212058,Although,0,0
212059,long-term,0,0
212060,follow-up,0,0
212061,studies,0,0
212062,are,0,0
212063,needed,0,0
212064,to,0,0
212065,confirm,0,0
212066,the,0,0
212067,results,0,0
212068,",",0,0
212069,this,0,0
212070,study,0,0
212071,suggests,0,0
212072,that,0,0
212073,cyproheptadine,0,1
212074,augmentation,0,0
212075,may,0,0
212076,be,0,0
212077,effective,0,0
212078,in,0,0
212079,treating,0,0
212080,chronic,0,0
212081,schizophrenic,0,0
212082,patients,0,0
212083,who,0,0
212084,are,0,0
212085,intolerant,0,0
212086,of,0,0
212087,extrapyramidal,0,0
212088,side,0,0
212089,effects,0,0
212090,of,0,0
212091,conventional,0,0
212092,antipsychotics,0,1
212093,.,0,0
212094,[,0,0
212095,Late,0,0
212096,cardiac,0,0
212097,toxicity,0,0
212098,in,0,0
212099,Hodgkin,0,0
212100,'s,0,0
212101,disease,0,0
212102,.,0,0
212103,A,0,0
212104,study,0,0
212105,with,0,0
212106,pulsed,1,0
212107,Doppler,1,0
212108,echocardiography,1,1
212109,],1,0
212110,.,0,0
212111,49,0,0
212112,patients,0,0
212113,(,0,0
212114,22,0,0
212115,women,0,0
212116,",",0,0
212117,27,0,0
212118,men,0,0
212119,",",0,0
212120,mean,0,0
212121,age,0,0
212122,43.7,0,0
212123,[,0,0
212124,21-65,0,0
212125,],0,0
212126,years,0,0
212127,),0,1
212128,with,0,0
212129,Hodgkin,0,0
212130,'s,0,0
212131,disease,0,0
212132,were,0,0
212133,examined,0,0
212134,by,0,0
212135,Doppler,1,0
212136,echocardiography,1,0
212137,a,0,0
212138,median,0,0
212139,of,0,0
212140,5.37,0,0
212141,(,0,0
212142,2-10,0,0
212143,),0,0
212144,years,0,0
212145,after,0,0
212146,the,0,0
212147,end,0,0
212148,of,0,0
212149,chemotherapy,0,1
212150,(,0,0
212151,given,0,0
212152,according,0,0
212153,to,0,0
212154,the,0,0
212155,COPP/ABVD,0,0
212156,scheme,0,0
212157,",",0,0
212158,with,0,0
212159,or,0,0
212160,without,0,0
212161,mediastinal,1,0
212162,irradiation,1,0
212163,),1,0
212164,for,0,0
212165,possible,0,0
212166,chronic,0,0
212167,changes,0,0
212168,in,0,0
212169,myocardium,0,0
212170,",",0,0
212171,pericardium,0,0
212172,or,0,0
212173,cardiac,0,0
212174,valves,0,0
212175,",",0,0
212176,as,0,0
212177,well,0,0
212178,as,0,0
212179,for,0,0
212180,any,0,0
212181,haemodynamic,0,0
212182,sequelae,0,1
212183,.,0,1
212184,Maximal,0,1
212185,and,0,0
212186,integrated,0,0
212187,early,0,0
212188,(,0,0
212189,E,0,0
212190,",",0,0
212191,Ei,0,1
212192,),0,0
212193,and,0,0
212194,late,0,0
212195,(,0,0
212196,A,0,1
212197,",",0,1
212198,Ai,0,1
212199,),0,1
212200,diastolic,0,0
212201,flow,0,0
212202,velocities,0,0
212203,and,0,0
212204,their,0,0
212205,ratio,0,0
212206,(,0,0
212207,E/A,0,1
212208,",",0,1
212209,Ei/Ai,0,1
212210,),0,0
212211,were,0,0
212212,measured,0,0
212213,by,0,0
212214,pulsed,1,0
212215,Doppler,1,0
212216,over,0,0
212217,the,0,0
212218,mitral,0,0
212219,and,0,0
212220,tricuspid,0,0
212221,valves,0,0
212222,.,0,0
212223,Although,0,0
212224,on,0,0
212225,two-dimensional,0,0
212226,echo,0,0
212227,21,0,0
212228,patients,0,0
212229,(,0,0
212230,42.9,0,0
212231,%,0,0
212232,),0,0
212233,were,0,0
212234,found,0,0
212235,to,0,0
212236,have,0,0
212237,valvar,0,0
212238,thickening,0,0
212239,",",0,0
212240,19,0,0
212241,(,0,0
212242,38.8,0,0
212243,%,0,0
212244,),0,0
212245,pericardial,0,0
212246,thickening,0,1
212247,and,0,0
212248,9,0,0
212249,(,0,0
212250,18.4,0,0
212251,%,0,0
212252,),0,0
212253,a,0,0
212254,reduced,0,0
212255,fibre,0,0
212256,shortening,0,0
212257,fraction,0,0
212258,",",0,0
212259,the,0,0
212260,Doppler,0,0
212261,indices,0,0
212262,were,0,0
212263,statistically,0,0
212264,not,0,0
212265,significantly,0,0
212266,different,0,0
212267,from,0,0
212268,those,0,0
212269,in,0,0
212270,25,0,0
212271,controls,0,0
212272,with,0,0
212273,normal,0,0
212274,hearts,0,0
212275,.,0,0
212276,These,0,0
212277,echocardiographic,0,0
212278,data,0,0
212279,of,0,0
212280,functional,0,0
212281,and,0,0
212282,morphological,0,0
212283,parameters,0,0
212284,indicate,0,0
212285,that,0,0
212286,there,0,0
212287,was,0,0
212288,no,0,0
212289,effect,0,0
212290,on,0,0
212291,various,0,0
212292,measurements,0,0
212293,of,0,0
212294,diastolic,0,0
212295,function,0,0
212296,after,0,0
212297,chemotherapy,0,0
212298,with,0,0
212299,or,0,0
212300,without,0,0
212301,mediastinal,0,0
212302,radiation,0,0
212303,.,0,0
212304,In,0,0
212305,successfully,0,0
212306,treated,0,0
212307,patients,0,0
212308,with,0,0
212309,Hodgkin,0,0
212310,'s,0,0
212311,disease,0,0
212312,the,0,0
212313,described,0,0
212314,changes,0,0
212315,are,0,0
212316,of,0,0
212317,minor,0,0
212318,significance,0,0
212319,.,0,0
212320,Expectant,1,0
212321,management,1,0
212322,of,0,0
212323,functional,0,0
212324,ovarian,0,0
212325,cysts,0,0
212326,:,0,0
212327,an,0,0
212328,alternative,0,0
212329,to,0,0
212330,hormonal,1,0
212331,therapy,1,0
212332,.,1,0
212333,OBJECTIVE,0,0
212334,We,0,0
212335,studied,0,0
212336,whether,0,0
212337,the,0,0
212338,administration,0,1
212339,of,0,1
212340,oral,1,1
212341,contraceptives,1,1
212342,facilitates,0,0
212343,the,0,0
212344,disappearance,0,0
212345,of,0,0
212346,spontaneously,0,0
212347,formed,0,0
212348,functional,0,0
212349,ovarian,0,0
212350,cysts,0,0
212351,.,0,0
212352,METHODS,0,0
212353,Eighty,0,0
212354,patients,0,0
212355,in,0,0
212356,whom,0,0
212357,ultrasonography,0,0
212358,revealed,0,0
212359,unilateral,0,0
212360,",",0,0
212361,mobile,0,0
212362,",",0,0
212363,unilocular,0,0
212364,",",0,0
212365,thin-walled,0,0
212366,ovarian,0,1
212367,cysts,0,0
212368,without,0,0
212369,internal,0,0
212370,echoes,0,0
212371,and,0,0
212372,greater,0,0
212373,than,0,0
212374,30,0,0
212375,mm,0,0
212376,but,0,0
212377,not,0,0
212378,exceeding,0,0
212379,60,0,0
212380,mm,0,0
212381,in,0,0
212382,diameter,0,0
212383,were,0,0
212384,enrolled,0,0
212385,into,0,0
212386,the,0,0
212387,study,0,0
212388,.,0,0
212389,Patients,0,0
212390,were,0,0
212391,randomized,0,0
212392,by,0,0
212393,stratification,0,0
212394,to,0,0
212395,receive,0,0
212396,a,0,0
212397,low-dose,1,1
212398,monophasic,1,1
212399,pill,1,1
212400,",",1,1
212401,a,1,1
212402,high-dose,1,1
212403,monophasic,1,1
212404,pill,1,1
212405,",",1,1
212406,a,1,0
212407,multiphasic,1,1
212408,pill,1,1
212409,or,1,1
212410,no,1,0
212411,therapy,1,0
212412,.,1,0
212413,Patients,0,0
212414,were,0,0
212415,re-evaluated,0,0
212416,after,0,0
212417,5,0,0
212418,weeks,0,0
212419,of,0,0
212420,therapy,0,0
212421,and,0,0
212422,at,0,0
212423,the,0,0
212424,end,0,0
212425,of,0,0
212426,therapy,0,1
212427,(,0,0
212428,10,0,0
212429,weeks,0,0
212430,),0,0
212431,.,0,0
212432,RESULTS,0,0
212433,The,0,0
212434,mean,0,0
212435,ages,0,0
212436,and,0,0
212437,the,0,0
212438,mean,0,0
212439,cyst,0,0
212440,diameters,0,0
212441,of,0,0
212442,the,0,0
212443,patients,0,0
212444,for,0,0
212445,each,0,0
212446,group,0,0
212447,were,0,0
212448,not,0,0
212449,significantly,0,0
212450,different,0,0
212451,.,0,0
212452,We,0,0
212453,did,0,0
212454,not,0,0
212455,find,0,0
212456,a,0,0
212457,significant,0,0
212458,effect,0,0
212459,of,0,0
212460,oral,0,1
212461,contraceptive,0,1
212462,administration,0,1
212463,on,0,0
212464,the,0,0
212465,disappearance,0,0
212466,rate,0,0
212467,of,0,0
212468,functional,0,0
212469,ovarian,0,0
212470,cysts,0,0
212471,over,0,0
212472,that,0,0
212473,of,0,0
212474,expectant,0,0
212475,management,0,0
212476,.,0,0
212477,CONCLUSION,0,0
212478,We,0,0
212479,conclude,0,0
212480,that,0,0
212481,oral,1,1
212482,contraceptive,1,1
212483,therapy,0,0
212484,even,0,0
212485,with,0,0
212486,multiphasic,0,0
212487,pills,0,1
212488,is,0,0
212489,very,0,0
212490,effective,0,0
212491,in,0,0
212492,the,0,0
212493,management,0,0
212494,of,0,0
212495,functional,0,0
212496,ovarian,0,0
212497,cysts,0,0
212498,but,0,0
212499,expectant,0,0
212500,management,0,0
212501,achieves,0,0
212502,similar,0,0
212503,success,0,0
212504,rates,0,0
212505,and,0,0
212506,may,0,0
212507,be,0,0
212508,a,0,0
212509,good,0,0
212510,alternative,0,0
212511,to,0,0
212512,oral,1,1
212513,contraceptive,1,1
212514,therapy,1,1
212515,.,1,0
212516,The,0,0
212517,influence,0,0
212518,of,0,0
212519,breast,0,0
212520,size,0,0
212521,on,0,0
212522,late,0,0
212523,radiation,0,0
212524,effects,0,0
212525,and,0,0
212526,association,0,0
212527,with,0,0
212528,radiotherapy,0,0
212529,dose,0,1
212530,inhomogeneity,0,1
212531,.,0,0
212532,A,0,0
212533,prospective,0,0
212534,assessment,0,0
212535,of,0,0
212536,late,0,0
212537,changes,0,0
212538,in,0,0
212539,breast,0,0
212540,appearance,0,0
212541,in,0,0
212542,559,0,0
212543,patients,0,0
212544,after,0,0
212545,tumour,1,0
212546,excision,1,0
212547,and,1,0
212548,radiotherapy,1,0
212549,for,0,0
212550,early,0,0
212551,breast,0,0
212552,cancer,0,0
212553,noted,0,0
212554,a,0,0
212555,strong,0,0
212556,association,0,0
212557,with,0,0
212558,breast,0,0
212559,size,0,0
212560,.,0,0
212561,Only,0,0
212562,3/48,0,0
212563,(,0,0
212564,6,0,0
212565,%,0,0
212566,),0,0
212567,patients,0,0
212568,with,0,0
212569,small,0,0
212570,breasts,0,0
212571,developed,0,0
212572,moderate,0,0
212573,or,0,0
212574,severe,0,0
212575,late,0,0
212576,changes,0,0
212577,compared,0,0
212578,with,0,0
212579,94/423,0,0
212580,(,0,0
212581,22,0,0
212582,%,0,0
212583,),0,0
212584,with,0,0
212585,medium,0,0
212586,sized,0,0
212587,breasts,0,0
212588,and,0,0
212589,34/88,0,0
212590,(,0,0
212591,39,0,0
212592,%,0,0
212593,),0,0
212594,patients,0,0
212595,with,0,0
212596,large,0,0
212597,breasts,0,0
212598,(,0,0
212599,p,0,0
212600,<,0,0
212601,0.001,0,0
212602,),0,0
212603,.,0,0
212604,One,0,0
212605,possibility,0,0
212606,is,0,0
212607,that,0,0
212608,greater,0,0
212609,radiation,0,0
212610,changes,0,0
212611,are,0,0
212612,related,0,0
212613,to,0,0
212614,greater,0,0
212615,dose,0,1
212616,inhomogeneity,0,1
212617,in,0,0
212618,women,0,0
212619,with,0,0
212620,large,0,0
212621,breasts,0,0
212622,.,0,0
212623,To,0,0
212624,explore,0,0
212625,this,0,0
212626,hypothesis,0,0
212627,",",0,0
212628,radiation,0,0
212629,dose,0,1
212630,distributions,0,0
212631,were,0,0
212632,assessed,0,0
212633,in,0,0
212634,a,0,0
212635,separate,0,0
212636,group,0,0
212637,of,0,0
212638,37,0,0
212639,women,0,0
212640,in,0,0
212641,whom,0,0
212642,three-level,0,0
212643,transverse,0,0
212644,computer,0,0
212645,tomographic,0,0
212646,images,0,0
212647,of,0,0
212648,the,0,0
212649,breast,0,0
212650,in,0,0
212651,the,0,0
212652,treatment,0,0
212653,position,0,0
212654,were,0,0
212655,available,0,0
212656,.,0,0
212657,A,0,0
212658,significant,0,0
212659,correlation,0,0
212660,was,0,0
212661,found,0,0
212662,between,0,0
212663,breast,0,0
212664,size,0,0
212665,and,0,0
212666,dose,0,1
212667,inhomogeneity,0,1
212668,which,0,0
212669,may,0,0
212670,account,0,0
212671,for,0,0
212672,the,0,0
212673,marked,0,0
212674,changes,0,0
212675,in,0,0
212676,breast,0,0
212677,appearance,0,0
212678,reported,0,0
212679,in,0,0
212680,women,0,0
212681,with,0,0
212682,large,0,0
212683,breasts,0,0
212684,.,0,0
212685,Effects,0,0
212686,of,0,0
212687,the,0,0
212688,cholinomimetic,1,1
212689,SDZ,1,1
212690,ENS-163,1,1
212691,on,0,0
212692,scopolamine-induced,0,1
212693,cognitive,0,1
212694,impairment,0,0
212695,in,0,0
212696,humans,0,0
212697,.,0,0
212698,Scopolamine-induced,0,1
212699,cognitive,0,1
212700,impairment,0,0
212701,was,0,0
212702,used,0,0
212703,in,0,0
212704,healthy,0,0
212705,men,0,0
212706,to,0,0
212707,evaluate,0,0
212708,the,0,0
212709,central,0,0
212710,nervous,0,0
212711,system,0,0
212712,activity,0,0
212713,of,0,0
212714,the,0,0
212715,new,1,0
212716,cholinomimetic,1,1
212717,SDZ,1,1
212718,ENS-163,1,1
212719,.,1,0
212720,Eighteen,0,0
212721,subjects,0,0
212722,were,0,0
212723,treated,0,0
212724,in,0,0
212725,a,0,0
212726,crossover,0,1
212727,design,0,1
212728,with,0,1
212729,oral,1,1
212730,placebo/intravenous,1,1
212731,saline,1,1
212732,",",1,1
212733,50,1,1
212734,mg,1,1
212735,of,1,1
212736,oral,1,1
212737,SDZ,1,1
212738,ENS-163/intravenous,1,1
212739,saline,1,1
212740,",",1,1
212741,oral,1,1
212742,placebo/0.4,1,1
212743,mg,1,1
212744,of,1,1
212745,intravenous,1,1
212746,scopolamine,1,1
212747,",",1,1
212748,and,1,1
212749,50,1,1
212750,mg,1,1
212751,of,1,1
212752,oral,1,1
212753,SDZ,1,1
212754,ENS-163/0.4,1,0
212755,mg,1,0
212756,of,1,0
212757,intravenous,1,1
212758,scopolamine,1,1
212759,.,1,1
212760,The,0,0
212761,administration,0,1
212762,of,0,0
212763,placebo,0,1
212764,with,0,1
212765,scopolamine,0,1
212766,caused,0,0
212767,significant,0,0
212768,cognitive,0,0
212769,impairment,0,0
212770,",",0,0
212771,as,0,0
212772,assessed,0,0
212773,by,0,0
212774,the,0,0
212775,Computerized,0,0
212776,Neuropsychological,0,1
212777,Test,0,1
212778,Battery,0,1
212779,(,0,1
212780,CNTB,0,1
212781,),0,1
212782,",",0,0
212783,and,0,0
212784,also,0,0
212785,decreased,0,0
212786,salivation,0,0
212787,and,0,0
212788,heart,0,0
212789,rate,0,0
212790,.,0,0
212791,In,0,0
212792,contrast,0,0
212793,",",0,0
212794,SDZ,0,0
212795,ENS-163,0,1
212796,with,0,0
212797,saline,0,1
212798,had,0,0
212799,no,0,0
212800,effect,0,0
212801,on,0,0
212802,CNTB,0,0
212803,scores,0,0
212804,",",0,0
212805,increased,0,0
212806,salivation,0,1
212807,",",0,0
212808,and,0,0
212809,increased,0,0
212810,heart,0,0
212811,rate,0,0
212812,.,0,0
212813,Despite,0,0
212814,the,0,0
212815,observed,0,0
212816,cholinomimetic,0,1
212817,effects,0,0
212818,of,0,0
212819,SDZ,0,0
212820,ENS-163,0,1
212821,when,0,0
212822,administered,0,1
212823,with,0,1
212824,saline,0,1
212825,",",0,0
212826,the,0,0
212827,changes,0,0
212828,in,0,0
212829,CNTB,0,0
212830,scores,0,0
212831,",",0,0
212832,heart,0,0
212833,rate,0,0
212834,",",0,0
212835,and,0,0
212836,salivation,0,1
212837,were,0,0
212838,indistinguishable,0,0
212839,between,0,0
212840,placebo/scopolamine,0,1
212841,and,0,1
212842,SDZ,0,1
212843,ENS-163/scopolamine,0,1
212844,.,0,1
212845,Thus,0,0
212846,",",0,0
212847,50,0,1
212848,mg,0,1
212849,of,0,1
212850,oral,0,1
212851,SDZ,0,1
212852,ENS-163,0,1
212853,has,0,0
212854,cholinomimetic,0,1
212855,activity,0,0
212856,in,0,0
212857,normal,0,0
212858,men,0,0
212859,",",0,0
212860,but,0,0
212861,this,0,0
212862,dose,0,1
212863,is,0,0
212864,insufficient,0,0
212865,to,0,0
212866,reverse,0,0
212867,the,0,0
212868,muscarinic,0,1
212869,effects,0,0
212870,of,0,0
212871,0.4,0,0
212872,mg,0,1
212873,of,0,0
212874,intravenous,0,1
212875,scopolamine,0,1
212876,.,0,1
212877,The,0,0
212878,costs,0,0
212879,and,0,0
212880,effects,0,0
212881,of,0,0
212882,a,0,0
212883,nutritional,1,0
212884,education,1,0
212885,program,1,0
212886,following,0,0
212887,work-site,0,1
212888,cholesterol,0,1
212889,screening,0,0
212890,.,0,0
212891,OBJECTIVES,0,0
212892,The,0,0
212893,purpose,0,0
212894,of,0,0
212895,this,0,0
212896,study,0,0
212897,was,0,0
212898,to,0,0
212899,assess,0,0
212900,the,0,0
212901,costs,0,0
212902,and,0,0
212903,impact,0,0
212904,of,0,0
212905,a,0,0
212906,nutrition,1,0
212907,education,1,0
212908,program,1,0
212909,following,0,0
212910,a,0,0
212911,cholesterol,0,1
212912,screening,0,0
212913,.,0,0
212914,METHODS,0,0
212915,Forty,0,0
212916,work-sites,0,0
212917,were,0,0
212918,randomly,0,0
212919,assigned,0,0
212920,to,0,0
212921,one,0,0
212922,of,0,0
212923,two,0,0
212924,educational,1,0
212925,interventions,1,0
212926,:,1,0
212927,a,0,0
212928,usual,1,0
212929,intervention,1,0
212930,of,1,0
212931,5,1,0
212932,minutes,1,0
212933,of,1,0
212934,counseling,1,0
212935,",",1,0
212936,or,1,0
212937,a,1,0
212938,special,1,0
212939,intervention,1,0
212940,of,1,0
212941,2,1,0
212942,hours,1,0
212943,of,1,0
212944,behaviorally,1,0
212945,based,1,0
212946,education,1,0
212947,on,1,0
212948,dietary,1,1
212949,changes,1,0
212950,to,1,0
212951,lower,1,0
212952,serum,1,1
212953,cholesterol,1,1
212954,.,1,1
212955,Costs,0,0
212956,were,0,0
212957,monitored,0,0
212958,",",0,0
212959,and,0,0
212960,cholesterol,0,1
212961,levels,0,0
212962,were,0,0
212963,retested,0,0
212964,6,0,0
212965,and,0,0
212966,12,0,0
212967,months,0,0
212968,later,0,0
212969,.,0,0
212970,RESULTS,0,0
212971,The,0,0
212972,total,0,0
212973,per-person,0,0
212974,cost,0,0
212975,for,0,0
212976,screening,0,0
212977,and,0,0
212978,the,0,0
212979,educational,0,0
212980,intervention,0,0
212981,was,0,0
212982,about,0,0
212983,$,0,0
212984,50,0,0
212985,.,0,0
212986,Cholesterol,0,1
212987,levels,0,0
212988,differed,0,0
212989,little,0,0
212990,between,0,0
212991,the,0,0
212992,two,0,0
212993,intervention,0,0
212994,groups,0,0
212995,6,0,0
212996,months,0,0
212997,after,0,0
212998,screening,0,0
212999,",",0,0
213000,but,0,0
213001,after,0,0
213002,12,0,0
213003,months,0,0
213004,those,0,0
213005,in,0,0
213006,the,0,0
213007,special,0,0
213008,intervention,0,0
213009,worksites,0,0
213010,showed,0,0
213011,a,0,0
213012,6.5,0,0
213013,%,0,0
213014,drop,0,0
213015,in,0,0
213016,cholesterol,0,1
213017,",",0,0
213018,whereas,0,0
213019,those,0,0
213020,at,0,0
213021,the,0,0
213022,usual,0,0
213023,intervention,0,0
213024,worksites,0,0
213025,showed,0,0
213026,a,0,0
213027,drop,0,0
213028,of,0,0
213029,only,0,0
213030,3.0,0,0
213031,%,0,0
213032,.,0,0
213033,Hence,0,0
213034,a,0,0
213035,3.5,0,0
213036,%,0,0
213037,cholesterol,0,0
213038,reduction,0,0
213039,was,0,0
213040,attributable,0,0
213041,to,0,0
213042,the,0,0
213043,special,0,0
213044,intervention,0,0
213045,.,0,0
213046,CONCLUSIONS,0,0
213047,A,0,1
213048,behaviorally,1,0
213049,based,1,0
213050,nutrition,1,0
213051,education,1,0
213052,program,1,0
213053,following,0,0
213054,cholesterol,0,1
213055,screening,0,0
213056,can,0,0
213057,have,0,0
213058,a,0,0
213059,meaningful,0,0
213060,impact,0,0
213061,on,0,0
213062,long-term,0,0
213063,cholesterol,0,1
213064,levels,0,0
213065,at,0,0
213066,a,0,0
213067,low,0,0
213068,cost,0,0
213069,.,0,0
213070,Nutrition,1,0
213071,education,1,0
213072,in,0,0
213073,work-sites,0,0
213074,may,0,0
213075,therefore,0,0
213076,be,0,0
213077,a,0,0
213078,useful,0,0
213079,way,0,0
213080,to,0,0
213081,lower,0,0
213082,the,0,0
213083,risk,0,0
213084,of,0,0
213085,heart,0,0
213086,disease,0,0
213087,in,0,0
213088,communities,0,0
213089,.,0,0
213090,The,0,0
213091,effect,0,0
213092,of,0,0
213093,fasting,1,1
213094,on,0,0
213095,total,0,1
213096,serum,0,1
213097,bilirubin,0,1
213098,concentrations,0,1
213099,.,0,0
213100,Thirty-seven,0,0
213101,healthy,0,0
213102,volunteers,0,0
213103,",",0,0
213104,19,0,0
213105,of,0,0
213106,whom,0,0
213107,had,0,0
213108,consistently,0,0
213109,elevated,0,0
213110,total,0,0
213111,serum,0,1
213112,bilirubin,0,1
213113,(,0,1
213114,TSB,0,1
213115,),0,1
213116,concentrations,0,1
213117,",",0,0
213118,took,0,0
213119,part,0,0
213120,in,0,0
213121,an,0,0
213122,open,0,0
213123,",",0,0
213124,randomised,0,1
213125,cross-over,0,1
213126,study,0,0
213127,to,0,0
213128,determine,0,0
213129,the,0,0
213130,effect,0,0
213131,of,0,0
213132,fasting,1,1
213133,on,0,0
213134,TSB,0,1
213135,concentrations,0,1
213136,.,0,0
213137,The,0,0
213138,study,0,0
213139,comprised,0,0
213140,of,0,0
213141,two,0,0
213142,treatments,0,0
213143,.,0,0
213144,During,0,0
213145,one,0,0
213146,treatment,0,0
213147,period,0,1
213148,volunteers,0,0
213149,ate,1,0
213150,a,1,0
213151,standard,1,1
213152,supper,1,1
213153,but,1,1
213154,fasted,1,1
213155,for,1,0
213156,24,1,0
213157,h,1,0
213158,thereafter,1,0
213159,.,1,0
213160,During,0,0
213161,the,0,0
213162,other,0,0
213163,treatment,0,0
213164,period,0,1
213165,volunteers,0,0
213166,ate,0,0
213167,a,0,0
213168,standard,1,1
213169,supper,1,1
213170,",",1,1
213171,snacks,1,1
213172,",",1,1
213173,breakfast,1,1
213174,and,1,1
213175,lunch,1,1
213176,.,1,1
213177,TSB,0,1
213178,concentrations,0,1
213179,were,0,0
213180,measured,0,0
213181,at,0,0
213182,regular,0,0
213183,intervals,0,0
213184,.,0,0
213185,In,0,0
213186,both,0,0
213187,the,0,0
213188,normal,0,0
213189,and,0,0
213190,high,0,0
213191,bilirubin,0,1
213192,groups,0,0
213193,",",0,0
213194,minimum,0,0
213195,TSB,0,0
213196,values,0,0
213197,were,0,0
213198,recorded,0,0
213199,4,0,0
213200,h,0,0
213201,after,0,0
213202,the,0,0
213203,supper,0,1
213204,.,0,1
213205,A,0,1
213206,24,0,0
213207,h,0,0
213208,fast,0,0
213209,more,0,0
213210,than,0,0
213211,doubled,0,0
213212,TSB,0,0
213213,concentration,0,0
213214,from,0,0
213215,baseline,0,0
213216,values,0,0
213217,in,0,0
213218,both,0,0
213219,the,0,0
213220,normal,0,0
213221,and,0,0
213222,high,0,0
213223,bilirubin,0,1
213224,groups,0,1
213225,.,0,0
213226,A,0,0
213227,clinically,0,0
213228,relevant,0,0
213229,rise,0,0
213230,in,0,0
213231,TSB,0,0
213232,took,0,0
213233,place,0,0
213234,after,0,0
213235,12,0,0
213236,h,0,0
213237,into,0,0
213238,the,0,0
213239,fasting,0,1
213240,period,0,1
213241,(,0,1
213242,TSB,0,0
213243,of,0,0
213244,17.3,0,0
213245,mumol,0,1
213246,l-1,0,1
213247,in,0,1
213248,the,0,0
213249,fasted,0,1
213250,group,0,0
213251,vs,0,0
213252,14.0,0,0
213253,mumol,0,0
213254,l-1,0,1
213255,in,0,1
213256,the,0,0
213257,non-fasted,0,1
213258,group,0,1
213259,),0,0
213260,.,0,0
213261,When,0,0
213262,designing,0,0
213263,a,0,0
213264,clinical,0,0
213265,trial,0,0
213266,",",0,0
213267,selecting,0,0
213268,volunteers,0,0
213269,",",0,0
213270,or,0,0
213271,judging,0,0
213272,the,0,0
213273,tolerance,0,0
213274,of,0,0
213275,a,0,0
213276,new,0,0
213277,drug,0,1
213278,",",0,0
213279,the,0,0
213280,rise,0,0
213281,in,0,0
213282,TSB,0,0
213283,caused,0,0
213284,by,0,0
213285,fasting,0,1
213286,must,0,0
213287,therefore,0,0
213288,be,0,0
213289,taken,0,0
213290,into,0,0
213291,account,0,0
213292,",",0,0
213293,particularly,0,0
213294,in,0,0
213295,trials,0,0
213296,where,0,0
213297,volunteers,0,0
213298,or,0,0
213299,patients,0,0
213300,fast,0,0
213301,before,0,0
213302,entering,0,0
213303,the,0,0
213304,study,0,0
213305,.,0,0
213306,[,0,1
213307,Postoperative,0,1
213308,analgesia,0,1
213309,:,0,1
213310,peridural,1,1
213311,morphine,1,1
213312,versus,0,1
213313,sublingual,1,1
213314,buprenorphine,1,1
213315,.,1,1
213316,Comparative,0,0
213317,clinical,0,0
213318,study,0,0
213319,],0,0
213320,.,0,0
213321,The,0,0
213322,authors,0,0
213323,herein,0,0
213324,present,0,0
213325,their,0,0
213326,personal,0,0
213327,series,0,0
213328,on,0,0
213329,the,0,0
213330,clinical,0,0
213331,evaluation,0,0
213332,of,0,0
213333,the,0,0
213334,analgesic,0,1
213335,efficacy,0,1
213336,of,0,0
213337,2,0,1
213338,opiodes,0,0
213339,",",0,1
213340,peridural,1,1
213341,morphine,1,1
213342,hydrochloride,1,1
213343,(,1,1
213344,0.5,1,1
213345,mg/kg,1,1
213346,),1,1
213347,administered,0,1
213348,to,0,1
213349,group,0,0
213350,A,0,0
213351,patients,0,0
213352,",",0,0
213353,and,0,1
213354,sublingual,1,1
213355,buprenorphine,1,1
213356,(,1,1
213357,0.4,1,1
213358,mg,1,1
213359,),1,1
213360,administered,0,1
213361,to,0,1
213362,group,0,0
213363,B,0,0
213364,patients,0,0
213365,in,0,0
213366,the,0,0
213367,management,0,0
213368,of,0,0
213369,post-operative,0,0
213370,pain,0,0
213371,in,0,0
213372,major,0,0
213373,abdominal,0,0
213374,surgery,0,0
213375,.,0,0
213376,The,0,0
213377,study,0,0
213378,was,0,0
213379,conducted,0,0
213380,on,0,0
213381,44,0,0
213382,patients,0,0
213383,",",0,0
213384,both,0,0
213385,male,0,0
213386,and,0,0
213387,female,0,0
213388,",",0,0
213389,classified,0,0
213390,as,0,0
213391,ASA,0,0
213392,II,0,1
213393,and,0,0
213394,III,0,1
213395,.,0,0
213396,Statistical,0,0
213397,analysis,0,0
213398,of,0,0
213399,cardiovascular,0,0
213400,parameters,0,0
213401,(,0,0
213402,BP,0,1
213403,and,0,0
213404,cardiac,0,0
213405,frequency,0,0
213406,),0,0
213407,",",0,0
213408,respiratory,0,0
213409,frequency,0,0
213410,and,0,0
213411,pain,0,0
213412,score,0,0
213413,showed,0,0
213414,an,0,0
213415,overlapping,0,0
213416,progression,0,0
213417,among,0,0
213418,the,0,0
213419,two,0,0
213420,groups,0,0
213421,.,0,0
213422,Spontaneous,0,0
213423,pain,0,0
213424,decreased,0,0
213425,significantly,0,0
213426,to,0,0
213427,zero,0,0
213428,at,0,0
213429,T6,0,0
213430,(,0,0
213431,p,0,0
213432,<,0,0
213433,0.001,0,0
213434,),0,0
213435,.,0,0
213436,However,0,0
213437,",",0,0
213438,the,0,0
213439,necessity,0,0
213440,to,0,0
213441,administer,0,1
213442,buprenorphine,1,1
213443,more,0,0
213444,frequently,0,0
213445,after,0,0
213446,the,0,0
213447,sixth,0,0
213448,hour,0,0
213449,and,0,0
213450,the,0,0
213451,consequent,0,0
213452,increase,0,0
213453,in,0,0
213454,side,0,0
213455,effects,0,0
213456,",",0,0
213457,lead,0,0
213458,us,0,0
213459,to,0,0
213460,believe,0,0
213461,that,0,0
213462,the,0,0
213463,method,0,0
213464,used,0,0
213465,for,0,0
213466,group,0,0
213467,A,0,0
213468,patients,0,0
213469,is,0,0
213470,more,0,0
213471,advantageous,0,0
213472,.,0,0
213473,[,0,1
213474,Double-blind,0,1
213475,placebo-controlled,0,1
213476,study,0,0
213477,of,0,0
213478,the,0,0
213479,effectiveness,0,0
213480,and,0,0
213481,tolerability,0,1
213482,of,0,0
213483,10,0,0
213484,and,0,0
213485,30,0,1
213486,mg,0,1
213487,ketorolac,1,1
213488,tromethamine,1,1
213489,suppositories,1,1
213490,in,0,1
213491,post-cholecystectomy,0,1
213492,pain,0,1
213493,],0,0
213494,.,0,0
213495,OBJECTIVE,0,0
213496,To,0,0
213497,evaluate,0,0
213498,the,0,0
213499,efficacy,0,0
213500,and,0,0
213501,tolerability,0,1
213502,of,0,1
213503,ketorolac,1,1
213504,tromethamine,1,1
213505,10,0,1
213506,mg,0,1
213507,and,0,1
213508,30,0,1
213509,mg,0,1
213510,suppositories,1,1
213511,in,0,0
213512,comparison,0,0
213513,to,0,0
213514,placebo,1,1
213515,",",0,0
213516,after,0,0
213517,single,0,0
213518,dose,0,1
213519,administration,0,1
213520,in,0,1
213521,patients,0,0
213522,suffering,0,0
213523,from,0,0
213524,post-operative,0,0
213525,pain,0,0
213526,after,0,0
213527,cholecystectomy,0,0
213528,.,0,0
213529,DESIGN,0,1
213530,Double-blind,0,1
213531,",",0,1
213532,randomized,0,1
213533,",",0,0
213534,controlled,0,0
213535,study,0,0
213536,.,0,0
213537,SETTING,0,0
213538,Anaesthesia,0,0
213539,Service,0,0
213540,.,0,0
213541,PATIENTS,0,0
213542,99,0,0
213543,patients,0,0
213544,with,0,0
213545,severe,0,0
213546,pain,0,0
213547,following,0,0
213548,surgery,0,0
213549,.,0,0
213550,INTERVENTIONS,0,0
213551,Cholecystectomy,1,0
213552,.,1,0
213553,MEASUREMENTS,0,0
213554,AND,0,1
213555,MAIN,0,1
213556,RESULTS,0,1
213557,The,0,0
213558,analgesia,0,1
213559,activity,0,0
213560,of,0,1
213561,ketorolac,1,1
213562,tromethamine,1,1
213563,10,1,1
213564,mg,1,1
213565,and,1,1
213566,30,1,1
213567,mg,1,1
213568,suppositories,1,1
213569,were,0,0
213570,evaluated,0,0
213571,after,0,0
213572,single,0,0
213573,dose,0,1
213574,administration,0,1
213575,by,0,1
213576,assessing,0,0
213577,pain,0,0
213578,intensity,0,0
213579,and,0,0
213580,pain,0,0
213581,relief,0,0
213582,using,0,0
213583,a,0,0
213584,4,0,0
213585,point,0,0
213586,scale,0,1
213587,(,0,1
213588,VRS,0,1
213589,),0,1
213590,.,0,0
213591,At,0,0
213592,the,0,0
213593,end,0,0
213594,of,0,0
213595,the,0,0
213596,treatment,0,0
213597,period,0,0
213598,overall,0,0
213599,assessment,0,0
213600,of,0,0
213601,safety,0,0
213602,and,0,0
213603,efficacy,0,0
213604,were,0,0
213605,recorded,0,0
213606,by,0,0
213607,physician,0,0
213608,and,0,0
213609,patient,0,0
213610,.,0,0
213611,The,0,0
213612,results,0,0
213613,show,0,0
213614,that,0,0
213615,in,0,0
213616,both,0,0
213617,active,0,0
213618,groups,0,0
213619,after,0,0
213620,30,0,0
213621,',0,0
213622,and,0,0
213623,until,0,0
213624,4,0,1
213625,hours,0,0
213626,",",0,0
213627,pain,0,0
213628,intensity,0,0
213629,decreased,0,0
213630,significantly,0,0
213631,with,0,0
213632,respect,0,0
213633,to,0,0
213634,the,0,0
213635,baseline,0,0
213636,.,0,0
213637,However,0,0
213638,a,0,0
213639,statistically,0,0
213640,significant,0,0
213641,difference,0,0
213642,between,0,0
213643,groups,0,0
213644,of,0,0
213645,p,0,0
213646,<,0,0
213647,0.02,0,0
213648,",",0,0
213649,p,0,0
213650,<,0,0
213651,0.01,0,0
213652,and,0,0
213653,p,0,0
213654,<,0,0
213655,0.05,0,0
213656,was,0,0
213657,found,0,0
213658,in,0,0
213659,favour,0,0
213660,of,0,0
213661,the,0,0
213662,30,0,1
213663,mg,0,1
213664,dose,0,1
213665,respectively,0,1
213666,at,0,0
213667,30,0,0
213668,',0,0
213669,",",0,0
213670,6,0,0
213671,and,0,0
213672,8,0,0
213673,hours,0,1
213674,after,0,0
213675,administration,0,1
213676,.,0,0
213677,All,0,0
213678,the,0,0
213679,patients,0,0
213680,treated,0,0
213681,with,0,0
213682,placebo,1,1
213683,suppositories,0,1
213684,required,0,0
213685,another,0,0
213686,rescue,0,0
213687,analgesic,0,1
213688,drug,0,1
213689,and,0,1
213690,withdrew,0,0
213691,from,0,0
213692,the,0,0
213693,trial,0,0
213694,.,0,0
213695,Three,0,0
213696,patients,0,0
213697,complained,0,0
213698,adverse,0,0
213699,events,0,0
213700,not,0,0
213701,related,0,0
213702,to,0,0
213703,treatment,0,0
213704,:,0,0
213705,two,0,0
213706,on,0,0
213707,placebo,0,1
213708,and,0,0
213709,one,0,0
213710,on,0,0
213711,ketorolac,0,1
213712,10,0,1
213713,mg,0,1
213714,.,0,0
213715,The,0,0
213716,systemic,0,0
213717,and,0,0
213718,local,0,0
213719,tolerability,0,1
213720,of,0,0
213721,the,0,0
213722,drug,0,1
213723,was,0,0
213724,good,0,0
213725,.,0,0
213726,CONCLUSIONS,0,0
213727,This,0,0
213728,study,0,0
213729,shows,0,0
213730,that,0,0
213731,ketorolac,1,1
213732,30,0,1
213733,mg,0,1
213734,suppositories,1,1
213735,are,0,0
213736,effective,0,0
213737,in,0,0
213738,clinical,0,0
213739,conditions,0,0
213740,",",0,0
213741,such,0,0
213742,as,0,0
213743,after,0,0
213744,surgery,0,0
213745,",",0,0
213746,in,0,0
213747,which,0,0
213748,pain,0,0
213749,control,0,0
213750,must,0,0
213751,be,0,0
213752,achieved,0,0
213753,within,0,0
213754,the,0,0
213755,shortest,0,0
213756,time,0,0
213757,interval,0,0
213758,and,0,0
213759,maintained,0,0
213760,or,0,0
213761,improved,0,0
213762,by,0,0
213763,means,0,0
213764,of,0,0
213765,a,0,0
213766,single,0,0
213767,route,0,0
213768,of,0,0
213769,administration,0,1
213770,.,0,0
213771,[,0,1
213772,A,0,1
213773,comparison,0,0
213774,of,0,0
213775,2,0,0
213776,methods,0,0
213777,of,0,0
213778,plastic,1,0
213779,cast,1,0
213780,fixation,1,0
213781,in,0,0
213782,treatment,0,0
213783,of,0,0
213784,loco,0,0
213785,classico,0,1
213786,radius,0,0
213787,fracture,0,0
213788,.,0,0
213789,A,0,0
213790,prospective,0,0
213791,",",0,0
213792,randomized,0,0
213793,study,0,0
213794,],0,0
213795,.,0,0
213796,The,0,0
213797,purpose,0,0
213798,of,0,0
213799,this,0,0
213800,study,0,0
213801,was,0,0
213802,to,0,0
213803,compare,0,0
213804,the,0,0
213805,functional,0,0
213806,and,0,0
213807,radiological,0,0
213808,result,0,0
213809,of,0,0
213810,two,0,0
213811,different,0,0
213812,positions,0,0
213813,of,0,0
213814,the,0,0
213815,wrist,0,0
213816,in,0,0
213817,a,0,0
213818,plaster,1,0
213819,cast,1,0
213820,following,0,0
213821,Colles,0,0
213822,',0,0
213823,fracture,0,0
213824,.,0,0
213825,For,0,0
213826,this,0,0
213827,prospective,0,0
213828,study,0,0
213829,",",0,0
213830,each,0,0
213831,of,0,0
213832,50,0,0
213833,patients,0,0
213834,with,0,0
213835,type,0,0
213836,A,0,0
213837,2.2,0,0
213838,",",0,0
213839,A,0,0
213840,3.3,0,0
213841,",",0,0
213842,C,0,0
213843,1.2,0,0
213844,or,0,0
213845,C,0,0
213846,2.2,0,0
213847,(,0,0
213848,AO,0,1
213849,classification,0,1
213850,),0,0
213851,fractures,0,0
213852,of,0,0
213853,the,0,0
213854,radius,0,0
213855,was,0,0
213856,randomly,0,0
213857,assigned,0,0
213858,to,0,0
213859,one,0,0
213860,of,0,0
213861,two,0,0
213862,groups,0,0
213863,.,0,0
213864,Both,0,0
213865,groups,0,0
213866,were,0,0
213867,treated,0,0
213868,in,0,0
213869,the,0,0
213870,same,0,0
213871,way,0,0
213872,as,0,0
213873,far,0,0
213874,as,0,0
213875,anaesthesia,0,0
213876,and,0,0
213877,reduction,0,0
213878,were,0,0
213879,concerned,0,0
213880,.,0,0
213881,The,0,0
213882,only,0,0
213883,difference,0,0
213884,in,0,0
213885,treatment,0,0
213886,lay,0,0
213887,in,0,0
213888,the,0,0
213889,position,0,0
213890,of,0,0
213891,fixation,0,0
213892,in,0,0
213893,plaster,0,0
213894,.,0,0
213895,In,0,0
213896,group,0,0
213897,1,0,0
213898,the,0,0
213899,wrist,1,0
213900,was,1,0
213901,immobilized,1,0
213902,in,1,0
213903,neutral,1,0
213904,flexion-extension,1,0
213905,.,1,0
213906,In,0,0
213907,group,0,0
213908,2,0,0
213909,the,0,0
213910,wrist,0,0
213911,was,0,0
213912,dorsiflexed,1,0
213913,20,1,0
213914,degrees,1,0
213915,",",1,0
213916,while,1,0
213917,the,1,0
213918,carpus,1,0
213919,was,1,0
213920,pushed,1,0
213921,in,1,0
213922,a,1,0
213923,volar,1,0
213924,direction,1,0
213925,by,1,0
213926,an,1,0
213927,impression,1,0
213928,in,1,0
213929,the,1,0
213930,plaster,1,0
213931,cast,1,0
213932,.,1,0
213933,At,0,0
213934,review,0,0
213935,2-7,0,0
213936,years,0,0
213937,after,0,0
213938,the,0,0
213939,accidents,0,0
213940,",",0,0
213941,the,0,0
213942,two,0,0
213943,groups,0,0
213944,were,0,0
213945,compared,0,0
213946,with,0,0
213947,reference,0,0
213948,to,0,0
213949,symptoms,0,0
213950,",",0,0
213951,range,0,0
213952,of,0,0
213953,motion,0,0
213954,at,0,0
213955,the,0,0
213956,wrist,0,0
213957,",",0,0
213958,power,0,0
213959,of,0,0
213960,first,0,0
213961,closure,0,0
213962,and,0,0
213963,radiographic,0,0
213964,appearance,0,0
213965,.,0,0
213966,In,0,0
213967,group,0,0
213968,1,0,0
213969,there,0,0
213970,were,0,0
213971,5,0,0
213972,patients,0,0
213973,with,0,0
213974,significant,0,0
213975,disability,0,0
213976,",",0,0
213977,compared,0,0
213978,with,0,0
213979,only,0,0
213980,1,0,0
213981,in,0,0
213982,group,0,0
213983,2,0,0
213984,.,0,0
213985,A,0,0
213986,significant,0,0
213987,difference,0,0
213988,was,0,0
213989,found,0,0
213990,in,0,0
213991,the,0,0
213992,range,0,0
213993,of,0,0
213994,movement,0,0
213995,between,0,0
213996,the,0,0
213997,two,0,0
213998,groups,0,0
213999,for,0,0
214000,flexion,0,0
214001,and,0,0
214002,ulnar,0,1
214003,abduction,0,0
214004,(,0,0
214005,p,0,0
214006,<,0,0
214007,0.01,0,0
214008,),0,0
214009,.,0,0
214010,The,0,0
214011,loss,0,0
214012,of,0,0
214013,power,0,0
214014,of,0,0
214015,first,0,0
214016,clenching,0,0
214017,(,0,0
214018,difference,0,0
214019,between,0,0
214020,injured,0,0
214021,and,0,0
214022,healthy,0,0
214023,hand,0,0
214024,),0,0
214025,was,0,0
214026,6.2,0,0
214027,mmHg,0,0
214028,for,0,0
214029,group,0,0
214030,1,0,0
214031,and,0,0
214032,3.8,0,0
214033,mmHg,0,0
214034,for,0,0
214035,group,0,0
214036,2,0,0
214037,(,0,0
214038,not,0,0
214039,significant,0,0
214040,),0,0
214041,.,0,0
214042,The,0,0
214043,radiographic,0,0
214044,examination,0,0
214045,showed,0,0
214046,significant,0,0
214047,differences,0,0
214048,both,0,0
214049,in,0,0
214050,sagittal,0,0
214051,inclination,0,0
214052,(,0,0
214053,p,0,0
214054,<,0,0
214055,0.001,0,0
214056,),0,0
214057,and,0,0
214058,in,0,0
214059,radial,0,0
214060,shortening,0,0
214061,(,0,0
214062,p,0,0
214063,<,0,0
214064,0.05,0,0
214065,),0,0
214066,.,0,0
214067,(,0,0
214068,ABSTRACT,0,1
214069,TRUNCATED,0,1
214070,AT,0,1
214071,250,0,1
214072,WORDS,0,1
214073,),0,1
214074,Physiological,1,0
214075,pacing,1,0
214076,improves,0,0
214077,symptoms,0,0
214078,and,0,0
214079,increases,0,0
214080,exercise,0,0
214081,capacity,0,0
214082,in,0,0
214083,the,0,0
214084,elderly,0,0
214085,patient,0,0
214086,.,0,0
214087,We,0,0
214088,evaluated,0,0
214089,the,0,0
214090,benefits,0,0
214091,of,0,0
214092,physiological,1,0
214093,pacing,1,0
214094,in,0,0
214095,the,0,0
214096,elderly,0,0
214097,by,0,0
214098,recruiting,0,0
214099,13,0,0
214100,subjects,0,0
214101,>,0,0
214102,75,0,0
214103,years,0,0
214104,of,0,0
214105,age,0,0
214106,",",0,0
214107,already,0,0
214108,fitted,0,0
214109,with,0,0
214110,a,0,0
214111,physiological,1,0
214112,pacing,1,0
214113,system,1,0
214114,.,1,0
214115,All,0,0
214116,had,0,0
214117,been,0,0
214118,paced,0,0
214119,for,0,0
214120,complete,0,0
214121,or,0,0
214122,Mobitz,0,0
214123,II,0,1
214124,heart,0,0
214125,block,0,0
214126,.,0,0
214127,Double,0,0
214128,blind,0,0
214129,cross,0,0
214130,over,0,0
214131,study,0,0
214132,was,0,0
214133,performed,0,0
214134,comparing,0,0
214135,exercise,0,0
214136,capacity,0,0
214137,",",0,0
214138,measuring,0,0
214139,distance,0,0
214140,walked,0,0
214141,on,0,0
214142,a,0,0
214143,6-min,0,0
214144,walking,0,0
214145,test,0,0
214146,and,0,0
214147,time,0,0
214148,taken,0,0
214149,to,0,0
214150,climb,0,0
214151,two,0,0
214152,flights,0,0
214153,of,0,0
214154,stairs,0,1
214155,;,0,0
214156,and,0,0
214157,symptoms,0,0
214158,",",0,0
214159,evaluated,0,0
214160,by,0,0
214161,an,0,0
214162,activity,0,0
214163,of,0,0
214164,daily,0,1
214165,living,0,0
214166,questionnaire,0,0
214167,",",0,0
214168,in,0,0
214169,atrioventricular,1,0
214170,synchronous,1,0
214171,and,1,0
214172,ventricular,1,0
214173,pacing,1,0
214174,.,1,0
214175,Mean,0,0
214176,distance,0,0
214177,walked,0,0
214178,was,0,0
214179,significantly,0,0
214180,higher,0,0
214181,in,0,0
214182,atrioventricular,1,0
214183,synchronous,1,0
214184,than,0,0
214185,in,0,0
214186,ventricular,1,1
214187,pacing,1,0
214188,(,0,0
214189,360,0,0
214190,+/-,0,0
214191,65,0,0
214192,m,0,0
214193,vs.,0,0
214194,327,0,0
214195,+/-,0,0
214196,69,0,0
214197,m,0,0
214198,;,0,0
214199,P,0,0
214200,<,0,0
214201,0.01,0,0
214202,),0,0
214203,.,0,0
214204,No,0,1
214205,significant,0,0
214206,difference,0,0
214207,was,0,0
214208,found,0,0
214209,in,0,0
214210,the,0,0
214211,ability,0,0
214212,to,0,0
214213,climb,0,0
214214,stairs,0,0
214215,but,0,0
214216,there,0,0
214217,was,0,0
214218,a,0,0
214219,marked,0,0
214220,improvement,0,0
214221,in,0,0
214222,the,0,0
214223,symptomatic,0,0
214224,questionnaire,0,0
214225,score,0,0
214226,",",0,0
214227,19,0,0
214228,+/-,0,0
214229,5,0,0
214230,in,0,0
214231,physiological,1,0
214232,pacing,1,0
214233,increasing,0,0
214234,to,0,0
214235,28,0,0
214236,+/-,0,0
214237,10,0,0
214238,with,0,0
214239,ventricular,0,0
214240,.,0,0
214241,Physiological,1,0
214242,pacing,1,0
214243,in,0,0
214244,the,0,0
214245,elderly,0,0
214246,produces,0,0
214247,an,0,0
214248,increase,0,0
214249,in,0,0
214250,exercise,0,0
214251,tolerance,0,0
214252,and,0,0
214253,improves,0,0
214254,symptoms,0,1
214255,;,0,0
214256,therefore,0,0
214257,",",0,0
214258,age,0,0
214259,alone,0,0
214260,should,0,0
214261,not,0,0
214262,be,0,0
214263,a,0,0
214264,contraindication,0,0
214265,to,0,0
214266,a,0,0
214267,physiological,0,0
214268,system,0,0
214269,.,0,0
214270,[,0,1
214271,Carbohydrate,0,1
214272,substitutes,0,0
214273,:,0,0
214274,comparative,0,0
214275,study,0,0
214276,of,0,0
214277,intestinal,0,0
214278,absorption,0,1
214279,of,0,0
214280,fructose,1,1
214281,",",1,1
214282,sorbitol,1,1
214283,and,1,1
214284,xylitol,1,1
214285,],1,1
214286,.,0,0
214287,BACKGROUND,0,0
214288,The,0,0
214289,carbohydrate,0,1
214290,substitutes,0,0
214291,fructose,1,1
214292,",",1,1
214293,sorbitol,1,1
214294,and,1,1
214295,xylitol,1,1
214296,are,0,0
214297,gaining,0,0
214298,more,0,0
214299,and,0,0
214300,more,0,0
214301,importance,0,0
214302,in,0,0
214303,the,0,0
214304,production,0,0
214305,of,0,0
214306,dietary,0,1
214307,food,0,1
214308,.,0,0
214309,But,0,0
214310,they,0,0
214311,can,0,0
214312,provoke,0,0
214313,gastrointestinal,0,0
214314,side-effects,0,1
214315,.,0,0
214316,In,0,0
214317,a,0,0
214318,randomized,0,0
214319,double,0,0
214320,blind,0,0
214321,study,0,0
214322,the,0,0
214323,rate,0,0
214324,of,0,0
214325,malabsorption,0,0
214326,of,0,0
214327,these,0,0
214328,sugars,0,1
214329,was,0,0
214330,compared,0,0
214331,and,0,0
214332,the,0,0
214333,concomitant,0,0
214334,symptoms,0,0
214335,were,0,0
214336,recorded,0,0
214337,.,0,0
214338,SUBJECTS,0,0
214339,AND,0,1
214340,METHODS,0,1
214341,25,0,0
214342,healthy,0,0
214343,controls,0,0
214344,received,0,0
214345,25,1,0
214346,g,1,0
214347,of,1,0
214348,each,1,0
214349,sugar,1,1
214350,within,0,0
214351,3,0,0
214352,consecutive,0,0
214353,days,0,0
214354,.,0,0
214355,The,0,0
214356,intestinal,0,0
214357,absorption,0,0
214358,was,0,0
214359,determined,0,0
214360,by,0,0
214361,H2-exhalation,0,0
214362,tests,0,0
214363,and,0,0
214364,the,0,0
214365,clinical,0,0
214366,symptoms,0,0
214367,were,0,0
214368,recorded,0,0
214369,.,0,0
214370,RESULTS,0,0
214371,The,0,0
214372,rate,0,0
214373,of,0,0
214374,malabsorption,0,0
214375,was,0,0
214376,84,0,0
214377,%,0,0
214378,for,0,0
214379,sorbitol,1,0
214380,",",0,0
214381,36,0,0
214382,%,0,0
214383,for,0,0
214384,fructose,1,1
214385,and,0,0
214386,12,0,0
214387,%,0,0
214388,for,0,0
214389,xylitol,1,0
214390,(,0,0
214391,p,0,0
214392,<,0,0
214393,0.01,0,0
214394,for,0,0
214395,sorbitol,1,1
214396,versus,1,1
214397,fructose,1,1
214398,and,1,1
214399,xylitol,1,1
214400,),1,0
214401,.,0,0
214402,57,0,0
214403,%,0,0
214404,of,0,0
214405,the,0,0
214406,participants,0,0
214407,with,0,0
214408,pathological,0,0
214409,H2-test,0,0
214410,after,0,0
214411,sorbitol,1,0
214412,and,0,0
214413,56,0,0
214414,%,0,0
214415,after,0,0
214416,fructose,1,0
214417,reported,0,0
214418,symptoms,0,0
214419,",",0,0
214420,while,0,0
214421,all,0,0
214422,of,0,0
214423,the,0,0
214424,3,0,0
214425,malabsorbers,0,0
214426,of,0,0
214427,xylitol,1,1
214428,were,0,0
214429,symptomatic,0,0
214430,.,0,0
214431,CONCLUSIONS,0,0
214432,There,0,0
214433,is,0,0
214434,an,0,0
214435,advantage,0,0
214436,to,0,0
214437,administering,0,1
214438,xylitol,1,1
214439,and,0,1
214440,fructose,1,1
214441,with,0,0
214442,regard,0,0
214443,to,0,0
214444,the,0,0
214445,intestinal,0,0
214446,absorption,0,0
214447,and,0,0
214448,concomitant,0,0
214449,symptoms,0,0
214450,as,0,0
214451,compared,0,0
214452,with,0,0
214453,sorbitol,1,1
214454,.,1,0
214455,H2-exhalation,0,0
214456,tests,0,0
214457,appear,0,0
214458,to,0,0
214459,be,0,0
214460,a,0,0
214461,reliable,0,0
214462,diagnostic,0,0
214463,tool,0,0
214464,to,0,0
214465,detect,0,0
214466,carbohydrate,0,1
214467,malabsorption,0,1
214468,and,0,0
214469,should,0,0
214470,find,0,0
214471,broader,0,0
214472,application,0,0
214473,in,0,0
214474,patients,0,0
214475,suffering,0,0
214476,from,0,0
214477,non-specific,0,0
214478,abdominal,0,0
214479,complaints,0,0
214480,.,0,0
214481,Epidemiology,0,0
214482,of,0,0
214483,stroke,0,0
214484,.,0,0
214485,Importance,0,0
214486,of,0,0
214487,preventive,1,0
214488,pharmacological,1,0
214489,strategies,1,0
214490,in,0,0
214491,elderly,0,0
214492,patients,0,0
214493,and,0,0
214494,associated,0,0
214495,costs,0,0
214496,.,0,0
214497,Stroke,0,0
214498,is,0,0
214499,a,0,0
214500,major,0,0
214501,cause,0,0
214502,of,0,0
214503,death,0,0
214504,and,0,0
214505,disability,0,0
214506,in,0,0
214507,developed,0,0
214508,countries,0,0
214509,.,0,0
214510,The,0,0
214511,incidence,0,0
214512,of,0,0
214513,stroke,0,0
214514,increases,0,0
214515,exponentially,0,0
214516,with,0,0
214517,age,0,0
214518,",",0,0
214519,yet,0,0
214520,",",0,0
214521,traditionally,0,0
214522,",",0,0
214523,many,0,0
214524,medical,0,0
214525,practitioners,0,0
214526,have,0,0
214527,been,0,0
214528,reluctant,0,0
214529,to,0,0
214530,treat,0,0
214531,hypertension,0,0
214532,in,0,0
214533,older,0,0
214534,patients,0,0
214535,.,0,0
214536,Since,0,0
214537,1991,0,0
214538,",",0,0
214539,the,0,0
214540,results,0,0
214541,of,0,0
214542,3,0,0
214543,major,0,0
214544,trials,0,0
214545,--,0,0
214546,the,0,0
214547,British,0,0
214548,Medical,0,0
214549,Research,0,0
214550,Council,0,1
214551,(,0,1
214552,MRC,0,1
214553,),0,1
214554,trial,0,0
214555,of,0,0
214556,treatment,0,0
214557,in,0,0
214558,older,0,0
214559,adults,0,0
214560,",",0,0
214561,the,0,0
214562,Swedish,0,0
214563,Trial,0,0
214564,in,0,0
214565,Old,0,0
214566,Patients,0,0
214567,with,0,0
214568,Hypertension,0,0
214569,(,0,1
214570,STOP-Hypertension,0,1
214571,),0,1
214572,and,0,0
214573,the,0,0
214574,Systolic,0,0
214575,Hypertension,0,0
214576,in,0,0
214577,the,0,0
214578,Elderly,0,0
214579,Program,0,0
214580,(,0,1
214581,SHEP,0,1
214582,),0,1
214583,--,0,0
214584,have,0,0
214585,conclusively,0,0
214586,established,0,0
214587,the,0,0
214588,benefits,0,0
214589,of,0,0
214590,treating,1,0
214591,older,0,0
214592,patients,0,0
214593,(,0,0
214594,>,0,0
214595,60,0,0
214596,years,0,1
214597,),0,0
214598,with,0,0
214599,both,0,0
214600,diastolic,0,0
214601,and,0,0
214602,isolated,1,0
214603,systolic,1,0
214604,hypertension,1,0
214605,.,1,0
214606,International,0,0
214607,guidelines,0,0
214608,for,0,0
214609,the,0,0
214610,management,0,0
214611,of,0,0
214612,hypertension,0,0
214613,--,0,0
214614,including,0,0
214615,the,0,0
214616,Fifth,0,0
214617,Report,0,0
214618,of,0,0
214619,the,0,0
214620,Joint,0,0
214621,National,0,0
214622,Committee,0,0
214623,",",0,0
214624,the,0,0
214625,1993,0,0
214626,report,0,0
214627,of,0,0
214628,the,0,0
214629,World,0,0
214630,Health,0,0
214631,Organization,0,0
214632,and,0,0
214633,the,0,0
214634,International,0,0
214635,Society,0,0
214636,of,0,0
214637,Hypertension,0,0
214638,and,0,0
214639,the,0,0
214640,second,0,0
214641,report,0,0
214642,of,0,0
214643,the,0,0
214644,British,0,0
214645,Hypertension,0,0
214646,Society,0,0
214647,Working,0,0
214648,Party,0,0
214649,--,0,0
214650,have,0,0
214651,all,0,0
214652,been,0,0
214653,modified,0,0
214654,to,0,0
214655,reflect,0,0
214656,the,0,0
214657,emerging,0,0
214658,evidence,0,0
214659,concerning,0,0
214660,the,0,0
214661,benefits,0,0
214662,of,0,0
214663,treating,1,0
214664,older,0,0
214665,patients,0,0
214666,.,0,0
214667,Cost-effectiveness,0,0
214668,data,0,0
214669,are,0,0
214670,similarly,0,0
214671,in,0,0
214672,accord,0,0
214673,with,0,0
214674,giving,0,0
214675,high,0,0
214676,priority,0,0
214677,to,0,0
214678,the,0,0
214679,treatment,1,0
214680,of,0,0
214681,older,0,0
214682,individuals,0,0
214683,with,0,0
214684,hypertension,0,0
214685,.,0,0
214686,Measurement,0,0
214687,of,0,0
214688,transfer,0,0
214689,factor,0,0
214690,during,0,0
214691,constant,1,0
214692,exhalation,1,0
214693,.,1,0
214694,BACKGROUND,0,0
214695,Transfer,0,0
214696,factor,0,0
214697,of,0,0
214698,the,0,0
214699,lung,0,0
214700,for,0,0
214701,carbon,0,0
214702,monoxide,0,1
214703,(,0,1
214704,TLCO,0,1
214705,),0,0
214706,was,0,0
214707,measured,0,0
214708,by,0,0
214709,a,0,0
214710,new,0,0
214711,method,0,0
214712,based,0,0
214713,on,0,0
214714,analysis,0,0
214715,of,0,0
214716,the,0,0
214717,ratio,0,0
214718,of,0,0
214719,the,0,0
214720,concentrations,0,0
214721,of,0,0
214722,carbon,0,0
214723,monoxide,0,1
214724,to,0,0
214725,an,0,0
214726,inert,0,0
214727,gas,0,0
214728,(,0,1
214729,methane,0,0
214730,),0,1
214731,relative,0,0
214732,to,0,0
214733,lung,0,0
214734,volume,0,0
214735,during,0,0
214736,a,0,0
214737,constant,1,0
214738,exhalation,1,0
214739,.,1,0
214740,Since,0,0
214741,this,0,0
214742,new,0,0
214743,technique,0,0
214744,is,0,0
214745,based,0,0
214746,solely,0,0
214747,upon,0,0
214748,exhalation,0,0
214749,",",0,0
214750,anomalies,0,0
214751,associated,0,0
214752,with,0,0
214753,inspiration,0,0
214754,and,0,0
214755,breath,0,0
214756,holding,0,0
214757,do,0,0
214758,not,0,0
214759,affect,0,0
214760,results,0,0
214761,.,0,0
214762,Additionally,0,0
214763,",",0,0
214764,because,0,0
214765,prolonged,0,0
214766,breath,0,0
214767,holding,0,0
214768,is,0,0
214769,not,0,0
214770,required,0,0
214771,",",0,0
214772,measurements,0,0
214773,can,0,0
214774,readily,0,0
214775,be,0,0
214776,made,0,0
214777,in,0,0
214778,dyspnoeic,0,0
214779,patients,0,0
214780,.,0,0
214781,METHODS,0,0
214782,Exhalation,1,1
214783,TLCO,1,1
214784,(,1,1
214785,TLCO,1,1
214786,",",1,0
214787,ex,1,0
214788,),1,0
214789,was,0,0
214790,compared,0,0
214791,with,0,0
214792,the,0,0
214793,standard,1,0
214794,(,1,0
214795,Jones,1,0
214796,and,1,0
214797,Meade,1,1
214798,),1,0
214799,10,1,0
214800,second,1,0
214801,breath,1,0
214802,holding,1,0
214803,TLCO,1,1
214804,(,1,0
214805,TLCO,1,1
214806,",",1,1
214807,bh,1,1
214808,),1,0
214809,in,0,0
214810,100,0,0
214811,consecutive,0,0
214812,patients,0,0
214813,.,0,0
214814,Patients,0,0
214815,did,0,0
214816,not,0,0
214817,practise,0,0
214818,the,0,0
214819,exhalation,0,0
214820,manoeuvre,0,0
214821,prior,0,0
214822,to,0,0
214823,testing,0,0
214824,.,0,0
214825,RESULTS,0,0
214826,The,0,0
214827,comparative,0,0
214828,results,0,0
214829,were,0,0
214830,very,0,0
214831,close,0,0
214832,;,0,0
214833,mean,0,0
214834,difference,0,0
214835,(,0,0
214836,bias,0,0
214837,),0,0
214838,+/-,0,0
214839,standard,0,0
214840,deviation,0,0
214841,(,0,1
214842,precision,0,1
214843,),0,0
214844,was,0,0
214845,0.05,0,0
214846,(,0,0
214847,0.84,0,0
214848,),0,0
214849,mmol/min/kPa,0,0
214850,.,0,0
214851,The,0,0
214852,relation,0,0
214853,was,0,0
214854,equally,0,0
214855,strong,0,0
214856,in,0,0
214857,patients,0,0
214858,with,0,0
214859,severe,0,0
214860,pulmonary,0,1
214861,disease,0,1
214862,;,0,0
214863,for,0,0
214864,patients,0,0
214865,with,0,0
214866,FEV1,0,0
214867,<,0,0
214868,1.51,0,0
214869,the,0,0
214870,mean,0,0
214871,difference,0,0
214872,was,0,0
214873,0.21,0,0
214874,(,0,0
214875,0.80,0,0
214876,),0,0
214877,mmol/min/kPa,0,0
214878,.,0,0
214879,CONCLUSIONS,0,0
214880,Since,0,0
214881,the,0,0
214882,results,0,0
214883,were,0,0
214884,essentially,0,0
214885,identical,0,0
214886,between,0,0
214887,the,0,0
214888,techniques,0,0
214889,",",0,0
214890,it,0,0
214891,seems,0,0
214892,that,0,0
214893,comparable,0,0
214894,pathophysiological,0,0
214895,factors,0,0
214896,affect,0,0
214897,TLCO,0,0
214898,during,0,0
214899,breath,1,0
214900,holding,1,0
214901,and,0,0
214902,constant,1,0
214903,exhalation,1,0
214904,.,1,0
214905,Constant,1,0
214906,exhalation,1,0
214907,may,0,0
214908,therefore,0,0
214909,be,0,0
214910,a,0,0
214911,useful,0,0
214912,alternative,0,0
214913,to,0,0
214914,the,0,0
214915,breath,1,0
214916,holding,1,0
214917,technique,0,0
214918,for,0,0
214919,clinical,0,0
214920,measurement,0,0
214921,of,0,0
214922,TLCO,0,0
214923,.,0,0
214924,Dexamethasone,1,1
214925,for,0,0
214926,the,0,0
214927,treatment,0,0
214928,of,0,0
214929,depression,0,0
214930,:,0,0
214931,a,0,0
214932,randomized,0,0
214933,",",0,0
214934,placebo-controlled,0,1
214935,",",0,1
214936,double-blind,0,1
214937,trial,0,1
214938,.,0,0
214939,OBJECTIVE,0,0
214940,The,0,0
214941,authors,0,0
214942,',0,0
214943,goal,0,0
214944,was,0,0
214945,to,0,0
214946,assess,0,0
214947,dexamethasone,1,1
214948,for,0,0
214949,the,0,0
214950,treatment,0,0
214951,of,0,0
214952,depression,0,0
214953,.,0,0
214954,METHOD,0,0
214955,Thirty-seven,0,0
214956,outpatients,0,0
214957,(,0,0
214958,11,0,0
214959,men,0,0
214960,and,0,0
214961,26,0,0
214962,women,0,0
214963,),0,0
214964,meeting,0,1
214965,DSM-III-R,0,1
214966,criteria,0,0
214967,for,0,0
214968,major,0,0
214969,depressive,0,0
214970,disorder,0,0
214971,were,0,0
214972,randomly,0,0
214973,assigned,0,0
214974,to,0,0
214975,receive,0,0
214976,either,0,0
214977,placebo,1,1
214978,or,1,1
214979,4,1,1
214980,mg/day,1,1
214981,of,1,1
214982,oral,1,1
214983,dexamethasone,1,1
214984,for,1,1
214985,4,1,1
214986,days,1,0
214987,.,1,0
214988,Baseline,0,0
214989,Hamilton,0,0
214990,depression,0,1
214991,scale,0,0
214992,scores,0,0
214993,were,0,0
214994,compared,0,0
214995,with,0,0
214996,scores,0,0
214997,obtained,0,0
214998,14,0,0
214999,days,0,0
215000,after,0,0
215001,the,0,0
215002,first,0,0
215003,dose,0,1
215004,of,0,0
215005,study,0,0
215006,medication,0,0
215007,.,0,0
215008,Data,0,0
215009,were,0,0
215010,analyzed,0,0
215011,by,0,0
215012,using,0,0
215013,two-sample,0,1
215014,t,0,0
215015,tests,0,0
215016,",",0,0
215017,chi-square,0,0
215018,methods,0,0
215019,",",0,0
215020,and,0,0
215021,Fisher,0,0
215022,'s,0,0
215023,exact,0,0
215024,test,0,0
215025,.,0,0
215026,RESULTS,0,0
215027,Seven,0,0
215028,(,0,0
215029,37,0,0
215030,%,0,0
215031,),0,0
215032,of,0,0
215033,the,0,0
215034,19,0,0
215035,patients,0,0
215036,given,0,0
215037,dexamethasone,0,1
215038,but,0,0
215039,only,0,0
215040,one,0,0
215041,(,0,0
215042,6,0,0
215043,%,0,0
215044,),0,0
215045,of,0,0
215046,the,0,0
215047,18,0,0
215048,patients,0,0
215049,given,0,0
215050,placebo,0,1
215051,responded,0,0
215052,positively,0,0
215053,.,0,0
215054,No,0,1
215055,adverse,0,0
215056,events,0,0
215057,or,0,0
215058,side,0,0
215059,effects,0,0
215060,were,0,0
215061,reported,0,0
215062,",",0,0
215063,and,0,0
215064,all,0,0
215065,patients,0,0
215066,who,0,0
215067,entered,0,0
215068,the,0,0
215069,study,0,0
215070,completed,0,0
215071,it,0,0
215072,.,0,0
215073,CONCLUSIONS,0,0
215074,A,0,1
215075,brief,0,0
215076,course,0,0
215077,of,0,1
215078,oral,0,1
215079,dexamethasone,1,1
215080,(,0,1
215081,4,0,1
215082,days,0,1
215083,),0,0
215084,was,0,0
215085,significantly,0,0
215086,more,0,0
215087,effective,0,0
215088,than,0,0
215089,placebo,1,1
215090,within,0,1
215091,14,0,0
215092,days,0,0
215093,for,0,0
215094,the,0,0
215095,treatment,0,0
215096,of,0,0
215097,depression,0,0
215098,in,0,0
215099,a,0,0
215100,randomized,0,0
215101,",",0,0
215102,double-blind,0,1
215103,study,0,0
215104,of,0,0
215105,depressed,0,0
215106,outpatients,0,0
215107,.,0,0
215108,Peritonsillar,0,0
215109,infiltration,0,1
215110,with,0,0
215111,bupivacaine,1,1
215112,for,0,0
215113,paediatric,0,1
215114,tonsillectomy,0,0
215115,.,0,0
215116,In,0,0
215117,a,0,0
215118,double-blind,0,1
215119,study,0,0
215120,forty-two,0,0
215121,children,0,0
215122,scheduled,0,0
215123,for,0,0
215124,elective,0,0
215125,adenotonsillectomy,0,0
215126,were,0,0
215127,randomized,0,0
215128,to,0,0
215129,receive,0,0
215130,peritonsillar,0,0
215131,infiltration,1,0
215132,",",0,0
215133,following,0,0
215134,induction,0,0
215135,of,0,0
215136,anaesthesia,0,0
215137,",",0,0
215138,with,0,0
215139,either,0,0
215140,0.25,1,0
215141,%,1,0
215142,plain,1,0
215143,bupivacaine,1,0
215144,or,1,0
215145,0.9,1,0
215146,%,1,0
215147,saline,1,0
215148,",",0,0
215149,0.5,0,1
215150,ml/kg,0,1
215151,to,0,0
215152,a,0,0
215153,maximum,0,0
215154,of,0,0
215155,10,0,0
215156,ml,0,0
215157,.,0,0
215158,The,0,0
215159,children,0,0
215160,were,0,0
215161,assessed,0,0
215162,on,0,0
215163,awakening,0,0
215164,",",0,0
215165,and,0,0
215166,then,0,0
215167,10,0,0
215168,minutes,0,0
215169,",",0,0
215170,1,0,0
215171,hour,0,0
215172,",",0,1
215173,4,0,1
215174,hours,0,0
215175,and,0,1
215176,24,0,1
215177,hours,0,0
215178,later,0,0
215179,.,0,0
215180,On,0,0
215181,each,0,0
215182,occasion,0,0
215183,the,0,0
215184,observer,0,0
215185,gave,0,0
215186,the,0,0
215187,child,0,0
215188,a,0,0
215189,pain,0,0
215190,score,0,0
215191,from,0,0
215192,1,0,0
215193,(,0,0
215194,no,0,1
215195,pain,0,1
215196,),0,0
215197,to,0,0
215198,5,0,0
215199,(,0,0
215200,severe,0,1
215201,pain,0,1
215202,),0,0
215203,.,0,0
215204,The,0,0
215205,scores,0,0
215206,on,0,0
215207,awakening,0,0
215208,and,0,0
215209,after,0,0
215210,10,0,0
215211,minutes,0,0
215212,were,0,0
215213,significantly,0,0
215214,lower,0,0
215215,in,0,0
215216,the,0,0
215217,bupivacaine,1,1
215218,group,0,0
215219,(,0,0
215220,P,0,0
215221,<,0,0
215222,0.05,0,0
215223,",",0,0
215224,Mann-Whitney,0,0
215225,U,0,1
215226,test,0,1
215227,),0,0
215228,.,0,0
215229,Thereafter,0,0
215230,there,0,0
215231,was,0,0
215232,no,0,0
215233,difference,0,0
215234,between,0,0
215235,the,0,0
215236,groups,0,0
215237,.,0,0
215238,The,0,0
215239,authors,0,0
215240,conclude,0,0
215241,that,0,0
215242,peritonsillar,0,0
215243,infiltration,0,0
215244,with,0,0
215245,bupivacaine,1,1
215246,is,0,0
215247,only,0,0
215248,moderately,0,0
215249,useful,0,0
215250,as,0,0
215251,analgesia,0,1
215252,for,0,0
215253,children,0,0
215254,having,0,0
215255,tonsillectomy,0,0
215256,.,0,0
215257,Naltrexone,1,1
215258,in,0,1
215259,young,0,1
215260,autistic,0,0
215261,children,0,0
215262,:,0,0
215263,a,0,0
215264,double-blind,0,1
215265,",",0,1
215266,placebo-controlled,1,1
215267,crossover,0,1
215268,study,0,1
215269,.,0,0
215270,OBJECTIVE,0,0
215271,This,0,0
215272,study,0,0
215273,evaluated,0,0
215274,the,0,0
215275,efficacy,0,0
215276,and,0,0
215277,safety,0,0
215278,of,0,0
215279,naltrexone,1,1
215280,",",0,1
215281,an,0,1
215282,opiate,0,1
215283,blocker,0,1
215284,",",0,1
215285,in,0,0
215286,the,0,0
215287,treatment,0,0
215288,of,0,0
215289,autism,0,0
215290,.,0,0
215291,METHOD,0,0
215292,Thirteen,0,1
215293,children,0,0
215294,with,0,0
215295,autistic,0,0
215296,disorder,0,0
215297,",",0,0
215298,aged,0,0
215299,3.4,0,0
215300,to,0,0
215301,8.3,0,0
215302,years,0,0
215303,(,0,0
215304,mean,0,0
215305,5.4,0,0
215306,),0,0
215307,",",0,0
215308,were,0,0
215309,studied,0,0
215310,in,0,0
215311,home,0,0
215312,",",0,0
215313,school,0,0
215314,",",0,0
215315,and,0,0
215316,outpatient,0,0
215317,laboratory,0,1
215318,.,0,1
215319,Naltrexone,1,1
215320,",",1,1
215321,1.0,1,1
215322,mg/kg,1,1
215323,",",1,1
215324,was,1,0
215325,given,1,0
215326,daily,1,1
215327,in,1,0
215328,a,1,0
215329,randomized,1,0
215330,",",1,0
215331,double-blind,1,1
215332,",",1,1
215333,placebo-controlled,1,1
215334,crossover,1,1
215335,design,1,1
215336,.,1,0
215337,Dependent,1,0
215338,measures,1,0
215339,included,1,0
215340,parent,1,0
215341,and,1,0
215342,teacher,1,0
215343,Clinical,1,0
215344,Global,1,0
215345,Impressions,1,0
215346,(,1,0
215347,CGI,1,0
215348,),1,1
215349,",",1,0
215350,Conners,1,0
215351,Rating,1,0
215352,Scales,1,0
215353,",",1,0
215354,and,1,0
215355,Naltrexone,1,1
215356,Side-Effects,1,1
215357,(,1,1
215358,SE,1,1
215359,),1,1
215360,Rating,1,0
215361,Scale,1,1
215362,;,1,0
215363,laboratory,1,0
215364,CGI,1,0
215365,",",1,0
215366,movement,1,0
215367,actometer,1,0
215368,readings,1,0
215369,",",1,0
215370,and,1,0
215371,a,1,0
215372,10-second,1,0
215373,interval,1,0
215374,recording,1,0
215375,system,1,0
215376,analysis,1,0
215377,of,1,0
215378,on-task,1,0
215379,",",1,0
215380,communication,1,0
215381,initiations,1,0
215382,",",1,0
215383,disruptive,1,0
215384,behavior,1,0
215385,",",1,0
215386,and,1,0
215387,self-stimulation,1,0
215388,.,1,0
215389,RESULTS,0,0
215390,Eight,0,0
215391,of,0,0
215392,13,0,0
215393,subjects,0,0
215394,improved,0,0
215395,in,0,0
215396,two,0,0
215397,or,0,0
215398,more,0,0
215399,settings,0,0
215400,.,0,0
215401,Changes,0,0
215402,in,0,0
215403,parent,0,0
215404,measures,0,0
215405,(,0,0
215406,CGI,0,0
215407,",",0,0
215408,Conners,0,0
215409,Impulsivity-Hyperactivity,0,0
215410,Factor,0,0
215411,",",0,0
215412,and,0,0
215413,SE-Restlessness,0,1
215414,),0,0
215415,and,0,0
215416,Teacher,0,0
215417,CGI,0,0
215418,achieved,0,0
215419,statistical,0,0
215420,significance,0,0
215421,.,0,0
215422,Teacher,0,0
215423,SE-Restlessness,0,0
215424,and,0,0
215425,initiation,0,0
215426,of,0,0
215427,communication,0,0
215428,in,0,0
215429,the,0,0
215430,clinic,0,0
215431,showed,0,0
215432,a,0,0
215433,trend,0,0
215434,toward,0,0
215435,improvement,0,0
215436,.,0,0
215437,Actometer,0,0
215438,readings,0,0
215439,improved,0,0
215440,in,0,0
215441,two,0,0
215442,children,0,0
215443,who,0,0
215444,were,0,0
215445,very,0,0
215446,active,0,0
215447,at,0,0
215448,baseline,0,0
215449,.,0,0
215450,Adverse,0,0
215451,side,0,0
215452,effects,0,0
215453,were,0,0
215454,behavioral,0,0
215455,",",0,0
215456,mild,0,0
215457,",",0,0
215458,and,0,0
215459,transient,0,0
215460,.,0,0
215461,Administering,0,0
215462,the,0,0
215463,bitter,0,1
215464,tablet,0,1
215465,was,0,0
215466,a,0,0
215467,challenge,0,0
215468,.,0,0
215469,CONCLUSIONS,0,1
215470,Naltrexone,1,1
215471,offers,0,0
215472,promise,0,0
215473,as,0,0
215474,an,0,0
215475,agent,0,0
215476,for,0,0
215477,modest,0,0
215478,improvement,0,0
215479,of,0,0
215480,behavior,0,0
215481,and,0,0
215482,social,0,0
215483,communication,0,0
215484,in,0,0
215485,young,0,0
215486,children,0,0
215487,with,0,0
215488,autism,0,0
215489,.,0,0
215490,Parent,0,0
215491,and,0,0
215492,teacher,0,0
215493,measures,0,0
215494,can,0,0
215495,be,0,0
215496,useful,0,0
215497,in,0,0
215498,outpatient,0,0
215499,trials,0,0
215500,to,0,0
215501,evaluate,0,0
215502,change,0,0
215503,.,0,0
215504,Evaluation,0,0
215505,of,0,0
215506,an,0,0
215507,intervention,0,0
215508,to,0,0
215509,change,0,0
215510,benzodiazepine-prescribing,1,1
215511,behavior,0,0
215512,in,0,0
215513,a,0,0
215514,prepaid,0,0
215515,group,0,0
215516,practice,0,0
215517,setting,0,0
215518,.,0,0
215519,To,0,0
215520,determine,0,0
215521,the,0,0
215522,effect,0,0
215523,of,0,0
215524,two,0,0
215525,levels,0,0
215526,of,0,0
215527,educational,1,0
215528,intervention,1,1
215529,on,1,0
215530,benzodiazepine-prescribing,1,1
215531,behavior,1,0
215532,in,0,0
215533,an,0,0
215534,elderly,0,0
215535,population,0,0
215536,in,0,0
215537,a,0,0
215538,controlled,0,0
215539,prepaid,0,0
215540,group,0,0
215541,practice,0,1
215542,(,0,1
215543,PPGP,0,1
215544,),0,1
215545,setting,0,0
215546,",",0,0
215547,we,0,0
215548,designed,0,0
215549,a,0,0
215550,prospective,0,0
215551,controlled,0,0
215552,trial,0,0
215553,",",0,0
215554,with,0,0
215555,six-month,0,0
215556,follow-up,0,0
215557,.,0,0
215558,Our,0,0
215559,setting,0,0
215560,was,0,0
215561,a,0,0
215562,"270,000",0,0
215563,member,0,0
215564,group-model,0,0
215565,PPGP,0,0
215566,in,0,0
215567,Colorado,0,0
215568,",",0,0
215569,from,0,0
215570,1990,0,0
215571,to,0,0
215572,1991,0,0
215573,.,0,0
215574,Participants,0,0
215575,included,0,0
215576,91,0,0
215577,physicians,0,0
215578,",",0,0
215579,62,0,0
215580,men,0,0
215581,and,0,0
215582,29,0,0
215583,women,0,0
215584,;,0,0
215585,median,0,0
215586,age,0,0
215587,was,0,0
215588,38.7,0,0
215589,years,0,0
215590,.,0,0
215591,Group,0,0
215592,1,0,0
215593,received,0,0
215594,a,0,0
215595,one-on-one,1,0
215596,educational,1,0
215597,presentation,1,0
215598,by,1,0
215599,a,1,0
215600,clinical,1,0
215601,pharmacist,1,0
215602,",",1,0
215603,written,1,0
215604,educational,1,0
215605,materials,1,0
215606,",",1,0
215607,a,1,0
215608,brief,1,0
215609,follow-up,1,0
215610,visit,1,0
215611,",",1,0
215612,and,1,0
215613,feedback,1,0
215614,with,1,0
215615,recommendations,1,0
215616,.,1,0
215617,Group,0,0
215618,2,0,0
215619,received,0,0
215620,only,0,0
215621,a,0,0
215622,face-to-face,1,0
215623,presentation,1,0
215624,",",1,0
215625,given,1,0
215626,to,1,0
215627,departmental,1,0
215628,groups,1,0
215629,",",1,0
215630,as,1,0
215631,well,1,0
215632,as,1,0
215633,the,1,0
215634,same,1,0
215635,written,1,0
215636,educational,1,0
215637,materials,1,0
215638,used,1,0
215639,in,1,0
215640,group,1,0
215641,1,1,0
215642,.,1,0
215643,Controls,0,0
215644,received,0,0
215645,no,1,0
215646,intervention,1,0
215647,.,1,0
215648,Our,0,0
215649,primary,0,0
215650,outcome,0,0
215651,measure,0,0
215652,was,0,0
215653,the,0,0
215654,benzodiazepine,0,1
215655,on/off,0,1
215656,status,0,0
215657,of,0,0
215658,the,0,0
215659,elderly,0,0
215660,PPGP,0,0
215661,members,0,0
215662,.,0,0
215663,The,0,0
215664,secondary,0,0
215665,outcome,0,0
215666,measure,0,0
215667,was,0,0
215668,the,0,0
215669,median,0,0
215670,change,0,0
215671,(,0,0
215672,preintervention,0,1
215673,minus,0,1
215674,postintervention,0,1
215675,),0,0
215676,in,0,0
215677,a,0,0
215678,standardized,0,0
215679,amount,0,0
215680,of,0,0
215681,benzodiazepines,0,1
215682,prescribed,0,1
215683,per,0,0
215684,physician,0,0
215685,.,0,0
215686,Logistic,0,0
215687,regression,0,0
215688,analysis,0,0
215689,failed,0,0
215690,to,0,0
215691,show,0,0
215692,a,0,0
215693,significant,0,0
215694,effect,0,0
215695,on,0,0
215696,postintervention,0,0
215697,benzodiazepine,1,1
215698,on/off,0,1
215699,status,0,0
215700,between,0,0
215701,study,0,0
215702,groups,0,0
215703,",",0,0
215704,when,0,0
215705,controlling,0,0
215706,for,0,0
215707,preintervention,0,0
215708,on/off,0,0
215709,status,0,0
215710,",",0,0
215711,PPGP-member,0,1
215712,age,0,1
215713,",",0,0
215714,PPGP-member,0,1
215715,gender,0,0
215716,",",0,0
215717,and,0,0
215718,all,0,0
215719,possible,0,0
215720,interactions,0,0
215721,.,0,0
215722,Analysis,0,0
215723,of,0,0
215724,variance,0,0
215725,failed,0,0
215726,to,0,0
215727,demonstrate,0,0
215728,an,0,0
215729,effect,0,0
215730,of,0,0
215731,either,0,0
215732,intervention,0,0
215733,on,0,0
215734,the,0,0
215735,median,0,0
215736,change,0,0
215737,in,0,0
215738,standardized,0,0
215739,amount,0,0
215740,of,0,0
215741,benzodiazepines,0,1
215742,prescribed,0,1
215743,per,0,0
215744,physician,0,0
215745,",",0,0
215746,with,0,0
215747,groups,0,0
215748,1,0,0
215749,",",0,0
215750,2,0,0
215751,",",0,0
215752,and,0,0
215753,controls,0,0
215754,yielding,0,0
215755,values,0,0
215756,of,0,0
215757,-278,0,0
215758,(,0,0
215759,range,0,0
215760,:,0,0
215761,"-4,137",0,0
215762,",",0,0
215763,"2,844",0,0
215764,),0,0
215765,",",0,0
215766,-330,0,0
215767,(,0,0
215768,"-1,531",0,0
215769,",",0,0
215770,"1,358",0,0
215771,),0,0
215772,",",0,0
215773,and,0,0
215774,-541,0,1
215775,(,0,0
215776,range,0,0
215777,:,0,0
215778,"-3,716",0,0
215779,",",0,0
215780,"2,185",0,0
215781,),0,0
215782,",",0,0
215783,respectively,0,0
215784,.,0,0
215785,We,0,0
215786,conclude,0,0
215787,that,0,0
215788,strategies,0,0
215789,effective,0,0
215790,in,0,0
215791,changing,0,0
215792,physician,0,0
215793,prescribing,0,0
215794,behavior,0,0
215795,in,0,0
215796,other,0,0
215797,settings,0,0
215798,may,0,0
215799,not,0,0
215800,be,0,0
215801,effective,0,0
215802,in,0,0
215803,a,0,0
215804,PPGP,0,0
215805,setting,0,1
215806,with,0,0
215807,benzodiazepines,1,1
215808,in,0,0
215809,the,0,0
215810,elderly,0,0
215811,as,0,0
215812,the,0,0
215813,target,0,0
215814,for,0,0
215815,change,0,0
215816,.,0,0
215817,Aerosolized,1,1
215818,pentamidine,1,1
215819,as,0,1
215820,primary,0,0
215821,prophylaxis,0,0
215822,for,0,0
215823,Pneumocystis,0,1
215824,carinii,0,1
215825,pneumonia,0,1
215826,:,0,0
215827,efficacy,0,0
215828,",",0,0
215829,mortality,0,0
215830,and,0,0
215831,morbidity,0,0
215832,.,0,0
215833,OBJECTIVE,0,0
215834,Primary,0,0
215835,prophylaxis,0,0
215836,against,0,0
215837,Pneumocystis,0,1
215838,carinii,0,1
215839,pneumonia,0,1
215840,(,0,1
215841,PCP,0,1
215842,),0,0
215843,for,0,0
215844,patients,0,0
215845,with,0,0
215846,HIV,0,0
215847,infection,0,0
215848,has,0,0
215849,been,0,0
215850,recommended,0,0
215851,by,0,0
215852,the,0,0
215853,Centers,0,0
215854,for,0,0
215855,Disease,0,0
215856,Control,0,0
215857,and,0,0
215858,Prevention,0,0
215859,.,0,0
215860,We,0,0
215861,evaluated,0,0
215862,alternatives,0,0
215863,to,0,0
215864,routine,0,0
215865,primary,0,0
215866,PCP,0,0
215867,prophylaxis,0,1
215868,with,0,1
215869,aerosolized,1,1
215870,pentamidine,1,1
215871,.,1,1
215872,METHODS,0,1
215873,A,0,0
215874,total,0,0
215875,of,0,0
215876,121,0,0
215877,HIV-infected,0,0
215878,patients,0,0
215879,with,0,0
215880,CD4+,0,0
215881,cell,0,0
215882,counts,0,0
215883,<,0,0
215884,or,0,0
215885,=,0,0
215886,200,0,0
215887,x,0,0
215888,10,0,0
215889,(,0,1
215890,6,0,0
215891,),0,0
215892,/l,0,0
215893,or,0,0
215894,an,0,0
215895,AIDS,0,0
215896,diagnosis,0,0
215897,were,0,0
215898,enrolled,0,0
215899,in,0,0
215900,a,0,0
215901,controlled,0,0
215902,study,0,0
215903,of,0,0
215904,aerosolized,1,1
215905,pentamidine,1,1
215906,as,0,0
215907,primary,0,0
215908,PCP,0,0
215909,prophylaxis,0,0
215910,.,0,0
215911,Patients,0,0
215912,were,0,0
215913,randomly,0,0
215914,assigned,0,0
215915,to,0,0
215916,treatment,0,0
215917,(,0,0
215918,n,0,0
215919,=,0,0
215920,61,0,0
215921,),0,0
215922,with,0,0
215923,aerosolized,1,1
215924,pentamidine,1,1
215925,once,0,1
215926,every,0,1
215927,month,0,0
215928,or,0,0
215929,to,0,0
215930,no,1,0
215931,treatment,1,0
215932,(,0,0
215933,n,0,0
215934,=,0,0
215935,60,0,0
215936,),0,0
215937,.,0,0
215938,Patients,0,0
215939,were,0,0
215940,evaluated,0,0
215941,for,0,0
215942,PCP,0,0
215943,",",0,0
215944,mortality,0,0
215945,",",0,0
215946,morbidity,0,0
215947,and,0,0
215948,progression,0,0
215949,of,0,0
215950,HIV,0,0
215951,disease,0,0
215952,.,0,0
215953,Morbidity,0,0
215954,was,0,0
215955,estimated,0,0
215956,from,0,0
215957,the,0,0
215958,number,0,0
215959,of,0,0
215960,days,0,0
215961,patients,0,0
215962,were,0,0
215963,unable,0,0
215964,to,0,0
215965,work,0,0
215966,due,0,0
215967,to,0,0
215968,illness,0,0
215969,",",0,0
215970,number,0,0
215971,of,0,0
215972,days,0,0
215973,hospitalized,0,1
215974,and,0,0
215975,AIDS,0,0
215976,events,0,0
215977,.,0,0
215978,RESULTS,0,0
215979,Baseline,0,0
215980,characteristics,0,0
215981,were,0,0
215982,similar,0,0
215983,in,0,0
215984,the,0,0
215985,treatment,0,0
215986,and,0,0
215987,control,0,0
215988,groups,0,0
215989,and,0,0
215990,mean,0,0
215991,CD4+,0,0
215992,cell,0,0
215993,counts,0,0
215994,were,0,0
215995,116,0,0
215996,and,0,0
215997,107,0,0
215998,x,0,0
215999,10,0,0
216000,(,0,1
216001,6,0,0
216002,),0,0
216003,/l,0,0
216004,",",0,0
216005,respectively,0,0
216006,.,0,0
216007,Eight,0,0
216008,incidents,0,0
216009,of,0,0
216010,PCP,0,0
216011,and,0,0
216012,19,0,0
216013,deaths,0,0
216014,were,0,0
216015,observed,0,0
216016,in,0,0
216017,the,0,0
216018,treatment,0,0
216019,group,0,0
216020,during,0,0
216021,a,0,0
216022,median,0,0
216023,follow-up,0,0
216024,of,0,0
216025,16.4,0,0
216026,months,0,0
216027,(,0,0
216028,range,0,0
216029,",",0,0
216030,2.3-32.4,0,0
216031,months,0,0
216032,),0,0
216033,.,0,0
216034,Nineteen,0,0
216035,incidents,0,0
216036,of,0,0
216037,PCP,0,0
216038,and,0,0
216039,13,0,0
216040,deaths,0,0
216041,",",0,0
216042,of,0,0
216043,which,0,0
216044,one,0,0
216045,was,0,0
216046,related,0,0
216047,to,0,0
216048,an,0,0
216049,acute,0,0
216050,episode,0,0
216051,of,0,0
216052,PCP,0,0
216053,",",0,0
216054,were,0,0
216055,noted,0,0
216056,in,0,0
216057,the,0,0
216058,control,0,0
216059,group,0,0
216060,.,0,0
216061,Median,0,0
216062,follow-up,0,0
216063,of,0,0
216064,controls,0,0
216065,was,0,0
216066,18.5,0,0
216067,months,0,0
216068,(,0,0
216069,range,0,0
216070,",",0,0
216071,3.1-32.9,0,0
216072,months,0,0
216073,),0,0
216074,.,0,0
216075,Patients,0,0
216076,in,0,0
216077,the,0,0
216078,treatment,0,0
216079,group,0,0
216080,were,0,0
216081,unable,0,0
216082,to,0,0
216083,work,0,0
216084,19,0,0
216085,%,0,0
216086,of,0,0
216087,the,0,0
216088,observation,0,0
216089,time,0,0
216090,and,0,0
216091,were,0,0
216092,hospitalized,0,0
216093,for,0,0
216094,4.3,0,0
216095,%,0,0
216096,of,0,0
216097,that,0,0
216098,time,0,0
216099,.,0,0
216100,Corresponding,0,0
216101,figures,0,0
216102,were,0,0
216103,20,0,0
216104,and,0,0
216105,3.0,0,0
216106,%,0,0
216107,",",0,0
216108,respectively,0,0
216109,",",0,0
216110,in,0,0
216111,the,0,0
216112,control,0,0
216113,group,0,0
216114,.,0,0
216115,CONCLUSIONS,0,1
216116,Aerosolized,1,1
216117,pentamidine,1,1
216118,had,0,0
216119,significant,0,0
216120,prophylactic,0,0
216121,efficacy,0,0
216122,",",0,0
216123,but,0,0
216124,we,0,0
216125,could,0,0
216126,not,0,0
216127,detect,0,0
216128,any,0,0
216129,major,0,0
216130,effect,0,0
216131,on,0,0
216132,mortality,0,0
216133,and,0,0
216134,morbidity,0,0
216135,.,0,0
216136,The,0,0
216137,overall,0,0
216138,mortality,0,0
216139,and,0,0
216140,morbidity,0,0
216141,were,0,0
216142,not,0,0
216143,markedly,0,0
216144,influenced,0,0
216145,by,0,0
216146,PCP,0,0
216147,.,0,0
216148,Clinical,0,0
216149,check-ups,0,0
216150,and,0,0
216151,treatment,0,0
216152,of,0,0
216153,acute,0,0
216154,PCP,0,0
216155,could,0,0
216156,be,0,0
216157,a,0,0
216158,justifiable,0,0
216159,alternative,0,0
216160,to,0,0
216161,drug,0,1
216162,prophylaxis,0,1
216163,with,0,1
216164,aerosolized,1,1
216165,pentamidine,1,1
216166,in,0,0
216167,selected,0,0
216168,patients,0,0
216169,.,0,0
216170,The,0,0
216171,degrees,0,0
216172,of,0,0
216173,UVB-induced,0,0
216174,erythema,0,0
216175,and,0,0
216176,pigmentation,0,0
216177,correlate,0,0
216178,linearly,0,0
216179,and,0,0
216180,are,0,0
216181,reduced,0,0
216182,in,0,0
216183,a,0,0
216184,parallel,0,0
216185,manner,0,0
216186,by,0,0
216187,topical,1,1
216188,anti-inflammatory,1,1
216189,agents,1,1
216190,.,1,0
216191,To,0,0
216192,examine,0,0
216193,whether,0,0
216194,it,0,0
216195,is,0,0
216196,possible,0,0
216197,to,0,0
216198,evaluate,0,0
216199,the,0,0
216200,degree,0,0
216201,of,0,0
216202,ultraviolet,1,1
216203,B,1,1
216204,(,1,1
216205,UVB,1,1
216206,),1,1
216207,-induced,1,0
216208,inflammation,0,0
216209,by,0,0
216210,measuring,0,0
216211,the,0,0
216212,degree,0,0
216213,of,0,0
216214,hyperpigmentation,0,0
216215,",",0,0
216216,we,0,0
216217,investigated,0,0
216218,the,0,0
216219,relationship,0,0
216220,between,0,0
216221,UVB-induced,0,0
216222,erythema,0,0
216223,and,0,0
216224,the,0,0
216225,subsequent,0,0
216226,pigmentation,0,0
216227,quantitatively,0,0
216228,.,0,0
216229,At,0,0
216230,24,0,0
216231,h,0,0
216232,and,0,0
216233,7,0,0
216234,d,0,0
216235,after,0,0
216236,irradiation,0,0
216237,with,0,0
216238,erythemogenic,0,1
216239,doses,0,1
216240,of,0,1
216241,UVB,0,0
216242,to,0,0
216243,the,0,0
216244,backs,0,0
216245,of,0,0
216246,16,0,0
216247,Japanese,0,0
216248,subjects,0,0
216249,",",0,0
216250,the,0,0
216251,degree,0,0
216252,of,0,0
216253,induced,0,0
216254,erythema,0,1
216255,(,0,0
216256,delta,0,0
216257,erythema,0,1
216258,index,0,1
216259,),0,0
216260,and,0,0
216261,that,0,0
216262,of,0,0
216263,pigmentation,0,0
216264,(,0,0
216265,delta,0,0
216266,melanin,0,0
216267,index,0,0
216268,),0,0
216269,were,0,0
216270,examined,0,0
216271,by,0,0
216272,an,0,0
216273,image,1,0
216274,analytic,1,0
216275,method,1,0
216276,using,1,0
216277,a,1,0
216278,videomicroscope,1,0
216279,interfaced,1,0
216280,with,1,0
216281,a,1,0
216282,computer,1,0
216283,.,1,0
216284,The,0,0
216285,relationship,0,0
216286,between,0,0
216287,two,0,0
216288,indices,0,0
216289,was,0,0
216290,linear,0,0
216291,in,0,0
216292,each,0,0
216293,subject,0,0
216294,",",0,0
216295,and,0,0
216296,the,0,0
216297,correlation,0,0
216298,coefficient,0,0
216299,was,0,0
216300,0.83,0,0
216301,when,0,0
216302,evaluated,0,0
216303,using,0,0
216304,whole,0,0
216305,data,0,0
216306,.,0,0
216307,The,0,0
216308,slope,0,0
216309,of,0,0
216310,the,0,0
216311,regression,0,0
216312,line,0,0
216313,for,0,0
216314,the,0,0
216315,delta,0,0
216316,melanin,0,0
216317,index,0,0
216318,against,0,0
216319,delta,0,0
216320,erythema,0,0
216321,index,0,0
216322,tended,0,0
216323,to,0,0
216324,become,0,0
216325,steeper,0,0
216326,as,0,0
216327,non-irradiated,0,0
216328,skin,0,0
216329,color,0,0
216330,became,0,0
216331,darker,0,1
216332,(,0,0
216333,r,0,0
216334,=,0,0
216335,0.63,0,0
216336,),0,0
216337,",",0,0
216338,suggesting,0,0
216339,that,0,0
216340,more,0,0
216341,efficient,0,0
216342,melanogenesis,0,0
216343,takes,0,0
216344,place,0,0
216345,after,0,0
216346,the,0,0
216347,same,0,0
216348,level,0,0
216349,of,0,0
216350,inflammation,0,0
216351,in,0,0
216352,the,0,0
216353,subject,0,0
216354,with,0,0
216355,darker,0,0
216356,skin,0,0
216357,.,0,0
216358,Both,0,0
216359,erythema,0,0
216360,and,0,0
216361,hyperpigmentation,0,0
216362,were,0,0
216363,suppressed,0,0
216364,significantly,0,0
216365,and,0,0
216366,in,0,0
216367,a,0,0
216368,parallel,0,0
216369,manner,0,0
216370,by,0,0
216371,corticosteroids,1,1
216372,and,0,1
216373,indomethacin,1,1
216374,applied,0,1
216375,topically,0,1
216376,immediately,0,0
216377,after,0,0
216378,UVB,0,0
216379,irradiation,0,0
216380,.,0,0
216381,These,0,0
216382,results,0,0
216383,imply,0,0
216384,that,0,0
216385,the,0,0
216386,post-inflammatory,0,0
216387,hyperpigmentation,0,0
216388,correlates,0,0
216389,closely,0,0
216390,with,0,0
216391,the,0,0
216392,severity,0,0
216393,of,0,0
216394,the,0,0
216395,prior,0,0
216396,inflammation,0,0
216397,and,0,0
216398,that,0,0
216399,chemical,0,0
216400,mediators,0,0
216401,released,0,0
216402,in,0,0
216403,the,0,0
216404,inflammatory,0,0
216405,process,0,0
216406,have,0,0
216407,considerable,0,0
216408,influence,0,0
216409,on,0,0
216410,the,0,0
216411,melanogenesis,0,0
216412,.,0,0
216413,We,0,0
216414,conclude,0,0
216415,that,0,0
216416,the,0,0
216417,measurement,0,0
216418,of,0,0
216419,UVB-induced,0,0
216420,hyperpigmentation,0,0
216421,can,0,0
216422,be,0,0
216423,utilized,0,0
216424,for,0,0
216425,the,0,0
216426,assessment,0,0
216427,of,0,0
216428,topical,1,1
216429,anti-inflammatory,1,1
216430,agents,1,1
216431,",",0,0
216432,unless,0,0
216433,these,0,0
216434,have,0,0
216435,direct,0,0
216436,actions,0,0
216437,on,0,0
216438,the,0,0
216439,tyrosinase,0,0
216440,activity,0,0
216441,of,0,0
216442,melanocytes,0,0
216443,.,0,0
216444,Osteocalcin,1,1
216445,in,0,0
216446,patients,0,0
216447,with,0,0
216448,rheumatoid,0,0
216449,arthritis,0,0
216450,.,0,0
216451,A,0,0
216452,one-year,0,0
216453,followup,0,0
216454,study,0,0
216455,.,0,0
216456,OBJECTIVE,0,0
216457,To,0,0
216458,analyze,0,0
216459,clinical,0,0
216460,",",0,0
216461,radiological,0,0
216462,",",0,0
216463,and,0,1
216464,drug,0,1
216465,(,0,1
216466,disease,0,1
216467,modifying,0,1
216468,antirheumatic,0,1
216469,drug,0,1
216470,",",0,1
216471,DMARD,0,1
216472,),0,0
216473,dependent,0,0
216474,factors,0,0
216475,influencing,0,0
216476,bone,0,0
216477,turnover,0,0
216478,in,0,0
216479,patients,0,0
216480,with,0,0
216481,rheumatoid,0,0
216482,arthritis,0,1
216483,(,0,1
216484,RA,0,1
216485,),0,1
216486,.,0,0
216487,METHODS,0,0
216488,We,0,0
216489,investigated,0,0
216490,in,0,0
216491,a,0,0
216492,one-year,0,0
216493,double,0,0
216494,blind,0,0
216495,randomized,0,0
216496,study,0,0
216497,comparing,0,0
216498,intramuscular,1,1
216499,(,1,1
216500,im,1,1
216501,),1,1
216502,gold,1,0
216503,with,1,1
216504,im,1,1
216505,methotrexate,1,1
216506,(,1,1
216507,MTX,1,1
216508,),1,1
216509,",",0,0
216510,whether,0,0
216511,the,0,0
216512,variation,0,0
216513,of,0,0
216514,inflammatory,0,0
216515,activity,0,0
216516,or,0,0
216517,functional,0,0
216518,capacity,0,0
216519,",",0,0
216520,the,0,0
216521,ascending,0,0
216522,anatomic,0,0
216523,stage,0,0
216524,",",0,0
216525,or,0,0
216526,DMARD,0,1
216527,treatments,0,0
216528,have,0,0
216529,an,0,0
216530,influence,0,0
216531,on,0,0
216532,bone,0,0
216533,formation,0,0
216534,(,0,1
216535,osteocalcin,0,1
216536,),0,1
216537,in,0,0
216538,patients,0,0
216539,with,0,0
216540,RA,0,0
216541,.,0,0
216542,RESULTS,0,0
216543,Patients,0,0
216544,(,0,0
216545,n,0,0
216546,=,0,0
216547,48,0,0
216548,),0,0
216549,enrolled,0,0
216550,at,0,0
216551,the,0,0
216552,beginning,0,0
216553,of,0,0
216554,our,0,0
216555,study,0,0
216556,had,0,0
216557,significantly,0,0
216558,increased,0,0
216559,osteocalcin,0,1
216560,levels,0,0
216561,(,0,0
216562,3.45,0,0
216563,+/-,0,0
216564,0.93,0,0
216565,--,0,0
216566,>,0,0
216567,4.42,0,0
216568,+/-,0,0
216569,1.39,0,0
216570,ng/ml,0,0
216571,p,0,0
216572,<,0,0
216573,0.02,0,0
216574,),0,0
216575,after,0,0
216576,one,0,0
216577,year,0,0
216578,if,0,0
216579,inflammatory,0,0
216580,activity,0,0
216581,decreased,0,0
216582,(,0,0
216583,>,0,0
216584,or,0,0
216585,=,0,0
216586,1,0,0
216587,SD,0,0
216588,:,0,0
216589,erythrocyte,0,0
216590,sedimentation,0,0
216591,rate,0,0
216592,(,0,0
216593,ESR,0,0
216594,),0,0
216595,26.4,0,0
216596,mm/h,0,0
216597,",",0,0
216598,C-reactive,0,0
216599,protein,0,0
216600,(,0,0
216601,CRP,0,1
216602,),0,0
216603,3.8,0,0
216604,mg/dl,0,0
216605,),0,0
216606,.,0,0
216607,We,0,0
216608,found,0,0
216609,a,0,0
216610,significant,0,0
216611,negative,0,0
216612,correlation,0,0
216613,of,0,0
216614,the,0,0
216615,one-year,0,0
216616,CRP-,0,1
216617,(,0,0
216618,r,0,0
216619,=,0,0
216620,-0.44,0,0
216621,",",0,0
216622,p,0,0
216623,<,0,0
216624,0.001,0,0
216625,),0,0
216626,or,0,0
216627,ESR,0,1
216628,differences,0,1
216629,(,0,0
216630,r,0,0
216631,=,0,0
216632,-0.45,0,0
216633,",",0,0
216634,p,0,0
216635,<,0,0
216636,0.001,0,0
216637,),0,0
216638,with,0,0
216639,the,0,0
216640,corresponding,0,0
216641,osteocalcin,0,1
216642,differences,0,0
216643,.,0,0
216644,This,0,0
216645,was,0,0
216646,also,0,0
216647,evident,0,0
216648,if,0,0
216649,these,0,0
216650,patients,0,0
216651,were,0,0
216652,pooled,0,0
216653,with,0,0
216654,15,0,0
216655,patients,0,0
216656,excluded,0,0
216657,from,0,0
216658,the,0,0
216659,double,0,0
216660,blind,0,0
216661,study,0,0
216662,as,0,0
216663,already,0,0
216664,receiving,0,0
216665,DMARD,1,0
216666,treatment,1,1
216667,(,0,0
216668,n,0,0
216669,=,0,0
216670,63,0,0
216671,;,0,0
216672,p,0,0
216673,<,0,0
216674,0.01,0,0
216675,),0,0
216676,.,0,0
216677,Patients,0,0
216678,with,0,0
216679,impaired,0,0
216680,functional,0,0
216681,capacity,0,0
216682,also,0,0
216683,had,0,0
216684,significantly,0,0
216685,reduced,0,0
216686,osteocalcin,0,1
216687,levels,0,0
216688,(,0,0
216689,p,0,0
216690,<,0,0
216691,0.01,0,0
216692,),0,0
216693,.,0,0
216694,In,0,0
216695,both,0,0
216696,cases,0,0
216697,",",0,0
216698,alkaline,0,0
216699,phosphatase,0,0
216700,showed,0,0
216701,no,0,0
216702,significant,0,0
216703,differences,0,0
216704,.,0,0
216705,CONCLUSIONS,0,0
216706,Our,0,0
216707,data,0,0
216708,suggest,0,0
216709,that,0,0
216710,osteocalcin,0,1
216711,",",0,0
216712,a,0,0
216713,useful,0,0
216714,followup,0,0
216715,variable,0,0
216716,of,0,0
216717,bone,0,0
216718,turnover,0,0
216719,",",0,0
216720,is,0,0
216721,changed,0,0
216722,significantly,0,0
216723,(,0,0
216724,p,0,0
216725,<,0,0
216726,0.02,0,0
216727,),0,0
216728,in,0,0
216729,patients,0,0
216730,with,0,0
216731,RA,0,0
216732,regarding,0,0
216733,inflammatory,0,0
216734,activity,0,0
216735,and,0,0
216736,functional,0,0
216737,capacity,0,0
216738,.,0,0
216739,In,0,0
216740,contrast,0,0
216741,to,0,0
216742,alkaline,0,0
216743,phosphatase,0,0
216744,",",0,0
216745,a,0,0
216746,fall,0,0
216747,in,0,0
216748,inflammatory,0,0
216749,activity,0,0
216750,stimulated,0,0
216751,and,0,0
216752,impairment,0,0
216753,of,0,0
216754,functional,0,0
216755,capacity,0,0
216756,significantly,0,0
216757,decreased,0,0
216758,osteocalcin,0,1
216759,levels,0,0
216760,in,0,0
216761,patients,0,0
216762,with,0,0
216763,RA,0,0
216764,.,0,0
216765,Treatment,0,0
216766,of,0,0
216767,multiple,0,0
216768,myeloma,0,0
216769,according,0,0
216770,to,0,0
216771,the,0,0
216772,extension,0,0
216773,of,0,0
216774,the,0,0
216775,disease,0,0
216776,:,0,0
216777,a,0,0
216778,prospective,0,0
216779,",",0,0
216780,randomised,0,0
216781,study,0,0
216782,comparing,0,0
216783,a,0,0
216784,less,0,0
216785,with,0,0
216786,a,0,0
216787,more,0,0
216788,aggressive,1,1
216789,cystostatic,1,1
216790,policy,0,1
216791,.,0,0
216792,Cooperative,0,0
216793,Group,0,0
216794,of,0,0
216795,Study,0,0
216796,and,0,0
216797,Treatment,0,0
216798,of,0,0
216799,Multiple,0,0
216800,Myeloma,0,0
216801,.,0,0
216802,The,0,0
216803,purpose,0,0
216804,of,0,0
216805,the,0,0
216806,study,0,0
216807,was,0,0
216808,to,0,0
216809,ascertain,0,0
216810,whether,0,0
216811,the,0,0
216812,prognostic,0,0
216813,significance,0,0
216814,of,0,0
216815,staging,0,0
216816,in,0,0
216817,multiple,0,0
216818,myeloma,0,0
216819,(,0,1
216820,MM,0,1
216821,),0,0
216822,is,0,0
216823,influenced,0,0
216824,by,0,0
216825,the,0,0
216826,aggressiveness,1,0
216827,of,1,0
216828,effective,1,0
216829,induction,1,0
216830,treatment,1,0
216831,and/or,0,0
216832,by,0,0
216833,continuing,0,0
216834,or,0,0
216835,discontinuing,0,0
216836,maintenance,1,0
216837,chemotherapy,1,0
216838,.,1,0
216839,Patients,0,0
216840,with,0,0
216841,untreated,0,0
216842,stage,0,0
216843,I,0,0
216844,MM,0,1
216845,(,0,0
216846,defined,0,0
216847,according,0,0
216848,to,0,0
216849,Durie,0,0
216850,and,0,0
216851,Salmon,0,0
216852,),0,0
216853,were,0,0
216854,randomised,0,0
216855,between,0,0
216856,being,0,0
216857,followed,1,0
216858,without,1,0
216859,cytostatics,1,1
216860,until,0,1
216861,the,0,0
216862,disease,0,0
216863,progressed,0,0
216864,and,0,0
216865,receiving,1,0
216866,six,1,0
216867,courses,1,0
216868,of,1,0
216869,melphalan,1,1
216870,and,1,1
216871,prednisone,1,1
216872,(,1,1
216873,MP-P,1,1
216874,),1,1
216875,just,0,0
216876,after,0,0
216877,diagnosis,0,0
216878,;,0,0
216879,stage,0,0
216880,II,0,0
216881,patients,0,0
216882,were,0,0
216883,uniformly,0,0
216884,treated,0,0
216885,with,0,0
216886,MPH-P,1,0
216887,and,0,0
216888,stage,0,0
216889,III,0,0
216890,patients,0,0
216891,were,0,0
216892,randomised,0,0
216893,between,0,0
216894,MPH-P,1,0
216895,and,1,0
216896,four,1,0
216897,courses,1,0
216898,of,1,0
216899,combination,1,0
216900,chemotherapy,1,0
216901,with,1,0
216902,Peptichemio,1,1
216903,",",1,1
216904,vincristine,1,1
216905,and,1,1
216906,prednisone,1,1
216907,(,1,1
216908,PTC-VCR-P,1,1
216909,),1,1
216910,.,1,0
216911,Within,0,0
216912,each,0,0
216913,stage,0,0
216914,",",0,0
216915,responsive,0,0
216916,patients,0,0
216917,were,0,0
216918,randomised,0,0
216919,between,0,0
216920,receiving,0,0
216921,additional,0,0
216922,therapy,0,0
216923,only,0,0
216924,until,0,0
216925,maximal,0,0
216926,tumour,0,0
216927,reduction,0,0
216928,was,0,0
216929,reached,0,0
216930,(,0,0
216931,plateau,0,0
216932,phase,0,0
216933,),0,0
216934,and,0,0
216935,continuing,0,0
216936,induction,0,0
216937,therapy,0,0
216938,indefinitely,0,0
216939,until,0,0
216940,relapse,0,0
216941,.,0,0
216942,With,0,0
216943,resistant,0,0
216944,",",0,0
216945,progressive,0,0
216946,or,0,0
216947,relapsing,0,0
216948,disease,0,0
216949,",",0,0
216950,patients,0,0
216951,originally,0,0
216952,treated,0,0
216953,with,0,0
216954,MPH-P,1,0
216955,for,0,0
216956,induction,0,0
216957,received,0,0
216958,combination,0,0
216959,chemotherapy,0,0
216960,and,0,0
216961,vice,0,0
216962,versa,0,0
216963,.,0,0
216964,The,0,0
216965,overall,0,0
216966,first,0,0
216967,response,0,0
216968,rate,0,0
216969,was,0,0
216970,43.8,0,0
216971,%,0,0
216972,(,0,0
216973,42.2,0,0
216974,%,0,0
216975,in,0,0
216976,206,0,0
216977,stage,0,0
216978,I,0,0
216979,",",0,0
216980,II,0,0
216981,and,0,0
216982,III,0,0
216983,patients,0,0
216984,treated,0,0
216985,with,0,0
216986,MPH-P,1,0
216987,and,0,0
216988,48.0,0,0
216989,%,0,0
216990,in,0,0
216991,75,0,0
216992,stage,0,0
216993,III,0,0
216994,patients,0,0
216995,treated,0,0
216996,with,0,0
216997,combination,1,0
216998,chemotherapy,1,0
216999,",",0,0
217000,P,0,0
217001,=,0,0
217002,NS,0,0
217003,),0,0
217004,.,0,0
217005,Combination,1,0
217006,chemotherapy,1,0
217007,was,0,0
217008,more,0,0
217009,myelotoxic,0,1
217010,than,0,1
217011,MPH-P,1,1
217012,and,0,0
217013,",",0,0
217014,in,0,0
217015,particular,0,0
217016,",",0,0
217017,caused,0,0
217018,more,0,0
217019,non-haematological,0,0
217020,side-effects,0,1
217021,.,0,0
217022,Both,0,0
217023,the,0,0
217024,less,0,0
217025,and,0,0
217026,the,0,0
217027,more,0,0
217028,aggressive,0,0
217029,induction,0,0
217030,policies,0,0
217031,gave,0,0
217032,the,0,0
217033,same,0,0
217034,disease,0,0
217035,control,0,0
217036,.,0,0
217037,Progression,0,0
217038,of,0,0
217039,disease,0,0
217040,was,0,0
217041,statistically,0,0
217042,similar,0,0
217043,in,0,0
217044,stage,0,0
217045,I,0,0
217046,patients,0,0
217047,who,0,0
217048,were,0,0
217049,initially,0,0
217050,left,0,0
217051,untreated,0,0
217052,and,0,0
217053,in,0,0
217054,t,0,0
217055,hose,0,0
217056,who,0,0
217057,received,0,0
217058,MPH-P,1,0
217059,just,0,0
217060,after,0,0
217061,diagnosis,0,0
217062,;,0,0
217063,median,0,0
217064,duration,0,0
217065,of,0,0
217066,first,0,0
217067,response,0,0
217068,was,0,0
217069,similar,0,0
217070,in,0,0
217071,stage,0,0
217072,III,0,0
217073,patients,0,0
217074,receiving,0,0
217075,MPH-P,1,0
217076,and,0,0
217077,in,0,0
217078,those,0,0
217079,on,0,0
217080,combination,1,0
217081,chemotherapy,1,0
217082,.,1,0
217083,In,0,0
217084,all,0,0
217085,stages,0,0
217086,",",0,0
217087,discontinuing,0,0
217088,or,0,0
217089,continuing,0,0
217090,maintenance,0,0
217091,did,0,0
217092,not,0,0
217093,alter,0,0
217094,the,0,0
217095,median,0,0
217096,duration,0,0
217097,of,0,0
217098,first,0,0
217099,response,0,0
217100,.,0,0
217101,The,0,0
217102,overall,0,0
217103,second,0,0
217104,response,0,0
217105,rate,0,0
217106,was,0,0
217107,28.5,0,0
217108,%,0,0
217109,(,0,0
217110,34.0,0,0
217111,%,0,0
217112,to,0,0
217113,MPH-P,0,0
217114,and,0,0
217115,25.3,0,0
217116,%,0,0
217117,to,0,0
217118,combination,0,0
217119,chemotherapy,1,0
217120,",",0,0
217121,P,0,0
217122,=,0,0
217123,NS,0,0
217124,),0,0
217125,.,0,0
217126,Median,0,0
217127,survival,0,0
217128,was,0,0
217129,greater,0,0
217130,than,0,0
217131,78,0,0
217132,months,0,0
217133,in,0,0
217134,stage,0,0
217135,I,0,0
217136,",",0,0
217137,was,0,0
217138,46.3,0,0
217139,months,0,0
217140,in,0,0
217141,stage,0,0
217142,II,0,0
217143,and,0,0
217144,was,0,0
217145,24.3,0,0
217146,months,0,0
217147,in,0,0
217148,stage,0,0
217149,III,0,0
217150,patients,0,0
217151,",",0,0
217152,still,0,0
217153,independent,0,0
217154,of,0,0
217155,both,0,0
217156,induction,0,0
217157,and,0,0
217158,post-induction,0,0
217159,policies,0,0
217160,.,0,0
217161,In,0,0
217162,MM,0,0
217163,",",0,0
217164,the,0,0
217165,significance,0,0
217166,of,0,0
217167,staging,0,0
217168,for,0,0
217169,survival,0,0
217170,is,0,0
217171,independent,0,0
217172,of,0,0
217173,both,0,0
217174,the,0,0
217175,aggressiveness,0,0
217176,of,0,0
217177,induction,0,0
217178,and,0,0
217179,of,0,0
217180,continuing,0,0
217181,or,0,0
217182,discontinuing,0,0
217183,maintenance,0,0
217184,chemotherapy,0,0
217185,after,0,0
217186,the,0,0
217187,maximal,0,0
217188,tumor,0,0
217189,reduction,0,0
217190,has,0,0
217191,been,0,0
217192,achieved,0,0
217193,.,0,0
217194,Both,0,0
217195,MPH-P,1,0
217196,and,0,0
217197,and,0,0
217198,the,0,0
217199,association,0,0
217200,of,0,0
217201,PTC,1,0
217202,",",1,0
217203,VCR,1,0
217204,and,1,0
217205,P,1,0
217206,are,0,0
217207,effective,0,0
217208,in,0,0
217209,inducing,0,0
217210,first,0,0
217211,response,0,0
217212,and,0,0
217213,also,0,0
217214,second,0,0
217215,response,0,0
217216,in,0,0
217217,patients,0,0
217218,failing,0,0
217219,on,0,0
217220,the,0,0
217221,alternative,0,0
217222,regimen,0,1
217223,",",0,0
217224,but,0,0
217225,PTC-VCR-P,1,0
217226,causes,0,0
217227,more,0,0
217228,side,0,0
217229,effects,0,0
217230,.,0,0
217231,Thus,0,0
217232,",",0,0
217233,the,0,0
217234,overwhelming,0,0
217235,majority,0,0
217236,of,0,0
217237,patients,0,0
217238,with,0,0
217239,MM,0,0
217240,can,0,0
217241,safely,0,0
217242,be,0,0
217243,given,0,0
217244,MPH-P,1,0
217245,as,0,0
217246,first,0,0
217247,therapy,0,0
217248,",",0,0
217249,and,0,0
217250,this,0,0
217251,treatment,0,0
217252,may,0,0
217253,be,0,0
217254,delayed,0,0
217255,in,0,0
217256,early,0,0
217257,diseases,0,0
217258,.,0,0
217259,Effect,0,0
217260,of,0,0
217261,simultaneous,0,0
217262,didanosine,1,1
217263,administration,0,1
217264,on,0,1
217265,itraconazole,1,1
217266,absorption,0,1
217267,in,0,0
217268,healthy,0,0
217269,volunteers,0,0
217270,.,0,0
217271,STUDY,0,0
217272,OBJECTIVE,0,0
217273,To,0,0
217274,investigate,0,0
217275,the,0,0
217276,effect,0,0
217277,of,0,0
217278,simultaneously,0,0
217279,administered,0,1
217280,didanosine,1,1
217281,(,1,1
217282,ddI,1,1
217283,),1,1
217284,on,0,0
217285,the,0,0
217286,absorption,0,0
217287,of,0,0
217288,a,0,0
217289,single,0,0
217290,dose,0,1
217291,of,0,1
217292,itraconazole,1,1
217293,.,1,1
217294,DESIGN,0,1
217295,Randomized,0,1
217296,",",0,0
217297,crossover,0,1
217298,",",0,1
217299,unblinded,0,1
217300,single-dose,0,1
217301,pharmacokinetic,0,1
217302,study,0,0
217303,in,0,0
217304,healthy,0,0
217305,volunteers,0,0
217306,.,0,0
217307,Comparisons,0,0
217308,of,0,0
217309,itraconazole,1,1
217310,alone,1,0
217311,and,0,0
217312,itraconazole,1,1
217313,with,1,0
217314,simultaneous,1,0
217315,ddI,1,0
217316,were,0,0
217317,performed,0,0
217318,on,0,0
217319,days,0,0
217320,1,0,0
217321,and,0,0
217322,15,0,0
217323,.,0,0
217324,SETTING,0,0
217325,A,0,1
217326,university,0,0
217327,medical,0,0
217328,center,0,0
217329,.,0,0
217330,PATIENTS,0,0
217331,Seven,0,0
217332,healthy,0,0
217333,men,0,0
217334,and,0,0
217335,women,0,0
217336,.,0,0
217337,Six,0,1
217338,subjects,0,0
217339,(,0,0
217340,86,0,0
217341,%,0,0
217342,),0,0
217343,completed,0,0
217344,the,0,0
217345,study,0,0
217346,;,0,0
217347,one,0,0
217348,was,0,0
217349,removed,0,0
217350,due,0,0
217351,to,0,0
217352,the,0,0
217353,development,0,0
217354,of,0,0
217355,a,0,0
217356,rash,0,0
217357,.,0,0
217358,INTERVENTIONS,0,0
217359,Volunteers,0,0
217360,received,0,0
217361,a,0,0
217362,single,1,0
217363,200-mg,1,1
217364,oral,1,1
217365,dose,1,1
217366,of,1,1
217367,itraconazole,1,1
217368,or,1,1
217369,itraconazole,1,1
217370,with,1,1
217371,concomitant,1,0
217372,oral,1,1
217373,ddI,1,1
217374,300,1,1
217375,mg,1,1
217376,(,1,1
217377,two,1,1
217378,150-mg,1,1
217379,tablets,1,1
217380,),1,1
217381,dispersed,0,0
217382,in,0,0
217383,240,0,0
217384,ml,0,0
217385,water,0,0
217386,.,0,0
217387,Each,0,0
217388,regimen,0,1
217389,was,0,0
217390,separated,0,0
217391,by,0,0
217392,a,0,0
217393,2-week,0,1
217394,washout,0,1
217395,period,0,1
217396,.,0,0
217397,Serum,0,0
217398,samples,0,0
217399,were,0,0
217400,obtained,0,0
217401,frequently,0,0
217402,for,0,0
217403,12,0,0
217404,hours,0,0
217405,after,0,0
217406,the,0,0
217407,dose,0,1
217408,.,0,1
217409,MEASUREMENTS,0,1
217410,AND,0,1
217411,MAIN,0,1
217412,RESULTS,0,1
217413,Concentrations,0,1
217414,of,0,0
217415,itraconazole,1,1
217416,were,0,0
217417,determined,0,0
217418,using,0,0
217419,a,0,0
217420,microbiologic,0,0
217421,assay,0,0
217422,.,0,0
217423,Individual,0,0
217424,concentrations,0,1
217425,in,0,1
217426,serum,0,1
217427,versus,0,0
217428,time,0,0
217429,data,0,0
217430,were,0,0
217431,evaluated,0,0
217432,by,0,0
217433,linear,0,0
217434,regression,0,0
217435,analysis,0,0
217436,.,0,0
217437,Peak,0,1
217438,serum,0,1
217439,concentration,0,0
217440,and,0,0
217441,time,0,0
217442,to,0,0
217443,peak,0,0
217444,were,0,0
217445,determined,0,0
217446,by,0,0
217447,visual,0,0
217448,inspection,0,0
217449,of,0,0
217450,each,0,0
217451,individual,0,0
217452,'s,0,1
217453,serum,0,1
217454,concentration-time,0,1
217455,curve,0,1
217456,.,0,0
217457,A,0,0
217458,mean,0,0
217459,+/-,0,0
217460,SD,0,0
217461,peak,0,0
217462,serum,0,1
217463,itraconazole,1,1
217464,concentration,0,0
217465,of,0,0
217466,0.90,0,0
217467,+/-,0,0
217468,0.30,0,0
217469,micrograms/ml,0,0
217470,was,0,0
217471,observed,0,0
217472,at,0,0
217473,3.0,0,0
217474,+/-,0,0
217475,0.7,0,0
217476,hours,0,0
217477,when,0,0
217478,itraconazole,0,1
217479,was,0,0
217480,administered,0,1
217481,alone,0,0
217482,",",0,0
217483,compared,0,0
217484,with,0,0
217485,undetectable,0,0
217486,levels,0,0
217487,in,0,0
217488,all,0,0
217489,patients,0,0
217490,during,0,0
217491,therapy,0,0
217492,with,0,0
217493,ddI,0,0
217494,.,0,0
217495,CONCLUSIONS,0,0
217496,Simultaneous,0,0
217497,oral,1,1
217498,administration,1,1
217499,of,1,1
217500,ddI,1,0
217501,significantly,0,0
217502,decreases,0,0
217503,absorption,0,1
217504,of,0,0
217505,itraconazole,1,1
217506,.,1,1
217507,These,0,1
217508,drugs,0,1
217509,should,0,0
217510,not,0,0
217511,be,0,0
217512,administered,0,1
217513,concurrently,0,0
217514,.,0,0
217515,Disopyramide,1,1
217516,in,0,0
217517,the,0,0
217518,treatment,0,0
217519,and,0,0
217520,prevention,0,0
217521,of,0,0
217522,arrhythmias,0,0
217523,following,0,0
217524,myocardial,0,0
217525,infarction,0,0
217526,.,0,0
217527,Effectiveness,0,0
217528,of,0,0
217529,a,0,0
217530,calculus,1,0
217531,scaling,1,0
217532,gel,1,1
217533,.,1,1
217534,This,0,0
217535,study,0,0
217536,evaluated,0,0
217537,the,0,0
217538,effect,0,0
217539,of,0,0
217540,a,0,0
217541,calculus,1,0
217542,scaling,1,0
217543,gel,1,1
217544,(,1,1
217545,SofScale,1,1
217546,),1,1
217547,on,0,0
217548,time,0,0
217549,and,0,0
217550,ease,0,0
217551,of,0,0
217552,the,0,0
217553,scaling,0,0
217554,procedure,0,0
217555,in,0,0
217556,a,0,0
217557,double-blind,0,1
217558,",",0,1
217559,split-mouth,0,1
217560,clinical,0,0
217561,study,0,0
217562,of,0,0
217563,32,0,0
217564,subjects,0,0
217565,.,0,0
217566,The,0,0
217567,Volpe-Manhold,1,0
217568,calculus,1,0
217569,index,1,0
217570,was,0,0
217571,used,0,0
217572,to,0,0
217573,quantify,0,0
217574,the,0,0
217575,distribution,0,0
217576,and,0,0
217577,amount,0,0
217578,of,0,0
217579,calculus,0,0
217580,deposition,0,0
217581,on,0,0
217582,the,0,0
217583,lingual,0,0
217584,aspect,0,0
217585,of,0,0
217586,the,0,0
217587,mandibular,0,0
217588,6,0,0
217589,anterior,0,0
217590,teeth,0,0
217591,at,0,0
217592,baseline,0,0
217593,.,0,0
217594,The,0,0
217595,gel,1,1
217596,was,1,0
217597,applied,1,0
217598,directly,1,0
217599,to,1,0
217600,the,1,0
217601,calculus,1,0
217602,and,1,1
217603,subgingivally,1,1
217604,to,1,0
217605,the,1,0
217606,area,1,0
217607,to,1,0
217608,be,1,0
217609,scaled,1,0
217610,.,1,0
217611,Pre-,1,0
217612,and,1,0
217613,post-treatment,1,0
217614,gingival,1,0
217615,and,1,0
217616,stain,1,0
217617,indices,1,0
217618,were,1,0
217619,taken,1,0
217620,.,1,0
217621,Operator,0,0
217622,and,0,0
217623,subject,0,0
217624,questionnaires,0,0
217625,were,0,0
217626,completed,0,0
217627,immediately,0,0
217628,after,0,0
217629,treatment,0,0
217630,to,0,0
217631,determine,0,0
217632,ease,0,0
217633,of,0,0
217634,the,0,0
217635,scaling,0,0
217636,procedure,0,0
217637,.,0,0
217638,Results,0,0
217639,were,0,0
217640,analyzed,0,0
217641,with,0,0
217642,paired,0,0
217643,t-tests,0,0
217644,.,0,0
217645,The,0,0
217646,time,0,0
217647,difference,0,0
217648,in,0,0
217649,scaling,0,0
217650,between,0,0
217651,the,0,0
217652,product,0,0
217653,and,0,0
217654,placebo,0,1
217655,side,0,0
217656,was,0,0
217657,not,0,0
217658,significant,0,0
217659,.,0,0
217660,This,0,0
217661,study,0,0
217662,found,0,0
217663,that,0,0
217664,SofScale,1,0
217665,is,0,0
217666,safe,0,0
217667,to,0,0
217668,gingival,0,0
217669,tissues,0,0
217670,and,0,0
217671,does,0,0
217672,not,0,0
217673,promote,0,0
217674,tooth,0,0
217675,sensitivity,0,0
217676,.,0,0
217677,However,0,0
217678,",",0,0
217679,this,0,0
217680,study,0,0
217681,did,0,0
217682,not,0,0
217683,find,0,0
217684,significant,0,0
217685,differences,0,0
217686,in,0,0
217687,scaling,0,0
217688,time,0,0
217689,between,0,0
217690,product,0,0
217691,and,0,0
217692,placebo,1,1
217693,when,0,0
217694,using,0,0
217695,a,0,0
217696,2-minute,0,0
217697,gel,0,1
217698,contact,0,0
217699,time,0,0
217700,.,0,0
217701,Paromomycin,1,1
217702,for,0,0
217703,cryptosporidiosis,0,0
217704,in,0,0
217705,AIDS,0,0
217706,:,0,0
217707,a,0,0
217708,prospective,0,0
217709,",",0,0
217710,double-blind,0,1
217711,trial,0,1
217712,.,0,0
217713,To,0,0
217714,test,0,0
217715,the,0,0
217716,effects,0,0
217717,of,0,0
217718,paromomycin,1,1
217719,",",0,0
217720,10,0,0
217721,patients,0,0
217722,with,0,0
217723,AIDS,0,0
217724,and,0,0
217725,cryptosporidiosis,0,0
217726,were,0,0
217727,randomized,0,0
217728,to,0,0
217729,paromomycin,1,1
217730,or,1,1
217731,placebo,1,1
217732,in,0,0
217733,a,0,0
217734,double-blind,0,1
217735,trial,0,1
217736,.,0,1
217737,After,0,0
217738,14,0,0
217739,days,0,0
217740,",",0,0
217741,patients,0,0
217742,were,0,0
217743,switched,0,0
217744,to,0,0
217745,the,0,0
217746,other,0,0
217747,treatment,0,0
217748,for,0,0
217749,14,0,0
217750,additional,0,0
217751,days,0,0
217752,.,0,0
217753,Measures,0,0
217754,included,0,0
217755,the,0,0
217756,number,0,0
217757,and,0,0
217758,character,0,0
217759,of,0,0
217760,each,0,0
217761,stool,0,0
217762,and,0,1
217763,weekly,0,1
217764,24-h,0,1
217765,stool,0,1
217766,specimens,0,0
217767,for,0,0
217768,weight,0,0
217769,and,0,0
217770,oocyst,0,1
217771,excretion,0,1
217772,.,0,0
217773,During,0,0
217774,the,0,0
217775,paromomycin,1,1
217776,treatment,0,0
217777,phase,0,0
217778,",",0,0
217779,oocyst,0,1
217780,excretion,0,1
217781,decreased,0,0
217782,from,0,0
217783,314,0,0
217784,x,0,0
217785,10,0,0
217786,(,0,1
217787,6,0,0
217788,),0,0
217789,to,0,0
217790,109,0,0
217791,x,0,0
217792,10,0,0
217793,(,0,1
217794,6,0,1
217795,),0,1
217796,24,0,0
217797,h,0,0
217798,(,0,0
217799,P,0,0
217800,<,0,0
217801,.02,0,0
217802,),0,0
217803,.,0,0
217804,Oocyst,0,1
217805,excretion,0,1
217806,increased,0,0
217807,for,0,0
217808,the,0,0
217809,4,0,0
217810,patients,0,0
217811,initially,0,0
217812,on,0,0
217813,placebo,1,1
217814,compared,0,0
217815,to,0,0
217816,a,0,0
217817,median,0,0
217818,decrease,0,0
217819,of,0,0
217820,128,0,0
217821,x,0,0
217822,10,0,0
217823,(,0,1
217824,6,0,0
217825,),0,0
217826,/24,0,0
217827,h,0,0
217828,for,0,0
217829,the,0,0
217830,6,0,0
217831,initially,0,0
217832,treated,0,0
217833,with,0,0
217834,drug,0,0
217835,(,0,0
217836,P,0,0
217837,<,0,0
217838,.02,0,0
217839,),0,0
217840,.,0,0
217841,Stool,0,0
217842,frequency,0,0
217843,also,0,0
217844,decreased,0,0
217845,more,0,0
217846,in,0,0
217847,those,0,0
217848,treated,0,0
217849,with,0,0
217850,drug,1,1
217851,(,0,0
217852,3.6,0,0
217853,fewer,0,0
217854,vs.,0,0
217855,1.25,0,0
217856,fewer/24,0,0
217857,h,0,0
217858,",",0,0
217859,P,0,0
217860,<,0,0
217861,.05,0,0
217862,),0,0
217863,.,0,0
217864,Trends,0,0
217865,favored,0,0
217866,drug,0,1
217867,over,0,1
217868,placebo,1,1
217869,for,0,0
217870,stool,0,1
217871,weight,0,0
217872,",",0,0
217873,stool,0,0
217874,character,0,0
217875,",",0,0
217876,and,0,0
217877,Karnofsky,0,0
217878,score,0,1
217879,.,0,0
217880,Paromomycin,1,1
217881,treatment,0,0
217882,resulted,0,0
217883,in,0,0
217884,improvement,0,0
217885,in,0,0
217886,both,0,0
217887,clinical,0,0
217888,and,0,0
217889,parasitologic,0,0
217890,parameters,0,0
217891,in,0,0
217892,cryptosporidiosis,0,0
217893,in,0,0
217894,AIDS,0,0
217895,.,0,0
217896,Bronchodilator,1,1
217897,treatment,1,1
217898,in,0,0
217899,asthma,0,0
217900,and,0,0
217901,bronchitis,0,0
217902,.,0,0
217903,Milk,0,0
217904,production,0,0
217905,in,0,0
217906,cows,0,0
217907,with,0,0
217908,endotoxin-induced,1,1
217909,mastitis,1,0
217910,treated,0,0
217911,with,0,0
217912,isotonic,1,1
217913,or,1,1
217914,hypertonic,1,1
217915,sodium,1,1
217916,chloride,1,1
217917,solution,1,0
217918,.,1,0
217919,Milk,0,0
217920,production,0,0
217921,was,0,0
217922,monitored,0,0
217923,in,0,0
217924,16,0,0
217925,cows,0,0
217926,for,0,0
217927,6,0,0
217928,milkings,0,1
217929,after,0,1
217930,intramammary,0,1
217931,infusion,0,1
217932,of,0,1
217933,1,0,1
217934,mg,0,1
217935,of,0,1
217936,endotoxin,1,1
217937,in,0,0
217938,a,0,0
217939,single,0,0
217940,forequarter,0,0
217941,.,0,0
217942,The,0,0
217943,cows,0,0
217944,were,0,0
217945,randomly,0,0
217946,assigned,0,0
217947,to,0,0
217948,1,0,0
217949,of,0,0
217950,2,0,0
217951,treatment,0,0
217952,groups,0,1
217953,;,0,0
217954,8,0,0
217955,cows,0,0
217956,were,0,0
217957,treated,0,0
217958,with,0,0
217959,isotonic,1,1
217960,saline,1,1
217961,solution,1,1
217962,and,0,0
217963,8,0,0
217964,cows,0,0
217965,were,0,0
217966,treated,0,0
217967,with,0,0
217968,hypertonic,1,1
217969,saline,1,1
217970,solution,1,1
217971,.,1,1
217972,Saline,1,0
217973,solutions,0,0
217974,were,0,0
217975,administered,0,1
217976,IV,0,1
217977,(,0,1
217978,5,0,0
217979,ml/kg,0,1
217980,of,0,0
217981,body,0,1
217982,weight,0,1
217983,),0,1
217984,4,0,1
217985,hours,0,1
217986,after,0,1
217987,infusion,0,1
217988,of,0,0
217989,endotoxin,1,1
217990,.,1,1
217991,Mean,0,0
217992,cumulative,0,0
217993,change,0,0
217994,in,0,0
217995,milk,0,1
217996,yield,0,0
217997,and,0,0
217998,interval,0,0
217999,change,0,0
218000,in,0,0
218001,milk,0,1
218002,yield,0,0
218003,were,0,0
218004,greater,0,0
218005,in,0,0
218006,cows,0,0
218007,treated,0,0
218008,with,0,0
218009,isotonic,0,1
218010,saline,0,1
218011,solution,1,1
218012,than,0,0
218013,in,0,0
218014,cows,0,0
218015,treated,0,0
218016,with,0,0
218017,hypertonic,1,1
218018,saline,1,1
218019,solution,1,1
218020,.,1,0
218021,Significant,0,0
218022,differences,0,0
218023,between,0,0
218024,treatment,0,0
218025,groups,0,0
218026,were,0,0
218027,not,0,0
218028,detected,0,0
218029,.,0,0
218030,Intestinal,0,1
218031,absorption,0,1
218032,of,0,1
218033,dietary,0,1
218034,fat,0,1
218035,in,0,0
218036,patients,0,0
218037,with,0,0
218038,multiple,0,0
218039,sclerosis,0,0
218040,.,0,0
218041,Fat,1,0
218042,absorption,1,1
218043,was,0,0
218044,studied,0,0
218045,in,0,0
218046,24,0,0
218047,patients,0,0
218048,with,0,0
218049,clinically,0,0
218050,definite,0,0
218051,multiple,0,0
218052,sclerosis,0,0
218053,and,0,0
218054,in,0,0
218055,36,0,0
218056,healthy,0,0
218057,control,1,0
218058,subjects,0,0
218059,.,0,0
218060,Beta-carotene,1,1
218061,and,1,1
218062,vitamin,1,1
218063,A,1,1
218064,in,1,0
218065,their,1,0
218066,plasma,1,0
218067,were,1,0
218068,also,1,0
218069,measured,1,0
218070,.,1,0
218071,This,0,0
218072,double-blind,0,1
218073,and,0,1
218074,randomized,0,0
218075,study,0,0
218076,showed,0,0
218077,no,0,0
218078,differences,0,0
218079,between,0,0
218080,these,0,0
218081,two,0,0
218082,populations,0,0
218083,with,0,0
218084,regard,0,0
218085,to,0,0
218086,the,0,0
218087,three,0,0
218088,parameters,0,0
218089,.,0,0
218090,We,0,0
218091,did,0,0
218092,not,0,0
218093,find,0,0
218094,evidence,0,0
218095,for,0,0
218096,fat,0,0
218097,malabsorption,0,0
218098,in,0,0
218099,multiple,0,0
218100,sclerosis,0,0
218101,.,0,0
218102,[,0,1
218103,The,0,0
218104,anti-ischemic,0,1
218105,effect,0,0
218106,of,0,0
218107,phosphodiesterase,0,1
218108,III,0,1
218109,inhibitors,0,1
218110,],0,1
218111,.,0,1
218112,When,0,1
218113,enoximone,1,1
218114,is,0,0
218115,acutely,0,0
218116,administered,0,1
218117,to,0,0
218118,patients,0,0
218119,with,0,0
218120,stable,0,0
218121,angina,0,0
218122,and,0,0
218123,angiographically,0,0
218124,proven,0,0
218125,relevant,0,0
218126,coronary,0,0
218127,stenosis,0,1
218128,i.v,0,1
218129,.,0,0
218130,application,0,0
218131,of,0,0
218132,0.75,0,0
218133,mg/kg,0,0
218134,exhibits,0,0
218135,pronounced,0,0
218136,antiischemic,0,1
218137,effects,0,0
218138,.,0,0
218139,This,0,0
218140,could,0,0
218141,be,0,0
218142,observed,0,0
218143,in,0,0
218144,patients,0,0
218145,during,0,0
218146,exercise,0,0
218147,and,0,0
218148,in,0,0
218149,those,0,0
218150,in,0,0
218151,whom,0,0
218152,the,0,0
218153,ischemia,0,0
218154,was,0,0
218155,provoked,0,0
218156,by,0,0
218157,rapid,0,0
218158,cardiac,0,0
218159,stimulation,0,0
218160,.,0,0
218161,The,0,0
218162,antiischemic,0,0
218163,effects,0,0
218164,were,0,0
218165,documented,0,0
218166,by,0,0
218167,relief,0,0
218168,of,0,0
218169,symptoms,0,0
218170,",",0,0
218171,reduction,0,0
218172,of,0,0
218173,ST-depression,0,0
218174,",",0,0
218175,improvement,0,0
218176,of,0,0
218177,impaired,0,0
218178,myocardial,0,0
218179,wall,0,0
218180,motion,0,0
218181,",",0,0
218182,decrease,0,0
218183,to,0,0
218184,normalization,0,0
218185,of,0,0
218186,pathologically,0,0
218187,elevated,0,0
218188,filling,0,0
218189,pressure,0,0
218190,",",0,0
218191,amelioration,0,0
218192,of,0,0
218193,coronary,0,0
218194,blood,0,0
218195,flow,0,0
218196,as,0,0
218197,evidenced,0,0
218198,by,0,0
218199,myocard,0,0
218200,scintigraphy,0,1
218201,and,0,0
218202,washout,0,1
218203,time,0,0
218204,of,0,0
218205,an,0,0
218206,intracoronarily,0,1
218207,injected,0,0
218208,echo-contrast,0,0
218209,medium,0,0
218210,.,0,0
218211,There,0,0
218212,was,0,0
218213,also,0,0
218214,a,0,0
218215,definite,0,0
218216,improvement,0,0
218217,of,0,0
218218,ischemia-caused,0,0
218219,mitral,0,0
218220,regurgitation,0,0
218221,.,0,0
218222,Similar,0,0
218223,observations,0,0
218224,were,0,0
218225,found,0,0
218226,when,0,0
218227,the,0,0
218228,drug,0,1
218229,was,0,0
218230,injected,0,0
218231,in,0,0
218232,the,0,0
218233,diseased,0,0
218234,coronary,0,0
218235,arteries,0,0
218236,in,0,0
218237,a,0,0
218238,small,0,0
218239,dose,0,1
218240,(,0,1
218241,0.075,0,1
218242,mg/kg,0,1
218243,),0,0
218244,so,0,0
218245,that,0,0
218246,peripheral,0,0
218247,effects,0,0
218248,were,0,0
218249,not,0,0
218250,present,0,0
218251,.,0,0
218252,In,0,0
218253,comparison,0,0
218254,to,0,0
218255,the,0,0
218256,Ca,0,1
218257,(,0,1
218258,++,0,1
218259,),0,1
218260,-blocker,0,1
218261,Gallopamil,1,1
218262,the,0,1
218263,antiischemic,0,1
218264,effects,0,0
218265,of,0,0
218266,Enoximone,1,1
218267,were,0,0
218268,more,0,0
218269,pronounced,0,0
218270,",",0,0
218271,a,0,0
218272,synergistic,0,0
218273,action,0,0
218274,was,0,0
218275,",",0,0
218276,however,0,0
218277,",",0,0
218278,observed,0,0
218279,.,0,0
218280,Negative,0,0
218281,dromotropic,0,1
218282,effects,0,0
218283,of,0,0
218284,Gallopamil,1,1
218285,could,0,0
218286,be,0,0
218287,abolished,0,0
218288,by,0,0
218289,Enoximone,1,1
218290,.,1,1
218291,With,0,1
218292,oral,0,1
218293,administration,0,1
218294,of,0,1
218295,the,0,0
218296,drug,0,1
218297,over,0,0
218298,a,0,0
218299,period,0,0
218300,of,0,0
218301,one,0,0
218302,week,0,0
218303,antiischemic,0,1
218304,effects,0,0
218305,could,0,0
218306,also,0,0
218307,be,0,0
218308,documented,0,0
218309,with,0,0
218310,Holter,0,0
218311,monitoring,0,0
218312,as,0,0
218313,well,0,0
218314,as,0,0
218315,during,0,0
218316,exercise,0,0
218317,.,0,0
218318,There,0,0
218319,was,0,0
218320,a,0,0
218321,reduction,0,0
218322,of,0,0
218323,ST-depression,0,0
218324,both,0,0
218325,at,0,0
218326,spontaneously,0,0
218327,occurring,0,0
218328,ischemic,0,0
218329,episodes,0,0
218330,and,0,0
218331,during,0,0
218332,exercise,0,0
218333,",",0,0
218334,in,0,0
218335,the,0,0
218336,number,0,0
218337,and,0,0
218338,duration,0,0
218339,of,0,0
218340,episodes,0,0
218341,of,0,0
218342,silent,0,0
218343,ischemia,0,0
218344,",",0,0
218345,particularly,0,0
218346,",",0,0
218347,however,0,0
218348,",",0,0
218349,a,0,0
218350,decrease,0,0
218351,in,0,0
218352,symptomatic,0,0
218353,episodes,0,0
218354,.,0,0
218355,In,0,0
218356,none,0,0
218357,of,0,0
218358,the,0,0
218359,patients,0,0
218360,under,0,0
218361,study,0,0
218362,proarrhythmic,0,1
218363,effects,0,0
218364,were,0,0
218365,observed,0,0
218366,.,0,0
218367,Recovery,0,1
218368,following,0,0
218369,outpatient,1,0
218370,anesthesia,1,0
218371,:,1,0
218372,use,0,0
218373,of,0,0
218374,enflurane,1,1
218375,versus,1,1
218376,propofol,1,1
218377,.,1,1
218378,STUDY,0,1
218379,OBJECTIVE,0,0
218380,To,0,0
218381,compare,0,0
218382,the,0,0
218383,intraoperative,0,0
218384,conditions,0,0
218385,and,0,0
218386,postoperative,0,0
218387,recovery,0,0
218388,of,0,0
218389,patients,0,0
218390,following,0,0
218391,the,0,0
218392,use,0,0
218393,of,0,0
218394,either,0,0
218395,propofol-nitrous,1,1
218396,oxide,1,1
218397,(,1,1
218398,N2O,1,1
218399,),1,1
218400,or,1,0
218401,enflurane-N2O,1,1
218402,for,1,0
218403,maintenance,0,0
218404,of,0,0
218405,outpatient,0,0
218406,anesthesia,0,0
218407,.,0,0
218408,DESIGN,0,0
218409,Randomized,0,1
218410,",",0,0
218411,single-blind,0,1
218412,study,0,0
218413,.,0,0
218414,SETTING,0,0
218415,University,0,0
218416,hospital,0,1
218417,outpatient,0,0
218418,surgery,0,0
218419,center,0,0
218420,.,0,0
218421,PATIENTS,0,0
218422,61,0,0
218423,ASA,0,0
218424,physical,0,0
218425,status,0,0
218426,I,0,0
218427,and,0,0
218428,II,0,0
218429,",",0,0
218430,healthy,0,0
218431,female,0,0
218432,outpatients,0,1
218433,undergoing,0,1
218434,laparoscopic,0,0
218435,surgery,0,0
218436,.,0,0
218437,INTERVENTIONS,0,0
218438,Patients,0,0
218439,were,0,0
218440,randomly,0,0
218441,assigned,0,0
218442,to,0,0
218443,one,0,0
218444,of,0,0
218445,three,0,0
218446,anesthetic,0,1
218447,regimens,0,1
218448,.,0,1
218449,Group,1,0
218450,1,1,0
218451,(,1,0
218452,control,1,0
218453,),1,0
218454,received,1,1
218455,thiopental,1,1
218456,sodium,1,1
218457,4,1,1
218458,mg/kg,1,1
218459,intravenously,1,1
218460,(,1,1
218461,i.v,1,1
218462,.,1,1
218463,),1,0
218464,",",1,0
218465,followed,1,0
218466,by,1,0
218467,0.5,1,0
218468,%,1,0
218469,to,1,0
218470,1.5,1,0
218471,%,1,0
218472,enflurane,1,0
218473,and,1,0
218474,67,1,0
218475,%,1,0
218476,N2O,1,0
218477,in,1,0
218478,oxygen,1,0
218479,(,1,0
218480,O2,1,1
218481,),1,1
218482,.,1,0
218483,Group,1,0
218484,2,1,0
218485,received,1,0
218486,propofol,1,1
218487,2,1,1
218488,mg/kg,1,1
218489,i.v.,1,1
218490,",",0,1
218491,followed,1,0
218492,by,1,0
218493,0.5,1,0
218494,%,1,0
218495,to,1,0
218496,1.5,1,0
218497,%,1,0
218498,enflurane,1,0
218499,and,1,0
218500,67,1,0
218501,%,1,0
218502,N2O,1,0
218503,in,1,0
218504,O2,1,0
218505,.,1,0
218506,Group,1,0
218507,3,1,0
218508,received,1,0
218509,propofol,1,1
218510,2,1,1
218511,mg/kg,1,1
218512,i.v.,1,1
218513,",",0,1
218514,followed,1,0
218515,by,1,0
218516,propofol,1,1
218517,50,1,0
218518,to,1,0
218519,160,1,0
218520,micrograms/kg/min,1,1
218521,i.v,1,1
218522,.,1,1
218523,and,1,0
218524,67,1,0
218525,%,1,0
218526,N2O,1,0
218527,in,1,0
218528,O2,1,0
218529,.,1,0
218530,All,0,0
218531,patients,0,0
218532,received,0,0
218533,succinylcholine,1,1
218534,1,0,1
218535,mg/kg,0,1
218536,i.v,0,1
218537,.,0,1
218538,to,0,0
218539,facilitate,0,0
218540,tracheal,0,0
218541,intubation,0,1
218542,and,0,1
218543,atracurium,1,1
218544,10,0,1
218545,to,0,0
218546,20,0,1
218547,mg,0,1
218548,i.v,0,1
218549,.,0,1
218550,to,0,0
218551,provide,0,0
218552,adequate,0,0
218553,relaxation,0,0
218554,during,0,0
218555,the,0,0
218556,maintenance,0,0
218557,period,0,0
218558,.,0,0
218559,MEASUREMENTS,0,0
218560,AND,0,1
218561,MAIN,0,1
218562,RESULTS,0,1
218563,Recovery,0,1
218564,from,0,0
218565,anesthesia,1,0
218566,was,0,0
218567,assessed,0,0
218568,by,0,0
218569,a,0,0
218570,research,0,0
218571,nurse,0,0
218572,who,0,0
218573,was,0,0
218574,unaware,0,0
218575,of,0,0
218576,the,0,0
218577,anesthetic,0,1
218578,technique,0,0
218579,used,0,0
218580,.,0,0
218581,The,0,0
218582,mean,0,0
218583,+/-,0,0
218584,SD,0,0
218585,time,0,0
218586,to,0,0
218587,eye,0,0
218588,opening,0,0
218589,was,0,0
218590,significantly,0,0
218591,longer,0,0
218592,in,0,0
218593,the,0,0
218594,thiopental-enflurane-N2O,1,1
218595,group,1,1
218596,(,1,1
218597,Group,1,0
218598,1,1,1
218599,),1,0
218600,than,0,0
218601,in,0,0
218602,the,0,0
218603,propofol-propofol-N2O,1,1
218604,group,1,1
218605,(,1,1
218606,Group,1,0
218607,3,1,1
218608,),1,0
218609,(,0,0
218610,6.1,0,0
218611,+/-,0,0
218612,2.5,0,0
218613,minutes,0,0
218614,vs.,0,0
218615,3.5,0,0
218616,+/-,0,0
218617,2.8,0,0
218618,minutes,0,0
218619,",",0,0
218620,respectively,0,0
218621,),0,0
218622,.,0,0
218623,In,0,0
218624,addition,0,0
218625,",",0,0
218626,the,0,0
218627,mean,0,0
218628,time,0,0
218629,to,0,0
218630,respond,0,0
218631,to,0,0
218632,verbal,0,0
218633,commands,0,0
218634,was,0,0
218635,significantly,0,0
218636,shorter,0,0
218637,in,0,0
218638,the,0,0
218639,propofol,1,1
218640,induction,0,0
218641,groups,0,0
218642,compared,0,0
218643,with,0,0
218644,the,0,0
218645,thiopental,1,1
218646,induction,0,0
218647,group,0,0
218648,.,0,0
218649,However,0,0
218650,",",0,0
218651,the,0,0
218652,use,0,0
218653,of,0,0
218654,enflurane,1,1
218655,versus,0,1
218656,propofol,1,1
218657,for,0,0
218658,maintenance,0,0
218659,of,0,0
218660,anesthesia,0,0
218661,did,0,0
218662,not,0,0
218663,significantly,0,0
218664,prolong,0,0
218665,the,0,0
218666,time,0,0
218667,from,0,0
218668,arrival,0,0
218669,in,0,0
218670,the,0,0
218671,recovery,0,0
218672,room,0,0
218673,to,0,0
218674,sitting,0,1
218675,",",0,1
218676,tolerating,0,1
218677,oral,0,1
218678,fluids,0,1
218679,",",0,1
218680,walking,0,1
218681,",",0,0
218682,or,0,0
218683,being,0,0
218684,judged,0,0
218685,fit,0,0
218686,for,0,0
218687,discharge,0,0
218688,.,0,0
218689,There,0,0
218690,were,0,0
218691,no,0,0
218692,differences,0,0
218693,among,0,0
218694,the,0,0
218695,three,0,0
218696,groups,0,0
218697,with,0,0
218698,respect,0,0
218699,to,0,0
218700,postoperative,0,0
218701,pain,0,1
218702,or,0,0
218703,analgesic,0,1
218704,requirements,0,0
218705,.,0,0
218706,Finally,0,0
218707,",",0,0
218708,patients,0,0
218709,who,0,0
218710,received,0,0
218711,enflurane,1,1
218712,for,0,0
218713,maintenance,0,0
218714,of,0,0
218715,anesthesia,0,0
218716,had,0,0
218717,a,0,0
218718,significantly,0,0
218719,higher,0,0
218720,frequency,0,0
218721,of,0,0
218722,nausea,0,1
218723,and,0,1
218724,vomiting,0,1
218725,than,0,0
218726,the,0,0
218727,propofol,0,1
218728,maintenance,0,0
218729,group,0,0
218730,.,0,0
218731,CONCLUSION,0,0
218732,Induction,0,0
218733,of,0,0
218734,anesthesia,0,0
218735,with,0,0
218736,propofol,1,1
218737,is,0,0
218738,associated,0,0
218739,with,0,0
218740,a,0,0
218741,more,0,0
218742,rapid,0,0
218743,emergence,0,0
218744,from,0,0
218745,anesthesia,0,0
218746,than,0,0
218747,induction,0,0
218748,with,0,0
218749,thiopental,1,1
218750,.,1,0
218751,Maintenance,0,0
218752,of,0,0
218753,anesthesia,0,0
218754,with,0,0
218755,enflurane,1,1
218756,did,0,0
218757,not,0,0
218758,prolong,0,0
218759,recovery,0,0
218760,compared,0,0
218761,with,0,0
218762,maintenance,0,0
218763,with,0,0
218764,propofol,1,1
218765,",",0,0
218766,but,0,0
218767,enflurane,1,1
218768,was,0,0
218769,associated,0,0
218770,with,0,0
218771,increased,0,0
218772,frequency,0,0
218773,of,0,0
218774,postoperative,0,1
218775,nausea,0,1
218776,and,0,1
218777,vomiting,0,0
218778,.,0,0
218779,Treatment,0,1
218780,with,0,0
218781,coumarin,1,1
218782,to,0,0
218783,prevent,0,0
218784,or,0,0
218785,delay,0,0
218786,recurrence,0,0
218787,of,0,0
218788,malignant,0,0
218789,melanoma,0,0
218790,.,0,0
218791,Both,0,1
218792,coumarin,1,1
218793,(,1,1
218794,"1,2-benzopyrone",1,1
218795,),1,1
218796,and,1,1
218797,warfarin,1,1
218798,(,1,1
218799,4-hydroxycoumarin,1,1
218800,),1,1
218801,have,0,0
218802,been,0,0
218803,shown,0,0
218804,to,0,0
218805,prevent,0,0
218806,the,0,0
218807,recurrence,0,0
218808,of,0,0
218809,malignant,0,0
218810,melanoma,0,0
218811,.,0,0
218812,Their,0,0
218813,action,0,0
218814,is,0,0
218815,macrophage-dependent,0,0
218816,and,0,0
218817,the,0,0
218818,dosage,0,1
218819,is,0,0
218820,critical,0,0
218821,.,0,0
218822,In,0,0
218823,1984,0,0
218824,a,0,0
218825,multicentre,0,0
218826,",",0,0
218827,prospective,0,0
218828,",",0,0
218829,randomised,0,1
218830,",",0,1
218831,double-blind,0,1
218832,trial,0,1
218833,of,0,1
218834,coumarin,1,1
218835,",",0,1
218836,given,0,0
218837,as,0,0
218838,a,0,0
218839,daily,0,1
218840,50-mg,0,1
218841,dose,0,1
218842,for,0,1
218843,2,0,0
218844,years,0,0
218845,after,0,0
218846,surgery,0,0
218847,in,0,0
218848,patients,0,0
218849,with,0,0
218850,high-risk,0,0
218851,melanoma,0,0
218852,",",0,0
218853,was,0,0
218854,started,0,0
218855,.,0,0
218856,the,0,0
218857,patients,0,0
218858,had,0,0
218859,lesions,0,0
218860,greater,0,0
218861,than,0,0
218862,1.70,0,0
218863,mm,0,0
218864,thick,0,0
218865,and,0,0
218866,TNM,0,0
218867,stage,0,0
218868,IB,0,0
218869,or,0,0
218870,stage,0,0
218871,II,0,0
218872,disease,0,0
218873,.,0,0
218874,To,0,0
218875,date,0,0
218876,there,0,0
218877,are,0,0
218878,4,0,0
218879,recurrences,0,0
218880,in,0,0
218881,the,0,0
218882,coumarin-treated,0,0
218883,group,0,0
218884,of,0,0
218885,13,0,0
218886,patients,0,0
218887,",",0,0
218888,and,0,0
218889,10,0,0
218890,recurrences,0,0
218891,in,0,0
218892,the,0,0
218893,placebo-treated,0,0
218894,group,0,0
218895,of,0,0
218896,14,0,0
218897,patients,0,0
218898,(,0,0
218899,P,0,0
218900,<,0,0
218901,0.01,0,0
218902,),0,0
218903,.,0,0
218904,There,0,0
218905,were,0,0
218906,no,0,0
218907,toxic,0,0
218908,effects,0,0
218909,.,0,0
218910,Antifungal,0,0
218911,prophylaxis,0,0
218912,during,0,0
218913,remission,0,0
218914,induction,0,0
218915,therapy,0,0
218916,for,0,0
218917,acute,0,1
218918,leukemia,0,1
218919,fluconazole,0,1
218920,versus,1,1
218921,intravenous,1,1
218922,amphotericin,1,1
218923,B,1,1
218924,.,1,1
218925,BACKGROUND,0,0
218926,Fungal,0,1
218927,infection,0,0
218928,is,0,0
218929,a,0,0
218930,frequent,0,0
218931,and,0,0
218932,often,0,0
218933,fatal,0,0
218934,complication,0,0
218935,in,0,0
218936,patients,0,0
218937,undergoing,0,0
218938,remission,0,0
218939,induction,0,0
218940,therapy,0,0
218941,for,0,0
218942,acute,0,0
218943,leukemia,0,0
218944,.,0,0
218945,Although,0,0
218946,candidiasis,0,0
218947,is,0,0
218948,the,0,0
218949,most,0,0
218950,common,0,0
218951,infection,0,0
218952,",",0,0
218953,mold,0,0
218954,infections,0,0
218955,are,0,0
218956,increasing,0,0
218957,in,0,0
218958,frequency,0,0
218959,.,0,1
218960,Fluconazole,1,1
218961,(,1,1
218962,FLU,1,1
218963,),1,0
218964,is,0,0
218965,a,0,0
218966,new,0,0
218967,antifungal,0,1
218968,agent,0,0
218969,that,0,0
218970,has,0,0
218971,been,0,0
218972,used,0,0
218973,successfully,0,0
218974,to,0,0
218975,treat,0,0
218976,Candida,0,1
218977,infections,0,0
218978,and,0,0
218979,has,0,0
218980,modest,0,0
218981,activity,0,0
218982,against,0,0
218983,aspergillosis,0,0
218984,in,0,0
218985,animal,0,0
218986,models,0,0
218987,.,0,1
218988,Subtherapeutic,0,1
218989,doses,0,1
218990,of,0,1
218991,amphotericin,1,1
218992,B,1,1
218993,(,1,1
218994,AMB,1,1
218995,),1,0
218996,have,0,0
218997,been,0,0
218998,considered,0,0
218999,effective,0,0
219000,as,0,0
219001,prophylaxis,0,0
219002,in,0,0
219003,these,0,0
219004,patients,0,0
219005,.,0,0
219006,This,0,0
219007,study,0,0
219008,was,0,0
219009,designed,0,0
219010,to,0,0
219011,compare,0,0
219012,the,0,0
219013,efficacy,0,0
219014,and,0,0
219015,toxicity,0,0
219016,of,0,0
219017,these,0,0
219018,agents,0,0
219019,as,0,0
219020,antifungal,0,1
219021,prophylaxis,0,1
219022,.,0,0
219023,METHODS,0,0
219024,Adults,0,0
219025,with,0,0
219026,acute,0,0
219027,leukemia,0,0
219028,undergoing,0,0
219029,remission,0,0
219030,induction,0,0
219031,chemotherapy,0,0
219032,randomly,0,0
219033,were,0,0
219034,assigned,0,0
219035,to,0,0
219036,receive,1,1
219037,antifungal,1,1
219038,prophylaxis,1,1
219039,with,1,1
219040,AMB,1,1
219041,(,1,1
219042,0.5,1,1
219043,mg/kg,1,1
219044,three,1,0
219045,times,1,1
219046,weekly,1,1
219047,),1,1
219048,or,1,1
219049,FLU,1,1
219050,(,1,1
219051,400,1,1
219052,mg,1,1
219053,daily,1,1
219054,),1,1
219055,.,1,1
219056,Trimethoprim-sulfamethoxazole,1,1
219057,was,1,0
219058,administered,1,1
219059,as,1,0
219060,an,1,0
219061,antibacterial,1,1
219062,prophylaxis,1,1
219063,.,1,0
219064,Prophylaxis,1,0
219065,was,1,0
219066,continued,1,0
219067,until,1,0
219068,the,1,0
219069,patient,1,0
219070,achieved,1,0
219071,complete,1,0
219072,remission,1,0
219073,or,1,0
219074,was,1,0
219075,treated,1,0
219076,for,1,0
219077,8,1,0
219078,weeks,1,0
219079,without,1,0
219080,antileukemic,1,1
219081,response,1,0
219082,.,1,0
219083,Prophylaxis,0,0
219084,was,0,0
219085,discontinued,0,1
219086,if,0,0
219087,the,0,0
219088,patient,0,0
219089,experienced,0,0
219090,a,0,0
219091,possible,0,0
219092,or,0,0
219093,proven,0,0
219094,fungal,0,0
219095,infection,0,0
219096,or,0,0
219097,a,0,0
219098,serious,0,0
219099,toxicity,0,0
219100,.,0,0
219101,RESULTS,0,0
219102,Overall,0,0
219103,",",0,0
219104,58,0,0
219105,%,0,0
219106,of,0,0
219107,the,0,0
219108,36,0,0
219109,patients,0,0
219110,assigned,0,0
219111,to,0,0
219112,AMB,1,0
219113,successfully,0,0
219114,completed,0,0
219115,prophylaxis,0,0
219116,compared,0,0
219117,with,0,0
219118,80,0,0
219119,%,0,0
219120,of,0,0
219121,the,0,0
219122,41,0,0
219123,patients,0,0
219124,assigned,0,0
219125,to,0,0
219126,FLU,1,0
219127,(,0,0
219128,<,0,0
219129,0.05,0,0
219130,),0,0
219131,.,0,0
219132,Proven,0,0
219133,",",0,0
219134,probable,0,0
219135,",",0,0
219136,or,0,0
219137,possible,0,0
219138,fungal,0,0
219139,infections,0,0
219140,occurred,0,0
219141,in,0,0
219142,31,0,0
219143,%,0,0
219144,and,0,0
219145,17,0,0
219146,%,0,0
219147,of,0,0
219148,the,0,0
219149,patients,0,0
219150,",",0,0
219151,respectively,0,0
219152,.,0,0
219153,The,0,0
219154,risk,0,0
219155,of,0,0
219156,discontinuing,0,0
219157,prophylaxis,0,0
219158,due,0,0
219159,to,0,0
219160,fungal,0,0
219161,infection,0,0
219162,or,0,0
219163,toxicity,0,0
219164,increased,0,0
219165,with,0,0
219166,time,0,0
219167,in,0,0
219168,the,0,0
219169,study,0,0
219170,and,0,0
219171,was,0,0
219172,significantly,0,0
219173,greater,0,0
219174,for,0,0
219175,AMB,0,0
219176,(,0,0
219177,P,0,0
219178,=,0,0
219179,0.02,0,0
219180,),0,0
219181,.,0,0
219182,CONCLUSIONS,0,0
219183,At,0,1
219184,the,0,0
219185,dose,0,1
219186,used,0,0
219187,in,0,0
219188,this,0,0
219189,study,0,0
219190,",",0,0
219191,AMB,1,0
219192,was,0,0
219193,no,0,0
219194,more,0,0
219195,effective,0,0
219196,and,0,0
219197,was,0,0
219198,more,0,0
219199,toxic,0,0
219200,than,0,0
219201,FLU,1,0
219202,for,0,0
219203,prophylaxis,0,0
219204,of,0,0
219205,fungal,0,0
219206,infections,0,0
219207,in,0,0
219208,patients,0,0
219209,undergoing,0,0
219210,remission,0,0
219211,induction,0,0
219212,chemotherapy,0,0
219213,for,0,0
219214,acute,0,0
219215,leukemia,0,0
219216,.,0,0
219217,Evaluation,0,0
219218,of,0,0
219219,postural,0,0
219220,stability,0,0
219221,by,0,0
219222,computerised,1,0
219223,posturography,1,0
219224,following,0,0
219225,outpatient,0,0
219226,paediatric,1,0
219227,anaesthesia,1,0
219228,.,1,0
219229,Comparison,0,0
219230,of,0,0
219231,propofol/alfentanil/N2O,1,1
219232,anaesthesia,1,1
219233,with,1,1
219234,thiopentone/halothane/N2O,1,1
219235,anaesthesia,1,1
219236,.,1,0
219237,Simple,0,0
219238,clinical,0,0
219239,tests,0,0
219240,",",0,0
219241,like,0,0
219242,Romberg,0,0
219243,'s,0,0
219244,test,0,0
219245,or,0,0
219246,a,0,0
219247,walking,0,0
219248,test,0,0
219249,",",0,0
219250,have,0,0
219251,proved,0,0
219252,to,0,0
219253,be,0,0
219254,inadequate,0,0
219255,guidelines,0,0
219256,for,0,0
219257,safe,0,0
219258,discharge,0,0
219259,after,0,0
219260,outpatient,0,0
219261,anaesthesia,0,0
219262,.,0,0
219263,A,0,0
219264,randomised,0,0
219265,study,0,0
219266,was,0,0
219267,therefore,0,0
219268,planned,0,0
219269,to,0,0
219270,compare,0,0
219271,postural,0,0
219272,stability,0,0
219273,measured,0,0
219274,by,0,0
219275,computerised,0,0
219276,posturography,0,0
219277,in,0,0
219278,31,0,0
219279,oral,1,1
219280,midazolam-atropine,1,1
219281,premedicated,0,1
219282,children,0,1
219283,aged,0,0
219284,6.9,0,0
219285,(,0,0
219286,s.e,0,0
219287,.,0,0
219288,0.4,0,0
219289,),0,0
219290,years,0,0
219291,who,0,0
219292,had,0,0
219293,been,0,0
219294,anaesthetised,1,1
219295,with,0,1
219296,either,0,0
219297,propofol/alfentanil/N2O,1,1
219298,or,1,1
219299,thiopentone/halothane/N2O,1,1
219300,.,1,1
219301,The,0,0
219302,sway,0,0
219303,velocity,0,0
219304,of,0,0
219305,the,0,0
219306,children,0,0
219307,was,0,0
219308,measured,0,0
219309,before,0,0
219310,premedication,0,1
219311,and,0,0
219312,1,0,1
219313,",",0,0
219314,2,0,0
219315,and,0,0
219316,3,0,0
219317,h,0,0
219318,after,0,0
219319,the,0,0
219320,end,0,0
219321,of,0,0
219322,anaesthesia,0,0
219323,.,0,0
219324,Results,0,0
219325,show,0,0
219326,that,0,0
219327,sway,0,0
219328,velocity,0,0
219329,had,0,0
219330,returned,0,0
219331,to,0,0
219332,baseline,0,0
219333,values,0,0
219334,3,0,0
219335,h,0,0
219336,after,0,0
219337,the,0,0
219338,end,0,0
219339,of,0,0
219340,anaesthesia,0,0
219341,in,0,0
219342,all,0,0
219343,children,0,0
219344,who,0,0
219345,had,0,0
219346,received,0,0
219347,propofol/alfentanil/N2O,1,1
219348,and,0,1
219349,in,0,0
219350,12,0,0
219351,of,0,0
219352,the,0,0
219353,15,0,0
219354,children,0,0
219355,who,0,0
219356,had,0,0
219357,received,0,0
219358,thiopentone/halothane/N2O,1,1
219359,.,1,0
219360,The,0,0
219361,quantified,0,0
219362,version,0,0
219363,of,0,0
219364,the,0,0
219365,Romberg,0,0
219366,test,0,0
219367,performed,0,0
219368,with,0,0
219369,eyes,0,0
219370,open,0,0
219371,or,0,0
219372,closed,0,0
219373,was,0,0
219374,not,0,0
219375,impaired,0,0
219376,after,0,0
219377,anaesthesia,0,0
219378,",",0,0
219379,compared,0,0
219380,with,0,0
219381,the,0,0
219382,control,0,0
219383,values,0,0
219384,",",0,0
219385,indicating,0,0
219386,that,0,0
219387,in,0,0
219388,children,0,0
219389,poor,0,0
219390,equilibrium,0,0
219391,is,0,0
219392,not,0,0
219393,compensated,0,0
219394,by,0,0
219395,vision,0,0
219396,.,0,0
219397,The,0,0
219398,clinical,0,0
219399,recovery,0,0
219400,with,0,0
219401,respect,0,0
219402,to,0,0
219403,the,0,0
219404,times,0,0
219405,to,0,0
219406,eye,0,0
219407,opening,0,0
219408,",",0,0
219409,to,0,0
219410,responding,0,0
219411,to,0,0
219412,command,0,0
219413,or,0,0
219414,to,0,0
219415,being,0,0
219416,fully,0,0
219417,awake,0,0
219418,did,0,0
219419,not,0,0
219420,differ,0,0
219421,between,0,0
219422,the,0,0
219423,two,0,0
219424,anaesthesia,0,0
219425,methods,0,0
219426,.,0,0
219427,On,0,0
219428,the,0,0
219429,basis,0,0
219430,of,0,0
219431,recovery,0,0
219432,assessed,0,0
219433,by,0,0
219434,postural,0,0
219435,stability,0,0
219436,",",0,0
219437,propofol/alfentanil/N2O,1,1
219438,anaesthesia,1,1
219439,was,0,0
219440,not,0,0
219441,preferable,0,0
219442,to,0,0
219443,thiopentone/halothane/N2O,1,1
219444,anaesthesia,1,1
219445,after,0,0
219446,minor,0,0
219447,paediatric,0,0
219448,otolaryngological,1,0
219449,surgery,1,0
219450,.,1,0
219451,A,0,1
219452,double-blind,0,1
219453,comparison,0,0
219454,of,0,1
219455,oral,1,1
219456,ketoprofen,1,1
219457,'controlled,1,1
219458,release,1,0
219459,',1,0
219460,and,0,1
219461,indomethacin,1,1
219462,suppository,1,1
219463,in,0,0
219464,the,0,0
219465,treatment,0,0
219466,of,0,0
219467,rheumatoid,0,0
219468,arthritis,0,0
219469,with,0,0
219470,special,0,0
219471,regard,0,0
219472,to,0,0
219473,morning,0,0
219474,stiffness,0,0
219475,and,0,0
219476,pain,0,0
219477,on,0,0
219478,awakening,0,0
219479,.,0,0
219480,A,0,1
219481,double-blind,0,1
219482,",",0,1
219483,double-dummy,0,1
219484,",",0,1
219485,crossover,0,1
219486,study,0,0
219487,was,0,0
219488,carried,0,0
219489,out,0,0
219490,in,0,0
219491,8,0,0
219492,centres,0,0
219493,to,0,0
219494,compare,0,0
219495,the,0,0
219496,efficacy,0,0
219497,and,0,0
219498,tolerability,0,1
219499,of,0,1
219500,'controlled-release,1,1
219501,',1,1
219502,ketoprofen,1,1
219503,tablets,1,1
219504,(,0,1
219505,200,0,1
219506,mg,0,1
219507,),0,1
219508,with,0,0
219509,that,0,0
219510,of,0,0
219511,indomethacin,1,1
219512,suppositories,1,1
219513,(,0,1
219514,100,0,1
219515,mg,0,1
219516,),0,1
219517,in,0,0
219518,out-patients,0,0
219519,with,0,0
219520,definite,0,0
219521,or,0,0
219522,classical,0,0
219523,rheumatoid,0,0
219524,arthritis,0,0
219525,.,0,0
219526,Patients,0,0
219527,were,0,0
219528,allocated,0,0
219529,at,0,0
219530,random,0,0
219531,to,0,0
219532,receive,0,0
219533,a,0,0
219534,daily,0,1
219535,bedtime,0,1
219536,dose,0,1
219537,of,0,1
219538,either,0,0
219539,1,0,1
219540,ketoprofen,1,1
219541,tablet,0,1
219542,or,0,1
219543,1,0,1
219544,indomethacin,1,1
219545,suppository,1,1
219546,plus,0,0
219547,the,0,0
219548,dummy,0,0
219549,of,0,0
219550,the,0,0
219551,other,0,0
219552,formulation,0,1
219553,for,0,0
219554,a,0,0
219555,period,0,0
219556,of,0,0
219557,3,0,0
219558,weeks,0,0
219559,.,0,0
219560,They,0,0
219561,were,0,0
219562,then,0,0
219563,crossed,0,0
219564,over,0,0
219565,to,0,0
219566,the,0,0
219567,alternative,0,0
219568,treatment,0,0
219569,for,0,0
219570,a,0,0
219571,further,0,0
219572,3,0,0
219573,weeks,0,0
219574,.,0,0
219575,Daily,0,0
219576,diary,0,0
219577,records,0,0
219578,were,0,0
219579,kept,0,0
219580,by,0,0
219581,patients,0,0
219582,of,0,0
219583,the,0,0
219584,number,0,0
219585,of,0,0
219586,night-time,0,0
219587,awakenings,0,0
219588,due,0,0
219589,to,0,0
219590,pain,0,0
219591,",",0,0
219592,pain,0,0
219593,severity,0,0
219594,at,0,0
219595,awakening,0,0
219596,in,0,0
219597,the,0,0
219598,morning,0,0
219599,and,0,0
219600,the,0,0
219601,duration,0,0
219602,of,0,0
219603,early,0,0
219604,morning,0,0
219605,stiffness,0,0
219606,.,0,0
219607,Treatment,0,0
219608,efficacy,0,0
219609,was,0,0
219610,also,0,0
219611,assessed,0,0
219612,at,0,0
219613,the,0,0
219614,end,0,0
219615,of,0,0
219616,each,0,0
219617,trial,0,0
219618,period,0,0
219619,by,0,0
219620,means,0,0
219621,of,0,0
219622,an,0,0
219623,articular,0,0
219624,index,0,0
219625,and,0,0
219626,by,0,0
219627,physician,0,0
219628,'s,0,0
219629,and,0,0
219630,patient,0,0
219631,'s,0,0
219632,overall,0,0
219633,evaluation,0,0
219634,of,0,0
219635,response,0,0
219636,.,0,0
219637,Adverse,0,0
219638,effects,0,0
219639,spontaneously,0,0
219640,mentioned,0,0
219641,by,0,0
219642,the,0,0
219643,patients,0,0
219644,or,0,0
219645,elicited,0,0
219646,by,0,0
219647,direct,0,0
219648,questioning,0,0
219649,using,0,0
219650,a,0,0
219651,symptom,0,0
219652,check-list,0,0
219653,were,0,0
219654,recorded,0,0
219655,.,0,0
219656,Statistical,0,0
219657,analysis,0,0
219658,of,0,0
219659,the,0,0
219660,results,0,0
219661,from,0,0
219662,83,0,0
219663,evaluable,0,0
219664,patients,0,0
219665,showed,0,0
219666,that,0,0
219667,the,0,0
219668,'controlled-release,0,1
219669,',0,1
219670,tablet,0,1
219671,formulation,0,1
219672,of,0,1
219673,200,0,1
219674,mg,0,1
219675,ketoprofen,1,1
219676,was,0,0
219677,equally,0,0
219678,as,0,0
219679,effective,0,0
219680,as,0,0
219681,the,0,0
219682,100,0,1
219683,mg,0,1
219684,indomethacin,1,1
219685,suppository,1,1
219686,in,0,0
219687,the,0,0
219688,treatment,0,0
219689,of,0,0
219690,rheumatoid,0,0
219691,arthritis,0,0
219692,",",0,0
219693,especially,0,0
219694,with,0,0
219695,regard,0,0
219696,to,0,0
219697,pain,0,0
219698,at,0,0
219699,awakening,0,0
219700,and,0,0
219701,morning,0,0
219702,stiffness,0,0
219703,.,0,0
219704,Side-effects,0,0
219705,in,0,0
219706,both,0,0
219707,groups,0,0
219708,were,0,0
219709,those,0,0
219710,commonly,0,0
219711,seen,0,0
219712,with,0,1
219713,non-steroidal,0,1
219714,anti-inflammatory,0,1
219715,drugs,0,1
219716,and,0,1
219717,",",0,0
219718,as,0,0
219719,expected,0,0
219720,",",0,0
219721,gastro-intestinal,0,0
219722,and,0,0
219723,CNS,0,0
219724,disturbances,0,0
219725,predominated,0,0
219726,.,0,0
219727,Overall,0,0
219728,",",0,0
219729,side-effects,0,0
219730,were,0,0
219731,fewer,0,0
219732,with,0,0
219733,ketoprofen,1,1
219734,than,0,1
219735,with,0,1
219736,indomethacin,1,1
219737,.,1,0
219738,Deficiency,0,0
219739,of,0,0
219740,serum,0,1
219741,ionized,0,1
219742,magnesium,0,1
219743,in,0,0
219744,patients,0,0
219745,receiving,0,0
219746,hemodialysis,0,0
219747,or,0,0
219748,peritoneal,0,0
219749,dialysis,0,0
219750,.,0,0
219751,Serum,0,0
219752,total,0,0
219753,magnesium,0,1
219754,(,0,1
219755,TMg,0,1
219756,),0,0
219757,measurements,0,0
219758,in,0,0
219759,dialysis,0,0
219760,patients,0,0
219761,are,0,0
219762,variable,0,0
219763,",",0,0
219764,with,0,0
219765,some,0,0
219766,groups,0,0
219767,reporting,0,1
219768,hypermagnesemia,0,1
219769,and,0,1
219770,some,0,0
219771,hypomagnesemia,0,1
219772,.,0,0
219773,It,0,0
219774,had,0,0
219775,not,0,0
219776,been,0,0
219777,possible,0,0
219778,to,0,0
219779,measure,0,0
219780,the,0,0
219781,biologically,0,0
219782,active,0,0
219783,fraction,0,0
219784,",",0,0
219785,ionized,0,1
219786,magnesium,0,1
219787,(,0,1
219788,IMg2+,0,1
219789,),0,1
219790,.,0,0
219791,The,0,0
219792,authors,0,0
219793,utilized,0,0
219794,an,0,0
219795,ion-selective,0,1
219796,electrode,0,0
219797,to,0,0
219798,measure,0,0
219799,IMg,0,0
219800,in,0,0
219801,26,0,0
219802,hemodialysis,0,0
219803,patients,0,0
219804,and,0,0
219805,10,0,0
219806,peritoneal,0,1
219807,dialysis,0,1
219808,(,0,1
219809,CAPD,0,1
219810,),0,1
219811,patients,0,0
219812,and,0,0
219813,compared,0,0
219814,the,0,0
219815,results,0,0
219816,with,0,0
219817,those,0,0
219818,from,0,0
219819,66,0,0
219820,age,0,0
219821,matched,0,0
219822,control,0,0
219823,subjects,0,0
219824,.,0,0
219825,Dialysate,1,1
219826,magnesium,1,1
219827,was,0,0
219828,0.375,0,0
219829,mM/L,0,0
219830,for,0,0
219831,the,0,0
219832,hemodialysis,0,0
219833,and,0,0
219834,0.25,0,0
219835,mM/L,0,0
219836,for,0,0
219837,the,0,0
219838,CAPD,0,0
219839,patients,0,0
219840,.,0,0
219841,When,0,0
219842,compared,0,0
219843,with,0,0
219844,control,0,0
219845,subjects,0,0
219846,",",0,0
219847,both,0,0
219848,hemodialysis,0,0
219849,and,0,0
219850,CAPD,0,0
219851,patients,0,0
219852,had,0,0
219853,significantly,0,0
219854,lower,0,0
219855,IMg2+,0,0
219856,(,0,0
219857,0.55,0,0
219858,+/-,0,0
219859,0.02,0,0
219860,and,0,0
219861,0.50,0,0
219862,+/-,0,0
219863,0.02,0,0
219864,vs.,0,0
219865,0.60,0,0
219866,+/-,0,0
219867,0.004,0,0
219868,mM/L,0,0
219869,;,0,0
219870,p,0,0
219871,<,0,0
219872,0.05,0,0
219873,),0,0
219874,and,0,0
219875,greater,0,0
219876,or,0,0
219877,normal,0,0
219878,TMg,0,0
219879,values,0,0
219880,(,0,0
219881,0.99,0,0
219882,+/-,0,0
219883,0.04,0,0
219884,",",0,0
219885,different,0,0
219886,at,0,0
219887,the,0,0
219888,p,0,0
219889,<,0,0
219890,0.001,0,0
219891,level,0,0
219892,",",0,0
219893,and,0,0
219894,0.85,0,0
219895,+/-,0,0
219896,0.04,0,0
219897,vs.,0,0
219898,0.84,0,0
219899,+/-,0,0
219900,0.008,0,0
219901,),0,0
219902,.,0,0
219903,Ionized,0,0
219904,calcium,0,1
219905,(,0,1
219906,ICa2+,0,1
219907,),0,0
219908,values,0,0
219909,were,0,0
219910,similar,0,0
219911,for,0,0
219912,all,0,0
219913,three,0,0
219914,groups,0,0
219915,(,0,0
219916,1.15,0,0
219917,+/-,0,0
219918,0.02,0,0
219919,and,0,0
219920,1.21,0,0
219921,+/-,0,0
219922,0.04,0,0
219923,vs.,0,0
219924,1.17,0,0
219925,+/-,0,0
219926,0.01,0,0
219927,),0,0
219928,",",0,0
219929,resulting,0,0
219930,in,0,0
219931,increased,0,0
219932,mean,0,0
219933,ICa2+/IMg2+,0,0
219934,ratios,0,0
219935,(,0,0
219936,2.14,0,0
219937,+/-,0,0
219938,0.07,0,0
219939,and,0,0
219940,2.42,0,0
219941,+/-,0,0
219942,0.06,0,0
219943,vs.,0,0
219944,1.95,0,0
219945,+/-,0,0
219946,0.02,0,0
219947,for,0,0
219948,the,0,0
219949,control,0,0
219950,subjects,0,0
219951,;,0,0
219952,p,0,0
219953,<,0,0
219954,0.05,0,0
219955,),0,0
219956,.,0,0
219957,The,0,0
219958,percent,0,0
219959,of,0,0
219960,total,0,0
219961,magnesium,0,1
219962,that,0,0
219963,was,0,0
219964,ionized,0,0
219965,(,0,0
219966,%,0,0
219967,IMg2+,0,0
219968,),0,0
219969,was,0,0
219970,low,0,0
219971,in,0,0
219972,both,0,0
219973,the,0,0
219974,hemodialysis,0,0
219975,and,0,0
219976,CAPD,0,1
219977,patients,0,0
219978,(,0,0
219979,55.6,0,0
219980,+/-,0,0
219981,0.93,0,0
219982,and,0,0
219983,59.2,0,0
219984,+/-,0,0
219985,1.05,0,0
219986,),0,0
219987,compared,0,0
219988,with,0,0
219989,that,0,0
219990,of,0,0
219991,control,0,0
219992,subjects,0,0
219993,(,0,0
219994,72,0,0
219995,+/-,0,0
219996,0.61,0,0
219997,;,0,0
219998,p,0,0
219999,<,0,0
220000,0.05,0,0
220001,),0,0
220002,.,0,0
220003,IMg2+,0,0
220004,values,0,0
220005,correlated,0,0
220006,with,0,0
220007,TMg,0,0
220008,values,0,0
220009,in,0,0
220010,both,0,0
220011,hemodialysis,0,1
220012,(,0,0
220013,r,0,0
220014,=,0,0
220015,0.93,0,0
220016,;,0,0
220017,p,0,0
220018,<,0,0
220019,0.0001,0,0
220020,),0,0
220021,and,0,0
220022,CAPD,0,1
220023,(,0,0
220024,r,0,0
220025,=,0,0
220026,0.92,0,0
220027,;,0,0
220028,p,0,0
220029,<,0,0
220030,0.0001,0,0
220031,),0,0
220032,patients,0,0
220033,did,0,0
220034,not,0,0
220035,correlate,0,0
220036,with,0,0
220037,age,0,0
220038,",",0,0
220039,time,0,0
220040,on,0,0
220041,dialysis,0,0
220042,",",0,0
220043,weight,0,1
220044,",",0,1
220045,fasting,0,1
220046,cholesterol,0,1
220047,or,0,1
220048,triglyceride,0,1
220049,",",0,1
220050,albumin,0,1
220051,",",0,1
220052,blood,0,1
220053,urea,0,1
220054,nitrogen,0,1
220055,(,0,1
220056,BUN,0,1
220057,),0,1
220058,",",0,1
220059,creatinine,0,1
220060,",",0,1
220061,hematocrit,0,1
220062,",",0,0
220063,phosphate,0,1
220064,",",0,0
220065,or,0,0
220066,PTH,0,0
220067,values,0,0
220068,.,0,0
220069,(,0,0
220070,ABSTRACT,0,1
220071,TRUNCATED,0,1
220072,AT,0,1
220073,250,0,1
220074,WORDS,0,1
220075,),0,1
220076,Noradrenergic,0,1
220077,response,0,1
220078,to,0,1
220079,intravenous,1,1
220080,yohimbine,1,1
220081,in,0,0
220082,patients,0,0
220083,with,0,0
220084,depression,0,0
220085,and,0,0
220086,comorbidity,0,0
220087,of,0,0
220088,depression,0,0
220089,and,0,0
220090,panic,0,0
220091,.,0,0
220092,Adrenergic,0,1
220093,response,0,0
220094,following,0,0
220095,infusions,0,1
220096,of,0,1
220097,yohimbine,1,1
220098,or,1,1
220099,normal,1,1
220100,saline,1,1
220101,was,0,0
220102,evaluated,0,0
220103,in,0,0
220104,9,0,0
220105,control,0,0
220106,subjects,0,0
220107,",",0,0
220108,8,0,0
220109,patients,0,0
220110,suffering,0,0
220111,from,0,0
220112,a,0,0
220113,major,0,0
220114,depressive,0,0
220115,episode,0,1
220116,(,0,1
220117,MDE,0,1
220118,),0,1
220119,",",0,0
220120,and,0,0
220121,12,0,0
220122,patients,0,0
220123,suffering,0,0
220124,from,0,0
220125,concurrent,0,0
220126,MDE,0,0
220127,and,0,0
220128,panic,0,1
220129,disorder,0,1
220130,(,0,1
220131,MDE,0,0
220132,+,0,0
220133,P,0,0
220134,),0,0
220135,.,0,0
220136,Blood,0,0
220137,was,0,0
220138,drawn,0,0
220139,at,0,0
220140,-20,0,0
220141,",",0,0
220142,0,0,0
220143,",",0,0
220144,5,0,0
220145,",",0,0
220146,10,0,0
220147,",",0,0
220148,20,0,0
220149,",",0,0
220150,45,0,0
220151,",",0,0
220152,and,0,0
220153,90,0,0
220154,min,0,0
220155,following,0,0
220156,the,0,0
220157,infusions,0,1
220158,",",0,0
220159,and,0,0
220160,assayed,0,0
220161,for,0,0
220162,norepinephrine,0,1
220163,(,0,1
220164,NE,0,1
220165,),0,1
220166,and,0,1
220167,3-methoxy-4-hydroxy-phenyl,0,1
220168,glycol,0,1
220169,(,0,1
220170,MHPG,0,1
220171,),0,1
220172,.,0,0
220173,Although,0,0
220174,the,0,0
220175,patient,0,0
220176,groups,0,0
220177,exhibited,0,0
220178,higher,0,0
220179,baseline,0,0
220180,NE,0,1
220181,concentrations,0,1
220182,",",0,0
220183,and,0,0
220184,a,0,0
220185,greater,0,0
220186,NE,0,0
220187,area,0,0
220188,under,0,0
220189,the,0,0
220190,plasma,0,0
220191,concentration,0,0
220192,versus,0,0
220193,time,0,0
220194,curve,0,1
220195,(,0,1
220196,AUC0-90,0,1
220197,),0,0
220198,during,0,0
220199,the,0,1
220200,yohimbine,1,1
220201,infusion,0,1
220202,",",0,1
220203,the,0,0
220204,differences,0,0
220205,were,0,0
220206,not,0,0
220207,statistically,0,0
220208,significant,0,0
220209,.,0,0
220210,Baseline,0,0
220211,NE,0,0
220212,was,0,0
220213,significantly,0,0
220214,correlated,0,0
220215,with,0,0
220216,the,0,0
220217,NE,0,0
220218,AUC0-90,0,0
220219,in,0,0
220220,all,0,0
220221,three,0,0
220222,groups,0,0
220223,",",0,0
220224,suggesting,0,0
220225,that,0,0
220226,",",0,0
220227,although,0,0
220228,the,0,0
220229,NE,0,0
220230,system,0,0
220231,may,0,0
220232,be,0,0
220233,dysregulated,0,0
220234,in,0,0
220235,the,0,0
220236,MDE,0,0
220237,and,0,0
220238,MDE,0,0
220239,+,0,0
220240,P,0,0
220241,patients,0,0
220242,",",0,0
220243,the,0,0
220244,NE,0,0
220245,system,0,0
220246,still,0,0
220247,appears,0,0
220248,to,0,0
220249,respond,0,0
220250,somewhat,0,0
220251,predictably,0,0
220252,following,0,0
220253,a,0,0
220254,challenge,0,0
220255,",",0,0
220256,even,0,0
220257,though,0,0
220258,the,0,0
220259,actual,0,0
220260,magnitude,0,0
220261,of,0,0
220262,response,0,0
220263,may,0,0
220264,vary,0,0
220265,.,0,0
220266,[,0,0
220267,Opiate,0,0
220268,hypothesis,0,0
220269,in,0,0
220270,infantile,0,0
220271,autism,0,0
220272,?,0,1
220273,Therapeutic,0,0
220274,trials,0,1
220275,with,0,1
220276,naltrexone,1,1
220277,],1,1
220278,.,0,1
220279,The,0,0
220280,opioid,0,1
220281,hypothesis,0,0
220282,suggests,0,0
220283,that,0,0
220284,childhood,0,0
220285,autism,0,0
220286,may,0,0
220287,result,0,0
220288,from,0,0
220289,excessive,0,0
220290,brain,0,0
220291,opioid,0,1
220292,activity,0,0
220293,during,0,0
220294,neonatal,0,0
220295,period,0,0
220296,which,0,0
220297,may,0,0
220298,constitutionally,0,0
220299,inhibit,0,0
220300,social,0,0
220301,motivation,0,0
220302,",",0,0
220303,yielding,0,0
220304,autistic,0,0
220305,isolation,0,0
220306,and,0,0
220307,aloofness,0,1
220308,(,0,0
220309,Panksepp,0,1
220310,",",0,1
220311,1979,0,1
220312,),0,0
220313,.,0,0
220314,This,0,0
220315,hypothesis,0,0
220316,has,0,0
220317,now,0,0
220318,received,0,0
220319,strong,0,0
220320,support,0,0
220321,and,0,0
220322,is,0,0
220323,currently,0,0
220324,based,0,0
220325,on,0,0
220326,three,0,0
220327,types,0,0
220328,of,0,0
220329,arguments,0,0
220330,:,0,0
220331,(,0,0
220332,1,0,0
220333,),0,0
220334,similarity,0,0
220335,between,0,0
220336,autistic,0,0
220337,symptomatology,0,0
220338,and,0,0
220339,abnormal,0,0
220340,behaviors,0,0
220341,induced,0,0
220342,in,0,0
220343,young,0,0
220344,animals,0,0
220345,by,0,0
220346,injections,0,1
220347,of,0,0
220348,exogenous,0,0
220349,opioids,0,1
220350,",",0,0
220351,such,0,0
220352,as,0,0
220353,increasing,0,0
220354,social,0,0
220355,aloofness,0,0
220356,and,0,0
220357,decreasing,0,0
220358,social,0,1
220359,vocalization,0,1
220360,;,0,1
220361,(,0,1
220362,2,0,1
220363,),0,0
220364,direct,0,0
220365,biochemical,0,0
220366,evidence,0,0
220367,of,0,0
220368,abnormalities,0,0
220369,of,0,0
220370,peripheral,0,0
220371,endogenous,0,0
220372,opioids,0,1
220373,being,0,0
220374,reported,0,0
220375,in,0,0
220376,autism,0,0
220377,and,0,0
220378,(,0,1
220379,3,0,1
220380,),0,0
220381,therapeutic,0,0
220382,effects,0,0
220383,of,0,0
220384,the,0,0
220385,long,0,0
220386,lasting,0,0
220387,opioid,0,1
220388,receptor,0,0
220389,blocking,0,0
220390,agent,0,0
220391,naltrexone,0,1
220392,in,0,0
220393,autism,0,0
220394,.,0,0
220395,In,0,0
220396,this,0,0
220397,article,0,0
220398,",",0,0
220399,we,0,0
220400,give,0,0
220401,description,0,0
220402,of,0,0
220403,open,0,0
220404,and,0,0
220405,double-blind,0,1
220406,studies,0,0
220407,of,0,0
220408,naltrexone,1,1
220409,in,0,0
220410,autism,0,1
220411,.,0,0
220412,Naltrexone,1,1
220413,has,0,0
220414,been,0,0
220415,tested,0,0
220416,in,0,0
220417,several,0,0
220418,open,0,0
220419,studies,0,0
220420,.,0,0
220421,We,0,0
220422,performed,0,0
220423,an,0,0
220424,open,0,0
220425,trial,0,1
220426,with,0,0
220427,naltrexone,1,1
220428,in,0,0
220429,2,0,0
220430,autistic,0,0
220431,girls,0,0
220432,",",0,0
220433,displaying,0,0
220434,serious,0,0
220435,self-injurious,0,0
220436,behavior,0,0
220437,",",0,0
220438,reduced,0,0
220439,crying,0,0
220440,and,0,0
220441,a,0,0
220442,marked,0,0
220443,preference,0,0
220444,for,0,0
220445,salty,0,1
220446,and,0,1
220447,spicy,0,1
220448,foods,0,0
220449,",",0,0
220450,symptoms,0,0
220451,that,0,0
220452,could,0,0
220453,be,0,0
220454,related,0,0
220455,to,0,0
220456,a,0,0
220457,dysfunction,0,0
220458,of,0,0
220459,the,0,0
220460,opioid,0,1
220461,system,0,0
220462,.,0,0
220463,With,0,0
220464,dosages,0,1
220465,of,0,1
220466,1,0,1
220467,mg/kg/day,0,1
220468,",",0,0
220469,we,0,0
220470,observed,0,0
220471,an,0,0
220472,immediate,0,0
220473,reduction,0,0
220474,of,0,0
220475,hyperactivity,0,0
220476,",",0,0
220477,self-injurious,0,0
220478,behavior,0,0
220479,and,0,0
220480,aggressiveness,0,0
220481,",",0,0
220482,while,0,0
220483,attention,0,0
220484,improved,0,0
220485,.,0,0
220486,In,0,0
220487,addition,0,0
220488,",",0,0
220489,social,0,0
220490,behaviors,0,1
220491,",",0,0
220492,smiling,0,0
220493,",",0,0
220494,social,0,1
220495,seeking,0,1
220496,behaviors,0,1
220497,and,0,0
220498,play,0,0
220499,interactions,0,0
220500,increased,0,0
220501,(,0,0
220502,Leboyer,0,1
220503,",",0,0
220504,Bouvard,0,1
220505,et,0,1
220506,Dugas,0,1
220507,",",0,1
220508,1988,0,1
220509,),0,0
220510,.,0,0
220511,Campbell,0,1
220512,et,0,1
220513,al,0,1
220514,.,0,1
220515,(,0,1
220516,1988,0,1
220517,),0,0
220518,has,0,0
220519,also,0,0
220520,reported,0,0
220521,a,0,0
220522,tranquilizing,0,1
220523,and,0,0
220524,a,0,0
220525,stimulating,0,0
220526,effect,0,0
220527,in,0,0
220528,6,0,0
220529,out,0,0
220530,of,0,0
220531,8,0,0
220532,children,0,0
220533,with,0,0
220534,autism,0,0
220535,.,0,0
220536,We,0,0
220537,did,0,0
220538,confirm,0,0
220539,these,0,0
220540,preliminary,0,0
220541,results,0,0
220542,in,0,0
220543,a,0,0
220544,double-blind,0,1
220545,study,0,0
220546,performed,0,0
220547,on,0,0
220548,4,0,0
220549,children,0,0
220550,with,0,0
220551,autism,0,0
220552,.,0,0
220553,In,0,0
220554,a,0,0
220555,cross-over,0,1
220556,double-blind,0,1
220557,study,0,1
220558,",",0,0
220559,three,0,0
220560,dosages,0,1
220561,of,0,1
220562,naltrexone,0,1
220563,(,0,1
220564,0.5,0,1
220565,",",0,0
220566,1,0,0
220567,and,0,0
220568,2,0,1
220569,mg/kg/day,0,1
220570,),0,1
220571,and,0,1
220572,placebo,0,1
220573,were,0,0
220574,compared,0,0
220575,.,0,0
220576,(,0,0
220577,ABSTRACT,0,1
220578,TRUNCATED,0,1
220579,AT,0,1
220580,250,0,1
220581,WORDS,0,1
220582,),0,1
220583,Enoxaparin,1,1
220584,in,0,1
220585,the,0,0
220586,prevention,0,0
220587,of,0,0
220588,deep,0,0
220589,venous,0,0
220590,thrombosis,0,0
220591,after,0,0
220592,major,0,0
220593,surgery,0,0
220594,:,0,0
220595,multicentric,0,0
220596,study,0,0
220597,.,0,0
220598,The,0,0
220599,Italian,0,0
220600,Study,0,0
220601,Group,0,0
220602,.,0,0
220603,DVT,0,0
220604,is,0,0
220605,a,0,0
220606,very,0,0
220607,frequent,0,0
220608,complication,0,0
220609,of,0,0
220610,general,0,0
220611,surgery,0,0
220612,.,0,0
220613,Heparin,0,1
220614,and,0,0
220615,",",0,0
220616,more,0,0
220617,recently,0,0
220618,",",0,0
220619,LMWHs,1,0
220620,can,0,0
220621,successfully,0,0
220622,prevent,0,0
220623,post,0,0
220624,surgical,0,0
220625,thromboembolism,0,0
220626,.,0,0
220627,One,0,0
220628,thousand,0,0
220629,one,0,0
220630,hundred,0,0
220631,and,0,0
220632,twenty-two,0,0
220633,patients,0,0
220634,(,0,0
220635,533,0,0
220636,males,0,0
220637,and,0,0
220638,589,0,0
220639,females,0,0
220640,;,0,0
220641,mean,0,0
220642,age,0,0
220643,62.2,0,0
220644,+/-,0,0
220645,11.4,0,0
220646,yrs,0,0
220647,),0,0
220648,were,0,0
220649,enrolled,0,0
220650,in,0,0
220651,a,0,0
220652,multicentre,0,0
220653,controlled,0,0
220654,study,0,0
220655,",",0,0
220656,to,0,0
220657,evaluate,0,0
220658,the,0,0
220659,efficacy,0,0
220660,and,0,0
220661,safety,0,0
220662,of,0,0
220663,enoxaparin,1,1
220664,in,0,0
220665,comparison,0,0
220666,to,0,0
220667,calcium,1,1
220668,heparin,1,1
220669,in,0,1
220670,the,0,0
220671,prevention,0,0
220672,of,0,0
220673,deep,0,0
220674,venous,0,1
220675,thrombosis,0,1
220676,(,0,1
220677,DVT,0,1
220678,),0,0
220679,following,0,0
220680,general,0,0
220681,surgery,0,0
220682,.,0,0
220683,Patients,0,0
220684,assigned,0,0
220685,to,0,0
220686,the,0,0
220687,enoxaparin,1,1
220688,and,0,1
220689,the,0,1
220690,calcium,1,1
220691,heparin,1,1
220692,groups,0,1
220693,received,0,0
220694,1,0,1
220695,daily,0,1
220696,dose,0,1
220697,of,0,1
220698,20,0,1
220699,mg,0,1
220700,(,0,1
220701,2000,0,1
220702,I.U,0,1
220703,.,0,1
220704,),0,0
220705,and,0,0
220706,2,0,1
220707,daily,0,1
220708,doses,0,1
220709,of,0,0
220710,0.2,0,0
220711,ml,0,0
220712,(,0,0
220713,5000,0,0
220714,I.U,0,1
220715,.,0,1
220716,),0,0
220717,",",0,0
220718,respectively,0,0
220719,starting,0,0
220720,2,0,0
220721,hours,0,0
220722,before,0,0
220723,the,0,0
220724,operation,0,0
220725,.,0,0
220726,Both,0,0
220727,drugs,0,1
220728,were,0,0
220729,given,0,0
220730,by,0,0
220731,subcutaneous,0,1
220732,route,0,0
220733,.,0,0
220734,A,0,0
220735,Doppler,0,0
220736,or,0,0
220737,Duplex,0,0
220738,Scan,0,0
220739,diagnosis,0,0
220740,of,0,0
220741,DVT,0,0
220742,was,0,0
220743,made,0,0
220744,in,0,0
220745,3,0,0
220746,(,0,0
220747,0.5,0,0
220748,%,0,0
220749,),0,0
220750,patients,0,0
220751,in,0,0
220752,the,0,0
220753,enoxaparin,1,1
220754,group,0,1
220755,(,0,0
220756,2,0,0
220757,cases,0,0
220758,during,0,0
220759,treatment,0,0
220760,and,0,0
220761,1,0,0
220762,patient,0,0
220763,at,0,0
220764,the,0,0
220765,end,0,0
220766,of,0,0
220767,treatment,0,0
220768,),0,0
220769,and,0,0
220770,in,0,0
220771,6,0,0
220772,(,0,0
220773,1.1,0,0
220774,%,0,0
220775,),0,0
220776,patients,0,0
220777,in,0,0
220778,the,0,0
220779,calcium,1,1
220780,heparin,1,1
220781,group,0,1
220782,(,0,0
220783,5,0,0
220784,cases,0,0
220785,during,0,0
220786,treatment,0,0
220787,and,0,0
220788,1,0,0
220789,",",0,0
220790,bilateral,0,0
220791,",",0,0
220792,after,0,0
220793,the,0,0
220794,end,0,0
220795,of,0,0
220796,treatment,0,0
220797,),0,0
220798,.,0,0
220799,Pulmonary,0,1
220800,embolism,0,1
220801,(,0,1
220802,PE,0,1
220803,),0,0
220804,was,0,0
220805,ascertained,0,0
220806,by,0,0
220807,angiography,0,0
220808,in,0,0
220809,1,0,0
220810,patient,0,0
220811,(,0,0
220812,0.18,0,0
220813,%,0,0
220814,),0,0
220815,in,0,0
220816,the,0,0
220817,enoxaparin,1,1
220818,group,0,0
220819,and,0,0
220820,in,0,0
220821,2,0,0
220822,patients,0,0
220823,(,0,0
220824,0.36,0,0
220825,%,0,0
220826,),0,0
220827,in,0,0
220828,the,0,1
220829,calcium,1,1
220830,heparin,1,1
220831,one,0,1
220832,.,0,0
220833,Hemorrhagic,0,0
220834,complications,0,0
220835,occurred,0,0
220836,in,0,0
220837,29,0,0
220838,patients,0,0
220839,(,0,0
220840,5.2,0,0
220841,%,0,0
220842,),0,0
220843,in,0,0
220844,the,0,0
220845,enoxaparin,1,1
220846,group,0,0
220847,and,0,0
220848,in,0,0
220849,34,0,0
220850,(,0,0
220851,6.1,0,0
220852,%,0,0
220853,),0,0
220854,in,0,0
220855,the,0,1
220856,calcium,1,1
220857,heparin,1,1
220858,group,0,1
220859,.,0,0
220860,Haematomas,0,0
220861,located,0,0
220862,in,0,0
220863,the,0,0
220864,injection,0,1
220865,site,0,0
220866,were,0,0
220867,reported,0,0
220868,in,0,0
220869,16.1,0,0
220870,%,0,0
220871,and,0,0
220872,25.3,0,0
220873,%,0,0
220874,in,0,0
220875,the,0,0
220876,enoxaparin,1,1
220877,and,0,1
220878,calcium,1,1
220879,heparin,1,1
220880,groups,0,1
220881,respectively,0,0
220882,(,0,0
220883,p,0,0
220884,=,0,0
220885,0.0001,0,0
220886,),0,0
220887,.,0,0
220888,Local,0,0
220889,pain,0,0
220890,in,0,0
220891,the,0,0
220892,injection,0,1
220893,site,0,0
220894,at,0,0
220895,the,0,0
220896,5th,0,0
220897,day,0,0
220898,of,0,0
220899,treatment,0,0
220900,was,0,0
220901,reported,0,0
220902,in,0,0
220903,8.4,0,0
220904,%,0,0
220905,and,0,0
220906,16.6,0,0
220907,%,0,0
220908,in,0,0
220909,the,0,0
220910,enoxaparin,0,1
220911,and,0,1
220912,calcium,0,1
220913,heparin,0,1
220914,groups,0,1
220915,respectively,0,0
220916,(,0,0
220917,p,0,0
220918,=,0,0
220919,0.0001,0,0
220920,),0,0
220921,.,0,0
220922,(,0,0
220923,ABSTRACT,0,1
220924,TRUNCATED,0,1
220925,AT,0,1
220926,250,0,1
220927,WORDS,0,1
220928,),0,1
220929,[,0,1
220930,Hemostatic,0,0
220931,balance,0,0
220932,during,0,0
220933,treatment,0,0
220934,with,0,0
220935,the,0,0
220936,newest,0,0
220937,contraceptives,0,1
220938,],0,0
220939,.,0,0
220940,Thirty-four,0,0
220941,healthy,0,0
220942,young,0,0
220943,women,0,0
220944,were,0,0
220945,allocated,1,0
220946,to,1,0
220947,12,1,0
220948,consecutive,1,0
220949,cycles,1,0
220950,of,1,0
220951,treatment,1,0
220952,with,1,0
220953,monophasic,1,1
220954,combinations,1,0
220955,of,1,0
220956,:,1,0
220957,20,1,0
220958,micrograms,1,1
220959,ethinyl,1,1
220960,estradiol,1,1
220961,and,1,1
220962,150,1,1
220963,micrograms,1,1
220964,desogestrel,1,1
220965,(,1,1
220966,n,1,0
220967,=,1,0
220968,15,1,0
220969,),1,0
220970,or,1,0
220971,30,1,1
220972,micrograms,1,1
220973,ethinyl,1,1
220974,estradiol,1,1
220975,and,1,1
220976,75,1,0
220977,micrograms,1,1
220978,gestodene,1,1
220979,(,1,1
220980,n,1,0
220981,=,1,0
220982,19,1,0
220983,),1,0
220984,.,0,0
220985,In,0,0
220986,both,0,0
220987,groups,0,0
220988,plasma,0,0
220989,levels,0,0
220990,of,0,0
220991,fibrinogen,0,1
220992,and,0,0
220993,factor,0,0
220994,VII,0,0
220995,increased,0,0
220996,while,0,0
220997,the,0,0
220998,capacity,0,0
220999,of,0,0
221000,coagulation,0,0
221001,inhibition,0,0
221002,was,0,0
221003,affected,0,0
221004,by,0,0
221005,increased,0,0
221006,protein,0,0
221007,C,0,0
221008,and,0,0
221009,decreased,0,0
221010,protein,0,0
221011,S,0,0
221012,levels,0,0
221013,.,0,0
221014,Increased,0,0
221015,fibrinolytic,0,1
221016,capacity,0,0
221017,was,0,0
221018,indicated,0,0
221019,by,0,0
221020,elevated,0,0
221021,activity,0,0
221022,and,0,0
221023,reduced,0,0
221024,antigen,0,0
221025,levels,0,0
221026,of,0,0
221027,tissue,0,0
221028,plasminogen,0,1
221029,activator,0,1
221030,and,0,0
221031,reduced,0,0
221032,activity,0,0
221033,and,0,0
221034,concentration,0,0
221035,of,0,0
221036,tissue,0,0
221037,plasminogen,0,1
221038,activator,0,1
221039,inhibitor,0,1
221040,.,0,1
221041,The,0,0
221042,ratio,0,0
221043,between,0,0
221044,thrombin-antithrombin-III-complexes,0,1
221045,and,0,1
221046,fibrin,0,1
221047,degradation,0,0
221048,products,0,0
221049,were,0,0
221050,unchanged,0,0
221051,signifying,0,0
221052,no,0,0
221053,effect,0,0
221054,of,0,0
221055,hormonal,0,1
221056,intake,0,1
221057,on,0,0
221058,the,0,0
221059,balance,0,0
221060,between,0,0
221061,thrombin,0,1
221062,formation,0,1
221063,and,0,1
221064,fibrin,0,1
221065,resolution,0,0
221066,.,0,0
221067,In,0,0
221068,conclusion,0,0
221069,",",0,0
221070,the,0,0
221071,dynamic,0,0
221072,balance,0,0
221073,between,0,0
221074,generation,0,0
221075,and,0,0
221076,resolution,0,0
221077,of,0,0
221078,fibrin,0,1
221079,was,0,0
221080,undisturbed,0,0
221081,during,0,0
221082,treatment,0,0
221083,with,0,0
221084,both,0,0
221085,hormonal,0,0
221086,compounds,0,0
221087,and,0,0
221088,our,0,0
221089,findings,0,0
221090,do,0,0
221091,not,0,0
221092,provide,0,0
221093,evidence,0,0
221094,for,0,0
221095,increased,0,0
221096,risk,0,0
221097,of,0,0
221098,thrombosis,0,0
221099,in,0,0
221100,normal,0,0
221101,women,0,0
221102,.,0,0
221103,Granulocyte-macrophage,1,1
221104,colony-stimulating,1,1
221105,factor,1,1
221106,(,1,1
221107,GM-CSF,1,1
221108,),1,0
221109,allows,0,0
221110,acceleration,0,0
221111,and,0,0
221112,dose,0,1
221113,intensity,0,0
221114,increase,0,0
221115,of,0,0
221116,CEF,1,0
221117,chemotherapy,1,0
221118,:,1,0
221119,a,0,0
221120,randomised,0,0
221121,study,0,0
221122,in,0,0
221123,patients,0,0
221124,with,0,0
221125,advanced,0,0
221126,breast,0,0
221127,cancer,0,0
221128,.,0,0
221129,A,0,0
221130,randomised,0,0
221131,study,0,0
221132,was,0,0
221133,conducted,0,0
221134,in,0,0
221135,62,0,0
221136,patients,0,0
221137,with,0,0
221138,advanced,0,0
221139,breast,0,0
221140,cancer,0,0
221141,to,0,0
221142,assess,0,0
221143,whether,0,0
221144,granulocyte-macrophage,0,1
221145,colony-stimulating,0,1
221146,factor,0,1
221147,(,1,1
221148,GM-CSF,1,1
221149,),1,0
221150,would,0,0
221151,yield,0,0
221152,an,0,0
221153,increase,0,0
221154,in,0,0
221155,the,0,0
221156,dose,0,1
221157,intensity,0,0
221158,of,0,0
221159,a,0,0
221160,standard-dose,1,1
221161,CEF,1,1
221162,regimen,1,1
221163,through,0,0
221164,an,0,0
221165,acceleration,0,0
221166,of,0,0
221167,chemotherapy,1,0
221168,administration,0,1
221169,.,0,0
221170,Patients,0,0
221171,received,0,0
221172,CEF,1,1
221173,(,1,1
221174,cyclophosphamide,1,1
221175,600,1,1
221176,mg,1,1
221177,m-2,1,1
221178,",",1,1
221179,epidoxorubicin,1,1
221180,60,1,1
221181,mg,1,1
221182,m-2,1,1
221183,and,1,1
221184,fluorouracil,1,1
221185,600,1,1
221186,mg,1,1
221187,m-2,1,1
221188,),1,1
221189,i.v,0,1
221190,.,0,1
221191,on,0,0
221192,day,0,0
221193,1,0,0
221194,or,0,0
221195,the,0,0
221196,same,0,0
221197,chemotherapy,1,0
221198,",",0,0
221199,plus,0,0
221200,GM-CSF,1,1
221201,10,0,1
221202,micrograms,0,1
221203,kg-1,0,1
221204,s.c.,0,1
221205,starting,0,1
221206,from,0,0
221207,day,0,0
221208,4,0,0
221209,",",0,0
221210,repeated,0,0
221211,as,0,0
221212,soon,0,0
221213,as,0,0
221214,haematopoietic,0,0
221215,recovery,0,0
221216,from,0,0
221217,nadir,0,0
221218,occurred,0,0
221219,.,0,0
221220,Patients,0,0
221221,in,0,0
221222,the,0,0
221223,CEF,1,0
221224,+,1,0
221225,GM-CSF,1,1
221226,group,0,0
221227,received,0,0
221228,chemotherapy,0,0
221229,at,0,0
221230,a,0,0
221231,median,0,0
221232,interval,0,0
221233,of,0,0
221234,16,0,0
221235,days,0,0
221236,compared,0,0
221237,with,0,0
221238,20,0,0
221239,days,0,0
221240,in,0,0
221241,the,0,0
221242,control,0,0
221243,group,0,0
221244,.,0,0
221245,This,0,0
221246,led,0,0
221247,to,0,0
221248,a,0,0
221249,significant,0,0
221250,increase,0,0
221251,(,0,0
221252,P,0,0
221253,=,0,0
221254,0.02,0,0
221255,),0,0
221256,in,0,0
221257,the,0,0
221258,dose,0,1
221259,intensity,0,0
221260,actually,0,0
221261,administered,0,1
221262,in,0,0
221263,the,0,0
221264,third,0,0
221265,",",0,0
221266,fourth,0,0
221267,and,0,0
221268,sixth,0,0
221269,cycles,0,0
221270,:,0,0
221271,+28,0,0
221272,%,0,0
221273,",",0,0
221274,+25,0,0
221275,%,0,0
221276,",",0,0
221277,+20,0,0
221278,%,0,0
221279,respectively,0,0
221280,.,0,0
221281,Non-haematological,0,0
221282,toxicity,0,0
221283,was,0,0
221284,mild,0,0
221285,.,0,0
221286,GM-CSF,1,0
221287,had,0,0
221288,to,0,0
221289,be,0,0
221290,reduced,0,0
221291,or,0,0
221292,suspended,0,0
221293,in,0,0
221294,50,0,0
221295,%,0,0
221296,of,0,0
221297,patients,0,0
221298,because,0,0
221299,of,0,0
221300,toxicity,0,0
221301,.,0,0
221302,Haematological,0,0
221303,toxicity,0,0
221304,",",0,0
221305,mainly,0,0
221306,cumulative,0,0
221307,anaemia,0,0
221308,and,0,0
221309,thrombocytopenia,0,0
221310,",",0,0
221311,was,0,0
221312,manageable,0,0
221313,.,0,0
221314,An,0,1
221315,increase,0,0
221316,in,0,0
221317,response,0,0
221318,rate,0,0
221319,for,0,0
221320,patients,0,0
221321,with,0,0
221322,measurable,0,0
221323,disease,0,0
221324,",",0,0
221325,of,0,0
221326,borderline,0,0
221327,statistical,0,0
221328,significance,0,0
221329,(,0,0
221330,P,0,0
221331,=,0,0
221332,0.088,0,0
221333,",",0,0
221334,P,0,0
221335,for,0,0
221336,trend,0,0
221337,=,0,0
221338,0.018,0,0
221339,),0,0
221340,",",0,0
221341,from,0,0
221342,42,0,0
221343,%,0,0
221344,in,0,0
221345,the,0,0
221346,CEF,1,0
221347,group,0,0
221348,to,0,0
221349,69,0,0
221350,%,0,0
221351,in,0,0
221352,the,0,0
221353,CEF,1,0
221354,+,1,0
221355,GM-CSF,1,1
221356,group,0,0
221357,",",0,0
221358,was,0,0
221359,observed,0,0
221360,.,0,0
221361,This,0,0
221362,randomised,0,0
221363,trial,0,0
221364,indicates,0,0
221365,that,0,0
221366,GM-CSF,1,0
221367,is,0,0
221368,useful,0,0
221369,for,0,0
221370,chemotherapy,0,0
221371,acceleration,0,0
221372,.,0,0
221373,Accelerated,0,0
221374,CEF,1,0
221375,+,1,0
221376,GM-CSF,1,0
221377,is,0,0
221378,a,0,0
221379,moderately,0,0
221380,dose-intensive,0,1
221381,regimen,0,1
221382,that,0,0
221383,can,0,0
221384,be,0,0
221385,administered,0,1
221386,in,0,0
221387,an,0,0
221388,outpatient,0,0
221389,clinic,0,0
221390,and,0,0
221391,is,0,0
221392,associated,0,0
221393,with,0,0
221394,a,0,0
221395,high,0,0
221396,objective,0,0
221397,response,0,0
221398,.,0,0
221399,MR,0,1
221400,imaging,0,0
221401,of,0,0
221402,pituitary,0,0
221403,region,0,0
221404,lesions,0,0
221405,with,0,1
221406,gadodiamide,1,1
221407,injection,0,1
221408,.,0,1
221409,Twelve,0,0
221410,patients,0,0
221411,with,0,0
221412,known,0,0
221413,or,0,0
221414,suspected,0,0
221415,pituitary,0,0
221416,lesions,0,0
221417,underwent,0,0
221418,MR,1,0
221419,imaging,1,1
221420,with,0,1
221421,gadodiamide,1,1
221422,injection,1,1
221423,at,0,1
221424,a,0,0
221425,dose,0,0
221426,of,0,0
221427,0.1,0,0
221428,(,0,0
221429,n,0,0
221430,=,0,0
221431,5,0,0
221432,),0,0
221433,or,0,0
221434,0.3,0,0
221435,(,0,0
221436,n,0,0
221437,=,0,0
221438,7,0,0
221439,),0,0
221440,mM/kg,0,1
221441,.,0,1
221442,Six,0,1
221443,of,0,0
221444,the,0,0
221445,patients,0,0
221446,were,0,0
221447,also,0,0
221448,studied,0,0
221449,with,0,0
221450,0.1,1,0
221451,mM/kg,1,1
221452,gadopentetate,1,1
221453,dimeglumine,1,1
221454,.,1,1
221455,Consistent,0,0
221456,with,0,0
221457,previous,0,0
221458,reports,0,0
221459,gadodiamide,1,1
221460,injection,0,1
221461,was,0,0
221462,found,0,0
221463,to,0,0
221464,be,0,0
221465,a,0,0
221466,safe,0,0
221467,and,0,0
221468,effective,0,0
221469,contrast,0,0
221470,medium,0,0
221471,for,0,0
221472,MR,0,0
221473,imaging,0,0
221474,of,0,0
221475,the,0,0
221476,pituitary,0,0
221477,region,0,0
221478,.,0,0
221479,No,0,1
221480,additional,0,0
221481,diagnostic,0,0
221482,information,0,0
221483,was,0,0
221484,obtained,0,0
221485,using,0,0
221486,0.3,0,0
221487,mM/kg,0,1
221488,gadodiamide,1,1
221489,injection,0,1
221490,compared,0,0
221491,to,0,0
221492,0.1,0,0
221493,mM/kg,0,1
221494,gadopentate,0,1
221495,dimeglumine,0,1
221496,in,0,0
221497,the,0,0
221498,same,0,0
221499,patients,0,0
221500,.,0,0
221501,The,0,0
221502,high,0,0
221503,dose,0,1
221504,(,0,1
221505,0.3,0,1
221506,mM/kg,0,1
221507,),0,1
221508,gadodiamide,1,1
221509,injection,0,1
221510,in,0,1
221511,7,0,0
221512,patients,0,0
221513,did,0,0
221514,not,0,0
221515,shorten,0,0
221516,the,0,0
221517,T2,0,0
221518,value,0,0
221519,sufficiently,0,0
221520,to,0,0
221521,overwhelm,0,0
221522,the,0,0
221523,T1,0,0
221524,shortening,0,0
221525,and,0,0
221526,leave,0,0
221527,pathologic,0,0
221528,lesions,0,0
221529,hypointense,0,0
221530,compared,0,0
221531,to,0,0
221532,precontrast,0,0
221533,studies,0,0
221534,.,0,0
221535,With,0,0
221536,the,0,0
221537,comparable,0,0
221538,relaxivities,0,1
221539,of,0,1
221540,gadodiamide,1,1
221541,injection,0,1
221542,and,0,1
221543,gadopentetate,1,1
221544,dimeglumine,1,1
221545,",",0,1
221546,similarities,0,0
221547,in,0,0
221548,results,0,0
221549,have,0,0
221550,to,0,0
221551,be,0,0
221552,expected,0,0
221553,when,0,0
221554,using,0,0
221555,these,0,0
221556,media,0,0
221557,for,0,0
221558,MR,0,0
221559,image,0,0
221560,enhancement,0,0
221561,.,0,0
221562,Fusidic,0,1
221563,acid,0,1
221564,prophylaxis,0,1
221565,before,0,0
221566,cataract,0,0
221567,surgery,0,0
221568,:,0,0
221569,patient,0,0
221570,self-administration,0,1
221571,.,0,1
221572,In,0,0
221573,a,0,0
221574,placebo-controlled,0,1
221575,",",0,1
221576,randomised,0,1
221577,",",0,1
221578,double-blind,0,1
221579,clinical,0,1
221580,trial,0,1
221581,",",0,0
221582,the,0,0
221583,authors,0,0
221584,evaluated,0,0
221585,the,0,0
221586,efficacy,0,0
221587,of,0,0
221588,patient-administered,0,0
221589,1,0,0
221590,%,0,0
221591,fusidic,1,1
221592,acid,1,1
221593,viscous,1,1
221594,eye,1,1
221595,drops,1,1
221596,in,0,0
221597,clearing,0,0
221598,the,0,0
221599,commonest,0,0
221600,organisms,0,0
221601,causing,0,0
221602,pseudophakic,0,0
221603,endophthalmitis,0,1
221604,(,0,1
221605,Staphylococcus,0,1
221606,epidermidis,0,1
221607,and,0,1
221608,aureus,0,1
221609,),0,1
221610,from,0,0
221611,the,0,0
221612,lids,0,0
221613,and,0,0
221614,conjunctivae,0,0
221615,of,0,0
221616,79,0,0
221617,patients,0,0
221618,before,0,0
221619,cataract,0,0
221620,surgery,0,0
221621,.,0,0
221622,The,0,0
221623,treatment,0,0
221624,group,0,0
221625,self-administered,0,1
221626,fusidic,1,1
221627,acid,1,1
221628,viscous,0,1
221629,eye,0,1
221630,drops,0,1
221631,four,0,0
221632,times,0,1
221633,daily,0,1
221634,for,0,0
221635,seven,0,0
221636,days,0,0
221637,before,0,0
221638,surgery,0,1
221639,;,0,0
221640,the,0,0
221641,placebo,0,1
221642,group,0,0
221643,received,0,0
221644,inert,1,0
221645,ophthalmic,1,1
221646,drops,1,1
221647,.,1,1
221648,Fellow,0,0
221649,eyes,0,0
221650,of,0,0
221651,both,0,0
221652,groups,0,0
221653,remained,0,0
221654,untreated,0,0
221655,as,0,0
221656,a,0,0
221657,natural,0,0
221658,control,0,0
221659,.,0,0
221660,Lower,0,0
221661,fornix,0,0
221662,and,0,0
221663,lid,0,0
221664,margin,0,0
221665,cultures,0,0
221666,were,0,0
221667,taken,0,0
221668,from,0,0
221669,both,0,0
221670,eyes,0,0
221671,before,0,0
221672,and,0,0
221673,after,0,0
221674,treatment,0,0
221675,.,0,0
221676,Before,0,0
221677,treatment,0,0
221678,",",0,0
221679,there,0,0
221680,was,0,0
221681,no,0,0
221682,statistical,0,0
221683,difference,0,0
221684,in,0,0
221685,organism,0,0
221686,counts,0,0
221687,between,0,0
221688,the,0,0
221689,groups,0,0
221690,.,0,0
221691,After,0,0
221692,treatment,0,0
221693,",",0,0
221694,eyes,0,1
221695,receiving,0,0
221696,fusidic,1,1
221697,acid,1,1
221698,were,0,0
221699,more,0,0
221700,likely,0,0
221701,to,0,0
221702,be,0,0
221703,free,0,0
221704,of,0,0
221705,clinically,0,0
221706,relevant,0,0
221707,Staphylococcus,0,1
221708,spp,0,0
221709,.,0,0
221710,than,0,0
221711,all,0,0
221712,pre-treatment,0,0
221713,eyes,0,0
221714,(,0,0
221715,for,0,0
221716,lids,0,0
221717,",",0,0
221718,P,0,0
221719,<,0,0
221720,0.001,0,0
221721,;,0,0
221722,conjunctivae,0,0
221723,",",0,0
221724,P,0,0
221725,=,0,0
221726,0.02,0,0
221727,),0,0
221728,.,0,0
221729,A,0,0
221730,highly,0,0
221731,significant,0,0
221732,(,0,0
221733,P,0,0
221734,<,0,0
221735,0.001,0,0
221736,),0,0
221737,number,0,0
221738,of,0,0
221739,lid,0,0
221740,margins,0,0
221741,were,0,0
221742,rendered,0,0
221743,'clinically,0,0
221744,clean,0,0
221745,',0,0
221746,(,0,0
221747,i.e.,0,0
221748,",",0,0
221749,0-49,0,0
221750,organisms/swab,0,0
221751,),0,0
221752,by,0,0
221753,fusidic,0,1
221754,acid,0,1
221755,when,0,0
221756,compared,0,0
221757,with,0,0
221758,untreated,0,0
221759,eyes,0,0
221760,.,0,0
221761,Treatment,0,0
221762,also,0,0
221763,effectively,0,0
221764,(,0,0
221765,P,0,0
221766,<,0,0
221767,0.05,0,0
221768,),0,0
221769,reduced,0,0
221770,the,0,0
221771,numbers,0,0
221772,of,0,0
221773,bacteria,0,0
221774,isolated,0,0
221775,from,0,0
221776,conjunctivae,0,0
221777,.,0,0
221778,This,0,0
221779,study,0,0
221780,indicates,0,0
221781,that,0,0
221782,there,0,0
221783,is,0,0
221784,a,0,0
221785,highly,0,0
221786,significant,0,0
221787,reduction,0,0
221788,of,0,0
221789,Staphylococcus,0,1
221790,spp,0,0
221791,.,0,0
221792,(,0,0
221793,P,0,0
221794,<,0,0
221795,0.001,0,0
221796,),0,0
221797,",",0,0
221798,non-Staphylococcus,0,1
221799,spp,0,0
221800,.,0,0
221801,(,0,0
221802,P,0,0
221803,<,0,0
221804,0.001,0,0
221805,),0,0
221806,and,0,0
221807,attainment,0,0
221808,of,0,0
221809,sterile,0,0
221810,eyes,0,0
221811,(,0,0
221812,P,0,0
221813,<,0,0
221814,0.001,0,0
221815,),0,0
221816,at,0,0
221817,operation,0,0
221818,gained,0,0
221819,by,0,0
221820,patient,0,0
221821,self-administration,0,1
221822,of,0,0
221823,1,0,0
221824,%,0,0
221825,fusidic,0,1
221826,acid,0,1
221827,four,0,1
221828,times,0,1
221829,daily,0,1
221830,for,0,0
221831,seven,0,0
221832,days,0,0
221833,before,0,0
221834,surgery,0,0
221835,.,0,0
221836,A,0,1
221837,multicenter,0,0
221838,study,0,0
221839,on,0,0
221840,the,0,0
221841,use,0,0
221842,of,0,0
221843,pulsed,1,0
221844,low-intensity,1,0
221845,direct,1,0
221846,current,1,0
221847,for,0,0
221848,healing,0,0
221849,chronic,0,0
221850,stage,0,0
221851,II,0,0
221852,and,0,0
221853,stage,0,0
221854,III,0,1
221855,decubitus,0,0
221856,ulcers,0,0
221857,.,0,0
221858,BACKGROUND,0,0
221859,AND,0,1
221860,DESIGN,0,1
221861,Pulsed,1,0
221862,low-intensity,1,0
221863,direct,1,0
221864,current,1,0
221865,(,1,0
221866,300,1,0
221867,to,1,0
221868,600,1,0
221869,microA,1,0
221870,),1,0
221871,has,0,0
221872,been,0,0
221873,used,0,0
221874,in,0,0
221875,a,0,0
221876,double-blind,0,1
221877,placebo,0,1
221878,multicenter,0,1
221879,study,0,0
221880,in,0,0
221881,the,0,0
221882,treatment,0,0
221883,of,0,0
221884,stage,0,0
221885,II,0,0
221886,and,0,0
221887,stage,0,0
221888,III,0,1
221889,chronic,0,0
221890,decubitus,0,0
221891,ulcers,0,0
221892,.,0,0
221893,RESULTS,0,0
221894,Seventy-four,0,0
221895,ulcers,0,0
221896,were,0,0
221897,treated,0,0
221898,in,0,0
221899,four,0,0
221900,centers,0,0
221901,.,0,0
221902,Forty-three,0,0
221903,patients,0,0
221904,were,0,0
221905,selected,0,0
221906,for,0,0
221907,the,0,0
221908,experimental,0,0
221909,group,0,0
221910,",",0,0
221911,and,0,0
221912,31,0,0
221913,control,0,0
221914,subjects,0,0
221915,used,0,0
221916,the,0,0
221917,sham,1,0
221918,instrument,1,1
221919,(,1,1
221920,placebo,1,1
221921,group,1,1
221922,),1,0
221923,.,1,0
221924,In,0,0
221925,the,0,0
221926,treated,0,0
221927,group,0,0
221928,",",0,0
221929,25,0,0
221930,ulcers,0,0
221931,(,0,0
221932,58,0,0
221933,%,0,0
221934,),0,0
221935,healed,0,0
221936,in,0,0
221937,8,0,0
221938,weeks,0,0
221939,",",0,0
221940,whereas,0,0
221941,in,0,0
221942,the,0,0
221943,placebo,0,1
221944,group,0,0
221945,",",0,0
221946,only,0,0
221947,one,0,0
221948,ulcer,0,1
221949,(,0,0
221950,3,0,0
221951,%,0,0
221952,),0,0
221953,healed,0,0
221954,and,0,0
221955,most,0,0
221956,ulcers,0,0
221957,increased,0,0
221958,in,0,0
221959,size,0,0
221960,.,0,0
221961,Statistical,0,0
221962,analysis,0,0
221963,",",0,0
221964,based,0,0
221965,on,0,0
221966,surface,0,0
221967,area,0,0
221968,and,0,0
221969,ulcer,0,0
221970,depth,0,0
221971,before,0,0
221972,and,0,0
221973,after,0,0
221974,treatment,0,0
221975,",",0,0
221976,showed,0,0
221977,that,0,0
221978,low-intensity,1,0
221979,direct,1,0
221980,current,1,0
221981,had,0,0
221982,a,0,0
221983,significant,0,0
221984,influence,0,0
221985,on,0,0
221986,the,0,0
221987,healing,0,0
221988,rates,0,0
221989,for,0,0
221990,these,0,0
221991,ulcers,0,0
221992,(,0,0
221993,P,0,0
221994,<,0,0
221995,.0001,0,0
221996,),0,0
221997,.,0,0
221998,Experiments,0,0
221999,with,0,0
222000,guinea,0,1
222001,pigs,0,1
222002,(,0,0
222003,n,0,0
222004,=,0,0
222005,10,0,0
222006,),0,0
222007,showed,0,0
222008,that,0,0
222009,pulsed,1,0
222010,low-intensity,1,0
222011,direct,1,0
222012,current,1,0
222013,caused,0,0
222014,a,0,0
222015,rapid,0,0
222016,calcium,0,1
222017,flux,0,0
222018,in,0,0
222019,the,0,0
222020,epidermis,0,0
222021,.,0,0
222022,CONCLUSIONS,0,0
222023,Pulsed,1,0
222024,low-intensity,1,0
222025,direct,1,0
222026,current,1,0
222027,represents,0,0
222028,a,0,0
222029,useful,0,0
222030,approach,0,0
222031,for,0,0
222032,the,0,0
222033,treatment,0,0
222034,of,0,0
222035,stage,0,0
222036,II,0,0
222037,and,0,0
222038,stage,0,0
222039,III,0,1
222040,chronic,0,0
222041,decubitus,0,0
222042,ulcers,0,0
222043,by,0,0
222044,increasing,0,0
222045,the,0,0
222046,healing,0,0
222047,rate,0,0
222048,.,0,0
222049,The,0,0
222050,growth,0,0
222051,of,0,0
222052,fibroblasts,0,0
222053,and,0,0
222054,keratinocytes,0,0
222055,may,0,0
222056,be,0,0
222057,enhanced,0,0
222058,by,0,0
222059,pulsed,1,0
222060,low-intensity,1,0
222061,direct,1,0
222062,current,1,0
222063,due,0,0
222064,to,0,0
222065,changes,0,0
222066,in,0,0
222067,calcium,0,1
222068,homeostasis,0,0
222069,.,0,0
222070,Use,0,0
222071,of,0,0
222072,activated,0,0
222073,charcoal,0,1
222074,in,0,0
222075,a,0,0
222076,simulated,0,0
222077,poisoning,0,1
222078,with,0,1
222079,acetaminophen,0,1
222080,:,0,0
222081,a,0,0
222082,new,0,0
222083,loading,0,0
222084,dose,0,1
222085,for,0,1
222086,N-acetylcysteine,1,1
222087,?,0,1
222088,STUDY,0,1
222089,OBJECTIVES,0,1
222090,To,0,0
222091,investigate,0,0
222092,the,0,0
222093,ability,0,0
222094,of,0,0
222095,a,0,0
222096,supranormal,0,0
222097,dose,0,1
222098,of,0,1
222099,N-acetylcysteine,1,1
222100,to,0,0
222101,overcome,0,0
222102,the,0,0
222103,effects,0,0
222104,of,0,0
222105,activated,0,0
222106,charcoal,0,1
222107,on,0,1
222108,N-acetylcysteine,0,1
222109,bioavailability,0,1
222110,and,0,1
222111,to,0,0
222112,determine,0,0
222113,the,0,0
222114,effects,0,0
222115,of,0,0
222116,activated,0,0
222117,charcoal,0,1
222118,on,0,1
222119,serum,0,1
222120,acetaminophen,0,1
222121,levels,0,1
222122,.,0,0
222123,DESIGN,0,0
222124,",",0,0
222125,SETTING,0,1
222126,",",0,0
222127,AND,0,1
222128,PARTICIPANTS,0,1
222129,Ten,0,0
222130,healthy,0,0
222131,adult,0,0
222132,volunteers,0,0
222133,participated,0,0
222134,in,0,0
222135,a,0,0
222136,controlled,0,0
222137,cross-over,0,1
222138,experiment,0,0
222139,.,0,0
222140,During,0,0
222141,phase,0,0
222142,I,0,0
222143,(,0,0
222144,control,0,0
222145,),0,0
222146,",",0,0
222147,subjects,0,0
222148,ingested,0,1
222149,3,1,1
222150,g,1,1
222151,acetaminophen,1,1
222152,",",0,1
222153,followed,0,0
222154,one,1,0
222155,hour,1,0
222156,later,1,0
222157,by,1,0
222158,the,1,0
222159,normal,1,0
222160,loading,1,0
222161,dose,1,1
222162,of,1,1
222163,N-acetylcysteine,1,1
222164,(,0,1
222165,140,0,1
222166,mg/kg,0,1
222167,),0,0
222168,.,0,0
222169,During,0,0
222170,phase,0,0
222171,II,0,1
222172,(,0,1
222173,charcoal,0,1
222174,),0,1
222175,",",0,0
222176,subjects,0,0
222177,ingested,0,1
222178,3,1,1
222179,g,1,1
222180,acetaminophen,1,1
222181,",",0,1
222182,followed,0,0
222183,one,0,0
222184,hour,0,0
222185,later,0,0
222186,by,0,0
222187,60,1,0
222188,g,1,0
222189,activated,1,0
222190,charcoal,1,1
222191,and,1,0
222192,a,1,0
222193,supranormal,1,0
222194,loading,1,0
222195,dose,1,1
222196,of,1,1
222197,N-acetylcysteine,1,1
222198,(,0,1
222199,235,0,1
222200,mg/kg,0,1
222201,),0,0
222202,.,0,1
222203,MAIN,0,0
222204,OUTCOME,0,1
222205,MEASURES,0,1
222206,Serum,0,0
222207,levels,0,0
222208,of,0,0
222209,N-acetylcysteine,1,1
222210,were,0,0
222211,measured,0,0
222212,every,0,0
222213,30,0,0
222214,minutes,0,0
222215,for,0,0
222216,six,0,0
222217,hours,0,0
222218,.,0,1
222219,A,0,1
222220,serum,0,1
222221,acetaminophen,0,1
222222,level,0,0
222223,was,0,0
222224,measured,0,0
222225,at,0,0
222226,four,0,0
222227,hours,0,0
222228,.,0,0
222229,RESULTS,0,0
222230,The,0,0
222231,area,0,0
222232,under,0,0
222233,the,0,0
222234,curve,0,0
222235,for,0,0
222236,N-acetylcysteine,1,1
222237,was,0,0
222238,significantly,0,0
222239,higher,0,0
222240,for,0,0
222241,phase,0,0
222242,II,0,0
222243,than,0,0
222244,phase,0,0
222245,I,0,0
222246,(,0,0
222247,P,0,0
222248,<,0,0
222249,.05,0,0
222250,",",0,0
222251,two-tailed,0,0
222252,paired,0,0
222253,t-test,0,0
222254,),0,0
222255,.,0,0
222256,Peak,0,1
222257,N-acetylcysteine,0,1
222258,and,0,0
222259,time,0,0
222260,to,0,0
222261,peak,0,0
222262,were,0,0
222263,not,0,0
222264,significantly,0,0
222265,different,0,0
222266,.,0,0
222267,The,0,0
222268,four-hour,0,1
222269,serum,0,1
222270,acetaminophen,0,1
222271,level,0,0
222272,was,0,0
222273,significantly,0,0
222274,lower,0,0
222275,for,0,0
222276,phase,0,0
222277,II,0,0
222278,than,0,0
222279,phase,0,0
222280,I,0,0
222281,(,0,0
222282,P,0,0
222283,<,0,0
222284,.05,0,0
222285,",",0,0
222286,two-tailed,0,0
222287,paired,0,0
222288,t-test,0,0
222289,),0,0
222290,.,0,0
222291,Diarrhea,0,0
222292,occurred,0,0
222293,during,0,0
222294,both,0,0
222295,phases,0,0
222296,",",0,0
222297,but,0,0
222298,N-acetylcysteine,1,1
222299,was,0,0
222300,otherwise,0,0
222301,well,0,0
222302,tolerated,0,1
222303,.,0,0
222304,CONCLUSION,0,1
222305,These,0,0
222306,results,0,0
222307,suggest,0,0
222308,that,0,0
222309,activated,0,0
222310,charcoal,0,1
222311,can,0,0
222312,be,0,0
222313,used,0,0
222314,safely,0,0
222315,for,0,0
222316,victims,0,0
222317,of,0,0
222318,acetaminophen,0,1
222319,overdose,0,1
222320,.,0,1
222321,A,0,0
222322,beneficial,0,0
222323,effect,0,0
222324,in,0,0
222325,preventing,0,0
222326,acetaminophen,0,1
222327,absorption,0,1
222328,can,0,0
222329,be,0,0
222330,expected,0,0
222331,if,0,0
222332,it,0,0
222333,is,0,0
222334,given,0,0
222335,within,0,0
222336,one,0,0
222337,hour,0,0
222338,after,0,0
222339,ingestion,0,1
222340,.,0,1
222341,If,0,1
222342,N-acetylcysteine,1,1
222343,is,0,0
222344,needed,0,0
222345,because,0,0
222346,of,0,0
222347,a,0,0
222348,toxic,0,0
222349,serum,0,1
222350,acetaminophen,0,1
222351,level,0,1
222352,",",0,1
222353,bioavailability,0,1
222354,can,0,0
222355,be,0,0
222356,ensured,0,0
222357,by,0,0
222358,increasing,0,0
222359,the,0,0
222360,N-acetylcysteine,1,1
222361,loading,0,1
222362,dose,0,1
222363,from,0,0
222364,140,0,0
222365,mg/kg,0,0
222366,to,0,0
222367,235,0,0
222368,mg/kg,0,0
222369,.,0,0
222370,Early,1,0
222371,versus,1,0
222372,late,1,0
222373,replacement,1,0
222374,of,1,0
222375,autotransfused,1,0
222376,blood,1,0
222377,in,0,0
222378,elective,0,0
222379,spinal,1,0
222380,surgery,1,0
222381,.,1,0
222382,A,0,0
222383,prospective,0,0
222384,randomized,0,0
222385,study,0,0
222386,.,0,0
222387,The,0,0
222388,use,0,0
222389,of,0,0
222390,autologous,1,0
222391,blood,1,0
222392,is,0,0
222393,a,0,0
222394,well,0,0
222395,established,0,0
222396,and,0,0
222397,extremely,0,0
222398,popular,0,0
222399,technique,0,0
222400,to,0,0
222401,decrease,0,0
222402,the,0,0
222403,necessity,0,0
222404,for,0,0
222405,homologous,0,0
222406,transfusions,0,0
222407,and,0,0
222408,the,0,0
222409,attendant,0,0
222410,risks,0,0
222411,of,0,0
222412,hepatitis,0,0
222413,",",0,0
222414,HIV,0,0
222415,",",0,0
222416,and,0,0
222417,HTLV,0,0
222418,--,0,0
222419,I/II,0,0
222420,infections,0,0
222421,.,0,0
222422,The,0,0
222423,most,0,0
222424,beneficial,0,0
222425,timing,0,0
222426,for,0,0
222427,autologous,1,0
222428,reinfusion,0,1
222429,of,0,0
222430,predonated,0,0
222431,blood,0,0
222432,remains,0,0
222433,unknown,0,0
222434,.,0,0
222435,The,0,0
222436,present,0,0
222437,study,0,0
222438,was,0,0
222439,undertaken,0,0
222440,to,0,0
222441,determine,0,0
222442,the,0,0
222443,optimal,0,0
222444,timing,0,0
222445,of,0,0
222446,autologous,1,0
222447,blood,1,1
222448,reinfusion,1,1
222449,in,1,0
222450,elective,1,1
222451,spinal,1,0
222452,surgery,1,0
222453,.,1,0
222454,Fifty-seven,0,0
222455,patients,0,0
222456,were,0,0
222457,prospectively,0,0
222458,individually,0,0
222459,randomly,0,0
222460,allocated,0,0
222461,into,0,0
222462,early,1,0
222463,versus,1,0
222464,delayed,1,1
222465,reinfusion,1,1
222466,groups,1,1
222467,prior,0,0
222468,to,0,0
222469,undergoing,0,0
222470,elective,1,0
222471,spinal,1,0
222472,surgery,1,0
222473,by,0,0
222474,a,0,0
222475,single,0,0
222476,surgeon,0,0
222477,.,0,0
222478,Three,0,0
222479,surgical,0,0
222480,subgroups,0,0
222481,were,0,0
222482,entered,0,0
222483,into,0,0
222484,the,0,0
222485,study,0,0
222486,:,0,0
222487,anterior/posterior,0,0
222488,(,0,1
222489,A/P,0,1
222490,),0,1
222491,spinal,0,0
222492,fusion,0,0
222493,patients,0,0
222494,",",0,0
222495,posterior,0,0
222496,thoracolumbar,0,0
222497,scoliosis,0,0
222498,fusion,0,0
222499,patients,0,0
222500,(,0,0
222501,PSF,0,1
222502,),0,1
222503,",",0,0
222504,and,0,0
222505,degenerative,0,0
222506,posterior,0,0
222507,lumbar,0,0
222508,fusion,0,0
222509,patients,0,0
222510,(,0,0
222511,LF,0,1
222512,),0,1
222513,.,0,0
222514,Randomization,0,0
222515,was,0,0
222516,successful,0,0
222517,in,0,0
222518,that,0,0
222519,three,0,0
222520,was,0,0
222521,no,0,0
222522,significant,0,0
222523,difference,0,0
222524,in,0,0
222525,male,0,0
222526,to,0,0
222527,female,0,0
222528,ratio,0,0
222529,",",0,0
222530,age,0,0
222531,",",0,0
222532,preoperative,0,1
222533,hemoglobin,0,1
222534,",",0,0
222535,or,0,0
222536,number,0,0
222537,of,0,0
222538,units,0,0
222539,predonated,0,0
222540,between,0,0
222541,the,0,0
222542,early,1,0
222543,and,1,0
222544,delayed,1,1
222545,reinfusion,1,1
222546,groups,1,1
222547,.,1,0
222548,Likewise,0,0
222549,",",0,0
222550,there,0,0
222551,was,0,0
222552,no,0,0
222553,significant,0,0
222554,difference,0,0
222555,in,0,0
222556,the,0,0
222557,details,0,0
222558,of,0,0
222559,the,0,0
222560,operative,0,0
222561,procedure,0,0
222562,when,0,0
222563,compared,0,0
222564,as,0,0
222565,a,0,0
222566,group,0,0
222567,for,0,0
222568,the,0,0
222569,early,0,0
222570,versus,0,0
222571,delayed,0,1
222572,reinfusion,0,1
222573,groups,0,1
222574,.,0,0
222575,A,0,0
222576,significant,0,0
222577,increase,0,0
222578,in,0,0
222579,the,0,0
222580,postoperative,0,0
222581,day,0,0
222582,#,0,0
222583,1,0,0
222584,",",0,0
222585,2,0,0
222586,and,0,0
222587,3,0,1
222588,hemoglobin,0,1
222589,was,0,0
222590,seen,0,0
222591,in,0,0
222592,the,0,0
222593,early,1,0
222594,reinfusion,1,1
222595,group,1,0
222596,",",0,0
222597,while,0,0
222598,there,0,0
222599,was,0,0
222600,no,0,0
222601,significant,0,0
222602,difference,0,0
222603,seen,0,0
222604,in,0,0
222605,the,0,0
222606,postoperative,0,0
222607,day,0,0
222608,#,0,0
222609,7,0,1
222610,hemoglobin,0,1
222611,between,0,0
222612,the,0,0
222613,early,1,0
222614,versus,1,0
222615,delayed,1,1
222616,reinfusion,1,1
222617,group,0,1
222618,.,0,0
222619,There,0,0
222620,was,0,0
222621,no,0,0
222622,effect,0,0
222623,of,0,0
222624,surgical,0,0
222625,grouping,0,0
222626,on,0,0
222627,these,0,0
222628,significant,0,0
222629,comparisons,0,0
222630,.,0,0
222631,Earlier,0,0
222632,patient,0,0
222633,mobilization,0,0
222634,was,0,0
222635,also,0,0
222636,seen,0,0
222637,in,0,0
222638,the,0,0
222639,early,1,0
222640,reinfusion,1,1
222641,groups,0,0
222642,for,0,0
222643,the,0,0
222644,A/P,0,0
222645,and,0,0
222646,PSF,0,1
222647,groups,0,0
222648,.,0,0
222649,There,0,0
222650,was,0,0
222651,no,0,0
222652,difference,0,0
222653,in,0,0
222654,patients,0,0
222655,',0,0
222656,subjective,0,0
222657,evaluation,0,0
222658,of,0,0
222659,satisfaction,0,0
222660,and,0,0
222661,discomfort,0,0
222662,between,0,0
222663,the,0,0
222664,early,0,0
222665,or,0,0
222666,delayed,0,1
222667,reinfusion,0,1
222668,groups,0,0
222669,as,0,0
222670,determined,0,0
222671,by,0,0
222672,blinded,0,0
222673,interview,0,1
222674,on,0,0
222675,days,0,0
222676,1,0,0
222677,",",0,0
222678,3,0,0
222679,",",0,0
222680,5,0,0
222681,",",0,0
222682,and,0,0
222683,7,0,0
222684,postoperatively,0,0
222685,.,0,0
222686,(,0,0
222687,ABSTRACT,0,1
222688,TRUNCATED,0,1
222689,AT,0,1
222690,250,0,1
222691,WORDS,0,1
222692,),0,1
222693,Torasemide,1,1
222694,versus,0,1
222695,furosemide,1,1
222696,in,0,0
222697,cirrhosis,0,0
222698,:,0,0
222699,a,0,0
222700,long-term,0,0
222701,",",0,0
222702,double-blind,0,1
222703,",",0,1
222704,randomized,0,1
222705,clinical,0,0
222706,study,0,0
222707,.,0,0
222708,The,0,0
222709,effects,0,0
222710,of,0,0
222711,long-term,0,0
222712,therapy,0,0
222713,(,0,0
222714,70,0,0
222715,days,0,0
222716,),0,0
222717,with,0,1
222718,torasemide,1,1
222719,(,0,1
222720,20,0,1
222721,mg/day,0,1
222722,),0,1
222723,",",0,0
222724,a,0,0
222725,new,0,0
222726,loop,0,0
222727,diuretic,0,1
222728,",",0,0
222729,were,0,0
222730,compared,0,0
222731,with,0,0
222732,those,0,0
222733,of,0,0
222734,furosemide,1,1
222735,(,0,1
222736,50,0,1
222737,mg/day,0,1
222738,),0,1
222739,in,0,0
222740,a,0,0
222741,randomized,0,1
222742,double-blind,0,1
222743,trial,0,1
222744,.,0,1
222745,Both,0,0
222746,drugs,0,1
222747,were,0,1
222748,administered,0,1
222749,in,0,0
222750,association,0,0
222751,with,0,1
222752,spironolactone,1,1
222753,(,0,1
222754,200,0,1
222755,mg/day,0,1
222756,),0,1
222757,in,0,0
222758,28,0,0
222759,nonazotemic,0,0
222760,cirrhotic,0,0
222761,patients,0,0
222762,with,0,0
222763,controlled,0,0
222764,ascites,0,0
222765,.,0,0
222766,The,0,0
222767,treatments,0,0
222768,did,0,0
222769,not,0,0
222770,modify,0,0
222771,creatinine,0,1
222772,clearance,0,1
222773,and,0,1
222774,exhibited,0,0
222775,a,0,0
222776,similar,0,0
222777,effect,0,0
222778,on,0,0
222779,body,0,0
222780,weight,0,0
222781,",",0,0
222782,urinary,0,0
222783,volume,0,0
222784,",",0,0
222785,and,0,0
222786,fractional,0,1
222787,excretion,0,1
222788,of,0,1
222789,uric,0,1
222790,acid,0,1
222791,",",0,1
222792,sodium,0,1
222793,",",0,1
222794,and,0,0
222795,chloride,0,1
222796,.,0,0
222797,The,0,0
222798,effect,0,0
222799,of,0,0
222800,torasemide,1,1
222801,on,0,1
222802,fractional,0,1
222803,potassium,0,1
222804,excretion,0,1
222805,was,0,0
222806,lower,0,0
222807,than,0,0
222808,that,0,0
222809,of,0,0
222810,furosemide,1,1
222811,.,1,1
222812,Torasemide,1,1
222813,showed,0,0
222814,higher,0,0
222815,sparing,0,0
222816,effect,0,0
222817,than,0,0
222818,furosemide,1,1
222819,on,0,1
222820,calcium,0,1
222821,",",0,1
222822,inorganic,0,1
222823,phosphate,0,1
222824,",",0,1
222825,and,0,1
222826,magnesium,0,1
222827,excretion,0,1
222828,and,0,1
222829,stronger,0,0
222830,action,0,0
222831,on,0,0
222832,free,0,0
222833,water,0,0
222834,clearance,0,1
222835,.,0,1
222836,No,0,1
222837,changes,0,0
222838,in,0,0
222839,serum,0,1
222840,parameters,0,0
222841,were,0,0
222842,induced,0,0
222843,by,0,0
222844,either,0,0
222845,treatment,0,0
222846,.,0,0
222847,Two,0,1
222848,episodes,0,0
222849,of,0,0
222850,hepatic,0,0
222851,encephalopathy,0,0
222852,occurred,0,0
222853,in,0,0
222854,the,0,0
222855,torasemide,1,1
222856,group,0,0
222857,.,0,0
222858,In,0,0
222859,view,0,0
222860,of,0,0
222861,its,0,0
222862,effects,0,0
222863,on,0,0
222864,sodium,0,1
222865,and,0,0
222866,water,0,0
222867,excretion,0,1
222868,and,0,0
222869,on,0,0
222870,other,0,0
222871,urinary,0,0
222872,parameters,0,0
222873,",",0,0
222874,torasemide,1,1
222875,can,0,0
222876,represent,0,0
222877,an,0,0
222878,alternative,0,0
222879,tool,0,0
222880,for,0,0
222881,the,0,0
222882,long-term,0,0
222883,treatment,0,0
222884,of,0,0
222885,ascites,0,0
222886,.,0,0
222887,Effect,0,0
222888,of,0,0
222889,extradural,1,1
222890,analgesia,1,1
222891,on,0,0
222892,stress,0,0
222893,responses,0,0
222894,to,0,0
222895,abdominal,0,0
222896,surgery,0,0
222897,in,0,0
222898,infants,0,0
222899,.,0,0
222900,We,0,0
222901,studied,0,0
222902,40,0,0
222903,children,0,0
222904,younger,0,1
222905,than,0,0
222906,4,0,0
222907,yr,0,0
222908,having,0,0
222909,elective,0,0
222910,abdominal,0,0
222911,surgery,0,0
222912,under,0,0
222913,general,1,0
222914,anaesthesia,1,0
222915,supplemented,0,0
222916,with,0,0
222917,either,0,0
222918,systemic,1,0
222919,opioids,1,1
222920,or,1,1
222921,extradural,1,1
222922,bupivacaine,1,1
222923,.,1,0
222924,Venous,1,0
222925,blood,1,0
222926,samples,1,0
222927,were,0,0
222928,obtained,0,0
222929,before,0,0
222930,tracheal,0,0
222931,intubation,0,0
222932,to,0,0
222933,measure,0,0
222934,baseline,0,0
222935,concentrations,0,1
222936,of,0,1
222937,adrenaline,0,1
222938,",",0,1
222939,noradrenaline,0,1
222940,",",0,1
222941,glucose,0,1
222942,",",0,1
222943,ACTH,0,1
222944,and,0,1
222945,cortisol,0,1
222946,.,0,0
222947,Additional,0,0
222948,samples,0,0
222949,were,0,0
222950,obtained,0,0
222951,45,0,0
222952,min,0,0
222953,after,0,0
222954,the,0,0
222955,start,0,0
222956,of,0,0
222957,surgery,0,0
222958,",",0,0
222959,at,0,0
222960,the,0,0
222961,end,0,0
222962,of,0,0
222963,surgery,0,0
222964,",",0,0
222965,1,0,0
222966,h,0,0
222967,and,0,0
222968,24,0,0
222969,h,0,0
222970,after,0,0
222971,the,0,0
222972,end,0,0
222973,of,0,0
222974,surgery,0,0
222975,.,0,0
222976,Plasma,0,1
222977,concentrations,0,1
222978,of,0,1
222979,bupivacaine,1,1
222980,were,0,0
222981,measured,0,0
222982,also,0,0
222983,in,0,0
222984,the,0,0
222985,extradural,0,0
222986,group,0,0
222987,at,0,0
222988,each,0,0
222989,sampling,0,0
222990,time,0,0
222991,.,0,0
222992,Both,0,0
222993,techniques,0,0
222994,provided,0,0
222995,acceptable,0,1
222996,analgesia,0,1
222997,",",0,0
222998,but,0,0
222999,the,0,0
223000,perioperative,0,0
223001,increases,0,0
223002,in,0,0
223003,adrenaline,0,1
223004,",",0,1
223005,glucose,0,1
223006,and,0,0
223007,ACTH,0,0
223008,were,0,0
223009,significantly,0,0
223010,greater,0,0
223011,in,0,0
223012,the,0,0
223013,opioid,0,1
223014,group,0,1
223015,.,0,1
223016,Noradrenaline,0,1
223017,concentrations,0,1
223018,decreased,0,0
223019,to,0,0
223020,less,0,0
223021,than,0,0
223022,baseline,0,0
223023,values,0,0
223024,in,0,0
223025,the,0,0
223026,extradural,0,0
223027,group,0,0
223028,and,0,0
223029,were,0,0
223030,significantly,0,0
223031,less,0,0
223032,than,0,0
223033,in,0,0
223034,the,0,0
223035,opioid,0,1
223036,group,0,0
223037,.,0,0
223038,The,0,0
223039,perioperative,0,0
223040,increase,0,0
223041,in,0,0
223042,cortisol,0,1
223043,was,0,0
223044,similar,0,0
223045,in,0,0
223046,the,0,0
223047,two,0,0
223048,groups,0,0
223049,",",0,0
223050,despite,0,0
223051,the,0,0
223052,differences,0,0
223053,in,0,0
223054,ACTH,0,0
223055,responses,0,0
223056,.,0,0
223057,Most,0,0
223058,responses,0,0
223059,returned,0,0
223060,to,0,0
223061,the,0,0
223062,baseline,0,0
223063,values,0,0
223064,within,0,0
223065,24,0,0
223066,h.,0,1
223067,Plasma,0,1
223068,bupivacaine,1,1
223069,concentrations,0,1
223070,remained,0,0
223071,within,0,0
223072,safe,0,0
223073,limits,0,0
223074,during,0,0
223075,the,0,0
223076,study,0,0
223077,",",0,0
223078,but,0,0
223079,systemic,0,0
223080,concentrations,0,0
223081,increased,0,0
223082,in,0,0
223083,some,0,0
223084,of,0,0
223085,the,0,0
223086,patients,0,0
223087,during,0,0
223088,postoperative,0,1
223089,infusion,0,1
223090,with,0,0
223091,0.125,0,1
223092,%,0,0
223093,bupivacaine,0,1
223094,.,0,0
223095,The,0,0
223096,relative,0,0
223097,contributions,0,0
223098,of,0,0
223099,medication,1,0
223100,adherence,1,0
223101,and,1,0
223102,AA,1,1
223103,meeting,1,1
223104,attendance,1,0
223105,to,0,0
223106,abstinent,0,0
223107,outcome,0,0
223108,for,0,0
223109,chronic,0,0
223110,alcoholics,0,0
223111,.,0,0
223112,Our,0,0
223113,preliminary,0,0
223114,studies,0,0
223115,of,0,0
223116,the,0,0
223117,efficacy,0,0
223118,of,0,0
223119,lithium,1,1
223120,carbonate,1,1
223121,therapy,1,1
223122,for,0,0
223123,alcoholism,0,0
223124,under,0,0
223125,double-blind,0,1
223126,",",0,1
223127,placebo-controlled,0,1
223128,conditions,0,0
223129,demonstrated,0,0
223130,that,0,0
223131,alcoholics,0,0
223132,who,0,0
223133,took,0,0
223134,their,0,0
223135,assigned,0,0
223136,medication,0,1
223137,(,1,1
223138,lithium,1,1
223139,or,1,1
223140,placebo,1,1
223141,),1,1
223142,for,0,0
223143,the,0,0
223144,first,0,0
223145,6,0,0
223146,months,0,0
223147,after,0,0
223148,discharge,0,0
223149,from,0,0
223150,an,0,0
223151,inpatient,0,0
223152,rehabilitation,0,0
223153,program,0,0
223154,were,0,0
223155,more,0,0
223156,likely,0,0
223157,to,0,0
223158,abstain,0,0
223159,from,0,0
223160,any,0,0
223161,alcohol,0,0
223162,use,0,0
223163,for,0,0
223164,18,0,0
223165,months,0,0
223166,following,0,0
223167,discharge,0,0
223168,than,0,0
223169,were,0,0
223170,alcoholics,0,0
223171,who,0,0
223172,took,0,0
223173,their,0,0
223174,medication,0,0
223175,erratically,0,0
223176,or,0,0
223177,not,0,0
223178,at,0,0
223179,all,0,0
223180,.,0,0
223181,Attendance,0,0
223182,at,0,0
223183,Alcoholics,0,0
223184,Anonymous,0,1
223185,(,0,1
223186,AA,0,1
223187,),0,1
223188,meetings,0,0
223189,was,0,0
223190,also,0,0
223191,associated,0,0
223192,with,0,0
223193,medication,0,0
223194,adherence,0,0
223195,.,0,0
223196,We,0,0
223197,applied,0,0
223198,a,0,0
223199,structural,0,0
223200,equation,0,0
223201,model,0,0
223202,to,0,0
223203,data,0,0
223204,on,0,0
223205,the,0,0
223206,relationships,0,0
223207,between,0,0
223208,medication,0,0
223209,adherence,0,0
223210,",",0,0
223211,AA,0,1
223212,meeting,0,1
223213,attendance,0,0
223214,and,0,0
223215,abstinent,0,0
223216,outcome,0,0
223217,to,0,0
223218,clarify,0,0
223219,whether,0,0
223220,medication,0,0
223221,adherence,0,0
223222,or,0,0
223223,AA,0,1
223224,meeting,0,1
223225,attendance,0,0
223226,better,0,0
223227,explains,0,0
223228,the,0,0
223229,positive-outcome,0,0
223230,adherence,0,0
223231,effect,0,0
223232,we,0,0
223233,observed,0,0
223234,.,0,0
223235,Both,0,0
223236,medication,0,0
223237,adherence,0,0
223238,and,0,0
223239,AA,0,1
223240,meeting,0,1
223241,attendance,0,0
223242,evidenced,0,0
223243,direct,0,0
223244,and,0,0
223245,independent,0,0
223246,influences,0,0
223247,on,0,0
223248,abstinent,0,0
223249,outcome,0,0
223250,:,0,0
223251,medication,0,0
223252,adherence,0,0
223253,showed,0,0
223254,a,0,0
223255,small,0,0
223256,direct,0,0
223257,influence,0,0
223258,",",0,0
223259,and,0,0
223260,AA,0,1
223261,meeting,0,0
223262,attendance,0,0
223263,showed,0,0
223264,a,0,0
223265,much,0,0
223266,larger,0,0
223267,",",0,0
223268,independent,0,0
223269,influence,0,0
223270,.,0,0
223271,[,0,0
223272,The,0,0
223273,effect,0,0
223274,of,0,0
223275,indobufen,1,1
223276,on,0,0
223277,aortocoronary,0,0
223278,bypass,0,0
223279,patency,0,0
223280,after,0,0
223281,1,0,0
223282,week,0,0
223283,and,0,0
223284,after,0,0
223285,1,0,0
223286,year,0,0
223287,],0,0
223288,.,0,0
223289,A,0,1
223290,randomized,0,0
223291,clinical,0,0
223292,study,0,0
223293,was,0,0
223294,conducted,0,0
223295,to,0,0
223296,compare,0,0
223297,the,0,0
223298,effect,0,0
223299,of,0,0
223300,conventional,1,0
223301,antiaggregation,1,1
223302,therapy,1,1
223303,(,1,1
223304,ASA,1,1
223305,plus,1,1
223306,dipyridamole,1,1
223307,),1,1
223308,versus,0,1
223309,indobufen,1,1
223310,in,0,0
223311,patients,0,0
223312,after,0,0
223313,aortocoronary,0,0
223314,bypass,0,1
223315,(,0,1
223316,ACB,0,1
223317,),0,1
223318,surgery,0,0
223319,.,0,0
223320,The,0,0
223321,patency,0,0
223322,of,0,0
223323,venous,0,0
223324,ACB,0,0
223325,using,0,0
223326,coronary,0,0
223327,DSA,0,0
223328,one,0,0
223329,week,0,0
223330,and,0,0
223331,one,0,0
223332,year,0,0
223333,after,0,0
223334,surgery,0,0
223335,was,0,0
223336,evaluated,0,0
223337,in,0,0
223338,52,0,0
223339,patients,0,0
223340,divided,0,0
223341,into,0,0
223342,two,0,0
223343,groups,0,0
223344,.,0,0
223345,The,0,0
223346,study,0,0
223347,included,0,0
223348,only,0,0
223349,ACB,0,0
223350,'s,0,0
223351,with,0,0
223352,intraoperative,0,0
223353,blood,0,0
223354,flow,0,0
223355,rates,0,0
223356,<,0,0
223357,or,0,0
223358,=,0,0
223359,40,0,0
223360,ml/min,0,0
223361,as,0,0
223362,it,0,0
223363,is,0,0
223364,just,0,0
223365,these,0,0
223366,ACB,0,0
223367,'s,0,0
223368,which,0,0
223369,are,0,0
223370,at,0,0
223371,the,0,0
223372,highest,0,0
223373,risk,0,0
223374,of,0,0
223375,early,0,0
223376,and,0,0
223377,late,0,0
223378,occlusions,0,0
223379,.,0,0
223380,While,0,0
223381,",",0,0
223382,in,0,0
223383,the,0,0
223384,ASA,1,0
223385,plus,1,0
223386,dipyridamole-treated,1,1
223387,group,0,1
223388,",",0,0
223389,occlusions,0,0
223390,were,0,0
223391,found,0,0
223392,in,0,0
223393,11,0,0
223394,of,0,0
223395,the,0,0
223396,39,0,0
223397,reconstructions,0,0
223398,(,0,0
223399,28.2,0,0
223400,%,0,0
223401,),0,0
223402,",",0,0
223403,the,0,0
223404,proportion,0,0
223405,was,0,0
223406,nine,0,0
223407,out,0,0
223408,of,0,0
223409,37,0,0
223410,procedures,0,0
223411,(,0,0
223412,24.3,0,0
223413,%,0,0
223414,),0,0
223415,in,0,0
223416,the,0,0
223417,indobufen,1,1
223418,group,0,0
223419,.,0,0
223420,One,0,0
223421,year,0,0
223422,after,0,0
223423,surgery,0,0
223424,",",0,0
223425,occlusion,0,0
223426,was,0,0
223427,found,0,0
223428,in,0,0
223429,14,0,0
223430,out,0,0
223431,of,0,0
223432,32,0,0
223433,ACB,0,0
223434,'s,0,0
223435,(,0,0
223436,43.7,0,0
223437,%,0,0
223438,),0,0
223439,in,0,0
223440,the,0,0
223441,ASA,0,0
223442,plus,0,0
223443,dipyridamole,1,1
223444,group,0,0
223445,compared,0,0
223446,to,0,0
223447,14,0,0
223448,occlusions,0,0
223449,in,0,0
223450,31,0,0
223451,ACB,0,0
223452,'s,0,0
223453,(,0,0
223454,45.2,0,0
223455,%,0,0
223456,),0,0
223457,in,0,0
223458,the,0,0
223459,indobufen,1,1
223460,group,0,0
223461,.,0,0
223462,The,0,0
223463,difference,0,0
223464,in,0,0
223465,the,0,0
223466,number,0,0
223467,of,0,0
223468,occlusions,0,0
223469,between,0,0
223470,the,0,0
223471,two,0,0
223472,groups,0,0
223473,was,0,0
223474,not,0,0
223475,statistically,0,0
223476,significant,0,0
223477,.,0,0
223478,Because,0,0
223479,of,0,0
223480,some,0,0
223481,benefits,0,0
223482,of,0,0
223483,indobufen,0,1
223484,compared,0,0
223485,to,0,0
223486,ASA,0,1
223487,(,0,0
223488,shorter,0,0
223489,time,0,0
223490,of,0,0
223491,effect,0,0
223492,",",0,0
223493,superior,0,0
223494,tolerance,0,0
223495,in,0,0
223496,patients,0,0
223497,with,0,0
223498,ulceration,0,0
223499,),0,0
223500,",",0,0
223501,the,0,0
223502,former,0,0
223503,drug,0,1
223504,can,0,0
223505,be,0,0
223506,recommended,0,0
223507,for,0,0
223508,use,0,0
223509,in,0,0
223510,some,0,0
223511,indicated,0,0
223512,cases,0,0
223513,.,0,0
223514,Neostigmine,1,1
223515,and,0,1
223516,edrophonium,1,1
223517,antagonism,0,1
223518,of,0,1
223519,moderate,0,0
223520,neuromuscular,0,0
223521,block,0,0
223522,induced,0,0
223523,by,0,0
223524,pancuronium,0,1
223525,or,0,1
223526,tubocurarine,0,1
223527,.,0,1
223528,Edrophonium,1,1
223529,and,1,1
223530,neostigmine,1,1
223531,are,0,1
223532,anticholinesterase,0,1
223533,drugs,0,1
223534,used,0,0
223535,commonly,0,0
223536,to,0,0
223537,antagonize,0,0
223538,competitive,0,0
223539,neuromuscular,0,0
223540,block,0,0
223541,.,0,0
223542,Although,0,0
223543,it,0,0
223544,has,0,0
223545,a,0,0
223546,faster,0,0
223547,onset,0,0
223548,of,0,0
223549,action,0,0
223550,than,0,0
223551,neostigmine,1,1
223552,",",1,1
223553,edrophonium,1,1
223554,is,0,0
223555,unreliable,0,0
223556,when,0,0
223557,used,0,0
223558,to,0,0
223559,antagonize,0,1
223560,deep,0,1
223561,neuromuscular,0,0
223562,block,0,0
223563,.,0,0
223564,We,0,0
223565,have,0,0
223566,compared,0,0
223567,the,0,0
223568,antagonist,0,1
223569,characteristics,0,0
223570,of,0,0
223571,these,0,0
223572,two,0,0
223573,drugs,0,1
223574,when,0,0
223575,used,0,0
223576,to,0,0
223577,antagonize,0,0
223578,a,0,0
223579,moderate,0,0
223580,degree,0,0
223581,of,0,0
223582,pancuronium-,0,1
223583,or,0,1
223584,tubocurarine-induced,0,1
223585,neuromuscular,0,1
223586,block,0,0
223587,.,0,0
223588,Forty,0,0
223589,ASA,0,0
223590,I,0,0
223591,or,0,0
223592,II,0,0
223593,patients,0,0
223594,undergoing,0,0
223595,surgical,0,0
223596,procedures,0,0
223597,were,0,0
223598,allocated,1,0
223599,randomly,1,0
223600,to,1,0
223601,receive,1,0
223602,either,1,0
223603,pancuronium,1,1
223604,70,1,1
223605,micrograms,1,1
223606,kg-1,1,1
223607,or,1,1
223608,tubocurarine,1,1
223609,0.5,1,1
223610,mg,1,1
223611,kg-1,1,1
223612,",",1,1
223613,and,1,0
223614,to,1,0
223615,receive,1,0
223616,either,1,0
223617,edrophonium,1,1
223618,0.5,1,1
223619,mg,1,1
223620,kg-1,1,1
223621,or,1,1
223622,neostigmine,1,1
223623,0.05,1,1
223624,mg,1,1
223625,kg-1,1,1
223626,.,1,1
223627,Antagonism,0,0
223628,was,0,0
223629,attempted,0,0
223630,when,0,0
223631,the,0,0
223632,first,0,0
223633,response,0,0
223634,to,0,0
223635,train-of-four,0,0
223636,(,0,1
223637,TOF,0,1
223638,),0,0
223639,stimulation,0,0
223640,recovered,0,0
223641,spontaneously,0,0
223642,to,0,0
223643,25,0,0
223644,%,0,0
223645,of,0,0
223646,the,0,0
223647,control,0,0
223648,height,0,0
223649,.,0,0
223650,Neuromuscular,0,0
223651,function,0,0
223652,was,0,0
223653,monitored,0,0
223654,using,0,0
223655,the,0,0
223656,evoked,0,0
223657,integrated,0,0
223658,electromyogram,0,0
223659,of,0,0
223660,the,0,0
223661,first,0,0
223662,dorsal,0,0
223663,interosseous,0,0
223664,muscle,0,0
223665,of,0,0
223666,the,0,0
223667,hand,0,0
223668,.,0,0
223669,Adequate,0,0
223670,recovery,0,0
223671,was,0,0
223672,defined,0,0
223673,as,0,0
223674,the,0,0
223675,achievement,0,0
223676,of,0,0
223677,a,0,0
223678,TOF,0,0
223679,ratio,0,0
223680,of,0,0
223681,0.70,0,0
223682,or,0,0
223683,greater,0,0
223684,.,0,0
223685,Only,0,0
223686,seven,0,0
223687,of,0,0
223688,20,0,0
223689,patients,0,0
223690,who,0,0
223691,received,0,0
223692,edrophonium,0,1
223693,demonstrated,0,0
223694,adequate,0,0
223695,recovery,0,0
223696,30,0,0
223697,min,0,0
223698,after,0,0
223699,antagonism,0,1
223700,.,0,0
223701,Under,0,0
223702,the,0,0
223703,conditions,0,0
223704,described,0,0
223705,in,0,0
223706,this,0,0
223707,study,0,0
223708,",",0,0
223709,edrophonium,0,1
223710,0.5,0,1
223711,mg,0,1
223712,kg-1,0,1
223713,was,0,0
223714,less,0,0
223715,effective,0,0
223716,as,0,0
223717,an,0,0
223718,antagonist,0,1
223719,than,0,1
223720,neostigmine,0,1
223721,0.05,0,1
223722,mg,0,1
223723,kg-1,0,1
223724,.,0,1
223725,Beta-carotene,1,1
223726,in,0,1
223727,HIV,0,1
223728,infection,0,1
223729,.,0,0
223730,beta-Carotene,1,1
223731,has,0,0
223732,been,0,0
223733,reported,0,0
223734,to,0,0
223735,have,0,0
223736,an,0,0
223737,immunostimulatory,0,1
223738,effect,0,0
223739,.,0,0
223740,Recent,0,0
223741,studies,0,0
223742,suggest,0,0
223743,that,0,0
223744,beta-carotene,1,1
223745,supplementation,1,1
223746,can,0,0
223747,increase,0,0
223748,CD4,0,0
223749,counts,0,0
223750,in,0,0
223751,HIV-infected,0,0
223752,patients,0,0
223753,.,0,0
223754,Our,0,0
223755,double-blind,0,1
223756,",",0,1
223757,placebo-controlled,1,1
223758,clinical,0,1
223759,trial,0,0
223760,was,0,0
223761,designed,0,0
223762,to,0,0
223763,test,0,0
223764,the,0,0
223765,efficacy,0,0
223766,of,0,0
223767,beta-carotene,1,1
223768,in,0,0
223769,raising,0,0
223770,CD4,0,0
223771,counts,0,0
223772,in,0,0
223773,HIV-infected,0,0
223774,patients,0,0
223775,.,0,0
223776,Twenty-one,0,0
223777,HIV-seropositive,0,0
223778,patients,0,0
223779,were,0,0
223780,randomized,0,0
223781,to,0,0
223782,receive,0,0
223783,either,0,0
223784,beta-carotene,1,1
223785,",",1,0
223786,180,1,0
223787,mg/day,1,1
223788,or,1,0
223789,placebo,1,1
223790,for,0,0
223791,4,0,0
223792,weeks,0,0
223793,",",0,0
223794,and,0,0
223795,then,0,0
223796,crossed,0,0
223797,over,0,0
223798,to,0,0
223799,receive,0,0
223800,the,0,0
223801,alternative,0,0
223802,treatment,0,0
223803,for,0,0
223804,the,0,0
223805,following,0,0
223806,4,0,0
223807,weeks,0,0
223808,.,0,0
223809,beta-Carotene,0,1
223810,resulted,0,0
223811,in,0,0
223812,a,0,0
223813,statistically,0,0
223814,significant,0,0
223815,increase,0,0
223816,in,0,0
223817,total,0,0
223818,WBC,0,1
223819,count,0,0
223820,(,0,0
223821,p,0,0
223822,=,0,0
223823,0.01,0,0
223824,),0,0
223825,",",0,0
223826,%,0,0
223827,change,0,0
223828,in,0,0
223829,CD4,0,1
223830,count,0,0
223831,(,0,0
223832,p,0,0
223833,=,0,0
223834,0.02,0,0
223835,),0,0
223836,",",0,0
223837,and,0,0
223838,%,0,0
223839,change,0,0
223840,in,0,0
223841,CD4/CD8,0,0
223842,ratios,0,0
223843,(,0,0
223844,p,0,0
223845,=,0,0
223846,0.02,0,0
223847,),0,0
223848,compared,0,0
223849,to,0,0
223850,placebo,0,1
223851,.,0,0
223852,The,0,0
223853,absolute,0,0
223854,CD4,0,0
223855,count,0,0
223856,",",0,0
223857,absolute,0,0
223858,CD4/CD8,0,1
223859,ratio,0,0
223860,",",0,0
223861,and,0,0
223862,total,0,0
223863,and,0,0
223864,B-lymphocytes,0,0
223865,all,0,0
223866,increased,0,0
223867,on,0,0
223868,carotene,0,1
223869,and,0,0
223870,fell,0,0
223871,during,0,0
223872,placebo,0,1
223873,",",0,0
223874,but,0,0
223875,these,0,0
223876,differences,0,0
223877,did,0,0
223878,not,0,0
223879,reach,0,0
223880,statistical,0,0
223881,significance,0,0
223882,.,0,0
223883,No,0,0
223884,toxicity,0,0
223885,was,0,0
223886,observed,0,0
223887,on,0,0
223888,either,0,0
223889,treatment,0,0
223890,.,0,0
223891,beta-Carotene,0,1
223892,appears,0,0
223893,to,0,0
223894,have,0,0
223895,an,0,0
223896,immunostimulatory,0,1
223897,effect,0,0
223898,in,0,0
223899,HIV-infected,0,0
223900,patients,0,0
223901,.,0,0
223902,Further,0,0
223903,studies,0,0
223904,are,0,0
223905,needed,0,0
223906,to,0,0
223907,demonstrate,0,0
223908,whether,0,0
223909,beta-carotene,0,1
223910,has,0,0
223911,a,0,0
223912,role,0,0
223913,as,0,0
223914,adjunct,0,0
223915,therapy,0,0
223916,in,0,0
223917,treatment,0,0
223918,of,0,0
223919,HIV-infected,0,0
223920,patients,0,0
223921,.,0,0
223922,Antinuclear,0,0
223923,antibodies,0,0
223924,with,0,0
223925,enalapril,1,1
223926,.,1,0
223927,A,0,1
223928,randomized,0,0
223929,trial,0,0
223930,of,0,0
223931,radiation,1,0
223932,therapy,1,0
223933,compared,0,0
223934,to,0,0
223935,split,1,0
223936,course,1,0
223937,radiation,1,0
223938,therapy,1,0
223939,combined,1,0
223940,with,1,0
223941,mitomycin,1,1
223942,C,1,1
223943,and,1,1
223944,5,1,0
223945,fluorouracil,1,1
223946,as,0,0
223947,initial,0,0
223948,treatment,0,0
223949,for,0,0
223950,advanced,0,0
223951,laryngeal,0,0
223952,and,0,0
223953,hypopharyngeal,0,0
223954,squamous,0,0
223955,carcinoma,0,0
223956,.,0,0
223957,Two,0,0
223958,hundred,0,0
223959,and,0,0
223960,twelve,0,0
223961,patients,0,0
223962,with,0,0
223963,previously,0,0
223964,untreated,0,0
223965,advanced,0,0
223966,squamous,0,0
223967,carcinoma,0,0
223968,of,0,0
223969,the,0,0
223970,larynx,0,0
223971,or,0,0
223972,hypopharynx,0,0
223973,were,0,0
223974,randomized,0,0
223975,to,0,0
223976,receive,0,0
223977,initial,0,0
223978,treatment,0,0
223979,with,0,0
223980,radiotherapy,1,0
223981,",",1,0
223982,50,1,0
223983,Gy,1,0
223984,in,1,0
223985,20,1,0
223986,fractions,1,0
223987,in,1,0
223988,28,1,0
223989,days,1,0
223990,or,0,0
223991,split,1,0
223992,course,1,0
223993,radiotherapy,1,0
223994,and,1,0
223995,concurrent,1,0
223996,chemotherapy,1,0
223997,",",1,0
223998,25,1,0
223999,Gy,1,0
224000,in,1,0
224001,10,1,0
224002,fractions,1,0
224003,in,1,0
224004,14,1,0
224005,days,1,0
224006,followed,1,0
224007,by,1,0
224008,a,1,0
224009,4,1,0
224010,week,1,0
224011,rest,1,0
224012,and,1,0
224013,a,1,0
224014,further,1,0
224015,25,1,0
224016,Gy,1,0
224017,in,1,0
224018,10,1,0
224019,fractions,1,0
224020,in,1,0
224021,14,1,0
224022,days,1,0
224023,starting,1,0
224024,on,1,0
224025,day,1,0
224026,43,1,0
224027,;,1,0
224028,Mitomycin,1,1
224029,C,1,1
224030,was,1,0
224031,given,1,0
224032,on,1,0
224033,day,1,0
224034,1,1,0
224035,and,1,0
224036,day,1,0
224037,43,1,0
224038,and,1,0
224039,5FU,1,0
224040,continuous,1,0
224041,infusions,1,1
224042,on,1,1
224043,days,1,0
224044,1,1,0
224045,--,1,0
224046,4,1,0
224047,and,1,0
224048,days,1,0
224049,43,1,0
224050,--,1,0
224051,46,1,0
224052,.,1,0
224053,Surgery,0,0
224054,was,0,0
224055,reserved,0,0
224056,for,0,0
224057,persistent,0,0
224058,or,0,0
224059,recurrent,0,0
224060,disease,0,0
224061,.,0,0
224062,Two,0,0
224063,hundred,0,0
224064,and,0,0
224065,nine,0,0
224066,of,0,0
224067,the,0,0
224068,212,0,0
224069,patients,0,0
224070,randomized,0,0
224071,were,0,0
224072,included,0,0
224073,in,0,0
224074,the,0,0
224075,analyses,0,0
224076,.,0,0
224077,Outcome,0,0
224078,analyses,0,0
224079,were,0,0
224080,performed,0,0
224081,at,0,0
224082,a,0,0
224083,median,0,0
224084,follow-up,0,0
224085,interval,0,0
224086,of,0,0
224087,4.4,0,0
224088,years,0,0
224089,.,0,0
224090,No,0,0
224091,patients,0,0
224092,were,0,0
224093,lost,0,0
224094,to,0,0
224095,follow-up,0,0
224096,.,0,0
224097,No,0,0
224098,significant,0,0
224099,difference,0,0
224100,was,0,0
224101,found,0,0
224102,between,0,0
224103,the,0,0
224104,two,0,0
224105,arms,0,0
224106,for,0,0
224107,the,0,0
224108,end,0,0
224109,points,0,0
224110,of,0,0
224111,local,0,0
224112,relapse-free,0,0
224113,rate,0,0
224114,(,0,0
224115,p,0,0
224116,=,0,0
224117,0.91,0,0
224118,),0,0
224119,",",0,0
224120,regional,0,0
224121,relapse-free,0,0
224122,rate,0,0
224123,(,0,0
224124,p,0,0
224125,=,0,0
224126,0.17,0,0
224127,",",0,0
224128,adjusted,0,0
224129,),0,0
224130,or,0,0
224131,overall,0,0
224132,survival,0,0
224133,(,0,0
224134,p,0,0
224135,=,0,0
224136,0.86,0,0
224137,),0,0
224138,.,0,0
224139,Eight-eight,0,0
224140,patients,0,0
224141,had,0,0
224142,attempted,0,0
224143,surgical,0,0
224144,resection,0,0
224145,following,0,0
224146,radiotherapy,1,0
224147,failure,0,0
224148,.,0,0
224149,The,0,0
224150,contribution,0,0
224151,of,0,0
224152,salvage,0,0
224153,surgery,0,0
224154,to,0,0
224155,overall,0,0
224156,survival,0,0
224157,was,0,0
224158,similar,0,0
224159,for,0,0
224160,both,0,0
224161,arms,0,0
224162,of,0,0
224163,the,0,0
224164,study,0,0
224165,as,0,0
224166,was,0,0
224167,the,0,0
224168,surgical,0,0
224169,complication,0,0
224170,rate,0,0
224171,.,0,0
224172,Serious,0,0
224173,late,0,0
224174,radiation,0,0
224175,toxicity,0,0
224176,was,0,0
224177,minimal,0,0
224178,(,0,0
224179,3,0,0
224180,%,0,0
224181,in,0,0
224182,the,0,0
224183,RT,0,0
224184,group,0,0
224185,",",0,0
224186,0,0,0
224187,%,0,0
224188,in,0,0
224189,the,0,0
224190,radiation,0,0
224191,therapy,0,0
224192,plus,0,0
224193,chemotherapy,0,1
224194,group,0,0
224195,),0,0
224196,.,0,0
224197,The,0,0
224198,result,0,0
224199,of,0,0
224200,the,0,0
224201,trial,0,0
224202,shows,0,0
224203,no,0,0
224204,advantage,0,0
224205,in,0,0
224206,terms,0,0
224207,of,0,0
224208,local,0,0
224209,control,0,0
224210,or,0,0
224211,survival,0,0
224212,for,0,0
224213,the,0,0
224214,experimental,0,0
224215,treatment,0,0
224216,arm,0,0
224217,of,0,0
224218,split,0,0
224219,course,0,0
224220,radiotherapy,1,0
224221,and,0,0
224222,concurrent,1,0
224223,chemotherapy,1,0
224224,with,1,0
224225,Mitomycin,1,1
224226,C,1,1
224227,and,1,1
224228,5,1,0
224229,Fluorouracil,1,1
224230,compared,0,0
224231,to,0,0
224232,radiotherapy,0,0
224233,alone,0,0
224234,.,0,0
224235,Hypotensive,0,1
224236,effects,0,1
224237,and,0,0
224238,influence,0,0
224239,on,0,0
224240,serum,0,1
224241,lipids,0,0
224242,of,0,0
224243,"SQ29,852",1,0
224244,",",1,0
224245,a,1,0
224246,new,1,0
224247,angiotensin,1,1
224248,converting,1,0
224249,enzyme,1,0
224250,inhibitor,1,0
224251,",",0,0
224252,in,0,0
224253,patients,0,0
224254,with,0,0
224255,essential,0,0
224256,hypertension,0,0
224257,:,0,0
224258,a,0,0
224259,comparison,0,0
224260,with,0,0
224261,atenolol,1,1
224262,.,1,0
224263,The,0,0
224264,effects,0,0
224265,of,0,0
224266,"SQ29,852",1,1
224267,(,0,0
224268,n,0,0
224269,=,0,0
224270,24,0,0
224271,),0,0
224272,",",0,0
224273,a,0,0
224274,new,0,0
224275,angiotensin,1,1
224276,converting,1,0
224277,enzyme,1,0
224278,inhibitor,1,1
224279,",",0,1
224280,and,0,1
224281,atenolol,1,1
224282,(,0,0
224283,n,0,0
224284,=,0,0
224285,22,0,0
224286,),0,0
224287,",",0,0
224288,monotherapies,0,1
224289,were,0,0
224290,compared,0,0
224291,in,0,0
224292,46,0,0
224293,patients,0,0
224294,with,0,0
224295,mild,0,0
224296,to,0,0
224297,moderate,0,0
224298,essential,0,0
224299,hypertension,0,0
224300,.,0,0
224301,Both,0,1
224302,"SQ29,852",1,1
224303,(,0,0
224304,mean,0,0
224305,dose,0,0
224306,15.0,0,0
224307,+/-,0,0
224308,5.1,0,0
224309,mg/day,0,0
224310,),0,1
224311,and,0,1
224312,atenolol,1,1
224313,(,0,1
224314,mean,0,0
224315,dose,0,0
224316,37.5,0,0
224317,+/-,0,0
224318,18.5,0,0
224319,mg/day,0,0
224320,),0,0
224321,significantly,0,0
224322,decreased,0,0
224323,both,0,0
224324,systolic,0,0
224325,and,0,0
224326,diastolic,0,0
224327,blood,0,0
224328,pressures,0,0
224329,.,0,0
224330,There,0,0
224331,were,0,0
224332,no,0,0
224333,significant,0,0
224334,changes,0,0
224335,in,0,0
224336,serum,0,1
224337,lipids,0,1
224338,",",0,1
224339,apolipoproteins,0,1
224340,",",0,1
224341,lipoproteins,0,1
224342,or,0,1
224343,atherosclerotic,0,0
224344,indices,0,0
224345,after,0,0
224346,both,0,0
224347,"SQ29,852",1,0
224348,and,0,0
224349,atenolol,1,1
224350,.,1,0
224351,There,0,0
224352,were,0,0
224353,also,0,0
224354,no,0,0
224355,significant,0,0
224356,inter-group,0,0
224357,differences,0,0
224358,.,0,0
224359,There,0,0
224360,were,0,0
224361,no,0,0
224362,serious,0,0
224363,side,0,0
224364,effects,0,0
224365,or,0,0
224366,abnormal,0,0
224367,laboratory,0,0
224368,tests,0,0
224369,in,0,0
224370,both,0,0
224371,treatment,0,0
224372,groups,0,0
224373,.,0,0
224374,It,0,0
224375,is,0,0
224376,concluded,0,0
224377,that,0,0
224378,"SQ29,852",1,0
224379,is,0,0
224380,an,0,0
224381,effective,0,0
224382,antihypertensive,0,1
224383,drug,0,1
224384,without,0,1
224385,adverse,0,0
224386,effect,0,0
224387,on,0,0
224388,lipid,0,0
224389,metabolism,0,0
224390,.,0,0
224391,[,0,1
224392,Prevention,0,0
224393,of,0,0
224394,pneumonia,0,0
224395,by,0,0
224396,endotracheal,0,1
224397,micronebulization,0,1
224398,of,0,1
224399,tobramycin,1,1
224400,],1,1
224401,.,0,0
224402,In,0,0
224403,69,0,0
224404,artificially,0,0
224405,ventilated,0,0
224406,patients,0,0
224407,the,0,0
224408,clinical,0,0
224409,",",0,0
224410,bacteriological,0,0
224411,and,0,0
224412,pharmacological,0,0
224413,effects,0,0
224414,of,0,0
224415,endotracheally,0,1
224416,administered,0,1
224417,tobramycin,1,1
224418,were,0,0
224419,studied,0,0
224420,in,0,0
224421,comparison,0,0
224422,to,0,0
224423,a,0,0
224424,control,0,0
224425,group,0,0
224426,.,0,0
224427,In,0,0
224428,the,0,0
224429,therapy,0,0
224430,group,0,0
224431,",",0,0
224432,52,0,0
224433,%,0,0
224434,of,0,0
224435,all,0,0
224436,specimens,0,0
224437,were,0,0
224438,sterile,0,0
224439,",",0,0
224440,in,0,0
224441,the,0,0
224442,control,0,0
224443,group,0,0
224444,only,0,0
224445,25,0,0
224446,%,0,0
224447,.,0,0
224448,During,0,0
224449,the,0,0
224450,first,0,0
224451,4,0,0
224452,days,0,0
224453,these,0,0
224454,changes,0,0
224455,were,0,0
224456,significant,0,0
224457,(,0,0
224458,p,0,0
224459,<,0,0
224460,0.05,0,0
224461,),0,0
224462,.,0,0
224463,In,0,0
224464,the,0,0
224465,therapy,0,0
224466,group,0,0
224467,the,0,0
224468,endotracheal,0,0
224469,colonisation,0,0
224470,with,0,0
224471,ps,0,0
224472,.,0,0
224473,aeruginosa,0,0
224474,was,0,0
224475,significantly,0,0
224476,lower,0,0
224477,between,0,0
224478,the,0,0
224479,4th,0,0
224480,and,0,0
224481,14th,0,1
224482,day,0,0
224483,(,0,0
224484,p,0,0
224485,<,0,0
224486,0.05,0,0
224487,),0,0
224488,.,0,0
224489,The,0,0
224490,incidence,0,0
224491,of,0,0
224492,secondary,0,0
224493,pneumonia,0,0
224494,was,0,0
224495,reduced,0,0
224496,from,0,0
224497,42,0,0
224498,%,0,0
224499,to,0,0
224500,17.5,0,0
224501,%,0,0
224502,(,0,0
224503,not,0,0
224504,significant,0,0
224505,),0,0
224506,.,0,0
224507,Systemic,0,1
224508,administration,0,1
224509,of,0,1
224510,antibiotics,0,1
224511,",",0,0
224512,e.g,0,0
224513,.,0,0
224514,of,0,0
224515,aminoglycosides,0,1
224516,",",0,0
224517,was,0,0
224518,significantly,0,0
224519,more,0,0
224520,often,0,0
224521,necessary,0,0
224522,in,0,0
224523,the,0,0
224524,control,0,0
224525,group,0,0
224526,.,0,0
224527,No,0,1
224528,increasing,0,0
224529,of,0,0
224530,growth,0,0
224531,of,0,0
224532,fungi,0,0
224533,in,0,0
224534,the,0,0
224535,upper,0,0
224536,respiratory,0,0
224537,tract,0,0
224538,was,0,0
224539,observed,0,0
224540,",",0,0
224541,but,0,0
224542,these,0,0
224543,was,0,0
224544,a,0,0
224545,non-significantly,0,0
224546,higher,0,0
224547,incidence,0,0
224548,mainly,0,0
224549,of,0,0
224550,staph,0,0
224551,.,0,0
224552,epidermidis,0,1
224553,.,0,0
224554,The,0,0
224555,application,0,0
224556,of,0,0
224557,80,0,1
224558,mg,0,1
224559,tobramycin,0,1
224560,four,0,0
224561,times,0,1
224562,a,0,0
224563,day,0,0
224564,as,0,0
224565,an,0,0
224566,aerosol,0,1
224567,was,0,0
224568,well,0,0
224569,tolerated,0,1
224570,by,0,0
224571,the,0,0
224572,patients,0,0
224573,.,0,0
224574,Under,0,0
224575,there,0,0
224576,conditions,0,0
224577,",",0,0
224578,tobramycin,0,1
224579,could,0,0
224580,not,0,0
224581,be,0,0
224582,measured,0,0
224583,in,0,0
224584,the,0,0
224585,serum,0,1
224586,.,0,1
224587,No,0,1
224588,allergic,0,0
224589,reactions,0,0
224590,",",0,0
224591,increased,0,0
224592,respiratory,0,0
224593,pressures,0,1
224594,or,0,0
224595,bronchoconstrictions,0,1
224596,were,0,0
224597,observed,0,0
224598,.,0,0
224599,Double-blind,0,1
224600,randomized,0,1
224601,evaluation,0,0
224602,of,0,0
224603,intercostal,1,0
224604,nerve,1,0
224605,blocks,1,0
224606,as,0,0
224607,an,0,0
224608,adjuvant,0,1
224609,to,0,1
224610,subarachnoid,0,1
224611,administered,0,1
224612,morphine,1,1
224613,for,0,1
224614,post-thoracotomy,0,1
224615,analgesia,0,1
224616,.,0,1
224617,BACKGROUND,0,1
224618,AND,0,1
224619,OBJECTIVES,0,1
224620,Thoracotomy,0,0
224621,is,0,0
224622,associated,0,0
224623,with,0,0
224624,pain,0,0
224625,and,0,0
224626,compromised,0,0
224627,pulmonary,0,0
224628,function,0,0
224629,.,0,0
224630,Intercostal,1,0
224631,nerve,1,0
224632,blocks,1,0
224633,(,1,1
224634,INB,1,1
224635,),1,1
224636,and,0,0
224637,subarachnoid,1,1
224638,morphine,1,1
224639,(,1,1
224640,SM,1,1
224641,),1,1
224642,act,0,0
224643,on,0,0
224644,different,0,0
224645,portions,0,0
224646,of,0,0
224647,the,0,0
224648,pain,0,0
224649,pathway,0,0
224650,.,0,0
224651,Each,0,0
224652,is,0,0
224653,effective,0,0
224654,for,0,0
224655,post-thoracotomy,0,0
224656,pain,0,0
224657,relief,0,0
224658,.,0,0
224659,The,0,0
224660,combination,0,0
224661,of,0,0
224662,these,0,0
224663,two,0,0
224664,modalities,0,0
224665,in,0,0
224666,relieving,0,0
224667,post-thoracotomy,0,0
224668,pain,0,0
224669,and,0,0
224670,improving,0,0
224671,postoperative,0,0
224672,pulmonary,0,0
224673,function,0,0
224674,has,0,0
224675,not,0,0
224676,been,0,0
224677,investigated,0,0
224678,.,0,0
224679,METHODS,0,0
224680,In,0,0
224681,a,0,0
224682,double-blind,0,1
224683,study,0,0
224684,",",0,0
224685,20,0,0
224686,patients,0,0
224687,undergoing,0,0
224688,lateral,0,0
224689,thoracotomy,1,0
224690,for,0,0
224691,lung,0,0
224692,resection,0,0
224693,were,0,0
224694,randomized,0,0
224695,to,0,0
224696,receive,0,1
224697,0.5,1,1
224698,mg,1,1
224699,SM,1,1
224700,preoperatively,1,1
224701,and,1,0
224702,INB,1,1
224703,with,1,1
224704,bupivacaine,1,1
224705,(,1,1
224706,INB+,1,1
224707,),1,1
224708,prior,1,0
224709,to,1,0
224710,wound,1,0
224711,closure,1,0
224712,or,1,0
224713,0.5,1,1
224714,mg,1,1
224715,SM,1,1
224716,with,1,0
224717,INB,1,0
224718,using,1,0
224719,saline,1,1
224720,(,1,1
224721,INB-,1,1
224722,),1,1
224723,.,1,0
224724,Visual,0,0
224725,analog,0,1
224726,scale,0,1
224727,pain,0,1
224728,scores,0,0
224729,at,0,0
224730,rest,0,0
224731,",",0,0
224732,with,0,0
224733,cough,0,0
224734,",",0,0
224735,and,0,0
224736,with,0,0
224737,movement,0,0
224738,of,0,0
224739,the,0,0
224740,ipsilateral,0,0
224741,arm,0,0
224742,",",0,0
224743,forced,0,0
224744,expiratory,0,0
224745,volume,0,0
224746,in,0,0
224747,1,0,0
224748,second,0,0
224749,(,0,1
224750,FEV1,0,1
224751,),0,1
224752,",",0,0
224753,and,0,0
224754,forced,0,0
224755,vital,0,0
224756,capacity,0,0
224757,(,0,0
224758,FVC,0,1
224759,),0,0
224760,were,0,0
224761,measured,0,0
224762,at,0,0
224763,4,0,0
224764,",",0,0
224765,24,0,0
224766,",",0,0
224767,48,0,0
224768,",",0,0
224769,and,0,0
224770,72,0,0
224771,hours,0,0
224772,after,0,0
224773,the,0,0
224774,operation,0,0
224775,.,0,0
224776,Opioid,0,0
224777,use,0,0
224778,was,0,0
224779,measured,0,0
224780,during,0,0
224781,the,0,0
224782,initial,0,0
224783,24,0,0
224784,hours,0,0
224785,after,0,0
224786,the,0,0
224787,operation,0,0
224788,.,0,0
224789,RESULTS,0,0
224790,At,0,1
224791,4,0,1
224792,hours,0,0
224793,",",0,0
224794,the,0,0
224795,INB+,1,1
224796,group,0,0
224797,demonstrated,0,0
224798,better,0,0
224799,FEV1,0,0
224800,(,0,0
224801,56.6,0,0
224802,%,0,0
224803,vs.,0,0
224804,40.4,0,0
224805,%,0,0
224806,of,0,0
224807,baseline,0,0
224808,",",0,0
224809,P,0,0
224810,<,0,0
224811,.05,0,0
224812,),0,0
224813,and,0,0
224814,FVC,0,1
224815,values,0,0
224816,(,0,0
224817,54.6,0,0
224818,%,0,0
224819,vs.,0,0
224820,39.6,0,0
224821,%,0,0
224822,of,0,0
224823,baseline,0,0
224824,",",0,0
224825,P,0,0
224826,<,0,0
224827,.05,0,0
224828,),0,0
224829,and,0,0
224830,less,0,0
224831,resting,0,0
224832,and,0,0
224833,cough,0,1
224834,pain,0,0
224835,(,0,0
224836,P,0,0
224837,<,0,0
224838,.05,0,0
224839,),0,0
224840,.,0,0
224841,However,0,0
224842,",",0,0
224843,FEV1,0,0
224844,continued,0,0
224845,to,0,0
224846,decline,0,0
224847,in,0,0
224848,the,0,0
224849,INB+,1,0
224850,group,0,0
224851,at,0,0
224852,24,0,0
224853,hours,0,0
224854,to,0,0
224855,lower,0,0
224856,than,0,0
224857,the,0,0
224858,INB-,1,1
224859,group,0,0
224860,although,0,0
224861,pain,0,0
224862,scores,0,0
224863,were,0,0
224864,similar,0,0
224865,beyond,0,0
224866,4,0,0
224867,hours,0,0
224868,.,0,0
224869,Opioid,0,0
224870,usage,0,0
224871,during,0,0
224872,the,0,0
224873,first,0,0
224874,24,0,0
224875,hours,0,0
224876,was,0,0
224877,similar,0,0
224878,(,1,0
224879,INB-,1,0
224880,",",0,0
224881,16.7,0,0
224882,mg,0,0
224883,vs.,0,0
224884,INB+,1,0
224885,",",0,0
224886,13.2,0,0
224887,mg,0,0
224888,",",0,0
224889,P,0,0
224890,=,0,0
224891,.7,0,0
224892,),0,0
224893,.,0,0
224894,CONCLUSIONS,0,0
224895,Although,0,0
224896,postoperative,0,0
224897,INB,1,0
224898,provided,0,0
224899,modest,0,0
224900,improvements,0,0
224901,in,0,0
224902,pain,0,0
224903,and,0,0
224904,pulmonary,0,0
224905,function,0,0
224906,when,0,0
224907,used,0,0
224908,as,0,0
224909,an,0,0
224910,adjuvant,0,1
224911,to,0,1
224912,0.5,0,1
224913,mg,0,1
224914,SM,1,1
224915,for,0,1
224916,post-thoracotomy,0,1
224917,analgesia,0,1
224918,",",0,0
224919,the,0,0
224920,benefits,0,0
224921,were,0,0
224922,transient,0,0
224923,.,0,0
224924,The,0,0
224925,authors,0,0
224926,do,0,0
224927,not,0,0
224928,recommend,0,0
224929,adding,0,0
224930,INB,1,0
224931,for,0,0
224932,patients,0,0
224933,undergoing,0,0
224934,lateral,0,0
224935,thoracotomy,0,0
224936,who,0,0
224937,receive,0,1
224938,0.5,0,1
224939,mg,0,1
224940,SM,1,1
224941,.,1,0
224942,Lack,0,0
224943,of,0,0
224944,interaction,0,0
224945,between,0,0
224946,pantoprazole,1,1
224947,and,1,1
224948,digoxin,1,1
224949,at,0,1
224950,therapeutic,0,1
224951,doses,0,1
224952,in,0,0
224953,man,0,0
224954,.,0,0
224955,Substituted,1,1
224956,benzimidazole,1,1
224957,inhibitors,1,1
224958,of,0,0
224959,the,0,0
224960,gastric,0,0
224961,H+/K+ATPase,0,0
224962,may,0,0
224963,interact,0,0
224964,with,0,0
224965,the,0,0
224966,cytochrome,0,0
224967,P450,0,1
224968,enzyme,0,0
224969,system,0,0
224970,and,0,0
224971,alter,0,0
224972,the,0,0
224973,pharmacokinetics,0,1
224974,of,0,1
224975,coadministered,0,1
224976,drugs,0,1
224977,.,0,1
224978,On,0,0
224979,the,0,0
224980,other,0,0
224981,hand,0,0
224982,",",0,0
224983,changes,0,0
224984,in,0,0
224985,intragastric,0,1
224986,pH,0,1
224987,might,0,0
224988,alter,0,0
224989,the,0,0
224990,absorption,0,0
224991,of,0,0
224992,other,0,0
224993,drugs,0,1
224994,.,0,0
224995,The,0,0
224996,primary,0,0
224997,aim,0,0
224998,of,0,0
224999,the,0,0
225000,present,0,0
225001,study,0,0
225002,was,0,0
225003,to,0,0
225004,determine,0,0
225005,whether,0,0
225006,pantoprazole,1,1
225007,modifies,0,0
225008,the,0,0
225009,steady-state,0,0
225010,serum,0,1
225011,concentrations,0,1
225012,of,0,1
225013,orally,0,1
225014,administered,0,1
225015,digoxin,1,1
225016,.,1,1
225017,Secondary,0,0
225018,aims,0,0
225019,were,0,0
225020,the,0,0
225021,influence,0,0
225022,of,0,0
225023,digoxin,1,1
225024,on,0,0
225025,the,0,0
225026,pharmacokinetics,0,1
225027,of,0,1
225028,pantoprazole,1,1
225029,as,0,0
225030,well,0,0
225031,as,0,0
225032,safety,0,0
225033,and,0,0
225034,tolerability,0,1
225035,.,0,1
225036,Eighteen,0,0
225037,healthy,0,0
225038,volunteers,0,0
225039,received,0,0
225040,a,0,0
225041,single,0,0
225042,oral,1,1
225043,dose,1,1
225044,of,1,1
225045,pantoprazole,1,1
225046,(,1,1
225047,40,1,1
225048,mg,1,1
225049,),1,1
225050,and,1,1
225051,serum,1,1
225052,concentrations,1,1
225053,were,0,0
225054,determined,0,0
225055,.,0,0
225056,Three,0,0
225057,to,0,0
225058,10,0,0
225059,days,0,0
225060,later,0,0
225061,",",0,0
225062,subjects,0,0
225063,received,0,0
225064,in,0,0
225065,a,0,0
225066,single-blind,0,1
225067,",",0,1
225068,randomized,0,1
225069,",",0,0
225070,crossover,0,1
225071,fashion,0,1
225072,oral,0,1
225073,beta-acetyldigoxin,1,1
225074,(,0,1
225075,0.2,0,1
225076,mg,0,1
225077,),0,1
225078,twice,0,1
225079,daily,0,1
225080,and,0,1
225081,concomitant,1,1
225082,oral,1,1
225083,pantoprazole,1,1
225084,(,0,1
225085,40,0,1
225086,mg,0,1
225087,),0,1
225088,or,0,1
225089,placebo,1,1
225090,once,0,1
225091,daily,0,1
225092,for,0,1
225093,5,0,0
225094,days,0,0
225095,.,0,0
225096,Serum,0,1
225097,concentrations,0,1
225098,of,0,1
225099,pantoprazole,1,1
225100,and,1,1
225101,digoxin,1,1
225102,were,0,0
225103,determined,0,0
225104,on,0,0
225105,day,0,0
225106,5,0,0
225107,.,0,0
225108,Primary,0,0
225109,characteristics,0,0
225110,for,0,0
225111,confirmative,0,0
225112,assessment,0,0
225113,of,0,0
225114,no,0,0
225115,interaction,0,0
225116,were,0,0
225117,AUC,0,0
225118,and,0,0
225119,Cmax,0,1
225120,of,0,0
225121,digoxin,1,1
225122,.,1,0
225123,Lack,0,0
225124,of,0,0
225125,interaction,0,0
225126,in,0,0
225127,the,0,0
225128,sense,0,0
225129,of,0,0
225130,equivalence,0,0
225131,was,0,0
225132,concluded,0,0
225133,for,0,0
225134,both,0,0
225135,digoxin,0,1
225136,(,0,1
225137,with,0,0
225138,and,0,0
225139,without,0,0
225140,pantoprazole,1,1
225141,),1,1
225142,and,0,1
225143,pantoprazole,1,1
225144,(,1,1
225145,with,1,0
225146,and,1,0
225147,without,1,0
225148,digoxin,1,1
225149,),1,0
225150,as,0,0
225151,the,0,0
225152,90,0,0
225153,%,0,0
225154,-confidence,0,0
225155,intervals,0,0
225156,of,0,0
225157,the,0,0
225158,respective,0,0
225159,AUC-,0,0
225160,and,0,0
225161,Cmax-ratios,0,0
225162,were,0,0
225163,within,0,0
225164,the,0,0
225165,equivalence,0,0
225166,range,0,0
225167,of,0,0
225168,0.8-1.25,0,0
225169,.,0,0
225170,Pantoprazole,1,0
225171,did,0,0
225172,not,0,0
225173,influence,0,0
225174,the,0,0
225175,characteristic,0,0
225176,ECG,0,0
225177,modifications,0,0
225178,(,0,1
225179,T-wave,0,1
225180,),0,0
225181,caused,0,0
225182,by,0,0
225183,digoxin,0,1
225184,.,0,1
225185,Both,0,1
225186,drugs,0,1
225187,were,0,1
225188,well,0,0
225189,tolerated,0,1
225190,and,0,0
225191,no,0,0
225192,adverse,0,0
225193,events,0,0
225194,or,0,0
225195,clinically,0,0
225196,relevant,0,0
225197,alterations,0,0
225198,in,0,0
225199,vital,0,0
225200,signs,0,0
225201,or,0,0
225202,clinical,0,0
225203,laboratory,0,0
225204,parameters,0,0
225205,were,0,0
225206,observed,0,0
225207,during,0,0
225208,treatment,0,0
225209,.,0,0
225210,In,0,0
225211,conclusion,0,0
225212,",",0,0
225213,pantoprazole,1,1
225214,and,1,1
225215,digoxin,1,1
225216,may,0,0
225217,be,0,0
225218,administered,0,1
225219,concomitantly,0,0
225220,without,0,0
225221,the,0,0
225222,need,0,0
225223,for,0,0
225224,dose,0,1
225225,adjustment,0,1
225226,.,0,0
225227,Laparoscopic,0,0
225228,hysterectomy,0,0
225229,:,0,0
225230,is,0,0
225231,dissecting,1,0
225232,the,1,0
225233,ureter,1,0
225234,necessary,0,0
225235,?,0,0
225236,Laparoscopic,1,0
225237,hysterectomy,1,0
225238,has,0,0
225239,been,0,0
225240,first,0,0
225241,reported,0,0
225242,by,0,0
225243,Reich,0,0
225244,et,0,1
225245,al,0,0
225246,.,0,0
225247,in,0,0
225248,1989,0,0
225249,",",0,0
225250,which,0,0
225251,confirmed,0,0
225252,the,0,0
225253,possibility,0,0
225254,of,0,0
225255,laparoscopic,0,0
225256,hysterectomy,0,0
225257,being,0,0
225258,employed,0,0
225259,as,0,0
225260,a,0,0
225261,replacement,0,0
225262,of,0,0
225263,the,0,0
225264,vast,0,0
225265,majority,0,0
225266,of,0,0
225267,traditional,0,0
225268,abdominal,0,0
225269,hysterectomies,0,0
225270,.,0,0
225271,There,0,0
225272,are,0,0
225273,three,0,0
225274,critical,0,0
225275,points,0,0
225276,in,0,0
225277,laparoscopic,0,0
225278,hysterectomy,0,0
225279,.,0,0
225280,The,0,0
225281,most,0,0
225282,important,0,0
225283,critical,0,0
225284,point,0,0
225285,is,0,0
225286,to,0,0
225287,identify,0,0
225288,uterine,0,0
225289,arteries,0,0
225290,from,0,0
225291,the,0,0
225292,ureter,0,0
225293,in,0,0
225294,the,0,0
225295,paracervical,0,0
225296,area,0,0
225297,.,0,0
225298,Several,0,0
225299,ureteral,0,0
225300,injuries,0,0
225301,at,0,0
225302,operative,0,0
225303,laparoscopy,0,0
225304,have,0,0
225305,been,0,0
225306,reported,0,0
225307,.,0,0
225308,We,0,0
225309,performed,0,0
225310,two,0,0
225311,hundred,0,0
225312,and,0,0
225313,thirty,0,0
225314,laparoscopic,1,0
225315,hysterectomies,1,0
225316,during,0,0
225317,the,0,0
225318,period,0,0
225319,from,0,0
225320,March,0,0
225321,1991,0,0
225322,to,0,0
225323,October,0,0
225324,1993,0,0
225325,.,0,0
225326,Sixty,0,0
225327,patients,0,0
225328,were,0,0
225329,later,0,0
225330,included,0,0
225331,in,0,0
225332,this,0,0
225333,study,0,0
225334,.,0,0
225335,Thirty,0,0
225336,of,0,0
225337,these,0,0
225338,applied,0,0
225339,the,0,0
225340,technique,0,0
225341,of,0,0
225342,dissecting,1,0
225343,the,1,0
225344,ureter,1,0
225345,at,0,0
225346,the,0,0
225347,initiation,0,0
225348,of,0,0
225349,laparoscopic,0,0
225350,hysterectomy,0,0
225351,.,0,0
225352,Most,0,0
225353,of,0,0
225354,the,0,0
225355,patients,0,0
225356,were,0,0
225357,discharged,0,0
225358,on,0,0
225359,the,0,0
225360,second,0,0
225361,postoperative,0,0
225362,day,0,0
225363,.,0,0
225364,Although,0,0
225365,dissecting,1,0
225366,the,1,0
225367,ureter,1,0
225368,at,0,0
225369,the,0,0
225370,beginning,0,0
225371,of,0,0
225372,the,0,0
225373,operation,0,0
225374,did,0,0
225375,not,0,0
225376,produce,0,0
225377,a,0,0
225378,significant,0,0
225379,discrepancy,0,0
225380,in,0,0
225381,operation,0,0
225382,time,0,0
225383,",",0,0
225384,blood,0,0
225385,loss,0,0
225386,",",0,0
225387,hospitalization,0,0
225388,day,0,0
225389,and,0,0
225390,ureter,0,1
225391,injury,0,0
225392,when,0,0
225393,compared,0,0
225394,with,0,0
225395,the,0,0
225396,control,0,0
225397,group,0,0
225398,",",0,0
225399,the,0,0
225400,uterine,0,0
225401,arteries,0,0
225402,",",0,0
225403,however,0,0
225404,",",0,0
225405,may,0,0
225406,be,0,0
225407,confidently,0,0
225408,desiccated,0,0
225409,once,0,0
225410,the,0,0
225411,path,0,0
225412,of,0,0
225413,the,0,0
225414,ureter,0,0
225415,near,0,0
225416,the,0,0
225417,uterosacral,0,0
225418,ligament,0,0
225419,is,0,0
225420,identified,0,0
225421,.,0,0
225422,Long-term,0,0
225423,efficacy,0,0
225424,of,0,1
225425,subcutaneous,1,1
225426,sumatriptan,1,1
225427,using,0,0
225428,a,0,0
225429,novel,0,0
225430,self-injector,0,0
225431,.,0,0
225432,An,0,1
225433,open,0,1
225434,",",0,0
225435,multicenter,0,0
225436,study,0,0
225437,investigated,0,0
225438,the,0,0
225439,long-term,0,0
225440,efficacy,0,1
225441,",",0,0
225442,tolerability,0,1
225443,",",0,1
225444,and,0,0
225445,acceptability,0,0
225446,to,0,0
225447,patients,0,0
225448,of,0,0
225449,subcutaneous,0,1
225450,sumatriptan,1,1
225451,6,0,1
225452,mg,0,1
225453,",",0,1
225454,administered,0,1
225455,using,0,0
225456,a,0,0
225457,novel,0,0
225458,cartridge,0,1
225459,system,0,0
225460,self-injector,0,0
225461,",",0,0
225462,for,0,0
225463,the,0,0
225464,acute,0,0
225465,treatment,0,0
225466,of,0,0
225467,migraine,0,0
225468,.,0,0
225469,Eighty,0,0
225470,patients,0,0
225471,treated,0,0
225472,all,0,0
225473,migraine,0,0
225474,attacks,0,0
225475,for,0,0
225476,6,0,0
225477,months,0,0
225478,at,0,0
225479,home,0,0
225480,with,0,0
225481,a,0,0
225482,subcutaneous,0,1
225483,injection,1,1
225484,of,1,1
225485,sumatriptan,1,1
225486,6,1,1
225487,mg.,1,1
225488,A,0,1
225489,second,0,1
225490,injection,0,1
225491,could,0,0
225492,be,0,0
225493,taken,0,0
225494,after,0,0
225495,1,0,0
225496,to,0,0
225497,24,0,0
225498,hours,0,0
225499,if,0,0
225500,relief,0,0
225501,was,0,0
225502,inadequate,0,0
225503,",",0,0
225504,or,0,0
225505,if,0,0
225506,the,0,0
225507,headache,0,0
225508,recurred,0,0
225509,",",0,0
225510,and,0,0
225511,rescue,0,0
225512,medication,0,0
225513,could,0,0
225514,be,0,0
225515,taken,0,0
225516,1,0,0
225517,hour,0,0
225518,after,0,0
225519,the,0,0
225520,second,0,0
225521,injection,0,1
225522,.,0,0
225523,The,0,0
225524,primary,0,0
225525,end,0,0
225526,point,0,0
225527,was,0,0
225528,the,0,0
225529,percentage,0,0
225530,of,0,0
225531,attacks,0,0
225532,in,0,0
225533,which,0,0
225534,headache,0,0
225535,improved,0,0
225536,from,0,0
225537,severe,0,0
225538,or,0,0
225539,moderate,0,0
225540,before,0,0
225541,treatment,0,0
225542,to,0,0
225543,mild,0,0
225544,or,0,0
225545,absent,0,0
225546,at,0,0
225547,1,0,0
225548,hour,0,0
225549,after,0,0
225550,the,0,0
225551,first,0,0
225552,injection,0,1
225553,.,0,0
225554,A,0,0
225555,total,0,0
225556,of,0,0
225557,1566,0,0
225558,attacks,0,0
225559,were,0,0
225560,treated,0,0
225561,by,0,0
225562,the,0,0
225563,80,0,0
225564,patients,0,0
225565,and,0,0
225566,69,0,0
225567,patients,0,0
225568,completed,0,0
225569,6,0,0
225570,months,0,0
225571,of,0,0
225572,treatment,0,0
225573,.,0,0
225574,Headache,0,0
225575,relief,0,0
225576,was,0,0
225577,reported,0,0
225578,1,0,0
225579,hour,0,0
225580,after,0,0
225581,the,0,0
225582,first,0,0
225583,injection,0,1
225584,in,0,0
225585,a,0,0
225586,mean,0,0
225587,of,0,0
225588,78,0,0
225589,%,0,0
225590,of,0,0
225591,attacks,0,0
225592,(,0,0
225593,83,0,0
225594,%,0,0
225595,in,0,0
225596,the,0,0
225597,first,0,0
225598,3,0,0
225599,months,0,0
225600,and,0,0
225601,76,0,0
225602,%,0,0
225603,in,0,0
225604,the,0,0
225605,second,0,0
225606,3,0,0
225607,months,0,0
225608,),0,0
225609,.,0,0
225610,A,0,1
225611,second,0,0
225612,injection,0,1
225613,was,0,0
225614,required,0,0
225615,in,0,0
225616,a,0,0
225617,mean,0,0
225618,of,0,0
225619,40,0,0
225620,%,0,0
225621,of,0,0
225622,attacks,0,0
225623,",",0,0
225624,and,0,0
225625,headache,0,0
225626,was,0,0
225627,mild,0,0
225628,or,0,0
225629,absent,0,0
225630,1,0,0
225631,hour,0,0
225632,after,0,0
225633,the,0,0
225634,second,0,0
225635,injection,0,1
225636,in,0,0
225637,a,0,0
225638,mean,0,0
225639,of,0,0
225640,77,0,0
225641,%,0,0
225642,of,0,0
225643,attacks,0,0
225644,.,0,0
225645,Rescue,0,0
225646,medication,0,0
225647,was,0,0
225648,required,0,0
225649,after,0,0
225650,the,0,0
225651,second,0,0
225652,injection,0,1
225653,in,0,0
225654,a,0,0
225655,mean,0,0
225656,of,0,0
225657,14,0,0
225658,%,0,0
225659,of,0,0
225660,attacks,0,0
225661,.,0,0
225662,At,0,0
225663,the,0,0
225664,end,0,0
225665,of,0,0
225666,the,0,0
225667,study,0,0
225668,",",0,0
225669,87,0,0
225670,%,0,0
225671,of,0,0
225672,patients,0,0
225673,said,0,0
225674,that,0,0
225675,they,0,0
225676,would,0,0
225677,take,0,0
225678,the,0,0
225679,medication,0,0
225680,again,0,0
225681,",",0,0
225682,and,0,0
225683,at,0,0
225684,each,0,0
225685,clinic,0,0
225686,visit,0,0
225687,over,0,0
225688,80,0,0
225689,%,0,0
225690,said,0,0
225691,that,0,0
225692,they,0,0
225693,found,0,0
225694,the,0,0
225695,injector,0,1
225696,easy,0,1
225697,to,0,0
225698,use,0,0
225699,.,0,0
225700,Adverse,0,0
225701,events,0,0
225702,were,0,0
225703,similar,0,0
225704,to,0,0
225705,those,0,0
225706,reported,0,0
225707,previously,0,0
225708,with,0,0
225709,sumatriptan,1,1
225710,and,0,0
225711,were,0,0
225712,mostly,0,0
225713,mild,0,0
225714,to,0,0
225715,moderate,0,0
225716,in,0,0
225717,intensity,0,0
225718,",",0,0
225719,short-lived,0,0
225720,",",0,0
225721,and,0,0
225722,resolved,0,0
225723,spontaneously,0,0
225724,.,0,0
225725,Subcutaneous,0,0
225726,sumatriptan,1,1
225727,6,0,1
225728,mg,0,1
225729,is,0,0
225730,an,0,0
225731,effective,0,0
225732,",",0,0
225733,well,0,0
225734,tolerated,0,1
225735,",",0,0
225736,and,0,0
225737,well,0,0
225738,accepted,0,0
225739,",",0,0
225740,long-term,0,0
225741,",",0,0
225742,acute,0,0
225743,treatment,0,0
225744,for,0,0
225745,migraine,0,0
225746,when,0,0
225747,self-injected,0,1
225748,by,0,0
225749,patients,0,0
225750,using,0,0
225751,the,0,0
225752,novel,0,0
225753,self-injector,0,0
225754,.,0,0
225755,A,0,1
225756,community-based,0,1
225757,randomized,0,0
225758,trial,0,0
225759,of,0,0
225760,praziquantel,1,1
225761,to,0,0
225762,control,0,0
225763,schistosomiasis,0,0
225764,morbidity,0,0
225765,in,0,0
225766,schoolchildren,0,0
225767,in,0,0
225768,Zambia,0,0
225769,.,0,0
225770,A,0,0
225771,community-based,0,1
225772,",",0,0
225773,double-blind,0,1
225774,",",0,1
225775,randomized,0,1
225776,trial,0,1
225777,of,0,0
225778,praziquantel,1,1
225779,was,0,0
225780,carried,0,0
225781,out,0,0
225782,in,0,0
225783,an,0,0
225784,area,0,0
225785,of,0,0
225786,Zambia,0,0
225787,endemic,0,0
225788,for,0,0
225789,schistosomiasis,0,0
225790,.,0,0
225791,The,0,0
225792,aim,0,0
225793,of,0,0
225794,the,0,0
225795,study,0,0
225796,was,0,0
225797,to,0,0
225798,assess,0,0
225799,the,0,0
225800,impact,0,0
225801,of,0,0
225802,the,0,0
225803,treatment,0,0
225804,on,0,0
225805,Schistosoma,0,0
225806,mansoni,0,0
225807,morbidity,0,0
225808,.,0,0
225809,A,0,0
225810,total,0,0
225811,of,0,0
225812,377,0,0
225813,infected,0,0
225814,children,0,0
225815,",",0,0
225816,aged,0,0
225817,seven,0,0
225818,to,0,0
225819,19,0,0
225820,years,0,0
225821,",",0,0
225822,was,0,0
225823,randomized,0,0
225824,into,0,0
225825,two,0,0
225826,groups,0,0
225827,:,0,0
225828,one,0,0
225829,of,0,0
225830,190,0,0
225831,(,0,0
225832,group,0,0
225833,A,0,1
225834,),0,1
225835,and,0,0
225836,one,0,0
225837,of,0,0
225838,187,0,0
225839,(,0,0
225840,group,0,0
225841,B,0,1
225842,),0,1
225843,.,0,0
225844,All,0,0
225845,children,0,0
225846,were,0,0
225847,treated,0,0
225848,with,0,0
225849,40,0,1
225850,mg,0,1
225851,praziquantel/kg,1,1
225852,at,0,1
225853,the,0,0
225854,start,0,0
225855,of,0,0
225856,the,0,0
225857,study,0,0
225858,.,0,0
225859,Six,0,0
225860,months,0,0
225861,later,0,0
225862,",",0,0
225863,the,0,0
225864,children,0,0
225865,in,0,0
225866,group,0,0
225867,A,0,0
225868,were,0,0
225869,re-treated,0,0
225870,with,0,0
225871,the,0,0
225872,same,0,0
225873,dose,0,1
225874,of,0,1
225875,praziquantel,1,1
225876,",",0,0
225877,while,0,0
225878,the,0,0
225879,children,0,0
225880,in,0,0
225881,group,0,0
225882,B,0,0
225883,were,0,0
225884,given,0,0
225885,placebos,1,1
225886,.,1,1
225887,All,0,0
225888,children,0,0
225889,were,0,0
225890,followed,0,0
225891,up,0,0
225892,three,0,0
225893,",",0,0
225894,six,0,0
225895,and,0,0
225896,12,0,0
225897,months,0,0
225898,after,0,0
225899,the,0,0
225900,initial,0,0
225901,treatment,0,0
225902,",",0,0
225903,morbidity,0,0
225904,being,0,0
225905,clinically,0,0
225906,evaluated,0,0
225907,at,0,0
225908,the,0,0
225909,six-,0,0
225910,and,0,0
225911,12-month,0,0
225912,follow-ups,0,0
225913,.,0,0
225914,The,0,0
225915,results,0,0
225916,show,0,0
225917,that,0,0
225918,",",0,0
225919,in,0,0
225920,both,0,0
225921,groups,0,0
225922,of,0,0
225923,children,0,0
225924,",",0,0
225925,there,0,0
225926,were,0,0
225927,significant,0,0
225928,reductions,0,0
225929,in,0,0
225930,splenomegaly,0,0
225931,",",0,0
225932,hepatomegaly,0,0
225933,",",0,0
225934,and,0,0
225935,subjective,0,0
225936,symptoms,0,0
225937,of,0,0
225938,morbidity,0,0
225939,six,0,0
225940,and,0,0
225941,12,0,0
225942,months,0,0
225943,after,0,0
225944,initial,0,0
225945,treatment,0,0
225946,.,0,0
225947,However,0,0
225948,",",0,0
225949,there,0,0
225950,were,0,0
225951,no,0,0
225952,significant,0,0
225953,differences,0,0
225954,",",0,0
225955,between,0,0
225956,the,0,0
225957,two,0,0
225958,groups,0,0
225959,",",0,0
225960,in,0,0
225961,the,0,0
225962,prevalences,0,0
225963,of,0,0
225964,these,0,0
225965,symptoms,0,0
225966,of,0,0
225967,morbidity,0,0
225968,.,0,0
225969,It,0,0
225970,therefore,0,0
225971,appears,0,0
225972,that,0,0
225973,once-yearly,0,1
225974,treatment,0,0
225975,of,0,0
225976,children,0,0
225977,",",0,0
225978,in,0,0
225979,this,0,0
225980,and,0,0
225981,similar,0,0
225982,endemic,0,0
225983,areas,0,0
225984,",",0,0
225985,is,0,0
225986,sufficient,0,0
225987,to,0,0
225988,reduce,0,0
225989,schistosomiasis,0,0
225990,morbidity,0,0
225991,to,0,0
225992,",",0,0
225993,and,0,0
225994,maintain,0,0
225995,it,0,0
225996,at,0,0
225997,",",0,0
225998,a,0,0
225999,tolerable,0,1
226000,level,0,0
226001,.,0,0
226002,Correlation,0,0
226003,of,0,0
226004,quantitative,0,0
226005,measures,0,0
226006,with,0,0
226007,the,0,0
226008,modified,1,0
226009,Ashworth,1,0
226010,scale,1,0
226011,in,0,0
226012,the,0,0
226013,assessment,0,0
226014,of,0,0
226015,plantar,0,0
226016,flexor,0,0
226017,spasticity,0,0
226018,in,0,0
226019,patients,0,0
226020,with,0,0
226021,traumatic,0,0
226022,brain,0,0
226023,injury,0,0
226024,.,0,0
226025,This,0,0
226026,study,0,0
226027,of,0,0
226028,plantar,0,0
226029,flexor,0,0
226030,spasticity,0,0
226031,describes,0,0
226032,relationships,0,0
226033,among,0,0
226034,a,0,0
226035,traditional,0,0
226036,qualitative,0,0
226037,spasticity,0,0
226038,scale,0,0
226039,",",0,0
226040,three,0,0
226041,potential,0,0
226042,quantitative,0,0
226043,spasticity,0,0
226044,measures,0,0
226045,and,0,0
226046,a,0,0
226047,measure,0,0
226048,of,0,0
226049,voluntary,0,0
226050,ankle,0,0
226051,muscle,0,0
226052,function,0,0
226053,.,0,0
226054,Thirty-four,0,0
226055,volunteer,0,0
226056,adult,0,0
226057,patients,0,0
226058,with,0,0
226059,traumatic,0,0
226060,brain,0,0
226061,injuries,0,0
226062,participated,0,0
226063,.,0,0
226064,There,0,0
226065,were,0,0
226066,28,0,0
226067,males,0,0
226068,and,0,0
226069,6,0,0
226070,females,0,0
226071,;,0,0
226072,the,0,0
226073,mean,0,0
226074,age,0,0
226075,was,0,0
226076,30.3,0,0
226077,years,0,0
226078,.,0,0
226079,A,0,0
226080,battery,0,0
226081,of,0,0
226082,five,0,0
226083,randomly,1,0
226084,sequenced,1,0
226085,tests,1,0
226086,was,0,0
226087,performed,0,0
226088,for,0,0
226089,each,0,0
226090,subject,0,0
226091,on,0,0
226092,one,0,0
226093,ankle,0,0
226094,.,0,0
226095,Tests,0,0
226096,were,0,0
226097,:,0,0
226098,modified,0,0
226099,Ashworth,1,0
226100,scale,1,1
226101,(,1,1
226102,MAS,1,1
226103,),1,1
226104,scoring,0,1
226105,;,0,1
226106,H-reflex,1,0
226107,testing,1,0
226108,with,1,0
226109,and,1,0
226110,without,1,0
226111,Achilles,1,0
226112,tendon,1,0
226113,vibration,1,1
226114,;,1,1
226115,H-reflex,1,0
226116,testing,1,0
226117,with,1,0
226118,and,1,0
226119,without,1,0
226120,dorsiflexor,1,0
226121,contraction,1,0
226122,;,1,0
226123,reflex,1,1
226124,threshold,1,1
226125,angle,1,1
226126,and,1,0
226127,timed,1,0
226128,toe,1,1
226129,tapping,1,1
226130,(,1,1
226131,TTT,1,0
226132,),1,0
226133,.,1,0
226134,Twenty-six,0,0
226135,subjects,0,0
226136,returned,0,0
226137,to,0,0
226138,have,0,0
226139,the,0,0
226140,second,0,0
226141,ankle,0,0
226142,tested,0,0
226143,",",0,0
226144,resulting,0,0
226145,in,0,0
226146,60,0,0
226147,ankles,0,0
226148,for,0,0
226149,the,0,0
226150,analyses,0,0
226151,.,0,0
226152,Spearman,0,0
226153,'s,0,0
226154,coefficients,0,0
226155,for,0,0
226156,correlation,0,0
226157,of,0,0
226158,quantitative,0,0
226159,spasticity,0,0
226160,measures,0,0
226161,with,0,0
226162,MAS,0,0
226163,scores,0,0
226164,ranged,0,0
226165,from,0,0
226166,0.39,0,0
226167,to,0,0
226168,0.49,0,0
226169,with,0,0
226170,associated,0,0
226171,probabilities,0,0
226172,<,0,0
226173,or,0,0
226174,=,0,0
226175,0.002,0,0
226176,.,0,0
226177,Pearson,0,0
226178,coefficients,0,0
226179,for,0,0
226180,correlation,0,0
226181,of,0,0
226182,quantitative,0,0
226183,spasticity,0,0
226184,measures,0,0
226185,with,0,0
226186,TTT,0,0
226187,scores,0,0
226188,were,0,0
226189,lower,0,0
226190,but,0,0
226191,also,0,0
226192,significant,0,0
226193,(,0,0
226194,P,0,0
226195,<,0,0
226196,or,0,0
226197,=,0,0
226198,0.07,0,0
226199,),0,0
226200,.,0,0
226201,Multiple,0,0
226202,correlation,0,0
226203,for,0,0
226204,the,0,0
226205,set,0,0
226206,of,0,0
226207,quantitative,0,0
226208,measures,0,0
226209,yielded,0,0
226210,R,0,0
226211,=,0,0
226212,0.614,0,0
226213,(,0,0
226214,P,0,0
226215,<,0,0
226216,0.001,0,0
226217,),0,0
226218,with,0,0
226219,MAS,0,0
226220,scores,0,0
226221,and,0,0
226222,R,0,0
226223,=,0,0
226224,0.365,0,0
226225,(,0,0
226226,P,0,0
226227,=,0,0
226228,0.045,0,0
226229,),0,0
226230,with,0,0
226231,TTT,0,0
226232,scores,0,0
226233,.,0,0
226234,These,0,0
226235,findings,0,0
226236,reveal,0,0
226237,statistically,0,0
226238,significant,0,0
226239,relationships,0,0
226240,of,0,0
226241,low,0,0
226242,to,0,0
226243,moderate,0,0
226244,strength,0,0
226245,among,0,0
226246,potential,0,0
226247,quantitative,0,0
226248,spasticity,0,0
226249,measures,0,0
226250,",",0,0
226251,a,0,0
226252,traditional,0,0
226253,qualitative,0,0
226254,spasticity,0,0
226255,scale,0,0
226256,and,0,0
226257,a,0,0
226258,simple,0,0
226259,measure,0,0
226260,of,0,0
226261,voluntary,0,0
226262,ankle,0,0
226263,muscle,0,0
226264,function,0,0
226265,.,0,0
226266,Understanding,0,0
226267,these,0,0
226268,relationships,0,0
226269,is,0,0
226270,an,0,0
226271,essential,0,0
226272,part,0,0
226273,of,0,0
226274,the,0,0
226275,ongoing,0,0
226276,search,0,0
226277,for,0,0
226278,quantitative,0,0
226279,spasticity,0,0
226280,measures,0,0
226281,.,0,0
226282,Placebo-controlled,1,1
226283,acute,0,1
226284,dosage,0,1
226285,naltrexone,1,1
226286,study,0,1
226287,in,0,0
226288,young,0,0
226289,autistic,0,0
226290,children,0,0
226291,.,0,0
226292,In,0,0
226293,a,0,0
226294,double-blind,0,1
226295,",",0,1
226296,placebo-controlled,1,1
226297,crossover,0,1
226298,trial,0,1
226299,23,0,0
226300,autistic,0,0
226301,children,0,0
226302,were,0,0
226303,treated,0,0
226304,with,0,0
226305,a,0,0
226306,single,0,0
226307,40-mg,0,1
226308,dose,0,1
226309,of,0,1
226310,the,0,1
226311,opiate,0,1
226312,antagonist,0,1
226313,naltrexone,1,1
226314,.,1,1
226315,Drug,0,0
226316,effects,0,0
226317,were,0,0
226318,monitored,0,0
226319,by,0,0
226320,detailed,0,0
226321,playroom,0,0
226322,observations,0,0
226323,",",0,0
226324,actometers,0,0
226325,",",0,0
226326,and,0,0
226327,parents,0,0
226328,',0,0
226329,checklist,0,1
226330,ratings,0,1
226331,(,0,0
226332,Aberrant,0,0
226333,Behavior,0,0
226334,Checklist,0,0
226335,",",0,0
226336,social,0,0
226337,items,0,0
226338,and,0,0
226339,target,0,0
226340,behaviors,0,1
226341,),0,1
226342,.,0,1
226343,Naltrexone,1,1
226344,treatment,0,0
226345,failed,0,0
226346,to,0,0
226347,produce,0,0
226348,significant,0,0
226349,changes,0,0
226350,in,0,0
226351,social,0,0
226352,behavior,0,0
226353,",",0,0
226354,but,0,0
226355,it,0,0
226356,did,0,0
226357,reduce,0,0
226358,irritability,0,0
226359,and,0,0
226360,target,0,0
226361,scores,0,0
226362,on,0,0
226363,behavior,0,0
226364,checklists,0,0
226365,.,0,0
226366,The,0,0
226367,playroom,0,0
226368,data,0,0
226369,indicated,0,0
226370,that,0,0
226371,naltrexone,1,1
226372,significantly,0,0
226373,affected,0,0
226374,indices,0,0
226375,of,0,0
226376,activity,0,0
226377,and,0,0
226378,attention,0,0
226379,.,0,0
226380,Five-year,0,0
226381,follow-up,0,0
226382,of,0,0
226383,the,0,0
226384,Fluorouracil,1,1
226385,Filtering,1,0
226386,Surgery,1,1
226387,Study,0,0
226388,.,0,0
226389,The,0,0
226390,Fluorouracil,1,1
226391,Filtering,1,0
226392,Surgery,1,0
226393,Study,1,0
226394,Group,0,0
226395,.,0,0
226396,PURPOSE,0,0
226397,To,0,0
226398,determine,0,0
226399,the,0,0
226400,efficacy,0,0
226401,and,0,0
226402,safety,0,0
226403,of,0,1
226404,subconjunctival,1,1
226405,5-,1,1
226406,fluorouracil,1,1
226407,injections,1,1
226408,after,0,1
226409,trabeculectomy,0,0
226410,in,0,0
226411,patients,0,0
226412,with,0,0
226413,poor,0,0
226414,prognoses,0,0
226415,",",0,0
226416,to,0,0
226417,determine,0,0
226418,risk,0,0
226419,factors,0,0
226420,for,0,0
226421,surgical,0,0
226422,failure,0,0
226423,and,0,0
226424,to,0,0
226425,examine,0,0
226426,the,0,0
226427,relationship,0,0
226428,of,0,0
226429,intraocular,0,0
226430,pressure,0,0
226431,and,0,0
226432,visual,0,0
226433,function,0,0
226434,.,0,0
226435,METHODS,0,0
226436,In,0,0
226437,this,0,0
226438,multicenter,0,0
226439,clinical,0,0
226440,trial,0,0
226441,",",0,0
226442,213,0,0
226443,patients,0,0
226444,with,0,0
226445,previous,0,0
226446,cataract,0,0
226447,surgery,0,0
226448,or,0,0
226449,previous,0,0
226450,failed,0,0
226451,filtering,0,0
226452,surgery,0,0
226453,were,0,0
226454,randomly,0,0
226455,assigned,0,0
226456,to,0,0
226457,receive,0,0
226458,either,0,0
226459,trabeculectomy,1,0
226460,alone,1,0
226461,or,1,0
226462,trabeculectomy,1,0
226463,with,1,0
226464,postoperative,1,1
226465,subconjunctival,1,1
226466,5-fluorouracil,1,1
226467,injections,1,1
226468,.,1,1
226469,Measurements,0,0
226470,of,0,0
226471,intraocular,0,0
226472,pressure,0,0
226473,",",0,0
226474,visual,0,0
226475,acuity,0,0
226476,",",0,0
226477,and,0,0
226478,visual,0,0
226479,fields,0,0
226480,were,0,0
226481,performed,0,0
226482,throughout,0,0
226483,the,0,0
226484,five,0,0
226485,years,0,0
226486,",",0,0
226487,with,0,0
226488,the,0,0
226489,clinician,0,0
226490,masked,0,0
226491,to,0,0
226492,the,0,0
226493,treatment,0,0
226494,group,0,0
226495,.,0,0
226496,Failure,0,0
226497,was,0,0
226498,defined,0,0
226499,as,0,0
226500,a,0,0
226501,reoperation,0,0
226502,to,0,0
226503,control,0,0
226504,intraocular,0,0
226505,pressure,0,0
226506,or,0,0
226507,an,0,0
226508,intraocular,0,0
226509,pressure,0,0
226510,greater,0,0
226511,than,0,0
226512,21,0,0
226513,mm,0,0
226514,Hg,0,0
226515,at,0,0
226516,or,0,0
226517,after,0,0
226518,the,0,0
226519,first-year,0,0
226520,examination,0,0
226521,.,0,0
226522,RESULTS,0,0
226523,Fifty-four,0,0
226524,(,0,0
226525,51,0,0
226526,%,0,0
226527,),0,0
226528,of,0,0
226529,the,0,0
226530,105,0,0
226531,eyes,0,0
226532,in,0,0
226533,the,0,0
226534,5-fluorouracil,1,1
226535,group,0,1
226536,and,0,0
226537,80,0,0
226538,(,0,0
226539,74,0,0
226540,%,0,0
226541,),0,0
226542,of,0,0
226543,the,0,0
226544,108,0,0
226545,eyes,0,0
226546,in,0,0
226547,the,0,0
226548,standard,0,0
226549,filtering,0,0
226550,surgery,0,0
226551,group,0,0
226552,were,0,0
226553,classified,0,0
226554,as,0,0
226555,failures,0,0
226556,(,0,0
226557,P,0,0
226558,<,0,0
226559,.001,0,0
226560,",",0,0
226561,Mantel-Cox,0,0
226562,survival,0,1
226563,analysis,0,0
226564,),0,0
226565,.,0,0
226566,Risk,0,0
226567,factors,0,0
226568,for,0,0
226569,failure,0,0
226570,include,0,0
226571,high,0,0
226572,intraocular,0,0
226573,pressure,0,0
226574,",",0,0
226575,a,0,0
226576,short,0,0
226577,time,0,0
226578,interval,0,0
226579,after,0,0
226580,the,0,0
226581,last,0,0
226582,procedure,0,0
226583,involving,0,0
226584,a,0,0
226585,conjunctival,0,0
226586,incision,0,0
226587,",",0,0
226588,the,0,0
226589,number,0,0
226590,of,0,0
226591,procedures,0,0
226592,with,0,0
226593,conjunctival,0,0
226594,incisions,0,0
226595,",",0,0
226596,and,0,0
226597,Hispanic,0,0
226598,ethnicity,0,0
226599,.,0,0
226600,Patients,0,0
226601,in,0,0
226602,both,0,0
226603,treatment,0,0
226604,groups,0,0
226605,with,0,0
226606,controlled,0,0
226607,intraocular,0,0
226608,pressures,0,0
226609,were,0,0
226610,more,0,0
226611,likely,0,0
226612,to,0,0
226613,maintain,0,0
226614,visual,0,0
226615,acuity,0,0
226616,.,0,0
226617,Patients,0,0
226618,in,0,0
226619,the,0,0
226620,5-fluorouracil,1,1
226621,group,0,0
226622,had,0,0
226623,a,0,0
226624,higher,0,0
226625,risk,0,0
226626,of,0,0
226627,late-onset,0,0
226628,bleb,0,1
226629,leaks,0,1
226630,(,0,0
226631,9,0,0
226632,%,0,0
226633,nine,0,0
226634,of,0,0
226635,105,0,0
226636,),0,0
226637,than,0,0
226638,those,0,0
226639,in,0,0
226640,the,0,0
226641,standard,0,0
226642,filtering,0,0
226643,surgery,0,1
226644,group,0,0
226645,(,0,0
226646,2,0,0
226647,%,0,0
226648,two,0,0
226649,of,0,0
226650,108,0,0
226651,),0,0
226652,(,0,0
226653,P,0,0
226654,=,0,0
226655,.032,0,0
226656,",",0,0
226657,Fisher,0,0
226658,'s,0,0
226659,exact,0,0
226660,test,0,0
226661,),0,0
226662,.,0,0
226663,CONCLUSIONS,0,1
226664,We,0,1
226665,recommend,0,0
226666,the,0,0
226667,use,0,0
226668,of,0,0
226669,subconjunctival,1,1
226670,5-fluorouracil,1,1
226671,after,0,1
226672,trabeculectomy,0,0
226673,in,0,0
226674,eyes,0,0
226675,after,0,0
226676,previous,0,0
226677,cataract,0,0
226678,surgery,0,0
226679,or,0,0
226680,unsuccessful,0,0
226681,filtering,0,0
226682,surgery,0,0
226683,",",0,0
226684,but,0,0
226685,caution,0,0
226686,against,0,0
226687,its,0,0
226688,routine,0,0
226689,use,0,0
226690,in,0,0
226691,patients,0,0
226692,with,0,0
226693,good,0,0
226694,prognoses,0,0
226695,.,0,0
226696,The,0,0
226697,sequencing,0,0
226698,of,0,0
226699,chemotherapy,1,0
226700,and,0,0
226701,radiation,1,0
226702,therapy,1,0
226703,after,0,0
226704,conservative,0,0
226705,surgery,0,0
226706,for,0,0
226707,early-stage,0,0
226708,breast,0,0
226709,cancer,0,0
226710,.,0,0
226711,BACKGROUND,0,0
226712,Patients,0,0
226713,with,0,0
226714,early-stage,0,0
226715,breast,0,0
226716,cancer,0,0
226717,who,0,0
226718,are,0,0
226719,at,0,0
226720,substantial,0,0
226721,risk,0,0
226722,for,0,0
226723,systemic,0,0
226724,metastases,0,0
226725,are,0,0
226726,increasingly,0,0
226727,treated,0,0
226728,with,0,0
226729,breast-conserving,1,0
226730,therapy,1,0
226731,and,1,1
226732,adjuvant,1,1
226733,chemotherapy,1,1
226734,.,1,0
226735,However,0,0
226736,",",0,0
226737,the,0,0
226738,optimal,0,0
226739,sequencing,0,0
226740,of,0,0
226741,chemotherapy,1,0
226742,and,1,0
226743,radiation,1,0
226744,therapy,1,0
226745,is,0,0
226746,not,0,0
226747,clear,0,0
226748,.,0,0
226749,METHODS,0,0
226750,Two,0,0
226751,hundred,0,0
226752,forty-four,0,0
226753,patients,0,0
226754,with,0,0
226755,stage,0,0
226756,I,0,0
226757,or,0,0
226758,II,0,1
226759,breast,0,1
226760,cancer,0,0
226761,who,0,0
226762,were,0,0
226763,at,0,0
226764,substantial,0,0
226765,risk,0,0
226766,for,0,0
226767,distant,0,0
226768,metastases,0,0
226769,were,0,0
226770,randomly,0,0
226771,assigned,0,0
226772,to,0,0
226773,receive,0,0
226774,a,0,0
226775,12-week,1,0
226776,course,1,0
226777,of,1,0
226778,chemotherapy,1,0
226779,either,1,0
226780,before,1,0
226781,or,1,0
226782,after,1,0
226783,radiation,1,0
226784,therapy,1,0
226785,.,1,0
226786,All,0,0
226787,had,0,0
226788,had,0,0
226789,breast-conserving,0,0
226790,surgery,0,0
226791,.,0,0
226792,The,0,0
226793,median,0,0
226794,length,0,0
226795,of,0,0
226796,follow-up,0,0
226797,in,0,0
226798,surviving,0,0
226799,patients,0,0
226800,was,0,0
226801,58,0,0
226802,months,0,0
226803,(,0,0
226804,range,0,0
226805,",",0,0
226806,10,0,0
226807,to,0,0
226808,124,0,0
226809,),0,0
226810,.,0,0
226811,RESULTS,0,0
226812,The,0,0
226813,five-year,0,0
226814,actuarial,0,0
226815,rates,0,0
226816,of,0,0
226817,cancer,0,0
226818,recurrence,0,0
226819,at,0,0
226820,any,0,0
226821,site,0,0
226822,and,0,0
226823,of,0,0
226824,distant,0,0
226825,metastases,0,0
226826,in,0,0
226827,the,0,0
226828,radiotherapy-first,1,0
226829,group,0,0
226830,and,0,0
226831,the,0,0
226832,chemotherapy-first,1,0
226833,group,0,0
226834,were,0,0
226835,38,0,0
226836,percent,0,0
226837,and,0,0
226838,31,0,0
226839,percent,0,0
226840,(,0,0
226841,P,0,0
226842,=,0,0
226843,0.17,0,0
226844,),0,0
226845,and,0,0
226846,36,0,0
226847,percent,0,0
226848,and,0,0
226849,25,0,0
226850,percent,0,0
226851,(,0,0
226852,P,0,0
226853,=,0,0
226854,0.05,0,0
226855,),0,0
226856,",",0,0
226857,respectively,0,0
226858,.,0,0
226859,Overall,0,0
226860,survival,0,0
226861,was,0,0
226862,73,0,0
226863,percent,0,0
226864,and,0,0
226865,81,0,0
226866,percent,0,0
226867,(,0,0
226868,P,0,0
226869,=,0,0
226870,0.11,0,0
226871,),0,0
226872,",",0,0
226873,respectively,0,0
226874,.,0,0
226875,The,0,0
226876,five-year,0,0
226877,crude,0,0
226878,rates,0,0
226879,of,0,0
226880,first,0,0
226881,recurrence,0,0
226882,according,0,0
226883,to,0,0
226884,site,0,0
226885,in,0,0
226886,the,0,0
226887,radiotherapy-first,1,0
226888,and,1,0
226889,chemotherapy-first,1,0
226890,groups,0,0
226891,",",0,0
226892,respectively,0,0
226893,",",0,0
226894,were,0,0
226895,5,0,0
226896,percent,0,0
226897,and,0,0
226898,14,0,0
226899,percent,0,0
226900,for,0,0
226901,local,0,0
226902,recurrence,0,0
226903,and,0,0
226904,32,0,0
226905,percent,0,0
226906,and,0,0
226907,20,0,0
226908,percent,0,0
226909,for,0,0
226910,distant,0,0
226911,or,0,0
226912,regional,0,0
226913,recurrence,0,0
226914,or,0,0
226915,both,0,0
226916,.,0,0
226917,This,0,0
226918,difference,0,0
226919,in,0,0
226920,the,0,0
226921,pattern,0,0
226922,of,0,0
226923,recurrence,0,0
226924,was,0,0
226925,of,0,0
226926,borderline,0,0
226927,statistical,0,0
226928,significance,0,0
226929,(,0,0
226930,P,0,0
226931,=,0,0
226932,0.07,0,0
226933,),0,0
226934,.,0,0
226935,CONCLUSIONS,0,0
226936,This,0,0
226937,study,0,0
226938,suggests,0,0
226939,that,0,0
226940,for,0,0
226941,patients,0,0
226942,ar,0,0
226943,substantial,0,0
226944,risk,0,0
226945,for,0,0
226946,systemic,0,0
226947,metastases,0,0
226948,",",0,0
226949,it,0,0
226950,is,0,0
226951,preferable,0,0
226952,to,0,0
226953,give,0,0
226954,a,0,0
226955,12-week,0,0
226956,course,0,0
226957,of,0,0
226958,chemotherapy,1,0
226959,followed,0,0
226960,by,0,0
226961,radiation,1,0
226962,therapy,1,0
226963,",",0,0
226964,rather,0,0
226965,than,0,0
226966,radiation,1,0
226967,therapy,1,0
226968,followed,1,0
226969,by,1,0
226970,chemotherapy,1,0
226971,.,1,0
226972,Measurement,0,0
226973,of,0,0
226974,health-related,0,0
226975,quality,0,0
226976,of,0,0
226977,life,0,0
226978,in,0,0
226979,multiple,0,0
226980,myeloma,0,0
226981,.,0,0
226982,Nordic,0,0
226983,Myeloma,0,0
226984,Study,0,0
226985,Group,0,0
226986,.,0,0
226987,When,0,0
226988,a,0,0
226989,randomized,0,1
226990,trial,0,1
226991,(,0,0
226992,NMSG,0,0
226993,4/90,0,0
226994,),0,0
226995,comparing,0,0
226996,treatment,0,0
226997,with,0,0
226998,melphalan/prednisone,1,1
226999,to,0,1
227000,melphalan/,1,1
227001,prednisone,1,1
227002,+,1,1
227003,interferon,1,1
227004,alpha-2b,1,1
227005,in,0,1
227006,newly,0,0
227007,diagnosed,0,0
227008,multiple,0,0
227009,myeloma,0,0
227010,was,0,0
227011,initiated,0,0
227012,in,0,0
227013,1990,0,0
227014,",",0,0
227015,a,0,0
227016,quality-of-life,0,0
227017,assessment,0,0
227018,was,0,0
227019,integrated,0,0
227020,into,0,0
227021,the,0,0
227022,study,0,0
227023,.,0,0
227024,We,0,0
227025,used,0,0
227026,the,0,0
227027,questionnaire,0,0
227028,(,0,1
227029,QLQ-C30,0,1
227030,),0,0
227031,developed,0,0
227032,by,0,0
227033,the,0,0
227034,European,0,0
227035,Organization,0,0
227036,of,0,0
227037,Research,0,0
227038,and,0,0
227039,Treatment,0,0
227040,of,0,0
227041,Cancer,0,1
227042,(,0,1
227043,EORTC,0,1
227044,),0,1
227045,Study,0,0
227046,Group,0,0
227047,on,0,0
227048,Quality,0,0
227049,of,0,0
227050,Life,0,1
227051,.,0,0
227052,The,0,0
227053,QLQ-C30,0,0
227054,incorporates,0,0
227055,five,0,0
227056,functional,0,0
227057,scales,0,0
227058,",",0,0
227059,three,0,0
227060,symptom,0,0
227061,scales,0,0
227062,",",0,0
227063,a,0,0
227064,global,0,0
227065,health,0,0
227066,and,0,0
227067,quality-of,0,0
227068,life,0,0
227069,scale,0,0
227070,and,0,0
227071,some,0,0
227072,single,0,0
227073,symptom,0,0
227074,measures,0,0
227075,.,0,0
227076,The,0,0
227077,questionnaire,0,0
227078,was,0,0
227079,completed,0,0
227080,prior,0,0
227081,to,0,0
227082,treatment,0,0
227083,and,0,0
227084,after,0,0
227085,1,0,0
227086,",",0,0
227087,6,0,0
227088,",",0,0
227089,12,0,0
227090,",",0,0
227091,24,0,0
227092,",",0,0
227093,36,0,0
227094,and,0,0
227095,48,0,0
227096,months,0,0
227097,.,0,0
227098,524,0,0
227099,(,0,0
227100,90.2,0,0
227101,%,0,0
227102,),0,0
227103,of,0,0
227104,581,0,0
227105,patients,0,0
227106,enrolled,0,0
227107,in,0,0
227108,the,0,0
227109,NMSG,0,0
227110,4/90,0,0
227111,completed,0,0
227112,the,0,0
227113,first,0,0
227114,questionnaire,0,0
227115,",",0,0
227116,and,0,0
227117,484,0,0
227118,(,0,0
227119,83.3,0,0
227120,%,0,0
227121,),0,0
227122,completed,0,0
227123,all,0,0
227124,questionnaires,0,0
227125,given,0,0
227126,to,0,0
227127,them,0,0
227128,.,0,0
227129,All,0,0
227130,but,0,0
227131,one,0,0
227132,of,0,0
227133,the,0,0
227134,scales,0,0
227135,met,0,0
227136,the,0,0
227137,minimum,0,0
227138,criteria,0,0
227139,of,0,0
227140,reliability,0,1
227141,(,0,0
227142,Cronbach,0,0
227143,'s,0,0
227144,alpha,0,0
227145,>,0,0
227146,/,0,0
227147,0.70,0,0
227148,),0,0
227149,.,0,0
227150,Validity,0,0
227151,was,0,0
227152,shown,0,0
227153,by,0,0
227154,(,0,0
227155,1,0,0
227156,),0,0
227157,the,0,0
227158,ability,0,0
227159,of,0,0
227160,the,0,0
227161,scales,0,0
227162,to,0,0
227163,discriminate,0,0
227164,clearly,0,0
227165,between,0,0
227166,patients,0,0
227167,differing,0,0
227168,in,0,0
227169,clinical,0,0
227170,status,0,0
227171,as,0,0
227172,defined,0,0
227173,by,0,0
227174,pretreatment,0,1
227175,W.H.O,0,1
227176,.,0,0
227177,performance,0,0
227178,index,0,0
227179,and,0,0
227180,Durie,0,1
227181,&,0,1
227182,Salmon,0,0
227183,stage,0,0
227184,",",0,0
227185,and,0,0
227186,(,0,1
227187,2,0,1
227188,),0,0
227189,the,0,0
227190,sensitivity,0,0
227191,to,0,0
227192,changes,0,0
227193,in,0,0
227194,objective,0,0
227195,disease,0,1
227196,status,0,1
227197,(,0,0
227198,response,0,0
227199,and,0,0
227200,relapse,0,0
227201,),0,0
227202,.,0,0
227203,This,0,0
227204,is,0,0
227205,the,0,0
227206,first,0,0
227207,report,0,0
227208,of,0,0
227209,the,0,0
227210,measurement,0,0
227211,of,0,0
227212,health-related,0,0
227213,quality,0,0
227214,of,0,0
227215,life,0,0
227216,in,0,0
227217,a,0,0
227218,prospective,0,0
227219,clinical,0,0
227220,trial,0,0
227221,in,0,0
227222,multiple,0,0
227223,myeloma,0,0
227224,.,0,0
227225,The,0,0
227226,results,0,0
227227,demonstrate,0,0
227228,that,0,0
227229,the,0,0
227230,QLQ-C30,0,0
227231,is,0,0
227232,a,0,0
227233,reliable,0,0
227234,and,0,0
227235,valid,0,0
227236,instrument,0,0
227237,for,0,0
227238,the,0,0
227239,measurement,0,0
227240,of,0,0
227241,quality,0,0
227242,of,0,0
227243,life,0,0
227244,in,0,0
227245,these,0,0
227246,patients,0,0
227247,.,0,0
227248,The,0,0
227249,data,0,0
227250,will,0,0
227251,be,0,0
227252,used,0,0
227253,for,0,0
227254,a,0,0
227255,cost-utility,0,0
227256,analysis,0,0
227257,of,0,0
227258,the,0,0
227259,results,0,0
227260,of,0,0
227261,the,0,0
227262,NMSG,0,0
227263,4/90,0,0
227264,trial,0,0
227265,.,0,0
227266,Iobitridol,1,1
227267,300,1,1
227268,compared,0,0
227269,to,0,0
227270,iopromide,1,1
227271,300,1,0
227272,--,1,0
227273,a,1,0
227274,double-blind,0,1
227275,randomized,0,1
227276,phase-III,0,1
227277,study,0,0
227278,of,0,0
227279,clinical,0,0
227280,tolerance,0,0
227281,in,0,0
227282,total,0,0
227283,body,0,0
227284,CT.,0,1
227285,UNLABELLED,0,1
227286,PURPOSE,0,1
227287,",",0,0
227288,MATERIAL,0,1
227289,AND,0,1
227290,METHODS,0,1
227291,:,0,0
227292,The,0,0
227293,clinical,0,0
227294,safety,0,0
227295,of,0,0
227296,iobitriodol,1,1
227297,300,1,1
227298,mg,1,1
227299,I/ml,1,0
227300,and,1,0
227301,iopromide,1,1
227302,300,1,1
227303,mg,1,1
227304,I/ml,1,0
227305,were,0,0
227306,compared,0,0
227307,in,0,0
227308,a,0,0
227309,randomized,0,0
227310,double,0,0
227311,blind,0,0
227312,phase-III,0,0
227313,study,0,0
227314,conducted,0,0
227315,on,0,0
227316,60,0,0
227317,patients,0,0
227318,undergoing,0,0
227319,abdominal,0,0
227320,CT,0,0
227321,for,0,0
227322,a,0,0
227323,variety,0,0
227324,of,0,0
227325,indications,0,0
227326,.,0,0
227327,Each,0,0
227328,examination,0,0
227329,was,0,0
227330,rated,0,0
227331,as,0,0
227332,diagnostic,0,0
227333,or,0,0
227334,nondiagnostic,0,0
227335,and,0,0
227336,the,0,0
227337,image,0,0
227338,quality,0,0
227339,was,0,0
227340,noted,0,0
227341,.,0,0
227342,Nature,0,0
227343,",",0,0
227344,onset,0,0
227345,",",0,0
227346,intensity,0,0
227347,as,0,0
227348,well,0,0
227349,as,0,0
227350,outcome,0,0
227351,of,0,0
227352,each,0,0
227353,adverse,0,0
227354,reaction,0,0
227355,were,0,0
227356,recorded,0,0
227357,.,0,0
227358,RESULTS,0,0
227359,There,0,0
227360,was,0,0
227361,no,0,0
227362,significant,0,0
227363,difference,0,0
227364,in,0,0
227365,imaging,0,0
227366,quality,0,0
227367,and,0,0
227368,side,0,0
227369,effects,0,0
227370,between,0,0
227371,the,0,0
227372,contrast,0,0
227373,media,0,0
227374,.,0,0
227375,In,0,0
227376,this,0,0
227377,study,0,0
227378,",",0,0
227379,both,0,0
227380,iobitridol,1,1
227381,and,0,1
227382,iopromide,1,1
227383,provided,0,0
227384,excellent,0,0
227385,image,0,0
227386,quality,0,0
227387,and,0,0
227388,a,0,0
227389,low,0,0
227390,rate,0,0
227391,of,0,0
227392,side,0,0
227393,effects,0,0
227394,.,0,0
227395,CONCLUSION,0,1
227396,Iobitridol,1,1
227397,is,0,0
227398,a,0,0
227399,safe,0,0
227400,and,0,0
227401,effective,0,0
227402,nonionic,0,1
227403,contrast,0,0
227404,agent,0,0
227405,for,0,0
227406,contrast-enhanced,0,0
227407,body,0,0
227408,CT,0,0
227409,.,0,0
227410,Recovery,0,1
227411,profile,0,0
227412,after,0,0
227413,desflurane,1,1
227414,with,1,0
227415,or,1,0
227416,without,1,0
227417,ondansetron,1,1
227418,compared,1,0
227419,with,1,0
227420,propofol,1,1
227421,in,0,0
227422,patients,0,0
227423,undergoing,0,0
227424,outpatient,0,1
227425,gynecological,1,0
227426,laparoscopy,1,0
227427,.,1,0
227428,We,0,0
227429,studied,0,0
227430,the,0,0
227431,effect,0,0
227432,of,0,0
227433,combining,0,0
227434,prophylactic,1,1
227435,ondansetron,1,1
227436,(,0,1
227437,4,0,1
227438,mg,0,1
227439,intravenously,0,1
227440,[,0,1
227441,IV,0,1
227442,],0,1
227443,),0,1
227444,to,1,1
227445,desflurane-based,1,1
227446,anesthesia,1,1
227447,in,0,0
227448,90,0,0
227449,ASA,0,0
227450,grade,0,1
227451,I,0,0
227452,or,0,0
227453,11,0,0
227454,women,0,0
227455,undergoing,0,1
227456,outpatient,0,1
227457,gynecological,1,0
227458,laparoscopy,1,0
227459,.,1,0
227460,Recovery,0,0
227461,after,0,0
227462,anesthesia,0,0
227463,",",0,0
227464,with,0,0
227465,special,0,0
227466,focus,0,0
227467,on,0,0
227468,postoperative,0,0
227469,nausea,0,1
227470,and,0,1
227471,vomiting,0,1
227472,(,0,1
227473,PONV,0,1
227474,),0,1
227475,",",0,0
227476,was,0,0
227477,assessed,0,0
227478,.,0,0
227479,Control,0,0
227480,groups,0,0
227481,received,0,0
227482,a,0,0
227483,similar,0,0
227484,desflurane,1,1
227485,anesthetic,1,1
227486,(,1,1
227487,placebo,1,1
227488,),1,1
227489,or,1,1
227490,a,1,1
227491,propofol-infusion-based,1,1
227492,(,1,0
227493,active,1,0
227494,control,1,0
227495,),1,0
227496,anesthetic,1,1
227497,.,1,1
227498,The,0,0
227499,study,0,0
227500,design,0,0
227501,was,0,0
227502,randomized,0,0
227503,",",0,0
227504,controlled,0,0
227505,",",0,0
227506,and,0,1
227507,double-blind,0,1
227508,(,0,1
227509,regarding,0,1
227510,ondansetron,1,1
227511,),1,1
227512,and,0,1
227513,single-blind,0,1
227514,(,0,1
227515,regarding,0,0
227516,the,0,0
227517,anesthetic,0,1
227518,technique,0,1
227519,),0,1
227520,.,0,0
227521,Early,0,0
227522,recovery,0,0
227523,(,0,0
227524,eye,0,0
227525,opening,0,0
227526,",",0,0
227527,orientation,0,0
227528,",",0,0
227529,following,0,0
227530,commands,0,0
227531,",",0,0
227532,sitting,0,1
227533,),0,0
227534,was,0,0
227535,similar,0,0
227536,in,0,0
227537,the,0,0
227538,three,0,0
227539,groups,0,0
227540,.,0,0
227541,However,0,0
227542,",",0,0
227543,overall,0,0
227544,home,0,1
227545,readiness,0,1
227546,(,0,0
227547,toleration,0,1
227548,of,0,1
227549,oral,0,1
227550,fluids,0,1
227551,",",0,1
227552,walking,0,1
227553,",",0,0
227554,pain,0,1
227555,tolerable,0,1
227556,by,0,1
227557,oral,0,1
227558,analgesics,0,1
227559,",",0,1
227560,no,0,0
227561,or,0,0
227562,only,0,0
227563,mild,0,1
227564,nausea,0,1
227565,),0,1
227566,was,0,0
227567,achieved,0,0
227568,faster,0,0
227569,in,0,0
227570,the,0,0
227571,desflurane,0,1
227572,group,0,1
227573,receiving,0,1
227574,ondansetron,1,1
227575,(,0,1
227576,109,0,0
227577,[,0,0
227578,21-937,0,0
227579,],0,0
227580,min,0,0
227581,",",0,0
227582,P,0,0
227583,<,0,0
227584,0.01,0,0
227585,),0,0
227586,and,0,0
227587,in,0,0
227588,the,0,0
227589,propofol,0,1
227590,group,0,1
227591,(,0,0
227592,110,0,0
227593,[,0,0
227594,33-642,0,0
227595,],0,0
227596,min,0,0
227597,",",0,0
227598,P,0,0
227599,<,0,0
227600,0.001,0,0
227601,),0,0
227602,when,0,0
227603,compared,0,0
227604,to,0,0
227605,the,0,0
227606,desflurane,1,1
227607,only,0,1
227608,group,0,0
227609,(,0,0
227610,372,0,0
227611,[,0,0
227612,45-723,0,0
227613,],0,0
227614,min,0,0
227615,),0,0
227616,(,0,0
227617,median,0,0
227618,[,0,0
227619,range,0,0
227620,],0,1
227621,),0,0
227622,.,0,0
227623,The,0,0
227624,total,0,0
227625,incidence,0,0
227626,of,0,0
227627,PONV,0,0
227628,in,0,0
227629,the,0,0
227630,desflurane-only,1,1
227631,group,0,1
227632,was,0,0
227633,80,0,0
227634,%,0,0
227635,(,0,0
227636,P,0,0
227637,<,0,0
227638,0.01,0,0
227639,),0,0
227640,",",0,0
227641,compared,0,0
227642,to,0,0
227643,40,0,0
227644,%,0,0
227645,and,0,0
227646,20,0,0
227647,%,0,0
227648,in,0,0
227649,the,0,0
227650,desflurane,1,1
227651,group,0,1
227652,receiving,0,0
227653,ondansetron,0,1
227654,and,0,1
227655,the,0,1
227656,propofol,1,1
227657,group,0,0
227658,",",0,0
227659,respectively,0,0
227660,.,0,0
227661,The,0,0
227662,postoperative,0,0
227663,antiemetic,0,1
227664,requirements,0,0
227665,were,0,0
227666,consistently,0,0
227667,and,0,0
227668,significantly,0,0
227669,(,0,0
227670,P,0,0
227671,<,0,0
227672,0.01,0,0
227673,),0,0
227674,higher,0,0
227675,in,0,0
227676,the,0,0
227677,desflurane-only,1,1
227678,group,0,0
227679,compared,0,0
227680,to,0,0
227681,the,0,0
227682,other,0,0
227683,two,0,0
227684,groups,0,0
227685,.,0,0
227686,Postoperative,0,0
227687,sedation,0,0
227688,",",0,0
227689,analgesic,0,1
227690,requirements,0,0
227691,",",0,0
227692,and,0,0
227693,psychomotor,0,0
227694,recovery,0,0
227695,(,0,0
227696,assessed,0,0
227697,by,0,0
227698,the,0,0
227699,Maddox,0,0
227700,Wing,0,0
227701,and,0,0
227702,the,0,0
227703,Digit,0,0
227704,Symbol,0,0
227705,Substitution,0,0
227706,Tests,0,0
227707,),0,0
227708,were,0,0
227709,similar,0,0
227710,in,0,0
227711,the,0,0
227712,three,0,0
227713,groups,0,0
227714,.,0,0
227715,Our,0,0
227716,results,0,0
227717,suggest,0,0
227718,that,0,0
227719,in,0,0
227720,order,0,0
227721,to,0,0
227722,achieve,0,0
227723,a,0,0
227724,propofol-like,1,1
227725,recovery,0,0
227726,profile,0,0
227727,in,0,0
227728,patients,0,0
227729,with,0,0
227730,a,0,0
227731,high,0,0
227732,likelihood,0,0
227733,of,0,0
227734,PONV,0,1
227735,",",0,0
227736,desflurane,1,1
227737,should,0,0
227738,be,0,0
227739,combined,0,0
227740,with,0,0
227741,a,0,0
227742,potent,0,1
227743,antiemetic,0,1
227744,(,0,1
227745,e.g.,0,0
227746,",",0,1
227747,ondansetron,0,1
227748,),0,1
227749,.,0,0
227750,Tight-fitting,1,0
227751,underwear,1,0
227752,and,0,0
227753,sperm,0,0
227754,quality,0,0
227755,.,0,0
227756,[,1,1
227757,Radiotherapy,1,0
227758,and/or,1,0
227759,chemotherapy,1,0
227760,in,0,0
227761,children,0,0
227762,with,0,0
227763,primitive,0,0
227764,neuroectodermal,0,0
227765,tumor,0,1
227766,(,0,1
227767,PNET,0,1
227768,),0,0
227769,of,0,0
227770,the,0,0
227771,pineal,0,0
227772,region,0,0
227773,],0,0
227774,.,0,0
227775,Randomized,0,0
227776,trial,0,0
227777,comparing,0,0
227778,induction,1,0
227779,chemotherapy,1,0
227780,versus,0,0
227781,induction,1,0
227782,chemotherapy,1,0
227783,followed,1,0
227784,by,1,0
227785,maintenance,1,0
227786,chemotherapy,1,0
227787,in,0,0
227788,small-cell,0,0
227789,lung,0,0
227790,cancer,0,0
227791,.,0,0
227792,European,0,0
227793,Lung,0,1
227794,Cancer,0,1
227795,Working,0,0
227796,Party,0,0
227797,.,0,0
227798,PURPOSE,0,0
227799,AND,0,0
227800,METHODS,0,1
227801,The,0,0
227802,European,0,0
227803,Lung,0,0
227804,Cancer,0,1
227805,Working,0,0
227806,Party,0,1
227807,(,0,1
227808,ELCWP,0,1
227809,),0,0
227810,performed,0,0
227811,a,0,0
227812,randomized,0,0
227813,trial,0,0
227814,with,0,0
227815,the,0,0
227816,primary,0,0
227817,end,0,0
227818,point,0,0
227819,to,0,0
227820,determine,0,0
227821,if,0,0
227822,maintenance,0,0
227823,chemotherapy,0,0
227824,with,0,0
227825,12,0,0
227826,courses,0,0
227827,of,0,1
227828,etoposide,1,1
227829,(,0,1
227830,120,0,1
227831,mg/m2,0,1
227832,on,0,1
227833,days,0,0
227834,1,0,0
227835,and,0,0
227836,3,0,1
227837,),0,0
227838,and,0,1
227839,vindesine,1,1
227840,(,0,1
227841,3,0,1
227842,mg/m2,0,1
227843,on,0,1
227844,day,0,1
227845,3,0,1
227846,),0,0
227847,could,0,0
227848,improve,0,0
227849,progression-free,0,0
227850,survival,0,0
227851,in,0,0
227852,small-cell,0,0
227853,lung,0,1
227854,cancer,0,1
227855,(,0,1
227856,SCLC,0,1
227857,),0,1
227858,patients,0,0
227859,who,0,0
227860,responded,0,0
227861,to,0,0
227862,six,0,0
227863,courses,0,0
227864,of,0,0
227865,induction,1,0
227866,chemotherapy,1,0
227867,with,1,0
227868,ifosfamide,1,1
227869,",",1,1
227870,etoposide,1,1
227871,",",1,1
227872,and,1,0
227873,an,1,1
227874,anthracycline,1,1
227875,(,1,1
227876,doxorubicin,1,1
227877,or,1,1
227878,epirubicin,1,1
227879,),1,1
227880,.,1,1
227881,RESULTS,0,0
227882,Among,0,0
227883,235,0,0
227884,eligible,0,0
227885,patients,0,0
227886,initially,0,0
227887,registered,0,0
227888,",",0,0
227889,91,0,0
227890,were,0,0
227891,randomized,0,0
227892,to,0,0
227893,receive,0,0
227894,maintenance,0,0
227895,therapy,0,0
227896,",",0,0
227897,including,0,0
227898,seven,0,0
227899,patients,0,0
227900,who,0,0
227901,were,0,0
227902,no,0,0
227903,longer,0,0
227904,responding,0,0
227905,.,0,0
227906,Among,0,0
227907,84,0,0
227908,randomized,0,0
227909,responders,0,0
227910,",",0,0
227911,progression-free,0,0
227912,survival,0,0
227913,was,0,0
227914,significantly,0,0
227915,improved,0,0
227916,(,0,0
227917,P,0,0
227918,=,0,0
227919,.003,0,0
227920,),0,0
227921,by,0,0
227922,maintenance,0,0
227923,therapy,0,0
227924,",",0,0
227925,with,0,0
227926,median,0,0
227927,durations,0,0
227928,(,0,0
227929,maintenance,0,0
227930,v,0,0
227931,follow-up,0,0
227932,),0,0
227933,of,0,0
227934,25,0,0
227935,versus,0,0
227936,12,0,0
227937,weeks,0,0
227938,after,0,0
227939,the,0,0
227940,second,0,0
227941,randomization,0,0
227942,",",0,0
227943,but,0,0
227944,survival,0,0
227945,was,0,0
227946,not,0,0
227947,significantly,0,0
227948,increased,0,0
227949,(,0,0
227950,P,0,0
227951,=,0,0
227952,.10,0,0
227953,),0,0
227954,",",0,0
227955,with,0,0
227956,median,0,0
227957,durations,0,0
227958,of,0,0
227959,48,0,0
227960,and,0,0
227961,38,0,0
227962,weeks,0,0
227963,.,0,0
227964,However,0,0
227965,",",0,0
227966,in,0,0
227967,a,0,0
227968,multi-variate,0,0
227969,analysis,0,0
227970,that,0,0
227971,took,0,0
227972,into,0,0
227973,account,0,0
227974,disease,0,0
227975,extent,0,0
227976,",",0,0
227977,maintenance,0,0
227978,therapy,0,0
227979,",",0,0
227980,Karnofsky,0,0
227981,performance,0,1
227982,status,0,1
227983,(,0,1
227984,PS,0,1
227985,),0,0
227986,",",0,0
227987,and,0,0
227988,absolute,0,1
227989,dose-intensity,0,1
227990,(,0,1
227991,ADI,0,1
227992,),0,1
227993,of,0,0
227994,anthracycline,0,1
227995,given,0,1
227996,during,0,0
227997,induction,0,0
227998,",",0,0
227999,limited,0,0
228000,disease,0,1
228001,(,0,1
228002,LD,0,1
228003,),0,1
228004,and,0,0
228005,maintenance,0,0
228006,were,0,0
228007,found,0,0
228008,to,0,0
228009,be,0,0
228010,independent,0,0
228011,positive,0,0
228012,predictors,0,0
228013,of,0,0
228014,survival,0,0
228015,.,0,0
228016,CONCLUSION,0,0
228017,We,0,0
228018,conclude,0,0
228019,that,0,0
228020,maintenance,0,0
228021,chemotherapy,0,0
228022,in,0,0
228023,responding,0,0
228024,patients,0,0
228025,is,0,0
228026,beneficial,0,0
228027,in,0,0
228028,SCLC,0,0
228029,.,0,0
228030,Comparison,0,0
228031,of,0,1
228032,diclofenac,1,1
228033,sodium,1,1
228034,and,1,1
228035,morphine,1,1
228036,sulphate,1,1
228037,for,0,1
228038,postoperative,0,1
228039,analgesia,0,1
228040,after,0,1
228041,day,0,0
228042,case,0,0
228043,inguinal,0,1
228044,hernia,0,0
228045,surgery,0,0
228046,.,0,0
228047,Postoperative,0,0
228048,pain,0,0
228049,may,0,0
228050,be,0,0
228051,a,0,0
228052,significant,0,0
228053,reason,0,0
228054,for,0,0
228055,delayed,0,0
228056,discharge,0,0
228057,from,0,0
228058,hospital,0,0
228059,",",0,0
228060,increased,0,0
228061,morbidity,0,0
228062,and,0,0
228063,reduced,0,0
228064,patient,0,0
228065,satisfaction,0,0
228066,with,0,0
228067,ambulatory,0,0
228068,hernia,0,0
228069,surgery,0,0
228070,.,0,0
228071,This,0,0
228072,study,0,0
228073,compared,0,0
228074,two,0,0
228075,postoperative,0,1
228076,oral,0,1
228077,analgesic,0,1
228078,protocols,0,1
228079,after,0,0
228080,day,0,0
228081,case,0,0
228082,inguinal,0,1
228083,hernia,0,1
228084,repair,0,1
228085,;,0,1
228086,30,1,1
228087,mg,1,1
228088,morphine,1,1
228089,sulphate,1,1
228090,(,1,1
228091,MST,1,1
228092,),1,1
228093,and,0,1
228094,10,1,1
228095,mg,1,1
228096,metoclopramide,1,1
228097,every,0,1
228098,8,0,1
228099,h,0,0
228100,for,0,0
228101,48,0,0
228102,h,0,0
228103,or,0,0
228104,75,1,0
228105,mg,1,1
228106,diclofenac,1,1
228107,twice,0,1
228108,daily,0,1
228109,for,0,1
228110,48,0,0
228111,h.,0,0
228112,The,0,0
228113,pain,0,0
228114,reported,0,0
228115,in,0,0
228116,the,0,0
228117,MST,1,0
228118,group,0,0
228119,was,0,0
228120,significantly,0,0
228121,greater,0,0
228122,on,0,0
228123,both,0,0
228124,the,0,0
228125,day,0,0
228126,of,0,0
228127,operation,0,0
228128,and,0,0
228129,the,0,0
228130,first,0,0
228131,postoperative,0,1
228132,day,0,0
228133,(,0,0
228134,P,0,0
228135,<,0,0
228136,0.05,0,0
228137,",",0,0
228138,Mann-Whitney,0,0
228139,U,0,1
228140,test,0,1
228141,),0,1
228142,.,0,0
228143,A,0,0
228144,significantly,0,0
228145,higher,0,0
228146,proportion,0,0
228147,of,0,0
228148,patients,0,0
228149,taking,0,0
228150,MST,1,0
228151,complained,0,0
228152,of,0,0
228153,nausea,0,1
228154,on,0,0
228155,the,0,0
228156,day,0,0
228157,of,0,0
228158,operation,0,1
228159,and,0,0
228160,on,0,0
228161,the,0,0
228162,1st,0,0
228163,postoperative,0,1
228164,day,0,0
228165,(,0,0
228166,P,0,0
228167,<,0,0
228168,0.05,0,0
228169,",",0,0
228170,chi,0,0
228171,2,0,1
228172,),0,0
228173,.,0,0
228174,The,0,0
228175,time,0,0
228176,taken,0,0
228177,to,0,0
228178,walk,0,0
228179,",",0,0
228180,dress,0,0
228181,and,0,0
228182,leave,0,0
228183,home,0,0
228184,alone,0,0
228185,were,0,0
228186,achieved,0,0
228187,in,0,0
228188,a,0,0
228189,significantly,0,0
228190,shorter,0,0
228191,duration,0,0
228192,in,0,0
228193,patients,0,0
228194,taking,0,0
228195,diclofenac,1,1
228196,.,1,0
228197,We,0,0
228198,conclude,0,0
228199,that,0,0
228200,diclofenac,1,1
228201,provides,0,0
228202,effective,0,0
228203,analgesia,0,1
228204,",",0,0
228205,has,0,0
228206,a,0,0
228207,more,0,0
228208,acceptable,0,0
228209,side-effect,0,1
228210,profile,0,0
228211,than,0,1
228212,morphine,1,1
228213,sulphate,1,1
228214,and,0,1
228215,is,0,0
228216,the,0,0
228217,treatment,0,0
228218,of,0,0
228219,choice,0,0
228220,after,0,0
228221,ambulatory,0,0
228222,hernia,0,0
228223,surgery,0,0
228224,.,0,0
228225,Pharmacokinetics,0,1
228226,of,0,1
228227,adriamycin,1,1
228228,and,0,1
228229,adriamycin,1,1
228230,--,1,1
228231,DNA,1,0
228232,complex,1,0
228233,in,0,0
228234,L1210,0,0
228235,mice,0,0
228236,and,0,0
228237,men,0,0
228238,.,0,0
228239,Accuracy,0,0
228240,of,0,0
228241,pelvic,0,0
228242,radiotherapy,1,0
228243,:,1,0
228244,prospective,0,0
228245,analysis,0,0
228246,of,0,0
228247,90,0,0
228248,patients,0,0
228249,in,0,0
228250,a,0,0
228251,randomised,0,0
228252,trial,0,0
228253,of,0,0
228254,blocked,0,0
228255,versus,0,0
228256,standard,0,0
228257,radiotherapy,0,0
228258,.,0,0
228259,The,0,0
228260,aim,0,0
228261,of,0,0
228262,this,0,0
228263,study,0,0
228264,was,0,0
228265,to,0,0
228266,assess,0,0
228267,the,0,0
228268,accuracy,0,0
228269,of,0,0
228270,pelvic,0,0
228271,radiotherapy,1,0
228272,during,0,0
228273,a,0,0
228274,trial,0,0
228275,of,0,0
228276,blocked,0,0
228277,radiotherapy,0,0
228278,at,0,0
228279,the,0,0
228280,Royal,0,0
228281,Marsden,0,0
228282,Hospital,0,0
228283,",",0,0
228284,UK,0,0
228285,.,0,0
228286,Prospective,0,0
228287,evaluation,0,0
228288,was,0,0
228289,performed,0,0
228290,on,0,0
228291,90,0,0
228292,patients,0,0
228293,receiving,0,0
228294,CT,1,0
228295,planned,1,0
228296,pelvic,1,0
228297,radiotherapy,1,0
228298,using,0,0
228299,weekly,0,0
228300,anterior-posterior,0,0
228301,and,0,0
228302,lateral,0,0
228303,portal,0,0
228304,films,0,0
228305,.,0,0
228306,Field,0,0
228307,placement,0,1
228308,errors,0,1
228309,(,0,1
228310,FPEs,0,1
228311,),0,0
228312,were,0,0
228313,calculated,0,0
228314,by,0,0
228315,comparing,0,0
228316,field,0,0
228317,centres,0,0
228318,of,0,0
228319,each,0,0
228320,film,0,0
228321,with,0,0
228322,a,0,0
228323,designated,0,0
228324,point,0,0
228325,of,0,0
228326,interest,0,0
228327,.,0,0
228328,Data,0,0
228329,was,0,0
228330,evaluated,0,0
228331,to,0,0
228332,calculate,0,0
228333,the,0,0
228334,overall,0,0
228335,treatment,0,0
228336,simulator,0,0
228337,differences,0,0
228338,",",0,0
228339,the,0,0
228340,number,0,0
228341,of,0,0
228342,error,0,0
228343,free,0,0
228344,treatments,0,0
228345,",",0,0
228346,and,0,0
228347,mean,0,0
228348,treatment-simulator,0,0
228349,position,0,0
228350,and,0,0
228351,to,0,0
228352,evaluate,0,0
228353,the,0,0
228354,role,0,0
228355,of,0,0
228356,systematic,0,0
228357,versus,0,0
228358,random,0,0
228359,errors,0,1
228360,.,0,1
228361,Age,0,1
228362,",",0,0
228363,weight,0,1
228364,",",0,0
228365,disease,0,0
228366,site,0,0
228367,",",0,0
228368,position,0,0
228369,of,0,0
228370,treatment,0,0
228371,",",0,0
228372,fractionation,0,0
228373,",",0,0
228374,blocked,0,0
228375,versus,0,0
228376,conventional,0,0
228377,techniques,0,0
228378,were,0,0
228379,assessed,0,0
228380,for,0,0
228381,their,0,0
228382,effect,0,0
228383,on,0,0
228384,treatment,0,0
228385,accuracy,0,0
228386,.,0,0
228387,The,0,0
228388,mean,0,0
228389,absolute,0,0
228390,error,0,0
228391,between,0,0
228392,treatment,0,0
228393,and,0,0
228394,simulator,0,0
228395,films,0,1
228396,was,0,0
228397,anterior,0,0
228398,right-left,0,1
228399,(,0,1
228400,ARL,0,1
228401,),0,1
228402,0.25,0,0
228403,cm,0,0
228404,",",0,0
228405,anterior,0,1
228406,superior-inferior,0,1
228407,(,0,1
228408,ASI,0,1
228409,),0,0
228410,0.32,0,0
228411,cm,0,0
228412,",",0,0
228413,lateral,0,0
228414,anterior-posterior,0,1
228415,(,0,1
228416,LAP,0,1
228417,),0,0
228418,0.42,0,0
228419,cm,0,0
228420,",",0,0
228421,and,0,0
228422,lateral,0,0
228423,superior-inferior,0,1
228424,(,0,1
228425,LSI,0,1
228426,),0,0
228427,0.28,0,0
228428,cm,0,0
228429,.,0,0
228430,On,0,0
228431,average,0,0
228432,the,0,0
228433,field,0,0
228434,centre,0,0
228435,was,0,0
228436,displaced,0,0
228437,by,0,0
228438,0.66,0,0
228439,cm,0,0
228440,(,0,0
228441,standard,0,1
228442,deviation,0,1
228443,",",0,0
228444,S.D,0,0
228445,.,0,0
228446,=,0,0
228447,0.34,0,0
228448,),0,0
228449,from,0,0
228450,that,0,0
228451,intended,0,0
228452,.,0,0
228453,On,0,0
228454,each,0,0
228455,treatment,0,0
228456,day,0,0
228457,29,0,0
228458,%,0,0
228459,of,0,0
228460,anterior,0,0
228461,films,0,0
228462,and,0,0
228463,45,0,0
228464,%,0,0
228465,of,0,0
228466,lateral,0,0
228467,films,0,0
228468,had,0,0
228469,at,0,0
228470,least,0,0
228471,one,0,0
228472,0.5,0,0
228473,cm,0,0
228474,error,0,0
228475,.,0,0
228476,Overall,0,0
228477,59,0,0
228478,%,0,0
228479,of,0,0
228480,treatments,0,0
228481,had,0,0
228482,at,0,0
228483,least,0,0
228484,one,0,0
228485,0.5,0,0
228486,cm,0,0
228487,error,0,0
228488,and,0,0
228489,9,0,0
228490,%,0,0
228491,a,0,0
228492,1.0,0,0
228493,cm,0,0
228494,error,0,0
228495,.,0,0
228496,The,0,0
228497,field,0,0
228498,centre,0,0
228499,was,0,0
228500,more,0,0
228501,than,0,0
228502,0.5,0,0
228503,cm,0,0
228504,from,0,0
228505,the,0,0
228506,position,0,0
228507,intended,0,0
228508,in,0,0
228509,66,0,0
228510,%,0,0
228511,of,0,0
228512,treatments,0,0
228513,and,0,0
228514,over,0,0
228515,1,0,0
228516,cm,0,0
228517,for,0,0
228518,14,0,0
228519,%,0,0
228520,of,0,0
228521,treatments,0,0
228522,.,0,0
228523,Analysis,0,0
228524,of,0,0
228525,variance,0,0
228526,showed,0,0
228527,that,0,0
228528,both,0,0
228529,random,0,0
228530,and,0,0
228531,systematic,0,0
228532,errors,0,0
228533,occurred,0,0
228534,in,0,0
228535,all,0,0
228536,directions,0,0
228537,.,0,0
228538,Though,0,0
228539,random,0,0
228540,errors,0,0
228541,were,0,0
228542,of,0,0
228543,similar,0,0
228544,magnitude,0,0
228545,in,0,0
228546,all,0,0
228547,direction,0,0
228548,(,0,0
228549,variance,0,0
228550,sigma,0,0
228551,2,0,0
228552,=,0,0
228553,0.06-0.09,0,0
228554,cm2,0,0
228555,),0,0
228556,;,0,0
228557,systematic,0,1
228558,errors,0,0
228559,showed,0,0
228560,a,0,0
228561,4-fold,0,0
228562,variation,0,0
228563,being,0,0
228564,greatest,0,0
228565,in,0,0
228566,the,0,0
228567,LAP,0,0
228568,direction,0,0
228569,(,0,0
228570,sigma,0,0
228571,2,0,0
228572,=,0,0
228573,0.19,0,0
228574,cm2,0,0
228575,),0,0
228576,and,0,0
228577,least,0,0
228578,the,0,0
228579,ARL,0,0
228580,direction,0,0
228581,(,0,0
228582,sigma,0,0
228583,2,0,0
228584,=,0,0
228585,0.048,0,0
228586,cm2,0,0
228587,),0,0
228588,.,0,0
228589,No,0,1
228590,factor,0,0
228591,consistently,0,0
228592,predicted,0,0
228593,for,0,0
228594,worse,0,0
228595,outcome,0,0
228596,in,0,0
228597,all,0,0
228598,directions,0,0
228599,.,0,0
228600,Hypofractionated,0,0
228601,treatments,0,0
228602,were,0,0
228603,less,0,0
228604,accurate,0,0
228605,in,0,0
228606,the,0,0
228607,LSI,0,0
228608,direction,0,0
228609,(,0,0
228610,P,0,0
228611,>,0,0
228612,0.05,0,0
228613,),0,0
228614,.,0,0
228615,Systematic,0,0
228616,errors,0,0
228617,were,0,0
228618,associated,0,0
228619,in,0,0
228620,the,0,0
228621,ARL,0,0
228622,direction,0,0
228623,with,0,0
228624,hypofractionation,0,0
228625,(,0,0
228626,P,0,0
228627,<,0,0
228628,0.01,0,0
228629,),0,0
228630,and,0,0
228631,",",0,0
228632,in,0,0
228633,the,0,0
228634,LSI,0,0
228635,direction,0,0
228636,with,0,0
228637,weight,0,0
228638,(,0,0
228639,P,0,0
228640,<,0,0
228641,0.03,0,0
228642,),0,0
228643,and,0,0
228644,age,0,0
228645,(,0,0
228646,P,0,0
228647,<,0,0
228648,0.05,0,0
228649,),0,0
228650,.,0,0
228651,We,0,0
228652,conclude,0,0
228653,that,0,0
228654,significant,0,0
228655,random,0,0
228656,and,0,0
228657,systematic,0,0
228658,errors,0,0
228659,can,0,0
228660,occur,0,0
228661,during,0,0
228662,pelvic,0,0
228663,radiotherapy,1,0
228664,especially,0,0
228665,in,0,0
228666,the,0,0
228667,LAP,0,0
228668,direction,0,0
228669,.,0,0
228670,These,0,0
228671,results,0,0
228672,suggest,0,0
228673,that,0,0
228674,in,0,0
228675,the,0,0
228676,absence,0,0
228677,of,0,0
228678,a,0,0
228679,customised,0,0
228680,immobilisation,0,0
228681,device,0,0
228682,",",0,0
228683,to,0,0
228684,cover,0,0
228685,95,0,0
228686,%,0,0
228687,of,0,0
228688,errors,0,0
228689,",",0,0
228690,margins,0,0
228691,of,0,0
228692,0.6,0,0
228693,cm,0,0
228694,for,0,0
228695,RL,0,0
228696,and,0,0
228697,SI,0,0
228698,directions,0,0
228699,and,0,0
228700,0.9,0,0
228701,cm,0,0
228702,for,0,0
228703,AP,0,0
228704,direction,0,0
228705,should,0,0
228706,be,0,0
228707,allowed,0,0
228708,between,0,0
228709,the,0,0
228710,planning,0,0
228711,and,0,0
228712,clinical,0,0
228713,target,0,0
228714,volumes,0,0
228715,.,0,0
228716,However,0,0
228717,",",0,0
228718,ideally,0,0
228719,",",0,0
228720,each,0,0
228721,centre,0,0
228722,should,0,0
228723,determine,0,0
228724,their,0,0
228725,own,0,0
228726,margin,0,0
228727,requirements,0,0
228728,according,0,0
228729,to,0,0
228730,local,0,0
228731,clinical,0,0
228732,practice,0,0
228733,.,0,0
228734,[,0,1
228735,Intraoperative,0,0
228736,continuous,0,0
228737,epidural,0,0
228738,block,0,0
228739,influences,0,0
228740,postoperative,0,0
228741,changes,0,0
228742,in,0,0
228743,breathing,0,0
228744,pattern,0,0
228745,and,0,0
228746,thoracoabdominal,0,0
228747,movement,0,0
228748,associated,0,0
228749,with,0,0
228750,upper,0,0
228751,abdominal,0,1
228752,surgery,0,1
228753,],0,0
228754,.,0,0
228755,We,0,0
228756,have,0,0
228757,examined,0,0
228758,the,0,0
228759,changes,0,0
228760,in,0,0
228761,breathing,0,0
228762,pattern,0,0
228763,and,0,0
228764,thoracoabdominal,0,0
228765,movement,0,0
228766,associated,0,0
228767,with,0,0
228768,upper,0,0
228769,abdominal,0,0
228770,surgery,0,0
228771,in,0,0
228772,order,0,0
228773,to,0,0
228774,evaluate,0,0
228775,the,0,0
228776,possible,0,0
228777,influences,0,0
228778,of,0,0
228779,nociceptive,0,0
228780,input,0,0
228781,on,0,0
228782,respiration,0,0
228783,.,0,0
228784,Sixteen,0,0
228785,patients,0,0
228786,scheduled,0,0
228787,for,0,0
228788,gastrectomy,0,0
228789,were,0,0
228790,studied,0,0
228791,.,0,0
228792,Continuous,1,0
228793,epidural,1,0
228794,block,1,0
228795,was,1,0
228796,instituted,1,0
228797,prior,1,0
228798,to,1,0
228799,the,1,0
228800,induction,1,0
228801,of,1,0
228802,anesthesia,1,0
228803,and,1,0
228804,maintained,1,0
228805,throughout,1,0
228806,the,1,0
228807,surgery,1,0
228808,in,1,0
228809,8,1,0
228810,of,1,0
228811,16,1,0
228812,patients,1,0
228813,(,1,0
228814,Group,1,0
228815,1,1,0
228816,),1,0
228817,while,1,0
228818,it,1,0
228819,was,1,0
228820,instituted,1,0
228821,upon,1,0
228822,the,1,0
228823,peritoneal,1,0
228824,closure,1,0
228825,and,1,0
228826,maintained,1,0
228827,thereafter,1,0
228828,in,1,0
228829,the,1,0
228830,remaining,1,0
228831,8,1,0
228832,patients,1,0
228833,(,1,0
228834,Group,1,0
228835,2,1,0
228836,),1,0
228837,.,0,0
228838,Breathing,0,0
228839,pattern,0,0
228840,and,0,0
228841,thoracoabdominal,0,0
228842,motion,0,0
228843,were,0,0
228844,determined,0,0
228845,before,0,0
228846,and,0,0
228847,after,0,0
228848,surgery,0,0
228849,while,0,0
228850,the,0,0
228851,patients,0,0
228852,awake,0,0
228853,by,0,0
228854,respiratory,1,0
228855,inductance,1,1
228856,plethysmography,1,1
228857,(,1,1
228858,Respisomnography,1,0
228859,",",1,0
228860,Chest,1,0
228861,MI,1,1
228862,),1,0
228863,.,1,0
228864,Breathing,0,0
228865,frequency,0,0
228866,and,0,0
228867,minute,0,0
228868,ventilation,0,0
228869,increased,0,0
228870,significantly,0,0
228871,while,0,0
228872,tidal,0,0
228873,volume,0,0
228874,was,0,0
228875,unchanged,0,0
228876,after,0,0
228877,the,0,0
228878,operation,0,0
228879,regardless,0,0
228880,of,0,0
228881,the,0,0
228882,intraoperative,0,0
228883,epidural,0,0
228884,block,0,0
228885,.,0,0
228886,Furthermore,0,0
228887,",",0,0
228888,there,0,0
228889,were,0,0
228890,identical,0,0
228891,shortening,0,0
228892,of,0,0
228893,inspiratory,0,0
228894,time,0,0
228895,and,0,0
228896,prolongation,0,0
228897,of,0,0
228898,duty,0,1
228899,ratio,0,0
228900,(,0,0
228901,inspiratory,0,0
228902,time/duration,0,0
228903,of,0,0
228904,a,0,0
228905,breath,0,0
228906,),0,0
228907,in,0,0
228908,the,0,0
228909,two,0,0
228910,groups,0,0
228911,.,0,0
228912,Contribution,0,0
228913,of,0,0
228914,rib,0,0
228915,cage,0,0
228916,movement,0,0
228917,on,0,0
228918,tidal,0,0
228919,volume,0,0
228920,increased,0,0
228921,significantly,0,0
228922,postoperatively,0,0
228923,in,0,0
228924,all,0,0
228925,the,0,0
228926,patients,0,0
228927,.,0,0
228928,However,0,0
228929,",",0,0
228930,the,0,0
228931,changes,0,0
228932,were,0,0
228933,significantly,0,0
228934,smaller,0,0
228935,in,0,0
228936,patients,0,0
228937,receiving,0,0
228938,intraoperative,0,0
228939,epidural,0,0
228940,block,0,0
228941,.,0,0
228942,These,0,0
228943,results,0,0
228944,indicate,0,0
228945,that,0,0
228946,the,0,0
228947,causes,0,0
228948,of,0,0
228949,tachypnea,0,0
228950,and,0,0
228951,increased,0,0
228952,minute,0,0
228953,ventilation,0,0
228954,are,0,0
228955,different,0,0
228956,from,0,0
228957,the,0,0
228958,mechanism,0,0
228959,responsible,0,0
228960,for,0,0
228961,the,0,0
228962,alteration,0,0
228963,of,0,0
228964,thoracoabdominal,0,0
228965,partitioning,0,0
228966,of,0,0
228967,ventilation,0,0
228968,after,0,0
228969,upper,0,0
228970,abdominal,0,0
228971,surgery,0,0
228972,.,0,0
228973,The,0,0
228974,former,0,0
228975,may,0,0
228976,be,0,0
228977,related,0,0
228978,to,0,0
228979,the,0,0
228980,metabolic,0,0
228981,changes,0,0
228982,and,0,0
228983,",",0,0
228984,conceivably,0,0
228985,",",0,0
228986,unaffected,0,0
228987,by,0,0
228988,continuous,0,0
228989,epidural,0,0
228990,block,0,0
228991,.,0,0
228992,While,0,0
228993,the,0,0
228994,latter,0,0
228995,may,0,0
228996,be,0,0
228997,the,0,0
228998,consequence,0,0
228999,of,0,0
229000,the,0,0
229001,reflex,0,0
229002,inhibition,0,0
229003,of,0,0
229004,the,0,0
229005,diaphragmatic,0,0
229006,function,0,0
229007,that,0,0
229008,can,0,0
229009,be,0,0
229010,",",0,0
229011,at,0,0
229012,least,0,0
229013,partially,0,0
229014,",",0,0
229015,modified,0,0
229016,by,0,0
229017,continuous,0,0
229018,epidural,0,0
229019,block,0,0
229020,.,0,0
229021,Prediction,0,0
229022,of,0,0
229023,the,0,0
229024,infarct-related,0,0
229025,artery,0,0
229026,in,0,0
229027,acute,0,0
229028,myocardial,0,0
229029,infarction,0,0
229030,by,0,0
229031,a,0,0
229032,scoring,0,0
229033,system,0,0
229034,using,0,0
229035,summary,1,0
229036,ST-segment,1,0
229037,and,1,0
229038,T-wave,1,0
229039,changes,1,0
229040,.,1,0
229041,We,0,0
229042,developed,0,0
229043,a,0,0
229044,scoring,0,0
229045,system,0,0
229046,to,0,0
229047,predict,0,0
229048,the,0,0
229049,artery,0,0
229050,responsible,0,0
229051,for,0,0
229052,an,0,0
229053,acute,0,0
229054,myocardial,0,1
229055,infarction,0,1
229056,(,0,1
229057,AMI,0,1
229058,),0,1
229059,using,0,0
229060,ST-segment,1,0
229061,and,1,0
229062,T-wave,1,0
229063,changes,1,0
229064,on,1,0
229065,the,1,0
229066,initial,1,0
229067,electrocardiogram,1,0
229068,(,1,1
229069,ECG,1,1
229070,),1,0
229071,using,0,0
229072,data,0,0
229073,from,0,0
229074,228,0,0
229075,patients,0,0
229076,(,0,0
229077,development,0,0
229078,set,0,0
229079,),0,0
229080,with,0,0
229081,symptoms,0,0
229082,compatible,0,0
229083,with,0,0
229084,AMI,0,0
229085,and,0,0
229086,tested,0,0
229087,in,0,0
229088,a,0,0
229089,similar,0,0
229090,group,0,0
229091,of,0,0
229092,223,0,0
229093,patients,0,0
229094,(,0,0
229095,test,0,0
229096,set,0,0
229097,),0,0
229098,from,0,0
229099,the,0,0
229100,Thrombolysis,0,0
229101,and,0,0
229102,Angioplasty,0,0
229103,in,0,0
229104,Myocardial,0,1
229105,Infarction,0,1
229106,(,0,1
229107,TAMI-5,0,1
229108,),0,0
229109,Trial,0,0
229110,.,0,0
229111,Using,0,0
229112,stepwise,0,0
229113,logistic,0,0
229114,regression,0,0
229115,we,0,0
229116,were,0,0
229117,able,0,0
229118,to,0,0
229119,accurately,0,0
229120,predict,0,0
229121,the,0,0
229122,left,0,0
229123,anterior,0,1
229124,descending,0,1
229125,(,0,1
229126,LAD,0,1
229127,),0,1
229128,",",0,0
229129,right,0,0
229130,",",0,0
229131,or,0,0
229132,left,0,1
229133,circumflex,0,1
229134,(,0,1
229135,LC,0,1
229136,),0,1
229137,coronary,0,0
229138,artery,0,0
229139,as,0,0
229140,the,0,0
229141,infarct-related,0,0
229142,artery,0,0
229143,using,0,0
229144,2,0,0
229145,variables,0,0
229146,:,0,1
229147,(,0,0
229148,1,0,0
229149,),0,0
229150,the,0,0
229151,summation,0,0
229152,of,0,0
229153,the,0,0
229154,ST-segment,0,0
229155,elevation,0,0
229156,in,0,0
229157,leads,0,0
229158,V1,0,0
229159,to,0,0
229160,V4,0,1
229161,;,0,1
229162,and,0,1
229163,(,0,1
229164,2,0,1
229165,),0,0
229166,the,0,0
229167,summation,0,0
229168,of,0,0
229169,the,0,0
229170,T-wave,0,0
229171,negativity,0,0
229172,in,0,0
229173,leads,0,0
229174,I,0,0
229175,",",0,0
229176,aVL,0,0
229177,",",0,0
229178,and,0,0
229179,V5,0,0
229180,.,0,0
229181,In,0,0
229182,the,0,0
229183,development,0,0
229184,set,0,0
229185,",",0,0
229186,these,0,0
229187,2,0,0
229188,variables,0,0
229189,demonstrated,0,0
229190,respective,0,0
229191,sensitivity,0,0
229192,and,0,0
229193,specificity,0,0
229194,of,0,0
229195,98,0,0
229196,%,0,0
229197,and,0,0
229198,90,0,0
229199,%,0,0
229200,for,0,0
229201,LAD,0,0
229202,lesions,0,0
229203,",",0,0
229204,82,0,0
229205,%,0,0
229206,and,0,0
229207,85,0,0
229208,%,0,0
229209,for,0,0
229210,right,0,0
229211,narrowings,0,0
229212,",",0,0
229213,and,0,0
229214,82,0,0
229215,%,0,0
229216,and,0,0
229217,84,0,0
229218,%,0,0
229219,for,0,0
229220,LC,0,0
229221,narrowings,0,0
229222,.,0,0
229223,In,0,0
229224,the,0,0
229225,test,0,0
229226,set,0,0
229227,",",0,0
229228,the,0,0
229229,sensitivity,0,0
229230,and,0,0
229231,specificity,0,0
229232,were,0,0
229233,97,0,0
229234,%,0,0
229235,and,0,0
229236,95,0,0
229237,%,0,0
229238,for,0,0
229239,LAD,0,0
229240,lesions,0,0
229241,",",0,0
229242,85,0,0
229243,%,0,0
229244,and,0,0
229245,86,0,0
229246,%,0,0
229247,for,0,0
229248,right,0,0
229249,lesions,0,0
229250,",",0,0
229251,and,0,0
229252,73,0,0
229253,%,0,0
229254,and,0,0
229255,60,0,0
229256,%,0,0
229257,for,0,0
229258,LC,0,0
229259,coronary,0,1
229260,artery,0,0
229261,lesions,0,0
229262,.,0,0
229263,Information,0,0
229264,easily,0,0
229265,obtained,0,0
229266,on,0,0
229267,the,0,0
229268,ECG,0,0
229269,can,0,0
229270,accurately,0,0
229271,predict,0,0
229272,the,0,0
229273,likelihood,0,0
229274,of,0,0
229275,the,0,0
229276,LAD,0,0
229277,",",0,0
229278,right,0,0
229279,",",0,0
229280,or,0,0
229281,LC,0,1
229282,artery,0,0
229283,as,0,0
229284,the,0,0
229285,infarct-related,0,0
229286,artery,0,0
229287,.,0,0
229288,This,0,0
229289,may,0,0
229290,be,0,0
229291,useful,0,0
229292,in,0,0
229293,the,0,0
229294,decision,0,0
229295,to,0,0
229296,administer,0,1
229297,thrombolytic,0,1
229298,treatment,0,0
229299,.,0,0
229300,Comparison,0,0
229301,of,0,0
229302,analgesic,0,1
229303,effect,0,0
229304,of,0,0
229305,locally,0,0
229306,and,0,0
229307,systemically,0,0
229308,administered,0,1
229309,ketorolac,1,1
229310,in,0,1
229311,mastectomy,0,0
229312,patients,0,0
229313,.,0,0
229314,BACKGROUND,0,1
229315,Ketorolac,1,1
229316,is,0,0
229317,a,0,1
229318,parenteral,0,1
229319,nonsteroidal,0,1
229320,antiinflammatory,0,1
229321,drug,0,1
229322,(,0,1
229323,NSAID,0,1
229324,),0,1
229325,.,0,0
229326,Two,0,0
229327,features,0,0
229328,have,0,0
229329,limited,0,0
229330,its,0,0
229331,clinical,0,0
229332,utility,0,0
229333,:,0,0
229334,tendency,0,0
229335,to,0,0
229336,elicit,0,0
229337,kidney,0,0
229338,failure,0,0
229339,and,0,0
229340,inability,0,0
229341,to,0,0
229342,produce,0,0
229343,complete,0,0
229344,analgesia,0,1
229345,.,0,0
229346,Because,0,0
229347,most,0,0
229348,NSAIDs,1,0
229349,are,0,0
229350,weak,0,0
229351,acids,0,1
229352,(,0,1
229353,pKa,0,1
229354,3-5,0,1
229355,),0,0
229356,and,0,0
229357,become,0,0
229358,concentrated,0,0
229359,in,0,0
229360,acidic,0,0
229361,tissues,0,0
229362,",",0,0
229363,such,0,0
229364,as,0,0
229365,injured,0,0
229366,and,0,0
229367,inflamed,0,0
229368,tissues,0,0
229369,",",0,0
229370,we,0,0
229371,hypothesized,0,0
229372,that,0,0
229373,local,0,0
229374,administration,0,1
229375,may,0,0
229376,enhance,0,0
229377,its,0,0
229378,analgesic,0,1
229379,efficacy,0,1
229380,while,0,0
229381,lowering,0,0
229382,the,0,0
229383,potential,0,0
229384,for,0,0
229385,systemic,0,0
229386,complications,0,0
229387,.,0,0
229388,METHODS,0,0
229389,We,0,0
229390,conducted,0,0
229391,a,0,0
229392,randomized,0,0
229393,",",0,0
229394,placebo-controlled,1,1
229395,study,0,0
229396,of,0,0
229397,60,0,0
229398,group,0,0
229399,I-II,0,1
229400,(,0,1
229401,American,0,0
229402,Society,0,0
229403,of,0,0
229404,Anesthesiology,0,1
229405,criteria,0,1
229406,),0,0
229407,mastectomy,0,0
229408,patients,0,0
229409,",",0,0
229410,20,0,0
229411,in,0,0
229412,each,0,0
229413,group,0,0
229414,.,0,0
229415,Near,0,0
229416,the,0,0
229417,end,0,0
229418,of,0,0
229419,surgery,0,0
229420,and,0,0
229421,every,0,0
229422,6,0,0
229423,h,0,0
229424,postoperatively,0,0
229425,",",0,0
229426,20,0,0
229427,ml,0,0
229428,of,0,0
229429,the,0,0
229430,study,0,0
229431,solution,0,0
229432,containing,0,0
229433,normal,1,0
229434,saline,1,1
229435,with,1,0
229436,or,1,0
229437,without,1,0
229438,30,1,0
229439,mg,1,1
229440,of,1,1
229441,ketorolac,1,1
229442,were,0,1
229443,administered,0,1
229444,simultaneously,0,0
229445,either,0,0
229446,via,0,0
229447,a,0,0
229448,Jackson-Pratt,0,0
229449,drain,0,1
229450,or,0,0
229451,intravenously,0,1
229452,in,0,0
229453,a,0,0
229454,double-blind,0,1
229455,fashion,0,0
229456,.,0,0
229457,The,0,0
229458,quality,0,0
229459,of,0,0
229460,pain,0,0
229461,control,0,0
229462,",",0,0
229463,the,0,0
229464,amount,0,0
229465,and,0,0
229466,character,0,0
229467,of,0,0
229468,the,0,0
229469,drain,0,0
229470,fluid,0,1
229471,",",0,0
229472,incidence,0,0
229473,of,0,0
229474,nausea,0,1
229475,and,0,1
229476,vomiting,0,1
229477,",",0,0
229478,length,0,0
229479,of,0,0
229480,stay,0,0
229481,in,0,0
229482,the,0,0
229483,postoperative,0,0
229484,care,0,0
229485,unit,0,0
229486,",",0,0
229487,and,0,0
229488,amount,0,0
229489,of,0,0
229490,morphine,0,1
229491,used,0,0
229492,for,0,0
229493,treatment,0,0
229494,of,0,0
229495,break-through,0,0
229496,pain,0,0
229497,were,0,0
229498,recorded,0,0
229499,.,0,0
229500,RESULTS,0,0
229501,Intraoperative,0,1
229502,administration,0,1
229503,of,0,1
229504,ketorolac,1,1
229505,resulted,0,0
229506,in,0,0
229507,better,0,0
229508,quality,0,0
229509,of,0,0
229510,pain,0,0
229511,control,0,0
229512,in,0,0
229513,the,0,0
229514,immediate,0,0
229515,postoperative,0,0
229516,period,0,0
229517,regardless,0,0
229518,of,0,0
229519,route,0,0
229520,of,0,0
229521,administration,0,1
229522,.,0,0
229523,The,0,0
229524,incidence,0,0
229525,of,0,0
229526,nausea,0,1
229527,was,0,0
229528,significantly,0,0
229529,higher,0,0
229530,in,0,0
229531,the,0,0
229532,placebo,0,1
229533,group,0,1
229534,",",0,0
229535,and,0,0
229536,drain,0,0
229537,output,0,0
229538,in,0,0
229539,the,0,0
229540,ketorolac,1,1
229541,groups,0,0
229542,did,0,0
229543,not,0,0
229544,exceed,0,0
229545,the,0,0
229546,output,0,0
229547,in,0,0
229548,the,0,0
229549,placebo,1,1
229550,group,0,1
229551,.,0,0
229552,CONCLUSION,0,1
229553,Analgesic,0,1
229554,of,0,0
229555,the,0,0
229556,locally,0,0
229557,administered,0,1
229558,ketorolac,1,1
229559,is,0,0
229560,equally,0,0
229561,effective,0,0
229562,to,0,0
229563,the,0,0
229564,efficacy,0,0
229565,of,0,0
229566,ketorolac,1,1
229567,administered,0,1
229568,intravenously,0,1
229569,.,0,1
229570,Randomized,0,0
229571,controlled,0,0
229572,trial,0,0
229573,of,0,0
229574,acellular,1,1
229575,diphtheria,1,1
229576,",",1,1
229577,pertussis,1,1
229578,and,1,1
229579,tetanus,1,1
229580,vaccines,1,1
229581,in,0,0
229582,southern,0,0
229583,Ghana,0,0
229584,.,0,0
229585,A,0,0
229586,randomized,0,0
229587,controlled,0,0
229588,trial,0,0
229589,of,0,0
229590,acellular,1,1
229591,diphtheria/pertussis/tetanus,1,1
229592,(,1,1
229593,ADPT,1,1
229594,),1,1
229595,freeze-dried,1,1
229596,and,1,1
229597,liquid,1,1
229598,vaccines,1,1
229599,in,0,0
229600,infants,0,0
229601,was,0,0
229602,conducted,0,0
229603,in,0,0
229604,a,0,0
229605,peri-urban,0,0
229606,community,0,1
229607,(,0,1
229608,Ashaiman,0,1
229609,),0,0
229610,in,0,0
229611,southern,0,0
229612,Ghana,0,0
229613,.,0,0
229614,Immunogenicity,0,0
229615,of,0,0
229616,the,0,0
229617,acellular,0,0
229618,vaccines,0,0
229619,",",0,0
229620,persistence,0,0
229621,of,0,0
229622,antibodies,0,0
229623,and,0,0
229624,adverse,0,0
229625,reactions,0,0
229626,were,0,0
229627,compared,0,0
229628,with,0,0
229629,those,0,0
229630,achieved,0,0
229631,with,0,0
229632,a,0,0
229633,whole-cell,1,0
229634,diphtheria-pertussis-tetanus,1,1
229635,(,1,1
229636,DPT,1,1
229637,),1,1
229638,vaccine,1,1
229639,.,1,1
229640,The,0,0
229641,incidence,0,0
229642,of,0,0
229643,pertussis,0,1
229644,in,0,0
229645,the,0,1
229646,vaccine,0,1
229647,groups,0,1
229648,and,0,0
229649,prevalence,0,1
229650,of,0,0
229651,pertussis,0,1
229652,in,0,0
229653,children,0,0
229654,under,0,0
229655,5,0,0
229656,years,0,0
229657,of,0,0
229658,age,0,0
229659,in,0,0
229660,the,0,0
229661,study,0,0
229662,area,0,0
229663,were,0,0
229664,also,0,0
229665,determined,0,0
229666,.,0,0
229667,The,0,0
229668,acellular,0,0
229669,vaccines,0,0
229670,produced,0,0
229671,significantly,0,0
229672,fewer,0,0
229673,local,0,0
229674,and,0,0
229675,systemic,0,0
229676,reactions,0,0
229677,.,0,0
229678,Local,0,0
229679,reactions,0,0
229680,such,0,0
229681,as,0,0
229682,swelling,0,0
229683,and,0,0
229684,redness,0,0
229685,were,0,0
229686,observed,0,0
229687,in,0,0
229688,2,0,0
229689,%,0,0
229690,(,0,0
229691,8/399,0,0
229692,),0,0
229693,to,0,0
229694,2.3,0,0
229695,%,0,0
229696,(,0,0
229697,9/385,0,0
229698,),0,0
229699,of,0,0
229700,the,0,0
229701,acellular,1,1
229702,vaccine,1,1
229703,recipients,0,0
229704,as,0,0
229705,against,0,0
229706,31,0,0
229707,%,0,0
229708,(,0,0
229709,122/394,0,0
229710,),0,0
229711,in,0,0
229712,the,0,0
229713,whole-cell,0,0
229714,vaccine,0,1
229715,group,0,0
229716,.,0,1
229717,Fever,0,1
229718,(,0,0
229719,>,0,0
229720,or,0,0
229721,=,0,0
229722,37.5,0,0
229723,degrees,0,0
229724,C,0,0
229725,),0,0
229726,occurred,0,0
229727,in,0,0
229728,7.27,0,0
229729,%,0,0
229730,(,0,0
229731,29/399,0,0
229732,),0,0
229733,to,0,0
229734,9.8,0,0
229735,%,0,0
229736,(,0,0
229737,38/385,0,0
229738,),0,0
229739,in,0,0
229740,the,0,0
229741,acellular,1,1
229742,vaccine,1,1
229743,groups,0,0
229744,compared,0,0
229745,with,0,0
229746,36.6,0,0
229747,%,0,0
229748,(,0,0
229749,145/394,0,0
229750,),0,0
229751,in,0,0
229752,the,0,0
229753,whole-cell,0,0
229754,vaccine,0,1
229755,group,0,0
229756,.,0,0
229757,Geometric,0,0
229758,mean,0,0
229759,titres,0,1
229760,(,0,1
229761,GMTs,0,1
229762,),0,1
229763,",",0,0
229764,measured,0,0
229765,by,0,0
229766,ELISA,0,0
229767,",",0,0
229768,to,0,0
229769,pertussis,0,1
229770,toxin,0,1
229771,(,0,1
229772,PT,0,1
229773,),0,1
229774,and,0,0
229775,filamentous,0,1
229776,haemagglutinin,0,1
229777,(,0,1
229778,FHA,0,1
229779,),0,0
229780,were,0,0
229781,significantly,0,0
229782,higher,0,0
229783,in,0,0
229784,the,0,0
229785,acellular,1,1
229786,vaccine,1,1
229787,groups,0,1
229788,than,0,0
229789,in,0,0
229790,the,0,0
229791,whole-cell,1,0
229792,DPT,1,1
229793,(,1,1
229794,WCDPT,1,1
229795,),1,1
229796,group,0,0
229797,.,0,0
229798,There,0,0
229799,were,0,0
229800,no,0,0
229801,significant,0,0
229802,differences,0,0
229803,in,0,0
229804,the,0,0
229805,GMTs,0,0
229806,of,0,0
229807,tetanus,0,1
229808,and,0,1
229809,diphtheria,0,1
229810,antitoxins,0,1
229811,between,0,0
229812,the,0,0
229813,two,0,0
229814,groups,0,0
229815,after,0,0
229816,each,0,0
229817,vaccination,0,0
229818,.,0,0
229819,Twelve,0,0
229820,months,0,0
229821,after,0,0
229822,primary,0,0
229823,vaccination,0,0
229824,",",0,0
229825,GMTs,0,0
229826,to,0,0
229827,PT,0,0
229828,in,0,0
229829,the,0,0
229830,freeze-dried,0,1
229831,",",0,1
229832,liquid,0,1
229833,ADPT,0,1
229834,groups,0,0
229835,and,0,0
229836,the,0,0
229837,WCDPT,0,1
229838,group,0,0
229839,have,0,0
229840,fallen,0,0
229841,from,0,0
229842,56.23,0,0
229843,",",0,0
229844,62.63,0,0
229845,and,0,0
229846,44.97,0,0
229847,ELISA,0,0
229848,U/ml,0,0
229849,to,0,0
229850,6.08,0,0
229851,",",0,0
229852,6.18,0,0
229853,and,0,0
229854,11.30,0,0
229855,ELISA,0,0
229856,U/ml,0,0
229857,",",0,0
229858,respectively,0,0
229859,.,0,0
229860,GMTs,0,0
229861,to,0,0
229862,FHA,0,0
229863,in,0,0
229864,all,0,0
229865,the,0,0
229866,vaccine,0,1
229867,groups,0,0
229868,also,0,0
229869,dropped,0,0
229870,during,0,0
229871,the,0,0
229872,same,0,0
229873,period,0,0
229874,from,0,0
229875,49.94,0,0
229876,",",0,0
229877,41.73,0,0
229878,and,0,0
229879,20.74,0,0
229880,ELISA,0,0
229881,U/ml,0,0
229882,to,0,0
229883,7.26,0,0
229884,",",0,0
229885,7.72,0,0
229886,and,0,0
229887,5.91,0,0
229888,ELISA,0,0
229889,U/ml,0,0
229890,",",0,0
229891,respectively,0,0
229892,.,0,0
229893,In,0,0
229894,this,0,0
229895,comparative,0,0
229896,controlled,0,0
229897,trial,0,0
229898,",",0,0
229899,the,0,0
229900,ADPT,1,0
229901,vaccines,1,0
229902,were,0,0
229903,more,0,0
229904,immunogenic,0,0
229905,",",0,0
229906,with,0,0
229907,less,0,0
229908,local,0,0
229909,and,0,0
229910,systemic,0,0
229911,reactions,0,0
229912,",",0,0
229913,than,0,0
229914,the,0,0
229915,WCDPT,1,1
229916,vaccine,1,1
229917,but,0,0
229918,there,0,0
229919,was,0,0
229920,a,0,0
229921,considerable,0,0
229922,drop,0,0
229923,in,0,0
229924,antibody,0,0
229925,titres,0,1
229926,in,0,0
229927,all,0,0
229928,the,0,0
229929,vaccine,0,1
229930,groups,0,0
229931,12,0,0
229932,months,0,0
229933,after,0,0
229934,primary,0,0
229935,vaccination,0,0
229936,.,0,0
229937,However,0,0
229938,",",0,0
229939,the,0,0
229940,levels,0,0
229941,of,0,0
229942,titres,0,1
229943,of,0,1
229944,anti-PT,0,1
229945,and,0,1
229946,anti-FHA,0,1
229947,antibodies,0,0
229948,in,0,0
229949,all,0,0
229950,the,0,0
229951,three,0,0
229952,vaccines,0,0
229953,that,0,0
229954,confer,0,0
229955,protection,0,0
229956,are,0,0
229957,not,0,0
229958,known,0,0
229959,.,0,0
229960,Further,0,0
229961,studies,0,0
229962,are,0,0
229963,necessary,0,0
229964,to,0,0
229965,provide,0,0
229966,this,0,0
229967,information,0,0
229968,in,0,0
229969,order,0,0
229970,to,0,0
229971,assess,0,0
229972,the,0,0
229973,need,0,0
229974,for,0,0
229975,subsequent,0,0
229976,booster,0,1
229977,doses,0,1
229978,after,0,0
229979,primary,0,0
229980,immunization,0,0
229981,with,0,0
229982,both,0,0
229983,ADPT,1,0
229984,and,0,0
229985,WCDPT,1,0
229986,vaccines,0,0
229987,.,0,0
229988,Prospective,0,0
229989,evaluation,0,0
229990,of,0,0
229991,the,0,0
229992,macrolide,1,1
229993,antibiotic,1,1
229994,dirithromycin,1,1
229995,for,0,0
229996,the,0,0
229997,treatment,0,0
229998,of,0,0
229999,Helicobacter,0,1
230000,pylori,0,1
230001,.,0,1
230002,BACKGROUND,0,1
230003,Macrolide,1,1
230004,antibiotics,1,1
230005,are,0,0
230006,active,0,0
230007,in,0,0
230008,vitro,0,0
230009,and,0,0
230010,in,0,0
230011,vivo,0,0
230012,against,0,0
230013,Helicobacter,0,1
230014,pylori,0,1
230015,.,0,0
230016,We,0,0
230017,assessed,0,0
230018,a,0,0
230019,newer,0,1
230020,macrolide,1,1
230021,",",1,1
230022,dirithromycin,1,1
230023,",",0,0
230024,for,0,0
230025,the,0,0
230026,treatment,0,0
230027,of,0,0
230028,H.,0,0
230029,pylori,0,0
230030,in,0,0
230031,two,0,0
230032,separate,0,0
230033,studies,0,0
230034,.,0,0
230035,METHODS,0,0
230036,Volunteers,0,0
230037,with,0,0
230038,H.,0,0
230039,pylori,0,1
230040,infection,0,1
230041,(,0,0
230042,by,0,0
230043,13C-urea,0,1
230044,breath,0,1
230045,test,0,0
230046,),0,0
230047,were,0,0
230048,randomly,0,0
230049,assigned,0,0
230050,to,0,0
230051,2-week,0,1
230052,treatment,0,1
230053,regimens,0,1
230054,.,0,1
230055,Study,0,0
230056,1,0,0
230057,:,0,0
230058,dirithromycin,1,1
230059,500,1,1
230060,mg,1,1
230061,q.d.s.,1,1
230062,",",0,1
230063,dirithromycin,1,1
230064,500,1,1
230065,mg,1,1
230066,q.d.s,1,1
230067,.,1,1
230068,plus,1,0
230069,omeprazole,1,1
230070,40,1,1
230071,mg,1,1
230072,q.d.s.,1,1
230073,",",0,1
230074,or,1,1
230075,dirithromycin,1,1
230076,500,1,1
230077,mg,1,1
230078,q.d.s,1,1
230079,.,1,1
230080,plus,1,0
230081,metronidazole,1,1
230082,500,1,1
230083,mg,1,1
230084,t.d.s,1,1
230085,.,1,1
230086,Study,0,0
230087,2,0,0
230088,:,0,0
230089,dirithromycin,1,1
230090,500,1,1
230091,mg,1,1
230092,q.d.s,1,1
230093,.,1,1
230094,plus,1,0
230095,omeprazole,1,1
230096,20,1,1
230097,mg,1,1
230098,b.d.,1,1
230099,",",0,1
230100,dirithromycin,1,1
230101,1000,1,1
230102,mg,1,1
230103,q.d.s,1,1
230104,.,1,1
230105,plus,1,0
230106,omeprazole,1,1
230107,20,1,1
230108,mg,1,1
230109,b.d.,1,1
230110,",",0,1
230111,or,1,1
230112,amoxycillin,1,1
230113,500,1,1
230114,mg,1,1
230115,q.d.s,1,1
230116,.,1,1
230117,plus,1,0
230118,omepirazole,1,1
230119,20,1,1
230120,mg,1,1
230121,b.d,1,1
230122,.,1,1
230123,Four,0,0
230124,weeks,0,0
230125,after,0,0
230126,the,0,0
230127,completion,0,0
230128,of,0,0
230129,therapy,0,0
230130,a,0,0
230131,repeat,0,0
230132,13C-urea,0,1
230133,breath,0,0
230134,test,0,0
230135,was,0,0
230136,done,0,0
230137,to,0,0
230138,assess,0,0
230139,for,0,0
230140,cure,0,0
230141,.,0,0
230142,RESULTS,0,1
230143,No,0,1
230144,patient,0,1
230145,taking,0,1
230146,dirithromycin,1,1
230147,alone,0,0
230148,(,0,0
230149,n,0,0
230150,=,0,0
230151,6,0,0
230152,),0,0
230153,or,0,0
230154,in,0,0
230155,combination,0,0
230156,with,0,1
230157,omeprazole,1,1
230158,(,0,0
230159,n,0,0
230160,=,0,0
230161,26,0,0
230162,),0,0
230163,achieved,0,0
230164,cure,0,0
230165,of,0,0
230166,their,0,0
230167,infection,0,0
230168,.,0,0
230169,Eradication,0,0
230170,of,0,0
230171,H.,0,0
230172,pylori,0,0
230173,was,0,0
230174,seen,0,0
230175,in,0,0
230176,one,0,0
230177,of,0,0
230178,seven,0,0
230179,patients,0,0
230180,taking,0,0
230181,dirithromycin,1,1
230182,plus,0,1
230183,metronidazole,1,1
230184,.,1,1
230185,Five,0,0
230186,of,0,0
230187,10,0,0
230188,patients,0,0
230189,taking,0,0
230190,omeprazole-amoxycillin,1,1
230191,dual,0,0
230192,therapy,0,0
230193,had,0,0
230194,their,0,0
230195,H.,0,0
230196,pylori,0,0
230197,infection,0,1
230198,cured,0,0
230199,(,0,0
230200,P,0,0
230201,=,0,0
230202,0.0007,0,0
230203,vs.,0,0
230204,patients,0,0
230205,taking,0,0
230206,dirithromycin,1,1
230207,plus,0,1
230208,omeprazole,1,1
230209,),1,1
230210,.,0,1
230211,Eleven,0,0
230212,(,0,0
230213,47,0,0
230214,%,0,0
230215,),0,0
230216,of,0,0
230217,32,0,0
230218,patients,0,0
230219,taking,0,0
230220,dirithromycin,1,1
230221,alone,0,0
230222,or,0,0
230223,combined,0,0
230224,with,0,0
230225,omeprazole,1,1
230226,reported,0,0
230227,side-effects,0,1
230228,",",0,0
230229,but,0,0
230230,only,0,0
230231,two,0,0
230232,(,0,0
230233,6,0,0
230234,%,0,0
230235,),0,0
230236,stopped,0,1
230237,therapy,0,1
230238,prematurely,0,0
230239,as,0,0
230240,a,0,0
230241,result,0,0
230242,of,0,0
230243,side-effects,0,1
230244,.,0,0
230245,CONCLUSION,0,1
230246,No,0,1
230247,subject,0,1
230248,taking,0,0
230249,dirithromycin,1,1
230250,alone,0,0
230251,or,0,0
230252,in,0,0
230253,combination,0,0
230254,with,0,0
230255,omeprazole,1,1
230256,had,0,0
230257,their,0,0
230258,H.,0,0
230259,pylori,0,0
230260,infection,0,0
230261,cured,0,0
230262,.,0,0
230263,Dirithromycin,1,1
230264,",",0,0
230265,in,0,0
230266,the,0,0
230267,regimen,0,1
230268,used,0,0
230269,",",0,0
230270,shows,0,0
230271,little,0,0
230272,promise,0,0
230273,in,0,0
230274,the,0,0
230275,treatment,0,0
230276,of,0,0
230277,patients,0,0
230278,with,0,0
230279,H.,0,0
230280,pylori,0,0
230281,infection,0,0
230282,.,0,0
230283,The,0,0
230284,use,0,0
230285,of,0,0
230286,a,0,0
230287,water,1,0
230288,extract,1,0
230289,from,1,0
230290,the,1,0
230291,bark,1,1
230292,of,1,0
230293,Choerospondias,1,1
230294,axillaris,1,0
230295,in,0,0
230296,the,0,0
230297,treatment,0,0
230298,of,0,0
230299,second,0,0
230300,degree,0,0
230301,burns,0,0
230302,.,0,0
230303,Burns,0,0
230304,are,0,0
230305,common,0,0
230306,in,0,0
230307,Vietnam,0,0
230308,",",0,0
230309,and,0,0
230310,because,0,0
230311,of,0,0
230312,economic,0,0
230313,constraints,0,0
230314,and,0,0
230315,limited,0,0
230316,resources,0,0
230317,for,0,0
230318,the,0,0
230319,import,0,0
230320,of,0,0
230321,appropriate,0,0
230322,treatments,0,0
230323,",",0,0
230324,the,0,0
230325,health,0,0
230326,authorities,0,0
230327,are,0,0
230328,obliged,0,0
230329,to,0,0
230330,rely,0,0
230331,on,0,0
230332,traditional,0,0
230333,herbal,0,1
230334,remedies,0,1
230335,.,0,0
230336,It,0,0
230337,is,0,0
230338,therefore,0,0
230339,essential,0,0
230340,to,0,0
230341,evaluate,0,0
230342,current,0,0
230343,drugs,0,1
230344,",",0,0
230345,one,0,0
230346,of,0,0
230347,which,0,0
230348,is,0,0
230349,the,0,0
230350,water,1,0
230351,extract,1,0
230352,of,1,0
230353,the,1,0
230354,bark,1,1
230355,of,1,0
230356,the,1,0
230357,tree,1,0
230358,Choerospondias,1,0
230359,axillaris,1,0
230360,.,1,0
230361,It,0,0
230362,has,0,0
230363,been,0,0
230364,used,0,0
230365,for,0,0
230366,many,0,0
230367,years,0,0
230368,in,0,0
230369,the,0,0
230370,Vietnam-Sweden,0,0
230371,hospital,0,0
230372,at,0,0
230373,Uong,0,0
230374,Bi,0,0
230375,in,0,0
230376,northern,0,0
230377,Vietnam,0,0
230378,.,0,0
230379,We,0,0
230380,assessed,0,0
230381,the,0,0
230382,efficacy,0,0
230383,of,0,0
230384,the,0,0
230385,remedy,0,0
230386,in,0,0
230387,an,0,0
230388,open,0,0
230389,",",0,0
230390,randomised,0,0
230391,controlled,0,0
230392,clinical,0,0
230393,trial,0,0
230394,",",0,0
230395,in,0,0
230396,which,0,0
230397,20,0,0
230398,patients,0,0
230399,with,0,0
230400,second,0,0
230401,degree,0,0
230402,burns,0,0
230403,were,0,0
230404,treated,0,0
230405,with,0,0
230406,the,0,0
230407,extract,1,0
230408,of,1,0
230409,the,1,0
230410,Choerospondias,1,0
230411,axillaris,1,0
230412,and,0,0
230413,19,0,0
230414,with,0,1
230415,saline,1,1
230416,gauze,1,1
230417,.,1,1
230418,The,0,0
230419,mean,0,0
230420,healing,0,0
230421,time,0,0
230422,was,0,0
230423,significantly,0,0
230424,shorter,0,0
230425,for,0,0
230426,patients,0,0
230427,treated,0,0
230428,with,0,0
230429,Choerospondias,1,1
230430,axillaris,1,1
230431,(,0,1
230432,11,0,1
230433,days,0,1
230434,),0,0
230435,compared,0,0
230436,with,0,0
230437,patients,0,0
230438,treated,0,0
230439,with,0,1
230440,saline,1,1
230441,gauze,1,1
230442,(,0,1
230443,17,0,1
230444,days,0,1
230445,),0,1
230446,(,0,0
230447,p,0,0
230448,<,0,0
230449,0.01,0,0
230450,),0,0
230451,",",0,0
230452,and,0,0
230453,the,0,0
230454,number,0,0
230455,of,0,0
230456,wound,0,0
230457,infections,0,0
230458,was,0,0
230459,significantly,0,0
230460,lower,0,0
230461,in,0,0
230462,the,0,0
230463,Choerospondias,1,0
230464,axillaris,1,1
230465,group,0,0
230466,(,0,0
230467,7/20,0,0
230468,compared,0,0
230469,with,0,0
230470,16/19,0,0
230471,",",0,0
230472,p,0,0
230473,=,0,0
230474,0.003,0,0
230475,),0,0
230476,.,0,0
230477,The,0,0
230478,bark,1,1
230479,extract,1,1
230480,was,0,0
230481,easy,0,0
230482,to,0,0
230483,apply,0,0
230484,and,0,0
230485,additional,0,0
230486,wound,0,0
230487,care,0,0
230488,was,0,0
230489,not,0,0
230490,usually,0,0
230491,necessary,0,0
230492,",",0,0
230493,while,0,0
230494,the,0,0
230495,treatment,0,0
230496,with,0,1
230497,saline,1,1
230498,gauze,1,1
230499,was,0,0
230500,laborious,0,0
230501,for,0,0
230502,both,0,0
230503,patients,0,0
230504,and,0,0
230505,staff,0,0
230506,and,0,0
230507,was,0,0
230508,much,0,0
230509,more,0,0
230510,expensive,0,0
230511,.,0,0
230512,The,0,0
230513,extract,1,0
230514,from,1,0
230515,Choerospondias,1,1
230516,axillaris,1,0
230517,is,0,0
230518,a,0,0
230519,convenient,0,0
230520,treatment,0,0
230521,for,0,0
230522,second,0,0
230523,degree,0,0
230524,burns,0,0
230525,in,0,0
230526,both,0,0
230527,children,0,0
230528,and,0,0
230529,adults,0,0
230530,.,0,0
230531,One,1,0
230532,quadrant,1,0
230533,sub-Tenon,1,0
230534,'s,1,1
230535,capsule,1,1
230536,anesthesia,1,1
230537,in,0,0
230538,anterior,0,0
230539,segment,0,0
230540,surgery,0,0
230541,.,0,0
230542,Reports,0,0
230543,of,0,0
230544,complications,0,0
230545,associated,0,0
230546,with,0,0
230547,local,0,0
230548,anesthesia,0,0
230549,in,0,0
230550,ophthalmic,0,0
230551,surgery,0,0
230552,have,0,0
230553,increased,0,0
230554,conspicuously,0,0
230555,in,0,0
230556,recent,0,0
230557,years,0,0
230558,.,0,0
230559,Sub-Tenon,1,1
230560,'s,1,1
230561,capsule,1,1
230562,anesthesia,1,1
230563,for,0,0
230564,anterior,0,0
230565,segment,0,0
230566,surgery,0,0
230567,avoids,0,0
230568,the,0,0
230569,risks,0,0
230570,of,0,0
230571,retrobulbar,1,0
230572,and,0,1
230573,peribulbar,0,1
230574,injections,0,1
230575,.,0,1
230576,This,0,0
230577,study,0,0
230578,compared,0,0
230579,sub-Tenon,1,0
230580,'s,1,0
230581,and,0,0
230582,retrobulbar,1,0
230583,anesthesia,1,0
230584,.,1,0
230585,Patients,0,0
230586,undergoing,0,0
230587,various,0,0
230588,anterior,0,0
230589,segment,0,0
230590,surgery,0,0
230591,were,0,0
230592,randomly,0,0
230593,assigned,0,0
230594,to,0,0
230595,sub-Tenon,1,0
230596,'s,1,0
230597,or,1,0
230598,retrobulbar,1,1
230599,anesthesia,1,1
230600,;,1,0
230601,300,0,0
230602,were,0,0
230603,operated,0,0
230604,with,0,0
230605,1-quadrant,1,0
230606,sub-Tenon,1,0
230607,'s,1,1
230608,anesthesia,1,1
230609,(,1,1
230610,1-QST,1,1
230611,),1,1
230612,and,0,0
230613,the,0,0
230614,results,0,0
230615,were,0,0
230616,compared,0,0
230617,with,0,0
230618,270,0,0
230619,patients,0,0
230620,operated,0,0
230621,with,0,0
230622,retrobulbar,1,0
230623,anesthesia,1,0
230624,.,1,1
230625,Retrobulbar,1,1
230626,anesthesia,1,1
230627,consisted,0,0
230628,of,0,0
230629,a,0,0
230630,2.5,0,0
230631,ml,0,0
230632,injection,0,1
230633,of,0,0
230634,a,0,0
230635,1:1,0,1
230636,mixture,0,0
230637,of,0,0
230638,2,0,0
230639,%,0,0
230640,lidocaine,1,1
230641,without,1,0
230642,epinephrine,1,1
230643,and,1,0
230644,0.5,1,0
230645,%,1,0
230646,bupivacaine,1,1
230647,.,1,0
230648,Sub-Tenon,1,1
230649,'s,1,0
230650,anesthesia,1,0
230651,involved,0,0
230652,direct,0,0
230653,transconjunctival,0,0
230654,infiltration,0,0
230655,of,0,0
230656,the,0,0
230657,same,0,0
230658,local,0,0
230659,anesthetic,0,1
230660,directly,0,0
230661,into,0,0
230662,the,0,0
230663,sub-Tenon,0,0
230664,'s,0,0
230665,space,0,0
230666,",",0,0
230667,in,0,0
230668,the,0,0
230669,inferior-nasal,0,0
230670,quadrant,0,0
230671,",",0,0
230672,using,0,0
230673,a,0,0
230674,blunt,0,0
230675,23-gauge,0,0
230676,cannula,0,0
230677,.,0,0
230678,Patients,0,0
230679,undergoing,0,0
230680,various,0,0
230681,anterior,0,0
230682,segment,0,0
230683,surgery,0,0
230684,procedures,0,0
230685,were,0,0
230686,randomly,0,0
230687,assigned,0,0
230688,to,0,0
230689,1-QST,1,0
230690,or,0,0
230691,retrobulbar,1,1
230692,anesthesia,1,1
230693,;,1,0
230694,300,0,0
230695,patients,0,0
230696,were,0,0
230697,operated,0,0
230698,with,0,0
230699,1-QST,0,0
230700,and,0,0
230701,the,0,0
230702,results,0,0
230703,were,0,0
230704,compared,0,0
230705,with,0,0
230706,270,0,0
230707,patients,0,0
230708,operated,0,0
230709,with,0,0
230710,retrobulbar,0,0
230711,anesthesia,0,0
230712,.,0,0
230713,Preinjection,0,1
230714,mean,0,0
230715,(,0,0
230716,+/-,0,0
230717,SD,0,1
230718,),0,0
230719,IOP,0,0
230720,wer,0,0
230721,12.9,0,0
230722,+/-,0,0
230723,3.7,0,0
230724,mmHg,0,0
230725,in,0,0
230726,the,0,0
230727,retrobulbar,1,0
230728,and,0,0
230729,13.4,0,0
230730,+/-,0,0
230731,3.2,0,0
230732,mmHg,0,0
230733,in,0,0
230734,the,0,0
230735,1-QST,1,0
230736,patients,0,0
230737,.,0,0
230738,Preoperative,0,0
230739,intraocular,0,0
230740,pressures,0,0
230741,were,0,0
230742,8.7,0,0
230743,+/-,0,0
230744,3.0,0,0
230745,mmHg,0,0
230746,in,0,0
230747,the,0,0
230748,retrobulbar,1,0
230749,and,0,0
230750,9.2,0,0
230751,+/-,0,0
230752,3.2,0,0
230753,mmHg,0,0
230754,in,0,0
230755,1-QST,1,0
230756,patients,0,0
230757,.,0,0
230758,Pre-,0,0
230759,and,0,0
230760,postinjection,0,0
230761,IOP,0,1
230762,for,0,0
230763,retrobulbar,1,0
230764,and,0,0
230765,1-QST,1,0
230766,patients,0,0
230767,were,0,0
230768,similar,0,0
230769,.,0,0
230770,Pain,0,0
230771,scores,0,0
230772,for,0,0
230773,delivery,0,0
230774,of,0,0
230775,the,0,0
230776,anesthetic,0,1
230777,",",0,0
230778,using,0,0
230779,a,0,0
230780,numerical,0,0
230781,rating,0,0
230782,scale,0,0
230783,",",0,0
230784,produced,0,0
230785,a,0,0
230786,median,0,0
230787,score,0,0
230788,of,0,0
230789,1,0,0
230790,for,0,0
230791,1-QST,0,1
230792,and,0,0
230793,2,0,0
230794,for,0,0
230795,the,0,0
230796,retrobulbar,1,0
230797,technique,0,0
230798,.,0,0
230799,For,0,0
230800,the,0,0
230801,subsequent,0,0
230802,operative,0,0
230803,procedure,0,0
230804,",",0,0
230805,the,0,0
230806,median,0,0
230807,score,0,0
230808,was,0,0
230809,1,0,0
230810,for,0,0
230811,1-QST,1,1
230812,and,0,0
230813,2,0,0
230814,for,0,0
230815,the,0,0
230816,retrobulbar,0,0
230817,patients,0,0
230818,.,0,0
230819,Complete,0,0
230820,akinesia,0,0
230821,was,0,0
230822,achieved,0,0
230823,in,0,0
230824,41,0,0
230825,%,0,0
230826,with,0,0
230827,1-QST,1,0
230828,and,0,0
230829,in,0,0
230830,69,0,0
230831,%,0,0
230832,of,0,0
230833,retrobulbar,0,0
230834,patients,0,0
230835,.,0,0
230836,1-QST,1,0
230837,patients,0,0
230838,with,0,0
230839,incomplete,0,0
230840,akinesia,0,0
230841,most,0,0
230842,often,0,0
230843,had,0,0
230844,lateral,0,0
230845,muscle,0,0
230846,function,0,0
230847,which,0,0
230848,did,0,0
230849,not,0,0
230850,interfere,0,0
230851,with,0,0
230852,the,0,0
230853,operation,0,0
230854,.,0,0
230855,We,0,0
230856,found,0,0
230857,the,0,0
230858,use,0,0
230859,of,0,0
230860,a,0,0
230861,blunt,0,0
230862,cannula,0,0
230863,to,0,0
230864,deliver,0,0
230865,anesthetic,0,1
230866,into,0,0
230867,the,0,0
230868,sub-Tenon,0,0
230869,'s,0,0
230870,space,0,0
230871,as,0,0
230872,a,0,0
230873,simple,0,0
230874,",",0,0
230875,safe,0,0
230876,and,0,0
230877,effective,0,0
230878,alternative,0,0
230879,approach,0,0
230880,to,0,0
230881,traditional,0,0
230882,retrobulbar,1,0
230883,anesthesia,1,0
230884,in,0,0
230885,anterior,0,0
230886,segment,0,0
230887,surgery,0,0
230888,.,0,0
230889,Clonidine,1,1
230890,increases,0,1
230891,the,0,0
230892,sweating,0,0
230893,threshold,0,0
230894,",",0,0
230895,but,0,0
230896,does,0,0
230897,not,0,0
230898,reduce,0,0
230899,the,0,0
230900,gain,0,0
230901,of,0,0
230902,sweating,0,0
230903,.,0,0
230904,We,0,0
230905,tested,0,0
230906,the,0,0
230907,hypothesis,0,0
230908,that,0,0
230909,clonidine,1,1
230910,produces,0,0
230911,a,0,0
230912,dose-dependent,0,0
230913,increase,0,0
230914,in,0,0
230915,the,0,0
230916,sweating,0,0
230917,threshold,0,0
230918,but,0,0
230919,does,0,0
230920,not,0,0
230921,reduce,0,0
230922,the,0,0
230923,gain,0,0
230924,of,0,0
230925,sweating,0,0
230926,.,0,0
230927,Six,0,1
230928,healthy,0,0
230929,male,0,0
230930,volunteers,0,0
230931,were,0,0
230932,evaluated,0,0
230933,",",0,0
230934,each,0,0
230935,on,0,0
230936,three,0,0
230937,separate,0,0
230938,days,0,0
230939,in,0,0
230940,random,0,0
230941,order,0,0
230942,.,0,0
230943,In,0,0
230944,one,0,0
230945,",",0,0
230946,saline,1,1
230947,was,0,1
230948,administered,0,1
230949,;,0,1
230950,in,0,0
230951,another,0,0
230952,",",0,0
230953,a,0,0
230954,2-micrograms/kg,1,1
230955,bolus,1,1
230956,of,1,1
230957,clonidine,1,1
230958,was,0,0
230959,followed,0,0
230960,by,0,0
230961,an,0,0
230962,infusion,0,1
230963,at,0,1
230964,2,0,1
230965,micrograms.kg-1.h-1,0,1
230966,",",0,1
230967,and,0,0
230968,on,0,0
230969,a,0,0
230970,third,0,0
230971,day,0,0
230972,",",0,0
230973,a,0,1
230974,4-micrograms/kg,0,1
230975,bolus,0,1
230976,was,0,0
230977,followed,0,0
230978,by,0,0
230979,an,0,0
230980,infusion,0,1
230981,at,0,1
230982,4,0,1
230983,micrograms.kg-1.h-1,0,1
230984,.,0,0
230985,Core,0,0
230986,temperature,0,0
230987,was,0,0
230988,measured,0,0
230989,at,0,0
230990,the,0,0
230991,tympanic,0,0
230992,membrane,0,0
230993,and,0,0
230994,mean,0,0
230995,skin,0,0
230996,temperature,0,0
230997,was,0,0
230998,determined,0,0
230999,from,0,0
231000,four,0,0
231001,sites,0,0
231002,.,0,0
231003,A,0,0
231004,chest,0,0
231005,sweating,0,0
231006,rate,0,0
231007,of,0,0
231008,40,0,0
231009,g.m-2.h-1,0,0
231010,was,0,0
231011,considered,0,0
231012,significant,0,0
231013,.,0,0
231014,The,0,0
231015,core,0,0
231016,temperature,0,0
231017,triggering,0,0
231018,sweating,0,0
231019,",",0,0
231020,adjusted,0,0
231021,to,0,0
231022,a,0,0
231023,designated,0,0
231024,mean,0,0
231025,skin,0,0
231026,temperature,0,0
231027,of,0,0
231028,34,0,0
231029,degrees,0,0
231030,C,0,0
231031,",",0,0
231032,identified,0,0
231033,the,0,0
231034,threshold,0,0
231035,for,0,0
231036,this,0,0
231037,response,0,0
231038,.,0,0
231039,Gain,0,0
231040,was,0,0
231041,defined,0,0
231042,by,0,0
231043,the,0,0
231044,adjusted,0,0
231045,core,0,0
231046,temperature,0,0
231047,increase,0,0
231048,required,0,0
231049,to,0,0
231050,augment,0,0
231051,sweating,0,0
231052,from,0,0
231053,100,0,0
231054,to,0,0
231055,300,0,0
231056,g.m-2.h-1,0,0
231057,.,0,0
231058,degree,0,0
231059,C-1,0,0
231060,.,0,1
231061,Plasma,0,1
231062,clonidine,0,1
231063,concentrations,0,1
231064,were,0,0
231065,0.8,0,0
231066,+/-,0,0
231067,0.1,0,0
231068,and,0,0
231069,1.6,0,0
231070,+/-,0,0
231071,0.2,0,0
231072,ng/mL,0,0
231073,on,0,0
231074,the,0,0
231075,small-,0,0
231076,and,0,0
231077,large-dose,0,1
231078,days,0,0
231079,",",0,0
231080,respectively,0,0
231081,.,0,0
231082,Clonidine,0,1
231083,administration,0,1
231084,increased,0,1
231085,the,0,0
231086,sweating,0,0
231087,threshold,0,0
231088,approximately,0,0
231089,0.4,0,0
231090,degree,0,0
231091,C,0,0
231092,(,0,0
231093,P,0,0
231094,<,0,0
231095,0.05,0,0
231096,),0,0
231097,",",0,0
231098,but,0,0
231099,the,0,0
231100,increase,0,0
231101,was,0,0
231102,comparable,0,0
231103,at,0,0
231104,each,0,0
231105,dose,0,1
231106,.,0,0
231107,The,0,0
231108,gain,0,0
231109,of,0,0
231110,sweating,0,0
231111,was,0,0
231112,approximately,0,0
231113,0.2,0,0
231114,degree,0,0
231115,C,0,0
231116,and,0,0
231117,was,0,0
231118,not,0,0
231119,influenced,0,0
231120,by,0,0
231121,clonidine,0,1
231122,administration,0,1
231123,.,0,1
231124,The,0,0
231125,thermoregulatory,0,0
231126,effects,0,0
231127,of,0,0
231128,clonidine,0,1
231129,thus,0,0
231130,resemble,0,0
231131,those,0,0
231132,of,0,0
231133,volatile,0,1
231134,anesthetics,0,1
231135,",",0,1
231136,opioids,0,1
231137,",",0,1
231138,and,0,1
231139,propofol,0,1
231140,.,0,1
231141,These,0,0
231142,data,0,0
231143,suggest,0,0
231144,that,0,0
231145,the,0,0
231146,antishivering,0,1
231147,effect,0,0
231148,of,0,0
231149,clonidine,0,1
231150,results,0,0
231151,from,0,0
231152,central,0,0
231153,thermoregulatory,0,0
231154,inhibition,0,0
231155,rather,0,0
231156,than,0,0
231157,a,0,0
231158,specific,0,0
231159,peripheral,0,0
231160,action,0,0
231161,on,0,0
231162,thermogenic,0,0
231163,muscular,0,0
231164,activity,0,0
231165,.,0,0
231166,Unlike,0,0
231167,other,0,0
231168,sedatives,0,1
231169,and,0,1
231170,anesthetics,0,1
231171,",",0,0
231172,the,0,0
231173,concentration-dependence,0,0
231174,of,0,0
231175,clonidine,0,1
231176,demonstrates,0,0
231177,a,0,0
231178,ceiling,0,0
231179,beyond,0,0
231180,which,0,0
231181,the,0,0
231182,administration,0,1
231183,of,0,0
231184,an,0,0
231185,additional,0,0
231186,drug,0,1
231187,fails,0,0
231188,to,0,0
231189,enhance,0,0
231190,the,0,0
231191,effect,0,0
231192,",",0,0
231193,suggesting,0,0
231194,that,0,0
231195,the,0,0
231196,thermoregulatory,0,0
231197,effect,0,0
231198,of,0,0
231199,clonidine,0,1
231200,may,0,0
231201,be,0,0
231202,limited,0,0
231203,",",0,0
231204,even,0,0
231205,at,0,0
231206,high,0,0
231207,plasma,0,1
231208,concentrations,0,1
231209,.,0,0
231210,The,0,0
231211,gain,0,0
231212,of,0,0
231213,sweating,0,0
231214,was,0,0
231215,well,0,0
231216,preserved,0,0
231217,indicating,0,0
231218,that,0,0
231219,this,0,0
231220,response,0,0
231221,remains,0,0
231222,effective,0,0
231223,in,0,0
231224,the,0,0
231225,presence,0,0
231226,of,0,0
231227,sedatives,0,1
231228,and,0,1
231229,anesthetics,0,1
231230,.,0,0
231231,Long-term,0,0
231232,results,0,0
231233,regarding,0,0
231234,the,0,0
231235,use,0,0
231236,of,0,0
231237,recombinant,1,1
231238,interferon,1,1
231239,alpha-2b,1,1
231240,in,0,0
231241,the,0,0
231242,treatment,0,0
231243,of,0,0
231244,II,0,0
231245,type,0,0
231246,mixed,0,0
231247,essential,0,0
231248,cryoglobulinemia,0,0
231249,.,0,0
231250,Thirty-three,0,0
231251,patients,0,0
231252,with,0,0
231253,II,0,0
231254,type,0,0
231255,mixed,0,0
231256,essential,0,0
231257,cryoglobulinemia,0,0
231258,(,0,1
231259,MEC,0,1
231260,),0,1
231261,were,0,0
231262,randomized,0,0
231263,into,0,0
231264,two,0,0
231265,groups,0,0
231266,:,0,0
231267,one,0,0
231268,to,0,0
231269,receive,0,0
231270,combined,1,0
231271,therapy,1,0
231272,including,1,0
231273,prednisone,1,1
231274,plus,1,1
231275,interferon,1,1
231276,",",1,0
231277,the,1,0
231278,other,1,0
231279,to,1,0
231280,receive,1,1
231281,prednisone,1,1
231282,therapy,1,1
231283,.,1,1
231284,Interferon,1,1
231285,was,0,0
231286,administered,0,1
231287,as,0,0
231288,induction,0,0
231289,treatment,0,0
231290,(,0,1
231291,3,0,1
231292,Mu/day,0,1
231293,),0,1
231294,and,0,0
231295,then,0,0
231296,as,0,0
231297,maintenance,0,0
231298,therapy,0,1
231299,(,0,0
231300,3,0,0
231301,Mu,0,0
231302,three,0,0
231303,times,0,0
231304,a,0,0
231305,week,0,0
231306,),0,0
231307,.,0,0
231308,83,0,0
231309,%,0,0
231310,of,0,0
231311,the,0,0
231312,combined,0,0
231313,therapy,0,0
231314,patients,0,0
231315,responded,0,0
231316,as,0,0
231317,opposed,0,0
231318,to,0,0
231319,27,0,0
231320,%,0,0
231321,of,0,0
231322,the,0,0
231323,prednisone,0,1
231324,treated,0,0
231325,patients,0,0
231326,.,0,0
231327,Among,0,0
231328,the,0,0
231329,patients,0,0
231330,that,0,0
231331,responded,0,0
231332,to,0,0
231333,combined,0,0
231334,therapy,0,0
231335,",",0,0
231336,nine,0,0
231337,of,0,0
231338,them,0,0
231339,had,0,0
231340,a,0,0
231341,complete,0,0
231342,response,0,0
231343,",",0,0
231344,four,0,0
231345,a,0,0
231346,partial,0,0
231347,response,0,0
231348,",",0,0
231349,and,0,0
231350,two,0,0
231351,a,0,0
231352,minor,0,0
231353,response,0,0
231354,.,0,0
231355,None,0,1
231356,of,0,0
231357,the,0,0
231358,patients,0,0
231359,treated,0,0
231360,with,0,0
231361,prednisone,1,1
231362,therapy,0,1
231363,responded,0,0
231364,completely,0,0
231365,but,0,0
231366,only,0,0
231367,two,0,0
231368,had,0,0
231369,a,0,0
231370,partial,0,0
231371,and,0,0
231372,two,0,0
231373,a,0,0
231374,minor,0,0
231375,response,0,0
231376,.,0,0
231377,Four,0,0
231378,patients,0,0
231379,(,0,0
231380,three,0,0
231381,of,0,0
231382,combined,1,0
231383,therapy,1,0
231384,and,0,0
231385,one,0,0
231386,of,0,0
231387,prednisone,1,1
231388,therapy,0,1
231389,),0,1
231390,showed,0,0
231391,proteinuria,0,0
231392,before,0,0
231393,the,0,0
231394,treatment,0,0
231395,which,0,0
231396,improved,0,0
231397,at,0,0
231398,the,0,0
231399,end,0,0
231400,of,0,0
231401,the,0,0
231402,induction,0,0
231403,therapy,0,0
231404,.,0,0
231405,Ten,0,0
231406,patients,0,0
231407,showed,0,0
231408,anti-HCV,0,1
231409,positivity,0,0
231410,which,0,0
231411,remained,0,0
231412,unchanged,0,0
231413,after,0,0
231414,the,0,0
231415,treatment,0,0
231416,.,0,0
231417,Three,0,0
231418,patients,0,0
231419,showed,0,0
231420,liver,0,0
231421,involvement,0,0
231422,secondary,0,0
231423,to,0,0
231424,cryoglobulinemia,0,0
231425,and,0,0
231426,an,0,0
231427,improvement,0,0
231428,of,0,0
231429,histological,0,0
231430,pattern,0,0
231431,after,0,0
231432,the,0,0
231433,induction,0,0
231434,with,0,0
231435,combined,0,0
231436,therapy,0,0
231437,.,0,0
231438,One,0,0
231439,patient,0,0
231440,showed,0,0
231441,an,0,0
231442,improvement,0,0
231443,of,0,0
231444,peripheral,0,0
231445,neuropathy,0,0
231446,after,0,0
231447,induction,0,0
231448,with,0,0
231449,the,0,0
231450,combined,1,0
231451,therapy,1,0
231452,.,1,0
231453,These,0,0
231454,data,0,0
231455,suggest,0,0
231456,the,0,0
231457,effectiveness,0,0
231458,of,0,0
231459,interferon,1,1
231460,given,0,1
231461,as,0,0
231462,induction,0,0
231463,and,0,0
231464,as,0,0
231465,maintenance,0,0
231466,treatment,0,0
231467,in,0,0
231468,the,0,0
231469,therapy,0,0
231470,of,0,0
231471,II,0,0
231472,type,0,0
231473,mixed,0,0
231474,essential,0,0
231475,cryoglobulinemia,0,0
231476,.,0,0
231477,Effects,0,0
231478,of,0,0
231479,perioperative,0,1
231480,indomethacin,1,1
231481,on,0,0
231482,intracranial,0,0
231483,pressure,0,0
231484,",",0,0
231485,cerebral,0,0
231486,blood,0,0
231487,flow,0,0
231488,",",0,0
231489,and,0,0
231490,cerebral,0,0
231491,metabolism,0,0
231492,in,0,0
231493,patients,0,0
231494,subjected,0,0
231495,to,0,0
231496,craniotomy,0,0
231497,for,0,0
231498,cerebral,0,0
231499,tumors,0,0
231500,.,0,0
231501,This,0,0
231502,study,0,0
231503,was,0,0
231504,carried,0,0
231505,out,0,0
231506,to,0,0
231507,evaluate,0,0
231508,the,0,0
231509,effects,0,0
231510,of,0,0
231511,perioperative,0,1
231512,indomethacin,0,1
231513,on,0,0
231514,intracranial,0,1
231515,pressure,0,1
231516,(,0,1
231517,ICP,0,1
231518,),0,1
231519,",",0,0
231520,cerebral,0,0
231521,blood,0,1
231522,flow,0,0
231523,(,0,1
231524,CBF,0,1
231525,),0,1
231526,",",0,0
231527,and,0,0
231528,cerebral,0,0
231529,metabolism,0,0
231530,.,0,0
231531,Twenty,0,0
231532,patients,0,0
231533,subjected,0,0
231534,to,0,0
231535,craniotomy,0,0
231536,for,0,0
231537,supratentorial,0,0
231538,cerebral,0,0
231539,tumors,0,0
231540,were,0,0
231541,anesthetized,1,1
231542,with,1,1
231543,thiopental,1,1
231544,",",1,1
231545,fentanyl,1,1
231546,",",1,1
231547,nitrous,1,1
231548,oxide,1,1
231549,",",1,1
231550,and,1,1
231551,isoflurane,1,1
231552,.,1,1
231553,A,0,1
231554,PaCO2,0,0
231555,level,0,0
231556,averaging,0,0
231557,4.8,0,0
231558,kPa,0,0
231559,(,0,0
231560,median,0,0
231561,),0,0
231562,was,0,0
231563,achieved,0,0
231564,.,0,0
231565,The,0,0
231566,patients,0,0
231567,were,0,0
231568,randomized,0,0
231569,to,0,1
231570,intravenous,1,1
231571,indomethacin,1,1
231572,50,1,1
231573,mg,1,1
231574,or,1,1
231575,placebo,1,1
231576,administrated,1,1
231577,after,1,0
231578,exposure,1,0
231579,of,1,0
231580,the,1,0
231581,dura,1,0
231582,.,1,0
231583,ICP,1,0
231584,was,1,0
231585,measured,1,0
231586,continuously,1,0
231587,subdurally,1,0
231588,with,1,0
231589,a,1,0
231590,22-gauge,1,0
231591,canula,1,0
231592,connected,1,0
231593,to,1,0
231594,a,1,0
231595,transducer,1,0
231596,.,1,0
231597,CBF,0,0
231598,and,0,0
231599,the,0,0
231600,arteriovenous,0,0
231601,difference,0,0
231602,of,0,0
231603,oxygen,0,0
231604,(,0,0
231605,AVDO2,0,1
231606,),0,0
231607,were,0,0
231608,measured,0,0
231609,twice,0,0
231610,",",0,0
231611,before,0,0
231612,and,0,0
231613,after,0,0
231614,indomethacin/placebo,1,1
231615,administration,0,1
231616,.,0,1
231617,A,0,0
231618,significant,0,0
231619,decrease,0,0
231620,in,0,0
231621,ICP,0,0
231622,from,0,0
231623,6.5,0,0
231624,to,0,0
231625,1.5,0,0
231626,mm,0,0
231627,Hg,0,0
231628,(,0,0
231629,median,0,0
231630,),0,0
231631,was,0,0
231632,found,0,0
231633,after,0,0
231634,indomethacin,0,1
231635,administration,0,1
231636,.,0,1
231637,This,0,0
231638,decrease,0,0
231639,was,0,0
231640,caused,0,0
231641,by,0,0
231642,a,0,0
231643,significant,0,0
231644,decrease,0,0
231645,in,0,0
231646,CBF,0,0
231647,associated,0,0
231648,with,0,0
231649,a,0,0
231650,significant,0,0
231651,increase,0,0
231652,in,0,0
231653,AVDO2,0,1
231654,.,0,0
231655,Indomethacin,0,1
231656,did,0,0
231657,not,0,0
231658,affect,0,0
231659,the,0,0
231660,cerebral,0,0
231661,metabolic,0,0
231662,rate,0,0
231663,of,0,0
231664,oxygen,0,0
231665,",",0,0
231666,the,0,0
231667,arteriovenous,0,0
231668,difference,0,0
231669,of,0,0
231670,lactate,0,1
231671,",",0,0
231672,or,0,0
231673,the,0,0
231674,lactate/oxygen,0,1
231675,index,0,1
231676,",",0,0
231677,suggesting,0,0
231678,that,0,0
231679,indomethacin,0,1
231680,did,0,0
231681,not,0,0
231682,provoke,0,0
231683,global,0,0
231684,cerebral,0,0
231685,ischemia,0,0
231686,.,0,0
231687,In,0,0
231688,the,0,0
231689,indomethacin,0,1
231690,group,0,1
231691,",",0,0
231692,dura,0,0
231693,was,0,0
231694,sufficiently,0,0
231695,relaxed,0,0
231696,in,0,0
231697,eight,0,0
231698,of,0,0
231699,nine,0,0
231700,patients,0,0
231701,and,0,0
231702,dura,0,0
231703,was,0,0
231704,opened,0,0
231705,without,0,0
231706,the,0,0
231707,occurrence,0,0
231708,of,0,0
231709,cerebral,0,0
231710,swelling,0,0
231711,.,0,0
231712,In,0,0
231713,one,0,0
231714,patient,0,0
231715,",",0,0
231716,mannitol,0,1
231717,treatment,0,0
231718,was,0,0
231719,necessary,0,0
231720,to,0,0
231721,prevent,0,0
231722,dural,0,0
231723,tightness,0,0
231724,.,0,0
231725,In,0,0
231726,the,0,0
231727,placebo,0,1
231728,group,0,1
231729,",",0,1
231730,mannitol,0,1
231731,supplemented,0,0
231732,with,0,0
231733,hypocapnia,0,0
231734,was,0,0
231735,applied,0,0
231736,in,0,0
231737,five,0,0
231738,patients,0,0
231739,.,0,0
231740,These,0,0
231741,findings,0,0
231742,suggest,0,0
231743,that,0,0
231744,perioperative,0,0
231745,treatment,0,0
231746,with,0,0
231747,indomethacin,1,1
231748,is,0,0
231749,an,0,0
231750,excellent,0,0
231751,treatment,0,0
231752,of,0,0
231753,intracranial,0,0
231754,hypertension,0,0
231755,during,0,1
231756,normocapnic,0,1
231757,isoflurane,0,1
231758,anesthesia,0,1
231759,for,0,0
231760,craniotomy,0,0
231761,.,0,0
231762,Age,0,1
231763,and,0,1
231764,autonomic,0,0
231765,effects,0,0
231766,on,0,0
231767,interrelationships,0,0
231768,between,0,0
231769,lung,0,0
231770,volume,0,0
231771,and,0,0
231772,heart,0,0
231773,rate,0,0
231774,.,0,0
231775,To,0,0
231776,determine,0,0
231777,effects,0,0
231778,of,0,0
231779,aging,0,0
231780,and,0,0
231781,autonomic,0,0
231782,input,0,0
231783,on,0,0
231784,interrelationships,0,0
231785,between,0,0
231786,respiratory,0,0
231787,and,0,0
231788,heart,0,0
231789,rate,0,0
231790,variability,0,0
231791,",",0,0
231792,we,0,0
231793,collected,0,0
231794,5,0,0
231795,min,0,0
231796,of,0,0
231797,lung,0,0
231798,volume,0,0
231799,of,0,0
231800,R-R,0,0
231801,interval,0,0
231802,data,0,0
231803,from,0,0
231804,7,0,0
231805,young,0,0
231806,[,0,0
231807,27,0,0
231808,+/-,0,0
231809,3,0,0
231810,(,0,0
231811,SD,0,1
231812,),0,0
231813,yr,0,0
231814,],0,0
231815,and,0,0
231816,10,0,1
231817,older,0,0
231818,(,0,0
231819,69,0,0
231820,+/-,0,0
231821,6,0,0
231822,yr,0,0
231823,),0,0
231824,healthy,0,0
231825,supine,0,0
231826,humans,0,0
231827,before,0,0
231828,and,0,0
231829,after,0,0
231830,double,0,0
231831,pharmacological,0,0
231832,autonomic,0,1
231833,blockade,0,1
231834,with,0,1
231835,propranolol,1,1
231836,(,0,1
231837,0.2,0,1
231838,mg/kg,0,1
231839,iv,0,1
231840,),0,1
231841,and,0,1
231842,atropine,1,1
231843,(,0,1
231844,0.04,0,1
231845,mg/kg,0,1
231846,iv,0,1
231847,),0,1
231848,.,0,0
231849,Estimates,0,0
231850,of,0,0
231851,respiratory,0,0
231852,and,0,0
231853,heart,0,0
231854,rate,0,0
231855,power,0,0
231856,spectra,0,0
231857,and,0,0
231858,linear,0,0
231859,transfer,0,0
231860,functions,0,0
231861,between,0,0
231862,the,0,0
231863,two,0,0
231864,groups,0,0
231865,were,0,0
231866,generated,0,0
231867,by,0,0
231868,Fourier,0,0
231869,analysis,0,0
231870,.,0,0
231871,Age,0,0
231872,",",0,0
231873,double,0,0
231874,blockade,0,1
231875,effects,0,0
231876,",",0,0
231877,the,0,0
231878,age-drug,0,1
231879,interactions,0,0
231880,were,0,0
231881,determined,0,0
231882,by,0,0
231883,analysis,0,0
231884,of,0,0
231885,variance,0,0
231886,for,0,0
231887,repeated,0,0
231888,measures,0,0
231889,.,0,0
231890,Basal,0,0
231891,R-R,0,0
231892,intervals,0,0
231893,were,0,0
231894,unaffected,0,0
231895,by,0,0
231896,age,0,0
231897,.,0,0
231898,Double,0,0
231899,blockade,0,1
231900,decreased,0,0
231901,R-R,0,0
231902,intervals,0,0
231903,and,0,0
231904,variability,0,0
231905,in,0,0
231906,both,0,0
231907,age,0,1
231908,groups,0,0
231909,(,0,0
231910,P,0,0
231911,<,0,0
231912,0.0001,0,0
231913,),0,0
231914,",",0,0
231915,but,0,0
231916,R-R,0,0
231917,intervals,0,0
231918,decreased,0,0
231919,less,0,0
231920,in,0,0
231921,older,0,0
231922,than,0,0
231923,in,0,0
231924,young,0,1
231925,subjects,0,0
231926,(,0,0
231927,P,0,0
231928,<,0,0
231929,0.0001,0,0
231930,),0,0
231931,.,0,0
231932,In,0,0
231933,contrast,0,0
231934,",",0,0
231935,basal,0,0
231936,respiratory,0,0
231937,intervals,0,0
231938,and,0,0
231939,standard,0,0
231940,deviation,0,0
231941,were,0,0
231942,greater,0,0
231943,in,0,0
231944,older,0,0
231945,subjects,0,0
231946,(,0,0
231947,P,0,0
231948,=,0,0
231949,0.05,0,0
231950,),0,0
231951,and,0,0
231952,were,0,0
231953,unaffected,0,0
231954,by,0,0
231955,double,0,0
231956,blockade,0,1
231957,in,0,0
231958,young,0,1
231959,and,0,0
231960,older,0,0
231961,subjects,0,0
231962,.,0,0
231963,Lung,0,0
231964,volume-to-heart,0,0
231965,rate,0,0
231966,spectral,0,0
231967,coherence,0,0
231968,was,0,0
231969,highest,0,0
231970,at,0,0
231971,frequencies,0,0
231972,associated,0,0
231973,with,0,0
231974,respiration,0,0
231975,and,0,0
231976,greater,0,0
231977,in,0,0
231978,young,0,0
231979,than,0,0
231980,in,0,0
231981,older,0,1
231982,subjects,0,0
231983,(,0,0
231984,P,0,0
231985,<,0,0
231986,0.07,0,0
231987,),0,0
231988,.,0,0
231989,Double,0,0
231990,blockade,0,1
231991,decreased,0,0
231992,lung,0,0
231993,volume-to-heart,0,0
231994,rate,0,0
231995,variability,0,0
231996,transfer,0,0
231997,function,0,0
231998,magnitude,0,0
231999,(,0,0
232000,P,0,0
232001,<,0,0
232002,0.007,0,0
232003,),0,0
232004,and,0,0
232005,increased,0,0
232006,phase,0,0
232007,angle,0,0
232008,(,0,0
232009,P,0,0
232010,<,0,0
232011,0.02,0,0
232012,),0,0
232013,without,0,0
232014,age,0,0
232015,effects,0,0
232016,or,0,0
232017,age-drug,0,1
232018,interactions,0,0
232019,.,0,0
232020,In,0,0
232021,conclusion,0,0
232022,",",0,0
232023,heart,0,0
232024,rate,0,0
232025,",",0,0
232026,respiration,0,0
232027,",",0,0
232028,and,0,0
232029,respiration-heart,0,0
232030,rate,0,0
232031,interrelations,0,0
232032,are,0,0
232033,altered,0,0
232034,by,0,0
232035,aging,0,0
232036,",",0,0
232037,and,0,0
232038,double,0,0
232039,autonomic,0,0
232040,pharmacological,0,1
232041,blockade,0,1
232042,does,0,0
232043,not,0,0
232044,eliminate,0,0
232045,all,0,0
232046,age-related,0,0
232047,differences,0,0
232048,.,0,0
232049,The,0,0
232050,immunogenicity,0,0
232051,of,0,0
232052,three,0,0
232053,Haemophilus,1,1
232054,influenzae,1,1
232055,type,1,1
232056,B,1,1
232057,conjugate,1,1
232058,vaccines,1,1
232059,after,0,0
232060,a,0,0
232061,primary,0,0
232062,vaccination,0,0
232063,series,0,0
232064,in,0,0
232065,Philippine,0,0
232066,infants,0,0
232067,.,0,0
232068,Serum,0,0
232069,antibody,0,0
232070,responses,0,0
232071,to,0,0
232072,three,0,0
232073,Haemophilus,1,1
232074,influenzae,1,1
232075,type,1,1
232076,b,1,1
232077,(,1,1
232078,Hib,1,1
232079,),1,1
232080,capsular,1,1
232081,polysaccharide-protein,1,1
232082,conjugate,1,1
232083,vaccine,1,1
232084,(,1,1
232085,PRP-OMP,1,1
232086,",",1,0
232087,PRP-T,1,0
232088,",",1,0
232089,and,1,0
232090,HbOC,1,1
232091,),1,0
232092,were,0,0
232093,evaluated,0,0
232094,in,0,0
232095,174,0,0
232096,Philippine,0,0
232097,infants,0,0
232098,after,0,0
232099,a,0,0
232100,primary,0,0
232101,vaccination,0,0
232102,series,0,0
232103,.,0,0
232104,Children,0,0
232105,were,0,0
232106,randomized,0,0
232107,to,0,0
232108,receive,0,0
232109,one,0,0
232110,of,0,0
232111,the,0,0
232112,Hib,1,1
232113,vaccines,1,1
232114,(,1,1
232115,Hib,1,1
232116,groups,1,1
232117,),1,0
232118,or,1,0
232119,into,1,0
232120,a,1,0
232121,control,1,0
232122,group,1,0
232123,.,1,0
232124,Vaccination,0,0
232125,was,0,0
232126,carried,0,0
232127,out,0,0
232128,at,0,0
232129,six,0,0
232130,",",0,0
232131,10,0,0
232132,and,0,0
232133,14,0,0
232134,weeks,0,0
232135,of,0,0
232136,age,0,0
232137,based,0,0
232138,on,0,0
232139,the,0,0
232140,local,0,0
232141,Expanded,0,0
232142,Program,0,0
232143,of,0,0
232144,Immunization,0,0
232145,schedule,0,0
232146,.,0,0
232147,Sera,0,0
232148,were,0,0
232149,collected,0,0
232150,at,0,0
232151,six,0,0
232152,weeks,0,0
232153,of,0,0
232154,age,0,0
232155,for,0,0
232156,the,0,0
232157,Hib,0,1
232158,groups,0,0
232159,and,0,0
232160,one,0,0
232161,month,0,0
232162,after,0,0
232163,the,0,0
232164,third,0,0
232165,dose,0,1
232166,for,0,0
232167,all,0,0
232168,subjects,0,0
232169,.,0,0
232170,Anti-Hib,0,0
232171,concentrations,0,1
232172,were,0,0
232173,determined,0,0
232174,by,0,0
232175,the,0,0
232176,Farr-type,0,0
232177,radioimmunoassay,0,1
232178,.,0,0
232179,There,0,0
232180,were,0,0
232181,no,0,0
232182,significant,0,0
232183,differences,0,0
232184,(,0,0
232185,P,0,0
232186,=,0,0
232187,0.3626,0,0
232188,),0,0
232189,in,0,0
232190,the,0,0
232191,prevaccination,0,0
232192,anti-Hib,0,1
232193,geometric,0,0
232194,mean,0,0
232195,concentration,0,0
232196,(,0,0
232197,GMC,0,1
232198,),0,0
232199,among,0,0
232200,the,0,0
232201,three,0,0
232202,Hib,0,1
232203,groups,0,0
232204,.,0,0
232205,Differences,0,0
232206,in,0,0
232207,the,0,0
232208,GMC,0,0
232209,after,0,0
232210,the,0,0
232211,primary,0,0
232212,series,0,0
232213,of,0,0
232214,three,0,0
232215,doses,0,1
232216,were,0,0
232217,significant,0,0
232218,(,0,0
232219,P,0,0
232220,<,0,0
232221,0.0001,0,0
232222,),0,0
232223,;,0,0
232224,GMC,0,1
232225,was,0,0
232226,highest,0,0
232227,for,0,0
232228,PRP-T,0,0
232229,(,0,0
232230,6.62,0,0
232231,micrograms/ml,0,1
232232,),0,0
232233,",",0,0
232234,followed,0,0
232235,by,0,0
232236,HbOC,0,1
232237,(,0,0
232238,1.9,0,0
232239,micrograms/ml,0,1
232240,),0,0
232241,",",0,0
232242,then,0,0
232243,PRP-OMP,0,1
232244,(,0,0
232245,1.06,0,0
232246,micrograms/ml,0,1
232247,),0,0
232248,",",0,0
232249,and,0,0
232250,lowest,0,0
232251,for,0,0
232252,the,0,0
232253,control,0,0
232254,group,0,0
232255,(,0,0
232256,0.11,0,1
232257,microgram/ml,0,1
232258,),0,0
232259,.,0,0
232260,We,0,0
232261,conclude,0,0
232262,that,0,0
232263,all,0,0
232264,three,0,0
232265,Hib,1,1
232266,conjugate,1,1
232267,vaccines,1,1
232268,(,1,1
232269,PRP-T,1,1
232270,",",1,0
232271,HbOC,1,0
232272,",",0,0
232273,and,0,0
232274,PRP-OMP,1,1
232275,),1,0
232276,were,0,0
232277,immunogenic,0,0
232278,after,0,0
232279,three,0,0
232280,primary,0,0
232281,doses,0,1
232282,among,0,0
232283,Philippine,0,0
232284,infants,0,0
232285,.,0,0
232286,Thoracoscopic,1,1
232287,talc,1,1
232288,insufflation,1,1
232289,versus,0,1
232290,talc,1,1
232291,slurry,1,1
232292,for,0,1
232293,symptomatic,0,1
232294,malignant,0,0
232295,pleural,0,0
232296,effusion,0,0
232297,.,0,0
232298,BACKGROUND,0,0
232299,Talc,0,0
232300,has,0,0
232301,been,0,0
232302,generally,0,0
232303,accepted,0,0
232304,to,0,0
232305,be,0,0
232306,the,0,0
232307,most,0,0
232308,effective,0,0
232309,sclerosant,0,1
232310,for,0,0
232311,chemical,0,0
232312,pleurodesis,0,0
232313,",",0,0
232314,although,0,0
232315,the,0,0
232316,optimal,0,0
232317,route,0,0
232318,of,0,0
232319,administration,0,1
232320,remains,0,0
232321,unclear,0,0
232322,.,0,0
232323,METHODS,0,0
232324,We,0,0
232325,designed,0,0
232326,a,0,0
232327,prospective,0,0
232328,",",0,0
232329,randomized,0,0
232330,study,0,0
232331,to,0,0
232332,compare,0,0
232333,video-assisted,1,0
232334,thoracoscopic,1,1
232335,talc,1,1
232336,insufflation,1,1
232337,with,1,1
232338,bedside,1,1
232339,talc,1,1
232340,slurry,1,1
232341,in,1,0
232342,the,0,0
232343,treatment,0,0
232344,of,0,0
232345,malignant,0,0
232346,pleural,0,0
232347,effusion,0,0
232348,.,0,0
232349,From,0,0
232350,September,0,0
232351,1993,0,0
232352,to,0,0
232353,November,0,0
232354,1995,0,0
232355,",",0,0
232356,57,0,0
232357,patients,0,0
232358,were,0,0
232359,recruited,0,0
232360,and,0,0
232361,randomized,0,0
232362,to,0,0
232363,either,0,0
232364,video-assisted,1,0
232365,thoracoscopic,1,1
232366,talc,1,1
232367,insufflation,1,1
232368,under,0,0
232369,general,1,0
232370,anesthesia,1,1
232371,(,0,0
232372,n,0,0
232373,=,0,0
232374,28,0,0
232375,),0,0
232376,or,0,0
232377,talc,0,1
232378,slurry,0,1
232379,by,0,0
232380,the,0,0
232381,bedside,0,1
232382,(,0,0
232383,n,0,0
232384,=,0,0
232385,29,0,0
232386,),0,0
232387,.,0,0
232388,Patients,0,0
232389,with,0,0
232390,poor,0,0
232391,general,0,0
232392,condition,0,0
232393,(,0,0
232394,Karnofsky,0,0
232395,score,0,0
232396,less,0,0
232397,than,0,0
232398,30,0,0
232399,%,0,0
232400,),0,0
232401,",",0,0
232402,poor,0,0
232403,pulmonary,0,0
232404,function,0,0
232405,(,0,0
232406,forced,0,0
232407,expiratory,0,0
232408,volume,0,0
232409,in,0,0
232410,1,0,0
232411,second,0,0
232412,less,0,0
232413,than,0,0
232414,0.5,0,0
232415,L,0,0
232416,),0,0
232417,",",0,0
232418,or,0,0
232419,trapped,0,0
232420,lungs,0,0
232421,were,0,0
232422,excluded,0,0
232423,from,0,0
232424,this,0,0
232425,study,0,0
232426,.,0,0
232427,Five,0,0
232428,grams,0,1
232429,of,0,0
232430,purified,0,0
232431,talc,0,1
232432,was,0,0
232433,used,0,0
232434,for,0,0
232435,either,0,0
232436,video-assisted,0,0
232437,thoracoscopic,0,1
232438,talc,0,1
232439,insufflation,0,1
232440,or,0,1
232441,talc,0,1
232442,slurry,0,1
232443,.,0,1
232444,RESULTS,0,0
232445,There,0,0
232446,was,0,0
232447,no,0,0
232448,statistically,0,0
232449,significant,0,0
232450,difference,0,0
232451,between,0,0
232452,the,0,0
232453,two,0,0
232454,groups,0,0
232455,of,0,0
232456,patients,0,0
232457,with,0,0
232458,respect,0,0
232459,to,0,0
232460,age,0,0
232461,",",0,0
232462,sex,0,0
232463,ratio,0,0
232464,",",0,0
232465,chest,0,0
232466,drainage,0,0
232467,duration,0,0
232468,",",0,0
232469,postprocedural,0,0
232470,hospital,0,0
232471,stay,0,1
232472,",",0,1
232473,parenteral,0,1
232474,narcotics,0,1
232475,requirement,0,1
232476,",",0,0
232477,complications,0,0
232478,",",0,0
232479,or,0,0
232480,procedure,0,1
232481,failure,0,1
232482,(,0,0
232483,ie,0,0
232484,",",0,1
232485,recurrence,0,1
232486,),0,0
232487,.,0,0
232488,CONCLUSIONS,0,1
232489,Video-assisted,0,1
232490,thoracoscopic,0,1
232491,talc,0,1
232492,insufflation,0,1
232493,has,0,0
232494,not,0,0
232495,been,0,0
232496,shown,0,0
232497,to,0,0
232498,be,0,0
232499,a,0,0
232500,superior,0,0
232501,approach,0,0
232502,compared,0,0
232503,with,0,0
232504,talc,0,1
232505,slurry,0,1
232506,in,0,0
232507,our,0,0
232508,study,0,0
232509,.,0,0
232510,Because,0,0
232511,the,0,0
232512,former,0,0
232513,demands,0,0
232514,more,0,0
232515,resources,0,0
232516,",",0,0
232517,we,0,0
232518,advocate,0,0
232519,that,0,0
232520,talc,0,1
232521,slurry,0,1
232522,should,0,0
232523,be,0,0
232524,considered,0,0
232525,as,0,0
232526,the,0,0
232527,procedure,0,0
232528,of,0,0
232529,choice,0,0
232530,in,0,0
232531,the,0,0
232532,treatment,0,0
232533,of,0,0
232534,symptomatic,0,0
232535,malignant,0,0
232536,pleural,0,0
232537,effusion,0,0
232538,in,0,0
232539,patients,0,0
232540,who,0,0
232541,do,0,0
232542,not,0,0
232543,have,0,0
232544,trapped,0,0
232545,lungs,0,0
232546,.,0,0
232547,Modulation,1,0
232548,of,1,0
232549,oxidant,1,0
232550,stress,1,0
232551,in,1,0
232552,vivo,1,0
232553,in,0,0
232554,chronic,0,0
232555,cigarette,0,0
232556,smokers,0,0
232557,.,0,0
232558,BACKGROUND,0,0
232559,Free,0,0
232560,radical-induced,0,0
232561,oxidative,0,0
232562,damage,0,0
232563,is,0,0
232564,thought,0,0
232565,to,0,0
232566,be,0,0
232567,involved,0,0
232568,in,0,0
232569,the,0,0
232570,pathogenesis,0,0
232571,of,0,0
232572,diseases,0,0
232573,associated,0,0
232574,with,0,0
232575,cigarette,0,0
232576,smoking,0,0
232577,.,0,0
232578,We,0,0
232579,examined,0,0
232580,the,0,0
232581,production,0,0
232582,of,0,0
232583,8-epi-prostaglandin,1,1
232584,(,1,1
232585,PG,1,1
232586,),1,1
232587,F2,1,0
232588,alpha,1,0
232589,",",1,0
232590,a,1,0
232591,stable,1,0
232592,product,1,0
232593,of,1,0
232594,lipid,1,0
232595,peroxidation,1,1
232596,in,1,0
232597,vivo,1,0
232598,",",0,0
232599,and,0,0
232600,its,0,0
232601,modulation,1,0
232602,by,1,0
232603,aspirin,1,1
232604,and,1,1
232605,antioxidant,1,1
232606,vitamins,1,1
232607,in,0,1
232608,chronic,0,1
232609,cigarette,0,0
232610,smokers,0,0
232611,.,0,0
232612,METHODS,0,0
232613,AND,0,1
232614,RESULTS,0,1
232615,We,0,0
232616,performed,0,0
232617,the,0,0
232618,following,0,0
232619,studies,0,0
232620,:,0,0
232621,(,0,0
232622,1,0,0
232623,),0,0
232624,a,0,0
232625,cross-sectional,0,0
232626,comparison,0,0
232627,of,0,0
232628,smokers,0,0
232629,and,0,0
232630,control,0,0
232631,subjects,0,0
232632,",",0,0
232633,(,0,1
232634,2,0,1
232635,),0,0
232636,an,0,0
232637,examination,0,0
232638,of,0,0
232639,the,0,0
232640,dose-response,0,1
232641,relationship,0,1
232642,",",0,1
232643,(,0,1
232644,3,0,1
232645,),0,0
232646,an,0,0
232647,exploration,0,0
232648,of,0,0
232649,the,0,0
232650,effect,0,0
232651,of,0,0
232652,smoking,1,0
232653,cessation,1,1
232654,(,1,0
232655,3,1,0
232656,weeks,1,0
232657,),1,1
232658,and,1,1
232659,nicotine,1,1
232660,patch,1,1
232661,supplementation,1,1
232662,",",0,1
232663,(,0,1
232664,4,0,1
232665,),0,0
232666,the,0,0
232667,effect,0,0
232668,of,0,0
232669,aspirin,1,1
232670,consumption,1,1
232671,",",0,1
232672,and,0,0
232673,(,0,1
232674,5,0,0
232675,),0,0
232676,the,0,0
232677,effects,0,0
232678,of,0,0
232679,5,0,0
232680,days,0,0
232681,',0,0
232682,dosing,0,1
232683,with,0,1
232684,vitamin,1,1
232685,E,1,1
232686,(,0,1
232687,100,0,0
232688,and,0,1
232689,800,0,1
232690,U,0,1
232691,),0,1
232692,",",0,1
232693,vitamin,1,1
232694,C,1,1
232695,(,1,1
232696,2,1,1
232697,g,1,1
232698,),1,1
232699,",",0,0
232700,and,0,0
232701,their,0,0
232702,combination,0,0
232703,.,0,0
232704,8-epi-PGF2,0,0
232705,alpha,0,0
232706,excretion,0,1
232707,(,0,0
232708,in,0,0
232709,pmol/mmol,0,0
232710,",",0,0
232711,mean,0,0
232712,+/-,0,0
232713,SEM,0,0
232714,),0,0
232715,was,0,0
232716,176.5+/-30.6,0,0
232717,in,0,0
232718,heavy,0,0
232719,smokers,0,0
232720,",",0,0
232721,92.7+/-4.8,0,0
232722,(,0,0
232723,P,0,0
232724,<,0,0
232725,.05,0,0
232726,),0,0
232727,in,0,0
232728,moderate,0,0
232729,smokers,0,0
232730,",",0,0
232731,and,0,0
232732,54.1+/-2.7,0,0
232733,(,0,0
232734,P,0,0
232735,<,0,0
232736,.005,0,0
232737,),0,0
232738,in,0,0
232739,nonsmokers,0,0
232740,.,0,0
232741,Urinary,0,0
232742,levels,0,0
232743,fell,0,0
232744,from,0,0
232745,145.5+/-24.9,0,0
232746,to,0,0
232747,114.6+/-27.1,0,0
232748,(,0,0
232749,week,0,0
232750,2,0,0
232751,",",0,0
232752,P,0,0
232753,<,0,0
232754,.05,0,0
232755,),0,0
232756,and,0,0
232757,112.6+/-24.9,0,0
232758,(,0,0
232759,week,0,0
232760,3,0,0
232761,",",0,0
232762,P,0,0
232763,<,0,0
232764,.05,0,0
232765,),0,0
232766,on,0,0
232767,cessation,0,0
232768,of,0,0
232769,smoking,0,0
232770,.,0,0
232771,Aspirin,1,1
232772,treatment,1,0
232773,failed,0,0
232774,to,0,0
232775,suppress,0,0
232776,urinary,0,0
232777,levels,0,0
232778,of,0,0
232779,8-epi-PGF2,0,0
232780,alpha,0,0
232781,despite,0,0
232782,a,0,0
232783,significant,0,0
232784,reduction,0,0
232785,in,0,0
232786,urinary,0,0
232787,11-dehydro-TxB2,0,1
232788,production,0,0
232789,and,0,0
232790,suppression,0,0
232791,of,0,0
232792,8-epi-PGF2,0,0
232793,alpha,0,0
232794,and,0,0
232795,TxB2,0,0
232796,in,0,0
232797,serum,0,1
232798,.,0,1
232799,Vitamin,1,1
232800,C,1,1
232801,(,0,0
232802,pre,0,0
232803,",",0,0
232804,194.6+/-40.9,0,0
232805,;,0,0
232806,post,0,0
232807,",",0,0
232808,137.2+/-34.1,0,0
232809,;,0,0
232810,P,0,0
232811,<,0,0
232812,.05,0,0
232813,),0,0
232814,and,0,0
232815,a,0,0
232816,combination,1,0
232817,of,1,0
232818,vitamin,1,1
232819,C,1,1
232820,and,1,1
232821,E,1,0
232822,(,0,0
232823,pre,0,0
232824,",",0,0
232825,171.0+/-39.8,0,0
232826,;,0,0
232827,post,0,0
232828,",",0,0
232829,133.5+/-29.6,0,0
232830,P,0,0
232831,<,0,0
232832,.05,0,0
232833,),0,0
232834,suppressed,0,0
232835,urinary,0,0
232836,8-epi-PGF2,0,0
232837,alpha,0,0
232838,",",0,0
232839,whereas,0,0
232840,vitamin,1,1
232841,E,1,0
232842,alone,0,0
232843,had,0,0
232844,no,0,0
232845,effect,0,0
232846,.,0,0
232847,CONCLUSIONS,0,0
232848,Urinary,0,0
232849,8-epi-PGF2,0,0
232850,alpha,0,0
232851,may,0,0
232852,represent,0,0
232853,a,0,0
232854,noninvasive,0,0
232855,",",0,0
232856,quantitative,0,0
232857,index,0,0
232858,of,0,0
232859,oxidant,0,0
232860,stress,0,0
232861,in,0,0
232862,vivo,0,0
232863,.,0,0
232864,Elevated,0,0
232865,levels,0,0
232866,of,0,0
232867,8-epi-PGF2,0,0
232868,alpha,0,0
232869,in,0,0
232870,smokers,0,0
232871,may,0,0
232872,be,0,0
232873,modulated,0,0
232874,by,0,0
232875,quitting,1,0
232876,cigarettes,1,0
232877,and,1,0
232878,switching,1,0
232879,to,1,0
232880,nicotine,1,1
232881,patches,1,0
232882,or,0,0
232883,by,0,0
232884,antioxidant,1,1
232885,vitamin,1,1
232886,therapy,1,1
232887,.,1,0
232888,Treatment,0,0
232889,of,0,0
232890,men,0,0
232891,with,0,0
232892,flat,0,0
232893,(,0,0
232894,FC,0,1
232895,),0,1
232896,or,0,0
232897,acuminata,0,1
232898,(,0,1
232899,CA,0,1
232900,),0,1
232901,condylomata,0,1
232902,with,0,1
232903,interferon,1,1
232904,alpha-2a,1,1
232905,.,1,1
232906,This,0,0
232907,study,0,0
232908,was,0,0
232909,undertaken,0,0
232910,to,0,0
232911,assess,0,0
232912,the,0,0
232913,effect,0,0
232914,of,0,0
232915,CO2,1,0
232916,laser,1,0
232917,vaporization,1,1
232918,",",1,1
232919,5-fluorouracil,1,1
232920,5,1,0
232921,%,1,0
232922,(,1,0
232923,5-FU,1,1
232924,),1,1
232925,topical,1,1
232926,application,1,1
232927,and,1,1
232928,Interferon,1,1
232929,alpha-2a,1,1
232930,(,1,1
232931,IFA,1,1
232932,alpha-2a,1,1
232933,),1,1
232934,in,0,0
232935,the,0,0
232936,treatment,0,0
232937,of,0,0
232938,C.A,0,0
232939,.,0,0
232940,or,0,0
232941,F.C,0,0
232942,.,0,0
232943,of,0,0
232944,the,0,0
232945,male,0,0
232946,genital,0,0
232947,tract,0,0
232948,.,0,0
232949,From,0,0
232950,March,0,1
232951,1986,0,0
232952,to,0,0
232953,September,0,0
232954,1991,0,0
232955,",",0,0
232956,1372,0,0
232957,men,0,0
232958,",",0,0
232959,sexual,0,0
232960,partners,0,0
232961,of,0,0
232962,women,0,0
232963,with,0,0
232964,F.C,0,0
232965,.,0,0
232966,or,0,0
232967,C.A,0,0
232968,.,0,0
232969,or,0,0
232970,cervical,0,0
232971,intraepithelial,0,0
232972,neoplasia,0,0
232973,",",0,0
232974,were,0,0
232975,submitted,0,0
232976,to,0,0
232977,peoscopy,1,0
232978,.,1,0
232979,One,0,0
232980,thousand,0,0
232981,and,0,0
232982,nineteen,0,0
232983,(,0,0
232984,74.27,0,0
232985,%,0,0
232986,),0,0
232987,men,0,0
232988,presented,0,0
232989,with,0,0
232990,various,0,0
232991,penile,0,0
232992,lesions,0,0
232993,caused,0,0
232994,by,0,0
232995,HPV,0,1
232996,(,0,0
232997,histologically,0,1
232998,confirmed,0,1
232999,),0,1
233000,;,0,0
233001,of,0,0
233002,these,0,0
233003,505,0,0
233004,were,0,0
233005,treated,0,0
233006,for,0,0
233007,C.A,0,0
233008,.,0,0
233009,or,0,0
233010,F.C,0,0
233011,.,0,0
233012,or,0,0
233013,a,0,0
233014,combination,0,0
233015,of,0,0
233016,F.C,0,0
233017,.,0,0
233018,and,0,0
233019,C.A,0,0
233020,.,0,0
233021,The,0,0
233022,best,0,0
233023,treatment,0,0
233024,modalities,0,0
233025,",",0,0
233026,irrespective,0,0
233027,of,0,0
233028,the,0,0
233029,kind,0,0
233030,of,0,0
233031,lesion,0,0
233032,",",0,0
233033,were,0,0
233034,found,0,0
233035,to,0,0
233036,be,0,0
233037,the,0,0
233038,combination,0,0
233039,of,0,0
233040,5-FU,1,0
233041,plus,1,0
233042,IFN,1,1
233043,alpha-2a,1,1
233044,(,0,1
233045,high,0,1
233046,dose,0,1
233047,),0,1
233048,(,0,0
233049,98.27,0,0
233050,%,0,0
233051,),0,0
233052,",",0,0
233053,the,0,0
233054,combination,0,0
233055,of,0,0
233056,CO2,1,0
233057,laser,1,0
233058,vaporization,1,0
233059,plus,1,0
233060,5-FU,1,0
233061,plus,1,0
233062,IFN,1,1
233063,alpha-2a,1,1
233064,(,1,1
233065,high,1,1
233066,dose,1,1
233067,),1,1
233068,(,1,0
233069,93.93,1,0
233070,%,1,0
233071,),1,0
233072,and,0,0
233073,the,0,0
233074,combination,1,0
233075,of,1,0
233076,CO2,1,0
233077,laser,1,0
233078,vaporization,1,0
233079,plus,1,0
233080,5-FU,1,0
233081,(,0,0
233082,87.23,0,0
233083,%,0,0
233084,),0,0
233085,.,0,0
233086,In,0,0
233087,conclusion,0,0
233088,we,0,0
233089,believe,0,0
233090,that,0,0
233091,IFN,1,1
233092,alpha-2a,1,1
233093,can,0,0
233094,be,0,0
233095,used,0,0
233096,with,0,0
233097,excellent,0,0
233098,results,0,0
233099,as,0,0
233100,first,0,0
233101,line,0,0
233102,treatment,0,0
233103,in,0,0
233104,combination,0,0
233105,with,0,0
233106,CO2,1,0
233107,laser,1,0
233108,vaporization,1,0
233109,or/plus,1,0
233110,5-FU,1,0
233111,in,0,0
233112,patients,0,0
233113,with,0,0
233114,C.A,0,0
233115,.,0,0
233116,or,0,0
233117,F.C,0,0
233118,.,0,0
233119,or,0,0
233120,combined,0,0
233121,condylomata,0,0
233122,.,0,0
233123,Chlorhexidine,1,1
233124,swabbing,0,1
233125,applications,0,0
233126,under,0,0
233127,various,0,0
233128,conditions,0,0
233129,of,0,0
233130,use,0,0
233131,in,0,0
233132,preventive,0,1
233133,oral,0,1
233134,care,0,1
233135,for,0,0
233136,persons,0,0
233137,with,0,0
233138,disabilities,0,0
233139,.,0,0
233140,A,0,0
233141,sample,0,0
233142,of,0,0
233143,44,0,0
233144,adults,0,0
233145,with,0,0
233146,severe,0,0
233147,disabilities,0,0
233148,completed,0,0
233149,a,0,0
233150,randomized,0,1
233151,single-blind,0,1
233152,cross-over,0,1
233153,study,0,1
233154,testing,0,1
233155,chlorhexidine,1,1
233156,swabbing,0,1
233157,under,0,0
233158,various,0,0
233159,conditions,0,0
233160,:,0,0
233161,with/without,0,0
233162,prior,0,0
233163,dental,0,0
233164,prophylaxis,0,0
233165,",",0,0
233166,reduced,0,0
233167,frequency,0,0
233168,of,0,0
233169,application,0,0
233170,(,0,0
233171,2,0,0
233172,vs.,0,0
233173,5,0,0
233174,times,0,0
233175,per,0,0
233176,week,0,0
233177,),0,0
233178,",",0,0
233179,and,0,0
233180,prolonged,0,0
233181,use,0,0
233182,(,0,0
233183,42,0,0
233184,weeks,0,0
233185,),0,0
233186,.,0,0
233187,All,0,0
233188,subjects,0,0
233189,received,0,0
233190,therapeutic,0,1
233191,doses,0,1
233192,of,0,0
233193,10,1,0
233194,mL,1,0
233195,0.12,1,0
233196,%,1,0
233197,chlorhexidine,1,1
233198,gluconate,1,1
233199,(,0,1
233200,Peridex,0,1
233201,",",0,1
233202,Procter,0,1
233203,&,0,1
233204,Gamble,0,0
233205,),0,0
233206,and,0,0
233207,10,1,0
233208,mL,1,0
233209,0.05,1,0
233210,%,1,0
233211,NaF,1,0
233212,applied,1,0
233213,with,1,0
233214,a,1,0
233215,Toothette,1,0
233216,(,0,0
233217,Sage,0,1
233218,Products,0,0
233219,),0,0
233220,.,0,0
233221,Clinical,0,0
233222,effectiveness,0,0
233223,of,0,0
233224,chlorhexidine,1,1
233225,swabbing,0,1
233226,compared,0,0
233227,with,0,0
233228,placebo,1,1
233229,was,0,0
233230,previously,0,0
233231,reported,0,0
233232,.,0,0
233233,In,0,0
233234,the,0,0
233235,present,0,0
233236,study,0,0
233237,",",0,0
233238,while,0,0
233239,initial,0,0
233240,benefits,0,0
233241,were,0,0
233242,observed,0,0
233243,to,0,0
233244,be,0,0
233245,independent,0,0
233246,of,0,0
233247,dental,0,0
233248,prophylaxis,0,0
233249,",",0,0
233250,significant,0,0
233251,reductions,0,0
233252,in,0,0
233253,periodontal,0,0
233254,scores,0,0
233255,were,0,0
233256,sustained,0,0
233257,by,0,0
233258,a,0,0
233259,combination,0,0
233260,of,0,0
233261,dental,0,0
233262,prophylaxis,0,0
233263,and,0,0
233264,swabbing,0,0
233265,protocol,0,0
233266,",",0,0
233267,at,0,0
233268,reduced,0,0
233269,frequency,0,0
233270,of,0,0
233271,application,0,0
233272,and,0,0
233273,over,0,0
233274,prolonged,0,0
233275,time,0,0
233276,.,0,0
233277,High,0,0
233278,levels,0,0
233279,of,0,0
233280,acceptance,0,0
233281,and,0,0
233282,compliance,0,0
233283,by,0,0
233284,subjects/caregivers,0,0
233285,were,0,0
233286,maintained,0,0
233287,.,0,0
233288,Subjects/caregivers,0,0
233289,reported,0,0
233290,improvements,0,0
233291,in,0,0
233292,dental,0,0
233293,health,0,0
233294,as,0,0
233295,well,0,0
233296,as,0,0
233297,in,0,0
233298,attitude,0,0
233299,",",0,0
233300,quality,0,0
233301,of,0,0
233302,life,0,0
233303,",",0,0
233304,and,0,0
233305,smile,0,1
233306,.,0,1
233307,Chlorhexidine,1,1
233308,swabbing,0,1
233309,at,0,0
233310,maintenance,0,0
233311,frequency,0,0
233312,",",0,0
233313,combined,0,0
233314,with,0,0
233315,periodic,0,0
233316,dental,0,0
233317,prophylaxis,0,0
233318,",",0,0
233319,may,0,0
233320,offer,0,0
233321,an,0,0
233322,effective,0,0
233323,and,0,0
233324,pragmatic,0,0
233325,long-term,0,1
233326,preventive,0,1
233327,regimen,0,1
233328,for,0,0
233329,persons,0,0
233330,with,0,0
233331,disabilities,0,0
233332,.,0,0
233333,Topical,0,0
233334,beta-blockade,0,1
233335,with,0,1
233336,intrinsic,0,0
233337,sympathomimetic,0,1
233338,activity,0,0
233339,offers,0,0
233340,no,0,0
233341,advantage,0,0
233342,for,0,0
233343,the,0,0
233344,respiratory,0,0
233345,and,0,0
233346,cardiovascular,0,0
233347,function,0,0
233348,of,0,0
233349,elderly,0,0
233350,people,0,0
233351,.,0,0
233352,Topical,1,0
233353,therapy,1,0
233354,with,1,0
233355,beta-antagonists,1,1
233356,",",0,0
233357,such,0,0
233358,as,0,0
233359,timolol,1,1
233360,",",0,0
233361,may,0,0
233362,cause,0,0
233363,unrecognized,0,0
233364,impairment,0,0
233365,of,0,0
233366,respiratory,0,0
233367,and,0,0
233368,cardiovascular,0,0
233369,function,0,0
233370,in,0,0
233371,elderly,0,0
233372,people,0,1
233373,.,0,0
233374,Beta-antagonists,0,1
233375,with,0,1
233376,intrinsic,0,0
233377,sympathomimetic,0,1
233378,or,0,1
233379,cardioselective,0,1
233380,properties,0,0
233381,",",0,0
233382,such,0,0
233383,as,0,0
233384,carteolol,1,1
233385,or,0,1
233386,betaxolol,1,1
233387,",",0,0
233388,may,0,0
233389,cause,0,0
233390,less,0,0
233391,impairment,0,0
233392,.,0,0
233393,In,0,0
233394,a,0,0
233395,randomized,0,0
233396,",",0,0
233397,double-masked,0,1
233398,study,0,0
233399,of,0,0
233400,glaucoma,0,0
233401,patients,0,0
233402,",",0,0
233403,over,0,0
233404,60,0,0
233405,years,0,0
233406,of,0,0
233407,age,0,0
233408,",",0,0
233409,without,0,0
233410,history,0,0
233411,of,0,0
233412,bronchospasm,0,1
233413,and,0,0
233414,who,0,0
233415,were,0,0
233416,using,0,0
233417,timolol,1,1
233418,(,0,0
233419,0.5,0,0
233420,%,0,0
233421,),0,0
233422,",",0,0
233423,60,0,0
233424,patients,0,0
233425,were,0,0
233426,allocated,0,0
233427,to,0,0
233428,betaxolol,1,1
233429,(,0,0
233430,0.5,0,0
233431,%,0,0
233432,),0,0
233433,or,0,0
233434,carteolol,1,1
233435,(,0,0
233436,2,0,0
233437,%,0,0
233438,),0,0
233439,or,0,0
233440,continued,0,1
233441,timolol,1,1
233442,(,0,0
233443,0.5,0,0
233444,%,0,0
233445,),0,0
233446,treatment,0,0
233447,.,0,0
233448,Spirometry,0,0
233449,",",0,0
233450,pulse,0,0
233451,and,0,0
233452,blood,0,0
233453,pressure,0,0
233454,were,0,0
233455,measured,0,0
233456,on,0,0
233457,enrollment,0,0
233458,and,0,0
233459,after,0,0
233460,4,0,0
233461,weeks,0,0
233462,.,0,0
233463,In,0,0
233464,the,0,0
233465,timolol,0,1
233466,and,0,1
233467,carteolol,0,1
233468,groups,0,0
233469,there,0,0
233470,were,0,0
233471,no,0,0
233472,significant,0,0
233473,changes,0,0
233474,in,0,0
233475,mean,0,0
233476,spirometric,0,0
233477,values,0,0
233478,.,0,0
233479,Changing,0,0
233480,to,0,0
233481,betaxolol,0,1
233482,improved,0,0
233483,mean,0,0
233484,peak,0,0
233485,flow,0,0
233486,(,0,0
233487,PF,0,1
233488,),0,0
233489,by,0,0
233490,9.1,0,0
233491,%,0,0
233492,",",0,0
233493,from,0,0
233494,310,0,0
233495,to,0,0
233496,3411/min,0,0
233497,(,0,0
233498,p,0,0
233499,<,0,0
233500,0.05,0,0
233501,),0,0
233502,and,0,0
233503,forced,0,0
233504,expiratory,0,0
233505,volume,0,0
233506,in,0,0
233507,1,0,0
233508,second,0,0
233509,(,0,1
233510,FEV1,0,1
233511,),0,0
233512,by,0,0
233513,9.4,0,0
233514,%,0,0
233515,",",0,0
233516,from,0,0
233517,1.74,0,0
233518,to,0,0
233519,1.861,0,0
233520,(,0,0
233521,p,0,0
233522,<,0,0
233523,0.05,0,0
233524,),0,0
233525,.,0,0
233526,Differences,0,0
233527,in,0,0
233528,the,0,0
233529,changes,0,0
233530,in,0,0
233531,PF,0,0
233532,and,0,0
233533,FEV1,0,1
233534,between,0,0
233535,betaxolol,0,1
233536,and,0,1
233537,timolol,0,1
233538,as,0,0
233539,well,0,0
233540,as,0,0
233541,betaxolol,0,1
233542,and,0,1
233543,carteolol,0,1
233544,groups,0,0
233545,were,0,0
233546,statistically,0,0
233547,significant,0,0
233548,(,0,0
233549,p,0,0
233550,<,0,0
233551,0.05,0,0
233552,),0,0
233553,.,0,0
233554,Twenty-one,0,0
233555,per,0,0
233556,cent,0,0
233557,of,0,0
233558,those,0,0
233559,allocated,0,0
233560,to,0,0
233561,betaxolol,0,1
233562,showed,0,0
233563,clinically,0,0
233564,significant,0,0
233565,improvement,0,0
233566,in,0,0
233567,FEV1,0,0
233568,.,0,0
233569,There,0,0
233570,was,0,0
233571,no,0,0
233572,change,0,0
233573,in,0,0
233574,pulse,0,0
233575,or,0,0
233576,blood,0,0
233577,pressure,0,1
233578,when,0,0
233579,carteolol,0,1
233580,was,0,0
233581,substituted,0,0
233582,for,0,0
233583,timolol,0,1
233584,but,0,0
233585,an,0,0
233586,increase,0,0
233587,of,0,0
233588,10,0,0
233589,beats,0,0
233590,per,0,0
233591,minute,0,0
233592,(,0,0
233593,p,0,0
233594,<,0,0
233595,0.05,0,0
233596,),0,0
233597,in,0,0
233598,mean,0,0
233599,resting,0,0
233600,pulse,0,0
233601,in,0,0
233602,the,0,0
233603,betaxolol,0,1
233604,group,0,1
233605,.,0,0
233606,Therapy,0,0
233607,with,0,1
233608,cardioselective,0,1
233609,beta-blockade,0,1
233610,may,0,0
233611,offer,0,0
233612,significant,0,0
233613,advantages,0,0
233614,in,0,0
233615,respiratory,0,0
233616,function,0,0
233617,for,0,0
233618,elderly,0,0
233619,people,0,0
233620,with,0,0
233621,glaucoma,0,0
233622,over,0,0
233623,non-selective,0,1
233624,drugs,0,1
233625,",",0,1
233626,even,0,0
233627,if,0,0
233628,they,0,0
233629,have,0,0
233630,sympathomimetic,0,1
233631,activity,0,0
233632,.,0,0
233633,Feasibility,0,0
233634,and,0,0
233635,effects,0,0
233636,of,0,0
233637,nurse,1,0
233638,run,1,0
233639,clinics,1,0
233640,for,0,0
233641,patients,0,0
233642,with,0,0
233643,epilepsy,0,0
233644,in,0,0
233645,general,0,0
233646,practice,0,0
233647,:,0,0
233648,randomised,0,0
233649,controlled,0,0
233650,trial,0,0
233651,.,0,0
233652,Epilepsy,0,0
233653,Care,0,0
233654,Evaluation,0,0
233655,Group,0,0
233656,.,0,0
233657,OBJECTIVE,0,0
233658,To,0,0
233659,test,0,0
233660,the,0,0
233661,feasibility,0,0
233662,and,0,0
233663,effect,0,0
233664,of,0,0
233665,nurse,1,0
233666,run,1,0
233667,epilepsy,1,0
233668,clinics,1,0
233669,in,0,0
233670,primary,0,0
233671,care,0,0
233672,.,0,0
233673,DESIGN,0,0
233674,A,0,1
233675,randomised,0,0
233676,controlled,0,0
233677,trial,0,0
233678,of,0,0
233679,nurse,1,0
233680,run,1,0
233681,clinics,1,1
233682,versus,0,0
233683,usual,1,0
233684,care,1,0
233685,.,1,0
233686,SETTING,0,1
233687,Six,0,1
233688,general,0,0
233689,practices,0,0
233690,in,0,0
233691,the,0,0
233692,South,0,0
233693,Thames,0,0
233694,region,0,0
233695,.,0,0
233696,SUBJECTS,0,0
233697,251,0,0
233698,patients,0,0
233699,aged,0,0
233700,over,0,0
233701,15,0,0
233702,years,0,0
233703,who,0,0
233704,were,0,0
233705,taking,0,0
233706,anti-epileptic,0,1
233707,drugs,0,1
233708,or,0,1
233709,had,0,0
233710,a,0,0
233711,diagnosis,0,0
233712,of,0,0
233713,epilepsy,0,0
233714,and,0,0
233715,an,0,0
233716,attack,0,0
233717,in,0,0
233718,the,0,0
233719,past,0,0
233720,two,0,0
233721,years,0,0
233722,who,0,0
233723,met,0,0
233724,specified,0,0
233725,inclusion,0,0
233726,criteria,0,0
233727,and,0,0
233728,had,0,0
233729,responded,0,0
233730,to,0,0
233731,a,0,0
233732,questionnaire,0,0
233733,.,0,0
233734,MAIN,0,0
233735,OUTCOME,0,1
233736,MEASURES,0,1
233737,Questionnaire,1,0
233738,responses,1,0
233739,and,0,0
233740,recording,0,0
233741,of,0,0
233742,key,0,0
233743,variables,0,0
233744,extracted,0,0
233745,from,0,0
233746,the,0,0
233747,clinical,0,0
233748,records,0,0
233749,before,0,0
233750,and,0,0
233751,after,0,0
233752,the,0,0
233753,intervention,0,0
233754,.,0,0
233755,RESULTS,0,0
233756,127,0,0
233757,patients,0,0
233758,were,0,0
233759,randomised,0,0
233760,to,0,0
233761,a,0,0
233762,nurse,0,0
233763,run,0,0
233764,clinic,0,0
233765,",",0,0
233766,of,0,0
233767,whom,0,0
233768,106,0,0
233769,(,0,0
233770,83,0,0
233771,%,0,0
233772,),0,0
233773,attended,0,0
233774,.,0,0
233775,The,0,0
233776,nurse,0,0
233777,wrote,0,0
233778,28,0,0
233779,letters,0,0
233780,to,0,0
233781,the,0,0
233782,general,0,0
233783,practitioners,0,0
233784,suggesting,0,0
233785,changes,1,0
233786,in,1,0
233787,epilepsy,1,0
233788,management,1,0
233789,.,1,0
233790,For,0,0
233791,this,0,0
233792,intervention,0,0
233793,group,0,0
233794,compared,0,0
233795,with,0,0
233796,the,0,0
233797,usual,1,0
233798,care,1,0
233799,group,0,0
233800,there,0,0
233801,was,0,0
233802,a,0,0
233803,highly,0,0
233804,significant,0,0
233805,improvement,0,0
233806,in,0,0
233807,the,0,0
233808,level,0,0
233809,of,0,0
233810,advice,0,0
233811,recorded,0,0
233812,as,0,0
233813,having,0,0
233814,been,0,0
233815,given,0,0
233816,on,0,0
233817,drug,0,1
233818,compliance,0,1
233819,",",0,1
233820,adverse,0,1
233821,drug,0,1
233822,effects,0,0
233823,",",0,0
233824,driving,0,0
233825,",",0,1
233826,alcohol,0,1
233827,intake,0,1
233828,",",0,1
233829,and,0,0
233830,self,0,0
233831,help,0,0
233832,groups,0,0
233833,.,0,0
233834,CONCLUSIONS,0,0
233835,Nurse,1,0
233836,run,1,0
233837,clinics,1,0
233838,for,0,0
233839,patients,0,0
233840,with,0,0
233841,epilepsy,0,0
233842,were,0,0
233843,feasible,0,0
233844,and,0,0
233845,well,0,0
233846,attended,0,0
233847,.,0,0
233848,Such,0,0
233849,clinics,0,0
233850,can,0,0
233851,significantly,0,0
233852,improve,0,0
233853,the,0,0
233854,level,0,0
233855,of,0,0
233856,advice,0,0
233857,and,0,0
233858,drug,0,1
233859,management,0,1
233860,recorded,0,0
233861,.,0,0
233862,Marginal,0,0
233863,zone,0,0
233864,B,0,0
233865,cell,0,0
233866,lymphoma,0,0
233867,of,0,0
233868,the,0,0
233869,parotid,0,0
233870,glands,0,0
233871,:,0,0
233872,results,0,0
233873,of,0,0
233874,a,0,0
233875,randomised,0,0
233876,trial,0,0
233877,comparing,0,0
233878,radiotherapy,1,0
233879,to,0,0
233880,combined,1,0
233881,therapy,1,0
233882,.,1,0
233883,39,0,0
233884,patients,0,0
233885,with,0,0
233886,marginal,0,0
233887,zone,0,0
233888,B,0,0
233889,cell,0,0
233890,lymphoma,0,1
233891,(,0,1
233892,MZBCL,0,1
233893,),0,0
233894,of,0,0
233895,the,0,0
233896,parotid,0,0
233897,glands,0,0
233898,(,0,0
233899,stages,0,0
233900,I,0,0
233901,or,0,0
233902,II,0,1
233903,),0,0
233904,were,0,0
233905,studied,0,0
233906,.,0,0
233907,They,0,0
233908,were,0,0
233909,randomized,0,0
233910,to,0,0
233911,be,0,0
233912,treated,0,0
233913,with,0,0
233914,either,0,0
233915,radiotherapy,1,0
233916,alone,1,0
233917,(,0,0
233918,extended,0,0
233919,fields,0,0
233920,",",0,0
233921,4500,0,0
233922,cGy,0,0
233923,),0,0
233924,or,0,0
233925,radiotherapy,1,1
233926,(,1,0
233927,the,1,0
233928,same,1,0
233929,schedule,1,0
233930,),1,0
233931,plus,1,0
233932,adjuvant,1,1
233933,chemotherapy,1,1
233934,(,1,1
233935,cyclophosphamide,1,1
233936,",",1,1
233937,vincristine,1,1
233938,and,1,1
233939,prednisone,1,1
233940,),1,1
233941,.,1,0
233942,The,0,0
233943,end,0,0
233944,points,0,0
233945,were,0,0
233946,survival,0,0
233947,and,0,0
233948,time,0,0
233949,to,0,0
233950,treatment,0,0
233951,failure,0,1
233952,(,0,1
233953,TTF,0,1
233954,),0,1
233955,.,0,0
233956,Patients,0,0
233957,who,0,0
233958,received,0,0
233959,radiotherapy,1,0
233960,alone,0,0
233961,had,0,0
233962,a,0,0
233963,complete,0,0
233964,remission,0,0
233965,rate,0,0
233966,of,0,0
233967,100,0,0
233968,%,0,0
233969,",",0,0
233970,the,0,0
233971,TTF,0,0
233972,was,0,0
233973,90,0,0
233974,%,0,0
233975,at,0,0
233976,5,0,0
233977,years,0,0
233978,and,0,0
233979,overall,0,0
233980,survival,0,0
233981,at,0,0
233982,5,0,0
233983,years,0,0
233984,was,0,0
233985,90,0,0
233986,%,0,0
233987,with,0,0
233988,no,0,0
233989,statistical,0,0
233990,difference,0,0
233991,when,0,0
233992,compared,0,0
233993,with,0,0
233994,patients,0,0
233995,who,0,0
233996,received,0,0
233997,combined,1,0
233998,therapy,1,1
233999,[,0,0
234000,100,0,0
234001,",",0,0
234002,80,0,0
234003,and,0,0
234004,95,0,0
234005,%,0,0
234006,",",0,0
234007,respectively,0,0
234008,(,0,0
234009,P,0,0
234010,=,0,0
234011,0.5,0,0
234012,),0,0
234013,],0,0
234014,.,0,0
234015,Although,0,0
234016,adjuvant,1,1
234017,chemotherapy,1,1
234018,was,0,0
234019,well,0,0
234020,tolerated,0,1
234021,",",0,0
234022,the,0,0
234023,use,0,0
234024,of,0,0
234025,this,0,0
234026,therapeutic,0,0
234027,approach,0,0
234028,in,0,0
234029,patients,0,0
234030,with,0,0
234031,early,0,0
234032,stage,0,0
234033,MZBCL,0,0
234034,did,0,0
234035,not,0,0
234036,offer,0,0
234037,any,0,0
234038,advantage,0,0
234039,over,0,0
234040,radiotherapy,0,0
234041,alone,0,0
234042,as,0,0
234043,the,0,0
234044,initial,0,0
234045,treatment,0,0
234046,.,0,0
234047,Until,0,1
234048,now,0,0
234049,",",0,0
234050,radiotherapy,1,0
234051,was,0,0
234052,considered,0,0
234053,the,0,0
234054,treatment,0,0
234055,of,0,0
234056,choice,0,0
234057,in,0,0
234058,this,0,0
234059,clinical,0,0
234060,setting,0,0
234061,of,0,0
234062,patients,0,0
234063,.,0,0
234064,Dexamethasone,1,1
234065,in,0,1
234066,salbutamol-treated,0,1
234067,inpatients,0,1
234068,with,0,0
234069,acute,0,0
234070,bronchiolitis,0,0
234071,:,0,0
234072,a,0,0
234073,randomized,0,0
234074,",",0,0
234075,controlled,0,0
234076,trial,0,0
234077,.,0,0
234078,OBJECTIVE,0,0
234079,To,0,0
234080,determine,0,0
234081,the,0,0
234082,clinical,0,0
234083,benefit,0,0
234084,of,0,1
234085,oral,0,1
234086,dexamethasone,0,1
234087,in,0,1
234088,children,0,1
234089,admitted,0,0
234090,to,0,0
234091,the,0,0
234092,hospital,0,0
234093,with,0,0
234094,bronchiolitis,0,0
234095,treated,0,0
234096,with,0,0
234097,nebulized,0,1
234098,salbutamol,0,1
234099,.,0,1
234100,METHODS,0,1
234101,Randomized,0,1
234102,",",0,0
234103,double-blind,0,1
234104,",",0,1
234105,placebo-controlled,0,1
234106,trial,0,1
234107,in,0,0
234108,the,0,0
234109,inpatient,0,0
234110,wards,0,0
234111,of,0,0
234112,a,0,0
234113,pediatric,0,0
234114,tertiary,0,0
234115,care,0,0
234116,hospital,0,0
234117,.,0,0
234118,The,0,0
234119,participants,0,0
234120,",",0,0
234121,children,0,0
234122,aged,0,0
234123,6,0,0
234124,weeks,0,0
234125,to,0,0
234126,15,0,0
234127,months,0,0
234128,",",0,0
234129,admitted,0,0
234130,with,0,0
234131,first-time,0,0
234132,wheezing,0,0
234133,",",0,0
234134,were,0,0
234135,eligible,0,0
234136,if,0,0
234137,their,0,0
234138,oxygen,0,0
234139,saturation,0,0
234140,was,0,0
234141,less,0,0
234142,than,0,0
234143,95,0,0
234144,%,0,0
234145,on,0,0
234146,admission,0,0
234147,to,0,0
234148,the,0,0
234149,hospital,0,0
234150,and,0,0
234151,their,0,0
234152,Respiratory,0,0
234153,Distress,0,0
234154,Assessment,0,1
234155,Instrument,0,1
234156,(,0,1
234157,RDAI,0,1
234158,),0,1
234159,score,0,0
234160,was,0,0
234161,greater,0,0
234162,than,0,0
234163,6,0,0
234164,.,0,0
234165,Patients,0,0
234166,were,0,0
234167,excluded,0,0
234168,if,0,0
234169,they,0,0
234170,had,0,0
234171,any,0,0
234172,one,0,0
234173,of,0,0
234174,the,0,0
234175,following,0,0
234176,:,0,0
234177,an,0,0
234178,underlying,0,0
234179,disease,0,0
234180,that,0,0
234181,might,0,0
234182,affect,0,0
234183,cardiopulmonary,0,0
234184,status,0,0
234185,",",0,0
234186,asthma,0,0
234187,",",0,0
234188,recent,0,0
234189,treatment,0,0
234190,with,0,1
234191,steroids,0,1
234192,(,0,1
234193,within,0,0
234194,2,0,0
234195,weeks,0,0
234196,),0,0
234197,",",0,0
234198,or,0,0
234199,any,0,0
234200,history,0,0
234201,of,0,0
234202,adverse,0,0
234203,reaction,0,0
234204,to,0,0
234205,steroids,0,1
234206,.,0,0
234207,Patients,0,0
234208,were,0,0
234209,randomly,0,0
234210,assigned,0,0
234211,to,0,0
234212,receive,0,0
234213,either,0,0
234214,orally,0,1
234215,administered,0,1
234216,dexamethasone,1,1
234217,with,1,1
234218,0.5,1,1
234219,mg/kg,1,1
234220,as,0,0
234221,the,0,0
234222,first,0,0
234223,dose,0,1
234224,and,0,0
234225,0.3,0,0
234226,mg/kg,0,0
234227,for,0,0
234228,the,0,0
234229,next,0,0
234230,2,0,0
234231,mornings,0,0
234232,",",0,0
234233,or,0,0
234234,an,0,0
234235,equal,0,0
234236,volume,0,0
234237,of,0,0
234238,an,0,0
234239,orally,0,1
234240,administered,0,1
234241,placebo,1,1
234242,with,0,1
234243,an,0,0
234244,identical,0,0
234245,appearance,0,0
234246,.,0,0
234247,All,0,0
234248,patients,0,0
234249,received,0,0
234250,nebulized,0,1
234251,salbutamol,1,1
234252,at,0,1
234253,0.15,0,0
234254,mg/kg,0,1
234255,every,0,1
234256,4,0,1
234257,hours,0,0
234258,for,0,0
234259,the,0,0
234260,first,0,0
234261,24,0,0
234262,hours,0,0
234263,.,0,0
234264,The,0,0
234265,primary,0,0
234266,outcome,0,0
234267,measure,0,0
234268,was,0,0
234269,the,0,0
234270,change,0,0
234271,from,0,0
234272,baseline,0,0
234273,in,0,0
234274,the,0,0
234275,RDAI,0,0
234276,score,0,0
234277,at,0,0
234278,24,0,0
234279,hours,0,0
234280,.,0,0
234281,Secondary,0,0
234282,outcome,0,0
234283,measures,0,0
234284,were,0,0
234285,oxygen,0,0
234286,saturation,0,0
234287,",",0,0
234288,respiratory,0,0
234289,rate,0,0
234290,",",0,0
234291,RDAI,0,0
234292,measurement,0,0
234293,twice,0,1
234294,daily,0,1
234295,for,0,0
234296,the,0,0
234297,first,0,0
234298,4,0,0
234299,days,0,0
234300,",",0,0
234301,and,0,0
234302,the,0,0
234303,length,0,0
234304,of,0,0
234305,hospitalization,0,0
234306,.,0,0
234307,RESULTS,0,0
234308,At,0,1
234309,24,0,0
234310,hours,0,0
234311,the,0,0
234312,mean,0,0
234313,change,0,0
234314,(,0,0
234315,SD,0,1
234316,),0,1
234317,from,0,0
234318,baseline,0,0
234319,in,0,0
234320,the,0,0
234321,RDAI,0,0
234322,score,0,0
234323,was,0,0
234324,1.6,0,0
234325,(,0,0
234326,2.3,0,0
234327,),0,0
234328,in,0,0
234329,the,0,0
234330,placebo,0,1
234331,group,0,1
234332,(,0,0
234333,n,0,0
234334,=,0,0
234335,28,0,0
234336,),0,0
234337,and,0,0
234338,1.4,0,1
234339,(,0,1
234340,2.0,0,0
234341,),0,0
234342,in,0,0
234343,the,0,0
234344,dexamethasone,0,1
234345,group,0,1
234346,(,0,0
234347,n,0,0
234348,=,0,0
234349,33,0,0
234350,;,0,0
234351,p,0,0
234352,=,0,0
234353,0.74,0,0
234354,),0,0
234355,.,0,0
234356,There,0,0
234357,were,0,0
234358,no,0,0
234359,significant,0,0
234360,differences,0,0
234361,between,0,0
234362,the,0,0
234363,two,0,0
234364,groups,0,0
234365,in,0,0
234366,change,0,0
234367,in,0,0
234368,oxygen,0,0
234369,saturation,0,0
234370,",",0,0
234371,respiratory,0,0
234372,rate,0,0
234373,",",0,0
234374,and,0,0
234375,RDAI,0,1
234376,score,0,0
234377,at,0,0
234378,any,0,0
234379,assessment,0,0
234380,period,0,0
234381,.,0,0
234382,The,0,0
234383,median,0,0
234384,length,0,0
234385,of,0,0
234386,stay,0,0
234387,(,0,0
234388,95,0,0
234389,%,0,0
234390,confidence,0,0
234391,interval,0,0
234392,),0,0
234393,for,0,0
234394,the,0,0
234395,placebo,0,1
234396,group,0,1
234397,was,0,0
234398,48,0,0
234399,(,0,0
234400,42,0,0
234401,",",0,0
234402,54,0,0
234403,),0,0
234404,hours,0,0
234405,compared,0,0
234406,with,0,0
234407,57,0,0
234408,(,0,0
234409,38,0,0
234410,",",0,0
234411,76,0,0
234412,),0,0
234413,hours,0,0
234414,in,0,0
234415,the,0,0
234416,dexamethasone,0,1
234417,group,0,0
234418,(,0,0
234419,p,0,0
234420,=,0,0
234421,0.19,0,0
234422,),0,0
234423,.,0,0
234424,CONCLUSIONS,0,1
234425,Oral,0,1
234426,dexamethasone,0,1
234427,therapy,0,1
234428,does,0,0
234429,not,0,0
234430,affect,0,0
234431,the,0,0
234432,clinical,0,0
234433,course,0,0
234434,of,0,0
234435,children,0,0
234436,hospitalized,0,0
234437,with,0,0
234438,bronchiolitis,0,0
234439,and,0,0
234440,therefore,0,0
234441,can,0,0
234442,not,0,0
234443,be,0,0
234444,recommended,0,0
234445,in,0,0
234446,this,0,0
234447,clinical,0,0
234448,situation,0,0
234449,.,0,0
234450,Temporal,0,0
234451,variation,0,0
234452,in,0,0
234453,the,0,0
234454,effects,0,0
234455,of,0,0
234456,ophthalmic,1,1
234457,timolol,1,1
234458,on,0,0
234459,cardiovascular,0,0
234460,and,0,0
234461,respiratory,0,0
234462,functions,0,0
234463,in,0,0
234464,healthy,0,0
234465,men,0,0
234466,.,0,0
234467,This,0,0
234468,study,0,0
234469,examined,0,0
234470,the,0,0
234471,effects,0,0
234472,of,0,0
234473,ophthalmic,1,1
234474,timolol,1,1
234475,and,0,0
234476,time,0,0
234477,of,0,0
234478,administration,0,1
234479,on,0,0
234480,cardiovascular,0,0
234481,and,0,0
234482,respiratory,0,0
234483,functions,0,0
234484,in,0,0
234485,healthy,0,0
234486,young,0,0
234487,male,0,0
234488,volunteers,0,0
234489,.,0,0
234490,Eight,0,0
234491,participants,0,0
234492,(,0,0
234493,mean,0,0
234494,age,0,0
234495,+/-,0,0
234496,standard,0,0
234497,deviation,0,0
234498,",",0,0
234499,22,0,0
234500,+/-,0,0
234501,0.9,0,0
234502,years,0,0
234503,),0,0
234504,received,0,0
234505,either,0,0
234506,50,0,0
234507,microL,0,0
234508,of,0,0
234509,0.5,0,0
234510,%,0,0
234511,timolol,1,1
234512,or,0,0
234513,placebo,1,1
234514,in,0,0
234515,the,0,0
234516,lower,0,0
234517,conjunctival,0,0
234518,sacs,0,0
234519,of,0,0
234520,both,0,0
234521,eyes,0,0
234522,in,0,0
234523,the,0,0
234524,morning,0,0
234525,or,0,0
234526,evening,0,0
234527,.,0,0
234528,Intraocular,0,0
234529,pressure,0,0
234530,",",0,0
234531,blood,0,0
234532,pressure,0,0
234533,",",0,0
234534,heart,0,0
234535,rate,0,0
234536,",",0,0
234537,and,0,0
234538,respiratory,0,0
234539,functions,0,0
234540,",",0,0
234541,including,0,0
234542,percent,0,0
234543,forced,0,0
234544,expiratory,0,0
234545,volume,0,0
234546,in,0,0
234547,1,0,0
234548,second,0,0
234549,and,0,0
234550,peak,0,0
234551,expiratory,0,0
234552,flow,0,0
234553,rate,0,0
234554,",",0,0
234555,were,0,0
234556,then,0,0
234557,measured,0,0
234558,for,0,0
234559,3,0,0
234560,hours,0,0
234561,after,0,1
234562,drug,0,1
234563,administration,0,1
234564,.,0,1
234565,Timolol,1,1
234566,reduced,0,0
234567,intraocular,0,1
234568,pressure,0,0
234569,and,0,0
234570,cardiovascular,0,0
234571,function,0,0
234572,at,0,0
234573,both,0,0
234574,administration,0,1
234575,times,0,1
234576,.,0,0
234577,However,0,0
234578,",",0,0
234579,a,0,0
234580,timolol-induced,1,1
234581,reduction,0,0
234582,in,0,0
234583,respiratory,0,0
234584,function,0,0
234585,was,0,0
234586,observed,0,0
234587,only,0,0
234588,in,0,0
234589,the,0,0
234590,evening,0,0
234591,:,0,0
234592,percent,0,0
234593,forced,0,0
234594,expiratory,0,0
234595,volume,0,0
234596,in,0,0
234597,1,0,0
234598,second,0,0
234599,",",0,0
234600,peak,0,0
234601,expiratory,0,0
234602,flow,0,0
234603,rate,0,0
234604,",",0,0
234605,and,0,0
234606,expiratory,0,0
234607,flow,0,0
234608,rate,0,0
234609,at,0,0
234610,75,0,0
234611,%,0,0
234612,vital,0,0
234613,capacity,0,0
234614,were,0,0
234615,reduced,0,0
234616,by,0,0
234617,3,0,0
234618,%,0,0
234619,",",0,0
234620,7,0,0
234621,%,0,0
234622,",",0,0
234623,and,0,0
234624,12,0,0
234625,%,0,0
234626,",",0,0
234627,respectively,0,0
234628,",",0,0
234629,3,0,0
234630,hours,0,0
234631,after,0,1
234632,administration,0,1
234633,.,0,0
234634,These,0,0
234635,results,0,0
234636,indicate,0,0
234637,that,0,0
234638,ophthalmic,1,0
234639,timolol,1,1
234640,reduces,0,0
234641,cardiovascular,0,1
234642,and,0,0
234643,respiratory,0,0
234644,functions,0,0
234645,in,0,0
234646,healthy,0,0
234647,young,0,0
234648,male,0,0
234649,subjects,0,0
234650,and,0,0
234651,that,0,0
234652,bronchial,0,0
234653,sensitivity,0,0
234654,to,0,0
234655,timolol,0,1
234656,differs,0,0
234657,between,0,0
234658,morning,0,0
234659,and,0,0
234660,evening,0,0
234661,.,0,0
234662,Soluble,1,0
234663,intercellular,1,0
234664,adhesion,1,0
234665,molecule-1,1,1
234666,in,0,0
234667,primary,0,0
234668,biliary,0,0
234669,cirrhosis,0,0
234670,:,0,0
234671,effect,0,0
234672,of,0,0
234673,ursodeoxycholic,1,1
234674,acid,1,1
234675,and,0,1
234676,immunosuppressive,1,1
234677,therapy,1,1
234678,.,1,1
234679,OBJECTIVES,0,0
234680,Soluble,1,0
234681,intercellular,1,0
234682,adhesion,1,0
234683,molecule-1,1,1
234684,(,1,1
234685,sICAM-1,1,1
234686,),1,0
234687,is,0,0
234688,thought,0,0
234689,to,0,0
234690,be,0,0
234691,released,0,0
234692,by,0,0
234693,a,0,0
234694,variety,0,0
234695,of,0,0
234696,cells,0,0
234697,at,0,0
234698,sites,0,0
234699,of,0,0
234700,inflammation,0,0
234701,",",0,0
234702,and,0,0
234703,their,0,0
234704,serum,0,1
234705,levels,0,0
234706,have,0,0
234707,been,0,0
234708,used,0,0
234709,as,0,0
234710,markers,0,0
234711,of,0,0
234712,inflammatory,0,0
234713,and,0,0
234714,immune,0,0
234715,activity,0,0
234716,.,0,0
234717,Our,0,0
234718,aim,0,0
234719,was,0,0
234720,to,0,0
234721,determine,0,0
234722,the,0,0
234723,effect,0,0
234724,of,0,0
234725,therapy,0,0
234726,with,0,1
234727,ursodeoxycholic,1,1
234728,acid,1,1
234729,alone,1,0
234730,and,0,0
234731,in,0,0
234732,combination,0,0
234733,with,0,0
234734,azathioprine,1,1
234735,and,1,1
234736,prednisone,1,1
234737,on,0,1
234738,serum,0,1
234739,sICAM-1,0,1
234740,levels,0,0
234741,in,0,0
234742,primary,0,0
234743,biliary,0,0
234744,cirrhosis,0,0
234745,.,0,0
234746,DESIGN/METHODS,0,0
234747,Twenty-four,0,0
234748,patients,0,0
234749,with,0,0
234750,primary,0,0
234751,biliary,0,0
234752,cirrhosis,0,0
234753,and,0,0
234754,17,0,0
234755,healthy,0,0
234756,subjects,0,0
234757,were,0,0
234758,studied,0,0
234759,.,0,0
234760,Primary,0,0
234761,biliary,0,0
234762,cirrhosis,0,0
234763,patients,0,0
234764,received,0,0
234765,ursodeoxycholic,1,1
234766,acid,1,1
234767,for,0,0
234768,12,0,0
234769,months,0,0
234770,and,0,0
234771,were,0,0
234772,then,0,0
234773,randomized,0,0
234774,in,0,0
234775,a,0,0
234776,double-blind,0,1
234777,fashion,0,0
234778,to,0,0
234779,receive,0,1
234780,prednisone,1,1
234781,and,1,1
234782,azathioprine,1,1
234783,",",1,1
234784,or,1,1
234785,placebo,1,1
234786,in,1,0
234787,addition,1,0
234788,to,1,0
234789,ursodeoxycholic,1,1
234790,acid,1,1
234791,.,1,1
234792,RESULTS,0,0
234793,sICAM-1,0,0
234794,levels,0,0
234795,were,0,0
234796,significantly,0,0
234797,higher,0,0
234798,in,0,0
234799,primary,0,0
234800,biliary,0,0
234801,cirrhosis,0,0
234802,patients,0,0
234803,than,0,0
234804,healthy,0,0
234805,subjects,0,0
234806,and,0,0
234807,fell,0,0
234808,by,0,0
234809,a,0,0
234810,median,0,0
234811,of,0,0
234812,20,0,0
234813,%,0,0
234814,after,0,0
234815,12,0,0
234816,months,0,0
234817,',0,0
234818,therapy,0,0
234819,with,0,1
234820,ursodeoxycholic,1,1
234821,acid,1,1
234822,(,0,0
234823,P,0,0
234824,<,0,0
234825,0.0004,0,0
234826,),0,0
234827,.,0,0
234828,Addition,0,0
234829,of,0,0
234830,azathioprine,1,1
234831,and,1,1
234832,prednisone,1,1
234833,to,0,1
234834,ursodeoxycholic,1,1
234835,acid,1,1
234836,resulted,0,0
234837,in,0,0
234838,a,0,0
234839,further,0,0
234840,reduction,0,0
234841,of,0,0
234842,sICAM-1,0,0
234843,levels,0,0
234844,by,0,0
234845,a,0,0
234846,median,0,0
234847,of,0,0
234848,25,0,0
234849,%,0,0
234850,(,0,0
234851,P,0,0
234852,<,0,0
234853,0.01,0,0
234854,),0,0
234855,.,0,0
234856,Reductions,0,0
234857,in,0,0
234858,sICAM-1,0,0
234859,were,0,0
234860,accompanied,0,0
234861,by,0,0
234862,improvement,0,0
234863,in,0,0
234864,liver,0,0
234865,function,0,0
234866,tests,0,0
234867,but,0,0
234868,not,0,0
234869,in,0,0
234870,the,0,0
234871,lymphocyte,0,0
234872,activation,0,0
234873,marker,0,0
234874,",",0,0
234875,soluble,0,0
234876,interleukin-2,0,1
234877,receptor,0,0
234878,.,0,0
234879,CONCLUSION,0,0
234880,sICAM-1,0,0
234881,levels,0,0
234882,in,0,0
234883,primary,0,0
234884,biliary,0,0
234885,cirrhosis,0,0
234886,are,0,0
234887,reduced,0,0
234888,by,0,0
234889,ursodeoxycholic,1,1
234890,acid,1,1
234891,.,1,0
234892,Further,0,0
234893,reductions,0,0
234894,were,0,0
234895,achieved,0,0
234896,by,0,0
234897,adding,0,0
234898,prednisone,1,1
234899,and,1,1
234900,azathioprine,1,1
234901,.,1,1
234902,These,0,0
234903,reductions,0,0
234904,probably,0,0
234905,reflect,0,0
234906,an,0,0
234907,improvement,0,0
234908,in,0,0
234909,hepatobiliary,0,1
234910,excretion,0,1
234911,and,0,0
234912,a,0,0
234913,reduction,0,0
234914,in,0,0
234915,cellular,0,0
234916,production,0,0
234917,of,0,0
234918,sICAM-1,0,0
234919,.,0,0
234920,Long-term,0,0
234921,follow-up,0,0
234922,of,0,1
234923,cytostatic,1,1
234924,intravesical,1,1
234925,instillation,1,1
234926,in,0,0
234927,patients,0,0
234928,with,0,0
234929,superficial,0,0
234930,bladder,0,0
234931,carcinoma,0,0
234932,.,0,0
234933,Is,0,0
234934,short-term,0,0
234935,",",0,0
234936,intensive,0,1
234937,instillation,0,1
234938,better,0,0
234939,than,0,0
234940,maintenance,0,0
234941,therapy,0,0
234942,?,0,0
234943,OBJECTIVES,0,1
234944,Comparisons,0,0
234945,of,0,0
234946,two,0,0
234947,3-year,0,0
234948,protocols,0,0
234949,",",0,0
234950,one,0,0
234951,20-week,0,0
234952,protocol,0,0
234953,of,0,0
234954,mitomycin,1,1
234955,C,1,1
234956,instillation,1,1
234957,and,0,0
234958,one,0,0
234959,3-year,0,0
234960,protocol,0,0
234961,of,0,1
234962,doxorubicin,1,1
234963,instillation,1,1
234964,for,0,1
234965,the,0,0
234966,prevention,0,0
234967,of,0,0
234968,recurrent,0,0
234969,tumors,0,0
234970,and,0,0
234971,progression,0,0
234972,in,0,0
234973,patients,0,0
234974,whose,0,0
234975,superficial,0,0
234976,bladder,0,0
234977,tumors,0,0
234978,had,0,0
234979,been,0,0
234980,removed,0,0
234981,by,0,0
234982,transurethral,0,0
234983,resection,0,0
234984,.,0,0
234985,METHODS,0,0
234986,A,0,1
234987,prospective,0,1
234988,",",0,0
234989,randomized,0,0
234990,parallel,0,0
234991,group,0,0
234992,multicenter,0,0
234993,trial,0,0
234994,was,0,0
234995,conducted,0,0
234996,.,0,0
234997,419,0,0
234998,patients,0,0
234999,were,0,0
235000,evaluated,0,0
235001,after,0,0
235002,a,0,0
235003,median,0,0
235004,follow-up,0,0
235005,of,0,0
235006,57,0,0
235007,months,0,0
235008,.,0,0
235009,Cox,0,0
235010,proportional,0,0
235011,hazards,0,0
235012,analysis,0,0
235013,was,0,0
235014,performed,0,0
235015,.,0,0
235016,RESULTS,0,1
235017,An,0,1
235018,overall,0,0
235019,recurrence,0,0
235020,rate,0,0
235021,of,0,0
235022,22.7,0,0
235023,%,0,0
235024,and,0,0
235025,an,0,0
235026,overall,0,0
235027,progression,0,0
235028,rate,0,0
235029,of,0,0
235030,9.8,0,0
235031,%,0,0
235032,was,0,0
235033,found,0,0
235034,.,0,0
235035,For,0,0
235036,time,0,0
235037,to,0,0
235038,progression,0,0
235039,a,0,0
235040,significant,0,0
235041,overall,0,0
235042,treatment,0,0
235043,effect,0,0
235044,was,0,0
235045,detected,0,0
235046,dependent,0,0
235047,on,0,0
235048,the,0,0
235049,recurrence,0,0
235050,status,0,0
235051,before,0,0
235052,entry,0,0
235053,into,0,0
235054,the,0,0
235055,study,0,0
235056,(,0,0
235057,p,0,0
235058,=,0,0
235059,0.0059,0,0
235060,),0,0
235061,.,0,0
235062,Pairwise,0,0
235063,comparisons,0,0
235064,showed,0,0
235065,the,0,0
235066,mitomycin,0,1
235067,protocol,0,1
235068,with,0,0
235069,short-term,0,0
235070,intensive,0,1
235071,(,0,1
235072,weekly,0,1
235073,),0,1
235074,combined,0,0
235075,with,0,0
235076,long-term,0,0
235077,maintenance,0,0
235078,instillation,0,1
235079,to,0,0
235080,have,0,0
235081,a,0,0
235082,highly,0,0
235083,beneficial,0,0
235084,effect,0,0
235085,compared,0,0
235086,to,0,0
235087,long-term,0,0
235088,maintenance,0,0
235089,instillation,0,1
235090,only,0,0
235091,especially,0,0
235092,for,0,0
235093,patients,0,0
235094,entering,0,0
235095,the,0,0
235096,study,0,0
235097,with,0,0
235098,recurrent,0,0
235099,tumors,0,1
235100,(,0,0
235101,RR,0,0
235102,=,0,0
235103,0.06,0,0
235104,",",0,0
235105,95,0,0
235106,%,0,0
235107,CI,0,0
235108,:,0,0
235109,[,0,0
235110,0.008,0,0
235111,",",0,0
235112,0.506,0,0
235113,],0,0
235114,.,0,0
235115,CONCLUSION,0,0
235116,These,0,0
235117,results,0,0
235118,show,0,0
235119,that,0,0
235120,intensive,0,0
235121,therapeutic,0,1
235122,instillation,0,1
235123,may,0,0
235124,have,0,0
235125,an,0,0
235126,advantage,0,0
235127,over,0,0
235128,less,0,0
235129,intensive,0,0
235130,",",0,0
235131,prophylactic,0,1
235132,regimens,0,1
235133,.,0,0
235134,Comparative,0,0
235135,efficacy,0,0
235136,and,0,0
235137,safety,0,0
235138,of,0,0
235139,twice,0,1
235140,daily,0,1
235141,fluticasone,1,1
235142,propionate,1,1
235143,powder,1,1
235144,versus,0,1
235145,placebo,1,1
235146,in,0,0
235147,the,0,0
235148,treatment,0,0
235149,of,0,0
235150,moderate,0,0
235151,asthma,0,0
235152,.,0,0
235153,BACKGROUND,0,1
235154,Fluticasone,1,1
235155,propionate,1,1
235156,",",0,1
235157,an,0,1
235158,inhaled,0,1
235159,corticosteroid,0,1
235160,with,0,1
235161,negligible,0,0
235162,systemic,0,0
235163,bioavailability,0,1
235164,via,0,0
235165,the,0,0
235166,oral,0,1
235167,route,0,0
235168,",",0,0
235169,is,0,0
235170,efficacious,0,0
235171,in,0,0
235172,the,0,0
235173,treatment,0,0
235174,of,0,0
235175,asthma,0,0
235176,when,0,0
235177,administered,0,1
235178,via,0,1
235179,metered-dose,0,1
235180,inhaler,0,1
235181,.,0,1
235182,OBJECTIVE,0,1
235183,To,0,0
235184,evaluate,0,0
235185,the,0,0
235186,efficacy,0,0
235187,and,0,0
235188,safety,0,0
235189,of,0,1
235190,inhaled,1,1
235191,fluticasone,1,1
235192,propionate,1,1
235193,powder,1,1
235194,in,0,0
235195,patients,0,0
235196,with,0,0
235197,moderate,0,0
235198,asthma,0,0
235199,previously,0,0
235200,treated,0,0
235201,with,0,0
235202,an,0,0
235203,inhaled,0,1
235204,corticosteroid,0,1
235205,.,0,1
235206,METHODS,0,0
235207,This,0,0
235208,was,0,0
235209,a,0,0
235210,randomized,0,0
235211,",",0,0
235212,double-blind,0,1
235213,",",0,1
235214,placebo-controlled,0,1
235215,",",0,1
235216,parallel-group,0,1
235217,",",0,1
235218,multicenter,0,0
235219,study,0,0
235220,of,0,0
235221,342,0,0
235222,adolescent,0,0
235223,and,0,0
235224,adult,0,0
235225,patients,0,0
235226,with,0,0
235227,moderate,0,0
235228,asthma,0,0
235229,[,0,0
235230,forced,0,0
235231,expiratory,0,0
235232,volume,0,0
235233,in,0,0
235234,1,0,0
235235,second,0,0
235236,(,0,1
235237,FEV1,0,1
235238,),0,1
235239,between,0,0
235240,50,0,0
235241,%,0,0
235242,and,0,0
235243,80,0,0
235244,%,0,0
235245,of,0,0
235246,predicted,0,0
235247,],0,0
235248,treated,0,0
235249,previously,0,0
235250,by,0,0
235251,beclomethasone,1,1
235252,dipropionate,1,1
235253,or,0,1
235254,triamcinolone,1,1
235255,acetonide,1,1
235256,.,1,1
235257,Patients,0,0
235258,received,0,0
235259,fluticasone,1,1
235260,propionate,1,1
235261,powder,1,1
235262,50,0,1
235263,micrograms,0,1
235264,",",0,1
235265,100,0,1
235266,micrograms,0,1
235267,",",0,1
235268,250,0,1
235269,micrograms,0,1
235270,",",0,1
235271,or,0,1
235272,placebo,1,1
235273,via,0,1
235274,a,0,1
235275,breath-actuated,0,1
235276,inhalation,0,1
235277,device,0,1
235278,",",0,0
235279,the,0,0
235280,Diskhaler,0,1
235281,",",0,1
235282,twice,0,1
235283,daily,0,1
235284,for,0,1
235285,12,0,0
235286,weeks,0,0
235287,.,0,0
235288,RESULTS,0,0
235289,Patients,0,0
235290,in,0,0
235291,the,0,0
235292,fluticasone,0,1
235293,propionate,0,1
235294,groups,0,1
235295,experienced,0,0
235296,a,0,0
235297,mean,0,0
235298,increase,0,0
235299,from,0,0
235300,baseline,0,0
235301,to,0,0
235302,endpoint,0,0
235303,in,0,0
235304,FEV1,0,0
235305,ranging,0,0
235306,from,0,0
235307,0.43,0,0
235308,L,0,0
235309,to,0,0
235310,0.47,0,0
235311,L.,0,0
235312,Patients,0,0
235313,in,0,0
235314,the,0,0
235315,placebo,0,1
235316,group,0,1
235317,experienced,0,0
235318,a,0,0
235319,mean,0,0
235320,decrease,0,0
235321,from,0,0
235322,baseline,0,0
235323,of,0,0
235324,0.22,0,0
235325,L,0,0
235326,(,0,0
235327,P,0,0
235328,<,0,0
235329,.001,0,0
235330,),0,0
235331,.,0,0
235332,The,0,0
235333,probability,0,0
235334,of,0,0
235335,patients,0,0
235336,remaining,0,0
235337,in,0,0
235338,the,0,0
235339,study,0,0
235340,over,0,0
235341,time,0,0
235342,without,0,0
235343,developing,0,0
235344,signs,0,0
235345,of,0,0
235346,exacerbating,0,0
235347,asthma,0,0
235348,was,0,0
235349,significantly,0,0
235350,greater,0,0
235351,in,0,0
235352,the,0,0
235353,fluticasone,0,1
235354,propionate,0,1
235355,groups,0,1
235356,than,0,0
235357,in,0,0
235358,the,0,0
235359,placebo,0,1
235360,group,0,0
235361,(,0,0
235362,P,0,0
235363,=,0,0
235364,.001,0,0
235365,),0,0
235366,.,0,0
235367,Asthma,0,0
235368,symptom,0,0
235369,scores,0,0
235370,",",0,0
235371,supplemental,0,0
235372,rescue,0,0
235373,albuterol,0,1
235374,use,0,0
235375,",",0,0
235376,and,0,0
235377,number,0,0
235378,of,0,0
235379,nighttime,0,0
235380,awakenings,0,0
235381,due,0,0
235382,to,0,0
235383,asthma,0,0
235384,requiring,0,0
235385,treatment,0,0
235386,also,0,0
235387,improved,0,0
235388,significantly,0,0
235389,with,0,0
235390,all,0,0
235391,fluticasone,0,1
235392,propionate,0,1
235393,treatment,0,1
235394,regimens,0,1
235395,compared,0,1
235396,with,0,1
235397,placebo,0,0
235398,(,0,0
235399,P,0,0
235400,<,0,0
235401,.001,0,0
235402,),0,0
235403,.,0,0
235404,There,0,0
235405,were,0,0
235406,no,0,0
235407,statistically,0,0
235408,significant,0,0
235409,differences,0,0
235410,at,0,0
235411,endpoint,0,0
235412,among,0,0
235413,the,0,0
235414,three,0,0
235415,fluticasone,0,1
235416,propionate,0,1
235417,groups,0,1
235418,.,0,1
235419,No,0,1
235420,serious,0,1
235421,drug-related,0,1
235422,adverse,0,0
235423,events,0,0
235424,occurred,0,0
235425,.,0,0
235426,CONCLUSIONS,0,1
235427,Fluticasone,0,1
235428,propionate,0,1
235429,powder,0,1
235430,(,0,1
235431,50,0,0
235432,",",0,0
235433,100,0,0
235434,",",0,0
235435,and,0,0
235436,250,0,1
235437,micrograms,0,1
235438,),0,1
235439,was,0,0
235440,well-tolerated,0,1
235441,and,0,0
235442,significantly,0,0
235443,improved,0,0
235444,lung,0,0
235445,function,0,0
235446,in,0,0
235447,patients,0,0
235448,with,0,0
235449,moderate,0,0
235450,asthma,0,0
235451,.,0,0
235452,Field,0,0
235453,trials,0,0
235454,of,0,0
235455,a,0,0
235456,vaccine,1,0
235457,against,0,0
235458,bovine,0,0
235459,mastitis,0,0
235460,.,0,0
235461,1,0,0
235462,.,0,0
235463,Evaluation,0,0
235464,in,0,0
235465,heifers,0,1
235466,.,0,1
235467,A,0,1
235468,vaccine,1,1
235469,was,0,0
235470,developed,0,0
235471,against,0,0
235472,bovine,0,0
235473,mastitis,0,0
235474,based,0,0
235475,on,0,0
235476,inactivated,0,0
235477,",",0,0
235478,highly,0,0
235479,encapsulated,0,0
235480,Staphylococcus,0,1
235481,aureus,0,1
235482,cells,0,1
235483,;,0,0
235484,a,0,0
235485,crude,0,0
235486,extract,0,0
235487,of,0,0
235488,Staph,0,1
235489,.,0,1
235490,aureus,0,1
235491,exopolysaccharides,0,1
235492,;,0,1
235493,and,0,0
235494,inactivated,0,0
235495,",",0,0
235496,unencapsulated,0,1
235497,Staph,0,1
235498,",",0,1
235499,aureus,0,1
235500,and,0,1
235501,Streptococcus,0,0
235502,spp,0,0
235503,.,0,0
235504,cells,0,0
235505,.,0,0
235506,This,0,0
235507,vaccine,1,0
235508,was,0,0
235509,tested,0,0
235510,on,0,0
235511,30,0,0
235512,heifers,0,1
235513,during,0,0
235514,a,0,0
235515,7-mo,0,0
235516,period,0,0
235517,.,0,0
235518,The,0,0
235519,30,0,0
235520,heifers,0,0
235521,were,0,0
235522,randomly,0,0
235523,assigned,0,0
235524,to,0,0
235525,three,0,0
235526,groups,0,0
235527,of,0,0
235528,10,0,0
235529,heifers,0,1
235530,each,0,0
235531,.,0,0
235532,The,0,0
235533,prepartum,0,1
235534,group,0,0
235535,received,0,0
235536,two,0,0
235537,injections,0,1
235538,of,0,0
235539,the,0,0
235540,vaccine,1,1
235541,at,0,0
235542,8,0,0
235543,and,0,0
235544,4,0,0
235545,wk,0,0
235546,before,0,0
235547,calving,0,0
235548,",",0,0
235549,and,0,0
235550,the,0,0
235551,postpartum,0,0
235552,group,0,0
235553,received,0,0
235554,two,0,0
235555,injections,0,1
235556,at,0,0
235557,1,0,0
235558,and,0,0
235559,5,0,0
235560,wk,0,0
235561,after,0,0
235562,calving,0,0
235563,.,0,0
235564,The,0,0
235565,control,0,0
235566,group,0,0
235567,received,0,0
235568,two,0,0
235569,injections,0,1
235570,of,0,0
235571,a,0,0
235572,placebo,0,1
235573,at,0,0
235574,8,0,0
235575,and,0,0
235576,4,0,0
235577,wk,0,0
235578,before,0,0
235579,calving,0,0
235580,.,0,0
235581,The,0,0
235582,vaccine,1,0
235583,or,0,0
235584,the,0,0
235585,placebo,1,1
235586,was,0,1
235587,administered,0,1
235588,subcutaneously,0,1
235589,in,0,1
235590,the,0,0
235591,brachiocephalicus,0,0
235592,muscle,0,0
235593,of,0,0
235594,the,0,0
235595,neck,0,0
235596,.,0,0
235597,The,0,0
235598,frequencies,0,0
235599,of,0,0
235600,intramammary,0,1
235601,infections,0,1
235602,caused,0,0
235603,by,0,0
235604,Staph,0,1
235605,.,0,0
235606,aureus,0,0
235607,were,0,0
235608,reduced,0,0
235609,from,0,0
235610,18.8,0,0
235611,%,0,0
235612,for,0,0
235613,heifers,0,0
235614,in,0,0
235615,the,0,0
235616,control,0,0
235617,group,0,0
235618,to,0,0
235619,6.7,0,0
235620,and,0,0
235621,6.0,0,0
235622,%,0,0
235623,for,0,0
235624,heifers,0,0
235625,in,0,0
235626,the,0,0
235627,prepartum,0,1
235628,and,0,1
235629,postpartum,0,1
235630,groups,0,0
235631,",",0,0
235632,respectively,0,0
235633,.,0,0
235634,This,0,0
235635,protective,0,0
235636,effect,0,0
235637,was,0,0
235638,maintained,0,0
235639,for,0,0
235640,at,0,0
235641,least,0,0
235642,6,0,0
235643,mo,0,0
235644,.,0,0
235645,The,0,0
235646,relative,0,0
235647,risk,0,0
235648,of,0,0
235649,mastitis,0,0
235650,caused,0,0
235651,by,0,0
235652,Staph,0,1
235653,.,0,1
235654,aureus,0,0
235655,was,0,0
235656,0.31,0,0
235657,and,0,0
235658,0.28,0,0
235659,for,0,0
235660,heifers,0,0
235661,in,0,0
235662,the,0,0
235663,prepartum,0,1
235664,and,0,1
235665,postpartum,0,1
235666,groups,0,0
235667,",",0,0
235668,respectively,0,0
235669,",",0,0
235670,compared,0,0
235671,with,0,0
235672,that,0,0
235673,for,0,0
235674,heifers,0,1
235675,in,0,0
235676,the,0,0
235677,control,0,0
235678,group,0,0
235679,.,0,0
235680,The,0,0
235681,results,0,0
235682,of,0,0
235683,the,0,0
235684,trial,0,0
235685,indicated,0,0
235686,the,0,0
235687,effectiveness,0,0
235688,of,0,0
235689,the,0,0
235690,vaccine,0,0
235691,in,0,0
235692,decreasing,0,0
235693,the,0,0
235694,incidence,0,0
235695,of,0,0
235696,intrammammary,0,0
235697,infections,0,0
235698,caused,0,0
235699,by,0,0
235700,Staph,0,1
235701,.,0,1
235702,aureus,0,0
235703,.,0,0
235704,A,0,0
235705,slight,0,0
235706,but,0,0
235707,nonsignificant,0,0
235708,increase,0,0
235709,occurred,0,0
235710,in,0,0
235711,fat,0,0
235712,production,0,0
235713,in,0,0
235714,the,0,0
235715,milk,0,1
235716,of,0,0
235717,vaccinated,0,0
235718,cows,0,0
235719,.,0,0
235720,The,0,0
235721,vaccine,0,0
235722,had,0,0
235723,no,0,0
235724,observable,0,0
235725,effect,0,0
235726,on,0,0
235727,somatic,0,0
235728,cell,0,0
235729,count,0,0
235730,or,0,0
235731,streptococcal,0,0
235732,infections,0,0
235733,.,0,0
235734,Clinical,0,0
235735,evaluation,0,0
235736,of,0,0
235737,the,0,0
235738,speed,0,0
235739,and,0,0
235740,effectiveness,0,0
235741,of,0,0
235742,subgingival,0,0
235743,calculus,0,0
235744,removal,0,0
235745,on,0,0
235746,single-rooted,0,0
235747,teeth,0,0
235748,with,0,0
235749,diamond-coated,1,0
235750,ultrasonic,1,0
235751,tips,1,0
235752,.,1,0
235753,Several,0,0
235754,studies,0,0
235755,have,0,0
235756,found,0,0
235757,incomplete,0,0
235758,calculus,0,0
235759,removal,0,0
235760,during,0,0
235761,periodontal,0,0
235762,treatment,0,0
235763,with,0,0
235764,traditional,0,0
235765,hand,0,0
235766,curets,0,0
235767,",",0,0
235768,sonic,0,0
235769,",",0,0
235770,and,0,0
235771,ultrasonic,0,0
235772,instruments,0,0
235773,.,0,0
235774,This,0,0
235775,study,0,0
235776,evaluated,0,0
235777,the,0,0
235778,speed,0,0
235779,and,0,0
235780,effectiveness,0,0
235781,of,0,0
235782,subgingival,1,0
235783,calculus,1,0
235784,removal,1,0
235785,with,0,0
235786,new,1,0
235787,diamond-coated,1,0
235788,ultrasonic,1,0
235789,tips,1,0
235790,on,0,0
235791,single-rooted,0,0
235792,teeth,0,0
235793,.,0,0
235794,Single,0,0
235795,session,0,0
235796,subgingival,0,0
235797,scaling,0,0
235798,and,0,0
235799,root,0,0
235800,planing,0,0
235801,was,0,0
235802,performed,0,0
235803,on,0,0
235804,80,0,0
235805,teeth,0,0
235806,with,0,0
235807,5,0,0
235808,to,0,0
235809,12,0,0
235810,mm,0,0
235811,probing,0,0
235812,depths,0,0
235813,in,0,0
235814,15,0,0
235815,patients,0,0
235816,.,0,0
235817,Each,0,0
235818,patient,0,0
235819,provided,0,0
235820,groups,0,0
235821,of,0,0
235822,4,0,0
235823,teeth,0,0
235824,that,0,0
235825,were,0,0
235826,randomly,0,0
235827,treated,0,0
235828,with,0,0
235829,either,0,0
235830,hand,1,0
235831,curets,1,0
235832,(,1,1
235833,HAND,1,1
235834,),1,1
235835,;,1,0
235836,standard,1,0
235837,smooth,1,0
235838,ultrasonic,1,0
235839,tip,1,0
235840,(,1,1
235841,US,1,1
235842,),1,1
235843,;,1,0
235844,or,1,0
235845,fine,1,0
235846,grit,1,1
235847,(,1,1
235848,FINDIAM,1,1
235849,),1,1
235850,or,1,0
235851,medium,1,0
235852,grit,1,1
235853,(,1,1
235854,MEDDIAM,1,1
235855,),1,1
235856,diamond-coated,1,0
235857,ultrasonic,1,0
235858,tips,1,0
235859,.,1,0
235860,The,0,0
235861,time,0,0
235862,taken,0,0
235863,to,0,0
235864,reach,0,0
235865,the,0,0
235866,therapeutic,0,0
235867,endpoint,0,0
235868,of,0,0
235869,a,0,0
235870,clean,0,0
235871,",",0,0
235872,smooth,0,0
235873,root,0,0
235874,surface,0,0
235875,in,0,0
235876,a,0,0
235877,defined,0,0
235878,region,0,0
235879,on,0,0
235880,each,0,0
235881,tooth,0,0
235882,with,0,0
235883,each,0,0
235884,instrument,0,0
235885,by,0,0
235886,the,0,0
235887,3,0,0
235888,therapists,0,0
235889,with,0,0
235890,differing,0,0
235891,experience,0,0
235892,levels,0,0
235893,was,0,0
235894,recorded,0,0
235895,.,0,0
235896,The,0,0
235897,teeth,0,0
235898,were,0,0
235899,then,0,0
235900,atraumatically,0,0
235901,extracted,0,0
235902,",",0,0
235903,stored,0,0
235904,in,0,0
235905,a,0,0
235906,surfactant,0,1
235907,",",0,0
235908,photographed,0,0
235909,at,0,0
235910,10X,0,0
235911,",",0,0
235912,and,0,0
235913,the,0,0
235914,percent,0,0
235915,of,0,0
235916,calculus,0,0
235917,present,0,0
235918,in,0,0
235919,the,0,0
235920,area,0,0
235921,of,0,0
235922,the,0,0
235923,pocket,0,0
235924,or,0,0
235925,on,0,0
235926,a,0,0
235927,comparable,0,0
235928,control,0,0
235929,surface,0,0
235930,calculated,0,0
235931,by,0,0
235932,histometric,0,0
235933,point,0,0
235934,counting,0,0
235935,.,0,0
235936,ANOVA,0,0
235937,and,0,0
235938,paired,0,0
235939,t,0,0
235940,tests,0,0
235941,showed,0,0
235942,that,0,0
235943,mean,0,0
235944,percent,0,0
235945,remaining,0,0
235946,calculus,0,0
235947,on,0,0
235948,treated,0,0
235949,versus,0,0
235950,control,0,0
235951,surfaces,0,0
235952,was,0,0
235953,HAND,0,0
235954,4.6,0,0
235955,+/-,0,0
235956,5.3,0,0
235957,versus,0,0
235958,57.5,0,0
235959,+/-,0,0
235960,28.2,0,0
235961,",",0,0
235962,US,0,0
235963,4.7,0,0
235964,+/-,0,0
235965,6.4,0,0
235966,versus,0,0
235967,54.4,0,0
235968,+/-,0,0
235969,25.9,0,0
235970,",",0,0
235971,FINDIAM,0,0
235972,4.3,0,0
235973,+/-,0,0
235974,5.2,0,0
235975,versus,0,0
235976,37.5,0,0
235977,+/-,0,0
235978,22.1,0,0
235979,",",0,0
235980,and,0,0
235981,MEDDIAM,0,0
235982,3.4,0,0
235983,+/-,0,0
235984,4.2,0,0
235985,versus,0,0
235986,50.7,0,0
235987,+/-,0,0
235988,20.1,0,0
235989,",",0,0
235990,respectively,0,0
235991,(,0,0
235992,all,0,0
235993,P,0,0
235994,<,0,0
235995,0.01,0,0
235996,),0,0
235997,.,0,0
235998,The,0,0
235999,mean,0,0
236000,time,0,0
236001,in,0,0
236002,seconds,0,0
236003,to,0,0
236004,reach,0,0
236005,the,0,0
236006,clinical,0,0
236007,endpoint,0,0
236008,ranged,0,0
236009,from,0,0
236010,HAND,0,0
236011,289,0,0
236012,+/-,0,0
236013,193,0,0
236014,",",0,0
236015,US,0,0
236016,194,0,0
236017,+/-,0,0
236018,67,0,0
236019,",",0,0
236020,FINDIAM,0,0
236021,167,0,0
236022,+/-,0,0
236023,71,0,0
236024,",",0,0
236025,to,0,0
236026,MEDDIAM,0,0
236027,147,0,0
236028,+/-,0,0
236029,92,0,0
236030,.,0,0
236031,All,0,0
236032,powered,0,0
236033,instruments,0,0
236034,were,0,0
236035,significantly,0,0
236036,faster,0,0
236037,than,0,0
236038,HAND,0,0
236039,(,0,0
236040,P,0,0
236041,<,0,0
236042,0.05,0,0
236043,),0,0
236044,",",0,0
236045,but,0,0
236046,did,0,0
236047,not,0,0
236048,differ,0,0
236049,from,0,0
236050,each,0,0
236051,other,0,0
236052,.,0,0
236053,On,0,0
236054,a,0,0
236055,0,0,0
236056,=,0,0
236057,smooth,0,0
236058,to,0,0
236059,3,0,0
236060,=,0,0
236061,rough,0,0
236062,scale,0,0
236063,",",0,0
236064,most,0,0
236065,often,0,0
236066,HAND,0,0
236067,resulted,0,0
236068,in,0,0
236069,smooth,0,0
236070,surfaces,0,0
236071,(,0,0
236072,10/20,0,0
236073,),0,0
236074,",",0,0
236075,the,0,0
236076,powered,0,0
236077,tips,0,0
236078,of,0,0
236079,all,0,0
236080,types,0,0
236081,slight,0,0
236082,surface,0,0
236083,roughness,0,0
236084,(,0,0
236085,10/20,0,0
236086,each,0,0
236087,),0,0
236088,",",0,0
236089,and,0,0
236090,US,0,0
236091,the,0,0
236092,most,0,0
236093,moderate,0,0
236094,roughness,0,0
236095,(,0,0
236096,7/20,0,0
236097,),0,0
236098,.,0,0
236099,There,0,0
236100,were,0,0
236101,no,0,0
236102,differences,0,0
236103,in,0,0
236104,percent,0,0
236105,calculus,0,0
236106,remaining,0,0
236107,",",0,0
236108,surface,0,0
236109,roughness,0,0
236110,",",0,0
236111,or,0,0
236112,time,0,0
236113,spent,0,0
236114,among,0,0
236115,the,0,0
236116,3,0,0
236117,treating,0,0
236118,clinicians,0,0
236119,despite,0,0
236120,their,0,0
236121,varying,0,0
236122,experience,0,0
236123,levels,0,0
236124,.,0,0
236125,The,0,0
236126,results,0,0
236127,of,0,0
236128,this,0,0
236129,study,0,0
236130,showed,0,0
236131,that,0,0
236132,percent,0,0
236133,calculus,0,0
236134,remaining,0,0
236135,was,0,0
236136,<,0,0
236137,5,0,0
236138,%,0,0
236139,with,0,0
236140,all,0,0
236141,the,0,0
236142,instruments,0,0
236143,given,0,0
236144,time,0,0
236145,ad,0,1
236146,libitum,0,1
236147,on,0,0
236148,a,0,0
236149,given,0,0
236150,root,0,0
236151,surface,0,0
236152,.,0,0
236153,Root,0,0
236154,roughness,0,0
236155,was,0,0
236156,generally,0,0
236157,slightly,0,0
236158,greater,0,0
236159,with,0,0
236160,all,0,0
236161,3,0,0
236162,powered,0,0
236163,tips,0,0
236164,.,0,0
236165,All,0,0
236166,of,0,0
236167,the,0,0
236168,powered,0,0
236169,instruments,0,0
236170,took,0,0
236171,significantly,0,0
236172,less,0,0
236173,time,0,0
236174,than,0,0
236175,the,0,0
236176,HAND,0,0
236177,.,0,0
236178,Both,0,0
236179,DIAM,0,0
236180,tips,0,0
236181,took,0,0
236182,less,0,0
236183,time,0,0
236184,than,0,0
236185,US,1,0
236186,.,1,0
236187,Diamond-coated,1,0
236188,ultrasonic,1,0
236189,tips,1,0
236190,appeared,0,0
236191,to,0,0
236192,be,0,0
236193,much,0,0
236194,more,0,0
236195,efficient,0,0
236196,than,0,0
236197,HAND,0,0
236198,or,0,0
236199,US,0,0
236200,in,0,0
236201,removing,0,0
236202,calculus,0,0
236203,in,0,0
236204,moderate-deep,0,0
236205,probing,0,0
236206,depths,0,0
236207,on,0,0
236208,single-rooted,0,0
236209,teeth,0,0
236210,in,0,0
236211,vivo,0,0
236212,.,0,0
236213,Dose-response,0,0
236214,relationship,0,0
236215,of,0,0
236216,complementary,1,0
236217,radiotherapy,1,0
236218,following,0,0
236219,four,0,0
236220,cycles,0,0
236221,of,0,0
236222,combination,1,0
236223,chemotherapy,1,0
236224,in,0,0
236225,intermediate-stage,0,0
236226,Hodgkin,0,0
236227,'s,0,0
236228,disease,0,0
236229,.,0,0
236230,PURPOSE,0,0
236231,To,0,0
236232,determine,0,0
236233,the,0,0
236234,appropriate,0,0
236235,irradiation,0,0
236236,dose,0,1
236237,after,0,0
236238,four,0,0
236239,cycles,0,0
236240,of,0,0
236241,modern,1,0
236242,combination,1,0
236243,chemotherapy,1,0
236244,in,0,0
236245,nonbulky,0,0
236246,involved,0,0
236247,field,0,0
236248,(,0,0
236249,IF/BF,0,1
236250,),0,1
236251,and,0,0
236252,noninvolved,0,0
236253,extended-field,0,0
236254,(,0,1
236255,EF/IF,0,1
236256,),0,0
236257,sites,0,0
236258,in,0,0
236259,patients,0,0
236260,with,0,0
236261,intermediate-stage,0,0
236262,Hodgkin,0,0
236263,'s,0,1
236264,disease,0,1
236265,(,0,1
236266,HD,0,1
236267,),0,1
236268,.,0,0
236269,MATERIALS,0,0
236270,AND,0,1
236271,METHODS,0,1
236272,HD,0,1
236273,patients,0,0
236274,in,0,0
236275,stage,0,0
236276,I,0,0
236277,to,0,0
236278,IIIA,0,0
236279,with,0,0
236280,a,0,0
236281,large,0,0
236282,mediastinal,0,0
236283,mass,0,0
236284,",",0,0
236285,E,0,0
236286,stage,0,0
236287,",",0,0
236288,or,0,0
236289,massive,0,0
236290,spleen,0,0
236291,involvement,0,0
236292,were,0,0
236293,treated,0,0
236294,with,0,0
236295,two,0,0
236296,double,0,0
236297,cycles,1,0
236298,of,1,0
236299,alternating,1,0
236300,cyclophosphamide,1,1
236301,",",1,1
236302,vincristine,1,1
236303,",",1,1
236304,procarbazine,1,1
236305,",",1,1
236306,and,1,1
236307,prednisone,1,1
236308,(,1,1
236309,COPP,1,1
236310,),1,1
236311,plus,1,0
236312,doxorubicin,1,1
236313,",",1,1
236314,bleomycin,1,1
236315,",",1,1
236316,vinblastine,1,1
236317,",",1,1
236318,and,1,1
236319,dacarbazine,1,1
236320,(,1,1
236321,ABVD,1,1
236322,),1,0
236323,followed,1,0
236324,by,1,0
236325,EF,1,0
236326,irradiation,1,0
236327,in,0,0
236328,two,0,0
236329,successive,0,0
236330,trials,0,0
236331,(,0,0
236332,HD1,0,1
236333,and,0,1
236334,HD5,0,1
236335,),0,0
236336,.,0,0
236337,In,0,0
236338,the,0,0
236339,HD1,0,1
236340,trial,0,1
236341,(,0,0
236342,1983,0,0
236343,to,0,0
236344,1988,0,1
236345,),0,0
236346,",",0,0
236347,146,0,0
236348,patients,0,0
236349,who,0,0
236350,responded,0,0
236351,to,0,0
236352,chemotherapy,0,0
236353,were,0,0
236354,randomized,0,0
236355,to,0,0
236356,receive,0,0
236357,20,0,0
236358,Gy,0,0
236359,(,0,0
236360,70,0,0
236361,patients,0,0
236362,),0,0
236363,or,0,0
236364,40,0,1
236365,Gy,0,0
236366,(,0,0
236367,76,0,0
236368,patients,0,0
236369,),0,0
236370,of,0,0
236371,EF,0,0
236372,irradiation,0,0
236373,in,0,0
236374,all,0,0
236375,fields,0,0
236376,outside,0,0
236377,bulky,0,0
236378,disease,0,0
236379,sites,0,0
236380,.,0,0
236381,A,0,0
236382,cohort,0,0
236383,of,0,0
236384,111,0,0
236385,patients,0,0
236386,who,0,0
236387,fulfilled,0,0
236388,the,0,0
236389,same,0,0
236390,inclusion,0,0
236391,criteria,0,0
236392,in,0,0
236393,the,0,0
236394,subsequent,0,0
236395,trial,0,0
236396,HD5,0,1
236397,(,0,1
236398,1988,0,0
236399,to,0,0
236400,1993,0,0
236401,),0,0
236402,were,0,0
236403,treated,0,0
236404,with,0,0
236405,30,0,0
236406,Gy,0,0
236407,.,0,0
236408,Bulky,0,0
236409,disease,0,0
236410,always,0,0
236411,received,0,0
236412,40,0,0
236413,Gy,0,0
236414,.,0,0
236415,RESULTS,0,1
236416,Freedom-from-treatment-failure,0,1
236417,(,0,1
236418,FFTF,0,1
236419,),0,1
236420,and,0,0
236421,survival,0,1
236422,(,0,1
236423,SV,0,1
236424,),0,0
236425,curves,0,0
236426,showed,0,0
236427,no,0,0
236428,differences,0,0
236429,between,0,0
236430,the,0,0
236431,20-,0,0
236432,",",0,0
236433,30-,0,0
236434,",",0,0
236435,and,0,0
236436,40-Gy,0,0
236437,groups,0,0
236438,.,0,0
236439,However,0,0
236440,",",0,0
236441,acute,0,0
236442,toxicities,0,1
236443,were,0,0
236444,more,0,0
236445,frequent,0,0
236446,in,0,0
236447,the,0,0
236448,40-Gy,0,0
236449,arm,0,0
236450,.,0,0
236451,Analysis,0,0
236452,of,0,0
236453,relapse,0,0
236454,patterns,0,0
236455,showed,0,0
236456,that,0,0
236457,18,0,0
236458,of,0,0
236459,26,0,0
236460,relapsing,0,0
236461,patients,0,0
236462,either,0,0
236463,failed,0,0
236464,to,0,0
236465,respond,0,0
236466,in,0,0
236467,initial,0,0
236468,bulky,0,0
236469,sites,0,0
236470,(,0,0
236471,n,0,0
236472,=,0,0
236473,5,0,0
236474,),0,0
236475,or,0,0
236476,had,0,0
236477,an,0,0
236478,extranodal,0,0
236479,relapse,0,1
236480,(,0,0
236481,n,0,0
236482,=,0,0
236483,9,0,0
236484,),0,0
236485,or,0,0
236486,both,0,0
236487,(,0,0
236488,n,0,0
236489,=,0,0
236490,4,0,0
236491,),0,0
236492,.,0,0
236493,After,0,0
236494,5,0,0
236495,years,0,0
236496,",",0,0
236497,the,0,0
236498,cumulative,0,0
236499,risk,0,0
236500,for,0,0
236501,relapse,0,0
236502,in,0,0
236503,bulky,0,0
236504,sites,0,0
236505,is,0,0
236506,10,0,0
236507,%,0,0
236508,",",0,0
236509,despite,0,0
236510,40,0,0
236511,Gy,0,0
236512,of,0,0
236513,radiation,1,0
236514,.,1,0
236515,CONCLUSION,0,0
236516,Our,0,0
236517,results,0,0
236518,strongly,0,0
236519,suggest,0,0
236520,that,0,0
236521,there,0,0
236522,is,0,0
236523,no,0,0
236524,relevant,0,0
236525,radiotherapy,1,0
236526,dose,0,1
236527,effect,0,0
236528,in,0,0
236529,the,0,0
236530,range,0,0
236531,between,0,0
236532,20,0,0
236533,Gy,0,0
236534,and,0,0
236535,40,0,0
236536,Gy,0,0
236537,in,0,0
236538,IF/BF,0,0
236539,and,0,0
236540,EF/IF,0,1
236541,after,0,0
236542,4,0,0
236543,months,0,0
236544,of,0,0
236545,modern,0,0
236546,polychemotherapy,1,0
236547,in,0,0
236548,patients,0,0
236549,with,0,0
236550,intermediate-stage,0,0
236551,HD,0,0
236552,.,0,0
236553,Relapse,0,0
236554,patterns,0,0
236555,indicate,0,0
236556,that,0,0
236557,patients,0,0
236558,destined,0,0
236559,to,0,0
236560,relapse,0,0
236561,need,0,0
236562,more,0,0
236563,systemic,0,0
236564,",",0,0
236565,rather,0,0
236566,than,0,0
236567,local,0,0
236568,",",0,0
236569,treatment,0,0
236570,.,0,0
236571,Based,0,0
236572,on,0,0
236573,our,0,0
236574,data,0,0
236575,",",0,0
236576,we,0,0
236577,conclude,0,0
236578,that,0,0
236579,20,0,0
236580,Gy,0,0
236581,is,0,0
236582,sufficient,0,0
236583,in,0,0
236584,EF/IF,0,0
236585,of,0,0
236586,intermediate-stage,0,0
236587,HD,0,0
236588,following,0,0
236589,four,0,0
236590,cycles,0,0
236591,of,0,0
236592,modern,0,0
236593,polychemotherapy,1,0
236594,.,1,0
236595,Acute,0,0
236596,rejection,0,0
236597,and,0,0
236598,heart,0,0
236599,infection,0,0
236600,rates,0,0
236601,in,0,0
236602,FK,1,0
236603,506-,1,0
236604,versus,0,0
236605,cyclosporine,1,1
236606,A-treated,1,1
236607,heart,0,0
236608,transplant,0,0
236609,recipients,0,0
236610,:,0,0
236611,an,0,0
236612,endomyocardial,0,0
236613,biopsy,0,0
236614,pathologic,0,0
236615,study,0,0
236616,.,0,0
236617,Dose-response,0,0
236618,comparison,0,0
236619,of,0,0
236620,RRR-alpha-tocopherol,1,1
236621,and,1,1
236622,all-racemic,1,1
236623,alpha-tocopherol,1,1
236624,on,0,1
236625,LDL,0,0
236626,oxidation,0,0
236627,.,0,0
236628,Much,0,0
236629,data,0,0
236630,have,0,0
236631,accrued,0,0
236632,in,0,0
236633,support,0,0
236634,of,0,0
236635,the,0,0
236636,concept,0,0
236637,that,0,0
236638,oxidation,0,0
236639,of,0,0
236640,LDL,0,0
236641,is,0,0
236642,a,0,0
236643,key,0,0
236644,early,0,0
236645,step,0,0
236646,in,0,0
236647,atherogenesis,0,0
236648,.,0,0
236649,The,0,0
236650,most,0,0
236651,consistent,0,0
236652,data,0,0
236653,with,0,0
236654,respect,0,0
236655,to,0,0
236656,micronutrient,0,1
236657,antioxidants,0,1
236658,and,0,1
236659,atherosclerosis,0,0
236660,appear,0,0
236661,to,0,0
236662,relate,0,0
236663,to,0,0
236664,alpha-tocopherol,1,1
236665,(,0,1
236666,AT,0,1
236667,),0,1
236668,",",0,0
236669,the,0,0
236670,predominant,0,0
236671,lipid-soluble,0,1
236672,antioxidant,0,1
236673,in,0,1
236674,LDL,0,1
236675,.,0,0
236676,There,0,0
236677,are,0,0
236678,scant,0,0
236679,data,0,0
236680,on,0,0
236681,the,0,0
236682,direct,0,0
236683,comparison,0,0
236684,of,0,0
236685,RRR-AT,0,1
236686,and,0,1
236687,all-racemic,0,1
236688,(,0,1
236689,rac,0,1
236690,),0,0
236691,-AT,0,1
236692,on,0,0
236693,LDL,0,1
236694,oxidizability,0,1
236695,.,0,0
236696,Hence,0,0
236697,",",0,0
236698,the,0,0
236699,aim,0,0
236700,of,0,0
236701,the,0,0
236702,present,0,0
236703,study,0,0
236704,was,0,0
236705,to,0,0
236706,examine,0,0
236707,the,0,0
236708,relative,0,0
236709,effects,0,0
236710,of,0,0
236711,RRR-AT,0,1
236712,and,0,0
236713,all-rac-AT,0,1
236714,on,0,1
236715,plasma,0,1
236716,antioxidant,0,1
236717,levels,0,1
236718,and,0,0
236719,LDL,0,0
236720,oxidation,0,0
236721,in,0,0
236722,healthy,0,0
236723,persons,0,0
236724,in,0,0
236725,a,0,0
236726,dose-response,0,1
236727,study,0,0
236728,.,0,0
236729,The,0,0
236730,effect,0,0
236731,of,0,0
236732,RRR-AT,1,1
236733,and,1,0
236734,all-rac-AT,1,1
236735,at,0,1
236736,doses,0,1
236737,of,0,0
236738,100,0,0
236739,",",0,0
236740,200,0,0
236741,",",0,0
236742,400,0,0
236743,",",0,0
236744,and,0,0
236745,800,0,0
236746,IU/d,0,1
236747,on,0,0
236748,plasma,0,0
236749,and,0,0
236750,LDL,0,1
236751,AT,0,1
236752,levels,0,0
236753,and,0,0
236754,LDL,0,0
236755,oxidation,0,0
236756,was,0,0
236757,tested,0,0
236758,in,0,0
236759,a,0,0
236760,randomized,0,0
236761,",",0,0
236762,placebo-controlled,0,1
236763,study,0,0
236764,of,0,0
236765,79,0,0
236766,healthy,0,0
236767,subjects,0,0
236768,.,0,0
236769,Copper-catalyzed,0,1
236770,oxidation,0,0
236771,of,0,0
236772,LDL,0,0
236773,was,0,0
236774,monitored,0,0
236775,by,0,0
236776,measuring,0,0
236777,the,0,0
236778,formation,0,0
236779,of,0,0
236780,conjugated,0,1
236781,dienes,0,1
236782,and,0,1
236783,lipid,0,1
236784,peroxides,0,1
236785,over,0,0
236786,an,0,0
236787,8-hour,0,1
236788,time,0,0
236789,course,0,0
236790,at,0,0
236791,baseline,0,0
236792,and,0,0
236793,again,0,0
236794,after,0,0
236795,8,0,0
236796,weeks,0,0
236797,.,0,0
236798,Plasma,0,1
236799,AT,0,1
236800,",",0,0
236801,lipid-standardized,0,0
236802,AT,0,1
236803,",",0,0
236804,and,0,0
236805,LDL,0,1
236806,AT,0,0
236807,levels,0,0
236808,rose,0,0
236809,in,0,0
236810,a,0,0
236811,dose-dependent,0,0
236812,fashion,0,0
236813,in,0,0
236814,both,0,0
236815,the,0,0
236816,RRR-AT,0,1
236817,and,0,1
236818,all-rac-AT,0,1
236819,groups,0,0
236820,compared,0,0
236821,with,0,0
236822,baseline,0,0
236823,.,0,0
236824,There,0,0
236825,were,0,0
236826,no,0,0
236827,significant,0,0
236828,differences,0,0
236829,in,0,0
236830,plasma,0,1
236831,",",0,0
236832,lipid-standardized,0,0
236833,",",0,0
236834,and,0,0
236835,LDL,0,1
236836,AT,0,0
236837,levels,0,0
236838,between,0,0
236839,RRR-AT,0,1
236840,and,0,1
236841,all-rac-AT,0,1
236842,supplementation,0,1
236843,at,0,1
236844,any,0,0
236845,dose,0,1
236846,comparison,0,0
236847,.,0,0
236848,The,0,0
236849,lag,0,0
236850,phases,0,0
236851,of,0,0
236852,oxidation,0,0
236853,were,0,0
236854,significantly,0,0
236855,prolonged,0,0
236856,with,0,0
236857,doses,0,1
236858,>,0,0
236859,or,0,0
236860,=,0,0
236861,400,0,0
236862,IU/d,0,0
236863,of,0,0
236864,RRR-AT,0,1
236865,and,0,0
236866,all-rac-AT,0,1
236867,",",0,0
236868,as,0,0
236869,measured,0,0
236870,by,0,0
236871,conjugated-dienes,0,1
236872,assay,0,0
236873,and,0,0
236874,at,0,0
236875,400,0,0
236876,IU/d,0,0
236877,of,0,0
236878,RRR-AT,0,1
236879,and,0,0
236880,800,0,0
236881,IU/d,0,1
236882,of,0,0
236883,both,0,0
236884,forms,0,0
236885,of,0,0
236886,AT,0,0
236887,by,0,0
236888,lipid,0,0
236889,peroxide,0,0
236890,assay,0,0
236891,.,0,0
236892,Again,0,0
236893,",",0,0
236894,there,0,0
236895,were,0,0
236896,no,0,0
236897,significant,0,0
236898,differences,0,0
236899,in,0,0
236900,the,0,0
236901,lag,0,0
236902,phase,0,0
236903,of,0,0
236904,oxidation,0,0
236905,at,0,0
236906,each,0,0
236907,dose,0,1
236908,for,0,0
236909,RRR-AT,0,0
236910,when,0,0
236911,compared,0,0
236912,with,0,0
236913,all-rac-AT,0,1
236914,.,0,0
236915,Also,0,0
236916,",",0,0
236917,there,0,0
236918,were,0,0
236919,no,0,0
236920,significant,0,0
236921,differences,0,0
236922,in,0,0
236923,LDL,0,0
236924,oxidation,0,0
236925,after,0,0
236926,in,0,0
236927,vitro,0,0
236928,enrichment,0,0
236929,of,0,0
236930,LDL,0,0
236931,with,0,0
236932,RRR-AT,0,0
236933,and,0,0
236934,all-rac-AT,0,1
236935,.,0,1
236936,Thus,0,1
236937,",",0,0
236938,supplementation,0,1
236939,with,0,0
236940,either,0,0
236941,RRR-AT,0,0
236942,or,0,0
236943,all-rac-AT,0,1
236944,resulted,0,0
236945,in,0,0
236946,similar,0,0
236947,increases,0,0
236948,in,0,0
236949,plasma,0,1
236950,and,0,0
236951,LDL,0,1
236952,AT,0,0
236953,levels,0,0
236954,at,0,0
236955,equivalent,0,0
236956,IU,0,1
236957,doses,0,1
236958,",",0,0
236959,and,0,0
236960,the,0,0
236961,degree,0,0
236962,of,0,0
236963,protection,0,0
236964,against,0,0
236965,copper-catalyzed,0,1
236966,LDL,0,1
236967,oxidation,0,0
236968,was,0,0
236969,only,0,0
236970,evident,0,0
236971,at,0,0
236972,doses,0,1
236973,>,0,0
236974,or,0,0
236975,=,0,0
236976,400,0,0
236977,IU/d,0,0
236978,for,0,0
236979,both,0,0
236980,forms,0,0
236981,.,0,0
236982,The,0,0
236983,influence,0,0
236984,of,0,0
236985,type,1,0
236986,of,1,0
236987,incision,1,0
236988,on,0,0
236989,the,0,0
236990,success,0,0
236991,rate,0,0
236992,of,0,0
236993,implant,0,0
236994,integration,0,0
236995,at,0,0
236996,stage,0,0
236997,II,0,0
236998,uncovering,0,0
236999,surgery,1,0
237000,.,1,0
237001,In,0,0
237002,1991,0,0
237003,",",0,0
237004,the,0,0
237005,Dental,0,0
237006,Implant,0,0
237007,Clinical,0,0
237008,Research,0,0
237009,Group,0,0
237010,comprising,0,0
237011,30,0,0
237012,Department,0,0
237013,of,0,0
237014,Veterans,0,0
237015,Affairs,0,0
237016,medical,0,0
237017,centers,0,0
237018,and,0,0
237019,two,0,0
237020,dental,0,0
237021,schools,0,0
237022,initiated,0,0
237023,a,0,0
237024,long-term,0,0
237025,clinical,0,0
237026,study,0,0
237027,to,0,0
237028,investigate,0,0
237029,the,0,0
237030,clinical,0,0
237031,performance,0,0
237032,of,0,0
237033,implants,1,0
237034,within,0,0
237035,the,0,0
237036,Spectra-System,0,1
237037,(,0,0
237038,Core-Vent,0,0
237039,Corporation,0,0
237040,",",0,0
237041,Las,0,0
237042,Vegas,0,1
237043,",",0,1
237044,NV,0,1
237045,),0,1
237046,.,0,0
237047,This,0,0
237048,article,0,0
237049,focuses,0,0
237050,on,0,0
237051,a,0,0
237052,portion,0,0
237053,of,0,0
237054,the,0,0
237055,study,0,0
237056,database,0,0
237057,related,0,0
237058,to,0,0
237059,incision,0,0
237060,type,0,0
237061,",",0,0
237062,implant,0,0
237063,success,0,0
237064,rates,0,0
237065,",",0,0
237066,and,0,0
237067,response,0,0
237068,of,0,0
237069,crestal,0,0
237070,bone,0,0
237071,up,0,0
237072,to,0,0
237073,the,0,0
237074,time,0,0
237075,of,0,0
237076,surgical,1,0
237077,uncovering,1,0
237078,.,1,0
237079,The,0,0
237080,crestal,1,0
237081,incision,1,0
237082,was,0,0
237083,used,0,0
237084,for,0,0
237085,"1,705",0,0
237086,implants,0,0
237087,(,0,0
237088,381,0,0
237089,patients,0,0
237090,),0,0
237091,and,0,0
237092,the,0,0
237093,remote,1,0
237094,incision,1,0
237095,for,0,0
237096,593,0,0
237097,implants,0,0
237098,(,0,0
237099,141,0,0
237100,patients,0,0
237101,),0,0
237102,.,0,0
237103,No,0,1
237104,statistically,0,0
237105,significant,0,0
237106,difference,0,0
237107,(,0,0
237108,P,0,0
237109,=,0,0
237110,.092,0,0
237111,chi-square,0,0
237112,statistic,0,0
237113,),0,0
237114,was,0,0
237115,found,0,0
237116,in,0,0
237117,implant,0,0
237118,integration,0,0
237119,or,0,0
237120,the,0,0
237121,response,0,0
237122,of,0,0
237123,crestal,0,0
237124,bone,0,0
237125,.,0,0
237126,A,0,1
237127,carbohydrate,1,1
237128,meal,1,1
237129,attenuates,0,0
237130,the,0,0
237131,forearm,0,0
237132,vasoconstrictor,0,1
237133,response,0,0
237134,to,0,0
237135,lower,0,0
237136,body,0,0
237137,subatmospheric,0,0
237138,pressure,0,0
237139,in,0,0
237140,healthy,0,0
237141,young,0,0
237142,adults,0,0
237143,.,0,0
237144,The,0,0
237145,cardiovascular,0,0
237146,(,0,0
237147,CV,0,1
237148,),0,0
237149,responses,0,0
237150,to,0,1
237151,meal,1,1
237152,ingestion,1,1
237153,and,0,1
237154,orthostasis,0,0
237155,are,0,0
237156,well,0,0
237157,established,0,0
237158,.,0,0
237159,The,0,0
237160,effect,0,0
237161,of,0,0
237162,meal,0,1
237163,ingestion,0,1
237164,and,0,1
237165,meal,0,1
237166,composition,0,0
237167,on,0,0
237168,the,0,0
237169,CV,0,0
237170,responses,0,0
237171,to,0,0
237172,orthostasis,0,0
237173,are,0,0
237174,unknown,0,0
237175,.,0,0
237176,The,0,0
237177,effect,0,0
237178,of,0,0
237179,high,1,0
237180,carbohydrate,1,1
237181,(,1,1
237182,HC,1,1
237183,),1,1
237184,and,1,0
237185,high,1,0
237186,fat,1,1
237187,(,1,1
237188,HF,1,1
237189,),1,1
237190,meal,1,1
237191,ingestion,1,1
237192,on,0,0
237193,the,0,0
237194,CV,0,0
237195,responses,0,0
237196,to,0,0
237197,simulated,0,0
237198,orthostatic,0,0
237199,stress,0,0
237200,(,0,0
237201,using,0,0
237202,graded,0,0
237203,lower,0,0
237204,body,0,0
237205,subatmospheric,0,1
237206,pressure,0,1
237207,(,0,1
237208,LBSP,0,1
237209,),0,1
237210,),0,0
237211,was,0,0
237212,assessed,0,0
237213,in,0,0
237214,nine,0,0
237215,healthy,0,0
237216,young,0,0
237217,volunteers,0,0
237218,.,0,0
237219,Cardiac,0,0
237220,output,0,1
237221,(,0,1
237222,CO,0,1
237223,),0,1
237224,",",0,0
237225,forearm,0,0
237226,blood,0,1
237227,flow,0,0
237228,(,0,1
237229,FABF,0,1
237230,),0,1
237231,heart,0,1
237232,rate,0,0
237233,(,0,1
237234,HR,0,1
237235,),0,1
237236,and,0,0
237237,blood,0,1
237238,pressure,0,1
237239,(,0,1
237240,BP,0,1
237241,),0,0
237242,were,0,0
237243,measured,0,0
237244,before,0,0
237245,and,0,0
237246,during,0,0
237247,LBSP,0,1
237248,while,0,0
237249,fasted,0,1
237250,and,0,0
237251,after,0,0
237252,eating,1,0
237253,HC,1,0
237254,and,1,0
237255,HF,1,1
237256,meals,1,1
237257,.,1,1
237258,Ingestion,0,0
237259,of,0,0
237260,both,0,0
237261,meals,0,1
237262,led,0,0
237263,to,0,0
237264,an,0,0
237265,increase,0,0
237266,in,0,0
237267,CO,0,0
237268,and,0,0
237269,HR,0,0
237270,.,0,1
237271,Both,0,1
237272,meals,0,1
237273,resulted,0,0
237274,in,0,0
237275,a,0,0
237276,fall,0,0
237277,in,0,0
237278,total,0,0
237279,peripheral,0,0
237280,resistance,0,0
237281,but,0,0
237282,only,0,0
237283,HC,0,0
237284,led,0,0
237285,to,0,0
237286,a,0,0
237287,significant,0,0
237288,fall,0,0
237289,in,0,0
237290,BP,0,0
237291,(,0,0
237292,p,0,0
237293,<,0,0
237294,0.05,0,0
237295,),0,0
237296,.,0,0
237297,HF,0,0
237298,had,0,0
237299,no,0,0
237300,effect,0,0
237301,on,0,0
237302,the,0,0
237303,CV,0,0
237304,responses,0,0
237305,to,0,0
237306,LBSP,0,0
237307,",",0,0
237308,whereas,0,0
237309,HC,0,0
237310,resulted,0,0
237311,in,0,0
237312,attenuated,0,0
237313,FABF,0,0
237314,and,0,0
237315,forearm,0,0
237316,vascular,0,0
237317,resistance,0,0
237318,responses,0,0
237319,(,0,0
237320,p,0,0
237321,<,0,0
237322,0.05,0,0
237323,),0,0
237324,.,0,0
237325,Thus,0,0
237326,",",0,0
237327,ingestion,0,1
237328,of,0,0
237329,an,0,0
237330,HC,1,1
237331,meal,1,1
237332,significantly,0,0
237333,attenuates,0,0
237334,the,0,0
237335,forearm,0,0
237336,vascular,0,0
237337,response,0,0
237338,to,0,0
237339,orthostatic,0,0
237340,stress,0,0
237341,and,0,0
237342,the,0,0
237343,hypotensive,0,1
237344,effect,0,0
237345,of,0,0
237346,orthostasis,0,0
237347,is,0,0
237348,additive,0,0
237349,to,0,0
237350,that,0,0
237351,occurring,0,0
237352,after,0,0
237353,an,0,0
237354,HC,0,1
237355,meal,0,1
237356,.,0,0
237357,[,0,1
237358,Value,0,1
237359,of,0,0
237360,absorbable,1,1
237361,clips,1,1
237362,in,0,0
237363,laparoscopic,1,0
237364,cholecystectomy,1,0
237365,.,1,0
237366,A,0,0
237367,randomized,0,0
237368,prospective,0,1
237369,study,0,0
237370,],0,0
237371,.,0,0
237372,Most,0,0
237373,surgeons,0,0
237374,use,0,0
237375,metal,0,0
237376,clips,0,0
237377,in,0,0
237378,laparoscopic,1,0
237379,cholecystectomy,1,0
237380,.,1,0
237381,The,0,0
237382,aim,0,0
237383,of,0,0
237384,this,0,0
237385,prospective,0,0
237386,randomized,0,0
237387,controlled,0,0
237388,study,0,0
237389,was,0,0
237390,to,0,0
237391,evaluate,0,0
237392,the,0,0
237393,efficacy,0,0
237394,of,0,0
237395,absorbable,1,1
237396,clips,1,1
237397,in,0,0
237398,elective,1,0
237399,laparoscopic,1,0
237400,cholecystectomy,1,0
237401,.,1,0
237402,One,0,0
237403,hundred,0,0
237404,consecutive,0,0
237405,patients,0,0
237406,with,0,0
237407,symptomatic,0,0
237408,gallstones,0,0
237409,without,0,0
237410,complications,0,0
237411,were,0,0
237412,randomized,0,0
237413,into,0,0
237414,groups,0,0
237415,;,0,0
237416,group,0,0
237417,T,0,0
237418,had,0,0
237419,two,1,0
237420,metal,1,0
237421,clips,1,0
237422,(,1,0
237423,titan,1,0
237424,clip,1,1
237425,ETHICONR,1,1
237426,),1,1
237427,",",0,0
237428,group,0,1
237429,R,0,1
237430,(,1,1
237431,laproclipR,1,0
237432,Davis,1,1
237433,and,1,1
237434,Geck,1,1
237435,),1,0
237436,had,0,0
237437,one,1,0
237438,absorbable,1,1
237439,clip,1,1
237440,applied,1,0
237441,on,1,0
237442,the,1,0
237443,cystic,1,0
237444,duct,1,0
237445,and,1,0
237446,cystic,1,0
237447,artery,1,0
237448,.,1,0
237449,The,0,0
237450,patients,0,0
237451,were,0,0
237452,followed,0,0
237453,for,0,0
237454,one,0,0
237455,year,0,0
237456,.,0,0
237457,There,0,0
237458,was,0,0
237459,no,0,0
237460,difference,0,0
237461,between,0,0
237462,the,0,0
237463,two,0,0
237464,groups,0,0
237465,concerning,0,0
237466,operative,0,0
237467,time,0,0
237468,",",0,0
237469,hospital,0,0
237470,stay,0,0
237471,and,0,0
237472,postoperative,0,0
237473,complications,0,0
237474,.,0,0
237475,The,0,0
237476,absorbable,1,1
237477,clips,1,0
237478,seem,0,0
237479,to,0,0
237480,be,0,0
237481,as,0,0
237482,effective,0,0
237483,as,0,0
237484,metal,1,0
237485,clips,1,0
237486,in,0,0
237487,providing,0,0
237488,hemostasis,0,0
237489,in,0,0
237490,cystic,0,0
237491,artery,0,0
237492,and,0,0
237493,in,0,0
237494,cystic,0,0
237495,duct,0,0
237496,ligation,0,0
237497,.,0,0
237498,Incidence,0,0
237499,and,0,0
237500,clinical,0,0
237501,significance,0,0
237502,of,0,0
237503,false-negative,0,0
237504,sextant,0,0
237505,prostate,0,0
237506,biopsies,0,0
237507,.,0,0
237508,PURPOSE,0,0
237509,Since,0,0
237510,most,0,0
237511,patients,0,0
237512,do,0,0
237513,not,0,0
237514,undergo,0,0
237515,repeat,0,0
237516,sextant,0,0
237517,prostate,0,0
237518,biopsies,0,0
237519,after,0,0
237520,a,0,0
237521,biopsy,0,0
237522,is,0,0
237523,positive,0,0
237524,for,0,0
237525,prostate,0,0
237526,cancer,0,0
237527,",",0,0
237528,the,0,0
237529,true,0,0
237530,incidence,0,0
237531,of,0,0
237532,false-negative,0,0
237533,biopsies,0,0
237534,is,0,0
237535,not,0,0
237536,well,0,0
237537,defined,0,0
237538,.,0,0
237539,We,0,0
237540,assess,0,0
237541,the,0,0
237542,incidence,0,0
237543,and,0,0
237544,clinical,0,0
237545,significance,0,0
237546,of,0,0
237547,false-negative,0,0
237548,sextant,0,0
237549,prostate,0,0
237550,biopsies,0,0
237551,in,0,0
237552,patients,0,0
237553,undergoing,0,0
237554,radical,1,0
237555,prostatectomy,1,0
237556,.,1,0
237557,MATERIALS,0,0
237558,AND,0,1
237559,METHODS,0,1
237560,A,0,0
237561,total,0,0
237562,of,0,0
237563,118,0,0
237564,patients,0,0
237565,with,0,0
237566,biopsy,0,0
237567,proved,0,0
237568,prostate,0,0
237569,cancer,0,0
237570,underwent,0,0
237571,repeat,1,0
237572,sextant,1,1
237573,prostate,1,0
237574,biopsy,1,0
237575,before,0,0
237576,enrollment,0,0
237577,in,0,0
237578,a,0,0
237579,prospective,0,0
237580,randomized,0,0
237581,trial,0,0
237582,of,0,0
237583,radical,1,0
237584,prostatectomy,1,0
237585,with,1,0
237586,or,1,0
237587,without,1,0
237588,neoadjuvant,1,0
237589,hormonal,1,0
237590,therapy,1,0
237591,.,1,0
237592,Clinical,0,0
237593,parameters,0,0
237594,were,0,0
237595,assessed,0,0
237596,to,0,0
237597,determine,0,0
237598,potential,0,0
237599,sources,0,0
237600,of,0,0
237601,bias,0,0
237602,.,0,0
237603,Pathological,0,0
237604,parameters,0,0
237605,and,0,0
237606,prostate,0,0
237607,specific,0,0
237608,antigen,0,0
237609,relapse-free,0,0
237610,survival,0,0
237611,rates,0,0
237612,were,0,0
237613,compared,0,0
237614,to,0,0
237615,determine,0,0
237616,the,0,0
237617,clinical,0,0
237618,significance,0,0
237619,of,0,0
237620,false-negative,0,0
237621,biopsies,0,0
237622,.,0,0
237623,RESULTS,0,0
237624,Of,0,0
237625,the,0,0
237626,118,0,0
237627,patients,0,0
237628,27,0,0
237629,(,0,0
237630,23,0,0
237631,%,0,0
237632,),0,0
237633,had,0,0
237634,a,0,0
237635,negative,0,0
237636,repeat,0,0
237637,sextant,0,0
237638,biopsy,0,0
237639,.,0,0
237640,Except,0,0
237641,for,0,0
237642,initial,0,0
237643,clinical,0,0
237644,stage,0,0
237645,",",0,0
237646,no,0,0
237647,differences,0,0
237648,were,0,0
237649,noted,0,0
237650,in,0,0
237651,the,0,0
237652,clinical,0,0
237653,or,0,0
237654,pathological,0,0
237655,parameters,0,0
237656,",",0,0
237657,or,0,0
237658,prostate,0,0
237659,specific,0,0
237660,antigen,0,0
237661,relapse,0,0
237662,rates,0,0
237663,in,0,0
237664,patients,0,0
237665,with,0,0
237666,negative,0,0
237667,versus,0,0
237668,positive,0,0
237669,repeat,0,0
237670,biopsies,0,0
237671,.,0,0
237672,CONCLUSIONS,0,0
237673,Our,0,0
237674,findings,0,0
237675,suggest,0,0
237676,that,0,0
237677,this,0,0
237678,23,0,0
237679,%,0,0
237680,incidence,0,0
237681,of,0,0
237682,false-negative,0,0
237683,biopsies,0,0
237684,represents,0,0
237685,significant,0,0
237686,cancer,0,0
237687,.,0,0
237688,This,0,0
237689,relatively,0,0
237690,high,0,0
237691,incidence,0,0
237692,is,0,0
237693,important,0,0
237694,to,0,0
237695,consider,0,0
237696,in,0,0
237697,treatment,0,0
237698,modalities,0,0
237699,in,0,0
237700,which,0,0
237701,prostate,0,0
237702,biopsy,0,0
237703,may,0,0
237704,be,0,0
237705,performed,0,0
237706,to,0,0
237707,determine,0,0
237708,response,0,0
237709,to,0,0
237710,therapy,0,0
237711,.,0,0
237712,Efficacy,0,0
237713,of,0,1
237714,intravenous,0,1
237715,granisetron,1,1
237716,to,0,1
237717,control,0,0
237718,nausea,0,1
237719,and,0,1
237720,vomiting,0,0
237721,during,0,0
237722,multiple,0,0
237723,cycles,0,0
237724,of,0,0
237725,cisplatin-based,1,1
237726,chemotherapy,1,1
237727,.,1,0
237728,The,0,0
237729,safety,0,0
237730,and,0,0
237731,efficacy,0,0
237732,of,0,1
237733,granisetron,1,1
237734,(,0,1
237735,10,0,1
237736,micrograms/kg,0,1
237737,and,0,1
237738,40,0,1
237739,micrograms/kg,0,1
237740,),0,1
237741,were,0,0
237742,evaluated,0,0
237743,during,0,0
237744,a,0,0
237745,second,0,0
237746,(,0,0
237747,n,0,0
237748,=,0,0
237749,393,0,0
237750,),0,0
237751,and,0,0
237752,third,0,0
237753,(,0,0
237754,n,0,0
237755,=,0,0
237756,200,0,0
237757,),0,0
237758,cycle,0,0
237759,of,0,0
237760,chemotherapy,0,0
237761,in,0,0
237762,this,0,0
237763,multicenter,0,0
237764,",",0,0
237765,double-blind,0,1
237766,",",0,1
237767,randomized,0,1
237768,",",0,0
237769,parallel-group,0,1
237770,study,0,1
237771,.,0,1
237772,Granisetron,1,1
237773,was,0,0
237774,administered,0,1
237775,as,0,0
237776,a,0,0
237777,single,0,0
237778,intravenous,0,1
237779,dose,0,1
237780,before,0,1
237781,the,0,0
237782,start,0,0
237783,of,0,0
237784,cisplatin,1,1
237785,chemotherapy,1,1
237786,(,0,1
237787,>,0,0
237788,or,0,0
237789,=,0,0
237790,60,0,0
237791,mg/m2,0,1
237792,),0,1
237793,.,0,0
237794,Total,0,0
237795,control,0,0
237796,(,0,0
237797,no,0,0
237798,vomiting,0,0
237799,",",0,0
237800,no,0,0
237801,retching,0,0
237802,",",0,0
237803,no,0,0
237804,nausea,0,1
237805,",",0,0
237806,and,0,0
237807,no,0,0
237808,use,0,0
237809,of,0,0
237810,antiemetic,0,1
237811,rescue,0,1
237812,medication,0,1
237813,),0,0
237814,after,0,0
237815,the,0,0
237816,first,0,0
237817,24,0,0
237818,hr,0,0
237819,following,0,0
237820,chemotherapy,1,0
237821,was,0,0
237822,achieved,0,0
237823,in,0,0
237824,40,0,0
237825,%,0,0
237826,and,0,0
237827,49,0,0
237828,%,0,0
237829,of,0,0
237830,patients,0,0
237831,in,0,0
237832,Cycles,0,0
237833,2,0,0
237834,and,0,0
237835,3,0,0
237836,",",0,0
237837,respectively,0,0
237838,",",0,0
237839,for,0,0
237840,the,0,0
237841,10,0,0
237842,micrograms/kg,0,1
237843,group,0,1
237844,",",0,0
237845,and,0,0
237846,in,0,0
237847,42,0,0
237848,%,0,0
237849,and,0,0
237850,38,0,0
237851,%,0,0
237852,of,0,0
237853,patients,0,0
237854,in,0,0
237855,Cycles,0,0
237856,2,0,0
237857,and,0,0
237858,3,0,0
237859,",",0,0
237860,respectively,0,0
237861,",",0,0
237862,for,0,0
237863,the,0,0
237864,40,0,0
237865,micrograms/kg,0,1
237866,group,0,1
237867,.,0,0
237868,Both,0,1
237869,dose,0,1
237870,levels,0,0
237871,of,0,0
237872,granisetron,1,1
237873,were,0,0
237874,well,0,0
237875,tolerated,0,1
237876,.,0,0
237877,The,0,0
237878,results,0,0
237879,demonstrate,0,0
237880,comparable,0,0
237881,efficacy,0,0
237882,between,0,0
237883,the,0,0
237884,10,0,0
237885,micrograms/kg,0,1
237886,and,0,1
237887,40,0,1
237888,micrograms/kg,0,1
237889,doses,0,1
237890,of,0,1
237891,granisetron,1,1
237892,in,0,0
237893,preventing,0,0
237894,nausea,0,1
237895,and,0,0
237896,vomiting,0,0
237897,during,0,0
237898,repeat,0,0
237899,cycles,0,0
237900,of,0,0
237901,high-dose,0,1
237902,cisplatin-based,1,1
237903,chemotherapy,1,1
237904,.,1,0
237905,The,0,0
237906,results,0,0
237907,of,0,0
237908,this,0,0
237909,study,0,0
237910,show,0,0
237911,that,0,0
237912,granisetron,1,1
237913,10,0,1
237914,micrograms/kg,0,1
237915,is,0,0
237916,safe,0,1
237917,and,0,0
237918,well,0,0
237919,tolerated,0,1
237920,",",0,0
237921,and,0,0
237922,remains,0,0
237923,effective,0,0
237924,with,0,0
237925,repeat,0,0
237926,cycle,0,0
237927,use,0,0
237928,.,0,0
237929,Pruritus,0,0
237930,in,0,0
237931,HIV-1,0,0
237932,disease,0,0
237933,:,0,0
237934,therapy,0,0
237935,with,0,0
237936,drugs,0,1
237937,which,0,0
237938,may,0,0
237939,modulate,0,0
237940,the,0,0
237941,pattern,0,0
237942,of,0,0
237943,immune,0,0
237944,dysregulation,0,0
237945,.,0,0
237946,BACKGROUND,0,0
237947,Pruritus,0,0
237948,in,0,0
237949,HIV-1+,0,0
237950,patients,0,0
237951,is,0,0
237952,common,0,0
237953,and,0,0
237954,increases,0,0
237955,with,0,0
237956,disease,0,0
237957,progression,0,0
237958,.,0,0
237959,The,0,0
237960,causes,0,0
237961,of,0,0
237962,pruritus,0,0
237963,are,0,0
237964,numerous,0,0
237965,including,0,0
237966,xerosis,0,0
237967,",",0,0
237968,drug,0,1
237969,and,0,1
237970,photoeruptions,0,1
237971,",",0,0
237972,follicular,0,0
237973,and,0,0
237974,papular,0,0
237975,eruptions,0,0
237976,as,0,0
237977,well,0,0
237978,as,0,0
237979,infestations,0,0
237980,and,0,0
237981,infections,0,0
237982,by,0,0
237983,a,0,0
237984,wide,0,0
237985,range,0,0
237986,of,0,0
237987,organisms,0,0
237988,.,0,0
237989,One,0,0
237990,other,0,0
237991,possible,0,0
237992,factor,0,0
237993,contributing,0,0
237994,to,0,0
237995,pruritus,0,0
237996,is,0,0
237997,the,0,0
237998,pattern,0,0
237999,of,0,0
238000,immune,0,0
238001,dysregulation,0,0
238002,.,0,0
238003,With,0,0
238004,advancing,0,0
238005,HIV-1,0,0
238006,disease,0,0
238007,there,0,0
238008,is,0,0
238009,Th1,0,0
238010,to,0,0
238011,Th2,0,0
238012,cytokine,0,0
238013,switching,0,0
238014,.,0,0
238015,METHODS,0,0
238016,After,0,0
238017,some,0,0
238018,positive,0,0
238019,results,0,0
238020,with,0,0
238021,prostaglandin,0,1
238022,inhibitors,0,1
238023,",",0,1
238024,we,0,0
238025,undertook,0,0
238026,a,0,0
238027,study,0,0
238028,in,0,0
238029,which,0,0
238030,we,0,0
238031,randomly,0,0
238032,placed,0,0
238033,patients,0,0
238034,on,0,0
238035,four,0,0
238036,different,0,0
238037,forms,0,0
238038,of,0,0
238039,therapy,0,0
238040,for,0,0
238041,their,0,0
238042,pruritus,0,0
238043,.,0,0
238044,The,0,0
238045,therapies,0,0
238046,included,0,0
238047,hydroxyzine,1,1
238048,with,1,1
238049,or,1,0
238050,without,1,0
238051,doxepin,1,1
238052,at,1,0
238053,night,1,1
238054,",",1,0
238055,pentoxifylline,1,1
238056,",",1,1
238057,indomethacin,1,1
238058,and,1,1
238059,topical,1,1
238060,moisturization,1,1
238061,with,1,1
238062,medium-strength,1,0
238063,topical,1,1
238064,steroids,1,1
238065,.,1,1
238066,All,0,0
238067,patients,0,0
238068,were,0,0
238069,evaluated,0,0
238070,for,0,0
238071,both,0,0
238072,subjective,0,0
238073,relief,0,0
238074,as,0,0
238075,well,0,0
238076,as,0,0
238077,side,0,0
238078,effects,0,0
238079,.,0,0
238080,RESULTS,0,0
238081,Patients,0,0
238082,placed,0,0
238083,on,0,0
238084,indomethacin,0,1
238085,obtained,0,0
238086,relief,0,0
238087,more,0,0
238088,consistently,0,0
238089,and,0,0
238090,more,0,0
238091,completely,0,0
238092,.,0,0
238093,Patients,0,0
238094,on,0,0
238095,pentoxifylline,0,1
238096,had,0,0
238097,the,0,0
238098,fewest,0,0
238099,side,0,0
238100,effects,0,0
238101,of,0,0
238102,all,0,0
238103,oral,0,1
238104,therapies,0,1
238105,.,0,0
238106,Patients,0,0
238107,on,0,0
238108,antihistamines,0,1
238109,with,0,0
238110,or,0,0
238111,without,0,0
238112,doxepin,0,1
238113,had,0,0
238114,the,0,0
238115,highest,0,0
238116,incidence,0,0
238117,of,0,0
238118,side,0,0
238119,effects,0,0
238120,",",0,0
238121,although,0,0
238122,more,0,0
238123,of,0,0
238124,these,0,0
238125,patients,0,0
238126,reported,0,0
238127,a,0,0
238128,greater,0,0
238129,degree,0,0
238130,of,0,0
238131,relief,0,0
238132,than,0,0
238133,patients,0,0
238134,on,0,0
238135,pentoxifylline,0,1
238136,.,0,0
238137,All,0,0
238138,patients,0,0
238139,on,0,0
238140,oral,0,1
238141,therapy,0,0
238142,overall,0,0
238143,had,0,0
238144,greater,0,0
238145,relief,0,0
238146,than,0,0
238147,patients,0,0
238148,using,0,0
238149,topical,0,1
238150,steroids,0,1
238151,.,0,1
238152,CONCLUSION,0,0
238153,The,0,0
238154,systemic,0,0
238155,therapies,0,0
238156,which,0,0
238157,may,0,0
238158,modulate,0,0
238159,the,0,0
238160,pattern,0,0
238161,of,0,0
238162,immune,0,0
238163,dysregulation,0,0
238164,seen,0,0
238165,in,0,0
238166,HIV-1,0,0
238167,disease,0,0
238168,may,0,0
238169,be,0,0
238170,beneficial,0,0
238171,in,0,0
238172,the,0,0
238173,pruritus,0,0
238174,seen,0,0
238175,in,0,0
238176,late-stage,0,0
238177,patients,0,0
238178,.,0,0
238179,Interfering,0,0
238180,with,0,0
238181,the,0,0
238182,central,0,0
238183,executive,0,0
238184,by,0,0
238185,means,0,0
238186,of,0,0
238187,a,0,0
238188,random,1,0
238189,interval,1,0
238190,repetition,1,0
238191,task,1,0
238192,.,1,0
238193,Four,0,0
238194,dual-task,0,0
238195,experiments,0,0
238196,are,0,0
238197,reported,0,0
238198,in,0,0
238199,which,0,0
238200,a,0,0
238201,short-term,1,0
238202,memory,1,0
238203,task,1,0
238204,is,0,0
238205,performed,0,0
238206,concurrently,0,0
238207,with,0,0
238208,a,0,0
238209,random,1,0
238210,interval,1,0
238211,repetition,1,0
238212,task,1,0
238213,",",0,0
238214,which,0,0
238215,was,0,0
238216,designed,0,0
238217,to,0,0
238218,interfere,0,0
238219,with,0,0
238220,functions,0,0
238221,normally,0,0
238222,attributed,0,0
238223,to,0,0
238224,the,0,0
238225,central,0,0
238226,executive,0,0
238227,in,0,0
238228,the,0,0
238229,working,0,0
238230,memory,0,0
238231,model,0,0
238232,of,0,0
238233,Baddeley,0,0
238234,and,0,0
238235,Hitch,0,1
238236,(,0,1
238237,1974,0,1
238238,),0,0
238239,.,0,0
238240,The,0,0
238241,task,1,0
238242,was,0,0
238243,found,0,0
238244,to,0,0
238245,interfere,0,0
238246,with,0,0
238247,supra-span,0,0
238248,serial,0,0
238249,recall,0,0
238250,and,0,0
238251,with,0,0
238252,backward,0,0
238253,memory,0,0
238254,span,0,0
238255,",",0,0
238256,but,0,0
238257,did,0,0
238258,not,0,0
238259,disrupt,0,0
238260,performance,0,0
238261,on,0,0
238262,a,0,0
238263,forward-memory-span,1,0
238264,task,1,0
238265,.,1,0
238266,The,0,0
238267,effects,0,0
238268,were,0,0
238269,observed,0,0
238270,in,0,0
238271,dissociation,0,0
238272,with,0,0
238273,effects,0,0
238274,of,0,0
238275,articulatory,0,0
238276,suppression,0,0
238277,and,0,0
238278,matrix,0,0
238279,tapping,0,0
238280,",",0,0
238281,so,0,0
238282,that,0,0
238283,the,0,0
238284,locus,0,0
238285,of,0,0
238286,the,0,0
238287,effects,0,0
238288,of,0,0
238289,the,0,0
238290,new,0,0
238291,task,0,0
238292,is,0,0
238293,not,0,0
238294,due,0,0
238295,to,0,0
238296,the,0,0
238297,slave,0,0
238298,systems,0,0
238299,.,0,0
238300,In,0,0
238301,addition,0,0
238302,",",0,0
238303,single-task,1,0
238304,random-interval,1,1
238305,repetition,0,0
238306,performance,0,0
238307,was,0,0
238308,sampled,0,0
238309,and,0,0
238310,compared,0,0
238311,to,0,0
238312,performance,0,0
238313,in,0,0
238314,the,0,0
238315,dual-task,1,0
238316,conditions,0,0
238317,of,0,0
238318,all,0,0
238319,four,0,0
238320,experiments,0,0
238321,.,0,0
238322,Although,0,0
238323,quality,0,0
238324,of,0,0
238325,tapping,0,0
238326,performance,0,0
238327,differed,0,0
238328,between,0,0
238329,the,0,0
238330,single-task,1,0
238331,and,0,0
238332,the,0,0
238333,dual-task,1,0
238334,conditions,0,0
238335,",",0,0
238336,it,0,0
238337,was,0,0
238338,not,0,0
238339,related,0,0
238340,to,0,0
238341,recall,0,0
238342,performance,0,0
238343,.,0,0
238344,All,0,0
238345,the,0,0
238346,results,0,0
238347,are,0,0
238348,discussed,0,0
238349,with,0,0
238350,reference,0,0
238351,to,0,0
238352,the,0,0
238353,working,0,0
238354,memory,0,0
238355,model,0,0
238356,.,0,0
238357,Determinants,0,0
238358,of,0,0
238359,total,0,0
238360,and,0,0
238361,specific,0,0
238362,IgE,0,0
238363,in,0,0
238364,infants,0,0
238365,with,0,0
238366,atopic,0,0
238367,dermatitis,0,0
238368,.,0,0
238369,ETAC,0,0
238370,Study,0,0
238371,Group,0,0
238372,.,0,0
238373,Early,0,0
238374,Treatment,0,0
238375,of,0,0
238376,the,0,0
238377,Atopic,0,0
238378,Child,0,0
238379,.,0,0
238380,ETAC,0,1
238381,(,0,0
238382,Early,0,0
238383,Treatment,0,0
238384,of,0,0
238385,the,0,0
238386,Atopic,0,0
238387,Child,0,0
238388,),0,0
238389,",",0,0
238390,a,0,0
238391,multi-centre,0,0
238392,predominantly,0,0
238393,European,0,0
238394,study,0,0
238395,to,0,0
238396,investigate,0,0
238397,the,0,0
238398,potential,0,0
238399,for,0,0
238400,cetirizine,1,1
238401,to,0,0
238402,prevent,0,0
238403,the,0,0
238404,development,0,0
238405,of,0,0
238406,asthma,0,0
238407,in,0,0
238408,infants,0,0
238409,with,0,0
238410,atopic,0,0
238411,dermatitis,0,0
238412,has,0,0
238413,completed,0,0
238414,enrollment,0,0
238415,:,0,0
238416,817,0,0
238417,children,0,0
238418,have,0,0
238419,been,0,0
238420,randomised,0,0
238421,to,0,0
238422,18,0,0
238423,months,0,0
238424,',0,0
238425,treatment,0,0
238426,with,0,0
238427,either,0,0
238428,active,1,0
238429,or,0,0
238430,placebo,1,1
238431,and,0,0
238432,a,0,0
238433,subsequent,0,0
238434,18,0,0
238435,months,0,0
238436,of,0,0
238437,post-treatment,0,0
238438,follow-up,0,0
238439,.,0,0
238440,Results,0,0
238441,of,0,0
238442,the,0,0
238443,therapeutic,0,0
238444,effects,0,0
238445,will,0,0
238446,not,0,0
238447,be,0,0
238448,available,0,0
238449,for,0,0
238450,some,0,0
238451,time,0,0
238452,",",0,0
238453,but,0,0
238454,the,0,0
238455,study,0,0
238456,has,0,0
238457,provided,0,0
238458,an,0,0
238459,opportunity,0,0
238460,to,0,0
238461,investigate,0,0
238462,influences,0,0
238463,on,0,0
238464,sensitization,0,0
238465,to,0,0
238466,allergens,0,1
238467,in,0,0
238468,a,0,0
238469,large,0,0
238470,cohort,0,0
238471,of,0,0
238472,1-2,0,0
238473,years,0,1
238474,olds,0,1
238475,with,0,0
238476,already,0,0
238477,established,0,0
238478,atopic,0,0
238479,dermatitis,0,0
238480,",",0,0
238481,resident,0,0
238482,in,0,0
238483,different,0,0
238484,countries,0,0
238485,and,0,0
238486,in,0,0
238487,different,0,0
238488,environments,0,0
238489,.,0,0
238490,The,0,0
238491,study,0,0
238492,shows,0,0
238493,that,0,0
238494,in,0,0
238495,infants,0,0
238496,with,0,0
238497,atopic,0,0
238498,dermatitis,0,0
238499,",",0,0
238500,raised,0,0
238501,serum,0,1
238502,total,0,0
238503,IgE,0,0
238504,has,0,0
238505,significantly,0,0
238506,different,0,0
238507,determinants,0,0
238508,from,0,0
238509,that,0,0
238510,a,0,0
238511,specific,0,0
238512,allergen,0,1
238513,sensitization,0,0
238514,.,0,0
238515,In,0,0
238516,infancy,0,0
238517,",",0,0
238518,increased,0,0
238519,total,0,0
238520,IgE,0,0
238521,is,0,0
238522,more,0,0
238523,affected,0,0
238524,by,0,0
238525,factors,0,0
238526,increasing,0,0
238527,risk,0,0
238528,of,0,0
238529,intercurrent,0,0
238530,infection,0,0
238531,and,0,0
238532,non-specific,0,0
238533,airway,0,0
238534,inflammation,0,0
238535,",",0,0
238536,such,0,0
238537,as,0,0
238538,environmental,0,0
238539,tobacco,0,0
238540,smoke,0,0
238541,exposure,0,0
238542,(,0,0
238543,p,0,0
238544,<,0,0
238545,0.001,0,0
238546,),0,0
238547,and,0,0
238548,the,0,0
238549,use,0,0
238550,of,0,0
238551,gas,0,0
238552,cookers,0,0
238553,(,0,0
238554,p,0,0
238555,=,0,0
238556,0.02,0,0
238557,),0,0
238558,.,0,0
238559,Specific,0,0
238560,allergen,0,1
238561,sensitization,0,0
238562,as,0,0
238563,represented,0,0
238564,by,0,0
238565,detectable,0,0
238566,IgE,0,0
238567,antibodies,0,0
238568,is,0,0
238569,influenced,0,0
238570,primarily,0,0
238571,by,0,0
238572,allergen,0,1
238573,exposure,0,0
238574,.,0,0
238575,In,0,0
238576,Sweden,0,0
238577,",",0,0
238578,low,0,0
238579,level,0,0
238580,exposure,0,0
238581,to,0,0
238582,allergens,0,1
238583,is,0,0
238584,associated,0,0
238585,with,0,0
238586,reduced,0,0
238587,specific,0,0
238588,allergen,0,1
238589,sensitization,0,0
238590,rates,0,0
238591,even,0,0
238592,though,0,0
238593,the,0,0
238594,infants,0,0
238595,already,0,0
238596,have,0,0
238597,atopic,0,0
238598,dermatitis,0,0
238599,.,0,0
238600,[,0,1
238601,Treatment,0,0
238602,of,0,0
238603,irresectable,0,0
238604,hepatocellular,0,0
238605,carcinoma,0,0
238606,with,0,0
238607,repeated,1,0
238608,transient,1,0
238609,dearterialization,1,0
238610,],1,0
238611,.,0,0
238612,A,0,1
238613,joint,0,0
238614,clinical,0,0
238615,prospective,0,0
238616,study,0,0
238617,between,0,0
238618,SUMS,0,0
238619,and,0,0
238620,Lund,0,0
238621,university,0,0
238622,was,0,0
238623,reported,0,0
238624,.,0,0
238625,40,0,0
238626,patients,0,0
238627,with,0,0
238628,the,0,0
238629,irresectable,0,0
238630,hepatocellular,0,1
238631,carcinoma,0,1
238632,(,0,1
238633,HCC,0,1
238634,),0,1
238635,admitted,0,0
238636,to,0,0
238637,the,0,0
238638,department,0,0
238639,of,0,0
238640,HPB,0,0
238641,surgery,0,0
238642,in,0,0
238643,the,0,0
238644,First,0,0
238645,Affiliated,0,0
238646,Hospital,0,0
238647,of,0,0
238648,SUMS,0,0
238649,were,0,0
238650,randomized,0,0
238651,into,0,0
238652,two,0,0
238653,groups,0,0
238654,:,0,0
238655,(,0,0
238656,20,0,0
238657,each,0,0
238658,),0,0
238659,from,0,0
238660,Feb.,0,1
238661,1994,0,0
238662,to,0,0
238663,April,0,1
238664,",",0,0
238665,1995,0,0
238666,.,0,0
238667,The,0,0
238668,patients,0,0
238669,were,0,0
238670,treated,0,0
238671,with,0,0
238672,hepatic,1,0
238673,artery,1,0
238674,ligation,1,0
238675,(,1,1
238676,HAL,1,1
238677,),1,1
238678,and,1,0
238679,repeated,1,0
238680,transient,1,0
238681,dearterialization,1,0
238682,(,1,1
238683,RTD,1,1
238684,),1,0
238685,respectively,0,0
238686,.,0,0
238687,Postoperative,0,0
238688,response,0,0
238689,to,0,0
238690,treatment,0,0
238691,",",0,0
238692,liver,0,0
238693,function,0,0
238694,change,0,0
238695,(,0,0
238696,ALT,0,1
238697,),0,1
238698,",",0,0
238699,AFP,0,1
238700,",",0,0
238701,imaging,0,0
238702,examination,0,0
238703,of,0,0
238704,the,0,0
238705,tumor,0,0
238706,",",0,0
238707,patient,0,0
238708,'s,0,0
238709,survival,0,0
238710,were,0,0
238711,evaluated,0,0
238712,.,0,0
238713,It,0,0
238714,has,0,0
238715,been,0,0
238716,shown,0,0
238717,that,0,0
238718,RTD,1,0
238719,is,0,0
238720,superior,0,0
238721,to,0,0
238722,HAL,0,0
238723,in,0,0
238724,terms,0,0
238725,of,0,0
238726,the,0,0
238727,objective,0,0
238728,response,0,0
238729,to,0,0
238730,the,0,0
238731,therapy,0,0
238732,",",0,0
238733,reduction,0,0
238734,of,0,0
238735,tumor,0,0
238736,size,0,0
238737,",",0,0
238738,patient,0,0
238739,'s,0,1
238740,symptom,0,0
238741,relief,0,0
238742,",",0,0
238743,liver,0,0
238744,function,0,0
238745,and,0,0
238746,AFP,0,0
238747,changes,0,0
238748,and,0,0
238749,patient,0,0
238750,'s,0,0
238751,survival,0,0
238752,.,0,0
238753,In,0,0
238754,the,0,0
238755,RTD,1,0
238756,group,0,0
238757,",",0,0
238758,the,0,0
238759,effective,0,0
238760,rate,0,0
238761,was,0,0
238762,70,0,0
238763,%,0,0
238764,",",0,0
238765,the,0,0
238766,mean,0,0
238767,survival,0,0
238768,time,0,0
238769,was,0,0
238770,8.2,0,0
238771,months,0,0
238772,",",0,0
238773,and,0,0
238774,the,0,0
238775,6-month,0,0
238776,survival,0,0
238777,rate,0,0
238778,was,0,0
238779,79.7,0,0
238780,%,0,0
238781,.,0,0
238782,In,0,0
238783,HAL,0,0
238784,group,0,0
238785,",",0,0
238786,the,0,0
238787,effective,0,0
238788,rate,0,0
238789,was,0,0
238790,only,0,0
238791,5,0,0
238792,%,0,0
238793,",",0,0
238794,the,0,0
238795,mean,0,0
238796,survival,0,0
238797,time,0,0
238798,was,0,0
238799,5.1,0,0
238800,months,0,0
238801,",",0,0
238802,6,0,0
238803,months,0,0
238804,survival,0,0
238805,rate,0,0
238806,was,0,0
238807,35.8,0,0
238808,%,0,0
238809,.,0,0
238810,It,0,0
238811,has,0,0
238812,been,0,0
238813,postulated,0,0
238814,that,0,0
238815,RTD,1,0
238816,may,0,0
238817,prevent,0,0
238818,the,0,0
238819,rapid,0,0
238820,development,0,0
238821,of,0,0
238822,collateral,0,0
238823,circulation,0,0
238824,and,0,0
238825,increase,0,0
238826,the,0,0
238827,production,0,0
238828,of,0,0
238829,oxygen-derived,0,0
238830,free,0,0
238831,radicals,0,0
238832,",",0,0
238833,which,0,0
238834,may,0,0
238835,be,0,0
238836,the,0,0
238837,responsible,0,0
238838,factors,0,0
238839,for,0,0
238840,the,0,0
238841,ischemic,0,0
238842,treatment,0,0
238843,of,0,0
238844,hepatic,0,0
238845,tumours,0,0
238846,.,0,0
238847,We,0,0
238848,consider,0,0
238849,that,0,0
238850,RTD,1,0
238851,would,0,0
238852,be,0,0
238853,a,0,0
238854,promising,0,0
238855,polliative,0,0
238856,method,0,0
238857,for,0,0
238858,HCC,0,0
238859,.,0,0
238860,Humoral,0,0
238861,immune,0,0
238862,response,0,0
238863,to,0,0
238864,tetanus-diphtheria,1,1
238865,vaccine,1,1
238866,given,0,1
238867,during,0,0
238868,extended,0,0
238869,use,0,0
238870,of,0,0
238871,chloroquine,1,1
238872,or,1,1
238873,primaquine,1,1
238874,malaria,1,1
238875,chemoprophylaxis,1,1
238876,.,1,0
238877,Immune,0,0
238878,suppression,0,0
238879,resulting,0,0
238880,from,0,0
238881,prolonged,0,0
238882,chemoprophylaxis,0,0
238883,and,0,0
238884,potential,0,0
238885,drug-vaccine,0,0
238886,interaction,0,0
238887,were,0,0
238888,investigated,0,0
238889,within,0,0
238890,the,0,0
238891,context,0,0
238892,of,0,0
238893,a,0,0
238894,randomized,0,1
238895,placebo-controlled,1,1
238896,trial,0,0
238897,that,0,0
238898,compared,0,0
238899,daily,0,1
238900,primaquine,1,1
238901,or,0,1
238902,weekly,0,1
238903,chloroquine,1,1
238904,administration,0,1
238905,for,0,1
238906,malaria,0,1
238907,prevention,0,0
238908,.,0,0
238909,After,0,0
238910,11,0,0
238911,months,0,0
238912,of,0,0
238913,prophylaxis,0,0
238914,",",0,0
238915,adult,0,0
238916,male,0,0
238917,subjects,0,0
238918,received,0,0
238919,a,0,0
238920,tetanus-diphtheria,1,1
238921,(,1,1
238922,Td,1,1
238923,),1,1
238924,vaccination,1,1
238925,.,1,0
238926,Prophylaxis,0,0
238927,continued,0,0
238928,4,0,0
238929,weeks,0,0
238930,longer,0,0
238931,.,0,0
238932,Anti-tetanus,0,1
238933,and,0,1
238934,anti-diphtheria,0,1
238935,antibody,0,0
238936,levels,0,0
238937,were,0,0
238938,measured,0,0
238939,by,0,0
238940,ELISA,1,0
238941,at,0,0
238942,baseline,0,0
238943,and,0,0
238944,at,0,0
238945,1,0,0
238946,",",0,0
238947,3,0,0
238948,",",0,0
238949,7,0,0
238950,",",0,0
238951,and,0,0
238952,14,0,0
238953,months,0,0
238954,after,0,0
238955,Td,0,1
238956,vaccination,0,0
238957,.,0,0
238958,All,0,0
238959,groups,0,0
238960,were,0,0
238961,comparable,0,0
238962,at,0,0
238963,baseline,0,0
238964,.,0,0
238965,Immunization,0,0
238966,triggered,0,0
238967,significant,0,0
238968,increases,0,0
238969,in,0,0
238970,anti-tetanus,0,1
238971,and,0,1
238972,anti-diphtheria,0,1
238973,IgG,0,1
238974,levels,0,0
238975,over,0,0
238976,each,0,0
238977,group,0,0
238978,'s,0,0
238979,pre-Td,0,1
238980,baseline,0,0
238981,levels,0,0
238982,and,0,0
238983,those,0,0
238984,of,0,0
238985,an,0,0
238986,unvaccinated,0,0
238987,control,0,0
238988,group,0,0
238989,.,0,0
238990,Geometric,0,0
238991,mean,0,0
238992,anti-tetanus,0,1
238993,titers,0,1
238994,(,0,1
238995,GMTs,0,1
238996,),0,0
238997,in,0,0
238998,the,0,0
238999,primaquine,0,1
239000,group,0,0
239001,were,0,0
239002,significantly,0,0
239003,higher,0,0
239004,than,0,0
239005,those,0,0
239006,of,0,0
239007,the,0,0
239008,placebo,1,1
239009,group,0,1
239010,at,0,0
239011,1,0,0
239012,",",0,0
239013,3,0,0
239014,",",0,0
239015,and,0,0
239016,14,0,0
239017,months,0,0
239018,.,0,0
239019,Anti-tetanus,0,1
239020,GMTs,0,1
239021,in,0,1
239022,placebo,1,1
239023,and,0,1
239024,chloroquine,1,1
239025,groups,0,1
239026,declined,0,0
239027,over,0,0
239028,14,0,0
239029,months,0,0
239030,to,0,0
239031,levels,0,0
239032,comparable,0,0
239033,to,0,0
239034,those,0,0
239035,of,0,0
239036,unvaccinated,0,0
239037,controls,0,0
239038,",",0,0
239039,but,0,0
239040,levels,0,0
239041,in,0,0
239042,the,0,0
239043,primaquine,0,1
239044,group,0,0
239045,remained,0,0
239046,significantly,0,0
239047,higher,0,0
239048,than,0,0
239049,in,0,0
239050,controls,0,0
239051,.,0,0
239052,Long-term,0,0
239053,evaluation,0,0
239054,of,0,0
239055,tamsulosin,1,1
239056,in,0,0
239057,benign,0,1
239058,prostatic,0,0
239059,hyperplasia,0,1
239060,:,0,1
239061,placebo-controlled,1,1
239062,",",0,1
239063,double-blind,0,1
239064,extension,0,0
239065,of,0,0
239066,phase,0,0
239067,III,0,0
239068,trial,0,1
239069,.,0,1
239070,Tamsulosin,0,1
239071,Investigator,0,1
239072,Group,0,0
239073,.,0,0
239074,OBJECTIVES,0,0
239075,To,0,0
239076,evaluate,0,0
239077,the,0,0
239078,long-term,0,0
239079,efficacy,0,0
239080,and,0,0
239081,safety,0,0
239082,of,0,1
239083,once-daily,0,1
239084,tamsulosin,1,1
239085,(,0,1
239086,0.4,0,0
239087,and,0,0
239088,0.8,0,0
239089,mg,0,1
239090,),0,0
239091,",",0,0
239092,a,0,0
239093,unique,0,0
239094,selective,0,0
239095,alpha1A-adrenoceptor,0,1
239096,antagonist,0,1
239097,in,0,0
239098,patients,0,0
239099,with,0,0
239100,benign,0,0
239101,prostatic,0,1
239102,hyperplasia,0,1
239103,(,0,1
239104,BPH,0,1
239105,),0,1
239106,.,0,0
239107,METHODS,0,1
239108,This,0,0
239109,trial,0,0
239110,extended,0,0
239111,a,0,0
239112,13-week,0,1
239113,",",0,0
239114,Phase,0,0
239115,III,0,1
239116,multicenter,0,1
239117,placebo-controlled,0,1
239118,",",0,1
239119,double-blind,0,1
239120,outpatient,0,1
239121,trial,0,0
239122,for,0,0
239123,an,0,0
239124,additional,0,0
239125,40,0,0
239126,weeks,0,0
239127,.,0,0
239128,Of,0,0
239129,618,0,0
239130,patients,0,0
239131,",",0,0
239132,418,0,0
239133,(,0,0
239134,68,0,0
239135,%,0,0
239136,),0,0
239137,continued,0,0
239138,into,0,0
239139,the,0,0
239140,extension,0,0
239141,phase,0,0
239142,on,0,0
239143,the,0,0
239144,same,0,0
239145,double-blind,0,1
239146,medication,0,1
239147,and,0,1
239148,dose,0,1
239149,.,0,0
239150,The,0,0
239151,primary,0,0
239152,efficacy,0,0
239153,parameters,0,0
239154,were,0,0
239155,total,0,0
239156,American,0,0
239157,Urological,0,0
239158,Association,0,0
239159,(,0,1
239160,AUA,0,1
239161,),0,1
239162,symptom,0,0
239163,score,0,0
239164,and,0,0
239165,maximum,0,0
239166,urinary,0,0
239167,flow,0,0
239168,(,0,0
239169,Qmax,0,0
239170,),0,0
239171,.,0,0
239172,RESULTS,0,0
239173,The,0,0
239174,mean,0,0
239175,changes,0,0
239176,in,0,0
239177,AUA,0,0
239178,symptom,0,0
239179,score,0,0
239180,from,0,0
239181,baseline,0,0
239182,to,0,0
239183,end,0,0
239184,point,0,0
239185,were,0,0
239186,statistically,0,0
239187,significant,0,0
239188,in,0,0
239189,all,0,0
239190,groups,0,0
239191,(,0,0
239192,P,0,0
239193,<,0,0
239194,0.001,0,0
239195,),0,0
239196,.,0,0
239197,Significant,0,0
239198,improvements,0,0
239199,were,0,0
239200,observed,0,0
239201,in,0,0
239202,Qmax,0,0
239203,for,0,0
239204,both,0,0
239205,tamsulosin,1,1
239206,groups,0,0
239207,but,0,0
239208,not,0,0
239209,for,0,0
239210,the,0,0
239211,placebo,1,1
239212,group,0,0
239213,.,0,0
239214,The,0,0
239215,statistically,0,0
239216,significant,0,0
239217,improvements,0,0
239218,from,0,0
239219,baseline,0,0
239220,in,0,0
239221,efficacy,0,0
239222,parameters,0,0
239223,observed,0,0
239224,for,0,0
239225,each,0,0
239226,tamsulosin,1,1
239227,group,0,0
239228,at,0,0
239229,the,0,0
239230,end,0,0
239231,of,0,0
239232,the,0,0
239233,13-week,0,1
239234,Phase,0,0
239235,III,0,1
239236,trial,0,0
239237,were,0,0
239238,maintained,0,0
239239,during,0,0
239240,the,0,0
239241,long-term,0,0
239242,extension,0,0
239243,phase,0,0
239244,.,0,0
239245,Tamsulosin,0,1
239246,at,0,1
239247,both,0,0
239248,dosages,0,1
239249,was,0,0
239250,well,0,0
239251,tolerated,0,1
239252,as,0,0
239253,maintenance,0,0
239254,therapy,0,0
239255,.,0,0
239256,Clinically,0,0
239257,significant,0,0
239258,orthostatic,0,0
239259,hypotension,0,0
239260,was,0,0
239261,not,0,0
239262,observed,0,0
239263,.,0,0
239264,Vital,0,0
239265,sign,0,0
239266,changes,0,0
239267,in,0,0
239268,either,0,0
239269,hypertensive,0,0
239270,or,0,0
239271,normotensive,0,1
239272,patients,0,0
239273,were,0,0
239274,not,0,0
239275,clinically,0,0
239276,significantly,0,0
239277,different,0,0
239278,across,0,0
239279,the,0,0
239280,three,0,0
239281,groups,0,0
239282,.,0,0
239283,CONCLUSIONS,0,1
239284,Tamsulosin,1,1
239285,once-daily,0,1
239286,at,0,0
239287,0.4,0,0
239288,or,0,0
239289,0.8,0,0
239290,mg,0,0
239291,was,0,0
239292,shown,0,0
239293,to,0,0
239294,be,0,0
239295,effective,0,0
239296,",",0,0
239297,safe,0,0
239298,",",0,0
239299,and,0,0
239300,well,0,0
239301,tolerated,0,1
239302,in,0,0
239303,the,0,0
239304,target,0,0
239305,BPH,0,0
239306,population,0,0
239307,during,0,0
239308,long-term,0,0
239309,use,0,0
239310,.,0,0
239311,Diet,0,0
239312,design,0,0
239313,for,0,0
239314,a,0,0
239315,multicenter,0,0
239316,controlled,0,0
239317,feeding,0,0
239318,trial,0,0
239319,:,0,0
239320,the,0,0
239321,DELTA,0,0
239322,program,0,0
239323,.,0,0
239324,Delta,0,0
239325,Research,0,0
239326,Group,0,0
239327,.,0,0
239328,OBJECTIVE,0,0
239329,To,0,0
239330,describe,0,0
239331,the,0,0
239332,process,0,0
239333,and,0,0
239334,results,0,0
239335,of,0,0
239336,diet,0,1
239337,standardization,0,1
239338,",",0,1
239339,diet,0,1
239340,validation,0,1
239341,",",0,0
239342,and,0,0
239343,monitoring,0,0
239344,of,0,0
239345,diet,0,1
239346,composition,0,0
239347,",",0,0
239348,which,0,0
239349,were,0,0
239350,key,0,0
239351,components,0,0
239352,of,0,0
239353,protocol,0,0
239354,1,0,0
239355,of,0,0
239356,Dietary,0,0
239357,Effects,0,0
239358,on,0,0
239359,Lipoproteins,0,0
239360,and,0,0
239361,Thrombogenic,0,0
239362,Activity,0,0
239363,(,0,1
239364,DELTA-1,0,1
239365,),0,1
239366,",",0,0
239367,the,0,0
239368,initial,0,0
239369,protocol,0,0
239370,in,0,0
239371,a,0,0
239372,program,0,0
239373,of,0,0
239374,multicenter,0,0
239375,human,0,0
239376,feeding,0,0
239377,studies,0,0
239378,designed,0,0
239379,to,0,0
239380,evaluate,0,0
239381,the,0,0
239382,effects,0,0
239383,of,0,0
239384,amount,0,0
239385,and,0,0
239386,type,0,0
239387,of,0,0
239388,fat,0,0
239389,on,0,0
239390,lipoproteins,0,1
239391,and,0,0
239392,hemostasis,0,0
239393,parameters,0,0
239394,in,0,0
239395,various,0,0
239396,demographic,0,0
239397,groups,0,0
239398,.,0,0
239399,DESIGN,0,0
239400,DELTA-1,0,0
239401,was,0,0
239402,based,0,0
239403,on,0,0
239404,a,0,0
239405,randomized,0,0
239406,",",0,0
239407,blinded,0,1
239408,",",0,0
239409,crossover,0,1
239410,experimental,0,0
239411,design,0,0
239412,.,0,0
239413,Three,1,0
239414,diets,1,1
239415,were,0,0
239416,fed,0,0
239417,for,0,0
239418,8,0,0
239419,weeks,0,0
239420,to,0,0
239421,103,0,0
239422,healthy,0,0
239423,men,0,0
239424,and,0,0
239425,women,0,0
239426,aged,0,0
239427,22,0,0
239428,to,0,0
239429,67,0,0
239430,years,0,0
239431,at,0,0
239432,4,0,0
239433,field,0,0
239434,centers,0,0
239435,.,0,0
239436,Diet,1,0
239437,A,1,0
239438,",",1,0
239439,an,1,0
239440,average,1,0
239441,American,1,0
239442,diet,1,1
239443,",",1,0
239444,was,1,0
239445,designed,1,0
239446,to,1,0
239447,provide,1,0
239448,37,1,0
239449,%,1,0
239450,of,1,0
239451,energy,1,0
239452,from,1,0
239453,fat,1,0
239454,",",1,0
239455,16,1,0
239456,%,1,0
239457,of,1,0
239458,energy,1,0
239459,from,1,0
239460,saturated,1,0
239461,fatty,1,1
239462,acids,1,1
239463,(,1,1
239464,SFAs,1,1
239465,),1,1
239466,;,1,1
239467,diet,1,1
239468,B,1,1
239469,(,1,1
239470,step,1,0
239471,1,1,1
239472,diet,1,1
239473,),1,1
239474,was,1,0
239475,designed,1,0
239476,to,1,0
239477,provide,1,0
239478,30,1,0
239479,%,1,0
239480,of,1,0
239481,energy,1,0
239482,from,1,0
239483,fat,1,0
239484,",",1,0
239485,9,1,0
239486,%,1,0
239487,of,1,0
239488,energy,1,0
239489,from,1,0
239490,SFA,1,1
239491,;,1,1
239492,and,0,1
239493,diet,1,1
239494,C,1,1
239495,(,1,1
239496,low,1,0
239497,SFA,1,1
239498,diet,1,1
239499,),1,1
239500,was,1,0
239501,designed,1,0
239502,to,1,0
239503,provide,1,0
239504,26,1,0
239505,%,1,0
239506,of,1,0
239507,energy,1,0
239508,from,1,0
239509,fat,1,0
239510,",",1,0
239511,5,1,0
239512,%,1,0
239513,of,1,0
239514,energy,1,0
239515,from,0,0
239516,SFA,0,0
239517,.,0,0
239518,Key,0,0
239519,features,0,0
239520,of,0,0
239521,diet,0,1
239522,standardization,0,0
239523,included,0,0
239524,central,0,0
239525,procurement,0,0
239526,of,0,0
239527,fat-containing,0,0
239528,foods,0,0
239529,",",0,0
239530,inclusion,0,0
239531,of,0,0
239532,standard,0,1
239533,ingredients,0,1
239534,",",0,1
239535,precision,0,1
239536,weighing,0,0
239537,of,0,0
239538,foods,0,0
239539,--,0,0
239540,especially,0,0
239541,sources,0,0
239542,of,0,0
239543,fat,0,0
239544,and,0,0
239545,cholesterol,0,1
239546,--,0,1
239547,and,0,0
239548,use,0,0
239549,of,0,0
239550,standardized,0,0
239551,written,0,0
239552,procedures,0,0
239553,.,0,0
239554,SETTING,0,0
239555,For,0,0
239556,menu,0,0
239557,validation,0,0
239558,",",0,0
239559,a,0,0
239560,set,0,0
239561,of,0,0
239562,12,0,0
239563,menus,0,0
239564,for,0,0
239565,each,0,0
239566,diet,0,1
239567,was,0,0
239568,prepared,0,0
239569,in,0,0
239570,duplicate,0,0
239571,and,0,0
239572,chemically,0,0
239573,assayed,0,0
239574,.,0,0
239575,For,0,0
239576,monitoring,0,0
239577,of,0,0
239578,diet,0,1
239579,composition,0,0
239580,during,0,0
239581,the,0,0
239582,study,0,0
239583,",",0,0
239584,an,0,0
239585,8-day,0,1
239586,diet,0,1
239587,cycle,0,1
239588,(,0,1
239589,6,0,0
239590,weekday,0,1
239591,and,0,0
239592,2,0,0
239593,weekend,0,1
239594,menus,0,1
239595,),0,0
239596,was,0,0
239597,sampled,0,0
239598,by,0,0
239599,every,0,0
239600,field,0,0
239601,center,0,0
239602,twice,0,0
239603,during,0,0
239604,each,0,0
239605,of,0,0
239606,3,0,0
239607,feeding,0,0
239608,periods,0,0
239609,.,0,0
239610,STATISTICAL,0,0
239611,ANALYSES,0,1
239612,Means,0,0
239613,(,0,0
239614,+/-,0,0
239615,standard,0,0
239616,error,0,0
239617,),0,0
239618,were,0,0
239619,calculated,0,0
239620,and,0,0
239621,compared,0,0
239622,with,0,0
239623,target,0,0
239624,nutrient,0,0
239625,specifications,0,0
239626,.,0,0
239627,RESULTS,0,0
239628,DELTA-1,0,0
239629,was,0,0
239630,able,0,0
239631,to,0,0
239632,provide,0,0
239633,a,0,0
239634,standardized,0,0
239635,diet,0,1
239636,that,0,0
239637,met,0,1
239638,nutrient,0,0
239639,specifications,0,0
239640,across,0,0
239641,4,0,0
239642,field,0,0
239643,centers,0,0
239644,over,0,0
239645,24,0,0
239646,weeks,0,0
239647,of,0,0
239648,participant,0,0
239649,feeding,0,0
239650,spanning,0,0
239651,a,0,0
239652,total,0,0
239653,of,0,0
239654,8,0,0
239655,months,0,0
239656,.,0,0
239657,APPLICATIONS,0,0
239658,Prestudy,0,0
239659,chemical,0,0
239660,validation,0,0
239661,of,0,0
239662,menus,0,0
239663,and,0,0
239664,continuous,0,0
239665,sampling,0,0
239666,and,0,0
239667,assay,0,0
239668,of,0,0
239669,diets,0,1
239670,throughout,0,0
239671,the,0,0
239672,study,0,0
239673,are,0,0
239674,essential,0,0
239675,to,0,0
239676,standardize,0,0
239677,experimental,0,0
239678,diets,0,1
239679,and,0,0
239680,to,0,0
239681,ensure,0,0
239682,that,0,0
239683,nutrient,0,0
239684,target,0,0
239685,goals,0,0
239686,are,0,0
239687,met,0,0
239688,and,0,0
239689,maintained,0,0
239690,throughout,0,0
239691,a,0,0
239692,controlled,0,0
239693,multicenter,0,0
239694,feeding,0,0
239695,study,0,0
239696,.,0,0
239697,Impact,0,0
239698,of,0,0
239699,work,1,0
239700,site,1,0
239701,health,1,0
239702,promotion,1,0
239703,on,0,0
239704,stages,0,0
239705,of,0,0
239706,dietary,0,1
239707,change,0,0
239708,:,0,0
239709,the,0,0
239710,Working,0,0
239711,Well,0,0
239712,Trial,0,0
239713,.,0,0
239714,The,0,0
239715,stages,0,0
239716,of,0,0
239717,change,0,0
239718,construct,0,0
239719,has,0,0
239720,been,0,0
239721,applied,0,0
239722,to,0,0
239723,healthful,0,0
239724,dietary,0,1
239725,behavior,0,0
239726,in,0,0
239727,cross-sectional,0,0
239728,studies,0,0
239729,.,0,0
239730,This,0,0
239731,report,0,0
239732,examines,0,0
239733,associations,0,0
239734,of,0,0
239735,stages,0,0
239736,of,0,0
239737,change,0,0
239738,with,0,0
239739,diet,0,1
239740,prospectively,0,1
239741,and,0,0
239742,addresses,0,0
239743,whether,0,0
239744,(,0,0
239745,1,0,1
239746,),0,0
239747,baseline,0,0
239748,stage,0,0
239749,of,0,0
239750,change,0,0
239751,predicts,0,0
239752,participation,0,0
239753,",",0,0
239754,(,0,1
239755,2,0,1
239756,),0,0
239757,forward,0,0
239758,changes,0,0
239759,in,0,0
239760,stage,0,0
239761,movement,0,0
239762,were,0,0
239763,greater,0,0
239764,in,0,0
239765,treatment,0,0
239766,work,0,0
239767,sites,0,0
239768,",",0,0
239769,and,0,0
239770,(,0,1
239771,3,0,1
239772,),0,0
239773,change,0,0
239774,in,0,0
239775,stage,0,0
239776,was,0,0
239777,associated,0,0
239778,with,0,0
239779,adoption,0,0
239780,of,0,0
239781,healthful,0,1
239782,diets,0,1
239783,",",0,0
239784,using,0,0
239785,data,0,0
239786,from,0,0
239787,a,0,0
239788,cohort,0,0
239789,of,0,0
239790,"11,237",0,0
239791,employees,0,0
239792,.,0,0
239793,Findings,0,0
239794,indicate,0,0
239795,that,0,0
239796,persons,0,0
239797,in,0,0
239798,later,0,0
239799,stages,0,0
239800,of,0,0
239801,change,0,0
239802,reported,0,0
239803,higher,0,0
239804,participation,0,0
239805,levels,0,0
239806,.,0,0
239807,Employees,0,0
239808,from,0,0
239809,intervention,0,0
239810,work,0,0
239811,sites,0,0
239812,who,0,0
239813,were,0,0
239814,in,0,0
239815,preaction,0,0
239816,stages,0,0
239817,at,0,0
239818,baseline,0,0
239819,were,0,0
239820,much,0,0
239821,more,0,0
239822,likely,0,0
239823,to,0,0
239824,shift,0,0
239825,into,0,0
239826,action,0,0
239827,and,0,0
239828,maintenance,0,0
239829,stages,0,0
239830,than,0,0
239831,controls,0,0
239832,.,0,0
239833,Changes,0,0
239834,in,0,0
239835,dietary,0,1
239836,stage,0,0
239837,of,0,0
239838,change,0,0
239839,were,0,0
239840,associated,0,0
239841,with,0,0
239842,decreases,0,0
239843,in,0,0
239844,fat,0,1
239845,intake,0,1
239846,and,0,0
239847,increases,0,0
239848,in,0,0
239849,fiber,0,0
239850,",",0,0
239851,fruit,0,0
239852,and,0,1
239853,vegetable,0,1
239854,intake,0,1
239855,.,0,1
239856,Net,0,0
239857,change,0,0
239858,in,0,0
239859,diet,0,1
239860,due,0,0
239861,to,0,0
239862,the,0,0
239863,intervention,0,0
239864,was,0,0
239865,modest,0,0
239866,.,0,0
239867,Stage,0,0
239868,of,0,0
239869,change,0,0
239870,appears,0,0
239871,to,0,0
239872,be,0,0
239873,useful,0,0
239874,for,0,0
239875,understanding,0,0
239876,mediators,0,0
239877,of,0,0
239878,health,0,0
239879,promotion,0,0
239880,intervention,0,0
239881,effectiveness,0,0
239882,.,0,0
239883,The,0,0
239884,Treatment,0,0
239885,of,0,0
239886,Lead-exposed,0,0
239887,Children,0,0
239888,(,0,1
239889,TLC,0,1
239890,),0,1
239891,trial,0,0
239892,:,0,0
239893,design,0,0
239894,and,0,0
239895,recruitment,0,0
239896,for,0,0
239897,a,0,0
239898,study,0,0
239899,of,0,0
239900,the,0,0
239901,effect,0,0
239902,of,0,0
239903,oral,1,1
239904,chelation,1,1
239905,on,0,0
239906,growth,0,0
239907,and,0,0
239908,development,0,0
239909,in,0,0
239910,toddlers,0,0
239911,.,0,0
239912,Exposure,0,0
239913,to,0,0
239914,lead,0,0
239915,impairs,0,0
239916,cognitive,0,0
239917,development,0,0
239918,in,0,0
239919,young,0,0
239920,children,0,0
239921,",",0,0
239922,but,0,0
239923,the,0,0
239924,benefits,0,0
239925,of,0,0
239926,lowering,0,0
239927,blood,0,0
239928,lead,0,0
239929,pharmacologically,0,0
239930,are,0,0
239931,not,0,0
239932,clear,0,0
239933,.,0,0
239934,This,0,0
239935,report,0,0
239936,describes,0,0
239937,the,0,0
239938,design,0,0
239939,",",0,0
239940,recruitment,0,0
239941,",",0,0
239942,enrolment,0,0
239943,and,0,0
239944,baseline,0,0
239945,results,0,0
239946,of,0,0
239947,the,0,0
239948,Treatment,0,0
239949,of,0,0
239950,Lead-Exposed,0,1
239951,Children,0,1
239952,(,0,1
239953,TLC,0,1
239954,),0,1
239955,trial,0,0
239956,",",0,0
239957,a,0,0
239958,randomised,0,0
239959,",",0,0
239960,multicentre,0,1
239961,",",0,1
239962,placebo-controlled,0,1
239963,",",0,1
239964,double-blind,0,1
239965,clinical,0,1
239966,trial,0,0
239967,of,0,0
239968,the,0,0
239969,effects,0,0
239970,of,0,0
239971,treating,0,0
239972,lead-exposed,0,0
239973,children,0,0
239974,with,0,1
239975,succimer,1,1
239976,",",0,0
239977,a,0,0
239978,drug,0,1
239979,that,0,0
239980,enhances,0,0
239981,urinary,0,0
239982,excretion,0,1
239983,of,0,0
239984,lead,0,0
239985,",",0,0
239986,on,0,0
239987,cognitive,0,0
239988,",",0,0
239989,behavioural,0,0
239990,and,0,0
239991,physical,0,0
239992,development,0,0
239993,.,0,0
239994,TLC,0,0
239995,clinical,0,0
239996,sites,0,0
239997,were,0,0
239998,in,0,0
239999,Baltimore,0,0
240000,",",0,0
240001,Cincinnati,0,0
240002,and,0,0
240003,Columbus,0,0
240004,",",0,0
240005,Newark,0,0
240006,and,0,0
240007,Philadelphia,0,0
240008,.,0,0
240009,Children,0,0
240010,were,0,0
240011,eligible,0,0
240012,for,0,0
240013,TLC,0,0
240014,if,0,0
240015,they,0,0
240016,were,0,0
240017,between,0,0
240018,12,0,0
240019,and,0,0
240020,33,0,0
240021,months,0,0
240022,of,0,0
240023,age,0,0
240024,",",0,0
240025,had,0,0
240026,a,0,0
240027,confirmed,0,0
240028,blood,0,0
240029,lead,0,0
240030,concentration,0,0
240031,between,0,0
240032,20,0,0
240033,and,0,0
240034,44,0,0
240035,micrograms/dL,0,1
240036,and,0,0
240037,lived,0,0
240038,in,0,0
240039,a,0,0
240040,residence,0,0
240041,suitable,0,0
240042,for,0,0
240043,lead,0,0
240044,dust,0,0
240045,reduction,0,0
240046,.,0,0
240047,Randomised,0,0
240048,children,0,0
240049,received,0,0
240050,up,0,0
240051,to,0,0
240052,three,0,0
240053,26-day,0,1
240054,courses,0,1
240055,of,0,1
240056,succimer,1,1
240057,or,1,1
240058,placebo,1,1
240059,",",0,0
240060,and,0,0
240061,were,0,0
240062,then,0,0
240063,followed,0,0
240064,for,0,0
240065,3,0,0
240066,years,0,0
240067,.,0,0
240068,The,0,0
240069,study,0,0
240070,can,0,0
240071,detect,0,0
240072,a,0,0
240073,three-point,0,0
240074,difference,0,0
240075,in,0,0
240076,full-scale,0,0
240077,IQ,0,0
240078,at,0,0
240079,3-year,0,0
240080,follow-up,0,0
240081,.,0,0
240082,Statistical,0,0
240083,power,0,0
240084,for,0,0
240085,the,0,0
240086,other,0,0
240087,end,0,0
240088,points,0,0
240089,is,0,0
240090,more,0,0
240091,difficult,0,0
240092,to,0,0
240093,estimate,0,0
240094,.,0,0
240095,A,0,0
240096,total,0,0
240097,of,0,0
240098,1854,0,0
240099,children,0,0
240100,were,0,0
240101,evaluated,0,0
240102,and,0,0
240103,780,0,0
240104,children,0,0
240105,were,0,0
240106,randomised,0,0
240107,between,0,0
240108,August,0,0
240109,1994,0,0
240110,and,0,0
240111,January,0,0
240112,1997,0,0
240113,.,0,0
240114,The,0,0
240115,mean,0,0
240116,age,0,0
240117,of,0,0
240118,randomised,0,0
240119,children,0,0
240120,was,0,0
240121,24,0,0
240122,months,0,0
240123,and,0,0
240124,mean,0,0
240125,blood,0,0
240126,lead,0,0
240127,level,0,0
240128,26,0,0
240129,micrograms/dL,0,0
240130,.,0,0
240131,Three-quarters,0,0
240132,were,0,0
240133,African-American,0,0
240134,.,0,0
240135,Most,0,0
240136,children,0,0
240137,had,0,0
240138,poor,0,0
240139,",",0,0
240140,single,0,0
240141,mothers,0,0
240142,who,0,0
240143,had,0,0
240144,completed,0,0
240145,12,0,0
240146,or,0,0
240147,fewer,0,0
240148,years,0,0
240149,of,0,0
240150,school,0,0
240151,and,0,0
240152,who,0,0
240153,lived,0,0
240154,in,0,0
240155,older,0,0
240156,",",0,0
240157,poorly,0,0
240158,maintained,0,0
240159,residences,0,0
240160,.,0,0
240161,Laser,1,0
240162,therapy,1,0
240163,combined,1,0
240164,with,1,0
240165,brachytherapy,1,0
240166,for,0,0
240167,the,0,0
240168,palliation,0,0
240169,of,0,0
240170,malignant,0,0
240171,dysphagia,0,0
240172,.,0,0
240173,BACKGROUND/AIM,0,0
240174,OF,0,1
240175,STUDY,0,1
240176,Laser,1,0
240177,therapy,1,0
240178,is,0,0
240179,effective,0,0
240180,in,0,0
240181,relieving,0,0
240182,malignant,0,0
240183,dysphagia,0,0
240184,",",0,0
240185,but,0,0
240186,repeated,0,0
240187,treatments,0,0
240188,at,0,0
240189,4,0,0
240190,to,0,0
240191,6,0,0
240192,week,0,0
240193,intervals,0,0
240194,are,0,0
240195,usually,0,0
240196,required,0,0
240197,.,0,0
240198,This,0,0
240199,prospective,0,0
240200,randomised,0,0
240201,trial,0,0
240202,is,0,0
240203,designed,0,0
240204,to,0,0
240205,determine,0,0
240206,if,0,0
240207,addition,0,0
240208,of,0,0
240209,brachytherapy,0,0
240210,offers,0,0
240211,any,0,0
240212,advantages,0,0
240213,over,0,0
240214,laser,1,0
240215,therapy,1,0
240216,alone,0,0
240217,.,0,0
240218,METHODS,0,0
240219,Patients,0,0
240220,with,0,0
240221,inoperable,0,0
240222,carcinoma,0,0
240223,of,0,0
240224,the,0,0
240225,oesophagus,0,0
240226,were,0,0
240227,randomised,0,0
240228,to,0,0
240229,receive,0,0
240230,either,0,0
240231,endoscopic,1,0
240232,Nd,1,0
240233,:,1,0
240234,YAG,1,0
240235,laser,1,0
240236,therapy,1,0
240237,alone,0,0
240238,",",0,0
240239,or,0,0
240240,laser,1,0
240241,followed,0,0
240242,by,0,0
240243,brachytherapy,1,0
240244,.,1,0
240245,Patients,0,0
240246,who,0,0
240247,developed,0,0
240248,worsening,0,0
240249,dysphagia,0,0
240250,during,0,0
240251,follow-up,0,0
240252,were,0,0
240253,offered,0,0
240254,further,0,0
240255,treatment,0,0
240256,as,0,0
240257,appropriate,0,0
240258,.,0,0
240259,RESULTS,0,0
240260,Fourteen,0,0
240261,patients,0,0
240262,were,0,0
240263,randomised,0,0
240264,to,0,0
240265,receive,0,0
240266,laser,1,0
240267,only,1,0
240268,",",0,0
240269,and,0,0
240270,12,0,0
240271,to,0,0
240272,receive,0,0
240273,laser,0,0
240274,followed,0,0
240275,by,0,0
240276,brachytherapy,1,0
240277,.,1,0
240278,Of,0,0
240279,these,0,0
240280,12,0,0
240281,",",0,0
240282,one,0,0
240283,was,0,0
240284,lost,0,0
240285,to,0,0
240286,follow-up,0,0
240287,and,0,0
240288,four,0,0
240289,did,0,0
240290,not,0,0
240291,receive,0,0
240292,brachytherapy,1,0
240293,because,0,0
240294,they,0,0
240295,were,0,0
240296,unfit,0,0
240297,",",0,0
240298,had,0,0
240299,extension,0,0
240300,into,0,0
240301,the,0,0
240302,cardia,0,0
240303,or,0,0
240304,had,0,0
240305,mainly,0,0
240306,extrinsic,0,0
240307,compression,0,0
240308,.,0,0
240309,These,0,0
240310,4,0,0
240311,are,0,0
240312,included,0,0
240313,on,0,0
240314,an,0,0
240315,'intention-to-treat,0,0
240316,',0,0
240317,basis,0,0
240318,.,0,0
240319,The,0,0
240320,mean,0,0
240321,therapeutic,0,0
240322,interval,0,0
240323,for,0,0
240324,the,0,0
240325,brachytherapy,0,0
240326,group,0,0
240327,was,0,0
240328,significantly,0,0
240329,longer,0,0
240330,",",0,0
240331,83,0,0
240332,days,0,0
240333,compared,0,0
240334,to,0,0
240335,36,0,0
240336,days,0,0
240337,for,0,0
240338,the,0,0
240339,laser,0,1
240340,group,0,0
240341,(,0,0
240342,p,0,0
240343,=,0,0
240344,0.026,0,0
240345,),0,0
240346,.,0,0
240347,There,0,0
240348,were,0,0
240349,no,0,0
240350,differences,0,0
240351,in,0,0
240352,the,0,0
240353,degree,0,0
240354,of,0,0
240355,dysphagia,0,0
240356,relief,0,0
240357,",",0,0
240358,number,0,0
240359,of,0,0
240360,endoscopic,0,0
240361,procedures,0,0
240362,or,0,0
240363,survival,0,0
240364,times,0,0
240365,.,0,0
240366,CONCLUSION,0,0
240367,The,0,0
240368,preliminary,0,0
240369,results,0,0
240370,of,0,0
240371,this,0,0
240372,trial,0,0
240373,suggest,0,0
240374,that,0,0
240375,brachytherapy,1,0
240376,in,0,0
240377,addition,0,0
240378,to,0,0
240379,laser,0,0
240380,therapy,0,0
240381,prolongs,0,0
240382,the,0,0
240383,first,0,0
240384,therapeutic,0,0
240385,interval,0,0
240386,.,0,0
240387,However,0,0
240388,",",0,0
240389,no,0,0
240390,long-term,0,0
240391,advantages,0,0
240392,have,0,0
240393,been,0,0
240394,shown,0,0
240395,.,0,0
240396,Efficacy,0,0
240397,and,0,0
240398,safety,0,0
240399,relative,0,0
240400,to,0,0
240401,placebo,1,1
240402,of,0,0
240403,an,0,1
240404,oral,0,1
240405,formulation,0,1
240406,of,0,1
240407,cetirizine,1,1
240408,and,0,1
240409,sustained-release,0,1
240410,pseudoephedrine,1,1
240411,in,0,1
240412,the,0,0
240413,management,0,0
240414,of,0,0
240415,nasal,0,0
240416,congestion,0,0
240417,.,0,0
240418,BACKGROUND,0,0
240419,The,0,0
240420,aim,0,0
240421,of,0,0
240422,this,0,0
240423,study,0,0
240424,was,0,0
240425,to,0,0
240426,assess,0,0
240427,the,0,0
240428,clinical,0,0
240429,efficacy,0,0
240430,of,0,0
240431,an,0,0
240432,oral,0,1
240433,formulation,0,1
240434,of,0,1
240435,cetirizine,1,1
240436,5,0,1
240437,mg,0,1
240438,with,0,1
240439,sustained-release,0,1
240440,pseudoephedrine,1,1
240441,(,0,1
240442,PSE,0,1
240443,),0,1
240444,120,0,1
240445,mg,0,1
240446,relative,0,0
240447,to,0,0
240448,placebo,1,1
240449,in,0,0
240450,patients,0,0
240451,with,0,0
240452,nasal,0,0
240453,congestion,0,0
240454,.,0,0
240455,METHODS,0,0
240456,Twenty-four,0,0
240457,patients,0,0
240458,with,0,0
240459,perennial,0,0
240460,rhinitis,0,0
240461,due,0,0
240462,to,0,0
240463,house-dust-mite,0,0
240464,(,0,1
240465,HDM,0,1
240466,),0,1
240467,allergy,0,0
240468,were,0,0
240469,recruited,0,0
240470,in,0,0
240471,this,0,0
240472,crossover,0,1
240473,study,0,0
240474,.,0,0
240475,A,0,0
240476,treatment,0,0
240477,period,0,0
240478,of,0,0
240479,1,0,0
240480,week,0,0
240481,",",0,0
240482,in,0,0
240483,which,0,0
240484,cetirizine/PSE,1,1
240485,was,0,1
240486,administered,0,1
240487,twice,0,1
240488,daily,0,1
240489,",",0,1
240490,was,0,0
240491,followed,0,0
240492,by,0,0
240493,a,0,0
240494,washout,0,1
240495,period,0,1
240496,of,0,0
240497,at,0,0
240498,least,0,0
240499,2,0,0
240500,weeks,0,0
240501,and,0,0
240502,a,0,0
240503,further,0,0
240504,period,0,0
240505,of,0,0
240506,1,0,0
240507,week,0,0
240508,in,0,0
240509,which,0,0
240510,the,0,0
240511,alternative,0,0
240512,treatment,0,0
240513,was,0,0
240514,given,0,0
240515,to,0,0
240516,each,0,0
240517,patient,0,0
240518,.,0,0
240519,Immediately,0,0
240520,after,0,0
240521,the,0,0
240522,first,0,0
240523,dose,0,1
240524,of,0,0
240525,each,0,0
240526,medication,0,1
240527,(,0,1
240528,day,0,1
240529,1,0,1
240530,),0,1
240531,",",0,0
240532,nasal,0,1
240533,congestion,0,0
240534,and,0,0
240535,related,0,0
240536,symptoms,0,0
240537,were,0,0
240538,assessed,0,0
240539,during,0,0
240540,a,0,0
240541,7-h,0,1
240542,challenge,0,0
240543,with,0,0
240544,HDM,0,1
240545,feces,0,1
240546,",",0,0
240547,with,0,0
240548,the,0,0
240549,Vienna,0,0
240550,Challenge,0,1
240551,Chamber,0,1
240552,(,0,1
240553,VCC,0,1
240554,),0,0
240555,",",0,0
240556,to,0,0
240557,investigate,0,0
240558,onset,0,0
240559,of,0,0
240560,action,0,0
240561,of,0,0
240562,the,0,0
240563,preparation,0,0
240564,.,0,0
240565,A,0,0
240566,second,0,0
240567,challenge,0,0
240568,of,0,0
240569,3-h,0,1
240570,duration,0,1
240571,",",0,0
240572,carried,0,0
240573,out,0,0
240574,at,0,0
240575,least,0,0
240576,12,0,0
240577,h,0,0
240578,after,0,0
240579,the,0,0
240580,final,0,0
240581,dose,0,1
240582,",",0,0
240583,was,0,0
240584,undertaken,0,0
240585,after,0,0
240586,1,0,0
240587,week,0,0
240588,(,0,0
240589,mean,0,0
240590,),0,0
240591,of,0,0
240592,twice-daily,0,1
240593,treatment,0,0
240594,to,0,0
240595,assess,0,0
240596,residual,0,0
240597,effects,0,0
240598,of,0,0
240599,the,0,0
240600,formulation,0,1
240601,after,0,0
240602,achievement,0,0
240603,of,0,0
240604,steady,0,0
240605,state,0,0
240606,.,0,0
240607,RESULTS,0,0
240608,The,0,0
240609,oral,0,1
240610,formulation,0,1
240611,of,0,1
240612,cetirizine/PSE,1,1
240613,was,0,0
240614,significantly,0,0
240615,(,0,0
240616,P,0,0
240617,<,0,0
240618,0.001,0,0
240619,),0,0
240620,superior,0,0
240621,to,0,0
240622,placebo,1,1
240623,in,0,0
240624,improving,0,0
240625,nasal,0,0
240626,obstruction,0,0
240627,during,0,0
240628,both,0,0
240629,challenges,0,0
240630,.,0,0
240631,The,0,0
240632,improvement,0,0
240633,in,0,0
240634,nasal,0,0
240635,airflow,0,0
240636,and,0,0
240637,nasal,0,0
240638,patency,0,0
240639,was,0,0
240640,significantly,0,0
240641,greater,0,0
240642,with,0,0
240643,cetirizine/PSE,1,1
240644,than,0,1
240645,with,0,1
240646,placebo,1,1
240647,(,0,0
240648,P,0,0
240649,<,0,0
240650,0.02,0,0
240651,),0,0
240652,.,0,0
240653,In,0,0
240654,addition,0,0
240655,",",0,0
240656,subjective,0,0
240657,assessment,0,0
240658,of,0,0
240659,nasal,0,0
240660,symptoms,0,0
240661,showed,0,0
240662,that,0,0
240663,cetirizine/PSE,0,1
240664,was,0,0
240665,significantly,0,0
240666,superior,0,0
240667,to,0,0
240668,placebo,1,1
240669,in,0,0
240670,both,0,0
240671,challenges,0,0
240672,for,0,0
240673,the,0,0
240674,sum,0,0
240675,of,0,0
240676,nasal,0,0
240677,obstruction,0,1
240678,scores,0,0
240679,(,0,0
240680,P,0,0
240681,<,0,0
240682,0.01,0,0
240683,),0,0
240684,.,0,0
240685,Both,0,1
240686,medications,0,1
240687,were,0,1
240688,well,0,0
240689,tolerated,0,1
240690,",",0,0
240691,and,0,0
240692,no,0,0
240693,serious,0,0
240694,adverse,0,0
240695,events,0,0
240696,occurred,0,0
240697,during,0,0
240698,the,0,0
240699,study,0,0
240700,.,0,0
240701,CONCLUSIONS,0,0
240702,In,0,0
240703,this,0,0
240704,study,0,0
240705,",",0,0
240706,cetirizine/PSE,1,1
240707,relieved,0,0
240708,nasal,0,1
240709,congestion,0,0
240710,and,0,0
240711,other,0,0
240712,objective,0,0
240713,and,0,0
240714,subjective,0,0
240715,symptoms,0,0
240716,to,0,0
240717,a,0,0
240718,significantly,0,0
240719,greater,0,0
240720,extent,0,0
240721,than,0,0
240722,placebo,0,1
240723,.,0,1
240724,No,0,1
240725,serious,0,1
240726,adverse,0,0
240727,events,0,0
240728,occurred,0,0
240729,",",0,0
240730,and,0,0
240731,both,0,0
240732,regimens,0,1
240733,were,0,0
240734,equally,0,0
240735,well,0,0
240736,tolerated,0,1
240737,.,0,0
240738,The,0,0
240739,SPEM,0,0
240740,(,0,0
240741,Studio,0,0
240742,Policentrico,0,0
240743,Elettrocateteri,0,1
240744,Membrane,0,1
240745,),0,0
240746,:,0,0
240747,a,0,0
240748,multicenter,0,0
240749,study,0,0
240750,on,0,0
240751,membrane,0,0
240752,leads,0,0
240753,.,0,0
240754,SPEM,0,0
240755,is,0,0
240756,a,0,0
240757,multicenter,0,0
240758,randomized,0,1
240759,double-blind,0,1
240760,study,0,0
240761,performed,0,0
240762,to,0,0
240763,test,0,0
240764,the,0,0
240765,acute,0,0
240766,and,0,0
240767,chronic,0,0
240768,electrophysiological,0,0
240769,behavior,0,0
240770,of,0,0
240771,three,0,0
240772,different,0,0
240773,ventricular,0,0
240774,leads,0,0
240775,:,0,0
240776,(,0,0
240777,1,0,0
240778,),0,0
240779,an,1,0
240780,ion,1,0
240781,exchange,1,0
240782,membrane,1,0
240783,with,1,1
240784,30-microgram,1,1
240785,dexamethasone,1,1
240786,elution,1,1
240787,in,1,0
240788,a,1,0
240789,contoured,1,0
240790,activated,1,0
240791,carbon,1,0
240792,tip,1,0
240793,lead,1,0
240794,(,0,0
240795,Membrane,0,0
240796,1400T,0,0
240797,",",0,0
240798,30,0,0
240799,patients,0,0
240800,),0,1
240801,;,0,1
240802,(,0,1
240803,2,0,1
240804,),0,0
240805,the,1,0
240806,same,1,0
240807,lead,1,0
240808,design,1,0
240809,without,1,0
240810,steroid,1,1
240811,(,0,1
240812,Membrane,0,1
240813,1401T,0,1
240814,",",0,0
240815,24,0,0
240816,patients,0,0
240817,),0,1
240818,;,0,1
240819,and,0,1
240820,(,0,1
240821,3,0,1
240822,),0,0
240823,the,1,0
240824,same,1,0
240825,lead,1,0
240826,design,1,0
240827,without,1,0
240828,steroid,1,1
240829,or,1,0
240830,membrane,1,0
240831,(,0,0
240832,control,0,0
240833,group,0,0
240834,",",0,0
240835,27,0,0
240836,patients,0,0
240837,),0,0
240838,.,0,0
240839,Twenty-three,0,0
240840,of,0,0
240841,the,0,0
240842,81,0,0
240843,patients,0,0
240844,were,0,0
240845,women,0,0
240846,;,0,0
240847,the,0,0
240848,mean,0,0
240849,age,0,0
240850,for,0,0
240851,all,0,0
240852,patients,0,0
240853,was,0,0
240854,74,0,0
240855,+/-,0,0
240856,10,0,0
240857,years,0,0
240858,.,0,0
240859,Parameters,0,0
240860,are,0,0
240861,calculated,0,0
240862,both,0,0
240863,in,0,0
240864,uni-,0,0
240865,and,0,0
240866,bipolar,0,0
240867,configuration,0,0
240868,at,0,0
240869,implant,0,0
240870,and,0,0
240871,at,0,0
240872,follow-up,0,0
240873,after,0,0
240874,1,0,0
240875,",",0,0
240876,5,0,0
240877,",",0,0
240878,15,0,0
240879,",",0,0
240880,30,0,0
240881,",",0,0
240882,90,0,0
240883,",",0,0
240884,180,0,0
240885,",",0,0
240886,and,0,0
240887,360,0,0
240888,days,0,0
240889,.,0,0
240890,Implant,0,1
240891,threshold,0,1
240892,(,0,0
240893,chronaxie,0,0
240894,=,0,0
240895,0.413,0,0
240896,+/-,0,0
240897,0.280,0,0
240898,ms,0,0
240899,",",0,0
240900,rheobase,0,0
240901,=,0,0
240902,0.264,0,0
240903,+/-,0,0
240904,0.099,0,0
240905,V,0,0
240906,),0,0
240907,",",0,0
240908,signal,0,0
240909,amplitude,0,0
240910,(,0,0
240911,13.45,0,0
240912,+/-,0,0
240913,5.87,0,0
240914,mV,0,0
240915,),0,0
240916,",",0,0
240917,and,0,0
240918,slew,0,0
240919,rate,0,0
240920,(,0,0
240921,2.05,0,0
240922,+/-,0,0
240923,1.38,0,0
240924,V/s,0,0
240925,),0,0
240926,reveal,0,0
240927,no,0,0
240928,significant,0,0
240929,differences,0,0
240930,.,0,0
240931,Pacing,0,0
240932,impedance,0,0
240933,values,0,0
240934,both,0,0
240935,at,0,0
240936,implant,0,0
240937,(,0,0
240938,unipolar,0,0
240939,571,0,0
240940,+/-,0,0
240941,165,0,0
240942,omega,0,0
240943,;,0,0
240944,bipolar,0,0
240945,605,0,0
240946,+/-,0,0
240947,123,0,0
240948,omega,0,0
240949,),0,0
240950,and,0,0
240951,at,0,1
240952,follow-ups,0,0
240953,(,0,0
240954,unipolar,0,0
240955,480,0,0
240956,+/-,0,0
240957,72,0,0
240958,omega,0,0
240959,;,0,0
240960,bipolar,0,0
240961,518,0,0
240962,+/-,0,0
240963,75,0,0
240964,omega,0,0
240965,),0,0
240966,are,0,0
240967,slightly,0,0
240968,lower,0,0
240969,in,0,0
240970,the,0,0
240971,unipolar,0,0
240972,configuration,0,0
240973,.,0,0
240974,At,0,0
240975,15,0,0
240976,and,0,0
240977,30-day,0,0
240978,follow-ups,0,0
240979,",",0,0
240980,control,0,0
240981,group,0,0
240982,and,0,0
240983,nonsteroid,0,1
240984,leads,0,0
240985,show,0,0
240986,a,0,0
240987,higher,0,0
240988,threshold,0,0
240989,value,0,0
240990,growth,0,0
240991,(,0,0
240992,in,0,0
240993,unipolar,0,0
240994,from,0,0
240995,0.16,0,0
240996,+/-,0,0
240997,0.11,0,0
240998,to,0,0
240999,1.19,0,0
241000,+/-,0,0
241001,0.85,0,0
241002,microJ,0,0
241003,;,0,0
241004,in,0,0
241005,bipolar,0,0
241006,from,0,0
241007,0.18,0,0
241008,+/-,0,0
241009,0.13,0,0
241010,to,0,0
241011,1.24,0,0
241012,+/-,0,0
241013,0.88,0,0
241014,microJ,0,0
241015,),0,0
241016,than,0,0
241017,the,0,0
241018,membrane,0,0
241019,steroid,0,1
241020,leads,0,1
241021,(,0,0
241022,in,0,0
241023,unipolar,0,0
241024,from,0,0
241025,0.13,0,0
241026,+/-,0,0
241027,0.11,0,0
241028,to,0,0
241029,0.70,0,0
241030,+/-,0,0
241031,0.39,0,0
241032,microJ,0,0
241033,;,0,0
241034,in,0,0
241035,bipolar,0,0
241036,from,0,0
241037,0.23,0,0
241038,+/-,0,0
241039,0.32,0,0
241040,to,0,0
241041,0.76,0,0
241042,+/-,0,0
241043,0.36,0,0
241044,microJ,0,0
241045,),0,0
241046,;,0,0
241047,the,0,0
241048,threshold,0,1
241049,of,0,0
241050,nonsteroid,0,1
241051,leads,0,0
241052,decreases,0,0
241053,after,0,0
241054,1-3,0,0
241055,months,0,0
241056,and,0,0
241057,it,0,0
241058,settles,0,0
241059,at,0,0
241060,the,0,0
241061,same,0,0
241062,threshold,0,0
241063,level,0,0
241064,of,0,0
241065,the,0,0
241066,leads,0,0
241067,with,0,0
241068,membrane,0,0
241069,and,0,0
241070,steroid,0,1
241071,(,0,1
241072,in,0,0
241073,unipolar,0,0
241074,0.60,0,0
241075,+/-,0,0
241076,0.33,0,0
241077,microJ,0,0
241078,;,0,0
241079,in,0,0
241080,bipolar,0,0
241081,0.55,0,0
241082,+/-,0,0
241083,0.26,0,0
241084,microJ,0,0
241085,),0,0
241086,",",0,0
241087,which,0,0
241088,has,0,0
241089,been,0,0
241090,stable,0,0
241091,since,0,0
241092,the,0,0
241093,first,0,0
241094,month,0,0
241095,.,0,0
241096,The,0,0
241097,ion,1,0
241098,exchange,1,0
241099,membrane,1,0
241100,is,0,0
241101,effective,0,0
241102,in,0,0
241103,reducing,0,0
241104,the,0,0
241105,chronic,0,0
241106,pacing,0,0
241107,threshold,0,0
241108,like,0,0
241109,acute,0,1
241110,steroid,0,1
241111,elution,0,1
241112,at,0,1
241113,low,0,0
241114,doses,0,1
241115,",",0,0
241116,but,0,0
241117,membrane,0,0
241118,alone,0,0
241119,does,0,0
241120,not,0,0
241121,prevent,0,0
241122,an,0,0
241123,acute,0,0
241124,pacing,0,0
241125,threshold,0,0
241126,increase,0,0
241127,through,0,0
241128,the,0,0
241129,first,0,0
241130,month,0,0
241131,postimplant,0,0
241132,.,0,0
241133,Amonafide,1,1
241134,:,1,1
241135,An,0,1
241136,active,0,0
241137,agent,0,0
241138,in,0,0
241139,the,0,0
241140,treatment,0,0
241141,of,0,0
241142,previously,0,0
241143,untreated,0,0
241144,advanced,0,0
241145,breast,0,0
241146,cancer,0,0
241147,--,0,0
241148,a,0,0
241149,cancer,0,0
241150,and,0,0
241151,leukemia,0,0
241152,group,0,0
241153,B,0,0
241154,study,0,0
241155,(,0,0
241156,CALGB,0,0
241157,8642,0,0
241158,),0,0
241159,.,0,0
241160,Amonafide,1,1
241161,is,0,0
241162,a,0,0
241163,new,0,0
241164,imide,0,1
241165,derivative,0,1
241166,of,0,1
241167,naphthalic,0,1
241168,acid,0,1
241169,.,0,1
241170,The,0,0
241171,drug,0,1
241172,had,0,0
241173,demonstrated,0,0
241174,significant,0,0
241175,activity,0,0
241176,in,0,0
241177,preclinical,0,0
241178,studies,0,0
241179,and,0,0
241180,some,0,0
241181,activity,0,0
241182,in,0,0
241183,Phase,0,0
241184,I,0,0
241185,trials,0,0
241186,.,0,0
241187,The,0,0
241188,drug,0,1
241189,is,0,0
241190,extensively,0,0
241191,metabolized,0,0
241192,and,0,0
241193,detected,0,0
241194,in,0,0
241195,plasma,0,1
241196,and,0,1
241197,urine,0,1
241198,.,0,1
241199,Its,0,0
241200,toxicity,0,0
241201,has,0,0
241202,previously,0,0
241203,been,0,0
241204,correlated,0,0
241205,to,0,0
241206,the,0,0
241207,formation,0,0
241208,of,0,0
241209,an,0,0
241210,active,0,0
241211,metabolite,0,1
241212,",",0,1
241213,N-acetyl-amonafide,0,1
241214,.,0,1
241215,Amonafide,1,1
241216,was,0,0
241217,chosen,0,0
241218,for,0,0
241219,inclusion,0,0
241220,in,0,0
241221,the,0,0
241222,Cancer,0,0
241223,and,0,0
241224,Leukemia,0,0
241225,Group,0,0
241226,B,0,1
241227,(,0,1
241228,CALGB,0,1
241229,),0,1
241230,master,0,0
241231,metastatic,0,0
241232,breast,0,0
241233,cancer,0,0
241234,protocol,0,0
241235,.,0,0
241236,CALGB,0,0
241237,8642,0,0
241238,randomizes,0,0
241239,previously,0,0
241240,untreated,0,0
241241,metastatic,0,0
241242,breast,0,0
241243,cancer,0,0
241244,patients,0,0
241245,either,0,0
241246,to,0,0
241247,one,0,0
241248,of,0,0
241249,several,0,0
241250,Phase,0,0
241251,II,0,0
241252,agents,0,0
241253,given,0,0
241254,for,0,0
241255,up,0,0
241256,to,0,0
241257,four,0,0
241258,cycles,0,0
241259,and,0,0
241260,then,0,0
241261,followed,0,0
241262,by,0,0
241263,standard,1,1
241264,cyclophosphamide-doxorubicin-5-fluorouracil,1,1
241265,",",0,0
241266,or,0,0
241267,to,0,0
241268,immediate,1,0
241269,treatment,1,0
241270,with,1,0
241271,standard,1,0
241272,cyclophosphamide-doxorubicin-5-fluorouracil,1,1
241273,.,1,0
241274,The,0,0
241275,end,0,0
241276,point,0,0
241277,of,0,0
241278,CALGB,0,0
241279,8642,0,0
241280,is,0,0
241281,to,0,0
241282,assess,0,0
241283,the,0,0
241284,difference,0,0
241285,in,0,0
241286,survival,0,0
241287,",",0,0
241288,toxicity,0,0
241289,",",0,0
241290,and,0,0
241291,overall,0,0
241292,response,0,0
241293,when,0,0
241294,limited,0,0
241295,exposure,0,0
241296,to,0,0
241297,Phase,0,0
241298,II,0,0
241299,agents,0,0
241300,precedes,0,0
241301,standard,0,0
241302,chemotherapy,0,0
241303,.,0,0
241304,This,0,0
241305,report,0,0
241306,deals,0,0
241307,only,0,0
241308,with,0,0
241309,amonafide,1,1
241310,as,0,0
241311,a,0,0
241312,Phase,0,0
241313,II,0,0
241314,agent,0,0
241315,.,0,0
241316,Comparisons,0,0
241317,with,0,0
241318,the,0,0
241319,cyclophosphamide-doxorubicin-5-fluorouracil,1,1
241320,arm,0,1
241321,will,0,0
241322,not,0,0
241323,be,0,0
241324,addressed,0,0
241325,.,0,0
241326,Patients,0,0
241327,had,0,0
241328,to,0,0
241329,have,0,0
241330,histologically,0,0
241331,documented,0,0
241332,measurable,0,0
241333,breast,0,0
241334,cancer,0,0
241335,and,0,0
241336,a,0,0
241337,performance,0,0
241338,status,0,0
241339,of,0,0
241340,0-1,0,0
241341,.,0,0
241342,Patients,0,0
241343,could,0,0
241344,not,0,0
241345,have,0,0
241346,had,0,0
241347,prior,0,0
241348,chemotherapy,0,0
241349,for,0,0
241350,metastatic,0,0
241351,disease,0,0
241352,.,0,0
241353,Prior,0,1
241354,adjuvant,0,1
241355,chemotherapy,0,1
241356,was,0,0
241357,permitted,0,0
241358,.,0,0
241359,Patients,0,0
241360,could,0,0
241361,not,0,0
241362,have,0,0
241363,visceral,0,0
241364,crisis,0,1
241365,.,0,0
241366,Amonafide,1,1
241367,was,0,0
241368,given,0,0
241369,at,0,0
241370,300,0,0
241371,mg/m2/day,0,1
241372,i.v,0,1
241373,.,0,1
241374,for,0,0
241375,5,0,0
241376,days,0,0
241377,",",0,0
241378,and,0,0
241379,repeated,0,0
241380,at,0,0
241381,21-day,0,1
241382,intervals,0,0
241383,for,0,0
241384,a,0,0
241385,maximum,0,0
241386,of,0,0
241387,four,0,0
241388,cycles,0,0
241389,.,0,0
241390,Escalation,0,0
241391,and,0,0
241392,reduction,0,0
241393,in,0,0
241394,dose,0,1
241395,was,0,0
241396,mandated,0,0
241397,dependent,0,0
241398,on,0,0
241399,hematotoxicity,0,1
241400,or,0,0
241401,lack,0,0
241402,thereof,0,0
241403,.,0,0
241404,Toxicity,0,0
241405,was,0,0
241406,primarily,0,0
241407,hematological,0,0
241408,and,0,0
241409,bimodal,0,0
241410,:,0,0
241411,32,0,0
241412,%,0,0
241413,had,0,0
241414,grade,0,0
241415,3,0,0
241416,or,0,0
241417,4,0,1
241418,leukopenia,0,1
241419,and,0,0
241420,24,0,0
241421,%,0,0
241422,had,0,0
241423,grade,0,0
241424,3,0,0
241425,or,0,0
241426,4,0,1
241427,thrombocytopenia,0,0
241428,;,0,0
241429,22,0,0
241430,%,0,0
241431,had,0,0
241432,no,0,0
241433,leukopenia,0,1
241434,and,0,0
241435,44,0,0
241436,%,0,0
241437,had,0,0
241438,no,0,0
241439,thrombocytopenia,0,0
241440,.,0,0
241441,The,0,0
241442,response,0,0
241443,rate,0,0
241444,was,0,0
241445,18,0,0
241446,%,0,0
241447,",",0,0
241448,including,0,0
241449,one,0,0
241450,complete,0,0
241451,response,0,0
241452,.,0,0
241453,When,0,0
241454,response,0,0
241455,was,0,0
241456,analyzed,0,0
241457,by,0,0
241458,hematological,0,0
241459,toxicity,0,0
241460,",",0,0
241461,there,0,0
241462,was,0,0
241463,a,0,0
241464,35.7,0,0
241465,%,0,0
241466,response,0,0
241467,if,0,0
241468,patients,0,0
241469,had,0,0
241470,leukopenia,0,1
241471,grade,0,1
241472,3/4,0,1
241473,(,0,0
241474,versus,0,0
241475,8.3,0,0
241476,%,0,0
241477,",",0,0
241478,P,0,0
241479,=,0,0
241480,0.08,0,0
241481,),0,0
241482,.,0,0
241483,There,0,0
241484,was,0,0
241485,a,0,0
241486,50,0,0
241487,%,0,0
241488,response,0,0
241489,if,0,0
241490,patients,0,0
241491,had,0,0
241492,thrombocytopenia,0,0
241493,grade,0,1
241494,3/4,0,1
241495,(,0,0
241496,versus,0,0
241497,7.1,0,0
241498,%,0,0
241499,",",0,0
241500,P,0,0
241501,=,0,0
241502,<,0,0
241503,0.01,0,0
241504,),0,0
241505,.,0,0
241506,We,0,0
241507,conclude,0,0
241508,that,0,0
241509,amonafide,1,1
241510,is,0,0
241511,somewhat,0,0
241512,active,0,0
241513,in,0,0
241514,previously,0,0
241515,untreated,0,0
241516,breast,0,0
241517,cancer,0,0
241518,patients,0,0
241519,.,0,0
241520,There,0,0
241521,may,0,0
241522,be,0,0
241523,a,0,0
241524,steep,0,0
241525,dose-response,0,1
241526,curve,0,1
241527,",",0,0
241528,based,0,0
241529,on,0,0
241530,the,0,0
241531,significant,0,0
241532,correlation,0,0
241533,between,0,0
241534,myelosuppression,0,1
241535,and,0,0
241536,response,0,0
241537,.,0,0
241538,Rates,0,0
241539,of,0,0
241540,responses,0,0
241541,in,0,0
241542,patients,0,0
241543,adequately,0,1
241544,dosed,0,1
241545,(,0,1
241546,i.e.,0,0
241547,",",0,0
241548,with,0,0
241549,significant,0,0
241550,hematotoxicity,0,1
241551,),0,1
241552,with,0,1
241553,amonafide,0,1
241554,ranged,0,0
241555,from,0,0
241556,35,0,0
241557,to,0,0
241558,50,0,0
241559,%,0,0
241560,.,0,0
241561,Further,0,0
241562,studies,0,0
241563,will,0,0
241564,incorporate,0,0
241565,individualized,0,0
241566,dosing,0,1
241567,based,0,0
241568,on,0,0
241569,pretreatment,0,1
241570,acetylator,0,1
241571,phenotyping,0,0
241572,.,0,0
241573,Basal,0,0
241574,cell,0,0
241575,carcinoma,0,0
241576,of,0,0
241577,the,0,0
241578,face,0,0
241579,:,0,0
241580,surgery,1,0
241581,or,1,0
241582,radiotherapy,1,0
241583,?,0,0
241584,Results,0,0
241585,of,0,0
241586,a,0,0
241587,randomized,0,0
241588,study,0,0
241589,.,0,0
241590,Marginal,0,0
241591,benefit/disadvantage,0,0
241592,of,0,0
241593,granulocyte,1,1
241594,colony-stimulating,1,1
241595,factor,1,1
241596,therapy,1,1
241597,after,0,0
241598,autologous,0,0
241599,blood,0,0
241600,stem,0,0
241601,cell,0,0
241602,transplantation,0,0
241603,in,0,0
241604,children,0,0
241605,:,0,0
241606,results,0,0
241607,of,0,0
241608,a,0,0
241609,prospective,0,0
241610,randomized,0,0
241611,trial,0,0
241612,.,0,0
241613,The,0,0
241614,Japanese,0,0
241615,Cooperative,0,0
241616,Study,0,0
241617,Group,0,0
241618,of,0,0
241619,PBSCT,0,0
241620,.,0,0
241621,In,0,0
241622,this,0,0
241623,prospective,0,0
241624,trial,0,0
241625,",",0,0
241626,a,0,0
241627,total,0,0
241628,of,0,0
241629,74,0,0
241630,children,0,0
241631,who,0,0
241632,were,0,0
241633,scheduled,0,0
241634,to,0,0
241635,undergo,0,0
241636,high-dose,1,1
241637,chemotherapy,1,1
241638,followed,0,0
241639,by,0,0
241640,autologous,1,0
241641,peripheral,1,0
241642,blood,1,0
241643,stem,1,0
241644,cell,1,0
241645,transplantation,1,0
241646,(,0,1
241647,PBSCT,0,1
241648,),0,1
241649,were,0,0
241650,prospectively,0,0
241651,randomized,0,0
241652,at,0,0
241653,diagnosis,0,0
241654,to,0,0
241655,evaluate,0,0
241656,the,0,0
241657,effectiveness,0,0
241658,of,0,0
241659,exogenous,0,0
241660,granulocyte,1,1
241661,colony-stimulating,1,1
241662,factor,1,1
241663,(,0,1
241664,G-CSF,0,1
241665,),0,0
241666,treatment,0,0
241667,in,0,0
241668,accelerating,0,0
241669,hematopoietic,0,0
241670,recovery,0,0
241671,after,0,0
241672,PBSCT,0,0
241673,.,0,0
241674,The,0,0
241675,diagnosis,0,0
241676,included,0,0
241677,acute,0,0
241678,lymphoblastic,0,1
241679,leukemia,0,1
241680,(,0,1
241681,ALL,0,1
241682,),0,1
241683,(,0,0
241684,n,0,0
241685,=,0,0
241686,27,0,0
241687,),0,0
241688,",",0,0
241689,neuroblastoma,0,1
241690,(,0,0
241691,n,0,0
241692,=,0,0
241693,29,0,0
241694,),0,0
241695,",",0,0
241696,and,0,0
241697,miscellaneous,0,0
241698,solid,0,0
241699,tumors,0,1
241700,(,0,0
241701,n,0,0
241702,=,0,0
241703,18,0,0
241704,),0,0
241705,.,0,0
241706,Eligibility,0,0
241707,criteria,0,0
241708,included,0,0
241709,(,0,0
241710,1,0,0
241711,),0,0
241712,primary,1,0
241713,PBSCT,1,1
241714,",",0,1
241715,(,0,1
241716,2,0,1
241717,),0,0
241718,chemotherapy-responsive,0,1
241719,disease,0,1
241720,",",0,0
241721,and,0,0
241722,(,0,1
241723,3,0,1
241724,),0,0
241725,collected,0,0
241726,cell,0,0
241727,number,0,0
241728,>,0,0
241729,1,0,0
241730,x,0,0
241731,10,0,0
241732,(,0,1
241733,5,0,1
241734,),0,1
241735,colony-forming,0,1
241736,unit-granulocyte-macrophage,0,1
241737,(,0,1
241738,CFU-GM,0,1
241739,),0,1
241740,/kg,0,1
241741,and,0,1
241742,>,0,0
241743,1,0,0
241744,x,0,0
241745,10,0,0
241746,(,0,1
241747,6,0,1
241748,),0,1
241749,CD34,0,1
241750,(,0,1
241751,+,0,1
241752,),0,1
241753,cells/kg,0,1
241754,patient,0,1
241755,'s,0,1
241756,body,0,0
241757,weight,0,0
241758,.,0,0
241759,After,0,0
241760,applying,0,0
241761,the,0,0
241762,above,0,0
241763,criteria,0,0
241764,",",0,0
241765,11,0,0
241766,patients,0,0
241767,were,0,0
241768,excluded,0,0
241769,due,0,0
241770,to,0,0
241771,disease,0,0
241772,progression,0,0
241773,before,0,0
241774,PBSCT,1,1
241775,(,0,0
241776,n,0,0
241777,=,0,0
241778,6,0,0
241779,),0,0
241780,or,0,0
241781,a,0,0
241782,low,0,0
241783,number,0,0
241784,of,0,0
241785,harvested,0,0
241786,cells,0,0
241787,(,0,0
241788,n,0,0
241789,=,0,0
241790,5,0,0
241791,),0,0
241792,",",0,0
241793,leaving,0,0
241794,63,0,0
241795,patients,0,0
241796,for,0,0
241797,analysis,0,0
241798,;,0,0
241799,32,0,0
241800,patients,0,0
241801,in,0,0
241802,the,0,0
241803,treatment,0,0
241804,group,0,0
241805,(,0,1
241806,300,0,1
241807,microg/m2,0,1
241808,of,0,1
241809,G-CSF,1,1
241810,intravenously,0,1
241811,over,0,1
241812,1,0,0
241813,hour,0,0
241814,from,0,1
241815,day,0,0
241816,1,0,0
241817,of,0,0
241818,PBSCT,1,1
241819,),1,0
241820,and,0,0
241821,31,0,0
241822,in,0,0
241823,the,0,0
241824,control,1,0
241825,group,1,0
241826,without,0,0
241827,treatment,0,0
241828,.,0,0
241829,Two,0,0
241830,distinct,0,0
241831,disease-oriented,0,1
241832,high-dose,1,1
241833,regimens,1,1
241834,without,1,1
241835,total,1,0
241836,body,1,0
241837,irradiation,1,0
241838,consisted,1,0
241839,of,1,0
241840,the,1,0
241841,MCVAC,1,1
241842,regimen,1,1
241843,using,1,1
241844,ranimustine,1,1
241845,(,1,1
241846,MCNU,1,1
241847,",",1,0
241848,450,1,0
241849,mg/m2,1,1
241850,),1,1
241851,",",1,1
241852,cytosine,1,1
241853,arabinoside,1,1
241854,(,1,1
241855,16,1,1
241856,g/m2,1,1
241857,),1,1
241858,",",1,1
241859,etoposide,1,1
241860,(,1,1
241861,1.6,1,1
241862,g/m2,1,1
241863,),1,1
241864,",",1,1
241865,and,1,1
241866,cyclophosphamide,1,1
241867,(,0,1
241868,100,0,1
241869,mg/kg,0,1
241870,),0,1
241871,for,0,0
241872,patients,0,0
241873,with,0,0
241874,ALL,0,0
241875,",",0,0
241876,and,0,0
241877,the,0,0
241878,Hi-MEC,1,1
241879,regimen,1,1
241880,using,1,1
241881,melphalan,1,1
241882,(,0,0
241883,180,0,1
241884,mg/m2,0,1
241885,),0,1
241886,",",0,1
241887,etoposide,1,1
241888,(,0,1
241889,1.6,0,1
241890,g/m2,0,1
241891,),0,1
241892,",",0,1
241893,and,0,1
241894,carboplatinum,1,1
241895,(,0,1
241896,1.6,0,1
241897,g/m2,0,1
241898,),0,1
241899,for,0,0
241900,those,0,0
241901,with,0,0
241902,solid,0,0
241903,tumors,0,0
241904,.,0,0
241905,Five,0,0
241906,patients,0,0
241907,(,0,0
241908,two,0,0
241909,in,0,0
241910,the,0,0
241911,treatment,0,0
241912,group,0,0
241913,and,0,0
241914,three,0,0
241915,in,0,0
241916,the,0,0
241917,control,0,0
241918,group,0,0
241919,),0,0
241920,were,0,0
241921,subsequently,0,0
241922,removed,0,0
241923,due,0,0
241924,to,0,0
241925,protocol,0,0
241926,violations,0,0
241927,.,0,0
241928,All,0,0
241929,patients,0,0
241930,survived,0,0
241931,PBSCT,0,0
241932,.,0,0
241933,The,0,0
241934,median,0,0
241935,numbers,0,0
241936,of,0,0
241937,transfused,0,0
241938,mononuclear,0,0
241939,cells,0,0
241940,(,0,1
241941,MNC,0,1
241942,),0,1
241943,",",0,0
241944,CD34,0,1
241945,(,0,1
241946,+,0,1
241947,),0,0
241948,cells,0,0
241949,",",0,0
241950,and,0,0
241951,CFU-GM,0,0
241952,were,0,0
241953,",",0,0
241954,respectively,0,0
241955,",",0,0
241956,4.5,0,0
241957,(,0,0
241958,range,0,0
241959,",",0,0
241960,1,0,0
241961,to,0,0
241962,19,0,0
241963,),0,0
241964,x,0,0
241965,10,0,0
241966,(,0,1
241967,8,0,1
241968,),0,1
241969,/kg,0,1
241970,",",0,1
241971,8.0,0,0
241972,(,0,0
241973,1.1,0,0
241974,to,0,0
241975,25,0,0
241976,),0,0
241977,x,0,0
241978,10,0,0
241979,(,0,1
241980,6,0,1
241981,),0,1
241982,/kg,0,1
241983,",",0,0
241984,and,0,0
241985,3.7,0,0
241986,(,0,0
241987,1.2,0,0
241988,to,0,0
241989,23,0,0
241990,),0,0
241991,x,0,0
241992,10,0,0
241993,(,0,1
241994,5,0,1
241995,),0,1
241996,/kg,0,1
241997,in,0,0
241998,the,0,0
241999,treatment,0,0
242000,group,0,0
242001,(,0,0
242002,n,0,0
242003,=,0,0
242004,30,0,0
242005,),0,0
242006,and,0,0
242007,2.9,0,0
242008,(,0,0
242009,0.8,0,0
242010,to,0,0
242011,21,0,0
242012,),0,0
242013,x,0,0
242014,10,0,0
242015,(,0,1
242016,8,0,1
242017,),0,1
242018,/kg,0,1
242019,",",0,1
242020,6.3,0,0
242021,(,0,0
242022,1.1,0,0
242023,to,0,0
242024,34,0,0
242025,),0,0
242026,x,0,0
242027,10,0,0
242028,(,0,1
242029,6,0,1
242030,),0,1
242031,/kg,0,1
242032,",",0,0
242033,and,0,0
242034,5.5,0,0
242035,(,0,0
242036,1.3,0,0
242037,to,0,0
242038,37,0,0
242039,),0,0
242040,x,0,0
242041,10,0,0
242042,(,0,1
242043,5,0,1
242044,),0,1
242045,/kg,0,1
242046,",",0,0
242047,respectively,0,0
242048,",",0,0
242049,in,0,0
242050,the,0,0
242051,control,0,0
242052,group,0,0
242053,(,0,0
242054,n,0,0
242055,=,0,0
242056,28,0,0
242057,),0,0
242058,",",0,0
242059,with,0,0
242060,no,0,0
242061,significant,0,0
242062,difference,0,0
242063,.,0,0
242064,After,0,0
242065,PBSCT,0,0
242066,",",0,0
242067,the,0,0
242068,time,0,0
242069,to,0,0
242070,achieve,0,0
242071,an,0,0
242072,absolute,0,0
242073,neutrophil,0,1
242074,count,0,1
242075,(,0,1
242076,ANC,0,1
242077,),0,1
242078,of,0,0
242079,>,0,0
242080,0.5,0,0
242081,x,0,0
242082,10,0,0
242083,(,0,1
242084,9,0,1
242085,),0,0
242086,/L,0,0
242087,in,0,0
242088,the,0,0
242089,treatment,0,0
242090,group,0,0
242091,was,0,0
242092,less,0,0
242093,than,0,0
242094,that,0,0
242095,in,0,0
242096,the,0,0
242097,control,0,0
242098,group,0,0
242099,(,0,0
242100,median,0,0
242101,",",0,0
242102,11,0,0
242103,v,0,0
242104,12,0,0
242105,days,0,0
242106,;,0,1
242107,the,0,0
242108,log-rank,0,0
242109,test,0,0
242110,",",0,0
242111,P,0,0
242112,=.046,0,0
242113,),0,0
242114,",",0,0
242115,although,0,0
242116,the,0,0
242117,last,0,0
242118,day,0,0
242119,of,0,0
242120,red,0,0
242121,blood,0,0
242122,cell,0,0
242123,(,0,1
242124,RBC,0,1
242125,),0,1
242126,transfusion,0,1
242127,(,0,1
242128,day,0,0
242129,11,0,0
242130,v,0,0
242131,day,0,0
242132,10,0,0
242133,),0,0
242134,and,0,0
242135,the,0,0
242136,duration,0,0
242137,of,0,0
242138,febrile,0,1
242139,days,0,1
242140,(,0,0
242141,>,0,0
242142,38,0,0
242143,degrees,0,0
242144,C,0,0
242145,),0,1
242146,after,0,0
242147,PBSCT,0,1
242148,(,0,0
242149,4,0,0
242150,v,0,0
242151,4,0,1
242152,days,0,0
242153,),0,0
242154,were,0,0
242155,identical,0,0
242156,in,0,0
242157,both,0,0
242158,groups,0,0
242159,.,0,0
242160,However,0,0
242161,",",0,0
242162,platelet,0,1
242163,recovery,0,0
242164,to,0,0
242165,>,0,0
242166,20,0,0
242167,x,0,0
242168,10,0,0
242169,(,0,1
242170,9,0,1
242171,),0,0
242172,/L,0,0
242173,was,0,0
242174,significantly,0,0
242175,longer,0,0
242176,in,0,0
242177,treatment,0,0
242178,group,0,0
242179,than,0,0
242180,control,0,0
242181,group,0,0
242182,(,0,0
242183,26,0,0
242184,v,0,0
242185,16,0,0
242186,days,0,0
242187,;,0,0
242188,P,0,0
242189,=.009,0,0
242190,),0,0
242191,and,0,0
242192,>,0,0
242193,50,0,0
242194,x,0,0
242195,10,0,0
242196,(,0,1
242197,9,0,1
242198,),0,0
242199,/L,0,0
242200,tended,0,0
242201,to,0,0
242202,take,0,0
242203,longer,0,0
242204,in,0,0
242205,the,0,0
242206,treatment,0,0
242207,group,0,0
242208,(,0,0
242209,29,0,0
242210,v,0,0
242211,26,0,0
242212,days,0,0
242213,;,0,0
242214,P,0,0
242215,=.126,0,0
242216,),0,0
242217,",",0,0
242218,with,0,0
242219,significantly,0,0
242220,more,0,0
242221,platelet,0,1
242222,transfusion-dependent,0,1
242223,days,0,1
242224,(,0,0
242225,27,0,0
242226,v,0,0
242227,13,0,0
242228,days,0,0
242229,;,0,1
242230,t-test,0,0
242231,",",0,0
242232,P,0,0
242233,=.037,0,0
242234,),0,0
242235,.,0,0
242236,When,0,0
242237,patients,0,0
242238,were,0,0
242239,divided,0,0
242240,into,0,0
242241,two,0,0
242242,different,0,0
242243,disease,0,0
242244,cohorts,0,0
242245,",",0,0
242246,ALL,0,0
242247,patients,0,0
242248,showed,0,0
242249,no,0,0
242250,difference,0,0
242251,in,0,0
242252,engraftment,0,0
242253,kinetics,0,0
242254,between,0,0
242255,the,0,0
242256,G-CSF,0,0
242257,treatment,0,0
242258,and,0,0
242259,control,0,0
242260,groups,0,0
242261,",",0,0
242262,while,0,0
242263,differences,0,0
242264,were,0,0
242265,seen,0,0
242266,in,0,0
242267,those,0,0
242268,with,0,0
242269,solid,0,0
242270,tumors,0,0
242271,.,0,0
242272,We,0,0
242273,concluded,0,0
242274,that,0,0
242275,the,0,0
242276,marginal,0,0
242277,clinical,0,0
242278,benefit,0,0
242279,of,0,0
242280,1,0,0
242281,day,0,0
242282,earlier,0,0
242283,recovery,0,0
242284,of,0,0
242285,granulocytes,0,0
242286,could,0,0
242287,be,0,0
242288,offset,0,0
242289,by,0,0
242290,the,0,0
242291,delayed,0,0
242292,recovery,0,0
242293,of,0,0
242294,platelets,0,1
242295,.,0,1
242296,We,0,1
242297,recommend,0,0
242298,that,0,0
242299,the,0,0
242300,routine,0,0
242301,application,0,0
242302,of,0,0
242303,costly,0,0
242304,G-CSF,0,0
242305,therapy,0,0
242306,in,0,0
242307,children,0,0
242308,undergoing,0,0
242309,PBSCT,0,0
242310,should,0,0
242311,be,0,0
242312,seriously,0,0
242313,reconsidered,0,0
242314,.,0,0
242315,Optimization,0,0
242316,of,0,0
242317,acid,0,0
242318,suppression,0,0
242319,for,0,0
242320,patients,0,0
242321,with,0,0
242322,peptic,0,0
242323,ulcer,0,0
242324,bleeding,0,0
242325,:,0,0
242326,an,0,0
242327,intragastric,0,1
242328,pH-metry,0,1
242329,study,0,0
242330,with,0,0
242331,omeprazole,1,1
242332,.,1,0
242333,OBJECTIVE,0,1
242334,To,0,0
242335,study,0,0
242336,whether,0,0
242337,an,0,0
242338,intravenous,0,1
242339,infusion,0,1
242340,dose,0,1
242341,of,0,1
242342,omeprazole,1,1
242343,(,0,1
242344,80,0,1
242345,mg,0,1
242346,+,0,1
242347,8,0,1
242348,mg/h,0,1
242349,),0,1
242350,during,0,0
242351,24,0,0
242352,h,0,0
242353,can,0,0
242354,be,0,0
242355,subsequently,0,0
242356,reduced,0,0
242357,with,0,0
242358,maintained,0,0
242359,effect,0,0
242360,.,0,0
242361,Second,0,0
242362,",",0,0
242363,to,0,0
242364,study,0,0
242365,the,0,0
242366,effect,0,0
242367,of,0,0
242368,oral,0,1
242369,omeprazole,1,1
242370,20,0,1
242371,mg,0,1
242372,given,0,1
242373,once,0,1
242374,or,0,1
242375,twice,0,1
242376,daily,0,1
242377,up,0,1
242378,to,0,0
242379,day,0,0
242380,10,0,0
242381,",",0,0
242382,after,0,0
242383,cessation,0,0
242384,of,0,0
242385,a,0,0
242386,3-day,0,1
242387,intravenous,0,1
242388,infusion,0,1
242389,(,0,1
242390,80,0,1
242391,mg,0,1
242392,+,0,1
242393,8,0,1
242394,mg/h,0,1
242395,),0,1
242396,.,0,1
242397,DESIGN,0,0
242398,Prospective,0,0
242399,",",0,0
242400,randomized,0,0
242401,",",0,0
242402,partly,0,0
242403,blinded,0,0
242404,study,0,0
242405,.,0,0
242406,METHODS,0,0
242407,Twelve,0,1
242408,Helicobacter,0,1
242409,pylori,0,1
242410,(,0,1
242411,+,0,1
242412,),0,1
242413,patients,0,0
242414,and,0,0
242415,12,0,0
242416,H.,0,1
242417,pylori,0,1
242418,(,0,1
242419,-,0,1
242420,),0,0
242421,subjects,0,0
242422,were,0,0
242423,included,0,0
242424,.,0,0
242425,In,0,0
242426,part,0,0
242427,I,0,0
242428,the,0,0
242429,patients,0,0
242430,received,0,0
242431,omeprazole,1,1
242432,",",0,1
242433,80,0,1
242434,mg,0,1
242435,+,0,1
242436,8,0,1
242437,mg/h,0,1
242438,",",0,1
242439,during,0,0
242440,24,0,0
242441,h,0,0
242442,followed,0,0
242443,by,0,0
242444,8,0,0
242445,",",0,0
242446,4,0,0
242447,or,0,0
242448,2,0,1
242449,mg/h,0,1
242450,.,0,1
242451,In,0,0
242452,part,0,0
242453,II,0,0
242454,the,0,0
242455,subjects,0,0
242456,received,0,0
242457,80,0,1
242458,mg,0,1
242459,+,0,1
242460,8,0,1
242461,mg/h,0,1
242462,during,0,1
242463,3,0,0
242464,days,0,0
242465,followed,0,0
242466,by,0,0
242467,20,0,1
242468,mg,0,1
242469,omeprazole,1,1
242470,orally,0,1
242471,",",0,1
242472,once,0,1
242473,or,0,1
242474,twice,0,1
242475,daily,0,1
242476,until,0,1
242477,day,0,1
242478,10,0,0
242479,.,0,1
242480,Intragastric,0,1
242481,pH,0,1
242482,was,0,0
242483,measured,0,0
242484,.,0,0
242485,RESULTS,0,0
242486,All,0,1
242487,H.,0,1
242488,pylori,0,1
242489,(,0,1
242490,+,0,1
242491,),0,0
242492,patients,0,0
242493,showed,0,0
242494,a,0,0
242495,rapid,0,0
242496,increase,0,0
242497,of,0,0
242498,intragastric,0,1
242499,pH,0,1
242500,with,0,0
242501,a,0,0
242502,mean,0,0
242503,intragastric,0,0
242504,pH,0,0
242505,of,0,0
242506,6.7,0,0
242507,during,0,0
242508,the,0,0
242509,second,0,0
242510,half,0,0
242511,of,0,0
242512,the,0,0
242513,first,0,0
242514,day,0,0
242515,.,0,0
242516,After,0,0
242517,the,0,0
242518,subsequent,0,0
242519,dose,0,1
242520,reduction,0,0
242521,",",0,0
242522,the,0,0
242523,mean,0,0
242524,pH,0,0
242525,decreased,0,0
242526,to,0,0
242527,6.1-6.2,0,0
242528,.,0,0
242529,Patients,0,0
242530,continuing,0,0
242531,on,0,0
242532,8,0,0
242533,mg/h,0,1
242534,showed,0,0
242535,the,0,0
242536,best,0,0
242537,results,0,0
242538,.,0,0
242539,Likewise,0,0
242540,",",0,0
242541,all,0,0
242542,H.,0,1
242543,pylori,0,1
242544,(,0,1
242545,-,0,1
242546,),0,0
242547,subjects,0,0
242548,showed,0,0
242549,a,0,0
242550,rapid,0,0
242551,and,0,0
242552,sustained,0,0
242553,reduction,0,0
242554,of,0,0
242555,intragastric,0,1
242556,acidity,0,1
242557,during,0,1
242558,the,0,0
242559,infusion,0,1
242560,.,0,1
242561,Subsequent,0,0
242562,dose,0,1
242563,reduction,0,0
242564,to,0,0
242565,20,0,1
242566,mg,0,1
242567,once,0,1
242568,daily,0,1
242569,led,0,0
242570,to,0,0
242571,a,0,0
242572,stable,0,0
242573,fraction,0,0
242574,of,0,0
242575,time,0,0
242576,with,0,0
242577,pH,0,0
242578,>,0,0
242579,3,0,0
242580,of,0,0
242581,72,0,0
242582,%,0,0
242583,.,0,0
242584,CONCLUSIONS,0,0
242585,Omeprazole,1,1
242586,given,0,1
242587,as,0,0
242588,a,0,0
242589,continuous,0,0
242590,infusion,0,1
242591,of,0,1
242592,80,0,1
242593,mg,0,1
242594,+,0,1
242595,8,0,1
242596,mg/h,0,1
242597,for,0,0
242598,72,0,0
242599,h,0,0
242600,followed,0,0
242601,by,0,0
242602,omeprazole,1,1
242603,20,0,1
242604,mg,0,1
242605,once,0,1
242606,daily,0,1
242607,raised,0,1
242608,the,0,0
242609,intragastric,0,1
242610,pH,0,1
242611,to,0,0
242612,and,0,0
242613,above,0,0
242614,levels,0,0
242615,alleged,0,0
242616,to,0,0
242617,allow,0,0
242618,haemostasis,0,0
242619,in,0,0
242620,patients,0,0
242621,with,0,0
242622,peptic,0,0
242623,ulcer,0,0
242624,bleeding,0,0
242625,and,0,0
242626,subsequent,0,0
242627,healing,0,0
242628,of,0,0
242629,the,0,0
242630,ulcer,0,0
242631,.,0,0
242632,The,0,0
242633,tolerability,0,1
242634,of,0,0
242635,lactated,1,1
242636,Ringer,1,1
242637,'s,1,0
242638,solution,1,0
242639,and,0,0
242640,BSS,1,0
242641,plus,1,0
242642,for,0,0
242643,ocular,0,0
242644,irrigation,0,0
242645,with,0,0
242646,and,0,0
242647,without,0,0
242648,the,0,0
242649,Morgan,0,0
242650,therapeutic,0,0
242651,lens,0,0
242652,.,0,0
242653,OBJECTIVE,0,0
242654,To,0,0
242655,evaluate,0,0
242656,two,0,0
242657,solutions,0,0
242658,",",0,0
242659,lactated,1,1
242660,Ringer,1,1
242661,'s,1,1
242662,(,1,1
242663,LR,1,1
242664,),1,1
242665,and,1,0
242666,a,1,0
242667,balanced,1,0
242668,salt,1,1
242669,solution,1,0
242670,(,0,0
242671,BSS,0,1
242672,Plus,0,1
242673,",",0,0
242674,Alcon,0,0
242675,Laboratories,0,0
242676,",",0,0
242677,Ft.,0,0
242678,Worth,0,1
242679,",",0,0
242680,TX,0,1
242681,),0,0
242682,",",0,0
242683,compared,0,0
242684,with,0,0
242685,normal,0,0
242686,saline,1,1
242687,solution,1,1
242688,(,1,1
242689,NSS,1,1
242690,),1,1
242691,",",0,0
242692,for,0,0
242693,ocular,0,0
242694,irrigation,0,0
242695,in,0,0
242696,healthy,0,0
242697,adult,0,0
242698,volunteers,0,0
242699,with,0,0
242700,and,0,0
242701,without,0,0
242702,the,0,0
242703,Morgan,0,0
242704,therapeutic,0,0
242705,lens,0,0
242706,(,0,1
242707,MTL,0,1
242708,),0,1
242709,.,0,0
242710,METHODS,0,0
242711,This,0,0
242712,was,0,0
242713,a,0,0
242714,prospective,0,0
242715,",",0,0
242716,double-blind,0,1
242717,",",0,1
242718,randomized,0,0
242719,study,0,0
242720,of,0,0
242721,healthy,0,0
242722,volunteers,0,0
242723,who,0,0
242724,were,0,0
242725,at,0,0
242726,least,0,0
242727,18,0,0
242728,years,0,0
242729,of,0,0
242730,age,0,0
242731,.,0,0
242732,Exclusion,0,0
242733,criteria,0,0
242734,included,0,0
242735,the,0,0
242736,use,0,0
242737,of,0,0
242738,analgesics,0,1
242739,within,0,0
242740,four,0,0
242741,hours,0,0
242742,of,0,0
242743,the,0,0
242744,study,0,0
242745,.,0,0
242746,A,0,0
242747,complete,0,0
242748,ophthalmologic,0,0
242749,examination,0,0
242750,was,0,0
242751,performed,0,0
242752,at,0,0
242753,baseline,0,0
242754,and,0,0
242755,at,0,0
242756,the,0,0
242757,completion,0,0
242758,of,0,0
242759,the,0,0
242760,study,0,0
242761,.,0,0
242762,Following,0,0
242763,randomization,0,0
242764,and,0,0
242765,prior,0,0
242766,to,0,0
242767,any,0,0
242768,intervention,0,0
242769,",",0,0
242770,baseline,0,0
242771,discomfort,0,0
242772,scores,0,0
242773,were,0,0
242774,obtained,0,0
242775,by,0,0
242776,means,0,0
242777,of,0,0
242778,a,0,0
242779,verbally,0,1
242780,administered,0,1
242781,",",0,0
242782,horizontal,0,0
242783,",",0,0
242784,100-mm,0,0
242785,",",0,0
242786,unnumbered,0,0
242787,analog,0,1
242788,discomfort,0,1
242789,scale,0,1
242790,.,0,0
242791,Both,0,0
242792,eyes,1,0
242793,of,1,0
242794,each,1,0
242795,volunteer,1,0
242796,were,1,0
242797,irrigated,1,0
242798,simultaneously,1,0
242799,for,1,0
242800,15,1,0
242801,minutes,1,0
242802,",",0,0
242803,with,0,0
242804,additional,0,0
242805,discomfort,0,0
242806,scores,0,0
242807,being,0,0
242808,recorded,0,0
242809,every,0,0
242810,5,0,0
242811,minutes,0,0
242812,using,0,0
242813,the,0,0
242814,same,0,0
242815,100-mm,0,0
242816,",",0,0
242817,unnumbered,0,0
242818,analog,0,1
242819,discomfort,0,1
242820,scale,0,1
242821,.,0,0
242822,A,0,0
242823,global,0,0
242824,evaluation,0,0
242825,to,0,0
242826,assess,0,0
242827,the,0,0
242828,method,0,0
242829,of,0,0
242830,irrigation,0,0
242831,and,0,0
242832,the,0,0
242833,solutions,0,0
242834,used,0,0
242835,for,0,0
242836,irrigation,0,0
242837,was,0,0
242838,completed,0,0
242839,by,0,0
242840,both,0,0
242841,the,0,0
242842,physician,0,0
242843,blinded,0,0
242844,to,0,0
242845,the,0,0
242846,treatment,0,0
242847,groups,0,0
242848,and,0,0
242849,the,0,0
242850,volunteers,0,0
242851,.,0,0
242852,The,0,0
242853,volunteers,0,0
242854,were,0,0
242855,continuously,0,0
242856,monitored,0,0
242857,for,0,0
242858,any,0,0
242859,adverse,0,0
242860,effects,0,0
242861,resulting,0,0
242862,from,0,0
242863,the,0,0
242864,irrigation,0,0
242865,solutions,0,0
242866,or,0,0
242867,MTL,0,0
242868,.,0,0
242869,RESULTS,0,0
242870,Sixty-three,0,0
242871,volunteers,0,0
242872,were,0,0
242873,recruited,0,0
242874,into,0,0
242875,the,0,0
242876,study,0,0
242877,",",0,0
242878,with,0,0
242879,61,0,0
242880,entered,0,0
242881,in,0,0
242882,the,0,0
242883,final,0,0
242884,analysis,0,0
242885,.,0,0
242886,Age,0,0
242887,and,0,0
242888,gender,0,0
242889,were,0,0
242890,balanced,0,0
242891,within,0,0
242892,each,0,0
242893,group,0,0
242894,.,0,0
242895,There,0,0
242896,was,0,0
242897,no,0,0
242898,significant,0,0
242899,difference,0,0
242900,in,0,0
242901,discomfort,0,0
242902,scores,0,0
242903,between,0,0
242904,the,0,0
242905,two,0,0
242906,groups,0,0
242907,;,0,0
242908,however,0,0
242909,",",0,0
242910,all,0,0
242911,discomfort,0,0
242912,scores,0,0
242913,decreased,0,0
242914,over,0,0
242915,time,0,0
242916,(,0,0
242917,p,0,0
242918,=,0,0
242919,0.008,0,0
242920,),0,0
242921,.,0,0
242922,A,0,1
242923,lens-solution,0,1
242924,interaction,0,0
242925,was,0,0
242926,identified,0,0
242927,",",0,0
242928,with,0,0
242929,LR,0,0
242930,being,0,0
242931,the,0,0
242932,most,0,0
242933,tolerated,0,1
242934,when,0,1
242935,administered,0,1
242936,with,0,0
242937,the,0,0
242938,MTL,0,0
242939,.,0,0
242940,A,0,0
242941,statistically,0,0
242942,higher,0,0
242943,ocular,0,0
242944,pH,0,0
242945,difference,0,0
242946,was,0,0
242947,seen,0,0
242948,between,0,0
242949,the,0,0
242950,pre-,0,0
242951,and,0,0
242952,postirrigation,0,0
242953,readings,0,0
242954,for,0,0
242955,the,0,0
242956,control,0,0
242957,eye,0,0
242958,in,0,0
242959,volunteers,0,0
242960,irrigated,0,0
242961,with,0,0
242962,MTL,0,0
242963,(,0,0
242964,p,0,0
242965,=,0,0
242966,0.046,0,0
242967,),0,0
242968,.,0,0
242969,Analysis,0,0
242970,of,0,0
242971,the,0,0
242972,global,0,0
242973,evaluations,0,0
242974,for,0,0
242975,each,0,0
242976,group,0,0
242977,revealed,0,0
242978,no,0,0
242979,difference,0,0
242980,in,0,0
242981,the,0,0
242982,distributions,0,0
242983,of,0,0
242984,physician,0,0
242985,and,0,0
242986,volunteer,0,0
242987,scores,0,1
242988,.,0,0
242989,No,0,1
242990,adverse,0,0
242991,event,0,0
242992,was,0,0
242993,reported,0,0
242994,in,0,0
242995,either,0,0
242996,group,0,0
242997,.,0,0
242998,CONCLUSION,0,0
242999,There,0,0
243000,does,0,0
243001,not,0,0
243002,appear,0,0
243003,to,0,0
243004,be,0,0
243005,any,0,0
243006,difference,0,0
243007,in,0,0
243008,discomfort,0,0
243009,scores,0,0
243010,between,0,0
243011,the,0,0
243012,ocular,0,0
243013,irrigation,0,1
243014,fluids,0,1
243015,when,0,0
243016,used,0,0
243017,without,0,0
243018,the,0,0
243019,MTL,0,0
243020,.,0,0
243021,Overall,0,0
243022,",",0,0
243023,the,0,0
243024,use,0,0
243025,of,0,0
243026,the,0,0
243027,MTL,0,0
243028,appears,0,0
243029,well,0,0
243030,tolerated,0,1
243031,by,0,0
243032,healthy,0,0
243033,",",0,0
243034,adult,0,0
243035,volunteers,0,0
243036,.,0,0
243037,However,0,0
243038,",",0,0
243039,there,0,0
243040,does,0,0
243041,appear,0,0
243042,to,0,0
243043,be,0,0
243044,a,0,0
243045,significant,0,0
243046,lens-solution,0,1
243047,effect,0,0
243048,on,0,0
243049,volunteers,0,0
243050,',0,0
243051,discomfort,0,0
243052,scores,0,0
243053,",",0,0
243054,with,0,0
243055,LR,0,0
243056,having,0,0
243057,significantly,0,0
243058,lower,0,0
243059,discomfort,0,0
243060,scores,0,0
243061,when,0,0
243062,used,0,0
243063,for,0,0
243064,ocular,0,0
243065,irrigation,0,0
243066,with,0,0
243067,the,0,0
243068,MTL,0,0
243069,.,0,0
243070,The,0,0
243071,authors,0,0
243072,conclude,0,0
243073,that,0,0
243074,the,0,0
243075,use,0,0
243076,of,0,0
243077,the,0,0
243078,MTL,0,0
243079,for,0,0
243080,ocular,0,0
243081,irrigation,0,0
243082,is,0,0
243083,well,0,0
243084,tolerated,0,1
243085,and,0,0
243086,recommend,0,0
243087,using,0,0
243088,LR,0,0
243089,as,0,0
243090,the,0,0
243091,irrigation,0,0
243092,solution,0,0
243093,for,0,0
243094,maximal,0,0
243095,patient,0,0
243096,comfort,0,0
243097,.,0,0
243098,The,0,0
243099,preparation,0,0
243100,of,0,0
243101,patients,0,0
243102,for,0,0
243103,cardiac,0,0
243104,surgery,0,0
243105,.,0,0
243106,This,0,0
243107,study,0,0
243108,examines,0,0
243109,the,0,0
243110,impact,0,0
243111,of,0,0
243112,a,0,0
243113,preadmission,1,0
243114,telephone,1,0
243115,intervention,1,0
243116,on,0,0
243117,anxiety,0,0
243118,",",0,0
243119,knowledge,0,0
243120,",",0,0
243121,and,0,0
243122,readiness,0,0
243123,for,0,0
243124,discharge,0,0
243125,for,0,0
243126,patients,0,0
243127,attending,0,0
243128,a,0,0
243129,preadmission,0,0
243130,teaching,0,0
243131,program,0,0
243132,prior,0,0
243133,to,0,0
243134,cardiac,0,0
243135,surgery,0,0
243136,.,0,0
243137,The,0,0
243138,primary,0,0
243139,goal,0,0
243140,of,0,0
243141,the,0,0
243142,telephone,1,0
243143,intervention,1,0
243144,was,0,0
243145,to,0,0
243146,provide,0,0
243147,support,0,0
243148,by,0,0
243149,giving,0,0
243150,additional,0,0
243151,information,0,0
243152,about,0,0
243153,individual,0,0
243154,concerns,0,0
243155,.,0,0
243156,The,0,0
243157,telephone,0,0
243158,intervention,0,0
243159,did,0,0
243160,not,0,0
243161,have,0,0
243162,an,0,0
243163,effect,0,0
243164,on,0,0
243165,anxiety,0,0
243166,and,0,0
243167,knowledge,0,0
243168,.,0,0
243169,A,0,0
243170,significantly,0,0
243171,higher,0,0
243172,level,0,0
243173,of,0,0
243174,anxiety,0,0
243175,was,0,0
243176,found,0,0
243177,in,0,0
243178,the,0,0
243179,experimental,0,0
243180,group,0,0
243181,on,0,0
243182,admission,0,0
243183,",",0,0
243184,but,0,0
243185,this,0,0
243186,difference,0,0
243187,became,0,0
243188,nonsignificant,0,0
243189,when,0,0
243190,baseline,0,0
243191,level,0,0
243192,and,0,0
243193,length,0,0
243194,of,0,0
243195,waiting,0,0
243196,time,0,0
243197,were,0,0
243198,entered,0,0
243199,as,0,0
243200,covariates,0,0
243201,.,0,0
243202,The,0,0
243203,more,0,0
243204,anxious,0,0
243205,group,0,0
243206,rated,0,0
243207,their,0,0
243208,perceived,0,0
243209,knowledge,0,0
243210,level,0,0
243211,lower,0,0
243212,",",0,0
243213,despite,0,0
243214,the,0,0
243215,fact,0,0
243216,that,0,0
243217,both,0,0
243218,groups,0,0
243219,had,0,0
243220,similar,0,0
243221,scores,0,0
243222,in,0,0
243223,actual,0,0
243224,knowledge,0,0
243225,.,0,0
243226,Given,0,0
243227,the,0,0
243228,potential,0,0
243229,barrier,0,0
243230,that,0,0
243231,anxiety,0,0
243232,can,0,0
243233,pose,0,0
243234,for,0,0
243235,patient,0,0
243236,learning,0,0
243237,",",0,0
243238,nurses,0,0
243239,need,0,0
243240,to,0,0
243241,adapt,0,0
243242,their,0,0
243243,interventions,0,0
243244,to,0,0
243245,deal,0,0
243246,with,0,0
243247,the,0,0
243248,patients,0,0
243249,',0,0
243250,feelings,0,0
243251,of,0,0
243252,anxiety,0,0
243253,that,0,0
243254,accompany,0,0
243255,cardiac,0,0
243256,surgery,0,0
243257,to,0,0
243258,make,0,0
243259,the,0,0
243260,learning,0,0
243261,process,0,0
243262,effective,0,0
243263,.,0,0
243264,[,0,0
243265,Effect,0,0
243266,of,0,0
243267,alanyl-glutamine,1,1
243268,in,0,0
243269,postoperative,0,1
243270,total,0,0
243271,parenteral,0,1
243272,nutrition,0,1
243273,on,0,0
243274,postoperative,0,0
243275,immunosuppression,0,0
243276,and,0,0
243277,morbidity,0,0
243278,.,0,0
243279,Preliminary,0,0
243280,results,0,0
243281,of,0,0
243282,a,0,0
243283,prospective,0,0
243284,randomized,0,0
243285,study,0,0
243286,],0,0
243287,.,0,0
243288,The,0,0
243289,impact,0,0
243290,of,0,0
243291,glutamine,1,0
243292,substitution,1,0
243293,on,0,0
243294,postoperative,0,0
243295,immunosuppression,0,0
243296,and,0,0
243297,morbidity,0,0
243298,was,0,0
243299,investigated,0,0
243300,in,0,0
243301,patients,0,0
243302,with,0,0
243303,surgical,0,0
243304,interventions,0,0
243305,and,0,0
243306,total,0,0
243307,parenteral,0,1
243308,nutrition,0,1
243309,in,0,0
243310,a,0,0
243311,prospective,0,0
243312,randomized,0,0
243313,trial,0,0
243314,.,0,0
243315,To,0,0
243316,analyze,0,0
243317,immune,0,0
243318,competence,0,0
243319,",",0,0
243320,the,0,0
243321,expression,0,0
243322,of,0,0
243323,CD3,0,0
243324,",",0,0
243325,CD4,0,0
243326,",",0,0
243327,and,0,0
243328,CD8,0,1
243329,on,0,0
243330,lymphocytes,0,0
243331,and,0,0
243332,of,0,0
243333,HLA-DR,0,0
243334,and,0,0
243335,CD14,0,1
243336,on,0,0
243337,monocytes,0,0
243338,as,0,0
243339,well,0,0
243340,as,0,0
243341,the,0,0
243342,plasma,0,0
243343,levels,0,0
243344,of,0,0
243345,IL-6,0,0
243346,and,0,0
243347,IL-10,0,0
243348,was,0,0
243349,evaluated,0,0
243350,before,0,0
243351,",",0,0
243352,1,0,0
243353,",",0,0
243354,2,0,0
243355,",",0,0
243356,4,0,0
243357,",",0,0
243358,and,0,0
243359,7,0,0
243360,days,0,0
243361,after,0,0
243362,surgery,0,0
243363,.,0,0
243364,A,0,0
243365,total,0,0
243366,of,0,0
243367,34,0,0
243368,patients,0,0
243369,have,0,0
243370,been,0,0
243371,included,0,0
243372,(,1,0
243373,with,1,0
243374,glutamine,1,1
243375,:,1,0
243376,n,1,0
243377,=,1,0
243378,18,1,0
243379,;,1,0
243380,without,1,0
243381,glutamine,1,1
243382,:,1,0
243383,n,0,0
243384,=,0,0
243385,16,0,0
243386,),0,0
243387,.,0,0
243388,Patients,0,0
243389,with,0,0
243390,glutamine,1,0
243391,substitution,1,0
243392,showed,0,0
243393,decreased,0,0
243394,systemic,0,0
243395,inflammation,0,0
243396,",",0,0
243397,significant,0,0
243398,faster,0,0
243399,compensation,0,0
243400,for,0,0
243401,postoperative,0,0
243402,immunosuppression,0,0
243403,and,0,0
243404,a,0,0
243405,lower,0,0
243406,incidence,0,0
243407,of,0,0
243408,postoperative,0,0
243409,complications,0,0
243410,.,0,0
243411,Patients,0,0
243412,without,0,0
243413,postoperative,0,0
243414,complications,0,0
243415,showed,0,0
243416,no,0,0
243417,significant,0,0
243418,differences,0,0
243419,in,0,0
243420,postoperative,0,0
243421,immunosuppression,0,0
243422,.,0,0
243423,Erythropoiesis,0,0
243424,after,0,0
243425,therapy,0,0
243426,with,0,0
243427,recombinant,1,1
243428,human,1,0
243429,erythropoietin,1,1
243430,:,1,1
243431,a,0,0
243432,dose-response,0,1
243433,study,0,0
243434,in,0,0
243435,anemic,0,0
243436,cancer,0,0
243437,surgery,0,0
243438,patients,0,0
243439,.,0,0
243440,BACKGROUND,0,0
243441,AND,0,1
243442,OBJECTIVES,0,1
243443,Preoperative,0,0
243444,treatment,0,0
243445,with,0,0
243446,600,0,0
243447,U/kg,0,1
243448,of,0,0
243449,recombinant,1,1
243450,human,1,1
243451,erythropoietin,1,1
243452,(,1,1
243453,r-HuEPO,1,1
243454,),1,0
243455,effectively,0,0
243456,increases,0,0
243457,erythropoiesis,0,1
243458,in,0,0
243459,cancer,0,0
243460,patients,0,0
243461,.,0,0
243462,The,0,0
243463,aim,0,0
243464,of,0,0
243465,this,0,0
243466,study,0,0
243467,was,0,0
243468,to,0,0
243469,evaluate,0,0
243470,the,0,0
243471,erythropoietic,0,1
243472,response,0,0
243473,after,0,0
243474,different,0,0
243475,doses,0,1
243476,of,0,0
243477,r-HuEPO,1,0
243478,in,0,0
243479,order,0,0
243480,to,0,0
243481,find,0,0
243482,the,0,0
243483,minimum,0,0
243484,effective,0,0
243485,dose,0,1
243486,.,0,1
243487,MATERIALS,0,1
243488,AND,0,1
243489,METHODS,0,1
243490,Twenty,0,1
243491,anemic,0,0
243492,sideropenic,0,1
243493,patients,0,0
243494,(,0,0
243495,hemoglobin,0,1
243496,<,0,0
243497,/=110,0,0
243498,g/l,0,0
243499,;,0,0
243500,serum,0,1
243501,iron,0,1
243502,<,0,0
243503,600,0,0
243504,microg/l,0,0
243505,),0,0
243506,with,0,0
243507,cancer,0,0
243508,of,0,0
243509,the,0,0
243510,gastrointestinal,0,0
243511,tract,0,0
243512,were,0,0
243513,randomly,0,0
243514,allocated,0,0
243515,to,0,0
243516,two,0,0
243517,groups,0,0
243518,:,0,0
243519,the,0,0
243520,first,0,0
243521,(,0,0
243522,n,0,0
243523,=,0,0
243524,10,0,0
243525,),0,0
243526,received,0,0
243527,400,1,0
243528,U/kg,1,1
243529,of,1,0
243530,r-Hu,1,1
243531,EPO,1,0
243532,divided,1,0
243533,in,1,0
243534,4,1,1
243535,doses,1,1
243536,(,0,1
243537,100,0,1
243538,U/kg,0,1
243539,each,0,0
243540,",",0,1
243541,every,0,0
243542,4,0,1
243543,days,0,1
243544,),0,1
243545,;,0,1
243546,the,0,0
243547,second,0,0
243548,(,0,0
243549,n,0,0
243550,=,0,0
243551,10,0,0
243552,),0,0
243553,received,1,0
243554,200,1,0
243555,U/kg,1,1
243556,of,1,1
243557,r-HuEPO,1,1
243558,(,0,1
243559,50,0,0
243560,U/kg,0,1
243561,each,0,0
243562,",",0,1
243563,every,0,0
243564,4,0,1
243565,days,0,1
243566,),0,1
243567,.,0,1
243568,Both,0,0
243569,groups,0,0
243570,were,0,0
243571,given,0,1
243572,intravenous,1,1
243573,iron,1,1
243574,gluconate,1,1
243575,(,0,1
243576,125,0,1
243577,mg,0,1
243578,),0,1
243579,every,0,1
243580,day,0,1
243581,for,0,1
243582,15,0,0
243583,days,0,0
243584,.,0,0
243585,RESULTS,0,1
243586,After,0,0
243587,treatment,0,0
243588,",",0,0
243589,the,0,0
243590,serum,0,1
243591,iron,0,1
243592,level,0,0
243593,significantly,0,0
243594,rose,0,0
243595,in,0,0
243596,both,0,0
243597,groups,0,0
243598,.,0,0
243599,The,0,0
243600,production,0,0
243601,of,0,0
243602,new,0,0
243603,red,0,0
243604,blood,0,0
243605,cells,0,0
243606,was,0,0
243607,176.3+/-90.8,0,0
243608,ml,0,0
243609,in,0,0
243610,the,0,0
243611,200,0,0
243612,U/kg,0,1
243613,group,0,0
243614,and,0,0
243615,268.4+/-79.4,0,0
243616,ml,0,0
243617,in,0,0
243618,the,0,0
243619,400,0,0
243620,U/kg,0,1
243621,group,0,0
243622,(,0,0
243623,p,0,0
243624,=,0,0
243625,0.036,0,0
243626,),0,0
243627,.,0,0
243628,The,0,0
243629,increase,0,0
243630,of,0,0
243631,hemoglobin,0,1
243632,was,0,0
243633,significantly,0,0
243634,higher,0,0
243635,in,0,0
243636,the,0,0
243637,400,0,0
243638,U/kg,0,1
243639,group,0,0
243640,(,0,0
243641,22.3+/-2.0,0,0
243642,g/l,0,0
243643,),0,0
243644,than,0,0
243645,in,0,0
243646,the,0,0
243647,200,0,0
243648,U/kg,0,1
243649,group,0,0
243650,(,0,0
243651,14.1+/-2.7,0,0
243652,g/l,0,0
243653,),0,0
243654,(,0,0
243655,p,0,0
243656,=,0,0
243657,0.017,0,0
243658,),0,0
243659,.,0,0
243660,CONCLUSION,0,0
243661,The,0,0
243662,r-HuEPO,0,1
243663,dose,0,1
243664,of,0,1
243665,400,0,1
243666,U/kg,0,0
243667,appears,0,0
243668,significantly,0,0
243669,more,0,0
243670,effective,0,0
243671,than,0,0
243672,the,0,0
243673,200,0,0
243674,U/kg,0,1
243675,to,0,0
243676,stimulate,0,0
243677,erythropoiesis,0,1
243678,in,0,0
243679,anemic,0,1
243680,sideropenic,0,0
243681,cancer,0,0
243682,patients,0,0
243683,.,0,0
